id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
155266088|NCT01486758|560409003|FG000|Overall Study|Lost to Follow-up|0|||
155266089|NCT01486758|560409004|FG001|Overall Study|Lost to Follow-up|1|||
155266090|NCT01062763|560409005|FG000|Overall Study|Adverse Event|3|||
155266091|NCT01062763|560409006|FG001|Overall Study|Adverse Event|4|||
155266092|NCT02392611|560409007|FG000|Overall Study|Adverse Event|0|||
155266093|NCT02392611|560409008|FG001|Overall Study|Adverse Event|0|||
155266094|NCT02392611|560409009|FG002|Overall Study|Adverse Event|0|||
155266095|NCT02392611|560409010|FG003|Overall Study|Adverse Event|1|||
155266096|NCT02392611|560409011|FG004|Overall Study|Adverse Event|0|||
155266097|NCT02392611|560409012|FG005|Overall Study|Adverse Event|0|||
155266098|NCT02392611|560409013|FG006|Overall Study|Adverse Event|0|||
155266099|NCT02392611|560409014|FG007|Overall Study|Adverse Event|0|||
155266100|NCT02392611|560409015|FG008|Overall Study|Adverse Event|0|||
155266101|NCT02392611|560409007|FG000|Overall Study|Progressive disease|0|||
155266102|NCT02392611|560409008|FG001|Overall Study|Progressive disease|0|||
155266103|NCT02392611|560409009|FG002|Overall Study|Progressive disease|0|||
155266104|NCT02392611|560409010|FG003|Overall Study|Progressive disease|2|||
155266105|NCT02392611|560409011|FG004|Overall Study|Progressive disease|1|||
155266106|NCT02392611|560409012|FG005|Overall Study|Progressive disease|0|||
155266107|NCT02392611|560409013|FG006|Overall Study|Progressive disease|0|||
155266108|NCT02392611|560409014|FG007|Overall Study|Progressive disease|0|||
155266109|NCT02392611|560409015|FG008|Overall Study|Progressive disease|0|||
155266110|NCT02392611|560409007|FG000|Overall Study|Death|1|||
155266111|NCT02392611|560409008|FG001|Overall Study|Death|0|||
155266112|NCT02392611|560409009|FG002|Overall Study|Death|0|||
155266113|NCT02392611|560409010|FG003|Overall Study|Death|0|||
155266114|NCT02392611|560409011|FG004|Overall Study|Death|0|||
155266115|NCT02392611|560409012|FG005|Overall Study|Death|1|||
155266116|NCT02392611|560409013|FG006|Overall Study|Death|0|||
155266117|NCT02392611|560409014|FG007|Overall Study|Death|0|||
155266118|NCT02392611|560409015|FG008|Overall Study|Death|0|||
155266119|NCT02392611|560409007|FG000|Overall Study|Withdrawal by Subject|0|||
155266120|NCT02392611|560409008|FG001|Overall Study|Withdrawal by Subject|0|||
155266121|NCT02392611|560409009|FG002|Overall Study|Withdrawal by Subject|0|||
155266122|NCT02392611|560409010|FG003|Overall Study|Withdrawal by Subject|1|||
155266123|NCT02392611|560409011|FG004|Overall Study|Withdrawal by Subject|0|||
155266124|NCT02392611|560409012|FG005|Overall Study|Withdrawal by Subject|0|||
155266125|NCT02392611|560409013|FG006|Overall Study|Withdrawal by Subject|0|||
155266126|NCT02392611|560409014|FG007|Overall Study|Withdrawal by Subject|0|||
155266127|NCT02392611|560409015|FG008|Overall Study|Withdrawal by Subject|0|||
155266128|NCT02392611|560409007|FG000|Overall Study|Lost to Follow-up|0|||
155266129|NCT02392611|560409008|FG001|Overall Study|Lost to Follow-up|0|||
155266130|NCT02392611|560409009|FG002|Overall Study|Lost to Follow-up|0|||
155266131|NCT02392611|560409010|FG003|Overall Study|Lost to Follow-up|0|||
155266132|NCT02392611|560409011|FG004|Overall Study|Lost to Follow-up|0|||
155266133|NCT02392611|560409012|FG005|Overall Study|Lost to Follow-up|0|||
155266134|NCT02392611|560409013|FG006|Overall Study|Lost to Follow-up|1|||
155266135|NCT02392611|560409014|FG007|Overall Study|Lost to Follow-up|0|||
155266136|NCT02392611|560409015|FG008|Overall Study|Lost to Follow-up|0|||
155266137|NCT02392611|560409007|FG000|Overall Study|Enrolled, not treated|0|||
155266138|NCT02392611|560409008|FG001|Overall Study|Enrolled, not treated|0|||
155266139|NCT02392611|560409009|FG002|Overall Study|Enrolled, not treated|0|||
155266140|NCT02392611|560409010|FG003|Overall Study|Enrolled, not treated|2|||
155266141|NCT02392611|560409011|FG004|Overall Study|Enrolled, not treated|0|||
155266142|NCT02392611|560409012|FG005|Overall Study|Enrolled, not treated|0|||
155266143|NCT02392611|560409013|FG006|Overall Study|Enrolled, not treated|0|||
155266144|NCT02392611|560409014|FG007|Overall Study|Enrolled, not treated|0|||
155266145|NCT02392611|560409015|FG008|Overall Study|Enrolled, not treated|0|||
155266146|NCT03239873|560409019|FG000|Overall Study|Lost to Follow-up|15|||
155266147|NCT03239873|560409020|FG001|Overall Study|Lost to Follow-up|16|||
155266148|NCT03239873|560409019|FG000|Overall Study|Physician Decision|1|||
155266149|NCT03239873|560409020|FG001|Overall Study|Physician Decision|0|||
155266150|NCT03239873|560409019|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
155266151|NCT03239873|560409020|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
155266152|NCT03239873|560409019|FG000|Overall Study|Withdrawal by Subject|2|||
155266153|NCT03239873|560409020|FG001|Overall Study|Withdrawal by Subject|0|||
155266154|NCT03239873|560409019|FG000|Overall Study|Contraindication to study medication|1|||
155266155|NCT03239873|560409020|FG001|Overall Study|Contraindication to study medication|0|||
155266156|NCT03239873|560409019|FG000|Overall Study|Protocol Violation|1|||
155266157|NCT03239873|560409020|FG001|Overall Study|Protocol Violation|0|||
155266158|NCT02291432|560409025|FG000|Overall Study|Withdrawal by Subject|2|||
155266159|NCT02145078|560409028|FG000|Overall Study|Death|1|||
155266160|NCT02145078|560409028|FG000|Overall Study|Reason not given|3|||
155266161|NCT00519896|560409029|FG000|Overall Study|Protocol Violation|1|||
155266162|NCT00519896|560409029|FG000|Overall Study|Adverse Event|1|||
155266163|NCT00810082|560409030|FG000|Overall Study|Lost to Follow-up|0|||
155266164|NCT00810082|560409031|FG001|Overall Study|Lost to Follow-up|4|||
155266165|NCT03327402|560409032|FG000|Overall Study|Withdrawal by Subject|1|||
155266166|NCT03327402|560409032|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
155266167|NCT01454830|560409035|FG000|Overall Study|Withdrawal by Subject|4|||
155266168|NCT01454830|560409036|FG001|Overall Study|Withdrawal by Subject|4|||
155266169|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
155266170|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
155266171|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
155266172|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
155266173|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
155266174|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
155266175|NCT01454830|560409035|FG000|Overall Study|Withdrawal - no polysomnography|3|||
155266176|NCT01454830|560409036|FG001|Overall Study|Withdrawal - no polysomnography|2|||
155266177|NCT00584805|560409037|FG000|Overall Study|No longer at risk of exposure|39|||
155266178|NCT00584805|560409037|FG000|Overall Study|Relocation|36|||
155266179|NCT00584805|560409037|FG000|Overall Study|Withdrawal by Subject|18|||
155266180|NCT00584805|560409037|FG000|Overall Study|Non-compliance|1|||
155266181|NCT00584805|560409037|FG000|Overall Study|Lost to follow up|3|||
155266182|NCT00584805|560409037|FG000|Overall Study|Screen failures|2|||
155266183|NCT01077362|560409038|FG000|Overall Study|Lack of Efficacy|13|||
155266184|NCT01077362|560409039|FG001|Overall Study|Lack of Efficacy|8|||
155266185|NCT01077362|560409040|FG002|Overall Study|Lack of Efficacy|10|||
155266186|NCT01077362|560409038|FG000|Overall Study|Lost to Follow-up|1|||
155266187|NCT01077362|560409039|FG001|Overall Study|Lost to Follow-up|0|||
155266188|NCT01077362|560409040|FG002|Overall Study|Lost to Follow-up|3|||
155266189|NCT01077362|560409038|FG000|Overall Study|Adverse Event|12|||
155266190|NCT01077362|560409039|FG001|Overall Study|Adverse Event|7|||
155266191|NCT01077362|560409040|FG002|Overall Study|Adverse Event|4|||
155266192|NCT01077362|560409038|FG000|Overall Study|Withdrawal by Subject|5|||
155266193|NCT01077362|560409039|FG001|Overall Study|Withdrawal by Subject|3|||
155266194|NCT01077362|560409040|FG002|Overall Study|Withdrawal by Subject|5|||
155266195|NCT01077362|560409038|FG000|Overall Study|Other|0|||
155266196|NCT01077362|560409039|FG001|Overall Study|Other|1|||
155266197|NCT01077362|560409040|FG002|Overall Study|Other|2|||
155266198|NCT00301080|560409041|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
155266199|NCT00301080|560409042|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266200|NCT00301080|560409043|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266201|NCT00301080|560409044|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266202|NCT00301080|560409045|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266203|NCT03097861|560409046|FG000|Overall Study|Adverse Event|3|||
155266204|NCT03097861|560409047|FG001|Overall Study|Adverse Event|8|||
155266205|NCT03097861|560409048|FG002|Overall Study|Adverse Event|4|||
155266206|NCT03097861|560409046|FG000|Overall Study|Investigator Decision|0|||
155266207|NCT03097861|560409047|FG001|Overall Study|Investigator Decision|1|||
155266208|NCT03097861|560409048|FG002|Overall Study|Investigator Decision|0|||
155266209|NCT03097861|560409046|FG000|Overall Study|Lost to Follow-up|0|||
155266210|NCT03097861|560409047|FG001|Overall Study|Lost to Follow-up|7|||
155721393|NCT03414983|562080029|FG000|Pre-Treatment|Other reasons|1|||
155721394|NCT03414983|562080030|FG001|Pre-Treatment|Other reasons|0|||
155721395|NCT03414983|562080029|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155721396|NCT03414983|562080030|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
155721397|NCT03414983|562080029|FG000|Pre-Treatment|Participant withdrew consent|1|||
155721398|NCT03414983|562080030|FG001|Pre-Treatment|Participant withdrew consent|3|||
155721399|NCT03414983|562080029|FG000|Treatment|Participant withdrew consent|4|||
155266211|NCT03097861|560409048|FG002|Overall Study|Lost to Follow-up|1|||
155266212|NCT03097861|560409046|FG000|Overall Study|Withdrawal by Subject|1|||
155266213|NCT03097861|560409047|FG001|Overall Study|Withdrawal by Subject|5|||
155266214|NCT03097861|560409048|FG002|Overall Study|Withdrawal by Subject|3|||
155266215|NCT03097861|560409046|FG000|Overall Study|Reason not provided|3|||
155266216|NCT03097861|560409047|FG001|Overall Study|Reason not provided|1|||
155266217|NCT03097861|560409048|FG002|Overall Study|Reason not provided|1|||
155266218|NCT03502616|560409049|FG000|Up to Week 16|Withdrawal by Subject|1|||
155493319|NCT00457249|561231378|FG000|Overall Study|Lost to Follow-up|3|||
155493320|NCT00457249|561231379|FG001|Overall Study|Lost to Follow-up|0|||
155493321|NCT00457249|561231378|FG000|Overall Study|Protocol Violation|4|||
155493322|NCT00457249|561231379|FG001|Overall Study|Protocol Violation|1|||
155266219|NCT03502616|560409050|FG001|Up to Week 16|Withdrawal by Subject|2|||
155266220|NCT03502616|560409049|FG000|Up to Week 16|Lost to Follow-up|0|||
155266221|NCT03502616|560409050|FG001|Up to Week 16|Lost to Follow-up|1|||
155493323|NCT00457249|561231378|FG000|Overall Study|Withdrawal by Subject|3|||
155721400|NCT03414983|562080030|FG001|Treatment|Participant withdrew consent|3|||
155721401|NCT03414983|562080029|FG000|Treatment|Participant request to discontinue study treatment|8|||
155721402|NCT03414983|562080030|FG001|Treatment|Participant request to discontinue study treatment|10|||
155721403|NCT03414983|562080029|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
155266222|NCT03502616|560409049|FG000|Up to Week 16|Randomized, but not treated|1|||
155266223|NCT03502616|560409050|FG001|Up to Week 16|Randomized, but not treated|0|||
155266224|NCT03502616|560409049|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
155266225|NCT03502616|560409050|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
155266226|NCT03502616|560409049|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
155266227|NCT03502616|560409050|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
155266228|NCT01785563|560409052|FG000|Overall Study|Physician Decision|10|||
155266229|NCT01785563|560409052|FG000|Overall Study|Withdrawal by Subject|1|||
155266230|NCT01785563|560409052|FG000|Overall Study|Protocol Violation|2|||
155266231|NCT01616771|560409055|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
155266232|NCT00744328|560409056|FG000|Overall Study|Lost to Follow-up|2|||
155266233|NCT00744328|560409057|FG001|Overall Study|Lost to Follow-up|5|||
155721404|NCT03414983|562080030|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
155721405|NCT03414983|562080029|FG000|Treatment|Death|0|||
155721406|NCT03414983|562080030|FG001|Treatment|Death|1|||
155721407|NCT03414983|562080029|FG000|Treatment|Study Drug Toxicity|10|||
155721408|NCT03414983|562080030|FG001|Treatment|Study Drug Toxicity|5|||
155721409|NCT03414983|562080029|FG000|Treatment|Disease Progression|75|||
155721410|NCT03414983|562080030|FG001|Treatment|Disease Progression|29|||
155721411|NCT03414983|562080029|FG000|Treatment|Not reported|1|||
155721412|NCT03414983|562080030|FG001|Treatment|Not reported|0|||
155721413|NCT03414983|562080029|FG000|Treatment|Other reasons|3|||
155721414|NCT03414983|562080030|FG001|Treatment|Other reasons|2|||
155721415|NCT03414983|562080029|FG000|Treatment|Poor/non-compliance|2|||
155721416|NCT03414983|562080030|FG001|Treatment|Poor/non-compliance|0|||
155721417|NCT03414983|562080029|FG000|Treatment|Maximum clinical benefit|5|||
155721418|NCT03414983|562080030|FG001|Treatment|Maximum clinical benefit|9|||
155721419|NCT03414983|562080029|FG000|Treatment|Lost to Follow-up|0|||
155721420|NCT03414983|562080030|FG001|Treatment|Lost to Follow-up|1|||
155721421|NCT03414983|562080029|FG000|Treatment|Administrative reasons by sponsor|1|||
155721422|NCT03414983|562080030|FG001|Treatment|Administrative reasons by sponsor|0|||
155721423|NCT02608684|562080031|FG000|Overall Study|Physician Decision|2|||
155721424|NCT02608684|562080031|FG000|Overall Study|Withdrawal by Subject|1|||
155721425|NCT01910298|562080032|FG000|Overall Study|Adverse Event|1|||
155721426|NCT01910298|562080033|FG001|Overall Study|Adverse Event|0|||
155721427|NCT01910298|562080032|FG000|Overall Study|Withdrawal by Subject|2|||
155721428|NCT01910298|562080033|FG001|Overall Study|Withdrawal by Subject|7|||
155721429|NCT01910298|562080032|FG000|Overall Study|Protocol Deviation|0|||
155721430|NCT01910298|562080033|FG001|Overall Study|Protocol Deviation|5|||
155721431|NCT01910298|562080032|FG000|Overall Study|Lost to Follow-up|1|||
155721432|NCT01910298|562080033|FG001|Overall Study|Lost to Follow-up|1|||
155721433|NCT01910298|562080032|FG000|Overall Study|Study Terminated by Sponsor|1|||
155721434|NCT01910298|562080033|FG001|Overall Study|Study Terminated by Sponsor|17|||
155721435|NCT01910298|562080032|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155721436|NCT01910298|562080033|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155721437|NCT01775501|562080034|FG000|Overall Study|Discontinued prior to treatment|1|||
155721438|NCT03037385|562080035|FG000|Overall Study|Adverse Event|0|||
155721439|NCT03037385|562080036|FG001|Overall Study|Adverse Event|0|||
155721440|NCT03037385|562080037|FG002|Overall Study|Adverse Event|1|||
155721441|NCT03037385|562080038|FG003|Overall Study|Adverse Event|0|||
155721442|NCT03037385|562080039|FG004|Overall Study|Adverse Event|0|||
155721443|NCT03037385|562080040|FG005|Overall Study|Adverse Event|0|||
155721444|NCT03037385|562080041|FG006|Overall Study|Adverse Event|0|||
155721445|NCT03037385|562080042|FG007|Overall Study|Adverse Event|0|||
155721446|NCT03037385|562080043|FG008|Overall Study|Adverse Event|0|||
155721447|NCT03037385|562080044|FG009|Overall Study|Adverse Event|6|||
155721448|NCT03037385|562080035|FG000|Overall Study|Death|1|||
155721449|NCT03037385|562080036|FG001|Overall Study|Death|4|||
155721450|NCT03037385|562080037|FG002|Overall Study|Death|2|||
155721451|NCT03037385|562080038|FG003|Overall Study|Death|2|||
155721452|NCT03037385|562080039|FG004|Overall Study|Death|5|||
155721453|NCT03037385|562080040|FG005|Overall Study|Death|2|||
155721454|NCT03037385|562080041|FG006|Overall Study|Death|1|||
155721455|NCT03037385|562080042|FG007|Overall Study|Death|4|||
155721456|NCT03037385|562080043|FG008|Overall Study|Death|3|||
155721457|NCT03037385|562080044|FG009|Overall Study|Death|240|||
155266234|NCT00744328|560409058|FG002|Overall Study|Lost to Follow-up|3|||
155266235|NCT00744328|560409056|FG000|Overall Study|Withdrawal by Subject|5|||
155266236|NCT00744328|560409057|FG001|Overall Study|Withdrawal by Subject|3|||
155721458|NCT03037385|562080035|FG000|Overall Study|Initiation of Another Therapy|1|||
155721459|NCT03037385|562080036|FG001|Overall Study|Initiation of Another Therapy|0|||
155721460|NCT03037385|562080037|FG002|Overall Study|Initiation of Another Therapy|0|||
155721461|NCT03037385|562080038|FG003|Overall Study|Initiation of Another Therapy|0|||
155721462|NCT03037385|562080039|FG004|Overall Study|Initiation of Another Therapy|0|||
155721463|NCT03037385|562080040|FG005|Overall Study|Initiation of Another Therapy|0|||
155721464|NCT03037385|562080041|FG006|Overall Study|Initiation of Another Therapy|0|||
155721465|NCT03037385|562080042|FG007|Overall Study|Initiation of Another Therapy|1|||
155721466|NCT03037385|562080043|FG008|Overall Study|Initiation of Another Therapy|0|||
155266237|NCT00744328|560409058|FG002|Overall Study|Withdrawal by Subject|4|||
155266238|NCT00744328|560409056|FG000|Overall Study|Found ineligible after randomization|0|||
155721467|NCT03037385|562080044|FG009|Overall Study|Initiation of Another Therapy|2|||
155721468|NCT03037385|562080035|FG000|Overall Study|Lost to Follow-up|0|||
155721469|NCT03037385|562080036|FG001|Overall Study|Lost to Follow-up|0|||
155721470|NCT03037385|562080037|FG002|Overall Study|Lost to Follow-up|0|||
155721471|NCT03037385|562080038|FG003|Overall Study|Lost to Follow-up|0|||
155266239|NCT00744328|560409057|FG001|Overall Study|Found ineligible after randomization|0|||
155266240|NCT00744328|560409058|FG002|Overall Study|Found ineligible after randomization|1|||
155721472|NCT03037385|562080039|FG004|Overall Study|Lost to Follow-up|0|||
155721473|NCT03037385|562080040|FG005|Overall Study|Lost to Follow-up|1|||
155721474|NCT03037385|562080041|FG006|Overall Study|Lost to Follow-up|0|||
155721475|NCT03037385|562080042|FG007|Overall Study|Lost to Follow-up|0|||
155721476|NCT03037385|562080043|FG008|Overall Study|Lost to Follow-up|0|||
155721477|NCT03037385|562080044|FG009|Overall Study|Lost to Follow-up|16|||
155721478|NCT03037385|562080035|FG000|Overall Study|Physician Decision|0|||
155721479|NCT03037385|562080036|FG001|Overall Study|Physician Decision|0|||
155721480|NCT03037385|562080037|FG002|Overall Study|Physician Decision|0|||
155721481|NCT03037385|562080038|FG003|Overall Study|Physician Decision|0|||
155721482|NCT03037385|562080039|FG004|Overall Study|Physician Decision|0|||
155721483|NCT03037385|562080040|FG005|Overall Study|Physician Decision|0|||
155721484|NCT03037385|562080041|FG006|Overall Study|Physician Decision|0|||
155721485|NCT03037385|562080042|FG007|Overall Study|Physician Decision|0|||
155721486|NCT03037385|562080043|FG008|Overall Study|Physician Decision|0|||
155721487|NCT03037385|562080044|FG009|Overall Study|Physician Decision|1|||
155721488|NCT03037385|562080035|FG000|Overall Study|Progressive Disease|0|||
155721489|NCT03037385|562080036|FG001|Overall Study|Progressive Disease|1|||
155721490|NCT03037385|562080037|FG002|Overall Study|Progressive Disease|1|||
155721491|NCT03037385|562080038|FG003|Overall Study|Progressive Disease|5|||
155721492|NCT03037385|562080039|FG004|Overall Study|Progressive Disease|2|||
155721493|NCT03037385|562080040|FG005|Overall Study|Progressive Disease|0|||
155721494|NCT03037385|562080041|FG006|Overall Study|Progressive Disease|1|||
155721495|NCT03037385|562080042|FG007|Overall Study|Progressive Disease|0|||
155721496|NCT03037385|562080043|FG008|Overall Study|Progressive Disease|0|||
155721497|NCT03037385|562080044|FG009|Overall Study|Progressive Disease|30|||
155721498|NCT03037385|562080035|FG000|Overall Study|Withdrawal by Subject|0|||
155721499|NCT03037385|562080036|FG001|Overall Study|Withdrawal by Subject|0|||
155721500|NCT03037385|562080037|FG002|Overall Study|Withdrawal by Subject|1|||
155721501|NCT03037385|562080038|FG003|Overall Study|Withdrawal by Subject|2|||
155721502|NCT03037385|562080039|FG004|Overall Study|Withdrawal by Subject|1|||
155721503|NCT03037385|562080040|FG005|Overall Study|Withdrawal by Subject|3|||
155721504|NCT03037385|562080041|FG006|Overall Study|Withdrawal by Subject|0|||
155721505|NCT03037385|562080042|FG007|Overall Study|Withdrawal by Subject|0|||
155721506|NCT03037385|562080043|FG008|Overall Study|Withdrawal by Subject|0|||
155721507|NCT03037385|562080044|FG009|Overall Study|Withdrawal by Subject|52|||
155721508|NCT03037385|562080035|FG000|Overall Study|Reason Not Specified|0|||
155721509|NCT03037385|562080036|FG001|Overall Study|Reason Not Specified|1|||
155266241|NCT04399356|560409062|FG000|Overall Study|Lost to Follow-up|1|||
155266242|NCT04399356|560409063|FG001|Overall Study|Lost to Follow-up|1|||
155266243|NCT04399356|560409062|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
155266244|NCT04399356|560409063|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
155266245|NCT04399356|560409062|FG000|Overall Study|Withdrawal by Subject|1|||
155266246|NCT04399356|560409063|FG001|Overall Study|Withdrawal by Subject|0|||
155266247|NCT02091739|560409064|FG000|MP: 16 Weeks|Adverse Event|1|||
155266248|NCT02091739|560409065|FG001|MP: 16 Weeks|Adverse Event|1|||
155266249|NCT02091739|560409066|FG002|MP: 16 Weeks|Adverse Event|1|||
155266250|NCT02091739|560409067|FG003|MP: 16 Weeks|Adverse Event|0|||
155266251|NCT02091739|560409068|FG004|MP: 16 Weeks|Adverse Event|0|||
155266252|NCT02091739|560409064|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
155266253|NCT02091739|560409065|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
155266254|NCT02091739|560409066|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
155266255|NCT02091739|560409067|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
155266256|NCT02091739|560409068|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
155266257|NCT02091739|560409064|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
155607363|NCT02913105|561651528|FG000|Overall Study|Adverse Event|11|||
155607364|NCT02913105|561651529|FG001|Overall Study|Adverse Event|0|||
155607365|NCT02913105|561651530|FG002|Overall Study|Adverse Event|4|||
155607366|NCT02913105|561651528|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155607367|NCT02913105|561651529|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155607368|NCT02913105|561651530|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155607369|NCT02913105|561651528|FG000|Overall Study|Reason Not Specified|3|||
155650545|NCT00147537|561812504|FG002|Phase 2|Lost to Follow-up|0|||
155721510|NCT03037385|562080037|FG002|Overall Study|Reason Not Specified|0|||
155721511|NCT03037385|562080038|FG003|Overall Study|Reason Not Specified|4|||
155721512|NCT03037385|562080039|FG004|Overall Study|Reason Not Specified|3|||
155721513|NCT03037385|562080040|FG005|Overall Study|Reason Not Specified|6|||
155721514|NCT03037385|562080041|FG006|Overall Study|Reason Not Specified|2|||
155721515|NCT03037385|562080042|FG007|Overall Study|Reason Not Specified|0|||
155721516|NCT03037385|562080043|FG008|Overall Study|Reason Not Specified|1|||
155721517|NCT03037385|562080044|FG009|Overall Study|Reason Not Specified|181|||
155721518|NCT03007966|562080048|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
155266258|NCT02091739|560409065|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
155266259|NCT02091739|560409066|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
155721519|NCT03007966|562080049|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
155721520|NCT00474487|562080053|FG000|Overall Study|Withdrawal by Subject|6|||
155721521|NCT00474487|562080054|FG001|Overall Study|Withdrawal by Subject|0|||
155721522|NCT00474487|562080055|FG002|Overall Study|Withdrawal by Subject|0|||
155721523|NCT00474487|562080056|FG003|Overall Study|Withdrawal by Subject|0|||
155721524|NCT00474487|562080053|FG000|Overall Study|Lost to Follow-up|20|||
155721525|NCT00474487|562080054|FG001|Overall Study|Lost to Follow-up|1|||
155721526|NCT00474487|562080055|FG002|Overall Study|Lost to Follow-up|7|||
155721527|NCT00474487|562080056|FG003|Overall Study|Lost to Follow-up|0|||
155721528|NCT00474487|562080053|FG000|Overall Study|Inappropriate enrollment|4|||
155721529|NCT00474487|562080054|FG001|Overall Study|Inappropriate enrollment|0|||
155721530|NCT00474487|562080055|FG002|Overall Study|Inappropriate enrollment|7|||
155721531|NCT00474487|562080056|FG003|Overall Study|Inappropriate enrollment|0|||
155721532|NCT00474487|562080053|FG000|Overall Study|Death|0|||
155721533|NCT00474487|562080054|FG001|Overall Study|Death|1|||
155721534|NCT00474487|562080055|FG002|Overall Study|Death|0|||
155721535|NCT00474487|562080056|FG003|Overall Study|Death|0|||
155721536|NCT00419393|562080057|FG000|Overall Study|Adverse Event|5|||
155721537|NCT00419393|562080057|FG000|Overall Study|Protocol Violation|5|||
155721538|NCT00419393|562080057|FG000|Overall Study|Withdrawal by Subject|7|||
155721539|NCT00419393|562080057|FG000|Overall Study|Other: Sponsor request|3|||
155721540|NCT00419393|562080057|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
155721541|NCT00419393|562080057|FG000|Overall Study|Other: Site closure|1|||
155721542|NCT00419393|562080057|FG000|Overall Study|Other: Other health problems|1|||
155721543|NCT00419393|562080057|FG000|Overall Study|Other: Investigator decision|1|||
155721544|NCT02220920|562080058|FG000|Overall Study|Adverse Event|1|||
155721545|NCT02220920|562080059|FG001|Overall Study|Adverse Event|0|||
155721546|NCT02220920|562080058|FG000|Overall Study|Lack of Efficacy|0|||
155721547|NCT02220920|562080059|FG001|Overall Study|Lack of Efficacy|1|||
155721548|NCT02220920|562080058|FG000|Overall Study|Withdrawal by Subject|1|||
155721549|NCT02220920|562080059|FG001|Overall Study|Withdrawal by Subject|0|||
155721550|NCT02220920|562080058|FG000|Overall Study|Conflict with the stopping criteria|1|||
155721551|NCT02220920|562080059|FG001|Overall Study|Conflict with the stopping criteria|2|||
155721552|NCT05176314|562080062|FG000|Overall Study|Lost to Follow-up|2|||
155721553|NCT05176314|562080062|FG000|Overall Study|Physician Decision|1|||
155721554|NCT05176314|562080062|FG000|Overall Study|Adverse Event|1|||
155721555|NCT05543265|562080065|FG000|Overall Study|Lost to Follow-up|3|||
155721556|NCT05543265|562080066|FG001|Overall Study|Lost to Follow-up|3|||
155721557|NCT05543265|562080065|FG000|Overall Study|Withdrawal by Subject|0|||
155721558|NCT05543265|562080066|FG001|Overall Study|Withdrawal by Subject|1|||
155721559|NCT05316597|562080067|FG000|First Session|Withdrawal by Subject|0|||
155721560|NCT05316597|562080068|FG001|First Session|Withdrawal by Subject|1|||
155721561|NCT05316597|562080067|FG000|Washout Period|Lost to Follow-up|1|||
155721562|NCT05316597|562080068|FG001|Washout Period|Lost to Follow-up|2|||
155721563|NCT05316597|562080067|FG000|Washout Period|Physician Decision|1|||
155721564|NCT05316597|562080068|FG001|Washout Period|Physician Decision|1|||
155721565|NCT05316597|562080067|FG000|Washout Period|Excluded before second session|1|||
155721566|NCT05316597|562080068|FG001|Washout Period|Excluded before second session|1|||
155266260|NCT02091739|560409067|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
155607370|NCT02913105|561651529|FG001|Overall Study|Reason Not Specified|1|||
155266261|NCT02091739|560409068|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
155266262|NCT02091739|560409064|FG000|EP: 48 Weeks|Other|0|||
155266263|NCT02091739|560409065|FG001|EP: 48 Weeks|Other|0|||
155266264|NCT02091739|560409066|FG002|EP: 48 Weeks|Other|0|||
155266265|NCT02091739|560409067|FG003|EP: 48 Weeks|Other|1|||
155266266|NCT02091739|560409068|FG004|EP: 48 Weeks|Other|0|||
155266267|NCT02091739|560409064|FG000|EP: 48 Weeks|Death|0|||
155266268|NCT02091739|560409065|FG001|EP: 48 Weeks|Death|0|||
155266269|NCT02091739|560409066|FG002|EP: 48 Weeks|Death|0|||
155266270|NCT02091739|560409067|FG003|EP: 48 Weeks|Death|3|||
155266271|NCT02091739|560409068|FG004|EP: 48 Weeks|Death|2|||
155266272|NCT02091739|560409064|FG000|EP: 48 Weeks|Adverse Event|0|||
155266273|NCT02091739|560409065|FG001|EP: 48 Weeks|Adverse Event|0|||
155266274|NCT02091739|560409066|FG002|EP: 48 Weeks|Adverse Event|0|||
155266275|NCT02091739|560409067|FG003|EP: 48 Weeks|Adverse Event|2|||
155607371|NCT02913105|561651530|FG002|Overall Study|Reason Not Specified|1|||
155607372|NCT02913105|561651528|FG000|Overall Study|Physician Decision|1|||
155721567|NCT05316597|562080067|FG000|Washout Period|Withdrawal by Subject|0|||
155721568|NCT05316597|562080068|FG001|Washout Period|Withdrawal by Subject|4|||
155721569|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
155721570|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
155721571|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
155266276|NCT02091739|560409068|FG004|EP: 48 Weeks|Adverse Event|6|||
155266277|NCT02091739|560409064|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
155266278|NCT02091739|560409065|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
155721572|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Death|9|||
155721573|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Death|0|||
155721574|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Death|0|||
155266279|NCT02091739|560409066|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
155721575|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
155721576|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155721577|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155721578|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
155721579|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
155721580|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
155721581|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Other|135|||
155721582|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Other|0|||
155721583|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Other|0|||
155721584|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
155266280|NCT02091739|560409067|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
155266281|NCT02091739|560409068|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
155266282|NCT00130793|560409082|FG000|Overall Study|Lost to Follow-up|1|||
155266283|NCT00130793|560409083|FG001|Overall Study|Lost to Follow-up|4|||
155266284|NCT00130793|560409082|FG000|Overall Study|Withdrew consent|2|||
155266285|NCT00130793|560409083|FG001|Overall Study|Withdrew consent|0|||
155266286|NCT00211237|560409084|FG000|Baseline|Withdrew|1|||
155266287|NCT00211237|560409085|FG001|Baseline|Withdrew|3|||
155266288|NCT00211237|560409086|FG002|Baseline|Withdrew|0|||
155266289|NCT00211237|560409084|FG000|Baseline|Refused random assignment|1|||
155266290|NCT00211237|560409085|FG001|Baseline|Refused random assignment|0|||
155266291|NCT00211237|560409086|FG002|Baseline|Refused random assignment|0|||
155266292|NCT00211237|560409084|FG000|1 Month|Death|2|||
155266293|NCT00211237|560409085|FG001|1 Month|Death|1|||
155266294|NCT00211237|560409086|FG002|1 Month|Death|0|||
155266295|NCT00211237|560409084|FG000|1 Month|Lost to Follow-up|0|||
155266296|NCT00211237|560409085|FG001|1 Month|Lost to Follow-up|2|||
155721585|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
155721586|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
155721587|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
155721588|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
155721589|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
155721590|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
155721591|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
155721592|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
155721593|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Other|3|||
155721594|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Other|0|||
155721595|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Other|0|||
155721596|NCT02118584|562080069|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
155721597|NCT02118584|562080070|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155721598|NCT02118584|562080071|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155266297|NCT00211237|560409086|FG002|1 Month|Lost to Follow-up|0|||
155721599|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155721600|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
155721601|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155721602|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
155721603|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
155721604|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
155721605|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
155721606|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
155721607|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
155721608|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155721609|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155721610|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
155721611|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155721612|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
155721613|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155721614|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
155721615|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
155721616|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
155721617|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155721618|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
155721619|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155721620|NCT02118584|562080069|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
155266298|NCT00211237|560409084|FG000|1 Month|Withdrew|0|||
155266299|NCT00211237|560409085|FG001|1 Month|Withdrew|4|||
155266300|NCT00211237|560409086|FG002|1 Month|Withdrew|0|||
155266301|NCT00211237|560409084|FG000|1 Month|Additional surgery needed|1|||
155266302|NCT00211237|560409085|FG001|1 Month|Additional surgery needed|0|||
155266303|NCT00211237|560409086|FG002|1 Month|Additional surgery needed|0|||
155721621|NCT02118584|562080070|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
155721622|NCT02118584|562080071|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
155721623|NCT02939287|562080077|FG000|Overall Study|met exclusion criteria|1|||
155721624|NCT02939287|562080078|FG001|Overall Study|met exclusion criteria|1|||
155721625|NCT02939287|562080079|FG002|Overall Study|met exclusion criteria|1|||
155721626|NCT02939287|562080077|FG000|Overall Study|Did not complete survey|2|||
155721627|NCT02939287|562080078|FG001|Overall Study|Did not complete survey|2|||
155721628|NCT02939287|562080079|FG002|Overall Study|Did not complete survey|0|||
155721629|NCT02939287|562080077|FG000|Overall Study|Withdrawal by Subject|1|||
155721630|NCT02939287|562080078|FG001|Overall Study|Withdrawal by Subject|1|||
155721631|NCT02939287|562080079|FG002|Overall Study|Withdrawal by Subject|0|||
155721632|NCT02927301|562080080|FG000|Overall Study|Death|39|||
155721633|NCT02927301|562080080|FG000|Overall Study|Lost to Follow-up|8|||
155721634|NCT02927301|562080080|FG000|Overall Study|Physician Decision|2|||
155721635|NCT02927301|562080080|FG000|Overall Study|Withdrawal by Subject|12|||
155721636|NCT02927301|562080080|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
155721637|NCT02218372|562080081|FG000|Overall Study|Adverse Event|1|||
155721638|NCT02218372|562080082|FG001|Overall Study|Adverse Event|1|||
155721639|NCT02218372|562080081|FG000|Overall Study|Miscellaneous|2|||
155721640|NCT02218372|562080082|FG001|Overall Study|Miscellaneous|1|||
155721641|NCT02218372|562080081|FG000|Overall Study|Randomized but did not receive treatment|2|||
155721642|NCT02218372|562080082|FG001|Overall Study|Randomized but did not receive treatment|3|||
155721643|NCT02218372|562080081|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155721644|NCT02218372|562080082|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155721645|NCT03406780|562080087|FG000|Overall Study|Withdrawal by Subject|1|||
155721646|NCT03406780|562080088|FG001|Overall Study|Withdrawal by Subject|1|||
155721647|NCT03406780|562080087|FG000|Overall Study|Other|0|||
155721648|NCT03406780|562080088|FG001|Overall Study|Other|2|||
155721649|NCT01488045|562080090|FG000|Overall Study|Withdrawal by Subject|6|||
155721650|NCT01488045|562080091|FG001|Overall Study|Withdrawal by Subject|11|||
155721651|NCT01488045|562080090|FG000|Overall Study|Failure to present for colonoscopy|3|||
155721652|NCT01488045|562080091|FG001|Overall Study|Failure to present for colonoscopy|6|||
155721653|NCT01488045|562080090|FG000|Overall Study|Failure to report exclusion criteria|0|||
155721654|NCT01488045|562080091|FG001|Overall Study|Failure to report exclusion criteria|1|||
155721655|NCT00333775|562080093|FG000|Overall Study|Death|144|||
155721656|NCT00333775|562080094|FG001|Overall Study|Death|149|||
155721657|NCT00333775|562080095|FG002|Overall Study|Death|143|||
155721658|NCT00333775|562080093|FG000|Overall Study|In Follow-up When Study Stopped|87|||
155721659|NCT00333775|562080094|FG001|Overall Study|In Follow-up When Study Stopped|92|||
155721660|NCT00333775|562080095|FG002|Overall Study|In Follow-up When Study Stopped|96|||
155721661|NCT00333775|562080093|FG000|Overall Study|Lost to Follow-up|10|||
155721662|NCT00333775|562080094|FG001|Overall Study|Lost to Follow-up|7|||
155721663|NCT00333775|562080095|FG002|Overall Study|Lost to Follow-up|8|||
155721664|NCT02476617|562080096|FG000|Overall Study|Adverse Event|1|||
155721665|NCT02476617|562080096|FG000|Overall Study|Lost to Follow-up|1|||
155721666|NCT01383928|562080097|FG000|Overall Study|Initiation of ASCT|2|||
155721667|NCT01383928|562080098|FG001|Overall Study|Initiation of ASCT|1|||
155721668|NCT01383928|562080099|FG002|Overall Study|Initiation of ASCT|18|||
155721669|NCT01383928|562080097|FG000|Overall Study|Adverse Event|1|||
155721670|NCT01383928|562080098|FG001|Overall Study|Adverse Event|2|||
155721671|NCT01383928|562080099|FG002|Overall Study|Adverse Event|8|||
155721672|NCT01383928|562080097|FG000|Overall Study|Other|1|||
155721673|NCT01383928|562080098|FG001|Overall Study|Other|3|||
155721674|NCT01383928|562080099|FG002|Overall Study|Other|4|||
155721675|NCT01383928|562080097|FG000|Overall Study|Progressive Disease|1|||
155721676|NCT01383928|562080098|FG001|Overall Study|Progressive Disease|1|||
155721677|NCT01383928|562080099|FG002|Overall Study|Progressive Disease|5|||
155721678|NCT01383928|562080097|FG000|Overall Study|Withdrawal by Subject|0|||
155721679|NCT01383928|562080098|FG001|Overall Study|Withdrawal by Subject|0|||
155721680|NCT01383928|562080099|FG002|Overall Study|Withdrawal by Subject|4|||
155721681|NCT01383928|562080097|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
155721682|NCT01383928|562080098|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155721683|NCT01383928|562080099|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
155721684|NCT02491684|562080100|FG000|Treatment Phase|Adverse Event|2|||
155721685|NCT02491684|562080101|FG001|Treatment Phase|Adverse Event|2|||
155721686|NCT02491684|562080100|FG000|Treatment Phase|Incorrect randomisation|1|||
155721687|NCT02491684|562080101|FG001|Treatment Phase|Incorrect randomisation|0|||
155721688|NCT02491684|562080100|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
155721689|NCT02491684|562080101|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
155721690|NCT01149096|562080102|FG000|Overall Study|Lost to Follow-up|0|||
155721691|NCT01149096|562080103|FG001|Overall Study|Lost to Follow-up|1|||
155721692|NCT04739982|562080105|FG000|Overall Study|Lost to Follow-up|176|||
155721693|NCT04739982|562080106|FG001|Overall Study|Lost to Follow-up|65|||
155721694|NCT04739982|562080105|FG000|Overall Study|Withdrawal by Subject|19|||
155721695|NCT04739982|562080106|FG001|Overall Study|Withdrawal by Subject|0|||
155721696|NCT04739982|562080105|FG000|Overall Study|Protocol Violation|0|||
155721697|NCT04739982|562080106|FG001|Overall Study|Protocol Violation|5|||
155721698|NCT03651765|562080107|FG000|Overall Study|Adverse Event|6|||
155721699|NCT03651765|562080107|FG000|Overall Study|Lack of Efficacy|18|||
155721700|NCT03651765|562080107|FG000|Overall Study|Lost to Follow-up|5|||
155721701|NCT03651765|562080107|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155721702|NCT03651765|562080107|FG000|Overall Study|Physician Decision|6|||
155721703|NCT03651765|562080107|FG000|Overall Study|Pregnancy|1|||
155721704|NCT03651765|562080107|FG000|Overall Study|Discontinued by Sponsor|40|||
155721705|NCT03651765|562080107|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
155266304|NCT00211237|560409084|FG000|1 Month|Non-medical problem|0|||
155266305|NCT00211237|560409085|FG001|1 Month|Non-medical problem|2|||
155266306|NCT00211237|560409086|FG002|1 Month|Non-medical problem|0|||
155266307|NCT00211237|560409084|FG000|3 Months|Death|7|||
155266308|NCT00211237|560409085|FG001|3 Months|Death|3|||
155266309|NCT00211237|560409086|FG002|3 Months|Death|0|||
155266310|NCT00211237|560409084|FG000|3 Months|Could not comply with protocol|1|||
155266311|NCT00211237|560409085|FG001|3 Months|Could not comply with protocol|0|||
155266312|NCT00211237|560409086|FG002|3 Months|Could not comply with protocol|0|||
155266313|NCT00211237|560409084|FG000|3 Months|Withdrew|0|||
155266314|NCT00211237|560409085|FG001|3 Months|Withdrew|1|||
155266315|NCT00211237|560409086|FG002|3 Months|Withdrew|0|||
155266316|NCT00211237|560409084|FG000|3 Months|Non-medical problem|0|||
155266317|NCT00211237|560409085|FG001|3 Months|Non-medical problem|0|||
155266318|NCT00211237|560409086|FG002|3 Months|Non-medical problem|1|||
155266319|NCT00211237|560409084|FG000|6 Months|Death|6|||
155266320|NCT00211237|560409085|FG001|6 Months|Death|0|||
155266321|NCT00211237|560409086|FG002|6 Months|Death|3|||
155266322|NCT00211237|560409084|FG000|6 Months|Lost to Follow-up|2|||
155266323|NCT00211237|560409085|FG001|6 Months|Lost to Follow-up|0|||
155266324|NCT00211237|560409086|FG002|6 Months|Lost to Follow-up|0|||
155266325|NCT00211237|560409084|FG000|6 Months|Could not comply with protocol|0|||
155266326|NCT00211237|560409085|FG001|6 Months|Could not comply with protocol|2|||
155266327|NCT00211237|560409086|FG002|6 Months|Could not comply with protocol|0|||
155266328|NCT00211237|560409084|FG000|12 Months|Death|8|||
155266329|NCT00211237|560409085|FG001|12 Months|Death|2|||
155266330|NCT00211237|560409086|FG002|12 Months|Death|3|||
155266331|NCT00211237|560409084|FG000|12 Months|Lost to Follow-up|1|||
155266332|NCT00211237|560409085|FG001|12 Months|Lost to Follow-up|0|||
155266333|NCT00211237|560409086|FG002|12 Months|Lost to Follow-up|1|||
155266334|NCT00211237|560409084|FG000|12 Months|Withdrew|0|||
155266335|NCT00211237|560409085|FG001|12 Months|Withdrew|0|||
155266336|NCT00211237|560409086|FG002|12 Months|Withdrew|1|||
155266337|NCT00211237|560409084|FG000|12 Months|unrelated medical problem|0|||
155266338|NCT00211237|560409085|FG001|12 Months|unrelated medical problem|0|||
155266339|NCT00211237|560409086|FG002|12 Months|unrelated medical problem|1|||
155266340|NCT01003639|560409089|FG000|Overall Study|Lost to Follow-up|6|||
155266341|NCT01003639|560409090|FG001|Overall Study|Lost to Follow-up|9|||
155266342|NCT01003639|560409089|FG000|Overall Study|Withdrawal by Subject|9|||
155266343|NCT01003639|560409090|FG001|Overall Study|Withdrawal by Subject|5|||
155266344|NCT01003639|560409089|FG000|Overall Study|Lack of Efficacy|1|||
155266345|NCT01003639|560409090|FG001|Overall Study|Lack of Efficacy|6|||
155266346|NCT01003639|560409089|FG000|Overall Study|Adverse Event|0|||
155379445|NCT02359877|560822334|FG000|Overall Study|Withdrawal by Subject|1|||
155379446|NCT02359877|560822335|FG001|Overall Study|Withdrawal by Subject|0|||
155379447|NCT02359877|560822336|FG002|Overall Study|Withdrawal by Subject|0|||
155379448|NCT02359877|560822337|FG003|Overall Study|Withdrawal by Subject|2|||
155379449|NCT02359877|560822334|FG000|Overall Study|Adverse Event|0|||
155379450|NCT02359877|560822335|FG001|Overall Study|Adverse Event|0|||
155379451|NCT02359877|560822336|FG002|Overall Study|Adverse Event|0|||
155379452|NCT02359877|560822337|FG003|Overall Study|Adverse Event|1|||
155379453|NCT00910689|560822351|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
155379454|NCT00910689|560822352|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
155379455|NCT00910689|560822353|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
155379456|NCT00910689|560822354|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
155379457|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
155379458|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
155379459|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
155379460|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
155379461|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
155379462|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
155379463|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
155266347|NCT01003639|560409090|FG001|Overall Study|Adverse Event|1|||
155266348|NCT01003639|560409089|FG000|Overall Study|Protocol Violation|0|||
155266349|NCT01003639|560409090|FG001|Overall Study|Protocol Violation|1|||
155266350|NCT01003639|560409089|FG000|Overall Study|Physician Decision|1|||
155266351|NCT01003639|560409090|FG001|Overall Study|Physician Decision|0|||
155266352|NCT02954458|560409091|FG000|Overall Study|Adverse Event|0|||
155266353|NCT02954458|560409092|FG001|Overall Study|Adverse Event|0|||
155266354|NCT02954458|560409093|FG002|Overall Study|Adverse Event|0|||
155379464|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
155379465|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
155379466|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
155379467|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
155379468|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
155379469|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
155379470|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
155379471|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
155379472|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
155379473|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379474|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379475|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
155379476|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379477|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
155379478|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
155379479|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
155379480|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
155379481|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
155379482|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379483|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379484|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379485|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
155379486|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
155379487|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
155379488|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
155379489|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
155379490|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
155379491|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
155379492|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
155266355|NCT02954458|560409094|FG003|Overall Study|Adverse Event|1|||
155266356|NCT02954458|560409091|FG000|Overall Study|Withdrawal by Subject|0|||
155266357|NCT02954458|560409092|FG001|Overall Study|Withdrawal by Subject|0|||
155266358|NCT02954458|560409093|FG002|Overall Study|Withdrawal by Subject|0|||
155266359|NCT02954458|560409094|FG003|Overall Study|Withdrawal by Subject|1|||
155266360|NCT02954458|560409091|FG000|Overall Study|Physician Decision|0|||
155266361|NCT02954458|560409092|FG001|Overall Study|Physician Decision|0|||
155266362|NCT02954458|560409093|FG002|Overall Study|Physician Decision|1|||
155266363|NCT02954458|560409094|FG003|Overall Study|Physician Decision|1|||
155266364|NCT02954458|560409091|FG000|Overall Study|Lost to Follow-up|1|||
155266365|NCT02954458|560409092|FG001|Overall Study|Lost to Follow-up|0|||
155266366|NCT02954458|560409093|FG002|Overall Study|Lost to Follow-up|0|||
155266367|NCT02954458|560409094|FG003|Overall Study|Lost to Follow-up|1|||
155266368|NCT02954458|560409091|FG000|Overall Study|Death|0|||
155266369|NCT02954458|560409092|FG001|Overall Study|Death|0|||
155266370|NCT02954458|560409093|FG002|Overall Study|Death|0|||
155266371|NCT02954458|560409094|FG003|Overall Study|Death|1|||
155266372|NCT02954458|560409091|FG000|Overall Study|Other|0|||
155266373|NCT02954458|560409092|FG001|Overall Study|Other|0|||
155266374|NCT02954458|560409093|FG002|Overall Study|Other|0|||
155266375|NCT02954458|560409094|FG003|Overall Study|Other|7|||
155266376|NCT04000594|560409095|FG000|Overall Study|Withdrawal by Subject|1|||
155266377|NCT04000594|560409096|FG001|Overall Study|Withdrawal by Subject|0|||
155266378|NCT04000594|560409097|FG002|Overall Study|Withdrawal by Subject|0|||
155266379|NCT01552954|560409098|FG000|Overall Study|Adverse Event|1|||
155266380|NCT01552954|560409099|FG001|Overall Study|Adverse Event|2|||
155266381|NCT01552954|560409098|FG000|Overall Study|Lost to Follow-up|1|||
155266382|NCT01552954|560409099|FG001|Overall Study|Lost to Follow-up|1|||
155266383|NCT01552954|560409098|FG000|Overall Study|Withdrawal by Subject|1|||
155266384|NCT01552954|560409099|FG001|Overall Study|Withdrawal by Subject|1|||
155266385|NCT01552954|560409098|FG000|Overall Study|Protocol Violation|1|||
155266386|NCT01552954|560409099|FG001|Overall Study|Protocol Violation|2|||
155266387|NCT01552954|560409098|FG000|Overall Study|diagnosed DM|1|||
155266388|NCT01552954|560409099|FG001|Overall Study|diagnosed DM|0|||
155266389|NCT00779779|560409100|FG000|Overall Study|Adverse Event|1|||
155266390|NCT00779779|560409100|FG000|Overall Study|Protocol Violation|14|||
155266391|NCT00779779|560409100|FG000|Overall Study|Withdrawal by Subject|4|||
155266392|NCT00779779|560409100|FG000|Overall Study|Lost to Follow-up|5|||
155266393|NCT01395823|560409101|FG000|Overall Study|Death|4|||
155266394|NCT01395823|560409102|FG001|Overall Study|Death|4|||
155266395|NCT01395823|560409101|FG000|Overall Study|Physician Decision|3|||
155266396|NCT01395823|560409102|FG001|Overall Study|Physician Decision|1|||
155266397|NCT01395823|560409101|FG000|Overall Study|Lost to Follow-up|1|||
155266398|NCT01395823|560409102|FG001|Overall Study|Lost to Follow-up|0|||
155266399|NCT01395823|560409101|FG000|Overall Study|Transplant|1|||
155266400|NCT01395823|560409102|FG001|Overall Study|Transplant|0|||
155266401|NCT01395823|560409101|FG000|Overall Study|GI symptoms|1|||
155266402|NCT01395823|560409102|FG001|Overall Study|GI symptoms|0|||
155266403|NCT01395823|560409101|FG000|Overall Study|Withdrawal by Subject|5|||
155266404|NCT01395823|560409102|FG001|Overall Study|Withdrawal by Subject|4|||
155266405|NCT01778556|560409103|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
155266406|NCT01778556|560409104|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
155266407|NCT01778556|560409103|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155266408|NCT01778556|560409104|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
155266409|NCT01778556|560409103|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
155266410|NCT01778556|560409104|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
155266411|NCT01778556|560409103|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
155266412|NCT01778556|560409104|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
155266413|NCT03300570|560409106|FG000|Overall Study|Adverse Event|0|||
155266414|NCT03300570|560409107|FG001|Overall Study|Adverse Event|1|||
155266415|NCT03300570|560409106|FG000|Overall Study|Withdrawal by Subject|1|||
155266416|NCT03300570|560409107|FG001|Overall Study|Withdrawal by Subject|0|||
155266417|NCT03300570|560409106|FG000|Overall Study|Inadequate bowel prep|1|||
155266418|NCT03300570|560409107|FG001|Overall Study|Inadequate bowel prep|0|||
155266419|NCT00116272|560409108|FG000|Overall Study|Lost to Follow-up|11|||
155266420|NCT00116272|560409109|FG001|Overall Study|Lost to Follow-up|6|||
155266421|NCT03188120|560409110|FG000|Overall Study|Adverse Event|4|||
155266422|NCT03188120|560409110|FG000|Overall Study|Insufficient Effectiveness|8|||
155266423|NCT03188120|560409110|FG000|Overall Study|Improved|12|||
155266424|NCT03188120|560409110|FG000|Overall Study|Lost to Follow-up|7|||
155266425|NCT03188120|560409110|FG000|Overall Study|Other than specified|3|||
155266426|NCT03188120|560409110|FG000|Overall Study|No visit after the first visit|13|||
155266427|NCT02178566|560409118|FG000|Overall Study|patient did not complete due to noncompliance|0|||
155266428|NCT02178566|560409119|FG001|Overall Study|patient did not complete due to noncompliance|1|||
155266429|NCT05778526|560409120|FG000|Overall Study|Lost to Follow-up|0|||
155266430|NCT05778526|560409121|FG001|Overall Study|Lost to Follow-up|1|||
155266431|NCT05778526|560409122|FG002|Overall Study|Lost to Follow-up|3|||
155266432|NCT05778526|560409120|FG000|Overall Study|Protocol Violation|0|||
155266433|NCT05778526|560409121|FG001|Overall Study|Protocol Violation|0|||
155266434|NCT05778526|560409122|FG002|Overall Study|Protocol Violation|8|||
155266435|NCT00085202|560409123|FG000|Overall Study|Still on therapy|2|||
155266436|NCT00085202|560409124|FG001|Overall Study|Still on therapy|0|||
155266437|NCT00085202|560409123|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
155266438|NCT00085202|560409124|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
155266439|NCT00085202|560409123|FG000|Overall Study|Excessive toxicity|6|||
155266440|NCT00085202|560409124|FG001|Overall Study|Excessive toxicity|5|||
155266441|NCT00085202|560409123|FG000|Overall Study|Non-specified|3|||
155266442|NCT00085202|560409124|FG001|Overall Study|Non-specified|5|||
155266443|NCT00085202|560409123|FG000|Overall Study|Withdrawal by Subject|2|||
155266444|NCT00085202|560409124|FG001|Overall Study|Withdrawal by Subject|1|||
155266445|NCT00085202|560409123|FG000|Overall Study|Physician Decision|4|||
155266446|NCT00085202|560409124|FG001|Overall Study|Physician Decision|1|||
155266447|NCT00085202|560409123|FG000|Overall Study|Progressive disease|1|||
155266448|NCT00085202|560409124|FG001|Overall Study|Progressive disease|11|||
155266449|NCT03238300|560409125|FG000|Baseline (Before Intervention)|Physician Decision|0|||
155266450|NCT03238300|560409126|FG001|Baseline (Before Intervention)|Physician Decision|1|||
155266451|NCT03238300|560409125|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
155266452|NCT03238300|560409126|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
155266453|NCT03238300|560409125|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
155266454|NCT03238300|560409126|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
155266455|NCT03238300|560409125|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
155266456|NCT03238300|560409126|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
155266457|NCT01436201|560409134|FG000|Overall Study|Adverse Event|2|||
155266458|NCT01436201|560409134|FG000|Overall Study|Withdrawal by Subject|1|||
155266459|NCT01436201|560409134|FG000|Overall Study|Protocol Violation|1|||
155266460|NCT00110890|560409135|FG000|Overall Study|Adverse Event|30|||
155266461|NCT00110890|560409136|FG001|Overall Study|Adverse Event|7|||
155266462|NCT00110890|560409135|FG000|Overall Study|Death|16|||
155266463|NCT00110890|560409136|FG001|Overall Study|Death|9|||
155266464|NCT00110890|560409135|FG000|Overall Study|Lost to Follow-up|3|||
155266465|NCT00110890|560409136|FG001|Overall Study|Lost to Follow-up|1|||
155266466|NCT00110890|560409135|FG000|Overall Study|Physician Decision|4|||
155266467|NCT00110890|560409136|FG001|Overall Study|Physician Decision|5|||
155266468|NCT00110890|560409135|FG000|Overall Study|Withdrawal by Subject|17|||
155266469|NCT00110890|560409136|FG001|Overall Study|Withdrawal by Subject|5|||
155266470|NCT00110890|560409135|FG000|Overall Study|Protocol Deviation|1|||
155266471|NCT00110890|560409136|FG001|Overall Study|Protocol Deviation|0|||
155266472|NCT00110890|560409135|FG000|Overall Study|Noncompliance|10|||
155266473|NCT00110890|560409136|FG001|Overall Study|Noncompliance|0|||
155266474|NCT00110890|560409135|FG000|Overall Study|Kidney Transplant|16|||
155266475|NCT00110890|560409136|FG001|Overall Study|Kidney Transplant|12|||
155266476|NCT00110890|560409135|FG000|Overall Study|Invest. Product Commercially Available|217|||
155266477|NCT00110890|560409136|FG001|Overall Study|Invest. Product Commercially Available|110|||
155266478|NCT00110890|560409135|FG000|Overall Study|Other|34|||
155266479|NCT00110890|560409136|FG001|Overall Study|Other|23|||
155266480|NCT00110890|560409135|FG000|Overall Study|Ineligibility determined|3|||
155266481|NCT00110890|560409136|FG001|Overall Study|Ineligibility determined|0|||
155266482|NCT00110890|560409135|FG000|Overall Study|Requirement for alternative therapy|0|||
155266483|NCT00110890|560409136|FG001|Overall Study|Requirement for alternative therapy|1|||
155266484|NCT00110890|560409135|FG000|Overall Study|Disease progression|0|||
155266485|NCT00110890|560409136|FG001|Overall Study|Disease progression|1|||
155266486|NCT00110890|560409135|FG000|Overall Study|Parathyroidectomy|0|||
155266487|NCT00110890|560409136|FG001|Overall Study|Parathyroidectomy|1|||
155266488|NCT00110890|560409135|FG000|Overall Study|Did not enter follow-up phase|10|||
155266489|NCT00110890|560409136|FG001|Overall Study|Did not enter follow-up phase|4|||
155266490|NCT01686581|560409137|FG000|Overall Study|Side-effects or Health Problems|15|||
155266491|NCT01686581|560409137|FG000|Overall Study|Lack of Efficacy|90|||
155266492|NCT01686581|560409137|FG000|Overall Study|Participant Concerned about Risks|6|||
155266493|NCT01686581|560409137|FG000|Overall Study|Thinks Injections Too Painful|8|||
155266494|NCT01686581|560409137|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
155266495|NCT01686581|560409137|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
155266496|NCT01686581|560409137|FG000|Overall Study|Thinks it is Inconvenient|17|||
155266497|NCT01686581|560409137|FG000|Overall Study|Other Miscellaneous Reasons|36|||
155266498|NCT01686581|560409137|FG000|Overall Study|Reason Missing|1|||
155266499|NCT01975220|560409138|FG000|Test Period 1|Not treated|0|||
155266500|NCT01975220|560409139|FG001|Test Period 1|Not treated|1|||
155266501|NCT01975220|560409140|FG002|Test Period 1|Not treated|0|||
155266502|NCT01975220|560409141|FG003|Test Period 1|Not treated|0|||
155266503|NCT01975220|560409142|FG004|Test Period 1|Not treated|0|||
155266504|NCT01975220|560409143|FG005|Test Period 1|Not treated|0|||
155266505|NCT02839343|560409144|FG000|Overall Study|Withdrawal by Subject|3|||
155266506|NCT02839343|560409145|FG001|Overall Study|Withdrawal by Subject|1|||
155266507|NCT02839343|560409144|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
155266508|NCT02839343|560409145|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
155266509|NCT02839343|560409144|FG000|Overall Study|Adverse Event|1|||
155266510|NCT02839343|560409145|FG001|Overall Study|Adverse Event|0|||
155266511|NCT01852058|560409148|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
155266512|NCT01852058|560409149|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266513|NCT01852058|560409150|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266514|NCT01852058|560409151|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266515|NCT01852058|560409152|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266516|NCT01852058|560409153|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266517|NCT01852058|560409154|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266518|NCT01852058|560409155|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266519|NCT01852058|560409156|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266520|NCT01852058|560409157|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266521|NCT01852058|560409158|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266522|NCT01852058|560409159|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266523|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266524|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266525|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266526|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266527|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
155266528|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266529|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266530|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266531|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266532|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266533|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266534|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266535|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266536|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266537|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266538|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266539|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
155266540|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
155266541|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266542|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266543|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266544|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266545|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266546|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266547|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266548|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266549|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266550|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266551|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
155266552|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266553|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266554|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266555|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266556|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266557|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266558|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266559|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266560|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266561|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266562|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266563|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
155266564|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
155266565|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266566|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266567|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266568|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266569|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266570|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266571|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266572|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266573|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266574|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
155266575|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266576|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266577|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266578|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266579|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266580|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266581|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266582|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266583|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266584|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266585|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266586|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266587|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
155266588|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
155266589|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266590|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266591|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266592|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266593|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266594|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266595|NCT01852058|560409148|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266596|NCT01852058|560409149|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266597|NCT01852058|560409150|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266598|NCT01852058|560409151|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266599|NCT01852058|560409152|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266600|NCT01852058|560409153|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266601|NCT01852058|560409154|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266602|NCT01852058|560409155|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
155266603|NCT01852058|560409156|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266604|NCT01852058|560409157|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266605|NCT01852058|560409158|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266606|NCT01852058|560409159|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266607|NCT01852058|560409148|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266608|NCT01852058|560409149|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155435814|NCT00624338|561022961|FG002|Overall Study|Lost to Follow-up|0|||
155266609|NCT01852058|560409150|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266610|NCT01852058|560409151|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266611|NCT01852058|560409152|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266612|NCT01852058|560409153|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266613|NCT01852058|560409154|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266614|NCT01852058|560409155|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266615|NCT01852058|560409156|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
155266616|NCT01852058|560409157|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266617|NCT01852058|560409158|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266618|NCT01852058|560409159|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266619|NCT01279343|560409161|FG000|Overall Study|Did not receive treatment|2|||
155266620|NCT01279343|560409162|FG001|Overall Study|Did not receive treatment|6|||
155266621|NCT03287414|560409163|FG000|Treatment Epoch|Adverse Event|0|||
155266622|NCT03287414|560409164|FG001|Treatment Epoch|Adverse Event|1|||
155266623|NCT03287414|560409163|FG000|Treatment Epoch|Study terminated by sponsor|2|||
155266624|NCT03287414|560409164|FG001|Treatment Epoch|Study terminated by sponsor|2|||
155266625|NCT03287414|560409163|FG000|Treatment Epoch|Subject/Guardian decision|4|||
155266626|NCT03287414|560409164|FG001|Treatment Epoch|Subject/Guardian decision|0|||
155266627|NCT03287414|560409163|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
155266628|NCT03287414|560409164|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
155266629|NCT03287414|560409163|FG000|Treatment Epoch|Withdrawal by Subject|1|||
155266630|NCT03287414|560409164|FG001|Treatment Epoch|Withdrawal by Subject|0|||
155266631|NCT03287414|560409163|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
155266632|NCT03287414|560409164|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
155266633|NCT03287414|560409163|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
155266634|NCT03287414|560409164|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
155266635|NCT01119898|560409167|FG000|Overall Study|Adverse Event|4|||
155266636|NCT01119898|560409168|FG001|Overall Study|Adverse Event|5|||
155266637|NCT01119898|560409167|FG000|Overall Study|Withdrawal by Subject|1|||
155266638|NCT01119898|560409168|FG001|Overall Study|Withdrawal by Subject|4|||
155266639|NCT01119898|560409167|FG000|Overall Study|Lack of Efficacy|0|||
155266640|NCT01119898|560409168|FG001|Overall Study|Lack of Efficacy|2|||
155266641|NCT01119898|560409167|FG000|Overall Study|Protocol Violation|1|||
155266642|NCT01119898|560409168|FG001|Overall Study|Protocol Violation|1|||
155266643|NCT01119898|560409167|FG000|Overall Study|Medical procedure|1|||
155266644|NCT01119898|560409168|FG001|Overall Study|Medical procedure|0|||
155266645|NCT01119898|560409167|FG000|Overall Study|Randomized in error did not participate|1|||
155266646|NCT01119898|560409168|FG001|Overall Study|Randomized in error did not participate|0|||
155266647|NCT02217280|560409169|FG000|Overall Study|Withdrawal by Subject|2|||
155266648|NCT02217280|560409169|FG000|Overall Study|Post-consent sceen fail|2|||
155266649|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
155266650|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
155266651|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
155266652|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
155266653|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
155266654|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
155266655|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
155266656|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
155266657|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
155266658|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
155266659|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
155266660|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
155266661|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
155266662|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
155266663|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
155266664|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
155266665|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
155266666|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
155266667|NCT01933880|560409174|FG000|Overall Study|Withdrawal by Subject|5|||
155266668|NCT01933880|560409175|FG001|Overall Study|Withdrawal by Subject|0|||
155266669|NCT01933880|560409174|FG000|Overall Study|Lack of Efficacy|1|||
155266670|NCT01933880|560409175|FG001|Overall Study|Lack of Efficacy|0|||
155266671|NCT01933880|560409174|FG000|Overall Study|Concomitant medication Interference|0|||
155266672|NCT01933880|560409175|FG001|Overall Study|Concomitant medication Interference|1|||
155266673|NCT01933880|560409174|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
155266674|NCT01933880|560409175|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
155266675|NCT01933880|560409174|FG000|Overall Study|Other|4|||
155266676|NCT01933880|560409175|FG001|Overall Study|Other|0|||
155266677|NCT01933880|560409174|FG000|Overall Study|Protocol Violation|1|||
155266678|NCT01933880|560409175|FG001|Overall Study|Protocol Violation|0|||
155266679|NCT01125722|560409178|FG000|Overall Study|Withdrawal by Subject|2|||
155266680|NCT01125722|560409179|FG001|Overall Study|Withdrawal by Subject|1|||
155266681|NCT01125722|560409178|FG000|Overall Study|Lost to Follow-up|1|||
155266682|NCT01125722|560409179|FG001|Overall Study|Lost to Follow-up|0|||
155266683|NCT00709059|560409182|FG000|Overall Study|Lost to Follow-up|34|||
155266684|NCT00709059|560409182|FG000|Overall Study|Withdrawal by Subject|19|||
155266685|NCT00709059|560409182|FG000|Overall Study|Physician Decision|7|||
155266686|NCT00709059|560409182|FG000|Overall Study|Disease complication|3|||
155266687|NCT00709059|560409182|FG000|Overall Study|Side effects|20|||
155266688|NCT00709059|560409182|FG000|Overall Study|Serious side effects|11|||
155266689|NCT02172625|560409183|FG000|Overall Study|Adverse Event|0|||
155266690|NCT02172625|560409184|FG001|Overall Study|Adverse Event|1|||
155266691|NCT02172625|560409183|FG000|Overall Study|Pregnancy|0|||
155266692|NCT02172625|560409184|FG001|Overall Study|Pregnancy|1|||
155266693|NCT02172625|560409183|FG000|Overall Study|car accident|0|||
155266694|NCT02172625|560409184|FG001|Overall Study|car accident|1|||
155266695|NCT02944656|560409185|FG000|Overall Study|No longer eligible|3|||
155266696|NCT02944656|560409186|FG001|Overall Study|No longer eligible|0|||
155266697|NCT02944656|560409185|FG000|Overall Study|Lost to Follow-up|7|||
155266698|NCT02944656|560409186|FG001|Overall Study|Lost to Follow-up|10|||
155266699|NCT03722264|560410854|FG000|Overall Study|Physician Decision|3|||
155266700|NCT02494921|560410855|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
155266701|NCT02494921|560410856|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
155266702|NCT02494921|560410857|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
155266703|NCT02494921|560410858|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
155266704|NCT02494921|560410859|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
155266705|NCT02494921|560410855|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
155266706|NCT02494921|560410856|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
155266707|NCT02494921|560410857|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
155266708|NCT02494921|560410858|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
155266709|NCT02494921|560410859|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
155266710|NCT02494921|560410855|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266711|NCT02494921|560410856|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266712|NCT02494921|560410857|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
155266713|NCT02494921|560410858|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266714|NCT02494921|560410859|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266715|NCT04105972|560410860|FG000|Overall Study|Adverse Event|2|||
155266716|NCT04105972|560410861|FG001|Overall Study|Adverse Event|1|||
155266717|NCT00768430|560410866|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
155266718|NCT00768430|560410867|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
155266719|NCT01478113|560410868|FG000|Overall Study|Withdrawal by Subject|0|||
155266720|NCT01478113|560410869|FG001|Overall Study|Withdrawal by Subject|1|||
155266721|NCT01478113|560410868|FG000|Overall Study|Physician Decision|1|||
155266722|NCT01478113|560410869|FG001|Overall Study|Physician Decision|0|||
155266723|NCT03585296|560410875|FG000|Overall Study|Adverse Event|1|||
155266724|NCT03585296|560410875|FG000|Overall Study|Lost to Follow-up|2|||
155266725|NCT03585296|560410875|FG000|Overall Study|Withdrawal by Subject|2|||
155266726|NCT00041756|560410876|FG000|Overall Study|Adverse Event|4|||
155266727|NCT00041756|560410877|FG001|Overall Study|Adverse Event|10|||
155266728|NCT00041756|560410878|FG002|Overall Study|Adverse Event|6|||
155266729|NCT00041756|560410879|FG003|Overall Study|Adverse Event|11|||
155266730|NCT00041756|560410880|FG004|Overall Study|Adverse Event|34|||
155266731|NCT00041756|560410876|FG000|Overall Study|Protocol Violation|1|||
155266732|NCT00041756|560410877|FG001|Overall Study|Protocol Violation|1|||
155266733|NCT00041756|560410878|FG002|Overall Study|Protocol Violation|2|||
155266734|NCT00041756|560410879|FG003|Overall Study|Protocol Violation|2|||
155266735|NCT00041756|560410880|FG004|Overall Study|Protocol Violation|1|||
155266736|NCT00041756|560410876|FG000|Overall Study|Withdrawal by Subject|3|||
155266737|NCT00041756|560410877|FG001|Overall Study|Withdrawal by Subject|3|||
155266738|NCT00041756|560410878|FG002|Overall Study|Withdrawal by Subject|4|||
155266739|NCT00041756|560410879|FG003|Overall Study|Withdrawal by Subject|2|||
155266740|NCT00041756|560410880|FG004|Overall Study|Withdrawal by Subject|3|||
155266741|NCT00041756|560410876|FG000|Overall Study|Lost to Follow-up|0|||
155266742|NCT00041756|560410877|FG001|Overall Study|Lost to Follow-up|1|||
155266743|NCT00041756|560410878|FG002|Overall Study|Lost to Follow-up|0|||
155266744|NCT00041756|560410879|FG003|Overall Study|Lost to Follow-up|1|||
155266745|NCT00041756|560410880|FG004|Overall Study|Lost to Follow-up|0|||
155266746|NCT00041756|560410876|FG000|Overall Study|Unable to meet protocol criteria|0|||
155266747|NCT00041756|560410877|FG001|Overall Study|Unable to meet protocol criteria|0|||
155266748|NCT00041756|560410878|FG002|Overall Study|Unable to meet protocol criteria|1|||
155266749|NCT00041756|560410879|FG003|Overall Study|Unable to meet protocol criteria|0|||
155266750|NCT00041756|560410880|FG004|Overall Study|Unable to meet protocol criteria|1|||
155607373|NCT02913105|561651529|FG001|Overall Study|Physician Decision|1|||
155607374|NCT02913105|561651530|FG002|Overall Study|Physician Decision|0|||
155266751|NCT00041756|560410876|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
155266752|NCT00041756|560410877|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
155266753|NCT00041756|560410878|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
155266754|NCT00041756|560410879|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
155266755|NCT00041756|560410880|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
155266756|NCT03980184|560410881|FG000|Overall Study|Dropped out before treatment|2|||
155266757|NCT03980184|560410882|FG001|Overall Study|Dropped out before treatment|2|||
155266758|NCT03980184|560410881|FG000|Overall Study|Lost to Follow-up|11|||
155266759|NCT03980184|560410882|FG001|Overall Study|Lost to Follow-up|13|||
155266760|NCT02002884|560410883|FG000|Main Period (MP)|Other|0|||
155266761|NCT02002884|560410884|FG001|Main Period (MP)|Other|3|||
155266762|NCT02002884|560410885|FG002|Main Period (MP)|Other|3|||
155266763|NCT02002884|560410886|FG003|Main Period (MP)|Other|0|||
155266764|NCT02002884|560410883|FG000|Main Period (MP)|Adverse Event|0|||
155266765|NCT02002884|560410884|FG001|Main Period (MP)|Adverse Event|1|||
155266766|NCT02002884|560410885|FG002|Main Period (MP)|Adverse Event|1|||
155266767|NCT02002884|560410886|FG003|Main Period (MP)|Adverse Event|0|||
155266768|NCT02002884|560410883|FG000|Main Period (MP)|Withdrawal by Subject|6|||
155266769|NCT02002884|560410884|FG001|Main Period (MP)|Withdrawal by Subject|2|||
155266770|NCT02002884|560410885|FG002|Main Period (MP)|Withdrawal by Subject|2|||
155266771|NCT02002884|560410886|FG003|Main Period (MP)|Withdrawal by Subject|0|||
155266772|NCT02002884|560410883|FG000|Main Period (MP)|Lost to Follow-up|0|||
155266773|NCT02002884|560410884|FG001|Main Period (MP)|Lost to Follow-up|0|||
155266774|NCT02002884|560410885|FG002|Main Period (MP)|Lost to Follow-up|2|||
155266775|NCT02002884|560410886|FG003|Main Period (MP)|Lost to Follow-up|0|||
155266776|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Other|0|||
155266777|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Other|0|||
155266778|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Other|0|||
155266779|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Other|24|||
155266780|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266781|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266782|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266783|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
155266784|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
155493324|NCT00457249|561231379|FG001|Overall Study|Withdrawal by Subject|1|||
155493325|NCT00457249|561231378|FG000|Overall Study|Serious Adverse Events|2|||
155493326|NCT00457249|561231379|FG001|Overall Study|Serious Adverse Events|0|||
155493327|NCT02411110|561231382|FG000|Treatment Period 1|Adverse Event|4|||
155493328|NCT02411110|561231383|FG001|Treatment Period 1|Adverse Event|2|||
155493329|NCT02411110|561231382|FG000|Treatment Period 1|Lost to Follow-up|1|||
155493330|NCT02411110|561231383|FG001|Treatment Period 1|Lost to Follow-up|0|||
155493331|NCT02411110|561231382|FG000|Treatment Period 1|Personal Reasons|2|||
155493332|NCT02411110|561231383|FG001|Treatment Period 1|Personal Reasons|5|||
155493333|NCT02411110|561231382|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
155493334|NCT02411110|561231383|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
155493335|NCT02411110|561231382|FG000|Treatment Period 2|Adverse Event|1|||
155493336|NCT02411110|561231383|FG001|Treatment Period 2|Adverse Event|0|||
155493337|NCT02411110|561231382|FG000|Treatment Period 2|Lost to Follow-up|0|||
155493338|NCT02411110|561231383|FG001|Treatment Period 2|Lost to Follow-up|2|||
155493339|NCT02411110|561231382|FG000|Treatment Period 2|Personal Reasons|0|||
155493340|NCT02411110|561231383|FG001|Treatment Period 2|Personal Reasons|2|||
155493341|NCT04888377|561231384|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
155493342|NCT04888377|561231385|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
155493343|NCT04888377|561231384|FG000|Overall Study|Physician Decision|6|||
155493344|NCT04888377|561231385|FG001|Overall Study|Physician Decision|6|||
155493345|NCT04888377|561231384|FG000|Overall Study|Withdrawal by Subject|7|||
155493346|NCT04888377|561231385|FG001|Overall Study|Withdrawal by Subject|3|||
155493347|NCT00526162|561231386|FG000|Overall Study|Device not implanted|3|||
155493348|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
155493349|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
155493350|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
155493351|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493352|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493353|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493354|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493355|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493356|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
155493357|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
155493358|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493359|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493360|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155513841|NCT03093454|561308151|FG001|Overall Study|Physician Decision|1|||
155607375|NCT02913105|561651528|FG000|Overall Study|Withdrawal by Subject|0|||
155607376|NCT02913105|561651529|FG001|Overall Study|Withdrawal by Subject|3|||
155607377|NCT02913105|561651530|FG002|Overall Study|Withdrawal by Subject|1|||
155266785|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
155435815|NCT00624338|561022959|FG000|Overall Study|Lack of Efficacy|11|||
155493361|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493362|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
155266786|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
155266787|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
155266788|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266789|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266790|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266791|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
155266792|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
155266793|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
155493363|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
155493364|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
155493365|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493366|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493367|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493368|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493369|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
155493370|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
155493371|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
155493372|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493373|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493374|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493375|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493376|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
155493377|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155493378|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155493379|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155493380|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155493381|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155493382|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
155266794|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
155266795|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
155266796|NCT02341456|560410888|FG000|Overall Study|Disease progression|2|||
155266797|NCT02341456|560410889|FG001|Overall Study|Disease progression|3|||
155266798|NCT02341456|560410890|FG002|Overall Study|Disease progression|1|||
155266799|NCT02341456|560410888|FG000|Overall Study|Death|1|||
155266800|NCT02341456|560410889|FG001|Overall Study|Death|1|||
155266801|NCT02341456|560410890|FG002|Overall Study|Death|1|||
155266802|NCT02341456|560410888|FG000|Overall Study|Withdrawal by Subject|0|||
155266803|NCT02341456|560410889|FG001|Overall Study|Withdrawal by Subject|1|||
155266804|NCT02341456|560410890|FG002|Overall Study|Withdrawal by Subject|1|||
155266805|NCT02341456|560410888|FG000|Overall Study|Moved to local access programme.|0|||
155266806|NCT02341456|560410889|FG001|Overall Study|Moved to local access programme.|1|||
155266807|NCT02341456|560410890|FG002|Overall Study|Moved to local access programme.|1|||
155266808|NCT02341456|560410888|FG000|Overall Study|Physician Decision|1|||
155266809|NCT02341456|560410889|FG001|Overall Study|Physician Decision|0|||
155266810|NCT02341456|560410890|FG002|Overall Study|Physician Decision|0|||
155266811|NCT01111838|560410894|FG000|Overall Study|Patient Ineligible|2|||
155266812|NCT01111838|560410894|FG000|Overall Study|Not Treated|3|||
155266813|NCT01111838|560410894|FG000|Overall Study|Clinical deterioration|1|||
155266814|NCT01111838|560410894|FG000|Overall Study|Other Complicating Disease|1|||
155266815|NCT02567825|560410899|FG000|Overall Study|No follow-up post-randomization|5|||
155266816|NCT02567825|560410900|FG001|Overall Study|No follow-up post-randomization|1|||
155266817|NCT02567825|560410899|FG000|Overall Study|Follow-up less than 23 months|16|||
155266818|NCT02567825|560410900|FG001|Overall Study|Follow-up less than 23 months|20|||
155266819|NCT05061537|560410905|FG000|Treatment Phase|Progressive disease|0|||
155266820|NCT05061537|560410906|FG001|Treatment Phase|Progressive disease|1|||
155493383|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155493384|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155493385|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
155493386|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155607378|NCT05243563|561651531|FG000|Overall Study|Withdrawal by Subject|1|||
155266821|NCT05061537|560410907|FG002|Treatment Phase|Progressive disease|2|||
155266822|NCT05061537|560410908|FG003|Treatment Phase|Progressive disease|0|||
155266823|NCT05061537|560410909|FG004|Treatment Phase|Progressive disease|0|||
155266824|NCT05061537|560410905|FG000|Treatment Phase|Adverse Event|0|||
155266825|NCT05061537|560410906|FG001|Treatment Phase|Adverse Event|0|||
155266826|NCT05061537|560410907|FG002|Treatment Phase|Adverse Event|2|||
155493387|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155266827|NCT05061537|560410908|FG003|Treatment Phase|Adverse Event|0|||
155266828|NCT05061537|560410909|FG004|Treatment Phase|Adverse Event|0|||
155266829|NCT05061537|560410905|FG000|Treatment Phase|Global deterioration of health status|0|||
155493388|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155493389|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155493390|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155493391|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155493392|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
155493393|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155266830|NCT05061537|560410906|FG001|Treatment Phase|Global deterioration of health status|1|||
155493394|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155493395|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155493396|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155493397|NCT04242446|561231391|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493398|NCT04242446|561231392|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
155493399|NCT04242446|561231393|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
155493400|NCT04242446|561231394|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493401|NCT04242446|561231395|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493402|NCT04242446|561231396|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493403|NCT04242446|561231397|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493404|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493405|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493406|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493407|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
155493408|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
155493409|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
155493410|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
155493411|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493412|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493413|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493414|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
155493415|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
155493416|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
155493417|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
155493418|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493419|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493420|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493421|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
155493422|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
155493423|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
155493424|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
155493425|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493426|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493427|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493428|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
155493429|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
155493430|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
155493431|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
155493432|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155493433|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155493434|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155493435|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
155493436|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
155607379|NCT05243563|561651532|FG001|Overall Study|Withdrawal by Subject|0|||
155607380|NCT05243563|561651531|FG000|Overall Study|Physician Decision|1|||
155266831|NCT05061537|560410907|FG002|Treatment Phase|Global deterioration of health status|0|||
155266832|NCT05061537|560410908|FG003|Treatment Phase|Global deterioration of health status|0|||
155266833|NCT05061537|560410909|FG004|Treatment Phase|Global deterioration of health status|0|||
155266834|NCT05061537|560410905|FG000|Follow up|Other|2|||
155266835|NCT05061537|560410906|FG001|Follow up|Other|0|||
155266836|NCT05061537|560410907|FG002|Follow up|Other|2|||
155266837|NCT05061537|560410908|FG003|Follow up|Other|0|||
155607381|NCT05243563|561651532|FG001|Overall Study|Physician Decision|0|||
155607382|NCT00703326|561651533|FG000|Overall Study|Lost to Follow-up|47|||
155607383|NCT00703326|561651534|FG001|Overall Study|Lost to Follow-up|18|||
155607384|NCT00703326|561651533|FG000|Overall Study|Withdrawal by Subject|54|||
155607385|NCT00703326|561651534|FG001|Overall Study|Withdrawal by Subject|20|||
155607386|NCT00703326|561651533|FG000|Overall Study|Adverse Event|1|||
155607387|NCT00703326|561651534|FG001|Overall Study|Adverse Event|0|||
155607388|NCT02661061|561651536|FG000|Overall Study|Lack of Efficacy|1|||
155607389|NCT02661061|561651537|FG001|Overall Study|Lack of Efficacy|1|||
155607390|NCT02661061|561651536|FG000|Overall Study|Withdrawal by Subject|1|||
155607391|NCT02661061|561651537|FG001|Overall Study|Withdrawal by Subject|1|||
155607392|NCT02578940|561651538|FG000|Overall Study|Screening failure|5|||
155607393|NCT02578940|561651538|FG000|Overall Study|Lost to Follow-up|1|||
155607394|NCT03341936|561651543|FG000|Overall Study|Ineligible|1|||
155607395|NCT03341936|561651543|FG000|Overall Study|Disease Progression|2|||
155607396|NCT03341936|561651543|FG000|Overall Study|Withdrew Consent|4|||
155607397|NCT03341936|561651543|FG000|Overall Study|Non-Compliance|1|||
155607398|NCT03341936|561651543|FG000|Overall Study|Physician Decision|1|||
155607399|NCT03341936|561651543|FG000|Overall Study|Withdrawal by Subject|1|||
155607400|NCT03341936|561651543|FG000|Overall Study|Other|1|||
155607401|NCT02131636|561651549|FG000|Overall Study|Personal Reasons|4|||
155607402|NCT02131636|561651550|FG001|Overall Study|Personal Reasons|4|||
155607403|NCT02131636|561651549|FG000|Overall Study|Lost to Follow-up|4|||
155607404|NCT02131636|561651550|FG001|Overall Study|Lost to Follow-up|0|||
155607405|NCT02131636|561651549|FG000|Overall Study|Adverse Event|4|||
155607406|NCT02131636|561651550|FG001|Overall Study|Adverse Event|1|||
155607407|NCT02173379|561651551|FG000|Overall Study|Lost to Follow-up|89|||
155607408|NCT02173379|561651552|FG001|Overall Study|Lost to Follow-up|81|||
155607409|NCT02173379|561651551|FG000|Overall Study|Withdrawal by Subject|24|||
155607410|NCT02173379|561651552|FG001|Overall Study|Withdrawal by Subject|29|||
155607411|NCT02173379|561651551|FG000|Overall Study|Physician Decision|8|||
155607412|NCT02173379|561651552|FG001|Overall Study|Physician Decision|8|||
155607413|NCT02173379|561651551|FG000|Overall Study|Death|75|||
155493437|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
155493438|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
155607414|NCT02173379|561651552|FG001|Overall Study|Death|72|||
155493439|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493440|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493441|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493442|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
155493443|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493444|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493445|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155493446|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493447|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493448|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493449|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493450|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
155493451|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493452|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
155493453|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493454|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493455|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493456|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493457|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
155493458|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493459|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
155493460|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155493461|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155493462|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155493463|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155607415|NCT02173379|561651551|FG000|Overall Study|Other Reason|1|||
155607416|NCT02173379|561651552|FG001|Overall Study|Other Reason|0|||
155607417|NCT06226649|561651554|FG000|Overall Study|Withdrawal by Subject|4|||
155607418|NCT06226649|561651555|FG001|Overall Study|Withdrawal by Subject|1|||
155493464|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
155493465|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155493466|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
155493467|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493468|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493469|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493470|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493471|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
155493472|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493473|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
155493474|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493475|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493476|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493477|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493478|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
155493479|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493480|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
155493481|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493482|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493483|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493484|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493485|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493486|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
155493487|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
155493488|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493489|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493490|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493491|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493492|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493493|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
155493494|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
155493495|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493496|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493497|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493498|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493499|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493500|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
155493501|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
155493502|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493503|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493504|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493505|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493506|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493507|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
155493508|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
155493509|NCT04242446|561231391|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155493510|NCT04242446|561231392|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155493511|NCT04242446|561231393|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155493512|NCT04242446|561231394|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155607419|NCT01636947|561651561|FG000|Overall Study|Not Treated|2|||
155607420|NCT01636947|561651562|FG001|Overall Study|Not Treated|2|||
155493513|NCT04242446|561231395|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155493514|NCT04242446|561231396|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155493515|NCT04242446|561231397|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
155493516|NCT03587116|561231398|FG000|Overall Study|Lost to Follow-up|0|||
155607421|NCT01636947|561651561|FG000|Overall Study|Lost to Follow-up|4|||
155607422|NCT01636947|561651562|FG001|Overall Study|Lost to Follow-up|0|||
155607423|NCT01636947|561651561|FG000|Overall Study|Protocol Violation|1|||
155493517|NCT03587116|561231399|FG001|Overall Study|Lost to Follow-up|1|||
155493518|NCT03587116|561231398|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
155493519|NCT03587116|561231399|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
155493520|NCT03587116|561231398|FG000|Overall Study|Withdrawal by Subject|4|||
155493521|NCT03587116|561231399|FG001|Overall Study|Withdrawal by Subject|0|||
155493522|NCT05993299|561231403|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
155493523|NCT05993299|561231403|FG000|Overall Study|Ongoing|4|||
155493524|NCT05644756|561231404|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
155493525|NCT05644756|561231404|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
155493526|NCT03526549|561231406|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
155493527|NCT03526549|561231407|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
155493528|NCT03526549|561231406|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
155493529|NCT03526549|561231407|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
155493530|NCT03526549|561231406|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
155493531|NCT03526549|561231407|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
155493532|NCT03526549|561231406|FG000|Open-label Phase|Adverse Event|4|||
155493533|NCT03526549|561231407|FG001|Open-label Phase|Adverse Event|0|||
155493534|NCT03526549|561231406|FG000|Open-label Phase|Withdrawal by Subject|54|||
155493535|NCT03526549|561231407|FG001|Open-label Phase|Withdrawal by Subject|0|||
155493536|NCT03526549|561231406|FG000|Open-label Phase|Lost to Follow-up|35|||
155493537|NCT03526549|561231407|FG001|Open-label Phase|Lost to Follow-up|0|||
155493538|NCT03526549|561231406|FG000|Open-label Phase|Other than Specified|5|||
155493539|NCT03526549|561231407|FG001|Open-label Phase|Other than Specified|0|||
155493540|NCT00478933|561231408|FG000|Overall Study|Protocol Violation|22|||
155493541|NCT00478933|561231408|FG000|Overall Study|Informed consent not verified|3|||
155493542|NCT00478933|561231408|FG000|Overall Study|Inadequate data available|53|||
155493543|NCT00643006|561231409|FG000|Overall Study|Lost to Follow-up|5|||
155493544|NCT00643006|561231410|FG001|Overall Study|Lost to Follow-up|4|||
155493545|NCT01283009|561231416|FG000|Overall Study|Death|83|||
155493546|NCT01283009|561231417|FG001|Overall Study|Death|78|||
155493547|NCT01283009|561231416|FG000|Overall Study|Study ended early|23|||
155493548|NCT01283009|561231417|FG001|Overall Study|Study ended early|26|||
155493549|NCT01283009|561231416|FG000|Overall Study|Withdrawal by Subject|10|||
155493550|NCT01283009|561231417|FG001|Overall Study|Withdrawal by Subject|8|||
155493551|NCT01283009|561231416|FG000|Overall Study|Physician Decision|1|||
155493552|NCT01283009|561231417|FG001|Overall Study|Physician Decision|1|||
155493553|NCT01283009|561231416|FG000|Overall Study|Lost to Follow-up|1|||
155493554|NCT01283009|561231417|FG001|Overall Study|Lost to Follow-up|0|||
155493555|NCT01283009|561231416|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
155493556|NCT01283009|561231417|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
155493557|NCT00183170|561231420|FG000|First Intervention|Did not complete study|1|||
155493558|NCT00183170|561231421|FG001|First Intervention|Did not complete study|0|||
155493559|NCT00183170|561231420|FG000|First Intervention|Did not meet targeted BrAC|1|||
155493560|NCT00183170|561231421|FG001|First Intervention|Did not meet targeted BrAC|0|||
155493561|NCT00183170|561231420|FG000|Washout 1 Week|Did not complete study|6|||
155493562|NCT00183170|561231421|FG001|Washout 1 Week|Did not complete study|8|||
155493563|NCT00183170|561231420|FG000|Second Intervention|Did not complete study|1|||
155493564|NCT00183170|561231421|FG001|Second Intervention|Did not complete study|0|||
155493565|NCT00183170|561231420|FG000|Second Intervention|Did not meet targeted BrAC|0|||
155493566|NCT00183170|561231421|FG001|Second Intervention|Did not meet targeted BrAC|2|||
155493567|NCT03707145|561231422|FG000|Overall Study|Lost to Follow-up|0|||
155493568|NCT03707145|561231423|FG001|Overall Study|Lost to Follow-up|1|||
155493569|NCT03707145|561231424|FG002|Overall Study|Lost to Follow-up|1|||
155493570|NCT03707145|561231425|FG003|Overall Study|Lost to Follow-up|0|||
155493571|NCT04221477|561231426|FG000|Overall Study|Adverse Event|1|||
155493572|NCT04221477|561231427|FG001|Overall Study|Adverse Event|1|||
155493573|NCT04221477|561231426|FG000|Overall Study|Death|5|||
155493574|NCT04221477|561231427|FG001|Overall Study|Death|4|||
155493575|NCT04221477|561231426|FG000|Overall Study|Lack of Efficacy|1|||
155493576|NCT04221477|561231427|FG001|Overall Study|Lack of Efficacy|2|||
155493577|NCT04221477|561231426|FG000|Overall Study|Lost to Follow-up|1|||
155493578|NCT04221477|561231427|FG001|Overall Study|Lost to Follow-up|2|||
155493579|NCT04221477|561231426|FG000|Overall Study|Non-compliance with Study Drug|1|||
155493580|NCT04221477|561231427|FG001|Overall Study|Non-compliance with Study Drug|0|||
155493581|NCT04221477|561231426|FG000|Overall Study|Reason not Specified|0|||
155493582|NCT04221477|561231427|FG001|Overall Study|Reason not Specified|5|||
155493583|NCT04221477|561231426|FG000|Overall Study|Physician Decision|0|||
155493584|NCT04221477|561231427|FG001|Overall Study|Physician Decision|6|||
155493585|NCT04221477|561231426|FG000|Overall Study|Withdrawal by Subject|10|||
155493586|NCT04221477|561231427|FG001|Overall Study|Withdrawal by Subject|14|||
155493587|NCT04221477|561231426|FG000|Overall Study|Ongoing in the Study|116|||
155493588|NCT04221477|561231427|FG001|Overall Study|Ongoing in the Study|102|||
155721706|NCT03651765|562080107|FG000|Overall Study|Withdrawal by Subject|24|||
155493589|NCT01215968|561231434|FG000|Overall Study|Adverse Event|0|||
155493590|NCT01215968|561231435|FG001|Overall Study|Adverse Event|2|||
155493591|NCT01215968|561231434|FG000|Overall Study|Protocol Violation|2|||
155493592|NCT01215968|561231435|FG001|Overall Study|Protocol Violation|4|||
155493593|NCT01215968|561231434|FG000|Overall Study|Not received study drug|0|||
155493594|NCT01215968|561231435|FG001|Overall Study|Not received study drug|1|||
155493595|NCT05643573|561231438|FG000|Overall Study|Adverse Event|117|||
155493596|NCT05643573|561231439|FG001|Overall Study|Adverse Event|90|||
155493597|NCT05643573|561231438|FG000|Overall Study|Death|53|||
155493598|NCT05643573|561231439|FG001|Overall Study|Death|57|||
155493599|NCT05643573|561231438|FG000|Overall Study|Lost to Follow-up|6|||
155493600|NCT05643573|561231439|FG001|Overall Study|Lost to Follow-up|3|||
155493601|NCT05643573|561231438|FG000|Overall Study|Other|18|||
155493602|NCT05643573|561231439|FG001|Overall Study|Other|15|||
155493603|NCT05643573|561231438|FG000|Overall Study|Outcome event|64|||
155493604|NCT05643573|561231439|FG001|Overall Study|Outcome event|36|||
155493605|NCT05643573|561231438|FG000|Overall Study|Physician Decision|33|||
155493606|NCT05643573|561231439|FG001|Overall Study|Physician Decision|19|||
155493607|NCT05643573|561231438|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
155493608|NCT05643573|561231439|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
155493609|NCT05643573|561231438|FG000|Overall Study|Site terminated by sponsor|10|||
155493610|NCT05643573|561231439|FG001|Overall Study|Site terminated by sponsor|10|||
155493611|NCT05643573|561231438|FG000|Overall Study|Study terminated by sponsor|1|||
155493612|NCT05643573|561231439|FG001|Overall Study|Study terminated by sponsor|0|||
155493613|NCT05643573|561231438|FG000|Overall Study|Withdrawal by Subject|178|||
155493614|NCT05643573|561231439|FG001|Overall Study|Withdrawal by Subject|130|||
155493615|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
155493616|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
155493617|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
155493618|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493619|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493620|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493621|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
155493622|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493623|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493624|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
155493625|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493626|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493627|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493628|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155493629|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
155493630|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493631|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
155493632|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493633|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493634|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493635|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155493636|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
155493637|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493638|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
155493639|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493640|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493641|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493642|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
155493643|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
155493644|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
155493645|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
155493646|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493647|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493648|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493649|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
155493650|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493651|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493652|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
155493653|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493654|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493655|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493656|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
155493657|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493658|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493659|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
155493660|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493661|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493662|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493663|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
155493664|NCT04242498|561231444|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493665|NCT04242498|561231445|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
155493666|NCT04242498|561231446|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
155493667|NCT04242498|561231447|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493668|NCT04242498|561231448|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493669|NCT04242498|561231449|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493670|NCT04242498|561231450|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
155493671|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493672|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493673|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493674|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
155493675|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
155607424|NCT01636947|561651562|FG001|Overall Study|Protocol Violation|1|||
155607425|NCT01636947|561651561|FG000|Overall Study|Withdrawal by Subject|3|||
155607426|NCT01636947|561651562|FG001|Overall Study|Withdrawal by Subject|3|||
155607427|NCT01636947|561651561|FG000|Overall Study|Adverse Event|1|||
155607428|NCT01636947|561651562|FG001|Overall Study|Adverse Event|1|||
155607429|NCT01636947|561651561|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155607430|NCT01636947|561651562|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
155493676|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
155493677|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
155493678|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493679|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493680|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493681|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
155493682|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
155493683|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
155493684|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
155493685|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493686|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493687|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493688|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493689|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
155493690|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
155493691|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
155493692|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493693|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493694|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
155493695|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
155493696|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
155493697|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
155493698|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
155607431|NCT02696434|561651563|FG000|Overall Study|Adverse Event|3|||
155607432|NCT02696434|561651564|FG001|Overall Study|Adverse Event|1|||
155607433|NCT02696434|561651563|FG000|Overall Study|Lost to Follow-up|5|||
155607434|NCT02696434|561651564|FG001|Overall Study|Lost to Follow-up|4|||
155607435|NCT02696434|561651563|FG000|Overall Study|Withdrawal by Subject|14|||
155607436|NCT02696434|561651564|FG001|Overall Study|Withdrawal by Subject|12|||
155607437|NCT02696434|561651563|FG000|Overall Study|Physician Decision|0|||
155607438|NCT02696434|561651564|FG001|Overall Study|Physician Decision|1|||
155493699|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155493700|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155607439|NCT00427999|561651573|FG000|Overall Study|Adverse Event|6|||
155607440|NCT00427999|561651573|FG000|Overall Study|Abnormal laboratory values|1|||
155607441|NCT00427999|561651573|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
155493701|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
155493702|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
155513842|NCT02524379|561308155|FG000|Overall Study|Death|1|||
155607442|NCT00427999|561651573|FG000|Overall Study|Protocol Violation|2|||
155607443|NCT00427999|561651573|FG000|Overall Study|Withdrawal by Subject|9|||
155493703|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
155493704|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
155607444|NCT00427999|561651573|FG000|Overall Study|Death|1|||
155607445|NCT02284568|561651574|FG000|Overall Study|Adverse Event|2|||
155607446|NCT02284568|561651575|FG001|Overall Study|Adverse Event|9|||
155607447|NCT02284568|561651576|FG002|Overall Study|Adverse Event|4|||
155607448|NCT02284568|561651574|FG000|Overall Study|Withdrawal by Subject|22|||
155607449|NCT02284568|561651575|FG001|Overall Study|Withdrawal by Subject|21|||
155607450|NCT02284568|561651576|FG002|Overall Study|Withdrawal by Subject|1|||
155607451|NCT02284568|561651574|FG000|Overall Study|Noncompliance with study drug admin|1|||
155607452|NCT02284568|561651575|FG001|Overall Study|Noncompliance with study drug admin|2|||
155607453|NCT02284568|561651576|FG002|Overall Study|Noncompliance with study drug admin|0|||
155607454|NCT02284568|561651574|FG000|Overall Study|Noncompliance|1|||
155607455|NCT02284568|561651575|FG001|Overall Study|Noncompliance|0|||
155607456|NCT02284568|561651576|FG002|Overall Study|Noncompliance|0|||
155607457|NCT02284568|561651574|FG000|Overall Study|Protocol Violation|0|||
155607458|NCT02284568|561651575|FG001|Overall Study|Protocol Violation|1|||
155607459|NCT02284568|561651576|FG002|Overall Study|Protocol Violation|0|||
155607460|NCT02284568|561651574|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
155607461|NCT02284568|561651575|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
155607462|NCT02284568|561651576|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
155607463|NCT02284568|561651574|FG000|Overall Study|Lost to Follow-up|0|||
155607464|NCT02284568|561651575|FG001|Overall Study|Lost to Follow-up|3|||
155607465|NCT02284568|561651576|FG002|Overall Study|Lost to Follow-up|0|||
155607466|NCT02284568|561651574|FG000|Overall Study|Lack of Efficacy|4|||
155607467|NCT02284568|561651575|FG001|Overall Study|Lack of Efficacy|7|||
155607468|NCT02284568|561651576|FG002|Overall Study|Lack of Efficacy|0|||
155607469|NCT02284568|561651574|FG000|Overall Study|Other|1|||
155607470|NCT02284568|561651575|FG001|Overall Study|Other|2|||
155607471|NCT02284568|561651576|FG002|Overall Study|Other|0|||
155607472|NCT02284568|561651574|FG000|Overall Study|Withdrew before taking study drug|0|||
155607473|NCT02284568|561651575|FG001|Overall Study|Withdrew before taking study drug|1|||
155607474|NCT02284568|561651576|FG002|Overall Study|Withdrew before taking study drug|0|||
155607475|NCT03956615|561651587|FG000|Overall Study|No multiple myeloma confirmed|2|||
155607476|NCT03956615|561651587|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
155607477|NCT03956615|561651587|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
155607478|NCT03956615|561651587|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
155607479|NCT01955109|561651588|FG000|Overall Study|Adverse Event|2|||
155607480|NCT01955109|561651589|FG001|Overall Study|Adverse Event|0|||
155607481|NCT01955109|561651588|FG000|Overall Study|Participant unwilling to continue|35|||
155607482|NCT01955109|561651589|FG001|Overall Study|Participant unwilling to continue|7|||
155607483|NCT01955109|561651588|FG000|Overall Study|Physician Decision|2|||
155607484|NCT01955109|561651589|FG001|Overall Study|Physician Decision|0|||
155607485|NCT01955109|561651588|FG000|Overall Study|Lost to Follow-up|3|||
155607486|NCT01955109|561651589|FG001|Overall Study|Lost to Follow-up|1|||
155607487|NCT01955109|561651588|FG000|Overall Study|Non-compliance|3|||
155607488|NCT01955109|561651589|FG001|Overall Study|Non-compliance|1|||
155607489|NCT03013985|561651597|FG000|Overall Study|Protocol Violation|2|||
155607490|NCT03013985|561651598|FG001|Overall Study|Protocol Violation|2|||
155607491|NCT03013985|561651597|FG000|Overall Study|Withdrawal by Subject|14|||
155607492|NCT03013985|561651598|FG001|Overall Study|Withdrawal by Subject|17|||
155607493|NCT01887678|561651599|FG000|Overall Study|Adverse Event|4|||
155607494|NCT01887678|561651600|FG001|Overall Study|Adverse Event|6|||
155607495|NCT01887678|561651599|FG000|Overall Study|Exceeded rescue medication dosage|4|||
155607496|NCT01887678|561651600|FG001|Overall Study|Exceeded rescue medication dosage|5|||
155607497|NCT01887678|561651599|FG000|Overall Study|Withdrawal of consent|3|||
155607498|NCT01887678|561651600|FG001|Overall Study|Withdrawal of consent|4|||
155607499|NCT01887678|561651599|FG000|Overall Study|Lost to Follow-up|4|||
155607500|NCT01887678|561651600|FG001|Overall Study|Lost to Follow-up|2|||
155607501|NCT01887678|561651599|FG000|Overall Study|Deterioration of clinical condition|0|||
155607502|NCT01887678|561651600|FG001|Overall Study|Deterioration of clinical condition|4|||
155607503|NCT01887678|561651599|FG000|Overall Study|Lack of Efficacy|1|||
155607504|NCT01887678|561651600|FG001|Overall Study|Lack of Efficacy|2|||
155607505|NCT01887678|561651599|FG000|Overall Study|Non-compliance|0|||
155607506|NCT01887678|561651600|FG001|Overall Study|Non-compliance|3|||
155607507|NCT01887678|561651599|FG000|Overall Study|Specified|1|||
155607508|NCT01887678|561651600|FG001|Overall Study|Specified|2|||
155607509|NCT03411902|561651601|FG000|Overall Study|Lost to Follow-up|3|||
155607510|NCT03411902|561651602|FG001|Overall Study|Lost to Follow-up|0|||
155607511|NCT00791492|561651605|FG000|Overall Study|Withdrawal by Subject|1|||
155607512|NCT00791492|561651606|FG001|Overall Study|Withdrawal by Subject|2|||
155607513|NCT00791492|561651605|FG000|Overall Study|Liver transplantation|5|||
155607514|NCT00791492|561651606|FG001|Overall Study|Liver transplantation|1|||
155607515|NCT00076999|561651609|FG000|Overall Study|Adverse Event|2|||
155607516|NCT00076999|561651610|FG001|Overall Study|Adverse Event|8|||
155607517|NCT00076999|561651611|FG002|Overall Study|Adverse Event|6|||
155607518|NCT00076999|561651612|FG003|Overall Study|Adverse Event|0|||
155607519|NCT00076999|561651613|FG004|Overall Study|Adverse Event|2|||
155607520|NCT00076999|561651609|FG000|Overall Study|Protocol Violation|0|||
155607521|NCT00076999|561651610|FG001|Overall Study|Protocol Violation|3|||
155607522|NCT00076999|561651611|FG002|Overall Study|Protocol Violation|4|||
155607523|NCT00076999|561651612|FG003|Overall Study|Protocol Violation|0|||
155607524|NCT00076999|561651613|FG004|Overall Study|Protocol Violation|9|||
155607525|NCT00076999|561651609|FG000|Overall Study|Lost to Follow-up|2|||
155607526|NCT00076999|561651610|FG001|Overall Study|Lost to Follow-up|1|||
155607527|NCT00076999|561651611|FG002|Overall Study|Lost to Follow-up|0|||
155607528|NCT00076999|561651612|FG003|Overall Study|Lost to Follow-up|0|||
155607529|NCT00076999|561651613|FG004|Overall Study|Lost to Follow-up|0|||
155607530|NCT00076999|561651609|FG000|Overall Study|Withdrawal by Subject|0|||
155607531|NCT00076999|561651610|FG001|Overall Study|Withdrawal by Subject|4|||
155607532|NCT00076999|561651611|FG002|Overall Study|Withdrawal by Subject|3|||
155607533|NCT00076999|561651612|FG003|Overall Study|Withdrawal by Subject|0|||
155607534|NCT00076999|561651613|FG004|Overall Study|Withdrawal by Subject|1|||
155607535|NCT00076999|561651609|FG000|Overall Study|Other reason (not specified)|8|||
155607536|NCT00076999|561651610|FG001|Overall Study|Other reason (not specified)|8|||
155607537|NCT00076999|561651611|FG002|Overall Study|Other reason (not specified)|4|||
155607538|NCT00076999|561651612|FG003|Overall Study|Other reason (not specified)|1|||
155607539|NCT00076999|561651613|FG004|Overall Study|Other reason (not specified)|13|||
155607540|NCT01217385|561651615|FG000|Overall Study|Withdrawal by Subject|3|||
155607541|NCT01217385|561651615|FG000|Overall Study|DOSI not performed/not eval|12|||
155607542|NCT01217385|561651615|FG000|Overall Study|Central Path not Available|1|||
155607543|NCT01217385|561651615|FG000|Overall Study|Normal Breast TOI not available|10|||
155607544|NCT01534208|561651620|FG000|Overall Study|Lost to Follow-up|19|||
155607545|NCT01534208|561651621|FG001|Overall Study|Lost to Follow-up|14|||
155607546|NCT01534208|561651620|FG000|Overall Study|Withdrawal by Subject|6|||
155607547|NCT01534208|561651621|FG001|Overall Study|Withdrawal by Subject|20|||
155607548|NCT01534208|561651620|FG000|Overall Study|Adverse Event|15|||
155607549|NCT01534208|561651621|FG001|Overall Study|Adverse Event|8|||
155607550|NCT01534208|561651620|FG000|Overall Study|Physician Decision|2|||
155607551|NCT01534208|561651621|FG001|Overall Study|Physician Decision|0|||
155607552|NCT01534208|561651620|FG000|Overall Study|Lack of Efficacy|0|||
155607553|NCT01534208|561651621|FG001|Overall Study|Lack of Efficacy|3|||
155607554|NCT01534208|561651620|FG000|Overall Study|Protocol Violation|2|||
155607555|NCT01534208|561651621|FG001|Overall Study|Protocol Violation|2|||
155607556|NCT01534208|561651620|FG000|Overall Study|Sponsor decision|4|||
155607557|NCT01534208|561651621|FG001|Overall Study|Sponsor decision|1|||
155607558|NCT01534208|561651620|FG000|Overall Study|Subject relocation|2|||
155607559|NCT01534208|561651621|FG001|Overall Study|Subject relocation|0|||
155607560|NCT01534208|561651620|FG000|Overall Study|Lab assessment|2|||
155607561|NCT01534208|561651621|FG001|Overall Study|Lab assessment|1|||
155607562|NCT01534208|561651620|FG000|Overall Study|Eligibility error|3|||
155607563|NCT01534208|561651621|FG001|Overall Study|Eligibility error|0|||
155607564|NCT01534208|561651620|FG000|Overall Study|PCP decision|1|||
155607565|NCT01534208|561651621|FG001|Overall Study|PCP decision|0|||
155607566|NCT01534208|561651620|FG000|Overall Study|Needed prohibited meds|1|||
155607567|NCT01534208|561651621|FG001|Overall Study|Needed prohibited meds|0|||
155607568|NCT00672841|561651624|FG000|Overall Study|Comfort care|1|||
155607569|NCT00672841|561651625|FG001|Overall Study|Comfort care|4|||
155607570|NCT00672841|561651624|FG000|Overall Study|icteric specimens|0|||
155607571|NCT00672841|561651625|FG001|Overall Study|icteric specimens|3|||
155607572|NCT00672841|561651624|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
155607573|NCT00672841|561651625|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
155607574|NCT00672841|561651624|FG000|Overall Study|Adverse Event|0|||
155607575|NCT00672841|561651625|FG001|Overall Study|Adverse Event|3|||
155607576|NCT00672841|561651624|FG000|Overall Study|Pregnancy|0|||
155607577|NCT00672841|561651625|FG001|Overall Study|Pregnancy|1|||
155607578|NCT02638259|561651626|FG000|Treatment Period 1|Adverse Event|1|||
155607579|NCT02638259|561651627|FG001|Treatment Period 1|Adverse Event|5|||
155607580|NCT02638259|561651626|FG000|Treatment Period 1|Death|0|||
155266838|NCT05061537|560410909|FG004|Follow up|Other|0|||
155607581|NCT02638259|561651627|FG001|Treatment Period 1|Death|1|||
155607582|NCT02638259|561651626|FG000|Treatment Period 1|Lack of Efficacy|0|||
155607583|NCT02638259|561651627|FG001|Treatment Period 1|Lack of Efficacy|1|||
155607584|NCT02638259|561651626|FG000|Treatment Period 1|Protocol Violation|0|||
155607585|NCT02638259|561651627|FG001|Treatment Period 1|Protocol Violation|3|||
155607586|NCT02638259|561651626|FG000|Treatment Period 1|Withdrawal by Subject|4|||
155607587|NCT02638259|561651627|FG001|Treatment Period 1|Withdrawal by Subject|6|||
155607588|NCT02638259|561651626|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
155607589|NCT02638259|561651627|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
155266839|NCT05061537|560410905|FG000|Follow up|Study terminated by sponsor|0|||
155607590|NCT02638259|561651626|FG000|Treatment Period 2|Adverse Event|5|||
155607591|NCT02638259|561651627|FG001|Treatment Period 2|Adverse Event|4|||
155607592|NCT02638259|561651626|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155607593|NCT02638259|561651627|FG001|Treatment Period 2|Withdrawal by Subject|7|||
155607594|NCT04299048|561651629|FG000|Overall Study|Death|1|||
155607595|NCT04299048|561651629|FG000|Overall Study|Global deterioration of health status|2|||
155493705|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
155493706|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155513843|NCT01829464|561308156|FG000|Overall Study|Adverse Event|1|||
155607596|NCT04299048|561651629|FG000|Overall Study|Enrolled and not treated|1|||
155607597|NCT00634049|561651630|FG000|Overall Study|Never received study drug|1|||
155607598|NCT00634049|561651630|FG000|Overall Study|Died prior to receiving study drug|1|||
155607599|NCT00634049|561651630|FG000|Overall Study|Screening failure|1|||
155607600|NCT01717391|561651631|FG000|Overall Study|Withdrawal by Subject|5|||
155607601|NCT01717391|561651631|FG000|Overall Study|Physician Decision|1|||
155607602|NCT01717391|561651631|FG000|Overall Study|FLT technical failure|3|||
155607603|NCT03677934|561651632|FG000|Overall Study|Adverse Event|1|||
155607604|NCT03677934|561651633|FG001|Overall Study|Adverse Event|1|||
155607605|NCT03677934|561651632|FG000|Overall Study|Death|8|||
155607606|NCT03677934|561651633|FG001|Overall Study|Death|4|||
155607607|NCT03677934|561651632|FG000|Overall Study|Lost to Follow-up|3|||
155607608|NCT03677934|561651633|FG001|Overall Study|Lost to Follow-up|0|||
155607609|NCT03677934|561651632|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155607610|NCT03677934|561651633|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155607611|NCT03677934|561651632|FG000|Overall Study|Physician Decision|0|||
155607612|NCT03677934|561651633|FG001|Overall Study|Physician Decision|1|||
155607613|NCT03677934|561651632|FG000|Overall Study|Withdrawal by Subject|1|||
155607614|NCT03677934|561651633|FG001|Overall Study|Withdrawal by Subject|7|||
155607615|NCT04769739|561651650|FG000|Overall Study|Colorectal cancer obstruction|2|||
155607616|NCT04769739|561651651|FG001|Overall Study|Colorectal cancer obstruction|0|||
155607617|NCT04769739|561651652|FG002|Overall Study|Colorectal cancer obstruction|0|||
155607618|NCT04769739|561651653|FG003|Overall Study|Colorectal cancer obstruction|0|||
155607619|NCT04769739|561651650|FG000|Overall Study|Failed cecal intubation|1|||
155607620|NCT04769739|561651651|FG001|Overall Study|Failed cecal intubation|0|||
155607621|NCT04769739|561651652|FG002|Overall Study|Failed cecal intubation|0|||
155607622|NCT04769739|561651653|FG003|Overall Study|Failed cecal intubation|1|||
155607623|NCT04769739|561651650|FG000|Overall Study|Poor bowel preparation|0|||
155607624|NCT04769739|561651651|FG001|Overall Study|Poor bowel preparation|0|||
155607625|NCT04769739|561651652|FG002|Overall Study|Poor bowel preparation|0|||
155607626|NCT04769739|561651653|FG003|Overall Study|Poor bowel preparation|1|||
155607627|NCT01260584|561651654|FG000|Period 1|Protocol Violation|0|||
155607628|NCT01260584|561651655|FG001|Period 1|Protocol Violation|0|||
155607629|NCT01260584|561651656|FG002|Period 1|Protocol Violation|1|||
155607630|NCT01260584|561651657|FG003|Period 1|Protocol Violation|1|||
155607631|NCT01260584|561651654|FG000|Period 1|Adverse Event|0|||
155607632|NCT01260584|561651655|FG001|Period 1|Adverse Event|0|||
155607633|NCT01260584|561651656|FG002|Period 1|Adverse Event|1|||
155607634|NCT01260584|561651657|FG003|Period 1|Adverse Event|0|||
155607635|NCT01260584|561651654|FG000|Period 2|Protocol Violation|0|||
155607636|NCT01260584|561651655|FG001|Period 2|Protocol Violation|2|||
155607637|NCT01260584|561651656|FG002|Period 2|Protocol Violation|3|||
155607638|NCT01260584|561651657|FG003|Period 2|Protocol Violation|1|||
155607639|NCT01260584|561651654|FG000|Period 2|Adverse Event|1|||
155607640|NCT01260584|561651655|FG001|Period 2|Adverse Event|0|||
155607641|NCT01260584|561651656|FG002|Period 2|Adverse Event|2|||
155607642|NCT01260584|561651657|FG003|Period 2|Adverse Event|0|||
155607643|NCT01260584|561651654|FG000|Period 2|Withdrawal by Subject|0|||
155607644|NCT01260584|561651655|FG001|Period 2|Withdrawal by Subject|1|||
155607645|NCT01260584|561651656|FG002|Period 2|Withdrawal by Subject|0|||
155607646|NCT01260584|561651657|FG003|Period 2|Withdrawal by Subject|0|||
155607647|NCT00045734|561651658|FG000|Overall Study|Protocol Violation|1|||
155607648|NCT02069093|561651659|FG000|Overall Study|Disease progression|14|||
155607649|NCT02069093|561651659|FG000|Overall Study|New cancer therapy|1|||
155607650|NCT02069093|561651659|FG000|Overall Study|Death|1|||
155607651|NCT02069093|561651659|FG000|Overall Study|Administrative problems|1|||
155607652|NCT02069093|561651659|FG000|Overall Study|Withdrawal by Subject|2|||
155607653|NCT02069093|561651659|FG000|Overall Study|Abnormal laboratory values|1|||
155607654|NCT02069093|561651659|FG000|Overall Study|Adverse Event|10|||
155607655|NCT03434249|561651661|FG000|Overall Study|Adverse Event|1|||
155607656|NCT03434249|561651662|FG001|Overall Study|Adverse Event|0|||
155607657|NCT03434249|561651661|FG000|Overall Study|Lost to Follow-up|0|||
155607658|NCT03434249|561651662|FG001|Overall Study|Lost to Follow-up|1|||
155607659|NCT03434249|561651661|FG000|Overall Study|Non-compliance of family|2|||
155607660|NCT03434249|561651662|FG001|Overall Study|Non-compliance of family|1|||
155607661|NCT03434249|561651661|FG000|Overall Study|Difficulties in completing daily diary|2|||
155607662|NCT03434249|561651662|FG001|Overall Study|Difficulties in completing daily diary|1|||
155607663|NCT00561470|561651663|FG000|Overall Study|Adverse Event|74|||
155607664|NCT00561470|561651664|FG001|Overall Study|Adverse Event|163|||
155607665|NCT00561470|561651663|FG000|Overall Study|Disease progression|437|||
155607666|NCT00561470|561651664|FG001|Overall Study|Disease progression|305|||
155650546|NCT00147537|561812505|FG003|Phase 2|Lost to Follow-up|0|||
155607667|NCT00561470|561651663|FG000|Overall Study|poor compliance to protocol|4|||
155607668|NCT00561470|561651664|FG001|Overall Study|poor compliance to protocol|4|||
155607669|NCT00561470|561651663|FG000|Overall Study|Lost to Follow-up|2|||
155607670|NCT00561470|561651664|FG001|Overall Study|Lost to Follow-up|0|||
155607671|NCT00561470|561651663|FG000|Overall Study|Physician Decision|21|||
155607672|NCT00561470|561651664|FG001|Overall Study|Physician Decision|20|||
155607673|NCT00561470|561651663|FG000|Overall Study|Consent Withdrawn|2|||
155607674|NCT00561470|561651664|FG001|Overall Study|Consent Withdrawn|6|||
155607675|NCT00561470|561651663|FG000|Overall Study|Subject request|43|||
155607676|NCT00561470|561651664|FG001|Overall Study|Subject request|77|||
155607677|NCT00561470|561651663|FG000|Overall Study|Metastatic surgery|10|||
155607678|NCT00561470|561651664|FG001|Overall Study|Metastatic surgery|12|||
155607679|NCT00561470|561651663|FG000|Overall Study|Unauthorized procedure|3|||
155607680|NCT00561470|561651664|FG001|Overall Study|Unauthorized procedure|1|||
155607681|NCT00561470|561651663|FG000|Overall Study|Randomized but not treated|5|||
155607682|NCT00561470|561651664|FG001|Overall Study|Randomized but not treated|5|||
155607683|NCT00561470|561651663|FG000|Overall Study|Missed visit window|1|||
155607684|NCT00561470|561651664|FG001|Overall Study|Missed visit window|4|||
155607685|NCT00561470|561651663|FG000|Overall Study|Planning surgery|1|||
155607686|NCT00561470|561651664|FG001|Overall Study|Planning surgery|1|||
155607687|NCT00561470|561651663|FG000|Overall Study|Ongoing Treatment|11|||
155607688|NCT00561470|561651664|FG001|Overall Study|Ongoing Treatment|14|||
155607689|NCT00232596|561651666|FG000|6-Week Titration Phase|Adverse Event|6|||
155607690|NCT00232596|561651667|FG001|6-Week Titration Phase|Adverse Event|19|||
155607691|NCT00232596|561651666|FG000|6-Week Titration Phase|Failed to Return|2|||
155607692|NCT00232596|561651667|FG001|6-Week Titration Phase|Failed to Return|1|||
155607693|NCT00232596|561651666|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
155607694|NCT00232596|561651667|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
155607695|NCT00232596|561651666|FG000|6-Week Titration Phase|Protocol Violation|1|||
155607696|NCT00232596|561651667|FG001|6-Week Titration Phase|Protocol Violation|3|||
155607697|NCT00232596|561651666|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
155607698|NCT00232596|561651667|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
155607699|NCT00232596|561651666|FG000|6-Week Titration Phase|Other|3|||
155607700|NCT00232596|561651667|FG001|6-Week Titration Phase|Other|3|||
155607701|NCT00232596|561651666|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155607702|NCT00232596|561651667|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
155607703|NCT00232596|561651666|FG000|12-Week Maintenance Phase|Adverse Event|7|||
155607704|NCT00232596|561651667|FG001|12-Week Maintenance Phase|Adverse Event|22|||
155607705|NCT00232596|561651666|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
155607706|NCT00232596|561651667|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
155607707|NCT00232596|561651666|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
155607708|NCT00232596|561651667|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
155607709|NCT00232596|561651666|FG000|12-Week Maintenance Phase|Other|1|||
155607710|NCT00232596|561651667|FG001|12-Week Maintenance Phase|Other|3|||
155607711|NCT01253174|561651668|FG000|Period 1|Randomized but not treated|0|||
155607712|NCT01253174|561651669|FG001|Period 1|Randomized but not treated|1|||
155607713|NCT01253174|561651670|FG002|Period 1|Randomized but not treated|1|||
155607714|NCT01253174|561651671|FG003|Period 1|Randomized but not treated|0|||
155607715|NCT01253174|561651672|FG004|Period 1|Randomized but not treated|1|||
155607716|NCT01253174|561651673|FG005|Period 1|Randomized but not treated|0|||
155607717|NCT01253174|561651668|FG000|Period 2|Adverse Event|0|||
155607718|NCT01253174|561651669|FG001|Period 2|Adverse Event|0|||
155607719|NCT01253174|561651670|FG002|Period 2|Adverse Event|1|||
155607720|NCT01253174|561651671|FG003|Period 2|Adverse Event|0|||
155607721|NCT01253174|561651672|FG004|Period 2|Adverse Event|0|||
155607722|NCT01253174|561651673|FG005|Period 2|Adverse Event|0|||
155607723|NCT01253174|561651668|FG000|Period 3|Withdrawal by Subject|0|||
155607724|NCT01253174|561651669|FG001|Period 3|Withdrawal by Subject|1|||
155607725|NCT01253174|561651670|FG002|Period 3|Withdrawal by Subject|0|||
155607726|NCT01253174|561651671|FG003|Period 3|Withdrawal by Subject|0|||
155607727|NCT01253174|561651672|FG004|Period 3|Withdrawal by Subject|1|||
155607728|NCT01253174|561651673|FG005|Period 3|Withdrawal by Subject|0|||
155607729|NCT01253174|561651668|FG000|Period 3|Pregnancy|0|||
155607730|NCT01253174|561651669|FG001|Period 3|Pregnancy|0|||
155607731|NCT01253174|561651670|FG002|Period 3|Pregnancy|1|||
155607732|NCT01253174|561651671|FG003|Period 3|Pregnancy|0|||
155607733|NCT01253174|561651672|FG004|Period 3|Pregnancy|0|||
155607734|NCT01253174|561651673|FG005|Period 3|Pregnancy|0|||
155650547|NCT00147537|561812506|FG004|Phase 2|Lost to Follow-up|0|||
155650548|NCT00147537|561812507|FG005|Phase 2|Lost to Follow-up|0|||
155650549|NCT00147537|561812508|FG006|Phase 2|Lost to Follow-up|0|||
155650550|NCT00147537|561812509|FG007|Phase 2|Lost to Follow-up|0|||
155650551|NCT00147537|561812510|FG008|Phase 2|Lost to Follow-up|0|||
155650552|NCT00147537|561812511|FG009|Phase 2|Lost to Follow-up|12|||
155650553|NCT00147537|561812512|FG010|Phase 2|Lost to Follow-up|4|||
155650554|NCT00147537|561812502|FG000|Phase 2|Other|0|||
155650555|NCT00147537|561812503|FG001|Phase 2|Other|0|||
155650556|NCT00147537|561812504|FG002|Phase 2|Other|0|||
155650557|NCT00147537|561812505|FG003|Phase 2|Other|0|||
155607735|NCT02510820|561653579|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155607736|NCT02510820|561653580|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155607737|NCT02510820|561653579|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155607738|NCT02510820|561653580|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155607739|NCT03089853|561653581|FG000|Overall Study|Lost to Follow-up|2|||
155607740|NCT03089853|561653582|FG001|Overall Study|Lost to Follow-up|1|||
155607741|NCT01317004|561653583|FG000|Overall Study|Withdrawal by Subject|1|||
155607742|NCT01317004|561653584|FG001|Overall Study|Withdrawal by Subject|4|||
155607743|NCT01317004|561653583|FG000|Overall Study|Protocol Violation|0|||
155721707|NCT03651765|562080107|FG000|Overall Study|Miscellaneous|6|||
155721708|NCT03267277|562080108|FG000|Overall Study|Withdrawal by Subject|1|||
155721709|NCT00953667|562080109|FG000|Overall Study|Lost to Follow-up|11|||
155721710|NCT00953667|562080109|FG000|Overall Study|Physician Decision|35|||
155721711|NCT00953667|562080109|FG000|Overall Study|Withdrawal by Subject|63|||
155721712|NCT00953667|562080109|FG000|Overall Study|Adverse Event|10|||
155721713|NCT00953667|562080109|FG000|Overall Study|poor venous access,unable to draw blood|4|||
155721714|NCT03521570|562080110|FG000|Overall Study|Not eligible|11|||
155721715|NCT00322881|562080112|FG000|Overall Study|Death|2|||
155721716|NCT00322881|562080112|FG000|Overall Study|Adverse Event|1|||
155721717|NCT00322881|562080112|FG000|Overall Study|Disease Progression|2|||
155721718|NCT00537394|562080118|FG000|First Year of Follow-up|Death|7|||
155721719|NCT00537394|562080119|FG001|First Year of Follow-up|Death|0|||
155721720|NCT00537394|562080120|FG002|First Year of Follow-up|Death|0|||
155721721|NCT00537394|562080118|FG000|First Year of Follow-up|Severe debilitation|1|||
155721722|NCT00537394|562080119|FG001|First Year of Follow-up|Severe debilitation|0|||
155721723|NCT00537394|562080120|FG002|First Year of Follow-up|Severe debilitation|1|||
155721724|NCT00537394|562080118|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
155721725|NCT00537394|562080119|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
155721726|NCT00537394|562080120|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
155721727|NCT00537394|562080118|FG000|First Year of Follow-up|Lost to Follow-up|1|||
155721728|NCT00537394|562080119|FG001|First Year of Follow-up|Lost to Follow-up|5|||
155721729|NCT00537394|562080120|FG002|First Year of Follow-up|Lost to Follow-up|1|||
155721730|NCT00537394|562080118|FG000|2nd Year of Follow-up|Death|4|||
155721731|NCT00537394|562080119|FG001|2nd Year of Follow-up|Death|1|||
155721732|NCT00537394|562080120|FG002|2nd Year of Follow-up|Death|2|||
155721733|NCT00537394|562080118|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
155721734|NCT00537394|562080119|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
155721735|NCT00537394|562080120|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
155721736|NCT00537394|562080118|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
155721737|NCT00537394|562080119|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
155721738|NCT00537394|562080120|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
155266840|NCT05061537|560410906|FG001|Follow up|Study terminated by sponsor|0|||
155721739|NCT00537394|562080118|FG000|2nd Year of Follow-up|Clinic site closure|1|||
155721740|NCT00537394|562080119|FG001|2nd Year of Follow-up|Clinic site closure|0|||
155721741|NCT00537394|562080120|FG002|2nd Year of Follow-up|Clinic site closure|0|||
155721742|NCT02183675|562080121|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
155721743|NCT02183675|562080122|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
155721744|NCT02183675|562080123|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
155721745|NCT02183675|562080124|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
155721746|NCT02183675|562080125|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
155721747|NCT02183675|562080126|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
155721748|NCT01521117|562080127|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
155721749|NCT01521117|562080128|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155721750|NCT01521117|562080127|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
155721751|NCT01521117|562080128|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
155721752|NCT01521117|562080127|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155721753|NCT01521117|562080128|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
155721754|NCT01056822|562080129|FG000|Overall Study|Adverse Event|0|||
155721755|NCT01056822|562080130|FG001|Overall Study|Adverse Event|1|||
155721756|NCT01056822|562080129|FG000|Overall Study|Protocol Violation|6|||
155721757|NCT01056822|562080130|FG001|Overall Study|Protocol Violation|5|||
155721758|NCT01056822|562080129|FG000|Overall Study|Withdrawal by Subject|1|||
155721759|NCT01056822|562080130|FG001|Overall Study|Withdrawal by Subject|1|||
155721760|NCT01056822|562080129|FG000|Overall Study|Lost to Follow-up|1|||
155721761|NCT01056822|562080130|FG001|Overall Study|Lost to Follow-up|0|||
155721762|NCT05135871|562080144|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
155721763|NCT05135871|562080145|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
155721764|NCT05135871|562080146|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
155721765|NCT05135871|562080147|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
155721766|NCT00525512|562080148|FG000|Double-Blind Phase|Adverse Event|48|||
155721767|NCT00525512|562080149|FG001|Double-Blind Phase|Adverse Event|28|||
155266841|NCT05061537|560410907|FG002|Follow up|Study terminated by sponsor|2|||
155721768|NCT00525512|562080150|FG002|Double-Blind Phase|Adverse Event|0|||
155721769|NCT00525512|562080151|FG003|Double-Blind Phase|Adverse Event|0|||
155721770|NCT00525512|562080148|FG000|Double-Blind Phase|Protocol Violation|3|||
155721771|NCT00525512|562080149|FG001|Double-Blind Phase|Protocol Violation|1|||
155721772|NCT00525512|562080150|FG002|Double-Blind Phase|Protocol Violation|0|||
155721773|NCT00525512|562080151|FG003|Double-Blind Phase|Protocol Violation|0|||
155721774|NCT00525512|562080148|FG000|Double-Blind Phase|Lost to Follow-up|3|||
155721775|NCT00525512|562080149|FG001|Double-Blind Phase|Lost to Follow-up|7|||
155721776|NCT00525512|562080150|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155721777|NCT00525512|562080151|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155721778|NCT00525512|562080148|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
155721779|NCT00525512|562080149|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
155721780|NCT00525512|562080150|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155721781|NCT00525512|562080151|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155721782|NCT00525512|562080148|FG000|Double-Blind Phase|Lack of Efficacy|13|||
155721783|NCT00525512|562080149|FG001|Double-Blind Phase|Lack of Efficacy|5|||
155721784|NCT00525512|562080150|FG002|Double-Blind Phase|Lack of Efficacy|0|||
155721785|NCT00525512|562080151|FG003|Double-Blind Phase|Lack of Efficacy|0|||
155721786|NCT00525512|562080148|FG000|Double-Blind Phase|Other reason (not specified)|12|||
155721787|NCT00525512|562080149|FG001|Double-Blind Phase|Other reason (not specified)|13|||
155721788|NCT00525512|562080150|FG002|Double-Blind Phase|Other reason (not specified)|0|||
155721789|NCT00525512|562080151|FG003|Double-Blind Phase|Other reason (not specified)|0|||
155721790|NCT00525512|562080148|FG000|Open-Label Phase|Adverse Event|0|||
155721791|NCT00525512|562080149|FG001|Open-Label Phase|Adverse Event|0|||
155721792|NCT00525512|562080150|FG002|Open-Label Phase|Adverse Event|1|||
155721793|NCT00525512|562080151|FG003|Open-Label Phase|Adverse Event|0|||
155721794|NCT00525512|562080148|FG000|Open-Label Phase|Lost to Follow-up|0|||
155721795|NCT00525512|562080149|FG001|Open-Label Phase|Lost to Follow-up|0|||
155721796|NCT00525512|562080150|FG002|Open-Label Phase|Lost to Follow-up|1|||
155721797|NCT00525512|562080151|FG003|Open-Label Phase|Lost to Follow-up|0|||
155721798|NCT00525512|562080148|FG000|Open-Label Phase|Other reason (not specified)|0|||
155721799|NCT00525512|562080149|FG001|Open-Label Phase|Other reason (not specified)|0|||
155721800|NCT00525512|562080150|FG002|Open-Label Phase|Other reason (not specified)|4|||
155721801|NCT00525512|562080151|FG003|Open-Label Phase|Other reason (not specified)|5|||
155607744|NCT01317004|561653584|FG001|Overall Study|Protocol Violation|2|||
155607745|NCT01317004|561653583|FG000|Overall Study|Adverse Event|3|||
155607746|NCT01317004|561653584|FG001|Overall Study|Adverse Event|3|||
155607747|NCT04114656|561653589|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
155607748|NCT04114656|561653590|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
155607749|NCT04114656|561653589|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
155607750|NCT04114656|561653590|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
155607751|NCT04114656|561653589|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
155607752|NCT04114656|561653590|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
155607753|NCT04114656|561653589|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
155607754|NCT04114656|561653590|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
155607755|NCT04114656|561653589|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
155607756|NCT04114656|561653590|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
155607757|NCT01393106|561653591|FG000|Overall Study|Adverse Event|3|||
155607758|NCT01393106|561653591|FG000|Overall Study|Withdrawal by Subject|1|||
155607759|NCT01393106|561653591|FG000|Overall Study|Lack of Efficacy|1|||
155607760|NCT03052920|561653592|FG000|Overall Study|Withdrawal by Subject|1|||
155607761|NCT01698268|561653593|FG000|Overall Study|Physician Decision|2|||
155607762|NCT01698268|561653594|FG001|Overall Study|Physician Decision|1|||
155607763|NCT02263729|561653595|FG000|Overall Study|Lost to Follow-up|1|||
155607764|NCT02263729|561653596|FG001|Overall Study|Lost to Follow-up|1|||
155607765|NCT04591015|561653597|FG000|Overall Study|Death|6|||
155607766|NCT04591015|561653598|FG001|Overall Study|Death|4|||
155607767|NCT04591015|561653597|FG000|Overall Study|Withdrawal by Subject|6|||
155607768|NCT04591015|561653598|FG001|Overall Study|Withdrawal by Subject|3|||
155607769|NCT04591015|561653597|FG000|Overall Study|Lost to Follow-up|16|||
155607770|NCT04591015|561653598|FG001|Overall Study|Lost to Follow-up|11|||
155607771|NCT02509078|561653599|FG000|Overall Study|Protocol Violation|1|||
155607772|NCT02509078|561653600|FG001|Overall Study|Protocol Violation|1|||
155607773|NCT03594955|561653601|FG000|Overall Study|Adverse Event|1|||
155607774|NCT03594955|561653601|FG000|Overall Study|Progressive disease|5|||
155607775|NCT03594955|561653601|FG000|Overall Study|Sponsor's decision|1|||
155607776|NCT03539484|561653603|FG000|Overall Study|Death|1|||
155607777|NCT03539484|561653604|FG001|Overall Study|Death|0|||
155607778|NCT03539484|561653605|FG002|Overall Study|Death|0|||
155607779|NCT03539484|561653606|FG003|Overall Study|Death|2|||
155607780|NCT03539484|561653607|FG004|Overall Study|Death|8|||
155607781|NCT03539484|561653608|FG005|Overall Study|Death|3|||
155607782|NCT03539484|561653609|FG006|Overall Study|Death|0|||
155721802|NCT01601535|562080152|FG000|Phase 1|Adverse Event|1|||
155607783|NCT03539484|561653603|FG000|Overall Study|Lost to Follow-up|0|||
155607784|NCT03539484|561653604|FG001|Overall Study|Lost to Follow-up|1|||
155607785|NCT03539484|561653605|FG002|Overall Study|Lost to Follow-up|0|||
155607786|NCT03539484|561653606|FG003|Overall Study|Lost to Follow-up|0|||
155607787|NCT03539484|561653607|FG004|Overall Study|Lost to Follow-up|1|||
155607788|NCT03539484|561653608|FG005|Overall Study|Lost to Follow-up|0|||
155607789|NCT03539484|561653609|FG006|Overall Study|Lost to Follow-up|0|||
155607790|NCT03539484|561653603|FG000|Overall Study|Withdrawal by Subject|0|||
155607791|NCT03539484|561653604|FG001|Overall Study|Withdrawal by Subject|0|||
155607792|NCT03539484|561653605|FG002|Overall Study|Withdrawal by Subject|0|||
155607793|NCT03539484|561653606|FG003|Overall Study|Withdrawal by Subject|0|||
155607794|NCT03539484|561653607|FG004|Overall Study|Withdrawal by Subject|2|||
155607795|NCT03539484|561653608|FG005|Overall Study|Withdrawal by Subject|0|||
155607796|NCT03539484|561653609|FG006|Overall Study|Withdrawal by Subject|1|||
155721803|NCT01601535|562080153|FG001|Phase 1|Adverse Event|0|||
155721804|NCT01601535|562080154|FG002|Phase 1|Adverse Event|2|||
155721805|NCT01601535|562080155|FG003|Phase 1|Adverse Event|1|||
155721806|NCT01601535|562080156|FG004|Phase 1|Adverse Event|0|||
155721807|NCT01601535|562080157|FG005|Phase 1|Adverse Event|0|||
155721808|NCT01601535|562080152|FG000|Phase 1|Withdrawal by Subject|2|||
155721809|NCT01601535|562080153|FG001|Phase 1|Withdrawal by Subject|1|||
155721810|NCT01601535|562080154|FG002|Phase 1|Withdrawal by Subject|1|||
155607797|NCT03539484|561653603|FG000|Overall Study|Study Terminated by Sponsor|0|||
155607798|NCT03539484|561653604|FG001|Overall Study|Study Terminated by Sponsor|0|||
155607799|NCT03539484|561653605|FG002|Overall Study|Study Terminated by Sponsor|1|||
155607800|NCT03539484|561653606|FG003|Overall Study|Study Terminated by Sponsor|1|||
155607801|NCT03539484|561653607|FG004|Overall Study|Study Terminated by Sponsor|2|||
155607802|NCT03539484|561653608|FG005|Overall Study|Study Terminated by Sponsor|2|||
155607803|NCT03539484|561653609|FG006|Overall Study|Study Terminated by Sponsor|1|||
155607804|NCT00631163|561653612|FG000|Number of Participants in Year 1|Adverse Event|12|||
155607805|NCT00631163|561653612|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
155607806|NCT00631163|561653612|FG000|Number of Participants in Year 1|Death|6|||
155721811|NCT01601535|562080155|FG003|Phase 1|Withdrawal by Subject|2|||
155721812|NCT01601535|562080156|FG004|Phase 1|Withdrawal by Subject|0|||
155721813|NCT01601535|562080157|FG005|Phase 1|Withdrawal by Subject|0|||
155721814|NCT01601535|562080152|FG000|Phase 1|Progressive Disease|2|||
155721815|NCT01601535|562080153|FG001|Phase 1|Progressive Disease|3|||
155721816|NCT01601535|562080154|FG002|Phase 1|Progressive Disease|2|||
155721817|NCT01601535|562080155|FG003|Phase 1|Progressive Disease|1|||
155721818|NCT01601535|562080156|FG004|Phase 1|Progressive Disease|0|||
155721819|NCT01601535|562080157|FG005|Phase 1|Progressive Disease|0|||
155721820|NCT01601535|562080152|FG000|Phase 1|Started Another Treatment|1|||
155721821|NCT01601535|562080153|FG001|Phase 1|Started Another Treatment|2|||
155721822|NCT01601535|562080154|FG002|Phase 1|Started Another Treatment|0|||
155721823|NCT01601535|562080155|FG003|Phase 1|Started Another Treatment|0|||
155721824|NCT01601535|562080156|FG004|Phase 1|Started Another Treatment|0|||
155721825|NCT01601535|562080157|FG005|Phase 1|Started Another Treatment|0|||
155721826|NCT01601535|562080152|FG000|Phase 2|Adverse Event|0|||
155721827|NCT01601535|562080153|FG001|Phase 2|Adverse Event|0|||
155721828|NCT01601535|562080154|FG002|Phase 2|Adverse Event|0|||
155721829|NCT01601535|562080155|FG003|Phase 2|Adverse Event|0|||
155721830|NCT01601535|562080156|FG004|Phase 2|Adverse Event|5|||
155721831|NCT01601535|562080157|FG005|Phase 2|Adverse Event|1|||
155721832|NCT01601535|562080152|FG000|Phase 2|Withdrawal by Subject|0|||
155721833|NCT01601535|562080153|FG001|Phase 2|Withdrawal by Subject|0|||
155721834|NCT01601535|562080154|FG002|Phase 2|Withdrawal by Subject|0|||
155721835|NCT01601535|562080155|FG003|Phase 2|Withdrawal by Subject|0|||
155721836|NCT01601535|562080156|FG004|Phase 2|Withdrawal by Subject|8|||
155721837|NCT01601535|562080157|FG005|Phase 2|Withdrawal by Subject|2|||
155721838|NCT01601535|562080152|FG000|Phase 2|Progressive Disease|0|||
155721839|NCT01601535|562080153|FG001|Phase 2|Progressive Disease|0|||
155721840|NCT01601535|562080154|FG002|Phase 2|Progressive Disease|0|||
155721841|NCT01601535|562080155|FG003|Phase 2|Progressive Disease|0|||
155607807|NCT00631163|561653612|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
155607808|NCT00631163|561653612|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
155607809|NCT00631163|561653612|FG000|Number of Participants in Year 1|Administrative problems|6|||
155607810|NCT00631163|561653612|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
155607811|NCT00631163|561653612|FG000|Number of Participants in Year 2|Adverse Event|1|||
155607812|NCT00631163|561653612|FG000|Number of Participants in Year 2|Protocol Violation|1|||
155607813|NCT00631163|561653612|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
155607814|NCT00460265|561653631|FG000|Overall Study|Lost to Follow-up|14|||
155607815|NCT00460265|561653632|FG001|Overall Study|Lost to Follow-up|15|||
155607816|NCT00460265|561653631|FG000|Overall Study|Physician Decision|1|||
155607817|NCT00460265|561653632|FG001|Overall Study|Physician Decision|2|||
155607818|NCT00460265|561653631|FG000|Overall Study|Withdrawal by Subject|10|||
155607819|NCT00460265|561653632|FG001|Overall Study|Withdrawal by Subject|25|||
155607820|NCT00460265|561653631|FG000|Overall Study|Ongoing|60|||
155721842|NCT01601535|562080156|FG004|Phase 2|Progressive Disease|5|||
155607821|NCT00460265|561653632|FG001|Overall Study|Ongoing|47|||
155607822|NCT00904839|561653633|FG000|Overall Study|Adverse Event|0|||
155607823|NCT00904839|561653634|FG001|Overall Study|Adverse Event|5|||
155607824|NCT00904839|561653635|FG002|Overall Study|Adverse Event|4|||
155721843|NCT01601535|562080157|FG005|Phase 2|Progressive Disease|7|||
155721844|NCT01601535|562080152|FG000|Phase 2|Started Another Treatment|0|||
155721845|NCT01601535|562080153|FG001|Phase 2|Started Another Treatment|0|||
155721846|NCT01601535|562080154|FG002|Phase 2|Started Another Treatment|0|||
155721847|NCT01601535|562080155|FG003|Phase 2|Started Another Treatment|0|||
155721848|NCT01601535|562080156|FG004|Phase 2|Started Another Treatment|1|||
155721849|NCT01601535|562080157|FG005|Phase 2|Started Another Treatment|2|||
155721850|NCT04576988|562080160|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
155721851|NCT04576988|562080161|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
155721852|NCT04576988|562080160|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
155721853|NCT04576988|562080161|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
155721854|NCT04576988|562080160|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
155721855|NCT04576988|562080161|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
155721856|NCT04576988|562080160|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
155721857|NCT04576988|562080161|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
155721858|NCT04576988|562080160|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
155721859|NCT04576988|562080161|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
155721860|NCT04576988|562080160|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
155721861|NCT04576988|562080161|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
155721862|NCT04576988|562080160|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
155721863|NCT04576988|562080161|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
155721864|NCT04576988|562080160|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
155721865|NCT04576988|562080161|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
155721866|NCT04576988|562080160|FG000|Long Term Double Blind (LTDB)|Death|2|||
155721867|NCT04576988|562080161|FG001|Long Term Double Blind (LTDB)|Death|1|||
155721868|NCT04576988|562080160|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
155721869|NCT04576988|562080161|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
155721870|NCT04886154|562080170|FG000|Overall Study|Adverse Event|0|||
155721871|NCT04886154|562080171|FG001|Overall Study|Adverse Event|0|||
155721872|NCT04886154|562080172|FG002|Overall Study|Adverse Event|0|||
155721873|NCT04886154|562080173|FG003|Overall Study|Adverse Event|0|||
155721874|NCT04886154|562080174|FG004|Overall Study|Adverse Event|1|||
155721875|NCT04886154|562080175|FG005|Overall Study|Adverse Event|0|||
155721876|NCT04886154|562080176|FG006|Overall Study|Adverse Event|0|||
155721877|NCT04886154|562080177|FG007|Overall Study|Adverse Event|1|||
155721878|NCT04886154|562080178|FG008|Overall Study|Adverse Event|1|||
155721879|NCT04886154|562080179|FG009|Overall Study|Adverse Event|0|||
155721880|NCT04886154|562080180|FG010|Overall Study|Adverse Event|0|||
155721881|NCT04886154|562080181|FG011|Overall Study|Adverse Event|1|||
155721882|NCT04886154|562080182|FG012|Overall Study|Adverse Event|0|||
155721883|NCT04886154|562080183|FG013|Overall Study|Adverse Event|0|||
155721884|NCT04886154|562080184|FG014|Overall Study|Adverse Event|3|||
155721885|NCT04886154|562080170|FG000|Overall Study|Lost to Follow-up|1|||
155721886|NCT04886154|562080171|FG001|Overall Study|Lost to Follow-up|0|||
155721887|NCT04886154|562080172|FG002|Overall Study|Lost to Follow-up|2|||
155721888|NCT04886154|562080173|FG003|Overall Study|Lost to Follow-up|0|||
155721889|NCT04886154|562080174|FG004|Overall Study|Lost to Follow-up|17|||
155721890|NCT04886154|562080175|FG005|Overall Study|Lost to Follow-up|7|||
155721891|NCT04886154|562080176|FG006|Overall Study|Lost to Follow-up|8|||
155721892|NCT04886154|562080177|FG007|Overall Study|Lost to Follow-up|7|||
155721893|NCT04886154|562080178|FG008|Overall Study|Lost to Follow-up|8|||
155721894|NCT04886154|562080179|FG009|Overall Study|Lost to Follow-up|0|||
155721895|NCT04886154|562080180|FG010|Overall Study|Lost to Follow-up|2|||
155721896|NCT04886154|562080181|FG011|Overall Study|Lost to Follow-up|0|||
155721897|NCT04886154|562080182|FG012|Overall Study|Lost to Follow-up|0|||
155721898|NCT04886154|562080183|FG013|Overall Study|Lost to Follow-up|0|||
155721899|NCT04886154|562080184|FG014|Overall Study|Lost to Follow-up|0|||
155721900|NCT04886154|562080170|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721901|NCT04886154|562080171|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721902|NCT04886154|562080172|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721903|NCT04886154|562080173|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721904|NCT04886154|562080174|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721905|NCT04886154|562080175|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721906|NCT04886154|562080176|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
155721907|NCT04886154|562080177|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721908|NCT04886154|562080178|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721909|NCT04886154|562080179|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721910|NCT04886154|562080180|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721911|NCT04886154|562080181|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721912|NCT04886154|562080182|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721913|NCT04886154|562080183|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721914|NCT04886154|562080184|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155721915|NCT04886154|562080170|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721916|NCT04886154|562080171|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155607825|NCT00904839|561653633|FG000|Overall Study|Protocol Violation|0|||
155607826|NCT00904839|561653634|FG001|Overall Study|Protocol Violation|1|||
155607827|NCT00904839|561653635|FG002|Overall Study|Protocol Violation|1|||
155607828|NCT00904839|561653633|FG000|Overall Study|Lost to Follow-up|0|||
155607829|NCT00904839|561653634|FG001|Overall Study|Lost to Follow-up|1|||
155607830|NCT00904839|561653635|FG002|Overall Study|Lost to Follow-up|2|||
155607831|NCT00904839|561653633|FG000|Overall Study|Withdrawal by Subject|0|||
155607832|NCT00904839|561653634|FG001|Overall Study|Withdrawal by Subject|2|||
155607833|NCT00904839|561653635|FG002|Overall Study|Withdrawal by Subject|0|||
155607834|NCT00904839|561653633|FG000|Overall Study|Not treated|1|||
155607835|NCT00904839|561653634|FG001|Overall Study|Not treated|0|||
155607836|NCT00904839|561653635|FG002|Overall Study|Not treated|1|||
155607837|NCT00904839|561653633|FG000|Overall Study|Other than above|0|||
155607838|NCT00904839|561653634|FG001|Overall Study|Other than above|9|||
155607839|NCT00904839|561653635|FG002|Overall Study|Other than above|7|||
155607840|NCT01853696|561653642|FG000|Overall Study|Withdrawal by Subject|1|||
155607841|NCT01853696|561653643|FG001|Overall Study|Withdrawal by Subject|1|||
155607842|NCT01853696|561653642|FG000|Overall Study|Lost to Follow-up|5|||
155607843|NCT01853696|561653643|FG001|Overall Study|Lost to Follow-up|4|||
155607844|NCT01797094|561653644|FG000|Overall Study|Adverse Event|1|||
155607845|NCT01797094|561653645|FG001|Overall Study|Adverse Event|1|||
155607846|NCT01797094|561653644|FG000|Overall Study|Personal Reasons|4|||
155607847|NCT01797094|561653645|FG001|Overall Study|Personal Reasons|0|||
155607848|NCT01797094|561653644|FG000|Overall Study|Protocol Violation|0|||
155607849|NCT01797094|561653645|FG001|Overall Study|Protocol Violation|1|||
155607850|NCT01797094|561653644|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155607851|NCT01797094|561653645|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155607852|NCT02147067|561653646|FG000|Overall Study|Withdrawal by Subject|2|||
155607853|NCT02147067|561653647|FG001|Overall Study|Withdrawal by Subject|2|||
155607854|NCT00821015|561653648|FG000|Overall Study|Lost to Follow-up|12|||
155607855|NCT00090987|561653654|FG000|Overall Study|Adverse Event|5|||
155607856|NCT00090987|561653654|FG000|Overall Study|Lack of Efficacy|7|||
155607857|NCT00090987|561653654|FG000|Overall Study|Withdrawal by Subject|3|||
155607858|NCT00090987|561653654|FG000|Overall Study|alternative therapy|1|||
155607859|NCT00090987|561653654|FG000|Overall Study|Non-compliance|4|||
155607860|NCT00090987|561653654|FG000|Overall Study|Incarcerated|1|||
155607861|NCT00990665|561653659|FG000|Overall Study|Unsuccessful Implant|8|||
155607862|NCT00990665|561653659|FG000|Overall Study|Death|29|||
155607863|NCT00990665|561653659|FG000|Overall Study|Heart Transplant|1|||
155607864|NCT00990665|561653659|FG000|Overall Study|Withdrawal by Subject|6|||
155607865|NCT00990665|561653659|FG000|Overall Study|Lost to Follow-up|1|||
155607866|NCT00990665|561653659|FG000|Overall Study|System Explant|3|||
155607867|NCT02603562|561653660|FG000|Overall Study|Lost to Follow-up|1|||
155607868|NCT00270231|561653661|FG000|First Intervention|Lost to Follow-up|1|||
155607869|NCT00270231|561653662|FG001|First Intervention|Lost to Follow-up|1|||
155607870|NCT00270231|561653661|FG000|Washout Period|Lost to Follow-up|1|||
155607871|NCT00270231|561653662|FG001|Washout Period|Lost to Follow-up|0|||
155607872|NCT00270231|561653661|FG000|Second Intervention|Lost to Follow-up|0|||
155607873|NCT00270231|561653662|FG001|Second Intervention|Lost to Follow-up|1|||
155607874|NCT00574795|561653671|FG000|Infant Series|Withdrawal by Subject|2|||
155607875|NCT00574795|561653671|FG000|Infant Series|Protocol Violation|2|||
155607876|NCT00574795|561653671|FG000|Infant Series|Adverse Event|1|||
155607877|NCT00574795|561653671|FG000|After Infant Series|Withdrawal by Subject|1|||
155607878|NCT00574795|561653671|FG000|After Infant Series|Adverse Event|2|||
155607879|NCT00574795|561653671|FG000|Toddler Dose|Withdrawal by Subject|1|||
155607880|NCT00957905|561653674|FG000|Part B|Not Treated|0|||
155607881|NCT00957905|561653675|FG001|Part B|Not Treated|1|||
155607882|NCT00957905|561653674|FG000|Part B|Physician Decision|0|||
155607883|NCT00957905|561653675|FG001|Part B|Physician Decision|1|||
155607884|NCT00957905|561653674|FG000|Part B|Death|0|||
155607885|NCT00957905|561653675|FG001|Part B|Death|1|||
155607886|NCT00957905|561653674|FG000|Part B|Protocol Violation|0|||
155607887|NCT00957905|561653675|FG001|Part B|Protocol Violation|1|||
155607888|NCT02450552|561653677|FG000|Overall Study|Withdrawal by Subject|4|||
155607889|NCT02450552|561653678|FG001|Overall Study|Withdrawal by Subject|0|||
155607890|NCT02450552|561653679|FG002|Overall Study|Withdrawal by Subject|4|||
155607891|NCT02450552|561653677|FG000|Overall Study|Physician Decision|1|||
155607892|NCT02450552|561653678|FG001|Overall Study|Physician Decision|0|||
155607893|NCT02450552|561653679|FG002|Overall Study|Physician Decision|1|||
155607894|NCT01969084|561653687|FG000|Overall Study|Adverse Event|0|||
155607895|NCT01969084|561653688|FG001|Overall Study|Adverse Event|1|||
155607896|NCT05079230|561653689|FG000|Overall Study|Study Terminated by Sponsor|101|||
155607897|NCT05079230|561653690|FG001|Overall Study|Study Terminated by Sponsor|102|||
155607898|NCT05079230|561653689|FG000|Overall Study|Death|72|||
155607899|NCT05079230|561653690|FG001|Overall Study|Death|66|||
155721917|NCT04886154|562080172|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721918|NCT04886154|562080173|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721919|NCT04886154|562080174|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155721920|NCT04886154|562080175|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721921|NCT04886154|562080176|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155721922|NCT04886154|562080177|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155721923|NCT04886154|562080178|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721924|NCT04886154|562080179|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721925|NCT04886154|562080180|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721926|NCT04886154|562080181|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721927|NCT04886154|562080182|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721928|NCT04886154|562080183|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155721929|NCT04886154|562080184|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155721930|NCT04886154|562080170|FG000|Overall Study|Other, Not Specified|0|||
155721931|NCT04886154|562080171|FG001|Overall Study|Other, Not Specified|0|||
155721932|NCT04886154|562080172|FG002|Overall Study|Other, Not Specified|0|||
155721933|NCT04886154|562080173|FG003|Overall Study|Other, Not Specified|0|||
155721934|NCT04886154|562080174|FG004|Overall Study|Other, Not Specified|11|||
155721935|NCT04886154|562080175|FG005|Overall Study|Other, Not Specified|8|||
155721936|NCT04886154|562080176|FG006|Overall Study|Other, Not Specified|9|||
155721937|NCT04886154|562080177|FG007|Overall Study|Other, Not Specified|10|||
155721938|NCT04886154|562080178|FG008|Overall Study|Other, Not Specified|6|||
155721939|NCT04886154|562080179|FG009|Overall Study|Other, Not Specified|1|||
155721940|NCT04886154|562080180|FG010|Overall Study|Other, Not Specified|1|||
155721941|NCT04886154|562080181|FG011|Overall Study|Other, Not Specified|2|||
155721942|NCT04886154|562080182|FG012|Overall Study|Other, Not Specified|1|||
155721943|NCT04886154|562080183|FG013|Overall Study|Other, Not Specified|2|||
155721944|NCT04886154|562080184|FG014|Overall Study|Other, Not Specified|3|||
155721945|NCT03919773|562080193|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
155721946|NCT03919773|562080194|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
155721947|NCT03919773|562080193|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
155721948|NCT03919773|562080194|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
155721949|NCT04659044|562080197|FG000|Induction|Physician Decision|1|||
155721950|NCT04659044|562080197|FG000|Induction|Adverse Event|2|||
155721951|NCT04966013|562080199|FG000|Overall Study|Withdrawal by Subject|0|||
155721952|NCT04966013|562080200|FG001|Overall Study|Withdrawal by Subject|2|||
155721953|NCT04966013|562080201|FG002|Overall Study|Withdrawal by Subject|1|||
155721954|NCT04966013|562080199|FG000|Overall Study|Adverse Event|2|||
155721955|NCT04966013|562080200|FG001|Overall Study|Adverse Event|1|||
155721956|NCT04966013|562080201|FG002|Overall Study|Adverse Event|1|||
155721957|NCT03724942|562080202|FG000|Overall Study|Adverse Event|20|||
155721958|NCT03724942|562080203|FG001|Overall Study|Adverse Event|14|||
155721959|NCT03724942|562080202|FG000|Overall Study|Lack of Efficacy|0|||
155721960|NCT03724942|562080203|FG001|Overall Study|Lack of Efficacy|1|||
155721961|NCT03724942|562080202|FG000|Overall Study|Physician Decision|5|||
155721962|NCT03724942|562080203|FG001|Overall Study|Physician Decision|2|||
155721963|NCT03724942|562080202|FG000|Overall Study|Protocol Violation|1|||
155721964|NCT03724942|562080203|FG001|Overall Study|Protocol Violation|0|||
155721965|NCT03724942|562080202|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
155721966|NCT03724942|562080203|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
155721967|NCT03724942|562080202|FG000|Overall Study|Withdrawal by Legal Representative|3|||
155721968|NCT03724942|562080203|FG001|Overall Study|Withdrawal by Legal Representative|0|||
155721969|NCT04875975|562080204|FG000|Overall Study|Adverse Event|1|||
155721970|NCT04875975|562080205|FG001|Overall Study|Adverse Event|2|||
155721971|NCT04875975|562080204|FG000|Overall Study|Lack of Efficacy|2|||
155721972|NCT04875975|562080205|FG001|Overall Study|Lack of Efficacy|2|||
155721973|NCT04875975|562080204|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
155721974|NCT04875975|562080205|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
155721975|NCT04875975|562080204|FG000|Overall Study|Relapse With Insults|0|||
155721976|NCT04875975|562080205|FG001|Overall Study|Relapse With Insults|1|||
155721977|NCT04875975|562080204|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
155721978|NCT04875975|562080205|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
155721979|NCT02429830|562080206|FG000|Overall Study|Lost to Follow-up|1|||
155721980|NCT02429830|562080206|FG000|Overall Study|Device Explant|2|||
155721981|NCT03714672|562081766|FG000|Overall Study|Adverse Event|0|||
155721982|NCT03714672|562081767|FG001|Overall Study|Adverse Event|0|||
155721983|NCT03714672|562081768|FG002|Overall Study|Adverse Event|3|||
155721984|NCT03714672|562081769|FG003|Overall Study|Adverse Event|0|||
155721985|NCT03714672|562081766|FG000|Overall Study|Physician Decision|0|||
155721986|NCT03714672|562081767|FG001|Overall Study|Physician Decision|1|||
155721987|NCT03714672|562081768|FG002|Overall Study|Physician Decision|0|||
155721988|NCT03714672|562081769|FG003|Overall Study|Physician Decision|0|||
155721989|NCT03714672|562081766|FG000|Overall Study|Other Reason|1|||
155721990|NCT03714672|562081767|FG001|Overall Study|Other Reason|2|||
155721991|NCT03714672|562081768|FG002|Overall Study|Other Reason|1|||
155721992|NCT03714672|562081769|FG003|Overall Study|Other Reason|1|||
155721993|NCT03714672|562081766|FG000|Overall Study|Lost to Follow-up|1|||
155721994|NCT03714672|562081767|FG001|Overall Study|Lost to Follow-up|1|||
155721995|NCT03714672|562081768|FG002|Overall Study|Lost to Follow-up|0|||
155721996|NCT03714672|562081769|FG003|Overall Study|Lost to Follow-up|0|||
155721997|NCT01074502|562081776|FG000|Overall Study|Withdrawal by Subject|1|||
155721998|NCT00674817|562081784|FG000|Period 1|Withdrawal by Subject|2|||
155721999|NCT00674817|562081784|FG000|Period 1|Protocol Violation|1|||
155722000|NCT00674817|562081784|FG000|Period 3|Adverse Event|1|||
155722001|NCT00674817|562081784|FG000|Period 3|Protocol Violation|1|||
155722002|NCT00674817|562081784|FG000|Period 4|Adverse Event|1|||
155722003|NCT00726063|562081785|FG000|Overall Study|Adverse Event|9|||
155722004|NCT00726063|562081786|FG001|Overall Study|Adverse Event|7|||
155722005|NCT01231984|562081787|FG000|Study Period 1|Withdrawal by Subject|0|||
155722006|NCT01231984|562081788|FG001|Study Period 1|Withdrawal by Subject|0|||
155722007|NCT01231984|562081789|FG002|Study Period 1|Withdrawal by Subject|0|||
155722008|NCT01231984|562081790|FG003|Study Period 1|Withdrawal by Subject|1|||
155722009|NCT01231984|562081787|FG000|Study Period 1|Lost to Follow-up|1|||
155722010|NCT01231984|562081788|FG001|Study Period 1|Lost to Follow-up|1|||
155722011|NCT01231984|562081789|FG002|Study Period 1|Lost to Follow-up|1|||
155722012|NCT01231984|562081790|FG003|Study Period 1|Lost to Follow-up|0|||
155722013|NCT01231984|562081787|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
155722014|NCT01231984|562081788|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
155266842|NCT05061537|560410908|FG003|Follow up|Study terminated by sponsor|0|||
155722015|NCT01231984|562081789|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
155722016|NCT01231984|562081790|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
155722017|NCT01231984|562081787|FG000|Study Period 1|Screen Failure|0|||
155722018|NCT01231984|562081788|FG001|Study Period 1|Screen Failure|0|||
155722019|NCT01231984|562081789|FG002|Study Period 1|Screen Failure|0|||
155722020|NCT01231984|562081790|FG003|Study Period 1|Screen Failure|1|||
155722021|NCT01231984|562081787|FG000|Study Period 1|Non-compliance with study requirements|5|||
155722022|NCT01231984|562081788|FG001|Study Period 1|Non-compliance with study requirements|0|||
155722023|NCT01231984|562081789|FG002|Study Period 1|Non-compliance with study requirements|2|||
155722024|NCT01231984|562081790|FG003|Study Period 1|Non-compliance with study requirements|1|||
155722025|NCT01231984|562081787|FG000|Study Period 1|Protocol Violation|3|||
155722026|NCT01231984|562081788|FG001|Study Period 1|Protocol Violation|4|||
155722027|NCT01231984|562081789|FG002|Study Period 1|Protocol Violation|2|||
155722028|NCT01231984|562081790|FG003|Study Period 1|Protocol Violation|3|||
155722029|NCT01231984|562081787|FG000|Study Period 1|Adverse Event|1|||
155722030|NCT01231984|562081788|FG001|Study Period 1|Adverse Event|0|||
155722031|NCT01231984|562081789|FG002|Study Period 1|Adverse Event|0|||
155722032|NCT01231984|562081790|FG003|Study Period 1|Adverse Event|0|||
155722033|NCT01231984|562081787|FG000|Study Period 1|Other|0|||
155722034|NCT01231984|562081788|FG001|Study Period 1|Other|0|||
155722035|NCT01231984|562081789|FG002|Study Period 1|Other|0|||
155722036|NCT01231984|562081790|FG003|Study Period 1|Other|1|||
155722037|NCT01231984|562081787|FG000|Study Period 2|Withdrawal by Subject|1|||
155722038|NCT01231984|562081788|FG001|Study Period 2|Withdrawal by Subject|1|||
155722039|NCT01231984|562081789|FG002|Study Period 2|Withdrawal by Subject|0|||
155722040|NCT01231984|562081790|FG003|Study Period 2|Withdrawal by Subject|0|||
155722041|NCT01231984|562081787|FG000|Study Period 2|Lost to Follow-up|1|||
155722042|NCT01231984|562081788|FG001|Study Period 2|Lost to Follow-up|0|||
155722043|NCT01231984|562081789|FG002|Study Period 2|Lost to Follow-up|0|||
155722044|NCT01231984|562081790|FG003|Study Period 2|Lost to Follow-up|3|||
155722045|NCT01231984|562081787|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
155722046|NCT01231984|562081788|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
155722047|NCT01231984|562081789|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
155722048|NCT01231984|562081790|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
155722049|NCT02182895|562081791|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
155266843|NCT05061537|560410909|FG004|Follow up|Study terminated by sponsor|0|||
155722050|NCT02182895|562081792|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
155722051|NCT03103542|562081793|FG000|Overall Study|Physician Decision|2|||
155266844|NCT05061537|560410905|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
155722052|NCT03103542|562081793|FG000|Overall Study|Adverse Event|2|||
155722053|NCT03103542|562081793|FG000|Overall Study|Other|2|||
155435816|NCT00624338|561022960|FG001|Overall Study|Lack of Efficacy|3|||
155722054|NCT03103542|562081793|FG000|Overall Study|Withdrawal by Subject|1|||
155722055|NCT03566511|562081794|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
155722056|NCT03566511|562081795|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
155722057|NCT02903771|562081796|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
155722058|NCT02903771|562081797|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
155722059|NCT02903771|562081798|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
155722060|NCT02903771|562081799|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
155722061|NCT02903771|562081800|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
155722062|NCT02903771|562081801|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
155722063|NCT02903771|562081802|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
155722064|NCT02903771|562081796|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722065|NCT02903771|562081797|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
155722066|NCT02903771|562081798|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722067|NCT02903771|562081799|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722068|NCT02903771|562081800|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722069|NCT02903771|562081801|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722070|NCT02903771|562081802|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
155722071|NCT02903771|562081796|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155722072|NCT02903771|562081797|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155722073|NCT02903771|562081798|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
155722074|NCT02903771|562081799|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155722075|NCT02903771|562081800|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155722076|NCT02903771|562081801|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
155722077|NCT02903771|562081802|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155722078|NCT02903771|562081796|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722079|NCT02903771|562081797|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722080|NCT02903771|562081798|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722081|NCT02903771|562081799|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722082|NCT02903771|562081800|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
155722083|NCT02903771|562081801|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722084|NCT02903771|562081802|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155722085|NCT02903771|562081796|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722086|NCT02903771|562081797|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722087|NCT02903771|562081798|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722088|NCT02903771|562081799|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722089|NCT02903771|562081800|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722090|NCT02903771|562081801|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
155722091|NCT02903771|562081802|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
155722092|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722093|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722094|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722095|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722096|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
155722097|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722098|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155722099|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722100|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722101|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722102|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722103|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
155722104|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722105|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155722106|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722107|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722108|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722109|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722110|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
155722111|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722112|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155722113|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722114|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722115|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722116|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722117|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
155722118|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722119|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155722120|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722121|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722122|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722123|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722124|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
155722125|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722126|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155722127|NCT02903771|562081796|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722128|NCT02903771|562081797|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722129|NCT02903771|562081798|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722130|NCT02903771|562081799|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722131|NCT02903771|562081800|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
155722132|NCT02903771|562081801|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722133|NCT02903771|562081802|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155722134|NCT05365217|562081806|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155722135|NCT05365217|562081807|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155722136|NCT01680341|562081811|FG000|Overall Study|Adverse Event|3|||
155722137|NCT01680341|562081812|FG001|Overall Study|Adverse Event|2|||
155722138|NCT01680341|562081811|FG000|Overall Study|Unclassified|18|||
155722139|NCT01680341|562081812|FG001|Overall Study|Unclassified|15|||
155722140|NCT03796728|562081814|FG000|Overall Study|Lost to Follow-up|8|||
155722141|NCT03796728|562081814|FG000|Overall Study|Reason not Specified|16|||
155722142|NCT04914364|562081815|FG000|Overall Study|No longer eligible for study|1|||
155722143|NCT04914364|562081815|FG000|Overall Study|Lost to Follow-up|2|||
155722144|NCT01263769|562081816|FG000|Overall Study|Non-Compliant with treatment|1|||
155722145|NCT01346358|562081817|FG000|Overall Study|Withdrawal by Subject|1|||
155722146|NCT01346358|562081818|FG001|Overall Study|Withdrawal by Subject|0|||
155722147|NCT01346358|562081819|FG002|Overall Study|Withdrawal by Subject|1|||
155722148|NCT01346358|562081820|FG003|Overall Study|Withdrawal by Subject|1|||
155722149|NCT01346358|562081821|FG004|Overall Study|Withdrawal by Subject|0|||
155722150|NCT01346358|562081822|FG005|Overall Study|Withdrawal by Subject|2|||
155722151|NCT01346358|562081823|FG006|Overall Study|Withdrawal by Subject|1|||
155722152|NCT01346358|562081824|FG007|Overall Study|Withdrawal by Subject|1|||
155722153|NCT01346358|562081825|FG008|Overall Study|Withdrawal by Subject|1|||
155722154|NCT01346358|562081817|FG000|Overall Study|Adverse Event|1|||
155722155|NCT01346358|562081818|FG001|Overall Study|Adverse Event|0|||
155722156|NCT01346358|562081819|FG002|Overall Study|Adverse Event|0|||
155722157|NCT01346358|562081820|FG003|Overall Study|Adverse Event|0|||
155722158|NCT01346358|562081821|FG004|Overall Study|Adverse Event|1|||
155722159|NCT01346358|562081822|FG005|Overall Study|Adverse Event|0|||
155722160|NCT01346358|562081823|FG006|Overall Study|Adverse Event|0|||
155722161|NCT01346358|562081824|FG007|Overall Study|Adverse Event|0|||
155722162|NCT01346358|562081825|FG008|Overall Study|Adverse Event|1|||
155722163|NCT01346358|562081817|FG000|Overall Study|Non-Compliance|0|||
155722164|NCT01346358|562081818|FG001|Overall Study|Non-Compliance|0|||
155722165|NCT01346358|562081819|FG002|Overall Study|Non-Compliance|0|||
155722166|NCT01346358|562081820|FG003|Overall Study|Non-Compliance|0|||
155722167|NCT01346358|562081821|FG004|Overall Study|Non-Compliance|0|||
155722168|NCT01346358|562081822|FG005|Overall Study|Non-Compliance|0|||
155722169|NCT01346358|562081823|FG006|Overall Study|Non-Compliance|0|||
155722170|NCT01346358|562081824|FG007|Overall Study|Non-Compliance|2|||
155722171|NCT01346358|562081825|FG008|Overall Study|Non-Compliance|0|||
155722172|NCT01346358|562081817|FG000|Overall Study|Physician Decision|0|||
155722173|NCT01346358|562081818|FG001|Overall Study|Physician Decision|1|||
155722174|NCT01346358|562081819|FG002|Overall Study|Physician Decision|0|||
155722175|NCT01346358|562081820|FG003|Overall Study|Physician Decision|0|||
155722176|NCT01346358|562081821|FG004|Overall Study|Physician Decision|0|||
155722177|NCT01346358|562081822|FG005|Overall Study|Physician Decision|0|||
155722178|NCT01346358|562081823|FG006|Overall Study|Physician Decision|0|||
155722179|NCT01346358|562081824|FG007|Overall Study|Physician Decision|1|||
155722180|NCT01346358|562081825|FG008|Overall Study|Physician Decision|1|||
155722181|NCT05058365|562081828|FG000|Overall Study|Migration|1|||
155722182|NCT05058365|562081829|FG001|Overall Study|Migration|1|||
155266845|NCT05061537|560410906|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
155722183|NCT00702702|562081832|FG000|Overall Study|Study prematurely terminated|56|||
155722184|NCT01667900|562081835|FG000|Part B|Death|0|||
155722185|NCT01667900|562081836|FG001|Part B|Death|0|||
155722186|NCT01667900|562081837|FG002|Part B|Death|0|||
155722187|NCT01667900|562081838|FG003|Part B|Death|0|||
155722188|NCT01667900|562081839|FG004|Part B|Death|0|||
155722189|NCT01667900|562081840|FG005|Part B|Death|0|||
155722190|NCT01667900|562081841|FG006|Part B|Death|0|||
155722191|NCT01667900|562081842|FG007|Part B|Death|0|||
155722192|NCT01667900|562081843|FG008|Part B|Death|0|||
155722193|NCT01667900|562081844|FG009|Part B|Death|0|||
155722194|NCT01667900|562081845|FG010|Part B|Death|0|||
155722195|NCT01667900|562081846|FG011|Part B|Death|0|||
155722196|NCT01667900|562081847|FG012|Part B|Death|0|||
155722197|NCT01667900|562081848|FG013|Part B|Death|0|||
155722198|NCT01667900|562081849|FG014|Part B|Death|0|||
155722199|NCT01667900|562081850|FG015|Part B|Death|0|||
155722200|NCT01667900|562081851|FG016|Part B|Death|1|||
155722201|NCT01667900|562081852|FG017|Part B|Death|0|||
155722202|NCT01667900|562081853|FG018|Part B|Death|0|||
155722203|NCT01667900|562081854|FG019|Part B|Death|0|||
155722204|NCT00468169|562081857|FG000|Overall Study|Withdrawal by Subject|1|||
155266846|NCT05061537|560410907|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
155266847|NCT05061537|560410908|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
155722205|NCT00468169|562081858|FG001|Overall Study|Withdrawal by Subject|0|||
155722206|NCT00784563|562081859|FG000|Years 1 & 2|Withdrawal by Subject|3|||
155722207|NCT00784563|562081860|FG001|Years 1 & 2|Withdrawal by Subject|2|||
155722208|NCT00784563|562081861|FG002|Years 1 & 2|Withdrawal by Subject|0|||
155722209|NCT00784563|562081859|FG000|Years 1 & 2|Adverse Event|0|||
155722210|NCT00784563|562081860|FG001|Years 1 & 2|Adverse Event|3|||
155722211|NCT00784563|562081861|FG002|Years 1 & 2|Adverse Event|0|||
155722212|NCT00784563|562081859|FG000|Year 3|Withdrawal by Subject|0|||
155722213|NCT00784563|562081860|FG001|Year 3|Withdrawal by Subject|0|||
155722214|NCT00784563|562081861|FG002|Year 3|Withdrawal by Subject|2|||
155722215|NCT00784563|562081859|FG000|Year 3|Adverse Event|0|||
155722216|NCT00784563|562081860|FG001|Year 3|Adverse Event|0|||
155722217|NCT00784563|562081861|FG002|Year 3|Adverse Event|1|||
155722218|NCT00321789|562081862|FG000|Overall Study|Lost to Follow-up|4|||
155722219|NCT00321789|562081863|FG001|Overall Study|Lost to Follow-up|7|||
155722220|NCT00321789|562081862|FG000|Overall Study|Withdrawal by Subject|6|||
155722221|NCT00321789|562081863|FG001|Overall Study|Withdrawal by Subject|6|||
155722222|NCT00321789|562081862|FG000|Overall Study|Protocol Violation|5|||
155722223|NCT00321789|562081863|FG001|Overall Study|Protocol Violation|3|||
155722224|NCT01576341|562081864|FG000|Overall Study|Withdrawal by Subject|24|||
155722225|NCT01576341|562081864|FG000|Overall Study|Adverse Event|10|||
155722226|NCT01576341|562081864|FG000|Overall Study|Death|21|||
155722227|NCT01576341|562081864|FG000|Overall Study|Physician Decision|2|||
155722228|NCT01576341|562081864|FG000|Overall Study|Lost to Follow-up|2|||
155722229|NCT01576341|562081864|FG000|Overall Study|Kidney transplantation|10|||
155722230|NCT01576341|562081864|FG000|Overall Study|Protocol Violation|12|||
155722231|NCT01576341|562081864|FG000|Overall Study|Other|12|||
155722232|NCT00617734|562081865|FG000|Overall Study|Withdrew Consent|2|||
155722233|NCT00617734|562081866|FG001|Overall Study|Withdrew Consent|0|||
155722234|NCT00617734|562081865|FG000|Overall Study|Adverse Event|4|||
155722235|NCT00617734|562081866|FG001|Overall Study|Adverse Event|1|||
155722236|NCT00617734|562081865|FG000|Overall Study|Protocol Violation|1|||
155722237|NCT00617734|562081866|FG001|Overall Study|Protocol Violation|0|||
155722238|NCT00617734|562081865|FG000|Overall Study|Found Ineligible After Randomization|1|||
155722239|NCT00617734|562081866|FG001|Overall Study|Found Ineligible After Randomization|4|||
155722240|NCT00617734|562081865|FG000|Overall Study|Lost to Follow-up|0|||
155722241|NCT00617734|562081866|FG001|Overall Study|Lost to Follow-up|1|||
155722242|NCT00556075|562081867|FG000|Overall Study|Lost to Follow-up|3|||
155722243|NCT00556075|562081868|FG001|Overall Study|Lost to Follow-up|0|||
155722244|NCT00556075|562081869|FG002|Overall Study|Lost to Follow-up|3|||
155722245|NCT00556075|562081867|FG000|Overall Study|Withdrawal by Subject|3|||
155722246|NCT00556075|562081868|FG001|Overall Study|Withdrawal by Subject|3|||
155722247|NCT00556075|562081869|FG002|Overall Study|Withdrawal by Subject|0|||
155722248|NCT00556075|562081867|FG000|Overall Study|Protocol Violation|1|||
155722249|NCT00556075|562081868|FG001|Overall Study|Protocol Violation|1|||
155722250|NCT00556075|562081869|FG002|Overall Study|Protocol Violation|3|||
155722251|NCT00556075|562081867|FG000|Overall Study|Not eligible|1|||
155722252|NCT00556075|562081868|FG001|Overall Study|Not eligible|1|||
155722253|NCT00556075|562081869|FG002|Overall Study|Not eligible|2|||
155722254|NCT00556075|562081867|FG000|Overall Study|Adverse Event|1|||
155722255|NCT00556075|562081868|FG001|Overall Study|Adverse Event|2|||
155722256|NCT00556075|562081869|FG002|Overall Study|Adverse Event|0|||
155722257|NCT00556075|562081867|FG000|Overall Study|Personal issues|4|||
155722258|NCT00556075|562081868|FG001|Overall Study|Personal issues|1|||
155722259|NCT00556075|562081869|FG002|Overall Study|Personal issues|0|||
155722260|NCT00556075|562081867|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
155722261|NCT00556075|562081868|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
155266848|NCT05061537|560410909|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
155266849|NCT05061537|560410905|FG000|Long-term Follow-up|Death|0|||
155722262|NCT00556075|562081869|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
155722263|NCT02485691|562081870|FG000|Overall Study|Adverse Event|25|||
155722264|NCT02485691|562081871|FG001|Overall Study|Adverse Event|11|||
155722265|NCT02485691|562081870|FG000|Overall Study|Poor compliance to protocol|0|||
155722266|NCT02485691|562081871|FG001|Overall Study|Poor compliance to protocol|1|||
155722267|NCT02485691|562081870|FG000|Overall Study|Disease progression|57|||
155722268|NCT02485691|562081871|FG001|Overall Study|Disease progression|92|||
155722269|NCT02485691|562081870|FG000|Overall Study|Investigator's decision|23|||
155722270|NCT02485691|562081871|FG001|Overall Study|Investigator's decision|5|||
155722271|NCT02485691|562081870|FG000|Overall Study|Participant's request|13|||
155722272|NCT02485691|562081871|FG001|Overall Study|Participant's request|6|||
155722273|NCT02485691|562081870|FG000|Overall Study|Other reason|8|||
155722274|NCT02485691|562081871|FG001|Overall Study|Other reason|9|||
155722275|NCT02485691|562081870|FG000|Overall Study|Randomized and not treated|3|||
155722276|NCT02485691|562081871|FG001|Overall Study|Randomized and not treated|2|||
155722277|NCT01420861|562081880|FG000|Overall Study|Adverse Event|2|||
155722278|NCT01420861|562081880|FG000|Overall Study|Study terminated by Sponsor|7|||
155722279|NCT01420861|562081880|FG000|Overall Study|Screen failure|7|||
155722280|NCT01420861|562081880|FG000|Overall Study|Randomized not Treated|2|||
155722281|NCT00791934|562081881|FG000|Overall Study|Withdrawal by Subject|2|||
155722282|NCT00791934|562081881|FG000|Overall Study|Did not consent for extended follow-up|13|||
155722283|NCT03413891|562081883|FG000|Overall Study|Lost to Follow-up|2|||
155722284|NCT03413891|562081884|FG001|Overall Study|Lost to Follow-up|1|||
155722285|NCT03413891|562081883|FG000|Overall Study|Protocol Violation|0|||
155722286|NCT03413891|562081884|FG001|Overall Study|Protocol Violation|1|||
155722287|NCT04905134|562081885|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
155722288|NCT04905134|562081885|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
155722289|NCT03137992|562081886|FG000|Washout Period 1|Adverse Event|1|||
155722290|NCT03137992|562081887|FG001|Washout Period 1|Adverse Event|1|||
155722291|NCT03137992|562081888|FG002|Washout Period 1|Adverse Event|0|||
155722292|NCT03137992|562081889|FG003|Washout Period 1|Adverse Event|0|||
155722293|NCT03137992|562081890|FG004|Washout Period 1|Adverse Event|0|||
155722294|NCT03137992|562081891|FG005|Washout Period 1|Adverse Event|1|||
155722295|NCT03137992|562081886|FG000|Washout Period 1|Withdrawal by Subject|0|||
155722296|NCT03137992|562081887|FG001|Washout Period 1|Withdrawal by Subject|1|||
155722297|NCT03137992|562081888|FG002|Washout Period 1|Withdrawal by Subject|1|||
155722298|NCT03137992|562081889|FG003|Washout Period 1|Withdrawal by Subject|0|||
155722299|NCT03137992|562081890|FG004|Washout Period 1|Withdrawal by Subject|0|||
155722300|NCT03137992|562081891|FG005|Washout Period 1|Withdrawal by Subject|0|||
155722301|NCT03137992|562081886|FG000|Washout Period 1|Principal Investigator Discretion|0|||
155722302|NCT03137992|562081887|FG001|Washout Period 1|Principal Investigator Discretion|1|||
155722303|NCT03137992|562081888|FG002|Washout Period 1|Principal Investigator Discretion|0|||
155722304|NCT03137992|562081889|FG003|Washout Period 1|Principal Investigator Discretion|0|||
155722305|NCT03137992|562081890|FG004|Washout Period 1|Principal Investigator Discretion|0|||
155722306|NCT03137992|562081891|FG005|Washout Period 1|Principal Investigator Discretion|0|||
155722307|NCT03137992|562081886|FG000|Washout Period 1|COPD Exacerbation|1|||
155722308|NCT03137992|562081887|FG001|Washout Period 1|COPD Exacerbation|1|||
155722309|NCT03137992|562081888|FG002|Washout Period 1|COPD Exacerbation|1|||
155722310|NCT03137992|562081889|FG003|Washout Period 1|COPD Exacerbation|0|||
155722311|NCT03137992|562081890|FG004|Washout Period 1|COPD Exacerbation|1|||
155722312|NCT03137992|562081891|FG005|Washout Period 1|COPD Exacerbation|1|||
155722313|NCT03137992|562081886|FG000|Washout Period 1|Subject Noncompliance|1|||
155722314|NCT03137992|562081887|FG001|Washout Period 1|Subject Noncompliance|0|||
155722315|NCT03137992|562081888|FG002|Washout Period 1|Subject Noncompliance|0|||
155722316|NCT03137992|562081889|FG003|Washout Period 1|Subject Noncompliance|0|||
155722317|NCT03137992|562081890|FG004|Washout Period 1|Subject Noncompliance|1|||
155722318|NCT03137992|562081891|FG005|Washout Period 1|Subject Noncompliance|0|||
155722319|NCT03137992|562081886|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
155722320|NCT03137992|562081887|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
155722321|NCT03137992|562081888|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
155722322|NCT03137992|562081889|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
155722323|NCT03137992|562081890|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
155722324|NCT03137992|562081891|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
155722325|NCT03137992|562081886|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
155722326|NCT03137992|562081887|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155722327|NCT03137992|562081888|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155722328|NCT03137992|562081889|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
155722329|NCT03137992|562081890|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155722330|NCT03137992|562081891|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
155722331|NCT03137992|562081886|FG000|Period 2 (Visit 3)|Adverse Event|0|||
155722332|NCT03137992|562081887|FG001|Period 2 (Visit 3)|Adverse Event|1|||
155722333|NCT03137992|562081888|FG002|Period 2 (Visit 3)|Adverse Event|0|||
155722334|NCT03137992|562081889|FG003|Period 2 (Visit 3)|Adverse Event|0|||
155722335|NCT03137992|562081890|FG004|Period 2 (Visit 3)|Adverse Event|0|||
155722336|NCT03137992|562081891|FG005|Period 2 (Visit 3)|Adverse Event|0|||
155722337|NCT03137992|562081886|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
155722338|NCT03137992|562081887|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
155722339|NCT03137992|562081888|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
155722340|NCT03137992|562081889|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
155722341|NCT03137992|562081890|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
155722342|NCT03137992|562081891|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
155722343|NCT03137992|562081886|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155722344|NCT03137992|562081887|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
155722345|NCT03137992|562081888|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155722346|NCT03137992|562081889|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155722347|NCT03137992|562081890|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
155607900|NCT05079230|561653689|FG000|Overall Study|Withdrew Consent|16|||
155607901|NCT05079230|561653690|FG001|Overall Study|Withdrew Consent|18|||
155607902|NCT05079230|561653689|FG000|Overall Study|Lost to Follow-up|0|||
155607903|NCT05079230|561653690|FG001|Overall Study|Lost to Follow-up|3|||
155607904|NCT01524783|561653691|FG000|Blinded Period|Adverse Event|64|||
155607905|NCT01524783|561653692|FG001|Blinded Period|Adverse Event|7|||
155607906|NCT01524783|561653693|FG002|Blinded Period|Adverse Event|0|||
155607907|NCT01524783|561653691|FG000|Blinded Period|Disease Progression|89|||
155607908|NCT01524783|561653692|FG001|Blinded Period|Disease Progression|75|||
155607909|NCT01524783|561653693|FG002|Blinded Period|Disease Progression|0|||
155607910|NCT01524783|561653691|FG000|Blinded Period|Withdrawal by Subject|19|||
155607911|NCT01524783|561653692|FG001|Blinded Period|Withdrawal by Subject|6|||
155607912|NCT01524783|561653693|FG002|Blinded Period|Withdrawal by Subject|0|||
155607913|NCT01524783|561653691|FG000|Blinded Period|Protocol deviation|2|||
155607914|NCT01524783|561653692|FG001|Blinded Period|Protocol deviation|1|||
155607915|NCT01524783|561653693|FG002|Blinded Period|Protocol deviation|0|||
155607916|NCT01524783|561653691|FG000|Blinded Period|Death|5|||
155607917|NCT01524783|561653692|FG001|Blinded Period|Death|2|||
155607918|NCT01524783|561653693|FG002|Blinded Period|Death|0|||
155607919|NCT01524783|561653691|FG000|Open-label Period|Disease progression|13|||
155607920|NCT01524783|561653692|FG001|Open-label Period|Disease progression|0|||
155607921|NCT01524783|561653693|FG002|Open-label Period|Disease progression|2|||
155607922|NCT01524783|561653691|FG000|Open-label Period|Administrative problems|5|||
155607923|NCT01524783|561653692|FG001|Open-label Period|Administrative problems|0|||
155607924|NCT01524783|561653693|FG002|Open-label Period|Administrative problems|2|||
155607925|NCT01524783|561653691|FG000|Open-label Period|Adverse Event|5|||
155607926|NCT01524783|561653692|FG001|Open-label Period|Adverse Event|0|||
155607927|NCT01524783|561653693|FG002|Open-label Period|Adverse Event|1|||
155607928|NCT01524783|561653691|FG000|Open-label Period|Withdrawal by Subject|2|||
155607929|NCT01524783|561653692|FG001|Open-label Period|Withdrawal by Subject|0|||
155607930|NCT01524783|561653693|FG002|Open-label Period|Withdrawal by Subject|1|||
155607931|NCT01524783|561653691|FG000|Open-label Period|Protocol deviation|1|||
155607932|NCT01524783|561653692|FG001|Open-label Period|Protocol deviation|0|||
155607933|NCT01524783|561653693|FG002|Open-label Period|Protocol deviation|0|||
155607934|NCT02920177|561653695|FG000|Overall Study|Withdrawal by Subject|1|||
155607935|NCT02920177|561653696|FG001|Overall Study|Withdrawal by Subject|1|||
155607936|NCT02920177|561653695|FG000|Overall Study|Physician Decision|1|||
155607937|NCT02920177|561653696|FG001|Overall Study|Physician Decision|0|||
155607938|NCT02920177|561653695|FG000|Overall Study|Lost to Follow-up|0|||
155607939|NCT02920177|561653696|FG001|Overall Study|Lost to Follow-up|1|||
155607940|NCT03164265|561653697|FG000|Overall Study|Physician Decision|3|||
155607941|NCT04907227|561653698|FG000|Overall Study|Death|12|||
155607942|NCT04907227|561653699|FG001|Overall Study|Death|8|||
155607943|NCT04907227|561653698|FG000|Overall Study|Withdrawal by Subject|2|||
155607944|NCT04907227|561653699|FG001|Overall Study|Withdrawal by Subject|2|||
155607945|NCT04907227|561653698|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
155607946|NCT04907227|561653699|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155607947|NCT04907227|561653698|FG000|Overall Study|Sponsor Decision|25|||
155607948|NCT04907227|561653699|FG001|Overall Study|Sponsor Decision|30|||
155607949|NCT04907227|561653698|FG000|Overall Study|Physician Decision|1|||
155607950|NCT04907227|561653699|FG001|Overall Study|Physician Decision|0|||
155607951|NCT03723070|561653700|FG000|Overall Study|Lost to Follow-up|2|||
155607952|NCT03723070|561653700|FG000|Overall Study|Physician Decision|1|||
155607953|NCT03723070|561653700|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
155607954|NCT00721279|561653702|FG000|Overall Study|Lack of Efficacy|6|||
155607955|NCT00721279|561653703|FG001|Overall Study|Lack of Efficacy|3|||
155607956|NCT00721279|561653702|FG000|Overall Study|Tolerability insufficient|5|||
155607957|NCT00721279|561653703|FG001|Overall Study|Tolerability insufficient|2|||
155607958|NCT00721279|561653702|FG000|Overall Study|Withdrawal by Subject|13|||
155607959|NCT00721279|561653703|FG001|Overall Study|Withdrawal by Subject|3|||
155607960|NCT00721279|561653702|FG000|Overall Study|Other|12|||
155607961|NCT00721279|561653703|FG001|Overall Study|Other|16|||
155607962|NCT03673345|561653704|FG000|Overall Study|Lost to Follow-up|1|||
155607963|NCT03673345|561653705|FG001|Overall Study|Lost to Follow-up|0|||
155607964|NCT03673345|561653706|FG002|Overall Study|Lost to Follow-up|3|||
155607965|NCT03673345|561653707|FG003|Overall Study|Lost to Follow-up|3|||
155607966|NCT03673345|561653708|FG004|Overall Study|Lost to Follow-up|2|||
155607967|NCT03673345|561653709|FG005|Overall Study|Lost to Follow-up|1|||
155607968|NCT03673345|561653710|FG006|Overall Study|Lost to Follow-up|0|||
155607969|NCT03673345|561653711|FG007|Overall Study|Lost to Follow-up|0|||
155607970|NCT03673345|561653704|FG000|Overall Study|Withdrawal by Subject|1|||
155607971|NCT03673345|561653705|FG001|Overall Study|Withdrawal by Subject|0|||
155607972|NCT03673345|561653706|FG002|Overall Study|Withdrawal by Subject|4|||
155607973|NCT03673345|561653707|FG003|Overall Study|Withdrawal by Subject|2|||
155607974|NCT03673345|561653708|FG004|Overall Study|Withdrawal by Subject|0|||
155607975|NCT03673345|561653709|FG005|Overall Study|Withdrawal by Subject|0|||
155607976|NCT03673345|561653710|FG006|Overall Study|Withdrawal by Subject|0|||
155607977|NCT03673345|561653711|FG007|Overall Study|Withdrawal by Subject|0|||
155722348|NCT03137992|562081891|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155722349|NCT03137992|562081886|FG000|Washout Period 2|COPD Exacerbation|1|||
155722350|NCT03137992|562081887|FG001|Washout Period 2|COPD Exacerbation|1|||
155722351|NCT03137992|562081888|FG002|Washout Period 2|COPD Exacerbation|0|||
155722352|NCT03137992|562081889|FG003|Washout Period 2|COPD Exacerbation|0|||
155722353|NCT03137992|562081890|FG004|Washout Period 2|COPD Exacerbation|1|||
155722354|NCT03137992|562081891|FG005|Washout Period 2|COPD Exacerbation|0|||
155722355|NCT03137992|562081886|FG000|Washout Period 2|Subject Non-compliance|0|||
155722356|NCT03137992|562081887|FG001|Washout Period 2|Subject Non-compliance|1|||
155722357|NCT03137992|562081888|FG002|Washout Period 2|Subject Non-compliance|0|||
155722358|NCT03137992|562081889|FG003|Washout Period 2|Subject Non-compliance|0|||
155722359|NCT03137992|562081890|FG004|Washout Period 2|Subject Non-compliance|0|||
155722360|NCT03137992|562081891|FG005|Washout Period 2|Subject Non-compliance|0|||
155722361|NCT03137992|562081886|FG000|Washout Period 2|Adverse Event|0|||
155722362|NCT03137992|562081887|FG001|Washout Period 2|Adverse Event|0|||
155722363|NCT03137992|562081888|FG002|Washout Period 2|Adverse Event|0|||
155722364|NCT03137992|562081889|FG003|Washout Period 2|Adverse Event|1|||
155722365|NCT03137992|562081890|FG004|Washout Period 2|Adverse Event|1|||
155722366|NCT03137992|562081891|FG005|Washout Period 2|Adverse Event|0|||
155722367|NCT03137992|562081886|FG000|Washout Period 2|Withdrawal by Subject|1|||
155722368|NCT03137992|562081887|FG001|Washout Period 2|Withdrawal by Subject|0|||
155722369|NCT03137992|562081888|FG002|Washout Period 2|Withdrawal by Subject|0|||
155722370|NCT03137992|562081889|FG003|Washout Period 2|Withdrawal by Subject|0|||
155722371|NCT03137992|562081890|FG004|Washout Period 2|Withdrawal by Subject|1|||
155722372|NCT03137992|562081891|FG005|Washout Period 2|Withdrawal by Subject|0|||
155722373|NCT03137992|562081886|FG000|Washout Period 2|Sponsor Decision|0|||
155722374|NCT03137992|562081887|FG001|Washout Period 2|Sponsor Decision|0|||
155722375|NCT03137992|562081888|FG002|Washout Period 2|Sponsor Decision|0|||
155722376|NCT03137992|562081889|FG003|Washout Period 2|Sponsor Decision|0|||
155722377|NCT03137992|562081890|FG004|Washout Period 2|Sponsor Decision|0|||
155722378|NCT03137992|562081891|FG005|Washout Period 2|Sponsor Decision|1|||
155722379|NCT03137992|562081886|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
155722380|NCT03137992|562081887|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
155722381|NCT03137992|562081888|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
155722382|NCT03137992|562081889|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
155722383|NCT03137992|562081890|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
155266850|NCT05061537|560410906|FG001|Long-term Follow-up|Death|1|||
155266851|NCT05061537|560410907|FG002|Long-term Follow-up|Death|0|||
155266852|NCT05061537|560410908|FG003|Long-term Follow-up|Death|0|||
155266853|NCT05061537|560410909|FG004|Long-term Follow-up|Death|0|||
155266854|NCT02247804|560410912|FG000|Treatment Period 1|Adverse Event|9|||
155266855|NCT02247804|560410913|FG001|Treatment Period 1|Adverse Event|2|||
155266856|NCT02247804|560410914|FG002|Treatment Period 1|Adverse Event|0|||
155266857|NCT02247804|560410912|FG000|Treatment Period 1|Lack of Efficacy|0|||
155266858|NCT02247804|560410913|FG001|Treatment Period 1|Lack of Efficacy|0|||
155266859|NCT02247804|560410914|FG002|Treatment Period 1|Lack of Efficacy|2|||
155266860|NCT02247804|560410912|FG000|Treatment Period 1|Lost to Follow-up|1|||
155266861|NCT02247804|560410913|FG001|Treatment Period 1|Lost to Follow-up|0|||
155266862|NCT02247804|560410914|FG002|Treatment Period 1|Lost to Follow-up|2|||
155266863|NCT02247804|560410912|FG000|Treatment Period 1|Personal Reasons|7|||
155266864|NCT02247804|560410913|FG001|Treatment Period 1|Personal Reasons|1|||
155266865|NCT02247804|560410914|FG002|Treatment Period 1|Personal Reasons|2|||
155266866|NCT02247804|560410912|FG000|Treatment Period 1|Protocol Deviation|0|||
155266867|NCT02247804|560410913|FG001|Treatment Period 1|Protocol Deviation|0|||
155266868|NCT02247804|560410914|FG002|Treatment Period 1|Protocol Deviation|1|||
155266869|NCT02247804|560410912|FG000|Treatment Period 1|Randomized but not Treated|5|||
155266870|NCT02247804|560410913|FG001|Treatment Period 1|Randomized but not Treated|1|||
155266871|NCT02247804|560410914|FG002|Treatment Period 1|Randomized but not Treated|1|||
155266872|NCT02247804|560410912|FG000|Treatment Period 2|Adverse Event|6|||
155266873|NCT02247804|560410913|FG001|Treatment Period 2|Adverse Event|3|||
155266874|NCT02247804|560410914|FG002|Treatment Period 2|Adverse Event|3|||
155266875|NCT02247804|560410912|FG000|Treatment Period 2|Lack of Efficacy|0|||
155266876|NCT02247804|560410913|FG001|Treatment Period 2|Lack of Efficacy|0|||
155266877|NCT02247804|560410914|FG002|Treatment Period 2|Lack of Efficacy|1|||
155266878|NCT02247804|560410912|FG000|Treatment Period 2|Lost to Follow-up|0|||
155266879|NCT02247804|560410913|FG001|Treatment Period 2|Lost to Follow-up|1|||
155266880|NCT02247804|560410914|FG002|Treatment Period 2|Lost to Follow-up|1|||
155266881|NCT02247804|560410912|FG000|Treatment Period 2|Personal Reasons|2|||
155266882|NCT02247804|560410913|FG001|Treatment Period 2|Personal Reasons|1|||
155722384|NCT03137992|562081891|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
155722385|NCT03137992|562081886|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155722386|NCT03137992|562081887|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
155266883|NCT02247804|560410914|FG002|Treatment Period 2|Personal Reasons|1|||
155266884|NCT02247804|560410912|FG000|Treatment Period 2|Reason not Specified|0|||
155266885|NCT02247804|560410913|FG001|Treatment Period 2|Reason not Specified|0|||
155266886|NCT02247804|560410914|FG002|Treatment Period 2|Reason not Specified|2|||
155266887|NCT02247804|560410912|FG000|Treatment Period 3|Adverse Event|4|||
155266888|NCT02247804|560410913|FG001|Treatment Period 3|Adverse Event|3|||
155266889|NCT02247804|560410914|FG002|Treatment Period 3|Adverse Event|3|||
155266890|NCT02247804|560410912|FG000|Treatment Period 3|Lack of Efficacy|0|||
155266891|NCT02247804|560410913|FG001|Treatment Period 3|Lack of Efficacy|1|||
155266892|NCT02247804|560410914|FG002|Treatment Period 3|Lack of Efficacy|0|||
155266893|NCT02247804|560410912|FG000|Treatment Period 3|Lost to Follow-up|1|||
155266894|NCT02247804|560410913|FG001|Treatment Period 3|Lost to Follow-up|2|||
155266895|NCT02247804|560410914|FG002|Treatment Period 3|Lost to Follow-up|2|||
155266896|NCT02247804|560410912|FG000|Treatment Period 3|Personal Reasons|4|||
155266897|NCT02247804|560410913|FG001|Treatment Period 3|Personal Reasons|3|||
155266898|NCT02247804|560410914|FG002|Treatment Period 3|Personal Reasons|2|||
155266899|NCT02247804|560410912|FG000|Treatment Period 3|Reason not Specified|2|||
155266900|NCT02247804|560410913|FG001|Treatment Period 3|Reason not Specified|1|||
155266901|NCT02247804|560410914|FG002|Treatment Period 3|Reason not Specified|3|||
155266902|NCT01834222|560410915|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
155266903|NCT01054573|560410916|FG000|Overall Study|Adverse Event|1|||
155266904|NCT01054573|560410917|FG001|Overall Study|Adverse Event|0|||
155266905|NCT01054573|560410918|FG002|Overall Study|Adverse Event|1|||
155266906|NCT01054573|560410919|FG003|Overall Study|Adverse Event|1|||
155266907|NCT01054573|560410916|FG000|Overall Study|Lost to Follow-up|0|||
155266908|NCT01054573|560410917|FG001|Overall Study|Lost to Follow-up|2|||
155266909|NCT01054573|560410918|FG002|Overall Study|Lost to Follow-up|0|||
155266910|NCT01054573|560410919|FG003|Overall Study|Lost to Follow-up|0|||
155266911|NCT01054573|560410916|FG000|Overall Study|Withdrawal by Subject|0|||
155266912|NCT01054573|560410917|FG001|Overall Study|Withdrawal by Subject|2|||
155266913|NCT01054573|560410918|FG002|Overall Study|Withdrawal by Subject|2|||
155266914|NCT01054573|560410919|FG003|Overall Study|Withdrawal by Subject|1|||
155266915|NCT03812536|560410920|FG000|Overall Study|Protocol Violation|2|||
155266916|NCT03812536|560410921|FG001|Overall Study|Protocol Violation|0|||
155266917|NCT03812536|560410920|FG000|Overall Study|Withdrawal by Subject|1|||
155266918|NCT03812536|560410921|FG001|Overall Study|Withdrawal by Subject|1|||
155266919|NCT00152009|560410922|FG000|Overall Study|Adverse Event|9|||
155266920|NCT00152009|560410923|FG001|Overall Study|Adverse Event|13|||
155266921|NCT00152009|560410924|FG002|Overall Study|Adverse Event|20|||
155266922|NCT00152009|560410925|FG003|Overall Study|Adverse Event|1|||
155266923|NCT00152009|560410922|FG000|Overall Study|Protocol Violation|3|||
155266924|NCT00152009|560410923|FG001|Overall Study|Protocol Violation|0|||
155266925|NCT00152009|560410924|FG002|Overall Study|Protocol Violation|0|||
155266926|NCT00152009|560410925|FG003|Overall Study|Protocol Violation|1|||
155266927|NCT00152009|560410922|FG000|Overall Study|Withdrawal by Subject|2|||
155379493|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
155379494|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379495|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379496|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379497|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
155379498|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
155379499|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
155379500|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
155379501|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379502|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379503|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
155379504|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379505|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
155722387|NCT03137992|562081888|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
155722388|NCT03137992|562081889|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155722389|NCT03137992|562081890|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
155722390|NCT03137992|562081891|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155722391|NCT03137992|562081886|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
155722392|NCT03137992|562081887|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155722393|NCT03137992|562081888|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
155722394|NCT03137992|562081889|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155722395|NCT03137992|562081890|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155722396|NCT03137992|562081891|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155722397|NCT03137992|562081886|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155722398|NCT03137992|562081887|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155722399|NCT03137992|562081888|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155722400|NCT03137992|562081889|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
155266928|NCT00152009|560410923|FG001|Overall Study|Withdrawal by Subject|3|||
155379506|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
155379507|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
155379508|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
155379509|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
155722401|NCT03137992|562081890|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155722402|NCT03137992|562081891|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155722403|NCT03137992|562081886|FG000|Part 2 (Open-label Extension)|Per study team|1|||
155722404|NCT03137992|562081887|FG001|Part 2 (Open-label Extension)|Per study team|0|||
155722405|NCT03137992|562081888|FG002|Part 2 (Open-label Extension)|Per study team|0|||
155722406|NCT03137992|562081889|FG003|Part 2 (Open-label Extension)|Per study team|0|||
155722407|NCT03137992|562081890|FG004|Part 2 (Open-label Extension)|Per study team|0|||
155722408|NCT03137992|562081891|FG005|Part 2 (Open-label Extension)|Per study team|0|||
155722409|NCT03137992|562081886|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155722410|NCT03137992|562081887|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155722411|NCT03137992|562081888|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155722412|NCT03137992|562081889|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155722413|NCT03137992|562081890|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155722414|NCT03137992|562081891|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
155722415|NCT03221556|562081894|FG000|Allocation|post-randomization exclusion|0|||
155722416|NCT03221556|562081895|FG001|Allocation|post-randomization exclusion|1|||
155722417|NCT03221556|562081894|FG000|Follow-Up|Withdrawal by Subject|0|||
155722418|NCT03221556|562081895|FG001|Follow-Up|Withdrawal by Subject|1|||
155722419|NCT01486966|562081898|FG000|Overall Study|Adverse Event|0|||
155722420|NCT01486966|562081899|FG001|Overall Study|Adverse Event|1|||
155722421|NCT01486966|562081898|FG000|Overall Study|Withdrawal by Subject|0|||
155722422|NCT01486966|562081899|FG001|Overall Study|Withdrawal by Subject|1|||
155722423|NCT00506350|562081903|FG000|Overall Study|Serious Adverse Event|1|||
155722424|NCT00506350|562081904|FG001|Overall Study|Serious Adverse Event|0|||
155722425|NCT00506350|562081905|FG002|Overall Study|Serious Adverse Event|0|||
155722426|NCT00506350|562081906|FG003|Overall Study|Serious Adverse Event|0|||
155722427|NCT00506350|562081907|FG004|Overall Study|Serious Adverse Event|0|||
155722428|NCT00506350|562081908|FG005|Overall Study|Serious Adverse Event|0|||
155722429|NCT00506350|562081909|FG006|Overall Study|Serious Adverse Event|0|||
155722430|NCT00506350|562081910|FG007|Overall Study|Serious Adverse Event|0|||
155722431|NCT00506350|562081911|FG008|Overall Study|Serious Adverse Event|0|||
155722432|NCT00506350|562081903|FG000|Overall Study|Adverse Event|0|||
155722433|NCT00506350|562081904|FG001|Overall Study|Adverse Event|0|||
155722434|NCT00506350|562081905|FG002|Overall Study|Adverse Event|0|||
155722435|NCT00506350|562081906|FG003|Overall Study|Adverse Event|0|||
155722436|NCT00506350|562081907|FG004|Overall Study|Adverse Event|0|||
155722437|NCT00506350|562081908|FG005|Overall Study|Adverse Event|0|||
155722438|NCT00506350|562081909|FG006|Overall Study|Adverse Event|0|||
155722439|NCT00506350|562081910|FG007|Overall Study|Adverse Event|1|||
155722440|NCT00506350|562081911|FG008|Overall Study|Adverse Event|1|||
155722441|NCT00506350|562081903|FG000|Overall Study|Protocol Violation|0|||
155722442|NCT00506350|562081904|FG001|Overall Study|Protocol Violation|0|||
155722443|NCT00506350|562081905|FG002|Overall Study|Protocol Violation|1|||
155722444|NCT00506350|562081906|FG003|Overall Study|Protocol Violation|0|||
155722445|NCT00506350|562081907|FG004|Overall Study|Protocol Violation|0|||
155722446|NCT00506350|562081908|FG005|Overall Study|Protocol Violation|0|||
155722447|NCT00506350|562081909|FG006|Overall Study|Protocol Violation|1|||
155722448|NCT00506350|562081910|FG007|Overall Study|Protocol Violation|0|||
155722449|NCT00506350|562081911|FG008|Overall Study|Protocol Violation|0|||
155722450|NCT00506350|562081903|FG000|Overall Study|Withdrawal by Subject|0|||
155722451|NCT00506350|562081904|FG001|Overall Study|Withdrawal by Subject|1|||
155722452|NCT00506350|562081905|FG002|Overall Study|Withdrawal by Subject|1|||
155722453|NCT00506350|562081906|FG003|Overall Study|Withdrawal by Subject|1|||
155722454|NCT00506350|562081907|FG004|Overall Study|Withdrawal by Subject|4|||
155722455|NCT00506350|562081908|FG005|Overall Study|Withdrawal by Subject|1|||
155722456|NCT00506350|562081909|FG006|Overall Study|Withdrawal by Subject|1|||
155722457|NCT00506350|562081910|FG007|Overall Study|Withdrawal by Subject|2|||
155722458|NCT00506350|562081911|FG008|Overall Study|Withdrawal by Subject|0|||
155722459|NCT00506350|562081903|FG000|Overall Study|Lost to Follow-up|1|||
155722460|NCT00506350|562081904|FG001|Overall Study|Lost to Follow-up|1|||
155722461|NCT00506350|562081905|FG002|Overall Study|Lost to Follow-up|1|||
155722462|NCT00506350|562081906|FG003|Overall Study|Lost to Follow-up|1|||
155722463|NCT00506350|562081907|FG004|Overall Study|Lost to Follow-up|2|||
155722464|NCT00506350|562081908|FG005|Overall Study|Lost to Follow-up|1|||
155722465|NCT00506350|562081909|FG006|Overall Study|Lost to Follow-up|0|||
155722466|NCT00506350|562081910|FG007|Overall Study|Lost to Follow-up|0|||
155722467|NCT00506350|562081911|FG008|Overall Study|Lost to Follow-up|2|||
155722468|NCT00506350|562081903|FG000|Overall Study|Medical Reason|0|||
155722469|NCT00506350|562081904|FG001|Overall Study|Medical Reason|0|||
155722470|NCT00506350|562081905|FG002|Overall Study|Medical Reason|0|||
155722471|NCT00506350|562081906|FG003|Overall Study|Medical Reason|0|||
155722472|NCT00506350|562081907|FG004|Overall Study|Medical Reason|1|||
155722473|NCT00506350|562081908|FG005|Overall Study|Medical Reason|0|||
155722474|NCT00506350|562081909|FG006|Overall Study|Medical Reason|0|||
155722475|NCT00506350|562081910|FG007|Overall Study|Medical Reason|0|||
155722476|NCT00506350|562081911|FG008|Overall Study|Medical Reason|0|||
155722477|NCT00506350|562081903|FG000|Overall Study|Other|1|||
155722478|NCT00506350|562081904|FG001|Overall Study|Other|1|||
155722479|NCT00506350|562081905|FG002|Overall Study|Other|3|||
155722480|NCT00506350|562081906|FG003|Overall Study|Other|0|||
155722481|NCT00506350|562081907|FG004|Overall Study|Other|3|||
155722482|NCT00506350|562081908|FG005|Overall Study|Other|0|||
155722483|NCT00506350|562081909|FG006|Overall Study|Other|0|||
155722484|NCT00506350|562081910|FG007|Overall Study|Other|2|||
155379510|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
155722485|NCT00506350|562081911|FG008|Overall Study|Other|2|||
155722486|NCT01607957|562081912|FG000|Overall Study|Not treated|1|||
155722487|NCT01607957|562081913|FG001|Overall Study|Not treated|1|||
155722488|NCT01607957|562081912|FG000|Overall Study|Death|367|||
155722489|NCT01607957|562081913|FG001|Overall Study|Death|211|||
155722490|NCT01607957|562081912|FG000|Overall Study|Lost to Follow-up|3|||
155722491|NCT01607957|562081913|FG001|Overall Study|Lost to Follow-up|3|||
155722492|NCT01607957|562081912|FG000|Overall Study|Participant refusal|1|||
155722493|NCT01607957|562081913|FG001|Overall Study|Participant refusal|0|||
155722494|NCT01691794|562081914|FG000|Overall Study|Poor/Non-Compliance|1|||
155722495|NCT01691794|562081915|FG001|Overall Study|Poor/Non-Compliance|4|||
155722496|NCT01691794|562081916|FG002|Overall Study|Poor/Non-Compliance|1|||
155722497|NCT01691794|562081914|FG000|Overall Study|Death|0|||
155722498|NCT01691794|562081915|FG001|Overall Study|Death|0|||
155722499|NCT01691794|562081916|FG002|Overall Study|Death|1|||
155722500|NCT01691794|562081914|FG000|Overall Study|Lack of Efficacy|0|||
155722501|NCT01691794|562081915|FG001|Overall Study|Lack of Efficacy|7|||
155722502|NCT01691794|562081916|FG002|Overall Study|Lack of Efficacy|1|||
155722503|NCT01691794|562081914|FG000|Overall Study|Participant request to discontinue|0|||
155722504|NCT01691794|562081915|FG001|Overall Study|Participant request to discontinue|1|||
155722505|NCT01691794|562081916|FG002|Overall Study|Participant request to discontinue|0|||
155722506|NCT01691794|562081914|FG000|Overall Study|Adverse Event|0|||
155722507|NCT01691794|562081915|FG001|Overall Study|Adverse Event|1|||
155722508|NCT01691794|562081916|FG002|Overall Study|Adverse Event|1|||
155722509|NCT01691794|562081914|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
155722510|NCT01691794|562081915|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
155722511|NCT01691794|562081916|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
155722512|NCT01691794|562081914|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
155722513|NCT01691794|562081915|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
155722514|NCT01691794|562081916|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
155722515|NCT04972786|562081917|FG000|First Intervention (1 Day)|Adverse Event|1|||
155722516|NCT04972786|562081918|FG001|First Intervention (1 Day)|Adverse Event|0|||
155722517|NCT00844844|562081919|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
155722518|NCT00844844|562081919|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
155722519|NCT00844844|562081919|FG000|Extension Treatment Period|Adverse Event|2|||
155722520|NCT00844844|562081919|FG000|Post Treatment Period|Withdrawal by Subject|1|||
155722521|NCT03905096|562081920|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
155722522|NCT03905096|562081921|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
155722523|NCT02016781|562081923|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
155722524|NCT02016781|562081924|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
155722525|NCT02016781|562081923|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
155722526|NCT02016781|562081924|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
155722527|NCT02016781|562081923|FG000|Final Database Lock|Withdrawal by Subject|2|||
155722528|NCT02016781|562081924|FG001|Final Database Lock|Withdrawal by Subject|1|||
155722529|NCT02016781|562081923|FG000|Final Database Lock|Lost to Follow-up|11|||
155722530|NCT02016781|562081924|FG001|Final Database Lock|Lost to Follow-up|4|||
155722531|NCT02016781|562081923|FG000|Final Database Lock|Missing data|0|||
155722532|NCT02016781|562081924|FG001|Final Database Lock|Missing data|3|||
155722533|NCT00781768|562083872|FG000|Overall Study|Not transplanted.|0|||
155722534|NCT00781768|562083873|FG001|Overall Study|Not transplanted.|2|||
155722535|NCT02458313|562083876|FG000|Overall Study|Withdrawal by Subject|6|||
155722536|NCT02458313|562083877|FG001|Overall Study|Withdrawal by Subject|8|||
155722537|NCT02458313|562083876|FG000|Overall Study|Excluded for motion during MRI|1|||
155722538|NCT02458313|562083877|FG001|Overall Study|Excluded for motion during MRI|2|||
155722539|NCT00199381|562083878|FG000|Overall Study|Withdrawal by Subject|38|||
155722540|NCT00199381|562083878|FG000|Overall Study|Adverse Event|73|||
155722541|NCT00199381|562083878|FG000|Overall Study|Protocol Violation|6|||
155722542|NCT00199381|562083878|FG000|Overall Study|Lack of Efficacy|27|||
155722543|NCT00199381|562083878|FG000|Overall Study|Not including due to early termination|37|||
155722544|NCT00199381|562083878|FG000|Overall Study|Study termination by Sponsor|323|||
155722545|NCT02892344|562083879|FG000|Overall Study|Protocol deviation|3|||
155722546|NCT02892344|562083880|FG001|Overall Study|Protocol deviation|4|||
155722547|NCT02892344|562083879|FG000|Overall Study|Adverse Event|1|||
155722548|NCT02892344|562083880|FG001|Overall Study|Adverse Event|8|||
155722549|NCT02892344|562083879|FG000|Overall Study|Lost to Follow-up|0|||
155722550|NCT02892344|562083880|FG001|Overall Study|Lost to Follow-up|1|||
155722551|NCT02892344|562083879|FG000|Overall Study|Non-compliance with study treatment|0|||
155722552|NCT02892344|562083880|FG001|Overall Study|Non-compliance with study treatment|1|||
155722553|NCT02892344|562083879|FG000|Overall Study|Physician Decision|0|||
155722554|NCT02892344|562083880|FG001|Overall Study|Physician Decision|2|||
155722555|NCT02892344|562083879|FG000|Overall Study|Subject/guardian decision|0|||
155722556|NCT02892344|562083880|FG001|Overall Study|Subject/guardian decision|4|||
155722557|NCT02892344|562083879|FG000|Overall Study|Technical problems|0|||
155722558|NCT02892344|562083880|FG001|Overall Study|Technical problems|1|||
155722559|NCT00751296|562083881|FG000|Overall Study|Adverse Event|2|||
155722560|NCT02318706|562083884|FG000|Double-blind Phase|Adverse Event|7|||
155722561|NCT02318706|562083885|FG001|Double-blind Phase|Adverse Event|4|||
155722562|NCT02318706|562083886|FG002|Double-blind Phase|Adverse Event|3|||
155722563|NCT02318706|562083887|FG003|Double-blind Phase|Adverse Event|10|||
155722564|NCT02318706|562083888|FG004|Double-blind Phase|Adverse Event|0|||
155722565|NCT02318706|562083884|FG000|Double-blind Phase|Lost to Follow-up|1|||
155722566|NCT02318706|562083885|FG001|Double-blind Phase|Lost to Follow-up|0|||
155722567|NCT02318706|562083886|FG002|Double-blind Phase|Lost to Follow-up|0|||
155722568|NCT02318706|562083887|FG003|Double-blind Phase|Lost to Follow-up|0|||
155722569|NCT02318706|562083888|FG004|Double-blind Phase|Lost to Follow-up|0|||
155722570|NCT02318706|562083884|FG000|Double-blind Phase|Protocol Violation|4|||
155722571|NCT02318706|562083885|FG001|Double-blind Phase|Protocol Violation|2|||
155722572|NCT02318706|562083886|FG002|Double-blind Phase|Protocol Violation|4|||
155722573|NCT02318706|562083887|FG003|Double-blind Phase|Protocol Violation|3|||
155722574|NCT02318706|562083888|FG004|Double-blind Phase|Protocol Violation|0|||
155722575|NCT02318706|562083884|FG000|Double-blind Phase|Withdrawal by Subject|9|||
155379511|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
155379512|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
155379513|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379514|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
155379515|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379516|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379517|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
155379518|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379519|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379520|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379521|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
155379522|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
155379523|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
155379524|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
155379525|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
155379526|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
155379527|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
155379528|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
155379529|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379530|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379531|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379532|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
155379533|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
155379534|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
155379535|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
155379536|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
155379537|NCT01290029|560822355|FG000|Overall Study|Other|2|||
155379538|NCT00189488|560822356|FG000|Overall Study|Ineligibility determined|1|||
155379539|NCT00189488|560822357|FG001|Overall Study|Ineligibility determined|0|||
155379540|NCT00189488|560822356|FG000|Overall Study|Protocol deviation|2|||
155379541|NCT00189488|560822357|FG001|Overall Study|Protocol deviation|1|||
155379542|NCT00189488|560822356|FG000|Overall Study|Adverse Event|2|||
155379543|NCT00189488|560822357|FG001|Overall Study|Adverse Event|1|||
155379544|NCT00189488|560822356|FG000|Overall Study|Withdrawal by Subject|2|||
155379545|NCT00189488|560822357|FG001|Overall Study|Withdrawal by Subject|6|||
155379546|NCT00189488|560822356|FG000|Overall Study|Disease progression|2|||
155379547|NCT00189488|560822357|FG001|Overall Study|Disease progression|4|||
155379548|NCT00189488|560822356|FG000|Overall Study|Administrative Decision|0|||
155379549|NCT00189488|560822357|FG001|Overall Study|Administrative Decision|2|||
155379550|NCT00189488|560822356|FG000|Overall Study|Death|5|||
155379551|NCT00189488|560822357|FG001|Overall Study|Death|8|||
155379552|NCT00189488|560822356|FG000|Overall Study|Other|1|||
155379553|NCT00189488|560822357|FG001|Overall Study|Other|0|||
155379554|NCT02349425|560822360|FG000|Period 1|Adverse Event|1|||
155379555|NCT02349425|560822361|FG001|Period 1|Adverse Event|1|||
155379556|NCT02349425|560822362|FG002|Period 1|Adverse Event|0|||
155379557|NCT02349425|560822363|FG003|Period 1|Adverse Event|0|||
155379558|NCT02349425|560822360|FG000|Period 2|Adverse Event|0|||
155379559|NCT02349425|560822361|FG001|Period 2|Adverse Event|1|||
155379560|NCT02349425|560822362|FG002|Period 2|Adverse Event|1|||
155379561|NCT02349425|560822363|FG003|Period 2|Adverse Event|0|||
155379562|NCT01143038|560822364|FG000|Overall Study|Withdrawal by Subject|4|||
155722576|NCT02318706|562083885|FG001|Double-blind Phase|Withdrawal by Subject|5|||
155379563|NCT01143038|560822364|FG000|Overall Study|Requirement for alternative therapy|5|||
155379564|NCT01143038|560822364|FG000|Overall Study|Adverse Event|3|||
155379565|NCT01143038|560822364|FG000|Overall Study|Lost to Follow-up|2|||
155379566|NCT01143038|560822364|FG000|Overall Study|Protocol Deviation|1|||
155379567|NCT01143038|560822364|FG000|Overall Study|Death|1|||
155379568|NCT02336178|560822365|FG000|Overall Study|Lost to Follow-up|1|||
155379569|NCT02336178|560822365|FG000|Overall Study|Protocol Violation|1|||
155379570|NCT02336178|560822365|FG000|Overall Study|Withdrawal by Subject|1|||
155379571|NCT02336178|560822365|FG000|Overall Study|Other|1|||
155379572|NCT03310268|560822366|FG000|Overall Study|(Not specified)|1|||
155379573|NCT03310268|560822367|FG001|Overall Study|(Not specified)|5|||
155379574|NCT03310268|560822368|FG002|Overall Study|(Not specified)|0|||
155379575|NCT01236365|560822371|FG000|Overall Study|Lost to Follow-up|0|||
155379576|NCT01236365|560822372|FG001|Overall Study|Lost to Follow-up|2|||
155379577|NCT01236365|560822371|FG000|Overall Study|Moved Out of State|1|||
155379578|NCT01236365|560822372|FG001|Overall Study|Moved Out of State|0|||
155379579|NCT01236365|560822371|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
155379580|NCT01236365|560822372|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
155379581|NCT00558259|560822373|FG000|Overall Study|Adverse Event|50|||
155379582|NCT00558259|560822374|FG001|Overall Study|Adverse Event|81|||
155379583|NCT00558259|560822373|FG000|Overall Study|Protocol Violation|9|||
155379584|NCT00558259|560822374|FG001|Overall Study|Protocol Violation|5|||
155379585|NCT00558259|560822373|FG000|Overall Study|Withdrawal by Subject|12|||
155379586|NCT00558259|560822374|FG001|Overall Study|Withdrawal by Subject|13|||
155379587|NCT01183234|560822377|FG000|First Intervention|Adverse Event|1|||
155379588|NCT01183234|560822378|FG001|First Intervention|Adverse Event|0|||
155379589|NCT00822172|560822383|FG000|Overall Study|Adverse Event|10|||
155379590|NCT00822172|560822384|FG001|Overall Study|Adverse Event|12|||
155379591|NCT00822172|560822383|FG000|Overall Study|Death|1|||
155379592|NCT00822172|560822384|FG001|Overall Study|Death|0|||
155379593|NCT00822172|560822383|FG000|Overall Study|Lost to Follow-up|3|||
155379594|NCT00822172|560822384|FG001|Overall Study|Lost to Follow-up|1|||
155379595|NCT00822172|560822383|FG000|Overall Study|Withdrawal by Subject|1|||
155379596|NCT00822172|560822384|FG001|Overall Study|Withdrawal by Subject|4|||
155379597|NCT00822172|560822383|FG000|Overall Study|site closed|0|||
155379598|NCT00822172|560822384|FG001|Overall Study|site closed|1|||
155379599|NCT00822172|560822383|FG000|Overall Study|Other|0|||
155379600|NCT00822172|560822384|FG001|Overall Study|Other|1|||
155379601|NCT00700258|560822385|FG000|Overall Study|Premature discontinuation of documentation|136|||
155379602|NCT00700258|560822385|FG000|Overall Study|Type of study end not documented|1|||
155379603|NCT00700258|560822385|FG000|Overall Study|Lost to Follow-up|81|||
155379604|NCT00700258|560822385|FG000|Overall Study|Premature discontinuation of therapy|1013|||
155379605|NCT04772898|560822387|FG000|Overall Study|Withdrawal by Subject|0|||
155379606|NCT04772898|560822388|FG001|Overall Study|Withdrawal by Subject|1|||
155379607|NCT00473265|560822389|FG000|Overall Study|Unrelated adverse event|5|||
155379608|NCT00473265|560822389|FG000|Overall Study|Off treatment early|15|||
155379609|NCT00370331|560822391|FG000|Overall Study|Adverse Event|4|||
155379610|NCT00370331|560822392|FG001|Overall Study|Adverse Event|13|||
155379611|NCT00370331|560822391|FG000|Overall Study|Withdrawal by Subject|2|||
155379612|NCT00370331|560822392|FG001|Overall Study|Withdrawal by Subject|4|||
155379613|NCT00370331|560822391|FG000|Overall Study|Lost to Follow-up|0|||
155379614|NCT00370331|560822392|FG001|Overall Study|Lost to Follow-up|3|||
155379615|NCT00370331|560822391|FG000|Overall Study|Lack of Efficacy|0|||
155379616|NCT00370331|560822392|FG001|Overall Study|Lack of Efficacy|1|||
155379617|NCT00370331|560822391|FG000|Overall Study|Non-compliance|0|||
155379618|NCT00370331|560822392|FG001|Overall Study|Non-compliance|1|||
155379619|NCT00370331|560822391|FG000|Overall Study|Protocol Violation|1|||
155379620|NCT00370331|560822392|FG001|Overall Study|Protocol Violation|1|||
155379621|NCT02947087|560822393|FG000|Overall Study|Withdrawal by Subject|3|||
155379622|NCT02947087|560822394|FG001|Overall Study|Withdrawal by Subject|2|||
155379623|NCT00545051|560822395|FG000|Overall Study|Adverse Event|7|||
155379624|NCT00545051|560822396|FG001|Overall Study|Adverse Event|3|||
155379625|NCT00545051|560822395|FG000|Overall Study|Death|1|||
155379626|NCT00545051|560822396|FG001|Overall Study|Death|0|||
155379627|NCT00545051|560822395|FG000|Overall Study|Violation of inclusion/exclusion|0|||
155379628|NCT00545051|560822396|FG001|Overall Study|Violation of inclusion/exclusion|2|||
155379629|NCT00545051|560822395|FG000|Overall Study|Protocol Violation|1|||
155379630|NCT00545051|560822396|FG001|Overall Study|Protocol Violation|0|||
155379631|NCT00545051|560822395|FG000|Overall Study|Withdrawal by Subject|0|||
155379632|NCT00545051|560822396|FG001|Overall Study|Withdrawal by Subject|1|||
155379633|NCT00545051|560822395|FG000|Overall Study|Administrative reasons|0|||
155379634|NCT00545051|560822396|FG001|Overall Study|Administrative reasons|1|||
155379635|NCT01888900|560822399|FG000|Overall Study|failed treatment|0|||
155379636|NCT01888900|560822400|FG001|Overall Study|failed treatment|2|||
155379637|NCT03271021|560822401|FG000|Overall Study|Adverse Event|3|||
155379638|NCT03271021|560822402|FG001|Overall Study|Adverse Event|2|||
155379639|NCT03271021|560822401|FG000|Overall Study|Withdrawal by Subject|36|||
155379640|NCT03271021|560822402|FG001|Overall Study|Withdrawal by Subject|53|||
155379641|NCT03271021|560822401|FG000|Overall Study|Lost to Follow-up|34|||
155379642|NCT03271021|560822402|FG001|Overall Study|Lost to Follow-up|39|||
155379643|NCT03271021|560822401|FG000|Overall Study|Protocol Violation|6|||
155379644|NCT03271021|560822402|FG001|Overall Study|Protocol Violation|4|||
155379645|NCT03271021|560822401|FG000|Overall Study|Abnormal Lab Results|1|||
155379646|NCT03271021|560822402|FG001|Overall Study|Abnormal Lab Results|0|||
155379647|NCT03271021|560822401|FG000|Overall Study|Miscellaneous|9|||
155379648|NCT03271021|560822402|FG001|Overall Study|Miscellaneous|8|||
155379649|NCT03215810|560822403|FG000|Overall Study|Still responding to nivolumab|1|||
155379650|NCT03215810|560822403|FG000|Overall Study|Insufficient TIL growth|1|||
155379651|NCT03215810|560822403|FG000|Overall Study|Decline in performance status|1|||
155379652|NCT03215810|560822403|FG000|Overall Study|Withdrawal by Subject|1|||
155379653|NCT02313233|560822404|FG000|Overall Study|Withdrawal by Subject|1|||
155379654|NCT02313233|560822405|FG001|Overall Study|Withdrawal by Subject|2|||
155379655|NCT02313233|560822404|FG000|Overall Study|Administrative reason|1|||
155379656|NCT02313233|560822405|FG001|Overall Study|Administrative reason|1|||
155379657|NCT01859988|560822407|FG000|Overall Study|Withdrawal by Subject|6|||
155379658|NCT01859988|560822408|FG001|Overall Study|Withdrawal by Subject|3|||
155379659|NCT01859988|560822409|FG002|Overall Study|Withdrawal by Subject|4|||
155379660|NCT01859988|560822410|FG003|Overall Study|Withdrawal by Subject|3|||
155379661|NCT01859988|560822411|FG004|Overall Study|Withdrawal by Subject|2|||
155379662|NCT01859988|560822412|FG005|Overall Study|Withdrawal by Subject|2|||
155379663|NCT01859988|560822407|FG000|Overall Study|Lack of Efficacy|1|||
155379664|NCT01859988|560822408|FG001|Overall Study|Lack of Efficacy|1|||
155379665|NCT01859988|560822409|FG002|Overall Study|Lack of Efficacy|5|||
155379666|NCT01859988|560822410|FG003|Overall Study|Lack of Efficacy|0|||
155379667|NCT01859988|560822411|FG004|Overall Study|Lack of Efficacy|7|||
155379668|NCT01859988|560822412|FG005|Overall Study|Lack of Efficacy|9|||
155379669|NCT01859988|560822407|FG000|Overall Study|Physician Decision|1|||
155379670|NCT01859988|560822408|FG001|Overall Study|Physician Decision|3|||
155379671|NCT01859988|560822409|FG002|Overall Study|Physician Decision|1|||
155379672|NCT01859988|560822410|FG003|Overall Study|Physician Decision|3|||
155379673|NCT01859988|560822411|FG004|Overall Study|Physician Decision|4|||
155379674|NCT01859988|560822412|FG005|Overall Study|Physician Decision|1|||
155379675|NCT01859988|560822407|FG000|Overall Study|Adverse Event|2|||
155379676|NCT01859988|560822408|FG001|Overall Study|Adverse Event|1|||
155379677|NCT01859988|560822409|FG002|Overall Study|Adverse Event|3|||
155379678|NCT01859988|560822410|FG003|Overall Study|Adverse Event|1|||
155379679|NCT01859988|560822411|FG004|Overall Study|Adverse Event|2|||
155379680|NCT01859988|560822412|FG005|Overall Study|Adverse Event|2|||
155379681|NCT01859988|560822407|FG000|Overall Study|Lost to Follow-up|1|||
155379682|NCT01859988|560822408|FG001|Overall Study|Lost to Follow-up|2|||
155379683|NCT01859988|560822409|FG002|Overall Study|Lost to Follow-up|3|||
155379684|NCT01859988|560822410|FG003|Overall Study|Lost to Follow-up|0|||
155379685|NCT01859988|560822411|FG004|Overall Study|Lost to Follow-up|3|||
155379686|NCT01859988|560822412|FG005|Overall Study|Lost to Follow-up|2|||
155379687|NCT01859988|560822407|FG000|Overall Study|Protocol Violation|0|||
155379688|NCT01859988|560822408|FG001|Overall Study|Protocol Violation|0|||
155379689|NCT01859988|560822409|FG002|Overall Study|Protocol Violation|1|||
155379690|NCT01859988|560822410|FG003|Overall Study|Protocol Violation|0|||
155379691|NCT01859988|560822411|FG004|Overall Study|Protocol Violation|0|||
155379692|NCT01859988|560822412|FG005|Overall Study|Protocol Violation|0|||
155379693|NCT01859988|560822407|FG000|Overall Study|Other than specified above|0|||
155379694|NCT01859988|560822408|FG001|Overall Study|Other than specified above|2|||
155379695|NCT01859988|560822409|FG002|Overall Study|Other than specified above|11|||
155379696|NCT01859988|560822410|FG003|Overall Study|Other than specified above|3|||
155379697|NCT01859988|560822411|FG004|Overall Study|Other than specified above|5|||
155379698|NCT01859988|560822412|FG005|Overall Study|Other than specified above|3|||
155379699|NCT02930226|560822413|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379700|NCT02930226|560822414|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379701|NCT02930226|560822415|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379702|NCT02930226|560822416|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379703|NCT02930226|560822417|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
155379704|NCT02930226|560822418|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379705|NCT00635427|560822419|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379706|NCT00635427|560822420|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379707|NCT00635427|560822421|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
155379708|NCT00635427|560822422|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379709|NCT00635427|560822423|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379710|NCT00635427|560822419|FG000|Overall Study|Death|0|||
155379711|NCT00635427|560822420|FG001|Overall Study|Death|0|||
155379712|NCT00635427|560822421|FG002|Overall Study|Death|0|||
155379713|NCT00635427|560822422|FG003|Overall Study|Death|1|||
155379714|NCT00635427|560822423|FG004|Overall Study|Death|0|||
155379715|NCT00635427|560822419|FG000|Overall Study|Termination Of Study By Sponsor|12|||
155379716|NCT00635427|560822420|FG001|Overall Study|Termination Of Study By Sponsor|6|||
155379717|NCT00635427|560822421|FG002|Overall Study|Termination Of Study By Sponsor|10|||
155435817|NCT00624338|561022961|FG002|Overall Study|Lack of Efficacy|14|||
155379718|NCT00635427|560822422|FG003|Overall Study|Termination Of Study By Sponsor|6|||
155379719|NCT00635427|560822423|FG004|Overall Study|Termination Of Study By Sponsor|6|||
155379720|NCT00635427|560822419|FG000|Overall Study|Withdrawal Of Consent|0|||
155379721|NCT00635427|560822420|FG001|Overall Study|Withdrawal Of Consent|0|||
155379722|NCT00635427|560822421|FG002|Overall Study|Withdrawal Of Consent|0|||
155379723|NCT00635427|560822422|FG003|Overall Study|Withdrawal Of Consent|2|||
155379724|NCT00635427|560822423|FG004|Overall Study|Withdrawal Of Consent|2|||
155379725|NCT01506609|560822426|FG000|Overall Study|Adverse Event Related to Progression|0|||
155379726|NCT01506609|560822427|FG001|Overall Study|Adverse Event Related to Progression|0|||
155379727|NCT01506609|560822428|FG002|Overall Study|Adverse Event Related to Progression|0|||
155379728|NCT01506609|560822429|FG003|Overall Study|Adverse Event Related to Progression|3|||
155379729|NCT01506609|560822430|FG004|Overall Study|Adverse Event Related to Progression|7|||
155379730|NCT01506609|560822431|FG005|Overall Study|Adverse Event Related to Progression|3|||
155379731|NCT01506609|560822426|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
155379732|NCT01506609|560822427|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
155379733|NCT01506609|560822428|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
155379734|NCT01506609|560822429|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
155379735|NCT01506609|560822430|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
155379736|NCT01506609|560822431|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
155379737|NCT01506609|560822426|FG000|Overall Study|Withdrawal by Subject|0|||
155379738|NCT01506609|560822427|FG001|Overall Study|Withdrawal by Subject|0|||
155379739|NCT01506609|560822428|FG002|Overall Study|Withdrawal by Subject|0|||
155379740|NCT01506609|560822429|FG003|Overall Study|Withdrawal by Subject|9|||
155379741|NCT01506609|560822430|FG004|Overall Study|Withdrawal by Subject|7|||
155379742|NCT01506609|560822431|FG005|Overall Study|Withdrawal by Subject|7|||
155379743|NCT01506609|560822426|FG000|Overall Study|Lost to Follow-up|0|||
155379744|NCT01506609|560822427|FG001|Overall Study|Lost to Follow-up|0|||
155379745|NCT01506609|560822428|FG002|Overall Study|Lost to Follow-up|0|||
155379746|NCT01506609|560822429|FG003|Overall Study|Lost to Follow-up|1|||
155379747|NCT01506609|560822430|FG004|Overall Study|Lost to Follow-up|2|||
155379748|NCT01506609|560822431|FG005|Overall Study|Lost to Follow-up|0|||
155379749|NCT01506609|560822426|FG000|Overall Study|Sponsor Discontinued Study|0|||
155379750|NCT01506609|560822427|FG001|Overall Study|Sponsor Discontinued Study|0|||
155379751|NCT01506609|560822428|FG002|Overall Study|Sponsor Discontinued Study|0|||
155379752|NCT01506609|560822429|FG003|Overall Study|Sponsor Discontinued Study|2|||
155379753|NCT01506609|560822430|FG004|Overall Study|Sponsor Discontinued Study|2|||
155379754|NCT01506609|560822431|FG005|Overall Study|Sponsor Discontinued Study|0|||
155379755|NCT01506609|560822426|FG000|Overall Study|Progressive Disease per Protocol|1|||
155379756|NCT01506609|560822427|FG001|Overall Study|Progressive Disease per Protocol|0|||
155379757|NCT01506609|560822428|FG002|Overall Study|Progressive Disease per Protocol|0|||
155379758|NCT01506609|560822429|FG003|Overall Study|Progressive Disease per Protocol|64|||
155379759|NCT01506609|560822430|FG004|Overall Study|Progressive Disease per Protocol|57|||
155379760|NCT01506609|560822431|FG005|Overall Study|Progressive Disease per Protocol|74|||
155379761|NCT01506609|560822426|FG000|Overall Study|Other, Not Specified|0|||
155379762|NCT01506609|560822427|FG001|Overall Study|Other, Not Specified|0|||
155379763|NCT01506609|560822428|FG002|Overall Study|Other, Not Specified|0|||
155379764|NCT01506609|560822429|FG003|Overall Study|Other, Not Specified|10|||
155379765|NCT01506609|560822430|FG004|Overall Study|Other, Not Specified|7|||
155379766|NCT01506609|560822431|FG005|Overall Study|Other, Not Specified|3|||
155379767|NCT01506609|560822426|FG000|Overall Study|Missing / Unknown Reason|1|||
155379768|NCT01506609|560822427|FG001|Overall Study|Missing / Unknown Reason|0|||
155379769|NCT01506609|560822428|FG002|Overall Study|Missing / Unknown Reason|1|||
155379770|NCT01506609|560822429|FG003|Overall Study|Missing / Unknown Reason|4|||
155379771|NCT01506609|560822430|FG004|Overall Study|Missing / Unknown Reason|4|||
155379772|NCT01506609|560822431|FG005|Overall Study|Missing / Unknown Reason|2|||
155379773|NCT00577473|560822436|FG000|Overall Study|Protocol Violation|1|||
155379774|NCT00577473|560822437|FG001|Overall Study|Protocol Violation|4|||
155379775|NCT00577473|560822436|FG000|Overall Study|Adverse Event|8|||
155379776|NCT00577473|560822437|FG001|Overall Study|Adverse Event|5|||
155379777|NCT00577473|560822436|FG000|Overall Study|Withdrawal by Subject|2|||
155379778|NCT00577473|560822437|FG001|Overall Study|Withdrawal by Subject|6|||
155379779|NCT00577473|560822436|FG000|Overall Study|Physician Decision|2|||
155379780|NCT00577473|560822437|FG001|Overall Study|Physician Decision|2|||
155379781|NCT00577473|560822436|FG000|Overall Study|Lack of Efficacy|8|||
155379782|NCT00577473|560822437|FG001|Overall Study|Lack of Efficacy|7|||
155379783|NCT01990560|560822438|FG000|Overall Study|Withdrawal by Subject|1|||
155379784|NCT02084056|560822444|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
155379785|NCT02084056|560822445|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379786|NCT02084056|560822446|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379787|NCT02084056|560822447|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379788|NCT02084056|560822444|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
155379789|NCT02084056|560822445|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379790|NCT02084056|560822446|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379791|NCT02084056|560822447|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379792|NCT00938860|560822448|FG000|Overall Study|Adverse Event|2|||
155379793|NCT00938860|560822449|FG001|Overall Study|Adverse Event|1|||
155379794|NCT00938860|560822448|FG000|Overall Study|Abnormal laboratory values|2|||
155379795|NCT00938860|560822449|FG001|Overall Study|Abnormal laboratory values|2|||
155379796|NCT00938860|560822448|FG000|Overall Study|Withdrawal by Subject|11|||
155379797|NCT00938860|560822449|FG001|Overall Study|Withdrawal by Subject|8|||
155379798|NCT00938860|560822448|FG000|Overall Study|Lost to Follow-up|4|||
155379799|NCT00938860|560822449|FG001|Overall Study|Lost to Follow-up|4|||
155379800|NCT00938860|560822448|FG000|Overall Study|Administration problems|2|||
155379801|NCT00938860|560822449|FG001|Overall Study|Administration problems|0|||
155379802|NCT00938860|560822448|FG000|Overall Study|Death|1|||
155379803|NCT00938860|560822449|FG001|Overall Study|Death|1|||
155379804|NCT00938860|560822448|FG000|Overall Study|Protocol Violation|3|||
155379805|NCT00938860|560822449|FG001|Overall Study|Protocol Violation|1|||
155379806|NCT01605019|560822450|FG000|Overall Study|pt did not meet transplant endpoint|3|||
155379807|NCT01605019|560822451|FG001|Overall Study|pt did not meet transplant endpoint|0|||
155379808|NCT00468559|560822455|FG000|Open-label Treatment Phase|Adverse Event|5|||
155379809|NCT00468559|560822456|FG001|Open-label Treatment Phase|Adverse Event|0|||
155379810|NCT00468559|560822457|FG002|Open-label Treatment Phase|Adverse Event|0|||
155379811|NCT00468559|560822455|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
155379812|NCT00468559|560822456|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
155379813|NCT00468559|560822457|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
155379814|NCT00468559|560822455|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
155379815|NCT00468559|560822456|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
155379816|NCT00468559|560822457|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
155379817|NCT00468559|560822455|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
155379818|NCT00468559|560822456|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
155379819|NCT00468559|560822457|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
155379820|NCT00468559|560822455|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
155379821|NCT00468559|560822456|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
155379822|NCT00468559|560822457|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
155379823|NCT00862719|560822458|FG000|Overall Study|Disease Progression|5|||
155379824|NCT00862719|560822459|FG001|Overall Study|Disease Progression|0|||
155379825|NCT00862719|560822460|FG002|Overall Study|Disease Progression|1|||
155379826|NCT00862719|560822461|FG003|Overall Study|Disease Progression|0|||
155379827|NCT00862719|560822458|FG000|Overall Study|Death|5|||
155379828|NCT00862719|560822459|FG001|Overall Study|Death|6|||
155379829|NCT00862719|560822460|FG002|Overall Study|Death|1|||
155379830|NCT00862719|560822461|FG003|Overall Study|Death|1|||
155379831|NCT00862719|560822458|FG000|Overall Study|Engraftment failure|0|||
155379832|NCT00862719|560822459|FG001|Overall Study|Engraftment failure|0|||
155379833|NCT00862719|560822460|FG002|Overall Study|Engraftment failure|1|||
155379834|NCT00862719|560822461|FG003|Overall Study|Engraftment failure|0|||
155379835|NCT00862719|560822458|FG000|Overall Study|Veno-Occlusive Disease|0|||
155379836|NCT00862719|560822459|FG001|Overall Study|Veno-Occlusive Disease|0|||
155379837|NCT00862719|560822460|FG002|Overall Study|Veno-Occlusive Disease|1|||
155379838|NCT00862719|560822461|FG003|Overall Study|Veno-Occlusive Disease|0|||
155379839|NCT00324116|560822462|FG000|Overall Study|Adverse Event|5|||
155379840|NCT00324116|560822462|FG000|Overall Study|Lack of Efficacy|17|||
155379841|NCT00324116|560822462|FG000|Overall Study|Withdrawal by Subject|5|||
155379842|NCT00324116|560822462|FG000|Overall Study|Other|5|||
155379843|NCT01153958|560822463|FG000|Overall Study|Study Terminated|36|||
155379844|NCT01153958|560822464|FG001|Overall Study|Study Terminated|32|||
155379845|NCT02624791|560822466|FG000|Overall Study|Withdrawal by Subject|2|||
155379846|NCT02624791|560822467|FG001|Overall Study|Withdrawal by Subject|0|||
155379847|NCT02624791|560822468|FG002|Overall Study|Withdrawal by Subject|0|||
155379848|NCT02624791|560822469|FG003|Overall Study|Withdrawal by Subject|0|||
155379849|NCT02624791|560822470|FG004|Overall Study|Withdrawal by Subject|0|||
155379850|NCT02624791|560822471|FG005|Overall Study|Withdrawal by Subject|0|||
155379851|NCT00998790|560822472|FG000|Overall Study|Withdrawal by Subject|21|||
155379852|NCT01605916|560822473|FG000|Overall Study|Adverse Event|1|||
155379853|NCT01605916|560822474|FG001|Overall Study|Adverse Event|0|||
155379854|NCT01605916|560822475|FG002|Overall Study|Adverse Event|0|||
155379855|NCT01605916|560822476|FG003|Overall Study|Adverse Event|1|||
155379856|NCT01605916|560822477|FG004|Overall Study|Adverse Event|0|||
155379857|NCT01605916|560822473|FG000|Overall Study|Lack of Efficacy|2|||
155379858|NCT01605916|560822474|FG001|Overall Study|Lack of Efficacy|3|||
155379859|NCT01605916|560822475|FG002|Overall Study|Lack of Efficacy|3|||
155379860|NCT01605916|560822476|FG003|Overall Study|Lack of Efficacy|5|||
155379861|NCT01605916|560822477|FG004|Overall Study|Lack of Efficacy|4|||
155379862|NCT01605916|560822473|FG000|Overall Study|Withdrawal by Subject|1|||
155379863|NCT01605916|560822474|FG001|Overall Study|Withdrawal by Subject|1|||
155379864|NCT01605916|560822475|FG002|Overall Study|Withdrawal by Subject|0|||
155379865|NCT01605916|560822476|FG003|Overall Study|Withdrawal by Subject|0|||
155379866|NCT01605916|560822477|FG004|Overall Study|Withdrawal by Subject|2|||
155379867|NCT01103362|560822484|FG000|Overall Study|study terminated|596|||
155379868|NCT00412061|560822486|FG000|Double Blind Phase|Disease Progression|101|||
155379869|NCT00412061|560822487|FG001|Double Blind Phase|Disease Progression|154|||
155379870|NCT00412061|560822486|FG000|Double Blind Phase|Adverse Event|61|||
155379871|NCT00412061|560822487|FG001|Double Blind Phase|Adverse Event|16|||
155379872|NCT00412061|560822486|FG000|Double Blind Phase|Final Primary Analysis|26|||
155379873|NCT00412061|560822487|FG001|Double Blind Phase|Final Primary Analysis|14|||
155379874|NCT00412061|560822486|FG000|Double Blind Phase|Withdrawal by Subject|18|||
155379875|NCT00412061|560822487|FG001|Double Blind Phase|Withdrawal by Subject|20|||
155379876|NCT00412061|560822486|FG000|Double Blind Phase|Death|6|||
155379877|NCT00412061|560822487|FG001|Double Blind Phase|Death|3|||
155379878|NCT00412061|560822486|FG000|Double Blind Phase|Protocol Violation|3|||
155379879|NCT00412061|560822487|FG001|Double Blind Phase|Protocol Violation|4|||
155379880|NCT00412061|560822486|FG000|Double Blind Phase|New Cander Therapy|1|||
155379881|NCT00412061|560822487|FG001|Double Blind Phase|New Cander Therapy|1|||
155379882|NCT00412061|560822486|FG000|Double Blind Phase|Lost to Follow-up|0|||
155379883|NCT00412061|560822487|FG001|Double Blind Phase|Lost to Follow-up|1|||
155379884|NCT00412061|560822486|FG000|Open Label Phase|Disease Progression|0|||
155379885|NCT00412061|560822487|FG001|Open Label Phase|Disease Progression|86|||
155379886|NCT00412061|560822486|FG000|Open Label Phase|Adverse Event|0|||
155379887|NCT00412061|560822487|FG001|Open Label Phase|Adverse Event|46|||
155379888|NCT00412061|560822486|FG000|Open Label Phase|Withdrawal by Subject|0|||
155379889|NCT00412061|560822487|FG001|Open Label Phase|Withdrawal by Subject|15|||
155379890|NCT00412061|560822486|FG000|Open Label Phase|Administrative Problems|0|||
155379891|NCT00412061|560822487|FG001|Open Label Phase|Administrative Problems|13|||
155379892|NCT00412061|560822486|FG000|Open Label Phase|Death|0|||
155379893|NCT00412061|560822487|FG001|Open Label Phase|Death|7|||
155379894|NCT00412061|560822486|FG000|Open Label Phase|Lost to Follow-up|0|||
155379895|NCT00412061|560822487|FG001|Open Label Phase|Lost to Follow-up|2|||
155379896|NCT00412061|560822486|FG000|Open Label Phase|New Cancer Therapy|0|||
155379897|NCT00412061|560822487|FG001|Open Label Phase|New Cancer Therapy|1|||
155379898|NCT03406078|560822489|FG000|Overall Study|Death|1|||
155379899|NCT03406078|560822490|FG001|Overall Study|Death|0|||
155379900|NCT03406078|560822489|FG000|Overall Study|Lost to Follow-up|0|||
155379901|NCT03406078|560822490|FG001|Overall Study|Lost to Follow-up|1|||
155379902|NCT03406078|560822489|FG000|Overall Study|Withdrawal by Subject|5|||
155379903|NCT03406078|560822490|FG001|Overall Study|Withdrawal by Subject|2|||
155379904|NCT03616977|560822492|FG000|Period 1|Physician Decision|0|||
155379905|NCT03616977|560822493|FG001|Period 1|Physician Decision|1|||
155379906|NCT03616977|560822492|FG000|Period 3|Adverse Event|1|||
155379907|NCT03616977|560822493|FG001|Period 3|Adverse Event|1|||
155379908|NCT02859324|560822494|FG000|Overall Study|Death|4|||
155379909|NCT02859324|560822495|FG001|Overall Study|Death|6|||
155379910|NCT02859324|560822496|FG002|Overall Study|Death|5|||
155379911|NCT02859324|560822494|FG000|Overall Study|Other reasons|3|||
155379912|NCT02859324|560822495|FG001|Overall Study|Other reasons|3|||
155379913|NCT02859324|560822496|FG002|Overall Study|Other reasons|0|||
155379914|NCT03798691|560822497|FG000|Overall Study|Lost to Follow-up|2|||
155379915|NCT03798691|560822498|FG001|Overall Study|Lost to Follow-up|2|||
155435818|NCT00624338|561022959|FG000|Overall Study|Protocol Violation|3|||
155435819|NCT00624338|561022960|FG001|Overall Study|Protocol Violation|3|||
155435820|NCT00624338|561022961|FG002|Overall Study|Protocol Violation|2|||
155435821|NCT00624338|561022959|FG000|Overall Study|Death|0|||
155435822|NCT00624338|561022960|FG001|Overall Study|Death|2|||
155435823|NCT00624338|561022961|FG002|Overall Study|Death|0|||
155435824|NCT00624338|561022959|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
155435825|NCT00624338|561022960|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
155435826|NCT00624338|561022961|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
155435827|NCT00624338|561022959|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
155435828|NCT00624338|561022960|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
155435829|NCT00624338|561022961|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
155435830|NCT00624338|561022959|FG000|Overall Study|Other|15|||
155435831|NCT00624338|561022960|FG001|Overall Study|Other|5|||
155435832|NCT00624338|561022961|FG002|Overall Study|Other|9|||
155435833|NCT00624338|561022959|FG000|Overall Study|Randomized but not treated|2|||
155435834|NCT00624338|561022960|FG001|Overall Study|Randomized but not treated|1|||
155435835|NCT00624338|561022961|FG002|Overall Study|Randomized but not treated|3|||
155435836|NCT01548638|561022962|FG000|Overall Study|Protocol Violation|3|||
155435837|NCT01548638|561022962|FG000|Overall Study|Withdrawal by Subject|1|||
155435838|NCT01476787|561022966|FG000|Treatment|Progression|64|||
155435839|NCT01476787|561022967|FG001|Treatment|Progression|71|||
155435840|NCT01476787|561022966|FG000|Treatment|Toxicity|44|||
155435841|NCT01476787|561022967|FG001|Treatment|Toxicity|16|||
155435842|NCT01476787|561022966|FG000|Treatment|Death|0|||
155435843|NCT01476787|561022967|FG001|Treatment|Death|1|||
155435844|NCT01476787|561022966|FG000|Treatment|Withdrawal by Subject|3|||
155435845|NCT01476787|561022967|FG001|Treatment|Withdrawal by Subject|14|||
155435846|NCT01476787|561022966|FG000|Treatment|Major protocol violation|1|||
155435847|NCT01476787|561022967|FG001|Treatment|Major protocol violation|6|||
155435848|NCT01476787|561022966|FG000|Treatment|Other reasons|10|||
155435849|NCT01476787|561022967|FG001|Treatment|Other reasons|22|||
155379916|NCT02186223|560823873|FG000|Overall Study|Not eligible for device placement|6|||
155379917|NCT02186223|560823873|FG000|Overall Study|Unable to obtain femoral access|3|||
155379918|NCT02186223|560823873|FG000|Overall Study|Death|3|||
155379919|NCT02186223|560823873|FG000|Overall Study|Device in place less than 48 hours|9|||
155379920|NCT00252733|560823874|FG000|Overall Study|Withdrawal by Subject|73|||
155379921|NCT00252733|560823875|FG001|Overall Study|Withdrawal by Subject|67|||
155379922|NCT00252733|560823874|FG000|Overall Study|Death|7|||
155379923|NCT00252733|560823875|FG001|Overall Study|Death|5|||
155379924|NCT00252733|560823874|FG000|Overall Study|Lost to Follow-up|12|||
155379925|NCT00252733|560823875|FG001|Overall Study|Lost to Follow-up|6|||
155379926|NCT00252733|560823874|FG000|Overall Study|Multiple Reasons|14|||
155379927|NCT00252733|560823875|FG001|Overall Study|Multiple Reasons|14|||
155379928|NCT00618982|560823876|FG000|Overall Study|Adverse Event|23|||
155379929|NCT00618982|560823876|FG000|Overall Study|Withdrawal by Subject|1|||
155379930|NCT00618982|560823876|FG000|Overall Study|Protocol Violation|1|||
155379931|NCT00618982|560823876|FG000|Overall Study|ongoing, still treated with study med.|25|||
155379932|NCT00706433|560823880|FG000|Overall Study|Lost to Follow-up|3|||
155379933|NCT00706433|560823881|FG001|Overall Study|Lost to Follow-up|1|||
155379934|NCT00706433|560823882|FG002|Overall Study|Lost to Follow-up|6|||
155379935|NCT00706433|560823883|FG003|Overall Study|Lost to Follow-up|0|||
155379936|NCT00706433|560823880|FG000|Overall Study|Withdrawal by Subject|1|||
155379937|NCT00706433|560823881|FG001|Overall Study|Withdrawal by Subject|2|||
155379938|NCT00706433|560823882|FG002|Overall Study|Withdrawal by Subject|3|||
155379939|NCT00706433|560823883|FG003|Overall Study|Withdrawal by Subject|1|||
155379940|NCT00706433|560823880|FG000|Overall Study|Adverse Event|0|||
155379941|NCT00706433|560823881|FG001|Overall Study|Adverse Event|0|||
155379942|NCT00706433|560823882|FG002|Overall Study|Adverse Event|1|||
155379943|NCT00706433|560823883|FG003|Overall Study|Adverse Event|0|||
155379944|NCT00706433|560823880|FG000|Overall Study|Protocol Violation|1|||
155379945|NCT00706433|560823881|FG001|Overall Study|Protocol Violation|0|||
155379946|NCT00706433|560823882|FG002|Overall Study|Protocol Violation|0|||
155379947|NCT00706433|560823883|FG003|Overall Study|Protocol Violation|0|||
155379948|NCT00706433|560823880|FG000|Overall Study|new job|0|||
155379949|NCT00706433|560823881|FG001|Overall Study|new job|0|||
155379950|NCT00706433|560823882|FG002|Overall Study|new job|0|||
155379951|NCT00706433|560823883|FG003|Overall Study|new job|1|||
155379952|NCT04101318|560823885|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
155379953|NCT04101318|560823886|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
155379954|NCT04101318|560823885|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
155379955|NCT04101318|560823886|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
155379956|NCT04101318|560823885|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
155379957|NCT04101318|560823886|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
155379958|NCT00993668|560823892|FG000|Single-Blind Period|Adverse Event|1|||
155379959|NCT00993668|560823893|FG001|Single-Blind Period|Adverse Event|1|||
155379960|NCT00993668|560823892|FG000|Single-Blind Period|Lack of Efficacy|0|||
155379961|NCT00993668|560823893|FG001|Single-Blind Period|Lack of Efficacy|1|||
155379962|NCT00993668|560823892|FG000|Single-Blind Period|Lost to Follow-up|3|||
155379963|NCT00993668|560823893|FG001|Single-Blind Period|Lost to Follow-up|1|||
155379964|NCT00993668|560823892|FG000|Open-Label Period|Adverse Event|9|||
155379965|NCT00993668|560823893|FG001|Open-Label Period|Adverse Event|8|||
155379966|NCT00993668|560823892|FG000|Open-Label Period|Lack of Efficacy|4|||
155379967|NCT00993668|560823893|FG001|Open-Label Period|Lack of Efficacy|3|||
155379968|NCT00993668|560823892|FG000|Open-Label Period|Withdrawal by Subject|4|||
155379969|NCT00993668|560823893|FG001|Open-Label Period|Withdrawal by Subject|3|||
155379970|NCT00993668|560823892|FG000|Open-Label Period|Lost to Follow-up|6|||
155379971|NCT00993668|560823893|FG001|Open-Label Period|Lost to Follow-up|1|||
155379972|NCT02207569|560823894|FG000|1-Month|Death|6|||
155379973|NCT02207569|560823894|FG000|1-Month|Withdrawal by Subject|2|||
155379974|NCT02207569|560823894|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
155379975|NCT02207569|560823894|FG000|6-Month|Death|8|||
155379976|NCT02207569|560823894|FG000|6-Month|Withdrawal by Subject|2|||
155379977|NCT02207569|560823894|FG000|12-Month|Death|14|||
155379978|NCT02207569|560823894|FG000|12-Month|Withdrawal by Subject|2|||
155379979|NCT02207569|560823894|FG000|24-Month|Death|23|||
155379980|NCT02207569|560823894|FG000|24-Month|Withdrawal by Subject|3|||
155379981|NCT02207569|560823894|FG000|36-Month|Death|23|||
155379982|NCT02207569|560823894|FG000|36-Month|Withdrawal by Subject|4|||
155379983|NCT02207569|560823894|FG000|48-Month|Death|25|||
155379984|NCT02207569|560823894|FG000|48-Month|Withdrawal by Subject|2|||
155379985|NCT02207569|560823894|FG000|48-Month|Lost to Follow-up|4|||
155379986|NCT02207569|560823894|FG000|60-Month|Death|1|||
155379987|NCT02207569|560823894|FG000|60-Month|Lost to Follow-up|1|||
155379988|NCT02207569|560823894|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
155379989|NCT02207569|560823894|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
155379990|NCT02585232|560823895|FG000|Overall Study|Lost to Follow-up|8|||
155379991|NCT02585232|560823896|FG001|Overall Study|Lost to Follow-up|8|||
155379992|NCT02585232|560823895|FG000|Overall Study|Withdrawal by Subject|4|||
155435850|NCT01476787|561022966|FG000|Treatment|Concurrent illness|12|||
155379993|NCT02585232|560823896|FG001|Overall Study|Withdrawal by Subject|8|||
155379994|NCT00297232|560823897|FG000|Overall Study|Lack of Efficacy|7|||
155379995|NCT00297232|560823897|FG000|Overall Study|Lost to Follow-up|10|||
155379996|NCT00297232|560823897|FG000|Overall Study|Adverse Event|63|||
155379997|NCT00297232|560823897|FG000|Overall Study|Voluntary Withdrawal|120|||
155379998|NCT00297232|560823897|FG000|Overall Study|Subject was Noncompliant|9|||
155379999|NCT00297232|560823897|FG000|Overall Study|Death|9|||
155380000|NCT00297232|560823897|FG000|Overall Study|Anti-natalizumab Positive|8|||
155380001|NCT00297232|560823897|FG000|Overall Study|Switched to Commercial Tysabri|22|||
155380002|NCT00297232|560823897|FG000|Overall Study|Disease Progression|8|||
155380003|NCT00297232|560823897|FG000|Overall Study|Fear of PML|10|||
155380004|NCT00297232|560823897|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
155380005|NCT00297232|560823897|FG000|Overall Study|Miscellaneous|5|||
155380006|NCT00297232|560823897|FG000|Overall Study|Sponsor Decision|34|||
155380007|NCT00297232|560823897|FG000|Overall Study|Subject Relocated|7|||
155380008|NCT00297232|560823897|FG000|Overall Study|Subject Withdrew Consent|37|||
155380009|NCT00297232|560823897|FG000|Overall Study|Persistently Positive Antibodies|11|||
155380010|NCT00297232|560823897|FG000|Overall Study|Investigator Withdrew From Program|19|||
155380011|NCT00297232|560823897|FG000|Overall Study|Did Not Enroll to Week 264|34|||
155380012|NCT00297232|560823897|FG000|Overall Study|Did Not Enroll to Week 480|17|||
155380013|NCT00297232|560823897|FG000|Overall Study|No data available after Week 264|161|||
155380014|NCT00297232|560823897|FG000|Overall Study|Other|1|||
155380015|NCT03038438|560823900|FG000|Overall Study|Death|3|||
155380016|NCT03038438|560823900|FG000|Overall Study|Lost to Follow-up|8|||
155380017|NCT03038438|560823900|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
155380018|NCT03038438|560823900|FG000|Overall Study|Withdrawal by Subject|5|||
155380019|NCT03038438|560823900|FG000|Overall Study|No 36-Month Follow-Up|18|||
155380020|NCT03406260|560823901|FG000|Period 1|Adverse Event|0|||
155380021|NCT03406260|560823902|FG001|Period 1|Adverse Event|0|||
155380022|NCT03406260|560823903|FG002|Period 1|Adverse Event|0|||
155380023|NCT03406260|560823904|FG003|Period 1|Adverse Event|0|||
155380024|NCT03406260|560823905|FG004|Period 1|Adverse Event|1|||
155380025|NCT03406260|560823906|FG005|Period 1|Adverse Event|0|||
155380026|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
155380027|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
155380028|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
155380029|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
155380030|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
155380031|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
155380032|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
155380033|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
155380034|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Death|0|||
155380035|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Death|1|||
155380036|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
155380037|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
155380038|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
155380039|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
155380040|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
155380041|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
155380042|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
155380043|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
155380044|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
155380045|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
155380046|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
155380047|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
155380048|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
155380049|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
155380050|NCT02095951|560823915|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
155380051|NCT02095951|560823916|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
155380052|NCT05383508|560823917|FG000|Overall Study|Withdrawal by Subject|1|||
155380053|NCT05383508|560823918|FG001|Overall Study|Withdrawal by Subject|0|||
155380054|NCT05383508|560823919|FG002|Overall Study|Withdrawal by Subject|1|||
155380055|NCT05383508|560823920|FG003|Overall Study|Withdrawal by Subject|1|||
155380056|NCT05383508|560823921|FG004|Overall Study|Withdrawal by Subject|2|||
155380057|NCT05383508|560823922|FG005|Overall Study|Withdrawal by Subject|0|||
155380058|NCT01621568|560823923|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
155380059|NCT01621568|560823924|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
155380060|NCT01621568|560823923|FG000|Week 5-6 No Treatment|Death|1|||
155380061|NCT01621568|560823924|FG001|Week 5-6 No Treatment|Death|0|||
155380062|NCT02399254|560823925|FG000|Overall Study|Physician Decision|2|||
155380063|NCT01642251|560823930|FG000|Overall Study|Progressive disease|0|||
155380064|NCT01642251|560823931|FG001|Overall Study|Progressive disease|0|||
155380065|NCT01642251|560823932|FG002|Overall Study|Progressive disease|3|||
155380066|NCT01642251|560823933|FG003|Overall Study|Progressive disease|3|||
155380067|NCT01642251|560823930|FG000|Overall Study|Adverse Event|0|||
155380068|NCT01642251|560823931|FG001|Overall Study|Adverse Event|0|||
155380069|NCT01642251|560823932|FG002|Overall Study|Adverse Event|5|||
155380070|NCT01642251|560823933|FG003|Overall Study|Adverse Event|4|||
155380071|NCT01642251|560823930|FG000|Overall Study|Death|0|||
155380072|NCT01642251|560823931|FG001|Overall Study|Death|0|||
155380073|NCT01642251|560823932|FG002|Overall Study|Death|1|||
155380074|NCT01642251|560823933|FG003|Overall Study|Death|3|||
155380075|NCT01642251|560823930|FG000|Overall Study|Withdrawal by Subject|0|||
155380076|NCT01642251|560823931|FG001|Overall Study|Withdrawal by Subject|0|||
155380077|NCT01642251|560823932|FG002|Overall Study|Withdrawal by Subject|1|||
155380078|NCT01642251|560823933|FG003|Overall Study|Withdrawal by Subject|3|||
155380079|NCT01642251|560823930|FG000|Overall Study|Alternative therapy|0|||
155380080|NCT01642251|560823931|FG001|Overall Study|Alternative therapy|0|||
155380081|NCT01642251|560823932|FG002|Overall Study|Alternative therapy|0|||
155380082|NCT01642251|560823933|FG003|Overall Study|Alternative therapy|2|||
155380083|NCT01642251|560823930|FG000|Overall Study|Other complicating disease|0|||
155380084|NCT01642251|560823931|FG001|Overall Study|Other complicating disease|0|||
155380085|NCT01642251|560823932|FG002|Overall Study|Other complicating disease|1|||
155380086|NCT01642251|560823933|FG003|Overall Study|Other complicating disease|0|||
155380087|NCT01642251|560823930|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
155380088|NCT01642251|560823931|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
155380089|NCT01642251|560823932|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
155380090|NCT01642251|560823933|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
155380091|NCT01993927|560823935|FG000|Overall Study|Case Report Forms Uncollected|18|||
155380092|NCT01993927|560823935|FG000|Overall Study|Protocol Violation|11|||
155380093|NCT00895154|560823936|FG000|Overall Study|Lost to Follow-up|1|||
155380094|NCT00895154|560823937|FG001|Overall Study|Lost to Follow-up|1|||
155380095|NCT00895154|560823936|FG000|Overall Study|Withdrawal by Subject|0|||
155380096|NCT00895154|560823937|FG001|Overall Study|Withdrawal by Subject|1|||
155380097|NCT00540046|560823940|FG000|Overall Study|Lost to Follow-up|33|||
155380098|NCT00540046|560823941|FG001|Overall Study|Lost to Follow-up|23|||
155380099|NCT02533531|560823945|FG000|Overall Study|Device did not turn on|1|||
155380100|NCT03814187|560823946|FG000|Overall Study|Sponsor's Administrative Decision|0|||
155380101|NCT03814187|560823947|FG001|Overall Study|Sponsor's Administrative Decision|0|||
155380102|NCT03814187|560823948|FG002|Overall Study|Sponsor's Administrative Decision|272|||
155380103|NCT03814187|560823946|FG000|Overall Study|Death|80|||
155380104|NCT03814187|560823947|FG001|Overall Study|Death|81|||
155380105|NCT03814187|560823948|FG002|Overall Study|Death|4|||
155380106|NCT03814187|560823946|FG000|Overall Study|Withdrew Consent|77|||
155380107|NCT03814187|560823947|FG001|Overall Study|Withdrew Consent|78|||
155380108|NCT03814187|560823948|FG002|Overall Study|Withdrew Consent|2|||
155380109|NCT03814187|560823946|FG000|Overall Study|Lost to Follow-up|47|||
155380110|NCT03814187|560823947|FG001|Overall Study|Lost to Follow-up|52|||
155380111|NCT03814187|560823948|FG002|Overall Study|Lost to Follow-up|1|||
155380112|NCT03814187|560823946|FG000|Overall Study|Adverse Event|22|||
155380113|NCT03814187|560823947|FG001|Overall Study|Adverse Event|23|||
155380114|NCT03814187|560823948|FG002|Overall Study|Adverse Event|0|||
155380115|NCT03814187|560823946|FG000|Overall Study|Physician Decision|7|||
155380116|NCT03814187|560823947|FG001|Overall Study|Physician Decision|4|||
155380117|NCT03814187|560823948|FG002|Overall Study|Physician Decision|2|||
155380118|NCT03814187|560823946|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
155380119|NCT03814187|560823947|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
155380120|NCT03814187|560823948|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
155380121|NCT03814187|560823946|FG000|Overall Study|Other reasons|34|||
155380122|NCT03814187|560823947|FG001|Overall Study|Other reasons|40|||
155380123|NCT03814187|560823948|FG002|Overall Study|Other reasons|2|||
155380124|NCT02047903|560823949|FG000|Overall Study|Adverse Event|14|||
155380125|NCT02047903|560823949|FG000|Overall Study|Serious adverse event|10|||
155380126|NCT02047903|560823949|FG000|Overall Study|Withdrawal by Subject|16|||
155380127|NCT02047903|560823949|FG000|Overall Study|Lost to Follow-up|4|||
155380128|NCT02047903|560823949|FG000|Overall Study|Reason not listed|6|||
155380129|NCT02047903|560823949|FG000|Overall Study|Not Treated|9|||
155380130|NCT01014533|560823950|FG000|Overall Study|Protocol Violation|3|||
155380131|NCT01014533|560823951|FG001|Overall Study|Protocol Violation|2|||
155380132|NCT01014533|560823950|FG000|Overall Study|Withdrawal by Subject|2|||
155380133|NCT01014533|560823951|FG001|Overall Study|Withdrawal by Subject|0|||
155380134|NCT01014533|560823950|FG000|Overall Study|unable to come to appointment|0|||
155380135|NCT01014533|560823951|FG001|Overall Study|unable to come to appointment|3|||
155380136|NCT02689518|560823952|FG000|Overall Study|Withdrawal by Subject|3|||
155380137|NCT01942590|560823953|FG000|Overall Study|Withdrawal by Subject|0|||
155380138|NCT01942590|560823954|FG001|Overall Study|Withdrawal by Subject|1|||
155380139|NCT01942590|560823953|FG000|Overall Study|Adverse Event|1|||
155380140|NCT01942590|560823954|FG001|Overall Study|Adverse Event|0|||
155380141|NCT01226095|560823957|FG000|Overall Study|Poor compliance|1|||
155380142|NCT00911768|560823963|FG000|Overall Study|Protocol Violation|5|||
155380143|NCT00911768|560823964|FG001|Overall Study|Protocol Violation|4|||
155380144|NCT00911768|560823963|FG000|Overall Study|Withdrawal by Subject|1|||
155380145|NCT00911768|560823964|FG001|Overall Study|Withdrawal by Subject|0|||
155380146|NCT00515853|560823968|FG000|Overall Study|Lost to Follow-up|9|||
155380147|NCT00515853|560823969|FG001|Overall Study|Lost to Follow-up|13|||
155380148|NCT00515853|560823968|FG000|Overall Study|Withdrawal by Subject|6|||
155380149|NCT00515853|560823969|FG001|Overall Study|Withdrawal by Subject|4|||
155380150|NCT03965351|560823970|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155380151|NCT03965351|560823971|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155380152|NCT03965351|560823970|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
155380153|NCT03965351|560823971|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
155380154|NCT00943111|560823976|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
155380155|NCT00943111|560823977|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
155380156|NCT00943111|560823978|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
155380157|NCT00943111|560823976|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
155380158|NCT00943111|560823977|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
155380159|NCT00943111|560823978|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
155380160|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
155380161|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
155380162|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
155380163|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
155380164|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
155380165|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
155380166|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
155380167|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
155380168|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
155380169|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
155380170|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
155380171|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
155380172|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
155380173|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
155380174|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
155380175|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
155380176|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
155380177|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
155380178|NCT02665338|560823980|FG000|Overall Study|Withdrawal by Subject|0|||
155380179|NCT02665338|560823981|FG001|Overall Study|Withdrawal by Subject|1|||
155380180|NCT00998335|560823982|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
155380181|NCT00998335|560823983|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
155380182|NCT05593445|560823998|FG000|12-Week DBVC Period|Adverse Event|1|||
155380183|NCT05593445|560823999|FG001|12-Week DBVC Period|Adverse Event|0|||
155380184|NCT05593445|560824000|FG002|12-Week DBVC Period|Adverse Event|0|||
155380185|NCT05593445|560824001|FG003|12-Week DBVC Period|Adverse Event|0|||
155380186|NCT05593445|560823998|FG000|12-Week DBVC Period|Physician Decision|0|||
155380187|NCT05593445|560823999|FG001|12-Week DBVC Period|Physician Decision|1|||
155380188|NCT05593445|560824000|FG002|12-Week DBVC Period|Physician Decision|0|||
155380189|NCT05593445|560824001|FG003|12-Week DBVC Period|Physician Decision|0|||
155380190|NCT05593445|560823998|FG000|12-Week DBVC Period|Protocol Violation|0|||
155380191|NCT05593445|560823999|FG001|12-Week DBVC Period|Protocol Violation|1|||
155380192|NCT05593445|560824000|FG002|12-Week DBVC Period|Protocol Violation|0|||
155380193|NCT05593445|560824001|FG003|12-Week DBVC Period|Protocol Violation|0|||
155380194|NCT05593445|560823998|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
155380195|NCT05593445|560823999|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
155380196|NCT05593445|560824000|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
155380197|NCT05593445|560824001|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
155380198|NCT05593445|560823998|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
155380199|NCT05593445|560823999|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380200|NCT05593445|560824000|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380201|NCT05593445|560824001|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380202|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
155380203|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
155380204|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
155380205|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
155380206|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
155380207|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
155380208|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
155380209|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
155380210|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380211|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380212|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
155380213|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380214|NCT05559476|560824002|FG000|Overall Study|Adverse Event|2|||
155380215|NCT05559476|560824003|FG001|Overall Study|Adverse Event|0|||
155380216|NCT05559476|560824002|FG000|Overall Study|Lost to Follow-up|13|||
155380217|NCT05559476|560824003|FG001|Overall Study|Lost to Follow-up|12|||
155380218|NCT05559476|560824002|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
155380219|NCT05559476|560824003|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
155380220|NCT05559476|560824002|FG000|Overall Study|Other|0|||
155380221|NCT05559476|560824003|FG001|Overall Study|Other|2|||
155380222|NCT05110690|560824004|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
155380223|NCT05110690|560824004|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
155380224|NCT05110690|560824004|FG000|Completion of Intervention|Lost to Follow-up|1|||
155380225|NCT05110690|560824004|FG000|Completion of Intervention|Death|1|||
155380226|NCT05110690|560824004|FG000|Completion of Intervention|Withdrawal by Subject|2|||
155380227|NCT04289051|560826785|FG000|Overall Study|Lost to Follow-up|0|||
155380228|NCT04289051|560826786|FG001|Overall Study|Lost to Follow-up|0|||
155380229|NCT04289051|560826787|FG002|Overall Study|Lost to Follow-up|2|||
155380230|NCT00717067|560826788|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380231|NCT00717067|560826789|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380232|NCT00717067|560826790|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
155380233|NCT00717067|560826791|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380234|NCT00717067|560826792|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380235|NCT02090959|560826793|FG000|Overall Study|Withdrawal by Subject|10|||
155380236|NCT02090959|560826793|FG000|Overall Study|Adverse Event|1|||
155380237|NCT02090959|560826793|FG000|Overall Study|Investigator decision|2|||
155380238|NCT02090959|560826793|FG000|Overall Study|Study termination|6|||
155380239|NCT02090959|560826793|FG000|Overall Study|Enrolled but not treated|1|||
155380240|NCT02090959|560826793|FG000|Overall Study|Transfer for compassionate use medicine|4|||
155380241|NCT02090959|560826793|FG000|Overall Study|Move to medical need program|3|||
155380242|NCT02090959|560826793|FG000|Overall Study|Entered in to other study|34|||
155380243|NCT02090959|560826793|FG000|Overall Study|Switched to commercial supply|88|||
155380244|NCT02090959|560826793|FG000|Overall Study|Other than specified|2|||
155380245|NCT00522873|560826796|FG000|Overall Study|Adverse Event|41|||
155380246|NCT00522873|560826797|FG001|Overall Study|Adverse Event|26|||
155380247|NCT00522873|560826796|FG000|Overall Study|Withdrawal by Subject|20|||
155380248|NCT00522873|560826797|FG001|Overall Study|Withdrawal by Subject|9|||
155380249|NCT00522873|560826796|FG000|Overall Study|Protocol Violation|14|||
155380250|NCT00522873|560826797|FG001|Overall Study|Protocol Violation|4|||
155380251|NCT00522873|560826796|FG000|Overall Study|Lost to Follow-up|11|||
155380252|NCT00522873|560826797|FG001|Overall Study|Lost to Follow-up|3|||
155380253|NCT00522873|560826796|FG000|Overall Study|Personal Reasons|8|||
155380254|NCT00522873|560826797|FG001|Overall Study|Personal Reasons|1|||
155380255|NCT00522873|560826796|FG000|Overall Study|Medication Errors|1|||
155380256|NCT00522873|560826797|FG001|Overall Study|Medication Errors|1|||
155380257|NCT00522873|560826796|FG000|Overall Study|Never Received Medication|1|||
155380258|NCT00522873|560826797|FG001|Overall Study|Never Received Medication|0|||
155380259|NCT00657020|560826798|FG000|PERIOD 1|Adverse Event|0|||
155380260|NCT00657020|560826799|FG001|PERIOD 1|Adverse Event|1|||
155380261|NCT02029846|560826802|FG000|Overall Study|n=1 each arm|1|||
155380262|NCT02029846|560826803|FG001|Overall Study|n=1 each arm|1|||
155380263|NCT02966301|560826807|FG000|Overall Study|Death|2|||
155380264|NCT02966301|560826807|FG000|Overall Study|Withdrawal by Subject|1|||
155380265|NCT02937454|560826810|FG000|Overall Study|Adverse Event|0|||
155380266|NCT02937454|560826811|FG001|Overall Study|Adverse Event|1|||
155380267|NCT02937454|560826810|FG000|Overall Study|Death|98|||
155380268|NCT02937454|560826811|FG001|Overall Study|Death|95|||
155380269|NCT02937454|560826810|FG000|Overall Study|Lost to Follow-up|1|||
155380270|NCT02937454|560826811|FG001|Overall Study|Lost to Follow-up|1|||
155380271|NCT02937454|560826810|FG000|Overall Study|Physician Decision|0|||
155380272|NCT02937454|560826811|FG001|Overall Study|Physician Decision|1|||
155380273|NCT02937454|560826810|FG000|Overall Study|Protocol Violation|6|||
155380274|NCT02937454|560826811|FG001|Overall Study|Protocol Violation|10|||
155380275|NCT02937454|560826810|FG000|Overall Study|Withdrawal by Subject|27|||
155380276|NCT02937454|560826811|FG001|Overall Study|Withdrawal by Subject|15|||
155380277|NCT02937454|560826810|FG000|Overall Study|Other|8|||
155380278|NCT02937454|560826811|FG001|Overall Study|Other|5|||
155380279|NCT01375114|560826812|FG000|Overall Study|Lost to Follow-up|1|||
155380280|NCT01375114|560826813|FG001|Overall Study|Lost to Follow-up|0|||
155380281|NCT01375114|560826814|FG002|Overall Study|Lost to Follow-up|1|||
155380282|NCT01375114|560826812|FG000|Overall Study|Disease Progression|3|||
155380283|NCT01375114|560826813|FG001|Overall Study|Disease Progression|2|||
155380284|NCT01375114|560826814|FG002|Overall Study|Disease Progression|2|||
155380285|NCT01375114|560826812|FG000|Overall Study|Patient Changed Mind|0|||
155380286|NCT01375114|560826813|FG001|Overall Study|Patient Changed Mind|0|||
155380287|NCT01375114|560826814|FG002|Overall Study|Patient Changed Mind|2|||
155380288|NCT01375114|560826812|FG000|Overall Study|Pruritus|0|||
155380289|NCT01375114|560826813|FG001|Overall Study|Pruritus|0|||
155380290|NCT01375114|560826814|FG002|Overall Study|Pruritus|1|||
155380291|NCT01375114|560826812|FG000|Overall Study|Restlessness|0|||
155380292|NCT01375114|560826813|FG001|Overall Study|Restlessness|0|||
155380293|NCT01375114|560826814|FG002|Overall Study|Restlessness|1|||
155380294|NCT01375114|560826812|FG000|Overall Study|Diarrhea|0|||
155380295|NCT01375114|560826813|FG001|Overall Study|Diarrhea|0|||
155380296|NCT01375114|560826814|FG002|Overall Study|Diarrhea|1|||
155380297|NCT01375114|560826812|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
155380298|NCT01375114|560826813|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
155380299|NCT01375114|560826814|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
155380300|NCT01375114|560826812|FG000|Overall Study|Nausea|0|||
155380301|NCT01375114|560826813|FG001|Overall Study|Nausea|1|||
155380302|NCT01375114|560826814|FG002|Overall Study|Nausea|0|||
155380303|NCT01375114|560826812|FG000|Overall Study|Increased AST/ALT|0|||
155380304|NCT01375114|560826813|FG001|Overall Study|Increased AST/ALT|1|||
155380305|NCT01375114|560826814|FG002|Overall Study|Increased AST/ALT|0|||
155380306|NCT01375114|560826812|FG000|Overall Study|Vaginal Hemorrhage|0|||
155380307|NCT01375114|560826813|FG001|Overall Study|Vaginal Hemorrhage|1|||
155380308|NCT01375114|560826814|FG002|Overall Study|Vaginal Hemorrhage|0|||
155380309|NCT01375114|560826812|FG000|Overall Study|Family problem|0|||
155380310|NCT01375114|560826813|FG001|Overall Study|Family problem|1|||
155380311|NCT01375114|560826814|FG002|Overall Study|Family problem|0|||
155380312|NCT01375114|560826812|FG000|Overall Study|Protocol Violation|2|||
155380313|NCT01375114|560826813|FG001|Overall Study|Protocol Violation|0|||
155380314|NCT01375114|560826814|FG002|Overall Study|Protocol Violation|0|||
155380315|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
155380316|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
155380317|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
155380318|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
155380319|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380320|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380321|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380322|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
155380323|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
155380324|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380325|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380326|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380327|NCT03606668|560826823|FG000|Overall Study|Screen Failure|1|||
155380328|NCT03606668|560826823|FG000|Overall Study|Lost to Follow-up|1|||
155380329|NCT01014143|560826824|FG000|Second Intervention|Lost to Follow-up|2|||
155380330|NCT01014143|560826825|FG001|Second Intervention|Lost to Follow-up|0|||
155380331|NCT01014143|560826826|FG002|Second Intervention|Lost to Follow-up|0|||
155380332|NCT01878214|560826832|FG000|Overall Study|Withdrawal by Subject|18|||
155380333|NCT01878214|560826833|FG001|Overall Study|Withdrawal by Subject|7|||
155380334|NCT01878214|560826832|FG000|Overall Study|Death|0|||
155380335|NCT01878214|560826833|FG001|Overall Study|Death|1|||
155380336|NCT01878214|560826832|FG000|Overall Study|Lost to Follow-up|35|||
155380337|NCT01878214|560826833|FG001|Overall Study|Lost to Follow-up|36|||
155380338|NCT00495586|560826834|FG000|Overall Study|Withdrawal by Subject|4|||
155380339|NCT00495586|560826835|FG001|Overall Study|Withdrawal by Subject|4|||
155380340|NCT02038543|560826838|FG000|Overall Study|Screen Failure|0|||
155380341|NCT02038543|560826839|FG001|Overall Study|Screen Failure|0|||
155380342|NCT02038543|560826840|FG002|Overall Study|Screen Failure|0|||
155380343|NCT02038543|560826841|FG003|Overall Study|Screen Failure|1|||
155380344|NCT02038543|560826838|FG000|Overall Study|Withdrawal by Subject|0|||
155380345|NCT02038543|560826839|FG001|Overall Study|Withdrawal by Subject|0|||
155380346|NCT02038543|560826840|FG002|Overall Study|Withdrawal by Subject|0|||
155380347|NCT02038543|560826841|FG003|Overall Study|Withdrawal by Subject|1|||
155380348|NCT02647866|560826842|FG000|Overall Study|Adverse Event|0|||
155380349|NCT02647866|560826843|FG001|Overall Study|Adverse Event|0|||
155380350|NCT02647866|560826844|FG002|Overall Study|Adverse Event|2|||
155380351|NCT02647866|560826845|FG003|Overall Study|Adverse Event|2|||
155380352|NCT02647866|560826846|FG004|Overall Study|Adverse Event|1|||
155380353|NCT02647866|560826842|FG000|Overall Study|Disease Worsening|3|||
155380354|NCT02647866|560826843|FG001|Overall Study|Disease Worsening|1|||
155380355|NCT02647866|560826844|FG002|Overall Study|Disease Worsening|0|||
155380356|NCT02647866|560826845|FG003|Overall Study|Disease Worsening|0|||
155380357|NCT02647866|560826846|FG004|Overall Study|Disease Worsening|1|||
155380358|NCT02647866|560826842|FG000|Overall Study|Withdrawal by Subject|1|||
155380359|NCT02647866|560826843|FG001|Overall Study|Withdrawal by Subject|1|||
155380360|NCT02647866|560826844|FG002|Overall Study|Withdrawal by Subject|2|||
155380361|NCT02647866|560826845|FG003|Overall Study|Withdrawal by Subject|4|||
155380362|NCT02647866|560826846|FG004|Overall Study|Withdrawal by Subject|4|||
155380363|NCT02647866|560826842|FG000|Overall Study|Physician Decision|0|||
155380364|NCT02647866|560826843|FG001|Overall Study|Physician Decision|1|||
155380365|NCT02647866|560826844|FG002|Overall Study|Physician Decision|1|||
155380366|NCT02647866|560826845|FG003|Overall Study|Physician Decision|0|||
155380367|NCT02647866|560826846|FG004|Overall Study|Physician Decision|2|||
155380368|NCT02647866|560826842|FG000|Overall Study|Death|0|||
155380369|NCT02647866|560826843|FG001|Overall Study|Death|1|||
155380370|NCT02647866|560826844|FG002|Overall Study|Death|0|||
155380371|NCT02647866|560826845|FG003|Overall Study|Death|0|||
155380372|NCT02647866|560826846|FG004|Overall Study|Death|0|||
155380373|NCT02647866|560826842|FG000|Overall Study|Subject moved to different country|1|||
155380374|NCT02647866|560826843|FG001|Overall Study|Subject moved to different country|0|||
155380375|NCT02647866|560826844|FG002|Overall Study|Subject moved to different country|0|||
155380376|NCT02647866|560826845|FG003|Overall Study|Subject moved to different country|0|||
155380377|NCT02647866|560826846|FG004|Overall Study|Subject moved to different country|0|||
155380378|NCT03618823|560826847|FG000|Overall Study|Lost to Follow-up|63|||
155380379|NCT03618823|560826848|FG001|Overall Study|Lost to Follow-up|61|||
155380380|NCT02334423|560826851|FG000|Overall Study|Protocol Violation|10|||
155380381|NCT02334423|560826852|FG001|Overall Study|Protocol Violation|3|||
155380382|NCT02224690|560826856|FG000|Overall Study|Adverse Event|8|||
155380383|NCT02224690|560826857|FG001|Overall Study|Adverse Event|1|||
155380384|NCT02224690|560826856|FG000|Overall Study|Met Withdrawal Criteria|4|||
155380385|NCT02224690|560826857|FG001|Overall Study|Met Withdrawal Criteria|0|||
155380386|NCT02224690|560826856|FG000|Overall Study|Use of G-tube|1|||
155380387|NCT02224690|560826857|FG001|Overall Study|Use of G-tube|0|||
155380388|NCT02224690|560826856|FG000|Overall Study|Did not meet eligibility criteria|1|||
155380389|NCT02224690|560826857|FG001|Overall Study|Did not meet eligibility criteria|0|||
155380390|NCT02962960|560826858|FG000|Overall Study|Withdrawal by Subject|1|||
155380391|NCT02962960|560826859|FG001|Overall Study|Withdrawal by Subject|1|||
155380392|NCT02962960|560826860|FG002|Overall Study|Withdrawal by Subject|0|||
155380393|NCT02962960|560826858|FG000|Overall Study|Adverse Event|1|||
155380394|NCT02962960|560826859|FG001|Overall Study|Adverse Event|1|||
155380395|NCT02962960|560826860|FG002|Overall Study|Adverse Event|0|||
155380396|NCT02962960|560826858|FG000|Overall Study|Protocol Violation|1|||
155380397|NCT02962960|560826859|FG001|Overall Study|Protocol Violation|0|||
155380398|NCT02962960|560826860|FG002|Overall Study|Protocol Violation|0|||
155380399|NCT00528645|560826862|FG000|Overall Study|Adverse Event|3|||
155380400|NCT01154010|560826863|FG000|Overall Study|Lost to Follow-up|0|||
155380401|NCT01154010|560826864|FG001|Overall Study|Lost to Follow-up|1|||
155493707|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155493708|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155493709|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155493710|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
155493711|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155493712|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155513844|NCT01829464|561308157|FG001|Overall Study|Adverse Event|0|||
155380402|NCT00439231|560826865|FG000|Overall Study|Lack of Efficacy|28|||
155380403|NCT02413333|560826871|FG000|Period 1|Adverse Event|1|||
155380404|NCT02413333|560826872|FG001|Period 1|Adverse Event|0|||
155380405|NCT02413333|560826871|FG000|Period 1|Reason Not Specified|0|||
155380406|NCT02413333|560826872|FG001|Period 1|Reason Not Specified|1|||
155380407|NCT02413333|560826871|FG000|Period 2|Protocol Deviation|1|||
155380408|NCT02413333|560826872|FG001|Period 2|Protocol Deviation|0|||
155380409|NCT01465347|560826873|FG000|Overall Study|Withdrawal by Subject|1|||
155380410|NCT01465347|560826874|FG001|Overall Study|Withdrawal by Subject|1|||
155380411|NCT01465347|560826873|FG000|Overall Study|Physician Decision|0|||
155380412|NCT01465347|560826874|FG001|Overall Study|Physician Decision|1|||
155380413|NCT01465347|560826873|FG000|Overall Study|Admitted to hospice|0|||
155380414|NCT01465347|560826874|FG001|Overall Study|Admitted to hospice|1|||
155380415|NCT02996474|560826875|FG000|Overall Study|Physician Decision|5|||
155380416|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
155380417|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
155380418|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
155380419|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
155380420|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
155380421|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
155380422|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
155380423|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
155380424|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
155380425|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
155380426|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
155380427|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
155380428|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
155380429|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
155380430|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
155380431|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
155380432|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
155380433|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
155380434|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
155380435|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
155380436|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
155380437|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
155380438|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
155380439|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
155380440|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
155380441|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
155380442|NCT02891837|560826878|FG000|Overall Study|Lost to Follow-up|2|||
155380443|NCT02891837|560826879|FG001|Overall Study|Lost to Follow-up|0|||
155380444|NCT02891837|560826878|FG000|Overall Study|Withdrawal by Subject|1|||
155380445|NCT02891837|560826879|FG001|Overall Study|Withdrawal by Subject|0|||
155380446|NCT00709852|560826880|FG000|Period 1|Adverse Event|2|||
155380447|NCT00709852|560826881|FG001|Period 1|Adverse Event|0|||
155380448|NCT00709852|560826880|FG000|Period 1|Withdrawal by Subject|4|||
155380449|NCT00709852|560826881|FG001|Period 1|Withdrawal by Subject|2|||
155380450|NCT00709852|560826880|FG000|Period 1|Protocol Violation|1|||
155380451|NCT00709852|560826881|FG001|Period 1|Protocol Violation|0|||
155380452|NCT00709852|560826880|FG000|Period 1|Defective scanner|0|||
155380453|NCT00709852|560826881|FG001|Period 1|Defective scanner|1|||
155380454|NCT00709852|560826880|FG000|Period 1|Lost to Follow-up|1|||
155380455|NCT00709852|560826881|FG001|Period 1|Lost to Follow-up|0|||
155380456|NCT00709852|560826880|FG000|Period 2|Protocol Violation|4|||
155380457|NCT00709852|560826881|FG001|Period 2|Protocol Violation|1|||
155380458|NCT00709852|560826880|FG000|Period 2|Adverse Event|1|||
155380459|NCT00709852|560826881|FG001|Period 2|Adverse Event|1|||
155380460|NCT00709852|560826880|FG000|Period 2|Lost to Follow-up|1|||
155380461|NCT00709852|560826881|FG001|Period 2|Lost to Follow-up|0|||
155380462|NCT00709852|560826880|FG000|Period 2|No 72-hour follow-up|3|||
155380463|NCT00709852|560826881|FG001|Period 2|No 72-hour follow-up|0|||
155380464|NCT00185965|560826882|FG000|Overall Study|Adverse Event|0|||
155380465|NCT00185965|560826883|FG001|Overall Study|Adverse Event|1|||
155380466|NCT01048671|560826884|FG000|Overall Study|Protocol Violation|0|||
155380467|NCT01048671|560826885|FG001|Overall Study|Protocol Violation|1|||
155380468|NCT01048671|560826886|FG002|Overall Study|Protocol Violation|1|||
155380469|NCT00296400|560826890|FG000|Overall Study|Adverse Event|7|||
155380470|NCT00296400|560826891|FG001|Overall Study|Adverse Event|7|||
155380471|NCT00296400|560826892|FG002|Overall Study|Adverse Event|7|||
155380472|NCT00296400|560826890|FG000|Overall Study|Withdrawal by Subject|5|||
155380473|NCT00296400|560826891|FG001|Overall Study|Withdrawal by Subject|6|||
155380474|NCT00296400|560826892|FG002|Overall Study|Withdrawal by Subject|2|||
155380475|NCT00296400|560826890|FG000|Overall Study|Incorrect enrollment|2|||
155380476|NCT00296400|560826891|FG001|Overall Study|Incorrect enrollment|0|||
155380477|NCT00296400|560826892|FG002|Overall Study|Incorrect enrollment|0|||
155380478|NCT00296400|560826890|FG000|Overall Study|Protocol Violation|1|||
155380479|NCT00296400|560826891|FG001|Overall Study|Protocol Violation|1|||
155380480|NCT00296400|560826892|FG002|Overall Study|Protocol Violation|1|||
155380481|NCT00296400|560826890|FG000|Overall Study|Lost to Follow-up|1|||
155380482|NCT00296400|560826891|FG001|Overall Study|Lost to Follow-up|1|||
155380483|NCT00296400|560826892|FG002|Overall Study|Lost to Follow-up|2|||
155380484|NCT00296400|560826890|FG000|Overall Study|Study specific discontinuation criteria|0|||
155380485|NCT00296400|560826891|FG001|Overall Study|Study specific discontinuation criteria|0|||
155380486|NCT00296400|560826892|FG002|Overall Study|Study specific discontinuation criteria|1|||
155380487|NCT00296400|560826890|FG000|Overall Study|Visit 10 was performed earlier|0|||
155380488|NCT00296400|560826891|FG001|Overall Study|Visit 10 was performed earlier|1|||
155380489|NCT00296400|560826892|FG002|Overall Study|Visit 10 was performed earlier|0|||
155380490|NCT00296400|560826890|FG000|Overall Study|Pregnancy|1|||
155380491|NCT00296400|560826891|FG001|Overall Study|Pregnancy|2|||
155380492|NCT00296400|560826892|FG002|Overall Study|Pregnancy|0|||
155380493|NCT00513604|560826893|FG000|Overall Study|Not treated|2|||
155380494|NCT00513604|560826894|FG001|Overall Study|Not treated|0|||
155380495|NCT00513604|560826895|FG002|Overall Study|Not treated|1|||
155380496|NCT00513604|560826896|FG003|Overall Study|Not treated|0|||
155380497|NCT00513604|560826897|FG004|Overall Study|Not treated|0|||
155380498|NCT00513604|560826893|FG000|Overall Study|Death during treatment|0|||
155380499|NCT00513604|560826894|FG001|Overall Study|Death during treatment|3|||
155380500|NCT00513604|560826895|FG002|Overall Study|Death during treatment|2|||
155380501|NCT00513604|560826896|FG003|Overall Study|Death during treatment|0|||
155380502|NCT00513604|560826897|FG004|Overall Study|Death during treatment|0|||
155380503|NCT02433340|560826902|FG000|Overall Study|Adverse Event|0|||
155380504|NCT02433340|560826903|FG001|Overall Study|Adverse Event|0|||
155380505|NCT02433340|560826904|FG002|Overall Study|Adverse Event|1|||
155380506|NCT02433340|560826905|FG003|Overall Study|Adverse Event|0|||
155380507|NCT02433340|560826902|FG000|Overall Study|Withdrawal by Subject|1|||
155722577|NCT02318706|562083886|FG002|Double-blind Phase|Withdrawal by Subject|7|||
155380508|NCT02433340|560826903|FG001|Overall Study|Withdrawal by Subject|0|||
155380509|NCT02433340|560826904|FG002|Overall Study|Withdrawal by Subject|1|||
155380510|NCT02433340|560826905|FG003|Overall Study|Withdrawal by Subject|2|||
155380511|NCT02433340|560826902|FG000|Overall Study|Lost to Follow-up|0|||
155380512|NCT02433340|560826903|FG001|Overall Study|Lost to Follow-up|1|||
155380513|NCT02433340|560826904|FG002|Overall Study|Lost to Follow-up|0|||
155380514|NCT02433340|560826905|FG003|Overall Study|Lost to Follow-up|0|||
155380515|NCT02433340|560826902|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
155380516|NCT02433340|560826903|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
155380517|NCT02433340|560826904|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
155493713|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493714|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493715|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493716|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493717|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493718|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
155493719|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
155493720|NCT04242498|561231444|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
155493721|NCT04242498|561231445|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
155493722|NCT04242498|561231446|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
155493723|NCT04242498|561231447|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
155493724|NCT04242498|561231448|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
155493725|NCT04242498|561231449|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
155493726|NCT04242498|561231450|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
155493727|NCT02500732|561231453|FG000|Overall Study|Physician Decision|0|||
155493728|NCT02500732|561231454|FG001|Overall Study|Physician Decision|1|||
155493729|NCT03205605|561231455|FG000|Overall Study|Withdrawal by Subject|1|||
155493730|NCT01958619|561231456|FG000|Overall Study|Protocol Violation|2|||
155493731|NCT01958619|561231457|FG001|Overall Study|Protocol Violation|0|||
155493732|NCT01958619|561231458|FG002|Overall Study|Protocol Violation|1|||
155493733|NCT01958619|561231459|FG003|Overall Study|Protocol Violation|0|||
155493734|NCT03759340|561231464|FG000|Overall Study|Adverse Event|2|||
155493735|NCT03759340|561231464|FG000|Overall Study|Lost to Follow-up|1|||
155493736|NCT03759340|561231464|FG000|Overall Study|Withdrawal by Subject|15|||
155493737|NCT03759340|561231464|FG000|Overall Study|Study Terminated by Sponsor|38|||
155493738|NCT03795233|561231465|FG000|Overall Study|Withdrawal by Subject|2|||
155607978|NCT03673345|561653704|FG000|Overall Study|Physician Decision|0|||
155607979|NCT03673345|561653705|FG001|Overall Study|Physician Decision|0|||
155607980|NCT03673345|561653706|FG002|Overall Study|Physician Decision|2|||
155607981|NCT03673345|561653707|FG003|Overall Study|Physician Decision|0|||
155607982|NCT03673345|561653708|FG004|Overall Study|Physician Decision|0|||
155607983|NCT03673345|561653709|FG005|Overall Study|Physician Decision|0|||
155607984|NCT03673345|561653710|FG006|Overall Study|Physician Decision|0|||
155607985|NCT03673345|561653711|FG007|Overall Study|Physician Decision|0|||
155607986|NCT05153148|561653712|FG000|Overall Study|Adverse Event|1|||
155607987|NCT05153148|561653713|FG001|Overall Study|Adverse Event|0|||
155607988|NCT05153148|561653714|FG002|Overall Study|Adverse Event|3|||
155607989|NCT05153148|561653715|FG003|Overall Study|Adverse Event|5|||
155607990|NCT05153148|561653712|FG000|Overall Study|Lost to Follow-up|1|||
155607991|NCT05153148|561653713|FG001|Overall Study|Lost to Follow-up|1|||
155607992|NCT05153148|561653714|FG002|Overall Study|Lost to Follow-up|2|||
155607993|NCT05153148|561653715|FG003|Overall Study|Lost to Follow-up|0|||
155380518|NCT02433340|560826905|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
155380519|NCT02433340|560826902|FG000|Overall Study|Other|0|||
155380520|NCT02433340|560826903|FG001|Overall Study|Other|1|||
155380521|NCT02433340|560826904|FG002|Overall Study|Other|0|||
155380522|NCT02433340|560826905|FG003|Overall Study|Other|0|||
155380523|NCT01178385|560826906|FG000|Overall Study|Withdrawal by Subject|2|||
155380524|NCT01178385|560826907|FG001|Overall Study|Withdrawal by Subject|0|||
155380525|NCT00985946|560826912|FG000|Overall Study|Lost to Follow-up|6|||
155380526|NCT00985946|560826912|FG000|Overall Study|Withdrawal by Subject|1|||
155380527|NCT02679508|560826914|FG000|Healing Phase|Protocol Violation|1|||
155380528|NCT02679508|560826915|FG001|Healing Phase|Protocol Violation|1|||
155380529|NCT02679508|560826914|FG000|Healing Phase|Lost to Follow-up|1|||
155380530|NCT02679508|560826915|FG001|Healing Phase|Lost to Follow-up|0|||
155607994|NCT05153148|561653712|FG000|Overall Study|Withdrawal by Subject|6|||
155607995|NCT05153148|561653713|FG001|Overall Study|Withdrawal by Subject|8|||
155607996|NCT05153148|561653714|FG002|Overall Study|Withdrawal by Subject|6|||
155607997|NCT05153148|561653715|FG003|Overall Study|Withdrawal by Subject|8|||
155607998|NCT05153148|561653712|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155607999|NCT05153148|561653713|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155380531|NCT02679508|560826914|FG000|Maintenance Phase|Adverse Event|12|||
155608000|NCT05153148|561653714|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
155380532|NCT02679508|560826915|FG001|Maintenance Phase|Adverse Event|2|||
155380533|NCT02679508|560826914|FG000|Maintenance Phase|Lost to Follow-up|0|||
155380534|NCT02679508|560826915|FG001|Maintenance Phase|Lost to Follow-up|1|||
155380535|NCT02679508|560826914|FG000|Maintenance Phase|Withdrawal by Subject|15|||
155380536|NCT02679508|560826915|FG001|Maintenance Phase|Withdrawal by Subject|8|||
155380537|NCT02679508|560826914|FG000|Maintenance Phase|Other|5|||
155380538|NCT02679508|560826915|FG001|Maintenance Phase|Other|4|||
155380539|NCT03538301|560826916|FG000|Overall Study|Adverse Event|1|||
155380540|NCT03538301|560826917|FG001|Overall Study|Adverse Event|4|||
155380541|NCT03538301|560826918|FG002|Overall Study|Adverse Event|4|||
155380542|NCT03538301|560826916|FG000|Overall Study|Death|1|||
155380543|NCT03538301|560826917|FG001|Overall Study|Death|1|||
155380544|NCT03538301|560826918|FG002|Overall Study|Death|0|||
155380545|NCT03538301|560826916|FG000|Overall Study|Physician Decision|0|||
155380546|NCT03538301|560826917|FG001|Overall Study|Physician Decision|1|||
155380547|NCT03538301|560826918|FG002|Overall Study|Physician Decision|0|||
155380548|NCT03538301|560826916|FG000|Overall Study|Protocol Violation|0|||
155380549|NCT03538301|560826917|FG001|Overall Study|Protocol Violation|0|||
155380550|NCT03538301|560826918|FG002|Overall Study|Protocol Violation|1|||
155380551|NCT03538301|560826916|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
155380552|NCT03538301|560826917|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
155380553|NCT03538301|560826918|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
155380554|NCT05326815|560826920|FG000|Overall Study|Withdrawal by Subject|3|||
155380555|NCT05326815|560826920|FG000|Overall Study|Did not complete required labs|6|||
155380556|NCT05326815|560826920|FG000|Overall Study|Screen fail- abnormal labs|5|||
155380557|NCT02631577|560826921|FG000|Overall Study|Death|1|||
155380558|NCT02631577|560826922|FG001|Overall Study|Death|7|||
155380559|NCT02631577|560826921|FG000|Overall Study|Withdrawal by Subject|0|||
155380560|NCT02631577|560826922|FG001|Overall Study|Withdrawal by Subject|3|||
155380561|NCT00979134|560826925|FG000|Overall Study|Disease progression|18|||
155380562|NCT00979134|560826926|FG001|Overall Study|Disease progression|2|||
155380563|NCT00979134|560826927|FG002|Overall Study|Disease progression|5|||
155380564|NCT00979134|560826925|FG000|Overall Study|Adverse Event|0|||
155380565|NCT00979134|560826926|FG001|Overall Study|Adverse Event|0|||
155608001|NCT05153148|561653715|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155608002|NCT05153148|561653712|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155380566|NCT00979134|560826927|FG002|Overall Study|Adverse Event|2|||
155380567|NCT00979134|560826925|FG000|Overall Study|Withdrawal by Subject|1|||
155380568|NCT00979134|560826926|FG001|Overall Study|Withdrawal by Subject|1|||
155380569|NCT00979134|560826927|FG002|Overall Study|Withdrawal by Subject|2|||
155380570|NCT00979134|560826925|FG000|Overall Study|Lost to Follow-up|2|||
155380571|NCT00979134|560826926|FG001|Overall Study|Lost to Follow-up|2|||
155380572|NCT00979134|560826927|FG002|Overall Study|Lost to Follow-up|0|||
155380573|NCT00979134|560826925|FG000|Overall Study|Death|4|||
155380574|NCT00979134|560826926|FG001|Overall Study|Death|0|||
155380575|NCT00979134|560826927|FG002|Overall Study|Death|26|||
155380576|NCT00979134|560826925|FG000|Overall Study|Other|8|||
155380577|NCT00979134|560826926|FG001|Overall Study|Other|1|||
155380578|NCT00979134|560826927|FG002|Overall Study|Other|5|||
155380579|NCT05172050|560826928|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
155380580|NCT05172050|560826929|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
155380581|NCT05172050|560826930|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
155380582|NCT05172050|560826928|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
155380583|NCT05172050|560826929|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
155380584|NCT05172050|560826930|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
155380585|NCT05172050|560826928|FG000|Overall Study|Other|2|||
155380586|NCT05172050|560826929|FG001|Overall Study|Other|2|||
155380587|NCT05172050|560826930|FG002|Overall Study|Other|1|||
155380588|NCT05917470|560826931|FG000|Overall Study|Progressive Disease|1|||
155380589|NCT05917470|560826932|FG001|Overall Study|Progressive Disease|1|||
155380590|NCT05917470|560826933|FG002|Overall Study|Progressive Disease|2|||
155380591|NCT05917470|560826934|FG003|Overall Study|Progressive Disease|3|||
155380592|NCT05917470|560826935|FG004|Overall Study|Progressive Disease|1|||
155380593|NCT05917470|560826936|FG005|Overall Study|Progressive Disease|1|||
155380594|NCT05917470|560826937|FG006|Overall Study|Progressive Disease|0|||
155380595|NCT05917470|560826938|FG007|Overall Study|Progressive Disease|0|||
155380596|NCT05917470|560826931|FG000|Overall Study|Withdrawal by Subject|0|||
155380597|NCT05917470|560826932|FG001|Overall Study|Withdrawal by Subject|0|||
155380598|NCT05917470|560826933|FG002|Overall Study|Withdrawal by Subject|1|||
155380599|NCT05917470|560826934|FG003|Overall Study|Withdrawal by Subject|0|||
155380600|NCT05917470|560826935|FG004|Overall Study|Withdrawal by Subject|0|||
155608003|NCT05153148|561653713|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155380601|NCT05917470|560826936|FG005|Overall Study|Withdrawal by Subject|0|||
155380602|NCT05917470|560826937|FG006|Overall Study|Withdrawal by Subject|0|||
155380603|NCT05917470|560826938|FG007|Overall Study|Withdrawal by Subject|0|||
155380604|NCT05917470|560826931|FG000|Overall Study|Sponsor Decision|0|||
155380605|NCT05917470|560826932|FG001|Overall Study|Sponsor Decision|0|||
155380606|NCT05917470|560826933|FG002|Overall Study|Sponsor Decision|1|||
155380607|NCT05917470|560826934|FG003|Overall Study|Sponsor Decision|0|||
155608004|NCT05153148|561653714|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155608005|NCT05153148|561653715|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
155608006|NCT05153148|561653712|FG000|Overall Study|Reason not Specified|1|||
155608007|NCT05153148|561653713|FG001|Overall Study|Reason not Specified|1|||
155608008|NCT05153148|561653714|FG002|Overall Study|Reason not Specified|1|||
155608009|NCT05153148|561653715|FG003|Overall Study|Reason not Specified|1|||
155608010|NCT02267135|561653716|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
155608011|NCT02267135|561653717|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
155380608|NCT05917470|560826935|FG004|Overall Study|Sponsor Decision|2|||
155380609|NCT05917470|560826936|FG005|Overall Study|Sponsor Decision|1|||
155380610|NCT05917470|560826937|FG006|Overall Study|Sponsor Decision|3|||
155380611|NCT05917470|560826938|FG007|Overall Study|Sponsor Decision|3|||
155380612|NCT05917470|560826931|FG000|Overall Study|Adverse Event|0|||
155380613|NCT05917470|560826932|FG001|Overall Study|Adverse Event|0|||
155380614|NCT05917470|560826933|FG002|Overall Study|Adverse Event|0|||
155380615|NCT05917470|560826934|FG003|Overall Study|Adverse Event|0|||
155380616|NCT05917470|560826935|FG004|Overall Study|Adverse Event|0|||
155380617|NCT05917470|560826936|FG005|Overall Study|Adverse Event|1|||
155380618|NCT05917470|560826937|FG006|Overall Study|Adverse Event|0|||
155380619|NCT05917470|560826938|FG007|Overall Study|Adverse Event|0|||
155380620|NCT01586910|560828593|FG000|Overall Study|Death|4|||
155380621|NCT01586910|560828594|FG001|Overall Study|Death|4|||
155380622|NCT01586910|560828593|FG000|Overall Study|Withdrawal by Subject|6|||
155380623|NCT01586910|560828594|FG001|Overall Study|Withdrawal by Subject|43|||
155380624|NCT01586910|560828593|FG000|Overall Study|Physician withdrew Subject|5|||
155380625|NCT01586910|560828594|FG001|Overall Study|Physician withdrew Subject|24|||
155608012|NCT02267135|561653716|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
155608013|NCT02267135|561653717|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
155608014|NCT02267135|561653716|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
155608015|NCT02267135|561653717|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
155608016|NCT02267135|561653716|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
155608017|NCT02267135|561653717|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
155608018|NCT02267135|561653716|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
155608019|NCT02267135|561653717|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
155608020|NCT00900731|561653718|FG000|Overall Study|Adverse Event|31|||
155608021|NCT00900731|561653719|FG001|Overall Study|Adverse Event|27|||
155608022|NCT00900731|561653718|FG000|Overall Study|Withdrawal by Subject|8|||
155608023|NCT00900731|561653719|FG001|Overall Study|Withdrawal by Subject|7|||
155608024|NCT00900731|561653718|FG000|Overall Study|Protocol Deviation|8|||
155608025|NCT00900731|561653719|FG001|Overall Study|Protocol Deviation|11|||
155608026|NCT00900731|561653718|FG000|Overall Study|Administrative Problems|5|||
155608027|NCT00900731|561653719|FG001|Overall Study|Administrative Problems|4|||
155608028|NCT00900731|561653718|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
155380626|NCT00953407|560828595|FG000|Overall Study|Failed inclusion criteria|1|||
155608029|NCT00900731|561653719|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155608030|NCT00900731|561653718|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
155608031|NCT00900731|561653719|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
155608032|NCT00900731|561653718|FG000|Overall Study|Lost to Follow-up|2|||
155608033|NCT00900731|561653719|FG001|Overall Study|Lost to Follow-up|3|||
155608034|NCT00900731|561653718|FG000|Overall Study|Lack of Efficacy|1|||
155608035|NCT00900731|561653719|FG001|Overall Study|Lack of Efficacy|3|||
155608036|NCT00900731|561653718|FG000|Overall Study|Death|0|||
155608037|NCT00900731|561653719|FG001|Overall Study|Death|2|||
155608038|NCT00131365|561653720|FG000|Overall Study|Withdrawal by Subject|1|||
155608039|NCT00131365|561653720|FG000|Overall Study|Alternative treatment|3|||
155608040|NCT04608344|561653721|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
155608041|NCT04608344|561653722|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
155380627|NCT00953407|560828596|FG001|Overall Study|Failed inclusion criteria|1|||
155380628|NCT00953407|560828597|FG002|Overall Study|Failed inclusion criteria|1|||
155380629|NCT00953407|560828598|FG003|Overall Study|Failed inclusion criteria|1|||
155380630|NCT00953407|560828599|FG004|Overall Study|Failed inclusion criteria|1|||
155380631|NCT00953407|560828595|FG000|Overall Study|Lost to Follow-up|0|||
155380632|NCT00953407|560828596|FG001|Overall Study|Lost to Follow-up|0|||
155380633|NCT00953407|560828597|FG002|Overall Study|Lost to Follow-up|0|||
155380634|NCT00953407|560828598|FG003|Overall Study|Lost to Follow-up|1|||
155380635|NCT00953407|560828599|FG004|Overall Study|Lost to Follow-up|0|||
155380636|NCT02502097|560828600|FG000|Period 1|Adverse Event|0|||
155380637|NCT02502097|560828601|FG001|Period 1|Adverse Event|0|||
155380638|NCT02502097|560828602|FG002|Period 1|Adverse Event|1|||
155380639|NCT02502097|560828603|FG003|Period 1|Adverse Event|0|||
155380640|NCT02502097|560828600|FG000|Wash Out Period|Adverse Event|0|||
155380641|NCT02502097|560828601|FG001|Wash Out Period|Adverse Event|1|||
155380642|NCT02502097|560828602|FG002|Wash Out Period|Adverse Event|1|||
155608042|NCT04608344|561653721|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
155380643|NCT02502097|560828603|FG003|Wash Out Period|Adverse Event|1|||
155380644|NCT02502097|560828600|FG000|Period 2|Adverse Event|0|||
155380645|NCT02502097|560828601|FG001|Period 2|Adverse Event|0|||
155380646|NCT02502097|560828602|FG002|Period 2|Adverse Event|1|||
155380647|NCT02502097|560828603|FG003|Period 2|Adverse Event|0|||
155380648|NCT01111474|560828604|FG000|Overall Study|Lost to Follow-up|12|||
155380649|NCT02518490|560828614|FG000|Overall Study|Withdrawal by Subject|1|||
155380650|NCT02518490|560828615|FG001|Overall Study|Withdrawal by Subject|1|||
155380651|NCT00346632|560828616|FG000|Overall Study|Progressive Disease|2|||
155380652|NCT00346632|560828617|FG001|Overall Study|Progressive Disease|2|||
155380653|NCT00346632|560828618|FG002|Overall Study|Progressive Disease|4|||
155380654|NCT00346632|560828619|FG003|Overall Study|Progressive Disease|3|||
155380655|NCT00346632|560828620|FG004|Overall Study|Progressive Disease|3|||
155380656|NCT00346632|560828621|FG005|Overall Study|Progressive Disease|1|||
155380657|NCT00346632|560828622|FG006|Overall Study|Progressive Disease|2|||
155380658|NCT00346632|560828623|FG007|Overall Study|Progressive Disease|2|||
155380659|NCT00346632|560828624|FG008|Overall Study|Progressive Disease|2|||
155380660|NCT00346632|560828625|FG009|Overall Study|Progressive Disease|2|||
155380661|NCT00346632|560828616|FG000|Overall Study|Adverse Event|0|||
155380662|NCT00346632|560828617|FG001|Overall Study|Adverse Event|0|||
155380663|NCT00346632|560828618|FG002|Overall Study|Adverse Event|0|||
155380664|NCT00346632|560828619|FG003|Overall Study|Adverse Event|0|||
155380665|NCT00346632|560828620|FG004|Overall Study|Adverse Event|1|||
155380666|NCT00346632|560828621|FG005|Overall Study|Adverse Event|1|||
155380667|NCT00346632|560828622|FG006|Overall Study|Adverse Event|1|||
155380668|NCT00346632|560828623|FG007|Overall Study|Adverse Event|0|||
155380669|NCT00346632|560828624|FG008|Overall Study|Adverse Event|0|||
155380670|NCT00346632|560828625|FG009|Overall Study|Adverse Event|0|||
155380671|NCT00346632|560828616|FG000|Overall Study|Death|0|||
155380672|NCT00346632|560828617|FG001|Overall Study|Death|0|||
155380673|NCT00346632|560828618|FG002|Overall Study|Death|1|||
155380674|NCT00346632|560828619|FG003|Overall Study|Death|0|||
155380675|NCT00346632|560828620|FG004|Overall Study|Death|0|||
155380676|NCT00346632|560828621|FG005|Overall Study|Death|0|||
155380677|NCT00346632|560828622|FG006|Overall Study|Death|0|||
155380678|NCT00346632|560828623|FG007|Overall Study|Death|0|||
155380679|NCT00346632|560828624|FG008|Overall Study|Death|0|||
155380680|NCT00346632|560828625|FG009|Overall Study|Death|0|||
155380681|NCT00346632|560828616|FG000|Overall Study|Protocol Violation|0|||
155380682|NCT00346632|560828617|FG001|Overall Study|Protocol Violation|0|||
155380683|NCT00346632|560828618|FG002|Overall Study|Protocol Violation|0|||
155380684|NCT00346632|560828619|FG003|Overall Study|Protocol Violation|0|||
155380685|NCT00346632|560828620|FG004|Overall Study|Protocol Violation|0|||
155380686|NCT00346632|560828621|FG005|Overall Study|Protocol Violation|0|||
155380687|NCT00346632|560828622|FG006|Overall Study|Protocol Violation|1|||
155380688|NCT00346632|560828623|FG007|Overall Study|Protocol Violation|0|||
155380689|NCT00346632|560828624|FG008|Overall Study|Protocol Violation|0|||
155380690|NCT00346632|560828625|FG009|Overall Study|Protocol Violation|0|||
155380691|NCT00346632|560828616|FG000|Overall Study|Withdrawal by Subject|0|||
155380692|NCT00346632|560828617|FG001|Overall Study|Withdrawal by Subject|0|||
155380693|NCT00346632|560828618|FG002|Overall Study|Withdrawal by Subject|0|||
155380694|NCT00346632|560828619|FG003|Overall Study|Withdrawal by Subject|0|||
155380695|NCT00346632|560828620|FG004|Overall Study|Withdrawal by Subject|0|||
155380696|NCT00346632|560828621|FG005|Overall Study|Withdrawal by Subject|0|||
155380697|NCT00346632|560828622|FG006|Overall Study|Withdrawal by Subject|1|||
155380698|NCT00346632|560828623|FG007|Overall Study|Withdrawal by Subject|0|||
155380699|NCT00346632|560828624|FG008|Overall Study|Withdrawal by Subject|0|||
155380700|NCT00346632|560828625|FG009|Overall Study|Withdrawal by Subject|0|||
155380701|NCT00346632|560828616|FG000|Overall Study|Switched to alternative treatment|0|||
155380702|NCT00346632|560828617|FG001|Overall Study|Switched to alternative treatment|0|||
155380703|NCT00346632|560828618|FG002|Overall Study|Switched to alternative treatment|1|||
155380704|NCT00346632|560828619|FG003|Overall Study|Switched to alternative treatment|0|||
155380705|NCT00346632|560828620|FG004|Overall Study|Switched to alternative treatment|0|||
155380706|NCT00346632|560828621|FG005|Overall Study|Switched to alternative treatment|0|||
155608043|NCT04608344|561653722|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
155722578|NCT02318706|562083887|FG003|Double-blind Phase|Withdrawal by Subject|10|||
155380707|NCT00346632|560828622|FG006|Overall Study|Switched to alternative treatment|0|||
155380708|NCT00346632|560828623|FG007|Overall Study|Switched to alternative treatment|0|||
155380709|NCT00346632|560828624|FG008|Overall Study|Switched to alternative treatment|0|||
155380710|NCT00346632|560828625|FG009|Overall Study|Switched to alternative treatment|0|||
155380711|NCT00346632|560828616|FG000|Overall Study|Not Stated|1|||
155380712|NCT00346632|560828617|FG001|Overall Study|Not Stated|1|||
155380713|NCT00346632|560828618|FG002|Overall Study|Not Stated|0|||
155380714|NCT00346632|560828619|FG003|Overall Study|Not Stated|0|||
155380715|NCT00346632|560828620|FG004|Overall Study|Not Stated|0|||
155380716|NCT00346632|560828621|FG005|Overall Study|Not Stated|0|||
155380717|NCT00346632|560828622|FG006|Overall Study|Not Stated|0|||
155380718|NCT00346632|560828623|FG007|Overall Study|Not Stated|2|||
155380719|NCT00346632|560828624|FG008|Overall Study|Not Stated|2|||
155380720|NCT00346632|560828625|FG009|Overall Study|Not Stated|1|||
155380721|NCT02354508|560828628|FG000|Period 1: Core Phase|Adverse Event|1|||
155380722|NCT02354508|560828629|FG001|Period 1: Core Phase|Adverse Event|1|||
155380723|NCT02354508|560828630|FG002|Period 1: Core Phase|Adverse Event|2|||
155380724|NCT02354508|560828628|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
155380725|NCT02354508|560828629|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
155380726|NCT02354508|560828630|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
155380727|NCT02354508|560828628|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
155380728|NCT02354508|560828629|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
155380729|NCT02354508|560828630|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
155380730|NCT02354508|560828628|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
155380731|NCT02354508|560828629|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
155380732|NCT02354508|560828630|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
155380733|NCT02354508|560828628|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
155380734|NCT02354508|560828629|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
155380735|NCT02354508|560828630|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
155380736|NCT02354508|560828628|FG000|Period 2: Extension Phase|Physician Decision|5|||
155380737|NCT02354508|560828629|FG001|Period 2: Extension Phase|Physician Decision|0|||
155380738|NCT02354508|560828630|FG002|Period 2: Extension Phase|Physician Decision|1|||
155380739|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
155608044|NCT05249127|561653723|FG000|Overall Study|Protocol Violation|13|||
155608045|NCT05249127|561653723|FG000|Overall Study|Physician Decision|4|||
155608046|NCT05249127|561653723|FG000|Overall Study|Withdrawal by Subject|2|||
155608047|NCT05249127|561653723|FG000|Overall Study|Participant Non-compliance|1|||
155608048|NCT03053427|561653724|FG000|Overall Study|Adverse Event|4|||
155608049|NCT03053427|561653725|FG001|Overall Study|Adverse Event|4|||
155608050|NCT03053427|561653724|FG000|Overall Study|Lack of Efficacy|1|||
155608051|NCT03053427|561653725|FG001|Overall Study|Lack of Efficacy|3|||
155608052|NCT03053427|561653724|FG000|Overall Study|Lost to Follow-up|2|||
155608053|NCT03053427|561653725|FG001|Overall Study|Lost to Follow-up|2|||
155608054|NCT03053427|561653724|FG000|Overall Study|Worsening of the target disease|0|||
155608055|NCT03053427|561653725|FG001|Overall Study|Worsening of the target disease|1|||
155608056|NCT03053427|561653724|FG000|Overall Study|Protocol Deviation|3|||
155608057|NCT03053427|561653725|FG001|Overall Study|Protocol Deviation|3|||
155608058|NCT03053427|561653724|FG000|Overall Study|Withdrawal by Subject|3|||
155608059|NCT03053427|561653725|FG001|Overall Study|Withdrawal by Subject|2|||
155608060|NCT03053427|561653724|FG000|Overall Study|Miscellaneous|0|||
155608061|NCT03053427|561653725|FG001|Overall Study|Miscellaneous|1|||
155608062|NCT02607306|561653730|FG000|Overall Study|Adverse Event|8|||
155608063|NCT02607306|561653731|FG001|Overall Study|Adverse Event|6|||
155608064|NCT02607306|561653732|FG002|Overall Study|Adverse Event|6|||
155608065|NCT02607306|561653730|FG000|Overall Study|Unclassified|1|||
155608066|NCT02607306|561653731|FG001|Overall Study|Unclassified|4|||
155608067|NCT02607306|561653732|FG002|Overall Study|Unclassified|0|||
155608068|NCT02607306|561653730|FG000|Overall Study|Withdrawal by Subject|8|||
155608069|NCT02607306|561653731|FG001|Overall Study|Withdrawal by Subject|10|||
155608070|NCT02607306|561653732|FG002|Overall Study|Withdrawal by Subject|2|||
155608071|NCT02607306|561653730|FG000|Overall Study|Lack of Efficacy|0|||
155608072|NCT02607306|561653731|FG001|Overall Study|Lack of Efficacy|1|||
155608073|NCT02607306|561653732|FG002|Overall Study|Lack of Efficacy|1|||
155608074|NCT02607306|561653730|FG000|Overall Study|Protocol Violation|4|||
155608075|NCT02607306|561653731|FG001|Overall Study|Protocol Violation|2|||
155608076|NCT02607306|561653732|FG002|Overall Study|Protocol Violation|1|||
155608077|NCT02360475|561653737|FG000|Overall Study|Lost to Follow-up|4|||
155608078|NCT02360475|561653738|FG001|Overall Study|Lost to Follow-up|12|||
155608079|NCT02360475|561653739|FG002|Overall Study|Lost to Follow-up|6|||
155608080|NCT02360475|561653740|FG003|Overall Study|Lost to Follow-up|4|||
155608081|NCT02360475|561653737|FG000|Overall Study|Withdrawal by Subject|0|||
155608082|NCT02360475|561653738|FG001|Overall Study|Withdrawal by Subject|1|||
155608083|NCT02360475|561653739|FG002|Overall Study|Withdrawal by Subject|2|||
155608084|NCT02360475|561653740|FG003|Overall Study|Withdrawal by Subject|0|||
155608085|NCT02360475|561653737|FG000|Overall Study|Migrated/moved from study area|0|||
155608086|NCT02360475|561653738|FG001|Overall Study|Migrated/moved from study area|0|||
155608087|NCT02360475|561653739|FG002|Overall Study|Migrated/moved from study area|0|||
155608088|NCT02360475|561653740|FG003|Overall Study|Migrated/moved from study area|1|||
155608089|NCT00642954|561655012|FG000|Overall Study|Progressive Disease|3|||
155608090|NCT00642954|561655013|FG001|Overall Study|Progressive Disease|3|||
155608091|NCT00642954|561655014|FG002|Overall Study|Progressive Disease|3|||
155608092|NCT00642954|561655015|FG003|Overall Study|Progressive Disease|3|||
155493739|NCT03795233|561231466|FG001|Overall Study|Withdrawal by Subject|1|||
155493740|NCT03795233|561231465|FG000|Overall Study|Lost to Follow-up|1|||
155493741|NCT03795233|561231466|FG001|Overall Study|Lost to Follow-up|0|||
155722579|NCT02318706|562083888|FG004|Double-blind Phase|Withdrawal by Subject|0|||
155380740|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
155493742|NCT03795233|561231465|FG000|Overall Study|Death|1|||
155493743|NCT03795233|561231466|FG001|Overall Study|Death|0|||
155608093|NCT00642954|561655016|FG004|Overall Study|Progressive Disease|9|||
155608094|NCT00642954|561655012|FG000|Overall Study|Withdrawal by Subject|0|||
155380741|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
155493744|NCT02756182|561231467|FG000|Overall Study|StudyTechnical Difficulties|4|||
155493745|NCT01003691|561231469|FG000|Overall Study|Adverse Event|0|||
155493746|NCT01003691|561231470|FG001|Overall Study|Adverse Event|0|||
155493747|NCT01003691|561231471|FG002|Overall Study|Adverse Event|0|||
155493748|NCT01003691|561231472|FG003|Overall Study|Adverse Event|1|||
155493749|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
155493750|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
155493751|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
155493752|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
155493753|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
155513845|NCT01829464|561308158|FG002|Overall Study|Adverse Event|0|||
155513846|NCT01829464|561308156|FG000|Overall Study|Lost to Follow-up|0|||
155513847|NCT01829464|561308157|FG001|Overall Study|Lost to Follow-up|0|||
155513848|NCT01829464|561308158|FG002|Overall Study|Lost to Follow-up|1|||
155513849|NCT01829464|561308156|FG000|Overall Study|Withdrawal by Subject|2|||
155513850|NCT01829464|561308157|FG001|Overall Study|Withdrawal by Subject|0|||
155513851|NCT01829464|561308158|FG002|Overall Study|Withdrawal by Subject|0|||
155513852|NCT01829464|561308156|FG000|Overall Study|Study terminated by sponsor|25|||
155513853|NCT01829464|561308157|FG001|Overall Study|Study terminated by sponsor|28|||
155513854|NCT01829464|561308158|FG002|Overall Study|Study terminated by sponsor|25|||
155513855|NCT01829464|561308156|FG000|Overall Study|Lack of Efficacy|0|||
155513856|NCT01829464|561308157|FG001|Overall Study|Lack of Efficacy|1|||
155513857|NCT01829464|561308158|FG002|Overall Study|Lack of Efficacy|0|||
155513858|NCT00635778|561308159|FG000|Overall Study|Adverse Event|1|||
155513859|NCT00635778|561308160|FG001|Overall Study|Adverse Event|0|||
155513860|NCT00635778|561308161|FG002|Overall Study|Adverse Event|0|||
155513861|NCT00635778|561308162|FG003|Overall Study|Adverse Event|3|||
155513862|NCT00635778|561308163|FG004|Overall Study|Adverse Event|3|||
155513863|NCT00635778|561308164|FG005|Overall Study|Adverse Event|6|||
155513864|NCT00635778|561308165|FG006|Overall Study|Adverse Event|1|||
155513865|NCT00635778|561308159|FG000|Overall Study|Withdrawal by Subject|0|||
155513866|NCT00635778|561308160|FG001|Overall Study|Withdrawal by Subject|0|||
155513867|NCT00635778|561308161|FG002|Overall Study|Withdrawal by Subject|0|||
155513868|NCT00635778|561308162|FG003|Overall Study|Withdrawal by Subject|1|||
155513869|NCT00635778|561308163|FG004|Overall Study|Withdrawal by Subject|0|||
155513870|NCT00635778|561308164|FG005|Overall Study|Withdrawal by Subject|1|||
155513871|NCT00635778|561308165|FG006|Overall Study|Withdrawal by Subject|1|||
155513872|NCT00635778|561308159|FG000|Overall Study|Progressive disease|0|||
155513873|NCT00635778|561308160|FG001|Overall Study|Progressive disease|3|||
155513874|NCT00635778|561308161|FG002|Overall Study|Progressive disease|3|||
155513875|NCT00635778|561308162|FG003|Overall Study|Progressive disease|4|||
155513876|NCT00635778|561308163|FG004|Overall Study|Progressive disease|5|||
155513877|NCT00635778|561308164|FG005|Overall Study|Progressive disease|14|||
155513878|NCT00635778|561308165|FG006|Overall Study|Progressive disease|4|||
155513879|NCT00812253|561308166|FG000|Overall Study|Withdrawal by Subject|3|||
155513880|NCT00812253|561308167|FG001|Overall Study|Withdrawal by Subject|2|||
155513881|NCT00812253|561308166|FG000|Overall Study|Protocol Violation|1|||
155513882|NCT00812253|561308167|FG001|Overall Study|Protocol Violation|1|||
155513883|NCT00812253|561308166|FG000|Overall Study|Lost to Follow-up|2|||
155513884|NCT00812253|561308167|FG001|Overall Study|Lost to Follow-up|0|||
155513885|NCT01884025|561308168|FG000|Overall Study|Lost to Follow-up|3|||
155513886|NCT01884025|561308169|FG001|Overall Study|Lost to Follow-up|4|||
155513887|NCT01700621|561308174|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
155513888|NCT01700621|561308175|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
155513889|NCT01700621|561308174|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
155513890|NCT01700621|561308175|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
155513891|NCT01700621|561308174|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
155513892|NCT01700621|561308175|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
155513893|NCT02035137|561308178|FG000|Overall Study|Physician Decision|0|||
155513894|NCT02035137|561308179|FG001|Overall Study|Physician Decision|0|||
155513895|NCT02035137|561308180|FG002|Overall Study|Physician Decision|1|||
155513896|NCT02035137|561308178|FG000|Overall Study|Withdrawal by Subject|0|||
155513897|NCT02035137|561308179|FG001|Overall Study|Withdrawal by Subject|1|||
155513898|NCT02035137|561308180|FG002|Overall Study|Withdrawal by Subject|2|||
155513899|NCT02035137|561308178|FG000|Overall Study|Ineligible|0|||
155513900|NCT02035137|561308179|FG001|Overall Study|Ineligible|1|||
155513901|NCT02035137|561308180|FG002|Overall Study|Ineligible|2|||
155513902|NCT02035137|561308178|FG000|Overall Study|Disease progression prior to treatment start|2|||
155513903|NCT02035137|561308179|FG001|Overall Study|Disease progression prior to treatment start|0|||
155513904|NCT02035137|561308180|FG002|Overall Study|Disease progression prior to treatment start|0|||
155513905|NCT03349333|561308187|FG000|Overall Study|Progression of Disease|36|||
155513906|NCT03349333|561308187|FG000|Overall Study|Adverse Event|11|||
155513907|NCT03349333|561308187|FG000|Overall Study|Other|6|||
155608095|NCT00642954|561655013|FG001|Overall Study|Withdrawal by Subject|0|||
155608096|NCT00642954|561655014|FG002|Overall Study|Withdrawal by Subject|0|||
155608097|NCT00642954|561655015|FG003|Overall Study|Withdrawal by Subject|0|||
155608098|NCT00642954|561655016|FG004|Overall Study|Withdrawal by Subject|1|||
155608099|NCT00642954|561655012|FG000|Overall Study|Adverse Event|1|||
155608100|NCT00642954|561655013|FG001|Overall Study|Adverse Event|1|||
155608101|NCT00642954|561655014|FG002|Overall Study|Adverse Event|0|||
155608102|NCT00642954|561655015|FG003|Overall Study|Adverse Event|0|||
155608103|NCT00642954|561655016|FG004|Overall Study|Adverse Event|6|||
155608104|NCT01344759|561655017|FG000|Overall Study|Patients failed to reach sedation level|0|||
155608105|NCT01344759|561655018|FG001|Overall Study|Patients failed to reach sedation level|2|||
155608106|NCT01890759|561655019|FG000|Overall Study|Protocol Violation|0|||
155608107|NCT01890759|561655020|FG001|Overall Study|Protocol Violation|2|||
155608108|NCT01890759|561655019|FG000|Overall Study|Lost to Follow-up|0|||
155608109|NCT01890759|561655020|FG001|Overall Study|Lost to Follow-up|2|||
155608110|NCT01890759|561655019|FG000|Overall Study|Withdrawal by Subject|2|||
155608111|NCT01890759|561655020|FG001|Overall Study|Withdrawal by Subject|8|||
155608112|NCT02732015|561655021|FG000|Overall Study|Lost to Follow-up|0|||
155608113|NCT02732015|561655022|FG001|Overall Study|Lost to Follow-up|1|||
155608114|NCT01980628|561655023|FG000|Overall Study|Adverse Event|12|||
155608115|NCT01980628|561655023|FG000|Overall Study|Physician Decision|5|||
155608116|NCT01980628|561655023|FG000|Overall Study|Withdrawal by Subject|4|||
155608117|NCT01980628|561655023|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
155608118|NCT05437640|561655026|FG000|Washout (1 Week)|Adverse Event|1|||
155608119|NCT05437640|561655027|FG001|Washout (1 Week)|Adverse Event|0|||
155608120|NCT02474355|561655028|FG000|Overall Study|Other|43|||
155608121|NCT02474355|561655028|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
155608122|NCT02474355|561655028|FG000|Overall Study|Lost to Follow-up|98|||
155608123|NCT02474355|561655028|FG000|Overall Study|Withdrawal by Subject|124|||
155608124|NCT02474355|561655028|FG000|Overall Study|Death|1361|||
155608125|NCT03015194|561655030|FG000|Overall Study|Death|10|||
155608126|NCT03015194|561655030|FG000|Overall Study|Withdrawal by Subject|2|||
155608127|NCT01937715|561655034|FG000|Overall Study|Death|0|||
155608128|NCT01937715|561655035|FG001|Overall Study|Death|0|||
155608129|NCT01937715|561655036|FG002|Overall Study|Death|0|||
155608130|NCT01937715|561655037|FG003|Overall Study|Death|1|||
155608131|NCT01937715|561655038|FG004|Overall Study|Death|0|||
155608132|NCT01937715|561655034|FG000|Overall Study|Withdrawal by Subject|0|||
155608133|NCT01937715|561655035|FG001|Overall Study|Withdrawal by Subject|1|||
155608134|NCT01937715|561655036|FG002|Overall Study|Withdrawal by Subject|0|||
155608135|NCT01937715|561655037|FG003|Overall Study|Withdrawal by Subject|0|||
155608136|NCT01937715|561655038|FG004|Overall Study|Withdrawal by Subject|2|||
155608137|NCT01937715|561655034|FG000|Overall Study|Other|0|||
155608138|NCT01937715|561655035|FG001|Overall Study|Other|0|||
155608139|NCT01937715|561655036|FG002|Overall Study|Other|0|||
155608140|NCT01937715|561655037|FG003|Overall Study|Other|3|||
155608141|NCT01937715|561655038|FG004|Overall Study|Other|0|||
155608142|NCT00433017|561655041|FG000|Overall Study|Adverse Event|5|||
155608143|NCT00433017|561655042|FG001|Overall Study|Adverse Event|3|||
155608144|NCT00433017|561655041|FG000|Overall Study|Withdrawal by Subject|4|||
155608145|NCT00433017|561655042|FG001|Overall Study|Withdrawal by Subject|5|||
155608146|NCT00433017|561655041|FG000|Overall Study|Lost to Follow-up|3|||
155608147|NCT00433017|561655042|FG001|Overall Study|Lost to Follow-up|4|||
155608148|NCT00433017|561655041|FG000|Overall Study|Administrative problems|80|||
155608149|NCT00433017|561655042|FG001|Overall Study|Administrative problems|86|||
155608150|NCT00433017|561655041|FG000|Overall Study|Protocol Violation|1|||
155608151|NCT00433017|561655042|FG001|Overall Study|Protocol Violation|0|||
155608152|NCT00433017|561655041|FG000|Overall Study|Death|2|||
155608153|NCT00433017|561655042|FG001|Overall Study|Death|2|||
155608154|NCT00433017|561655041|FG000|Overall Study|Subject no longer requires study drug|1|||
155608155|NCT00433017|561655042|FG001|Overall Study|Subject no longer requires study drug|1|||
155608156|NCT00153816|561655043|FG000|Overall Study|Death|6|||
155608157|NCT00153816|561655044|FG001|Overall Study|Death|5|||
155608158|NCT00153816|561655045|FG002|Overall Study|Death|4|||
155380742|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
155380743|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
155493754|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
155493755|NCT00828009|561231477|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
155493756|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
155493757|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
155493758|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Death|1|||
155493759|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
155493760|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
155608159|NCT00153816|561655046|FG003|Overall Study|Death|6|||
155608160|NCT00153816|561655047|FG004|Overall Study|Death|0|||
155608161|NCT00153816|561655048|FG005|Overall Study|Death|2|||
155608162|NCT00153816|561655043|FG000|Overall Study|Lost to Follow-up|7|||
155608163|NCT00153816|561655044|FG001|Overall Study|Lost to Follow-up|8|||
155493761|NCT00828009|561231477|FG000|Step 2 - Maintenance Therapy|Other|1|||
155380744|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
155493762|NCT01676818|561231481|FG000|Overall Study|Physician Decision|1|||
155493763|NCT01676818|561231481|FG000|Overall Study|Withdrawal by Subject|1|||
155513908|NCT03349333|561308187|FG000|Overall Study|Withdrawal by Subject|5|||
155513909|NCT03349333|561308187|FG000|Overall Study|Conditions interfere with participation|2|||
155513910|NCT03349333|561308187|FG000|Overall Study|Physician Decision|2|||
155513911|NCT03349333|561308187|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
155513912|NCT03349333|561308187|FG000|Overall Study|Patients in treatment less than 24 month|8|||
155513913|NCT02985151|561308188|FG000|Original Randomization|Withdrawal by Subject|0|||
155513914|NCT02985151|561308189|FG001|Original Randomization|Withdrawal by Subject|1|||
155513915|NCT02116803|561308194|FG000|Overall Study|Adverse Event|2|||
155513916|NCT02116803|561308195|FG001|Overall Study|Adverse Event|1|||
155608164|NCT00153816|561655045|FG002|Overall Study|Lost to Follow-up|5|||
155608165|NCT00153816|561655046|FG003|Overall Study|Lost to Follow-up|8|||
155608166|NCT00153816|561655047|FG004|Overall Study|Lost to Follow-up|7|||
155608167|NCT00153816|561655048|FG005|Overall Study|Lost to Follow-up|9|||
155608168|NCT00153816|561655043|FG000|Overall Study|Withdrawal by Subject|9|||
155608169|NCT00153816|561655044|FG001|Overall Study|Withdrawal by Subject|9|||
155608170|NCT00153816|561655045|FG002|Overall Study|Withdrawal by Subject|9|||
155608171|NCT00153816|561655046|FG003|Overall Study|Withdrawal by Subject|4|||
155608172|NCT00153816|561655047|FG004|Overall Study|Withdrawal by Subject|1|||
155608173|NCT00153816|561655048|FG005|Overall Study|Withdrawal by Subject|5|||
155608174|NCT00153816|561655043|FG000|Overall Study|Follow-up exam not done|8|||
155608175|NCT00153816|561655044|FG001|Overall Study|Follow-up exam not done|7|||
155608176|NCT00153816|561655045|FG002|Overall Study|Follow-up exam not done|11|||
155608177|NCT00153816|561655046|FG003|Overall Study|Follow-up exam not done|10|||
155608178|NCT00153816|561655047|FG004|Overall Study|Follow-up exam not done|8|||
155608179|NCT00153816|561655048|FG005|Overall Study|Follow-up exam not done|9|||
155608180|NCT00153816|561655043|FG000|Overall Study|Follow-up exam done, histology missing|2|||
155608181|NCT00153816|561655044|FG001|Overall Study|Follow-up exam done, histology missing|3|||
155608182|NCT00153816|561655045|FG002|Overall Study|Follow-up exam done, histology missing|3|||
155608183|NCT00153816|561655046|FG003|Overall Study|Follow-up exam done, histology missing|3|||
155608184|NCT00153816|561655047|FG004|Overall Study|Follow-up exam done, histology missing|1|||
155608185|NCT00153816|561655048|FG005|Overall Study|Follow-up exam done, histology missing|2|||
155608186|NCT01760447|561655049|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
155608187|NCT01760447|561655050|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
155608188|NCT01760447|561655051|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
155608189|NCT01760447|561655052|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
155608190|NCT01760447|561655049|FG000|Weeks 0-20|Withdrawal by Subject|2|||
155608191|NCT01760447|561655050|FG001|Weeks 0-20|Withdrawal by Subject|0|||
155608192|NCT01760447|561655051|FG002|Weeks 0-20|Withdrawal by Subject|1|||
155608193|NCT01760447|561655052|FG003|Weeks 0-20|Withdrawal by Subject|0|||
155608194|NCT01760447|561655049|FG000|Weeks 0-20|Lost to Follow-up|1|||
155608195|NCT01760447|561655050|FG001|Weeks 0-20|Lost to Follow-up|0|||
155608196|NCT01760447|561655051|FG002|Weeks 0-20|Lost to Follow-up|1|||
155608197|NCT01760447|561655052|FG003|Weeks 0-20|Lost to Follow-up|1|||
155608198|NCT01760447|561655049|FG000|Weeks 0-20|Randomized but not treated|0|||
155608199|NCT01760447|561655050|FG001|Weeks 0-20|Randomized but not treated|0|||
155608200|NCT01760447|561655051|FG002|Weeks 0-20|Randomized but not treated|2|||
155608201|NCT01760447|561655052|FG003|Weeks 0-20|Randomized but not treated|0|||
155608202|NCT01760447|561655049|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155608203|NCT01760447|561655050|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155380745|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
155380746|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
155380747|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
155380748|NCT03587974|560828631|FG000|Overall Study|caregiver demented, care recipient died|3|||
155380749|NCT03587974|560828632|FG001|Overall Study|caregiver demented, care recipient died|3|||
155380750|NCT03587974|560828631|FG000|Overall Study|Withdrawal by Subject|2|||
155380751|NCT03587974|560828632|FG001|Overall Study|Withdrawal by Subject|1|||
155380752|NCT04447846|560828633|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
155380753|NCT00946101|560828634|FG000|Overall Study|Lost to Follow-up|2|||
155380754|NCT00946101|560828635|FG001|Overall Study|Lost to Follow-up|1|||
155380755|NCT00946101|560828634|FG000|Overall Study|Withdrawal of consent|2|||
155380756|NCT00946101|560828635|FG001|Overall Study|Withdrawal of consent|0|||
155380757|NCT00946101|560828634|FG000|Overall Study|Physician Decision|0|||
155380758|NCT00946101|560828635|FG001|Overall Study|Physician Decision|1|||
155380759|NCT00093808|560828636|FG000|Overall Study|Cancel participation before receiving tx|1|||
155380760|NCT00093808|560828636|FG000|Overall Study|Protocol Violation|1|||
155435851|NCT01476787|561022967|FG001|Treatment|Concurrent illness|9|||
155608204|NCT01760447|561655051|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155608205|NCT01760447|561655052|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
155608206|NCT01760447|561655049|FG000|Weeks 20-54|Withdrawal by Subject|2|||
155380761|NCT00871780|560828637|FG000|Overall Study|Enrolled But Not Treated|6|||
155380762|NCT00871780|560828637|FG000|Overall Study|Withdrawal by Subject|9|||
155380763|NCT00871780|560828637|FG000|Overall Study|Adverse Event|6|||
155380764|NCT00871780|560828637|FG000|Overall Study|Voluntary Discontinuation|4|||
155380765|NCT00871780|560828637|FG000|Overall Study|Death|1|||
155380766|NCT00871780|560828637|FG000|Overall Study|Physician Decision|1|||
155380767|NCT00523640|560828640|FG000|Overall Study|Death|1|||
155380768|NCT06377488|560828641|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
155380769|NCT06377488|560828641|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
155380770|NCT06377488|560828641|FG000|Overall Study|Protocol Violation|1|||
155380771|NCT06377488|560828641|FG000|Overall Study|Lost to Follow-up|1|||
155380772|NCT06377488|560828641|FG000|Overall Study|Incorrect Lens Dispensed|2|||
155380773|NCT00652327|560828644|FG000|Overall Study|Adverse Event|0|||
155380774|NCT00652327|560828645|FG001|Overall Study|Adverse Event|2|||
155380775|NCT00652327|560828644|FG000|Overall Study|Lost to Follow-up|0|||
155380776|NCT00652327|560828645|FG001|Overall Study|Lost to Follow-up|3|||
155608207|NCT01760447|561655050|FG001|Weeks 20-54|Withdrawal by Subject|1|||
155608208|NCT01760447|561655051|FG002|Weeks 20-54|Withdrawal by Subject|1|||
155608209|NCT01760447|561655052|FG003|Weeks 20-54|Withdrawal by Subject|2|||
155608210|NCT01760447|561655049|FG000|Weeks 20-54|Lost to Follow-up|0|||
155608211|NCT01760447|561655050|FG001|Weeks 20-54|Lost to Follow-up|0|||
155608212|NCT01760447|561655051|FG002|Weeks 20-54|Lost to Follow-up|1|||
155608213|NCT01760447|561655052|FG003|Weeks 20-54|Lost to Follow-up|2|||
155608214|NCT01937884|561655056|FG000|Overall Study|Withdrawal by Subject|1|||
155608215|NCT01937884|561655057|FG001|Overall Study|Withdrawal by Subject|0|||
155608216|NCT01167634|561655064|FG000|Overall Study|Lost to Follow-up|1|||
155608217|NCT01167634|561655065|FG001|Overall Study|Lost to Follow-up|3|||
155608218|NCT01167634|561655066|FG002|Overall Study|Lost to Follow-up|3|||
155608219|NCT01167634|561655067|FG003|Overall Study|Lost to Follow-up|4|||
155608220|NCT01167634|561655064|FG000|Overall Study|Withdrawal by Subject|1|||
155608221|NCT01167634|561655065|FG001|Overall Study|Withdrawal by Subject|1|||
155608222|NCT01167634|561655066|FG002|Overall Study|Withdrawal by Subject|0|||
155608223|NCT01167634|561655067|FG003|Overall Study|Withdrawal by Subject|0|||
155608224|NCT03003000|561655076|FG000|Overall Study|Adverse Event|1|||
155608225|NCT03003000|561655077|FG001|Overall Study|Adverse Event|2|||
155608226|NCT03003000|561655078|FG002|Overall Study|Adverse Event|3|||
155608227|NCT03003000|561655076|FG000|Overall Study|Lack of Efficacy|1|||
155608228|NCT03003000|561655077|FG001|Overall Study|Lack of Efficacy|0|||
155608229|NCT03003000|561655078|FG002|Overall Study|Lack of Efficacy|0|||
155608230|NCT03003000|561655076|FG000|Overall Study|Non-compliant with protocol|0|||
155608231|NCT03003000|561655077|FG001|Overall Study|Non-compliant with protocol|1|||
155608232|NCT03003000|561655078|FG002|Overall Study|Non-compliant with protocol|1|||
155608233|NCT03003000|561655076|FG000|Overall Study|Refused to continue medication|2|||
155608234|NCT03003000|561655077|FG001|Overall Study|Refused to continue medication|0|||
155608235|NCT03003000|561655078|FG002|Overall Study|Refused to continue medication|0|||
155608236|NCT03003000|561655076|FG000|Overall Study|Other than listed|1|||
155608237|NCT03003000|561655077|FG001|Overall Study|Other than listed|1|||
155608238|NCT03003000|561655078|FG002|Overall Study|Other than listed|1|||
155608239|NCT04933617|561655080|FG000|Dose Escalation|Early closure of study|0|||
155608240|NCT04933617|561655081|FG001|Dose Escalation|Early closure of study|3|||
155608241|NCT04933617|561655082|FG002|Dose Escalation|Early closure of study|0|||
155608242|NCT04933617|561655083|FG003|Dose Escalation|Early closure of study|0|||
155608243|NCT04933617|561655084|FG004|Dose Escalation|Early closure of study|0|||
155608244|NCT02191046|561655086|FG000|Overall Study|low compliance|5|||
155608245|NCT02191046|561655087|FG001|Overall Study|low compliance|1|||
155608246|NCT01964716|561655088|FG000|Overall Study|Withdrawal by Subject|2|||
155608247|NCT01964716|561655089|FG001|Overall Study|Withdrawal by Subject|3|||
155608248|NCT01964716|561655088|FG000|Overall Study|Lost to Follow-up|1|||
155608249|NCT01964716|561655089|FG001|Overall Study|Lost to Follow-up|2|||
155608250|NCT01964716|561655088|FG000|Overall Study|No longer met eligibility criteria|1|||
155608251|NCT01964716|561655089|FG001|Overall Study|No longer met eligibility criteria|1|||
155608252|NCT01964716|561655088|FG000|Overall Study|Death|1|||
155608253|NCT01964716|561655089|FG001|Overall Study|Death|0|||
155608254|NCT00089635|561655090|FG000|Overall Study|Adverse Event|2|||
155608255|NCT00089635|561655090|FG000|Overall Study|Death|17|||
155608256|NCT00089635|561655090|FG000|Overall Study|Disease Progression|12|||
155380777|NCT01076647|560828646|FG000|Overall Study|Adverse Event|4|||
155380778|NCT01076647|560828647|FG001|Overall Study|Adverse Event|1|||
155380779|NCT01076647|560828646|FG000|Overall Study|Lack of Efficacy|0|||
155380780|NCT01076647|560828647|FG001|Overall Study|Lack of Efficacy|1|||
155608257|NCT00089635|561655090|FG000|Overall Study|Lost to Follow-up|3|||
155608258|NCT00089635|561655090|FG000|Overall Study|Withdrawal by Subject|6|||
155608259|NCT00089635|561655090|FG000|Overall Study|Ineligibility determined|1|||
155608260|NCT00089635|561655090|FG000|Overall Study|Other|2|||
155608261|NCT02603107|561655091|FG000|Randomized Phase|Withdrew consent|8|||
155608262|NCT02603107|561655092|FG001|Randomized Phase|Withdrew consent|15|||
155608263|NCT02603107|561655091|FG000|Randomized Phase|Lost to Follow-up|1|||
155608264|NCT02603107|561655092|FG001|Randomized Phase|Lost to Follow-up|3|||
155380781|NCT01076647|560828646|FG000|Overall Study|Protocol Violation|7|||
155380782|NCT01076647|560828647|FG001|Overall Study|Protocol Violation|9|||
155380783|NCT01076647|560828646|FG000|Overall Study|Withdrawal criteria|2|||
155380784|NCT01076647|560828647|FG001|Overall Study|Withdrawal criteria|2|||
155380785|NCT01076647|560828646|FG000|Overall Study|Unclassified|12|||
155380786|NCT01076647|560828647|FG001|Overall Study|Unclassified|12|||
155380787|NCT02292927|560828652|FG000|Overall Study|Protocol Violation|13|||
155380788|NCT02292927|560828653|FG001|Overall Study|Protocol Violation|7|||
155380789|NCT01656733|560828657|FG000|Overall Study|No permission to collect birth outcomes|0|||
155380790|NCT01656733|560828658|FG001|Overall Study|No permission to collect birth outcomes|1|||
155380791|NCT01656733|560828657|FG000|Overall Study|Delivery at another hospital|0|||
155380792|NCT01656733|560828658|FG001|Overall Study|Delivery at another hospital|2|||
155380793|NCT01656733|560828657|FG000|Overall Study|Spontaneous abortion|0|||
155380794|NCT01656733|560828658|FG001|Overall Study|Spontaneous abortion|1|||
155380795|NCT03625895|560828659|FG000|Overall Study|Protocol Violation|585|||
155380796|NCT02081417|560828660|FG000|Overall Study|Lost to Follow-up|26|||
155380797|NCT02081417|560828661|FG001|Overall Study|Lost to Follow-up|23|||
155380798|NCT02081417|560828660|FG000|Overall Study|Moved Away|1|||
155380799|NCT02081417|560828661|FG001|Overall Study|Moved Away|2|||
155380800|NCT02081417|560828660|FG000|Overall Study|Incarcerated|2|||
155380801|NCT02081417|560828661|FG001|Overall Study|Incarcerated|2|||
155380802|NCT02081417|560828660|FG000|Overall Study|Death|4|||
155380803|NCT02081417|560828661|FG001|Overall Study|Death|3|||
155380804|NCT02081417|560828660|FG000|Overall Study|Withdrawal by Subject|4|||
155380805|NCT02081417|560828661|FG001|Overall Study|Withdrawal by Subject|0|||
155380806|NCT02081417|560828660|FG000|Overall Study|Admitted to Residential Treatment|2|||
155380807|NCT02081417|560828661|FG001|Overall Study|Admitted to Residential Treatment|0|||
155380808|NCT02081417|560828660|FG000|Overall Study|Did not start treatment|17|||
155380809|NCT02081417|560828661|FG001|Overall Study|Did not start treatment|21|||
155380810|NCT01415531|560828664|FG000|Overall Study|Adverse Event|7|||
155380811|NCT01415531|560828665|FG001|Overall Study|Adverse Event|10|||
155380812|NCT01415531|560828664|FG000|Overall Study|Lack of Efficacy|3|||
155380813|NCT01415531|560828665|FG001|Overall Study|Lack of Efficacy|2|||
155380814|NCT01415531|560828664|FG000|Overall Study|Protocol Violation|0|||
155380815|NCT01415531|560828665|FG001|Overall Study|Protocol Violation|1|||
155380816|NCT01415531|560828664|FG000|Overall Study|Withdrawal by Subject|5|||
155380817|NCT01415531|560828665|FG001|Overall Study|Withdrawal by Subject|4|||
155380818|NCT01415531|560828664|FG000|Overall Study|Lost to Follow-up|6|||
155380819|NCT01415531|560828665|FG001|Overall Study|Lost to Follow-up|14|||
155380820|NCT01415531|560828664|FG000|Overall Study|Lack of Compliance|1|||
155380821|NCT01415531|560828665|FG001|Overall Study|Lack of Compliance|4|||
155380822|NCT01415531|560828664|FG000|Overall Study|Other Reasons|3|||
155380823|NCT01415531|560828665|FG001|Overall Study|Other Reasons|2|||
155380824|NCT05753670|560828666|FG000|Overall Study|Withdrawal by Subject|6|||
155380825|NCT05753670|560828667|FG001|Overall Study|Withdrawal by Subject|8|||
155380826|NCT05753670|560828666|FG000|Overall Study|Protocol Violation|3|||
155380827|NCT05753670|560828667|FG001|Overall Study|Protocol Violation|1|||
155380828|NCT00122460|560828668|FG000|Overall Study|investigational study phase ongoing|7|||
155380829|NCT00122460|560828669|FG001|Overall Study|investigational study phase ongoing|1|||
155380830|NCT01236339|560828670|FG000|Overall Study|Termination of study by sponsor|11|||
155380831|NCT01236339|560828671|FG001|Overall Study|Termination of study by sponsor|13|||
155380832|NCT02054741|560828672|FG000|Overall Study|Protocol Violation|13|||
155380833|NCT02054741|560828673|FG001|Overall Study|Protocol Violation|2|||
155380834|NCT02054741|560828672|FG000|Overall Study|Withdrawal by Subject|10|||
155380835|NCT02054741|560828673|FG001|Overall Study|Withdrawal by Subject|5|||
155380836|NCT02054741|560828672|FG000|Overall Study|Death|94|||
155380837|NCT02054741|560828673|FG001|Overall Study|Death|90|||
155380838|NCT02054741|560828672|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
155380839|NCT02054741|560828673|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
155380840|NCT02325557|560828674|FG000|Overall Study|Progressive disease|1|||
155380841|NCT02325557|560828675|FG001|Overall Study|Progressive disease|0|||
155380842|NCT02325557|560828676|FG002|Overall Study|Progressive disease|0|||
155380843|NCT02325557|560828677|FG003|Overall Study|Progressive disease|0|||
155380844|NCT02325557|560828674|FG000|Overall Study|Withdrawal by Subject|4|||
155380845|NCT02325557|560828675|FG001|Overall Study|Withdrawal by Subject|0|||
155380846|NCT02325557|560828676|FG002|Overall Study|Withdrawal by Subject|0|||
155380847|NCT02325557|560828677|FG003|Overall Study|Withdrawal by Subject|15|||
155380848|NCT02325557|560828674|FG000|Overall Study|Death|5|||
155380849|NCT02325557|560828675|FG001|Overall Study|Death|1|||
155380850|NCT02325557|560828676|FG002|Overall Study|Death|1|||
155380851|NCT02325557|560828677|FG003|Overall Study|Death|16|||
155380852|NCT02325557|560828674|FG000|Overall Study|Lost to Follow-up|0|||
155380853|NCT02325557|560828675|FG001|Overall Study|Lost to Follow-up|0|||
155380854|NCT02325557|560828676|FG002|Overall Study|Lost to Follow-up|1|||
155380855|NCT02325557|560828677|FG003|Overall Study|Lost to Follow-up|1|||
155380856|NCT02325557|560828674|FG000|Overall Study|Other|0|||
155380857|NCT02325557|560828675|FG001|Overall Study|Other|0|||
155380858|NCT02325557|560828676|FG002|Overall Study|Other|0|||
155380859|NCT02325557|560828677|FG003|Overall Study|Other|5|||
155380860|NCT01502631|560828678|FG000|Overall Study|Adverse Event|5|||
155380861|NCT01502631|560828679|FG001|Overall Study|Adverse Event|8|||
155380862|NCT01502631|560828678|FG000|Overall Study|Lost to Follow-up|2|||
155380863|NCT01502631|560828679|FG001|Overall Study|Lost to Follow-up|2|||
155380864|NCT01502631|560828678|FG000|Overall Study|Participant withdrew consent|2|||
155380865|NCT01502631|560828679|FG001|Overall Study|Participant withdrew consent|4|||
155380866|NCT01502631|560828678|FG000|Overall Study|Participant non-compliant|1|||
155380867|NCT01502631|560828679|FG001|Overall Study|Participant non-compliant|0|||
155380868|NCT01502631|560828678|FG000|Overall Study|Investigator's decision|0|||
155380869|NCT01502631|560828679|FG001|Overall Study|Investigator's decision|1|||
155380870|NCT01502631|560828678|FG000|Overall Study|Other|10|||
155380871|NCT01502631|560828679|FG001|Overall Study|Other|5|||
155380872|NCT01488487|560828680|FG000|Overall Study|Adverse Event|6|||
155380873|NCT01488487|560828680|FG000|Overall Study|Death|1|||
155380874|NCT01488487|560828680|FG000|Overall Study|Withdrawal by Subject|2|||
155380875|NCT00395460|560828683|FG000|Overall Study|Withdrawal by Subject|1|||
155380876|NCT00395460|560828684|FG001|Overall Study|Withdrawal by Subject|0|||
155380877|NCT02319525|560828690|FG000|Overall Study|Withdrawal by Subject|2|||
155380878|NCT02319525|560828691|FG001|Overall Study|Withdrawal by Subject|1|||
155380879|NCT04223830|560828695|FG000|Overall Study|Lost to Follow-up|9|||
155380880|NCT04223830|560828695|FG000|Overall Study|Adverse Event|1|||
155380881|NCT01806623|560828696|FG000|Overall Study|Withdrawal by Subject|1|||
155380882|NCT01806623|560828696|FG000|Overall Study|Adverse Event|1|||
155380883|NCT01806623|560828696|FG000|Overall Study|Did not meet the inclusion criteria|56|||
155380884|NCT01737827|560828697|FG000|Overall Study|Adverse Event|3|||
155380885|NCT01737827|560828698|FG001|Overall Study|Adverse Event|6|||
155380886|NCT01737827|560828699|FG002|Overall Study|Adverse Event|0|||
155380887|NCT01737827|560828697|FG000|Overall Study|Lost to Follow-up|0|||
155380888|NCT01737827|560828698|FG001|Overall Study|Lost to Follow-up|1|||
155380889|NCT01737827|560828699|FG002|Overall Study|Lost to Follow-up|0|||
155380890|NCT01737827|560828697|FG000|Overall Study|Physician Decision|0|||
155380891|NCT01737827|560828698|FG001|Overall Study|Physician Decision|2|||
155380892|NCT01737827|560828699|FG002|Overall Study|Physician Decision|0|||
155380893|NCT01737827|560828697|FG000|Overall Study|Progressive Disease|5|||
155380894|NCT01737827|560828698|FG001|Overall Study|Progressive Disease|16|||
155380895|NCT01737827|560828699|FG002|Overall Study|Progressive Disease|2|||
155380896|NCT01737827|560828697|FG000|Overall Study|Study Terminated by Sponsor|0|||
155380897|NCT01737827|560828698|FG001|Overall Study|Study Terminated by Sponsor|1|||
155380898|NCT01737827|560828699|FG002|Overall Study|Study Terminated by Sponsor|0|||
155380899|NCT01737827|560828697|FG000|Overall Study|Subject/Guardian Decision|0|||
155380900|NCT01737827|560828698|FG001|Overall Study|Subject/Guardian Decision|2|||
155380901|NCT01737827|560828699|FG002|Overall Study|Subject/Guardian Decision|0|||
155380902|NCT01451827|560828700|FG000|Overall Study|Adverse Event|2|||
155380903|NCT01451827|560828701|FG001|Overall Study|Adverse Event|0|||
155380904|NCT01451827|560828702|FG002|Overall Study|Adverse Event|1|||
155380905|NCT01451827|560828703|FG003|Overall Study|Adverse Event|1|||
155380906|NCT01451827|560828700|FG000|Overall Study|Protocol deviation|1|||
155380907|NCT01451827|560828701|FG001|Overall Study|Protocol deviation|0|||
155380908|NCT01451827|560828702|FG002|Overall Study|Protocol deviation|0|||
155380909|NCT01451827|560828703|FG003|Overall Study|Protocol deviation|0|||
155380910|NCT01451827|560828700|FG000|Overall Study|Lost to Follow-up|0|||
155380911|NCT01451827|560828701|FG001|Overall Study|Lost to Follow-up|3|||
155380912|NCT01451827|560828702|FG002|Overall Study|Lost to Follow-up|0|||
155380913|NCT01451827|560828703|FG003|Overall Study|Lost to Follow-up|2|||
155380914|NCT01451827|560828700|FG000|Overall Study|Participant met withdrawal criteria|0|||
155380915|NCT01451827|560828701|FG001|Overall Study|Participant met withdrawal criteria|2|||
155380916|NCT01451827|560828702|FG002|Overall Study|Participant met withdrawal criteria|0|||
155380917|NCT01451827|560828703|FG003|Overall Study|Participant met withdrawal criteria|0|||
155380918|NCT01451827|560828700|FG000|Overall Study|Withdrawal by Subject|0|||
155380919|NCT01451827|560828701|FG001|Overall Study|Withdrawal by Subject|0|||
155380920|NCT01451827|560828702|FG002|Overall Study|Withdrawal by Subject|1|||
155380921|NCT01451827|560828703|FG003|Overall Study|Withdrawal by Subject|1|||
155380922|NCT01964924|560828704|FG000|Trametinib Monotherapy|Progression|19|||
155380923|NCT01964924|560828705|FG001|Trametinib Monotherapy|Progression|0|||
155380924|NCT01528345|560828706|FG000|Overall Study|Adverse Event|10|||
155380925|NCT01528345|560828707|FG001|Overall Study|Adverse Event|1|||
155380926|NCT01528345|560828706|FG000|Overall Study|Death|1|||
155380927|NCT01528345|560828707|FG001|Overall Study|Death|1|||
155380928|NCT01528345|560828706|FG000|Overall Study|Non-compliance with study treatment|1|||
155380929|NCT01528345|560828707|FG001|Overall Study|Non-compliance with study treatment|0|||
155380930|NCT01528345|560828706|FG000|Overall Study|Progressive Disease|26|||
155380931|NCT01528345|560828707|FG001|Overall Study|Progressive Disease|40|||
155380932|NCT01528345|560828706|FG000|Overall Study|Study Terminated by Sponsor|4|||
155380933|NCT01528345|560828707|FG001|Overall Study|Study Terminated by Sponsor|8|||
155380934|NCT01528345|560828706|FG000|Overall Study|Subject/Guardian Decision|5|||
155380935|NCT01528345|560828707|FG001|Overall Study|Subject/Guardian Decision|0|||
155380936|NCT01034163|560828708|FG000|Overall Study|Treatment completed as per protocol|8|||
155380937|NCT01034163|560828709|FG001|Overall Study|Treatment completed as per protocol|7|||
155380938|NCT01034163|560828708|FG000|Overall Study|Withdrawal by Subject|8|||
155380939|NCT01034163|560828709|FG001|Overall Study|Withdrawal by Subject|2|||
155380940|NCT01034163|560828708|FG000|Overall Study|Protocol deviation|1|||
155380941|NCT01034163|560828709|FG001|Overall Study|Protocol deviation|0|||
155380942|NCT01034163|560828708|FG000|Overall Study|Disease progression|3|||
155380943|NCT01034163|560828709|FG001|Overall Study|Disease progression|4|||
155380944|NCT01034163|560828708|FG000|Overall Study|Adverse Event|6|||
155380945|NCT01034163|560828709|FG001|Overall Study|Adverse Event|0|||
155380946|NCT01034163|560828708|FG000|Overall Study|Administrative problems|0|||
155380947|NCT01034163|560828709|FG001|Overall Study|Administrative problems|1|||
155380948|NCT01034163|560828708|FG000|Overall Study|Abnormal laboratory value|1|||
155380949|NCT01034163|560828709|FG001|Overall Study|Abnormal laboratory value|0|||
155380950|NCT02424734|560828710|FG000|Overall Study|Treatment stopped to be discharged home|2|||
155380951|NCT02424734|560828711|FG001|Overall Study|Treatment stopped to be discharged home|2|||
155380952|NCT02424734|560828712|FG002|Overall Study|Treatment stopped to be discharged home|0|||
155380953|NCT01445301|560828713|FG000|Overall Study|Adverse Event|15|||
155380954|NCT01445301|560828714|FG001|Overall Study|Adverse Event|25|||
155380955|NCT01445301|560828715|FG002|Overall Study|Adverse Event|4|||
155380956|NCT01445301|560828713|FG000|Overall Study|Lack of Efficacy|0|||
155380957|NCT01445301|560828714|FG001|Overall Study|Lack of Efficacy|1|||
155380958|NCT01445301|560828715|FG002|Overall Study|Lack of Efficacy|0|||
155380959|NCT01445301|560828713|FG000|Overall Study|Protocol Violation|1|||
155380960|NCT01445301|560828714|FG001|Overall Study|Protocol Violation|0|||
155380961|NCT01445301|560828715|FG002|Overall Study|Protocol Violation|0|||
155380962|NCT01445301|560828713|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
155380963|NCT01445301|560828714|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
155380964|NCT01445301|560828715|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
155380965|NCT01445301|560828713|FG000|Overall Study|Physician Decision|0|||
155380966|NCT01445301|560828714|FG001|Overall Study|Physician Decision|2|||
155380967|NCT01445301|560828715|FG002|Overall Study|Physician Decision|0|||
155380968|NCT01445301|560828713|FG000|Overall Study|Withdrawal by Subject|5|||
155380969|NCT01445301|560828714|FG001|Overall Study|Withdrawal by Subject|6|||
155380970|NCT01445301|560828715|FG002|Overall Study|Withdrawal by Subject|4|||
155380971|NCT00752557|560828716|FG000|Overall Study|Withdrawal by Subject|4|||
155380972|NCT00752557|560828717|FG001|Overall Study|Withdrawal by Subject|3|||
155380973|NCT00752557|560828718|FG002|Overall Study|Withdrawal by Subject|3|||
155380974|NCT00752557|560828716|FG000|Overall Study|Unspecified resaons|0|||
155380975|NCT00752557|560828717|FG001|Overall Study|Unspecified resaons|2|||
155380976|NCT00752557|560828718|FG002|Overall Study|Unspecified resaons|2|||
155380977|NCT00752557|560828716|FG000|Overall Study|Lost to Follow-up|1|||
155380978|NCT00752557|560828717|FG001|Overall Study|Lost to Follow-up|0|||
155380979|NCT00752557|560828718|FG002|Overall Study|Lost to Follow-up|1|||
155380980|NCT02150343|560828723|FG000|Overall Study|Adverse Event|2|||
155380981|NCT02150343|560828724|FG001|Overall Study|Adverse Event|0|||
155380982|NCT02150343|560828725|FG002|Overall Study|Adverse Event|1|||
155380983|NCT02150343|560828726|FG003|Overall Study|Adverse Event|1|||
155380984|NCT02150343|560828723|FG000|Overall Study|Withdrawal by Subject|13|||
155380985|NCT02150343|560828724|FG001|Overall Study|Withdrawal by Subject|10|||
155380986|NCT02150343|560828725|FG002|Overall Study|Withdrawal by Subject|9|||
155380987|NCT02150343|560828726|FG003|Overall Study|Withdrawal by Subject|4|||
155380988|NCT02150343|560828723|FG000|Overall Study|Lost to Follow-up|4|||
155380989|NCT02150343|560828724|FG001|Overall Study|Lost to Follow-up|4|||
155380990|NCT02150343|560828725|FG002|Overall Study|Lost to Follow-up|2|||
155380991|NCT02150343|560828726|FG003|Overall Study|Lost to Follow-up|3|||
155380992|NCT02150343|560828723|FG000|Overall Study|Other|2|||
155380993|NCT02150343|560828724|FG001|Overall Study|Other|6|||
155380994|NCT02150343|560828725|FG002|Overall Study|Other|0|||
155380995|NCT02150343|560828726|FG003|Overall Study|Other|2|||
155380996|NCT00190749|560828727|FG000|Overall Study|Lost to Follow-up|8|||
155380997|NCT00190749|560828728|FG001|Overall Study|Lost to Follow-up|11|||
155380998|NCT00190749|560828727|FG000|Overall Study|Withdrawal by Subject|10|||
155380999|NCT00190749|560828728|FG001|Overall Study|Withdrawal by Subject|6|||
155381000|NCT00190749|560828727|FG000|Overall Study|Protocol Violation|5|||
155381001|NCT00190749|560828728|FG001|Overall Study|Protocol Violation|4|||
155381002|NCT00190749|560828727|FG000|Overall Study|Adverse Event|0|||
155381003|NCT00190749|560828728|FG001|Overall Study|Adverse Event|5|||
155381004|NCT00190749|560828727|FG000|Overall Study|Lack of Efficacy|2|||
155722580|NCT02318706|562083884|FG000|Double-blind Phase|Other|4|||
155381005|NCT00190749|560828728|FG001|Overall Study|Lack of Efficacy|3|||
155381006|NCT00190749|560828727|FG000|Overall Study|Reason Not Specified|0|||
155381007|NCT00190749|560828728|FG001|Overall Study|Reason Not Specified|2|||
155381008|NCT00190749|560828727|FG000|Overall Study|Sponsor Decision|1|||
155381009|NCT00190749|560828728|FG001|Overall Study|Sponsor Decision|0|||
155381010|NCT02729753|560828729|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
155381011|NCT02729753|560828730|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
155381012|NCT01090427|560828731|FG000|After Controlled Period|Death|0|||
155381013|NCT01090427|560828732|FG001|After Controlled Period|Death|0|||
155608265|NCT02603107|561655091|FG000|Randomized Phase|Adverse Event|2|||
155608266|NCT02603107|561655092|FG001|Randomized Phase|Adverse Event|0|||
155608267|NCT02603107|561655091|FG000|Randomized Phase|Death|1|||
155608268|NCT02603107|561655092|FG001|Randomized Phase|Death|1|||
155608269|NCT02603107|561655091|FG000|Randomized Phase|Non-compliance with study drug|1|||
155608270|NCT02603107|561655092|FG001|Randomized Phase|Non-compliance with study drug|1|||
155608271|NCT02603107|561655091|FG000|Randomized Phase|Investigator's discretion|0|||
155608272|NCT02603107|561655092|FG001|Randomized Phase|Investigator's discretion|1|||
155608273|NCT02603107|561655091|FG000|Randomized Phase|Lack of Efficacy|1|||
155608274|NCT02603107|561655092|FG001|Randomized Phase|Lack of Efficacy|0|||
155608275|NCT02603107|561655091|FG000|Randomized Phase|Protocol Violation|1|||
155608276|NCT02603107|561655092|FG001|Randomized Phase|Protocol Violation|0|||
155608277|NCT02603107|561655091|FG000|Optional Extension Phase|Lost to Follow-up|3|||
155608278|NCT02603107|561655092|FG001|Optional Extension Phase|Lost to Follow-up|3|||
155608279|NCT02603107|561655091|FG000|Optional Extension Phase|Withdrew consent|3|||
155608280|NCT02603107|561655092|FG001|Optional Extension Phase|Withdrew consent|2|||
155608281|NCT02603107|561655091|FG000|Optional Extension Phase|Investigator's discretion|2|||
155608282|NCT02603107|561655092|FG001|Optional Extension Phase|Investigator's discretion|2|||
155608283|NCT02603107|561655091|FG000|Optional Extension Phase|Pregnancy|0|||
155608284|NCT02603107|561655092|FG001|Optional Extension Phase|Pregnancy|3|||
155608285|NCT02603107|561655091|FG000|Optional Extension Phase|Adverse Event|0|||
155608286|NCT02603107|561655092|FG001|Optional Extension Phase|Adverse Event|2|||
155608287|NCT02603107|561655091|FG000|Optional Extension Phase|Not treated in extension phase|0|||
155608288|NCT02603107|561655092|FG001|Optional Extension Phase|Not treated in extension phase|1|||
155608289|NCT02603107|561655091|FG000|Optional Extension Phase|Protocol Violation|1|||
155608290|NCT02603107|561655092|FG001|Optional Extension Phase|Protocol Violation|0|||
155608291|NCT01693185|561655094|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
155608292|NCT01693185|561655095|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
155608293|NCT00419159|561655096|FG000|Overall Study|Adverse Event|7|||
155608294|NCT00419159|561655097|FG001|Overall Study|Adverse Event|15|||
155608295|NCT00419159|561655096|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155608296|NCT00419159|561655097|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155608297|NCT00419159|561655096|FG000|Overall Study|Subject's no longer requires study drug|0|||
155608298|NCT00419159|561655097|FG001|Overall Study|Subject's no longer requires study drug|1|||
155608299|NCT00419159|561655096|FG000|Overall Study|Protocol Violation|1|||
155608300|NCT00419159|561655097|FG001|Overall Study|Protocol Violation|0|||
155608301|NCT00419159|561655096|FG000|Overall Study|Withdrawal by Subject|10|||
155608302|NCT00419159|561655097|FG001|Overall Study|Withdrawal by Subject|3|||
155608303|NCT00419159|561655096|FG000|Overall Study|Lost to Follow-up|0|||
155608304|NCT00419159|561655097|FG001|Overall Study|Lost to Follow-up|1|||
155608305|NCT00419159|561655096|FG000|Overall Study|Death|2|||
155608306|NCT00419159|561655097|FG001|Overall Study|Death|2|||
155608307|NCT00419159|561655096|FG000|Overall Study|Disease progression|79|||
155608308|NCT00419159|561655097|FG001|Overall Study|Disease progression|76|||
155608309|NCT01017601|561655098|FG000|Overall Study|Disease Progression|12|||
155608310|NCT01017601|561655099|FG001|Overall Study|Disease Progression|12|||
155608311|NCT01017601|561655098|FG000|Overall Study|Withdrawal by Subject|0|||
155608312|NCT01017601|561655099|FG001|Overall Study|Withdrawal by Subject|1|||
155608313|NCT01857102|561655100|FG000|Period 1|No longer meets Eligibility Criteria|0|||
155608314|NCT01857102|561655101|FG001|Period 1|No longer meets Eligibility Criteria|2|||
155608315|NCT01857102|561655100|FG000|Period 1|Lost to Follow-up|0|||
155608316|NCT01857102|561655101|FG001|Period 1|Lost to Follow-up|3|||
155608317|NCT01857102|561655100|FG000|Period 1|Unsatisfactory Lens Fit|1|||
155608318|NCT01857102|561655101|FG001|Period 1|Unsatisfactory Lens Fit|0|||
155608319|NCT01857102|561655100|FG000|Period 1|Unsatisfactory Visual Response|1|||
155608320|NCT01857102|561655101|FG001|Period 1|Unsatisfactory Visual Response|0|||
155608321|NCT01857102|561655100|FG000|Period 1|Physician Decision|1|||
155608322|NCT01857102|561655101|FG001|Period 1|Physician Decision|0|||
155608323|NCT01857102|561655100|FG000|Period 2|Lens Discomfort|1|||
155608324|NCT01857102|561655101|FG001|Period 2|Lens Discomfort|0|||
155608325|NCT01857102|561655100|FG000|Period 2|Unsatisfactory Lens Fit|1|||
155608326|NCT01857102|561655101|FG001|Period 2|Unsatisfactory Lens Fit|0|||
155608327|NCT02117713|561655114|FG000|Week 48|Adverse Event|4|||
155608328|NCT02117713|561655114|FG000|Week 48|Withdrawal by caregiver|2|||
155608329|NCT02117713|561655114|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
155608330|NCT02117713|561655114|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
155608331|NCT02117713|561655114|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
155608332|NCT02117713|561655114|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
155608333|NCT01094782|561655115|FG000|Overall Study|Withdrawal by Subject|5|||
155608334|NCT01094782|561655116|FG001|Overall Study|Withdrawal by Subject|5|||
155608335|NCT01094782|561655117|FG002|Overall Study|Withdrawal by Subject|1|||
155608336|NCT01094782|561655118|FG003|Overall Study|Withdrawal by Subject|5|||
155608337|NCT01094782|561655119|FG004|Overall Study|Withdrawal by Subject|5|||
155608338|NCT01094782|561655120|FG005|Overall Study|Withdrawal by Subject|0|||
155608339|NCT01094782|561655115|FG000|Overall Study|Lost to Follow-up|1|||
155608340|NCT01094782|561655116|FG001|Overall Study|Lost to Follow-up|0|||
155608341|NCT01094782|561655117|FG002|Overall Study|Lost to Follow-up|0|||
155608342|NCT01094782|561655118|FG003|Overall Study|Lost to Follow-up|2|||
155608343|NCT01094782|561655119|FG004|Overall Study|Lost to Follow-up|1|||
155608344|NCT01094782|561655120|FG005|Overall Study|Lost to Follow-up|4|||
155608345|NCT01094782|561655115|FG000|Overall Study|Positive Drug Screen|2|||
155608346|NCT01094782|561655116|FG001|Overall Study|Positive Drug Screen|2|||
155608347|NCT01094782|561655117|FG002|Overall Study|Positive Drug Screen|1|||
155608348|NCT01094782|561655118|FG003|Overall Study|Positive Drug Screen|1|||
155608349|NCT01094782|561655119|FG004|Overall Study|Positive Drug Screen|3|||
155608350|NCT01094782|561655120|FG005|Overall Study|Positive Drug Screen|2|||
155608351|NCT01094782|561655115|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
155608352|NCT01094782|561655116|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
155608353|NCT01094782|561655117|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
155608354|NCT01094782|561655118|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
155608355|NCT01094782|561655119|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
155608356|NCT01094782|561655120|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
155608357|NCT01094782|561655115|FG000|Overall Study|Unable to Complete Questionnaires|0|||
155608358|NCT01094782|561655116|FG001|Overall Study|Unable to Complete Questionnaires|1|||
155608359|NCT01094782|561655117|FG002|Overall Study|Unable to Complete Questionnaires|0|||
155608360|NCT01094782|561655118|FG003|Overall Study|Unable to Complete Questionnaires|0|||
155608361|NCT01094782|561655119|FG004|Overall Study|Unable to Complete Questionnaires|0|||
155608362|NCT01094782|561655120|FG005|Overall Study|Unable to Complete Questionnaires|0|||
155608363|NCT01094782|561655115|FG000|Overall Study|Healthy Subject Had Pain|0|||
155381014|NCT01090427|560828733|FG002|After Controlled Period|Death|0|||
155381015|NCT01090427|560828734|FG003|After Controlled Period|Death|0|||
155381016|NCT01090427|560828735|FG004|After Controlled Period|Death|0|||
155381017|NCT01090427|560828736|FG005|After Controlled Period|Death|1|||
155381018|NCT01090427|560828737|FG006|After Controlled Period|Death|0|||
155381019|NCT01090427|560828731|FG000|After Controlled Period|Lack of Efficacy|0|||
155381020|NCT01090427|560828732|FG001|After Controlled Period|Lack of Efficacy|0|||
155381021|NCT01090427|560828733|FG002|After Controlled Period|Lack of Efficacy|0|||
155381022|NCT01090427|560828734|FG003|After Controlled Period|Lack of Efficacy|0|||
155381023|NCT01090427|560828735|FG004|After Controlled Period|Lack of Efficacy|0|||
155381024|NCT01090427|560828736|FG005|After Controlled Period|Lack of Efficacy|3|||
155381025|NCT01090427|560828737|FG006|After Controlled Period|Lack of Efficacy|2|||
155381026|NCT01090427|560828731|FG000|After Controlled Period|Adverse Event|0|||
155381027|NCT01090427|560828732|FG001|After Controlled Period|Adverse Event|0|||
155381028|NCT01090427|560828733|FG002|After Controlled Period|Adverse Event|0|||
155381029|NCT01090427|560828734|FG003|After Controlled Period|Adverse Event|2|||
155381030|NCT01090427|560828735|FG004|After Controlled Period|Adverse Event|0|||
155381031|NCT01090427|560828736|FG005|After Controlled Period|Adverse Event|1|||
155381032|NCT01090427|560828737|FG006|After Controlled Period|Adverse Event|0|||
155381033|NCT00928018|560828745|FG000|Overall Study|Withdrawal by Subject|1|||
155381034|NCT00928018|560828746|FG001|Overall Study|Withdrawal by Subject|0|||
155381035|NCT02008877|560828747|FG000|Overall Study|Inevaluable|0|||
155381036|NCT02008877|560828748|FG001|Overall Study|Inevaluable|1|||
155381037|NCT02008877|560828749|FG002|Overall Study|Inevaluable|0|||
155381038|NCT04227704|560828752|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
155381039|NCT04227704|560828753|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
155381040|NCT04227704|560828754|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
155381041|NCT04227704|560828752|FG000|Overall Study|due to C/S being cancelled|1|||
155381042|NCT04227704|560828753|FG001|Overall Study|due to C/S being cancelled|0|||
155381043|NCT04227704|560828754|FG002|Overall Study|due to C/S being cancelled|0|||
155381044|NCT02317432|560828755|FG000|Overall Study|Death|4|||
155381045|NCT02317432|560828756|FG001|Overall Study|Death|1|||
155381046|NCT02317432|560828755|FG000|Overall Study|Lost to Follow-up|0|||
155381047|NCT02317432|560828756|FG001|Overall Study|Lost to Follow-up|5|||
155381048|NCT02317432|560828755|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
155608364|NCT01094782|561655116|FG001|Overall Study|Healthy Subject Had Pain|1|||
155608365|NCT01094782|561655117|FG002|Overall Study|Healthy Subject Had Pain|0|||
155608366|NCT01094782|561655118|FG003|Overall Study|Healthy Subject Had Pain|0|||
155608367|NCT01094782|561655119|FG004|Overall Study|Healthy Subject Had Pain|0|||
155608368|NCT01094782|561655120|FG005|Overall Study|Healthy Subject Had Pain|0|||
155608369|NCT01094782|561655115|FG000|Overall Study|Hypertension|0|||
155608370|NCT01094782|561655116|FG001|Overall Study|Hypertension|0|||
155608371|NCT01094782|561655117|FG002|Overall Study|Hypertension|1|||
155608372|NCT01094782|561655118|FG003|Overall Study|Hypertension|0|||
155608373|NCT01094782|561655119|FG004|Overall Study|Hypertension|0|||
155608374|NCT01094782|561655120|FG005|Overall Study|Hypertension|0|||
155650558|NCT00147537|561812506|FG004|Phase 2|Other|0|||
155381049|NCT02317432|560828756|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
155381050|NCT00156819|560830794|FG000|Overall Study|Lost to Follow-up|1|||
155381051|NCT00156819|560830795|FG001|Overall Study|Lost to Follow-up|1|||
155381052|NCT00156819|560830796|FG002|Overall Study|Lost to Follow-up|3|||
155381053|NCT02808143|560830797|FG000|Maintenance Phase|Disease recurrence|1|||
155608375|NCT01094782|561655115|FG000|Overall Study|Wrong Pain Condition|0|||
155608376|NCT01094782|561655116|FG001|Overall Study|Wrong Pain Condition|0|||
155608377|NCT01094782|561655117|FG002|Overall Study|Wrong Pain Condition|0|||
155608378|NCT01094782|561655118|FG003|Overall Study|Wrong Pain Condition|2|||
155608379|NCT01094782|561655119|FG004|Overall Study|Wrong Pain Condition|1|||
155608380|NCT01094782|561655120|FG005|Overall Study|Wrong Pain Condition|1|||
155608381|NCT01094782|561655115|FG000|Overall Study|Recent Interventional Injection|0|||
155608382|NCT01094782|561655116|FG001|Overall Study|Recent Interventional Injection|0|||
155608383|NCT01094782|561655117|FG002|Overall Study|Recent Interventional Injection|0|||
155608384|NCT01094782|561655118|FG003|Overall Study|Recent Interventional Injection|0|||
155608385|NCT01094782|561655119|FG004|Overall Study|Recent Interventional Injection|0|||
155608386|NCT01094782|561655120|FG005|Overall Study|Recent Interventional Injection|1|||
155608387|NCT01094782|561655115|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155608388|NCT01094782|561655116|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155608389|NCT01094782|561655117|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155608390|NCT01094782|561655118|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155608391|NCT01094782|561655119|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
155608392|NCT01094782|561655120|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155608393|NCT01094782|561655115|FG000|Overall Study|Noncompliance With Study Schedule|0|||
155608394|NCT01094782|561655116|FG001|Overall Study|Noncompliance With Study Schedule|0|||
155608395|NCT01094782|561655117|FG002|Overall Study|Noncompliance With Study Schedule|0|||
155608396|NCT01094782|561655118|FG003|Overall Study|Noncompliance With Study Schedule|1|||
155608397|NCT01094782|561655119|FG004|Overall Study|Noncompliance With Study Schedule|0|||
155608398|NCT01094782|561655120|FG005|Overall Study|Noncompliance With Study Schedule|0|||
155608399|NCT02073656|561655123|FG000|Primary Study|Lost to Follow-up|6|||
155608400|NCT02073656|561655123|FG000|Primary Study|Death|1|||
155608401|NCT02073656|561655123|FG000|Primary Study|Withdrew Consent|1|||
155608402|NCT02054910|561655126|FG000|Overall Study|Lost to Follow-up|4|||
155608403|NCT02054910|561655127|FG001|Overall Study|Lost to Follow-up|1|||
155608404|NCT01625689|561655128|FG000|Overall Study|Migration|2|||
155608405|NCT01625689|561655129|FG001|Overall Study|Migration|1|||
155608406|NCT02208050|561655136|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
155608407|NCT02208050|561655137|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
155608408|NCT03806231|561655138|FG000|Overall Study|Physician Decision|1|||
155608409|NCT03806231|561655139|FG001|Overall Study|Physician Decision|0|||
155608410|NCT03806231|561655138|FG000|Overall Study|Withdrawal by Subject|1|||
155608411|NCT03806231|561655139|FG001|Overall Study|Withdrawal by Subject|0|||
155608412|NCT00467961|561655140|FG000|Overall Study|Technical Failures|5|||
155608413|NCT00467961|561655140|FG000|Overall Study|Disease Progression|2|||
155608414|NCT02429310|561655142|FG000|Overall Study|Lost to Follow-up|1|||
155608415|NCT02429310|561655143|FG001|Overall Study|Lost to Follow-up|2|||
155608416|NCT02429310|561655142|FG000|Overall Study|Protocol Violation|1|||
155608417|NCT02429310|561655143|FG001|Overall Study|Protocol Violation|1|||
155608418|NCT00394433|561655144|FG000|Overall Study|Adverse Event|2|||
155608419|NCT00394433|561655144|FG000|Overall Study|Alternative Therapy|1|||
155608420|NCT03646305|561655145|FG000|Overall Study|Lost to Follow-up|4|||
155608421|NCT03646305|561655146|FG001|Overall Study|Lost to Follow-up|2|||
155608422|NCT03646305|561655147|FG002|Overall Study|Lost to Follow-up|2|||
155608423|NCT03646305|561655148|FG003|Overall Study|Lost to Follow-up|1|||
155608424|NCT03646305|561655145|FG000|Overall Study|Withdrawal by Subject|1|||
155608425|NCT03646305|561655146|FG001|Overall Study|Withdrawal by Subject|0|||
155608426|NCT03646305|561655147|FG002|Overall Study|Withdrawal by Subject|0|||
155608427|NCT03646305|561655148|FG003|Overall Study|Withdrawal by Subject|1|||
155608428|NCT01554176|561655149|FG000|Treatment Phase|Protocol Violation|1|||
155608429|NCT01554176|561655150|FG001|Treatment Phase|Protocol Violation|2|||
155608430|NCT01554176|561655151|FG002|Treatment Phase|Protocol Violation|0|||
155608431|NCT01554176|561655152|FG003|Treatment Phase|Protocol Violation|0|||
155608432|NCT01554176|561655153|FG004|Treatment Phase|Protocol Violation|0|||
155608433|NCT01554176|561655149|FG000|Treatment Phase|Physician Decision|1|||
155608434|NCT01554176|561655150|FG001|Treatment Phase|Physician Decision|1|||
155608435|NCT01554176|561655151|FG002|Treatment Phase|Physician Decision|0|||
155608436|NCT01554176|561655152|FG003|Treatment Phase|Physician Decision|0|||
155608437|NCT01554176|561655153|FG004|Treatment Phase|Physician Decision|0|||
155608438|NCT01554176|561655149|FG000|Treatment Phase|Lack of Efficacy|0|||
155608439|NCT01554176|561655150|FG001|Treatment Phase|Lack of Efficacy|1|||
155608440|NCT01554176|561655151|FG002|Treatment Phase|Lack of Efficacy|0|||
155608441|NCT01554176|561655152|FG003|Treatment Phase|Lack of Efficacy|0|||
155608442|NCT01554176|561655153|FG004|Treatment Phase|Lack of Efficacy|0|||
155608443|NCT01554176|561655149|FG000|Treatment Phase|Adverse event, non-fatal|1|||
155608444|NCT01554176|561655150|FG001|Treatment Phase|Adverse event, non-fatal|1|||
155608445|NCT01554176|561655151|FG002|Treatment Phase|Adverse event, non-fatal|0|||
155608446|NCT01554176|561655152|FG003|Treatment Phase|Adverse event, non-fatal|0|||
155608447|NCT01554176|561655153|FG004|Treatment Phase|Adverse event, non-fatal|0|||
155608448|NCT01554176|561655149|FG000|Treatment Phase|Non-compliance with study drug|1|||
155722581|NCT02318706|562083885|FG001|Double-blind Phase|Other|1|||
155608449|NCT01554176|561655150|FG001|Treatment Phase|Non-compliance with study drug|0|||
155608450|NCT01554176|561655151|FG002|Treatment Phase|Non-compliance with study drug|0|||
155608451|NCT01554176|561655152|FG003|Treatment Phase|Non-compliance with study drug|0|||
155608452|NCT01554176|561655153|FG004|Treatment Phase|Non-compliance with study drug|0|||
155608453|NCT01554176|561655149|FG000|Treatment Phase|Withdrawal by Subject|1|||
155608454|NCT01554176|561655150|FG001|Treatment Phase|Withdrawal by Subject|0|||
155608455|NCT01554176|561655151|FG002|Treatment Phase|Withdrawal by Subject|0|||
155608456|NCT01554176|561655152|FG003|Treatment Phase|Withdrawal by Subject|0|||
155608457|NCT01554176|561655153|FG004|Treatment Phase|Withdrawal by Subject|0|||
155608458|NCT01554176|561655149|FG000|Treatment Phase|Lost to Follow-up|3|||
155608459|NCT01554176|561655150|FG001|Treatment Phase|Lost to Follow-up|0|||
155608460|NCT01554176|561655151|FG002|Treatment Phase|Lost to Follow-up|0|||
155608461|NCT01554176|561655152|FG003|Treatment Phase|Lost to Follow-up|0|||
155608462|NCT01554176|561655153|FG004|Treatment Phase|Lost to Follow-up|0|||
155608463|NCT01554176|561655149|FG000|Run-out Phase|Protocol Violation|0|||
155608464|NCT01554176|561655150|FG001|Run-out Phase|Protocol Violation|0|||
155608465|NCT01554176|561655151|FG002|Run-out Phase|Protocol Violation|0|||
155608466|NCT01554176|561655152|FG003|Run-out Phase|Protocol Violation|1|||
155608467|NCT01554176|561655153|FG004|Run-out Phase|Protocol Violation|0|||
155608468|NCT02678000|561655154|FG000|PART 2|Adverse Event|0|||
155608469|NCT02678000|561655155|FG001|PART 2|Adverse Event|0|||
155608470|NCT02678000|561655156|FG002|PART 2|Adverse Event|2|||
155608471|NCT02678000|561655157|FG003|PART 2|Adverse Event|1|||
155608472|NCT02678000|561655158|FG004|PART 2|Adverse Event|0|||
155608473|NCT02678000|561655154|FG000|PART 2|Withdrawal by Subject|0|||
155608474|NCT02678000|561655155|FG001|PART 2|Withdrawal by Subject|0|||
155608475|NCT02678000|561655156|FG002|PART 2|Withdrawal by Subject|1|||
155608476|NCT02678000|561655157|FG003|PART 2|Withdrawal by Subject|0|||
155608477|NCT02678000|561655158|FG004|PART 2|Withdrawal by Subject|0|||
155608478|NCT03759366|561655159|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
155608479|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
155608480|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
155608481|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
155608482|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
155608483|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
155608484|NCT03759366|561655159|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
155608485|NCT00539032|561655160|FG000|Overall Study|Withdrawal by Subject|2|||
155608486|NCT00539032|561655161|FG001|Overall Study|Withdrawal by Subject|1|||
155608487|NCT01653327|561655162|FG000|Overall Study|Withdrawal by Subject|1|||
155608488|NCT01859949|561656717|FG000|Overall Study|Family Matters|0|||
155608489|NCT01859949|561656718|FG001|Overall Study|Family Matters|1|||
155608490|NCT01859949|561656717|FG000|Overall Study|Physician Decision|2|||
155608491|NCT01859949|561656718|FG001|Overall Study|Physician Decision|4|||
155608492|NCT01859949|561656717|FG000|Overall Study|Withdrawal by Subject|11|||
155608493|NCT01859949|561656718|FG001|Overall Study|Withdrawal by Subject|10|||
155608494|NCT01859949|561656717|FG000|Overall Study|Protocol Violation|1|||
155608495|NCT01859949|561656718|FG001|Overall Study|Protocol Violation|1|||
155608496|NCT01859949|561656717|FG000|Overall Study|Adverse Event|0|||
155608497|NCT01859949|561656718|FG001|Overall Study|Adverse Event|1|||
155608498|NCT03041467|561656719|FG000|Overall Study|Death|46|||
155608499|NCT03041467|561656720|FG001|Overall Study|Death|39|||
155608500|NCT03041467|561656719|FG000|Overall Study|Withdrawal by Subject|36|||
155608501|NCT03041467|561656720|FG001|Overall Study|Withdrawal by Subject|37|||
155608502|NCT03041467|561656719|FG000|Overall Study|Lost to Follow-up|6|||
155608503|NCT03041467|561656720|FG001|Overall Study|Lost to Follow-up|8|||
155608504|NCT03041467|561656719|FG000|Overall Study|Declined consent for study extension|21|||
155608505|NCT03041467|561656720|FG001|Overall Study|Declined consent for study extension|33|||
155608506|NCT03041467|561656719|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
155608507|NCT03041467|561656720|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
155608508|NCT04228965|561656724|FG000|Overall Study|Lost to Follow-up|26|||
155608509|NCT04228965|561656725|FG001|Overall Study|Lost to Follow-up|11|||
155608510|NCT04228965|561656724|FG000|Overall Study|Withdrawal by Subject|18|||
155608511|NCT04228965|561656725|FG001|Overall Study|Withdrawal by Subject|5|||
155608512|NCT00734656|561656728|FG000|Lab Session 1|Withdrawal by Subject|2|||
155608513|NCT00734656|561656729|FG001|Lab Session 1|Withdrawal by Subject|0|||
155608514|NCT00734656|561656730|FG002|Lab Session 1|Withdrawal by Subject|0|||
155608515|NCT00734656|561656731|FG003|Lab Session 1|Withdrawal by Subject|0|||
155608516|NCT00734656|561656728|FG000|Washout 1|Withdrawal by Subject|1|||
155608517|NCT00734656|561656729|FG001|Washout 1|Withdrawal by Subject|5|||
155608518|NCT00734656|561656730|FG002|Washout 1|Withdrawal by Subject|2|||
155608519|NCT00734656|561656731|FG003|Washout 1|Withdrawal by Subject|3|||
155608520|NCT00734656|561656728|FG000|Lab Session 2|Withdrawal by Subject|1|||
155608521|NCT00734656|561656729|FG001|Lab Session 2|Withdrawal by Subject|0|||
155608522|NCT00734656|561656730|FG002|Lab Session 2|Withdrawal by Subject|0|||
155608523|NCT00734656|561656731|FG003|Lab Session 2|Withdrawal by Subject|1|||
155608524|NCT00734656|561656728|FG000|Washout 2|Withdrawal by Subject|1|||
155608525|NCT00734656|561656729|FG001|Washout 2|Withdrawal by Subject|1|||
155608526|NCT00734656|561656730|FG002|Washout 2|Withdrawal by Subject|1|||
155608527|NCT00734656|561656731|FG003|Washout 2|Withdrawal by Subject|0|||
155608528|NCT00734656|561656728|FG000|Washout 3|Withdrawal by Subject|1|||
155608529|NCT00734656|561656729|FG001|Washout 3|Withdrawal by Subject|0|||
155608530|NCT00734656|561656730|FG002|Washout 3|Withdrawal by Subject|0|||
155608531|NCT00734656|561656731|FG003|Washout 3|Withdrawal by Subject|1|||
155608532|NCT00734656|561656728|FG000|Lab Session 4|Withdrawal by Subject|0|||
155608533|NCT00734656|561656729|FG001|Lab Session 4|Withdrawal by Subject|0|||
155608534|NCT00734656|561656730|FG002|Lab Session 4|Withdrawal by Subject|0|||
155608535|NCT00734656|561656731|FG003|Lab Session 4|Withdrawal by Subject|1|||
155608536|NCT03214679|561656732|FG000|Overall Study|Lost to Follow-up|12|||
155608537|NCT03214679|561656733|FG001|Overall Study|Lost to Follow-up|14|||
155608538|NCT03214679|561656732|FG000|Overall Study|not eligible|2|||
155608539|NCT03214679|561656733|FG001|Overall Study|not eligible|0|||
155608540|NCT00298363|561656739|FG000|Overall Study|Lost to Follow-up|0|||
155608541|NCT00298363|561656740|FG001|Overall Study|Lost to Follow-up|0|||
155608542|NCT00298363|561656741|FG002|Overall Study|Lost to Follow-up|1|||
155608543|NCT00298363|561656739|FG000|Overall Study|Physician Decision|4|||
155608544|NCT00298363|561656740|FG001|Overall Study|Physician Decision|1|||
155608545|NCT00298363|561656741|FG002|Overall Study|Physician Decision|0|||
155608546|NCT00298363|561656739|FG000|Overall Study|Protocol Violation|1|||
155381054|NCT02808143|560830798|FG001|Maintenance Phase|Disease recurrence|3|||
155381055|NCT02808143|560830797|FG000|Maintenance Phase|Disease progression|1|||
155381056|NCT02808143|560830798|FG001|Maintenance Phase|Disease progression|2|||
155381057|NCT02808143|560830797|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
155381058|NCT02808143|560830798|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
155381059|NCT02808143|560830797|FG000|Survival Follow-Up|Disease recurrence|0|||
155381060|NCT02808143|560830798|FG001|Survival Follow-Up|Disease recurrence|2|||
155381061|NCT02808143|560830797|FG000|Survival Follow-Up|Adverse Event|0|||
155381062|NCT02808143|560830798|FG001|Survival Follow-Up|Adverse Event|1|||
155381063|NCT02808143|560830797|FG000|Survival Follow-Up|Death|1|||
155381064|NCT02808143|560830798|FG001|Survival Follow-Up|Death|0|||
155381065|NCT03718533|560830799|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
155381066|NCT03718533|560830799|FG000|Overall Study|Protocol deviation|1|||
155381067|NCT03718533|560830799|FG000|Overall Study|Disease progression|1|||
155381068|NCT03718533|560830799|FG000|Overall Study|Relapse|1|||
155381069|NCT03718533|560830799|FG000|Overall Study|Physician Decision|2|||
155381070|NCT03718533|560830799|FG000|Overall Study|Physician Decision and Adverse Event|1|||
155381071|NCT01248065|560830802|FG000|Overall Study|Lost to Follow-up|3|||
155381072|NCT01248065|560830803|FG001|Overall Study|Lost to Follow-up|5|||
155381073|NCT01248065|560830802|FG000|Overall Study|Withdrawal by Subject|14|||
155381074|NCT01248065|560830803|FG001|Overall Study|Withdrawal by Subject|11|||
155381075|NCT01248065|560830802|FG000|Overall Study|Adverse Event|3|||
155381076|NCT01248065|560830803|FG001|Overall Study|Adverse Event|0|||
155381077|NCT01248065|560830802|FG000|Overall Study|Third treatment failure event|3|||
155381078|NCT01248065|560830803|FG001|Overall Study|Third treatment failure event|1|||
155381079|NCT01248065|560830802|FG000|Overall Study|Other|3|||
155381080|NCT01248065|560830803|FG001|Overall Study|Other|5|||
155381081|NCT02781844|560830807|FG000|Treatment Period 1|Adverse Event|0|||
155381082|NCT02781844|560830808|FG001|Treatment Period 1|Adverse Event|0|||
155381083|NCT02781844|560830809|FG002|Treatment Period 1|Adverse Event|0|||
155381084|NCT02781844|560830810|FG003|Treatment Period 1|Adverse Event|0|||
155381085|NCT02781844|560830811|FG004|Treatment Period 1|Adverse Event|0|||
155381086|NCT02781844|560830812|FG005|Treatment Period 1|Adverse Event|1|||
155381087|NCT02781844|560830813|FG006|Treatment Period 1|Adverse Event|0|||
155381088|NCT02781844|560830814|FG007|Treatment Period 1|Adverse Event|0|||
155381089|NCT04256629|560830817|FG000|Overall Study|Adverse Event|0|||
155381090|NCT04256629|560830818|FG001|Overall Study|Adverse Event|0|||
155381091|NCT04256629|560830819|FG002|Overall Study|Adverse Event|0|||
155381092|NCT04256629|560830820|FG003|Overall Study|Adverse Event|0|||
155381093|NCT04256629|560830821|FG004|Overall Study|Adverse Event|0|||
155381094|NCT04256629|560830822|FG005|Overall Study|Adverse Event|1|||
155608547|NCT00298363|561656740|FG001|Overall Study|Protocol Violation|1|||
155608548|NCT00298363|561656741|FG002|Overall Study|Protocol Violation|0|||
155608549|NCT00298363|561656739|FG000|Overall Study|Withdrawal by Subject|5|||
155608550|NCT00298363|561656740|FG001|Overall Study|Withdrawal by Subject|1|||
155608551|NCT00298363|561656741|FG002|Overall Study|Withdrawal by Subject|3|||
155608552|NCT00298363|561656739|FG000|Overall Study|Adverse Event|5|||
155608553|NCT00298363|561656740|FG001|Overall Study|Adverse Event|2|||
155381095|NCT04256629|560830817|FG000|Overall Study|Protocol Violation|0|||
155381096|NCT04256629|560830818|FG001|Overall Study|Protocol Violation|1|||
155381097|NCT04256629|560830819|FG002|Overall Study|Protocol Violation|0|||
155381098|NCT04256629|560830820|FG003|Overall Study|Protocol Violation|0|||
155381099|NCT04256629|560830821|FG004|Overall Study|Protocol Violation|0|||
155381100|NCT04256629|560830822|FG005|Overall Study|Protocol Violation|0|||
155381101|NCT00321373|560830823|FG000|Overall Study|Adverse Event|0|||
155381102|NCT00321373|560830824|FG001|Overall Study|Adverse Event|0|||
155608554|NCT00298363|561656741|FG002|Overall Study|Adverse Event|2|||
155608555|NCT00298363|561656739|FG000|Overall Study|Lack of Efficacy|2|||
155608556|NCT00298363|561656740|FG001|Overall Study|Lack of Efficacy|3|||
155608557|NCT00298363|561656741|FG002|Overall Study|Lack of Efficacy|0|||
155608558|NCT00135356|561656742|FG000|Overall Study|Adverse Event|6|||
155608559|NCT00135356|561656743|FG001|Overall Study|Adverse Event|2|||
155608560|NCT00135356|561656742|FG000|Overall Study|Lack of Efficacy|2|||
155608561|NCT00135356|561656743|FG001|Overall Study|Lack of Efficacy|0|||
155608562|NCT00135356|561656742|FG000|Overall Study|Lost to Follow-up|3|||
155608563|NCT00135356|561656743|FG001|Overall Study|Lost to Follow-up|1|||
155608564|NCT00135356|561656742|FG000|Overall Study|Surgery for abdominal fat|1|||
155608565|NCT00135356|561656743|FG001|Overall Study|Surgery for abdominal fat|0|||
155608566|NCT00135356|561656742|FG000|Overall Study|Change in antiviral regimen|0|||
155608567|NCT00135356|561656743|FG001|Overall Study|Change in antiviral regimen|1|||
155608568|NCT00135356|561656742|FG000|Overall Study|Poor/noncompliance|1|||
155608569|NCT00135356|561656743|FG001|Overall Study|Poor/noncompliance|1|||
155608570|NCT00135356|561656742|FG000|Overall Study|No longer meets study criteria|2|||
155608571|NCT00135356|561656743|FG001|Overall Study|No longer meets study criteria|0|||
155608572|NCT00135356|561656742|FG000|Overall Study|Withdrawal by Subject|2|||
155608573|NCT00135356|561656743|FG001|Overall Study|Withdrawal by Subject|4|||
155608574|NCT01306214|561656744|FG000|Overall Study|Death|0|||
155608575|NCT01306214|561656745|FG001|Overall Study|Death|0|||
155608576|NCT01306214|561656746|FG002|Overall Study|Death|1|||
155608577|NCT01306214|561656744|FG000|Overall Study|Lost to Follow-up|3|||
155381103|NCT00321373|560830825|FG002|Overall Study|Adverse Event|1|||
155381104|NCT00321373|560830823|FG000|Overall Study|Lost to Follow-up|1|||
155381105|NCT00321373|560830824|FG001|Overall Study|Lost to Follow-up|0|||
155381106|NCT00321373|560830825|FG002|Overall Study|Lost to Follow-up|1|||
155381107|NCT00321373|560830823|FG000|Overall Study|Withdrawal by Subject|1|||
155381108|NCT00321373|560830824|FG001|Overall Study|Withdrawal by Subject|0|||
155381109|NCT00321373|560830825|FG002|Overall Study|Withdrawal by Subject|0|||
155381110|NCT00321373|560830823|FG000|Overall Study|Other|0|||
155381111|NCT00321373|560830824|FG001|Overall Study|Other|0|||
155381112|NCT00321373|560830825|FG002|Overall Study|Other|1|||
155381113|NCT01774487|560830826|FG000|Overall Study|Did not tolerate taste|4|||
155381114|NCT01774487|560830827|FG001|Overall Study|Did not tolerate taste|4|||
155381115|NCT01383499|560830828|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
155381116|NCT01383499|560830829|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381117|NCT01383499|560830830|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381118|NCT01383499|560830831|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381119|NCT00477334|560830832|FG000|Overall Study|Discontinued prior to taking study drug|106|||
155381120|NCT00477334|560830833|FG001|Overall Study|Discontinued prior to taking study drug|53|||
155381121|NCT00477334|560830832|FG000|Overall Study|Adverse Event|1|||
155381122|NCT00477334|560830833|FG001|Overall Study|Adverse Event|2|||
155381123|NCT00477334|560830832|FG000|Overall Study|Withdrawal by Subject|2|||
155381124|NCT00477334|560830833|FG001|Overall Study|Withdrawal by Subject|1|||
155381125|NCT00477334|560830832|FG000|Overall Study|Lost to Follow-up|15|||
155381126|NCT00477334|560830833|FG001|Overall Study|Lost to Follow-up|4|||
155381127|NCT00477334|560830832|FG000|Overall Study|Administrative Problems|39|||
155381128|NCT00477334|560830833|FG001|Overall Study|Administrative Problems|15|||
155381129|NCT00477334|560830832|FG000|Overall Study|Protocol Violation|7|||
155381130|NCT00477334|560830833|FG001|Overall Study|Protocol Violation|1|||
155381131|NCT02572882|560830834|FG000|Overall Study|Withdrawal by Subject|1|||
155381132|NCT02572882|560830834|FG000|Overall Study|Participant received kidney transplant|1|||
155381133|NCT04275089|560830835|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
155381134|NCT01079663|560830839|FG000|Overall Study|Adverse Event|0|||
155381135|NCT01079663|560830840|FG001|Overall Study|Adverse Event|2|||
155381136|NCT01079663|560830839|FG000|Overall Study|Protocol Violation|0|||
155381137|NCT01079663|560830840|FG001|Overall Study|Protocol Violation|2|||
155381138|NCT00461032|560830844|FG000|Overall Study|Adverse Event|5|||
155381139|NCT00461032|560830845|FG001|Overall Study|Adverse Event|6|||
155381140|NCT00461032|560830844|FG000|Overall Study|Lack of Efficacy|5|||
155381141|NCT00461032|560830845|FG001|Overall Study|Lack of Efficacy|1|||
155381142|NCT00461032|560830844|FG000|Overall Study|Lost to Follow-up|7|||
155381143|NCT00461032|560830845|FG001|Overall Study|Lost to Follow-up|12|||
155381144|NCT00461032|560830844|FG000|Overall Study|Protocol Violation|4|||
155381145|NCT00461032|560830845|FG001|Overall Study|Protocol Violation|4|||
155381146|NCT00461032|560830844|FG000|Overall Study|Withdrawal by Subject|7|||
155381147|NCT00461032|560830845|FG001|Overall Study|Withdrawal by Subject|15|||
155381148|NCT00461032|560830844|FG000|Overall Study|Patient Moved or Relocated|2|||
155381149|NCT00461032|560830845|FG001|Overall Study|Patient Moved or Relocated|1|||
155608578|NCT01306214|561656745|FG001|Overall Study|Lost to Follow-up|5|||
155608579|NCT01306214|561656746|FG002|Overall Study|Lost to Follow-up|4|||
155608580|NCT01306214|561656744|FG000|Overall Study|Withdrawal by Subject|24|||
155608581|NCT01306214|561656745|FG001|Overall Study|Withdrawal by Subject|22|||
155608582|NCT01306214|561656746|FG002|Overall Study|Withdrawal by Subject|16|||
155608583|NCT01306214|561656744|FG000|Overall Study|Not treated|1|||
155381150|NCT00461032|560830844|FG000|Overall Study|Other|7|||
155381151|NCT00461032|560830845|FG001|Overall Study|Other|5|||
155608584|NCT01306214|561656745|FG001|Overall Study|Not treated|1|||
155608585|NCT01306214|561656746|FG002|Overall Study|Not treated|1|||
155381152|NCT03486457|560830847|FG000|Up to Month 3|Adverse Event|2|||
155381153|NCT03486457|560830848|FG001|Up to Month 3|Adverse Event|5|||
155381154|NCT03486457|560830847|FG000|Up to Month 3|Lack of Efficacy|1|||
155381155|NCT03486457|560830848|FG001|Up to Month 3|Lack of Efficacy|0|||
155381156|NCT03486457|560830847|FG000|Up to Month 3|Withdrawal by Subject|1|||
155381157|NCT03486457|560830848|FG001|Up to Month 3|Withdrawal by Subject|0|||
155381158|NCT03486457|560830847|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
155381159|NCT03486457|560830848|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
155381160|NCT03486457|560830847|FG000|Up to Month 3|Other|1|||
155381161|NCT03486457|560830848|FG001|Up to Month 3|Other|0|||
155608586|NCT02686814|561656747|FG000|Overall Study|Physician Decision|14|||
155608587|NCT02686814|561656747|FG000|Overall Study|Withdrawal by Subject|4|||
155608588|NCT02686814|561656747|FG000|Overall Study|Death|1|||
155608589|NCT01026818|561656748|FG000|Screening Period|Entry Criteria Not Met|105|||
155608590|NCT01026818|561656749|FG001|Screening Period|Entry Criteria Not Met|0|||
155608591|NCT01026818|561656750|FG002|Screening Period|Entry Criteria Not Met|0|||
155608592|NCT01026818|561656751|FG003|Screening Period|Entry Criteria Not Met|0|||
155608593|NCT01026818|561656748|FG000|Screening Period|Withdrawal by Subject|49|||
155608594|NCT01026818|561656749|FG001|Screening Period|Withdrawal by Subject|0|||
155608595|NCT01026818|561656750|FG002|Screening Period|Withdrawal by Subject|0|||
155608596|NCT01026818|561656751|FG003|Screening Period|Withdrawal by Subject|0|||
155608597|NCT01026818|561656748|FG000|Screening Period|Protocol Deviation|3|||
155608598|NCT01026818|561656749|FG001|Screening Period|Protocol Deviation|0|||
155608599|NCT01026818|561656750|FG002|Screening Period|Protocol Deviation|0|||
155608600|NCT01026818|561656751|FG003|Screening Period|Protocol Deviation|0|||
155608601|NCT01026818|561656748|FG000|Screening Period|Adverse Event|2|||
155608602|NCT01026818|561656749|FG001|Screening Period|Adverse Event|0|||
155608603|NCT01026818|561656750|FG002|Screening Period|Adverse Event|0|||
155381162|NCT03486457|560830847|FG000|Month 3 to Month 6|Adverse Event|2|||
155381163|NCT03486457|560830848|FG001|Month 3 to Month 6|Adverse Event|0|||
155381164|NCT03486457|560830847|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
155381165|NCT03486457|560830848|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
155381166|NCT03486457|560830847|FG000|Month 3 to Month 6|Pregnancy|0|||
155381167|NCT03486457|560830848|FG001|Month 3 to Month 6|Pregnancy|1|||
155381168|NCT03486457|560830847|FG000|Month 3 to Month 6|Other|1|||
155381169|NCT03486457|560830848|FG001|Month 3 to Month 6|Other|0|||
155381170|NCT02257567|560830849|FG000|Overall Study|Adverse Event|0|||
155381171|NCT02257567|560830850|FG001|Overall Study|Adverse Event|0|||
155381172|NCT02257567|560830851|FG002|Overall Study|Adverse Event|0|||
155381173|NCT02257567|560830852|FG003|Overall Study|Adverse Event|1|||
155608604|NCT01026818|561656751|FG003|Screening Period|Adverse Event|0|||
155608605|NCT01026818|561656748|FG000|Screening Period|Physician Decision|1|||
155608606|NCT01026818|561656749|FG001|Screening Period|Physician Decision|0|||
155608607|NCT01026818|561656750|FG002|Screening Period|Physician Decision|0|||
155608608|NCT01026818|561656751|FG003|Screening Period|Physician Decision|0|||
155381174|NCT02257567|560830853|FG004|Overall Study|Adverse Event|1|||
155381175|NCT02257567|560830854|FG005|Overall Study|Adverse Event|0|||
155381176|NCT02257567|560830855|FG006|Overall Study|Adverse Event|0|||
155381177|NCT02257567|560830856|FG007|Overall Study|Adverse Event|0|||
155381178|NCT02257567|560830857|FG008|Overall Study|Adverse Event|1|||
155381179|NCT02257567|560830858|FG009|Overall Study|Adverse Event|0|||
155381180|NCT02257567|560830859|FG010|Overall Study|Adverse Event|0|||
155381181|NCT02257567|560830849|FG000|Overall Study|Death|2|||
155381182|NCT02257567|560830850|FG001|Overall Study|Death|2|||
155381183|NCT02257567|560830851|FG002|Overall Study|Death|2|||
155381184|NCT02257567|560830852|FG003|Overall Study|Death|4|||
155381185|NCT02257567|560830853|FG004|Overall Study|Death|15|||
155381186|NCT02257567|560830854|FG005|Overall Study|Death|11|||
155381187|NCT02257567|560830855|FG006|Overall Study|Death|26|||
155381188|NCT02257567|560830856|FG007|Overall Study|Death|30|||
155381189|NCT02257567|560830857|FG008|Overall Study|Death|2|||
155381190|NCT02257567|560830858|FG009|Overall Study|Death|18|||
155381191|NCT02257567|560830859|FG010|Overall Study|Death|65|||
155381192|NCT02257567|560830849|FG000|Overall Study|Lost to Follow-up|0|||
155381193|NCT02257567|560830850|FG001|Overall Study|Lost to Follow-up|0|||
155381194|NCT02257567|560830851|FG002|Overall Study|Lost to Follow-up|0|||
155381195|NCT02257567|560830852|FG003|Overall Study|Lost to Follow-up|0|||
155381196|NCT02257567|560830853|FG004|Overall Study|Lost to Follow-up|2|||
155381197|NCT02257567|560830854|FG005|Overall Study|Lost to Follow-up|2|||
155381198|NCT02257567|560830855|FG006|Overall Study|Lost to Follow-up|0|||
155608609|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
155381199|NCT02257567|560830856|FG007|Overall Study|Lost to Follow-up|0|||
155608610|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
155608611|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
155608612|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
155608613|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
155608614|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
155608615|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
155381200|NCT02257567|560830857|FG008|Overall Study|Lost to Follow-up|0|||
155381201|NCT02257567|560830858|FG009|Overall Study|Lost to Follow-up|1|||
155381202|NCT02257567|560830859|FG010|Overall Study|Lost to Follow-up|1|||
155381203|NCT02257567|560830849|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381204|NCT02257567|560830850|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381205|NCT02257567|560830851|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381206|NCT02257567|560830852|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381207|NCT02257567|560830853|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
155381208|NCT02257567|560830854|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381209|NCT02257567|560830855|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
155381210|NCT02257567|560830856|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381211|NCT02257567|560830857|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381212|NCT02257567|560830858|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381213|NCT02257567|560830859|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381214|NCT02257567|560830849|FG000|Overall Study|Physician Decision|0|||
155381215|NCT02257567|560830850|FG001|Overall Study|Physician Decision|0|||
155381216|NCT02257567|560830851|FG002|Overall Study|Physician Decision|0|||
155381217|NCT02257567|560830852|FG003|Overall Study|Physician Decision|0|||
155381218|NCT02257567|560830853|FG004|Overall Study|Physician Decision|0|||
155381219|NCT02257567|560830854|FG005|Overall Study|Physician Decision|0|||
155381220|NCT02257567|560830855|FG006|Overall Study|Physician Decision|0|||
155381221|NCT02257567|560830856|FG007|Overall Study|Physician Decision|2|||
155381222|NCT02257567|560830857|FG008|Overall Study|Physician Decision|0|||
155381223|NCT02257567|560830858|FG009|Overall Study|Physician Decision|1|||
155381224|NCT02257567|560830859|FG010|Overall Study|Physician Decision|0|||
155381225|NCT02257567|560830849|FG000|Overall Study|Withdrawal by Subject|0|||
155381226|NCT02257567|560830850|FG001|Overall Study|Withdrawal by Subject|0|||
155381227|NCT02257567|560830851|FG002|Overall Study|Withdrawal by Subject|2|||
155381228|NCT02257567|560830852|FG003|Overall Study|Withdrawal by Subject|0|||
155381229|NCT02257567|560830853|FG004|Overall Study|Withdrawal by Subject|0|||
155381230|NCT02257567|560830854|FG005|Overall Study|Withdrawal by Subject|6|||
155381231|NCT02257567|560830855|FG006|Overall Study|Withdrawal by Subject|6|||
155381232|NCT02257567|560830856|FG007|Overall Study|Withdrawal by Subject|6|||
155381233|NCT02257567|560830857|FG008|Overall Study|Withdrawal by Subject|1|||
155381234|NCT02257567|560830858|FG009|Overall Study|Withdrawal by Subject|1|||
155381235|NCT02257567|560830859|FG010|Overall Study|Withdrawal by Subject|10|||
155381236|NCT03536143|560830860|FG000|Overall Study|Early termination, Sponsor decision|1|||
155381237|NCT01174160|560830861|FG000|Overall Study|Adverse Event|1|||
155381238|NCT01174160|560830862|FG001|Overall Study|Adverse Event|0|||
155608616|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
155608617|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
155608618|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
155608619|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
155608620|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
155608621|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
155608622|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
155608623|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
155608624|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
155608625|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
155608626|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
155608627|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
155608628|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
155608629|NCT01026818|561656748|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
155608630|NCT01026818|561656749|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
155608631|NCT01026818|561656750|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
155608632|NCT01026818|561656751|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
155608633|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
155608634|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
155608635|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
155608636|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
155608637|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
155608638|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
155608639|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
155608640|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
155608641|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
155381239|NCT01174160|560830861|FG000|Overall Study|Lost to Follow-up|1|||
155381240|NCT01174160|560830862|FG001|Overall Study|Lost to Follow-up|0|||
155381241|NCT01174160|560830861|FG000|Overall Study|Physician Decision|1|||
155381242|NCT01174160|560830862|FG001|Overall Study|Physician Decision|0|||
155381243|NCT01174160|560830861|FG000|Overall Study|Protocol Violation|4|||
155381244|NCT01174160|560830862|FG001|Overall Study|Protocol Violation|6|||
155381245|NCT01174160|560830861|FG000|Overall Study|Withdrawal by Subject|1|||
155381246|NCT01174160|560830862|FG001|Overall Study|Withdrawal by Subject|0|||
155381247|NCT01590017|560830863|FG000|Overall Study|Adverse Event|1|||
155381248|NCT01590017|560830863|FG000|Overall Study|Withdrawal by Subject|1|||
155381249|NCT01590017|560830863|FG000|Overall Study|Lack of Efficacy|1|||
155381250|NCT01590017|560830863|FG000|Overall Study|Physician Decision|1|||
155381251|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
155381252|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381253|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381254|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381255|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381256|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381257|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
155381258|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381259|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381260|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381261|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381262|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381263|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381264|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
155381265|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381266|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381267|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381268|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381269|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Other|4|||
155381270|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Other|3|||
155381271|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Other|0|||
155381272|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Other|0|||
155381273|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Other|0|||
155381274|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Other|0|||
155381275|NCT02527343|560830864|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381276|NCT02527343|560830865|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381277|NCT02527343|560830866|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
155381278|NCT02527343|560830867|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381279|NCT02527343|560830868|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381280|NCT02527343|560830869|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381281|NCT02527343|560830864|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381282|NCT02527343|560830865|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381283|NCT02527343|560830866|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381284|NCT02527343|560830867|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
155381285|NCT02527343|560830868|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381286|NCT02527343|560830869|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381287|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381288|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381289|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381290|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381291|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
155381292|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381293|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381294|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381295|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381296|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381297|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
155381298|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
155381299|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381300|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381301|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381302|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381303|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
155381304|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
155381305|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381306|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381307|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381308|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
155608642|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
155608643|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
155608644|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
155608645|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
155608646|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
155608647|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
155608648|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
155608649|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
155608650|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
155608651|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
155608652|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
155608653|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155608654|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
155608655|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155608656|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155608657|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
155608658|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
155608659|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
155608660|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
155608661|NCT01026818|561656748|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155608662|NCT01026818|561656749|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155608663|NCT01026818|561656750|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155608664|NCT01026818|561656751|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
155608665|NCT01026818|561656748|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155608666|NCT01026818|561656749|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
155608667|NCT01026818|561656750|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155608668|NCT01026818|561656751|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155608669|NCT01026818|561656748|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155608670|NCT01026818|561656749|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
155608671|NCT01026818|561656750|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155608672|NCT01026818|561656751|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155608673|NCT01026818|561656748|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
155608674|NCT01026818|561656749|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
155608675|NCT01026818|561656750|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
155608676|NCT01026818|561656751|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
155608677|NCT01026818|561656748|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
155608678|NCT01026818|561656749|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
155608679|NCT01026818|561656750|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
155608680|NCT01026818|561656751|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
155608681|NCT01026818|561656748|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
155608682|NCT01026818|561656749|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
155608683|NCT01026818|561656750|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
155608684|NCT01026818|561656751|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
155608685|NCT01908582|561656752|FG000|Period 2|Physician Decision|1|||
155608686|NCT01908582|561656752|FG000|Period 2|Withdrawal by Subject|1|||
155608687|NCT01090050|561656754|FG000|Overall Study|Lost to Follow-up|0|||
155608688|NCT01090050|561656755|FG001|Overall Study|Lost to Follow-up|1|||
155608689|NCT01090050|561656754|FG000|Overall Study|Lack of Efficacy|1|||
155608690|NCT01090050|561656755|FG001|Overall Study|Lack of Efficacy|5|||
155608691|NCT01090050|561656754|FG000|Overall Study|Physician Decision|0|||
155608692|NCT01090050|561656755|FG001|Overall Study|Physician Decision|1|||
155608693|NCT02232061|561656756|FG000|Overall Study|Administrative problems|1|||
155608694|NCT02232061|561656756|FG000|Overall Study|Withdrawal by Subject|1|||
155608695|NCT06439095|561656757|FG000|Overall Study|Lost to Follow-up|2|||
155608696|NCT02368886|561656758|FG000|Overall Study|Cancel|1|||
155608697|NCT02368886|561656759|FG001|Overall Study|Cancel|1|||
155608698|NCT02368886|561656760|FG002|Overall Study|Cancel|1|||
155608699|NCT02368886|561656761|FG003|Overall Study|Cancel|3|||
155608700|NCT02368886|561656758|FG000|Overall Study|Ineligible|0|||
155608701|NCT02368886|561656759|FG001|Overall Study|Ineligible|0|||
155608702|NCT02368886|561656760|FG002|Overall Study|Ineligible|0|||
155608703|NCT02368886|561656761|FG003|Overall Study|Ineligible|1|||
155608704|NCT03484403|561656763|FG000|Overall Study|Withdrawal by Subject|6|||
155608705|NCT03484403|561656764|FG001|Overall Study|Withdrawal by Subject|4|||
155608706|NCT04278924|561656765|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
155608707|NCT04278924|561656766|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
155608708|NCT04278924|561656767|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155608709|NCT04278924|561656768|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
155608710|NCT04278924|561656769|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155608711|NCT04278924|561656770|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155608712|NCT04278924|561656771|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155608713|NCT04278924|561656765|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608714|NCT04278924|561656766|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
155608715|NCT04278924|561656767|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608716|NCT04278924|561656768|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608717|NCT04278924|561656769|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608718|NCT04278924|561656770|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608719|NCT04278924|561656771|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
155608720|NCT04767529|561656772|FG000|Overall Study|Adverse Event|0|||
155608721|NCT04767529|561656773|FG001|Overall Study|Adverse Event|4|||
155608722|NCT04767529|561656774|FG002|Overall Study|Adverse Event|3|||
155608723|NCT04767529|561656772|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
155608724|NCT04767529|561656773|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
155608725|NCT04767529|561656774|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
155608726|NCT04767529|561656772|FG000|Overall Study|Required use of a prohibited medication|0|||
155608727|NCT04767529|561656773|FG001|Overall Study|Required use of a prohibited medication|1|||
155608728|NCT04767529|561656774|FG002|Overall Study|Required use of a prohibited medication|0|||
155608729|NCT04767529|561656772|FG000|Overall Study|Withdrawal by Subject|7|||
155608730|NCT04767529|561656773|FG001|Overall Study|Withdrawal by Subject|5|||
155608731|NCT04767529|561656774|FG002|Overall Study|Withdrawal by Subject|4|||
155608732|NCT04767529|561656772|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
155608733|NCT04767529|561656773|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
155608734|NCT04767529|561656774|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
155608735|NCT04767529|561656772|FG000|Overall Study|Lost to Follow-up|0|||
155608736|NCT04767529|561656773|FG001|Overall Study|Lost to Follow-up|2|||
155608737|NCT04767529|561656774|FG002|Overall Study|Lost to Follow-up|3|||
155608738|NCT00253370|561656775|FG000|Overall Study|Adverse Event|18|||
155608739|NCT00253370|561656775|FG000|Overall Study|Disease progression|13|||
155608740|NCT00253370|561656775|FG000|Overall Study|Death|2|||
155608741|NCT00253370|561656775|FG000|Overall Study|Withdrawal by Subject|6|||
155608742|NCT00253370|561656775|FG000|Overall Study|Non-protocol therapy|1|||
155608743|NCT00253370|561656775|FG000|Overall Study|Physician Decision|1|||
155608744|NCT00253370|561656775|FG000|Overall Study|Protocol Violation|1|||
155608745|NCT00253370|561656775|FG000|Overall Study|Abdominal pain due to disease|1|||
155608746|NCT00004088|561656777|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
155608747|NCT00004088|561656777|FG000|Overall Study|Withdrawal by Subject|1|||
155608748|NCT00004088|561656777|FG000|Overall Study|Protocol Violation|3|||
155608749|NCT00004088|561656777|FG000|Overall Study|Physician Decision|1|||
155608750|NCT02636699|561656782|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
155608751|NCT02636699|561656783|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
155608752|NCT02636699|561656784|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
155608753|NCT02636699|561656782|FG000|Screening Period|Withdrawal by Subject|0|||
155608754|NCT02636699|561656783|FG001|Screening Period|Withdrawal by Subject|0|||
155608755|NCT02636699|561656784|FG002|Screening Period|Withdrawal by Subject|23|||
155608756|NCT02636699|561656782|FG000|Screening Period|Adverse Event|0|||
155608757|NCT02636699|561656783|FG001|Screening Period|Adverse Event|0|||
155608758|NCT02636699|561656784|FG002|Screening Period|Adverse Event|1|||
155608759|NCT02636699|561656782|FG000|Screening Period|Other not specified|0|||
155608760|NCT02636699|561656783|FG001|Screening Period|Other not specified|0|||
155608761|NCT02636699|561656784|FG002|Screening Period|Other not specified|3|||
155608762|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
155608763|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
155608764|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
155608765|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
155608766|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
155608767|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
155608768|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
155608769|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
155608770|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
155608771|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
155608772|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
155608773|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
155608774|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
155608775|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
155608776|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
155608777|NCT02636699|561656782|FG000|Treatment and Follow-up Periods|Other|3|||
155608778|NCT02636699|561656783|FG001|Treatment and Follow-up Periods|Other|1|||
155608779|NCT02636699|561656784|FG002|Treatment and Follow-up Periods|Other|0|||
155608780|NCT00624832|561656785|FG000|Overall Study|Adverse Event|0|||
155381309|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
155381310|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
155381311|NCT02527343|560830864|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381312|NCT02527343|560830865|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381313|NCT02527343|560830866|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381314|NCT02527343|560830867|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381315|NCT02527343|560830868|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
155381316|NCT02527343|560830869|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
155381317|NCT02527343|560830864|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381318|NCT02527343|560830865|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381319|NCT02527343|560830866|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381320|NCT02527343|560830867|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381321|NCT02527343|560830868|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
155381322|NCT02527343|560830869|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381323|NCT02527343|560830864|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
155381324|NCT02527343|560830865|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
155381325|NCT02527343|560830866|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
155381326|NCT02527343|560830867|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
155381327|NCT02527343|560830868|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
155381328|NCT02527343|560830869|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
155381329|NCT05767021|560830870|FG000|Overall Study|Adverse Event|2|||
155381330|NCT05767021|560830870|FG000|Overall Study|Protocol Deviation|1|||
155381331|NCT05767021|560830870|FG000|Overall Study|Withdrawal by Subject|1|||
155381332|NCT05767021|560830870|FG000|Overall Study|Physician Decision|1|||
155381333|NCT05767021|560830870|FG000|Overall Study|Lack of Efficacy|11|||
155381334|NCT05767021|560830870|FG000|Overall Study|Assigned Treatment by Mistake|1|||
155608781|NCT00624832|561656786|FG001|Overall Study|Adverse Event|1|||
155608782|NCT00624832|561656787|FG002|Overall Study|Adverse Event|0|||
155608783|NCT00624832|561656788|FG003|Overall Study|Adverse Event|1|||
155608784|NCT00624832|561656785|FG000|Overall Study|Abnormal Laboratory Value|2|||
155608785|NCT00624832|561656786|FG001|Overall Study|Abnormal Laboratory Value|0|||
155608786|NCT00624832|561656787|FG002|Overall Study|Abnormal Laboratory Value|0|||
155608787|NCT00624832|561656788|FG003|Overall Study|Abnormal Laboratory Value|0|||
155608788|NCT01939223|561656789|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
155608789|NCT01939223|561656790|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
155608790|NCT01939223|561656789|FG000|Overall Study|Disease recurrence (radiological)|1|||
155608791|NCT01939223|561656790|FG001|Overall Study|Disease recurrence (radiological)|3|||
155608792|NCT01939223|561656789|FG000|Overall Study|Study stopped by Sponsor|5|||
155608793|NCT01939223|561656790|FG001|Overall Study|Study stopped by Sponsor|7|||
155608794|NCT01939223|561656789|FG000|Overall Study|Withdrawal by Subject|6|||
155608795|NCT01939223|561656790|FG001|Overall Study|Withdrawal by Subject|0|||
155608796|NCT04379700|561656791|FG000|Overall Study|Withdrawal by Subject|10|||
155608797|NCT04379700|561656791|FG000|Overall Study|Screen Fail|4|||
155608798|NCT04379700|561656791|FG000|Overall Study|Lost to Follow-up|3|||
155608799|NCT03004924|561656794|FG000|Overall Study|Adverse Event|6|||
155608800|NCT03004924|561656795|FG001|Overall Study|Adverse Event|5|||
155608801|NCT03004924|561656796|FG002|Overall Study|Adverse Event|10|||
155608802|NCT03004924|561656794|FG000|Overall Study|Protocol Violation|4|||
155608803|NCT03004924|561656795|FG001|Overall Study|Protocol Violation|0|||
155608804|NCT03004924|561656796|FG002|Overall Study|Protocol Violation|1|||
155608805|NCT03004924|561656794|FG000|Overall Study|Withdrawal by Subject|5|||
155608806|NCT03004924|561656795|FG001|Overall Study|Withdrawal by Subject|3|||
155608807|NCT03004924|561656796|FG002|Overall Study|Withdrawal by Subject|5|||
155608808|NCT03004924|561656794|FG000|Overall Study|Lost to Follow-up|6|||
155608809|NCT03004924|561656795|FG001|Overall Study|Lost to Follow-up|1|||
155608810|NCT03004924|561656796|FG002|Overall Study|Lost to Follow-up|4|||
155608811|NCT03004924|561656794|FG000|Overall Study|Lack of Efficacy|2|||
155608812|NCT03004924|561656795|FG001|Overall Study|Lack of Efficacy|4|||
155608813|NCT03004924|561656796|FG002|Overall Study|Lack of Efficacy|2|||
155608814|NCT03004924|561656794|FG000|Overall Study|Physician Decision|1|||
155608815|NCT03004924|561656795|FG001|Overall Study|Physician Decision|0|||
155608816|NCT03004924|561656796|FG002|Overall Study|Physician Decision|1|||
155608817|NCT03004924|561656794|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155608818|NCT03004924|561656795|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155608819|NCT03004924|561656796|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155608820|NCT03004924|561656794|FG000|Overall Study|Screen Failure|1|||
155608821|NCT03004924|561656795|FG001|Overall Study|Screen Failure|0|||
155608822|NCT03004924|561656796|FG002|Overall Study|Screen Failure|0|||
155608823|NCT03004924|561656794|FG000|Overall Study|Pregnancy|0|||
155608824|NCT03004924|561656795|FG001|Overall Study|Pregnancy|1|||
155608825|NCT03004924|561656796|FG002|Overall Study|Pregnancy|0|||
155608826|NCT03004924|561656794|FG000|Overall Study|Terminated by Sponsor|0|||
155608827|NCT03004924|561656795|FG001|Overall Study|Terminated by Sponsor|0|||
155608828|NCT03004924|561656796|FG002|Overall Study|Terminated by Sponsor|1|||
155608829|NCT03004924|561656794|FG000|Overall Study|Missed Study Visit|0|||
155608830|NCT03004924|561656795|FG001|Overall Study|Missed Study Visit|0|||
155608831|NCT03004924|561656796|FG002|Overall Study|Missed Study Visit|2|||
155608832|NCT03004924|561656794|FG000|Overall Study|HSV1 Positive|1|||
155608833|NCT03004924|561656795|FG001|Overall Study|HSV1 Positive|0|||
155608834|NCT03004924|561656796|FG002|Overall Study|HSV1 Positive|0|||
155608835|NCT01370616|561656804|FG000|Overall Study|Adverse Event|11|||
155608836|NCT01370616|561656805|FG001|Overall Study|Adverse Event|16|||
155608837|NCT01370616|561656804|FG000|Overall Study|Death|1|||
155608838|NCT01370616|561656805|FG001|Overall Study|Death|0|||
155608839|NCT01370616|561656804|FG000|Overall Study|Lack of Efficacy|6|||
155608840|NCT01370616|561656805|FG001|Overall Study|Lack of Efficacy|2|||
155608841|NCT01370616|561656804|FG000|Overall Study|Lost to Follow-up|0|||
155608842|NCT01370616|561656805|FG001|Overall Study|Lost to Follow-up|3|||
155608843|NCT01370616|561656804|FG000|Overall Study|Physician Decision|6|||
155608844|NCT01370616|561656805|FG001|Overall Study|Physician Decision|6|||
155608845|NCT01370616|561656804|FG000|Overall Study|Progressive Disease|0|||
155608846|NCT01370616|561656805|FG001|Overall Study|Progressive Disease|1|||
155608847|NCT01370616|561656804|FG000|Overall Study|Recovery|1|||
155608848|NCT01370616|561656805|FG001|Overall Study|Recovery|0|||
155608849|NCT01370616|561656804|FG000|Overall Study|Technical Problems|3|||
155608850|NCT01370616|561656805|FG001|Overall Study|Technical Problems|5|||
155608851|NCT01370616|561656804|FG000|Overall Study|Withdrawal by Subject|34|||
155608852|NCT01370616|561656805|FG001|Overall Study|Withdrawal by Subject|34|||
155608853|NCT00187278|561656808|FG000|Overall Study|Protocol Violation|10|||
155608854|NCT00187278|561656809|FG001|Overall Study|Protocol Violation|13|||
155608855|NCT02735096|561656810|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
155608856|NCT01080391|561656811|FG000|Overall Study|Randomized but not treated|7|||
155608857|NCT01080391|561656812|FG001|Overall Study|Randomized but not treated|4|||
155608858|NCT02083653|561656814|FG000|Overall Study|Randomized but not Treated|0|||
155608859|NCT02083653|561656815|FG001|Overall Study|Randomized but not Treated|2|||
155608860|NCT02083653|561656816|FG002|Overall Study|Randomized but not Treated|7|||
155608861|NCT02083653|561656814|FG000|Overall Study|Adverse Event|12|||
155608862|NCT02083653|561656815|FG001|Overall Study|Adverse Event|5|||
155608863|NCT02083653|561656816|FG002|Overall Study|Adverse Event|4|||
155608864|NCT02083653|561656814|FG000|Overall Study|Lost to Follow-up|1|||
155608865|NCT02083653|561656815|FG001|Overall Study|Lost to Follow-up|0|||
155608866|NCT02083653|561656816|FG002|Overall Study|Lost to Follow-up|0|||
155608867|NCT02083653|561656814|FG000|Overall Study|Death|2|||
155608868|NCT02083653|561656815|FG001|Overall Study|Death|2|||
155608869|NCT02083653|561656816|FG002|Overall Study|Death|2|||
155608870|NCT02083653|561656814|FG000|Overall Study|Progressive Disease|65|||
155608871|NCT02083653|561656815|FG001|Overall Study|Progressive Disease|73|||
155608872|NCT02083653|561656816|FG002|Overall Study|Progressive Disease|63|||
155608873|NCT02083653|561656814|FG000|Overall Study|Withdrawal by Subject|2|||
155608874|NCT02083653|561656815|FG001|Overall Study|Withdrawal by Subject|1|||
155608875|NCT02083653|561656816|FG002|Overall Study|Withdrawal by Subject|2|||
155608876|NCT02083653|561656814|FG000|Overall Study|Other Events|0|||
155608877|NCT02083653|561656815|FG001|Overall Study|Other Events|2|||
155608878|NCT02083653|561656816|FG002|Overall Study|Other Events|2|||
155608879|NCT02083653|561656814|FG000|Overall Study|Reason Missing|0|||
155608880|NCT02083653|561656815|FG001|Overall Study|Reason Missing|0|||
155608881|NCT02083653|561656816|FG002|Overall Study|Reason Missing|4|||
155608882|NCT03423147|561656820|FG000|Overall Study|Lost to Follow-up|5|||
155608883|NCT03423147|561656821|FG001|Overall Study|Lost to Follow-up|8|||
155608884|NCT03423147|561656820|FG000|Overall Study|Withdrawal by Subject|1|||
155608885|NCT03423147|561656821|FG001|Overall Study|Withdrawal by Subject|0|||
155608886|NCT03423147|561656820|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
155608887|NCT03423147|561656821|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
155608888|NCT03423147|561656820|FG000|Overall Study|Age < 18|1|||
155608889|NCT03423147|561656821|FG001|Overall Study|Age < 18|0|||
155608890|NCT03423147|561656820|FG000|Overall Study|No Trial of Labor|0|||
155608891|NCT03423147|561656821|FG001|Overall Study|No Trial of Labor|1|||
155608892|NCT01048099|561656822|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
155608893|NCT01048099|561656822|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
155608894|NCT01987232|561656823|FG000|Overall Study|Ongoing in Study|0|||
155608895|NCT01987232|561656824|FG001|Overall Study|Ongoing in Study|0|||
155608896|NCT01987232|561656825|FG002|Overall Study|Ongoing in Study|0|||
155608897|NCT01987232|561656826|FG003|Overall Study|Ongoing in Study|1|||
155608898|NCT01987232|561656827|FG004|Overall Study|Ongoing in Study|0|||
155608899|NCT01731470|561656829|FG000|Overall Study|Withdrawal by Subject|1|||
155608900|NCT01731470|561656829|FG000|Overall Study|Did not meet study criteria|1|||
155608901|NCT00564395|561656830|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
155608902|NCT00564395|561656831|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
155608903|NCT00564395|561656830|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
155608904|NCT00564395|561656831|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
155608905|NCT01324570|561656832|FG000|Overall Study|Adverse Event|4|||
155608906|NCT01324570|561656833|FG001|Overall Study|Adverse Event|7|||
155608907|NCT01324570|561656832|FG000|Overall Study|Withdrawal by Subject|0|||
155608908|NCT01324570|561656833|FG001|Overall Study|Withdrawal by Subject|3|||
155608909|NCT01324570|561656832|FG000|Overall Study|Lack of Efficacy|0|||
155608910|NCT01324570|561656833|FG001|Overall Study|Lack of Efficacy|1|||
155608911|NCT01324570|561656832|FG000|Overall Study|Confirmed or suspected diversion|0|||
155608912|NCT01324570|561656833|FG001|Overall Study|Confirmed or suspected diversion|1|||
155608913|NCT01324570|561656832|FG000|Overall Study|Administrative|0|||
155608914|NCT01324570|561656833|FG001|Overall Study|Administrative|2|||
155608915|NCT00207727|561656834|FG000|Overall Study|Withdrawal by Subject|0|||
155608916|NCT00207727|561656835|FG001|Overall Study|Withdrawal by Subject|0|||
155608917|NCT00207727|561656836|FG002|Overall Study|Withdrawal by Subject|0|||
155608918|NCT00207727|561656837|FG003|Overall Study|Withdrawal by Subject|0|||
155608919|NCT00207727|561656838|FG004|Overall Study|Withdrawal by Subject|1|||
155608920|NCT00207727|561656834|FG000|Overall Study|Lost to Follow-up|0|||
155608921|NCT00207727|561656835|FG001|Overall Study|Lost to Follow-up|1|||
155608922|NCT00207727|561656836|FG002|Overall Study|Lost to Follow-up|0|||
155608923|NCT00207727|561656837|FG003|Overall Study|Lost to Follow-up|0|||
155608924|NCT00207727|561656838|FG004|Overall Study|Lost to Follow-up|0|||
155608925|NCT00207727|561656834|FG000|Overall Study|Other|38|||
155608926|NCT00207727|561656835|FG001|Overall Study|Other|41|||
155608927|NCT00207727|561656836|FG002|Overall Study|Other|41|||
155608928|NCT00207727|561656837|FG003|Overall Study|Other|37|||
155608929|NCT00207727|561656838|FG004|Overall Study|Other|33|||
155608930|NCT03611582|561656844|FG000|Overall Study|Adverse Event|26|||
155608931|NCT03611582|561656845|FG001|Overall Study|Adverse Event|6|||
155608932|NCT03611582|561656844|FG000|Overall Study|Protocol Violation|0|||
155608933|NCT03611582|561656845|FG001|Overall Study|Protocol Violation|1|||
155608934|NCT03611582|561656844|FG000|Overall Study|Pregnancy|1|||
155608935|NCT03611582|561656845|FG001|Overall Study|Pregnancy|2|||
155608936|NCT03611582|561656844|FG000|Overall Study|Lack of Efficacy|0|||
155608937|NCT03611582|561656845|FG001|Overall Study|Lack of Efficacy|1|||
155608938|NCT03611582|561656844|FG000|Overall Study|At the discretion of the investigator|1|||
155608939|NCT03611582|561656845|FG001|Overall Study|At the discretion of the investigator|0|||
155608940|NCT03611582|561656844|FG000|Overall Study|Safety concern as judged by the investigator|1|||
155608941|NCT03611582|561656845|FG001|Overall Study|Safety concern as judged by the investigator|2|||
155608942|NCT03611582|561656844|FG000|Overall Study|Withdrawal by Subject|4|||
155608943|NCT03611582|561656845|FG001|Overall Study|Withdrawal by Subject|3|||
155608944|NCT03611582|561656844|FG000|Overall Study|Lost to Follow-up|18|||
155608945|NCT03611582|561656845|FG001|Overall Study|Lost to Follow-up|7|||
155608946|NCT03611582|561656844|FG000|Overall Study|other|17|||
155608947|NCT03611582|561656845|FG001|Overall Study|other|16|||
155608948|NCT01783821|561656846|FG000|Overall Study|Screen Failure|1|||
155608949|NCT01783821|561656847|FG001|Overall Study|Screen Failure|1|||
155608950|NCT02333383|561656848|FG000|Overall Study|Adalimumab discontinuation|21|||
155608951|NCT02333383|561656848|FG000|Overall Study|Lost to Follow-up|15|||
155608952|NCT02333383|561656848|FG000|Overall Study|Withdrawal by Subject|3|||
155608953|NCT02333383|561656848|FG000|Overall Study|Transfer to another hospital|2|||
155608954|NCT00463840|561656850|FG000|Overall Study|Disease progression|7|||
155608955|NCT00463840|561656850|FG000|Overall Study|Withdrawal by Subject|2|||
155608956|NCT00463840|561656850|FG000|Overall Study|Adverse Event|3|||
155608957|NCT00866333|561656856|FG000|Overall Study|Withdrawal of consent|0|||
155608958|NCT00866333|561656857|FG001|Overall Study|Withdrawal of consent|1|||
155608959|NCT00866333|561656858|FG002|Overall Study|Withdrawal of consent|2|||
155608960|NCT00866333|561656856|FG000|Overall Study|Reason not Specified|3|||
155608961|NCT00866333|561656857|FG001|Overall Study|Reason not Specified|1|||
155608962|NCT00866333|561656858|FG002|Overall Study|Reason not Specified|1|||
155608963|NCT00866333|561656856|FG000|Overall Study|Study Terminated by Sponsor|2|||
155608964|NCT00866333|561656857|FG001|Overall Study|Study Terminated by Sponsor|5|||
155608965|NCT00866333|561656858|FG002|Overall Study|Study Terminated by Sponsor|9|||
155608966|NCT02669082|561656859|FG000|Overall Study|Adverse Event|1|||
155608967|NCT04918355|561656863|FG000|Overall Study|no qualifying health encounter|497|||
155608968|NCT04918355|561656864|FG001|Overall Study|no qualifying health encounter|192|||
155608969|NCT04918355|561656865|FG002|Overall Study|no qualifying health encounter|438|||
155608970|NCT04918355|561656866|FG003|Overall Study|no qualifying health encounter|424|||
155608971|NCT04683939|561656867|FG000|Overall Study|Study termination by the sponsor|0|||
155608972|NCT04683939|561656868|FG001|Overall Study|Study termination by the sponsor|1|||
155608973|NCT04683939|561656869|FG002|Overall Study|Study termination by the sponsor|2|||
155608974|NCT04683939|561656870|FG003|Overall Study|Study termination by the sponsor|2|||
155608975|NCT04683939|561656867|FG000|Overall Study|Death|1|||
155608976|NCT04683939|561656868|FG001|Overall Study|Death|1|||
155608977|NCT04683939|561656869|FG002|Overall Study|Death|2|||
155608978|NCT04683939|561656870|FG003|Overall Study|Death|1|||
155608979|NCT04683939|561656867|FG000|Overall Study|Withdrawal by Subject|1|||
155608980|NCT04683939|561656868|FG001|Overall Study|Withdrawal by Subject|0|||
155608981|NCT04683939|561656869|FG002|Overall Study|Withdrawal by Subject|0|||
155608982|NCT04683939|561656870|FG003|Overall Study|Withdrawal by Subject|0|||
155608983|NCT04683939|561656867|FG000|Overall Study|Physician Decision|1|||
155608984|NCT04683939|561656868|FG001|Overall Study|Physician Decision|0|||
155608985|NCT04683939|561656869|FG002|Overall Study|Physician Decision|0|||
155608986|NCT04683939|561656870|FG003|Overall Study|Physician Decision|0|||
155608987|NCT04683939|561656867|FG000|Overall Study|Lost to Follow-up|0|||
155608988|NCT04683939|561656868|FG001|Overall Study|Lost to Follow-up|1|||
155608989|NCT04683939|561656869|FG002|Overall Study|Lost to Follow-up|0|||
155608990|NCT04683939|561656870|FG003|Overall Study|Lost to Follow-up|0|||
155608991|NCT04852276|561656871|FG000|Overall Study|Death|2|||
155608992|NCT04852276|561656872|FG001|Overall Study|Death|0|||
155608993|NCT04852276|561656871|FG000|Overall Study|Lost to Follow-up|15|||
155608994|NCT04852276|561656872|FG001|Overall Study|Lost to Follow-up|9|||
155608995|NCT04852276|561656871|FG000|Overall Study|Withdrawal by Subject|26|||
155608996|NCT04852276|561656872|FG001|Overall Study|Withdrawal by Subject|6|||
155608997|NCT01687283|561659187|FG000|Overall Study|Adverse Event|11|||
155608998|NCT01687283|561659188|FG001|Overall Study|Adverse Event|4|||
155608999|NCT01687283|561659187|FG000|Overall Study|Lack of Efficacy|3|||
155609000|NCT01687283|561659188|FG001|Overall Study|Lack of Efficacy|1|||
155609001|NCT01687283|561659187|FG000|Overall Study|Protocol Violation|1|||
155609002|NCT01687283|561659188|FG001|Overall Study|Protocol Violation|3|||
155609003|NCT01687283|561659187|FG000|Overall Study|protocol defined stopping criteria|8|||
155609004|NCT01687283|561659188|FG001|Overall Study|protocol defined stopping criteria|10|||
155609005|NCT01687283|561659187|FG000|Overall Study|Lost to Follow-up|1|||
155609006|NCT01687283|561659188|FG001|Overall Study|Lost to Follow-up|1|||
155609007|NCT01687283|561659187|FG000|Overall Study|Investigator discretion|2|||
155609008|NCT01687283|561659188|FG001|Overall Study|Investigator discretion|0|||
155609009|NCT01687283|561659187|FG000|Overall Study|Withdrawal by Subject|9|||
155609010|NCT01687283|561659188|FG001|Overall Study|Withdrawal by Subject|8|||
155609011|NCT01153009|561659192|FG000|Overall Study|Adverse Event|4|||
155609012|NCT01153009|561659193|FG001|Overall Study|Adverse Event|14|||
155609013|NCT01153009|561659194|FG002|Overall Study|Adverse Event|14|||
155609014|NCT01153009|561659195|FG003|Overall Study|Adverse Event|10|||
155609015|NCT01153009|561659192|FG000|Overall Study|Lack of Efficacy|9|||
155609016|NCT01153009|561659193|FG001|Overall Study|Lack of Efficacy|0|||
155609017|NCT01153009|561659194|FG002|Overall Study|Lack of Efficacy|2|||
155609018|NCT01153009|561659195|FG003|Overall Study|Lack of Efficacy|1|||
155609019|NCT01153009|561659192|FG000|Overall Study|Noncompliance with Study Medication|1|||
155609020|NCT01153009|561659193|FG001|Overall Study|Noncompliance with Study Medication|3|||
155609021|NCT01153009|561659194|FG002|Overall Study|Noncompliance with Study Medication|4|||
155609022|NCT01153009|561659195|FG003|Overall Study|Noncompliance with Study Medication|1|||
155609023|NCT01153009|561659192|FG000|Overall Study|Protocol Deviations|4|||
155609024|NCT01153009|561659193|FG001|Overall Study|Protocol Deviations|3|||
155609025|NCT01153009|561659194|FG002|Overall Study|Protocol Deviations|3|||
155609026|NCT01153009|561659195|FG003|Overall Study|Protocol Deviations|2|||
155609027|NCT01153009|561659192|FG000|Overall Study|Withdrawal of Consent|5|||
155609028|NCT01153009|561659193|FG001|Overall Study|Withdrawal of Consent|5|||
155609029|NCT01153009|561659194|FG002|Overall Study|Withdrawal of Consent|4|||
155609030|NCT01153009|561659195|FG003|Overall Study|Withdrawal of Consent|6|||
155609031|NCT01153009|561659192|FG000|Overall Study|Lost to Follow-up|8|||
155609032|NCT01153009|561659193|FG001|Overall Study|Lost to Follow-up|8|||
155609033|NCT01153009|561659194|FG002|Overall Study|Lost to Follow-up|11|||
155609034|NCT01153009|561659195|FG003|Overall Study|Lost to Follow-up|15|||
155609035|NCT01153009|561659192|FG000|Overall Study|Other|1|||
155609036|NCT01153009|561659193|FG001|Overall Study|Other|1|||
155609037|NCT01153009|561659194|FG002|Overall Study|Other|3|||
155609038|NCT01153009|561659195|FG003|Overall Study|Other|2|||
155609039|NCT00410072|561659196|FG000|Day 1 to Week 48|Adverse Event|1|||
155609040|NCT00410072|561659197|FG001|Day 1 to Week 48|Adverse Event|2|||
155609041|NCT00410072|561659196|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
155609042|NCT00410072|561659197|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
155609043|NCT00410072|561659196|FG000|Day 1 to Week 48|Other|0|||
155609044|NCT00410072|561659197|FG001|Day 1 to Week 48|Other|1|||
155609045|NCT00410072|561659196|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
155609046|NCT00410072|561659197|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
155609047|NCT00410072|561659196|FG000|Day 1 to Week 48|Pregnancy|0|||
155609048|NCT00410072|561659197|FG001|Day 1 to Week 48|Pregnancy|2|||
155609049|NCT00410072|561659196|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
155609050|NCT00410072|561659197|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
155609051|NCT00410072|561659196|FG000|After Week 48 to Week 96|Adverse Event|1|||
155609052|NCT00410072|561659197|FG001|After Week 48 to Week 96|Adverse Event|2|||
155722582|NCT02318706|562083886|FG002|Double-blind Phase|Other|2|||
155609053|NCT00410072|561659196|FG000|After Week 48 to Week 96|Death|0|||
155609054|NCT00410072|561659197|FG001|After Week 48 to Week 96|Death|1|||
155609055|NCT00410072|561659196|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
155609056|NCT00410072|561659197|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
155609057|NCT00410072|561659196|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
155609058|NCT00410072|561659197|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
155609059|NCT00410072|561659196|FG000|After Week 48 to Week 96|Other|2|||
155609060|NCT00410072|561659197|FG001|After Week 48 to Week 96|Other|0|||
155609061|NCT00410072|561659196|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
155609062|NCT00410072|561659197|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
155609063|NCT00410072|561659196|FG000|After Week 48 to Week 96|Pregnancy|0|||
155609064|NCT00410072|561659197|FG001|After Week 48 to Week 96|Pregnancy|2|||
155609065|NCT00410072|561659196|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
155609066|NCT00410072|561659197|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
155609067|NCT03307837|561659201|FG000|Overall Study|Withdrawal by Subject|0|||
155609068|NCT03307837|561659202|FG001|Overall Study|Withdrawal by Subject|0|||
155609069|NCT03307837|561659203|FG002|Overall Study|Withdrawal by Subject|1|||
155609070|NCT03307837|561659204|FG003|Overall Study|Withdrawal by Subject|0|||
155609071|NCT03307837|561659205|FG004|Overall Study|Withdrawal by Subject|0|||
155609072|NCT03307837|561659206|FG005|Overall Study|Withdrawal by Subject|1|||
155609073|NCT03307837|561659201|FG000|Overall Study|Lost to Follow-up|1|||
155609074|NCT03307837|561659202|FG001|Overall Study|Lost to Follow-up|1|||
155609075|NCT03307837|561659203|FG002|Overall Study|Lost to Follow-up|0|||
155609076|NCT03307837|561659204|FG003|Overall Study|Lost to Follow-up|0|||
155609077|NCT03307837|561659205|FG004|Overall Study|Lost to Follow-up|0|||
155609078|NCT03307837|561659206|FG005|Overall Study|Lost to Follow-up|1|||
155609079|NCT01744483|561659207|FG000|Overall Study|Death|9|||
155609080|NCT01744483|561659208|FG001|Overall Study|Death|4|||
155609081|NCT01744483|561659209|FG002|Overall Study|Death|11|||
155609082|NCT01744483|561659207|FG000|Overall Study|Lost to Follow-up|8|||
155609083|NCT01744483|561659208|FG001|Overall Study|Lost to Follow-up|9|||
155609084|NCT01744483|561659209|FG002|Overall Study|Lost to Follow-up|11|||
155609085|NCT01744483|561659207|FG000|Overall Study|Protocol Violation|1|||
155609086|NCT01744483|561659208|FG001|Overall Study|Protocol Violation|2|||
155609087|NCT01744483|561659209|FG002|Overall Study|Protocol Violation|1|||
155609088|NCT01744483|561659207|FG000|Overall Study|Withdrawal by Subject|4|||
155609089|NCT01744483|561659208|FG001|Overall Study|Withdrawal by Subject|6|||
155609090|NCT01744483|561659209|FG002|Overall Study|Withdrawal by Subject|2|||
155609091|NCT01744483|561659207|FG000|Overall Study|No ICU Admit|5|||
155609092|NCT01744483|561659208|FG001|Overall Study|No ICU Admit|1|||
155609093|NCT01744483|561659209|FG002|Overall Study|No ICU Admit|2|||
155609094|NCT01744483|561659207|FG000|Overall Study|Routed to OSH|2|||
155609095|NCT01744483|561659208|FG001|Overall Study|Routed to OSH|0|||
155609096|NCT01744483|561659209|FG002|Overall Study|Routed to OSH|1|||
155609097|NCT03915626|561659210|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
155609098|NCT01754766|561659213|FG000|Overall Study|Personal reasons|1|||
155609099|NCT01754766|561659214|FG001|Overall Study|Personal reasons|1|||
155609100|NCT01754766|561659215|FG002|Overall Study|Personal reasons|0|||
155609101|NCT02469168|561659217|FG000|Overall Study|Trial closed|1|||
155609102|NCT02469168|561659218|FG001|Overall Study|Trial closed|0|||
155609103|NCT01533688|561659219|FG000|Overall Study|Withdrawal by Subject|5|||
155609104|NCT01533688|561659220|FG001|Overall Study|Withdrawal by Subject|4|||
155609105|NCT01533688|561659221|FG002|Overall Study|Withdrawal by Subject|3|||
155609106|NCT01533688|561659219|FG000|Overall Study|Medically unstable|1|||
155609107|NCT01533688|561659220|FG001|Overall Study|Medically unstable|3|||
155609108|NCT01533688|561659221|FG002|Overall Study|Medically unstable|3|||
155609109|NCT01533688|561659219|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
155609110|NCT01533688|561659220|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
155609111|NCT01533688|561659221|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
155609112|NCT02335346|561659233|FG000|Overall Study|Adverse Event|11|||
155609113|NCT02335346|561659233|FG000|Overall Study|Withdrawal by Subject|1|||
155609114|NCT03300050|561659234|FG000|Overall Study|Lost to Follow-up|2|||
155609115|NCT03300050|561659235|FG001|Overall Study|Lost to Follow-up|1|||
155609116|NCT03300050|561659236|FG002|Overall Study|Lost to Follow-up|0|||
155609117|NCT03300050|561659237|FG003|Overall Study|Lost to Follow-up|0|||
155609118|NCT03300050|561659238|FG004|Overall Study|Lost to Follow-up|1|||
155609119|NCT03300050|561659234|FG000|Overall Study|Withdrawal by Subject|1|||
155609120|NCT03300050|561659235|FG001|Overall Study|Withdrawal by Subject|1|||
155609121|NCT03300050|561659236|FG002|Overall Study|Withdrawal by Subject|1|||
155609122|NCT03300050|561659237|FG003|Overall Study|Withdrawal by Subject|0|||
155609123|NCT03300050|561659238|FG004|Overall Study|Withdrawal by Subject|0|||
155609124|NCT03300050|561659234|FG000|Overall Study|Death|0|||
155609125|NCT03300050|561659235|FG001|Overall Study|Death|0|||
155609126|NCT03300050|561659236|FG002|Overall Study|Death|1|||
155609127|NCT03300050|561659237|FG003|Overall Study|Death|0|||
155609128|NCT03300050|561659238|FG004|Overall Study|Death|0|||
155609129|NCT03300050|561659234|FG000|Overall Study|Not Eligible at Randomization|0|||
155609130|NCT03300050|561659235|FG001|Overall Study|Not Eligible at Randomization|0|||
155609131|NCT03300050|561659236|FG002|Overall Study|Not Eligible at Randomization|1|||
155609132|NCT03300050|561659237|FG003|Overall Study|Not Eligible at Randomization|1|||
155609133|NCT03300050|561659238|FG004|Overall Study|Not Eligible at Randomization|0|||
155609134|NCT01214668|561659239|FG000|Overall Study|Adverse Event|0|||
155609135|NCT01214668|561659240|FG001|Overall Study|Adverse Event|1|||
155609136|NCT01214668|561659241|FG002|Overall Study|Adverse Event|0|||
155609137|NCT01214668|561659242|FG003|Overall Study|Adverse Event|2|||
155609138|NCT01214668|561659243|FG004|Overall Study|Adverse Event|1|||
155609139|NCT01214668|561659244|FG005|Overall Study|Adverse Event|1|||
155609140|NCT01214668|561659239|FG000|Overall Study|Death|0|||
155609141|NCT01214668|561659240|FG001|Overall Study|Death|0|||
155609142|NCT01214668|561659241|FG002|Overall Study|Death|1|||
155609143|NCT01214668|561659242|FG003|Overall Study|Death|0|||
155609144|NCT01214668|561659243|FG004|Overall Study|Death|0|||
155609145|NCT01214668|561659244|FG005|Overall Study|Death|0|||
155609146|NCT01214668|561659239|FG000|Overall Study|Progressive Disease|4|||
155609147|NCT01214668|561659240|FG001|Overall Study|Progressive Disease|2|||
155609148|NCT01214668|561659241|FG002|Overall Study|Progressive Disease|5|||
155609149|NCT01214668|561659242|FG003|Overall Study|Progressive Disease|4|||
155609150|NCT01214668|561659243|FG004|Overall Study|Progressive Disease|4|||
155609151|NCT01214668|561659244|FG005|Overall Study|Progressive Disease|5|||
155609152|NCT01214668|561659239|FG000|Overall Study|Withdrawal by Subject|0|||
155609153|NCT01214668|561659240|FG001|Overall Study|Withdrawal by Subject|0|||
155609154|NCT01214668|561659241|FG002|Overall Study|Withdrawal by Subject|0|||
155609155|NCT01214668|561659242|FG003|Overall Study|Withdrawal by Subject|0|||
155609156|NCT01214668|561659243|FG004|Overall Study|Withdrawal by Subject|1|||
155609157|NCT01214668|561659244|FG005|Overall Study|Withdrawal by Subject|0|||
155609158|NCT02907619|561659245|FG000|Overall Study|Study terminated by sponsor|18|||
155609159|NCT02907619|561659246|FG001|Overall Study|Study terminated by sponsor|18|||
155609160|NCT02907619|561659247|FG002|Overall Study|Study terminated by sponsor|19|||
155609161|NCT02907619|561659245|FG000|Overall Study|Death|0|||
155609162|NCT02907619|561659246|FG001|Overall Study|Death|0|||
155609163|NCT02907619|561659247|FG002|Overall Study|Death|1|||
155609164|NCT02907619|561659245|FG000|Overall Study|Withdrawal by Subject|1|||
155609165|NCT02907619|561659246|FG001|Overall Study|Withdrawal by Subject|1|||
155609166|NCT02907619|561659247|FG002|Overall Study|Withdrawal by Subject|0|||
155609167|NCT02907619|561659245|FG000|Overall Study|Other|0|||
155609168|NCT02907619|561659246|FG001|Overall Study|Other|1|||
155609169|NCT02907619|561659247|FG002|Overall Study|Other|0|||
155609170|NCT03326518|561659248|FG000|Overall Study|Protocol Violation|1|||
155609171|NCT03326518|561659249|FG001|Overall Study|Protocol Violation|0|||
155609172|NCT03326518|561659250|FG002|Overall Study|Protocol Violation|0|||
155609173|NCT03326518|561659248|FG000|Overall Study|Withdrawal by Subject|1|||
155609174|NCT03326518|561659249|FG001|Overall Study|Withdrawal by Subject|0|||
155609175|NCT03326518|561659250|FG002|Overall Study|Withdrawal by Subject|0|||
155609176|NCT03326518|561659248|FG000|Overall Study|Lost to Follow-up|1|||
155609177|NCT03326518|561659249|FG001|Overall Study|Lost to Follow-up|0|||
155609178|NCT03326518|561659250|FG002|Overall Study|Lost to Follow-up|1|||
155609179|NCT01375374|561659251|FG000|Overall Study|Adverse Event|1|||
155609180|NCT02065518|561659252|FG000|Overall Study|Lost to Follow-up|3|||
155609181|NCT02065518|561659253|FG001|Overall Study|Lost to Follow-up|4|||
155609182|NCT02065518|561659254|FG002|Overall Study|Lost to Follow-up|0|||
155609183|NCT02065518|561659255|FG003|Overall Study|Lost to Follow-up|3|||
155609184|NCT02065518|561659252|FG000|Overall Study|Withdrawal by Subject|3|||
155609185|NCT02065518|561659253|FG001|Overall Study|Withdrawal by Subject|4|||
155609186|NCT02065518|561659254|FG002|Overall Study|Withdrawal by Subject|9|||
155609187|NCT02065518|561659255|FG003|Overall Study|Withdrawal by Subject|2|||
155609188|NCT01066663|561659256|FG000|Overall Study|Adverse Event|0|||
155609189|NCT01066663|561659257|FG001|Overall Study|Adverse Event|0|||
155609190|NCT01066663|561659258|FG002|Overall Study|Adverse Event|1|||
155609191|NCT00571103|561659259|FG000|Overall Study|Withdrawal by Subject|1|||
155609192|NCT00571103|561659259|FG000|Overall Study|Lost to Follow-up|1|||
155609193|NCT00564278|561659262|FG000|Overall Study|Lost to Follow-up|35|||
155609194|NCT00564278|561659263|FG001|Overall Study|Lost to Follow-up|33|||
155609195|NCT00564278|561659262|FG000|Overall Study|Physician Decision|1|||
155609196|NCT00564278|561659263|FG001|Overall Study|Physician Decision|2|||
155609197|NCT00564278|561659262|FG000|Overall Study|Withdrawal by Subject|11|||
155609198|NCT00564278|561659263|FG001|Overall Study|Withdrawal by Subject|7|||
155609199|NCT00560703|561659264|FG000|Overall Study|Adverse Event|0|||
155609200|NCT00560703|561659265|FG001|Overall Study|Adverse Event|2|||
155609201|NCT00560703|561659264|FG000|Overall Study|Protocol Violation|0|||
155609202|NCT00560703|561659265|FG001|Overall Study|Protocol Violation|2|||
155609203|NCT00560703|561659264|FG000|Overall Study|Withdrawal by Subject|0|||
155609204|NCT00560703|561659265|FG001|Overall Study|Withdrawal by Subject|1|||
155609205|NCT00560703|561659264|FG000|Overall Study|non-compliance|0|||
155609206|NCT00560703|561659265|FG001|Overall Study|non-compliance|1|||
155609207|NCT04847232|561659266|FG000|Overall Study|Death|123|||
155609208|NCT04847232|561659267|FG001|Overall Study|Death|115|||
155609209|NCT04847232|561659266|FG000|Overall Study|Lost to Follow-up|3|||
155381335|NCT04055090|560830871|FG000|Overall Study|screen failure|1|||
155609210|NCT04847232|561659267|FG001|Overall Study|Lost to Follow-up|10|||
155609211|NCT04847232|561659266|FG000|Overall Study|Withdrawal by Subject|73|||
155609212|NCT04847232|561659267|FG001|Overall Study|Withdrawal by Subject|101|||
155609213|NCT04847232|561659266|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
155609214|NCT04847232|561659267|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
155609215|NCT02476916|561659272|FG000|Core Period|Adverse Event|2|||
155609216|NCT02476916|561659273|FG001|Core Period|Adverse Event|2|||
155609217|NCT02476916|561659272|FG000|Core Period|Investigator decision|1|||
155609218|NCT02476916|561659273|FG001|Core Period|Investigator decision|1|||
155609219|NCT02476916|561659272|FG000|Core Period|Withdrawal by Subject|3|||
155609220|NCT02476916|561659273|FG001|Core Period|Withdrawal by Subject|0|||
155650559|NCT00147537|561812507|FG005|Phase 2|Other|0|||
155609221|NCT02476916|561659272|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
155609222|NCT02476916|561659273|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
155609223|NCT02476916|561659272|FG000|Extension Period|On Treatment|12|||
155609224|NCT02476916|561659273|FG001|Extension Period|On Treatment|17|||
155609225|NCT06010732|561659275|FG000|Crossover Period 1|Protocol Violation|0|||
155609226|NCT06010732|561659276|FG001|Crossover Period 1|Protocol Violation|0|||
155609227|NCT06010732|561659277|FG002|Crossover Period 1|Protocol Violation|1|||
155609228|NCT06010732|561659278|FG003|Crossover Period 1|Protocol Violation|0|||
155609229|NCT06010732|561659279|FG004|Crossover Period 1|Protocol Violation|1|||
155609230|NCT06010732|561659280|FG005|Crossover Period 1|Protocol Violation|0|||
155609231|NCT06010732|561659275|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155609232|NCT06010732|561659276|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
155609233|NCT06010732|561659277|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155609234|NCT06010732|561659278|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155609235|NCT06010732|561659279|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155609236|NCT06010732|561659280|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155609237|NCT06010732|561659275|FG000|Crossover Period 2|Adverse Event|0|||
155609238|NCT06010732|561659276|FG001|Crossover Period 2|Adverse Event|1|||
155609239|NCT06010732|561659277|FG002|Crossover Period 2|Adverse Event|0|||
155609240|NCT06010732|561659278|FG003|Crossover Period 2|Adverse Event|0|||
155609241|NCT06010732|561659279|FG004|Crossover Period 2|Adverse Event|0|||
155609242|NCT06010732|561659280|FG005|Crossover Period 2|Adverse Event|0|||
155609243|NCT06010732|561659275|FG000|Crossover Period 2|broken denture|0|||
155609244|NCT06010732|561659276|FG001|Crossover Period 2|broken denture|0|||
155609245|NCT06010732|561659277|FG002|Crossover Period 2|broken denture|1|||
155609246|NCT06010732|561659278|FG003|Crossover Period 2|broken denture|0|||
155609247|NCT06010732|561659279|FG004|Crossover Period 2|broken denture|0|||
155609248|NCT06010732|561659280|FG005|Crossover Period 2|broken denture|0|||
155609249|NCT00715520|561659282|FG000|Overall Study|Screen failure|8|||
155609250|NCT00715520|561659283|FG001|Overall Study|Screen failure|1|||
155609251|NCT00715520|561659284|FG002|Overall Study|Screen failure|1|||
155609252|NCT00715520|561659282|FG000|Overall Study|Withdrawal by Subject|2|||
155609253|NCT00715520|561659283|FG001|Overall Study|Withdrawal by Subject|0|||
155609254|NCT00715520|561659284|FG002|Overall Study|Withdrawal by Subject|1|||
155609255|NCT04942210|561659288|FG000|Overall Study|Adverse Event|0|||
155609256|NCT04942210|561659289|FG001|Overall Study|Adverse Event|1|||
155609257|NCT04942210|561659288|FG000|Overall Study|Protocol Deviation|4|||
155609258|NCT04942210|561659289|FG001|Overall Study|Protocol Deviation|1|||
155609259|NCT04942210|561659288|FG000|Overall Study|Withdrawal by Subject|5|||
155609260|NCT04942210|561659289|FG001|Overall Study|Withdrawal by Subject|2|||
155609261|NCT04942210|561659288|FG000|Overall Study|Lost to Follow-up|16|||
155609262|NCT04942210|561659289|FG001|Overall Study|Lost to Follow-up|7|||
155609263|NCT04942210|561659288|FG000|Overall Study|Ongoing at the time of DBL date|60|||
155609264|NCT04942210|561659289|FG001|Overall Study|Ongoing at the time of DBL date|25|||
155609265|NCT04942210|561659288|FG000|Overall Study|Randomized but did not receive vaccination|3|||
155609266|NCT04942210|561659289|FG001|Overall Study|Randomized but did not receive vaccination|0|||
155609267|NCT04122625|561659292|FG000|Part A (up to 2.92 Years)|Death|2|||
155609268|NCT04122625|561659293|FG001|Part A (up to 2.92 Years)|Death|4|||
155609269|NCT04122625|561659294|FG002|Part A (up to 2.92 Years)|Death|0|||
155609270|NCT04122625|561659295|FG003|Part A (up to 2.92 Years)|Death|0|||
155609271|NCT04122625|561659296|FG004|Part A (up to 2.92 Years)|Death|0|||
155609272|NCT04122625|561659297|FG005|Part A (up to 2.92 Years)|Death|0|||
155609273|NCT04122625|561659292|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155609274|NCT04122625|561659293|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155609275|NCT04122625|561659294|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
155609276|NCT04122625|561659295|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
155609277|NCT04122625|561659296|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
155609278|NCT04122625|561659297|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155609279|NCT04122625|561659292|FG000|Part B (up to 2.33 Years)|Death|0|||
155609280|NCT04122625|561659293|FG001|Part B (up to 2.33 Years)|Death|0|||
155609281|NCT04122625|561659294|FG002|Part B (up to 2.33 Years)|Death|5|||
155609282|NCT04122625|561659295|FG003|Part B (up to 2.33 Years)|Death|7|||
155609283|NCT04122625|561659296|FG004|Part B (up to 2.33 Years)|Death|6|||
155609284|NCT04122625|561659297|FG005|Part B (up to 2.33 Years)|Death|7|||
155609285|NCT04348500|561659298|FG000|Overall Study|Death|2|||
155609286|NCT04348500|561659299|FG001|Overall Study|Death|2|||
155609287|NCT04348500|561659298|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
155609288|NCT04348500|561659299|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
155381336|NCT04055090|560830872|FG001|Overall Study|screen failure|0|||
155609289|NCT02776670|561659300|FG000|Overall Study|Adverse Event|0|||
155609290|NCT02776670|561659301|FG001|Overall Study|Adverse Event|2|||
155609291|NCT02776670|561659300|FG000|Overall Study|Protocol Violation|0|||
155609292|NCT02776670|561659301|FG001|Overall Study|Protocol Violation|2|||
155609293|NCT02776670|561659300|FG000|Overall Study|Withdrawal by Subject|0|||
155609294|NCT02776670|561659301|FG001|Overall Study|Withdrawal by Subject|1|||
155609295|NCT02776670|561659300|FG000|Overall Study|Other - Reason not given|0|||
155609296|NCT02776670|561659301|FG001|Overall Study|Other - Reason not given|1|||
155609297|NCT03699540|561659302|FG000|Overall Study|Lost to Follow-up|1|||
155609298|NCT02697591|561659307|FG000|Overall Study|Lost to Follow-up|0|||
155609299|NCT02697591|561659308|FG001|Overall Study|Lost to Follow-up|0|||
155609300|NCT02697591|561659309|FG002|Overall Study|Lost to Follow-up|0|||
155609301|NCT02697591|561659310|FG003|Overall Study|Lost to Follow-up|0|||
155609302|NCT02697591|561659311|FG004|Overall Study|Lost to Follow-up|0|||
155609303|NCT02697591|561659312|FG005|Overall Study|Lost to Follow-up|1|||
155609304|NCT02697591|561659313|FG006|Overall Study|Lost to Follow-up|1|||
155609305|NCT02697591|561659314|FG007|Overall Study|Lost to Follow-up|0|||
155609306|NCT02697591|561659315|FG008|Overall Study|Lost to Follow-up|0|||
155609307|NCT02697591|561659316|FG009|Overall Study|Lost to Follow-up|1|||
155609308|NCT02697591|561659307|FG000|Overall Study|Withdrawal by Subject|1|||
155609309|NCT02697591|561659308|FG001|Overall Study|Withdrawal by Subject|1|||
155609310|NCT02697591|561659309|FG002|Overall Study|Withdrawal by Subject|2|||
155609311|NCT02697591|561659310|FG003|Overall Study|Withdrawal by Subject|1|||
155609312|NCT02697591|561659311|FG004|Overall Study|Withdrawal by Subject|7|||
155609313|NCT02697591|561659312|FG005|Overall Study|Withdrawal by Subject|6|||
155609314|NCT02697591|561659313|FG006|Overall Study|Withdrawal by Subject|9|||
155609315|NCT02697591|561659314|FG007|Overall Study|Withdrawal by Subject|1|||
155609316|NCT02697591|561659315|FG008|Overall Study|Withdrawal by Subject|6|||
155609317|NCT02697591|561659316|FG009|Overall Study|Withdrawal by Subject|10|||
155609318|NCT02697591|561659307|FG000|Overall Study|Physician Decision|1|||
155609319|NCT02697591|561659308|FG001|Overall Study|Physician Decision|0|||
155609320|NCT02697591|561659309|FG002|Overall Study|Physician Decision|0|||
155609321|NCT02697591|561659310|FG003|Overall Study|Physician Decision|0|||
155609322|NCT02697591|561659311|FG004|Overall Study|Physician Decision|1|||
155609323|NCT02697591|561659312|FG005|Overall Study|Physician Decision|2|||
155609324|NCT02697591|561659313|FG006|Overall Study|Physician Decision|0|||
155609325|NCT02697591|561659314|FG007|Overall Study|Physician Decision|0|||
155609326|NCT02697591|561659315|FG008|Overall Study|Physician Decision|1|||
155609327|NCT02697591|561659316|FG009|Overall Study|Physician Decision|1|||
155609328|NCT02697591|561659307|FG000|Overall Study|Death|2|||
155609329|NCT02697591|561659308|FG001|Overall Study|Death|3|||
155609330|NCT02697591|561659309|FG002|Overall Study|Death|1|||
155609331|NCT02697591|561659310|FG003|Overall Study|Death|1|||
155609332|NCT02697591|561659311|FG004|Overall Study|Death|4|||
155609333|NCT02697591|561659312|FG005|Overall Study|Death|5|||
155609334|NCT02697591|561659313|FG006|Overall Study|Death|3|||
155609335|NCT02697591|561659314|FG007|Overall Study|Death|1|||
155609336|NCT02697591|561659315|FG008|Overall Study|Death|1|||
155609337|NCT02697591|561659316|FG009|Overall Study|Death|5|||
155609338|NCT02697591|561659307|FG000|Overall Study|Reason not Specified|0|||
155609339|NCT02697591|561659308|FG001|Overall Study|Reason not Specified|0|||
155609340|NCT02697591|561659309|FG002|Overall Study|Reason not Specified|0|||
155609341|NCT02697591|561659310|FG003|Overall Study|Reason not Specified|1|||
155609342|NCT02697591|561659311|FG004|Overall Study|Reason not Specified|1|||
155609343|NCT02697591|561659312|FG005|Overall Study|Reason not Specified|2|||
155609344|NCT02697591|561659313|FG006|Overall Study|Reason not Specified|3|||
155609345|NCT02697591|561659314|FG007|Overall Study|Reason not Specified|1|||
155609346|NCT02697591|561659315|FG008|Overall Study|Reason not Specified|1|||
155609347|NCT02697591|561659316|FG009|Overall Study|Reason not Specified|3|||
155609348|NCT02722746|561659317|FG000|Overall Study|Withdrawal by Subject|0|||
155609349|NCT02722746|561659318|FG001|Overall Study|Withdrawal by Subject|1|||
155609350|NCT02722746|561659319|FG002|Overall Study|Withdrawal by Subject|0|||
155609351|NCT02722746|561659317|FG000|Overall Study|Protocol Violation|8|||
155609352|NCT02722746|561659318|FG001|Overall Study|Protocol Violation|4|||
155609353|NCT02722746|561659319|FG002|Overall Study|Protocol Violation|6|||
155609354|NCT03624569|561659321|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155609355|NCT03624569|561659322|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
155609356|NCT03624569|561659321|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
155609357|NCT03624569|561659322|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
155609358|NCT01618916|561659325|FG000|Overall Study|Adverse Event|1|||
155609359|NCT01618916|561659326|FG001|Overall Study|Adverse Event|0|||
155609360|NCT01618916|561659327|FG002|Overall Study|Adverse Event|0|||
155609361|NCT01618916|561659328|FG003|Overall Study|Adverse Event|0|||
155609362|NCT01618916|561659329|FG004|Overall Study|Adverse Event|0|||
155609363|NCT01618916|561659330|FG005|Overall Study|Adverse Event|0|||
155609364|NCT01618916|561659325|FG000|Overall Study|Withdrawal by Subject|0|||
155609365|NCT01618916|561659326|FG001|Overall Study|Withdrawal by Subject|1|||
155609366|NCT01618916|561659327|FG002|Overall Study|Withdrawal by Subject|1|||
155609367|NCT01618916|561659328|FG003|Overall Study|Withdrawal by Subject|0|||
155609368|NCT01618916|561659329|FG004|Overall Study|Withdrawal by Subject|1|||
155609369|NCT01618916|561659330|FG005|Overall Study|Withdrawal by Subject|0|||
155609370|NCT01618916|561659325|FG000|Overall Study|Lost to Follow-up|1|||
155609371|NCT01618916|561659326|FG001|Overall Study|Lost to Follow-up|0|||
155609372|NCT01618916|561659327|FG002|Overall Study|Lost to Follow-up|0|||
155609373|NCT01618916|561659328|FG003|Overall Study|Lost to Follow-up|2|||
155609374|NCT01618916|561659329|FG004|Overall Study|Lost to Follow-up|0|||
155381337|NCT04055090|560830871|FG000|Overall Study|Withdrawal by Subject|1|||
155381338|NCT04055090|560830872|FG001|Overall Study|Withdrawal by Subject|0|||
155381339|NCT04426851|560830873|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
155381340|NCT04426851|560830874|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
155381341|NCT04426851|560830873|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
155381342|NCT04426851|560830874|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
155381343|NCT03256851|560830878|FG000|Overall Study|Withdrawal by Subject|1|||
155381344|NCT03256851|560830879|FG001|Overall Study|Withdrawal by Subject|0|||
155381345|NCT01065844|560830880|FG000|Overall Study|Adverse Event|5|||
155381346|NCT00552240|560830881|FG000|Overall Study|Adverse Event|9|||
155381347|NCT00552240|560830882|FG001|Overall Study|Adverse Event|9|||
155381348|NCT00552240|560830881|FG000|Overall Study|Protocol Violation|1|||
155381349|NCT00552240|560830882|FG001|Overall Study|Protocol Violation|1|||
155381350|NCT00552240|560830881|FG000|Overall Study|Lost to Follow-up|5|||
155381351|NCT00552240|560830882|FG001|Overall Study|Lost to Follow-up|6|||
155381352|NCT00552240|560830881|FG000|Overall Study|Withdrawal by Subject|2|||
155381353|NCT00552240|560830882|FG001|Overall Study|Withdrawal by Subject|2|||
155381354|NCT00552240|560830881|FG000|Overall Study|Lack of Efficacy|6|||
155381355|NCT00552240|560830882|FG001|Overall Study|Lack of Efficacy|0|||
155381356|NCT00552240|560830881|FG000|Overall Study|Other|1|||
155381357|NCT00552240|560830882|FG001|Overall Study|Other|0|||
155381358|NCT02679573|560830884|FG000|Overall Study|Adverse Event|13|||
155381359|NCT02679573|560830885|FG001|Overall Study|Adverse Event|6|||
155381360|NCT02679573|560830884|FG000|Overall Study|Lack of Efficacy|12|||
155381361|NCT02679573|560830885|FG001|Overall Study|Lack of Efficacy|15|||
155381362|NCT02679573|560830884|FG000|Overall Study|Could not complete required study visits|6|||
155381363|NCT02679573|560830885|FG001|Overall Study|Could not complete required study visits|2|||
155381364|NCT02679573|560830884|FG000|Overall Study|Withdrawal by Subject|2|||
155381365|NCT02679573|560830885|FG001|Overall Study|Withdrawal by Subject|9|||
155381366|NCT02679573|560830884|FG000|Overall Study|Death|2|||
155381367|NCT02679573|560830885|FG001|Overall Study|Death|0|||
155381368|NCT02679573|560830884|FG000|Overall Study|Physician Decision|2|||
155381369|NCT02679573|560830885|FG001|Overall Study|Physician Decision|4|||
155381370|NCT02679573|560830884|FG000|Overall Study|Lost to Follow-up|0|||
155381371|NCT02679573|560830885|FG001|Overall Study|Lost to Follow-up|3|||
155381372|NCT03545503|560830887|FG000|Overall Study|Protocol Violation|14|||
155381373|NCT03545503|560830888|FG001|Overall Study|Protocol Violation|16|||
155381374|NCT02128542|560830889|FG000|Overall Study|Lost to Follow-up|3|||
155381375|NCT02128542|560830890|FG001|Overall Study|Lost to Follow-up|0|||
155381376|NCT02128542|560830889|FG000|Overall Study|Withdrew Consent|1|||
155381377|NCT02128542|560830890|FG001|Overall Study|Withdrew Consent|0|||
155381378|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
155381379|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
155381380|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155381381|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155381382|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
155381383|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
155381384|NCT02483585|560830891|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
155381385|NCT02483585|560830892|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
155381386|NCT02483585|560830891|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
155381387|NCT02483585|560830892|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
155381388|NCT02483585|560830891|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
155381389|NCT02483585|560830892|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
155381390|NCT02483585|560830891|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
155381391|NCT02483585|560830892|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
155381392|NCT00825916|560830896|FG000|Overall Study|Lost to Follow-up|4|||
155381393|NCT00825916|560830897|FG001|Overall Study|Lost to Follow-up|2|||
155381394|NCT00825916|560830898|FG002|Overall Study|Lost to Follow-up|1|||
155381395|NCT01098097|560830902|FG000|Overall Study|Adverse Event|17|||
155381396|NCT01098097|560830902|FG000|Overall Study|Lost to Follow-up|18|||
155381397|NCT01098097|560830902|FG000|Overall Study|Status unknown|16|||
155381398|NCT01098097|560830902|FG000|Overall Study|No reason reported|31|||
155381399|NCT00394082|560830905|FG000|Overall Study|Unacceptable toxicity|15|||
155381400|NCT00394082|560830905|FG000|Overall Study|Adverse Event|4|||
155381401|NCT00394082|560830905|FG000|Overall Study|Physician Decision|4|||
155381402|NCT00394082|560830905|FG000|Overall Study|Withdrawal by Subject|2|||
155381403|NCT00394082|560830905|FG000|Overall Study|Other|1|||
155381404|NCT01768117|560830909|FG000|Overall Study|Lost to Follow-up|1|||
155381405|NCT01768117|560830909|FG000|Overall Study|Withdrawal by Subject|2|||
155381406|NCT01768117|560830909|FG000|Overall Study|Protocol Violation|3|||
155381407|NCT01945060|560830910|FG000|Overall Study|Lost to follow up|1|||
155381408|NCT01945060|560830911|FG001|Overall Study|Lost to follow up|0|||
155381409|NCT01945060|560830910|FG000|Overall Study|Distress related to IV access|0|||
155381410|NCT01945060|560830911|FG001|Overall Study|Distress related to IV access|1|||
155381411|NCT01000636|560830914|FG000|Overall Study|Withdrawal by Subject|1|||
155381412|NCT01000636|560830914|FG000|Overall Study|Adverse Event|1|||
155381413|NCT00138671|560830915|FG000|Overall Study|Death|0|||
155609375|NCT01618916|561659330|FG005|Overall Study|Lost to Follow-up|0|||
155609376|NCT01084538|561659332|FG000|Overall Study|Drug not available|30|||
155609377|NCT01084538|561659332|FG000|Overall Study|Adverse Event|9|||
155609378|NCT01084538|561659332|FG000|Overall Study|Kidney transplant|6|||
155609379|NCT01084538|561659332|FG000|Overall Study|Serious Adverse Event|3|||
155609380|NCT01084538|561659332|FG000|Overall Study|Lack of effectiveness|2|||
155609381|NCT01084538|561659332|FG000|Overall Study|Patient noncompliance|2|||
155609382|NCT01084538|561659332|FG000|Overall Study|Hyperphosphatemia|2|||
155609383|NCT01084538|561659332|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
155609384|NCT01084538|561659332|FG000|Overall Study|Change of residence|2|||
155609385|NCT01084538|561659332|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
155609386|NCT01084538|561659332|FG000|Overall Study|Reason unknown|8|||
155609387|NCT00803205|561659333|FG000|Overall Study|Adverse Event|7|||
155609388|NCT00803205|561659334|FG001|Overall Study|Adverse Event|2|||
155609389|NCT00803205|561659333|FG000|Overall Study|Lost to Follow-up|1|||
155609390|NCT00803205|561659334|FG001|Overall Study|Lost to Follow-up|0|||
155609391|NCT00803205|561659333|FG000|Overall Study|Withdrawal by Subject|9|||
155609392|NCT00803205|561659334|FG001|Overall Study|Withdrawal by Subject|9|||
155609393|NCT00803205|561659333|FG000|Overall Study|Physician Decision|1|||
155609394|NCT00803205|561659334|FG001|Overall Study|Physician Decision|0|||
155609395|NCT00803205|561659333|FG000|Overall Study|Protocol Violation|1|||
155609396|NCT00803205|561659334|FG001|Overall Study|Protocol Violation|1|||
155609397|NCT00803205|561659333|FG000|Overall Study|Medical Monitor Decision|1|||
155609398|NCT00803205|561659334|FG001|Overall Study|Medical Monitor Decision|0|||
155609399|NCT00803205|561659333|FG000|Overall Study|Acquired a Lung Infection|0|||
155609400|NCT00803205|561659334|FG001|Overall Study|Acquired a Lung Infection|1|||
155609401|NCT00803205|561659333|FG000|Overall Study|Sponsor Decision|0|||
155609402|NCT00803205|561659334|FG001|Overall Study|Sponsor Decision|1|||
155609403|NCT00090584|561659335|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
155609404|NCT00090584|561659336|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
155609405|NCT00090584|561659335|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
155609406|NCT00090584|561659336|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
155609407|NCT02536781|561659338|FG000|Overall Study|Lost to Follow-up|2|||
155609408|NCT02536781|561659339|FG001|Overall Study|Lost to Follow-up|0|||
155609409|NCT00508157|561659340|FG000|Overall Study|Adverse Event|0|||
155609410|NCT00508157|561659341|FG001|Overall Study|Adverse Event|1|||
155609411|NCT00508157|561659340|FG000|Overall Study|Subject Withdrew Consent|1|||
155609412|NCT00508157|561659341|FG001|Overall Study|Subject Withdrew Consent|0|||
155609413|NCT00508157|561659340|FG000|Overall Study|Lost to Follow-up|1|||
155609414|NCT00508157|561659341|FG001|Overall Study|Lost to Follow-up|0|||
155609415|NCT00508157|561659340|FG000|Overall Study|Subject no longer met study criteria|0|||
155609416|NCT00508157|561659341|FG001|Overall Study|Subject no longer met study criteria|1|||
155609417|NCT00508157|561659340|FG000|Overall Study|Other known cause|0|||
155609418|NCT00508157|561659341|FG001|Overall Study|Other known cause|1|||
155609419|NCT02258334|561659344|FG000|Overall Study|Adverse Event|1|||
155609420|NCT02258334|561659345|FG001|Overall Study|Adverse Event|0|||
155609421|NCT02258334|561659346|FG002|Overall Study|Adverse Event|0|||
155609422|NCT02258334|561659347|FG003|Overall Study|Adverse Event|0|||
155609423|NCT03564795|561659350|FG000|Overall Study|Withdrawal by Subject|3|||
155609424|NCT03564795|561659350|FG000|Overall Study|Lost to Follow-up|6|||
155609425|NCT03564795|561659350|FG000|Overall Study|Physician Decision|2|||
155609426|NCT00432276|561659355|FG000|Overall Study|Hyperglycemic Rescue|44|||
155609427|NCT00432276|561659356|FG001|Overall Study|Hyperglycemic Rescue|87|||
155609428|NCT00432276|561659355|FG000|Overall Study|Adverse Event|13|||
155609429|NCT00432276|561659356|FG001|Overall Study|Adverse Event|16|||
155609430|NCT00432276|561659355|FG000|Overall Study|Protocol Violation|25|||
155609431|NCT00432276|561659356|FG001|Overall Study|Protocol Violation|20|||
155609432|NCT00432276|561659355|FG000|Overall Study|Lost to Follow-up|6|||
155609433|NCT00432276|561659356|FG001|Overall Study|Lost to Follow-up|2|||
155609434|NCT00432276|561659355|FG000|Overall Study|Withdrawal by Subject|25|||
155609435|NCT00432276|561659356|FG001|Overall Study|Withdrawal by Subject|20|||
155609436|NCT00432276|561659355|FG000|Overall Study|Physician Decision|6|||
155609437|NCT00432276|561659356|FG001|Overall Study|Physician Decision|8|||
155609438|NCT00432276|561659355|FG000|Overall Study|Other|2|||
155609439|NCT00432276|561659356|FG001|Overall Study|Other|3|||
155609440|NCT00594386|561659357|FG000|Overall Study|Major protocol violation|2|||
155609441|NCT00594386|561659357|FG000|Overall Study|Lack of Efficacy|12|||
155609442|NCT00594386|561659357|FG000|Overall Study|Adverse Event|68|||
155609443|NCT00594386|561659357|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
155609444|NCT00594386|561659357|FG000|Overall Study|Subject withdrew consent|35|||
155609445|NCT00594386|561659357|FG000|Overall Study|Study ended per sponsor|115|||
155609446|NCT00594386|561659357|FG000|Overall Study|Lost to Follow-up|6|||
155609447|NCT00594386|561659357|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
155609448|NCT00594386|561659357|FG000|Overall Study|Other: Subject moved to Seattle|1|||
155609449|NCT00594386|561659357|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
155609450|NCT00594386|561659357|FG000|Overall Study|Other: Study terminated per investigator|2|||
155609451|NCT00594386|561659357|FG000|Overall Study|Other: Sponsor closure of study|1|||
155609452|NCT00594386|561659357|FG000|Overall Study|Other: Site terminated participation|1|||
155609453|NCT00594386|561659357|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
155609454|NCT00594386|561659357|FG000|Overall Study|Other: Loss of drivers license|1|||
155609455|NCT04459598|561659362|FG000|Overall Study|Adverse Event|1|||
155609456|NCT04459598|561659363|FG001|Overall Study|Adverse Event|1|||
155609457|NCT00422292|561659364|FG000|Overall Study|Serious adverse events|1|||
155609458|NCT00422292|561659365|FG001|Overall Study|Serious adverse events|4|||
155609459|NCT00422292|561659366|FG002|Overall Study|Serious adverse events|0|||
155609460|NCT00422292|561659367|FG003|Overall Study|Serious adverse events|0|||
155609461|NCT00422292|561659364|FG000|Overall Study|Adverse Event|1|||
155609462|NCT00422292|561659365|FG001|Overall Study|Adverse Event|0|||
155609463|NCT00422292|561659366|FG002|Overall Study|Adverse Event|1|||
155609464|NCT00422292|561659367|FG003|Overall Study|Adverse Event|0|||
155609465|NCT00422292|561659364|FG000|Overall Study|Protocol Violation|4|||
155609466|NCT00422292|561659365|FG001|Overall Study|Protocol Violation|25|||
155609467|NCT00422292|561659366|FG002|Overall Study|Protocol Violation|8|||
155609468|NCT00422292|561659367|FG003|Overall Study|Protocol Violation|5|||
155609469|NCT00422292|561659364|FG000|Overall Study|Lost to Follow-up|6|||
155609470|NCT00422292|561659365|FG001|Overall Study|Lost to Follow-up|12|||
155609471|NCT00422292|561659366|FG002|Overall Study|Lost to Follow-up|6|||
155609472|NCT00422292|561659367|FG003|Overall Study|Lost to Follow-up|6|||
155609473|NCT00422292|561659364|FG000|Overall Study|Withdrawal by Subject|6|||
155609474|NCT00422292|561659365|FG001|Overall Study|Withdrawal by Subject|25|||
155609475|NCT00422292|561659366|FG002|Overall Study|Withdrawal by Subject|7|||
155609476|NCT00422292|561659367|FG003|Overall Study|Withdrawal by Subject|13|||
155609477|NCT02243046|561659368|FG000|Overall Study|Lost to Follow-up|1|||
155609478|NCT02243046|561659369|FG001|Overall Study|Lost to Follow-up|1|||
155609479|NCT02243046|561659370|FG002|Overall Study|Lost to Follow-up|4|||
155609480|NCT04494425|561661306|FG000|Overall Study|Death|160|||
155609481|NCT04494425|561661307|FG001|Overall Study|Death|166|||
155609482|NCT04494425|561661306|FG000|Overall Study|Withdrawal by Subject|10|||
155609483|NCT04494425|561661307|FG001|Overall Study|Withdrawal by Subject|40|||
155609484|NCT04494425|561661306|FG000|Overall Study|Other|1|||
155609485|NCT04494425|561661307|FG001|Overall Study|Other|1|||
155609486|NCT04494425|561661306|FG000|Overall Study|Ongoing at the time of PCD|265|||
155609487|NCT04494425|561661307|FG001|Overall Study|Ongoing at the time of PCD|223|||
155609488|NCT01270321|561661309|FG000|Overall Study|Death|3|||
155609489|NCT01270321|561661310|FG001|Overall Study|Death|1|||
155609490|NCT01270321|561661311|FG002|Overall Study|Death|4|||
155609491|NCT01270321|561661309|FG000|Overall Study|Adverse Event|7|||
155609492|NCT01270321|561661310|FG001|Overall Study|Adverse Event|9|||
155609493|NCT01270321|561661311|FG002|Overall Study|Adverse Event|5|||
155609494|NCT04003623|561661315|FG000|Overall Study|Withdrawal by Subject|1|||
155609495|NCT04003623|561661316|FG001|Overall Study|Withdrawal by Subject|0|||
155609496|NCT01190189|561661319|FG000|Overall Study|Lost to Follow-up|4|||
155609497|NCT01190189|561661319|FG000|Overall Study|Withdrawal by Subject|1|||
155609498|NCT01190189|561661319|FG000|Overall Study|Migrated/moved from study area|1|||
155609499|NCT00904917|561661320|FG000|Overall Study|Lost to Follow-up|2|||
155609500|NCT00904917|561661321|FG001|Overall Study|Lost to Follow-up|2|||
155609501|NCT00904917|561661322|FG002|Overall Study|Lost to Follow-up|2|||
155609502|NCT00904917|561661323|FG003|Overall Study|Lost to Follow-up|2|||
155609503|NCT02442206|561661324|FG000|Period 1|Adverse Event|1|||
155609504|NCT02442206|561661325|FG001|Period 1|Adverse Event|1|||
155609505|NCT02442206|561661324|FG000|Period 1|withdrew consent|0|||
155609506|NCT02442206|561661325|FG001|Period 1|withdrew consent|1|||
155609507|NCT02442206|561661324|FG000|Period 1|COPD exacerbation|0|||
155609508|NCT02442206|561661325|FG001|Period 1|COPD exacerbation|1|||
155609509|NCT02442206|561661324|FG000|Period 2|Adverse Event|1|||
155609510|NCT02442206|561661325|FG001|Period 2|Adverse Event|0|||
155609511|NCT01471444|561661326|FG000|Overall Study|Physician Decision|3|||
155609512|NCT01471444|561661327|FG001|Overall Study|Physician Decision|2|||
155609513|NCT01471444|561661326|FG000|Overall Study|Withdrawal by Subject|0|||
155609514|NCT01471444|561661327|FG001|Overall Study|Withdrawal by Subject|1|||
155609515|NCT01709409|561661332|FG000|Overall Study|Protocol Violation|1|||
155609516|NCT01709409|561661333|FG001|Overall Study|Protocol Violation|0|||
155609517|NCT02412878|561661334|FG000|Overall Study|Withdrawal by Subject|19|||
155609518|NCT02412878|561661335|FG001|Overall Study|Withdrawal by Subject|10|||
155609519|NCT02412878|561661334|FG000|Overall Study|Lost to Follow-up|2|||
155609520|NCT02412878|561661335|FG001|Overall Study|Lost to Follow-up|3|||
155609521|NCT02190721|561661336|FG000|Overall Study|Patient was out of the city|0|||
155609522|NCT02190721|561661337|FG001|Overall Study|Patient was out of the city|1|||
155609523|NCT02190721|561661338|FG002|Overall Study|Patient was out of the city|0|||
155609524|NCT05025332|561661339|FG000|Screening|Screen failure|12|||
155609525|NCT05025332|561661339|FG000|Treatment & Follow Up|Protocol Violation|1|||
155609526|NCT05025332|561661339|FG000|Treatment & Follow Up|Adverse Event|4|||
155609527|NCT04676152|561661340|FG000|Overall Study|screen fail|9|||
155609528|NCT01928199|561661341|FG000|Overall Study|Lost to Follow-up|2|||
155609529|NCT01928199|561661342|FG001|Overall Study|Lost to Follow-up|1|||
155609530|NCT01928199|561661341|FG000|Overall Study|Withdrawal by Subject|3|||
155609531|NCT01928199|561661342|FG001|Overall Study|Withdrawal by Subject|5|||
155609532|NCT02107313|561661344|FG000|Overall Study|One participant did not do the FED cohor|0|||
155609533|NCT02107313|561661345|FG001|Overall Study|One participant did not do the FED cohor|1|||
155609534|NCT01031004|561661348|FG000|Overall Study|Protocol Violation|0|||
155609535|NCT01031004|561661349|FG001|Overall Study|Protocol Violation|1|||
155609536|NCT01031004|561661348|FG000|Overall Study|Lost to Follow-up|1|||
155609537|NCT01031004|561661349|FG001|Overall Study|Lost to Follow-up|0|||
155609538|NCT01641471|561661350|FG000|Overall Study|Withdrawal by Subject|19|||
155609539|NCT01641471|561661351|FG001|Overall Study|Withdrawal by Subject|19|||
155609540|NCT01641471|561661350|FG000|Overall Study|Lost to Follow-up|2|||
155609541|NCT01641471|561661351|FG001|Overall Study|Lost to Follow-up|4|||
155609542|NCT01641471|561661350|FG000|Overall Study|Protocol Violation|2|||
155609543|NCT01641471|561661351|FG001|Overall Study|Protocol Violation|4|||
155609544|NCT04575584|561661352|FG000|Overall Study|Death|6|||
155609545|NCT04575584|561661353|FG001|Overall Study|Death|4|||
155609546|NCT04575584|561661354|FG002|Overall Study|Death|6|||
155609547|NCT04575584|561661355|FG003|Overall Study|Death|2|||
155609548|NCT04575584|561661356|FG004|Overall Study|Death|0|||
155609549|NCT04575584|561661357|FG005|Overall Study|Death|0|||
155609550|NCT04575584|561661352|FG000|Overall Study|Lost to Follow-up|1|||
155609551|NCT04575584|561661353|FG001|Overall Study|Lost to Follow-up|1|||
155609552|NCT04575584|561661354|FG002|Overall Study|Lost to Follow-up|1|||
155609553|NCT04575584|561661355|FG003|Overall Study|Lost to Follow-up|1|||
155609554|NCT04575584|561661356|FG004|Overall Study|Lost to Follow-up|0|||
155609555|NCT04575584|561661357|FG005|Overall Study|Lost to Follow-up|0|||
155609556|NCT04575584|561661352|FG000|Overall Study|Physician Decision|0|||
155609557|NCT04575584|561661353|FG001|Overall Study|Physician Decision|1|||
155609558|NCT04575584|561661354|FG002|Overall Study|Physician Decision|1|||
155609559|NCT04575584|561661355|FG003|Overall Study|Physician Decision|1|||
155609560|NCT04575584|561661356|FG004|Overall Study|Physician Decision|0|||
155609561|NCT04575584|561661357|FG005|Overall Study|Physician Decision|0|||
155609562|NCT04575584|561661352|FG000|Overall Study|Withdrawal by Subject|7|||
155609563|NCT04575584|561661353|FG001|Overall Study|Withdrawal by Subject|9|||
155609564|NCT04575584|561661354|FG002|Overall Study|Withdrawal by Subject|5|||
155609565|NCT04575584|561661355|FG003|Overall Study|Withdrawal by Subject|3|||
155609566|NCT04575584|561661356|FG004|Overall Study|Withdrawal by Subject|0|||
155609567|NCT04575584|561661357|FG005|Overall Study|Withdrawal by Subject|0|||
155609568|NCT04575584|561661352|FG000|Overall Study|Not recorded|0|||
155609569|NCT04575584|561661353|FG001|Overall Study|Not recorded|0|||
155609570|NCT04575584|561661354|FG002|Overall Study|Not recorded|0|||
155609571|NCT04575584|561661355|FG003|Overall Study|Not recorded|1|||
155609572|NCT04575584|561661356|FG004|Overall Study|Not recorded|0|||
155609573|NCT04575584|561661357|FG005|Overall Study|Not recorded|0|||
155609574|NCT02634801|561661358|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
155609575|NCT02634801|561661359|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
155609576|NCT02634801|561661360|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
155609577|NCT02634801|561661358|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
155609578|NCT02634801|561661359|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
155609579|NCT02634801|561661360|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
155609580|NCT02634801|561661358|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
155609581|NCT02634801|561661359|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
155609582|NCT02634801|561661360|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
155609583|NCT02634801|561661358|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
155609584|NCT02634801|561661359|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
155609585|NCT02634801|561661360|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
155609586|NCT02634801|561661358|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
155609587|NCT02634801|561661359|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
155609588|NCT02634801|561661360|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
155609589|NCT02634801|561661358|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
155609590|NCT02634801|561661359|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
155609591|NCT02634801|561661360|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
155609592|NCT02634801|561661358|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
155609593|NCT02634801|561661359|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
155609594|NCT02634801|561661360|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
155609595|NCT02634801|561661358|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155609596|NCT02634801|561661359|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155609597|NCT02634801|561661360|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155609598|NCT02634801|561661358|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
155609599|NCT02634801|561661359|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
155609600|NCT02634801|561661360|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
155609601|NCT02634801|561661358|FG000|Follow-up Period|Lost to Follow-up|3|||
155609602|NCT02634801|561661359|FG001|Follow-up Period|Lost to Follow-up|1|||
155609603|NCT02634801|561661360|FG002|Follow-up Period|Lost to Follow-up|2|||
155609604|NCT02634801|561661358|FG000|Follow-up Period|Physician Decision|0|||
155609605|NCT02634801|561661359|FG001|Follow-up Period|Physician Decision|0|||
155722583|NCT02318706|562083887|FG003|Double-blind Phase|Other|1|||
155609606|NCT02634801|561661360|FG002|Follow-up Period|Physician Decision|1|||
155609607|NCT02634801|561661358|FG000|Follow-up Period|Withdrawal by Subject|1|||
155609608|NCT02634801|561661359|FG001|Follow-up Period|Withdrawal by Subject|2|||
155609609|NCT02634801|561661360|FG002|Follow-up Period|Withdrawal by Subject|5|||
155609610|NCT02634801|561661358|FG000|Follow-up Period|Adverse Event|1|||
155609611|NCT02634801|561661359|FG001|Follow-up Period|Adverse Event|5|||
155609612|NCT02634801|561661360|FG002|Follow-up Period|Adverse Event|0|||
155609613|NCT01548768|561661381|FG000|Overall Study|Withdrawal by Subject|0|||
155609614|NCT01548768|561661382|FG001|Overall Study|Withdrawal by Subject|2|||
155609615|NCT01548768|561661383|FG002|Overall Study|Withdrawal by Subject|1|||
155609616|NCT01548768|561661384|FG003|Overall Study|Withdrawal by Subject|0|||
155609617|NCT01548768|561661381|FG000|Overall Study|Physician Decision|1|||
155609618|NCT01548768|561661382|FG001|Overall Study|Physician Decision|0|||
155609619|NCT01548768|561661383|FG002|Overall Study|Physician Decision|0|||
155609620|NCT01548768|561661384|FG003|Overall Study|Physician Decision|0|||
155609621|NCT01548768|561661381|FG000|Overall Study|Adverse Event|0|||
155609622|NCT01548768|561661382|FG001|Overall Study|Adverse Event|0|||
155609623|NCT01548768|561661383|FG002|Overall Study|Adverse Event|0|||
155609624|NCT01548768|561661384|FG003|Overall Study|Adverse Event|1|||
155609625|NCT01548768|561661381|FG000|Overall Study|Non-Compliance|0|||
155609626|NCT01548768|561661382|FG001|Overall Study|Non-Compliance|0|||
155609627|NCT01548768|561661383|FG002|Overall Study|Non-Compliance|0|||
155609628|NCT01548768|561661384|FG003|Overall Study|Non-Compliance|3|||
155609629|NCT02784288|561661385|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
155609630|NCT02757625|561661386|FG000|Overall Study|Investigator's discretion|0|||
155609631|NCT02757625|561661387|FG001|Overall Study|Investigator's discretion|0|||
155609632|NCT02757625|561661388|FG002|Overall Study|Investigator's discretion|1|||
155609633|NCT02757625|561661389|FG003|Overall Study|Investigator's discretion|0|||
155609634|NCT02757625|561661386|FG000|Overall Study|Adverse Event|0|||
155609635|NCT02757625|561661387|FG001|Overall Study|Adverse Event|0|||
155609636|NCT02757625|561661388|FG002|Overall Study|Adverse Event|1|||
155609637|NCT02757625|561661389|FG003|Overall Study|Adverse Event|0|||
155609638|NCT00645671|561661390|FG000|Overall Study|Protocol Violation|1|||
155609639|NCT00645671|561661391|FG001|Overall Study|Protocol Violation|0|||
155609640|NCT00645671|561661390|FG000|Overall Study|Withdrawal by Subject|0|||
155609641|NCT00645671|561661391|FG001|Overall Study|Withdrawal by Subject|4|||
155609642|NCT00645671|561661390|FG000|Overall Study|Adverse Event|0|||
155609643|NCT00645671|561661391|FG001|Overall Study|Adverse Event|1|||
155609644|NCT00645671|561661390|FG000|Overall Study|Physician Decision|0|||
155609645|NCT00645671|561661391|FG001|Overall Study|Physician Decision|1|||
155609646|NCT05600036|561661392|FG000|Overall Study|Adverse Event|0|||
155609647|NCT05600036|561661393|FG001|Overall Study|Adverse Event|2|||
155609648|NCT05600036|561661394|FG002|Overall Study|Adverse Event|1|||
155609649|NCT05600036|561661395|FG003|Overall Study|Adverse Event|0|||
155609650|NCT05600036|561661396|FG004|Overall Study|Adverse Event|1|||
155609651|NCT05600036|561661397|FG005|Overall Study|Adverse Event|0|||
155609652|NCT05600036|561661392|FG000|Overall Study|Lost to Follow-up|0|||
155609653|NCT05600036|561661393|FG001|Overall Study|Lost to Follow-up|2|||
155609654|NCT05600036|561661394|FG002|Overall Study|Lost to Follow-up|1|||
155609655|NCT05600036|561661395|FG003|Overall Study|Lost to Follow-up|1|||
155609656|NCT05600036|561661396|FG004|Overall Study|Lost to Follow-up|0|||
155609657|NCT05600036|561661397|FG005|Overall Study|Lost to Follow-up|0|||
155609658|NCT05600036|561661392|FG000|Overall Study|Protocol Violation|0|||
155609659|NCT05600036|561661393|FG001|Overall Study|Protocol Violation|0|||
155609660|NCT05600036|561661394|FG002|Overall Study|Protocol Violation|2|||
155609661|NCT05600036|561661395|FG003|Overall Study|Protocol Violation|0|||
155609662|NCT05600036|561661396|FG004|Overall Study|Protocol Violation|0|||
155609663|NCT05600036|561661397|FG005|Overall Study|Protocol Violation|0|||
155609664|NCT05600036|561661392|FG000|Overall Study|Withdrawal by Subject|0|||
155609665|NCT05600036|561661393|FG001|Overall Study|Withdrawal by Subject|1|||
155609666|NCT05600036|561661394|FG002|Overall Study|Withdrawal by Subject|2|||
155609667|NCT05600036|561661395|FG003|Overall Study|Withdrawal by Subject|0|||
155609668|NCT05600036|561661396|FG004|Overall Study|Withdrawal by Subject|3|||
155609669|NCT05600036|561661397|FG005|Overall Study|Withdrawal by Subject|5|||
155609670|NCT05600036|561661392|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155609671|NCT05600036|561661393|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155609672|NCT05600036|561661394|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155609673|NCT05600036|561661395|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
155609674|NCT05600036|561661396|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155609675|NCT05600036|561661397|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155609676|NCT05600036|561661392|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155609677|NCT05600036|561661393|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
155609678|NCT05600036|561661394|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155609679|NCT05600036|561661395|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155722584|NCT02318706|562083888|FG004|Double-blind Phase|Other|0|||
155609680|NCT05600036|561661396|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155609681|NCT05600036|561661397|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155609682|NCT05600036|561661392|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155609683|NCT05600036|561661393|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155609684|NCT05600036|561661394|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155609685|NCT05600036|561661395|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
155609686|NCT05600036|561661396|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155609687|NCT05600036|561661397|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155609688|NCT04401202|561661398|FG000|Overall Study|Lost to Follow-up|2|||
155609689|NCT04401202|561661399|FG001|Overall Study|Lost to Follow-up|2|||
155609690|NCT04401202|561661398|FG000|Overall Study|Adverse Event|0|||
155609691|NCT04401202|561661399|FG001|Overall Study|Adverse Event|1|||
155609692|NCT04401202|561661398|FG000|Overall Study|Hospitalized|4|||
155609693|NCT04401202|561661399|FG001|Overall Study|Hospitalized|1|||
155609694|NCT02714036|561661401|FG000|Overall Study|Adverse Event|9|||
155609695|NCT02714036|561661402|FG001|Overall Study|Adverse Event|2|||
155609696|NCT02714036|561661401|FG000|Overall Study|Withdrawal by Subject|3|||
155609697|NCT02714036|561661402|FG001|Overall Study|Withdrawal by Subject|2|||
155609698|NCT01006590|561661403|FG000|Overall Study|Adverse Event|2|||
155609699|NCT01006590|561661404|FG001|Overall Study|Adverse Event|3|||
155609700|NCT01006590|561661403|FG000|Overall Study|Death|1|||
155609701|NCT01006590|561661404|FG001|Overall Study|Death|1|||
155609702|NCT01006590|561661403|FG000|Overall Study|Lost to Follow-up|1|||
155609703|NCT01006590|561661404|FG001|Overall Study|Lost to Follow-up|1|||
155609704|NCT01006590|561661403|FG000|Overall Study|Protocol Violation|1|||
155609705|NCT01006590|561661404|FG001|Overall Study|Protocol Violation|0|||
155609706|NCT01006590|561661403|FG000|Overall Study|Withdrawal by Subject|4|||
155609707|NCT01006590|561661404|FG001|Overall Study|Withdrawal by Subject|2|||
155609708|NCT01006590|561661403|FG000|Overall Study|Study specific discontinuation criteria|16|||
155609709|NCT01006590|561661404|FG001|Overall Study|Study specific discontinuation criteria|23|||
155609710|NCT01006590|561661403|FG000|Overall Study|Other|3|||
155609711|NCT01006590|561661404|FG001|Overall Study|Other|2|||
155609712|NCT03332095|561661405|FG000|Overall Study|Lost to Follow-up|1|||
155609713|NCT03332095|561661406|FG001|Overall Study|Lost to Follow-up|0|||
155609714|NCT03332095|561661405|FG000|Overall Study|Pregnancy|0|||
155609715|NCT03332095|561661406|FG001|Overall Study|Pregnancy|1|||
155609716|NCT05697627|561661407|FG000|Overall Study|Adverse Event|1|||
155609717|NCT02700698|561661414|FG000|Overall Study|Withdrawal by Subject|1|||
155609718|NCT02700698|561661415|FG001|Overall Study|Withdrawal by Subject|0|||
155609719|NCT00703118|561661416|FG000|Overall Study|Adverse Event|1|||
155609720|NCT00703118|561661417|FG001|Overall Study|Adverse Event|2|||
155609721|NCT00703118|561661418|FG002|Overall Study|Adverse Event|2|||
155609722|NCT00703118|561661416|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
155609723|NCT00703118|561661417|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
155609724|NCT00703118|561661418|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
155609725|NCT00703118|561661416|FG000|Overall Study|Lost to Follow-up|6|||
155609726|NCT00703118|561661417|FG001|Overall Study|Lost to Follow-up|4|||
155609727|NCT00703118|561661418|FG002|Overall Study|Lost to Follow-up|4|||
155609728|NCT00703118|561661416|FG000|Overall Study|Withdrawal by Subject|8|||
155609729|NCT00703118|561661417|FG001|Overall Study|Withdrawal by Subject|7|||
155609730|NCT00703118|561661418|FG002|Overall Study|Withdrawal by Subject|13|||
155609731|NCT00703118|561661416|FG000|Overall Study|Other|0|||
155609732|NCT00703118|561661417|FG001|Overall Study|Other|0|||
155609733|NCT00703118|561661418|FG002|Overall Study|Other|1|||
155609734|NCT04527978|561661427|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
155609735|NCT04527978|561661428|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
155609736|NCT00055497|561661429|FG000|Overall Study|Adverse Event|1|||
155609737|NCT00055497|561661430|FG001|Overall Study|Adverse Event|1|||
155609738|NCT00055497|561661431|FG002|Overall Study|Adverse Event|1|||
155609739|NCT00055497|561661432|FG003|Overall Study|Adverse Event|28|||
155609740|NCT00055497|561661429|FG000|Overall Study|Withdrawal by Subject|3|||
155609741|NCT00055497|561661430|FG001|Overall Study|Withdrawal by Subject|1|||
155609742|NCT00055497|561661431|FG002|Overall Study|Withdrawal by Subject|1|||
155609743|NCT00055497|561661432|FG003|Overall Study|Withdrawal by Subject|15|||
155609744|NCT00055497|561661429|FG000|Overall Study|Lost to Follow-up|0|||
155609745|NCT00055497|561661430|FG001|Overall Study|Lost to Follow-up|1|||
155609746|NCT00055497|561661431|FG002|Overall Study|Lost to Follow-up|0|||
155609747|NCT00055497|561661432|FG003|Overall Study|Lost to Follow-up|5|||
155609748|NCT00055497|561661429|FG000|Overall Study|Protocol Violation|0|||
155609749|NCT00055497|561661430|FG001|Overall Study|Protocol Violation|0|||
155609750|NCT00055497|561661431|FG002|Overall Study|Protocol Violation|0|||
155609751|NCT00055497|561661432|FG003|Overall Study|Protocol Violation|3|||
155609752|NCT00055497|561661429|FG000|Overall Study|Lack of Efficacy|1|||
155609753|NCT00055497|561661430|FG001|Overall Study|Lack of Efficacy|0|||
155609754|NCT00055497|561661431|FG002|Overall Study|Lack of Efficacy|0|||
155609755|NCT00055497|561661432|FG003|Overall Study|Lack of Efficacy|27|||
155609756|NCT00055497|561661429|FG000|Overall Study|Administrative Reasons|0|||
155609757|NCT00055497|561661430|FG001|Overall Study|Administrative Reasons|0|||
155609758|NCT00055497|561661431|FG002|Overall Study|Administrative Reasons|0|||
155609759|NCT00055497|561661432|FG003|Overall Study|Administrative Reasons|1|||
155609760|NCT00055497|561661429|FG000|Overall Study|Other|0|||
155609761|NCT00055497|561661430|FG001|Overall Study|Other|0|||
155609762|NCT00055497|561661431|FG002|Overall Study|Other|0|||
155609763|NCT00055497|561661432|FG003|Overall Study|Other|11|||
155609764|NCT00048165|561661433|FG000|Completed 6 Months Study|Administration/Other|8|||
155609765|NCT00048165|561661434|FG001|Completed 6 Months Study|Administration/Other|8|||
155609766|NCT00048165|561661433|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
155609767|NCT00048165|561661434|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
155609768|NCT00048165|561661433|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
155381414|NCT00138671|560830916|FG001|Overall Study|Death|3|||
155381415|NCT00138671|560830915|FG000|Overall Study|Adverse Event|6|||
155381416|NCT00138671|560830916|FG001|Overall Study|Adverse Event|3|||
155381417|NCT00138671|560830915|FG000|Overall Study|Lost to Follow-up|1|||
155381418|NCT00138671|560830916|FG001|Overall Study|Lost to Follow-up|2|||
155381419|NCT00138671|560830915|FG000|Overall Study|Withdrawal by Subject|3|||
155381420|NCT00138671|560830916|FG001|Overall Study|Withdrawal by Subject|5|||
155381421|NCT00138671|560830915|FG000|Overall Study|Other|3|||
155381422|NCT00138671|560830916|FG001|Overall Study|Other|3|||
155381423|NCT00906945|560830918|FG000|Overall Study|Found to be not eligible|0|||
155381424|NCT00906945|560830919|FG001|Overall Study|Found to be not eligible|0|||
155381425|NCT00906945|560830920|FG002|Overall Study|Found to be not eligible|0|||
155381426|NCT00906945|560830921|FG003|Overall Study|Found to be not eligible|1|||
155381427|NCT00906945|560830922|FG004|Overall Study|Found to be not eligible|1|||
155381428|NCT00906945|560830923|FG005|Overall Study|Found to be not eligible|1|||
155381429|NCT00906945|560830918|FG000|Overall Study|Physician Decision|0|||
155381430|NCT00906945|560830919|FG001|Overall Study|Physician Decision|0|||
155381431|NCT00906945|560830920|FG002|Overall Study|Physician Decision|0|||
155381432|NCT00906945|560830921|FG003|Overall Study|Physician Decision|0|||
155381433|NCT00906945|560830922|FG004|Overall Study|Physician Decision|0|||
155381434|NCT00906945|560830923|FG005|Overall Study|Physician Decision|1|||
155381435|NCT01853644|560830924|FG000|Registration and Treatment Start|Did not start treatment|1|||
155381436|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
155381437|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
155381438|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
155381439|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
155381440|NCT01853644|560830924|FG000|Continued Treatment After First Response|Adverse Event|2|||
155381441|NCT01853644|560830924|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
155381442|NCT00705523|560830925|FG000|Overall Study|Lost to Follow-up|2|||
155381443|NCT00705523|560830926|FG001|Overall Study|Lost to Follow-up|3|||
155381444|NCT02673515|560830927|FG000|Overall Study|Lack of motivation|2|||
155381445|NCT02673515|560830928|FG001|Overall Study|Lack of motivation|1|||
155381446|NCT01323972|560830929|FG000|Overall Study|Withdrawal by Subject|1|||
155381447|NCT01323972|560830930|FG001|Overall Study|Withdrawal by Subject|0|||
155381448|NCT01323972|560830931|FG002|Overall Study|Withdrawal by Subject|1|||
155381449|NCT01323972|560830932|FG003|Overall Study|Withdrawal by Subject|0|||
155381450|NCT01323972|560830929|FG000|Overall Study|Migrated/moved from study area|1|||
155609769|NCT00048165|561661434|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
155609770|NCT00048165|561661433|FG000|Completed 6 Months Study|Death|12|||
155609771|NCT00048165|561661434|FG001|Completed 6 Months Study|Death|6|||
155609772|NCT00048165|561661433|FG000|Completed 6 Months Study|Insufficient therapy|1|||
155609773|NCT00048165|561661434|FG001|Completed 6 Months Study|Insufficient therapy|4|||
155609774|NCT00048165|561661433|FG000|Completed 6 Months Study|Other violation|4|||
155609775|NCT00048165|561661434|FG001|Completed 6 Months Study|Other violation|6|||
155609776|NCT00048165|561661433|FG000|Completed 6 Months Study|Refused treatment|5|||
155381451|NCT01323972|560830930|FG001|Overall Study|Migrated/moved from study area|2|||
155381452|NCT01323972|560830931|FG002|Overall Study|Migrated/moved from study area|0|||
155381453|NCT01323972|560830932|FG003|Overall Study|Migrated/moved from study area|0|||
155381454|NCT01323972|560830929|FG000|Overall Study|Lost to Follow-up|0|||
155381455|NCT01323972|560830930|FG001|Overall Study|Lost to Follow-up|1|||
155381456|NCT01323972|560830931|FG002|Overall Study|Lost to Follow-up|1|||
155381457|NCT01323972|560830932|FG003|Overall Study|Lost to Follow-up|1|||
155381458|NCT00994682|560830933|FG000|Double Bilnd|Withdrawal by Subject|5|||
155381459|NCT00994682|560830934|FG001|Double Bilnd|Withdrawal by Subject|6|||
155381460|NCT00994682|560830933|FG000|Double Bilnd|Lost to Follow-up|3|||
155381461|NCT00994682|560830934|FG001|Double Bilnd|Lost to Follow-up|3|||
155381462|NCT00994682|560830933|FG000|Double Bilnd|Adverse Event|1|||
155381463|NCT00994682|560830934|FG001|Double Bilnd|Adverse Event|0|||
155381464|NCT00994682|560830933|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
155381465|NCT00994682|560830934|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
155381466|NCT00994682|560830933|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
155381467|NCT00994682|560830934|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
155609777|NCT00048165|561661434|FG001|Completed 6 Months Study|Refused treatment|5|||
155609778|NCT00048165|561661433|FG000|Completed 6 Months Study|Violation criteria|0|||
155609779|NCT00048165|561661434|FG001|Completed 6 Months Study|Violation criteria|2|||
155609780|NCT00048165|561661433|FG000|Completed 6 Months Study|Did not receive study drug|6|||
155609781|NCT00048165|561661434|FG001|Completed 6 Months Study|Did not receive study drug|6|||
155609782|NCT00048165|561661433|FG000|Completed 12 Months Study|Administration/Other|0|||
155609783|NCT00048165|561661434|FG001|Completed 12 Months Study|Administration/Other|2|||
155609784|NCT00048165|561661433|FG000|Completed 12 Months Study|Death|2|||
155609785|NCT00048165|561661434|FG001|Completed 12 Months Study|Death|1|||
155609786|NCT00048165|561661433|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
155609787|NCT00048165|561661434|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
155609788|NCT00731731|561661435|FG000|Overall Study|Protocol Violation|0|||
155609789|NCT00731731|561661436|FG001|Overall Study|Protocol Violation|0|||
155609790|NCT00731731|561661437|FG002|Overall Study|Protocol Violation|1|||
155609791|NCT00731731|561661435|FG000|Overall Study|Cancel prior to treatment|0|||
155609792|NCT00731731|561661436|FG001|Overall Study|Cancel prior to treatment|0|||
155609793|NCT00731731|561661437|FG002|Overall Study|Cancel prior to treatment|2|||
155609794|NCT01490697|561661444|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
155609795|NCT01490697|561661445|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
155609796|NCT00379808|561661446|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
155609797|NCT00379808|561661447|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
155609798|NCT03742258|561661452|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
155609799|NCT03742258|561661453|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
155609800|NCT03742258|561661454|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
155609801|NCT03742258|561661452|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
155609802|NCT03742258|561661453|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
155609803|NCT03742258|561661454|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
155609804|NCT03742258|561661452|FG000|Survival Follow-Up|Still in Follow-up|0|||
155609805|NCT03742258|561661453|FG001|Survival Follow-Up|Still in Follow-up|0|||
155609806|NCT03742258|561661454|FG002|Survival Follow-Up|Still in Follow-up|2|||
155609807|NCT01380691|561661455|FG000|Washout (7 Days)|Protocol Violation|0|||
155609808|NCT01380691|561661456|FG001|Washout (7 Days)|Protocol Violation|0|||
155609809|NCT01380691|561661457|FG002|Washout (7 Days)|Protocol Violation|0|||
155609810|NCT01380691|561661458|FG003|Washout (7 Days)|Protocol Violation|1|||
155609811|NCT01380691|561661455|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155609812|NCT01380691|561661456|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
155609813|NCT01380691|561661457|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
155609814|NCT01380691|561661458|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
155609815|NCT01952080|561661459|FG000|Overall Study|Withdrawal by Subject|0|||
155609816|NCT01952080|561661460|FG001|Overall Study|Withdrawal by Subject|0|||
155609817|NCT01952080|561661461|FG002|Overall Study|Withdrawal by Subject|0|||
155609818|NCT01952080|561661462|FG003|Overall Study|Withdrawal by Subject|1|||
155609819|NCT01952080|561661459|FG000|Overall Study|Protocol Non-compliance|0|||
155609820|NCT01952080|561661460|FG001|Overall Study|Protocol Non-compliance|1|||
155609821|NCT01952080|561661461|FG002|Overall Study|Protocol Non-compliance|0|||
155609822|NCT01952080|561661462|FG003|Overall Study|Protocol Non-compliance|0|||
155609823|NCT01333956|561661467|FG000|Overall Study|Lost to Follow-up|1|||
155609824|NCT01333956|561661468|FG001|Overall Study|Lost to Follow-up|2|||
155609825|NCT01333956|561661469|FG002|Overall Study|Lost to Follow-up|0|||
155609826|NCT01333956|561661470|FG003|Overall Study|Lost to Follow-up|1|||
155609827|NCT01333956|561661467|FG000|Overall Study|Unable to complete study procedure|1|||
155609828|NCT01333956|561661468|FG001|Overall Study|Unable to complete study procedure|0|||
155609829|NCT01333956|561661469|FG002|Overall Study|Unable to complete study procedure|0|||
155609830|NCT01333956|561661470|FG003|Overall Study|Unable to complete study procedure|1|||
155609831|NCT01333956|561661467|FG000|Overall Study|Withdrawal by Subject|0|||
155609832|NCT01333956|561661468|FG001|Overall Study|Withdrawal by Subject|2|||
155609833|NCT01333956|561661469|FG002|Overall Study|Withdrawal by Subject|1|||
155609834|NCT01333956|561661470|FG003|Overall Study|Withdrawal by Subject|0|||
155609835|NCT02134353|561661471|FG000|Overall Study|Adverse Event|10|||
155609836|NCT02134353|561661472|FG001|Overall Study|Adverse Event|6|||
155609837|NCT02134353|561661471|FG000|Overall Study|Lost to Follow-up|1|||
155609838|NCT02134353|561661472|FG001|Overall Study|Lost to Follow-up|1|||
155609839|NCT02134353|561661471|FG000|Overall Study|Lack of Efficacy|2|||
155609840|NCT02134353|561661472|FG001|Overall Study|Lack of Efficacy|1|||
155609841|NCT02134353|561661471|FG000|Overall Study|Withdrawal by Subject|12|||
155609842|NCT02134353|561661472|FG001|Overall Study|Withdrawal by Subject|13|||
155609843|NCT02134353|561661471|FG000|Overall Study|Death|0|||
155609844|NCT02134353|561661472|FG001|Overall Study|Death|1|||
155609845|NCT02134353|561661471|FG000|Overall Study|Pregnancy|0|||
155609846|NCT02134353|561661472|FG001|Overall Study|Pregnancy|1|||
155609847|NCT02134353|561661471|FG000|Overall Study|Relocation|1|||
155609848|NCT02134353|561661472|FG001|Overall Study|Relocation|0|||
155609849|NCT02134353|561661471|FG000|Overall Study|Other - Patient's Choice|0|||
155609850|NCT02134353|561661472|FG001|Overall Study|Other - Patient's Choice|1|||
155609851|NCT00477607|561661473|FG000|Overall Study|Lost to Follow-up|7|||
155609852|NCT00477607|561661474|FG001|Overall Study|Lost to Follow-up|7|||
155609853|NCT01732471|561661475|FG000|Overall Study|Withdrawal by Subject|1|||
155609854|NCT00474786|561661478|FG000|Overall Study|Not Meeting Study Criteria|0|||
155609855|NCT00474786|561661479|FG001|Overall Study|Not Meeting Study Criteria|1|||
155609856|NCT00474786|561661478|FG000|Overall Study|Investigator Request|2|||
155609857|NCT00474786|561661479|FG001|Overall Study|Investigator Request|1|||
155609858|NCT00474786|561661478|FG000|Overall Study|Death|189|||
155609859|NCT00474786|561661479|FG001|Overall Study|Death|170|||
155609860|NCT00474786|561661478|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
155609861|NCT00474786|561661479|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
155609862|NCT00474786|561661478|FG000|Overall Study|Lost to Follow-up|4|||
155609863|NCT00474786|561661479|FG001|Overall Study|Lost to Follow-up|7|||
155609864|NCT00474786|561661478|FG000|Overall Study|Protocol Violation|2|||
155609865|NCT00474786|561661479|FG001|Overall Study|Protocol Violation|0|||
155609866|NCT00474786|561661478|FG000|Overall Study|Withdrawal by Subject|15|||
155609867|NCT00474786|561661479|FG001|Overall Study|Withdrawal by Subject|15|||
155609868|NCT00474786|561661478|FG000|Overall Study|Other|5|||
155609869|NCT00474786|561661479|FG001|Overall Study|Other|0|||
155609870|NCT02892513|561661480|FG000|Overall Study|Withdrawal by Subject|0|||
155609871|NCT02892513|561661481|FG001|Overall Study|Withdrawal by Subject|1|||
155609872|NCT03426436|561661482|FG000|Overall Study|Incorrect lead placement|12|||
155609873|NCT03426436|561661482|FG000|Overall Study|Withdrawal by Subject|2|||
155609874|NCT03426436|561661482|FG000|Overall Study|Consent issue|1|||
155609875|NCT03426436|561661482|FG000|Overall Study|ECGs not saved|4|||
155609876|NCT04776018|561661483|FG000|Overall Study|Death|0|||
155609877|NCT04776018|561661484|FG001|Overall Study|Death|1|||
155609878|NCT04776018|561661485|FG002|Overall Study|Death|4|||
155609879|NCT04776018|561661486|FG003|Overall Study|Death|1|||
155609880|NCT04776018|561661487|FG004|Overall Study|Death|4|||
155609881|NCT04776018|561661488|FG005|Overall Study|Death|0|||
155609882|NCT04776018|561661489|FG006|Overall Study|Death|0|||
155609883|NCT04776018|561661483|FG000|Overall Study|Study terminated by sponsor|2|||
155609884|NCT04776018|561661484|FG001|Overall Study|Study terminated by sponsor|1|||
155609885|NCT04776018|561661485|FG002|Overall Study|Study terminated by sponsor|4|||
155609886|NCT04776018|561661486|FG003|Overall Study|Study terminated by sponsor|0|||
155609887|NCT04776018|561661487|FG004|Overall Study|Study terminated by sponsor|3|||
155609888|NCT04776018|561661488|FG005|Overall Study|Study terminated by sponsor|0|||
155609889|NCT04776018|561661489|FG006|Overall Study|Study terminated by sponsor|0|||
155609890|NCT04776018|561661483|FG000|Overall Study|Withdrawal by Subject|1|||
155609891|NCT04776018|561661484|FG001|Overall Study|Withdrawal by Subject|0|||
155609892|NCT04776018|561661485|FG002|Overall Study|Withdrawal by Subject|0|||
155609893|NCT04776018|561661486|FG003|Overall Study|Withdrawal by Subject|2|||
155609894|NCT04776018|561661487|FG004|Overall Study|Withdrawal by Subject|1|||
155609895|NCT04776018|561661488|FG005|Overall Study|Withdrawal by Subject|0|||
155609896|NCT04776018|561661489|FG006|Overall Study|Withdrawal by Subject|0|||
155609897|NCT04776018|561661483|FG000|Overall Study|Other|0|||
155609898|NCT04776018|561661484|FG001|Overall Study|Other|1|||
155609899|NCT04776018|561661485|FG002|Overall Study|Other|1|||
155609900|NCT04776018|561661486|FG003|Overall Study|Other|0|||
155609901|NCT04776018|561661487|FG004|Overall Study|Other|0|||
155609902|NCT04776018|561661488|FG005|Overall Study|Other|0|||
155609903|NCT04776018|561661489|FG006|Overall Study|Other|0|||
155609904|NCT04776018|561661483|FG000|Overall Study|Lost to Follow-up|0|||
155609905|NCT04776018|561661484|FG001|Overall Study|Lost to Follow-up|0|||
155609906|NCT04776018|561661485|FG002|Overall Study|Lost to Follow-up|1|||
155609907|NCT04776018|561661486|FG003|Overall Study|Lost to Follow-up|0|||
155609908|NCT04776018|561661487|FG004|Overall Study|Lost to Follow-up|0|||
155609909|NCT04776018|561661488|FG005|Overall Study|Lost to Follow-up|0|||
155609910|NCT04776018|561661489|FG006|Overall Study|Lost to Follow-up|0|||
155609911|NCT00386425|561661492|FG000|Overall Study|Physician Decision|3|||
155609912|NCT00386425|561661493|FG001|Overall Study|Physician Decision|0|||
155609913|NCT00386425|561661494|FG002|Overall Study|Physician Decision|0|||
155609914|NCT00386425|561661492|FG000|Overall Study|Withdrawal by Subject|0|||
155609915|NCT00386425|561661493|FG001|Overall Study|Withdrawal by Subject|1|||
155609916|NCT00386425|561661494|FG002|Overall Study|Withdrawal by Subject|0|||
155609917|NCT02440854|561661495|FG000|Overall Study|Relocation of patient|1|||
155609918|NCT02440854|561661495|FG000|Overall Study|Death|6|||
155609919|NCT02440854|561661495|FG000|Overall Study|Lost to Follow-up|10|||
155609920|NCT02440854|561661495|FG000|Overall Study|Afatinib discontinuation|46|||
155609921|NCT02440854|561661495|FG000|Overall Study|stopped study at earlier timepoint|14|||
155609922|NCT02440854|561661495|FG000|Overall Study|Study medication not received|1|||
155609923|NCT02440854|561661495|FG000|Overall Study|Violation of inclusion criteria|2|||
155609924|NCT01108237|561663105|FG000|Overall Study|No alignment data|2|||
155609925|NCT01108237|561663106|FG001|Overall Study|No alignment data|15|||
155609926|NCT01108237|561663105|FG000|Overall Study|Did not meet criteria for analysis|7|||
155609927|NCT01108237|561663106|FG001|Overall Study|Did not meet criteria for analysis|0|||
155609928|NCT02178358|561663109|FG000|Overall Study|Withdrawal by Subject|0|||
155609929|NCT02178358|561663110|FG001|Overall Study|Withdrawal by Subject|2|||
155609930|NCT02178358|561663111|FG002|Overall Study|Withdrawal by Subject|2|||
155609931|NCT02178358|561663109|FG000|Overall Study|Lost to Follow-up|1|||
155609932|NCT02178358|561663110|FG001|Overall Study|Lost to Follow-up|0|||
155609933|NCT02178358|561663111|FG002|Overall Study|Lost to Follow-up|0|||
155609934|NCT03297021|561663112|FG000|Overall Study|Incomplete/illegible data sheet|4|||
155609935|NCT03297021|561663113|FG001|Overall Study|Incomplete/illegible data sheet|2|||
155609936|NCT03297021|561663114|FG002|Overall Study|Incomplete/illegible data sheet|3|||
155609937|NCT03297021|561663112|FG000|Overall Study|Missing Post-Op Data|1|||
155609938|NCT03297021|561663113|FG001|Overall Study|Missing Post-Op Data|2|||
155609939|NCT03297021|561663114|FG002|Overall Study|Missing Post-Op Data|1|||
155609940|NCT02734862|561663115|FG000|Part A|Death|3|||
155609941|NCT02734862|561663116|FG001|Part A|Death|4|||
155609942|NCT02734862|561663117|FG002|Part A|Death|6|||
155609943|NCT02734862|561663115|FG000|Part A|Lost to Follow-up|2|||
155609944|NCT02734862|561663116|FG001|Part A|Lost to Follow-up|1|||
155609945|NCT02734862|561663117|FG002|Part A|Lost to Follow-up|1|||
155609946|NCT02734862|561663115|FG000|Part A|Withdrawal by Subject|1|||
155609947|NCT02734862|561663116|FG001|Part A|Withdrawal by Subject|1|||
155609948|NCT02734862|561663117|FG002|Part A|Withdrawal by Subject|2|||
155609949|NCT02734862|561663115|FG000|Part A|Physician Decision|2|||
155609950|NCT02734862|561663116|FG001|Part A|Physician Decision|0|||
155609951|NCT02734862|561663117|FG002|Part A|Physician Decision|1|||
155609952|NCT02734862|561663115|FG000|Part A|Adverse Event|2|||
155609953|NCT02734862|561663116|FG001|Part A|Adverse Event|0|||
155609954|NCT02734862|561663117|FG002|Part A|Adverse Event|1|||
155609955|NCT02734862|561663115|FG000|Part A|Noncompliance|1|||
155609956|NCT02734862|561663116|FG001|Part A|Noncompliance|1|||
155609957|NCT02734862|561663117|FG002|Part A|Noncompliance|0|||
155609958|NCT02734862|561663115|FG000|Part A|Other|1|||
155609959|NCT02734862|561663116|FG001|Part A|Other|1|||
155609960|NCT02734862|561663117|FG002|Part A|Other|3|||
155609961|NCT02734862|561663115|FG000|Part B|Death|8|||
155609962|NCT02734862|561663116|FG001|Part B|Death|3|||
155609963|NCT02734862|561663117|FG002|Part B|Death|5|||
155609964|NCT02734862|561663115|FG000|Part B|Lost to Follow-up|2|||
155609965|NCT02734862|561663116|FG001|Part B|Lost to Follow-up|2|||
155609966|NCT02734862|561663117|FG002|Part B|Lost to Follow-up|0|||
155609967|NCT02734862|561663115|FG000|Part B|Withdrawal by Subject|3|||
155609968|NCT02734862|561663116|FG001|Part B|Withdrawal by Subject|1|||
155609969|NCT02734862|561663117|FG002|Part B|Withdrawal by Subject|0|||
155609970|NCT02734862|561663115|FG000|Part B|Other|0|||
155609971|NCT02734862|561663116|FG001|Part B|Other|1|||
155609972|NCT02734862|561663117|FG002|Part B|Other|0|||
155609973|NCT02095197|561663118|FG000|Overall Study|Lost to Follow-up|0|||
155609974|NCT02095197|561663119|FG001|Overall Study|Lost to Follow-up|3|||
155609975|NCT00493311|561663120|FG000|Overall Study|Need for rescue medication|2|||
155609976|NCT00493311|561663121|FG001|Overall Study|Need for rescue medication|2|||
155609977|NCT02779075|561663122|FG000|Overall Study|Withdrawal by Subject|1|||
155609978|NCT02779075|561663123|FG001|Overall Study|Withdrawal by Subject|3|||
155609979|NCT02779075|561663122|FG000|Overall Study|IV lost during 2nd study|1|||
155609980|NCT02779075|561663123|FG001|Overall Study|IV lost during 2nd study|0|||
155609981|NCT00790556|561663124|FG000|Treatment Period 1|Physician Decision|1|||
155609982|NCT00790556|561663125|FG001|Treatment Period 1|Physician Decision|0|||
155609983|NCT00790556|561663124|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155609984|NCT00790556|561663125|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155609985|NCT01005901|561663128|FG000|Overall Study|Withdrawal by Subject|38|||
155609986|NCT01005901|561663129|FG001|Overall Study|Withdrawal by Subject|14|||
155609987|NCT01005901|561663128|FG000|Overall Study|Adverse Event|30|||
155609988|NCT01005901|561663129|FG001|Overall Study|Adverse Event|16|||
155609989|NCT01005901|561663128|FG000|Overall Study|Administrative problems|21|||
155609990|NCT01005901|561663129|FG001|Overall Study|Administrative problems|13|||
155609991|NCT01005901|561663128|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155609992|NCT01005901|561663129|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
155609993|NCT01005901|561663128|FG000|Overall Study|Protocol Violation|4|||
155609994|NCT01005901|561663129|FG001|Overall Study|Protocol Violation|3|||
155609995|NCT01005901|561663128|FG000|Overall Study|Death|2|||
155609996|NCT01005901|561663129|FG001|Overall Study|Death|3|||
155609997|NCT01005901|561663128|FG000|Overall Study|Lost to Follow-up|1|||
155609998|NCT01005901|561663129|FG001|Overall Study|Lost to Follow-up|2|||
155609999|NCT01005901|561663128|FG000|Overall Study|Patient's inability to use the device|1|||
155610000|NCT01005901|561663129|FG001|Overall Study|Patient's inability to use the device|1|||
155610001|NCT01005901|561663128|FG000|Overall Study|No longer requires study drug|0|||
155610002|NCT01005901|561663129|FG001|Overall Study|No longer requires study drug|1|||
155610003|NCT00957424|561663130|FG000|Overall Study|Lost to Follow-up|19|||
155610004|NCT00957424|561663130|FG000|Overall Study|Protocol Violation|3|||
155610005|NCT00957424|561663130|FG000|Overall Study|Withdrawal by Subject|1|||
155610006|NCT01038752|561663131|FG000|Overall Study|Tumor Progression|2|||
155610007|NCT01038752|561663132|FG001|Overall Study|Tumor Progression|2|||
155610008|NCT01038752|561663131|FG000|Overall Study|Lost to Follow-up|3|||
155610009|NCT01038752|561663132|FG001|Overall Study|Lost to Follow-up|3|||
155610010|NCT04165135|561663139|FG000|Overall Study|Protocol Violation|10|||
155610011|NCT04165135|561663139|FG000|Overall Study|Participants withdrawal of consent|5|||
155610012|NCT05053035|561663146|FG000|Overall Study|Withdrawal by Subject|1|||
155610013|NCT05053035|561663147|FG001|Overall Study|Withdrawal by Subject|0|||
155610014|NCT00438256|561663148|FG000|Overall Study|Ineligible for Resection|2|||
155610015|NCT00438256|561663149|FG001|Overall Study|Ineligible for Resection|1|||
155610016|NCT00438256|561663150|FG002|Overall Study|Ineligible for Resection|1|||
155610017|NCT00438256|561663151|FG003|Overall Study|Ineligible for Resection|7|||
155610018|NCT00438256|561663148|FG000|Overall Study|Excluded final Diagnosis|0|||
155610019|NCT00438256|561663149|FG001|Overall Study|Excluded final Diagnosis|0|||
155610020|NCT00438256|561663150|FG002|Overall Study|Excluded final Diagnosis|0|||
155610021|NCT00438256|561663151|FG003|Overall Study|Excluded final Diagnosis|2|||
155610022|NCT02005627|561663152|FG000|Overall Study|Lost to Follow-up|1|||
155610023|NCT02005627|561663153|FG001|Overall Study|Lost to Follow-up|2|||
155610024|NCT02005627|561663152|FG000|Overall Study|Withdrawal by Subject|1|||
155610025|NCT02005627|561663153|FG001|Overall Study|Withdrawal by Subject|2|||
155610026|NCT00938587|561663159|FG000|Overall Study|Adverse Event|2|||
155610027|NCT00938587|561663160|FG001|Overall Study|Adverse Event|0|||
155610028|NCT00938587|561663161|FG002|Overall Study|Adverse Event|0|||
155610029|NCT00938587|561663162|FG003|Overall Study|Adverse Event|2|||
155610030|NCT00938587|561663159|FG000|Overall Study|Did not meet entrance criteria|0|||
155610031|NCT00938587|561663160|FG001|Overall Study|Did not meet entrance criteria|0|||
155610032|NCT00938587|561663161|FG002|Overall Study|Did not meet entrance criteria|1|||
155610033|NCT00938587|561663162|FG003|Overall Study|Did not meet entrance criteria|0|||
155610034|NCT00938587|561663159|FG000|Overall Study|Withdrawal by Subject|1|||
155610035|NCT00938587|561663160|FG001|Overall Study|Withdrawal by Subject|1|||
155610036|NCT00938587|561663161|FG002|Overall Study|Withdrawal by Subject|0|||
155610037|NCT00938587|561663162|FG003|Overall Study|Withdrawal by Subject|0|||
155610038|NCT00849290|561663163|FG000|Overall Study|Adverse Event|3|||
155610039|NCT00849290|561663163|FG000|Overall Study|Death|14|||
155610040|NCT00849290|561663163|FG000|Overall Study|Withdrawal by Subject|11|||
155610041|NCT00849290|561663163|FG000|Overall Study|Lost to Follow-up|2|||
155610042|NCT00849290|561663163|FG000|Overall Study|Protocol Violation|5|||
155610043|NCT00849290|561663163|FG000|Overall Study|Disease Progression|20|||
155610044|NCT03913104|561663170|FG000|Overall Study|Lost to Follow-up|20|||
155610045|NCT03913104|561663170|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
155610046|NCT03913104|561663170|FG000|Overall Study|Withdrawal by Subject|2|||
155610047|NCT00048997|561663173|FG000|Overall Study|Protocol Violation|7|||
155610048|NCT00048997|561663174|FG001|Overall Study|Protocol Violation|2|||
155610049|NCT00048997|561663173|FG000|Overall Study|Withdrawal by Subject|6|||
155610050|NCT00048997|561663174|FG001|Overall Study|Withdrawal by Subject|1|||
155610051|NCT02819440|561663175|FG000|Overall Study|Adverse Event|3|||
155610052|NCT02819440|561663176|FG001|Overall Study|Adverse Event|1|||
155610053|NCT02819440|561663175|FG000|Overall Study|Lost to Follow-up|1|||
155610054|NCT02819440|561663176|FG001|Overall Study|Lost to Follow-up|3|||
155610055|NCT02819440|561663175|FG000|Overall Study|Withdrawal by Subject|9|||
155610056|NCT02819440|561663176|FG001|Overall Study|Withdrawal by Subject|8|||
155610057|NCT00002525|561663182|FG000|Overall Study|Adverse Event|36|||
155610058|NCT00002525|561663183|FG001|Overall Study|Adverse Event|0|||
155610059|NCT00002525|561663182|FG000|Overall Study|Death|5|||
155610060|NCT00002525|561663183|FG001|Overall Study|Death|0|||
155610061|NCT00002525|561663182|FG000|Overall Study|Withdrawal by Subject|11|||
155610062|NCT00002525|561663183|FG001|Overall Study|Withdrawal by Subject|0|||
155610063|NCT00002525|561663182|FG000|Overall Study|Start non-protocol therapy|1|||
155610064|NCT00002525|561663183|FG001|Overall Study|Start non-protocol therapy|0|||
155610065|NCT00002525|561663182|FG000|Overall Study|Other complicating disease|1|||
155610066|NCT00002525|561663183|FG001|Overall Study|Other complicating disease|0|||
155610067|NCT00002525|561663182|FG000|Overall Study|Duke's A, B1, D disease|92|||
155610068|NCT00002525|561663183|FG001|Overall Study|Duke's A, B1, D disease|0|||
155610069|NCT00002525|561663182|FG000|Overall Study|Error|6|||
155610070|NCT00002525|561663183|FG001|Overall Study|Error|0|||
155610071|NCT00002525|561663182|FG000|Overall Study|Other|26|||
155610072|NCT00002525|561663183|FG001|Overall Study|Other|0|||
155610073|NCT00002525|561663182|FG000|Overall Study|Never start protocol therapy|8|||
155610074|NCT00002525|561663183|FG001|Overall Study|Never start protocol therapy|0|||
155610075|NCT03304184|561663184|FG000|Overall Study|Withdrawal by Subject|1|||
155610076|NCT03304184|561663185|FG001|Overall Study|Withdrawal by Subject|2|||
155610077|NCT03420222|561663188|FG000|Overall Study|Withdrawal by Subject|5|||
155610078|NCT03420222|561663189|FG001|Overall Study|Withdrawal by Subject|0|||
155610079|NCT03420222|561663188|FG000|Overall Study|Physician Decision|0|||
155610080|NCT03420222|561663189|FG001|Overall Study|Physician Decision|1|||
155610081|NCT02112877|561663192|FG000|Overall Study|Withdrawal by Subject|1|||
155610082|NCT02112877|561663193|FG001|Overall Study|Withdrawal by Subject|7|||
155610083|NCT02112877|561663192|FG000|Overall Study|Visit Missed|1|||
155610084|NCT02112877|561663193|FG001|Overall Study|Visit Missed|6|||
155610085|NCT01578499|561663206|FG000|Overall Study|Reason not Specified|0|||
155610086|NCT01578499|561663207|FG001|Overall Study|Reason not Specified|1|||
155610087|NCT01578499|561663206|FG000|Overall Study|Lost to Follow-up|2|||
155610088|NCT01578499|561663207|FG001|Overall Study|Lost to Follow-up|1|||
155610089|NCT01578499|561663206|FG000|Overall Study|Withdrawal by Subject|10|||
155610090|NCT01578499|561663207|FG001|Overall Study|Withdrawal by Subject|16|||
155610091|NCT01578499|561663206|FG000|Overall Study|Death|20|||
155610092|NCT01578499|561663207|FG001|Overall Study|Death|25|||
155610093|NCT01578499|561663206|FG000|Overall Study|Died and End of Study Page not Completed|2|||
155610094|NCT01578499|561663207|FG001|Overall Study|Died and End of Study Page not Completed|0|||
155610095|NCT01606748|561663208|FG000|Overall Study|Adverse Event|1|||
155610096|NCT01606748|561663209|FG001|Overall Study|Adverse Event|0|||
155610097|NCT01606748|561663208|FG000|Overall Study|Progressive Disease|1|||
155610098|NCT01606748|561663209|FG001|Overall Study|Progressive Disease|0|||
155722585|NCT02318706|562083884|FG000|Double-blind Phase|Death|0|||
155722586|NCT02318706|562083885|FG001|Double-blind Phase|Death|0|||
155722587|NCT02318706|562083886|FG002|Double-blind Phase|Death|2|||
155722588|NCT02318706|562083887|FG003|Double-blind Phase|Death|0|||
155722589|NCT02318706|562083888|FG004|Double-blind Phase|Death|0|||
155722590|NCT02318706|562083884|FG000|Open-label Extension Phase|Adverse Event|0|||
155722591|NCT02318706|562083885|FG001|Open-label Extension Phase|Adverse Event|0|||
155722592|NCT02318706|562083886|FG002|Open-label Extension Phase|Adverse Event|0|||
155722593|NCT02318706|562083887|FG003|Open-label Extension Phase|Adverse Event|0|||
155722594|NCT02318706|562083888|FG004|Open-label Extension Phase|Adverse Event|21|||
155722595|NCT02318706|562083884|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
155722596|NCT02318706|562083885|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
155722597|NCT02318706|562083886|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
155722598|NCT02318706|562083887|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
155722599|NCT02318706|562083888|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
155722600|NCT02318706|562083884|FG000|Open-label Extension Phase|Death|0|||
155722601|NCT02318706|562083885|FG001|Open-label Extension Phase|Death|0|||
155722602|NCT02318706|562083886|FG002|Open-label Extension Phase|Death|0|||
155722603|NCT02318706|562083887|FG003|Open-label Extension Phase|Death|0|||
155722604|NCT02318706|562083888|FG004|Open-label Extension Phase|Death|1|||
155722605|NCT02318706|562083884|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
155722606|NCT02318706|562083885|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
155610099|NCT01606748|561663208|FG000|Overall Study|Withdrawal by Subject|1|||
155610100|NCT01606748|561663209|FG001|Overall Study|Withdrawal by Subject|0|||
155610101|NCT00862459|561663213|FG000|Overall Study|Lost to Follow-up|1|||
155610102|NCT00862459|561663214|FG001|Overall Study|Lost to Follow-up|2|||
155610103|NCT00862459|561663215|FG002|Overall Study|Lost to Follow-up|2|||
155610104|NCT00862459|561663213|FG000|Overall Study|Protocol Violation|1|||
155610105|NCT00862459|561663214|FG001|Overall Study|Protocol Violation|0|||
155610106|NCT00862459|561663215|FG002|Overall Study|Protocol Violation|0|||
155610107|NCT00862459|561663213|FG000|Overall Study|Withdrawal by Subject|1|||
155610108|NCT00862459|561663214|FG001|Overall Study|Withdrawal by Subject|1|||
155610109|NCT00862459|561663215|FG002|Overall Study|Withdrawal by Subject|3|||
155610110|NCT00862459|561663213|FG000|Overall Study|Adverse Event|0|||
155610111|NCT00862459|561663214|FG001|Overall Study|Adverse Event|1|||
155610112|NCT00862459|561663215|FG002|Overall Study|Adverse Event|0|||
155610113|NCT00862459|561663213|FG000|Overall Study|Personal reasons|1|||
155610114|NCT00862459|561663214|FG001|Overall Study|Personal reasons|0|||
155610115|NCT00862459|561663215|FG002|Overall Study|Personal reasons|0|||
155610116|NCT00862459|561663213|FG000|Overall Study|Operation|1|||
155610117|NCT00862459|561663214|FG001|Overall Study|Operation|1|||
155610118|NCT00862459|561663215|FG002|Overall Study|Operation|0|||
155610119|NCT00862459|561663213|FG000|Overall Study|Intravenous (IV) site problems|1|||
155610120|NCT00862459|561663214|FG001|Overall Study|Intravenous (IV) site problems|0|||
155610121|NCT00862459|561663215|FG002|Overall Study|Intravenous (IV) site problems|1|||
155610122|NCT00862459|561663213|FG000|Overall Study|Unable to hold still for imaging|0|||
155610123|NCT00862459|561663214|FG001|Overall Study|Unable to hold still for imaging|1|||
155610124|NCT00862459|561663215|FG002|Overall Study|Unable to hold still for imaging|0|||
155610125|NCT00862459|561663213|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155610126|NCT00862459|561663214|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
155610127|NCT00862459|561663215|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155610128|NCT00862459|561663213|FG000|Overall Study|Administrative problems|0|||
155610129|NCT00862459|561663214|FG001|Overall Study|Administrative problems|1|||
155610130|NCT00862459|561663215|FG002|Overall Study|Administrative problems|0|||
155610131|NCT00358956|561663216|FG000|Overall Study|Adverse Event|3|||
155610132|NCT00358956|561663216|FG000|Overall Study|condition under investigation worsened|4|||
155610133|NCT00358956|561663216|FG000|Overall Study|Withdrawal by Subject|1|||
155610134|NCT00655681|561663217|FG000|Overall Study|Lost to Follow-up|1|||
155610135|NCT00655681|561663218|FG001|Overall Study|Lost to Follow-up|1|||
155610136|NCT03417024|561663222|FG000|Overall Study|Study Termination prior to follow-up|11|||
155610137|NCT03417024|561663222|FG000|Overall Study|Physician Decision|2|||
155610138|NCT03168919|561663223|FG000|Overall Study|Withdrawal by Subject|2|||
155610139|NCT01085136|561663224|FG000|Part A|Other Adverse event|223|||
155722607|NCT02318706|562083886|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
155722608|NCT02318706|562083887|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
155610140|NCT01085136|561663225|FG001|Part A|Other Adverse event|0|||
155610141|NCT01085136|561663226|FG002|Part A|Other Adverse event|0|||
155610142|NCT01085136|561663224|FG000|Part A|Protocol Violation|3|||
155610143|NCT01085136|561663225|FG001|Part A|Protocol Violation|0|||
155610144|NCT01085136|561663226|FG002|Part A|Protocol Violation|0|||
155610145|NCT01085136|561663224|FG000|Part A|Lost to Follow-up|3|||
155610146|NCT01085136|561663225|FG001|Part A|Lost to Follow-up|0|||
155610147|NCT01085136|561663226|FG002|Part A|Lost to Follow-up|0|||
155610148|NCT01085136|561663224|FG000|Part A|Refusal to continue trial medication|64|||
155610149|NCT01085136|561663225|FG001|Part A|Refusal to continue trial medication|0|||
155610150|NCT01085136|561663226|FG002|Part A|Refusal to continue trial medication|0|||
155610151|NCT01085136|561663224|FG000|Part A|Other reason not defined above|30|||
155610152|NCT01085136|561663225|FG001|Part A|Other reason not defined above|0|||
155610153|NCT01085136|561663226|FG002|Part A|Other reason not defined above|0|||
155610154|NCT01085136|561663224|FG000|Part B|Other AE|0|||
155610155|NCT01085136|561663225|FG001|Part B|Other AE|29|||
155610156|NCT01085136|561663226|FG002|Part B|Other AE|8|||
155610157|NCT01085136|561663224|FG000|Part B|Refusal to continue trial medication|0|||
155610158|NCT01085136|561663225|FG001|Part B|Refusal to continue trial medication|12|||
155610159|NCT01085136|561663226|FG002|Part B|Refusal to continue trial medication|7|||
155610160|NCT01085136|561663224|FG000|Part B|Not treated|0|||
155610161|NCT01085136|561663225|FG001|Part B|Not treated|4|||
155610162|NCT01085136|561663226|FG002|Part B|Not treated|8|||
155610163|NCT01085136|561663224|FG000|Part B|Other reason not defined above|0|||
155610164|NCT01085136|561663225|FG001|Part B|Other reason not defined above|6|||
155610165|NCT01085136|561663226|FG002|Part B|Other reason not defined above|3|||
155610166|NCT02195427|561663227|FG000|Overall Study|Did not consent to study extension|13|||
155381468|NCT00994682|560830933|FG000|Pioglitazone Open Label|Physician Decision|6|||
155610167|NCT02195427|561663228|FG001|Overall Study|Did not consent to study extension|9|||
155610168|NCT02195427|561663227|FG000|Overall Study|Withdrawal by Subject|4|||
155610169|NCT02195427|561663228|FG001|Overall Study|Withdrawal by Subject|2|||
155610170|NCT02195427|561663227|FG000|Overall Study|Lost to Follow-up|0|||
155610171|NCT02195427|561663228|FG001|Overall Study|Lost to Follow-up|1|||
155610172|NCT02195427|561663227|FG000|Overall Study|Protocol Violation|7|||
155610173|NCT02195427|561663228|FG001|Overall Study|Protocol Violation|14|||
155610174|NCT02195427|561663227|FG000|Overall Study|Conditional re-treatment at W52|2|||
155610175|NCT02195427|561663228|FG001|Overall Study|Conditional re-treatment at W52|1|||
155610176|NCT01210144|561663230|FG000|Overall Study|Lack of ovarian response|1|||
155610177|NCT01210144|561663231|FG001|Overall Study|Lack of ovarian response|0|||
155610178|NCT01210144|561663230|FG000|Overall Study|No fertilization|1|||
155610179|NCT01210144|561663231|FG001|Overall Study|No fertilization|0|||
155610180|NCT01210144|561663230|FG000|Overall Study|No transfer|1|||
155610181|NCT01210144|561663231|FG001|Overall Study|No transfer|0|||
155610182|NCT02655419|561663232|FG000|Overall Study|Enrolled but not treated|1|||
155610183|NCT02655419|561663233|FG001|Overall Study|Enrolled but not treated|5|||
155610184|NCT02655419|561663232|FG000|Overall Study|Withdrawal by Subject|4|||
155610185|NCT02655419|561663233|FG001|Overall Study|Withdrawal by Subject|1|||
155610186|NCT02655419|561663232|FG000|Overall Study|Other|0|||
155610187|NCT02655419|561663233|FG001|Overall Study|Other|1|||
155610188|NCT04226495|561663237|FG000|Overall Study|Withdrawal by Subject|3|||
155610189|NCT04226495|561663238|FG001|Overall Study|Withdrawal by Subject|3|||
155610190|NCT04226495|561663237|FG000|Overall Study|PI discretion|3|||
155610191|NCT04226495|561663238|FG001|Overall Study|PI discretion|4|||
155610192|NCT00762034|561664874|FG000|Induction Period|Protocol Violation|1|||
155610193|NCT00762034|561664875|FG001|Induction Period|Protocol Violation|2|||
155610194|NCT00762034|561664874|FG000|Induction Period|Entry Criterion Not Met|12|||
155610195|NCT00762034|561664875|FG001|Induction Period|Entry Criterion Not Met|11|||
155610196|NCT00762034|561664874|FG000|Induction Period|Adverse Event|27|||
155610197|NCT00762034|561664875|FG001|Induction Period|Adverse Event|38|||
155610198|NCT00762034|561664874|FG000|Induction Period|Lost to Follow-up|1|||
155610199|NCT00762034|561664875|FG001|Induction Period|Lost to Follow-up|1|||
155610200|NCT00762034|561664874|FG000|Induction Period|Progressive Disease|73|||
155610201|NCT00762034|561664875|FG001|Induction Period|Progressive Disease|55|||
155610202|NCT00762034|561664874|FG000|Induction Period|Physician Decision|21|||
155610203|NCT00762034|561664875|FG001|Induction Period|Physician Decision|20|||
155610204|NCT00762034|561664874|FG000|Induction Period|Withdrawal by Subject|15|||
155610205|NCT00762034|561664875|FG001|Induction Period|Withdrawal by Subject|19|||
155610206|NCT00762034|561664874|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
155610207|NCT00762034|561664875|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
155610208|NCT00762034|561664874|FG000|Induction Period|Deaths Due to Study Disease|9|||
155610209|NCT00762034|561664875|FG001|Induction Period|Deaths Due to Study Disease|9|||
155610210|NCT00762034|561664874|FG000|Maintenance Period|Protocol Violation|1|||
155610211|NCT00762034|561664875|FG001|Maintenance Period|Protocol Violation|3|||
155610212|NCT00762034|561664874|FG000|Maintenance Period|Entry Criterion Not Met|0|||
155610213|NCT00762034|561664875|FG001|Maintenance Period|Entry Criterion Not Met|2|||
155610214|NCT00762034|561664874|FG000|Maintenance Period|Adverse Event|42|||
155610215|NCT00762034|561664875|FG001|Maintenance Period|Adverse Event|26|||
155610216|NCT00762034|561664874|FG000|Maintenance Period|Progressive Disease|186|||
155610217|NCT00762034|561664875|FG001|Maintenance Period|Progressive Disease|224|||
155610218|NCT00762034|561664874|FG000|Maintenance Period|Physician Decision|25|||
155610219|NCT00762034|561664875|FG001|Maintenance Period|Physician Decision|20|||
155610220|NCT00762034|561664874|FG000|Maintenance Period|Withdrawal by Subject|34|||
155610221|NCT00762034|561664875|FG001|Maintenance Period|Withdrawal by Subject|14|||
155610222|NCT00762034|561664874|FG000|Maintenance Period|Death not due to study disease|2|||
155610223|NCT00762034|561664875|FG001|Maintenance Period|Death not due to study disease|5|||
155610224|NCT00762034|561664874|FG000|Maintenance Period|Death due to study disease|3|||
155610225|NCT00762034|561664875|FG001|Maintenance Period|Death due to study disease|3|||
155610226|NCT00762034|561664874|FG000|Maintenance Period|Other|1|||
155610227|NCT00762034|561664875|FG001|Maintenance Period|Other|1|||
155610228|NCT00497146|561664876|FG000|Treatment Period|Adverse Event|6|||
155610229|NCT00497146|561664877|FG001|Treatment Period|Adverse Event|2|||
155610230|NCT00497146|561664876|FG000|Treatment Period|Withdrawal by Subject|5|||
155610231|NCT00497146|561664877|FG001|Treatment Period|Withdrawal by Subject|9|||
155610232|NCT00497146|561664876|FG000|Treatment Period|Lost to Follow-up|1|||
155610233|NCT00497146|561664877|FG001|Treatment Period|Lost to Follow-up|3|||
155610234|NCT00497146|561664876|FG000|Treatment Period|Required dialysis|4|||
155610235|NCT00497146|561664877|FG001|Treatment Period|Required dialysis|1|||
155610236|NCT00497146|561664876|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
155610237|NCT00497146|561664877|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
155610238|NCT00497146|561664876|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
155610239|NCT00497146|561664877|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
155610240|NCT00497146|561664876|FG000|Treatment Period|Other Reason|2|||
155610241|NCT00497146|561664877|FG001|Treatment Period|Other Reason|3|||
155610242|NCT00497146|561664876|FG000|Long-term Follow-up Period|Adverse Event|2|||
155610243|NCT00497146|561664877|FG001|Long-term Follow-up Period|Adverse Event|2|||
155610244|NCT00497146|561664876|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
155610245|NCT00497146|561664877|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
155610246|NCT00497146|561664876|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
155610247|NCT00497146|561664877|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
155610248|NCT00497146|561664876|FG000|Long-term Follow-up Period|Other|0|||
155610249|NCT00497146|561664877|FG001|Long-term Follow-up Period|Other|1|||
155610250|NCT04571385|561664880|FG000|Overall Study|Participant non-compliance|1|||
155610251|NCT04571385|561664881|FG001|Overall Study|Participant non-compliance|0|||
155610252|NCT04571385|561664882|FG002|Overall Study|Participant non-compliance|0|||
155610253|NCT04571385|561664880|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
155610254|NCT04571385|561664881|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
155610255|NCT04571385|561664882|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
155610256|NCT04571385|561664880|FG000|Overall Study|Screen failure|0|||
155610257|NCT04571385|561664881|FG001|Overall Study|Screen failure|0|||
155610258|NCT04571385|561664882|FG002|Overall Study|Screen failure|1|||
155610259|NCT02499263|561664883|FG000|Overall Study|Lost to Follow-up|9|||
155610260|NCT02499263|561664883|FG000|Overall Study|Participant's withdrawal of consent|4|||
155610261|NCT02499263|561664883|FG000|Overall Study|Lack of Efficacy|22|||
155610262|NCT02499263|561664883|FG000|Overall Study|investigator's judgment|12|||
155610263|NCT02499263|561664883|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
155610264|NCT02499263|561664883|FG000|Overall Study|Participant's decision|3|||
155610265|NCT02499263|561664883|FG000|Overall Study|Pregnancy|1|||
155610266|NCT00424593|561664884|FG000|Acute Double-Blind Period|Adverse Event|16|||
155610267|NCT00424593|561664885|FG001|Acute Double-Blind Period|Adverse Event|7|||
155610268|NCT00424593|561664884|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
155610269|NCT00424593|561664885|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
155610270|NCT00424593|561664884|FG000|Acute Double-Blind Period|Protocol Violation|2|||
155610271|NCT00424593|561664885|FG001|Acute Double-Blind Period|Protocol Violation|2|||
155610272|NCT00424593|561664884|FG000|Acute Double-Blind Period|Physician Decision|1|||
155610273|NCT00424593|561664885|FG001|Acute Double-Blind Period|Physician Decision|2|||
155610274|NCT00424593|561664884|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
155610275|NCT00424593|561664885|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
155610276|NCT00424593|561664884|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
155610277|NCT00424593|561664885|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
155610278|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
155610279|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
155610280|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Adverse Event|18|||
155610281|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Adverse Event|0|||
155610282|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
155610283|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
155610284|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
155610285|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
155610286|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
155610287|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
155610288|NCT00424593|561664884|FG000|Dose-Blind Extension Period|Physician Decision|3|||
155610289|NCT00424593|561664885|FG001|Dose-Blind Extension Period|Physician Decision|0|||
155610290|NCT02496039|561664886|FG000|Overall Study|Adverse Event|3|||
155610291|NCT02496039|561664886|FG000|Overall Study|Protocol Violation|1|||
155610292|NCT00255840|561664887|FG000|Overall Study|Lost to Follow-up|10|||
155610293|NCT00255840|561664888|FG001|Overall Study|Lost to Follow-up|14|||
155610294|NCT00255840|561664887|FG000|Overall Study|Discontinued intervention|53|||
155610295|NCT00255840|561664888|FG001|Overall Study|Discontinued intervention|56|||
155610296|NCT00530790|561664889|FG000|Overall Study|Adverse Event|2|||
155610297|NCT00530790|561664889|FG000|Overall Study|Withdrawal by Subject|2|||
155610298|NCT00530790|561664889|FG000|Overall Study|Physician Decision|1|||
155610299|NCT01464619|561664890|FG000|Overall Study|Lost to Follow-up|3|||
155610300|NCT01464619|561664891|FG001|Overall Study|Lost to Follow-up|4|||
155610301|NCT00080483|561664896|FG000|Overall Study|Lost to Follow-up|1|||
155610302|NCT00080483|561664897|FG001|Overall Study|Lost to Follow-up|1|||
155610303|NCT00080483|561664896|FG000|Overall Study|Physician Decision|1|||
155610304|NCT00080483|561664897|FG001|Overall Study|Physician Decision|1|||
155610305|NCT01119846|561664900|FG000|Overall Study|Adverse Event|1|||
155610306|NCT01119846|561664901|FG001|Overall Study|Adverse Event|0|||
155610307|NCT01119846|561664902|FG002|Overall Study|Adverse Event|6|||
155610308|NCT01119846|561664900|FG000|Overall Study|Physician Decision|1|||
155610309|NCT01119846|561664901|FG001|Overall Study|Physician Decision|0|||
155610310|NCT01119846|561664902|FG002|Overall Study|Physician Decision|0|||
155610311|NCT01119846|561664900|FG000|Overall Study|Protocol Violation|0|||
155610312|NCT01119846|561664901|FG001|Overall Study|Protocol Violation|0|||
155610313|NCT01119846|561664902|FG002|Overall Study|Protocol Violation|1|||
155610314|NCT01119846|561664900|FG000|Overall Study|Withdrawal by Subject|0|||
155610315|NCT01119846|561664901|FG001|Overall Study|Withdrawal by Subject|0|||
155610316|NCT01119846|561664902|FG002|Overall Study|Withdrawal by Subject|4|||
155610317|NCT01404949|561664903|FG000|Overall Study|Not Treated|1|||
155610318|NCT02334384|561664906|FG000|Overall Study|Lost to Follow-up|1|||
155610319|NCT02334384|561664907|FG001|Overall Study|Lost to Follow-up|1|||
155610320|NCT02651688|561664908|FG000|Overall Study|Non-compliance|0|||
155610321|NCT02651688|561664909|FG001|Overall Study|Non-compliance|0|||
155610322|NCT02651688|561664910|FG002|Overall Study|Non-compliance|1|||
155610323|NCT02651688|561664908|FG000|Overall Study|Principal Investigator (PI) decision|0|||
155610324|NCT02651688|561664909|FG001|Overall Study|Principal Investigator (PI) decision|2|||
155610325|NCT02651688|561664910|FG002|Overall Study|Principal Investigator (PI) decision|0|||
155610326|NCT02651688|561664908|FG000|Overall Study|Lost to Follow-up|1|||
155610327|NCT02651688|561664909|FG001|Overall Study|Lost to Follow-up|3|||
155610328|NCT02651688|561664910|FG002|Overall Study|Lost to Follow-up|0|||
155610329|NCT02651688|561664908|FG000|Overall Study|Withdrawal by Subject|1|||
155610330|NCT02651688|561664909|FG001|Overall Study|Withdrawal by Subject|0|||
155610331|NCT02651688|561664910|FG002|Overall Study|Withdrawal by Subject|2|||
155610332|NCT00625183|561664911|FG000|Overall Study|Disease Progression|1|||
155610333|NCT01863732|561664912|FG000|Overall Study|Adverse Event|2|||
155610334|NCT01863732|561664913|FG001|Overall Study|Adverse Event|0|||
155610335|NCT01863732|561664914|FG002|Overall Study|Adverse Event|3|||
155610336|NCT01863732|561664915|FG003|Overall Study|Adverse Event|3|||
155610337|NCT01863732|561664912|FG000|Overall Study|Lack of Efficacy|1|||
155610338|NCT01863732|561664913|FG001|Overall Study|Lack of Efficacy|0|||
155610339|NCT01863732|561664914|FG002|Overall Study|Lack of Efficacy|2|||
155610340|NCT01863732|561664915|FG003|Overall Study|Lack of Efficacy|1|||
155610341|NCT01863732|561664912|FG000|Overall Study|Lost to Follow-up|2|||
155610342|NCT01863732|561664913|FG001|Overall Study|Lost to Follow-up|2|||
155610343|NCT01863732|561664914|FG002|Overall Study|Lost to Follow-up|1|||
155610344|NCT01863732|561664915|FG003|Overall Study|Lost to Follow-up|1|||
155610345|NCT01863732|561664912|FG000|Overall Study|Physician Decision|1|||
155610346|NCT01863732|561664913|FG001|Overall Study|Physician Decision|0|||
155610347|NCT01863732|561664914|FG002|Overall Study|Physician Decision|1|||
155610348|NCT01863732|561664915|FG003|Overall Study|Physician Decision|0|||
155610349|NCT01863732|561664912|FG000|Overall Study|Pregnancy|0|||
155610350|NCT01863732|561664913|FG001|Overall Study|Pregnancy|0|||
155610351|NCT01863732|561664914|FG002|Overall Study|Pregnancy|0|||
155610352|NCT01863732|561664915|FG003|Overall Study|Pregnancy|1|||
155610353|NCT01863732|561664912|FG000|Overall Study|Technical problems|0|||
155610354|NCT01863732|561664913|FG001|Overall Study|Technical problems|1|||
155610355|NCT01863732|561664914|FG002|Overall Study|Technical problems|1|||
155610356|NCT01863732|561664915|FG003|Overall Study|Technical problems|0|||
155610357|NCT01863732|561664912|FG000|Overall Study|Subject/guardian decision|6|||
155610358|NCT01863732|561664913|FG001|Overall Study|Subject/guardian decision|9|||
155610359|NCT01863732|561664914|FG002|Overall Study|Subject/guardian decision|3|||
155610360|NCT01863732|561664915|FG003|Overall Study|Subject/guardian decision|1|||
155610361|NCT01863732|561664912|FG000|Overall Study|Death|1|||
155610362|NCT01863732|561664913|FG001|Overall Study|Death|0|||
155610363|NCT01863732|561664914|FG002|Overall Study|Death|0|||
155610364|NCT01863732|561664915|FG003|Overall Study|Death|1|||
155610365|NCT03084315|561664916|FG000|Overall Study|Lost to Follow-up|8|||
155610366|NCT03084315|561664917|FG001|Overall Study|Lost to Follow-up|7|||
155610367|NCT03084315|561664916|FG000|Overall Study|Withdrawal by Subject|2|||
155610368|NCT03084315|561664917|FG001|Overall Study|Withdrawal by Subject|2|||
155610369|NCT04424914|561664918|FG000|Overall Study|Other|0|||
155610370|NCT04424914|561664919|FG001|Overall Study|Other|0|||
155610371|NCT04424914|561664920|FG002|Overall Study|Other|28|||
155610372|NCT04424914|561664918|FG000|Overall Study|Withdrawal by Subject|3|||
155610373|NCT04424914|561664919|FG001|Overall Study|Withdrawal by Subject|0|||
155610374|NCT04424914|561664920|FG002|Overall Study|Withdrawal by Subject|0|||
155610375|NCT04424914|561664918|FG000|Overall Study|Study terminated by sponsor|23|||
155610376|NCT04424914|561664919|FG001|Overall Study|Study terminated by sponsor|7|||
155610377|NCT04424914|561664920|FG002|Overall Study|Study terminated by sponsor|0|||
155610378|NCT04424914|561664918|FG000|Overall Study|Lost to Follow-up|0|||
155610379|NCT04424914|561664919|FG001|Overall Study|Lost to Follow-up|0|||
155610380|NCT04424914|561664920|FG002|Overall Study|Lost to Follow-up|1|||
155610381|NCT04424914|561664918|FG000|Overall Study|Death|3|||
155610382|NCT04424914|561664919|FG001|Overall Study|Death|1|||
155610383|NCT04424914|561664920|FG002|Overall Study|Death|0|||
155610384|NCT00460746|561664921|FG000|Overall Study|Adverse Event|1|||
155610385|NCT00460746|561664921|FG000|Overall Study|Lost to Follow-up|1|||
155610386|NCT02791438|561664923|FG000|Treatment Period|Adverse Event|1|||
155610387|NCT02791438|561664924|FG001|Treatment Period|Adverse Event|0|||
155610388|NCT02791438|561664923|FG000|Treatment Period|Withdrawal by Subject|0|||
155610389|NCT02791438|561664924|FG001|Treatment Period|Withdrawal by Subject|1|||
155610390|NCT02791438|561664923|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
155610391|NCT02791438|561664924|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
155610392|NCT01603394|561664925|FG000|Overall Study|Adverse Event|1|||
155610393|NCT00394771|561664928|FG000|Overall Study|Did not meet protocol requirements|1|||
155610394|NCT00394771|561664929|FG001|Overall Study|Did not meet protocol requirements|0|||
155610395|NCT00394771|561664930|FG002|Overall Study|Did not meet protocol requirements|2|||
155610396|NCT00394771|561664931|FG003|Overall Study|Did not meet protocol requirements|0|||
155610397|NCT00394771|561664928|FG000|Overall Study|Protocol Violation|2|||
155610398|NCT00394771|561664929|FG001|Overall Study|Protocol Violation|4|||
155610399|NCT00394771|561664930|FG002|Overall Study|Protocol Violation|9|||
155610400|NCT00394771|561664931|FG003|Overall Study|Protocol Violation|7|||
155610401|NCT00394771|561664928|FG000|Overall Study|Withdrawal by Subject|10|||
155610402|NCT00394771|561664929|FG001|Overall Study|Withdrawal by Subject|6|||
155610403|NCT00394771|561664930|FG002|Overall Study|Withdrawal by Subject|8|||
155610404|NCT00394771|561664931|FG003|Overall Study|Withdrawal by Subject|12|||
155610405|NCT00394771|561664928|FG000|Overall Study|Adverse Event|10|||
155610406|NCT00394771|561664929|FG001|Overall Study|Adverse Event|5|||
155610407|NCT00394771|561664930|FG002|Overall Study|Adverse Event|12|||
155610408|NCT00394771|561664931|FG003|Overall Study|Adverse Event|8|||
155610409|NCT00394771|561664928|FG000|Overall Study|Participant pregnant|0|||
155610410|NCT00394771|561664929|FG001|Overall Study|Participant pregnant|1|||
155610411|NCT00394771|561664930|FG002|Overall Study|Participant pregnant|2|||
155610412|NCT00394771|561664931|FG003|Overall Study|Participant pregnant|2|||
155610413|NCT00394771|561664928|FG000|Overall Study|Lost to Follow-up|15|||
155610414|NCT00394771|561664929|FG001|Overall Study|Lost to Follow-up|15|||
155610415|NCT00394771|561664930|FG002|Overall Study|Lost to Follow-up|13|||
155610416|NCT00394771|561664931|FG003|Overall Study|Lost to Follow-up|10|||
155610417|NCT00394771|561664928|FG000|Overall Study|Other|3|||
155610418|NCT00394771|561664929|FG001|Overall Study|Other|3|||
155610419|NCT00394771|561664930|FG002|Overall Study|Other|1|||
155610420|NCT00394771|561664931|FG003|Overall Study|Other|0|||
155610421|NCT02906033|561664933|FG000|Baseline|Protocol Violation|37|||
155610422|NCT02906033|561664934|FG001|Baseline|Protocol Violation|33|||
155610423|NCT02906033|561664933|FG000|Follow-up|Lost to Follow-up|46|||
155610424|NCT02906033|561664934|FG001|Follow-up|Lost to Follow-up|62|||
155610425|NCT03782974|561664951|FG000|Overall Study|Withdrawal by Subject|7|||
155610426|NCT03782974|561664952|FG001|Overall Study|Withdrawal by Subject|7|||
155610427|NCT03782974|561664951|FG000|Overall Study|Pregnancy|1|||
155610428|NCT03782974|561664952|FG001|Overall Study|Pregnancy|0|||
155610429|NCT00505661|561664955|FG000|Overall Study|Not Eligible|4|||
155610430|NCT01907217|561664957|FG000|Overall Study|Withdrawal by Subject|0|||
155610431|NCT01907217|561664958|FG001|Overall Study|Withdrawal by Subject|2|||
155610432|NCT01764659|561664963|FG000|Overall Study|Death|1|||
155610433|NCT01764659|561664963|FG000|Overall Study|Physician Decision|1|||
155610434|NCT01210352|561664965|FG000|Overall Study|Adverse Event|0|||
155610435|NCT01210352|561664966|FG001|Overall Study|Adverse Event|0|||
155610436|NCT01210352|561664967|FG002|Overall Study|Adverse Event|0|||
155610437|NCT01210352|561664968|FG003|Overall Study|Adverse Event|0|||
155610438|NCT01210352|561664969|FG004|Overall Study|Adverse Event|0|||
155610439|NCT01210352|561664970|FG005|Overall Study|Adverse Event|0|||
155610440|NCT01210352|561664971|FG006|Overall Study|Adverse Event|0|||
155610441|NCT01210352|561664972|FG007|Overall Study|Adverse Event|2|||
155610442|NCT01210352|561664973|FG008|Overall Study|Adverse Event|1|||
155610443|NCT01210352|561664965|FG000|Overall Study|Lack of Efficacy|0|||
155610444|NCT01210352|561664966|FG001|Overall Study|Lack of Efficacy|0|||
155610445|NCT01210352|561664967|FG002|Overall Study|Lack of Efficacy|0|||
155610446|NCT01210352|561664968|FG003|Overall Study|Lack of Efficacy|0|||
155610447|NCT01210352|561664969|FG004|Overall Study|Lack of Efficacy|0|||
155610448|NCT01210352|561664970|FG005|Overall Study|Lack of Efficacy|0|||
155610449|NCT01210352|561664971|FG006|Overall Study|Lack of Efficacy|1|||
155610450|NCT01210352|561664972|FG007|Overall Study|Lack of Efficacy|0|||
155610451|NCT01210352|561664973|FG008|Overall Study|Lack of Efficacy|0|||
155610452|NCT01210352|561664965|FG000|Overall Study|Physician Decision|0|||
155610453|NCT01210352|561664966|FG001|Overall Study|Physician Decision|0|||
155610454|NCT01210352|561664967|FG002|Overall Study|Physician Decision|0|||
155610455|NCT01210352|561664968|FG003|Overall Study|Physician Decision|0|||
155610456|NCT01210352|561664969|FG004|Overall Study|Physician Decision|0|||
155610457|NCT01210352|561664970|FG005|Overall Study|Physician Decision|0|||
155610458|NCT01210352|561664971|FG006|Overall Study|Physician Decision|0|||
155610459|NCT01210352|561664972|FG007|Overall Study|Physician Decision|1|||
155610460|NCT01210352|561664973|FG008|Overall Study|Physician Decision|2|||
155610461|NCT01210352|561664965|FG000|Overall Study|Withdrawal by Subject|0|||
155610462|NCT01210352|561664966|FG001|Overall Study|Withdrawal by Subject|0|||
155610463|NCT01210352|561664967|FG002|Overall Study|Withdrawal by Subject|1|||
155610464|NCT01210352|561664968|FG003|Overall Study|Withdrawal by Subject|0|||
155610465|NCT01210352|561664969|FG004|Overall Study|Withdrawal by Subject|0|||
155610466|NCT01210352|561664970|FG005|Overall Study|Withdrawal by Subject|0|||
155610467|NCT01210352|561664971|FG006|Overall Study|Withdrawal by Subject|1|||
155610468|NCT01210352|561664972|FG007|Overall Study|Withdrawal by Subject|0|||
155610469|NCT01210352|561664973|FG008|Overall Study|Withdrawal by Subject|1|||
155610470|NCT01210352|561664965|FG000|Overall Study|Patient Discharged Early|0|||
155610471|NCT01210352|561664966|FG001|Overall Study|Patient Discharged Early|0|||
155610472|NCT01210352|561664967|FG002|Overall Study|Patient Discharged Early|1|||
155610473|NCT01210352|561664968|FG003|Overall Study|Patient Discharged Early|0|||
155610474|NCT01210352|561664969|FG004|Overall Study|Patient Discharged Early|0|||
155610475|NCT01210352|561664970|FG005|Overall Study|Patient Discharged Early|0|||
155610476|NCT01210352|561664971|FG006|Overall Study|Patient Discharged Early|0|||
155610477|NCT01210352|561664972|FG007|Overall Study|Patient Discharged Early|0|||
155610478|NCT01210352|561664973|FG008|Overall Study|Patient Discharged Early|0|||
155610479|NCT03338569|561664974|FG000|Overall Study|Physician Decision|8|||
155610480|NCT03338569|561664975|FG001|Overall Study|Physician Decision|3|||
155610481|NCT03338569|561664974|FG000|Overall Study|Withdrawal by Subject|0|||
155610482|NCT03338569|561664975|FG001|Overall Study|Withdrawal by Subject|1|||
155610483|NCT03338569|561664974|FG000|Overall Study|Lost to Follow-up|0|||
155610484|NCT03338569|561664975|FG001|Overall Study|Lost to Follow-up|1|||
155610485|NCT04607980|561664976|FG000|Overall Study|Adverse Event|3|||
155610486|NCT04607980|561664977|FG001|Overall Study|Adverse Event|4|||
155610487|NCT04607980|561664976|FG000|Overall Study|Death|0|||
155610488|NCT04607980|561664977|FG001|Overall Study|Death|1|||
155610489|NCT04607980|561664976|FG000|Overall Study|Withdrawal by Subject|2|||
155610490|NCT04607980|561664977|FG001|Overall Study|Withdrawal by Subject|5|||
155610491|NCT04607980|561664976|FG000|Overall Study|Lost to Follow-up|4|||
155610492|NCT04607980|561664977|FG001|Overall Study|Lost to Follow-up|8|||
155610493|NCT04607980|561664976|FG000|Overall Study|Protocol Violation|0|||
155610494|NCT04607980|561664977|FG001|Overall Study|Protocol Violation|3|||
155610495|NCT04607980|561664976|FG000|Overall Study|Other|3|||
155610496|NCT04607980|561664977|FG001|Overall Study|Other|0|||
155610497|NCT00448812|561664979|FG000|Year 2|Missed visit but remained in study|4|||
155610498|NCT00448812|561664980|FG001|Year 2|Missed visit but remained in study|1|||
155610499|NCT00448812|561664979|FG000|Year 3|Withdrawal by Subject|1|||
155610500|NCT00448812|561664980|FG001|Year 3|Withdrawal by Subject|3|||
155610501|NCT00448812|561664979|FG000|Year 3|Lost to Follow-up|1|||
155610502|NCT00448812|561664980|FG001|Year 3|Lost to Follow-up|0|||
155610503|NCT00448812|561664979|FG000|Year 3|Missed visit but remained in study|2|||
155610504|NCT00448812|561664980|FG001|Year 3|Missed visit but remained in study|0|||
155610505|NCT00448812|561664979|FG000|Year 5|Missed visit but remained in study|1|||
155610506|NCT00448812|561664980|FG001|Year 5|Missed visit but remained in study|0|||
155610507|NCT01854879|561664983|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
155610508|NCT01854879|561664983|FG000|Overall Study|screen fail|3|||
155610509|NCT01854879|561664983|FG000|Overall Study|incomplete data set|1|||
155610510|NCT02012959|561664984|FG000|Treatment Phase A|Adverse Event|2|||
155610511|NCT02012959|561664985|FG001|Treatment Phase A|Adverse Event|0|||
155610512|NCT02012959|561664986|FG002|Treatment Phase A|Adverse Event|0|||
155610513|NCT02012959|561664987|FG003|Treatment Phase A|Adverse Event|0|||
155610514|NCT02012959|561664988|FG004|Treatment Phase A|Adverse Event|0|||
155610515|NCT01212159|561666385|FG000|Overall Study|Withdrawal by Subject|12|||
155610516|NCT01212159|561666386|FG001|Overall Study|Withdrawal by Subject|12|||
155610517|NCT00582426|561666397|FG000|Overall Study|Lost to Follow-up|0|||
155610518|NCT00582426|561666398|FG001|Overall Study|Lost to Follow-up|2|||
155610519|NCT00582426|561666397|FG000|Overall Study|Adverse Event|4|||
155610520|NCT00582426|561666398|FG001|Overall Study|Adverse Event|2|||
155610521|NCT00582426|561666397|FG000|Overall Study|Protocol Violation|6|||
155610522|NCT00582426|561666398|FG001|Overall Study|Protocol Violation|2|||
155610523|NCT00582426|561666397|FG000|Overall Study|Death|4|||
155610524|NCT00582426|561666398|FG001|Overall Study|Death|3|||
155610525|NCT00582426|561666397|FG000|Overall Study|Withdrawal by Subject|3|||
155610526|NCT00582426|561666398|FG001|Overall Study|Withdrawal by Subject|2|||
155610527|NCT00582426|561666397|FG000|Overall Study|Disease Progression|2|||
155610528|NCT00582426|561666398|FG001|Overall Study|Disease Progression|2|||
155610529|NCT00582426|561666397|FG000|Overall Study|Use of illicit drugs|1|||
155610530|NCT00582426|561666398|FG001|Overall Study|Use of illicit drugs|0|||
155610531|NCT00199849|561666399|FG000|Overall Study|Unrelated illness or complication|0|||
155610532|NCT00199849|561666400|FG001|Overall Study|Unrelated illness or complication|1|||
155610533|NCT00199849|561666401|FG002|Overall Study|Unrelated illness or complication|0|||
155610534|NCT00199849|561666399|FG000|Overall Study|Progressive disease requiring intervention|0|||
155610535|NCT00199849|561666400|FG001|Overall Study|Progressive disease requiring intervention|0|||
155610536|NCT00199849|561666401|FG002|Overall Study|Progressive disease requiring intervention|1|||
155610537|NCT00199849|561666399|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
155610538|NCT00199849|561666400|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
155610539|NCT00199849|561666401|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
155610540|NCT00662311|561666402|FG000|Overall Study|Respiratory Infection|1|||
155610541|NCT00662311|561666403|FG001|Overall Study|Respiratory Infection|0|||
155610542|NCT00662311|561666404|FG002|Overall Study|Respiratory Infection|0|||
155610543|NCT02164318|561666405|FG000|Overall Study|Withdrawal by Subject|0|||
155610544|NCT02164318|561666406|FG001|Overall Study|Withdrawal by Subject|1|||
155610545|NCT02164318|561666407|FG002|Overall Study|Withdrawal by Subject|0|||
155610546|NCT02164318|561666408|FG003|Overall Study|Withdrawal by Subject|1|||
155610547|NCT04727528|561666409|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
155610548|NCT04727528|561666410|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
155610549|NCT04727528|561666409|FG000|Open-label Period|Randomized who did not receive treatment|1|||
155610550|NCT04727528|561666410|FG001|Open-label Period|Randomized who did not receive treatment|0|||
155610551|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155610552|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Adverse Event|1|||
155610553|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Death|0|||
155610554|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Death|1|||
155610555|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
155610556|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
155610557|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
155610558|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
155610559|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Physician Decision|0|||
155610560|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Physician Decision|1|||
155610561|NCT04727528|561666409|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
155610562|NCT04727528|561666410|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155610563|NCT01467271|561666414|FG000|Overall Study|Death|84|||
155610564|NCT01467271|561666414|FG000|Overall Study|Lost to Follow-up|83|||
155610565|NCT01467271|561666414|FG000|Overall Study|Retraction of patient's consent|21|||
155610566|NCT01467271|561666414|FG000|Overall Study|Other reason|14|||
155610567|NCT01964989|561666416|FG000|Overall Study|Protocol Violation|3|||
155610568|NCT01964989|561666417|FG001|Overall Study|Protocol Violation|4|||
155610569|NCT01964989|561666416|FG000|Overall Study|Administrative Reason|103|||
155610570|NCT01964989|561666417|FG001|Overall Study|Administrative Reason|95|||
155610571|NCT01964989|561666416|FG000|Overall Study|Adverse Event|0|||
155610572|NCT01964989|561666417|FG001|Overall Study|Adverse Event|1|||
155610573|NCT01964989|561666416|FG000|Overall Study|Death|1|||
155610574|NCT01964989|561666417|FG001|Overall Study|Death|3|||
155610575|NCT01964989|561666416|FG000|Overall Study|Withdrawal by Subject|156|||
155610576|NCT01964989|561666417|FG001|Overall Study|Withdrawal by Subject|160|||
155610577|NCT01964989|561666416|FG000|Overall Study|Lost to Follow-up|254|||
155610578|NCT01964989|561666417|FG001|Overall Study|Lost to Follow-up|232|||
155610579|NCT01964989|561666416|FG000|Overall Study|Other|267|||
155610580|NCT01964989|561666417|FG001|Overall Study|Other|252|||
155610581|NCT02815267|561666418|FG000|Double-Blind Phase|Adverse Event|0|||
155610582|NCT02815267|561666419|FG001|Double-Blind Phase|Adverse Event|3|||
155610583|NCT02815267|561666418|FG000|Double-Blind Phase|Lost to Follow-up|17|||
155610584|NCT02815267|561666419|FG001|Double-Blind Phase|Lost to Follow-up|9|||
155610585|NCT02815267|561666418|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
155610586|NCT02815267|561666419|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
155610587|NCT02815267|561666418|FG000|Double-Blind Phase|Protocol Violation|3|||
155610588|NCT02815267|561666419|FG001|Double-Blind Phase|Protocol Violation|2|||
155610589|NCT02815267|561666418|FG000|Double-Blind Phase|Site withdrawal|1|||
155610590|NCT02815267|561666419|FG001|Double-Blind Phase|Site withdrawal|6|||
155610591|NCT02815267|561666418|FG000|Double-Blind Phase|Received a disallowed medication|1|||
155610592|NCT02815267|561666419|FG001|Double-Blind Phase|Received a disallowed medication|1|||
155610593|NCT02815267|561666418|FG000|Open-Label Phase|Adverse Event|1|||
155610594|NCT02815267|561666419|FG001|Open-Label Phase|Adverse Event|1|||
155610595|NCT02815267|561666418|FG000|Open-Label Phase|Lost to Follow-up|23|||
155610596|NCT02815267|561666419|FG001|Open-Label Phase|Lost to Follow-up|9|||
155610597|NCT02815267|561666418|FG000|Open-Label Phase|Withdrawal by Subject|24|||
155610598|NCT02815267|561666419|FG001|Open-Label Phase|Withdrawal by Subject|13|||
155610599|NCT02815267|561666418|FG000|Open-Label Phase|Protocol Violation|0|||
155610600|NCT02815267|561666419|FG001|Open-Label Phase|Protocol Violation|1|||
155610601|NCT02815267|561666418|FG000|Open-Label Phase|Administrative|21|||
155610602|NCT02815267|561666419|FG001|Open-Label Phase|Administrative|12|||
155610603|NCT02815267|561666418|FG000|Open-Label Phase|Other|2|||
155610604|NCT02815267|561666419|FG001|Open-Label Phase|Other|5|||
155610605|NCT02769312|561666420|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
155610606|NCT02769312|561666421|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
155610607|NCT02769312|561666420|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
155610608|NCT02769312|561666421|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
155610609|NCT02769312|561666420|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
155610610|NCT02769312|561666421|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
155610611|NCT02769312|561666420|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
155610612|NCT02769312|561666421|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
155610613|NCT02769312|561666420|FG000|Follow-up|Lost to Follow-up|1|||
155610614|NCT02769312|561666421|FG001|Follow-up|Lost to Follow-up|1|||
155610615|NCT04126317|561666424|FG000|Overall Study|Adverse Event|0|||
155610616|NCT04126317|561666425|FG001|Overall Study|Adverse Event|1|||
155610617|NCT04126317|561666424|FG000|Overall Study|Withdrawal by Subject|4|||
155610618|NCT04126317|561666425|FG001|Overall Study|Withdrawal by Subject|1|||
155610619|NCT00660595|561666426|FG000|Overall Study|Lost to Follow-up|0|||
155610620|NCT00660595|561666427|FG001|Overall Study|Lost to Follow-up|1|||
155610621|NCT00660595|561666426|FG000|Overall Study|Did not consent to participate in study|12|||
155610622|NCT00660595|561666427|FG001|Overall Study|Did not consent to participate in study|8|||
155610623|NCT00660595|561666426|FG000|Overall Study|Participant left hospital|1|||
155610624|NCT00660595|561666427|FG001|Overall Study|Participant left hospital|0|||
155610625|NCT00660595|561666426|FG000|Overall Study|Non Specified reasons|5|||
155610626|NCT00660595|561666427|FG001|Overall Study|Non Specified reasons|0|||
155610627|NCT01148459|561666428|FG000|Overall Study|Serious Adverse Event|5|||
155610628|NCT01148459|561666429|FG001|Overall Study|Serious Adverse Event|4|||
155610629|NCT01148459|561666428|FG000|Overall Study|Withdrawal by Subject|1|||
155610630|NCT01148459|561666429|FG001|Overall Study|Withdrawal by Subject|0|||
155610631|NCT01148459|561666428|FG000|Overall Study|Migrated/moved from study area|3|||
155610632|NCT01148459|561666429|FG001|Overall Study|Migrated/moved from study area|6|||
155610633|NCT01148459|561666428|FG000|Overall Study|Lost to Follow-up|2|||
155610634|NCT01148459|561666429|FG001|Overall Study|Lost to Follow-up|0|||
155610635|NCT01148459|561666428|FG000|Overall Study|Refusal|1|||
155610636|NCT01148459|561666429|FG001|Overall Study|Refusal|0|||
155610637|NCT01148459|561666428|FG000|Overall Study|Failure to comply with study procedures|0|||
155610638|NCT01148459|561666429|FG001|Overall Study|Failure to comply with study procedures|1|||
155610639|NCT00948922|561666430|FG000|Overall Study|Did not start study treatment|2|||
155610640|NCT00948922|561666431|FG001|Overall Study|Did not start study treatment|5|||
155610641|NCT00948922|561666432|FG002|Overall Study|Did not start study treatment|0|||
155610642|NCT00948922|561666430|FG000|Overall Study|Withdrawal by Subject|0|||
155610643|NCT00948922|561666431|FG001|Overall Study|Withdrawal by Subject|2|||
155610644|NCT00948922|561666432|FG002|Overall Study|Withdrawal by Subject|1|||
155610645|NCT00948922|561666430|FG000|Overall Study|Death|3|||
155610646|NCT00948922|561666431|FG001|Overall Study|Death|0|||
155610647|NCT00948922|561666432|FG002|Overall Study|Death|0|||
155610648|NCT00948922|561666430|FG000|Overall Study|Disease progression|0|||
155610649|NCT00948922|561666431|FG001|Overall Study|Disease progression|1|||
155610650|NCT00948922|561666432|FG002|Overall Study|Disease progression|0|||
155610651|NCT00948922|561666430|FG000|Overall Study|Insurance issues|1|||
155610652|NCT00948922|561666431|FG001|Overall Study|Insurance issues|0|||
155610653|NCT00948922|561666432|FG002|Overall Study|Insurance issues|0|||
155610654|NCT00948922|561666430|FG000|Overall Study|Transplant eligibility issues|2|||
155610655|NCT00948922|561666431|FG001|Overall Study|Transplant eligibility issues|3|||
155610656|NCT00948922|561666432|FG002|Overall Study|Transplant eligibility issues|0|||
155610657|NCT00948922|561666430|FG000|Overall Study|Not evaluable at time of analysis|0|||
155610658|NCT00948922|561666431|FG001|Overall Study|Not evaluable at time of analysis|3|||
155610659|NCT00948922|561666432|FG002|Overall Study|Not evaluable at time of analysis|0|||
155610660|NCT04854057|561666433|FG000|Overall Study|Adverse Event|0|||
155610661|NCT04854057|561666434|FG001|Overall Study|Adverse Event|1|||
155610662|NCT02131233|561666435|FG000|Overall Study|Not Treated|2|||
155610663|NCT02131233|561666436|FG001|Overall Study|Not Treated|3|||
155610664|NCT02131233|561666435|FG000|Overall Study|Adverse Event|7|||
155610665|NCT02131233|561666436|FG001|Overall Study|Adverse Event|6|||
155610666|NCT02131233|561666435|FG000|Overall Study|Death|0|||
155610667|NCT02131233|561666436|FG001|Overall Study|Death|1|||
155610668|NCT02131233|561666435|FG000|Overall Study|Lack of Efficacy|6|||
155610669|NCT02131233|561666436|FG001|Overall Study|Lack of Efficacy|3|||
155610670|NCT02131233|561666435|FG000|Overall Study|Lost to Follow-up|14|||
155610671|NCT02131233|561666436|FG001|Overall Study|Lost to Follow-up|13|||
155610672|NCT02131233|561666435|FG000|Overall Study|Non-Compliance With Study Drug|8|||
155610673|NCT02131233|561666436|FG001|Overall Study|Non-Compliance With Study Drug|5|||
155610674|NCT02131233|561666435|FG000|Overall Study|Physician Decision|7|||
155610675|NCT02131233|561666436|FG001|Overall Study|Physician Decision|0|||
155610676|NCT02131233|561666435|FG000|Overall Study|Pregnancy|4|||
155610677|NCT02131233|561666436|FG001|Overall Study|Pregnancy|0|||
155610678|NCT02131233|561666435|FG000|Overall Study|Withdrawal by Subject|18|||
155610679|NCT02131233|561666436|FG001|Overall Study|Withdrawal by Subject|11|||
155610680|NCT05114564|561666437|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
155610681|NCT05114564|561666438|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
155610682|NCT05114564|561666437|FG000|First Intervention|Adverse Event|0|||
155610683|NCT05114564|561666438|FG001|First Intervention|Adverse Event|1|||
155610684|NCT00339833|561666447|FG000|Overall Study|Withdrawal by Subject|1|||
155610685|NCT00339833|561666448|FG001|Overall Study|Withdrawal by Subject|2|||
155610686|NCT00339833|561666447|FG000|Overall Study|toothache|0|||
155610687|NCT00339833|561666448|FG001|Overall Study|toothache|1|||
155610688|NCT00339833|561666447|FG000|Overall Study|indigestion|0|||
155610689|NCT00339833|561666448|FG001|Overall Study|indigestion|1|||
155610690|NCT00339833|561666447|FG000|Overall Study|Chest pain|0|||
155610691|NCT00339833|561666448|FG001|Overall Study|Chest pain|1|||
155610692|NCT00339833|561666447|FG000|Overall Study|minor infection|0|||
155610693|NCT00339833|561666448|FG001|Overall Study|minor infection|1|||
155722609|NCT02318706|562083888|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
155722610|NCT04328077|562083889|FG000|Overall Study|Lost to Follow-up|0|||
155722611|NCT04328077|562083890|FG001|Overall Study|Lost to Follow-up|1|||
155722612|NCT04328077|562083891|FG002|Overall Study|Lost to Follow-up|0|||
155722613|NCT04328077|562083892|FG003|Overall Study|Lost to Follow-up|0|||
155722614|NCT04328077|562083889|FG000|Overall Study|Withdrawal by Subject|0|||
155722615|NCT04328077|562083890|FG001|Overall Study|Withdrawal by Subject|1|||
155722616|NCT04328077|562083891|FG002|Overall Study|Withdrawal by Subject|1|||
155722617|NCT04328077|562083892|FG003|Overall Study|Withdrawal by Subject|3|||
155722618|NCT01702311|562083893|FG000|Overall Study|Withdrawal by Subject|3|||
155722619|NCT01702311|562083894|FG001|Overall Study|Withdrawal by Subject|2|||
155722620|NCT01702311|562083893|FG000|Overall Study|Discharge less than 24 hours|10|||
155722621|NCT01702311|562083894|FG001|Overall Study|Discharge less than 24 hours|7|||
155722622|NCT01702311|562083893|FG000|Overall Study|Physician Decision|3|||
155722623|NCT01702311|562083894|FG001|Overall Study|Physician Decision|4|||
155722624|NCT00804908|562083898|FG000|Overall Study|Other|115|||
155722625|NCT00804908|562083899|FG001|Overall Study|Other|116|||
155722626|NCT00804908|562083900|FG002|Overall Study|Other|114|||
155722627|NCT01428258|562083901|FG000|Intervention 1|Withdrawal by Subject|2|||
155722628|NCT01428258|562083902|FG001|Intervention 1|Withdrawal by Subject|0|||
155722629|NCT00981656|562083905|FG000|Overall Study|Protocol Violation|1|||
155722630|NCT00981656|562083905|FG000|Overall Study|Did not start protocol treatment|2|||
155722631|NCT00687596|562083906|FG000|Overall Study|Adverse Event (AE)|10|||
155722632|NCT00687596|562083907|FG001|Overall Study|Adverse Event (AE)|3|||
155722633|NCT00687596|562083906|FG000|Overall Study|Radiological Disease Progression|6|||
155722634|NCT00687596|562083907|FG001|Overall Study|Radiological Disease Progression|2|||
155722635|NCT00687596|562083906|FG000|Overall Study|Clinical Disease Progression|1|||
155722636|NCT00687596|562083907|FG001|Overall Study|Clinical Disease Progression|3|||
155722637|NCT00687596|562083906|FG000|Overall Study|Investigator Discretion|3|||
155722638|NCT00687596|562083907|FG001|Overall Study|Investigator Discretion|1|||
155722639|NCT00687596|562083906|FG000|Overall Study|Sponsor Terminated Study|6|||
155722640|NCT00687596|562083907|FG001|Overall Study|Sponsor Terminated Study|17|||
155722641|NCT00499486|562083910|FG000|Overall Study|Withdrawal by Subject|16|||
155722642|NCT01867671|562083914|FG000|Overall Study|Adverse Event|5|||
155722643|NCT01867671|562083915|FG001|Overall Study|Adverse Event|3|||
155722644|NCT01867671|562083914|FG000|Overall Study|Anaphylaxis|0|||
155722645|NCT01867671|562083915|FG001|Overall Study|Anaphylaxis|1|||
155722646|NCT01867671|562083914|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
155722647|NCT01867671|562083915|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
155722648|NCT01867671|562083914|FG000|Overall Study|Lost to Follow-up|0|||
155722649|NCT01867671|562083915|FG001|Overall Study|Lost to Follow-up|1|||
155722650|NCT01867671|562083914|FG000|Overall Study|Non-compliance with Study Drug|1|||
155722651|NCT01867671|562083915|FG001|Overall Study|Non-compliance with Study Drug|2|||
155722652|NCT01867671|562083914|FG000|Overall Study|Withdrawal by Subject|21|||
155722653|NCT01867671|562083915|FG001|Overall Study|Withdrawal by Subject|21|||
155722654|NCT04819945|562083922|FG000|Overall Study|Lost to Follow-up|1|||
155722655|NCT00551759|562083923|FG000|Overall Study|Adverse Event|7|||
155722656|NCT00551759|562083923|FG000|Overall Study|Death|5|||
155722657|NCT00551759|562083923|FG000|Overall Study|Ineligible|1|||
155722658|NCT04531176|562083924|FG000|Overall Study|Study was stopped early|24|||
155722659|NCT04531176|562083925|FG001|Overall Study|Study was stopped early|26|||
155722660|NCT04531176|562083926|FG002|Overall Study|Study was stopped early|24|||
155722661|NCT00561652|562083929|FG000|Overall Study|Withdrawal by Subject|0|||
155610694|NCT00339833|561666447|FG000|Overall Study|Poor venous access|2|||
155722662|NCT00561652|562083930|FG001|Overall Study|Withdrawal by Subject|1|||
155722663|NCT04484961|562083933|FG000|Overall Study|Lost to Follow-up|9|||
155722664|NCT04484961|562083934|FG001|Overall Study|Lost to Follow-up|9|||
155722665|NCT00388349|562083935|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
155722666|NCT00388349|562083936|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
155722667|NCT01345240|562083941|FG000|Overall Study|Adverse Event|3|||
155722668|NCT01345240|562083942|FG001|Overall Study|Adverse Event|5|||
155722669|NCT01345240|562083943|FG002|Overall Study|Adverse Event|4|||
155722670|NCT01345240|562083944|FG003|Overall Study|Adverse Event|2|||
155722671|NCT01345240|562083945|FG004|Overall Study|Adverse Event|1|||
155722672|NCT01345240|562083941|FG000|Overall Study|Lost to Follow-up|8|||
155722673|NCT01345240|562083942|FG001|Overall Study|Lost to Follow-up|9|||
155722674|NCT01345240|562083943|FG002|Overall Study|Lost to Follow-up|14|||
155722675|NCT01345240|562083944|FG003|Overall Study|Lost to Follow-up|7|||
155722676|NCT01345240|562083945|FG004|Overall Study|Lost to Follow-up|9|||
155722677|NCT00774046|562083947|FG000|Screening|Not eligible|56|||
155722678|NCT00774046|562083947|FG000|Enrollment|Desired other therapy/refused|28|||
155722679|NCT00774046|562083947|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
155722680|NCT00762164|562083952|FG000|Overall Study|Lost to Follow-up|1|||
155722681|NCT00762164|562083953|FG001|Overall Study|Lost to Follow-up|1|||
155722682|NCT00762164|562083952|FG000|Overall Study|Discontinued medication|2|||
155722683|NCT00762164|562083953|FG001|Overall Study|Discontinued medication|0|||
155722684|NCT00762164|562083952|FG000|Overall Study|Withdrawal by Subject|0|||
155722685|NCT00762164|562083953|FG001|Overall Study|Withdrawal by Subject|1|||
155722686|NCT02946580|562083957|FG000|Overall Study|Withdrawal by Subject|1|||
155722687|NCT02946580|562083958|FG001|Overall Study|Withdrawal by Subject|2|||
155722688|NCT02946580|562083957|FG000|Overall Study|Adverse Event|0|||
155722689|NCT02946580|562083958|FG001|Overall Study|Adverse Event|2|||
155722690|NCT02946580|562083957|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
155722691|NCT02946580|562083958|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
155722692|NCT00685165|562083959|FG000|Washout Period of 14 Days|Adverse Event|1|||
155722693|NCT00685165|562083960|FG001|Washout Period of 14 Days|Adverse Event|0|||
155722694|NCT03050801|562083961|FG000|Experiment 1|Lost to Follow-up|0|||
155722695|NCT03050801|562083962|FG001|Experiment 1|Lost to Follow-up|1|||
155722696|NCT03050801|562083963|FG002|Experiment 1|Lost to Follow-up|0|||
155722697|NCT03050801|562083964|FG003|Experiment 1|Lost to Follow-up|0|||
155722698|NCT03050801|562083965|FG004|Experiment 1|Lost to Follow-up|0|||
155722699|NCT03050801|562083966|FG005|Experiment 1|Lost to Follow-up|0|||
155722700|NCT03050801|562083961|FG000|Experiment 1|Physician Decision|0|||
155722701|NCT03050801|562083962|FG001|Experiment 1|Physician Decision|3|||
155722702|NCT03050801|562083963|FG002|Experiment 1|Physician Decision|0|||
155722703|NCT03050801|562083964|FG003|Experiment 1|Physician Decision|0|||
155722704|NCT03050801|562083965|FG004|Experiment 1|Physician Decision|0|||
155722705|NCT03050801|562083966|FG005|Experiment 1|Physician Decision|0|||
155722706|NCT03050801|562083961|FG000|Experiment 1|Change of experimental design|0|||
155722707|NCT03050801|562083962|FG001|Experiment 1|Change of experimental design|3|||
155722708|NCT03050801|562083963|FG002|Experiment 1|Change of experimental design|0|||
155722709|NCT03050801|562083964|FG003|Experiment 1|Change of experimental design|0|||
155722710|NCT03050801|562083965|FG004|Experiment 1|Change of experimental design|0|||
155722711|NCT03050801|562083966|FG005|Experiment 1|Change of experimental design|0|||
155722712|NCT03050801|562083961|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
155722713|NCT03050801|562083962|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
155722714|NCT03050801|562083963|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
155722715|NCT03050801|562083964|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
155722716|NCT03050801|562083965|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
155722717|NCT03050801|562083966|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
155722718|NCT03050801|562083961|FG000|Experiment 2|Lost to Follow-up|0|||
155722719|NCT03050801|562083962|FG001|Experiment 2|Lost to Follow-up|0|||
155722720|NCT03050801|562083963|FG002|Experiment 2|Lost to Follow-up|0|||
155722721|NCT03050801|562083964|FG003|Experiment 2|Lost to Follow-up|1|||
155722722|NCT03050801|562083965|FG004|Experiment 2|Lost to Follow-up|1|||
155722723|NCT03050801|562083966|FG005|Experiment 2|Lost to Follow-up|0|||
155722724|NCT03050801|562083961|FG000|Experiment 2|Physician Decision|0|||
155722725|NCT03050801|562083962|FG001|Experiment 2|Physician Decision|0|||
155722726|NCT03050801|562083963|FG002|Experiment 2|Physician Decision|0|||
155722727|NCT03050801|562083964|FG003|Experiment 2|Physician Decision|0|||
155722728|NCT03050801|562083965|FG004|Experiment 2|Physician Decision|1|||
155722729|NCT03050801|562083966|FG005|Experiment 2|Physician Decision|0|||
155722730|NCT03050801|562083961|FG000|Experiment 2|Pregnancy|0|||
155722731|NCT03050801|562083962|FG001|Experiment 2|Pregnancy|0|||
155722732|NCT03050801|562083963|FG002|Experiment 2|Pregnancy|0|||
155722733|NCT03050801|562083964|FG003|Experiment 2|Pregnancy|0|||
155722734|NCT03050801|562083965|FG004|Experiment 2|Pregnancy|1|||
155722735|NCT03050801|562083966|FG005|Experiment 2|Pregnancy|0|||
155722736|NCT03050801|562083961|FG000|Experiment 2|Withdrawal by Subject|0|||
155722737|NCT03050801|562083962|FG001|Experiment 2|Withdrawal by Subject|0|||
155722738|NCT03050801|562083963|FG002|Experiment 2|Withdrawal by Subject|0|||
155722739|NCT03050801|562083964|FG003|Experiment 2|Withdrawal by Subject|1|||
155722740|NCT03050801|562083965|FG004|Experiment 2|Withdrawal by Subject|0|||
155722741|NCT03050801|562083966|FG005|Experiment 2|Withdrawal by Subject|0|||
155722742|NCT03050801|562083961|FG000|Experiment 2|Poor data quality|0|||
155722743|NCT03050801|562083962|FG001|Experiment 2|Poor data quality|0|||
155722744|NCT03050801|562083963|FG002|Experiment 2|Poor data quality|0|||
155722745|NCT03050801|562083964|FG003|Experiment 2|Poor data quality|4|||
155722746|NCT03050801|562083965|FG004|Experiment 2|Poor data quality|1|||
155435852|NCT01476787|561022966|FG000|Treatment|Insufficient response|15|||
155610695|NCT00339833|561666448|FG001|Overall Study|Poor venous access|2|||
155610696|NCT00339833|561666447|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
155610697|NCT00339833|561666448|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
155610698|NCT00339833|561666447|FG000|Overall Study|Error in data records|1|||
155610699|NCT00339833|561666448|FG001|Overall Study|Error in data records|0|||
155610700|NCT00217581|561666449|FG000|Overall Study|Withdrawal by Subject|1|||
155610701|NCT02829047|561666450|FG000|Overall Study|Withdrawal by Subject|1|||
155610702|NCT03077607|561666452|FG000|Period 1 (15 Days)|Adverse Event|1|||
155610703|NCT03077607|561666453|FG001|Period 1 (15 Days)|Adverse Event|0|||
155610704|NCT03077607|561666452|FG000|Period 1 (15 Days)|Death|1|||
155610705|NCT03077607|561666453|FG001|Period 1 (15 Days)|Death|0|||
155610706|NCT03077607|561666452|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
155610707|NCT03077607|561666453|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
155610708|NCT03077607|561666452|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
155610709|NCT03077607|561666453|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
155610710|NCT01597492|561666454|FG000|Overall Study|Withdrawal by Subject|1|||
155610711|NCT01597492|561666455|FG001|Overall Study|Withdrawal by Subject|2|||
155610712|NCT01597492|561666454|FG000|Overall Study|Adverse Event|3|||
155610713|NCT01597492|561666455|FG001|Overall Study|Adverse Event|0|||
155610714|NCT01597492|561666454|FG000|Overall Study|Lost to Follow-up|0|||
155610715|NCT01597492|561666455|FG001|Overall Study|Lost to Follow-up|2|||
155610716|NCT01597492|561666454|FG000|Overall Study|Other Reason|2|||
155610717|NCT01597492|561666455|FG001|Overall Study|Other Reason|0|||
155610718|NCT02570750|561666456|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
155610719|NCT02570750|561666457|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
155610720|NCT02570750|561666456|FG000|Overall Study|Protocol deviation|4|||
155610721|NCT02570750|561666457|FG001|Overall Study|Protocol deviation|2|||
155610722|NCT02570750|561666456|FG000|Overall Study|Withdrawal by Subject|5|||
155610723|NCT02570750|561666457|FG001|Overall Study|Withdrawal by Subject|0|||
155610724|NCT02570750|561666456|FG000|Overall Study|Lost to Follow-up|2|||
155610725|NCT02570750|561666457|FG001|Overall Study|Lost to Follow-up|2|||
155610726|NCT02570750|561666456|FG000|Overall Study|Adverse Event|2|||
155610727|NCT02570750|561666457|FG001|Overall Study|Adverse Event|1|||
155610728|NCT01410240|561666458|FG000|Overall Study|Physician Decision|0|||
155610729|NCT01410240|561666459|FG001|Overall Study|Physician Decision|0|||
155610730|NCT01410240|561666460|FG002|Overall Study|Physician Decision|1|||
155610731|NCT01410240|561666458|FG000|Overall Study|Missed week 6 assessments|1|||
155610732|NCT01410240|561666459|FG001|Overall Study|Missed week 6 assessments|1|||
155610733|NCT01410240|561666460|FG002|Overall Study|Missed week 6 assessments|1|||
155610734|NCT00496587|561666461|FG000|Overall Study|Adverse Event|2|||
155610735|NCT00496587|561666461|FG000|Overall Study|Progressive Disease|24|||
155610736|NCT00496587|561666461|FG000|Overall Study|Withdrawal by Subject|2|||
155610737|NCT00496587|561666461|FG000|Overall Study|Death|1|||
155610738|NCT00496587|561666461|FG000|Overall Study|Complications unrelated|2|||
155610739|NCT00482170|561666462|FG000|Overall Study|Adverse Event|5|||
155610740|NCT00482170|561666463|FG001|Overall Study|Adverse Event|14|||
155610741|NCT00482170|561666462|FG000|Overall Study|Withdrawal by Subject|6|||
155610742|NCT00482170|561666463|FG001|Overall Study|Withdrawal by Subject|1|||
155610743|NCT00482170|561666462|FG000|Overall Study|Protocol Violation|2|||
155610744|NCT00482170|561666463|FG001|Overall Study|Protocol Violation|3|||
155610745|NCT00482170|561666462|FG000|Overall Study|Lost to Follow-up|2|||
155610746|NCT00482170|561666463|FG001|Overall Study|Lost to Follow-up|0|||
155610747|NCT00482170|561666462|FG000|Overall Study|Unspecified reason|0|||
155610748|NCT00482170|561666463|FG001|Overall Study|Unspecified reason|2|||
155610749|NCT01557517|561666464|FG000|Overall Study|Death|1|||
155610750|NCT01557517|561666465|FG001|Overall Study|Death|0|||
155610751|NCT01557517|561666464|FG000|Overall Study|Refused further treatment|0|||
155610752|NCT01557517|561666465|FG001|Overall Study|Refused further treatment|2|||
155610753|NCT01557517|561666464|FG000|Overall Study|Adverse Event|0|||
155610754|NCT01557517|561666465|FG001|Overall Study|Adverse Event|2|||
155610755|NCT01557517|561666464|FG000|Overall Study|Pt declined before treatment started|1|||
155610756|NCT01557517|561666465|FG001|Overall Study|Pt declined before treatment started|0|||
155610757|NCT00162097|561666466|FG000|Overall Study|Participant no longer met study criteria|0|||
155610758|NCT00162097|561666467|FG001|Overall Study|Participant no longer met study criteria|0|||
155610759|NCT00162097|561666468|FG002|Overall Study|Participant no longer met study criteria|0|||
155610760|NCT00162097|561666469|FG003|Overall Study|Participant no longer met study criteria|1|||
155610761|NCT01204918|561666470|FG000|Overall Study|Withdrawal by Subject|4|||
155610762|NCT01204918|561666471|FG001|Overall Study|Withdrawal by Subject|10|||
155610763|NCT01204918|561666472|FG002|Overall Study|Withdrawal by Subject|5|||
155610764|NCT03517449|561666477|FG000|Overall Study|Death|184|||
155610765|NCT03517449|561666478|FG001|Overall Study|Death|236|||
155610766|NCT03517449|561666477|FG000|Overall Study|Lost to Follow-up|0|||
155610767|NCT03517449|561666478|FG001|Overall Study|Lost to Follow-up|2|||
155722747|NCT03050801|562083966|FG005|Experiment 2|Poor data quality|0|||
155722748|NCT03050801|562083961|FG000|Experiment 2|Discomfort during stimulation|0|||
155722749|NCT03050801|562083962|FG001|Experiment 2|Discomfort during stimulation|0|||
155722750|NCT03050801|562083963|FG002|Experiment 2|Discomfort during stimulation|0|||
155722751|NCT03050801|562083964|FG003|Experiment 2|Discomfort during stimulation|0|||
155722752|NCT03050801|562083965|FG004|Experiment 2|Discomfort during stimulation|0|||
155722753|NCT03050801|562083966|FG005|Experiment 2|Discomfort during stimulation|2|||
155722754|NCT03600909|562083967|FG000|Overall Study|Not treated|0|||
155722755|NCT03600909|562083968|FG001|Overall Study|Not treated|3|||
155722756|NCT03600909|562083969|FG002|Overall Study|Not treated|0|||
155722757|NCT01844765|562083970|FG000|Overall Study|Adverse Event|6|||
155722758|NCT01844765|562083971|FG001|Overall Study|Adverse Event|8|||
155722759|NCT01844765|562083970|FG000|Overall Study|Withdrawal by Subject|2|||
155722760|NCT01844765|562083971|FG001|Overall Study|Withdrawal by Subject|3|||
155722761|NCT01844765|562083970|FG000|Overall Study|Disease progression|1|||
155722762|NCT01844765|562083971|FG001|Overall Study|Disease progression|0|||
155722763|NCT01844765|562083970|FG000|Overall Study|Administrative problems|3|||
155722764|NCT01844765|562083971|FG001|Overall Study|Administrative problems|4|||
155722765|NCT01844765|562083970|FG000|Overall Study|Protocol deviation|2|||
155722766|NCT01844765|562083971|FG001|Overall Study|Protocol deviation|0|||
155722767|NCT01844765|562083970|FG000|Overall Study|Untreated|1|||
155722768|NCT01844765|562083971|FG001|Overall Study|Untreated|0|||
155722769|NCT04292535|562083972|FG000|Overall Study|Withdrawal by Subject|0|||
155722770|NCT04292535|562083973|FG001|Overall Study|Withdrawal by Subject|0|||
155722771|NCT04292535|562083974|FG002|Overall Study|Withdrawal by Subject|0|||
155722772|NCT04292535|562083975|FG003|Overall Study|Withdrawal by Subject|0|||
155722773|NCT04292535|562083976|FG004|Overall Study|Withdrawal by Subject|0|||
155722774|NCT04292535|562083977|FG005|Overall Study|Withdrawal by Subject|0|||
155722775|NCT04292535|562083978|FG006|Overall Study|Withdrawal by Subject|0|||
155722776|NCT04292535|562083979|FG007|Overall Study|Withdrawal by Subject|1|||
155722777|NCT04292535|562083980|FG008|Overall Study|Withdrawal by Subject|0|||
155722778|NCT04292535|562083981|FG009|Overall Study|Withdrawal by Subject|0|||
155722779|NCT04292535|562083982|FG010|Overall Study|Withdrawal by Subject|0|||
155722780|NCT04292535|562083983|FG011|Overall Study|Withdrawal by Subject|0|||
155722781|NCT04292535|562083984|FG012|Overall Study|Withdrawal by Subject|0|||
155722782|NCT04292535|562083985|FG013|Overall Study|Withdrawal by Subject|0|||
155722783|NCT04292535|562083972|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722784|NCT04292535|562083973|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155610768|NCT03517449|561666477|FG000|Overall Study|Withdrawal by Subject|7|||
155610769|NCT03517449|561666478|FG001|Overall Study|Withdrawal by Subject|26|||
155610770|NCT03517449|561666477|FG000|Overall Study|Participants Ongoing|220|||
155610771|NCT03517449|561666478|FG001|Overall Study|Participants Ongoing|152|||
155610772|NCT00269477|561666488|FG000|Overall Study|Protocol Violation|5|||
155610773|NCT00269477|561666489|FG001|Overall Study|Protocol Violation|5|||
155610774|NCT00269477|561666490|FG002|Overall Study|Protocol Violation|1|||
155610775|NCT00269477|561666491|FG003|Overall Study|Protocol Violation|0|||
155610776|NCT00269477|561666488|FG000|Overall Study|Missed post-vaccination blood draw|0|||
155610777|NCT00269477|561666489|FG001|Overall Study|Missed post-vaccination blood draw|1|||
155610778|NCT00269477|561666490|FG002|Overall Study|Missed post-vaccination blood draw|0|||
155610779|NCT00269477|561666491|FG003|Overall Study|Missed post-vaccination blood draw|0|||
155610780|NCT00431067|561666492|FG000|Overall Study|Other Adverse Event|9|||
155610781|NCT00431067|561666492|FG000|Overall Study|Progressive disease|30|||
155610782|NCT00431067|561666492|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
155610783|NCT03760458|561666494|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
155610784|NCT03760458|561666495|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
155610785|NCT03760458|561666496|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155610786|NCT03760458|561666497|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155610787|NCT03760458|561666498|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155610788|NCT00750919|561666499|FG000|Overall Study|Adverse Event|9|||
155610789|NCT00750919|561666499|FG000|Overall Study|Withdrawal by Subject|1|||
155610790|NCT00750919|561666499|FG000|Overall Study|Lack of Efficacy|8|||
155610791|NCT00750919|561666499|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
155610792|NCT00750919|561666499|FG000|Overall Study|Other|36|||
155610793|NCT02670382|561666511|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
155610794|NCT02670382|561666512|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
155610795|NCT03244618|561666513|FG000|Overall Study|Lost to Follow-up|3|||
155722785|NCT04292535|562083974|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722786|NCT04292535|562083975|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722787|NCT04292535|562083976|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722788|NCT04292535|562083977|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722789|NCT04292535|562083978|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722790|NCT04292535|562083979|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155722791|NCT04292535|562083980|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722792|NCT04292535|562083981|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722793|NCT04292535|562083982|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722794|NCT04292535|562083983|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155722795|NCT04292535|562083984|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155722796|NCT04292535|562083985|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155722797|NCT04292535|562083972|FG000|Overall Study|Report of Dizziness|0|||
155722798|NCT04292535|562083973|FG001|Overall Study|Report of Dizziness|0|||
155722799|NCT04292535|562083974|FG002|Overall Study|Report of Dizziness|0|||
155722800|NCT04292535|562083975|FG003|Overall Study|Report of Dizziness|0|||
155722801|NCT04292535|562083976|FG004|Overall Study|Report of Dizziness|0|||
155722802|NCT04292535|562083977|FG005|Overall Study|Report of Dizziness|0|||
155722803|NCT04292535|562083978|FG006|Overall Study|Report of Dizziness|0|||
155722804|NCT04292535|562083979|FG007|Overall Study|Report of Dizziness|0|||
155722805|NCT04292535|562083980|FG008|Overall Study|Report of Dizziness|0|||
155722806|NCT04292535|562083981|FG009|Overall Study|Report of Dizziness|0|||
155722807|NCT04292535|562083982|FG010|Overall Study|Report of Dizziness|0|||
155722808|NCT04292535|562083983|FG011|Overall Study|Report of Dizziness|0|||
155722809|NCT04292535|562083984|FG012|Overall Study|Report of Dizziness|0|||
155722810|NCT04292535|562083985|FG013|Overall Study|Report of Dizziness|1|||
155722811|NCT04292535|562083972|FG000|Overall Study|Equipment Failure|0|||
155722812|NCT04292535|562083973|FG001|Overall Study|Equipment Failure|0|||
155722813|NCT04292535|562083974|FG002|Overall Study|Equipment Failure|0|||
155722814|NCT04292535|562083975|FG003|Overall Study|Equipment Failure|0|||
155722815|NCT04292535|562083976|FG004|Overall Study|Equipment Failure|0|||
155722816|NCT04292535|562083977|FG005|Overall Study|Equipment Failure|0|||
155722817|NCT04292535|562083978|FG006|Overall Study|Equipment Failure|0|||
155722818|NCT04292535|562083979|FG007|Overall Study|Equipment Failure|0|||
155722819|NCT04292535|562083980|FG008|Overall Study|Equipment Failure|0|||
155722820|NCT04292535|562083981|FG009|Overall Study|Equipment Failure|0|||
155722821|NCT04292535|562083982|FG010|Overall Study|Equipment Failure|0|||
155722822|NCT04292535|562083983|FG011|Overall Study|Equipment Failure|1|||
155722823|NCT04292535|562083984|FG012|Overall Study|Equipment Failure|0|||
155722824|NCT04292535|562083985|FG013|Overall Study|Equipment Failure|0|||
155722825|NCT03914417|562083986|FG000|Overall Study|Withdrawal by Subject|2|||
155722826|NCT03836625|562083987|FG000|Overall Study|Lost to Follow-up|9|||
155722827|NCT03836625|562083988|FG001|Overall Study|Lost to Follow-up|9|||
155722828|NCT03836625|562083987|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
155722829|NCT03836625|562083988|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
155722830|NCT03836625|562083987|FG000|Overall Study|Death|0|||
155722831|NCT03836625|562083988|FG001|Overall Study|Death|1|||
155722832|NCT03836625|562083987|FG000|Overall Study|Refused follow-up|0|||
155722833|NCT03836625|562083988|FG001|Overall Study|Refused follow-up|1|||
155722834|NCT04609319|562083989|FG000|Overall Study|Death|64|||
155722835|NCT04609319|562083990|FG001|Overall Study|Death|49|||
155722836|NCT04609319|562083991|FG002|Overall Study|Death|1|||
155722837|NCT04609319|562083989|FG000|Overall Study|Withdrawal of consent|15|||
155722838|NCT04609319|562083990|FG001|Overall Study|Withdrawal of consent|3|||
155722839|NCT04609319|562083991|FG002|Overall Study|Withdrawal of consent|0|||
155722840|NCT04609319|562083989|FG000|Overall Study|Lost to Follow-up|20|||
155722841|NCT04609319|562083990|FG001|Overall Study|Lost to Follow-up|33|||
155722842|NCT04609319|562083991|FG002|Overall Study|Lost to Follow-up|0|||
155722843|NCT04609319|562083989|FG000|Overall Study|Alive until end of follow-up|60|||
155722844|NCT04609319|562083990|FG001|Overall Study|Alive until end of follow-up|53|||
155722845|NCT04609319|562083991|FG002|Overall Study|Alive until end of follow-up|1|||
155722846|NCT01247324|562083992|FG000|Overall Study|Death|6|||
155722847|NCT01247324|562083993|FG001|Overall Study|Death|10|||
155722848|NCT01247324|562083992|FG000|Overall Study|Physician Decision|2|||
155722849|NCT01247324|562083993|FG001|Overall Study|Physician Decision|3|||
155722850|NCT01247324|562083992|FG000|Overall Study|Non-compliance with study drug|3|||
155722851|NCT01247324|562083993|FG001|Overall Study|Non-compliance with study drug|0|||
155722852|NCT01247324|562083992|FG000|Overall Study|Lack of Efficacy|24|||
155722853|NCT01247324|562083993|FG001|Overall Study|Lack of Efficacy|14|||
155722854|NCT01247324|562083992|FG000|Overall Study|Non-compliance|3|||
155722855|NCT01247324|562083993|FG001|Overall Study|Non-compliance|2|||
155722856|NCT01247324|562083992|FG000|Overall Study|Pregnancy|5|||
155722857|NCT01247324|562083993|FG001|Overall Study|Pregnancy|10|||
155722858|NCT01247324|562083992|FG000|Overall Study|Protocol Violation|1|||
155722859|NCT01247324|562083993|FG001|Overall Study|Protocol Violation|1|||
155722860|NCT01247324|562083992|FG000|Overall Study|Reason not specified|42|||
155722861|NCT01247324|562083993|FG001|Overall Study|Reason not specified|32|||
155722862|NCT01247324|562083992|FG000|Overall Study|Consent withdrawn by participant|41|||
155722863|NCT01247324|562083993|FG001|Overall Study|Consent withdrawn by participant|56|||
155722864|NCT01247324|562083992|FG000|Overall Study|Adverse Event|49|||
155722865|NCT01247324|562083993|FG001|Overall Study|Adverse Event|35|||
155722866|NCT01247324|562083992|FG000|Overall Study|Lost to Follow-up|3|||
155722867|NCT01247324|562083993|FG001|Overall Study|Lost to Follow-up|6|||
155722868|NCT01247324|562083992|FG000|Overall Study|Study Terminated by Sponsor|4|||
155722869|NCT01247324|562083993|FG001|Overall Study|Study Terminated by Sponsor|1|||
155722870|NCT01247324|562083992|FG000|Overall Study|Missing|2|||
155722871|NCT01247324|562083993|FG001|Overall Study|Missing|1|||
155722872|NCT00301808|562083994|FG000|Overall Study|Adverse Event|5|||
155722873|NCT00301808|562083994|FG000|Overall Study|Death|3|||
155722874|NCT00301808|562083994|FG000|Overall Study|Lack of Efficacy|4|||
155722875|NCT02234843|562083995|FG000|Overall Study|Death|1|||
155722876|NCT02234843|562083996|FG001|Overall Study|Death|0|||
155722877|NCT02234843|562083997|FG002|Overall Study|Death|0|||
155722878|NCT02234843|562083998|FG003|Overall Study|Death|0|||
155722879|NCT02234843|562083999|FG004|Overall Study|Death|0|||
155722880|NCT02234843|562084000|FG005|Overall Study|Death|0|||
155722881|NCT02234843|562084001|FG006|Overall Study|Death|0|||
155722882|NCT02234843|562084002|FG007|Overall Study|Death|0|||
155722883|NCT02234843|562084003|FG008|Overall Study|Death|0|||
155722884|NCT02234843|562084004|FG009|Overall Study|Death|0|||
155722885|NCT02234843|562083995|FG000|Overall Study|Protocol Violation|1|||
155722886|NCT02234843|562083996|FG001|Overall Study|Protocol Violation|0|||
155722887|NCT02234843|562083997|FG002|Overall Study|Protocol Violation|1|||
155722888|NCT02234843|562083998|FG003|Overall Study|Protocol Violation|0|||
155722889|NCT02234843|562083999|FG004|Overall Study|Protocol Violation|0|||
155722890|NCT02234843|562084000|FG005|Overall Study|Protocol Violation|0|||
155722891|NCT02234843|562084001|FG006|Overall Study|Protocol Violation|0|||
155722892|NCT02234843|562084002|FG007|Overall Study|Protocol Violation|0|||
155722893|NCT02234843|562084003|FG008|Overall Study|Protocol Violation|0|||
155722894|NCT02234843|562084004|FG009|Overall Study|Protocol Violation|0|||
155722895|NCT02234843|562083995|FG000|Overall Study|Efficacy outcome reached|2|||
155722896|NCT02234843|562083996|FG001|Overall Study|Efficacy outcome reached|0|||
155722897|NCT02234843|562083997|FG002|Overall Study|Efficacy outcome reached|0|||
155722898|NCT02234843|562083998|FG003|Overall Study|Efficacy outcome reached|0|||
155722899|NCT02234843|562083999|FG004|Overall Study|Efficacy outcome reached|0|||
155722900|NCT02234843|562084000|FG005|Overall Study|Efficacy outcome reached|2|||
155722901|NCT02234843|562084001|FG006|Overall Study|Efficacy outcome reached|0|||
155722902|NCT02234843|562084002|FG007|Overall Study|Efficacy outcome reached|0|||
155722903|NCT02234843|562084003|FG008|Overall Study|Efficacy outcome reached|0|||
155722904|NCT02234843|562084004|FG009|Overall Study|Efficacy outcome reached|0|||
155722905|NCT02234843|562083995|FG000|Overall Study|Patient convenience|2|||
155722906|NCT02234843|562083996|FG001|Overall Study|Patient convenience|0|||
155722907|NCT02234843|562083997|FG002|Overall Study|Patient convenience|0|||
155722908|NCT02234843|562083998|FG003|Overall Study|Patient convenience|0|||
155722909|NCT02234843|562083999|FG004|Overall Study|Patient convenience|0|||
155722910|NCT02234843|562084000|FG005|Overall Study|Patient convenience|1|||
155722911|NCT02234843|562084001|FG006|Overall Study|Patient convenience|0|||
155722912|NCT02234843|562084002|FG007|Overall Study|Patient convenience|0|||
155722913|NCT02234843|562084003|FG008|Overall Study|Patient convenience|0|||
155722914|NCT02234843|562084004|FG009|Overall Study|Patient convenience|0|||
155722915|NCT02234843|562083995|FG000|Overall Study|Withdrawal by Subject|5|||
155722916|NCT02234843|562083996|FG001|Overall Study|Withdrawal by Subject|1|||
155722917|NCT02234843|562083997|FG002|Overall Study|Withdrawal by Subject|1|||
155722918|NCT02234843|562083998|FG003|Overall Study|Withdrawal by Subject|0|||
155722919|NCT02234843|562083999|FG004|Overall Study|Withdrawal by Subject|0|||
155722920|NCT02234843|562084000|FG005|Overall Study|Withdrawal by Subject|7|||
155722921|NCT02234843|562084001|FG006|Overall Study|Withdrawal by Subject|0|||
155722922|NCT02234843|562084002|FG007|Overall Study|Withdrawal by Subject|0|||
155722923|NCT02234843|562084003|FG008|Overall Study|Withdrawal by Subject|0|||
155722924|NCT02234843|562084004|FG009|Overall Study|Withdrawal by Subject|0|||
155722925|NCT02234843|562083995|FG000|Overall Study|Recovery|1|||
155722926|NCT02234843|562083996|FG001|Overall Study|Recovery|0|||
155722927|NCT02234843|562083997|FG002|Overall Study|Recovery|0|||
155722928|NCT02234843|562083998|FG003|Overall Study|Recovery|0|||
155722929|NCT02234843|562083999|FG004|Overall Study|Recovery|0|||
155722930|NCT02234843|562084000|FG005|Overall Study|Recovery|0|||
155722931|NCT02234843|562084001|FG006|Overall Study|Recovery|0|||
155722932|NCT02234843|562084002|FG007|Overall Study|Recovery|0|||
155722933|NCT02234843|562084003|FG008|Overall Study|Recovery|0|||
155722934|NCT02234843|562084004|FG009|Overall Study|Recovery|0|||
155722935|NCT02234843|562083995|FG000|Overall Study|Other|0|||
155722936|NCT02234843|562083996|FG001|Overall Study|Other|2|||
155722937|NCT02234843|562083997|FG002|Overall Study|Other|0|||
155722938|NCT02234843|562083998|FG003|Overall Study|Other|1|||
155722939|NCT02234843|562083999|FG004|Overall Study|Other|0|||
155722940|NCT02234843|562084000|FG005|Overall Study|Other|1|||
155722941|NCT02234843|562084001|FG006|Overall Study|Other|0|||
155722942|NCT02234843|562084002|FG007|Overall Study|Other|1|||
155722943|NCT02234843|562084003|FG008|Overall Study|Other|0|||
155722944|NCT02234843|562084004|FG009|Overall Study|Other|0|||
155722945|NCT02234843|562083995|FG000|Overall Study|Physician Decision|4|||
155722946|NCT02234843|562083996|FG001|Overall Study|Physician Decision|1|||
155722947|NCT02234843|562083997|FG002|Overall Study|Physician Decision|0|||
155722948|NCT02234843|562083998|FG003|Overall Study|Physician Decision|1|||
155722949|NCT02234843|562083999|FG004|Overall Study|Physician Decision|0|||
155722950|NCT02234843|562084000|FG005|Overall Study|Physician Decision|0|||
155722951|NCT02234843|562084001|FG006|Overall Study|Physician Decision|0|||
155722952|NCT02234843|562084002|FG007|Overall Study|Physician Decision|1|||
155722953|NCT02234843|562084003|FG008|Overall Study|Physician Decision|0|||
155722954|NCT02234843|562084004|FG009|Overall Study|Physician Decision|0|||
155722955|NCT02234843|562083995|FG000|Overall Study|Adverse Event|5|||
155722956|NCT02234843|562083996|FG001|Overall Study|Adverse Event|1|||
155722957|NCT02234843|562083997|FG002|Overall Study|Adverse Event|1|||
155722958|NCT02234843|562083998|FG003|Overall Study|Adverse Event|3|||
155722959|NCT02234843|562083999|FG004|Overall Study|Adverse Event|2|||
155722960|NCT02234843|562084000|FG005|Overall Study|Adverse Event|1|||
155722961|NCT02234843|562084001|FG006|Overall Study|Adverse Event|0|||
155722962|NCT02234843|562084002|FG007|Overall Study|Adverse Event|0|||
155722963|NCT02234843|562084003|FG008|Overall Study|Adverse Event|1|||
155722964|NCT02234843|562084004|FG009|Overall Study|Adverse Event|0|||
155722965|NCT02234843|562083995|FG000|Overall Study|Non-compliance with study drug|1|||
155722966|NCT02234843|562083996|FG001|Overall Study|Non-compliance with study drug|0|||
155722967|NCT02234843|562083997|FG002|Overall Study|Non-compliance with study drug|0|||
155722968|NCT02234843|562083998|FG003|Overall Study|Non-compliance with study drug|0|||
155722969|NCT02234843|562083999|FG004|Overall Study|Non-compliance with study drug|0|||
155722970|NCT02234843|562084000|FG005|Overall Study|Non-compliance with study drug|1|||
155722971|NCT02234843|562084001|FG006|Overall Study|Non-compliance with study drug|1|||
155722972|NCT02234843|562084002|FG007|Overall Study|Non-compliance with study drug|0|||
155722973|NCT02234843|562084003|FG008|Overall Study|Non-compliance with study drug|0|||
155722974|NCT02234843|562084004|FG009|Overall Study|Non-compliance with study drug|0|||
155722975|NCT02234843|562083995|FG000|Overall Study|Lost to Follow-up|0|||
155722976|NCT02234843|562083996|FG001|Overall Study|Lost to Follow-up|1|||
155722977|NCT02234843|562083997|FG002|Overall Study|Lost to Follow-up|0|||
155722978|NCT02234843|562083998|FG003|Overall Study|Lost to Follow-up|0|||
155722979|NCT02234843|562083999|FG004|Overall Study|Lost to Follow-up|0|||
155722980|NCT02234843|562084000|FG005|Overall Study|Lost to Follow-up|0|||
155722981|NCT02234843|562084001|FG006|Overall Study|Lost to Follow-up|1|||
155722982|NCT02234843|562084002|FG007|Overall Study|Lost to Follow-up|0|||
155722983|NCT02234843|562084003|FG008|Overall Study|Lost to Follow-up|0|||
155722984|NCT02234843|562084004|FG009|Overall Study|Lost to Follow-up|0|||
155722985|NCT03518086|562084012|FG000|Overall Study|Adverse Event|23|||
155722986|NCT03518086|562084013|FG001|Overall Study|Adverse Event|15|||
155722987|NCT03518086|562084014|FG002|Overall Study|Adverse Event|3|||
155722988|NCT03518086|562084015|FG003|Overall Study|Adverse Event|2|||
155722989|NCT03518086|562084012|FG000|Overall Study|Withdrawal by Subject|8|||
155722990|NCT03518086|562084013|FG001|Overall Study|Withdrawal by Subject|5|||
155722991|NCT03518086|562084014|FG002|Overall Study|Withdrawal by Subject|1|||
155722992|NCT03518086|562084015|FG003|Overall Study|Withdrawal by Subject|0|||
155722993|NCT03518086|562084012|FG000|Overall Study|Lack of Efficacy|5|||
155722994|NCT03518086|562084013|FG001|Overall Study|Lack of Efficacy|5|||
155722995|NCT03518086|562084014|FG002|Overall Study|Lack of Efficacy|0|||
155722996|NCT03518086|562084015|FG003|Overall Study|Lack of Efficacy|2|||
155722997|NCT03518086|562084012|FG000|Overall Study|Protocol Violation|1|||
155722998|NCT03518086|562084013|FG001|Overall Study|Protocol Violation|5|||
155722999|NCT03518086|562084014|FG002|Overall Study|Protocol Violation|1|||
155723000|NCT03518086|562084015|FG003|Overall Study|Protocol Violation|3|||
155723001|NCT03518086|562084012|FG000|Overall Study|Lost to Follow-up|0|||
155723002|NCT03518086|562084013|FG001|Overall Study|Lost to Follow-up|3|||
155723003|NCT03518086|562084014|FG002|Overall Study|Lost to Follow-up|0|||
155723004|NCT03518086|562084015|FG003|Overall Study|Lost to Follow-up|0|||
155723005|NCT03518086|562084012|FG000|Overall Study|Insufficient Diary Data|0|||
155723006|NCT03518086|562084013|FG001|Overall Study|Insufficient Diary Data|2|||
155723007|NCT03518086|562084014|FG002|Overall Study|Insufficient Diary Data|0|||
155723008|NCT03518086|562084015|FG003|Overall Study|Insufficient Diary Data|0|||
155723009|NCT03518086|562084012|FG000|Overall Study|Non- compliance to Protocol|0|||
155723010|NCT03518086|562084013|FG001|Overall Study|Non- compliance to Protocol|1|||
155723011|NCT03518086|562084014|FG002|Overall Study|Non- compliance to Protocol|0|||
155723012|NCT03518086|562084015|FG003|Overall Study|Non- compliance to Protocol|0|||
155723013|NCT03518086|562084012|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
155723014|NCT03518086|562084013|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
155723015|NCT03518086|562084014|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
155723016|NCT03518086|562084015|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
155723017|NCT03518086|562084012|FG000|Overall Study|Site Terminated by Sponsor|0|||
155723018|NCT03518086|562084013|FG001|Overall Study|Site Terminated by Sponsor|1|||
155723019|NCT03518086|562084014|FG002|Overall Study|Site Terminated by Sponsor|0|||
155723020|NCT03518086|562084015|FG003|Overall Study|Site Terminated by Sponsor|0|||
155723021|NCT03518086|562084012|FG000|Overall Study|Pregnancy|0|||
155723022|NCT03518086|562084013|FG001|Overall Study|Pregnancy|0|||
155723023|NCT03518086|562084014|FG002|Overall Study|Pregnancy|0|||
155723024|NCT03518086|562084015|FG003|Overall Study|Pregnancy|2|||
155723025|NCT02336282|562084019|FG000|Overall Study|Unrelated illness|1|||
155723026|NCT02336282|562084019|FG000|Overall Study|Uncomfortable with technology|1|||
155723027|NCT02336282|562084019|FG000|Overall Study|Lost to Follow-up|1|||
155723028|NCT02336282|562084019|FG000|Overall Study|Not enough time to complete sessions|2|||
155723029|NCT00668148|562084035|FG000|Overall Study|Adverse Event|5|||
155723030|NCT00668148|562084035|FG000|Overall Study|Subject Non-compliance|1|||
155723031|NCT00668148|562084035|FG000|Overall Study|Progressive Disease Before Treatment|2|||
155723032|NCT00668148|562084035|FG000|Overall Study|Withdrawal of Consent|2|||
155723033|NCT02702492|562084036|FG000|Overall Study|Disease progression|3|||
155723034|NCT02702492|562084037|FG001|Overall Study|Disease progression|3|||
155723035|NCT02702492|562084038|FG002|Overall Study|Disease progression|2|||
155723036|NCT02702492|562084039|FG003|Overall Study|Disease progression|4|||
155723037|NCT02702492|562084040|FG004|Overall Study|Disease progression|4|||
155723038|NCT02702492|562084041|FG005|Overall Study|Disease progression|1|||
155723039|NCT02702492|562084042|FG006|Overall Study|Disease progression|2|||
155723040|NCT02702492|562084043|FG007|Overall Study|Disease progression|8|||
155723041|NCT02702492|562084044|FG008|Overall Study|Disease progression|5|||
155723042|NCT02702492|562084045|FG009|Overall Study|Disease progression|1|||
155723043|NCT02702492|562084046|FG010|Overall Study|Disease progression|0|||
155723044|NCT02702492|562084047|FG011|Overall Study|Disease progression|3|||
155723045|NCT02702492|562084048|FG012|Overall Study|Disease progression|2|||
155723046|NCT02702492|562084036|FG000|Overall Study|Clinical progression|0|||
155723047|NCT02702492|562084037|FG001|Overall Study|Clinical progression|0|||
155723048|NCT02702492|562084038|FG002|Overall Study|Clinical progression|2|||
155723049|NCT02702492|562084039|FG003|Overall Study|Clinical progression|1|||
155723050|NCT02702492|562084040|FG004|Overall Study|Clinical progression|0|||
155723051|NCT02702492|562084041|FG005|Overall Study|Clinical progression|2|||
155723052|NCT02702492|562084042|FG006|Overall Study|Clinical progression|1|||
155723053|NCT02702492|562084043|FG007|Overall Study|Clinical progression|4|||
155723054|NCT02702492|562084044|FG008|Overall Study|Clinical progression|0|||
155723055|NCT02702492|562084045|FG009|Overall Study|Clinical progression|0|||
155723056|NCT02702492|562084046|FG010|Overall Study|Clinical progression|1|||
155723057|NCT02702492|562084047|FG011|Overall Study|Clinical progression|2|||
155723058|NCT02702492|562084048|FG012|Overall Study|Clinical progression|0|||
155723059|NCT02702492|562084036|FG000|Overall Study|Adverse Event|0|||
155723060|NCT02702492|562084037|FG001|Overall Study|Adverse Event|0|||
155723061|NCT02702492|562084038|FG002|Overall Study|Adverse Event|1|||
155723062|NCT02702492|562084039|FG003|Overall Study|Adverse Event|2|||
155723063|NCT02702492|562084040|FG004|Overall Study|Adverse Event|1|||
155723064|NCT02702492|562084041|FG005|Overall Study|Adverse Event|0|||
155723065|NCT02702492|562084042|FG006|Overall Study|Adverse Event|1|||
155723066|NCT02702492|562084043|FG007|Overall Study|Adverse Event|0|||
155723067|NCT02702492|562084044|FG008|Overall Study|Adverse Event|2|||
155723068|NCT02702492|562084045|FG009|Overall Study|Adverse Event|0|||
155723069|NCT02702492|562084046|FG010|Overall Study|Adverse Event|0|||
155723070|NCT02702492|562084047|FG011|Overall Study|Adverse Event|0|||
155723071|NCT02702492|562084048|FG012|Overall Study|Adverse Event|1|||
155723072|NCT02702492|562084036|FG000|Overall Study|Other|0|||
155723073|NCT02702492|562084037|FG001|Overall Study|Other|0|||
155723074|NCT02702492|562084038|FG002|Overall Study|Other|0|||
155723075|NCT02702492|562084039|FG003|Overall Study|Other|0|||
155723076|NCT02702492|562084040|FG004|Overall Study|Other|0|||
155723077|NCT02702492|562084041|FG005|Overall Study|Other|0|||
155723078|NCT02702492|562084042|FG006|Overall Study|Other|0|||
155723079|NCT02702492|562084043|FG007|Overall Study|Other|0|||
155723080|NCT02702492|562084044|FG008|Overall Study|Other|0|||
155723081|NCT02702492|562084045|FG009|Overall Study|Other|0|||
155723082|NCT02702492|562084046|FG010|Overall Study|Other|0|||
155723083|NCT02702492|562084047|FG011|Overall Study|Other|0|||
155723084|NCT02702492|562084048|FG012|Overall Study|Other|1|||
155723085|NCT05472090|562084049|FG000|Overall Study|Adverse Event|2|||
155723086|NCT05472090|562084050|FG001|Overall Study|Adverse Event|3|||
155723087|NCT05472090|562084049|FG000|Overall Study|Lack of Efficacy|1|||
155723088|NCT05472090|562084050|FG001|Overall Study|Lack of Efficacy|0|||
155723089|NCT05472090|562084049|FG000|Overall Study|Physician Decision|1|||
155723090|NCT05472090|562084050|FG001|Overall Study|Physician Decision|0|||
155723091|NCT05472090|562084049|FG000|Overall Study|Withdrawal by Subject|2|||
155723092|NCT05472090|562084050|FG001|Overall Study|Withdrawal by Subject|0|||
155723093|NCT05472090|562084049|FG000|Overall Study|Lost to Follow-up|0|||
155723094|NCT05472090|562084050|FG001|Overall Study|Lost to Follow-up|3|||
155723095|NCT01456039|562085525|FG000|Phase 1 (First Step)|Disease Progression|1|||
155723096|NCT01456039|562085526|FG001|Phase 1 (First Step)|Disease Progression|1|||
155723097|NCT01456039|562085527|FG002|Phase 1 (First Step)|Disease Progression|0|||
155723098|NCT01456039|562085525|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
155723099|NCT01456039|562085526|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
155723100|NCT01456039|562085527|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
155723101|NCT01456039|562085525|FG000|Phase 1 (First Step)|Adverse Event|0|||
155723102|NCT01456039|562085526|FG001|Phase 1 (First Step)|Adverse Event|3|||
155723103|NCT01456039|562085527|FG002|Phase 1 (First Step)|Adverse Event|0|||
155723104|NCT01456039|562085525|FG000|Phase 1 (First Step)|Other|0|||
155723105|NCT01456039|562085526|FG001|Phase 1 (First Step)|Other|1|||
155435853|NCT01476787|561022967|FG001|Treatment|Insufficient response|3|||
155723106|NCT01456039|562085527|FG002|Phase 1 (First Step)|Other|0|||
155723107|NCT01456039|562085525|FG000|Phase 2 (Second Step)|Disease Progression|0|||
155723108|NCT01456039|562085526|FG001|Phase 2 (Second Step)|Disease Progression|0|||
155723109|NCT01456039|562085527|FG002|Phase 2 (Second Step)|Disease Progression|17|||
155723110|NCT01456039|562085525|FG000|Phase 2 (Second Step)|Adverse Event|0|||
155723111|NCT01456039|562085526|FG001|Phase 2 (Second Step)|Adverse Event|0|||
155723112|NCT01456039|562085527|FG002|Phase 2 (Second Step)|Adverse Event|10|||
155723113|NCT01456039|562085525|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
155723114|NCT01456039|562085526|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
155723115|NCT01456039|562085527|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
155723116|NCT01456039|562085525|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
155723117|NCT01456039|562085526|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
155723118|NCT01456039|562085527|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
155723119|NCT01456039|562085525|FG000|Phase 2 (Second Step)|Other|0|||
155723120|NCT01456039|562085526|FG001|Phase 2 (Second Step)|Other|0|||
155723121|NCT01456039|562085527|FG002|Phase 2 (Second Step)|Other|1|||
155723122|NCT04106557|562085536|FG000|Overall Study|Physician Decision|0|||
155723123|NCT04106557|562085537|FG001|Overall Study|Physician Decision|1|||
155723124|NCT04106557|562085538|FG002|Overall Study|Physician Decision|0|||
155723125|NCT04106557|562085536|FG000|Overall Study|Protocol Violation|0|||
155723126|NCT04106557|562085537|FG001|Overall Study|Protocol Violation|1|||
155723127|NCT04106557|562085538|FG002|Overall Study|Protocol Violation|0|||
155723128|NCT02326155|562085539|FG000|Overall Study|Adverse Event|21|||
155723129|NCT02326155|562085540|FG001|Overall Study|Adverse Event|5|||
155723130|NCT02326155|562085539|FG000|Overall Study|Death|3|||
155723131|NCT02326155|562085540|FG001|Overall Study|Death|0|||
155723132|NCT02326155|562085539|FG000|Overall Study|Lack of Efficacy|49|||
155723133|NCT02326155|562085540|FG001|Overall Study|Lack of Efficacy|5|||
155723134|NCT02326155|562085539|FG000|Overall Study|Lost to Follow-up|14|||
155723135|NCT02326155|562085540|FG001|Overall Study|Lost to Follow-up|3|||
155723136|NCT02326155|562085539|FG000|Overall Study|Protocol Violation|2|||
155723137|NCT02326155|562085540|FG001|Overall Study|Protocol Violation|0|||
155723138|NCT02326155|562085539|FG000|Overall Study|Withdrawal by Subject|34|||
155723139|NCT02326155|562085540|FG001|Overall Study|Withdrawal by Subject|11|||
155723140|NCT02326155|562085539|FG000|Overall Study|Disease progression|37|||
155723141|NCT02326155|562085540|FG001|Overall Study|Disease progression|4|||
155723142|NCT02326155|562085539|FG000|Overall Study|Study close|188|||
155723143|NCT02326155|562085540|FG001|Overall Study|Study close|21|||
155723144|NCT02326155|562085539|FG000|Overall Study|except for study close|46|||
155723145|NCT02326155|562085540|FG001|Overall Study|except for study close|13|||
155723146|NCT00939393|562085541|FG000|Overall Study|Withdrawal by Subject|1|||
155723147|NCT00939393|562085542|FG001|Overall Study|Withdrawal by Subject|0|||
155723148|NCT00939393|562085541|FG000|Overall Study|Lost to Follow-up|3|||
155723149|NCT00939393|562085542|FG001|Overall Study|Lost to Follow-up|0|||
155723150|NCT00313014|562085543|FG000|Overall Study|Withdrawal by Subject|11|||
155723151|NCT00313014|562085544|FG001|Overall Study|Withdrawal by Subject|7|||
155723152|NCT00313014|562085545|FG002|Overall Study|Withdrawal by Subject|5|||
155723153|NCT00313014|562085543|FG000|Overall Study|Adverse Event|14|||
155723154|NCT00313014|562085544|FG001|Overall Study|Adverse Event|29|||
155723155|NCT00313014|562085545|FG002|Overall Study|Adverse Event|16|||
155723156|NCT00313014|562085543|FG000|Overall Study|Lost to Follow-up|7|||
155723157|NCT00313014|562085544|FG001|Overall Study|Lost to Follow-up|6|||
155723158|NCT00313014|562085545|FG002|Overall Study|Lost to Follow-up|10|||
155723159|NCT00313014|562085543|FG000|Overall Study|Administrative|9|||
155723160|NCT00313014|562085544|FG001|Overall Study|Administrative|6|||
155723161|NCT00313014|562085545|FG002|Overall Study|Administrative|14|||
155723162|NCT00313014|562085543|FG000|Overall Study|Lack of Efficacy|52|||
155723163|NCT00313014|562085544|FG001|Overall Study|Lack of Efficacy|25|||
155723164|NCT00313014|562085545|FG002|Overall Study|Lack of Efficacy|16|||
155723165|NCT01280903|562085546|FG000|Overall Study|Lost to Follow-up|23|||
155723166|NCT01280903|562085547|FG001|Overall Study|Lost to Follow-up|16|||
155723167|NCT03453164|562085548|FG000|Overall Study|Lack of Efficacy|16|||
155723168|NCT03453164|562085548|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
155723169|NCT03829228|562085549|FG000|Overall Study|Protocol Violation|1|||
155723170|NCT02177695|562085550|FG000|ITT Analysis|Ineligible|5|||
155723171|NCT02177695|562085551|FG001|ITT Analysis|Ineligible|5|||
155723172|NCT02177695|562085550|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
155723173|NCT02177695|562085551|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
155723174|NCT02177695|562085550|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
155723175|NCT02177695|562085551|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
155723176|NCT02177695|562085550|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
155723177|NCT02177695|562085551|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
155723178|NCT03085095|562085554|FG000|Overall Study|Adverse Event|23|||
155723179|NCT03085095|562085555|FG001|Overall Study|Adverse Event|8|||
155723180|NCT03085095|562085554|FG000|Overall Study|Protocol Violation|0|||
155723181|NCT03085095|562085555|FG001|Overall Study|Protocol Violation|1|||
155723182|NCT03085095|562085554|FG000|Overall Study|Lost to Follow-up|2|||
155723183|NCT03085095|562085555|FG001|Overall Study|Lost to Follow-up|1|||
155723184|NCT03085095|562085554|FG000|Overall Study|Withdrawal by Subject|17|||
155723185|NCT03085095|562085555|FG001|Overall Study|Withdrawal by Subject|6|||
155723186|NCT03085095|562085554|FG000|Overall Study|Physician Decision|9|||
155723187|NCT03085095|562085555|FG001|Overall Study|Physician Decision|3|||
155723188|NCT03085095|562085554|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
155723189|NCT03085095|562085555|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
155723190|NCT03085095|562085554|FG000|Overall Study|Did not Receive Study Drug|2|||
155723191|NCT03085095|562085555|FG001|Overall Study|Did not Receive Study Drug|2|||
155723192|NCT03085095|562085554|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
155723193|NCT03085095|562085555|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
155723194|NCT03459079|562085557|FG000|Overall Study|Adverse Event|4|||
155723195|NCT03459079|562085558|FG001|Overall Study|Adverse Event|2|||
155723196|NCT03459079|562085559|FG002|Overall Study|Adverse Event|0|||
155723197|NCT03459079|562085557|FG000|Overall Study|Withdrawal by Subject|2|||
155723198|NCT03459079|562085558|FG001|Overall Study|Withdrawal by Subject|2|||
155723199|NCT03459079|562085559|FG002|Overall Study|Withdrawal by Subject|0|||
155723200|NCT05101122|562085561|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
155723201|NCT05101122|562085561|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
155723202|NCT05101122|562085561|FG000|AD313 80/5|Withdrawal by Subject|1|||
155723203|NCT05101122|562085561|FG000|AD313 80/10|Physician Decision|1|||
155723204|NCT04945733|562085565|FG000|Overall Study|Physician Decision|1|||
155723205|NCT04945733|562085566|FG001|Overall Study|Physician Decision|3|||
155723206|NCT04945733|562085567|FG002|Overall Study|Physician Decision|0|||
155723207|NCT04945733|562085565|FG000|Overall Study|Withdrawal by Subject|3|||
155723208|NCT04945733|562085566|FG001|Overall Study|Withdrawal by Subject|3|||
155723209|NCT04945733|562085567|FG002|Overall Study|Withdrawal by Subject|0|||
155723210|NCT02007096|562085568|FG000|Overall Study|medication not available|2|||
155723211|NCT02007096|562085569|FG001|Overall Study|medication not available|0|||
155723212|NCT02007096|562085568|FG000|Overall Study|did not inject saline|0|||
155723213|NCT02007096|562085569|FG001|Overall Study|did not inject saline|3|||
155723214|NCT02007096|562085568|FG000|Overall Study|did not follow postoperative protocol|8|||
155723215|NCT02007096|562085569|FG001|Overall Study|did not follow postoperative protocol|11|||
155723216|NCT02007096|562085568|FG000|Overall Study|converted to open surgery|1|||
155723217|NCT02007096|562085569|FG001|Overall Study|converted to open surgery|1|||
155723218|NCT02007096|562085568|FG000|Overall Study|no mesh placed|0|||
155723219|NCT02007096|562085569|FG001|Overall Study|no mesh placed|1|||
155723220|NCT05660577|562085570|FG000|Overall Study|Discontinued|9|||
155723221|NCT03363841|562085576|FG000|Overall Study|Adverse Event|1|||
155723222|NCT03363841|562085576|FG000|Overall Study|Withdrawal by Subject|1|||
155723223|NCT03363841|562085576|FG000|Overall Study|Death|7|||
155723224|NCT03363841|562085576|FG000|Overall Study|Physician Decision|1|||
155723225|NCT02156076|562085579|FG000|Treatment Period|no longer meets study criteria|0|||
155723226|NCT02156076|562085580|FG001|Treatment Period|no longer meets study criteria|0|||
155723227|NCT02156076|562085581|FG002|Treatment Period|no longer meets study criteria|1|||
155723228|NCT02156076|562085582|FG003|Treatment Period|no longer meets study criteria|0|||
155723229|NCT02156076|562085579|FG000|Treatment Period|Poor/non-compliance|0|||
155723230|NCT02156076|562085580|FG001|Treatment Period|Poor/non-compliance|1|||
155723231|NCT02156076|562085581|FG002|Treatment Period|Poor/non-compliance|0|||
155723232|NCT02156076|562085582|FG003|Treatment Period|Poor/non-compliance|0|||
155723233|NCT02156076|562085579|FG000|Treatment Period|Lost to Follow-up|0|||
155723234|NCT02156076|562085580|FG001|Treatment Period|Lost to Follow-up|0|||
155723235|NCT02156076|562085581|FG002|Treatment Period|Lost to Follow-up|0|||
155723236|NCT02156076|562085582|FG003|Treatment Period|Lost to Follow-up|1|||
155723237|NCT02156076|562085579|FG000|Treatment Period|Withdrawal by Subject|0|||
155723238|NCT02156076|562085580|FG001|Treatment Period|Withdrawal by Subject|0|||
155723239|NCT02156076|562085581|FG002|Treatment Period|Withdrawal by Subject|1|||
155723240|NCT02156076|562085582|FG003|Treatment Period|Withdrawal by Subject|0|||
155723241|NCT02156076|562085579|FG000|Treatment Period|Subject request to discontinue treatment|0|||
155723242|NCT02156076|562085580|FG001|Treatment Period|Subject request to discontinue treatment|1|||
155723243|NCT02156076|562085581|FG002|Treatment Period|Subject request to discontinue treatment|0|||
155723244|NCT02156076|562085582|FG003|Treatment Period|Subject request to discontinue treatment|0|||
155723245|NCT02156076|562085579|FG000|Treatment Period|Adverse Event|0|||
155723246|NCT02156076|562085580|FG001|Treatment Period|Adverse Event|0|||
155723247|NCT02156076|562085581|FG002|Treatment Period|Adverse Event|0|||
155723248|NCT02156076|562085582|FG003|Treatment Period|Adverse Event|1|||
155723249|NCT02156076|562085579|FG000|Follow-up Period|Withdrawal by Subject|1|||
155723250|NCT02156076|562085580|FG001|Follow-up Period|Withdrawal by Subject|0|||
155723251|NCT02156076|562085581|FG002|Follow-up Period|Withdrawal by Subject|0|||
155723252|NCT02156076|562085582|FG003|Follow-up Period|Withdrawal by Subject|0|||
155723253|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
155723254|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
155723255|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155723256|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
155723257|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
155723258|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155723259|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155723260|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155723261|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
155723262|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155723263|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155723264|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155723265|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155723266|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155723267|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155723268|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
155723269|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
155723270|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
155723271|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
155723272|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
155723273|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155723274|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155723275|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155723276|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155723277|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155723278|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
155723279|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155723280|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155723281|NCT04026113|562085585|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155723282|NCT04026113|562085586|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
155723283|NCT04026113|562085587|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155723284|NCT04026113|562085588|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155723285|NCT04026113|562085585|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
155723286|NCT04026113|562085586|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
155723287|NCT04026113|562085587|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
155723288|NCT04026113|562085588|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
155723289|NCT01527149|562085590|FG000|Overall Study|Death|2|||
155723290|NCT02992288|562085591|FG000|Overall Study|Adverse Event|8|||
155723291|NCT02992288|562085592|FG001|Overall Study|Adverse Event|2|||
155723292|NCT02992288|562085593|FG002|Overall Study|Adverse Event|2|||
155723293|NCT02992288|562085594|FG003|Overall Study|Adverse Event|2|||
155723294|NCT02992288|562085595|FG004|Overall Study|Adverse Event|2|||
155723295|NCT02992288|562085596|FG005|Overall Study|Adverse Event|7|||
155723296|NCT02992288|562085591|FG000|Overall Study|Non-compliance with study drug|0|||
155723297|NCT02992288|562085592|FG001|Overall Study|Non-compliance with study drug|1|||
155723298|NCT02992288|562085593|FG002|Overall Study|Non-compliance with study drug|1|||
155723299|NCT02992288|562085594|FG003|Overall Study|Non-compliance with study drug|0|||
155723300|NCT02992288|562085595|FG004|Overall Study|Non-compliance with study drug|1|||
155723301|NCT02992288|562085596|FG005|Overall Study|Non-compliance with study drug|0|||
155723302|NCT02992288|562085591|FG000|Overall Study|Physician Decision|3|||
155723303|NCT02992288|562085592|FG001|Overall Study|Physician Decision|0|||
155723304|NCT02992288|562085593|FG002|Overall Study|Physician Decision|1|||
155723305|NCT02992288|562085594|FG003|Overall Study|Physician Decision|0|||
155723306|NCT02992288|562085595|FG004|Overall Study|Physician Decision|0|||
155723307|NCT02992288|562085596|FG005|Overall Study|Physician Decision|1|||
155723308|NCT02992288|562085591|FG000|Overall Study|Death|2|||
155723309|NCT02992288|562085592|FG001|Overall Study|Death|0|||
155723310|NCT02992288|562085593|FG002|Overall Study|Death|2|||
155723311|NCT02992288|562085594|FG003|Overall Study|Death|1|||
155723312|NCT02992288|562085595|FG004|Overall Study|Death|2|||
155723313|NCT02992288|562085596|FG005|Overall Study|Death|0|||
155723314|NCT02992288|562085591|FG000|Overall Study|Lost to Follow-up|0|||
155723315|NCT02992288|562085592|FG001|Overall Study|Lost to Follow-up|0|||
155723316|NCT02992288|562085593|FG002|Overall Study|Lost to Follow-up|0|||
155723317|NCT02992288|562085594|FG003|Overall Study|Lost to Follow-up|1|||
155723318|NCT02992288|562085595|FG004|Overall Study|Lost to Follow-up|0|||
155723319|NCT02992288|562085596|FG005|Overall Study|Lost to Follow-up|0|||
155723320|NCT02992288|562085591|FG000|Overall Study|Protocol Violation|0|||
155723321|NCT02992288|562085592|FG001|Overall Study|Protocol Violation|0|||
155723322|NCT02992288|562085593|FG002|Overall Study|Protocol Violation|0|||
155723323|NCT02992288|562085594|FG003|Overall Study|Protocol Violation|0|||
155723324|NCT02992288|562085595|FG004|Overall Study|Protocol Violation|0|||
155723325|NCT02992288|562085596|FG005|Overall Study|Protocol Violation|1|||
155723326|NCT02992288|562085591|FG000|Overall Study|Withdrawal by Subject|4|||
155723327|NCT02992288|562085592|FG001|Overall Study|Withdrawal by Subject|2|||
155723328|NCT02992288|562085593|FG002|Overall Study|Withdrawal by Subject|1|||
155723329|NCT02992288|562085594|FG003|Overall Study|Withdrawal by Subject|5|||
155723330|NCT02992288|562085595|FG004|Overall Study|Withdrawal by Subject|3|||
155723331|NCT02992288|562085596|FG005|Overall Study|Withdrawal by Subject|4|||
155723332|NCT00656513|562085597|FG000|Overall Study|Protocol Violation|1|||
155723333|NCT00656513|562085598|FG001|Overall Study|Protocol Violation|0|||
155723334|NCT00656513|562085599|FG002|Overall Study|Protocol Violation|2|||
155723335|NCT00656513|562085597|FG000|Overall Study|Withdrawal by Subject|0|||
155723336|NCT00656513|562085598|FG001|Overall Study|Withdrawal by Subject|11|||
155723337|NCT00656513|562085599|FG002|Overall Study|Withdrawal by Subject|4|||
155723338|NCT00656513|562085597|FG000|Overall Study|Death|0|||
155723339|NCT00656513|562085598|FG001|Overall Study|Death|0|||
155723340|NCT00656513|562085599|FG002|Overall Study|Death|1|||
155723341|NCT00656513|562085597|FG000|Overall Study|Missing data|0|||
155723342|NCT00656513|562085598|FG001|Overall Study|Missing data|11|||
155723343|NCT00656513|562085599|FG002|Overall Study|Missing data|9|||
155723344|NCT00656513|562085597|FG000|Overall Study|Incomplete treatment|3|||
155723345|NCT00656513|562085598|FG001|Overall Study|Incomplete treatment|0|||
155723346|NCT00656513|562085599|FG002|Overall Study|Incomplete treatment|0|||
155723347|NCT00656513|562085597|FG000|Overall Study|Treatment completed outside of timeframe|0|||
155723348|NCT00656513|562085598|FG001|Overall Study|Treatment completed outside of timeframe|3|||
155723349|NCT00656513|562085599|FG002|Overall Study|Treatment completed outside of timeframe|1|||
155723350|NCT00656513|562085597|FG000|Overall Study|Missing baseline form|0|||
155723351|NCT00656513|562085598|FG001|Overall Study|Missing baseline form|5|||
155723352|NCT00656513|562085599|FG002|Overall Study|Missing baseline form|5|||
155723353|NCT03962491|562085604|FG000|Overall Study|Lost to Follow-up|4|||
155723354|NCT03962491|562085605|FG001|Overall Study|Lost to Follow-up|5|||
155723355|NCT00106704|562085606|FG000|Overall Study|Adverse Event|10|||
155723356|NCT00106704|562085607|FG001|Overall Study|Adverse Event|7|||
155723357|NCT00106704|562085606|FG000|Overall Study|Death|2|||
155723358|NCT00106704|562085607|FG001|Overall Study|Death|1|||
155723359|NCT00106704|562085606|FG000|Overall Study|Lack of Efficacy|67|||
155723360|NCT00106704|562085607|FG001|Overall Study|Lack of Efficacy|69|||
155723361|NCT00106704|562085606|FG000|Overall Study|Lost to Follow-up|7|||
155723362|NCT00106704|562085607|FG001|Overall Study|Lost to Follow-up|3|||
155723363|NCT00106704|562085606|FG000|Overall Study|Pregnancy|1|||
155723364|NCT00106704|562085607|FG001|Overall Study|Pregnancy|0|||
155723365|NCT00106704|562085606|FG000|Overall Study|Protocol Violation|4|||
155723366|NCT00106704|562085607|FG001|Overall Study|Protocol Violation|7|||
155723367|NCT00106704|562085606|FG000|Overall Study|Withdrawal by Subject|14|||
155723368|NCT00106704|562085607|FG001|Overall Study|Withdrawal by Subject|21|||
155723369|NCT00106704|562085606|FG000|Overall Study|Patient moved|1|||
155723370|NCT00106704|562085607|FG001|Overall Study|Patient moved|0|||
155723371|NCT00106704|562085606|FG000|Overall Study|Site terminated|0|||
155723372|NCT00106704|562085607|FG001|Overall Study|Site terminated|1|||
155723373|NCT00106704|562085606|FG000|Overall Study|Planned major surgery|1|||
155723374|NCT00106704|562085607|FG001|Overall Study|Planned major surgery|0|||
155723375|NCT00106704|562085606|FG000|Overall Study|Patient Received Glycemic Medication|22|||
155723376|NCT00106704|562085607|FG001|Overall Study|Patient Received Glycemic Medication|41|||
155723377|NCT00106704|562085606|FG000|Overall Study|Unable to re-enter US|1|||
155723378|NCT00106704|562085607|FG001|Overall Study|Unable to re-enter US|0|||
155723379|NCT00106704|562085606|FG000|Overall Study|Laboratory test|1|||
155723380|NCT00106704|562085607|FG001|Overall Study|Laboratory test|1|||
155723381|NCT05236270|562085610|FG000|Overall Study|Lost to Follow-up|3|||
155723382|NCT05236270|562085611|FG001|Overall Study|Lost to Follow-up|2|||
155723383|NCT05236270|562085612|FG002|Overall Study|Lost to Follow-up|0|||
155723384|NCT05236270|562085613|FG003|Overall Study|Lost to Follow-up|0|||
155723385|NCT05236270|562085614|FG004|Overall Study|Lost to Follow-up|2|||
155723386|NCT05236270|562085615|FG005|Overall Study|Lost to Follow-up|0|||
155723387|NCT05236270|562085616|FG006|Overall Study|Lost to Follow-up|1|||
155723388|NCT05236270|562085617|FG007|Overall Study|Lost to Follow-up|3|||
155723389|NCT03486912|562085618|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155723390|NCT03486912|562085619|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
155723391|NCT03486912|562085620|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155723392|NCT03486912|562085621|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155723393|NCT03486912|562085618|FG000|Treatment Period|Withdrawal by Subject|3|||
155723394|NCT03486912|562085619|FG001|Treatment Period|Withdrawal by Subject|3|||
155723395|NCT03486912|562085620|FG002|Treatment Period|Withdrawal by Subject|3|||
155723396|NCT03486912|562085621|FG003|Treatment Period|Withdrawal by Subject|2|||
155723397|NCT03486912|562085618|FG000|Treatment Period|Other Reasons|0|||
155723398|NCT03486912|562085619|FG001|Treatment Period|Other Reasons|2|||
155723399|NCT03486912|562085620|FG002|Treatment Period|Other Reasons|1|||
155723400|NCT03486912|562085621|FG003|Treatment Period|Other Reasons|1|||
155723401|NCT03486912|562085618|FG000|Treatment Period|Adverse Event|0|||
155723402|NCT03486912|562085619|FG001|Treatment Period|Adverse Event|1|||
155723403|NCT03486912|562085620|FG002|Treatment Period|Adverse Event|1|||
155723404|NCT03486912|562085621|FG003|Treatment Period|Adverse Event|0|||
155723405|NCT03486912|562085618|FG000|Treatment Period|Lost to Follow-up|1|||
155723406|NCT03486912|562085619|FG001|Treatment Period|Lost to Follow-up|0|||
155723407|NCT03486912|562085620|FG002|Treatment Period|Lost to Follow-up|0|||
155723408|NCT03486912|562085621|FG003|Treatment Period|Lost to Follow-up|2|||
155723409|NCT01499940|562085622|FG000|Overall Study|Study was withdrawn before completion.|9|||
155723410|NCT01339832|562085626|FG000|Overall Study|Lost to Follow-up|3|||
155723411|NCT01339832|562085626|FG000|Overall Study|Death|11|||
155723412|NCT01614249|562085630|FG000|Overall Study|Lost to Follow-up|11|||
155723413|NCT01614249|562085631|FG001|Overall Study|Lost to Follow-up|23|||
155723414|NCT02954536|562085632|FG000|Overall Study|Adverse Event|2|||
155723415|NCT02954536|562085632|FG000|Overall Study|Death|12|||
155723416|NCT05498649|562085633|FG000|Overall Study|Lost to Follow-up|1|||
155723417|NCT03094416|562085645|FG000|Run-in|Screening failure|8|||
155723418|NCT03094416|562085645|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
155723419|NCT03094416|562085645|FG000|Run-in|Withdrawal by Subject|3|||
155723420|NCT03094416|562085645|FG000|Treatment Period|Withdrawal by Subject|2|||
155723421|NCT02158442|562085648|FG000|Overall Study|Withdrawal by Subject|1|||
155723422|NCT02158442|562085649|FG001|Overall Study|Withdrawal by Subject|0|||
155723423|NCT02158442|562085648|FG000|Overall Study|Perfusion staff not available|1|||
155723424|NCT02158442|562085649|FG001|Overall Study|Perfusion staff not available|0|||
155723425|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
155723426|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
155723427|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
155723428|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
155723429|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
155723430|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
155723431|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
155723432|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
155723433|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
155723434|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
155723435|NCT01668784|562085650|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
155723436|NCT01668784|562085651|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
155723437|NCT01668784|562085650|FG000|Treatment Period|Disease Progression|316|||
155723438|NCT01668784|562085651|FG001|Treatment Period|Disease Progression|293|||
155723439|NCT01668784|562085650|FG000|Treatment Period|Study Drug Toxicity|46|||
155723440|NCT01668784|562085651|FG001|Treatment Period|Study Drug Toxicity|53|||
155723441|NCT01668784|562085650|FG000|Treatment Period|Death|1|||
155723442|NCT01668784|562085651|FG001|Treatment Period|Death|1|||
155723443|NCT01668784|562085650|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
155723444|NCT01668784|562085651|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
155723445|NCT01668784|562085650|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
155723446|NCT01668784|562085651|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
155723447|NCT01668784|562085650|FG000|Treatment Period|Withdrawal by Subject|5|||
155723448|NCT01668784|562085651|FG001|Treatment Period|Withdrawal by Subject|3|||
155723449|NCT01668784|562085650|FG000|Treatment Period|Maximal Clinical Benefit|3|||
155723450|NCT01668784|562085651|FG001|Treatment Period|Maximal Clinical Benefit|3|||
155723451|NCT01668784|562085650|FG000|Treatment Period|Other|2|||
155723452|NCT01668784|562085651|FG001|Treatment Period|Other|8|||
155723453|NCT01668784|562085650|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
155723454|NCT01668784|562085651|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
155723455|NCT02761330|562085652|FG000|Treatment Week 1|Withdrawal by Subject|0|||
155723456|NCT02761330|562085653|FG001|Treatment Week 1|Withdrawal by Subject|0|||
155723457|NCT02761330|562085654|FG002|Treatment Week 1|Withdrawal by Subject|0|||
155723458|NCT02761330|562085655|FG003|Treatment Week 1|Withdrawal by Subject|1|||
155723459|NCT02761330|562085656|FG004|Treatment Week 1|Withdrawal by Subject|0|||
155723460|NCT02761330|562085657|FG005|Treatment Week 1|Withdrawal by Subject|1|||
155723461|NCT05386329|562085658|FG000|Overall Study|Lost to Follow-up|3|||
155723462|NCT02657889|562085663|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
155723463|NCT02657889|562085664|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
155723464|NCT02657889|562085665|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
155723465|NCT02657889|562085666|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
155723466|NCT02657889|562085663|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
155723467|NCT02657889|562085664|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
155723468|NCT02657889|562085665|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
155723469|NCT02657889|562085666|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
155723470|NCT02657889|562085663|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
155723471|NCT02657889|562085664|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
155723472|NCT02657889|562085665|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
155723473|NCT02657889|562085666|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
155723474|NCT02657889|562085663|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155723475|NCT02657889|562085664|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
155723476|NCT02657889|562085665|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155723477|NCT02657889|562085666|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155723478|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
155723479|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
155723480|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
155723481|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
155723482|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
155723483|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
155723484|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
155723485|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
155723486|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
155723487|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
155723488|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
155723489|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
155723490|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
155723491|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
155723492|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
155723493|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
155723494|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
155723495|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
155723496|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
155723497|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
155723498|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155723499|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155723500|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155723501|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
155723502|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
155723503|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
155723504|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
155723505|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
155723506|NCT02657889|562085663|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155723507|NCT02657889|562085664|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155723508|NCT02657889|562085665|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155723509|NCT02657889|562085666|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
155723510|NCT03341299|562085669|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155723511|NCT03341299|562085670|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155723512|NCT03341299|562085671|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
155723513|NCT03341299|562085672|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155723514|NCT00335777|562087562|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
155723515|NCT00335777|562087562|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
155723516|NCT00335777|562087562|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
155723517|NCT00335777|562087562|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
155723518|NCT00335777|562087562|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
155723519|NCT05024032|562087569|FG000|Overall Study|Withdrawal by Subject|0|||
155723520|NCT05024032|562087570|FG001|Overall Study|Withdrawal by Subject|3|||
155723521|NCT05024032|562087571|FG002|Overall Study|Withdrawal by Subject|4|||
155723522|NCT05024032|562087569|FG000|Overall Study|Adverse Event|0|||
155723523|NCT05024032|562087570|FG001|Overall Study|Adverse Event|1|||
155723524|NCT05024032|562087571|FG002|Overall Study|Adverse Event|0|||
155723525|NCT05024032|562087569|FG000|Overall Study|Protocol Deviation|1|||
155723526|NCT05024032|562087570|FG001|Overall Study|Protocol Deviation|0|||
155723527|NCT05024032|562087571|FG002|Overall Study|Protocol Deviation|0|||
155723528|NCT01209689|562087572|FG000|Overall Study|Insufficient Therapeutic Response|7|||
155723529|NCT01209689|562087573|FG001|Overall Study|Insufficient Therapeutic Response|2|||
155723530|NCT01209689|562087572|FG000|Overall Study|Refused Treatment|8|||
155723531|NCT01209689|562087573|FG001|Overall Study|Refused Treatment|3|||
155723532|NCT01209689|562087572|FG000|Overall Study|Adverse Event|4|||
155723533|NCT01209689|562087573|FG001|Overall Study|Adverse Event|0|||
155723534|NCT01209689|562087572|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155723535|NCT01209689|562087573|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155723536|NCT01209689|562087572|FG000|Overall Study|Failure to Return|3|||
155723537|NCT01209689|562087573|FG001|Overall Study|Failure to Return|0|||
155723538|NCT01209689|562087572|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
155723539|NCT01209689|562087573|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
155723540|NCT03780244|562087574|FG000|Overall Study|Lost to Follow-up|1|||
155723541|NCT03780244|562087575|FG001|Overall Study|Lost to Follow-up|0|||
155723542|NCT02345070|562087576|FG000|Overall Study|Adverse Event|12|||
155723543|NCT02345070|562087577|FG001|Overall Study|Adverse Event|8|||
155723544|NCT02345070|562087578|FG002|Overall Study|Adverse Event|16|||
155723545|NCT02345070|562087576|FG000|Overall Study|Poor compliance to protocol|2|||
155723546|NCT02345070|562087577|FG001|Overall Study|Poor compliance to protocol|0|||
155381469|NCT00994682|560830934|FG001|Pioglitazone Open Label|Physician Decision|1|||
155381470|NCT01049217|560830935|FG000|Overall Study|Adverse Event|2|||
155610796|NCT03244618|561666514|FG001|Overall Study|Lost to Follow-up|4|||
155610797|NCT03244618|561666513|FG000|Overall Study|Protocol Violation|4|||
155610798|NCT03244618|561666514|FG001|Overall Study|Protocol Violation|3|||
155610799|NCT03244618|561666513|FG000|Overall Study|Withdrawal by Subject|0|||
155610800|NCT03244618|561666514|FG001|Overall Study|Withdrawal by Subject|2|||
155610801|NCT03469999|561666517|FG000|Overall Study|Lost to Follow-up|2|||
155610802|NCT00094536|561666518|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
155610803|NCT00094536|561666518|FG000|Treatment and Follow-up|Adverse Event|4|||
155610804|NCT00094536|561666518|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
155610805|NCT00094536|561666518|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
155610806|NCT00094536|561666518|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
155610807|NCT00094536|561666518|FG000|Treatment and Follow-up|Subject non-compliance|9|||
155610808|NCT00094536|561666518|FG000|Treatment and Follow-up|Unable to attend visits|1|||
155610809|NCT01900431|561666519|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
155610810|NCT01900431|561666520|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
155610811|NCT01900431|561666521|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
155610812|NCT01900431|561666519|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
155610813|NCT01900431|561666520|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
155610814|NCT01900431|561666521|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
155610815|NCT01900431|561666519|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
155610816|NCT01900431|561666520|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
155610817|NCT01900431|561666521|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
155610818|NCT01900431|561666519|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
155610819|NCT01900431|561666520|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
155610820|NCT01900431|561666521|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
155610821|NCT01900431|561666519|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
155610822|NCT01900431|561666520|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
155610823|NCT01900431|561666521|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
155610824|NCT01900431|561666519|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
155610825|NCT01900431|561666520|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
155610826|NCT01900431|561666521|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
155610827|NCT01900431|561666519|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
155610828|NCT01900431|561666520|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
155610829|NCT01900431|561666521|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
155610830|NCT01900431|561666519|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
155610831|NCT01900431|561666520|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
155610832|NCT01900431|561666521|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
155610833|NCT01900431|561666519|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
155610834|NCT01900431|561666520|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
155610835|NCT01900431|561666521|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
155610836|NCT00435019|561666522|FG000|Overall Study|Adverse Event|1|||
155610837|NCT00435019|561666523|FG001|Overall Study|Adverse Event|0|||
155610838|NCT00435019|561666522|FG000|Overall Study|Lack of Efficacy|1|||
155610839|NCT00435019|561666523|FG001|Overall Study|Lack of Efficacy|2|||
155610840|NCT00435019|561666522|FG000|Overall Study|Protocol Violation|3|||
155610841|NCT00435019|561666523|FG001|Overall Study|Protocol Violation|1|||
155610842|NCT00435019|561666522|FG000|Overall Study|Personal reasons for withdrawal|8|||
155610843|NCT00435019|561666523|FG001|Overall Study|Personal reasons for withdrawal|7|||
155610844|NCT00385827|561668481|FG000|Part 1|Adverse Event|1|||
155610845|NCT00385827|561668482|FG001|Part 1|Adverse Event|0|||
155610846|NCT00385827|561668483|FG002|Part 1|Adverse Event|0|||
155610847|NCT00385827|561668481|FG000|Part 1|Death|2|||
155610848|NCT00385827|561668482|FG001|Part 1|Death|0|||
155610849|NCT00385827|561668483|FG002|Part 1|Death|0|||
155610850|NCT00385827|561668481|FG000|Part 1|Lack of Efficacy|5|||
155610851|NCT00385827|561668482|FG001|Part 1|Lack of Efficacy|0|||
155610852|NCT00385827|561668483|FG002|Part 1|Lack of Efficacy|0|||
155610853|NCT00385827|561668481|FG000|Part 1|Other|1|||
155610854|NCT00385827|561668482|FG001|Part 1|Other|0|||
155610855|NCT00385827|561668483|FG002|Part 1|Other|0|||
155610856|NCT00385827|561668481|FG000|Part 2|Adverse Event|0|||
155610857|NCT00385827|561668482|FG001|Part 2|Adverse Event|6|||
155610858|NCT00385827|561668483|FG002|Part 2|Adverse Event|10|||
155610859|NCT00385827|561668481|FG000|Part 2|Death|0|||
155610860|NCT00385827|561668482|FG001|Part 2|Death|0|||
155610861|NCT00385827|561668483|FG002|Part 2|Death|2|||
155610862|NCT00385827|561668481|FG000|Part 2|Lack of Efficacy|0|||
155610863|NCT00385827|561668482|FG001|Part 2|Lack of Efficacy|14|||
155610864|NCT00385827|561668483|FG002|Part 2|Lack of Efficacy|13|||
155610865|NCT00385827|561668481|FG000|Part 2|Randomized but not treated|0|||
155610866|NCT00385827|561668482|FG001|Part 2|Randomized but not treated|2|||
155610867|NCT00385827|561668483|FG002|Part 2|Randomized but not treated|2|||
155610868|NCT00385827|561668481|FG000|Part 2|Other|0|||
155610869|NCT00385827|561668482|FG001|Part 2|Other|11|||
155610870|NCT00385827|561668483|FG002|Part 2|Other|21|||
155610871|NCT01421147|561668484|FG000|Treatment Period|Adverse Event|2|||
155723547|NCT02345070|562087578|FG002|Overall Study|Poor compliance to protocol|0|||
155723548|NCT02345070|562087576|FG000|Overall Study|Other than specified above|6|||
155723549|NCT02345070|562087577|FG001|Overall Study|Other than specified above|3|||
155723550|NCT02345070|562087578|FG002|Overall Study|Other than specified above|7|||
155723551|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
155723552|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723553|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723554|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723555|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723556|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723557|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155723558|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
155723559|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723560|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723561|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723562|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723563|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723564|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
155723565|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
155723566|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723567|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723568|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723569|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723570|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723571|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155723572|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
155723573|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723574|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723575|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723576|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723577|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723578|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155723579|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
155723580|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723581|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723582|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723583|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723584|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723585|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
155723586|NCT01054885|562087579|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
155723587|NCT01054885|562087580|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723588|NCT01054885|562087581|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723589|NCT01054885|562087582|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723590|NCT01054885|562087583|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723591|NCT01054885|562087584|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723592|NCT01054885|562087585|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155723593|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155723594|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
155723595|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
155723596|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
155723597|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
155723598|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
155723599|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
155723600|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155723601|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155723602|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155723603|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
155723604|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155723605|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
155723606|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155723607|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155723608|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
155723609|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
155723610|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
155723611|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
155723612|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
155723613|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
155723614|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155723615|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
155723616|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
155723617|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155723618|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155723619|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
155723620|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155723621|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
155723622|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155723623|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
155723624|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155723625|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155723626|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
155723627|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
155723628|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155723629|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155723630|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
155723631|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155723632|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155723633|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155723634|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
155723635|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155723636|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
155723637|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155723638|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155723639|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155723640|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155723641|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155723642|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155723643|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
155723644|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
155723645|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
155723646|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
155723647|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
155723648|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
155723649|NCT01054885|562087579|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155723650|NCT01054885|562087580|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
155723651|NCT01054885|562087581|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155723652|NCT01054885|562087582|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
155723653|NCT01054885|562087583|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
155723654|NCT01054885|562087584|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155723655|NCT01054885|562087585|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
155723656|NCT02443688|562087586|FG000|Overall Study|Adverse Event|2|||
155723657|NCT02443688|562087587|FG001|Overall Study|Adverse Event|3|||
155723658|NCT02443688|562087588|FG002|Overall Study|Adverse Event|2|||
155723659|NCT02443688|562087586|FG000|Overall Study|Lost to Follow-up|1|||
155723660|NCT02443688|562087587|FG001|Overall Study|Lost to Follow-up|0|||
155723661|NCT02443688|562087588|FG002|Overall Study|Lost to Follow-up|0|||
155723662|NCT02443688|562087586|FG000|Overall Study|Physician Decision|3|||
155723663|NCT02443688|562087587|FG001|Overall Study|Physician Decision|0|||
155723664|NCT02443688|562087588|FG002|Overall Study|Physician Decision|1|||
155723665|NCT02443688|562087586|FG000|Overall Study|Pregnancy|0|||
155723666|NCT02443688|562087587|FG001|Overall Study|Pregnancy|0|||
155723667|NCT02443688|562087588|FG002|Overall Study|Pregnancy|1|||
155723668|NCT02443688|562087586|FG000|Overall Study|Withdrawal by Subject|3|||
155723669|NCT02443688|562087587|FG001|Overall Study|Withdrawal by Subject|3|||
155723670|NCT02443688|562087588|FG002|Overall Study|Withdrawal by Subject|4|||
155723671|NCT02443688|562087586|FG000|Overall Study|Non-compliance with study drug|1|||
155723672|NCT02443688|562087587|FG001|Overall Study|Non-compliance with study drug|2|||
155381471|NCT01049217|560830936|FG001|Overall Study|Adverse Event|1|||
155381472|NCT01049217|560830935|FG000|Overall Study|Lack of Efficacy|1|||
155381473|NCT01049217|560830936|FG001|Overall Study|Lack of Efficacy|1|||
155381474|NCT01049217|560830935|FG000|Overall Study|Lost to Follow-up|3|||
155723673|NCT02443688|562087588|FG002|Overall Study|Non-compliance with study drug|4|||
155723674|NCT02443688|562087586|FG000|Overall Study|Sponsor Request|2|||
155723675|NCT02443688|562087587|FG001|Overall Study|Sponsor Request|1|||
155723676|NCT02443688|562087588|FG002|Overall Study|Sponsor Request|0|||
155723677|NCT02379728|562087589|FG000|Overall Study|Lost to Follow-up|1|||
155723678|NCT02379728|562087590|FG001|Overall Study|Lost to Follow-up|0|||
155723679|NCT02379728|562087591|FG002|Overall Study|Lost to Follow-up|3|||
155723680|NCT02379728|562087592|FG003|Overall Study|Lost to Follow-up|0|||
155723681|NCT02379728|562087589|FG000|Overall Study|Withdrawal by Subject|5|||
155723682|NCT02379728|562087590|FG001|Overall Study|Withdrawal by Subject|0|||
155723683|NCT02379728|562087591|FG002|Overall Study|Withdrawal by Subject|5|||
155723684|NCT02379728|562087592|FG003|Overall Study|Withdrawal by Subject|3|||
155723685|NCT02379728|562087589|FG000|Overall Study|Protocol Violation|0|||
155723686|NCT02379728|562087590|FG001|Overall Study|Protocol Violation|0|||
155723687|NCT02379728|562087591|FG002|Overall Study|Protocol Violation|2|||
155723688|NCT02379728|562087592|FG003|Overall Study|Protocol Violation|0|||
155723689|NCT01112917|562087593|FG000|Overall Study|Death|2|||
155723690|NCT01112917|562087594|FG001|Overall Study|Death|11|||
155723691|NCT01112917|562087593|FG000|Overall Study|Lost to Follow-up|1|||
155723692|NCT01112917|562087594|FG001|Overall Study|Lost to Follow-up|1|||
155723693|NCT01112917|562087593|FG000|Overall Study|Withdrawal by Subject|1|||
155723694|NCT01112917|562087594|FG001|Overall Study|Withdrawal by Subject|3|||
155723695|NCT01112917|562087593|FG000|Overall Study|Unable to Convert Filter|3|||
155723696|NCT01112917|562087594|FG001|Overall Study|Unable to Convert Filter|0|||
155723697|NCT00837434|562087606|FG000|Overall Study|Physician Decision|3|||
155723698|NCT00837434|562087607|FG001|Overall Study|Physician Decision|0|||
155723699|NCT00837434|562087606|FG000|Overall Study|Lost to Follow-up|1|||
155723700|NCT00837434|562087607|FG001|Overall Study|Lost to Follow-up|1|||
155723701|NCT00837434|562087606|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
155723702|NCT00837434|562087607|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
155723703|NCT00837434|562087606|FG000|Overall Study|Noncompliant|2|||
155723704|NCT00837434|562087607|FG001|Overall Study|Noncompliant|0|||
155723705|NCT00837434|562087606|FG000|Overall Study|Baseline assessments not done in time|1|||
155723706|NCT00837434|562087607|FG001|Overall Study|Baseline assessments not done in time|0|||
155723707|NCT00837434|562087606|FG000|Overall Study|Unable to obtain study drug|1|||
155723708|NCT00837434|562087607|FG001|Overall Study|Unable to obtain study drug|0|||
155723709|NCT01709721|562087608|FG000|Open Label Phase|Withdrawal by Subject|0|||
155723710|NCT01709721|562087609|FG001|Open Label Phase|Withdrawal by Subject|0|||
155723711|NCT01709721|562087610|FG002|Open Label Phase|Withdrawal by Subject|5|||
155723712|NCT01709721|562087608|FG000|Open Label Phase|Adverse Event|0|||
155723713|NCT01709721|562087609|FG001|Open Label Phase|Adverse Event|0|||
155723714|NCT01709721|562087610|FG002|Open Label Phase|Adverse Event|8|||
155723715|NCT01709721|562087608|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
155723716|NCT01709721|562087609|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
155723717|NCT01709721|562087610|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
155723718|NCT01709721|562087608|FG000|Open Label Phase|Investigator Decision|0|||
155723719|NCT01709721|562087609|FG001|Open Label Phase|Investigator Decision|0|||
155723720|NCT01709721|562087610|FG002|Open Label Phase|Investigator Decision|1|||
155723721|NCT01709721|562087608|FG000|Open Label Phase|Sponsor Decision|0|||
155723722|NCT01709721|562087609|FG001|Open Label Phase|Sponsor Decision|0|||
155723723|NCT01709721|562087610|FG002|Open Label Phase|Sponsor Decision|2|||
155723724|NCT01709721|562087608|FG000|Open Label Phase|Protocol Violation|0|||
155723725|NCT01709721|562087609|FG001|Open Label Phase|Protocol Violation|0|||
155723726|NCT01709721|562087610|FG002|Open Label Phase|Protocol Violation|1|||
155723727|NCT01709721|562087608|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
155723728|NCT01709721|562087609|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
155723729|NCT01709721|562087610|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
155723730|NCT01709721|562087608|FG000|Open Label Phase|Inadequate Pain Control|0|||
155723731|NCT01709721|562087609|FG001|Open Label Phase|Inadequate Pain Control|0|||
155723732|NCT01709721|562087610|FG002|Open Label Phase|Inadequate Pain Control|37|||
155723733|NCT01709721|562087608|FG000|Open Label Phase|Other, Specify in text field in database|0|||
155723734|NCT01709721|562087609|FG001|Open Label Phase|Other, Specify in text field in database|0|||
155723735|NCT01709721|562087610|FG002|Open Label Phase|Other, Specify in text field in database|14|||
155723736|NCT01709721|562087608|FG000|Randomized Phase|Adverse Event|0|||
155723737|NCT01709721|562087609|FG001|Randomized Phase|Adverse Event|1|||
155723738|NCT01709721|562087610|FG002|Randomized Phase|Adverse Event|0|||
155723739|NCT01709721|562087608|FG000|Randomized Phase|Lost to Follow-up|1|||
155723740|NCT01709721|562087609|FG001|Randomized Phase|Lost to Follow-up|0|||
155723741|NCT01709721|562087610|FG002|Randomized Phase|Lost to Follow-up|0|||
155723742|NCT01709721|562087608|FG000|Randomized Phase|Inadequate Pain Control|1|||
155723743|NCT01709721|562087609|FG001|Randomized Phase|Inadequate Pain Control|2|||
155723744|NCT01709721|562087610|FG002|Randomized Phase|Inadequate Pain Control|0|||
155723745|NCT01709721|562087608|FG000|Randomized Phase|Other, Specify text field in database|1|||
155723746|NCT01709721|562087609|FG001|Randomized Phase|Other, Specify text field in database|3|||
155723747|NCT01709721|562087610|FG002|Randomized Phase|Other, Specify text field in database|0|||
155723748|NCT02230410|562087611|FG000|Overall Study|Screen Failure|3|||
155723749|NCT02558894|562087617|FG000|Overall Study|Death; any cause, entire study duration|28|||
155723750|NCT02558894|562087618|FG001|Overall Study|Death; any cause, entire study duration|31|||
155723751|NCT02558894|562087617|FG000|Overall Study|Withdrawal by Subject|2|||
155723752|NCT02558894|562087618|FG001|Overall Study|Withdrawal by Subject|1|||
155723753|NCT02558894|562087617|FG000|Overall Study|Closure of Part A|2|||
155723754|NCT02558894|562087618|FG001|Overall Study|Closure of Part A|1|||
155723755|NCT04558125|562087619|FG000|Overall Study|Death|1|||
155723756|NCT01748292|562087620|FG000|Overall Study|Adverse Event|2|||
155723757|NCT01748292|562087621|FG001|Overall Study|Adverse Event|4|||
155723758|NCT01748292|562087620|FG000|Overall Study|Lost to Follow-up|0|||
155723759|NCT01748292|562087621|FG001|Overall Study|Lost to Follow-up|3|||
155723760|NCT01748292|562087620|FG000|Overall Study|Death|0|||
155723761|NCT01748292|562087621|FG001|Overall Study|Death|3|||
155723762|NCT01748292|562087620|FG000|Overall Study|Withdrawal by Subject|0|||
155723763|NCT01748292|562087621|FG001|Overall Study|Withdrawal by Subject|2|||
155723764|NCT03199976|562087622|FG000|Overall Study|Lack of Efficacy|3|||
155723765|NCT03199976|562087623|FG001|Overall Study|Lack of Efficacy|6|||
155723766|NCT03199976|562087624|FG002|Overall Study|Lack of Efficacy|13|||
155723767|NCT03199976|562087622|FG000|Overall Study|Withdrawal by Subject|1|||
155723768|NCT03199976|562087623|FG001|Overall Study|Withdrawal by Subject|0|||
155723769|NCT03199976|562087624|FG002|Overall Study|Withdrawal by Subject|0|||
155723770|NCT03199976|562087622|FG000|Overall Study|Lost to Follow-up|0|||
155723771|NCT03199976|562087623|FG001|Overall Study|Lost to Follow-up|1|||
155723772|NCT03199976|562087624|FG002|Overall Study|Lost to Follow-up|1|||
155723773|NCT01761877|562087625|FG000|Overall Study|Adverse Event|7|||
155723774|NCT01761877|562087626|FG001|Overall Study|Adverse Event|0|||
155723775|NCT01761877|562087625|FG000|Overall Study|Withdrawal by Subject|6|||
155723776|NCT01761877|562087626|FG001|Overall Study|Withdrawal by Subject|4|||
155723777|NCT01761877|562087625|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
155723778|NCT01761877|562087626|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
155723779|NCT01761877|562087625|FG000|Overall Study|Death|0|||
155723780|NCT01761877|562087626|FG001|Overall Study|Death|1|||
155723781|NCT01761877|562087625|FG000|Overall Study|MRI intolerant|1|||
155723782|NCT01761877|562087626|FG001|Overall Study|MRI intolerant|6|||
155723783|NCT00003475|562087627|FG000|Overall Study|Not evaluable|13|||
155723784|NCT03697252|562087634|FG000|Overall Study|Adverse Event|3|||
155723785|NCT03697252|562087635|FG001|Overall Study|Adverse Event|2|||
155723786|NCT03697252|562087634|FG000|Overall Study|Withdrawal by Subject|14|||
155723787|NCT03697252|562087635|FG001|Overall Study|Withdrawal by Subject|14|||
155723788|NCT03697252|562087634|FG000|Overall Study|Lost to Follow-up|0|||
155723789|NCT03697252|562087635|FG001|Overall Study|Lost to Follow-up|1|||
155723790|NCT03697252|562087634|FG000|Overall Study|Physician Decision|1|||
155723791|NCT03697252|562087635|FG001|Overall Study|Physician Decision|1|||
155723792|NCT03697252|562087634|FG000|Overall Study|Other|0|||
155723793|NCT03697252|562087635|FG001|Overall Study|Other|1|||
155723794|NCT01780506|562087636|FG000|Double-Blind Phase|Randomized but not Treated|3|||
155723795|NCT01780506|562087637|FG001|Double-Blind Phase|Randomized but not Treated|2|||
155723796|NCT01780506|562087636|FG000|Double-Blind Phase|Adverse Event|4|||
155723797|NCT01780506|562087637|FG001|Double-Blind Phase|Adverse Event|14|||
155723798|NCT01780506|562087636|FG000|Double-Blind Phase|Death|1|||
155723799|NCT01780506|562087637|FG001|Double-Blind Phase|Death|2|||
155723800|NCT01780506|562087636|FG000|Double-Blind Phase|Pregnancy|2|||
155723801|NCT01780506|562087637|FG001|Double-Blind Phase|Pregnancy|1|||
155723802|NCT01780506|562087636|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155723803|NCT01780506|562087637|FG001|Double-Blind Phase|Lack of Efficacy|1|||
155723804|NCT01780506|562087636|FG000|Double-Blind Phase|Investigator's Discretion|5|||
155723805|NCT01780506|562087637|FG001|Double-Blind Phase|Investigator's Discretion|2|||
155723806|NCT01780506|562087636|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
155723807|NCT01780506|562087637|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
155723808|NCT01780506|562087636|FG000|Double-Blind Phase|Protocol Violation|4|||
155723809|NCT01780506|562087637|FG001|Double-Blind Phase|Protocol Violation|3|||
155723810|NCT01780506|562087636|FG000|Double-Blind Phase|Withdrew Consent|23|||
155723811|NCT01780506|562087637|FG001|Double-Blind Phase|Withdrew Consent|24|||
155723812|NCT01780506|562087636|FG000|Double-Blind Phase|Lost to Follow-up|23|||
155723813|NCT01780506|562087637|FG001|Double-Blind Phase|Lost to Follow-up|26|||
155723814|NCT01780506|562087636|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
155723815|NCT01780506|562087637|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
155723816|NCT00412984|562087642|FG000|Overall Study|Death|331|||
155723817|NCT00412984|562087643|FG001|Overall Study|Death|349|||
155723818|NCT00412984|562087642|FG000|Overall Study|Adverse Event|679|||
155723819|NCT00412984|562087643|FG001|Overall Study|Adverse Event|738|||
155723820|NCT00412984|562087642|FG000|Overall Study|Withdrawal by Subject|921|||
155723821|NCT00412984|562087643|FG001|Overall Study|Withdrawal by Subject|989|||
155723822|NCT00412984|562087642|FG000|Overall Study|Lost to Follow-up|51|||
155723823|NCT00412984|562087643|FG001|Overall Study|Lost to Follow-up|39|||
155723824|NCT00412984|562087642|FG000|Overall Study|Poor/Noncompliance|57|||
155723825|NCT00412984|562087643|FG001|Overall Study|Poor/Noncompliance|77|||
155723826|NCT00412984|562087642|FG000|Overall Study|Pregnancy|1|||
155723827|NCT00412984|562087643|FG001|Overall Study|Pregnancy|0|||
155723828|NCT00412984|562087642|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
155723829|NCT00412984|562087643|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
155723830|NCT00412984|562087642|FG000|Overall Study|Administrative Reason by Sponsor|11|||
155723831|NCT00412984|562087643|FG001|Overall Study|Administrative Reason by Sponsor|8|||
155723832|NCT00412984|562087642|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
155723833|NCT00412984|562087643|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
155723834|NCT00412984|562087642|FG000|Overall Study|Other Reason|80|||
155723835|NCT00412984|562087643|FG001|Overall Study|Other Reason|92|||
155723836|NCT00412984|562087642|FG000|Overall Study|Not Reported|11|||
155723837|NCT00412984|562087643|FG001|Overall Study|Not Reported|12|||
155723838|NCT04097678|562087645|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
155723839|NCT04097678|562087646|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
155723840|NCT03694678|562087647|FG000|Overall Study|Withdrawal by Subject|2|||
155723841|NCT03694678|562087648|FG001|Overall Study|Withdrawal by Subject|0|||
155723842|NCT03694678|562087647|FG000|Overall Study|Lost to Follow-up|2|||
155723843|NCT03694678|562087648|FG001|Overall Study|Lost to Follow-up|3|||
155723844|NCT02435212|562087649|FG000|Core Phase|Adverse Event|8|||
155723845|NCT02435212|562087650|FG001|Core Phase|Adverse Event|5|||
155723846|NCT02435212|562087649|FG000|Core Phase|Withdrawal by Subject|3|||
155723847|NCT02435212|562087650|FG001|Core Phase|Withdrawal by Subject|0|||
155723848|NCT02435212|562087649|FG000|Core Phase|Withdrawal by parent/guardian|9|||
155723849|NCT02435212|562087650|FG001|Core Phase|Withdrawal by parent/guardian|4|||
155723850|NCT02435212|562087649|FG000|Core Phase|Protocol Violation|1|||
155723851|NCT02435212|562087650|FG001|Core Phase|Protocol Violation|2|||
155723852|NCT02435212|562087649|FG000|Core Phase|Physician Decision|3|||
155723853|NCT02435212|562087650|FG001|Core Phase|Physician Decision|0|||
155723854|NCT02435212|562087649|FG000|Core Phase|Lost to Follow-up|0|||
155723855|NCT02435212|562087650|FG001|Core Phase|Lost to Follow-up|1|||
155723856|NCT02435212|562087649|FG000|Core Phase|Lack of Efficacy|0|||
155723857|NCT02435212|562087650|FG001|Core Phase|Lack of Efficacy|1|||
155723858|NCT02435212|562087649|FG000|Core Phase|Recovery|1|||
155723859|NCT02435212|562087650|FG001|Core Phase|Recovery|0|||
155723860|NCT02435212|562087649|FG000|Optional Extension Phase|Adverse Event|3|||
155723861|NCT02435212|562087650|FG001|Optional Extension Phase|Adverse Event|9|||
155723862|NCT02435212|562087649|FG000|Optional Extension Phase|Physician Decision|6|||
155723863|NCT02435212|562087650|FG001|Optional Extension Phase|Physician Decision|8|||
155723864|NCT02435212|562087649|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
155723865|NCT02435212|562087650|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
155723866|NCT02435212|562087649|FG000|Optional Extension Phase|Lack of Efficacy|2|||
155723867|NCT02435212|562087650|FG001|Optional Extension Phase|Lack of Efficacy|3|||
155723868|NCT02435212|562087649|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
155723869|NCT02435212|562087650|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
155723870|NCT02435212|562087649|FG000|Optional Extension Phase|Protocol Violation|0|||
155723871|NCT02435212|562087650|FG001|Optional Extension Phase|Protocol Violation|1|||
155723872|NCT02435212|562087649|FG000|Optional Extension Phase|Recovery|1|||
155723873|NCT02435212|562087650|FG001|Optional Extension Phase|Recovery|1|||
155723874|NCT02435212|562087649|FG000|Optional Extension Phase|Death|1|||
155723875|NCT02435212|562087650|FG001|Optional Extension Phase|Death|0|||
155723876|NCT02435212|562087649|FG000|Optional Extension Phase|Technical problems|2|||
155723877|NCT02435212|562087650|FG001|Optional Extension Phase|Technical problems|0|||
155723878|NCT04852302|562087651|FG000|Overall Study|Withdrawal by Subject|2|||
155723879|NCT04852302|562087651|FG000|Overall Study|Did not complete CALM therapy.|2|||
155723880|NCT04711850|562087652|FG000|Overall Study|Graft loss|2|||
155723881|NCT04711850|562087653|FG001|Overall Study|Graft loss|1|||
155723882|NCT04711850|562087652|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
155723883|NCT04711850|562087653|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
155723884|NCT04711850|562087652|FG000|Overall Study|Study terminated by sponsor|5|||
155723885|NCT04711850|562087653|FG001|Overall Study|Study terminated by sponsor|3|||
155723886|NCT04711850|562087652|FG000|Overall Study|Sponsor decision|0|||
155723887|NCT04711850|562087653|FG001|Overall Study|Sponsor decision|2|||
155723888|NCT05249582|562087654|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
155723889|NCT05249582|562087655|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
155723890|NCT05249582|562087654|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
155723891|NCT05249582|562087655|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
155723892|NCT05249582|562087654|FG000|Overall Study|Declined to use virtual reality headset|1|||
155723893|NCT05249582|562087655|FG001|Overall Study|Declined to use virtual reality headset|0|||
155723894|NCT03279081|562087673|FG000|Overall Study|Withdrawal by Subject|12|||
155723895|NCT03279081|562087674|FG001|Overall Study|Withdrawal by Subject|20|||
155723896|NCT03279081|562087673|FG000|Overall Study|Physician Decision|4|||
155723897|NCT03279081|562087674|FG001|Overall Study|Physician Decision|1|||
155723898|NCT03279081|562087673|FG000|Overall Study|Lost to Follow-up|8|||
155723899|NCT03279081|562087674|FG001|Overall Study|Lost to Follow-up|8|||
155723900|NCT03279081|562087673|FG000|Overall Study|Death|0|||
155723901|NCT03279081|562087674|FG001|Overall Study|Death|1|||
155723902|NCT03279081|562087673|FG000|Overall Study|Adverse Event|1|||
155723903|NCT03279081|562087674|FG001|Overall Study|Adverse Event|0|||
155723904|NCT03279081|562087673|FG000|Overall Study|Reason not Specified|14|||
155723905|NCT03279081|562087674|FG001|Overall Study|Reason not Specified|4|||
155723906|NCT00771914|562087677|FG000|Overall Study|Physician Decision|0|||
155723907|NCT00771914|562087678|FG001|Overall Study|Physician Decision|0|||
155723908|NCT00771914|562087679|FG002|Overall Study|Physician Decision|0|||
155723909|NCT00771914|562087680|FG003|Overall Study|Physician Decision|1|||
155723910|NCT00771914|562087677|FG000|Overall Study|Lost to Follow-up|0|||
155723911|NCT00771914|562087678|FG001|Overall Study|Lost to Follow-up|0|||
155723912|NCT00771914|562087679|FG002|Overall Study|Lost to Follow-up|0|||
155723913|NCT00771914|562087680|FG003|Overall Study|Lost to Follow-up|1|||
155723914|NCT04842747|562087681|FG000|Overall Study|Withdrawal by Subject|6|||
155723915|NCT04842747|562087682|FG001|Overall Study|Withdrawal by Subject|2|||
155723916|NCT04842747|562087681|FG000|Overall Study|Lost to Follow-up|1|||
155723917|NCT04842747|562087682|FG001|Overall Study|Lost to Follow-up|2|||
155723918|NCT04842747|562087681|FG000|Overall Study|Physician Decision|1|||
155723919|NCT04842747|562087682|FG001|Overall Study|Physician Decision|0|||
155723920|NCT04842747|562087681|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
155723921|NCT04842747|562087682|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
155723922|NCT01743469|562087683|FG000|Active Treatment Phase|Adverse Event|10|||
155723923|NCT01743469|562087684|FG001|Active Treatment Phase|Adverse Event|5|||
155723924|NCT01743469|562087685|FG002|Active Treatment Phase|Adverse Event|8|||
155723925|NCT01743469|562087686|FG003|Active Treatment Phase|Adverse Event|1|||
155723926|NCT01743469|562087683|FG000|Active Treatment Phase|Disease Progression|40|||
155723927|NCT01743469|562087684|FG001|Active Treatment Phase|Disease Progression|47|||
155723928|NCT01743469|562087685|FG002|Active Treatment Phase|Disease Progression|30|||
155723929|NCT01743469|562087686|FG003|Active Treatment Phase|Disease Progression|20|||
155723930|NCT01743469|562087683|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
155723931|NCT01743469|562087684|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
155723932|NCT01743469|562087685|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
155723933|NCT01743469|562087686|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
155723934|NCT01743469|562087683|FG000|Active Treatment Phase|Missing|1|||
155723935|NCT01743469|562087684|FG001|Active Treatment Phase|Missing|0|||
155723936|NCT01743469|562087685|FG002|Active Treatment Phase|Missing|0|||
155723937|NCT01743469|562087686|FG003|Active Treatment Phase|Missing|0|||
155723938|NCT01743469|562087683|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
155723939|NCT01743469|562087684|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
155723940|NCT01743469|562087685|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
155723941|NCT01743469|562087686|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
155723942|NCT01743469|562087683|FG000|Follow-up Period - Post-Treatment|Death|43|||
155723943|NCT01743469|562087684|FG001|Follow-up Period - Post-Treatment|Death|47|||
155723944|NCT01743469|562087685|FG002|Follow-up Period - Post-Treatment|Death|22|||
155723945|NCT01743469|562087686|FG003|Follow-up Period - Post-Treatment|Death|16|||
155723946|NCT01743469|562087683|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
155723947|NCT01743469|562087684|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
155723948|NCT01743469|562087685|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
155723949|NCT01743469|562087686|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
155723950|NCT00317473|562087687|FG000|Overall Study|Withdrawal by Subject|2|||
155723951|NCT00317473|562087688|FG001|Overall Study|Withdrawal by Subject|1|||
155723952|NCT00317473|562087689|FG002|Overall Study|Withdrawal by Subject|2|||
155723953|NCT00317473|562087690|FG003|Overall Study|Withdrawal by Subject|1|||
155723954|NCT00317473|562087691|FG004|Overall Study|Withdrawal by Subject|3|||
155723955|NCT00317473|562087692|FG005|Overall Study|Withdrawal by Subject|1|||
155723956|NCT00317473|562087687|FG000|Overall Study|Relocation|1|||
155723957|NCT00317473|562087688|FG001|Overall Study|Relocation|0|||
155723958|NCT00317473|562087689|FG002|Overall Study|Relocation|1|||
155723959|NCT00317473|562087690|FG003|Overall Study|Relocation|1|||
155723960|NCT00317473|562087691|FG004|Overall Study|Relocation|5|||
155723961|NCT00317473|562087692|FG005|Overall Study|Relocation|2|||
155723962|NCT00317473|562087687|FG000|Overall Study|Death|1|||
155723963|NCT00317473|562087688|FG001|Overall Study|Death|0|||
155723964|NCT00317473|562087689|FG002|Overall Study|Death|0|||
155723965|NCT00317473|562087690|FG003|Overall Study|Death|0|||
155723966|NCT00317473|562087691|FG004|Overall Study|Death|0|||
155723967|NCT00317473|562087692|FG005|Overall Study|Death|0|||
155723968|NCT00317473|562087687|FG000|Overall Study|Other|0|||
155723969|NCT00317473|562087688|FG001|Overall Study|Other|2|||
155723970|NCT00317473|562087689|FG002|Overall Study|Other|0|||
155723971|NCT00317473|562087690|FG003|Overall Study|Other|0|||
155723972|NCT00317473|562087691|FG004|Overall Study|Other|0|||
155723973|NCT00317473|562087692|FG005|Overall Study|Other|0|||
155723974|NCT02285855|562087693|FG000|Overall Study|Withdrawal by Subject|2|||
155723975|NCT02285855|562087694|FG001|Overall Study|Withdrawal by Subject|1|||
155723976|NCT01451606|562087699|FG000|Overall Study|Withdrawal by Subject|4|||
155723977|NCT01451606|562087700|FG001|Overall Study|Withdrawal by Subject|3|||
155723978|NCT02718898|562087701|FG000|Blinded Treatment Period|Adverse Event|5|||
155723979|NCT02718898|562087702|FG001|Blinded Treatment Period|Adverse Event|1|||
155723980|NCT02718898|562087703|FG002|Blinded Treatment Period|Adverse Event|0|||
155723981|NCT02718898|562087704|FG003|Blinded Treatment Period|Adverse Event|0|||
155723982|NCT02718898|562087705|FG004|Blinded Treatment Period|Adverse Event|0|||
155723983|NCT02718898|562087706|FG005|Blinded Treatment Period|Adverse Event|0|||
155723984|NCT02718898|562087707|FG006|Blinded Treatment Period|Adverse Event|0|||
155723985|NCT02718898|562087701|FG000|Blinded Treatment Period|Physician Decision|1|||
155723986|NCT02718898|562087702|FG001|Blinded Treatment Period|Physician Decision|0|||
155723987|NCT02718898|562087703|FG002|Blinded Treatment Period|Physician Decision|0|||
155723988|NCT02718898|562087704|FG003|Blinded Treatment Period|Physician Decision|0|||
155723989|NCT02718898|562087705|FG004|Blinded Treatment Period|Physician Decision|0|||
155723990|NCT02718898|562087706|FG005|Blinded Treatment Period|Physician Decision|0|||
155723991|NCT02718898|562087707|FG006|Blinded Treatment Period|Physician Decision|0|||
155723992|NCT02718898|562087701|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
155723993|NCT02718898|562087702|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
155723994|NCT02718898|562087703|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
155723995|NCT02718898|562087704|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
155723996|NCT02718898|562087705|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
155723997|NCT02718898|562087706|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
155723998|NCT02718898|562087707|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
155723999|NCT02718898|562087701|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
155724000|NCT02718898|562087702|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
155724001|NCT02718898|562087703|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
155724002|NCT02718898|562087704|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
155724003|NCT02718898|562087705|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
155724004|NCT02718898|562087706|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
155724005|NCT02718898|562087707|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
155724006|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155724007|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155724008|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
155724009|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
155724010|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155724011|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155724012|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155724013|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724014|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724015|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724016|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
155724017|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724018|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724019|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155724020|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724021|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724022|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155724023|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
155724024|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724025|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724026|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724027|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155724028|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155724029|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
155724030|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
155724031|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155724032|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155724033|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155724034|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724035|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724036|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724037|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
155724038|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724039|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724040|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155724041|NCT02718898|562087701|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155724042|NCT02718898|562087702|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155381475|NCT01049217|560830936|FG001|Overall Study|Lost to Follow-up|8|||
155381476|NCT01049217|560830935|FG000|Overall Study|Withdrawal by Subject|4|||
155381477|NCT01049217|560830936|FG001|Overall Study|Withdrawal by Subject|3|||
155381478|NCT01049217|560830935|FG000|Overall Study|Protocol Violation|1|||
155381479|NCT01049217|560830936|FG001|Overall Study|Protocol Violation|3|||
155381480|NCT01049217|560830935|FG000|Overall Study|Pregnancy|1|||
155381481|NCT01049217|560830936|FG001|Overall Study|Pregnancy|0|||
155381482|NCT01049217|560830935|FG000|Overall Study|Study Terminated by Sponsor|43|||
155724043|NCT02718898|562087703|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155724044|NCT02718898|562087704|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
155724045|NCT02718898|562087705|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155724046|NCT02718898|562087706|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155724047|NCT02718898|562087707|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155724048|NCT02718898|562087701|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
155724049|NCT02718898|562087702|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
155724050|NCT02718898|562087703|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
155724051|NCT02718898|562087704|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
155724052|NCT02718898|562087705|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
155724053|NCT02718898|562087706|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
155724054|NCT02718898|562087707|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
155724055|NCT02718898|562087701|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155724056|NCT02718898|562087702|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155724057|NCT02718898|562087703|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155724058|NCT02718898|562087704|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155724059|NCT02718898|562087705|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
155724060|NCT02718898|562087706|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
155724061|NCT02718898|562087707|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
155724062|NCT02718898|562087701|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155724063|NCT02718898|562087702|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155724064|NCT02718898|562087703|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155724065|NCT02718898|562087704|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155724066|NCT02718898|562087705|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155724067|NCT02718898|562087706|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
155724068|NCT02718898|562087707|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
155724069|NCT02163538|562087710|FG000|Overall Study|Protocol Violation|1|||
155724070|NCT02163538|562087711|FG001|Overall Study|Protocol Violation|0|||
155724071|NCT02163538|562087710|FG000|Overall Study|Physician Decision|0|||
155724072|NCT02163538|562087711|FG001|Overall Study|Physician Decision|1|||
155724073|NCT04011540|562087712|FG000|Overall Study|Lost to Follow-up|9|||
155724074|NCT04011540|562087713|FG001|Overall Study|Lost to Follow-up|6|||
155724075|NCT01126749|562087715|FG000|Phase 1b|Other|0|||
155724076|NCT01126749|562087716|FG001|Phase 1b|Other|1|||
155724077|NCT01126749|562087717|FG002|Phase 1b|Other|0|||
155724078|NCT01126749|562087718|FG003|Phase 1b|Other|0|||
155724079|NCT01126749|562087715|FG000|Phase 1b|Withdrawal by Subject|0|||
155724080|NCT01126749|562087716|FG001|Phase 1b|Withdrawal by Subject|1|||
155724081|NCT01126749|562087717|FG002|Phase 1b|Withdrawal by Subject|0|||
155724082|NCT01126749|562087718|FG003|Phase 1b|Withdrawal by Subject|0|||
155724083|NCT01126749|562087715|FG000|Phase 1b|Death|3|||
155724084|NCT01126749|562087716|FG001|Phase 1b|Death|4|||
155724085|NCT01126749|562087717|FG002|Phase 1b|Death|0|||
155724086|NCT01126749|562087718|FG003|Phase 1b|Death|0|||
155724087|NCT01126749|562087715|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
155724088|NCT01126749|562087716|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
155724089|NCT01126749|562087717|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
155724090|NCT01126749|562087718|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
155724091|NCT01126749|562087715|FG000|Phase 2|Study Termination by Sponsor|0|||
155724092|NCT01126749|562087716|FG001|Phase 2|Study Termination by Sponsor|0|||
155724093|NCT01126749|562087717|FG002|Phase 2|Study Termination by Sponsor|12|||
155724094|NCT01126749|562087718|FG003|Phase 2|Study Termination by Sponsor|6|||
155724095|NCT01126749|562087715|FG000|Phase 2|Other|0|||
155724096|NCT01126749|562087716|FG001|Phase 2|Other|0|||
155724097|NCT01126749|562087717|FG002|Phase 2|Other|4|||
155724098|NCT01126749|562087718|FG003|Phase 2|Other|2|||
155724099|NCT01126749|562087715|FG000|Phase 2|Withdrawal by Subject|0|||
155724100|NCT01126749|562087716|FG001|Phase 2|Withdrawal by Subject|0|||
155724101|NCT01126749|562087717|FG002|Phase 2|Withdrawal by Subject|0|||
155724102|NCT01126749|562087718|FG003|Phase 2|Withdrawal by Subject|2|||
155724103|NCT01126749|562087715|FG000|Phase 2|Lost to Follow-up|0|||
155724104|NCT01126749|562087716|FG001|Phase 2|Lost to Follow-up|0|||
155724105|NCT01126749|562087717|FG002|Phase 2|Lost to Follow-up|0|||
155724106|NCT01126749|562087718|FG003|Phase 2|Lost to Follow-up|1|||
155724107|NCT01126749|562087715|FG000|Phase 2|Death|0|||
155724108|NCT01126749|562087716|FG001|Phase 2|Death|0|||
155381483|NCT01049217|560830936|FG001|Overall Study|Study Terminated by Sponsor|43|||
155724109|NCT01126749|562087717|FG002|Phase 2|Death|22|||
155724110|NCT01126749|562087718|FG003|Phase 2|Death|22|||
155610872|NCT01421147|561668485|FG001|Treatment Period|Adverse Event|3|||
155610873|NCT01421147|561668484|FG000|Treatment Period|Lost to Follow-up|2|||
155610874|NCT01421147|561668485|FG001|Treatment Period|Lost to Follow-up|1|||
155610875|NCT01421147|561668484|FG000|Treatment Period|Physician Decision|2|||
155610876|NCT01421147|561668485|FG001|Treatment Period|Physician Decision|2|||
155610877|NCT01421147|561668484|FG000|Treatment Period|Withdrawal by Subject|10|||
155610878|NCT01421147|561668485|FG001|Treatment Period|Withdrawal by Subject|5|||
155610879|NCT01421147|561668484|FG000|Extension Period|Adverse Event|0|||
155610880|NCT01421147|561668485|FG001|Extension Period|Adverse Event|2|||
155610881|NCT01421147|561668484|FG000|Extension Period|Death|0|||
155610882|NCT01421147|561668485|FG001|Extension Period|Death|1|||
155610883|NCT01421147|561668484|FG000|Extension Period|Lost to Follow-up|2|||
155610884|NCT01421147|561668485|FG001|Extension Period|Lost to Follow-up|5|||
155610885|NCT01421147|561668484|FG000|Extension Period|Physician Decision|1|||
155610886|NCT01421147|561668485|FG001|Extension Period|Physician Decision|0|||
155724111|NCT01126749|562087715|FG000|Phase 2|Adverse Event|0|||
155724112|NCT01126749|562087716|FG001|Phase 2|Adverse Event|0|||
155724113|NCT01126749|562087717|FG002|Phase 2|Adverse Event|0|||
155724114|NCT01126749|562087718|FG003|Phase 2|Adverse Event|1|||
155724115|NCT00976274|562087720|FG000|Overall Study|Lost to Follow-up|5|||
155724116|NCT00976274|562087721|FG001|Overall Study|Lost to Follow-up|5|||
155724117|NCT00976274|562087720|FG000|Overall Study|Withdrawal by Subject|1|||
155724118|NCT00976274|562087721|FG001|Overall Study|Withdrawal by Subject|1|||
155724119|NCT00976274|562087720|FG000|Overall Study|Physician Decision|1|||
155724120|NCT00976274|562087721|FG001|Overall Study|Physician Decision|2|||
155724121|NCT00627393|562087722|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
155724122|NCT00627393|562087723|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
155724123|NCT00627393|562087722|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
155724124|NCT00627393|562087723|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
155724125|NCT00627393|562087722|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
155724126|NCT00627393|562087723|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
155724127|NCT00627393|562087722|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
155724128|NCT00627393|562087723|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
155724129|NCT05194124|562087724|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724130|NCT05194124|562087725|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724131|NCT05194124|562087726|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724132|NCT05194124|562087727|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
155724133|NCT05194124|562087728|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724134|NCT05194124|562087729|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
155724135|NCT05194124|562087730|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724136|NCT05194124|562087731|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724137|NCT05194124|562087732|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724138|NCT05194124|562087733|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155724139|NCT05194124|562087724|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724140|NCT05194124|562087725|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724141|NCT05194124|562087726|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724142|NCT05194124|562087727|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724143|NCT05194124|562087728|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724144|NCT05194124|562087729|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724145|NCT05194124|562087730|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724146|NCT05194124|562087731|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724147|NCT05194124|562087732|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155724148|NCT05194124|562087733|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
155724149|NCT03694353|562087736|FG000|Overall Study|Withdrawal by Subject|1|||
155724150|NCT03694353|562087736|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
155724151|NCT03804528|562087737|FG000|Overall Study|Time Commitment|18|||
155724152|NCT03804528|562087737|FG000|Overall Study|Health Reasons|5|||
155724153|NCT05138653|562087740|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
155724154|NCT05138653|562087741|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724155|NCT05138653|562087742|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724156|NCT05138653|562087743|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724157|NCT05138653|562087744|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724158|NCT05138653|562087745|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724159|NCT05138653|562087746|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724160|NCT05138653|562087747|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724161|NCT05138653|562087748|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155610887|NCT01421147|561668484|FG000|Extension Period|Withdrawal by Subject|5|||
155610888|NCT01421147|561668485|FG001|Extension Period|Withdrawal by Subject|3|||
155610889|NCT00171158|561668488|FG000|Core Study|Death|27|||
155610890|NCT00171158|561668488|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
155610891|NCT00171158|561668488|FG000|Core Study|Protocol Violation|4|||
155610892|NCT00171158|561668488|FG000|Core Study|Administrative problems|1|||
155610893|NCT00171158|561668488|FG000|Core Study|Adverse event, non-fatal|21|||
155610894|NCT00171158|561668488|FG000|Core Study|Consent withdrawn by subject|6|||
155610895|NCT00171158|561668488|FG000|Core Study|No longer required drug (BMT)|14|||
155610896|NCT00171158|561668488|FG000|Core Study|Abnormal Laboratory Values|2|||
155610897|NCT00171158|561668488|FG000|Core Study|Lost to Follow-up|1|||
155610898|NCT00171158|561668488|FG000|E2 Extension|Other|7|||
155610899|NCT03630705|561668489|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
155610900|NCT03630705|561668490|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
155610901|NCT03630705|561668491|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155610902|NCT03630705|561668492|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155610903|NCT03630705|561668489|FG000|Overall Study|Lost to Follow-up|1|||
155610904|NCT03630705|561668490|FG001|Overall Study|Lost to Follow-up|2|||
155610905|NCT03630705|561668491|FG002|Overall Study|Lost to Follow-up|0|||
155610906|NCT03630705|561668492|FG003|Overall Study|Lost to Follow-up|0|||
155610907|NCT02757352|561668493|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
155610908|NCT02757352|561668494|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610909|NCT02757352|561668495|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
155610910|NCT02757352|561668496|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610911|NCT02757352|561668497|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610912|NCT02757352|561668498|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610913|NCT02757352|561668499|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610914|NCT02757352|561668500|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610915|NCT02757352|561668501|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610916|NCT02757352|561668502|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155610917|NCT02757352|561668493|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610918|NCT02757352|561668494|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610919|NCT02757352|561668495|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
155610920|NCT02757352|561668496|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610921|NCT02757352|561668497|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610922|NCT02757352|561668498|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610923|NCT02757352|561668499|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610924|NCT02757352|561668500|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610925|NCT02757352|561668501|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610926|NCT02757352|561668502|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155610927|NCT02757352|561668493|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
155610928|NCT02757352|561668494|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
155610929|NCT02757352|561668495|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
155610930|NCT02757352|561668496|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610931|NCT02757352|561668497|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610932|NCT02757352|561668498|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610933|NCT02757352|561668499|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610934|NCT02757352|561668500|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610935|NCT02757352|561668501|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610936|NCT02757352|561668502|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155610937|NCT02757352|561668493|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610938|NCT02757352|561668494|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
155610939|NCT02757352|561668495|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610940|NCT02757352|561668496|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610941|NCT02757352|561668497|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610942|NCT02757352|561668498|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610943|NCT02757352|561668499|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610944|NCT02757352|561668500|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610945|NCT02757352|561668501|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610946|NCT02757352|561668502|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155610947|NCT02757352|561668493|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610948|NCT02757352|561668494|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155610949|NCT02757352|561668495|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610950|NCT02757352|561668496|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610951|NCT02757352|561668497|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610952|NCT02757352|561668498|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610953|NCT02757352|561668499|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610954|NCT02757352|561668500|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610955|NCT02757352|561668501|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610956|NCT02757352|561668502|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610957|NCT02757352|561668493|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155724162|NCT05138653|562087749|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724163|NCT05138653|562087750|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724164|NCT05138653|562087751|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724165|NCT05138653|562087752|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724166|NCT05138653|562087753|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724167|NCT05138653|562087754|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724168|NCT05138653|562087755|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155724169|NCT05138653|562087740|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724170|NCT05138653|562087741|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
155724171|NCT05138653|562087742|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724172|NCT05138653|562087743|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724173|NCT05138653|562087744|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724174|NCT05138653|562087745|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724175|NCT05138653|562087746|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724176|NCT05138653|562087747|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724177|NCT05138653|562087748|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
155724178|NCT05138653|562087749|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724179|NCT05138653|562087750|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724180|NCT05138653|562087751|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724181|NCT05138653|562087752|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724182|NCT05138653|562087753|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724183|NCT05138653|562087754|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155724184|NCT05138653|562087755|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155381484|NCT01049217|560830935|FG000|Overall Study|Other|1|||
155381485|NCT01049217|560830936|FG001|Overall Study|Other|2|||
155381486|NCT01049217|560830935|FG000|Overall Study|Randomized but not Treated|0|||
155381487|NCT01049217|560830936|FG001|Overall Study|Randomized but not Treated|2|||
155381488|NCT00589121|560830937|FG000|Overall Study|Protocol Violation|2|||
155381489|NCT00589121|560830938|FG001|Overall Study|Protocol Violation|6|||
155381490|NCT00589121|560830937|FG000|Overall Study|No protocol treatment received|0|||
155381491|NCT00589121|560830938|FG001|Overall Study|No protocol treatment received|1|||
155381492|NCT02412371|560830939|FG000|Overall Study|Withdrawal by Subject|0|||
155381493|NCT02412371|560830940|FG001|Overall Study|Withdrawal by Subject|2|||
155381494|NCT02412371|560830941|FG002|Overall Study|Withdrawal by Subject|0|||
155381495|NCT02412371|560830942|FG003|Overall Study|Withdrawal by Subject|1|||
155381496|NCT02412371|560830943|FG004|Overall Study|Withdrawal by Subject|1|||
155381497|NCT02412371|560830944|FG005|Overall Study|Withdrawal by Subject|0|||
155381498|NCT02412371|560830939|FG000|Overall Study|Sponsor Discontinued Study|1|||
155381499|NCT02412371|560830940|FG001|Overall Study|Sponsor Discontinued Study|4|||
155381500|NCT02412371|560830941|FG002|Overall Study|Sponsor Discontinued Study|6|||
155381501|NCT02412371|560830942|FG003|Overall Study|Sponsor Discontinued Study|4|||
155381502|NCT02412371|560830943|FG004|Overall Study|Sponsor Discontinued Study|5|||
155381503|NCT02412371|560830944|FG005|Overall Study|Sponsor Discontinued Study|0|||
155381504|NCT02412371|560830939|FG000|Overall Study|Death|4|||
155381505|NCT02412371|560830940|FG001|Overall Study|Death|2|||
155381506|NCT02412371|560830941|FG002|Overall Study|Death|1|||
155381507|NCT02412371|560830942|FG003|Overall Study|Death|3|||
155381508|NCT02412371|560830943|FG004|Overall Study|Death|5|||
155381509|NCT02412371|560830944|FG005|Overall Study|Death|2|||
155381510|NCT02412371|560830939|FG000|Overall Study|Other|2|||
155381511|NCT02412371|560830940|FG001|Overall Study|Other|1|||
155381512|NCT02412371|560830941|FG002|Overall Study|Other|0|||
155381513|NCT02412371|560830942|FG003|Overall Study|Other|0|||
155381514|NCT02412371|560830943|FG004|Overall Study|Other|1|||
155381515|NCT02412371|560830944|FG005|Overall Study|Other|3|||
155381516|NCT00847808|560830945|FG000|Overall Study|Adverse Event|7|||
155381517|NCT00847808|560830945|FG000|Overall Study|Protocol Violation|1|||
155381518|NCT00847808|560830945|FG000|Overall Study|Lost to Follow-up|1|||
155381519|NCT00847808|560830945|FG000|Overall Study|Withdrawal by Subject|4|||
155381520|NCT00847808|560830945|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
155381521|NCT00847808|560830945|FG000|Overall Study|Participant Took Excluded Medication|1|||
155381522|NCT05000931|560830954|FG000|Overall Study|Lost to Follow-up|1|||
155724185|NCT05138653|562087740|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724186|NCT05138653|562087741|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
155381523|NCT00925132|560830955|FG000|Overall Study|Withdrawal by Subject|2|||
155381524|NCT00925132|560830956|FG001|Overall Study|Withdrawal by Subject|0|||
155381525|NCT00925132|560830957|FG002|Overall Study|Withdrawal by Subject|0|||
155381526|NCT00925132|560830958|FG003|Overall Study|Withdrawal by Subject|0|||
155381527|NCT00925132|560830959|FG004|Overall Study|Withdrawal by Subject|1|||
155381528|NCT00925132|560830955|FG000|Overall Study|Removed due to disease progression|0|||
155381529|NCT00925132|560830956|FG001|Overall Study|Removed due to disease progression|0|||
155381530|NCT00925132|560830957|FG002|Overall Study|Removed due to disease progression|0|||
155610958|NCT02757352|561668494|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155610959|NCT02757352|561668495|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
155610960|NCT02757352|561668496|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610961|NCT02757352|561668497|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610962|NCT02757352|561668498|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610963|NCT02757352|561668499|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610964|NCT02757352|561668500|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610965|NCT02757352|561668501|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610966|NCT02757352|561668502|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155610967|NCT02757352|561668493|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
155610968|NCT02757352|561668494|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
155610969|NCT02757352|561668495|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
155610970|NCT02757352|561668496|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610971|NCT02757352|561668497|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610972|NCT02757352|561668498|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610973|NCT02757352|561668499|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610974|NCT02757352|561668500|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610975|NCT02757352|561668501|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610976|NCT02757352|561668502|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155610977|NCT02757352|561668493|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610978|NCT02757352|561668494|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610979|NCT02757352|561668495|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610980|NCT02757352|561668496|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
155610981|NCT02757352|561668497|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610982|NCT02757352|561668498|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
155610983|NCT02757352|561668499|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610984|NCT02757352|561668500|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610985|NCT02757352|561668501|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610986|NCT02757352|561668502|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155610987|NCT02757352|561668493|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610988|NCT02757352|561668494|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610989|NCT02757352|561668495|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610990|NCT02757352|561668496|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
155610991|NCT02757352|561668497|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155610992|NCT02757352|561668498|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
155610993|NCT02757352|561668499|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610994|NCT02757352|561668500|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610995|NCT02757352|561668501|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610996|NCT02757352|561668502|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155610997|NCT02757352|561668493|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155610998|NCT02757352|561668494|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155610999|NCT02757352|561668495|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611000|NCT02757352|561668496|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611001|NCT02757352|561668497|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
155611002|NCT02757352|561668498|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611003|NCT02757352|561668499|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611004|NCT02757352|561668500|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611005|NCT02757352|561668501|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611006|NCT02757352|561668502|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155611007|NCT02757352|561668493|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611008|NCT02757352|561668494|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611009|NCT02757352|561668495|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611010|NCT02757352|561668496|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611011|NCT02757352|561668497|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611012|NCT02757352|561668498|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
155611013|NCT02757352|561668499|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611014|NCT02757352|561668500|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611015|NCT02757352|561668501|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611016|NCT02757352|561668502|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155611017|NCT02757352|561668493|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611018|NCT02757352|561668494|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155724187|NCT05138653|562087742|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724188|NCT05138653|562087743|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724189|NCT05138653|562087744|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
155724190|NCT05138653|562087745|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724191|NCT05138653|562087746|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724192|NCT05138653|562087747|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724193|NCT05138653|562087748|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724194|NCT05138653|562087749|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724195|NCT05138653|562087750|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724196|NCT05138653|562087751|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724197|NCT05138653|562087752|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724198|NCT05138653|562087753|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724199|NCT05138653|562087754|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724200|NCT05138653|562087755|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155724201|NCT05138653|562087740|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724202|NCT05138653|562087741|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724203|NCT05138653|562087742|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724204|NCT05138653|562087743|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724205|NCT05138653|562087744|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724206|NCT05138653|562087745|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724207|NCT05138653|562087746|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
155724208|NCT05138653|562087747|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724209|NCT05138653|562087748|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724210|NCT05138653|562087749|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724211|NCT05138653|562087750|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724212|NCT05138653|562087751|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724213|NCT05138653|562087752|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724214|NCT05138653|562087753|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724215|NCT05138653|562087754|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724216|NCT05138653|562087755|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155724217|NCT05138653|562087740|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724218|NCT05138653|562087741|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724219|NCT05138653|562087742|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724220|NCT05138653|562087743|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724221|NCT05138653|562087744|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724222|NCT05138653|562087745|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724223|NCT05138653|562087746|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724224|NCT05138653|562087747|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724225|NCT05138653|562087748|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724226|NCT05138653|562087749|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724227|NCT05138653|562087750|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155724228|NCT05138653|562087751|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724229|NCT05138653|562087752|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155724230|NCT05138653|562087753|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724231|NCT05138653|562087754|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155724232|NCT05138653|562087755|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155724233|NCT05138653|562087740|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724234|NCT05138653|562087741|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724235|NCT05138653|562087742|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724236|NCT05138653|562087743|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724237|NCT05138653|562087744|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724238|NCT05138653|562087745|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724239|NCT05138653|562087746|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724240|NCT05138653|562087747|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724241|NCT05138653|562087748|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724242|NCT05138653|562087749|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724243|NCT05138653|562087750|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724244|NCT05138653|562087751|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724245|NCT05138653|562087752|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724246|NCT05138653|562087753|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724247|NCT05138653|562087754|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155724248|NCT05138653|562087755|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
155724249|NCT05138653|562087740|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724250|NCT05138653|562087741|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155493764|NCT01100073|561232646|FG000|Overall Study|Lack of Efficacy|4|||
155724251|NCT05138653|562087742|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724252|NCT05138653|562087743|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724253|NCT05138653|562087744|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724254|NCT05138653|562087745|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724255|NCT05138653|562087746|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724256|NCT05138653|562087747|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724257|NCT05138653|562087748|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724258|NCT05138653|562087749|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724259|NCT05138653|562087750|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724260|NCT05138653|562087751|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724261|NCT05138653|562087752|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724262|NCT05138653|562087753|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
155724263|NCT05138653|562087754|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724264|NCT05138653|562087755|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155724265|NCT04607005|562087756|FG000|Overall Study|Adverse Event|0|||
155611019|NCT02757352|561668495|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611020|NCT02757352|561668496|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
155611021|NCT02757352|561668497|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155611022|NCT02757352|561668498|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155611023|NCT02757352|561668499|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611024|NCT02757352|561668500|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611025|NCT02757352|561668501|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611026|NCT02757352|561668502|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155611027|NCT02757352|561668493|FG000|Follow-Up Period|Adverse Event|0|||
155611028|NCT02757352|561668494|FG001|Follow-Up Period|Adverse Event|0|||
155611029|NCT02757352|561668495|FG002|Follow-Up Period|Adverse Event|0|||
155611030|NCT02757352|561668496|FG003|Follow-Up Period|Adverse Event|0|||
155611031|NCT02757352|561668497|FG004|Follow-Up Period|Adverse Event|0|||
155611032|NCT02757352|561668498|FG005|Follow-Up Period|Adverse Event|0|||
155611033|NCT02757352|561668499|FG006|Follow-Up Period|Adverse Event|1|||
155611034|NCT02757352|561668500|FG007|Follow-Up Period|Adverse Event|0|||
155611035|NCT02757352|561668501|FG008|Follow-Up Period|Adverse Event|2|||
155611036|NCT02757352|561668502|FG009|Follow-Up Period|Adverse Event|0|||
155611037|NCT02757352|561668493|FG000|Follow-Up Period|Lost to Follow-up|0|||
155611038|NCT02757352|561668494|FG001|Follow-Up Period|Lost to Follow-up|0|||
155611039|NCT02757352|561668495|FG002|Follow-Up Period|Lost to Follow-up|0|||
155611040|NCT02757352|561668496|FG003|Follow-Up Period|Lost to Follow-up|0|||
155611041|NCT02757352|561668497|FG004|Follow-Up Period|Lost to Follow-up|0|||
155611042|NCT02757352|561668498|FG005|Follow-Up Period|Lost to Follow-up|0|||
155611043|NCT02757352|561668499|FG006|Follow-Up Period|Lost to Follow-up|0|||
155611044|NCT02757352|561668500|FG007|Follow-Up Period|Lost to Follow-up|0|||
155611045|NCT02757352|561668501|FG008|Follow-Up Period|Lost to Follow-up|1|||
155611046|NCT02757352|561668502|FG009|Follow-Up Period|Lost to Follow-up|0|||
155611047|NCT02757352|561668493|FG000|Follow-Up Period|Lack of Efficacy|0|||
155611048|NCT02757352|561668494|FG001|Follow-Up Period|Lack of Efficacy|0|||
155611049|NCT02757352|561668495|FG002|Follow-Up Period|Lack of Efficacy|0|||
155611050|NCT02757352|561668496|FG003|Follow-Up Period|Lack of Efficacy|0|||
155611051|NCT02757352|561668497|FG004|Follow-Up Period|Lack of Efficacy|0|||
155611052|NCT02757352|561668498|FG005|Follow-Up Period|Lack of Efficacy|0|||
155724266|NCT04607005|562087757|FG001|Overall Study|Adverse Event|1|||
155724267|NCT04607005|562087756|FG000|Overall Study|Lack of Efficacy|1|||
155724268|NCT04607005|562087757|FG001|Overall Study|Lack of Efficacy|6|||
155724269|NCT04607005|562087756|FG000|Overall Study|Withdrawal by Subject|4|||
155724270|NCT04607005|562087757|FG001|Overall Study|Withdrawal by Subject|9|||
155724271|NCT04607005|562087756|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
155611053|NCT02757352|561668499|FG006|Follow-Up Period|Lack of Efficacy|0|||
155611054|NCT02757352|561668500|FG007|Follow-Up Period|Lack of Efficacy|0|||
155611055|NCT02757352|561668501|FG008|Follow-Up Period|Lack of Efficacy|1|||
155724272|NCT04607005|562087757|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
155724273|NCT02331134|562087758|FG000|Overall Study|Withdrawal by Subject|1|||
155611056|NCT02757352|561668502|FG009|Follow-Up Period|Lack of Efficacy|1|||
155611057|NCT02757352|561668493|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155611058|NCT02757352|561668494|FG001|Follow-Up Period|Withdrawal by Subject|0|||
155611059|NCT02757352|561668495|FG002|Follow-Up Period|Withdrawal by Subject|0|||
155611060|NCT02757352|561668496|FG003|Follow-Up Period|Withdrawal by Subject|0|||
155611061|NCT02757352|561668497|FG004|Follow-Up Period|Withdrawal by Subject|0|||
155611062|NCT02757352|561668498|FG005|Follow-Up Period|Withdrawal by Subject|0|||
155611063|NCT02757352|561668499|FG006|Follow-Up Period|Withdrawal by Subject|0|||
155724274|NCT04825574|562087759|FG000|Overall Study|Commercial treatment became available|1|||
155724275|NCT04825574|562087759|FG000|Overall Study|Disease progression|1|||
155724276|NCT05967260|562087760|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
155724277|NCT05967260|562087761|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
155724278|NCT05565742|562087762|FG000|Overall Study|Withdrawal by Subject|0|||
155724279|NCT05565742|562087763|FG001|Overall Study|Withdrawal by Subject|0|||
155724280|NCT05565742|562087764|FG002|Overall Study|Withdrawal by Subject|2|||
155724281|NCT05565742|562087765|FG003|Overall Study|Withdrawal by Subject|2|||
155724282|NCT05565742|562087766|FG004|Overall Study|Withdrawal by Subject|2|||
155724283|NCT05565742|562087762|FG000|Overall Study|Death|1|||
155724284|NCT05565742|562087763|FG001|Overall Study|Death|0|||
155724285|NCT05565742|562087764|FG002|Overall Study|Death|0|||
155724286|NCT05565742|562087765|FG003|Overall Study|Death|0|||
155724287|NCT05565742|562087766|FG004|Overall Study|Death|0|||
155724288|NCT05565742|562087762|FG000|Overall Study|Participant Travelled Abroad|0|||
155724289|NCT05565742|562087763|FG001|Overall Study|Participant Travelled Abroad|0|||
155724290|NCT05565742|562087764|FG002|Overall Study|Participant Travelled Abroad|0|||
155724291|NCT05565742|562087765|FG003|Overall Study|Participant Travelled Abroad|0|||
155724292|NCT05565742|562087766|FG004|Overall Study|Participant Travelled Abroad|1|||
155724293|NCT04163341|562087767|FG000|Overall Study|Withdrawal by Subject|2|||
155724294|NCT04163341|562087768|FG001|Overall Study|Withdrawal by Subject|0|||
155724295|NCT04163341|562087767|FG000|Overall Study|Lost to Follow-up|3|||
155724296|NCT04163341|562087768|FG001|Overall Study|Lost to Follow-up|4|||
155724297|NCT00079417|562089656|FG000|Overall Study|Physician Decision|2|||
155724298|NCT00079417|562089656|FG000|Overall Study|Ineligible|7|||
155724299|NCT01615939|562089657|FG000|Overall Study|Lost to Follow-up|5|||
155724300|NCT01615939|562089658|FG001|Overall Study|Lost to Follow-up|0|||
155724301|NCT01586364|562089662|FG000|Overall Study|Withdrawal by Subject|40|||
155724302|NCT01586364|562089662|FG000|Overall Study|Adverse Event|37|||
155724303|NCT01586364|562089662|FG000|Overall Study|Lost to Follow-up|17|||
155724304|NCT01586364|562089662|FG000|Overall Study|Protocol Violation|16|||
155724305|NCT01586364|562089662|FG000|Overall Study|Lack of Efficacy|1|||
155724306|NCT01586364|562089662|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
155724307|NCT01586364|562089662|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
155724308|NCT01586364|562089662|FG000|Overall Study|Other-Site closure due to PI illness|1|||
155724309|NCT01586364|562089662|FG000|Overall Study|Other-PI discretion, site closing|2|||
155724310|NCT01586364|562089662|FG000|Overall Study|Other-Not specified|1|||
155724311|NCT02121535|562089663|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
155724312|NCT02121535|562089664|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
155724313|NCT02121535|562089663|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
155724314|NCT02121535|562089664|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
155724315|NCT04944992|562089665|FG000|Overall Study|Lost to Follow-up|1|||
155724316|NCT04944992|562089666|FG001|Overall Study|Lost to Follow-up|1|||
155724317|NCT04944992|562089665|FG000|Overall Study|Physician Decision|1|||
155724318|NCT04944992|562089666|FG001|Overall Study|Physician Decision|0|||
155724319|NCT04944992|562089665|FG000|Overall Study|Withdrawal by Subject|6|||
155724320|NCT04944992|562089666|FG001|Overall Study|Withdrawal by Subject|1|||
155724321|NCT00091949|562089667|FG000|Overall Study|Withdrawal by Subject|117|||
155724322|NCT00091949|562089668|FG001|Overall Study|Withdrawal by Subject|110|||
155724323|NCT00091949|562089667|FG000|Overall Study|Lost to Follow-up|58|||
155724324|NCT00091949|562089668|FG001|Overall Study|Lost to Follow-up|41|||
155724325|NCT00303069|562089669|FG000|Overall Study|Lost to Follow-up|1|||
155724326|NCT00303069|562089670|FG001|Overall Study|Lost to Follow-up|0|||
155724327|NCT00303069|562089671|FG002|Overall Study|Lost to Follow-up|0|||
155724328|NCT00303069|562089672|FG003|Overall Study|Lost to Follow-up|2|||
155724329|NCT00303069|562089669|FG000|Overall Study|subject moved|1|||
155724330|NCT00303069|562089670|FG001|Overall Study|subject moved|0|||
155724331|NCT00303069|562089671|FG002|Overall Study|subject moved|0|||
155724332|NCT00303069|562089672|FG003|Overall Study|subject moved|0|||
155724333|NCT00303069|562089669|FG000|Overall Study|Recruitment into Army Reserves|0|||
155724334|NCT00303069|562089670|FG001|Overall Study|Recruitment into Army Reserves|0|||
155724335|NCT00303069|562089671|FG002|Overall Study|Recruitment into Army Reserves|1|||
155724336|NCT00303069|562089672|FG003|Overall Study|Recruitment into Army Reserves|0|||
155724337|NCT01520506|562089673|FG000|Overall Study|Missed Visit|4|||
155724338|NCT01520506|562089673|FG000|Overall Study|Lost to Follow-up|1|||
155724339|NCT01520506|562089673|FG000|Overall Study|Withdrawal by Subject|1|||
155724340|NCT01256788|562089678|FG000|Overall Study|Lost to Follow-up|5|||
155724341|NCT01256788|562089679|FG001|Overall Study|Lost to Follow-up|8|||
155724342|NCT01256788|562089680|FG002|Overall Study|Lost to Follow-up|3|||
155724343|NCT01972217|562089681|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155724344|NCT01972217|562089682|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
155724345|NCT01972217|562089683|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155724346|NCT01972217|562089684|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155724347|NCT01972217|562089681|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
155724348|NCT01972217|562089682|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
155724349|NCT01972217|562089683|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
155724350|NCT01972217|562089684|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
155724351|NCT01972217|562089681|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155724352|NCT01972217|562089682|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
155724353|NCT01972217|562089683|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155724354|NCT01972217|562089684|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155724355|NCT01972217|562089681|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
155724356|NCT01972217|562089682|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
155724357|NCT01972217|562089683|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
155724358|NCT01972217|562089684|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
155724359|NCT01972217|562089681|FG000|Part B Double-blind, Randomised Period|Death|0|||
155724360|NCT01972217|562089682|FG001|Part B Double-blind, Randomised Period|Death|0|||
155724361|NCT01972217|562089683|FG002|Part B Double-blind, Randomised Period|Death|43|||
155724362|NCT01972217|562089684|FG003|Part B Double-blind, Randomised Period|Death|44|||
155724363|NCT01972217|562089681|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155724364|NCT01972217|562089682|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155724365|NCT01972217|562089683|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
155724366|NCT01972217|562089684|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155724367|NCT01972217|562089681|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
155724368|NCT01972217|562089682|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
155724369|NCT01972217|562089683|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
155724370|NCT01972217|562089684|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
155724371|NCT01972217|562089681|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
155724372|NCT01972217|562089682|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
155381531|NCT00925132|560830958|FG003|Overall Study|Removed due to disease progression|0|||
155381532|NCT00925132|560830959|FG004|Overall Study|Removed due to disease progression|4|||
155381533|NCT02545933|560830960|FG000|Overall Study|Adverse Event|3|||
155381534|NCT02545933|560830961|FG001|Overall Study|Adverse Event|0|||
155381535|NCT02545933|560830962|FG002|Overall Study|Adverse Event|0|||
155381536|NCT02545933|560830960|FG000|Overall Study|Withdrawal by Subject|2|||
155381537|NCT02545933|560830961|FG001|Overall Study|Withdrawal by Subject|3|||
155381538|NCT02545933|560830962|FG002|Overall Study|Withdrawal by Subject|3|||
155381539|NCT02545933|560830960|FG000|Overall Study|Protocol Violation|1|||
155381540|NCT02545933|560830961|FG001|Overall Study|Protocol Violation|0|||
155381541|NCT02545933|560830962|FG002|Overall Study|Protocol Violation|1|||
155381542|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Death|0|||
155381543|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Death|0|||
155381544|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Death|0|||
155381545|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Death|1|||
155381546|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Death|2|||
155381547|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Death|1|||
155381548|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Death|1|||
155381549|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Death|2|||
155381550|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Death|4|||
155381551|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Death|1|||
155381552|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Death|0|||
155381553|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Death|0|||
155381554|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Death|1|||
155381555|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381556|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381557|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381558|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381559|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381560|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381561|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381562|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
155381563|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381564|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381565|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381566|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381567|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
155381568|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381569|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381570|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381571|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
155381572|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155381573|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
155381574|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155724373|NCT01972217|562089683|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
155724374|NCT01972217|562089684|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
155724375|NCT01972217|562089681|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155724376|NCT01972217|562089682|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155724377|NCT01972217|562089683|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155724378|NCT01972217|562089684|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
155724379|NCT05366738|562089685|FG000|Overall Study|Adverse Event|0|||
155724380|NCT05366738|562089686|FG001|Overall Study|Adverse Event|1|||
155724381|NCT05366738|562089687|FG002|Overall Study|Adverse Event|0|||
155724382|NCT04639245|562089690|FG000|Overall Study|Death|1|||
155611064|NCT02757352|561668500|FG007|Follow-Up Period|Withdrawal by Subject|1|||
155611065|NCT02757352|561668501|FG008|Follow-Up Period|Withdrawal by Subject|6|||
155611066|NCT02757352|561668502|FG009|Follow-Up Period|Withdrawal by Subject|2|||
155611067|NCT03536663|561668503|FG000|Endexo|Protocol Violation|1|||
155611068|NCT04750278|561668504|FG000|Overall Study|Death|9|||
155611069|NCT04750278|561668505|FG001|Overall Study|Death|10|||
155611070|NCT04750278|561668506|FG002|Overall Study|Death|10|||
155724383|NCT00535496|562089691|FG000|Overall Study|Lost to Follow-up|0|||
155724384|NCT00535496|562089692|FG001|Overall Study|Lost to Follow-up|1|||
155724385|NCT00535496|562089693|FG002|Overall Study|Lost to Follow-up|0|||
155724386|NCT00535496|562089694|FG003|Overall Study|Lost to Follow-up|0|||
155724387|NCT00535496|562089691|FG000|Overall Study|Not treated with sugammadex|0|||
155724388|NCT00535496|562089692|FG001|Overall Study|Not treated with sugammadex|1|||
155724389|NCT00535496|562089693|FG002|Overall Study|Not treated with sugammadex|0|||
155724390|NCT00535496|562089694|FG003|Overall Study|Not treated with sugammadex|0|||
155724391|NCT03175367|562089696|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155724392|NCT03175367|562089697|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155724393|NCT03175367|562089698|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
155724394|NCT03175367|562089699|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
155724395|NCT03175367|562089700|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155724396|NCT03175367|562089701|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155724397|NCT03175367|562089702|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
155724398|NCT03175367|562089696|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155724399|NCT03175367|562089697|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155724400|NCT03175367|562089698|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155724401|NCT03175367|562089699|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155724402|NCT03175367|562089700|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
155724403|NCT03175367|562089701|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155724404|NCT03175367|562089702|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155724405|NCT03175367|562089696|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155724406|NCT03175367|562089697|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155724407|NCT03175367|562089698|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
155724408|NCT03175367|562089699|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
155724409|NCT03175367|562089700|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155724410|NCT03175367|562089701|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155724411|NCT03175367|562089702|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155724412|NCT03175367|562089696|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
155724413|NCT03175367|562089697|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
155724414|NCT03175367|562089698|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
155724415|NCT03175367|562089699|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
155724416|NCT03175367|562089700|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155724417|NCT03175367|562089701|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155724418|NCT03175367|562089702|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155724419|NCT03175367|562089696|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155724420|NCT03175367|562089697|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155724421|NCT03175367|562089698|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155724422|NCT03175367|562089699|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155724423|NCT03175367|562089700|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155724424|NCT03175367|562089701|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155724425|NCT03175367|562089702|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155724426|NCT03175367|562089696|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724427|NCT03175367|562089697|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724428|NCT03175367|562089698|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724429|NCT03175367|562089699|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724430|NCT03175367|562089700|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724431|NCT03175367|562089701|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155724432|NCT03175367|562089702|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
155611071|NCT04750278|561668504|FG000|Overall Study|Withdrawal by Subject|4|||
155611072|NCT04750278|561668505|FG001|Overall Study|Withdrawal by Subject|1|||
155724433|NCT03175367|562089696|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724434|NCT03175367|562089697|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724435|NCT03175367|562089698|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724436|NCT03175367|562089699|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724437|NCT03175367|562089700|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155724438|NCT03175367|562089701|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
155724439|NCT03175367|562089702|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155724440|NCT02851615|562089703|FG000|Overall Study|Cognitive Issue|1|||
155724441|NCT02851615|562089704|FG001|Overall Study|Cognitive Issue|0|||
155724442|NCT02851615|562089703|FG000|Overall Study|Lost to Follow-up|0|||
155724443|NCT02851615|562089704|FG001|Overall Study|Lost to Follow-up|4|||
155724444|NCT00371150|562089706|FG000|Overall Study|Lost to Follow-up|3|||
155724445|NCT00371150|562089707|FG001|Overall Study|Lost to Follow-up|2|||
155724446|NCT03337477|562089708|FG000|Overall Study|not categorized into the listed ones|11|||
155724447|NCT03337477|562089709|FG001|Overall Study|not categorized into the listed ones|9|||
155724448|NCT03337477|562089708|FG000|Overall Study|Withdrawal by Subject|0|||
155724449|NCT03337477|562089709|FG001|Overall Study|Withdrawal by Subject|1|||
155724450|NCT03337477|562089708|FG000|Overall Study|Death|0|||
155724451|NCT03337477|562089709|FG001|Overall Study|Death|1|||
155724452|NCT03337477|562089708|FG000|Overall Study|Lost to Follow-up|0|||
155724453|NCT03337477|562089709|FG001|Overall Study|Lost to Follow-up|2|||
155724454|NCT03304626|562089710|FG000|Overall Study|Adverse Event|1|||
155724455|NCT03304626|562089711|FG001|Overall Study|Adverse Event|0|||
155724456|NCT03304626|562089710|FG000|Overall Study|Lack of Efficacy|1|||
155724457|NCT03304626|562089711|FG001|Overall Study|Lack of Efficacy|1|||
155724458|NCT00744497|562089712|FG000|Overall Study|Withdrawal by Subject|21|||
155724459|NCT00744497|562089713|FG001|Overall Study|Withdrawal by Subject|18|||
155724460|NCT00744497|562089712|FG000|Overall Study|Death|11|||
155724461|NCT00744497|562089713|FG001|Overall Study|Death|9|||
155724462|NCT00744497|562089712|FG000|Overall Study|Lost to Follow-up|4|||
155724463|NCT00744497|562089713|FG001|Overall Study|Lost to Follow-up|2|||
155724464|NCT00744497|562089712|FG000|Overall Study|Poor compliance/noncompliance|9|||
155724465|NCT00744497|562089713|FG001|Overall Study|Poor compliance/noncompliance|5|||
155724466|NCT00744497|562089712|FG000|Overall Study|No longer meets study criteria|7|||
155724467|NCT00744497|562089713|FG001|Overall Study|No longer meets study criteria|3|||
155724468|NCT00744497|562089712|FG000|Overall Study|Administrative Reason By Sponsor|25|||
155724469|NCT00744497|562089713|FG001|Overall Study|Administrative Reason By Sponsor|8|||
155724470|NCT00744497|562089712|FG000|Overall Study|Disease progression|312|||
155724471|NCT00744497|562089713|FG001|Overall Study|Disease progression|219|||
155724472|NCT00744497|562089712|FG000|Overall Study|Study drug toxicity|68|||
155724473|NCT00744497|562089713|FG001|Overall Study|Study drug toxicity|141|||
155611073|NCT04750278|561668506|FG002|Overall Study|Withdrawal by Subject|2|||
155611074|NCT04750278|561668504|FG000|Overall Study|Lost to Follow-up|1|||
155611075|NCT04750278|561668505|FG001|Overall Study|Lost to Follow-up|1|||
155611076|NCT04750278|561668506|FG002|Overall Study|Lost to Follow-up|1|||
155611077|NCT04750278|561668504|FG000|Overall Study|Pregnancy|1|||
155611078|NCT04750278|561668505|FG001|Overall Study|Pregnancy|0|||
155611079|NCT04750278|561668506|FG002|Overall Study|Pregnancy|0|||
155611080|NCT04750278|561668504|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
155611081|NCT04750278|561668505|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
155611082|NCT04750278|561668506|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
155611083|NCT04750278|561668504|FG000|Overall Study|Non-compliance|0|||
155611084|NCT04750278|561668505|FG001|Overall Study|Non-compliance|0|||
155611085|NCT04750278|561668506|FG002|Overall Study|Non-compliance|1|||
155611086|NCT04750278|561668504|FG000|Overall Study|Transfer to Outside Facility|0|||
155611087|NCT04750278|561668505|FG001|Overall Study|Transfer to Outside Facility|2|||
155611088|NCT04750278|561668506|FG002|Overall Study|Transfer to Outside Facility|1|||
155611089|NCT04750278|561668504|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
155611090|NCT04750278|561668505|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
155611091|NCT04750278|561668506|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
155611092|NCT04750278|561668504|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
155611093|NCT04750278|561668505|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
155724474|NCT00744497|562089712|FG000|Overall Study|Adverse event unrelated to study drug|78|||
155381575|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155611094|NCT04750278|561668506|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
155724475|NCT00744497|562089713|FG001|Overall Study|Adverse event unrelated to study drug|122|||
155724476|NCT00744497|562089712|FG000|Overall Study|Patient requested to stop study drug|65|||
155724477|NCT00744497|562089713|FG001|Overall Study|Patient requested to stop study drug|80|||
155381576|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155724478|NCT00744497|562089712|FG000|Overall Study|Maximum clinical benefit|141|||
155724479|NCT00744497|562089713|FG001|Overall Study|Maximum clinical benefit|142|||
155724480|NCT00744497|562089712|FG000|Overall Study|Not defined|19|||
155611095|NCT01616758|561668510|FG000|Overall Study|Adverse Event|1|||
155611096|NCT01616758|561668510|FG000|Overall Study|Withdrawal by Subject|2|||
155611097|NCT01616758|561668510|FG000|Overall Study|Disease progression|18|||
155611098|NCT01616758|561668510|FG000|Overall Study|Study termination by Sponsor|1|||
155611099|NCT01054222|561668515|FG000|Overall Study|Lack of Efficacy|1|||
155611100|NCT01054222|561668515|FG000|Overall Study|Lost to Follow-up|4|||
155611101|NCT01054222|561668515|FG000|Overall Study|Withdrawal by Subject|6|||
155611102|NCT03782571|561668516|FG000|Period 1|Withdrawal by Subject|1|||
155611103|NCT03782571|561668517|FG001|Period 1|Withdrawal by Subject|0|||
155611104|NCT03782571|561668518|FG002|Period 1|Withdrawal by Subject|0|||
155611105|NCT03782571|561668519|FG003|Period 1|Withdrawal by Subject|0|||
155611106|NCT03782571|561668516|FG000|Period 3|Subject Unable to Attend V5|1|||
155611107|NCT03782571|561668517|FG001|Period 3|Subject Unable to Attend V5|0|||
155611108|NCT03782571|561668518|FG002|Period 3|Subject Unable to Attend V5|0|||
155611109|NCT03782571|561668519|FG003|Period 3|Subject Unable to Attend V5|0|||
155611110|NCT03782571|561668516|FG000|Period 3|Adverse Event|1|||
155611111|NCT03782571|561668517|FG001|Period 3|Adverse Event|0|||
155611112|NCT03782571|561668518|FG002|Period 3|Adverse Event|0|||
155611113|NCT03782571|561668519|FG003|Period 3|Adverse Event|0|||
155611114|NCT03504189|561668520|FG000|Overall Study|Withdrawal by Subject|1|||
155611115|NCT03504189|561668520|FG000|Overall Study|Screening Failure|1|||
155611116|NCT03504189|561668520|FG000|Overall Study|Device Failure|2|||
155611117|NCT01134263|561668554|FG000|Overall Study|Serious adverse event|2|||
155611118|NCT01134263|561668555|FG001|Overall Study|Serious adverse event|1|||
155611119|NCT01134263|561668556|FG002|Overall Study|Serious adverse event|1|||
155611120|NCT01134263|561668557|FG003|Overall Study|Serious adverse event|1|||
155611121|NCT01134263|561668558|FG004|Overall Study|Serious adverse event|1|||
155611122|NCT01134263|561668554|FG000|Overall Study|Other adverse event|1|||
155611123|NCT01134263|561668555|FG001|Overall Study|Other adverse event|2|||
155611124|NCT01134263|561668556|FG002|Overall Study|Other adverse event|5|||
155611125|NCT01134263|561668557|FG003|Overall Study|Other adverse event|3|||
155611126|NCT01134263|561668558|FG004|Overall Study|Other adverse event|0|||
155611127|NCT01134263|561668554|FG000|Overall Study|Protocol Violation|8|||
155611128|NCT01134263|561668555|FG001|Overall Study|Protocol Violation|7|||
155611129|NCT01134263|561668556|FG002|Overall Study|Protocol Violation|2|||
155611130|NCT01134263|561668557|FG003|Overall Study|Protocol Violation|4|||
155611131|NCT01134263|561668558|FG004|Overall Study|Protocol Violation|2|||
155611132|NCT01134263|561668554|FG000|Overall Study|Lost to Follow-up|4|||
155611133|NCT01134263|561668555|FG001|Overall Study|Lost to Follow-up|3|||
155611134|NCT01134263|561668556|FG002|Overall Study|Lost to Follow-up|5|||
155611135|NCT01134263|561668557|FG003|Overall Study|Lost to Follow-up|3|||
155611136|NCT01134263|561668558|FG004|Overall Study|Lost to Follow-up|1|||
155611137|NCT01134263|561668554|FG000|Overall Study|Withdrawal by Subject|8|||
155611138|NCT01134263|561668555|FG001|Overall Study|Withdrawal by Subject|6|||
155611139|NCT01134263|561668556|FG002|Overall Study|Withdrawal by Subject|16|||
155611140|NCT01134263|561668557|FG003|Overall Study|Withdrawal by Subject|7|||
155611141|NCT01134263|561668558|FG004|Overall Study|Withdrawal by Subject|5|||
155611142|NCT01134263|561668554|FG000|Overall Study|Enrolled, but not treated|1|||
155611143|NCT01134263|561668555|FG001|Overall Study|Enrolled, but not treated|1|||
155611144|NCT01134263|561668556|FG002|Overall Study|Enrolled, but not treated|0|||
155611145|NCT01134263|561668557|FG003|Overall Study|Enrolled, but not treated|1|||
155611146|NCT01134263|561668558|FG004|Overall Study|Enrolled, but not treated|0|||
155611147|NCT03585712|561668559|FG000|Treatment Period 1|Protocol Violation|1|||
155611148|NCT03585712|561668560|FG001|Treatment Period 1|Protocol Violation|0|||
155611149|NCT03585712|561668561|FG002|Treatment Period 1|Protocol Violation|0|||
155611150|NCT03585712|561668559|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
155611151|NCT03585712|561668560|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
155611152|NCT03585712|561668561|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
155611153|NCT03585712|561668559|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
155611154|NCT03585712|561668560|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
155611155|NCT03585712|561668561|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
155611156|NCT03585712|561668559|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
155611157|NCT03585712|561668560|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
155611158|NCT03585712|561668561|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
155611159|NCT01280682|561668566|FG000|Overall Study|Lost to Follow-up|0|||
155611160|NCT01280682|561668567|FG001|Overall Study|Lost to Follow-up|6|||
155611161|NCT01280682|561668566|FG000|Overall Study|Withdrawal by Subject|0|||
155611162|NCT01280682|561668567|FG001|Overall Study|Withdrawal by Subject|7|||
155611163|NCT00548249|561668568|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
155611164|NCT00548249|561668569|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155611165|NCT00548249|561668570|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155611166|NCT00548249|561668571|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
155611167|NCT00548249|561668572|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155650560|NCT00147537|561812508|FG006|Phase 2|Other|0|||
155650561|NCT00147537|561812509|FG007|Phase 2|Other|0|||
155650562|NCT00147537|561812510|FG008|Phase 2|Other|0|||
155650563|NCT00147537|561812511|FG009|Phase 2|Other|47|||
155611168|NCT00548249|561668568|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
155611169|NCT00548249|561668569|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
155611170|NCT00548249|561668570|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
155611171|NCT00548249|561668571|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
155611172|NCT00548249|561668572|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
155611173|NCT00548249|561668568|FG000|Overall Study|Protocol Violation|1|||
155611174|NCT00548249|561668569|FG001|Overall Study|Protocol Violation|1|||
155611175|NCT00548249|561668570|FG002|Overall Study|Protocol Violation|4|||
155611176|NCT00548249|561668571|FG003|Overall Study|Protocol Violation|0|||
155611177|NCT00548249|561668572|FG004|Overall Study|Protocol Violation|3|||
155611178|NCT00548249|561668568|FG000|Overall Study|Miscellaneous|2|||
155611179|NCT00548249|561668569|FG001|Overall Study|Miscellaneous|3|||
155611180|NCT00548249|561668570|FG002|Overall Study|Miscellaneous|2|||
155611181|NCT00548249|561668571|FG003|Overall Study|Miscellaneous|0|||
155611182|NCT00548249|561668572|FG004|Overall Study|Miscellaneous|2|||
155611183|NCT00548249|561668568|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
155611184|NCT00548249|561668569|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
155611185|NCT00548249|561668570|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
155611186|NCT00548249|561668571|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
155611187|NCT00548249|561668572|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
155611188|NCT00548249|561668568|FG000|Overall Study|Adverse Event|2|||
155611189|NCT00548249|561668569|FG001|Overall Study|Adverse Event|2|||
155611190|NCT00548249|561668570|FG002|Overall Study|Adverse Event|0|||
155611191|NCT00548249|561668571|FG003|Overall Study|Adverse Event|1|||
155611192|NCT00548249|561668572|FG004|Overall Study|Adverse Event|1|||
155611193|NCT00548249|561668568|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
155611194|NCT00548249|561668569|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
155611195|NCT00548249|561668570|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
155611196|NCT00548249|561668571|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
155611197|NCT00548249|561668572|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
155611198|NCT00548249|561668568|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
155611199|NCT00548249|561668569|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
155611200|NCT00548249|561668570|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
155611201|NCT00548249|561668571|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
155611202|NCT00548249|561668572|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
155611203|NCT00548249|561668568|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155611204|NCT00548249|561668569|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155611205|NCT00548249|561668570|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155611206|NCT00548249|561668571|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155611207|NCT00548249|561668572|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
155611208|NCT00548249|561668568|FG000|Overall Study|Prolonged hospitalization|0|||
155611209|NCT00548249|561668569|FG001|Overall Study|Prolonged hospitalization|0|||
155611210|NCT00548249|561668570|FG002|Overall Study|Prolonged hospitalization|2|||
155611211|NCT00548249|561668571|FG003|Overall Study|Prolonged hospitalization|1|||
155611212|NCT00548249|561668572|FG004|Overall Study|Prolonged hospitalization|0|||
155650564|NCT00147537|561812512|FG010|Phase 2|Other|12|||
155650565|NCT00147537|561812502|FG000|Phase 2|Withdrawal by Subject|0|||
155650566|NCT00147537|561812503|FG001|Phase 2|Withdrawal by Subject|0|||
155650567|NCT00147537|561812504|FG002|Phase 2|Withdrawal by Subject|0|||
155650568|NCT00147537|561812505|FG003|Phase 2|Withdrawal by Subject|0|||
155650569|NCT00147537|561812506|FG004|Phase 2|Withdrawal by Subject|0|||
155650570|NCT00147537|561812507|FG005|Phase 2|Withdrawal by Subject|0|||
155650571|NCT00147537|561812508|FG006|Phase 2|Withdrawal by Subject|0|||
155650572|NCT00147537|561812509|FG007|Phase 2|Withdrawal by Subject|0|||
155650573|NCT00147537|561812510|FG008|Phase 2|Withdrawal by Subject|0|||
155650574|NCT00147537|561812511|FG009|Phase 2|Withdrawal by Subject|16|||
155650575|NCT00147537|561812512|FG010|Phase 2|Withdrawal by Subject|4|||
155650576|NCT00147537|561812502|FG000|Phase 2|Randomized but not treated|0|||
155650577|NCT00147537|561812503|FG001|Phase 2|Randomized but not treated|0|||
155650578|NCT00147537|561812504|FG002|Phase 2|Randomized but not treated|0|||
155650579|NCT00147537|561812505|FG003|Phase 2|Randomized but not treated|0|||
155650580|NCT00147537|561812506|FG004|Phase 2|Randomized but not treated|0|||
155650581|NCT00147537|561812507|FG005|Phase 2|Randomized but not treated|0|||
155650582|NCT00147537|561812508|FG006|Phase 2|Randomized but not treated|0|||
155650583|NCT00147537|561812509|FG007|Phase 2|Randomized but not treated|0|||
155650584|NCT00147537|561812510|FG008|Phase 2|Randomized but not treated|0|||
155650585|NCT00147537|561812511|FG009|Phase 2|Randomized but not treated|1|||
155650586|NCT00147537|561812512|FG010|Phase 2|Randomized but not treated|1|||
155650587|NCT01927861|561812513|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
155650588|NCT01927861|561812514|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
155650589|NCT01927861|561812513|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
155650590|NCT01927861|561812514|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
155650591|NCT00452530|561812515|FG000|Overall Study|Death|1|||
155650592|NCT00452530|561812516|FG001|Overall Study|Death|0|||
155724481|NCT00744497|562089713|FG001|Overall Study|Not defined|13|||
155724482|NCT03182374|562089714|FG000|Overall Study|Lost to Follow-up|3|||
155724483|NCT03182374|562089715|FG001|Overall Study|Lost to Follow-up|2|||
155724484|NCT03182374|562089714|FG000|Overall Study|Lack of Efficacy|8|||
155724485|NCT03182374|562089715|FG001|Overall Study|Lack of Efficacy|14|||
155724486|NCT03182374|562089714|FG000|Overall Study|Withdrawal by Subject|1|||
155724487|NCT03182374|562089715|FG001|Overall Study|Withdrawal by Subject|1|||
155724488|NCT03182374|562089714|FG000|Overall Study|exit for non-compliance|1|||
155724489|NCT03182374|562089715|FG001|Overall Study|exit for non-compliance|1|||
155724490|NCT03182374|562089714|FG000|Overall Study|one subject was randomized but not treated|1|||
155724491|NCT03182374|562089715|FG001|Overall Study|one subject was randomized but not treated|0|||
155724492|NCT03182374|562089714|FG000|Overall Study|Other reasons|0|||
155724493|NCT03182374|562089715|FG001|Overall Study|Other reasons|3|||
155724494|NCT06271993|562089719|FG000|Overall Study|Not reactive to histamine|5|||
155724495|NCT06271993|562089720|FG001|Overall Study|Not reactive to histamine|5|||
155724496|NCT06271993|562089721|FG002|Overall Study|Not reactive to histamine|5|||
155724497|NCT04613362|562089722|FG000|3 Month Follow-up|Lost to Follow-up|1|||
155724498|NCT04613362|562089723|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155724499|NCT04613362|562089722|FG000|6 Month Follow-up|Lost to Follow-up|0|||
155724500|NCT04613362|562089723|FG001|6 Month Follow-up|Lost to Follow-up|1|||
155724501|NCT03331315|562089725|FG000|Overall Study|Physician Decision|18|||
155724502|NCT03331315|562089726|FG001|Overall Study|Physician Decision|14|||
155724503|NCT00481832|562089727|FG000|Enrollment|Physician Decision|8|||
155724504|NCT00481832|562089727|FG000|Enrollment|Unable to collect enough stem cells|2|||
155724505|NCT00481832|562089727|FG000|Inter-transplant Period|Adverse Event|4|||
155724506|NCT00481832|562089727|FG000|Inter-transplant Period|Death|3|||
155724507|NCT00481832|562089727|FG000|Inter-transplant Period|Physician Decision|4|||
155611213|NCT00548249|561668568|FG000|Overall Study|Withdrawal by Subject|2|||
155611214|NCT00548249|561668569|FG001|Overall Study|Withdrawal by Subject|0|||
155611215|NCT00548249|561668570|FG002|Overall Study|Withdrawal by Subject|0|||
155611216|NCT00548249|561668571|FG003|Overall Study|Withdrawal by Subject|0|||
155611217|NCT00548249|561668572|FG004|Overall Study|Withdrawal by Subject|0|||
155611218|NCT00548249|561668568|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155611219|NCT00548249|561668569|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
155611220|NCT00548249|561668570|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155611221|NCT00548249|561668571|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155611222|NCT00548249|561668572|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
155611223|NCT00548249|561668568|FG000|Overall Study|Sponsor's request|0|||
155611224|NCT00548249|561668569|FG001|Overall Study|Sponsor's request|0|||
155611225|NCT00548249|561668570|FG002|Overall Study|Sponsor's request|0|||
155611226|NCT00548249|561668571|FG003|Overall Study|Sponsor's request|1|||
155611227|NCT00548249|561668572|FG004|Overall Study|Sponsor's request|0|||
155611228|NCT02007278|561668573|FG000|Overall Study|Failure to comply with an eligibility|0|||
155611229|NCT02007278|561668574|FG001|Overall Study|Failure to comply with an eligibility|1|||
155611230|NCT02007278|561668573|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
155611231|NCT02007278|561668574|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
155611232|NCT02007278|561668573|FG000|Overall Study|Incorrect medication administration|1|||
155611233|NCT02007278|561668574|FG001|Overall Study|Incorrect medication administration|0|||
155611234|NCT02007278|561668573|FG000|Overall Study|Mis-randomization|1|||
155611235|NCT02007278|561668574|FG001|Overall Study|Mis-randomization|1|||
155611236|NCT02886884|561668578|FG000|Follow-up|Withdrawal by Subject|0|||
155611237|NCT02886884|561668579|FG001|Follow-up|Withdrawal by Subject|0|||
155611238|NCT02886884|561668580|FG002|Follow-up|Withdrawal by Subject|0|||
155611239|NCT02886884|561668581|FG003|Follow-up|Withdrawal by Subject|1|||
155611240|NCT01429441|561668582|FG000|Overall Study|Adverse Event|5|||
155611241|NCT01429441|561668583|FG001|Overall Study|Adverse Event|1|||
155611242|NCT01429441|561668582|FG000|Overall Study|Death|0|||
155611243|NCT01429441|561668583|FG001|Overall Study|Death|2|||
155724508|NCT00481832|562089727|FG000|Inter-transplant Period|Disease relapse|11|||
155724509|NCT00481832|562089727|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
155724510|NCT00581308|562089731|FG000|Pre Discharge|Lost to Follow-up|1|||
155724511|NCT00581308|562089731|FG000|Pre Discharge|Device Removed|1|||
155724512|NCT00581308|562089731|FG000|Month 1|Lost to Follow-up|3|||
155724513|NCT00581308|562089731|FG000|Month 1|Withdrawal by Subject|2|||
155611244|NCT01429441|561668582|FG000|Overall Study|Lost to Follow-up|5|||
155611245|NCT01429441|561668583|FG001|Overall Study|Lost to Follow-up|2|||
155611246|NCT01429441|561668582|FG000|Overall Study|Physician Decision|1|||
155611247|NCT01429441|561668583|FG001|Overall Study|Physician Decision|0|||
155611248|NCT01429441|561668582|FG000|Overall Study|Withdrawal by Subject|27|||
155724514|NCT00581308|562089731|FG000|Month 1|Device Removed|2|||
155724515|NCT00581308|562089731|FG000|Month 1|Uknown|1|||
155724516|NCT00581308|562089731|FG000|Month 6|Lost to Follow-up|1|||
155724517|NCT00581308|562089731|FG000|Month 6|Withdrawal by Subject|2|||
155724518|NCT00581308|562089731|FG000|Month 12|Death|1|||
155611249|NCT01429441|561668583|FG001|Overall Study|Withdrawal by Subject|18|||
155611250|NCT02279745|561668584|FG000|Overall Study|Adverse Event|7|||
155611251|NCT02279745|561668584|FG000|Overall Study|Death|6|||
155724519|NCT00581308|562089731|FG000|Month 12|Lost to Follow-up|14|||
155724520|NCT00581308|562089731|FG000|Month 12|Withdrawal by Subject|3|||
155724521|NCT00581308|562089731|FG000|Month 12|Device Removed|1|||
155724522|NCT00581308|562089731|FG000|Month 12|Other|1|||
155724523|NCT00456846|562089732|FG000|Overall Study|Adverse Event|2|||
155724524|NCT00456846|562089733|FG001|Overall Study|Adverse Event|15|||
155724525|NCT00456846|562089732|FG000|Overall Study|Physician Decision|11|||
155724526|NCT00456846|562089733|FG001|Overall Study|Physician Decision|6|||
155724527|NCT00456846|562089732|FG000|Overall Study|Protocol Deviation|2|||
155724528|NCT00456846|562089733|FG001|Overall Study|Protocol Deviation|0|||
155724529|NCT00456846|562089732|FG000|Overall Study|Participant Discretion|1|||
155724530|NCT00456846|562089733|FG001|Overall Study|Participant Discretion|5|||
155724531|NCT00456846|562089732|FG000|Overall Study|Other|0|||
155724532|NCT00456846|562089733|FG001|Overall Study|Other|2|||
155724533|NCT03137381|562089734|FG000|Overall Study|Adverse Event|3|||
155724534|NCT03137381|562089735|FG001|Overall Study|Adverse Event|0|||
155724535|NCT03137381|562089736|FG002|Overall Study|Adverse Event|2|||
155724536|NCT03137381|562089737|FG003|Overall Study|Adverse Event|0|||
155724537|NCT03137381|562089734|FG000|Overall Study|Lost to Follow-up|2|||
155724538|NCT03137381|562089735|FG001|Overall Study|Lost to Follow-up|1|||
155724539|NCT03137381|562089736|FG002|Overall Study|Lost to Follow-up|1|||
155724540|NCT03137381|562089737|FG003|Overall Study|Lost to Follow-up|0|||
155724541|NCT03137381|562089734|FG000|Overall Study|Protocol deviation|1|||
155724542|NCT03137381|562089735|FG001|Overall Study|Protocol deviation|1|||
155724543|NCT03137381|562089736|FG002|Overall Study|Protocol deviation|0|||
155724544|NCT03137381|562089737|FG003|Overall Study|Protocol deviation|1|||
155724545|NCT03137381|562089734|FG000|Overall Study|Withdrawal by Investigator|0|||
155724546|NCT03137381|562089735|FG001|Overall Study|Withdrawal by Investigator|1|||
155724547|NCT03137381|562089736|FG002|Overall Study|Withdrawal by Investigator|1|||
155724548|NCT03137381|562089737|FG003|Overall Study|Withdrawal by Investigator|0|||
155724549|NCT03137381|562089734|FG000|Overall Study|Withdrawal by Subject|3|||
155724550|NCT03137381|562089735|FG001|Overall Study|Withdrawal by Subject|4|||
155724551|NCT03137381|562089736|FG002|Overall Study|Withdrawal by Subject|3|||
155724552|NCT03137381|562089737|FG003|Overall Study|Withdrawal by Subject|0|||
155724553|NCT03137381|562089734|FG000|Overall Study|Pregnancy|0|||
155724554|NCT03137381|562089735|FG001|Overall Study|Pregnancy|0|||
155724555|NCT03137381|562089736|FG002|Overall Study|Pregnancy|1|||
155724556|NCT03137381|562089737|FG003|Overall Study|Pregnancy|0|||
155724557|NCT01980017|562089738|FG000|Overall Study|Lost to Follow-up|30|||
155724558|NCT01980017|562089739|FG001|Overall Study|Lost to Follow-up|21|||
155724559|NCT01980017|562089738|FG000|Overall Study|Death|0|||
155724560|NCT01980017|562089739|FG001|Overall Study|Death|1|||
155724561|NCT03044106|562089741|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
155724562|NCT03044106|562089742|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
155724563|NCT02057250|562089743|FG000|AID Assessment Phase|Adverse Event|3|||
155724564|NCT02057250|562089744|FG001|AID Assessment Phase|Adverse Event|2|||
155724565|NCT02057250|562089745|FG002|AID Assessment Phase|Adverse Event|6|||
155724566|NCT02057250|562089746|FG003|AID Assessment Phase|Adverse Event|1|||
155724567|NCT02057250|562089747|FG004|AID Assessment Phase|Adverse Event|0|||
155724568|NCT02057250|562089743|FG000|AID Assessment Phase|Other than specified above|1|||
155724569|NCT02057250|562089744|FG001|AID Assessment Phase|Other than specified above|1|||
155724570|NCT02057250|562089745|FG002|AID Assessment Phase|Other than specified above|1|||
155724571|NCT02057250|562089746|FG003|AID Assessment Phase|Other than specified above|1|||
155724572|NCT02057250|562089747|FG004|AID Assessment Phase|Other than specified above|0|||
155724573|NCT02057250|562089743|FG000|Extension Phase|Adverse Event|0|||
155724574|NCT02057250|562089744|FG001|Extension Phase|Adverse Event|0|||
155724575|NCT02057250|562089745|FG002|Extension Phase|Adverse Event|0|||
155724576|NCT02057250|562089746|FG003|Extension Phase|Adverse Event|0|||
155724577|NCT02057250|562089747|FG004|Extension Phase|Adverse Event|15|||
155724578|NCT02057250|562089743|FG000|Extension Phase|Lack of Efficacy|0|||
155724579|NCT02057250|562089744|FG001|Extension Phase|Lack of Efficacy|0|||
155724580|NCT02057250|562089745|FG002|Extension Phase|Lack of Efficacy|0|||
155724581|NCT02057250|562089746|FG003|Extension Phase|Lack of Efficacy|0|||
155724582|NCT02057250|562089747|FG004|Extension Phase|Lack of Efficacy|10|||
155724583|NCT02057250|562089743|FG000|Extension Phase|Entered in this period but not treated|0|||
155724584|NCT02057250|562089744|FG001|Extension Phase|Entered in this period but not treated|0|||
155724585|NCT02057250|562089745|FG002|Extension Phase|Entered in this period but not treated|0|||
155724586|NCT02057250|562089746|FG003|Extension Phase|Entered in this period but not treated|0|||
155724587|NCT02057250|562089747|FG004|Extension Phase|Entered in this period but not treated|4|||
155724588|NCT02057250|562089743|FG000|Extension Phase|Other than specified above|0|||
155724589|NCT02057250|562089744|FG001|Extension Phase|Other than specified above|0|||
155724590|NCT02057250|562089745|FG002|Extension Phase|Other than specified above|0|||
155724591|NCT02057250|562089746|FG003|Extension Phase|Other than specified above|0|||
155724592|NCT02057250|562089747|FG004|Extension Phase|Other than specified above|7|||
155724593|NCT03379818|562089748|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
155724594|NCT03379818|562089749|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
155724595|NCT03379818|562089748|FG000|Overall Study|Withdrawal by Subject|2|||
155724596|NCT03379818|562089749|FG001|Overall Study|Withdrawal by Subject|3|||
155724597|NCT03379818|562089748|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
155724598|NCT03379818|562089749|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
155724599|NCT03367793|562089750|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155724600|NCT03367793|562089751|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155724601|NCT03367793|562089752|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
155724602|NCT03367793|562089753|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155724603|NCT03367793|562089754|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155724604|NCT03367793|562089755|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155724605|NCT00260533|562089756|FG000|Overall Study|Other|3|||
155724606|NCT00260533|562089757|FG001|Overall Study|Other|3|||
155724607|NCT01310777|562089758|FG000|Overall Study|Adverse Event|23|||
155724608|NCT01310777|562089759|FG001|Overall Study|Adverse Event|1|||
155724609|NCT01310777|562089760|FG002|Overall Study|Adverse Event|15|||
155724610|NCT01310777|562089758|FG000|Overall Study|Lost to Follow-up|0|||
155724611|NCT01310777|562089759|FG001|Overall Study|Lost to Follow-up|4|||
155724612|NCT01310777|562089760|FG002|Overall Study|Lost to Follow-up|1|||
155724613|NCT01310777|562089758|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
155724614|NCT01310777|562089759|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
155724615|NCT01310777|562089760|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
155724616|NCT01310777|562089758|FG000|Overall Study|Inadequate Control of IOP|5|||
155724617|NCT01310777|562089759|FG001|Overall Study|Inadequate Control of IOP|7|||
155724618|NCT01310777|562089760|FG002|Overall Study|Inadequate Control of IOP|10|||
155724619|NCT01310777|562089758|FG000|Overall Study|Other|4|||
155724620|NCT01310777|562089759|FG001|Overall Study|Other|1|||
155724621|NCT01310777|562089760|FG002|Overall Study|Other|2|||
155724622|NCT04218240|562089762|FG000|Overall Study|Withdrawal by Subject|6|||
155724623|NCT04218240|562089763|FG001|Overall Study|Withdrawal by Subject|0|||
155724624|NCT04218240|562089762|FG000|Overall Study|Lack of Efficacy|24|||
155724625|NCT04218240|562089763|FG001|Overall Study|Lack of Efficacy|19|||
155724626|NCT04218240|562089762|FG000|Overall Study|Physician Decision|0|||
155724627|NCT04218240|562089763|FG001|Overall Study|Physician Decision|1|||
155724628|NCT04218240|562089762|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
155724629|NCT04218240|562089763|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
155724630|NCT00888134|562089780|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
155724631|NCT00888134|562089780|FG000|Follow-up|being followed for long-term survival|1|||
155724632|NCT03043313|562089781|FG000|Overall Study|Withdrawal by Subject|5|||
155724633|NCT03043313|562089782|FG001|Overall Study|Withdrawal by Subject|1|||
155724634|NCT03043313|562089783|FG002|Overall Study|Withdrawal by Subject|1|||
155724635|NCT03043313|562089781|FG000|Overall Study|Lost to Follow-up|1|||
155724636|NCT03043313|562089782|FG001|Overall Study|Lost to Follow-up|1|||
155724637|NCT03043313|562089783|FG002|Overall Study|Lost to Follow-up|0|||
155724638|NCT03043313|562089781|FG000|Overall Study|Death|28|||
155724639|NCT03043313|562089782|FG001|Overall Study|Death|26|||
155724640|NCT03043313|562089783|FG002|Overall Study|Death|17|||
155724641|NCT03043313|562089781|FG000|Overall Study|Participation terminated by sponsor|11|||
155724642|NCT03043313|562089782|FG001|Overall Study|Participation terminated by sponsor|13|||
155724643|NCT03043313|562089783|FG002|Overall Study|Participation terminated by sponsor|13|||
155724644|NCT00795535|562089784|FG000|Overall Study|incomplete data and technical problems|20|||
155724645|NCT02651675|562089787|FG000|Overall Study|Death|0|||
155724646|NCT02651675|562089788|FG001|Overall Study|Death|0|||
155724647|NCT02651675|562089789|FG002|Overall Study|Death|1|||
155724648|NCT00374140|562089790|FG000|Overall Study|Lost to Follow-up|1|||
155724649|NCT00374140|562089790|FG000|Overall Study|Protocol Violation|1|||
155724650|NCT02246530|562089791|FG000|Overall Study|Lost to Follow-up|4|||
155724651|NCT02246530|562089792|FG001|Overall Study|Lost to Follow-up|0|||
155724652|NCT01506596|562089794|FG000|Overall Study|ineligible pathology|1|||
155724653|NCT01488890|562089795|FG000|Overall Study|Serious adverse event|2|||
155724654|NCT01488890|562089796|FG001|Overall Study|Serious adverse event|0|||
155724655|NCT01488890|562089797|FG002|Overall Study|Serious adverse event|0|||
155724656|NCT01488890|562089798|FG003|Overall Study|Serious adverse event|0|||
155724657|NCT01488890|562089795|FG000|Overall Study|Protocol Violation|3|||
155724658|NCT01488890|562089796|FG001|Overall Study|Protocol Violation|0|||
155381577|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155513917|NCT02116803|561308194|FG000|Overall Study|Physician Decision|1|||
155724659|NCT01488890|562089797|FG002|Overall Study|Protocol Violation|4|||
155724660|NCT01488890|562089798|FG003|Overall Study|Protocol Violation|0|||
155724661|NCT01488890|562089795|FG000|Overall Study|Lost to Follow-up|13|||
155724662|NCT01488890|562089796|FG001|Overall Study|Lost to Follow-up|10|||
155724663|NCT01488890|562089797|FG002|Overall Study|Lost to Follow-up|20|||
155724664|NCT01488890|562089798|FG003|Overall Study|Lost to Follow-up|3|||
155724665|NCT01488890|562089795|FG000|Overall Study|Withdrawal by Subject|14|||
155724666|NCT01488890|562089796|FG001|Overall Study|Withdrawal by Subject|10|||
155724667|NCT01488890|562089797|FG002|Overall Study|Withdrawal by Subject|11|||
155724668|NCT01488890|562089798|FG003|Overall Study|Withdrawal by Subject|2|||
155724669|NCT05712460|562089799|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724670|NCT05712460|562089800|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724671|NCT05712460|562089801|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724672|NCT05712460|562089802|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724673|NCT05712460|562089803|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724674|NCT05712460|562089804|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724675|NCT05712460|562089805|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724676|NCT05712460|562089806|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
155724677|NCT05712460|562089807|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724678|NCT05712460|562089808|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724679|NCT05712460|562089809|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724680|NCT05712460|562089810|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155724681|NCT05082857|562089813|FG000|Overall Study|participants relocated and could not continue|2|||
155724682|NCT05082857|562089814|FG001|Overall Study|participants relocated and could not continue|1|||
155724683|NCT05082857|562089813|FG000|Overall Study|Lost to Follow-up|1|||
155724684|NCT05082857|562089814|FG001|Overall Study|Lost to Follow-up|3|||
155724685|NCT04363320|562089815|FG000|Overall Study|Lost to Follow-up|43|||
155724686|NCT04363320|562089816|FG001|Overall Study|Lost to Follow-up|42|||
155724687|NCT04363320|562089817|FG002|Overall Study|Lost to Follow-up|24|||
155724688|NCT04363320|562089818|FG003|Overall Study|Lost to Follow-up|29|||
155724689|NCT04363320|562089815|FG000|Overall Study|Death|0|||
155724690|NCT04363320|562089816|FG001|Overall Study|Death|0|||
155724691|NCT04363320|562089817|FG002|Overall Study|Death|1|||
155724692|NCT04363320|562089818|FG003|Overall Study|Death|0|||
155724693|NCT00604565|562089822|FG000|Overall Study|Study terminated|0|||
155724694|NCT00604565|562089823|FG001|Overall Study|Study terminated|3|||
155724695|NCT02260934|562089831|FG000|Overall Study|Lost to Follow-up|2|||
155724696|NCT02260934|562089832|FG001|Overall Study|Lost to Follow-up|1|||
155724697|NCT02260934|562089831|FG000|Overall Study|Withdrawal by Subject|0|||
155724698|NCT02260934|562089832|FG001|Overall Study|Withdrawal by Subject|2|||
155724699|NCT02260934|562089831|FG000|Overall Study|Participant Relocated|1|||
155724700|NCT02260934|562089832|FG001|Overall Study|Participant Relocated|0|||
155724701|NCT02260934|562089831|FG000|Overall Study|Site error|0|||
155724702|NCT02260934|562089832|FG001|Overall Study|Site error|1|||
155724703|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
155724704|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
155724705|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
155724706|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
155724707|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
155724708|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
155724709|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
155724710|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
155724711|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
155724712|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
155724713|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
155724714|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
155724715|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
155724716|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
155724717|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
155724718|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
155724719|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
155724720|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
155724721|NCT03605667|562089835|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
155724722|NCT03605667|562089836|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
155724723|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
155724724|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
155724725|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Other|6|||
155724726|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Other|8|||
155724727|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
155724728|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
155381578|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381579|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381580|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381581|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Other|0|||
155724729|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
155724730|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
155724731|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
155724732|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
155724733|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
155724734|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
155724735|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
155724736|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
155724737|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
155724738|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
155724739|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Death|0|||
155724740|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Death|2|||
155724741|NCT03605667|562089835|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
155724742|NCT03605667|562089836|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
155724743|NCT05632211|562089837|FG000|Overall Study|Withdrawal by Subject|2|||
155724744|NCT05632211|562089838|FG001|Overall Study|Withdrawal by Subject|0|||
155724745|NCT05632211|562089839|FG002|Overall Study|Withdrawal by Subject|2|||
155724746|NCT05632211|562089837|FG000|Overall Study|Other reasons|1|||
155724747|NCT05632211|562089838|FG001|Overall Study|Other reasons|1|||
155724748|NCT05632211|562089839|FG002|Overall Study|Other reasons|1|||
155724749|NCT04366349|562089840|FG000|Overall Study|Withdrawal by Subject|1|||
155724750|NCT04366349|562089841|FG001|Overall Study|Withdrawal by Subject|0|||
155724751|NCT04366349|562089842|FG002|Overall Study|Withdrawal by Subject|0|||
155724752|NCT04366349|562089843|FG003|Overall Study|Withdrawal by Subject|0|||
155724753|NCT04366349|562089844|FG004|Overall Study|Withdrawal by Subject|0|||
155724754|NCT04366349|562089845|FG005|Overall Study|Withdrawal by Subject|0|||
155724755|NCT03642873|562089850|FG000|Third Intervention (1 Day)|Screen failure|0|||
155724756|NCT03642873|562089851|FG001|Third Intervention (1 Day)|Screen failure|0|||
155724757|NCT03642873|562089852|FG002|Third Intervention (1 Day)|Screen failure|0|||
155724758|NCT03642873|562089853|FG003|Third Intervention (1 Day)|Screen failure|0|||
155724759|NCT03642873|562089854|FG004|Third Intervention (1 Day)|Screen failure|1|||
155724760|NCT03642873|562089855|FG005|Third Intervention (1 Day)|Screen failure|0|||
155724761|NCT03472885|562089863|FG000|24-Week Treatment Period|Adverse Event|1|||
155724762|NCT00092417|562091264|FG000|Overall Study|Lost to Follow-up|2|||
155381582|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Other|0|||
155381583|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Other|0|||
155381584|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Other|0|||
155381585|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Other|0|||
155381586|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Other|0|||
155381587|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Other|0|||
155381588|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Other|1|||
155381589|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Other|0|||
155381590|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Other|1|||
155381591|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Other|0|||
155381592|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Other|0|||
155381593|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Other|0|||
155381594|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381595|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381596|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381597|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381598|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381599|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
155381600|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
155381601|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381602|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
155381603|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381604|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381605|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381606|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381607|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381608|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381609|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381610|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381611|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
155381612|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381613|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381614|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
155381615|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
155381616|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381617|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381618|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
155724763|NCT00092417|562091265|FG001|Overall Study|Lost to Follow-up|0|||
155724764|NCT00092417|562091264|FG000|Overall Study|Withdrawal by Subject|2|||
155724765|NCT00092417|562091265|FG001|Overall Study|Withdrawal by Subject|1|||
155724766|NCT00092417|562091264|FG000|Overall Study|Other|1|||
155381619|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
155381620|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155724767|NCT00092417|562091265|FG001|Overall Study|Other|0|||
155724768|NCT00425269|562091266|FG000|Overall Study|Pregnancy|5|||
155724769|NCT00425269|562091267|FG001|Overall Study|Pregnancy|7|||
155724770|NCT00425269|562091266|FG000|Overall Study|Lost to Follow-up|9|||
155724771|NCT00425269|562091267|FG001|Overall Study|Lost to Follow-up|9|||
155724772|NCT00425269|562091266|FG000|Overall Study|moved or medical reason|5|||
155724773|NCT00425269|562091267|FG001|Overall Study|moved or medical reason|4|||
155724774|NCT01084655|562091268|FG000|Overall Study|Radiographic disease progression|3|||
155724775|NCT01084655|562091269|FG001|Overall Study|Radiographic disease progression|2|||
155724776|NCT01084655|562091270|FG002|Overall Study|Radiographic disease progression|8|||
155724777|NCT01084655|562091268|FG000|Overall Study|Withdrawal by Subject|1|||
155724778|NCT01084655|562091269|FG001|Overall Study|Withdrawal by Subject|0|||
155724779|NCT01084655|562091270|FG002|Overall Study|Withdrawal by Subject|4|||
155724780|NCT01084655|562091268|FG000|Overall Study|Adverse Event|2|||
155724781|NCT01084655|562091269|FG001|Overall Study|Adverse Event|1|||
155724782|NCT01084655|562091270|FG002|Overall Study|Adverse Event|2|||
155724783|NCT01084655|562091268|FG000|Overall Study|Other|0|||
155724784|NCT01084655|562091269|FG001|Overall Study|Other|3|||
155724785|NCT01084655|562091270|FG002|Overall Study|Other|2|||
155724786|NCT01084655|562091268|FG000|Overall Study|Symptomatic deterioration|0|||
155724787|NCT01084655|562091269|FG001|Overall Study|Symptomatic deterioration|0|||
155724788|NCT01084655|562091270|FG002|Overall Study|Symptomatic deterioration|2|||
155724789|NCT01084655|562091268|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
155724790|NCT01084655|562091269|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
155724791|NCT01084655|562091270|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
155724792|NCT00906204|562091271|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
155724793|NCT00906204|562091272|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
155724794|NCT00906204|562091271|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
155724795|NCT00906204|562091272|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
155724796|NCT00906204|562091271|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
155724797|NCT00906204|562091272|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
155724798|NCT00906204|562091271|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
155724799|NCT00906204|562091272|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
155724800|NCT00906204|562091271|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
155724801|NCT00906204|562091272|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
155724802|NCT00696072|562091273|FG000|Overall Study|continuing active treatment|10|||
155724803|NCT00696072|562091274|FG001|Overall Study|continuing active treatment|13|||
155724804|NCT00696072|562091273|FG000|Overall Study|Adverse Event|10|||
155724805|NCT00696072|562091274|FG001|Overall Study|Adverse Event|6|||
155724806|NCT00696072|562091273|FG000|Overall Study|Patient Request|3|||
155724807|NCT00696072|562091274|FG001|Overall Study|Patient Request|7|||
155724808|NCT00696072|562091273|FG000|Overall Study|Investigator Request|1|||
155724809|NCT00696072|562091274|FG001|Overall Study|Investigator Request|4|||
155724810|NCT00696072|562091273|FG000|Overall Study|Sponsor Request|0|||
155724811|NCT00696072|562091274|FG001|Overall Study|Sponsor Request|1|||
155724812|NCT00696072|562091273|FG000|Overall Study|Disease Progression|32|||
155724813|NCT00696072|562091274|FG001|Overall Study|Disease Progression|30|||
155724814|NCT00696072|562091273|FG000|Overall Study|Non-specified|1|||
155724815|NCT00696072|562091274|FG001|Overall Study|Non-specified|2|||
155724816|NCT01597596|562091275|FG000|Overall Study|Study terminated by sponsor|1|||
155724817|NCT01597596|562091276|FG001|Overall Study|Study terminated by sponsor|0|||
155724818|NCT01597596|562091275|FG000|Overall Study|Physician Decision|0|||
155724819|NCT01597596|562091276|FG001|Overall Study|Physician Decision|1|||
155724820|NCT00992108|562091283|FG000|Overall Study|Lost to Follow-up|0|||
155724821|NCT00992108|562091284|FG001|Overall Study|Lost to Follow-up|1|||
155724822|NCT02419001|562091287|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
155724823|NCT02419001|562091288|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
155724824|NCT02151058|562091292|FG000|Overall Study|Withdrawal by Subject|1|||
155724825|NCT02151058|562091293|FG001|Overall Study|Withdrawal by Subject|1|||
155724826|NCT02151058|562091294|FG002|Overall Study|Withdrawal by Subject|3|||
155724827|NCT02151058|562091292|FG000|Overall Study|Lost to Follow-up|1|||
155724828|NCT02151058|562091293|FG001|Overall Study|Lost to Follow-up|0|||
155724829|NCT02151058|562091294|FG002|Overall Study|Lost to Follow-up|2|||
155724830|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
155724831|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
155724832|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
155724833|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
155724834|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
155381621|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155724835|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155724836|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155724837|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
155724838|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155724839|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155611252|NCT02279745|561668584|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
155611253|NCT02279745|561668584|FG000|Overall Study|Withdrawal by Subject|2|||
155611254|NCT02279745|561668584|FG000|Overall Study|Pregnancy|1|||
155611255|NCT02279745|561668584|FG000|Overall Study|Study Non-compliance|1|||
155724840|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
155724841|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
155724842|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
155611256|NCT02279745|561668584|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
155611257|NCT03383692|561668589|FG000|Overall Study|Progressive disease as per RECIST|3|||
155611258|NCT03383692|561668590|FG001|Overall Study|Progressive disease as per RECIST|3|||
155611259|NCT03383692|561668589|FG000|Overall Study|Clinical progression|0|||
155611260|NCT03383692|561668590|FG001|Overall Study|Clinical progression|1|||
155611261|NCT03383692|561668589|FG000|Overall Study|Adverse Event|3|||
155611262|NCT03383692|561668590|FG001|Overall Study|Adverse Event|0|||
155611263|NCT03816007|561668591|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
155611264|NCT03816007|561668592|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
155611265|NCT03816007|561668591|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
155611266|NCT03816007|561668592|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
155611267|NCT03816007|561668591|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
155611268|NCT03816007|561668592|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
155611269|NCT01428115|561668595|FG000|Overall Study|Lack of Efficacy|3|||
155611270|NCT01428115|561668595|FG000|Overall Study|Lost to Follow-up|10|||
155611271|NCT01428115|561668595|FG000|Overall Study|Pregnancy|1|||
155611272|NCT01428115|561668595|FG000|Overall Study|Protocol Violation|3|||
155611273|NCT01428115|561668595|FG000|Overall Study|Withdrawal by Subject|4|||
155611274|NCT02179749|561668596|FG000|Overall Study|Adverse Event|0|||
155611275|NCT02179749|561668597|FG001|Overall Study|Adverse Event|0|||
155611276|NCT02179749|561668598|FG002|Overall Study|Adverse Event|1|||
155611277|NCT02179749|561668596|FG000|Overall Study|Withdrawal by Subject|0|||
155611278|NCT02179749|561668597|FG001|Overall Study|Withdrawal by Subject|0|||
155611279|NCT02179749|561668598|FG002|Overall Study|Withdrawal by Subject|1|||
155611280|NCT01810783|561668600|FG000|Overall Study|Adverse Event|32|||
155611281|NCT01810783|561668600|FG000|Overall Study|Withdrawal by Subject|22|||
155611282|NCT01810783|561668600|FG000|Overall Study|Lack of Efficacy|12|||
155611283|NCT01810783|561668600|FG000|Overall Study|Lost to Follow-up|10|||
155611284|NCT01810783|561668600|FG000|Overall Study|Protocol Violation|5|||
155611285|NCT01810783|561668600|FG000|Overall Study|Non-compliance with IMP|4|||
155611286|NCT01810783|561668600|FG000|Overall Study|Adminstrative or other reason(s)|23|||
155611287|NCT01810783|561668600|FG000|Overall Study|Enrolled, not treated|1|||
155611288|NCT00793546|561668601|FG000|Overall Study|Death|3|||
155611289|NCT00793546|561668602|FG001|Overall Study|Death|0|||
155611290|NCT00793546|561668601|FG000|Overall Study|Lost to Follow-up|1|||
155611291|NCT00793546|561668602|FG001|Overall Study|Lost to Follow-up|0|||
155611292|NCT00793546|561668601|FG000|Overall Study|Withdrawal by Subject|1|||
155611293|NCT00793546|561668602|FG001|Overall Study|Withdrawal by Subject|1|||
155611294|NCT00793546|561668601|FG000|Overall Study|Study Terminated by Sponsor|8|||
155724843|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
155724844|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
155724845|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Other|1|||
155724846|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Other|5|||
155724847|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Other|0|||
155724848|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Other|2|||
155724849|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Other|3|||
155724850|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
155724851|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
155724852|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
155724853|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
155724854|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
155724855|NCT02006472|562091297|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155724856|NCT02006472|562091298|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
155724857|NCT02006472|562091299|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155611295|NCT00793546|561668602|FG001|Overall Study|Study Terminated by Sponsor|27|||
155611296|NCT00793546|561668601|FG000|Overall Study|Other|1|||
155611297|NCT00793546|561668602|FG001|Overall Study|Other|0|||
155611298|NCT02620384|561668603|FG000|Overall Study|Adverse Event|2|||
155611299|NCT02620384|561668604|FG001|Overall Study|Adverse Event|1|||
155611300|NCT02620384|561668603|FG000|Overall Study|Discharged prior to 2nd dose|2|||
155611301|NCT02620384|561668604|FG001|Overall Study|Discharged prior to 2nd dose|5|||
155611302|NCT02620384|561668603|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
155611303|NCT02620384|561668604|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
155611304|NCT02071082|561668605|FG000|Overall Study|Enrolled and Never Treated|1|||
155611305|NCT02071082|561668606|FG001|Overall Study|Enrolled and Never Treated|1|||
155611306|NCT02071082|561668605|FG000|Overall Study|Adverse Event|0|||
155724858|NCT02006472|562091300|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
155724859|NCT02006472|562091301|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155724860|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155724861|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
155724862|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
155724863|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155724864|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155724865|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
155724866|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
155724867|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
155724868|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
155724869|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
155724870|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
155724871|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
155724872|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
155724873|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
155724874|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
155724875|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Other|0|||
155724876|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Other|1|||
155724877|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Other|0|||
155724878|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Other|1|||
155724879|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Other|0|||
155724880|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Not treated|0|||
155724881|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Not treated|0|||
155724882|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Not treated|2|||
155724883|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Not treated|0|||
155724884|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Not treated|0|||
155724885|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
155724886|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
155724887|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
155724888|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
155724889|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
155724890|NCT02006472|562091297|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
155724891|NCT02006472|562091298|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
155724892|NCT02006472|562091299|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
155724893|NCT02006472|562091300|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
155724894|NCT02006472|562091301|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
155724895|NCT00886379|562091302|FG000|Overall Study|Transferred Schools|0|||
155724896|NCT00886379|562091303|FG001|Overall Study|Transferred Schools|0|||
155724897|NCT00886379|562091304|FG002|Overall Study|Transferred Schools|2|||
155724898|NCT00886379|562091305|FG003|Overall Study|Transferred Schools|1|||
155724899|NCT00886379|562091306|FG004|Overall Study|Transferred Schools|1|||
155724900|NCT00886379|562091302|FG000|Overall Study|Final blood draw not obtained|3|||
155724901|NCT00886379|562091303|FG001|Overall Study|Final blood draw not obtained|3|||
155724902|NCT00886379|562091304|FG002|Overall Study|Final blood draw not obtained|4|||
155724903|NCT00886379|562091305|FG003|Overall Study|Final blood draw not obtained|2|||
155724904|NCT00886379|562091306|FG004|Overall Study|Final blood draw not obtained|2|||
155724905|NCT00459316|562091311|FG000|Steps 1 & 2|Other eligibility failure|1|||
155724906|NCT00459316|562091312|FG001|Steps 1 & 2|Other eligibility failure|1|||
155724907|NCT00459316|562091313|FG002|Steps 1 & 2|Other eligibility failure|0|||
155724908|NCT00459316|562091311|FG000|Steps 1 & 2|Death|1|||
155724909|NCT00459316|562091312|FG001|Steps 1 & 2|Death|1|||
155724910|NCT00459316|562091313|FG002|Steps 1 & 2|Death|0|||
155724911|NCT00459316|562091311|FG000|Steps 1 & 2|Not able to get to clinic|7|||
155724912|NCT00459316|562091312|FG001|Steps 1 & 2|Not able to get to clinic|4|||
155724913|NCT00459316|562091313|FG002|Steps 1 & 2|Not able to get to clinic|0|||
155724914|NCT00459316|562091311|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
155724915|NCT00459316|562091312|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
155724916|NCT00459316|562091313|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
155724917|NCT00459316|562091311|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
155724918|NCT00459316|562091312|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
155724919|NCT00459316|562091313|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
155724920|NCT00459316|562091311|FG000|Steps 1 & 2|Lost to Follow-up|5|||
155724921|NCT00459316|562091312|FG001|Steps 1 & 2|Lost to Follow-up|0|||
155724922|NCT00459316|562091313|FG002|Steps 1 & 2|Lost to Follow-up|2|||
155724923|NCT00459316|562091311|FG000|Step 3|Withdrawal by Subject|3|||
155724924|NCT00459316|562091312|FG001|Step 3|Withdrawal by Subject|0|||
155724925|NCT00459316|562091313|FG002|Step 3|Withdrawal by Subject|1|||
155724926|NCT01614886|562091314|FG000|Overall Study|Adverse Event|15|||
155724927|NCT01614886|562091315|FG001|Overall Study|Adverse Event|20|||
155724928|NCT01614886|562091314|FG000|Overall Study|Withdrawal by Subject|4|||
155724929|NCT01614886|562091315|FG001|Overall Study|Withdrawal by Subject|4|||
155724930|NCT01614886|562091314|FG000|Overall Study|Death|1|||
155724931|NCT01614886|562091315|FG001|Overall Study|Death|0|||
155724932|NCT01614886|562091314|FG000|Overall Study|Protocol deviation|0|||
155724933|NCT01614886|562091315|FG001|Overall Study|Protocol deviation|2|||
155724934|NCT01207414|562091316|FG000|Overall Study|Adverse Event|25|||
155724935|NCT01207414|562091317|FG001|Overall Study|Adverse Event|39|||
155724936|NCT01207414|562091316|FG000|Overall Study|Abnormal test procedure results|0|||
155724937|NCT01207414|562091317|FG001|Overall Study|Abnormal test procedure results|1|||
155724938|NCT01207414|562091316|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155724939|NCT01207414|562091317|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155724940|NCT01207414|562091316|FG000|Overall Study|Patient withdrew consent|14|||
155724941|NCT01207414|562091317|FG001|Overall Study|Patient withdrew consent|11|||
155724942|NCT01207414|562091316|FG000|Overall Study|Lost to Follow-up|15|||
155724943|NCT01207414|562091317|FG001|Overall Study|Lost to Follow-up|17|||
155724944|NCT01207414|562091316|FG000|Overall Study|Administrative problems|1|||
155724945|NCT01207414|562091317|FG001|Overall Study|Administrative problems|1|||
155724946|NCT01207414|562091316|FG000|Overall Study|Protocol deviation|12|||
155724947|NCT01207414|562091317|FG001|Overall Study|Protocol deviation|9|||
155724948|NCT01207414|562091316|FG000|Overall Study|Randomized in error|1|||
155724949|NCT01207414|562091317|FG001|Overall Study|Randomized in error|0|||
155724950|NCT01435382|562091320|FG000|Overall Study|Lost to Follow-up|1|||
155724951|NCT01435382|562091321|FG001|Overall Study|Lost to Follow-up|0|||
155724952|NCT01435382|562091322|FG002|Overall Study|Lost to Follow-up|1|||
155724953|NCT01435382|562091323|FG003|Overall Study|Lost to Follow-up|0|||
155724954|NCT01435382|562091320|FG000|Overall Study|Withdrawal by Subject|0|||
155724955|NCT01435382|562091321|FG001|Overall Study|Withdrawal by Subject|2|||
155724956|NCT01435382|562091322|FG002|Overall Study|Withdrawal by Subject|0|||
155724957|NCT01435382|562091323|FG003|Overall Study|Withdrawal by Subject|1|||
155724958|NCT00910650|562091324|FG000|Overall Study|Death|2|||
155724959|NCT00423579|562091325|FG000|Overall Study|Lost to Follow-up|3|||
155724960|NCT00423579|562091326|FG001|Overall Study|Lost to Follow-up|0|||
155724961|NCT00423579|562091325|FG000|Overall Study|Protocol Violation|1|||
155724962|NCT00423579|562091326|FG001|Overall Study|Protocol Violation|3|||
155724963|NCT00423579|562091325|FG000|Overall Study|Diagnosis of diabetes|0|||
155724964|NCT00423579|562091326|FG001|Overall Study|Diagnosis of diabetes|1|||
155724965|NCT04004988|562091328|FG000|Period 1|Physician Decision|2|||
155724966|NCT04004988|562091329|FG001|Period 1|Physician Decision|0|||
155724967|NCT04004988|562091328|FG000|Period 1|Withdrawal by Subject|0|||
155724968|NCT04004988|562091329|FG001|Period 1|Withdrawal by Subject|1|||
155724969|NCT04004988|562091328|FG000|Period 1|Adverse Event|1|||
155724970|NCT04004988|562091329|FG001|Period 1|Adverse Event|2|||
155724971|NCT03873116|562091330|FG000|Part 1|Study drug discontinuation due to rash|0|||
155724972|NCT03873116|562091331|FG001|Part 1|Study drug discontinuation due to rash|0|||
155724973|NCT03873116|562091332|FG002|Part 1|Study drug discontinuation due to rash|0|||
155724974|NCT03873116|562091333|FG003|Part 1|Study drug discontinuation due to rash|0|||
155724975|NCT03873116|562091334|FG004|Part 1|Study drug discontinuation due to rash|0|||
155724976|NCT03873116|562091335|FG005|Part 1|Study drug discontinuation due to rash|1|||
155724977|NCT03873116|562091330|FG000|Part 2|Withdrawal by Subject|0|||
155724978|NCT03873116|562091331|FG001|Part 2|Withdrawal by Subject|0|||
155724979|NCT03873116|562091332|FG002|Part 2|Withdrawal by Subject|1|||
155724980|NCT03873116|562091333|FG003|Part 2|Withdrawal by Subject|0|||
155724981|NCT03873116|562091334|FG004|Part 2|Withdrawal by Subject|0|||
155724982|NCT03873116|562091335|FG005|Part 2|Withdrawal by Subject|0|||
155724983|NCT03873116|562091330|FG000|Part 2|Lab abnormality or AE|0|||
155724984|NCT03873116|562091331|FG001|Part 2|Lab abnormality or AE|0|||
155724985|NCT03873116|562091332|FG002|Part 2|Lab abnormality or AE|0|||
155724986|NCT03873116|562091333|FG003|Part 2|Lab abnormality or AE|0|||
155724987|NCT03873116|562091334|FG004|Part 2|Lab abnormality or AE|1|||
155724988|NCT03873116|562091335|FG005|Part 2|Lab abnormality or AE|0|||
155724989|NCT03873116|562091330|FG000|Part 3|Withdrawal by Subject|0|||
155724990|NCT03873116|562091331|FG001|Part 3|Withdrawal by Subject|0|||
155724991|NCT03873116|562091332|FG002|Part 3|Withdrawal by Subject|0|||
155724992|NCT03873116|562091333|FG003|Part 3|Withdrawal by Subject|0|||
155724993|NCT03873116|562091334|FG004|Part 3|Withdrawal by Subject|1|||
155724994|NCT03873116|562091335|FG005|Part 3|Withdrawal by Subject|0|||
155724995|NCT04682366|562091336|FG000|Overall Study|Lost to Follow-up|1|||
155724996|NCT04682366|562091337|FG001|Overall Study|Lost to Follow-up|1|||
155724997|NCT02383576|562091338|FG000|Overall Study|Death|53|||
155724998|NCT02383576|562091339|FG001|Overall Study|Death|33|||
155724999|NCT02383576|562091338|FG000|Overall Study|Lost to Follow-up|7|||
155725000|NCT02383576|562091339|FG001|Overall Study|Lost to Follow-up|1|||
155725001|NCT02383576|562091338|FG000|Overall Study|Withdrew Consent|1|||
155725002|NCT02383576|562091339|FG001|Overall Study|Withdrew Consent|6|||
155725003|NCT02383576|562091338|FG000|Overall Study|Investigator's Decision|0|||
155725004|NCT02383576|562091339|FG001|Overall Study|Investigator's Decision|1|||
155725005|NCT02383576|562091338|FG000|Overall Study|Administrative/Other|2|||
155725006|NCT02383576|562091339|FG001|Overall Study|Administrative/Other|4|||
155725007|NCT02738801|562091340|FG000|Overall Study|Adverse Event|1|||
155725008|NCT02738801|562091341|FG001|Overall Study|Adverse Event|1|||
155725009|NCT02738801|562091340|FG000|Overall Study|Withdrawal by Subject|0|||
155725010|NCT02738801|562091341|FG001|Overall Study|Withdrawal by Subject|1|||
155725011|NCT00231816|562091343|FG000|Overall Study|Adverse Event|1|||
155725012|NCT00231816|562091344|FG001|Overall Study|Adverse Event|0|||
155725013|NCT00231816|562091343|FG000|Overall Study|Lost to Follow-up|8|||
155725014|NCT00231816|562091344|FG001|Overall Study|Lost to Follow-up|5|||
155725015|NCT00231816|562091343|FG000|Overall Study|Protocol Violation|2|||
155611307|NCT02071082|561668606|FG001|Overall Study|Adverse Event|1|||
155611308|NCT02071082|561668605|FG000|Overall Study|Withdrew Consent|0|||
155611309|NCT02071082|561668606|FG001|Overall Study|Withdrew Consent|4|||
155611310|NCT02071082|561668605|FG000|Overall Study|Lost to Follow-up|1|||
155611311|NCT02071082|561668606|FG001|Overall Study|Lost to Follow-up|1|||
155611312|NCT02101359|561668607|FG000|Overall Study|Not included|23|||
155611313|NCT02101359|561668608|FG001|Overall Study|Not included|13|||
155611314|NCT02101359|561668607|FG000|Overall Study|Withdrawal by Subject|5|||
155611315|NCT02101359|561668608|FG001|Overall Study|Withdrawal by Subject|4|||
155725016|NCT00231816|562091344|FG001|Overall Study|Protocol Violation|3|||
155611316|NCT02101359|561668607|FG000|Overall Study|Lost to Follow-up|1|||
155611317|NCT02101359|561668608|FG001|Overall Study|Lost to Follow-up|0|||
155611318|NCT02101359|561668607|FG000|Overall Study|Protocol Violation|0|||
155611319|NCT02101359|561668608|FG001|Overall Study|Protocol Violation|2|||
155611320|NCT00494221|561668609|FG000|Overall Study|Death|15|||
155611321|NCT00494221|561668610|FG001|Overall Study|Death|9|||
155611322|NCT00494221|561668611|FG002|Overall Study|Death|14|||
155611323|NCT00494221|561668609|FG000|Overall Study|Withdrawal by Subject|1|||
155611324|NCT00494221|561668610|FG001|Overall Study|Withdrawal by Subject|2|||
155611325|NCT00494221|561668611|FG002|Overall Study|Withdrawal by Subject|0|||
155611326|NCT01841567|561668616|FG000|Overall Study|Adverse Event|3|||
155611327|NCT00630747|561668617|FG000|Overall Study|Death|1|||
155611328|NCT00630747|561668617|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
155611329|NCT00630747|561668617|FG000|Overall Study|Returned to country of origin|1|||
155611330|NCT02732327|561668620|FG000|Overall Study|Protocol Violation|0|||
155725017|NCT00231816|562091343|FG000|Overall Study|Withdrawal by Subject|3|||
155725018|NCT00231816|562091344|FG001|Overall Study|Withdrawal by Subject|3|||
155725019|NCT00231816|562091343|FG000|Overall Study|Other|2|||
155725020|NCT00231816|562091344|FG001|Overall Study|Other|1|||
155725021|NCT01075243|562091345|FG000|Overall Study|Lost to Follow-up|5|||
155725022|NCT01075243|562091346|FG001|Overall Study|Lost to Follow-up|2|||
155725023|NCT01075243|562091347|FG002|Overall Study|Lost to Follow-up|0|||
155725024|NCT01075243|562091345|FG000|Overall Study|Withdrawal by Subject|1|||
155725025|NCT01075243|562091346|FG001|Overall Study|Withdrawal by Subject|1|||
155725026|NCT01075243|562091347|FG002|Overall Study|Withdrawal by Subject|0|||
155725027|NCT00551642|562091348|FG000|Treatment Period|Protocol Deviation|6|||
155725028|NCT00551642|562091349|FG001|Treatment Period|Protocol Deviation|11|||
155725029|NCT00551642|562091348|FG000|Treatment Period|Delivery device failure|1|||
155611331|NCT02732327|561668621|FG001|Overall Study|Protocol Violation|1|||
155611332|NCT04503668|561668622|FG000|Overall Study|Incomplete data|4|||
155611333|NCT04503668|561668623|FG001|Overall Study|Incomplete data|3|||
155725030|NCT00551642|562091349|FG001|Treatment Period|Delivery device failure|3|||
155725031|NCT00551642|562091348|FG000|Treatment Period|Physician Decision|0|||
155725032|NCT00551642|562091349|FG001|Treatment Period|Physician Decision|1|||
155725033|NCT00551642|562091348|FG000|Treatment Period|Death|33|||
155725034|NCT00551642|562091349|FG001|Treatment Period|Death|31|||
155725035|NCT00551642|562091348|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
155725036|NCT00551642|562091349|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
155725037|NCT00551642|562091348|FG000|Treatment Period|Adverse Event|15|||
155725038|NCT00551642|562091349|FG001|Treatment Period|Adverse Event|12|||
155725039|NCT00551642|562091348|FG000|Treatment Period|Withdrawal by Subject|2|||
155725040|NCT00551642|562091349|FG001|Treatment Period|Withdrawal by Subject|1|||
155725041|NCT03337308|562091350|FG000|Overall Study|Adverse Event|2|||
155725042|NCT03337308|562091351|FG001|Overall Study|Adverse Event|3|||
155725043|NCT03337308|562091352|FG002|Overall Study|Adverse Event|3|||
155725044|NCT03337308|562091353|FG003|Overall Study|Adverse Event|1|||
155725045|NCT03337308|562091350|FG000|Overall Study|Lost to Follow-up|1|||
155725046|NCT03337308|562091351|FG001|Overall Study|Lost to Follow-up|2|||
155725047|NCT03337308|562091352|FG002|Overall Study|Lost to Follow-up|0|||
155725048|NCT03337308|562091353|FG003|Overall Study|Lost to Follow-up|0|||
155725049|NCT03337308|562091350|FG000|Overall Study|Withdrawal by Subject|2|||
155725050|NCT03337308|562091351|FG001|Overall Study|Withdrawal by Subject|1|||
155725051|NCT03337308|562091352|FG002|Overall Study|Withdrawal by Subject|2|||
155725052|NCT03337308|562091353|FG003|Overall Study|Withdrawal by Subject|1|||
155611334|NCT04503668|561668622|FG000|Overall Study|Withdrawal by Subject|1|||
155611335|NCT04503668|561668623|FG001|Overall Study|Withdrawal by Subject|1|||
155611336|NCT04503668|561668622|FG000|Overall Study|Adverse Event|2|||
155611337|NCT04503668|561668623|FG001|Overall Study|Adverse Event|0|||
155611338|NCT02306694|561668624|FG000|Overall Study|Withdrawal by Subject|3|||
155611339|NCT02306694|561668624|FG000|Overall Study|Lost to Follow-up|1|||
155611340|NCT00603382|561668625|FG000|Overall Study|Adverse Event|0|||
155611341|NCT00603382|561668626|FG001|Overall Study|Adverse Event|1|||
155611342|NCT00603382|561668627|FG002|Overall Study|Adverse Event|1|||
155725053|NCT03337308|562091350|FG000|Overall Study|Protocol Violation|0|||
155725054|NCT03337308|562091351|FG001|Overall Study|Protocol Violation|1|||
155725055|NCT03337308|562091352|FG002|Overall Study|Protocol Violation|0|||
155725056|NCT03337308|562091353|FG003|Overall Study|Protocol Violation|0|||
155725057|NCT05135767|562091359|FG000|Baseline|Lost to Follow-up|1|||
155725058|NCT05135767|562091360|FG001|Baseline|Lost to Follow-up|1|||
155725059|NCT05135767|562091359|FG000|Baseline|Withdrawal by Subject|0|||
155725060|NCT05135767|562091360|FG001|Baseline|Withdrawal by Subject|2|||
155725061|NCT05135767|562091359|FG000|Active Study Phase|Lost to Follow-up|2|||
155725062|NCT05135767|562091360|FG001|Active Study Phase|Lost to Follow-up|0|||
155725063|NCT02694185|562091361|FG000|Overall Study|Withdrawal by Subject|45|||
155725064|NCT02694185|562091362|FG001|Overall Study|Withdrawal by Subject|0|||
155725065|NCT02532517|562091363|FG000|Overall Study|Did not complete 24-Month visit|4|||
155725066|NCT02532517|562091363|FG000|Overall Study|Failed Angiographic eligibility|1|||
155725067|NCT02532517|562091363|FG000|Overall Study|Lost to Follow-up|4|||
155725068|NCT02532517|562091363|FG000|Overall Study|Withdrawal by Subject|4|||
155725069|NCT02532517|562091363|FG000|Overall Study|Death|4|||
155725070|NCT03312231|562091364|FG000|Overall Study|Lost to Follow-up|2|||
155725071|NCT03312231|562091365|FG001|Overall Study|Lost to Follow-up|6|||
155725072|NCT03312231|562091366|FG002|Overall Study|Lost to Follow-up|1|||
155725073|NCT03312231|562091367|FG003|Overall Study|Lost to Follow-up|3|||
155725074|NCT03312231|562091368|FG004|Overall Study|Lost to Follow-up|1|||
155725075|NCT03312231|562091364|FG000|Overall Study|Withdrawal by Subject|0|||
155725076|NCT03312231|562091365|FG001|Overall Study|Withdrawal by Subject|3|||
155725077|NCT03312231|562091366|FG002|Overall Study|Withdrawal by Subject|1|||
155725078|NCT03312231|562091367|FG003|Overall Study|Withdrawal by Subject|0|||
155725079|NCT03312231|562091368|FG004|Overall Study|Withdrawal by Subject|0|||
155725080|NCT03312231|562091364|FG000|Overall Study|Death|0|||
155725081|NCT03312231|562091365|FG001|Overall Study|Death|1|||
155725082|NCT03312231|562091366|FG002|Overall Study|Death|1|||
155725083|NCT03312231|562091367|FG003|Overall Study|Death|0|||
155725084|NCT03312231|562091368|FG004|Overall Study|Death|0|||
155725085|NCT03312231|562091364|FG000|Overall Study|Study Vaccination not Received|1|||
155725086|NCT03312231|562091365|FG001|Overall Study|Study Vaccination not Received|1|||
155725087|NCT03312231|562091366|FG002|Overall Study|Study Vaccination not Received|1|||
155725088|NCT03312231|562091367|FG003|Overall Study|Study Vaccination not Received|0|||
155725089|NCT03312231|562091368|FG004|Overall Study|Study Vaccination not Received|0|||
155725090|NCT03157830|562091369|FG000|Overall Study|Lost to Follow-up|1|||
155725091|NCT03157830|562091369|FG000|Overall Study|Withdrawal by Subject|1|||
155725092|NCT05417438|562091370|FG000|Overall Study|Withdrawal by Subject|3|||
155725093|NCT04272242|562091375|FG000|Overall Study|Withdrawal by Subject|3|||
155725094|NCT04272242|562091375|FG000|Overall Study|Lost to Follow-up|1|||
155725095|NCT04272242|562091375|FG000|Overall Study|Adverse Event|1|||
155725096|NCT02681523|562091378|FG000|Overall Study|Adverse Event|1|||
155725097|NCT02681523|562091378|FG000|Overall Study|Patient Non-compliance|1|||
155725098|NCT03253393|562091383|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
155725099|NCT03253393|562091384|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
155725100|NCT03253393|562091385|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
155725101|NCT03204188|562091386|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
155725102|NCT03204188|562091386|FG000|Immunotherapy Phase (1 Year)|Death|1|||
155725103|NCT03204188|562091386|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
155725104|NCT03204188|562091386|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
155725105|NCT01350999|562091388|FG000|Overall Study|Adverse Event|4|||
155725106|NCT01350999|562091389|FG001|Overall Study|Adverse Event|9|||
155725107|NCT01350999|562091390|FG002|Overall Study|Adverse Event|10|||
155725108|NCT01350999|562091388|FG000|Overall Study|Voluntary withdrawal|3|||
155725109|NCT01350999|562091389|FG001|Overall Study|Voluntary withdrawal|4|||
155725110|NCT01350999|562091390|FG002|Overall Study|Voluntary withdrawal|6|||
155725111|NCT01350999|562091388|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
155725112|NCT01350999|562091389|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
155725113|NCT01350999|562091390|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
155725114|NCT01462370|562093689|FG000|Overall Study|Lack of Qualifying Event|1|||
155725115|NCT01462370|562093690|FG001|Overall Study|Lack of Qualifying Event|1|||
155725116|NCT01462370|562093689|FG000|Overall Study|Physician Decision|0|||
155725117|NCT01462370|562093690|FG001|Overall Study|Physician Decision|1|||
155725118|NCT01462370|562093689|FG000|Overall Study|Withdrawal by Subject|0|||
155725119|NCT01462370|562093690|FG001|Overall Study|Withdrawal by Subject|3|||
155725120|NCT03198715|562093693|FG000|Overall Study|Death|0|||
155725121|NCT03198715|562093694|FG001|Overall Study|Death|0|||
155725122|NCT03198715|562093695|FG002|Overall Study|Death|1|||
155725123|NCT03198715|562093696|FG003|Overall Study|Death|0|||
155381622|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155725124|NCT03198715|562093697|FG004|Overall Study|Death|2|||
155725125|NCT03198715|562093693|FG000|Overall Study|Other|0|||
155725126|NCT03198715|562093694|FG001|Overall Study|Other|1|||
155725127|NCT03198715|562093695|FG002|Overall Study|Other|1|||
155725128|NCT03198715|562093696|FG003|Overall Study|Other|0|||
155725129|NCT03198715|562093697|FG004|Overall Study|Other|0|||
155725130|NCT00473564|562093698|FG000|Overall Study|robot surgery aborted in OR|23|||
155725131|NCT00914316|562093699|FG000|Phase 1|Physician Decision|4|||
155725132|NCT00914316|562093700|FG001|Phase 1|Physician Decision|0|||
155725133|NCT00914316|562093701|FG002|Phase 1|Physician Decision|1|||
155611343|NCT00603382|561668628|FG003|Overall Study|Adverse Event|2|||
155611344|NCT00603382|561668629|FG004|Overall Study|Adverse Event|1|||
155611345|NCT00603382|561668630|FG005|Overall Study|Adverse Event|2|||
155611346|NCT00603382|561668625|FG000|Overall Study|Lack of Efficacy|14|||
155611347|NCT00603382|561668626|FG001|Overall Study|Lack of Efficacy|9|||
155611348|NCT00603382|561668627|FG002|Overall Study|Lack of Efficacy|3|||
155611349|NCT00603382|561668628|FG003|Overall Study|Lack of Efficacy|6|||
155611350|NCT00603382|561668629|FG004|Overall Study|Lack of Efficacy|6|||
155611351|NCT00603382|561668630|FG005|Overall Study|Lack of Efficacy|11|||
155611352|NCT00603382|561668625|FG000|Overall Study|Protocol Violation|1|||
155611353|NCT00603382|561668626|FG001|Overall Study|Protocol Violation|0|||
155611354|NCT00603382|561668627|FG002|Overall Study|Protocol Violation|1|||
155611355|NCT00603382|561668628|FG003|Overall Study|Protocol Violation|2|||
155611356|NCT00603382|561668629|FG004|Overall Study|Protocol Violation|1|||
155611357|NCT00603382|561668630|FG005|Overall Study|Protocol Violation|0|||
155611358|NCT00603382|561668625|FG000|Overall Study|Lost to Follow-up|0|||
155611359|NCT00603382|561668626|FG001|Overall Study|Lost to Follow-up|1|||
155611360|NCT00603382|561668627|FG002|Overall Study|Lost to Follow-up|1|||
155611361|NCT00603382|561668628|FG003|Overall Study|Lost to Follow-up|1|||
155611362|NCT00603382|561668629|FG004|Overall Study|Lost to Follow-up|0|||
155611363|NCT00603382|561668630|FG005|Overall Study|Lost to Follow-up|1|||
155611364|NCT00603382|561668625|FG000|Overall Study|Physician Decision|0|||
155611365|NCT00603382|561668626|FG001|Overall Study|Physician Decision|0|||
155611366|NCT00603382|561668627|FG002|Overall Study|Physician Decision|2|||
155611367|NCT00603382|561668628|FG003|Overall Study|Physician Decision|0|||
155611368|NCT00603382|561668629|FG004|Overall Study|Physician Decision|1|||
155611369|NCT00603382|561668630|FG005|Overall Study|Physician Decision|3|||
155611370|NCT00603382|561668625|FG000|Overall Study|Withdrawal by Subject|3|||
155611371|NCT00603382|561668626|FG001|Overall Study|Withdrawal by Subject|3|||
155611372|NCT00603382|561668627|FG002|Overall Study|Withdrawal by Subject|1|||
155611373|NCT00603382|561668628|FG003|Overall Study|Withdrawal by Subject|1|||
155611374|NCT00603382|561668629|FG004|Overall Study|Withdrawal by Subject|0|||
155611375|NCT00603382|561668630|FG005|Overall Study|Withdrawal by Subject|1|||
155611376|NCT00395642|561668631|FG000|Overall Study|Death|4|||
155611377|NCT00395642|561668631|FG000|Overall Study|Lost to Follow-up|1|||
155611378|NCT00395642|561668631|FG000|Overall Study|Physician Decision|7|||
155611379|NCT00395642|561668631|FG000|Overall Study|Withdrawal by Subject|1|||
155611380|NCT01573754|561668637|FG000|Overall Study|Noncompliance or remission not achieved|3|||
155611381|NCT01573754|561668638|FG001|Overall Study|Noncompliance or remission not achieved|15|||
155611382|NCT01078298|561668641|FG000|Overall Study|Lost to Follow-up|12|||
155611383|NCT01078298|561668642|FG001|Overall Study|Lost to Follow-up|13|||
155611384|NCT01078298|561668641|FG000|Overall Study|Withdrawal by Subject|31|||
155611385|NCT01078298|561668642|FG001|Overall Study|Withdrawal by Subject|33|||
155611386|NCT01078298|561668641|FG000|Overall Study|Protocol Violation|6|||
155611387|NCT01078298|561668642|FG001|Overall Study|Protocol Violation|6|||
155611388|NCT01078298|561668641|FG000|Overall Study|Adverse Event|6|||
155611389|NCT01078298|561668642|FG001|Overall Study|Adverse Event|5|||
155611390|NCT01078298|561668641|FG000|Overall Study|Death|2|||
155611391|NCT01078298|561668642|FG001|Overall Study|Death|0|||
155611392|NCT01078298|561668641|FG000|Overall Study|Did not meet entrance criteria|0|||
155611393|NCT01078298|561668642|FG001|Overall Study|Did not meet entrance criteria|1|||
155611394|NCT01078298|561668641|FG000|Overall Study|Other|24|||
155611395|NCT01078298|561668642|FG001|Overall Study|Other|32|||
155725134|NCT00914316|562093702|FG003|Phase 1|Physician Decision|2|||
155725135|NCT00914316|562093699|FG000|Phase 1|Withdrawal by Subject|0|||
155725136|NCT00914316|562093700|FG001|Phase 1|Withdrawal by Subject|2|||
155725137|NCT00914316|562093701|FG002|Phase 1|Withdrawal by Subject|4|||
155725138|NCT00914316|562093702|FG003|Phase 1|Withdrawal by Subject|0|||
155725139|NCT00914316|562093699|FG000|Phase 1|Adverse Event|1|||
155725140|NCT00914316|562093700|FG001|Phase 1|Adverse Event|0|||
155725141|NCT00914316|562093701|FG002|Phase 1|Adverse Event|0|||
155725142|NCT00914316|562093702|FG003|Phase 1|Adverse Event|0|||
155725143|NCT00914316|562093699|FG000|Phase 2|Withdrawal by Subject|1|||
155725144|NCT00914316|562093700|FG001|Phase 2|Withdrawal by Subject|0|||
155725145|NCT00914316|562093701|FG002|Phase 2|Withdrawal by Subject|1|||
155611396|NCT00659776|561668646|FG000|Overall Study|Withdrawal by Subject|12|||
155611397|NCT00659776|561668647|FG001|Overall Study|Withdrawal by Subject|2|||
155611398|NCT00659776|561668648|FG002|Overall Study|Withdrawal by Subject|0|||
155611399|NCT00742027|561668649|FG000|Overall Study|Disease Progression|76|||
155611400|NCT00742027|561668649|FG000|Overall Study|New Cancer Therapy|19|||
155611401|NCT00742027|561668649|FG000|Overall Study|Withdrawal by Subject|18|||
155611402|NCT00742027|561668649|FG000|Overall Study|Death|7|||
155611403|NCT00742027|561668649|FG000|Overall Study|Lost to Follow-up|4|||
155611404|NCT00742027|561668649|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
155611405|NCT00742027|561668649|FG000|Overall Study|Missing|2|||
155611406|NCT00742027|561668649|FG000|Overall Study|Administrative Problems|1|||
155611407|NCT01180049|561668650|FG000|Overall Study|Other|9|||
155611408|NCT01180049|561668651|FG001|Overall Study|Other|7|||
155725146|NCT00914316|562093702|FG003|Phase 2|Withdrawal by Subject|0|||
155725147|NCT03131219|562093703|FG000|Initial Evaluation Period|Adverse Event|2|||
155725148|NCT03131219|562093704|FG001|Initial Evaluation Period|Adverse Event|0|||
155725149|NCT03131219|562093703|FG000|Initial Evaluation Period|Protocol Violation|1|||
155725150|NCT03131219|562093704|FG001|Initial Evaluation Period|Protocol Violation|0|||
155725151|NCT03131219|562093703|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
155725152|NCT03131219|562093704|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
155725153|NCT03131219|562093703|FG000|Initial Evaluation Period|Physician Decision|1|||
155725154|NCT03131219|562093704|FG001|Initial Evaluation Period|Physician Decision|0|||
155725155|NCT03131219|562093703|FG000|Extension Period|Physician Decision|1|||
155725156|NCT03131219|562093704|FG001|Extension Period|Physician Decision|0|||
155725157|NCT00616759|562093706|FG000|Overall Study|Physician Decision|2|||
155725158|NCT00616759|562093707|FG001|Overall Study|Physician Decision|0|||
155725159|NCT00616759|562093706|FG000|Overall Study|Withdrawal by Subject|1|||
155725160|NCT00616759|562093707|FG001|Overall Study|Withdrawal by Subject|2|||
155725161|NCT02399163|562093710|FG000|Overall Study|Adverse Event|2|||
155725162|NCT02399163|562093710|FG000|Overall Study|Protocol Deviation|2|||
155725163|NCT02399163|562093710|FG000|Overall Study|Withdrawal by Participant|5|||
155725164|NCT04225897|562093714|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725165|NCT04225897|562093715|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
155725166|NCT04225897|562093716|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725167|NCT04225897|562093717|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725168|NCT04225897|562093718|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725169|NCT04225897|562093719|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725170|NCT04225897|562093720|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725171|NCT04225897|562093721|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725172|NCT04225897|562093722|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725173|NCT04225897|562093723|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725174|NCT04225897|562093724|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725175|NCT04225897|562093725|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155725176|NCT04225897|562093714|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725177|NCT04225897|562093715|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725178|NCT04225897|562093716|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
155725179|NCT04225897|562093717|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725180|NCT04225897|562093718|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725181|NCT04225897|562093719|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725182|NCT04225897|562093720|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725183|NCT04225897|562093721|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725184|NCT04225897|562093722|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725185|NCT04225897|562093723|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725186|NCT04225897|562093724|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725187|NCT04225897|562093725|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155725188|NCT04225897|562093714|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725189|NCT04225897|562093715|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725190|NCT04225897|562093716|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
155725191|NCT04225897|562093717|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725192|NCT04225897|562093718|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725193|NCT04225897|562093719|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725194|NCT04225897|562093720|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725195|NCT04225897|562093721|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725196|NCT04225897|562093722|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725197|NCT04225897|562093723|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725198|NCT04225897|562093724|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725199|NCT04225897|562093725|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155725200|NCT04225897|562093714|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725201|NCT04225897|562093715|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725202|NCT04225897|562093716|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725203|NCT04225897|562093717|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725204|NCT04225897|562093718|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725205|NCT04225897|562093719|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725206|NCT04225897|562093720|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725207|NCT04225897|562093721|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
155725208|NCT04225897|562093722|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725209|NCT04225897|562093723|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725210|NCT04225897|562093724|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725211|NCT04225897|562093725|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155725212|NCT00074711|562093726|FG000|Overall Study|Withdrawal by Subject|1|||
155725213|NCT00074711|562093727|FG001|Overall Study|Withdrawal by Subject|1|||
155725214|NCT00074711|562093726|FG000|Overall Study|Lost to Follow-up|10|||
155611409|NCT01180049|561668650|FG000|Overall Study|Lost to Follow-up|8|||
155611410|NCT01180049|561668651|FG001|Overall Study|Lost to Follow-up|6|||
155725215|NCT00074711|562093727|FG001|Overall Study|Lost to Follow-up|8|||
155725216|NCT00074711|562093726|FG000|Overall Study|Participant stopped study drug|4|||
155725217|NCT00074711|562093727|FG001|Overall Study|Participant stopped study drug|6|||
155725218|NCT03466658|562093728|FG000|Overall Study|Withdrawal by Subject|3|||
155725219|NCT00360230|562093733|FG000|Overall Study|Withdrawal by Subject|1|||
155725220|NCT00360230|562093734|FG001|Overall Study|Withdrawal by Subject|1|||
155725221|NCT00360230|562093735|FG002|Overall Study|Withdrawal by Subject|0|||
155725222|NCT00360230|562093736|FG003|Overall Study|Withdrawal by Subject|1|||
155725223|NCT00360230|562093737|FG004|Overall Study|Withdrawal by Subject|1|||
155725224|NCT00360230|562093738|FG005|Overall Study|Withdrawal by Subject|1|||
155725225|NCT00360230|562093739|FG006|Overall Study|Withdrawal by Subject|0|||
155725226|NCT00360230|562093733|FG000|Overall Study|Migrated|4|||
155725227|NCT00360230|562093734|FG001|Overall Study|Migrated|1|||
155725228|NCT00360230|562093735|FG002|Overall Study|Migrated|3|||
155725229|NCT00360230|562093736|FG003|Overall Study|Migrated|1|||
155725230|NCT00360230|562093737|FG004|Overall Study|Migrated|4|||
155725231|NCT00360230|562093738|FG005|Overall Study|Migrated|1|||
155725232|NCT00360230|562093739|FG006|Overall Study|Migrated|1|||
155725233|NCT00360230|562093733|FG000|Overall Study|Other|1|||
155725234|NCT00360230|562093734|FG001|Overall Study|Other|0|||
155611411|NCT01180049|561668650|FG000|Overall Study|Death|36|||
155611412|NCT01180049|561668651|FG001|Overall Study|Death|35|||
155611413|NCT00628927|561668652|FG000|Overall Study|Problems performing blood draw|6|||
155611414|NCT00628927|561668653|FG001|Overall Study|Problems performing blood draw|0|||
155611415|NCT00628927|561668652|FG000|Overall Study|Lost to Follow-up|1|||
155611416|NCT00628927|561668653|FG001|Overall Study|Lost to Follow-up|0|||
155611417|NCT00628927|561668652|FG000|Overall Study|Equipment failure|1|||
155611418|NCT00628927|561668653|FG001|Overall Study|Equipment failure|0|||
155611419|NCT01298141|561668657|FG000|Overall Study|Adverse Event|3|||
155611420|NCT01298141|561668657|FG000|Overall Study|Refusal of Required Study Procedures|1|||
155611421|NCT01298141|561668657|FG000|Overall Study|Withdrawal by Subject|6|||
155611422|NCT01298141|561668657|FG000|Overall Study|Termination of Study by the Investigator|5|||
155611423|NCT01298141|561668657|FG000|Overall Study|Other|5|||
155611424|NCT01298141|561668657|FG000|Overall Study|Lost to Follow-up|1|||
155611425|NCT01298141|561668657|FG000|Overall Study|Death|6|||
155611426|NCT01298141|561668657|FG000|Overall Study|Not treated|4|||
155611427|NCT02109445|561668658|FG000|Overall Study|Symptomatic deterioration|2|||
155611428|NCT02109445|561668658|FG000|Overall Study|Adverse Event|1|||
155611429|NCT00958412|561668659|FG000|Overall Study|Study prematurely terminated|18|||
155611430|NCT02552888|561668660|FG000|Overall Study|Lost to Follow-up|1|||
155611431|NCT02552888|561668661|FG001|Overall Study|Lost to Follow-up|1|||
155611432|NCT04227405|561670232|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
155611433|NCT04227405|561670233|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
155611434|NCT04227405|561670232|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
155611435|NCT04227405|561670233|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
155611436|NCT04227405|561670232|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
155611437|NCT04227405|561670233|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
155611438|NCT03396822|561670234|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
155611439|NCT03396822|561670234|FG000|Overall Study|Physician Decision|1|||
155611440|NCT04985942|561670235|FG000|Overall Study|Adverse Event|14|||
155611441|NCT04985942|561670236|FG001|Overall Study|Adverse Event|2|||
155611442|NCT04985942|561670235|FG000|Overall Study|Lack of Efficacy|0|||
155725235|NCT00360230|562093735|FG002|Overall Study|Other|0|||
155725236|NCT00360230|562093736|FG003|Overall Study|Other|0|||
155725237|NCT00360230|562093737|FG004|Overall Study|Other|0|||
155725238|NCT00360230|562093738|FG005|Overall Study|Other|0|||
155725239|NCT00360230|562093739|FG006|Overall Study|Other|0|||
155725240|NCT00360230|562093733|FG000|Overall Study|Protocol Violation|0|||
155725241|NCT00360230|562093734|FG001|Overall Study|Protocol Violation|0|||
155725242|NCT00360230|562093735|FG002|Overall Study|Protocol Violation|0|||
155725243|NCT00360230|562093736|FG003|Overall Study|Protocol Violation|0|||
155611443|NCT04985942|561670236|FG001|Overall Study|Lack of Efficacy|3|||
155611444|NCT04985942|561670235|FG000|Overall Study|Lost to Follow-up|1|||
155611445|NCT04985942|561670236|FG001|Overall Study|Lost to Follow-up|1|||
155725244|NCT00360230|562093737|FG004|Overall Study|Protocol Violation|0|||
155611446|NCT04985942|561670235|FG000|Overall Study|Protocol Violation|1|||
155611447|NCT04985942|561670236|FG001|Overall Study|Protocol Violation|1|||
155611448|NCT04985942|561670235|FG000|Overall Study|Withdrawal by Subject|5|||
155611449|NCT04985942|561670236|FG001|Overall Study|Withdrawal by Subject|4|||
155611450|NCT01128400|561670241|FG000|Overall Study|Lost to Follow-up|1|||
155611451|NCT01128400|561670242|FG001|Overall Study|Lost to Follow-up|0|||
155725245|NCT00360230|562093738|FG005|Overall Study|Protocol Violation|1|||
155725246|NCT00360230|562093739|FG006|Overall Study|Protocol Violation|0|||
155725247|NCT00360230|562093733|FG000|Overall Study|Death|0|||
155725248|NCT00360230|562093734|FG001|Overall Study|Death|1|||
155725249|NCT00360230|562093735|FG002|Overall Study|Death|0|||
155725250|NCT00360230|562093736|FG003|Overall Study|Death|0|||
155725251|NCT00360230|562093737|FG004|Overall Study|Death|0|||
155725252|NCT00360230|562093738|FG005|Overall Study|Death|1|||
155725253|NCT00360230|562093739|FG006|Overall Study|Death|1|||
155725254|NCT02703597|562093740|FG000|Assignment to Baseline|Lost to Follow-up|17|||
155725255|NCT02703597|562093741|FG001|Assignment to Baseline|Lost to Follow-up|16|||
155725256|NCT02703597|562093740|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
155725257|NCT02703597|562093741|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
155725258|NCT02703597|562093740|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
155725259|NCT02703597|562093741|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
155725260|NCT02703597|562093740|FG000|First Post-test to First Follow-up|Site drop out|0|||
155725261|NCT02703597|562093741|FG001|First Post-test to First Follow-up|Site drop out|58|||
155725262|NCT02703597|562093740|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
155725263|NCT02703597|562093741|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
155725264|NCT02703597|562093740|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
155725265|NCT02703597|562093741|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
155725266|NCT02703597|562093740|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
155725267|NCT02703597|562093741|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
155725268|NCT03219723|562093742|FG000|Overall Study|Case Report Forms Uncollected|6|||
155725269|NCT03219723|562093742|FG000|Overall Study|Protocol Deviation|4|||
155725270|NCT02461758|562093743|FG000|Overall Study|Lost to Follow-up|0|||
155725271|NCT02461758|562093744|FG001|Overall Study|Lost to Follow-up|1|||
155725272|NCT02461758|562093745|FG002|Overall Study|Lost to Follow-up|1|||
155725273|NCT02461758|562093746|FG003|Overall Study|Lost to Follow-up|0|||
155725274|NCT00929695|562093747|FG000|Overall Study|Death|2|||
155725275|NCT00929695|562093748|FG001|Overall Study|Death|1|||
155725276|NCT00929695|562093747|FG000|Overall Study|Withdrawal by Subject|0|||
155725277|NCT00929695|562093748|FG001|Overall Study|Withdrawal by Subject|2|||
155725278|NCT00929695|562093747|FG000|Overall Study|discharge home|4|||
155725279|NCT00929695|562093748|FG001|Overall Study|discharge home|3|||
155611452|NCT01128400|561670243|FG002|Overall Study|Lost to Follow-up|1|||
155611453|NCT01128400|561670241|FG000|Overall Study|Screening failure|1|||
155725280|NCT00929695|562093747|FG000|Overall Study|incorrect stratification|2|||
155725281|NCT00929695|562093748|FG001|Overall Study|incorrect stratification|0|||
155725282|NCT01352715|562093749|FG000|Overall Study|Death|3|||
155725283|NCT01352715|562093750|FG001|Overall Study|Death|3|||
155725284|NCT01352715|562093749|FG000|Overall Study|Lost to Follow-up|5|||
155725285|NCT01352715|562093750|FG001|Overall Study|Lost to Follow-up|7|||
155725286|NCT01352715|562093749|FG000|Overall Study|Withdrawal by Subject|4|||
155725287|NCT01352715|562093750|FG001|Overall Study|Withdrawal by Subject|8|||
155611454|NCT01128400|561670242|FG001|Overall Study|Screening failure|0|||
155611455|NCT01128400|561670243|FG002|Overall Study|Screening failure|0|||
155611456|NCT01128400|561670241|FG000|Overall Study|were not invited to participate on taste|0|||
155611457|NCT01128400|561670242|FG001|Overall Study|were not invited to participate on taste|0|||
155611458|NCT01128400|561670243|FG002|Overall Study|were not invited to participate on taste|15|||
155611459|NCT01128400|561670241|FG000|Overall Study|Excluded due to sinus problems|0|||
155611460|NCT01128400|561670242|FG001|Overall Study|Excluded due to sinus problems|1|||
155611461|NCT01128400|561670243|FG002|Overall Study|Excluded due to sinus problems|0|||
155611462|NCT03488563|561670244|FG000|Overall Study|Lost to Follow-up|7|||
155611463|NCT03488563|561670245|FG001|Overall Study|Lost to Follow-up|6|||
155611464|NCT03488563|561670246|FG002|Overall Study|Lost to Follow-up|7|||
155611465|NCT03488563|561670244|FG000|Overall Study|Withdrawal by Subject|8|||
155611466|NCT03488563|561670245|FG001|Overall Study|Withdrawal by Subject|7|||
155611467|NCT03488563|561670246|FG002|Overall Study|Withdrawal by Subject|7|||
155611468|NCT03488563|561670244|FG000|Overall Study|Physician Decision|0|||
155611469|NCT03488563|561670245|FG001|Overall Study|Physician Decision|0|||
155611470|NCT03488563|561670246|FG002|Overall Study|Physician Decision|1|||
155611471|NCT03488563|561670244|FG000|Overall Study|Protocol Violation|3|||
155611472|NCT03488563|561670245|FG001|Overall Study|Protocol Violation|2|||
155611473|NCT03488563|561670246|FG002|Overall Study|Protocol Violation|6|||
155611474|NCT03488563|561670244|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
155611475|NCT03488563|561670245|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
155611476|NCT03488563|561670246|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
155611477|NCT03488563|561670244|FG000|Overall Study|Use of prohibited medication|2|||
155611478|NCT03488563|561670245|FG001|Overall Study|Use of prohibited medication|0|||
155611479|NCT03488563|561670246|FG002|Overall Study|Use of prohibited medication|0|||
155611480|NCT03488563|561670244|FG000|Overall Study|Adverse Event|1|||
155611481|NCT03488563|561670245|FG001|Overall Study|Adverse Event|0|||
155611482|NCT03488563|561670246|FG002|Overall Study|Adverse Event|1|||
155611483|NCT03488563|561670244|FG000|Overall Study|Subject returned for ET visit|0|||
155725288|NCT01352715|562093749|FG000|Overall Study|site closure|16|||
155611484|NCT03488563|561670245|FG001|Overall Study|Subject returned for ET visit|1|||
155611485|NCT03488563|561670246|FG002|Overall Study|Subject returned for ET visit|0|||
155611486|NCT03488563|561670244|FG000|Overall Study|Sponsor's decision|0|||
155611487|NCT03488563|561670245|FG001|Overall Study|Sponsor's decision|0|||
155611488|NCT03488563|561670246|FG002|Overall Study|Sponsor's decision|1|||
155611489|NCT01411319|561670253|FG000|Overall Study|Lost to Follow-up|1|||
155611490|NCT00460239|561670273|FG000|Overall Study|Physician Decision|0|||
155611491|NCT00460239|561670274|FG001|Overall Study|Physician Decision|1|||
155611492|NCT00460239|561670275|FG002|Overall Study|Physician Decision|0|||
155611493|NCT00460239|561670276|FG003|Overall Study|Physician Decision|0|||
155611494|NCT00460239|561670277|FG004|Overall Study|Physician Decision|0|||
155611495|NCT00460239|561670278|FG005|Overall Study|Physician Decision|2|||
155611496|NCT00460239|561670279|FG006|Overall Study|Physician Decision|0|||
155611497|NCT00460239|561670280|FG007|Overall Study|Physician Decision|0|||
155611498|NCT00460239|561670281|FG008|Overall Study|Physician Decision|0|||
155611499|NCT00460239|561670273|FG000|Overall Study|Withdrawal by Subject|0|||
155611500|NCT00460239|561670274|FG001|Overall Study|Withdrawal by Subject|0|||
155611501|NCT00460239|561670275|FG002|Overall Study|Withdrawal by Subject|0|||
155611502|NCT00460239|561670276|FG003|Overall Study|Withdrawal by Subject|0|||
155611503|NCT00460239|561670277|FG004|Overall Study|Withdrawal by Subject|0|||
155611504|NCT00460239|561670278|FG005|Overall Study|Withdrawal by Subject|1|||
155611505|NCT00460239|561670279|FG006|Overall Study|Withdrawal by Subject|0|||
155611506|NCT00460239|561670280|FG007|Overall Study|Withdrawal by Subject|0|||
155611507|NCT00460239|561670281|FG008|Overall Study|Withdrawal by Subject|0|||
155611508|NCT01535443|561670284|FG000|Overall Study|Physician Decision|3|||
155611509|NCT00760487|561670288|FG000|Overall Study|Unilateral implantation|3|||
155611510|NCT02260817|561670292|FG000|Overall Study|Lost to Follow-up|0|||
155611511|NCT02260817|561670293|FG001|Overall Study|Lost to Follow-up|14|||
155611512|NCT02260817|561670292|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
155611513|NCT02260817|561670293|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
155611514|NCT02260817|561670292|FG000|Overall Study|Observation, no biopsy|0|||
155611515|NCT02260817|561670293|FG001|Overall Study|Observation, no biopsy|1|||
155611516|NCT02260817|561670292|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
155611517|NCT02260817|561670293|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
155611518|NCT02260817|561670292|FG000|Overall Study|Protocol Violation|0|||
155611519|NCT02260817|561670293|FG001|Overall Study|Protocol Violation|14|||
155611520|NCT03299101|561670294|FG000|Overall Study|Lost to Follow-up|1|||
155611521|NCT03299101|561670294|FG000|Overall Study|Withdrawal by Subject|5|||
155611522|NCT03299101|561670294|FG000|Overall Study|Surgery was changed|3|||
155611523|NCT03299101|561670294|FG000|Overall Study|Not enough time to complete prehab|1|||
155611524|NCT05259917|561670301|FG000|Overall Study|Protocol Violation|0|||
155611525|NCT05259917|561670302|FG001|Overall Study|Protocol Violation|0|||
155611526|NCT05259917|561670303|FG002|Overall Study|Protocol Violation|1|||
155611527|NCT05259917|561670304|FG003|Overall Study|Protocol Violation|0|||
155611528|NCT05259917|561670305|FG004|Overall Study|Protocol Violation|0|||
155611529|NCT05259917|561670306|FG005|Overall Study|Protocol Violation|0|||
155725289|NCT01352715|562093750|FG001|Overall Study|site closure|15|||
155725290|NCT01352715|562093749|FG000|Overall Study|no final visit in closeout period|15|||
155725291|NCT01352715|562093750|FG001|Overall Study|no final visit in closeout period|12|||
155725292|NCT01352715|562093749|FG000|Overall Study|major ineligibility|2|||
155725293|NCT01352715|562093750|FG001|Overall Study|major ineligibility|1|||
155725294|NCT02000440|562093751|FG000|Overall Study|Adverse Event|3|||
155725295|NCT02000440|562093751|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
155725296|NCT05966142|562093759|FG000|Overall Study|Death|3|||
155725297|NCT05966142|562093760|FG001|Overall Study|Death|3|||
155725298|NCT05966142|562093759|FG000|Overall Study|Lost to Follow-up|55|||
155725299|NCT05966142|562093760|FG001|Overall Study|Lost to Follow-up|52|||
155725300|NCT05966142|562093759|FG000|Overall Study|Physician Decision|1|||
155725301|NCT05966142|562093760|FG001|Overall Study|Physician Decision|0|||
155725302|NCT05966142|562093759|FG000|Overall Study|Withdrawal by Subject|9|||
155725303|NCT05966142|562093760|FG001|Overall Study|Withdrawal by Subject|8|||
155725304|NCT05966142|562093759|FG000|Overall Study|Duplicate Enrollment|1|||
155725305|NCT05966142|562093760|FG001|Overall Study|Duplicate Enrollment|0|||
155725306|NCT05966142|562093759|FG000|Overall Study|Study Logistical Reason|1|||
155725307|NCT05966142|562093760|FG001|Overall Study|Study Logistical Reason|0|||
155725308|NCT05966142|562093759|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
155725309|NCT05966142|562093760|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
155725310|NCT04849364|562093761|FG000|Overall Study|Eligibility criteria not meet|0|||
155611530|NCT05259917|561670301|FG000|Overall Study|Lost to Follow-up|0|||
155611531|NCT05259917|561670302|FG001|Overall Study|Lost to Follow-up|0|||
155725311|NCT04849364|562093762|FG001|Overall Study|Eligibility criteria not meet|1|||
155725312|NCT04849364|562093763|FG002|Overall Study|Eligibility criteria not meet|0|||
155725313|NCT01643668|562093764|FG000|Overall Study|Death|1|||
155725314|NCT03253796|562093767|FG000|Period 1: Run-In|Adverse Event|4|||
155611532|NCT05259917|561670303|FG002|Overall Study|Lost to Follow-up|1|||
155611533|NCT05259917|561670304|FG003|Overall Study|Lost to Follow-up|0|||
155611534|NCT05259917|561670305|FG004|Overall Study|Lost to Follow-up|0|||
155611535|NCT05259917|561670306|FG005|Overall Study|Lost to Follow-up|1|||
155611536|NCT05259917|561670301|FG000|Overall Study|Physician Decision|0|||
155725315|NCT03253796|562093768|FG001|Period 1: Run-In|Adverse Event|0|||
155725316|NCT03253796|562093769|FG002|Period 1: Run-In|Adverse Event|0|||
155725317|NCT03253796|562093770|FG003|Period 1: Run-In|Adverse Event|0|||
155725318|NCT03253796|562093771|FG004|Period 1: Run-In|Adverse Event|0|||
155725319|NCT03253796|562093767|FG000|Period 1: Run-In|Lack of Efficacy|1|||
155725320|NCT03253796|562093768|FG001|Period 1: Run-In|Lack of Efficacy|0|||
155725321|NCT03253796|562093769|FG002|Period 1: Run-In|Lack of Efficacy|0|||
155725322|NCT03253796|562093770|FG003|Period 1: Run-In|Lack of Efficacy|0|||
155725323|NCT03253796|562093771|FG004|Period 1: Run-In|Lack of Efficacy|0|||
155725324|NCT03253796|562093767|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
155725325|NCT03253796|562093768|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
155725326|NCT03253796|562093769|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
155725327|NCT03253796|562093770|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
155725328|NCT03253796|562093771|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
155725329|NCT03253796|562093767|FG000|Period 1: Run-In|Protocol Violation|5|||
155725330|NCT03253796|562093768|FG001|Period 1: Run-In|Protocol Violation|0|||
155725331|NCT03253796|562093769|FG002|Period 1: Run-In|Protocol Violation|0|||
155725332|NCT03253796|562093770|FG003|Period 1: Run-In|Protocol Violation|0|||
155725333|NCT03253796|562093771|FG004|Period 1: Run-In|Protocol Violation|0|||
155725334|NCT03253796|562093767|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
155725335|NCT03253796|562093768|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
155725336|NCT03253796|562093769|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
155725337|NCT03253796|562093770|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
155725338|NCT03253796|562093771|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
155725339|NCT03253796|562093767|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155725340|NCT03253796|562093768|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155725341|NCT03253796|562093769|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
155725342|NCT03253796|562093770|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155725343|NCT03253796|562093771|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155725344|NCT03253796|562093767|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155725345|NCT03253796|562093768|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155725346|NCT03253796|562093769|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
155725347|NCT03253796|562093770|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155725348|NCT03253796|562093771|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155725349|NCT03253796|562093767|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155725350|NCT03253796|562093768|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155725351|NCT03253796|562093769|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
155725352|NCT03253796|562093770|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
155725353|NCT03253796|562093771|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155725354|NCT03253796|562093767|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155725355|NCT03253796|562093768|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155725356|NCT03253796|562093769|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
155725357|NCT03253796|562093770|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155725358|NCT03253796|562093771|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155725359|NCT03253796|562093767|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
155725360|NCT03253796|562093768|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
155725361|NCT03253796|562093769|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
155725362|NCT03253796|562093770|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
155611537|NCT05259917|561670302|FG001|Overall Study|Physician Decision|1|||
155611538|NCT05259917|561670303|FG002|Overall Study|Physician Decision|0|||
155611539|NCT05259917|561670304|FG003|Overall Study|Physician Decision|0|||
155611540|NCT05259917|561670305|FG004|Overall Study|Physician Decision|0|||
155611541|NCT05259917|561670306|FG005|Overall Study|Physician Decision|0|||
155611542|NCT05259917|561670301|FG000|Overall Study|Withdrawal by Subject|0|||
155611543|NCT05259917|561670302|FG001|Overall Study|Withdrawal by Subject|1|||
155611544|NCT05259917|561670303|FG002|Overall Study|Withdrawal by Subject|0|||
155611545|NCT05259917|561670304|FG003|Overall Study|Withdrawal by Subject|0|||
155611546|NCT05259917|561670305|FG004|Overall Study|Withdrawal by Subject|1|||
155611547|NCT05259917|561670306|FG005|Overall Study|Withdrawal by Subject|1|||
155611548|NCT05259917|561670301|FG000|Overall Study|Trial Termination by Sponsor|7|||
155611549|NCT05259917|561670302|FG001|Overall Study|Trial Termination by Sponsor|2|||
155611550|NCT05259917|561670303|FG002|Overall Study|Trial Termination by Sponsor|3|||
155611551|NCT05259917|561670304|FG003|Overall Study|Trial Termination by Sponsor|5|||
155611552|NCT05259917|561670305|FG004|Overall Study|Trial Termination by Sponsor|11|||
155611553|NCT05259917|561670306|FG005|Overall Study|Trial Termination by Sponsor|4|||
155611554|NCT05259917|561670301|FG000|Overall Study|Other|1|||
155611555|NCT05259917|561670302|FG001|Overall Study|Other|0|||
155611556|NCT05259917|561670303|FG002|Overall Study|Other|2|||
155611557|NCT05259917|561670304|FG003|Overall Study|Other|0|||
155611558|NCT05259917|561670305|FG004|Overall Study|Other|0|||
155611559|NCT05259917|561670306|FG005|Overall Study|Other|0|||
155611560|NCT00592592|561670307|FG000|Overall Study|Patient found ineligible upon chart review|1|||
155611561|NCT00435188|561670311|FG000|Overall Study|Death|1|||
155611562|NCT00435188|561670312|FG001|Overall Study|Death|6|||
155611563|NCT00435188|561670311|FG000|Overall Study|Withdrawal by Subject|16|||
155611564|NCT00435188|561670312|FG001|Overall Study|Withdrawal by Subject|11|||
155611565|NCT00435188|561670311|FG000|Overall Study|Lost to Follow-up|5|||
155611566|NCT00435188|561670312|FG001|Overall Study|Lost to Follow-up|6|||
155611567|NCT01915771|561670313|FG000|Day 1|Withdrawal by Subject|1|||
155611568|NCT01915771|561670313|FG000|Day 15|Withdrawal by Subject|1|||
155611569|NCT00575510|561670316|FG000|Overall Study|Lost to Follow-up|4|||
155611570|NCT00575510|561670317|FG001|Overall Study|Lost to Follow-up|6|||
155611571|NCT00575510|561670318|FG002|Overall Study|Lost to Follow-up|9|||
155611572|NCT00575510|561670316|FG000|Overall Study|Withdrawal by Subject|1|||
155611573|NCT00575510|561670317|FG001|Overall Study|Withdrawal by Subject|0|||
155611574|NCT00575510|561670318|FG002|Overall Study|Withdrawal by Subject|0|||
155725363|NCT03253796|562093771|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
155725364|NCT03253796|562093767|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155725365|NCT03253796|562093768|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155725366|NCT03253796|562093769|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155725367|NCT03253796|562093770|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155725368|NCT03253796|562093771|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
155725369|NCT00528112|562093772|FG000|Treatment up to 3 Years|Adverse Event|313|||
155725370|NCT00528112|562093773|FG001|Treatment up to 3 Years|Adverse Event|278|||
155725371|NCT00528112|562093772|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
155725372|NCT00528112|562093773|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
155725373|NCT00528112|562093772|FG000|Treatment up to 3 Years|Protocol Violation|16|||
155725374|NCT00528112|562093773|FG001|Treatment up to 3 Years|Protocol Violation|16|||
155725375|NCT00528112|562093772|FG000|Treatment up to 3 Years|Death|0|||
155725376|NCT00528112|562093773|FG001|Treatment up to 3 Years|Death|1|||
155725377|NCT00528112|562093772|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
155725378|NCT00528112|562093773|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
155725379|NCT00528112|562093772|FG000|Treatment up to 3 Years|Pregnancy|9|||
155725380|NCT00528112|562093773|FG001|Treatment up to 3 Years|Pregnancy|10|||
155725381|NCT00528112|562093772|FG000|Treatment up to 3 Years|Other reasons|186|||
155725382|NCT00528112|562093773|FG001|Treatment up to 3 Years|Other reasons|186|||
155725383|NCT00528112|562093772|FG000|Extension Phase|Withdrawal by Subject|0|||
155725384|NCT00528112|562093773|FG001|Extension Phase|Withdrawal by Subject|3|||
155725385|NCT00528112|562093772|FG000|Extension Phase|Other reasons|0|||
155725386|NCT00528112|562093773|FG001|Extension Phase|Other reasons|100|||
155725387|NCT00528112|562093772|FG000|Extension Phase|Pregnancy|0|||
155725388|NCT00528112|562093773|FG001|Extension Phase|Pregnancy|3|||
155725389|NCT00528112|562093772|FG000|Extension Phase|Lost to Follow-up|0|||
155725390|NCT00528112|562093773|FG001|Extension Phase|Lost to Follow-up|12|||
155725391|NCT00528112|562093772|FG000|Extension Phase|Death|0|||
155725392|NCT00528112|562093773|FG001|Extension Phase|Death|1|||
155725393|NCT00528112|562093772|FG000|Extension Phase|Adverse Event|0|||
155725394|NCT00528112|562093773|FG001|Extension Phase|Adverse Event|36|||
155725395|NCT00528112|562093772|FG000|Extension Phase|Protocol Violation|0|||
155725396|NCT00528112|562093773|FG001|Extension Phase|Protocol Violation|2|||
155725397|NCT02559622|562093774|FG000|Overall Study|Progressive disease|0|||
155381623|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381624|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381625|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381626|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381627|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
155381628|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381629|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381630|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
155381631|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381632|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381633|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
155381634|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
155381635|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
155381636|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
155611575|NCT00575510|561670316|FG000|Overall Study|Clinic Called Patient|7|||
155611576|NCT00575510|561670317|FG001|Overall Study|Clinic Called Patient|7|||
155611577|NCT00575510|561670318|FG002|Overall Study|Clinic Called Patient|7|||
155611578|NCT00575510|561670316|FG000|Overall Study|Pregnancy|0|||
155725398|NCT02559622|562093775|FG001|Overall Study|Progressive disease|1|||
155725399|NCT02559622|562093776|FG002|Overall Study|Progressive disease|0|||
155725400|NCT02559622|562093777|FG003|Overall Study|Progressive disease|0|||
155725401|NCT02559622|562093774|FG000|Overall Study|Adverse Event|0|||
155725402|NCT02559622|562093775|FG001|Overall Study|Adverse Event|2|||
155725403|NCT02559622|562093776|FG002|Overall Study|Adverse Event|2|||
155725404|NCT02559622|562093777|FG003|Overall Study|Adverse Event|2|||
155725405|NCT02559622|562093774|FG000|Overall Study|Patient/guardian decision|1|||
155725406|NCT02559622|562093775|FG001|Overall Study|Patient/guardian decision|2|||
155725407|NCT02559622|562093776|FG002|Overall Study|Patient/guardian decision|0|||
155725408|NCT02559622|562093777|FG003|Overall Study|Patient/guardian decision|1|||
155725409|NCT00894803|562093778|FG000|Overall Study|Death|20|||
155725410|NCT00894803|562093779|FG001|Overall Study|Death|4|||
155725411|NCT00894803|562093778|FG000|Overall Study|Lost to Follow-up|0|||
155725412|NCT00894803|562093779|FG001|Overall Study|Lost to Follow-up|1|||
155725413|NCT00449696|562093780|FG000|Overall Study|Other Treatment Required|6|||
155725414|NCT00449696|562093781|FG001|Overall Study|Other Treatment Required|1|||
155725415|NCT00449696|562093780|FG000|Overall Study|Withdrawal by Subject|5|||
155725416|NCT00449696|562093781|FG001|Overall Study|Withdrawal by Subject|5|||
155725417|NCT00449696|562093780|FG000|Overall Study|Lost to Follow-up|2|||
155725418|NCT00449696|562093781|FG001|Overall Study|Lost to Follow-up|3|||
155725419|NCT00449696|562093780|FG000|Overall Study|Others|7|||
155725420|NCT00449696|562093781|FG001|Overall Study|Others|0|||
155725421|NCT01033019|562093784|FG000|Overall Study|Withdrawal by Subject|1|||
155725422|NCT01033019|562093785|FG001|Overall Study|Withdrawal by Subject|0|||
155725423|NCT01052493|562093788|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
155725424|NCT01052493|562093789|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
155725425|NCT01052493|562093790|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
155725426|NCT03944577|562093798|FG000|Overall Study|Adverse Event|3|||
155725427|NCT03011099|562093801|FG000|Overall Study|Withdrawal by Subject|0|||
155725428|NCT03011099|562093802|FG001|Overall Study|Withdrawal by Subject|2|||
155725429|NCT00283296|562093805|FG000|Overall Study|in-home trial not completed|5|||
155725430|NCT03558737|562093806|FG000|Overall Study|Death|1|||
155725431|NCT03558737|562093807|FG001|Overall Study|Death|1|||
155725432|NCT01294553|562093808|FG000|Overall Study|Duplicated Participants|1|||
155725433|NCT01294553|562093808|FG000|Overall Study|Protocol Violation|268|||
155725434|NCT01217229|562093809|FG000|Overall Study|Adverse Event|1|||
155725435|NCT01217229|562093809|FG000|Overall Study|Disease progression, deterioration|2|||
155725436|NCT01217229|562093809|FG000|Overall Study|Disease progression, Cheson criteria|14|||
155725437|NCT01217229|562093809|FG000|Overall Study|Protocol Violation|1|||
155725438|NCT01217229|562093809|FG000|Overall Study|Disease progression not confirmed|2|||
155725439|NCT00453206|562093811|FG000|Overall Study|Death|1|||
155725440|NCT03058146|562093812|FG000|Overall Study|Withdrawal by Subject|4|||
155725441|NCT03058146|562093813|FG001|Overall Study|Withdrawal by Subject|1|||
155725442|NCT03058146|562093812|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
155725443|NCT03058146|562093813|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
155725444|NCT00632229|562093814|FG000|Overall Study|Adverse Event|6|||
155725445|NCT00632229|562093815|FG001|Overall Study|Adverse Event|0|||
155725446|NCT00632229|562093814|FG000|Overall Study|Lost to Follow-up|0|||
155725447|NCT00632229|562093815|FG001|Overall Study|Lost to Follow-up|3|||
155725448|NCT00632229|562093814|FG000|Overall Study|Lack of Efficacy|0|||
155725449|NCT00632229|562093815|FG001|Overall Study|Lack of Efficacy|2|||
155725450|NCT00632229|562093814|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
155725451|NCT00632229|562093815|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
155725452|NCT00577889|562093816|FG000|Overall Study|Withdrawal by Subject|1|||
155725453|NCT00577889|562093817|FG001|Overall Study|Withdrawal by Subject|0|||
155725454|NCT00577889|562093818|FG002|Overall Study|Withdrawal by Subject|0|||
155725455|NCT03041181|562093820|FG000|Overall Study|Disease Progression|1|||
155725456|NCT03041181|562093821|FG001|Overall Study|Disease Progression|2|||
155725457|NCT01903460|562093824|FG000|Overall Study|Adverse Event|0|||
155725458|NCT01903460|562093825|FG001|Overall Study|Adverse Event|0|||
155725459|NCT01903460|562093826|FG002|Overall Study|Adverse Event|0|||
155725460|NCT01903460|562093827|FG003|Overall Study|Adverse Event|1|||
155725461|NCT03104868|562093828|FG000|6 Week Follow up|Lost to Follow-up|5|||
155725462|NCT03104868|562093829|FG001|6 Week Follow up|Lost to Follow-up|8|||
155725463|NCT03104868|562093828|FG000|6 Week Follow up|Death|1|||
155725464|NCT03104868|562093829|FG001|6 Week Follow up|Death|1|||
155725465|NCT03104868|562093828|FG000|6 Week Follow up|Withdrawal by Subject|7|||
155725466|NCT03104868|562093829|FG001|6 Week Follow up|Withdrawal by Subject|6|||
155725467|NCT03104868|562093828|FG000|6 Week Follow up|Completed Later Timepoint|24|||
155725468|NCT03104868|562093829|FG001|6 Week Follow up|Completed Later Timepoint|22|||
155725469|NCT03104868|562093828|FG000|6 Month Follow up|Lost to Follow-up|2|||
155725470|NCT03104868|562093829|FG001|6 Month Follow up|Lost to Follow-up|2|||
155725471|NCT03104868|562093828|FG000|6 Month Follow up|Death|0|||
155725472|NCT03104868|562093829|FG001|6 Month Follow up|Death|1|||
155725473|NCT03104868|562093828|FG000|6 Month Follow up|Completed Later Timepoint|22|||
155725474|NCT03104868|562093829|FG001|6 Month Follow up|Completed Later Timepoint|32|||
155725475|NCT03104868|562093828|FG000|12 Month Follow up|Lost to Follow-up|1|||
155725476|NCT03104868|562093829|FG001|12 Month Follow up|Lost to Follow-up|2|||
155725477|NCT03104868|562093828|FG000|12 Month Follow up|Death|0|||
155725478|NCT03104868|562093829|FG001|12 Month Follow up|Death|1|||
155725479|NCT03104868|562093828|FG000|12 Month Follow up|Withdrawal by Subject|0|||
155725480|NCT03104868|562093829|FG001|12 Month Follow up|Withdrawal by Subject|3|||
155611579|NCT00575510|561670317|FG001|Overall Study|Pregnancy|0|||
155611580|NCT00575510|561670318|FG002|Overall Study|Pregnancy|1|||
155611581|NCT02697734|561670319|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
155611582|NCT02697734|561670320|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
155611583|NCT02697734|561670319|FG000|Core Phase - up to Week 48|Adverse Event|1|||
155611584|NCT02697734|561670320|FG001|Core Phase - up to Week 48|Adverse Event|2|||
155611585|NCT02697734|561670319|FG000|Core Phase - up to Week 48|Physician Decision|1|||
155611586|NCT02697734|561670320|FG001|Core Phase - up to Week 48|Physician Decision|0|||
155611587|NCT02697734|561670319|FG000|Optional Extension Phase|Adverse Event|5|||
155611588|NCT02697734|561670320|FG001|Optional Extension Phase|Adverse Event|1|||
155611589|NCT02697734|561670319|FG000|Optional Extension Phase|Physician Decision|0|||
155611590|NCT02697734|561670320|FG001|Optional Extension Phase|Physician Decision|1|||
155611591|NCT02324699|561670321|FG000|Overall Study|study terminated|1|||
155611592|NCT03970200|561670322|FG000|Overall Study|Death|2|||
155611593|NCT03970200|561670323|FG001|Overall Study|Death|2|||
155611594|NCT03970200|561670324|FG002|Overall Study|Death|1|||
155611595|NCT03970200|561670322|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
155611596|NCT03970200|561670323|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
155611597|NCT03970200|561670324|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
155611598|NCT01098162|561670325|FG000|Overall Study|Adverse Event|37|||
155611599|NCT01098162|561670325|FG000|Overall Study|Lack of Efficacy|4|||
155611600|NCT01098162|561670325|FG000|Overall Study|Wish of Patient|7|||
155611601|NCT01098162|561670325|FG000|Overall Study|Lost to Follow-up|9|||
155611602|NCT01098162|561670325|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
155611603|NCT01098162|561670325|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
155611604|NCT01098162|561670325|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
155611605|NCT01098162|561670325|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
155611606|NCT01098162|561670325|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
155611607|NCT01098162|561670325|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
155611608|NCT01098162|561670325|FG000|Overall Study|Other Reason|1|||
155611609|NCT01098162|561670325|FG000|Overall Study|Reason Unknown|26|||
155611610|NCT01605825|561670326|FG000|Overall Study|Adverse Event|4|||
155611611|NCT01605825|561670327|FG001|Overall Study|Adverse Event|2|||
155611612|NCT01605825|561670326|FG000|Overall Study|Withdrawal by Subject|0|||
155725481|NCT03104868|562093828|FG000|12 Month Follow up|Completed Later Timepoint|32|||
155725482|NCT03104868|562093829|FG001|12 Month Follow up|Completed Later Timepoint|29|||
155725483|NCT03104868|562093828|FG000|18 Month Follow up|Lost to Follow-up|7|||
155725484|NCT03104868|562093829|FG001|18 Month Follow up|Lost to Follow-up|11|||
155725485|NCT03104868|562093828|FG000|18 Month Follow up|Death|2|||
155725486|NCT03104868|562093829|FG001|18 Month Follow up|Death|1|||
155725487|NCT03104868|562093828|FG000|18 Month Follow up|Withdrawal by Subject|1|||
155725488|NCT03104868|562093829|FG001|18 Month Follow up|Withdrawal by Subject|2|||
155725489|NCT03104868|562093828|FG000|18 Month Follow up|Graft Loss|1|||
155725490|NCT03104868|562093829|FG001|18 Month Follow up|Graft Loss|1|||
155725491|NCT03104868|562093828|FG000|18 Month Follow up|Completed Later Timepoint|19|||
155725492|NCT03104868|562093829|FG001|18 Month Follow up|Completed Later Timepoint|20|||
155725493|NCT03104868|562093828|FG000|24 Month Follow up|Lost to Follow-up|15|||
155725494|NCT03104868|562093829|FG001|24 Month Follow up|Lost to Follow-up|16|||
155725495|NCT03104868|562093828|FG000|24 Month Follow up|Death|3|||
155725496|NCT03104868|562093829|FG001|24 Month Follow up|Death|2|||
155725497|NCT03104868|562093828|FG000|24 Month Follow up|Withdrawal by Subject|1|||
155725498|NCT03104868|562093829|FG001|24 Month Follow up|Withdrawal by Subject|0|||
155725499|NCT03104868|562093828|FG000|24 Month Follow up|Graft Loss|2|||
155725500|NCT03104868|562093829|FG001|24 Month Follow up|Graft Loss|0|||
155725501|NCT00005780|562093830|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
155725502|NCT04973449|562093831|FG000|Overall Study|Withdrawal by Subject|3|||
155725503|NCT04973449|562093832|FG001|Overall Study|Withdrawal by Subject|3|||
155725504|NCT04973449|562093833|FG002|Overall Study|Withdrawal by Subject|2|||
155725505|NCT04973449|562093834|FG003|Overall Study|Withdrawal by Subject|5|||
155725506|NCT04973449|562093835|FG004|Overall Study|Withdrawal by Subject|5|||
155725507|NCT04973449|562093836|FG005|Overall Study|Withdrawal by Subject|4|||
155725508|NCT04973449|562093837|FG006|Overall Study|Withdrawal by Subject|7|||
155725509|NCT04973449|562093838|FG007|Overall Study|Withdrawal by Subject|5|||
155725510|NCT04973449|562093831|FG000|Overall Study|Lost to Follow-up|15|||
155725511|NCT04973449|562093832|FG001|Overall Study|Lost to Follow-up|16|||
155725512|NCT04973449|562093833|FG002|Overall Study|Lost to Follow-up|16|||
155725513|NCT04973449|562093834|FG003|Overall Study|Lost to Follow-up|13|||
155725514|NCT04973449|562093835|FG004|Overall Study|Lost to Follow-up|5|||
155611613|NCT01605825|561670327|FG001|Overall Study|Withdrawal by Subject|1|||
155611614|NCT01605825|561670326|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
155611615|NCT01605825|561670327|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
155611616|NCT01605825|561670326|FG000|Overall Study|Non-Compliance with Protocol|3|||
155611617|NCT01605825|561670327|FG001|Overall Study|Non-Compliance with Protocol|0|||
155611618|NCT00380718|561670330|FG000|Overall Study|Adverse Event|1|||
155611619|NCT00380718|561670330|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
155611620|NCT01706575|561670332|FG000|Overall Study|Participant Withdrew Consent|4|||
155611621|NCT01706575|561670332|FG000|Overall Study|Lost to Follow-up|2|||
155611622|NCT01706575|561670332|FG000|Overall Study|Started but not Treated|6|||
155611623|NCT00621517|561670337|FG000|Overall Study|Lost to Follow-up|3|||
155611624|NCT00621517|561670338|FG001|Overall Study|Lost to Follow-up|3|||
155611625|NCT00621517|561670337|FG000|Overall Study|Withdrawal by Subject|3|||
155611626|NCT00621517|561670338|FG001|Overall Study|Withdrawal by Subject|4|||
155611627|NCT00621517|561670337|FG000|Overall Study|Adverse Event|1|||
155611628|NCT00621517|561670338|FG001|Overall Study|Adverse Event|0|||
155611629|NCT02155322|561670343|FG000|Overall Study|Adverse Event|1|||
155611630|NCT02155322|561670343|FG000|Overall Study|Physician Decision|1|||
155611631|NCT02155322|561670343|FG000|Overall Study|Relapse/Recurrence|8|||
155611632|NCT02155322|561670343|FG000|Overall Study|Withdrawal by Subject|4|||
155611633|NCT01215435|561670351|FG000|Overall Study|Adverse Event|1|||
155611634|NCT01215435|561670352|FG001|Overall Study|Adverse Event|0|||
155611635|NCT01215435|561670351|FG000|Overall Study|Protocol Violation|2|||
155611636|NCT01215435|561670352|FG001|Overall Study|Protocol Violation|0|||
155611637|NCT01215435|561670351|FG000|Overall Study|Withdrawal Criteria|8|||
155611638|NCT01215435|561670352|FG001|Overall Study|Withdrawal Criteria|11|||
155611639|NCT01215435|561670351|FG000|Overall Study|Lost to Follow-up|3|||
155611640|NCT01215435|561670352|FG001|Overall Study|Lost to Follow-up|0|||
155611641|NCT01215435|561670351|FG000|Overall Study|Unclassified|5|||
155611642|NCT01215435|561670352|FG001|Overall Study|Unclassified|5|||
155611643|NCT00840034|561670353|FG000|Acute Treatment Phase|Adverse Event|6|||
155611644|NCT00840034|561670354|FG001|Acute Treatment Phase|Adverse Event|8|||
155611645|NCT00840034|561670353|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
155611646|NCT00840034|561670354|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
155611647|NCT00840034|561670353|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
155611648|NCT00840034|561670354|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
155611649|NCT00840034|561670353|FG000|Acute Treatment Phase|Physician Decision|0|||
155611650|NCT00840034|561670354|FG001|Acute Treatment Phase|Physician Decision|1|||
155611651|NCT00840034|561670353|FG000|Acute Treatment Phase|Protocol Violation|2|||
155611652|NCT00840034|561670354|FG001|Acute Treatment Phase|Protocol Violation|4|||
155611653|NCT00840034|561670353|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
155611654|NCT00840034|561670354|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
155611655|NCT00840034|561670353|FG000|Taper Phase|Adverse Event|1|||
155611656|NCT00840034|561670354|FG001|Taper Phase|Adverse Event|0|||
155611657|NCT00840034|561670353|FG000|Taper Phase|Lost to Follow-up|1|||
155611658|NCT00840034|561670354|FG001|Taper Phase|Lost to Follow-up|1|||
155611659|NCT00840034|561670353|FG000|Taper Phase|Withdrawal by Subject|1|||
155611660|NCT00840034|561670354|FG001|Taper Phase|Withdrawal by Subject|1|||
155611661|NCT02839876|561670363|FG000|Overall Study|Protocol Violation|10|||
155611662|NCT02839876|561670364|FG001|Overall Study|Protocol Violation|11|||
155611663|NCT00636961|561670365|FG000|Period 1|Administrative problems|1|||
155611664|NCT00636961|561670366|FG001|Period 1|Administrative problems|1|||
155611665|NCT00636961|561670365|FG000|Period 2|Adverse Event|1|||
155611666|NCT00636961|561670366|FG001|Period 2|Adverse Event|0|||
155611667|NCT01156051|561670369|FG000|Overall Study|Lost to Follow-up|1|||
155611668|NCT01156051|561670370|FG001|Overall Study|Lost to Follow-up|0|||
155611669|NCT01156051|561670369|FG000|Overall Study|patient not compliant with protocol|0|||
155611670|NCT01156051|561670370|FG001|Overall Study|patient not compliant with protocol|1|||
155611671|NCT01738191|561670371|FG000|Overall Study|Withdrawal by Subject|4|||
155611672|NCT01738191|561670372|FG001|Overall Study|Withdrawal by Subject|1|||
155611673|NCT02483572|561670373|FG000|Overall Study|Withdrawal by Subject|1|||
155611674|NCT02483572|561670374|FG001|Overall Study|Withdrawal by Subject|0|||
155611675|NCT02483572|561670373|FG000|Overall Study|Lost to Follow-up|1|||
155611676|NCT02483572|561670374|FG001|Overall Study|Lost to Follow-up|0|||
155611677|NCT02483572|561670373|FG000|Overall Study|Physician Decision|0|||
155611678|NCT02483572|561670374|FG001|Overall Study|Physician Decision|1|||
155611679|NCT00350779|561670375|FG000|Overall Study|Adverse Event|4|||
155611680|NCT00350779|561670376|FG001|Overall Study|Adverse Event|2|||
155611681|NCT00350779|561670375|FG000|Overall Study|Lack of Efficacy|0|||
155611682|NCT00350779|561670376|FG001|Overall Study|Lack of Efficacy|4|||
155611683|NCT00350779|561670375|FG000|Overall Study|Lost to Follow-up|2|||
155611684|NCT00350779|561670376|FG001|Overall Study|Lost to Follow-up|0|||
155611685|NCT00350779|561670375|FG000|Overall Study|Physician Decision|2|||
155611686|NCT00350779|561670376|FG001|Overall Study|Physician Decision|4|||
155611687|NCT00350779|561670375|FG000|Overall Study|Protocol Violation|3|||
155611688|NCT00350779|561670376|FG001|Overall Study|Protocol Violation|1|||
155611689|NCT00350779|561670375|FG000|Overall Study|Withdrawal by Subject|9|||
155611690|NCT00350779|561670376|FG001|Overall Study|Withdrawal by Subject|8|||
155611691|NCT00350779|561670375|FG000|Overall Study|Patient Moved|2|||
155611692|NCT00350779|561670376|FG001|Overall Study|Patient Moved|1|||
155611693|NCT00350779|561670375|FG000|Overall Study|Non-compliance with study procedures|0|||
155611694|NCT00350779|561670376|FG001|Overall Study|Non-compliance with study procedures|1|||
155611695|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
155611696|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611697|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155725515|NCT04973449|562093836|FG005|Overall Study|Lost to Follow-up|6|||
155725516|NCT04973449|562093837|FG006|Overall Study|Lost to Follow-up|10|||
155725517|NCT04973449|562093838|FG007|Overall Study|Lost to Follow-up|6|||
155725518|NCT04973449|562093831|FG000|Overall Study|Death|1|||
155725519|NCT04973449|562093832|FG001|Overall Study|Death|0|||
155725520|NCT04973449|562093833|FG002|Overall Study|Death|0|||
155725521|NCT04973449|562093834|FG003|Overall Study|Death|0|||
155725522|NCT04973449|562093835|FG004|Overall Study|Death|0|||
155725523|NCT04973449|562093836|FG005|Overall Study|Death|1|||
155725524|NCT04973449|562093837|FG006|Overall Study|Death|0|||
155725525|NCT04973449|562093838|FG007|Overall Study|Death|0|||
155725526|NCT04973449|562093831|FG000|Overall Study|Other|1|||
155725527|NCT04973449|562093832|FG001|Overall Study|Other|1|||
155725528|NCT04973449|562093833|FG002|Overall Study|Other|2|||
155725529|NCT04973449|562093834|FG003|Overall Study|Other|1|||
155725530|NCT04973449|562093835|FG004|Overall Study|Other|4|||
155725531|NCT04973449|562093836|FG005|Overall Study|Other|0|||
155725532|NCT04973449|562093837|FG006|Overall Study|Other|2|||
155725533|NCT04973449|562093838|FG007|Overall Study|Other|2|||
155725534|NCT00521079|562093839|FG000|Overall Study|Adverse Event|7|||
155725535|NCT00521079|562093840|FG001|Overall Study|Adverse Event|1|||
155725536|NCT00521079|562093839|FG000|Overall Study|Lost to Follow-up|2|||
155725537|NCT00521079|562093840|FG001|Overall Study|Lost to Follow-up|1|||
155725538|NCT00521079|562093839|FG000|Overall Study|Withdrawal by Subject|5|||
155725539|NCT00521079|562093840|FG001|Overall Study|Withdrawal by Subject|3|||
155725540|NCT00888173|562093841|FG000|Overall Study|Wrong Primary|1|||
155725541|NCT00888173|562093841|FG000|Overall Study|Ineligible: required test not done|1|||
155725542|NCT04408989|562093849|FG000|Overall Study|Lost to Follow-up|0|||
155725543|NCT04408989|562093850|FG001|Overall Study|Lost to Follow-up|0|||
155725544|NCT04408989|562093851|FG002|Overall Study|Lost to Follow-up|1|||
155725545|NCT04408989|562093849|FG000|Overall Study|Withdrawal by Subject|0|||
155725546|NCT04408989|562093850|FG001|Overall Study|Withdrawal by Subject|0|||
155725547|NCT04408989|562093851|FG002|Overall Study|Withdrawal by Subject|2|||
155725548|NCT02628873|562093852|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
155725549|NCT02628873|562093853|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
155725550|NCT02628873|562093852|FG000|Second Test (1 Hour)|Physician Decision|1|||
155725551|NCT02628873|562093853|FG001|Second Test (1 Hour)|Physician Decision|0|||
155725552|NCT04672239|562093854|FG000|Week 2 Survey|Failed survey check items|1|||
155725553|NCT04672239|562093855|FG001|Week 2 Survey|Failed survey check items|2|||
155725554|NCT04672239|562093856|FG002|Week 2 Survey|Failed survey check items|3|||
155725555|NCT04672239|562093854|FG000|Week 2 Survey|Partially completed survey|7|||
155725556|NCT04672239|562093855|FG001|Week 2 Survey|Partially completed survey|1|||
155725557|NCT04672239|562093856|FG002|Week 2 Survey|Partially completed survey|4|||
155725558|NCT04672239|562093854|FG000|Week 2 Survey|Withdrawal by Subject|0|||
155725559|NCT04672239|562093855|FG001|Week 2 Survey|Withdrawal by Subject|1|||
155725560|NCT04672239|562093856|FG002|Week 2 Survey|Withdrawal by Subject|0|||
155725561|NCT04672239|562093854|FG000|Week 2 Survey|Lost to Follow-up|3|||
155725562|NCT04672239|562093855|FG001|Week 2 Survey|Lost to Follow-up|2|||
155725563|NCT04672239|562093856|FG002|Week 2 Survey|Lost to Follow-up|5|||
155725564|NCT04672239|562093854|FG000|Week 6 Survey|Failed survey check items|2|||
155725565|NCT04672239|562093855|FG001|Week 6 Survey|Failed survey check items|2|||
155725566|NCT04672239|562093856|FG002|Week 6 Survey|Failed survey check items|2|||
155725567|NCT04672239|562093854|FG000|Week 6 Survey|Partially completed survey|3|||
155725568|NCT04672239|562093855|FG001|Week 6 Survey|Partially completed survey|3|||
155725569|NCT04672239|562093856|FG002|Week 6 Survey|Partially completed survey|2|||
155725570|NCT04672239|562093854|FG000|Week 6 Survey|Withdrawal by Subject|1|||
155725571|NCT04672239|562093855|FG001|Week 6 Survey|Withdrawal by Subject|1|||
155725572|NCT04672239|562093856|FG002|Week 6 Survey|Withdrawal by Subject|1|||
155725573|NCT04672239|562093854|FG000|Week 6 Survey|Withdrawn by PI|0|||
155725574|NCT04672239|562093855|FG001|Week 6 Survey|Withdrawn by PI|1|||
155725575|NCT04672239|562093856|FG002|Week 6 Survey|Withdrawn by PI|0|||
155725576|NCT04672239|562093854|FG000|Week 6 Survey|Lost to Follow-up|12|||
155725577|NCT04672239|562093855|FG001|Week 6 Survey|Lost to Follow-up|2|||
155725578|NCT04672239|562093856|FG002|Week 6 Survey|Lost to Follow-up|5|||
155725579|NCT04672239|562093854|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
155725580|NCT04672239|562093855|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
155725581|NCT04672239|562093856|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
155725582|NCT04672239|562093854|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
155725583|NCT04672239|562093855|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
155725584|NCT04672239|562093856|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
155725585|NCT04672239|562093854|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
155725586|NCT04672239|562093855|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
155725587|NCT04672239|562093856|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
155725588|NCT04672239|562093854|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
155611698|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611699|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155725589|NCT04672239|562093855|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
155611700|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611701|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611702|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611703|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155611704|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155611705|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
155611706|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
155611707|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
155611708|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155611709|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
155611710|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
155611711|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155611712|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155611713|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
155611714|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
155611715|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
155611716|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
155611717|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
155611718|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
155611719|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
155611720|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
155611721|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
155611722|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
155611723|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
155611724|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155611725|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155611726|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155611727|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155611728|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155611729|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155611730|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
155611731|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611732|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611733|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611734|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
155611735|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611736|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
155611737|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611738|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611739|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155611740|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155611741|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611742|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155611743|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611744|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611745|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155611746|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611747|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611748|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155611749|NCT00528372|561670377|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
155611750|NCT00528372|561670378|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611751|NCT00528372|561670379|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611752|NCT00528372|561670380|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
155611753|NCT00528372|561670381|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611754|NCT00528372|561670382|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611755|NCT00528372|561670383|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611756|NCT00528372|561670384|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
155611757|NCT00528372|561670385|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155611758|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
155611759|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
155611760|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
155611761|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155611762|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155611763|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155725590|NCT04672239|562093856|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
155725591|NCT04672239|562093854|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
155725592|NCT04672239|562093855|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
155725593|NCT04672239|562093856|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
155725594|NCT04672239|562093854|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
155725595|NCT04672239|562093855|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
155611764|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
155611765|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
155611766|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
155611767|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
155611768|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
155611769|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
155611770|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155611771|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
155611772|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
155611773|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
155611774|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155611775|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155611776|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
155611777|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
155611778|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
155611779|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
155611780|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
155611781|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
155611782|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
155611783|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
155611784|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
155611785|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
155611786|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
155611787|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155611788|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155611789|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
155611790|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
155611791|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
155611792|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
155611793|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155611794|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155611795|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155725596|NCT04672239|562093856|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
155725597|NCT04672239|562093854|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
155725598|NCT04672239|562093855|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
155725599|NCT04672239|562093856|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
155725600|NCT03597347|562093858|FG000|Overall Study|Withdrawal by Subject|1|||
155725601|NCT03597347|562093859|FG001|Overall Study|Withdrawal by Subject|1|||
155725602|NCT03597347|562093860|FG002|Overall Study|Withdrawal by Subject|0|||
155725603|NCT03597347|562093858|FG000|Overall Study|Withdrawal due to Covid-19|3|||
155725604|NCT03597347|562093859|FG001|Overall Study|Withdrawal due to Covid-19|0|||
155725605|NCT03597347|562093860|FG002|Overall Study|Withdrawal due to Covid-19|0|||
155725606|NCT03597347|562093858|FG000|Overall Study|Sponsor decision to terminate study|3|||
155725607|NCT03597347|562093859|FG001|Overall Study|Sponsor decision to terminate study|2|||
155725608|NCT03597347|562093860|FG002|Overall Study|Sponsor decision to terminate study|4|||
155725609|NCT04606134|562093861|FG000|Overall Study|Adverse Event|0|||
155725610|NCT04606134|562093862|FG001|Overall Study|Adverse Event|1|||
155725611|NCT00107653|562093863|FG000|Overall Study|Adverse Event|24|||
155725612|NCT00107653|562093864|FG001|Overall Study|Adverse Event|43|||
155725613|NCT00107653|562093863|FG000|Overall Study|Insufficient Therapeutic Response|25|||
155725614|NCT00107653|562093864|FG001|Overall Study|Insufficient Therapeutic Response|11|||
155725615|NCT00107653|562093863|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155725616|NCT00107653|562093864|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155725617|NCT00107653|562093863|FG000|Overall Study|Protocol Violation|1|||
155725618|NCT00107653|562093864|FG001|Overall Study|Protocol Violation|0|||
155725619|NCT00107653|562093863|FG000|Overall Study|Withdrawal by Subject|12|||
155725620|NCT00107653|562093864|FG001|Overall Study|Withdrawal by Subject|13|||
155725621|NCT00107653|562093863|FG000|Overall Study|Lost to Follow-up|13|||
155725622|NCT00107653|562093864|FG001|Overall Study|Lost to Follow-up|5|||
155725623|NCT00107653|562093863|FG000|Overall Study|Administrative Reasons|3|||
155725624|NCT00107653|562093864|FG001|Overall Study|Administrative Reasons|3|||
155725625|NCT00541658|562093865|FG000|Overall Study|Adverse Event|28|||
155725626|NCT00541658|562093866|FG001|Overall Study|Adverse Event|37|||
155725627|NCT00541658|562093867|FG002|Overall Study|Adverse Event|25|||
155725628|NCT00541658|562093865|FG000|Overall Study|Physician Decision|0|||
155725629|NCT00541658|562093866|FG001|Overall Study|Physician Decision|0|||
155725630|NCT00541658|562093867|FG002|Overall Study|Physician Decision|4|||
155725631|NCT00541658|562093865|FG000|Overall Study|Lost to Follow-up|3|||
155725632|NCT00541658|562093866|FG001|Overall Study|Lost to Follow-up|3|||
155725633|NCT00541658|562093867|FG002|Overall Study|Lost to Follow-up|6|||
155725634|NCT00541658|562093865|FG000|Overall Study|Protocol Violation|0|||
155725635|NCT00541658|562093866|FG001|Overall Study|Protocol Violation|1|||
155725636|NCT00541658|562093867|FG002|Overall Study|Protocol Violation|1|||
155725637|NCT00541658|562093865|FG000|Overall Study|Withdrawal by Subject|28|||
155611796|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155611797|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155611798|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155611799|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155611800|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155611801|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155611802|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155611803|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611804|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611805|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611806|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611807|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
155611808|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
155611809|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611810|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611811|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155611812|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611813|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155611814|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611815|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611816|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611817|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611818|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155611819|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155611820|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155611821|NCT00528372|561670377|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
155611822|NCT00528372|561670378|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
155611823|NCT00528372|561670379|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
155611824|NCT00528372|561670380|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
155611825|NCT00528372|561670381|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
155611826|NCT00528372|561670382|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
155611827|NCT00528372|561670383|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
155611828|NCT00528372|561670384|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
155611829|NCT00528372|561670385|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
155611830|NCT02432144|561670388|FG000|Overall Study|Participant Non-Compliance|1|||
155611831|NCT00262002|561670389|FG000|Overall Study|Adverse Event|2|||
155611832|NCT00262002|561670390|FG001|Overall Study|Adverse Event|1|||
155611833|NCT00262002|561670391|FG002|Overall Study|Adverse Event|0|||
155611834|NCT00262002|561670392|FG003|Overall Study|Adverse Event|0|||
155611835|NCT00262002|561670393|FG004|Overall Study|Adverse Event|0|||
155611836|NCT00262002|561670394|FG005|Overall Study|Adverse Event|1|||
155611837|NCT00262002|561670395|FG006|Overall Study|Adverse Event|0|||
155611838|NCT00262002|561670389|FG000|Overall Study|Withdrawal by Subject|4|||
155611839|NCT00262002|561670390|FG001|Overall Study|Withdrawal by Subject|2|||
155611840|NCT00262002|561670391|FG002|Overall Study|Withdrawal by Subject|0|||
155611841|NCT00262002|561670392|FG003|Overall Study|Withdrawal by Subject|1|||
155611842|NCT00262002|561670393|FG004|Overall Study|Withdrawal by Subject|2|||
155611843|NCT00262002|561670394|FG005|Overall Study|Withdrawal by Subject|2|||
155611844|NCT00262002|561670395|FG006|Overall Study|Withdrawal by Subject|2|||
155611845|NCT00262002|561670389|FG000|Overall Study|Lost to Follow-up|2|||
155611846|NCT00262002|561670390|FG001|Overall Study|Lost to Follow-up|0|||
155611847|NCT00262002|561670391|FG002|Overall Study|Lost to Follow-up|0|||
155611848|NCT00262002|561670392|FG003|Overall Study|Lost to Follow-up|2|||
155611849|NCT00262002|561670393|FG004|Overall Study|Lost to Follow-up|0|||
155611850|NCT00262002|561670394|FG005|Overall Study|Lost to Follow-up|1|||
155725638|NCT00541658|562093866|FG001|Overall Study|Withdrawal by Subject|32|||
155725639|NCT00541658|562093867|FG002|Overall Study|Withdrawal by Subject|32|||
155725640|NCT00541658|562093865|FG000|Overall Study|Took No Study Drug|1|||
155725641|NCT00541658|562093866|FG001|Overall Study|Took No Study Drug|0|||
155725642|NCT00541658|562093867|FG002|Overall Study|Took No Study Drug|0|||
155725643|NCT01099267|562093868|FG000|MDS-003 Study|Adverse Event|37|||
155725644|NCT01099267|562093868|FG000|MDS-003 Study|Lack of Efficacy|52|||
155725645|NCT01099267|562093868|FG000|MDS-003 Study|Withdrawal by Subject|8|||
155725646|NCT01099267|562093868|FG000|MDS-003 Study|Lost to Follow-up|1|||
155725647|NCT01099267|562093868|FG000|MDS-003 Study|Death|11|||
155725648|NCT01099267|562093868|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
155611851|NCT00262002|561670395|FG006|Overall Study|Lost to Follow-up|0|||
155611852|NCT00262002|561670389|FG000|Overall Study|Inapropriate enrollment|0|||
155611853|NCT00262002|561670390|FG001|Overall Study|Inapropriate enrollment|1|||
155611854|NCT00262002|561670391|FG002|Overall Study|Inapropriate enrollment|0|||
155725649|NCT01099267|562093868|FG000|MDS-003 Study|Disease Progression|7|||
155725650|NCT01099267|562093868|FG000|MDS-003 Study|Investigator Decision|2|||
155725651|NCT01099267|562093868|FG000|MDS-003 Study|Non-Compliance|2|||
155725652|NCT01099267|562093868|FG000|MDS-003 Study|Loss of Response|1|||
155725653|NCT01099267|562093868|FG000|MDS-003 Study|Secondary Malign Disease|1|||
155725654|NCT04986904|562093869|FG000|Overall Study|Lost to Follow-up|11|||
155725655|NCT04986904|562093869|FG000|Overall Study|Withdrawal by Subject|1|||
155725656|NCT02023086|562093878|FG000|Overall Study|Withdrawal by Subject|2|||
155725657|NCT02023086|562093879|FG001|Overall Study|Withdrawal by Subject|0|||
155725658|NCT01083771|562096267|FG000|Overall Study|non-compliant|2|||
155725659|NCT01083771|562096267|FG000|Overall Study|Withdrawal by Subject|3|||
155725660|NCT00124943|562096274|FG000|Phase II|Adverse Event|0|||
155725661|NCT00124943|562096275|FG001|Phase II|Adverse Event|2|||
155725662|NCT00124943|562096276|FG002|Phase II|Adverse Event|0|||
155725663|NCT00124943|562096277|FG003|Phase II|Adverse Event|1|||
155725664|NCT00124943|562096274|FG000|Phase II|Protocol Violation|0|||
155725665|NCT00124943|562096275|FG001|Phase II|Protocol Violation|0|||
155725666|NCT00124943|562096276|FG002|Phase II|Protocol Violation|0|||
155725667|NCT00124943|562096277|FG003|Phase II|Protocol Violation|1|||
155725668|NCT00124943|562096274|FG000|Phase II|Lost to Follow-up|0|||
155725669|NCT00124943|562096275|FG001|Phase II|Lost to Follow-up|0|||
155611855|NCT00262002|561670392|FG003|Overall Study|Inapropriate enrollment|0|||
155611856|NCT00262002|561670393|FG004|Overall Study|Inapropriate enrollment|0|||
155725670|NCT00124943|562096276|FG002|Phase II|Lost to Follow-up|0|||
155725671|NCT00124943|562096277|FG003|Phase II|Lost to Follow-up|1|||
155725672|NCT00124943|562096274|FG000|Phase II|Withdrawal by Subject|0|||
155725673|NCT00124943|562096275|FG001|Phase II|Withdrawal by Subject|0|||
155725674|NCT00124943|562096276|FG002|Phase II|Withdrawal by Subject|0|||
155725675|NCT00124943|562096277|FG003|Phase II|Withdrawal by Subject|2|||
155725676|NCT00321620|562096278|FG000|Overall Study|Death|269|||
155725677|NCT00321620|562096279|FG001|Overall Study|Death|294|||
155725678|NCT00321620|562096278|FG000|Overall Study|Withdrawal by Subject|164|||
155725679|NCT00321620|562096279|FG001|Overall Study|Withdrawal by Subject|147|||
155725680|NCT00321620|562096278|FG000|Overall Study|Disease progression|113|||
155725681|NCT00321620|562096279|FG001|Overall Study|Disease progression|117|||
155725682|NCT00321620|562096278|FG000|Overall Study|Adverse Event|43|||
155725683|NCT00321620|562096279|FG001|Overall Study|Adverse Event|56|||
155725684|NCT00321620|562096278|FG000|Overall Study|Lost to Follow-up|13|||
155725685|NCT00321620|562096279|FG001|Overall Study|Lost to Follow-up|9|||
155725686|NCT00321620|562096278|FG000|Overall Study|Physician Decision|4|||
155725687|NCT00321620|562096279|FG001|Overall Study|Physician Decision|1|||
155725688|NCT00321620|562096278|FG000|Overall Study|Noncompliance|14|||
155725689|NCT00321620|562096279|FG001|Overall Study|Noncompliance|7|||
155725690|NCT00321620|562096278|FG000|Overall Study|Protocol deviation|4|||
155725691|NCT00321620|562096279|FG001|Overall Study|Protocol deviation|3|||
155725692|NCT00321620|562096278|FG000|Overall Study|Ineligibility determined|2|||
155725693|NCT00321620|562096279|FG001|Overall Study|Ineligibility determined|3|||
155725694|NCT00321620|562096278|FG000|Overall Study|Participant request|75|||
155725695|NCT00321620|562096279|FG001|Overall Study|Participant request|52|||
155725696|NCT00321620|562096278|FG000|Overall Study|Other|42|||
155725697|NCT00321620|562096279|FG001|Overall Study|Other|33|||
155725698|NCT03181932|562096280|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
155725699|NCT03181932|562096281|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
155725700|NCT03181932|562096280|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
155381637|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
155611857|NCT00262002|561670394|FG005|Overall Study|Inapropriate enrollment|0|||
155611858|NCT00262002|561670395|FG006|Overall Study|Inapropriate enrollment|0|||
155725701|NCT03181932|562096281|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
155725702|NCT03181932|562096280|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
155725703|NCT03181932|562096281|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
155725704|NCT03181932|562096280|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
155725705|NCT03181932|562096281|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
155725706|NCT03181932|562096280|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
155611859|NCT00262002|561670389|FG000|Overall Study|Protocol Violation|3|||
155725707|NCT03181932|562096281|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
155725708|NCT03181932|562096280|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
155611860|NCT00262002|561670390|FG001|Overall Study|Protocol Violation|2|||
155611861|NCT00262002|561670391|FG002|Overall Study|Protocol Violation|0|||
155611862|NCT00262002|561670392|FG003|Overall Study|Protocol Violation|2|||
155611863|NCT00262002|561670393|FG004|Overall Study|Protocol Violation|5|||
155611864|NCT00262002|561670394|FG005|Overall Study|Protocol Violation|3|||
155611865|NCT00262002|561670395|FG006|Overall Study|Protocol Violation|2|||
155611866|NCT00262002|561670389|FG000|Overall Study|Unable to classify|0|||
155611867|NCT00262002|561670390|FG001|Overall Study|Unable to classify|0|||
155611868|NCT00262002|561670391|FG002|Overall Study|Unable to classify|0|||
155611869|NCT00262002|561670392|FG003|Overall Study|Unable to classify|0|||
155611870|NCT00262002|561670393|FG004|Overall Study|Unable to classify|0|||
155611871|NCT00262002|561670394|FG005|Overall Study|Unable to classify|0|||
155611872|NCT00262002|561670395|FG006|Overall Study|Unable to classify|2|||
155611873|NCT03951753|561670396|FG000|Overall Study|Adverse Event|1|||
155611874|NCT03951753|561670397|FG001|Overall Study|Adverse Event|0|||
155611875|NCT03951753|561670398|FG002|Overall Study|Adverse Event|3|||
155611876|NCT03951753|561670396|FG000|Overall Study|Withdrawal by Subject|3|||
155611877|NCT03951753|561670397|FG001|Overall Study|Withdrawal by Subject|1|||
155611878|NCT03951753|561670398|FG002|Overall Study|Withdrawal by Subject|0|||
155611879|NCT03951753|561670396|FG000|Overall Study|Lost to Follow-up|0|||
155611880|NCT03951753|561670397|FG001|Overall Study|Lost to Follow-up|0|||
155611881|NCT03951753|561670398|FG002|Overall Study|Lost to Follow-up|1|||
155611882|NCT00966355|561670405|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
155611883|NCT00966355|561670406|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
155611884|NCT00966355|561670407|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
155611885|NCT00966355|561670405|FG000|Overall Study|newly diagnosed advanced HCC|11|||
155611886|NCT00966355|561670406|FG001|Overall Study|newly diagnosed advanced HCC|12|||
155611887|NCT00966355|561670407|FG002|Overall Study|newly diagnosed advanced HCC|10|||
155611888|NCT00966355|561670405|FG000|Overall Study|Lost to Follow-up|5|||
155611889|NCT00966355|561670406|FG001|Overall Study|Lost to Follow-up|4|||
155611890|NCT00966355|561670407|FG002|Overall Study|Lost to Follow-up|3|||
155611891|NCT01299896|561671718|FG000|Overall Study|Withdrawal by Subject|1|||
155611892|NCT01299896|561671719|FG001|Overall Study|Withdrawal by Subject|7|||
155611893|NCT01299896|561671718|FG000|Overall Study|Lost to Follow-up|0|||
155611894|NCT01299896|561671719|FG001|Overall Study|Lost to Follow-up|11|||
155611895|NCT01502956|561671722|FG000|Overall Study|Death|0|||
155611896|NCT01502956|561671723|FG001|Overall Study|Death|2|||
155611897|NCT01502956|561671722|FG000|Overall Study|Lost to Follow-up|14|||
155611898|NCT01502956|561671723|FG001|Overall Study|Lost to Follow-up|11|||
155611899|NCT01502956|561671722|FG000|Overall Study|Physician Decision|2|||
155611900|NCT01502956|561671723|FG001|Overall Study|Physician Decision|3|||
155611901|NCT01502956|561671722|FG000|Overall Study|Withdrawal by Subject|8|||
155611902|NCT01502956|561671723|FG001|Overall Study|Withdrawal by Subject|10|||
155611903|NCT04076319|561671724|FG000|Overall Study|Withdrawal by Subject|2|||
155611904|NCT04076319|561671725|FG001|Overall Study|Withdrawal by Subject|0|||
155611905|NCT04076319|561671724|FG000|Overall Study|Death|1|||
155611906|NCT04076319|561671725|FG001|Overall Study|Death|0|||
155611907|NCT02626000|561671728|FG000|Overall Study|Decision by Sponsor|1|||
155611908|NCT02626000|561671728|FG000|Overall Study|Death|29|||
155725709|NCT03181932|562096281|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
155725710|NCT03181932|562096280|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
155725711|NCT03181932|562096281|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
155725712|NCT03181932|562096280|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
155725713|NCT03181932|562096281|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
155725714|NCT03181932|562096280|FG000|Period 2 (Open-label Period)|Reason missing|2|||
155725715|NCT03181932|562096281|FG001|Period 2 (Open-label Period)|Reason missing|0|||
155725716|NCT00408317|562096286|FG000|First Intervention Period|Adverse Event|0|||
155725717|NCT00408317|562096287|FG001|First Intervention Period|Adverse Event|1|||
155611909|NCT03746405|561671737|FG000|Overall Study|Withdrawal by Subject|3|||
155611910|NCT03746405|561671738|FG001|Overall Study|Withdrawal by Subject|0|||
155611911|NCT03746405|561671737|FG000|Overall Study|technical difficulties|0|||
155611912|NCT03746405|561671738|FG001|Overall Study|technical difficulties|2|||
155611913|NCT03479008|561671739|FG000|Overall Study|Withdrawal by Subject|3|||
155611914|NCT00412932|561671740|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
155611915|NCT00412932|561671740|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
155725718|NCT00408317|562096286|FG000|Second Intervention Period|Adverse Event|2|||
155725719|NCT00408317|562096287|FG001|Second Intervention Period|Adverse Event|0|||
155611916|NCT00412932|561671740|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
155611917|NCT00412932|561671740|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
155611918|NCT00412932|561671740|FG000|Olmesartan (Olm) 20 mg|Other|1|||
155611919|NCT00412932|561671740|FG000|Olmesartan 40 mg|Adverse Event|4|||
155611920|NCT00412932|561671740|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
155611921|NCT00412932|561671740|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
155611922|NCT00412932|561671740|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
155611923|NCT00412932|561671740|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
155611924|NCT00412932|561671740|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
155725720|NCT00408317|562096286|FG000|Second Intervention Period|Protocol Violation|0|||
155725721|NCT00408317|562096287|FG001|Second Intervention Period|Protocol Violation|1|||
155725722|NCT00408317|562096286|FG000|Second Intervention Period|Withdrawal of consent|0|||
155725723|NCT00408317|562096287|FG001|Second Intervention Period|Withdrawal of consent|1|||
155725724|NCT01747876|562096288|FG000|Overall Study|Adverse Event|1|||
155725725|NCT01747876|562096289|FG001|Overall Study|Adverse Event|0|||
155725726|NCT01747876|562096290|FG002|Overall Study|Adverse Event|2|||
155725727|NCT01747876|562096288|FG000|Overall Study|Withdrawal by Subject|0|||
155725728|NCT01747876|562096289|FG001|Overall Study|Withdrawal by Subject|1|||
155725729|NCT01747876|562096290|FG002|Overall Study|Withdrawal by Subject|1|||
155725730|NCT01747876|562096288|FG000|Overall Study|Disease progression|4|||
155725731|NCT01747876|562096289|FG001|Overall Study|Disease progression|13|||
155725732|NCT01747876|562096290|FG002|Overall Study|Disease progression|8|||
155725733|NCT01747876|562096288|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
155725734|NCT01747876|562096289|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
155725735|NCT01747876|562096290|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
155725736|NCT00853307|562096291|FG000|Overall Study|Adverse Event|1|||
155725737|NCT00853307|562096292|FG001|Overall Study|Adverse Event|2|||
155725738|NCT00853307|562096291|FG000|Overall Study|Withdrawal by Subject|1|||
155725739|NCT00853307|562096292|FG001|Overall Study|Withdrawal by Subject|2|||
155725740|NCT00853307|562096291|FG000|Overall Study|Reason Not Specified|0|||
155725741|NCT00853307|562096292|FG001|Overall Study|Reason Not Specified|1|||
155725742|NCT02177123|562096297|FG000|Overall Study|Lost to Follow-up|6|||
155725743|NCT02177123|562096297|FG000|Overall Study|Withdrawal by Subject|4|||
155725744|NCT02177123|562096297|FG000|Overall Study|Adverse Event|4|||
155725745|NCT02177123|562096297|FG000|Overall Study|Physician Decision|3|||
155725746|NCT02177123|562096297|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
155725747|NCT02177123|562096297|FG000|Overall Study|Excluded for medical reasons|2|||
155725748|NCT02177123|562096297|FG000|Overall Study|Death|1|||
155725749|NCT02177123|562096297|FG000|Overall Study|Other|1|||
155725750|NCT02177123|562096297|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
155725751|NCT01391546|562096298|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
155725752|NCT01391546|562096299|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
155725753|NCT01921205|562096305|FG000|Overall Study|Adverse Event|12|||
155725754|NCT01921205|562096306|FG001|Overall Study|Adverse Event|7|||
155725755|NCT01921205|562096305|FG000|Overall Study|Lack of Efficacy|1|||
155725756|NCT01921205|562096306|FG001|Overall Study|Lack of Efficacy|0|||
155725757|NCT01921205|562096305|FG000|Overall Study|Protocol Violation|1|||
155725758|NCT01921205|562096306|FG001|Overall Study|Protocol Violation|3|||
155725759|NCT01921205|562096305|FG000|Overall Study|Lost to Follow-up|1|||
155725760|NCT01921205|562096306|FG001|Overall Study|Lost to Follow-up|1|||
155725761|NCT01921205|562096305|FG000|Overall Study|Withdrawal by Subject|6|||
155725762|NCT01921205|562096306|FG001|Overall Study|Withdrawal by Subject|5|||
155725763|NCT01921205|562096305|FG000|Overall Study|Use Of Prohibited Medication|0|||
155725764|NCT01921205|562096306|FG001|Overall Study|Use Of Prohibited Medication|1|||
155725765|NCT01921205|562096305|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
155725766|NCT01921205|562096306|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
155725767|NCT01921205|562096305|FG000|Overall Study|Non Compliance Of The Parent|0|||
155725768|NCT01921205|562096306|FG001|Overall Study|Non Compliance Of The Parent|1|||
155725769|NCT01921205|562096305|FG000|Overall Study|Non Compliance Of Child|0|||
155725770|NCT01921205|562096306|FG001|Overall Study|Non Compliance Of Child|1|||
155725771|NCT03125395|562096328|FG000|Overall Study|Adverse Event|2|||
155725772|NCT03125395|562096328|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155725773|NCT03125395|562096328|FG000|Overall Study|Physician Decision|2|||
155725774|NCT03125395|562096328|FG000|Overall Study|Commercial drug is available|5|||
155725775|NCT02531802|562096329|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
155725776|NCT02531802|562096330|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
155725777|NCT02531802|562096331|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
155725778|NCT02531802|562096332|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
155725779|NCT02531802|562096333|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
155725780|NCT02531802|562096334|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
155381638|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
155611925|NCT00412932|561671740|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
155611926|NCT01796301|561671745|FG000|Overall Study|Withdrawal by Subject|15|||
155611927|NCT01796301|561671746|FG001|Overall Study|Withdrawal by Subject|15|||
155611928|NCT01796301|561671745|FG000|Overall Study|Lost to Follow-up|3|||
155725781|NCT02531802|562096335|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
155611929|NCT01796301|561671746|FG001|Overall Study|Lost to Follow-up|3|||
155725782|NCT02531802|562096336|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
155725783|NCT02531802|562096337|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
155725784|NCT02531802|562096338|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
155725785|NCT02531802|562096339|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
155725786|NCT02531802|562096340|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
155725787|NCT02531802|562096341|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
155725788|NCT02531802|562096342|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
155725789|NCT02531802|562096343|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
155725790|NCT02531802|562096344|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
155725791|NCT02531802|562096345|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
155725792|NCT02531802|562096346|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
155725793|NCT02531802|562096347|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
155725794|NCT02531802|562096348|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
155725795|NCT02531802|562096349|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
155725796|NCT02531802|562096329|FG000|Received Vaccination 2|Physician Decision|0|||
155725797|NCT02531802|562096330|FG001|Received Vaccination 2|Physician Decision|0|||
155725798|NCT02531802|562096331|FG002|Received Vaccination 2|Physician Decision|0|||
155725799|NCT02531802|562096332|FG003|Received Vaccination 2|Physician Decision|0|||
155725800|NCT02531802|562096333|FG004|Received Vaccination 2|Physician Decision|0|||
155725801|NCT02531802|562096334|FG005|Received Vaccination 2|Physician Decision|1|||
155725802|NCT02531802|562096335|FG006|Received Vaccination 2|Physician Decision|0|||
155725803|NCT02531802|562096336|FG007|Received Vaccination 2|Physician Decision|0|||
155725804|NCT02531802|562096337|FG008|Received Vaccination 2|Physician Decision|0|||
155725805|NCT02531802|562096338|FG009|Received Vaccination 2|Physician Decision|2|||
155725806|NCT02531802|562096339|FG010|Received Vaccination 2|Physician Decision|0|||
155725807|NCT02531802|562096340|FG011|Received Vaccination 2|Physician Decision|0|||
155725808|NCT02531802|562096341|FG012|Received Vaccination 2|Physician Decision|0|||
155725809|NCT02531802|562096342|FG013|Received Vaccination 2|Physician Decision|1|||
155725810|NCT02531802|562096343|FG014|Received Vaccination 2|Physician Decision|0|||
155725811|NCT02531802|562096344|FG015|Received Vaccination 2|Physician Decision|0|||
155725812|NCT02531802|562096345|FG016|Received Vaccination 2|Physician Decision|0|||
155725813|NCT02531802|562096346|FG017|Received Vaccination 2|Physician Decision|1|||
155725814|NCT02531802|562096347|FG018|Received Vaccination 2|Physician Decision|0|||
155725815|NCT02531802|562096348|FG019|Received Vaccination 2|Physician Decision|0|||
155725816|NCT02531802|562096349|FG020|Received Vaccination 2|Physician Decision|0|||
155725817|NCT02531802|562096329|FG000|Received Vaccination 2|Adverse Event|0|||
155725818|NCT02531802|562096330|FG001|Received Vaccination 2|Adverse Event|0|||
155725819|NCT02531802|562096331|FG002|Received Vaccination 2|Adverse Event|0|||
155725820|NCT02531802|562096332|FG003|Received Vaccination 2|Adverse Event|0|||
155725821|NCT02531802|562096333|FG004|Received Vaccination 2|Adverse Event|0|||
155725822|NCT02531802|562096334|FG005|Received Vaccination 2|Adverse Event|2|||
155725823|NCT02531802|562096335|FG006|Received Vaccination 2|Adverse Event|0|||
155725824|NCT02531802|562096336|FG007|Received Vaccination 2|Adverse Event|0|||
155725825|NCT02531802|562096337|FG008|Received Vaccination 2|Adverse Event|0|||
155725826|NCT02531802|562096338|FG009|Received Vaccination 2|Adverse Event|0|||
155725827|NCT02531802|562096339|FG010|Received Vaccination 2|Adverse Event|0|||
155725828|NCT02531802|562096340|FG011|Received Vaccination 2|Adverse Event|0|||
155725829|NCT02531802|562096341|FG012|Received Vaccination 2|Adverse Event|0|||
155725830|NCT02531802|562096342|FG013|Received Vaccination 2|Adverse Event|0|||
155725831|NCT02531802|562096343|FG014|Received Vaccination 2|Adverse Event|0|||
155725832|NCT02531802|562096344|FG015|Received Vaccination 2|Adverse Event|0|||
155725833|NCT02531802|562096345|FG016|Received Vaccination 2|Adverse Event|0|||
155725834|NCT02531802|562096346|FG017|Received Vaccination 2|Adverse Event|2|||
155725835|NCT02531802|562096347|FG018|Received Vaccination 2|Adverse Event|1|||
155725836|NCT02531802|562096348|FG019|Received Vaccination 2|Adverse Event|0|||
155725837|NCT02531802|562096349|FG020|Received Vaccination 2|Adverse Event|1|||
155725838|NCT02531802|562096329|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155725839|NCT02531802|562096330|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155725840|NCT02531802|562096331|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
155725841|NCT02531802|562096332|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155725842|NCT02531802|562096333|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155725843|NCT02531802|562096334|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
155725844|NCT02531802|562096335|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
155611930|NCT01796301|561671745|FG000|Overall Study|Death|0|||
155611931|NCT01796301|561671746|FG001|Overall Study|Death|1|||
155725845|NCT02531802|562096336|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
155725846|NCT02531802|562096337|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
155725847|NCT02531802|562096338|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
155725848|NCT02531802|562096339|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
155725849|NCT02531802|562096340|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
155725850|NCT02531802|562096341|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
155725851|NCT02531802|562096342|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
155725852|NCT02531802|562096343|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
155725853|NCT02531802|562096344|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
155725854|NCT02531802|562096345|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
155725855|NCT02531802|562096346|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
155611932|NCT01796301|561671745|FG000|Overall Study|Decision by Sponsor|0|||
155725856|NCT02531802|562096347|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
155725857|NCT02531802|562096348|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
155725858|NCT02531802|562096349|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
155725859|NCT04030143|562096351|FG000|Overall Study|Adverse Event|5|||
155725860|NCT04030143|562096352|FG001|Overall Study|Adverse Event|10|||
155725861|NCT04030143|562096351|FG000|Overall Study|Lost to Follow-up|3|||
155725862|NCT04030143|562096352|FG001|Overall Study|Lost to Follow-up|7|||
155725863|NCT04030143|562096351|FG000|Overall Study|Protocol Deviation|2|||
155725864|NCT04030143|562096352|FG001|Overall Study|Protocol Deviation|2|||
155725865|NCT04030143|562096351|FG000|Overall Study|Withdrawal by Subject|16|||
155725866|NCT04030143|562096352|FG001|Overall Study|Withdrawal by Subject|18|||
155725867|NCT04030143|562096351|FG000|Overall Study|Physician Decision|1|||
155725868|NCT04030143|562096352|FG001|Overall Study|Physician Decision|1|||
155725869|NCT04030143|562096351|FG000|Overall Study|Due to Covid-19|2|||
155725870|NCT04030143|562096352|FG001|Overall Study|Due to Covid-19|3|||
155725871|NCT04030143|562096351|FG000|Overall Study|Not Due to Covid-19|1|||
155725872|NCT04030143|562096352|FG001|Overall Study|Not Due to Covid-19|1|||
155725873|NCT00871975|562096353|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
155725874|NCT00871975|562096353|FG000|Overall Study|Catheters could not be inserted|1|||
155725875|NCT00871975|562096353|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
155725876|NCT00871975|562096353|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
155725877|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
155725878|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
155725879|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
155725880|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
155725881|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
155725882|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
155725883|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
155725884|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155725885|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155725886|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
155725887|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155725888|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155725889|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
155725890|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155725891|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155725892|NCT01436149|562096357|FG000|Antidepressant Lead-in Phase|Other|119|||
155725893|NCT01436149|562096358|FG001|Antidepressant Lead-in Phase|Other|0|||
155725894|NCT01436149|562096359|FG002|Antidepressant Lead-in Phase|Other|0|||
155725895|NCT01436149|562096357|FG000|Randomized Phase|Adverse Event|9|||
155725896|NCT01436149|562096358|FG001|Randomized Phase|Adverse Event|10|||
155725897|NCT01436149|562096359|FG002|Randomized Phase|Adverse Event|11|||
155725898|NCT01436149|562096357|FG000|Randomized Phase|Protocol Violation|4|||
155725899|NCT01436149|562096358|FG001|Randomized Phase|Protocol Violation|5|||
155725900|NCT01436149|562096359|FG002|Randomized Phase|Protocol Violation|0|||
155725901|NCT01436149|562096357|FG000|Randomized Phase|Withdrawal by Subject|16|||
155725902|NCT01436149|562096358|FG001|Randomized Phase|Withdrawal by Subject|10|||
155725903|NCT01436149|562096359|FG002|Randomized Phase|Withdrawal by Subject|10|||
155725904|NCT01436149|562096357|FG000|Randomized Phase|Lost to Follow-up|34|||
155725905|NCT01436149|562096358|FG001|Randomized Phase|Lost to Follow-up|5|||
155725906|NCT01436149|562096359|FG002|Randomized Phase|Lost to Follow-up|6|||
155725907|NCT01436149|562096357|FG000|Randomized Phase|Lack of Efficacy|0|||
155725908|NCT01436149|562096358|FG001|Randomized Phase|Lack of Efficacy|0|||
155725909|NCT01436149|562096359|FG002|Randomized Phase|Lack of Efficacy|1|||
155725910|NCT01436149|562096357|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
155725911|NCT01436149|562096358|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
155725912|NCT01436149|562096359|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
155725913|NCT01436149|562096357|FG000|Randomized Phase|Other|12|||
155725914|NCT01436149|562096358|FG001|Randomized Phase|Other|5|||
155725915|NCT01436149|562096359|FG002|Randomized Phase|Other|11|||
155725916|NCT01690143|562096360|FG000|Overall Study|Withdrawal by Subject|1|||
155725917|NCT01710345|562096376|FG000|Overall Study|Adverse Event|0|||
155725918|NCT01710345|562096377|FG001|Overall Study|Adverse Event|2|||
155725919|NCT01710345|562096378|FG002|Overall Study|Adverse Event|0|||
155725920|NCT01710345|562096376|FG000|Overall Study|Lack of Efficacy|2|||
155725921|NCT01710345|562096377|FG001|Overall Study|Lack of Efficacy|3|||
155725922|NCT01710345|562096378|FG002|Overall Study|Lack of Efficacy|1|||
155725923|NCT01710345|562096376|FG000|Overall Study|Drug Dosing Error|1|||
155725924|NCT01710345|562096377|FG001|Overall Study|Drug Dosing Error|0|||
155725925|NCT01710345|562096378|FG002|Overall Study|Drug Dosing Error|0|||
155725926|NCT01502293|562096380|FG000|Overall Study|Progressive Disease|20|||
155725927|NCT01502293|562096381|FG001|Overall Study|Progressive Disease|12|||
155381639|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
155725928|NCT01502293|562096382|FG002|Overall Study|Progressive Disease|2|||
155725929|NCT01502293|562096380|FG000|Overall Study|Withdrawal by Subject|3|||
155611933|NCT01796301|561671746|FG001|Overall Study|Decision by Sponsor|1|||
155611934|NCT00667563|561671747|FG000|Overall Study|Protocol Violation|24|||
155611935|NCT02187029|561671764|FG000|Overall Study|Adverse Event|0|||
155611936|NCT02187029|561671765|FG001|Overall Study|Adverse Event|1|||
155611937|NCT02187029|561671766|FG002|Overall Study|Adverse Event|1|||
155611938|NCT02187029|561671767|FG003|Overall Study|Adverse Event|0|||
155611939|NCT02187029|561671764|FG000|Overall Study|Study Terminated by Sponsor|0|||
155611940|NCT02187029|561671765|FG001|Overall Study|Study Terminated by Sponsor|0|||
155611941|NCT02187029|561671766|FG002|Overall Study|Study Terminated by Sponsor|10|||
155611942|NCT02187029|561671767|FG003|Overall Study|Study Terminated by Sponsor|3|||
155611943|NCT02187029|561671764|FG000|Overall Study|Withdrawal by Subject|1|||
155611944|NCT02187029|561671765|FG001|Overall Study|Withdrawal by Subject|0|||
155611945|NCT02187029|561671766|FG002|Overall Study|Withdrawal by Subject|0|||
155611946|NCT02187029|561671767|FG003|Overall Study|Withdrawal by Subject|0|||
155611947|NCT02985021|561671768|FG000|Overall Study|Inability to comply with study procedures|1|||
155611948|NCT01491841|561671769|FG000|Overall Study|Screen Failure|10|||
155611949|NCT01491841|561671769|FG000|Overall Study|Withdrawal by Subject|1|||
155611950|NCT00741598|561671770|FG000|Overall Study|Lost to Follow-up|3|||
155611951|NCT00741598|561671771|FG001|Overall Study|Lost to Follow-up|4|||
155611952|NCT00741598|561671770|FG000|Overall Study|Lack of Efficacy|1|||
155611953|NCT00741598|561671771|FG001|Overall Study|Lack of Efficacy|2|||
155611954|NCT00741598|561671770|FG000|Overall Study|Physician Decision|1|||
155611955|NCT00741598|561671771|FG001|Overall Study|Physician Decision|1|||
155611956|NCT00741598|561671770|FG000|Overall Study|Pregnancy|1|||
155611957|NCT00741598|561671771|FG001|Overall Study|Pregnancy|0|||
155611958|NCT00741598|561671770|FG000|Overall Study|Withdrawal by Subject|3|||
155611959|NCT00741598|561671771|FG001|Overall Study|Withdrawal by Subject|2|||
155611960|NCT04105842|561671772|FG000|Overall Study|Withdrawal by Subject|2|||
155611961|NCT01951573|561671773|FG000|Washout Period|Adverse Event|0|||
155611962|NCT01951573|561671774|FG001|Washout Period|Adverse Event|1|||
155611963|NCT04399889|561671775|FG000|Overall Study|Death|5|||
155611964|NCT04399889|561671776|FG001|Overall Study|Death|1|||
155611965|NCT04399889|561671777|FG002|Overall Study|Death|1|||
155611966|NCT00707980|561671781|FG000|Overall Study|Adverse Event|49|||
155611967|NCT00707980|561671781|FG000|Overall Study|Lack of Efficacy|35|||
155611968|NCT00707980|561671781|FG000|Overall Study|Non-Compliance with Study Drug|28|||
155611969|NCT00707980|561671781|FG000|Overall Study|Protocol Deviations|19|||
155611970|NCT00707980|561671781|FG000|Overall Study|Withdrawal of Consent|81|||
155611971|NCT00707980|561671781|FG000|Overall Study|Lost to Follow-up|59|||
155611972|NCT00707980|561671781|FG000|Overall Study|Other|39|||
155611973|NCT01152996|561671782|FG000|Overall Study|Withdrawal by Subject|142|||
155611974|NCT01152996|561671782|FG000|Overall Study|Adverse Event|115|||
155611975|NCT01152996|561671782|FG000|Overall Study|Lost to Follow-up|112|||
155611976|NCT01152996|561671782|FG000|Overall Study|Lack of Efficacy|68|||
155611977|NCT01152996|561671782|FG000|Overall Study|Noncompliance|41|||
155611978|NCT01152996|561671782|FG000|Overall Study|Other|36|||
155611979|NCT01152996|561671782|FG000|Overall Study|Protocol Violation|22|||
155611980|NCT01152996|561671782|FG000|Overall Study|Elevated liver enzymes|1|||
155611981|NCT02937636|561671785|FG000|Overall Study|Other (Not specified)|3|||
155611982|NCT02937636|561671786|FG001|Overall Study|Other (Not specified)|2|||
155611983|NCT00770913|561671787|FG000|Overall Study|Adverse Event|1|||
155611984|NCT00770913|561671788|FG001|Overall Study|Adverse Event|3|||
155611985|NCT00770913|561671789|FG002|Overall Study|Adverse Event|6|||
155611986|NCT00770913|561671787|FG000|Overall Study|Refusal to continue participation|6|||
155611987|NCT00770913|561671788|FG001|Overall Study|Refusal to continue participation|4|||
155611988|NCT00770913|561671789|FG002|Overall Study|Refusal to continue participation|5|||
155611989|NCT00770913|561671787|FG000|Overall Study|Physician Decision|0|||
155611990|NCT00770913|561671788|FG001|Overall Study|Physician Decision|1|||
155611991|NCT00770913|561671789|FG002|Overall Study|Physician Decision|1|||
155611992|NCT00770913|561671787|FG000|Overall Study|Protocol Violation|3|||
155611993|NCT00770913|561671788|FG001|Overall Study|Protocol Violation|0|||
155611994|NCT00770913|561671789|FG002|Overall Study|Protocol Violation|1|||
155611995|NCT00770913|561671787|FG000|Overall Study|Incorrect drug was allocated|1|||
155611996|NCT00770913|561671788|FG001|Overall Study|Incorrect drug was allocated|0|||
155611997|NCT00770913|561671789|FG002|Overall Study|Incorrect drug was allocated|0|||
155611998|NCT02347072|561671790|FG000|Overall Study|Adverse Event|2|||
155611999|NCT02347072|561671790|FG000|Overall Study|Withdrawal by Subject|6|||
155612000|NCT02347072|561671790|FG000|Overall Study|Physician Decision|1|||
155612001|NCT02347072|561671790|FG000|Overall Study|Lost to Follow-up|2|||
155612002|NCT02347072|561671790|FG000|Overall Study|Protocol Violation|1|||
155612003|NCT02347072|561671790|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
155612004|NCT01134393|561671795|FG000|Overall Study|Adverse Event|18|||
155612005|NCT01134393|561671795|FG000|Overall Study|Lack of Efficacy|2|||
155612006|NCT01134393|561671795|FG000|Overall Study|Protocol Violation|12|||
155612007|NCT01134393|561671795|FG000|Overall Study|Lost to Follow-up|3|||
155612008|NCT01134393|561671795|FG000|Overall Study|Withdrawal by Subject|11|||
155612009|NCT01134393|561671795|FG000|Overall Study|Other|6|||
155612010|NCT03230838|561671799|FG000|Overall Study|Withdrawal by Subject|3|||
155612011|NCT03230838|561671800|FG001|Overall Study|Withdrawal by Subject|0|||
155612012|NCT03230838|561671799|FG000|Overall Study|Temperature excursion|1|||
155612013|NCT03230838|561671800|FG001|Overall Study|Temperature excursion|0|||
155612014|NCT01607346|561671803|FG000|Overall Study|Adverse Event|3|||
155612015|NCT02912455|561671804|FG000|Overall Study|Withdrawal by Subject|0|||
155612016|NCT02912455|561671805|FG001|Overall Study|Withdrawal by Subject|1|||
155612017|NCT02912455|561671804|FG000|Overall Study|Lack of Efficacy|0|||
155612018|NCT02912455|561671805|FG001|Overall Study|Lack of Efficacy|1|||
155612019|NCT02912455|561671804|FG000|Overall Study|Lost to Follow-up|2|||
155612020|NCT02912455|561671805|FG001|Overall Study|Lost to Follow-up|1|||
155612021|NCT00073008|561671807|FG000|Overall Study|Missing|6|||
155612022|NCT00073008|561671808|FG001|Overall Study|Missing|6|||
155612023|NCT00073008|561671807|FG000|Overall Study|Withdrawal by Subject|2|||
155612024|NCT00073008|561671808|FG001|Overall Study|Withdrawal by Subject|2|||
155612025|NCT00073008|561671807|FG000|Overall Study|Lost to Follow-up|1|||
155612026|NCT00073008|561671808|FG001|Overall Study|Lost to Follow-up|3|||
155612027|NCT00073008|561671807|FG000|Overall Study|Death|46|||
155612028|NCT00073008|561671808|FG001|Overall Study|Death|47|||
155612029|NCT00073008|561671807|FG000|Overall Study|"Other selected on Case Report Form"|7|||
155612030|NCT00073008|561671808|FG001|Overall Study|"Other selected on Case Report Form"|5|||
155612031|NCT01778751|561671816|FG000|Overall Study|Lost to Follow-up|1|||
155612032|NCT01778751|561671817|FG001|Overall Study|Lost to Follow-up|0|||
155612033|NCT01778751|561671816|FG000|Overall Study|Withdrawal by Subject|0|||
155612034|NCT01778751|561671817|FG001|Overall Study|Withdrawal by Subject|2|||
155612035|NCT01778751|561671816|FG000|Overall Study|Transfered care|1|||
155612036|NCT01778751|561671817|FG001|Overall Study|Transfered care|0|||
155612037|NCT02669667|561671818|FG000|Overall Study|Lost to Follow-up|0|||
155612038|NCT02669667|561671819|FG001|Overall Study|Lost to Follow-up|0|||
155612039|NCT02669667|561671820|FG002|Overall Study|Lost to Follow-up|0|||
155612040|NCT02669667|561671821|FG003|Overall Study|Lost to Follow-up|0|||
155612041|NCT02669667|561671822|FG004|Overall Study|Lost to Follow-up|0|||
155612042|NCT02669667|561671823|FG005|Overall Study|Lost to Follow-up|1|||
155612043|NCT02669667|561671824|FG006|Overall Study|Lost to Follow-up|0|||
155612044|NCT03628716|561671829|FG000|Overall Study|Adverse Event|1|||
155612045|NCT03628716|561671830|FG001|Overall Study|Adverse Event|1|||
155612046|NCT03628716|561671829|FG000|Overall Study|Death|1|||
155612047|NCT03628716|561671830|FG001|Overall Study|Death|0|||
155612048|NCT03628716|561671829|FG000|Overall Study|Lack of Efficacy|15|||
155612049|NCT03628716|561671830|FG001|Overall Study|Lack of Efficacy|20|||
155612050|NCT03628716|561671829|FG000|Overall Study|Withdrawal by Subject|1|||
155612051|NCT03628716|561671830|FG001|Overall Study|Withdrawal by Subject|2|||
155612052|NCT03628716|561671829|FG000|Overall Study|Study Terminated by Sponsor|1|||
155612053|NCT03628716|561671830|FG001|Overall Study|Study Terminated by Sponsor|0|||
155612054|NCT00856843|561671831|FG000|Overall Study|Withdrawal by Subject|1|||
155612055|NCT00856843|561671832|FG001|Overall Study|Withdrawal by Subject|5|||
155612056|NCT00856843|561671831|FG000|Overall Study|Lack of Efficacy|1|||
155612057|NCT00856843|561671832|FG001|Overall Study|Lack of Efficacy|0|||
155612058|NCT03755518|561671833|FG000|Overall Study|Lack of Efficacy|10|||
155612059|NCT03755518|561671833|FG000|Overall Study|Adverse Event|7|||
155612060|NCT03755518|561671833|FG000|Overall Study|Study Terminated by Sponsor|5|||
155612061|NCT03755518|561671833|FG000|Overall Study|Death|1|||
155612062|NCT03755518|561671833|FG000|Overall Study|Withdrawal by Subject|3|||
155612063|NCT03755518|561671833|FG000|Overall Study|Progressive Disease|4|||
155612064|NCT03755518|561671833|FG000|Overall Study|Bone Marrow Transplant|4|||
155612065|NCT03755518|561671833|FG000|Overall Study|Physicians Decision|1|||
155612066|NCT03755518|561671833|FG000|Overall Study|Relapse|1|||
155612067|NCT03755518|561671833|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
155612068|NCT03755518|561671833|FG000|Overall Study|Withdrawal by PI|1|||
155612069|NCT03172364|561671834|FG000|Overall Study|Adverse Event|1|||
155612070|NCT03172364|561671835|FG001|Overall Study|Adverse Event|1|||
155612071|NCT03172364|561671834|FG000|Overall Study|Protocol Violation|1|||
155612072|NCT03172364|561671835|FG001|Overall Study|Protocol Violation|0|||
155612073|NCT01714609|561671836|FG000|Overall Study|Protocol Violation|1|||
155612074|NCT01714609|561671837|FG001|Overall Study|Protocol Violation|0|||
155612075|NCT03403621|561671838|FG000|Overall Study|Withdrawal by Subject|2|||
155612076|NCT03403621|561671839|FG001|Overall Study|Withdrawal by Subject|2|||
155612077|NCT00583102|561671840|FG000|Overall Study|Adverse Event|3|||
155612078|NCT01905592|561671843|FG000|Overall Study|Disease Progression|51|||
155612079|NCT01905592|561671844|FG001|Overall Study|Disease Progression|110|||
155612080|NCT01905592|561671843|FG000|Overall Study|Toxicity|1|||
155612081|NCT01905592|561671844|FG001|Overall Study|Toxicity|16|||
155612082|NCT01905592|561671843|FG000|Overall Study|Physician Decision|0|||
155612083|NCT01905592|561671844|FG001|Overall Study|Physician Decision|2|||
155612084|NCT01905592|561671843|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
155612085|NCT01905592|561671844|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
155612086|NCT01905592|561671843|FG000|Overall Study|Protocol Violation|0|||
155725930|NCT01502293|562096381|FG001|Overall Study|Withdrawal by Subject|3|||
155612087|NCT01905592|561671844|FG001|Overall Study|Protocol Violation|1|||
155612088|NCT01905592|561671843|FG000|Overall Study|Sponsor's decision|1|||
155612089|NCT01905592|561671844|FG001|Overall Study|Sponsor's decision|1|||
155612090|NCT01905592|561671843|FG000|Overall Study|Not treated|7|||
155612091|NCT01905592|561671844|FG001|Overall Study|Not treated|3|||
155725931|NCT01502293|562096382|FG002|Overall Study|Withdrawal by Subject|1|||
155725932|NCT01502293|562096380|FG000|Overall Study|Adverse Event|0|||
155725933|NCT01502293|562096381|FG001|Overall Study|Adverse Event|2|||
155725934|NCT01502293|562096382|FG002|Overall Study|Adverse Event|0|||
155725935|NCT01502293|562096380|FG000|Overall Study|Reason Not Specified|2|||
155725936|NCT01502293|562096381|FG001|Overall Study|Reason Not Specified|0|||
155725937|NCT01502293|562096382|FG002|Overall Study|Reason Not Specified|0|||
155725938|NCT01502293|562096380|FG000|Overall Study|Physician Decision|0|||
155725939|NCT01502293|562096381|FG001|Overall Study|Physician Decision|0|||
155725940|NCT01502293|562096382|FG002|Overall Study|Physician Decision|1|||
155725941|NCT00307801|562096383|FG000|Overall Study|Adverse Event|12|||
155725942|NCT00307801|562096384|FG001|Overall Study|Adverse Event|4|||
155725943|NCT00307801|562096383|FG000|Overall Study|Withdrawal by Subject|9|||
155725944|NCT00307801|562096384|FG001|Overall Study|Withdrawal by Subject|4|||
155725945|NCT00307801|562096383|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
155725946|NCT00307801|562096384|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
155725947|NCT00307801|562096383|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
155725948|NCT00307801|562096384|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
155725949|NCT00307801|562096383|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
155725950|NCT00307801|562096384|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
155725951|NCT00307801|562096383|FG000|Overall Study|Wrong Randomization|1|||
155725952|NCT00307801|562096384|FG001|Overall Study|Wrong Randomization|0|||
155725953|NCT00307801|562096383|FG000|Overall Study|Lack of Efficacy|0|||
155381640|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
155381641|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
155381642|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
155381643|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
155381644|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
155381645|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
155381646|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
155381647|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
155381648|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
155381649|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
155381650|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
155381651|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
155381652|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
155612092|NCT01905592|561671843|FG000|Overall Study|Withdrawal by Subject|10|||
155612093|NCT01905592|561671844|FG001|Overall Study|Withdrawal by Subject|2|||
155612094|NCT01483599|561671845|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
155612095|NCT01483599|561671846|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155381653|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
155381654|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
155381655|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
155612096|NCT01483599|561671847|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612097|NCT01483599|561671848|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
155612098|NCT01483599|561671849|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
155612099|NCT01483599|561671850|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
155612100|NCT01483599|561671851|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
155612101|NCT01483599|561671852|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612102|NCT01483599|561671853|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612103|NCT01483599|561671854|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612104|NCT01483599|561671855|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612105|NCT01483599|561671856|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612106|NCT01483599|561671857|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612107|NCT01483599|561671858|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155612108|NCT01483599|561671845|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612109|NCT01483599|561671846|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155612110|NCT01483599|561671847|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612111|NCT01483599|561671848|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155612112|NCT01483599|561671849|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612113|NCT01483599|561671850|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612114|NCT01483599|561671851|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155612115|NCT01483599|561671852|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612116|NCT01483599|561671853|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612117|NCT01483599|561671854|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612118|NCT01483599|561671855|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612119|NCT01483599|561671856|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612120|NCT01483599|561671857|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612121|NCT01483599|561671858|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155612122|NCT01483599|561671845|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
155612123|NCT01483599|561671846|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612124|NCT01483599|561671847|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612125|NCT01483599|561671848|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612126|NCT01483599|561671849|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612127|NCT01483599|561671850|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612128|NCT01483599|561671851|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612129|NCT01483599|561671852|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612130|NCT01483599|561671853|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612131|NCT01483599|561671854|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612132|NCT01483599|561671855|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612133|NCT01483599|561671856|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612134|NCT01483599|561671857|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612135|NCT01483599|561671858|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155612136|NCT01483599|561671845|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
155612137|NCT01483599|561671846|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
155612138|NCT01483599|561671847|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
155612139|NCT01483599|561671848|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
155612140|NCT01483599|561671849|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
155612141|NCT01483599|561671850|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
155612142|NCT01483599|561671851|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
155612143|NCT01483599|561671852|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
155612144|NCT01483599|561671853|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
155612145|NCT01483599|561671854|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
155612146|NCT01483599|561671855|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
155612147|NCT01483599|561671856|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
155612148|NCT01483599|561671857|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
155612149|NCT01483599|561671858|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
155612150|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
155612151|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
155612152|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
155612153|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
155612154|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
155612155|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
155612156|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
155612157|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
155612158|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
155612159|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
155612160|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
155612161|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
155612162|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
155612163|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
155612164|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612165|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612166|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612167|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612168|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612169|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612170|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612171|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155612172|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155612173|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612174|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612175|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155612176|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155612177|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155612178|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612179|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612180|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612181|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612182|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612183|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612184|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612185|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612186|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155612187|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612188|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612189|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155612190|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155612191|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155612192|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612193|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612194|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612195|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612196|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612197|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612198|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612199|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612200|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
155612201|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612202|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
155612203|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612204|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155612205|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
155612206|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612207|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612208|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612209|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612210|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612211|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612212|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612213|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612214|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
155612215|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612216|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612217|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155612218|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
155612219|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
155612220|NCT01483599|561671845|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
155612221|NCT01483599|561671846|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
155612222|NCT01483599|561671847|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
155612223|NCT01483599|561671848|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
155612224|NCT01483599|561671849|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
155612225|NCT01483599|561671850|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
155612226|NCT01483599|561671851|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
155612227|NCT01483599|561671852|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
155612228|NCT01483599|561671853|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
155612229|NCT01483599|561671854|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
155612230|NCT01483599|561671855|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
155612231|NCT01483599|561671856|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
155612232|NCT01483599|561671857|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
155612233|NCT01483599|561671858|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
155612234|NCT00401193|561673709|FG000|Overall Study|Adverse Event|1|||
155612235|NCT00401193|561673710|FG001|Overall Study|Adverse Event|3|||
155612236|NCT00401193|561673711|FG002|Overall Study|Adverse Event|1|||
155612237|NCT00401193|561673709|FG000|Overall Study|Protocol Violation|3|||
155612238|NCT00401193|561673710|FG001|Overall Study|Protocol Violation|1|||
155612239|NCT00401193|561673711|FG002|Overall Study|Protocol Violation|1|||
155612240|NCT00401193|561673709|FG000|Overall Study|Lost to Follow-up|6|||
155612241|NCT00401193|561673710|FG001|Overall Study|Lost to Follow-up|5|||
155612242|NCT00401193|561673711|FG002|Overall Study|Lost to Follow-up|1|||
155612243|NCT00401193|561673709|FG000|Overall Study|Withdrawal by Subject|2|||
155612244|NCT00401193|561673710|FG001|Overall Study|Withdrawal by Subject|0|||
155612245|NCT00401193|561673711|FG002|Overall Study|Withdrawal by Subject|1|||
155612246|NCT00401193|561673709|FG000|Overall Study|Other Event|3|||
155612247|NCT00401193|561673710|FG001|Overall Study|Other Event|2|||
155612248|NCT00401193|561673711|FG002|Overall Study|Other Event|2|||
155612249|NCT02526160|561673712|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
155612250|NCT02526160|561673713|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
155612251|NCT02526160|561673712|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
155612252|NCT02526160|561673713|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
155725954|NCT00307801|562096384|FG001|Overall Study|Lack of Efficacy|2|||
155725955|NCT00307801|562096383|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
155612253|NCT02526160|561673712|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
155612254|NCT02526160|561673713|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
155612255|NCT02526160|561673712|FG000|Open-Label Treatment Extension Period I|Death|0|||
155612256|NCT02526160|561673713|FG001|Open-Label Treatment Extension Period I|Death|1|||
155612257|NCT02526160|561673712|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
155612258|NCT02526160|561673713|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
155612259|NCT02526160|561673712|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
155612260|NCT02526160|561673713|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
155612261|NCT02526160|561673712|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
155612262|NCT02526160|561673713|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
155612263|NCT02526160|561673712|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
155612264|NCT02526160|561673713|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
155612265|NCT00398216|561673714|FG000|Overall Study|Adverse Event|4|||
155612266|NCT00398216|561673715|FG001|Overall Study|Adverse Event|2|||
155612267|NCT00398216|561673716|FG002|Overall Study|Adverse Event|5|||
155612268|NCT00398216|561673717|FG003|Overall Study|Adverse Event|7|||
155612269|NCT00398216|561673718|FG004|Overall Study|Adverse Event|2|||
155612270|NCT00398216|561673714|FG000|Overall Study|Protocol Violation|2|||
155612271|NCT00398216|561673715|FG001|Overall Study|Protocol Violation|4|||
155612272|NCT00398216|561673716|FG002|Overall Study|Protocol Violation|5|||
155612273|NCT00398216|561673717|FG003|Overall Study|Protocol Violation|7|||
155612274|NCT00398216|561673718|FG004|Overall Study|Protocol Violation|5|||
155612275|NCT00398216|561673714|FG000|Overall Study|Lost to Follow-up|1|||
155612276|NCT00398216|561673715|FG001|Overall Study|Lost to Follow-up|6|||
155612277|NCT00398216|561673716|FG002|Overall Study|Lost to Follow-up|4|||
155612278|NCT00398216|561673717|FG003|Overall Study|Lost to Follow-up|4|||
155612279|NCT00398216|561673718|FG004|Overall Study|Lost to Follow-up|1|||
155612280|NCT00398216|561673714|FG000|Overall Study|Death|0|||
155612281|NCT00398216|561673715|FG001|Overall Study|Death|3|||
155612282|NCT00398216|561673716|FG002|Overall Study|Death|0|||
155612283|NCT00398216|561673717|FG003|Overall Study|Death|0|||
155612284|NCT00398216|561673718|FG004|Overall Study|Death|0|||
155612285|NCT00398216|561673714|FG000|Overall Study|Withdrawal by Subject|1|||
155612286|NCT00398216|561673715|FG001|Overall Study|Withdrawal by Subject|0|||
155612287|NCT00398216|561673716|FG002|Overall Study|Withdrawal by Subject|3|||
155612288|NCT00398216|561673717|FG003|Overall Study|Withdrawal by Subject|1|||
155612289|NCT00398216|561673718|FG004|Overall Study|Withdrawal by Subject|2|||
155612290|NCT00398216|561673714|FG000|Overall Study|administrative reasons|3|||
155612291|NCT00398216|561673715|FG001|Overall Study|administrative reasons|4|||
155612292|NCT00398216|561673716|FG002|Overall Study|administrative reasons|4|||
155612293|NCT00398216|561673717|FG003|Overall Study|administrative reasons|3|||
155612294|NCT00398216|561673718|FG004|Overall Study|administrative reasons|3|||
155612295|NCT00398216|561673714|FG000|Overall Study|entrance criteria|0|||
155612296|NCT00398216|561673715|FG001|Overall Study|entrance criteria|0|||
155612297|NCT00398216|561673716|FG002|Overall Study|entrance criteria|0|||
155612298|NCT00398216|561673717|FG003|Overall Study|entrance criteria|0|||
155612299|NCT00398216|561673718|FG004|Overall Study|entrance criteria|2|||
155612300|NCT04378569|561673722|FG000|Overall Study|Adverse Event|0|||
155612301|NCT04378569|561673723|FG001|Overall Study|Adverse Event|0|||
155612302|NCT04378569|561673724|FG002|Overall Study|Adverse Event|2|||
155612303|NCT04378569|561673725|FG003|Overall Study|Adverse Event|0|||
155612304|NCT04378569|561673726|FG004|Overall Study|Adverse Event|3|||
155612305|NCT04378569|561673727|FG005|Overall Study|Adverse Event|3|||
155612306|NCT04378569|561673722|FG000|Overall Study|Lost to Follow-up|0|||
155612307|NCT04378569|561673723|FG001|Overall Study|Lost to Follow-up|3|||
155612308|NCT04378569|561673724|FG002|Overall Study|Lost to Follow-up|1|||
155612309|NCT04378569|561673725|FG003|Overall Study|Lost to Follow-up|0|||
155612310|NCT04378569|561673726|FG004|Overall Study|Lost to Follow-up|1|||
155725956|NCT00307801|562096384|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
155725957|NCT00307801|562096383|FG000|Overall Study|Frustration with e-diary|1|||
155725958|NCT00307801|562096384|FG001|Overall Study|Frustration with e-diary|0|||
155725959|NCT00307801|562096383|FG000|Overall Study|Protocol Violation|3|||
155725960|NCT00307801|562096384|FG001|Overall Study|Protocol Violation|2|||
155725961|NCT00307801|562096383|FG000|Overall Study|No reason specified|2|||
155725962|NCT00307801|562096384|FG001|Overall Study|No reason specified|0|||
155725963|NCT00307801|562096383|FG000|Overall Study|Pregnancy|0|||
155725964|NCT00307801|562096384|FG001|Overall Study|Pregnancy|1|||
155725965|NCT00391586|562096386|FG000|Overall Study|Progressive disease|13|||
155725966|NCT00391586|562096386|FG000|Overall Study|Adverse Event|5|||
155725967|NCT00391586|562096386|FG000|Overall Study|Physician Decision|2|||
155725968|NCT00391586|562096386|FG000|Overall Study|Death|4|||
155725969|NCT00198822|562096387|FG000|Overall Study|Lost to Follow-up|14|||
155725970|NCT00198822|562096388|FG001|Overall Study|Lost to Follow-up|20|||
155725971|NCT00198822|562096389|FG002|Overall Study|Lost to Follow-up|21|||
155725972|NCT01409707|562096390|FG000|Overall Study|Withdrawal by Subject|5|||
155725973|NCT01409707|562096391|FG001|Overall Study|Withdrawal by Subject|17|||
155725974|NCT01409707|562096392|FG002|Overall Study|Withdrawal by Subject|16|||
155612311|NCT04378569|561673727|FG005|Overall Study|Lost to Follow-up|1|||
155612312|NCT04378569|561673722|FG000|Overall Study|Protocol Violation|0|||
155612313|NCT04378569|561673723|FG001|Overall Study|Protocol Violation|0|||
155612314|NCT04378569|561673724|FG002|Overall Study|Protocol Violation|0|||
155612315|NCT04378569|561673725|FG003|Overall Study|Protocol Violation|0|||
155725975|NCT03224819|562096395|FG000|Overall Study|Withdrawal by Subject|0|||
155725976|NCT03224819|562096396|FG001|Overall Study|Withdrawal by Subject|0|||
155725977|NCT03224819|562096397|FG002|Overall Study|Withdrawal by Subject|0|||
155725978|NCT03224819|562096398|FG003|Overall Study|Withdrawal by Subject|0|||
155725979|NCT03224819|562096399|FG004|Overall Study|Withdrawal by Subject|0|||
155725980|NCT03224819|562096400|FG005|Overall Study|Withdrawal by Subject|0|||
155725981|NCT03224819|562096401|FG006|Overall Study|Withdrawal by Subject|0|||
155725982|NCT03224819|562096402|FG007|Overall Study|Withdrawal by Subject|0|||
155725983|NCT03224819|562096403|FG008|Overall Study|Withdrawal by Subject|0|||
155725984|NCT03224819|562096404|FG009|Overall Study|Withdrawal by Subject|0|||
155725985|NCT03224819|562096405|FG010|Overall Study|Withdrawal by Subject|0|||
155725986|NCT03224819|562096406|FG011|Overall Study|Withdrawal by Subject|0|||
155725987|NCT03224819|562096407|FG012|Overall Study|Withdrawal by Subject|1|||
155725988|NCT03224819|562096408|FG013|Overall Study|Withdrawal by Subject|0|||
155725989|NCT03224819|562096395|FG000|Overall Study|Sponsor Decision|0|||
155725990|NCT03224819|562096396|FG001|Overall Study|Sponsor Decision|0|||
155725991|NCT03224819|562096397|FG002|Overall Study|Sponsor Decision|0|||
155725992|NCT03224819|562096398|FG003|Overall Study|Sponsor Decision|1|||
155725993|NCT03224819|562096399|FG004|Overall Study|Sponsor Decision|1|||
155725994|NCT03224819|562096400|FG005|Overall Study|Sponsor Decision|2|||
155725995|NCT03224819|562096401|FG006|Overall Study|Sponsor Decision|1|||
155725996|NCT03224819|562096402|FG007|Overall Study|Sponsor Decision|1|||
155725997|NCT03224819|562096403|FG008|Overall Study|Sponsor Decision|1|||
155725998|NCT03224819|562096404|FG009|Overall Study|Sponsor Decision|2|||
155725999|NCT03224819|562096405|FG010|Overall Study|Sponsor Decision|1|||
155726000|NCT03224819|562096406|FG011|Overall Study|Sponsor Decision|1|||
155726001|NCT03224819|562096407|FG012|Overall Study|Sponsor Decision|1|||
155726002|NCT03224819|562096408|FG013|Overall Study|Sponsor Decision|0|||
155726003|NCT03224819|562096395|FG000|Overall Study|Lost to Follow-up|0|||
155612316|NCT04378569|561673726|FG004|Overall Study|Protocol Violation|0|||
155612317|NCT04378569|561673727|FG005|Overall Study|Protocol Violation|1|||
155612318|NCT04378569|561673722|FG000|Overall Study|Withdrawal by Subject|0|||
155612319|NCT04378569|561673723|FG001|Overall Study|Withdrawal by Subject|6|||
155612320|NCT04378569|561673724|FG002|Overall Study|Withdrawal by Subject|7|||
155612321|NCT04378569|561673725|FG003|Overall Study|Withdrawal by Subject|4|||
155612322|NCT04378569|561673726|FG004|Overall Study|Withdrawal by Subject|5|||
155612323|NCT04378569|561673727|FG005|Overall Study|Withdrawal by Subject|4|||
155612324|NCT04378569|561673722|FG000|Overall Study|Lack of response|0|||
155612325|NCT04378569|561673723|FG001|Overall Study|Lack of response|0|||
155612326|NCT04378569|561673724|FG002|Overall Study|Lack of response|1|||
155612327|NCT04378569|561673725|FG003|Overall Study|Lack of response|0|||
155612328|NCT04378569|561673726|FG004|Overall Study|Lack of response|1|||
155612329|NCT04378569|561673727|FG005|Overall Study|Lack of response|1|||
155612330|NCT01048944|561673728|FG000|Overall Study|Protocol Violation|8|||
155612331|NCT01048944|561673729|FG001|Overall Study|Protocol Violation|10|||
155612332|NCT01048944|561673730|FG002|Overall Study|Protocol Violation|10|||
155612333|NCT01048944|561673731|FG003|Overall Study|Protocol Violation|2|||
155612334|NCT01844817|561673732|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
155612335|NCT01844817|561673733|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
155612336|NCT01844817|561673732|FG000|Treatment|Progressive Disease|27|||
155612337|NCT01844817|561673733|FG001|Treatment|Progressive Disease|36|||
155612338|NCT01844817|561673732|FG000|Treatment|Adverse Event|17|||
155612339|NCT01844817|561673733|FG001|Treatment|Adverse Event|9|||
155612340|NCT01844817|561673732|FG000|Treatment|Withdrawal by Subject|10|||
155612341|NCT01844817|561673733|FG001|Treatment|Withdrawal by Subject|6|||
155612342|NCT01844817|561673732|FG000|Treatment|Death|10|||
155612343|NCT01844817|561673733|FG001|Treatment|Death|8|||
155612344|NCT01844817|561673732|FG000|Treatment|Lost to Follow-up|0|||
155612345|NCT01844817|561673733|FG001|Treatment|Lost to Follow-up|1|||
155612346|NCT01844817|561673732|FG000|Treatment|Other|0|||
155612347|NCT01844817|561673733|FG001|Treatment|Other|3|||
155612348|NCT01133704|561673734|FG000|Overall Study|Death|44|||
155612349|NCT01133704|561673735|FG001|Overall Study|Death|26|||
155612350|NCT01133704|561673734|FG000|Overall Study|Patient refused to continue|4|||
155612351|NCT01133704|561673735|FG001|Overall Study|Patient refused to continue|0|||
155612352|NCT01133704|561673734|FG000|Overall Study|Study Closure|1|||
155726004|NCT03224819|562096396|FG001|Overall Study|Lost to Follow-up|0|||
155726005|NCT03224819|562096397|FG002|Overall Study|Lost to Follow-up|0|||
155726006|NCT03224819|562096398|FG003|Overall Study|Lost to Follow-up|0|||
155726007|NCT03224819|562096399|FG004|Overall Study|Lost to Follow-up|0|||
155612353|NCT01133704|561673735|FG001|Overall Study|Study Closure|0|||
155612354|NCT02207400|561673736|FG000|Overall Study|Adverse Event|1|||
155726008|NCT03224819|562096400|FG005|Overall Study|Lost to Follow-up|0|||
155726009|NCT03224819|562096401|FG006|Overall Study|Lost to Follow-up|0|||
155726010|NCT03224819|562096402|FG007|Overall Study|Lost to Follow-up|0|||
155726011|NCT03224819|562096403|FG008|Overall Study|Lost to Follow-up|1|||
155726012|NCT03224819|562096404|FG009|Overall Study|Lost to Follow-up|0|||
155726013|NCT03224819|562096405|FG010|Overall Study|Lost to Follow-up|0|||
155381656|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
155381657|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
155381658|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
155381659|NCT01892540|560830976|FG000|Overall Study|Did not complete PET/MRI|0|||
155381660|NCT01892540|560830977|FG001|Overall Study|Did not complete PET/MRI|0|||
155381661|NCT01892540|560830978|FG002|Overall Study|Did not complete PET/MRI|2|||
155381662|NCT01892540|560830976|FG000|Overall Study|Did not fit in scanner|0|||
155381663|NCT01892540|560830977|FG001|Overall Study|Did not fit in scanner|0|||
155381664|NCT01892540|560830978|FG002|Overall Study|Did not fit in scanner|1|||
155381665|NCT01370590|560830979|FG000|Period 1|Adverse Event|8|||
155381666|NCT01370590|560830980|FG001|Period 1|Adverse Event|4|||
155381667|NCT01370590|560830979|FG000|Period 1|Lost to Follow-up|2|||
155381668|NCT01370590|560830980|FG001|Period 1|Lost to Follow-up|2|||
155381669|NCT01370590|560830979|FG000|Period 1|Protocol Violation|2|||
155381670|NCT01370590|560830980|FG001|Period 1|Protocol Violation|2|||
155381671|NCT01370590|560830979|FG000|Period 1|Withdrawal by Subject|4|||
155381672|NCT01370590|560830980|FG001|Period 1|Withdrawal by Subject|2|||
155381673|NCT01370590|560830979|FG000|Period 1|Could not access randomization system|0|||
155381674|NCT01370590|560830980|FG001|Period 1|Could not access randomization system|1|||
155381675|NCT01370590|560830979|FG000|Crossover Washout Period|Adverse Event|1|||
155381676|NCT01370590|560830980|FG001|Crossover Washout Period|Adverse Event|4|||
155381677|NCT01370590|560830979|FG000|Crossover Washout Period|Lost to Follow-up|2|||
155381678|NCT01370590|560830980|FG001|Crossover Washout Period|Lost to Follow-up|0|||
155381679|NCT01370590|560830979|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
155381680|NCT01370590|560830980|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
155381681|NCT01370590|560830979|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
155381682|NCT01370590|560830980|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
155381683|NCT01370590|560830979|FG000|Period 2|Adverse Event|0|||
155381684|NCT01370590|560830980|FG001|Period 2|Adverse Event|1|||
155381685|NCT01370590|560830979|FG000|Period 2|Withdrawal by Subject|1|||
155612355|NCT02207400|561673737|FG001|Overall Study|Adverse Event|1|||
155726014|NCT03224819|562096406|FG011|Overall Study|Lost to Follow-up|0|||
155726015|NCT03224819|562096407|FG012|Overall Study|Lost to Follow-up|0|||
155726016|NCT03224819|562096408|FG013|Overall Study|Lost to Follow-up|0|||
155726017|NCT03224819|562096395|FG000|Overall Study|Death|0|||
155726018|NCT03224819|562096396|FG001|Overall Study|Death|1|||
155726019|NCT03224819|562096397|FG002|Overall Study|Death|0|||
155726020|NCT03224819|562096398|FG003|Overall Study|Death|0|||
155726021|NCT03224819|562096399|FG004|Overall Study|Death|0|||
155726022|NCT03224819|562096400|FG005|Overall Study|Death|0|||
155726023|NCT03224819|562096401|FG006|Overall Study|Death|0|||
155726024|NCT03224819|562096402|FG007|Overall Study|Death|1|||
155381686|NCT01370590|560830980|FG001|Period 2|Withdrawal by Subject|1|||
155381687|NCT04617275|560830984|FG000|Treatment Period|Adverse Event|1|||
155381688|NCT04617275|560830985|FG001|Treatment Period|Adverse Event|6|||
155381689|NCT04617275|560830986|FG002|Treatment Period|Adverse Event|4|||
155381690|NCT04617275|560830987|FG003|Treatment Period|Adverse Event|6|||
155381691|NCT04617275|560830988|FG004|Treatment Period|Adverse Event|7|||
155381692|NCT04617275|560830989|FG005|Treatment Period|Adverse Event|8|||
155381693|NCT04617275|560830990|FG006|Treatment Period|Adverse Event|0|||
155381694|NCT04617275|560830991|FG007|Treatment Period|Adverse Event|12|||
155381695|NCT04617275|560830984|FG000|Treatment Period|Lost to Follow-up|0|||
155612356|NCT02207400|561673736|FG000|Overall Study|Lost to Follow-up|6|||
155612357|NCT02207400|561673737|FG001|Overall Study|Lost to Follow-up|7|||
155612358|NCT02207400|561673736|FG000|Overall Study|Protocol Violation|1|||
155612359|NCT02207400|561673737|FG001|Overall Study|Protocol Violation|1|||
155612360|NCT02207400|561673736|FG000|Overall Study|Withdrawal by Subject|8|||
155612361|NCT02207400|561673737|FG001|Overall Study|Withdrawal by Subject|4|||
155612362|NCT02207400|561673736|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
155612363|NCT02207400|561673737|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
155612364|NCT02362425|561673738|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
155612365|NCT02362425|561673739|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155612366|NCT02362425|561673740|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155612367|NCT02362425|561673741|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155612368|NCT02362425|561673738|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
155612369|NCT02362425|561673739|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155612370|NCT02362425|561673740|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155612371|NCT02362425|561673741|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155612372|NCT02362425|561673738|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
155612373|NCT02362425|561673739|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
155612374|NCT02362425|561673740|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
155612375|NCT02362425|561673741|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
155650593|NCT00452530|561812515|FG000|Overall Study|Adverse Event|40|||
155612376|NCT02362425|561673738|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
155612377|NCT02362425|561673739|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155612378|NCT02362425|561673740|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155612379|NCT02362425|561673741|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155612380|NCT02362425|561673738|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
155612381|NCT02362425|561673739|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
155612382|NCT02362425|561673740|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
155612383|NCT02362425|561673741|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
155612384|NCT02362425|561673738|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155612385|NCT02362425|561673739|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155612386|NCT02362425|561673740|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155612387|NCT02362425|561673741|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
155612388|NCT02362425|561673738|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155612389|NCT02362425|561673739|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155612390|NCT02362425|561673740|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155612391|NCT02362425|561673741|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
155612392|NCT02362425|561673738|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155612393|NCT02362425|561673739|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155612394|NCT02362425|561673740|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
155612395|NCT02362425|561673741|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155612396|NCT04304508|561673749|FG000|Overall Study|Subject Decision|29|||
155612397|NCT04304508|561673750|FG001|Overall Study|Subject Decision|39|||
155612398|NCT04304508|561673751|FG002|Overall Study|Subject Decision|37|||
155612399|NCT04304508|561673752|FG003|Overall Study|Subject Decision|48|||
155612400|NCT04304508|561673749|FG000|Overall Study|Death|6|||
155612401|NCT04304508|561673750|FG001|Overall Study|Death|1|||
155612402|NCT04304508|561673751|FG002|Overall Study|Death|8|||
155612403|NCT04304508|561673752|FG003|Overall Study|Death|5|||
155612404|NCT04304508|561673749|FG000|Overall Study|Non-compliance With Study Drug|3|||
155612405|NCT04304508|561673750|FG001|Overall Study|Non-compliance With Study Drug|1|||
155612406|NCT04304508|561673751|FG002|Overall Study|Non-compliance With Study Drug|2|||
155612407|NCT04304508|561673752|FG003|Overall Study|Non-compliance With Study Drug|0|||
155612408|NCT04304508|561673749|FG000|Overall Study|Switching To Other Therapy|1|||
155612409|NCT04304508|561673750|FG001|Overall Study|Switching To Other Therapy|1|||
155612410|NCT04304508|561673751|FG002|Overall Study|Switching To Other Therapy|1|||
155612411|NCT04304508|561673752|FG003|Overall Study|Switching To Other Therapy|2|||
155612412|NCT04304508|561673749|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
155612413|NCT04304508|561673750|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
155612414|NCT04304508|561673751|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
155612415|NCT04304508|561673752|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
155612416|NCT04304508|561673749|FG000|Overall Study|Withdrawal by Subject|7|||
155612417|NCT04304508|561673750|FG001|Overall Study|Withdrawal by Subject|5|||
155612418|NCT04304508|561673751|FG002|Overall Study|Withdrawal by Subject|11|||
155612419|NCT04304508|561673752|FG003|Overall Study|Withdrawal by Subject|6|||
155612420|NCT04304508|561673749|FG000|Overall Study|Logistical Difficulties|2|||
155612421|NCT04304508|561673750|FG001|Overall Study|Logistical Difficulties|2|||
155612422|NCT04304508|561673751|FG002|Overall Study|Logistical Difficulties|3|||
155612423|NCT04304508|561673752|FG003|Overall Study|Logistical Difficulties|2|||
155612424|NCT04304508|561673749|FG000|Overall Study|Missing Information|1|||
155612425|NCT04304508|561673750|FG001|Overall Study|Missing Information|2|||
155612426|NCT04304508|561673751|FG002|Overall Study|Missing Information|1|||
155612427|NCT04304508|561673752|FG003|Overall Study|Missing Information|3|||
155612428|NCT04304508|561673749|FG000|Overall Study|Other|7|||
155612429|NCT04304508|561673750|FG001|Overall Study|Other|6|||
155612430|NCT04304508|561673751|FG002|Overall Study|Other|5|||
155612431|NCT04304508|561673752|FG003|Overall Study|Other|4|||
155612432|NCT04304508|561673749|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
155612433|NCT04304508|561673750|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155612434|NCT04304508|561673751|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155612435|NCT04304508|561673752|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155612436|NCT04304508|561673749|FG000|Overall Study|Physician Decision|3|||
155612437|NCT04304508|561673750|FG001|Overall Study|Physician Decision|4|||
155612438|NCT04304508|561673751|FG002|Overall Study|Physician Decision|9|||
155612439|NCT04304508|561673752|FG003|Overall Study|Physician Decision|7|||
155612440|NCT04304508|561673749|FG000|Overall Study|Study drug never administered|10|||
155612441|NCT04304508|561673750|FG001|Overall Study|Study drug never administered|4|||
155612442|NCT04304508|561673751|FG002|Overall Study|Study drug never administered|4|||
155612443|NCT04304508|561673752|FG003|Overall Study|Study drug never administered|4|||
155612444|NCT04304508|561673749|FG000|Overall Study|Adverse Event|49|||
155612445|NCT04304508|561673750|FG001|Overall Study|Adverse Event|50|||
155612446|NCT04304508|561673751|FG002|Overall Study|Adverse Event|51|||
155612447|NCT04304508|561673752|FG003|Overall Study|Adverse Event|56|||
155612448|NCT04304508|561673749|FG000|Overall Study|Lost to Follow-up|1|||
155381696|NCT04617275|560830985|FG001|Treatment Period|Lost to Follow-up|0|||
155612449|NCT04304508|561673750|FG001|Overall Study|Lost to Follow-up|5|||
155612450|NCT04304508|561673751|FG002|Overall Study|Lost to Follow-up|2|||
155612451|NCT04304508|561673752|FG003|Overall Study|Lost to Follow-up|3|||
155612452|NCT02688764|561673759|FG000|Overall Study|Adverse Event|3|||
155612453|NCT02688764|561673760|FG001|Overall Study|Adverse Event|3|||
155612454|NCT02688764|561673759|FG000|Overall Study|AE/Kidney transplant|1|||
155612455|NCT02688764|561673760|FG001|Overall Study|AE/Kidney transplant|0|||
155612456|NCT02688764|561673759|FG000|Overall Study|AE/Lack of efficacy|1|||
155612457|NCT02688764|561673760|FG001|Overall Study|AE/Lack of efficacy|0|||
155612458|NCT02688764|561673759|FG000|Overall Study|AE/Non-compl.|1|||
155612459|NCT02688764|561673760|FG001|Overall Study|AE/Non-compl.|0|||
155612460|NCT02688764|561673759|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
155612461|NCT02688764|561673760|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
155612462|NCT02688764|561673759|FG000|Overall Study|AE/Other|0|||
155612463|NCT02688764|561673760|FG001|Overall Study|AE/Other|1|||
155612464|NCT02688764|561673759|FG000|Overall Study|AE/Physician decision|1|||
155612465|NCT02688764|561673760|FG001|Overall Study|AE/Physician decision|0|||
155612466|NCT02688764|561673759|FG000|Overall Study|AE/Withd. parent|3|||
155612467|NCT02688764|561673760|FG001|Overall Study|AE/Withd. parent|0|||
155612468|NCT02688764|561673759|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
155612469|NCT02688764|561673760|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
155612470|NCT02688764|561673759|FG000|Overall Study|AE/Withd. subject|1|||
155612471|NCT02688764|561673760|FG001|Overall Study|AE/Withd. subject|0|||
155612472|NCT02688764|561673759|FG000|Overall Study|Kidney transplant|10|||
155612473|NCT02688764|561673760|FG001|Overall Study|Kidney transplant|4|||
155612474|NCT02688764|561673759|FG000|Overall Study|Lack of Efficacy|3|||
155612475|NCT02688764|561673760|FG001|Overall Study|Lack of Efficacy|2|||
155612476|NCT02688764|561673759|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
155612477|NCT02688764|561673760|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
155612478|NCT02688764|561673759|FG000|Overall Study|Non-compliance with study drug|4|||
155612479|NCT02688764|561673760|FG001|Overall Study|Non-compliance with study drug|0|||
155612480|NCT02688764|561673759|FG000|Overall Study|Non-compl./Physician decision|2|||
155612481|NCT02688764|561673760|FG001|Overall Study|Non-compl./Physician decision|0|||
155612482|NCT02688764|561673759|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
155612483|NCT02688764|561673760|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
155612484|NCT02688764|561673759|FG000|Overall Study|Non-compl./Withd. subject|0|||
155612485|NCT02688764|561673760|FG001|Overall Study|Non-compl./Withd. subject|2|||
155612486|NCT02688764|561673759|FG000|Overall Study|Phosphorus level outside safe range|0|||
155612487|NCT02688764|561673760|FG001|Overall Study|Phosphorus level outside safe range|1|||
155612488|NCT02688764|561673759|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
155612489|NCT02688764|561673760|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
155612490|NCT02688764|561673759|FG000|Overall Study|Study drug taste/Withd. parent|1|||
155612491|NCT02688764|561673760|FG001|Overall Study|Study drug taste/Withd. parent|0|||
155612492|NCT02688764|561673759|FG000|Overall Study|Subject moving out|2|||
155612493|NCT02688764|561673760|FG001|Overall Study|Subject moving out|0|||
155612494|NCT02688764|561673759|FG000|Overall Study|Subject taken off dialysis|1|||
155612495|NCT02688764|561673760|FG001|Overall Study|Subject taken off dialysis|0|||
155612496|NCT02688764|561673759|FG000|Overall Study|Withdrawal by parent|3|||
155612497|NCT02688764|561673760|FG001|Overall Study|Withdrawal by parent|0|||
155612498|NCT02113007|561673761|FG000|Overall Study|Progressive disease|2|||
155612499|NCT00885378|561673762|FG000|Overall Study|Lack of Efficacy|2|||
155612500|NCT00885378|561673763|FG001|Overall Study|Lack of Efficacy|2|||
155612501|NCT00885378|561673762|FG000|Overall Study|Withdrawal by Subject|1|||
155612502|NCT00885378|561673763|FG001|Overall Study|Withdrawal by Subject|2|||
155612503|NCT00885378|561673762|FG000|Overall Study|Lost to Follow-up|1|||
155612504|NCT00885378|561673763|FG001|Overall Study|Lost to Follow-up|2|||
155612505|NCT00885378|561673762|FG000|Overall Study|Poor/Noncompliance|2|||
155612506|NCT00885378|561673763|FG001|Overall Study|Poor/Noncompliance|2|||
155612507|NCT00885378|561673762|FG000|Overall Study|Protocol Violation|2|||
155612508|NCT00885378|561673763|FG001|Overall Study|Protocol Violation|0|||
155612509|NCT01775787|561673764|FG000|First 7-10 Days|Adverse Event|0|||
155612510|NCT01775787|561673765|FG001|First 7-10 Days|Adverse Event|1|||
155612511|NCT01775787|561673764|FG000|First 7-10 Days|family emergency|0|||
155612512|NCT01775787|561673765|FG001|First 7-10 Days|family emergency|1|||
155612513|NCT01775787|561673764|FG000|First 7-10 Days|time commitment|0|||
155612514|NCT01775787|561673765|FG001|First 7-10 Days|time commitment|2|||
155612515|NCT01775787|561673764|FG000|First 7-10 Days|concerns with using IV|1|||
155612516|NCT01775787|561673765|FG001|First 7-10 Days|concerns with using IV|2|||
155612517|NCT01775787|561673764|FG000|Second 7-10 Days|time commitment|0|||
155612518|NCT01775787|561673765|FG001|Second 7-10 Days|time commitment|1|||
155612519|NCT01775787|561673764|FG000|Second 7-10 Days|concerns with using IV|0|||
155612520|NCT01775787|561673765|FG001|Second 7-10 Days|concerns with using IV|1|||
155650594|NCT00452530|561812516|FG001|Overall Study|Adverse Event|44|||
155612521|NCT03026283|561673766|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
155612522|NCT03026283|561673767|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
155612523|NCT03026283|561673768|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
155612524|NCT03026283|561673769|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
155612525|NCT03026283|561673770|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
155612526|NCT03026283|561673771|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
155612527|NCT03026283|561673772|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
155612528|NCT03026283|561673773|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
155612529|NCT03026283|561673766|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
155612530|NCT03026283|561673767|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
155612531|NCT03026283|561673768|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
155612532|NCT03026283|561673769|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
155612533|NCT03026283|561673770|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
155612534|NCT03026283|561673771|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
155612535|NCT03026283|561673772|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
155612536|NCT03026283|561673773|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
155612537|NCT03026283|561673766|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612538|NCT03026283|561673767|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
155612539|NCT03026283|561673768|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612540|NCT03026283|561673769|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612541|NCT03026283|561673770|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612542|NCT03026283|561673771|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612543|NCT03026283|561673772|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612544|NCT03026283|561673773|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155612545|NCT03026283|561673766|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155612546|NCT03026283|561673767|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155612547|NCT03026283|561673768|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
155612548|NCT03026283|561673769|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155612549|NCT03026283|561673770|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155726025|NCT03224819|562096403|FG008|Overall Study|Death|0|||
155726026|NCT03224819|562096404|FG009|Overall Study|Death|0|||
155726027|NCT03224819|562096405|FG010|Overall Study|Death|0|||
155726028|NCT03224819|562096406|FG011|Overall Study|Death|1|||
155726029|NCT03224819|562096407|FG012|Overall Study|Death|0|||
155726030|NCT03224819|562096408|FG013|Overall Study|Death|0|||
155726031|NCT02059278|562096409|FG000|Overall Study|Adverse Event|1|||
155726032|NCT02059278|562096410|FG001|Overall Study|Adverse Event|1|||
155726033|NCT02059278|562096409|FG000|Overall Study|Lost to Follow-up|1|||
155726034|NCT02059278|562096410|FG001|Overall Study|Lost to Follow-up|0|||
155726035|NCT02059278|562096409|FG000|Overall Study|Withdrawal by Subject|0|||
155726036|NCT02059278|562096410|FG001|Overall Study|Withdrawal by Subject|3|||
155726037|NCT02059278|562096409|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
155726038|NCT02059278|562096410|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
155726039|NCT00737672|562096411|FG000|Overall Study|Graft Abandonment|48|||
155726040|NCT00737672|562096412|FG001|Overall Study|Graft Abandonment|56|||
155726041|NCT00737672|562096411|FG000|Overall Study|Death|23|||
155726042|NCT00737672|562096412|FG001|Overall Study|Death|22|||
155726043|NCT00737672|562096411|FG000|Overall Study|Withdrawal by Subject|1|||
155726044|NCT00737672|562096412|FG001|Overall Study|Withdrawal by Subject|2|||
155726045|NCT00737672|562096411|FG000|Overall Study|Lost to Follow-up|1|||
155726046|NCT00737672|562096412|FG001|Overall Study|Lost to Follow-up|0|||
155726047|NCT00737672|562096411|FG000|Overall Study|Miscellaneous|7|||
155726048|NCT00737672|562096412|FG001|Overall Study|Miscellaneous|1|||
155726049|NCT00737672|562096411|FG000|Overall Study|Physician Decision|0|||
155726050|NCT00737672|562096412|FG001|Overall Study|Physician Decision|2|||
155726051|NCT00829426|562096416|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155726052|NCT00829426|562096417|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155726053|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
155726054|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
155726055|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
155726056|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
155612550|NCT03026283|561673771|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155612551|NCT03026283|561673772|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155726057|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Adverse Event|2|||
155726058|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Adverse Event|5|||
155726059|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Adverse Event|1|||
155726060|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Adverse Event|2|||
155726061|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Death|13|||
155726062|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Death|17|||
155726063|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Death|1|||
155726064|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Death|0|||
155726065|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
155726066|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
155612552|NCT03026283|561673773|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155612553|NCT03026283|561673766|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612554|NCT03026283|561673767|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612555|NCT03026283|561673768|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612556|NCT03026283|561673769|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
155612557|NCT03026283|561673770|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
155612558|NCT03026283|561673771|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612559|NCT03026283|561673772|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612560|NCT03026283|561673773|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155612561|NCT03026283|561673766|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155612562|NCT03026283|561673767|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155612563|NCT03026283|561673768|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155612564|NCT03026283|561673769|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
155612565|NCT03026283|561673770|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
155612566|NCT03026283|561673771|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
155612567|NCT03026283|561673772|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155612568|NCT03026283|561673773|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155612569|NCT03026283|561673766|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612570|NCT03026283|561673767|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612571|NCT03026283|561673768|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612572|NCT03026283|561673769|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
155612573|NCT03026283|561673770|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612574|NCT03026283|561673771|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
155612575|NCT03026283|561673772|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612576|NCT03026283|561673773|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155612577|NCT03026283|561673766|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612578|NCT03026283|561673767|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612579|NCT03026283|561673768|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612580|NCT03026283|561673769|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
155612581|NCT03026283|561673770|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612582|NCT03026283|561673771|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612583|NCT03026283|561673772|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612584|NCT03026283|561673773|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155612585|NCT03026283|561673766|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612586|NCT03026283|561673767|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612587|NCT03026283|561673768|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612588|NCT03026283|561673769|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612589|NCT03026283|561673770|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
155612590|NCT03026283|561673771|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
155612591|NCT03026283|561673772|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612592|NCT03026283|561673773|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155612593|NCT00824655|561673774|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
155612594|NCT00824655|561673775|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
155612595|NCT00824655|561673774|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
155612596|NCT00824655|561673775|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
155612597|NCT03252145|561673776|FG000|Overall Study|Withdrawal by Subject|1|||
155612598|NCT03252145|561673777|FG001|Overall Study|Withdrawal by Subject|0|||
155612599|NCT03252145|561673776|FG000|Overall Study|Complicating Disease|1|||
155612600|NCT03252145|561673777|FG001|Overall Study|Complicating Disease|2|||
155612601|NCT03091738|561673778|FG000|Overall Study|Adverse Event|1|||
155612602|NCT03091738|561673778|FG000|Overall Study|Lost to Follow-up|1|||
155612603|NCT01763827|561673780|FG000|Overall Study|Withdrawal by Subject|1|||
155612604|NCT01763827|561673781|FG001|Overall Study|Withdrawal by Subject|0|||
155612605|NCT01763827|561673782|FG002|Overall Study|Withdrawal by Subject|0|||
155612606|NCT01763827|561673783|FG003|Overall Study|Withdrawal by Subject|0|||
155612607|NCT01763827|561673784|FG004|Overall Study|Withdrawal by Subject|2|||
155612608|NCT01763827|561673785|FG005|Overall Study|Withdrawal by Subject|0|||
155612609|NCT01763827|561673780|FG000|Overall Study|Decision by sponsor|2|||
155612610|NCT01763827|561673781|FG001|Overall Study|Decision by sponsor|0|||
155612611|NCT01763827|561673782|FG002|Overall Study|Decision by sponsor|3|||
155612612|NCT01763827|561673783|FG003|Overall Study|Decision by sponsor|0|||
155612613|NCT01763827|561673784|FG004|Overall Study|Decision by sponsor|2|||
155726067|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
155726068|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
155612614|NCT01763827|561673785|FG005|Overall Study|Decision by sponsor|1|||
155612615|NCT01763827|561673780|FG000|Overall Study|Lost to Follow-up|0|||
155612616|NCT01763827|561673781|FG001|Overall Study|Lost to Follow-up|1|||
155612617|NCT01763827|561673782|FG002|Overall Study|Lost to Follow-up|1|||
155612618|NCT01763827|561673783|FG003|Overall Study|Lost to Follow-up|1|||
155612619|NCT01763827|561673784|FG004|Overall Study|Lost to Follow-up|2|||
155612620|NCT01763827|561673785|FG005|Overall Study|Lost to Follow-up|1|||
155612621|NCT01826981|561673786|FG000|Overall Study|Lack of Efficacy|0|||
155612622|NCT01826981|561673787|FG001|Overall Study|Lack of Efficacy|1|||
155612623|NCT01826981|561673788|FG002|Overall Study|Lack of Efficacy|0|||
155612624|NCT01826981|561673789|FG003|Overall Study|Lack of Efficacy|0|||
155612625|NCT01826981|561673790|FG004|Overall Study|Lack of Efficacy|5|||
155612626|NCT01826981|561673791|FG005|Overall Study|Lack of Efficacy|0|||
155612627|NCT01826981|561673792|FG006|Overall Study|Lack of Efficacy|0|||
155612628|NCT01826981|561673793|FG007|Overall Study|Lack of Efficacy|8|||
155612629|NCT01826981|561673794|FG008|Overall Study|Lack of Efficacy|7|||
155612630|NCT01826981|561673795|FG009|Overall Study|Lack of Efficacy|0|||
155612631|NCT01826981|561673796|FG010|Overall Study|Lack of Efficacy|1|||
155612632|NCT01826981|561673797|FG011|Overall Study|Lack of Efficacy|0|||
155612633|NCT01826981|561673798|FG012|Overall Study|Lack of Efficacy|0|||
155612634|NCT01826981|561673799|FG013|Overall Study|Lack of Efficacy|3|||
155612635|NCT01826981|561673800|FG014|Overall Study|Lack of Efficacy|0|||
155612636|NCT01826981|561673786|FG000|Overall Study|Lost to Follow-up|0|||
155612637|NCT01826981|561673787|FG001|Overall Study|Lost to Follow-up|0|||
155612638|NCT01826981|561673788|FG002|Overall Study|Lost to Follow-up|0|||
155612639|NCT01826981|561673789|FG003|Overall Study|Lost to Follow-up|0|||
155612640|NCT01826981|561673790|FG004|Overall Study|Lost to Follow-up|1|||
155612641|NCT01826981|561673791|FG005|Overall Study|Lost to Follow-up|1|||
155612642|NCT01826981|561673792|FG006|Overall Study|Lost to Follow-up|0|||
155612643|NCT01826981|561673793|FG007|Overall Study|Lost to Follow-up|1|||
155612644|NCT01826981|561673794|FG008|Overall Study|Lost to Follow-up|0|||
155612645|NCT01826981|561673795|FG009|Overall Study|Lost to Follow-up|1|||
155612646|NCT01826981|561673796|FG010|Overall Study|Lost to Follow-up|1|||
155612647|NCT01826981|561673797|FG011|Overall Study|Lost to Follow-up|1|||
155612648|NCT01826981|561673798|FG012|Overall Study|Lost to Follow-up|1|||
155726069|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Disease Progression|2|||
155726070|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Disease Progression|0|||
155726071|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Disease Progression|0|||
155726072|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Disease Progression|0|||
155726073|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
155726074|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
155726075|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
155726076|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
155726077|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
155726078|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
155726079|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
155726080|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
155726081|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
155726082|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
155726083|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
155726084|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
155726085|NCT03955146|562096418|FG000|DB Period (48 Weeks)|Participant Decision|9|||
155726086|NCT03955146|562096419|FG001|DB Period (48 Weeks)|Participant Decision|12|||
155726087|NCT03955146|562096420|FG002|DB Period (48 Weeks)|Participant Decision|1|||
155726088|NCT03955146|562096421|FG003|DB Period (48 Weeks)|Participant Decision|1|||
155726089|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
155726090|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
155726091|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
155726092|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
155726093|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
155726094|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
155726095|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
155726096|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
155726097|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155726098|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
155726099|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155612649|NCT01826981|561673799|FG013|Overall Study|Lost to Follow-up|0|||
155612650|NCT01826981|561673800|FG014|Overall Study|Lost to Follow-up|0|||
155612651|NCT01826981|561673786|FG000|Overall Study|Withdrew Consent|0|||
155612652|NCT01826981|561673787|FG001|Overall Study|Withdrew Consent|0|||
155612653|NCT01826981|561673788|FG002|Overall Study|Withdrew Consent|0|||
155612654|NCT01826981|561673789|FG003|Overall Study|Withdrew Consent|0|||
155612655|NCT01826981|561673790|FG004|Overall Study|Withdrew Consent|0|||
155612656|NCT01826981|561673791|FG005|Overall Study|Withdrew Consent|0|||
155726100|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155726101|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
155726102|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
155612657|NCT01826981|561673792|FG006|Overall Study|Withdrew Consent|1|||
155612658|NCT01826981|561673793|FG007|Overall Study|Withdrew Consent|1|||
155612659|NCT01826981|561673794|FG008|Overall Study|Withdrew Consent|0|||
155612660|NCT01826981|561673795|FG009|Overall Study|Withdrew Consent|0|||
155612661|NCT01826981|561673796|FG010|Overall Study|Withdrew Consent|0|||
155612662|NCT01826981|561673797|FG011|Overall Study|Withdrew Consent|1|||
155612663|NCT01826981|561673798|FG012|Overall Study|Withdrew Consent|0|||
155612664|NCT01826981|561673799|FG013|Overall Study|Withdrew Consent|1|||
155612665|NCT01826981|561673800|FG014|Overall Study|Withdrew Consent|0|||
155612666|NCT01826981|561673786|FG000|Overall Study|Adverse Event|0|||
155612667|NCT01826981|561673787|FG001|Overall Study|Adverse Event|0|||
155612668|NCT01826981|561673788|FG002|Overall Study|Adverse Event|0|||
155612669|NCT01826981|561673789|FG003|Overall Study|Adverse Event|0|||
155612670|NCT01826981|561673790|FG004|Overall Study|Adverse Event|1|||
155612671|NCT01826981|561673791|FG005|Overall Study|Adverse Event|0|||
155612672|NCT01826981|561673792|FG006|Overall Study|Adverse Event|0|||
155612673|NCT01826981|561673793|FG007|Overall Study|Adverse Event|0|||
155612674|NCT01826981|561673794|FG008|Overall Study|Adverse Event|0|||
155612675|NCT01826981|561673795|FG009|Overall Study|Adverse Event|0|||
155612676|NCT01826981|561673796|FG010|Overall Study|Adverse Event|0|||
155612677|NCT01826981|561673797|FG011|Overall Study|Adverse Event|0|||
155612678|NCT01826981|561673798|FG012|Overall Study|Adverse Event|0|||
155612679|NCT01826981|561673799|FG013|Overall Study|Adverse Event|0|||
155612680|NCT01826981|561673800|FG014|Overall Study|Adverse Event|0|||
155612681|NCT01826981|561673786|FG000|Overall Study|Upper G-I Haemorrhage|0|||
155612682|NCT01826981|561673787|FG001|Overall Study|Upper G-I Haemorrhage|0|||
155612683|NCT01826981|561673788|FG002|Overall Study|Upper G-I Haemorrhage|0|||
155612684|NCT01826981|561673789|FG003|Overall Study|Upper G-I Haemorrhage|0|||
155612685|NCT01826981|561673790|FG004|Overall Study|Upper G-I Haemorrhage|0|||
155612686|NCT01826981|561673791|FG005|Overall Study|Upper G-I Haemorrhage|0|||
155612687|NCT01826981|561673792|FG006|Overall Study|Upper G-I Haemorrhage|0|||
155612688|NCT01826981|561673793|FG007|Overall Study|Upper G-I Haemorrhage|0|||
155612689|NCT01826981|561673794|FG008|Overall Study|Upper G-I Haemorrhage|0|||
155612690|NCT01826981|561673795|FG009|Overall Study|Upper G-I Haemorrhage|0|||
155612691|NCT01826981|561673796|FG010|Overall Study|Upper G-I Haemorrhage|0|||
155612692|NCT01826981|561673797|FG011|Overall Study|Upper G-I Haemorrhage|0|||
155612693|NCT01826981|561673798|FG012|Overall Study|Upper G-I Haemorrhage|0|||
155612694|NCT01826981|561673799|FG013|Overall Study|Upper G-I Haemorrhage|1|||
155612695|NCT01826981|561673800|FG014|Overall Study|Upper G-I Haemorrhage|0|||
155612696|NCT01826981|561673786|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612697|NCT01826981|561673787|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612698|NCT01826981|561673788|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612699|NCT01826981|561673789|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612700|NCT01826981|561673790|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612701|NCT01826981|561673791|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612702|NCT01826981|561673792|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612703|NCT01826981|561673793|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
155612704|NCT01826981|561673794|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612705|NCT01826981|561673795|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612706|NCT01826981|561673796|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612707|NCT01826981|561673797|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612708|NCT01826981|561673798|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612709|NCT01826981|561673799|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612710|NCT01826981|561673800|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
155612711|NCT02384538|561673805|FG000|Overall Study|Adverse Event|1|||
155612712|NCT02384538|561673806|FG001|Overall Study|Adverse Event|4|||
155612713|NCT02384538|561673805|FG000|Overall Study|Lack of Efficacy|4|||
155612714|NCT02384538|561673806|FG001|Overall Study|Lack of Efficacy|4|||
155612715|NCT02384538|561673805|FG000|Overall Study|Withdrew Consent|0|||
155612716|NCT02384538|561673806|FG001|Overall Study|Withdrew Consent|4|||
155612717|NCT02384538|561673805|FG000|Overall Study|Other|1|||
155612718|NCT02384538|561673806|FG001|Overall Study|Other|3|||
155612719|NCT01763203|561673809|FG000|Overall Study|Death|4|||
155612720|NCT01763203|561673810|FG001|Overall Study|Death|7|||
155612721|NCT01763203|561673809|FG000|Overall Study|Lost to Follow-up|12|||
155612722|NCT01763203|561673810|FG001|Overall Study|Lost to Follow-up|12|||
155612723|NCT01763203|561673809|FG000|Overall Study|Withdrawal by Subject|8|||
155612724|NCT01763203|561673810|FG001|Overall Study|Withdrawal by Subject|12|||
155612725|NCT01763203|561673809|FG000|Overall Study|Moved out of study region|7|||
155612726|NCT01763203|561673810|FG001|Overall Study|Moved out of study region|10|||
155612727|NCT01763203|561673809|FG000|Overall Study|Physician Decision|2|||
155612728|NCT01763203|561673810|FG001|Overall Study|Physician Decision|1|||
155612729|NCT02187861|561673811|FG000|Overall Study|Adverse Event|2|||
155612730|NCT02187861|561673812|FG001|Overall Study|Adverse Event|1|||
155612731|NCT02187861|561673813|FG002|Overall Study|Adverse Event|2|||
155612732|NCT02187861|561673814|FG003|Overall Study|Adverse Event|1|||
155612733|NCT02187861|561673811|FG000|Overall Study|Death|0|||
155612734|NCT02187861|561673812|FG001|Overall Study|Death|3|||
155612735|NCT02187861|561673813|FG002|Overall Study|Death|1|||
155612736|NCT02187861|561673814|FG003|Overall Study|Death|2|||
155726103|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
155726104|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
155726105|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
155726106|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
155726107|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
155726108|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
155726109|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
155726110|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155726111|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155726112|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155726113|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
155726114|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
155726115|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
155726116|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
155726117|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
155726118|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
155726119|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
155726120|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
155726121|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
155726122|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155726123|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155726124|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155726125|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
155726126|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
155726127|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
155726128|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
155726129|NCT03955146|562096418|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
155726130|NCT03955146|562096419|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155726131|NCT03955146|562096420|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155726132|NCT03955146|562096421|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155726133|NCT02002598|562096426|FG000|Dose Level 1|Withdrawal by Subject|1|||
155726134|NCT02002598|562096427|FG001|Dose Level 1|Withdrawal by Subject|0|||
155726135|NCT02002598|562096428|FG002|Dose Level 1|Withdrawal by Subject|0|||
155726136|NCT02002598|562096429|FG003|Dose Level 1|Withdrawal by Subject|0|||
155726137|NCT02002598|562096430|FG004|Dose Level 1|Withdrawal by Subject|0|||
155726138|NCT04123470|562096440|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
155726139|NCT04123470|562096441|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155726140|NCT04123470|562096440|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
155726141|NCT04123470|562096441|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
155726142|NCT04123470|562096440|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
155726143|NCT04123470|562096441|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
155726144|NCT04123470|562096440|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
155726145|NCT04123470|562096441|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
155726146|NCT02018562|562096445|FG000|Overall Study|Withdrawal by Subject|2|||
155726147|NCT02018562|562096446|FG001|Overall Study|Withdrawal by Subject|0|||
155726148|NCT02018562|562096445|FG000|Overall Study|Discharged prior to study completion|1|||
155726149|NCT02018562|562096446|FG001|Overall Study|Discharged prior to study completion|0|||
155726150|NCT05408429|562096449|FG000|Overall Study|Lost to Follow-up|1|||
155726151|NCT05408429|562096450|FG001|Overall Study|Lost to Follow-up|1|||
155726152|NCT05408429|562096451|FG002|Overall Study|Lost to Follow-up|0|||
155726153|NCT05408429|562096449|FG000|Overall Study|Withdrawal by Subject|5|||
155726154|NCT05408429|562096450|FG001|Overall Study|Withdrawal by Subject|0|||
155726155|NCT05408429|562096451|FG002|Overall Study|Withdrawal by Subject|1|||
155726156|NCT03435211|562096452|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
155726157|NCT01253291|562096453|FG000|Overall Study|Withdrawal by Subject|1|||
155726158|NCT01253291|562096454|FG001|Overall Study|Withdrawal by Subject|1|||
155726159|NCT01253291|562096455|FG002|Overall Study|Withdrawal by Subject|0|||
155726160|NCT01253291|562096456|FG003|Overall Study|Withdrawal by Subject|0|||
155726161|NCT01253291|562096457|FG004|Overall Study|Withdrawal by Subject|0|||
155726162|NCT01253291|562096453|FG000|Overall Study|Adverse Event|0|||
155726163|NCT01253291|562096454|FG001|Overall Study|Adverse Event|1|||
155726164|NCT01253291|562096455|FG002|Overall Study|Adverse Event|0|||
155726165|NCT01253291|562096456|FG003|Overall Study|Adverse Event|0|||
155726166|NCT01253291|562096457|FG004|Overall Study|Adverse Event|0|||
155726167|NCT01253291|562096453|FG000|Overall Study|Lack of Efficacy|1|||
155726168|NCT01253291|562096454|FG001|Overall Study|Lack of Efficacy|0|||
155726169|NCT01253291|562096455|FG002|Overall Study|Lack of Efficacy|0|||
155726170|NCT01253291|562096456|FG003|Overall Study|Lack of Efficacy|0|||
155726171|NCT01253291|562096457|FG004|Overall Study|Lack of Efficacy|0|||
155726172|NCT01253291|562096453|FG000|Overall Study|Physician Decision|2|||
155612737|NCT02187861|561673811|FG000|Overall Study|Physician Decision|0|||
155612738|NCT02187861|561673812|FG001|Overall Study|Physician Decision|1|||
155612739|NCT02187861|561673813|FG002|Overall Study|Physician Decision|0|||
155612740|NCT02187861|561673814|FG003|Overall Study|Physician Decision|3|||
155612741|NCT02187861|561673811|FG000|Overall Study|Progressive Disease|4|||
155612742|NCT02187861|561673812|FG001|Overall Study|Progressive Disease|42|||
155612743|NCT02187861|561673813|FG002|Overall Study|Progressive Disease|19|||
155612744|NCT02187861|561673814|FG003|Overall Study|Progressive Disease|22|||
155612745|NCT02187861|561673811|FG000|Overall Study|Withdrawal by Subject|0|||
155612746|NCT02187861|561673812|FG001|Overall Study|Withdrawal by Subject|0|||
155612747|NCT02187861|561673813|FG002|Overall Study|Withdrawal by Subject|3|||
155612748|NCT02187861|561673814|FG003|Overall Study|Withdrawal by Subject|3|||
155612749|NCT02187861|561673811|FG000|Overall Study|Other|0|||
155612750|NCT02187861|561673812|FG001|Overall Study|Other|1|||
155612751|NCT02187861|561673813|FG002|Overall Study|Other|7|||
155612752|NCT02187861|561673814|FG003|Overall Study|Other|1|||
155612753|NCT02756819|561673815|FG000|Overall Study|Lost for observation|23|||
155612754|NCT02756819|561673815|FG000|Overall Study|Patient's unwillingness|16|||
155612755|NCT02756819|561673815|FG000|Overall Study|Insufficient efficacy|2|||
155612756|NCT02756819|561673815|FG000|Overall Study|Adverse Event|2|||
155612757|NCT02756819|561673815|FG000|Overall Study|Reason not Specified|9|||
155612758|NCT04217317|561673821|FG000|Overall Study|Lack of Efficacy|4|||
155612759|NCT04217317|561673821|FG000|Overall Study|Physician Decision|1|||
155612760|NCT02087943|561673822|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
155612761|NCT02087943|561673823|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
155612762|NCT02087943|561673824|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
155612763|NCT02087943|561673825|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
155612764|NCT02087943|561673826|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
155612765|NCT02087943|561673822|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
155612766|NCT02087943|561673823|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
155612767|NCT02087943|561673824|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
155612768|NCT02087943|561673825|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
155612769|NCT02087943|561673826|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
155612770|NCT02087943|561673822|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
155612771|NCT02087943|561673823|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
155612772|NCT02087943|561673824|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
155612773|NCT02087943|561673825|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
155612774|NCT02087943|561673826|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
155612775|NCT02087943|561673822|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
155612776|NCT02087943|561673823|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155612777|NCT02087943|561673824|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
155612778|NCT02087943|561673825|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155612779|NCT02087943|561673826|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155612780|NCT02087943|561673822|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155612781|NCT02087943|561673823|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
155612782|NCT02087943|561673824|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155612783|NCT02087943|561673825|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155612784|NCT02087943|561673826|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155612785|NCT02087943|561673822|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
155612786|NCT02087943|561673823|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
155612787|NCT02087943|561673824|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
155612788|NCT02087943|561673825|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
155612789|NCT02087943|561673826|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
155612790|NCT02087943|561673822|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
155612791|NCT02087943|561673823|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
155612792|NCT02087943|561673824|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
155612793|NCT02087943|561673825|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
155612794|NCT02087943|561673826|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
155612795|NCT02087943|561673822|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155612796|NCT02087943|561673823|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155612797|NCT02087943|561673824|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
155612798|NCT02087943|561673825|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155612799|NCT02087943|561673826|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155612800|NCT02087943|561673822|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155612801|NCT02087943|561673823|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155612802|NCT02087943|561673824|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155612803|NCT02087943|561673825|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155612804|NCT02087943|561673826|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
155612805|NCT02087943|561673822|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155612806|NCT02087943|561673823|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155612807|NCT02087943|561673824|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
155612808|NCT02087943|561673825|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
155612809|NCT02087943|561673826|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155612810|NCT01690299|561673827|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
155612811|NCT01690299|561673828|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
155612812|NCT01690299|561673829|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
155612813|NCT01690299|561673830|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155612814|NCT01690299|561673831|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155612815|NCT01690299|561673832|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155612816|NCT01690299|561673827|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
155612817|NCT01690299|561673828|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155612818|NCT01690299|561673829|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155612819|NCT01690299|561673830|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155612820|NCT01690299|561673831|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155612821|NCT01690299|561673832|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155612822|NCT01690299|561673827|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
155612823|NCT01690299|561673828|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
155612824|NCT01690299|561673829|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155612825|NCT01690299|561673830|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155612826|NCT01690299|561673831|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155612827|NCT01690299|561673832|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155612828|NCT01690299|561673827|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
155612829|NCT01690299|561673828|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
155612830|NCT01690299|561673829|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
155612831|NCT01690299|561673830|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155612832|NCT01690299|561673831|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155612833|NCT01690299|561673832|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155726173|NCT01253291|562096454|FG001|Overall Study|Physician Decision|0|||
155726174|NCT01253291|562096455|FG002|Overall Study|Physician Decision|0|||
155726175|NCT01253291|562096456|FG003|Overall Study|Physician Decision|0|||
155726176|NCT01253291|562096457|FG004|Overall Study|Physician Decision|2|||
155726177|NCT01838395|562096458|FG000|Overall Study|Withdrawal by Subject|0|||
155726178|NCT01838395|562096459|FG001|Overall Study|Withdrawal by Subject|0|||
155726179|NCT01838395|562096460|FG002|Overall Study|Withdrawal by Subject|0|||
155726180|NCT01838395|562096461|FG003|Overall Study|Withdrawal by Subject|0|||
155726181|NCT01838395|562096462|FG004|Overall Study|Withdrawal by Subject|1|||
155726182|NCT01838395|562096463|FG005|Overall Study|Withdrawal by Subject|0|||
155726183|NCT01838395|562096458|FG000|Overall Study|Death|0|||
155726184|NCT01838395|562096459|FG001|Overall Study|Death|0|||
155726185|NCT01838395|562096460|FG002|Overall Study|Death|1|||
155726186|NCT01838395|562096461|FG003|Overall Study|Death|0|||
155726187|NCT01838395|562096462|FG004|Overall Study|Death|0|||
155726188|NCT01838395|562096463|FG005|Overall Study|Death|0|||
155726189|NCT01838395|562096458|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155726190|NCT01838395|562096459|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
155726191|NCT01838395|562096460|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155726192|NCT01838395|562096461|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155726193|NCT01838395|562096462|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155726194|NCT01838395|562096463|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155726195|NCT05972993|562096464|FG000|Overall Study|Lost to Follow-up|2|||
155726196|NCT05972993|562096465|FG001|Overall Study|Lost to Follow-up|0|||
155726197|NCT05972993|562096466|FG002|Overall Study|Lost to Follow-up|1|||
155726198|NCT05972993|562096467|FG003|Overall Study|Lost to Follow-up|0|||
155726199|NCT05972993|562096468|FG004|Overall Study|Lost to Follow-up|0|||
155726200|NCT05972993|562096469|FG005|Overall Study|Lost to Follow-up|0|||
155726201|NCT05972993|562096470|FG006|Overall Study|Lost to Follow-up|0|||
155726202|NCT05972993|562096471|FG007|Overall Study|Lost to Follow-up|2|||
155726203|NCT05972993|562096472|FG008|Overall Study|Lost to Follow-up|0|||
155726204|NCT03866577|562096473|FG000|Overall Study|Protocol Violation|0|||
155726205|NCT03866577|562096474|FG001|Overall Study|Protocol Violation|0|||
155726206|NCT03866577|562096475|FG002|Overall Study|Protocol Violation|0|||
155726207|NCT03866577|562096476|FG003|Overall Study|Protocol Violation|0|||
155381697|NCT04617275|560830986|FG002|Treatment Period|Lost to Follow-up|2|||
155726208|NCT03866577|562096477|FG004|Overall Study|Protocol Violation|0|||
155726209|NCT03866577|562096478|FG005|Overall Study|Protocol Violation|0|||
155726210|NCT03866577|562096479|FG006|Overall Study|Protocol Violation|0|||
155726211|NCT03866577|562096480|FG007|Overall Study|Protocol Violation|0|||
155726212|NCT03866577|562096481|FG008|Overall Study|Protocol Violation|0|||
155726213|NCT03866577|562096482|FG009|Overall Study|Protocol Violation|0|||
155726214|NCT03866577|562096483|FG010|Overall Study|Protocol Violation|0|||
155726215|NCT03866577|562096484|FG011|Overall Study|Protocol Violation|1|||
155726216|NCT03866577|562096485|FG012|Overall Study|Protocol Violation|0|||
155726217|NCT03866577|562096473|FG000|Overall Study|Withdrawal by Subject|0|||
155726218|NCT03866577|562096474|FG001|Overall Study|Withdrawal by Subject|0|||
155726219|NCT03866577|562096475|FG002|Overall Study|Withdrawal by Subject|0|||
155726220|NCT03866577|562096476|FG003|Overall Study|Withdrawal by Subject|0|||
155726221|NCT03866577|562096477|FG004|Overall Study|Withdrawal by Subject|0|||
155726222|NCT03866577|562096478|FG005|Overall Study|Withdrawal by Subject|0|||
155726223|NCT03866577|562096479|FG006|Overall Study|Withdrawal by Subject|0|||
155726224|NCT03866577|562096480|FG007|Overall Study|Withdrawal by Subject|0|||
155726225|NCT03866577|562096481|FG008|Overall Study|Withdrawal by Subject|1|||
155726226|NCT03866577|562096482|FG009|Overall Study|Withdrawal by Subject|1|||
155726227|NCT03866577|562096483|FG010|Overall Study|Withdrawal by Subject|0|||
155726228|NCT03866577|562096484|FG011|Overall Study|Withdrawal by Subject|0|||
155726229|NCT03866577|562096485|FG012|Overall Study|Withdrawal by Subject|0|||
155726230|NCT03866577|562096473|FG000|Overall Study|Not qualified for IVIg infusion|0|||
155726231|NCT03866577|562096474|FG001|Overall Study|Not qualified for IVIg infusion|0|||
155726232|NCT03866577|562096475|FG002|Overall Study|Not qualified for IVIg infusion|0|||
155726233|NCT03866577|562096476|FG003|Overall Study|Not qualified for IVIg infusion|0|||
155726234|NCT03866577|562096477|FG004|Overall Study|Not qualified for IVIg infusion|0|||
155726235|NCT03866577|562096478|FG005|Overall Study|Not qualified for IVIg infusion|0|||
155726236|NCT03866577|562096479|FG006|Overall Study|Not qualified for IVIg infusion|0|||
155726237|NCT03866577|562096480|FG007|Overall Study|Not qualified for IVIg infusion|0|||
155726238|NCT03866577|562096481|FG008|Overall Study|Not qualified for IVIg infusion|0|||
155726239|NCT03866577|562096482|FG009|Overall Study|Not qualified for IVIg infusion|1|||
155726240|NCT03866577|562096483|FG010|Overall Study|Not qualified for IVIg infusion|0|||
155726241|NCT03866577|562096484|FG011|Overall Study|Not qualified for IVIg infusion|0|||
155726242|NCT03866577|562096485|FG012|Overall Study|Not qualified for IVIg infusion|0|||
155726243|NCT05530252|562096487|FG000|Overall Study|Lost to Follow-up|1|||
155726244|NCT05530252|562096488|FG001|Overall Study|Lost to Follow-up|1|||
155726245|NCT05530252|562096489|FG002|Overall Study|Lost to Follow-up|1|||
155726246|NCT02195518|562096490|FG000|Overall Study|Adverse Event|1|||
155726247|NCT02195518|562096490|FG000|Overall Study|Protocol Violation|4|||
155726248|NCT02195518|562096490|FG000|Overall Study|Pregnancy|2|||
155726249|NCT02195518|562096490|FG000|Overall Study|Withdrawal by Subject|1|||
155726250|NCT02195518|562096490|FG000|Overall Study|Lost to Follow-up|1|||
155726251|NCT04825678|562096491|FG000|Overall Study|Decision by Sponsor|2|||
155726252|NCT04825678|562096492|FG001|Overall Study|Decision by Sponsor|3|||
155726253|NCT04825678|562096491|FG000|Overall Study|Withdrawal of Consent From Study|7|||
155726254|NCT04825678|562096492|FG001|Overall Study|Withdrawal of Consent From Study|9|||
155726255|NCT04825678|562096491|FG000|Overall Study|Lost to Follow-up|3|||
155726256|NCT04825678|562096492|FG001|Overall Study|Lost to Follow-up|4|||
155726257|NCT04825678|562096491|FG000|Overall Study|Never Received Investigational Product|1|||
155726258|NCT04825678|562096492|FG001|Overall Study|Never Received Investigational Product|1|||
155726259|NCT03818256|562096494|FG000|Overall Study|Withdrawal by Subject|2|||
155726260|NCT03818256|562096495|FG001|Overall Study|Withdrawal by Subject|2|||
155726261|NCT03818256|562096494|FG000|Overall Study|Adverse Event|3|||
155726262|NCT03818256|562096495|FG001|Overall Study|Adverse Event|1|||
155726263|NCT03818256|562096494|FG000|Overall Study|Lost to Follow-up|0|||
155726264|NCT03818256|562096495|FG001|Overall Study|Lost to Follow-up|5|||
155726265|NCT03818256|562096494|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
155726266|NCT03818256|562096495|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
155726267|NCT03818256|562096494|FG000|Overall Study|Not reporting for scheduled visits|1|||
155726268|NCT03818256|562096495|FG001|Overall Study|Not reporting for scheduled visits|0|||
155726269|NCT03818256|562096494|FG000|Overall Study|Non-compliant with investigational product|1|||
155726270|NCT03818256|562096495|FG001|Overall Study|Non-compliant with investigational product|0|||
155726271|NCT00400179|562096502|FG000|Overall Study|Adverse Event|2|||
155726272|NCT00400179|562096503|FG001|Overall Study|Adverse Event|2|||
155726273|NCT00400179|562096502|FG000|Overall Study|Death|1|||
155726274|NCT00400179|562096503|FG001|Overall Study|Death|2|||
155726275|NCT00400179|562096502|FG000|Overall Study|Withdrew Consent|1|||
155726276|NCT00400179|562096503|FG001|Overall Study|Withdrew Consent|5|||
155726277|NCT00400179|562096502|FG000|Overall Study|Disease progression|1|||
155726278|NCT00400179|562096503|FG001|Overall Study|Disease progression|1|||
155726279|NCT00400179|562096502|FG000|Overall Study|Intercurrent illness|0|||
155726280|NCT00400179|562096503|FG001|Overall Study|Intercurrent illness|1|||
155726281|NCT00400179|562096502|FG000|Overall Study|Investigator judgment|0|||
155726282|NCT00400179|562096503|FG001|Overall Study|Investigator judgment|1|||
155726283|NCT00400179|562096502|FG000|Overall Study|Randomization error/patient ineligible|1|||
155726284|NCT00400179|562096503|FG001|Overall Study|Randomization error/patient ineligible|6|||
155726285|NCT03589859|562096504|FG000|Overall Study|Withdrawal by Subject|0|||
155726286|NCT03589859|562096505|FG001|Overall Study|Withdrawal by Subject|6|||
155726287|NCT00626106|562096507|FG000|Overall Study|Withdrawal by Subject|2|||
155726288|NCT00626106|562096508|FG001|Overall Study|Withdrawal by Subject|1|||
155726289|NCT00626106|562096507|FG000|Overall Study|Lost to Follow-up|1|||
155726290|NCT00626106|562096508|FG001|Overall Study|Lost to Follow-up|4|||
155612834|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155612835|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155612836|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155612837|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
155612838|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
155612839|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
155612840|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155612841|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155612842|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155612843|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
155612844|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
155612845|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
155612846|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155612847|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155612848|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155612849|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155612850|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
155612851|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
155612852|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155612853|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155612854|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155612855|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
155612856|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
155612857|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
155612858|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
155612859|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
155612860|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
155612861|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
155612862|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
155612863|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
155612864|NCT01690299|561673827|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155612865|NCT01690299|561673828|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155612866|NCT01690299|561673829|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155612867|NCT01690299|561673830|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155612868|NCT01690299|561673831|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155612869|NCT01690299|561673832|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
155612870|NCT04313400|561673833|FG000|Overall Study|Withdrawal by Subject|0|||
155612871|NCT04313400|561673834|FG001|Overall Study|Withdrawal by Subject|0|||
155612872|NCT04313400|561673835|FG002|Overall Study|Withdrawal by Subject|0|||
155612873|NCT04313400|561673836|FG003|Overall Study|Withdrawal by Subject|0|||
155612874|NCT04313400|561673837|FG004|Overall Study|Withdrawal by Subject|0|||
155612875|NCT04313400|561673838|FG005|Overall Study|Withdrawal by Subject|4|||
155612876|NCT04313400|561673839|FG006|Overall Study|Withdrawal by Subject|1|||
155612877|NCT04313400|561673833|FG000|Overall Study|Adverse Event|0|||
155612878|NCT04313400|561673834|FG001|Overall Study|Adverse Event|0|||
155612879|NCT04313400|561673835|FG002|Overall Study|Adverse Event|0|||
155612880|NCT04313400|561673836|FG003|Overall Study|Adverse Event|0|||
155612881|NCT04313400|561673837|FG004|Overall Study|Adverse Event|0|||
155612882|NCT04313400|561673838|FG005|Overall Study|Adverse Event|1|||
155612883|NCT04313400|561673839|FG006|Overall Study|Adverse Event|0|||
155612884|NCT04313400|561673833|FG000|Overall Study|Lost to Follow-up|0|||
155612885|NCT04313400|561673834|FG001|Overall Study|Lost to Follow-up|0|||
155612886|NCT04313400|561673835|FG002|Overall Study|Lost to Follow-up|0|||
155612887|NCT04313400|561673836|FG003|Overall Study|Lost to Follow-up|0|||
155612888|NCT04313400|561673837|FG004|Overall Study|Lost to Follow-up|0|||
155612889|NCT04313400|561673838|FG005|Overall Study|Lost to Follow-up|1|||
155612890|NCT04313400|561673839|FG006|Overall Study|Lost to Follow-up|0|||
155612891|NCT00329745|561673840|FG000|Overall Study|Protocol Violation|1|||
155612892|NCT00329745|561673841|FG001|Overall Study|Protocol Violation|0|||
155612893|NCT00329745|561673840|FG000|Overall Study|Withdrawal by Subject|0|||
155612894|NCT00329745|561673841|FG001|Overall Study|Withdrawal by Subject|1|||
155612895|NCT00329745|561673840|FG000|Overall Study|Lost to Follow-up|86|||
155612896|NCT00329745|561673841|FG001|Overall Study|Lost to Follow-up|101|||
155612897|NCT03146741|561673842|FG000|Overall Study|Txp with non-HCV+ heart|4|||
155612898|NCT03146741|561673842|FG000|Overall Study|Listeted for MOT|2|||
155612899|NCT03146741|561673842|FG000|Overall Study|Physician Decision|2|||
155612900|NCT03146741|561673842|FG000|Overall Study|Awaiting txp|2|||
155612901|NCT03224624|561673843|FG000|Overall Study|Lost to Follow-up|9|||
155612902|NCT03224624|561673844|FG001|Overall Study|Lost to Follow-up|4|||
155612903|NCT03224624|561673843|FG000|Overall Study|Death|1|||
155612904|NCT03224624|561673844|FG001|Overall Study|Death|0|||
155612905|NCT01884545|561673847|FG000|Overall Study|Lost to Follow-up|6|||
155612906|NCT01884545|561673848|FG001|Overall Study|Lost to Follow-up|4|||
155612907|NCT01884545|561673849|FG002|Overall Study|Lost to Follow-up|9|||
155612908|NCT01884545|561673850|FG003|Overall Study|Lost to Follow-up|4|||
155612909|NCT01884545|561673847|FG000|Overall Study|Patient withdrawn|7|||
155612910|NCT01884545|561673848|FG001|Overall Study|Patient withdrawn|12|||
155612911|NCT01884545|561673849|FG002|Overall Study|Patient withdrawn|5|||
155726291|NCT00626106|562096507|FG000|Overall Study|Death|64|||
155726292|NCT00626106|562096508|FG001|Overall Study|Death|19|||
155726293|NCT02201953|562096509|FG000|Overall Study|Randomized but Never Treated|1|||
155726294|NCT02201953|562096510|FG001|Overall Study|Randomized but Never Treated|5|||
155726295|NCT02201953|562096509|FG000|Overall Study|Lack of Efficacy|9|||
155726296|NCT02201953|562096510|FG001|Overall Study|Lack of Efficacy|30|||
155726297|NCT02201953|562096509|FG000|Overall Study|Lost to Follow-up|8|||
155726298|NCT02201953|562096510|FG001|Overall Study|Lost to Follow-up|8|||
155726299|NCT02201953|562096509|FG000|Overall Study|Withdrew Consent|2|||
155726300|NCT02201953|562096510|FG001|Overall Study|Withdrew Consent|5|||
155726301|NCT02201953|562096509|FG000|Overall Study|Adverse Event|0|||
155726302|NCT02201953|562096510|FG001|Overall Study|Adverse Event|5|||
155726303|NCT02201953|562096509|FG000|Overall Study|Death|0|||
155726304|NCT02201953|562096510|FG001|Overall Study|Death|3|||
155726305|NCT03591406|562098057|FG000|Overall Study|Adverse Event|5|||
155726306|NCT03591406|562098058|FG001|Overall Study|Adverse Event|3|||
155726307|NCT03591406|562098057|FG000|Overall Study|Protocol Violation|2|||
155726308|NCT03591406|562098058|FG001|Overall Study|Protocol Violation|1|||
155726309|NCT03591406|562098057|FG000|Overall Study|Withdrawal by Subject|0|||
155726310|NCT03591406|562098058|FG001|Overall Study|Withdrawal by Subject|5|||
155726311|NCT02144610|562098059|FG000|Overall Study|Physician Decision|1|||
155726312|NCT02144610|562098060|FG001|Overall Study|Physician Decision|0|||
155726313|NCT02144610|562098059|FG000|Overall Study|Withdrawal by Subject|1|||
155726314|NCT02144610|562098060|FG001|Overall Study|Withdrawal by Subject|5|||
155726315|NCT02144610|562098059|FG000|Overall Study|Death|2|||
155726316|NCT02144610|562098060|FG001|Overall Study|Death|2|||
155726317|NCT02144610|562098059|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
155726318|NCT02144610|562098060|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
155726319|NCT02144610|562098059|FG000|Overall Study|Other|0|||
155726320|NCT02144610|562098060|FG001|Overall Study|Other|1|||
155726321|NCT02796170|562098064|FG000|Overall Study|Lost to Follow-up|3|||
155726322|NCT02796170|562098065|FG001|Overall Study|Lost to Follow-up|0|||
155726323|NCT01527370|562098066|FG000|Overall Study|Withdrawal by Subject|4|||
155726324|NCT01527370|562098066|FG000|Overall Study|Physician Decision|1|||
155726325|NCT01527370|562098066|FG000|Overall Study|Death|1|||
155726326|NCT00482053|562098072|FG000|Inter-treatment Period|Disease progression|1|||
155726327|NCT02224560|562098075|FG000|Overall Study|Protocol Deviation|1|||
155726328|NCT02224560|562098076|FG001|Overall Study|Protocol Deviation|0|||
155726329|NCT02224560|562098077|FG002|Overall Study|Protocol Deviation|0|||
155726330|NCT02224560|562098075|FG000|Overall Study|Withdrawal by Subject|2|||
155726331|NCT02224560|562098076|FG001|Overall Study|Withdrawal by Subject|0|||
155726332|NCT02224560|562098077|FG002|Overall Study|Withdrawal by Subject|1|||
155726333|NCT02224560|562098075|FG000|Overall Study|Met Withdrawal Criteria|1|||
155726334|NCT02224560|562098076|FG001|Overall Study|Met Withdrawal Criteria|0|||
155726335|NCT02224560|562098077|FG002|Overall Study|Met Withdrawal Criteria|0|||
155726336|NCT02224560|562098075|FG000|Overall Study|Adverse Event|4|||
155726337|NCT02224560|562098076|FG001|Overall Study|Adverse Event|1|||
155726338|NCT02224560|562098077|FG002|Overall Study|Adverse Event|1|||
155726339|NCT02224560|562098075|FG000|Overall Study|Withdrawn by Investigator|1|||
155612912|NCT01884545|561673850|FG003|Overall Study|Patient withdrawn|5|||
155612913|NCT01884545|561673847|FG000|Overall Study|Non-adherence|0|||
155726340|NCT02224560|562098076|FG001|Overall Study|Withdrawn by Investigator|1|||
155726341|NCT02224560|562098077|FG002|Overall Study|Withdrawn by Investigator|0|||
155726342|NCT00728689|562098078|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
155726343|NCT00728689|562098079|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
155726344|NCT01523366|562098080|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155726345|NCT01523366|562098081|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155726346|NCT01523366|562098080|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
155726347|NCT01523366|562098081|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
155726348|NCT04543279|562098083|FG000|Overall Study|Withdrawal by Subject|1|||
155726349|NCT04543279|562098084|FG001|Overall Study|Withdrawal by Subject|0|||
155726350|NCT04543279|562098083|FG000|Overall Study|Adverse Event|1|||
155726351|NCT04543279|562098084|FG001|Overall Study|Adverse Event|0|||
155612914|NCT01884545|561673848|FG001|Overall Study|Non-adherence|2|||
155612915|NCT01884545|561673849|FG002|Overall Study|Non-adherence|0|||
155726352|NCT04543279|562098083|FG000|Overall Study|Physician Decision|1|||
155726353|NCT04543279|562098084|FG001|Overall Study|Physician Decision|0|||
155726354|NCT03216226|562098087|FG000|Overall Study|Adverse Event|3|||
155726355|NCT03216226|562098088|FG001|Overall Study|Adverse Event|0|||
155726356|NCT03216226|562098087|FG000|Overall Study|Protocol Violation|1|||
155726357|NCT03216226|562098088|FG001|Overall Study|Protocol Violation|3|||
155726358|NCT03216226|562098087|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
155726359|NCT03216226|562098088|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
155726360|NCT03216226|562098087|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
155726361|NCT03216226|562098088|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
155726362|NCT03216226|562098087|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
155726363|NCT03216226|562098088|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
155726364|NCT00887809|562098090|FG000|Overall Study|Patient Not Treated|3|||
155726365|NCT00887809|562098091|FG001|Overall Study|Patient Not Treated|0|||
155726366|NCT00887809|562098090|FG000|Overall Study|Death|1|||
155726367|NCT00887809|562098091|FG001|Overall Study|Death|0|||
155726368|NCT03131570|562098092|FG000|Overall Study|Adverse Event|1|||
155726369|NCT03131570|562098093|FG001|Overall Study|Adverse Event|0|||
155726370|NCT04596267|562098094|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
155726371|NCT04596267|562098095|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
155726372|NCT04596267|562098094|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
155726373|NCT04596267|562098095|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
155726374|NCT00071058|562098096|FG000|Overall Study|brain tumor-removed from study|1|||
155726375|NCT03995368|562098104|FG000|Overall Study|Lost to Follow-up|1|||
155726376|NCT03995368|562098105|FG001|Overall Study|Lost to Follow-up|4|||
155726377|NCT03995368|562098106|FG002|Overall Study|Lost to Follow-up|1|||
155726378|NCT03995368|562098104|FG000|Overall Study|Did not meet inclusion criteria|1|||
155726379|NCT03995368|562098105|FG001|Overall Study|Did not meet inclusion criteria|6|||
155726380|NCT03995368|562098106|FG002|Overall Study|Did not meet inclusion criteria|3|||
155726381|NCT03995368|562098104|FG000|Overall Study|Withdrawal by Subject|0|||
155726382|NCT03995368|562098105|FG001|Overall Study|Withdrawal by Subject|1|||
155726383|NCT03995368|562098106|FG002|Overall Study|Withdrawal by Subject|1|||
155726384|NCT03755934|562098107|FG000|Overall Study|Adverse Event|4|||
155726385|NCT03755934|562098108|FG001|Overall Study|Adverse Event|1|||
155726386|NCT03755934|562098109|FG002|Overall Study|Adverse Event|1|||
155726387|NCT03755934|562098110|FG003|Overall Study|Adverse Event|3|||
155726388|NCT03755934|562098107|FG000|Overall Study|Physician Decision|2|||
155726389|NCT03755934|562098108|FG001|Overall Study|Physician Decision|0|||
155726390|NCT03755934|562098109|FG002|Overall Study|Physician Decision|0|||
155726391|NCT03755934|562098110|FG003|Overall Study|Physician Decision|1|||
155726392|NCT03755934|562098107|FG000|Overall Study|Withdrawal by Subject|5|||
155726393|NCT03755934|562098108|FG001|Overall Study|Withdrawal by Subject|0|||
155726394|NCT03755934|562098109|FG002|Overall Study|Withdrawal by Subject|0|||
155726395|NCT03755934|562098110|FG003|Overall Study|Withdrawal by Subject|1|||
155726396|NCT03755934|562098107|FG000|Overall Study|Other|3|||
155726397|NCT03755934|562098108|FG001|Overall Study|Other|1|||
155726398|NCT03755934|562098109|FG002|Overall Study|Other|3|||
155266929|NCT00152009|560410924|FG002|Overall Study|Withdrawal by Subject|4|||
155266930|NCT00152009|560410925|FG003|Overall Study|Withdrawal by Subject|9|||
155266931|NCT00152009|560410922|FG000|Overall Study|Lost to Follow-up|2|||
155266932|NCT00152009|560410923|FG001|Overall Study|Lost to Follow-up|4|||
155266933|NCT00152009|560410924|FG002|Overall Study|Lost to Follow-up|3|||
155266934|NCT00152009|560410925|FG003|Overall Study|Lost to Follow-up|3|||
155266935|NCT00152009|560410922|FG000|Overall Study|Lack of Efficacy|8|||
155266936|NCT00152009|560410923|FG001|Overall Study|Lack of Efficacy|6|||
155266937|NCT00152009|560410924|FG002|Overall Study|Lack of Efficacy|7|||
155266938|NCT00152009|560410925|FG003|Overall Study|Lack of Efficacy|15|||
155266939|NCT00152009|560410922|FG000|Overall Study|ECG abnormalities|2|||
155266940|NCT00152009|560410923|FG001|Overall Study|ECG abnormalities|2|||
155266941|NCT00152009|560410924|FG002|Overall Study|ECG abnormalities|2|||
155266942|NCT00152009|560410925|FG003|Overall Study|ECG abnormalities|1|||
155266943|NCT00152009|560410922|FG000|Overall Study|Sponsor's decision|3|||
155266944|NCT00152009|560410923|FG001|Overall Study|Sponsor's decision|3|||
155266945|NCT00152009|560410924|FG002|Overall Study|Sponsor's decision|1|||
155612916|NCT01884545|561673850|FG003|Overall Study|Non-adherence|0|||
155612917|NCT01424241|561673851|FG000|Overall Study|Withdrawal by Subject|1|||
155612918|NCT01424241|561673851|FG000|Overall Study|Time constraints|2|||
155612919|NCT00551525|561673852|FG000|Overall Study|Protocol Violation|5|||
155612920|NCT00303472|561673857|FG000|Treatment Period|Adverse Event|0|||
155612921|NCT00303472|561673858|FG001|Treatment Period|Adverse Event|0|||
155612922|NCT00303472|561673859|FG002|Treatment Period|Adverse Event|0|||
155612923|NCT00303472|561673860|FG003|Treatment Period|Adverse Event|0|||
155612924|NCT00303472|561673861|FG004|Treatment Period|Adverse Event|1|||
155612925|NCT00303472|561673862|FG005|Treatment Period|Adverse Event|0|||
155612926|NCT00303472|561673863|FG006|Treatment Period|Adverse Event|0|||
155612927|NCT00303472|561673857|FG000|Treatment Period|Death|0|||
155612928|NCT00303472|561673858|FG001|Treatment Period|Death|0|||
155612929|NCT00303472|561673859|FG002|Treatment Period|Death|0|||
155612930|NCT00303472|561673860|FG003|Treatment Period|Death|1|||
155612931|NCT00303472|561673861|FG004|Treatment Period|Death|0|||
155612932|NCT00303472|561673862|FG005|Treatment Period|Death|0|||
155612933|NCT00303472|561673863|FG006|Treatment Period|Death|1|||
155612934|NCT00303472|561673857|FG000|Treatment Period|Withdrawal by Subject|0|||
155612935|NCT00303472|561673858|FG001|Treatment Period|Withdrawal by Subject|0|||
155612936|NCT00303472|561673859|FG002|Treatment Period|Withdrawal by Subject|0|||
155612937|NCT00303472|561673860|FG003|Treatment Period|Withdrawal by Subject|1|||
155612938|NCT00303472|561673861|FG004|Treatment Period|Withdrawal by Subject|0|||
155612939|NCT00303472|561673862|FG005|Treatment Period|Withdrawal by Subject|1|||
155612940|NCT00303472|561673863|FG006|Treatment Period|Withdrawal by Subject|0|||
155612941|NCT00303472|561673857|FG000|Treatment Period|Other|0|||
155612942|NCT00303472|561673858|FG001|Treatment Period|Other|0|||
155612943|NCT00303472|561673859|FG002|Treatment Period|Other|0|||
155612944|NCT00303472|561673860|FG003|Treatment Period|Other|0|||
155612945|NCT00303472|561673861|FG004|Treatment Period|Other|1|||
155612946|NCT00303472|561673862|FG005|Treatment Period|Other|0|||
155612947|NCT00303472|561673863|FG006|Treatment Period|Other|1|||
155612948|NCT00303472|561673857|FG000|Treatment Period|Disease Progression (to AML)|0|||
155612949|NCT00303472|561673858|FG001|Treatment Period|Disease Progression (to AML)|0|||
155612950|NCT00303472|561673859|FG002|Treatment Period|Disease Progression (to AML)|0|||
155612951|NCT00303472|561673860|FG003|Treatment Period|Disease Progression (to AML)|0|||
155612952|NCT00303472|561673861|FG004|Treatment Period|Disease Progression (to AML)|1|||
155612953|NCT00303472|561673862|FG005|Treatment Period|Disease Progression (to AML)|0|||
155612954|NCT00303472|561673863|FG006|Treatment Period|Disease Progression (to AML)|0|||
155612955|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Adverse Event|1|||
155612956|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Adverse Event|0|||
155612957|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Adverse Event|1|||
155612958|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Adverse Event|0|||
155612959|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Adverse Event|0|||
155612960|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Adverse Event|0|||
155612961|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Adverse Event|0|||
155612962|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Death|2|||
155612963|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Death|0|||
155612964|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Death|1|||
155612965|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Death|0|||
155612966|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Death|0|||
155612967|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Death|0|||
155612968|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Death|0|||
155612969|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612970|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612971|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612972|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
155612973|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612974|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612975|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
155612976|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Physician Decision|0|||
155612977|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Physician Decision|4|||
155612978|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Physician Decision|2|||
155612979|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Physician Decision|3|||
155612980|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Physician Decision|2|||
155612981|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Physician Decision|0|||
155612982|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Physician Decision|0|||
155612983|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155612984|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155612985|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155612986|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
155612987|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155612988|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155612989|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155612990|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Other|0|||
155612991|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Other|2|||
155612992|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Other|4|||
155612993|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Other|2|||
155612994|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Other|1|||
155612995|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Other|0|||
155612996|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Other|0|||
155612997|NCT00303472|561673857|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
155612998|NCT00303472|561673858|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155612999|NCT00303472|561673859|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155613000|NCT00303472|561673860|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155613001|NCT00303472|561673861|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155613002|NCT00303472|561673862|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
155613003|NCT00303472|561673863|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155613004|NCT00359294|561673875|FG000|Overall Study|Progressive disease|1|||
155613005|NCT00359294|561673876|FG001|Overall Study|Progressive disease|1|||
155613006|NCT00359294|561673877|FG002|Overall Study|Progressive disease|2|||
155613007|NCT00359294|561673878|FG003|Overall Study|Progressive disease|3|||
155613008|NCT00359294|561673879|FG004|Overall Study|Progressive disease|2|||
155613009|NCT00359294|561673875|FG000|Overall Study|Withdrawal by Subject|0|||
155613010|NCT00359294|561673876|FG001|Overall Study|Withdrawal by Subject|0|||
155613011|NCT00359294|561673877|FG002|Overall Study|Withdrawal by Subject|0|||
155613012|NCT00359294|561673878|FG003|Overall Study|Withdrawal by Subject|0|||
155613013|NCT00359294|561673879|FG004|Overall Study|Withdrawal by Subject|1|||
155613014|NCT00359294|561673875|FG000|Overall Study|Not treated|0|||
155613015|NCT00359294|561673876|FG001|Overall Study|Not treated|0|||
155613016|NCT00359294|561673877|FG002|Overall Study|Not treated|0|||
155613017|NCT00359294|561673878|FG003|Overall Study|Not treated|1|||
155613018|NCT00359294|561673879|FG004|Overall Study|Not treated|0|||
155613019|NCT00359294|561673875|FG000|Overall Study|Physician Decision|0|||
155613020|NCT00359294|561673876|FG001|Overall Study|Physician Decision|0|||
155613021|NCT00359294|561673877|FG002|Overall Study|Physician Decision|1|||
155613022|NCT00359294|561673878|FG003|Overall Study|Physician Decision|0|||
155613023|NCT00359294|561673879|FG004|Overall Study|Physician Decision|0|||
155613024|NCT04208412|561673882|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
155613025|NCT04208412|561673883|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
155613026|NCT04208412|561673882|FG000|Overall Study|Withdrawal by Subject|1|||
155613027|NCT04208412|561673883|FG001|Overall Study|Withdrawal by Subject|0|||
155613028|NCT04208412|561673882|FG000|Overall Study|Lost to Follow-up|0|||
155613029|NCT04208412|561673883|FG001|Overall Study|Lost to Follow-up|1|||
155613030|NCT01808222|561673885|FG000|Overall Study|mpMR scan was not performed|1|||
155613031|NCT00830518|561673891|FG000|Overall Study|Progressive Disease|18|||
155613032|NCT00830518|561673892|FG001|Overall Study|Progressive Disease|8|||
155613033|NCT00830518|561673891|FG000|Overall Study|Symptomatic Deterioration|4|||
155613034|NCT00830518|561673892|FG001|Overall Study|Symptomatic Deterioration|1|||
155613035|NCT00830518|561673891|FG000|Overall Study|Adverse Event|14|||
155613036|NCT00830518|561673892|FG001|Overall Study|Adverse Event|1|||
155613037|NCT00830518|561673891|FG000|Overall Study|Withdrawal by Patient|2|||
155613038|NCT00830518|561673892|FG001|Overall Study|Withdrawal by Patient|0|||
155613039|NCT00830518|561673891|FG000|Overall Study|Reason not Specified|8|||
155613040|NCT00830518|561673892|FG001|Overall Study|Reason not Specified|1|||
155613041|NCT04318132|561673893|FG000|Overall Study|Protocol Violation|0|||
155613042|NCT04318132|561673894|FG001|Overall Study|Protocol Violation|0|||
155613043|NCT04318132|561673895|FG002|Overall Study|Protocol Violation|3|||
155613044|NCT04318132|561673896|FG003|Overall Study|Protocol Violation|0|||
155613045|NCT00586898|561673903|FG000|Overall Study|Adverse Event|1|||
155613046|NCT00586898|561673903|FG000|Overall Study|Patiemt Non-compliance|1|||
155613047|NCT00586898|561673903|FG000|Overall Study|Evaluable for Toxicity Only|5|||
155613048|NCT01994902|561673905|FG000|Test Period 1|Withdrawal by Subject|3|||
155613049|NCT01994902|561673906|FG001|Test Period 1|Withdrawal by Subject|0|||
155613050|NCT01994902|561673905|FG000|Test Period 1|device deficiency with adverse event|0|||
155613051|NCT01994902|561673906|FG001|Test Period 1|device deficiency with adverse event|1|||
155613052|NCT01994902|561673905|FG000|Test Period 1|Adverse Event|2|||
155613053|NCT01994902|561673906|FG001|Test Period 1|Adverse Event|1|||
155613054|NCT01994902|561673905|FG000|Test Period 1|Lack of Efficacy|0|||
155726399|NCT03755934|562098110|FG003|Overall Study|Other|1|||
155726400|NCT01498068|562098111|FG000|Overall Study|Withdrawal by Subject|1|||
155726401|NCT01498068|562098112|FG001|Overall Study|Withdrawal by Subject|1|||
155726402|NCT00361296|562098113|FG000|Overall Study|Physician Decision|1|||
155726403|NCT00361296|562098113|FG000|Overall Study|Lack of Efficacy|2|||
155726404|NCT01353898|562098116|FG000|Overall Study|Study site terminated|0|||
155726405|NCT01353898|562098117|FG001|Overall Study|Study site terminated|0|||
155726406|NCT01353898|562098118|FG002|Overall Study|Study site terminated|0|||
155726407|NCT01353898|562098119|FG003|Overall Study|Study site terminated|0|||
155726408|NCT01353898|562098120|FG004|Overall Study|Study site terminated|0|||
155726409|NCT01353898|562098121|FG005|Overall Study|Study site terminated|1|||
155613055|NCT01994902|561673906|FG001|Test Period 1|Lack of Efficacy|1|||
155613056|NCT01994902|561673905|FG000|Test Period 1|bag too small|1|||
155613057|NCT01994902|561673906|FG001|Test Period 1|bag too small|0|||
155613058|NCT01994902|561673905|FG000|Test Period 2|Withdrawal by Subject|0|||
155613059|NCT01994902|561673906|FG001|Test Period 2|Withdrawal by Subject|2|||
155613060|NCT01994902|561673905|FG000|Test Period 2|Lack of Efficacy|0|||
155613061|NCT01994902|561673906|FG001|Test Period 2|Lack of Efficacy|1|||
155613062|NCT01994902|561673905|FG000|Test Period 2|Other|0|||
155613063|NCT01994902|561673906|FG001|Test Period 2|Other|3|||
155613064|NCT01085084|561673907|FG000|Overall Study|Withdrawal by Subject|1|||
155613065|NCT01085084|561673908|FG001|Overall Study|Withdrawal by Subject|0|||
155613066|NCT01085084|561673909|FG002|Overall Study|Withdrawal by Subject|0|||
155613067|NCT01085084|561673907|FG000|Overall Study|Lost to Follow-up|2|||
155613068|NCT01085084|561673908|FG001|Overall Study|Lost to Follow-up|1|||
155613069|NCT01085084|561673909|FG002|Overall Study|Lost to Follow-up|1|||
155613070|NCT01085084|561673907|FG000|Overall Study|Adverse Event|4|||
155613071|NCT01085084|561673908|FG001|Overall Study|Adverse Event|3|||
155613072|NCT01085084|561673909|FG002|Overall Study|Adverse Event|6|||
155613073|NCT01085084|561673907|FG000|Overall Study|Treatment Failure|0|||
155613074|NCT01085084|561673908|FG001|Overall Study|Treatment Failure|1|||
155613075|NCT01085084|561673909|FG002|Overall Study|Treatment Failure|2|||
155613076|NCT01962948|561675742|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
155613077|NCT01962948|561675743|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
155613078|NCT01962948|561675744|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
155613079|NCT01962948|561675745|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
155613080|NCT00376532|561675746|FG000|Overall Study|Lack sufficient blood sample|6|||
155613081|NCT00376532|561675747|FG001|Overall Study|Lack sufficient blood sample|6|||
155613082|NCT02849704|561675748|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
155613083|NCT02849704|561675749|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
155613084|NCT02849704|561675748|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
155613085|NCT02849704|561675749|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
155613086|NCT02849704|561675748|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
155613087|NCT02849704|561675749|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
155613088|NCT00314808|561675755|FG000|Overall Study|Disease Progression without AE|4|||
155613089|NCT00314808|561675755|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
155613090|NCT02579382|561675756|FG000|Main Study Phase|Lost to Follow-up|0|||
155613091|NCT02579382|561675757|FG001|Main Study Phase|Lost to Follow-up|0|||
155613092|NCT02579382|561675758|FG002|Main Study Phase|Lost to Follow-up|2|||
155613093|NCT02579382|561675759|FG003|Main Study Phase|Lost to Follow-up|0|||
155613094|NCT02579382|561675756|FG000|Main Study Phase|Withdrew Consent|0|||
155613095|NCT02579382|561675757|FG001|Main Study Phase|Withdrew Consent|0|||
155613096|NCT02579382|561675758|FG002|Main Study Phase|Withdrew Consent|0|||
155613097|NCT02579382|561675759|FG003|Main Study Phase|Withdrew Consent|2|||
155613098|NCT02579382|561675756|FG000|Main Study Phase|Lack of Efficacy|0|||
155613099|NCT02579382|561675757|FG001|Main Study Phase|Lack of Efficacy|0|||
155613100|NCT02579382|561675758|FG002|Main Study Phase|Lack of Efficacy|0|||
155613101|NCT02579382|561675759|FG003|Main Study Phase|Lack of Efficacy|1|||
155613102|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
155613103|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
155613104|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
155613105|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
155613106|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
155613107|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
155613108|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
155613109|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
155613110|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
155613111|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155613112|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155613113|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155613114|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155613115|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
155266946|NCT00152009|560410925|FG003|Overall Study|Sponsor's decision|3|||
155266947|NCT01306201|560410926|FG000|Overall Study|Arrhythmia|4|||
155613116|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155613117|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155613118|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155613119|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
155266948|NCT01306201|560410926|FG000|Overall Study|Files could not be processed|3|||
155266949|NCT01306201|560410926|FG000|Overall Study|Files unreadable|3|||
155613120|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155613121|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155613122|NCT02579382|561675756|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155613123|NCT02579382|561675757|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
155613124|NCT02579382|561675758|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155613125|NCT02579382|561675759|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155613126|NCT03084302|561675762|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
155613127|NCT03084302|561675762|FG000|Overall Study|No valid objective monitor data|6|||
155613128|NCT01301079|561675763|FG000|Overall Study|Lost to Follow-up|2|||
155613129|NCT01301079|561675764|FG001|Overall Study|Lost to Follow-up|2|||
155613130|NCT00715299|561675773|FG000|Overall Study|Withdrawal by Subject|1|||
155613131|NCT00715299|561675773|FG000|Overall Study|Adverse Event|3|||
155613132|NCT00715299|561675773|FG000|Overall Study|failed the pre-screen exercise test|2|||
155613133|NCT02020889|561675774|FG000|Overall Study|Adverse Event|0|||
155613134|NCT02020889|561675775|FG001|Overall Study|Adverse Event|1|||
155613135|NCT02020889|561675774|FG000|Overall Study|Lack of Efficacy|1|||
155613136|NCT02020889|561675775|FG001|Overall Study|Lack of Efficacy|0|||
155613137|NCT02020889|561675774|FG000|Overall Study|Lost to Follow-up|1|||
155613138|NCT02020889|561675775|FG001|Overall Study|Lost to Follow-up|0|||
155613139|NCT02020889|561675774|FG000|Overall Study|Physician Decision|2|||
155613140|NCT02020889|561675775|FG001|Overall Study|Physician Decision|0|||
155613141|NCT02020889|561675774|FG000|Overall Study|Withdrawal by Subject|3|||
155613142|NCT02020889|561675775|FG001|Overall Study|Withdrawal by Subject|2|||
155613143|NCT01540981|561675776|FG000|Overall Study|Withdrawal by Subject|1|||
155613144|NCT01540981|561675777|FG001|Overall Study|Withdrawal by Subject|0|||
155613145|NCT00809094|561675778|FG000|Overall Study|Lost to Follow-up|0|||
155613146|NCT00809094|561675779|FG001|Overall Study|Lost to Follow-up|1|||
155613147|NCT02457195|561675780|FG000|Overall Study|Adverse Event|3|||
155613148|NCT02457195|561675780|FG000|Overall Study|Protocol Violation|2|||
155613149|NCT02457195|561675780|FG000|Overall Study|Withdrawal by Subject|4|||
155613150|NCT02768792|561675782|FG000|Overall Study|Adverse Event|1|||
155613151|NCT04819438|561675783|FG000|Overall Study|Withdrawal by Subject|1|||
155613152|NCT04819438|561675784|FG001|Overall Study|Withdrawal by Subject|0|||
155613153|NCT04819438|561675783|FG000|Overall Study|Adverse Event|0|||
155613154|NCT04819438|561675784|FG001|Overall Study|Adverse Event|1|||
155613155|NCT04819438|561675783|FG000|Overall Study|Protocol Violation|0|||
155613156|NCT04819438|561675784|FG001|Overall Study|Protocol Violation|1|||
155613157|NCT05359952|561675786|FG000|Overall Study|Lost to Follow-up|1|||
155613158|NCT05359952|561675787|FG001|Overall Study|Lost to Follow-up|0|||
155613159|NCT03836209|561675788|FG000|Overall Study|Adverse Event|5|||
155613160|NCT03836209|561675789|FG001|Overall Study|Adverse Event|2|||
155613161|NCT03836209|561675788|FG000|Overall Study|Death|4|||
155613162|NCT03836209|561675789|FG001|Overall Study|Death|1|||
155613163|NCT03836209|561675788|FG000|Overall Study|Lack of Efficacy|7|||
155613164|NCT03836209|561675789|FG001|Overall Study|Lack of Efficacy|10|||
155613165|NCT03836209|561675788|FG000|Overall Study|Physician Decision|7|||
155613166|NCT03836209|561675789|FG001|Overall Study|Physician Decision|11|||
155613167|NCT03836209|561675788|FG000|Overall Study|Protocol Violation|0|||
155613168|NCT03836209|561675789|FG001|Overall Study|Protocol Violation|3|||
155613169|NCT03836209|561675788|FG000|Overall Study|Withdrawal by Subject|2|||
155613170|NCT03836209|561675789|FG001|Overall Study|Withdrawal by Subject|10|||
155613171|NCT03836209|561675788|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
155613172|NCT03836209|561675789|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
155613173|NCT05980013|561675790|FG000|Overall Study|Withdrawal by Subject|0|||
155613174|NCT05980013|561675791|FG001|Overall Study|Withdrawal by Subject|1|||
155613175|NCT05980013|561675790|FG000|Overall Study|Device Error|0|||
155613176|NCT05980013|561675791|FG001|Overall Study|Device Error|1|||
155613177|NCT03739710|561675792|FG000|Overall Study|Screen Failed|81|||
155613178|NCT01753115|561675793|FG000|Overall Study|Lost to Follow-up|3|||
155613179|NCT01753115|561675794|FG001|Overall Study|Lost to Follow-up|6|||
155613180|NCT01753115|561675795|FG002|Overall Study|Lost to Follow-up|8|||
155613181|NCT01753115|561675793|FG000|Overall Study|Withdrawal by Subject|6|||
155613182|NCT01753115|561675794|FG001|Overall Study|Withdrawal by Subject|5|||
155613183|NCT01753115|561675795|FG002|Overall Study|Withdrawal by Subject|6|||
155613184|NCT01753115|561675793|FG000|Overall Study|Subject non-compliant|3|||
155613185|NCT01753115|561675794|FG001|Overall Study|Subject non-compliant|3|||
155613186|NCT01753115|561675795|FG002|Overall Study|Subject non-compliant|0|||
155613187|NCT01753115|561675793|FG000|Overall Study|Used excluded drug|0|||
155613188|NCT01753115|561675794|FG001|Overall Study|Used excluded drug|1|||
155613189|NCT01753115|561675795|FG002|Overall Study|Used excluded drug|0|||
155613190|NCT01882803|561675807|FG000|Overall Study|Disease Progression|1|||
155613191|NCT01882803|561675807|FG000|Overall Study|Withdrawal by Subject|9|||
155613192|NCT01882803|561675807|FG000|Overall Study|Death|68|||
155613193|NCT01882803|561675807|FG000|Overall Study|Physician Decision|3|||
155613194|NCT01882803|561675807|FG000|Overall Study|Lost to Follow-up|3|||
155613195|NCT01882803|561675807|FG000|Overall Study|Follow-up Completed|39|||
155613196|NCT01882803|561675807|FG000|Overall Study|Study Terminated by the Sponsor|6|||
155613197|NCT02869893|561675808|FG000|Overall Study|participant aversion to IV|5|||
155613198|NCT02869893|561675808|FG000|Overall Study|participant fear of MRI scanner|2|||
155613199|NCT01563913|561675809|FG000|Overall Study|Physician Decision|1|||
155613200|NCT01563913|561675810|FG001|Overall Study|Physician Decision|0|||
155613201|NCT01563913|561675809|FG000|Overall Study|Spouse Passed Away|1|||
155613202|NCT01563913|561675810|FG001|Overall Study|Spouse Passed Away|0|||
155613203|NCT03066778|561675811|FG000|Overall Study|Death|195|||
155613204|NCT03066778|561675812|FG001|Overall Study|Death|205|||
155613205|NCT03066778|561675811|FG000|Overall Study|Withdrawal by Subject|5|||
155613206|NCT03066778|561675812|FG001|Overall Study|Withdrawal by Subject|7|||
155613207|NCT02091414|561675815|FG000|Overall Study|Withdrawal by Subject|2|||
155613208|NCT02091414|561675815|FG000|Overall Study|Death|2|||
155613209|NCT04676724|561675820|FG000|Overall Study|Adverse Event|2|||
155613210|NCT04676724|561675821|FG001|Overall Study|Adverse Event|0|||
155613211|NCT04676724|561675820|FG000|Overall Study|Lost to Follow-up|1|||
155613212|NCT04676724|561675821|FG001|Overall Study|Lost to Follow-up|0|||
155613213|NCT04676724|561675820|FG000|Overall Study|Physician Decision|0|||
155613214|NCT04676724|561675821|FG001|Overall Study|Physician Decision|1|||
155613215|NCT04676724|561675820|FG000|Overall Study|Withdrawal by Subject|3|||
155613216|NCT04676724|561675821|FG001|Overall Study|Withdrawal by Subject|2|||
155613217|NCT02782377|561675824|FG000|Overall Study|Physician Decision|5|||
155613218|NCT02521792|561675828|FG000|Overall Study|Study Terminated|6|||
155613219|NCT00398047|561675829|FG000|Overall Study|all patient progressed before completion|3|||
155613220|NCT01188668|561675830|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
155613221|NCT01188668|561675830|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
155613222|NCT01188668|561675830|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
155613223|NCT00902746|561675831|FG000|Overall Study|Protocol Violation|7|||
155613224|NCT00902746|561675831|FG000|Overall Study|Withdrawal by Subject|16|||
155613225|NCT00902746|561675831|FG000|Overall Study|Adverse Event|8|||
155613226|NCT00902746|561675831|FG000|Overall Study|Lost to Follow-up|3|||
155613227|NCT00902746|561675831|FG000|Overall Study|Physician Decision|2|||
155613228|NCT02588092|561675838|FG000|Overall Study|Death|4|||
155613229|NCT02588092|561675839|FG001|Overall Study|Death|3|||
155613230|NCT02588092|561675840|FG002|Overall Study|Death|3|||
155613231|NCT02588092|561675841|FG003|Overall Study|Death|3|||
155613232|NCT02588092|561675842|FG004|Overall Study|Death|2|||
155613233|NCT02588092|561675843|FG005|Overall Study|Death|2|||
155613234|NCT02588092|561675844|FG006|Overall Study|Death|2|||
155613235|NCT02588092|561675845|FG007|Overall Study|Death|1|||
155613236|NCT02588092|561675846|FG008|Overall Study|Death|5|||
155613237|NCT02588092|561675847|FG009|Overall Study|Death|2|||
155613238|NCT02588092|561675838|FG000|Overall Study|Withdrawal by Subject|0|||
155613239|NCT02588092|561675839|FG001|Overall Study|Withdrawal by Subject|0|||
155613240|NCT02588092|561675840|FG002|Overall Study|Withdrawal by Subject|0|||
155613241|NCT02588092|561675841|FG003|Overall Study|Withdrawal by Subject|0|||
155613242|NCT02588092|561675842|FG004|Overall Study|Withdrawal by Subject|0|||
155613243|NCT02588092|561675843|FG005|Overall Study|Withdrawal by Subject|1|||
155613244|NCT02588092|561675844|FG006|Overall Study|Withdrawal by Subject|1|||
155613245|NCT02588092|561675845|FG007|Overall Study|Withdrawal by Subject|2|||
155613246|NCT02588092|561675846|FG008|Overall Study|Withdrawal by Subject|0|||
155613247|NCT02588092|561675847|FG009|Overall Study|Withdrawal by Subject|0|||
155613248|NCT02588092|561675838|FG000|Overall Study|Started Another Treatment|0|||
155613249|NCT02588092|561675839|FG001|Overall Study|Started Another Treatment|0|||
155613250|NCT02588092|561675840|FG002|Overall Study|Started Another Treatment|0|||
155613251|NCT02588092|561675841|FG003|Overall Study|Started Another Treatment|0|||
155613252|NCT02588092|561675842|FG004|Overall Study|Started Another Treatment|1|||
155613253|NCT02588092|561675843|FG005|Overall Study|Started Another Treatment|0|||
155613254|NCT02588092|561675844|FG006|Overall Study|Started Another Treatment|0|||
155613255|NCT02588092|561675845|FG007|Overall Study|Started Another Treatment|1|||
155613256|NCT02588092|561675846|FG008|Overall Study|Started Another Treatment|0|||
155613257|NCT02588092|561675847|FG009|Overall Study|Started Another Treatment|0|||
155613258|NCT02588092|561675838|FG000|Overall Study|Sponsor Decision|0|||
155613259|NCT02588092|561675839|FG001|Overall Study|Sponsor Decision|0|||
155613260|NCT02588092|561675840|FG002|Overall Study|Sponsor Decision|0|||
155613261|NCT02588092|561675841|FG003|Overall Study|Sponsor Decision|0|||
155613262|NCT02588092|561675842|FG004|Overall Study|Sponsor Decision|0|||
155613263|NCT02588092|561675843|FG005|Overall Study|Sponsor Decision|0|||
155613264|NCT02588092|561675844|FG006|Overall Study|Sponsor Decision|0|||
155613265|NCT02588092|561675845|FG007|Overall Study|Sponsor Decision|0|||
155613266|NCT02588092|561675846|FG008|Overall Study|Sponsor Decision|1|||
155613267|NCT02588092|561675847|FG009|Overall Study|Sponsor Decision|1|||
155613268|NCT01348100|561675848|FG000|Overall Study|Subject Withdrew Consent|0|||
155613269|NCT01348100|561675849|FG001|Overall Study|Subject Withdrew Consent|0|||
155613270|NCT01348100|561675850|FG002|Overall Study|Subject Withdrew Consent|2|||
155613271|NCT01348100|561675851|FG003|Overall Study|Subject Withdrew Consent|0|||
155613272|NCT01348100|561675852|FG004|Overall Study|Subject Withdrew Consent|1|||
155613273|NCT01348100|561675853|FG005|Overall Study|Subject Withdrew Consent|0|||
155613274|NCT01348100|561675854|FG006|Overall Study|Subject Withdrew Consent|1|||
155613275|NCT01348100|561675848|FG000|Overall Study|Protocol Deviation|0|||
155613276|NCT01348100|561675849|FG001|Overall Study|Protocol Deviation|0|||
155613277|NCT01348100|561675850|FG002|Overall Study|Protocol Deviation|0|||
155613278|NCT01348100|561675851|FG003|Overall Study|Protocol Deviation|1|||
155613279|NCT01348100|561675852|FG004|Overall Study|Protocol Deviation|0|||
155613280|NCT01348100|561675853|FG005|Overall Study|Protocol Deviation|0|||
155613281|NCT01348100|561675854|FG006|Overall Study|Protocol Deviation|0|||
155613282|NCT01348100|561675848|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613283|NCT01348100|561675849|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613284|NCT01348100|561675850|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613285|NCT01348100|561675851|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613286|NCT01348100|561675852|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613287|NCT01348100|561675853|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155613288|NCT01348100|561675854|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155613289|NCT01348100|561675848|FG000|Overall Study|Lost to Follow-up|0|||
155613290|NCT01348100|561675849|FG001|Overall Study|Lost to Follow-up|0|||
155613291|NCT01348100|561675850|FG002|Overall Study|Lost to Follow-up|0|||
155613292|NCT01348100|561675851|FG003|Overall Study|Lost to Follow-up|0|||
155613293|NCT01348100|561675852|FG004|Overall Study|Lost to Follow-up|0|||
155613294|NCT01348100|561675853|FG005|Overall Study|Lost to Follow-up|0|||
155613295|NCT01348100|561675854|FG006|Overall Study|Lost to Follow-up|1|||
155613296|NCT01348100|561675848|FG000|Overall Study|Administrative Problems|0|||
155613297|NCT01348100|561675849|FG001|Overall Study|Administrative Problems|0|||
155613298|NCT01348100|561675850|FG002|Overall Study|Administrative Problems|0|||
155613299|NCT01348100|561675851|FG003|Overall Study|Administrative Problems|0|||
155613300|NCT01348100|561675852|FG004|Overall Study|Administrative Problems|0|||
155613301|NCT01348100|561675853|FG005|Overall Study|Administrative Problems|1|||
155613302|NCT01348100|561675854|FG006|Overall Study|Administrative Problems|1|||
155613303|NCT03882957|561675857|FG000|Overall Study|Did not complete all three arms|1|||
155613304|NCT03762681|561675858|FG000|Part 1|Withdrawal by Subject|0|||
155613305|NCT03762681|561675859|FG001|Part 1|Withdrawal by Subject|0|||
155613306|NCT03762681|561675860|FG002|Part 1|Withdrawal by Subject|0|||
155613307|NCT03762681|561675861|FG003|Part 1|Withdrawal by Subject|1|||
155613308|NCT03762681|561675862|FG004|Part 1|Withdrawal by Subject|0|||
155613309|NCT03762681|561675863|FG005|Part 1|Withdrawal by Subject|0|||
155613310|NCT03762681|561675864|FG006|Part 1|Withdrawal by Subject|0|||
155613311|NCT03762681|561675865|FG007|Part 1|Withdrawal by Subject|0|||
155613312|NCT03762681|561675858|FG000|Part 2a|Pandemic Travel Restrictions|0|||
155613313|NCT03762681|561675859|FG001|Part 2a|Pandemic Travel Restrictions|0|||
155613314|NCT03762681|561675860|FG002|Part 2a|Pandemic Travel Restrictions|0|||
155613315|NCT03762681|561675861|FG003|Part 2a|Pandemic Travel Restrictions|0|||
155613316|NCT03762681|561675862|FG004|Part 2a|Pandemic Travel Restrictions|0|||
155613317|NCT03762681|561675863|FG005|Part 2a|Pandemic Travel Restrictions|0|||
155613318|NCT03762681|561675864|FG006|Part 2a|Pandemic Travel Restrictions|0|||
155613319|NCT03762681|561675865|FG007|Part 2a|Pandemic Travel Restrictions|1|||
155613320|NCT03148067|561675869|FG000|Overall Study|Lost to Follow-up|3|||
155613321|NCT03148067|561675869|FG000|Overall Study|Death|1|||
155613322|NCT03337048|561675871|FG000|Overall Study|Withdrawal by Subject|2|||
155613323|NCT03337048|561675872|FG001|Overall Study|Withdrawal by Subject|0|||
155613324|NCT03337048|561675873|FG002|Overall Study|Withdrawal by Subject|0|||
155613325|NCT03796676|561675874|FG000|Overall Study|Adverse Event|2|||
155613326|NCT03796676|561675875|FG001|Overall Study|Adverse Event|1|||
155613327|NCT03796676|561675876|FG002|Overall Study|Adverse Event|2|||
155613328|NCT03796676|561675874|FG000|Overall Study|Lost to Follow-up|2|||
155613329|NCT03796676|561675875|FG001|Overall Study|Lost to Follow-up|1|||
155613330|NCT03796676|561675876|FG002|Overall Study|Lost to Follow-up|0|||
155613331|NCT03796676|561675874|FG000|Overall Study|Protocol Violation|0|||
155613332|NCT03796676|561675875|FG001|Overall Study|Protocol Violation|0|||
155613333|NCT03796676|561675876|FG002|Overall Study|Protocol Violation|1|||
155613334|NCT03796676|561675874|FG000|Overall Study|Withdrawal by Subject|1|||
155726410|NCT02072668|562098122|FG000|Second Intervention|Lost to Follow-up|1|||
155613335|NCT03796676|561675875|FG001|Overall Study|Withdrawal by Subject|1|||
155613336|NCT03796676|561675876|FG002|Overall Study|Withdrawal by Subject|0|||
155613337|NCT03796676|561675874|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
155613338|NCT03796676|561675875|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
155613339|NCT03796676|561675876|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
155613340|NCT02772809|561675878|FG000|Overall Study|not completed some tasks|6|||
155613341|NCT00534105|561675884|FG000|Overall Study|Lost to Follow-up|23|||
155613342|NCT00534105|561675885|FG001|Overall Study|Lost to Follow-up|39|||
155613343|NCT00723697|561675886|FG000|Overall Study|Physician questionnaires not received|2|||
155613344|NCT00723697|561675886|FG000|Overall Study|Missing Informed Consent Form|10|||
155613345|NCT00723697|561675886|FG000|Overall Study|Other exclusion criteria applied|6|||
155613346|NCT01289574|561675887|FG000|Overall Study|Lack of Efficacy|4|||
155613347|NCT01289574|561675888|FG001|Overall Study|Lack of Efficacy|0|||
155613348|NCT01289574|561675889|FG002|Overall Study|Lack of Efficacy|1|||
155613349|NCT01289574|561675887|FG000|Overall Study|Lost to Follow-up|2|||
155613350|NCT01289574|561675888|FG001|Overall Study|Lost to Follow-up|0|||
155613351|NCT01289574|561675889|FG002|Overall Study|Lost to Follow-up|1|||
155613352|NCT01289574|561675887|FG000|Overall Study|Withdrawal by Subject|1|||
155613353|NCT01289574|561675888|FG001|Overall Study|Withdrawal by Subject|1|||
155613354|NCT01289574|561675889|FG002|Overall Study|Withdrawal by Subject|1|||
155613355|NCT01289574|561675887|FG000|Overall Study|Adverse Event|0|||
155613356|NCT01289574|561675888|FG001|Overall Study|Adverse Event|1|||
155613357|NCT01289574|561675889|FG002|Overall Study|Adverse Event|0|||
155613358|NCT01289574|561675887|FG000|Overall Study|Subject wanted alternate treatment|0|||
155613359|NCT01289574|561675888|FG001|Overall Study|Subject wanted alternate treatment|1|||
155613360|NCT01289574|561675889|FG002|Overall Study|Subject wanted alternate treatment|0|||
155613361|NCT00978341|561675894|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
155613362|NCT00978341|561675895|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
155613363|NCT02452554|561675896|FG000|Overall Study|Death|2|||
155613364|NCT02452554|561675897|FG001|Overall Study|Death|1|||
155613365|NCT02452554|561675898|FG002|Overall Study|Death|0|||
155613366|NCT02452554|561675899|FG003|Overall Study|Death|0|||
155613367|NCT02452554|561675900|FG004|Overall Study|Death|0|||
155613368|NCT02452554|561675901|FG005|Overall Study|Death|0|||
155613369|NCT02452554|561675896|FG000|Overall Study|Lack of Efficacy|13|||
155613370|NCT02452554|561675897|FG001|Overall Study|Lack of Efficacy|14|||
155613371|NCT02452554|561675898|FG002|Overall Study|Lack of Efficacy|9|||
155613372|NCT02452554|561675899|FG003|Overall Study|Lack of Efficacy|1|||
155613373|NCT02452554|561675900|FG004|Overall Study|Lack of Efficacy|5|||
155613374|NCT02452554|561675901|FG005|Overall Study|Lack of Efficacy|8|||
155613375|NCT02452554|561675896|FG000|Overall Study|Physician Decision|0|||
155613376|NCT02452554|561675897|FG001|Overall Study|Physician Decision|1|||
155613377|NCT02452554|561675898|FG002|Overall Study|Physician Decision|0|||
155613378|NCT02452554|561675899|FG003|Overall Study|Physician Decision|0|||
155613379|NCT02452554|561675900|FG004|Overall Study|Physician Decision|0|||
155613380|NCT02452554|561675901|FG005|Overall Study|Physician Decision|0|||
155613381|NCT02452554|561675896|FG000|Overall Study|Withdrawal by Subject|1|||
155613382|NCT02452554|561675897|FG001|Overall Study|Withdrawal by Subject|0|||
155613383|NCT02452554|561675898|FG002|Overall Study|Withdrawal by Subject|2|||
155613384|NCT02452554|561675899|FG003|Overall Study|Withdrawal by Subject|0|||
155613385|NCT02452554|561675900|FG004|Overall Study|Withdrawal by Subject|0|||
155613386|NCT02452554|561675901|FG005|Overall Study|Withdrawal by Subject|1|||
155613387|NCT02452554|561675896|FG000|Overall Study|Ineligible|0|||
155613388|NCT02452554|561675897|FG001|Overall Study|Ineligible|1|||
155613389|NCT02452554|561675898|FG002|Overall Study|Ineligible|0|||
155613390|NCT02452554|561675899|FG003|Overall Study|Ineligible|0|||
155613391|NCT02452554|561675900|FG004|Overall Study|Ineligible|0|||
155613392|NCT02452554|561675901|FG005|Overall Study|Ineligible|0|||
155613393|NCT02452554|561675896|FG000|Overall Study|Never Received Treatment|1|||
155613394|NCT02452554|561675897|FG001|Overall Study|Never Received Treatment|0|||
155613395|NCT02452554|561675898|FG002|Overall Study|Never Received Treatment|0|||
155613396|NCT02452554|561675899|FG003|Overall Study|Never Received Treatment|0|||
155613397|NCT02452554|561675900|FG004|Overall Study|Never Received Treatment|0|||
155613398|NCT02452554|561675901|FG005|Overall Study|Never Received Treatment|0|||
155613399|NCT02749799|561675902|FG000|Overall Study|Adverse Event|2|||
155613400|NCT02749799|561675902|FG000|Overall Study|Lost to Follow-up|4|||
155613401|NCT02749799|561675902|FG000|Overall Study|Protocol Violation|1|||
155613402|NCT02749799|561675902|FG000|Overall Study|Withdrawal by Subject|1|||
155613403|NCT02070978|561675903|FG000|Overall Study|Adverse Event|6|||
155613404|NCT02070978|561675904|FG001|Overall Study|Adverse Event|2|||
155613405|NCT02070978|561675905|FG002|Overall Study|Adverse Event|0|||
155613406|NCT02070978|561675903|FG000|Overall Study|Lost to Follow-up|1|||
155613407|NCT02070978|561675904|FG001|Overall Study|Lost to Follow-up|3|||
155613408|NCT02070978|561675905|FG002|Overall Study|Lost to Follow-up|4|||
155613409|NCT02070978|561675903|FG000|Overall Study|Withdrawal by Subject|3|||
155613410|NCT02070978|561675904|FG001|Overall Study|Withdrawal by Subject|5|||
155726411|NCT02072668|562098123|FG001|Second Intervention|Lost to Follow-up|0|||
155613411|NCT02070978|561675905|FG002|Overall Study|Withdrawal by Subject|3|||
155613412|NCT02070978|561675903|FG000|Overall Study|Protocol Violation|1|||
155613413|NCT02070978|561675904|FG001|Overall Study|Protocol Violation|0|||
155613414|NCT02070978|561675905|FG002|Overall Study|Protocol Violation|3|||
155613415|NCT02070978|561675903|FG000|Overall Study|Lack of Efficacy|0|||
155613416|NCT02070978|561675904|FG001|Overall Study|Lack of Efficacy|1|||
155613417|NCT02070978|561675905|FG002|Overall Study|Lack of Efficacy|0|||
155613418|NCT02070978|561675903|FG000|Overall Study|Death|0|||
155613419|NCT02070978|561675904|FG001|Overall Study|Death|0|||
155613420|NCT02070978|561675905|FG002|Overall Study|Death|2|||
155613421|NCT02070978|561675903|FG000|Overall Study|Un-specified|3|||
155613422|NCT02070978|561675904|FG001|Overall Study|Un-specified|2|||
155613423|NCT02070978|561675905|FG002|Overall Study|Un-specified|2|||
155613424|NCT02070978|561675903|FG000|Overall Study|Terminated by Sponsor|33|||
155613425|NCT02070978|561675904|FG001|Overall Study|Terminated by Sponsor|40|||
155613426|NCT02070978|561675905|FG002|Overall Study|Terminated by Sponsor|39|||
155613427|NCT00520767|561675907|FG000|Overall Study|Death|2|||
155613428|NCT02753816|561677804|FG000|Overall Study|Protocol Violation|0|||
155613429|NCT02753816|561677805|FG001|Overall Study|Protocol Violation|1|||
155613430|NCT02753816|561677806|FG002|Overall Study|Protocol Violation|0|||
155613431|NCT02259400|561677807|FG000|Overall Study|Death|0|||
155613432|NCT02259400|561677808|FG001|Overall Study|Death|2|||
155613433|NCT02372383|561677812|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
155613434|NCT02372383|561677813|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
155613435|NCT02372383|561677814|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
155613436|NCT01255904|561677815|FG000|Overall Study|Physician Decision|1|||
155613437|NCT01255904|561677816|FG001|Overall Study|Physician Decision|4|||
155613438|NCT02061813|561677818|FG000|Overall Study|Withdrawal by Subject|1|||
155613439|NCT02061813|561677818|FG000|Overall Study|Protocol Violation|2|||
155613440|NCT01705080|561677819|FG000|Overall Study|Missed visit|10|||
155613441|NCT01705080|561677820|FG001|Overall Study|Missed visit|4|||
155613442|NCT01705080|561677821|FG002|Overall Study|Missed visit|1|||
155613443|NCT01705080|561677819|FG000|Overall Study|Death|4|||
155613444|NCT01705080|561677820|FG001|Overall Study|Death|4|||
155613445|NCT01705080|561677821|FG002|Overall Study|Death|6|||
155613446|NCT01705080|561677819|FG000|Overall Study|Withdrawal by Subject|61|||
155613447|NCT01705080|561677820|FG001|Overall Study|Withdrawal by Subject|44|||
155613448|NCT01705080|561677821|FG002|Overall Study|Withdrawal by Subject|9|||
155613449|NCT01704755|561677825|FG000|Overall Study|Adverse Event|4|||
155613450|NCT01704755|561677826|FG001|Overall Study|Adverse Event|1|||
155613451|NCT01704755|561677825|FG000|Overall Study|Lost to Follow-up|3|||
155613452|NCT01704755|561677826|FG001|Overall Study|Lost to Follow-up|4|||
155613453|NCT01704755|561677825|FG000|Overall Study|Withdrew consent|1|||
155613454|NCT01704755|561677826|FG001|Overall Study|Withdrew consent|1|||
155613455|NCT01704755|561677825|FG000|Overall Study|Other (not specified)|3|||
155613456|NCT01704755|561677826|FG001|Overall Study|Other (not specified)|1|||
155613457|NCT01704755|561677825|FG000|Overall Study|Withdrew consent and personal issues|1|||
155613458|NCT01704755|561677826|FG001|Overall Study|Withdrew consent and personal issues|0|||
155613459|NCT02075008|561677839|FG000|Overall Study|Technical problems|1|||
155613460|NCT02075008|561677839|FG000|Overall Study|Pregnancy|1|||
155613461|NCT02075008|561677839|FG000|Overall Study|Physician Decision|1|||
155613462|NCT02075008|561677839|FG000|Overall Study|Lost to Follow-up|1|||
155613463|NCT02075008|561677839|FG000|Overall Study|Lack of Efficacy|1|||
155613464|NCT02075008|561677839|FG000|Overall Study|Death|1|||
155613465|NCT02075008|561677839|FG000|Overall Study|Adverse Event|5|||
155613466|NCT02075008|561677839|FG000|Overall Study|Withdrawal by Subject|6|||
155613467|NCT02075008|561677839|FG000|Overall Study|Study terminated by Sponsor|159|||
155613468|NCT03130959|561677840|FG000|Overall Study|Disease progression|19|||
155613469|NCT03130959|561677841|FG001|Overall Study|Disease progression|7|||
155613470|NCT03130959|561677842|FG002|Overall Study|Disease progression|12|||
155613471|NCT03130959|561677843|FG003|Overall Study|Disease progression|7|||
155613472|NCT03130959|561677844|FG004|Overall Study|Disease progression|12|||
155613473|NCT03130959|561677845|FG005|Overall Study|Disease progression|3|||
155613474|NCT03130959|561677846|FG006|Overall Study|Disease progression|6|||
155613475|NCT03130959|561677847|FG007|Overall Study|Disease progression|3|||
155613476|NCT03130959|561677848|FG008|Overall Study|Disease progression|15|||
155613477|NCT03130959|561677849|FG009|Overall Study|Disease progression|8|||
155613478|NCT03130959|561677840|FG000|Overall Study|Study drug toxicity|2|||
155613479|NCT03130959|561677841|FG001|Overall Study|Study drug toxicity|2|||
155613480|NCT03130959|561677842|FG002|Overall Study|Study drug toxicity|1|||
155613481|NCT03130959|561677843|FG003|Overall Study|Study drug toxicity|2|||
155613482|NCT03130959|561677844|FG004|Overall Study|Study drug toxicity|1|||
155613483|NCT03130959|561677845|FG005|Overall Study|Study drug toxicity|1|||
155613484|NCT03130959|561677846|FG006|Overall Study|Study drug toxicity|3|||
155613485|NCT03130959|561677847|FG007|Overall Study|Study drug toxicity|0|||
155613486|NCT03130959|561677848|FG008|Overall Study|Study drug toxicity|3|||
155613487|NCT03130959|561677849|FG009|Overall Study|Study drug toxicity|3|||
155613488|NCT03130959|561677840|FG000|Overall Study|Other reasons|0|||
155613489|NCT03130959|561677841|FG001|Overall Study|Other reasons|0|||
155613490|NCT03130959|561677842|FG002|Overall Study|Other reasons|0|||
155613491|NCT03130959|561677843|FG003|Overall Study|Other reasons|0|||
155613492|NCT03130959|561677844|FG004|Overall Study|Other reasons|0|||
155613493|NCT03130959|561677845|FG005|Overall Study|Other reasons|1|||
155613494|NCT03130959|561677846|FG006|Overall Study|Other reasons|1|||
155613495|NCT03130959|561677847|FG007|Overall Study|Other reasons|0|||
155613496|NCT03130959|561677848|FG008|Overall Study|Other reasons|0|||
155613497|NCT03130959|561677849|FG009|Overall Study|Other reasons|0|||
155613498|NCT03130959|561677840|FG000|Overall Study|Subject request to discontinue therapy|0|||
155613499|NCT03130959|561677841|FG001|Overall Study|Subject request to discontinue therapy|0|||
155613500|NCT03130959|561677842|FG002|Overall Study|Subject request to discontinue therapy|1|||
155613501|NCT03130959|561677843|FG003|Overall Study|Subject request to discontinue therapy|1|||
155613502|NCT03130959|561677844|FG004|Overall Study|Subject request to discontinue therapy|0|||
155613503|NCT03130959|561677845|FG005|Overall Study|Subject request to discontinue therapy|0|||
155613504|NCT03130959|561677846|FG006|Overall Study|Subject request to discontinue therapy|1|||
155613505|NCT03130959|561677847|FG007|Overall Study|Subject request to discontinue therapy|1|||
155613506|NCT03130959|561677848|FG008|Overall Study|Subject request to discontinue therapy|0|||
155613507|NCT03130959|561677849|FG009|Overall Study|Subject request to discontinue therapy|0|||
155613508|NCT03130959|561677840|FG000|Overall Study|Not reported|0|||
155613509|NCT03130959|561677841|FG001|Overall Study|Not reported|0|||
155613510|NCT03130959|561677842|FG002|Overall Study|Not reported|0|||
155613511|NCT03130959|561677843|FG003|Overall Study|Not reported|1|||
155613512|NCT03130959|561677844|FG004|Overall Study|Not reported|0|||
155613513|NCT03130959|561677845|FG005|Overall Study|Not reported|1|||
155613514|NCT03130959|561677846|FG006|Overall Study|Not reported|0|||
155613515|NCT03130959|561677847|FG007|Overall Study|Not reported|0|||
155613516|NCT03130959|561677848|FG008|Overall Study|Not reported|0|||
155613517|NCT03130959|561677849|FG009|Overall Study|Not reported|1|||
155613518|NCT03130959|561677840|FG000|Overall Study|Adverse Event unrelated to drug|0|||
155613519|NCT03130959|561677841|FG001|Overall Study|Adverse Event unrelated to drug|0|||
155613520|NCT03130959|561677842|FG002|Overall Study|Adverse Event unrelated to drug|1|||
155613521|NCT03130959|561677843|FG003|Overall Study|Adverse Event unrelated to drug|1|||
155613522|NCT03130959|561677844|FG004|Overall Study|Adverse Event unrelated to drug|1|||
155613523|NCT03130959|561677845|FG005|Overall Study|Adverse Event unrelated to drug|0|||
155613524|NCT03130959|561677846|FG006|Overall Study|Adverse Event unrelated to drug|1|||
155613525|NCT03130959|561677847|FG007|Overall Study|Adverse Event unrelated to drug|0|||
155613526|NCT03130959|561677848|FG008|Overall Study|Adverse Event unrelated to drug|1|||
155613527|NCT03130959|561677849|FG009|Overall Study|Adverse Event unrelated to drug|1|||
155613528|NCT03130959|561677840|FG000|Overall Study|Participant withdrew consent|0|||
155613529|NCT03130959|561677841|FG001|Overall Study|Participant withdrew consent|1|||
155613530|NCT03130959|561677842|FG002|Overall Study|Participant withdrew consent|0|||
155613531|NCT03130959|561677843|FG003|Overall Study|Participant withdrew consent|2|||
155613532|NCT03130959|561677844|FG004|Overall Study|Participant withdrew consent|1|||
155613533|NCT03130959|561677845|FG005|Overall Study|Participant withdrew consent|0|||
155613534|NCT03130959|561677846|FG006|Overall Study|Participant withdrew consent|0|||
155613535|NCT03130959|561677847|FG007|Overall Study|Participant withdrew consent|0|||
155613536|NCT03130959|561677848|FG008|Overall Study|Participant withdrew consent|0|||
155613537|NCT03130959|561677849|FG009|Overall Study|Participant withdrew consent|2|||
155613538|NCT03130959|561677840|FG000|Overall Study|Administrative reason by sponsor|1|||
155613539|NCT03130959|561677841|FG001|Overall Study|Administrative reason by sponsor|0|||
155613540|NCT03130959|561677842|FG002|Overall Study|Administrative reason by sponsor|1|||
155613541|NCT03130959|561677843|FG003|Overall Study|Administrative reason by sponsor|0|||
155613542|NCT03130959|561677844|FG004|Overall Study|Administrative reason by sponsor|0|||
155613543|NCT03130959|561677845|FG005|Overall Study|Administrative reason by sponsor|0|||
155613544|NCT03130959|561677846|FG006|Overall Study|Administrative reason by sponsor|0|||
155613545|NCT03130959|561677847|FG007|Overall Study|Administrative reason by sponsor|0|||
155613546|NCT03130959|561677848|FG008|Overall Study|Administrative reason by sponsor|0|||
155613547|NCT03130959|561677849|FG009|Overall Study|Administrative reason by sponsor|0|||
155613548|NCT03130959|561677840|FG000|Overall Study|Lost to Follow-up|1|||
155613549|NCT03130959|561677841|FG001|Overall Study|Lost to Follow-up|0|||
155613550|NCT03130959|561677842|FG002|Overall Study|Lost to Follow-up|0|||
155613551|NCT03130959|561677843|FG003|Overall Study|Lost to Follow-up|0|||
155613552|NCT03130959|561677844|FG004|Overall Study|Lost to Follow-up|0|||
155613553|NCT03130959|561677845|FG005|Overall Study|Lost to Follow-up|0|||
155613554|NCT03130959|561677846|FG006|Overall Study|Lost to Follow-up|0|||
155613555|NCT03130959|561677847|FG007|Overall Study|Lost to Follow-up|0|||
155613556|NCT03130959|561677848|FG008|Overall Study|Lost to Follow-up|0|||
155613557|NCT03130959|561677849|FG009|Overall Study|Lost to Follow-up|0|||
155613558|NCT04446429|561677850|FG000|Overall Study|Lost to Follow-up|6|||
155613559|NCT04446429|561677851|FG001|Overall Study|Lost to Follow-up|0|||
155613560|NCT05205005|561677852|FG000|Overall Study|Withdrawal by Subject|1|||
155613561|NCT05205005|561677853|FG001|Overall Study|Withdrawal by Subject|0|||
155613562|NCT05205005|561677852|FG000|Overall Study|Adverse Event|1|||
155613563|NCT05205005|561677853|FG001|Overall Study|Adverse Event|0|||
155613564|NCT02821416|561677854|FG000|Overall Study|Adverse Event|0|||
155613565|NCT02821416|561677855|FG001|Overall Study|Adverse Event|1|||
155613566|NCT02821416|561677854|FG000|Overall Study|Withdrawal by Subject|2|||
155613567|NCT02821416|561677855|FG001|Overall Study|Withdrawal by Subject|0|||
155613568|NCT02821416|561677854|FG000|Overall Study|Lost to Follow-up|1|||
155613569|NCT02821416|561677855|FG001|Overall Study|Lost to Follow-up|0|||
155613570|NCT03042910|561677860|FG000|Overall Study|Adverse Event|1|||
155613571|NCT03042910|561677860|FG000|Overall Study|Disease Progression|2|||
155613572|NCT03042910|561677860|FG000|Overall Study|Withdrawal by Subject|3|||
155613573|NCT03042910|561677860|FG000|Overall Study|Enrolled but not treated|1|||
155613574|NCT02256917|561677861|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
155726412|NCT02668653|562098124|FG000|Overall Study|Refractory disease|41|||
155726413|NCT02668653|562098125|FG001|Overall Study|Refractory disease|70|||
155726414|NCT02668653|562098124|FG000|Overall Study|Relapse|44|||
155613575|NCT02256917|561677861|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
155726415|NCT02668653|562098125|FG001|Overall Study|Relapse|65|||
155381698|NCT04617275|560830987|FG003|Treatment Period|Lost to Follow-up|0|||
155613576|NCT02256917|561677861|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
155613577|NCT02256917|561677861|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
155613578|NCT02256917|561677861|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
155613579|NCT02933528|561677862|FG000|Overall Study|Lost to Follow-up|2|||
155613580|NCT00313586|561677865|FG000|Overall Study|Disease progression|14|||
155613581|NCT00313586|561677866|FG001|Overall Study|Disease progression|19|||
155613582|NCT00313586|561677867|FG002|Overall Study|Disease progression|10|||
155613583|NCT00313586|561677868|FG003|Overall Study|Disease progression|3|||
155613584|NCT00313586|561677865|FG000|Overall Study|Adverse Event|12|||
155613585|NCT00313586|561677866|FG001|Overall Study|Adverse Event|18|||
155613586|NCT00313586|561677867|FG002|Overall Study|Adverse Event|3|||
155613587|NCT00313586|561677868|FG003|Overall Study|Adverse Event|10|||
155613588|NCT00313586|561677865|FG000|Overall Study|Death|11|||
155613589|NCT00313586|561677866|FG001|Overall Study|Death|8|||
155613590|NCT00313586|561677867|FG002|Overall Study|Death|1|||
155613591|NCT00313586|561677868|FG003|Overall Study|Death|7|||
155613592|NCT00313586|561677865|FG000|Overall Study|Withdrawal by Subject|13|||
155613593|NCT00313586|561677866|FG001|Overall Study|Withdrawal by Subject|6|||
155613594|NCT00313586|561677867|FG002|Overall Study|Withdrawal by Subject|6|||
155613595|NCT00313586|561677868|FG003|Overall Study|Withdrawal by Subject|2|||
155613596|NCT00313586|561677865|FG000|Overall Study|Alternative therapy|3|||
155613597|NCT00313586|561677866|FG001|Overall Study|Alternative therapy|6|||
155613598|NCT00313586|561677867|FG002|Overall Study|Alternative therapy|2|||
155613599|NCT00313586|561677868|FG003|Overall Study|Alternative therapy|0|||
155613600|NCT00313586|561677865|FG000|Overall Study|Other complicating disease|2|||
155613601|NCT00313586|561677866|FG001|Overall Study|Other complicating disease|2|||
155613602|NCT00313586|561677867|FG002|Overall Study|Other complicating disease|0|||
155613603|NCT00313586|561677868|FG003|Overall Study|Other complicating disease|0|||
155613604|NCT00313586|561677865|FG000|Overall Study|Did not achieve HI-major/better response|10|||
155613605|NCT00313586|561677866|FG001|Overall Study|Did not achieve HI-major/better response|7|||
155613606|NCT00313586|561677867|FG002|Overall Study|Did not achieve HI-major/better response|2|||
155613607|NCT00313586|561677868|FG003|Overall Study|Did not achieve HI-major/better response|1|||
155613608|NCT00313586|561677865|FG000|Overall Study|Physician Decision|2|||
155613609|NCT00313586|561677866|FG001|Overall Study|Physician Decision|1|||
155613610|NCT00313586|561677867|FG002|Overall Study|Physician Decision|0|||
155613611|NCT00313586|561677868|FG003|Overall Study|Physician Decision|0|||
155613612|NCT00313586|561677865|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
155613613|NCT00313586|561677866|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
155613614|NCT00313586|561677867|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
155613615|NCT00313586|561677868|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
155613616|NCT00313586|561677865|FG000|Overall Study|Lost insurance|0|||
155613617|NCT00313586|561677866|FG001|Overall Study|Lost insurance|1|||
155613618|NCT00313586|561677867|FG002|Overall Study|Lost insurance|0|||
155613619|NCT00313586|561677868|FG003|Overall Study|Lost insurance|0|||
155613620|NCT00313586|561677865|FG000|Overall Study|Moved|0|||
155613621|NCT00313586|561677866|FG001|Overall Study|Moved|1|||
155613622|NCT00313586|561677867|FG002|Overall Study|Moved|0|||
155613623|NCT00313586|561677868|FG003|Overall Study|Moved|0|||
155613624|NCT00313586|561677865|FG000|Overall Study|Death before starting treatment|1|||
155613625|NCT00313586|561677866|FG001|Overall Study|Death before starting treatment|0|||
155613626|NCT00313586|561677867|FG002|Overall Study|Death before starting treatment|0|||
155613627|NCT00313586|561677868|FG003|Overall Study|Death before starting treatment|0|||
155613628|NCT01639703|561677869|FG000|Overall Study|Withdrawal by Subject|5|||
155613629|NCT01639703|561677869|FG000|Overall Study|Other reason|7|||
155613630|NCT02087670|561677870|FG000|Overall Study|Withdrawal by Subject|3|||
155613631|NCT02087670|561677871|FG001|Overall Study|Withdrawal by Subject|2|||
155613632|NCT00264290|561677873|FG000|Intervention (8 Weeks)|Adverse Event|1|||
155613633|NCT00264290|561677874|FG001|Intervention (8 Weeks)|Adverse Event|0|||
155613634|NCT04472494|561677875|FG000|Pre-treatment|Other reasons|2|||
155613635|NCT04472494|561677876|FG001|Pre-treatment|Other reasons|0|||
155613636|NCT04472494|561677875|FG000|Treatment|Death|5|||
155613637|NCT04472494|561677876|FG001|Treatment|Death|2|||
155613638|NCT04472494|561677875|FG000|Treatment|Hospital discharge|1|||
155613639|NCT04472494|561677876|FG001|Treatment|Hospital discharge|1|||
155613640|NCT03519919|561677877|FG000|Overall Study|Withdrawal by Subject|1|||
155613641|NCT03519919|561677877|FG000|Overall Study|Lack of Efficacy|1|||
155613642|NCT03519919|561677877|FG000|Overall Study|Screen Failure|1|||
155613643|NCT03076996|561677878|FG000|Overall Study|Withdrawal by Subject|2|||
155613644|NCT03076996|561677878|FG000|Overall Study|Lost to Follow-up|3|||
155613645|NCT03076996|561677878|FG000|Overall Study|Literacy precluded participation|1|||
155613646|NCT00587795|561677879|FG000|Overall Study|Withdrawal by Subject|1|||
155613647|NCT00587795|561677880|FG001|Overall Study|Withdrawal by Subject|0|||
155613648|NCT02144077|561677881|FG000|Overall Study|Withdrawal by Subject|3|||
155613649|NCT02144077|561677882|FG001|Overall Study|Withdrawal by Subject|3|||
155613650|NCT02144077|561677881|FG000|Overall Study|Adverse Event|2|||
155613651|NCT02144077|561677882|FG001|Overall Study|Adverse Event|3|||
155513918|NCT02116803|561308195|FG001|Overall Study|Physician Decision|0|||
155513919|NCT02116803|561308194|FG000|Overall Study|Progressive disease|4|||
155513920|NCT02116803|561308195|FG001|Overall Study|Progressive disease|0|||
155513921|NCT02116803|561308194|FG000|Overall Study|Study terminated by sponsor|2|||
155513922|NCT02116803|561308195|FG001|Overall Study|Study terminated by sponsor|1|||
155513923|NCT02116803|561308194|FG000|Overall Study|Death|1|||
155513924|NCT02116803|561308195|FG001|Overall Study|Death|0|||
155513925|NCT03213210|561308196|FG000|Overall Study|Lost to Follow-up|2|||
155513926|NCT03213210|561308196|FG000|Overall Study|Study termination|3|||
155513927|NCT02540356|561308197|FG000|Overall Study|Terminated due to disease progression|1|||
155513928|NCT02540356|561308198|FG001|Overall Study|Terminated due to disease progression|0|||
155513929|NCT00684671|561308199|FG000|Overall Study|Adverse Event|1|||
155513930|NCT00684671|561308200|FG001|Overall Study|Adverse Event|0|||
155513931|NCT00684671|561308201|FG002|Overall Study|Adverse Event|0|||
155513932|NCT00684671|561308199|FG000|Overall Study|Lost to Follow-up|1|||
155513933|NCT00684671|561308200|FG001|Overall Study|Lost to Follow-up|0|||
155513934|NCT00684671|561308201|FG002|Overall Study|Lost to Follow-up|0|||
155513935|NCT00684671|561308199|FG000|Overall Study|Alcoholic dependance|1|||
155513936|NCT00684671|561308200|FG001|Overall Study|Alcoholic dependance|0|||
155513937|NCT00684671|561308201|FG002|Overall Study|Alcoholic dependance|0|||
155513938|NCT00481247|561308204|FG000|Overall Study|Death|0|||
155513939|NCT00481247|561308205|FG001|Overall Study|Death|1|||
155513940|NCT00481247|561308204|FG000|Overall Study|Disease progression|18|||
155513941|NCT00481247|561308205|FG001|Overall Study|Disease progression|22|||
155513942|NCT00481247|561308204|FG000|Overall Study|Intolerance|42|||
155513943|NCT00481247|561308205|FG001|Overall Study|Intolerance|17|||
155513944|NCT00481247|561308204|FG000|Overall Study|Treatment failure|10|||
155513945|NCT00481247|561308205|FG001|Overall Study|Treatment failure|14|||
155513946|NCT00481247|561308204|FG000|Overall Study|AE unrelated to study drug|13|||
155513947|NCT00481247|561308205|FG001|Overall Study|AE unrelated to study drug|4|||
155513948|NCT00481247|561308204|FG000|Overall Study|Withdrawal by Subject|8|||
155513949|NCT00481247|561308205|FG001|Overall Study|Withdrawal by Subject|13|||
155513950|NCT00481247|561308204|FG000|Overall Study|Pregnancy|2|||
155513951|NCT00481247|561308205|FG001|Overall Study|Pregnancy|1|||
155513952|NCT00481247|561308204|FG000|Overall Study|Lost to Follow-up|1|||
155513953|NCT00481247|561308205|FG001|Overall Study|Lost to Follow-up|2|||
155513954|NCT00481247|561308204|FG000|Overall Study|Poor compliance/noncompliance|1|||
155513955|NCT00481247|561308205|FG001|Overall Study|Poor compliance/noncompliance|7|||
155513956|NCT00481247|561308204|FG000|Overall Study|Administrative reason by sponsor|157|||
155513957|NCT00481247|561308205|FG001|Overall Study|Administrative reason by sponsor|162|||
155513958|NCT00481247|561308204|FG000|Overall Study|Varied|6|||
155513959|NCT00481247|561308205|FG001|Overall Study|Varied|15|||
155513960|NCT00481247|561308204|FG000|Overall Study|Did not receive treatment|1|||
155513961|NCT00481247|561308205|FG001|Overall Study|Did not receive treatment|2|||
155513962|NCT02649231|561308208|FG000|Overall Study|Adverse Event|0|||
155513963|NCT02649231|561308209|FG001|Overall Study|Adverse Event|0|||
155513964|NCT02649231|561308210|FG002|Overall Study|Adverse Event|0|||
155513965|NCT02649231|561308211|FG003|Overall Study|Adverse Event|1|||
155513966|NCT02649231|561308208|FG000|Overall Study|Lost to Follow-up|2|||
155513967|NCT02649231|561308209|FG001|Overall Study|Lost to Follow-up|1|||
155513968|NCT02649231|561308210|FG002|Overall Study|Lost to Follow-up|1|||
155513969|NCT02649231|561308211|FG003|Overall Study|Lost to Follow-up|0|||
155513970|NCT02649231|561308208|FG000|Overall Study|Withdrawal by Subject|0|||
155513971|NCT02649231|561308209|FG001|Overall Study|Withdrawal by Subject|1|||
155513972|NCT02649231|561308210|FG002|Overall Study|Withdrawal by Subject|0|||
155513973|NCT02649231|561308211|FG003|Overall Study|Withdrawal by Subject|1|||
155513974|NCT02649231|561308208|FG000|Overall Study|Protocol Violation|2|||
155513975|NCT02649231|561308209|FG001|Overall Study|Protocol Violation|1|||
155513976|NCT02649231|561308210|FG002|Overall Study|Protocol Violation|1|||
155513977|NCT02649231|561308211|FG003|Overall Study|Protocol Violation|0|||
155513978|NCT02970669|561308212|FG000|Double-blind Period|Adverse Event|4|||
155513979|NCT02970669|561308213|FG001|Double-blind Period|Adverse Event|0|||
155513980|NCT02970669|561308212|FG000|Double-blind Period|Death|1|||
155513981|NCT02970669|561308213|FG001|Double-blind Period|Death|0|||
155513982|NCT02970669|561308212|FG000|Double-blind Period|Study terminated by sponsor|1|||
155513983|NCT02970669|561308213|FG001|Double-blind Period|Study terminated by sponsor|2|||
155513984|NCT02970669|561308212|FG000|Double-blind Period|Physician Decision|0|||
155513985|NCT02970669|561308213|FG001|Double-blind Period|Physician Decision|2|||
155513986|NCT02970669|561308212|FG000|Double-blind Period|Withdrawal by Subject|2|||
155513987|NCT02970669|561308213|FG001|Double-blind Period|Withdrawal by Subject|2|||
155513988|NCT02970669|561308212|FG000|Open-label Period|Withdrawal by Subject|2|||
155513989|NCT02970669|561308213|FG001|Open-label Period|Withdrawal by Subject|2|||
155513990|NCT02970669|561308212|FG000|Open-label Period|Adverse Event|1|||
155513991|NCT02970669|561308213|FG001|Open-label Period|Adverse Event|0|||
155513992|NCT02970669|561308212|FG000|Open-label Period|Physician Decision|1|||
155513993|NCT02970669|561308213|FG001|Open-label Period|Physician Decision|0|||
155613652|NCT02144077|561677881|FG000|Overall Study|Lost to Follow-up|2|||
155613653|NCT02144077|561677882|FG001|Overall Study|Lost to Follow-up|2|||
155613654|NCT02144077|561677881|FG000|Overall Study|Protocol Violation|1|||
155613655|NCT02144077|561677882|FG001|Overall Study|Protocol Violation|2|||
155613656|NCT02144077|561677881|FG000|Overall Study|Death|0|||
155613657|NCT02144077|561677882|FG001|Overall Study|Death|1|||
155613658|NCT02144077|561677881|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
155613659|NCT02144077|561677882|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
155613660|NCT00943592|561677883|FG000|Overall Study|Death|3|||
155613661|NCT01909973|561677884|FG000|Overall Study|Lost to Follow-up|1|||
155613662|NCT01909973|561677885|FG001|Overall Study|Lost to Follow-up|0|||
155613663|NCT00169104|561677888|FG000|Overall Study|Withdrawal by Subject|2|||
155613664|NCT00169104|561677889|FG001|Overall Study|Withdrawal by Subject|0|||
155613665|NCT00169104|561677888|FG000|Overall Study|Protocol Violation|0|||
155613666|NCT00169104|561677889|FG001|Overall Study|Protocol Violation|1|||
155613667|NCT00169104|561677888|FG000|Overall Study|Physician Decision|0|||
155613668|NCT00169104|561677889|FG001|Overall Study|Physician Decision|1|||
155613669|NCT00232557|561677890|FG000|Overall Study|Lost to Follow-up|3|||
155613670|NCT00232557|561677891|FG001|Overall Study|Lost to Follow-up|5|||
155613671|NCT02438280|561677894|FG000|Overall Study|Physician Decision|1|||
155613672|NCT02438280|561677895|FG001|Overall Study|Physician Decision|0|||
155613673|NCT04435808|561677898|FG000|Overall Study|Study stopped by DSMB|0|||
155613674|NCT04435808|561677899|FG001|Overall Study|Study stopped by DSMB|1|||
155613675|NCT02081001|561677901|FG000|Overall Study|Adverse Event|0|||
155613676|NCT02081001|561677902|FG001|Overall Study|Adverse Event|0|||
155613677|NCT02081001|561677903|FG002|Overall Study|Adverse Event|0|||
155613678|NCT02081001|561677904|FG003|Overall Study|Adverse Event|0|||
155613679|NCT02081001|561677905|FG004|Overall Study|Adverse Event|1|||
155613680|NCT02081001|561677906|FG005|Overall Study|Adverse Event|0|||
155613681|NCT02081001|561677907|FG006|Overall Study|Adverse Event|0|||
155613682|NCT02081001|561677908|FG007|Overall Study|Adverse Event|0|||
155613683|NCT02081001|561677909|FG008|Overall Study|Adverse Event|0|||
155613684|NCT02081001|561677910|FG009|Overall Study|Adverse Event|0|||
155613685|NCT02081001|561677911|FG010|Overall Study|Adverse Event|0|||
155613686|NCT02081001|561677912|FG011|Overall Study|Adverse Event|0|||
155613687|NCT00524680|561677913|FG000|Overall Study|progression|0|||
155613688|NCT00524680|561677914|FG001|Overall Study|progression|0|||
155613689|NCT00524680|561677915|FG002|Overall Study|progression|0|||
155613690|NCT00524680|561677916|FG003|Overall Study|progression|1|||
155613691|NCT00524680|561677913|FG000|Overall Study|Adverse Event|2|||
155613692|NCT00524680|561677914|FG001|Overall Study|Adverse Event|0|||
155613693|NCT00524680|561677915|FG002|Overall Study|Adverse Event|0|||
155613694|NCT00524680|561677916|FG003|Overall Study|Adverse Event|1|||
155613695|NCT00524680|561677913|FG000|Overall Study|Other|0|||
155613696|NCT00524680|561677914|FG001|Overall Study|Other|1|||
155613697|NCT00524680|561677915|FG002|Overall Study|Other|2|||
155613698|NCT00524680|561677916|FG003|Overall Study|Other|3|||
155613699|NCT00524680|561677913|FG000|Overall Study|Withdrawal by Subject|1|||
155613700|NCT00524680|561677914|FG001|Overall Study|Withdrawal by Subject|0|||
155613701|NCT00524680|561677915|FG002|Overall Study|Withdrawal by Subject|1|||
155613702|NCT00524680|561677916|FG003|Overall Study|Withdrawal by Subject|1|||
155613703|NCT01146561|561677917|FG000|Overall Study|Withdrawal by Subject|1|||
155613704|NCT01146561|561677917|FG000|Overall Study|Lost to Follow-up|1|||
155613705|NCT00893971|561677920|FG000|Overall Study|Physician Decision|3|||
155613706|NCT00492232|561677921|FG000|Placebo Run-in|Adverse Event|0|||
155613707|NCT00492232|561677922|FG001|Placebo Run-in|Adverse Event|2|||
155613708|NCT00492232|561677921|FG000|Placebo Run-in|Protocol Violation|0|||
155613709|NCT00492232|561677922|FG001|Placebo Run-in|Protocol Violation|3|||
155613710|NCT00492232|561677921|FG000|Placebo Run-in|Lost to Follow-up|0|||
155613711|NCT00492232|561677922|FG001|Placebo Run-in|Lost to Follow-up|3|||
155613712|NCT00492232|561677921|FG000|Placebo Run-in|Withdrawal by Subject|0|||
155613713|NCT00492232|561677922|FG001|Placebo Run-in|Withdrawal by Subject|8|||
155613714|NCT00492232|561677921|FG000|Placebo Run-in|Pregnancy|0|||
155613715|NCT00492232|561677922|FG001|Placebo Run-in|Pregnancy|1|||
155613716|NCT00492232|561677921|FG000|Placebo Run-in|Entrance criteria not met|0|||
155613717|NCT00492232|561677922|FG001|Placebo Run-in|Entrance criteria not met|45|||
155613718|NCT00492232|561677921|FG000|Placebo Run-in|Other|0|||
155613719|NCT00492232|561677922|FG001|Placebo Run-in|Other|6|||
155613720|NCT00492232|561677921|FG000|Placebo Run-in|Missing|0|||
155613721|NCT00492232|561677922|FG001|Placebo Run-in|Missing|2|||
155613722|NCT00492232|561677921|FG000|Double-Blind Treatment|Adverse Event|1|||
155613723|NCT00492232|561677922|FG001|Double-Blind Treatment|Adverse Event|2|||
155613724|NCT00492232|561677921|FG000|Double-Blind Treatment|Protocol Violation|3|||
155613725|NCT00492232|561677922|FG001|Double-Blind Treatment|Protocol Violation|7|||
155613726|NCT00492232|561677921|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
155613727|NCT00492232|561677922|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
155613728|NCT00492232|561677921|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
155613729|NCT00492232|561677922|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
155613730|NCT00492232|561677921|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
155613731|NCT00492232|561677922|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
155613732|NCT00492232|561677921|FG000|Double-Blind Treatment|Other|6|||
155613733|NCT00492232|561677922|FG001|Double-Blind Treatment|Other|5|||
155613734|NCT00492232|561677921|FG000|Double-Blind Treatment|Randomized not treated|1|||
155613735|NCT00492232|561677922|FG001|Double-Blind Treatment|Randomized not treated|0|||
155613736|NCT00492232|561677921|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
155613737|NCT00492232|561677922|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155613738|NCT01416155|561677923|FG000|Overall Study|Adverse Event|8|||
155613739|NCT01416155|561677923|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
155613740|NCT01416155|561677923|FG000|Overall Study|Withdrawal by Subject|33|||
155613741|NCT01416155|561677923|FG000|Overall Study|Investigator decision|8|||
155613742|NCT01416155|561677923|FG000|Overall Study|Other|7|||
155613743|NCT00829829|561677927|FG000|Overall Study|Protocol Violation|0|||
155613744|NCT00829829|561677928|FG001|Overall Study|Protocol Violation|3|||
155613745|NCT00829829|561677929|FG002|Overall Study|Protocol Violation|0|||
155613746|NCT00829829|561677927|FG000|Overall Study|Adverse Event|4|||
155613747|NCT00829829|561677928|FG001|Overall Study|Adverse Event|4|||
155613748|NCT00829829|561677929|FG002|Overall Study|Adverse Event|3|||
155613749|NCT00829829|561677927|FG000|Overall Study|Withdrawal by Subject|8|||
155613750|NCT00829829|561677928|FG001|Overall Study|Withdrawal by Subject|4|||
155613751|NCT00829829|561677929|FG002|Overall Study|Withdrawal by Subject|2|||
155613752|NCT00829829|561677927|FG000|Overall Study|Decision by the Sponsor|1|||
155613753|NCT00829829|561677928|FG001|Overall Study|Decision by the Sponsor|0|||
155613754|NCT00829829|561677929|FG002|Overall Study|Decision by the Sponsor|2|||
155613755|NCT00829829|561677927|FG000|Overall Study|Lost to Follow-up|7|||
155613756|NCT00829829|561677928|FG001|Overall Study|Lost to Follow-up|3|||
155613757|NCT00829829|561677929|FG002|Overall Study|Lost to Follow-up|3|||
155613758|NCT00829829|561677927|FG000|Overall Study|Other than specified above|2|||
155613759|NCT00829829|561677928|FG001|Overall Study|Other than specified above|2|||
155613760|NCT00829829|561677929|FG002|Overall Study|Other than specified above|1|||
155613761|NCT02685072|561677930|FG000|Treatment Period|Lost to Follow-up|12|||
155613762|NCT02685072|561677931|FG001|Treatment Period|Lost to Follow-up|6|||
155613763|NCT02685072|561677930|FG000|Treatment Period|Withdrawal by Subject|1|||
155613764|NCT02685072|561677931|FG001|Treatment Period|Withdrawal by Subject|3|||
155613765|NCT02685072|561677930|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
155613766|NCT02685072|561677931|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
155613767|NCT00382109|561677934|FG000|Overall Study|Adverse Event|3|||
155613768|NCT00382109|561677935|FG001|Overall Study|Adverse Event|0|||
155613769|NCT00382109|561677934|FG000|Overall Study|Physician Decision|6|||
155613770|NCT00382109|561677935|FG001|Overall Study|Physician Decision|1|||
155613771|NCT00382109|561677934|FG000|Overall Study|Withdrawal by Subject|1|||
155613772|NCT00382109|561677935|FG001|Overall Study|Withdrawal by Subject|0|||
155613773|NCT00382109|561677934|FG000|Overall Study|ineligible|2|||
155613774|NCT00382109|561677935|FG001|Overall Study|ineligible|0|||
155613775|NCT00382109|561677934|FG000|Overall Study|Other|0|||
155613776|NCT00382109|561677935|FG001|Overall Study|Other|2|||
155613777|NCT00382109|561677934|FG000|Overall Study|consent withdrawal|0|||
155613778|NCT00382109|561677935|FG001|Overall Study|consent withdrawal|1|||
155613779|NCT01249833|561677936|FG000|Overall Study|Lost to Follow-up|0|||
155613780|NCT01249833|561677937|FG001|Overall Study|Lost to Follow-up|1|||
155613781|NCT01900899|561677938|FG000|Overall Study|Withdrawal by Subject|7|||
155613782|NCT01900899|561677939|FG001|Overall Study|Withdrawal by Subject|1|||
155613783|NCT01900899|561677938|FG000|Overall Study|Migrated from study area|2|||
155613784|NCT01900899|561677939|FG001|Overall Study|Migrated from study area|0|||
155613785|NCT02774005|561677940|FG000|Overall Study|Adverse Event|8|||
155613786|NCT02774005|561677940|FG000|Overall Study|Withdrawal by Subject|23|||
155613787|NCT02774005|561677940|FG000|Overall Study|Lost to Follow-up|7|||
155613788|NCT02774005|561677940|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
155613789|NCT02774005|561677940|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
155613790|NCT02774005|561677940|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
155613791|NCT02774005|561677940|FG000|Overall Study|Death|1|||
155613792|NCT02774005|561677940|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
155613793|NCT02774005|561677940|FG000|Overall Study|Lack of compliance with study medication|4|||
155613794|NCT02774005|561677940|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
155613795|NCT02774005|561677940|FG000|Overall Study|another study|1|||
155613796|NCT02774005|561677940|FG000|Overall Study|cardiologist imposed travel restriction|1|||
155613797|NCT03035916|561677941|FG000|Overall Study|Puncture failed|0|||
155613798|NCT03035916|561677942|FG001|Overall Study|Puncture failed|2|||
155613799|NCT03035916|561677943|FG002|Overall Study|Puncture failed|0|||
155613800|NCT03885999|561677944|FG000|Overall Study|Adverse Event|1|||
155613801|NCT01451554|561677945|FG000|Overall Study|Withdrawal by Subject|14|||
155613802|NCT01451554|561677946|FG001|Overall Study|Withdrawal by Subject|9|||
155613803|NCT01790516|561677947|FG000|Overall Study|Physician Decision|1|||
155613804|NCT01790516|561677948|FG001|Overall Study|Physician Decision|0|||
155613805|NCT01402986|561677949|FG000|Overall Study|Withdrawal by Subject|7|||
155613806|NCT01402986|561677950|FG001|Overall Study|Withdrawal by Subject|10|||
155613807|NCT01402986|561677951|FG002|Overall Study|Withdrawal by Subject|7|||
155613808|NCT01402986|561677952|FG003|Overall Study|Withdrawal by Subject|13|||
155613809|NCT01402986|561677949|FG000|Overall Study|Death|0|||
155613810|NCT01402986|561677950|FG001|Overall Study|Death|0|||
155613811|NCT01402986|561677951|FG002|Overall Study|Death|0|||
155613812|NCT01402986|561677952|FG003|Overall Study|Death|2|||
155613813|NCT01402986|561677949|FG000|Overall Study|Lost to Follow-up|0|||
155613814|NCT01402986|561677950|FG001|Overall Study|Lost to Follow-up|0|||
155613815|NCT01402986|561677951|FG002|Overall Study|Lost to Follow-up|0|||
155613816|NCT01402986|561677952|FG003|Overall Study|Lost to Follow-up|1|||
155613817|NCT01402986|561677949|FG000|Overall Study|Other|2|||
155613818|NCT01402986|561677950|FG001|Overall Study|Other|5|||
155613819|NCT01402986|561677951|FG002|Overall Study|Other|1|||
155613820|NCT01402986|561677952|FG003|Overall Study|Other|6|||
155613821|NCT03749109|561677953|FG000|Overall Study|Adverse Event|2|||
155613822|NCT03749109|561677954|FG001|Overall Study|Adverse Event|0|||
155613823|NCT03178851|561677955|FG000|Overall Study|Death|48|||
155613824|NCT03178851|561677956|FG001|Overall Study|Death|2|||
155613825|NCT03178851|561677957|FG002|Overall Study|Death|25|||
155613826|NCT03178851|561677955|FG000|Overall Study|Withdrawal by Subject|8|||
155613827|NCT03178851|561677956|FG001|Overall Study|Withdrawal by Subject|0|||
155613828|NCT03178851|561677957|FG002|Overall Study|Withdrawal by Subject|0|||
155613829|NCT03178851|561677955|FG000|Overall Study|Lost to Follow-up|5|||
155613830|NCT03178851|561677956|FG001|Overall Study|Lost to Follow-up|2|||
155613831|NCT03178851|561677957|FG002|Overall Study|Lost to Follow-up|0|||
155613832|NCT03178851|561677955|FG000|Overall Study|Adverse Event|0|||
155613833|NCT03178851|561677956|FG001|Overall Study|Adverse Event|0|||
155613834|NCT03178851|561677957|FG002|Overall Study|Adverse Event|1|||
155613835|NCT03178851|561677955|FG000|Overall Study|Study Termination by Sponsor|31|||
155613836|NCT03178851|561677956|FG001|Overall Study|Study Termination by Sponsor|7|||
155613837|NCT03178851|561677957|FG002|Overall Study|Study Termination by Sponsor|26|||
155613838|NCT02226120|561677958|FG000|Overall Study|Adverse Event|60|||
155613839|NCT02226120|561677958|FG000|Overall Study|Death|172|||
155613840|NCT02226120|561677958|FG000|Overall Study|Study terminated by sponsor|1|||
155613841|NCT02226120|561677958|FG000|Overall Study|Technical problems|4|||
155613842|NCT02226120|561677958|FG000|Overall Study|Lost to Follow-up|13|||
155613843|NCT02226120|561677958|FG000|Overall Study|Physician Decision|21|||
155613844|NCT02226120|561677958|FG000|Overall Study|Withdrawal by parent/guardian|36|||
155613845|NCT02226120|561677958|FG000|Overall Study|Non-compliance with study drug|10|||
155613846|NCT02226120|561677958|FG000|Overall Study|Protocol deviation|1|||
155613847|NCT02226120|561677958|FG000|Overall Study|missing treatment disposition pages|2|||
155613848|NCT03034135|561677961|FG000|Overall Study|Withdrawal by Subject|2|||
155613849|NCT02669043|561677962|FG000|Overall Study|Didn't meet I/E criteria|4|||
155613850|NCT03638466|561680001|FG000|Overall Study|Early Termination|0|||
155613851|NCT03638466|561680002|FG001|Overall Study|Early Termination|1|||
155613852|NCT02576977|561680003|FG000|Overall Study|Adverse Event|13|||
155613853|NCT02576977|561680004|FG001|Overall Study|Adverse Event|2|||
155613854|NCT02576977|561680003|FG000|Overall Study|Death|73|||
155613855|NCT02576977|561680004|FG001|Overall Study|Death|60|||
155613856|NCT02576977|561680003|FG000|Overall Study|Screen failure|1|||
155613857|NCT02576977|561680004|FG001|Overall Study|Screen failure|0|||
155613858|NCT02576977|561680003|FG000|Overall Study|Study Terminated at Selected Sites|27|||
155613859|NCT02576977|561680004|FG001|Overall Study|Study Terminated at Selected Sites|50|||
155613860|NCT02576977|561680003|FG000|Overall Study|Withdrawal by Subject|11|||
155613861|NCT02576977|561680004|FG001|Overall Study|Withdrawal by Subject|11|||
155613862|NCT02576977|561680003|FG000|Overall Study|Final Disposition Unknown|0|||
155613863|NCT02576977|561680004|FG001|Overall Study|Final Disposition Unknown|1|||
155613864|NCT02576977|561680003|FG000|Overall Study|Lost to Follow-up|1|||
155613865|NCT02576977|561680004|FG001|Overall Study|Lost to Follow-up|0|||
155613866|NCT02576977|561680003|FG000|Overall Study|Progressive Disease|0|||
155613867|NCT02576977|561680004|FG001|Overall Study|Progressive Disease|1|||
155613868|NCT03251482|561680005|FG000|Overall Study|Withdrawal by Subject|0|||
155613869|NCT03251482|561680006|FG001|Overall Study|Withdrawal by Subject|1|||
155613870|NCT03251482|561680007|FG002|Overall Study|Withdrawal by Subject|0|||
155613871|NCT03251482|561680008|FG003|Overall Study|Withdrawal by Subject|0|||
155613872|NCT03251482|561680009|FG004|Overall Study|Withdrawal by Subject|0|||
155613873|NCT02447328|561680012|FG000|Overall Study|Withdrawal by Subject|1|||
155613874|NCT02823470|561680015|FG000|Overall Study|Adverse Event|1|||
155613875|NCT02823470|561680016|FG001|Overall Study|Adverse Event|0|||
155613876|NCT02823470|561680015|FG000|Overall Study|Study terminated by sponsor|8|||
155613877|NCT02823470|561680016|FG001|Overall Study|Study terminated by sponsor|15|||
155613878|NCT02155309|561680017|FG000|Overall Study|Protocol Violation|0|||
155613879|NCT02155309|561680018|FG001|Overall Study|Protocol Violation|0|||
155613880|NCT02155309|561680019|FG002|Overall Study|Protocol Violation|1|||
155613881|NCT01073163|561680020|FG000|Overall Study|Adverse Event|1|||
155613882|NCT01073163|561680020|FG000|Overall Study|Disease Progression|1|||
155613883|NCT01073163|561680020|FG000|Overall Study|Early termination|1|||
155613884|NCT00703677|561680021|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
155613885|NCT01677182|561680022|FG000|Overall Study|Adverse Event|2|||
155613886|NCT01677182|561680023|FG001|Overall Study|Adverse Event|1|||
155613887|NCT01677182|561680024|FG002|Overall Study|Adverse Event|8|||
155613888|NCT01677182|561680022|FG000|Overall Study|Protocol Violation|5|||
155613889|NCT01677182|561680023|FG001|Overall Study|Protocol Violation|1|||
155613890|NCT01677182|561680024|FG002|Overall Study|Protocol Violation|4|||
155613891|NCT01677182|561680022|FG000|Overall Study|Lost to Follow-up|4|||
155613892|NCT01677182|561680023|FG001|Overall Study|Lost to Follow-up|0|||
155613893|NCT01677182|561680024|FG002|Overall Study|Lost to Follow-up|3|||
155613894|NCT01677182|561680022|FG000|Overall Study|Withdrawal by Subject|7|||
155613895|NCT01677182|561680023|FG001|Overall Study|Withdrawal by Subject|12|||
155613896|NCT01677182|561680024|FG002|Overall Study|Withdrawal by Subject|10|||
155613897|NCT01677182|561680022|FG000|Overall Study|Study termination|12|||
155613898|NCT01677182|561680023|FG001|Overall Study|Study termination|9|||
155613899|NCT01677182|561680024|FG002|Overall Study|Study termination|11|||
155613900|NCT01677182|561680022|FG000|Overall Study|Lack of Efficacy|3|||
155613901|NCT01677182|561680023|FG001|Overall Study|Lack of Efficacy|0|||
155613902|NCT01677182|561680024|FG002|Overall Study|Lack of Efficacy|1|||
155613903|NCT01677182|561680022|FG000|Overall Study|Other reasons|1|||
155613904|NCT01677182|561680023|FG001|Overall Study|Other reasons|5|||
155613905|NCT01677182|561680024|FG002|Overall Study|Other reasons|2|||
155613906|NCT02501161|561680025|FG000|Overall Study|Adverse Event|2|||
155613907|NCT02501161|561680026|FG001|Overall Study|Adverse Event|6|||
155613908|NCT02501161|561680025|FG000|Overall Study|Lost to Follow-up|7|||
155613909|NCT02501161|561680026|FG001|Overall Study|Lost to Follow-up|4|||
155613910|NCT02501161|561680025|FG000|Overall Study|Withdrawal by Subject|10|||
155613911|NCT02501161|561680026|FG001|Overall Study|Withdrawal by Subject|15|||
155613912|NCT02501161|561680025|FG000|Overall Study|Other|3|||
155613913|NCT02501161|561680026|FG001|Overall Study|Other|0|||
155613914|NCT00762762|561680027|FG000|Overall Study|Did not return for appointments|6|||
155613915|NCT00762762|561680028|FG001|Overall Study|Did not return for appointments|8|||
155613916|NCT02748057|561680029|FG000|Overall Study|Adverse Event|1|||
155613917|NCT02748057|561680030|FG001|Overall Study|Adverse Event|0|||
155613918|NCT02748057|561680029|FG000|Overall Study|Physician Decision|0|||
155613919|NCT02748057|561680030|FG001|Overall Study|Physician Decision|1|||
155613920|NCT02748057|561680029|FG000|Overall Study|Protocol Violation|2|||
155613921|NCT02748057|561680030|FG001|Overall Study|Protocol Violation|1|||
155613922|NCT02748057|561680029|FG000|Overall Study|Participant Moved|1|||
155613923|NCT02748057|561680030|FG001|Overall Study|Participant Moved|0|||
155613924|NCT02748057|561680029|FG000|Overall Study|Withdrawal by Subject|1|||
155613925|NCT02748057|561680030|FG001|Overall Study|Withdrawal by Subject|0|||
155613926|NCT01990573|561680031|FG000|Overall Study|Physician Decision|0|||
155613927|NCT01990573|561680032|FG001|Overall Study|Physician Decision|0|||
155613928|NCT01990573|561680033|FG002|Overall Study|Physician Decision|1|||
155613929|NCT02906579|561680040|FG000|Overall Study|Adverse Event|1|||
155613930|NCT02906579|561680040|FG000|Overall Study|Physician Decision|1|||
155613931|NCT02030119|561680041|FG000|Overall Study|Withdrawal by Subject|3|||
155613932|NCT02030119|561680042|FG001|Overall Study|Withdrawal by Subject|1|||
155613933|NCT02030119|561680043|FG002|Overall Study|Withdrawal by Subject|5|||
155613934|NCT02030119|561680044|FG003|Overall Study|Withdrawal by Subject|3|||
155613935|NCT02030119|561680041|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
155613936|NCT02030119|561680042|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
155613937|NCT02030119|561680043|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
155613938|NCT02030119|561680044|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
155613939|NCT00759655|561680045|FG000|Overall Study|Termination of the study by sponsor|1|||
155613940|NCT00905567|561680052|FG000|Washout|Withdrawal by Subject|0|||
155613941|NCT00905567|561680053|FG001|Washout|Withdrawal by Subject|1|||
155613942|NCT01473940|561680054|FG000|Induction Therapy|Death|0|||
155613943|NCT01473940|561680055|FG001|Induction Therapy|Death|0|||
155613944|NCT01473940|561680056|FG002|Induction Therapy|Death|1|||
155613945|NCT01473940|561680057|FG003|Induction Therapy|Death|1|||
155613946|NCT01473940|561680054|FG000|Induction Therapy|Progressive Disease|0|||
155613947|NCT01473940|561680055|FG001|Induction Therapy|Progressive Disease|1|||
155613948|NCT01473940|561680056|FG002|Induction Therapy|Progressive Disease|1|||
155613949|NCT01473940|561680057|FG003|Induction Therapy|Progressive Disease|0|||
155613950|NCT01473940|561680054|FG000|Maintenance Therapy|Progressive Disease|1|||
155613951|NCT01473940|561680055|FG001|Maintenance Therapy|Progressive Disease|2|||
155613952|NCT01473940|561680056|FG002|Maintenance Therapy|Progressive Disease|1|||
155613953|NCT01473940|561680057|FG003|Maintenance Therapy|Progressive Disease|4|||
155266950|NCT00393523|560410927|FG000|Overall Study|Lost to Follow-up|0|||
155266951|NCT00393523|560410928|FG001|Overall Study|Lost to Follow-up|0|||
155613954|NCT00534248|561680058|FG000|Overall Study|Adverse Event|19|||
155613955|NCT00534248|561680059|FG001|Overall Study|Adverse Event|29|||
155613956|NCT00534248|561680058|FG000|Overall Study|Lost to Follow-up|353|||
155613957|NCT00534248|561680059|FG001|Overall Study|Lost to Follow-up|375|||
155613958|NCT00534248|561680058|FG000|Overall Study|Other protocol specified criteria|13|||
155613959|NCT00534248|561680059|FG001|Overall Study|Other protocol specified criteria|3|||
155613960|NCT00534248|561680058|FG000|Overall Study|Physician Decision|10|||
155613961|NCT00534248|561680059|FG001|Overall Study|Physician Decision|7|||
155613962|NCT00534248|561680058|FG000|Overall Study|Protocol Violation|3|||
155613963|NCT00534248|561680059|FG001|Overall Study|Protocol Violation|4|||
155613964|NCT00534248|561680058|FG000|Overall Study|Withdrawal by Subject|263|||
155613965|NCT00534248|561680059|FG001|Overall Study|Withdrawal by Subject|255|||
155613966|NCT02532257|561680060|FG000|Overall Study|Adverse Event|2|||
155613967|NCT02532257|561680060|FG000|Overall Study|Physician Decision|4|||
155613968|NCT02532257|561680060|FG000|Overall Study|Withdrawal by Subject|3|||
155613969|NCT02532257|561680060|FG000|Overall Study|Progressive Disease|10|||
155613970|NCT02849171|561680061|FG000|Overall Study|Withdrawal by Subject|1|||
155613971|NCT02849171|561680061|FG000|Overall Study|Not treated|1|||
155613972|NCT03498313|561680068|FG000|Experimental Period 1|Adverse Event|1|||
155613973|NCT03498313|561680069|FG001|Experimental Period 1|Adverse Event|0|||
155613974|NCT03498313|561680070|FG002|Experimental Period 1|Adverse Event|0|||
155613975|NCT03498313|561680071|FG003|Experimental Period 1|Adverse Event|1|||
155613976|NCT03498313|561680072|FG004|Experimental Period 1|Adverse Event|0|||
155613977|NCT03498313|561680073|FG005|Experimental Period 1|Adverse Event|0|||
155613978|NCT03498313|561680068|FG000|Experimental Period 1|Withdrawal by Subject|0|||
155613979|NCT03498313|561680069|FG001|Experimental Period 1|Withdrawal by Subject|1|||
155613980|NCT03498313|561680070|FG002|Experimental Period 1|Withdrawal by Subject|0|||
155613981|NCT03498313|561680071|FG003|Experimental Period 1|Withdrawal by Subject|0|||
155613982|NCT03498313|561680072|FG004|Experimental Period 1|Withdrawal by Subject|0|||
155613983|NCT03498313|561680073|FG005|Experimental Period 1|Withdrawal by Subject|0|||
155613984|NCT03498313|561680068|FG000|Washout Period 1|Anovulation|1|||
155613985|NCT03498313|561680069|FG001|Washout Period 1|Anovulation|0|||
155613986|NCT03498313|561680070|FG002|Washout Period 1|Anovulation|0|||
155613987|NCT03498313|561680071|FG003|Washout Period 1|Anovulation|0|||
155613988|NCT03498313|561680072|FG004|Washout Period 1|Anovulation|0|||
155613989|NCT03498313|561680073|FG005|Washout Period 1|Anovulation|0|||
155613990|NCT03498313|561680068|FG000|Washout Period 1|Withdrawal by Subject|0|||
155613991|NCT03498313|561680069|FG001|Washout Period 1|Withdrawal by Subject|3|||
155613992|NCT03498313|561680070|FG002|Washout Period 1|Withdrawal by Subject|0|||
155613993|NCT03498313|561680071|FG003|Washout Period 1|Withdrawal by Subject|1|||
155613994|NCT03498313|561680072|FG004|Washout Period 1|Withdrawal by Subject|0|||
155613995|NCT03498313|561680073|FG005|Washout Period 1|Withdrawal by Subject|1|||
155613996|NCT03498313|561680068|FG000|Experimental Period 2|Adverse Event|0|||
155613997|NCT03498313|561680069|FG001|Experimental Period 2|Adverse Event|0|||
155613998|NCT03498313|561680070|FG002|Experimental Period 2|Adverse Event|0|||
155613999|NCT03498313|561680071|FG003|Experimental Period 2|Adverse Event|0|||
155614000|NCT03498313|561680072|FG004|Experimental Period 2|Adverse Event|1|||
155614001|NCT03498313|561680073|FG005|Experimental Period 2|Adverse Event|2|||
155614002|NCT03498313|561680068|FG000|Washout Period 2|Physician Decision|1|||
155614003|NCT03498313|561680069|FG001|Washout Period 2|Physician Decision|0|||
155614004|NCT03498313|561680070|FG002|Washout Period 2|Physician Decision|0|||
155614005|NCT03498313|561680071|FG003|Washout Period 2|Physician Decision|1|||
155614006|NCT03498313|561680072|FG004|Washout Period 2|Physician Decision|0|||
155614007|NCT03498313|561680073|FG005|Washout Period 2|Physician Decision|1|||
155614008|NCT03498313|561680068|FG000|Washout Period 2|Withdrawal by Subject|3|||
155614009|NCT03498313|561680069|FG001|Washout Period 2|Withdrawal by Subject|2|||
155614010|NCT03498313|561680070|FG002|Washout Period 2|Withdrawal by Subject|0|||
155614011|NCT03498313|561680071|FG003|Washout Period 2|Withdrawal by Subject|0|||
155614012|NCT03498313|561680072|FG004|Washout Period 2|Withdrawal by Subject|2|||
155614013|NCT03498313|561680073|FG005|Washout Period 2|Withdrawal by Subject|0|||
155614014|NCT03498313|561680068|FG000|Washout Period 2|Anovulation|0|||
155614015|NCT03498313|561680069|FG001|Washout Period 2|Anovulation|0|||
155614016|NCT03498313|561680070|FG002|Washout Period 2|Anovulation|0|||
155614017|NCT03498313|561680071|FG003|Washout Period 2|Anovulation|0|||
155614018|NCT03498313|561680072|FG004|Washout Period 2|Anovulation|0|||
155614019|NCT03498313|561680073|FG005|Washout Period 2|Anovulation|1|||
155614020|NCT02630563|561680076|FG000|Overall Study|Administrative|1|||
155614021|NCT00929994|561680079|FG000|Overall Study|Withdrawal by Subject|1|||
155614022|NCT00929994|561680079|FG000|Overall Study|medical issue unrelated to intervention|4|||
155614023|NCT00929994|561680079|FG000|Overall Study|employment|1|||
155614024|NCT00621257|561680080|FG000|Overall Study|Lost to Follow-up|4|||
155614025|NCT00621257|561680081|FG001|Overall Study|Lost to Follow-up|0|||
155614026|NCT00621257|561680082|FG002|Overall Study|Lost to Follow-up|2|||
155614027|NCT00621257|561680083|FG003|Overall Study|Lost to Follow-up|4|||
155614028|NCT00621257|561680084|FG004|Overall Study|Lost to Follow-up|7|||
155614029|NCT00621257|561680080|FG000|Overall Study|Adverse Event|0|||
155614030|NCT00621257|561680081|FG001|Overall Study|Adverse Event|1|||
155614031|NCT00621257|561680082|FG002|Overall Study|Adverse Event|1|||
155614032|NCT00621257|561680083|FG003|Overall Study|Adverse Event|0|||
155614033|NCT00621257|561680084|FG004|Overall Study|Adverse Event|0|||
155614034|NCT00621257|561680080|FG000|Overall Study|Physician Decision|0|||
155726416|NCT02668653|562098124|FG000|Overall Study|Adverse Event|58|||
155614035|NCT00621257|561680081|FG001|Overall Study|Physician Decision|2|||
155614036|NCT00621257|561680082|FG002|Overall Study|Physician Decision|0|||
155614037|NCT00621257|561680083|FG003|Overall Study|Physician Decision|1|||
155614038|NCT00621257|561680084|FG004|Overall Study|Physician Decision|1|||
155614039|NCT00621257|561680080|FG000|Overall Study|Withdrawal by Subject|0|||
155614040|NCT00621257|561680081|FG001|Overall Study|Withdrawal by Subject|0|||
155614041|NCT00621257|561680082|FG002|Overall Study|Withdrawal by Subject|0|||
155614042|NCT00621257|561680083|FG003|Overall Study|Withdrawal by Subject|1|||
155614043|NCT00621257|561680084|FG004|Overall Study|Withdrawal by Subject|1|||
155614044|NCT00184002|561680085|FG000|Overall Study|Adverse Event|9|||
155614045|NCT00184002|561680085|FG000|Overall Study|Death|3|||
155614046|NCT00184002|561680085|FG000|Overall Study|Physician Decision|1|||
155614047|NCT00184002|561680085|FG000|Overall Study|Withdrawal by Subject|4|||
155614048|NCT00694356|561680087|FG000|Overall Study|Adverse Event|1|||
155614049|NCT00694356|561680088|FG001|Overall Study|Adverse Event|0|||
155614050|NCT00694356|561680089|FG002|Overall Study|Adverse Event|0|||
155614051|NCT00694356|561680087|FG000|Overall Study|Progressive Disease|2|||
155614052|NCT00694356|561680088|FG001|Overall Study|Progressive Disease|6|||
155614053|NCT00694356|561680089|FG002|Overall Study|Progressive Disease|6|||
155614054|NCT01042392|561680090|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
155614055|NCT01042392|561680091|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
155614056|NCT01042392|561680092|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
155614057|NCT01042392|561680093|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
155614058|NCT01042392|561680090|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
155614059|NCT01042392|561680091|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155614060|NCT01042392|561680092|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155614061|NCT01042392|561680093|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155614062|NCT01042392|561680090|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
155614063|NCT01042392|561680091|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
155614064|NCT01042392|561680092|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
155614065|NCT01042392|561680093|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
155614066|NCT01042392|561680090|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155614067|NCT01042392|561680091|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155614068|NCT01042392|561680092|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
155614069|NCT01042392|561680093|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155614070|NCT01042392|561680090|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
155614071|NCT01042392|561680091|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155614072|NCT01042392|561680092|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155614073|NCT01042392|561680093|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155614074|NCT01042392|561680090|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155614075|NCT01042392|561680091|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155614076|NCT01042392|561680092|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
155614077|NCT01042392|561680093|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155614078|NCT01042392|561680090|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
155614079|NCT01042392|561680091|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155614080|NCT01042392|561680092|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155266952|NCT00393523|560410929|FG002|Overall Study|Lost to Follow-up|0|||
155266953|NCT00393523|560410930|FG003|Overall Study|Lost to Follow-up|2|||
155614081|NCT01042392|561680093|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155614082|NCT01042392|561680090|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155614083|NCT01042392|561680091|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155614084|NCT01042392|561680092|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
155614085|NCT01042392|561680093|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155614086|NCT01042392|561680090|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
155614087|NCT01042392|561680091|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155614088|NCT01042392|561680092|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155614089|NCT01042392|561680093|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155614090|NCT03117361|561680094|FG000|Overall Study|Progressive disease|5|||
155614091|NCT03117361|561680094|FG000|Overall Study|Death|1|||
155614092|NCT03117361|561680094|FG000|Overall Study|Physician Decision|2|||
155614093|NCT03117361|561680094|FG000|Overall Study|On study treatment at the end of study|1|||
155614094|NCT03117361|561680094|FG000|Overall Study|Treatment-related adverse event|1|||
155614095|NCT00540644|561680095|FG000|Overall Study|Adverse Event|3|||
155614096|NCT00540644|561680096|FG001|Overall Study|Adverse Event|1|||
155614097|NCT00540644|561680095|FG000|Overall Study|Disease Progression|3|||
155614098|NCT00540644|561680096|FG001|Overall Study|Disease Progression|1|||
155614099|NCT00540644|561680095|FG000|Overall Study|Physician Decision|0|||
155614100|NCT00540644|561680096|FG001|Overall Study|Physician Decision|5|||
155614101|NCT00540644|561680095|FG000|Overall Study|Withdrawal by Subject|2|||
155614102|NCT00540644|561680096|FG001|Overall Study|Withdrawal by Subject|2|||
155381699|NCT04617275|560830988|FG004|Treatment Period|Lost to Follow-up|0|||
155614103|NCT00540644|561680095|FG000|Overall Study|Noncomplilance|1|||
155614104|NCT00540644|561680096|FG001|Overall Study|Noncomplilance|0|||
155614105|NCT01869777|561680097|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
155614106|NCT00878800|561680098|FG000|Overall Study|Adverse Event|0|||
155614107|NCT00878800|561680099|FG001|Overall Study|Adverse Event|0|||
155614108|NCT00878800|561680100|FG002|Overall Study|Adverse Event|2|||
155614109|NCT00878800|561680101|FG003|Overall Study|Adverse Event|0|||
155614110|NCT00878800|561680102|FG004|Overall Study|Adverse Event|1|||
155614111|NCT00878800|561680098|FG000|Overall Study|Progressive disease|1|||
155266954|NCT00393523|560410931|FG004|Overall Study|Lost to Follow-up|1|||
155266955|NCT00393523|560410927|FG000|Overall Study|Protocol Violation|6|||
155266956|NCT00393523|560410928|FG001|Overall Study|Protocol Violation|2|||
155266957|NCT00393523|560410929|FG002|Overall Study|Protocol Violation|0|||
155266958|NCT00393523|560410930|FG003|Overall Study|Protocol Violation|1|||
155266959|NCT00393523|560410931|FG004|Overall Study|Protocol Violation|0|||
155266960|NCT00393523|560410927|FG000|Overall Study|Withdrawal by Subject|6|||
155266961|NCT00393523|560410928|FG001|Overall Study|Withdrawal by Subject|7|||
155266962|NCT00393523|560410929|FG002|Overall Study|Withdrawal by Subject|2|||
155266963|NCT00393523|560410930|FG003|Overall Study|Withdrawal by Subject|3|||
155266964|NCT00393523|560410931|FG004|Overall Study|Withdrawal by Subject|0|||
155266965|NCT00393523|560410927|FG000|Overall Study|Difficulties in specimen collection|0|||
155266966|NCT00393523|560410928|FG001|Overall Study|Difficulties in specimen collection|0|||
155266967|NCT00393523|560410929|FG002|Overall Study|Difficulties in specimen collection|1|||
155266968|NCT00393523|560410930|FG003|Overall Study|Difficulties in specimen collection|0|||
155266969|NCT00393523|560410931|FG004|Overall Study|Difficulties in specimen collection|0|||
155266970|NCT00393523|560410927|FG000|Overall Study|Vaccine supply issue|0|||
155266971|NCT00393523|560410928|FG001|Overall Study|Vaccine supply issue|0|||
155266972|NCT00393523|560410929|FG002|Overall Study|Vaccine supply issue|1|||
155266973|NCT00393523|560410930|FG003|Overall Study|Vaccine supply issue|0|||
155266974|NCT00393523|560410931|FG004|Overall Study|Vaccine supply issue|0|||
155266975|NCT04145037|560410937|FG000|Overall Study|Study terminated|2|||
155266976|NCT04145037|560410938|FG001|Overall Study|Study terminated|0|||
155266977|NCT04145037|560410937|FG000|Overall Study|Withdrawal by Subject|1|||
155266978|NCT04145037|560410938|FG001|Overall Study|Withdrawal by Subject|0|||
155266979|NCT04145037|560410937|FG000|Overall Study|Lost to Follow-up|1|||
155266980|NCT04145037|560410938|FG001|Overall Study|Lost to Follow-up|0|||
155266981|NCT00525265|560410943|FG000|Overall Study|Protocol Violation|1|||
155266982|NCT00525265|560410944|FG001|Overall Study|Protocol Violation|0|||
155266983|NCT00098254|560410947|FG000|Overall Study|Adverse Event|2|||
155266984|NCT00098254|560410947|FG000|Overall Study|Death|1|||
155266985|NCT00744263|560410948|FG000|Overall Study|Death|3006|||
155266986|NCT00744263|560410949|FG001|Overall Study|Death|3005|||
155266987|NCT00744263|560410948|FG000|Overall Study|Lost to Follow-up|2038|||
155266988|NCT00744263|560410949|FG001|Overall Study|Lost to Follow-up|2135|||
155266989|NCT00744263|560410948|FG000|Overall Study|Withdrawal by Subject|166|||
155266990|NCT00744263|560410949|FG001|Overall Study|Withdrawal by Subject|150|||
155266991|NCT00744263|560410948|FG000|Overall Study|Physician Decision|20|||
155266992|NCT00744263|560410949|FG001|Overall Study|Physician Decision|23|||
155266993|NCT00744263|560410948|FG000|Overall Study|Protocol Violation|3|||
155266994|NCT00744263|560410949|FG001|Overall Study|Protocol Violation|5|||
155266995|NCT00744263|560410948|FG000|Overall Study|Adverse Event|1|||
155266996|NCT00744263|560410949|FG001|Overall Study|Adverse Event|0|||
155266997|NCT00744263|560410948|FG000|Overall Study|Other|2|||
155266998|NCT00744263|560410949|FG001|Overall Study|Other|2|||
155266999|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
155267000|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
155267001|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
155267002|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
155267003|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
155267004|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
155267005|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
155267006|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
155267007|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
155267008|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
155267009|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
155267010|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
155267011|NCT03500640|560410950|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
155381700|NCT04617275|560830989|FG005|Treatment Period|Lost to Follow-up|3|||
155381701|NCT04617275|560830990|FG006|Treatment Period|Lost to Follow-up|0|||
155267012|NCT03500640|560410951|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
155267013|NCT03500640|560410952|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
155267014|NCT03500640|560410950|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
155267015|NCT03500640|560410951|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
155267016|NCT03500640|560410952|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
155614112|NCT00878800|561680099|FG001|Overall Study|Progressive disease|5|||
155267017|NCT03500640|560410950|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
155267018|NCT03500640|560410951|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
155267019|NCT03500640|560410952|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
155267020|NCT03500640|560410950|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
155267021|NCT03500640|560410951|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
155267022|NCT03500640|560410952|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
155267023|NCT03500640|560410950|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
155614113|NCT00878800|561680100|FG002|Overall Study|Progressive disease|6|||
155614114|NCT00878800|561680101|FG003|Overall Study|Progressive disease|5|||
155614115|NCT00878800|561680102|FG004|Overall Study|Progressive disease|13|||
155614116|NCT00878800|561680098|FG000|Overall Study|Withdrew consent|1|||
155614117|NCT00878800|561680099|FG001|Overall Study|Withdrew consent|1|||
155614118|NCT00878800|561680100|FG002|Overall Study|Withdrew consent|0|||
155614119|NCT00878800|561680101|FG003|Overall Study|Withdrew consent|1|||
155614120|NCT00878800|561680102|FG004|Overall Study|Withdrew consent|1|||
155614121|NCT00878800|561680098|FG000|Overall Study|Death|0|||
155614122|NCT00878800|561680099|FG001|Overall Study|Death|0|||
155614123|NCT00878800|561680100|FG002|Overall Study|Death|1|||
155614124|NCT00878800|561680101|FG003|Overall Study|Death|0|||
155614125|NCT00878800|561680102|FG004|Overall Study|Death|0|||
155614126|NCT00878800|561680098|FG000|Overall Study|Other|1|||
155614127|NCT00878800|561680099|FG001|Overall Study|Other|1|||
155614128|NCT00878800|561680100|FG002|Overall Study|Other|0|||
155614129|NCT00878800|561680101|FG003|Overall Study|Other|0|||
155614130|NCT00878800|561680102|FG004|Overall Study|Other|1|||
155614131|NCT02072941|561680103|FG000|Overall Study|Withdrawal by Subject|29|||
155614132|NCT02072941|561680104|FG001|Overall Study|Withdrawal by Subject|21|||
155614133|NCT02072941|561680103|FG000|Overall Study|Lost to Follow-up|4|||
155614134|NCT02072941|561680104|FG001|Overall Study|Lost to Follow-up|4|||
155614135|NCT02072941|561680103|FG000|Overall Study|Death|3|||
155614136|NCT02072941|561680104|FG001|Overall Study|Death|2|||
155614137|NCT02072941|561680103|FG000|Overall Study|Removed by Study Staff|2|||
155614138|NCT02072941|561680104|FG001|Overall Study|Removed by Study Staff|2|||
155614139|NCT01247350|561680105|FG000|Overall Study|Adverse Event|0|||
155614140|NCT01247350|561680106|FG001|Overall Study|Adverse Event|0|||
155614141|NCT01247350|561680107|FG002|Overall Study|Adverse Event|1|||
155614142|NCT01247350|561680108|FG003|Overall Study|Adverse Event|0|||
155614143|NCT01247350|561680109|FG004|Overall Study|Adverse Event|0|||
155614144|NCT01247350|561680105|FG000|Overall Study|Withdrawal by Subject|0|||
155614145|NCT01247350|561680106|FG001|Overall Study|Withdrawal by Subject|0|||
155614146|NCT01247350|561680107|FG002|Overall Study|Withdrawal by Subject|0|||
155614147|NCT01247350|561680108|FG003|Overall Study|Withdrawal by Subject|1|||
155614148|NCT01247350|561680109|FG004|Overall Study|Withdrawal by Subject|0|||
155614149|NCT01247350|561680105|FG000|Overall Study|Entry criteria not met|0|||
155614150|NCT01247350|561680106|FG001|Overall Study|Entry criteria not met|0|||
155614151|NCT01247350|561680107|FG002|Overall Study|Entry criteria not met|0|||
155614152|NCT01247350|561680108|FG003|Overall Study|Entry criteria not met|0|||
155614153|NCT01247350|561680109|FG004|Overall Study|Entry criteria not met|1|||
155614154|NCT02982863|561680110|FG000|Overall Study|Not eligible patients|809|||
155614155|NCT02982863|561680111|FG001|Overall Study|Not eligible patients|4261|||
155614156|NCT02982863|561680112|FG002|Overall Study|Not eligible patients|1852|||
155614157|NCT02982863|561680113|FG003|Overall Study|Not eligible patients|1400|||
155614158|NCT02982863|561680114|FG004|Overall Study|Not eligible patients|492|||
155614159|NCT02328937|561680117|FG000|Period 1|Lost to Follow-up|0|||
155614160|NCT02328937|561680118|FG001|Period 1|Lost to Follow-up|0|||
155614161|NCT02328937|561680119|FG002|Period 1|Lost to Follow-up|0|||
155614162|NCT02328937|561680120|FG003|Period 1|Lost to Follow-up|1|||
155614163|NCT02328937|561680121|FG004|Period 1|Lost to Follow-up|0|||
155614164|NCT02328937|561680122|FG005|Period 1|Lost to Follow-up|0|||
155614165|NCT02328937|561680117|FG000|Period 2|Adverse Event|0|||
155614166|NCT02328937|561680118|FG001|Period 2|Adverse Event|0|||
155614167|NCT02328937|561680119|FG002|Period 2|Adverse Event|1|||
155614168|NCT02328937|561680120|FG003|Period 2|Adverse Event|0|||
155614169|NCT02328937|561680121|FG004|Period 2|Adverse Event|0|||
155614170|NCT02328937|561680122|FG005|Period 2|Adverse Event|0|||
155614171|NCT00435461|561680123|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
155614172|NCT00435461|561680124|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
155614173|NCT00435461|561680125|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
155614174|NCT00435461|561680123|FG000|Overall Study|Protocol Violation|6|||
155614175|NCT00435461|561680124|FG001|Overall Study|Protocol Violation|9|||
155614176|NCT00435461|561680125|FG002|Overall Study|Protocol Violation|10|||
155614177|NCT00435461|561680123|FG000|Overall Study|Participant randomized(inadequate score)|1|||
155614178|NCT00435461|561680124|FG001|Overall Study|Participant randomized(inadequate score)|0|||
155614179|NCT00435461|561680125|FG002|Overall Study|Participant randomized(inadequate score)|0|||
155614180|NCT00435461|561680123|FG000|Overall Study|Compliance less than 80 percent|1|||
155614181|NCT00435461|561680124|FG001|Overall Study|Compliance less than 80 percent|0|||
155614182|NCT00435461|561680125|FG002|Overall Study|Compliance less than 80 percent|0|||
155726417|NCT02668653|562098125|FG001|Overall Study|Adverse Event|23|||
155614183|NCT00435461|561680123|FG000|Overall Study|In error, two study medications switched|1|||
155614184|NCT00435461|561680124|FG001|Overall Study|In error, two study medications switched|0|||
155614185|NCT00435461|561680125|FG002|Overall Study|In error, two study medications switched|0|||
155614186|NCT00435461|561680123|FG000|Overall Study|Lack of Efficacy|2|||
155614187|NCT00435461|561680124|FG001|Overall Study|Lack of Efficacy|1|||
155614188|NCT00435461|561680125|FG002|Overall Study|Lack of Efficacy|0|||
155614189|NCT00435461|561680123|FG000|Overall Study|Withdrawal by Subject|1|||
155614190|NCT00435461|561680124|FG001|Overall Study|Withdrawal by Subject|0|||
155614191|NCT00435461|561680125|FG002|Overall Study|Withdrawal by Subject|2|||
155614192|NCT00435461|561680123|FG000|Overall Study|Randomized in error|1|||
155614193|NCT00435461|561680124|FG001|Overall Study|Randomized in error|0|||
155614194|NCT00435461|561680125|FG002|Overall Study|Randomized in error|0|||
155614195|NCT00435461|561680123|FG000|Overall Study|Participant could not tolerate symptoms|0|||
155614196|NCT00435461|561680124|FG001|Overall Study|Participant could not tolerate symptoms|0|||
155614197|NCT00435461|561680125|FG002|Overall Study|Participant could not tolerate symptoms|1|||
155614198|NCT00435461|561680123|FG000|Overall Study|Participant could not swallow capsule|0|||
155614199|NCT00435461|561680124|FG001|Overall Study|Participant could not swallow capsule|0|||
155614200|NCT00435461|561680125|FG002|Overall Study|Participant could not swallow capsule|1|||
155614201|NCT00435461|561680123|FG000|Overall Study|Pregnancy|2|||
155614202|NCT00435461|561680124|FG001|Overall Study|Pregnancy|0|||
155614203|NCT00435461|561680125|FG002|Overall Study|Pregnancy|0|||
155614204|NCT00435461|561680123|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
155614205|NCT00435461|561680124|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
155614206|NCT00435461|561680125|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
155614207|NCT00435461|561680123|FG000|Overall Study|Participant ended study one day early|1|||
155614208|NCT00435461|561680124|FG001|Overall Study|Participant ended study one day early|0|||
155614209|NCT00435461|561680125|FG002|Overall Study|Participant ended study one day early|0|||
155614210|NCT00435461|561680123|FG000|Overall Study|Noncompliance with study requirements|1|||
155614211|NCT00435461|561680124|FG001|Overall Study|Noncompliance with study requirements|1|||
155614212|NCT00435461|561680125|FG002|Overall Study|Noncompliance with study requirements|1|||
155614213|NCT00435461|561680123|FG000|Overall Study|Adverse Event|1|||
155614214|NCT00435461|561680124|FG001|Overall Study|Adverse Event|2|||
155614215|NCT00435461|561680125|FG002|Overall Study|Adverse Event|6|||
155614216|NCT00435461|561680123|FG000|Overall Study|Non-Compliance of diary|2|||
155614217|NCT00435461|561680124|FG001|Overall Study|Non-Compliance of diary|0|||
155614218|NCT00435461|561680125|FG002|Overall Study|Non-Compliance of diary|1|||
155614219|NCT00435461|561680123|FG000|Overall Study|Lost to Follow-up|1|||
155614220|NCT00435461|561680124|FG001|Overall Study|Lost to Follow-up|1|||
155614221|NCT00435461|561680125|FG002|Overall Study|Lost to Follow-up|2|||
155614222|NCT01768559|561680126|FG000|Overall Study|Randomized but not treated|0|||
155614223|NCT01768559|561680127|FG001|Overall Study|Randomized but not treated|0|||
155614224|NCT01768559|561680128|FG002|Overall Study|Randomized but not treated|1|||
155614225|NCT01768559|561680126|FG000|Overall Study|Adverse Event|15|||
155614226|NCT01768559|561680127|FG001|Overall Study|Adverse Event|2|||
155614227|NCT01768559|561680128|FG002|Overall Study|Adverse Event|5|||
155614228|NCT01768559|561680126|FG000|Overall Study|Lack of Efficacy|6|||
155614229|NCT01768559|561680127|FG001|Overall Study|Lack of Efficacy|4|||
155614230|NCT01768559|561680128|FG002|Overall Study|Lack of Efficacy|0|||
155614231|NCT01768559|561680126|FG000|Overall Study|Poor compliance to protocol|0|||
155614232|NCT01768559|561680127|FG001|Overall Study|Poor compliance to protocol|3|||
155614233|NCT01768559|561680128|FG002|Overall Study|Poor compliance to protocol|2|||
155614234|NCT01768559|561680126|FG000|Overall Study|Other than specified|9|||
155614235|NCT01768559|561680127|FG001|Overall Study|Other than specified|8|||
155614236|NCT01768559|561680128|FG002|Overall Study|Other than specified|5|||
155614237|NCT00237692|561680131|FG000|Overall Study|Lost to Follow-up|9|||
155614238|NCT00237692|561680132|FG001|Overall Study|Lost to Follow-up|3|||
155614239|NCT00237692|561680133|FG002|Overall Study|Lost to Follow-up|5|||
155614240|NCT00237692|561680134|FG003|Overall Study|Lost to Follow-up|3|||
155614241|NCT00237692|561680131|FG000|Overall Study|Death|1|||
155614242|NCT00237692|561680132|FG001|Overall Study|Death|2|||
155614243|NCT00237692|561680133|FG002|Overall Study|Death|2|||
155267024|NCT03500640|560410951|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
155267025|NCT03500640|560410952|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
155267026|NCT03500640|560410950|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
155267027|NCT03500640|560410951|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
155614244|NCT00237692|561680134|FG003|Overall Study|Death|3|||
155614245|NCT00237692|561680131|FG000|Overall Study|Excluded - did not meet criteria|4|||
155614246|NCT00237692|561680132|FG001|Overall Study|Excluded - did not meet criteria|3|||
155614247|NCT00237692|561680133|FG002|Overall Study|Excluded - did not meet criteria|5|||
155614248|NCT00237692|561680134|FG003|Overall Study|Excluded - did not meet criteria|9|||
155614249|NCT00237692|561680131|FG000|Overall Study|Withdrawal by Subject|4|||
155267028|NCT03500640|560410952|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
155267029|NCT00661661|560410958|FG000|Overall Study|Adverse Event|99|||
155614250|NCT00237692|561680132|FG001|Overall Study|Withdrawal by Subject|6|||
155614251|NCT00237692|561680133|FG002|Overall Study|Withdrawal by Subject|10|||
155614252|NCT00237692|561680134|FG003|Overall Study|Withdrawal by Subject|4|||
155614253|NCT01737879|561680135|FG000|Overall Study|Death|1|||
155614254|NCT01737879|561680135|FG000|Overall Study|Sponsor decision|40|||
155614255|NCT01386944|561680142|FG000|Overall Study|Adverse Event|26|||
155614256|NCT01386944|561680142|FG000|Overall Study|Lack of Efficacy|14|||
155614257|NCT01386944|561680142|FG000|Overall Study|Lost to Follow-up|8|||
155614258|NCT01386944|561680142|FG000|Overall Study|Unspecified reason|8|||
155614259|NCT03883477|561680143|FG000|Overall Study|Death|1|||
155614260|NCT03883477|561680144|FG001|Overall Study|Death|0|||
155614261|NCT03883477|561680143|FG000|Overall Study|Protocol Violation|0|||
155614262|NCT03883477|561680144|FG001|Overall Study|Protocol Violation|1|||
155614263|NCT04186221|561680145|FG000|Overall Study|Death|1|||
155614264|NCT00531947|561680146|FG000|Overall Study|Adverse Event|5|||
155614265|NCT00531947|561680147|FG001|Overall Study|Adverse Event|10|||
155614266|NCT00531947|561680146|FG000|Overall Study|Lost to Follow-up|12|||
155614267|NCT00531947|561680147|FG001|Overall Study|Lost to Follow-up|9|||
155614268|NCT00531947|561680146|FG000|Overall Study|Withdrawal by Subject|14|||
155614269|NCT00531947|561680147|FG001|Overall Study|Withdrawal by Subject|19|||
155614270|NCT00531947|561680146|FG000|Overall Study|Protocol Violation|2|||
155614271|NCT00531947|561680147|FG001|Overall Study|Protocol Violation|1|||
155614272|NCT00531947|561680146|FG000|Overall Study|Non-Compliance|4|||
155614273|NCT00531947|561680147|FG001|Overall Study|Non-Compliance|7|||
155614274|NCT00531947|561680146|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
155614275|NCT00531947|561680147|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
155614276|NCT02348008|561680156|FG000|Overall Study|Adverse Event|2|||
155614277|NCT02348008|561680157|FG001|Overall Study|Adverse Event|3|||
155614278|NCT02348008|561680158|FG002|Overall Study|Adverse Event|3|||
155614279|NCT02348008|561680156|FG000|Overall Study|Disease Progression|1|||
155614280|NCT02348008|561680157|FG001|Overall Study|Disease Progression|5|||
155614281|NCT02348008|561680158|FG002|Overall Study|Disease Progression|16|||
155614282|NCT02348008|561680156|FG000|Overall Study|Withdrawal by Subject|0|||
155614283|NCT02348008|561680157|FG001|Overall Study|Withdrawal by Subject|1|||
155614284|NCT02348008|561680158|FG002|Overall Study|Withdrawal by Subject|0|||
155614285|NCT02348008|561680156|FG000|Overall Study|Symptomatic Deterioration|0|||
155614286|NCT02348008|561680157|FG001|Overall Study|Symptomatic Deterioration|1|||
155614287|NCT02348008|561680158|FG002|Overall Study|Symptomatic Deterioration|0|||
155614288|NCT04399538|561680159|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
155614289|NCT04399538|561680160|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
155614290|NCT04399538|561680161|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
155614291|NCT04399538|561680162|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
155614292|NCT04399538|561680163|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
155614293|NCT04399538|561680159|FG000|Double-Blind Treatment|Adverse Event|0|||
155614294|NCT04399538|561680160|FG001|Double-Blind Treatment|Adverse Event|0|||
155614295|NCT04399538|561680161|FG002|Double-Blind Treatment|Adverse Event|0|||
155614296|NCT04399538|561680162|FG003|Double-Blind Treatment|Adverse Event|0|||
155614297|NCT04399538|561680163|FG004|Double-Blind Treatment|Adverse Event|1|||
155614298|NCT04399538|561680159|FG000|Follow-Up|Adverse Event|0|||
155614299|NCT04399538|561680160|FG001|Follow-Up|Adverse Event|0|||
155614300|NCT04399538|561680161|FG002|Follow-Up|Adverse Event|0|||
155614301|NCT04399538|561680162|FG003|Follow-Up|Adverse Event|0|||
155614302|NCT04399538|561680163|FG004|Follow-Up|Adverse Event|1|||
155614303|NCT04399538|561680159|FG000|Follow-Up|Withdrawal by Subject|0|||
155614304|NCT04399538|561680160|FG001|Follow-Up|Withdrawal by Subject|0|||
155267030|NCT00661661|560410959|FG001|Overall Study|Adverse Event|24|||
155614305|NCT04399538|561680161|FG002|Follow-Up|Withdrawal by Subject|0|||
155614306|NCT04399538|561680162|FG003|Follow-Up|Withdrawal by Subject|2|||
155267031|NCT00661661|560410958|FG000|Overall Study|Lack of Efficacy|3|||
155267032|NCT00661661|560410959|FG001|Overall Study|Lack of Efficacy|2|||
155267033|NCT00661661|560410958|FG000|Overall Study|Lost to Follow-up|0|||
155267034|NCT00661661|560410959|FG001|Overall Study|Lost to Follow-up|1|||
155267035|NCT00661661|560410958|FG000|Overall Study|Withdrawal by Subject|15|||
155267036|NCT00661661|560410959|FG001|Overall Study|Withdrawal by Subject|5|||
155267037|NCT00661661|560410958|FG000|Overall Study|Other|22|||
155267038|NCT00661661|560410959|FG001|Overall Study|Other|7|||
155267039|NCT00661661|560410958|FG000|Overall Study|Not assigned treatment|1|||
155614307|NCT04399538|561680163|FG004|Follow-Up|Withdrawal by Subject|0|||
155614308|NCT01588405|561680165|FG000|Overall Study|Adverse Event|1|||
155614309|NCT01588405|561680165|FG000|Overall Study|Clinical Worsening|1|||
155614310|NCT03268005|561680166|FG000|Overall Study|Death|2|||
155614311|NCT03268005|561680167|FG001|Overall Study|Death|1|||
155614312|NCT03268005|561680166|FG000|Overall Study|Lost to Follow-up|2|||
155267040|NCT00661661|560410959|FG001|Overall Study|Not assigned treatment|0|||
155267041|NCT04512066|560410960|FG000|Double-blind Treatment Period|Adverse Event|6|||
155614313|NCT03268005|561680167|FG001|Overall Study|Lost to Follow-up|2|||
155614314|NCT03268005|561680166|FG000|Overall Study|Withdrawal by Subject|11|||
155614315|NCT03268005|561680167|FG001|Overall Study|Withdrawal by Subject|11|||
155614316|NCT01926197|561680169|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
155614317|NCT01926197|561680170|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
155614318|NCT01926197|561680169|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
155267042|NCT04512066|560410961|FG001|Double-blind Treatment Period|Adverse Event|4|||
155267043|NCT04512066|560410962|FG002|Double-blind Treatment Period|Adverse Event|5|||
155267044|NCT04512066|560410963|FG003|Double-blind Treatment Period|Adverse Event|1|||
155267045|NCT04512066|560410964|FG004|Double-blind Treatment Period|Adverse Event|0|||
155267046|NCT04512066|560410965|FG005|Double-blind Treatment Period|Adverse Event|0|||
155267047|NCT04512066|560410960|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
155614319|NCT01926197|561680170|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
155614320|NCT02756364|561680172|FG000|Overall Study|Site Terminated by Sponsor|24|||
155614321|NCT02756364|561680173|FG001|Overall Study|Site Terminated by Sponsor|30|||
155614322|NCT02756364|561680174|FG002|Overall Study|Site Terminated by Sponsor|21|||
155614323|NCT02756364|561680172|FG000|Overall Study|Death|20|||
155614324|NCT02756364|561680173|FG001|Overall Study|Death|15|||
155614325|NCT02756364|561680174|FG002|Overall Study|Death|18|||
155614326|NCT02756364|561680172|FG000|Overall Study|Withdrawal by Patient|2|||
155614327|NCT02756364|561680173|FG001|Overall Study|Withdrawal by Patient|1|||
155614328|NCT02756364|561680174|FG002|Overall Study|Withdrawal by Patient|8|||
155614329|NCT02756364|561680172|FG000|Overall Study|Lost to Follow-up|0|||
155614330|NCT02756364|561680173|FG001|Overall Study|Lost to Follow-up|1|||
155614331|NCT02756364|561680174|FG002|Overall Study|Lost to Follow-up|1|||
155614332|NCT02223364|561680175|FG000|Overall Study|Protocol Violation|3|||
155614333|NCT02223364|561680176|FG001|Overall Study|Protocol Violation|0|||
155614334|NCT02223364|561680177|FG002|Overall Study|Protocol Violation|3|||
155614335|NCT02223364|561680175|FG000|Overall Study|subject expired before surgery|1|||
155614336|NCT02223364|561680176|FG001|Overall Study|subject expired before surgery|0|||
155614337|NCT02223364|561680177|FG002|Overall Study|subject expired before surgery|0|||
155614338|NCT02223364|561680175|FG000|Overall Study|Physician Decision|1|||
155614339|NCT02223364|561680176|FG001|Overall Study|Physician Decision|0|||
155614340|NCT02223364|561680177|FG002|Overall Study|Physician Decision|0|||
155614341|NCT02984267|561680178|FG000|Overall Study|Protocol Violation|1|||
155614342|NCT02984267|561680179|FG001|Overall Study|Protocol Violation|0|||
155614343|NCT02984267|561680178|FG000|Overall Study|Withdrawal by Subject|0|||
155614344|NCT02984267|561680179|FG001|Overall Study|Withdrawal by Subject|1|||
155614345|NCT04811664|561680181|FG000|Overall Study|Lost to Follow-up|78|||
155614346|NCT04811664|561680182|FG001|Overall Study|Lost to Follow-up|125|||
155614347|NCT04811664|561680183|FG002|Overall Study|Lost to Follow-up|46|||
155614348|NCT04811664|561680181|FG000|Overall Study|Withdrawal by Subject|39|||
155614349|NCT04811664|561680182|FG001|Overall Study|Withdrawal by Subject|76|||
155614350|NCT04811664|561680183|FG002|Overall Study|Withdrawal by Subject|12|||
155614351|NCT04811664|561680181|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
155614352|NCT04811664|561680182|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
155614353|NCT04811664|561680183|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
155614354|NCT04811664|561680181|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
155614355|NCT04811664|561680182|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
155614356|NCT04811664|561680183|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
155614357|NCT04811664|561680181|FG000|Overall Study|Protocol Violation|0|||
155614358|NCT04811664|561680182|FG001|Overall Study|Protocol Violation|5|||
155614359|NCT04811664|561680183|FG002|Overall Study|Protocol Violation|11|||
155614360|NCT04811664|561680181|FG000|Overall Study|Study Terminated by Sponsor|4|||
155614361|NCT04811664|561680182|FG001|Overall Study|Study Terminated by Sponsor|3|||
155614362|NCT04811664|561680183|FG002|Overall Study|Study Terminated by Sponsor|34|||
155614363|NCT04811664|561680181|FG000|Overall Study|Early Study Closure|3|||
155614364|NCT04811664|561680182|FG001|Overall Study|Early Study Closure|7|||
155614365|NCT04811664|561680183|FG002|Overall Study|Early Study Closure|79|||
155614366|NCT04811664|561680181|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
155614367|NCT04811664|561680182|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
155614368|NCT04811664|561680183|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
155614369|NCT02717442|561680184|FG000|Overall Study|Study Terminated by Sponsor|31|||
155614370|NCT02717442|561680185|FG001|Overall Study|Study Terminated by Sponsor|29|||
155614371|NCT02717442|561680184|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
155614372|NCT02717442|561680185|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
155614373|NCT02717442|561680184|FG000|Overall Study|Other - Not Specified|2|||
155614374|NCT02717442|561680185|FG001|Overall Study|Other - Not Specified|0|||
155614375|NCT00802672|561682910|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
155614376|NCT00802672|561682911|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
155614377|NCT00802672|561682912|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
155614378|NCT00802672|561682910|FG000|Overall Study|Adverse Event|1|||
155267048|NCT04512066|560410961|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
155267049|NCT04512066|560410962|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
155614379|NCT00802672|561682911|FG001|Overall Study|Adverse Event|1|||
155614380|NCT00802672|561682912|FG002|Overall Study|Adverse Event|1|||
155614381|NCT00802672|561682910|FG000|Overall Study|Protocol Violation|2|||
155614382|NCT00802672|561682911|FG001|Overall Study|Protocol Violation|1|||
155614383|NCT00802672|561682912|FG002|Overall Study|Protocol Violation|1|||
155614384|NCT00802672|561682910|FG000|Overall Study|Lost to Follow-up|5|||
155614385|NCT00802672|561682911|FG001|Overall Study|Lost to Follow-up|5|||
155614386|NCT00802672|561682912|FG002|Overall Study|Lost to Follow-up|3|||
155614387|NCT00802672|561682910|FG000|Overall Study|Withdrawal by Subject|1|||
155614388|NCT00802672|561682911|FG001|Overall Study|Withdrawal by Subject|1|||
155614389|NCT00802672|561682912|FG002|Overall Study|Withdrawal by Subject|2|||
155614390|NCT00802672|561682910|FG000|Overall Study|other|3|||
155614391|NCT00802672|561682911|FG001|Overall Study|other|1|||
155614392|NCT00802672|561682912|FG002|Overall Study|other|2|||
155614393|NCT04441788|561682914|FG000|Overall Study|Voluntary Withdrawl|0|||
155614394|NCT04441788|561682915|FG001|Overall Study|Voluntary Withdrawl|1|||
155614395|NCT04441788|561682916|FG002|Overall Study|Voluntary Withdrawl|0|||
155614396|NCT04441788|561682914|FG000|Overall Study|Ineligibility|1|||
155614397|NCT04441788|561682915|FG001|Overall Study|Ineligibility|0|||
155614398|NCT04441788|561682916|FG002|Overall Study|Ineligibility|0|||
155614399|NCT04441788|561682914|FG000|Overall Study|Adverse Event|0|||
155614400|NCT04441788|561682915|FG001|Overall Study|Adverse Event|0|||
155614401|NCT04441788|561682916|FG002|Overall Study|Adverse Event|4|||
155614402|NCT04441788|561682914|FG000|Overall Study|Study Terminated by Sponsor|16|||
155614403|NCT04441788|561682915|FG001|Overall Study|Study Terminated by Sponsor|16|||
155614404|NCT04441788|561682916|FG002|Overall Study|Study Terminated by Sponsor|12|||
155614405|NCT03859648|561682919|FG000|Overall Study|Lost to Follow-up|1|||
155614406|NCT03859648|561682919|FG000|Overall Study|Adverse Event|1|||
155614407|NCT02315664|561682920|FG000|Overall Study|Lost to Follow-up|1|||
155614408|NCT02315664|561682921|FG001|Overall Study|Lost to Follow-up|1|||
155614409|NCT02315664|561682920|FG000|Overall Study|Withdrawal by Subject|0|||
155614410|NCT02315664|561682921|FG001|Overall Study|Withdrawal by Subject|3|||
155614411|NCT00667992|561682926|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
155614412|NCT00667992|561682927|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
155614413|NCT00667992|561682926|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
155614414|NCT00667992|561682927|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
155614415|NCT00667992|561682926|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155614416|NCT00667992|561682927|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155614417|NCT00667992|561682926|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
155614418|NCT00667992|561682927|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
155614419|NCT00667992|561682926|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155614420|NCT00667992|561682927|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155614421|NCT00667992|561682926|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
155614422|NCT00667992|561682927|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
155614423|NCT00667992|561682926|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
155267050|NCT04512066|560410963|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
155267051|NCT04512066|560410964|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
155267052|NCT04512066|560410965|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
155267053|NCT04512066|560410960|FG000|Double-blind Treatment Period|Physician Decision|1|||
155267054|NCT04512066|560410961|FG001|Double-blind Treatment Period|Physician Decision|0|||
155267055|NCT04512066|560410962|FG002|Double-blind Treatment Period|Physician Decision|1|||
155614424|NCT00667992|561682927|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
155614425|NCT00667992|561682926|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
155614426|NCT00667992|561682927|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
155614427|NCT00667992|561682926|FG000|Wash-out|Not within one doubling dilution|4|||
155614428|NCT00667992|561682927|FG001|Wash-out|Not within one doubling dilution|3|||
155614429|NCT00667992|561682926|FG000|Wash-out|Failure to wash-out|2|||
155614430|NCT00667992|561682927|FG001|Wash-out|Failure to wash-out|2|||
155614431|NCT00667992|561682926|FG000|Wash-out|Withdrawal by Subject|1|||
155614432|NCT00667992|561682927|FG001|Wash-out|Withdrawal by Subject|0|||
155614433|NCT00667992|561682926|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
155614434|NCT00667992|561682927|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
155614435|NCT00667992|561682926|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155614436|NCT00667992|561682927|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155614437|NCT04336475|561682928|FG000|Overall Study|pain|1|||
155614438|NCT04336475|561682929|FG001|Overall Study|pain|0|||
155614439|NCT04336475|561682928|FG000|Overall Study|upper respiratory infection|1|||
155614440|NCT04336475|561682929|FG001|Overall Study|upper respiratory infection|0|||
155614441|NCT04336475|561682928|FG000|Overall Study|Lost to Follow-up|0|||
155614442|NCT04336475|561682929|FG001|Overall Study|Lost to Follow-up|2|||
155614443|NCT02489448|561682932|FG000|Overall Study|Death|3|||
155614444|NCT02489448|561682932|FG000|Overall Study|Withdrawal by Subject|2|||
155614445|NCT02793947|561682940|FG000|Overall Study|Death|1|||
155614446|NCT02793947|561682941|FG001|Overall Study|Death|0|||
155614447|NCT02793947|561682940|FG000|Overall Study|Physician Decision|1|||
155614448|NCT02793947|561682941|FG001|Overall Study|Physician Decision|5|||
155614449|NCT02213380|561682945|FG000|Underwent Randomization|Withdrawal by Subject|2|||
155614450|NCT02213380|561682946|FG001|Underwent Randomization|Withdrawal by Subject|0|||
155614451|NCT02213380|561682945|FG000|Underwent Randomization|Not treated|3|||
155267056|NCT04512066|560410963|FG003|Double-blind Treatment Period|Physician Decision|0|||
155614452|NCT02213380|561682946|FG001|Underwent Randomization|Not treated|3|||
155614453|NCT02213380|561682945|FG000|Per-protocol Analysis|Protocol Violation|32|||
155614454|NCT02213380|561682946|FG001|Per-protocol Analysis|Protocol Violation|36|||
155614455|NCT01310127|561682950|FG000|Overall Study|Protocol Violation|1|||
155614456|NCT01310127|561682951|FG001|Overall Study|Protocol Violation|1|||
155614457|NCT01310127|561682950|FG000|Overall Study|advanced psc cataract outlier|1|||
155614458|NCT01310127|561682951|FG001|Overall Study|advanced psc cataract outlier|0|||
155614459|NCT01490840|561682952|FG000|Phase 1|Lost to Follow-up|1|||
155614460|NCT01490840|561682953|FG001|Phase 1|Lost to Follow-up|0|||
155614461|NCT01490840|561682952|FG000|Phase 1|Adverse Event|2|||
155614462|NCT01490840|561682953|FG001|Phase 1|Adverse Event|1|||
155614463|NCT01490840|561682952|FG000|Phase 1|Withdrawal by Subject|6|||
155614464|NCT01490840|561682953|FG001|Phase 1|Withdrawal by Subject|5|||
155614465|NCT01490840|561682952|FG000|Phase 1|Visit 6a omitted|1|||
155614466|NCT01490840|561682953|FG001|Phase 1|Visit 6a omitted|0|||
155614467|NCT01490840|561682952|FG000|Phase 2|Withdrawal by Subject|4|||
155614468|NCT01490840|561682953|FG001|Phase 2|Withdrawal by Subject|3|||
155614469|NCT01490840|561682952|FG000|Phase 2|Permanent interruption of fingolimod|0|||
155614470|NCT01490840|561682953|FG001|Phase 2|Permanent interruption of fingolimod|1|||
155614471|NCT01490840|561682952|FG000|Phase 2|Lost to Follow-up|1|||
155614472|NCT01490840|561682953|FG001|Phase 2|Lost to Follow-up|1|||
155614473|NCT01490840|561682952|FG000|Phase 2|Adverse Event|1|||
155614474|NCT01490840|561682953|FG001|Phase 2|Adverse Event|1|||
155614475|NCT01025284|561682957|FG000|Overall Study|Investigator Decision|0|||
155614476|NCT01025284|561682958|FG001|Overall Study|Investigator Decision|1|||
155614477|NCT01025284|561682959|FG002|Overall Study|Investigator Decision|0|||
155614478|NCT01025284|561682957|FG000|Overall Study|Withdrawal by Subject|0|||
155614479|NCT01025284|561682958|FG001|Overall Study|Withdrawal by Subject|1|||
155614480|NCT01025284|561682959|FG002|Overall Study|Withdrawal by Subject|0|||
155614481|NCT01465230|561682960|FG000|Overall Study|Withdrawal by Subject|2|||
155614482|NCT02542397|561682962|FG000|Overall Study|Death|2|||
155614483|NCT02542397|561682962|FG000|Overall Study|Physician Decision|6|||
155614484|NCT02542397|561682962|FG000|Overall Study|Withdrawal by Subject|6|||
155614485|NCT02542397|561682962|FG000|Overall Study|Lost to Follow-up|2|||
155614486|NCT01738919|561682967|FG000|Overall Study|Lost to Follow-up|1|||
155614487|NCT01738919|561682968|FG001|Overall Study|Lost to Follow-up|0|||
155614488|NCT01738919|561682967|FG000|Overall Study|Immigrated|0|||
155614489|NCT01738919|561682968|FG001|Overall Study|Immigrated|1|||
155614490|NCT01738919|561682967|FG000|Overall Study|Withdrawal by Subject|0|||
155614491|NCT01738919|561682968|FG001|Overall Study|Withdrawal by Subject|1|||
155614492|NCT01738919|561682967|FG000|Overall Study|Not treated in accordance to guidelines|0|||
155614493|NCT01738919|561682968|FG001|Overall Study|Not treated in accordance to guidelines|1|||
155614494|NCT00547248|561682969|FG000|Overall Study|Protocol Violation|0|||
155614495|NCT00547248|561682970|FG001|Overall Study|Protocol Violation|0|||
155614496|NCT00547248|561682971|FG002|Overall Study|Protocol Violation|1|||
155614497|NCT00547248|561682972|FG003|Overall Study|Protocol Violation|1|||
155614498|NCT00547248|561682969|FG000|Overall Study|Migrated/moved from study area|0|||
155614499|NCT00547248|561682970|FG001|Overall Study|Migrated/moved from study area|0|||
155614500|NCT00547248|561682971|FG002|Overall Study|Migrated/moved from study area|2|||
155614501|NCT00547248|561682972|FG003|Overall Study|Migrated/moved from study area|0|||
155614502|NCT00547248|561682969|FG000|Overall Study|Withdrawal by Subject|0|||
155614503|NCT00547248|561682970|FG001|Overall Study|Withdrawal by Subject|0|||
155614504|NCT00547248|561682971|FG002|Overall Study|Withdrawal by Subject|7|||
155614505|NCT00547248|561682972|FG003|Overall Study|Withdrawal by Subject|1|||
155267057|NCT04512066|560410964|FG004|Double-blind Treatment Period|Physician Decision|0|||
155267058|NCT04512066|560410965|FG005|Double-blind Treatment Period|Physician Decision|0|||
155267059|NCT04512066|560410960|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
155267060|NCT04512066|560410961|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
155513994|NCT02611752|561308216|FG000|Overall Study|Adverse Event|0|||
155513995|NCT02611752|561308217|FG001|Overall Study|Adverse Event|1|||
155513996|NCT01214330|561308218|FG000|Overall Study|Withdrawal by Subject|2|||
155513997|NCT01214330|561308218|FG000|Overall Study|Withdrawal by Subject|2|||
155513998|NCT00249821|561308219|FG000|Overall Study|Technical problem|0|||
155513999|NCT00249821|561308220|FG001|Overall Study|Technical problem|1|||
155514000|NCT01411995|561308221|FG000|Overall Study|Failed IUD insertion|0|||
155514001|NCT01411995|561308222|FG001|Overall Study|Failed IUD insertion|1|||
155514002|NCT01185288|561308223|FG000|Overall Study|Adverse Event|7|||
155514003|NCT01185288|561308224|FG001|Overall Study|Adverse Event|6|||
155514004|NCT01185288|561308223|FG000|Overall Study|Withdrawal by Subject|6|||
155514005|NCT01185288|561308224|FG001|Overall Study|Withdrawal by Subject|4|||
155514006|NCT01185288|561308223|FG000|Overall Study|Lost to Follow-up|2|||
155514007|NCT01185288|561308224|FG001|Overall Study|Lost to Follow-up|5|||
155514008|NCT01185288|561308223|FG000|Overall Study|Lack of Efficacy|2|||
155514009|NCT01185288|561308224|FG001|Overall Study|Lack of Efficacy|0|||
155514010|NCT01185288|561308223|FG000|Overall Study|Investigator discretion|1|||
155514011|NCT01185288|561308224|FG001|Overall Study|Investigator discretion|0|||
155614506|NCT02090283|561682975|FG000|Overall Study|Withdrawal by Subject|6|||
155614507|NCT02090283|561682976|FG001|Overall Study|Withdrawal by Subject|6|||
155614508|NCT02090283|561682977|FG002|Overall Study|Withdrawal by Subject|6|||
155614509|NCT02090283|561682975|FG000|Overall Study|Sponsor Terminated Study|6|||
155614510|NCT02090283|561682976|FG001|Overall Study|Sponsor Terminated Study|6|||
155614511|NCT02090283|561682977|FG002|Overall Study|Sponsor Terminated Study|1|||
155614512|NCT02090283|561682975|FG000|Overall Study|Lost to Follow-up|2|||
155614513|NCT02090283|561682976|FG001|Overall Study|Lost to Follow-up|2|||
155614514|NCT02090283|561682977|FG002|Overall Study|Lost to Follow-up|3|||
155614515|NCT02090283|561682975|FG000|Overall Study|Adverse Event|1|||
155614516|NCT02090283|561682976|FG001|Overall Study|Adverse Event|1|||
155614517|NCT02090283|561682977|FG002|Overall Study|Adverse Event|0|||
155614518|NCT02090283|561682975|FG000|Overall Study|Protocol Violation|2|||
155614519|NCT02090283|561682976|FG001|Overall Study|Protocol Violation|0|||
155614520|NCT02090283|561682977|FG002|Overall Study|Protocol Violation|0|||
155614521|NCT00697593|561682979|FG000|Overall Study|Adverse Event|3|||
155614522|NCT00697593|561682979|FG000|Overall Study|Protocol Violation|1|||
155614523|NCT00697593|561682979|FG000|Overall Study|Lack of Efficacy|3|||
155614524|NCT00697593|561682979|FG000|Overall Study|Suspension of the study by sponsor|12|||
155614525|NCT00685360|561682980|FG000|Overall Study|Lost to Follow-up|0|||
155614526|NCT00685360|561682981|FG001|Overall Study|Lost to Follow-up|1|||
155614527|NCT00685360|561682982|FG002|Overall Study|Lost to Follow-up|2|||
155614528|NCT00685360|561682980|FG000|Overall Study|Adverse Event|4|||
155267061|NCT04512066|560410962|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
155267062|NCT04512066|560410963|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
155267063|NCT04512066|560410964|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155267064|NCT04512066|560410965|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
155267065|NCT04512066|560410960|FG000|Extension Period|Adverse Event|0|||
155267066|NCT04512066|560410961|FG001|Extension Period|Adverse Event|1|||
155267067|NCT04512066|560410962|FG002|Extension Period|Adverse Event|4|||
155267068|NCT04512066|560410963|FG003|Extension Period|Adverse Event|3|||
155267069|NCT04512066|560410964|FG004|Extension Period|Adverse Event|1|||
155267070|NCT04512066|560410965|FG005|Extension Period|Adverse Event|3|||
155267071|NCT04512066|560410960|FG000|Extension Period|Death|0|||
155267072|NCT04512066|560410961|FG001|Extension Period|Death|0|||
155267073|NCT04512066|560410962|FG002|Extension Period|Death|0|||
155267074|NCT04512066|560410963|FG003|Extension Period|Death|0|||
155267075|NCT04512066|560410964|FG004|Extension Period|Death|0|||
155267076|NCT04512066|560410965|FG005|Extension Period|Death|1|||
155267077|NCT04512066|560410960|FG000|Extension Period|Lack of Efficacy|0|||
155267078|NCT04512066|560410961|FG001|Extension Period|Lack of Efficacy|4|||
155267079|NCT04512066|560410962|FG002|Extension Period|Lack of Efficacy|4|||
155267080|NCT04512066|560410963|FG003|Extension Period|Lack of Efficacy|1|||
155267081|NCT04512066|560410964|FG004|Extension Period|Lack of Efficacy|3|||
155267082|NCT04512066|560410965|FG005|Extension Period|Lack of Efficacy|3|||
155267083|NCT04512066|560410960|FG000|Extension Period|Lost to Follow-up|0|||
155267084|NCT04512066|560410961|FG001|Extension Period|Lost to Follow-up|1|||
155267085|NCT04512066|560410962|FG002|Extension Period|Lost to Follow-up|5|||
155267086|NCT04512066|560410963|FG003|Extension Period|Lost to Follow-up|2|||
155267087|NCT04512066|560410964|FG004|Extension Period|Lost to Follow-up|3|||
155267088|NCT04512066|560410965|FG005|Extension Period|Lost to Follow-up|2|||
155267089|NCT04512066|560410960|FG000|Extension Period|Non-compliance with study drug|0|||
155267090|NCT04512066|560410961|FG001|Extension Period|Non-compliance with study drug|1|||
155267091|NCT04512066|560410962|FG002|Extension Period|Non-compliance with study drug|0|||
155267092|NCT04512066|560410963|FG003|Extension Period|Non-compliance with study drug|0|||
155267093|NCT04512066|560410964|FG004|Extension Period|Non-compliance with study drug|0|||
155267094|NCT04512066|560410965|FG005|Extension Period|Non-compliance with study drug|1|||
155267095|NCT04512066|560410960|FG000|Extension Period|Other|0|||
155267096|NCT04512066|560410961|FG001|Extension Period|Other|2|||
155267097|NCT04512066|560410962|FG002|Extension Period|Other|0|||
155267098|NCT04512066|560410963|FG003|Extension Period|Other|0|||
155614529|NCT00685360|561682981|FG001|Overall Study|Adverse Event|6|||
155614530|NCT00685360|561682982|FG002|Overall Study|Adverse Event|4|||
155614531|NCT00685360|561682980|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
155614532|NCT00685360|561682981|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
155614533|NCT00685360|561682982|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
155614534|NCT00685360|561682980|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
155267099|NCT04512066|560410964|FG004|Extension Period|Other|0|||
155267100|NCT04512066|560410965|FG005|Extension Period|Other|0|||
155267101|NCT04512066|560410960|FG000|Extension Period|Physician Decision|0|||
155267102|NCT04512066|560410961|FG001|Extension Period|Physician Decision|2|||
155267103|NCT04512066|560410962|FG002|Extension Period|Physician Decision|0|||
155267104|NCT04512066|560410963|FG003|Extension Period|Physician Decision|1|||
155267105|NCT04512066|560410964|FG004|Extension Period|Physician Decision|1|||
155267106|NCT04512066|560410965|FG005|Extension Period|Physician Decision|0|||
155267107|NCT04512066|560410960|FG000|Extension Period|Withdrawal by Subject|0|||
155650595|NCT00452530|561812515|FG000|Overall Study|Withdrawal by Subject|68|||
155267108|NCT04512066|560410961|FG001|Extension Period|Withdrawal by Subject|3|||
155267109|NCT04512066|560410962|FG002|Extension Period|Withdrawal by Subject|7|||
155267110|NCT04512066|560410963|FG003|Extension Period|Withdrawal by Subject|11|||
155267111|NCT04512066|560410964|FG004|Extension Period|Withdrawal by Subject|8|||
155267112|NCT04512066|560410965|FG005|Extension Period|Withdrawal by Subject|4|||
155267113|NCT01657266|560410967|FG000|Overall Study|Lost to Follow-up|2|||
155267114|NCT01657266|560410968|FG001|Overall Study|Lost to Follow-up|2|||
155267115|NCT01657266|560410967|FG000|Overall Study|Adverse Event|2|||
155267116|NCT01657266|560410968|FG001|Overall Study|Adverse Event|3|||
155267117|NCT01353222|560410971|FG000|Overall Study|Death|30|||
155267118|NCT01353222|560410972|FG001|Overall Study|Death|30|||
155267119|NCT01353222|560410971|FG000|Overall Study|Withdrawal by Subject|8|||
155267120|NCT01353222|560410972|FG001|Overall Study|Withdrawal by Subject|5|||
155267121|NCT01353222|560410971|FG000|Overall Study|Study Terminated|31|||
155267122|NCT01353222|560410972|FG001|Overall Study|Study Terminated|37|||
155267123|NCT01353222|560410971|FG000|Overall Study|Site closed research department|1|||
155267124|NCT01353222|560410972|FG001|Overall Study|Site closed research department|0|||
155267125|NCT03474549|560410975|FG000|Overall Study|Death|31|||
155267126|NCT03474549|560410975|FG000|Overall Study|Lost to Follow-up|4|||
155267127|NCT03474549|560410975|FG000|Overall Study|Withdrawal by Subject|2|||
155267128|NCT01861522|560410976|FG000|Overall Study|Adverse Event|1|||
155267129|NCT01861522|560410977|FG001|Overall Study|Adverse Event|0|||
155267130|NCT01861522|560410976|FG000|Overall Study|Withdrawal by Subject|2|||
155267131|NCT01861522|560410977|FG001|Overall Study|Withdrawal by Subject|0|||
155267132|NCT03573908|560410981|FG000|Treatment Period|Adverse Event|4|||
155267133|NCT03573908|560410982|FG001|Treatment Period|Adverse Event|9|||
155267134|NCT03573908|560410983|FG002|Treatment Period|Adverse Event|0|||
155267135|NCT03573908|560410984|FG003|Treatment Period|Adverse Event|0|||
155267136|NCT03573908|560410985|FG004|Treatment Period|Adverse Event|0|||
155267137|NCT03573908|560410981|FG000|Treatment Period|Protocol Violation|1|||
155267138|NCT03573908|560410982|FG001|Treatment Period|Protocol Violation|0|||
155267139|NCT03573908|560410983|FG002|Treatment Period|Protocol Violation|0|||
155267140|NCT03573908|560410984|FG003|Treatment Period|Protocol Violation|0|||
155267141|NCT03573908|560410985|FG004|Treatment Period|Protocol Violation|0|||
155267142|NCT03573908|560410981|FG000|Treatment Period|Withdrawal by Subject|7|||
155267143|NCT03573908|560410982|FG001|Treatment Period|Withdrawal by Subject|5|||
155267144|NCT03573908|560410983|FG002|Treatment Period|Withdrawal by Subject|0|||
155267145|NCT03573908|560410984|FG003|Treatment Period|Withdrawal by Subject|0|||
155267146|NCT03573908|560410985|FG004|Treatment Period|Withdrawal by Subject|0|||
155267147|NCT03573908|560410981|FG000|Treatment Period|Lost to Follow-up|7|||
155267148|NCT03573908|560410982|FG001|Treatment Period|Lost to Follow-up|6|||
155267149|NCT03573908|560410983|FG002|Treatment Period|Lost to Follow-up|0|||
155267150|NCT03573908|560410984|FG003|Treatment Period|Lost to Follow-up|0|||
155267151|NCT03573908|560410985|FG004|Treatment Period|Lost to Follow-up|0|||
155267152|NCT03573908|560410981|FG000|Treatment Period|Pregnancy|1|||
155267153|NCT03573908|560410982|FG001|Treatment Period|Pregnancy|0|||
155267154|NCT03573908|560410983|FG002|Treatment Period|Pregnancy|0|||
155267155|NCT03573908|560410984|FG003|Treatment Period|Pregnancy|0|||
155267156|NCT03573908|560410985|FG004|Treatment Period|Pregnancy|0|||
155267157|NCT03573908|560410981|FG000|Treatment Period|Other, Not Specified|4|||
155267158|NCT03573908|560410982|FG001|Treatment Period|Other, Not Specified|6|||
155267159|NCT03573908|560410983|FG002|Treatment Period|Other, Not Specified|0|||
155267160|NCT03573908|560410984|FG003|Treatment Period|Other, Not Specified|0|||
155267161|NCT03573908|560410985|FG004|Treatment Period|Other, Not Specified|0|||
155267162|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Adverse Event|0|||
155267163|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Adverse Event|0|||
155267164|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Adverse Event|3|||
155267165|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Adverse Event|0|||
155381702|NCT04617275|560830991|FG007|Treatment Period|Lost to Follow-up|2|||
155381703|NCT04617275|560830984|FG000|Treatment Period|No longer meets eligibility criteria|0|||
155381704|NCT04617275|560830985|FG001|Treatment Period|No longer meets eligibility criteria|0|||
155381705|NCT04617275|560830986|FG002|Treatment Period|No longer meets eligibility criteria|0|||
155267166|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Adverse Event|0|||
155267167|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267168|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267169|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267170|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267171|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
155267172|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267173|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267174|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
155267175|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267176|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267177|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
155267178|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
155267179|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
155267180|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
155267181|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
155267182|NCT04006925|560410986|FG000|Overall Study|Side effects|2|||
155267183|NCT04006925|560410987|FG001|Overall Study|Side effects|0|||
155267184|NCT00738101|560410993|FG000|Overall Study|Physician Decision|5|||
155267185|NCT00738101|560410993|FG000|Overall Study|Death|1|||
155267186|NCT00738101|560410993|FG000|Overall Study|Repeat enrollment|1|||
155267187|NCT00926003|560410994|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
155267188|NCT00926003|560410995|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
155267189|NCT00926003|560410996|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
155267190|NCT00926003|560410994|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
155267191|NCT00926003|560410995|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
155267192|NCT00926003|560410996|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
155267193|NCT01396317|560410997|FG000|Overall Study|Adverse Event|1|||
155267194|NCT01396317|560410998|FG001|Overall Study|Adverse Event|0|||
155267195|NCT00524030|560411001|FG000|Overall Study|Lack of Efficacy|10|||
155267196|NCT00524030|560411002|FG001|Overall Study|Lack of Efficacy|24|||
155267197|NCT00524030|560411001|FG000|Overall Study|Lost to Follow-up|0|||
155267198|NCT00524030|560411002|FG001|Overall Study|Lost to Follow-up|2|||
155267199|NCT00524030|560411001|FG000|Overall Study|Withdrawal by Subject|3|||
155267200|NCT00524030|560411002|FG001|Overall Study|Withdrawal by Subject|8|||
155267201|NCT00524030|560411001|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
155267202|NCT00524030|560411002|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
155267203|NCT00524030|560411001|FG000|Overall Study|Protocol Violation|0|||
155267204|NCT00524030|560411002|FG001|Overall Study|Protocol Violation|1|||
155267205|NCT00524030|560411001|FG000|Overall Study|Pregnancy|1|||
155267206|NCT00524030|560411002|FG001|Overall Study|Pregnancy|0|||
155267207|NCT00524030|560411001|FG000|Overall Study|Adverse Event|3|||
155267208|NCT00524030|560411002|FG001|Overall Study|Adverse Event|21|||
155267209|NCT00524030|560411001|FG000|Overall Study|Death|0|||
155267210|NCT00524030|560411002|FG001|Overall Study|Death|1|||
155267211|NCT03315130|560411003|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267212|NCT03315130|560411004|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
155267213|NCT03315130|560411005|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267214|NCT03315130|560411006|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267215|NCT03315130|560411003|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267216|NCT03315130|560411004|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
155267217|NCT03315130|560411005|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267218|NCT03315130|560411006|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267219|NCT03315130|560411003|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
155267220|NCT03315130|560411004|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267221|NCT03315130|560411005|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267222|NCT03315130|560411006|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267223|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267224|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
155267225|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267226|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267227|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267228|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
155267229|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267230|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267231|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
155267232|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
155267233|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
155267234|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
155267235|NCT04398537|560411007|FG000|Overall Study|Physician Decision|10|||
155267236|NCT04398537|560411008|FG001|Overall Study|Physician Decision|15|||
155267237|NCT03535337|560411009|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
155267238|NCT03535337|560411010|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
155267239|NCT03535337|560411011|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
155267240|NCT03535337|560411012|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
155267241|NCT03535337|560411013|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
155267242|NCT03535337|560411014|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
155267243|NCT03535337|560411015|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
155267244|NCT03535337|560411016|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
155267245|NCT03535337|560411017|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
155267246|NCT03535337|560411018|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
155381706|NCT04617275|560830987|FG003|Treatment Period|No longer meets eligibility criteria|1|||
155267247|NCT00386308|560412457|FG000|Overall Study|Adverse Event|3|||
155267248|NCT00386308|560412458|FG001|Overall Study|Adverse Event|3|||
155267249|NCT00386308|560412457|FG000|Overall Study|Protocol Violation|2|||
155267250|NCT00386308|560412458|FG001|Overall Study|Protocol Violation|5|||
155267251|NCT00386308|560412457|FG000|Overall Study|Lack of Efficacy|0|||
155267252|NCT00386308|560412458|FG001|Overall Study|Lack of Efficacy|2|||
155267253|NCT00386308|560412457|FG000|Overall Study|Lost to Follow-up|10|||
155267254|NCT00386308|560412458|FG001|Overall Study|Lost to Follow-up|6|||
155267255|NCT00386308|560412457|FG000|Overall Study|Withdrawal by Subject|6|||
155267256|NCT00386308|560412458|FG001|Overall Study|Withdrawal by Subject|2|||
155267257|NCT00386308|560412457|FG000|Overall Study|Other Event|8|||
155267258|NCT00386308|560412458|FG001|Overall Study|Other Event|1|||
155267259|NCT03518658|560412459|FG000|Overall Study|Other|51|||
155267260|NCT03518658|560412460|FG001|Overall Study|Other|0|||
155267261|NCT00649389|560412461|FG000|Overall Study|Adverse Event|22|||
155267262|NCT00649389|560412462|FG001|Overall Study|Adverse Event|46|||
155267263|NCT00649389|560412463|FG002|Overall Study|Adverse Event|38|||
155267264|NCT00649389|560412464|FG003|Overall Study|Adverse Event|48|||
155267265|NCT00649389|560412461|FG000|Overall Study|Lost to Follow-up|15|||
155267266|NCT00649389|560412462|FG001|Overall Study|Lost to Follow-up|17|||
155267267|NCT00649389|560412463|FG002|Overall Study|Lost to Follow-up|21|||
155267268|NCT00649389|560412464|FG003|Overall Study|Lost to Follow-up|26|||
155267269|NCT00649389|560412461|FG000|Overall Study|Protocol Violation|11|||
155267270|NCT00649389|560412462|FG001|Overall Study|Protocol Violation|13|||
155267271|NCT00649389|560412463|FG002|Overall Study|Protocol Violation|9|||
155267272|NCT00649389|560412464|FG003|Overall Study|Protocol Violation|8|||
155267273|NCT00649389|560412461|FG000|Overall Study|Withdrawal by Subject|20|||
155267274|NCT00649389|560412462|FG001|Overall Study|Withdrawal by Subject|21|||
155267275|NCT00649389|560412463|FG002|Overall Study|Withdrawal by Subject|19|||
155267276|NCT00649389|560412464|FG003|Overall Study|Withdrawal by Subject|23|||
155267277|NCT00649389|560412461|FG000|Overall Study|Other|3|||
155267278|NCT00649389|560412462|FG001|Overall Study|Other|9|||
155267279|NCT00649389|560412463|FG002|Overall Study|Other|1|||
155267280|NCT00649389|560412464|FG003|Overall Study|Other|6|||
155267281|NCT02746575|560412467|FG000|Overall Study|Surgery cancelled or time chaned|13|||
155381707|NCT04617275|560830988|FG004|Treatment Period|No longer meets eligibility criteria|0|||
155381708|NCT04617275|560830989|FG005|Treatment Period|No longer meets eligibility criteria|0|||
155726418|NCT02668653|562098124|FG000|Overall Study|Subject decision to stop study drug|25|||
155726419|NCT02668653|562098125|FG001|Overall Study|Subject decision to stop study drug|23|||
155726420|NCT02668653|562098124|FG000|Overall Study|Other reasons not specified|16|||
155726421|NCT02668653|562098125|FG001|Overall Study|Other reasons not specified|11|||
155726422|NCT02668653|562098124|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
155726423|NCT02668653|562098125|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
155726424|NCT02668653|562098124|FG000|Overall Study|Investigator decision|10|||
155726425|NCT02668653|562098125|FG001|Overall Study|Investigator decision|7|||
155726426|NCT02668653|562098124|FG000|Overall Study|Failure to meet continuation criteria|5|||
155726427|NCT02668653|562098125|FG001|Overall Study|Failure to meet continuation criteria|12|||
155726428|NCT02668653|562098124|FG000|Overall Study|Lost to Follow-up|1|||
155726429|NCT02668653|562098125|FG001|Overall Study|Lost to Follow-up|0|||
155726430|NCT02668653|562098124|FG000|Overall Study|Pregnancy|0|||
155726431|NCT02668653|562098125|FG001|Overall Study|Pregnancy|1|||
155726432|NCT02668653|562098124|FG000|Overall Study|Death|0|||
155726433|NCT02668653|562098125|FG001|Overall Study|Death|1|||
155726434|NCT01352793|562098131|FG000|Overall Study|Lost to Follow-up|289|||
155726435|NCT01352793|562098132|FG001|Overall Study|Lost to Follow-up|125|||
155726436|NCT01352793|562098131|FG000|Overall Study|Withdrawal by Subject|120|||
155726437|NCT01352793|562098132|FG001|Overall Study|Withdrawal by Subject|55|||
155726438|NCT01352793|562098131|FG000|Overall Study|Protocol Violation|44|||
155726439|NCT01352793|562098132|FG001|Overall Study|Protocol Violation|23|||
155726440|NCT01352793|562098131|FG000|Overall Study|Adverse Event|44|||
155726441|NCT01352793|562098132|FG001|Overall Study|Adverse Event|10|||
155726442|NCT01352793|562098131|FG000|Overall Study|Physician Decision|1|||
155726443|NCT01352793|562098132|FG001|Overall Study|Physician Decision|0|||
155726444|NCT01352793|562098131|FG000|Overall Study|Pregnancy|26|||
155726445|NCT01352793|562098132|FG001|Overall Study|Pregnancy|8|||
155726446|NCT01352793|562098131|FG000|Overall Study|Other|25|||
155726447|NCT01352793|562098132|FG001|Overall Study|Other|7|||
155726448|NCT01352793|562098131|FG000|Overall Study|Medication error|2|||
155726449|NCT01352793|562098132|FG001|Overall Study|Medication error|2|||
155726450|NCT01352793|562098131|FG000|Overall Study|Death|1|||
155726451|NCT01352793|562098132|FG001|Overall Study|Death|0|||
155726452|NCT01352793|562098131|FG000|Overall Study|Randomized but not vaccinated|8|||
155726453|NCT01352793|562098132|FG001|Overall Study|Randomized but not vaccinated|0|||
155726454|NCT01352793|562098131|FG000|Overall Study|No longer meets eligibility criteria|25|||
155726455|NCT01352793|562098132|FG001|Overall Study|No longer meets eligibility criteria|15|||
155267282|NCT02746575|560412467|FG000|Overall Study|Received epidural|10|||
155267283|NCT02746575|560412467|FG000|Overall Study|Withdrawal by Subject|3|||
155267284|NCT02746575|560412467|FG000|Overall Study|Bradycardia/hypotension|9|||
155267285|NCT02746575|560412467|FG000|Overall Study|Study paused|8|||
155267286|NCT02746575|560412467|FG000|Overall Study|put on beta-blocker|3|||
155267287|NCT02746575|560412467|FG000|Overall Study|type of surgery|1|||
155267288|NCT02746575|560412467|FG000|Overall Study|typ of surgery|1|||
155267289|NCT02746575|560412467|FG000|Overall Study|PI unavailable|1|||
155267290|NCT02746575|560412467|FG000|Overall Study|Unknown history of CVA|1|||
155267291|NCT00976482|560412468|FG000|Overall Study|Death|208|||
155267292|NCT00976482|560412468|FG000|Overall Study|Withdrawal by Subject|45|||
155267293|NCT00976482|560412468|FG000|Overall Study|Center terminated|1|||
155267294|NCT00976482|560412468|FG000|Overall Study|Protocol Violation|5|||
155267295|NCT02959671|560412469|FG000|Overall Study|Adverse Event|2|||
155267296|NCT02959671|560412469|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
155267297|NCT02254408|560412480|FG000|Overall Study|Randomized But Not Treated|1|||
155267298|NCT02254408|560412481|FG001|Overall Study|Randomized But Not Treated|3|||
155267299|NCT02254408|560412480|FG000|Overall Study|Adverse Event|1|||
155267300|NCT02254408|560412481|FG001|Overall Study|Adverse Event|0|||
155267301|NCT02254408|560412480|FG000|Overall Study|Death|2|||
155267302|NCT02254408|560412481|FG001|Overall Study|Death|3|||
155267303|NCT02254408|560412480|FG000|Overall Study|Investigator's Discretion|0|||
155267304|NCT02254408|560412481|FG001|Overall Study|Investigator's Discretion|1|||
155267305|NCT02254408|560412480|FG000|Overall Study|Withdrawal by Subject|3|||
155267306|NCT02254408|560412481|FG001|Overall Study|Withdrawal by Subject|3|||
155267307|NCT02254408|560412480|FG000|Overall Study|Lost to Follow-up|1|||
155267308|NCT02254408|560412481|FG001|Overall Study|Lost to Follow-up|0|||
155267309|NCT00917267|560412482|FG000|Overall Study|Adverse Event|15|||
155267310|NCT00917267|560412483|FG001|Overall Study|Adverse Event|36|||
155267311|NCT00917267|560412482|FG000|Overall Study|Physician Decision|2|||
155267312|NCT00917267|560412483|FG001|Overall Study|Physician Decision|4|||
155267313|NCT00917267|560412482|FG000|Overall Study|Protocol Violation|9|||
155267314|NCT00917267|560412483|FG001|Overall Study|Protocol Violation|18|||
155267315|NCT00917267|560412482|FG000|Overall Study|Withdrawal by Subject|5|||
155267316|NCT00917267|560412483|FG001|Overall Study|Withdrawal by Subject|12|||
155267317|NCT00917267|560412482|FG000|Overall Study|Lost to follow up|0|||
155267318|NCT00917267|560412483|FG001|Overall Study|Lost to follow up|2|||
155267319|NCT00917267|560412482|FG000|Overall Study|Entry Criteria Not Met|1|||
155267320|NCT00917267|560412483|FG001|Overall Study|Entry Criteria Not Met|0|||
155267321|NCT00917267|560412482|FG000|Overall Study|Sponsor Decision|5|||
155267322|NCT00917267|560412483|FG001|Overall Study|Sponsor Decision|5|||
155267323|NCT00917267|560412482|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
155267324|NCT00917267|560412483|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
155267325|NCT00802659|560412488|FG000|Overall Study|Physician Decision|0|||
155267326|NCT00802659|560412489|FG001|Overall Study|Physician Decision|1|||
155267327|NCT00802659|560412490|FG002|Overall Study|Physician Decision|0|||
155267328|NCT00802659|560412491|FG003|Overall Study|Physician Decision|0|||
155267329|NCT00289770|560412492|FG000|Year 15|Withdrawal by Subject|1|||
155267330|NCT00423293|560412493|FG000|Overall Study|Ineligible / No protocol treatment|11|||
155267331|NCT00067990|560412499|FG000|Overall Study|Death|5|||
155267332|NCT00067990|560412500|FG001|Overall Study|Death|7|||
155267333|NCT00067990|560412499|FG000|Overall Study|ESRD, Non IF/TA|1|||
155267334|NCT00067990|560412500|FG001|Overall Study|ESRD, Non IF/TA|3|||
155267335|NCT00067990|560412499|FG000|Overall Study|Withdrawal by Subject|4|||
155267336|NCT00067990|560412500|FG001|Overall Study|Withdrawal by Subject|12|||
155267337|NCT03810313|560412507|FG000|Overall Study|Study terminated by sponsor|164|||
155267338|NCT03810313|560412508|FG001|Overall Study|Study terminated by sponsor|159|||
155267339|NCT03810313|560412507|FG000|Overall Study|Subject decision|10|||
155267340|NCT03810313|560412508|FG001|Overall Study|Subject decision|11|||
155267341|NCT03810313|560412507|FG000|Overall Study|Lost to Follow-up|3|||
155267342|NCT03810313|560412508|FG001|Overall Study|Lost to Follow-up|3|||
155267343|NCT03810313|560412507|FG000|Overall Study|Adverse Event|2|||
155267344|NCT03810313|560412508|FG001|Overall Study|Adverse Event|1|||
155267345|NCT03810313|560412507|FG000|Overall Study|Death|2|||
155267346|NCT03810313|560412508|FG001|Overall Study|Death|1|||
155267347|NCT03810313|560412507|FG000|Overall Study|Physician Decision|0|||
155267348|NCT03810313|560412508|FG001|Overall Study|Physician Decision|1|||
155267349|NCT01872910|560412515|FG000|Overall Study|Lost to Follow-up|2|||
155267350|NCT01872910|560412516|FG001|Overall Study|Lost to Follow-up|0|||
155267351|NCT01872910|560412517|FG002|Overall Study|Lost to Follow-up|2|||
155267352|NCT01872910|560412518|FG003|Overall Study|Lost to Follow-up|0|||
155267353|NCT01872910|560412519|FG004|Overall Study|Lost to Follow-up|0|||
155267354|NCT01872910|560412520|FG005|Overall Study|Lost to Follow-up|0|||
155267355|NCT01540565|560412521|FG000|Overall Study|Ineligible|2|||
155267356|NCT00154310|560412522|FG000|Overall Study|Adverse Event|19|||
155267357|NCT00154310|560412523|FG001|Overall Study|Adverse Event|9|||
155267358|NCT00154310|560412522|FG000|Overall Study|Lack of Efficacy|5|||
155267359|NCT00154310|560412523|FG001|Overall Study|Lack of Efficacy|4|||
155267360|NCT00154310|560412522|FG000|Overall Study|Protocol Violation|4|||
155267361|NCT00154310|560412523|FG001|Overall Study|Protocol Violation|2|||
155267362|NCT00154310|560412522|FG000|Overall Study|Withdrawal by Subject|9|||
155267363|NCT00154310|560412523|FG001|Overall Study|Withdrawal by Subject|3|||
155267364|NCT00154310|560412522|FG000|Overall Study|Lost to Follow-up|0|||
155267365|NCT00154310|560412523|FG001|Overall Study|Lost to Follow-up|8|||
155267366|NCT00154310|560412522|FG000|Overall Study|Administrative problems|0|||
155267367|NCT00154310|560412523|FG001|Overall Study|Administrative problems|1|||
155267368|NCT00154310|560412522|FG000|Overall Study|Death|0|||
155267369|NCT00154310|560412523|FG001|Overall Study|Death|1|||
155267370|NCT03469349|560412524|FG000|Overall Study|Withdrawal by Subject|1|||
155267371|NCT03469349|560412525|FG001|Overall Study|Withdrawal by Subject|3|||
155267372|NCT03469349|560412524|FG000|Overall Study|Progressive Disease|0|||
155267373|NCT03469349|560412525|FG001|Overall Study|Progressive Disease|1|||
155267374|NCT03469349|560412524|FG000|Overall Study|Lost to Follow-up|2|||
155267375|NCT03469349|560412525|FG001|Overall Study|Lost to Follow-up|2|||
155267376|NCT03469349|560412524|FG000|Overall Study|Adverse Event|2|||
155267377|NCT03469349|560412525|FG001|Overall Study|Adverse Event|4|||
155267378|NCT02086162|560412527|FG000|Overall Study|Withdrawal by Subject|4|||
155267379|NCT02086162|560412528|FG001|Overall Study|Withdrawal by Subject|4|||
155267380|NCT02086162|560412527|FG000|Overall Study|moved|1|||
155267381|NCT02086162|560412528|FG001|Overall Study|moved|1|||
155267382|NCT02086162|560412527|FG000|Overall Study|Lost to Follow-up|4|||
155267383|NCT02086162|560412528|FG001|Overall Study|Lost to Follow-up|2|||
155267384|NCT02086162|560412527|FG000|Overall Study|Death|1|||
155267385|NCT02086162|560412528|FG001|Overall Study|Death|0|||
155267386|NCT03447730|560412529|FG000|Overall Study|Adverse Event|0|||
155267387|NCT03447730|560412530|FG001|Overall Study|Adverse Event|2|||
155267388|NCT03447730|560412531|FG002|Overall Study|Adverse Event|0|||
155267389|NCT01350505|560412535|FG000|Overall Study|Lost to Follow-up|4|||
155267390|NCT04702568|560412539|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
155267391|NCT04702568|560412540|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
155267392|NCT04702568|560412539|FG000|Overall Study|Pregnancy|1|||
155267393|NCT04702568|560412540|FG001|Overall Study|Pregnancy|0|||
155267394|NCT04702568|560412539|FG000|Overall Study|Bone marrow transplant|1|||
155267395|NCT04702568|560412540|FG001|Overall Study|Bone marrow transplant|0|||
155267396|NCT04702568|560412539|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
155267397|NCT04702568|560412540|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
155267398|NCT04702568|560412539|FG000|Overall Study|Withdrawal by Subject|0|||
155267399|NCT04702568|560412540|FG001|Overall Study|Withdrawal by Subject|2|||
155267400|NCT01735396|560412541|FG000|Overall Study|not evaluable|1|||
155267401|NCT00423852|560412544|FG000|Overall Study|Removed pior to the high-dose portion|3|||
155267402|NCT00980005|560412545|FG000|Overall Study|Withdrawal by Subject|6|||
155267403|NCT00980005|560412546|FG001|Overall Study|Withdrawal by Subject|17|||
155267404|NCT00980005|560412545|FG000|Overall Study|Lost to Follow-up|37|||
155267405|NCT00980005|560412546|FG001|Overall Study|Lost to Follow-up|43|||
155267406|NCT00980005|560412545|FG000|Overall Study|Other|4|||
155267407|NCT00980005|560412546|FG001|Overall Study|Other|3|||
155267408|NCT00572624|560412547|FG000|Overall Study|Lost to Follow-up|10|||
155267409|NCT00572624|560412548|FG001|Overall Study|Lost to Follow-up|4|||
155267410|NCT00572624|560412547|FG000|Overall Study|Wanted to do a different diet program|1|||
155267411|NCT00572624|560412548|FG001|Overall Study|Wanted to do a different diet program|0|||
155267412|NCT00572624|560412547|FG000|Overall Study|Medication change|1|||
155267413|NCT00572624|560412548|FG001|Overall Study|Medication change|0|||
155267414|NCT00572624|560412547|FG000|Overall Study|Started a new job-- no time for study|1|||
155267415|NCT00572624|560412548|FG001|Overall Study|Started a new job-- no time for study|0|||
155267416|NCT00572624|560412547|FG000|Overall Study|Admitted to being a smoker|1|||
155267417|NCT00572624|560412548|FG001|Overall Study|Admitted to being a smoker|0|||
155267418|NCT00572624|560412547|FG000|Overall Study|Refused to do the stress test|1|||
155267419|NCT00572624|560412548|FG001|Overall Study|Refused to do the stress test|0|||
155267420|NCT00572624|560412547|FG000|Overall Study|Problem with vascular access|1|||
155267421|NCT00572624|560412548|FG001|Overall Study|Problem with vascular access|0|||
155267422|NCT00572624|560412547|FG000|Overall Study|Health issues unrelated to the study|1|||
155267423|NCT00572624|560412548|FG001|Overall Study|Health issues unrelated to the study|0|||
155267424|NCT04078035|560412553|FG000|Session 2|Lost to Follow-up|3|||
155267425|NCT04078035|560412554|FG001|Session 2|Lost to Follow-up|1|||
155267426|NCT04078035|560412553|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
155267427|NCT04078035|560412554|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
155267428|NCT01905046|560412559|FG000|Months 13-24|Withdrawal by Subject|10|||
155267429|NCT01905046|560412560|FG001|Months 13-24|Withdrawal by Subject|10|||
155267430|NCT01905046|560412559|FG000|Months 13-24|Adverse Event|3|||
155267431|NCT01905046|560412560|FG001|Months 13-24|Adverse Event|2|||
155267432|NCT01905046|560412559|FG000|Months 13-24|Protocol Violation|3|||
155267433|NCT01905046|560412560|FG001|Months 13-24|Protocol Violation|3|||
155267434|NCT01905046|560412559|FG000|Months 13-24|Physician Decision|1|||
155267435|NCT01905046|560412560|FG001|Months 13-24|Physician Decision|0|||
155267436|NCT00612534|560412564|FG000|Overall Study|Adverse Event|0|||
155267437|NCT00612534|560412565|FG001|Overall Study|Adverse Event|4|||
155267438|NCT00612534|560412566|FG002|Overall Study|Adverse Event|2|||
155267439|NCT00612534|560412567|FG003|Overall Study|Adverse Event|1|||
155267440|NCT00612534|560412564|FG000|Overall Study|Lack of Efficacy|13|||
155267441|NCT00612534|560412565|FG001|Overall Study|Lack of Efficacy|12|||
155267442|NCT00612534|560412566|FG002|Overall Study|Lack of Efficacy|5|||
155267443|NCT00612534|560412567|FG003|Overall Study|Lack of Efficacy|16|||
155267444|NCT00612534|560412564|FG000|Overall Study|Other Reason|0|||
155267445|NCT00612534|560412565|FG001|Overall Study|Other Reason|1|||
155267446|NCT00612534|560412566|FG002|Overall Study|Other Reason|0|||
155267447|NCT00612534|560412567|FG003|Overall Study|Other Reason|0|||
155267448|NCT01435655|560412573|FG000|Overall Study|Death|2|||
155267449|NCT01435655|560412573|FG000|Overall Study|Other|1|||
155267450|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267451|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
155267452|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267453|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267454|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
155267455|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
155267456|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
155267457|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
155267458|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
155267459|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
155267460|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
155267461|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
155267462|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267463|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
155267464|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
155267465|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267466|NCT04534114|560412574|FG000|Main Treatment Period|Physician Decision|0|||
155267467|NCT04534114|560412575|FG001|Main Treatment Period|Physician Decision|0|||
155267468|NCT04534114|560412576|FG002|Main Treatment Period|Physician Decision|0|||
155267469|NCT04534114|560412577|FG003|Main Treatment Period|Physician Decision|1|||
155267470|NCT04534114|560412574|FG000|Main Treatment Period|Death|1|||
155267471|NCT04534114|560412575|FG001|Main Treatment Period|Death|0|||
155267472|NCT04534114|560412576|FG002|Main Treatment Period|Death|0|||
155267473|NCT04534114|560412577|FG003|Main Treatment Period|Death|1|||
155267474|NCT04534114|560412574|FG000|Main Treatment Period|Other reason|1|||
155267475|NCT04534114|560412575|FG001|Main Treatment Period|Other reason|1|||
155267476|NCT04534114|560412576|FG002|Main Treatment Period|Other reason|0|||
155267477|NCT04534114|560412577|FG003|Main Treatment Period|Other reason|0|||
155267478|NCT04534114|560412574|FG000|Main Treatment Period|Participant decision|1|||
155267479|NCT04534114|560412575|FG001|Main Treatment Period|Participant decision|3|||
155267480|NCT04534114|560412576|FG002|Main Treatment Period|Participant decision|3|||
155267481|NCT04534114|560412577|FG003|Main Treatment Period|Participant decision|1|||
155267482|NCT04534114|560412574|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
155267483|NCT04534114|560412575|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
155267484|NCT04534114|560412576|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
155267485|NCT04534114|560412577|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
155267486|NCT04534114|560412574|FG000|Main Treatment Period|Adverse Event|4|||
155267487|NCT04534114|560412575|FG001|Main Treatment Period|Adverse Event|2|||
155267488|NCT04534114|560412576|FG002|Main Treatment Period|Adverse Event|1|||
155267489|NCT04534114|560412577|FG003|Main Treatment Period|Adverse Event|2|||
155267490|NCT04534114|560412574|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267491|NCT04534114|560412575|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267492|NCT04534114|560412576|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267493|NCT04534114|560412577|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
155267494|NCT04534114|560412574|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267495|NCT04534114|560412575|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267496|NCT04534114|560412576|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267497|NCT04534114|560412577|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267498|NCT04534114|560412574|FG000|Extension Treatment Period|Other reason|0|||
155267499|NCT04534114|560412575|FG001|Extension Treatment Period|Other reason|1|||
155267500|NCT04534114|560412576|FG002|Extension Treatment Period|Other reason|0|||
155267501|NCT04534114|560412577|FG003|Extension Treatment Period|Other reason|0|||
155267502|NCT04534114|560412574|FG000|Extension Treatment Period|Death|0|||
155267503|NCT04534114|560412575|FG001|Extension Treatment Period|Death|0|||
155267504|NCT04534114|560412576|FG002|Extension Treatment Period|Death|1|||
155267505|NCT04534114|560412577|FG003|Extension Treatment Period|Death|2|||
155267506|NCT04534114|560412574|FG000|Extension Treatment Period|Adverse Event|0|||
155267507|NCT04534114|560412575|FG001|Extension Treatment Period|Adverse Event|1|||
155267508|NCT04534114|560412576|FG002|Extension Treatment Period|Adverse Event|0|||
155267509|NCT04534114|560412577|FG003|Extension Treatment Period|Adverse Event|1|||
155267510|NCT04534114|560412574|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
155267511|NCT04534114|560412575|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
155267512|NCT04534114|560412576|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
155267513|NCT04534114|560412577|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
155267514|NCT02223754|560412578|FG000|Period 1|Adverse Event|1|||
155267515|NCT02223754|560412579|FG001|Period 1|Adverse Event|0|||
155267516|NCT02223754|560412578|FG000|Period 1|Lost to Follow-up|0|||
155267517|NCT02223754|560412579|FG001|Period 1|Lost to Follow-up|1|||
155267518|NCT02223754|560412578|FG000|Period 1|Protocol Violation|2|||
155267519|NCT02223754|560412579|FG001|Period 1|Protocol Violation|4|||
155267520|NCT02223754|560412578|FG000|Period 1|Withdrawal by Subject|0|||
155267521|NCT02223754|560412579|FG001|Period 1|Withdrawal by Subject|4|||
155267522|NCT02223754|560412578|FG000|Period 1|Test Article No Longer Available|1|||
155267523|NCT02223754|560412579|FG001|Period 1|Test Article No Longer Available|5|||
155267524|NCT02223754|560412578|FG000|Period 1|Unsatisfactory Visual Response|0|||
155267525|NCT02223754|560412579|FG001|Period 1|Unsatisfactory Visual Response|1|||
155267526|NCT02223754|560412578|FG000|Period 2|Adverse Event|0|||
155267527|NCT02223754|560412579|FG001|Period 2|Adverse Event|1|||
155267528|NCT02223754|560412578|FG000|Period 2|Protocol Violation|1|||
155267529|NCT02223754|560412579|FG001|Period 2|Protocol Violation|0|||
155267530|NCT02223754|560412578|FG000|Period 2|Lens Discomfort|1|||
155267531|NCT02223754|560412579|FG001|Period 2|Lens Discomfort|1|||
155267532|NCT02223754|560412578|FG000|Period 2|Lost to Follow-up|1|||
155267533|NCT02223754|560412579|FG001|Period 2|Lost to Follow-up|0|||
155267534|NCT02223754|560412578|FG000|Period 2|Test Article No Longer Available|0|||
155267535|NCT02223754|560412579|FG001|Period 2|Test Article No Longer Available|1|||
155267536|NCT01008475|560412581|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
155267537|NCT01008475|560412582|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
155267538|NCT01008475|560412583|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
155267539|NCT01008475|560412584|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
155267540|NCT01008475|560412585|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
155267541|NCT01008475|560412586|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
155267542|NCT01008475|560412587|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
155267543|NCT02668016|560412588|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
155267544|NCT02668016|560412588|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
155267545|NCT02668016|560412588|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
155267546|NCT02668016|560412588|FG000|Month 4|Withdrawal due to severe symptoms|1|||
155267547|NCT02668016|560412588|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
155267548|NCT02668016|560412588|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
155267549|NCT02668016|560412588|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
155267550|NCT02668016|560412588|FG000|Month 6|Withdrawal due to severe symptoms|2|||
155267551|NCT02668016|560412588|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
155267552|NCT02668016|560412588|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
155267553|NCT02668016|560412588|FG000|Month 8|Withdrawal due to severe symptoms|1|||
155267554|NCT02668016|560412588|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
155267555|NCT02668016|560412588|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
155267556|NCT02668016|560412588|FG000|Month 10|Withdrawal due to severe symptoms|1|||
155267557|NCT02668016|560412588|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
155267558|NCT01122381|560412590|FG000|Overall Study|study terminated early|0|||
155267559|NCT01122381|560412591|FG001|Overall Study|study terminated early|1|||
155267560|NCT02395133|560412592|FG000|Overall Study|Adverse Event|4|||
155267561|NCT02395133|560412593|FG001|Overall Study|Adverse Event|1|||
155267562|NCT02395133|560412594|FG002|Overall Study|Adverse Event|3|||
155267563|NCT02395133|560412595|FG003|Overall Study|Adverse Event|0|||
155267564|NCT02395133|560412592|FG000|Overall Study|Lack of Efficacy|1|||
155267565|NCT02395133|560412593|FG001|Overall Study|Lack of Efficacy|0|||
155267566|NCT02395133|560412594|FG002|Overall Study|Lack of Efficacy|1|||
155267567|NCT02395133|560412595|FG003|Overall Study|Lack of Efficacy|1|||
155267568|NCT02395133|560412592|FG000|Overall Study|Protocol Violation|1|||
155267569|NCT02395133|560412593|FG001|Overall Study|Protocol Violation|1|||
155267570|NCT02395133|560412594|FG002|Overall Study|Protocol Violation|0|||
155267571|NCT02395133|560412595|FG003|Overall Study|Protocol Violation|3|||
155267572|NCT02395133|560412592|FG000|Overall Study|Lost to Follow-up|0|||
155267573|NCT02395133|560412593|FG001|Overall Study|Lost to Follow-up|1|||
155267574|NCT02395133|560412594|FG002|Overall Study|Lost to Follow-up|1|||
155267575|NCT02395133|560412595|FG003|Overall Study|Lost to Follow-up|0|||
155267576|NCT02395133|560412592|FG000|Overall Study|Pregnancy|0|||
155267577|NCT02395133|560412593|FG001|Overall Study|Pregnancy|0|||
155267578|NCT02395133|560412594|FG002|Overall Study|Pregnancy|3|||
155267579|NCT02395133|560412595|FG003|Overall Study|Pregnancy|0|||
155267580|NCT02395133|560412592|FG000|Overall Study|Consent withdrawn with no reason given|1|||
155267581|NCT02395133|560412593|FG001|Overall Study|Consent withdrawn with no reason given|3|||
155267582|NCT02395133|560412594|FG002|Overall Study|Consent withdrawn with no reason given|0|||
155267583|NCT02395133|560412595|FG003|Overall Study|Consent withdrawn with no reason given|2|||
155267584|NCT02395133|560412592|FG000|Overall Study|Consent withdrawn with personal reason|0|||
155267585|NCT02395133|560412593|FG001|Overall Study|Consent withdrawn with personal reason|1|||
155267586|NCT02395133|560412594|FG002|Overall Study|Consent withdrawn with personal reason|0|||
155267587|NCT02395133|560412595|FG003|Overall Study|Consent withdrawn with personal reason|3|||
155267588|NCT02395133|560412592|FG000|Overall Study|Sponsor decision|2|||
155267589|NCT02395133|560412593|FG001|Overall Study|Sponsor decision|0|||
155267590|NCT02395133|560412594|FG002|Overall Study|Sponsor decision|0|||
155267591|NCT02395133|560412595|FG003|Overall Study|Sponsor decision|1|||
155267592|NCT02395133|560412592|FG000|Overall Study|Other than specified above|5|||
155267593|NCT02395133|560412593|FG001|Overall Study|Other than specified above|2|||
155267594|NCT02395133|560412594|FG002|Overall Study|Other than specified above|2|||
155267595|NCT02395133|560412595|FG003|Overall Study|Other than specified above|4|||
155267596|NCT00510458|560412596|FG000|Overall Study|5 year not evaluable/missed|21|||
155267597|NCT00510458|560412596|FG000|Overall Study|Death|1|||
155267598|NCT00510458|560412596|FG000|Overall Study|Terminated|14|||
155267599|NCT00510458|560412596|FG000|Overall Study|Lost to Follow-up|6|||
155267600|NCT00510458|560412596|FG000|Overall Study|Withdrawal by Subject|3|||
155267601|NCT00510458|560412596|FG000|Overall Study|Revision|2|||
155267602|NCT02569710|560412597|FG000|Overall Study|Adverse Event|1|||
155267603|NCT02569710|560412598|FG001|Overall Study|Adverse Event|0|||
155267604|NCT02569710|560412599|FG002|Overall Study|Adverse Event|0|||
155267605|NCT02569710|560412600|FG003|Overall Study|Adverse Event|0|||
155267606|NCT02569710|560412601|FG004|Overall Study|Adverse Event|0|||
155267607|NCT02569710|560412602|FG005|Overall Study|Adverse Event|0|||
155267608|NCT02569710|560412603|FG006|Overall Study|Adverse Event|0|||
155267609|NCT02569710|560412604|FG007|Overall Study|Adverse Event|0|||
155267610|NCT02569710|560412605|FG008|Overall Study|Adverse Event|0|||
155267611|NCT02569710|560412606|FG009|Overall Study|Adverse Event|0|||
155267612|NCT02569710|560412597|FG000|Overall Study|Lost to Follow-up|0|||
155267613|NCT02569710|560412598|FG001|Overall Study|Lost to Follow-up|0|||
155267614|NCT02569710|560412599|FG002|Overall Study|Lost to Follow-up|0|||
155267615|NCT02569710|560412600|FG003|Overall Study|Lost to Follow-up|0|||
155267616|NCT02569710|560412601|FG004|Overall Study|Lost to Follow-up|0|||
155267617|NCT02569710|560412602|FG005|Overall Study|Lost to Follow-up|0|||
155267618|NCT02569710|560412603|FG006|Overall Study|Lost to Follow-up|1|||
155267619|NCT02569710|560412604|FG007|Overall Study|Lost to Follow-up|0|||
155267620|NCT02569710|560412605|FG008|Overall Study|Lost to Follow-up|1|||
155267621|NCT02569710|560412606|FG009|Overall Study|Lost to Follow-up|0|||
155267622|NCT02569710|560412597|FG000|Overall Study|Virologic failure|0|||
155267623|NCT02569710|560412598|FG001|Overall Study|Virologic failure|0|||
155267624|NCT02569710|560412599|FG002|Overall Study|Virologic failure|0|||
155267625|NCT02569710|560412600|FG003|Overall Study|Virologic failure|0|||
155267626|NCT02569710|560412601|FG004|Overall Study|Virologic failure|1|||
155267627|NCT02569710|560412602|FG005|Overall Study|Virologic failure|0|||
155267628|NCT02569710|560412603|FG006|Overall Study|Virologic failure|1|||
155267629|NCT02569710|560412604|FG007|Overall Study|Virologic failure|0|||
155267630|NCT02569710|560412605|FG008|Overall Study|Virologic failure|0|||
155267631|NCT02569710|560412606|FG009|Overall Study|Virologic failure|0|||
155267632|NCT02569710|560412597|FG000|Overall Study|Withdrawal by Subject|0|||
155267633|NCT02569710|560412598|FG001|Overall Study|Withdrawal by Subject|0|||
155267634|NCT02569710|560412599|FG002|Overall Study|Withdrawal by Subject|0|||
155267635|NCT02569710|560412600|FG003|Overall Study|Withdrawal by Subject|0|||
155267636|NCT02569710|560412601|FG004|Overall Study|Withdrawal by Subject|0|||
155267637|NCT02569710|560412602|FG005|Overall Study|Withdrawal by Subject|1|||
155267638|NCT02569710|560412603|FG006|Overall Study|Withdrawal by Subject|0|||
155267639|NCT02569710|560412604|FG007|Overall Study|Withdrawal by Subject|0|||
155614535|NCT00685360|561682981|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
155267640|NCT02569710|560412605|FG008|Overall Study|Withdrawal by Subject|0|||
155267641|NCT02569710|560412606|FG009|Overall Study|Withdrawal by Subject|0|||
155381709|NCT04617275|560830990|FG006|Treatment Period|No longer meets eligibility criteria|0|||
155381710|NCT04617275|560830991|FG007|Treatment Period|No longer meets eligibility criteria|0|||
155381711|NCT04617275|560830984|FG000|Treatment Period|Other|0|||
155381712|NCT04617275|560830985|FG001|Treatment Period|Other|1|||
155381713|NCT04617275|560830986|FG002|Treatment Period|Other|0|||
155381714|NCT04617275|560830987|FG003|Treatment Period|Other|0|||
155381715|NCT04617275|560830988|FG004|Treatment Period|Other|0|||
155381716|NCT04617275|560830989|FG005|Treatment Period|Other|0|||
155381717|NCT04617275|560830990|FG006|Treatment Period|Other|0|||
155381718|NCT04617275|560830991|FG007|Treatment Period|Other|0|||
155381719|NCT04617275|560830984|FG000|Treatment Period|Withdrawal by Subject|2|||
155381720|NCT04617275|560830985|FG001|Treatment Period|Withdrawal by Subject|0|||
155381721|NCT04617275|560830986|FG002|Treatment Period|Withdrawal by Subject|0|||
155381722|NCT04617275|560830987|FG003|Treatment Period|Withdrawal by Subject|2|||
155381723|NCT04617275|560830988|FG004|Treatment Period|Withdrawal by Subject|2|||
155614536|NCT00685360|561682982|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
155381724|NCT04617275|560830989|FG005|Treatment Period|Withdrawal by Subject|0|||
155381725|NCT04617275|560830990|FG006|Treatment Period|Withdrawal by Subject|1|||
155381726|NCT04617275|560830991|FG007|Treatment Period|Withdrawal by Subject|2|||
155381727|NCT04617275|560830984|FG000|Follow-up Period|Adverse Event|1|||
155614537|NCT00685360|561682980|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
155267642|NCT00432835|560414360|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
155267643|NCT00432835|560414361|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
155267644|NCT01827254|560414364|FG000|Overall Study|Death|10|||
155267645|NCT01827254|560414364|FG000|Overall Study|Case report form not completed|4|||
155267646|NCT01827254|560414364|FG000|Overall Study|Invalidated centre|3|||
155267647|NCT01827254|560414364|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
155267648|NCT01827254|560414364|FG000|Overall Study|Did not complete re-challenge|1|||
155267649|NCT01827254|560414364|FG000|Overall Study|Disease progression|36|||
155267650|NCT01827254|560414364|FG000|Overall Study|Intolerance to treatment|4|||
155267651|NCT00308737|560414368|FG000|Overall Study|Adverse Event|104|||
155267652|NCT00308737|560414369|FG001|Overall Study|Adverse Event|9|||
155267653|NCT00308737|560414370|FG002|Overall Study|Adverse Event|0|||
155267654|NCT00308737|560414368|FG000|Overall Study|Death|4|||
155267655|NCT00308737|560414369|FG001|Overall Study|Death|3|||
155267656|NCT00308737|560414370|FG002|Overall Study|Death|0|||
155267657|NCT00308737|560414368|FG000|Overall Study|Lost to Follow-up|56|||
155267658|NCT00308737|560414369|FG001|Overall Study|Lost to Follow-up|80|||
155267659|NCT00308737|560414370|FG002|Overall Study|Lost to Follow-up|5|||
155267660|NCT00308737|560414368|FG000|Overall Study|Physician Decision|15|||
155267661|NCT00308737|560414369|FG001|Overall Study|Physician Decision|2|||
155267662|NCT00308737|560414370|FG002|Overall Study|Physician Decision|1|||
155267663|NCT00308737|560414368|FG000|Overall Study|Protocol Violation|34|||
155267664|NCT00308737|560414369|FG001|Overall Study|Protocol Violation|9|||
155267665|NCT00308737|560414370|FG002|Overall Study|Protocol Violation|5|||
155267666|NCT00308737|560414368|FG000|Overall Study|Withdrawal by Subject|218|||
155267667|NCT00308737|560414369|FG001|Overall Study|Withdrawal by Subject|166|||
155267668|NCT00308737|560414370|FG002|Overall Study|Withdrawal by Subject|18|||
155267669|NCT00308737|560414368|FG000|Overall Study|Various|32|||
155267670|NCT00308737|560414369|FG001|Overall Study|Various|20|||
155267671|NCT00308737|560414370|FG002|Overall Study|Various|8|||
155267672|NCT01225822|560414371|FG000|Overall Study|Adverse Event|13|||
155267673|NCT01225822|560414372|FG001|Overall Study|Adverse Event|31|||
155267674|NCT01225822|560414373|FG002|Overall Study|Adverse Event|18|||
155267675|NCT01225822|560414374|FG003|Overall Study|Adverse Event|23|||
155267676|NCT01225822|560414375|FG004|Overall Study|Adverse Event|14|||
155267677|NCT01225822|560414371|FG000|Overall Study|Protocol Violation|6|||
155267678|NCT01225822|560414372|FG001|Overall Study|Protocol Violation|8|||
155267679|NCT01225822|560414373|FG002|Overall Study|Protocol Violation|6|||
155267680|NCT01225822|560414374|FG003|Overall Study|Protocol Violation|7|||
155267681|NCT01225822|560414375|FG004|Overall Study|Protocol Violation|4|||
155267682|NCT01225822|560414371|FG000|Overall Study|Lost to Follow-up|0|||
155267683|NCT01225822|560414372|FG001|Overall Study|Lost to Follow-up|0|||
155267684|NCT01225822|560414373|FG002|Overall Study|Lost to Follow-up|0|||
155267685|NCT01225822|560414374|FG003|Overall Study|Lost to Follow-up|1|||
155267686|NCT01225822|560414375|FG004|Overall Study|Lost to Follow-up|0|||
155267687|NCT01225822|560414371|FG000|Overall Study|Withdrawal by Subject|6|||
155267688|NCT01225822|560414372|FG001|Overall Study|Withdrawal by Subject|7|||
155267689|NCT01225822|560414373|FG002|Overall Study|Withdrawal by Subject|7|||
155267690|NCT01225822|560414374|FG003|Overall Study|Withdrawal by Subject|11|||
155267691|NCT01225822|560414375|FG004|Overall Study|Withdrawal by Subject|6|||
155267692|NCT01225822|560414371|FG000|Overall Study|Other|13|||
155267693|NCT01225822|560414372|FG001|Overall Study|Other|10|||
155267694|NCT01225822|560414373|FG002|Overall Study|Other|7|||
155267695|NCT01225822|560414374|FG003|Overall Study|Other|10|||
155267696|NCT01225822|560414375|FG004|Overall Study|Other|7|||
155267697|NCT01290822|560414376|FG000|Overall Study|Withdrawal by Subject|1|||
155267698|NCT01290822|560414376|FG000|Overall Study|Physician Decision|10|||
155267699|NCT01515189|560414377|FG000|Induction|Disease Progression|109|||
155267700|NCT01515189|560414378|FG001|Induction|Disease Progression|155|||
155267701|NCT01515189|560414377|FG000|Induction|Study drug toxicity|86|||
155267702|NCT01515189|560414378|FG001|Induction|Study drug toxicity|36|||
155267703|NCT01515189|560414377|FG000|Induction|Death|24|||
155267704|NCT01515189|560414378|FG001|Induction|Death|17|||
155267705|NCT01515189|560414377|FG000|Induction|Adverse Event|14|||
155267706|NCT01515189|560414378|FG001|Induction|Adverse Event|9|||
155267707|NCT01515189|560414377|FG000|Induction|Withdrawal by Subject|3|||
155267708|NCT01515189|560414378|FG001|Induction|Withdrawal by Subject|9|||
155267709|NCT01515189|560414377|FG000|Induction|No longer meets study criteria|0|||
155267710|NCT01515189|560414378|FG001|Induction|No longer meets study criteria|2|||
155267711|NCT01515189|560414377|FG000|Induction|Lost to Follow-up|1|||
155267712|NCT01515189|560414378|FG001|Induction|Lost to Follow-up|0|||
155267713|NCT01515189|560414377|FG000|Induction|Other|0|||
155267714|NCT01515189|560414378|FG001|Induction|Other|4|||
155267715|NCT01515189|560414377|FG000|First Re-Induction Phase|Disease progression|6|||
155267716|NCT01515189|560414378|FG001|First Re-Induction Phase|Disease progression|14|||
155267717|NCT01515189|560414377|FG000|First Re-Induction Phase|Study drug toxicity|5|||
155267718|NCT01515189|560414378|FG001|First Re-Induction Phase|Study drug toxicity|0|||
155267719|NCT01515189|560414377|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
155267720|NCT01515189|560414378|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
155267721|NCT01515189|560414377|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
155267722|NCT01515189|560414378|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
155267723|NCT01515189|560414377|FG000|First Re-Induction Phase|Other|1|||
155267724|NCT01515189|560414378|FG001|First Re-Induction Phase|Other|0|||
155267725|NCT02100722|560414379|FG000|Overall Study|Withdrawal pre-procedure|4|||
155267726|NCT02100722|560414380|FG001|Overall Study|Withdrawal pre-procedure|9|||
155267727|NCT02100722|560414379|FG000|Overall Study|Withdrawal post-procedure|0|||
155267728|NCT02100722|560414380|FG001|Overall Study|Withdrawal post-procedure|3|||
155267729|NCT02100722|560414379|FG000|Overall Study|Lost to Follow-up|2|||
155267730|NCT02100722|560414380|FG001|Overall Study|Lost to Follow-up|2|||
155267731|NCT02100722|560414379|FG000|Overall Study|Continuing on study|751|||
155267732|NCT02100722|560414380|FG001|Overall Study|Continuing on study|729|||
155267733|NCT02541383|560414381|FG000|Overall Study|Death|50|||
155267734|NCT02541383|560414382|FG001|Overall Study|Death|37|||
155267735|NCT02541383|560414383|FG002|Overall Study|Death|48|||
155267736|NCT02541383|560414384|FG003|Overall Study|Death|41|||
155267737|NCT02541383|560414385|FG004|Overall Study|Death|21|||
155267738|NCT02541383|560414386|FG005|Overall Study|Death|25|||
155267739|NCT02541383|560414381|FG000|Overall Study|Lost to Follow-up|5|||
155267740|NCT02541383|560414382|FG001|Overall Study|Lost to Follow-up|3|||
155267741|NCT02541383|560414383|FG002|Overall Study|Lost to Follow-up|1|||
155267742|NCT02541383|560414384|FG003|Overall Study|Lost to Follow-up|1|||
155267743|NCT02541383|560414385|FG004|Overall Study|Lost to Follow-up|3|||
155267744|NCT02541383|560414386|FG005|Overall Study|Lost to Follow-up|0|||
155267745|NCT02541383|560414381|FG000|Overall Study|Consent withdrawn|5|||
155267746|NCT02541383|560414382|FG001|Overall Study|Consent withdrawn|6|||
155267747|NCT02541383|560414383|FG002|Overall Study|Consent withdrawn|1|||
155267748|NCT02541383|560414384|FG003|Overall Study|Consent withdrawn|1|||
155267749|NCT02541383|560414385|FG004|Overall Study|Consent withdrawn|0|||
155267750|NCT02541383|560414386|FG005|Overall Study|Consent withdrawn|0|||
155267751|NCT02541383|560414381|FG000|Overall Study|Sponsor's decision|1|||
155267752|NCT02541383|560414382|FG001|Overall Study|Sponsor's decision|1|||
155267753|NCT02541383|560414383|FG002|Overall Study|Sponsor's decision|0|||
155267754|NCT02541383|560414384|FG003|Overall Study|Sponsor's decision|0|||
155267755|NCT02541383|560414385|FG004|Overall Study|Sponsor's decision|0|||
155267756|NCT02541383|560414386|FG005|Overall Study|Sponsor's decision|0|||
155267757|NCT05644353|560414387|FG000|Overall Study|Physician Decision|1|||
155267758|NCT05644353|560414388|FG001|Overall Study|Physician Decision|0|||
155267759|NCT05644353|560414389|FG002|Overall Study|Physician Decision|0|||
155267760|NCT05644353|560414390|FG003|Overall Study|Physician Decision|0|||
155267761|NCT05644353|560414391|FG004|Overall Study|Physician Decision|0|||
155267762|NCT05644353|560414392|FG005|Overall Study|Physician Decision|0|||
155267763|NCT05644353|560414387|FG000|Overall Study|Protocol Violation|1|||
155267764|NCT05644353|560414388|FG001|Overall Study|Protocol Violation|0|||
155267765|NCT05644353|560414389|FG002|Overall Study|Protocol Violation|0|||
155267766|NCT05644353|560414390|FG003|Overall Study|Protocol Violation|0|||
155267767|NCT05644353|560414391|FG004|Overall Study|Protocol Violation|0|||
155267768|NCT05644353|560414392|FG005|Overall Study|Protocol Violation|0|||
155267769|NCT05644353|560414387|FG000|Overall Study|Withdrawal by Subject|0|||
155267770|NCT05644353|560414388|FG001|Overall Study|Withdrawal by Subject|2|||
155267771|NCT05644353|560414389|FG002|Overall Study|Withdrawal by Subject|0|||
155267772|NCT05644353|560414390|FG003|Overall Study|Withdrawal by Subject|0|||
155267773|NCT05644353|560414391|FG004|Overall Study|Withdrawal by Subject|1|||
155267774|NCT05644353|560414392|FG005|Overall Study|Withdrawal by Subject|0|||
155267775|NCT05644353|560414387|FG000|Overall Study|Lost to Follow-up|0|||
155267776|NCT05644353|560414388|FG001|Overall Study|Lost to Follow-up|0|||
155267777|NCT05644353|560414389|FG002|Overall Study|Lost to Follow-up|1|||
155267778|NCT05644353|560414390|FG003|Overall Study|Lost to Follow-up|0|||
155267779|NCT05644353|560414391|FG004|Overall Study|Lost to Follow-up|0|||
155267780|NCT05644353|560414392|FG005|Overall Study|Lost to Follow-up|0|||
155267781|NCT04986982|560414393|FG000|Overall Study|Withdrawal by Subject|3|||
155267782|NCT04986982|560414394|FG001|Overall Study|Withdrawal by Subject|1|||
155267783|NCT04986982|560414393|FG000|Overall Study|Lack of Efficacy|0|||
155267784|NCT04986982|560414394|FG001|Overall Study|Lack of Efficacy|2|||
155267785|NCT04986982|560414393|FG000|Overall Study|Ineligibility|3|||
155267786|NCT04986982|560414394|FG001|Overall Study|Ineligibility|0|||
155267787|NCT04986982|560414393|FG000|Overall Study|Adverse Event|4|||
155267788|NCT04986982|560414394|FG001|Overall Study|Adverse Event|4|||
155267789|NCT04986982|560414393|FG000|Overall Study|Lost to Follow-up|0|||
155267790|NCT04986982|560414394|FG001|Overall Study|Lost to Follow-up|1|||
155267791|NCT04986982|560414393|FG000|Overall Study|Sponsor's discretion|1|||
155267792|NCT04986982|560414394|FG001|Overall Study|Sponsor's discretion|0|||
155267793|NCT05796518|560414395|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
155267794|NCT01535274|560414396|FG000|Overall Study|Determined to be ineligible|0|||
155267795|NCT01535274|560414397|FG001|Overall Study|Determined to be ineligible|1|||
155267796|NCT01535274|560414396|FG000|Overall Study|Misallocated to propofol intervention|0|||
155267797|NCT01535274|560414397|FG001|Overall Study|Misallocated to propofol intervention|1|||
155267798|NCT02690077|560414400|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
155381728|NCT04617275|560830985|FG001|Follow-up Period|Adverse Event|1|||
155267799|NCT02690077|560414401|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
155267800|NCT02690077|560414400|FG000|Overall Study|Withdrawal by Subject|0|||
155267801|NCT02690077|560414401|FG001|Overall Study|Withdrawal by Subject|5|||
155267802|NCT02690077|560414400|FG000|Overall Study|Excluded by IRB|0|||
155267803|NCT02690077|560414401|FG001|Overall Study|Excluded by IRB|2|||
155267804|NCT01845974|560414402|FG000|Overall Study|screen failure|1|||
155267805|NCT01845974|560414403|FG001|Overall Study|screen failure|0|||
155267806|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Adverse Event|1|||
155267807|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Adverse Event|3|||
155267808|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Adverse Event|1|||
155267809|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Adverse Event|0|||
155267810|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Adverse Event|0|||
155267811|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Disease Progression|1|||
155267812|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Disease Progression|4|||
155267813|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Disease Progression|3|||
155267814|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Disease Progression|0|||
155267815|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Disease Progression|0|||
155267816|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267817|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267818|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
155267819|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267820|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267821|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Adverse Event|0|||
155267822|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Adverse Event|0|||
155267823|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Adverse Event|0|||
155267824|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Adverse Event|9|||
155267825|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Adverse Event|0|||
155267826|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267827|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267828|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267829|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
155267830|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267831|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Disease Progression|0|||
155267832|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Disease Progression|0|||
155267833|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Disease Progression|0|||
155267834|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Disease Progression|38|||
155267835|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Disease Progression|0|||
155267836|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267837|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267838|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267839|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
155267840|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267841|NCT02667886|560414404|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267842|NCT02667886|560414405|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267843|NCT02667886|560414406|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267844|NCT02667886|560414407|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267845|NCT02667886|560414408|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
155267846|NCT02667886|560414404|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
155267847|NCT02667886|560414405|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
155267848|NCT02667886|560414406|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
155267849|NCT02667886|560414407|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
155267850|NCT02667886|560414408|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
155267851|NCT00594217|560414409|FG000|Overall Study|Withdrawal by Subject|1|||
155267852|NCT00594217|560414410|FG001|Overall Study|Withdrawal by Subject|3|||
155267853|NCT05672680|560414411|FG000|Overall Study|Patient Did Not Complete the Form|5|||
155267854|NCT05672680|560414412|FG001|Overall Study|Patient Did Not Complete the Form|4|||
155267855|NCT05672680|560414411|FG000|Overall Study|Procedure Aborted|1|||
155267856|NCT05672680|560414412|FG001|Overall Study|Procedure Aborted|0|||
155267857|NCT04186403|560414413|FG000|Overall Study|Adverse Event|1|||
155267858|NCT04186403|560414414|FG001|Overall Study|Adverse Event|8|||
155267859|NCT04186403|560414413|FG000|Overall Study|Lost to Follow-up|7|||
155267860|NCT04186403|560414414|FG001|Overall Study|Lost to Follow-up|3|||
155267861|NCT04186403|560414413|FG000|Overall Study|Physician Decision|1|||
155267862|NCT04186403|560414414|FG001|Overall Study|Physician Decision|0|||
155267863|NCT04186403|560414413|FG000|Overall Study|Withdrawal by Subject|7|||
155267864|NCT04186403|560414414|FG001|Overall Study|Withdrawal by Subject|8|||
155267865|NCT04186403|560414413|FG000|Overall Study|Other: Not Related to Covid-19|3|||
155267866|NCT04186403|560414414|FG001|Overall Study|Other: Not Related to Covid-19|0|||
155267867|NCT03929562|560414419|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
155267868|NCT03929562|560414420|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
155267869|NCT03929562|560414419|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
155381729|NCT04617275|560830986|FG002|Follow-up Period|Adverse Event|2|||
155267870|NCT03929562|560414420|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
155267871|NCT03929562|560414419|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
155267872|NCT03929562|560414420|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
155267873|NCT01407354|560414428|FG000|First Intervention|Withdrawal by Subject|0|||
155267874|NCT01407354|560414429|FG001|First Intervention|Withdrawal by Subject|2|||
155267875|NCT01407354|560414428|FG000|First Intervention|Adverse Event|1|||
155267876|NCT01407354|560414429|FG001|First Intervention|Adverse Event|0|||
155267877|NCT01407354|560414428|FG000|First Intervention|Physician Decision|1|||
155267878|NCT01407354|560414429|FG001|First Intervention|Physician Decision|0|||
155267879|NCT01036022|560414430|FG000|Overall Study|Adverse Event|1|||
155267880|NCT01036022|560414431|FG001|Overall Study|Adverse Event|3|||
155267881|NCT01036022|560414432|FG002|Overall Study|Adverse Event|2|||
155267882|NCT01036022|560414433|FG003|Overall Study|Adverse Event|1|||
155267883|NCT01036022|560414434|FG004|Overall Study|Adverse Event|0|||
155267884|NCT01036022|560414435|FG005|Overall Study|Adverse Event|2|||
155267885|NCT01036022|560414430|FG000|Overall Study|Lack of Efficacy|1|||
155267886|NCT01036022|560414431|FG001|Overall Study|Lack of Efficacy|1|||
155267887|NCT01036022|560414432|FG002|Overall Study|Lack of Efficacy|1|||
155267888|NCT01036022|560414433|FG003|Overall Study|Lack of Efficacy|0|||
155267889|NCT01036022|560414434|FG004|Overall Study|Lack of Efficacy|1|||
155267890|NCT01036022|560414435|FG005|Overall Study|Lack of Efficacy|1|||
155267891|NCT01036022|560414430|FG000|Overall Study|Physician Decision|0|||
155267892|NCT01036022|560414431|FG001|Overall Study|Physician Decision|0|||
155267893|NCT01036022|560414432|FG002|Overall Study|Physician Decision|1|||
155267894|NCT01036022|560414433|FG003|Overall Study|Physician Decision|0|||
155267895|NCT01036022|560414434|FG004|Overall Study|Physician Decision|0|||
155267896|NCT01036022|560414435|FG005|Overall Study|Physician Decision|0|||
155267897|NCT01036022|560414430|FG000|Overall Study|Withdrawal by Subject|0|||
155267898|NCT01036022|560414431|FG001|Overall Study|Withdrawal by Subject|0|||
155267899|NCT01036022|560414432|FG002|Overall Study|Withdrawal by Subject|0|||
155267900|NCT01036022|560414433|FG003|Overall Study|Withdrawal by Subject|1|||
155267901|NCT01036022|560414434|FG004|Overall Study|Withdrawal by Subject|2|||
155267902|NCT01036022|560414435|FG005|Overall Study|Withdrawal by Subject|0|||
155267903|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
155267904|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
155267905|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
155267906|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
155267907|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
155267908|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
155267909|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
155267910|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
155267911|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
155267912|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
155267913|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
155267914|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
155267915|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267916|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267917|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267918|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267919|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
155267920|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267921|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
155267922|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267923|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267924|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267925|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267926|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
155267927|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267928|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267929|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267930|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
155267931|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
155267932|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267933|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267934|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
155267935|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267936|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
155267937|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
155267938|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267939|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
155267940|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267941|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
155267942|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
155267943|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267944|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267945|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267946|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
155267947|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267948|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267949|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267950|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267951|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
155267952|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
155267953|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
155267954|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
155267955|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
155267956|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
155267957|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
155267958|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267959|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
155267960|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267961|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267962|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267963|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267964|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267965|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267966|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267967|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267968|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267969|NCT00405639|560414443|FG000|Overall Study|Withdrawal by Subject|1|||
155267970|NCT00405639|560414444|FG001|Overall Study|Withdrawal by Subject|0|||
155267971|NCT00405639|560414443|FG000|Overall Study|Adverse Event|1|||
155267972|NCT00405639|560414444|FG001|Overall Study|Adverse Event|0|||
155267973|NCT00405639|560414443|FG000|Overall Study|Seizure prior to receiving BNP|1|||
155267974|NCT00405639|560414444|FG001|Overall Study|Seizure prior to receiving BNP|0|||
155267975|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
155267976|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
155267977|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
155267978|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
155267979|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
155267980|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
155267981|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
155267982|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
155267983|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
155267984|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
155267985|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
155267986|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
155267987|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
155267988|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
155267989|NCT02487095|560414451|FG000|Dose Expansion|Unable to scan/restage participant|0|||
155267990|NCT02487095|560414452|FG001|Dose Expansion|Unable to scan/restage participant|0|||
155267991|NCT02487095|560414453|FG002|Dose Expansion|Unable to scan/restage participant|0|||
155267992|NCT02487095|560414454|FG003|Dose Expansion|Unable to scan/restage participant|0|||
155267993|NCT02487095|560414455|FG004|Dose Expansion|Unable to scan/restage participant|1|||
155267994|NCT02130284|560414463|FG000|Overall Study|Withdrawal by Subject|3|||
155267995|NCT02130284|560414463|FG000|Overall Study|Subject Withdrew Consent|1|||
155267996|NCT02130284|560414463|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
155267997|NCT02130284|560414463|FG000|Overall Study|Subject was screened as backup for study|3|||
155267998|NCT02130284|560414463|FG000|Overall Study|Screen Failure|1|||
155267999|NCT03108157|560414464|FG000|Overall Study|Protocol Violation|15|||
155268000|NCT03108157|560414465|FG001|Overall Study|Protocol Violation|4|||
155268001|NCT04395183|560414466|FG000|Overall Study|Withdrawal by Subject|1|||
155268002|NCT04395183|560414467|FG001|Overall Study|Withdrawal by Subject|0|||
155268003|NCT04395183|560414468|FG002|Overall Study|Withdrawal by Subject|2|||
155268004|NCT04395183|560414469|FG003|Overall Study|Withdrawal by Subject|2|||
155268005|NCT01807650|560414476|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
155268006|NCT01807650|560414476|FG000|Overall Study|Adverse Event|5|||
155268007|NCT01807650|560414476|FG000|Overall Study|Other|2|||
155268008|NCT00736489|560414477|FG000|Period 1|Lost to Follow-up|1|||
155268009|NCT00736489|560414478|FG001|Period 1|Lost to Follow-up|0|||
155268010|NCT00736489|560414479|FG002|Period 1|Lost to Follow-up|0|||
155268011|NCT00736489|560414480|FG003|Period 1|Lost to Follow-up|0|||
155268012|NCT00736489|560414481|FG004|Period 1|Lost to Follow-up|0|||
155268013|NCT00736489|560414482|FG005|Period 1|Lost to Follow-up|0|||
155268014|NCT00736489|560414477|FG000|Period 1|Withdrawal by Subject|0|||
155268015|NCT00736489|560414478|FG001|Period 1|Withdrawal by Subject|0|||
155268016|NCT00736489|560414479|FG002|Period 1|Withdrawal by Subject|0|||
155268017|NCT00736489|560414480|FG003|Period 1|Withdrawal by Subject|0|||
155268018|NCT00736489|560414481|FG004|Period 1|Withdrawal by Subject|0|||
155268019|NCT00736489|560414482|FG005|Period 1|Withdrawal by Subject|1|||
155268020|NCT02946918|560414487|FG000|Overall Study|Patient unblinded himself|1|||
155268021|NCT02946918|560414488|FG001|Overall Study|Patient unblinded himself|0|||
155268022|NCT02946918|560414487|FG000|Overall Study|Physician Decision|0|||
155268023|NCT02946918|560414488|FG001|Overall Study|Physician Decision|2|||
155268024|NCT02946918|560414487|FG000|Overall Study|Ran out of study medication|0|||
155268025|NCT02946918|560414488|FG001|Overall Study|Ran out of study medication|1|||
155268026|NCT00069784|560414489|FG000|Overall Study|Adverse Event|105|||
155268027|NCT00069784|560414490|FG001|Overall Study|Adverse Event|0|||
155268028|NCT00069784|560414489|FG000|Overall Study|Withdrawal by Subject|1090|||
155268029|NCT00069784|560414490|FG001|Overall Study|Withdrawal by Subject|0|||
155268030|NCT00069784|560414489|FG000|Overall Study|Other|17|||
155268031|NCT00069784|560414490|FG001|Overall Study|Other|0|||
155268032|NCT02669095|560414494|FG000|Overall Study|Adverse Event|1|||
155268033|NCT02669095|560414495|FG001|Overall Study|Adverse Event|0|||
155268034|NCT02669095|560414494|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155268035|NCT02669095|560414495|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155268036|NCT02669095|560414494|FG000|Overall Study|Torn Lens|0|||
155268037|NCT02669095|560414495|FG001|Overall Study|Torn Lens|1|||
155268038|NCT02669095|560414494|FG000|Overall Study|Visit 5 assessments not completed|0|||
155268039|NCT02669095|560414495|FG001|Overall Study|Visit 5 assessments not completed|1|||
155268040|NCT01555164|560414500|FG000|Overall Study|Adverse Event|5|||
155268041|NCT01555164|560414501|FG001|Overall Study|Adverse Event|7|||
155268042|NCT01555164|560414500|FG000|Overall Study|Hyperglycemia|0|||
155268043|NCT01555164|560414501|FG001|Overall Study|Hyperglycemia|1|||
155268044|NCT01555164|560414500|FG000|Overall Study|Investigator's Discretion|2|||
155268045|NCT01555164|560414501|FG001|Overall Study|Investigator's Discretion|2|||
155268046|NCT01555164|560414500|FG000|Overall Study|Lost to Follow-up|4|||
155268047|NCT01555164|560414501|FG001|Overall Study|Lost to Follow-up|3|||
155268048|NCT01555164|560414500|FG000|Overall Study|Protocol Violation|9|||
155268049|NCT01555164|560414501|FG001|Overall Study|Protocol Violation|5|||
155268050|NCT01555164|560414500|FG000|Overall Study|Subject Non-compliance|14|||
155268051|NCT01555164|560414501|FG001|Overall Study|Subject Non-compliance|6|||
155268052|NCT01555164|560414500|FG000|Overall Study|Subject Withdrew Consent|6|||
155268053|NCT01555164|560414501|FG001|Overall Study|Subject Withdrew Consent|11|||
155268054|NCT03203694|560414502|FG000|Overall Study|Withdrawal by Subject|2|||
155268055|NCT03203694|560414503|FG001|Overall Study|Withdrawal by Subject|0|||
155268056|NCT03203694|560414504|FG002|Overall Study|Withdrawal by Subject|0|||
155268057|NCT03203694|560414505|FG003|Overall Study|Withdrawal by Subject|0|||
155268058|NCT03203694|560414506|FG004|Overall Study|Withdrawal by Subject|0|||
155268059|NCT03203694|560414507|FG005|Overall Study|Withdrawal by Subject|0|||
155268060|NCT03443713|560414508|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
155268061|NCT03443713|560414509|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
155268062|NCT03443713|560414510|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
155268063|NCT01672853|560414515|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
155268064|NCT01672853|560414516|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
155268065|NCT01672853|560414517|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
155268066|NCT01672853|560414515|FG000|Overall Study|Pregnancy|0|||
155268067|NCT01672853|560414516|FG001|Overall Study|Pregnancy|1|||
155268068|NCT01672853|560414517|FG002|Overall Study|Pregnancy|0|||
155268069|NCT01672853|560414515|FG000|Overall Study|Investigator's Discretion|1|||
155268070|NCT01672853|560414516|FG001|Overall Study|Investigator's Discretion|0|||
155614538|NCT00685360|561682981|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
155268071|NCT01672853|560414517|FG002|Overall Study|Investigator's Discretion|0|||
155268072|NCT01672853|560414515|FG000|Overall Study|Withdrew Consent|5|||
155268073|NCT01672853|560414516|FG001|Overall Study|Withdrew Consent|5|||
155268074|NCT01672853|560414517|FG002|Overall Study|Withdrew Consent|5|||
155268075|NCT01672853|560414515|FG000|Overall Study|Adverse Event|4|||
155381730|NCT04617275|560830987|FG003|Follow-up Period|Adverse Event|3|||
155381731|NCT04617275|560830988|FG004|Follow-up Period|Adverse Event|4|||
155614539|NCT00685360|561682982|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
155268076|NCT01672853|560414516|FG001|Overall Study|Adverse Event|6|||
155268077|NCT01672853|560414517|FG002|Overall Study|Adverse Event|8|||
155268078|NCT01672853|560414515|FG000|Overall Study|Lost to Follow-up|0|||
155268079|NCT01672853|560414516|FG001|Overall Study|Lost to Follow-up|1|||
155268080|NCT01672853|560414517|FG002|Overall Study|Lost to Follow-up|0|||
155268081|NCT01672853|560414515|FG000|Overall Study|Randomized but Never Treated|0|||
155268082|NCT01672853|560414516|FG001|Overall Study|Randomized but Never Treated|0|||
155381732|NCT04617275|560830989|FG005|Follow-up Period|Adverse Event|3|||
155268083|NCT01672853|560414517|FG002|Overall Study|Randomized but Never Treated|1|||
155268084|NCT02969525|560414518|FG000|Double-Blind Period|Adverse Event|0|||
155268085|NCT02969525|560414519|FG001|Double-Blind Period|Adverse Event|0|||
155268086|NCT02969525|560414520|FG002|Double-Blind Period|Adverse Event|1|||
155268087|NCT02969525|560414521|FG003|Double-Blind Period|Adverse Event|1|||
155268088|NCT02969525|560414522|FG004|Double-Blind Period|Adverse Event|0|||
155268089|NCT02969525|560414523|FG005|Double-Blind Period|Adverse Event|0|||
155268090|NCT02969525|560414524|FG006|Double-Blind Period|Adverse Event|0|||
155268091|NCT02969525|560414525|FG007|Double-Blind Period|Adverse Event|0|||
155268092|NCT02969525|560414526|FG008|Double-Blind Period|Adverse Event|0|||
155268093|NCT02969525|560414527|FG009|Double-Blind Period|Adverse Event|0|||
155268094|NCT02969525|560414528|FG010|Double-Blind Period|Adverse Event|0|||
155268095|NCT02969525|560414529|FG011|Double-Blind Period|Adverse Event|0|||
155268096|NCT02969525|560414518|FG000|Double-Blind Period|LOW EGFR|0|||
155268097|NCT02969525|560414519|FG001|Double-Blind Period|LOW EGFR|0|||
155268098|NCT02969525|560414520|FG002|Double-Blind Period|LOW EGFR|0|||
155268099|NCT02969525|560414521|FG003|Double-Blind Period|LOW EGFR|1|||
155268100|NCT02969525|560414522|FG004|Double-Blind Period|LOW EGFR|0|||
155268101|NCT02969525|560414523|FG005|Double-Blind Period|LOW EGFR|0|||
155268102|NCT02969525|560414524|FG006|Double-Blind Period|LOW EGFR|0|||
155268103|NCT02969525|560414525|FG007|Double-Blind Period|LOW EGFR|0|||
155268104|NCT02969525|560414526|FG008|Double-Blind Period|LOW EGFR|0|||
155268105|NCT02969525|560414527|FG009|Double-Blind Period|LOW EGFR|0|||
155268106|NCT02969525|560414528|FG010|Double-Blind Period|LOW EGFR|0|||
155268107|NCT02969525|560414529|FG011|Double-Blind Period|LOW EGFR|0|||
155268108|NCT02969525|560414518|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
155268109|NCT02969525|560414519|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268110|NCT02969525|560414520|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268111|NCT02969525|560414521|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
155268112|NCT02969525|560414522|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268113|NCT02969525|560414523|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268114|NCT02969525|560414524|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268115|NCT02969525|560414525|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268116|NCT02969525|560414526|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268117|NCT02969525|560414527|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268118|NCT02969525|560414528|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268119|NCT02969525|560414529|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268120|NCT02969525|560414518|FG000|Dose-Blind Period|Adverse Event|0|||
155268121|NCT02969525|560414519|FG001|Dose-Blind Period|Adverse Event|0|||
155268122|NCT02969525|560414520|FG002|Dose-Blind Period|Adverse Event|0|||
155268123|NCT02969525|560414521|FG003|Dose-Blind Period|Adverse Event|0|||
155268124|NCT02969525|560414522|FG004|Dose-Blind Period|Adverse Event|0|||
155268125|NCT02969525|560414523|FG005|Dose-Blind Period|Adverse Event|0|||
155268126|NCT02969525|560414524|FG006|Dose-Blind Period|Adverse Event|0|||
155268127|NCT02969525|560414525|FG007|Dose-Blind Period|Adverse Event|0|||
155268128|NCT02969525|560414526|FG008|Dose-Blind Period|Adverse Event|0|||
155268129|NCT02969525|560414527|FG009|Dose-Blind Period|Adverse Event|1|||
155268130|NCT02969525|560414528|FG010|Dose-Blind Period|Adverse Event|1|||
155268131|NCT02969525|560414529|FG011|Dose-Blind Period|Adverse Event|1|||
155268132|NCT02969525|560414518|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
155268133|NCT02969525|560414519|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
155268134|NCT02969525|560414520|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
155268135|NCT02969525|560414521|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
155268136|NCT02969525|560414522|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
155268137|NCT02969525|560414523|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
155268138|NCT02969525|560414524|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
155268139|NCT02969525|560414525|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
155268140|NCT02969525|560414526|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
155268141|NCT02969525|560414527|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
155268142|NCT02969525|560414528|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
155268143|NCT02969525|560414529|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
155268144|NCT02969525|560414518|FG000|Dose-Blind Period|Non-cooperating patient|0|||
155268145|NCT02969525|560414519|FG001|Dose-Blind Period|Non-cooperating patient|0|||
155268146|NCT02969525|560414520|FG002|Dose-Blind Period|Non-cooperating patient|0|||
155268147|NCT02969525|560414521|FG003|Dose-Blind Period|Non-cooperating patient|0|||
155268148|NCT02969525|560414522|FG004|Dose-Blind Period|Non-cooperating patient|0|||
155268149|NCT02969525|560414523|FG005|Dose-Blind Period|Non-cooperating patient|0|||
155268150|NCT02969525|560414524|FG006|Dose-Blind Period|Non-cooperating patient|0|||
155268151|NCT02969525|560414525|FG007|Dose-Blind Period|Non-cooperating patient|0|||
155268152|NCT02969525|560414526|FG008|Dose-Blind Period|Non-cooperating patient|0|||
155268153|NCT02969525|560414527|FG009|Dose-Blind Period|Non-cooperating patient|0|||
155268154|NCT02969525|560414528|FG010|Dose-Blind Period|Non-cooperating patient|0|||
155268155|NCT02969525|560414529|FG011|Dose-Blind Period|Non-cooperating patient|1|||
155268156|NCT02969525|560414518|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155614540|NCT00685360|561682980|FG000|Overall Study|Protocol Deviation|0|||
155614541|NCT00685360|561682981|FG001|Overall Study|Protocol Deviation|1|||
155614542|NCT00685360|561682982|FG002|Overall Study|Protocol Deviation|1|||
155614543|NCT01408901|561682985|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
155614544|NCT01408901|561682986|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
155614545|NCT01408901|561682987|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
155614546|NCT01408901|561682988|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
155614547|NCT01408901|561682985|FG000|6-Week Follow-Up|Death|1|||
155614548|NCT01408901|561682986|FG001|6-Week Follow-Up|Death|0|||
155614549|NCT01408901|561682987|FG002|6-Week Follow-Up|Death|0|||
155614550|NCT01408901|561682988|FG003|6-Week Follow-Up|Death|0|||
155614551|NCT01408901|561682985|FG000|6-Week Follow-Up|Cancelled visit|0|||
155614552|NCT01408901|561682986|FG001|6-Week Follow-Up|Cancelled visit|1|||
155614553|NCT01408901|561682987|FG002|6-Week Follow-Up|Cancelled visit|0|||
155614554|NCT01408901|561682988|FG003|6-Week Follow-Up|Cancelled visit|2|||
155614555|NCT01408901|561682985|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155614556|NCT01408901|561682986|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155614557|NCT01408901|561682987|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155614558|NCT01408901|561682988|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
155614559|NCT01408901|561682985|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
155614560|NCT01408901|561682986|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155614561|NCT01408901|561682987|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155614562|NCT01408901|561682988|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155614563|NCT01408901|561682985|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
155614564|NCT01408901|561682986|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
155614565|NCT01408901|561682987|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
155614566|NCT01408901|561682988|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
155614567|NCT01408901|561682985|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
155614568|NCT01408901|561682986|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
155614569|NCT01408901|561682987|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
155614570|NCT01408901|561682988|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
155614571|NCT01408901|561682985|FG000|26-Week Follow-Up|Death|0|||
155614572|NCT01408901|561682986|FG001|26-Week Follow-Up|Death|1|||
155614573|NCT01408901|561682987|FG002|26-Week Follow-Up|Death|0|||
155614574|NCT01408901|561682988|FG003|26-Week Follow-Up|Death|0|||
155614575|NCT00547157|561682998|FG000|Overall Study|Other|1|||
155614576|NCT00547157|561682999|FG001|Overall Study|Other|0|||
155614577|NCT00547157|561682998|FG000|Overall Study|Death|38|||
155614578|NCT00547157|561682999|FG001|Overall Study|Death|18|||
155614579|NCT00547157|561682998|FG000|Overall Study|Withdrawal by Subject|3|||
155614580|NCT00547157|561682999|FG001|Overall Study|Withdrawal by Subject|1|||
155614581|NCT00547157|561682998|FG000|Overall Study|Administrative decision|3|||
155614582|NCT00547157|561682999|FG001|Overall Study|Administrative decision|2|||
155614583|NCT00547157|561682998|FG000|Overall Study|Lost to Follow-up|4|||
155614584|NCT00547157|561682999|FG001|Overall Study|Lost to Follow-up|2|||
155614585|NCT01151345|561683002|FG000|First Intervention Period|Protocol Violation|0|||
155614586|NCT01151345|561683003|FG001|First Intervention Period|Protocol Violation|1|||
155614587|NCT01765569|561683004|FG000|Period B|Withdrawal by Subject|1|||
155614588|NCT01765569|561683004|FG000|Period C|Death|1|||
155614589|NCT01030718|561683005|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
155614590|NCT01030718|561683006|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
155614591|NCT01030718|561683007|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
155614592|NCT01030718|561683005|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
155614593|NCT01030718|561683006|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
155614594|NCT01030718|561683007|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
155614595|NCT01030718|561683005|FG000|Studies CA180-031 and -036 Combined|Death|0|||
155614596|NCT01030718|561683006|FG001|Studies CA180-031 and -036 Combined|Death|1|||
155614597|NCT01030718|561683007|FG002|Studies CA180-031 and -036 Combined|Death|0|||
155614598|NCT01030718|561683005|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
155614599|NCT01030718|561683006|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
155614600|NCT01030718|561683007|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
155614601|NCT01030718|561683005|FG000|Study CA180-036 Only|insufficient effect|1|||
155614602|NCT01030718|561683006|FG001|Study CA180-036 Only|insufficient effect|1|||
155614603|NCT01030718|561683007|FG002|Study CA180-036 Only|insufficient effect|5|||
155614604|NCT01030718|561683005|FG000|Study CA180-036 Only|Adverse Event|2|||
155614605|NCT01030718|561683006|FG001|Study CA180-036 Only|Adverse Event|3|||
155614606|NCT01030718|561683007|FG002|Study CA180-036 Only|Adverse Event|0|||
155614607|NCT01030718|561683005|FG000|Study CA180-036 Only|Death|0|||
155614608|NCT01030718|561683006|FG001|Study CA180-036 Only|Death|1|||
155614609|NCT01030718|561683007|FG002|Study CA180-036 Only|Death|0|||
155614610|NCT01030718|561683005|FG000|Study CA180-036 Only|Other Reasons|0|||
155614611|NCT01030718|561683006|FG001|Study CA180-036 Only|Other Reasons|2|||
155614612|NCT01030718|561683007|FG002|Study CA180-036 Only|Other Reasons|0|||
155614613|NCT00423813|561683008|FG000|Overall Study|Adverse Event|11|||
155614614|NCT00423813|561683009|FG001|Overall Study|Adverse Event|30|||
155614615|NCT00423813|561683010|FG002|Overall Study|Adverse Event|40|||
155614616|NCT00423813|561683008|FG000|Overall Study|Withdrawal by Subject|6|||
155268157|NCT02969525|560414519|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268158|NCT02969525|560414520|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268159|NCT02969525|560414521|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268160|NCT02969525|560414522|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268161|NCT02969525|560414523|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268162|NCT02969525|560414524|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268163|NCT02969525|560414525|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268164|NCT02969525|560414526|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268165|NCT02969525|560414527|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268166|NCT02969525|560414528|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
155268167|NCT02969525|560414529|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268168|NCT03445065|560414530|FG000|Overall Study|Withdrawal by Subject|3|||
155268169|NCT03445065|560414531|FG001|Overall Study|Withdrawal by Subject|6|||
155268170|NCT03445065|560414532|FG002|Overall Study|Withdrawal by Subject|2|||
155268171|NCT03445065|560414533|FG003|Overall Study|Withdrawal by Subject|2|||
155268172|NCT03445065|560414530|FG000|Overall Study|Other|4|||
155268173|NCT03445065|560414531|FG001|Overall Study|Other|3|||
155268174|NCT03445065|560414532|FG002|Overall Study|Other|3|||
155268175|NCT03445065|560414533|FG003|Overall Study|Other|1|||
155268176|NCT01158378|560416372|FG000|Overall Study|Death|4|||
155268177|NCT01158378|560416373|FG001|Overall Study|Death|5|||
155268178|NCT01158378|560416372|FG000|Overall Study|Lost to Follow-up|2|||
155268179|NCT01158378|560416373|FG001|Overall Study|Lost to Follow-up|4|||
155268180|NCT01158378|560416372|FG000|Overall Study|Withdrawal by Subject|4|||
155268181|NCT01158378|560416373|FG001|Overall Study|Withdrawal by Subject|0|||
155268182|NCT03017235|560416374|FG000|Overall Study|Withdrawal by Subject|4|||
155268183|NCT03017235|560416375|FG001|Overall Study|Withdrawal by Subject|3|||
155268184|NCT03017235|560416374|FG000|Overall Study|Lost to Follow-up|2|||
155268185|NCT03017235|560416375|FG001|Overall Study|Lost to Follow-up|7|||
155268186|NCT03017235|560416374|FG000|Overall Study|Adverse Event|0|||
155268187|NCT03017235|560416375|FG001|Overall Study|Adverse Event|1|||
155268188|NCT03017235|560416374|FG000|Overall Study|Protocol Violation|2|||
155268189|NCT03017235|560416375|FG001|Overall Study|Protocol Violation|1|||
155268190|NCT03017235|560416374|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
155268191|NCT03017235|560416375|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
155268192|NCT00453310|560416380|FG000|Overall Study|Progression of Disease|10|||
155268193|NCT01806740|560416381|FG000|Overall Study|Withdrawal by Subject|4|||
155268194|NCT01806740|560416381|FG000|Overall Study|Physician Decision|1|||
155268195|NCT01806740|560416381|FG000|Overall Study|Patient's refusal of treatment|1|||
155268196|NCT04666922|560416382|FG000|Overall Study|Withdrawal by Subject|1|||
155268197|NCT04666922|560416383|FG001|Overall Study|Withdrawal by Subject|0|||
155268198|NCT04666922|560416384|FG002|Overall Study|Withdrawal by Subject|0|||
155268199|NCT04666922|560416385|FG003|Overall Study|Withdrawal by Subject|0|||
155268200|NCT04666922|560416386|FG004|Overall Study|Withdrawal by Subject|0|||
155268201|NCT04666922|560416387|FG005|Overall Study|Withdrawal by Subject|0|||
155268202|NCT04666922|560416388|FG006|Overall Study|Withdrawal by Subject|0|||
155268203|NCT01382940|560416391|FG000|Overall Study|Adverse Event|19|||
155268204|NCT01382940|560416391|FG000|Overall Study|Lost to Follow-up|4|||
155268205|NCT01382940|560416391|FG000|Overall Study|Physician Decision|7|||
155268206|NCT01382940|560416391|FG000|Overall Study|Withdrawal by Subject|23|||
155268207|NCT01382940|560416391|FG000|Overall Study|Protocol Violation|20|||
155268208|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
155268209|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268210|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268211|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268212|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268213|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
155268214|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268215|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268216|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268217|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268218|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
155268219|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268220|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155726456|NCT04322526|562098135|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
155268221|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268222|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268223|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
155381733|NCT04617275|560830990|FG006|Follow-up Period|Adverse Event|0|||
155268224|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268225|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268226|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268227|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268228|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
155268229|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268230|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268231|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268232|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268233|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
155268234|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268235|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268236|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268237|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268238|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
155268239|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268240|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268241|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268242|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268243|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
155268244|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268245|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268246|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268247|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268248|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
155268249|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268250|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268251|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268252|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268253|NCT02105636|560416400|FG000|Pre-Treatment|Disease Progression|1|||
155268254|NCT02105636|560416401|FG001|Pre-Treatment|Disease Progression|0|||
155268255|NCT02105636|560416400|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
155268256|NCT02105636|560416401|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
155268257|NCT02105636|560416400|FG000|Pre-Treatment|Participant withdrew consent|0|||
155268258|NCT02105636|560416401|FG001|Pre-Treatment|Participant withdrew consent|6|||
155268259|NCT02105636|560416400|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155268260|NCT02105636|560416401|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
155268261|NCT02105636|560416400|FG000|Treatment|Study Drug Toxicity|14|||
155268262|NCT02105636|560416401|FG001|Treatment|Study Drug Toxicity|10|||
155268263|NCT02105636|560416400|FG000|Treatment|Adverse event unrelated to study drug|19|||
155268264|NCT02105636|560416401|FG001|Treatment|Adverse event unrelated to study drug|3|||
155268265|NCT02105636|560416400|FG000|Treatment|Participant request to discontinue study treatment|8|||
155268266|NCT02105636|560416401|FG001|Treatment|Participant request to discontinue study treatment|6|||
155268267|NCT02105636|560416400|FG000|Treatment|Participant withdrew consent|5|||
155268268|NCT02105636|560416401|FG001|Treatment|Participant withdrew consent|1|||
155268269|NCT02105636|560416400|FG000|Treatment|Lost to Follow-up|1|||
155268270|NCT02105636|560416401|FG001|Treatment|Lost to Follow-up|0|||
155268271|NCT02105636|560416400|FG000|Treatment|Maximum Clinical Benefit|1|||
155268272|NCT02105636|560416401|FG001|Treatment|Maximum Clinical Benefit|3|||
155268273|NCT02105636|560416400|FG000|Treatment|Poor/Non-compliance|0|||
155268274|NCT02105636|560416401|FG001|Treatment|Poor/Non-compliance|1|||
155268275|NCT02105636|560416400|FG000|Treatment|Participant no longer meets study criteria|1|||
155268276|NCT02105636|560416401|FG001|Treatment|Participant no longer meets study criteria|0|||
155268277|NCT02105636|560416400|FG000|Treatment|Other reasons|1|||
155268278|NCT02105636|560416401|FG001|Treatment|Other reasons|0|||
155268279|NCT02105636|560416400|FG000|Treatment|Disease Progression|185|||
155268280|NCT02105636|560416401|FG001|Treatment|Disease Progression|87|||
155268281|NCT00720902|560416402|FG000|Overall Study|Withdrawal by Subject|1|||
155268282|NCT00720902|560416403|FG001|Overall Study|Withdrawal by Subject|0|||
155268283|NCT00720902|560416402|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
155268284|NCT00720902|560416403|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
155381734|NCT04617275|560830991|FG007|Follow-up Period|Adverse Event|3|||
155381735|NCT04617275|560830984|FG000|Follow-up Period|Lost to Follow-up|0|||
155268285|NCT03462706|560416405|FG000|Overall Study|Polyp was pedunculated|1|||
155268286|NCT03462706|560416406|FG001|Overall Study|Polyp was pedunculated|0|||
155268287|NCT03462706|560416407|FG002|Overall Study|Polyp was pedunculated|1|||
155268288|NCT03462706|560416408|FG003|Overall Study|Polyp was pedunculated|0|||
155268289|NCT03462706|560416405|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
155268290|NCT03462706|560416406|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
155268291|NCT03462706|560416407|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
155268292|NCT03462706|560416408|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
155268293|NCT00474929|560416418|FG000|Overall Study|Withdrawal by Subject|0|||
155268294|NCT00474929|560416419|FG001|Overall Study|Withdrawal by Subject|1|||
155268295|NCT00474929|560416420|FG002|Overall Study|Withdrawal by Subject|0|||
155268296|NCT00474929|560416421|FG003|Overall Study|Withdrawal by Subject|0|||
155268297|NCT00474929|560416422|FG004|Overall Study|Withdrawal by Subject|0|||
155268298|NCT00474929|560416418|FG000|Overall Study|Unrelated medical condition|0|||
155268299|NCT00474929|560416419|FG001|Overall Study|Unrelated medical condition|0|||
155268300|NCT00474929|560416420|FG002|Overall Study|Unrelated medical condition|1|||
155268301|NCT00474929|560416421|FG003|Overall Study|Unrelated medical condition|0|||
155268302|NCT00474929|560416422|FG004|Overall Study|Unrelated medical condition|0|||
155268303|NCT00474929|560416418|FG000|Overall Study|Physician Decision|0|||
155268304|NCT00474929|560416419|FG001|Overall Study|Physician Decision|0|||
155268305|NCT00474929|560416420|FG002|Overall Study|Physician Decision|1|||
155268306|NCT00474929|560416421|FG003|Overall Study|Physician Decision|2|||
155268307|NCT00474929|560416422|FG004|Overall Study|Physician Decision|0|||
155268308|NCT03661996|560416425|FG000|Overall Study|Adverse Event|0|||
155268309|NCT03661996|560416426|FG001|Overall Study|Adverse Event|0|||
155268310|NCT03661996|560416427|FG002|Overall Study|Adverse Event|1|||
155268311|NCT03661996|560416428|FG003|Overall Study|Adverse Event|1|||
155268312|NCT03661996|560416429|FG004|Overall Study|Adverse Event|0|||
155268313|NCT03661996|560416425|FG000|Overall Study|Lost to Follow-up|5|||
155268314|NCT03661996|560416426|FG001|Overall Study|Lost to Follow-up|1|||
155268315|NCT03661996|560416427|FG002|Overall Study|Lost to Follow-up|2|||
155268316|NCT03661996|560416428|FG003|Overall Study|Lost to Follow-up|2|||
155268317|NCT03661996|560416429|FG004|Overall Study|Lost to Follow-up|6|||
155268318|NCT03661996|560416425|FG000|Overall Study|Physician Decision|1|||
155268319|NCT03661996|560416426|FG001|Overall Study|Physician Decision|1|||
155268320|NCT03661996|560416427|FG002|Overall Study|Physician Decision|1|||
155268321|NCT03661996|560416428|FG003|Overall Study|Physician Decision|2|||
155268322|NCT03661996|560416429|FG004|Overall Study|Physician Decision|0|||
155268323|NCT03661996|560416425|FG000|Overall Study|Protocol Violation|0|||
155268324|NCT03661996|560416426|FG001|Overall Study|Protocol Violation|0|||
155268325|NCT03661996|560416427|FG002|Overall Study|Protocol Violation|0|||
155268326|NCT03661996|560416428|FG003|Overall Study|Protocol Violation|0|||
155268327|NCT03661996|560416429|FG004|Overall Study|Protocol Violation|1|||
155268328|NCT03661996|560416425|FG000|Overall Study|Withdrawal by Subject|3|||
155268329|NCT03661996|560416426|FG001|Overall Study|Withdrawal by Subject|5|||
155268330|NCT03661996|560416427|FG002|Overall Study|Withdrawal by Subject|1|||
155268331|NCT03661996|560416428|FG003|Overall Study|Withdrawal by Subject|7|||
155268332|NCT03661996|560416429|FG004|Overall Study|Withdrawal by Subject|7|||
155268333|NCT03661996|560416425|FG000|Overall Study|Sponsors Decision|2|||
155268334|NCT03661996|560416426|FG001|Overall Study|Sponsors Decision|0|||
155268335|NCT03661996|560416427|FG002|Overall Study|Sponsors Decision|0|||
155268336|NCT03661996|560416428|FG003|Overall Study|Sponsors Decision|0|||
155268337|NCT03661996|560416429|FG004|Overall Study|Sponsors Decision|0|||
155268338|NCT03661996|560416425|FG000|Overall Study|Other|1|||
155268339|NCT03661996|560416426|FG001|Overall Study|Other|1|||
155268340|NCT03661996|560416427|FG002|Overall Study|Other|1|||
155268341|NCT03661996|560416428|FG003|Overall Study|Other|1|||
155268342|NCT03661996|560416429|FG004|Overall Study|Other|0|||
155268343|NCT03321513|560416430|FG000|Overall Study|Death|11|||
155268344|NCT03321513|560416431|FG001|Overall Study|Death|5|||
155268345|NCT03321513|560416430|FG000|Overall Study|Withdrawal by Subject|5|||
155268346|NCT03321513|560416431|FG001|Overall Study|Withdrawal by Subject|10|||
155268347|NCT03321513|560416430|FG000|Overall Study|Lost to Follow-up|10|||
155268348|NCT03321513|560416431|FG001|Overall Study|Lost to Follow-up|11|||
155268349|NCT01976364|560416432|FG000|Main Study (36 Months)|Adverse Event|63|||
155268350|NCT01976364|560416433|FG001|Main Study (36 Months)|Adverse Event|0|||
155268351|NCT01976364|560416434|FG002|Main Study (36 Months)|Adverse Event|0|||
155268352|NCT01976364|560416432|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
155268353|NCT01976364|560416433|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
155268354|NCT01976364|560416434|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
155726457|NCT04322526|562098136|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155268355|NCT01976364|560416432|FG000|Main Study (36 Months)|Other|13|||
155268356|NCT01976364|560416433|FG001|Main Study (36 Months)|Other|0|||
155268357|NCT01976364|560416434|FG002|Main Study (36 Months)|Other|0|||
155268358|NCT01976364|560416432|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
155268359|NCT01976364|560416433|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
155268360|NCT01976364|560416434|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
155268361|NCT01976364|560416432|FG000|Main Study (36 Months)|Medication error|1|||
155268362|NCT01976364|560416433|FG001|Main Study (36 Months)|Medication error|0|||
155268363|NCT01976364|560416434|FG002|Main Study (36 Months)|Medication error|0|||
155268364|NCT01976364|560416432|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
155268365|NCT01976364|560416433|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
155268366|NCT01976364|560416434|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
155268367|NCT01976364|560416432|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
155268368|NCT01976364|560416433|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
155268369|NCT01976364|560416434|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
155268370|NCT01976364|560416432|FG000|Main Study (36 Months)|Protocol Violation|13|||
155268371|NCT01976364|560416433|FG001|Main Study (36 Months)|Protocol Violation|0|||
155268372|NCT01976364|560416434|FG002|Main Study (36 Months)|Protocol Violation|0|||
155268373|NCT01976364|560416432|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
155268374|NCT01976364|560416433|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
155268375|NCT01976364|560416434|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
155268376|NCT01976364|560416432|FG000|Main Study (36 Months)|Death|5|||
155268377|NCT01976364|560416433|FG001|Main Study (36 Months)|Death|0|||
155268378|NCT01976364|560416434|FG002|Main Study (36 Months)|Death|0|||
155268379|NCT01976364|560416432|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
155268380|NCT01976364|560416433|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
155268381|NCT01976364|560416434|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
155268382|NCT01976364|560416432|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
155268383|NCT01976364|560416433|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
155268384|NCT01976364|560416434|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
155268385|NCT01976364|560416432|FG000|Sub-study (12 Months)|Protocol Violation|0|||
155268386|NCT01976364|560416433|FG001|Sub-study (12 Months)|Protocol Violation|1|||
155268387|NCT01976364|560416434|FG002|Sub-study (12 Months)|Protocol Violation|1|||
155268388|NCT01976364|560416432|FG000|Sub-study (12 Months)|Adverse Event|0|||
155268389|NCT01976364|560416433|FG001|Sub-study (12 Months)|Adverse Event|4|||
155268390|NCT01976364|560416434|FG002|Sub-study (12 Months)|Adverse Event|3|||
155268391|NCT02757521|560416435|FG000|Overall Study|Adverse Event|1|||
155268392|NCT02757521|560416436|FG001|Overall Study|Adverse Event|0|||
155268393|NCT01161472|560416437|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
155268394|NCT01161472|560416438|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268395|NCT01161472|560416439|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268396|NCT01161472|560416440|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268397|NCT00003511|560416441|FG000|Overall Study|Not evaluable|4|||
155268398|NCT02914184|560416442|FG000|Overall Study|Lost to Follow-up|7|||
155268399|NCT02914184|560416443|FG001|Overall Study|Lost to Follow-up|10|||
155268400|NCT02914184|560416444|FG002|Overall Study|Lost to Follow-up|8|||
155268401|NCT02914184|560416445|FG003|Overall Study|Lost to Follow-up|7|||
155268402|NCT02914184|560416442|FG000|Overall Study|Withdrawal by Subject|4|||
155268403|NCT02914184|560416443|FG001|Overall Study|Withdrawal by Subject|2|||
155268404|NCT02914184|560416444|FG002|Overall Study|Withdrawal by Subject|7|||
155268405|NCT02914184|560416445|FG003|Overall Study|Withdrawal by Subject|3|||
155268406|NCT02914184|560416442|FG000|Overall Study|Other|1|||
155268407|NCT02914184|560416443|FG001|Overall Study|Other|0|||
155268408|NCT02914184|560416444|FG002|Overall Study|Other|0|||
155268409|NCT02914184|560416445|FG003|Overall Study|Other|0|||
155268410|NCT02914184|560416442|FG000|Overall Study|Migrated/moved from the study area|2|||
155268411|NCT02914184|560416443|FG001|Overall Study|Migrated/moved from the study area|1|||
155268412|NCT02914184|560416444|FG002|Overall Study|Migrated/moved from the study area|2|||
155268413|NCT02914184|560416445|FG003|Overall Study|Migrated/moved from the study area|1|||
155268414|NCT00798174|560416449|FG000|Overall Study|inability to implant azygos coil|3|||
155268415|NCT00798174|560416450|FG001|Overall Study|inability to implant azygos coil|3|||
155268416|NCT00798174|560416449|FG000|Overall Study|Inability to sedate for DFT testing|1|||
155268417|NCT00798174|560416450|FG001|Overall Study|Inability to sedate for DFT testing|0|||
155268418|NCT01683994|560416469|FG000|Overall Study|Withdrawal by Subject|1|||
155268419|NCT01683994|560416470|FG001|Overall Study|Withdrawal by Subject|0|||
155268420|NCT01683994|560416471|FG002|Overall Study|Withdrawal by Subject|0|||
155268421|NCT01683994|560416472|FG003|Overall Study|Withdrawal by Subject|1|||
155268422|NCT01683994|560416473|FG004|Overall Study|Withdrawal by Subject|0|||
155268423|NCT01683994|560416469|FG000|Overall Study|Intercurrent illness|0|||
155268424|NCT01683994|560416470|FG001|Overall Study|Intercurrent illness|0|||
155268425|NCT01683994|560416471|FG002|Overall Study|Intercurrent illness|0|||
155268426|NCT01683994|560416472|FG003|Overall Study|Intercurrent illness|2|||
155268427|NCT01683994|560416473|FG004|Overall Study|Intercurrent illness|1|||
155268428|NCT00999661|560416474|FG000|Overall Study|Lost to Follow-up|59|||
155268429|NCT00999661|560416474|FG000|Overall Study|Adverse Event|1|||
155268430|NCT00999661|560416474|FG000|Overall Study|Withdrawal by Subject|1|||
155268431|NCT00999661|560416474|FG000|Overall Study|Not meeting eligibility criteria|9|||
155268432|NCT00312858|560416475|FG000|Overall Study|Adverse Event|0|||
155268433|NCT00312858|560416476|FG001|Overall Study|Adverse Event|1|||
155268434|NCT00312858|560416475|FG000|Overall Study|Lost to Follow-up|25|||
155268435|NCT00312858|560416476|FG001|Overall Study|Lost to Follow-up|42|||
155268436|NCT00312858|560416475|FG000|Overall Study|Protocol Violation|3|||
155268437|NCT00312858|560416476|FG001|Overall Study|Protocol Violation|8|||
155268438|NCT00312858|560416475|FG000|Overall Study|Withdraw by Participant|20|||
155268439|NCT00312858|560416476|FG001|Overall Study|Withdraw by Participant|20|||
155268440|NCT00312858|560416475|FG000|Overall Study|Participant Moved|11|||
155268441|NCT00312858|560416476|FG001|Overall Study|Participant Moved|10|||
155268442|NCT00312858|560416475|FG000|Overall Study|Other|9|||
155268443|NCT00312858|560416476|FG001|Overall Study|Other|12|||
155268444|NCT03638635|560416477|FG000|Initial Hospitalization|Study terminated prematurely|0|||
155268445|NCT03638635|560416478|FG001|Initial Hospitalization|Study terminated prematurely|1|||
155268446|NCT03638635|560416477|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
155268447|NCT03638635|560416478|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
155268448|NCT03638635|560416477|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
155268449|NCT03638635|560416478|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
155268450|NCT02318719|560416481|FG000|Double-blind Phase|Adverse Event|7|||
155268451|NCT02318719|560416482|FG001|Double-blind Phase|Adverse Event|6|||
155268452|NCT02318719|560416483|FG002|Double-blind Phase|Adverse Event|12|||
155268453|NCT02318719|560416484|FG003|Double-blind Phase|Adverse Event|4|||
155268454|NCT02318719|560416485|FG004|Double-blind Phase|Adverse Event|0|||
155268455|NCT02318719|560416481|FG000|Double-blind Phase|Lack of Efficacy|5|||
155268456|NCT02318719|560416482|FG001|Double-blind Phase|Lack of Efficacy|0|||
155268457|NCT02318719|560416483|FG002|Double-blind Phase|Lack of Efficacy|1|||
155268458|NCT02318719|560416484|FG003|Double-blind Phase|Lack of Efficacy|1|||
155268459|NCT02318719|560416485|FG004|Double-blind Phase|Lack of Efficacy|0|||
155268460|NCT02318719|560416481|FG000|Double-blind Phase|Protocol Violation|0|||
155268461|NCT02318719|560416482|FG001|Double-blind Phase|Protocol Violation|1|||
155268462|NCT02318719|560416483|FG002|Double-blind Phase|Protocol Violation|3|||
155268463|NCT02318719|560416484|FG003|Double-blind Phase|Protocol Violation|0|||
155268464|NCT02318719|560416485|FG004|Double-blind Phase|Protocol Violation|0|||
155268465|NCT02318719|560416481|FG000|Double-blind Phase|Withdrawal by Subject|25|||
155268466|NCT02318719|560416482|FG001|Double-blind Phase|Withdrawal by Subject|7|||
155268467|NCT02318719|560416483|FG002|Double-blind Phase|Withdrawal by Subject|9|||
155268468|NCT02318719|560416484|FG003|Double-blind Phase|Withdrawal by Subject|10|||
155614617|NCT00423813|561683009|FG001|Overall Study|Withdrawal by Subject|8|||
155614618|NCT00423813|561683010|FG002|Overall Study|Withdrawal by Subject|5|||
155614619|NCT00423813|561683008|FG000|Overall Study|Lost to Follow-up|5|||
155614620|NCT00423813|561683009|FG001|Overall Study|Lost to Follow-up|4|||
155614621|NCT00423813|561683010|FG002|Overall Study|Lost to Follow-up|4|||
155614622|NCT00423813|561683008|FG000|Overall Study|Lack of Efficacy|23|||
155614623|NCT00423813|561683009|FG001|Overall Study|Lack of Efficacy|18|||
155614624|NCT00423813|561683010|FG002|Overall Study|Lack of Efficacy|19|||
155614625|NCT00423813|561683008|FG000|Overall Study|Physician Decision|2|||
155614626|NCT00423813|561683009|FG001|Overall Study|Physician Decision|0|||
155614627|NCT00423813|561683010|FG002|Overall Study|Physician Decision|0|||
155614628|NCT00423813|561683008|FG000|Overall Study|Sponsor Decision|0|||
155614629|NCT00423813|561683009|FG001|Overall Study|Sponsor Decision|1|||
155614630|NCT00423813|561683010|FG002|Overall Study|Sponsor Decision|0|||
155614631|NCT00423813|561683008|FG000|Overall Study|Protocol Violation|9|||
155614632|NCT00423813|561683009|FG001|Overall Study|Protocol Violation|4|||
155614633|NCT00423813|561683010|FG002|Overall Study|Protocol Violation|4|||
155614634|NCT00423813|561683008|FG000|Overall Study|Pregnancy|0|||
155614635|NCT00423813|561683009|FG001|Overall Study|Pregnancy|0|||
155614636|NCT00423813|561683010|FG002|Overall Study|Pregnancy|1|||
155614637|NCT00423813|561683008|FG000|Overall Study|Subject started night shift work|1|||
155614638|NCT00423813|561683009|FG001|Overall Study|Subject started night shift work|0|||
155614639|NCT00423813|561683010|FG002|Overall Study|Subject started night shift work|0|||
155614640|NCT00423813|561683008|FG000|Overall Study|Will start exclusionary medications|0|||
155614641|NCT00423813|561683009|FG001|Overall Study|Will start exclusionary medications|1|||
155614642|NCT00423813|561683010|FG002|Overall Study|Will start exclusionary medications|0|||
155614643|NCT00423813|561683008|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
155614644|NCT00423813|561683009|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
155614645|NCT00423813|561683010|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
155614646|NCT01904032|561683011|FG000|Overall Study|Adverse Event|3|||
155614647|NCT01904032|561683012|FG001|Overall Study|Adverse Event|1|||
155614648|NCT01904032|561683011|FG000|Overall Study|Lost to Follow-up|4|||
155614649|NCT01904032|561683012|FG001|Overall Study|Lost to Follow-up|2|||
155268469|NCT02318719|560416485|FG004|Double-blind Phase|Withdrawal by Subject|0|||
155268470|NCT02318719|560416481|FG000|Double-blind Phase|Other|1|||
155268471|NCT02318719|560416482|FG001|Double-blind Phase|Other|2|||
155268472|NCT02318719|560416483|FG002|Double-blind Phase|Other|0|||
155614650|NCT02383355|561683014|FG000|Overall Study|Adverse Event|2|||
155614651|NCT02383355|561683015|FG001|Overall Study|Adverse Event|0|||
155614652|NCT00980655|561683030|FG000|Overall Study|Adverse Event|13|||
155614653|NCT00980655|561683031|FG001|Overall Study|Adverse Event|31|||
155614654|NCT00980655|561683030|FG000|Overall Study|Death|0|||
155268473|NCT02318719|560416484|FG003|Double-blind Phase|Other|0|||
155268474|NCT02318719|560416485|FG004|Double-blind Phase|Other|0|||
155268475|NCT02318719|560416481|FG000|Open-label Extension Phase|Adverse Event|0|||
155268476|NCT02318719|560416482|FG001|Open-label Extension Phase|Adverse Event|0|||
155268477|NCT02318719|560416483|FG002|Open-label Extension Phase|Adverse Event|0|||
155268478|NCT02318719|560416484|FG003|Open-label Extension Phase|Adverse Event|0|||
155268479|NCT02318719|560416485|FG004|Open-label Extension Phase|Adverse Event|15|||
155268480|NCT02318719|560416481|FG000|Open-label Extension Phase|Death|0|||
155268481|NCT02318719|560416482|FG001|Open-label Extension Phase|Death|0|||
155268482|NCT02318719|560416483|FG002|Open-label Extension Phase|Death|0|||
155268483|NCT02318719|560416484|FG003|Open-label Extension Phase|Death|0|||
155268484|NCT02318719|560416485|FG004|Open-label Extension Phase|Death|1|||
155268485|NCT02318719|560416481|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
155268486|NCT02318719|560416482|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
155268487|NCT02318719|560416483|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
155268488|NCT02318719|560416484|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
155268489|NCT02318719|560416485|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
155268490|NCT02318719|560416481|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
155268491|NCT02318719|560416482|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
155268492|NCT02318719|560416483|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
155268493|NCT02318719|560416484|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
155268494|NCT02318719|560416485|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
155268495|NCT02318719|560416481|FG000|Open-label Extension Phase|Other|0|||
155268496|NCT02318719|560416482|FG001|Open-label Extension Phase|Other|0|||
155268497|NCT02318719|560416483|FG002|Open-label Extension Phase|Other|0|||
155268498|NCT02318719|560416484|FG003|Open-label Extension Phase|Other|0|||
155268499|NCT02318719|560416485|FG004|Open-label Extension Phase|Other|7|||
155268500|NCT03093428|560416486|FG000|Overall Study|Not eligible for treatment|2|||
155268501|NCT03093428|560416487|FG001|Overall Study|Not eligible for treatment|1|||
155268502|NCT03093428|560416486|FG000|Overall Study|Progression|14|||
155268503|NCT03093428|560416487|FG001|Overall Study|Progression|4|||
155268504|NCT03093428|560416486|FG000|Overall Study|Death|1|||
155268505|NCT03093428|560416487|FG001|Overall Study|Death|0|||
155268506|NCT03093428|560416486|FG000|Overall Study|Adverse Event|1|||
155268507|NCT03093428|560416487|FG001|Overall Study|Adverse Event|0|||
155268508|NCT03093428|560416486|FG000|Overall Study|Withdrawal by Subject|1|||
155268509|NCT03093428|560416487|FG001|Overall Study|Withdrawal by Subject|1|||
155268510|NCT01014975|560416488|FG000|Overall Study|Withdrawal by Subject|1|||
155268511|NCT01014975|560416489|FG001|Overall Study|Withdrawal by Subject|0|||
155268512|NCT01014975|560416490|FG002|Overall Study|Withdrawal by Subject|1|||
155268513|NCT01014975|560416488|FG000|Overall Study|Death|3|||
155268514|NCT01014975|560416489|FG001|Overall Study|Death|3|||
155268515|NCT01014975|560416490|FG002|Overall Study|Death|4|||
155268516|NCT01014975|560416488|FG000|Overall Study|Lost to Follow-up|0|||
155268517|NCT01014975|560416489|FG001|Overall Study|Lost to Follow-up|0|||
155268518|NCT01014975|560416490|FG002|Overall Study|Lost to Follow-up|1|||
155268519|NCT01336634|560416491|FG000|Overall Study|Study closed/terminated|5|||
155268520|NCT01336634|560416492|FG001|Overall Study|Study closed/terminated|6|||
155268521|NCT01336634|560416493|FG002|Overall Study|Study closed/terminated|6|||
155268522|NCT01336634|560416491|FG000|Overall Study|Lost to Follow-up|2|||
155268523|NCT01336634|560416492|FG001|Overall Study|Lost to Follow-up|1|||
155268524|NCT01336634|560416493|FG002|Overall Study|Lost to Follow-up|1|||
155268525|NCT01336634|560416491|FG000|Overall Study|Physician Decision|1|||
155268526|NCT01336634|560416492|FG001|Overall Study|Physician Decision|1|||
155268527|NCT01336634|560416493|FG002|Overall Study|Physician Decision|0|||
155268528|NCT01336634|560416491|FG000|Overall Study|Withdrawal by Subject|6|||
155268529|NCT01336634|560416492|FG001|Overall Study|Withdrawal by Subject|0|||
155268530|NCT01336634|560416493|FG002|Overall Study|Withdrawal by Subject|2|||
155268531|NCT02176421|560416494|FG000|Overall Study|Lost to Follow-up|4|||
155268532|NCT02176421|560416494|FG000|Overall Study|Adverse Event|1|||
155268533|NCT02632786|560416499|FG000|Overall Study|Adverse Event|2|||
155268534|NCT02632786|560416500|FG001|Overall Study|Adverse Event|1|||
155268535|NCT02632786|560416499|FG000|Overall Study|Death|3|||
155268536|NCT02632786|560416500|FG001|Overall Study|Death|2|||
155268537|NCT02632786|560416499|FG000|Overall Study|Physician Decision|5|||
155268538|NCT02632786|560416500|FG001|Overall Study|Physician Decision|4|||
155268539|NCT02632786|560416499|FG000|Overall Study|Withdrawal by Subject|1|||
155268540|NCT02632786|560416500|FG001|Overall Study|Withdrawal by Subject|0|||
155268541|NCT05266963|560416504|FG000|Drug Period A|Withdrawal by Subject|0|||
155268542|NCT05266963|560416505|FG001|Drug Period A|Withdrawal by Subject|1|||
155268543|NCT02912468|560416506|FG000|Overall Study|Adverse Event|3|||
155268544|NCT02912468|560416507|FG001|Overall Study|Adverse Event|2|||
155268545|NCT02912468|560416506|FG000|Overall Study|Withdrawal by Subject|6|||
155268546|NCT02912468|560416507|FG001|Overall Study|Withdrawal by Subject|2|||
155268547|NCT02912468|560416506|FG000|Overall Study|Randomized and not treated|0|||
155268548|NCT02912468|560416507|FG001|Overall Study|Randomized and not treated|1|||
155268549|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268550|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268551|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155614655|NCT00980655|561683031|FG001|Overall Study|Death|7|||
155268552|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268553|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268554|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268555|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268556|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268557|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
155268558|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
155268559|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268560|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268561|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268562|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268563|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268564|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268565|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
155268566|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
155268567|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268568|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268569|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268570|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268571|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268572|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268573|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268574|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268575|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
155268576|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268577|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268578|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
155268579|NCT01107743|560416518|FG000|Overall Study|Protocol Violation|46|||
155268580|NCT01913639|560416521|FG000|Overall Study|Not Eligible|3|||
155268581|NCT00962247|560416526|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
155268582|NCT00962247|560416526|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
155268583|NCT00886639|560416536|FG000|Overall Study|acute exacerbation|14|||
155268584|NCT00886639|560416536|FG000|Overall Study|non-compliance|2|||
155268585|NCT01871558|560416537|FG000|Overall Study|Other reason|0|||
155268586|NCT01871558|560416538|FG001|Overall Study|Other reason|1|||
155268587|NCT01871558|560416537|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
155268588|NCT01871558|560416538|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
155268589|NCT01871558|560416537|FG000|Overall Study|Withdrawal by Subject|2|||
155268590|NCT01871558|560416538|FG001|Overall Study|Withdrawal by Subject|0|||
155268591|NCT01709305|560416539|FG000|Phase 1|Clinical Adverse Event|80|||
155268592|NCT01709305|560416540|FG001|Phase 1|Clinical Adverse Event|0|||
155268593|NCT01709305|560416541|FG002|Phase 1|Clinical Adverse Event|0|||
155268594|NCT01709305|560416542|FG003|Phase 1|Clinical Adverse Event|0|||
155268595|NCT01709305|560416543|FG004|Phase 1|Clinical Adverse Event|0|||
155268596|NCT01709305|560416539|FG000|Phase 1|Death|2|||
155268597|NCT01709305|560416540|FG001|Phase 1|Death|0|||
155268598|NCT01709305|560416541|FG002|Phase 1|Death|0|||
155268599|NCT01709305|560416542|FG003|Phase 1|Death|0|||
155268600|NCT01709305|560416543|FG004|Phase 1|Death|0|||
155268601|NCT01709305|560416539|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
155268602|NCT01709305|560416540|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268603|NCT01709305|560416541|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268604|NCT01709305|560416542|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268605|NCT01709305|560416543|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268606|NCT01709305|560416539|FG000|Phase 1|Laboratory Adverse Event|16|||
155268607|NCT01709305|560416540|FG001|Phase 1|Laboratory Adverse Event|0|||
155268608|NCT01709305|560416541|FG002|Phase 1|Laboratory Adverse Event|0|||
155268609|NCT01709305|560416542|FG003|Phase 1|Laboratory Adverse Event|0|||
155268610|NCT01709305|560416543|FG004|Phase 1|Laboratory Adverse Event|0|||
155268611|NCT01709305|560416539|FG000|Phase 1|Lost to Follow-up|147|||
155268612|NCT01709305|560416540|FG001|Phase 1|Lost to Follow-up|0|||
155268613|NCT01709305|560416541|FG002|Phase 1|Lost to Follow-up|0|||
155268614|NCT01709305|560416542|FG003|Phase 1|Lost to Follow-up|0|||
155268615|NCT01709305|560416543|FG004|Phase 1|Lost to Follow-up|0|||
155268616|NCT01709305|560416539|FG000|Phase 1|Travel, moving, etc.|30|||
155268617|NCT01709305|560416540|FG001|Phase 1|Travel, moving, etc.|0|||
155268618|NCT01709305|560416541|FG002|Phase 1|Travel, moving, etc.|0|||
155614656|NCT00980655|561683030|FG000|Overall Study|Protocol Violation|2|||
155614657|NCT00980655|561683031|FG001|Overall Study|Protocol Violation|7|||
155268619|NCT01709305|560416542|FG003|Phase 1|Travel, moving, etc.|0|||
155268620|NCT01709305|560416543|FG004|Phase 1|Travel, moving, etc.|0|||
155268621|NCT01709305|560416539|FG000|Phase 1|Physician Decision|13|||
155268622|NCT01709305|560416540|FG001|Phase 1|Physician Decision|0|||
155268623|NCT01709305|560416541|FG002|Phase 1|Physician Decision|0|||
155268624|NCT01709305|560416542|FG003|Phase 1|Physician Decision|0|||
155268625|NCT01709305|560416543|FG004|Phase 1|Physician Decision|0|||
155268626|NCT01709305|560416539|FG000|Phase 1|Protocol Violation|118|||
155268627|NCT01709305|560416540|FG001|Phase 1|Protocol Violation|0|||
155268628|NCT01709305|560416541|FG002|Phase 1|Protocol Violation|0|||
155268629|NCT01709305|560416542|FG003|Phase 1|Protocol Violation|0|||
155268630|NCT01709305|560416543|FG004|Phase 1|Protocol Violation|0|||
155268631|NCT01709305|560416539|FG000|Phase 1|Withdrawal by Subject|218|||
155268632|NCT01709305|560416540|FG001|Phase 1|Withdrawal by Subject|0|||
155268633|NCT01709305|560416541|FG002|Phase 1|Withdrawal by Subject|0|||
155268634|NCT01709305|560416542|FG003|Phase 1|Withdrawal by Subject|0|||
155268635|NCT01709305|560416543|FG004|Phase 1|Withdrawal by Subject|0|||
155268636|NCT01709305|560416539|FG000|Phase 2|Clinical Adverse Event|0|||
155268637|NCT01709305|560416540|FG001|Phase 2|Clinical Adverse Event|10|||
155268638|NCT01709305|560416541|FG002|Phase 2|Clinical Adverse Event|10|||
155268639|NCT01709305|560416542|FG003|Phase 2|Clinical Adverse Event|6|||
155268640|NCT01709305|560416543|FG004|Phase 2|Clinical Adverse Event|11|||
155268641|NCT01709305|560416539|FG000|Phase 2|Death|0|||
155268642|NCT01709305|560416540|FG001|Phase 2|Death|0|||
155268643|NCT01709305|560416541|FG002|Phase 2|Death|1|||
155268644|NCT01709305|560416542|FG003|Phase 2|Death|0|||
155268645|NCT01709305|560416543|FG004|Phase 2|Death|0|||
155268646|NCT01709305|560416539|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268647|NCT01709305|560416540|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268648|NCT01709305|560416541|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268649|NCT01709305|560416542|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268650|NCT01709305|560416543|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
155268651|NCT01709305|560416539|FG000|Phase 2|Laboratory Adverse Event|0|||
155268652|NCT01709305|560416540|FG001|Phase 2|Laboratory Adverse Event|1|||
155268653|NCT01709305|560416541|FG002|Phase 2|Laboratory Adverse Event|0|||
155268654|NCT01709305|560416542|FG003|Phase 2|Laboratory Adverse Event|1|||
155268655|NCT01709305|560416543|FG004|Phase 2|Laboratory Adverse Event|1|||
155268656|NCT01709305|560416539|FG000|Phase 2|Lost to Follow-up|0|||
155268657|NCT01709305|560416540|FG001|Phase 2|Lost to Follow-up|10|||
155268658|NCT01709305|560416541|FG002|Phase 2|Lost to Follow-up|6|||
155268659|NCT01709305|560416542|FG003|Phase 2|Lost to Follow-up|9|||
155268660|NCT01709305|560416543|FG004|Phase 2|Lost to Follow-up|5|||
155268661|NCT01709305|560416539|FG000|Phase 2|Travel, moving, etc.|0|||
155268662|NCT01709305|560416540|FG001|Phase 2|Travel, moving, etc.|2|||
155268663|NCT01709305|560416541|FG002|Phase 2|Travel, moving, etc.|3|||
155268664|NCT01709305|560416542|FG003|Phase 2|Travel, moving, etc.|3|||
155268665|NCT01709305|560416543|FG004|Phase 2|Travel, moving, etc.|5|||
155268666|NCT01709305|560416539|FG000|Phase 2|Physician Decision|0|||
155268667|NCT01709305|560416540|FG001|Phase 2|Physician Decision|2|||
155268668|NCT01709305|560416541|FG002|Phase 2|Physician Decision|0|||
155268669|NCT01709305|560416542|FG003|Phase 2|Physician Decision|1|||
155268670|NCT01709305|560416543|FG004|Phase 2|Physician Decision|2|||
155268671|NCT01709305|560416539|FG000|Phase 2|Protocol Violation|0|||
155268672|NCT01709305|560416540|FG001|Phase 2|Protocol Violation|19|||
155268673|NCT01709305|560416541|FG002|Phase 2|Protocol Violation|19|||
155268674|NCT01709305|560416542|FG003|Phase 2|Protocol Violation|13|||
155268675|NCT01709305|560416543|FG004|Phase 2|Protocol Violation|9|||
155268676|NCT01709305|560416539|FG000|Phase 2|Withdrawal by Subject|0|||
155268677|NCT01709305|560416540|FG001|Phase 2|Withdrawal by Subject|8|||
155268678|NCT01709305|560416541|FG002|Phase 2|Withdrawal by Subject|6|||
155268679|NCT01709305|560416542|FG003|Phase 2|Withdrawal by Subject|15|||
155268680|NCT01709305|560416543|FG004|Phase 2|Withdrawal by Subject|12|||
155268681|NCT00118898|560416546|FG000|Overall Study|Death|6|||
155268682|NCT00118898|560416547|FG001|Overall Study|Death|11|||
155268683|NCT00118898|560416548|FG002|Overall Study|Death|6|||
155268684|NCT00118898|560416549|FG003|Overall Study|Death|8|||
155268685|NCT00118898|560416546|FG000|Overall Study|Lost to Follow-up|26|||
155268686|NCT00118898|560416547|FG001|Overall Study|Lost to Follow-up|34|||
155268687|NCT00118898|560416548|FG002|Overall Study|Lost to Follow-up|33|||
155268688|NCT00118898|560416549|FG003|Overall Study|Lost to Follow-up|33|||
155268689|NCT00118898|560416546|FG000|Overall Study|Withdrawal by Subject|10|||
155268690|NCT00118898|560416547|FG001|Overall Study|Withdrawal by Subject|5|||
155268691|NCT00118898|560416548|FG002|Overall Study|Withdrawal by Subject|8|||
155268692|NCT00118898|560416549|FG003|Overall Study|Withdrawal by Subject|8|||
155268693|NCT00118898|560416546|FG000|Overall Study|Site Closure|33|||
155268694|NCT00118898|560416547|FG001|Overall Study|Site Closure|31|||
155268695|NCT00118898|560416548|FG002|Overall Study|Site Closure|28|||
155268696|NCT00118898|560416549|FG003|Overall Study|Site Closure|37|||
155726458|NCT04322526|562098135|FG000|Washout (1 Week)|Lost to Follow-up|1|||
155268697|NCT00118898|560416546|FG000|Overall Study|Severe debilitation|1|||
155268698|NCT00118898|560416547|FG001|Overall Study|Severe debilitation|4|||
155268699|NCT00118898|560416548|FG002|Overall Study|Severe debilitation|6|||
155268700|NCT00118898|560416549|FG003|Overall Study|Severe debilitation|4|||
155268701|NCT00118898|560416546|FG000|Overall Study|Not compliant with requirements|11|||
155268702|NCT00118898|560416547|FG001|Overall Study|Not compliant with requirements|13|||
155726459|NCT04322526|562098136|FG001|Washout (1 Week)|Lost to Follow-up|2|||
155268703|NCT00118898|560416548|FG002|Overall Study|Not compliant with requirements|11|||
155268704|NCT00118898|560416549|FG003|Overall Study|Not compliant with requirements|11|||
155268705|NCT00118898|560416546|FG000|Overall Study|Not able to get to clinic|34|||
155268706|NCT00118898|560416547|FG001|Overall Study|Not able to get to clinic|43|||
155268707|NCT00118898|560416548|FG002|Overall Study|Not able to get to clinic|31|||
155268708|NCT00118898|560416549|FG003|Overall Study|Not able to get to clinic|40|||
155268709|NCT01338012|560416552|FG000|Overall Study|Death|4|||
155268710|NCT01338012|560416552|FG000|Overall Study|Study terminated|4|||
155268711|NCT02714205|560416553|FG000|Overall Study|Cannot tolerate medication|1|||
155268712|NCT02714205|560416554|FG001|Overall Study|Cannot tolerate medication|0|||
155268713|NCT02714205|560416553|FG000|Overall Study|Adverse Event|2|||
155268714|NCT02714205|560416554|FG001|Overall Study|Adverse Event|0|||
155268715|NCT02714205|560416553|FG000|Overall Study|Too busy|1|||
155268716|NCT02714205|560416554|FG001|Overall Study|Too busy|0|||
155268717|NCT02714205|560416553|FG000|Overall Study|Incomplete outcome data|0|||
155268718|NCT02714205|560416554|FG001|Overall Study|Incomplete outcome data|1|||
155268719|NCT05879198|560416555|FG000|Overall Study|Lost to Follow-up|1|||
155268720|NCT02089230|560416556|FG000|Overall Study|Death|0|||
155268721|NCT02089230|560416557|FG001|Overall Study|Death|0|||
155268722|NCT02089230|560416558|FG002|Overall Study|Death|2|||
155268723|NCT02089230|560416556|FG000|Overall Study|Seeking Alternative Therapy|0|||
155268724|NCT02089230|560416557|FG001|Overall Study|Seeking Alternative Therapy|0|||
155268725|NCT02089230|560416558|FG002|Overall Study|Seeking Alternative Therapy|4|||
155268726|NCT01598298|560416559|FG000|Overall Study|Not eligible|5|||
155268727|NCT01598298|560416560|FG001|Overall Study|Not eligible|5|||
155268728|NCT01598298|560416559|FG000|Overall Study|Adverse Event|21|||
155268729|NCT01598298|560416560|FG001|Overall Study|Adverse Event|19|||
155268730|NCT01598298|560416559|FG000|Overall Study|Progression/relapse|0|||
155268731|NCT01598298|560416560|FG001|Overall Study|Progression/relapse|2|||
155268732|NCT01598298|560416559|FG000|Overall Study|Withdrawal by Subject|10|||
155268733|NCT01598298|560416560|FG001|Overall Study|Withdrawal by Subject|15|||
155268734|NCT01598298|560416559|FG000|Overall Study|Other reason (not protocol specified)|4|||
155268735|NCT01598298|560416560|FG001|Overall Study|Other reason (not protocol specified)|0|||
155268736|NCT02073097|560416561|FG000|Overall Study|Adverse Event|0|||
155268737|NCT02073097|560416562|FG001|Overall Study|Adverse Event|0|||
155268738|NCT02073097|560416563|FG002|Overall Study|Adverse Event|0|||
155268739|NCT02073097|560416564|FG003|Overall Study|Adverse Event|0|||
155268740|NCT02073097|560416565|FG004|Overall Study|Adverse Event|0|||
155268741|NCT02073097|560416566|FG005|Overall Study|Adverse Event|0|||
155268742|NCT02073097|560416567|FG006|Overall Study|Adverse Event|0|||
155268743|NCT02073097|560416568|FG007|Overall Study|Adverse Event|2|||
155268744|NCT02073097|560416561|FG000|Overall Study|Withdrawal by Subject|0|||
155268745|NCT02073097|560416562|FG001|Overall Study|Withdrawal by Subject|0|||
155268746|NCT02073097|560416563|FG002|Overall Study|Withdrawal by Subject|0|||
155268747|NCT02073097|560416564|FG003|Overall Study|Withdrawal by Subject|0|||
155268748|NCT02073097|560416565|FG004|Overall Study|Withdrawal by Subject|0|||
155268749|NCT02073097|560416566|FG005|Overall Study|Withdrawal by Subject|0|||
155268750|NCT02073097|560416567|FG006|Overall Study|Withdrawal by Subject|0|||
155268751|NCT02073097|560416568|FG007|Overall Study|Withdrawal by Subject|2|||
155268752|NCT02073097|560416561|FG000|Overall Study|Death|0|||
155268753|NCT02073097|560416562|FG001|Overall Study|Death|0|||
155268754|NCT02073097|560416563|FG002|Overall Study|Death|0|||
155268755|NCT02073097|560416564|FG003|Overall Study|Death|0|||
155268756|NCT02073097|560416565|FG004|Overall Study|Death|0|||
155268757|NCT02073097|560416566|FG005|Overall Study|Death|0|||
155268758|NCT02073097|560416567|FG006|Overall Study|Death|0|||
155268759|NCT02073097|560416568|FG007|Overall Study|Death|1|||
155268760|NCT02073097|560416561|FG000|Overall Study|Physician Decision|0|||
155268761|NCT02073097|560416562|FG001|Overall Study|Physician Decision|0|||
155268762|NCT02073097|560416563|FG002|Overall Study|Physician Decision|0|||
155268763|NCT02073097|560416564|FG003|Overall Study|Physician Decision|0|||
155268764|NCT02073097|560416565|FG004|Overall Study|Physician Decision|0|||
155268765|NCT02073097|560416566|FG005|Overall Study|Physician Decision|0|||
155268766|NCT02073097|560416567|FG006|Overall Study|Physician Decision|0|||
155268767|NCT02073097|560416568|FG007|Overall Study|Physician Decision|1|||
155268768|NCT03813147|560416569|FG000|Overall Study|Lack of Efficacy|4|||
155268769|NCT03813147|560416570|FG001|Overall Study|Lack of Efficacy|4|||
155268770|NCT03813147|560416569|FG000|Overall Study|Physician Decision|2|||
155268771|NCT03813147|560416570|FG001|Overall Study|Physician Decision|1|||
155268772|NCT01693692|560416571|FG000|Overall Study|Withdrawal by Subject|12|||
155268773|NCT01693692|560416572|FG001|Overall Study|Withdrawal by Subject|10|||
155268774|NCT01693692|560416573|FG002|Overall Study|Withdrawal by Subject|11|||
155268775|NCT01693692|560416571|FG000|Overall Study|Adverse Event|7|||
155268776|NCT01693692|560416572|FG001|Overall Study|Adverse Event|14|||
155268777|NCT01693692|560416573|FG002|Overall Study|Adverse Event|9|||
155268778|NCT01693692|560416571|FG000|Overall Study|Physician Decision|0|||
155268779|NCT01693692|560416572|FG001|Overall Study|Physician Decision|0|||
155268780|NCT01693692|560416573|FG002|Overall Study|Physician Decision|1|||
155268781|NCT01693692|560416571|FG000|Overall Study|Protocol Violation|5|||
155268782|NCT01693692|560416572|FG001|Overall Study|Protocol Violation|4|||
155268783|NCT01693692|560416573|FG002|Overall Study|Protocol Violation|6|||
155268784|NCT01693692|560416571|FG000|Overall Study|Lost to Follow-up|2|||
155268785|NCT01693692|560416572|FG001|Overall Study|Lost to Follow-up|2|||
155268786|NCT01693692|560416573|FG002|Overall Study|Lost to Follow-up|3|||
155268787|NCT01693692|560416571|FG000|Overall Study|Other|4|||
155268788|NCT01693692|560416572|FG001|Overall Study|Other|4|||
155268789|NCT01693692|560416573|FG002|Overall Study|Other|6|||
155268790|NCT02906683|560418913|FG000|Overall Study|Adverse Event|0|||
155268791|NCT02906683|560418914|FG001|Overall Study|Adverse Event|1|||
155268792|NCT02906683|560418915|FG002|Overall Study|Adverse Event|0|||
155268793|NCT02906683|560418913|FG000|Overall Study|Physician Decision|0|||
155268794|NCT02906683|560418914|FG001|Overall Study|Physician Decision|1|||
155268795|NCT02906683|560418915|FG002|Overall Study|Physician Decision|1|||
155268796|NCT02906683|560418913|FG000|Overall Study|Withdrawal by Subject|0|||
155268797|NCT02906683|560418914|FG001|Overall Study|Withdrawal by Subject|2|||
155268798|NCT02906683|560418915|FG002|Overall Study|Withdrawal by Subject|1|||
155268799|NCT02906683|560418913|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
155268800|NCT02906683|560418914|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
155268801|NCT02906683|560418915|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
155268802|NCT02906683|560418913|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
155268803|NCT02906683|560418914|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155268804|NCT02906683|560418915|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155268805|NCT01167179|560418918|FG000|Overall Study|disease recurrence|4|||
155268806|NCT01167179|560418919|FG001|Overall Study|disease recurrence|4|||
155268807|NCT01167179|560418918|FG000|Overall Study|Death|4|||
155268808|NCT01167179|560418919|FG001|Overall Study|Death|10|||
155268809|NCT01167179|560418918|FG000|Overall Study|Withdrawal by Subject|1|||
155268810|NCT01167179|560418919|FG001|Overall Study|Withdrawal by Subject|2|||
155268811|NCT01167179|560418918|FG000|Overall Study|diverse|6|||
155268812|NCT01167179|560418919|FG001|Overall Study|diverse|5|||
155268813|NCT00663117|560418920|FG000|Overall Study|Lack of Efficacy|1|||
155268814|NCT00663117|560418921|FG001|Overall Study|Lack of Efficacy|0|||
155268815|NCT02769065|560418922|FG000|Overall Study|Voluntary Withdrawal|1|||
155268816|NCT02769065|560418923|FG001|Overall Study|Voluntary Withdrawal|0|||
155268817|NCT02769065|560418924|FG002|Overall Study|Voluntary Withdrawal|0|||
155268818|NCT02769065|560418925|FG003|Overall Study|Voluntary Withdrawal|0|||
155268819|NCT02769065|560418926|FG004|Overall Study|Voluntary Withdrawal|0|||
155268820|NCT02769065|560418927|FG005|Overall Study|Voluntary Withdrawal|0|||
155268821|NCT02769065|560418928|FG006|Overall Study|Voluntary Withdrawal|0|||
155268822|NCT02769065|560418929|FG007|Overall Study|Voluntary Withdrawal|0|||
155268823|NCT02769065|560418930|FG008|Overall Study|Voluntary Withdrawal|0|||
155268824|NCT02769065|560418931|FG009|Overall Study|Voluntary Withdrawal|0|||
155268825|NCT02769065|560418932|FG010|Overall Study|Voluntary Withdrawal|0|||
155268826|NCT02769065|560418933|FG011|Overall Study|Voluntary Withdrawal|0|||
155268827|NCT02769065|560418934|FG012|Overall Study|Voluntary Withdrawal|0|||
155268828|NCT02769065|560418935|FG013|Overall Study|Voluntary Withdrawal|0|||
155268829|NCT02769065|560418936|FG014|Overall Study|Voluntary Withdrawal|0|||
155268830|NCT02769065|560418937|FG015|Overall Study|Voluntary Withdrawal|0|||
155268831|NCT02769065|560418938|FG016|Overall Study|Voluntary Withdrawal|0|||
155268832|NCT02769065|560418939|FG017|Overall Study|Voluntary Withdrawal|0|||
155268833|NCT02769065|560418940|FG018|Overall Study|Voluntary Withdrawal|0|||
155268834|NCT02769065|560418941|FG019|Overall Study|Voluntary Withdrawal|0|||
155268835|NCT02769065|560418942|FG020|Overall Study|Voluntary Withdrawal|0|||
155268836|NCT02769065|560418943|FG021|Overall Study|Voluntary Withdrawal|0|||
155268837|NCT02769065|560418944|FG022|Overall Study|Voluntary Withdrawal|0|||
155268838|NCT02769065|560418945|FG023|Overall Study|Voluntary Withdrawal|0|||
155268839|NCT02769065|560418946|FG024|Overall Study|Voluntary Withdrawal|0|||
155268840|NCT02769065|560418947|FG025|Overall Study|Voluntary Withdrawal|0|||
155268841|NCT02769065|560418948|FG026|Overall Study|Voluntary Withdrawal|0|||
155268842|NCT02769065|560418949|FG027|Overall Study|Voluntary Withdrawal|0|||
155268843|NCT02769065|560418950|FG028|Overall Study|Voluntary Withdrawal|0|||
155268844|NCT02769065|560418951|FG029|Overall Study|Voluntary Withdrawal|0|||
155268845|NCT02769065|560418922|FG000|Overall Study|Reason Not Specified|0|||
155268846|NCT02769065|560418923|FG001|Overall Study|Reason Not Specified|0|||
155268847|NCT02769065|560418924|FG002|Overall Study|Reason Not Specified|0|||
155268848|NCT02769065|560418925|FG003|Overall Study|Reason Not Specified|0|||
155268849|NCT02769065|560418926|FG004|Overall Study|Reason Not Specified|0|||
155268850|NCT02769065|560418927|FG005|Overall Study|Reason Not Specified|0|||
155268851|NCT02769065|560418928|FG006|Overall Study|Reason Not Specified|1|||
155268852|NCT02769065|560418929|FG007|Overall Study|Reason Not Specified|0|||
155268853|NCT02769065|560418930|FG008|Overall Study|Reason Not Specified|0|||
155268854|NCT02769065|560418931|FG009|Overall Study|Reason Not Specified|0|||
155268855|NCT02769065|560418932|FG010|Overall Study|Reason Not Specified|0|||
155268856|NCT02769065|560418933|FG011|Overall Study|Reason Not Specified|0|||
155268857|NCT02769065|560418934|FG012|Overall Study|Reason Not Specified|0|||
155268858|NCT02769065|560418935|FG013|Overall Study|Reason Not Specified|0|||
155268859|NCT02769065|560418936|FG014|Overall Study|Reason Not Specified|0|||
155268860|NCT02769065|560418937|FG015|Overall Study|Reason Not Specified|0|||
155268861|NCT02769065|560418938|FG016|Overall Study|Reason Not Specified|0|||
155268862|NCT02769065|560418939|FG017|Overall Study|Reason Not Specified|0|||
155268863|NCT02769065|560418940|FG018|Overall Study|Reason Not Specified|0|||
155268864|NCT02769065|560418941|FG019|Overall Study|Reason Not Specified|0|||
155268865|NCT02769065|560418942|FG020|Overall Study|Reason Not Specified|0|||
155268866|NCT02769065|560418943|FG021|Overall Study|Reason Not Specified|0|||
155268867|NCT02769065|560418944|FG022|Overall Study|Reason Not Specified|0|||
155268868|NCT02769065|560418945|FG023|Overall Study|Reason Not Specified|0|||
155268869|NCT02769065|560418946|FG024|Overall Study|Reason Not Specified|0|||
155268870|NCT02769065|560418947|FG025|Overall Study|Reason Not Specified|0|||
155268871|NCT02769065|560418948|FG026|Overall Study|Reason Not Specified|0|||
155268872|NCT02769065|560418949|FG027|Overall Study|Reason Not Specified|0|||
155268873|NCT02769065|560418950|FG028|Overall Study|Reason Not Specified|0|||
155268874|NCT02769065|560418951|FG029|Overall Study|Reason Not Specified|0|||
155268875|NCT02769065|560418922|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268876|NCT02769065|560418923|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268877|NCT02769065|560418924|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268878|NCT02769065|560418925|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268879|NCT02769065|560418926|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268880|NCT02769065|560418927|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268881|NCT02769065|560418928|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268882|NCT02769065|560418929|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268883|NCT02769065|560418930|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268884|NCT02769065|560418931|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268885|NCT02769065|560418932|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
155268886|NCT02769065|560418933|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268887|NCT02769065|560418934|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268888|NCT02769065|560418935|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268889|NCT02769065|560418936|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268890|NCT02769065|560418937|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268891|NCT02769065|560418938|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268892|NCT02769065|560418939|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268893|NCT02769065|560418940|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268894|NCT02769065|560418941|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268895|NCT02769065|560418942|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268896|NCT02769065|560418943|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268897|NCT02769065|560418944|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268898|NCT02769065|560418945|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268899|NCT02769065|560418946|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268900|NCT02769065|560418947|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268901|NCT02769065|560418948|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268902|NCT02769065|560418949|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268903|NCT02769065|560418950|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268904|NCT02769065|560418951|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268905|NCT02531295|560418952|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268906|NCT02531295|560418953|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268907|NCT02531295|560418954|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268908|NCT02531295|560418955|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268909|NCT02531295|560418956|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268910|NCT02531295|560418957|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
155268911|NCT01923896|560418959|FG000|Overall Study|Adverse Event|1|||
155268912|NCT01923896|560418960|FG001|Overall Study|Adverse Event|0|||
155268913|NCT03545113|560418961|FG000|Overall Study|Surgery Cancelled|1|||
155268914|NCT03545113|560418962|FG001|Overall Study|Surgery Cancelled|0|||
155268915|NCT03545113|560418961|FG000|Overall Study|Death|1|||
155268916|NCT03545113|560418962|FG001|Overall Study|Death|0|||
155268917|NCT03545113|560418961|FG000|Overall Study|Adverse Event|2|||
155268918|NCT03545113|560418962|FG001|Overall Study|Adverse Event|0|||
155268919|NCT03545113|560418961|FG000|Overall Study|Received different surgery|1|||
155268920|NCT03545113|560418962|FG001|Overall Study|Received different surgery|0|||
155268921|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
155268922|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
155268923|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
155268924|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
155268925|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
155268926|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
155268927|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
155268928|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
155268929|NCT02593305|560418965|FG000|Post 1|Comparison only group. No intervention.|0|||
155268930|NCT02593305|560418966|FG001|Post 1|Comparison only group. No intervention.|0|||
155268931|NCT02593305|560418967|FG002|Post 1|Comparison only group. No intervention.|10|||
155268932|NCT01993017|560418968|FG000|Overall Study|Death|23|||
155268933|NCT01993017|560418969|FG001|Overall Study|Death|26|||
155268934|NCT01993017|560418970|FG002|Overall Study|Death|18|||
155268935|NCT01993017|560418968|FG000|Overall Study|Could not be contacted|43|||
155268936|NCT01993017|560418969|FG001|Overall Study|Could not be contacted|42|||
155268937|NCT01993017|560418970|FG002|Overall Study|Could not be contacted|38|||
155268938|NCT01993017|560418968|FG000|Overall Study|Dropped out|19|||
155268939|NCT01993017|560418969|FG001|Overall Study|Dropped out|6|||
155268940|NCT01993017|560418970|FG002|Overall Study|Dropped out|11|||
155268941|NCT01993017|560418968|FG000|Overall Study|Other reasons|17|||
155268942|NCT01993017|560418969|FG001|Overall Study|Other reasons|11|||
155268943|NCT01993017|560418970|FG002|Overall Study|Other reasons|7|||
155268944|NCT01993017|560418968|FG000|Overall Study|Ineligible after randomization|4|||
155268945|NCT01993017|560418969|FG001|Overall Study|Ineligible after randomization|5|||
155268946|NCT01993017|560418970|FG002|Overall Study|Ineligible after randomization|5|||
155268947|NCT00068380|560418971|FG000|Overall Study|Withdrawal by Subject|3|||
155268948|NCT00068380|560418971|FG000|Overall Study|Adverse Event|2|||
155268949|NCT01190215|560418972|FG000|Up to Month 6|Lost to Follow-up|2|||
155268950|NCT01190215|560418973|FG001|Up to Month 6|Lost to Follow-up|0|||
155268951|NCT02960763|560418976|FG000|Step 1|Withdrawal by Subject|10|||
155268952|NCT02960763|560418977|FG001|Step 1|Withdrawal by Subject|8|||
155268953|NCT02960763|560418978|FG002|Step 1|Withdrawal by Subject|13|||
155268954|NCT02960763|560418979|FG003|Step 1|Withdrawal by Subject|0|||
155268955|NCT02960763|560418980|FG004|Step 1|Withdrawal by Subject|0|||
155268956|NCT02960763|560418976|FG000|Step 1|Lost to Follow-up|7|||
155268957|NCT02960763|560418977|FG001|Step 1|Lost to Follow-up|9|||
155268958|NCT02960763|560418978|FG002|Step 1|Lost to Follow-up|12|||
155268959|NCT02960763|560418979|FG003|Step 1|Lost to Follow-up|0|||
155268960|NCT02960763|560418980|FG004|Step 1|Lost to Follow-up|0|||
155268961|NCT02960763|560418976|FG000|Step 1|Death|1|||
155268962|NCT02960763|560418977|FG001|Step 1|Death|1|||
155268963|NCT02960763|560418978|FG002|Step 1|Death|1|||
155268964|NCT02960763|560418979|FG003|Step 1|Death|0|||
155268965|NCT02960763|560418980|FG004|Step 1|Death|0|||
155268966|NCT02960763|560418976|FG000|Step 1|Investigator discretion|1|||
155268967|NCT02960763|560418977|FG001|Step 1|Investigator discretion|0|||
155268968|NCT02960763|560418978|FG002|Step 1|Investigator discretion|1|||
155268969|NCT02960763|560418979|FG003|Step 1|Investigator discretion|0|||
155268970|NCT02960763|560418980|FG004|Step 1|Investigator discretion|0|||
155268971|NCT02960763|560418976|FG000|Step 1|Other|0|||
155268972|NCT02960763|560418977|FG001|Step 1|Other|0|||
155268973|NCT02960763|560418978|FG002|Step 1|Other|1|||
155268974|NCT02960763|560418979|FG003|Step 1|Other|0|||
155268975|NCT02960763|560418980|FG004|Step 1|Other|0|||
155268976|NCT02960763|560418976|FG000|Step 2|Withdrawal by Subject|0|||
155268977|NCT02960763|560418977|FG001|Step 2|Withdrawal by Subject|0|||
155268978|NCT02960763|560418978|FG002|Step 2|Withdrawal by Subject|0|||
155268979|NCT02960763|560418979|FG003|Step 2|Withdrawal by Subject|7|||
155268980|NCT02960763|560418980|FG004|Step 2|Withdrawal by Subject|3|||
155268981|NCT02960763|560418976|FG000|Step 2|Lost to Follow-up|0|||
155268982|NCT02960763|560418977|FG001|Step 2|Lost to Follow-up|0|||
155268983|NCT02960763|560418978|FG002|Step 2|Lost to Follow-up|0|||
155268984|NCT02960763|560418979|FG003|Step 2|Lost to Follow-up|4|||
155268985|NCT02960763|560418980|FG004|Step 2|Lost to Follow-up|1|||
155268986|NCT02960763|560418976|FG000|Step 2|Investigator discretion|0|||
155268987|NCT02960763|560418977|FG001|Step 2|Investigator discretion|0|||
155268988|NCT02960763|560418978|FG002|Step 2|Investigator discretion|0|||
155268989|NCT02960763|560418979|FG003|Step 2|Investigator discretion|0|||
155268990|NCT02960763|560418980|FG004|Step 2|Investigator discretion|1|||
155268991|NCT05340751|560418985|FG000|Overall Study|Physician Decision|3|||
155268992|NCT01973491|560419000|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
155268993|NCT01973491|560419000|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
155268994|NCT01973491|560419000|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
155268995|NCT01863043|560419001|FG000|Overall Study|Death|6|||
155268996|NCT01863043|560419002|FG001|Overall Study|Death|1|||
155268997|NCT01863043|560419001|FG000|Overall Study|Withdrawal by Subject|0|||
155268998|NCT01863043|560419002|FG001|Overall Study|Withdrawal by Subject|2|||
155268999|NCT01863043|560419001|FG000|Overall Study|Adverse Event|7|||
155269000|NCT01863043|560419002|FG001|Overall Study|Adverse Event|8|||
155269001|NCT01863043|560419001|FG000|Overall Study|exclusion criteria found after enrollment|0|||
155269002|NCT01863043|560419002|FG001|Overall Study|exclusion criteria found after enrollment|1|||
155269003|NCT01987596|560419003|FG000|Overall Study|Physician Decision|1|||
155269004|NCT01987596|560419004|FG001|Overall Study|Physician Decision|0|||
155269005|NCT01987596|560419003|FG000|Overall Study|Progressive Disease; missing all period|0|||
155269006|NCT01987596|560419004|FG001|Overall Study|Progressive Disease; missing all period|1|||
155269007|NCT00854295|560419005|FG000|Overall Study|Death|7|||
155269008|NCT00854295|560419006|FG001|Overall Study|Death|0|||
155269009|NCT00854295|560419007|FG002|Overall Study|Death|1|||
155269010|NCT00854295|560419008|FG003|Overall Study|Death|1|||
155269011|NCT00854295|560419005|FG000|Overall Study|Adverse Event|6|||
155269012|NCT00854295|560419006|FG001|Overall Study|Adverse Event|1|||
155269013|NCT00854295|560419007|FG002|Overall Study|Adverse Event|1|||
155269014|NCT00854295|560419008|FG003|Overall Study|Adverse Event|3|||
155269015|NCT00854295|560419005|FG000|Overall Study|Lost to Follow-up|18|||
155269016|NCT00854295|560419006|FG001|Overall Study|Lost to Follow-up|5|||
155269017|NCT00854295|560419007|FG002|Overall Study|Lost to Follow-up|21|||
155269018|NCT00854295|560419008|FG003|Overall Study|Lost to Follow-up|21|||
155269019|NCT00854295|560419005|FG000|Overall Study|Physician Decision|10|||
155269020|NCT00854295|560419006|FG001|Overall Study|Physician Decision|0|||
155269021|NCT00854295|560419007|FG002|Overall Study|Physician Decision|0|||
155269022|NCT00854295|560419008|FG003|Overall Study|Physician Decision|0|||
155269023|NCT00709592|560419009|FG000|Overall Study|Unable to proceed to transplant|0|||
155269024|NCT00709592|560419010|FG001|Overall Study|Unable to proceed to transplant|1|||
155269025|NCT02440594|560419014|FG000|Overall Study|Lost to Follow-up|34|||
155269026|NCT02440594|560419015|FG001|Overall Study|Lost to Follow-up|33|||
155269027|NCT02440594|560419016|FG002|Overall Study|Lost to Follow-up|54|||
155269028|NCT02440594|560419017|FG003|Overall Study|Lost to Follow-up|47|||
155269029|NCT02440594|560419018|FG004|Overall Study|Lost to Follow-up|5|||
155269030|NCT02440594|560419019|FG005|Overall Study|Lost to Follow-up|4|||
155269031|NCT02440594|560419020|FG006|Overall Study|Lost to Follow-up|28|||
155269032|NCT02440594|560419021|FG007|Overall Study|Lost to Follow-up|48|||
155269033|NCT02440594|560419014|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
155269034|NCT02440594|560419015|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
155269035|NCT02440594|560419016|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
155269036|NCT02440594|560419017|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
155269037|NCT02440594|560419018|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
155269038|NCT02440594|560419019|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
155269039|NCT02440594|560419020|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
155269040|NCT02440594|560419021|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
155269041|NCT02440594|560419014|FG000|Overall Study|Withdrawal by Subject|81|||
155269042|NCT02440594|560419015|FG001|Overall Study|Withdrawal by Subject|67|||
155269043|NCT02440594|560419016|FG002|Overall Study|Withdrawal by Subject|59|||
155269044|NCT02440594|560419017|FG003|Overall Study|Withdrawal by Subject|38|||
155269045|NCT02440594|560419018|FG004|Overall Study|Withdrawal by Subject|2|||
155269046|NCT02440594|560419019|FG005|Overall Study|Withdrawal by Subject|2|||
155269047|NCT02440594|560419020|FG006|Overall Study|Withdrawal by Subject|7|||
155269048|NCT02440594|560419021|FG007|Overall Study|Withdrawal by Subject|7|||
155269049|NCT02440594|560419014|FG000|Overall Study|Administratively w/drawn|3|||
155269050|NCT02440594|560419015|FG001|Overall Study|Administratively w/drawn|2|||
155269051|NCT02440594|560419016|FG002|Overall Study|Administratively w/drawn|0|||
155269052|NCT02440594|560419017|FG003|Overall Study|Administratively w/drawn|0|||
155269053|NCT02440594|560419018|FG004|Overall Study|Administratively w/drawn|0|||
155269054|NCT02440594|560419019|FG005|Overall Study|Administratively w/drawn|0|||
155269055|NCT02440594|560419020|FG006|Overall Study|Administratively w/drawn|2|||
155269056|NCT02440594|560419021|FG007|Overall Study|Administratively w/drawn|1|||
155269057|NCT04250337|560419022|FG000|Overall Study|Adverse Event|0|||
155269058|NCT04250337|560419023|FG001|Overall Study|Adverse Event|3|||
155269059|NCT04250337|560419022|FG000|Overall Study|Lack of Efficacy|1|||
155269060|NCT04250337|560419023|FG001|Overall Study|Lack of Efficacy|3|||
155269061|NCT04250337|560419022|FG000|Overall Study|Physician Decision|1|||
155269062|NCT04250337|560419023|FG001|Overall Study|Physician Decision|0|||
155269063|NCT04250337|560419022|FG000|Overall Study|Protocol Deviation|2|||
155269064|NCT04250337|560419023|FG001|Overall Study|Protocol Deviation|2|||
155269065|NCT04250337|560419022|FG000|Overall Study|Withdrawal by Subject|4|||
155269066|NCT04250337|560419023|FG001|Overall Study|Withdrawal by Subject|3|||
155269067|NCT01129336|560419024|FG000|Overall Study|Protocol Violation|1|||
155269068|NCT01129336|560419025|FG001|Overall Study|Protocol Violation|0|||
155269069|NCT01129336|560419024|FG000|Overall Study|Disease Progression|1|||
155269070|NCT01129336|560419025|FG001|Overall Study|Disease Progression|4|||
155269071|NCT01129336|560419024|FG000|Overall Study|Lost to Follow-up|1|||
155269072|NCT01129336|560419025|FG001|Overall Study|Lost to Follow-up|0|||
155269073|NCT01129336|560419024|FG000|Overall Study|Withdrawal by Subject|7|||
155269074|NCT01129336|560419025|FG001|Overall Study|Withdrawal by Subject|4|||
155269075|NCT01129336|560419024|FG000|Overall Study|Adverse Event|0|||
155269076|NCT01129336|560419025|FG001|Overall Study|Adverse Event|1|||
155269077|NCT01129336|560419024|FG000|Overall Study|Missing Study Completion Status|2|||
155269078|NCT01129336|560419025|FG001|Overall Study|Missing Study Completion Status|3|||
155269079|NCT01129336|560419024|FG000|Overall Study|Death|0|||
155269080|NCT01129336|560419025|FG001|Overall Study|Death|4|||
155269081|NCT00152763|560419026|FG000|Overall Study|Death|4|||
155269082|NCT00152763|560419027|FG001|Overall Study|Death|1|||
155381736|NCT04617275|560830985|FG001|Follow-up Period|Lost to Follow-up|1|||
155269083|NCT00152763|560419028|FG002|Overall Study|Death|2|||
155269084|NCT00152763|560419029|FG003|Overall Study|Death|1|||
155269085|NCT00152763|560419026|FG000|Overall Study|Lost to Follow-up|6|||
155269086|NCT00152763|560419027|FG001|Overall Study|Lost to Follow-up|4|||
155269087|NCT00152763|560419028|FG002|Overall Study|Lost to Follow-up|2|||
155269088|NCT00152763|560419029|FG003|Overall Study|Lost to Follow-up|13|||
155269089|NCT00569803|560419030|FG000|Overall Study|Lost to Follow-up|1|||
155269090|NCT00569803|560419031|FG001|Overall Study|Lost to Follow-up|0|||
155269091|NCT00569803|560419032|FG002|Overall Study|Lost to Follow-up|0|||
155269092|NCT00569803|560419033|FG003|Overall Study|Lost to Follow-up|0|||
155269093|NCT00569803|560419034|FG004|Overall Study|Lost to Follow-up|0|||
155269094|NCT00569803|560419035|FG005|Overall Study|Lost to Follow-up|0|||
155269095|NCT00569803|560419036|FG006|Overall Study|Lost to Follow-up|0|||
155269096|NCT00569803|560419037|FG007|Overall Study|Lost to Follow-up|0|||
155269097|NCT00569803|560419030|FG000|Overall Study|injection syringe leaked during dosing|0|||
155269098|NCT00569803|560419031|FG001|Overall Study|injection syringe leaked during dosing|0|||
155269099|NCT00569803|560419032|FG002|Overall Study|injection syringe leaked during dosing|0|||
155269100|NCT00569803|560419033|FG003|Overall Study|injection syringe leaked during dosing|1|||
155269101|NCT00569803|560419034|FG004|Overall Study|injection syringe leaked during dosing|0|||
155269102|NCT00569803|560419035|FG005|Overall Study|injection syringe leaked during dosing|0|||
155269103|NCT00569803|560419036|FG006|Overall Study|injection syringe leaked during dosing|0|||
155269104|NCT00569803|560419037|FG007|Overall Study|injection syringe leaked during dosing|0|||
155269105|NCT00569803|560419030|FG000|Overall Study|Withdrawal by Subject|0|||
155269106|NCT00569803|560419031|FG001|Overall Study|Withdrawal by Subject|0|||
155269107|NCT00569803|560419032|FG002|Overall Study|Withdrawal by Subject|0|||
155269108|NCT00569803|560419033|FG003|Overall Study|Withdrawal by Subject|0|||
155269109|NCT00569803|560419034|FG004|Overall Study|Withdrawal by Subject|0|||
155269110|NCT00569803|560419035|FG005|Overall Study|Withdrawal by Subject|0|||
155269111|NCT00569803|560419036|FG006|Overall Study|Withdrawal by Subject|0|||
155269112|NCT00569803|560419037|FG007|Overall Study|Withdrawal by Subject|1|||
155269113|NCT04668989|560419038|FG000|First Intervention|Covid-19 related self-isolation|0|||
155269114|NCT04668989|560419039|FG001|First Intervention|Covid-19 related self-isolation|1|||
155269115|NCT04668989|560419038|FG000|Second Intervention|Adverse Event|0|||
155269116|NCT04668989|560419039|FG001|Second Intervention|Adverse Event|1|||
155269117|NCT01993823|560419040|FG000|Overall Study|Requested by the patient|6|||
155269118|NCT01993823|560419041|FG001|Overall Study|Requested by the patient|11|||
155269119|NCT01993823|560419040|FG000|Overall Study|Protocol Violation|0|||
155269120|NCT01993823|560419041|FG001|Overall Study|Protocol Violation|1|||
155269121|NCT01993823|560419040|FG000|Overall Study|Lost to Follow-up|1|||
155269122|NCT01993823|560419041|FG001|Overall Study|Lost to Follow-up|4|||
155269123|NCT01622348|560419044|FG000|Overall Study|Withdrawal by Subject|1|||
155269124|NCT01622348|560419045|FG001|Overall Study|Withdrawal by Subject|0|||
155269125|NCT01622348|560419046|FG002|Overall Study|Withdrawal by Subject|1|||
155269126|NCT00791921|560419049|FG000|Overall Study|Protocol planed|24|||
155269127|NCT00791921|560419050|FG001|Overall Study|Protocol planed|88|||
155269128|NCT00791921|560419049|FG000|Overall Study|Withdrawal by Subject|1|||
155269129|NCT00791921|560419050|FG001|Overall Study|Withdrawal by Subject|2|||
155269130|NCT00791921|560419049|FG000|Overall Study|Adverse Event|8|||
155269131|NCT00791921|560419050|FG001|Overall Study|Adverse Event|2|||
155269132|NCT00791921|560419049|FG000|Overall Study|Lack of Efficacy|0|||
155269133|NCT00791921|560419050|FG001|Overall Study|Lack of Efficacy|2|||
155269134|NCT00791921|560419049|FG000|Overall Study|Lack of study drug administration|1|||
155269135|NCT00791921|560419050|FG001|Overall Study|Lack of study drug administration|1|||
155269136|NCT00791921|560419049|FG000|Overall Study|Reason other than those above|0|||
155269137|NCT00791921|560419050|FG001|Overall Study|Reason other than those above|1|||
155269138|NCT00422799|560419054|FG000|Overall Study|Withdrawal by Subject|6|||
155269139|NCT00422799|560419054|FG000|Overall Study|Adverse Event|7|||
155269140|NCT01965158|560419055|FG000|Overall Study|Adverse Event|14|||
155269141|NCT01965158|560419056|FG001|Overall Study|Adverse Event|5|||
155269142|NCT01965158|560419055|FG000|Overall Study|Withdrawal by Subject|16|||
155269143|NCT01965158|560419056|FG001|Overall Study|Withdrawal by Subject|24|||
155269144|NCT01965158|560419055|FG000|Overall Study|Lost to Follow-up|7|||
155269145|NCT01965158|560419056|FG001|Overall Study|Lost to Follow-up|5|||
155269146|NCT01965158|560419055|FG000|Overall Study|Protocol Violation|1|||
155269147|NCT01965158|560419056|FG001|Overall Study|Protocol Violation|1|||
155269148|NCT01965158|560419055|FG000|Overall Study|Other - Miscellaneous|3|||
155381737|NCT04617275|560830986|FG002|Follow-up Period|Lost to Follow-up|2|||
155381738|NCT04617275|560830987|FG003|Follow-up Period|Lost to Follow-up|0|||
155269149|NCT01965158|560419056|FG001|Overall Study|Other - Miscellaneous|0|||
155269150|NCT00474175|560419057|FG000|Overall Study|Lack of Efficacy|0|||
155269151|NCT00474175|560419058|FG001|Overall Study|Lack of Efficacy|0|||
155269152|NCT00474175|560419059|FG002|Overall Study|Lack of Efficacy|1|||
155269153|NCT00474175|560419057|FG000|Overall Study|Withdrawal by Subject|0|||
155269154|NCT00474175|560419058|FG001|Overall Study|Withdrawal by Subject|1|||
155269155|NCT00474175|560419059|FG002|Overall Study|Withdrawal by Subject|1|||
155269156|NCT00474175|560419057|FG000|Overall Study|Ineligible|1|||
155269157|NCT00474175|560419058|FG001|Overall Study|Ineligible|3|||
155269158|NCT00474175|560419059|FG002|Overall Study|Ineligible|1|||
155269159|NCT00474175|560419057|FG000|Overall Study|Protocol Violation|0|||
155269160|NCT00474175|560419058|FG001|Overall Study|Protocol Violation|2|||
155269161|NCT00474175|560419059|FG002|Overall Study|Protocol Violation|1|||
155269162|NCT00474175|560419057|FG000|Overall Study|Administrative|0|||
155269163|NCT00474175|560419058|FG001|Overall Study|Administrative|1|||
155269164|NCT00474175|560419059|FG002|Overall Study|Administrative|0|||
155269165|NCT00467142|560419060|FG000|Overall Study|Withdrawal by Subject|1|||
155269166|NCT00467142|560419060|FG000|Overall Study|Adverse Event|1|||
155269167|NCT00467142|560419060|FG000|Overall Study|Protocol Violation|1|||
155269168|NCT01619787|560419061|FG000|Overall Study|Lost to Follow-up|5|||
155269169|NCT04537897|560419062|FG000|Overall Study|Other than listed|0|||
155269170|NCT04537897|560419063|FG001|Overall Study|Other than listed|0|||
155269171|NCT04537897|560419064|FG002|Overall Study|Other than listed|0|||
155269172|NCT04537897|560419065|FG003|Overall Study|Other than listed|0|||
155269173|NCT04537897|560419066|FG004|Overall Study|Other than listed|0|||
155269174|NCT04537897|560419067|FG005|Overall Study|Other than listed|0|||
155269175|NCT04537897|560419068|FG006|Overall Study|Other than listed|1|||
155269176|NCT04537897|560419069|FG007|Overall Study|Other than listed|0|||
155269177|NCT04537897|560419070|FG008|Overall Study|Other than listed|0|||
155269178|NCT04537897|560419062|FG000|Overall Study|Adverse Event|0|||
155269179|NCT04537897|560419063|FG001|Overall Study|Adverse Event|0|||
155269180|NCT04537897|560419064|FG002|Overall Study|Adverse Event|0|||
155269181|NCT04537897|560419065|FG003|Overall Study|Adverse Event|1|||
155269182|NCT04537897|560419066|FG004|Overall Study|Adverse Event|0|||
155269183|NCT04537897|560419067|FG005|Overall Study|Adverse Event|0|||
155269184|NCT04537897|560419068|FG006|Overall Study|Adverse Event|0|||
155269185|NCT04537897|560419069|FG007|Overall Study|Adverse Event|0|||
155269186|NCT04537897|560419070|FG008|Overall Study|Adverse Event|0|||
155269187|NCT04537897|560419062|FG000|Overall Study|Withdrawal by Subject|0|||
155269188|NCT04537897|560419063|FG001|Overall Study|Withdrawal by Subject|1|||
155269189|NCT04537897|560419064|FG002|Overall Study|Withdrawal by Subject|0|||
155269190|NCT04537897|560419065|FG003|Overall Study|Withdrawal by Subject|0|||
155269191|NCT04537897|560419066|FG004|Overall Study|Withdrawal by Subject|0|||
155269192|NCT04537897|560419067|FG005|Overall Study|Withdrawal by Subject|0|||
155269193|NCT04537897|560419068|FG006|Overall Study|Withdrawal by Subject|0|||
155269194|NCT04537897|560419069|FG007|Overall Study|Withdrawal by Subject|0|||
155269195|NCT04537897|560419070|FG008|Overall Study|Withdrawal by Subject|0|||
155269196|NCT03029780|560419077|FG000|Overall Study|Disease Progression|20|||
155269197|NCT03029780|560419078|FG001|Overall Study|Disease Progression|22|||
155269198|NCT03029780|560419077|FG000|Overall Study|Study Drug Toxicity|15|||
155269199|NCT03029780|560419078|FG001|Overall Study|Study Drug Toxicity|11|||
155269200|NCT03029780|560419077|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155269201|NCT03029780|560419078|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155269202|NCT03029780|560419077|FG000|Overall Study|Participant request to discontinue study treatment|4|||
155269203|NCT03029780|560419078|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155269204|NCT03029780|560419077|FG000|Overall Study|Maximum clinical benefit|1|||
155269205|NCT03029780|560419078|FG001|Overall Study|Maximum clinical benefit|0|||
155269206|NCT03029780|560419077|FG000|Overall Study|Participant no longer meets study criteria|0|||
155269207|NCT03029780|560419078|FG001|Overall Study|Participant no longer meets study criteria|1|||
155269208|NCT03029780|560419077|FG000|Overall Study|Other reasons|6|||
155269209|NCT03029780|560419078|FG001|Overall Study|Other reasons|6|||
155269210|NCT03029780|560419077|FG000|Overall Study|Not reported|1|||
155269211|NCT03029780|560419078|FG001|Overall Study|Not reported|1|||
155269212|NCT03029780|560419077|FG000|Overall Study|Death|2|||
155269213|NCT03029780|560419078|FG001|Overall Study|Death|6|||
155269214|NCT00197028|560419079|FG000|Overall Study|Adverse Event|2|||
155269215|NCT00197028|560419080|FG001|Overall Study|Adverse Event|2|||
155269216|NCT00197028|560419079|FG000|Overall Study|Protocol Violation|2|||
155269217|NCT00197028|560419080|FG001|Overall Study|Protocol Violation|1|||
155269218|NCT00197028|560419079|FG000|Overall Study|Withdrawal by Subject|8|||
155269219|NCT00197028|560419080|FG001|Overall Study|Withdrawal by Subject|12|||
155269220|NCT00197028|560419079|FG000|Overall Study|Lost to Follow-up|1|||
155269221|NCT00197028|560419080|FG001|Overall Study|Lost to Follow-up|0|||
155269222|NCT00197028|560419079|FG000|Overall Study|Other|3|||
155269223|NCT00197028|560419080|FG001|Overall Study|Other|6|||
155726460|NCT01716234|562098140|FG000|Overall Study|Protocol Violation|0|||
155269224|NCT00178256|560419081|FG000|Overall Study|Adverse Event|2|||
155269225|NCT00178256|560419082|FG001|Overall Study|Adverse Event|0|||
155269226|NCT00178256|560419083|FG002|Overall Study|Adverse Event|0|||
155269227|NCT00178256|560419084|FG003|Overall Study|Adverse Event|0|||
155269228|NCT00178256|560419081|FG000|Overall Study|Death|0|||
155269229|NCT00178256|560419082|FG001|Overall Study|Death|1|||
155269230|NCT00178256|560419083|FG002|Overall Study|Death|0|||
155269231|NCT00178256|560419084|FG003|Overall Study|Death|1|||
155269232|NCT00178256|560419081|FG000|Overall Study|Cancer progression|2|||
155269233|NCT00178256|560419082|FG001|Overall Study|Cancer progression|0|||
155269234|NCT00178256|560419083|FG002|Overall Study|Cancer progression|0|||
155269235|NCT00178256|560419084|FG003|Overall Study|Cancer progression|1|||
155269236|NCT03066622|560419085|FG000|Overall Study|Lost to Follow-up|24|||
155269237|NCT03066622|560419086|FG001|Overall Study|Lost to Follow-up|25|||
155269238|NCT03066622|560419085|FG000|Overall Study|Withdrawal by Subject|2|||
155269239|NCT03066622|560419086|FG001|Overall Study|Withdrawal by Subject|1|||
155269240|NCT04741802|560419087|FG000|Overall Study|Death|1|||
155269241|NCT04741802|560419087|FG000|Overall Study|Lost to Follow-up|11|||
155269242|NCT03101241|560419088|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
155269243|NCT03101241|560419089|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
155269244|NCT03101241|560419088|FG000|Overall Study|Participant withdrew consent|3|||
155269245|NCT03101241|560419089|FG001|Overall Study|Participant withdrew consent|1|||
155269246|NCT03101241|560419088|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
155269247|NCT03101241|560419089|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
155269248|NCT03101241|560419088|FG000|Overall Study|Lost to Follow-up|2|||
155269249|NCT03101241|560419089|FG001|Overall Study|Lost to Follow-up|0|||
155269250|NCT03101241|560419088|FG000|Overall Study|Lack of Efficacy|0|||
155269251|NCT03101241|560419089|FG001|Overall Study|Lack of Efficacy|1|||
155269252|NCT03101241|560419088|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
155269253|NCT03101241|560419089|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
155269254|NCT00692406|560419090|FG000|Overall Study|PI dropped, bad data|57|||
155269255|NCT02597933|560419091|FG000|Overall Study|Withdrawal by Subject|7|||
155269256|NCT02597933|560419092|FG001|Overall Study|Withdrawal by Subject|5|||
155269257|NCT02597933|560419091|FG000|Overall Study|Protocol Violation|2|||
155269258|NCT02597933|560419092|FG001|Overall Study|Protocol Violation|2|||
155269259|NCT02597933|560419091|FG000|Overall Study|Adverse Event|20|||
155269260|NCT02597933|560419092|FG001|Overall Study|Adverse Event|28|||
155269261|NCT02597933|560419091|FG000|Overall Study|Not treated|2|||
155269262|NCT02597933|560419092|FG001|Overall Study|Not treated|2|||
155269263|NCT02597933|560419091|FG000|Overall Study|Other than stated above|7|||
155269264|NCT02597933|560419092|FG001|Overall Study|Other than stated above|14|||
155269265|NCT01617005|560419095|FG000|Overall Study|Pregnancy|1|||
155269266|NCT01617005|560419095|FG000|Overall Study|Lack of motivation for treatment|1|||
155269267|NCT01320735|560419099|FG000|Overall Study|Adverse Event|3|||
155269268|NCT01320735|560419099|FG000|Overall Study|Withdrawal by Subject|3|||
155269269|NCT01320735|560419099|FG000|Overall Study|Lost to Follow-up|13|||
155269270|NCT01320735|560419099|FG000|Overall Study|Administrative Reason|6|||
155269271|NCT01320735|560419099|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
155269272|NCT01320735|560419099|FG000|Overall Study|Protocol Violation|1|||
155269273|NCT01320735|560419099|FG000|Overall Study|Other|1|||
155269274|NCT01320735|560419099|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
155269275|NCT01320735|560419099|FG000|Overall Study|Investigator Unable to be Contacted|17|||
155269276|NCT04599101|560419100|FG000|Overall Study|Lost to Follow-up|5|||
155269277|NCT04599101|560419101|FG001|Overall Study|Lost to Follow-up|5|||
155269278|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
155269279|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
155269280|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
155269281|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
155269282|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
155269283|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
155269284|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
155269285|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
155269286|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
155269287|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
155269288|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
155269289|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
155269290|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
155269291|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
155269292|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
155269293|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
155269294|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
155269295|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
155269296|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
155269297|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
155269298|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
155269299|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
155269300|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
155269301|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
155269302|NCT02307513|560419102|FG000|Long-term Extension|Physician Decision|1|||
155269303|NCT02307513|560419103|FG001|Long-term Extension|Physician Decision|0|||
155269304|NCT05952297|560419104|FG000|Overall Study|Withdrawal by Subject|1|||
155269305|NCT05952297|560419105|FG001|Overall Study|Withdrawal by Subject|0|||
155269306|NCT00284089|560419108|FG000|Multiple Dose Phase|Adverse Event|1|||
155269307|NCT00284089|560419109|FG001|Multiple Dose Phase|Adverse Event|0|||
155269308|NCT00284089|560419110|FG002|Multiple Dose Phase|Adverse Event|1|||
155614658|NCT00980655|561683030|FG000|Overall Study|Withdrawal by Subject|0|||
155614659|NCT00980655|561683031|FG001|Overall Study|Withdrawal by Subject|4|||
155614660|NCT00980655|561683030|FG000|Overall Study|Lost to Follow-up|0|||
155614661|NCT00980655|561683031|FG001|Overall Study|Lost to Follow-up|1|||
155614662|NCT00980655|561683030|FG000|Overall Study|Parent/legal guardian request|1|||
155614663|NCT00980655|561683031|FG001|Overall Study|Parent/legal guardian request|0|||
155614664|NCT00980655|561683030|FG000|Overall Study|Other|0|||
155614665|NCT00980655|561683031|FG001|Overall Study|Other|1|||
155614666|NCT04162795|561683032|FG000|Overall Study|Other|16|||
155614667|NCT04162795|561683032|FG000|Overall Study|Screen failures|10|||
155614668|NCT02029274|561683036|FG000|Overall Study|Adverse Event|1|||
155614669|NCT02029274|561683037|FG001|Overall Study|Adverse Event|0|||
155614670|NCT02029274|561683038|FG002|Overall Study|Adverse Event|2|||
155614671|NCT02029274|561683039|FG003|Overall Study|Adverse Event|2|||
155614672|NCT00845676|561683042|FG000|Overall Study|Virologic breakthrough at week 20|1|||
155614673|NCT00845676|561683042|FG000|Overall Study|Adverse Event|1|||
155614674|NCT03597139|561683043|FG000|Overall Study|Adverse Event|3|||
155614675|NCT03597139|561683044|FG001|Overall Study|Adverse Event|0|||
155614676|NCT03597139|561683043|FG000|Overall Study|Protocol Non-compliance|1|||
155614677|NCT03597139|561683044|FG001|Overall Study|Protocol Non-compliance|0|||
155614678|NCT05052697|561683045|FG000|Substudy A|Lost to Follow-up|0|||
155614679|NCT05052697|561683046|FG001|Substudy A|Lost to Follow-up|0|||
155614680|NCT05052697|561683047|FG002|Substudy A|Lost to Follow-up|0|||
155614681|NCT05052697|561683048|FG003|Substudy A|Lost to Follow-up|0|||
155614682|NCT05052697|561683049|FG004|Substudy A|Lost to Follow-up|0|||
155614683|NCT05052697|561683050|FG005|Substudy A|Lost to Follow-up|1|||
155614684|NCT05052697|561683051|FG006|Substudy A|Lost to Follow-up|0|||
155614685|NCT05052697|561683052|FG007|Substudy A|Lost to Follow-up|0|||
155614686|NCT05052697|561683053|FG008|Substudy A|Lost to Follow-up|0|||
155614687|NCT05052697|561683054|FG009|Substudy A|Lost to Follow-up|0|||
155614688|NCT05052697|561683055|FG010|Substudy A|Lost to Follow-up|0|||
155614689|NCT05052697|561683056|FG011|Substudy A|Lost to Follow-up|0|||
155614690|NCT05052697|561683057|FG012|Substudy A|Lost to Follow-up|0|||
155614691|NCT05052697|561683058|FG013|Substudy A|Lost to Follow-up|0|||
155614692|NCT05052697|561683059|FG014|Substudy A|Lost to Follow-up|0|||
155614693|NCT05052697|561683060|FG015|Substudy A|Lost to Follow-up|2|||
155614694|NCT05052697|561683061|FG016|Substudy A|Lost to Follow-up|0|||
155614695|NCT05052697|561683062|FG017|Substudy A|Lost to Follow-up|0|||
155614696|NCT05052697|561683063|FG018|Substudy A|Lost to Follow-up|0|||
155614697|NCT05052697|561683064|FG019|Substudy A|Lost to Follow-up|0|||
155614698|NCT05052697|561683065|FG020|Substudy A|Lost to Follow-up|0|||
155614699|NCT05052697|561683066|FG021|Substudy A|Lost to Follow-up|0|||
155614700|NCT05052697|561683067|FG022|Substudy A|Lost to Follow-up|0|||
155614701|NCT05052697|561683068|FG023|Substudy A|Lost to Follow-up|0|||
155614702|NCT05052697|561683069|FG024|Substudy A|Lost to Follow-up|0|||
155614703|NCT05052697|561683070|FG025|Substudy A|Lost to Follow-up|0|||
155614704|NCT05052697|561683071|FG026|Substudy A|Lost to Follow-up|0|||
155614705|NCT05052697|561683072|FG027|Substudy A|Lost to Follow-up|0|||
155614706|NCT05052697|561683073|FG028|Substudy A|Lost to Follow-up|0|||
155614707|NCT05052697|561683074|FG029|Substudy A|Lost to Follow-up|0|||
155614708|NCT05052697|561683075|FG030|Substudy A|Lost to Follow-up|0|||
155614709|NCT05052697|561683076|FG031|Substudy A|Lost to Follow-up|0|||
155614710|NCT05052697|561683077|FG032|Substudy A|Lost to Follow-up|0|||
155614711|NCT05052697|561683078|FG033|Substudy A|Lost to Follow-up|0|||
155614712|NCT05052697|561683045|FG000|Substudy A|No longer met eligibility criteria|0|||
155614713|NCT05052697|561683046|FG001|Substudy A|No longer met eligibility criteria|0|||
155614714|NCT05052697|561683047|FG002|Substudy A|No longer met eligibility criteria|0|||
155614715|NCT05052697|561683048|FG003|Substudy A|No longer met eligibility criteria|0|||
155614716|NCT05052697|561683049|FG004|Substudy A|No longer met eligibility criteria|0|||
155614717|NCT05052697|561683050|FG005|Substudy A|No longer met eligibility criteria|0|||
155614718|NCT05052697|561683051|FG006|Substudy A|No longer met eligibility criteria|0|||
155614719|NCT05052697|561683052|FG007|Substudy A|No longer met eligibility criteria|0|||
155614720|NCT05052697|561683053|FG008|Substudy A|No longer met eligibility criteria|0|||
155614721|NCT05052697|561683054|FG009|Substudy A|No longer met eligibility criteria|0|||
155614722|NCT05052697|561683055|FG010|Substudy A|No longer met eligibility criteria|0|||
155614723|NCT05052697|561683056|FG011|Substudy A|No longer met eligibility criteria|0|||
155614724|NCT05052697|561683057|FG012|Substudy A|No longer met eligibility criteria|0|||
155614725|NCT05052697|561683058|FG013|Substudy A|No longer met eligibility criteria|1|||
155614726|NCT05052697|561683059|FG014|Substudy A|No longer met eligibility criteria|0|||
155614727|NCT05052697|561683060|FG015|Substudy A|No longer met eligibility criteria|0|||
155614728|NCT05052697|561683061|FG016|Substudy A|No longer met eligibility criteria|0|||
155614729|NCT05052697|561683062|FG017|Substudy A|No longer met eligibility criteria|0|||
155614730|NCT05052697|561683063|FG018|Substudy A|No longer met eligibility criteria|0|||
155614731|NCT05052697|561683064|FG019|Substudy A|No longer met eligibility criteria|0|||
155614732|NCT05052697|561683065|FG020|Substudy A|No longer met eligibility criteria|0|||
155614733|NCT05052697|561683066|FG021|Substudy A|No longer met eligibility criteria|0|||
155614734|NCT05052697|561683067|FG022|Substudy A|No longer met eligibility criteria|0|||
155269309|NCT00284089|560419111|FG003|Multiple Dose Phase|Adverse Event|1|||
155269310|NCT00284089|560419108|FG000|Multiple Dose Phase|Protocol Violation|0|||
155269311|NCT00284089|560419109|FG001|Multiple Dose Phase|Protocol Violation|0|||
155269312|NCT00284089|560419110|FG002|Multiple Dose Phase|Protocol Violation|1|||
155269313|NCT00284089|560419111|FG003|Multiple Dose Phase|Protocol Violation|0|||
155269314|NCT00284089|560419108|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
155269315|NCT00284089|560419109|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
155269316|NCT00284089|560419110|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
155269317|NCT00284089|560419111|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
155269318|NCT00284089|560419108|FG000|Multiple Dose Phase|Death|0|||
155269319|NCT00284089|560419109|FG001|Multiple Dose Phase|Death|0|||
155269320|NCT00284089|560419110|FG002|Multiple Dose Phase|Death|1|||
155269321|NCT00284089|560419111|FG003|Multiple Dose Phase|Death|1|||
155269322|NCT00284089|560419108|FG000|Extension Phase|Adverse Event|0|||
155269323|NCT00284089|560419109|FG001|Extension Phase|Adverse Event|0|||
155269324|NCT00284089|560419110|FG002|Extension Phase|Adverse Event|2|||
155269325|NCT00284089|560419111|FG003|Extension Phase|Adverse Event|2|||
155269326|NCT00284089|560419108|FG000|Extension Phase|condition no longer requires study drug|2|||
155269327|NCT00284089|560419109|FG001|Extension Phase|condition no longer requires study drug|0|||
155269328|NCT00284089|560419110|FG002|Extension Phase|condition no longer requires study drug|2|||
155269329|NCT00284089|560419111|FG003|Extension Phase|condition no longer requires study drug|7|||
155269330|NCT00284089|560419108|FG000|Extension Phase|Protocol Violation|0|||
155269331|NCT00284089|560419109|FG001|Extension Phase|Protocol Violation|0|||
155269332|NCT00284089|560419110|FG002|Extension Phase|Protocol Violation|1|||
155269333|NCT00284089|560419111|FG003|Extension Phase|Protocol Violation|0|||
155269334|NCT00284089|560419108|FG000|Extension Phase|Withdrawal by Subject|0|||
155269335|NCT00284089|560419109|FG001|Extension Phase|Withdrawal by Subject|0|||
155269336|NCT00284089|560419110|FG002|Extension Phase|Withdrawal by Subject|1|||
155269337|NCT00284089|560419111|FG003|Extension Phase|Withdrawal by Subject|3|||
155269338|NCT02759185|560419113|FG000|Stage 1|Adverse Event|0|||
155269339|NCT02759185|560419114|FG001|Stage 1|Adverse Event|1|||
155269340|NCT02759185|560419115|FG002|Stage 1|Adverse Event|3|||
155269341|NCT02759185|560419116|FG003|Stage 1|Adverse Event|0|||
155269342|NCT02759185|560419117|FG004|Stage 1|Adverse Event|0|||
155269343|NCT02759185|560419118|FG005|Stage 1|Adverse Event|0|||
155269344|NCT02759185|560419119|FG006|Stage 1|Adverse Event|0|||
155269345|NCT02759185|560419113|FG000|Stage 1|Withdrawal by Subject|1|||
155269346|NCT02759185|560419114|FG001|Stage 1|Withdrawal by Subject|0|||
155269347|NCT02759185|560419115|FG002|Stage 1|Withdrawal by Subject|0|||
155269348|NCT02759185|560419116|FG003|Stage 1|Withdrawal by Subject|0|||
155269349|NCT02759185|560419117|FG004|Stage 1|Withdrawal by Subject|0|||
155269350|NCT02759185|560419118|FG005|Stage 1|Withdrawal by Subject|0|||
155269351|NCT02759185|560419119|FG006|Stage 1|Withdrawal by Subject|0|||
155269352|NCT02759185|560419113|FG000|Stage 2|Adverse Event|0|||
155269353|NCT02759185|560419114|FG001|Stage 2|Adverse Event|0|||
155269354|NCT02759185|560419115|FG002|Stage 2|Adverse Event|0|||
155269355|NCT02759185|560419116|FG003|Stage 2|Adverse Event|0|||
155269356|NCT02759185|560419117|FG004|Stage 2|Adverse Event|1|||
155269357|NCT02759185|560419118|FG005|Stage 2|Adverse Event|2|||
155269358|NCT02759185|560419119|FG006|Stage 2|Adverse Event|0|||
155269359|NCT02759185|560419113|FG000|Stage 2|Withdrawal by Subject|0|||
155269360|NCT02759185|560419114|FG001|Stage 2|Withdrawal by Subject|0|||
155269361|NCT02759185|560419115|FG002|Stage 2|Withdrawal by Subject|0|||
155269362|NCT02759185|560419116|FG003|Stage 2|Withdrawal by Subject|0|||
155269363|NCT02759185|560419117|FG004|Stage 2|Withdrawal by Subject|1|||
155269364|NCT02759185|560419118|FG005|Stage 2|Withdrawal by Subject|1|||
155269365|NCT02759185|560419119|FG006|Stage 2|Withdrawal by Subject|1|||
155614735|NCT05052697|561683068|FG023|Substudy A|No longer met eligibility criteria|0|||
155614736|NCT05052697|561683069|FG024|Substudy A|No longer met eligibility criteria|0|||
155614737|NCT05052697|561683070|FG025|Substudy A|No longer met eligibility criteria|0|||
155614738|NCT05052697|561683071|FG026|Substudy A|No longer met eligibility criteria|0|||
155614739|NCT05052697|561683072|FG027|Substudy A|No longer met eligibility criteria|0|||
155614740|NCT05052697|561683073|FG028|Substudy A|No longer met eligibility criteria|0|||
155614741|NCT05052697|561683074|FG029|Substudy A|No longer met eligibility criteria|0|||
155614742|NCT05052697|561683075|FG030|Substudy A|No longer met eligibility criteria|0|||
155614743|NCT05052697|561683076|FG031|Substudy A|No longer met eligibility criteria|0|||
155614744|NCT05052697|561683077|FG032|Substudy A|No longer met eligibility criteria|0|||
155269366|NCT02234063|560419120|FG000|Overall Study|Lost to Follow-up|235|||
155269367|NCT02234063|560419121|FG001|Overall Study|Lost to Follow-up|42|||
155614745|NCT05052697|561683078|FG033|Substudy A|No longer met eligibility criteria|0|||
155726461|NCT01716234|562098141|FG001|Overall Study|Protocol Violation|0|||
155269368|NCT02234063|560419120|FG000|Overall Study|Withdrawal by Subject|20|||
155269369|NCT02234063|560419121|FG001|Overall Study|Withdrawal by Subject|1|||
155269370|NCT02781506|560420685|FG000|Overall Study|Adverse Event|5|||
155614746|NCT05052697|561683045|FG000|Substudy A|Not vaccinated|0|||
155269371|NCT00437125|560420686|FG000|Overall Study|Adverse Event|12|||
155269372|NCT00437125|560420686|FG000|Overall Study|Death|1|||
155269373|NCT00437125|560420686|FG000|Overall Study|Clinical Relapse|1|||
155614747|NCT05052697|561683046|FG001|Substudy A|Not vaccinated|0|||
155269374|NCT00437125|560420686|FG000|Overall Study|Lack of Efficacy|1|||
155269375|NCT00437125|560420686|FG000|Overall Study|Lost to Follow-up|1|||
155269376|NCT00437125|560420686|FG000|Overall Study|Withdrawal by Subject|13|||
155269377|NCT00437125|560420686|FG000|Overall Study|Withdrawal by Caregiver|2|||
155269378|NCT00437125|560420686|FG000|Overall Study|Physician Decision|1|||
155269379|NCT02248961|560420687|FG000|Overall Study|Adverse Event|1|||
155269380|NCT02248961|560420688|FG001|Overall Study|Adverse Event|0|||
155269381|NCT02248961|560420687|FG000|Overall Study|Withdrawal by Subject|1|||
155269382|NCT02248961|560420688|FG001|Overall Study|Withdrawal by Subject|2|||
155269383|NCT02248961|560420687|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
155269384|NCT02248961|560420688|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
155269385|NCT02802319|560420694|FG000|Overall Study|Physician Decision|2|||
155269386|NCT02802319|560420695|FG001|Overall Study|Physician Decision|1|||
155269387|NCT02802319|560420694|FG000|Overall Study|Lost to Follow-up|0|||
155269388|NCT02802319|560420695|FG001|Overall Study|Lost to Follow-up|4|||
155269389|NCT04651114|560420696|FG000|Overall Study|Withdrawal by Subject|8|||
155269390|NCT00235443|560420701|FG000|Overall Study|Adverse Event|4|||
155269391|NCT00235443|560420702|FG001|Overall Study|Adverse Event|12|||
155269392|NCT00235443|560420703|FG002|Overall Study|Adverse Event|17|||
155269393|NCT00235443|560420704|FG003|Overall Study|Adverse Event|44|||
155269394|NCT00235443|560420705|FG004|Overall Study|Adverse Event|10|||
155269395|NCT00235443|560420706|FG005|Overall Study|Adverse Event|15|||
155269396|NCT00235443|560420701|FG000|Overall Study|Lack of Efficacy|0|||
155269397|NCT00235443|560420702|FG001|Overall Study|Lack of Efficacy|1|||
155269398|NCT00235443|560420703|FG002|Overall Study|Lack of Efficacy|5|||
155269399|NCT00235443|560420704|FG003|Overall Study|Lack of Efficacy|12|||
155269400|NCT00235443|560420705|FG004|Overall Study|Lack of Efficacy|2|||
155269401|NCT00235443|560420706|FG005|Overall Study|Lack of Efficacy|9|||
155269402|NCT00235443|560420701|FG000|Overall Study|Withdrawal by Subject|3|||
155269403|NCT00235443|560420702|FG001|Overall Study|Withdrawal by Subject|9|||
155269404|NCT00235443|560420703|FG002|Overall Study|Withdrawal by Subject|25|||
155269405|NCT00235443|560420704|FG003|Overall Study|Withdrawal by Subject|24|||
155269406|NCT00235443|560420705|FG004|Overall Study|Withdrawal by Subject|10|||
155269407|NCT00235443|560420706|FG005|Overall Study|Withdrawal by Subject|12|||
155269408|NCT00235443|560420701|FG000|Overall Study|Lost to Follow-up|0|||
155269409|NCT00235443|560420702|FG001|Overall Study|Lost to Follow-up|8|||
155269410|NCT00235443|560420703|FG002|Overall Study|Lost to Follow-up|6|||
155269411|NCT00235443|560420704|FG003|Overall Study|Lost to Follow-up|6|||
155269412|NCT00235443|560420705|FG004|Overall Study|Lost to Follow-up|4|||
155269413|NCT00235443|560420706|FG005|Overall Study|Lost to Follow-up|3|||
155269414|NCT00235443|560420701|FG000|Overall Study|Unsatisfactory compliance|0|||
155269415|NCT00235443|560420702|FG001|Overall Study|Unsatisfactory compliance|2|||
155269416|NCT00235443|560420703|FG002|Overall Study|Unsatisfactory compliance|3|||
155269417|NCT00235443|560420704|FG003|Overall Study|Unsatisfactory compliance|4|||
155269418|NCT00235443|560420705|FG004|Overall Study|Unsatisfactory compliance|1|||
155269419|NCT00235443|560420706|FG005|Overall Study|Unsatisfactory compliance|0|||
155269420|NCT00235443|560420701|FG000|Overall Study|Other reasons for premature termination|1|||
155269421|NCT00235443|560420702|FG001|Overall Study|Other reasons for premature termination|6|||
155269422|NCT00235443|560420703|FG002|Overall Study|Other reasons for premature termination|6|||
155269423|NCT00235443|560420704|FG003|Overall Study|Other reasons for premature termination|7|||
155269424|NCT00235443|560420705|FG004|Overall Study|Other reasons for premature termination|3|||
155269425|NCT00235443|560420706|FG005|Overall Study|Other reasons for premature termination|6|||
155269426|NCT01763788|560420711|FG000|Overall Study|Lost to Follow-up|0|||
155269427|NCT01763788|560420712|FG001|Overall Study|Lost to Follow-up|0|||
155269428|NCT01763788|560420713|FG002|Overall Study|Lost to Follow-up|1|||
155269429|NCT01763788|560420714|FG003|Overall Study|Lost to Follow-up|0|||
155269430|NCT03321006|560420715|FG000|Overall Study|Death|1|||
155269431|NCT03321006|560420716|FG001|Overall Study|Death|0|||
155269432|NCT03321006|560420715|FG000|Overall Study|Lack of Efficacy|1|||
155269433|NCT03321006|560420716|FG001|Overall Study|Lack of Efficacy|0|||
155269434|NCT03303469|560420717|FG000|Overall Study|Lost to Follow-up|2|||
155269435|NCT03560258|560420720|FG000|Overall Study|Lost to Follow-up|3|||
155269436|NCT03560258|560420721|FG001|Overall Study|Lost to Follow-up|0|||
155269437|NCT03560258|560420722|FG002|Overall Study|Lost to Follow-up|0|||
155269438|NCT03560258|560420720|FG000|Overall Study|Protocol Violation|0|||
155269439|NCT03560258|560420721|FG001|Overall Study|Protocol Violation|1|||
155269440|NCT03560258|560420722|FG002|Overall Study|Protocol Violation|0|||
155269441|NCT03560258|560420720|FG000|Overall Study|Withdrawal by Subject|0|||
155269442|NCT03560258|560420721|FG001|Overall Study|Withdrawal by Subject|0|||
155269443|NCT03560258|560420722|FG002|Overall Study|Withdrawal by Subject|1|||
155269444|NCT01460160|560420723|FG000|Treatment Phase|Lack of Efficacy|3|||
155269445|NCT01460160|560420723|FG000|Treatment Phase|Study Drug Toxicity|2|||
155269446|NCT01460160|560420723|FG000|Treatment Phase|Adverse Event|8|||
155269447|NCT01460160|560420723|FG000|Treatment Phase|Withdrawal by Subject|4|||
155269448|NCT01460160|560420723|FG000|Treatment Phase|Death|2|||
155269449|NCT01460160|560420723|FG000|Treatment Phase|Other reasons|9|||
155269450|NCT01460160|560420723|FG000|Follow-up Phase|Withdrawal by Subject|4|||
155269451|NCT01460160|560420723|FG000|Follow-up Phase|Death|14|||
155269452|NCT01460160|560420723|FG000|Follow-up Phase|Lost to Follow-up|7|||
155269453|NCT01460160|560420723|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
155269454|NCT01460160|560420723|FG000|Follow-up Phase|Other and not reported reasons|5|||
155269455|NCT03893825|560420724|FG000|Overall Study|Death|2|||
155269456|NCT03893825|560420725|FG001|Overall Study|Death|1|||
155269457|NCT03893825|560420724|FG000|Overall Study|Adverse Event|0|||
155269458|NCT03893825|560420725|FG001|Overall Study|Adverse Event|2|||
155269459|NCT03893825|560420724|FG000|Overall Study|Withdrawal by Subject|19|||
155269460|NCT03893825|560420725|FG001|Overall Study|Withdrawal by Subject|21|||
155269461|NCT03893825|560420724|FG000|Overall Study|Protocol deviation|1|||
155269462|NCT03893825|560420725|FG001|Overall Study|Protocol deviation|0|||
155269463|NCT03893825|560420724|FG000|Overall Study|Lost to Follow-up|10|||
155269464|NCT03893825|560420725|FG001|Overall Study|Lost to Follow-up|10|||
155269465|NCT03893825|560420724|FG000|Overall Study|Other than specified|7|||
155269466|NCT03893825|560420725|FG001|Overall Study|Other than specified|6|||
155269467|NCT02006121|560420729|FG000|Double Blind Phase|Adverse Event|6|||
155269468|NCT02006121|560420730|FG001|Double Blind Phase|Adverse Event|0|||
155269469|NCT02006121|560420729|FG000|Double Blind Phase|Lack of Efficacy|1|||
155269470|NCT02006121|560420730|FG001|Double Blind Phase|Lack of Efficacy|16|||
155269471|NCT02006121|560420729|FG000|Double Blind Phase|Withdrawal by Subject|3|||
155269472|NCT02006121|560420730|FG001|Double Blind Phase|Withdrawal by Subject|4|||
155269473|NCT02006121|560420729|FG000|Double Blind Phase|Non-compliance with study drug|1|||
155269474|NCT02006121|560420730|FG001|Double Blind Phase|Non-compliance with study drug|3|||
155269475|NCT02006121|560420729|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
155269476|NCT02006121|560420730|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
155269477|NCT02006121|560420729|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
155269478|NCT02006121|560420730|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
155269479|NCT02006121|560420729|FG000|Open Label Phase|Adverse Event|15|||
155269480|NCT02006121|560420730|FG001|Open Label Phase|Adverse Event|0|||
155269481|NCT02006121|560420729|FG000|Open Label Phase|Lack of Efficacy|2|||
155269482|NCT02006121|560420730|FG001|Open Label Phase|Lack of Efficacy|0|||
155269483|NCT02006121|560420729|FG000|Open Label Phase|Protocol Violation|2|||
155269484|NCT02006121|560420730|FG001|Open Label Phase|Protocol Violation|0|||
155269485|NCT02006121|560420729|FG000|Open Label Phase|Withdrawal by Subject|3|||
155269486|NCT02006121|560420730|FG001|Open Label Phase|Withdrawal by Subject|0|||
155269487|NCT02006121|560420729|FG000|Open Label Phase|Non-compliance with study drug|3|||
155269488|NCT02006121|560420730|FG001|Open Label Phase|Non-compliance with study drug|0|||
155269489|NCT04498247|560420734|FG000|Overall Study|Lost to Follow-up|0|||
155269490|NCT04498247|560420735|FG001|Overall Study|Lost to Follow-up|0|||
155269491|NCT04498247|560420736|FG002|Overall Study|Lost to Follow-up|0|||
155269492|NCT04498247|560420737|FG003|Overall Study|Lost to Follow-up|1|||
155269493|NCT04498247|560420738|FG004|Overall Study|Lost to Follow-up|0|||
155269494|NCT04498247|560420739|FG005|Overall Study|Lost to Follow-up|0|||
155269495|NCT04498247|560420740|FG006|Overall Study|Lost to Follow-up|0|||
155269496|NCT04498247|560420741|FG007|Overall Study|Lost to Follow-up|0|||
155269497|NCT04498247|560420734|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
155269498|NCT04498247|560420735|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269499|NCT04498247|560420736|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269500|NCT04498247|560420737|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269501|NCT04498247|560420738|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269502|NCT04498247|560420739|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269503|NCT04498247|560420740|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269504|NCT04498247|560420741|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269505|NCT04498247|560420734|FG000|Overall Study|Withdrawal by Subject|0|||
155269506|NCT04498247|560420735|FG001|Overall Study|Withdrawal by Subject|8|||
155269507|NCT04498247|560420736|FG002|Overall Study|Withdrawal by Subject|0|||
155269508|NCT04498247|560420737|FG003|Overall Study|Withdrawal by Subject|7|||
155269509|NCT04498247|560420738|FG004|Overall Study|Withdrawal by Subject|0|||
155269510|NCT04498247|560420739|FG005|Overall Study|Withdrawal by Subject|0|||
155269511|NCT04498247|560420740|FG006|Overall Study|Withdrawal by Subject|1|||
155269512|NCT04498247|560420741|FG007|Overall Study|Withdrawal by Subject|0|||
155614748|NCT05052697|561683047|FG002|Substudy A|Not vaccinated|0|||
155614749|NCT05052697|561683048|FG003|Substudy A|Not vaccinated|1|||
155269513|NCT04498247|560420734|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269514|NCT04498247|560420735|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
155269515|NCT04498247|560420736|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269516|NCT04498247|560420737|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
155269517|NCT04498247|560420738|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269518|NCT04498247|560420739|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269519|NCT04498247|560420740|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
155614750|NCT05052697|561683049|FG004|Substudy A|Not vaccinated|0|||
155269520|NCT04498247|560420741|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269521|NCT00669903|560420742|FG000|Overall Study|Adverse Event|0|||
155269522|NCT00669903|560420743|FG001|Overall Study|Adverse Event|1|||
155614751|NCT05052697|561683050|FG005|Substudy A|Not vaccinated|0|||
155269523|NCT00669903|560420744|FG002|Overall Study|Adverse Event|3|||
155269524|NCT00669903|560420745|FG003|Overall Study|Adverse Event|1|||
155269525|NCT00669903|560420742|FG000|Overall Study|Withdrawal by Subject|0|||
155269526|NCT00669903|560420743|FG001|Overall Study|Withdrawal by Subject|2|||
155269527|NCT00669903|560420744|FG002|Overall Study|Withdrawal by Subject|2|||
155269528|NCT00669903|560420745|FG003|Overall Study|Withdrawal by Subject|2|||
155269529|NCT00669903|560420742|FG000|Overall Study|Lost to Follow-up|1|||
155269530|NCT00669903|560420743|FG001|Overall Study|Lost to Follow-up|1|||
155269531|NCT00669903|560420744|FG002|Overall Study|Lost to Follow-up|0|||
155269532|NCT00669903|560420745|FG003|Overall Study|Lost to Follow-up|1|||
155269533|NCT00669903|560420742|FG000|Overall Study|Protocol Violation|0|||
155269534|NCT00669903|560420743|FG001|Overall Study|Protocol Violation|1|||
155269535|NCT00669903|560420744|FG002|Overall Study|Protocol Violation|0|||
155269536|NCT00669903|560420745|FG003|Overall Study|Protocol Violation|0|||
155269537|NCT04488003|560420751|FG000|Assessed for Eligibility|Screen Failure|24|||
155269538|NCT04488003|560420752|FG001|Assessed for Eligibility|Screen Failure|0|||
155269539|NCT04488003|560420753|FG002|Assessed for Eligibility|Screen Failure|0|||
155269540|NCT04488003|560420751|FG000|Assessed for Eligibility|Adverse Event|1|||
155269541|NCT04488003|560420752|FG001|Assessed for Eligibility|Adverse Event|0|||
155269542|NCT04488003|560420753|FG002|Assessed for Eligibility|Adverse Event|0|||
155269543|NCT04488003|560420751|FG000|Assessed for Eligibility|Death|1|||
155269544|NCT04488003|560420752|FG001|Assessed for Eligibility|Death|0|||
155269545|NCT04488003|560420753|FG002|Assessed for Eligibility|Death|0|||
155269546|NCT04488003|560420751|FG000|Assessed for Eligibility|Physician Decision|1|||
155269547|NCT04488003|560420752|FG001|Assessed for Eligibility|Physician Decision|0|||
155269548|NCT04488003|560420753|FG002|Assessed for Eligibility|Physician Decision|0|||
155269549|NCT04488003|560420751|FG000|Allocated to Treatment|Progressive Disease|51|||
155269550|NCT04488003|560420752|FG001|Allocated to Treatment|Progressive Disease|0|||
155269551|NCT04488003|560420753|FG002|Allocated to Treatment|Progressive Disease|0|||
155269552|NCT04488003|560420751|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
155269553|NCT04488003|560420752|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
155269554|NCT04488003|560420753|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
155269555|NCT04488003|560420751|FG000|Allocated to Treatment|Adverse Event|6|||
155269556|NCT04488003|560420752|FG001|Allocated to Treatment|Adverse Event|0|||
155269557|NCT04488003|560420753|FG002|Allocated to Treatment|Adverse Event|0|||
155269558|NCT04488003|560420751|FG000|Allocated to Treatment|Other|5|||
155269559|NCT04488003|560420752|FG001|Allocated to Treatment|Other|0|||
155269560|NCT04488003|560420753|FG002|Allocated to Treatment|Other|0|||
155269561|NCT04488003|560420751|FG000|Allocated to Treatment|Physician Decision|4|||
155269562|NCT04488003|560420752|FG001|Allocated to Treatment|Physician Decision|0|||
155269563|NCT04488003|560420753|FG002|Allocated to Treatment|Physician Decision|0|||
155269564|NCT04488003|560420751|FG000|Allocated to Treatment|Death|4|||
155269565|NCT04488003|560420752|FG001|Allocated to Treatment|Death|0|||
155269566|NCT04488003|560420753|FG002|Allocated to Treatment|Death|0|||
155269567|NCT01737996|560420754|FG000|Overall Study|Adverse Event|0|||
155269568|NCT01737996|560420755|FG001|Overall Study|Adverse Event|1|||
155269569|NCT01737996|560420756|FG002|Overall Study|Adverse Event|1|||
155269570|NCT01737996|560420754|FG000|Overall Study|Withdrawal by Subject|0|||
155269571|NCT01737996|560420755|FG001|Overall Study|Withdrawal by Subject|0|||
155269572|NCT01737996|560420756|FG002|Overall Study|Withdrawal by Subject|1|||
155269573|NCT01248962|560420759|FG000|Overall Study|Withdrawal by Subject|1|||
155269574|NCT01248962|560420760|FG001|Overall Study|Withdrawal by Subject|1|||
155269575|NCT01248962|560420759|FG000|Overall Study|Adverse Event|2|||
155269576|NCT01248962|560420760|FG001|Overall Study|Adverse Event|1|||
155269577|NCT01248962|560420759|FG000|Overall Study|Complete Response after 4 Cycles|1|||
155269578|NCT01248962|560420760|FG001|Overall Study|Complete Response after 4 Cycles|0|||
155269579|NCT01248962|560420759|FG000|Overall Study|Complete Response after 3 Cycles|0|||
155269580|NCT01248962|560420760|FG001|Overall Study|Complete Response after 3 Cycles|1|||
155269581|NCT01248962|560420759|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
155269582|NCT01248962|560420760|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
155269583|NCT00245856|560420762|FG000|Period Two|Withdrawal by Subject|0|||
155269584|NCT00245856|560420763|FG001|Period Two|Withdrawal by Subject|1|||
155269585|NCT01003184|560420764|FG000|Overall Study|Adverse Event|12|||
155381739|NCT04617275|560830988|FG004|Follow-up Period|Lost to Follow-up|0|||
155269586|NCT01003184|560420765|FG001|Overall Study|Adverse Event|5|||
155269587|NCT01003184|560420764|FG000|Overall Study|Lost to Follow-up|1|||
155269588|NCT01003184|560420765|FG001|Overall Study|Lost to Follow-up|0|||
155269589|NCT01003184|560420764|FG000|Overall Study|Loss of glucose control|1|||
155269590|NCT01003184|560420765|FG001|Overall Study|Loss of glucose control|1|||
155269591|NCT01003184|560420764|FG000|Overall Study|Protocol Violation|3|||
155269592|NCT01003184|560420765|FG001|Overall Study|Protocol Violation|0|||
155269593|NCT01003184|560420764|FG000|Overall Study|Withdrawal by Subject|1|||
155269594|NCT01003184|560420765|FG001|Overall Study|Withdrawal by Subject|6|||
155269595|NCT01003184|560420764|FG000|Overall Study|Physician Decision|1|||
155269596|NCT01003184|560420765|FG001|Overall Study|Physician Decision|0|||
155614752|NCT05052697|561683051|FG006|Substudy A|Not vaccinated|0|||
155614753|NCT05052697|561683052|FG007|Substudy A|Not vaccinated|0|||
155269597|NCT00557622|560420766|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
155269598|NCT00557622|560420767|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
155269599|NCT00557622|560420766|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
155269600|NCT00557622|560420767|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
155269601|NCT00557622|560420766|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
155269602|NCT00557622|560420767|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
155269603|NCT01468922|560420768|FG000|Overall Study|Screening failure|0|||
155269604|NCT01468922|560420769|FG001|Overall Study|Screening failure|0|||
155269605|NCT01468922|560420770|FG002|Overall Study|Screening failure|0|||
155269606|NCT01468922|560420771|FG003|Overall Study|Screening failure|0|||
155269607|NCT01468922|560420772|FG004|Overall Study|Screening failure|0|||
155614754|NCT05052697|561683053|FG008|Substudy A|Not vaccinated|1|||
155269608|NCT01468922|560420773|FG005|Overall Study|Screening failure|0|||
155269609|NCT01468922|560420774|FG006|Overall Study|Screening failure|0|||
155269610|NCT01468922|560420775|FG007|Overall Study|Screening failure|0|||
155269611|NCT01468922|560420776|FG008|Overall Study|Screening failure|1|||
155269612|NCT01468922|560420768|FG000|Overall Study|Per patient choice|1|||
155269613|NCT01468922|560420769|FG001|Overall Study|Per patient choice|0|||
155269614|NCT01468922|560420770|FG002|Overall Study|Per patient choice|0|||
155269615|NCT01468922|560420771|FG003|Overall Study|Per patient choice|0|||
155269616|NCT01468922|560420772|FG004|Overall Study|Per patient choice|0|||
155269617|NCT01468922|560420773|FG005|Overall Study|Per patient choice|0|||
155269618|NCT01468922|560420774|FG006|Overall Study|Per patient choice|0|||
155269619|NCT01468922|560420775|FG007|Overall Study|Per patient choice|0|||
155269620|NCT01468922|560420776|FG008|Overall Study|Per patient choice|0|||
155269621|NCT01468922|560420768|FG000|Overall Study|Switched to alternative treatment|1|||
155269622|NCT01468922|560420769|FG001|Overall Study|Switched to alternative treatment|0|||
155269623|NCT01468922|560420770|FG002|Overall Study|Switched to alternative treatment|0|||
155269624|NCT01468922|560420771|FG003|Overall Study|Switched to alternative treatment|0|||
155269625|NCT01468922|560420772|FG004|Overall Study|Switched to alternative treatment|1|||
155269626|NCT01468922|560420773|FG005|Overall Study|Switched to alternative treatment|0|||
155269627|NCT01468922|560420774|FG006|Overall Study|Switched to alternative treatment|0|||
155269628|NCT01468922|560420775|FG007|Overall Study|Switched to alternative treatment|0|||
155269629|NCT01468922|560420776|FG008|Overall Study|Switched to alternative treatment|0|||
155269630|NCT01468922|560420768|FG000|Overall Study|Enrolled on new protocol|0|||
155269631|NCT01468922|560420769|FG001|Overall Study|Enrolled on new protocol|0|||
155269632|NCT01468922|560420770|FG002|Overall Study|Enrolled on new protocol|0|||
155269633|NCT01468922|560420771|FG003|Overall Study|Enrolled on new protocol|0|||
155269634|NCT01468922|560420772|FG004|Overall Study|Enrolled on new protocol|1|||
155269635|NCT01468922|560420773|FG005|Overall Study|Enrolled on new protocol|0|||
155269636|NCT01468922|560420774|FG006|Overall Study|Enrolled on new protocol|0|||
155269637|NCT01468922|560420775|FG007|Overall Study|Enrolled on new protocol|0|||
155269638|NCT01468922|560420776|FG008|Overall Study|Enrolled on new protocol|0|||
155269639|NCT01468922|560420768|FG000|Overall Study|Adverse Event|0|||
155269640|NCT01468922|560420769|FG001|Overall Study|Adverse Event|0|||
155269641|NCT01468922|560420770|FG002|Overall Study|Adverse Event|0|||
155269642|NCT01468922|560420771|FG003|Overall Study|Adverse Event|0|||
155269643|NCT01468922|560420772|FG004|Overall Study|Adverse Event|0|||
155269644|NCT01468922|560420773|FG005|Overall Study|Adverse Event|0|||
155269645|NCT01468922|560420774|FG006|Overall Study|Adverse Event|0|||
155269646|NCT01468922|560420775|FG007|Overall Study|Adverse Event|1|||
155269647|NCT01468922|560420776|FG008|Overall Study|Adverse Event|0|||
155269648|NCT01468922|560420768|FG000|Overall Study|Infection of blood|0|||
155269649|NCT01468922|560420769|FG001|Overall Study|Infection of blood|0|||
155269650|NCT01468922|560420770|FG002|Overall Study|Infection of blood|0|||
155269651|NCT01468922|560420771|FG003|Overall Study|Infection of blood|0|||
155269652|NCT01468922|560420772|FG004|Overall Study|Infection of blood|0|||
155614755|NCT05052697|561683054|FG009|Substudy A|Not vaccinated|0|||
155614756|NCT05052697|561683055|FG010|Substudy A|Not vaccinated|0|||
155614757|NCT05052697|561683056|FG011|Substudy A|Not vaccinated|0|||
155614758|NCT05052697|561683057|FG012|Substudy A|Not vaccinated|0|||
155269653|NCT01468922|560420773|FG005|Overall Study|Infection of blood|0|||
155269654|NCT01468922|560420774|FG006|Overall Study|Infection of blood|0|||
155269655|NCT01468922|560420775|FG007|Overall Study|Infection of blood|1|||
155269656|NCT01468922|560420776|FG008|Overall Study|Infection of blood|0|||
155269657|NCT01468922|560420768|FG000|Overall Study|Patient choice - surgery|0|||
155269658|NCT01468922|560420769|FG001|Overall Study|Patient choice - surgery|0|||
155269659|NCT01468922|560420770|FG002|Overall Study|Patient choice - surgery|0|||
155269660|NCT01468922|560420771|FG003|Overall Study|Patient choice - surgery|0|||
155269661|NCT01468922|560420772|FG004|Overall Study|Patient choice - surgery|0|||
155269662|NCT01468922|560420773|FG005|Overall Study|Patient choice - surgery|0|||
155269663|NCT01468922|560420774|FG006|Overall Study|Patient choice - surgery|0|||
155269664|NCT01468922|560420775|FG007|Overall Study|Patient choice - surgery|1|||
155269665|NCT01468922|560420776|FG008|Overall Study|Patient choice - surgery|0|||
155269666|NCT01468922|560420768|FG000|Overall Study|Refused further treatment|0|||
155614759|NCT05052697|561683058|FG013|Substudy A|Not vaccinated|0|||
155614760|NCT05052697|561683059|FG014|Substudy A|Not vaccinated|0|||
155614761|NCT05052697|561683060|FG015|Substudy A|Not vaccinated|0|||
155269667|NCT01468922|560420769|FG001|Overall Study|Refused further treatment|0|||
155269668|NCT01468922|560420770|FG002|Overall Study|Refused further treatment|0|||
155269669|NCT01468922|560420771|FG003|Overall Study|Refused further treatment|0|||
155269670|NCT01468922|560420772|FG004|Overall Study|Refused further treatment|0|||
155269671|NCT01468922|560420773|FG005|Overall Study|Refused further treatment|0|||
155269672|NCT01468922|560420774|FG006|Overall Study|Refused further treatment|0|||
155269673|NCT01468922|560420775|FG007|Overall Study|Refused further treatment|1|||
155269674|NCT01468922|560420776|FG008|Overall Study|Refused further treatment|0|||
155269675|NCT01923389|560420777|FG000|Overall Study|Protocol Violation|1|||
155269676|NCT01923389|560420778|FG001|Overall Study|Protocol Violation|0|||
155269677|NCT04848662|560420779|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
155269678|NCT04848662|560420780|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
155269679|NCT03237013|560420788|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
155269680|NCT03237013|560420789|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
155269681|NCT03237013|560420790|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
155269682|NCT00007475|560420793|FG000|Overall Study|Withdrawal by Subject|1|||
155269683|NCT00007475|560420794|FG001|Overall Study|Withdrawal by Subject|0|||
155269684|NCT00007475|560420795|FG002|Overall Study|Withdrawal by Subject|0|||
155269685|NCT00007475|560420796|FG003|Overall Study|Withdrawal by Subject|0|||
155269686|NCT00007475|560420793|FG000|Overall Study|Adverse Event|3|||
155269687|NCT00007475|560420794|FG001|Overall Study|Adverse Event|0|||
155269688|NCT00007475|560420795|FG002|Overall Study|Adverse Event|0|||
155269689|NCT00007475|560420796|FG003|Overall Study|Adverse Event|0|||
155269690|NCT01719224|560420797|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
155269691|NCT01719224|560420798|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
155269692|NCT00258440|560420799|FG000|Overall Study|Withdrawal by Subject|0|||
155269693|NCT00258440|560420800|FG001|Overall Study|Withdrawal by Subject|0|||
155269694|NCT00258440|560420801|FG002|Overall Study|Withdrawal by Subject|1|||
155269695|NCT00737061|560420802|FG000|Waiting Period|Lost to Follow-up|6|||
155269696|NCT00737061|560420802|FG000|Waiting Period|Withdrawal by Subject|1|||
155269697|NCT00737061|560420802|FG000|Waiting Period|Bilateral placement failure|34|||
155269698|NCT00737061|560420802|FG000|Waiting Period|Deemed patent following HSG|26|||
155269699|NCT00737061|560420802|FG000|Waiting Period|Alternative contraception failure|3|||
155269700|NCT00737061|560420802|FG000|Waiting Period|Elected surgical tubal ligation|5|||
155269701|NCT00737061|560420802|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
155269702|NCT00737061|560420802|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
155269703|NCT00737061|560420802|FG000|1 Year Wearing Period|Discontinued reilance|3|||
155269704|NCT00737061|560420802|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
155269705|NCT03000673|560420803|FG000|Overall Study|Withdrawal by Subject|1|||
155269706|NCT03000673|560420804|FG001|Overall Study|Withdrawal by Subject|0|||
155269707|NCT03000673|560420805|FG002|Overall Study|Withdrawal by Subject|0|||
155269708|NCT03000673|560420806|FG003|Overall Study|Withdrawal by Subject|0|||
155269709|NCT01512745|560420808|FG000|Overall Study|Adverse Event|22|||
155269710|NCT01512745|560420809|FG001|Overall Study|Adverse Event|3|||
155269711|NCT01512745|560420808|FG000|Overall Study|Death|9|||
155269712|NCT01512745|560420809|FG001|Overall Study|Death|13|||
155269713|NCT01512745|560420808|FG000|Overall Study|Withdrawal by Subject|2|||
155269714|NCT01512745|560420809|FG001|Overall Study|Withdrawal by Subject|2|||
155269715|NCT01512745|560420808|FG000|Overall Study|Lost to Follow-up|4|||
155269716|NCT01512745|560420809|FG001|Overall Study|Lost to Follow-up|0|||
155269717|NCT01512745|560420808|FG000|Overall Study|Lack of Efficacy|2|||
155269718|NCT01512745|560420809|FG001|Overall Study|Lack of Efficacy|2|||
155269719|NCT01512745|560420808|FG000|Overall Study|Protocol Violation|1|||
155269720|NCT01512745|560420809|FG001|Overall Study|Protocol Violation|0|||
155269721|NCT02357810|560420810|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
155269722|NCT02357810|560420810|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
155269723|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Adverse Event|5|||
155269724|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
155269725|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
155269726|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
155269727|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Death|1|||
155269728|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Physician Decision|1|||
155269729|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Other|1|||
155269730|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
155269731|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
155269732|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
155269733|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
155269734|NCT02357810|560420810|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
155269735|NCT02357810|560420810|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
155269736|NCT00562978|560420811|FG000|Overall Study|Patient had imaging dose only|1|||
155269737|NCT00562978|560420812|FG001|Overall Study|Patient had imaging dose only|11|||
155269738|NCT00152971|560420814|FG000|Overall Study|Adverse Event|12|||
155726462|NCT01716234|562098142|FG002|Overall Study|Protocol Violation|0|||
155269739|NCT00152971|560420815|FG001|Overall Study|Adverse Event|10|||
155269740|NCT00152971|560420816|FG002|Overall Study|Adverse Event|9|||
155269741|NCT00152971|560420814|FG000|Overall Study|Protocol Violation|10|||
155269742|NCT00152971|560420815|FG001|Overall Study|Protocol Violation|11|||
155269743|NCT00152971|560420816|FG002|Overall Study|Protocol Violation|8|||
155269744|NCT00152971|560420814|FG000|Overall Study|Lost to Follow-up|17|||
155269745|NCT00152971|560420815|FG001|Overall Study|Lost to Follow-up|14|||
155269746|NCT00152971|560420816|FG002|Overall Study|Lost to Follow-up|13|||
155269747|NCT00152971|560420814|FG000|Overall Study|Withdrawal by Subject|9|||
155269748|NCT00152971|560420815|FG001|Overall Study|Withdrawal by Subject|8|||
155269749|NCT00152971|560420816|FG002|Overall Study|Withdrawal by Subject|14|||
155269750|NCT00152971|560420814|FG000|Overall Study|Other|3|||
155269751|NCT00152971|560420815|FG001|Overall Study|Other|5|||
155269752|NCT00152971|560420816|FG002|Overall Study|Other|5|||
155269753|NCT00152971|560420814|FG000|Treatment|Adverse Event|49|||
155269754|NCT00152971|560420815|FG001|Treatment|Adverse Event|40|||
155269755|NCT00152971|560420816|FG002|Treatment|Adverse Event|54|||
155269756|NCT00152971|560420814|FG000|Treatment|Protocol Violation|8|||
155269757|NCT00152971|560420815|FG001|Treatment|Protocol Violation|6|||
155269758|NCT00152971|560420816|FG002|Treatment|Protocol Violation|10|||
155269759|NCT00152971|560420814|FG000|Treatment|Lost to Follow-up|1|||
155269760|NCT00152971|560420815|FG001|Treatment|Lost to Follow-up|2|||
155269761|NCT00152971|560420816|FG002|Treatment|Lost to Follow-up|1|||
155269762|NCT00152971|560420814|FG000|Treatment|Withdrawal by Subject|4|||
155269763|NCT00152971|560420815|FG001|Treatment|Withdrawal by Subject|4|||
155269764|NCT00152971|560420816|FG002|Treatment|Withdrawal by Subject|5|||
155269765|NCT00152971|560420814|FG000|Treatment|Other|9|||
155269766|NCT00152971|560420815|FG001|Treatment|Other|11|||
155269767|NCT00152971|560420816|FG002|Treatment|Other|10|||
155269768|NCT00675506|560420817|FG000|Overall Study|Lost to Follow-up|1|||
155269769|NCT00675506|560420818|FG001|Overall Study|Lost to Follow-up|5|||
155269770|NCT00675506|560420817|FG000|Overall Study|Lost interest|3|||
155269771|NCT00675506|560420818|FG001|Overall Study|Lost interest|5|||
155269772|NCT00675506|560420817|FG000|Overall Study|Elevated fasting glucose|2|||
155269773|NCT00675506|560420818|FG001|Overall Study|Elevated fasting glucose|1|||
155269774|NCT00675506|560420817|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
155269775|NCT00675506|560420818|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
155269776|NCT00675506|560420817|FG000|Overall Study|Elevated IGF-1|2|||
155269777|NCT00675506|560420818|FG001|Overall Study|Elevated IGF-1|0|||
155269778|NCT00675506|560420817|FG000|Overall Study|Hypersensitivity Reaction|1|||
155269779|NCT00675506|560420818|FG001|Overall Study|Hypersensitivity Reaction|0|||
155269780|NCT00675506|560420817|FG000|Overall Study|Disclosed history of cancer|1|||
155269781|NCT00675506|560420818|FG001|Overall Study|Disclosed history of cancer|0|||
155269782|NCT00675506|560420817|FG000|Overall Study|Declined participation|1|||
155269783|NCT00675506|560420818|FG001|Overall Study|Declined participation|0|||
155269784|NCT00675506|560420817|FG000|Overall Study|Schedule conflict|0|||
155269785|NCT00675506|560420818|FG001|Overall Study|Schedule conflict|1|||
155269786|NCT00936221|560420819|FG000|Overall Study|Withdrawal by Subject|1|||
155269787|NCT00936221|560420820|FG001|Overall Study|Withdrawal by Subject|1|||
155269788|NCT06173570|560420821|FG000|Overall Study|Adverse Event|1|||
155269789|NCT06173570|560420822|FG001|Overall Study|Adverse Event|0|||
155269790|NCT06173570|560420823|FG002|Overall Study|Adverse Event|0|||
155269791|NCT06173570|560420824|FG003|Overall Study|Adverse Event|2|||
155269792|NCT06173570|560420825|FG004|Overall Study|Adverse Event|0|||
155269793|NCT06173570|560420821|FG000|Overall Study|Lost to Follow-up|1|||
155269794|NCT06173570|560420822|FG001|Overall Study|Lost to Follow-up|0|||
155269795|NCT06173570|560420823|FG002|Overall Study|Lost to Follow-up|0|||
155269796|NCT06173570|560420824|FG003|Overall Study|Lost to Follow-up|0|||
155269797|NCT06173570|560420825|FG004|Overall Study|Lost to Follow-up|2|||
155269798|NCT06173570|560420821|FG000|Overall Study|Protocol Violation|0|||
155269799|NCT06173570|560420822|FG001|Overall Study|Protocol Violation|2|||
155269800|NCT06173570|560420823|FG002|Overall Study|Protocol Violation|0|||
155269801|NCT06173570|560420824|FG003|Overall Study|Protocol Violation|0|||
155381740|NCT04617275|560830989|FG005|Follow-up Period|Lost to Follow-up|4|||
155381741|NCT04617275|560830990|FG006|Follow-up Period|Lost to Follow-up|0|||
155269802|NCT06173570|560420825|FG004|Overall Study|Protocol Violation|1|||
155269803|NCT06173570|560420821|FG000|Overall Study|Withdrawal by Subject|0|||
155269804|NCT06173570|560420822|FG001|Overall Study|Withdrawal by Subject|1|||
155269805|NCT06173570|560420823|FG002|Overall Study|Withdrawal by Subject|1|||
155269806|NCT06173570|560420824|FG003|Overall Study|Withdrawal by Subject|1|||
155269807|NCT06173570|560420825|FG004|Overall Study|Withdrawal by Subject|1|||
155269808|NCT06173570|560420821|FG000|Overall Study|Non-compliance with Study Drug|1|||
155269809|NCT06173570|560420822|FG001|Overall Study|Non-compliance with Study Drug|0|||
155269810|NCT06173570|560420823|FG002|Overall Study|Non-compliance with Study Drug|0|||
155269811|NCT06173570|560420824|FG003|Overall Study|Non-compliance with Study Drug|0|||
155269812|NCT06173570|560420825|FG004|Overall Study|Non-compliance with Study Drug|0|||
155269813|NCT06173570|560420821|FG000|Overall Study|Screen Failure|0|||
155269814|NCT06173570|560420822|FG001|Overall Study|Screen Failure|0|||
155381742|NCT04617275|560830991|FG007|Follow-up Period|Lost to Follow-up|3|||
155269815|NCT06173570|560420823|FG002|Overall Study|Screen Failure|0|||
155269816|NCT06173570|560420824|FG003|Overall Study|Screen Failure|0|||
155614762|NCT05052697|561683061|FG016|Substudy A|Not vaccinated|0|||
155614763|NCT05052697|561683062|FG017|Substudy A|Not vaccinated|0|||
155614764|NCT05052697|561683063|FG018|Substudy A|Not vaccinated|0|||
155614765|NCT05052697|561683064|FG019|Substudy A|Not vaccinated|0|||
155614766|NCT05052697|561683065|FG020|Substudy A|Not vaccinated|0|||
155614767|NCT05052697|561683066|FG021|Substudy A|Not vaccinated|0|||
155614768|NCT05052697|561683067|FG022|Substudy A|Not vaccinated|0|||
155614769|NCT05052697|561683068|FG023|Substudy A|Not vaccinated|0|||
155614770|NCT05052697|561683069|FG024|Substudy A|Not vaccinated|0|||
155614771|NCT05052697|561683070|FG025|Substudy A|Not vaccinated|0|||
155614772|NCT05052697|561683071|FG026|Substudy A|Not vaccinated|0|||
155614773|NCT05052697|561683072|FG027|Substudy A|Not vaccinated|0|||
155614774|NCT05052697|561683073|FG028|Substudy A|Not vaccinated|0|||
155614775|NCT05052697|561683074|FG029|Substudy A|Not vaccinated|0|||
155614776|NCT05052697|561683075|FG030|Substudy A|Not vaccinated|0|||
155614777|NCT05052697|561683076|FG031|Substudy A|Not vaccinated|0|||
155614778|NCT05052697|561683077|FG032|Substudy A|Not vaccinated|0|||
155614779|NCT05052697|561683078|FG033|Substudy A|Not vaccinated|0|||
155614780|NCT05052697|561683045|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614781|NCT05052697|561683046|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614782|NCT05052697|561683047|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614783|NCT05052697|561683048|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614784|NCT05052697|561683049|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614785|NCT05052697|561683050|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614786|NCT05052697|561683051|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614787|NCT05052697|561683052|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614788|NCT05052697|561683053|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614789|NCT05052697|561683054|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614790|NCT05052697|561683055|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614791|NCT05052697|561683056|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614792|NCT05052697|561683057|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614793|NCT05052697|561683058|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614794|NCT05052697|561683059|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614795|NCT05052697|561683060|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614796|NCT05052697|561683061|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614797|NCT05052697|561683062|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614798|NCT05052697|561683063|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155614799|NCT05052697|561683064|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155614800|NCT05052697|561683065|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614801|NCT05052697|561683066|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155614802|NCT05052697|561683067|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
155614803|NCT05052697|561683068|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614804|NCT05052697|561683069|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614805|NCT05052697|561683070|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614806|NCT05052697|561683071|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614807|NCT05052697|561683072|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614808|NCT05052697|561683073|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614809|NCT05052697|561683074|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614810|NCT05052697|561683075|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614811|NCT05052697|561683076|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614812|NCT05052697|561683077|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614813|NCT05052697|561683078|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155614814|NCT05052697|561683045|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614815|NCT05052697|561683046|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614816|NCT05052697|561683047|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614817|NCT05052697|561683048|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614818|NCT05052697|561683049|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614819|NCT05052697|561683050|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614820|NCT05052697|561683051|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614821|NCT05052697|561683052|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614822|NCT05052697|561683053|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
155269817|NCT06173570|560420825|FG004|Overall Study|Screen Failure|1|||
155269818|NCT06173570|560420821|FG000|Overall Study|Other|2|||
155614823|NCT05052697|561683054|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614824|NCT05052697|561683055|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614825|NCT05052697|561683056|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614826|NCT05052697|561683057|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614827|NCT05052697|561683058|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614828|NCT05052697|561683059|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
155269819|NCT06173570|560420822|FG001|Overall Study|Other|1|||
155269820|NCT06173570|560420823|FG002|Overall Study|Other|0|||
155269821|NCT06173570|560420824|FG003|Overall Study|Other|2|||
155269822|NCT06173570|560420825|FG004|Overall Study|Other|0|||
155269823|NCT03820323|560420826|FG000|Overall Study|Lost to Follow-up|2|||
155269824|NCT03820323|560420827|FG001|Overall Study|Lost to Follow-up|1|||
155269825|NCT03820323|560420826|FG000|Overall Study|Missed 12-month visit|22|||
155269826|NCT03820323|560420827|FG001|Overall Study|Missed 12-month visit|14|||
155269827|NCT03820323|560420826|FG000|Overall Study|Death|2|||
155269828|NCT03820323|560420827|FG001|Overall Study|Death|1|||
155269829|NCT03820323|560420826|FG000|Overall Study|Transferred out|13|||
155269830|NCT03820323|560420827|FG001|Overall Study|Transferred out|11|||
155269831|NCT03820323|560420826|FG000|Overall Study|Terminated|0|||
155269832|NCT03820323|560420827|FG001|Overall Study|Terminated|3|||
155269833|NCT03820323|560420826|FG000|Overall Study|Withdrawal by Subject|1|||
155269834|NCT03820323|560420827|FG001|Overall Study|Withdrawal by Subject|6|||
155269835|NCT03151395|560420828|FG000|Overall Study|Adverse Event|2|||
155269836|NCT03151395|560420828|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
155269837|NCT03151395|560420828|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
155269838|NCT03151395|560420828|FG000|Overall Study|Unspecified reason|4|||
155269839|NCT00366301|560420829|FG000|Overall Study|Lost to Follow-up|4|||
155269840|NCT00366301|560420830|FG001|Overall Study|Lost to Follow-up|4|||
155269841|NCT00366301|560420831|FG002|Overall Study|Lost to Follow-up|3|||
155269842|NCT00366301|560420832|FG003|Overall Study|Lost to Follow-up|7|||
155269843|NCT00366301|560420829|FG000|Overall Study|Withdrawal by Subject|4|||
155269844|NCT00366301|560420830|FG001|Overall Study|Withdrawal by Subject|2|||
155269845|NCT00366301|560420831|FG002|Overall Study|Withdrawal by Subject|1|||
155269846|NCT00366301|560420832|FG003|Overall Study|Withdrawal by Subject|1|||
155269847|NCT01348776|560420833|FG000|Overall Study|Lost to Follow-up|3|||
155269848|NCT01372605|560420837|FG000|Overall Study|Death|1|||
155269849|NCT01372605|560420838|FG001|Overall Study|Death|2|||
155269850|NCT01372605|560420837|FG000|Overall Study|Lost to Follow-up|2|||
155269851|NCT01372605|560420838|FG001|Overall Study|Lost to Follow-up|1|||
155269852|NCT01372605|560420837|FG000|Overall Study|Withdrawal by Subject|4|||
155269853|NCT01372605|560420838|FG001|Overall Study|Withdrawal by Subject|7|||
155269854|NCT01372605|560420837|FG000|Overall Study|Moved|3|||
155269855|NCT01372605|560420838|FG001|Overall Study|Moved|0|||
155269856|NCT01372605|560420837|FG000|Overall Study|Changed medical home|2|||
155269857|NCT01372605|560420838|FG001|Overall Study|Changed medical home|0|||
155269858|NCT01108510|560420839|FG000|Overall Study|Randomized but Not Treated|5|||
155269859|NCT01108510|560420840|FG001|Overall Study|Randomized but Not Treated|1|||
155269860|NCT01108510|560420839|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
155269861|NCT01108510|560420840|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
155269862|NCT01108510|560420839|FG000|Overall Study|Adverse Event|26|||
155269863|NCT01108510|560420840|FG001|Overall Study|Adverse Event|19|||
155269864|NCT01108510|560420839|FG000|Overall Study|Lost to Follow-up|20|||
155269865|NCT01108510|560420840|FG001|Overall Study|Lost to Follow-up|17|||
155269866|NCT01108510|560420839|FG000|Overall Study|Withdrew Consent|21|||
155269867|NCT01108510|560420840|FG001|Overall Study|Withdrew Consent|15|||
155269868|NCT01108510|560420839|FG000|Overall Study|Investigator's Discretion|12|||
155269869|NCT01108510|560420840|FG001|Overall Study|Investigator's Discretion|10|||
155269870|NCT01108510|560420839|FG000|Overall Study|Participant Noncompliance|5|||
155269871|NCT01108510|560420840|FG001|Overall Study|Participant Noncompliance|7|||
155269872|NCT01108510|560420839|FG000|Overall Study|Lack of Efficacy|3|||
155269873|NCT01108510|560420840|FG001|Overall Study|Lack of Efficacy|0|||
155269874|NCT01108510|560420839|FG000|Overall Study|Pregnancy|0|||
155269875|NCT01108510|560420840|FG001|Overall Study|Pregnancy|3|||
155269876|NCT01108510|560420839|FG000|Overall Study|Death|1|||
155269877|NCT01108510|560420840|FG001|Overall Study|Death|1|||
155269878|NCT00210119|560420841|FG000|Overall Study|Protocol Violation|1|||
155269879|NCT00210119|560420841|FG000|Overall Study|Withdrawal by Subject|1|||
155269880|NCT00951509|560420842|FG000|Overall Study|Withdrawal by Subject|2|||
155269881|NCT03125941|560420844|FG000|Overall Study|did not receive intervention|1|||
155269882|NCT03125941|560420845|FG001|Overall Study|did not receive intervention|2|||
155269883|NCT00089895|560420846|FG000|Overall Study|Consent Withdrawn|11|||
155269884|NCT00089895|560420847|FG001|Overall Study|Consent Withdrawn|14|||
155269885|NCT00089895|560420846|FG000|Overall Study|Technical reason|7|||
155269886|NCT00089895|560420847|FG001|Overall Study|Technical reason|2|||
155726463|NCT01716234|562098143|FG003|Overall Study|Protocol Violation|1|||
155269887|NCT00089895|560420846|FG000|Overall Study|Surgery|0|||
155269888|NCT00089895|560420847|FG001|Overall Study|Surgery|1|||
155269889|NCT00089895|560420846|FG000|Overall Study|Bleeding|0|||
155269890|NCT00089895|560420847|FG001|Overall Study|Bleeding|2|||
155269891|NCT00089895|560420846|FG000|Overall Study|Physician Decision|3|||
155269892|NCT00089895|560420847|FG001|Overall Study|Physician Decision|7|||
155269893|NCT00089895|560420846|FG000|Overall Study|Exclusion criteria met|6|||
155269894|NCT00089895|560420847|FG001|Overall Study|Exclusion criteria met|6|||
155269895|NCT00089895|560420846|FG000|Overall Study|Not otherwise specified|4|||
155269896|NCT00089895|560420847|FG001|Overall Study|Not otherwise specified|8|||
155269897|NCT00089895|560420846|FG000|Overall Study|Missing|4|||
155269898|NCT00089895|560420847|FG001|Overall Study|Missing|2|||
155269899|NCT01103960|560420850|FG000|Overall Study|Adverse Event|2|||
155269900|NCT01103960|560420851|FG001|Overall Study|Adverse Event|1|||
155269901|NCT01103960|560420850|FG000|Overall Study|Withdrawal by Subject|2|||
155269902|NCT01103960|560420851|FG001|Overall Study|Withdrawal by Subject|1|||
155269903|NCT01103960|560420850|FG000|Overall Study|Other|1|||
155269904|NCT01103960|560420851|FG001|Overall Study|Other|0|||
155269905|NCT01017120|560422496|FG000|Overall Study|Adverse Event|9|||
155269906|NCT01017120|560422497|FG001|Overall Study|Adverse Event|0|||
155269907|NCT01017120|560422496|FG000|Overall Study|Lost to Follow-up|13|||
155269908|NCT01017120|560422497|FG001|Overall Study|Lost to Follow-up|11|||
155269909|NCT01017120|560422496|FG000|Overall Study|Lack of Efficacy|1|||
155269910|NCT01017120|560422497|FG001|Overall Study|Lack of Efficacy|0|||
155269911|NCT01017120|560422496|FG000|Overall Study|Withdrawal by Subject|39|||
155269912|NCT01017120|560422497|FG001|Overall Study|Withdrawal by Subject|21|||
155269913|NCT01017120|560422496|FG000|Overall Study|Pregnancy|1|||
155269914|NCT01017120|560422497|FG001|Overall Study|Pregnancy|1|||
155269915|NCT01017120|560422496|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155269916|NCT01017120|560422497|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155269917|NCT01017120|560422496|FG000|Overall Study|Relocated Out of Town|0|||
155269918|NCT01017120|560422497|FG001|Overall Study|Relocated Out of Town|2|||
155269919|NCT01017120|560422496|FG000|Overall Study|Protocol Violation|1|||
155269920|NCT01017120|560422497|FG001|Overall Study|Protocol Violation|0|||
155269921|NCT01017120|560422496|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
155269922|NCT01017120|560422497|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
155269923|NCT01087723|560422498|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
155269924|NCT01087723|560422499|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
155269925|NCT01087723|560422498|FG000|Overall Study|Withdrawal by Subject|10|||
155269926|NCT01087723|560422499|FG001|Overall Study|Withdrawal by Subject|13|||
155269927|NCT01087723|560422498|FG000|Overall Study|Physician Decision|2|||
155269928|NCT01087723|560422499|FG001|Overall Study|Physician Decision|0|||
155269929|NCT01087723|560422498|FG000|Overall Study|Lost to Follow-up|1|||
155269930|NCT01087723|560422499|FG001|Overall Study|Lost to Follow-up|4|||
155269931|NCT01087723|560422498|FG000|Overall Study|Reason Not Specified|1|||
155269932|NCT01087723|560422499|FG001|Overall Study|Reason Not Specified|2|||
155269933|NCT00806624|560422500|FG000|Overall Study|Adverse Event|2|||
155269934|NCT00806624|560422501|FG001|Overall Study|Adverse Event|8|||
155269935|NCT00806624|560422502|FG002|Overall Study|Adverse Event|0|||
155269936|NCT00806624|560422500|FG000|Overall Study|Death|0|||
155269937|NCT00806624|560422501|FG001|Overall Study|Death|1|||
155269938|NCT00806624|560422502|FG002|Overall Study|Death|1|||
155269939|NCT00806624|560422500|FG000|Overall Study|Lost to Follow-up|1|||
155269940|NCT00806624|560422501|FG001|Overall Study|Lost to Follow-up|0|||
155269941|NCT00806624|560422502|FG002|Overall Study|Lost to Follow-up|1|||
155269942|NCT00806624|560422500|FG000|Overall Study|Withdrawal by Subject|6|||
155269943|NCT00806624|560422501|FG001|Overall Study|Withdrawal by Subject|3|||
155269944|NCT00806624|560422502|FG002|Overall Study|Withdrawal by Subject|3|||
155269945|NCT00806624|560422500|FG000|Overall Study|discontinued before start of treatment|0|||
155269946|NCT00806624|560422501|FG001|Overall Study|discontinued before start of treatment|0|||
155269947|NCT00806624|560422502|FG002|Overall Study|discontinued before start of treatment|1|||
155269948|NCT01912222|560422503|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
155269949|NCT01912222|560422504|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
155269950|NCT01912222|560422505|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
155269951|NCT01912222|560422503|FG000|Part B: Treatment Period|Progressive disease|10|||
155269952|NCT01912222|560422504|FG001|Part B: Treatment Period|Progressive disease|12|||
155269953|NCT01912222|560422505|FG002|Part B: Treatment Period|Progressive disease|15|||
155269954|NCT01912222|560422503|FG000|Part B: Treatment Period|Adverse Event|1|||
155269955|NCT01912222|560422504|FG001|Part B: Treatment Period|Adverse Event|2|||
155269956|NCT01912222|560422505|FG002|Part B: Treatment Period|Adverse Event|3|||
155269957|NCT01912222|560422503|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
155269958|NCT01912222|560422504|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
155269959|NCT01912222|560422505|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
155269960|NCT00603265|560422506|FG000|Overall Study|Adverse Event|2|||
155269961|NCT00603265|560422507|FG001|Overall Study|Adverse Event|11|||
155269962|NCT00603265|560422508|FG002|Overall Study|Adverse Event|1|||
155269963|NCT00603265|560422506|FG000|Overall Study|Withdrawal by Subject|1|||
155269964|NCT00603265|560422507|FG001|Overall Study|Withdrawal by Subject|2|||
155269965|NCT00603265|560422508|FG002|Overall Study|Withdrawal by Subject|1|||
155269966|NCT00603265|560422506|FG000|Overall Study|Lack of Efficacy|3|||
155269967|NCT00603265|560422507|FG001|Overall Study|Lack of Efficacy|0|||
155269968|NCT00603265|560422508|FG002|Overall Study|Lack of Efficacy|3|||
155269969|NCT00603265|560422506|FG000|Overall Study|Lost to Follow-up|0|||
155269970|NCT00603265|560422507|FG001|Overall Study|Lost to Follow-up|1|||
155269971|NCT00603265|560422508|FG002|Overall Study|Lost to Follow-up|0|||
155269972|NCT00603265|560422506|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
155269973|NCT00603265|560422507|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
155269974|NCT00603265|560422508|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
155269975|NCT00603265|560422506|FG000|Overall Study|Participant Left Country, No Responses|0|||
155269976|NCT00603265|560422507|FG001|Overall Study|Participant Left Country, No Responses|1|||
155269977|NCT00603265|560422508|FG002|Overall Study|Participant Left Country, No Responses|0|||
155269978|NCT00603265|560422506|FG000|Overall Study|Protocol Violation|1|||
155269979|NCT00603265|560422507|FG001|Overall Study|Protocol Violation|0|||
155269980|NCT00603265|560422508|FG002|Overall Study|Protocol Violation|0|||
155269981|NCT04399551|560422509|FG000|Overall Study|Adverse Event|15|||
155269982|NCT04399551|560422509|FG000|Overall Study|Withdrawal by Subject|6|||
155269983|NCT04399551|560422509|FG000|Overall Study|Physician Decision|3|||
155269984|NCT04399551|560422509|FG000|Overall Study|Lost to Follow-up|2|||
155269985|NCT04399551|560422509|FG000|Overall Study|Protocol Deviation|2|||
155269986|NCT01118455|560422513|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
155269987|NCT01118455|560422514|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
155269988|NCT00636792|560422515|FG000|Overall Study|Adverse Event|16|||
155269989|NCT00636792|560422515|FG000|Overall Study|Physician Decision|7|||
155269990|NCT00636792|560422515|FG000|Overall Study|Progressive Disease|4|||
155269991|NCT00636792|560422515|FG000|Overall Study|Withdrawal by Subject|3|||
155269992|NCT00636792|560422515|FG000|Overall Study|Other|3|||
155269993|NCT01928225|560422518|FG000|Overall Study|Pregnancy|1|||
155269994|NCT01928225|560422519|FG001|Overall Study|Pregnancy|0|||
155269995|NCT01928225|560422518|FG000|Overall Study|basaloid cervical cancer|1|||
155269996|NCT01928225|560422519|FG001|Overall Study|basaloid cervical cancer|0|||
155269997|NCT01928225|560422518|FG000|Overall Study|Lost to Follow-up|1|||
155726464|NCT01716234|562098144|FG004|Overall Study|Protocol Violation|1|||
155726465|NCT01716234|562098145|FG005|Overall Study|Protocol Violation|1|||
155269998|NCT01928225|560422519|FG001|Overall Study|Lost to Follow-up|3|||
155269999|NCT00451217|560422521|FG000|Overall Study|Lost to Follow-up|0|||
155270000|NCT00451217|560422522|FG001|Overall Study|Lost to Follow-up|1|||
155270001|NCT00451217|560422523|FG002|Overall Study|Lost to Follow-up|1|||
155270002|NCT00451217|560422524|FG003|Overall Study|Lost to Follow-up|1|||
155270003|NCT00451217|560422521|FG000|Overall Study|Withdrawal by Subject|1|||
155270004|NCT00451217|560422522|FG001|Overall Study|Withdrawal by Subject|0|||
155270005|NCT00451217|560422523|FG002|Overall Study|Withdrawal by Subject|0|||
155270006|NCT00451217|560422524|FG003|Overall Study|Withdrawal by Subject|0|||
155270007|NCT00451217|560422521|FG000|Overall Study|Not Treated|1|||
155270008|NCT00451217|560422522|FG001|Overall Study|Not Treated|1|||
155270009|NCT00451217|560422523|FG002|Overall Study|Not Treated|3|||
155270010|NCT00451217|560422524|FG003|Overall Study|Not Treated|4|||
155270011|NCT03154359|560422525|FG000|Overall Study|Adverse Event|1|||
155270012|NCT03154359|560422525|FG000|Overall Study|Lack of Efficacy|2|||
155270013|NCT03154359|560422525|FG000|Overall Study|Lost to Follow-up|3|||
155270014|NCT03154359|560422525|FG000|Overall Study|Physician Decision|3|||
155614829|NCT05052697|561683060|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614830|NCT05052697|561683061|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614831|NCT05052697|561683062|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
155614832|NCT05052697|561683063|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614833|NCT05052697|561683064|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614834|NCT05052697|561683065|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614835|NCT05052697|561683066|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614836|NCT05052697|561683067|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614837|NCT05052697|561683068|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614838|NCT05052697|561683069|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614839|NCT05052697|561683070|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614840|NCT05052697|561683071|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614841|NCT05052697|561683072|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614842|NCT05052697|561683073|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614843|NCT05052697|561683074|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614844|NCT05052697|561683075|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614845|NCT05052697|561683076|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614846|NCT05052697|561683077|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614847|NCT05052697|561683078|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
155614848|NCT05052697|561683045|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614849|NCT05052697|561683046|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614850|NCT05052697|561683047|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614851|NCT05052697|561683048|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155270015|NCT03154359|560422525|FG000|Overall Study|Protocol Violation|4|||
155270016|NCT03154359|560422525|FG000|Overall Study|Withdrawal by Subject|5|||
155614852|NCT05052697|561683049|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614853|NCT05052697|561683050|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614854|NCT05052697|561683051|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155270017|NCT03154359|560422525|FG000|Overall Study|Disruption of study due to COVID-19|4|||
155270018|NCT05033743|560422532|FG000|Overall Study|Lost to Follow-up|1|||
155270019|NCT05033743|560422532|FG000|Overall Study|Protocol Violation|2|||
155270020|NCT05033743|560422532|FG000|Overall Study|Withdrawal by Subject|1|||
155270021|NCT01592695|560422533|FG000|Overall Study|Lost to Follow-up|8|||
155270022|NCT01592695|560422534|FG001|Overall Study|Lost to Follow-up|4|||
155270023|NCT00641719|560422536|FG000|Overall Study|Lack of Efficacy|1|||
155270024|NCT00641719|560422537|FG001|Overall Study|Lack of Efficacy|2|||
155270025|NCT00641719|560422536|FG000|Overall Study|Adverse Event|24|||
155270026|NCT00641719|560422537|FG001|Overall Study|Adverse Event|29|||
155270027|NCT00641719|560422536|FG000|Overall Study|Withdrawal by Subject|4|||
155270028|NCT00641719|560422537|FG001|Overall Study|Withdrawal by Subject|4|||
155270029|NCT00641719|560422536|FG000|Overall Study|Reason Not Specified|1|||
155270030|NCT00641719|560422537|FG001|Overall Study|Reason Not Specified|2|||
155270031|NCT00885352|560422538|FG000|Overall Study|Adverse Event|2|||
155270032|NCT00885352|560422539|FG001|Overall Study|Adverse Event|3|||
155270033|NCT00885352|560422538|FG000|Overall Study|Lost to Follow-up|2|||
155270034|NCT00885352|560422539|FG001|Overall Study|Lost to Follow-up|2|||
155270035|NCT00885352|560422538|FG000|Overall Study|Physician Decision|0|||
155270036|NCT00885352|560422539|FG001|Overall Study|Physician Decision|3|||
155270037|NCT00885352|560422538|FG000|Overall Study|Protocol Violation|0|||
155270038|NCT00885352|560422539|FG001|Overall Study|Protocol Violation|2|||
155270039|NCT00885352|560422538|FG000|Overall Study|Withdrawal by Subject|1|||
155270040|NCT00885352|560422539|FG001|Overall Study|Withdrawal by Subject|5|||
155270041|NCT00885352|560422538|FG000|Overall Study|Contradiction to study medication|0|||
155270042|NCT00885352|560422539|FG001|Overall Study|Contradiction to study medication|2|||
155270043|NCT00885352|560422538|FG000|Overall Study|Excluded medication|2|||
155270044|NCT00885352|560422539|FG001|Overall Study|Excluded medication|2|||
155270045|NCT00885352|560422538|FG000|Overall Study|Lab abnormalities|1|||
155270046|NCT00885352|560422539|FG001|Overall Study|Lab abnormalities|1|||
155270047|NCT01381874|560422540|FG000|Overall Study|Lost to Follow-up|1|||
155270048|NCT01381874|560422541|FG001|Overall Study|Lost to Follow-up|1|||
155270049|NCT01381874|560422542|FG002|Overall Study|Lost to Follow-up|0|||
155270050|NCT01381874|560422540|FG000|Overall Study|Withdrawal by Subject|9|||
155270051|NCT01381874|560422541|FG001|Overall Study|Withdrawal by Subject|10|||
155270052|NCT01381874|560422542|FG002|Overall Study|Withdrawal by Subject|9|||
155270053|NCT01381874|560422540|FG000|Overall Study|Other|67|||
155270054|NCT01381874|560422541|FG001|Overall Study|Other|52|||
155270055|NCT01381874|560422542|FG002|Overall Study|Other|67|||
155270056|NCT02765490|560422543|FG000|Overall Study|Lost to Follow-up|1|||
155270057|NCT02765490|560422544|FG001|Overall Study|Lost to Follow-up|1|||
155270058|NCT02765490|560422543|FG000|Overall Study|Other|0|||
155270059|NCT02765490|560422544|FG001|Overall Study|Other|1|||
155270060|NCT02765490|560422543|FG000|Overall Study|Death|0|||
155270061|NCT02765490|560422544|FG001|Overall Study|Death|1|||
155270062|NCT03662997|560422545|FG000|Overall Study|Adverse Event|0|||
155270063|NCT03662997|560422546|FG001|Overall Study|Adverse Event|2|||
155270064|NCT03662997|560422547|FG002|Overall Study|Adverse Event|0|||
155270065|NCT03662997|560422548|FG003|Overall Study|Adverse Event|0|||
155270066|NCT01830881|560422552|FG000|Overall Study|Changed decision to have an abortion|0|||
155270067|NCT01830881|560422553|FG001|Overall Study|Changed decision to have an abortion|1|||
155270068|NCT00734214|560422554|FG000|Overall Study|Withdrawal by Subject|3|||
155270069|NCT00734214|560422555|FG001|Overall Study|Withdrawal by Subject|4|||
155270070|NCT00734214|560422554|FG000|Overall Study|MD withdrawal|1|||
155270071|NCT00734214|560422555|FG001|Overall Study|MD withdrawal|0|||
155270072|NCT04362137|560422558|FG000|Overall Study|Death|9|||
155270073|NCT04362137|560422559|FG001|Overall Study|Death|3|||
155270074|NCT04362137|560422558|FG000|Overall Study|Patient decision|6|||
155270075|NCT04362137|560422559|FG001|Overall Study|Patient decision|3|||
155270076|NCT04362137|560422558|FG000|Overall Study|Adverse Event|1|||
155270077|NCT04362137|560422559|FG001|Overall Study|Adverse Event|0|||
155270078|NCT04362137|560422558|FG000|Overall Study|Lost to Follow-up|1|||
155270079|NCT04362137|560422559|FG001|Overall Study|Lost to Follow-up|0|||
155270080|NCT04362137|560422558|FG000|Overall Study|Protocol deviation|1|||
155270081|NCT04362137|560422559|FG001|Overall Study|Protocol deviation|0|||
155270082|NCT02494206|560422576|FG000|Overall Study|Adverse Event|1|||
155270083|NCT02494206|560422576|FG000|Overall Study|Disease Progression|1|||
155270084|NCT01013792|560422577|FG000|Overall Study|Study suspended|2|||
155270085|NCT01013792|560422578|FG001|Overall Study|Study suspended|1|||
155270086|NCT01013792|560422577|FG000|Overall Study|Adverse Event|0|||
155270087|NCT01013792|560422578|FG001|Overall Study|Adverse Event|3|||
155614855|NCT05052697|561683052|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155270088|NCT01013792|560422577|FG000|Overall Study|Lost to Follow-up|0|||
155270089|NCT01013792|560422578|FG001|Overall Study|Lost to Follow-up|1|||
155270090|NCT01121484|560422580|FG000|Overall Study|Adverse Event|12|||
155270091|NCT01121484|560422581|FG001|Overall Study|Adverse Event|5|||
155270092|NCT01121484|560422580|FG000|Overall Study|Lack of Efficacy|3|||
155270093|NCT01121484|560422581|FG001|Overall Study|Lack of Efficacy|11|||
155270094|NCT01121484|560422580|FG000|Overall Study|Lost to Follow-up|5|||
155270095|NCT01121484|560422581|FG001|Overall Study|Lost to Follow-up|9|||
155270096|NCT01121484|560422580|FG000|Overall Study|Physician Decision|0|||
155270097|NCT01121484|560422581|FG001|Overall Study|Physician Decision|3|||
155270098|NCT01121484|560422580|FG000|Overall Study|Protocol Violation|1|||
155270099|NCT01121484|560422581|FG001|Overall Study|Protocol Violation|0|||
155270100|NCT01121484|560422580|FG000|Overall Study|Withdrawal by Subject|8|||
155270101|NCT01121484|560422581|FG001|Overall Study|Withdrawal by Subject|7|||
155270102|NCT01121484|560422580|FG000|Overall Study|Discontinuation of study by sponsor|0|||
155270103|NCT01121484|560422581|FG001|Overall Study|Discontinuation of study by sponsor|1|||
155270104|NCT01121484|560422580|FG000|Overall Study|Other|3|||
155270105|NCT01121484|560422581|FG001|Overall Study|Other|3|||
155270106|NCT01121484|560422580|FG000|Overall Study|Randomized, not treated|1|||
155270107|NCT01121484|560422581|FG001|Overall Study|Randomized, not treated|4|||
155270108|NCT03679767|560422582|FG000|Overall Study|Death|16|||
155270109|NCT03679767|560422583|FG001|Overall Study|Death|11|||
155270110|NCT03679767|560422584|FG002|Overall Study|Death|17|||
155270111|NCT03679767|560422585|FG003|Overall Study|Death|10|||
155270112|NCT03679767|560422582|FG000|Overall Study|Lost to Follow-up|1|||
155270113|NCT03679767|560422583|FG001|Overall Study|Lost to Follow-up|1|||
155270114|NCT03679767|560422584|FG002|Overall Study|Lost to Follow-up|1|||
155270115|NCT03679767|560422585|FG003|Overall Study|Lost to Follow-up|1|||
155270116|NCT03679767|560422582|FG000|Overall Study|Withdrawal by Subject|0|||
155270117|NCT03679767|560422583|FG001|Overall Study|Withdrawal by Subject|0|||
155270118|NCT03679767|560422584|FG002|Overall Study|Withdrawal by Subject|0|||
155270119|NCT03679767|560422585|FG003|Overall Study|Withdrawal by Subject|1|||
155270120|NCT03679767|560422582|FG000|Overall Study|Follow-up Completed|18|||
155270121|NCT03679767|560422583|FG001|Overall Study|Follow-up Completed|11|||
155270122|NCT03679767|560422584|FG002|Overall Study|Follow-up Completed|11|||
155270123|NCT03679767|560422585|FG003|Overall Study|Follow-up Completed|20|||
155270124|NCT03679767|560422582|FG000|Overall Study|Entered Hospice Care|0|||
155270125|NCT03679767|560422583|FG001|Overall Study|Entered Hospice Care|0|||
155270126|NCT03679767|560422584|FG002|Overall Study|Entered Hospice Care|0|||
155270127|NCT03679767|560422585|FG003|Overall Study|Entered Hospice Care|1|||
155270128|NCT03679767|560422582|FG000|Overall Study|Progressive Disease|0|||
155270129|NCT03679767|560422583|FG001|Overall Study|Progressive Disease|0|||
155270130|NCT03679767|560422584|FG002|Overall Study|Progressive Disease|0|||
155270131|NCT03679767|560422585|FG003|Overall Study|Progressive Disease|1|||
155270132|NCT03915951|560422586|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
155270133|NCT03915951|560422587|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
155270134|NCT03915951|560422586|FG000|Overall Study|Adverse Event|12|||
155270135|NCT03915951|560422587|FG001|Overall Study|Adverse Event|6|||
155270136|NCT03915951|560422586|FG000|Overall Study|Disease progression (radiological)|17|||
155270137|NCT03915951|560422587|FG001|Overall Study|Disease progression (radiological)|15|||
155270138|NCT03915951|560422586|FG000|Overall Study|Disease progression (clinical)|4|||
155270139|NCT03915951|560422587|FG001|Overall Study|Disease progression (clinical)|1|||
155270140|NCT03915951|560422586|FG000|Overall Study|Patient decision|0|||
155270141|NCT03915951|560422587|FG001|Overall Study|Patient decision|4|||
155270142|NCT03915951|560422586|FG000|Overall Study|Investigator decision|0|||
155270143|NCT03915951|560422587|FG001|Overall Study|Investigator decision|1|||
155270144|NCT03915951|560422586|FG000|Overall Study|Consent withdrawn|1|||
155270145|NCT03915951|560422587|FG001|Overall Study|Consent withdrawn|1|||
155270146|NCT03915951|560422586|FG000|Overall Study|Death|0|||
155270147|NCT03915951|560422587|FG001|Overall Study|Death|3|||
155270148|NCT05408468|560422588|FG000|Overall Study|Lost to Follow-up|3|||
155270149|NCT05408468|560422589|FG001|Overall Study|Lost to Follow-up|1|||
155270150|NCT05408468|560422588|FG000|Overall Study|Physician Decision|1|||
155270151|NCT05408468|560422589|FG001|Overall Study|Physician Decision|0|||
155270152|NCT05408468|560422588|FG000|Overall Study|Overwhelmed by clinical situation|3|||
155270153|NCT05408468|560422589|FG001|Overall Study|Overwhelmed by clinical situation|0|||
155270154|NCT05408468|560422588|FG000|Overall Study|Personal illness precluding participation|1|||
155270155|NCT05408468|560422589|FG001|Overall Study|Personal illness precluding participation|0|||
155270156|NCT05408468|560422588|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
155270157|NCT05408468|560422589|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
155270158|NCT02204579|560422594|FG000|Overall Study|Screen failures|2|||
155270159|NCT01396395|560422595|FG000|Overall Study|Withdrawal by Subject|10|||
155270160|NCT01396395|560422596|FG001|Overall Study|Withdrawal by Subject|12|||
155270161|NCT01396395|560422595|FG000|Overall Study|Protocol Violation|3|||
155270162|NCT01396395|560422596|FG001|Overall Study|Protocol Violation|1|||
155270163|NCT01396395|560422595|FG000|Overall Study|Adverse Event|10|||
155270164|NCT01396395|560422596|FG001|Overall Study|Adverse Event|2|||
155270165|NCT01396395|560422595|FG000|Overall Study|Lost to Follow-up|17|||
155270166|NCT01396395|560422596|FG001|Overall Study|Lost to Follow-up|11|||
155270167|NCT01396395|560422595|FG000|Overall Study|Other|0|||
155270168|NCT01396395|560422596|FG001|Overall Study|Other|1|||
155270169|NCT01370005|560422597|FG000|Overall Study|Not treated|1|||
155270170|NCT01370005|560422598|FG001|Overall Study|Not treated|0|||
155270171|NCT01370005|560422599|FG002|Overall Study|Not treated|0|||
155270172|NCT01370005|560422597|FG000|Overall Study|Adverse Event|5|||
155270173|NCT01370005|560422598|FG001|Overall Study|Adverse Event|5|||
155270174|NCT01370005|560422599|FG002|Overall Study|Adverse Event|6|||
155270175|NCT01370005|560422597|FG000|Overall Study|Lack of Efficacy|1|||
155270176|NCT01370005|560422598|FG001|Overall Study|Lack of Efficacy|0|||
155270177|NCT01370005|560422599|FG002|Overall Study|Lack of Efficacy|0|||
155270178|NCT01370005|560422597|FG000|Overall Study|Non compliant with protocol|0|||
155270179|NCT01370005|560422598|FG001|Overall Study|Non compliant with protocol|1|||
155270180|NCT01370005|560422599|FG002|Overall Study|Non compliant with protocol|2|||
155270181|NCT01370005|560422597|FG000|Overall Study|Lost to Follow-up|1|||
155270182|NCT01370005|560422598|FG001|Overall Study|Lost to Follow-up|1|||
155270183|NCT01370005|560422599|FG002|Overall Study|Lost to Follow-up|1|||
155270184|NCT01370005|560422597|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
155270185|NCT01370005|560422598|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
155270186|NCT01370005|560422599|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
155270187|NCT01370005|560422597|FG000|Overall Study|Other reason not defined above|3|||
155270188|NCT01370005|560422598|FG001|Overall Study|Other reason not defined above|0|||
155270189|NCT01370005|560422599|FG002|Overall Study|Other reason not defined above|2|||
155270190|NCT03691948|560422600|FG000|Overall Study|Lost to Follow-up|1|||
155270191|NCT03691948|560422601|FG001|Overall Study|Lost to Follow-up|3|||
155270192|NCT03916744|560422603|FG000|Overall Study|Withdrawal by Subject|0|||
155270193|NCT03916744|560422604|FG001|Overall Study|Withdrawal by Subject|1|||
155270194|NCT03916744|560422605|FG002|Overall Study|Withdrawal by Subject|2|||
155270195|NCT03556358|560422610|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
155270196|NCT03556358|560422611|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
155270197|NCT03556358|560422610|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
155270198|NCT03556358|560422611|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
155270199|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
155270200|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
155270201|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
155270202|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
155270203|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
155270204|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
155270205|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
155270206|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
155270207|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
155270208|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
155270209|NCT00180713|560422620|FG000|Overall Study|Withdrawal by Subject|2|||
155270210|NCT00180713|560422621|FG001|Overall Study|Withdrawal by Subject|0|||
155270211|NCT00180713|560422620|FG000|Overall Study|Adverse Event|3|||
155270212|NCT00180713|560422621|FG001|Overall Study|Adverse Event|3|||
155270213|NCT05067933|560422623|FG000|Overall Study|Withdrawal by Subject|2|||
155270214|NCT05067933|560422624|FG001|Overall Study|Withdrawal by Subject|0|||
155270215|NCT05067933|560422625|FG002|Overall Study|Withdrawal by Subject|0|||
155270216|NCT05067933|560422626|FG003|Overall Study|Withdrawal by Subject|0|||
155270217|NCT05067933|560422627|FG004|Overall Study|Withdrawal by Subject|0|||
155270218|NCT05067933|560422628|FG005|Overall Study|Withdrawal by Subject|0|||
155270219|NCT05067933|560422623|FG000|Overall Study|Lost to Follow-up|1|||
155270220|NCT05067933|560422624|FG001|Overall Study|Lost to Follow-up|1|||
155270221|NCT05067933|560422625|FG002|Overall Study|Lost to Follow-up|1|||
155270222|NCT05067933|560422626|FG003|Overall Study|Lost to Follow-up|2|||
155270223|NCT05067933|560422627|FG004|Overall Study|Lost to Follow-up|1|||
155270224|NCT05067933|560422628|FG005|Overall Study|Lost to Follow-up|0|||
155270225|NCT05067933|560422623|FG000|Overall Study|Miscellaneous|1|||
155270226|NCT05067933|560422624|FG001|Overall Study|Miscellaneous|0|||
155270227|NCT05067933|560422625|FG002|Overall Study|Miscellaneous|0|||
155270228|NCT05067933|560422626|FG003|Overall Study|Miscellaneous|0|||
155270229|NCT05067933|560422627|FG004|Overall Study|Miscellaneous|0|||
155270230|NCT05067933|560422628|FG005|Overall Study|Miscellaneous|0|||
155270231|NCT05067933|560422623|FG000|Overall Study|Death|0|||
155270232|NCT05067933|560422624|FG001|Overall Study|Death|0|||
155270233|NCT05067933|560422625|FG002|Overall Study|Death|0|||
155270234|NCT05067933|560422626|FG003|Overall Study|Death|1|||
155270235|NCT05067933|560422627|FG004|Overall Study|Death|0|||
155270236|NCT05067933|560422628|FG005|Overall Study|Death|0|||
155270237|NCT01065350|560422629|FG000|Overall Study|Received incorrect drug allocation|0|||
155270238|NCT01065350|560422630|FG001|Overall Study|Received incorrect drug allocation|1|||
155270239|NCT02716038|560422637|FG000|Overall Study|Not evaluable|1|||
155270240|NCT02716038|560422637|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
155270241|NCT02716038|560422637|FG000|Overall Study|Unresectable|3|||
155270242|NCT02875834|560422640|FG000|Open-label Phase|Withdrawal by Subject|3|||
155270243|NCT02875834|560422641|FG001|Open-label Phase|Withdrawal by Subject|0|||
155270244|NCT02875834|560422642|FG002|Open-label Phase|Withdrawal by Subject|0|||
155270245|NCT02875834|560422643|FG003|Open-label Phase|Withdrawal by Subject|0|||
155270246|NCT02875834|560422640|FG000|Open-label Phase|(Not collected)|4|||
155270247|NCT02875834|560422641|FG001|Open-label Phase|(Not collected)|0|||
155270248|NCT02875834|560422642|FG002|Open-label Phase|(Not collected)|0|||
155270249|NCT02875834|560422643|FG003|Open-label Phase|(Not collected)|0|||
155270250|NCT02875834|560422640|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
155270251|NCT02875834|560422641|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
155270252|NCT02875834|560422642|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
155270253|NCT02875834|560422643|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
155270254|NCT02875834|560422640|FG000|Randomized Treatment Phase|Protocol Violation|0|||
155270255|NCT02875834|560422641|FG001|Randomized Treatment Phase|Protocol Violation|2|||
155270256|NCT02875834|560422642|FG002|Randomized Treatment Phase|Protocol Violation|0|||
155270257|NCT02875834|560422643|FG003|Randomized Treatment Phase|Protocol Violation|0|||
155270258|NCT02875834|560422640|FG000|Randomized Treatment Phase|(Not collected)|0|||
155270259|NCT02875834|560422641|FG001|Randomized Treatment Phase|(Not collected)|9|||
155270260|NCT02875834|560422642|FG002|Randomized Treatment Phase|(Not collected)|10|||
155270261|NCT02875834|560422643|FG003|Randomized Treatment Phase|(Not collected)|9|||
155270262|NCT05200936|560422646|FG000|Overall Study|Withdrawal by Subject|2|||
155270263|NCT05200936|560422647|FG001|Overall Study|Withdrawal by Subject|2|||
155270264|NCT05200936|560422646|FG000|Overall Study|Lost to Follow-up|2|||
155270265|NCT05200936|560422647|FG001|Overall Study|Lost to Follow-up|0|||
155270266|NCT05200936|560422646|FG000|Overall Study|Pregnancy|0|||
155270267|NCT05200936|560422647|FG001|Overall Study|Pregnancy|1|||
155270268|NCT00539279|560422648|FG000|Treatment|Withdrawal by Subject|10|||
155270269|NCT00539279|560422649|FG001|Treatment|Withdrawal by Subject|8|||
155270270|NCT00539279|560422648|FG000|Treatment|Death|1|||
155270271|NCT00539279|560422649|FG001|Treatment|Death|0|||
155270272|NCT00539279|560422648|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
155270273|NCT00539279|560422649|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
155270274|NCT00539279|560422648|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
155270275|NCT00539279|560422649|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
155270276|NCT01340482|560424097|FG000|Overall Study|Adverse Event|2|||
155270277|NCT01340482|560424098|FG001|Overall Study|Adverse Event|0|||
155270278|NCT01340482|560424099|FG002|Overall Study|Adverse Event|0|||
155270279|NCT02593539|560424100|FG000|Overall Study|Adverse Event|1|||
155270280|NCT01282476|560424101|FG000|Overall Study|Death|11|||
155270281|NCT01811563|560424108|FG000|Overall Study|Lost to Follow-up|5|||
155270282|NCT01811563|560424109|FG001|Overall Study|Lost to Follow-up|2|||
155270283|NCT01811563|560424108|FG000|Overall Study|Incorrect Randomization procedure|0|||
155270284|NCT01811563|560424109|FG001|Overall Study|Incorrect Randomization procedure|1|||
155270285|NCT04424290|560424111|FG000|Overall Study|Not treated|0|||
155270286|NCT04424290|560424112|FG001|Overall Study|Not treated|0|||
155270287|NCT04424290|560424113|FG002|Overall Study|Not treated|1|||
155270288|NCT04424290|560424114|FG003|Overall Study|Not treated|0|||
155270289|NCT04424290|560424115|FG004|Overall Study|Not treated|1|||
155270290|NCT04424290|560424111|FG000|Overall Study|Adverse Event|0|||
155270291|NCT04424290|560424112|FG001|Overall Study|Adverse Event|0|||
155270292|NCT04424290|560424113|FG002|Overall Study|Adverse Event|0|||
155270293|NCT04424290|560424114|FG003|Overall Study|Adverse Event|2|||
155270294|NCT04424290|560424115|FG004|Overall Study|Adverse Event|0|||
155270295|NCT04424290|560424111|FG000|Overall Study|Withdrawal by Subject|0|||
155270296|NCT04424290|560424112|FG001|Overall Study|Withdrawal by Subject|0|||
155270297|NCT04424290|560424113|FG002|Overall Study|Withdrawal by Subject|0|||
155270298|NCT04424290|560424114|FG003|Overall Study|Withdrawal by Subject|0|||
155270299|NCT04424290|560424115|FG004|Overall Study|Withdrawal by Subject|1|||
155270300|NCT04424290|560424111|FG000|Overall Study|Other than listed|0|||
155270301|NCT04424290|560424112|FG001|Overall Study|Other than listed|0|||
155270302|NCT04424290|560424113|FG002|Overall Study|Other than listed|0|||
155270303|NCT04424290|560424114|FG003|Overall Study|Other than listed|1|||
155270304|NCT04424290|560424115|FG004|Overall Study|Other than listed|0|||
155270305|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
155270306|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
155270307|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
155270308|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
155270309|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
155270310|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
155270311|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Death|0|||
155270312|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Death|1|||
155270313|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Adverse Event|11|||
155270314|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Adverse Event|11|||
155270315|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
155270316|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
155270317|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155270318|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155270319|NCT02936037|560424117|FG000|Open Label Extension|Adverse Event|0|||
155270320|NCT02936037|560424118|FG001|Open Label Extension|Adverse Event|3|||
155270321|NCT02936037|560424117|FG000|Open Label Extension|Other|0|||
155270322|NCT02936037|560424118|FG001|Open Label Extension|Other|3|||
155270323|NCT02936037|560424117|FG000|Open Label Extension|Withdrawal by Subject|0|||
155270324|NCT02936037|560424118|FG001|Open Label Extension|Withdrawal by Subject|4|||
155270325|NCT01267825|560424119|FG000|Overall Study|study terminated. no data collected.|1|||
155270326|NCT01267825|560424120|FG001|Overall Study|study terminated. no data collected.|0|||
155270327|NCT04249336|560424121|FG000|Overall Study|Lost to Follow-up|3|||
155270328|NCT04249336|560424122|FG001|Overall Study|Lost to Follow-up|3|||
155270329|NCT04249336|560424123|FG002|Overall Study|Lost to Follow-up|3|||
155270330|NCT04249336|560424124|FG003|Overall Study|Lost to Follow-up|3|||
155270331|NCT01242176|560424125|FG000|Washout Period of 7 Days|Adverse Event|0|||
155270332|NCT01242176|560424126|FG001|Washout Period of 7 Days|Adverse Event|2|||
155270333|NCT01242176|560424125|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
155270334|NCT01242176|560424126|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
155270335|NCT00871351|560424127|FG000|Overall Study|Withdrawal by Subject|1|||
155270336|NCT00871351|560424128|FG001|Overall Study|Withdrawal by Subject|0|||
155270337|NCT00871351|560424129|FG002|Overall Study|Withdrawal by Subject|0|||
155270338|NCT00871351|560424127|FG000|Overall Study|Adverse Event|3|||
155270339|NCT00871351|560424128|FG001|Overall Study|Adverse Event|1|||
155270340|NCT00871351|560424129|FG002|Overall Study|Adverse Event|0|||
155270341|NCT02791490|560424130|FG000|Overall Study|Lost to Follow-up|1|||
155270342|NCT02791490|560424131|FG001|Overall Study|Lost to Follow-up|2|||
155270343|NCT02791490|560424130|FG000|Overall Study|Withdrawal by Subject|2|||
155270344|NCT02791490|560424131|FG001|Overall Study|Withdrawal by Subject|6|||
155270345|NCT01189890|560424132|FG000|Overall Study|Adverse Event|3|||
155270346|NCT01189890|560424133|FG001|Overall Study|Adverse Event|4|||
155270347|NCT01189890|560424132|FG000|Overall Study|Lack of Efficacy|7|||
155270348|NCT01189890|560424133|FG001|Overall Study|Lack of Efficacy|2|||
155270349|NCT01189890|560424132|FG000|Overall Study|Lost to Follow-up|1|||
155270350|NCT01189890|560424133|FG001|Overall Study|Lost to Follow-up|7|||
155270351|NCT01189890|560424132|FG000|Overall Study|Protocol Violation|1|||
155270352|NCT01189890|560424133|FG001|Overall Study|Protocol Violation|5|||
155270353|NCT01189890|560424132|FG000|Overall Study|Withdrawal by Subject|15|||
155270354|NCT01189890|560424133|FG001|Overall Study|Withdrawal by Subject|11|||
155270355|NCT01189890|560424132|FG000|Overall Study|Non Compliance|0|||
155270356|NCT01189890|560424133|FG001|Overall Study|Non Compliance|1|||
155270357|NCT01189890|560424132|FG000|Overall Study|Physician Decision|5|||
155270358|NCT01189890|560424133|FG001|Overall Study|Physician Decision|4|||
155270359|NCT01189890|560424132|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
155270360|NCT01189890|560424133|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
155270361|NCT00077636|560424134|FG000|Overall Study|Refused Treatment|9|||
155270362|NCT00077636|560424135|FG001|Overall Study|Refused Treatment|31|||
155270363|NCT00077636|560424134|FG000|Overall Study|Admin|3|||
155270364|NCT00077636|560424135|FG001|Overall Study|Admin|3|||
155270365|NCT00077636|560424134|FG000|Overall Study|Withdrawal by Subject|2|||
155270366|NCT00077636|560424135|FG001|Overall Study|Withdrawal by Subject|2|||
155270367|NCT00077636|560424134|FG000|Overall Study|Adverse Event|17|||
155270368|NCT00077636|560424135|FG001|Overall Study|Adverse Event|34|||
155270369|NCT00077636|560424134|FG000|Overall Study|Protocol Violation|0|||
155270370|NCT00077636|560424135|FG001|Overall Study|Protocol Violation|2|||
155270371|NCT00077636|560424134|FG000|Overall Study|Lost to Follow-up|10|||
155270372|NCT00077636|560424135|FG001|Overall Study|Lost to Follow-up|18|||
155270373|NCT00077636|560424134|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
155270374|NCT00077636|560424135|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
155270375|NCT00592319|560424136|FG000|Overall Study|Lost to Follow-up|0|||
155270376|NCT00592319|560424137|FG001|Overall Study|Lost to Follow-up|3|||
155270377|NCT02032173|560424140|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
155270378|NCT01642602|560424143|FG000|Overall Study|Adverse Event|2|||
155270379|NCT01112514|560424144|FG000|Overall Study|Lost to Follow-up|1|||
155270380|NCT02961881|560424145|FG000|Overall Study|Adverse Event|1|||
155270381|NCT02961881|560424146|FG001|Overall Study|Adverse Event|2|||
155270382|NCT02961881|560424147|FG002|Overall Study|Adverse Event|2|||
155270383|NCT02961881|560424148|FG003|Overall Study|Adverse Event|0|||
155270384|NCT02961881|560424149|FG004|Overall Study|Adverse Event|1|||
155270385|NCT02961881|560424145|FG000|Overall Study|Participant request|0|||
155270386|NCT02961881|560424146|FG001|Overall Study|Participant request|2|||
155270387|NCT02961881|560424147|FG002|Overall Study|Participant request|0|||
155270388|NCT02961881|560424148|FG003|Overall Study|Participant request|0|||
155270389|NCT02961881|560424149|FG004|Overall Study|Participant request|0|||
155614856|NCT05052697|561683053|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155270390|NCT02961881|560424145|FG000|Overall Study|Disease progression|1|||
155270391|NCT02961881|560424146|FG001|Overall Study|Disease progression|0|||
155270392|NCT02961881|560424147|FG002|Overall Study|Disease progression|1|||
155270393|NCT02961881|560424148|FG003|Overall Study|Disease progression|0|||
155270394|NCT02961881|560424149|FG004|Overall Study|Disease progression|0|||
155270395|NCT01235975|560424155|FG000|Overall Study|Serious Adverse Event|0|||
155270396|NCT01235975|560424156|FG001|Overall Study|Serious Adverse Event|1|||
155270397|NCT01235975|560424155|FG000|Overall Study|Withdrawal by Subject|8|||
155270398|NCT01235975|560424156|FG001|Overall Study|Withdrawal by Subject|2|||
155270399|NCT01235975|560424155|FG000|Overall Study|Migrated/moved from study area|2|||
155270400|NCT01235975|560424156|FG001|Overall Study|Migrated/moved from study area|1|||
155270401|NCT01235975|560424155|FG000|Overall Study|Lost to Follow-up|7|||
155270402|NCT01235975|560424156|FG001|Overall Study|Lost to Follow-up|3|||
155270403|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
155270404|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
155270405|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155270406|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
155270407|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
155270408|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
155270409|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
155270410|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
155270411|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
155270412|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
155270413|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
155270414|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
155270415|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
155270416|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
155270417|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
155270418|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
155270419|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
155270420|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
155270421|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
155270422|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
155270423|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
155270424|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
155270425|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
155270426|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
155270427|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
155270428|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
155270429|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
155270430|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
155270431|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
155270432|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
155270433|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
155270434|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
155270435|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
155270436|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
155270437|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
155270438|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
155270439|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
155270440|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
155270441|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
155270442|NCT00365378|560424168|FG000|Extension|Adverse Event|0|||
155270443|NCT00365378|560424169|FG001|Extension|Adverse Event|0|||
155270444|NCT00365378|560424170|FG002|Extension|Adverse Event|1|||
155270445|NCT00365378|560424168|FG000|Extension|Moved|0|||
155270446|NCT00365378|560424169|FG001|Extension|Moved|0|||
155270447|NCT00365378|560424170|FG002|Extension|Moved|8|||
155270448|NCT00365378|560424168|FG000|Extension|Lost to Follow-up|0|||
155270449|NCT00365378|560424169|FG001|Extension|Lost to Follow-up|0|||
155270450|NCT00365378|560424170|FG002|Extension|Lost to Follow-up|57|||
155270451|NCT00365378|560424168|FG000|Extension|Protocol Violation|0|||
155270452|NCT00365378|560424169|FG001|Extension|Protocol Violation|0|||
155270453|NCT00365378|560424170|FG002|Extension|Protocol Violation|2|||
155270454|NCT00365378|560424168|FG000|Extension|Withdrawal by Subject|0|||
155270455|NCT00365378|560424169|FG001|Extension|Withdrawal by Subject|0|||
155270456|NCT00365378|560424170|FG002|Extension|Withdrawal by Subject|98|||
155270457|NCT00365378|560424168|FG000|Extension|Other|0|||
155270458|NCT00365378|560424169|FG001|Extension|Other|0|||
155270459|NCT00365378|560424170|FG002|Extension|Other|31|||
155270460|NCT00251927|560424176|FG000|Overall Study|Adverse Event|3|||
155270461|NCT00251927|560424177|FG001|Overall Study|Adverse Event|15|||
155270462|NCT00251927|560424176|FG000|Overall Study|Lack of Efficacy|22|||
155270463|NCT00251927|560424177|FG001|Overall Study|Lack of Efficacy|16|||
155270464|NCT00251927|560424176|FG000|Overall Study|Lost to Follow-up|22|||
155270465|NCT00251927|560424177|FG001|Overall Study|Lost to Follow-up|8|||
155270466|NCT00251927|560424176|FG000|Overall Study|Protocol Violation|1|||
155270467|NCT00251927|560424177|FG001|Overall Study|Protocol Violation|2|||
155270468|NCT00251927|560424176|FG000|Overall Study|Pregnancy|2|||
155270469|NCT00251927|560424177|FG001|Overall Study|Pregnancy|0|||
155270470|NCT00251927|560424176|FG000|Overall Study|Withdrawal by Subject|40|||
155270471|NCT00251927|560424177|FG001|Overall Study|Withdrawal by Subject|25|||
155381743|NCT04617275|560830984|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
155270472|NCT00251927|560424176|FG000|Overall Study|Study-specific discont. achieved|13|||
155270473|NCT00251927|560424177|FG001|Overall Study|Study-specific discont. achieved|2|||
155270474|NCT00251927|560424176|FG000|Overall Study|Study procedure non-compliance|5|||
155270475|NCT00251927|560424177|FG001|Overall Study|Study procedure non-compliance|6|||
155270476|NCT01678820|560424178|FG000|Overall Study|Study Terminated by Sponsor|45|||
155270477|NCT01678820|560424179|FG001|Overall Study|Study Terminated by Sponsor|43|||
155270478|NCT01678820|560424180|FG002|Overall Study|Study Terminated by Sponsor|43|||
155270479|NCT01678820|560424178|FG000|Overall Study|Withdrawal by Subject|2|||
155270480|NCT01678820|560424179|FG001|Overall Study|Withdrawal by Subject|5|||
155270481|NCT01678820|560424180|FG002|Overall Study|Withdrawal by Subject|2|||
155270482|NCT01678820|560424178|FG000|Overall Study|Protocol Specified Criteria|2|||
155270483|NCT01678820|560424179|FG001|Overall Study|Protocol Specified Criteria|3|||
155270484|NCT01678820|560424180|FG002|Overall Study|Protocol Specified Criteria|1|||
155270485|NCT01678820|560424178|FG000|Overall Study|Adverse Event|2|||
155270486|NCT01678820|560424179|FG001|Overall Study|Adverse Event|2|||
155270487|NCT01678820|560424180|FG002|Overall Study|Adverse Event|2|||
155270488|NCT01678820|560424178|FG000|Overall Study|Lost to Follow-up|7|||
155270489|NCT01678820|560424179|FG001|Overall Study|Lost to Follow-up|2|||
155270490|NCT01678820|560424180|FG002|Overall Study|Lost to Follow-up|2|||
155270491|NCT01678820|560424178|FG000|Overall Study|Non-compliance with study drug|0|||
155270492|NCT01678820|560424179|FG001|Overall Study|Non-compliance with study drug|1|||
155270493|NCT01678820|560424180|FG002|Overall Study|Non-compliance with study drug|0|||
155270494|NCT01678820|560424178|FG000|Overall Study|Physician Decision|0|||
155270495|NCT01678820|560424179|FG001|Overall Study|Physician Decision|0|||
155270496|NCT01678820|560424180|FG002|Overall Study|Physician Decision|1|||
155270497|NCT01678820|560424178|FG000|Overall Study|Protocol Violation|4|||
155270498|NCT01678820|560424179|FG001|Overall Study|Protocol Violation|5|||
155270499|NCT01678820|560424180|FG002|Overall Study|Protocol Violation|4|||
155270500|NCT01678820|560424178|FG000|Overall Study|Not treated with double-blind study drug|0|||
155270501|NCT01678820|560424179|FG001|Overall Study|Not treated with double-blind study drug|2|||
155270502|NCT01678820|560424180|FG002|Overall Study|Not treated with double-blind study drug|2|||
155270503|NCT00452413|560424184|FG000|Overall Study|Progressive Disease|4|||
155270504|NCT00452413|560424185|FG001|Overall Study|Progressive Disease|11|||
155270505|NCT00452413|560424186|FG002|Overall Study|Progressive Disease|30|||
155270506|NCT00452413|560424184|FG000|Overall Study|Withdrawal by Subject|0|||
155270507|NCT00452413|560424185|FG001|Overall Study|Withdrawal by Subject|1|||
155270508|NCT00452413|560424186|FG002|Overall Study|Withdrawal by Subject|4|||
155270509|NCT00452413|560424184|FG000|Overall Study|Adverse Event|0|||
155270510|NCT00452413|560424185|FG001|Overall Study|Adverse Event|0|||
155270511|NCT00452413|560424186|FG002|Overall Study|Adverse Event|5|||
155270512|NCT00452413|560424184|FG000|Overall Study|Physician Decision|0|||
155270513|NCT00452413|560424185|FG001|Overall Study|Physician Decision|0|||
155270514|NCT00452413|560424186|FG002|Overall Study|Physician Decision|4|||
155270515|NCT00452413|560424184|FG000|Overall Study|Death due to study disease|0|||
155270516|NCT00452413|560424185|FG001|Overall Study|Death due to study disease|0|||
155270517|NCT00452413|560424186|FG002|Overall Study|Death due to study disease|2|||
155270518|NCT00452413|560424184|FG000|Overall Study|Death due to adverse event (AE)|0|||
155270519|NCT00452413|560424185|FG001|Overall Study|Death due to adverse event (AE)|0|||
155270520|NCT00452413|560424186|FG002|Overall Study|Death due to adverse event (AE)|1|||
155270521|NCT00452413|560424184|FG000|Overall Study|On treatment|0|||
155270522|NCT00452413|560424185|FG001|Overall Study|On treatment|0|||
155270523|NCT00452413|560424186|FG002|Overall Study|On treatment|3|||
155270524|NCT03119610|560424188|FG000|Overall Study|Adverse Event|1|||
155270525|NCT03119610|560424189|FG001|Overall Study|Adverse Event|0|||
155270526|NCT03119610|560424188|FG000|Overall Study|Lost to Follow-up|0|||
155270527|NCT03119610|560424189|FG001|Overall Study|Lost to Follow-up|1|||
155270528|NCT00114634|560424214|FG000|Overall Study|failure to return forms|3|||
155270529|NCT00684762|560424215|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
155270530|NCT00684762|560424216|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
155270531|NCT01539863|560424223|FG000|Overall Study|Lost to Follow-up|5|||
155270532|NCT01539863|560424224|FG001|Overall Study|Lost to Follow-up|4|||
155270533|NCT02693834|560424225|FG000|Baseline Measurement|Withdrawal by Subject|1|||
155270534|NCT02693834|560424226|FG001|Baseline Measurement|Withdrawal by Subject|0|||
155270535|NCT02693834|560424225|FG000|Baseline Measurement|Adverse Event|1|||
155270536|NCT02693834|560424226|FG001|Baseline Measurement|Adverse Event|0|||
155270537|NCT02693834|560424225|FG000|Week 2 Practice|Adverse Event|0|||
155270538|NCT02693834|560424226|FG001|Week 2 Practice|Adverse Event|1|||
155270539|NCT03306043|560424233|FG000|Overall Study|Adverse Event|1|||
155270540|NCT03306043|560424233|FG000|Overall Study|Lost to Follow-up|1|||
155381744|NCT04617275|560830985|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
155726466|NCT01716234|562098146|FG006|Overall Study|Protocol Violation|0|||
155270541|NCT03306043|560424233|FG000|Overall Study|Withdrawal by Subject|2|||
155270542|NCT01544491|560424234|FG000|Overall Study|Withdrawal by Subject|3|||
155270543|NCT01544491|560424235|FG001|Overall Study|Withdrawal by Subject|2|||
155270544|NCT01544491|560424234|FG000|Overall Study|Lost to Follow-up|0|||
155270545|NCT01544491|560424235|FG001|Overall Study|Lost to Follow-up|1|||
155270546|NCT01544491|560424234|FG000|Overall Study|administrative problems|2|||
155270547|NCT01544491|560424235|FG001|Overall Study|administrative problems|0|||
155270548|NCT05229653|560424237|FG000|Overall Study|Lost to Follow-up|1|||
155726467|NCT01716234|562098140|FG000|Overall Study|Lack of Efficacy|0|||
155270549|NCT05229653|560424238|FG001|Overall Study|Lost to Follow-up|0|||
155270550|NCT05295732|560424239|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
155270551|NCT05295732|560424240|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
155270552|NCT05295732|560424241|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
155270553|NCT05295732|560424242|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
155270554|NCT05295732|560424243|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
155270555|NCT05295732|560424239|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270556|NCT05295732|560424240|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270557|NCT05295732|560424241|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270558|NCT05295732|560424242|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
155270559|NCT05295732|560424243|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
155270560|NCT00550550|560424244|FG000|Overall Study|Adverse Event|13|||
155270561|NCT00550550|560424245|FG001|Overall Study|Adverse Event|5|||
155270562|NCT00550550|560424244|FG000|Overall Study|Treatment Failure|0|||
155270563|NCT00550550|560424245|FG001|Overall Study|Treatment Failure|1|||
155270564|NCT00550550|560424244|FG000|Overall Study|Lost to Follow-up|4|||
155270565|NCT00550550|560424245|FG001|Overall Study|Lost to Follow-up|0|||
155270566|NCT00550550|560424244|FG000|Overall Study|Withdrawal by Subject|10|||
155270567|NCT00550550|560424245|FG001|Overall Study|Withdrawal by Subject|8|||
155270568|NCT00550550|560424244|FG000|Overall Study|Protocol Violation|5|||
155270569|NCT00550550|560424245|FG001|Overall Study|Protocol Violation|14|||
155270570|NCT00550550|560424244|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155270571|NCT00550550|560424245|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
155270572|NCT00550550|560424244|FG000|Overall Study|Randomized But Not Treated|1|||
155270573|NCT00550550|560424245|FG001|Overall Study|Randomized But Not Treated|0|||
155270574|NCT02459093|560424246|FG000|Overall Study|Protocol Violation|6|||
155270575|NCT02459093|560424247|FG001|Overall Study|Protocol Violation|11|||
155270576|NCT02459093|560424246|FG000|Overall Study|Lost to Follow-up|6|||
155270577|NCT02459093|560424247|FG001|Overall Study|Lost to Follow-up|7|||
155270578|NCT00591864|560424248|FG000|Overall Study|Incomplete Imaging|5|||
155270579|NCT00118092|560424253|FG000|Overall Study|Withdrawal by Subject|1|||
155270580|NCT00118092|560424253|FG000|Overall Study|Protocol Violation|1|||
155270581|NCT03311230|560424258|FG000|Overall Study|Withdrawal by Subject|1|||
155270582|NCT03311230|560424259|FG001|Overall Study|Withdrawal by Subject|4|||
155270583|NCT03311230|560424260|FG002|Overall Study|Withdrawal by Subject|2|||
155270584|NCT03311230|560424261|FG003|Overall Study|Withdrawal by Subject|7|||
155270585|NCT03311230|560424258|FG000|Overall Study|Unrelated injury|0|||
155270586|NCT03311230|560424259|FG001|Overall Study|Unrelated injury|1|||
155270587|NCT03311230|560424260|FG002|Overall Study|Unrelated injury|0|||
155270588|NCT03311230|560424261|FG003|Overall Study|Unrelated injury|0|||
155270589|NCT01302938|560424262|FG000|Overall Study|Withdrawal by Subject|1|||
155270590|NCT01302938|560424263|FG001|Overall Study|Withdrawal by Subject|0|||
155270591|NCT01302938|560424262|FG000|Overall Study|Adverse Event|1|||
155270592|NCT01302938|560424263|FG001|Overall Study|Adverse Event|0|||
155270593|NCT03342053|560424264|FG000|Overall Study|Adverse Event|2|||
155270594|NCT03342053|560424265|FG001|Overall Study|Adverse Event|0|||
155270595|NCT03342053|560424264|FG000|Overall Study|Withdrawal by Subject|0|||
155270596|NCT03342053|560424265|FG001|Overall Study|Withdrawal by Subject|1|||
155270597|NCT02294474|560424266|FG000|Overall Study|Adverse Event|7|||
155270598|NCT02294474|560424267|FG001|Overall Study|Adverse Event|7|||
155270599|NCT02294474|560424266|FG000|Overall Study|Lack of Efficacy|2|||
155270600|NCT02294474|560424267|FG001|Overall Study|Lack of Efficacy|1|||
155270601|NCT02294474|560424266|FG000|Overall Study|Protocol Violation|4|||
155270602|NCT02294474|560424267|FG001|Overall Study|Protocol Violation|2|||
155270603|NCT02294474|560424266|FG000|Overall Study|Other than specified above|12|||
155270604|NCT02294474|560424267|FG001|Overall Study|Other than specified above|12|||
155270605|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270606|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
155381745|NCT04617275|560830986|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
155270607|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
155270608|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270609|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270610|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270611|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270612|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
155270613|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270614|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270615|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270616|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270617|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270618|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270619|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
155270620|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155270621|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155270622|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270623|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270624|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270625|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270626|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270627|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
155270628|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
155270629|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270630|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270631|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270632|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270633|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270634|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270635|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
155270636|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270637|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270638|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270639|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270640|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
155270641|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
155270642|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
155270643|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270644|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270645|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270646|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270647|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
155270648|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
155270649|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270650|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270651|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270652|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270653|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270654|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270655|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270656|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270657|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270658|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270659|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270660|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
155270661|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270662|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270663|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270664|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155270665|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270666|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
155270667|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155270668|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270669|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270670|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270671|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
155270672|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
155270673|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
155270674|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
155270675|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270676|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270677|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270678|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270679|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270680|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270681|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270682|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270683|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270684|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270685|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
155270686|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
155270687|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
155270688|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
155270689|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270690|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270691|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270692|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
155270693|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270694|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
155270695|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
155270696|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270697|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270698|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270699|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
155270700|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270701|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270702|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
155270703|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270704|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270705|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270706|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270707|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270708|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
155270709|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
155270710|NCT04287868|560424282|FG000|Overall Study|Screening fail|1|||
155270711|NCT04287868|560424283|FG001|Overall Study|Screening fail|0|||
155270712|NCT02291289|560425739|FG000|Induction Treatment|Withdrawal by Subject|0|||
155270713|NCT02291289|560425740|FG001|Induction Treatment|Withdrawal by Subject|0|||
155270714|NCT02291289|560425741|FG002|Induction Treatment|Withdrawal by Subject|0|||
155270715|NCT02291289|560425742|FG003|Induction Treatment|Withdrawal by Subject|24|||
155270716|NCT02291289|560425743|FG004|Induction Treatment|Withdrawal by Subject|0|||
155270717|NCT02291289|560425744|FG005|Induction Treatment|Withdrawal by Subject|0|||
155270718|NCT02291289|560425745|FG006|Induction Treatment|Withdrawal by Subject|0|||
155270719|NCT02291289|560425746|FG007|Induction Treatment|Withdrawal by Subject|0|||
155270720|NCT02291289|560425747|FG008|Induction Treatment|Withdrawal by Subject|0|||
155270721|NCT02291289|560425748|FG009|Induction Treatment|Withdrawal by Subject|18|||
155270722|NCT02291289|560425749|FG010|Induction Treatment|Withdrawal by Subject|0|||
155270723|NCT02291289|560425750|FG011|Induction Treatment|Withdrawal by Subject|0|||
155270724|NCT02291289|560425751|FG012|Induction Treatment|Withdrawal by Subject|0|||
155270725|NCT02291289|560425739|FG000|Induction Treatment|Adverse Event|0|||
155270726|NCT02291289|560425740|FG001|Induction Treatment|Adverse Event|0|||
155270727|NCT02291289|560425741|FG002|Induction Treatment|Adverse Event|0|||
155270728|NCT02291289|560425742|FG003|Induction Treatment|Adverse Event|3|||
155270729|NCT02291289|560425743|FG004|Induction Treatment|Adverse Event|0|||
155270730|NCT02291289|560425744|FG005|Induction Treatment|Adverse Event|0|||
155270731|NCT02291289|560425745|FG006|Induction Treatment|Adverse Event|0|||
155270732|NCT02291289|560425746|FG007|Induction Treatment|Adverse Event|0|||
155270733|NCT02291289|560425747|FG008|Induction Treatment|Adverse Event|0|||
155270734|NCT02291289|560425748|FG009|Induction Treatment|Adverse Event|1|||
155270735|NCT02291289|560425749|FG010|Induction Treatment|Adverse Event|0|||
155270736|NCT02291289|560425750|FG011|Induction Treatment|Adverse Event|0|||
155381746|NCT04617275|560830987|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
155614857|NCT05052697|561683054|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614858|NCT05052697|561683055|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614859|NCT05052697|561683056|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614860|NCT05052697|561683057|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614861|NCT05052697|561683058|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614862|NCT05052697|561683059|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614863|NCT05052697|561683060|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614864|NCT05052697|561683061|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614865|NCT05052697|561683062|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614866|NCT05052697|561683063|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614867|NCT05052697|561683064|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
155614868|NCT05052697|561683065|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614869|NCT05052697|561683066|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614870|NCT05052697|561683067|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614871|NCT05052697|561683068|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614872|NCT05052697|561683069|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614873|NCT05052697|561683070|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614874|NCT05052697|561683071|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155726468|NCT01716234|562098141|FG001|Overall Study|Lack of Efficacy|0|||
155270737|NCT02291289|560425751|FG012|Induction Treatment|Adverse Event|0|||
155270738|NCT02291289|560425739|FG000|Induction Treatment|Death|25|||
155270739|NCT02291289|560425740|FG001|Induction Treatment|Death|0|||
155270740|NCT02291289|560425741|FG002|Induction Treatment|Death|0|||
155270741|NCT02291289|560425742|FG003|Induction Treatment|Death|111|||
155270742|NCT02291289|560425743|FG004|Induction Treatment|Death|0|||
155270743|NCT02291289|560425744|FG005|Induction Treatment|Death|0|||
155270744|NCT02291289|560425745|FG006|Induction Treatment|Death|1|||
155381747|NCT04617275|560830988|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
155381748|NCT04617275|560830989|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
155381749|NCT04617275|560830990|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
155381750|NCT04617275|560830991|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
155381751|NCT04617275|560830984|FG000|Follow-up Period|Other|0|||
155381752|NCT04617275|560830985|FG001|Follow-up Period|Other|1|||
155381753|NCT04617275|560830986|FG002|Follow-up Period|Other|0|||
155381754|NCT04617275|560830987|FG003|Follow-up Period|Other|0|||
155381755|NCT04617275|560830988|FG004|Follow-up Period|Other|0|||
155381756|NCT04617275|560830989|FG005|Follow-up Period|Other|0|||
155381757|NCT04617275|560830990|FG006|Follow-up Period|Other|0|||
155381758|NCT04617275|560830991|FG007|Follow-up Period|Other|0|||
155381759|NCT04617275|560830984|FG000|Follow-up Period|Withdrawal by Subject|2|||
155381760|NCT04617275|560830985|FG001|Follow-up Period|Withdrawal by Subject|0|||
155381761|NCT04617275|560830986|FG002|Follow-up Period|Withdrawal by Subject|0|||
155381762|NCT04617275|560830987|FG003|Follow-up Period|Withdrawal by Subject|2|||
155381763|NCT04617275|560830988|FG004|Follow-up Period|Withdrawal by Subject|2|||
155381764|NCT04617275|560830989|FG005|Follow-up Period|Withdrawal by Subject|0|||
155381765|NCT04617275|560830990|FG006|Follow-up Period|Withdrawal by Subject|1|||
155381766|NCT04617275|560830991|FG007|Follow-up Period|Withdrawal by Subject|2|||
155381767|NCT00729378|560833192|FG000|Baseline|Did not complete study measurements|72|||
155381768|NCT00729378|560833193|FG001|Baseline|Did not complete study measurements|33|||
155381769|NCT00729378|560833192|FG000|Baseline|Withdrawal by Subject|66|||
155381770|NCT00729378|560833193|FG001|Baseline|Withdrawal by Subject|59|||
155270745|NCT02291289|560425746|FG007|Induction Treatment|Death|0|||
155270746|NCT02291289|560425747|FG008|Induction Treatment|Death|0|||
155270747|NCT02291289|560425748|FG009|Induction Treatment|Death|82|||
155270748|NCT02291289|560425749|FG010|Induction Treatment|Death|0|||
155270749|NCT02291289|560425750|FG011|Induction Treatment|Death|0|||
155270750|NCT02291289|560425751|FG012|Induction Treatment|Death|0|||
155270751|NCT02291289|560425739|FG000|Induction Treatment|Lost to Follow-up|1|||
155270752|NCT02291289|560425740|FG001|Induction Treatment|Lost to Follow-up|0|||
155270753|NCT02291289|560425741|FG002|Induction Treatment|Lost to Follow-up|0|||
155270754|NCT02291289|560425742|FG003|Induction Treatment|Lost to Follow-up|12|||
155270755|NCT02291289|560425743|FG004|Induction Treatment|Lost to Follow-up|0|||
155270756|NCT02291289|560425744|FG005|Induction Treatment|Lost to Follow-up|0|||
155270757|NCT02291289|560425745|FG006|Induction Treatment|Lost to Follow-up|0|||
155270758|NCT02291289|560425746|FG007|Induction Treatment|Lost to Follow-up|0|||
155270759|NCT02291289|560425747|FG008|Induction Treatment|Lost to Follow-up|0|||
155270760|NCT02291289|560425748|FG009|Induction Treatment|Lost to Follow-up|9|||
155270761|NCT02291289|560425749|FG010|Induction Treatment|Lost to Follow-up|0|||
155270762|NCT02291289|560425750|FG011|Induction Treatment|Lost to Follow-up|0|||
155270763|NCT02291289|560425751|FG012|Induction Treatment|Lost to Follow-up|0|||
155270764|NCT02291289|560425739|FG000|Induction Treatment|Non-Compliance|0|||
155270765|NCT02291289|560425740|FG001|Induction Treatment|Non-Compliance|0|||
155270766|NCT02291289|560425741|FG002|Induction Treatment|Non-Compliance|0|||
155270767|NCT02291289|560425742|FG003|Induction Treatment|Non-Compliance|1|||
155270768|NCT02291289|560425743|FG004|Induction Treatment|Non-Compliance|0|||
155270769|NCT02291289|560425744|FG005|Induction Treatment|Non-Compliance|0|||
155270770|NCT02291289|560425745|FG006|Induction Treatment|Non-Compliance|0|||
155270771|NCT02291289|560425746|FG007|Induction Treatment|Non-Compliance|0|||
155270772|NCT02291289|560425747|FG008|Induction Treatment|Non-Compliance|0|||
155270773|NCT02291289|560425748|FG009|Induction Treatment|Non-Compliance|1|||
155270774|NCT02291289|560425749|FG010|Induction Treatment|Non-Compliance|0|||
155270775|NCT02291289|560425750|FG011|Induction Treatment|Non-Compliance|0|||
155270776|NCT02291289|560425751|FG012|Induction Treatment|Non-Compliance|0|||
155270777|NCT02291289|560425739|FG000|Induction Treatment|Reason Not Specified|0|||
155270778|NCT02291289|560425740|FG001|Induction Treatment|Reason Not Specified|0|||
155270779|NCT02291289|560425741|FG002|Induction Treatment|Reason Not Specified|0|||
155270780|NCT02291289|560425742|FG003|Induction Treatment|Reason Not Specified|4|||
155270781|NCT02291289|560425743|FG004|Induction Treatment|Reason Not Specified|0|||
155270782|NCT02291289|560425744|FG005|Induction Treatment|Reason Not Specified|0|||
155270783|NCT02291289|560425745|FG006|Induction Treatment|Reason Not Specified|0|||
155270784|NCT02291289|560425746|FG007|Induction Treatment|Reason Not Specified|0|||
155270785|NCT02291289|560425747|FG008|Induction Treatment|Reason Not Specified|0|||
155270786|NCT02291289|560425748|FG009|Induction Treatment|Reason Not Specified|7|||
155270787|NCT02291289|560425749|FG010|Induction Treatment|Reason Not Specified|0|||
155270788|NCT02291289|560425750|FG011|Induction Treatment|Reason Not Specified|0|||
155381771|NCT00729378|560833192|FG000|12-months|Lost to Follow-up|100|||
155381772|NCT00729378|560833193|FG001|12-months|Lost to Follow-up|65|||
155381773|NCT00729378|560833192|FG000|24-months|Lost to Follow-up|72|||
155270789|NCT02291289|560425751|FG012|Induction Treatment|Reason Not Specified|0|||
155270790|NCT02291289|560425739|FG000|Induction Treatment|Physician Decision|0|||
155381774|NCT00729378|560833193|FG001|24-months|Lost to Follow-up|51|||
155270791|NCT02291289|560425740|FG001|Induction Treatment|Physician Decision|0|||
155270792|NCT02291289|560425741|FG002|Induction Treatment|Physician Decision|0|||
155270793|NCT02291289|560425742|FG003|Induction Treatment|Physician Decision|3|||
155614875|NCT05052697|561683072|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614876|NCT05052697|561683073|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614877|NCT05052697|561683074|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614878|NCT05052697|561683075|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614879|NCT05052697|561683076|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614880|NCT05052697|561683077|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614881|NCT05052697|561683078|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155614882|NCT05052697|561683045|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614883|NCT05052697|561683046|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614884|NCT05052697|561683047|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614885|NCT05052697|561683048|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614886|NCT05052697|561683049|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614887|NCT05052697|561683050|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614888|NCT05052697|561683051|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614889|NCT05052697|561683052|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614890|NCT05052697|561683053|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614891|NCT05052697|561683054|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614892|NCT05052697|561683055|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614893|NCT05052697|561683056|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614894|NCT05052697|561683057|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614895|NCT05052697|561683058|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614896|NCT05052697|561683059|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614897|NCT05052697|561683060|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614898|NCT05052697|561683061|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614899|NCT05052697|561683062|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155614900|NCT05052697|561683063|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614901|NCT05052697|561683064|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614902|NCT05052697|561683065|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614903|NCT05052697|561683066|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614904|NCT05052697|561683067|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614905|NCT05052697|561683068|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614906|NCT05052697|561683069|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614907|NCT05052697|561683070|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155614908|NCT05052697|561683071|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614909|NCT05052697|561683072|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155614910|NCT05052697|561683073|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614911|NCT05052697|561683074|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614912|NCT05052697|561683075|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614913|NCT05052697|561683076|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614914|NCT05052697|561683077|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614915|NCT05052697|561683078|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155614916|NCT05052697|561683045|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614917|NCT05052697|561683046|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614918|NCT05052697|561683047|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614919|NCT05052697|561683048|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614920|NCT05052697|561683049|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614921|NCT05052697|561683050|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614922|NCT05052697|561683051|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614923|NCT05052697|561683052|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614924|NCT05052697|561683053|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614925|NCT05052697|561683054|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614926|NCT05052697|561683055|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614927|NCT05052697|561683056|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614928|NCT05052697|561683057|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614929|NCT05052697|561683058|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614930|NCT05052697|561683059|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614931|NCT05052697|561683060|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614932|NCT05052697|561683061|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614933|NCT05052697|561683062|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614934|NCT05052697|561683063|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614935|NCT05052697|561683064|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614936|NCT05052697|561683065|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614937|NCT05052697|561683066|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614938|NCT05052697|561683067|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155726469|NCT01716234|562098142|FG002|Overall Study|Lack of Efficacy|0|||
155726470|NCT01716234|562098143|FG003|Overall Study|Lack of Efficacy|1|||
155726471|NCT01716234|562098144|FG004|Overall Study|Lack of Efficacy|0|||
155381775|NCT00729378|560833192|FG000|36-months|Lost to Follow-up|15|||
155614939|NCT05052697|561683068|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614940|NCT05052697|561683069|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614941|NCT05052697|561683070|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614942|NCT05052697|561683071|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614943|NCT05052697|561683072|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614944|NCT05052697|561683073|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
155614945|NCT05052697|561683074|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614946|NCT05052697|561683075|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155614947|NCT05052697|561683076|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155614948|NCT05052697|561683077|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155614949|NCT05052697|561683078|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155614950|NCT05052697|561683045|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614951|NCT05052697|561683046|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614952|NCT05052697|561683047|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614953|NCT05052697|561683048|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614954|NCT05052697|561683049|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614955|NCT05052697|561683050|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614956|NCT05052697|561683051|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614957|NCT05052697|561683052|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614958|NCT05052697|561683053|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614959|NCT05052697|561683054|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614960|NCT05052697|561683055|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614961|NCT05052697|561683056|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614962|NCT05052697|561683057|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614963|NCT05052697|561683058|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614964|NCT05052697|561683059|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614965|NCT05052697|561683060|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614966|NCT05052697|561683061|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614967|NCT05052697|561683062|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614968|NCT05052697|561683063|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614969|NCT05052697|561683064|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614970|NCT05052697|561683065|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614971|NCT05052697|561683066|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614972|NCT05052697|561683067|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614973|NCT05052697|561683068|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614974|NCT05052697|561683069|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614975|NCT05052697|561683070|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614976|NCT05052697|561683071|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614977|NCT05052697|561683072|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614978|NCT05052697|561683073|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
155614979|NCT05052697|561683074|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
155614980|NCT05052697|561683075|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
155614981|NCT05052697|561683076|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
155614982|NCT05052697|561683077|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
155614983|NCT05052697|561683078|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155614984|NCT05052697|561683045|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614985|NCT05052697|561683046|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614986|NCT05052697|561683047|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614987|NCT05052697|561683048|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614988|NCT05052697|561683049|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614989|NCT05052697|561683050|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614990|NCT05052697|561683051|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614991|NCT05052697|561683052|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614992|NCT05052697|561683053|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614993|NCT05052697|561683054|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614994|NCT05052697|561683055|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614995|NCT05052697|561683056|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614996|NCT05052697|561683057|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614997|NCT05052697|561683058|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614998|NCT05052697|561683059|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155614999|NCT05052697|561683060|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615000|NCT05052697|561683061|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615001|NCT05052697|561683062|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615002|NCT05052697|561683063|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615003|NCT05052697|561683064|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615004|NCT05052697|561683065|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615005|NCT05052697|561683066|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155726472|NCT01716234|562098145|FG005|Overall Study|Lack of Efficacy|0|||
155381776|NCT00729378|560833193|FG001|36-months|Lost to Follow-up|6|||
155615006|NCT05052697|561683067|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615007|NCT05052697|561683068|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615008|NCT05052697|561683069|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615009|NCT05052697|561683070|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615010|NCT05052697|561683071|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615011|NCT05052697|561683072|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615012|NCT05052697|561683073|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615013|NCT05052697|561683074|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615014|NCT05052697|561683075|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615015|NCT05052697|561683076|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615016|NCT05052697|561683077|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
155615017|NCT05052697|561683078|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155615018|NCT05052697|561683045|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615019|NCT05052697|561683046|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615020|NCT05052697|561683047|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615021|NCT05052697|561683048|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615022|NCT05052697|561683049|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615023|NCT05052697|561683050|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615024|NCT05052697|561683051|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615025|NCT05052697|561683052|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615026|NCT05052697|561683053|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615027|NCT05052697|561683054|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615028|NCT05052697|561683055|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615029|NCT05052697|561683056|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615030|NCT05052697|561683057|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615031|NCT05052697|561683058|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615032|NCT05052697|561683059|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615033|NCT05052697|561683060|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615034|NCT05052697|561683061|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615035|NCT05052697|561683062|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615036|NCT05052697|561683063|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615037|NCT05052697|561683064|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615038|NCT05052697|561683065|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615039|NCT05052697|561683066|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615040|NCT05052697|561683067|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615041|NCT05052697|561683068|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615042|NCT05052697|561683069|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615043|NCT05052697|561683070|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615044|NCT05052697|561683071|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615045|NCT05052697|561683072|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615046|NCT05052697|561683073|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
155615047|NCT05052697|561683074|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
155615048|NCT05052697|561683075|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
155615049|NCT05052697|561683076|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615050|NCT05052697|561683077|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615051|NCT05052697|561683078|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155615052|NCT03275389|561683079|FG000|Overall Study|Lost to Follow-up|10|||
155615053|NCT03275389|561683080|FG001|Overall Study|Lost to Follow-up|10|||
155615054|NCT03275389|561683081|FG002|Overall Study|Lost to Follow-up|19|||
155615055|NCT03275389|561683082|FG003|Overall Study|Lost to Follow-up|12|||
155615056|NCT03275389|561683083|FG004|Overall Study|Lost to Follow-up|11|||
155615057|NCT03275389|561683084|FG005|Overall Study|Lost to Follow-up|12|||
155615058|NCT03275389|561683085|FG006|Overall Study|Lost to Follow-up|21|||
155615059|NCT03275389|561683086|FG007|Overall Study|Lost to Follow-up|15|||
155615060|NCT03275389|561683087|FG008|Overall Study|Lost to Follow-up|12|||
155615061|NCT03275389|561683088|FG009|Overall Study|Lost to Follow-up|14|||
155615062|NCT03275389|561683079|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615063|NCT03275389|561683080|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615064|NCT03275389|561683081|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615065|NCT03275389|561683082|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615066|NCT03275389|561683083|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615067|NCT03275389|561683084|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
155270794|NCT02291289|560425743|FG004|Induction Treatment|Physician Decision|0|||
155615068|NCT03275389|561683085|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615069|NCT03275389|561683086|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615070|NCT03275389|561683087|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155615071|NCT03275389|561683088|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
155726473|NCT01716234|562098146|FG006|Overall Study|Lack of Efficacy|0|||
155270795|NCT02291289|560425744|FG005|Induction Treatment|Physician Decision|0|||
155270796|NCT02291289|560425745|FG006|Induction Treatment|Physician Decision|0|||
155270797|NCT02291289|560425746|FG007|Induction Treatment|Physician Decision|0|||
155615072|NCT03275389|561683079|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155615073|NCT03275389|561683080|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155615074|NCT03275389|561683081|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155615075|NCT03275389|561683082|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
155615076|NCT03275389|561683083|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155615077|NCT03275389|561683084|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155615078|NCT03275389|561683085|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155615079|NCT03275389|561683086|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155615080|NCT03275389|561683087|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155615081|NCT03275389|561683088|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155615082|NCT03275389|561683079|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615083|NCT03275389|561683080|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155615084|NCT03275389|561683081|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615085|NCT03275389|561683082|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155615086|NCT03275389|561683083|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615087|NCT03275389|561683084|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615088|NCT03275389|561683085|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155615089|NCT03275389|561683086|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615090|NCT03275389|561683087|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615091|NCT03275389|561683088|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155615092|NCT03275389|561683079|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615093|NCT03275389|561683080|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615094|NCT03275389|561683081|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155615095|NCT03275389|561683082|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615096|NCT03275389|561683083|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615097|NCT03275389|561683084|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615098|NCT03275389|561683085|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615099|NCT03275389|561683086|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615100|NCT03275389|561683087|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155615101|NCT03275389|561683088|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155615102|NCT03275389|561683079|FG000|Overall Study|Other|0|||
155615103|NCT03275389|561683080|FG001|Overall Study|Other|4|||
155615104|NCT03275389|561683081|FG002|Overall Study|Other|3|||
155615105|NCT03275389|561683082|FG003|Overall Study|Other|2|||
155615106|NCT03275389|561683083|FG004|Overall Study|Other|2|||
155615107|NCT03275389|561683084|FG005|Overall Study|Other|2|||
155615108|NCT03275389|561683085|FG006|Overall Study|Other|0|||
155615109|NCT03275389|561683086|FG007|Overall Study|Other|0|||
155615110|NCT03275389|561683087|FG008|Overall Study|Other|1|||
155615111|NCT03275389|561683088|FG009|Overall Study|Other|0|||
155615112|NCT02427802|561683089|FG000|Overall Study|Adverse Event|11|||
155615113|NCT02427802|561683090|FG001|Overall Study|Adverse Event|3|||
155615114|NCT02427802|561683091|FG002|Overall Study|Adverse Event|7|||
155615115|NCT02427802|561683089|FG000|Overall Study|Death|0|||
155615116|NCT02427802|561683090|FG001|Overall Study|Death|4|||
155615117|NCT02427802|561683091|FG002|Overall Study|Death|1|||
155615118|NCT02427802|561683089|FG000|Overall Study|Lost to Follow-up|13|||
155615119|NCT02427802|561683090|FG001|Overall Study|Lost to Follow-up|8|||
155615120|NCT02427802|561683091|FG002|Overall Study|Lost to Follow-up|8|||
155270798|NCT02291289|560425747|FG008|Induction Treatment|Physician Decision|0|||
155270799|NCT02291289|560425748|FG009|Induction Treatment|Physician Decision|1|||
155270800|NCT02291289|560425749|FG010|Induction Treatment|Physician Decision|0|||
155270801|NCT02291289|560425750|FG011|Induction Treatment|Physician Decision|0|||
155270802|NCT02291289|560425751|FG012|Induction Treatment|Physician Decision|0|||
155270803|NCT02291289|560425739|FG000|Induction Treatment|Protocol Violation|0|||
155270804|NCT02291289|560425740|FG001|Induction Treatment|Protocol Violation|0|||
155270805|NCT02291289|560425741|FG002|Induction Treatment|Protocol Violation|0|||
155615121|NCT02427802|561683089|FG000|Overall Study|Physician Decision|4|||
155615122|NCT02427802|561683090|FG001|Overall Study|Physician Decision|2|||
155615123|NCT02427802|561683091|FG002|Overall Study|Physician Decision|4|||
155615124|NCT02427802|561683089|FG000|Overall Study|Withdrawal by Subject|10|||
155615125|NCT02427802|561683090|FG001|Overall Study|Withdrawal by Subject|5|||
155615126|NCT02427802|561683091|FG002|Overall Study|Withdrawal by Subject|11|||
155615127|NCT02427802|561683089|FG000|Overall Study|Protocol Violation|3|||
155615128|NCT02427802|561683090|FG001|Overall Study|Protocol Violation|1|||
155615129|NCT02427802|561683091|FG002|Overall Study|Protocol Violation|1|||
155615130|NCT02427802|561683089|FG000|Overall Study|protocol specific treatment unrelated|18|||
155615131|NCT02427802|561683090|FG001|Overall Study|protocol specific treatment unrelated|11|||
155615132|NCT02427802|561683091|FG002|Overall Study|protocol specific treatment unrelated|11|||
155615133|NCT02634983|561683092|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
155615134|NCT02634983|561683093|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
155270806|NCT02291289|560425742|FG003|Induction Treatment|Protocol Violation|3|||
155615135|NCT00467558|561683094|FG000|Overall Study|Lost to Follow-up|2|||
155615136|NCT00467558|561683095|FG001|Overall Study|Lost to Follow-up|0|||
155615137|NCT05188729|561683097|FG000|Overall Study|Withdrawal by Subject|0|||
155615138|NCT05188729|561683098|FG001|Overall Study|Withdrawal by Subject|0|||
155615139|NCT05188729|561683099|FG002|Overall Study|Withdrawal by Subject|0|||
155615140|NCT05188729|561683100|FG003|Overall Study|Withdrawal by Subject|0|||
155615141|NCT05188729|561683101|FG004|Overall Study|Withdrawal by Subject|0|||
155615142|NCT05188729|561683102|FG005|Overall Study|Withdrawal by Subject|0|||
155615143|NCT05188729|561683103|FG006|Overall Study|Withdrawal by Subject|0|||
155615144|NCT05188729|561683104|FG007|Overall Study|Withdrawal by Subject|0|||
155615145|NCT05188729|561683105|FG008|Overall Study|Withdrawal by Subject|0|||
155615146|NCT05188729|561683106|FG009|Overall Study|Withdrawal by Subject|1|||
155615147|NCT05188729|561683107|FG010|Overall Study|Withdrawal by Subject|0|||
155615148|NCT05188729|561683108|FG011|Overall Study|Withdrawal by Subject|0|||
155615149|NCT05188729|561683109|FG012|Overall Study|Withdrawal by Subject|0|||
155615150|NCT05188729|561683097|FG000|Overall Study|Lost to Follow-up|0|||
155615151|NCT05188729|561683098|FG001|Overall Study|Lost to Follow-up|0|||
155615152|NCT05188729|561683099|FG002|Overall Study|Lost to Follow-up|0|||
155615153|NCT05188729|561683100|FG003|Overall Study|Lost to Follow-up|0|||
155615154|NCT05188729|561683101|FG004|Overall Study|Lost to Follow-up|0|||
155615155|NCT05188729|561683102|FG005|Overall Study|Lost to Follow-up|0|||
155615156|NCT05188729|561683103|FG006|Overall Study|Lost to Follow-up|0|||
155615157|NCT05188729|561683104|FG007|Overall Study|Lost to Follow-up|0|||
155615158|NCT05188729|561683105|FG008|Overall Study|Lost to Follow-up|0|||
155615159|NCT05188729|561683106|FG009|Overall Study|Lost to Follow-up|0|||
155615160|NCT05188729|561683107|FG010|Overall Study|Lost to Follow-up|1|||
155615161|NCT05188729|561683108|FG011|Overall Study|Lost to Follow-up|1|||
155615162|NCT05188729|561683109|FG012|Overall Study|Lost to Follow-up|0|||
155615163|NCT02171429|561684841|FG000|Overall Study|Other|0|||
155615164|NCT02171429|561684842|FG001|Overall Study|Other|1|||
155615165|NCT02171429|561684843|FG002|Overall Study|Other|1|||
155615166|NCT02171429|561684841|FG000|Overall Study|Non-Compliance|0|||
155615167|NCT02171429|561684842|FG001|Overall Study|Non-Compliance|0|||
155615168|NCT02171429|561684843|FG002|Overall Study|Non-Compliance|1|||
155615169|NCT02171429|561684841|FG000|Overall Study|Physician Decision|0|||
155615170|NCT02171429|561684842|FG001|Overall Study|Physician Decision|0|||
155615171|NCT02171429|561684843|FG002|Overall Study|Physician Decision|1|||
155615172|NCT02171429|561684841|FG000|Overall Study|Withdrawal by Subject|1|||
155615173|NCT02171429|561684842|FG001|Overall Study|Withdrawal by Subject|1|||
155615174|NCT02171429|561684843|FG002|Overall Study|Withdrawal by Subject|1|||
155615175|NCT02171429|561684841|FG000|Overall Study|Lost to Follow-up|0|||
155615176|NCT02171429|561684842|FG001|Overall Study|Lost to Follow-up|1|||
155615177|NCT02171429|561684843|FG002|Overall Study|Lost to Follow-up|0|||
155615178|NCT02171429|561684841|FG000|Overall Study|Death|0|||
155615179|NCT02171429|561684842|FG001|Overall Study|Death|0|||
155615180|NCT02171429|561684843|FG002|Overall Study|Death|1|||
155615181|NCT01724177|561684848|FG000|Overall Study|Adverse Event|8|||
155615182|NCT01724177|561684848|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
155615183|NCT01724177|561684848|FG000|Overall Study|Nervous participant|1|||
155615184|NCT01724177|561684848|FG000|Overall Study|Serious Adverse Event Related|1|||
155615185|NCT00305227|561684851|FG000|Overall Study|Lost to Follow-up|7|||
155615186|NCT00305227|561684852|FG001|Overall Study|Lost to Follow-up|6|||
155615187|NCT00632125|561684853|FG000|Overall Study|Death|82|||
155615188|NCT00632125|561684853|FG000|Overall Study|Withdrawal by Subject|44|||
155615189|NCT00632125|561684853|FG000|Overall Study|Adverse Event|36|||
155615190|NCT00632125|561684853|FG000|Overall Study|Renal transplantation|17|||
155615191|NCT00632125|561684853|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
155615192|NCT00632125|561684853|FG000|Overall Study|Non-compliance|8|||
155615193|NCT00632125|561684853|FG000|Overall Study|Development of uncontrolled hypertension|5|||
155615194|NCT00632125|561684853|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
155615195|NCT05133323|561684854|FG000|Overall Study|Lack of Efficacy|0|||
155615196|NCT05133323|561684855|FG001|Overall Study|Lack of Efficacy|0|||
155615197|NCT05133323|561684856|FG002|Overall Study|Lack of Efficacy|1|||
155615198|NCT05133323|561684854|FG000|Overall Study|Withdrawal by Subject|2|||
155615199|NCT05133323|561684855|FG001|Overall Study|Withdrawal by Subject|1|||
155615200|NCT05133323|561684856|FG002|Overall Study|Withdrawal by Subject|0|||
155615201|NCT00577772|561684865|FG000|Overall Study|Lost to Follow-up|0|||
155615202|NCT00577772|561684866|FG001|Overall Study|Lost to Follow-up|1|||
155615203|NCT00572455|561684867|FG000|Stage I (14 Days)|Adverse Event|0|||
155615204|NCT00572455|561684868|FG001|Stage I (14 Days)|Adverse Event|0|||
155615205|NCT00572455|561684869|FG002|Stage I (14 Days)|Adverse Event|0|||
155615206|NCT00572455|561684870|FG003|Stage I (14 Days)|Adverse Event|0|||
155615207|NCT00572455|561684871|FG004|Stage I (14 Days)|Adverse Event|0|||
155615208|NCT00572455|561684872|FG005|Stage I (14 Days)|Adverse Event|3|||
155615209|NCT00572455|561684873|FG006|Stage I (14 Days)|Adverse Event|0|||
155615210|NCT00572455|561684874|FG007|Stage I (14 Days)|Adverse Event|0|||
155615211|NCT00572455|561684875|FG008|Stage I (14 Days)|Adverse Event|0|||
155615212|NCT00572455|561684876|FG009|Stage I (14 Days)|Adverse Event|0|||
155615213|NCT00572455|561684877|FG010|Stage I (14 Days)|Adverse Event|0|||
155615214|NCT00572455|561684878|FG011|Stage I (14 Days)|Adverse Event|0|||
155270807|NCT02291289|560425743|FG004|Induction Treatment|Protocol Violation|0|||
155270808|NCT02291289|560425744|FG005|Induction Treatment|Protocol Violation|0|||
155270809|NCT02291289|560425745|FG006|Induction Treatment|Protocol Violation|0|||
155270810|NCT02291289|560425746|FG007|Induction Treatment|Protocol Violation|0|||
155270811|NCT02291289|560425747|FG008|Induction Treatment|Protocol Violation|0|||
155270812|NCT02291289|560425748|FG009|Induction Treatment|Protocol Violation|2|||
155270813|NCT02291289|560425749|FG010|Induction Treatment|Protocol Violation|0|||
155270814|NCT02291289|560425750|FG011|Induction Treatment|Protocol Violation|0|||
155270815|NCT02291289|560425751|FG012|Induction Treatment|Protocol Violation|0|||
155270816|NCT02291289|560425739|FG000|Induction Treatment|Missing|4|||
155270817|NCT02291289|560425740|FG001|Induction Treatment|Missing|0|||
155270818|NCT02291289|560425741|FG002|Induction Treatment|Missing|0|||
155270819|NCT02291289|560425742|FG003|Induction Treatment|Missing|14|||
155270820|NCT02291289|560425743|FG004|Induction Treatment|Missing|0|||
155270821|NCT02291289|560425744|FG005|Induction Treatment|Missing|0|||
155270822|NCT02291289|560425745|FG006|Induction Treatment|Missing|0|||
155270823|NCT02291289|560425746|FG007|Induction Treatment|Missing|0|||
155270824|NCT02291289|560425747|FG008|Induction Treatment|Missing|0|||
155270825|NCT02291289|560425748|FG009|Induction Treatment|Missing|54|||
155270826|NCT02291289|560425749|FG010|Induction Treatment|Missing|0|||
155270827|NCT02291289|560425750|FG011|Induction Treatment|Missing|0|||
155270828|NCT02291289|560425751|FG012|Induction Treatment|Missing|0|||
155270829|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270830|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270831|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270832|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270833|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
155270834|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
155270835|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270836|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270837|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270838|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270839|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
155270840|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
155270841|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270842|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Death|0|||
155270843|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Death|29|||
155270844|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Death|16|||
155270845|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Death|0|||
155270846|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Death|188|||
155270847|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Death|107|||
155270848|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Death|0|||
155270849|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Death|1|||
155270850|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Death|1|||
155270851|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Death|0|||
155270852|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Death|46|||
155270853|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Death|19|||
155270854|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Death|0|||
155270855|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155270856|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Adverse Event|0|||
155270857|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Adverse Event|0|||
155270858|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Adverse Event|0|||
155270859|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Adverse Event|1|||
155270860|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Adverse Event|1|||
155270861|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Adverse Event|0|||
155270862|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Adverse Event|0|||
155270863|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Adverse Event|0|||
155381777|NCT00690443|560833194|FG000|Overall Study|Adverse Event|1|||
155615215|NCT00572455|561684879|FG012|Stage I (14 Days)|Adverse Event|0|||
155615216|NCT00572455|561684880|FG013|Stage I (14 Days)|Adverse Event|0|||
155615217|NCT00572455|561684867|FG000|Stage I (14 Days)|Other|0|||
155615218|NCT00572455|561684868|FG001|Stage I (14 Days)|Other|0|||
155615219|NCT00572455|561684869|FG002|Stage I (14 Days)|Other|0|||
155615220|NCT00572455|561684870|FG003|Stage I (14 Days)|Other|0|||
155270864|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Adverse Event|0|||
155270865|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Adverse Event|0|||
155270866|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Adverse Event|0|||
155270867|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Adverse Event|0|||
155270868|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270869|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
155615221|NCT00572455|561684871|FG004|Stage I (14 Days)|Other|1|||
155270870|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270871|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270872|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
155270873|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
155381778|NCT00690443|560833195|FG001|Overall Study|Adverse Event|2|||
155615222|NCT00572455|561684872|FG005|Stage I (14 Days)|Other|0|||
155270874|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270875|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
155270876|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270877|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270878|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
155270879|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
155270880|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270881|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
155270882|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
155270883|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
155270884|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
155270885|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
155270886|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
155270887|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
155270888|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
155270889|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
155270890|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
155270891|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
155270892|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
155270893|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
155270894|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Physician Decision|0|||
155270895|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Physician Decision|2|||
155270896|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Physician Decision|0|||
155270897|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Physician Decision|0|||
155270898|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Physician Decision|3|||
155270899|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Physician Decision|0|||
155270900|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Physician Decision|0|||
155270901|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Physician Decision|0|||
155270902|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Physician Decision|0|||
155270903|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Physician Decision|0|||
155270904|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Physician Decision|1|||
155270905|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Physician Decision|3|||
155270906|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Physician Decision|0|||
155270907|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Not Treated|0|||
155270908|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Not Treated|0|||
155270909|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Not Treated|2|||
155270910|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Not Treated|0|||
155270911|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Not Treated|0|||
155270912|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Not Treated|0|||
155270913|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Not Treated|0|||
155270914|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Not Treated|0|||
155270915|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Not Treated|0|||
155270916|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Not Treated|0|||
155270917|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Not Treated|0|||
155270918|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Not Treated|0|||
155270919|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Not Treated|0|||
155270920|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270921|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
155270922|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270923|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270924|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270925|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270926|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270927|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270928|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270929|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270930|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270931|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270932|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270933|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
155270934|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
155270935|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
155270936|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
155270937|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
155270938|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
155270939|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
155270940|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
155270941|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
155270942|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
155270943|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
155270944|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
155270945|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
155270946|NCT02291289|560425739|FG000|Early Disease Progression|Death|0|||
155270947|NCT02291289|560425740|FG001|Early Disease Progression|Death|0|||
155270948|NCT02291289|560425741|FG002|Early Disease Progression|Death|0|||
155270949|NCT02291289|560425742|FG003|Early Disease Progression|Death|0|||
155270950|NCT02291289|560425743|FG004|Early Disease Progression|Death|0|||
155270951|NCT02291289|560425744|FG005|Early Disease Progression|Death|0|||
155270952|NCT02291289|560425745|FG006|Early Disease Progression|Death|0|||
155270953|NCT02291289|560425746|FG007|Early Disease Progression|Death|0|||
155270954|NCT02291289|560425747|FG008|Early Disease Progression|Death|0|||
155270955|NCT02291289|560425748|FG009|Early Disease Progression|Death|0|||
155270956|NCT02291289|560425749|FG010|Early Disease Progression|Death|0|||
155270957|NCT02291289|560425750|FG011|Early Disease Progression|Death|0|||
155270958|NCT02291289|560425751|FG012|Early Disease Progression|Death|10|||
155270959|NCT02291289|560425739|FG000|Early Disease Progression|Lost to Follow-up|0|||
155270960|NCT02291289|560425740|FG001|Early Disease Progression|Lost to Follow-up|0|||
155270961|NCT02291289|560425741|FG002|Early Disease Progression|Lost to Follow-up|0|||
155270962|NCT02291289|560425742|FG003|Early Disease Progression|Lost to Follow-up|0|||
155270963|NCT02291289|560425743|FG004|Early Disease Progression|Lost to Follow-up|0|||
155270964|NCT02291289|560425744|FG005|Early Disease Progression|Lost to Follow-up|0|||
155270965|NCT02291289|560425745|FG006|Early Disease Progression|Lost to Follow-up|0|||
155270966|NCT02291289|560425746|FG007|Early Disease Progression|Lost to Follow-up|0|||
155270967|NCT02291289|560425747|FG008|Early Disease Progression|Lost to Follow-up|0|||
155270968|NCT02291289|560425748|FG009|Early Disease Progression|Lost to Follow-up|0|||
155270969|NCT02291289|560425749|FG010|Early Disease Progression|Lost to Follow-up|0|||
155270970|NCT02291289|560425750|FG011|Early Disease Progression|Lost to Follow-up|0|||
155270971|NCT02291289|560425751|FG012|Early Disease Progression|Lost to Follow-up|1|||
155270972|NCT01868035|560425755|FG000|Overall Study|Lost to Follow-up|3|||
155270973|NCT01868035|560425755|FG000|Overall Study|Withdrawal by Subject|1|||
155270974|NCT01868035|560425755|FG000|Overall Study|Progressive Disease|2|||
155270975|NCT01868035|560425755|FG000|Overall Study|Non-compliance|1|||
155270976|NCT00154063|560425762|FG000|Overall Study|Adverse Event|4|||
155270977|NCT00154063|560425763|FG001|Overall Study|Adverse Event|8|||
155270978|NCT00154063|560425762|FG000|Overall Study|Protocol Violation|1|||
155270979|NCT00154063|560425763|FG001|Overall Study|Protocol Violation|1|||
155270980|NCT00154063|560425762|FG000|Overall Study|Investigator or Sponsor Request|0|||
155270981|NCT00154063|560425763|FG001|Overall Study|Investigator or Sponsor Request|1|||
155270982|NCT00154063|560425762|FG000|Overall Study|Withdrawal by Subject|4|||
155270983|NCT00154063|560425763|FG001|Overall Study|Withdrawal by Subject|9|||
155270984|NCT00154063|560425762|FG000|Overall Study|Other|3|||
155270985|NCT00154063|560425763|FG001|Overall Study|Other|3|||
155270986|NCT01912781|560425767|FG000|Overall Study|Withdrawal by Subject|2|||
155270987|NCT01912781|560425768|FG001|Overall Study|Withdrawal by Subject|0|||
155270988|NCT03377790|560425769|FG000|Overall Study|Withdrawal by Subject|1|||
155270989|NCT03377790|560425770|FG001|Overall Study|Withdrawal by Subject|0|||
155270990|NCT03377790|560425769|FG000|Overall Study|Adverse Event|1|||
155270991|NCT03377790|560425770|FG001|Overall Study|Adverse Event|0|||
155270992|NCT03377790|560425769|FG000|Overall Study|Lost to Follow-up|0|||
155270993|NCT03377790|560425770|FG001|Overall Study|Lost to Follow-up|2|||
155270994|NCT03377790|560425769|FG000|Overall Study|Randomized but not treated|1|||
155270995|NCT03377790|560425770|FG001|Overall Study|Randomized but not treated|0|||
155270996|NCT03377790|560425769|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
155270997|NCT03377790|560425770|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
155270998|NCT00919893|560425771|FG000|Overall Study|Protocol Violation|19|||
155270999|NCT00919893|560425772|FG001|Overall Study|Protocol Violation|9|||
155271000|NCT00708305|560425777|FG000|Period 1|Protocol Violation|1|||
155615223|NCT00572455|561684873|FG006|Stage I (14 Days)|Other|0|||
155615224|NCT00572455|561684874|FG007|Stage I (14 Days)|Other|0|||
155615225|NCT00572455|561684875|FG008|Stage I (14 Days)|Other|0|||
155615226|NCT00572455|561684876|FG009|Stage I (14 Days)|Other|0|||
155615227|NCT00572455|561684877|FG010|Stage I (14 Days)|Other|0|||
155615228|NCT00572455|561684878|FG011|Stage I (14 Days)|Other|0|||
155271001|NCT00708305|560425778|FG001|Period 1|Protocol Violation|0|||
155271002|NCT00708305|560425779|FG002|Period 1|Protocol Violation|1|||
155271003|NCT00708305|560425780|FG003|Period 1|Protocol Violation|0|||
155271004|NCT00708305|560425777|FG000|Period 1|Other Reason|0|||
155271005|NCT00708305|560425778|FG001|Period 1|Other Reason|0|||
155271006|NCT00708305|560425779|FG002|Period 1|Other Reason|0|||
155271007|NCT00708305|560425780|FG003|Period 1|Other Reason|2|||
155271008|NCT00708305|560425777|FG000|Period 2|Lost to Follow-up|0|||
155271009|NCT00708305|560425778|FG001|Period 2|Lost to Follow-up|1|||
155271010|NCT00708305|560425779|FG002|Period 2|Lost to Follow-up|0|||
155271011|NCT00708305|560425780|FG003|Period 2|Lost to Follow-up|0|||
155271012|NCT00708305|560425777|FG000|Period 2|Protocol Violation|0|||
155271013|NCT00708305|560425778|FG001|Period 2|Protocol Violation|1|||
155271014|NCT00708305|560425779|FG002|Period 2|Protocol Violation|0|||
155271015|NCT00708305|560425780|FG003|Period 2|Protocol Violation|0|||
155271016|NCT00708305|560425777|FG000|Period 2|Other Reason|1|||
155271017|NCT00708305|560425778|FG001|Period 2|Other Reason|0|||
155271018|NCT00708305|560425779|FG002|Period 2|Other Reason|0|||
155271019|NCT00708305|560425780|FG003|Period 2|Other Reason|1|||
155271020|NCT00708305|560425777|FG000|Period 3|Protocol Violation|0|||
155271021|NCT00708305|560425778|FG001|Period 3|Protocol Violation|2|||
155271022|NCT00708305|560425779|FG002|Period 3|Protocol Violation|0|||
155271023|NCT00708305|560425780|FG003|Period 3|Protocol Violation|0|||
155271024|NCT00708305|560425777|FG000|Period 3|Other Reason|1|||
155271025|NCT00708305|560425778|FG001|Period 3|Other Reason|0|||
155271026|NCT00708305|560425779|FG002|Period 3|Other Reason|0|||
155271027|NCT00708305|560425780|FG003|Period 3|Other Reason|0|||
155271028|NCT03283696|560425785|FG000|Overall Study|Physician Decision|5|||
155271029|NCT03283696|560425786|FG001|Overall Study|Physician Decision|6|||
155271030|NCT03283696|560425785|FG000|Overall Study|Withdrawal by Subject|2|||
155271031|NCT03283696|560425786|FG001|Overall Study|Withdrawal by Subject|0|||
155271032|NCT02572817|560425792|FG000|Overall Study|Death|6|||
155271033|NCT02572817|560425793|FG001|Overall Study|Death|3|||
155271034|NCT02572817|560425792|FG000|Overall Study|Lost to Follow-up|3|||
155271035|NCT02572817|560425793|FG001|Overall Study|Lost to Follow-up|3|||
155271036|NCT02310126|560425799|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
155271037|NCT02310126|560425800|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
155271038|NCT02310126|560425799|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
155271039|NCT02310126|560425800|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
155271040|NCT02111213|560425803|FG000|Overall Study|Withdrawal by Subject|3|||
155271041|NCT02111213|560425804|FG001|Overall Study|Withdrawal by Subject|2|||
155271042|NCT02111213|560425803|FG000|Overall Study|Lost to Follow-up|3|||
155271043|NCT02111213|560425804|FG001|Overall Study|Lost to Follow-up|4|||
155271044|NCT00439179|560425807|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271045|NCT00439179|560425808|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
155271046|NCT00439179|560425809|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271047|NCT00439179|560425810|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271048|NCT02761629|560425811|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
155271049|NCT02761629|560425812|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
155271050|NCT02761629|560425811|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155271051|NCT02761629|560425812|FG001|Overall Study|Insufficient Therapeutic Response|7|||
155271052|NCT02761629|560425811|FG000|Overall Study|Failure to Return|2|||
155271053|NCT02761629|560425812|FG001|Overall Study|Failure to Return|4|||
155271054|NCT02761629|560425811|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
155271055|NCT02761629|560425812|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
155271056|NCT02761629|560425811|FG000|Overall Study|Protocol Violation|2|||
155271057|NCT02761629|560425812|FG001|Overall Study|Protocol Violation|2|||
155271058|NCT02761629|560425811|FG000|Overall Study|Withdrawal by Subject|0|||
155271059|NCT02761629|560425812|FG001|Overall Study|Withdrawal by Subject|3|||
155271060|NCT02761629|560425811|FG000|Overall Study|Other|0|||
155271061|NCT02761629|560425812|FG001|Overall Study|Other|2|||
155271062|NCT02761629|560425811|FG000|Overall Study|Lost to Follow-up|4|||
155271063|NCT02761629|560425812|FG001|Overall Study|Lost to Follow-up|1|||
155271064|NCT02761629|560425811|FG000|Overall Study|Randomized But Not Treated|8|||
155271065|NCT02761629|560425812|FG001|Overall Study|Randomized But Not Treated|4|||
155271066|NCT01844115|560425822|FG000|Overall Study|Adverse Event|4|||
155271067|NCT01844115|560425823|FG001|Overall Study|Adverse Event|22|||
155271068|NCT01844115|560425822|FG000|Overall Study|Lack of Efficacy|1|||
155271069|NCT01844115|560425823|FG001|Overall Study|Lack of Efficacy|4|||
155271070|NCT01844115|560425822|FG000|Overall Study|Protocol Violation|12|||
155271071|NCT01844115|560425823|FG001|Overall Study|Protocol Violation|10|||
155271072|NCT01844115|560425822|FG000|Overall Study|Withdrawal by Subject|11|||
155271073|NCT01844115|560425823|FG001|Overall Study|Withdrawal by Subject|11|||
155271074|NCT01844115|560425822|FG000|Overall Study|Lost to Follow-up|11|||
155271075|NCT01844115|560425823|FG001|Overall Study|Lost to Follow-up|10|||
155271076|NCT01844115|560425822|FG000|Overall Study|Pregnancy|0|||
155271077|NCT01844115|560425823|FG001|Overall Study|Pregnancy|1|||
155615229|NCT00572455|561684879|FG012|Stage I (14 Days)|Other|0|||
155271078|NCT00545363|560425824|FG000|Overall Study|Adverse Event|6|||
155271079|NCT00545363|560425825|FG001|Overall Study|Adverse Event|7|||
155271080|NCT00545363|560425824|FG000|Overall Study|Withdrawal by Subject|6|||
155271081|NCT00545363|560425825|FG001|Overall Study|Withdrawal by Subject|5|||
155271082|NCT00545363|560425824|FG000|Overall Study|Non-compliance|3|||
155271083|NCT00545363|560425825|FG001|Overall Study|Non-compliance|1|||
155271084|NCT00545363|560425824|FG000|Overall Study|Did not meet entry criteria|1|||
155271085|NCT00545363|560425825|FG001|Overall Study|Did not meet entry criteria|1|||
155271086|NCT00545363|560425824|FG000|Overall Study|Lost to Follow-up|2|||
155271087|NCT00545363|560425825|FG001|Overall Study|Lost to Follow-up|0|||
155271088|NCT00545363|560425824|FG000|Overall Study|Other|1|||
155271089|NCT00545363|560425825|FG001|Overall Study|Other|1|||
155271090|NCT01258660|560425826|FG000|Overall Study|Adverse Event|2|||
155271091|NCT01258660|560425827|FG001|Overall Study|Adverse Event|4|||
155271092|NCT01258660|560425826|FG000|Overall Study|Withdrawal by Subject|3|||
155271093|NCT01258660|560425827|FG001|Overall Study|Withdrawal by Subject|0|||
155271094|NCT01258660|560425826|FG000|Overall Study|due to relocation|2|||
155271095|NCT01258660|560425827|FG001|Overall Study|due to relocation|0|||
155271096|NCT01258660|560425826|FG000|Overall Study|Protocol Violation|0|||
155271097|NCT01258660|560425827|FG001|Overall Study|Protocol Violation|1|||
155271098|NCT01258660|560425826|FG000|Overall Study|Invalid for primary analysis data set|4|||
155271099|NCT01258660|560425827|FG001|Overall Study|Invalid for primary analysis data set|6|||
155271100|NCT00582491|560425828|FG000|Overall Study|Withdrawal by Subject|1|||
155271101|NCT00582491|560425829|FG001|Overall Study|Withdrawal by Subject|0|||
155271102|NCT04192630|560425832|FG000|Overall Study|Discontinued before surgery|2|||
155271103|NCT04192630|560425833|FG001|Overall Study|Discontinued before surgery|0|||
155271104|NCT04192630|560425832|FG000|Overall Study|Discontinued after surgery|5|||
155271105|NCT04192630|560425833|FG001|Overall Study|Discontinued after surgery|3|||
155271106|NCT01193582|560425834|FG000|Vaccination Series|Withdrawal by Subject|11|||
155271107|NCT01193582|560425835|FG001|Vaccination Series|Withdrawal by Subject|13|||
155271108|NCT01193582|560425836|FG002|Vaccination Series|Withdrawal by Subject|8|||
155271109|NCT01193582|560425837|FG003|Vaccination Series|Withdrawal by Subject|3|||
155271110|NCT01193582|560425834|FG000|12 Month Follow-up|Death|0|||
155271111|NCT01193582|560425835|FG001|12 Month Follow-up|Death|0|||
155271112|NCT01193582|560425836|FG002|12 Month Follow-up|Death|1|||
155271113|NCT01193582|560425837|FG003|12 Month Follow-up|Death|0|||
155271114|NCT01193582|560425834|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
155271115|NCT01193582|560425835|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
155271116|NCT01193582|560425836|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
155271117|NCT01193582|560425837|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
155271118|NCT01425632|560425838|FG000|Overall Study|Adverse Event|0|||
155271119|NCT01425632|560425839|FG001|Overall Study|Adverse Event|1|||
155271120|NCT01425632|560425840|FG002|Overall Study|Adverse Event|1|||
155271121|NCT01425632|560425838|FG000|Overall Study|Physician Decision|1|||
155271122|NCT01425632|560425839|FG001|Overall Study|Physician Decision|0|||
155271123|NCT01425632|560425840|FG002|Overall Study|Physician Decision|0|||
155271124|NCT01425632|560425838|FG000|Overall Study|Protocol Violation|0|||
155271125|NCT01425632|560425839|FG001|Overall Study|Protocol Violation|0|||
155271126|NCT01425632|560425840|FG002|Overall Study|Protocol Violation|2|||
155271127|NCT01425632|560425838|FG000|Overall Study|Withdrawal by Subject|0|||
155271128|NCT01425632|560425839|FG001|Overall Study|Withdrawal by Subject|0|||
155271129|NCT01425632|560425840|FG002|Overall Study|Withdrawal by Subject|1|||
155271130|NCT00406419|560425848|FG000|Overall Study|Death|3|||
155271131|NCT00406419|560425849|FG001|Overall Study|Death|1|||
155271132|NCT00406419|560425850|FG002|Overall Study|Death|4|||
155271133|NCT00406419|560425848|FG000|Overall Study|Protocol Violation|6|||
155271134|NCT00406419|560425849|FG001|Overall Study|Protocol Violation|2|||
155271135|NCT00406419|560425850|FG002|Overall Study|Protocol Violation|5|||
155271136|NCT00406419|560425848|FG000|Overall Study|Study Terminated by Sponsor|260|||
155271137|NCT00406419|560425849|FG001|Overall Study|Study Terminated by Sponsor|288|||
155271138|NCT00406419|560425850|FG002|Overall Study|Study Terminated by Sponsor|282|||
155271139|NCT00406419|560425848|FG000|Overall Study|Withdrawal by Subject|17|||
155271140|NCT00406419|560425849|FG001|Overall Study|Withdrawal by Subject|24|||
155271141|NCT00406419|560425850|FG002|Overall Study|Withdrawal by Subject|26|||
155271142|NCT00406419|560425848|FG000|Overall Study|Lack of Efficacy|12|||
155271143|NCT00406419|560425849|FG001|Overall Study|Lack of Efficacy|1|||
155271144|NCT00406419|560425850|FG002|Overall Study|Lack of Efficacy|6|||
155271145|NCT00406419|560425848|FG000|Overall Study|Non-Compliance with Study Drug|5|||
155271146|NCT00406419|560425849|FG001|Overall Study|Non-Compliance with Study Drug|6|||
155271147|NCT00406419|560425850|FG002|Overall Study|Non-Compliance with Study Drug|3|||
155271148|NCT00406419|560425848|FG000|Overall Study|Adverse Event|10|||
155271149|NCT00406419|560425849|FG001|Overall Study|Adverse Event|12|||
155271150|NCT00406419|560425850|FG002|Overall Study|Adverse Event|16|||
155271151|NCT00406419|560425848|FG000|Overall Study|Lost to Follow-up|11|||
155271152|NCT00406419|560425849|FG001|Overall Study|Lost to Follow-up|10|||
155271153|NCT00406419|560425850|FG002|Overall Study|Lost to Follow-up|5|||
155271154|NCT01775930|560425851|FG000|Overall Study|Futility stopping boundary met|1|||
155271155|NCT01208415|560425852|FG000|Overall Study|Death|1|||
155271156|NCT01208415|560425852|FG000|Overall Study|Lost to Follow-up|2|||
155271157|NCT01208415|560425852|FG000|Overall Study|Withdrawal by Subject|3|||
155615230|NCT00572455|561684880|FG013|Stage I (14 Days)|Other|0|||
155271158|NCT01208415|560425852|FG000|Overall Study|Device not placed|1|||
155271159|NCT01208415|560425852|FG000|Overall Study|Still be eligible for follow-up|33|||
155271160|NCT01115491|560425853|FG000|Overall Study|Death|22|||
155271161|NCT01115491|560425853|FG000|Overall Study|Adverse Event|3|||
155271162|NCT01115491|560425853|FG000|Overall Study|Lost to Follow-up|3|||
155271163|NCT01115491|560425853|FG000|Overall Study|Withdrawal by Subject|1|||
155271164|NCT01115491|560425853|FG000|Overall Study|Physician Decision|1|||
155271165|NCT03856996|560425854|FG000|Overall Study|Withdrawal by Subject|1|||
155271166|NCT03856996|560425855|FG001|Overall Study|Withdrawal by Subject|0|||
155271167|NCT03856996|560425854|FG000|Overall Study|Lost to Follow-up|0|||
155271168|NCT03856996|560425855|FG001|Overall Study|Lost to Follow-up|1|||
155271169|NCT03856996|560425854|FG000|Overall Study|Adverse Event|1|||
155271170|NCT03856996|560425855|FG001|Overall Study|Adverse Event|1|||
155271171|NCT03856996|560425854|FG000|Overall Study|Other|1|||
155271172|NCT03856996|560425855|FG001|Overall Study|Other|0|||
155271173|NCT02340520|560425858|FG000|Overall Study|Lost to Follow-up|1|||
155271174|NCT02340520|560425858|FG000|Overall Study|Patient did not take drug as specified|1|||
155271175|NCT02340520|560425858|FG000|Overall Study|Withdrawal by Subject|1|||
155271176|NCT01586338|560425860|FG000|Overall Study|Adverse Event|3|||
155271177|NCT01586338|560425860|FG000|Overall Study|Lost to Follow-up|1|||
155271178|NCT01586338|560425860|FG000|Overall Study|Withdrawal by participant|3|||
155271179|NCT01586338|560425860|FG000|Overall Study|Other|1|||
155271180|NCT01868074|560425861|FG000|Overall Study|Lost to Follow-up|3|||
155271181|NCT01868074|560425862|FG001|Overall Study|Lost to Follow-up|2|||
155271182|NCT01868074|560425861|FG000|Overall Study|Withdrawal by Subject|4|||
155271183|NCT01868074|560425862|FG001|Overall Study|Withdrawal by Subject|2|||
155271184|NCT00896454|560425863|FG000|Overall Study|Death|10|||
155271185|NCT00896454|560425863|FG000|Overall Study|Adverse Event|8|||
155271186|NCT00896454|560425863|FG000|Overall Study|Disease Progression|5|||
155271187|NCT00896454|560425863|FG000|Overall Study|Other|4|||
155271188|NCT00896454|560425863|FG000|Overall Study|Requirement for alternative therapy|3|||
155271189|NCT00896454|560425863|FG000|Overall Study|Ongoing in study|2|||
155271190|NCT00896454|560425863|FG000|Overall Study|Withdrawal by Subject|1|||
155271191|NCT01461993|560425864|FG000|Overall Study|Withdrawal by Subject|60|||
155271192|NCT01461993|560425865|FG001|Overall Study|Withdrawal by Subject|53|||
155271193|NCT01461993|560425866|FG002|Overall Study|Withdrawal by Subject|16|||
155271194|NCT01461993|560425864|FG000|Overall Study|Lost to Follow-up|44|||
155271195|NCT01461993|560425865|FG001|Overall Study|Lost to Follow-up|48|||
155271196|NCT01461993|560425866|FG002|Overall Study|Lost to Follow-up|22|||
155271197|NCT01461993|560425864|FG000|Overall Study|Protocol Violation|10|||
155271198|NCT01461993|560425865|FG001|Overall Study|Protocol Violation|9|||
155271199|NCT01461993|560425866|FG002|Overall Study|Protocol Violation|7|||
155271200|NCT01461993|560425864|FG000|Overall Study|Adverse Event|9|||
155271201|NCT01461993|560425865|FG001|Overall Study|Adverse Event|11|||
155271202|NCT01461993|560425866|FG002|Overall Study|Adverse Event|3|||
155271203|NCT01461993|560425864|FG000|Overall Study|No longer met eligibility criteria|13|||
155271204|NCT01461993|560425865|FG001|Overall Study|No longer met eligibility criteria|18|||
155271205|NCT01461993|560425866|FG002|Overall Study|No longer met eligibility criteria|10|||
155271206|NCT01461993|560425864|FG000|Overall Study|Did not meet entrance criteria|2|||
155271207|NCT01461993|560425865|FG001|Overall Study|Did not meet entrance criteria|3|||
155271208|NCT01461993|560425866|FG002|Overall Study|Did not meet entrance criteria|0|||
155271209|NCT01461993|560425864|FG000|Overall Study|Other|13|||
155271210|NCT01461993|560425865|FG001|Overall Study|Other|15|||
155271211|NCT01461993|560425866|FG002|Overall Study|Other|6|||
155271212|NCT00680056|560425867|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
155271213|NCT00680056|560425868|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
155271214|NCT00680056|560425867|FG000|Second Intervention|Protocol Violation|3|||
155271215|NCT00680056|560425868|FG001|Second Intervention|Protocol Violation|1|||
155271216|NCT01821898|560425869|FG000|Overall Study|Withdrawal by Subject|2|||
155271217|NCT01821898|560425870|FG001|Overall Study|Withdrawal by Subject|1|||
155271218|NCT05064735|560425871|FG000|Overall Study|Withdrawal by Subject|7|||
155271219|NCT05064735|560425872|FG001|Overall Study|Withdrawal by Subject|8|||
155271220|NCT05064735|560425871|FG000|Overall Study|Lost to Follow-up|7|||
155271221|NCT05064735|560425872|FG001|Overall Study|Lost to Follow-up|2|||
155271222|NCT05064735|560425871|FG000|Overall Study|Physician Decision|2|||
155271223|NCT05064735|560425872|FG001|Overall Study|Physician Decision|1|||
155271224|NCT05064735|560425871|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
155271225|NCT05064735|560425872|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
155271226|NCT05064735|560425871|FG000|Overall Study|Site Closure|7|||
155271227|NCT05064735|560425872|FG001|Overall Study|Site Closure|2|||
155381779|NCT02874924|560833196|FG000|Overall Study|Adverse Event|2|||
155381780|NCT02874924|560833197|FG001|Overall Study|Adverse Event|0|||
155381781|NCT02874924|560833198|FG002|Overall Study|Adverse Event|0|||
155381782|NCT02874924|560833196|FG000|Overall Study|Withdrawal by Subject|1|||
155381783|NCT02874924|560833197|FG001|Overall Study|Withdrawal by Subject|0|||
155381784|NCT02874924|560833198|FG002|Overall Study|Withdrawal by Subject|0|||
155381785|NCT01689337|560833199|FG000|Overall Study|Study Discontinuation|1|||
155381786|NCT01874431|560833200|FG000|Overall Study|Physician Decision|0|||
155381787|NCT01874431|560833201|FG001|Overall Study|Physician Decision|0|||
155381788|NCT01874431|560833202|FG002|Overall Study|Physician Decision|1|||
155381789|NCT01874431|560833203|FG003|Overall Study|Physician Decision|0|||
155381790|NCT01874431|560833204|FG004|Overall Study|Physician Decision|0|||
155381791|NCT01874431|560833205|FG005|Overall Study|Physician Decision|0|||
155381792|NCT01874431|560833206|FG006|Overall Study|Physician Decision|0|||
155271228|NCT01018563|560425874|FG000|Overall Study|Termination of the study by Sponsor|2|||
155271229|NCT01018563|560425875|FG001|Overall Study|Termination of the study by Sponsor|1|||
155271230|NCT04844970|560425878|FG000|Overall Study|Adverse Event|0|||
155381793|NCT01874431|560833207|FG007|Overall Study|Physician Decision|0|||
155271231|NCT04844970|560425879|FG001|Overall Study|Adverse Event|1|||
155271232|NCT04844970|560425878|FG000|Overall Study|Withdrawal by Subject|2|||
155271233|NCT04844970|560425879|FG001|Overall Study|Withdrawal by Subject|0|||
155271234|NCT00447954|560425880|FG000|Overall Study|Adverse Event|0|||
155615231|NCT00572455|561684867|FG000|Stage II (28 Days)|Adverse Event|0|||
155615232|NCT00572455|561684868|FG001|Stage II (28 Days)|Adverse Event|0|||
155615233|NCT00572455|561684869|FG002|Stage II (28 Days)|Adverse Event|0|||
155615234|NCT00572455|561684870|FG003|Stage II (28 Days)|Adverse Event|0|||
155615235|NCT00572455|561684871|FG004|Stage II (28 Days)|Adverse Event|0|||
155615236|NCT00572455|561684872|FG005|Stage II (28 Days)|Adverse Event|0|||
155615237|NCT00572455|561684873|FG006|Stage II (28 Days)|Adverse Event|0|||
155615238|NCT00572455|561684874|FG007|Stage II (28 Days)|Adverse Event|0|||
155271235|NCT00447954|560425881|FG001|Overall Study|Adverse Event|2|||
155271236|NCT00447954|560425882|FG002|Overall Study|Adverse Event|0|||
155271237|NCT00447954|560425880|FG000|Overall Study|Withdrawal by Subject|0|||
155271238|NCT00447954|560425881|FG001|Overall Study|Withdrawal by Subject|1|||
155271239|NCT00447954|560425882|FG002|Overall Study|Withdrawal by Subject|1|||
155271240|NCT00447954|560425880|FG000|Overall Study|Lost to Follow-up|0|||
155271241|NCT00447954|560425881|FG001|Overall Study|Lost to Follow-up|1|||
155271242|NCT00447954|560425882|FG002|Overall Study|Lost to Follow-up|0|||
155271243|NCT00447954|560425880|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
155615239|NCT00572455|561684875|FG008|Stage II (28 Days)|Adverse Event|1|||
155615240|NCT00572455|561684876|FG009|Stage II (28 Days)|Adverse Event|3|||
155615241|NCT00572455|561684877|FG010|Stage II (28 Days)|Adverse Event|3|||
155615242|NCT00572455|561684878|FG011|Stage II (28 Days)|Adverse Event|4|||
155271244|NCT00447954|560425881|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
155271245|NCT00447954|560425882|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
155271246|NCT00856661|560425883|FG000|Overall Study|Death|15|||
155271247|NCT00856661|560425884|FG001|Overall Study|Death|18|||
155271248|NCT00856661|560425883|FG000|Overall Study|Protocol Violation|2|||
155271249|NCT00856661|560425884|FG001|Overall Study|Protocol Violation|1|||
155271250|NCT00856661|560425883|FG000|Overall Study|Withdrawal by Subject|1|||
155271251|NCT00856661|560425884|FG001|Overall Study|Withdrawal by Subject|2|||
155271252|NCT00856661|560425883|FG000|Overall Study|Lost to Follow-up|1|||
155271253|NCT00856661|560425884|FG001|Overall Study|Lost to Follow-up|3|||
155271254|NCT00856661|560425883|FG000|Overall Study|Physician Judgement|8|||
155271255|NCT00856661|560425884|FG001|Overall Study|Physician Judgement|5|||
155271256|NCT02120664|560425885|FG000|Overall Study|Withdrawal by Subject|0|||
155271257|NCT02120664|560425886|FG001|Overall Study|Withdrawal by Subject|0|||
155271258|NCT02120664|560425887|FG002|Overall Study|Withdrawal by Subject|0|||
155271259|NCT02120664|560425888|FG003|Overall Study|Withdrawal by Subject|1|||
155271260|NCT02120664|560425889|FG004|Overall Study|Withdrawal by Subject|0|||
155271261|NCT03176238|560425890|FG000|Overall Study|Unacceptable AEs|15|||
155271262|NCT03176238|560425891|FG001|Overall Study|Unacceptable AEs|8|||
155271263|NCT03176238|560425890|FG000|Overall Study|Abnormal lab value(s)|2|||
155271264|NCT03176238|560425891|FG001|Overall Study|Abnormal lab value(s)|0|||
155271265|NCT03176238|560425890|FG000|Overall Study|Inter-current illness|0|||
155271266|NCT03176238|560425891|FG001|Overall Study|Inter-current illness|1|||
155271267|NCT03176238|560425890|FG000|Overall Study|Consent withdrawal|14|||
155271268|NCT03176238|560425891|FG001|Overall Study|Consent withdrawal|2|||
155271269|NCT03176238|560425890|FG000|Overall Study|Lost to Follow-up|3|||
155271270|NCT03176238|560425891|FG001|Overall Study|Lost to Follow-up|0|||
155271271|NCT03176238|560425890|FG000|Overall Study|Administrative problems|1|||
155271272|NCT03176238|560425891|FG001|Overall Study|Administrative problems|0|||
155271273|NCT03176238|560425890|FG000|Overall Study|Death|3|||
155615243|NCT00572455|561684879|FG012|Stage II (28 Days)|Adverse Event|5|||
155615244|NCT00572455|561684880|FG013|Stage II (28 Days)|Adverse Event|1|||
155615245|NCT00572455|561684867|FG000|Stage II (28 Days)|Death|0|||
155615246|NCT00572455|561684868|FG001|Stage II (28 Days)|Death|0|||
155615247|NCT00572455|561684869|FG002|Stage II (28 Days)|Death|0|||
155615248|NCT00572455|561684870|FG003|Stage II (28 Days)|Death|0|||
155271274|NCT03176238|560425891|FG001|Overall Study|Death|0|||
155271275|NCT03176238|560425890|FG000|Overall Study|Disease Progression|133|||
155271276|NCT03176238|560425891|FG001|Overall Study|Disease Progression|22|||
155271277|NCT03176238|560425890|FG000|Overall Study|Tx duration completed per EAP|0|||
155271278|NCT03176238|560425891|FG001|Overall Study|Tx duration completed per EAP|1|||
155271279|NCT03176238|560425890|FG000|Overall Study|Patient is switched to commercial drug|16|||
155271280|NCT03176238|560425891|FG001|Overall Study|Patient is switched to commercial drug|1|||
155271281|NCT03176238|560425890|FG000|Overall Study|Protocol Violation|1|||
155271282|NCT03176238|560425891|FG001|Overall Study|Protocol Violation|0|||
155271283|NCT03176238|560425890|FG000|Overall Study|Changes in the patient's condition|2|||
155271284|NCT03176238|560425891|FG001|Overall Study|Changes in the patient's condition|1|||
155271285|NCT03176238|560425890|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
155271286|NCT03176238|560425891|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
155271287|NCT04524598|560425892|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
155271288|NCT04524598|560425893|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
155271289|NCT04524598|560425894|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
155271290|NCT04524598|560425895|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
155615249|NCT00572455|561684871|FG004|Stage II (28 Days)|Death|0|||
155615250|NCT00572455|561684872|FG005|Stage II (28 Days)|Death|0|||
155615251|NCT00572455|561684873|FG006|Stage II (28 Days)|Death|0|||
155615252|NCT00572455|561684874|FG007|Stage II (28 Days)|Death|0|||
155271291|NCT04524598|560425896|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
155271292|NCT04524598|560425892|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
155271293|NCT04524598|560425893|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
155271294|NCT04524598|560425894|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271295|NCT04524598|560425895|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271296|NCT04524598|560425896|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271297|NCT04524598|560425892|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
155271298|NCT04524598|560425893|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
155271299|NCT04524598|560425894|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
155271300|NCT04524598|560425895|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
155271301|NCT04524598|560425896|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
155271302|NCT04524598|560425892|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
155271303|NCT04524598|560425893|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
155271304|NCT04524598|560425894|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
155271305|NCT04524598|560425895|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
155271306|NCT04524598|560425896|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
155271307|NCT04524598|560425892|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271308|NCT04524598|560425893|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271309|NCT04524598|560425894|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
155271310|NCT04524598|560425895|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
155271311|NCT04524598|560425896|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271312|NCT04524598|560425892|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
155271313|NCT04524598|560425893|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
155271314|NCT04524598|560425894|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
155271315|NCT04524598|560425895|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
155271316|NCT04524598|560425896|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
155271317|NCT04524598|560425892|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271318|NCT04524598|560425893|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271319|NCT04524598|560425894|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271320|NCT04524598|560425895|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271321|NCT04524598|560425896|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
155271322|NCT02736968|560425900|FG000|Overall Study|Lost to Follow-up|0|||
155271323|NCT02736968|560425901|FG001|Overall Study|Lost to Follow-up|0|||
155271324|NCT02736968|560425902|FG002|Overall Study|Lost to Follow-up|0|||
155271325|NCT02736968|560425903|FG003|Overall Study|Lost to Follow-up|0|||
155271326|NCT02736968|560425904|FG004|Overall Study|Lost to Follow-up|0|||
155271327|NCT02736968|560425905|FG005|Overall Study|Lost to Follow-up|0|||
155271328|NCT02736968|560425906|FG006|Overall Study|Lost to Follow-up|5|||
155271329|NCT02736968|560425907|FG007|Overall Study|Lost to Follow-up|2|||
155271330|NCT02736968|560425900|FG000|Overall Study|COVID-19 Pandemic|0|||
155271331|NCT02736968|560425901|FG001|Overall Study|COVID-19 Pandemic|0|||
155271332|NCT02736968|560425902|FG002|Overall Study|COVID-19 Pandemic|0|||
155271333|NCT02736968|560425903|FG003|Overall Study|COVID-19 Pandemic|0|||
155271334|NCT02736968|560425904|FG004|Overall Study|COVID-19 Pandemic|0|||
155271335|NCT02736968|560425905|FG005|Overall Study|COVID-19 Pandemic|0|||
155271336|NCT02736968|560425906|FG006|Overall Study|COVID-19 Pandemic|2|||
155271337|NCT02736968|560425907|FG007|Overall Study|COVID-19 Pandemic|0|||
155271338|NCT02736968|560425900|FG000|Overall Study|Withdrawal by Subject|0|||
155271339|NCT02736968|560425901|FG001|Overall Study|Withdrawal by Subject|0|||
155271340|NCT02736968|560425902|FG002|Overall Study|Withdrawal by Subject|0|||
155271341|NCT02736968|560425903|FG003|Overall Study|Withdrawal by Subject|0|||
155271342|NCT02736968|560425904|FG004|Overall Study|Withdrawal by Subject|0|||
155271343|NCT02736968|560425905|FG005|Overall Study|Withdrawal by Subject|0|||
155271344|NCT02736968|560425906|FG006|Overall Study|Withdrawal by Subject|1|||
155271345|NCT02736968|560425907|FG007|Overall Study|Withdrawal by Subject|0|||
155271346|NCT01804673|560427257|FG000|Overall Study|Adverse Event|4|||
155271347|NCT01804673|560427257|FG000|Overall Study|Withdrawal by Subject|1|||
155615253|NCT00572455|561684875|FG008|Stage II (28 Days)|Death|1|||
155615254|NCT00572455|561684876|FG009|Stage II (28 Days)|Death|0|||
155271348|NCT01804673|560427257|FG000|Overall Study|Lack of Efficacy|9|||
155271349|NCT01804673|560427257|FG000|Overall Study|Change to Oral Therapy|37|||
155271350|NCT01804673|560427257|FG000|Overall Study|No Further Therapy Required|84|||
155271351|NCT01804673|560427257|FG000|Overall Study|Use of Prohibited Medication|1|||
155271352|NCT01804673|560427257|FG000|Overall Study|Other|4|||
155271353|NCT01857934|560427265|FG000|Overall Study|Relapse or progression|2|||
155271354|NCT01857934|560427265|FG000|Overall Study|Unacceptable toxicity|3|||
155271355|NCT01857934|560427265|FG000|Overall Study|Unwillingness or inability to comply|2|||
155271356|NCT01857934|560427265|FG000|Overall Study|Physician Decision|3|||
155271357|NCT01024959|560427266|FG000|Overall Study|ineligible|12|||
155615255|NCT00572455|561684877|FG010|Stage II (28 Days)|Death|0|||
155615256|NCT00572455|561684878|FG011|Stage II (28 Days)|Death|0|||
155271358|NCT01024959|560427266|FG000|Overall Study|results not evaluable|12|||
155271359|NCT01024959|560427266|FG000|Overall Study|missing results required for analysis|17|||
155271360|NCT00313911|560427267|FG000|Overall Study|Serious adverse event|6|||
155271361|NCT00313911|560427268|FG001|Overall Study|Serious adverse event|1|||
155271362|NCT00313911|560427267|FG000|Overall Study|Adverse Event|2|||
155271363|NCT00313911|560427268|FG001|Overall Study|Adverse Event|3|||
155271364|NCT00313911|560427267|FG000|Overall Study|Protocol Violation|19|||
155271365|NCT00313911|560427268|FG001|Overall Study|Protocol Violation|10|||
155271366|NCT00313911|560427267|FG000|Overall Study|Lost to Follow-up|27|||
155271367|NCT00313911|560427268|FG001|Overall Study|Lost to Follow-up|14|||
155271368|NCT00313911|560427267|FG000|Overall Study|Withdrawal by Subject|39|||
155271369|NCT00313911|560427268|FG001|Overall Study|Withdrawal by Subject|12|||
155271370|NCT00313911|560427267|FG000|Overall Study|Did not meet age criteria|1|||
155271371|NCT00313911|560427268|FG001|Overall Study|Did not meet age criteria|1|||
155271372|NCT04161807|560427271|FG000|Overall Study|Withdrawal by Subject|2|||
155271373|NCT04161807|560427271|FG000|Overall Study|Performed only 1 treatment|2|||
155271374|NCT00192023|560427278|FG000|Period III - Double-Blind|Adverse Event|3|||
155271375|NCT00192023|560427279|FG001|Period III - Double-Blind|Adverse Event|0|||
155271376|NCT00192023|560427278|FG000|Period III - Double-Blind|Physician Decision|2|||
155271377|NCT00192023|560427279|FG001|Period III - Double-Blind|Physician Decision|0|||
155271378|NCT00192023|560427278|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
155271379|NCT00192023|560427279|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
155271380|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
155271381|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
155271382|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
155271383|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
155271384|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
155271385|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
155271386|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
155271387|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
155271388|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
155271389|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
155271390|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
155271391|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
155271392|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
155271393|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
155271394|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
155271395|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
155271396|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
155271397|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
155271398|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
155271399|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
155271400|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155271401|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
155271402|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155271403|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
155271404|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
155271405|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
155271406|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
155271407|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
155271408|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
155271409|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
155271410|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
155271411|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
155271412|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
155271413|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
155271414|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
155271415|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
155271416|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
155381794|NCT01874431|560833200|FG000|Overall Study|Adverse Event|5|||
155381795|NCT01874431|560833201|FG001|Overall Study|Adverse Event|4|||
155615257|NCT00572455|561684879|FG012|Stage II (28 Days)|Death|0|||
155381796|NCT01874431|560833202|FG002|Overall Study|Adverse Event|6|||
155381797|NCT01874431|560833203|FG003|Overall Study|Adverse Event|5|||
155381798|NCT01874431|560833204|FG004|Overall Study|Adverse Event|2|||
155381799|NCT01874431|560833205|FG005|Overall Study|Adverse Event|8|||
155615258|NCT00572455|561684880|FG013|Stage II (28 Days)|Death|0|||
155381800|NCT01874431|560833206|FG006|Overall Study|Adverse Event|2|||
155615259|NCT00572455|561684867|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
155615260|NCT00572455|561684868|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
155615261|NCT00572455|561684869|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
155271417|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
155381801|NCT01874431|560833207|FG007|Overall Study|Adverse Event|3|||
155381802|NCT01874431|560833200|FG000|Overall Study|Protocol Violation|1|||
155381803|NCT01874431|560833201|FG001|Overall Study|Protocol Violation|1|||
155381804|NCT01874431|560833202|FG002|Overall Study|Protocol Violation|1|||
155381805|NCT01874431|560833203|FG003|Overall Study|Protocol Violation|0|||
155381806|NCT01874431|560833204|FG004|Overall Study|Protocol Violation|3|||
155381807|NCT01874431|560833205|FG005|Overall Study|Protocol Violation|2|||
155381808|NCT01874431|560833206|FG006|Overall Study|Protocol Violation|1|||
155381809|NCT01874431|560833207|FG007|Overall Study|Protocol Violation|1|||
155381810|NCT01874431|560833200|FG000|Overall Study|Non-compliance|0|||
155381811|NCT01874431|560833201|FG001|Overall Study|Non-compliance|0|||
155381812|NCT01874431|560833202|FG002|Overall Study|Non-compliance|0|||
155381813|NCT01874431|560833203|FG003|Overall Study|Non-compliance|0|||
155381814|NCT01874431|560833204|FG004|Overall Study|Non-compliance|1|||
155381815|NCT01874431|560833205|FG005|Overall Study|Non-compliance|0|||
155381816|NCT01874431|560833206|FG006|Overall Study|Non-compliance|1|||
155381817|NCT01874431|560833207|FG007|Overall Study|Non-compliance|0|||
155381818|NCT01874431|560833200|FG000|Overall Study|Logistical difficulties|0|||
155381819|NCT01874431|560833201|FG001|Overall Study|Logistical difficulties|0|||
155381820|NCT01874431|560833202|FG002|Overall Study|Logistical difficulties|0|||
155381821|NCT01874431|560833203|FG003|Overall Study|Logistical difficulties|0|||
155381822|NCT01874431|560833204|FG004|Overall Study|Logistical difficulties|0|||
155381823|NCT01874431|560833205|FG005|Overall Study|Logistical difficulties|0|||
155381824|NCT01874431|560833206|FG006|Overall Study|Logistical difficulties|1|||
155381825|NCT01874431|560833207|FG007|Overall Study|Logistical difficulties|0|||
155381826|NCT01874431|560833200|FG000|Overall Study|Withdrawal by Subject|0|||
155381827|NCT01874431|560833201|FG001|Overall Study|Withdrawal by Subject|0|||
155381828|NCT01874431|560833202|FG002|Overall Study|Withdrawal by Subject|1|||
155381829|NCT01874431|560833203|FG003|Overall Study|Withdrawal by Subject|2|||
155381830|NCT01874431|560833204|FG004|Overall Study|Withdrawal by Subject|1|||
155381831|NCT01874431|560833205|FG005|Overall Study|Withdrawal by Subject|1|||
155381832|NCT01874431|560833206|FG006|Overall Study|Withdrawal by Subject|3|||
155381833|NCT01874431|560833207|FG007|Overall Study|Withdrawal by Subject|0|||
155381834|NCT01874431|560833200|FG000|Overall Study|Sponsor decision|0|||
155381835|NCT01874431|560833201|FG001|Overall Study|Sponsor decision|0|||
155381836|NCT01874431|560833202|FG002|Overall Study|Sponsor decision|0|||
155381837|NCT01874431|560833203|FG003|Overall Study|Sponsor decision|0|||
155381838|NCT01874431|560833204|FG004|Overall Study|Sponsor decision|1|||
155381839|NCT01874431|560833205|FG005|Overall Study|Sponsor decision|0|||
155381840|NCT01874431|560833206|FG006|Overall Study|Sponsor decision|0|||
155381841|NCT01874431|560833207|FG007|Overall Study|Sponsor decision|0|||
155381842|NCT01874431|560833200|FG000|Overall Study|Lost to Follow-up|0|||
155381843|NCT01874431|560833201|FG001|Overall Study|Lost to Follow-up|0|||
155381844|NCT01874431|560833202|FG002|Overall Study|Lost to Follow-up|1|||
155381845|NCT01874431|560833203|FG003|Overall Study|Lost to Follow-up|0|||
155381846|NCT01874431|560833204|FG004|Overall Study|Lost to Follow-up|0|||
155381847|NCT01874431|560833205|FG005|Overall Study|Lost to Follow-up|0|||
155381848|NCT01874431|560833206|FG006|Overall Study|Lost to Follow-up|0|||
155381849|NCT01874431|560833207|FG007|Overall Study|Lost to Follow-up|0|||
155381850|NCT00642772|560833209|FG000|Overall Study|Lost to Follow-up|3|||
155381851|NCT00642772|560833209|FG000|Overall Study|Withdrawal by Subject|7|||
155381852|NCT05398237|560833218|FG000|Overall Study|Withdrawal by Subject|1|||
155381853|NCT01312857|560833220|FG000|Overall Study|Adverse Event|1|||
155381854|NCT01312857|560833221|FG001|Overall Study|Adverse Event|1|||
155381855|NCT01312857|560833220|FG000|Overall Study|Lost to Follow-up|2|||
155381856|NCT01312857|560833221|FG001|Overall Study|Lost to Follow-up|0|||
155381857|NCT01312857|560833220|FG000|Overall Study|Physician Decision|3|||
155381858|NCT01312857|560833221|FG001|Overall Study|Physician Decision|0|||
155381859|NCT01312857|560833220|FG000|Overall Study|Withdrawal by Subject|2|||
155381860|NCT01312857|560833221|FG001|Overall Study|Withdrawal by Subject|0|||
155381861|NCT01382706|560833224|FG000|Overall Study|Adverse Event|1|||
155615262|NCT00572455|561684870|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
155615263|NCT00572455|561684871|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
155615264|NCT00572455|561684872|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
155381862|NCT01382706|560833224|FG000|Overall Study|Withdrawal by Subject|1|||
155381863|NCT04745026|560833225|FG000|Overall Study|Physician Decision|1|||
155381864|NCT04745026|560833226|FG001|Overall Study|Physician Decision|0|||
155381865|NCT04745026|560833225|FG000|Overall Study|Adverse Event|2|||
155381866|NCT04745026|560833226|FG001|Overall Study|Adverse Event|2|||
155381867|NCT04745026|560833225|FG000|Overall Study|Protocol Violation|1|||
155381868|NCT04745026|560833226|FG001|Overall Study|Protocol Violation|3|||
155381869|NCT04745026|560833225|FG000|Overall Study|Lost to Follow-up|4|||
155381870|NCT04745026|560833226|FG001|Overall Study|Lost to Follow-up|3|||
155615265|NCT00572455|561684873|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
155381871|NCT04745026|560833225|FG000|Overall Study|Withdrawal by Subject|5|||
155615266|NCT00572455|561684874|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
155381872|NCT04745026|560833226|FG001|Overall Study|Withdrawal by Subject|5|||
155381873|NCT02344004|560833229|FG000|Overall Study|Adverse Event|11|||
155381874|NCT02344004|560833230|FG001|Overall Study|Adverse Event|1|||
155615267|NCT00572455|561684875|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
155271418|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
155271419|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
155271420|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
155271421|NCT02441946|560427283|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
155271422|NCT02441946|560427284|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
155271423|NCT02441946|560427285|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
155271424|NCT02441946|560427283|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
155271425|NCT02441946|560427284|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155271426|NCT02441946|560427285|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155271427|NCT00758160|560427288|FG000|Overall Study|No Longer Requires Study Medication|4|||
155271428|NCT00758160|560427288|FG000|Overall Study|Administration Problems|3|||
155271429|NCT00758160|560427288|FG000|Overall Study|Adverse Event|15|||
155271430|NCT00758160|560427288|FG000|Overall Study|Lack of Efficacy|10|||
155271431|NCT00758160|560427288|FG000|Overall Study|Lost to Follow-up|14|||
155271432|NCT00758160|560427288|FG000|Overall Study|Protocol Violation|12|||
155271433|NCT00758160|560427288|FG000|Overall Study|Withdrawal by Subject|8|||
155271434|NCT02153359|560427289|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
155271435|NCT02153359|560427290|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
155271436|NCT01234649|560427295|FG000|Overall Study|Withdrawal by Subject|32|||
155271437|NCT01234649|560427296|FG001|Overall Study|Withdrawal by Subject|26|||
155271438|NCT01234649|560427295|FG000|Overall Study|Pregnancy|6|||
155271439|NCT01234649|560427296|FG001|Overall Study|Pregnancy|6|||
155271440|NCT01234649|560427295|FG000|Overall Study|intolerant to side effects|4|||
155271441|NCT01234649|560427296|FG001|Overall Study|intolerant to side effects|3|||
155271442|NCT01234649|560427295|FG000|Overall Study|Allergic reaction|1|||
155271443|NCT01234649|560427296|FG001|Overall Study|Allergic reaction|0|||
155271444|NCT01234649|560427295|FG000|Overall Study|Lack of Efficacy|0|||
155271445|NCT01234649|560427296|FG001|Overall Study|Lack of Efficacy|3|||
155271446|NCT02733042|560427305|FG000|Overall Study|Adverse Event|1|||
155271447|NCT02733042|560427306|FG001|Overall Study|Adverse Event|0|||
155271448|NCT02733042|560427307|FG002|Overall Study|Adverse Event|1|||
155271449|NCT02733042|560427308|FG003|Overall Study|Adverse Event|1|||
155271450|NCT02733042|560427309|FG004|Overall Study|Adverse Event|0|||
155271451|NCT02733042|560427310|FG005|Overall Study|Adverse Event|0|||
155271452|NCT02733042|560427311|FG006|Overall Study|Adverse Event|0|||
155271453|NCT02733042|560427312|FG007|Overall Study|Adverse Event|0|||
155271454|NCT02733042|560427313|FG008|Overall Study|Adverse Event|0|||
155271455|NCT02733042|560427314|FG009|Overall Study|Adverse Event|0|||
155271456|NCT02733042|560427315|FG010|Overall Study|Adverse Event|2|||
155271457|NCT02733042|560427316|FG011|Overall Study|Adverse Event|2|||
155271458|NCT02733042|560427317|FG012|Overall Study|Adverse Event|0|||
155271459|NCT02733042|560427318|FG013|Overall Study|Adverse Event|2|||
155271460|NCT02733042|560427319|FG014|Overall Study|Adverse Event|0|||
155271461|NCT02733042|560427320|FG015|Overall Study|Adverse Event|0|||
155271462|NCT02733042|560427321|FG016|Overall Study|Adverse Event|0|||
155271463|NCT02733042|560427322|FG017|Overall Study|Adverse Event|1|||
155271464|NCT02733042|560427323|FG018|Overall Study|Adverse Event|0|||
155271465|NCT02733042|560427305|FG000|Overall Study|Progressive Disease|2|||
155271466|NCT02733042|560427306|FG001|Overall Study|Progressive Disease|1|||
155271467|NCT02733042|560427307|FG002|Overall Study|Progressive Disease|3|||
155271468|NCT02733042|560427308|FG003|Overall Study|Progressive Disease|1|||
155271469|NCT02733042|560427309|FG004|Overall Study|Progressive Disease|2|||
155271470|NCT02733042|560427310|FG005|Overall Study|Progressive Disease|3|||
155271471|NCT02733042|560427311|FG006|Overall Study|Progressive Disease|0|||
155271472|NCT02733042|560427312|FG007|Overall Study|Progressive Disease|3|||
155271473|NCT02733042|560427313|FG008|Overall Study|Progressive Disease|3|||
155271474|NCT02733042|560427314|FG009|Overall Study|Progressive Disease|2|||
155271475|NCT02733042|560427315|FG010|Overall Study|Progressive Disease|2|||
155615268|NCT00572455|561684876|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
155615269|NCT00572455|561684877|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
155271476|NCT02733042|560427316|FG011|Overall Study|Progressive Disease|2|||
155271477|NCT02733042|560427317|FG012|Overall Study|Progressive Disease|8|||
155271478|NCT02733042|560427318|FG013|Overall Study|Progressive Disease|1|||
155271479|NCT02733042|560427319|FG014|Overall Study|Progressive Disease|4|||
155271480|NCT02733042|560427320|FG015|Overall Study|Progressive Disease|7|||
155271481|NCT02733042|560427321|FG016|Overall Study|Progressive Disease|2|||
155271482|NCT02733042|560427322|FG017|Overall Study|Progressive Disease|3|||
155271483|NCT02733042|560427323|FG018|Overall Study|Progressive Disease|4|||
155271484|NCT02733042|560427305|FG000|Overall Study|Withdrawal by Subject|0|||
155271485|NCT02733042|560427306|FG001|Overall Study|Withdrawal by Subject|1|||
155381875|NCT02344004|560833229|FG000|Overall Study|Death|9|||
155381876|NCT02344004|560833230|FG001|Overall Study|Death|7|||
155271486|NCT02733042|560427307|FG002|Overall Study|Withdrawal by Subject|2|||
155271487|NCT02733042|560427308|FG003|Overall Study|Withdrawal by Subject|1|||
155271488|NCT02733042|560427309|FG004|Overall Study|Withdrawal by Subject|1|||
155271489|NCT02733042|560427310|FG005|Overall Study|Withdrawal by Subject|0|||
155381877|NCT02344004|560833229|FG000|Overall Study|Physician Decision|4|||
155271490|NCT02733042|560427311|FG006|Overall Study|Withdrawal by Subject|0|||
155271491|NCT02733042|560427312|FG007|Overall Study|Withdrawal by Subject|0|||
155271492|NCT02733042|560427313|FG008|Overall Study|Withdrawal by Subject|1|||
155271493|NCT02733042|560427314|FG009|Overall Study|Withdrawal by Subject|1|||
155271494|NCT02733042|560427315|FG010|Overall Study|Withdrawal by Subject|0|||
155271495|NCT02733042|560427316|FG011|Overall Study|Withdrawal by Subject|2|||
155271496|NCT02733042|560427317|FG012|Overall Study|Withdrawal by Subject|1|||
155271497|NCT02733042|560427318|FG013|Overall Study|Withdrawal by Subject|1|||
155271498|NCT02733042|560427319|FG014|Overall Study|Withdrawal by Subject|0|||
155271499|NCT02733042|560427320|FG015|Overall Study|Withdrawal by Subject|0|||
155271500|NCT02733042|560427321|FG016|Overall Study|Withdrawal by Subject|0|||
155271501|NCT02733042|560427322|FG017|Overall Study|Withdrawal by Subject|0|||
155271502|NCT02733042|560427323|FG018|Overall Study|Withdrawal by Subject|0|||
155271503|NCT02733042|560427305|FG000|Overall Study|Other Reasons|0|||
155271504|NCT02733042|560427306|FG001|Overall Study|Other Reasons|0|||
155271505|NCT02733042|560427307|FG002|Overall Study|Other Reasons|1|||
155271506|NCT02733042|560427308|FG003|Overall Study|Other Reasons|0|||
155271507|NCT02733042|560427309|FG004|Overall Study|Other Reasons|0|||
155271508|NCT02733042|560427310|FG005|Overall Study|Other Reasons|0|||
155271509|NCT02733042|560427311|FG006|Overall Study|Other Reasons|0|||
155271510|NCT02733042|560427312|FG007|Overall Study|Other Reasons|0|||
155271511|NCT02733042|560427313|FG008|Overall Study|Other Reasons|0|||
155271512|NCT02733042|560427314|FG009|Overall Study|Other Reasons|1|||
155271513|NCT02733042|560427315|FG010|Overall Study|Other Reasons|1|||
155271514|NCT02733042|560427316|FG011|Overall Study|Other Reasons|0|||
155271515|NCT02733042|560427317|FG012|Overall Study|Other Reasons|0|||
155271516|NCT02733042|560427318|FG013|Overall Study|Other Reasons|0|||
155271517|NCT02733042|560427319|FG014|Overall Study|Other Reasons|0|||
155271518|NCT02733042|560427320|FG015|Overall Study|Other Reasons|1|||
155271519|NCT02733042|560427321|FG016|Overall Study|Other Reasons|0|||
155271520|NCT02733042|560427322|FG017|Overall Study|Other Reasons|1|||
155271521|NCT02733042|560427323|FG018|Overall Study|Other Reasons|0|||
155271522|NCT02733042|560427305|FG000|Overall Study|Death|0|||
155271523|NCT02733042|560427306|FG001|Overall Study|Death|0|||
155271524|NCT02733042|560427307|FG002|Overall Study|Death|0|||
155271525|NCT02733042|560427308|FG003|Overall Study|Death|0|||
155271526|NCT02733042|560427309|FG004|Overall Study|Death|0|||
155271527|NCT02733042|560427310|FG005|Overall Study|Death|0|||
155271528|NCT02733042|560427311|FG006|Overall Study|Death|1|||
155271529|NCT02733042|560427312|FG007|Overall Study|Death|0|||
155271530|NCT02733042|560427313|FG008|Overall Study|Death|1|||
155271531|NCT02733042|560427314|FG009|Overall Study|Death|0|||
155271532|NCT02733042|560427315|FG010|Overall Study|Death|1|||
155271533|NCT02733042|560427316|FG011|Overall Study|Death|0|||
155271534|NCT02733042|560427317|FG012|Overall Study|Death|0|||
155271535|NCT02733042|560427318|FG013|Overall Study|Death|0|||
155271536|NCT02733042|560427319|FG014|Overall Study|Death|1|||
155271537|NCT02733042|560427320|FG015|Overall Study|Death|2|||
155271538|NCT02733042|560427321|FG016|Overall Study|Death|0|||
155271539|NCT02733042|560427322|FG017|Overall Study|Death|0|||
155271540|NCT02733042|560427323|FG018|Overall Study|Death|0|||
155271541|NCT02838628|560427324|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
155271542|NCT02838628|560427325|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
155271543|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Adverse Event|1|||
155271544|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Adverse Event|0|||
155271545|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Non-compliance|0|||
155271546|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Non-compliance|1|||
155271547|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
155271548|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
155271549|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Other un-specified|1|||
155271550|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Other un-specified|1|||
155271551|NCT04175912|560427330|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
155615270|NCT00572455|561684878|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
155271552|NCT04175912|560427331|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
155271553|NCT04175912|560427330|FG000|Overall Study|Adverse Event|0|||
155271554|NCT04175912|560427331|FG001|Overall Study|Adverse Event|3|||
155271555|NCT04175912|560427330|FG000|Overall Study|Never started treatment|3|||
155271556|NCT04175912|560427331|FG001|Overall Study|Never started treatment|3|||
155271557|NCT04175912|560427330|FG000|Overall Study|Death|0|||
155271558|NCT04175912|560427331|FG001|Overall Study|Death|1|||
155271559|NCT04654468|560427332|FG000|Overall Study|Death|1|||
155271560|NCT04654468|560427332|FG000|Overall Study|Ongoing in the Study|50|||
155271561|NCT06390826|560427333|FG000|Overall Study|Never Start Protocol Therapy|1|||
155271562|NCT06390826|560427333|FG000|Overall Study|Adverse Event|1|||
155271563|NCT06390826|560427333|FG000|Overall Study|Disease Progression|8|||
155271564|NCT02009696|560427334|FG000|Overall Study|Withdrawal by Subject|2|||
155271565|NCT02344537|560427335|FG000|Overall Study|Protocol Violation|1|||
155271566|NCT02344537|560427336|FG001|Overall Study|Protocol Violation|1|||
155271567|NCT02344537|560427335|FG000|Overall Study|Subject started another treatment after wk 6|1|||
155271568|NCT02344537|560427336|FG001|Overall Study|Subject started another treatment after wk 6|0|||
155271569|NCT02344537|560427335|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
155271570|NCT02344537|560427336|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
155271571|NCT05490329|560427337|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
155271572|NCT05490329|560427338|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
155271573|NCT05490329|560427337|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
155271574|NCT05490329|560427338|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
155271575|NCT05490329|560427337|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
155271576|NCT05490329|560427338|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
155271577|NCT02460263|560427339|FG000|Transition Period|Withdrawal by Subject|1|||
155271578|NCT02460263|560427339|FG000|Transition Period|Death|1|||
155271579|NCT02306122|560427340|FG000|Initial Physician Randomization|Physician Decision|0|||
155271580|NCT02306122|560427341|FG001|Initial Physician Randomization|Physician Decision|0|||
155271581|NCT02306122|560427342|FG002|Initial Physician Randomization|Physician Decision|0|||
155271582|NCT02306122|560427343|FG003|Initial Physician Randomization|Physician Decision|0|||
155271583|NCT02306122|560427344|FG004|Initial Physician Randomization|Physician Decision|0|||
155271584|NCT02306122|560427345|FG005|Initial Physician Randomization|Physician Decision|0|||
155271585|NCT02306122|560427346|FG006|Initial Physician Randomization|Physician Decision|0|||
155271586|NCT02306122|560427347|FG007|Initial Physician Randomization|Physician Decision|0|||
155271587|NCT02306122|560427348|FG008|Initial Physician Randomization|Physician Decision|1|||
155271588|NCT02306122|560427349|FG009|Initial Physician Randomization|Physician Decision|0|||
155271589|NCT02306122|560427350|FG010|Initial Physician Randomization|Physician Decision|0|||
155271590|NCT01351025|560427352|FG000|Week 0 - 20|Lost to Follow-up|2|||
155271591|NCT01351025|560427353|FG001|Week 0 - 20|Lost to Follow-up|1|||
155271592|NCT01351025|560427352|FG000|Week 0 - 20|Withdrawal by Subject|1|||
155271593|NCT01351025|560427353|FG001|Week 0 - 20|Withdrawal by Subject|0|||
155271594|NCT01351025|560427352|FG000|Week 24 - 44|Lost to Follow-up|0|||
155271595|NCT01351025|560427353|FG001|Week 24 - 44|Lost to Follow-up|2|||
155271596|NCT01351025|560427352|FG000|Week 24 - 44|Site closed|0|||
155271597|NCT01351025|560427353|FG001|Week 24 - 44|Site closed|1|||
155271598|NCT01351025|560427352|FG000|Week 24 - 44|unable to get to clinic|1|||
155271599|NCT01351025|560427353|FG001|Week 24 - 44|unable to get to clinic|1|||
155271600|NCT04152343|560427356|FG000|Overall Study|Transplanted|5|||
155271601|NCT04152343|560427356|FG000|Overall Study|Death|20|||
155271602|NCT04152343|560427356|FG000|Overall Study|Lost to Follow-up|3|||
155271603|NCT02090634|560427357|FG000|Overall Study|Lost to Follow-up|0|||
155271604|NCT02090634|560427358|FG001|Overall Study|Lost to Follow-up|1|||
155271605|NCT02090634|560427357|FG000|Overall Study|Death|0|||
155271606|NCT02090634|560427358|FG001|Overall Study|Death|1|||
155271607|NCT02090634|560427357|FG000|Overall Study|Protocol Violation|3|||
155271608|NCT02090634|560427358|FG001|Overall Study|Protocol Violation|1|||
155271609|NCT02090634|560427357|FG000|Overall Study|Adverse Event|2|||
155271610|NCT02090634|560427358|FG001|Overall Study|Adverse Event|0|||
155271611|NCT01965938|560427359|FG000|Overall Study|Withdrawal by Subject|1|||
155271612|NCT01965938|560427360|FG001|Overall Study|Withdrawal by Subject|0|||
155271613|NCT03757234|560427361|FG000|Overall Study|Adverse Event|0|||
155271614|NCT03757234|560427362|FG001|Overall Study|Adverse Event|0|||
155271615|NCT03757234|560427363|FG002|Overall Study|Adverse Event|0|||
155271616|NCT03757234|560427364|FG003|Overall Study|Adverse Event|0|||
155271617|NCT03757234|560427365|FG004|Overall Study|Adverse Event|1|||
155271618|NCT03757234|560427361|FG000|Overall Study|Lost to Follow-up|1|||
155271619|NCT03757234|560427362|FG001|Overall Study|Lost to Follow-up|0|||
155271620|NCT03757234|560427363|FG002|Overall Study|Lost to Follow-up|0|||
155271621|NCT03757234|560427364|FG003|Overall Study|Lost to Follow-up|0|||
155271622|NCT03757234|560427365|FG004|Overall Study|Lost to Follow-up|1|||
155271623|NCT03757234|560427361|FG000|Overall Study|Withdrawal by Subject|1|||
155271624|NCT03757234|560427362|FG001|Overall Study|Withdrawal by Subject|1|||
155271625|NCT03757234|560427363|FG002|Overall Study|Withdrawal by Subject|0|||
155271626|NCT03757234|560427364|FG003|Overall Study|Withdrawal by Subject|1|||
155271627|NCT03757234|560427365|FG004|Overall Study|Withdrawal by Subject|2|||
155271628|NCT03757234|560427361|FG000|Overall Study|Other|1|||
155271629|NCT03757234|560427362|FG001|Overall Study|Other|1|||
155271630|NCT03757234|560427363|FG002|Overall Study|Other|0|||
155271631|NCT03757234|560427364|FG003|Overall Study|Other|0|||
155271632|NCT03757234|560427365|FG004|Overall Study|Other|0|||
155271633|NCT00171873|560427370|FG000|Overall Study|Withdrawal by Subject|4|||
155271634|NCT00171873|560427371|FG001|Overall Study|Withdrawal by Subject|2|||
155271635|NCT00171873|560427370|FG000|Overall Study|Adverse Event|5|||
155271636|NCT00171873|560427371|FG001|Overall Study|Adverse Event|0|||
155271637|NCT00171873|560427370|FG000|Overall Study|Switched to Octreotide|0|||
155271638|NCT00171873|560427371|FG001|Overall Study|Switched to Octreotide|1|||
155271639|NCT02041923|560427372|FG000|Overall Study|Lost to Follow-up|26|||
155271640|NCT02041923|560427373|FG001|Overall Study|Lost to Follow-up|30|||
155271641|NCT00309608|560427378|FG000|Overall Study|Adverse Event|1|||
155271642|NCT00309608|560427379|FG001|Overall Study|Adverse Event|5|||
155271643|NCT00309608|560427380|FG002|Overall Study|Adverse Event|3|||
155271644|NCT00309608|560427381|FG003|Overall Study|Adverse Event|2|||
155271645|NCT00309608|560427382|FG004|Overall Study|Adverse Event|3|||
155271646|NCT00309608|560427378|FG000|Overall Study|Protocol Violation|2|||
155271647|NCT00309608|560427379|FG001|Overall Study|Protocol Violation|0|||
155271648|NCT00309608|560427380|FG002|Overall Study|Protocol Violation|0|||
155271649|NCT00309608|560427381|FG003|Overall Study|Protocol Violation|0|||
155271650|NCT00309608|560427382|FG004|Overall Study|Protocol Violation|0|||
155271651|NCT00309608|560427378|FG000|Overall Study|Lost to Follow-up|0|||
155271652|NCT00309608|560427379|FG001|Overall Study|Lost to Follow-up|0|||
155271653|NCT00309608|560427380|FG002|Overall Study|Lost to Follow-up|2|||
155271654|NCT00309608|560427381|FG003|Overall Study|Lost to Follow-up|0|||
155271655|NCT00309608|560427382|FG004|Overall Study|Lost to Follow-up|1|||
155271656|NCT00309608|560427378|FG000|Overall Study|Withdrawal by Subject|1|||
155271657|NCT00309608|560427379|FG001|Overall Study|Withdrawal by Subject|4|||
155271658|NCT00309608|560427380|FG002|Overall Study|Withdrawal by Subject|2|||
155271659|NCT00309608|560427381|FG003|Overall Study|Withdrawal by Subject|0|||
155271660|NCT00309608|560427382|FG004|Overall Study|Withdrawal by Subject|0|||
155271661|NCT00309608|560427378|FG000|Overall Study|Other incl. Lack of efficacy|10|||
155271662|NCT00309608|560427379|FG001|Overall Study|Other incl. Lack of efficacy|4|||
155271663|NCT00309608|560427380|FG002|Overall Study|Other incl. Lack of efficacy|3|||
155271664|NCT00309608|560427381|FG003|Overall Study|Other incl. Lack of efficacy|4|||
155271665|NCT00309608|560427382|FG004|Overall Study|Other incl. Lack of efficacy|0|||
155271666|NCT00621296|560427389|FG000|Overall Study|Adverse Event|2|||
155271667|NCT00621296|560427389|FG000|Overall Study|Lack of Efficacy|1|||
155271668|NCT00621296|560427389|FG000|Overall Study|Physician Decision|7|||
155271669|NCT00621296|560427389|FG000|Overall Study|Unmatch Criteria|1|||
155271670|NCT00621296|560427389|FG000|Overall Study|Stopping Criteria|3|||
155271671|NCT00127413|560427390|FG000|Overall Study|Lost to Follow-up|6|||
155271672|NCT00127413|560427391|FG001|Overall Study|Lost to Follow-up|4|||
155271673|NCT00127413|560427392|FG002|Overall Study|Lost to Follow-up|8|||
155271674|NCT00127413|560427393|FG003|Overall Study|Lost to Follow-up|2|||
155271675|NCT01051063|560427398|FG000|Overall Study|Death|2|||
155271676|NCT01051063|560427399|FG001|Overall Study|Death|2|||
155271677|NCT01051063|560427398|FG000|Overall Study|Withdrawal by Subject|1|||
155271678|NCT01051063|560427399|FG001|Overall Study|Withdrawal by Subject|1|||
155271679|NCT01051063|560427398|FG000|Overall Study|Termination of the study|5|||
155271680|NCT01051063|560427399|FG001|Overall Study|Termination of the study|0|||
155271681|NCT01051063|560427398|FG000|Overall Study|Moved from the study site area|1|||
155271682|NCT01051063|560427399|FG001|Overall Study|Moved from the study site area|0|||
155271683|NCT01051063|560427398|FG000|Overall Study|Other|1|||
155271684|NCT01051063|560427399|FG001|Overall Study|Other|0|||
155271685|NCT01051063|560427398|FG000|Overall Study|Lost to Follow-up|0|||
155271686|NCT01051063|560427399|FG001|Overall Study|Lost to Follow-up|1|||
155271687|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
155271688|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
155271689|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
155271690|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
155271691|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
155271692|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
155271693|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
155271694|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
155271695|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
155271696|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
155271697|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
155271698|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
155271699|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
155271700|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
155271701|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
155271702|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
155271703|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
155271704|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
155271705|NCT02023879|560427401|FG000|Extension Open Label Treatment|Adverse Event|1|||
155615271|NCT00572455|561684879|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
155615272|NCT00572455|561684880|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
155271706|NCT02023879|560427402|FG001|Extension Open Label Treatment|Adverse Event|7|||
155381878|NCT02344004|560833230|FG001|Overall Study|Physician Decision|1|||
155615273|NCT00572455|561684867|FG000|Stage II (28 Days)|Other|0|||
155615274|NCT00572455|561684868|FG001|Stage II (28 Days)|Other|0|||
155271707|NCT02023879|560427403|FG002|Extension Open Label Treatment|Adverse Event|3|||
155271708|NCT02023879|560427401|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
155381879|NCT02344004|560833229|FG000|Overall Study|Withdrawal by Subject|22|||
155615275|NCT00572455|561684869|FG002|Stage II (28 Days)|Other|0|||
155271709|NCT02023879|560427402|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
155271710|NCT02023879|560427403|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
155271711|NCT02023879|560427401|FG000|Extension Open Label Treatment|Participant moved|1|||
155271712|NCT02023879|560427402|FG001|Extension Open Label Treatment|Participant moved|2|||
155271713|NCT02023879|560427403|FG002|Extension Open Label Treatment|Participant moved|0|||
155271714|NCT02023879|560427401|FG000|Extension Open Label Treatment|Other than specified above|2|||
155271715|NCT02023879|560427402|FG001|Extension Open Label Treatment|Other than specified above|7|||
155271716|NCT02023879|560427403|FG002|Extension Open Label Treatment|Other than specified above|2|||
155271717|NCT03713021|560427404|FG000|Overall Study|Did not have CT sim scan available|6|||
155271718|NCT03713021|560427404|FG000|Overall Study|Not eligible|4|||
155271719|NCT03713021|560427404|FG000|Overall Study|Issues with TraceIT markers|5|||
155271720|NCT00874432|560427405|FG000|Overall Study|Withdrawal by Subject|1|||
155271721|NCT00874432|560427406|FG001|Overall Study|Withdrawal by Subject|0|||
155271722|NCT00874432|560427407|FG002|Overall Study|Withdrawal by Subject|0|||
155271723|NCT00874432|560427408|FG003|Overall Study|Withdrawal by Subject|0|||
155271724|NCT00874432|560427405|FG000|Overall Study|Physician Decision|1|||
155271725|NCT00874432|560427406|FG001|Overall Study|Physician Decision|0|||
155271726|NCT00874432|560427407|FG002|Overall Study|Physician Decision|0|||
155271727|NCT00874432|560427408|FG003|Overall Study|Physician Decision|0|||
155271728|NCT00874432|560427405|FG000|Overall Study|Other|1|||
155271729|NCT00874432|560427406|FG001|Overall Study|Other|2|||
155271730|NCT00874432|560427407|FG002|Overall Study|Other|8|||
155271731|NCT00874432|560427408|FG003|Overall Study|Other|3|||
155271732|NCT00384059|560427413|FG000|Infant Series|Not consented|2|||
155271733|NCT00384059|560427414|FG001|Infant Series|Not consented|6|||
155271734|NCT00384059|560427413|FG000|Infant Series|Withdrawal by Subject|2|||
155615276|NCT00572455|561684870|FG003|Stage II (28 Days)|Other|0|||
155615277|NCT00572455|561684871|FG004|Stage II (28 Days)|Other|0|||
155615278|NCT00572455|561684872|FG005|Stage II (28 Days)|Other|0|||
155615279|NCT00572455|561684873|FG006|Stage II (28 Days)|Other|0|||
155615280|NCT00572455|561684874|FG007|Stage II (28 Days)|Other|0|||
155615281|NCT00572455|561684875|FG008|Stage II (28 Days)|Other|1|||
155615282|NCT00572455|561684876|FG009|Stage II (28 Days)|Other|0|||
155615283|NCT00572455|561684877|FG010|Stage II (28 Days)|Other|0|||
155615284|NCT00572455|561684878|FG011|Stage II (28 Days)|Other|0|||
155615285|NCT00572455|561684879|FG012|Stage II (28 Days)|Other|0|||
155615286|NCT00572455|561684880|FG013|Stage II (28 Days)|Other|0|||
155615287|NCT00572455|561684867|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
155615288|NCT00572455|561684868|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
155615289|NCT00572455|561684869|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
155615290|NCT00572455|561684870|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
155615291|NCT00572455|561684871|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
155615292|NCT00572455|561684872|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
155615293|NCT00572455|561684873|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
155615294|NCT00572455|561684874|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
155615295|NCT00572455|561684875|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
155615296|NCT00572455|561684876|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
155615297|NCT00572455|561684877|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
155615298|NCT00572455|561684878|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
155615299|NCT00572455|561684879|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
155615300|NCT00572455|561684880|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
155615301|NCT04152083|561684887|FG000|Overall Study|Lost to Follow-up|2|||
155615302|NCT04152083|561684888|FG001|Overall Study|Lost to Follow-up|1|||
155615303|NCT04152083|561684887|FG000|Overall Study|Adverse Event|1|||
155615304|NCT04152083|561684888|FG001|Overall Study|Adverse Event|0|||
155615305|NCT04152083|561684887|FG000|Overall Study|Randomized but not treated|3|||
155615306|NCT04152083|561684888|FG001|Overall Study|Randomized but not treated|2|||
155615307|NCT01308463|561684889|FG000|Overall Study|Study Discontinued|23|||
155615308|NCT01308463|561684889|FG000|Overall Study|Death|4|||
155615309|NCT01308463|561684889|FG000|Overall Study|Revision|2|||
155615310|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
155615311|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
155271735|NCT00384059|560427414|FG001|Infant Series|Withdrawal by Subject|2|||
155615312|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
155615313|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
155271736|NCT00384059|560427413|FG000|Infant Series|Adverse Event|1|||
155271737|NCT00384059|560427414|FG001|Infant Series|Adverse Event|2|||
155271738|NCT00384059|560427413|FG000|Infant Series|Protocol Violation|1|||
155271739|NCT00384059|560427414|FG001|Infant Series|Protocol Violation|2|||
155615314|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
155615315|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
155615316|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
155615317|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
155615318|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
155615319|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
155271740|NCT00384059|560427413|FG000|Infant Series|Lost to Follow-up|0|||
155271741|NCT00384059|560427414|FG001|Infant Series|Lost to Follow-up|1|||
155271742|NCT00384059|560427413|FG000|After Infant Series|Protocol Violation|2|||
155271743|NCT00384059|560427414|FG001|After Infant Series|Protocol Violation|3|||
155271744|NCT00384059|560427413|FG000|After Infant Series|Withdrawal by Subject|2|||
155271745|NCT00384059|560427414|FG001|After Infant Series|Withdrawal by Subject|2|||
155271746|NCT00384059|560427413|FG000|After Infant Series|Failed to Return|0|||
155271747|NCT00384059|560427414|FG001|After Infant Series|Failed to Return|2|||
155271748|NCT00384059|560427413|FG000|After Infant Series|Adverse Event|0|||
155271749|NCT00384059|560427414|FG001|After Infant Series|Adverse Event|1|||
155271750|NCT00384059|560427413|FG000|After Infant Series|Physician Decision|0|||
155271751|NCT00384059|560427414|FG001|After Infant Series|Physician Decision|1|||
155271752|NCT00384059|560427413|FG000|After Infant Series|Lost to Follow-up|0|||
155271753|NCT00384059|560427414|FG001|After Infant Series|Lost to Follow-up|1|||
155271754|NCT00384059|560427413|FG000|Toddler Dose|Lost to Follow-up|1|||
155271755|NCT00384059|560427414|FG001|Toddler Dose|Lost to Follow-up|1|||
155271756|NCT00384059|560427413|FG000|Toddler Dose|Failed to return|0|||
155271757|NCT00384059|560427414|FG001|Toddler Dose|Failed to return|1|||
155271758|NCT00381641|560427417|FG000|Overall Study|Withdrawal by Subject|0|||
155271759|NCT00381641|560427418|FG001|Overall Study|Withdrawal by Subject|2|||
155271760|NCT03864926|560429642|FG000|Overall Study|Death|0|||
155271761|NCT03864926|560429643|FG001|Overall Study|Death|2|||
155271762|NCT00445601|560429644|FG000|Overall Study|Withdrawal by Subject|11|||
155271763|NCT00445601|560429645|FG001|Overall Study|Withdrawal by Subject|11|||
155271764|NCT00445601|560429644|FG000|Overall Study|TURBT Complication|12|||
155271765|NCT00445601|560429645|FG001|Overall Study|TURBT Complication|8|||
155271766|NCT00445601|560429644|FG000|Overall Study|Incorrect Disease Status|6|||
155271767|NCT00445601|560429645|FG001|Overall Study|Incorrect Disease Status|6|||
155271768|NCT00445601|560429644|FG000|Overall Study|Drug Delivery Issue|2|||
155271769|NCT00445601|560429645|FG001|Overall Study|Drug Delivery Issue|2|||
155271770|NCT00445601|560429644|FG000|Overall Study|Adverse Event|2|||
155271771|NCT00445601|560429645|FG001|Overall Study|Adverse Event|0|||
155271772|NCT00445601|560429644|FG000|Overall Study|Death prior to TURBT|0|||
155271773|NCT00445601|560429645|FG001|Overall Study|Death prior to TURBT|1|||
155271774|NCT01091428|560429646|FG000|Phase 1|Progressive Disease|24|||
155271775|NCT01091428|560429647|FG001|Phase 1|Progressive Disease|8|||
155271776|NCT01091428|560429648|FG002|Phase 1|Progressive Disease|0|||
155271777|NCT01091428|560429649|FG003|Phase 1|Progressive Disease|0|||
155271778|NCT01091428|560429646|FG000|Phase 1|Symptomatic Deterioration|3|||
155271779|NCT01091428|560429647|FG001|Phase 1|Symptomatic Deterioration|2|||
155271780|NCT01091428|560429648|FG002|Phase 1|Symptomatic Deterioration|0|||
155271781|NCT01091428|560429649|FG003|Phase 1|Symptomatic Deterioration|0|||
155271782|NCT01091428|560429646|FG000|Phase 1|Adverse Event|2|||
155271783|NCT01091428|560429647|FG001|Phase 1|Adverse Event|0|||
155271784|NCT01091428|560429648|FG002|Phase 1|Adverse Event|0|||
155271785|NCT01091428|560429649|FG003|Phase 1|Adverse Event|0|||
155271786|NCT01091428|560429646|FG000|Phase 1|Withdrawal by Subject|7|||
155271787|NCT01091428|560429647|FG001|Phase 1|Withdrawal by Subject|0|||
155271788|NCT01091428|560429648|FG002|Phase 1|Withdrawal by Subject|0|||
155271789|NCT01091428|560429649|FG003|Phase 1|Withdrawal by Subject|0|||
155271790|NCT01091428|560429646|FG000|Phase 1|Reason not specified|0|||
155271791|NCT01091428|560429647|FG001|Phase 1|Reason not specified|1|||
155271792|NCT01091428|560429648|FG002|Phase 1|Reason not specified|0|||
155271793|NCT01091428|560429649|FG003|Phase 1|Reason not specified|0|||
155271794|NCT01091428|560429646|FG000|Phase 1|Single-Patient IND|2|||
155271795|NCT01091428|560429647|FG001|Phase 1|Single-Patient IND|0|||
155271796|NCT01091428|560429648|FG002|Phase 1|Single-Patient IND|0|||
155271797|NCT01091428|560429649|FG003|Phase 1|Single-Patient IND|0|||
155615320|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
155615321|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
155615322|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
155615323|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
155615324|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Death|1|||
155271798|NCT01091428|560429646|FG000|Phase 2|Progressive Disease|0|||
155271799|NCT01091428|560429647|FG001|Phase 2|Progressive Disease|0|||
155381880|NCT02344004|560833230|FG001|Overall Study|Withdrawal by Subject|5|||
155615325|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Death|0|||
155615326|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
155271800|NCT01091428|560429648|FG002|Phase 2|Progressive Disease|44|||
155271801|NCT01091428|560429649|FG003|Phase 2|Progressive Disease|46|||
155271802|NCT01091428|560429646|FG000|Phase 2|Symptomatic Deterioration|0|||
155271803|NCT01091428|560429647|FG001|Phase 2|Symptomatic Deterioration|0|||
155271804|NCT01091428|560429648|FG002|Phase 2|Symptomatic Deterioration|1|||
155271805|NCT01091428|560429649|FG003|Phase 2|Symptomatic Deterioration|6|||
155271806|NCT01091428|560429646|FG000|Phase 2|Adverse Event|0|||
155271807|NCT01091428|560429647|FG001|Phase 2|Adverse Event|0|||
155271808|NCT01091428|560429648|FG002|Phase 2|Adverse Event|12|||
155271809|NCT01091428|560429649|FG003|Phase 2|Adverse Event|5|||
155271810|NCT01091428|560429646|FG000|Phase 2|Withdrawal by Subject|0|||
155271811|NCT01091428|560429647|FG001|Phase 2|Withdrawal by Subject|0|||
155271812|NCT01091428|560429648|FG002|Phase 2|Withdrawal by Subject|9|||
155271813|NCT01091428|560429649|FG003|Phase 2|Withdrawal by Subject|8|||
155271814|NCT01091428|560429646|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
155271815|NCT01091428|560429647|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
155271816|NCT01091428|560429648|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
155271817|NCT01091428|560429649|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
155271818|NCT01091428|560429646|FG000|Phase 2|Reason not specified|0|||
155271819|NCT01091428|560429647|FG001|Phase 2|Reason not specified|0|||
155271820|NCT01091428|560429648|FG002|Phase 2|Reason not specified|4|||
155271821|NCT01091428|560429649|FG003|Phase 2|Reason not specified|3|||
155271822|NCT01091428|560429646|FG000|Phase 2|Physician Decision|0|||
155271823|NCT01091428|560429647|FG001|Phase 2|Physician Decision|0|||
155271824|NCT01091428|560429648|FG002|Phase 2|Physician Decision|2|||
155271825|NCT01091428|560429649|FG003|Phase 2|Physician Decision|0|||
155271826|NCT04213989|560429656|FG000|Overall Study|Withdrawal by Subject|3|||
155271827|NCT04213989|560429657|FG001|Overall Study|Withdrawal by Subject|2|||
155726474|NCT01716234|562098140|FG000|Overall Study|Did not meet protocol eligibility|0|||
155271828|NCT04213989|560429656|FG000|Overall Study|Physician Decision|1|||
155271829|NCT04213989|560429657|FG001|Overall Study|Physician Decision|0|||
155271830|NCT04213989|560429656|FG000|Overall Study|Lost to Follow-up|0|||
155271831|NCT04213989|560429657|FG001|Overall Study|Lost to Follow-up|4|||
155271832|NCT03918239|560429660|FG000|Overall Study|Lost to Follow-up|3|||
155271833|NCT03918239|560429661|FG001|Overall Study|Lost to Follow-up|1|||
155271834|NCT03918239|560429660|FG000|Overall Study|Pregnancy|0|||
155271835|NCT03918239|560429661|FG001|Overall Study|Pregnancy|2|||
155271836|NCT03918239|560429660|FG000|Overall Study|Withdrawal by Subject|3|||
155271837|NCT03918239|560429661|FG001|Overall Study|Withdrawal by Subject|3|||
155271838|NCT03918239|560429660|FG000|Overall Study|positive urine drug screening results|4|||
155271839|NCT03918239|560429661|FG001|Overall Study|positive urine drug screening results|1|||
155271840|NCT00358215|560429663|FG000|Overall Study|Ineligibility determined|4|||
155271841|NCT00358215|560429664|FG001|Overall Study|Ineligibility determined|3|||
155271842|NCT00358215|560429663|FG000|Overall Study|Adverse Event|83|||
155271843|NCT00358215|560429664|FG001|Overall Study|Adverse Event|65|||
155271844|NCT00358215|560429663|FG000|Overall Study|Withdrawal by Subject|111|||
155271845|NCT00358215|560429664|FG001|Overall Study|Withdrawal by Subject|102|||
155271846|NCT00358215|560429663|FG000|Overall Study|Participant request|65|||
155271847|NCT00358215|560429664|FG001|Overall Study|Participant request|64|||
155271848|NCT00358215|560429663|FG000|Overall Study|Physician Decision|47|||
155271849|NCT00358215|560429664|FG001|Overall Study|Physician Decision|39|||
155271850|NCT00358215|560429663|FG000|Overall Study|Lost to Follow-up|16|||
155271851|NCT00358215|560429664|FG001|Overall Study|Lost to Follow-up|22|||
155271852|NCT00358215|560429663|FG000|Overall Study|Death|265|||
155271853|NCT00358215|560429664|FG001|Overall Study|Death|281|||
155271854|NCT00358215|560429663|FG000|Overall Study|Protocol Violation|64|||
155271855|NCT00358215|560429664|FG001|Overall Study|Protocol Violation|59|||
155271856|NCT00358215|560429663|FG000|Overall Study|Pregnancy|1|||
155271857|NCT00358215|560429664|FG001|Overall Study|Pregnancy|0|||
155271858|NCT00358215|560429663|FG000|Overall Study|Other|21|||
155271859|NCT00358215|560429664|FG001|Overall Study|Other|14|||
155271860|NCT00358215|560429663|FG000|Overall Study|Did not receive investigational product|2|||
155271861|NCT00358215|560429664|FG001|Overall Study|Did not receive investigational product|3|||
155271862|NCT00744237|560429665|FG000|Overall Study|Lack of Efficacy|1|||
155271863|NCT00744237|560429666|FG001|Overall Study|Lack of Efficacy|1|||
155271864|NCT00744237|560429667|FG002|Overall Study|Lack of Efficacy|0|||
155271865|NCT00744237|560429665|FG000|Overall Study|Withdrawal by Subject|9|||
155271866|NCT00744237|560429666|FG001|Overall Study|Withdrawal by Subject|5|||
155271867|NCT00744237|560429667|FG002|Overall Study|Withdrawal by Subject|3|||
155271868|NCT00744237|560429665|FG000|Overall Study|Lost to Follow-up|1|||
155271869|NCT00744237|560429666|FG001|Overall Study|Lost to Follow-up|1|||
155271870|NCT00744237|560429667|FG002|Overall Study|Lost to Follow-up|1|||
155271871|NCT00744237|560429665|FG000|Overall Study|Protocol Violation|3|||
155271872|NCT00744237|560429666|FG001|Overall Study|Protocol Violation|4|||
155271873|NCT00744237|560429667|FG002|Overall Study|Protocol Violation|3|||
155271874|NCT00744237|560429665|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
155271875|NCT00744237|560429666|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
155726475|NCT01716234|562098141|FG001|Overall Study|Did not meet protocol eligibility|0|||
155726476|NCT01716234|562098142|FG002|Overall Study|Did not meet protocol eligibility|1|||
155726477|NCT01716234|562098143|FG003|Overall Study|Did not meet protocol eligibility|0|||
155271876|NCT00744237|560429667|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
155271877|NCT00744237|560429665|FG000|Overall Study|Dosing Error|1|||
155271878|NCT00744237|560429666|FG001|Overall Study|Dosing Error|0|||
155271879|NCT00744237|560429667|FG002|Overall Study|Dosing Error|1|||
155271880|NCT00744237|560429665|FG000|Overall Study|Study Drug Error|1|||
155271881|NCT00744237|560429666|FG001|Overall Study|Study Drug Error|0|||
155271882|NCT00744237|560429667|FG002|Overall Study|Study Drug Error|0|||
155271883|NCT00744237|560429665|FG000|Overall Study|Prohibited Concomitant Medication|0|||
155271884|NCT00744237|560429666|FG001|Overall Study|Prohibited Concomitant Medication|0|||
155271885|NCT00744237|560429667|FG002|Overall Study|Prohibited Concomitant Medication|1|||
155615327|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
155615328|NCT00105989|561684891|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
155615329|NCT00105989|561684892|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
155615330|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
155615331|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
155615332|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
155615333|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
155615334|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
155615335|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
155615336|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
155615337|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
155615338|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
155615339|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
155615340|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
155615341|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
155615342|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
155615343|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
155615344|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Death|0|||
155615345|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Death|0|||
155615346|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
155615347|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
155615348|NCT00105989|561684891|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
155615349|NCT00105989|561684892|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
155615350|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
155615351|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
155271886|NCT00744237|560429665|FG000|Overall Study|Poor Compliance|0|||
155271887|NCT00744237|560429666|FG001|Overall Study|Poor Compliance|2|||
155271888|NCT00744237|560429667|FG002|Overall Study|Poor Compliance|0|||
155271889|NCT00744237|560429665|FG000|Overall Study|Administrative. Site Closed|1|||
155271890|NCT00744237|560429666|FG001|Overall Study|Administrative. Site Closed|1|||
155271891|NCT00744237|560429667|FG002|Overall Study|Administrative. Site Closed|1|||
155271892|NCT00744237|560429665|FG000|Overall Study|Adverse Event|9|||
155271893|NCT00744237|560429666|FG001|Overall Study|Adverse Event|13|||
155271894|NCT00744237|560429667|FG002|Overall Study|Adverse Event|5|||
155271895|NCT06017999|560429668|FG000|Overall Study|Withdrawal by Subject|0|||
155271896|NCT06017999|560429669|FG001|Overall Study|Withdrawal by Subject|4|||
155271897|NCT06017999|560429670|FG002|Overall Study|Withdrawal by Subject|3|||
155271898|NCT06017999|560429668|FG000|Overall Study|Adverse Event|2|||
155271899|NCT06017999|560429669|FG001|Overall Study|Adverse Event|1|||
155271900|NCT06017999|560429670|FG002|Overall Study|Adverse Event|1|||
155271901|NCT06017999|560429668|FG000|Overall Study|Lost to Follow-up|0|||
155271902|NCT06017999|560429669|FG001|Overall Study|Lost to Follow-up|0|||
155271903|NCT06017999|560429670|FG002|Overall Study|Lost to Follow-up|1|||
155271904|NCT06017999|560429668|FG000|Overall Study|Physician Decision|1|||
155271905|NCT06017999|560429669|FG001|Overall Study|Physician Decision|1|||
155271906|NCT06017999|560429670|FG002|Overall Study|Physician Decision|0|||
155271907|NCT06017999|560429668|FG000|Overall Study|Non-Compliance|0|||
155271908|NCT06017999|560429669|FG001|Overall Study|Non-Compliance|0|||
155271909|NCT06017999|560429670|FG002|Overall Study|Non-Compliance|1|||
155271910|NCT06017999|560429668|FG000|Overall Study|Lack of Efficacy|1|||
155271911|NCT06017999|560429669|FG001|Overall Study|Lack of Efficacy|0|||
155271912|NCT06017999|560429670|FG002|Overall Study|Lack of Efficacy|7|||
155271913|NCT06017999|560429668|FG000|Overall Study|COVID Positive|0|||
155271914|NCT06017999|560429669|FG001|Overall Study|COVID Positive|1|||
155271915|NCT06017999|560429670|FG002|Overall Study|COVID Positive|0|||
155271916|NCT06017999|560429668|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
155271917|NCT06017999|560429669|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
155271918|NCT06017999|560429670|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
155271919|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
155271920|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
155271921|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271922|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271923|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271924|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271925|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
155271926|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
155381881|NCT02344004|560833229|FG000|Overall Study|Rescue Medication|2|||
155615352|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
155615353|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
155615354|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
155615355|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
155615356|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
155615357|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
155615358|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
155615359|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
155615360|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
155615361|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
155726478|NCT01716234|562098144|FG004|Overall Study|Did not meet protocol eligibility|0|||
155726479|NCT01716234|562098145|FG005|Overall Study|Did not meet protocol eligibility|4|||
155726480|NCT01716234|562098146|FG006|Overall Study|Did not meet protocol eligibility|0|||
155726481|NCT01716234|562098140|FG000|Overall Study|Adverse Event|7|||
155726482|NCT01716234|562098141|FG001|Overall Study|Adverse Event|10|||
155726483|NCT01716234|562098142|FG002|Overall Study|Adverse Event|2|||
155726484|NCT01716234|562098143|FG003|Overall Study|Adverse Event|8|||
155726485|NCT01716234|562098144|FG004|Overall Study|Adverse Event|3|||
155726486|NCT01716234|562098145|FG005|Overall Study|Adverse Event|6|||
155726487|NCT01716234|562098146|FG006|Overall Study|Adverse Event|0|||
155726488|NCT01716234|562098140|FG000|Overall Study|Withdrawal by Subject|3|||
155726489|NCT01716234|562098141|FG001|Overall Study|Withdrawal by Subject|0|||
155726490|NCT01716234|562098142|FG002|Overall Study|Withdrawal by Subject|2|||
155726491|NCT01716234|562098143|FG003|Overall Study|Withdrawal by Subject|2|||
155726492|NCT01716234|562098144|FG004|Overall Study|Withdrawal by Subject|1|||
155726493|NCT01716234|562098145|FG005|Overall Study|Withdrawal by Subject|3|||
155726494|NCT01716234|562098146|FG006|Overall Study|Withdrawal by Subject|0|||
155726495|NCT02667119|562098147|FG000|Overall Study|Lost to Follow-up|3|||
155726496|NCT02667119|562098148|FG001|Overall Study|Lost to Follow-up|0|||
155726497|NCT01523756|562098149|FG000|Baseline Period|Adverse Event|0|||
155726498|NCT01523756|562098150|FG001|Baseline Period|Adverse Event|1|||
155726499|NCT01523756|562098149|FG000|Test Period 1|Adverse Event|1|||
155726500|NCT01523756|562098150|FG001|Test Period 1|Adverse Event|0|||
155726501|NCT01523756|562098149|FG000|Test Period 2|Withdrawal by Subject|0|||
155726502|NCT01523756|562098150|FG001|Test Period 2|Withdrawal by Subject|1|||
155726503|NCT00993967|562098151|FG000|Overall Study|Adverse Event|8|||
155726504|NCT00993967|562098151|FG000|Overall Study|Death|1|||
155726505|NCT00993967|562098151|FG000|Overall Study|Lost to Follow-up|14|||
155726506|NCT00993967|562098151|FG000|Overall Study|Withdrawal by Subject|36|||
155726507|NCT00993967|562098151|FG000|Overall Study|Protocol Violation|2|||
155726508|NCT03783078|562098154|FG000|Overall Study|Death|31|||
155726509|NCT03783078|562098154|FG000|Overall Study|Sponsor Decision|23|||
155726510|NCT03783078|562098154|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155726511|NCT01467960|562098156|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155726512|NCT01467960|562098157|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155726513|NCT01467960|562098158|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155726514|NCT01467960|562098159|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155726515|NCT01467960|562098160|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155726516|NCT01467960|562098161|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155726517|NCT00474812|562098164|FG000|Overall Study|Withdrawal by Subject|5|||
155726518|NCT00474812|562098164|FG000|Overall Study|No Initiation of treatment|2|||
155726519|NCT00651742|562098176|FG000|Overall Study|Objective Disease Progression|22|||
155726520|NCT00651742|562098176|FG000|Overall Study|Toxicity|3|||
155726521|NCT00651742|562098176|FG000|Overall Study|Investigator Judgment|1|||
155726522|NCT00651742|562098176|FG000|Overall Study|Withdrawal of Consent|1|||
155726523|NCT00651742|562098176|FG000|Overall Study|Enrolled but not treated|1|||
155726524|NCT05720897|562098179|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
155726525|NCT05720897|562098180|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
155726526|NCT04780061|562098181|FG000|Overall Study|Withdrawal by Subject|5|||
155726527|NCT04780061|562098182|FG001|Overall Study|Withdrawal by Subject|8|||
155726528|NCT04780061|562098181|FG000|Overall Study|Adverse Event|2|||
155726529|NCT04780061|562098182|FG001|Overall Study|Adverse Event|2|||
155726530|NCT04780061|562098181|FG000|Overall Study|Lost to Follow-up|1|||
155726531|NCT04780061|562098182|FG001|Overall Study|Lost to Follow-up|5|||
155726532|NCT04050553|562098184|FG000|Period 1|Physician Decision|2|||
155726533|NCT04050553|562098185|FG001|Period 1|Physician Decision|2|||
155726534|NCT04050553|562098184|FG000|Period 1|Adverse Event|1|||
155726535|NCT04050553|562098185|FG001|Period 1|Adverse Event|1|||
155726536|NCT04050553|562098184|FG000|Period 1|Withdrawal by Subject|0|||
155726537|NCT04050553|562098185|FG001|Period 1|Withdrawal by Subject|1|||
155726538|NCT04050553|562098184|FG000|Wash-out|Adverse Event|0|||
155726539|NCT04050553|562098185|FG001|Wash-out|Adverse Event|1|||
155726540|NCT04050553|562098184|FG000|Wash-out|Withdrawal by Subject|0|||
155726541|NCT04050553|562098185|FG001|Wash-out|Withdrawal by Subject|1|||
155726542|NCT01535040|562098186|FG000|Overall Study|Physician Decision|0|||
155726543|NCT01535040|562098187|FG001|Overall Study|Physician Decision|1|||
155615362|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
155271927|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271928|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271929|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271930|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271931|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
155271932|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
155271933|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271934|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271935|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271936|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271937|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271938|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
155271939|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271940|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271941|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271942|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271943|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
155271944|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271945|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271946|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271947|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271948|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271949|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
155271950|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
155271951|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271952|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271953|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271954|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271955|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
155271956|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
155271957|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271958|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271959|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271960|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271961|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
155271962|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
155271963|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271964|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271965|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271966|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271967|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
155271968|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
155271969|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
155271970|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
155615363|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
155615364|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
155615365|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
155615366|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
155615367|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
155615368|NCT00105989|561684891|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
155615369|NCT00105989|561684892|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
155615370|NCT03280056|561684893|FG000|Overall Study|Withdrawal by Subject|12|||
155615371|NCT03280056|561684894|FG001|Overall Study|Withdrawal by Subject|14|||
155615372|NCT03280056|561684893|FG000|Overall Study|Death|9|||
155615373|NCT03280056|561684894|FG001|Overall Study|Death|2|||
155615374|NCT03280056|561684893|FG000|Overall Study|Adverse Event|1|||
155615375|NCT03280056|561684894|FG001|Overall Study|Adverse Event|3|||
155615376|NCT03280056|561684893|FG000|Overall Study|Lost to Follow-up|1|||
155271971|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
155271972|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
155271973|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
155615377|NCT03280056|561684894|FG001|Overall Study|Lost to Follow-up|1|||
155271974|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
155271975|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271976|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271977|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155615378|NCT03280056|561684893|FG000|Overall Study|Physician Decision|0|||
155615379|NCT03280056|561684894|FG001|Overall Study|Physician Decision|1|||
155615380|NCT03280056|561684893|FG000|Overall Study|Early Discontinuation|1|||
155271978|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271979|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271980|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271981|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271982|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
155271983|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
155271984|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271985|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271986|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271987|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
155271988|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271989|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271990|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271991|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271992|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271993|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271994|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271995|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271996|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271997|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
155271998|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
155271999|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
155272000|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
155272001|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
155272002|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
155272003|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272004|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272005|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
155272006|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272007|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
155272008|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
155272009|NCT01757665|560429684|FG000|Overall Study|Still on Study - Visit Completed|240|||
155272010|NCT01757665|560429685|FG001|Overall Study|Still on Study - Visit Completed|30|||
155272011|NCT01757665|560429684|FG000|Overall Study|Still on Study - Visit Pending|398|||
155272012|NCT01757665|560429685|FG001|Overall Study|Still on Study - Visit Pending|40|||
155272013|NCT01757665|560429684|FG000|Overall Study|Still on Study - Missed Visit|14|||
155272014|NCT01757665|560429685|FG001|Overall Study|Still on Study - Missed Visit|1|||
155272015|NCT01757665|560429684|FG000|Overall Study|Death|25|||
155272016|NCT01757665|560429685|FG001|Overall Study|Death|8|||
155272017|NCT01757665|560429684|FG000|Overall Study|Explant|1|||
155272018|NCT01757665|560429685|FG001|Overall Study|Explant|2|||
155272019|NCT01757665|560429684|FG000|Overall Study|Withdrawal by Subject|10|||
155272020|NCT01757665|560429685|FG001|Overall Study|Withdrawal by Subject|0|||
155272021|NCT01757665|560429684|FG000|Overall Study|Lost to Follow-up|1|||
155272022|NCT01757665|560429685|FG001|Overall Study|Lost to Follow-up|1|||
155272023|NCT01757665|560429684|FG000|Overall Study|Not Implanted with Device|5|||
155272024|NCT01757665|560429685|FG001|Overall Study|Not Implanted with Device|1|||
155272025|NCT01702428|560429686|FG000|Overall Study|Adverse Event|2|||
155272026|NCT01702428|560429687|FG001|Overall Study|Adverse Event|0|||
155272027|NCT01702428|560429688|FG002|Overall Study|Adverse Event|0|||
155272028|NCT01702428|560429689|FG003|Overall Study|Adverse Event|0|||
155272029|NCT01702428|560429686|FG000|Overall Study|Lost to Follow-up|33|||
155272030|NCT01702428|560429687|FG001|Overall Study|Lost to Follow-up|41|||
155272031|NCT01702428|560429688|FG002|Overall Study|Lost to Follow-up|37|||
155272032|NCT01702428|560429689|FG003|Overall Study|Lost to Follow-up|44|||
155272033|NCT01702428|560429686|FG000|Overall Study|Parents cannot assist to site|1|||
155272034|NCT01702428|560429687|FG001|Overall Study|Parents cannot assist to site|0|||
155272035|NCT01702428|560429688|FG002|Overall Study|Parents cannot assist to site|1|||
155272036|NCT01702428|560429689|FG003|Overall Study|Parents cannot assist to site|0|||
155272037|NCT01702428|560429686|FG000|Overall Study|Lost Coverage|0|||
155272038|NCT01702428|560429687|FG001|Overall Study|Lost Coverage|0|||
155272039|NCT01702428|560429688|FG002|Overall Study|Lost Coverage|0|||
155272040|NCT01702428|560429689|FG003|Overall Study|Lost Coverage|1|||
155272041|NCT01702428|560429686|FG000|Overall Study|Lost Health Plan|3|||
155272042|NCT01702428|560429687|FG001|Overall Study|Lost Health Plan|5|||
155272043|NCT01702428|560429688|FG002|Overall Study|Lost Health Plan|0|||
155272044|NCT01702428|560429689|FG003|Overall Study|Lost Health Plan|2|||
155272045|NCT01702428|560429686|FG000|Overall Study|Mother transferred care|0|||
155272046|NCT01702428|560429687|FG001|Overall Study|Mother transferred care|1|||
155272047|NCT01702428|560429688|FG002|Overall Study|Mother transferred care|0|||
155272048|NCT01702428|560429689|FG003|Overall Study|Mother transferred care|0|||
155272049|NCT01702428|560429686|FG000|Overall Study|Parents too busy|1|||
155726544|NCT01535040|562098186|FG000|Overall Study|Withdrawal by Subject|13|||
155615381|NCT03280056|561684894|FG001|Overall Study|Early Discontinuation|0|||
155615382|NCT01029262|561684896|FG000|Overall Study|Adverse Event|9|||
155615383|NCT01029262|561684897|FG001|Overall Study|Adverse Event|52|||
155615384|NCT01029262|561684896|FG000|Overall Study|Lack of therapeutic effect|57|||
155615385|NCT01029262|561684897|FG001|Overall Study|Lack of therapeutic effect|76|||
155615386|NCT01029262|561684896|FG000|Overall Study|Withdrawal by Subject|10|||
155615387|NCT01029262|561684897|FG001|Overall Study|Withdrawal by Subject|17|||
155615388|NCT01029262|561684896|FG000|Overall Study|Protocol Violation|2|||
155615389|NCT01029262|561684897|FG001|Overall Study|Protocol Violation|3|||
155615390|NCT01029262|561684896|FG000|Overall Study|Miscellaneous|1|||
155615391|NCT01029262|561684897|FG001|Overall Study|Miscellaneous|9|||
155615392|NCT01029262|561684896|FG000|Overall Study|Death|0|||
155272050|NCT01702428|560429687|FG001|Overall Study|Parents too busy|0|||
155272051|NCT01702428|560429688|FG002|Overall Study|Parents too busy|0|||
155272052|NCT01702428|560429689|FG003|Overall Study|Parents too busy|0|||
155272053|NCT01702428|560429686|FG000|Overall Study|Protocol Violation|3|||
155272054|NCT01702428|560429687|FG001|Overall Study|Protocol Violation|0|||
155272055|NCT01702428|560429688|FG002|Overall Study|Protocol Violation|1|||
155272056|NCT01702428|560429689|FG003|Overall Study|Protocol Violation|0|||
155272057|NCT01702428|560429686|FG000|Overall Study|Withdrawal by Subject|21|||
155272058|NCT01702428|560429687|FG001|Overall Study|Withdrawal by Subject|23|||
155615393|NCT01029262|561684897|FG001|Overall Study|Death|3|||
155615394|NCT00807612|561684900|FG000|Overall Study|Death|8|||
155272059|NCT01702428|560429688|FG002|Overall Study|Withdrawal by Subject|14|||
155615395|NCT00807612|561684900|FG000|Overall Study|Study early termination|5|||
155615396|NCT00807612|561684900|FG000|Overall Study|Withdrawal by Subject|1|||
155272060|NCT01702428|560429689|FG003|Overall Study|Withdrawal by Subject|10|||
155272061|NCT02091869|560429690|FG000|Overall Study|Withdrawal by Subject|0|||
155272062|NCT02091869|560429691|FG001|Overall Study|Withdrawal by Subject|3|||
155272063|NCT01533714|560429693|FG000|Overall Study|Adverse Event|0|||
155272064|NCT01533714|560429694|FG001|Overall Study|Adverse Event|1|||
155272065|NCT01533714|560429695|FG002|Overall Study|Adverse Event|2|||
155272066|NCT01533714|560429696|FG003|Overall Study|Adverse Event|2|||
155272067|NCT01533714|560429697|FG004|Overall Study|Adverse Event|2|||
155272068|NCT01533714|560429698|FG005|Overall Study|Adverse Event|1|||
155272069|NCT01533714|560429693|FG000|Overall Study|Lack of Efficacy|0|||
155272070|NCT01533714|560429694|FG001|Overall Study|Lack of Efficacy|0|||
155272071|NCT01533714|560429695|FG002|Overall Study|Lack of Efficacy|0|||
155272072|NCT01533714|560429696|FG003|Overall Study|Lack of Efficacy|0|||
155272073|NCT01533714|560429697|FG004|Overall Study|Lack of Efficacy|0|||
155272074|NCT01533714|560429698|FG005|Overall Study|Lack of Efficacy|1|||
155272075|NCT01533714|560429693|FG000|Overall Study|Withdrawal by Subject|0|||
155615397|NCT04607135|561684901|FG000|Overall Study|Physician Decision|1|||
155615398|NCT04607135|561684901|FG000|Overall Study|Withdrawal by Subject|1|||
155615399|NCT04607135|561684901|FG000|Overall Study|Equipment not working|3|||
155615400|NCT03465709|561684902|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
155272076|NCT01533714|560429694|FG001|Overall Study|Withdrawal by Subject|1|||
155272077|NCT01533714|560429695|FG002|Overall Study|Withdrawal by Subject|0|||
155272078|NCT01533714|560429696|FG003|Overall Study|Withdrawal by Subject|1|||
155272079|NCT01533714|560429697|FG004|Overall Study|Withdrawal by Subject|1|||
155272080|NCT01533714|560429698|FG005|Overall Study|Withdrawal by Subject|0|||
155272081|NCT01533714|560429693|FG000|Overall Study|Exclusion criteria|0|||
155615401|NCT03465709|561684902|FG000|Overall Study|Withdrawal by Subject|3|||
155615402|NCT00705341|561684903|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
155615403|NCT00705341|561684904|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
155615404|NCT00705341|561684905|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
155615405|NCT00705341|561684906|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
155615406|NCT00705341|561684903|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155615407|NCT00705341|561684904|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155272082|NCT01533714|560429694|FG001|Overall Study|Exclusion criteria|1|||
155272083|NCT01533714|560429695|FG002|Overall Study|Exclusion criteria|0|||
155272084|NCT01533714|560429696|FG003|Overall Study|Exclusion criteria|0|||
155272085|NCT01533714|560429697|FG004|Overall Study|Exclusion criteria|0|||
155272086|NCT01533714|560429698|FG005|Overall Study|Exclusion criteria|0|||
155272087|NCT01533714|560429693|FG000|Overall Study|Positive for purified protein derivative|0|||
155272088|NCT01533714|560429694|FG001|Overall Study|Positive for purified protein derivative|0|||
155272089|NCT01533714|560429695|FG002|Overall Study|Positive for purified protein derivative|1|||
155272090|NCT01533714|560429696|FG003|Overall Study|Positive for purified protein derivative|0|||
155272091|NCT01533714|560429697|FG004|Overall Study|Positive for purified protein derivative|1|||
155272092|NCT01533714|560429698|FG005|Overall Study|Positive for purified protein derivative|0|||
155272093|NCT01533714|560429693|FG000|Overall Study|Withdrawal criteria|0|||
155272094|NCT01533714|560429694|FG001|Overall Study|Withdrawal criteria|0|||
155615408|NCT00705341|561684905|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
155615409|NCT00705341|561684906|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155615410|NCT03665077|561684909|FG000|Overall Study|Lost to Follow-up|2|||
155615411|NCT03665077|561684909|FG000|Overall Study|Physician Decision|2|||
155615412|NCT02959918|561684914|FG000|Overall Study|Adverse Event|1|||
155272095|NCT01533714|560429695|FG002|Overall Study|Withdrawal criteria|1|||
155272096|NCT01533714|560429696|FG003|Overall Study|Withdrawal criteria|0|||
155272097|NCT01533714|560429697|FG004|Overall Study|Withdrawal criteria|3|||
155272098|NCT01533714|560429698|FG005|Overall Study|Withdrawal criteria|1|||
155272099|NCT01533714|560429693|FG000|Overall Study|Ineligibility reason|0|||
155272100|NCT01533714|560429694|FG001|Overall Study|Ineligibility reason|0|||
155272101|NCT01533714|560429695|FG002|Overall Study|Ineligibility reason|0|||
155272102|NCT01533714|560429696|FG003|Overall Study|Ineligibility reason|1|||
155272103|NCT01533714|560429697|FG004|Overall Study|Ineligibility reason|0|||
155272104|NCT01533714|560429698|FG005|Overall Study|Ineligibility reason|0|||
155272105|NCT02564055|560429703|FG000|Overall Study|Adverse Event|1|||
155272106|NCT02564055|560429704|FG001|Overall Study|Adverse Event|0|||
155272107|NCT02564055|560429705|FG002|Overall Study|Adverse Event|4|||
155272108|NCT02564055|560429706|FG003|Overall Study|Adverse Event|1|||
155272109|NCT02564055|560429707|FG004|Overall Study|Adverse Event|4|||
155272110|NCT02564055|560429708|FG005|Overall Study|Adverse Event|1|||
155272111|NCT02564055|560429703|FG000|Overall Study|Protocol Violation|1|||
155272112|NCT02564055|560429704|FG001|Overall Study|Protocol Violation|0|||
155272113|NCT02564055|560429705|FG002|Overall Study|Protocol Violation|0|||
155272114|NCT02564055|560429706|FG003|Overall Study|Protocol Violation|0|||
155272115|NCT02564055|560429707|FG004|Overall Study|Protocol Violation|0|||
155272116|NCT02564055|560429708|FG005|Overall Study|Protocol Violation|0|||
155272117|NCT02564055|560429703|FG000|Overall Study|Reached stopping criteria|0|||
155272118|NCT02564055|560429704|FG001|Overall Study|Reached stopping criteria|0|||
155272119|NCT02564055|560429705|FG002|Overall Study|Reached stopping criteria|0|||
155272120|NCT02564055|560429706|FG003|Overall Study|Reached stopping criteria|0|||
155272121|NCT02564055|560429707|FG004|Overall Study|Reached stopping criteria|0|||
155272122|NCT02564055|560429708|FG005|Overall Study|Reached stopping criteria|1|||
155272123|NCT02564055|560429703|FG000|Overall Study|Lost to Follow-up|0|||
155272124|NCT02564055|560429704|FG001|Overall Study|Lost to Follow-up|1|||
155272125|NCT02564055|560429705|FG002|Overall Study|Lost to Follow-up|4|||
155272126|NCT02564055|560429706|FG003|Overall Study|Lost to Follow-up|2|||
155272127|NCT02564055|560429707|FG004|Overall Study|Lost to Follow-up|1|||
155272128|NCT02564055|560429708|FG005|Overall Study|Lost to Follow-up|0|||
155272129|NCT02564055|560429703|FG000|Overall Study|Physician Decision|0|||
155272130|NCT02564055|560429704|FG001|Overall Study|Physician Decision|0|||
155272131|NCT02564055|560429705|FG002|Overall Study|Physician Decision|1|||
155381882|NCT02344004|560833230|FG001|Overall Study|Rescue Medication|0|||
155381883|NCT02344004|560833229|FG000|Overall Study|Other Not Specified|12|||
155381884|NCT02344004|560833230|FG001|Overall Study|Other Not Specified|0|||
155381885|NCT02344004|560833229|FG000|Overall Study|Protocol Violation|1|||
155381886|NCT02344004|560833230|FG001|Overall Study|Protocol Violation|0|||
155381887|NCT00577577|560833232|FG000|Overall Study|Adverse Event|3|||
155381888|NCT00577577|560833233|FG001|Overall Study|Adverse Event|2|||
155381889|NCT00577577|560833232|FG000|Overall Study|Lost to Follow-up|1|||
155381890|NCT00577577|560833233|FG001|Overall Study|Lost to Follow-up|0|||
155381891|NCT00577577|560833232|FG000|Overall Study|Protocol Violation|0|||
155381892|NCT00577577|560833233|FG001|Overall Study|Protocol Violation|3|||
155381893|NCT00577577|560833232|FG000|Overall Study|Transportation|1|||
155381894|NCT00577577|560833233|FG001|Overall Study|Transportation|0|||
155381895|NCT00232544|560833234|FG000|Overall Study|Lost to Follow-up|20|||
155381896|NCT00232544|560833235|FG001|Overall Study|Lost to Follow-up|15|||
155381897|NCT00116753|560833236|FG000|Overall Study|Adverse Event|16|||
155381898|NCT00116753|560833237|FG001|Overall Study|Adverse Event|10|||
155381899|NCT00116753|560833238|FG002|Overall Study|Adverse Event|7|||
155381900|NCT00116753|560833236|FG000|Overall Study|Withdrawal by Subject|11|||
155381901|NCT00116753|560833237|FG001|Overall Study|Withdrawal by Subject|12|||
155381902|NCT00116753|560833238|FG002|Overall Study|Withdrawal by Subject|8|||
155381903|NCT00116753|560833236|FG000|Overall Study|Lost to Follow-up|0|||
155381904|NCT00116753|560833237|FG001|Overall Study|Lost to Follow-up|2|||
155381905|NCT00116753|560833238|FG002|Overall Study|Lost to Follow-up|1|||
155381906|NCT00116753|560833236|FG000|Overall Study|Protocol Violation|0|||
155381907|NCT00116753|560833237|FG001|Overall Study|Protocol Violation|0|||
155381908|NCT00116753|560833238|FG002|Overall Study|Protocol Violation|1|||
155381909|NCT00116753|560833236|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
155381910|NCT00116753|560833237|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
155381911|NCT00116753|560833238|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
155381912|NCT00116753|560833236|FG000|Overall Study|Disease Progression|3|||
155381913|NCT00116753|560833237|FG001|Overall Study|Disease Progression|4|||
155381914|NCT00116753|560833238|FG002|Overall Study|Disease Progression|3|||
155381915|NCT00116753|560833236|FG000|Overall Study|Abnormal Echocardiogram|0|||
155381916|NCT00116753|560833237|FG001|Overall Study|Abnormal Echocardiogram|0|||
155381917|NCT00116753|560833238|FG002|Overall Study|Abnormal Echocardiogram|1|||
155381918|NCT00116753|560833236|FG000|Overall Study|Progressive Parkinson's Disease|1|||
155381919|NCT00116753|560833237|FG001|Overall Study|Progressive Parkinson's Disease|0|||
155272132|NCT02564055|560429706|FG003|Overall Study|Physician Decision|0|||
155272133|NCT02564055|560429707|FG004|Overall Study|Physician Decision|0|||
155272134|NCT02564055|560429708|FG005|Overall Study|Physician Decision|0|||
155381920|NCT00116753|560833238|FG002|Overall Study|Progressive Parkinson's Disease|0|||
155272135|NCT02564055|560429703|FG000|Overall Study|Withdrawal by Subject|4|||
155272136|NCT02564055|560429704|FG001|Overall Study|Withdrawal by Subject|4|||
155272137|NCT02564055|560429705|FG002|Overall Study|Withdrawal by Subject|3|||
155272138|NCT02564055|560429706|FG003|Overall Study|Withdrawal by Subject|3|||
155272139|NCT02564055|560429707|FG004|Overall Study|Withdrawal by Subject|10|||
155272140|NCT02564055|560429708|FG005|Overall Study|Withdrawal by Subject|10|||
155272141|NCT01375959|560429709|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
155272142|NCT01375959|560429710|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
155272143|NCT01375959|560429709|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
155272144|NCT01375959|560429710|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
155272145|NCT01375959|560429709|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155272146|NCT01375959|560429710|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
155272147|NCT02771210|560429711|FG000|Period 1|Adverse Event|5|||
155272148|NCT02771210|560429712|FG001|Period 1|Adverse Event|3|||
155272149|NCT02771210|560429711|FG000|Period 1|Lack of Efficacy|3|||
155272150|NCT02771210|560429712|FG001|Period 1|Lack of Efficacy|6|||
155272151|NCT02771210|560429711|FG000|Period 1|Lost to Follow-up|2|||
155272152|NCT02771210|560429712|FG001|Period 1|Lost to Follow-up|0|||
155272153|NCT02771210|560429711|FG000|Period 1|Physician Decision|0|||
155272154|NCT02771210|560429712|FG001|Period 1|Physician Decision|1|||
155272155|NCT02771210|560429711|FG000|Period 1|Withdrawal by Subject|0|||
155272156|NCT02771210|560429712|FG001|Period 1|Withdrawal by Subject|3|||
155272157|NCT02771210|560429711|FG000|Period 1|Withdrawal of informed consent|1|||
155272158|NCT02771210|560429712|FG001|Period 1|Withdrawal of informed consent|5|||
155272159|NCT02771210|560429711|FG000|Period 2|Adverse Event|1|||
155272160|NCT02771210|560429712|FG001|Period 2|Adverse Event|0|||
155272161|NCT02771210|560429711|FG000|Period 2|Lack of Efficacy|0|||
155272162|NCT02771210|560429712|FG001|Period 2|Lack of Efficacy|1|||
155272163|NCT02771210|560429711|FG000|Period 2|Withdrawal by Subject|1|||
155272164|NCT02771210|560429712|FG001|Period 2|Withdrawal by Subject|0|||
155272165|NCT02771210|560429711|FG000|Period 2|Withdrawal of informed consent|0|||
155272166|NCT02771210|560429712|FG001|Period 2|Withdrawal of informed consent|2|||
155272167|NCT04012814|560429717|FG000|Overall Study|Lost to Follow-up|4|||
155272168|NCT04012814|560429717|FG000|Overall Study|Withdrawal by Subject|2|||
155272169|NCT04012814|560429717|FG000|Overall Study|Protocol Violation|1|||
155272170|NCT04012814|560429717|FG000|Overall Study|Adverse Event|1|||
155272171|NCT04397523|560429718|FG000|Overall Study|Lost to Follow-up|3|||
155272172|NCT04397523|560429718|FG000|Overall Study|Transfer from/to other hospital|8|||
155272173|NCT04789577|560429719|FG000|Overall Study|Withdrawal by Subject|1|||
155272174|NCT04789577|560429720|FG001|Overall Study|Withdrawal by Subject|1|||
155272175|NCT04789577|560429721|FG002|Overall Study|Withdrawal by Subject|1|||
155272176|NCT04789577|560429722|FG003|Overall Study|Withdrawal by Subject|3|||
155272177|NCT04789577|560429723|FG004|Overall Study|Withdrawal by Subject|1|||
155272178|NCT04789577|560429724|FG005|Overall Study|Withdrawal by Subject|7|||
155272179|NCT04789577|560429725|FG006|Overall Study|Withdrawal by Subject|1|||
155272180|NCT04789577|560429719|FG000|Overall Study|Lost to Follow-up|7|||
155272181|NCT04789577|560429720|FG001|Overall Study|Lost to Follow-up|12|||
155272182|NCT04789577|560429721|FG002|Overall Study|Lost to Follow-up|7|||
155272183|NCT04789577|560429722|FG003|Overall Study|Lost to Follow-up|10|||
155272184|NCT04789577|560429723|FG004|Overall Study|Lost to Follow-up|8|||
155272185|NCT04789577|560429724|FG005|Overall Study|Lost to Follow-up|6|||
155272186|NCT04789577|560429725|FG006|Overall Study|Lost to Follow-up|10|||
155272187|NCT04789577|560429719|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
155272188|NCT04789577|560429720|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
155272189|NCT04789577|560429721|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
155272190|NCT04789577|560429722|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
155272191|NCT04789577|560429723|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
155272192|NCT04789577|560429724|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
155272193|NCT04789577|560429725|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
155272194|NCT04789577|560429719|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
155272195|NCT04789577|560429720|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
155272196|NCT04789577|560429721|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
155272197|NCT04789577|560429722|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
155272198|NCT04789577|560429723|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
155272199|NCT04789577|560429724|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
155272200|NCT04789577|560429725|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
155272201|NCT01275196|560429726|FG000|Overall Study|Adverse Event|3|||
155272202|NCT01275196|560429727|FG001|Overall Study|Adverse Event|5|||
155272203|NCT01275196|560429726|FG000|Overall Study|Withdrawal by Subject|4|||
155272204|NCT01275196|560429727|FG001|Overall Study|Withdrawal by Subject|5|||
155272205|NCT01275196|560429726|FG000|Overall Study|Lost to Follow-up|1|||
155272206|NCT01275196|560429727|FG001|Overall Study|Lost to Follow-up|0|||
155272207|NCT01275196|560429726|FG000|Overall Study|Disease Progression|6|||
155272208|NCT01275196|560429727|FG001|Overall Study|Disease Progression|5|||
155272209|NCT01275196|560429726|FG000|Overall Study|Protocol Violation|1|||
155272210|NCT01275196|560429727|FG001|Overall Study|Protocol Violation|0|||
155272211|NCT01275196|560429726|FG000|Overall Study|Suboptimal response/treatment failure|5|||
155272212|NCT01275196|560429727|FG001|Overall Study|Suboptimal response/treatment failure|6|||
155272213|NCT01027364|560429728|FG000|Overall Study|Adverse Event|1|||
155272214|NCT01027364|560429729|FG001|Overall Study|Adverse Event|0|||
155272215|NCT01027364|560429730|FG002|Overall Study|Adverse Event|1|||
155272216|NCT01027364|560429731|FG003|Overall Study|Adverse Event|0|||
155272217|NCT01027364|560429728|FG000|Overall Study|Lost to Follow-up|1|||
155272218|NCT01027364|560429729|FG001|Overall Study|Lost to Follow-up|0|||
155272219|NCT01027364|560429730|FG002|Overall Study|Lost to Follow-up|0|||
155272220|NCT01027364|560429731|FG003|Overall Study|Lost to Follow-up|0|||
155272221|NCT01027364|560429728|FG000|Overall Study|Protocol Violation|1|||
155272222|NCT01027364|560429729|FG001|Overall Study|Protocol Violation|0|||
155272223|NCT01027364|560429730|FG002|Overall Study|Protocol Violation|0|||
155272224|NCT01027364|560429731|FG003|Overall Study|Protocol Violation|1|||
155272225|NCT01027364|560429728|FG000|Overall Study|Withdrawal by Subject|1|||
155272226|NCT01027364|560429729|FG001|Overall Study|Withdrawal by Subject|2|||
155272227|NCT01027364|560429730|FG002|Overall Study|Withdrawal by Subject|0|||
155272228|NCT01027364|560429731|FG003|Overall Study|Withdrawal by Subject|0|||
155272229|NCT01394250|560429732|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
155272230|NCT01394250|560429733|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
155272231|NCT01394250|560429732|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
155272232|NCT01394250|560429733|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
155272233|NCT02226172|560429734|FG000|Overall Study|Participant refused further follow-up|4|||
155272234|NCT02226172|560429734|FG000|Overall Study|Other|5|||
155272235|NCT02226172|560429734|FG000|Overall Study|Death|1|||
155272236|NCT02226172|560429734|FG000|Overall Study|Study terminated by sponsor|1|||
155272237|NCT02226172|560429734|FG000|Overall Study|Adverse Event|6|||
155272238|NCT00779584|560429737|FG000|Overall Study|Protocol Violation|0|||
155272239|NCT00779584|560429738|FG001|Overall Study|Protocol Violation|0|||
155272240|NCT00779584|560429739|FG002|Overall Study|Protocol Violation|0|||
155272241|NCT00779584|560429740|FG003|Overall Study|Protocol Violation|0|||
155272242|NCT00779584|560429741|FG004|Overall Study|Protocol Violation|0|||
155272243|NCT00779584|560429742|FG005|Overall Study|Protocol Violation|1|||
155272244|NCT00779584|560429743|FG006|Overall Study|Protocol Violation|0|||
155272245|NCT00779584|560429744|FG007|Overall Study|Protocol Violation|0|||
155272246|NCT00779584|560429745|FG008|Overall Study|Protocol Violation|0|||
155272247|NCT00779584|560429737|FG000|Overall Study|Withdrawal by Subject|1|||
155272248|NCT00779584|560429738|FG001|Overall Study|Withdrawal by Subject|1|||
155272249|NCT00779584|560429739|FG002|Overall Study|Withdrawal by Subject|2|||
155272250|NCT00779584|560429740|FG003|Overall Study|Withdrawal by Subject|0|||
155272251|NCT00779584|560429741|FG004|Overall Study|Withdrawal by Subject|0|||
155272252|NCT00779584|560429742|FG005|Overall Study|Withdrawal by Subject|2|||
155272253|NCT00779584|560429743|FG006|Overall Study|Withdrawal by Subject|1|||
155272254|NCT00779584|560429744|FG007|Overall Study|Withdrawal by Subject|0|||
155272255|NCT00779584|560429745|FG008|Overall Study|Withdrawal by Subject|0|||
155272256|NCT00779584|560429737|FG000|Overall Study|Lost to Follow-up|0|||
155272257|NCT00779584|560429738|FG001|Overall Study|Lost to Follow-up|0|||
155272258|NCT00779584|560429739|FG002|Overall Study|Lost to Follow-up|0|||
155272259|NCT00779584|560429740|FG003|Overall Study|Lost to Follow-up|0|||
155272260|NCT00779584|560429741|FG004|Overall Study|Lost to Follow-up|1|||
155272261|NCT00779584|560429742|FG005|Overall Study|Lost to Follow-up|0|||
155272262|NCT00779584|560429743|FG006|Overall Study|Lost to Follow-up|0|||
155272263|NCT00779584|560429744|FG007|Overall Study|Lost to Follow-up|0|||
155272264|NCT00779584|560429745|FG008|Overall Study|Lost to Follow-up|0|||
155272265|NCT00779584|560429737|FG000|Overall Study|Progression of Disease|0|||
155272266|NCT00779584|560429738|FG001|Overall Study|Progression of Disease|1|||
155272267|NCT00779584|560429739|FG002|Overall Study|Progression of Disease|2|||
155272268|NCT00779584|560429740|FG003|Overall Study|Progression of Disease|6|||
155272269|NCT00779584|560429741|FG004|Overall Study|Progression of Disease|5|||
155272270|NCT00779584|560429742|FG005|Overall Study|Progression of Disease|1|||
155272271|NCT00779584|560429743|FG006|Overall Study|Progression of Disease|4|||
155272272|NCT00779584|560429744|FG007|Overall Study|Progression of Disease|2|||
155272273|NCT00779584|560429745|FG008|Overall Study|Progression of Disease|1|||
155615413|NCT02959918|561684915|FG001|Overall Study|Adverse Event|1|||
155272274|NCT00779584|560429737|FG000|Overall Study|Adverse Event|1|||
155272275|NCT00779584|560429738|FG001|Overall Study|Adverse Event|0|||
155272276|NCT00779584|560429739|FG002|Overall Study|Adverse Event|2|||
155272277|NCT00779584|560429740|FG003|Overall Study|Adverse Event|0|||
155272278|NCT00779584|560429741|FG004|Overall Study|Adverse Event|0|||
155272279|NCT00779584|560429742|FG005|Overall Study|Adverse Event|0|||
155272280|NCT00779584|560429743|FG006|Overall Study|Adverse Event|2|||
155272281|NCT00779584|560429744|FG007|Overall Study|Adverse Event|1|||
155272282|NCT00779584|560429745|FG008|Overall Study|Adverse Event|1|||
155272283|NCT00779584|560429737|FG000|Overall Study|Symptomatic Deterioration|1|||
155272284|NCT00779584|560429738|FG001|Overall Study|Symptomatic Deterioration|1|||
155272285|NCT00779584|560429739|FG002|Overall Study|Symptomatic Deterioration|1|||
155272286|NCT00779584|560429740|FG003|Overall Study|Symptomatic Deterioration|0|||
155272287|NCT00779584|560429741|FG004|Overall Study|Symptomatic Deterioration|0|||
155272288|NCT00779584|560429742|FG005|Overall Study|Symptomatic Deterioration|1|||
155272289|NCT00779584|560429743|FG006|Overall Study|Symptomatic Deterioration|1|||
155272290|NCT00779584|560429744|FG007|Overall Study|Symptomatic Deterioration|0|||
155272291|NCT00779584|560429745|FG008|Overall Study|Symptomatic Deterioration|0|||
155272292|NCT00779584|560429737|FG000|Overall Study|Ongoing in Study|0|||
155272293|NCT00779584|560429738|FG001|Overall Study|Ongoing in Study|0|||
155272294|NCT00779584|560429739|FG002|Overall Study|Ongoing in Study|0|||
155272295|NCT00779584|560429740|FG003|Overall Study|Ongoing in Study|0|||
155272296|NCT00779584|560429741|FG004|Overall Study|Ongoing in Study|1|||
155272297|NCT00779584|560429742|FG005|Overall Study|Ongoing in Study|1|||
155272298|NCT00779584|560429743|FG006|Overall Study|Ongoing in Study|0|||
155272299|NCT00779584|560429744|FG007|Overall Study|Ongoing in Study|0|||
155272300|NCT00779584|560429745|FG008|Overall Study|Ongoing in Study|0|||
155272301|NCT03632434|560429746|FG000|Overall Study|Withdrawal by Subject|2|||
155272302|NCT04297241|560429750|FG000|Overall Study|Withdrawal by Subject|1|||
155272303|NCT04297241|560429750|FG000|Overall Study|Adverse Event|1|||
155272304|NCT04297241|560429750|FG000|Overall Study|Physician Decision|3|||
155272305|NCT00786474|560429759|FG000|Overall Study|Death|5|||
155272306|NCT00786474|560429760|FG001|Overall Study|Death|4|||
155272307|NCT00786474|560429759|FG000|Overall Study|Withdrawal by Subject|23|||
155272308|NCT00786474|560429760|FG001|Overall Study|Withdrawal by Subject|31|||
155272309|NCT00786474|560429759|FG000|Overall Study|Lost to Follow-up|3|||
155272310|NCT00786474|560429760|FG001|Overall Study|Lost to Follow-up|3|||
155272311|NCT00786474|560429759|FG000|Overall Study|Physician Decision|2|||
155272312|NCT00786474|560429760|FG001|Overall Study|Physician Decision|1|||
155272313|NCT00786474|560429759|FG000|Overall Study|Other|4|||
155272314|NCT00786474|560429760|FG001|Overall Study|Other|4|||
155272315|NCT01799720|560429761|FG000|Overall Study|Withdrawal by Subject|3|||
155272316|NCT01799720|560429762|FG001|Overall Study|Withdrawal by Subject|0|||
155272317|NCT01799720|560429763|FG002|Overall Study|Withdrawal by Subject|0|||
155272318|NCT01799720|560429761|FG000|Overall Study|Protocol Violation|0|||
155272319|NCT01799720|560429762|FG001|Overall Study|Protocol Violation|1|||
155272320|NCT01799720|560429763|FG002|Overall Study|Protocol Violation|0|||
155272321|NCT01799720|560429761|FG000|Overall Study|Pregnancy|0|||
155272322|NCT01799720|560429762|FG001|Overall Study|Pregnancy|0|||
155272323|NCT01799720|560429763|FG002|Overall Study|Pregnancy|1|||
155272324|NCT03688711|560429767|FG000|Overall Study|Withdrawal by Subject|0|||
155272325|NCT03688711|560429768|FG001|Overall Study|Withdrawal by Subject|1|||
155272326|NCT01088529|560429769|FG000|Overall Study|Did not receive study treatment|0|||
155272327|NCT01088529|560429770|FG001|Overall Study|Did not receive study treatment|1|||
155272328|NCT01155661|560429773|FG000|Overall Study|Adverse Event|101|||
155272329|NCT01155661|560429773|FG000|Overall Study|Death|1|||
155272330|NCT01155661|560429773|FG000|Overall Study|Lack of Efficacy|32|||
155272331|NCT01155661|560429773|FG000|Overall Study|Lost to Follow-up|22|||
155272332|NCT01155661|560429773|FG000|Overall Study|Physician Decision|3|||
155272333|NCT01155661|560429773|FG000|Overall Study|Protocol Violation|35|||
155272334|NCT01155661|560429773|FG000|Overall Study|Withdrawal by Subject|73|||
155272335|NCT01155661|560429773|FG000|Overall Study|Sponsor Decision|13|||
155272336|NCT01263106|560429774|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155272337|NCT01263106|560429775|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155272338|NCT03169881|560429785|FG000|Overall Study|Incomplete Follow-up|10|||
155272339|NCT03169881|560429786|FG001|Overall Study|Incomplete Follow-up|15|||
155272340|NCT03169881|560429785|FG000|Overall Study|Lost to Follow-up|18|||
155272341|NCT03169881|560429786|FG001|Overall Study|Lost to Follow-up|20|||
155272342|NCT03169881|560429785|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
155272343|NCT03169881|560429786|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
155272344|NCT03936777|560429787|FG000|Overall Study|Adverse Event|3|||
155272345|NCT03936777|560429787|FG000|Overall Study|Death|3|||
155272346|NCT03936777|560429787|FG000|Overall Study|Lack of Efficacy|24|||
155272347|NCT03936777|560429787|FG000|Overall Study|Lost to Follow-up|3|||
155726545|NCT01535040|562098187|FG001|Overall Study|Withdrawal by Subject|10|||
155726546|NCT01535040|562098186|FG000|Overall Study|Never Started|9|||
155272348|NCT03936777|560429787|FG000|Overall Study|Physician Decision|1|||
155272349|NCT03936777|560429787|FG000|Overall Study|Withdrawal by Subject|11|||
155272350|NCT03936777|560429787|FG000|Overall Study|Subjected Weaned of ZX008|1|||
155272351|NCT03936777|560429787|FG000|Overall Study|Missing|6|||
155272352|NCT02301156|560429788|FG000|Overall Study|Adverse Event|13|||
155272353|NCT02301156|560429789|FG001|Overall Study|Adverse Event|14|||
155272354|NCT02301156|560429788|FG000|Overall Study|Death|1|||
155272355|NCT02301156|560429789|FG001|Overall Study|Death|5|||
155272356|NCT02301156|560429788|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
155272357|NCT02301156|560429789|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
155272358|NCT02301156|560429788|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
155272359|NCT02301156|560429789|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
155272360|NCT02301156|560429788|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
155272361|NCT02301156|560429789|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
155272362|NCT02301156|560429788|FG000|Overall Study|Reason not Specified|6|||
155272363|NCT02301156|560429789|FG001|Overall Study|Reason not Specified|3|||
155615414|NCT02959918|561684916|FG002|Overall Study|Adverse Event|2|||
155615415|NCT02959918|561684917|FG003|Overall Study|Adverse Event|0|||
155615416|NCT02959918|561684918|FG004|Overall Study|Adverse Event|0|||
155615417|NCT02959918|561684919|FG005|Overall Study|Adverse Event|2|||
155615418|NCT02959918|561684920|FG006|Overall Study|Adverse Event|2|||
155615419|NCT02959918|561684921|FG007|Overall Study|Adverse Event|1|||
155615420|NCT02959918|561684922|FG008|Overall Study|Adverse Event|2|||
155615421|NCT02959918|561684923|FG009|Overall Study|Adverse Event|1|||
155615422|NCT02959918|561684924|FG010|Overall Study|Adverse Event|1|||
155615423|NCT02959918|561684925|FG011|Overall Study|Adverse Event|3|||
155615424|NCT02959918|561684926|FG012|Overall Study|Adverse Event|2|||
155615425|NCT02959918|561684927|FG013|Overall Study|Adverse Event|4|||
155615426|NCT02959918|561684914|FG000|Overall Study|Lost to Follow-up|0|||
155615427|NCT02959918|561684915|FG001|Overall Study|Lost to Follow-up|0|||
155272364|NCT02638623|560429790|FG000|Overall Study|Surgery timing|5|||
155272365|NCT02638623|560429791|FG001|Overall Study|Surgery timing|6|||
155272366|NCT02638623|560429790|FG000|Overall Study|Not given intervention|2|||
155272367|NCT02638623|560429791|FG001|Overall Study|Not given intervention|0|||
155272368|NCT03797326|560429795|FG000|Overall Study|Lost to Follow-up|1|||
155272369|NCT03797326|560429796|FG001|Overall Study|Lost to Follow-up|0|||
155272370|NCT03797326|560429797|FG002|Overall Study|Lost to Follow-up|0|||
155272371|NCT03797326|560429798|FG003|Overall Study|Lost to Follow-up|1|||
155272372|NCT03797326|560429799|FG004|Overall Study|Lost to Follow-up|0|||
155272373|NCT03797326|560429800|FG005|Overall Study|Lost to Follow-up|0|||
155272374|NCT03797326|560429801|FG006|Overall Study|Lost to Follow-up|0|||
155272375|NCT03797326|560429802|FG007|Overall Study|Lost to Follow-up|0|||
155272376|NCT03797326|560429795|FG000|Overall Study|Withdrawal by Subject|0|||
155272377|NCT03797326|560429796|FG001|Overall Study|Withdrawal by Subject|0|||
155272378|NCT03797326|560429797|FG002|Overall Study|Withdrawal by Subject|1|||
155272379|NCT03797326|560429798|FG003|Overall Study|Withdrawal by Subject|3|||
155272380|NCT03797326|560429799|FG004|Overall Study|Withdrawal by Subject|0|||
155272381|NCT03797326|560429800|FG005|Overall Study|Withdrawal by Subject|2|||
155272382|NCT03797326|560429801|FG006|Overall Study|Withdrawal by Subject|2|||
155272383|NCT03797326|560429802|FG007|Overall Study|Withdrawal by Subject|3|||
155272384|NCT03797326|560429795|FG000|Overall Study|Sponsor Decision|3|||
155272385|NCT03797326|560429796|FG001|Overall Study|Sponsor Decision|3|||
155272386|NCT03797326|560429797|FG002|Overall Study|Sponsor Decision|3|||
155272387|NCT03797326|560429798|FG003|Overall Study|Sponsor Decision|6|||
155272388|NCT03797326|560429799|FG004|Overall Study|Sponsor Decision|0|||
155272389|NCT03797326|560429800|FG005|Overall Study|Sponsor Decision|3|||
155272390|NCT03797326|560429801|FG006|Overall Study|Sponsor Decision|3|||
155272391|NCT03797326|560429802|FG007|Overall Study|Sponsor Decision|2|||
155272392|NCT03797326|560429795|FG000|Overall Study|Death|27|||
155272393|NCT03797326|560429796|FG001|Overall Study|Death|28|||
155272394|NCT03797326|560429797|FG002|Overall Study|Death|95|||
155272395|NCT03797326|560429798|FG003|Overall Study|Death|95|||
155615428|NCT02959918|561684916|FG002|Overall Study|Lost to Follow-up|0|||
155615429|NCT02959918|561684917|FG003|Overall Study|Lost to Follow-up|0|||
155615430|NCT02959918|561684918|FG004|Overall Study|Lost to Follow-up|0|||
155615431|NCT02959918|561684919|FG005|Overall Study|Lost to Follow-up|0|||
155615432|NCT02959918|561684920|FG006|Overall Study|Lost to Follow-up|0|||
155615433|NCT02959918|561684921|FG007|Overall Study|Lost to Follow-up|0|||
155615434|NCT02959918|561684922|FG008|Overall Study|Lost to Follow-up|0|||
155615435|NCT02959918|561684923|FG009|Overall Study|Lost to Follow-up|1|||
155615436|NCT02959918|561684924|FG010|Overall Study|Lost to Follow-up|0|||
155615437|NCT02959918|561684925|FG011|Overall Study|Lost to Follow-up|0|||
155615438|NCT02959918|561684926|FG012|Overall Study|Lost to Follow-up|1|||
155615439|NCT02959918|561684927|FG013|Overall Study|Lost to Follow-up|0|||
155615440|NCT02959918|561684914|FG000|Overall Study|Withdrawal by Subject|0|||
155272396|NCT03797326|560429799|FG004|Overall Study|Death|30|||
155272397|NCT03797326|560429800|FG005|Overall Study|Death|96|||
155272398|NCT03797326|560429801|FG006|Overall Study|Death|97|||
155272399|NCT03797326|560429802|FG007|Overall Study|Death|98|||
155272400|NCT03797326|560429795|FG000|Overall Study|Enrolled in error|0|||
155615441|NCT02959918|561684915|FG001|Overall Study|Withdrawal by Subject|0|||
155615442|NCT02959918|561684916|FG002|Overall Study|Withdrawal by Subject|1|||
155615443|NCT02959918|561684917|FG003|Overall Study|Withdrawal by Subject|2|||
155272401|NCT03797326|560429796|FG001|Overall Study|Enrolled in error|0|||
155272402|NCT03797326|560429797|FG002|Overall Study|Enrolled in error|3|||
155272403|NCT03797326|560429798|FG003|Overall Study|Enrolled in error|2|||
155272404|NCT03797326|560429799|FG004|Overall Study|Enrolled in error|2|||
155272405|NCT03797326|560429800|FG005|Overall Study|Enrolled in error|1|||
155272406|NCT03797326|560429801|FG006|Overall Study|Enrolled in error|1|||
155615444|NCT02959918|561684918|FG004|Overall Study|Withdrawal by Subject|0|||
155615445|NCT02959918|561684919|FG005|Overall Study|Withdrawal by Subject|0|||
155615446|NCT02959918|561684920|FG006|Overall Study|Withdrawal by Subject|1|||
155615447|NCT02959918|561684921|FG007|Overall Study|Withdrawal by Subject|0|||
155615448|NCT02959918|561684922|FG008|Overall Study|Withdrawal by Subject|1|||
155272407|NCT03797326|560429802|FG007|Overall Study|Enrolled in error|0|||
155272408|NCT03012061|560429803|FG000|Overall Study|Withdrawal by Subject|1|||
155272409|NCT03012061|560429804|FG001|Overall Study|Withdrawal by Subject|5|||
155272410|NCT03012061|560429805|FG002|Overall Study|Withdrawal by Subject|4|||
155272411|NCT03012061|560429803|FG000|Overall Study|Investigator Site Closed|1|||
155272412|NCT03012061|560429804|FG001|Overall Study|Investigator Site Closed|2|||
155272413|NCT03012061|560429805|FG002|Overall Study|Investigator Site Closed|0|||
155272414|NCT03012061|560429803|FG000|Overall Study|Lost to Follow-up|2|||
155272415|NCT03012061|560429804|FG001|Overall Study|Lost to Follow-up|1|||
155272416|NCT03012061|560429805|FG002|Overall Study|Lost to Follow-up|0|||
155272417|NCT03012061|560429803|FG000|Overall Study|Study closed/ Terminated|0|||
155272418|NCT03012061|560429804|FG001|Overall Study|Study closed/ Terminated|0|||
155272419|NCT03012061|560429805|FG002|Overall Study|Study closed/ Terminated|1|||
155272420|NCT03012061|560429803|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
155272421|NCT03012061|560429804|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
155272422|NCT03012061|560429805|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
155272423|NCT03012061|560429803|FG000|Overall Study|Protocol Violation|0|||
155272424|NCT03012061|560429804|FG001|Overall Study|Protocol Violation|0|||
155272425|NCT03012061|560429805|FG002|Overall Study|Protocol Violation|2|||
155272426|NCT03012061|560429803|FG000|Overall Study|Lack of Efficacy|0|||
155272427|NCT03012061|560429804|FG001|Overall Study|Lack of Efficacy|1|||
155272428|NCT03012061|560429805|FG002|Overall Study|Lack of Efficacy|0|||
155272429|NCT03012061|560429803|FG000|Overall Study|Adverse Event|2|||
155272430|NCT03012061|560429804|FG001|Overall Study|Adverse Event|0|||
155272431|NCT03012061|560429805|FG002|Overall Study|Adverse Event|0|||
155272432|NCT02401308|560429812|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
155272433|NCT02401308|560429813|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
155272434|NCT00147225|560429816|FG000|Overall Study|Withdrawal by Subject|1|||
155272435|NCT00147225|560429817|FG001|Overall Study|Withdrawal by Subject|0|||
155272436|NCT00147225|560429818|FG002|Overall Study|Withdrawal by Subject|1|||
155272437|NCT00147225|560429819|FG003|Overall Study|Withdrawal by Subject|0|||
155272438|NCT00147225|560429820|FG004|Overall Study|Withdrawal by Subject|0|||
155272439|NCT00147225|560429821|FG005|Overall Study|Withdrawal by Subject|1|||
155272440|NCT00147225|560429816|FG000|Overall Study|Adverse Event|0|||
155272441|NCT00147225|560429817|FG001|Overall Study|Adverse Event|0|||
155272442|NCT00147225|560429818|FG002|Overall Study|Adverse Event|1|||
155272443|NCT00147225|560429819|FG003|Overall Study|Adverse Event|1|||
155272444|NCT00147225|560429820|FG004|Overall Study|Adverse Event|0|||
155272445|NCT00147225|560429821|FG005|Overall Study|Adverse Event|0|||
155272446|NCT00147225|560429816|FG000|Overall Study|Screen Failure|0|||
155272447|NCT00147225|560429817|FG001|Overall Study|Screen Failure|0|||
155272448|NCT00147225|560429818|FG002|Overall Study|Screen Failure|0|||
155272449|NCT00147225|560429819|FG003|Overall Study|Screen Failure|0|||
155272450|NCT00147225|560429820|FG004|Overall Study|Screen Failure|1|||
155272451|NCT00147225|560429821|FG005|Overall Study|Screen Failure|0|||
155272452|NCT00147225|560429816|FG000|Overall Study|Chemotherapy Changed|0|||
155272453|NCT00147225|560429817|FG001|Overall Study|Chemotherapy Changed|0|||
155272454|NCT00147225|560429818|FG002|Overall Study|Chemotherapy Changed|0|||
155272455|NCT00147225|560429819|FG003|Overall Study|Chemotherapy Changed|0|||
155272456|NCT00147225|560429820|FG004|Overall Study|Chemotherapy Changed|0|||
155272457|NCT00147225|560429821|FG005|Overall Study|Chemotherapy Changed|1|||
155272458|NCT01032044|560429822|FG000|Overall Study|Protocol Violation|14|||
155272459|NCT01032044|560429823|FG001|Overall Study|Protocol Violation|8|||
155272460|NCT01032044|560429822|FG000|Overall Study|Adverse Event|0|||
155272461|NCT01032044|560429823|FG001|Overall Study|Adverse Event|1|||
155272462|NCT01032044|560429822|FG000|Overall Study|Lost to Follow-up|11|||
155272463|NCT01032044|560429823|FG001|Overall Study|Lost to Follow-up|11|||
155272464|NCT02998021|560429824|FG000|Overall Study|Withdrawal by Subject|3|||
155272465|NCT02998021|560429825|FG001|Overall Study|Withdrawal by Subject|1|||
155272466|NCT02998021|560429824|FG000|Overall Study|unsafe home|0|||
155615449|NCT02959918|561684923|FG009|Overall Study|Withdrawal by Subject|1|||
155615450|NCT02959918|561684924|FG010|Overall Study|Withdrawal by Subject|2|||
155615451|NCT02959918|561684925|FG011|Overall Study|Withdrawal by Subject|3|||
155615452|NCT02959918|561684926|FG012|Overall Study|Withdrawal by Subject|1|||
155272467|NCT02998021|560429825|FG001|Overall Study|unsafe home|1|||
155272468|NCT02961374|560429826|FG000|Overall Study|Adverse Event|4|||
155615453|NCT02959918|561684927|FG013|Overall Study|Withdrawal by Subject|1|||
155272469|NCT03390036|560431303|FG000|Overall Study|Lost to Follow-up|1|||
155272470|NCT03390036|560431304|FG001|Overall Study|Lost to Follow-up|0|||
155272471|NCT03390036|560431305|FG002|Overall Study|Lost to Follow-up|0|||
155272472|NCT03390036|560431303|FG000|Overall Study|Lack of Efficacy|1|||
155272473|NCT03390036|560431304|FG001|Overall Study|Lack of Efficacy|0|||
155272474|NCT03390036|560431305|FG002|Overall Study|Lack of Efficacy|0|||
155272475|NCT01984424|560431306|FG000|Overall Study|Withdrawal by Subject|3|||
155272476|NCT01984424|560431307|FG001|Overall Study|Withdrawal by Subject|5|||
155381921|NCT00116753|560833236|FG000|Overall Study|Dosing Error|0|||
155272477|NCT01984424|560431306|FG000|Overall Study|Sponsor Decision|0|||
155615454|NCT02959918|561684914|FG000|Overall Study|Protocol Violation|0|||
155726547|NCT01535040|562098187|FG001|Overall Study|Never Started|4|||
155726548|NCT01535040|562098186|FG000|Overall Study|Toxicity|7|||
155726549|NCT01535040|562098187|FG001|Overall Study|Toxicity|5|||
155726550|NCT01535040|562098186|FG000|Overall Study|Multiple Reasons|1|||
155726551|NCT01535040|562098187|FG001|Overall Study|Multiple Reasons|1|||
155726552|NCT01074970|562098189|FG000|Overall Study|Never Treated|0|||
155726553|NCT01074970|562098190|FG001|Overall Study|Never Treated|0|||
155726554|NCT01074970|562098191|FG002|Overall Study|Never Treated|8|||
155726555|NCT01074970|562098192|FG003|Overall Study|Never Treated|1|||
155726556|NCT01074970|562098189|FG000|Overall Study|Adverse Event|1|||
155726557|NCT01074970|562098190|FG001|Overall Study|Adverse Event|0|||
155726558|NCT01074970|562098191|FG002|Overall Study|Adverse Event|4|||
155726559|NCT01074970|562098192|FG003|Overall Study|Adverse Event|3|||
155726560|NCT01074970|562098189|FG000|Overall Study|Disease progression during treatment|3|||
155726561|NCT01074970|562098190|FG001|Overall Study|Disease progression during treatment|1|||
155726562|NCT01074970|562098191|FG002|Overall Study|Disease progression during treatment|2|||
155726563|NCT01074970|562098192|FG003|Overall Study|Disease progression during treatment|9|||
155726564|NCT01074970|562098189|FG000|Overall Study|Lost to Follow-up|0|||
155726565|NCT01074970|562098190|FG001|Overall Study|Lost to Follow-up|0|||
155726566|NCT01074970|562098191|FG002|Overall Study|Lost to Follow-up|1|||
155726567|NCT01074970|562098192|FG003|Overall Study|Lost to Follow-up|0|||
155726568|NCT01074970|562098189|FG000|Overall Study|Withdrawal by Subject|0|||
155726569|NCT01074970|562098190|FG001|Overall Study|Withdrawal by Subject|0|||
155726570|NCT01074970|562098191|FG002|Overall Study|Withdrawal by Subject|6|||
155726571|NCT01074970|562098192|FG003|Overall Study|Withdrawal by Subject|4|||
155726572|NCT00734149|562098193|FG000|Overall Study|Withdrawal by Subject|1|||
155726573|NCT05430854|562098194|FG000|Overall Study|Trial terminated by Sponsor|39|||
155726574|NCT05430854|562098195|FG001|Overall Study|Trial terminated by Sponsor|50|||
155726575|NCT05430854|562098196|FG002|Overall Study|Trial terminated by Sponsor|46|||
155726576|NCT05430854|562098194|FG000|Overall Study|Withdrawal by Subject|0|||
155726577|NCT05430854|562098195|FG001|Overall Study|Withdrawal by Subject|3|||
155726578|NCT05430854|562098196|FG002|Overall Study|Withdrawal by Subject|0|||
155726579|NCT04314284|562098197|FG000|Overall Study|Withdrawal by Subject|4|||
155726580|NCT04314284|562098198|FG001|Overall Study|Withdrawal by Subject|7|||
155726581|NCT04314284|562098197|FG000|Overall Study|Consented but did not complete survey|0|||
155726582|NCT04314284|562098198|FG001|Overall Study|Consented but did not complete survey|6|||
155726583|NCT01652235|562098204|FG000|Overall Study|Death|9|||
155726584|NCT01652235|562098204|FG000|Overall Study|Lost to Follow-up|5|||
155726585|NCT01652235|562098204|FG000|Overall Study|Withdrawal by Subject|2|||
155726586|NCT03043794|562098209|FG000|Overall Study|Lost to Follow-up|1|||
155726587|NCT05291520|562099750|FG000|Overall Study|Lost to Follow-up|0|||
155726588|NCT05291520|562099751|FG001|Overall Study|Lost to Follow-up|0|||
155726589|NCT05291520|562099752|FG002|Overall Study|Lost to Follow-up|1|||
155726590|NCT01347112|562099753|FG000|Overall Study|Withdrawal by Subject|1|||
155726591|NCT01347112|562099754|FG001|Overall Study|Withdrawal by Subject|7|||
155726592|NCT01347112|562099753|FG000|Overall Study|Lost to Follow-up|3|||
155726593|NCT01347112|562099754|FG001|Overall Study|Lost to Follow-up|5|||
155726594|NCT05462756|562099755|FG000|Treatment Period|Adverse Event|3|||
155726595|NCT05462756|562099756|FG001|Treatment Period|Adverse Event|0|||
155726596|NCT05462756|562099755|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
155726597|NCT05462756|562099756|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
155726598|NCT05462756|562099755|FG000|Treatment Period|Death|0|||
155726599|NCT05462756|562099756|FG001|Treatment Period|Death|1|||
155726600|NCT05462756|562099755|FG000|Treatment Period|Lost to Follow-up|2|||
155726601|NCT05462756|562099756|FG001|Treatment Period|Lost to Follow-up|1|||
155726602|NCT05462756|562099755|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
155726603|NCT05462756|562099756|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
155726604|NCT05462756|562099755|FG000|Treatment Period|Physician Decision|2|||
155726605|NCT05462756|562099756|FG001|Treatment Period|Physician Decision|0|||
155726606|NCT05462756|562099755|FG000|Treatment Period|Protocol Violation|0|||
155726607|NCT05462756|562099756|FG001|Treatment Period|Protocol Violation|1|||
155726608|NCT05462756|562099755|FG000|Treatment Period|Withdrawal by Subject|5|||
155726609|NCT05462756|562099756|FG001|Treatment Period|Withdrawal by Subject|12|||
155726610|NCT05462756|562099755|FG000|Follow-Up Period|Adverse Event|1|||
155726611|NCT05462756|562099756|FG001|Follow-Up Period|Adverse Event|0|||
155726612|NCT05462756|562099755|FG000|Follow-Up Period|Death|1|||
155726613|NCT05462756|562099756|FG001|Follow-Up Period|Death|0|||
155726614|NCT05462756|562099755|FG000|Follow-Up Period|Lost to Follow-up|3|||
155726615|NCT05462756|562099756|FG001|Follow-Up Period|Lost to Follow-up|1|||
155726616|NCT05462756|562099755|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155726617|NCT05462756|562099756|FG001|Follow-Up Period|Withdrawal by Subject|4|||
155726618|NCT02079246|562099757|FG000|OLEX|Withdrawal before treatment|1|||
155726619|NCT02079246|562099758|FG001|OLEX|Withdrawal before treatment|0|||
155726620|NCT02079246|562099757|FG000|OLEX|Death|11|||
155726621|NCT02079246|562099758|FG001|OLEX|Death|0|||
155726622|NCT02079246|562099757|FG000|OLEX|Adverse Event|66|||
155726623|NCT02079246|562099758|FG001|OLEX|Adverse Event|0|||
155726624|NCT02079246|562099757|FG000|OLEX|Withdrawal by Subject|60|||
155272478|NCT01984424|560431307|FG001|Overall Study|Sponsor Decision|1|||
155272479|NCT01984424|560431306|FG000|Overall Study|Lost to Follow-up|0|||
155272480|NCT01984424|560431307|FG001|Overall Study|Lost to Follow-up|1|||
155272481|NCT01807221|560431308|FG000|Overall Study|Progressive disease|1|||
155615455|NCT02959918|561684915|FG001|Overall Study|Protocol Violation|0|||
155615456|NCT02959918|561684916|FG002|Overall Study|Protocol Violation|1|||
155615457|NCT02959918|561684917|FG003|Overall Study|Protocol Violation|0|||
155615458|NCT02959918|561684918|FG004|Overall Study|Protocol Violation|0|||
155615459|NCT02959918|561684919|FG005|Overall Study|Protocol Violation|1|||
155615460|NCT02959918|561684920|FG006|Overall Study|Protocol Violation|0|||
155615461|NCT02959918|561684921|FG007|Overall Study|Protocol Violation|0|||
155615462|NCT02959918|561684922|FG008|Overall Study|Protocol Violation|2|||
155615463|NCT02959918|561684923|FG009|Overall Study|Protocol Violation|1|||
155615464|NCT02959918|561684924|FG010|Overall Study|Protocol Violation|0|||
155615465|NCT02959918|561684925|FG011|Overall Study|Protocol Violation|1|||
155615466|NCT02959918|561684926|FG012|Overall Study|Protocol Violation|1|||
155272482|NCT01807221|560431309|FG001|Overall Study|Progressive disease|0|||
155272483|NCT01807221|560431310|FG002|Overall Study|Progressive disease|1|||
155272484|NCT01807221|560431311|FG003|Overall Study|Progressive disease|0|||
155272485|NCT01807221|560431312|FG004|Overall Study|Progressive disease|0|||
155272486|NCT01807221|560431313|FG005|Overall Study|Progressive disease|0|||
155272487|NCT01807221|560431308|FG000|Overall Study|Death|7|||
155272488|NCT01807221|560431309|FG001|Overall Study|Death|9|||
155272489|NCT01807221|560431310|FG002|Overall Study|Death|4|||
155272490|NCT01807221|560431311|FG003|Overall Study|Death|2|||
155272491|NCT01807221|560431312|FG004|Overall Study|Death|1|||
155272492|NCT01807221|560431313|FG005|Overall Study|Death|6|||
155272493|NCT01807221|560431308|FG000|Overall Study|Physician Decision|2|||
155272494|NCT01807221|560431309|FG001|Overall Study|Physician Decision|1|||
155272495|NCT01807221|560431310|FG002|Overall Study|Physician Decision|0|||
155272496|NCT01807221|560431311|FG003|Overall Study|Physician Decision|0|||
155272497|NCT01807221|560431312|FG004|Overall Study|Physician Decision|0|||
155272498|NCT01807221|560431313|FG005|Overall Study|Physician Decision|0|||
155272499|NCT01807221|560431308|FG000|Overall Study|Adverse Event|33|||
155272500|NCT01807221|560431309|FG001|Overall Study|Adverse Event|22|||
155272501|NCT01807221|560431310|FG002|Overall Study|Adverse Event|26|||
155272502|NCT01807221|560431311|FG003|Overall Study|Adverse Event|25|||
155272503|NCT01807221|560431312|FG004|Overall Study|Adverse Event|18|||
155272504|NCT01807221|560431313|FG005|Overall Study|Adverse Event|21|||
155272505|NCT01807221|560431308|FG000|Overall Study|Protocol Violation|0|||
155272506|NCT01807221|560431309|FG001|Overall Study|Protocol Violation|2|||
155272507|NCT01807221|560431310|FG002|Overall Study|Protocol Violation|1|||
155272508|NCT01807221|560431311|FG003|Overall Study|Protocol Violation|2|||
155272509|NCT01807221|560431312|FG004|Overall Study|Protocol Violation|0|||
155272510|NCT01807221|560431313|FG005|Overall Study|Protocol Violation|1|||
155272511|NCT01807221|560431308|FG000|Overall Study|Non-compliance|1|||
155272512|NCT01807221|560431309|FG001|Overall Study|Non-compliance|2|||
155272513|NCT01807221|560431310|FG002|Overall Study|Non-compliance|0|||
155272514|NCT01807221|560431311|FG003|Overall Study|Non-compliance|1|||
155272515|NCT01807221|560431312|FG004|Overall Study|Non-compliance|0|||
155272516|NCT01807221|560431313|FG005|Overall Study|Non-compliance|0|||
155272517|NCT01807221|560431308|FG000|Overall Study|Logistical difficulties|0|||
155272518|NCT01807221|560431309|FG001|Overall Study|Logistical difficulties|1|||
155272519|NCT01807221|560431310|FG002|Overall Study|Logistical difficulties|0|||
155272520|NCT01807221|560431311|FG003|Overall Study|Logistical difficulties|0|||
155272521|NCT01807221|560431312|FG004|Overall Study|Logistical difficulties|1|||
155272522|NCT01807221|560431313|FG005|Overall Study|Logistical difficulties|0|||
155272523|NCT01807221|560431308|FG000|Overall Study|Withdrawal by Subject|33|||
155272524|NCT01807221|560431309|FG001|Overall Study|Withdrawal by Subject|15|||
155615467|NCT02959918|561684927|FG013|Overall Study|Protocol Violation|0|||
155615468|NCT02959918|561684914|FG000|Overall Study|Stopping Rule Met|1|||
155615469|NCT02959918|561684915|FG001|Overall Study|Stopping Rule Met|0|||
155272525|NCT01807221|560431310|FG002|Overall Study|Withdrawal by Subject|8|||
155272526|NCT01807221|560431311|FG003|Overall Study|Withdrawal by Subject|14|||
155272527|NCT01807221|560431312|FG004|Overall Study|Withdrawal by Subject|16|||
155272528|NCT01807221|560431313|FG005|Overall Study|Withdrawal by Subject|13|||
155272529|NCT01807221|560431308|FG000|Overall Study|Sponsor decision|2|||
155272530|NCT01807221|560431309|FG001|Overall Study|Sponsor decision|0|||
155272531|NCT01807221|560431310|FG002|Overall Study|Sponsor decision|1|||
155272532|NCT01807221|560431311|FG003|Overall Study|Sponsor decision|1|||
155272533|NCT01807221|560431312|FG004|Overall Study|Sponsor decision|0|||
155272534|NCT01807221|560431313|FG005|Overall Study|Sponsor decision|0|||
155615470|NCT02959918|561684916|FG002|Overall Study|Stopping Rule Met|3|||
155726625|NCT02079246|562099758|FG001|OLEX|Withdrawal by Subject|0|||
155272535|NCT01807221|560431308|FG000|Overall Study|Lost to Follow-up|1|||
155272536|NCT01807221|560431309|FG001|Overall Study|Lost to Follow-up|0|||
155272537|NCT01807221|560431310|FG002|Overall Study|Lost to Follow-up|2|||
155615471|NCT02959918|561684917|FG003|Overall Study|Stopping Rule Met|4|||
155615472|NCT02959918|561684918|FG004|Overall Study|Stopping Rule Met|5|||
155615473|NCT02959918|561684919|FG005|Overall Study|Stopping Rule Met|3|||
155615474|NCT02959918|561684920|FG006|Overall Study|Stopping Rule Met|2|||
155726626|NCT02079246|562099757|FG000|OLEX|Lost to Follow-up|6|||
155726627|NCT02079246|562099758|FG001|OLEX|Lost to Follow-up|0|||
155726628|NCT02079246|562099757|FG000|OLEX|Protocol Violation|6|||
155726629|NCT02079246|562099758|FG001|OLEX|Protocol Violation|0|||
155726630|NCT02079246|562099757|FG000|OLEX|Lack of Efficacy|3|||
155726631|NCT02079246|562099758|FG001|OLEX|Lack of Efficacy|0|||
155726632|NCT02079246|562099757|FG000|OLEX|Results of the lead-in studies|58|||
155726633|NCT02079246|562099758|FG001|OLEX|Results of the lead-in studies|0|||
155726634|NCT02079246|562099757|FG000|OLEX|Other: Disallowed medication|8|||
155726635|NCT02079246|562099758|FG001|OLEX|Other: Disallowed medication|0|||
155726636|NCT02079246|562099757|FG000|OLEX|Other: Insufficient compliance|2|||
155726637|NCT02079246|562099758|FG001|OLEX|Other: Insufficient compliance|0|||
155726638|NCT02079246|562099757|FG000|OLEX|Other: Caregiver unavailable|3|||
155726639|NCT02079246|562099758|FG001|OLEX|Other: Caregiver unavailable|0|||
155726640|NCT02079246|562099757|FG000|OLEX|Other: Coordinator decision|1|||
155726641|NCT02079246|562099758|FG001|OLEX|Other: Coordinator decision|0|||
155726642|NCT02079246|562099757|FG000|OLEX|Other: Worsening of condition|1|||
155726643|NCT02079246|562099758|FG001|OLEX|Other: Worsening of condition|0|||
155726644|NCT02079246|562099757|FG000|OLEX|Other: Moved to nursing home|1|||
155726645|NCT02079246|562099758|FG001|OLEX|Other: Moved to nursing home|0|||
155726646|NCT02079246|562099757|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
155726647|NCT02079246|562099758|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
155726648|NCT02079246|562099757|FG000|OLEX-MEM|Adverse Event|0|||
155726649|NCT02079246|562099758|FG001|OLEX-MEM|Adverse Event|6|||
155726650|NCT02079246|562099757|FG000|OLEX-MEM|Withdrawal by Subject|0|||
155726651|NCT02079246|562099758|FG001|OLEX-MEM|Withdrawal by Subject|7|||
155726652|NCT02079246|562099757|FG000|OLEX-MEM|Protocol Violation|0|||
155726653|NCT02079246|562099758|FG001|OLEX-MEM|Protocol Violation|2|||
155726654|NCT02079246|562099757|FG000|OLEX-MEM|Lost to Follow-up|0|||
155726655|NCT02079246|562099758|FG001|OLEX-MEM|Lost to Follow-up|1|||
155726656|NCT02079246|562099757|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
155726657|NCT02079246|562099758|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
155726658|NCT02536976|562099768|FG000|Overall Study|Physician Decision|0|||
155726659|NCT02536976|562099769|FG001|Overall Study|Physician Decision|1|||
155726660|NCT01671319|562099772|FG000|Overall Study|Withdrawal by Subject|1|||
155726661|NCT01389596|562099773|FG000|Overall Study|Protocol Violation|3|||
155726662|NCT01389596|562099774|FG001|Overall Study|Protocol Violation|4|||
155726663|NCT01389596|562099775|FG002|Overall Study|Protocol Violation|3|||
155726664|NCT01389596|562099773|FG000|Overall Study|Withdrawal by Subject|1|||
155726665|NCT01389596|562099774|FG001|Overall Study|Withdrawal by Subject|2|||
155726666|NCT01389596|562099775|FG002|Overall Study|Withdrawal by Subject|2|||
155726667|NCT01389596|562099773|FG000|Overall Study|Insufficient Clinical Response|3|||
155726668|NCT01389596|562099774|FG001|Overall Study|Insufficient Clinical Response|4|||
155726669|NCT01389596|562099775|FG002|Overall Study|Insufficient Clinical Response|5|||
155726670|NCT01389596|562099773|FG000|Overall Study|Adverse Event|1|||
155726671|NCT01389596|562099774|FG001|Overall Study|Adverse Event|4|||
155726672|NCT01389596|562099775|FG002|Overall Study|Adverse Event|0|||
155726673|NCT01389596|562099773|FG000|Overall Study|Death|0|||
155726674|NCT01389596|562099774|FG001|Overall Study|Death|1|||
155726675|NCT01389596|562099775|FG002|Overall Study|Death|0|||
155726676|NCT01389596|562099773|FG000|Overall Study|Other Unspecified|2|||
155726677|NCT01389596|562099774|FG001|Overall Study|Other Unspecified|1|||
155726678|NCT01389596|562099775|FG002|Overall Study|Other Unspecified|0|||
155726679|NCT01709084|562099776|FG000|Overall Study|Lost to Follow-up|4|||
155726680|NCT01709084|562099777|FG001|Overall Study|Lost to Follow-up|7|||
155726681|NCT01709084|562099776|FG000|Overall Study|Withdrawal by Subject|2|||
155726682|NCT01709084|562099777|FG001|Overall Study|Withdrawal by Subject|2|||
155726683|NCT01709084|562099776|FG000|Overall Study|Adverse Event|5|||
155726684|NCT01709084|562099777|FG001|Overall Study|Adverse Event|0|||
155726685|NCT01709084|562099776|FG000|Overall Study|Other|5|||
155726686|NCT01709084|562099777|FG001|Overall Study|Other|3|||
155726687|NCT01709084|562099776|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
155726688|NCT01709084|562099777|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
155726689|NCT01709084|562099776|FG000|Overall Study|Not Treated|0|||
155726690|NCT01709084|562099777|FG001|Overall Study|Not Treated|2|||
155726691|NCT00214201|562099778|FG000|Overall Study|Withdrawal by Subject|2|||
155726692|NCT00214201|562099779|FG001|Overall Study|Withdrawal by Subject|0|||
155726693|NCT00214201|562099778|FG000|Overall Study|Death|0|||
155726694|NCT00214201|562099779|FG001|Overall Study|Death|2|||
155726695|NCT01354899|562099780|FG000|Overall Study|discharge from the hospital|2|||
155726696|NCT01354899|562099780|FG000|Overall Study|Protocol Violation|1|||
155726697|NCT00463567|562099781|FG000|Overall Study|Adverse Event|29|||
155726698|NCT00463567|562099782|FG001|Overall Study|Adverse Event|26|||
155726699|NCT00463567|562099783|FG002|Overall Study|Adverse Event|17|||
155726700|NCT00463567|562099784|FG003|Overall Study|Adverse Event|46|||
155726701|NCT00463567|562099785|FG004|Overall Study|Adverse Event|10|||
155726702|NCT00463567|562099786|FG005|Overall Study|Adverse Event|10|||
155726703|NCT00463567|562099787|FG006|Overall Study|Adverse Event|4|||
155726704|NCT00463567|562099781|FG000|Overall Study|Withdrawal by Subject|29|||
155726705|NCT00463567|562099782|FG001|Overall Study|Withdrawal by Subject|22|||
155272538|NCT01807221|560431311|FG003|Overall Study|Lost to Follow-up|1|||
155272539|NCT01807221|560431312|FG004|Overall Study|Lost to Follow-up|0|||
155272540|NCT01807221|560431313|FG005|Overall Study|Lost to Follow-up|0|||
155272541|NCT00373295|560431314|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272542|NCT00373295|560431315|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
155272543|NCT00373295|560431316|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272544|NCT00373295|560431317|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272545|NCT00373295|560431318|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
155272546|NCT00373295|560431319|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272547|NCT04267614|560431320|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
155272548|NCT04267614|560431320|FG000|Overall Study|Lost to Follow-up|115|||
155272549|NCT00988351|560431324|FG000|Overall Study|Withdrawal by Subject|8|||
155272550|NCT00988351|560431325|FG001|Overall Study|Withdrawal by Subject|0|||
155272551|NCT00988351|560431324|FG000|Overall Study|Lost to Follow-up|6|||
155272552|NCT00988351|560431325|FG001|Overall Study|Lost to Follow-up|9|||
155272553|NCT00988351|560431324|FG000|Overall Study|not using CPAP|5|||
155272554|NCT00988351|560431325|FG001|Overall Study|not using CPAP|3|||
155272555|NCT02303626|560431337|FG000|Overall Study|Lack of Efficacy|1|||
155272556|NCT02303626|560431338|FG001|Overall Study|Lack of Efficacy|0|||
155272557|NCT02303626|560431339|FG002|Overall Study|Lack of Efficacy|1|||
155272558|NCT02303626|560431337|FG000|Overall Study|Adverse Event|0|||
155272559|NCT02303626|560431338|FG001|Overall Study|Adverse Event|2|||
155272560|NCT02303626|560431339|FG002|Overall Study|Adverse Event|0|||
155272561|NCT02303626|560431337|FG000|Overall Study|Protocol Violation|0|||
155272562|NCT02303626|560431338|FG001|Overall Study|Protocol Violation|1|||
155272563|NCT02303626|560431339|FG002|Overall Study|Protocol Violation|0|||
155272564|NCT02303626|560431337|FG000|Overall Study|Pregnancy|0|||
155272565|NCT02303626|560431338|FG001|Overall Study|Pregnancy|0|||
155272566|NCT02303626|560431339|FG002|Overall Study|Pregnancy|1|||
155272567|NCT02303626|560431337|FG000|Overall Study|Subject Non-Compliance|0|||
155272568|NCT02303626|560431338|FG001|Overall Study|Subject Non-Compliance|0|||
155272569|NCT02303626|560431339|FG002|Overall Study|Subject Non-Compliance|1|||
155615475|NCT02959918|561684921|FG007|Overall Study|Stopping Rule Met|4|||
155615476|NCT02959918|561684922|FG008|Overall Study|Stopping Rule Met|1|||
155615477|NCT02959918|561684923|FG009|Overall Study|Stopping Rule Met|1|||
155615478|NCT02959918|561684924|FG010|Overall Study|Stopping Rule Met|3|||
155615479|NCT02959918|561684925|FG011|Overall Study|Stopping Rule Met|5|||
155615480|NCT02959918|561684926|FG012|Overall Study|Stopping Rule Met|2|||
155615481|NCT02959918|561684927|FG013|Overall Study|Stopping Rule Met|1|||
155615482|NCT02959918|561684914|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
155615483|NCT02959918|561684915|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
155615484|NCT02959918|561684916|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
155615485|NCT02959918|561684917|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
155615486|NCT02959918|561684918|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615487|NCT02959918|561684919|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615488|NCT02959918|561684920|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615489|NCT02959918|561684921|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615490|NCT02959918|561684922|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615491|NCT02959918|561684923|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615492|NCT02959918|561684924|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615493|NCT02959918|561684925|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615494|NCT02959918|561684926|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615495|NCT02959918|561684927|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155615496|NCT02959918|561684914|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615497|NCT02959918|561684915|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615498|NCT02959918|561684916|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615499|NCT02959918|561684917|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615500|NCT02959918|561684918|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615501|NCT02959918|561684919|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615502|NCT02959918|561684920|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155272570|NCT05832437|560431340|FG000|Overall Study|time off work|1|||
155272571|NCT05832437|560431341|FG001|Overall Study|time off work|0|||
155272572|NCT05832437|560431342|FG002|Overall Study|time off work|0|||
155272573|NCT05832437|560431343|FG003|Overall Study|time off work|0|||
155272574|NCT05376371|560431344|FG000|Overall Study|change in release date|10|||
155272575|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272576|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272577|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272578|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272579|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155615503|NCT02959918|561684921|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
155615504|NCT02959918|561684922|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615505|NCT02959918|561684923|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615506|NCT02959918|561684924|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615507|NCT02959918|561684925|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615508|NCT02959918|561684926|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615509|NCT02959918|561684927|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155615510|NCT02959918|561684914|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615511|NCT02959918|561684915|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615512|NCT02959918|561684916|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615513|NCT02959918|561684917|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615514|NCT02959918|561684918|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615515|NCT02959918|561684919|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615516|NCT02959918|561684920|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615517|NCT02959918|561684921|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615518|NCT02959918|561684922|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
155615519|NCT02959918|561684923|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615520|NCT02959918|561684924|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615521|NCT02959918|561684925|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615522|NCT02959918|561684926|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615523|NCT02959918|561684927|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155615524|NCT02959918|561684914|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615525|NCT02959918|561684915|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615526|NCT02959918|561684916|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615527|NCT02959918|561684917|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615528|NCT02959918|561684918|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615529|NCT02959918|561684919|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615530|NCT02959918|561684920|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615531|NCT02959918|561684921|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155726706|NCT00463567|562099783|FG002|Overall Study|Withdrawal by Subject|20|||
155272580|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272581|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
155272582|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
155272583|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272584|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272585|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272586|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272587|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272588|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272589|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272590|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272591|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272592|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
155272593|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272594|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272595|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272596|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272597|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272598|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272599|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272600|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272601|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272602|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
155272603|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155381922|NCT00116753|560833237|FG001|Overall Study|Dosing Error|1|||
155381923|NCT00116753|560833238|FG002|Overall Study|Dosing Error|0|||
155381924|NCT01200589|560833239|FG000|Overall Study|Withdrawal by Subject|13|||
155272604|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272605|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272606|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272607|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272608|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272609|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272610|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272611|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272612|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272613|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272614|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
155272615|NCT05407311|560431355|FG000|Overall Study|Withdrawal by Subject|5|||
155272616|NCT05407311|560431355|FG000|Overall Study|Protocol Violation|3|||
155272617|NCT05407311|560431355|FG000|Overall Study|Physician Decision|1|||
155272618|NCT05407311|560431355|FG000|Overall Study|Non-compliance|1|||
155272619|NCT00337662|560431357|FG000|Study Period II|Lost to Follow-up|0|||
155272620|NCT00337662|560431358|FG001|Study Period II|Lost to Follow-up|0|||
155272621|NCT00337662|560431359|FG002|Study Period II|Lost to Follow-up|0|||
155272622|NCT00337662|560431360|FG003|Study Period II|Lost to Follow-up|35|||
155272623|NCT00337662|560431357|FG000|Study Period II|Withdrawal by Subject|0|||
155272624|NCT00337662|560431358|FG001|Study Period II|Withdrawal by Subject|0|||
155272625|NCT00337662|560431359|FG002|Study Period II|Withdrawal by Subject|0|||
155272626|NCT00337662|560431360|FG003|Study Period II|Withdrawal by Subject|20|||
155272627|NCT00337662|560431357|FG000|Study Period II|Adverse Event|0|||
155272628|NCT00337662|560431358|FG001|Study Period II|Adverse Event|0|||
155272629|NCT00337662|560431359|FG002|Study Period II|Adverse Event|0|||
155272630|NCT00337662|560431360|FG003|Study Period II|Adverse Event|16|||
155272631|NCT00337662|560431357|FG000|Study Period II|Physician Decision|0|||
155272632|NCT00337662|560431358|FG001|Study Period II|Physician Decision|0|||
155272633|NCT00337662|560431359|FG002|Study Period II|Physician Decision|0|||
155272634|NCT00337662|560431360|FG003|Study Period II|Physician Decision|13|||
155272635|NCT00337662|560431357|FG000|Study Period II|Entry Criteria Not Met|0|||
155272636|NCT00337662|560431358|FG001|Study Period II|Entry Criteria Not Met|0|||
155272637|NCT00337662|560431359|FG002|Study Period II|Entry Criteria Not Met|0|||
155272638|NCT00337662|560431360|FG003|Study Period II|Entry Criteria Not Met|6|||
155272639|NCT00337662|560431357|FG000|Study Period II|Protocol Violation|0|||
155272640|NCT00337662|560431358|FG001|Study Period II|Protocol Violation|0|||
155272641|NCT00337662|560431359|FG002|Study Period II|Protocol Violation|0|||
155272642|NCT00337662|560431360|FG003|Study Period II|Protocol Violation|6|||
155272643|NCT00337662|560431357|FG000|Study Period II|Lack of Efficacy|0|||
155272644|NCT00337662|560431358|FG001|Study Period II|Lack of Efficacy|0|||
155272645|NCT00337662|560431359|FG002|Study Period II|Lack of Efficacy|0|||
155272646|NCT00337662|560431360|FG003|Study Period II|Lack of Efficacy|7|||
155272647|NCT00337662|560431357|FG000|Study Period II|Sponsor Decision|0|||
155272648|NCT00337662|560431358|FG001|Study Period II|Sponsor Decision|0|||
155272649|NCT00337662|560431359|FG002|Study Period II|Sponsor Decision|0|||
155272650|NCT00337662|560431360|FG003|Study Period II|Sponsor Decision|2|||
155272651|NCT00337662|560431357|FG000|Study Period II|Parent/Caregiver Decision|0|||
155272652|NCT00337662|560431358|FG001|Study Period II|Parent/Caregiver Decision|0|||
155272653|NCT00337662|560431359|FG002|Study Period II|Parent/Caregiver Decision|0|||
155272654|NCT00337662|560431360|FG003|Study Period II|Parent/Caregiver Decision|1|||
155272655|NCT00337662|560431357|FG000|Study Period III|Lost to Follow-up|14|||
155272656|NCT00337662|560431358|FG001|Study Period III|Lost to Follow-up|16|||
155272657|NCT00337662|560431359|FG002|Study Period III|Lost to Follow-up|14|||
155272658|NCT00337662|560431360|FG003|Study Period III|Lost to Follow-up|0|||
155272659|NCT00337662|560431357|FG000|Study Period III|Withdrawal by Subject|18|||
155272660|NCT00337662|560431358|FG001|Study Period III|Withdrawal by Subject|14|||
155272661|NCT00337662|560431359|FG002|Study Period III|Withdrawal by Subject|12|||
155272662|NCT00337662|560431360|FG003|Study Period III|Withdrawal by Subject|0|||
155272663|NCT00337662|560431357|FG000|Study Period III|Adverse Event|9|||
155272664|NCT00337662|560431358|FG001|Study Period III|Adverse Event|10|||
155272665|NCT00337662|560431359|FG002|Study Period III|Adverse Event|8|||
155272666|NCT00337662|560431360|FG003|Study Period III|Adverse Event|0|||
155272667|NCT00337662|560431357|FG000|Study Period III|Protocol Violation|3|||
155272668|NCT00337662|560431358|FG001|Study Period III|Protocol Violation|8|||
155272669|NCT00337662|560431359|FG002|Study Period III|Protocol Violation|2|||
155272670|NCT00337662|560431360|FG003|Study Period III|Protocol Violation|0|||
155272671|NCT00337662|560431357|FG000|Study Period III|Physician Decision|6|||
155272672|NCT00337662|560431358|FG001|Study Period III|Physician Decision|5|||
155272673|NCT00337662|560431359|FG002|Study Period III|Physician Decision|0|||
155272674|NCT00337662|560431360|FG003|Study Period III|Physician Decision|0|||
155272675|NCT00337662|560431357|FG000|Study Period III|Entry Criteria Not Met|4|||
155272676|NCT00337662|560431358|FG001|Study Period III|Entry Criteria Not Met|1|||
155272677|NCT00337662|560431359|FG002|Study Period III|Entry Criteria Not Met|3|||
155272678|NCT00337662|560431360|FG003|Study Period III|Entry Criteria Not Met|0|||
155272679|NCT00337662|560431357|FG000|Study Period III|Lack of Efficacy|4|||
155272680|NCT00337662|560431358|FG001|Study Period III|Lack of Efficacy|4|||
155272681|NCT00337662|560431359|FG002|Study Period III|Lack of Efficacy|2|||
155272682|NCT00337662|560431360|FG003|Study Period III|Lack of Efficacy|0|||
155272683|NCT00337662|560431357|FG000|Study Period III|Parent/Caregiver Decision|0|||
155272684|NCT00337662|560431358|FG001|Study Period III|Parent/Caregiver Decision|0|||
155272685|NCT00337662|560431359|FG002|Study Period III|Parent/Caregiver Decision|2|||
155272686|NCT00337662|560431360|FG003|Study Period III|Parent/Caregiver Decision|0|||
155272687|NCT00337662|560431357|FG000|Study Period III|Sponsor Decision|1|||
155272688|NCT00337662|560431358|FG001|Study Period III|Sponsor Decision|0|||
155272689|NCT00337662|560431359|FG002|Study Period III|Sponsor Decision|1|||
155726707|NCT00463567|562099784|FG003|Overall Study|Withdrawal by Subject|37|||
155726708|NCT00463567|562099785|FG004|Overall Study|Withdrawal by Subject|6|||
155726709|NCT00463567|562099786|FG005|Overall Study|Withdrawal by Subject|5|||
155726710|NCT00463567|562099787|FG006|Overall Study|Withdrawal by Subject|1|||
155726711|NCT00463567|562099781|FG000|Overall Study|Protocol Deviation|13|||
155726712|NCT00463567|562099782|FG001|Overall Study|Protocol Deviation|9|||
155726713|NCT00463567|562099783|FG002|Overall Study|Protocol Deviation|14|||
155726714|NCT00463567|562099784|FG003|Overall Study|Protocol Deviation|11|||
155726715|NCT00463567|562099785|FG004|Overall Study|Protocol Deviation|1|||
155726716|NCT00463567|562099786|FG005|Overall Study|Protocol Deviation|1|||
155726717|NCT00463567|562099787|FG006|Overall Study|Protocol Deviation|2|||
155726718|NCT00463567|562099781|FG000|Overall Study|Lost to Follow-up|12|||
155726719|NCT00463567|562099782|FG001|Overall Study|Lost to Follow-up|6|||
155726720|NCT00463567|562099783|FG002|Overall Study|Lost to Follow-up|13|||
155726721|NCT00463567|562099784|FG003|Overall Study|Lost to Follow-up|8|||
155726722|NCT00463567|562099785|FG004|Overall Study|Lost to Follow-up|1|||
155726723|NCT00463567|562099786|FG005|Overall Study|Lost to Follow-up|1|||
155726724|NCT00463567|562099787|FG006|Overall Study|Lost to Follow-up|1|||
155726725|NCT00463567|562099781|FG000|Overall Study|Administrative problems|5|||
155726726|NCT00463567|562099782|FG001|Overall Study|Administrative problems|3|||
155726727|NCT00463567|562099783|FG002|Overall Study|Administrative problems|6|||
155726728|NCT00463567|562099784|FG003|Overall Study|Administrative problems|9|||
155726729|NCT00463567|562099785|FG004|Overall Study|Administrative problems|3|||
155726730|NCT00463567|562099786|FG005|Overall Study|Administrative problems|2|||
155726731|NCT00463567|562099787|FG006|Overall Study|Administrative problems|2|||
155726732|NCT00463567|562099781|FG000|Overall Study|Lack of Efficacy|4|||
155726733|NCT00463567|562099782|FG001|Overall Study|Lack of Efficacy|9|||
155726734|NCT00463567|562099783|FG002|Overall Study|Lack of Efficacy|9|||
155726735|NCT00463567|562099784|FG003|Overall Study|Lack of Efficacy|17|||
155726736|NCT00463567|562099785|FG004|Overall Study|Lack of Efficacy|1|||
155726737|NCT00463567|562099786|FG005|Overall Study|Lack of Efficacy|0|||
155726738|NCT00463567|562099787|FG006|Overall Study|Lack of Efficacy|1|||
155726739|NCT00463567|562099781|FG000|Overall Study|Abnormal lab value(s)|1|||
155726740|NCT00463567|562099782|FG001|Overall Study|Abnormal lab value(s)|1|||
155726741|NCT00463567|562099783|FG002|Overall Study|Abnormal lab value(s)|2|||
155726742|NCT00463567|562099784|FG003|Overall Study|Abnormal lab value(s)|1|||
155726743|NCT00463567|562099785|FG004|Overall Study|Abnormal lab value(s)|1|||
155726744|NCT00463567|562099786|FG005|Overall Study|Abnormal lab value(s)|0|||
155726745|NCT00463567|562099787|FG006|Overall Study|Abnormal lab value(s)|0|||
155726746|NCT00463567|562099781|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155726747|NCT00463567|562099782|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155726748|NCT00463567|562099783|FG002|Overall Study|Abnormal test procedure result(s)|6|||
155726749|NCT00463567|562099784|FG003|Overall Study|Abnormal test procedure result(s)|2|||
155726750|NCT00463567|562099785|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155726751|NCT00463567|562099786|FG005|Overall Study|Abnormal test procedure result(s)|2|||
155726752|NCT00463567|562099787|FG006|Overall Study|Abnormal test procedure result(s)|0|||
155726753|NCT00463567|562099781|FG000|Overall Study|Death|1|||
155726754|NCT00463567|562099782|FG001|Overall Study|Death|0|||
155726755|NCT00463567|562099783|FG002|Overall Study|Death|2|||
155726756|NCT00463567|562099784|FG003|Overall Study|Death|0|||
155726757|NCT00463567|562099785|FG004|Overall Study|Death|0|||
155726758|NCT00463567|562099786|FG005|Overall Study|Death|0|||
155726759|NCT00463567|562099787|FG006|Overall Study|Death|0|||
155726760|NCT00641667|562099790|FG000|Overall Study|Withdrawal by Subject|1|||
155272690|NCT00337662|560431360|FG003|Study Period III|Sponsor Decision|0|||
155272691|NCT00337662|560431357|FG000|Study Period III|Clinical Relapse|1|||
155726761|NCT00641667|562099790|FG000|Overall Study|Adverse Event|1|||
155726762|NCT00641667|562099790|FG000|Overall Study|Physician Decision|1|||
155726763|NCT00641667|562099790|FG000|Overall Study|Worsening of underlying disease|3|||
155726764|NCT01124006|562099791|FG000|Overall Study|Withdrawal by Subject|2|||
155726765|NCT01124006|562099792|FG001|Overall Study|Withdrawal by Subject|2|||
155272692|NCT00337662|560431358|FG001|Study Period III|Clinical Relapse|0|||
155272693|NCT00337662|560431359|FG002|Study Period III|Clinical Relapse|0|||
155272694|NCT00337662|560431360|FG003|Study Period III|Clinical Relapse|0|||
155726766|NCT01124006|562099793|FG002|Overall Study|Withdrawal by Subject|0|||
155726767|NCT01124006|562099791|FG000|Overall Study|Lost to Follow-up|1|||
155272695|NCT01265823|560431363|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
155272696|NCT01265823|560431363|FG000|Overall Study|Failure to Return|4|||
155272697|NCT01265823|560431363|FG000|Overall Study|Protocol Violation|1|||
155272698|NCT01265823|560431363|FG000|Overall Study|Participant Request|1|||
155272699|NCT00960752|560431372|FG000|Overall Study|Adverse Event|0|||
155272700|NCT00960752|560431373|FG001|Overall Study|Adverse Event|0|||
155272701|NCT00960752|560431374|FG002|Overall Study|Adverse Event|1|||
155272702|NCT00960752|560431372|FG000|Overall Study|Progression|0|||
155272703|NCT00960752|560431373|FG001|Overall Study|Progression|0|||
155272704|NCT00960752|560431374|FG002|Overall Study|Progression|1|||
155272705|NCT05027074|560431377|FG000|Overall Study|Death|47|||
155272706|NCT05027074|560431378|FG001|Overall Study|Death|42|||
155272707|NCT05027074|560431379|FG002|Overall Study|Death|39|||
155272708|NCT05027074|560431377|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155272709|NCT05027074|560431378|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155272710|NCT05027074|560431379|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155272711|NCT05027074|560431377|FG000|Overall Study|Site Terminated By Sponsor|3|||
155272712|NCT05027074|560431378|FG001|Overall Study|Site Terminated By Sponsor|0|||
155272713|NCT05027074|560431379|FG002|Overall Study|Site Terminated By Sponsor|2|||
155272714|NCT05027074|560431377|FG000|Overall Study|Withdrawal by Subject|13|||
155272715|NCT05027074|560431378|FG001|Overall Study|Withdrawal by Subject|8|||
155272716|NCT05027074|560431379|FG002|Overall Study|Withdrawal by Subject|10|||
155272717|NCT05027074|560431377|FG000|Overall Study|Lost to Follow-up|2|||
155272718|NCT05027074|560431378|FG001|Overall Study|Lost to Follow-up|4|||
155272719|NCT05027074|560431379|FG002|Overall Study|Lost to Follow-up|3|||
155272720|NCT05027074|560431377|FG000|Overall Study|Status Not Recorded|0|||
155272721|NCT05027074|560431378|FG001|Overall Study|Status Not Recorded|0|||
155272722|NCT05027074|560431379|FG002|Overall Study|Status Not Recorded|1|||
155272723|NCT03734991|560431384|FG000|Overall Study|Adverse Event|4|||
155272724|NCT03734991|560431385|FG001|Overall Study|Adverse Event|0|||
155272725|NCT03734991|560431384|FG000|Overall Study|Lost to Follow-up|4|||
155272726|NCT03734991|560431385|FG001|Overall Study|Lost to Follow-up|0|||
155272727|NCT03734991|560431384|FG000|Overall Study|Physician Decision|0|||
155272728|NCT03734991|560431385|FG001|Overall Study|Physician Decision|1|||
155272729|NCT03734991|560431384|FG000|Overall Study|Pregnancy|1|||
155272730|NCT03734991|560431385|FG001|Overall Study|Pregnancy|0|||
155272731|NCT03734991|560431384|FG000|Overall Study|Withdrawal by Subject|6|||
155272732|NCT03734991|560431385|FG001|Overall Study|Withdrawal by Subject|3|||
155272733|NCT03734991|560431384|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
155272734|NCT03734991|560431385|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
155272735|NCT03734991|560431384|FG000|Overall Study|Other|2|||
155272736|NCT03734991|560431385|FG001|Overall Study|Other|2|||
155272737|NCT02322814|560431388|FG000|Overall Study|Death|7|||
155272738|NCT02322814|560431389|FG001|Overall Study|Death|29|||
155272739|NCT02322814|560431390|FG002|Overall Study|Death|32|||
155272740|NCT02322814|560431391|FG003|Overall Study|Death|23|||
155272741|NCT02322814|560431392|FG004|Overall Study|Death|14|||
155272742|NCT02322814|560431388|FG000|Overall Study|Lost to Follow-up|1|||
155272743|NCT02322814|560431389|FG001|Overall Study|Lost to Follow-up|3|||
155272744|NCT02322814|560431390|FG002|Overall Study|Lost to Follow-up|3|||
155272745|NCT02322814|560431391|FG003|Overall Study|Lost to Follow-up|1|||
155272746|NCT02322814|560431392|FG004|Overall Study|Lost to Follow-up|0|||
155272747|NCT02322814|560431388|FG000|Overall Study|Various Reasons|2|||
155272748|NCT02322814|560431389|FG001|Overall Study|Various Reasons|0|||
155272749|NCT02322814|560431390|FG002|Overall Study|Various Reasons|1|||
155272750|NCT02322814|560431391|FG003|Overall Study|Various Reasons|1|||
155272751|NCT02322814|560431392|FG004|Overall Study|Various Reasons|0|||
155272752|NCT02322814|560431388|FG000|Overall Study|Progressive Disease|0|||
155272753|NCT02322814|560431389|FG001|Overall Study|Progressive Disease|0|||
155272754|NCT02322814|560431390|FG002|Overall Study|Progressive Disease|0|||
155272755|NCT02322814|560431391|FG003|Overall Study|Progressive Disease|1|||
155272756|NCT02322814|560431392|FG004|Overall Study|Progressive Disease|1|||
155272757|NCT02322814|560431388|FG000|Overall Study|Protocol Violation|1|||
155272758|NCT02322814|560431389|FG001|Overall Study|Protocol Violation|0|||
155272759|NCT02322814|560431390|FG002|Overall Study|Protocol Violation|0|||
155272760|NCT02322814|560431391|FG003|Overall Study|Protocol Violation|0|||
155272761|NCT02322814|560431392|FG004|Overall Study|Protocol Violation|0|||
155272762|NCT02322814|560431388|FG000|Overall Study|Study Terminated by Sponsor|0|||
155272763|NCT02322814|560431389|FG001|Overall Study|Study Terminated by Sponsor|7|||
155272764|NCT02322814|560431390|FG002|Overall Study|Study Terminated by Sponsor|9|||
155272765|NCT02322814|560431391|FG003|Overall Study|Study Terminated by Sponsor|5|||
155272766|NCT02322814|560431392|FG004|Overall Study|Study Terminated by Sponsor|13|||
155272767|NCT02322814|560431388|FG000|Overall Study|Withdrawal by Subject|5|||
155272768|NCT02322814|560431389|FG001|Overall Study|Withdrawal by Subject|4|||
155272769|NCT02322814|560431390|FG002|Overall Study|Withdrawal by Subject|2|||
155272770|NCT02322814|560431391|FG003|Overall Study|Withdrawal by Subject|1|||
155272771|NCT02322814|560431392|FG004|Overall Study|Withdrawal by Subject|3|||
155272772|NCT01164228|560431393|FG000|Overall Study|Progression|24|||
155272773|NCT01164228|560431394|FG001|Overall Study|Progression|25|||
155272774|NCT01164228|560431393|FG000|Overall Study|Adverse Event|13|||
155615532|NCT02959918|561684922|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615533|NCT02959918|561684923|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
155615534|NCT02959918|561684924|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615535|NCT02959918|561684925|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615536|NCT02959918|561684926|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615537|NCT02959918|561684927|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155615538|NCT00837967|561684928|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
155615539|NCT00837967|561684929|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
155615540|NCT02504320|561684930|FG000|Treatment Period 1|Positive Drug Screen|0|||
155615541|NCT02504320|561684931|FG001|Treatment Period 1|Positive Drug Screen|0|||
155615542|NCT02504320|561684932|FG002|Treatment Period 1|Positive Drug Screen|1|||
155615543|NCT02504320|561684933|FG003|Treatment Period 1|Positive Drug Screen|0|||
155615544|NCT02504320|561684930|FG000|Treatment Period 2|Positive Drug Screen|0|||
155615545|NCT02504320|561684931|FG001|Treatment Period 2|Positive Drug Screen|1|||
155615546|NCT02504320|561684932|FG002|Treatment Period 2|Positive Drug Screen|0|||
155615547|NCT02504320|561684933|FG003|Treatment Period 2|Positive Drug Screen|0|||
155615548|NCT02504320|561684930|FG000|Treatment Period 3|Positive Drug Screen|0|||
155615549|NCT02504320|561684931|FG001|Treatment Period 3|Positive Drug Screen|0|||
155615550|NCT02504320|561684932|FG002|Treatment Period 3|Positive Drug Screen|0|||
155615551|NCT02504320|561684933|FG003|Treatment Period 3|Positive Drug Screen|1|||
155615552|NCT02504320|561684930|FG000|Treatment Period 3|Adverse Event|0|||
155615553|NCT02504320|561684931|FG001|Treatment Period 3|Adverse Event|0|||
155615554|NCT02504320|561684932|FG002|Treatment Period 3|Adverse Event|1|||
155615555|NCT02504320|561684933|FG003|Treatment Period 3|Adverse Event|0|||
155615556|NCT00941304|561684934|FG000|Overall Study|Lost to Follow-up|1|||
155615557|NCT00941304|561684935|FG001|Overall Study|Lost to Follow-up|0|||
155615558|NCT00941304|561684936|FG002|Overall Study|Lost to Follow-up|0|||
155615559|NCT00941304|561684937|FG003|Overall Study|Lost to Follow-up|0|||
155615560|NCT00941304|561684938|FG004|Overall Study|Lost to Follow-up|0|||
155615561|NCT03293394|561684939|FG000|Follow-up (6 Months)|Adverse Event|4|||
155615562|NCT03293394|561684940|FG001|Follow-up (6 Months)|Adverse Event|2|||
155615563|NCT04978337|561684941|FG000|Overall Study|Withdrawal by Subject|0|||
155615564|NCT04978337|561684942|FG001|Overall Study|Withdrawal by Subject|1|||
155615565|NCT02497404|561684943|FG000|Overall Study|Adverse Event|1|||
155615566|NCT01436227|561684944|FG000|Overall Study|Adverse Event|7|||
155615567|NCT01436227|561684944|FG000|Overall Study|Death|1|||
155615568|NCT01436227|561684944|FG000|Overall Study|Lack of Efficacy|1|||
155615569|NCT01436227|561684944|FG000|Overall Study|Lost to Follow-up|3|||
155615570|NCT01436227|561684944|FG000|Overall Study|Physician Decision|1|||
155615571|NCT01436227|561684944|FG000|Overall Study|Withdrawal by Subject|7|||
155615572|NCT01436227|561684944|FG000|Overall Study|Disease progression, relapse|6|||
155615573|NCT04865419|561684945|FG000|Overall Study|Other|1|||
155615574|NCT04865419|561684946|FG001|Overall Study|Other|2|||
155615575|NCT04865419|561684947|FG002|Overall Study|Other|2|||
155615576|NCT04865419|561684948|FG003|Overall Study|Other|1|||
155615577|NCT04865419|561684949|FG004|Overall Study|Other|3|||
155615578|NCT04865419|561684950|FG005|Overall Study|Other|0|||
155615579|NCT04865419|561684951|FG006|Overall Study|Other|0|||
155615580|NCT04865419|561684952|FG007|Overall Study|Other|1|||
155615581|NCT04865419|561684953|FG008|Overall Study|Other|0|||
155615582|NCT04865419|561684954|FG009|Overall Study|Other|0|||
155615583|NCT04865419|561684955|FG010|Overall Study|Other|0|||
155615584|NCT04865419|561684945|FG000|Overall Study|Withdrawal by Subject|0|||
155615585|NCT04865419|561684946|FG001|Overall Study|Withdrawal by Subject|1|||
155615586|NCT04865419|561684947|FG002|Overall Study|Withdrawal by Subject|1|||
155615587|NCT04865419|561684948|FG003|Overall Study|Withdrawal by Subject|0|||
155615588|NCT04865419|561684949|FG004|Overall Study|Withdrawal by Subject|0|||
155615589|NCT04865419|561684950|FG005|Overall Study|Withdrawal by Subject|0|||
155615590|NCT04865419|561684951|FG006|Overall Study|Withdrawal by Subject|0|||
155615591|NCT04865419|561684952|FG007|Overall Study|Withdrawal by Subject|1|||
155615592|NCT04865419|561684953|FG008|Overall Study|Withdrawal by Subject|2|||
155615593|NCT04865419|561684954|FG009|Overall Study|Withdrawal by Subject|1|||
155615594|NCT04865419|561684955|FG010|Overall Study|Withdrawal by Subject|0|||
155615595|NCT04865419|561684945|FG000|Overall Study|Study terminated by Sponsor|0|||
155615596|NCT04865419|561684946|FG001|Overall Study|Study terminated by Sponsor|0|||
155726768|NCT01124006|562099792|FG001|Overall Study|Lost to Follow-up|0|||
155726769|NCT01124006|562099793|FG002|Overall Study|Lost to Follow-up|1|||
155726770|NCT01124006|562099791|FG000|Overall Study|Other|0|||
155726771|NCT01124006|562099792|FG001|Overall Study|Other|0|||
155726772|NCT01124006|562099793|FG002|Overall Study|Other|1|||
155615597|NCT04865419|561684947|FG002|Overall Study|Study terminated by Sponsor|0|||
155615598|NCT04865419|561684948|FG003|Overall Study|Study terminated by Sponsor|2|||
155615599|NCT04865419|561684949|FG004|Overall Study|Study terminated by Sponsor|2|||
155615600|NCT04865419|561684950|FG005|Overall Study|Study terminated by Sponsor|0|||
155615601|NCT04865419|561684951|FG006|Overall Study|Study terminated by Sponsor|0|||
155615602|NCT04865419|561684952|FG007|Overall Study|Study terminated by Sponsor|0|||
155726773|NCT00836693|562099796|FG000|Overall Study|Adverse Event|4|||
155615603|NCT04865419|561684953|FG008|Overall Study|Study terminated by Sponsor|0|||
155615604|NCT04865419|561684954|FG009|Overall Study|Study terminated by Sponsor|0|||
155615605|NCT04865419|561684955|FG010|Overall Study|Study terminated by Sponsor|1|||
155615606|NCT04865419|561684945|FG000|Overall Study|Death|3|||
155615607|NCT04865419|561684946|FG001|Overall Study|Death|1|||
155615608|NCT04865419|561684947|FG002|Overall Study|Death|4|||
155615609|NCT04865419|561684948|FG003|Overall Study|Death|2|||
155615610|NCT04865419|561684949|FG004|Overall Study|Death|5|||
155615611|NCT04865419|561684950|FG005|Overall Study|Death|2|||
155615612|NCT04865419|561684951|FG006|Overall Study|Death|1|||
155615613|NCT04865419|561684952|FG007|Overall Study|Death|1|||
155615614|NCT04865419|561684953|FG008|Overall Study|Death|2|||
155615615|NCT04865419|561684954|FG009|Overall Study|Death|2|||
155615616|NCT04865419|561684955|FG010|Overall Study|Death|1|||
155615617|NCT04865419|561684945|FG000|Overall Study|Lost to Follow-up|0|||
155615618|NCT04865419|561684946|FG001|Overall Study|Lost to Follow-up|0|||
155615619|NCT04865419|561684947|FG002|Overall Study|Lost to Follow-up|0|||
155615620|NCT04865419|561684948|FG003|Overall Study|Lost to Follow-up|0|||
155615621|NCT04865419|561684949|FG004|Overall Study|Lost to Follow-up|0|||
155615622|NCT04865419|561684950|FG005|Overall Study|Lost to Follow-up|0|||
155615623|NCT04865419|561684951|FG006|Overall Study|Lost to Follow-up|0|||
155615624|NCT04865419|561684952|FG007|Overall Study|Lost to Follow-up|0|||
155615625|NCT04865419|561684953|FG008|Overall Study|Lost to Follow-up|0|||
155615626|NCT04865419|561684954|FG009|Overall Study|Lost to Follow-up|1|||
155615627|NCT04865419|561684955|FG010|Overall Study|Lost to Follow-up|0|||
155615628|NCT03853291|561684956|FG000|Overall Study|Lost to Follow-up|1|||
155615629|NCT03853291|561684957|FG001|Overall Study|Lost to Follow-up|2|||
155615630|NCT03853291|561684958|FG002|Overall Study|Lost to Follow-up|0|||
155615631|NCT03853291|561684959|FG003|Overall Study|Lost to Follow-up|0|||
155615632|NCT03853291|561684960|FG004|Overall Study|Lost to Follow-up|0|||
155615633|NCT03853291|561684961|FG005|Overall Study|Lost to Follow-up|0|||
155615634|NCT03853291|561684956|FG000|Overall Study|Determined to be ineligible|1|||
155615635|NCT03853291|561684957|FG001|Overall Study|Determined to be ineligible|1|||
155615636|NCT03853291|561684958|FG002|Overall Study|Determined to be ineligible|0|||
155615637|NCT03853291|561684959|FG003|Overall Study|Determined to be ineligible|0|||
155615638|NCT03853291|561684960|FG004|Overall Study|Determined to be ineligible|0|||
155615639|NCT03853291|561684961|FG005|Overall Study|Determined to be ineligible|0|||
155615640|NCT01658904|561684969|FG000|Overall Study|Principal Investigator discretion|2|||
155615641|NCT01658904|561684970|FG001|Overall Study|Principal Investigator discretion|0|||
155615642|NCT01658904|561684971|FG002|Overall Study|Principal Investigator discretion|0|||
155615643|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
155615644|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
155615645|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
155615646|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
155615647|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
155615648|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
155615649|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
155615650|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
155615651|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
155615652|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
155615653|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155615654|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155615655|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155615656|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
155615657|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155615658|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155615659|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
155615660|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155272775|NCT01164228|560431394|FG001|Overall Study|Adverse Event|7|||
155272776|NCT01164228|560431393|FG000|Overall Study|Death|1|||
155272777|NCT01164228|560431394|FG001|Overall Study|Death|1|||
155272778|NCT01164228|560431393|FG000|Overall Study|Withdrawal by Subject|2|||
155615661|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155615662|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155615663|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155615664|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155272779|NCT01164228|560431394|FG001|Overall Study|Withdrawal by Subject|0|||
155615665|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
155615666|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155615667|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155615668|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155272780|NCT01164228|560431393|FG000|Overall Study|Physician Decision|1|||
155272781|NCT01164228|560431394|FG001|Overall Study|Physician Decision|2|||
155272782|NCT01164228|560431393|FG000|Overall Study|Symptomatic deterioration|1|||
155615669|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155615670|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155615671|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155272783|NCT01164228|560431394|FG001|Overall Study|Symptomatic deterioration|0|||
155272784|NCT01164228|560431393|FG000|Overall Study|Never started treatment|1|||
155272785|NCT01164228|560431394|FG001|Overall Study|Never started treatment|3|||
155272786|NCT01164228|560431393|FG000|Overall Study|Ineligible|1|||
155272787|NCT01164228|560431394|FG001|Overall Study|Ineligible|0|||
155272788|NCT04908449|560431395|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
155272789|NCT04908449|560431396|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
155272790|NCT04908449|560431395|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
155272791|NCT04908449|560431396|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
155272792|NCT01567865|560431399|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
155272793|NCT01567865|560431400|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
155272794|NCT01567865|560431401|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
155272795|NCT01567865|560431402|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
155272796|NCT01567865|560431399|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
155272797|NCT01567865|560431400|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
155272798|NCT01567865|560431401|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
155272799|NCT01567865|560431402|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
155272800|NCT05256381|560431403|FG000|Overall Study|Withdrawal by Subject|4|||
155272801|NCT05256381|560431404|FG001|Overall Study|Withdrawal by Subject|0|||
155272802|NCT05256381|560431405|FG002|Overall Study|Withdrawal by Subject|2|||
155272803|NCT05256381|560431406|FG003|Overall Study|Withdrawal by Subject|2|||
155272804|NCT05256381|560431407|FG004|Overall Study|Withdrawal by Subject|8|||
155272805|NCT05256381|560431408|FG005|Overall Study|Withdrawal by Subject|6|||
155272806|NCT05256381|560431403|FG000|Overall Study|Physician Decision|0|||
155272807|NCT05256381|560431404|FG001|Overall Study|Physician Decision|0|||
155272808|NCT05256381|560431405|FG002|Overall Study|Physician Decision|1|||
155272809|NCT05256381|560431406|FG003|Overall Study|Physician Decision|0|||
155272810|NCT05256381|560431407|FG004|Overall Study|Physician Decision|2|||
155272811|NCT05256381|560431408|FG005|Overall Study|Physician Decision|0|||
155272812|NCT05256381|560431403|FG000|Overall Study|Death|17|||
155272813|NCT05256381|560431404|FG001|Overall Study|Death|3|||
155272814|NCT05256381|560431405|FG002|Overall Study|Death|4|||
155272815|NCT05256381|560431406|FG003|Overall Study|Death|5|||
155272816|NCT05256381|560431407|FG004|Overall Study|Death|24|||
155272817|NCT05256381|560431408|FG005|Overall Study|Death|21|||
155272818|NCT05256381|560431403|FG000|Overall Study|Other, not specified|0|||
155272819|NCT05256381|560431404|FG001|Overall Study|Other, not specified|0|||
155272820|NCT05256381|560431405|FG002|Overall Study|Other, not specified|0|||
155272821|NCT05256381|560431406|FG003|Overall Study|Other, not specified|0|||
155272822|NCT05256381|560431407|FG004|Overall Study|Other, not specified|2|||
155272823|NCT05256381|560431408|FG005|Overall Study|Other, not specified|1|||
155272824|NCT05256381|560431403|FG000|Overall Study|Study terminated by sponsor|18|||
155272825|NCT05256381|560431404|FG001|Overall Study|Study terminated by sponsor|5|||
155272826|NCT05256381|560431405|FG002|Overall Study|Study terminated by sponsor|5|||
155272827|NCT05256381|560431406|FG003|Overall Study|Study terminated by sponsor|5|||
155272828|NCT05256381|560431407|FG004|Overall Study|Study terminated by sponsor|18|||
155272829|NCT05256381|560431408|FG005|Overall Study|Study terminated by sponsor|11|||
155272830|NCT05256381|560431403|FG000|Overall Study|Lost to Follow-up|1|||
155272831|NCT05256381|560431404|FG001|Overall Study|Lost to Follow-up|0|||
155272832|NCT05256381|560431405|FG002|Overall Study|Lost to Follow-up|0|||
155272833|NCT05256381|560431406|FG003|Overall Study|Lost to Follow-up|0|||
155272834|NCT05256381|560431407|FG004|Overall Study|Lost to Follow-up|1|||
155272835|NCT05256381|560431408|FG005|Overall Study|Lost to Follow-up|0|||
155272836|NCT05569954|560431409|FG000|Overall Study|Lost to Follow-up|3|||
155272837|NCT05569954|560431410|FG001|Overall Study|Lost to Follow-up|4|||
155272838|NCT05569954|560431409|FG000|Overall Study|Protocol Violation|1|||
155272839|NCT05569954|560431410|FG001|Overall Study|Protocol Violation|2|||
155272840|NCT05569954|560431409|FG000|Overall Study|Withdrawal by Subject|4|||
155272841|NCT05569954|560431410|FG001|Overall Study|Withdrawal by Subject|2|||
155272842|NCT01518946|560431418|FG000|Open-label Phase|Other|4|||
155615672|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155272843|NCT01518946|560431419|FG001|Open-label Phase|Other|0|||
155272844|NCT01518946|560431420|FG002|Open-label Phase|Other|0|||
155272845|NCT01518946|560431418|FG000|Randomized Phase (First Intervention)|Other|0|||
155272846|NCT01518946|560431419|FG001|Randomized Phase (First Intervention)|Other|1|||
155272847|NCT01518946|560431420|FG002|Randomized Phase (First Intervention)|Other|0|||
155272848|NCT03857841|560431421|FG000|Overall Study|Death|1|||
155272849|NCT03857841|560431422|FG001|Overall Study|Death|0|||
155272850|NCT03857841|560431423|FG002|Overall Study|Death|0|||
155272851|NCT03857841|560431424|FG003|Overall Study|Death|0|||
155272852|NCT03857841|560431421|FG000|Overall Study|Study Terminated by Sponsor|1|||
155272853|NCT03857841|560431422|FG001|Overall Study|Study Terminated by Sponsor|0|||
155615673|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615674|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615675|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615676|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615677|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615678|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
155615679|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615680|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
155615681|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615682|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155615683|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155615684|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155615685|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155615686|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155615687|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
155615688|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155615689|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155615690|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155615691|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155615692|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155615693|NCT04074330|561684976|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615694|NCT04074330|561684977|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155615695|NCT04074330|561684978|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155615696|NCT04074330|561684979|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155615697|NCT04074330|561684980|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615698|NCT04074330|561684981|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155615699|NCT04074330|561684982|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615700|NCT04074330|561684983|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615701|NCT04074330|561684984|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615702|NCT04074330|561684985|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155615703|NCT04074330|561684976|FG000|Dose Expansion (up to 42 Months)|Death|0|||
155615704|NCT04074330|561684977|FG001|Dose Expansion (up to 42 Months)|Death|0|||
155615705|NCT04074330|561684978|FG002|Dose Expansion (up to 42 Months)|Death|0|||
155615706|NCT04074330|561684979|FG003|Dose Expansion (up to 42 Months)|Death|0|||
155615707|NCT04074330|561684980|FG004|Dose Expansion (up to 42 Months)|Death|0|||
155615708|NCT04074330|561684981|FG005|Dose Expansion (up to 42 Months)|Death|0|||
155615709|NCT04074330|561684982|FG006|Dose Expansion (up to 42 Months)|Death|0|||
155615710|NCT04074330|561684983|FG007|Dose Expansion (up to 42 Months)|Death|0|||
155615711|NCT04074330|561684984|FG008|Dose Expansion (up to 42 Months)|Death|1|||
155615712|NCT04074330|561684985|FG009|Dose Expansion (up to 42 Months)|Death|0|||
155615713|NCT04074330|561684976|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615714|NCT04074330|561684977|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615715|NCT04074330|561684978|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615716|NCT04074330|561684979|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615717|NCT04074330|561684980|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615718|NCT04074330|561684981|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615719|NCT04074330|561684982|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615720|NCT04074330|561684983|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155615721|NCT04074330|561684984|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
155615722|NCT04074330|561684985|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
155615723|NCT00972283|561684986|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
155615724|NCT00972283|561684987|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
155615725|NCT00972283|561684986|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
155615726|NCT00972283|561684987|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
155615727|NCT00972283|561684986|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
155726774|NCT00836693|562099797|FG001|Overall Study|Adverse Event|1|||
155615728|NCT00972283|561684987|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
155726775|NCT00836693|562099796|FG000|Overall Study|Sponsor Decision|0|||
155726776|NCT00836693|562099797|FG001|Overall Study|Sponsor Decision|1|||
155726777|NCT00836693|562099796|FG000|Overall Study|Physician Decision|2|||
155726778|NCT00836693|562099797|FG001|Overall Study|Physician Decision|0|||
155726779|NCT00836693|562099796|FG000|Overall Study|Withdrawal by Subject|9|||
155726780|NCT00836693|562099797|FG001|Overall Study|Withdrawal by Subject|4|||
155726781|NCT00836693|562099796|FG000|Overall Study|Protocol Violation|1|||
155726782|NCT00836693|562099797|FG001|Overall Study|Protocol Violation|0|||
155726783|NCT00836693|562099796|FG000|Overall Study|Lost to Follow-up|1|||
155726784|NCT00836693|562099797|FG001|Overall Study|Lost to Follow-up|0|||
155615729|NCT00972283|561684986|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
155615730|NCT00972283|561684987|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
155615731|NCT00972283|561684986|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
155615732|NCT00972283|561684987|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
155615733|NCT00972283|561684986|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
155615734|NCT00972283|561684987|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
155615735|NCT00972283|561684986|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
155615736|NCT00972283|561684987|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
155615737|NCT00972283|561684986|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
155615738|NCT00972283|561684987|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
155615739|NCT00972283|561684986|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
155615740|NCT00972283|561684987|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
155615741|NCT00972283|561684986|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
155615742|NCT00972283|561684987|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
155615743|NCT02903420|561684992|FG000|Overall Study|Death|3|||
155615744|NCT03162328|561684993|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
155615745|NCT03162328|561684994|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
155615746|NCT03162328|561684995|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
155615747|NCT03162328|561684993|FG000|Screening Period|Withdrawal by Subject|1|||
155615748|NCT03162328|561684994|FG001|Screening Period|Withdrawal by Subject|0|||
155615749|NCT03162328|561684995|FG002|Screening Period|Withdrawal by Subject|0|||
155615750|NCT03162328|561684993|FG000|Study Period|Withdrawal by Subject|0|||
155615751|NCT03162328|561684994|FG001|Study Period|Withdrawal by Subject|0|||
155615752|NCT03162328|561684995|FG002|Study Period|Withdrawal by Subject|1|||
155615753|NCT03092791|561684996|FG000|Overall Study|Lost to Follow-up|0|||
155615754|NCT03092791|561684997|FG001|Overall Study|Lost to Follow-up|0|||
155615755|NCT03092791|561684998|FG002|Overall Study|Lost to Follow-up|0|||
155615756|NCT03092791|561684999|FG003|Overall Study|Lost to Follow-up|0|||
155615757|NCT03092791|561685000|FG004|Overall Study|Lost to Follow-up|0|||
155615758|NCT03092791|561685001|FG005|Overall Study|Lost to Follow-up|0|||
155615759|NCT03092791|561685002|FG006|Overall Study|Lost to Follow-up|1|||
155615760|NCT03092791|561685003|FG007|Overall Study|Lost to Follow-up|0|||
155615761|NCT03092791|561684996|FG000|Overall Study|Withdrawal of Consent|0|||
155615762|NCT03092791|561684997|FG001|Overall Study|Withdrawal of Consent|0|||
155615763|NCT03092791|561684998|FG002|Overall Study|Withdrawal of Consent|0|||
155615764|NCT03092791|561684999|FG003|Overall Study|Withdrawal of Consent|0|||
155615765|NCT03092791|561685000|FG004|Overall Study|Withdrawal of Consent|4|||
155615766|NCT03092791|561685001|FG005|Overall Study|Withdrawal of Consent|12|||
155615767|NCT03092791|561685002|FG006|Overall Study|Withdrawal of Consent|6|||
155615768|NCT03092791|561685003|FG007|Overall Study|Withdrawal of Consent|4|||
155615769|NCT03092791|561684996|FG000|Overall Study|Study Termination|0|||
155615770|NCT03092791|561684997|FG001|Overall Study|Study Termination|0|||
155615771|NCT03092791|561684998|FG002|Overall Study|Study Termination|0|||
155615772|NCT03092791|561684999|FG003|Overall Study|Study Termination|0|||
155615773|NCT03092791|561685000|FG004|Overall Study|Study Termination|55|||
155615774|NCT03092791|561685001|FG005|Overall Study|Study Termination|46|||
155615775|NCT03092791|561685002|FG006|Overall Study|Study Termination|53|||
155615776|NCT03092791|561685003|FG007|Overall Study|Study Termination|55|||
155615777|NCT03092791|561684996|FG000|Overall Study|Death|0|||
155615778|NCT03092791|561684997|FG001|Overall Study|Death|0|||
155615779|NCT03092791|561684998|FG002|Overall Study|Death|0|||
155615780|NCT03092791|561684999|FG003|Overall Study|Death|0|||
155615781|NCT03092791|561685000|FG004|Overall Study|Death|0|||
155615782|NCT03092791|561685001|FG005|Overall Study|Death|1|||
155615783|NCT03092791|561685002|FG006|Overall Study|Death|0|||
155615784|NCT03092791|561685003|FG007|Overall Study|Death|1|||
155615785|NCT03092791|561684996|FG000|Overall Study|Reason Not Specified|0|||
155615786|NCT03092791|561684997|FG001|Overall Study|Reason Not Specified|0|||
155615787|NCT03092791|561684998|FG002|Overall Study|Reason Not Specified|0|||
155615788|NCT03092791|561684999|FG003|Overall Study|Reason Not Specified|0|||
155615789|NCT03092791|561685000|FG004|Overall Study|Reason Not Specified|1|||
155615790|NCT03092791|561685001|FG005|Overall Study|Reason Not Specified|1|||
155615791|NCT03092791|561685002|FG006|Overall Study|Reason Not Specified|0|||
155615792|NCT03092791|561685003|FG007|Overall Study|Reason Not Specified|0|||
155615793|NCT02182830|561685004|FG000|Overall Study|Not Treated|1|||
155615794|NCT02182830|561685005|FG001|Overall Study|Not Treated|1|||
155615795|NCT02182830|561685004|FG000|Overall Study|Trial stopped, reason missing|3|||
155615796|NCT02182830|561685005|FG001|Overall Study|Trial stopped, reason missing|3|||
155726785|NCT01213472|562099798|FG000|Overall Study|Recurrence/Progressive disease|25|||
155272854|NCT03857841|560431423|FG002|Overall Study|Study Terminated by Sponsor|0|||
155615797|NCT02182830|561685004|FG000|Overall Study|Consent withdrawn|8|||
155615798|NCT02182830|561685005|FG001|Overall Study|Consent withdrawn|8|||
155615799|NCT02182830|561685004|FG000|Overall Study|Lost to Follow-up|3|||
155615800|NCT02182830|561685005|FG001|Overall Study|Lost to Follow-up|3|||
155615801|NCT00913770|561685006|FG000|Overall Study|Unable to contact|24|||
155615802|NCT00913770|561685007|FG001|Overall Study|Unable to contact|19|||
155615803|NCT00913770|561685008|FG002|Overall Study|Unable to contact|13|||
155615804|NCT00913770|561685006|FG000|Overall Study|Refused|11|||
155615805|NCT00913770|561685007|FG001|Overall Study|Refused|10|||
155615806|NCT00913770|561685008|FG002|Overall Study|Refused|8|||
155615807|NCT01990768|561685009|FG000|Intervention Started|Found to be ineligible|14|||
155615808|NCT01990768|561685010|FG001|Intervention Started|Found to be ineligible|13|||
155615809|NCT01990768|561685011|FG002|Intervention Started|Found to be ineligible|11|||
155615810|NCT01990768|561685009|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
155615811|NCT01990768|561685010|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
155615812|NCT01990768|561685011|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
155615813|NCT01990768|561685009|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
155615814|NCT01990768|561685010|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
155615815|NCT01990768|561685011|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
155615816|NCT01990768|561685009|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
155615817|NCT01990768|561685010|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
155615818|NCT01990768|561685011|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
155615819|NCT01990768|561685009|FG000|Intervention Started|Patient care priority|1|||
155615820|NCT01990768|561685010|FG001|Intervention Started|Patient care priority|2|||
155615821|NCT01990768|561685011|FG002|Intervention Started|Patient care priority|3|||
155615822|NCT01990768|561685009|FG000|Intervention Started|IV lost|2|||
155615823|NCT01990768|561685010|FG001|Intervention Started|IV lost|2|||
155615824|NCT01990768|561685011|FG002|Intervention Started|IV lost|2|||
155615825|NCT01990768|561685009|FG000|Intervention Started|Required CPR|1|||
155615826|NCT01990768|561685010|FG001|Intervention Started|Required CPR|1|||
155615827|NCT01990768|561685011|FG002|Intervention Started|Required CPR|0|||
155615828|NCT01990768|561685009|FG000|Intervention Started|Seizure or hx of seizure|0|||
155615829|NCT01990768|561685010|FG001|Intervention Started|Seizure or hx of seizure|0|||
155615830|NCT01990768|561685011|FG002|Intervention Started|Seizure or hx of seizure|2|||
155615831|NCT01990768|561685009|FG000|Intervention Started|Discovered to be pregnant|0|||
155615832|NCT01990768|561685010|FG001|Intervention Started|Discovered to be pregnant|1|||
155615833|NCT01990768|561685011|FG002|Intervention Started|Discovered to be pregnant|0|||
155615834|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
155615835|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
155615836|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
155615837|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
155615838|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
155615839|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
155615840|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
155615841|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
155615842|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
155615843|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
155615844|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
155615845|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
155615846|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Death|3|||
155615847|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Death|1|||
155615848|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Death|1|||
155615849|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Discharged|2|||
155615850|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Discharged|1|||
155615851|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Discharged|0|||
155615852|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
155615853|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
155615854|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
155615855|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
155615856|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
155615857|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
155615858|NCT01990768|561685009|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
155615859|NCT01990768|561685010|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
155615860|NCT01990768|561685011|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
155615861|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
155615862|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
155615863|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
155615864|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
155615865|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
155272855|NCT03857841|560431424|FG003|Overall Study|Study Terminated by Sponsor|0|||
155615866|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
155615867|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
155272856|NCT01625910|560432827|FG000|Overall Study|Lost to Follow-up|3|||
155615868|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
155272857|NCT01625910|560432828|FG001|Overall Study|Lost to Follow-up|4|||
155272858|NCT02391038|560432829|FG000|Overall Study|Progressive disease|3|||
155615869|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
155615870|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
155615871|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
155615872|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
155615873|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
155615874|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
155615875|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
155615876|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
155615877|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
155615878|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
155615879|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
155615880|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
155615881|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
155615882|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
155615883|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
155615884|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
155615885|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
155615886|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
155615887|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
155615888|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
155615889|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
155615890|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
155615891|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155615892|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155615893|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155615894|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
155615895|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
155615896|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
155615897|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
155615898|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
155615899|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
155615900|NCT01990768|561685009|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
155615901|NCT01990768|561685010|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
155615902|NCT01990768|561685011|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
155615903|NCT01990768|561685009|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
155615904|NCT01990768|561685010|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
155615905|NCT01990768|561685011|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
155615906|NCT01990768|561685009|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
155615907|NCT01990768|561685010|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
155615908|NCT01990768|561685011|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
155615909|NCT01990768|561685009|FG000|6-Month Follow-up|No contact information|5|||
155615910|NCT01990768|561685010|FG001|6-Month Follow-up|No contact information|6|||
155615911|NCT01990768|561685011|FG002|6-Month Follow-up|No contact information|5|||
155615912|NCT01990768|561685009|FG000|6-Month Follow-up|Homeless|4|||
155615913|NCT01990768|561685010|FG001|6-Month Follow-up|Homeless|3|||
155615914|NCT01990768|561685011|FG002|6-Month Follow-up|Homeless|6|||
155615915|NCT01990768|561685009|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
155615916|NCT01990768|561685010|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
155615917|NCT01990768|561685011|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
155615918|NCT01990768|561685009|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
155615919|NCT01990768|561685010|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
155615920|NCT01990768|561685011|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
155615921|NCT01990768|561685009|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
155615922|NCT01990768|561685010|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
155615923|NCT01990768|561685011|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
155615924|NCT00334295|561685012|FG000|Overall Study|Patients received fewer than 3 injection|5|||
155615925|NCT00248833|561685014|FG000|Overall Study|Adverse Event|2|||
155615926|NCT00248833|561685015|FG001|Overall Study|Adverse Event|0|||
155615927|NCT00248833|561685016|FG002|Overall Study|Adverse Event|0|||
155615928|NCT00248833|561685014|FG000|Overall Study|Withdrawal by Subject|0|||
155615929|NCT00248833|561685015|FG001|Overall Study|Withdrawal by Subject|1|||
155615930|NCT00248833|561685016|FG002|Overall Study|Withdrawal by Subject|1|||
155615931|NCT00248833|561685014|FG000|Overall Study|Lost to Follow-up|1|||
155615932|NCT00248833|561685015|FG001|Overall Study|Lost to Follow-up|1|||
155615933|NCT00248833|561685016|FG002|Overall Study|Lost to Follow-up|1|||
155615934|NCT00248833|561685014|FG000|Overall Study|Other|0|||
155615935|NCT00248833|561685015|FG001|Overall Study|Other|1|||
155615936|NCT00248833|561685016|FG002|Overall Study|Other|0|||
155615937|NCT01243177|561685017|FG000|Overall Study|Lack of Efficacy|47|||
155615938|NCT01243177|561685018|FG001|Overall Study|Lack of Efficacy|31|||
155615939|NCT01243177|561685017|FG000|Overall Study|Protocol Violation|11|||
155615940|NCT01243177|561685018|FG001|Overall Study|Protocol Violation|10|||
155615941|NCT01243177|561685017|FG000|Overall Study|Lost to Follow-up|15|||
155615942|NCT01243177|561685018|FG001|Overall Study|Lost to Follow-up|18|||
155615943|NCT01243177|561685017|FG000|Overall Study|Withdrawal by Subject|46|||
155615944|NCT01243177|561685018|FG001|Overall Study|Withdrawal by Subject|38|||
155615945|NCT01243177|561685017|FG000|Overall Study|AE, serious fatal|0|||
155615946|NCT01243177|561685018|FG001|Overall Study|AE, serious fatal|1|||
155615947|NCT01243177|561685017|FG000|Overall Study|SAE, non-fatal|7|||
155615948|NCT01243177|561685018|FG001|Overall Study|SAE, non-fatal|9|||
155615949|NCT01243177|561685017|FG000|Overall Study|AE, non-serious non-fatal|40|||
155615950|NCT01243177|561685018|FG001|Overall Study|AE, non-serious non-fatal|58|||
155615951|NCT01243177|561685017|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
155615952|NCT01243177|561685018|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
155615953|NCT01243177|561685017|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155615954|NCT01243177|561685018|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
155615955|NCT01243177|561685017|FG000|Overall Study|Other Reason|11|||
155615956|NCT01243177|561685018|FG001|Overall Study|Other Reason|12|||
155615957|NCT02636439|561685019|FG000|Overall Study|Adverse Event|2|||
155615958|NCT02636439|561685020|FG001|Overall Study|Adverse Event|2|||
155615959|NCT02636439|561685019|FG000|Overall Study|Lost to Follow-up|1|||
155615960|NCT02636439|561685020|FG001|Overall Study|Lost to Follow-up|0|||
155615961|NCT02636439|561685019|FG000|Overall Study|Non-compliance|1|||
155615962|NCT02636439|561685020|FG001|Overall Study|Non-compliance|1|||
155615963|NCT02636439|561685019|FG000|Overall Study|Personal reasons|2|||
155615964|NCT02636439|561685020|FG001|Overall Study|Personal reasons|0|||
155615965|NCT02494401|561685021|FG000|Overall Study|Lost to Follow-up|22|||
155615966|NCT02494401|561685022|FG001|Overall Study|Lost to Follow-up|25|||
155615967|NCT02494401|561685021|FG000|Overall Study|Withdrawal by Subject|3|||
155615968|NCT02494401|561685022|FG001|Overall Study|Withdrawal by Subject|2|||
155615969|NCT04530838|561686650|FG000|Overall Study|Other|2|||
155615970|NCT04530838|561686651|FG001|Overall Study|Other|1|||
155615971|NCT04530838|561686652|FG002|Overall Study|Other|0|||
155615972|NCT04530838|561686650|FG000|Overall Study|Physician Decision|0|||
155615973|NCT04530838|561686651|FG001|Overall Study|Physician Decision|0|||
155615974|NCT04530838|561686652|FG002|Overall Study|Physician Decision|1|||
155615975|NCT04530838|561686650|FG000|Overall Study|Death|0|||
155615976|NCT04530838|561686651|FG001|Overall Study|Death|0|||
155615977|NCT04530838|561686652|FG002|Overall Study|Death|1|||
155615978|NCT04530838|561686650|FG000|Overall Study|Adverse Event|0|||
155615979|NCT04530838|561686651|FG001|Overall Study|Adverse Event|1|||
155615980|NCT04530838|561686652|FG002|Overall Study|Adverse Event|0|||
155615981|NCT04530838|561686650|FG000|Overall Study|No longer meets eligibility criteria|1|||
155615982|NCT04530838|561686651|FG001|Overall Study|No longer meets eligibility criteria|0|||
155615983|NCT04530838|561686652|FG002|Overall Study|No longer meets eligibility criteria|2|||
155615984|NCT04530838|561686650|FG000|Overall Study|Withdrawal by parent/guardian|5|||
155615985|NCT04530838|561686651|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155615986|NCT04530838|561686652|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155615987|NCT00803712|561686653|FG000|Overall Study|Noncompliance|3|||
155615988|NCT00803712|561686654|FG001|Overall Study|Noncompliance|0|||
155615989|NCT00803712|561686653|FG000|Overall Study|Adverse Event|5|||
155615990|NCT00803712|561686654|FG001|Overall Study|Adverse Event|0|||
155615991|NCT00803712|561686653|FG000|Overall Study|Death|8|||
155615992|NCT00803712|561686654|FG001|Overall Study|Death|7|||
155615993|NCT00803712|561686653|FG000|Overall Study|Lost to Follow-up|3|||
155615994|NCT00803712|561686654|FG001|Overall Study|Lost to Follow-up|1|||
155615995|NCT00803712|561686653|FG000|Overall Study|Withdrawal by Subject|2|||
155615996|NCT00803712|561686654|FG001|Overall Study|Withdrawal by Subject|4|||
155615997|NCT00803712|561686653|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
155615998|NCT00803712|561686654|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
155615999|NCT00803712|561686653|FG000|Overall Study|Protocol criteria (other)|0|||
155616000|NCT00803712|561686654|FG001|Overall Study|Protocol criteria (other)|2|||
155616001|NCT00803712|561686653|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
155616002|NCT00803712|561686654|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
155616003|NCT00803712|561686653|FG000|Overall Study|Administrative decision|2|||
155616004|NCT00803712|561686654|FG001|Overall Study|Administrative decision|3|||
155616005|NCT00803712|561686653|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
155616006|NCT00803712|561686654|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
155616007|NCT03335813|561686661|FG000|Overall Study|Withdrawal by Subject|1|||
155616008|NCT02861664|561686662|FG000|Overall Study|Withdrawal of Consent|0|||
155616009|NCT02861664|561686663|FG001|Overall Study|Withdrawal of Consent|1|||
155616010|NCT00905632|561686664|FG000|Overall Study|Adverse Event|0|||
155616011|NCT00905632|561686665|FG001|Overall Study|Adverse Event|0|||
155616012|NCT00905632|561686666|FG002|Overall Study|Adverse Event|0|||
155616013|NCT00905632|561686667|FG003|Overall Study|Adverse Event|0|||
155616014|NCT00905632|561686668|FG004|Overall Study|Adverse Event|0|||
155616015|NCT00905632|561686669|FG005|Overall Study|Adverse Event|1|||
155616016|NCT00905632|561686670|FG006|Overall Study|Adverse Event|4|||
155616017|NCT02964338|561686673|FG000|Overall Study|Sponsor terminated study for futility|12|||
155616018|NCT02964338|561686674|FG001|Overall Study|Sponsor terminated study for futility|15|||
155616019|NCT02964338|561686675|FG002|Overall Study|Sponsor terminated study for futility|14|||
155616020|NCT02964338|561686673|FG000|Overall Study|Lack of Efficacy|0|||
155616021|NCT02964338|561686674|FG001|Overall Study|Lack of Efficacy|3|||
155616022|NCT02964338|561686675|FG002|Overall Study|Lack of Efficacy|0|||
155616023|NCT02964338|561686673|FG000|Overall Study|Lost to Follow-up|1|||
155616024|NCT02964338|561686674|FG001|Overall Study|Lost to Follow-up|0|||
155616025|NCT02964338|561686675|FG002|Overall Study|Lost to Follow-up|3|||
155616026|NCT02964338|561686673|FG000|Overall Study|Protocol Violation|0|||
155616027|NCT02964338|561686674|FG001|Overall Study|Protocol Violation|1|||
155616028|NCT02964338|561686675|FG002|Overall Study|Protocol Violation|0|||
155616029|NCT02964338|561686673|FG000|Overall Study|Withdrawal by Subject|1|||
155616030|NCT02964338|561686674|FG001|Overall Study|Withdrawal by Subject|3|||
155616031|NCT02964338|561686675|FG002|Overall Study|Withdrawal by Subject|1|||
155616032|NCT02964338|561686673|FG000|Overall Study|Adverse Event|2|||
155616033|NCT02964338|561686674|FG001|Overall Study|Adverse Event|1|||
155616034|NCT02964338|561686675|FG002|Overall Study|Adverse Event|1|||
155616035|NCT02964338|561686673|FG000|Overall Study|Non-compliant with e-diary|0|||
155616036|NCT02964338|561686674|FG001|Overall Study|Non-compliant with e-diary|1|||
155616037|NCT02964338|561686675|FG002|Overall Study|Non-compliant with e-diary|0|||
155616038|NCT02964338|561686673|FG000|Overall Study|Did not meet criteria|1|||
155616039|NCT02964338|561686674|FG001|Overall Study|Did not meet criteria|0|||
155616040|NCT02964338|561686675|FG002|Overall Study|Did not meet criteria|0|||
155616041|NCT02239640|561686676|FG000|Overall Study|Withdrawal by Subject|3|||
155616042|NCT02239640|561686676|FG000|Overall Study|Lost to Follow-up|72|||
155616043|NCT02239640|561686676|FG000|Overall Study|Death|142|||
155616044|NCT00327340|561686684|FG000|Overall Study|Withdrawal by Subject|1|||
155616045|NCT00327340|561686685|FG001|Overall Study|Withdrawal by Subject|5|||
155616046|NCT00327340|561686684|FG000|Overall Study|Physician Decision|1|||
155616047|NCT00327340|561686685|FG001|Overall Study|Physician Decision|1|||
155616048|NCT00327340|561686684|FG000|Overall Study|Disease Progression|10|||
155616049|NCT00327340|561686685|FG001|Overall Study|Disease Progression|19|||
155616050|NCT00327340|561686684|FG000|Overall Study|Symptomatic Disease|0|||
155616051|NCT00327340|561686685|FG001|Overall Study|Symptomatic Disease|2|||
155616052|NCT00327340|561686684|FG000|Overall Study|Adverse Event|3|||
155616053|NCT00327340|561686685|FG001|Overall Study|Adverse Event|3|||
155616054|NCT00206427|561686690|FG000|Overall Study|Adverse Event|2|||
155616055|NCT04085601|561686691|FG000|Overall Study|Lost to Follow-up|1|||
155616056|NCT04085601|561686692|FG001|Overall Study|Lost to Follow-up|0|||
155616057|NCT04085601|561686691|FG000|Overall Study|Death|1|||
155616058|NCT04085601|561686692|FG001|Overall Study|Death|1|||
155616059|NCT03492437|561686693|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155616060|NCT03492437|561686694|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155616061|NCT03872843|561686695|FG000|Overall Study|Lost to Follow-up|5|||
155616062|NCT03872843|561686696|FG001|Overall Study|Lost to Follow-up|7|||
155616063|NCT00281697|561686697|FG000|Overall Study|> 60 days since last dose of study drug|4|||
155616064|NCT00281697|561686698|FG001|Overall Study|> 60 days since last dose of study drug|4|||
155616065|NCT00281697|561686697|FG000|Overall Study|Adverse Event|54|||
155616066|NCT00281697|561686698|FG001|Overall Study|Adverse Event|15|||
155616067|NCT00281697|561686697|FG000|Overall Study|Death|8|||
155616068|NCT00281697|561686698|FG001|Overall Study|Death|3|||
155616069|NCT00281697|561686697|FG000|Overall Study|Disease progression|279|||
155616070|NCT00281697|561686698|FG001|Overall Study|Disease progression|149|||
155616071|NCT00281697|561686697|FG000|Overall Study|Other|5|||
155616072|NCT00281697|561686698|FG001|Overall Study|Other|6|||
155616073|NCT00281697|561686697|FG000|Overall Study|Physician's decision to withdraw|15|||
155616074|NCT00281697|561686698|FG001|Overall Study|Physician's decision to withdraw|12|||
155616075|NCT00281697|561686697|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
155616076|NCT00281697|561686698|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
155616077|NCT00281697|561686697|FG000|Overall Study|Did not receive study drug|3|||
155616078|NCT00281697|561686698|FG001|Overall Study|Did not receive study drug|2|||
155616079|NCT00856999|561686701|FG000|Overall Study|Withdrawal by Subject|5|||
155616080|NCT02465437|561686702|FG000|Overall Study|Physician Decision|0|||
155616081|NCT02465437|561686703|FG001|Overall Study|Physician Decision|0|||
155616082|NCT02465437|561686704|FG002|Overall Study|Physician Decision|1|||
155616083|NCT02465437|561686705|FG003|Overall Study|Physician Decision|0|||
155272859|NCT02391038|560432830|FG001|Overall Study|Progressive disease|3|||
155616084|NCT02465437|561686702|FG000|Overall Study|Withdrawal by Subject|1|||
155616085|NCT02465437|561686703|FG001|Overall Study|Withdrawal by Subject|0|||
155616086|NCT02465437|561686704|FG002|Overall Study|Withdrawal by Subject|0|||
155616087|NCT02465437|561686705|FG003|Overall Study|Withdrawal by Subject|1|||
155616088|NCT02465437|561686702|FG000|Overall Study|Adverse Event|0|||
155616089|NCT02465437|561686703|FG001|Overall Study|Adverse Event|1|||
155616090|NCT02465437|561686704|FG002|Overall Study|Adverse Event|0|||
155616091|NCT02465437|561686705|FG003|Overall Study|Adverse Event|0|||
155616092|NCT00003483|561686706|FG000|Overall Study|Not evaluable|1|||
155616093|NCT02609386|561686707|FG000|Overall Study|Withdrawal by Subject|6|||
155616094|NCT02609386|561686708|FG001|Overall Study|Withdrawal by Subject|1|||
155616095|NCT02609386|561686707|FG000|Overall Study|Lost to Follow-up|3|||
155616096|NCT02609386|561686708|FG001|Overall Study|Lost to Follow-up|5|||
155616097|NCT02609386|561686707|FG000|Overall Study|Death|19|||
155616098|NCT02609386|561686708|FG001|Overall Study|Death|9|||
155616099|NCT02609386|561686707|FG000|Overall Study|Physician Decision|0|||
155616100|NCT02609386|561686708|FG001|Overall Study|Physician Decision|2|||
155616101|NCT00103662|561686709|FG000|Overall Study|Entered Rescue Procedure|0|||
155616102|NCT00103662|561686710|FG001|Overall Study|Entered Rescue Procedure|7|||
155616103|NCT00103662|561686709|FG000|Overall Study|Death|7|||
155616104|NCT00103662|561686710|FG001|Overall Study|Death|7|||
155616105|NCT00103662|561686709|FG000|Overall Study|Elective Withdrawal|5|||
155616106|NCT00103662|561686710|FG001|Overall Study|Elective Withdrawal|5|||
155616107|NCT00103662|561686709|FG000|Overall Study|Lost to Follow-up|0|||
155616108|NCT00103662|561686710|FG001|Overall Study|Lost to Follow-up|1|||
155616109|NCT00103662|561686709|FG000|Overall Study|Other|6|||
155616110|NCT00103662|561686710|FG001|Overall Study|Other|9|||
155616111|NCT00103662|561686709|FG000|Overall Study|Failed mobilization|0|||
155616112|NCT00103662|561686710|FG001|Overall Study|Failed mobilization|4|||
155616113|NCT00103662|561686709|FG000|Overall Study|Intercurrent illness|1|||
155616114|NCT00103662|561686710|FG001|Overall Study|Intercurrent illness|0|||
155616115|NCT00610168|561686711|FG000|Overall Study|Withdrawal by Subject|2|||
155616116|NCT00610168|561686712|FG001|Overall Study|Withdrawal by Subject|0|||
155616117|NCT01135524|561686713|FG000|Overall Study|Withdrawal by Subject|14|||
155616118|NCT01135524|561686713|FG000|Overall Study|Adverse Event|20|||
155616119|NCT01135524|561686713|FG000|Overall Study|Lost to Follow-up|3|||
155616120|NCT01135524|561686713|FG000|Overall Study|Administrative|151|||
155616121|NCT01135524|561686713|FG000|Overall Study|Lack of Efficacy|8|||
155616122|NCT03318003|561686714|FG000|Overall Study|Withdrawal by Subject|1|||
155616123|NCT03318003|561686715|FG001|Overall Study|Withdrawal by Subject|1|||
155616124|NCT03318003|561686714|FG000|Overall Study|fetal loss|0|||
155616125|NCT03318003|561686715|FG001|Overall Study|fetal loss|1|||
155616126|NCT00397189|561686716|FG000|3 Weeks Period|Lost to Follow-up|5|||
155616127|NCT00397189|561686717|FG001|3 Weeks Period|Lost to Follow-up|4|||
155616128|NCT00397189|561686716|FG000|3 Weeks Period|Adverse Event|3|||
155616129|NCT00397189|561686717|FG001|3 Weeks Period|Adverse Event|2|||
155616130|NCT00397189|561686716|FG000|3 Weeks Period|Withdrawal by Subject|13|||
155616131|NCT00397189|561686717|FG001|3 Weeks Period|Withdrawal by Subject|9|||
155616132|NCT00397189|561686716|FG000|3 Weeks Period|Physician Decision|0|||
155616133|NCT00397189|561686717|FG001|3 Weeks Period|Physician Decision|2|||
155616134|NCT00397189|561686716|FG000|3 Weeks Period|Protocol Violation|0|||
155616135|NCT00397189|561686717|FG001|3 Weeks Period|Protocol Violation|3|||
155616136|NCT00397189|561686716|FG000|3 Weeks Period|Other|0|||
155616137|NCT00397189|561686717|FG001|3 Weeks Period|Other|2|||
155616138|NCT00411450|561686718|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
155616139|NCT01716663|561686719|FG000|Overall Study|Withdrawn prior to procedure|4|||
155616140|NCT01716663|561686719|FG000|Overall Study|Treated with non-study catheter|2|||
155616141|NCT01059773|561686720|FG000|Overall Study|Adverse Event|2|||
155616142|NCT01059773|561686721|FG001|Overall Study|Adverse Event|2|||
155272860|NCT02391038|560432831|FG002|Overall Study|Progressive disease|6|||
155272861|NCT02959138|560432832|FG000|Overall Study|Enrolled but Never Treated|0|||
155272862|NCT02959138|560432833|FG001|Overall Study|Enrolled but Never Treated|1|||
155272863|NCT02959138|560432834|FG002|Overall Study|Enrolled but Never Treated|0|||
155272864|NCT01327547|560432840|FG000|Overall Study|Adverse Event|4|||
155272865|NCT01327547|560432841|FG001|Overall Study|Adverse Event|1|||
155272866|NCT01327547|560432840|FG000|Overall Study|Death|1|||
155272867|NCT01327547|560432841|FG001|Overall Study|Death|2|||
155272868|NCT01327547|560432840|FG000|Overall Study|Lost to Follow-up|6|||
155272869|NCT01327547|560432841|FG001|Overall Study|Lost to Follow-up|6|||
155272870|NCT01327547|560432840|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
155272871|NCT01327547|560432841|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
155616143|NCT01059773|561686720|FG000|Overall Study|Withdrawal by Subject|1|||
155272872|NCT01327547|560432840|FG000|Overall Study|Withdrawal by Subject|3|||
155272873|NCT01327547|560432841|FG001|Overall Study|Withdrawal by Subject|7|||
155381925|NCT01200589|560833240|FG001|Overall Study|Withdrawal by Subject|11|||
155616144|NCT01059773|561686721|FG001|Overall Study|Withdrawal by Subject|5|||
155616145|NCT01059773|561686720|FG000|Overall Study|Lost to Follow-up|1|||
155616146|NCT01059773|561686721|FG001|Overall Study|Lost to Follow-up|1|||
155616147|NCT01059773|561686720|FG000|Overall Study|Pregnancy|1|||
155616148|NCT01059773|561686721|FG001|Overall Study|Pregnancy|1|||
155381926|NCT01200589|560833239|FG000|Overall Study|Physician Decision|2|||
155616149|NCT01059773|561686720|FG000|Overall Study|Protocol Violation|6|||
155272874|NCT01327547|560432840|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
155272875|NCT01327547|560432841|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
155616150|NCT01059773|561686721|FG001|Overall Study|Protocol Violation|2|||
155616151|NCT01059773|561686720|FG000|Overall Study|Physician Decision|5|||
155616152|NCT01059773|561686721|FG001|Overall Study|Physician Decision|4|||
155616153|NCT01059773|561686720|FG000|Overall Study|Lack of Efficacy|3|||
155616154|NCT01059773|561686721|FG001|Overall Study|Lack of Efficacy|3|||
155616155|NCT01059773|561686720|FG000|Overall Study|Death|0|||
155616156|NCT01059773|561686721|FG001|Overall Study|Death|1|||
155616157|NCT01059773|561686720|FG000|Overall Study|Malignancy including squamous cell skin|0|||
155616158|NCT01059773|561686721|FG001|Overall Study|Malignancy including squamous cell skin|1|||
155616159|NCT01059773|561686720|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
155616160|NCT01059773|561686721|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
155616161|NCT01059773|561686720|FG000|Overall Study|Other|1|||
155616162|NCT01059773|561686721|FG001|Overall Study|Other|3|||
155616163|NCT00141518|561686726|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
155616164|NCT00141518|561686727|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
155616165|NCT00141518|561686728|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
155616166|NCT00141518|561686726|FG000|Overall Study|Adverse Event|7|||
155616167|NCT00141518|561686727|FG001|Overall Study|Adverse Event|5|||
155616168|NCT00141518|561686728|FG002|Overall Study|Adverse Event|2|||
155616169|NCT00141518|561686726|FG000|Overall Study|Withdrawal by Subject|2|||
155616170|NCT00141518|561686727|FG001|Overall Study|Withdrawal by Subject|0|||
155616171|NCT00141518|561686728|FG002|Overall Study|Withdrawal by Subject|2|||
155616172|NCT00141518|561686726|FG000|Overall Study|Protocol Violation|1|||
155616173|NCT00141518|561686727|FG001|Overall Study|Protocol Violation|1|||
155616174|NCT00141518|561686728|FG002|Overall Study|Protocol Violation|2|||
155616175|NCT00141518|561686726|FG000|Overall Study|Lack of Efficacy|5|||
155616176|NCT00141518|561686727|FG001|Overall Study|Lack of Efficacy|0|||
155616177|NCT00141518|561686728|FG002|Overall Study|Lack of Efficacy|0|||
155616178|NCT01806168|561686729|FG000|Overall Study|Adverse Event|1|||
155616179|NCT01806168|561686730|FG001|Overall Study|Adverse Event|0|||
155726786|NCT01213472|562099798|FG000|Overall Study|Withdrawal by Subject|1|||
155726787|NCT01213472|562099798|FG000|Overall Study|Physician Decision|1|||
155726788|NCT00129402|562099799|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155726789|NCT00129402|562099800|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155726790|NCT00129402|562099801|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155726791|NCT00129402|562099802|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155726792|NCT00129402|562099803|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155726793|NCT00129402|562099804|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155726794|NCT00129402|562099805|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155726795|NCT00129402|562099799|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155726796|NCT00129402|562099800|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155726797|NCT00129402|562099801|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155616180|NCT01806168|561686731|FG002|Overall Study|Adverse Event|0|||
155616181|NCT01806168|561686729|FG000|Overall Study|Withdrawal by Subject|0|||
155616182|NCT01806168|561686730|FG001|Overall Study|Withdrawal by Subject|1|||
155616183|NCT01806168|561686731|FG002|Overall Study|Withdrawal by Subject|2|||
155616184|NCT01806168|561686729|FG000|Overall Study|Protocol Violation|0|||
155616185|NCT01806168|561686730|FG001|Overall Study|Protocol Violation|0|||
155616186|NCT01806168|561686731|FG002|Overall Study|Protocol Violation|1|||
155616187|NCT00614874|561686734|FG000|Overall Study|Protocol Violation|1|||
155616188|NCT00614874|561686734|FG000|Overall Study|Withdrawal by Subject|1|||
155616189|NCT03904420|561686735|FG000|Overall Study|Study terminated|2|||
155616190|NCT03904420|561686736|FG001|Overall Study|Study terminated|2|||
155616191|NCT01468454|561686737|FG000|Overall Study|Did not have surgery after PET|9|||
155616192|NCT02620787|561686738|FG000|Overall Study|Adverse Event|1|||
155616193|NCT02620787|561686739|FG001|Overall Study|Adverse Event|0|||
155616194|NCT02620787|561686738|FG000|Overall Study|Eligibility Criteria Not Met|1|||
155616195|NCT02620787|561686739|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155616196|NCT04892446|561686741|FG000|Overall Study|Death|4|||
155616197|NCT04892446|561686742|FG001|Overall Study|Death|4|||
155616198|NCT04892446|561686743|FG002|Overall Study|Death|0|||
155616199|NCT04892446|561686741|FG000|Overall Study|Withdrew consent|3|||
155616200|NCT04892446|561686742|FG001|Overall Study|Withdrew consent|0|||
155616201|NCT04892446|561686743|FG002|Overall Study|Withdrew consent|1|||
155616202|NCT04892446|561686741|FG000|Overall Study|Investigator's discretion|1|||
155616203|NCT04892446|561686742|FG001|Overall Study|Investigator's discretion|1|||
155616204|NCT04892446|561686743|FG002|Overall Study|Investigator's discretion|0|||
155616205|NCT04892446|561686741|FG000|Overall Study|Study terminated by sponsor|0|||
155616206|NCT04892446|561686742|FG001|Overall Study|Study terminated by sponsor|0|||
155616207|NCT04892446|561686743|FG002|Overall Study|Study terminated by sponsor|2|||
155616208|NCT03173456|561686745|FG000|Baseline|Medication dispensing system malfunction'|0|||
155616209|NCT03173456|561686746|FG001|Baseline|Medication dispensing system malfunction'|1|||
155616210|NCT03173456|561686747|FG002|Baseline|Medication dispensing system malfunction'|0|||
155616211|NCT03173456|561686748|FG003|Baseline|Medication dispensing system malfunction'|0|||
155616212|NCT03173456|561686749|FG004|Baseline|Medication dispensing system malfunction'|2|||
155616213|NCT03173456|561686745|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
155726798|NCT00129402|562099802|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155726799|NCT00129402|562099803|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155616214|NCT03173456|561686746|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
155616215|NCT03173456|561686747|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
155616216|NCT03173456|561686748|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
155616217|NCT03173456|561686749|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
155616218|NCT01733121|561686750|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
155616219|NCT01733121|561686751|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
155616220|NCT01733121|561686750|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
155616221|NCT01733121|561686751|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
155616222|NCT01733121|561686750|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
155616223|NCT01733121|561686751|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
155616224|NCT01733121|561686750|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
155616225|NCT01733121|561686751|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
155616226|NCT03061188|561686754|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
155616227|NCT03061188|561686755|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
155616228|NCT03061188|561686756|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
155616229|NCT03061188|561686757|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
155616230|NCT03061188|561686754|FG000|On Follow-up for 3 Years|Death|0|||
155616231|NCT03061188|561686755|FG001|On Follow-up for 3 Years|Death|3|||
155616232|NCT03061188|561686756|FG002|On Follow-up for 3 Years|Death|5|||
155616233|NCT03061188|561686757|FG003|On Follow-up for 3 Years|Death|4|||
155616234|NCT03061188|561686754|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155616235|NCT03061188|561686755|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155616236|NCT03061188|561686756|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155616237|NCT03061188|561686757|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
155616238|NCT05446142|561686758|FG000|Period 2|Adverse Event|1|||
155616239|NCT05446142|561686759|FG001|Period 2|Adverse Event|0|||
155616240|NCT05446142|561686760|FG002|Period 2|Adverse Event|0|||
155616241|NCT05446142|561686761|FG003|Period 2|Adverse Event|0|||
155616242|NCT05446142|561686762|FG004|Period 2|Adverse Event|0|||
155616243|NCT05446142|561686763|FG005|Period 2|Adverse Event|0|||
155616244|NCT04633226|561686767|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155616245|NCT04633226|561686767|FG000|Overall Study|Randomized by mistake without study treatment|1|||
155616246|NCT00184093|561686771|FG000|Overall Study|Adverse Event|3|||
155616247|NCT00184093|561686771|FG000|Overall Study|Lost to Follow-up|3|||
155616248|NCT00184093|561686771|FG000|Overall Study|Physician Decision|1|||
155616249|NCT00184093|561686771|FG000|Overall Study|Withdrawal by Subject|2|||
155616250|NCT01903993|561686772|FG000|Overall Study|Death|118|||
155616251|NCT01903993|561686773|FG001|Overall Study|Death|121|||
155616252|NCT01903993|561686772|FG000|Overall Study|Withdrawal by Subject|15|||
155616253|NCT01903993|561686773|FG001|Overall Study|Withdrawal by Subject|4|||
155616254|NCT01903993|561686772|FG000|Overall Study|Lost to Follow-up|2|||
155616255|NCT01903993|561686773|FG001|Overall Study|Lost to Follow-up|3|||
155616256|NCT01903993|561686772|FG000|Overall Study|Study Terminated by Sponsor|8|||
155616257|NCT01903993|561686773|FG001|Overall Study|Study Terminated by Sponsor|14|||
155616258|NCT01903993|561686772|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
155616259|NCT01903993|561686773|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
155616260|NCT05095311|561686774|FG000|Overall Study|Lost to Follow-up|7|||
155616261|NCT05095311|561686775|FG001|Overall Study|Lost to Follow-up|0|||
155272876|NCT01327547|560432840|FG000|Overall Study|Protocol Violation|1|||
155272877|NCT01327547|560432841|FG001|Overall Study|Protocol Violation|0|||
155272878|NCT01327547|560432840|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
155272879|NCT01327547|560432841|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
155272880|NCT01327547|560432840|FG000|Overall Study|Required prohibited medication|2|||
155272881|NCT01327547|560432841|FG001|Overall Study|Required prohibited medication|0|||
155272882|NCT01327547|560432840|FG000|Overall Study|Non-compliance with study procedures|1|||
155272883|NCT01327547|560432841|FG001|Overall Study|Non-compliance with study procedures|0|||
155272884|NCT01327547|560432840|FG000|Overall Study|By investigator in subject's interest|0|||
155272885|NCT01327547|560432841|FG001|Overall Study|By investigator in subject's interest|1|||
155272886|NCT00329719|560432842|FG000|Overall Study|Lost to Follow-up|0|||
155272887|NCT00329719|560432843|FG001|Overall Study|Lost to Follow-up|0|||
155272888|NCT00329719|560432844|FG002|Overall Study|Lost to Follow-up|0|||
155272889|NCT00329719|560432845|FG003|Overall Study|Lost to Follow-up|1|||
155272890|NCT01681368|560432850|FG000|Overall Study|Refused further treatment|1|||
155272891|NCT01681368|560432850|FG000|Overall Study|Refused further follow up|1|||
155381927|NCT01200589|560833240|FG001|Overall Study|Physician Decision|2|||
155616262|NCT05095311|561686776|FG002|Overall Study|Lost to Follow-up|0|||
155616263|NCT03124537|561686777|FG000|Overall Study|Lost to Follow-up|3|||
155616264|NCT03124537|561686778|FG001|Overall Study|Lost to Follow-up|5|||
155616265|NCT03124537|561686777|FG000|Overall Study|App Crash, Incomplete Data|7|||
155616266|NCT03124537|561686778|FG001|Overall Study|App Crash, Incomplete Data|8|||
155616267|NCT03681184|561686779|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
155272892|NCT00900627|560432855|FG000|Overall Study|Condition under investigation worsened|4|||
155272893|NCT00900627|560432856|FG001|Overall Study|Condition under investigation worsened|0|||
155381928|NCT01200589|560833239|FG000|Overall Study|Lost to Follow-up|5|||
155616268|NCT03681184|561686780|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
155616269|NCT02787083|561686781|FG000|Overall Study|Adverse Event|1|||
155616270|NCT02787083|561686782|FG001|Overall Study|Adverse Event|0|||
155616271|NCT02787083|561686781|FG000|Overall Study|Withdrawal by Subject|2|||
155616272|NCT02787083|561686782|FG001|Overall Study|Withdrawal by Subject|2|||
155616273|NCT00282152|561686783|FG000|Overall Study|Withdrawal by Subject|1|||
155616274|NCT00282152|561686784|FG001|Overall Study|Withdrawal by Subject|0|||
155616275|NCT03301831|561686785|FG000|Overall Study|Lost to Follow-up|5|||
155616276|NCT03301831|561686786|FG001|Overall Study|Lost to Follow-up|3|||
155616277|NCT03301831|561686785|FG000|Overall Study|Protocol Violation|4|||
155616278|NCT03301831|561686786|FG001|Overall Study|Protocol Violation|0|||
155616279|NCT03301831|561686785|FG000|Overall Study|Withdrawal by Subject|11|||
155272894|NCT00900627|560432857|FG002|Overall Study|Condition under investigation worsened|5|||
155616280|NCT03301831|561686786|FG001|Overall Study|Withdrawal by Subject|0|||
155616281|NCT03373461|561686789|FG000|Part 2|Adverse Event|0|||
155616282|NCT03373461|561686790|FG001|Part 2|Adverse Event|1|||
155616283|NCT03373461|561686791|FG002|Part 2|Adverse Event|0|||
155616284|NCT03373461|561686792|FG003|Part 2|Adverse Event|0|||
155616285|NCT03373461|561686793|FG004|Part 2|Adverse Event|1|||
155616286|NCT01972464|561686798|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
155616287|NCT01972464|561686799|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
155616288|NCT01972464|561686798|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
155616289|NCT01972464|561686799|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
155616290|NCT01972464|561686798|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
155616291|NCT01972464|561686799|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
155616292|NCT01972464|561686798|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
155616293|NCT01972464|561686799|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
155616294|NCT00613821|561688225|FG000|Overall Study|Withdrawal by Subject|1|||
155616295|NCT00613821|561688226|FG001|Overall Study|Withdrawal by Subject|0|||
155616296|NCT00613821|561688225|FG000|Overall Study|Physician Decision|1|||
155616297|NCT00613821|561688226|FG001|Overall Study|Physician Decision|1|||
155616298|NCT01266824|561688228|FG000|Overall Study|Study terminated prior to completion|2|||
155616299|NCT01266824|561688229|FG001|Overall Study|Study terminated prior to completion|3|||
155616300|NCT02302846|561688230|FG000|Overall Study|Withdrawal by Subject|1|||
155616301|NCT01896193|561688234|FG000|Overall Study|Lack of Efficacy|20|||
155616302|NCT01896193|561688235|FG001|Overall Study|Lack of Efficacy|11|||
155616303|NCT01896193|561688234|FG000|Overall Study|Protocol Violation|0|||
155616304|NCT01896193|561688235|FG001|Overall Study|Protocol Violation|1|||
155616305|NCT01896193|561688234|FG000|Overall Study|Withdrew Consent|1|||
155616306|NCT01896193|561688235|FG001|Overall Study|Withdrew Consent|0|||
155616307|NCT01048541|561688241|FG000|Overall Study|Withdrawal by Subject|1|||
155616308|NCT01048541|561688242|FG001|Overall Study|Withdrawal by Subject|0|||
155616309|NCT01300247|561688243|FG000|Overall Study|Death|1|||
155616310|NCT01300247|561688244|FG001|Overall Study|Death|1|||
155616311|NCT01300247|561688243|FG000|Overall Study|Lost to Follow-up|2|||
155616312|NCT01300247|561688244|FG001|Overall Study|Lost to Follow-up|0|||
155616313|NCT01300247|561688243|FG000|Overall Study|Withdrawal by Subject|1|||
155616314|NCT01300247|561688244|FG001|Overall Study|Withdrawal by Subject|0|||
155616315|NCT01300247|561688243|FG000|Overall Study|Non-Compliance|0|||
155616316|NCT01300247|561688244|FG001|Overall Study|Non-Compliance|1|||
155616317|NCT00922116|561688245|FG000|Overall Study|Adverse Event|4|||
155616318|NCT00922116|561688245|FG000|Overall Study|Death|1|||
155616319|NCT00922116|561688245|FG000|Overall Study|Lost to Follow-up|1|||
155616320|NCT00922116|561688245|FG000|Overall Study|Withdrawal by Subject|4|||
155616321|NCT00922116|561688245|FG000|Overall Study|Other|5|||
155616322|NCT03060291|561688247|FG000|3-month Follow-up|Declined to respond|8|||
155616323|NCT03060291|561688248|FG001|3-month Follow-up|Declined to respond|10|||
155616324|NCT03060291|561688249|FG002|3-month Follow-up|Declined to respond|2|||
155616325|NCT03060291|561688247|FG000|6-month Follow-up|Declined to respond|7|||
155616326|NCT03060291|561688248|FG001|6-month Follow-up|Declined to respond|13|||
155616327|NCT03060291|561688249|FG002|6-month Follow-up|Declined to respond|4|||
155616328|NCT03060291|561688247|FG000|12-month Follow-up|Declined to respond|7|||
155616329|NCT03060291|561688248|FG001|12-month Follow-up|Declined to respond|16|||
155616330|NCT03060291|561688249|FG002|12-month Follow-up|Declined to respond|6|||
155272895|NCT00900627|560432858|FG003|Overall Study|Condition under investigation worsened|3|||
155616331|NCT00618826|561688252|FG000|Overall Study|Adverse Event|1|||
155616332|NCT03193047|561688253|FG000|Overall Study|Physician Decision|1|||
155616333|NCT03193047|561688254|FG001|Overall Study|Physician Decision|0|||
155616334|NCT03193047|561688253|FG000|Overall Study|Participant Left State|1|||
155616335|NCT03193047|561688254|FG001|Overall Study|Participant Left State|0|||
155616336|NCT01509664|561688256|FG000|Overall Study|Lost to Follow-up|15|||
155616337|NCT01509664|561688257|FG001|Overall Study|Lost to Follow-up|21|||
155616338|NCT02306850|561688263|FG000|Overall Study|Lack of Efficacy|2|||
155616339|NCT02420262|561688264|FG000|Overall Study|Adverse Event|1|||
155616340|NCT02420262|561688265|FG001|Overall Study|Adverse Event|0|||
155616341|NCT02420262|561688264|FG000|Overall Study|Withdrawal by Subject|1|||
155616342|NCT02420262|561688265|FG001|Overall Study|Withdrawal by Subject|4|||
155616343|NCT02420262|561688264|FG000|Overall Study|Unclassified|0|||
155616344|NCT02420262|561688265|FG001|Overall Study|Unclassified|1|||
155616345|NCT01210222|561688266|FG000|Overall Study|Ineligible|2|||
155616346|NCT01210222|561688266|FG000|Overall Study|Never treated|1|||
155616347|NCT02098395|561688269|FG000|Overall Study|Protocol Violation|2|||
155616348|NCT02098395|561688270|FG001|Overall Study|Protocol Violation|2|||
155616349|NCT02098395|561688271|FG002|Overall Study|Protocol Violation|0|||
155616350|NCT02098395|561688272|FG003|Overall Study|Protocol Violation|7|||
155616351|NCT02098395|561688269|FG000|Overall Study|Withdrawal by Subject|10|||
155616352|NCT02098395|561688270|FG001|Overall Study|Withdrawal by Subject|10|||
155616353|NCT02098395|561688271|FG002|Overall Study|Withdrawal by Subject|5|||
155616354|NCT02098395|561688272|FG003|Overall Study|Withdrawal by Subject|13|||
155616355|NCT02098395|561688269|FG000|Overall Study|Adverse Event|12|||
155616356|NCT02098395|561688270|FG001|Overall Study|Adverse Event|19|||
155616357|NCT02098395|561688271|FG002|Overall Study|Adverse Event|34|||
155616358|NCT02098395|561688272|FG003|Overall Study|Adverse Event|2|||
155616359|NCT02098395|561688269|FG000|Overall Study|Lost to Follow-up|2|||
155616360|NCT02098395|561688270|FG001|Overall Study|Lost to Follow-up|1|||
155616361|NCT02098395|561688271|FG002|Overall Study|Lost to Follow-up|0|||
155616362|NCT02098395|561688272|FG003|Overall Study|Lost to Follow-up|3|||
155616363|NCT02098395|561688269|FG000|Overall Study|Unclassified|0|||
155616364|NCT02098395|561688270|FG001|Overall Study|Unclassified|0|||
155616365|NCT02098395|561688271|FG002|Overall Study|Unclassified|3|||
155616366|NCT02098395|561688272|FG003|Overall Study|Unclassified|2|||
155616367|NCT00110357|561688278|FG000|Overall Study|Deterioration without progression|2|||
155616368|NCT00110357|561688279|FG001|Overall Study|Deterioration without progression|0|||
155616369|NCT00110357|561688278|FG000|Overall Study|Disease progression/relapse|20|||
155616370|NCT00110357|561688279|FG001|Overall Study|Disease progression/relapse|15|||
155616371|NCT00110357|561688278|FG000|Overall Study|Study Closure|1|||
155616372|NCT00110357|561688279|FG001|Overall Study|Study Closure|0|||
155616373|NCT00110357|561688278|FG000|Overall Study|Study Drug Toxicity|1|||
155616374|NCT00110357|561688279|FG001|Overall Study|Study Drug Toxicity|3|||
155616375|NCT00110357|561688278|FG000|Overall Study|Withdrawal by Subject|3|||
155616376|NCT00110357|561688279|FG001|Overall Study|Withdrawal by Subject|1|||
155616377|NCT04004260|561688280|FG000|Overall Study|Withdrawal by Subject|7|||
155616378|NCT04004260|561688281|FG001|Overall Study|Withdrawal by Subject|3|||
155616379|NCT04004260|561688280|FG000|Overall Study|Lost to Follow-up|22|||
155616380|NCT04004260|561688281|FG001|Overall Study|Lost to Follow-up|12|||
155616381|NCT04004260|561688280|FG000|Overall Study|Did not engage in intervention|13|||
155616382|NCT04004260|561688281|FG001|Overall Study|Did not engage in intervention|17|||
155616383|NCT02360280|561688285|FG000|Overall Study|Withdrawal by Subject|2|||
155616384|NCT02360280|561688286|FG001|Overall Study|Withdrawal by Subject|0|||
155616385|NCT02360280|561688285|FG000|Overall Study|Adverse Event|0|||
155616386|NCT02360280|561688286|FG001|Overall Study|Adverse Event|1|||
155616387|NCT02360280|561688285|FG000|Overall Study|Lost to Follow-up|1|||
155616388|NCT02360280|561688286|FG001|Overall Study|Lost to Follow-up|0|||
155616389|NCT05415462|561688293|FG000|Overall Study|Death|18|||
155616390|NCT05415462|561688294|FG001|Overall Study|Death|10|||
155616391|NCT05415462|561688293|FG000|Overall Study|Lost to Follow-up|72|||
155616392|NCT05415462|561688294|FG001|Overall Study|Lost to Follow-up|64|||
155616393|NCT05415462|561688293|FG000|Overall Study|Physician Decision|5|||
155616394|NCT05415462|561688294|FG001|Overall Study|Physician Decision|5|||
155616395|NCT05415462|561688293|FG000|Overall Study|Protocol Deviation|1|||
155616396|NCT05415462|561688294|FG001|Overall Study|Protocol Deviation|0|||
155616397|NCT05415462|561688293|FG000|Overall Study|Withdrawal by Subject|129|||
155616398|NCT05415462|561688294|FG001|Overall Study|Withdrawal by Subject|101|||
155616399|NCT05415462|561688293|FG000|Overall Study|Other Than Specified|8|||
155616400|NCT05415462|561688294|FG001|Overall Study|Other Than Specified|8|||
155616401|NCT02998996|561688317|FG000|Overall Study|Lost to Follow-up|0|||
155616402|NCT02998996|561688318|FG001|Overall Study|Lost to Follow-up|0|||
155616403|NCT02998996|561688319|FG002|Overall Study|Lost to Follow-up|1|||
155616404|NCT02998996|561688320|FG003|Overall Study|Lost to Follow-up|0|||
155616405|NCT02998996|561688321|FG004|Overall Study|Lost to Follow-up|0|||
155616406|NCT02998996|561688322|FG005|Overall Study|Lost to Follow-up|0|||
155616407|NCT02998996|561688317|FG000|Overall Study|Pregnancy|0|||
155616408|NCT02998996|561688318|FG001|Overall Study|Pregnancy|1|||
155616409|NCT02998996|561688319|FG002|Overall Study|Pregnancy|0|||
155616410|NCT02998996|561688320|FG003|Overall Study|Pregnancy|0|||
155616411|NCT02998996|561688321|FG004|Overall Study|Pregnancy|0|||
155616412|NCT02998996|561688322|FG005|Overall Study|Pregnancy|0|||
155616413|NCT02998996|561688317|FG000|Overall Study|Family reasons|0|||
155616414|NCT02998996|561688318|FG001|Overall Study|Family reasons|0|||
155616415|NCT02998996|561688319|FG002|Overall Study|Family reasons|0|||
155616416|NCT02998996|561688320|FG003|Overall Study|Family reasons|0|||
155616417|NCT02998996|561688321|FG004|Overall Study|Family reasons|1|||
155616418|NCT02998996|561688322|FG005|Overall Study|Family reasons|0|||
155616419|NCT01087203|561688324|FG000|Overall Study|Lost to Follow-up|2|||
155616420|NCT01087203|561688325|FG001|Overall Study|Lost to Follow-up|0|||
155616421|NCT01087203|561688324|FG000|Overall Study|Withdrawal by Subject|2|||
155272896|NCT00900627|560432859|FG004|Overall Study|Condition under investigation worsened|0|||
155272897|NCT00900627|560432860|FG005|Overall Study|Condition under investigation worsened|0|||
155272898|NCT00900627|560432855|FG000|Overall Study|Withdrawal by Subject|1|||
155272899|NCT00900627|560432856|FG001|Overall Study|Withdrawal by Subject|0|||
155272900|NCT00900627|560432857|FG002|Overall Study|Withdrawal by Subject|1|||
155272901|NCT00900627|560432858|FG003|Overall Study|Withdrawal by Subject|0|||
155272902|NCT00900627|560432859|FG004|Overall Study|Withdrawal by Subject|1|||
155272903|NCT00900627|560432860|FG005|Overall Study|Withdrawal by Subject|2|||
155272904|NCT00900627|560432855|FG000|Overall Study|Adverse Event|1|||
155272905|NCT00900627|560432856|FG001|Overall Study|Adverse Event|2|||
155272906|NCT00900627|560432857|FG002|Overall Study|Adverse Event|0|||
155272907|NCT00900627|560432858|FG003|Overall Study|Adverse Event|3|||
155272908|NCT00900627|560432859|FG004|Overall Study|Adverse Event|0|||
155272909|NCT00900627|560432860|FG005|Overall Study|Adverse Event|0|||
155272910|NCT00900627|560432855|FG000|Overall Study|Death|0|||
155272911|NCT00900627|560432856|FG001|Overall Study|Death|0|||
155272912|NCT00900627|560432857|FG002|Overall Study|Death|0|||
155272913|NCT00900627|560432858|FG003|Overall Study|Death|0|||
155272914|NCT00900627|560432859|FG004|Overall Study|Death|28|||
155272915|NCT00900627|560432860|FG005|Overall Study|Death|24|||
155272916|NCT00594906|560432866|FG000|Overall Study|Physician Decision|1|||
155272917|NCT00594906|560432867|FG001|Overall Study|Physician Decision|0|||
155272918|NCT00594906|560432866|FG000|Overall Study|Physician Decision|0|||
155272919|NCT00594906|560432867|FG001|Overall Study|Physician Decision|1|||
155272920|NCT00594906|560432866|FG000|Overall Study|Death|0|||
155272921|NCT00594906|560432867|FG001|Overall Study|Death|1|||
155272922|NCT03685708|560432868|FG000|Overall Study|Withdrawal by Subject|0|||
155272923|NCT03685708|560432869|FG001|Overall Study|Withdrawal by Subject|0|||
155272924|NCT03685708|560432870|FG002|Overall Study|Withdrawal by Subject|1|||
155272925|NCT03685708|560432868|FG000|Overall Study|Screen Fail|0|||
155272926|NCT03685708|560432869|FG001|Overall Study|Screen Fail|1|||
155272927|NCT03685708|560432870|FG002|Overall Study|Screen Fail|1|||
155272928|NCT03685708|560432868|FG000|Overall Study|COVID 19 Pandemic|1|||
155272929|NCT03685708|560432869|FG001|Overall Study|COVID 19 Pandemic|1|||
155272930|NCT03685708|560432870|FG002|Overall Study|COVID 19 Pandemic|6|||
155272931|NCT03685708|560432868|FG000|Overall Study|Disease Progression|0|||
155272932|NCT03685708|560432869|FG001|Overall Study|Disease Progression|0|||
155272933|NCT03685708|560432870|FG002|Overall Study|Disease Progression|1|||
155272934|NCT02222896|560432878|FG000|Abdomen|Did not qualify|34|||
155272935|NCT02222896|560432879|FG001|Abdomen|Did not qualify|10|||
155272936|NCT02222896|560432880|FG002|Abdomen|Did not qualify|32|||
155272937|NCT02222896|560432878|FG000|Groin|Did not qualify|43|||
155272938|NCT02222896|560432879|FG001|Groin|Did not qualify|9|||
155272939|NCT02222896|560432880|FG002|Groin|Did not qualify|40|||
155272940|NCT01744496|560432881|FG000|Titration Period|Adverse Event|2|||
155272941|NCT01744496|560432882|FG001|Titration Period|Adverse Event|1|||
155272942|NCT01744496|560432881|FG000|Titration Period|Personal reasons|0|||
155272943|NCT01744496|560432882|FG001|Titration Period|Personal reasons|1|||
155272944|NCT01744496|560432881|FG000|Maintenance Period|Adverse Event|1|||
155272945|NCT01744496|560432882|FG001|Maintenance Period|Adverse Event|3|||
155272946|NCT01744496|560432881|FG000|Maintenance Period|Protocol Violation|1|||
155272947|NCT01744496|560432882|FG001|Maintenance Period|Protocol Violation|0|||
155272948|NCT01744496|560432881|FG000|Maintenance Period|Withdrawal by Subject|1|||
155272949|NCT01744496|560432882|FG001|Maintenance Period|Withdrawal by Subject|1|||
155272950|NCT01744496|560432881|FG000|Maintenance Period|Subject left town|1|||
155272951|NCT01744496|560432882|FG001|Maintenance Period|Subject left town|0|||
155272952|NCT01865617|560432886|FG000|Overall Study|Death|27|||
155272953|NCT01865617|560432887|FG001|Overall Study|Death|3|||
155272954|NCT01865617|560432888|FG002|Overall Study|Death|1|||
155272955|NCT01865617|560432889|FG003|Overall Study|Death|1|||
155272956|NCT01865617|560432890|FG004|Overall Study|Death|5|||
155272957|NCT01865617|560432891|FG005|Overall Study|Death|1|||
155272958|NCT01865617|560432892|FG006|Overall Study|Death|11|||
155272959|NCT01865617|560432893|FG007|Overall Study|Death|1|||
155272960|NCT01865617|560432894|FG008|Overall Study|Death|11|||
155272961|NCT01865617|560432895|FG009|Overall Study|Death|3|||
155272962|NCT01865617|560432896|FG010|Overall Study|Death|32|||
155272963|NCT01865617|560432897|FG011|Overall Study|Death|6|||
155272964|NCT01865617|560432898|FG012|Overall Study|Death|13|||
155272965|NCT01865617|560432886|FG000|Overall Study|Lost to Follow-up|2|||
155272966|NCT01865617|560432887|FG001|Overall Study|Lost to Follow-up|0|||
155272967|NCT01865617|560432888|FG002|Overall Study|Lost to Follow-up|0|||
155272968|NCT01865617|560432889|FG003|Overall Study|Lost to Follow-up|0|||
155272969|NCT01865617|560432890|FG004|Overall Study|Lost to Follow-up|0|||
155272970|NCT01865617|560432891|FG005|Overall Study|Lost to Follow-up|0|||
155272971|NCT01865617|560432892|FG006|Overall Study|Lost to Follow-up|0|||
155272972|NCT01865617|560432893|FG007|Overall Study|Lost to Follow-up|0|||
155272973|NCT01865617|560432894|FG008|Overall Study|Lost to Follow-up|0|||
155272974|NCT01865617|560432895|FG009|Overall Study|Lost to Follow-up|0|||
155272975|NCT01865617|560432896|FG010|Overall Study|Lost to Follow-up|0|||
155272976|NCT01865617|560432897|FG011|Overall Study|Lost to Follow-up|0|||
155272977|NCT01865617|560432898|FG012|Overall Study|Lost to Follow-up|0|||
155616422|NCT01087203|561688325|FG001|Overall Study|Withdrawal by Subject|6|||
155616423|NCT01087203|561688324|FG000|Overall Study|Lack of Efficacy|1|||
155616424|NCT01087203|561688325|FG001|Overall Study|Lack of Efficacy|2|||
155616425|NCT01087203|561688324|FG000|Overall Study|Study terminated by sponsor|27|||
155616426|NCT01087203|561688325|FG001|Overall Study|Study terminated by sponsor|27|||
155616427|NCT03283930|561688337|FG000|Overall Study|Scheduling conflict|8|||
155616428|NCT03283930|561688338|FG001|Overall Study|Scheduling conflict|10|||
155616429|NCT03283930|561688337|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
155616430|NCT03283930|561688338|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
155616431|NCT03283930|561688337|FG000|Overall Study|Technical software issue|2|||
155616432|NCT03283930|561688338|FG001|Overall Study|Technical software issue|2|||
155616433|NCT00805129|561688339|FG000|Overall Study|Not treated|1|||
155616434|NCT00571662|561688342|FG000|Overall Study|Withdrawal by Subject|2|||
155616435|NCT00571662|561688342|FG000|Overall Study|psychiatric instability|1|||
155616436|NCT00571662|561688342|FG000|Overall Study|Adverse Event|5|||
155616437|NCT02588664|561688343|FG000|Overall Study|Death|56|||
155616438|NCT02588664|561688344|FG001|Overall Study|Death|55|||
155616439|NCT02588664|561688343|FG000|Overall Study|Lost to Follow-up|1305|||
155616440|NCT02588664|561688344|FG001|Overall Study|Lost to Follow-up|990|||
155616441|NCT01429298|561688347|FG000|Overall Study|Protocol Violation|4|||
155616442|NCT01429298|561688348|FG001|Overall Study|Protocol Violation|6|||
155616443|NCT02500719|561688351|FG000|Overall Study|Lost to Follow-up|2|||
155616444|NCT02500719|561688352|FG001|Overall Study|Lost to Follow-up|3|||
155616445|NCT02500719|561688351|FG000|Overall Study|Trauma history|1|||
155616446|NCT02500719|561688352|FG001|Overall Study|Trauma history|0|||
155616447|NCT02500719|561688351|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
155616448|NCT02500719|561688352|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
155616449|NCT02500719|561688351|FG000|Overall Study|Did not meet criteria for PTSD|0|||
155616450|NCT02500719|561688352|FG001|Overall Study|Did not meet criteria for PTSD|1|||
155616451|NCT02500719|561688351|FG000|Overall Study|Claustrophobia|0|||
155616452|NCT02500719|561688352|FG001|Overall Study|Claustrophobia|1|||
155616453|NCT02500719|561688351|FG000|Overall Study|History of head trauma|0|||
155616454|NCT02500719|561688352|FG001|Overall Study|History of head trauma|1|||
155616455|NCT00181883|561688353|FG000|Overall Study|Lack of Efficacy|2|||
155616456|NCT00181883|561688353|FG000|Overall Study|Treatment Limiting AEs|3|||
155616457|NCT00181883|561688353|FG000|Overall Study|Withdrawal by Subject|4|||
155616458|NCT00181883|561688353|FG000|Overall Study|Lost to Follow-up|1|||
155616459|NCT05305989|561688354|FG000|Overall Study|Other|3|||
155616460|NCT05305989|561688355|FG001|Overall Study|Other|2|||
155616461|NCT05305989|561688356|FG002|Overall Study|Other|0|||
155616462|NCT05305989|561688354|FG000|Overall Study|Sponsor decision|2|||
155616463|NCT05305989|561688355|FG001|Overall Study|Sponsor decision|1|||
155616464|NCT05305989|561688356|FG002|Overall Study|Sponsor decision|0|||
155616465|NCT05305989|561688354|FG000|Overall Study|Protocol Violation|0|||
155616466|NCT05305989|561688355|FG001|Overall Study|Protocol Violation|1|||
155616467|NCT05305989|561688356|FG002|Overall Study|Protocol Violation|0|||
155616468|NCT05305989|561688354|FG000|Overall Study|Investigator decision|1|||
155616469|NCT05305989|561688355|FG001|Overall Study|Investigator decision|2|||
155616470|NCT05305989|561688356|FG002|Overall Study|Investigator decision|0|||
155616471|NCT05305989|561688354|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
155616472|NCT05305989|561688355|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
155616473|NCT05305989|561688356|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
155616474|NCT05305989|561688354|FG000|Overall Study|Adverse Event|1|||
155616475|NCT05305989|561688355|FG001|Overall Study|Adverse Event|1|||
155616476|NCT05305989|561688356|FG002|Overall Study|Adverse Event|0|||
155616477|NCT05305989|561688354|FG000|Overall Study|Enrolled but never dosed|3|||
155616478|NCT05305989|561688355|FG001|Overall Study|Enrolled but never dosed|2|||
155616479|NCT05305989|561688356|FG002|Overall Study|Enrolled but never dosed|1|||
155616480|NCT00585325|561688357|FG000|Overall Study|Withdrawal by Subject|1|||
155616481|NCT00585325|561688358|FG001|Overall Study|Withdrawal by Subject|1|||
155616482|NCT00154375|561688359|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
155616483|NCT00154375|561688360|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
155616484|NCT00154375|561688359|FG000|Overall Study|Adverse Event|18|||
155616485|NCT00154375|561688360|FG001|Overall Study|Adverse Event|20|||
155616486|NCT00154375|561688359|FG000|Overall Study|Withdrawal by Subject|14|||
155616487|NCT00154375|561688360|FG001|Overall Study|Withdrawal by Subject|10|||
155616488|NCT00154375|561688359|FG000|Overall Study|Death|5|||
155616489|NCT00154375|561688360|FG001|Overall Study|Death|13|||
155616490|NCT00154375|561688359|FG000|Overall Study|Study drug no longer required|5|||
155616491|NCT00154375|561688360|FG001|Overall Study|Study drug no longer required|3|||
155616492|NCT00154375|561688359|FG000|Overall Study|Lost to Follow-up|2|||
155616493|NCT00154375|561688360|FG001|Overall Study|Lost to Follow-up|1|||
155616494|NCT00154375|561688359|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155616495|NCT00154375|561688360|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155616496|NCT00154375|561688359|FG000|Overall Study|Protocol Violation|0|||
155616497|NCT00154375|561688360|FG001|Overall Study|Protocol Violation|1|||
155616498|NCT00154375|561688359|FG000|Overall Study|Suspected progression of disease|44|||
155616499|NCT00154375|561688360|FG001|Overall Study|Suspected progression of disease|30|||
155616500|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
155616501|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155616502|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155616503|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155616504|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
155616505|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155616506|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155616507|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155616508|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
155616509|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155616510|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155616511|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155616512|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
155616513|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155616514|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155616515|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155616516|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
155616517|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155616518|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155616519|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155616520|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
155616521|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155616522|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155616523|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155616524|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
155616525|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155616526|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155616527|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155616528|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
155616529|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155616530|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155616531|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155616532|NCT03538691|561688361|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
155616533|NCT03538691|561688362|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155616534|NCT03538691|561688363|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155616535|NCT03538691|561688364|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155616536|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155616537|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
155616538|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155616539|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155616540|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155616541|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
155616542|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155616543|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155616544|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155616545|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
155616546|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155616547|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155616548|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155616549|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
155616550|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155616551|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155616552|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155616553|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
155616554|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155616555|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155616556|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155616557|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
155616558|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155616559|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155616560|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155616561|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
155616562|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155616563|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155616564|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155616565|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
155616566|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155616567|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155616568|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155616569|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
155616570|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155616571|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155616572|NCT03538691|561688361|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155616573|NCT03538691|561688362|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
155616574|NCT03538691|561688363|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155616575|NCT03538691|561688364|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155616576|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
155616577|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
155616578|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
155616579|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
155616580|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
155616581|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
155616582|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
155616583|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
155616584|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
155616585|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
155616586|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
155616587|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
155616588|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
155616589|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
155616590|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
155616591|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
155616592|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
155616593|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
155616594|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
155616595|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
155616596|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155616597|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155616598|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
155616599|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155616600|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
155616601|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
155616602|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
155616603|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
155616604|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155616605|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155616606|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155616607|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
155616608|NCT03538691|561688361|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155616609|NCT03538691|561688362|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155616610|NCT03538691|561688363|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
155272978|NCT01865617|560432886|FG000|Overall Study|Withdrawal by Subject|1|||
155272979|NCT01865617|560432887|FG001|Overall Study|Withdrawal by Subject|0|||
155272980|NCT01865617|560432888|FG002|Overall Study|Withdrawal by Subject|0|||
155272981|NCT01865617|560432889|FG003|Overall Study|Withdrawal by Subject|0|||
155272982|NCT01865617|560432890|FG004|Overall Study|Withdrawal by Subject|0|||
155272983|NCT01865617|560432891|FG005|Overall Study|Withdrawal by Subject|0|||
155272984|NCT01865617|560432892|FG006|Overall Study|Withdrawal by Subject|0|||
155272985|NCT01865617|560432893|FG007|Overall Study|Withdrawal by Subject|0|||
155381929|NCT01200589|560833240|FG001|Overall Study|Lost to Follow-up|4|||
155272986|NCT01865617|560432894|FG008|Overall Study|Withdrawal by Subject|0|||
155616611|NCT03538691|561688364|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
155616612|NCT00792116|561688369|FG000|Overall Study|Lost to Follow-up|0|||
155616613|NCT00792116|561688370|FG001|Overall Study|Lost to Follow-up|1|||
155616614|NCT00792116|561688369|FG000|Overall Study|Discontnued intervention|1|||
155616615|NCT00792116|561688370|FG001|Overall Study|Discontnued intervention|0|||
155616616|NCT02453256|561688371|FG000|Double Blind Period|Death|1|||
155616617|NCT02453256|561688372|FG001|Double Blind Period|Death|1|||
155616618|NCT02453256|561688371|FG000|Double Blind Period|Adverse Event|3|||
155616619|NCT02453256|561688372|FG001|Double Blind Period|Adverse Event|2|||
155616620|NCT02453256|561688371|FG000|Double Blind Period|Withdrawal by Subject|9|||
155616621|NCT02453256|561688372|FG001|Double Blind Period|Withdrawal by Subject|5|||
155616622|NCT02453256|561688371|FG000|Double Blind Period|Other|0|||
155616623|NCT02453256|561688372|FG001|Double Blind Period|Other|1|||
155616624|NCT02453256|561688371|FG000|Open Label Period|Adverse Event|1|||
155616625|NCT02453256|561688372|FG001|Open Label Period|Adverse Event|3|||
155616626|NCT02453256|561688371|FG000|Open Label Period|Death|0|||
155616627|NCT02453256|561688372|FG001|Open Label Period|Death|1|||
155616628|NCT02453256|561688371|FG000|Open Label Period|Lost to Follow-up|1|||
155616629|NCT02453256|561688372|FG001|Open Label Period|Lost to Follow-up|0|||
155616630|NCT02453256|561688371|FG000|Open Label Period|Other|0|||
155616631|NCT02453256|561688372|FG001|Open Label Period|Other|2|||
155616632|NCT02453256|561688371|FG000|Open Label Period|Withdrawal by Subject|5|||
155616633|NCT02453256|561688372|FG001|Open Label Period|Withdrawal by Subject|1|||
155616634|NCT01066871|561688376|FG000|Overall Study|Lost to Follow-up|0|||
155616635|NCT01066871|561688377|FG001|Overall Study|Lost to Follow-up|2|||
155616636|NCT01066871|561688378|FG002|Overall Study|Lost to Follow-up|2|||
155616637|NCT01066871|561688379|FG003|Overall Study|Lost to Follow-up|0|||
155616638|NCT01066871|561688376|FG000|Overall Study|Protocol Violation|1|||
155616639|NCT01066871|561688377|FG001|Overall Study|Protocol Violation|0|||
155616640|NCT01066871|561688378|FG002|Overall Study|Protocol Violation|3|||
155616641|NCT01066871|561688379|FG003|Overall Study|Protocol Violation|2|||
155616642|NCT01066871|561688376|FG000|Overall Study|Lack of Efficacy|0|||
155616643|NCT01066871|561688377|FG001|Overall Study|Lack of Efficacy|0|||
155616644|NCT01066871|561688378|FG002|Overall Study|Lack of Efficacy|0|||
155616645|NCT01066871|561688379|FG003|Overall Study|Lack of Efficacy|1|||
155616646|NCT01066871|561688376|FG000|Overall Study|Withdrawal by Subject|3|||
155616647|NCT01066871|561688377|FG001|Overall Study|Withdrawal by Subject|1|||
155616648|NCT01066871|561688378|FG002|Overall Study|Withdrawal by Subject|0|||
155616649|NCT01066871|561688379|FG003|Overall Study|Withdrawal by Subject|0|||
155616650|NCT01066871|561688376|FG000|Overall Study|Other|0|||
155616651|NCT01066871|561688377|FG001|Overall Study|Other|2|||
155616652|NCT01066871|561688378|FG002|Overall Study|Other|1|||
155616653|NCT01066871|561688379|FG003|Overall Study|Other|2|||
155616654|NCT01941537|561688381|FG000|Overall Study|Lack of Efficacy|1|||
155616655|NCT01941537|561688382|FG001|Overall Study|Lack of Efficacy|2|||
155616656|NCT01941537|561688381|FG000|Overall Study|Lost to Follow-up|1|||
155616657|NCT01941537|561688382|FG001|Overall Study|Lost to Follow-up|0|||
155616658|NCT01941537|561688381|FG000|Overall Study|Pregnancy|1|||
155616659|NCT01941537|561688382|FG001|Overall Study|Pregnancy|0|||
155616660|NCT01941537|561688381|FG000|Overall Study|Adverse Event|1|||
155616661|NCT01941537|561688382|FG001|Overall Study|Adverse Event|0|||
155616662|NCT01941537|561688381|FG000|Overall Study|Withdrawal by Subject|0|||
155616663|NCT01941537|561688382|FG001|Overall Study|Withdrawal by Subject|1|||
155616664|NCT05259163|561690231|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
155616665|NCT05259163|561690232|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
155616666|NCT05251233|561690233|FG000|Overall Study|Disease progression - did not start treatment|0|||
155616667|NCT05251233|561690234|FG001|Overall Study|Disease progression - did not start treatment|0|||
155616668|NCT05251233|561690235|FG002|Overall Study|Disease progression - did not start treatment|5|||
155616669|NCT05251233|561690233|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
155616670|NCT05251233|561690234|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
155616671|NCT05251233|561690235|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
155616672|NCT05251233|561690233|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
155616673|NCT05251233|561690234|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
155616674|NCT05251233|561690235|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
155616675|NCT05251233|561690233|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
155616676|NCT05251233|561690234|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
155616677|NCT05251233|561690235|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
155616678|NCT05251233|561690233|FG000|Overall Study|Death - did not start treatment|3|||
155616679|NCT05251233|561690234|FG001|Overall Study|Death - did not start treatment|0|||
155616680|NCT05251233|561690235|FG002|Overall Study|Death - did not start treatment|0|||
155616681|NCT05251233|561690233|FG000|Overall Study|Withdrawal by Subject|2|||
155616682|NCT05251233|561690234|FG001|Overall Study|Withdrawal by Subject|2|||
155616683|NCT05251233|561690235|FG002|Overall Study|Withdrawal by Subject|0|||
155616684|NCT05251233|561690233|FG000|Overall Study|Other complicating disease|2|||
155616685|NCT05251233|561690234|FG001|Overall Study|Other complicating disease|1|||
155616686|NCT05251233|561690235|FG002|Overall Study|Other complicating disease|0|||
155616687|NCT05251233|561690233|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
155616688|NCT05251233|561690234|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
155616689|NCT05251233|561690235|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
155616690|NCT05251233|561690233|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
155616691|NCT05251233|561690234|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
155616692|NCT05251233|561690235|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
155616693|NCT00452439|561690237|FG000|Overall Study|Lost to Follow-up|1|||
155616694|NCT00452439|561690238|FG001|Overall Study|Lost to Follow-up|1|||
155616695|NCT00452439|561690237|FG000|Overall Study|Refused Treatment|4|||
155616696|NCT00452439|561690238|FG001|Overall Study|Refused Treatment|3|||
155616697|NCT00452439|561690237|FG000|Overall Study|Death|3|||
155616698|NCT00452439|561690238|FG001|Overall Study|Death|1|||
155616699|NCT00452439|561690237|FG000|Overall Study|Bone Marrow Transplant|0|||
155616700|NCT00452439|561690238|FG001|Overall Study|Bone Marrow Transplant|1|||
155616701|NCT00452439|561690237|FG000|Overall Study|Too Ill to Continue|0|||
155616702|NCT00452439|561690238|FG001|Overall Study|Too Ill to Continue|1|||
155616703|NCT00452439|561690237|FG000|Overall Study|Failed to achieve complete response|2|||
155616704|NCT00452439|561690238|FG001|Overall Study|Failed to achieve complete response|0|||
155616705|NCT00452439|561690237|FG000|Overall Study|Relapse|3|||
155616706|NCT00452439|561690238|FG001|Overall Study|Relapse|0|||
155616707|NCT00452439|561690237|FG000|Overall Study|Fracture|1|||
155616708|NCT00452439|561690238|FG001|Overall Study|Fracture|0|||
155616709|NCT00463801|561690242|FG000|Overall Study|Protocol Violation|1|||
155616710|NCT00463801|561690242|FG000|Overall Study|Lack of Efficacy|2|||
155616711|NCT00463801|561690242|FG000|Overall Study|Adverse Event|4|||
155616712|NCT00463801|561690242|FG000|Overall Study|Lost to Follow-up|5|||
155616713|NCT00463801|561690242|FG000|Overall Study|No longer require therapy|1|||
155616714|NCT00669318|561690243|FG000|Overall Study|Withdrawal by Subject|2|||
155616715|NCT00215644|561690248|FG000|Overall Study|Disease Progression|28|||
155616716|NCT00215644|561690249|FG001|Overall Study|Disease Progression|10|||
155616717|NCT00215644|561690248|FG000|Overall Study|Adverse Event|2|||
155616718|NCT00215644|561690249|FG001|Overall Study|Adverse Event|9|||
155616719|NCT00215644|561690248|FG000|Overall Study|Death|1|||
155616720|NCT00215644|561690249|FG001|Overall Study|Death|2|||
155616721|NCT00215644|561690248|FG000|Overall Study|Withdrawal by Subject|1|||
155616722|NCT00215644|561690249|FG001|Overall Study|Withdrawal by Subject|0|||
155616723|NCT00215644|561690248|FG000|Overall Study|Other|3|||
155616724|NCT00215644|561690249|FG001|Overall Study|Other|15|||
155616725|NCT00215644|561690248|FG000|Overall Study|Randomized but Not Treated|1|||
155616726|NCT00215644|561690249|FG001|Overall Study|Randomized but Not Treated|0|||
155616727|NCT03512353|561690252|FG000|Overall Study|Sponsor Decision|3|||
155616728|NCT03512353|561690252|FG000|Overall Study|Death|1|||
155616729|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
155616730|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
155616731|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
155616732|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
155616733|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
155616734|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
155616735|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
155616736|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
155616737|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
155616738|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
155616739|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
155616740|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
155616741|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
155616742|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
155616743|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
155616744|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
155272987|NCT01865617|560432895|FG009|Overall Study|Withdrawal by Subject|0|||
155272988|NCT01865617|560432896|FG010|Overall Study|Withdrawal by Subject|0|||
155272989|NCT01865617|560432897|FG011|Overall Study|Withdrawal by Subject|0|||
155616745|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
155616746|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
155616747|NCT03569098|561690253|FG000|Double-Blind Treatment Cycle 1|Other|1|||
155616748|NCT03569098|561690254|FG001|Double-Blind Treatment Cycle 1|Other|0|||
155616749|NCT03569098|561690255|FG002|Double-Blind Treatment Cycle 1|Other|1|||
155616750|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
155616751|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
155616752|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
155616753|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
155616754|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
155616755|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
155616756|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
155616757|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
155616758|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
155616759|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
155616760|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
155616761|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
155616762|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
155616763|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
155616764|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
155616765|NCT03569098|561690253|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
155616766|NCT03569098|561690254|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
155616767|NCT03569098|561690255|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
155616768|NCT02581488|561690258|FG000|Overall Study|Adverse Event|6|||
155616769|NCT02581488|561690259|FG001|Overall Study|Adverse Event|7|||
155616770|NCT02581488|561690258|FG000|Overall Study|Lost to Follow-up|1|||
155616771|NCT02581488|561690259|FG001|Overall Study|Lost to Follow-up|0|||
155616772|NCT02581488|561690258|FG000|Overall Study|Withdrawal by Subject|1|||
155616773|NCT02581488|561690259|FG001|Overall Study|Withdrawal by Subject|0|||
155616774|NCT02581488|561690258|FG000|Overall Study|Non-Compliance|1|||
155616775|NCT02581488|561690259|FG001|Overall Study|Non-Compliance|0|||
155616776|NCT02581488|561690258|FG000|Overall Study|Protocol Violation|0|||
155616777|NCT02581488|561690259|FG001|Overall Study|Protocol Violation|4|||
155616778|NCT01639144|561690260|FG000|Overall Study|Withdrawal by Subject|4|||
155616779|NCT01639144|561690261|FG001|Overall Study|Withdrawal by Subject|2|||
155616780|NCT01639144|561690260|FG000|Overall Study|Physician Decision|2|||
155616781|NCT01639144|561690261|FG001|Overall Study|Physician Decision|0|||
155616782|NCT01639144|561690260|FG000|Overall Study|Met postoperative exclusion criteria|4|||
155616783|NCT01639144|561690261|FG001|Overall Study|Met postoperative exclusion criteria|3|||
155616784|NCT02121795|561690265|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
155616785|NCT02121795|561690266|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
155616786|NCT02121795|561690265|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
155616787|NCT02121795|561690266|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
155616788|NCT02121795|561690265|FG000|Double-Blind Phase|Lost to Follow-up|7|||
155616789|NCT02121795|561690266|FG001|Double-Blind Phase|Lost to Follow-up|4|||
155616790|NCT02121795|561690265|FG000|Double-Blind Phase|Physician Decision|2|||
155616791|NCT02121795|561690266|FG001|Double-Blind Phase|Physician Decision|5|||
155616792|NCT02121795|561690265|FG000|Double-Blind Phase|Adverse Event|5|||
155616793|NCT02121795|561690266|FG001|Double-Blind Phase|Adverse Event|0|||
155616794|NCT02121795|561690265|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
155616795|NCT02121795|561690266|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155616796|NCT02121795|561690265|FG000|Double-Blind Phase|Protocol Violation|0|||
155616797|NCT02121795|561690266|FG001|Double-Blind Phase|Protocol Violation|3|||
155616798|NCT02121795|561690265|FG000|Double-Blind Phase|Death|1|||
155616799|NCT02121795|561690266|FG001|Double-Blind Phase|Death|1|||
155616800|NCT02121795|561690265|FG000|Open-Label Phase|Physician Decision|8|||
155616801|NCT02121795|561690266|FG001|Open-Label Phase|Physician Decision|8|||
155616802|NCT02121795|561690265|FG000|Open-Label Phase|Withdrawal by Subject|3|||
155616803|NCT02121795|561690266|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155616804|NCT02121795|561690265|FG000|Open-Label Phase|Lost to Follow-up|1|||
155616805|NCT02121795|561690266|FG001|Open-Label Phase|Lost to Follow-up|0|||
155616806|NCT01001910|561690269|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
155616807|NCT03200548|561690270|FG000|Overall Study|Withdrawal by Subject|5|||
155616808|NCT03200548|561690271|FG001|Overall Study|Withdrawal by Subject|11|||
155616809|NCT03200548|561690272|FG002|Overall Study|Withdrawal by Subject|7|||
155616810|NCT03200548|561690273|FG003|Overall Study|Withdrawal by Subject|6|||
155616811|NCT00511810|561690276|FG000|Overall Study|Lost to Follow-up|1|||
155616812|NCT00511810|561690277|FG001|Overall Study|Lost to Follow-up|2|||
155616813|NCT00511810|561690276|FG000|Overall Study|Lack of Efficacy|0|||
155616814|NCT00511810|561690277|FG001|Overall Study|Lack of Efficacy|2|||
155726800|NCT00129402|562099804|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
155616815|NCT00511810|561690276|FG000|Overall Study|Refused second scn|0|||
155616816|NCT00511810|561690277|FG001|Overall Study|Refused second scn|1|||
155616817|NCT02896569|561690278|FG000|Overall Study|Lost to Follow-up|2|||
155616818|NCT02896569|561690279|FG001|Overall Study|Lost to Follow-up|1|||
155616819|NCT02896569|561690278|FG000|Overall Study|Physician Decision|1|||
155616820|NCT02896569|561690279|FG001|Overall Study|Physician Decision|3|||
155616821|NCT02896569|561690278|FG000|Overall Study|Adverse Event|0|||
155616822|NCT02896569|561690279|FG001|Overall Study|Adverse Event|1|||
155616823|NCT02896569|561690278|FG000|Overall Study|Withdrawal by Subject|1|||
155616824|NCT02896569|561690279|FG001|Overall Study|Withdrawal by Subject|0|||
155616825|NCT01462630|561690280|FG000|Overall Study|Did not initiate therapy|3|||
155616826|NCT01462630|561690280|FG000|Overall Study|Death|1|||
155616827|NCT01462630|561690280|FG000|Overall Study|Protocol Violation|2|||
155616828|NCT01462630|561690280|FG000|Overall Study|Adverse Event|1|||
155616829|NCT02592447|561690281|FG000|Overall Study|Lost to Follow-up|1|||
155616830|NCT02592447|561690282|FG001|Overall Study|Lost to Follow-up|0|||
155616831|NCT02592447|561690281|FG000|Overall Study|Ineligible after randomization|1|||
155616832|NCT02592447|561690282|FG001|Overall Study|Ineligible after randomization|0|||
155616833|NCT02592447|561690281|FG000|Overall Study|Withdrawal by Subject|0|||
155616834|NCT02592447|561690282|FG001|Overall Study|Withdrawal by Subject|1|||
155616835|NCT03428100|561690283|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
155616836|NCT03428100|561690284|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616837|NCT03428100|561690285|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
155616838|NCT03428100|561690286|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
155616839|NCT03428100|561690287|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616840|NCT03428100|561690288|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616841|NCT03428100|561690289|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616842|NCT03428100|561690290|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616843|NCT03428100|561690291|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616844|NCT03428100|561690292|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616845|NCT03428100|561690293|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155272990|NCT01865617|560432898|FG012|Overall Study|Withdrawal by Subject|0|||
155272991|NCT01865617|560432886|FG000|Overall Study|Patient proceeded to new therapy|0|||
155272992|NCT01865617|560432887|FG001|Overall Study|Patient proceeded to new therapy|0|||
155616846|NCT03428100|561690294|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616847|NCT03428100|561690295|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616848|NCT03428100|561690296|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616849|NCT03428100|561690297|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616850|NCT03428100|561690298|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616851|NCT03428100|561690299|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616852|NCT03428100|561690300|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616853|NCT03428100|561690301|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155616854|NCT03428100|561690283|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
155616855|NCT03428100|561690284|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
155616856|NCT03428100|561690285|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
155616857|NCT03428100|561690286|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
155616858|NCT03428100|561690287|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616859|NCT03428100|561690288|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616860|NCT03428100|561690289|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616861|NCT03428100|561690290|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616862|NCT03428100|561690291|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616863|NCT03428100|561690292|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616864|NCT03428100|561690293|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616865|NCT03428100|561690294|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616866|NCT03428100|561690295|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616867|NCT03428100|561690296|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616868|NCT03428100|561690297|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616869|NCT03428100|561690298|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616870|NCT03428100|561690299|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616871|NCT03428100|561690300|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616872|NCT03428100|561690301|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155616873|NCT03428100|561690283|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616874|NCT03428100|561690284|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
155616875|NCT03428100|561690285|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
155616876|NCT03428100|561690286|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616877|NCT03428100|561690287|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616878|NCT03428100|561690288|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155726801|NCT00129402|562099805|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155272993|NCT01865617|560432888|FG002|Overall Study|Patient proceeded to new therapy|0|||
155272994|NCT01865617|560432889|FG003|Overall Study|Patient proceeded to new therapy|0|||
155272995|NCT01865617|560432890|FG004|Overall Study|Patient proceeded to new therapy|2|||
155272996|NCT01865617|560432891|FG005|Overall Study|Patient proceeded to new therapy|0|||
155272997|NCT01865617|560432892|FG006|Overall Study|Patient proceeded to new therapy|0|||
155272998|NCT01865617|560432893|FG007|Overall Study|Patient proceeded to new therapy|0|||
155272999|NCT01865617|560432894|FG008|Overall Study|Patient proceeded to new therapy|0|||
155273000|NCT01865617|560432895|FG009|Overall Study|Patient proceeded to new therapy|0|||
155273001|NCT01865617|560432896|FG010|Overall Study|Patient proceeded to new therapy|0|||
155381930|NCT01200589|560833239|FG000|Overall Study|Study terminated|170|||
155616879|NCT03428100|561690289|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616880|NCT03428100|561690290|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616881|NCT03428100|561690291|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616882|NCT03428100|561690292|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616883|NCT03428100|561690293|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616884|NCT03428100|561690294|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616885|NCT03428100|561690295|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616886|NCT03428100|561690296|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616887|NCT03428100|561690297|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616888|NCT03428100|561690298|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616889|NCT03428100|561690299|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616890|NCT03428100|561690300|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616891|NCT03428100|561690301|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155616892|NCT03428100|561690283|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
155616893|NCT03428100|561690284|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616894|NCT03428100|561690285|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616895|NCT03428100|561690286|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616896|NCT03428100|561690287|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616897|NCT03428100|561690288|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616898|NCT03428100|561690289|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616899|NCT03428100|561690290|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616900|NCT03428100|561690291|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616901|NCT03428100|561690292|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616902|NCT03428100|561690293|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616903|NCT03428100|561690294|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616904|NCT03428100|561690295|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616905|NCT03428100|561690296|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616906|NCT03428100|561690297|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616907|NCT03428100|561690298|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616908|NCT03428100|561690299|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616909|NCT03428100|561690300|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616910|NCT03428100|561690301|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155616911|NCT03428100|561690283|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616912|NCT03428100|561690284|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
155616913|NCT03428100|561690285|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616914|NCT03428100|561690286|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616915|NCT03428100|561690287|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616916|NCT03428100|561690288|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616917|NCT03428100|561690289|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155273002|NCT01865617|560432897|FG011|Overall Study|Patient proceeded to new therapy|0|||
155273003|NCT01865617|560432898|FG012|Overall Study|Patient proceeded to new therapy|0|||
155273004|NCT01865617|560432886|FG000|Overall Study|Other|0|||
155273005|NCT01865617|560432887|FG001|Overall Study|Other|0|||
155273006|NCT01865617|560432888|FG002|Overall Study|Other|0|||
155273007|NCT01865617|560432889|FG003|Overall Study|Other|0|||
155273008|NCT01865617|560432890|FG004|Overall Study|Other|0|||
155616918|NCT03428100|561690290|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616919|NCT03428100|561690291|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616920|NCT03428100|561690292|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155273009|NCT01865617|560432891|FG005|Overall Study|Other|0|||
155273010|NCT01865617|560432892|FG006|Overall Study|Other|1|||
155273011|NCT01865617|560432893|FG007|Overall Study|Other|0|||
155273012|NCT01865617|560432894|FG008|Overall Study|Other|0|||
155273013|NCT01865617|560432895|FG009|Overall Study|Other|0|||
155273014|NCT01865617|560432896|FG010|Overall Study|Other|0|||
155273015|NCT01865617|560432897|FG011|Overall Study|Other|0|||
155273016|NCT01865617|560432898|FG012|Overall Study|Other|0|||
155273017|NCT02500979|560432903|FG000|Period 1|Hyperglycemia|1|||
155273018|NCT02500979|560432904|FG001|Period 1|Hyperglycemia|0|||
155273019|NCT02500979|560432903|FG000|Period 1|Severe non-compliance to protocol|0|||
155273020|NCT02500979|560432904|FG001|Period 1|Severe non-compliance to protocol|1|||
155273021|NCT02500979|560432903|FG000|Period 1|Adverse Event|1|||
155273022|NCT02500979|560432904|FG001|Period 1|Adverse Event|0|||
155273023|NCT02500979|560432903|FG000|Period 1|Subject decision|2|||
155273024|NCT02500979|560432904|FG001|Period 1|Subject decision|0|||
155273025|NCT02500979|560432903|FG000|Period 2|Change in risk|1|||
155273026|NCT02500979|560432904|FG001|Period 2|Change in risk|0|||
155273027|NCT03772314|560432905|FG000|Overall Study|Adverse Event|7|||
155273028|NCT03772314|560432906|FG001|Overall Study|Adverse Event|2|||
155273029|NCT01613027|560432907|FG000|Overall Study|Lost to Follow-up|5|||
155273030|NCT01613027|560432907|FG000|Overall Study|Switched Physician|1|||
155616921|NCT03428100|561690293|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616922|NCT03428100|561690294|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616923|NCT03428100|561690295|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616924|NCT03428100|561690296|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616925|NCT03428100|561690297|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616926|NCT03428100|561690298|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616927|NCT03428100|561690299|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616928|NCT03428100|561690300|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616929|NCT03428100|561690301|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155616930|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616931|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616932|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616933|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616934|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616935|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
155616936|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616937|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
155616938|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616939|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616940|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616941|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616942|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
155616943|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616944|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616945|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155616946|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
155616947|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616948|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155616949|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
155616950|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
155616951|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
155616952|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
155616953|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
155616954|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
155616955|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
155616956|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
155616957|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
155616958|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
155616959|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
155616960|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
155616961|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
155616962|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
155616963|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
155616964|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
155616965|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
155616966|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
155616967|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
155616968|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616969|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616970|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616971|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616972|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
155616973|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
155616974|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
155616975|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155616976|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616977|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155616978|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155616979|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155616980|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
155616981|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
155616982|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
155616983|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
155616984|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155616985|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155616986|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
155616987|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616988|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616989|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616990|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616991|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616992|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616993|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616994|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155616995|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616996|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616997|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155616998|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
155616999|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155617000|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155617001|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
155617002|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155617003|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155617004|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155617005|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155617006|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
155617007|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
155617008|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
155617009|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
155617010|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
155617011|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
155617012|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
155617013|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
155617014|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
155617015|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
155617016|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
155617017|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
155617018|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
155617019|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
155617020|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
155617021|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
155617022|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
155617023|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
155617024|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
155617025|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617026|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617027|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617028|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617029|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617030|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617031|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
155617032|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617033|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617034|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617035|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617036|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617037|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617038|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617039|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617040|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617041|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617042|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155617043|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
155617044|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155617045|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155617046|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155617047|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155617048|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
155617049|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
155617050|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155617051|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155617052|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
155617053|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
155617054|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
155617055|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
155617056|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155617057|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
155617058|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
155617059|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
155617060|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
155617061|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
155617062|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
155617063|NCT03428100|561690283|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617064|NCT03428100|561690284|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617065|NCT03428100|561690285|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617066|NCT03428100|561690286|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617067|NCT03428100|561690287|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155617068|NCT03428100|561690288|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617069|NCT03428100|561690289|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155617070|NCT03428100|561690290|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155617071|NCT03428100|561690291|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617072|NCT03428100|561690292|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
155617073|NCT03428100|561690293|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
155617074|NCT03428100|561690294|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155617075|NCT03428100|561690295|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155617076|NCT03428100|561690296|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155617077|NCT03428100|561690297|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
155617078|NCT03428100|561690298|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617079|NCT03428100|561690299|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
155617080|NCT03428100|561690300|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155617081|NCT03428100|561690301|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155617082|NCT02105285|561690304|FG000|Overall Study|Adverse Event|1|||
155617083|NCT02105285|561690305|FG001|Overall Study|Adverse Event|1|||
155617084|NCT02105285|561690306|FG002|Overall Study|Adverse Event|0|||
155617085|NCT02105285|561690304|FG000|Overall Study|Protocol Violation|0|||
155617086|NCT02105285|561690305|FG001|Overall Study|Protocol Violation|1|||
155617087|NCT02105285|561690306|FG002|Overall Study|Protocol Violation|0|||
155617088|NCT02105285|561690304|FG000|Overall Study|Withdrawal by Subject|1|||
155617089|NCT02105285|561690305|FG001|Overall Study|Withdrawal by Subject|0|||
155617090|NCT02105285|561690306|FG002|Overall Study|Withdrawal by Subject|0|||
155617091|NCT02364388|561690307|FG000|Overall Study|Protocol Violation|1|||
155617092|NCT02364388|561690307|FG000|Overall Study|Technical Failure|3|||
155617093|NCT02364388|561690307|FG000|Overall Study|No OA/US data|2|||
155617094|NCT02364388|561690307|FG000|Overall Study|No Biopsy|2|||
155617095|NCT03231306|561690308|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
155617096|NCT03231306|561690308|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
155617097|NCT03231306|561690308|FG000|Overall Study|Treatment delay > 21 days|2|||
155617098|NCT03231306|561690308|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
155617099|NCT03231306|561690308|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
155617100|NCT03231306|561690308|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
155617101|NCT03231306|561690308|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
155617102|NCT03231306|561690308|FG000|Overall Study|More than 1 Reason|2|||
155617103|NCT02585713|561690309|FG000|Overall Study|Withdrew prior to treatment|2|||
155617104|NCT02585713|561690310|FG001|Overall Study|Withdrew prior to treatment|7|||
155617105|NCT02585713|561690309|FG000|Overall Study|Other|3|||
155617106|NCT02585713|561690310|FG001|Overall Study|Other|1|||
155617107|NCT02609984|561690316|FG000|Overall Study|Death|29|||
155617108|NCT02609984|561690317|FG001|Overall Study|Death|26|||
155617109|NCT02609984|561690316|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
155617110|NCT02609984|561690317|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
155617111|NCT02609984|561690316|FG000|Overall Study|Lost to Follow-up|1|||
155617112|NCT02609984|561690317|FG001|Overall Study|Lost to Follow-up|2|||
155617113|NCT02609984|561690316|FG000|Overall Study|Withdrawal by Subject|0|||
155617114|NCT02609984|561690317|FG001|Overall Study|Withdrawal by Subject|1|||
155617115|NCT02609984|561690316|FG000|Overall Study|Disease Progression|2|||
155381931|NCT01200589|560833240|FG001|Overall Study|Study terminated|172|||
155617116|NCT02609984|561690317|FG001|Overall Study|Disease Progression|0|||
155617117|NCT01843803|561690319|FG000|Overall Study|not a Veteran, did not see provider|1|||
155617118|NCT01843803|561690320|FG001|Overall Study|not a Veteran, did not see provider|3|||
155617119|NCT00784719|561690326|FG000|Overall Study|Adverse Event|0|||
155617120|NCT00784719|561690327|FG001|Overall Study|Adverse Event|2|||
155617121|NCT00784719|561690328|FG002|Overall Study|Adverse Event|0|||
155617122|NCT00784719|561690329|FG003|Overall Study|Adverse Event|0|||
155617123|NCT00784719|561690330|FG004|Overall Study|Adverse Event|1|||
155617124|NCT00784719|561690331|FG005|Overall Study|Adverse Event|1|||
155617125|NCT00784719|561690332|FG006|Overall Study|Adverse Event|1|||
155617126|NCT00784719|561690326|FG000|Overall Study|Lost to Follow-up|0|||
155617127|NCT00784719|561690327|FG001|Overall Study|Lost to Follow-up|0|||
155617128|NCT00784719|561690328|FG002|Overall Study|Lost to Follow-up|0|||
155617129|NCT00784719|561690329|FG003|Overall Study|Lost to Follow-up|0|||
155617130|NCT00784719|561690330|FG004|Overall Study|Lost to Follow-up|1|||
155617131|NCT00784719|561690331|FG005|Overall Study|Lost to Follow-up|1|||
155617132|NCT00784719|561690332|FG006|Overall Study|Lost to Follow-up|0|||
155617133|NCT00784719|561690326|FG000|Overall Study|Other|2|||
155617134|NCT00784719|561690327|FG001|Overall Study|Other|1|||
155617135|NCT00784719|561690328|FG002|Overall Study|Other|1|||
155617136|NCT00784719|561690329|FG003|Overall Study|Other|0|||
155617137|NCT00784719|561690330|FG004|Overall Study|Other|2|||
155617138|NCT00784719|561690331|FG005|Overall Study|Other|1|||
155617139|NCT00784719|561690332|FG006|Overall Study|Other|3|||
155617140|NCT00784719|561690326|FG000|Overall Study|Withdrawal by Subject|1|||
155617141|NCT00784719|561690327|FG001|Overall Study|Withdrawal by Subject|0|||
155617142|NCT00784719|561690328|FG002|Overall Study|Withdrawal by Subject|0|||
155617143|NCT00784719|561690329|FG003|Overall Study|Withdrawal by Subject|0|||
155617144|NCT00784719|561690330|FG004|Overall Study|Withdrawal by Subject|2|||
155617145|NCT00784719|561690331|FG005|Overall Study|Withdrawal by Subject|0|||
155617146|NCT00784719|561690332|FG006|Overall Study|Withdrawal by Subject|1|||
155617147|NCT05285787|561690335|FG000|Overall Study|Withdrawal by Subject|1|||
155617148|NCT03382418|561690336|FG000|Overall Study|Withdrawal by Subject|1|||
155617149|NCT03382418|561690337|FG001|Overall Study|Withdrawal by Subject|0|||
155617150|NCT03382418|561690338|FG002|Overall Study|Withdrawal by Subject|0|||
155617151|NCT03382418|561690336|FG000|Overall Study|Lost to Follow-up|2|||
155617152|NCT03382418|561690337|FG001|Overall Study|Lost to Follow-up|3|||
155617153|NCT03382418|561690338|FG002|Overall Study|Lost to Follow-up|0|||
155617154|NCT02472886|561690339|FG000|Overall Study|Lack of Efficacy|0|||
155617155|NCT02472886|561690340|FG001|Overall Study|Lack of Efficacy|2|||
155617156|NCT02472886|561690341|FG002|Overall Study|Lack of Efficacy|1|||
155617157|NCT01051817|561690342|FG000|Overall Study|Adverse Event|0|||
155617158|NCT01051817|561690343|FG001|Overall Study|Adverse Event|2|||
155617159|NCT01051817|561690342|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
155617160|NCT01051817|561690343|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
155617161|NCT01051817|561690342|FG000|Overall Study|Withdrawal by Subject|3|||
155617162|NCT01051817|561690343|FG001|Overall Study|Withdrawal by Subject|5|||
155617163|NCT01051817|561690342|FG000|Overall Study|Protocol Violation|0|||
155617164|NCT01051817|561690343|FG001|Overall Study|Protocol Violation|1|||
155617165|NCT00320788|561690345|FG000|Overall Study|Adverse Event|0|||
155617166|NCT00320788|561690346|FG001|Overall Study|Adverse Event|0|||
155617167|NCT00320788|561690347|FG002|Overall Study|Adverse Event|0|||
155617168|NCT00320788|561690348|FG003|Overall Study|Adverse Event|1|||
155617169|NCT00320788|561690349|FG004|Overall Study|Adverse Event|0|||
155617170|NCT00320788|561690345|FG000|Overall Study|Death|0|||
155617171|NCT00320788|561690346|FG001|Overall Study|Death|0|||
155617172|NCT00320788|561690347|FG002|Overall Study|Death|1|||
155617173|NCT00320788|561690348|FG003|Overall Study|Death|0|||
155617174|NCT00320788|561690349|FG004|Overall Study|Death|1|||
155617175|NCT00320788|561690345|FG000|Overall Study|Lost to Follow-up|0|||
155617176|NCT00320788|561690346|FG001|Overall Study|Lost to Follow-up|2|||
155617177|NCT00320788|561690347|FG002|Overall Study|Lost to Follow-up|1|||
155617178|NCT00320788|561690348|FG003|Overall Study|Lost to Follow-up|0|||
155617179|NCT00320788|561690349|FG004|Overall Study|Lost to Follow-up|0|||
155617180|NCT00320788|561690345|FG000|Overall Study|Decision by the Sponsor|1|||
155617181|NCT00320788|561690346|FG001|Overall Study|Decision by the Sponsor|1|||
155617182|NCT00320788|561690347|FG002|Overall Study|Decision by the Sponsor|0|||
155617183|NCT00320788|561690348|FG003|Overall Study|Decision by the Sponsor|0|||
155617184|NCT00320788|561690349|FG004|Overall Study|Decision by the Sponsor|1|||
155617185|NCT00320788|561690345|FG000|Overall Study|Other|1|||
155617186|NCT00320788|561690346|FG001|Overall Study|Other|2|||
155617187|NCT00320788|561690347|FG002|Overall Study|Other|1|||
155617188|NCT00320788|561690348|FG003|Overall Study|Other|1|||
155617189|NCT00320788|561690349|FG004|Overall Study|Other|1|||
155617190|NCT00320788|561690345|FG000|Overall Study|Physician Decision|1|||
155617191|NCT00320788|561690346|FG001|Overall Study|Physician Decision|1|||
155617192|NCT00320788|561690347|FG002|Overall Study|Physician Decision|0|||
155617193|NCT00320788|561690348|FG003|Overall Study|Physician Decision|0|||
155617194|NCT00320788|561690349|FG004|Overall Study|Physician Decision|0|||
155617195|NCT00320788|561690345|FG000|Overall Study|Protocol Violation|0|||
155617196|NCT00320788|561690346|FG001|Overall Study|Protocol Violation|0|||
155617197|NCT00320788|561690347|FG002|Overall Study|Protocol Violation|0|||
155617198|NCT00320788|561690348|FG003|Overall Study|Protocol Violation|0|||
155617199|NCT00320788|561690349|FG004|Overall Study|Protocol Violation|1|||
155617200|NCT00320788|561690345|FG000|Overall Study|Withdrawal by Subject|3|||
155617201|NCT00320788|561690346|FG001|Overall Study|Withdrawal by Subject|0|||
155617202|NCT00320788|561690347|FG002|Overall Study|Withdrawal by Subject|0|||
155617203|NCT00320788|561690348|FG003|Overall Study|Withdrawal by Subject|3|||
155617204|NCT00320788|561690349|FG004|Overall Study|Withdrawal by Subject|1|||
155617205|NCT04533438|561690353|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
155617206|NCT04533438|561690354|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
155617207|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
155617208|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
155617209|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
155617210|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
155617211|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
155617212|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
155617213|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
155617214|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155617215|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155617216|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155617217|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
155617218|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
155617219|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
155617220|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
155617221|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
155617222|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
155617223|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
155617224|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155617225|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155617226|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155617227|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
155617228|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155617229|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155617230|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155617231|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155617232|NCT02137226|561690356|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
155617233|NCT02137226|561690357|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
155617234|NCT02137226|561690358|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
155617235|NCT02137226|561690359|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
155617236|NCT02137226|561690360|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
155617237|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
155617238|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
155617239|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
155617240|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
155617241|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
155617242|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
155617243|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
155617244|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
155617245|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
155617246|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
155617247|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
155617248|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
155617249|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
155617250|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
155617251|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
155617252|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155617253|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155617254|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
155617255|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155617256|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155617257|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155617258|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155617259|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
155617260|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155617261|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155617262|NCT02137226|561690356|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
155617263|NCT02137226|561690357|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
155617264|NCT02137226|561690358|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
155617265|NCT02137226|561690359|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
155617266|NCT02137226|561690360|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
155617267|NCT01398358|561690365|FG000|Overall Study|Lost to Follow-up|11|||
155617268|NCT01398358|561690366|FG001|Overall Study|Lost to Follow-up|21|||
155617269|NCT01398358|561690367|FG002|Overall Study|Lost to Follow-up|18|||
155617270|NCT01398358|561690365|FG000|Overall Study|Withdrawal by Subject|3|||
155617271|NCT01398358|561690366|FG001|Overall Study|Withdrawal by Subject|2|||
155617272|NCT01398358|561690367|FG002|Overall Study|Withdrawal by Subject|2|||
155617273|NCT01398358|561690365|FG000|Overall Study|no longer eligible|1|||
155617274|NCT01398358|561690366|FG001|Overall Study|no longer eligible|0|||
155617275|NCT01398358|561690367|FG002|Overall Study|no longer eligible|1|||
155617276|NCT00003896|561690368|FG000|Overall Study|Adverse Event|16|||
155617277|NCT00003896|561690368|FG000|Overall Study|Withdrawal by Subject|1|||
155617278|NCT00003896|561690368|FG000|Overall Study|Lack of Efficacy|1|||
155617279|NCT00003896|561690368|FG000|Overall Study|Death|3|||
155617280|NCT00003896|561690368|FG000|Overall Study|not protocol specified|3|||
155617281|NCT00003896|561690368|FG000|Overall Study|ineligible|5|||
155617282|NCT00985686|561690371|FG000|Overall Study|Lost to Follow-up|1|||
155617283|NCT00985686|561690372|FG001|Overall Study|Lost to Follow-up|1|||
155617284|NCT00985686|561690373|FG002|Overall Study|Lost to Follow-up|0|||
155617285|NCT00985686|561690374|FG003|Overall Study|Lost to Follow-up|2|||
155617286|NCT03134911|561690375|FG000|Overall Study|Screen failure|31|||
155617287|NCT03134911|561690375|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
155617288|NCT02559570|561690376|FG000|Overall Study|Adverse Event|0|||
155617289|NCT02559570|561690377|FG001|Overall Study|Adverse Event|2|||
155617290|NCT02559570|561690378|FG002|Overall Study|Adverse Event|0|||
155617291|NCT02559570|561690379|FG003|Overall Study|Adverse Event|1|||
155617292|NCT02559570|561690380|FG004|Overall Study|Adverse Event|0|||
155617293|NCT02559570|561690376|FG000|Overall Study|Withdrawal of Consent|0|||
155617294|NCT02559570|561690377|FG001|Overall Study|Withdrawal of Consent|0|||
155617295|NCT02559570|561690378|FG002|Overall Study|Withdrawal of Consent|1|||
155617296|NCT02559570|561690379|FG003|Overall Study|Withdrawal of Consent|2|||
155617297|NCT02559570|561690380|FG004|Overall Study|Withdrawal of Consent|1|||
155617298|NCT02559570|561690376|FG000|Overall Study|Lost to Follow-up|1|||
155617299|NCT02559570|561690377|FG001|Overall Study|Lost to Follow-up|0|||
155617300|NCT02559570|561690378|FG002|Overall Study|Lost to Follow-up|0|||
155617301|NCT02559570|561690379|FG003|Overall Study|Lost to Follow-up|0|||
155617302|NCT02559570|561690380|FG004|Overall Study|Lost to Follow-up|0|||
155617303|NCT02559570|561690376|FG000|Overall Study|Protocol Violation|1|||
155617304|NCT02559570|561690377|FG001|Overall Study|Protocol Violation|0|||
155617305|NCT02559570|561690378|FG002|Overall Study|Protocol Violation|0|||
155617306|NCT02559570|561690379|FG003|Overall Study|Protocol Violation|0|||
155617307|NCT02559570|561690380|FG004|Overall Study|Protocol Violation|1|||
155617308|NCT02559570|561690376|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155617309|NCT02559570|561690377|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155617310|NCT02559570|561690378|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155617311|NCT02559570|561690379|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155617312|NCT02559570|561690380|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155617313|NCT00396383|561690384|FG000|Overall Study|Death|2|||
155617314|NCT00396383|561690384|FG000|Overall Study|Lost to Follow-up|1|||
155617315|NCT01839916|561690385|FG000|Overall Study|Death|9|||
155617316|NCT01839916|561690385|FG000|Overall Study|Physician Decision|17|||
155617317|NCT01839916|561690385|FG000|Overall Study|Relapse|12|||
155617318|NCT01839916|561690385|FG000|Overall Study|GVHD|2|||
155617319|NCT01839916|561690385|FG000|Overall Study|Graft Failure|1|||
155617320|NCT02385110|561690388|FG000|Overall Study|Early Death|1|||
155617321|NCT02385110|561690389|FG001|Overall Study|Early Death|0|||
155617322|NCT00534638|561690390|FG000|Overall Study|Withdrawal by Subject|3|||
155617323|NCT00534638|561690391|FG001|Overall Study|Withdrawal by Subject|4|||
155617324|NCT00534638|561690390|FG000|Overall Study|Migrated/moved from study area|13|||
155617325|NCT00534638|561690391|FG001|Overall Study|Migrated/moved from study area|11|||
155617326|NCT00534638|561690390|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
155617327|NCT00534638|561690391|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
155617328|NCT00534638|561690390|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
155617329|NCT00534638|561690391|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
155617330|NCT00534638|561690390|FG000|Overall Study|Other|1685|||
155617331|NCT00534638|561690391|FG001|Overall Study|Other|902|||
155617332|NCT02710084|561690394|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
155617333|NCT02710084|561690395|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
155617334|NCT01124292|561690396|FG000|Overall Study|Lost to Follow-up|2|||
155617335|NCT01124292|561690397|FG001|Overall Study|Lost to Follow-up|4|||
155617336|NCT01124292|561690398|FG002|Overall Study|Lost to Follow-up|3|||
155617337|NCT01124292|561690396|FG000|Overall Study|Physician Decision|0|||
155617338|NCT01124292|561690397|FG001|Overall Study|Physician Decision|3|||
155617339|NCT01124292|561690398|FG002|Overall Study|Physician Decision|2|||
155617340|NCT01124292|561690396|FG000|Overall Study|Withdrawal by Subject|0|||
155617341|NCT01124292|561690397|FG001|Overall Study|Withdrawal by Subject|6|||
155617342|NCT01124292|561690398|FG002|Overall Study|Withdrawal by Subject|2|||
155617343|NCT01124292|561690396|FG000|Overall Study|medical issue unrelated to the study|0|||
155617344|NCT01124292|561690397|FG001|Overall Study|medical issue unrelated to the study|0|||
155617345|NCT01124292|561690398|FG002|Overall Study|medical issue unrelated to the study|2|||
155617346|NCT01124292|561690396|FG000|Overall Study|piercing track closed|0|||
155617347|NCT01124292|561690397|FG001|Overall Study|piercing track closed|2|||
155617348|NCT01124292|561690398|FG002|Overall Study|piercing track closed|1|||
155617349|NCT00481767|561690399|FG000|Overall Study|Withdrawal by Subject|16|||
155617350|NCT00481767|561690400|FG001|Overall Study|Withdrawal by Subject|11|||
155617351|NCT00481767|561690399|FG000|Overall Study|Lost to Follow-up|16|||
155617352|NCT00481767|561690400|FG001|Overall Study|Lost to Follow-up|10|||
155617353|NCT01366638|561690401|FG000|Overall Study|Withdrawal by Subject|0|||
155617354|NCT01366638|561690402|FG001|Overall Study|Withdrawal by Subject|0|||
155617355|NCT01366638|561690403|FG002|Overall Study|Withdrawal by Subject|6|||
155617356|NCT01366638|561690401|FG000|Overall Study|Other|1|||
155617357|NCT01366638|561690402|FG001|Overall Study|Other|0|||
155617358|NCT01366638|561690403|FG002|Overall Study|Other|0|||
155617359|NCT00636636|561690404|FG000|Overall Study|Other reason|4|||
155617360|NCT00636636|561690405|FG001|Overall Study|Other reason|6|||
155617361|NCT00636636|561690404|FG000|Overall Study|Adverse Event|19|||
155617362|NCT00636636|561690405|FG001|Overall Study|Adverse Event|8|||
155617363|NCT00636636|561690404|FG000|Overall Study|Lack of Efficacy|7|||
155617364|NCT00636636|561690405|FG001|Overall Study|Lack of Efficacy|12|||
155617365|NCT00636636|561690404|FG000|Overall Study|Protocol Violation|2|||
155617366|NCT00636636|561690405|FG001|Overall Study|Protocol Violation|2|||
155617367|NCT00636636|561690404|FG000|Overall Study|Lost to Follow-up|0|||
155617368|NCT00636636|561690405|FG001|Overall Study|Lost to Follow-up|1|||
155617369|NCT00636636|561690404|FG000|Overall Study|Death|0|||
155617370|NCT00636636|561690405|FG001|Overall Study|Death|1|||
155617371|NCT00636636|561690404|FG000|Overall Study|Withdrawal by Subject|4|||
155617372|NCT00636636|561690405|FG001|Overall Study|Withdrawal by Subject|9|||
155617373|NCT00524173|561690406|FG000|Overall Study|Lost to Follow-up|0|||
155617374|NCT00524173|561690407|FG001|Overall Study|Lost to Follow-up|1|||
155617375|NCT00524173|561690406|FG000|Overall Study|Death|1|||
155726802|NCT00129402|562099799|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155726803|NCT00129402|562099800|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155726804|NCT00129402|562099801|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155726805|NCT00129402|562099802|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
155617376|NCT00524173|561690407|FG001|Overall Study|Death|0|||
155617377|NCT00524173|561690406|FG000|Overall Study|Had not reached endpoint at study close|4|||
155617378|NCT00524173|561690407|FG001|Overall Study|Had not reached endpoint at study close|1|||
155617379|NCT01554163|561690408|FG000|Overall Study|Adverse Event|3|||
155617380|NCT01554163|561690409|FG001|Overall Study|Adverse Event|0|||
155617381|NCT01554163|561690408|FG000|Overall Study|Lack of Efficacy|1|||
155617382|NCT01554163|561690409|FG001|Overall Study|Lack of Efficacy|0|||
155617383|NCT01554163|561690408|FG000|Overall Study|Lost to Follow-up|1|||
155617384|NCT01554163|561690409|FG001|Overall Study|Lost to Follow-up|0|||
155617385|NCT01554163|561690408|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155617386|NCT01554163|561690409|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155617387|NCT01554163|561690408|FG000|Overall Study|Protocol Violation|0|||
155617388|NCT01554163|561690409|FG001|Overall Study|Protocol Violation|4|||
155617389|NCT01554163|561690408|FG000|Overall Study|Withdrawal by Subject|1|||
155617390|NCT01554163|561690409|FG001|Overall Study|Withdrawal by Subject|5|||
155617391|NCT01554163|561690408|FG000|Overall Study|Not Treated|1|||
155617392|NCT01554163|561690409|FG001|Overall Study|Not Treated|0|||
155617393|NCT01381926|561692350|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
155617394|NCT01381926|561692351|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
155617395|NCT01381926|561692350|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
155617396|NCT01381926|561692351|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
155617397|NCT02624947|561692356|FG000|Maternal Participants|Adverse Event|5|||
155617398|NCT02624947|561692357|FG001|Maternal Participants|Adverse Event|0|||
155617399|NCT02624947|561692356|FG000|Maternal Participants|Investigator Decision|5|||
155617400|NCT02624947|561692357|FG001|Maternal Participants|Investigator Decision|3|||
155617401|NCT02624947|561692356|FG000|Maternal Participants|Lost to Follow-up|54|||
155617402|NCT02624947|561692357|FG001|Maternal Participants|Lost to Follow-up|24|||
155617403|NCT02624947|561692356|FG000|Maternal Participants|Non Compliance|8|||
155617404|NCT02624947|561692357|FG001|Maternal Participants|Non Compliance|5|||
155617405|NCT02624947|561692356|FG000|Maternal Participants|Sponsor Request|1|||
155726806|NCT00129402|562099803|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155617406|NCT02624947|561692357|FG001|Maternal Participants|Sponsor Request|1|||
155617407|NCT02624947|561692356|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
155617408|NCT02624947|561692357|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
155617409|NCT02624947|561692356|FG000|Maternal Participants|Miscellaneous|23|||
155617410|NCT02624947|561692357|FG001|Maternal Participants|Miscellaneous|15|||
155617411|NCT02624947|561692356|FG000|Infant Participants|Adverse Event|18|||
155617412|NCT02624947|561692357|FG001|Infant Participants|Adverse Event|11|||
155617413|NCT02624947|561692356|FG000|Infant Participants|Investigator Decision|5|||
155617414|NCT02624947|561692357|FG001|Infant Participants|Investigator Decision|4|||
155617415|NCT02624947|561692356|FG000|Infant Participants|Lost to Follow-up|93|||
155617416|NCT02624947|561692357|FG001|Infant Participants|Lost to Follow-up|58|||
155617417|NCT02624947|561692356|FG000|Infant Participants|Non Compliance|17|||
155617418|NCT02624947|561692357|FG001|Infant Participants|Non Compliance|7|||
155617419|NCT02624947|561692356|FG000|Infant Participants|Sponsor Request|0|||
155617420|NCT02624947|561692357|FG001|Infant Participants|Sponsor Request|1|||
155617421|NCT02624947|561692356|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
155617422|NCT02624947|561692357|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
155617423|NCT02624947|561692356|FG000|Infant Participants|Miscellaneous|50|||
155617424|NCT02624947|561692357|FG001|Infant Participants|Miscellaneous|26|||
155617425|NCT03654729|561692366|FG000|Overall Study|Death|9|||
155617426|NCT03654729|561692367|FG001|Overall Study|Death|9|||
155617427|NCT03654729|561692368|FG002|Overall Study|Death|16|||
155617428|NCT03654729|561692366|FG000|Overall Study|Withdrawal by Subject|8|||
155617429|NCT03654729|561692367|FG001|Overall Study|Withdrawal by Subject|6|||
155617430|NCT03654729|561692368|FG002|Overall Study|Withdrawal by Subject|4|||
155617431|NCT03654729|561692366|FG000|Overall Study|Study terminated by Sponsor|3|||
155617432|NCT03654729|561692367|FG001|Overall Study|Study terminated by Sponsor|5|||
155617433|NCT03654729|561692368|FG002|Overall Study|Study terminated by Sponsor|4|||
155617434|NCT03654729|561692366|FG000|Overall Study|Not reported|2|||
155617435|NCT03654729|561692367|FG001|Overall Study|Not reported|4|||
155617436|NCT03654729|561692368|FG002|Overall Study|Not reported|5|||
155617437|NCT03654729|561692366|FG000|Overall Study|Progressive disease|3|||
155617438|NCT03654729|561692367|FG001|Overall Study|Progressive disease|0|||
155617439|NCT03654729|561692368|FG002|Overall Study|Progressive disease|0|||
155617440|NCT03654729|561692366|FG000|Overall Study|Lost to Follow-up|2|||
155617441|NCT03654729|561692367|FG001|Overall Study|Lost to Follow-up|0|||
155617442|NCT03654729|561692368|FG002|Overall Study|Lost to Follow-up|0|||
155617443|NCT03654729|561692366|FG000|Overall Study|Physician Decision|2|||
155617444|NCT03654729|561692367|FG001|Overall Study|Physician Decision|0|||
155617445|NCT03654729|561692368|FG002|Overall Study|Physician Decision|0|||
155617446|NCT03654729|561692366|FG000|Overall Study|Protocol Violation|1|||
155617447|NCT03654729|561692367|FG001|Overall Study|Protocol Violation|1|||
155617448|NCT03654729|561692368|FG002|Overall Study|Protocol Violation|0|||
155617449|NCT03654729|561692366|FG000|Overall Study|Non-compliance with study drug|0|||
155617450|NCT03654729|561692367|FG001|Overall Study|Non-compliance with study drug|1|||
155617451|NCT03654729|561692368|FG002|Overall Study|Non-compliance with study drug|0|||
155617452|NCT03654729|561692366|FG000|Overall Study|Site terminated by Sponsor|1|||
155617453|NCT03654729|561692367|FG001|Overall Study|Site terminated by Sponsor|0|||
155617454|NCT03654729|561692368|FG002|Overall Study|Site terminated by Sponsor|0|||
155617455|NCT00493012|561692377|FG000|Overall Study|Lost to Follow-up|18|||
155617456|NCT00493012|561692378|FG001|Overall Study|Lost to Follow-up|17|||
155617457|NCT02915159|561692379|FG000|Overall Study|Participant no longer meets criteria|2|||
155617458|NCT02915159|561692380|FG001|Overall Study|Participant no longer meets criteria|0|||
155617459|NCT02915159|561692379|FG000|Overall Study|poor/non-compliance|1|||
155617460|NCT02915159|561692380|FG001|Overall Study|poor/non-compliance|0|||
155617461|NCT02915159|561692379|FG000|Overall Study|Participant withdrew consent|5|||
155617462|NCT02915159|561692380|FG001|Overall Study|Participant withdrew consent|1|||
155617463|NCT02915159|561692379|FG000|Overall Study|Request to discontinue treatment|1|||
155617464|NCT02915159|561692380|FG001|Overall Study|Request to discontinue treatment|2|||
155617465|NCT02915159|561692379|FG000|Overall Study|Adverse Event|2|||
155617466|NCT02915159|561692380|FG001|Overall Study|Adverse Event|2|||
155617467|NCT02915159|561692379|FG000|Overall Study|Lack of Efficacy|0|||
155617468|NCT02915159|561692380|FG001|Overall Study|Lack of Efficacy|3|||
155617469|NCT04534517|561692381|FG000|Overall Study|Adverse Event|1|||
155617470|NCT04534517|561692381|FG000|Overall Study|Withdrawal by Subject|1|||
155617471|NCT04534517|561692381|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155617472|NCT04534517|561692381|FG000|Overall Study|COVID-19 Related|1|||
155617473|NCT00872521|561692382|FG000|Completed PAD Induction|Patient choice|0|||
155617474|NCT00872521|561692383|FG001|Completed PAD Induction|Patient choice|1|||
155617475|NCT00872521|561692384|FG002|Completed PAD Induction|Patient choice|0|||
155617476|NCT00872521|561692382|FG000|Completed PAD Induction|Disease progression|0|||
155617477|NCT00872521|561692383|FG001|Completed PAD Induction|Disease progression|2|||
155273031|NCT01613027|560432907|FG000|Overall Study|Lack of Efficacy|1|||
155273032|NCT01613027|560432907|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
155273033|NCT00119262|560432911|FG000|Overall Study|Lack of Efficacy|0|||
155617478|NCT00872521|561692384|FG002|Completed PAD Induction|Disease progression|0|||
155617479|NCT00872521|561692382|FG000|Completed PAD Induction|Adverse Event|4|||
155617480|NCT00872521|561692383|FG001|Completed PAD Induction|Adverse Event|0|||
155617481|NCT00872521|561692384|FG002|Completed PAD Induction|Adverse Event|0|||
155617482|NCT00872521|561692382|FG000|Completed PAD Induction|Death|1|||
155617483|NCT00872521|561692383|FG001|Completed PAD Induction|Death|1|||
155617484|NCT00872521|561692384|FG002|Completed PAD Induction|Death|0|||
155273034|NCT00119262|560432912|FG001|Overall Study|Lack of Efficacy|3|||
155617485|NCT00872521|561692382|FG000|Primary Endpoint Analysis|Other|1|||
155617486|NCT00872521|561692383|FG001|Primary Endpoint Analysis|Other|2|||
155617487|NCT00872521|561692384|FG002|Primary Endpoint Analysis|Other|0|||
155617488|NCT00872521|561692382|FG000|Primary Endpoint Analysis|Patient choice|0|||
155617489|NCT00872521|561692383|FG001|Primary Endpoint Analysis|Patient choice|1|||
155617490|NCT00872521|561692384|FG002|Primary Endpoint Analysis|Patient choice|0|||
155617491|NCT00872521|561692382|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
155617492|NCT00872521|561692383|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
155617493|NCT00872521|561692384|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
155617494|NCT00872521|561692382|FG000|Primary Endpoint Analysis|Patient response missing|0|||
155617495|NCT00872521|561692383|FG001|Primary Endpoint Analysis|Patient response missing|0|||
155617496|NCT00872521|561692384|FG002|Primary Endpoint Analysis|Patient response missing|1|||
155617497|NCT00872521|561692382|FG000|Completed 3-month Follow up|Other|0|||
155617498|NCT00872521|561692383|FG001|Completed 3-month Follow up|Other|2|||
155617499|NCT00872521|561692384|FG002|Completed 3-month Follow up|Other|0|||
155617500|NCT00872521|561692382|FG000|Completed 3-month Follow up|Physician Decision|0|||
155617501|NCT00872521|561692383|FG001|Completed 3-month Follow up|Physician Decision|1|||
155617502|NCT00872521|561692384|FG002|Completed 3-month Follow up|Physician Decision|0|||
155617503|NCT00872521|561692382|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
155617504|NCT00872521|561692383|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
155617505|NCT00872521|561692384|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
155617506|NCT05225558|561692388|FG000|Overall Study|Withdrawal by Subject|4|||
155617507|NCT05225558|561692389|FG001|Overall Study|Withdrawal by Subject|3|||
155617508|NCT05225558|561692388|FG000|Overall Study|Adverse Event|1|||
155617509|NCT05225558|561692389|FG001|Overall Study|Adverse Event|0|||
155617510|NCT05225558|561692388|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
155617511|NCT05225558|561692389|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
155617512|NCT05225558|561692388|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
155617513|NCT05225558|561692389|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
155617514|NCT01089127|561692390|FG000|Overall Study|Adverse Event|5|||
155617515|NCT01089127|561692391|FG001|Overall Study|Adverse Event|1|||
155617516|NCT01089127|561692392|FG002|Overall Study|Adverse Event|1|||
155617517|NCT01089127|561692393|FG003|Overall Study|Adverse Event|0|||
155617518|NCT01089127|561692394|FG004|Overall Study|Adverse Event|0|||
155617519|NCT01089127|561692395|FG005|Overall Study|Adverse Event|1|||
155617520|NCT01089127|561692390|FG000|Overall Study|Subject withdrew consent|0|||
155617521|NCT01089127|561692391|FG001|Overall Study|Subject withdrew consent|1|||
155617522|NCT01089127|561692392|FG002|Overall Study|Subject withdrew consent|1|||
155617523|NCT01089127|561692393|FG003|Overall Study|Subject withdrew consent|1|||
155617524|NCT01089127|561692394|FG004|Overall Study|Subject withdrew consent|0|||
155617525|NCT01089127|561692395|FG005|Overall Study|Subject withdrew consent|2|||
155617526|NCT01089127|561692390|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155617527|NCT01089127|561692391|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155617528|NCT01089127|561692392|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155617529|NCT01089127|561692393|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155617530|NCT01089127|561692394|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155617531|NCT01089127|561692395|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155617532|NCT01089127|561692390|FG000|Overall Study|Lost to Follow-up|1|||
155617533|NCT01089127|561692391|FG001|Overall Study|Lost to Follow-up|1|||
155617534|NCT01089127|561692392|FG002|Overall Study|Lost to Follow-up|0|||
155617535|NCT01089127|561692393|FG003|Overall Study|Lost to Follow-up|0|||
155617536|NCT01089127|561692394|FG004|Overall Study|Lost to Follow-up|1|||
155617537|NCT01089127|561692395|FG005|Overall Study|Lost to Follow-up|0|||
155617538|NCT01089127|561692390|FG000|Overall Study|Protocol deviation|0|||
155617539|NCT01089127|561692391|FG001|Overall Study|Protocol deviation|1|||
155617540|NCT01089127|561692392|FG002|Overall Study|Protocol deviation|0|||
155617541|NCT01089127|561692393|FG003|Overall Study|Protocol deviation|0|||
155617542|NCT01089127|561692394|FG004|Overall Study|Protocol deviation|1|||
155617543|NCT01089127|561692395|FG005|Overall Study|Protocol deviation|0|||
155617544|NCT02258659|561692398|FG000|Overall Study|Withdrawal by Subject|1|||
155617545|NCT03990051|561692399|FG000|Masked Period|Lost to Follow-up|1|||
155617546|NCT03990051|561692400|FG001|Masked Period|Lost to Follow-up|0|||
155617547|NCT03990051|561692399|FG000|Long Term Period|Death|1|||
155617548|NCT03990051|561692400|FG001|Long Term Period|Death|1|||
155617549|NCT03990051|561692399|FG000|Long Term Period|Lost to Follow-up|7|||
155617550|NCT03990051|561692400|FG001|Long Term Period|Lost to Follow-up|2|||
155617551|NCT01411852|561692401|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
155617552|NCT01411852|561692402|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
155617553|NCT01411852|561692401|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
155617554|NCT01411852|561692402|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
155617555|NCT01411852|561692401|FG000|Prehospital Intervention Phase|Found to be under age|0|||
155617556|NCT01411852|561692402|FG001|Prehospital Intervention Phase|Found to be under age|1|||
155617557|NCT01411852|561692401|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
155617558|NCT01411852|561692402|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
155617559|NCT01411852|561692401|FG000|Hospital Intervention Phase|Severe head injury|5|||
155617560|NCT01411852|561692402|FG001|Hospital Intervention Phase|Severe head injury|4|||
155617561|NCT01411852|561692401|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
155617562|NCT01411852|561692402|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
155617563|NCT01411852|561692401|FG000|Hospital Intervention Phase|Miscommunication error|1|||
155617564|NCT01411852|561692402|FG001|Hospital Intervention Phase|Miscommunication error|2|||
155617565|NCT01411852|561692401|FG000|Hospital Intervention Phase|CPR administered|3|||
155617566|NCT01411852|561692402|FG001|Hospital Intervention Phase|CPR administered|1|||
155617567|NCT01411852|561692401|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
155617568|NCT01411852|561692402|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
155617569|NCT01411852|561692401|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
155617570|NCT01411852|561692402|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
155617571|NCT01411852|561692401|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
155617572|NCT01411852|561692402|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
155617573|NCT01411852|561692401|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
155617574|NCT01411852|561692402|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
155617575|NCT01411852|561692401|FG000|Hospital Intervention Phase|Other ineligible|2|||
155617576|NCT01411852|561692402|FG001|Hospital Intervention Phase|Other ineligible|2|||
155617577|NCT01411852|561692401|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
155617578|NCT01411852|561692402|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
155617579|NCT01411852|561692401|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
155617580|NCT01411852|561692402|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
155617581|NCT01411852|561692401|FG000|Hospital Intervention Phase|Vascular access failed|1|||
155617582|NCT01411852|561692402|FG001|Hospital Intervention Phase|Vascular access failed|0|||
155617583|NCT00272844|561692403|FG000|Overall Study|Withdrawal by Subject|5|||
155617584|NCT03743025|561692406|FG000|Overall Study|Surgery was cancelled|2|||
155617585|NCT03743025|561692407|FG001|Overall Study|Surgery was cancelled|1|||
155617586|NCT00791700|561692408|FG000|Overall Study|Insufficient clinical response|1|||
155617587|NCT00791700|561692409|FG001|Overall Study|Insufficient clinical response|4|||
155617588|NCT00791700|561692410|FG002|Overall Study|Insufficient clinical response|1|||
155617589|NCT00791700|561692411|FG003|Overall Study|Insufficient clinical response|8|||
155617590|NCT00791700|561692408|FG000|Overall Study|No longer willing to participate|1|||
155617591|NCT00791700|561692409|FG001|Overall Study|No longer willing to participate|1|||
155617592|NCT00791700|561692410|FG002|Overall Study|No longer willing to participate|0|||
155617593|NCT00791700|561692411|FG003|Overall Study|No longer willing to participate|8|||
155617594|NCT00791700|561692408|FG000|Overall Study|Non-compliance with study treatment|0|||
155617595|NCT00791700|561692409|FG001|Overall Study|Non-compliance with study treatment|2|||
155617596|NCT00791700|561692410|FG002|Overall Study|Non-compliance with study treatment|0|||
155617597|NCT00791700|561692411|FG003|Overall Study|Non-compliance with study treatment|4|||
155617598|NCT00791700|561692408|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155617599|NCT00791700|561692409|FG001|Overall Study|Withdrawn due to pregnancy|0|||
155617600|NCT00791700|561692410|FG002|Overall Study|Withdrawn due to pregnancy|0|||
155617601|NCT00791700|561692411|FG003|Overall Study|Withdrawn due to pregnancy|1|||
155617602|NCT00791700|561692408|FG000|Overall Study|Other|0|||
155617603|NCT00791700|561692409|FG001|Overall Study|Other|1|||
155617604|NCT00791700|561692410|FG002|Overall Study|Other|0|||
155617605|NCT00791700|561692411|FG003|Overall Study|Other|1|||
155617606|NCT00791700|561692408|FG000|Overall Study|Death|0|||
155617607|NCT00791700|561692409|FG001|Overall Study|Death|0|||
155617608|NCT00791700|561692410|FG002|Overall Study|Death|0|||
155617609|NCT00791700|561692411|FG003|Overall Study|Death|1|||
155617610|NCT00791700|561692408|FG000|Overall Study|Lost to Follow-up|4|||
155617611|NCT00791700|561692409|FG001|Overall Study|Lost to Follow-up|3|||
155617612|NCT00791700|561692410|FG002|Overall Study|Lost to Follow-up|4|||
155617613|NCT00791700|561692411|FG003|Overall Study|Lost to Follow-up|6|||
155617614|NCT00791700|561692408|FG000|Overall Study|Adverse Event|0|||
155617615|NCT00791700|561692409|FG001|Overall Study|Adverse Event|0|||
155273035|NCT00119262|560432911|FG000|Overall Study|Withdrawal by Subject|12|||
155273036|NCT00119262|560432912|FG001|Overall Study|Withdrawal by Subject|11|||
155273037|NCT00119262|560432911|FG000|Overall Study|Adverse Event|33|||
155273038|NCT00119262|560432912|FG001|Overall Study|Adverse Event|35|||
155273039|NCT00119262|560432911|FG000|Overall Study|other disease|0|||
155273040|NCT00119262|560432912|FG001|Overall Study|other disease|2|||
155617616|NCT00791700|561692410|FG002|Overall Study|Adverse Event|1|||
155617617|NCT00791700|561692411|FG003|Overall Study|Adverse Event|1|||
155617618|NCT00996034|561692414|FG000|Overall Study|Lost to Follow-up|2|||
155617619|NCT00996034|561692414|FG000|Overall Study|withdrawn by PI|1|||
155273041|NCT00119262|560432911|FG000|Overall Study|ineligble|1|||
155617620|NCT01720524|561692415|FG000|Part A|Insufficient Clinical Response|2|||
155617621|NCT01720524|561692416|FG001|Part A|Insufficient Clinical Response|4|||
155273042|NCT00119262|560432912|FG001|Overall Study|ineligble|2|||
155273043|NCT00119262|560432911|FG000|Overall Study|others|0|||
155617622|NCT01720524|561692415|FG000|Part A|Adverse Event|2|||
155617623|NCT01720524|561692416|FG001|Part A|Adverse Event|2|||
155617624|NCT01720524|561692415|FG000|Part A|Death|2|||
155617625|NCT01720524|561692416|FG001|Part A|Death|1|||
155617626|NCT01720524|561692415|FG000|Part A|Lost to Follow-up|0|||
155617627|NCT01720524|561692416|FG001|Part A|Lost to Follow-up|1|||
155617628|NCT01720524|561692415|FG000|Part A|Missed 28 day follow-up visit|1|||
155617629|NCT01720524|561692416|FG001|Part A|Missed 28 day follow-up visit|1|||
155617630|NCT01720524|561692415|FG000|Part A|Withdrawal by Subject|0|||
155617631|NCT01720524|561692416|FG001|Part A|Withdrawal by Subject|1|||
155617632|NCT01720524|561692415|FG000|Part A|Other|0|||
155617633|NCT01720524|561692416|FG001|Part A|Other|1|||
155617634|NCT01720524|561692415|FG000|Part A|Lost to Follow-up|0|||
155617635|NCT01720524|561692416|FG001|Part A|Lost to Follow-up|1|||
155617636|NCT01720524|561692415|FG000|Part B|No longer willing to participate in study|1|||
155617637|NCT01720524|561692416|FG001|Part B|No longer willing to participate in study|4|||
155617638|NCT01720524|561692415|FG000|Part B|Other|2|||
155617639|NCT01720524|561692416|FG001|Part B|Other|0|||
155617640|NCT01720524|561692415|FG000|Part B|Lost to Follow-up|2|||
155617641|NCT01720524|561692416|FG001|Part B|Lost to Follow-up|3|||
155617642|NCT01720524|561692415|FG000|Part B|Death|0|||
155617643|NCT01720524|561692416|FG001|Part B|Death|2|||
155617644|NCT00527826|561692420|FG000|Overall Study|Adverse Event|10|||
155617645|NCT00527826|561692421|FG001|Overall Study|Adverse Event|10|||
155617646|NCT00527826|561692420|FG000|Overall Study|Lost to Follow-up|3|||
155617647|NCT00527826|561692421|FG001|Overall Study|Lost to Follow-up|2|||
155617648|NCT00527826|561692420|FG000|Overall Study|Withdrawal by Subject|5|||
155617649|NCT00527826|561692421|FG001|Overall Study|Withdrawal by Subject|8|||
155617650|NCT00527826|561692420|FG000|Overall Study|Inclusion Criteria Not Met|3|||
155617651|NCT00527826|561692421|FG001|Overall Study|Inclusion Criteria Not Met|3|||
155617652|NCT00527826|561692420|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
155617653|NCT00527826|561692421|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
155617654|NCT00527826|561692420|FG000|Overall Study|Additional Intake of Viani forte|0|||
155617655|NCT00527826|561692421|FG001|Overall Study|Additional Intake of Viani forte|1|||
155617656|NCT00527826|561692420|FG000|Overall Study|Participant moved away|0|||
155617657|NCT00527826|561692421|FG001|Overall Study|Participant moved away|1|||
155617658|NCT00158262|561692422|FG000|Overall Study|Lost to Follow-up|1|||
155617659|NCT00158262|561692423|FG001|Overall Study|Lost to Follow-up|1|||
155617660|NCT01421641|561692424|FG000|Overall Study|Protocol Violation|2|||
155617661|NCT01421641|561692425|FG001|Overall Study|Protocol Violation|2|||
155617662|NCT02420119|561692427|FG000|Overall Study|insufficient laboratory data|5|||
155617663|NCT01808261|561692428|FG000|Overall Study|Physician Decision|0|||
155617664|NCT01808261|561692429|FG001|Overall Study|Physician Decision|2|||
155617665|NCT01808261|561692428|FG000|Overall Study|Study Closed/Terminated|25|||
155617666|NCT01808261|561692429|FG001|Overall Study|Study Closed/Terminated|23|||
155617667|NCT01808261|561692428|FG000|Overall Study|Adverse event, non-fatal|2|||
155617668|NCT01808261|561692429|FG001|Overall Study|Adverse event, non-fatal|0|||
155617669|NCT01808261|561692428|FG000|Overall Study|Consent withdrawn by subject|6|||
155617670|NCT01808261|561692429|FG001|Overall Study|Consent withdrawn by subject|7|||
155617671|NCT01808261|561692428|FG000|Overall Study|Lost to Follow-up|3|||
155617672|NCT01808261|561692429|FG001|Overall Study|Lost to Follow-up|1|||
155617673|NCT04501952|561692432|FG000|Overall Study|Adverse Event|0|||
155617674|NCT04501952|561692433|FG001|Overall Study|Adverse Event|3|||
155617675|NCT04501952|561692432|FG000|Overall Study|Investigator's Discretion|0|||
155617676|NCT04501952|561692433|FG001|Overall Study|Investigator's Discretion|1|||
155617677|NCT04501952|561692432|FG000|Overall Study|Protocol Violation|1|||
155617678|NCT04501952|561692433|FG001|Overall Study|Protocol Violation|1|||
155617679|NCT04501952|561692432|FG000|Overall Study|Withdrew Consent|5|||
155617680|NCT04501952|561692433|FG001|Overall Study|Withdrew Consent|4|||
155617681|NCT04501952|561692432|FG000|Overall Study|Lost to Follow-up|7|||
155617682|NCT04501952|561692433|FG001|Overall Study|Lost to Follow-up|2|||
155617683|NCT04501952|561692432|FG000|Overall Study|Randomized and Never Treated|13|||
155617684|NCT04501952|561692433|FG001|Overall Study|Randomized and Never Treated|9|||
155617685|NCT02080364|561692434|FG000|Baseline Period|Protocol Violation|2|||
155617686|NCT02080364|561692435|FG001|Baseline Period|Protocol Violation|1|||
155617687|NCT02080364|561692436|FG002|Baseline Period|Protocol Violation|0|||
155617688|NCT02080364|561692437|FG003|Baseline Period|Protocol Violation|0|||
155617689|NCT02080364|561692434|FG000|Baseline Period|Other|0|||
155617690|NCT02080364|561692435|FG001|Baseline Period|Other|1|||
155617691|NCT02080364|561692436|FG002|Baseline Period|Other|1|||
155617692|NCT02080364|561692437|FG003|Baseline Period|Other|0|||
155617693|NCT02080364|561692434|FG000|Treatment Period|Adverse Event|10|||
155617694|NCT02080364|561692435|FG001|Treatment Period|Adverse Event|15|||
155617695|NCT02080364|561692436|FG002|Treatment Period|Adverse Event|11|||
155617696|NCT02080364|561692437|FG003|Treatment Period|Adverse Event|14|||
155617697|NCT02080364|561692434|FG000|Treatment Period|Lost to Follow-up|2|||
155617698|NCT02080364|561692435|FG001|Treatment Period|Lost to Follow-up|3|||
155617699|NCT02080364|561692436|FG002|Treatment Period|Lost to Follow-up|5|||
155617700|NCT02080364|561692437|FG003|Treatment Period|Lost to Follow-up|0|||
155617701|NCT02080364|561692434|FG000|Treatment Period|Protocol Violation|5|||
155617702|NCT02080364|561692435|FG001|Treatment Period|Protocol Violation|3|||
155617703|NCT02080364|561692436|FG002|Treatment Period|Protocol Violation|5|||
155617704|NCT02080364|561692437|FG003|Treatment Period|Protocol Violation|1|||
155617705|NCT02080364|561692434|FG000|Treatment Period|Withdrawal by Subject|16|||
155617706|NCT02080364|561692435|FG001|Treatment Period|Withdrawal by Subject|16|||
155617707|NCT02080364|561692436|FG002|Treatment Period|Withdrawal by Subject|15|||
155617708|NCT02080364|561692437|FG003|Treatment Period|Withdrawal by Subject|10|||
155617709|NCT02080364|561692434|FG000|Treatment Period|Study Terminated by Sponsor|0|||
155617710|NCT02080364|561692435|FG001|Treatment Period|Study Terminated by Sponsor|0|||
155617711|NCT02080364|561692436|FG002|Treatment Period|Study Terminated by Sponsor|180|||
155617712|NCT02080364|561692437|FG003|Treatment Period|Study Terminated by Sponsor|183|||
155617713|NCT02080364|561692434|FG000|Treatment Period|Other|14|||
155617714|NCT02080364|561692435|FG001|Treatment Period|Other|12|||
155617715|NCT02080364|561692436|FG002|Treatment Period|Other|21|||
155617716|NCT02080364|561692437|FG003|Treatment Period|Other|16|||
155617717|NCT02256839|561692438|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
155617718|NCT02256839|561692439|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
155617719|NCT00436826|561692440|FG000|Double Blind Period (DBP)|Adverse Event|2|||
155617720|NCT00436826|561692441|FG001|Double Blind Period (DBP)|Adverse Event|0|||
155617721|NCT00436826|561692442|FG002|Double Blind Period (DBP)|Adverse Event|0|||
155617722|NCT00436826|561692443|FG003|Double Blind Period (DBP)|Adverse Event|0|||
155617723|NCT00436826|561692444|FG004|Double Blind Period (DBP)|Adverse Event|0|||
155617724|NCT00436826|561692445|FG005|Double Blind Period (DBP)|Adverse Event|0|||
155617725|NCT00436826|561692440|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
155617726|NCT00436826|561692441|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
155617727|NCT00436826|561692442|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
155617728|NCT00436826|561692443|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
155617729|NCT00436826|561692444|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
155617730|NCT00436826|561692445|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
155617731|NCT00436826|561692440|FG000|Double Blind Period (DBP)|Other|10|||
155617732|NCT00436826|561692441|FG001|Double Blind Period (DBP)|Other|11|||
155617733|NCT00436826|561692442|FG002|Double Blind Period (DBP)|Other|0|||
155617734|NCT00436826|561692443|FG003|Double Blind Period (DBP)|Other|0|||
155617735|NCT00436826|561692444|FG004|Double Blind Period (DBP)|Other|0|||
155617736|NCT00436826|561692445|FG005|Double Blind Period (DBP)|Other|0|||
155617737|NCT00436826|561692440|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155617738|NCT00436826|561692441|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155617739|NCT00436826|561692442|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155617740|NCT00436826|561692443|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
155617741|NCT00436826|561692444|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155617742|NCT00436826|561692445|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155617743|NCT00436826|561692440|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155617744|NCT00436826|561692441|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155617745|NCT00436826|561692442|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
155617746|NCT00436826|561692443|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
155617747|NCT00436826|561692444|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155617748|NCT00436826|561692445|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155617749|NCT00436826|561692440|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155617750|NCT00436826|561692441|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155617751|NCT00436826|561692442|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155617752|NCT00436826|561692443|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155617753|NCT00436826|561692444|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
155617754|NCT00436826|561692445|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
155617755|NCT05464420|561692454|FG000|Overall Study|Death|0|||
155617756|NCT05464420|561692455|FG001|Overall Study|Death|0|||
155617757|NCT05464420|561692456|FG002|Overall Study|Death|0|||
155617758|NCT05464420|561692457|FG003|Overall Study|Death|1|||
155617759|NCT05464420|561692454|FG000|Overall Study|Lost to Follow-up|16|||
155617760|NCT05464420|561692455|FG001|Overall Study|Lost to Follow-up|11|||
155617761|NCT05464420|561692456|FG002|Overall Study|Lost to Follow-up|11|||
155617762|NCT05464420|561692457|FG003|Overall Study|Lost to Follow-up|11|||
155726807|NCT00129402|562099804|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155617763|NCT05464420|561692454|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
155617764|NCT05464420|561692455|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
155617765|NCT05464420|561692456|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
155617766|NCT05464420|561692457|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
155617767|NCT05464420|561692454|FG000|Overall Study|Withdrawal by Subject|4|||
155617768|NCT05464420|561692455|FG001|Overall Study|Withdrawal by Subject|8|||
155617769|NCT05464420|561692456|FG002|Overall Study|Withdrawal by Subject|3|||
155617770|NCT05464420|561692457|FG003|Overall Study|Withdrawal by Subject|1|||
155726808|NCT00129402|562099805|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155617771|NCT05464420|561692454|FG000|Overall Study|Protocol Violation|0|||
155617772|NCT05464420|561692455|FG001|Overall Study|Protocol Violation|0|||
155617773|NCT05464420|561692456|FG002|Overall Study|Protocol Violation|1|||
155617774|NCT05464420|561692457|FG003|Overall Study|Protocol Violation|1|||
155617775|NCT05464420|561692454|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
155617776|NCT05464420|561692455|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
155617777|NCT05464420|561692456|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
155617778|NCT05464420|561692457|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
155617779|NCT01383018|561692458|FG000|Overall Study|Adverse Event|14|||
155617780|NCT01383018|561692458|FG000|Overall Study|Death|10|||
155617781|NCT01383018|561692458|FG000|Overall Study|Lost to Follow-up|5|||
155617782|NCT01383018|561692458|FG000|Overall Study|Physician Decision|5|||
155617783|NCT01383018|561692458|FG000|Overall Study|Withdrawal by Subject|9|||
155617784|NCT01383018|561692458|FG000|Overall Study|Subject not implanted|76|||
155617785|NCT01383018|561692458|FG000|Overall Study|Missed Visit|247|||
155617786|NCT01383018|561692458|FG000|Overall Study|Site closed early-not compliance related|7|||
155617787|NCT01383018|561692458|FG000|Overall Study|Patient moved away from site|1|||
155617788|NCT01383018|561692458|FG000|Overall Study|Subject Incarcerated|1|||
155617789|NCT04346199|561692459|FG000|Overall Study|Death|8|||
155617790|NCT04346199|561692460|FG001|Overall Study|Death|9|||
155617791|NCT04346199|561692459|FG000|Overall Study|Lost to Follow-up|0|||
155617792|NCT04346199|561692460|FG001|Overall Study|Lost to Follow-up|1|||
155617793|NCT04346199|561692459|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
155617794|NCT04346199|561692460|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
155617795|NCT04346199|561692459|FG000|Overall Study|Withdrawal by Subject|5|||
155617796|NCT04346199|561692460|FG001|Overall Study|Withdrawal by Subject|1|||
155617797|NCT00627926|561692461|FG000|Overall Study|Adverse Event|26|||
155617798|NCT00627926|561692462|FG001|Overall Study|Adverse Event|37|||
155617799|NCT00627926|561692463|FG002|Overall Study|Adverse Event|36|||
155617800|NCT00627926|561692461|FG000|Overall Study|Death|1|||
155617801|NCT00627926|561692462|FG001|Overall Study|Death|0|||
155617802|NCT00627926|561692463|FG002|Overall Study|Death|0|||
155617803|NCT00627926|561692461|FG000|Overall Study|Lost to Follow-up|4|||
155617804|NCT00627926|561692462|FG001|Overall Study|Lost to Follow-up|3|||
155617805|NCT00627926|561692463|FG002|Overall Study|Lost to Follow-up|4|||
155617806|NCT00627926|561692461|FG000|Overall Study|Withdrawal by Subject|2|||
155617807|NCT00627926|561692462|FG001|Overall Study|Withdrawal by Subject|1|||
155617808|NCT00627926|561692463|FG002|Overall Study|Withdrawal by Subject|0|||
155617809|NCT00627926|561692461|FG000|Overall Study|Lack of Efficacy|118|||
155617810|NCT00627926|561692462|FG001|Overall Study|Lack of Efficacy|40|||
155617811|NCT00627926|561692463|FG002|Overall Study|Lack of Efficacy|38|||
155617812|NCT00627926|561692461|FG000|Overall Study|Noncompliance/unspecified|8|||
155617813|NCT00627926|561692462|FG001|Overall Study|Noncompliance/unspecified|23|||
155617814|NCT00627926|561692463|FG002|Overall Study|Noncompliance/unspecified|17|||
155617815|NCT03414229|561692464|FG000|Overall Study|Adverse Event|1|||
155617816|NCT03414229|561692465|FG001|Overall Study|Adverse Event|0|||
155617817|NCT03414229|561692466|FG002|Overall Study|Adverse Event|2|||
155617818|NCT03414229|561692467|FG003|Overall Study|Adverse Event|1|||
155617819|NCT03414229|561692464|FG000|Overall Study|Lack of Efficacy|7|||
155617820|NCT03414229|561692465|FG001|Overall Study|Lack of Efficacy|4|||
155617821|NCT03414229|561692466|FG002|Overall Study|Lack of Efficacy|1|||
155617822|NCT03414229|561692467|FG003|Overall Study|Lack of Efficacy|9|||
155617823|NCT03414229|561692464|FG000|Overall Study|Change in therapy|1|||
155617824|NCT03414229|561692465|FG001|Overall Study|Change in therapy|0|||
155617825|NCT03414229|561692466|FG002|Overall Study|Change in therapy|0|||
155617826|NCT03414229|561692467|FG003|Overall Study|Change in therapy|0|||
155617827|NCT03414229|561692464|FG000|Overall Study|Pregnancy|0|||
155617828|NCT03414229|561692465|FG001|Overall Study|Pregnancy|0|||
155617829|NCT03414229|561692466|FG002|Overall Study|Pregnancy|1|||
155617830|NCT03414229|561692467|FG003|Overall Study|Pregnancy|0|||
155617831|NCT03414229|561692464|FG000|Overall Study|Withdrawal by Subject|0|||
155617832|NCT03414229|561692465|FG001|Overall Study|Withdrawal by Subject|1|||
155617833|NCT03414229|561692466|FG002|Overall Study|Withdrawal by Subject|1|||
155617834|NCT03414229|561692467|FG003|Overall Study|Withdrawal by Subject|0|||
155617835|NCT05568797|561692470|FG000|Overall Study|Adverse Event|0|||
155617836|NCT05568797|561692471|FG001|Overall Study|Adverse Event|8|||
155617837|NCT05568797|561692470|FG000|Overall Study|Lost to Follow-up|2|||
155617838|NCT05568797|561692471|FG001|Overall Study|Lost to Follow-up|3|||
155617839|NCT05568797|561692470|FG000|Overall Study|Withdrawal by Subject|1|||
155617840|NCT05568797|561692471|FG001|Overall Study|Withdrawal by Subject|10|||
155617841|NCT05568797|561692470|FG000|Overall Study|Other|2|||
155617842|NCT05568797|561692471|FG001|Overall Study|Other|2|||
155617843|NCT00099632|561692472|FG000|Overall Study|Lost to Follow-up|1|||
155617844|NCT00099632|561692473|FG001|Overall Study|Lost to Follow-up|0|||
155617845|NCT00099632|561692474|FG002|Overall Study|Lost to Follow-up|3|||
155617846|NCT00099632|561692475|FG003|Overall Study|Lost to Follow-up|1|||
155617847|NCT00099632|561692476|FG004|Overall Study|Lost to Follow-up|1|||
155617848|NCT00099632|561692477|FG005|Overall Study|Lost to Follow-up|0|||
155617849|NCT00099632|561692472|FG000|Overall Study|Withdrawal by Subject|0|||
155617850|NCT00099632|561692473|FG001|Overall Study|Withdrawal by Subject|1|||
155617851|NCT00099632|561692474|FG002|Overall Study|Withdrawal by Subject|0|||
155617852|NCT00099632|561692475|FG003|Overall Study|Withdrawal by Subject|0|||
155617853|NCT00099632|561692476|FG004|Overall Study|Withdrawal by Subject|0|||
155617854|NCT00099632|561692477|FG005|Overall Study|Withdrawal by Subject|1|||
155617855|NCT00099632|561692472|FG000|Overall Study|Protocol Violation|0|||
155617856|NCT00099632|561692473|FG001|Overall Study|Protocol Violation|0|||
155617857|NCT00099632|561692474|FG002|Overall Study|Protocol Violation|0|||
155617858|NCT00099632|561692475|FG003|Overall Study|Protocol Violation|0|||
155617859|NCT00099632|561692476|FG004|Overall Study|Protocol Violation|0|||
155617860|NCT00099632|561692477|FG005|Overall Study|Protocol Violation|1|||
155617861|NCT02797678|561692478|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
155617862|NCT02797678|561692479|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155617863|NCT02797678|561692480|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155617864|NCT02797678|561692481|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155617865|NCT02797678|561692478|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
155617866|NCT02797678|561692479|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
155617867|NCT02797678|561692480|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
155617868|NCT02797678|561692481|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
155617869|NCT02797678|561692478|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155617870|NCT02797678|561692479|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155617871|NCT02797678|561692480|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
155617872|NCT02797678|561692481|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155617873|NCT03131687|561692482|FG000|Overall Study|Adverse Event|0|||
155617874|NCT03131687|561692483|FG001|Overall Study|Adverse Event|1|||
155617875|NCT03131687|561692484|FG002|Overall Study|Adverse Event|0|||
155617876|NCT03131687|561692485|FG003|Overall Study|Adverse Event|1|||
155617877|NCT03131687|561692486|FG004|Overall Study|Adverse Event|2|||
155617878|NCT03131687|561692487|FG005|Overall Study|Adverse Event|2|||
155617879|NCT03131687|561692482|FG000|Overall Study|Death|1|||
155617880|NCT03131687|561692483|FG001|Overall Study|Death|0|||
155617881|NCT03131687|561692484|FG002|Overall Study|Death|0|||
155617882|NCT03131687|561692485|FG003|Overall Study|Death|0|||
155617883|NCT03131687|561692486|FG004|Overall Study|Death|0|||
155617884|NCT03131687|561692487|FG005|Overall Study|Death|0|||
155617885|NCT03131687|561692482|FG000|Overall Study|Withdrawal by Subject|3|||
155617886|NCT03131687|561692483|FG001|Overall Study|Withdrawal by Subject|3|||
155617887|NCT03131687|561692484|FG002|Overall Study|Withdrawal by Subject|3|||
155617888|NCT03131687|561692485|FG003|Overall Study|Withdrawal by Subject|1|||
155617889|NCT03131687|561692486|FG004|Overall Study|Withdrawal by Subject|2|||
155617890|NCT03131687|561692487|FG005|Overall Study|Withdrawal by Subject|1|||
155617891|NCT03131687|561692482|FG000|Overall Study|Lost to Follow-up|1|||
155617892|NCT03131687|561692483|FG001|Overall Study|Lost to Follow-up|4|||
155617893|NCT03131687|561692484|FG002|Overall Study|Lost to Follow-up|0|||
155617894|NCT03131687|561692485|FG003|Overall Study|Lost to Follow-up|1|||
155617895|NCT03131687|561692486|FG004|Overall Study|Lost to Follow-up|4|||
155617896|NCT03131687|561692487|FG005|Overall Study|Lost to Follow-up|2|||
155617897|NCT03131687|561692482|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
155617898|NCT03131687|561692483|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
155617899|NCT03131687|561692484|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
155617900|NCT03131687|561692485|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
155617901|NCT03131687|561692486|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
155617902|NCT03131687|561692487|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
155617903|NCT03131687|561692482|FG000|Overall Study|Principle Investigator Decision|0|||
155617904|NCT03131687|561692483|FG001|Overall Study|Principle Investigator Decision|1|||
155617905|NCT03131687|561692484|FG002|Overall Study|Principle Investigator Decision|0|||
155617906|NCT03131687|561692485|FG003|Overall Study|Principle Investigator Decision|0|||
155617907|NCT03131687|561692486|FG004|Overall Study|Principle Investigator Decision|0|||
155617908|NCT03131687|561692487|FG005|Overall Study|Principle Investigator Decision|0|||
155617909|NCT03131687|561692482|FG000|Overall Study|Inadvertent Enrollment|0|||
155617910|NCT03131687|561692483|FG001|Overall Study|Inadvertent Enrollment|0|||
155617911|NCT03131687|561692484|FG002|Overall Study|Inadvertent Enrollment|0|||
155617912|NCT03131687|561692485|FG003|Overall Study|Inadvertent Enrollment|1|||
155617913|NCT03131687|561692486|FG004|Overall Study|Inadvertent Enrollment|0|||
155273044|NCT00119262|560432912|FG001|Overall Study|others|5|||
155273045|NCT00882921|560432918|FG000|Overall Study|Death|2|||
155617914|NCT03131687|561692487|FG005|Overall Study|Inadvertent Enrollment|0|||
155617915|NCT00656175|561692490|FG000|Overall Study|Adverse Event|1|||
155617916|NCT00656175|561692491|FG001|Overall Study|Adverse Event|0|||
155617917|NCT00656175|561692490|FG000|Overall Study|Transportation issues|0|||
155617918|NCT00656175|561692491|FG001|Overall Study|Transportation issues|1|||
155617919|NCT01868165|561692492|FG000|Overall Study|Withdrawal by Subject|36|||
155273046|NCT00882921|560432918|FG000|Overall Study|Other|3|||
155617920|NCT01868165|561692492|FG000|Overall Study|Physician Decision|2|||
155617921|NCT01868165|561692492|FG000|Overall Study|Lost to Follow-up|3|||
155617922|NCT01868165|561692492|FG000|Overall Study|Death|4|||
155617923|NCT01216332|561692493|FG000|Overall Study|Withdrawal by Subject|4|||
155617924|NCT01216332|561692494|FG001|Overall Study|Withdrawal by Subject|0|||
155617925|NCT01237327|561692495|FG000|Overall Study|Protocol Violation: Core Study|1|||
155617926|NCT01237327|561692496|FG001|Overall Study|Protocol Violation: Core Study|0|||
155617927|NCT01237327|561692495|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
155617928|NCT01237327|561692496|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
155617929|NCT01237327|561692495|FG000|Overall Study|Progression of Disease: Core Study|18|||
155617930|NCT01237327|561692496|FG001|Overall Study|Progression of Disease: Core Study|22|||
155617931|NCT01237327|561692495|FG000|Overall Study|Progression of Disease: Extension Study|15|||
155617932|NCT01237327|561692496|FG001|Overall Study|Progression of Disease: Extension Study|13|||
155617933|NCT01237327|561692495|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
155617934|NCT01237327|561692496|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
155617935|NCT01237327|561692495|FG000|Overall Study|Withdrawal by Subject|1|||
155617936|NCT01237327|561692496|FG001|Overall Study|Withdrawal by Subject|3|||
155617937|NCT01237327|561692495|FG000|Overall Study|Lost to Follow-up|3|||
155617938|NCT01237327|561692496|FG001|Overall Study|Lost to Follow-up|0|||
155617939|NCT03300180|561692497|FG000|Baseline|Withdrawal by Subject|4|||
155617940|NCT03300180|561692498|FG001|Baseline|Withdrawal by Subject|6|||
155617941|NCT03300180|561692499|FG002|Baseline|Withdrawal by Subject|4|||
155617942|NCT03300180|561692497|FG000|6 Month Outcome|Withdrawal by Subject|12|||
155617943|NCT03300180|561692498|FG001|6 Month Outcome|Withdrawal by Subject|12|||
155617944|NCT03300180|561692499|FG002|6 Month Outcome|Withdrawal by Subject|19|||
155617945|NCT03300180|561692497|FG000|6 Month Outcome|Death|2|||
155617946|NCT03300180|561692498|FG001|6 Month Outcome|Death|4|||
155617947|NCT03300180|561692499|FG002|6 Month Outcome|Death|3|||
155617948|NCT03300180|561692497|FG000|6 Month Outcome|Missed Assessment|43|||
155617949|NCT03300180|561692498|FG001|6 Month Outcome|Missed Assessment|52|||
155617950|NCT03300180|561692499|FG002|6 Month Outcome|Missed Assessment|46|||
155617951|NCT03300180|561692497|FG000|12 Month Outcome|Withdrawal by Subject|3|||
155617952|NCT03300180|561692498|FG001|12 Month Outcome|Withdrawal by Subject|6|||
155617953|NCT03300180|561692499|FG002|12 Month Outcome|Withdrawal by Subject|6|||
155617954|NCT03300180|561692497|FG000|12 Month Outcome|Death|9|||
155617955|NCT03300180|561692498|FG001|12 Month Outcome|Death|6|||
155617956|NCT03300180|561692499|FG002|12 Month Outcome|Death|6|||
155617957|NCT03300180|561692497|FG000|12 Month Outcome|Missed Assessment|62|||
155617958|NCT03300180|561692498|FG001|12 Month Outcome|Missed Assessment|59|||
155617959|NCT03300180|561692499|FG002|12 Month Outcome|Missed Assessment|58|||
155617960|NCT03300180|561692497|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
155617961|NCT03300180|561692498|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
155617962|NCT03300180|561692499|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
155617963|NCT03300180|561692497|FG000|18 Month Outcome Assessment|Death|8|||
155617964|NCT03300180|561692498|FG001|18 Month Outcome Assessment|Death|5|||
155617965|NCT03300180|561692499|FG002|18 Month Outcome Assessment|Death|5|||
155617966|NCT03300180|561692497|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
155617967|NCT03300180|561692498|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
155617968|NCT03300180|561692499|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
155617969|NCT03300180|561692497|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
155617970|NCT03300180|561692498|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
155617971|NCT03300180|561692499|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
155617972|NCT03300180|561692497|FG000|24 Month Outcome Assessment|Death|13|||
155617973|NCT03300180|561692498|FG001|24 Month Outcome Assessment|Death|13|||
155617974|NCT03300180|561692499|FG002|24 Month Outcome Assessment|Death|3|||
155617975|NCT03300180|561692497|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
155617976|NCT03300180|561692498|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
155617977|NCT03300180|561692499|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
155617978|NCT02557516|561692504|FG000|Overall Study|Adverse Event|1|||
155617979|NCT02557516|561692505|FG001|Overall Study|Adverse Event|0|||
155617980|NCT02557516|561692506|FG002|Overall Study|Adverse Event|2|||
155617981|NCT02557516|561692507|FG003|Overall Study|Adverse Event|1|||
155617982|NCT02557516|561692504|FG000|Overall Study|Disease progression|0|||
155617983|NCT02557516|561692505|FG001|Overall Study|Disease progression|2|||
155617984|NCT02557516|561692506|FG002|Overall Study|Disease progression|0|||
155617985|NCT02557516|561692507|FG003|Overall Study|Disease progression|0|||
155617986|NCT02557516|561692504|FG000|Overall Study|Physician Decision|0|||
155617987|NCT02557516|561692505|FG001|Overall Study|Physician Decision|2|||
155617988|NCT02557516|561692506|FG002|Overall Study|Physician Decision|0|||
155617989|NCT02557516|561692507|FG003|Overall Study|Physician Decision|0|||
155617990|NCT02557516|561692504|FG000|Overall Study|Sponsor decision|0|||
155617991|NCT02557516|561692505|FG001|Overall Study|Sponsor decision|1|||
155617992|NCT02557516|561692506|FG002|Overall Study|Sponsor decision|2|||
155617993|NCT02557516|561692507|FG003|Overall Study|Sponsor decision|8|||
155617994|NCT00103285|561694007|FG000|Induction|Adverse Event|14|||
155617995|NCT00103285|561694008|FG001|Induction|Adverse Event|0|||
155617996|NCT00103285|561694009|FG002|Induction|Adverse Event|0|||
155617997|NCT00103285|561694010|FG003|Induction|Adverse Event|0|||
155617998|NCT00103285|561694011|FG004|Induction|Adverse Event|0|||
155617999|NCT00103285|561694012|FG005|Induction|Adverse Event|0|||
155618000|NCT00103285|561694013|FG006|Induction|Adverse Event|0|||
155618001|NCT00103285|561694014|FG007|Induction|Adverse Event|0|||
155618002|NCT00103285|561694007|FG000|Induction|Death|24|||
155618003|NCT00103285|561694008|FG001|Induction|Death|0|||
155618004|NCT00103285|561694009|FG002|Induction|Death|0|||
155618005|NCT00103285|561694010|FG003|Induction|Death|0|||
155618006|NCT00103285|561694011|FG004|Induction|Death|0|||
155618007|NCT00103285|561694012|FG005|Induction|Death|0|||
155618008|NCT00103285|561694013|FG006|Induction|Death|0|||
155618009|NCT00103285|561694014|FG007|Induction|Death|0|||
155618010|NCT00103285|561694007|FG000|Induction|Physician Decision|103|||
155618011|NCT00103285|561694008|FG001|Induction|Physician Decision|0|||
155618012|NCT00103285|561694009|FG002|Induction|Physician Decision|0|||
155618013|NCT00103285|561694010|FG003|Induction|Physician Decision|0|||
155618014|NCT00103285|561694011|FG004|Induction|Physician Decision|0|||
155618015|NCT00103285|561694012|FG005|Induction|Physician Decision|0|||
155618016|NCT00103285|561694013|FG006|Induction|Physician Decision|0|||
155618017|NCT00103285|561694014|FG007|Induction|Physician Decision|0|||
155618018|NCT00103285|561694007|FG000|Induction|Withdrawal by Subject|1|||
155618019|NCT00103285|561694008|FG001|Induction|Withdrawal by Subject|0|||
155618020|NCT00103285|561694009|FG002|Induction|Withdrawal by Subject|0|||
155618021|NCT00103285|561694010|FG003|Induction|Withdrawal by Subject|0|||
155618022|NCT00103285|561694011|FG004|Induction|Withdrawal by Subject|0|||
155618023|NCT00103285|561694012|FG005|Induction|Withdrawal by Subject|0|||
155618024|NCT00103285|561694013|FG006|Induction|Withdrawal by Subject|0|||
155618025|NCT00103285|561694014|FG007|Induction|Withdrawal by Subject|0|||
155618026|NCT00103285|561694007|FG000|Induction|Ineligible|43|||
155618027|NCT00103285|561694008|FG001|Induction|Ineligible|0|||
155618028|NCT00103285|561694009|FG002|Induction|Ineligible|0|||
155618029|NCT00103285|561694010|FG003|Induction|Ineligible|0|||
155618030|NCT00103285|561694011|FG004|Induction|Ineligible|0|||
155618031|NCT00103285|561694012|FG005|Induction|Ineligible|0|||
155618032|NCT00103285|561694013|FG006|Induction|Ineligible|0|||
155618033|NCT00103285|561694014|FG007|Induction|Ineligible|0|||
155618034|NCT00103285|561694007|FG000|Induction|Refusal|906|||
155618035|NCT00103285|561694008|FG001|Induction|Refusal|0|||
155618036|NCT00103285|561694009|FG002|Induction|Refusal|0|||
155618037|NCT00103285|561694010|FG003|Induction|Refusal|0|||
155618038|NCT00103285|561694011|FG004|Induction|Refusal|0|||
155618039|NCT00103285|561694012|FG005|Induction|Refusal|0|||
155618040|NCT00103285|561694013|FG006|Induction|Refusal|0|||
155618041|NCT00103285|561694014|FG007|Induction|Refusal|0|||
155618042|NCT00103285|561694007|FG000|Induction|Other|258|||
155618043|NCT00103285|561694008|FG001|Induction|Other|0|||
155618044|NCT00103285|561694009|FG002|Induction|Other|0|||
155618045|NCT00103285|561694010|FG003|Induction|Other|0|||
155618046|NCT00103285|561694011|FG004|Induction|Other|0|||
155618047|NCT00103285|561694012|FG005|Induction|Other|0|||
155618048|NCT00103285|561694013|FG006|Induction|Other|0|||
155618049|NCT00103285|561694014|FG007|Induction|Other|0|||
155618050|NCT00103285|561694007|FG000|Response Assignment|Adverse Event|0|||
155618051|NCT00103285|561694008|FG001|Response Assignment|Adverse Event|8|||
155618052|NCT00103285|561694009|FG002|Response Assignment|Adverse Event|3|||
155618053|NCT00103285|561694010|FG003|Response Assignment|Adverse Event|2|||
155618054|NCT00103285|561694011|FG004|Response Assignment|Adverse Event|3|||
155618055|NCT00103285|561694012|FG005|Response Assignment|Adverse Event|1|||
155618056|NCT00103285|561694013|FG006|Response Assignment|Adverse Event|1|||
155273047|NCT00882921|560432918|FG000|Overall Study|Lost to Follow-up|2|||
155618057|NCT00103285|561694014|FG007|Response Assignment|Adverse Event|2|||
155618058|NCT00103285|561694007|FG000|Response Assignment|Death|0|||
155618059|NCT00103285|561694008|FG001|Response Assignment|Death|5|||
155273048|NCT00882921|560432918|FG000|Overall Study|Termination By Investigator|3|||
155273049|NCT00882921|560432918|FG000|Overall Study|Withdrawal Of Consent|1|||
155618060|NCT00103285|561694009|FG002|Response Assignment|Death|2|||
155618061|NCT00103285|561694010|FG003|Response Assignment|Death|2|||
155618062|NCT00103285|561694011|FG004|Response Assignment|Death|3|||
155618063|NCT00103285|561694012|FG005|Response Assignment|Death|1|||
155618064|NCT00103285|561694013|FG006|Response Assignment|Death|0|||
155618065|NCT00103285|561694014|FG007|Response Assignment|Death|8|||
155618066|NCT00103285|561694007|FG000|Response Assignment|Lost to Follow-up|0|||
155618067|NCT00103285|561694008|FG001|Response Assignment|Lost to Follow-up|9|||
155273050|NCT02302066|560432919|FG000|Overall Study|Adverse Event|1|||
155618068|NCT00103285|561694009|FG002|Response Assignment|Lost to Follow-up|5|||
155618069|NCT00103285|561694010|FG003|Response Assignment|Lost to Follow-up|5|||
155618070|NCT00103285|561694011|FG004|Response Assignment|Lost to Follow-up|1|||
155618071|NCT00103285|561694012|FG005|Response Assignment|Lost to Follow-up|2|||
155618072|NCT00103285|561694013|FG006|Response Assignment|Lost to Follow-up|2|||
155618073|NCT00103285|561694014|FG007|Response Assignment|Lost to Follow-up|5|||
155618074|NCT00103285|561694007|FG000|Response Assignment|Physician Decision|0|||
155618075|NCT00103285|561694008|FG001|Response Assignment|Physician Decision|13|||
155618076|NCT00103285|561694009|FG002|Response Assignment|Physician Decision|14|||
155618077|NCT00103285|561694010|FG003|Response Assignment|Physician Decision|9|||
155618078|NCT00103285|561694011|FG004|Response Assignment|Physician Decision|13|||
155618079|NCT00103285|561694012|FG005|Response Assignment|Physician Decision|7|||
155618080|NCT00103285|561694013|FG006|Response Assignment|Physician Decision|4|||
155618081|NCT00103285|561694014|FG007|Response Assignment|Physician Decision|35|||
155618082|NCT00103285|561694007|FG000|Response Assignment|Protocol Violation|0|||
155618083|NCT00103285|561694008|FG001|Response Assignment|Protocol Violation|2|||
155618084|NCT00103285|561694009|FG002|Response Assignment|Protocol Violation|0|||
155618085|NCT00103285|561694010|FG003|Response Assignment|Protocol Violation|0|||
155618086|NCT00103285|561694011|FG004|Response Assignment|Protocol Violation|0|||
155618087|NCT00103285|561694012|FG005|Response Assignment|Protocol Violation|0|||
155618088|NCT00103285|561694013|FG006|Response Assignment|Protocol Violation|0|||
155618089|NCT00103285|561694014|FG007|Response Assignment|Protocol Violation|0|||
155618090|NCT00103285|561694007|FG000|Response Assignment|Withdrawal by Subject|0|||
155618091|NCT00103285|561694008|FG001|Response Assignment|Withdrawal by Subject|4|||
155618092|NCT00103285|561694009|FG002|Response Assignment|Withdrawal by Subject|1|||
155618093|NCT00103285|561694010|FG003|Response Assignment|Withdrawal by Subject|1|||
155618094|NCT00103285|561694011|FG004|Response Assignment|Withdrawal by Subject|2|||
155618095|NCT00103285|561694012|FG005|Response Assignment|Withdrawal by Subject|2|||
155618096|NCT00103285|561694013|FG006|Response Assignment|Withdrawal by Subject|0|||
155618097|NCT00103285|561694014|FG007|Response Assignment|Withdrawal by Subject|2|||
155618098|NCT00103285|561694007|FG000|Response Assignment|Ineligible|0|||
155618099|NCT00103285|561694008|FG001|Response Assignment|Ineligible|8|||
155618100|NCT00103285|561694009|FG002|Response Assignment|Ineligible|6|||
155618101|NCT00103285|561694010|FG003|Response Assignment|Ineligible|2|||
155618102|NCT00103285|561694011|FG004|Response Assignment|Ineligible|0|||
155618103|NCT00103285|561694012|FG005|Response Assignment|Ineligible|3|||
155618104|NCT00103285|561694013|FG006|Response Assignment|Ineligible|1|||
155618105|NCT00103285|561694014|FG007|Response Assignment|Ineligible|5|||
155618106|NCT00103285|561694007|FG000|Response Assignment|Refusal|0|||
155618107|NCT00103285|561694008|FG001|Response Assignment|Refusal|53|||
155618108|NCT00103285|561694009|FG002|Response Assignment|Refusal|5|||
155618109|NCT00103285|561694010|FG003|Response Assignment|Refusal|3|||
155618110|NCT00103285|561694011|FG004|Response Assignment|Refusal|25|||
155618111|NCT00103285|561694012|FG005|Response Assignment|Refusal|15|||
155618112|NCT00103285|561694013|FG006|Response Assignment|Refusal|30|||
155618113|NCT00103285|561694014|FG007|Response Assignment|Refusal|10|||
155618114|NCT00103285|561694007|FG000|Response Assignment|Other|0|||
155618115|NCT00103285|561694008|FG001|Response Assignment|Other|30|||
155618116|NCT00103285|561694009|FG002|Response Assignment|Other|48|||
155618117|NCT00103285|561694010|FG003|Response Assignment|Other|38|||
155618118|NCT00103285|561694011|FG004|Response Assignment|Other|37|||
155618119|NCT00103285|561694012|FG005|Response Assignment|Other|17|||
155618120|NCT00103285|561694013|FG006|Response Assignment|Other|11|||
155618121|NCT00103285|561694014|FG007|Response Assignment|Other|53|||
155618122|NCT01919164|561694020|FG000|Overall Study|Adverse Event|6|||
155618123|NCT01919164|561694021|FG001|Overall Study|Adverse Event|4|||
155618124|NCT01919164|561694022|FG002|Overall Study|Adverse Event|9|||
155618125|NCT01919164|561694023|FG003|Overall Study|Adverse Event|3|||
155618126|NCT01919164|561694024|FG004|Overall Study|Adverse Event|2|||
155618127|NCT01919164|561694020|FG000|Overall Study|Lost to Follow-up|2|||
155618128|NCT01919164|561694021|FG001|Overall Study|Lost to Follow-up|2|||
155618129|NCT01919164|561694022|FG002|Overall Study|Lost to Follow-up|2|||
155618130|NCT01919164|561694023|FG003|Overall Study|Lost to Follow-up|0|||
155618131|NCT01919164|561694024|FG004|Overall Study|Lost to Follow-up|4|||
155618132|NCT01919164|561694020|FG000|Overall Study|Death|1|||
155618133|NCT01919164|561694021|FG001|Overall Study|Death|0|||
155618134|NCT01919164|561694022|FG002|Overall Study|Death|0|||
155618135|NCT01919164|561694023|FG003|Overall Study|Death|0|||
155618136|NCT01919164|561694024|FG004|Overall Study|Death|0|||
155618137|NCT01919164|561694020|FG000|Overall Study|Protocol Violation|6|||
155618138|NCT01919164|561694021|FG001|Overall Study|Protocol Violation|0|||
155618139|NCT01919164|561694022|FG002|Overall Study|Protocol Violation|3|||
155618140|NCT01919164|561694023|FG003|Overall Study|Protocol Violation|2|||
155618141|NCT01919164|561694024|FG004|Overall Study|Protocol Violation|2|||
155618142|NCT01919164|561694020|FG000|Overall Study|Disease progression|2|||
155618143|NCT01919164|561694021|FG001|Overall Study|Disease progression|2|||
155618144|NCT01919164|561694022|FG002|Overall Study|Disease progression|1|||
155618145|NCT01919164|561694023|FG003|Overall Study|Disease progression|2|||
155618146|NCT01919164|561694024|FG004|Overall Study|Disease progression|1|||
155618147|NCT01919164|561694020|FG000|Overall Study|Withdrew consent|13|||
155618148|NCT01919164|561694021|FG001|Overall Study|Withdrew consent|13|||
155618149|NCT01919164|561694022|FG002|Overall Study|Withdrew consent|14|||
155618150|NCT01919164|561694023|FG003|Overall Study|Withdrew consent|14|||
155618151|NCT01919164|561694024|FG004|Overall Study|Withdrew consent|9|||
155618152|NCT01919164|561694020|FG000|Overall Study|Other Un-specified|13|||
155618153|NCT01919164|561694021|FG001|Overall Study|Other Un-specified|9|||
155618154|NCT01919164|561694022|FG002|Overall Study|Other Un-specified|8|||
155618155|NCT01919164|561694023|FG003|Overall Study|Other Un-specified|7|||
155618156|NCT01919164|561694024|FG004|Overall Study|Other Un-specified|15|||
155618157|NCT00588146|561694026|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
155618158|NCT00588146|561694027|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
155618159|NCT02100839|561694028|FG000|Multiple Ascending Dose|Adverse Event|2|||
155618160|NCT02100839|561694029|FG001|Multiple Ascending Dose|Adverse Event|0|||
155618161|NCT02100839|561694028|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
155618162|NCT02100839|561694029|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
155618163|NCT03272347|561694033|FG000|Overall Study|Death|0|||
155618164|NCT03272347|561694034|FG001|Overall Study|Death|0|||
155618165|NCT03272347|561694035|FG002|Overall Study|Death|0|||
155618166|NCT03272347|561694036|FG003|Overall Study|Death|1|||
155618167|NCT03272347|561694033|FG000|Overall Study|Lost to Follow-up|1|||
155618168|NCT03272347|561694034|FG001|Overall Study|Lost to Follow-up|3|||
155618169|NCT03272347|561694035|FG002|Overall Study|Lost to Follow-up|5|||
155618170|NCT03272347|561694036|FG003|Overall Study|Lost to Follow-up|1|||
155618171|NCT03272347|561694033|FG000|Overall Study|Physician Decision|4|||
155618172|NCT03272347|561694034|FG001|Overall Study|Physician Decision|2|||
155618173|NCT03272347|561694035|FG002|Overall Study|Physician Decision|5|||
155618174|NCT03272347|561694036|FG003|Overall Study|Physician Decision|4|||
155618175|NCT03272347|561694033|FG000|Overall Study|Screen Failure|1|||
155618176|NCT03272347|561694034|FG001|Overall Study|Screen Failure|0|||
155618177|NCT03272347|561694035|FG002|Overall Study|Screen Failure|0|||
155618178|NCT03272347|561694036|FG003|Overall Study|Screen Failure|0|||
155618179|NCT03272347|561694033|FG000|Overall Study|Withdrawal by Subject|5|||
155618180|NCT03272347|561694034|FG001|Overall Study|Withdrawal by Subject|1|||
155618181|NCT03272347|561694035|FG002|Overall Study|Withdrawal by Subject|2|||
155618182|NCT03272347|561694036|FG003|Overall Study|Withdrawal by Subject|1|||
155618183|NCT00940888|561694037|FG000|Overall Study|Unsuccessful Implant|4|||
155618184|NCT00940888|561694037|FG000|Overall Study|Death|461|||
155618185|NCT00940888|561694037|FG000|Overall Study|Withdrawn - Non-Death|364|||
155618186|NCT00940888|561694037|FG000|Overall Study|Lost to Follow-up|6|||
155618187|NCT00391872|561694039|FG000|Overall Study|Protocol Violation|7|||
155618188|NCT00391872|561694040|FG001|Overall Study|Protocol Violation|2|||
155618189|NCT00391872|561694039|FG000|Overall Study|Withdrawal by Subject|296|||
155618190|NCT00391872|561694040|FG001|Overall Study|Withdrawal by Subject|249|||
155618191|NCT00391872|561694039|FG000|Overall Study|Reason unknown|2|||
155618192|NCT00391872|561694040|FG001|Overall Study|Reason unknown|4|||
155618193|NCT00391872|561694039|FG000|Overall Study|Lost to Follow-up|2|||
155618194|NCT00391872|561694040|FG001|Overall Study|Lost to Follow-up|0|||
155618195|NCT01409915|561694041|FG000|Overall Study|Adverse Event|0|||
155618196|NCT01409915|561694042|FG001|Overall Study|Adverse Event|2|||
155618197|NCT01409915|561694041|FG000|Overall Study|Withdrawal by Subject|0|||
155618198|NCT01409915|561694042|FG001|Overall Study|Withdrawal by Subject|1|||
155618199|NCT01409915|561694041|FG000|Overall Study|Protocol Violation|1|||
155618200|NCT01409915|561694042|FG001|Overall Study|Protocol Violation|0|||
155618201|NCT01239394|561694043|FG000|Overall Study|Adverse Event|1|||
155618202|NCT01000974|561694050|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
155618203|NCT01000974|561694051|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
155618204|NCT01000974|561694052|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
155618205|NCT01000974|561694050|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
155618206|NCT01000974|561694051|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
155618207|NCT01000974|561694052|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
155618208|NCT01000974|561694050|FG000|Primary Vaccination Phase|Protocol Violation|40|||
155618209|NCT01000974|561694051|FG001|Primary Vaccination Phase|Protocol Violation|3|||
155618210|NCT01000974|561694052|FG002|Primary Vaccination Phase|Protocol Violation|2|||
155618211|NCT01000974|561694050|FG000|Primary Vaccination Phase|Adverse Event|14|||
155618212|NCT01000974|561694051|FG001|Primary Vaccination Phase|Adverse Event|2|||
155618213|NCT01000974|561694052|FG002|Primary Vaccination Phase|Adverse Event|2|||
155618214|NCT01000974|561694050|FG000|Primary Vaccination Phase|Other|4|||
155618215|NCT01000974|561694051|FG001|Primary Vaccination Phase|Other|9|||
155618216|NCT01000974|561694052|FG002|Primary Vaccination Phase|Other|12|||
155618217|NCT01000974|561694050|FG000|Booster Vaccination Phase|Protocol Violation|0|||
155618218|NCT01000974|561694051|FG001|Booster Vaccination Phase|Protocol Violation|0|||
155618219|NCT01000974|561694052|FG002|Booster Vaccination Phase|Protocol Violation|2|||
155618220|NCT01000974|561694050|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
155618221|NCT01000974|561694051|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
155618222|NCT01000974|561694052|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
155618223|NCT01000974|561694050|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
155618224|NCT01000974|561694051|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
155618225|NCT01000974|561694052|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
155618226|NCT01000974|561694050|FG000|Booster Vaccination Phase|Other|24|||
155618227|NCT01000974|561694051|FG001|Booster Vaccination Phase|Other|6|||
155618228|NCT01000974|561694052|FG002|Booster Vaccination Phase|Other|4|||
155618229|NCT01307891|561694054|FG000|Overall Study|Progressive Disease|3|||
155618230|NCT01307891|561694055|FG001|Overall Study|Progressive Disease|1|||
155618231|NCT03365934|561694056|FG000|Overall Study|Adverse Event|1|||
155618232|NCT03365934|561694056|FG000|Overall Study|Withdrawal by Subject|1|||
155618233|NCT02937740|561694057|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
155618234|NCT02937740|561694058|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
155618235|NCT02937740|561694057|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
155618236|NCT02937740|561694058|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
155618237|NCT02937740|561694057|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
155618238|NCT02937740|561694058|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
155618239|NCT02937740|561694057|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
155618240|NCT02937740|561694058|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
155618241|NCT02937740|561694057|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
155618242|NCT02937740|561694058|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
155618243|NCT02937740|561694057|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
155618244|NCT02937740|561694058|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
155618245|NCT04194489|561694059|FG000|Overall Study|Withdrawal by Subject|5|||
155618246|NCT04194489|561694059|FG000|Overall Study|Lost to Follow-up|48|||
155618247|NCT02291029|561694062|FG000|Overall Study|Withdrawal by Subject|0|||
155618248|NCT02291029|561694063|FG001|Overall Study|Withdrawal by Subject|0|||
155618249|NCT02291029|561694064|FG002|Overall Study|Withdrawal by Subject|1|||
155618250|NCT02291029|561694065|FG003|Overall Study|Withdrawal by Subject|0|||
155618251|NCT02291029|561694066|FG004|Overall Study|Withdrawal by Subject|0|||
155618252|NCT02291029|561694067|FG005|Overall Study|Withdrawal by Subject|0|||
155618253|NCT02291029|561694062|FG000|Overall Study|Adverse Event|0|||
155618254|NCT02291029|561694063|FG001|Overall Study|Adverse Event|1|||
155618255|NCT02291029|561694064|FG002|Overall Study|Adverse Event|0|||
155618256|NCT02291029|561694065|FG003|Overall Study|Adverse Event|0|||
155618257|NCT02291029|561694066|FG004|Overall Study|Adverse Event|0|||
155618258|NCT02291029|561694067|FG005|Overall Study|Adverse Event|0|||
155618259|NCT00377637|561694068|FG000|Induction Phase|Adverse Event|12|||
155273051|NCT02302066|560432920|FG001|Overall Study|Adverse Event|1|||
155273052|NCT02302066|560432921|FG002|Overall Study|Adverse Event|3|||
155273053|NCT02302066|560432922|FG003|Overall Study|Adverse Event|0|||
155273054|NCT02302066|560432919|FG000|Overall Study|Lost to Follow-up|4|||
155273055|NCT02302066|560432920|FG001|Overall Study|Lost to Follow-up|5|||
155273056|NCT02302066|560432921|FG002|Overall Study|Lost to Follow-up|24|||
155618260|NCT00377637|561694069|FG001|Induction Phase|Adverse Event|21|||
155618261|NCT00377637|561694070|FG002|Induction Phase|Adverse Event|0|||
155618262|NCT00377637|561694071|FG003|Induction Phase|Adverse Event|0|||
155618263|NCT00377637|561694068|FG000|Induction Phase|Deterioration/serum creatinine|2|||
155618264|NCT00377637|561694069|FG001|Induction Phase|Deterioration/serum creatinine|0|||
155618265|NCT00377637|561694070|FG002|Induction Phase|Deterioration/serum creatinine|0|||
155618266|NCT00377637|561694071|FG003|Induction Phase|Deterioration/serum creatinine|0|||
155618267|NCT00377637|561694068|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155618268|NCT00377637|561694069|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
155618269|NCT00377637|561694070|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155618270|NCT00377637|561694071|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155618271|NCT00377637|561694068|FG000|Induction Phase|Lost to Follow-up|2|||
155618272|NCT00377637|561694069|FG001|Induction Phase|Lost to Follow-up|1|||
155618273|NCT00377637|561694070|FG002|Induction Phase|Lost to Follow-up|0|||
155618274|NCT00377637|561694071|FG003|Induction Phase|Lost to Follow-up|0|||
155618275|NCT00377637|561694068|FG000|Induction Phase|Death|1|||
155618276|NCT00377637|561694069|FG001|Induction Phase|Death|3|||
155618277|NCT00377637|561694070|FG002|Induction Phase|Death|0|||
155618278|NCT00377637|561694071|FG003|Induction Phase|Death|0|||
155618279|NCT00377637|561694068|FG000|Induction Phase|Withdrawal by Subject|5|||
155618280|NCT00377637|561694069|FG001|Induction Phase|Withdrawal by Subject|6|||
155618281|NCT00377637|561694070|FG002|Induction Phase|Withdrawal by Subject|0|||
155618282|NCT00377637|561694071|FG003|Induction Phase|Withdrawal by Subject|0|||
155273057|NCT02302066|560432922|FG003|Overall Study|Lost to Follow-up|7|||
155273058|NCT02302066|560432919|FG000|Overall Study|Withdrawal by Subject|25|||
155273059|NCT02302066|560432920|FG001|Overall Study|Withdrawal by Subject|58|||
155273060|NCT02302066|560432921|FG002|Overall Study|Withdrawal by Subject|124|||
155273061|NCT02302066|560432922|FG003|Overall Study|Withdrawal by Subject|33|||
155273062|NCT02302066|560432919|FG000|Overall Study|Pregnancy|2|||
155726809|NCT00129402|562099799|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155273063|NCT02302066|560432920|FG001|Overall Study|Pregnancy|10|||
155273064|NCT02302066|560432921|FG002|Overall Study|Pregnancy|12|||
155273065|NCT02302066|560432922|FG003|Overall Study|Pregnancy|0|||
155618283|NCT00377637|561694068|FG000|Induction Phase|Physician Decision|3|||
155618284|NCT00377637|561694069|FG001|Induction Phase|Physician Decision|1|||
155618285|NCT00377637|561694070|FG002|Induction Phase|Physician Decision|0|||
155618286|NCT00377637|561694071|FG003|Induction Phase|Physician Decision|0|||
155618287|NCT00377637|561694068|FG000|Induction Phase|Sponsor decision|1|||
155618288|NCT00377637|561694069|FG001|Induction Phase|Sponsor decision|2|||
155618289|NCT00377637|561694070|FG002|Induction Phase|Sponsor decision|0|||
155618290|NCT00377637|561694071|FG003|Induction Phase|Sponsor decision|0|||
155618291|NCT00377637|561694068|FG000|Induction Phase|Non-Compliance|1|||
155726810|NCT00129402|562099800|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155273066|NCT02302066|560432919|FG000|Overall Study|Reason Not Specified|1|||
155618292|NCT00377637|561694069|FG001|Induction Phase|Non-Compliance|0|||
155618293|NCT00377637|561694070|FG002|Induction Phase|Non-Compliance|0|||
155618294|NCT00377637|561694071|FG003|Induction Phase|Non-Compliance|0|||
155618295|NCT00377637|561694068|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
155618296|NCT00377637|561694069|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
155618297|NCT00377637|561694070|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
155618298|NCT00377637|561694071|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
155618299|NCT00377637|561694068|FG000|Maintenance Phase|Adverse Event|0|||
155618300|NCT00377637|561694069|FG001|Maintenance Phase|Adverse Event|0|||
155618301|NCT00377637|561694070|FG002|Maintenance Phase|Adverse Event|29|||
155618302|NCT00377637|561694071|FG003|Maintenance Phase|Adverse Event|43|||
155618303|NCT00377637|561694068|FG000|Maintenance Phase|Physician Decision|0|||
155618304|NCT00377637|561694069|FG001|Maintenance Phase|Physician Decision|0|||
155618305|NCT00377637|561694070|FG002|Maintenance Phase|Physician Decision|5|||
155618306|NCT00377637|561694071|FG003|Maintenance Phase|Physician Decision|4|||
155618307|NCT00377637|561694068|FG000|Maintenance Phase|Lost to Follow-up|0|||
155618308|NCT00377637|561694069|FG001|Maintenance Phase|Lost to Follow-up|0|||
155618309|NCT00377637|561694070|FG002|Maintenance Phase|Lost to Follow-up|3|||
155618310|NCT00377637|561694071|FG003|Maintenance Phase|Lost to Follow-up|1|||
155618311|NCT00377637|561694068|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155618312|NCT00377637|561694069|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155618313|NCT00377637|561694070|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155618314|NCT00377637|561694071|FG003|Maintenance Phase|Withdrawal by Subject|3|||
155618315|NCT00377637|561694068|FG000|Maintenance Phase|Sponsor decision|0|||
155618316|NCT00377637|561694069|FG001|Maintenance Phase|Sponsor decision|0|||
155618317|NCT00377637|561694070|FG002|Maintenance Phase|Sponsor decision|2|||
155618318|NCT00377637|561694071|FG003|Maintenance Phase|Sponsor decision|3|||
155618319|NCT00377637|561694068|FG000|Maintenance Phase|Non-compliance|0|||
155618320|NCT00377637|561694069|FG001|Maintenance Phase|Non-compliance|0|||
155618321|NCT00377637|561694070|FG002|Maintenance Phase|Non-compliance|1|||
155618322|NCT00377637|561694071|FG003|Maintenance Phase|Non-compliance|1|||
155618323|NCT00377637|561694068|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
155618324|NCT00377637|561694069|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
155618325|NCT00377637|561694070|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
155618326|NCT00377637|561694071|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
155618327|NCT00377637|561694068|FG000|Maintenance Phase|Death|0|||
155618328|NCT00377637|561694069|FG001|Maintenance Phase|Death|0|||
155618329|NCT00377637|561694070|FG002|Maintenance Phase|Death|0|||
155618330|NCT00377637|561694071|FG003|Maintenance Phase|Death|1|||
155618331|NCT04147247|561694072|FG000|Overall Study|Progressive disease|3|||
155618332|NCT04147247|561694073|FG001|Overall Study|Progressive disease|3|||
155618333|NCT04147247|561694074|FG002|Overall Study|Progressive disease|4|||
155618334|NCT04147247|561694075|FG003|Overall Study|Progressive disease|4|||
155618335|NCT04147247|561694076|FG004|Overall Study|Progressive disease|3|||
155618336|NCT04147247|561694072|FG000|Overall Study|Physician Decision|0|||
155618337|NCT04147247|561694073|FG001|Overall Study|Physician Decision|1|||
155618338|NCT04147247|561694074|FG002|Overall Study|Physician Decision|0|||
155618339|NCT04147247|561694075|FG003|Overall Study|Physician Decision|0|||
155618340|NCT04147247|561694076|FG004|Overall Study|Physician Decision|0|||
155618341|NCT04147247|561694072|FG000|Overall Study|Clinical Disease Progression|0|||
155618342|NCT04147247|561694073|FG001|Overall Study|Clinical Disease Progression|0|||
155618343|NCT04147247|561694074|FG002|Overall Study|Clinical Disease Progression|0|||
155618344|NCT04147247|561694075|FG003|Overall Study|Clinical Disease Progression|0|||
155618345|NCT04147247|561694076|FG004|Overall Study|Clinical Disease Progression|1|||
155618346|NCT04147247|561694072|FG000|Overall Study|Adverse Event|0|||
155618347|NCT04147247|561694073|FG001|Overall Study|Adverse Event|0|||
155618348|NCT04147247|561694074|FG002|Overall Study|Adverse Event|1|||
155618349|NCT04147247|561694075|FG003|Overall Study|Adverse Event|0|||
155618350|NCT04147247|561694076|FG004|Overall Study|Adverse Event|1|||
155618351|NCT00823264|561694077|FG000|Overall Study|Protocol Violation|2|||
155618352|NCT00823264|561694078|FG001|Overall Study|Protocol Violation|0|||
155618353|NCT01714544|561694079|FG000|Overall Study|Lost to Follow-up|1|||
155618354|NCT01714544|561694079|FG000|Overall Study|Physician Decision|1|||
155273067|NCT02302066|560432920|FG001|Overall Study|Reason Not Specified|1|||
155273068|NCT02302066|560432921|FG002|Overall Study|Reason Not Specified|9|||
155618355|NCT01714544|561694079|FG000|Overall Study|Withdrawal by Subject|1|||
155618356|NCT00666211|561694080|FG000|Overall Study|Withdrawal by Subject|10|||
155618357|NCT00666211|561694081|FG001|Overall Study|Withdrawal by Subject|13|||
155618358|NCT00666211|561694080|FG000|Overall Study|went off medication, no more pain|1|||
155618359|NCT00666211|561694081|FG001|Overall Study|went off medication, no more pain|0|||
155618360|NCT00666211|561694080|FG000|Overall Study|patient non-compliant|6|||
155618361|NCT00666211|561694081|FG001|Overall Study|patient non-compliant|6|||
155618362|NCT00666211|561694080|FG000|Overall Study|disease progression|1|||
155618363|NCT00666211|561694081|FG001|Overall Study|disease progression|8|||
155618364|NCT00666211|561694080|FG000|Overall Study|Lost to Follow-up|2|||
155618365|NCT00666211|561694081|FG001|Overall Study|Lost to Follow-up|0|||
155618366|NCT00666211|561694080|FG000|Overall Study|toxicity|0|||
155618367|NCT00666211|561694081|FG001|Overall Study|toxicity|2|||
155618368|NCT00666211|561694080|FG000|Overall Study|hospital admission|0|||
155618369|NCT00666211|561694081|FG001|Overall Study|hospital admission|5|||
155618370|NCT00666211|561694080|FG000|Overall Study|Death|0|||
155618371|NCT00666211|561694081|FG001|Overall Study|Death|2|||
155618372|NCT00666211|561694080|FG000|Overall Study|off tx for other complicating disease|0|||
155618373|NCT00666211|561694081|FG001|Overall Study|off tx for other complicating disease|1|||
155618374|NCT00666211|561694080|FG000|Overall Study|Physician Decision|0|||
155618375|NCT00666211|561694081|FG001|Overall Study|Physician Decision|1|||
155618376|NCT03373760|561694086|FG000|Overall Study|Adverse Event|8|||
155618377|NCT03373760|561694086|FG000|Overall Study|Disease Progression|46|||
155618378|NCT03373760|561694086|FG000|Overall Study|Death|4|||
155618379|NCT00003537|561694089|FG000|Overall Study|Not evalauable|1|||
155618380|NCT02907463|561694090|FG000|Overall Study|Lost to Follow-up|17|||
155618381|NCT02907463|561694090|FG000|Overall Study|Death|10|||
155618382|NCT02907463|561694090|FG000|Overall Study|Withdrawal by Subject|4|||
155618383|NCT02907463|561694090|FG000|Overall Study|MIS Approach was not used|2|||
155618384|NCT02907463|561694090|FG000|Overall Study|Not Implanted with Study Device|2|||
155618385|NCT02907463|561694090|FG000|Overall Study|Device Explanted|1|||
155618386|NCT02907463|561694090|FG000|Overall Study|Missing Exit Form|1|||
155618387|NCT01447407|561694094|FG000|Overall Study|Withdrawal by Subject|2|||
155618388|NCT01447407|561694095|FG001|Overall Study|Withdrawal by Subject|0|||
155618389|NCT01447407|561694096|FG002|Overall Study|Withdrawal by Subject|0|||
155618390|NCT01447407|561694097|FG003|Overall Study|Withdrawal by Subject|1|||
155618391|NCT01447407|561694094|FG000|Overall Study|Physician Decision|0|||
155618392|NCT01447407|561694095|FG001|Overall Study|Physician Decision|0|||
155618393|NCT01447407|561694096|FG002|Overall Study|Physician Decision|1|||
155618394|NCT01447407|561694097|FG003|Overall Study|Physician Decision|1|||
155618395|NCT00875563|561694101|FG000|Overall Study|Death|4|||
155618396|NCT00875563|561694101|FG000|Overall Study|Withdrawal by Subject|7|||
155618397|NCT00875563|561694101|FG000|Overall Study|No long-term (3-5 year) consent|6|||
155618398|NCT00875563|561694101|FG000|Overall Study|Still be eligible for follow-up|7|||
155618399|NCT00313846|561694102|FG000|Overall Study|Withdrawal by Subject|2|||
155618400|NCT00313846|561694103|FG001|Overall Study|Withdrawal by Subject|0|||
155618401|NCT00313846|561694102|FG000|Overall Study|Adverse Event|1|||
155618402|NCT00313846|561694103|FG001|Overall Study|Adverse Event|8|||
155618403|NCT00313846|561694102|FG000|Overall Study|Administrative|2|||
155618404|NCT00313846|561694103|FG001|Overall Study|Administrative|3|||
155618405|NCT03478371|561694104|FG000|Overall Study|non-compliance|1|||
155618406|NCT03478371|561694104|FG000|Overall Study|Lost to Follow-up|4|||
155618407|NCT06060496|561694108|FG000|Overall Study|Withdrawal by Subject|2|||
155618408|NCT06060496|561694108|FG000|Overall Study|Lost to Follow-up|2|||
155618409|NCT02028507|561694109|FG000|Overall Study|Progressive Disease|122|||
155618410|NCT02028507|561694110|FG001|Overall Study|Progressive Disease|90|||
155618411|NCT02028507|561694111|FG002|Overall Study|Progressive Disease|102|||
155618412|NCT02028507|561694112|FG003|Overall Study|Progressive Disease|89|||
155618413|NCT02028507|561694109|FG000|Overall Study|Adverse Event|8|||
155618414|NCT02028507|561694110|FG001|Overall Study|Adverse Event|25|||
155618415|NCT02028507|561694111|FG002|Overall Study|Adverse Event|3|||
155618416|NCT02028507|561694112|FG003|Overall Study|Adverse Event|16|||
155618417|NCT02028507|561694109|FG000|Overall Study|Withdrawal by Subject|6|||
155618418|NCT02028507|561694110|FG001|Overall Study|Withdrawal by Subject|8|||
155618419|NCT02028507|561694111|FG002|Overall Study|Withdrawal by Subject|5|||
155618420|NCT02028507|561694112|FG003|Overall Study|Withdrawal by Subject|9|||
155618421|NCT02028507|561694109|FG000|Overall Study|Protocol Violation|2|||
155618422|NCT02028507|561694110|FG001|Overall Study|Protocol Violation|4|||
155618423|NCT02028507|561694111|FG002|Overall Study|Protocol Violation|1|||
155618424|NCT02028507|561694112|FG003|Overall Study|Protocol Violation|3|||
155618425|NCT02028507|561694109|FG000|Overall Study|Physician Decision|0|||
155618426|NCT02028507|561694110|FG001|Overall Study|Physician Decision|4|||
155618427|NCT02028507|561694111|FG002|Overall Study|Physician Decision|0|||
155618428|NCT02028507|561694112|FG003|Overall Study|Physician Decision|0|||
155618429|NCT02028507|561694109|FG000|Overall Study|Death|1|||
155618430|NCT02028507|561694110|FG001|Overall Study|Death|0|||
155618431|NCT02028507|561694111|FG002|Overall Study|Death|1|||
155618432|NCT02028507|561694112|FG003|Overall Study|Death|3|||
155618433|NCT02028507|561694109|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
155618434|NCT02028507|561694110|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
155618435|NCT02028507|561694111|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
155618436|NCT02028507|561694112|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
155618437|NCT02028507|561694109|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
155618438|NCT02028507|561694110|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
155618439|NCT02028507|561694111|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
155618440|NCT02028507|561694112|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
155618441|NCT02028507|561694109|FG000|Overall Study|Randomized But Not Treated|3|||
155618442|NCT02028507|561694110|FG001|Overall Study|Randomized But Not Treated|6|||
155618443|NCT02028507|561694111|FG002|Overall Study|Randomized But Not Treated|0|||
155618444|NCT02028507|561694112|FG003|Overall Study|Randomized But Not Treated|4|||
155618445|NCT02028507|561694109|FG000|Overall Study|Enzyme defect|0|||
155618446|NCT02028507|561694110|FG001|Overall Study|Enzyme defect|0|||
155618447|NCT02028507|561694111|FG002|Overall Study|Enzyme defect|0|||
155618448|NCT02028507|561694112|FG003|Overall Study|Enzyme defect|1|||
155618449|NCT02028507|561694109|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155618450|NCT02028507|561694110|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155618451|NCT02028507|561694111|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155618452|NCT02028507|561694112|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
155618453|NCT02028507|561694109|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
155618454|NCT02028507|561694110|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
155618455|NCT02028507|561694111|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
155618456|NCT02028507|561694112|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
155618457|NCT01556932|561694113|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
155618458|NCT01556932|561694114|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
155618459|NCT00991289|561694117|FG000|Overall Study|Adverse Event|1|||
155618460|NCT00991289|561694117|FG000|Overall Study|Physician Decision|2|||
155618461|NCT00991289|561694117|FG000|Overall Study|Withdrawal by Subject|3|||
155618462|NCT00991289|561694117|FG000|Overall Study|Lost to Follow-up|4|||
155618463|NCT00991289|561694117|FG000|Overall Study|Protocol Violation|2|||
155618464|NCT02401035|561694119|FG000|Overall Study|Withdrawal by Subject|1|||
155618465|NCT02401035|561694120|FG001|Overall Study|Withdrawal by Subject|0|||
155618466|NCT00869128|561694121|FG000|Overall Study|lack of Compliance|6|||
155618467|NCT00869128|561694122|FG001|Overall Study|lack of Compliance|6|||
155618468|NCT01118663|561694124|FG000|Overall Study|Adverse Event|2|||
155618469|NCT01118663|561694125|FG001|Overall Study|Adverse Event|1|||
155618470|NCT01118663|561694124|FG000|Overall Study|Withdrawal by Subject|0|||
155618471|NCT01118663|561694125|FG001|Overall Study|Withdrawal by Subject|1|||
155618472|NCT03046953|561694132|FG000|Overall Study|Relapse/progressive disease|21|||
155618473|NCT03046953|561694132|FG000|Overall Study|Death|2|||
155618474|NCT03046953|561694132|FG000|Overall Study|Withdrawal by Subject|3|||
155618475|NCT04039204|561694134|FG000|Overall Study|Withdrawal by Subject|0|||
155618476|NCT04039204|561694135|FG001|Overall Study|Withdrawal by Subject|2|||
155618477|NCT01189461|561694137|FG000|Overall Study|Lack of Efficacy|13|||
155618478|NCT01189461|561694137|FG000|Overall Study|Lost to Follow-up|1|||
155618479|NCT01189461|561694137|FG000|Overall Study|Withdrawal by Subject|6|||
155618480|NCT01189461|561694137|FG000|Overall Study|Protocol Violation|1|||
155618481|NCT01189461|561694137|FG000|Overall Study|Adverse Event|2|||
155618482|NCT01189461|561694137|FG000|Overall Study|Did not meet entrance criteria|3|||
155618483|NCT01189461|561694137|FG000|Overall Study|Other|8|||
155618484|NCT00420628|561694138|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
155618485|NCT00420628|561694139|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
155618486|NCT00420628|561694138|FG000|Overall Study|Lost to Follow-up|3|||
155618487|NCT00420628|561694139|FG001|Overall Study|Lost to Follow-up|2|||
155618488|NCT00420628|561694138|FG000|Overall Study|Adverse Event|1|||
155618489|NCT00420628|561694139|FG001|Overall Study|Adverse Event|0|||
155618490|NCT02716584|561694140|FG000|Overall Study|Lost to Follow-up|8|||
155618491|NCT02716584|561694141|FG001|Overall Study|Lost to Follow-up|5|||
155618492|NCT01971567|561695908|FG000|Overall Study|Withdrawal by Subject|3|||
155618493|NCT01971567|561695909|FG001|Overall Study|Withdrawal by Subject|2|||
155618494|NCT01971567|561695908|FG000|Overall Study|Lost to Follow-up|1|||
155618495|NCT01971567|561695909|FG001|Overall Study|Lost to Follow-up|0|||
155618496|NCT04826484|561695911|FG000|Overall Study|Lost to Follow-up|2|||
155618497|NCT04826484|561695912|FG001|Overall Study|Lost to Follow-up|0|||
155618498|NCT02250300|561695913|FG000|Expansion Phase|Death|6|||
155618499|NCT02250300|561695914|FG001|Expansion Phase|Death|7|||
155618500|NCT02250300|561695915|FG002|Expansion Phase|Death|0|||
155618501|NCT02250300|561695916|FG003|Expansion Phase|Death|0|||
155618502|NCT01845597|561695919|FG000|Overall Study|Death|8|||
155618503|NCT01845597|561695919|FG000|Overall Study|Lost to Follow-up|22|||
155618504|NCT01516736|561695921|FG000|Overall Study|Withdrawal by Subject|10|||
155618505|NCT01516736|561695922|FG001|Overall Study|Withdrawal by Subject|4|||
155618506|NCT01516736|561695921|FG000|Overall Study|Adverse Event|4|||
155618507|NCT01516736|561695922|FG001|Overall Study|Adverse Event|5|||
155618508|NCT01516736|561695921|FG000|Overall Study|Death|3|||
155618509|NCT01516736|561695922|FG001|Overall Study|Death|1|||
155618510|NCT01516736|561695921|FG000|Overall Study|Physician Decision|2|||
155618511|NCT01516736|561695922|FG001|Overall Study|Physician Decision|1|||
155618512|NCT01516736|561695921|FG000|Overall Study|Lack of Efficacy|1|||
155618513|NCT01516736|561695922|FG001|Overall Study|Lack of Efficacy|0|||
155618514|NCT01516736|561695921|FG000|Overall Study|Protocol Violation|0|||
155618515|NCT01516736|561695922|FG001|Overall Study|Protocol Violation|1|||
155618516|NCT01516736|561695921|FG000|Overall Study|Other (not specified)|0|||
155618517|NCT01516736|561695922|FG001|Overall Study|Other (not specified)|1|||
155618518|NCT00524771|561695925|FG000|Overall Study|Protocol Violation|220|||
155618519|NCT00524771|561695926|FG001|Overall Study|Protocol Violation|585|||
155618520|NCT02781818|561695927|FG000|Overall Study|Lost to Follow-up|4|||
155618521|NCT02781818|561695928|FG001|Overall Study|Lost to Follow-up|2|||
155618522|NCT02781818|561695929|FG002|Overall Study|Lost to Follow-up|1|||
155618523|NCT01877668|561695930|FG000|Overall Study|Death|0|||
155618524|NCT01877668|561695931|FG001|Overall Study|Death|0|||
155618525|NCT01877668|561695932|FG002|Overall Study|Death|0|||
155618526|NCT01877668|561695933|FG003|Overall Study|Death|1|||
155618527|NCT01877668|561695934|FG004|Overall Study|Death|0|||
155618528|NCT01877668|561695930|FG000|Overall Study|No longer met study criteria|1|||
155618529|NCT01877668|561695931|FG001|Overall Study|No longer met study criteria|0|||
155618530|NCT01877668|561695932|FG002|Overall Study|No longer met study criteria|1|||
155618531|NCT01877668|561695933|FG003|Overall Study|No longer met study criteria|0|||
155618532|NCT01877668|561695934|FG004|Overall Study|No longer met study criteria|0|||
155618533|NCT01877668|561695930|FG000|Overall Study|Insufficient clinical response|0|||
155618534|NCT01877668|561695931|FG001|Overall Study|Insufficient clinical response|1|||
155618535|NCT01877668|561695932|FG002|Overall Study|Insufficient clinical response|2|||
155618536|NCT01877668|561695933|FG003|Overall Study|Insufficient clinical response|2|||
155618537|NCT01877668|561695934|FG004|Overall Study|Insufficient clinical response|0|||
155618538|NCT01877668|561695930|FG000|Overall Study|Lost to Follow-up|0|||
155618539|NCT01877668|561695931|FG001|Overall Study|Lost to Follow-up|2|||
155618540|NCT01877668|561695932|FG002|Overall Study|Lost to Follow-up|1|||
155618541|NCT01877668|561695933|FG003|Overall Study|Lost to Follow-up|0|||
155618542|NCT01877668|561695934|FG004|Overall Study|Lost to Follow-up|0|||
155618543|NCT01877668|561695930|FG000|Overall Study|Withdrawal by Subject|2|||
155618544|NCT01877668|561695931|FG001|Overall Study|Withdrawal by Subject|0|||
155618545|NCT01877668|561695932|FG002|Overall Study|Withdrawal by Subject|3|||
155618546|NCT01877668|561695933|FG003|Overall Study|Withdrawal by Subject|2|||
155618547|NCT01877668|561695934|FG004|Overall Study|Withdrawal by Subject|2|||
155618548|NCT01877668|561695930|FG000|Overall Study|Other|1|||
155618549|NCT01877668|561695931|FG001|Overall Study|Other|1|||
155618550|NCT01877668|561695932|FG002|Overall Study|Other|1|||
155618551|NCT01877668|561695933|FG003|Overall Study|Other|1|||
155618552|NCT01877668|561695934|FG004|Overall Study|Other|3|||
155618553|NCT01877668|561695930|FG000|Overall Study|Protocol Violation|1|||
155618554|NCT01877668|561695931|FG001|Overall Study|Protocol Violation|1|||
155618555|NCT01877668|561695932|FG002|Overall Study|Protocol Violation|0|||
155618556|NCT01877668|561695933|FG003|Overall Study|Protocol Violation|0|||
155618557|NCT01877668|561695934|FG004|Overall Study|Protocol Violation|3|||
155618558|NCT01877668|561695930|FG000|Overall Study|Adverse event related to study drug|2|||
155618559|NCT01877668|561695931|FG001|Overall Study|Adverse event related to study drug|2|||
155618560|NCT01877668|561695932|FG002|Overall Study|Adverse event related to study drug|2|||
155618561|NCT01877668|561695933|FG003|Overall Study|Adverse event related to study drug|2|||
155618562|NCT01877668|561695934|FG004|Overall Study|Adverse event related to study drug|1|||
155618563|NCT01877668|561695930|FG000|Overall Study|Adverse event unrelated to study drug|4|||
155618564|NCT01877668|561695931|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155618565|NCT01877668|561695932|FG002|Overall Study|Adverse event unrelated to study drug|2|||
155618566|NCT01877668|561695933|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155618567|NCT01877668|561695934|FG004|Overall Study|Adverse event unrelated to study drug|1|||
155618568|NCT01223404|561695935|FG000|First Intervention (1 Day)|Adverse Event|0|||
155618569|NCT01223404|561695936|FG001|First Intervention (1 Day)|Adverse Event|0|||
155618570|NCT01223404|561695937|FG002|First Intervention (1 Day)|Adverse Event|0|||
155618571|NCT01223404|561695938|FG003|First Intervention (1 Day)|Adverse Event|1|||
155618572|NCT01223404|561695939|FG004|First Intervention (1 Day)|Adverse Event|0|||
155618573|NCT01223404|561695940|FG005|First Intervention (1 Day)|Adverse Event|0|||
155618574|NCT01223404|561695935|FG000|Second Intervention (1 Day)|Adverse Event|1|||
155618575|NCT01223404|561695936|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155618576|NCT01223404|561695937|FG002|Second Intervention (1 Day)|Adverse Event|0|||
155618577|NCT01223404|561695938|FG003|Second Intervention (1 Day)|Adverse Event|0|||
155618578|NCT01223404|561695939|FG004|Second Intervention (1 Day)|Adverse Event|0|||
155618579|NCT01223404|561695940|FG005|Second Intervention (1 Day)|Adverse Event|0|||
155618580|NCT01223404|561695935|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155618581|NCT01223404|561695936|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155618582|NCT01223404|561695937|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155618583|NCT01223404|561695938|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
155618584|NCT01223404|561695939|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155618585|NCT01223404|561695940|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155618586|NCT00954122|561695941|FG000|Overall Study|Withdrawal by Subject|5|||
155618587|NCT00954122|561695941|FG000|Overall Study|Adverse Event|1|||
155618588|NCT00954122|561695941|FG000|Overall Study|Safety Reason|1|||
155618589|NCT01957579|561695946|FG000|Overall Study|Withdrawal of concent|0|||
155618590|NCT01957579|561695947|FG001|Overall Study|Withdrawal of concent|1|||
155618591|NCT01957579|561695948|FG002|Overall Study|Withdrawal of concent|0|||
155618592|NCT01957579|561695949|FG003|Overall Study|Withdrawal of concent|0|||
155618593|NCT01957579|561695946|FG000|Overall Study|Death|0|||
155618594|NCT01957579|561695947|FG001|Overall Study|Death|0|||
155618595|NCT01957579|561695948|FG002|Overall Study|Death|2|||
155618596|NCT01957579|561695949|FG003|Overall Study|Death|0|||
155726811|NCT00129402|562099801|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
155618597|NCT02019550|561695950|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155618598|NCT02019550|561695951|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155618599|NCT02750332|561695953|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155618600|NCT02750332|561695954|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155618601|NCT02485483|561695958|FG000|Overall Study|Depression at baseline|15|||
155618602|NCT02485483|561695959|FG001|Overall Study|Depression at baseline|0|||
155618603|NCT02485483|561695958|FG000|Overall Study|Discontinued after baseline|39|||
155618604|NCT02485483|561695959|FG001|Overall Study|Discontinued after baseline|0|||
155618605|NCT00522548|561695961|FG000|Overall Study|Adverse Event|2|||
155618606|NCT00522548|561695962|FG001|Overall Study|Adverse Event|2|||
155618607|NCT00522548|561695961|FG000|Overall Study|Withdrawal by Subject|0|||
155618608|NCT00522548|561695962|FG001|Overall Study|Withdrawal by Subject|2|||
155618609|NCT03506438|561695963|FG000|Overall Study|Lost to Follow-up|8|||
155618610|NCT03506438|561695964|FG001|Overall Study|Lost to Follow-up|7|||
155618611|NCT03506438|561695965|FG002|Overall Study|Lost to Follow-up|8|||
155618612|NCT03506438|561695966|FG003|Overall Study|Lost to Follow-up|7|||
155618613|NCT03506438|561695967|FG004|Overall Study|Lost to Follow-up|0|||
155618614|NCT03506438|561695968|FG005|Overall Study|Lost to Follow-up|0|||
155618615|NCT01128296|561695969|FG000|Overall Study|Physician Decision|0|||
155618616|NCT01128296|561695970|FG001|Overall Study|Physician Decision|0|||
155618617|NCT01128296|561695971|FG002|Overall Study|Physician Decision|0|||
155618618|NCT01128296|561695972|FG003|Overall Study|Physician Decision|0|||
155618619|NCT01128296|561695973|FG004|Overall Study|Physician Decision|0|||
155618620|NCT01128296|561695974|FG005|Overall Study|Physician Decision|3|||
155618621|NCT01128296|561695969|FG000|Overall Study|Withdrawal by Subject|0|||
155618622|NCT01128296|561695970|FG001|Overall Study|Withdrawal by Subject|0|||
155618623|NCT01128296|561695971|FG002|Overall Study|Withdrawal by Subject|0|||
155618624|NCT01128296|561695972|FG003|Overall Study|Withdrawal by Subject|0|||
155618625|NCT01128296|561695973|FG004|Overall Study|Withdrawal by Subject|0|||
155618626|NCT01128296|561695974|FG005|Overall Study|Withdrawal by Subject|2|||
155618627|NCT04155463|561695975|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
155618628|NCT04155463|561695976|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
155618629|NCT00113295|561695977|FG000|Overall Study|Adverse Event|4|||
155618630|NCT00113295|561695978|FG001|Overall Study|Adverse Event|1|||
155618631|NCT00113295|561695977|FG000|Overall Study|Unrelated Medical Illness|1|||
155618632|NCT00113295|561695978|FG001|Overall Study|Unrelated Medical Illness|0|||
155618633|NCT01914393|561695979|FG000|Overall Study|Protocol Violation|11|||
155618634|NCT01914393|561695980|FG001|Overall Study|Protocol Violation|3|||
155618635|NCT01914393|561695981|FG002|Overall Study|Protocol Violation|19|||
155618636|NCT01914393|561695979|FG000|Overall Study|Lack of Efficacy|11|||
155618637|NCT01914393|561695980|FG001|Overall Study|Lack of Efficacy|16|||
155618638|NCT01914393|561695981|FG002|Overall Study|Lack of Efficacy|5|||
155618639|NCT01914393|561695979|FG000|Overall Study|no reason given|14|||
155618640|NCT01914393|561695980|FG001|Overall Study|no reason given|8|||
155618641|NCT01914393|561695981|FG002|Overall Study|no reason given|16|||
155618642|NCT01914393|561695979|FG000|Overall Study|Adverse Event|29|||
155618643|NCT01914393|561695980|FG001|Overall Study|Adverse Event|18|||
155618644|NCT01914393|561695981|FG002|Overall Study|Adverse Event|31|||
155618645|NCT01914393|561695979|FG000|Overall Study|Withdrawal by Subject|38|||
155618646|NCT01914393|561695980|FG001|Overall Study|Withdrawal by Subject|20|||
155618647|NCT01914393|561695981|FG002|Overall Study|Withdrawal by Subject|47|||
155618648|NCT01914393|561695979|FG000|Overall Study|Lost to Follow-up|12|||
155618649|NCT01914393|561695980|FG001|Overall Study|Lost to Follow-up|6|||
155618650|NCT01914393|561695981|FG002|Overall Study|Lost to Follow-up|19|||
155618651|NCT01914393|561695979|FG000|Overall Study|subject never dosed|0|||
155618652|NCT01914393|561695980|FG001|Overall Study|subject never dosed|0|||
155618653|NCT01914393|561695981|FG002|Overall Study|subject never dosed|1|||
155618654|NCT02806713|561695982|FG000|Overall Study|Urethral injury during procedure|1|||
155618655|NCT02806713|561695983|FG001|Overall Study|Urethral injury during procedure|0|||
155618656|NCT02806713|561695982|FG000|Overall Study|cancelled surgery|1|||
155618657|NCT02806713|561695983|FG001|Overall Study|cancelled surgery|2|||
155618658|NCT02999789|561695986|FG000|Overall Study|Withdrawal by Subject|0|||
155618659|NCT02999789|561695987|FG001|Overall Study|Withdrawal by Subject|1|||
155618660|NCT02999789|561695986|FG000|Overall Study|Became ineligible|1|||
155618661|NCT02999789|561695987|FG001|Overall Study|Became ineligible|2|||
155618662|NCT02824224|561695988|FG000|Overall Study|Discontinued, IUS expulsion|0|||
155618663|NCT02824224|561695989|FG001|Overall Study|Discontinued, IUS expulsion|1|||
155618664|NCT02824224|561695988|FG000|Overall Study|Did not show up for allocation visit|2|||
155618665|NCT02824224|561695989|FG001|Overall Study|Did not show up for allocation visit|0|||
155618666|NCT00368108|561695992|FG000|Overall Study|Adverse Event|38|||
155618667|NCT00368108|561695993|FG001|Overall Study|Adverse Event|26|||
155618668|NCT00368108|561695994|FG002|Overall Study|Adverse Event|44|||
155618669|NCT00368108|561695992|FG000|Overall Study|Abnormal Laboratory Value|0|||
155618670|NCT00368108|561695993|FG001|Overall Study|Abnormal Laboratory Value|0|||
155618671|NCT00368108|561695994|FG002|Overall Study|Abnormal Laboratory Value|3|||
155273069|NCT02302066|560432922|FG003|Overall Study|Reason Not Specified|1|||
155618672|NCT00368108|561695992|FG000|Overall Study|Protocol Violation|5|||
155273070|NCT02180438|560432932|FG000|Overall Study|Lost to Follow-up|1|||
155273071|NCT02058290|560432933|FG000|Overall Study|Protocol Violation|2|||
155273072|NCT02058290|560432934|FG001|Overall Study|Protocol Violation|1|||
155273073|NCT02058290|560432933|FG000|Overall Study|Physician Decision|1|||
155273074|NCT02058290|560432934|FG001|Overall Study|Physician Decision|0|||
155273075|NCT02058290|560432933|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
155273076|NCT02058290|560432934|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
155273077|NCT02058290|560432933|FG000|Overall Study|Withdrawal by Subject|0|||
155273078|NCT02058290|560432934|FG001|Overall Study|Withdrawal by Subject|1|||
155273079|NCT00785707|560432936|FG000|Overall Study|Lost to Follow-up|7|||
155618673|NCT00368108|561695993|FG001|Overall Study|Protocol Violation|9|||
155273080|NCT00105586|560432939|FG000|Overall Study|Adverse Event|4|||
155273081|NCT00105586|560432940|FG001|Overall Study|Adverse Event|3|||
155273082|NCT00105586|560432939|FG000|Overall Study|Physician Decision|13|||
155273083|NCT00105586|560432940|FG001|Overall Study|Physician Decision|13|||
155273084|NCT02262260|560432943|FG000|Overall Study|Adverse Event|4|||
155273085|NCT02262260|560432944|FG001|Overall Study|Adverse Event|1|||
155273086|NCT02262260|560432943|FG000|Overall Study|Withdrawal of consent|4|||
155273087|NCT02262260|560432944|FG001|Overall Study|Withdrawal of consent|2|||
155273088|NCT02262260|560432943|FG000|Overall Study|Lost to Follow-up|1|||
155273089|NCT02262260|560432944|FG001|Overall Study|Lost to Follow-up|2|||
155273090|NCT02262260|560432943|FG000|Overall Study|Protocol deviation|2|||
155273091|NCT02262260|560432944|FG001|Overall Study|Protocol deviation|5|||
155273092|NCT01794117|560432945|FG000|Overall Study|Adverse Event|1|||
155273093|NCT01794117|560432946|FG001|Overall Study|Adverse Event|0|||
155273094|NCT01794117|560432947|FG002|Overall Study|Adverse Event|0|||
155273095|NCT01794117|560432948|FG003|Overall Study|Adverse Event|0|||
155273096|NCT01794117|560432945|FG000|Overall Study|Participant noncompliance|0|||
155273097|NCT01794117|560432946|FG001|Overall Study|Participant noncompliance|1|||
155273098|NCT01794117|560432947|FG002|Overall Study|Participant noncompliance|0|||
155273099|NCT01794117|560432948|FG003|Overall Study|Participant noncompliance|0|||
155273100|NCT01794117|560432945|FG000|Overall Study|Refused further treatment|0|||
155273101|NCT01794117|560432946|FG001|Overall Study|Refused further treatment|2|||
155273102|NCT01794117|560432947|FG002|Overall Study|Refused further treatment|0|||
155273103|NCT01794117|560432948|FG003|Overall Study|Refused further treatment|0|||
155273104|NCT04150029|560432951|FG000|Overall Study|Disease Relapse|0|||
155273105|NCT04150029|560432952|FG001|Overall Study|Disease Relapse|18|||
155273106|NCT04150029|560432951|FG000|Overall Study|Progressive Disease|2|||
155273107|NCT04150029|560432952|FG001|Overall Study|Progressive Disease|16|||
155273108|NCT04150029|560432951|FG000|Overall Study|Adverse Event|1|||
155273109|NCT04150029|560432952|FG001|Overall Study|Adverse Event|11|||
155273110|NCT04150029|560432951|FG000|Overall Study|Physician Decision|0|||
155273111|NCT04150029|560432952|FG001|Overall Study|Physician Decision|10|||
155273112|NCT04150029|560432951|FG000|Overall Study|Study Terminated by Sponsor|1|||
155273113|NCT04150029|560432952|FG001|Overall Study|Study Terminated by Sponsor|10|||
155273114|NCT04150029|560432951|FG000|Overall Study|Death|0|||
155273115|NCT04150029|560432952|FG001|Overall Study|Death|8|||
155273116|NCT04150029|560432951|FG000|Overall Study|Participant Decision|0|||
155273117|NCT04150029|560432952|FG001|Overall Study|Participant Decision|7|||
155273118|NCT04150029|560432951|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
155273119|NCT04150029|560432952|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
155273120|NCT02696902|560432953|FG000|Overall Study|Lost to Follow-up|0|||
155273121|NCT02696902|560432954|FG001|Overall Study|Lost to Follow-up|1|||
155273122|NCT02696902|560432955|FG002|Overall Study|Lost to Follow-up|1|||
155273123|NCT02696902|560432953|FG000|Overall Study|Withdrawal by Subject|0|||
155618674|NCT00368108|561695994|FG002|Overall Study|Protocol Violation|9|||
155618675|NCT00368108|561695992|FG000|Overall Study|Withdrawal by Subject|9|||
155618676|NCT00368108|561695993|FG001|Overall Study|Withdrawal by Subject|3|||
155618677|NCT00368108|561695994|FG002|Overall Study|Withdrawal by Subject|5|||
155618678|NCT00368108|561695992|FG000|Overall Study|Lack of Efficacy|7|||
155618679|NCT00368108|561695993|FG001|Overall Study|Lack of Efficacy|8|||
155618680|NCT00368108|561695994|FG002|Overall Study|Lack of Efficacy|5|||
155618681|NCT00368108|561695992|FG000|Overall Study|Physician Decision|2|||
155618682|NCT00368108|561695993|FG001|Overall Study|Physician Decision|0|||
155618683|NCT00368108|561695994|FG002|Overall Study|Physician Decision|1|||
155273124|NCT02696902|560432954|FG001|Overall Study|Withdrawal by Subject|0|||
155273125|NCT02696902|560432955|FG002|Overall Study|Withdrawal by Subject|1|||
155273126|NCT02696902|560432953|FG000|Overall Study|Death|19|||
155273127|NCT02696902|560432954|FG001|Overall Study|Death|3|||
155273128|NCT02696902|560432955|FG002|Overall Study|Death|24|||
155273129|NCT02696902|560432953|FG000|Overall Study|Participant not fit post-randomization|0|||
155618684|NCT00368108|561695992|FG000|Overall Study|Other|3|||
155618685|NCT00368108|561695993|FG001|Overall Study|Other|7|||
155273130|NCT02696902|560432954|FG001|Overall Study|Participant not fit post-randomization|0|||
155273131|NCT02696902|560432955|FG002|Overall Study|Participant not fit post-randomization|1|||
155273132|NCT02696902|560432953|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
155618686|NCT00368108|561695994|FG002|Overall Study|Other|1|||
155618687|NCT02299388|561696001|FG000|Overall Study|Withdrawal by Subject|0|||
155618688|NCT02299388|561696002|FG001|Overall Study|Withdrawal by Subject|1|||
155618689|NCT03334188|561696005|FG000|Overall Study|Withdrawal by Subject|0|||
155618690|NCT03334188|561696006|FG001|Overall Study|Withdrawal by Subject|1|||
155618691|NCT03334188|561696005|FG000|Overall Study|Death|1|||
155618692|NCT03334188|561696006|FG001|Overall Study|Death|0|||
155618693|NCT03334188|561696005|FG000|Overall Study|Never had qualifying clinic visit|7|||
155618694|NCT03334188|561696006|FG001|Overall Study|Never had qualifying clinic visit|7|||
155618695|NCT01093586|561696011|FG000|Overall Study|Failed to engraft|3|||
155618696|NCT03442088|561696012|FG000|Overall Study|Adverse Event|1|||
155618697|NCT03442088|561696012|FG000|Overall Study|Lack of Efficacy|2|||
155618698|NCT03442088|561696012|FG000|Overall Study|Lost to Follow-up|2|||
155618699|NCT01001520|561696013|FG000|Medication Period 1|Withdrawal by Subject|2|||
155618700|NCT01001520|561696014|FG001|Medication Period 1|Withdrawal by Subject|2|||
155618701|NCT01001520|561696013|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
155618702|NCT01001520|561696014|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
155618703|NCT01001520|561696013|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
155618704|NCT01001520|561696014|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
155618705|NCT01001520|561696013|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
155618706|NCT01001520|561696014|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
155618707|NCT01001520|561696013|FG000|Washout Period|Withdrawal by Subject|2|||
155618708|NCT01001520|561696014|FG001|Washout Period|Withdrawal by Subject|1|||
155618709|NCT01001520|561696013|FG000|Medication Period 2|Withdrawal by Subject|0|||
155618710|NCT01001520|561696014|FG001|Medication Period 2|Withdrawal by Subject|3|||
155618711|NCT00357877|561696015|FG000|Overall Study|Death|2|||
155618712|NCT00357877|561696016|FG001|Overall Study|Death|1|||
155618713|NCT00357877|561696015|FG000|Overall Study|Lost to Follow-up|20|||
155618714|NCT00357877|561696016|FG001|Overall Study|Lost to Follow-up|23|||
155618715|NCT00357877|561696015|FG000|Overall Study|Withdrawal by Subject|3|||
155618716|NCT00357877|561696016|FG001|Overall Study|Withdrawal by Subject|3|||
155618717|NCT00357877|561696015|FG000|Overall Study|Administrative withdrawal|1|||
155618718|NCT00357877|561696016|FG001|Overall Study|Administrative withdrawal|1|||
155618719|NCT00357877|561696015|FG000|Overall Study|Other|0|||
155618720|NCT00357877|561696016|FG001|Overall Study|Other|2|||
155618721|NCT01051557|561696019|FG000|Overall Study|Physician Decision|1|||
155618722|NCT01051557|561696020|FG001|Overall Study|Physician Decision|0|||
155618723|NCT01051557|561696021|FG002|Overall Study|Physician Decision|0|||
155618724|NCT01051557|561696022|FG003|Overall Study|Physician Decision|0|||
155618725|NCT01051557|561696023|FG004|Overall Study|Physician Decision|0|||
155618726|NCT01051557|561696024|FG005|Overall Study|Physician Decision|0|||
155618727|NCT01051557|561696025|FG006|Overall Study|Physician Decision|0|||
155618728|NCT01051557|561696019|FG000|Overall Study|disease progression|3|||
155618729|NCT01051557|561696020|FG001|Overall Study|disease progression|3|||
155618730|NCT01051557|561696021|FG002|Overall Study|disease progression|5|||
155618731|NCT01051557|561696022|FG003|Overall Study|disease progression|2|||
155618732|NCT01051557|561696023|FG004|Overall Study|disease progression|4|||
155618733|NCT01051557|561696024|FG005|Overall Study|disease progression|3|||
155618734|NCT01051557|561696025|FG006|Overall Study|disease progression|1|||
155618735|NCT01051557|561696019|FG000|Overall Study|Withdrawal by Subject|0|||
155618736|NCT01051557|561696020|FG001|Overall Study|Withdrawal by Subject|0|||
155618737|NCT01051557|561696021|FG002|Overall Study|Withdrawal by Subject|1|||
155618738|NCT01051557|561696022|FG003|Overall Study|Withdrawal by Subject|0|||
155618739|NCT01051557|561696023|FG004|Overall Study|Withdrawal by Subject|2|||
155618740|NCT01051557|561696024|FG005|Overall Study|Withdrawal by Subject|0|||
155618741|NCT01051557|561696025|FG006|Overall Study|Withdrawal by Subject|1|||
155618742|NCT01051557|561696019|FG000|Overall Study|Adverse Event|0|||
155618743|NCT01051557|561696020|FG001|Overall Study|Adverse Event|0|||
155618744|NCT01051557|561696021|FG002|Overall Study|Adverse Event|0|||
155618745|NCT01051557|561696022|FG003|Overall Study|Adverse Event|1|||
155618746|NCT01051557|561696023|FG004|Overall Study|Adverse Event|1|||
155618747|NCT01051557|561696024|FG005|Overall Study|Adverse Event|3|||
155618748|NCT01051557|561696025|FG006|Overall Study|Adverse Event|4|||
155618749|NCT04668209|561696026|FG000|Overall Study|Withdrawal by Subject|2|||
155618750|NCT04668209|561696027|FG001|Overall Study|Withdrawal by Subject|2|||
155618751|NCT04668209|561696026|FG000|Overall Study|Lost to Follow-up|3|||
155618752|NCT04668209|561696027|FG001|Overall Study|Lost to Follow-up|4|||
155618753|NCT04668209|561696026|FG000|Overall Study|Subject Expired|2|||
155618754|NCT04668209|561696027|FG001|Overall Study|Subject Expired|0|||
155618755|NCT04668209|561696026|FG000|Overall Study|Withdrawn from study|0|||
155618756|NCT04668209|561696027|FG001|Overall Study|Withdrawn from study|1|||
155618757|NCT04668209|561696026|FG000|Overall Study|Adverse Event|0|||
155618758|NCT04668209|561696027|FG001|Overall Study|Adverse Event|1|||
155618759|NCT00613366|561696034|FG000|Overall Study|Withdrawal by Subject|3|||
155618760|NCT00613366|561696035|FG001|Overall Study|Withdrawal by Subject|2|||
155618761|NCT00268983|561696038|FG000|Overall Study|Death|3|||
155618762|NCT00268983|561696039|FG001|Overall Study|Death|0|||
155618763|NCT02532374|561696042|FG000|Overall Study|Withdrawal by Subject|1|||
155618764|NCT02532374|561696042|FG000|Overall Study|Physician Decision|1|||
155618765|NCT01348139|561696045|FG000|Period 1|Adverse Event|1|||
155618766|NCT01348139|561696046|FG001|Period 1|Adverse Event|0|||
155618767|NCT01348139|561696047|FG002|Period 1|Adverse Event|0|||
155618768|NCT01348139|561696048|FG003|Period 1|Adverse Event|0|||
155618769|NCT01348139|561696049|FG004|Period 1|Adverse Event|0|||
155618770|NCT01348139|561696050|FG005|Period 1|Adverse Event|0|||
155618771|NCT02762084|561696051|FG000|Overall Study|Withdrawal by Subject|1|||
155618772|NCT02762084|561696052|FG001|Overall Study|Withdrawal by Subject|0|||
155618773|NCT02762084|561696053|FG002|Overall Study|Withdrawal by Subject|0|||
155273133|NCT02696902|560432954|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
155273134|NCT02696902|560432955|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
155273135|NCT02696902|560432953|FG000|Overall Study|Principal investigator's decision|1|||
155273136|NCT02696902|560432954|FG001|Overall Study|Principal investigator's decision|0|||
155273137|NCT02696902|560432955|FG002|Overall Study|Principal investigator's decision|0|||
155273138|NCT02696902|560432953|FG000|Overall Study|Sponsor's decision|1|||
155273139|NCT02696902|560432954|FG001|Overall Study|Sponsor's decision|0|||
155273140|NCT02696902|560432955|FG002|Overall Study|Sponsor's decision|0|||
155273141|NCT02696902|560432953|FG000|Overall Study|Transferred to other hospital|1|||
155273142|NCT02696902|560432954|FG001|Overall Study|Transferred to other hospital|0|||
155273143|NCT02696902|560432955|FG002|Overall Study|Transferred to other hospital|0|||
155273144|NCT01233609|560432958|FG000|Overall Study|Death|1|||
155273145|NCT01233609|560432959|FG001|Overall Study|Death|0|||
155273146|NCT01233609|560432958|FG000|Overall Study|Lost to Follow-up|3|||
155273147|NCT01233609|560432959|FG001|Overall Study|Lost to Follow-up|1|||
155273148|NCT01233609|560432958|FG000|Overall Study|Adverse Event|2|||
155273149|NCT01233609|560432959|FG001|Overall Study|Adverse Event|1|||
155273150|NCT01233609|560432958|FG000|Overall Study|Withdrawal by Subject|3|||
155273151|NCT01233609|560432959|FG001|Overall Study|Withdrawal by Subject|0|||
155273152|NCT00735644|560432960|FG000|Overall Study|Did not receive study vaccine|0|||
155273153|NCT00735644|560432961|FG001|Overall Study|Did not receive study vaccine|1|||
155273154|NCT00735644|560432962|FG002|Overall Study|Did not receive study vaccine|0|||
155273155|NCT00735644|560432963|FG003|Overall Study|Did not receive study vaccine|0|||
155273156|NCT00735644|560432964|FG004|Overall Study|Did not receive study vaccine|0|||
155273157|NCT00735644|560432960|FG000|Overall Study|Withdrawal by Subject|0|||
155273158|NCT00735644|560432961|FG001|Overall Study|Withdrawal by Subject|1|||
155273159|NCT00735644|560432962|FG002|Overall Study|Withdrawal by Subject|1|||
155273160|NCT00735644|560432963|FG003|Overall Study|Withdrawal by Subject|1|||
155273161|NCT00735644|560432964|FG004|Overall Study|Withdrawal by Subject|0|||
155273162|NCT06385483|560432967|FG000|Overall Study|Withdrawal by Subject|2|||
155273163|NCT06385483|560432967|FG000|Overall Study|Never start protocol therapy|2|||
155273164|NCT06385483|560432967|FG000|Overall Study|Disease progression|15|||
155273165|NCT00654940|560434418|FG000|Period 1|Adverse Event|0|||
155273166|NCT00654940|560434419|FG001|Period 1|Adverse Event|1|||
155273167|NCT00654940|560434418|FG000|Period 1|Intolerable Pain Level|1|||
155273168|NCT00654940|560434419|FG001|Period 1|Intolerable Pain Level|0|||
155273169|NCT00802737|560434420|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
155273170|NCT00802737|560434421|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
155273171|NCT00802737|560434422|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
155273172|NCT00802737|560434420|FG000|Overall Study|Death|6|||
155273173|NCT00802737|560434421|FG001|Overall Study|Death|5|||
155273174|NCT00802737|560434422|FG002|Overall Study|Death|1|||
155273175|NCT00802737|560434420|FG000|Overall Study|Adverse Event|1|||
155618774|NCT02762084|561696051|FG000|Overall Study|Adverse Event|0|||
155618775|NCT02762084|561696052|FG001|Overall Study|Adverse Event|0|||
155618776|NCT02762084|561696053|FG002|Overall Study|Adverse Event|1|||
155618777|NCT03006562|561696054|FG000|Overall Study|Lost to Follow-up|0|||
155618778|NCT03006562|561696055|FG001|Overall Study|Lost to Follow-up|1|||
155618779|NCT02427841|561696064|FG000|Overall Study|Lack of Efficacy|5|||
155273176|NCT00802737|560434421|FG001|Overall Study|Adverse Event|0|||
155273177|NCT00802737|560434422|FG002|Overall Study|Adverse Event|0|||
155273178|NCT00802737|560434420|FG000|Overall Study|Received Prohibited Therapy|1|||
155273179|NCT00802737|560434421|FG001|Overall Study|Received Prohibited Therapy|0|||
155618780|NCT02427841|561696064|FG000|Overall Study|Physician Decision|2|||
155618781|NCT02427841|561696064|FG000|Overall Study|Withdrawal by Subject|1|||
155618782|NCT01765296|561696065|FG000|Overall Study|Protocol Violation|0|||
155273180|NCT00802737|560434422|FG002|Overall Study|Received Prohibited Therapy|0|||
155273181|NCT00802737|560434420|FG000|Overall Study|Ongoing CLL-Treatment|0|||
155273182|NCT00802737|560434421|FG001|Overall Study|Ongoing CLL-Treatment|1|||
155273183|NCT00802737|560434422|FG002|Overall Study|Ongoing CLL-Treatment|0|||
155273184|NCT00802737|560434420|FG000|Overall Study|Participant too Unwell|0|||
155273185|NCT00802737|560434421|FG001|Overall Study|Participant too Unwell|2|||
155273186|NCT00802737|560434422|FG002|Overall Study|Participant too Unwell|0|||
155273187|NCT00619476|560434428|FG000|Overall Study|Adverse Event|12|||
155618783|NCT01765296|561696066|FG001|Overall Study|Protocol Violation|5|||
155618784|NCT01765296|561696067|FG002|Overall Study|Protocol Violation|4|||
155273188|NCT00619476|560434429|FG001|Overall Study|Adverse Event|6|||
155273189|NCT00619476|560434430|FG002|Overall Study|Adverse Event|12|||
155618785|NCT01765296|561696065|FG000|Overall Study|Withdrawal by Subject|4|||
155618786|NCT01765296|561696066|FG001|Overall Study|Withdrawal by Subject|2|||
155618787|NCT01765296|561696067|FG002|Overall Study|Withdrawal by Subject|2|||
155618788|NCT01765296|561696065|FG000|Overall Study|Adverse Event|1|||
155618789|NCT01765296|561696066|FG001|Overall Study|Adverse Event|13|||
155618790|NCT01765296|561696067|FG002|Overall Study|Adverse Event|5|||
155618791|NCT01765296|561696065|FG000|Overall Study|Lack of Efficacy|0|||
155618792|NCT01765296|561696066|FG001|Overall Study|Lack of Efficacy|0|||
155618793|NCT01765296|561696067|FG002|Overall Study|Lack of Efficacy|2|||
155618794|NCT03257436|561696068|FG000|Overall Study|Withdrawal by Subject|76|||
155618795|NCT03257436|561696068|FG000|Overall Study|Death|19|||
155618796|NCT01619852|561696069|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
155618797|NCT01619852|561696070|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
155618798|NCT01619852|561696069|FG000|3 Month Follow up|Lost to Follow-up|31|||
155618799|NCT01619852|561696070|FG001|3 Month Follow up|Lost to Follow-up|34|||
155618800|NCT00970489|561696071|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
155618801|NCT00970489|561696072|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
155618802|NCT02659943|561696073|FG000|Overall Study|Switched to alternative treatment|1|||
155618803|NCT02659943|561696074|FG001|Overall Study|Switched to alternative treatment|1|||
155618804|NCT02659943|561696075|FG002|Overall Study|Switched to alternative treatment|0|||
155618805|NCT02659943|561696076|FG003|Overall Study|Switched to alternative treatment|2|||
155618806|NCT02659943|561696077|FG004|Overall Study|Switched to alternative treatment|1|||
155618807|NCT02659943|561696078|FG005|Overall Study|Switched to alternative treatment|0|||
155618808|NCT02659943|561696079|FG006|Overall Study|Switched to alternative treatment|1|||
155618809|NCT02659943|561696073|FG000|Overall Study|Disease progression on study|0|||
155618810|NCT02659943|561696074|FG001|Overall Study|Disease progression on study|1|||
155618811|NCT02659943|561696075|FG002|Overall Study|Disease progression on study|1|||
155618812|NCT02659943|561696076|FG003|Overall Study|Disease progression on study|1|||
155618813|NCT02659943|561696077|FG004|Overall Study|Disease progression on study|1|||
155618814|NCT02659943|561696078|FG005|Overall Study|Disease progression on study|4|||
155618815|NCT02659943|561696079|FG006|Overall Study|Disease progression on study|0|||
155618816|NCT02659943|561696073|FG000|Overall Study|Patient's condition per principal investigator|0|||
155618817|NCT02659943|561696074|FG001|Overall Study|Patient's condition per principal investigator|0|||
155618818|NCT02659943|561696075|FG002|Overall Study|Patient's condition per principal investigator|0|||
155618819|NCT02659943|561696076|FG003|Overall Study|Patient's condition per principal investigator|0|||
155618820|NCT02659943|561696077|FG004|Overall Study|Patient's condition per principal investigator|0|||
155618821|NCT02659943|561696078|FG005|Overall Study|Patient's condition per principal investigator|1|||
155618822|NCT02659943|561696079|FG006|Overall Study|Patient's condition per principal investigator|0|||
155618823|NCT02659943|561696073|FG000|Overall Study|Ineligible|0|||
155618824|NCT02659943|561696074|FG001|Overall Study|Ineligible|0|||
155618825|NCT02659943|561696075|FG002|Overall Study|Ineligible|0|||
155618826|NCT02659943|561696076|FG003|Overall Study|Ineligible|0|||
155618827|NCT02659943|561696077|FG004|Overall Study|Ineligible|0|||
155618828|NCT02659943|561696078|FG005|Overall Study|Ineligible|0|||
155618829|NCT02659943|561696079|FG006|Overall Study|Ineligible|1|||
155618830|NCT02659943|561696073|FG000|Overall Study|No longer meets eligibility|0|||
155618831|NCT02659943|561696074|FG001|Overall Study|No longer meets eligibility|0|||
155618832|NCT02659943|561696075|FG002|Overall Study|No longer meets eligibility|0|||
155618833|NCT02659943|561696076|FG003|Overall Study|No longer meets eligibility|0|||
155618834|NCT02659943|561696077|FG004|Overall Study|No longer meets eligibility|0|||
155618835|NCT02659943|561696078|FG005|Overall Study|No longer meets eligibility|0|||
155618836|NCT02659943|561696079|FG006|Overall Study|No longer meets eligibility|1|||
155618837|NCT02659943|561696073|FG000|Overall Study|No treatment, per protocol|0|||
155618838|NCT02659943|561696074|FG001|Overall Study|No treatment, per protocol|0|||
155618839|NCT02659943|561696075|FG002|Overall Study|No treatment, per protocol|0|||
155618840|NCT02659943|561696076|FG003|Overall Study|No treatment, per protocol|0|||
155618841|NCT02659943|561696077|FG004|Overall Study|No treatment, per protocol|0|||
155618842|NCT02659943|561696078|FG005|Overall Study|No treatment, per protocol|0|||
155618843|NCT02659943|561696079|FG006|Overall Study|No treatment, per protocol|3|||
155618844|NCT01096160|561696080|FG000|Overall Study|Adverse Event|0|||
155618845|NCT01096160|561696081|FG001|Overall Study|Adverse Event|0|||
155618846|NCT01096160|561696082|FG002|Overall Study|Adverse Event|1|||
155618847|NCT01096160|561696083|FG003|Overall Study|Adverse Event|0|||
155618848|NCT01096160|561696084|FG004|Overall Study|Adverse Event|0|||
155618849|NCT01096160|561696085|FG005|Overall Study|Adverse Event|0|||
155618850|NCT01096160|561696086|FG006|Overall Study|Adverse Event|0|||
155618851|NCT01096160|561696087|FG007|Overall Study|Adverse Event|0|||
155726812|NCT00129402|562099802|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155726813|NCT00129402|562099803|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
155618852|NCT01096160|561696088|FG008|Overall Study|Adverse Event|0|||
155618853|NCT01096160|561696089|FG009|Overall Study|Adverse Event|1|||
155618854|NCT01096160|561696080|FG000|Overall Study|Met stopping criteria per protocol|0|||
155618855|NCT01096160|561696081|FG001|Overall Study|Met stopping criteria per protocol|0|||
155618856|NCT01096160|561696082|FG002|Overall Study|Met stopping criteria per protocol|0|||
155726814|NCT00129402|562099804|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155618857|NCT01096160|561696083|FG003|Overall Study|Met stopping criteria per protocol|0|||
155618858|NCT01096160|561696084|FG004|Overall Study|Met stopping criteria per protocol|1|||
155618859|NCT01096160|561696085|FG005|Overall Study|Met stopping criteria per protocol|0|||
155618860|NCT01096160|561696086|FG006|Overall Study|Met stopping criteria per protocol|2|||
155618861|NCT01096160|561696087|FG007|Overall Study|Met stopping criteria per protocol|0|||
155618862|NCT01096160|561696088|FG008|Overall Study|Met stopping criteria per protocol|2|||
155618863|NCT01096160|561696089|FG009|Overall Study|Met stopping criteria per protocol|0|||
155618864|NCT00627497|561696090|FG000|Overall Study|Lost to Follow-up|1|||
155618865|NCT00627497|561696091|FG001|Overall Study|Lost to Follow-up|1|||
155618866|NCT00627497|561696092|FG002|Overall Study|Lost to Follow-up|0|||
155618867|NCT00627497|561696093|FG003|Overall Study|Lost to Follow-up|0|||
155618868|NCT00130689|561697731|FG000|Overall Study|Progressive Disease|29|||
155618869|NCT00130689|561697731|FG000|Overall Study|Death|1|||
155618870|NCT00130689|561697731|FG000|Overall Study|Clinical Deterioration|4|||
155618871|NCT00130689|561697731|FG000|Overall Study|Withdrawal by Subject|3|||
155618872|NCT00130689|561697731|FG000|Overall Study|Ineligible|6|||
155618873|NCT04878055|561697732|FG000|Overall Study|Patient transferred in another department|0|||
155618874|NCT04878055|561697733|FG001|Overall Study|Patient transferred in another department|2|||
155618875|NCT04878055|561697732|FG000|Overall Study|Physician Decision|1|||
155618876|NCT04878055|561697733|FG001|Overall Study|Physician Decision|1|||
155618877|NCT04878055|561697732|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
155618878|NCT04878055|561697733|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
155618879|NCT04878055|561697732|FG000|Overall Study|Adverse Event|12|||
155618880|NCT04878055|561697733|FG001|Overall Study|Adverse Event|7|||
155618881|NCT04878055|561697732|FG000|Overall Study|Other|5|||
155618882|NCT04878055|561697733|FG001|Overall Study|Other|0|||
155618883|NCT04878055|561697732|FG000|Overall Study|Withdrawal by Subject|7|||
155618884|NCT04878055|561697733|FG001|Overall Study|Withdrawal by Subject|3|||
155618885|NCT04878055|561697732|FG000|Overall Study|Lost to Follow-up|10|||
155618886|NCT04878055|561697733|FG001|Overall Study|Lost to Follow-up|1|||
155618887|NCT01968811|561697734|FG000|Overall Study|Protocol Violation|4|||
155618888|NCT01968811|561697734|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
155618889|NCT01178125|561697736|FG000|Overall Study|Lost to Follow-up|397|||
155618890|NCT01178125|561697736|FG000|Overall Study|Adverse Event|244|||
155618891|NCT01178125|561697736|FG000|Overall Study|Withdrawal by Subject|209|||
155618892|NCT01178125|561697736|FG000|Overall Study|Noncompliance|184|||
155618893|NCT01178125|561697736|FG000|Overall Study|Pregnancy|55|||
155618894|NCT01178125|561697736|FG000|Overall Study|Other Reason|39|||
155618895|NCT01178125|561697736|FG000|Overall Study|Sponsor Decision|28|||
155618896|NCT01178125|561697736|FG000|Overall Study|Protocol Violation|17|||
155618897|NCT01178125|561697736|FG000|Overall Study|Investigator Decision|5|||
155618898|NCT00369915|561697737|FG000|Overall Study|expected side effects|2|||
155618899|NCT00369915|561697738|FG001|Overall Study|expected side effects|1|||
155618900|NCT00369915|561697737|FG000|Overall Study|Withdrawal by Subject|4|||
155618901|NCT00369915|561697738|FG001|Overall Study|Withdrawal by Subject|1|||
155618902|NCT00369915|561697737|FG000|Overall Study|W/drawl by investigators|0|||
155618903|NCT00369915|561697738|FG001|Overall Study|W/drawl by investigators|1|||
155618904|NCT01719380|561697741|FG000|Overall Study|Adverse Event|0|||
155618905|NCT01719380|561697742|FG001|Overall Study|Adverse Event|0|||
155618906|NCT01719380|561697743|FG002|Overall Study|Adverse Event|1|||
155618907|NCT01719380|561697744|FG003|Overall Study|Adverse Event|2|||
155618908|NCT01719380|561697745|FG004|Overall Study|Adverse Event|0|||
155618909|NCT01719380|561697746|FG005|Overall Study|Adverse Event|1|||
155618910|NCT01719380|561697747|FG006|Overall Study|Adverse Event|0|||
155618911|NCT01719380|561697748|FG007|Overall Study|Adverse Event|1|||
155618912|NCT01719380|561697749|FG008|Overall Study|Adverse Event|4|||
155618913|NCT01719380|561697750|FG009|Overall Study|Adverse Event|3|||
155618914|NCT01719380|561697741|FG000|Overall Study|Death|0|||
155618915|NCT01719380|561697742|FG001|Overall Study|Death|1|||
155618916|NCT01719380|561697743|FG002|Overall Study|Death|0|||
155618917|NCT01719380|561697744|FG003|Overall Study|Death|0|||
155618918|NCT01719380|561697745|FG004|Overall Study|Death|0|||
155618919|NCT01719380|561697746|FG005|Overall Study|Death|0|||
155618920|NCT01719380|561697747|FG006|Overall Study|Death|0|||
155618921|NCT01719380|561697748|FG007|Overall Study|Death|0|||
155618922|NCT01719380|561697749|FG008|Overall Study|Death|3|||
155618923|NCT01719380|561697750|FG009|Overall Study|Death|3|||
155618924|NCT01719380|561697741|FG000|Overall Study|Participant/Guardian Decision|0|||
155618925|NCT01719380|561697742|FG001|Overall Study|Participant/Guardian Decision|0|||
155618926|NCT01719380|561697743|FG002|Overall Study|Participant/Guardian Decision|1|||
155618927|NCT01719380|561697744|FG003|Overall Study|Participant/Guardian Decision|0|||
155618928|NCT01719380|561697745|FG004|Overall Study|Participant/Guardian Decision|0|||
155618929|NCT01719380|561697746|FG005|Overall Study|Participant/Guardian Decision|0|||
155618930|NCT01719380|561697747|FG006|Overall Study|Participant/Guardian Decision|0|||
155618931|NCT01719380|561697748|FG007|Overall Study|Participant/Guardian Decision|0|||
155618932|NCT01719380|561697749|FG008|Overall Study|Participant/Guardian Decision|2|||
155618933|NCT01719380|561697750|FG009|Overall Study|Participant/Guardian Decision|2|||
155618934|NCT01719380|561697741|FG000|Overall Study|Physician Decision|0|||
155618935|NCT01719380|561697742|FG001|Overall Study|Physician Decision|0|||
155618936|NCT01719380|561697743|FG002|Overall Study|Physician Decision|2|||
155618937|NCT01719380|561697744|FG003|Overall Study|Physician Decision|0|||
155618938|NCT01719380|561697745|FG004|Overall Study|Physician Decision|0|||
155618939|NCT01719380|561697746|FG005|Overall Study|Physician Decision|0|||
155618940|NCT01719380|561697747|FG006|Overall Study|Physician Decision|0|||
155618941|NCT01719380|561697748|FG007|Overall Study|Physician Decision|0|||
155618942|NCT01719380|561697749|FG008|Overall Study|Physician Decision|1|||
155618943|NCT01719380|561697750|FG009|Overall Study|Physician Decision|1|||
155618944|NCT01719380|561697741|FG000|Overall Study|Lack of Efficacy|2|||
155618945|NCT01719380|561697742|FG001|Overall Study|Lack of Efficacy|6|||
155618946|NCT01719380|561697743|FG002|Overall Study|Lack of Efficacy|5|||
155618947|NCT01719380|561697744|FG003|Overall Study|Lack of Efficacy|6|||
155618948|NCT01719380|561697745|FG004|Overall Study|Lack of Efficacy|3|||
155618949|NCT01719380|561697746|FG005|Overall Study|Lack of Efficacy|7|||
155618950|NCT01719380|561697747|FG006|Overall Study|Lack of Efficacy|10|||
155618951|NCT01719380|561697748|FG007|Overall Study|Lack of Efficacy|6|||
155618952|NCT01719380|561697749|FG008|Overall Study|Lack of Efficacy|39|||
155618953|NCT01719380|561697750|FG009|Overall Study|Lack of Efficacy|42|||
155618954|NCT01719380|561697741|FG000|Overall Study|Progressive Disease|0|||
155618955|NCT01719380|561697742|FG001|Overall Study|Progressive Disease|0|||
155618956|NCT01719380|561697743|FG002|Overall Study|Progressive Disease|0|||
155618957|NCT01719380|561697744|FG003|Overall Study|Progressive Disease|0|||
155618958|NCT01719380|561697745|FG004|Overall Study|Progressive Disease|0|||
155618959|NCT01719380|561697746|FG005|Overall Study|Progressive Disease|0|||
155618960|NCT01719380|561697747|FG006|Overall Study|Progressive Disease|0|||
155618961|NCT01719380|561697748|FG007|Overall Study|Progressive Disease|0|||
155618962|NCT01719380|561697749|FG008|Overall Study|Progressive Disease|1|||
155618963|NCT01719380|561697750|FG009|Overall Study|Progressive Disease|0|||
155618964|NCT00249873|561697751|FG000|Overall Study|Not treated|7|||
155618965|NCT00249873|561697752|FG001|Overall Study|Not treated|8|||
155618966|NCT00249873|561697751|FG000|Overall Study|Significant thrombocytopenia|9|||
155618967|NCT00249873|561697752|FG001|Overall Study|Significant thrombocytopenia|8|||
155618968|NCT00249873|561697751|FG000|Overall Study|Severe allergic reaction|8|||
155618969|NCT00249873|561697752|FG001|Overall Study|Severe allergic reaction|1|||
155618970|NCT00249873|561697751|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
155618971|NCT00249873|561697752|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
155618972|NCT00249873|561697751|FG000|Overall Study|Other Serious Adverse Event|86|||
155618973|NCT00249873|561697752|FG001|Overall Study|Other Serious Adverse Event|97|||
155618974|NCT00249873|561697751|FG000|Overall Study|Qualifying condition not present|20|||
155618975|NCT00249873|561697752|FG001|Overall Study|Qualifying condition not present|23|||
155618976|NCT00249873|561697751|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
155618977|NCT00249873|561697752|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
155618978|NCT00249873|561697751|FG000|Overall Study|Withdrawal by Subject|504|||
155618979|NCT00249873|561697752|FG001|Overall Study|Withdrawal by Subject|466|||
155618980|NCT00249873|561697751|FG000|Overall Study|Lost to Follow-up|4|||
155618981|NCT00249873|561697752|FG001|Overall Study|Lost to Follow-up|7|||
155618982|NCT00249873|561697751|FG000|Overall Study|Minor bleeding|99|||
155618983|NCT00249873|561697752|FG001|Overall Study|Minor bleeding|37|||
155618984|NCT00249873|561697751|FG000|Overall Study|Non-compliance|41|||
155618985|NCT00249873|561697752|FG001|Overall Study|Non-compliance|46|||
155618986|NCT00249873|561697751|FG000|Overall Study|Other non serious Adverse Event|112|||
155618987|NCT00249873|561697752|FG001|Overall Study|Other non serious Adverse Event|108|||
155618988|NCT00249873|561697751|FG000|Overall Study|Other contraindicated medication|1|||
155618989|NCT00249873|561697752|FG001|Overall Study|Other contraindicated medication|0|||
155618990|NCT00249873|561697751|FG000|Overall Study|Patient not wish to continue after May08|3|||
155618991|NCT00249873|561697752|FG001|Overall Study|Patient not wish to continue after May08|4|||
155618992|NCT00249873|561697751|FG000|Overall Study|Physician withdrew consent|59|||
155618993|NCT00249873|561697752|FG001|Overall Study|Physician withdrew consent|60|||
155618994|NCT00249873|561697751|FG000|Overall Study|Open label clopidogrel required|31|||
155618995|NCT00249873|561697752|FG001|Overall Study|Open label clopidogrel required|42|||
155618996|NCT00249873|561697751|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
155618997|NCT00249873|561697752|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
155618998|NCT00249873|561697751|FG000|Overall Study|Oral anticoagulant required|159|||
155618999|NCT00249873|561697752|FG001|Overall Study|Oral anticoagulant required|157|||
155726815|NCT00129402|562099805|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155381932|NCT00986973|560833241|FG000|Overall Study|Withdrawn by study team|1|||
155619000|NCT00249873|561697751|FG000|Overall Study|Study drug intolerance|5|||
155619001|NCT00249873|561697752|FG001|Overall Study|Study drug intolerance|0|||
155619002|NCT00249873|561697751|FG000|Overall Study|Surgery/ procedure|9|||
155619003|NCT00249873|561697752|FG001|Overall Study|Surgery/ procedure|9|||
155619004|NCT00249873|561697751|FG000|Overall Study|Event related to cardiac condition|12|||
155619005|NCT00249873|561697752|FG001|Overall Study|Event related to cardiac condition|21|||
155619006|NCT00249873|561697751|FG000|Overall Study|Thromboembolic/outcome event|82|||
155619007|NCT00249873|561697752|FG001|Overall Study|Thromboembolic/outcome event|122|||
155619008|NCT02254772|561697755|FG000|Overall Study|Ineligible|1|||
155619009|NCT02254772|561697755|FG000|Overall Study|Withdrawal by Subject|1|||
155619010|NCT03361306|561697763|FG000|Overall Study|Death|6|||
155273190|NCT00619476|560434431|FG003|Overall Study|Adverse Event|16|||
155273191|NCT00619476|560434428|FG000|Overall Study|Lack of Efficacy|6|||
155273192|NCT00619476|560434429|FG001|Overall Study|Lack of Efficacy|1|||
155273193|NCT00619476|560434430|FG002|Overall Study|Lack of Efficacy|1|||
155273194|NCT00619476|560434431|FG003|Overall Study|Lack of Efficacy|4|||
155273195|NCT00619476|560434428|FG000|Overall Study|Protocol Violation|5|||
155273196|NCT00619476|560434429|FG001|Overall Study|Protocol Violation|4|||
155273197|NCT00619476|560434430|FG002|Overall Study|Protocol Violation|4|||
155273198|NCT00619476|560434431|FG003|Overall Study|Protocol Violation|9|||
155273199|NCT00619476|560434428|FG000|Overall Study|Lost to Follow-up|1|||
155273200|NCT00619476|560434429|FG001|Overall Study|Lost to Follow-up|2|||
155273201|NCT00619476|560434430|FG002|Overall Study|Lost to Follow-up|0|||
155273202|NCT00619476|560434431|FG003|Overall Study|Lost to Follow-up|1|||
155273203|NCT00619476|560434428|FG000|Overall Study|Investigator Discretion|2|||
155273204|NCT00619476|560434429|FG001|Overall Study|Investigator Discretion|2|||
155273205|NCT00619476|560434430|FG002|Overall Study|Investigator Discretion|2|||
155273206|NCT00619476|560434431|FG003|Overall Study|Investigator Discretion|0|||
155273207|NCT00619476|560434428|FG000|Overall Study|Withdrawal by Subject|5|||
155273208|NCT00619476|560434429|FG001|Overall Study|Withdrawal by Subject|7|||
155273209|NCT00619476|560434430|FG002|Overall Study|Withdrawal by Subject|5|||
155273210|NCT00619476|560434431|FG003|Overall Study|Withdrawal by Subject|4|||
155273211|NCT01155388|560434432|FG000|Overall Study|Adverse Event|1|||
155273212|NCT01155388|560434433|FG001|Overall Study|Adverse Event|0|||
155619011|NCT00807885|561697769|FG000|Overall Study|Lost to Follow-up|0|||
155619012|NCT00807885|561697770|FG001|Overall Study|Lost to Follow-up|0|||
155619013|NCT00807885|561697771|FG002|Overall Study|Lost to Follow-up|0|||
155273213|NCT03884231|560434434|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
155273214|NCT03884231|560434434|FG000|Overall Study|Subject Withdrew Consent|1|||
155273215|NCT03884231|560434434|FG000|Overall Study|MRI Scan Not Performed|1|||
155273216|NCT00830947|560434435|FG000|Overall Study|Lost to Follow-up|4|||
155273217|NCT00830947|560434436|FG001|Overall Study|Lost to Follow-up|4|||
155273218|NCT00502996|560434451|FG000|Overall Study|Lost to Follow-up|9|||
155273219|NCT00502996|560434451|FG000|Overall Study|Protocol Violation|2|||
155273220|NCT00502996|560434451|FG000|Overall Study|Treatment failure|25|||
155273221|NCT00502996|560434451|FG000|Overall Study|Withdrawal Informed Consent|6|||
155273222|NCT00502996|560434451|FG000|Overall Study|Adverse Event|2|||
155273223|NCT01729728|560434452|FG000|Overall Study|Adverse Event|0|||
155273224|NCT01729728|560434453|FG001|Overall Study|Adverse Event|6|||
155273225|NCT01729728|560434454|FG002|Overall Study|Adverse Event|0|||
155273226|NCT01729728|560434452|FG000|Overall Study|Protocol Violation|1|||
155273227|NCT01729728|560434453|FG001|Overall Study|Protocol Violation|0|||
155273228|NCT01729728|560434454|FG002|Overall Study|Protocol Violation|1|||
155273229|NCT00672958|560434457|FG000|Overall Study|Adverse Event|11|||
155273230|NCT00672958|560434458|FG001|Overall Study|Adverse Event|9|||
155273231|NCT00672958|560434457|FG000|Overall Study|Lack of Efficacy|6|||
155273232|NCT00672958|560434458|FG001|Overall Study|Lack of Efficacy|11|||
155273233|NCT00672958|560434457|FG000|Overall Study|Non-compliance with study drug|2|||
155273234|NCT00672958|560434458|FG001|Overall Study|Non-compliance with study drug|3|||
155273235|NCT00672958|560434457|FG000|Overall Study|Protocol deviations|11|||
155273236|NCT00672958|560434458|FG001|Overall Study|Protocol deviations|5|||
155273237|NCT00672958|560434457|FG000|Overall Study|Voluntary withdrawal|12|||
155273238|NCT00672958|560434458|FG001|Overall Study|Voluntary withdrawal|8|||
155273239|NCT00672958|560434457|FG000|Overall Study|Lost to Follow-up|22|||
155273240|NCT00672958|560434458|FG001|Overall Study|Lost to Follow-up|17|||
155273241|NCT00672958|560434457|FG000|Overall Study|Reason not specified|0|||
155273242|NCT00672958|560434458|FG001|Overall Study|Reason not specified|3|||
155273243|NCT01964521|560434459|FG000|Overall Study|Lost to Follow-up|4|||
155273244|NCT00579982|560434460|FG000|Overall Study|Adverse Event|4|||
155273245|NCT00579982|560434460|FG000|Overall Study|Protocol Violation|4|||
155273246|NCT01551303|560434476|FG000|Overall Study|failed awareness check on vision test|4|||
155273247|NCT01551303|560434477|FG001|Overall Study|failed awareness check on vision test|7|||
155619014|NCT00807885|561697772|FG003|Overall Study|Lost to Follow-up|0|||
155619015|NCT00807885|561697773|FG004|Overall Study|Lost to Follow-up|0|||
155273248|NCT02141659|560434481|FG000|Overall Study|Major Protocol Deviation|0|||
155273249|NCT02141659|560434482|FG001|Overall Study|Major Protocol Deviation|1|||
155273250|NCT02141659|560434483|FG002|Overall Study|Major Protocol Deviation|0|||
155273251|NCT02141659|560434484|FG003|Overall Study|Major Protocol Deviation|0|||
155273252|NCT02141659|560434485|FG004|Overall Study|Major Protocol Deviation|0|||
155273253|NCT02141659|560434486|FG005|Overall Study|Major Protocol Deviation|0|||
155273254|NCT02141659|560434481|FG000|Overall Study|Lack of Efficacy|0|||
155273255|NCT02141659|560434482|FG001|Overall Study|Lack of Efficacy|0|||
155273256|NCT02141659|560434483|FG002|Overall Study|Lack of Efficacy|0|||
155273257|NCT02141659|560434484|FG003|Overall Study|Lack of Efficacy|0|||
155273258|NCT02141659|560434485|FG004|Overall Study|Lack of Efficacy|0|||
155273259|NCT02141659|560434486|FG005|Overall Study|Lack of Efficacy|1|||
155619016|NCT00807885|561697774|FG005|Overall Study|Lost to Follow-up|1|||
155726816|NCT00129402|562099799|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726817|NCT00129402|562099800|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726818|NCT00129402|562099801|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
155726819|NCT00129402|562099802|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726820|NCT00129402|562099803|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726821|NCT00129402|562099804|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726822|NCT00129402|562099805|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155726823|NCT00129402|562099799|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155726824|NCT00129402|562099800|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155726825|NCT00129402|562099801|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
155726826|NCT00129402|562099802|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155726827|NCT00129402|562099803|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155726828|NCT00129402|562099804|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
155726829|NCT00129402|562099805|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155726830|NCT00129402|562099799|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726831|NCT00129402|562099800|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726832|NCT00129402|562099801|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
155726833|NCT00129402|562099802|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726834|NCT00129402|562099803|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726835|NCT00129402|562099804|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726836|NCT00129402|562099805|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155726837|NCT00129402|562099799|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155726838|NCT00129402|562099800|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155726839|NCT00129402|562099801|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
155726840|NCT00129402|562099802|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155726841|NCT00129402|562099803|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155726842|NCT00129402|562099804|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
155726843|NCT00129402|562099805|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155726844|NCT00129402|562099799|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155726845|NCT00129402|562099800|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155726846|NCT00129402|562099801|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
155726847|NCT00129402|562099802|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155726848|NCT00129402|562099803|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155726849|NCT00129402|562099804|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
155726850|NCT00129402|562099805|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155726851|NCT00129402|562099799|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726852|NCT00129402|562099800|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726853|NCT00129402|562099801|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726854|NCT00129402|562099802|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726855|NCT00129402|562099803|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726856|NCT00129402|562099804|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155726857|NCT00129402|562099805|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
155726858|NCT00129402|562099799|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726859|NCT00129402|562099800|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726860|NCT00129402|562099801|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726861|NCT00129402|562099802|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726862|NCT00129402|562099803|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726863|NCT00129402|562099804|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155726864|NCT00129402|562099805|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
155726865|NCT00129402|562099799|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726866|NCT00129402|562099800|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726867|NCT00129402|562099801|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726868|NCT00129402|562099802|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726869|NCT00129402|562099803|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726870|NCT00129402|562099804|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155726871|NCT00129402|562099805|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
155726872|NCT00129402|562099799|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155726873|NCT00129402|562099800|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155726874|NCT00129402|562099801|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155726875|NCT00129402|562099802|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155726876|NCT00129402|562099803|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155726877|NCT00129402|562099804|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155619017|NCT00807885|561697775|FG006|Overall Study|Lost to Follow-up|0|||
155619018|NCT00807885|561697776|FG007|Overall Study|Lost to Follow-up|0|||
155619019|NCT00807885|561697777|FG008|Overall Study|Lost to Follow-up|0|||
155619020|NCT03489343|561697778|FG000|Overall Study|Documented progressive disease|1|||
155619021|NCT03489343|561697779|FG001|Overall Study|Documented progressive disease|0|||
155619022|NCT03489343|561697780|FG002|Overall Study|Documented progressive disease|3|||
155619023|NCT03489343|561697781|FG003|Overall Study|Documented progressive disease|1|||
155619024|NCT03489343|561697782|FG004|Overall Study|Documented progressive disease|3|||
155619025|NCT03489343|561697783|FG005|Overall Study|Documented progressive disease|5|||
155619026|NCT03489343|561697784|FG006|Overall Study|Documented progressive disease|4|||
155619027|NCT03489343|561697778|FG000|Overall Study|Adverse Event|0|||
155619028|NCT03489343|561697779|FG001|Overall Study|Adverse Event|1|||
155619029|NCT03489343|561697780|FG002|Overall Study|Adverse Event|0|||
155619030|NCT03489343|561697781|FG003|Overall Study|Adverse Event|0|||
155619031|NCT03489343|561697782|FG004|Overall Study|Adverse Event|0|||
155619032|NCT03489343|561697783|FG005|Overall Study|Adverse Event|1|||
155619033|NCT03489343|561697784|FG006|Overall Study|Adverse Event|0|||
155619034|NCT03489343|561697778|FG000|Overall Study|Withdrawal by Subject|0|||
155619035|NCT03489343|561697779|FG001|Overall Study|Withdrawal by Subject|0|||
155619036|NCT03489343|561697780|FG002|Overall Study|Withdrawal by Subject|0|||
155619037|NCT03489343|561697781|FG003|Overall Study|Withdrawal by Subject|1|||
155619038|NCT03489343|561697782|FG004|Overall Study|Withdrawal by Subject|0|||
155619039|NCT03489343|561697783|FG005|Overall Study|Withdrawal by Subject|1|||
155619040|NCT03489343|561697784|FG006|Overall Study|Withdrawal by Subject|1|||
155619041|NCT03489343|561697778|FG000|Overall Study|Clinical progression|0|||
155273260|NCT02141659|560434481|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273261|NCT02141659|560434482|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273262|NCT02141659|560434483|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273263|NCT02141659|560434484|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273264|NCT02141659|560434485|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
155273265|NCT02141659|560434486|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
155273266|NCT02471404|560434489|FG000|Overall Study|Adverse Event|7|||
155273267|NCT02471404|560434490|FG001|Overall Study|Adverse Event|1|||
155273268|NCT02471404|560434491|FG002|Overall Study|Adverse Event|2|||
155273269|NCT02471404|560434489|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
155273270|NCT02471404|560434490|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
155273271|NCT02471404|560434491|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
155273272|NCT02471404|560434489|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
155273273|NCT02471404|560434490|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155273274|NCT02471404|560434491|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
155273275|NCT02471404|560434489|FG000|Overall Study|Lost to Follow-up|1|||
155273276|NCT02471404|560434490|FG001|Overall Study|Lost to Follow-up|1|||
155273277|NCT02471404|560434491|FG002|Overall Study|Lost to Follow-up|3|||
155273278|NCT02471404|560434489|FG000|Overall Study|Protocol Violation|1|||
155273279|NCT02471404|560434490|FG001|Overall Study|Protocol Violation|0|||
155273280|NCT02471404|560434491|FG002|Overall Study|Protocol Violation|0|||
155273281|NCT02471404|560434489|FG000|Overall Study|Withdrawal by Subject|8|||
155273282|NCT02471404|560434490|FG001|Overall Study|Withdrawal by Subject|4|||
155273283|NCT02471404|560434491|FG002|Overall Study|Withdrawal by Subject|5|||
155273284|NCT02471404|560434489|FG000|Overall Study|Other reasons not specified|10|||
155273285|NCT02471404|560434490|FG001|Overall Study|Other reasons not specified|7|||
155273286|NCT02471404|560434491|FG002|Overall Study|Other reasons not specified|12|||
155273287|NCT01927731|560434492|FG000|Overall Study|Graft Failure|1|||
155273288|NCT01927731|560434493|FG001|Overall Study|Graft Failure|2|||
155273289|NCT01927731|560434492|FG000|Overall Study|Physician Decision|2|||
155273290|NCT01927731|560434493|FG001|Overall Study|Physician Decision|3|||
155273291|NCT01927731|560434492|FG000|Overall Study|Withdrawal by Subject|0|||
155273292|NCT01927731|560434493|FG001|Overall Study|Withdrawal by Subject|2|||
155273293|NCT01927731|560434492|FG000|Overall Study|Death|0|||
155273294|NCT01927731|560434493|FG001|Overall Study|Death|3|||
155273295|NCT00305864|560434498|FG000|Overall Study|Ineligible / No protocol treatment|0|||
155273296|NCT00305864|560434499|FG001|Overall Study|Ineligible / No protocol treatment|1|||
155273297|NCT00305864|560434500|FG002|Overall Study|Ineligible / No protocol treatment|1|||
155273298|NCT00305864|560434501|FG003|Overall Study|Ineligible / No protocol treatment|13|||
155273299|NCT02836613|560434504|FG000|Overall Study|Accidental drowning|1|||
155273300|NCT02836613|560434505|FG001|Overall Study|Accidental drowning|0|||
155273301|NCT02836613|560434504|FG000|Overall Study|Lost to Follow-up|0|||
155273302|NCT02836613|560434505|FG001|Overall Study|Lost to Follow-up|1|||
155273303|NCT02836613|560434504|FG000|Overall Study|Withdrawal by Subject|0|||
155273304|NCT02836613|560434505|FG001|Overall Study|Withdrawal by Subject|2|||
155273305|NCT01464255|560434506|FG000|Overall Study|unresolve corneal staining|0|||
155273306|NCT01464255|560434507|FG001|Overall Study|unresolve corneal staining|1|||
155619042|NCT03489343|561697779|FG001|Overall Study|Clinical progression|0|||
155619043|NCT03489343|561697780|FG002|Overall Study|Clinical progression|0|||
155619044|NCT03489343|561697781|FG003|Overall Study|Clinical progression|1|||
155619045|NCT03489343|561697782|FG004|Overall Study|Clinical progression|0|||
155273307|NCT03881059|560434508|FG000|Treatment Period - Part A|Adverse Event|1|||
155273308|NCT03881059|560434509|FG001|Treatment Period - Part A|Adverse Event|3|||
155273309|NCT03881059|560434510|FG002|Treatment Period - Part A|Adverse Event|4|||
155273310|NCT03881059|560434508|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
155273311|NCT03881059|560434509|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
155273312|NCT03881059|560434510|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
155273313|NCT03881059|560434508|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
155273314|NCT03881059|560434509|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
155273315|NCT03881059|560434510|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
155273316|NCT03881059|560434508|FG000|Treatment Period - Part A|Other reasons|2|||
155273317|NCT03881059|560434509|FG001|Treatment Period - Part A|Other reasons|1|||
155273318|NCT03881059|560434510|FG002|Treatment Period - Part A|Other reasons|0|||
155273319|NCT03881059|560434508|FG000|Treatment Period - Part B|Adverse Event|0|||
155273320|NCT03881059|560434509|FG001|Treatment Period - Part B|Adverse Event|0|||
155273321|NCT03881059|560434510|FG002|Treatment Period - Part B|Adverse Event|3|||
155273322|NCT03881059|560434508|FG000|Treatment Period - Part B|Death|0|||
155273323|NCT03881059|560434509|FG001|Treatment Period - Part B|Death|1|||
155273324|NCT03881059|560434510|FG002|Treatment Period - Part B|Death|1|||
155273325|NCT03881059|560434508|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
155273326|NCT03881059|560434509|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
155273327|NCT03881059|560434510|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
155273328|NCT03881059|560434508|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
155273329|NCT03881059|560434509|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
155273330|NCT03881059|560434510|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
155273331|NCT03881059|560434508|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
155273332|NCT03881059|560434509|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
155273333|NCT03881059|560434510|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
155273334|NCT03881059|560434508|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
155273335|NCT03881059|560434509|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
155273336|NCT03881059|560434510|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
155273337|NCT03881059|560434508|FG000|Treatment Period - Part B|Other reasons|4|||
155273338|NCT03881059|560434509|FG001|Treatment Period - Part B|Other reasons|3|||
155273339|NCT03881059|560434510|FG002|Treatment Period - Part B|Other reasons|3|||
155273340|NCT02065570|560434511|FG000|Induction Study|Adverse Event|5|||
155273341|NCT02065570|560434512|FG001|Induction Study|Adverse Event|12|||
155273342|NCT02065570|560434513|FG002|Induction Study|Adverse Event|0|||
155273343|NCT02065570|560434514|FG003|Induction Study|Adverse Event|0|||
155273344|NCT02065570|560434511|FG000|Induction Study|Withdrawal by Subject|2|||
155619046|NCT03489343|561697783|FG005|Overall Study|Clinical progression|0|||
155619047|NCT03489343|561697784|FG006|Overall Study|Clinical progression|1|||
155619048|NCT01630135|561697786|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
155619049|NCT01630135|561697787|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
155619050|NCT04767373|561697789|FG000|Overall Study|Death|6|||
155619051|NCT04767373|561697790|FG001|Overall Study|Death|3|||
155619052|NCT04767373|561697789|FG000|Overall Study|Lost to Follow-up|67|||
155619053|NCT04767373|561697790|FG001|Overall Study|Lost to Follow-up|35|||
155619054|NCT04767373|561697789|FG000|Overall Study|Physician Decision|15|||
155619055|NCT04767373|561697790|FG001|Overall Study|Physician Decision|4|||
155619056|NCT04767373|561697789|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155619057|NCT04767373|561697790|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155619058|NCT04767373|561697789|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
155619059|NCT04767373|561697790|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
155619060|NCT04767373|561697789|FG000|Overall Study|Other|1|||
155619061|NCT04767373|561697790|FG001|Overall Study|Other|2|||
155619062|NCT01502033|561697791|FG000|Overall Study|1 participant had scalp discomfort|1|||
155619063|NCT01502033|561697791|FG000|Overall Study|1 participant had worsening depression|1|||
155619064|NCT01502033|561697791|FG000|Overall Study|1 participant went back to school|1|||
155619065|NCT02658669|561697792|FG000|Overall Study|Lost to Follow-up|7|||
155619066|NCT02658669|561697793|FG001|Overall Study|Lost to Follow-up|5|||
155619067|NCT00838097|561697794|FG000|Overall Study|Ineligibility determined|6|||
155273345|NCT02065570|560434512|FG001|Induction Study|Withdrawal by Subject|3|||
155273346|NCT02065570|560434513|FG002|Induction Study|Withdrawal by Subject|0|||
155273347|NCT02065570|560434514|FG003|Induction Study|Withdrawal by Subject|0|||
155273348|NCT02065570|560434511|FG000|Induction Study|Lost to Follow-up|1|||
155619068|NCT00838097|561697794|FG000|Overall Study|Adverse Event|2|||
155619069|NCT00838097|561697794|FG000|Overall Study|Withdrawal by Subject|3|||
155619070|NCT00838097|561697794|FG000|Overall Study|Requirement for alternative therapy|2|||
155619071|NCT00838097|561697794|FG000|Overall Study|Physician Decision|4|||
155273349|NCT02065570|560434512|FG001|Induction Study|Lost to Follow-up|1|||
155273350|NCT02065570|560434513|FG002|Induction Study|Lost to Follow-up|0|||
155273351|NCT02065570|560434514|FG003|Induction Study|Lost to Follow-up|0|||
155619072|NCT00838097|561697794|FG000|Overall Study|Lost to Follow-up|11|||
155619073|NCT00838097|561697794|FG000|Overall Study|Death|6|||
155619074|NCT00838097|561697794|FG000|Overall Study|Protocol-specified criteria|142|||
155273352|NCT02065570|560434511|FG000|Induction Study|Other, Not Specified|6|||
155273353|NCT02065570|560434512|FG001|Induction Study|Other, Not Specified|5|||
155273354|NCT02065570|560434513|FG002|Induction Study|Other, Not Specified|0|||
155273355|NCT02065570|560434514|FG003|Induction Study|Other, Not Specified|0|||
155273356|NCT02065570|560434511|FG000|Maintenance Study|Adverse Event|0|||
155273357|NCT02065570|560434512|FG001|Maintenance Study|Adverse Event|0|||
155273358|NCT02065570|560434513|FG002|Maintenance Study|Adverse Event|8|||
155273359|NCT02065570|560434514|FG003|Maintenance Study|Adverse Event|8|||
155273360|NCT02065570|560434511|FG000|Maintenance Study|Withdrawal by Subject|0|||
155273361|NCT02065570|560434512|FG001|Maintenance Study|Withdrawal by Subject|0|||
155273362|NCT02065570|560434513|FG002|Maintenance Study|Withdrawal by Subject|1|||
155273363|NCT02065570|560434514|FG003|Maintenance Study|Withdrawal by Subject|4|||
155273364|NCT02065570|560434511|FG000|Maintenance Study|Lost to Follow-up|0|||
155273365|NCT02065570|560434512|FG001|Maintenance Study|Lost to Follow-up|0|||
155273366|NCT02065570|560434513|FG002|Maintenance Study|Lost to Follow-up|2|||
155273367|NCT02065570|560434514|FG003|Maintenance Study|Lost to Follow-up|2|||
155273368|NCT02065570|560434511|FG000|Maintenance Study|Other, Not Specified|0|||
155273369|NCT02065570|560434512|FG001|Maintenance Study|Other, Not Specified|0|||
155273370|NCT02065570|560434513|FG002|Maintenance Study|Other, Not Specified|11|||
155273371|NCT02065570|560434514|FG003|Maintenance Study|Other, Not Specified|5|||
155273372|NCT02743793|560434515|FG000|Overall Study|Death|1|||
155273373|NCT02743793|560434516|FG001|Overall Study|Death|1|||
155273374|NCT02743793|560434515|FG000|Overall Study|Withdrawal by Subject|0|||
155273375|NCT02743793|560434516|FG001|Overall Study|Withdrawal by Subject|1|||
155273376|NCT02743793|560434515|FG000|Overall Study|Screen Failure|4|||
155273377|NCT02743793|560434516|FG001|Overall Study|Screen Failure|0|||
155273378|NCT02743793|560434515|FG000|Overall Study|No Primary Care Physician|0|||
155273379|NCT02743793|560434516|FG001|Overall Study|No Primary Care Physician|1|||
155273380|NCT02743793|560434515|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
155273381|NCT02743793|560434516|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
155273382|NCT02743793|560434515|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
155273383|NCT02743793|560434516|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
155273384|NCT04276090|560434519|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
155273385|NCT04276090|560434520|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
155273386|NCT04642469|560434521|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
155273387|NCT04642469|560434522|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
155273388|NCT04642469|560434521|FG000|Overall Study|Death|1|||
155273389|NCT04642469|560434522|FG001|Overall Study|Death|2|||
155273390|NCT04642469|560434521|FG000|Overall Study|Study/site closed following amendment 1|11|||
155273391|NCT04642469|560434522|FG001|Overall Study|Study/site closed following amendment 1|11|||
155273392|NCT04642469|560434521|FG000|Overall Study|Other|1|||
155273393|NCT04642469|560434522|FG001|Overall Study|Other|1|||
155273394|NCT04642469|560434521|FG000|Overall Study|Withdrawal by Subject|1|||
155273395|NCT04642469|560434522|FG001|Overall Study|Withdrawal by Subject|0|||
155273396|NCT02066532|560434527|FG000|Phase II|Withdrawal by Subject|1|||
155273397|NCT02066532|560434528|FG001|Phase II|Withdrawal by Subject|0|||
155273398|NCT02066532|560434529|FG002|Phase II|Withdrawal by Subject|0|||
155273399|NCT02066532|560434530|FG003|Phase II|Withdrawal by Subject|0|||
155273400|NCT05033080|560434531|FG000|Overall Study|Adverse Event|4|||
155273401|NCT05033080|560434532|FG001|Overall Study|Adverse Event|4|||
155273402|NCT05033080|560434531|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
155273403|NCT05033080|560434532|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
155273404|NCT05033080|560434531|FG000|Overall Study|Lost to Follow-up|1|||
155273405|NCT05033080|560434532|FG001|Overall Study|Lost to Follow-up|0|||
155273406|NCT05033080|560434531|FG000|Overall Study|Other non-compliance|0|||
155273407|NCT05033080|560434532|FG001|Overall Study|Other non-compliance|1|||
155273408|NCT05033080|560434531|FG000|Overall Study|Physician Decision|0|||
155273409|NCT05033080|560434532|FG001|Overall Study|Physician Decision|1|||
155273410|NCT05033080|560434531|FG000|Overall Study|Other|1|||
155273411|NCT05033080|560434532|FG001|Overall Study|Other|1|||
155273412|NCT03560245|560434533|FG000|Overall Study|Withdrawal by Subject|3|||
155273413|NCT03560245|560434534|FG001|Overall Study|Withdrawal by Subject|2|||
155273414|NCT03560245|560434533|FG000|Overall Study|Adverse Event|1|||
155273415|NCT03560245|560434534|FG001|Overall Study|Adverse Event|1|||
155273416|NCT03560245|560434533|FG000|Overall Study|Protocol Violation|1|||
155273417|NCT03560245|560434534|FG001|Overall Study|Protocol Violation|0|||
155273418|NCT03560245|560434533|FG000|Overall Study|Death|0|||
155273419|NCT03560245|560434534|FG001|Overall Study|Death|1|||
155273420|NCT03560245|560434533|FG000|Overall Study|Lost to Follow-up|0|||
155273421|NCT03560245|560434534|FG001|Overall Study|Lost to Follow-up|1|||
155273422|NCT03560245|560434533|FG000|Overall Study|Physician Decision|0|||
155273423|NCT03560245|560434534|FG001|Overall Study|Physician Decision|1|||
155273424|NCT03560245|560434533|FG000|Overall Study|Other|0|||
155273425|NCT03560245|560434534|FG001|Overall Study|Other|1|||
155273426|NCT01680458|560434541|FG000|Overall Study|Protocol Violation|3|||
155273427|NCT02138747|560434542|FG000|Treatment Period 1|Adverse Event|10|||
155273428|NCT02138747|560434543|FG001|Treatment Period 1|Adverse Event|14|||
155273429|NCT02138747|560434544|FG002|Treatment Period 1|Adverse Event|2|||
155273430|NCT02138747|560434545|FG003|Treatment Period 1|Adverse Event|1|||
155273431|NCT02138747|560434542|FG000|Treatment Period 1|Lost to Follow-up|0|||
155273432|NCT02138747|560434543|FG001|Treatment Period 1|Lost to Follow-up|1|||
155273433|NCT02138747|560434544|FG002|Treatment Period 1|Lost to Follow-up|1|||
155273434|NCT02138747|560434545|FG003|Treatment Period 1|Lost to Follow-up|0|||
155273435|NCT02138747|560434542|FG000|Treatment Period 1|Protocol Violation|0|||
155273436|NCT02138747|560434543|FG001|Treatment Period 1|Protocol Violation|2|||
155273437|NCT02138747|560434544|FG002|Treatment Period 1|Protocol Violation|0|||
155273438|NCT02138747|560434545|FG003|Treatment Period 1|Protocol Violation|0|||
155273439|NCT02138747|560434542|FG000|Treatment Period 1|Withdrawal by Subject|8|||
155273440|NCT02138747|560434543|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155273441|NCT02138747|560434544|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155273442|NCT02138747|560434545|FG003|Treatment Period 1|Withdrawal by Subject|3|||
155273443|NCT02138747|560434542|FG000|Treatment Period 1|Other - Miscellaneous|2|||
155273444|NCT02138747|560434543|FG001|Treatment Period 1|Other - Miscellaneous|4|||
155273445|NCT02138747|560434544|FG002|Treatment Period 1|Other - Miscellaneous|0|||
155273446|NCT02138747|560434545|FG003|Treatment Period 1|Other - Miscellaneous|0|||
155273447|NCT02138747|560434542|FG000|Treatment Period 2|Adverse Event|6|||
155273448|NCT02138747|560434543|FG001|Treatment Period 2|Adverse Event|3|||
155273449|NCT02138747|560434544|FG002|Treatment Period 2|Adverse Event|1|||
155273450|NCT02138747|560434545|FG003|Treatment Period 2|Adverse Event|1|||
155273451|NCT02138747|560434542|FG000|Treatment Period 2|Lost to Follow-up|2|||
155273452|NCT02138747|560434543|FG001|Treatment Period 2|Lost to Follow-up|0|||
155273453|NCT02138747|560434544|FG002|Treatment Period 2|Lost to Follow-up|0|||
155273454|NCT02138747|560434545|FG003|Treatment Period 2|Lost to Follow-up|0|||
155273455|NCT02138747|560434542|FG000|Treatment Period 2|Protocol Violation|1|||
155273456|NCT02138747|560434543|FG001|Treatment Period 2|Protocol Violation|0|||
155273457|NCT02138747|560434544|FG002|Treatment Period 2|Protocol Violation|0|||
155273458|NCT02138747|560434545|FG003|Treatment Period 2|Protocol Violation|0|||
155273459|NCT02138747|560434542|FG000|Treatment Period 2|Withdrawal by Subject|5|||
155273460|NCT02138747|560434543|FG001|Treatment Period 2|Withdrawal by Subject|4|||
155273461|NCT02138747|560434544|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155273462|NCT02138747|560434545|FG003|Treatment Period 2|Withdrawal by Subject|2|||
155273463|NCT02138747|560434542|FG000|Treatment Period 2|Other - Miscellaneous|3|||
155619075|NCT05279131|561697796|FG000|Overall Study|Lost to Follow-up|1|||
155619076|NCT05279131|561697796|FG000|Overall Study|Death|1|||
155619077|NCT05279131|561697796|FG000|Overall Study|Physician Decision|1|||
155273464|NCT02138747|560434543|FG001|Treatment Period 2|Other - Miscellaneous|0|||
155273465|NCT02138747|560434544|FG002|Treatment Period 2|Other - Miscellaneous|0|||
155273466|NCT02138747|560434545|FG003|Treatment Period 2|Other - Miscellaneous|0|||
155273467|NCT03406702|560434554|FG000|Overall Study|Missed Day 27 Dosing|1|||
155273468|NCT01040780|560436281|FG000|Overall Study|Protocol Violation|1|||
155273469|NCT01040780|560436282|FG001|Overall Study|Protocol Violation|3|||
155273470|NCT03681639|560436283|FG000|Overall Study|Death|4|||
155273471|NCT03681639|560436283|FG000|Overall Study|Lost to Follow-up|2|||
155273472|NCT03681639|560436283|FG000|Overall Study|Withdrawal by Subject|1|||
155273473|NCT03681639|560436283|FG000|Overall Study|Adverse Event|2|||
155273474|NCT01004250|560436286|FG000|Induction Therapy Period|Adverse Event|10|||
155273475|NCT01004250|560436286|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
155273476|NCT01004250|560436286|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
155273477|NCT01004250|560436286|FG000|Induction Therapy Period|Physician Decision|2|||
155273478|NCT01004250|560436286|FG000|Maintenance Therapy Period|Adverse Event|15|||
155273479|NCT01004250|560436286|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
155273480|NCT01004250|560436286|FG000|Maintenance Therapy Period|Protocol Violation|1|||
155273481|NCT01004250|560436286|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
155273482|NCT01004250|560436286|FG000|Maintenance Therapy Period|Physician Decision|4|||
155273483|NCT01004250|560436286|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
155619078|NCT02149264|561697804|FG000|Overall Study|Withdrawal by Subject|9|||
155273484|NCT03268590|560436287|FG000|Overall Study|Previously unknown exclusion criteria|1|||
155273485|NCT04076020|560436315|FG000|Overall Study|Death|4|||
155273486|NCT04076020|560436316|FG001|Overall Study|Death|6|||
155273487|NCT04076020|560436315|FG000|Overall Study|Withdrawal by Subject|12|||
155273488|NCT04076020|560436316|FG001|Overall Study|Withdrawal by Subject|8|||
155273489|NCT03537261|560436322|FG000|Overall Study|Lost to Follow-up|4|||
155273490|NCT03537261|560436323|FG001|Overall Study|Lost to Follow-up|5|||
155273491|NCT03537261|560436322|FG000|Overall Study|Withdrawal by Subject|4|||
155273492|NCT03537261|560436323|FG001|Overall Study|Withdrawal by Subject|6|||
155273493|NCT03537261|560436322|FG000|Overall Study|Did not return study questionnaires|0|||
155273494|NCT03537261|560436323|FG001|Overall Study|Did not return study questionnaires|1|||
155273495|NCT01316692|560436326|FG000|Overall Study|Adverse Event|5|||
155273496|NCT01316692|560436326|FG000|Overall Study|Disease Progression|7|||
155273497|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
155273498|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
155273499|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
155273500|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
155273501|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
155273502|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
155273503|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
155273504|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
155273505|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
155273506|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
155273507|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
155273508|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
155273509|NCT00993317|560436330|FG000|Overall Study|Adverse Event|2|||
155273510|NCT00993317|560436331|FG001|Overall Study|Adverse Event|4|||
155273511|NCT00993317|560436330|FG000|Overall Study|Lack of Efficacy|18|||
155273512|NCT00993317|560436331|FG001|Overall Study|Lack of Efficacy|18|||
155273513|NCT00993317|560436330|FG000|Overall Study|Withdrawal by Subject|0|||
155273514|NCT00993317|560436331|FG001|Overall Study|Withdrawal by Subject|2|||
155273515|NCT00993317|560436330|FG000|Overall Study|Investigator's opinion|0|||
155273516|NCT00993317|560436331|FG001|Overall Study|Investigator's opinion|1|||
155273517|NCT00993317|560436330|FG000|Overall Study|Early study termination at the site|1|||
155273518|NCT00993317|560436331|FG001|Overall Study|Early study termination at the site|0|||
155273519|NCT01380990|560436332|FG000|Overall Study|Treatment Failure|1|||
155273520|NCT01380990|560436333|FG001|Overall Study|Treatment Failure|0|||
155273521|NCT01380990|560436332|FG000|Overall Study|Death|0|||
155273522|NCT01380990|560436333|FG001|Overall Study|Death|1|||
155273523|NCT04422639|560436336|FG000|Overall Study|Death|1|||
155273524|NCT04422639|560436337|FG001|Overall Study|Death|0|||
155273525|NCT04422639|560436336|FG000|Overall Study|study closed prior to completion of FU visits|0|||
155273526|NCT04422639|560436337|FG001|Overall Study|study closed prior to completion of FU visits|2|||
155273527|NCT02374593|560436339|FG000|Overall Study|non-compliant|2|||
155273528|NCT02374593|560436340|FG001|Overall Study|non-compliant|0|||
155273529|NCT01284140|560436341|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
155273530|NCT01284140|560436342|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
155273531|NCT01284140|560436341|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
155273532|NCT01284140|560436342|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
155273533|NCT01463293|560436343|FG000|Overall Study|Lost to Follow-up|1|||
155273534|NCT01463293|560436344|FG001|Overall Study|Lost to Follow-up|4|||
155273535|NCT01463293|560436345|FG002|Overall Study|Lost to Follow-up|5|||
155273536|NCT01463293|560436343|FG000|Overall Study|Adverse Event|1|||
155273537|NCT01463293|560436344|FG001|Overall Study|Adverse Event|2|||
155273538|NCT01463293|560436345|FG002|Overall Study|Adverse Event|0|||
155273539|NCT01463293|560436343|FG000|Overall Study|Withdrawal by Subject|4|||
155273540|NCT01463293|560436344|FG001|Overall Study|Withdrawal by Subject|10|||
155273541|NCT01463293|560436345|FG002|Overall Study|Withdrawal by Subject|5|||
155273542|NCT01463293|560436343|FG000|Overall Study|Other|0|||
155273543|NCT01463293|560436344|FG001|Overall Study|Other|0|||
155273544|NCT01463293|560436345|FG002|Overall Study|Other|2|||
155619079|NCT02149264|561697804|FG000|Overall Study|Adverse Event|7|||
155619080|NCT02149264|561697804|FG000|Overall Study|Physician Decision|3|||
155619081|NCT02149264|561697804|FG000|Overall Study|Protocol Violation|1|||
155619082|NCT00672633|561697808|FG000|Overall Study|Withdrawal by Subject|0|||
155619083|NCT00672633|561697809|FG001|Overall Study|Withdrawal by Subject|1|||
155619084|NCT02824627|561697810|FG000|Overall Study|Adverse Event|1|||
155619085|NCT02824627|561697811|FG001|Overall Study|Adverse Event|2|||
155619086|NCT02824627|561697810|FG000|Overall Study|Lost to Follow-up|2|||
155619087|NCT02824627|561697811|FG001|Overall Study|Lost to Follow-up|1|||
155619088|NCT01938846|561697812|FG000|Overall Study|Progressive disease|26|||
155619089|NCT01938846|561697813|FG001|Overall Study|Progressive disease|18|||
155619090|NCT01938846|561697814|FG002|Overall Study|Progressive disease|16|||
155273545|NCT02796963|560436346|FG000|Overall Study|Lost to Follow-up|89|||
155273546|NCT02796963|560436347|FG001|Overall Study|Lost to Follow-up|76|||
155273547|NCT02796963|560436348|FG002|Overall Study|Lost to Follow-up|69|||
155273548|NCT02796963|560436349|FG003|Overall Study|Lost to Follow-up|72|||
155273549|NCT03192215|560436350|FG000|Overall Study|Death|28|||
155273550|NCT03192215|560436351|FG001|Overall Study|Death|23|||
155273551|NCT03192215|560436350|FG000|Overall Study|Lost to Follow-up|10|||
155619091|NCT01938846|561697812|FG000|Overall Study|Adverse Event|8|||
155619092|NCT01938846|561697813|FG001|Overall Study|Adverse Event|4|||
155619093|NCT01938846|561697814|FG002|Overall Study|Adverse Event|3|||
155619094|NCT01938846|561697812|FG000|Overall Study|Withdrawal by Subject|2|||
155619095|NCT01938846|561697813|FG001|Overall Study|Withdrawal by Subject|2|||
155273552|NCT03192215|560436351|FG001|Overall Study|Lost to Follow-up|15|||
155273553|NCT03192215|560436350|FG000|Overall Study|Withdrawal by Subject|49|||
155273554|NCT03192215|560436351|FG001|Overall Study|Withdrawal by Subject|48|||
155273555|NCT03192215|560436350|FG000|Overall Study|Other as reported in analysis|4|||
155619096|NCT01938846|561697814|FG002|Overall Study|Withdrawal by Subject|1|||
155619097|NCT01938846|561697812|FG000|Overall Study|Other than listed|5|||
155619098|NCT01938846|561697813|FG001|Overall Study|Other than listed|1|||
155619099|NCT01938846|561697814|FG002|Overall Study|Other than listed|4|||
155619100|NCT02499120|561697818|FG000|Overall Study|Death|52|||
155619101|NCT02499120|561697819|FG001|Overall Study|Death|43|||
155619102|NCT02499120|561697818|FG000|Overall Study|Lost to Follow-up|1|||
155619103|NCT02499120|561697819|FG001|Overall Study|Lost to Follow-up|2|||
155619104|NCT02499120|561697818|FG000|Overall Study|Participant refused further follow-up|1|||
155619105|NCT02499120|561697819|FG001|Overall Study|Participant refused further follow-up|0|||
155619106|NCT02499120|561697818|FG000|Overall Study|Withdrawal by Subject|2|||
155619107|NCT02499120|561697819|FG001|Overall Study|Withdrawal by Subject|5|||
155619108|NCT02499120|561697818|FG000|Overall Study|Other|9|||
155619109|NCT02499120|561697819|FG001|Overall Study|Other|10|||
155619110|NCT02282163|561697826|FG000|Overall Study|Protocol Violation|1|||
155619111|NCT03472521|561697827|FG000|Overall Study|Lost to Follow-up|3|||
155619112|NCT03472521|561697828|FG001|Overall Study|Lost to Follow-up|2|||
155619113|NCT03472521|561697827|FG000|Overall Study|Discontinued intervention|3|||
155619114|NCT03472521|561697828|FG001|Overall Study|Discontinued intervention|1|||
155619115|NCT01603407|561697829|FG000|Overall Study|Adverse Event|1|||
155619116|NCT01603407|561697830|FG001|Overall Study|Adverse Event|1|||
155619117|NCT01603407|561697831|FG002|Overall Study|Adverse Event|1|||
155619118|NCT01603407|561697829|FG000|Overall Study|Protocol Violation|2|||
155619119|NCT01603407|561697830|FG001|Overall Study|Protocol Violation|2|||
155619120|NCT01603407|561697831|FG002|Overall Study|Protocol Violation|0|||
155619121|NCT01603407|561697829|FG000|Overall Study|Withdrawal by Subject|8|||
155619122|NCT01603407|561697830|FG001|Overall Study|Withdrawal by Subject|5|||
155619123|NCT01603407|561697831|FG002|Overall Study|Withdrawal by Subject|7|||
155619124|NCT01603407|561697829|FG000|Overall Study|Lost to Follow-up|0|||
155619125|NCT01603407|561697830|FG001|Overall Study|Lost to Follow-up|3|||
155619126|NCT01603407|561697831|FG002|Overall Study|Lost to Follow-up|2|||
155619127|NCT01801111|561697839|FG000|Overall Study|Adverse Event|12|||
155619128|NCT01801111|561697839|FG000|Overall Study|Death|8|||
155619129|NCT01801111|561697839|FG000|Overall Study|Physician Decision|5|||
155619130|NCT01801111|561697839|FG000|Overall Study|Other|1|||
155619131|NCT01801111|561697839|FG000|Overall Study|Withdrawal by Subject|4|||
155619132|NCT01801111|561697839|FG000|Overall Study|Study Terminated by Sponsor|27|||
155619133|NCT01801111|561697839|FG000|Overall Study|Progressive Disease|81|||
155619134|NCT01210482|561697840|FG000|Overall Study|Protocol Violation|1|||
155619135|NCT01210482|561697840|FG000|Overall Study|Case Report Forms were not collected|18|||
155619136|NCT01210482|561697840|FG000|Overall Study|Duplicated|2|||
155619137|NCT01210482|561697840|FG000|Overall Study|No Drug Administration|28|||
155619138|NCT01223937|561697841|FG000|Overall Study|Withdrawal by Subject|3|||
155619139|NCT01223937|561697842|FG001|Overall Study|Withdrawal by Subject|2|||
155619140|NCT01223937|561697841|FG000|Overall Study|Lost to Follow-up|1|||
155619141|NCT01223937|561697842|FG001|Overall Study|Lost to Follow-up|4|||
155619142|NCT01223937|561697841|FG000|Overall Study|Adverse Event|1|||
155619143|NCT01223937|561697842|FG001|Overall Study|Adverse Event|4|||
155619144|NCT01223937|561697841|FG000|Overall Study|Protocol Violation|8|||
155619145|NCT01223937|561697842|FG001|Overall Study|Protocol Violation|7|||
155619146|NCT01223937|561697841|FG000|Overall Study|Other|4|||
155619147|NCT01223937|561697842|FG001|Overall Study|Other|1|||
155619148|NCT03284853|561697843|FG000|Overall Study|Adverse Event|40|||
155619149|NCT03284853|561697844|FG001|Overall Study|Adverse Event|4|||
155619150|NCT03284853|561697843|FG000|Overall Study|Withdrawal by Subject|5|||
155619151|NCT03284853|561697844|FG001|Overall Study|Withdrawal by Subject|1|||
155619152|NCT03284853|561697843|FG000|Overall Study|Lost to Follow-up|1|||
155619153|NCT03284853|561697844|FG001|Overall Study|Lost to Follow-up|0|||
155619154|NCT03284853|561697843|FG000|Overall Study|Lack of Efficacy|1|||
155619155|NCT03284853|561697844|FG001|Overall Study|Lack of Efficacy|0|||
155619156|NCT03284853|561697843|FG000|Overall Study|Disallowed Concurrent Medication|1|||
155619157|NCT03284853|561697844|FG001|Overall Study|Disallowed Concurrent Medication|1|||
155619158|NCT03284853|561697843|FG000|Overall Study|Protocol Violation|3|||
155619159|NCT03284853|561697844|FG001|Overall Study|Protocol Violation|3|||
155619160|NCT03284853|561697843|FG000|Overall Study|Death|0|||
155619161|NCT03284853|561697844|FG001|Overall Study|Death|1|||
155619162|NCT03284853|561697843|FG000|Overall Study|Other - Reason not reported in CSR|4|||
155619163|NCT03284853|561697844|FG001|Overall Study|Other - Reason not reported in CSR|3|||
155619164|NCT05176717|561697845|FG000|Overall Study|Sponsor Decision|1|||
155619165|NCT05176717|561697846|FG001|Overall Study|Sponsor Decision|2|||
155619166|NCT05176717|561697847|FG002|Overall Study|Sponsor Decision|2|||
155619167|NCT00765817|561697849|FG000|Overall Study|Adverse Event|13|||
155619168|NCT00765817|561697850|FG001|Overall Study|Adverse Event|1|||
155619169|NCT00765817|561697849|FG000|Overall Study|Death|0|||
155619170|NCT00765817|561697850|FG001|Overall Study|Death|1|||
155619171|NCT00765817|561697849|FG000|Overall Study|Entry criteria not met|2|||
155619172|NCT00765817|561697850|FG001|Overall Study|Entry criteria not met|2|||
155619173|NCT00765817|561697849|FG000|Overall Study|Loss of glucose control|0|||
155619174|NCT00765817|561697850|FG001|Overall Study|Loss of glucose control|2|||
155619175|NCT00765817|561697849|FG000|Overall Study|Lost to Follow-up|1|||
155619176|NCT00765817|561697850|FG001|Overall Study|Lost to Follow-up|3|||
155619177|NCT00765817|561697849|FG000|Overall Study|Physician Decision|2|||
155619178|NCT00765817|561697850|FG001|Overall Study|Physician Decision|1|||
155619179|NCT00765817|561697849|FG000|Overall Study|Protocol Violation|1|||
155619180|NCT00765817|561697850|FG001|Overall Study|Protocol Violation|1|||
155619181|NCT00765817|561697849|FG000|Overall Study|Subject decision|7|||
155619182|NCT00765817|561697850|FG001|Overall Study|Subject decision|11|||
155619183|NCT02308228|561697851|FG000|Overall Study|Adverse Event|3|||
155619184|NCT02308228|561697852|FG001|Overall Study|Adverse Event|4|||
155619185|NCT02308228|561697851|FG000|Overall Study|Withdrawal by Subject|5|||
155619186|NCT02308228|561697852|FG001|Overall Study|Withdrawal by Subject|3|||
155619187|NCT02143024|561697853|FG000|Overall Study|Lost to Follow-up|1|||
155619188|NCT02143024|561697854|FG001|Overall Study|Lost to Follow-up|1|||
155619189|NCT02143024|561697853|FG000|Overall Study|Withdrawal by Subject|1|||
155619190|NCT02143024|561697854|FG001|Overall Study|Withdrawal by Subject|0|||
155619191|NCT06597084|561697855|FG000|Overall Study|Withdrawal by Subject|4|||
155619192|NCT06597084|561697856|FG001|Overall Study|Withdrawal by Subject|9|||
155619193|NCT06597084|561697855|FG000|Overall Study|Consent was not given by the patient until V2|0|||
155619194|NCT06597084|561697856|FG001|Overall Study|Consent was not given by the patient until V2|3|||
155619195|NCT06597084|561697855|FG000|Overall Study|Physician Decision|1|||
155619196|NCT06597084|561697856|FG001|Overall Study|Physician Decision|0|||
155619197|NCT06597084|561697855|FG000|Overall Study|Adverse Event|3|||
155619198|NCT06597084|561697856|FG001|Overall Study|Adverse Event|2|||
155619199|NCT06597084|561697855|FG000|Overall Study|Death|4|||
155619200|NCT06597084|561697856|FG001|Overall Study|Death|0|||
155619201|NCT06597084|561697855|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
155619202|NCT06597084|561697856|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
155619203|NCT06597084|561697855|FG000|Overall Study|Lost to Follow-up|4|||
155619204|NCT06597084|561697856|FG001|Overall Study|Lost to Follow-up|2|||
155619205|NCT06597084|561697855|FG000|Overall Study|Other. Not specified|1|||
155619206|NCT06597084|561697856|FG001|Overall Study|Other. Not specified|0|||
155619207|NCT03999749|561697860|FG000|Overall Study|Toxicity|16|||
155619208|NCT03999749|561697860|FG000|Overall Study|Withdrawal by Subject|3|||
155619209|NCT03999749|561697860|FG000|Overall Study|Disease progression|26|||
155619210|NCT03999749|561697860|FG000|Overall Study|Physician Decision|4|||
155619211|NCT03999749|561697860|FG000|Overall Study|Death|5|||
155619212|NCT03999749|561697860|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
155619213|NCT00255164|561697861|FG000|Overall Study|Adverse Event|10|||
155619214|NCT00255164|561697862|FG001|Overall Study|Adverse Event|6|||
155619215|NCT00255164|561697863|FG002|Overall Study|Adverse Event|9|||
155619216|NCT00255164|561697861|FG000|Overall Study|Lost to Follow-up|4|||
155619217|NCT00255164|561697862|FG001|Overall Study|Lost to Follow-up|3|||
155619218|NCT00255164|561697863|FG002|Overall Study|Lost to Follow-up|4|||
155619219|NCT00255164|561697861|FG000|Overall Study|Withdrawal by Subject|18|||
155619220|NCT00255164|561697862|FG001|Overall Study|Withdrawal by Subject|17|||
155619221|NCT00255164|561697863|FG002|Overall Study|Withdrawal by Subject|8|||
155619222|NCT00255164|561697861|FG000|Overall Study|Noncompliance|0|||
155619223|NCT00255164|561697862|FG001|Overall Study|Noncompliance|1|||
155619224|NCT00255164|561697863|FG002|Overall Study|Noncompliance|2|||
155619225|NCT00255164|561697861|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
155619226|NCT00255164|561697862|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
155619227|NCT00255164|561697863|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
155619228|NCT00255164|561697861|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
155619229|NCT00255164|561697862|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
155619230|NCT00255164|561697863|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
155619231|NCT00255164|561697861|FG000|Overall Study|Possible Barrett's Esophagus|1|||
155619232|NCT00255164|561697862|FG001|Overall Study|Possible Barrett's Esophagus|3|||
155619233|NCT00255164|561697863|FG002|Overall Study|Possible Barrett's Esophagus|8|||
155619234|NCT00255164|561697861|FG000|Overall Study|Esophageal Stricture|0|||
155619235|NCT00255164|561697862|FG001|Overall Study|Esophageal Stricture|0|||
155619236|NCT00255164|561697863|FG002|Overall Study|Esophageal Stricture|1|||
155619237|NCT00255164|561697861|FG000|Overall Study|Therapeutic Failure|11|||
155619238|NCT00255164|561697862|FG001|Overall Study|Therapeutic Failure|2|||
155619239|NCT00255164|561697863|FG002|Overall Study|Therapeutic Failure|3|||
155619240|NCT03677869|561697864|FG000|Overall Study|Withdrawal by Subject|1|||
155619241|NCT05219968|561697865|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
155619242|NCT05219968|561697866|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155619243|NCT05219968|561697867|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155619244|NCT05219968|561697868|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155619245|NCT05219968|561697869|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155619246|NCT05219968|561697865|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
155619247|NCT05219968|561697866|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
155619248|NCT05219968|561697867|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
155619249|NCT05219968|561697868|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
155619250|NCT05219968|561697869|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
155619251|NCT05219968|561697865|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
155619252|NCT05219968|561697866|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
155619253|NCT05219968|561697867|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
155619254|NCT05219968|561697868|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
155619255|NCT05219968|561697869|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
155619256|NCT05219968|561697865|FG000|Week 24 Treatment Period|Adverse Event|3|||
155619257|NCT05219968|561697866|FG001|Week 24 Treatment Period|Adverse Event|0|||
155619258|NCT05219968|561697867|FG002|Week 24 Treatment Period|Adverse Event|0|||
155619259|NCT05219968|561697868|FG003|Week 24 Treatment Period|Adverse Event|0|||
155619260|NCT05219968|561697869|FG004|Week 24 Treatment Period|Adverse Event|0|||
155619261|NCT05219968|561697865|FG000|Week 24 Treatment Period|Physician Decision|0|||
155619262|NCT05219968|561697866|FG001|Week 24 Treatment Period|Physician Decision|1|||
155619263|NCT05219968|561697867|FG002|Week 24 Treatment Period|Physician Decision|0|||
155619264|NCT05219968|561697868|FG003|Week 24 Treatment Period|Physician Decision|0|||
155619265|NCT05219968|561697869|FG004|Week 24 Treatment Period|Physician Decision|0|||
155619266|NCT05219968|561697865|FG000|Week 24 Treatment Period|Other, not specified|3|||
155619267|NCT05219968|561697866|FG001|Week 24 Treatment Period|Other, not specified|0|||
155619268|NCT05219968|561697867|FG002|Week 24 Treatment Period|Other, not specified|0|||
155619269|NCT05219968|561697868|FG003|Week 24 Treatment Period|Other, not specified|0|||
155619270|NCT05219968|561697869|FG004|Week 24 Treatment Period|Other, not specified|0|||
155619271|NCT05219968|561697865|FG000|Safety Extension Period|Treatment administration failure|0|||
155619272|NCT05219968|561697866|FG001|Safety Extension Period|Treatment administration failure|0|||
155619273|NCT05219968|561697867|FG002|Safety Extension Period|Treatment administration failure|0|||
155619274|NCT05219968|561697868|FG003|Safety Extension Period|Treatment administration failure|1|||
155619275|NCT05219968|561697869|FG004|Safety Extension Period|Treatment administration failure|4|||
155619276|NCT05219968|561697865|FG000|Safety Extension Period|Bilateral dislodgement|0|||
155619277|NCT05219968|561697866|FG001|Safety Extension Period|Bilateral dislodgement|0|||
155619278|NCT05219968|561697867|FG002|Safety Extension Period|Bilateral dislodgement|4|||
155619279|NCT05219968|561697868|FG003|Safety Extension Period|Bilateral dislodgement|0|||
155619280|NCT05219968|561697869|FG004|Safety Extension Period|Bilateral dislodgement|1|||
155619281|NCT05219968|561697865|FG000|Safety Extension Period|Withdrawal by Subject|0|||
155619282|NCT05219968|561697866|FG001|Safety Extension Period|Withdrawal by Subject|0|||
155619283|NCT05219968|561697867|FG002|Safety Extension Period|Withdrawal by Subject|2|||
155619284|NCT05219968|561697868|FG003|Safety Extension Period|Withdrawal by Subject|0|||
155619285|NCT05219968|561697869|FG004|Safety Extension Period|Withdrawal by Subject|4|||
155619286|NCT05219968|561697865|FG000|Safety Extension Period|Adverse Event|0|||
155619287|NCT05219968|561697866|FG001|Safety Extension Period|Adverse Event|0|||
155619288|NCT05219968|561697867|FG002|Safety Extension Period|Adverse Event|2|||
155619289|NCT05219968|561697868|FG003|Safety Extension Period|Adverse Event|1|||
155619290|NCT05219968|561697869|FG004|Safety Extension Period|Adverse Event|1|||
155619291|NCT05219968|561697865|FG000|Safety Extension Period|Lost to Follow-up|0|||
155619292|NCT05219968|561697866|FG001|Safety Extension Period|Lost to Follow-up|0|||
155619293|NCT05219968|561697867|FG002|Safety Extension Period|Lost to Follow-up|0|||
155619294|NCT05219968|561697868|FG003|Safety Extension Period|Lost to Follow-up|1|||
155619295|NCT05219968|561697869|FG004|Safety Extension Period|Lost to Follow-up|0|||
155619296|NCT04587336|561697872|FG000|Overall Study|Lost to Follow-up|1|||
155619297|NCT04587336|561697873|FG001|Overall Study|Lost to Follow-up|0|||
155619298|NCT00758498|561699632|FG000|Overall Study|Adverse Event|2|||
155619299|NCT00758498|561699633|FG001|Overall Study|Adverse Event|2|||
155619300|NCT00758498|561699634|FG002|Overall Study|Adverse Event|3|||
155619301|NCT00758498|561699632|FG000|Overall Study|Subject legally detained out of state|1|||
155619302|NCT00758498|561699633|FG001|Overall Study|Subject legally detained out of state|0|||
155619303|NCT00758498|561699634|FG002|Overall Study|Subject legally detained out of state|0|||
155619304|NCT00758498|561699632|FG000|Overall Study|Withdrawal by Subject|0|||
155619305|NCT00758498|561699633|FG001|Overall Study|Withdrawal by Subject|0|||
155619306|NCT00758498|561699634|FG002|Overall Study|Withdrawal by Subject|1|||
155619307|NCT00758498|561699632|FG000|Overall Study|Noncompliance to study procedures|0|||
155619308|NCT00758498|561699633|FG001|Overall Study|Noncompliance to study procedures|0|||
155619309|NCT00758498|561699634|FG002|Overall Study|Noncompliance to study procedures|1|||
155619310|NCT02317991|561699635|FG000|Overall Study|Adverse Event|12|||
155619311|NCT02317991|561699635|FG000|Overall Study|Death|4|||
155619312|NCT02317991|561699635|FG000|Overall Study|Withdrawal by Subject|8|||
155619313|NCT02317991|561699635|FG000|Overall Study|Progressive Disease|41|||
155619314|NCT00707057|561699636|FG000|Overall Study|Withdrawal by Subject|8|||
155273556|NCT03192215|560436351|FG001|Overall Study|Other as reported in analysis|1|||
155619315|NCT00707057|561699637|FG001|Overall Study|Withdrawal by Subject|3|||
155619316|NCT00707057|561699636|FG000|Overall Study|Dosed incorrectly|0|||
155619317|NCT00707057|561699637|FG001|Overall Study|Dosed incorrectly|1|||
155619318|NCT02492165|561699638|FG000|Overall Study|Withdrawal by Subject|0|||
155619319|NCT02492165|561699639|FG001|Overall Study|Withdrawal by Subject|1|||
155273557|NCT02038764|560436354|FG000|Overall Study|Adverse Event|0|||
155619320|NCT02492165|561699640|FG002|Overall Study|Withdrawal by Subject|0|||
155273558|NCT02038764|560436355|FG001|Overall Study|Adverse Event|0|||
155273559|NCT02038764|560436356|FG002|Overall Study|Adverse Event|1|||
155619321|NCT02492165|561699641|FG003|Overall Study|Withdrawal by Subject|0|||
155619322|NCT01697800|561699642|FG000|Overall Study|Death|0|||
155619323|NCT01697800|561699643|FG001|Overall Study|Death|1|||
155619324|NCT00823134|561699646|FG000|Overall Study|Invalid measurement|1|||
155619325|NCT02922153|561699650|FG000|Overall Study|Death|8|||
155619326|NCT02922153|561699651|FG001|Overall Study|Death|1|||
155619327|NCT02922153|561699650|FG000|Overall Study|Lost to Follow-up|1|||
155619328|NCT02922153|561699651|FG001|Overall Study|Lost to Follow-up|0|||
155619329|NCT02922153|561699650|FG000|Overall Study|Physician Decision|1|||
155619330|NCT02922153|561699651|FG001|Overall Study|Physician Decision|1|||
155619331|NCT01053741|561699658|FG000|2nd Study Intervention|Physician Decision|0|||
155619332|NCT01053741|561699659|FG001|2nd Study Intervention|Physician Decision|1|||
155619333|NCT00994110|561699660|FG000|Overall Study|Withdrawal by Subject|9|||
155619334|NCT00994110|561699661|FG001|Overall Study|Withdrawal by Subject|9|||
155619335|NCT00994110|561699660|FG000|Overall Study|Not Treated|4|||
155619336|NCT00994110|561699661|FG001|Overall Study|Not Treated|8|||
155619337|NCT00994110|561699660|FG000|Overall Study|Adverse Event|1|||
155619338|NCT00994110|561699661|FG001|Overall Study|Adverse Event|0|||
155619339|NCT00994110|561699660|FG000|Overall Study|Patient not resected|41|||
155619340|NCT00994110|561699661|FG001|Overall Study|Patient not resected|52|||
155619341|NCT00994110|561699660|FG000|Overall Study|Pt not eligible|10|||
155619342|NCT00994110|561699661|FG001|Overall Study|Pt not eligible|5|||
155619343|NCT00943397|561699662|FG000|Overall Study|Adverse Event|0|||
155619344|NCT00943397|561699663|FG001|Overall Study|Adverse Event|6|||
155619345|NCT00943397|561699662|FG000|Overall Study|Lost to Follow-up|0|||
155619346|NCT00943397|561699663|FG001|Overall Study|Lost to Follow-up|4|||
155619347|NCT00943397|561699662|FG000|Overall Study|Protocol Violation|2|||
155619348|NCT00943397|561699663|FG001|Overall Study|Protocol Violation|5|||
155619349|NCT00943397|561699662|FG000|Overall Study|Withdrawal by Subject|1|||
155619350|NCT00943397|561699663|FG001|Overall Study|Withdrawal by Subject|1|||
155619351|NCT00943397|561699662|FG000|Overall Study|Site terminated and other|12|||
155619352|NCT00943397|561699663|FG001|Overall Study|Site terminated and other|56|||
155619353|NCT02948829|561699664|FG000|Overall Study|Lost to Follow-up|2|||
155619354|NCT02948829|561699664|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
155619355|NCT02948829|561699664|FG000|Overall Study|Pregnancy|1|||
155619356|NCT02948829|561699664|FG000|Overall Study|Other: Reason not Specified|8|||
155619357|NCT01004978|561699665|FG000|Overall Study|Disease progression|31|||
155619358|NCT01004978|561699666|FG001|Overall Study|Disease progression|48|||
155619359|NCT01004978|561699665|FG000|Overall Study|Adverse Event|42|||
155619360|NCT01004978|561699666|FG001|Overall Study|Adverse Event|22|||
155619361|NCT01004978|561699665|FG000|Overall Study|Death|3|||
155619362|NCT01004978|561699666|FG001|Overall Study|Death|2|||
155619363|NCT01004978|561699665|FG000|Overall Study|Withdrawal by Subject|16|||
155619364|NCT01004978|561699666|FG001|Overall Study|Withdrawal by Subject|16|||
155619365|NCT01004978|561699665|FG000|Overall Study|Alternative therapy|4|||
155619366|NCT01004978|561699666|FG001|Overall Study|Alternative therapy|8|||
155619367|NCT01004978|561699665|FG000|Overall Study|Physician Decision|6|||
155619368|NCT01004978|561699666|FG001|Overall Study|Physician Decision|3|||
155619369|NCT01004978|561699665|FG000|Overall Study|Other complicating disease|2|||
155619370|NCT01004978|561699666|FG001|Overall Study|Other complicating disease|2|||
155619371|NCT01004978|561699665|FG000|Overall Study|Protocol Violation|2|||
155619372|NCT01004978|561699666|FG001|Overall Study|Protocol Violation|3|||
155619373|NCT01004978|561699665|FG000|Overall Study|Non-compliance|3|||
155619374|NCT01004978|561699666|FG001|Overall Study|Non-compliance|2|||
155619375|NCT01004978|561699665|FG000|Overall Study|Ineligible|1|||
155619376|NCT01004978|561699666|FG001|Overall Study|Ineligible|0|||
155619377|NCT01004978|561699665|FG000|Overall Study|Unblinded|0|||
155619378|NCT01004978|561699666|FG001|Overall Study|Unblinded|1|||
155619379|NCT01004978|561699665|FG000|Overall Study|Performance status worsening|0|||
155273560|NCT02038764|560436357|FG003|Overall Study|Adverse Event|0|||
155273561|NCT02038764|560436358|FG004|Overall Study|Adverse Event|0|||
155619380|NCT01004978|561699666|FG001|Overall Study|Performance status worsening|1|||
155619381|NCT01004978|561699665|FG000|Overall Study|Never started treatment|8|||
155619382|NCT01004978|561699666|FG001|Overall Study|Never started treatment|9|||
155619383|NCT00447772|561699667|FG000|Overall Study|Lack of Efficacy|3|||
155273562|NCT02038764|560436354|FG000|Overall Study|Lost to Follow-up|0|||
155273563|NCT02038764|560436355|FG001|Overall Study|Lost to Follow-up|1|||
155619384|NCT00447772|561699667|FG000|Overall Study|Insufficient compliance|6|||
155619385|NCT00447772|561699667|FG000|Overall Study|Discontinuation of drug therapy|1|||
155619386|NCT00447772|561699667|FG000|Overall Study|Lost to Follow-up|9|||
155619387|NCT00447772|561699667|FG000|Overall Study|Withdrawal by Subject|1|||
155619388|NCT00447772|561699667|FG000|Overall Study|Unable to attend all study visits|2|||
155273564|NCT02038764|560436356|FG002|Overall Study|Lost to Follow-up|0|||
155273565|NCT02038764|560436357|FG003|Overall Study|Lost to Follow-up|0|||
155619389|NCT00447772|561699667|FG000|Overall Study|Adverse Event|1|||
155619390|NCT00447772|561699667|FG000|Overall Study|Patient relocated|1|||
155273566|NCT02038764|560436358|FG004|Overall Study|Lost to Follow-up|0|||
155619391|NCT00447772|561699667|FG000|Overall Study|Incomplete documentation at visit 1|1|||
155619392|NCT00447772|561699667|FG000|Overall Study|Chemotherapy for lung cancer|1|||
155619393|NCT00447772|561699667|FG000|Overall Study|Premature re-injection required|1|||
155619394|NCT01576575|561699668|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
155619395|NCT01576575|561699668|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
155619396|NCT01576575|561699668|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
155619397|NCT01723072|561699673|FG000|Overall Study|Withdrawal by Subject|7|||
155619398|NCT01723072|561699674|FG001|Overall Study|Withdrawal by Subject|13|||
155619399|NCT01723072|561699673|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
155619400|NCT01723072|561699674|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
155619401|NCT01723072|561699673|FG000|Overall Study|Other|4|||
155619402|NCT01723072|561699674|FG001|Overall Study|Other|3|||
155619403|NCT01841970|561699675|FG000|Overall Study|Withdrawal by Subject|1|||
155619404|NCT01841970|561699675|FG000|Overall Study|Physician Decision|2|||
155619405|NCT01841970|561699675|FG000|Overall Study|Lost to Follow-up|8|||
155619406|NCT01610037|561699682|FG000|All Patients|Adverse Event|27|||
155619407|NCT01610037|561699683|FG001|All Patients|Adverse Event|22|||
155619408|NCT01610037|561699684|FG002|All Patients|Adverse Event|26|||
155619409|NCT01610037|561699682|FG000|All Patients|Withdrawal by Subject|12|||
155619410|NCT01610037|561699683|FG001|All Patients|Withdrawal by Subject|10|||
155619411|NCT01610037|561699684|FG002|All Patients|Withdrawal by Subject|20|||
155619412|NCT01610037|561699682|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
155619413|NCT01610037|561699683|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
155619414|NCT01610037|561699684|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
155619415|NCT01610037|561699682|FG000|All Patients|Death|4|||
155619416|NCT01610037|561699683|FG001|All Patients|Death|2|||
155619417|NCT01610037|561699684|FG002|All Patients|Death|1|||
155619418|NCT01610037|561699682|FG000|All Patients|Protocol deviation|4|||
155273567|NCT02038764|560436354|FG000|Overall Study|Withdrawal by Subject|0|||
155273568|NCT02038764|560436355|FG001|Overall Study|Withdrawal by Subject|0|||
155273569|NCT02038764|560436356|FG002|Overall Study|Withdrawal by Subject|0|||
155273570|NCT02038764|560436357|FG003|Overall Study|Withdrawal by Subject|0|||
155273571|NCT02038764|560436358|FG004|Overall Study|Withdrawal by Subject|1|||
155273572|NCT02038764|560436354|FG000|Overall Study|Other|1|||
155273573|NCT02038764|560436355|FG001|Overall Study|Other|0|||
155273574|NCT02038764|560436356|FG002|Overall Study|Other|1|||
155273575|NCT02038764|560436357|FG003|Overall Study|Other|0|||
155273576|NCT02038764|560436358|FG004|Overall Study|Other|0|||
155273577|NCT03853317|560436359|FG000|Overall Study|Progressive Disease|5|||
155619419|NCT01610037|561699683|FG001|All Patients|Protocol deviation|3|||
155619420|NCT01610037|561699684|FG002|All Patients|Protocol deviation|3|||
155619421|NCT01610037|561699682|FG000|All Patients|Abnormal laboratory value|1|||
155619422|NCT01610037|561699683|FG001|All Patients|Abnormal laboratory value|1|||
155619423|NCT01610037|561699684|FG002|All Patients|Abnormal laboratory value|0|||
155619424|NCT01610037|561699682|FG000|All Patients|Administrative problems|1|||
155619425|NCT01610037|561699683|FG001|All Patients|Administrative problems|4|||
155619426|NCT01610037|561699684|FG002|All Patients|Administrative problems|4|||
155619427|NCT01610037|561699682|FG000|All Patients|Lost to Follow-up|1|||
155619428|NCT01610037|561699683|FG001|All Patients|Lost to Follow-up|0|||
155619429|NCT01610037|561699684|FG002|All Patients|Lost to Follow-up|0|||
155619430|NCT01610037|561699682|FG000|All Patients|Abnormal test procedure result(s)|0|||
155619431|NCT01610037|561699683|FG001|All Patients|Abnormal test procedure result(s)|1|||
155619432|NCT01610037|561699684|FG002|All Patients|Abnormal test procedure result(s)|3|||
155619433|NCT01610037|561699682|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
155619434|NCT01610037|561699683|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
155619435|NCT01610037|561699684|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
155619436|NCT01610037|561699682|FG000|Treatment and Follow up Period|Death|10|||
155619437|NCT01610037|561699683|FG001|Treatment and Follow up Period|Death|5|||
155619438|NCT01610037|561699684|FG002|Treatment and Follow up Period|Death|4|||
155619439|NCT01610037|561699682|FG000|Treatment and Follow up Period|Administrative problems|1|||
155619440|NCT01610037|561699683|FG001|Treatment and Follow up Period|Administrative problems|3|||
155619441|NCT01610037|561699684|FG002|Treatment and Follow up Period|Administrative problems|2|||
155619442|NCT01610037|561699682|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
155273578|NCT03853317|560436359|FG000|Overall Study|Adverse Event|1|||
155273579|NCT03853317|560436359|FG000|Overall Study|Death|1|||
155273580|NCT03853317|560436359|FG000|Overall Study|other event|2|||
155273581|NCT04844918|560436361|FG000|Overall Study|Adverse Event|7|||
155273582|NCT04844918|560436362|FG001|Overall Study|Adverse Event|8|||
155619443|NCT01610037|561699683|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
155619444|NCT01610037|561699684|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
155619445|NCT00274742|561699689|FG000|Overall Study|Adverse Event|0|||
155619446|NCT00274742|561699690|FG001|Overall Study|Adverse Event|4|||
155619447|NCT00274742|561699691|FG002|Overall Study|Adverse Event|1|||
155619448|NCT00274742|561699692|FG003|Overall Study|Adverse Event|4|||
155619449|NCT00274742|561699693|FG004|Overall Study|Adverse Event|12|||
155273583|NCT04844918|560436363|FG002|Overall Study|Adverse Event|5|||
155619450|NCT00274742|561699694|FG005|Overall Study|Adverse Event|3|||
155619451|NCT00274742|561699689|FG000|Overall Study|Lost to Follow-up|0|||
155619452|NCT00274742|561699690|FG001|Overall Study|Lost to Follow-up|0|||
155619453|NCT00274742|561699691|FG002|Overall Study|Lost to Follow-up|0|||
155619454|NCT00274742|561699692|FG003|Overall Study|Lost to Follow-up|0|||
155619455|NCT00274742|561699693|FG004|Overall Study|Lost to Follow-up|1|||
155619456|NCT00274742|561699694|FG005|Overall Study|Lost to Follow-up|0|||
155619457|NCT00274742|561699689|FG000|Overall Study|End of Study|0|||
155619458|NCT00274742|561699690|FG001|Overall Study|End of Study|0|||
155619459|NCT00274742|561699691|FG002|Overall Study|End of Study|0|||
155619460|NCT00274742|561699692|FG003|Overall Study|End of Study|1|||
155619461|NCT00274742|561699693|FG004|Overall Study|End of Study|0|||
155619462|NCT00274742|561699694|FG005|Overall Study|End of Study|0|||
155619463|NCT00274742|561699689|FG000|Overall Study|Disease Progression|0|||
155619464|NCT00274742|561699690|FG001|Overall Study|Disease Progression|1|||
155619465|NCT00274742|561699691|FG002|Overall Study|Disease Progression|1|||
155619466|NCT00274742|561699692|FG003|Overall Study|Disease Progression|0|||
155619467|NCT00274742|561699693|FG004|Overall Study|Disease Progression|1|||
155619468|NCT00274742|561699694|FG005|Overall Study|Disease Progression|0|||
155619469|NCT00274742|561699689|FG000|Overall Study|Other|0|||
155619470|NCT00274742|561699690|FG001|Overall Study|Other|3|||
155619471|NCT00274742|561699691|FG002|Overall Study|Other|0|||
155619472|NCT00274742|561699692|FG003|Overall Study|Other|0|||
155619473|NCT00274742|561699693|FG004|Overall Study|Other|2|||
155619474|NCT00274742|561699694|FG005|Overall Study|Other|0|||
155619475|NCT00149396|561699695|FG000|Overall Study|Death|15|||
155619476|NCT00149396|561699695|FG000|Overall Study|Withdrawal by Subject|1|||
155619477|NCT00149396|561699695|FG000|Overall Study|Subject noncompliance|2|||
155619478|NCT00149396|561699695|FG000|Overall Study|other treatment|5|||
155619479|NCT00327717|561699696|FG000|Overall Study|Adverse Event|6|||
155619480|NCT00327717|561699697|FG001|Overall Study|Adverse Event|6|||
155619481|NCT00327717|561699696|FG000|Overall Study|Lack of Efficacy|0|||
155619482|NCT00327717|561699697|FG001|Overall Study|Lack of Efficacy|1|||
155619483|NCT00327717|561699696|FG000|Overall Study|Withdrawal by Subject|3|||
155619484|NCT00327717|561699697|FG001|Overall Study|Withdrawal by Subject|7|||
155619485|NCT02983045|561699698|FG000|Overall Study|Withdrawal by Subject|0|||
155619486|NCT02983045|561699699|FG001|Overall Study|Withdrawal by Subject|1|||
155619487|NCT02983045|561699700|FG002|Overall Study|Withdrawal by Subject|0|||
155619488|NCT02983045|561699701|FG003|Overall Study|Withdrawal by Subject|5|||
155619489|NCT02983045|561699702|FG004|Overall Study|Withdrawal by Subject|0|||
155619490|NCT02983045|561699703|FG005|Overall Study|Withdrawal by Subject|72|||
155619491|NCT02983045|561699704|FG006|Overall Study|Withdrawal by Subject|0|||
155619492|NCT02983045|561699705|FG007|Overall Study|Withdrawal by Subject|0|||
155619493|NCT02983045|561699706|FG008|Overall Study|Withdrawal by Subject|0|||
155619494|NCT02983045|561699707|FG009|Overall Study|Withdrawal by Subject|2|||
155619495|NCT02983045|561699698|FG000|Overall Study|Lost to Follow-up|0|||
155619496|NCT02983045|561699699|FG001|Overall Study|Lost to Follow-up|0|||
155619497|NCT02983045|561699700|FG002|Overall Study|Lost to Follow-up|0|||
155619498|NCT02983045|561699701|FG003|Overall Study|Lost to Follow-up|0|||
155619499|NCT02983045|561699702|FG004|Overall Study|Lost to Follow-up|0|||
155619500|NCT02983045|561699703|FG005|Overall Study|Lost to Follow-up|10|||
155619501|NCT02983045|561699704|FG006|Overall Study|Lost to Follow-up|0|||
155619502|NCT02983045|561699705|FG007|Overall Study|Lost to Follow-up|0|||
155619503|NCT02983045|561699706|FG008|Overall Study|Lost to Follow-up|0|||
155619504|NCT02983045|561699707|FG009|Overall Study|Lost to Follow-up|0|||
155619505|NCT03311841|561699714|FG000|14-day Wash-out|Adverse Event|0|||
155619506|NCT03311841|561699715|FG001|14-day Wash-out|Adverse Event|1|||
155619507|NCT03311841|561699716|FG002|14-day Wash-out|Adverse Event|0|||
155619508|NCT03311841|561699717|FG003|14-day Wash-out|Adverse Event|0|||
155619509|NCT03311841|561699718|FG004|14-day Wash-out|Adverse Event|0|||
155619510|NCT03311841|561699714|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
155619511|NCT03311841|561699715|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
155619512|NCT03311841|561699716|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
155619513|NCT03311841|561699717|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
155619514|NCT03311841|561699718|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
155619515|NCT00977613|561699735|FG000|Overall Study|Lost to Follow-up|16|||
155273584|NCT04844918|560436361|FG000|Overall Study|Physician Decision|0|||
155619516|NCT01598610|561699740|FG000|Overall Study|Adverse Event|1|||
155619517|NCT02989402|561699748|FG000|Overall Study|Adverse event, or serious adverse event|4|||
155619518|NCT02989402|561699748|FG000|Overall Study|Death|2|||
155619519|NCT02989402|561699748|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
155619520|NCT02989402|561699748|FG000|Overall Study|Lost to Follow-up|8|||
155619521|NCT02989402|561699748|FG000|Overall Study|Patient no longer on monotherapy|1|||
155619522|NCT02989402|561699748|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
155619523|NCT02989402|561699748|FG000|Overall Study|Withdrawal by Subject|7|||
155619524|NCT02989402|561699748|FG000|Overall Study|Other|2|||
155619525|NCT03066830|561699749|FG000|Overall Study|At the Participant's own Request|16|||
155619526|NCT03066830|561699750|FG001|Overall Study|At the Participant's own Request|17|||
155619527|NCT03066830|561699749|FG000|Overall Study|Other|3|||
155619528|NCT03066830|561699750|FG001|Overall Study|Other|0|||
155619529|NCT03066830|561699749|FG000|Overall Study|Poor Compliance to Protocol|1|||
155619530|NCT03066830|561699750|FG001|Overall Study|Poor Compliance to Protocol|0|||
155619531|NCT03066830|561699749|FG000|Overall Study|Adverse Event|2|||
155619532|NCT03066830|561699750|FG001|Overall Study|Adverse Event|2|||
155619533|NCT03066830|561699749|FG000|Overall Study|Lost to Follow-up|11|||
155619534|NCT03066830|561699750|FG001|Overall Study|Lost to Follow-up|3|||
155619535|NCT02039778|561699752|FG000|Overall Study|Death|2|||
155619536|NCT02039778|561699752|FG000|Overall Study|Withdrawal by Subject|1|||
155619537|NCT02039778|561699752|FG000|Overall Study|Never started the protocol treatment|1|||
155619538|NCT01670045|561699764|FG000|Overall Study|Withdrawal by Subject|3|||
155619539|NCT01670045|561699764|FG000|Overall Study|Adverse Event|1|||
155619540|NCT01670045|561699764|FG000|Overall Study|Death|1|||
155619541|NCT01670045|561699764|FG000|Overall Study|Lost to Follow-up|11|||
155619542|NCT03360019|561699765|FG000|Overall Study|Withdrawal by Subject|2|||
155619543|NCT03360019|561699766|FG001|Overall Study|Withdrawal by Subject|0|||
155619544|NCT03360019|561699767|FG002|Overall Study|Withdrawal by Subject|0|||
155619545|NCT03360019|561699765|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
155619546|NCT03360019|561699766|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
155619547|NCT03360019|561699767|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
155619548|NCT01462110|561699770|FG000|Overall Study|Adverse Event|1|||
155619549|NCT01462110|561699771|FG001|Overall Study|Adverse Event|0|||
155619550|NCT00753675|561699772|FG000|Overall Study|other reason|11|||
155619551|NCT00753675|561699773|FG001|Overall Study|other reason|12|||
155619552|NCT00753675|561699774|FG002|Overall Study|other reason|13|||
155619553|NCT00753675|561699772|FG000|Overall Study|Death|1|||
155619554|NCT00753675|561699773|FG001|Overall Study|Death|2|||
155619555|NCT00753675|561699774|FG002|Overall Study|Death|4|||
155619556|NCT00753675|561699772|FG000|Overall Study|Adverse Event|11|||
155619557|NCT00753675|561699773|FG001|Overall Study|Adverse Event|9|||
155619558|NCT00753675|561699774|FG002|Overall Study|Adverse Event|4|||
155619559|NCT00753675|561699772|FG000|Overall Study|Objective progression of disease|35|||
155619560|NCT00753675|561699773|FG001|Overall Study|Objective progression of disease|35|||
155619561|NCT00753675|561699774|FG002|Overall Study|Objective progression of disease|35|||
155619562|NCT00753675|561699772|FG000|Overall Study|Withdrawal by Subject|0|||
155619563|NCT00753675|561699773|FG001|Overall Study|Withdrawal by Subject|1|||
155619564|NCT00753675|561699774|FG002|Overall Study|Withdrawal by Subject|0|||
155619565|NCT00753675|561699772|FG000|Overall Study|Lost to Follow-up|1|||
155619566|NCT00753675|561699773|FG001|Overall Study|Lost to Follow-up|0|||
155619567|NCT00753675|561699774|FG002|Overall Study|Lost to Follow-up|0|||
155619568|NCT00964028|561699778|FG000|Overall Study|Withdrawal by Subject|0|||
155619569|NCT00964028|561699779|FG001|Overall Study|Withdrawal by Subject|1|||
155619570|NCT02106351|561699780|FG000|Treatment Cycle 1|Adverse Event|2|||
155619571|NCT02106351|561699781|FG001|Treatment Cycle 1|Adverse Event|0|||
155619572|NCT02106351|561699782|FG002|Treatment Cycle 1|Adverse Event|0|||
155619573|NCT02106351|561699780|FG000|Treatment Cycle 1|Consent withdrawn|1|||
155619574|NCT02106351|561699781|FG001|Treatment Cycle 1|Consent withdrawn|0|||
155619575|NCT02106351|561699782|FG002|Treatment Cycle 1|Consent withdrawn|2|||
155619576|NCT02106351|561699780|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155619577|NCT02106351|561699781|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
155619578|NCT02106351|561699782|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
155619579|NCT02106351|561699780|FG000|Treatment Cycle 1|Other|0|||
155273585|NCT04844918|560436362|FG001|Overall Study|Physician Decision|1|||
155273586|NCT04844918|560436363|FG002|Overall Study|Physician Decision|0|||
155273587|NCT04844918|560436361|FG000|Overall Study|Withdrawal by Subject|6|||
155273588|NCT04844918|560436362|FG001|Overall Study|Withdrawal by Subject|3|||
155273589|NCT04844918|560436363|FG002|Overall Study|Withdrawal by Subject|3|||
155273590|NCT04844918|560436361|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
155273591|NCT04844918|560436362|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
155273592|NCT04844918|560436363|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
155273593|NCT01009047|560436367|FG000|Overall Study|Adverse Event|5|||
155273594|NCT01009047|560436368|FG001|Overall Study|Adverse Event|0|||
155273595|NCT01009047|560436367|FG000|Overall Study|Lost to Follow-up|0|||
155273596|NCT01009047|560436368|FG001|Overall Study|Lost to Follow-up|2|||
155273597|NCT01009047|560436367|FG000|Overall Study|Lack of Efficacy|4|||
155273598|NCT01009047|560436368|FG001|Overall Study|Lack of Efficacy|11|||
155381933|NCT00598273|560833242|FG000|Overall Study|Adverse Event|4|||
155726878|NCT00129402|562099805|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
155619580|NCT02106351|561699781|FG001|Treatment Cycle 1|Other|3|||
155726879|NCT02131259|562099806|FG000|Overall Study|Progressive disease|751|||
155273599|NCT01009047|560436367|FG000|Overall Study|Withdrawal by consent|16|||
155273600|NCT01009047|560436368|FG001|Overall Study|Withdrawal by consent|11|||
155273601|NCT01009047|560436367|FG000|Overall Study|Other|3|||
155619581|NCT02106351|561699782|FG002|Treatment Cycle 1|Other|1|||
155619582|NCT02106351|561699780|FG000|Treatment Cycle 1|Randomised but not treated|1|||
155619583|NCT02106351|561699781|FG001|Treatment Cycle 1|Randomised but not treated|0|||
155726880|NCT02131259|562099806|FG000|Overall Study|Adverse Event|341|||
155273602|NCT01009047|560436368|FG001|Overall Study|Other|2|||
155273603|NCT04716881|560436370|FG000|Overall Study|Adverse Event|1|||
155273604|NCT04716881|560436370|FG000|Overall Study|Lost to Follow-up|1|||
155273605|NCT01630590|560436374|FG000|Overall Study|Adverse Event|9|||
155273606|NCT01630590|560436374|FG000|Overall Study|Lack of Efficacy|37|||
155273607|NCT01630590|560436374|FG000|Overall Study|Withdrawal by Subject|4|||
155273608|NCT01630590|560436374|FG000|Overall Study|2nd primary tumor|2|||
155273609|NCT01630590|560436374|FG000|Overall Study|Automobile accident|1|||
155273610|NCT01630590|560436374|FG000|Overall Study|Maximum benefit|4|||
155273611|NCT02366936|560436376|FG000|Overall Study|Withdrawal by Subject|2|||
155273612|NCT02366936|560436376|FG000|Overall Study|Lost to Follow-up|4|||
155273613|NCT02366936|560436376|FG000|Overall Study|Physician Decision|2|||
155273614|NCT01751113|560436377|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273615|NCT01751113|560436378|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273616|NCT01751113|560436379|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273617|NCT01751113|560436380|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155273618|NCT01751113|560436381|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155273619|NCT01751113|560436382|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273620|NCT01751113|560436377|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273621|NCT01751113|560436378|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273622|NCT01751113|560436379|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273623|NCT01751113|560436380|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273624|NCT01751113|560436381|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273625|NCT01751113|560436382|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
155273626|NCT02878213|560436383|FG000|Overall Study|Withdrawal by Subject|2|||
155273627|NCT02878213|560436383|FG000|Overall Study|Adverse Event|1|||
155273628|NCT00363896|560436384|FG000|Overall Study|Withdrawal by Subject|29|||
155273629|NCT00363896|560436385|FG001|Overall Study|Withdrawal by Subject|16|||
155273630|NCT00363896|560436384|FG000|Overall Study|Adverse Event|24|||
155273631|NCT00363896|560436385|FG001|Overall Study|Adverse Event|13|||
155273632|NCT00363896|560436384|FG000|Overall Study|COPD exacerbation|13|||
155273633|NCT00363896|560436385|FG001|Overall Study|COPD exacerbation|7|||
155273634|NCT00363896|560436384|FG000|Overall Study|Lack of Efficacy|12|||
155273635|NCT00363896|560436385|FG001|Overall Study|Lack of Efficacy|8|||
155273636|NCT00363896|560436384|FG000|Overall Study|Protocol Violation|6|||
155273637|NCT00363896|560436385|FG001|Overall Study|Protocol Violation|1|||
155273638|NCT00363896|560436384|FG000|Overall Study|Lost to Follow-up|3|||
155273639|NCT00363896|560436385|FG001|Overall Study|Lost to Follow-up|0|||
155273640|NCT00363896|560436384|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
155273641|NCT00363896|560436385|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
155273642|NCT00363896|560436384|FG000|Overall Study|Other|1|||
155273643|NCT00363896|560436385|FG001|Overall Study|Other|2|||
155273644|NCT01558674|560436386|FG000|Part 1|Study Terminated by Sponsor|10|||
155273645|NCT01558674|560436387|FG001|Part 1|Study Terminated by Sponsor|0|||
155273646|NCT01558674|560436386|FG000|Part 1|Withdrawal by Subject|1|||
155273647|NCT01558674|560436387|FG001|Part 1|Withdrawal by Subject|0|||
155273648|NCT00785538|560436388|FG000|Treatment Period|Adverse Event|1|||
155273649|NCT00785538|560436389|FG001|Treatment Period|Adverse Event|2|||
155273650|NCT00785538|560436390|FG002|Treatment Period|Adverse Event|2|||
155273651|NCT00785538|560436391|FG003|Treatment Period|Adverse Event|0|||
155273652|NCT00785538|560436388|FG000|Treatment Period|Withdrawal by Subject|0|||
155273653|NCT00785538|560436389|FG001|Treatment Period|Withdrawal by Subject|0|||
155273654|NCT00785538|560436390|FG002|Treatment Period|Withdrawal by Subject|0|||
155273655|NCT00785538|560436391|FG003|Treatment Period|Withdrawal by Subject|1|||
155273656|NCT00322374|560436392|FG000|Starting Dose|Physician Decision|2|||
155273657|NCT00322374|560436393|FG001|Starting Dose|Physician Decision|0|||
155273658|NCT00322374|560436394|FG002|Starting Dose|Physician Decision|0|||
155273659|NCT00322374|560436395|FG003|Starting Dose|Physician Decision|0|||
155273660|NCT00322374|560436392|FG000|Starting Dose|Study Drug Toxicity|4|||
155273661|NCT00322374|560436393|FG001|Starting Dose|Study Drug Toxicity|0|||
155273662|NCT00322374|560436394|FG002|Starting Dose|Study Drug Toxicity|0|||
155273663|NCT00322374|560436395|FG003|Starting Dose|Study Drug Toxicity|0|||
155273664|NCT00322374|560436392|FG000|First Escalation|Documented Disease Progression|0|||
155273665|NCT00322374|560436393|FG001|First Escalation|Documented Disease Progression|6|||
155273666|NCT00322374|560436394|FG002|First Escalation|Documented Disease Progression|0|||
155273667|NCT00322374|560436395|FG003|First Escalation|Documented Disease Progression|0|||
155273668|NCT00322374|560436392|FG000|First Escalation|Physician Decision|0|||
155273669|NCT00322374|560436393|FG001|First Escalation|Physician Decision|12|||
155381934|NCT00598273|560833243|FG001|Overall Study|Adverse Event|5|||
155273670|NCT00322374|560436394|FG002|First Escalation|Physician Decision|0|||
155273671|NCT00322374|560436395|FG003|First Escalation|Physician Decision|0|||
155273672|NCT00322374|560436392|FG000|First Escalation|Study Drug Toxicity|0|||
155273673|NCT00322374|560436393|FG001|First Escalation|Study Drug Toxicity|11|||
155273674|NCT00322374|560436394|FG002|First Escalation|Study Drug Toxicity|0|||
155273675|NCT00322374|560436395|FG003|First Escalation|Study Drug Toxicity|0|||
155273676|NCT00322374|560436392|FG000|First Escalation|Participant Request|0|||
155273677|NCT00322374|560436393|FG001|First Escalation|Participant Request|1|||
155273678|NCT00322374|560436394|FG002|First Escalation|Participant Request|0|||
155273679|NCT00322374|560436395|FG003|First Escalation|Participant Request|0|||
155273680|NCT00322374|560436392|FG000|Second Escalation|Physician Decision|0|||
155273681|NCT00322374|560436393|FG001|Second Escalation|Physician Decision|0|||
155273682|NCT00322374|560436394|FG002|Second Escalation|Physician Decision|5|||
155273683|NCT00322374|560436395|FG003|Second Escalation|Physician Decision|0|||
155273684|NCT00322374|560436392|FG000|Second Escalation|Study Drug Toxicity|0|||
155273685|NCT00322374|560436393|FG001|Second Escalation|Study Drug Toxicity|0|||
155273686|NCT00322374|560436394|FG002|Second Escalation|Study Drug Toxicity|1|||
155273687|NCT00322374|560436395|FG003|Second Escalation|Study Drug Toxicity|0|||
155273688|NCT01000376|560436399|FG000|Cycle 1 Day 1|Adverse Event|1|||
155273689|NCT01000376|560436400|FG001|Cycle 1 Day 1|Adverse Event|0|||
155273690|NCT01000376|560436399|FG000|Cycle 1 Day 1|Progressive Disease|1|||
155619584|NCT02106351|561699782|FG002|Treatment Cycle 1|Randomised but not treated|1|||
155619585|NCT02106351|561699780|FG000|Treatment Cycle 2|Adverse Event|0|||
155619586|NCT02106351|561699781|FG001|Treatment Cycle 2|Adverse Event|2|||
155619587|NCT02106351|561699782|FG002|Treatment Cycle 2|Adverse Event|0|||
155619588|NCT02106351|561699780|FG000|Treatment Cycle 2|Consent withdrawn|0|||
155619589|NCT02106351|561699781|FG001|Treatment Cycle 2|Consent withdrawn|1|||
155619590|NCT02106351|561699782|FG002|Treatment Cycle 2|Consent withdrawn|1|||
155619591|NCT02106351|561699780|FG000|Treatment Cycle 2|Other|0|||
155619592|NCT02106351|561699781|FG001|Treatment Cycle 2|Other|2|||
155619593|NCT02106351|561699782|FG002|Treatment Cycle 2|Other|2|||
155619594|NCT02106351|561699780|FG000|Treatment Cycle 3|Adverse Event|0|||
155619595|NCT02106351|561699781|FG001|Treatment Cycle 3|Adverse Event|1|||
155619596|NCT02106351|561699782|FG002|Treatment Cycle 3|Adverse Event|0|||
155619597|NCT02106351|561699780|FG000|Treatment Cycle 3|Consent withdrawn|0|||
155619598|NCT02106351|561699781|FG001|Treatment Cycle 3|Consent withdrawn|0|||
155619599|NCT02106351|561699782|FG002|Treatment Cycle 3|Consent withdrawn|2|||
155619600|NCT02106351|561699780|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
155619601|NCT02106351|561699781|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
155619602|NCT02106351|561699782|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
155619603|NCT02106351|561699780|FG000|Treatment Cycle 3|Other|0|||
155619604|NCT02106351|561699781|FG001|Treatment Cycle 3|Other|2|||
155619605|NCT02106351|561699782|FG002|Treatment Cycle 3|Other|3|||
155619606|NCT02106351|561699780|FG000|Treatment Cycle 4|Consent withdrawn|0|||
155619607|NCT02106351|561699781|FG001|Treatment Cycle 4|Consent withdrawn|0|||
155619608|NCT02106351|561699782|FG002|Treatment Cycle 4|Consent withdrawn|2|||
155619609|NCT02106351|561699780|FG000|Treatment Cycle 4|Other|0|||
155619610|NCT02106351|561699781|FG001|Treatment Cycle 4|Other|1|||
155619611|NCT02106351|561699782|FG002|Treatment Cycle 4|Other|0|||
155619612|NCT00069823|561699783|FG000|Overall Study|Did not have follow-up diary cards|6|||
155619613|NCT00069823|561699784|FG001|Overall Study|Did not have follow-up diary cards|3|||
155619614|NCT02058589|561699786|FG000|Overall Study|Serious Adverse Event|1|||
155619615|NCT02058589|561699787|FG001|Overall Study|Serious Adverse Event|1|||
155619616|NCT02058589|561699786|FG000|Overall Study|Non-Serious Adverse Event|1|||
155619617|NCT02058589|561699787|FG001|Overall Study|Non-Serious Adverse Event|0|||
155619618|NCT02058589|561699786|FG000|Overall Study|Withdrawal by Subject|0|||
155619619|NCT02058589|561699787|FG001|Overall Study|Withdrawal by Subject|1|||
155619620|NCT00490971|561699790|FG000|Acute/Continuation|Adverse Event|62|||
155619621|NCT00490971|561699791|FG001|Acute/Continuation|Adverse Event|13|||
155619622|NCT00490971|561699792|FG002|Acute/Continuation|Adverse Event|0|||
155619623|NCT00490971|561699793|FG003|Acute/Continuation|Adverse Event|0|||
155619624|NCT00490971|561699794|FG004|Acute/Continuation|Adverse Event|0|||
155619625|NCT00490971|561699790|FG000|Acute/Continuation|Death|2|||
155619626|NCT00490971|561699791|FG001|Acute/Continuation|Death|0|||
155619627|NCT00490971|561699792|FG002|Acute/Continuation|Death|0|||
155619628|NCT00490971|561699793|FG003|Acute/Continuation|Death|0|||
155619629|NCT00490971|561699794|FG004|Acute/Continuation|Death|0|||
155619630|NCT00490971|561699790|FG000|Acute/Continuation|Lack of Efficacy|106|||
155619631|NCT00490971|561699791|FG001|Acute/Continuation|Lack of Efficacy|12|||
155619632|NCT00490971|561699792|FG002|Acute/Continuation|Lack of Efficacy|0|||
155619633|NCT00490971|561699793|FG003|Acute/Continuation|Lack of Efficacy|0|||
155619634|NCT00490971|561699794|FG004|Acute/Continuation|Lack of Efficacy|0|||
155619635|NCT00490971|561699790|FG000|Acute/Continuation|Lost to Follow-up|23|||
155273691|NCT01000376|560436400|FG001|Cycle 1 Day 1|Progressive Disease|0|||
155273692|NCT02269943|560436401|FG000|Treatment Period|Death|0|||
155619636|NCT00490971|561699791|FG001|Acute/Continuation|Lost to Follow-up|7|||
155619637|NCT00490971|561699792|FG002|Acute/Continuation|Lost to Follow-up|0|||
155619638|NCT00490971|561699793|FG003|Acute/Continuation|Lost to Follow-up|0|||
155619639|NCT00490971|561699794|FG004|Acute/Continuation|Lost to Follow-up|0|||
155619640|NCT00490971|561699790|FG000|Acute/Continuation|Protocol Violation|10|||
155619641|NCT00490971|561699791|FG001|Acute/Continuation|Protocol Violation|2|||
155619642|NCT00490971|561699792|FG002|Acute/Continuation|Protocol Violation|0|||
155619643|NCT00490971|561699793|FG003|Acute/Continuation|Protocol Violation|0|||
155619644|NCT00490971|561699794|FG004|Acute/Continuation|Protocol Violation|0|||
155619645|NCT00490971|561699790|FG000|Acute/Continuation|Withdrawal by Subject|92|||
155273693|NCT02269943|560436402|FG001|Treatment Period|Death|1|||
155273694|NCT02269943|560436401|FG000|Treatment Period|Adverse Event|1|||
155273695|NCT02269943|560436402|FG001|Treatment Period|Adverse Event|10|||
155273696|NCT02269943|560436401|FG000|Treatment Period|Progressive Disease|5|||
155273697|NCT02269943|560436402|FG001|Treatment Period|Progressive Disease|17|||
155273698|NCT02269943|560436401|FG000|Treatment Period|Symptomatic Deterioration|0|||
155273699|NCT02269943|560436402|FG001|Treatment Period|Symptomatic Deterioration|2|||
155273700|NCT02269943|560436401|FG000|Follow-Up Survival Period|Death|3|||
155273701|NCT02269943|560436402|FG001|Follow-Up Survival Period|Death|16|||
155273702|NCT02269943|560436401|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
155273703|NCT02269943|560436402|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
155273704|NCT02269943|560436401|FG000|Follow-Up Survival Period|Alive|2|||
155273705|NCT02269943|560436402|FG001|Follow-Up Survival Period|Alive|8|||
155273706|NCT04285229|560436404|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155273707|NCT04285229|560436405|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273708|NCT04285229|560436406|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273709|NCT04285229|560436407|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273710|NCT04285229|560436408|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273711|NCT04285229|560436409|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273712|NCT04285229|560436404|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
155273713|NCT04285229|560436405|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
155273714|NCT04285229|560436406|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
155273715|NCT04285229|560436407|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
155273716|NCT04285229|560436408|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
155273717|NCT04285229|560436409|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
155273718|NCT04285229|560436404|FG000|Extended Treatment Period|Adverse Event|0|||
155273719|NCT04285229|560436405|FG001|Extended Treatment Period|Adverse Event|0|||
155273720|NCT04285229|560436406|FG002|Extended Treatment Period|Adverse Event|0|||
155273721|NCT04285229|560436407|FG003|Extended Treatment Period|Adverse Event|1|||
155273722|NCT04285229|560436408|FG004|Extended Treatment Period|Adverse Event|0|||
155273723|NCT04285229|560436409|FG005|Extended Treatment Period|Adverse Event|0|||
155273724|NCT04285229|560436404|FG000|Extended Treatment Period|Physician Decision|0|||
155273725|NCT04285229|560436405|FG001|Extended Treatment Period|Physician Decision|0|||
155273726|NCT04285229|560436406|FG002|Extended Treatment Period|Physician Decision|1|||
155273727|NCT04285229|560436407|FG003|Extended Treatment Period|Physician Decision|0|||
155273728|NCT04285229|560436408|FG004|Extended Treatment Period|Physician Decision|0|||
155273729|NCT04285229|560436409|FG005|Extended Treatment Period|Physician Decision|0|||
155273730|NCT04285229|560436404|FG000|Follow-up Period|Adverse Event|0|||
155273731|NCT04285229|560436405|FG001|Follow-up Period|Adverse Event|0|||
155273732|NCT04285229|560436406|FG002|Follow-up Period|Adverse Event|0|||
155273733|NCT04285229|560436407|FG003|Follow-up Period|Adverse Event|0|||
155273734|NCT04285229|560436408|FG004|Follow-up Period|Adverse Event|1|||
155273735|NCT04285229|560436409|FG005|Follow-up Period|Adverse Event|4|||
155273736|NCT04285229|560436404|FG000|Follow-up Period|Withdrawal by Subject|0|||
155273737|NCT04285229|560436405|FG001|Follow-up Period|Withdrawal by Subject|0|||
155273738|NCT04285229|560436406|FG002|Follow-up Period|Withdrawal by Subject|0|||
155273739|NCT04285229|560436407|FG003|Follow-up Period|Withdrawal by Subject|0|||
155273740|NCT04285229|560436408|FG004|Follow-up Period|Withdrawal by Subject|0|||
155273741|NCT04285229|560436409|FG005|Follow-up Period|Withdrawal by Subject|5|||
155273742|NCT04285229|560436404|FG000|Follow-up Period|Covid-19|0|||
155273743|NCT04285229|560436405|FG001|Follow-up Period|Covid-19|0|||
155273744|NCT04285229|560436406|FG002|Follow-up Period|Covid-19|0|||
155273745|NCT04285229|560436407|FG003|Follow-up Period|Covid-19|0|||
155273746|NCT04285229|560436408|FG004|Follow-up Period|Covid-19|0|||
155273747|NCT04285229|560436409|FG005|Follow-up Period|Covid-19|2|||
155273748|NCT04285229|560436404|FG000|Follow-up Period|Physician Decision|0|||
155273749|NCT04285229|560436405|FG001|Follow-up Period|Physician Decision|0|||
155273750|NCT04285229|560436406|FG002|Follow-up Period|Physician Decision|0|||
155273751|NCT04285229|560436407|FG003|Follow-up Period|Physician Decision|0|||
155273752|NCT04285229|560436408|FG004|Follow-up Period|Physician Decision|0|||
155273753|NCT04285229|560436409|FG005|Follow-up Period|Physician Decision|1|||
155273754|NCT04793464|560436410|FG000|Overall Study|Lost to Follow-up|458|||
155273755|NCT04793464|560436411|FG001|Overall Study|Lost to Follow-up|168|||
155273756|NCT04793464|560436412|FG002|Overall Study|Lost to Follow-up|5|||
155273757|NCT04793464|560436410|FG000|Overall Study|Withdrawal by Subject|43|||
155273758|NCT04793464|560436411|FG001|Overall Study|Withdrawal by Subject|15|||
155273759|NCT04793464|560436412|FG002|Overall Study|Withdrawal by Subject|0|||
155273760|NCT00845871|560436415|FG000|Assessment Period|Adverse Event|2|||
155273761|NCT00845871|560436415|FG000|Assessment Period|Abnormal laboratory values|1|||
155273762|NCT00845871|560436415|FG000|Assessment Period|Abnormal test procedure results|1|||
155273763|NCT00845871|560436415|FG000|Assessment Period|Patient withdrew consent|3|||
155273764|NCT04318093|560436418|FG000|Overall Study|Adverse Event|2|||
155273765|NCT04318093|560436419|FG001|Overall Study|Adverse Event|2|||
155273766|NCT04318093|560436418|FG000|Overall Study|Participant withdrew consent|1|||
155726881|NCT02131259|562099806|FG000|Overall Study|Lost to Follow-up|7|||
155726882|NCT02131259|562099806|FG000|Overall Study|Relocation|32|||
155273767|NCT04318093|560436419|FG001|Overall Study|Participant withdrew consent|0|||
155273768|NCT04318093|560436418|FG000|Overall Study|Other reasons|0|||
155273769|NCT04318093|560436419|FG001|Overall Study|Other reasons|1|||
155273770|NCT00655551|560436424|FG000|All Periods Combined|Adverse Event|0|||
155273771|NCT00655551|560436425|FG001|All Periods Combined|Adverse Event|3|||
155273772|NCT00655551|560436426|FG002|All Periods Combined|Adverse Event|4|||
155273773|NCT00655551|560436424|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
155273774|NCT00655551|560436425|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
155273775|NCT00655551|560436426|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
155273776|NCT00655551|560436424|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
155273777|NCT00655551|560436425|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
155273778|NCT00655551|560436426|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
155273779|NCT00655551|560436424|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
155273780|NCT00655551|560436425|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
155273781|NCT00655551|560436426|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
155273782|NCT01734434|560436427|FG000|Overall Study|Death Infant|3|||
155273783|NCT01734434|560436428|FG001|Overall Study|Death Infant|1|||
155273784|NCT01734434|560436429|FG002|Overall Study|Death Infant|17|||
155273785|NCT01734434|560436430|FG003|Overall Study|Death Infant|5|||
155273786|NCT01734434|560436427|FG000|Overall Study|Lost to Follow-up|2|||
155273787|NCT01734434|560436428|FG001|Overall Study|Lost to Follow-up|9|||
155273788|NCT01734434|560436429|FG002|Overall Study|Lost to Follow-up|67|||
155273789|NCT01734434|560436430|FG003|Overall Study|Lost to Follow-up|11|||
155273790|NCT01734434|560436427|FG000|Overall Study|No Live Birth|1|||
155273791|NCT01734434|560436428|FG001|Overall Study|No Live Birth|2|||
155273792|NCT01734434|560436429|FG002|Overall Study|No Live Birth|32|||
155273793|NCT01734434|560436430|FG003|Overall Study|No Live Birth|6|||
155273794|NCT01734434|560436427|FG000|Overall Study|Withdrawal by Subject|4|||
155273795|NCT01734434|560436428|FG001|Overall Study|Withdrawal by Subject|0|||
155273796|NCT01734434|560436429|FG002|Overall Study|Withdrawal by Subject|8|||
155273797|NCT01734434|560436430|FG003|Overall Study|Withdrawal by Subject|1|||
155273798|NCT01734434|560436427|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
155273799|NCT01734434|560436428|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
155273800|NCT01734434|560436429|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
155273801|NCT01734434|560436430|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
155273802|NCT01734434|560436427|FG000|Overall Study|Subject Not Reachable|0|||
155273803|NCT01734434|560436428|FG001|Overall Study|Subject Not Reachable|0|||
155273804|NCT01734434|560436429|FG002|Overall Study|Subject Not Reachable|1|||
155273805|NCT01734434|560436430|FG003|Overall Study|Subject Not Reachable|0|||
155273806|NCT01734434|560436427|FG000|Overall Study|Treatment Defaulter|0|||
155273807|NCT01734434|560436428|FG001|Overall Study|Treatment Defaulter|0|||
155273808|NCT01734434|560436429|FG002|Overall Study|Treatment Defaulter|1|||
155273809|NCT01734434|560436430|FG003|Overall Study|Treatment Defaulter|0|||
155273810|NCT01734434|560436427|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
155273811|NCT01734434|560436428|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
155273812|NCT01734434|560436429|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
155273813|NCT01734434|560436430|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
155273814|NCT01734434|560436427|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273815|NCT01734434|560436428|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273816|NCT01734434|560436429|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
155273817|NCT01734434|560436430|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273818|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273819|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273820|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
155273821|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
155273822|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
155273823|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273824|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273825|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273826|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
155273827|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
155273828|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
155273829|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
155273830|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
155273831|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
155273832|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
155273833|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
155273834|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
155273835|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
155273836|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
155273837|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
155273838|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
155381935|NCT00598273|560833244|FG002|Overall Study|Adverse Event|2|||
155273839|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
155273840|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
155273841|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
155273842|NCT02855164|560436431|FG000|Part C (Randomized Set)|Adverse Event|0|||
155273843|NCT02855164|560436432|FG001|Part C (Randomized Set)|Adverse Event|0|||
155273844|NCT02855164|560436433|FG002|Part C (Randomized Set)|Adverse Event|0|||
155273845|NCT02855164|560436434|FG003|Part C (Randomized Set)|Adverse Event|0|||
155273846|NCT02855164|560436435|FG004|Part C (Randomized Set)|Adverse Event|0|||
155273847|NCT02855164|560436436|FG005|Part C (Randomized Set)|Adverse Event|5|||
155273848|NCT02855164|560436437|FG006|Part C (Randomized Set)|Adverse Event|9|||
155273849|NCT02855164|560436438|FG007|Part C (Randomized Set)|Adverse Event|2|||
155273850|NCT02855164|560436431|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
155273851|NCT02855164|560436432|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
155273852|NCT02855164|560436433|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
155273853|NCT02855164|560436434|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
155273854|NCT02855164|560436435|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
155273855|NCT02855164|560436436|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
155273856|NCT02855164|560436437|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
155273857|NCT02855164|560436438|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
155273858|NCT02855164|560436431|FG000|Part C (Randomized Set)|Physician Decision|0|||
155273859|NCT02855164|560436432|FG001|Part C (Randomized Set)|Physician Decision|0|||
155273860|NCT02855164|560436433|FG002|Part C (Randomized Set)|Physician Decision|0|||
155273861|NCT02855164|560436434|FG003|Part C (Randomized Set)|Physician Decision|0|||
155273862|NCT02855164|560436435|FG004|Part C (Randomized Set)|Physician Decision|0|||
155273863|NCT02855164|560436436|FG005|Part C (Randomized Set)|Physician Decision|1|||
155273864|NCT02855164|560436437|FG006|Part C (Randomized Set)|Physician Decision|0|||
155273865|NCT02855164|560436438|FG007|Part C (Randomized Set)|Physician Decision|1|||
155273866|NCT02855164|560436431|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273867|NCT02855164|560436432|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273868|NCT02855164|560436433|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273869|NCT02855164|560436434|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273870|NCT02855164|560436435|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273871|NCT02855164|560436436|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
155273872|NCT02855164|560436437|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
155273873|NCT02855164|560436438|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
155273874|NCT00876460|560436439|FG000|Combination Therapy Phase|Progressive disease|2|||
155273875|NCT00876460|560436440|FG001|Combination Therapy Phase|Progressive disease|3|||
155273876|NCT00876460|560436441|FG002|Combination Therapy Phase|Progressive disease|3|||
155273877|NCT00876460|560436442|FG003|Combination Therapy Phase|Progressive disease|3|||
155273878|NCT00876460|560436443|FG004|Combination Therapy Phase|Progressive disease|3|||
155273879|NCT00876460|560436444|FG005|Combination Therapy Phase|Progressive disease|1|||
155273880|NCT00876460|560436445|FG006|Combination Therapy Phase|Progressive disease|1|||
155273881|NCT00876460|560436446|FG007|Combination Therapy Phase|Progressive disease|1|||
155273882|NCT00876460|560436439|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
155273883|NCT00876460|560436440|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
155273884|NCT00876460|560436441|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
155273885|NCT00876460|560436442|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
155273886|NCT00876460|560436443|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
155273887|NCT00876460|560436444|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
155273888|NCT00876460|560436445|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
155273889|NCT00876460|560436446|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
155273890|NCT00876460|560436439|FG000|Combination Therapy Phase|Adverse Event|0|||
155273891|NCT00876460|560436440|FG001|Combination Therapy Phase|Adverse Event|2|||
155273892|NCT00876460|560436441|FG002|Combination Therapy Phase|Adverse Event|0|||
155273893|NCT00876460|560436442|FG003|Combination Therapy Phase|Adverse Event|2|||
155273894|NCT00876460|560436443|FG004|Combination Therapy Phase|Adverse Event|2|||
155273895|NCT00876460|560436444|FG005|Combination Therapy Phase|Adverse Event|0|||
155273896|NCT00876460|560436445|FG006|Combination Therapy Phase|Adverse Event|3|||
155273897|NCT00876460|560436446|FG007|Combination Therapy Phase|Adverse Event|2|||
155273898|NCT00876460|560436439|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
155273899|NCT00876460|560436440|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
155273900|NCT00876460|560436441|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
155273901|NCT00876460|560436442|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
155273902|NCT00876460|560436443|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
155273903|NCT00876460|560436444|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
155273904|NCT00876460|560436445|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
155273905|NCT00876460|560436446|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
155273906|NCT00876460|560436439|FG000|Combination Therapy Phase|Other reason not defined above|0|||
155273907|NCT00876460|560436440|FG001|Combination Therapy Phase|Other reason not defined above|0|||
155273908|NCT00876460|560436441|FG002|Combination Therapy Phase|Other reason not defined above|0|||
155273909|NCT00876460|560436442|FG003|Combination Therapy Phase|Other reason not defined above|0|||
155273910|NCT00876460|560436443|FG004|Combination Therapy Phase|Other reason not defined above|0|||
155273911|NCT00876460|560436444|FG005|Combination Therapy Phase|Other reason not defined above|0|||
155273912|NCT00876460|560436445|FG006|Combination Therapy Phase|Other reason not defined above|1|||
155273913|NCT00876460|560436446|FG007|Combination Therapy Phase|Other reason not defined above|2|||
155273914|NCT00876460|560436439|FG000|Combination Therapy Phase|Not treated|0|||
155273915|NCT00876460|560436440|FG001|Combination Therapy Phase|Not treated|0|||
155273916|NCT00876460|560436441|FG002|Combination Therapy Phase|Not treated|0|||
155273917|NCT00876460|560436442|FG003|Combination Therapy Phase|Not treated|0|||
155273918|NCT00876460|560436443|FG004|Combination Therapy Phase|Not treated|0|||
155273919|NCT00876460|560436444|FG005|Combination Therapy Phase|Not treated|0|||
155273920|NCT00876460|560436445|FG006|Combination Therapy Phase|Not treated|1|||
155273921|NCT00876460|560436446|FG007|Combination Therapy Phase|Not treated|0|||
155273922|NCT00876460|560436439|FG000|Mono Therapy Phase|Progressive disease|0|||
155273923|NCT00876460|560436440|FG001|Mono Therapy Phase|Progressive disease|0|||
155273924|NCT00876460|560436441|FG002|Mono Therapy Phase|Progressive disease|0|||
155273925|NCT00876460|560436442|FG003|Mono Therapy Phase|Progressive disease|0|||
155273926|NCT00876460|560436443|FG004|Mono Therapy Phase|Progressive disease|2|||
155273927|NCT00876460|560436444|FG005|Mono Therapy Phase|Progressive disease|0|||
155273928|NCT00876460|560436445|FG006|Mono Therapy Phase|Progressive disease|1|||
155273929|NCT00876460|560436446|FG007|Mono Therapy Phase|Progressive disease|3|||
155273930|NCT00876460|560436439|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
155273931|NCT00876460|560436440|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
155273932|NCT00876460|560436441|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
155273933|NCT00876460|560436442|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
155273934|NCT00876460|560436443|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
155273935|NCT00876460|560436444|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
155619646|NCT00490971|561699791|FG001|Acute/Continuation|Withdrawal by Subject|24|||
155619647|NCT00490971|561699792|FG002|Acute/Continuation|Withdrawal by Subject|0|||
155619648|NCT00490971|561699793|FG003|Acute/Continuation|Withdrawal by Subject|0|||
155619649|NCT00490971|561699794|FG004|Acute/Continuation|Withdrawal by Subject|0|||
155273936|NCT00876460|560436445|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
155273937|NCT00876460|560436446|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
155273938|NCT00876460|560436439|FG000|Mono Therapy Phase|Adverse Event|0|||
155273939|NCT00876460|560436440|FG001|Mono Therapy Phase|Adverse Event|0|||
155273940|NCT00876460|560436441|FG002|Mono Therapy Phase|Adverse Event|0|||
155273941|NCT00876460|560436442|FG003|Mono Therapy Phase|Adverse Event|1|||
155273942|NCT00876460|560436443|FG004|Mono Therapy Phase|Adverse Event|0|||
155273943|NCT00876460|560436444|FG005|Mono Therapy Phase|Adverse Event|0|||
155273944|NCT00876460|560436445|FG006|Mono Therapy Phase|Adverse Event|0|||
155273945|NCT00876460|560436446|FG007|Mono Therapy Phase|Adverse Event|0|||
155273946|NCT02049710|560436451|FG000|Overall Study|Lost to Follow-up|319|||
155273947|NCT02049710|560436452|FG001|Overall Study|Lost to Follow-up|324|||
155273948|NCT00003458|560436453|FG000|Overall Study|Not evaluable|4|||
155273949|NCT01216293|560436454|FG000|Main Study|Adverse Event|1|||
155273950|NCT01216293|560436455|FG001|Main Study|Adverse Event|4|||
155273951|NCT01216293|560436456|FG002|Main Study|Adverse Event|2|||
155273952|NCT01216293|560436454|FG000|Main Study|Major Protocol Deviation|1|||
155273953|NCT01216293|560436455|FG001|Main Study|Major Protocol Deviation|0|||
155273954|NCT01216293|560436456|FG002|Main Study|Major Protocol Deviation|1|||
155273955|NCT01216293|560436454|FG000|Main Study|Lost to Follow-up|3|||
155273956|NCT01216293|560436455|FG001|Main Study|Lost to Follow-up|1|||
155273957|NCT01216293|560436456|FG002|Main Study|Lost to Follow-up|0|||
155273958|NCT01216293|560436454|FG000|Main Study|Voluntary Withdrawal|2|||
155273959|NCT01216293|560436455|FG001|Main Study|Voluntary Withdrawal|2|||
155273960|NCT01216293|560436456|FG002|Main Study|Voluntary Withdrawal|2|||
155273961|NCT01216293|560436454|FG000|Main Study|Other Reason Not Specified|0|||
155273962|NCT01216293|560436455|FG001|Main Study|Other Reason Not Specified|1|||
155273963|NCT01216293|560436456|FG002|Main Study|Other Reason Not Specified|1|||
155273964|NCT01216293|560436454|FG000|Main Study|Randomized, Not Treated|1|||
155273965|NCT01216293|560436455|FG001|Main Study|Randomized, Not Treated|0|||
155273966|NCT01216293|560436456|FG002|Main Study|Randomized, Not Treated|0|||
155273967|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Adverse Event|0|||
155273968|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Adverse Event|2|||
155273969|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Adverse Event|0|||
155273970|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
155273971|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
155273972|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
155273973|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
155273974|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
155273975|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
155273976|NCT03391960|560436457|FG000|Overall Study|Protocol Violation|0|||
155273977|NCT03391960|560436458|FG001|Overall Study|Protocol Violation|0|||
155273978|NCT00581113|560438269|FG000|Overall Study|Withdrawal by Subject|0|||
155273979|NCT00581113|560438270|FG001|Overall Study|Withdrawal by Subject|1|||
155273980|NCT01818141|560438271|FG000|Overall Study|Withdrawal by Subject|2|||
155619650|NCT00490971|561699790|FG000|Acute/Continuation|Other|11|||
155273981|NCT01818141|560438272|FG001|Overall Study|Withdrawal by Subject|0|||
155273982|NCT01818141|560438271|FG000|Overall Study|No baseline C.diff colonies|1|||
155273983|NCT01818141|560438272|FG001|Overall Study|No baseline C.diff colonies|1|||
155273984|NCT01818141|560438271|FG000|Overall Study|Lost to Follow-up|0|||
155273985|NCT01818141|560438272|FG001|Overall Study|Lost to Follow-up|2|||
155273986|NCT02169830|560438278|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
155273987|NCT02169830|560438279|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
155273988|NCT02169830|560438280|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
155273989|NCT02169830|560438278|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
155273990|NCT02169830|560438279|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155273991|NCT02169830|560438280|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155273992|NCT02169830|560438278|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
155273993|NCT02169830|560438279|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
155273994|NCT02169830|560438280|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155273995|NCT02169830|560438278|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
155273996|NCT02169830|560438279|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
155273997|NCT02169830|560438280|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
155273998|NCT02169830|560438278|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
155273999|NCT02169830|560438279|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
155274000|NCT02169830|560438280|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
155274001|NCT03204695|560438281|FG000|Overall Study|Death|1|||
155274002|NCT03204695|560438281|FG000|Overall Study|Participant was treated with another device|1|||
155274003|NCT03204695|560438281|FG000|Overall Study|Physician Decision|2|||
155274004|NCT04834362|560438282|FG000|Overall Study|Death|1|||
155274005|NCT04834362|560438283|FG001|Overall Study|Death|2|||
155274006|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
155274007|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274008|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274009|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274010|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274011|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
155274012|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274013|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274014|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274015|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274016|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
155274017|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274018|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274019|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274020|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274021|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
155274022|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274023|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274024|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274025|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274026|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
155274027|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274028|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274029|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274030|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274031|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274032|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
155274033|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
155274034|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274035|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274036|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274037|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
155274038|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
155274039|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274040|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274041|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274042|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
155274043|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274044|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274045|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274046|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274047|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
155274048|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
155274049|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274050|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274051|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274052|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274053|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274054|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
155274055|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274056|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274057|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274058|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274059|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
155274060|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274061|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274062|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274063|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274064|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274065|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
155274066|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274067|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274068|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274069|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274070|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
155274071|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274072|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274073|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274074|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
155274075|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274076|NCT03095599|560438291|FG000|Overall Study|Withdrawal by Subject|1|||
155274077|NCT03095599|560438292|FG001|Overall Study|Withdrawal by Subject|0|||
155274078|NCT03095599|560438291|FG000|Overall Study|Lost to Follow-up|1|||
155274079|NCT03095599|560438292|FG001|Overall Study|Lost to Follow-up|0|||
155274080|NCT03095599|560438291|FG000|Overall Study|Withdrawal prior to vaccination|1|||
155274081|NCT03095599|560438292|FG001|Overall Study|Withdrawal prior to vaccination|0|||
155274082|NCT00742885|560438296|FG000|Overall Study|Lost to Follow-up|1|||
155274083|NCT00742885|560438297|FG001|Overall Study|Lost to Follow-up|0|||
155274084|NCT04781647|560438298|FG000|Overall Study|Study terminated by Sponsor|11|||
155274085|NCT04781647|560438299|FG001|Overall Study|Study terminated by Sponsor|9|||
155274086|NCT04781647|560438300|FG002|Overall Study|Study terminated by Sponsor|9|||
155274087|NCT04781647|560438298|FG000|Overall Study|Withdrawal by Subject|1|||
155274088|NCT04781647|560438299|FG001|Overall Study|Withdrawal by Subject|2|||
155274089|NCT04781647|560438300|FG002|Overall Study|Withdrawal by Subject|0|||
155274090|NCT04781647|560438298|FG000|Overall Study|Adverse Event|0|||
155274091|NCT04781647|560438299|FG001|Overall Study|Adverse Event|1|||
155274092|NCT04781647|560438300|FG002|Overall Study|Adverse Event|1|||
155274093|NCT04781647|560438298|FG000|Overall Study|Protocol Violation|1|||
155274094|NCT04781647|560438299|FG001|Overall Study|Protocol Violation|0|||
155274095|NCT04781647|560438300|FG002|Overall Study|Protocol Violation|0|||
155274096|NCT04781647|560438298|FG000|Overall Study|Pregnancy|0|||
155274097|NCT04781647|560438299|FG001|Overall Study|Pregnancy|0|||
155274098|NCT04781647|560438300|FG002|Overall Study|Pregnancy|1|||
155274099|NCT04781647|560438298|FG000|Overall Study|Virology rebounded|1|||
155274100|NCT04781647|560438299|FG001|Overall Study|Virology rebounded|0|||
155274101|NCT04781647|560438300|FG002|Overall Study|Virology rebounded|0|||
155274102|NCT00777803|560438301|FG000|Overall Study|Lost to Follow-up|12|||
155274103|NCT00777803|560438302|FG001|Overall Study|Lost to Follow-up|5|||
155274104|NCT00777803|560438301|FG000|Overall Study|Adverse Event|1|||
155274105|NCT00777803|560438302|FG001|Overall Study|Adverse Event|0|||
155274106|NCT00777803|560438301|FG000|Overall Study|Non-compliance|2|||
155274107|NCT00777803|560438302|FG001|Overall Study|Non-compliance|2|||
155274108|NCT01755689|560438303|FG000|Overall Study|Withdrawal by Subject|1|||
155274109|NCT01755689|560438304|FG001|Overall Study|Withdrawal by Subject|3|||
155274110|NCT01755689|560438305|FG002|Overall Study|Withdrawal by Subject|2|||
155274111|NCT01755689|560438306|FG003|Overall Study|Withdrawal by Subject|1|||
155274112|NCT01755689|560438307|FG004|Overall Study|Withdrawal by Subject|1|||
155274113|NCT01755689|560438303|FG000|Overall Study|Migrated/moved from study area|0|||
155274114|NCT01755689|560438304|FG001|Overall Study|Migrated/moved from study area|1|||
155274115|NCT01755689|560438305|FG002|Overall Study|Migrated/moved from study area|1|||
155274116|NCT01755689|560438306|FG003|Overall Study|Migrated/moved from study area|1|||
155274117|NCT01755689|560438307|FG004|Overall Study|Migrated/moved from study area|1|||
155274118|NCT01755689|560438303|FG000|Overall Study|Lost to Follow-up|1|||
155274119|NCT01755689|560438304|FG001|Overall Study|Lost to Follow-up|0|||
155274120|NCT01755689|560438305|FG002|Overall Study|Lost to Follow-up|1|||
155274121|NCT01755689|560438306|FG003|Overall Study|Lost to Follow-up|0|||
155274122|NCT01755689|560438307|FG004|Overall Study|Lost to Follow-up|2|||
155274123|NCT01755689|560438303|FG000|Overall Study|Pregnancy|1|||
155274124|NCT01755689|560438304|FG001|Overall Study|Pregnancy|1|||
155274125|NCT01755689|560438305|FG002|Overall Study|Pregnancy|2|||
155274126|NCT01755689|560438306|FG003|Overall Study|Pregnancy|4|||
155274127|NCT01755689|560438307|FG004|Overall Study|Pregnancy|2|||
155274128|NCT02930122|560438310|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
155274129|NCT02930122|560438311|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
155274130|NCT01995357|560438312|FG000|Period 5|Lack of Efficacy|1|||
155274131|NCT01995357|560438313|FG001|Period 5|Lack of Efficacy|0|||
155274132|NCT01995357|560438314|FG002|Period 5|Lack of Efficacy|0|||
155274133|NCT01995357|560438315|FG003|Period 5|Lack of Efficacy|0|||
155274134|NCT01995357|560438316|FG004|Period 5|Lack of Efficacy|0|||
155274135|NCT01995357|560438317|FG005|Period 5|Lack of Efficacy|0|||
155274136|NCT01995357|560438312|FG000|Period 5|Adverse Event|1|||
155274137|NCT01995357|560438313|FG001|Period 5|Adverse Event|0|||
155274138|NCT01995357|560438314|FG002|Period 5|Adverse Event|1|||
155274139|NCT01995357|560438315|FG003|Period 5|Adverse Event|0|||
155274140|NCT01995357|560438316|FG004|Period 5|Adverse Event|0|||
155274141|NCT01995357|560438317|FG005|Period 5|Adverse Event|0|||
155274142|NCT02609659|560438318|FG000|Overall Study|Adverse Event|1|||
155274143|NCT02609659|560438318|FG000|Overall Study|Lost to Follow-up|6|||
155274144|NCT02609659|560438318|FG000|Overall Study|Other|1|||
155274145|NCT03943589|560438319|FG000|Overall Study|Death|1|||
155274146|NCT03943589|560438319|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
155274147|NCT04329104|560438320|FG000|Efficacy Study|Withdrawal by Subject|0|||
155274148|NCT04329104|560438321|FG001|Efficacy Study|Withdrawal by Subject|0|||
155274149|NCT04329104|560438322|FG002|Efficacy Study|Withdrawal by Subject|0|||
155274150|NCT04329104|560438323|FG003|Efficacy Study|Withdrawal by Subject|5|||
155274151|NCT04329104|560438324|FG004|Efficacy Study|Withdrawal by Subject|6|||
155274152|NCT04329104|560438325|FG005|Efficacy Study|Withdrawal by Subject|8|||
155274153|NCT01474512|560438330|FG000|Induction Period|Adverse Event|6|||
155274154|NCT01474512|560438331|FG001|Induction Period|Adverse Event|10|||
155274155|NCT01474512|560438332|FG002|Induction Period|Adverse Event|10|||
155274156|NCT01474512|560438333|FG003|Induction Period|Adverse Event|0|||
155274157|NCT01474512|560438334|FG004|Induction Period|Adverse Event|0|||
155274158|NCT01474512|560438335|FG005|Induction Period|Adverse Event|0|||
155274159|NCT01474512|560438336|FG006|Induction Period|Adverse Event|0|||
155274160|NCT01474512|560438337|FG007|Induction Period|Adverse Event|0|||
155274161|NCT01474512|560438338|FG008|Induction Period|Adverse Event|0|||
155274162|NCT01474512|560438339|FG009|Induction Period|Adverse Event|0|||
155274163|NCT01474512|560438340|FG010|Induction Period|Adverse Event|0|||
155274164|NCT01474512|560438341|FG011|Induction Period|Adverse Event|0|||
155274165|NCT01474512|560438342|FG012|Induction Period|Adverse Event|0|||
155274166|NCT01474512|560438343|FG013|Induction Period|Adverse Event|0|||
155274167|NCT01474512|560438344|FG014|Induction Period|Adverse Event|0|||
155274168|NCT01474512|560438345|FG015|Induction Period|Adverse Event|0|||
155274169|NCT01474512|560438346|FG016|Induction Period|Adverse Event|0|||
155274170|NCT01474512|560438347|FG017|Induction Period|Adverse Event|0|||
155274171|NCT01474512|560438330|FG000|Induction Period|Lack of Efficacy|7|||
155274172|NCT01474512|560438331|FG001|Induction Period|Lack of Efficacy|1|||
155274173|NCT01474512|560438332|FG002|Induction Period|Lack of Efficacy|0|||
155274174|NCT01474512|560438333|FG003|Induction Period|Lack of Efficacy|0|||
155274175|NCT01474512|560438334|FG004|Induction Period|Lack of Efficacy|0|||
155274176|NCT01474512|560438335|FG005|Induction Period|Lack of Efficacy|0|||
155274177|NCT01474512|560438336|FG006|Induction Period|Lack of Efficacy|0|||
155274178|NCT01474512|560438337|FG007|Induction Period|Lack of Efficacy|0|||
155274179|NCT01474512|560438338|FG008|Induction Period|Lack of Efficacy|0|||
155274180|NCT01474512|560438339|FG009|Induction Period|Lack of Efficacy|0|||
155274181|NCT01474512|560438340|FG010|Induction Period|Lack of Efficacy|0|||
155274182|NCT01474512|560438341|FG011|Induction Period|Lack of Efficacy|0|||
155274183|NCT01474512|560438342|FG012|Induction Period|Lack of Efficacy|0|||
155274184|NCT01474512|560438343|FG013|Induction Period|Lack of Efficacy|0|||
155274185|NCT01474512|560438344|FG014|Induction Period|Lack of Efficacy|0|||
155274186|NCT01474512|560438345|FG015|Induction Period|Lack of Efficacy|0|||
155274187|NCT01474512|560438346|FG016|Induction Period|Lack of Efficacy|0|||
155274188|NCT01474512|560438347|FG017|Induction Period|Lack of Efficacy|0|||
155274189|NCT01474512|560438330|FG000|Induction Period|Withdrawal by Subject|6|||
155274190|NCT01474512|560438331|FG001|Induction Period|Withdrawal by Subject|6|||
155274191|NCT01474512|560438332|FG002|Induction Period|Withdrawal by Subject|5|||
155274192|NCT01474512|560438333|FG003|Induction Period|Withdrawal by Subject|0|||
155274193|NCT01474512|560438334|FG004|Induction Period|Withdrawal by Subject|0|||
155274194|NCT01474512|560438335|FG005|Induction Period|Withdrawal by Subject|0|||
155274195|NCT01474512|560438336|FG006|Induction Period|Withdrawal by Subject|0|||
155381936|NCT00598273|560833242|FG000|Overall Study|Death|6|||
155274196|NCT01474512|560438337|FG007|Induction Period|Withdrawal by Subject|0|||
155274197|NCT01474512|560438338|FG008|Induction Period|Withdrawal by Subject|0|||
155274198|NCT01474512|560438339|FG009|Induction Period|Withdrawal by Subject|0|||
155381937|NCT00598273|560833243|FG001|Overall Study|Death|12|||
155274199|NCT01474512|560438340|FG010|Induction Period|Withdrawal by Subject|0|||
155274200|NCT01474512|560438341|FG011|Induction Period|Withdrawal by Subject|0|||
155274201|NCT01474512|560438342|FG012|Induction Period|Withdrawal by Subject|0|||
155274202|NCT01474512|560438343|FG013|Induction Period|Withdrawal by Subject|0|||
155274203|NCT01474512|560438344|FG014|Induction Period|Withdrawal by Subject|0|||
155274204|NCT01474512|560438345|FG015|Induction Period|Withdrawal by Subject|0|||
155274205|NCT01474512|560438346|FG016|Induction Period|Withdrawal by Subject|0|||
155274206|NCT01474512|560438347|FG017|Induction Period|Withdrawal by Subject|0|||
155274207|NCT01474512|560438330|FG000|Induction Period|Protocol Violation|3|||
155274208|NCT01474512|560438331|FG001|Induction Period|Protocol Violation|6|||
155274209|NCT01474512|560438332|FG002|Induction Period|Protocol Violation|0|||
155274210|NCT01474512|560438333|FG003|Induction Period|Protocol Violation|0|||
155274211|NCT01474512|560438334|FG004|Induction Period|Protocol Violation|0|||
155274212|NCT01474512|560438335|FG005|Induction Period|Protocol Violation|0|||
155274213|NCT01474512|560438336|FG006|Induction Period|Protocol Violation|0|||
155274214|NCT01474512|560438337|FG007|Induction Period|Protocol Violation|0|||
155274215|NCT01474512|560438338|FG008|Induction Period|Protocol Violation|0|||
155274216|NCT01474512|560438339|FG009|Induction Period|Protocol Violation|0|||
155274217|NCT01474512|560438340|FG010|Induction Period|Protocol Violation|0|||
155274218|NCT01474512|560438341|FG011|Induction Period|Protocol Violation|0|||
155274219|NCT01474512|560438342|FG012|Induction Period|Protocol Violation|0|||
155274220|NCT01474512|560438343|FG013|Induction Period|Protocol Violation|0|||
155274221|NCT01474512|560438344|FG014|Induction Period|Protocol Violation|0|||
155274222|NCT01474512|560438345|FG015|Induction Period|Protocol Violation|0|||
155274223|NCT01474512|560438346|FG016|Induction Period|Protocol Violation|0|||
155274224|NCT01474512|560438347|FG017|Induction Period|Protocol Violation|0|||
155274225|NCT01474512|560438330|FG000|Induction Period|Sponsor Decision|1|||
155274226|NCT01474512|560438331|FG001|Induction Period|Sponsor Decision|1|||
155274227|NCT01474512|560438332|FG002|Induction Period|Sponsor Decision|1|||
155274228|NCT01474512|560438333|FG003|Induction Period|Sponsor Decision|0|||
155274229|NCT01474512|560438334|FG004|Induction Period|Sponsor Decision|0|||
155274230|NCT01474512|560438335|FG005|Induction Period|Sponsor Decision|0|||
155274231|NCT01474512|560438336|FG006|Induction Period|Sponsor Decision|0|||
155274232|NCT01474512|560438337|FG007|Induction Period|Sponsor Decision|0|||
155274233|NCT01474512|560438338|FG008|Induction Period|Sponsor Decision|0|||
155274234|NCT01474512|560438339|FG009|Induction Period|Sponsor Decision|0|||
155274235|NCT01474512|560438340|FG010|Induction Period|Sponsor Decision|0|||
155274236|NCT01474512|560438341|FG011|Induction Period|Sponsor Decision|0|||
155274237|NCT01474512|560438342|FG012|Induction Period|Sponsor Decision|0|||
155274238|NCT01474512|560438343|FG013|Induction Period|Sponsor Decision|0|||
155274239|NCT01474512|560438344|FG014|Induction Period|Sponsor Decision|0|||
155274240|NCT01474512|560438345|FG015|Induction Period|Sponsor Decision|0|||
155274241|NCT01474512|560438346|FG016|Induction Period|Sponsor Decision|0|||
155274242|NCT01474512|560438347|FG017|Induction Period|Sponsor Decision|0|||
155274243|NCT01474512|560438330|FG000|Induction Period|Lost to Follow-up|1|||
155274244|NCT01474512|560438331|FG001|Induction Period|Lost to Follow-up|0|||
155274245|NCT01474512|560438332|FG002|Induction Period|Lost to Follow-up|2|||
155274246|NCT01474512|560438333|FG003|Induction Period|Lost to Follow-up|0|||
155274247|NCT01474512|560438334|FG004|Induction Period|Lost to Follow-up|0|||
155274248|NCT01474512|560438335|FG005|Induction Period|Lost to Follow-up|0|||
155274249|NCT01474512|560438336|FG006|Induction Period|Lost to Follow-up|0|||
155274250|NCT01474512|560438337|FG007|Induction Period|Lost to Follow-up|0|||
155274251|NCT01474512|560438338|FG008|Induction Period|Lost to Follow-up|0|||
155274252|NCT01474512|560438339|FG009|Induction Period|Lost to Follow-up|0|||
155274253|NCT01474512|560438340|FG010|Induction Period|Lost to Follow-up|0|||
155274254|NCT01474512|560438341|FG011|Induction Period|Lost to Follow-up|0|||
155274255|NCT01474512|560438342|FG012|Induction Period|Lost to Follow-up|0|||
155274256|NCT01474512|560438343|FG013|Induction Period|Lost to Follow-up|0|||
155274257|NCT01474512|560438344|FG014|Induction Period|Lost to Follow-up|0|||
155274258|NCT01474512|560438345|FG015|Induction Period|Lost to Follow-up|0|||
155274259|NCT01474512|560438346|FG016|Induction Period|Lost to Follow-up|0|||
155274260|NCT01474512|560438347|FG017|Induction Period|Lost to Follow-up|0|||
155274261|NCT01474512|560438330|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274262|NCT01474512|560438331|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274263|NCT01474512|560438332|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274264|NCT01474512|560438333|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
155274265|NCT01474512|560438334|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
155274266|NCT01474512|560438335|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
155274267|NCT01474512|560438336|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
155274268|NCT01474512|560438337|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274269|NCT01474512|560438338|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274270|NCT01474512|560438339|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274271|NCT01474512|560438340|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274272|NCT01474512|560438341|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274273|NCT01474512|560438342|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155726883|NCT02131259|562099806|FG000|Overall Study|Other|63|||
155274274|NCT01474512|560438343|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274275|NCT01474512|560438344|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274276|NCT01474512|560438345|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274277|NCT01474512|560438346|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274278|NCT01474512|560438347|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274279|NCT01474512|560438330|FG000|Maintenance Period|Adverse Event|0|||
155274280|NCT01474512|560438331|FG001|Maintenance Period|Adverse Event|0|||
155274281|NCT01474512|560438332|FG002|Maintenance Period|Adverse Event|0|||
155274282|NCT01474512|560438333|FG003|Maintenance Period|Adverse Event|4|||
155274283|NCT01474512|560438334|FG004|Maintenance Period|Adverse Event|2|||
155274284|NCT01474512|560438335|FG005|Maintenance Period|Adverse Event|7|||
155274285|NCT01474512|560438336|FG006|Maintenance Period|Adverse Event|0|||
155274286|NCT01474512|560438337|FG007|Maintenance Period|Adverse Event|19|||
155274287|NCT01474512|560438338|FG008|Maintenance Period|Adverse Event|1|||
155274288|NCT01474512|560438339|FG009|Maintenance Period|Adverse Event|3|||
155274289|NCT01474512|560438340|FG010|Maintenance Period|Adverse Event|0|||
155274290|NCT01474512|560438341|FG011|Maintenance Period|Adverse Event|0|||
155274291|NCT01474512|560438342|FG012|Maintenance Period|Adverse Event|0|||
155274292|NCT01474512|560438343|FG013|Maintenance Period|Adverse Event|0|||
155274293|NCT01474512|560438344|FG014|Maintenance Period|Adverse Event|0|||
155274294|NCT01474512|560438345|FG015|Maintenance Period|Adverse Event|0|||
155274295|NCT01474512|560438346|FG016|Maintenance Period|Adverse Event|0|||
155274296|NCT01474512|560438347|FG017|Maintenance Period|Adverse Event|0|||
155274297|NCT01474512|560438330|FG000|Maintenance Period|Withdrawal by Subject|0|||
155274298|NCT01474512|560438331|FG001|Maintenance Period|Withdrawal by Subject|0|||
155274299|NCT01474512|560438332|FG002|Maintenance Period|Withdrawal by Subject|0|||
155274300|NCT01474512|560438333|FG003|Maintenance Period|Withdrawal by Subject|6|||
155274301|NCT01474512|560438334|FG004|Maintenance Period|Withdrawal by Subject|2|||
155274302|NCT01474512|560438335|FG005|Maintenance Period|Withdrawal by Subject|3|||
155274303|NCT01474512|560438336|FG006|Maintenance Period|Withdrawal by Subject|1|||
155274304|NCT01474512|560438337|FG007|Maintenance Period|Withdrawal by Subject|6|||
155274305|NCT01474512|560438338|FG008|Maintenance Period|Withdrawal by Subject|3|||
155274306|NCT01474512|560438339|FG009|Maintenance Period|Withdrawal by Subject|1|||
155274307|NCT01474512|560438340|FG010|Maintenance Period|Withdrawal by Subject|0|||
155274308|NCT01474512|560438341|FG011|Maintenance Period|Withdrawal by Subject|0|||
155274309|NCT01474512|560438342|FG012|Maintenance Period|Withdrawal by Subject|0|||
155274310|NCT01474512|560438343|FG013|Maintenance Period|Withdrawal by Subject|0|||
155274311|NCT01474512|560438344|FG014|Maintenance Period|Withdrawal by Subject|0|||
155274312|NCT01474512|560438345|FG015|Maintenance Period|Withdrawal by Subject|0|||
155274313|NCT01474512|560438346|FG016|Maintenance Period|Withdrawal by Subject|0|||
155274314|NCT01474512|560438347|FG017|Maintenance Period|Withdrawal by Subject|0|||
155274315|NCT01474512|560438330|FG000|Maintenance Period|Lost to Follow-up|0|||
155274316|NCT01474512|560438331|FG001|Maintenance Period|Lost to Follow-up|0|||
155274317|NCT01474512|560438332|FG002|Maintenance Period|Lost to Follow-up|0|||
155274318|NCT01474512|560438333|FG003|Maintenance Period|Lost to Follow-up|3|||
155274319|NCT01474512|560438334|FG004|Maintenance Period|Lost to Follow-up|3|||
155274320|NCT01474512|560438335|FG005|Maintenance Period|Lost to Follow-up|0|||
155274321|NCT01474512|560438336|FG006|Maintenance Period|Lost to Follow-up|0|||
155274322|NCT01474512|560438337|FG007|Maintenance Period|Lost to Follow-up|2|||
155274323|NCT01474512|560438338|FG008|Maintenance Period|Lost to Follow-up|1|||
155274324|NCT01474512|560438339|FG009|Maintenance Period|Lost to Follow-up|1|||
155274325|NCT01474512|560438340|FG010|Maintenance Period|Lost to Follow-up|0|||
155274326|NCT01474512|560438341|FG011|Maintenance Period|Lost to Follow-up|0|||
155274327|NCT01474512|560438342|FG012|Maintenance Period|Lost to Follow-up|0|||
155274328|NCT01474512|560438343|FG013|Maintenance Period|Lost to Follow-up|0|||
155274329|NCT01474512|560438344|FG014|Maintenance Period|Lost to Follow-up|0|||
155274330|NCT01474512|560438345|FG015|Maintenance Period|Lost to Follow-up|0|||
155274331|NCT01474512|560438346|FG016|Maintenance Period|Lost to Follow-up|0|||
155274332|NCT01474512|560438347|FG017|Maintenance Period|Lost to Follow-up|0|||
155274333|NCT01474512|560438330|FG000|Maintenance Period|Death|0|||
155274334|NCT01474512|560438331|FG001|Maintenance Period|Death|0|||
155274335|NCT01474512|560438332|FG002|Maintenance Period|Death|0|||
155274336|NCT01474512|560438333|FG003|Maintenance Period|Death|0|||
155274337|NCT01474512|560438334|FG004|Maintenance Period|Death|0|||
155274338|NCT01474512|560438335|FG005|Maintenance Period|Death|2|||
155274339|NCT01474512|560438336|FG006|Maintenance Period|Death|0|||
155726884|NCT02131259|562099806|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
155726885|NCT02131259|562099806|FG000|Overall Study|Progressive disease/relocation|1|||
155274340|NCT01474512|560438337|FG007|Maintenance Period|Death|0|||
155274341|NCT01474512|560438338|FG008|Maintenance Period|Death|0|||
155274342|NCT01474512|560438339|FG009|Maintenance Period|Death|0|||
155274343|NCT01474512|560438340|FG010|Maintenance Period|Death|0|||
155274344|NCT01474512|560438341|FG011|Maintenance Period|Death|0|||
155274345|NCT01474512|560438342|FG012|Maintenance Period|Death|0|||
155726886|NCT02131259|562099806|FG000|Overall Study|Progressive disease/other|2|||
155274346|NCT01474512|560438343|FG013|Maintenance Period|Death|0|||
155274347|NCT01474512|560438344|FG014|Maintenance Period|Death|0|||
155726887|NCT02131259|562099806|FG000|Overall Study|AE/lost to follow-up|1|||
155274348|NCT01474512|560438345|FG015|Maintenance Period|Death|0|||
155274349|NCT01474512|560438346|FG016|Maintenance Period|Death|0|||
155274350|NCT01474512|560438347|FG017|Maintenance Period|Death|0|||
155274351|NCT01474512|560438330|FG000|Maintenance Period|Physician Decision|0|||
155274352|NCT01474512|560438331|FG001|Maintenance Period|Physician Decision|0|||
155274353|NCT01474512|560438332|FG002|Maintenance Period|Physician Decision|0|||
155274354|NCT01474512|560438333|FG003|Maintenance Period|Physician Decision|0|||
155274355|NCT01474512|560438334|FG004|Maintenance Period|Physician Decision|0|||
155274356|NCT01474512|560438335|FG005|Maintenance Period|Physician Decision|1|||
155274357|NCT01474512|560438336|FG006|Maintenance Period|Physician Decision|0|||
155274358|NCT01474512|560438337|FG007|Maintenance Period|Physician Decision|2|||
155274359|NCT01474512|560438338|FG008|Maintenance Period|Physician Decision|0|||
155274360|NCT01474512|560438339|FG009|Maintenance Period|Physician Decision|0|||
155274361|NCT01474512|560438340|FG010|Maintenance Period|Physician Decision|0|||
155274362|NCT01474512|560438341|FG011|Maintenance Period|Physician Decision|0|||
155274363|NCT01474512|560438342|FG012|Maintenance Period|Physician Decision|0|||
155274364|NCT01474512|560438343|FG013|Maintenance Period|Physician Decision|0|||
155274365|NCT01474512|560438344|FG014|Maintenance Period|Physician Decision|0|||
155274366|NCT01474512|560438345|FG015|Maintenance Period|Physician Decision|0|||
155274367|NCT01474512|560438346|FG016|Maintenance Period|Physician Decision|0|||
155274368|NCT01474512|560438347|FG017|Maintenance Period|Physician Decision|0|||
155274369|NCT01474512|560438330|FG000|Maintenance Period|Clinical Relapse|0|||
155274370|NCT01474512|560438331|FG001|Maintenance Period|Clinical Relapse|0|||
155274371|NCT01474512|560438332|FG002|Maintenance Period|Clinical Relapse|0|||
155274372|NCT01474512|560438333|FG003|Maintenance Period|Clinical Relapse|1|||
155274373|NCT01474512|560438334|FG004|Maintenance Period|Clinical Relapse|0|||
155274374|NCT01474512|560438335|FG005|Maintenance Period|Clinical Relapse|0|||
155274375|NCT01474512|560438336|FG006|Maintenance Period|Clinical Relapse|0|||
155274376|NCT01474512|560438337|FG007|Maintenance Period|Clinical Relapse|0|||
155274377|NCT01474512|560438338|FG008|Maintenance Period|Clinical Relapse|0|||
155274378|NCT01474512|560438339|FG009|Maintenance Period|Clinical Relapse|0|||
155274379|NCT01474512|560438340|FG010|Maintenance Period|Clinical Relapse|0|||
155274380|NCT01474512|560438341|FG011|Maintenance Period|Clinical Relapse|0|||
155274381|NCT01474512|560438342|FG012|Maintenance Period|Clinical Relapse|0|||
155274382|NCT01474512|560438343|FG013|Maintenance Period|Clinical Relapse|0|||
155274383|NCT01474512|560438344|FG014|Maintenance Period|Clinical Relapse|0|||
155274384|NCT01474512|560438345|FG015|Maintenance Period|Clinical Relapse|0|||
155274385|NCT01474512|560438346|FG016|Maintenance Period|Clinical Relapse|0|||
155274386|NCT01474512|560438347|FG017|Maintenance Period|Clinical Relapse|0|||
155274387|NCT01474512|560438330|FG000|Maintenance Period|Lack of Efficacy|0|||
155274388|NCT01474512|560438331|FG001|Maintenance Period|Lack of Efficacy|0|||
155274389|NCT01474512|560438332|FG002|Maintenance Period|Lack of Efficacy|0|||
155274390|NCT01474512|560438333|FG003|Maintenance Period|Lack of Efficacy|1|||
155274391|NCT01474512|560438334|FG004|Maintenance Period|Lack of Efficacy|0|||
155274392|NCT01474512|560438335|FG005|Maintenance Period|Lack of Efficacy|0|||
155274393|NCT01474512|560438336|FG006|Maintenance Period|Lack of Efficacy|0|||
155274394|NCT01474512|560438337|FG007|Maintenance Period|Lack of Efficacy|11|||
155274395|NCT01474512|560438338|FG008|Maintenance Period|Lack of Efficacy|11|||
155274396|NCT01474512|560438339|FG009|Maintenance Period|Lack of Efficacy|12|||
155274397|NCT01474512|560438340|FG010|Maintenance Period|Lack of Efficacy|0|||
155274398|NCT01474512|560438341|FG011|Maintenance Period|Lack of Efficacy|0|||
155274399|NCT01474512|560438342|FG012|Maintenance Period|Lack of Efficacy|0|||
155274400|NCT01474512|560438343|FG013|Maintenance Period|Lack of Efficacy|0|||
155274401|NCT01474512|560438344|FG014|Maintenance Period|Lack of Efficacy|0|||
155274402|NCT01474512|560438345|FG015|Maintenance Period|Lack of Efficacy|0|||
155274403|NCT01474512|560438346|FG016|Maintenance Period|Lack of Efficacy|0|||
155274404|NCT01474512|560438347|FG017|Maintenance Period|Lack of Efficacy|0|||
155274405|NCT01474512|560438330|FG000|Maintenance Period|Protocol Violation|0|||
155274406|NCT01474512|560438331|FG001|Maintenance Period|Protocol Violation|0|||
155274407|NCT01474512|560438332|FG002|Maintenance Period|Protocol Violation|0|||
155274408|NCT01474512|560438333|FG003|Maintenance Period|Protocol Violation|1|||
155274409|NCT01474512|560438334|FG004|Maintenance Period|Protocol Violation|0|||
155274410|NCT01474512|560438335|FG005|Maintenance Period|Protocol Violation|0|||
155274411|NCT01474512|560438336|FG006|Maintenance Period|Protocol Violation|0|||
155274412|NCT01474512|560438337|FG007|Maintenance Period|Protocol Violation|1|||
155274413|NCT01474512|560438338|FG008|Maintenance Period|Protocol Violation|0|||
155274414|NCT01474512|560438339|FG009|Maintenance Period|Protocol Violation|1|||
155274415|NCT01474512|560438340|FG010|Maintenance Period|Protocol Violation|0|||
155274416|NCT01474512|560438341|FG011|Maintenance Period|Protocol Violation|0|||
155274417|NCT01474512|560438342|FG012|Maintenance Period|Protocol Violation|0|||
155274418|NCT01474512|560438343|FG013|Maintenance Period|Protocol Violation|0|||
155274419|NCT01474512|560438344|FG014|Maintenance Period|Protocol Violation|0|||
155274420|NCT01474512|560438345|FG015|Maintenance Period|Protocol Violation|0|||
155274421|NCT01474512|560438346|FG016|Maintenance Period|Protocol Violation|0|||
155274422|NCT01474512|560438347|FG017|Maintenance Period|Protocol Violation|0|||
155274423|NCT01474512|560438330|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
155274424|NCT01474512|560438331|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
155274425|NCT01474512|560438332|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
155274426|NCT01474512|560438333|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
155274427|NCT01474512|560438334|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
155274428|NCT01474512|560438335|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
155274429|NCT01474512|560438336|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
155274430|NCT01474512|560438337|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
155274431|NCT01474512|560438338|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
155274432|NCT01474512|560438339|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
155274433|NCT01474512|560438340|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
155274434|NCT01474512|560438341|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
155274435|NCT01474512|560438342|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
155274436|NCT01474512|560438343|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
155274437|NCT01474512|560438344|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
155274438|NCT01474512|560438345|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
155274439|NCT01474512|560438346|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
155274440|NCT01474512|560438347|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
155274441|NCT01474512|560438330|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
155274442|NCT01474512|560438331|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
155274443|NCT01474512|560438332|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
155274444|NCT01474512|560438333|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
155274445|NCT01474512|560438334|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
155274446|NCT01474512|560438335|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
155274447|NCT01474512|560438336|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
155274448|NCT01474512|560438337|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
155274449|NCT01474512|560438338|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
155274450|NCT01474512|560438339|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
155274451|NCT01474512|560438340|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
155274452|NCT01474512|560438341|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
155274453|NCT01474512|560438342|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
155274454|NCT01474512|560438343|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
155274455|NCT01474512|560438344|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
155274456|NCT01474512|560438345|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
155274457|NCT01474512|560438346|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
155274458|NCT01474512|560438347|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
155274459|NCT01474512|560438330|FG000|Long-Term Extension Period|Adverse Event|0|||
155274460|NCT01474512|560438331|FG001|Long-Term Extension Period|Adverse Event|0|||
155274461|NCT01474512|560438332|FG002|Long-Term Extension Period|Adverse Event|0|||
155274462|NCT01474512|560438333|FG003|Long-Term Extension Period|Adverse Event|0|||
155274463|NCT01474512|560438334|FG004|Long-Term Extension Period|Adverse Event|0|||
155274464|NCT01474512|560438335|FG005|Long-Term Extension Period|Adverse Event|0|||
155274465|NCT01474512|560438336|FG006|Long-Term Extension Period|Adverse Event|0|||
155274466|NCT01474512|560438337|FG007|Long-Term Extension Period|Adverse Event|0|||
155274467|NCT01474512|560438338|FG008|Long-Term Extension Period|Adverse Event|0|||
155274468|NCT01474512|560438339|FG009|Long-Term Extension Period|Adverse Event|0|||
155274469|NCT01474512|560438340|FG010|Long-Term Extension Period|Adverse Event|0|||
155274470|NCT01474512|560438341|FG011|Long-Term Extension Period|Adverse Event|1|||
155274471|NCT01474512|560438342|FG012|Long-Term Extension Period|Adverse Event|57|||
155274472|NCT01474512|560438343|FG013|Long-Term Extension Period|Adverse Event|58|||
155274473|NCT01474512|560438344|FG014|Long-Term Extension Period|Adverse Event|0|||
155274474|NCT01474512|560438345|FG015|Long-Term Extension Period|Adverse Event|0|||
155274475|NCT01474512|560438346|FG016|Long-Term Extension Period|Adverse Event|0|||
155274476|NCT01474512|560438347|FG017|Long-Term Extension Period|Adverse Event|0|||
155274477|NCT01474512|560438330|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
155274478|NCT01474512|560438331|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
155274479|NCT01474512|560438332|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
155274480|NCT01474512|560438333|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
155274481|NCT01474512|560438334|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
155274482|NCT01474512|560438335|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
155274483|NCT01474512|560438336|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
155274484|NCT01474512|560438337|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
155274485|NCT01474512|560438338|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
155274486|NCT01474512|560438339|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
155274487|NCT01474512|560438340|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
155274488|NCT01474512|560438341|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
155274489|NCT01474512|560438342|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
155274490|NCT01474512|560438343|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
155726888|NCT02131259|562099806|FG000|Overall Study|AE/other|1|||
155274491|NCT01474512|560438344|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
155274492|NCT01474512|560438345|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
155274493|NCT01474512|560438346|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
155274494|NCT01474512|560438347|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
155274495|NCT01474512|560438330|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
155274496|NCT01474512|560438331|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
155274497|NCT01474512|560438332|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
155274498|NCT01474512|560438333|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
155274499|NCT01474512|560438334|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
155274500|NCT01474512|560438335|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
155274501|NCT01474512|560438336|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
155274502|NCT01474512|560438337|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
155274503|NCT01474512|560438338|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
155274504|NCT01474512|560438339|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
155274505|NCT01474512|560438340|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
155274506|NCT01474512|560438341|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
155274507|NCT01474512|560438342|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
155274508|NCT01474512|560438343|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
155274509|NCT01474512|560438344|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
155274510|NCT01474512|560438345|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
155274511|NCT01474512|560438346|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
155274512|NCT01474512|560438347|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
155274513|NCT01474512|560438330|FG000|Long-Term Extension Period|Physician Decision|0|||
155274514|NCT01474512|560438331|FG001|Long-Term Extension Period|Physician Decision|0|||
155274515|NCT01474512|560438332|FG002|Long-Term Extension Period|Physician Decision|0|||
155274516|NCT01474512|560438333|FG003|Long-Term Extension Period|Physician Decision|0|||
155274517|NCT01474512|560438334|FG004|Long-Term Extension Period|Physician Decision|0|||
155274518|NCT01474512|560438335|FG005|Long-Term Extension Period|Physician Decision|0|||
155274519|NCT01474512|560438336|FG006|Long-Term Extension Period|Physician Decision|0|||
155274520|NCT01474512|560438337|FG007|Long-Term Extension Period|Physician Decision|0|||
155274521|NCT01474512|560438338|FG008|Long-Term Extension Period|Physician Decision|0|||
155274522|NCT01474512|560438339|FG009|Long-Term Extension Period|Physician Decision|0|||
155274523|NCT01474512|560438340|FG010|Long-Term Extension Period|Physician Decision|0|||
155274524|NCT01474512|560438341|FG011|Long-Term Extension Period|Physician Decision|0|||
155274525|NCT01474512|560438342|FG012|Long-Term Extension Period|Physician Decision|21|||
155274526|NCT01474512|560438343|FG013|Long-Term Extension Period|Physician Decision|21|||
155274527|NCT01474512|560438344|FG014|Long-Term Extension Period|Physician Decision|0|||
155274528|NCT01474512|560438345|FG015|Long-Term Extension Period|Physician Decision|0|||
155274529|NCT01474512|560438346|FG016|Long-Term Extension Period|Physician Decision|0|||
155274530|NCT01474512|560438347|FG017|Long-Term Extension Period|Physician Decision|0|||
155274531|NCT01474512|560438330|FG000|Long-Term Extension Period|Clinical Relapse|0|||
155274532|NCT01474512|560438331|FG001|Long-Term Extension Period|Clinical Relapse|0|||
155274533|NCT01474512|560438332|FG002|Long-Term Extension Period|Clinical Relapse|0|||
155274534|NCT01474512|560438333|FG003|Long-Term Extension Period|Clinical Relapse|0|||
155274535|NCT01474512|560438334|FG004|Long-Term Extension Period|Clinical Relapse|0|||
155274536|NCT01474512|560438335|FG005|Long-Term Extension Period|Clinical Relapse|0|||
155274537|NCT01474512|560438336|FG006|Long-Term Extension Period|Clinical Relapse|0|||
155274538|NCT01474512|560438337|FG007|Long-Term Extension Period|Clinical Relapse|0|||
155274539|NCT01474512|560438338|FG008|Long-Term Extension Period|Clinical Relapse|0|||
155274540|NCT01474512|560438339|FG009|Long-Term Extension Period|Clinical Relapse|0|||
155274541|NCT01474512|560438340|FG010|Long-Term Extension Period|Clinical Relapse|0|||
155274542|NCT01474512|560438341|FG011|Long-Term Extension Period|Clinical Relapse|0|||
155274543|NCT01474512|560438342|FG012|Long-Term Extension Period|Clinical Relapse|9|||
155274544|NCT01474512|560438343|FG013|Long-Term Extension Period|Clinical Relapse|9|||
155274545|NCT01474512|560438344|FG014|Long-Term Extension Period|Clinical Relapse|0|||
155274546|NCT01474512|560438345|FG015|Long-Term Extension Period|Clinical Relapse|0|||
155274547|NCT01474512|560438346|FG016|Long-Term Extension Period|Clinical Relapse|0|||
155274548|NCT01474512|560438347|FG017|Long-Term Extension Period|Clinical Relapse|0|||
155274549|NCT01474512|560438330|FG000|Long-Term Extension Period|Death|0|||
155274550|NCT01474512|560438331|FG001|Long-Term Extension Period|Death|0|||
155274551|NCT01474512|560438332|FG002|Long-Term Extension Period|Death|0|||
155274552|NCT01474512|560438333|FG003|Long-Term Extension Period|Death|0|||
155274553|NCT01474512|560438334|FG004|Long-Term Extension Period|Death|0|||
155274554|NCT01474512|560438335|FG005|Long-Term Extension Period|Death|0|||
155274555|NCT01474512|560438336|FG006|Long-Term Extension Period|Death|0|||
155274556|NCT01474512|560438337|FG007|Long-Term Extension Period|Death|0|||
155274557|NCT01474512|560438338|FG008|Long-Term Extension Period|Death|0|||
155274558|NCT01474512|560438339|FG009|Long-Term Extension Period|Death|0|||
155274559|NCT01474512|560438340|FG010|Long-Term Extension Period|Death|0|||
155274560|NCT01474512|560438341|FG011|Long-Term Extension Period|Death|0|||
155274561|NCT01474512|560438342|FG012|Long-Term Extension Period|Death|9|||
155274562|NCT01474512|560438343|FG013|Long-Term Extension Period|Death|9|||
155274563|NCT01474512|560438344|FG014|Long-Term Extension Period|Death|0|||
155274564|NCT01474512|560438345|FG015|Long-Term Extension Period|Death|0|||
155274565|NCT01474512|560438346|FG016|Long-Term Extension Period|Death|0|||
155274566|NCT01474512|560438347|FG017|Long-Term Extension Period|Death|0|||
155274567|NCT01474512|560438330|FG000|Long-Term Extension Period|Sponsor Decision|0|||
155274568|NCT01474512|560438331|FG001|Long-Term Extension Period|Sponsor Decision|0|||
155274569|NCT01474512|560438332|FG002|Long-Term Extension Period|Sponsor Decision|0|||
155274570|NCT01474512|560438333|FG003|Long-Term Extension Period|Sponsor Decision|0|||
155274571|NCT01474512|560438334|FG004|Long-Term Extension Period|Sponsor Decision|0|||
155274572|NCT01474512|560438335|FG005|Long-Term Extension Period|Sponsor Decision|0|||
155274573|NCT01474512|560438336|FG006|Long-Term Extension Period|Sponsor Decision|0|||
155274574|NCT01474512|560438337|FG007|Long-Term Extension Period|Sponsor Decision|0|||
155274575|NCT01474512|560438338|FG008|Long-Term Extension Period|Sponsor Decision|0|||
155274576|NCT01474512|560438339|FG009|Long-Term Extension Period|Sponsor Decision|0|||
155274577|NCT01474512|560438340|FG010|Long-Term Extension Period|Sponsor Decision|0|||
155274578|NCT01474512|560438341|FG011|Long-Term Extension Period|Sponsor Decision|0|||
155274579|NCT01474512|560438342|FG012|Long-Term Extension Period|Sponsor Decision|6|||
155274580|NCT01474512|560438343|FG013|Long-Term Extension Period|Sponsor Decision|6|||
155274581|NCT01474512|560438344|FG014|Long-Term Extension Period|Sponsor Decision|0|||
155274582|NCT01474512|560438345|FG015|Long-Term Extension Period|Sponsor Decision|0|||
155274583|NCT01474512|560438346|FG016|Long-Term Extension Period|Sponsor Decision|0|||
155274584|NCT01474512|560438347|FG017|Long-Term Extension Period|Sponsor Decision|0|||
155274585|NCT01474512|560438330|FG000|Long-Term Extension Period|Protocol Violation|0|||
155274586|NCT01474512|560438331|FG001|Long-Term Extension Period|Protocol Violation|0|||
155274587|NCT01474512|560438332|FG002|Long-Term Extension Period|Protocol Violation|0|||
155274588|NCT01474512|560438333|FG003|Long-Term Extension Period|Protocol Violation|0|||
155274589|NCT01474512|560438334|FG004|Long-Term Extension Period|Protocol Violation|0|||
155274590|NCT01474512|560438335|FG005|Long-Term Extension Period|Protocol Violation|0|||
155274591|NCT01474512|560438336|FG006|Long-Term Extension Period|Protocol Violation|0|||
155274592|NCT01474512|560438337|FG007|Long-Term Extension Period|Protocol Violation|0|||
155274593|NCT01474512|560438338|FG008|Long-Term Extension Period|Protocol Violation|0|||
155274594|NCT01474512|560438339|FG009|Long-Term Extension Period|Protocol Violation|0|||
155274595|NCT01474512|560438340|FG010|Long-Term Extension Period|Protocol Violation|0|||
155274596|NCT01474512|560438341|FG011|Long-Term Extension Period|Protocol Violation|0|||
155274597|NCT01474512|560438342|FG012|Long-Term Extension Period|Protocol Violation|5|||
155274598|NCT01474512|560438343|FG013|Long-Term Extension Period|Protocol Violation|5|||
155274599|NCT01474512|560438344|FG014|Long-Term Extension Period|Protocol Violation|0|||
155274600|NCT01474512|560438345|FG015|Long-Term Extension Period|Protocol Violation|0|||
155274601|NCT01474512|560438346|FG016|Long-Term Extension Period|Protocol Violation|0|||
155274602|NCT01474512|560438347|FG017|Long-Term Extension Period|Protocol Violation|0|||
155274603|NCT01474512|560438330|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274604|NCT01474512|560438331|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274605|NCT01474512|560438332|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274606|NCT01474512|560438333|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274607|NCT01474512|560438334|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274608|NCT01474512|560438335|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274609|NCT01474512|560438336|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274610|NCT01474512|560438337|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274611|NCT01474512|560438338|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274612|NCT01474512|560438339|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274613|NCT01474512|560438340|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274614|NCT01474512|560438341|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274615|NCT01474512|560438342|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
155274616|NCT01474512|560438343|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
155274617|NCT01474512|560438344|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274618|NCT01474512|560438345|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274619|NCT01474512|560438346|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155726889|NCT02131259|562099806|FG000|Overall Study|Progressive disease/AE/other|1|||
155726890|NCT02131259|562099806|FG000|Overall Study|Missing|3|||
155726891|NCT01472289|562099807|FG000|Overall Study|Death|2|||
155726892|NCT00907335|562099808|FG000|Overall Study|Withdrawal by Subject|2|||
155726893|NCT00907335|562099809|FG001|Overall Study|Withdrawal by Subject|0|||
155274620|NCT01474512|560438347|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274621|NCT01474512|560438330|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274622|NCT01474512|560438331|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274623|NCT01474512|560438332|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274624|NCT01474512|560438333|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274625|NCT01474512|560438334|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274626|NCT01474512|560438335|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155726894|NCT00907335|562099808|FG000|Overall Study|Adverse Event|4|||
155726895|NCT00907335|562099809|FG001|Overall Study|Adverse Event|1|||
155726896|NCT00907335|562099808|FG000|Overall Study|Lost to Follow-up|2|||
155274627|NCT01474512|560438336|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274628|NCT01474512|560438337|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274629|NCT01474512|560438338|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274630|NCT01474512|560438339|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274631|NCT01474512|560438340|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274632|NCT01474512|560438341|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
155274633|NCT01474512|560438342|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274634|NCT01474512|560438343|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274635|NCT01474512|560438344|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274636|NCT01474512|560438345|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274637|NCT01474512|560438346|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274638|NCT01474512|560438347|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274639|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
155274640|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
155274641|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
155274642|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
155274643|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
155274644|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
155274645|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
155274646|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
155274647|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
155274648|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
155274649|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
155274650|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
155274651|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
155274652|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
155274653|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
155274654|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
155274655|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
155274656|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
155274657|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274658|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274659|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274660|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274661|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274662|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274663|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274664|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274665|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274666|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274667|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274668|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274669|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274670|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274671|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
155274672|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
155274673|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
155274674|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
155274675|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274676|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274677|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274678|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274679|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274680|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274681|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274682|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274683|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274684|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274685|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274686|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274687|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274688|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274689|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
155274690|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
155274691|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
155274692|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
155274693|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274694|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274695|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274696|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274697|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274698|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274699|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274700|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274701|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274702|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274703|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274704|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274705|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274706|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274707|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274708|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274709|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
155274710|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
155274711|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
155274712|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
155274713|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
155274714|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
155274715|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
155274716|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
155274717|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
155274718|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
155274719|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
155274720|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
155274721|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
155274722|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
155274723|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
155274724|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
155274725|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
155274726|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
155274727|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
155274728|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
155274729|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274730|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274731|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274732|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274733|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274734|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274735|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274736|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274737|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274738|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274739|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274740|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274741|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274742|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274743|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274744|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274745|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
155274746|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
155274747|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
155274748|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
155274749|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
155274750|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
155274751|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
155274752|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
155274753|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
155274754|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
155274755|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
155274756|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
155274757|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
155274758|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
155274759|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
155274760|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
155274761|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
155274762|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
155274763|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
155274764|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
155274765|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274766|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274767|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274768|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274769|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274770|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274771|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274772|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274773|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274774|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274775|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274776|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274777|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274778|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274779|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
155274780|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274781|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
155274782|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274783|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274784|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274785|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274786|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274787|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274788|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274789|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274790|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274791|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274792|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274793|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274794|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274795|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274796|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274797|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
155274798|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274799|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274800|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
155274801|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Death|0|||
155274802|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Death|0|||
155274803|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Death|0|||
155274804|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Death|0|||
155274805|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Death|0|||
155274806|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Death|0|||
155274807|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Death|0|||
155274808|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Death|0|||
155274809|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Death|0|||
155274810|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Death|0|||
155274811|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Death|0|||
155274812|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Death|0|||
155274813|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Death|0|||
155274814|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Death|0|||
155274815|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Death|0|||
155274816|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Death|0|||
155274817|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Death|1|||
155274818|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Death|0|||
155274819|NCT01238575|560438348|FG000|Overall Study|Lack of Efficacy|2|||
155274820|NCT01238575|560438349|FG001|Overall Study|Lack of Efficacy|4|||
155274821|NCT01238575|560438348|FG000|Overall Study|Adverse Event|2|||
155274822|NCT01238575|560438349|FG001|Overall Study|Adverse Event|0|||
155274823|NCT02254421|560438357|FG000|Overall Study|Randomized but Not Treated|1|||
155274824|NCT02254421|560438358|FG001|Overall Study|Randomized but Not Treated|0|||
155274825|NCT02254421|560438357|FG000|Overall Study|Death|0|||
155274826|NCT02254421|560438358|FG001|Overall Study|Death|2|||
155274827|NCT02254421|560438357|FG000|Overall Study|Withdrew Consent|1|||
155274828|NCT02254421|560438358|FG001|Overall Study|Withdrew Consent|1|||
155274829|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
155274830|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
155274831|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
155274832|NCT00867490|560438359|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
155274833|NCT00867490|560438359|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
155274834|NCT00358150|560438360|FG000|Overall Study|Adverse Event|3|||
155274835|NCT00358150|560438360|FG000|Overall Study|Withdrawal by Subject|1|||
155274836|NCT00358150|560438360|FG000|Overall Study|Undefined|3|||
155619651|NCT00490971|561699791|FG001|Acute/Continuation|Other|4|||
155619652|NCT00490971|561699792|FG002|Acute/Continuation|Other|0|||
155274837|NCT00531011|560438361|FG000|Overall Study|Withdrawal by Subject|2|||
155274838|NCT00531011|560438362|FG001|Overall Study|Withdrawal by Subject|4|||
155274839|NCT00531011|560438361|FG000|Overall Study|Death|1|||
155274840|NCT00531011|560438362|FG001|Overall Study|Death|0|||
155274841|NCT00531011|560438361|FG000|Overall Study|Lost to Follow-up|1|||
155619653|NCT00490971|561699793|FG003|Acute/Continuation|Other|0|||
155619654|NCT00490971|561699794|FG004|Acute/Continuation|Other|0|||
155619655|NCT00490971|561699790|FG000|Maintenance|Adverse Event|0|||
155274842|NCT00531011|560438362|FG001|Overall Study|Lost to Follow-up|0|||
155274843|NCT00531011|560438361|FG000|Overall Study|Physician Decision|0|||
155274844|NCT00531011|560438362|FG001|Overall Study|Physician Decision|3|||
155274845|NCT02823964|560438363|FG000|Overall Study|Adverse Event|2|||
155274846|NCT02823964|560438363|FG000|Overall Study|Physician Decision|1|||
155274847|NCT02823964|560438363|FG000|Overall Study|Lack of Efficacy|1|||
155274848|NCT02823964|560438363|FG000|Overall Study|Withdrawal by Subject|1|||
155274849|NCT01177813|560438364|FG000|Overall Study|Adverse Event|8|||
155274850|NCT01177813|560438365|FG001|Overall Study|Adverse Event|2|||
155274851|NCT01177813|560438366|FG002|Overall Study|Adverse Event|4|||
155274852|NCT01177813|560438367|FG003|Overall Study|Adverse Event|6|||
155274853|NCT01177813|560438368|FG004|Overall Study|Adverse Event|3|||
155274854|NCT01177813|560438364|FG000|Overall Study|Lack of Efficacy|1|||
155274855|NCT01177813|560438365|FG001|Overall Study|Lack of Efficacy|0|||
155274856|NCT01177813|560438366|FG002|Overall Study|Lack of Efficacy|0|||
155274857|NCT01177813|560438367|FG003|Overall Study|Lack of Efficacy|0|||
155274858|NCT01177813|560438368|FG004|Overall Study|Lack of Efficacy|0|||
155274859|NCT01177813|560438364|FG000|Overall Study|Protocol Violation|3|||
155274860|NCT01177813|560438365|FG001|Overall Study|Protocol Violation|2|||
155274861|NCT01177813|560438366|FG002|Overall Study|Protocol Violation|2|||
155274862|NCT01177813|560438367|FG003|Overall Study|Protocol Violation|0|||
155274863|NCT01177813|560438368|FG004|Overall Study|Protocol Violation|1|||
155274864|NCT01177813|560438364|FG000|Overall Study|Lost to Follow-up|12|||
155274865|NCT01177813|560438365|FG001|Overall Study|Lost to Follow-up|5|||
155274866|NCT01177813|560438366|FG002|Overall Study|Lost to Follow-up|6|||
155274867|NCT01177813|560438367|FG003|Overall Study|Lost to Follow-up|3|||
155274868|NCT01177813|560438368|FG004|Overall Study|Lost to Follow-up|0|||
155274869|NCT01177813|560438364|FG000|Overall Study|Withdrawal by Subject|12|||
155274870|NCT01177813|560438365|FG001|Overall Study|Withdrawal by Subject|7|||
155274871|NCT01177813|560438366|FG002|Overall Study|Withdrawal by Subject|6|||
155274872|NCT01177813|560438367|FG003|Overall Study|Withdrawal by Subject|5|||
155274873|NCT01177813|560438368|FG004|Overall Study|Withdrawal by Subject|3|||
155274874|NCT01177813|560438364|FG000|Overall Study|Other reason not defined above|5|||
155274875|NCT01177813|560438365|FG001|Overall Study|Other reason not defined above|2|||
155274876|NCT01177813|560438366|FG002|Overall Study|Other reason not defined above|2|||
155274877|NCT01177813|560438367|FG003|Overall Study|Other reason not defined above|3|||
155274878|NCT01177813|560438368|FG004|Overall Study|Other reason not defined above|2|||
155274879|NCT04011384|560438375|FG000|Overall Study|Withdrawal by Subject|2|||
155274880|NCT04011384|560438376|FG001|Overall Study|Withdrawal by Subject|0|||
155274881|NCT00924469|560438378|FG000|Overall Study|Adverse Event|2|||
155274882|NCT00924469|560438379|FG001|Overall Study|Adverse Event|0|||
155274883|NCT00924469|560438378|FG000|Overall Study|Withdrawal by Subject|0|||
155274884|NCT00924469|560438379|FG001|Overall Study|Withdrawal by Subject|1|||
155274885|NCT00924469|560438378|FG000|Overall Study|Lost to Follow-up|0|||
155274886|NCT00924469|560438379|FG001|Overall Study|Lost to Follow-up|1|||
155274887|NCT04147260|560438382|FG000|Overall Study|Adverse Event|1|||
155274888|NCT04147260|560438383|FG001|Overall Study|Adverse Event|0|||
155274889|NCT04147260|560438384|FG002|Overall Study|Adverse Event|1|||
155274890|NCT04147260|560438385|FG003|Overall Study|Adverse Event|2|||
155274891|NCT04147260|560438386|FG004|Overall Study|Adverse Event|0|||
155274892|NCT04147260|560438382|FG000|Overall Study|Withdrawal by Subject|0|||
155274893|NCT04147260|560438383|FG001|Overall Study|Withdrawal by Subject|0|||
155274894|NCT04147260|560438384|FG002|Overall Study|Withdrawal by Subject|1|||
155274895|NCT04147260|560438385|FG003|Overall Study|Withdrawal by Subject|1|||
155274896|NCT04147260|560438386|FG004|Overall Study|Withdrawal by Subject|0|||
155274897|NCT00630058|560438387|FG000|Overall Study|Adverse Event|1|||
155274898|NCT00630058|560438388|FG001|Overall Study|Adverse Event|1|||
155274899|NCT00630058|560438387|FG000|Overall Study|Withdrawal by Subject|0|||
155274900|NCT00630058|560438388|FG001|Overall Study|Withdrawal by Subject|1|||
155274901|NCT00630058|560438387|FG000|Overall Study|stopping criteria|3|||
155274902|NCT00630058|560438388|FG001|Overall Study|stopping criteria|2|||
155274903|NCT01651936|560438389|FG000|Base Study|Adverse Event|3|||
155274904|NCT01651936|560438390|FG001|Base Study|Adverse Event|0|||
155274905|NCT01651936|560438391|FG002|Base Study|Adverse Event|0|||
155274906|NCT01651936|560438389|FG000|Base Study|Withdrawal by Subject|1|||
155274907|NCT01651936|560438390|FG001|Base Study|Withdrawal by Subject|1|||
155274908|NCT01651936|560438391|FG002|Base Study|Withdrawal by Subject|0|||
155274909|NCT01651936|560438389|FG000|Base Study|Early Escape|2|||
155274910|NCT01651936|560438390|FG001|Base Study|Early Escape|8|||
155274911|NCT01651936|560438391|FG002|Base Study|Early Escape|0|||
155274912|NCT01651936|560438389|FG000|Base Study|Study terminated by sponsor|21|||
155274913|NCT01651936|560438390|FG001|Base Study|Study terminated by sponsor|16|||
155274914|NCT01651936|560438391|FG002|Base Study|Study terminated by sponsor|0|||
155274915|NCT01651936|560438389|FG000|Extension Study|Lack of Efficacy|0|||
155274916|NCT01651936|560438390|FG001|Extension Study|Lack of Efficacy|0|||
155274917|NCT01651936|560438391|FG002|Extension Study|Lack of Efficacy|1|||
155274918|NCT01651936|560438389|FG000|Extension Study|Study terminated by sponsor|0|||
155274919|NCT01651936|560438390|FG001|Extension Study|Study terminated by sponsor|0|||
155274920|NCT01651936|560438391|FG002|Extension Study|Study terminated by sponsor|13|||
155274921|NCT03044353|560438392|FG000|Overall Study|Adverse Event|0|||
155274922|NCT03044353|560438393|FG001|Overall Study|Adverse Event|1|||
155274923|NCT03044353|560438394|FG002|Overall Study|Adverse Event|0|||
155274924|NCT01555021|560438401|FG000|Overall Study|Lost to Follow-up|1|||
155274925|NCT01555021|560438402|FG001|Overall Study|Lost to Follow-up|2|||
155274926|NCT02204293|560438403|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
155274927|NCT02204293|560438404|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
155274928|NCT02204293|560438405|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
155274929|NCT02204293|560438406|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
155274930|NCT02204293|560438407|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
155274931|NCT02204293|560438408|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
155274932|NCT02204293|560438403|FG000|Core Study Part I|Adverse Event|1|||
155274933|NCT02204293|560438404|FG001|Core Study Part I|Adverse Event|0|||
155274934|NCT02204293|560438405|FG002|Core Study Part I|Adverse Event|0|||
155274935|NCT02204293|560438406|FG003|Core Study Part I|Adverse Event|0|||
155274936|NCT02204293|560438407|FG004|Core Study Part I|Adverse Event|0|||
155274937|NCT02204293|560438408|FG005|Core Study Part I|Adverse Event|0|||
155274938|NCT02204293|560438403|FG000|Core Study Part I|Physician Decision|0|||
155274939|NCT02204293|560438404|FG001|Core Study Part I|Physician Decision|3|||
155274940|NCT02204293|560438405|FG002|Core Study Part I|Physician Decision|0|||
155274941|NCT02204293|560438406|FG003|Core Study Part I|Physician Decision|0|||
155274942|NCT02204293|560438407|FG004|Core Study Part I|Physician Decision|0|||
155274943|NCT02204293|560438408|FG005|Core Study Part I|Physician Decision|0|||
155274944|NCT02204293|560438403|FG000|LTE Phase|Study Suspended|0|||
155274945|NCT02204293|560438404|FG001|LTE Phase|Study Suspended|0|||
155274946|NCT02204293|560438405|FG002|LTE Phase|Study Suspended|0|||
155274947|NCT02204293|560438406|FG003|LTE Phase|Study Suspended|0|||
155274948|NCT02204293|560438407|FG004|LTE Phase|Study Suspended|0|||
155274949|NCT02204293|560438408|FG005|LTE Phase|Study Suspended|7|||
155274950|NCT01225835|560438409|FG000|Overall Study|Completed protocol|2|||
155274951|NCT01225835|560438410|FG001|Overall Study|Completed protocol|1|||
155274952|NCT01225835|560438409|FG000|Overall Study|Did not meet hCG criterion|2|||
155274953|NCT01225835|560438410|FG001|Overall Study|Did not meet hCG criterion|0|||
155274954|NCT01225835|560438409|FG000|Overall Study|Adverse Event|2|||
155274955|NCT01225835|560438410|FG001|Overall Study|Adverse Event|1|||
155274956|NCT01225835|560438409|FG000|Overall Study|Other|1|||
155274957|NCT01225835|560438410|FG001|Overall Study|Other|1|||
155274958|NCT02589392|560438413|FG000|Overall Study|Adverse Event|1|||
155274959|NCT02589392|560438414|FG001|Overall Study|Adverse Event|1|||
155274960|NCT02589392|560438413|FG000|Overall Study|Withdrawal by Subject|1|||
155274961|NCT02589392|560438414|FG001|Overall Study|Withdrawal by Subject|2|||
155274962|NCT02589392|560438413|FG000|Overall Study|Protocol Violation|1|||
155274963|NCT02589392|560438414|FG001|Overall Study|Protocol Violation|1|||
155274964|NCT02589392|560438413|FG000|Overall Study|Lost to Follow-up|2|||
155274965|NCT02589392|560438414|FG001|Overall Study|Lost to Follow-up|2|||
155274966|NCT02589392|560438413|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
155274967|NCT02589392|560438414|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
155274968|NCT01266993|560438415|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
155274969|NCT01266993|560438416|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
155274970|NCT01266993|560438415|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
155274971|NCT01266993|560438416|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
155274972|NCT03051659|560438417|FG000|Treatment Period|Withdrawal by Subject|0|||
155274973|NCT03051659|560438418|FG001|Treatment Period|Withdrawal by Subject|2|||
155274974|NCT03051659|560438417|FG000|Survival Follow-up|Lost to Follow-up|23|||
155274975|NCT03051659|560438418|FG001|Survival Follow-up|Lost to Follow-up|22|||
155274976|NCT02293837|560438419|FG000|Overall Study|Lost to Follow-up|0|||
155274977|NCT02293837|560438420|FG001|Overall Study|Lost to Follow-up|2|||
155274978|NCT02293837|560438421|FG002|Overall Study|Lost to Follow-up|1|||
155274979|NCT02293837|560438422|FG003|Overall Study|Lost to Follow-up|0|||
155274980|NCT02293837|560438419|FG000|Overall Study|Withdrawal by Subject|2|||
155274981|NCT02293837|560438420|FG001|Overall Study|Withdrawal by Subject|1|||
155274982|NCT02293837|560438421|FG002|Overall Study|Withdrawal by Subject|2|||
155274983|NCT02293837|560438422|FG003|Overall Study|Withdrawal by Subject|1|||
155274984|NCT02293837|560438419|FG000|Overall Study|COVID-19 Related|1|||
155274985|NCT02293837|560438420|FG001|Overall Study|COVID-19 Related|1|||
155274986|NCT02293837|560438421|FG002|Overall Study|COVID-19 Related|0|||
155274987|NCT02293837|560438422|FG003|Overall Study|COVID-19 Related|0|||
155274988|NCT02293837|560438419|FG000|Overall Study|Participant ill and could not be infused|0|||
155274989|NCT02293837|560438420|FG001|Overall Study|Participant ill and could not be infused|0|||
155274990|NCT02293837|560438421|FG002|Overall Study|Participant ill and could not be infused|1|||
155274991|NCT02293837|560438422|FG003|Overall Study|Participant ill and could not be infused|0|||
155274992|NCT04779242|560438423|FG000|Overall Study|Adverse Event|1|||
155274993|NCT04779242|560438424|FG001|Overall Study|Adverse Event|1|||
155274994|NCT04779242|560438423|FG000|Overall Study|Lost to Follow-up|2|||
155274995|NCT04779242|560438424|FG001|Overall Study|Lost to Follow-up|4|||
155274996|NCT04779242|560438423|FG000|Overall Study|Withdrawal by Subject|7|||
155274997|NCT04779242|560438424|FG001|Overall Study|Withdrawal by Subject|9|||
155274998|NCT04779242|560438423|FG000|Overall Study|Death|6|||
155274999|NCT04779242|560438424|FG001|Overall Study|Death|6|||
155275000|NCT04779242|560438423|FG000|Overall Study|COVID-19 related reasons|2|||
155275001|NCT04779242|560438424|FG001|Overall Study|COVID-19 related reasons|1|||
155275002|NCT04779242|560438423|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
155275003|NCT04779242|560438424|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
155275004|NCT04779242|560438423|FG000|Overall Study|Martial Law in Ukraine|2|||
155275005|NCT04779242|560438424|FG001|Overall Study|Martial Law in Ukraine|3|||
155275006|NCT03285113|560438425|FG000|Overall Study|Unable to implant leads|2|||
155275007|NCT01076088|560438427|FG000|Overall Study|Adverse Event|1|||
155275008|NCT01076088|560438428|FG001|Overall Study|Adverse Event|6|||
155275009|NCT01076088|560438429|FG002|Overall Study|Adverse Event|3|||
155275010|NCT01076088|560438430|FG003|Overall Study|Adverse Event|2|||
155275011|NCT01076088|560438431|FG004|Overall Study|Adverse Event|3|||
155275012|NCT01076088|560438432|FG005|Overall Study|Adverse Event|3|||
155275013|NCT01076088|560438427|FG000|Overall Study|Lost to Follow-up|1|||
155275014|NCT01076088|560438428|FG001|Overall Study|Lost to Follow-up|1|||
155275015|NCT01076088|560438429|FG002|Overall Study|Lost to Follow-up|0|||
155275016|NCT01076088|560438430|FG003|Overall Study|Lost to Follow-up|1|||
155275017|NCT01076088|560438431|FG004|Overall Study|Lost to Follow-up|1|||
155275018|NCT01076088|560438432|FG005|Overall Study|Lost to Follow-up|2|||
155275019|NCT01076088|560438427|FG000|Overall Study|Non-compliance with study drug|0|||
155275020|NCT01076088|560438428|FG001|Overall Study|Non-compliance with study drug|0|||
155275021|NCT01076088|560438429|FG002|Overall Study|Non-compliance with study drug|0|||
155275022|NCT01076088|560438430|FG003|Overall Study|Non-compliance with study drug|1|||
155275023|NCT01076088|560438431|FG004|Overall Study|Non-compliance with study drug|0|||
155275024|NCT01076088|560438432|FG005|Overall Study|Non-compliance with study drug|0|||
155275025|NCT01076088|560438427|FG000|Overall Study|Physician Decision|1|||
155275026|NCT01076088|560438428|FG001|Overall Study|Physician Decision|3|||
155275027|NCT01076088|560438429|FG002|Overall Study|Physician Decision|0|||
155275028|NCT01076088|560438430|FG003|Overall Study|Physician Decision|1|||
155275029|NCT01076088|560438431|FG004|Overall Study|Physician Decision|1|||
155275030|NCT01076088|560438432|FG005|Overall Study|Physician Decision|0|||
155275031|NCT01076088|560438427|FG000|Overall Study|Withdrawal by Subject|8|||
155275032|NCT01076088|560438428|FG001|Overall Study|Withdrawal by Subject|8|||
155275033|NCT01076088|560438429|FG002|Overall Study|Withdrawal by Subject|14|||
155275034|NCT01076088|560438430|FG003|Overall Study|Withdrawal by Subject|10|||
155275035|NCT01076088|560438431|FG004|Overall Study|Withdrawal by Subject|11|||
155275036|NCT01076088|560438432|FG005|Overall Study|Withdrawal by Subject|17|||
155275037|NCT01076088|560438427|FG000|Overall Study|Other protocol specified criteria|0|||
155275038|NCT01076088|560438428|FG001|Overall Study|Other protocol specified criteria|0|||
155275039|NCT01076088|560438429|FG002|Overall Study|Other protocol specified criteria|0|||
155275040|NCT01076088|560438430|FG003|Overall Study|Other protocol specified criteria|0|||
155275041|NCT01076088|560438431|FG004|Overall Study|Other protocol specified criteria|0|||
155275042|NCT01076088|560438432|FG005|Overall Study|Other protocol specified criteria|1|||
155275043|NCT03053492|560438435|FG000|Overall Study|Adverse Event|1|||
155275044|NCT03053492|560438436|FG001|Overall Study|Adverse Event|1|||
155275045|NCT03053492|560438435|FG000|Overall Study|Withdrawal by Subject|7|||
155275046|NCT03053492|560438436|FG001|Overall Study|Withdrawal by Subject|5|||
155275047|NCT00849680|560438439|FG000|Overall Study|Adverse Event|0|||
155275048|NCT00849680|560438440|FG001|Overall Study|Adverse Event|0|||
155275049|NCT00849680|560438441|FG002|Overall Study|Adverse Event|0|||
155275050|NCT00849680|560438442|FG003|Overall Study|Adverse Event|0|||
155275051|NCT00849680|560438443|FG004|Overall Study|Adverse Event|0|||
155275052|NCT00849680|560438444|FG005|Overall Study|Adverse Event|0|||
155275053|NCT00849680|560438445|FG006|Overall Study|Adverse Event|2|||
155275054|NCT00849680|560438446|FG007|Overall Study|Adverse Event|0|||
155275055|NCT00849680|560438439|FG000|Overall Study|Lost to Follow-up|7|||
155275056|NCT00849680|560438440|FG001|Overall Study|Lost to Follow-up|3|||
155275057|NCT00849680|560438441|FG002|Overall Study|Lost to Follow-up|12|||
155275058|NCT00849680|560438442|FG003|Overall Study|Lost to Follow-up|11|||
155275059|NCT00849680|560438443|FG004|Overall Study|Lost to Follow-up|8|||
155275060|NCT00849680|560438444|FG005|Overall Study|Lost to Follow-up|11|||
155275061|NCT00849680|560438445|FG006|Overall Study|Lost to Follow-up|12|||
155275062|NCT00849680|560438446|FG007|Overall Study|Lost to Follow-up|5|||
155275063|NCT00849680|560438439|FG000|Overall Study|Subject moved|1|||
155275064|NCT00849680|560438440|FG001|Overall Study|Subject moved|0|||
155275065|NCT00849680|560438441|FG002|Overall Study|Subject moved|3|||
155275066|NCT00849680|560438442|FG003|Overall Study|Subject moved|1|||
155275067|NCT00849680|560438443|FG004|Overall Study|Subject moved|0|||
155275068|NCT00849680|560438444|FG005|Overall Study|Subject moved|2|||
155275069|NCT00849680|560438445|FG006|Overall Study|Subject moved|2|||
155275070|NCT00849680|560438446|FG007|Overall Study|Subject moved|2|||
155275071|NCT00849680|560438439|FG000|Overall Study|Withdrawal by Subject|2|||
155275072|NCT00849680|560438440|FG001|Overall Study|Withdrawal by Subject|0|||
155275073|NCT00849680|560438441|FG002|Overall Study|Withdrawal by Subject|0|||
155275074|NCT00849680|560438442|FG003|Overall Study|Withdrawal by Subject|2|||
155275075|NCT00849680|560438443|FG004|Overall Study|Withdrawal by Subject|2|||
155275076|NCT00849680|560438444|FG005|Overall Study|Withdrawal by Subject|2|||
155275077|NCT00849680|560438445|FG006|Overall Study|Withdrawal by Subject|1|||
155275078|NCT00849680|560438446|FG007|Overall Study|Withdrawal by Subject|1|||
155275079|NCT00849680|560438439|FG000|Overall Study|Subject unable to comply with protocol|1|||
155275080|NCT00849680|560438440|FG001|Overall Study|Subject unable to comply with protocol|0|||
155275081|NCT00849680|560438441|FG002|Overall Study|Subject unable to comply with protocol|0|||
155275082|NCT00849680|560438442|FG003|Overall Study|Subject unable to comply with protocol|0|||
155275083|NCT00849680|560438443|FG004|Overall Study|Subject unable to comply with protocol|0|||
155275084|NCT00849680|560438444|FG005|Overall Study|Subject unable to comply with protocol|0|||
155275085|NCT00849680|560438445|FG006|Overall Study|Subject unable to comply with protocol|0|||
155275086|NCT00849680|560438446|FG007|Overall Study|Subject unable to comply with protocol|0|||
155275087|NCT03382600|560438448|FG000|Overall Study|Adverse Event|3|||
155275088|NCT03382600|560438449|FG001|Overall Study|Adverse Event|3|||
155275089|NCT03382600|560438448|FG000|Overall Study|Clinical Disease Progression|2|||
155275090|NCT03382600|560438449|FG001|Overall Study|Clinical Disease Progression|4|||
155275091|NCT03382600|560438448|FG000|Overall Study|Radiological Progression|40|||
155275092|NCT03382600|560438449|FG001|Overall Study|Radiological Progression|31|||
155275093|NCT03382600|560438448|FG000|Overall Study|Withdrawal by Subject|0|||
155275094|NCT03382600|560438449|FG001|Overall Study|Withdrawal by Subject|1|||
155275095|NCT03382600|560438448|FG000|Overall Study|Other|9|||
155275096|NCT03382600|560438449|FG001|Overall Study|Other|7|||
155275097|NCT01857622|560438454|FG000|Overall Study|Adverse Event|5|||
155275098|NCT01857622|560438455|FG001|Overall Study|Adverse Event|0|||
155275099|NCT01857622|560438456|FG002|Overall Study|Adverse Event|2|||
155275100|NCT01857622|560438454|FG000|Overall Study|Physician Decision|1|||
155275101|NCT01857622|560438455|FG001|Overall Study|Physician Decision|0|||
155275102|NCT01857622|560438456|FG002|Overall Study|Physician Decision|0|||
155275103|NCT01857622|560438454|FG000|Overall Study|Protocol Violation|4|||
155275104|NCT01857622|560438455|FG001|Overall Study|Protocol Violation|1|||
155275105|NCT01857622|560438456|FG002|Overall Study|Protocol Violation|0|||
155275106|NCT01857622|560438454|FG000|Overall Study|Withdrawal by Subject|1|||
155275107|NCT01857622|560438455|FG001|Overall Study|Withdrawal by Subject|0|||
155275108|NCT01857622|560438456|FG002|Overall Study|Withdrawal by Subject|0|||
155275109|NCT01291225|560438459|FG000|Overall Study|Lost to Follow-up|85|||
155275110|NCT01291225|560438460|FG001|Overall Study|Lost to Follow-up|39|||
155275111|NCT00514046|560438463|FG000|Overall Study|transferred to another protocol|2|||
155275112|NCT00514046|560438464|FG001|Overall Study|transferred to another protocol|1|||
155275113|NCT00514046|560438465|FG002|Overall Study|transferred to another protocol|3|||
155275114|NCT00514046|560438466|FG003|Overall Study|transferred to another protocol|0|||
155275115|NCT00514046|560438467|FG004|Overall Study|transferred to another protocol|1|||
155275116|NCT00514046|560438468|FG005|Overall Study|transferred to another protocol|0|||
155275117|NCT00514046|560438469|FG006|Overall Study|transferred to another protocol|0|||
155275118|NCT00514046|560438470|FG007|Overall Study|transferred to another protocol|0|||
155275119|NCT00514046|560438471|FG008|Overall Study|transferred to another protocol|0|||
155275120|NCT00514046|560438463|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
155275121|NCT00514046|560438464|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
155275122|NCT00514046|560438465|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
155275123|NCT00514046|560438466|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
155275124|NCT00514046|560438467|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
155275125|NCT00514046|560438468|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
155275126|NCT00514046|560438469|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
155275127|NCT00514046|560438470|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
155275128|NCT00514046|560438471|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
155275129|NCT00514046|560438463|FG000|Overall Study|Disease progression on study|0|||
155275130|NCT00514046|560438464|FG001|Overall Study|Disease progression on study|0|||
155275131|NCT00514046|560438465|FG002|Overall Study|Disease progression on study|2|||
155275132|NCT00514046|560438466|FG003|Overall Study|Disease progression on study|0|||
155275133|NCT00514046|560438467|FG004|Overall Study|Disease progression on study|0|||
155275134|NCT00514046|560438468|FG005|Overall Study|Disease progression on study|1|||
155275135|NCT00514046|560438469|FG006|Overall Study|Disease progression on study|0|||
155275136|NCT00514046|560438470|FG007|Overall Study|Disease progression on study|0|||
155275137|NCT00514046|560438471|FG008|Overall Study|Disease progression on study|0|||
155275138|NCT01163747|560438473|FG000|Overall Study|Adverse Event|0|||
155275139|NCT01163747|560438474|FG001|Overall Study|Adverse Event|5|||
155275140|NCT01163747|560438473|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155275141|NCT01163747|560438474|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155275142|NCT01163747|560438473|FG000|Overall Study|Protocol Violation|0|||
155275143|NCT01163747|560438474|FG001|Overall Study|Protocol Violation|1|||
155275144|NCT01163747|560438473|FG000|Overall Study|Refused Treatment|6|||
155275145|NCT01163747|560438474|FG001|Overall Study|Refused Treatment|4|||
155275146|NCT02044458|560438478|FG000|Overall Study|Protocol Violation|3|||
155275147|NCT02044458|560438479|FG001|Overall Study|Protocol Violation|8|||
155275148|NCT01853254|560440377|FG000|Overall Study|Abnormal Laboratory Test|1|||
155275149|NCT01853254|560440377|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
155275150|NCT01853254|560440377|FG000|Overall Study|Death|1|||
155275151|NCT01853254|560440377|FG000|Overall Study|Failure to Return|43|||
155275152|NCT01853254|560440377|FG000|Overall Study|Insufficient Therapeutic Response|22|||
155275153|NCT01853254|560440377|FG000|Overall Study|Refusal of Treatment|1|||
155275154|NCT01853254|560440377|FG000|Overall Study|Other Protocol Violation|1|||
155275155|NCT01853254|560440377|FG000|Overall Study|Withdrawal of Consent|16|||
155275156|NCT01853254|560440377|FG000|Overall Study|Administrative/Other|16|||
155275157|NCT02462083|560440378|FG000|Overall Study|Sponsor request|39|||
155275158|NCT02462083|560440378|FG000|Overall Study|Withdrawal by Subject|87|||
155275159|NCT02462083|560440378|FG000|Overall Study|Lost to Follow-up|41|||
155275160|NCT02462083|560440378|FG000|Overall Study|Lack of Efficacy|151|||
155275161|NCT02462083|560440378|FG000|Overall Study|Pregnancy|1|||
155275162|NCT02462083|560440378|FG000|Overall Study|Protocol Violation|6|||
155275163|NCT02462083|560440378|FG000|Overall Study|Adverse Event|33|||
155275164|NCT02462083|560440378|FG000|Overall Study|Worsening condition|16|||
155275165|NCT02462083|560440378|FG000|Overall Study|Other than specified|45|||
155275166|NCT01642186|560440379|FG000|Overall Study|Death|0|||
155275167|NCT01642186|560440380|FG001|Overall Study|Death|2|||
155275168|NCT01642186|560440381|FG002|Overall Study|Death|2|||
155275169|NCT01642186|560440379|FG000|Overall Study|Lost to Follow-up|0|||
155275170|NCT01642186|560440380|FG001|Overall Study|Lost to Follow-up|0|||
155275171|NCT01642186|560440381|FG002|Overall Study|Lost to Follow-up|1|||
155275172|NCT00163215|560440382|FG000|Overall Study|Lack of Efficacy|3|||
155275173|NCT00163215|560440382|FG000|Overall Study|Withdrawal by Subject|5|||
155275174|NCT00163215|560440382|FG000|Overall Study|Other|7|||
155275175|NCT01668147|560440385|FG000|Overall Study|Withdrawal by Subject|6|||
155275176|NCT01809210|560440386|FG000|Overall Study|Withdrawal by Subject|0|||
155275177|NCT01809210|560440387|FG001|Overall Study|Withdrawal by Subject|0|||
155275178|NCT01809210|560440388|FG002|Overall Study|Withdrawal by Subject|1|||
155275179|NCT01809210|560440389|FG003|Overall Study|Withdrawal by Subject|1|||
155275180|NCT01809210|560440390|FG004|Overall Study|Withdrawal by Subject|1|||
155275181|NCT01809210|560440391|FG005|Overall Study|Withdrawal by Subject|0|||
155275182|NCT01809210|560440392|FG006|Overall Study|Withdrawal by Subject|4|||
155275183|NCT01809210|560440386|FG000|Overall Study|Death|1|||
155275184|NCT01809210|560440387|FG001|Overall Study|Death|1|||
155275185|NCT01809210|560440388|FG002|Overall Study|Death|2|||
155275186|NCT01809210|560440389|FG003|Overall Study|Death|0|||
155275187|NCT01809210|560440390|FG004|Overall Study|Death|1|||
155275188|NCT01809210|560440391|FG005|Overall Study|Death|3|||
155275189|NCT01809210|560440392|FG006|Overall Study|Death|1|||
155275190|NCT01115998|560440395|FG000|Overall Study|Lost to Follow-up|6|||
155275191|NCT01115998|560440396|FG001|Overall Study|Lost to Follow-up|6|||
155275192|NCT00224133|560440397|FG000|Overall Study|Adverse Event|93|||
155275193|NCT00224133|560440397|FG000|Overall Study|Protocol Violation|6|||
155275194|NCT00224133|560440397|FG000|Overall Study|Withdrawal by Subject|33|||
155275195|NCT00224133|560440397|FG000|Overall Study|Lack of Efficacy|58|||
155275196|NCT00224133|560440397|FG000|Overall Study|Lost to Follow-up|21|||
155275197|NCT00224133|560440397|FG000|Overall Study|Physician Decision|1|||
155275198|NCT00224133|560440397|FG000|Overall Study|Other|14|||
155275199|NCT01118962|560440404|FG000|Overall Study|Adverse Event|2|||
155275200|NCT01118962|560440404|FG000|Overall Study|Lack of Efficacy|1|||
155275201|NCT01118962|560440404|FG000|Overall Study|Protocol Violation|1|||
155275202|NCT01118962|560440404|FG000|Overall Study|Withdrawal by Subject|4|||
155275203|NCT01118962|560440404|FG000|Overall Study|Pregnancy|1|||
155275204|NCT01118962|560440404|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
155275205|NCT00593554|560440405|FG000|Overall Study|Death|1|||
155275206|NCT00593554|560440406|FG001|Overall Study|Death|2|||
155275207|NCT00593554|560440405|FG000|Overall Study|Physician Decision|0|||
155275208|NCT00593554|560440406|FG001|Overall Study|Physician Decision|1|||
155275209|NCT00593554|560440405|FG000|Overall Study|Withdrawal by Subject|1|||
155275210|NCT00593554|560440406|FG001|Overall Study|Withdrawal by Subject|0|||
155275211|NCT00593554|560440405|FG000|Overall Study|Disease Progression|1|||
155275212|NCT00593554|560440406|FG001|Overall Study|Disease Progression|2|||
155275213|NCT00795132|560440409|FG000|Overall Study|Death|1|||
155275214|NCT00795132|560440409|FG000|Overall Study|Relapse|2|||
155619656|NCT00490971|561699791|FG001|Maintenance|Adverse Event|0|||
155275215|NCT00962585|560440410|FG000|Overall Study|Adverse Event|0|||
155275216|NCT00962585|560440411|FG001|Overall Study|Adverse Event|2|||
155275217|NCT00962585|560440412|FG002|Overall Study|Adverse Event|1|||
155275218|NCT00962585|560440413|FG003|Overall Study|Adverse Event|0|||
155275219|NCT00962585|560440410|FG000|Overall Study|Lost to Follow-up|3|||
155275220|NCT00962585|560440411|FG001|Overall Study|Lost to Follow-up|0|||
155275221|NCT00962585|560440412|FG002|Overall Study|Lost to Follow-up|1|||
155275222|NCT00962585|560440413|FG003|Overall Study|Lost to Follow-up|0|||
155275223|NCT00962585|560440410|FG000|Overall Study|Protocol Violation|0|||
155275224|NCT00962585|560440411|FG001|Overall Study|Protocol Violation|0|||
155275225|NCT00962585|560440412|FG002|Overall Study|Protocol Violation|1|||
155275226|NCT00962585|560440413|FG003|Overall Study|Protocol Violation|0|||
155381938|NCT00598273|560833244|FG002|Overall Study|Death|8|||
155275227|NCT00962585|560440410|FG000|Overall Study|Withdrawal by Subject|1|||
155275228|NCT00962585|560440411|FG001|Overall Study|Withdrawal by Subject|0|||
155275229|NCT00962585|560440412|FG002|Overall Study|Withdrawal by Subject|0|||
155275230|NCT00962585|560440413|FG003|Overall Study|Withdrawal by Subject|0|||
155275231|NCT00962585|560440410|FG000|Overall Study|Withdrew Consent|2|||
155275232|NCT00962585|560440411|FG001|Overall Study|Withdrew Consent|0|||
155275233|NCT00962585|560440412|FG002|Overall Study|Withdrew Consent|0|||
155275234|NCT00962585|560440413|FG003|Overall Study|Withdrew Consent|0|||
155275235|NCT00262743|560440414|FG000|Overall Study|Adverse Event|0|||
155275236|NCT00262743|560440415|FG001|Overall Study|Adverse Event|9|||
155275237|NCT00262743|560440414|FG000|Overall Study|Disease progression|0|||
155275238|NCT00262743|560440415|FG001|Overall Study|Disease progression|3|||
155275239|NCT04430335|560440422|FG000|Overall Study|Withdrawal by Subject|1|||
155275240|NCT00179010|560440425|FG000|Overall Study|Muscle probe defective|1|||
155275241|NCT00179010|560440426|FG001|Overall Study|Muscle probe defective|1|||
155275242|NCT00179010|560440425|FG000|Overall Study|Failure to place arterial line|0|||
155275243|NCT00179010|560440426|FG001|Overall Study|Failure to place arterial line|1|||
155275244|NCT03249376|560440444|FG000|Overall Study|Adverse Event|11|||
155275245|NCT03249376|560440445|FG001|Overall Study|Adverse Event|5|||
155275246|NCT03249376|560440444|FG000|Overall Study|Lack of Efficacy|2|||
155275247|NCT03249376|560440445|FG001|Overall Study|Lack of Efficacy|4|||
155275248|NCT03249376|560440444|FG000|Overall Study|Protocol Violation|3|||
155275249|NCT03249376|560440445|FG001|Overall Study|Protocol Violation|2|||
155275250|NCT03249376|560440444|FG000|Overall Study|Physician Decision|0|||
155275251|NCT03249376|560440445|FG001|Overall Study|Physician Decision|2|||
155275252|NCT03249376|560440444|FG000|Overall Study|Withdrawal by Subject|3|||
155275253|NCT03249376|560440445|FG001|Overall Study|Withdrawal by Subject|9|||
155275254|NCT03249376|560440444|FG000|Overall Study|LTFU|2|||
155275255|NCT03249376|560440445|FG001|Overall Study|LTFU|1|||
155275256|NCT00627042|560440446|FG000|Overall Study|Withdrawal by Subject|2|||
155275257|NCT04747275|560440447|FG000|Overall Study|Study terminated|0|||
155275258|NCT04747275|560440448|FG001|Overall Study|Study terminated|1|||
155275259|NCT04254679|560440451|FG000|Overall Study|Protocol Violation|1|||
155275260|NCT04254679|560440452|FG001|Overall Study|Protocol Violation|1|||
155275261|NCT04254679|560440451|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
155275262|NCT04254679|560440452|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
155275263|NCT01388530|560440460|FG000|Overall Study|Lost to Follow-up|5|||
155275264|NCT05284019|560440461|FG000|Overall Study|Study terminated|2|||
155275265|NCT05284019|560440462|FG001|Overall Study|Study terminated|2|||
155275266|NCT05284019|560440463|FG002|Overall Study|Study terminated|2|||
155275267|NCT05284019|560440464|FG003|Overall Study|Study terminated|5|||
155275268|NCT05284019|560440465|FG004|Overall Study|Study terminated|15|||
155275269|NCT05284019|560440461|FG000|Overall Study|Withdrawal by Subject|0|||
155275270|NCT05284019|560440462|FG001|Overall Study|Withdrawal by Subject|0|||
155275271|NCT05284019|560440463|FG002|Overall Study|Withdrawal by Subject|0|||
155275272|NCT05284019|560440464|FG003|Overall Study|Withdrawal by Subject|1|||
155275273|NCT05284019|560440465|FG004|Overall Study|Withdrawal by Subject|1|||
155275274|NCT05284019|560440461|FG000|Overall Study|Lost to Follow-up|1|||
155275275|NCT05284019|560440462|FG001|Overall Study|Lost to Follow-up|0|||
155275276|NCT05284019|560440463|FG002|Overall Study|Lost to Follow-up|0|||
155275277|NCT05284019|560440464|FG003|Overall Study|Lost to Follow-up|2|||
155275278|NCT05284019|560440465|FG004|Overall Study|Lost to Follow-up|1|||
155275279|NCT01990300|560440466|FG000|Overall Study|Case Report Forms Uncollected|89|||
155275280|NCT01990300|560440466|FG000|Overall Study|Protocol Deviation|53|||
155275281|NCT02420327|560440467|FG000|Overall Study|Adverse Event|7|||
155275282|NCT02420327|560440467|FG000|Overall Study|Pregnancy|1|||
155275283|NCT02420327|560440467|FG000|Overall Study|Withdrawal by Subject|6|||
155275284|NCT02420327|560440467|FG000|Overall Study|Lost to Follow-up|1|||
155275285|NCT02420327|560440467|FG000|Overall Study|Protocol Violation|1|||
155275286|NCT01146574|560440470|FG000|Overall Study|Death|0|||
155275287|NCT01146574|560440471|FG001|Overall Study|Death|1|||
155275288|NCT01146574|560440472|FG002|Overall Study|Death|1|||
155275289|NCT01146574|560440473|FG003|Overall Study|Death|0|||
155275290|NCT01146574|560440474|FG004|Overall Study|Death|0|||
155275291|NCT01146574|560440475|FG005|Overall Study|Death|0|||
155275292|NCT01146574|560440476|FG006|Overall Study|Death|0|||
155275293|NCT01146574|560440470|FG000|Overall Study|Other reasons|0|||
155275294|NCT01146574|560440471|FG001|Overall Study|Other reasons|0|||
155275295|NCT01146574|560440472|FG002|Overall Study|Other reasons|3|||
155275296|NCT01146574|560440473|FG003|Overall Study|Other reasons|0|||
155275297|NCT01146574|560440474|FG004|Overall Study|Other reasons|0|||
155275298|NCT01146574|560440475|FG005|Overall Study|Other reasons|0|||
155275299|NCT01146574|560440476|FG006|Overall Study|Other reasons|0|||
155275300|NCT01146574|560440470|FG000|Overall Study|Kidney transplant|0|||
155275301|NCT01146574|560440471|FG001|Overall Study|Kidney transplant|0|||
155275302|NCT01146574|560440472|FG002|Overall Study|Kidney transplant|1|||
155275303|NCT01146574|560440473|FG003|Overall Study|Kidney transplant|1|||
155275304|NCT01146574|560440474|FG004|Overall Study|Kidney transplant|0|||
155275305|NCT01146574|560440475|FG005|Overall Study|Kidney transplant|0|||
155275306|NCT01146574|560440476|FG006|Overall Study|Kidney transplant|0|||
155275307|NCT01146574|560440470|FG000|Overall Study|Withdrew consent|0|||
155275308|NCT01146574|560440471|FG001|Overall Study|Withdrew consent|0|||
155275309|NCT01146574|560440472|FG002|Overall Study|Withdrew consent|1|||
155275310|NCT01146574|560440473|FG003|Overall Study|Withdrew consent|1|||
155275311|NCT01146574|560440474|FG004|Overall Study|Withdrew consent|2|||
155275312|NCT01146574|560440475|FG005|Overall Study|Withdrew consent|1|||
155275313|NCT01146574|560440476|FG006|Overall Study|Withdrew consent|1|||
155275314|NCT00683449|560440479|FG000|Overall Study|Lost to Follow-up|0|||
155275315|NCT00683449|560440480|FG001|Overall Study|Lost to Follow-up|1|||
155275316|NCT00683449|560440481|FG002|Overall Study|Lost to Follow-up|0|||
155275317|NCT00683449|560440482|FG003|Overall Study|Lost to Follow-up|0|||
155275318|NCT00683449|560440483|FG004|Overall Study|Lost to Follow-up|0|||
155275319|NCT01448044|560440486|FG000|Treatment Period|Adverse Event|4|||
155275320|NCT01448044|560440487|FG001|Treatment Period|Adverse Event|3|||
155275321|NCT01448044|560440486|FG000|Treatment Period|Lack of Efficacy|5|||
155275322|NCT01448044|560440487|FG001|Treatment Period|Lack of Efficacy|12|||
155275323|NCT01448044|560440486|FG000|Treatment Period|Subject requested discontinue study drug|1|||
155275324|NCT01448044|560440487|FG001|Treatment Period|Subject requested discontinue study drug|0|||
155275325|NCT01448044|560440486|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
155275326|NCT01448044|560440487|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
155275327|NCT01448044|560440486|FG000|Treatment Period|Participant does not meet study criteria|1|||
155275328|NCT01448044|560440487|FG001|Treatment Period|Participant does not meet study criteria|0|||
155275329|NCT01448044|560440486|FG000|Treatment Period|Lost to Follow-up|2|||
155275330|NCT01448044|560440487|FG001|Treatment Period|Lost to Follow-up|1|||
155275331|NCT01448044|560440486|FG000|Treatment Period|Other reason|2|||
155275332|NCT01448044|560440487|FG001|Treatment Period|Other reason|0|||
155275333|NCT01448044|560440486|FG000|Follow Up Period|Withdrawal by Subject|1|||
155275334|NCT01448044|560440487|FG001|Follow Up Period|Withdrawal by Subject|1|||
155275335|NCT01448044|560440486|FG000|Follow Up Period|Lost to Follow-up|6|||
155275336|NCT01448044|560440487|FG001|Follow Up Period|Lost to Follow-up|2|||
155275337|NCT01448044|560440486|FG000|Follow Up Period|Other|5|||
155275338|NCT01448044|560440487|FG001|Follow Up Period|Other|11|||
155275339|NCT00507026|560440488|FG000|Overall Study|Lack of Efficacy|6|||
155275340|NCT00507026|560440489|FG001|Overall Study|Lack of Efficacy|4|||
155275341|NCT00507026|560440490|FG002|Overall Study|Lack of Efficacy|21|||
155275342|NCT00507026|560440488|FG000|Overall Study|Withdrawal by Subject|2|||
155275343|NCT00507026|560440489|FG001|Overall Study|Withdrawal by Subject|0|||
155275344|NCT00507026|560440490|FG002|Overall Study|Withdrawal by Subject|0|||
155275345|NCT00507026|560440488|FG000|Overall Study|Investigator Decision|1|||
155275346|NCT00507026|560440489|FG001|Overall Study|Investigator Decision|0|||
155275347|NCT00507026|560440490|FG002|Overall Study|Investigator Decision|0|||
155275348|NCT00507026|560440488|FG000|Overall Study|Adverse Event|2|||
155275349|NCT00507026|560440489|FG001|Overall Study|Adverse Event|0|||
155275350|NCT00507026|560440490|FG002|Overall Study|Adverse Event|0|||
155275351|NCT00507026|560440488|FG000|Overall Study|Protocol Violation|1|||
155275352|NCT00507026|560440489|FG001|Overall Study|Protocol Violation|0|||
155275353|NCT00507026|560440490|FG002|Overall Study|Protocol Violation|0|||
155275354|NCT00507026|560440488|FG000|Overall Study|Other|1|||
155275355|NCT00507026|560440489|FG001|Overall Study|Other|0|||
155275356|NCT00507026|560440490|FG002|Overall Study|Other|0|||
155275357|NCT00681187|560440491|FG000|Overall Study|Withdrawal by Subject|1|||
155275358|NCT00681187|560440492|FG001|Overall Study|Withdrawal by Subject|0|||
155275359|NCT00681187|560440491|FG000|Overall Study|Death|0|||
155275360|NCT00681187|560440492|FG001|Overall Study|Death|1|||
155275361|NCT00681187|560440491|FG000|Overall Study|Adverse Event|0|||
155275362|NCT00681187|560440492|FG001|Overall Study|Adverse Event|1|||
155275363|NCT04230980|560440493|FG000|Overall Study|Lost to Follow-up|1|||
155275364|NCT04230980|560440494|FG001|Overall Study|Lost to Follow-up|2|||
155275365|NCT04230980|560440493|FG000|Overall Study|Adverse Event|0|||
155275366|NCT04230980|560440494|FG001|Overall Study|Adverse Event|1|||
155275367|NCT02372058|560440497|FG000|Overall Study|Withdrawal by Subject|3|||
155619657|NCT00490971|561699792|FG002|Maintenance|Adverse Event|4|||
155275368|NCT00318149|560440500|FG000|Overall Study|Adverse Event|0|||
155275369|NCT00318149|560440501|FG001|Overall Study|Adverse Event|0|||
155275370|NCT00318149|560440502|FG002|Overall Study|Adverse Event|0|||
155275371|NCT00318149|560440503|FG003|Overall Study|Adverse Event|0|||
155275372|NCT00318149|560440504|FG004|Overall Study|Adverse Event|0|||
155275373|NCT00318149|560440505|FG005|Overall Study|Adverse Event|2|||
155275374|NCT03541642|560440506|FG000|Overall Study|Withdrawal by Subject|1|||
155275375|NCT03541642|560440507|FG001|Overall Study|Withdrawal by Subject|2|||
155275376|NCT03541642|560440506|FG000|Overall Study|Lost to Follow-up|16|||
155619658|NCT00490971|561699793|FG003|Maintenance|Adverse Event|5|||
155275377|NCT03541642|560440507|FG001|Overall Study|Lost to Follow-up|12|||
155275378|NCT03541642|560440506|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
155275379|NCT03541642|560440507|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
155275380|NCT03523871|560440508|FG000|Overall Study|Death|1|||
155275381|NCT00219141|560440509|FG000|Overall Study|Adverse Event|4|||
155275382|NCT00219141|560440510|FG001|Overall Study|Adverse Event|10|||
155275383|NCT00219141|560440511|FG002|Overall Study|Adverse Event|5|||
155275384|NCT00219141|560440509|FG000|Overall Study|Lack of Efficacy|3|||
155275385|NCT00219141|560440510|FG001|Overall Study|Lack of Efficacy|2|||
155275386|NCT00219141|560440511|FG002|Overall Study|Lack of Efficacy|0|||
155275387|NCT00219141|560440509|FG000|Overall Study|Administrative problems|0|||
155275388|NCT00219141|560440510|FG001|Overall Study|Administrative problems|1|||
155275389|NCT00219141|560440511|FG002|Overall Study|Administrative problems|0|||
155275390|NCT00219141|560440509|FG000|Overall Study|Lost to Follow-up|2|||
155275391|NCT00219141|560440510|FG001|Overall Study|Lost to Follow-up|4|||
155275392|NCT00219141|560440511|FG002|Overall Study|Lost to Follow-up|1|||
155275393|NCT00219141|560440509|FG000|Overall Study|Protocol Violation|3|||
155275394|NCT00219141|560440510|FG001|Overall Study|Protocol Violation|1|||
155275395|NCT00219141|560440511|FG002|Overall Study|Protocol Violation|1|||
155275396|NCT00219141|560440509|FG000|Overall Study|Withdrawal by Subject|1|||
155275397|NCT00219141|560440510|FG001|Overall Study|Withdrawal by Subject|3|||
155275398|NCT00219141|560440511|FG002|Overall Study|Withdrawal by Subject|5|||
155275399|NCT00219141|560440509|FG000|Overall Study|Condition no longer requires study drug|1|||
155275400|NCT00219141|560440510|FG001|Overall Study|Condition no longer requires study drug|0|||
155275401|NCT00219141|560440511|FG002|Overall Study|Condition no longer requires study drug|0|||
155275402|NCT00972179|560440512|FG000|Overall Study|Noncompliance|1|||
155275403|NCT00972179|560440513|FG001|Overall Study|Noncompliance|0|||
155275404|NCT00972179|560440514|FG002|Overall Study|Noncompliance|0|||
155275405|NCT00972179|560440515|FG003|Overall Study|Noncompliance|0|||
155275406|NCT00972179|560440516|FG004|Overall Study|Noncompliance|1|||
155275407|NCT00972179|560440517|FG005|Overall Study|Noncompliance|0|||
155275408|NCT00972179|560440518|FG006|Overall Study|Noncompliance|1|||
155275409|NCT00972179|560440512|FG000|Overall Study|Withdrawal by Subject|0|||
155275410|NCT00972179|560440513|FG001|Overall Study|Withdrawal by Subject|3|||
155275411|NCT00972179|560440514|FG002|Overall Study|Withdrawal by Subject|0|||
155275412|NCT00972179|560440515|FG003|Overall Study|Withdrawal by Subject|1|||
155275413|NCT00972179|560440516|FG004|Overall Study|Withdrawal by Subject|0|||
155275414|NCT00972179|560440517|FG005|Overall Study|Withdrawal by Subject|0|||
155275415|NCT00972179|560440518|FG006|Overall Study|Withdrawal by Subject|2|||
155275416|NCT00972179|560440512|FG000|Overall Study|Administrative Decision|0|||
155275417|NCT00972179|560440513|FG001|Overall Study|Administrative Decision|0|||
155275418|NCT00972179|560440514|FG002|Overall Study|Administrative Decision|0|||
155275419|NCT00972179|560440515|FG003|Overall Study|Administrative Decision|0|||
155275420|NCT00972179|560440516|FG004|Overall Study|Administrative Decision|1|||
155275421|NCT00972179|560440517|FG005|Overall Study|Administrative Decision|0|||
155275422|NCT00972179|560440518|FG006|Overall Study|Administrative Decision|0|||
155275423|NCT00972179|560440512|FG000|Overall Study|Lost to Follow-up|0|||
155275424|NCT00972179|560440513|FG001|Overall Study|Lost to Follow-up|0|||
155275425|NCT00972179|560440514|FG002|Overall Study|Lost to Follow-up|1|||
155275426|NCT00972179|560440515|FG003|Overall Study|Lost to Follow-up|0|||
155275427|NCT00972179|560440516|FG004|Overall Study|Lost to Follow-up|0|||
155275428|NCT00972179|560440517|FG005|Overall Study|Lost to Follow-up|3|||
155275429|NCT00972179|560440518|FG006|Overall Study|Lost to Follow-up|1|||
155275430|NCT03055832|560440519|FG000|Week 2|Withdrawal by Subject|1|||
155275431|NCT03055832|560440520|FG001|Week 2|Withdrawal by Subject|0|||
155275432|NCT01994720|560440521|FG000|Overall Study|Withdrawal by Subject|46|||
155275433|NCT01994720|560440522|FG001|Overall Study|Withdrawal by Subject|56|||
155275434|NCT03619174|560440523|FG000|Overall Study|Lost to Follow-up|3|||
155275435|NCT03619174|560440524|FG001|Overall Study|Lost to Follow-up|0|||
155275436|NCT03619174|560440523|FG000|Overall Study|Withdrawal by Subject|4|||
155275437|NCT03619174|560440524|FG001|Overall Study|Withdrawal by Subject|3|||
155275438|NCT03619174|560440523|FG000|Overall Study|Pregnancy|1|||
155275439|NCT03619174|560440524|FG001|Overall Study|Pregnancy|1|||
155275440|NCT03619174|560440523|FG000|Overall Study|Discomfort during treatment|1|||
155275441|NCT03619174|560440524|FG001|Overall Study|Discomfort during treatment|0|||
155275442|NCT01012973|560440528|FG000|Overall Study|Adverse Event|5|||
155275443|NCT01012973|560440529|FG001|Overall Study|Adverse Event|5|||
155275444|NCT01012973|560440528|FG000|Overall Study|Lack of Efficacy|0|||
155275445|NCT01012973|560440529|FG001|Overall Study|Lack of Efficacy|5|||
155275446|NCT01012973|560440528|FG000|Overall Study|Lost to Follow-up|1|||
155275447|NCT01012973|560440529|FG001|Overall Study|Lost to Follow-up|0|||
155275448|NCT01012973|560440528|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
155275449|NCT01012973|560440529|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
155275450|NCT01012973|560440528|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
155275451|NCT01012973|560440529|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
155275452|NCT01012973|560440528|FG000|Overall Study|Protocol Violation|5|||
155275453|NCT01012973|560440529|FG001|Overall Study|Protocol Violation|2|||
155275454|NCT01012973|560440528|FG000|Overall Study|Withdrawal by Subject|4|||
155275455|NCT01012973|560440529|FG001|Overall Study|Withdrawal by Subject|6|||
155275456|NCT02061761|560440530|FG000|Overall Study|Disease progression|2|||
155275457|NCT02061761|560440531|FG001|Overall Study|Disease progression|8|||
155275458|NCT02061761|560440532|FG002|Overall Study|Disease progression|4|||
155275459|NCT02061761|560440533|FG003|Overall Study|Disease progression|5|||
155275460|NCT02061761|560440534|FG004|Overall Study|Disease progression|9|||
155275461|NCT02061761|560440535|FG005|Overall Study|Disease progression|3|||
155275462|NCT02061761|560440536|FG006|Overall Study|Disease progression|1|||
155275463|NCT02061761|560440537|FG007|Overall Study|Disease progression|2|||
155275464|NCT02061761|560440538|FG008|Overall Study|Disease progression|28|||
155275465|NCT02061761|560440530|FG000|Overall Study|Study Drug toxicity|0|||
155275466|NCT02061761|560440531|FG001|Overall Study|Study Drug toxicity|0|||
155275467|NCT02061761|560440532|FG002|Overall Study|Study Drug toxicity|0|||
155275468|NCT02061761|560440533|FG003|Overall Study|Study Drug toxicity|0|||
155275469|NCT02061761|560440534|FG004|Overall Study|Study Drug toxicity|0|||
155275470|NCT02061761|560440535|FG005|Overall Study|Study Drug toxicity|1|||
155275471|NCT02061761|560440536|FG006|Overall Study|Study Drug toxicity|0|||
155275472|NCT02061761|560440537|FG007|Overall Study|Study Drug toxicity|2|||
155275473|NCT02061761|560440538|FG008|Overall Study|Study Drug toxicity|6|||
155275474|NCT02061761|560440530|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
155275475|NCT02061761|560440531|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
155275476|NCT02061761|560440532|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
155275477|NCT02061761|560440533|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
155275478|NCT02061761|560440534|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
155275479|NCT02061761|560440535|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
155275480|NCT02061761|560440536|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
155275481|NCT02061761|560440537|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
155275482|NCT02061761|560440538|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
155275483|NCT02061761|560440530|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155275484|NCT02061761|560440531|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155275485|NCT02061761|560440532|FG002|Overall Study|Participant request to discontinue study treatment|2|||
155275486|NCT02061761|560440533|FG003|Overall Study|Participant request to discontinue study treatment|2|||
155275487|NCT02061761|560440534|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155275488|NCT02061761|560440535|FG005|Overall Study|Participant request to discontinue study treatment|1|||
155275489|NCT02061761|560440536|FG006|Overall Study|Participant request to discontinue study treatment|0|||
155275490|NCT02061761|560440537|FG007|Overall Study|Participant request to discontinue study treatment|0|||
155275491|NCT02061761|560440538|FG008|Overall Study|Participant request to discontinue study treatment|2|||
155275492|NCT02061761|560440530|FG000|Overall Study|Withdrawal by Subject|0|||
155275493|NCT02061761|560440531|FG001|Overall Study|Withdrawal by Subject|0|||
155275494|NCT02061761|560440532|FG002|Overall Study|Withdrawal by Subject|0|||
155275495|NCT02061761|560440533|FG003|Overall Study|Withdrawal by Subject|0|||
155275496|NCT02061761|560440534|FG004|Overall Study|Withdrawal by Subject|0|||
155275497|NCT02061761|560440535|FG005|Overall Study|Withdrawal by Subject|0|||
155275498|NCT02061761|560440536|FG006|Overall Study|Withdrawal by Subject|0|||
155275499|NCT02061761|560440537|FG007|Overall Study|Withdrawal by Subject|0|||
155275500|NCT02061761|560440538|FG008|Overall Study|Withdrawal by Subject|2|||
155275501|NCT02061761|560440530|FG000|Overall Study|Maximum clinical benefit|0|||
155275502|NCT02061761|560440531|FG001|Overall Study|Maximum clinical benefit|0|||
155275503|NCT02061761|560440532|FG002|Overall Study|Maximum clinical benefit|0|||
155275504|NCT02061761|560440533|FG003|Overall Study|Maximum clinical benefit|1|||
155275505|NCT02061761|560440534|FG004|Overall Study|Maximum clinical benefit|0|||
155275506|NCT02061761|560440535|FG005|Overall Study|Maximum clinical benefit|0|||
155275507|NCT02061761|560440536|FG006|Overall Study|Maximum clinical benefit|0|||
155619659|NCT00490971|561699794|FG004|Maintenance|Adverse Event|7|||
155619660|NCT00490971|561699790|FG000|Maintenance|Death|0|||
155619661|NCT00490971|561699791|FG001|Maintenance|Death|0|||
155619662|NCT00490971|561699792|FG002|Maintenance|Death|0|||
155619663|NCT00490971|561699793|FG003|Maintenance|Death|2|||
155619664|NCT00490971|561699794|FG004|Maintenance|Death|0|||
155619665|NCT00490971|561699790|FG000|Maintenance|Lost to Follow-up|0|||
155619666|NCT00490971|561699791|FG001|Maintenance|Lost to Follow-up|0|||
155619667|NCT00490971|561699792|FG002|Maintenance|Lost to Follow-up|5|||
155619668|NCT00490971|561699793|FG003|Maintenance|Lost to Follow-up|8|||
155619669|NCT00490971|561699794|FG004|Maintenance|Lost to Follow-up|10|||
155619670|NCT00490971|561699790|FG000|Maintenance|Pregnancy|0|||
155619671|NCT00490971|561699791|FG001|Maintenance|Pregnancy|0|||
155619672|NCT00490971|561699792|FG002|Maintenance|Pregnancy|1|||
155275508|NCT02061761|560440537|FG007|Overall Study|Maximum clinical benefit|0|||
155275509|NCT02061761|560440538|FG008|Overall Study|Maximum clinical benefit|6|||
155275510|NCT02061761|560440530|FG000|Overall Study|Participant no longer meets study criteria|0|||
155275511|NCT02061761|560440531|FG001|Overall Study|Participant no longer meets study criteria|0|||
155275512|NCT02061761|560440532|FG002|Overall Study|Participant no longer meets study criteria|0|||
155275513|NCT02061761|560440533|FG003|Overall Study|Participant no longer meets study criteria|0|||
155275514|NCT02061761|560440534|FG004|Overall Study|Participant no longer meets study criteria|0|||
155275515|NCT02061761|560440535|FG005|Overall Study|Participant no longer meets study criteria|0|||
155619673|NCT00490971|561699793|FG003|Maintenance|Pregnancy|0|||
155619674|NCT00490971|561699794|FG004|Maintenance|Pregnancy|0|||
155619675|NCT00490971|561699790|FG000|Maintenance|Protocol Violation|0|||
155619676|NCT00490971|561699791|FG001|Maintenance|Protocol Violation|0|||
155275516|NCT02061761|560440536|FG006|Overall Study|Participant no longer meets study criteria|0|||
155275517|NCT02061761|560440537|FG007|Overall Study|Participant no longer meets study criteria|0|||
155275518|NCT02061761|560440538|FG008|Overall Study|Participant no longer meets study criteria|1|||
155275519|NCT02061761|560440530|FG000|Overall Study|Other reasons|0|||
155275520|NCT02061761|560440531|FG001|Overall Study|Other reasons|0|||
155275521|NCT02061761|560440532|FG002|Overall Study|Other reasons|0|||
155275522|NCT02061761|560440533|FG003|Overall Study|Other reasons|0|||
155275523|NCT02061761|560440534|FG004|Overall Study|Other reasons|2|||
155275524|NCT02061761|560440535|FG005|Overall Study|Other reasons|0|||
155275525|NCT02061761|560440536|FG006|Overall Study|Other reasons|0|||
155275526|NCT02061761|560440537|FG007|Overall Study|Other reasons|0|||
155275527|NCT02061761|560440538|FG008|Overall Study|Other reasons|6|||
155275528|NCT00967018|560440539|FG000|Overall Study|Adverse Event|2|||
155275529|NCT00967018|560440539|FG000|Overall Study|Physician Decision|7|||
155275530|NCT00967018|560440539|FG000|Overall Study|Lost to Follow-up|2|||
155275531|NCT00967018|560440539|FG000|Overall Study|Withdrawal by Subject|1|||
155275532|NCT00967018|560440539|FG000|Overall Study|Miscellaneous Reasons|9|||
155275533|NCT04170296|560440549|FG000|Overall Study|Adverse Event|1|||
155275534|NCT04170296|560440550|FG001|Overall Study|Adverse Event|0|||
155275535|NCT04170296|560440549|FG000|Overall Study|Withdrawal by Subject|3|||
155275536|NCT04170296|560440550|FG001|Overall Study|Withdrawal by Subject|2|||
155275537|NCT04170296|560440549|FG000|Overall Study|Lost to Follow-up|4|||
155275538|NCT04170296|560440550|FG001|Overall Study|Lost to Follow-up|2|||
155275539|NCT02468934|560440551|FG000|Overall Study|Withdrawal by Subject|4|||
155275540|NCT02468934|560440551|FG000|Overall Study|Screen Failure|3|||
155275541|NCT00383240|560440552|FG000|Overall Study|Adverse Event|4|||
155275542|NCT00383240|560440553|FG001|Overall Study|Adverse Event|6|||
155275543|NCT00383240|560440554|FG002|Overall Study|Adverse Event|9|||
155275544|NCT00383240|560440555|FG003|Overall Study|Adverse Event|7|||
155275545|NCT00383240|560440552|FG000|Overall Study|Treatment Failure|8|||
155275546|NCT00383240|560440553|FG001|Overall Study|Treatment Failure|13|||
155275547|NCT00383240|560440554|FG002|Overall Study|Treatment Failure|47|||
155275548|NCT00383240|560440555|FG003|Overall Study|Treatment Failure|46|||
155275549|NCT00383240|560440552|FG000|Overall Study|Lost to Follow-up|3|||
155275550|NCT00383240|560440553|FG001|Overall Study|Lost to Follow-up|0|||
155275551|NCT00383240|560440554|FG002|Overall Study|Lost to Follow-up|0|||
155275552|NCT00383240|560440555|FG003|Overall Study|Lost to Follow-up|2|||
155275553|NCT00383240|560440552|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
155275554|NCT00383240|560440553|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
155275555|NCT00383240|560440554|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
155275556|NCT00383240|560440555|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
155275557|NCT00383240|560440552|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
155275558|NCT00383240|560440553|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
155275559|NCT00383240|560440554|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
155275560|NCT00383240|560440555|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
155275561|NCT00383240|560440552|FG000|Overall Study|Protocol Violation|4|||
155275562|NCT00383240|560440553|FG001|Overall Study|Protocol Violation|5|||
155275563|NCT00383240|560440554|FG002|Overall Study|Protocol Violation|9|||
155275564|NCT00383240|560440555|FG003|Overall Study|Protocol Violation|6|||
155275565|NCT00383240|560440552|FG000|Overall Study|Did not meet protocol eligibility|9|||
155275566|NCT00383240|560440553|FG001|Overall Study|Did not meet protocol eligibility|4|||
155275567|NCT00383240|560440554|FG002|Overall Study|Did not meet protocol eligibility|9|||
155275568|NCT00383240|560440555|FG003|Overall Study|Did not meet protocol eligibility|3|||
155275569|NCT00383240|560440552|FG000|Overall Study|Administrative|1|||
155275570|NCT00383240|560440553|FG001|Overall Study|Administrative|1|||
155275571|NCT00383240|560440554|FG002|Overall Study|Administrative|0|||
155275572|NCT00383240|560440555|FG003|Overall Study|Administrative|0|||
155275573|NCT01370603|560440557|FG000|Period 1|Adverse Event|5|||
155275574|NCT01370603|560440558|FG001|Period 1|Adverse Event|3|||
155275575|NCT01370603|560440557|FG000|Period 1|Lost to Follow-up|2|||
155275576|NCT01370603|560440558|FG001|Period 1|Lost to Follow-up|0|||
155275577|NCT01370603|560440557|FG000|Period 1|Protocol Violation|2|||
155275578|NCT01370603|560440558|FG001|Period 1|Protocol Violation|2|||
155275579|NCT01370603|560440557|FG000|Period 1|Withdrawal by Subject|5|||
155275580|NCT01370603|560440558|FG001|Period 1|Withdrawal by Subject|5|||
155275581|NCT01370603|560440557|FG000|Crossover Washout|Adverse Event|2|||
155275582|NCT01370603|560440558|FG001|Crossover Washout|Adverse Event|1|||
155275583|NCT01370603|560440557|FG000|Crossover Washout|Lost to Follow-up|2|||
155275584|NCT01370603|560440558|FG001|Crossover Washout|Lost to Follow-up|0|||
155275585|NCT01370603|560440557|FG000|Crossover Washout|Protocol Violation|1|||
155275586|NCT01370603|560440558|FG001|Crossover Washout|Protocol Violation|0|||
155275587|NCT01370603|560440557|FG000|Crossover Washout|Withdrawal by Subject|4|||
155275588|NCT01370603|560440558|FG001|Crossover Washout|Withdrawal by Subject|1|||
155275589|NCT01370603|560440557|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
155275590|NCT01370603|560440558|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
155275591|NCT01370603|560440557|FG000|Period 2|Adverse Event|1|||
155275592|NCT01370603|560440558|FG001|Period 2|Adverse Event|4|||
155275593|NCT01370603|560440557|FG000|Period 2|Lost to Follow-up|1|||
155275594|NCT01370603|560440558|FG001|Period 2|Lost to Follow-up|0|||
155275595|NCT01370603|560440557|FG000|Period 2|Withdrawal by Subject|1|||
155275596|NCT01370603|560440558|FG001|Period 2|Withdrawal by Subject|0|||
155275597|NCT02133924|560440563|FG000|Overall Study|Death|38|||
155275598|NCT02133924|560440563|FG000|Overall Study|Physician Decision|1|||
155275599|NCT02133924|560440563|FG000|Overall Study|Withdrawal by Subject|3|||
155275600|NCT02924389|560440570|FG000|Overall Study|Lost to Follow-up|1|||
155275601|NCT02924389|560440571|FG001|Overall Study|Lost to Follow-up|0|||
155275602|NCT02924389|560440570|FG000|Overall Study|Physician Decision|2|||
155275603|NCT02924389|560440571|FG001|Overall Study|Physician Decision|0|||
155275604|NCT02924389|560440570|FG000|Overall Study|Withdrawal by Subject|3|||
155275605|NCT02924389|560440571|FG001|Overall Study|Withdrawal by Subject|0|||
155275606|NCT02924389|560440570|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
155275607|NCT02924389|560440571|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
155275608|NCT04714216|560442699|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
155275609|NCT04714216|560442699|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
155275610|NCT01349829|560442700|FG000|Overall Study|Lost to Follow-up|4|||
155275611|NCT01349829|560442701|FG001|Overall Study|Lost to Follow-up|8|||
155275612|NCT01349829|560442700|FG000|Overall Study|Consent withdrawal|3|||
155275613|NCT01349829|560442701|FG001|Overall Study|Consent withdrawal|8|||
155275614|NCT01349829|560442700|FG000|Overall Study|Migrated/moved|2|||
155275615|NCT01349829|560442701|FG001|Overall Study|Migrated/moved|7|||
155275616|NCT01852162|560442707|FG000|Overall Study|Adverse Event|1|||
155275617|NCT01852162|560442708|FG001|Overall Study|Adverse Event|0|||
155275618|NCT01852162|560442707|FG000|Overall Study|Withdrawal by Subject|3|||
155275619|NCT01852162|560442708|FG001|Overall Study|Withdrawal by Subject|1|||
155275620|NCT01500226|560442709|FG000|Overall Study|Adverse Event|31|||
155275621|NCT01500226|560442710|FG001|Overall Study|Adverse Event|38|||
155275622|NCT01500226|560442709|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
155275623|NCT01500226|560442710|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
155275624|NCT01500226|560442709|FG000|Overall Study|Withdrawal by Subject|93|||
155275625|NCT01500226|560442710|FG001|Overall Study|Withdrawal by Subject|96|||
155275626|NCT01500226|560442709|FG000|Overall Study|Death|12|||
155275627|NCT01500226|560442710|FG001|Overall Study|Death|4|||
155275628|NCT01500226|560442709|FG000|Overall Study|Disease Progression|16|||
155275629|NCT01500226|560442710|FG001|Overall Study|Disease Progression|14|||
155275630|NCT01500226|560442709|FG000|Overall Study|Protocol Violation|53|||
155275631|NCT01500226|560442710|FG001|Overall Study|Protocol Violation|39|||
155275632|NCT01500226|560442709|FG000|Overall Study|Physician Decision|17|||
155275633|NCT01500226|560442710|FG001|Overall Study|Physician Decision|15|||
155275634|NCT01500226|560442709|FG000|Overall Study|Lack of Efficacy|14|||
155275635|NCT01500226|560442710|FG001|Overall Study|Lack of Efficacy|30|||
155275636|NCT01500226|560442709|FG000|Overall Study|Lost to Follow-up|9|||
155275637|NCT01500226|560442710|FG001|Overall Study|Lost to Follow-up|5|||
155275638|NCT01500226|560442709|FG000|Overall Study|Other Reasons|19|||
155275639|NCT01500226|560442710|FG001|Overall Study|Other Reasons|16|||
155275640|NCT02955277|560442711|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
155275641|NCT02955277|560442712|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
155275642|NCT02955277|560442711|FG000|Post to Follow-up|Lost to Follow-up|8|||
155275643|NCT02955277|560442712|FG001|Post to Follow-up|Lost to Follow-up|11|||
155275644|NCT04212169|560442713|FG000|Overall Study|Adverse Event|0|||
155275645|NCT04212169|560442714|FG001|Overall Study|Adverse Event|0|||
155275646|NCT04212169|560442715|FG002|Overall Study|Adverse Event|0|||
155275647|NCT04212169|560442716|FG003|Overall Study|Adverse Event|2|||
155275648|NCT04212169|560442713|FG000|Overall Study|Lost to Follow-up|1|||
155275649|NCT04212169|560442714|FG001|Overall Study|Lost to Follow-up|0|||
155275650|NCT04212169|560442715|FG002|Overall Study|Lost to Follow-up|0|||
155275651|NCT04212169|560442716|FG003|Overall Study|Lost to Follow-up|2|||
155275652|NCT04212169|560442713|FG000|Overall Study|Withdrawal by Subject|10|||
155275653|NCT04212169|560442714|FG001|Overall Study|Withdrawal by Subject|2|||
155275654|NCT04212169|560442715|FG002|Overall Study|Withdrawal by Subject|5|||
155275655|NCT04212169|560442716|FG003|Overall Study|Withdrawal by Subject|7|||
155275656|NCT04212169|560442713|FG000|Overall Study|Other reason, unspecified|3|||
155275657|NCT04212169|560442714|FG001|Overall Study|Other reason, unspecified|1|||
155275658|NCT04212169|560442715|FG002|Overall Study|Other reason, unspecified|0|||
155275659|NCT04212169|560442716|FG003|Overall Study|Other reason, unspecified|2|||
155275660|NCT02176928|560442717|FG000|Overall Study|Lost to Follow-up|2|||
155275661|NCT02176928|560442718|FG001|Overall Study|Lost to Follow-up|4|||
155275662|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275663|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
155275664|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
155275665|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
155275666|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
155275667|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
155275668|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275669|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275670|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275671|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275672|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275673|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275674|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275675|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
155275676|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
155275677|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275678|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275679|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275680|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275681|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275682|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275683|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275684|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275685|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
155275686|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
155275687|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275688|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275689|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275690|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275691|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275692|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
155275693|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275694|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275695|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
155275696|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
155275697|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275698|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275699|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275700|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275701|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275702|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275703|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275704|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
155275705|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
155275706|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275707|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275708|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275709|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275710|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275711|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275712|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275713|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275714|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275715|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275716|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
155275717|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275718|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275719|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275720|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275721|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275722|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275723|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275724|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275725|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
155275726|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
155275727|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
155275728|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275729|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275730|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275731|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275732|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275733|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275734|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275735|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
155275736|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
155275737|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275738|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275739|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275740|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275741|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275742|NCT02018861|560442719|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275743|NCT02018861|560442720|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275744|NCT02018861|560442721|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275745|NCT02018861|560442722|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275746|NCT02018861|560442723|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275747|NCT02018861|560442724|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275748|NCT02018861|560442725|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
155275749|NCT02018861|560442726|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
155275750|NCT02018861|560442727|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275751|NCT02018861|560442728|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275752|NCT02018861|560442719|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275753|NCT02018861|560442720|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275754|NCT02018861|560442721|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275755|NCT02018861|560442722|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275756|NCT02018861|560442723|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275757|NCT02018861|560442724|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275758|NCT02018861|560442725|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
155275759|NCT02018861|560442726|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
155275760|NCT02018861|560442727|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275761|NCT02018861|560442728|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275762|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275763|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275764|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275765|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275766|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275767|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275768|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275769|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275770|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
155275771|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275772|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275773|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275774|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275775|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275776|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275777|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275778|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275779|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275780|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
155275781|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275782|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275783|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275784|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275785|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275786|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275787|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275788|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275789|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275790|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
155275791|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275792|NCT02819479|560442732|FG000|Overall Study|Adverse Event|2|||
155275793|NCT00504348|560442733|FG000|Overall Study|Adverse Event|3|||
155381939|NCT00598273|560833242|FG000|Overall Study|Lost to Follow-up|8|||
155381940|NCT00598273|560833243|FG001|Overall Study|Lost to Follow-up|3|||
155381941|NCT00598273|560833244|FG002|Overall Study|Lost to Follow-up|5|||
155275794|NCT00504348|560442733|FG000|Overall Study|Lack of Efficacy|4|||
155275795|NCT00504348|560442733|FG000|Overall Study|Physician Decision|1|||
155275796|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
155275797|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
155275798|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
155275799|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
155275800|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
155619677|NCT00490971|561699792|FG002|Maintenance|Protocol Violation|4|||
155619678|NCT00490971|561699793|FG003|Maintenance|Protocol Violation|1|||
155619679|NCT00490971|561699794|FG004|Maintenance|Protocol Violation|1|||
155619680|NCT00490971|561699790|FG000|Maintenance|Withdrawal by Subject|0|||
155619681|NCT00490971|561699791|FG001|Maintenance|Withdrawal by Subject|0|||
155619682|NCT00490971|561699792|FG002|Maintenance|Withdrawal by Subject|26|||
155619683|NCT00490971|561699793|FG003|Maintenance|Withdrawal by Subject|28|||
155619684|NCT00490971|561699794|FG004|Maintenance|Withdrawal by Subject|18|||
155619685|NCT00490971|561699790|FG000|Maintenance|Other|0|||
155619686|NCT00490971|561699791|FG001|Maintenance|Other|0|||
155619687|NCT00490971|561699792|FG002|Maintenance|Other|11|||
155619688|NCT00490971|561699793|FG003|Maintenance|Other|9|||
155619689|NCT00490971|561699794|FG004|Maintenance|Other|3|||
155619690|NCT04754542|561699799|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
155619691|NCT04754542|561699800|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
155619692|NCT02358031|561701321|FG000|Overall Study|Death|253|||
155619693|NCT02358031|561701322|FG001|Overall Study|Death|237|||
155619694|NCT02358031|561701323|FG002|Overall Study|Death|266|||
155619695|NCT02358031|561701321|FG000|Overall Study|Lost to Follow-up|1|||
155619696|NCT02358031|561701322|FG001|Overall Study|Lost to Follow-up|1|||
155619697|NCT02358031|561701323|FG002|Overall Study|Lost to Follow-up|0|||
155619698|NCT02358031|561701321|FG000|Overall Study|Withdrawal by Subject|19|||
155619699|NCT02358031|561701322|FG001|Overall Study|Withdrawal by Subject|14|||
155619700|NCT02358031|561701323|FG002|Overall Study|Withdrawal by Subject|18|||
155619701|NCT02358031|561701321|FG000|Overall Study|Sponsor Decision|26|||
155619702|NCT02358031|561701322|FG001|Overall Study|Sponsor Decision|28|||
155619703|NCT02358031|561701323|FG002|Overall Study|Sponsor Decision|16|||
155619704|NCT01212094|561701324|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
155619705|NCT01212094|561701325|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
155619706|NCT01212094|561701326|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
155619707|NCT01212094|561701324|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
155619708|NCT01212094|561701325|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
155619709|NCT01212094|561701326|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
155619710|NCT01212094|561701324|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
155619711|NCT01212094|561701325|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
155619712|NCT01212094|561701326|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
155619713|NCT01212094|561701324|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
155619714|NCT01212094|561701325|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
155619715|NCT01212094|561701326|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
155619716|NCT01212094|561701324|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
155619717|NCT01212094|561701325|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
155619718|NCT01212094|561701326|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
155619719|NCT01212094|561701324|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
155619720|NCT01212094|561701325|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
155619721|NCT01212094|561701326|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
155619722|NCT05664581|561701330|FG000|Overall Study|Withdrawal by Subject|2|||
155619723|NCT03101150|561701331|FG000|Overall Study|Lost to Follow-up|2|||
155619724|NCT03101150|561701332|FG001|Overall Study|Lost to Follow-up|4|||
155619725|NCT03101150|561701331|FG000|Overall Study|Miscarriage|3|||
155619726|NCT03101150|561701332|FG001|Overall Study|Miscarriage|6|||
155619727|NCT01317641|561701340|FG000|Overall Study|Not treated|0|||
155619728|NCT01317641|561701341|FG001|Overall Study|Not treated|0|||
155619729|NCT01317641|561701342|FG002|Overall Study|Not treated|0|||
155619730|NCT01317641|561701343|FG003|Overall Study|Not treated|0|||
155619731|NCT01317641|561701344|FG004|Overall Study|Not treated|0|||
155619732|NCT01317641|561701345|FG005|Overall Study|Not treated|0|||
155619733|NCT01317641|561701346|FG006|Overall Study|Not treated|0|||
155619734|NCT01317641|561701347|FG007|Overall Study|Not treated|1|||
155619735|NCT01317641|561701348|FG008|Overall Study|Not treated|1|||
155619736|NCT01317641|561701340|FG000|Overall Study|Adverse Event|0|||
155619737|NCT01317641|561701341|FG001|Overall Study|Adverse Event|1|||
155275801|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
155275802|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
155275803|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
155619738|NCT01317641|561701342|FG002|Overall Study|Adverse Event|0|||
155619739|NCT01317641|561701343|FG003|Overall Study|Adverse Event|1|||
155275804|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
155726897|NCT00907335|562099809|FG001|Overall Study|Lost to Follow-up|0|||
155619740|NCT01317641|561701344|FG004|Overall Study|Adverse Event|0|||
155275805|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
155275806|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
155275807|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
155275808|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
155275809|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
155275810|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
155275811|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
155275812|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
155275813|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
155275814|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
155275815|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
155275816|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
155275817|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Other|2|||
155275818|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Other|0|||
155275819|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Other|1|||
155275820|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Adverse Event|21|||
155275821|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Adverse Event|26|||
155275822|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Adverse Event|0|||
155275823|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
155275824|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
155275825|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
155275826|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
155275827|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
155275828|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
155275829|NCT02718417|560442736|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
155275830|NCT02718417|560442737|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
155275831|NCT02718417|560442738|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
155275832|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Physician's decision|6|||
155275833|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Physician's decision|7|||
155275834|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Physician's decision|0|||
155275835|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Progressive disease|100|||
155275836|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Progressive disease|88|||
155275837|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Progressive disease|0|||
155275838|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Other|2|||
155275839|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Other|1|||
155275840|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Other|0|||
155275841|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
155275842|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
155275843|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
155275844|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
155275845|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
155275846|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
155275847|NCT02718417|560442736|FG000|Observation Phase (OP)|Adverse Event|0|||
155275848|NCT02718417|560442737|FG001|Observation Phase (OP)|Adverse Event|0|||
155275849|NCT02718417|560442738|FG002|Observation Phase (OP)|Adverse Event|1|||
155275850|NCT02718417|560442736|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
155275851|NCT02718417|560442737|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
155275852|NCT02718417|560442738|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
155275853|NCT02718417|560442736|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
155275854|NCT02718417|560442737|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
155275855|NCT02718417|560442738|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
155275856|NCT02718417|560442736|FG000|Observation Phase (OP)|Physician Decision|0|||
155275857|NCT02718417|560442737|FG001|Observation Phase (OP)|Physician Decision|0|||
155275858|NCT02718417|560442738|FG002|Observation Phase (OP)|Physician Decision|9|||
155275859|NCT02718417|560442736|FG000|Observation Phase (OP)|Progressive disease|0|||
155275860|NCT02718417|560442737|FG001|Observation Phase (OP)|Progressive disease|0|||
155275861|NCT02718417|560442738|FG002|Observation Phase (OP)|Progressive disease|92|||
155275862|NCT02718417|560442736|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
155275863|NCT02718417|560442737|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
155275864|NCT02718417|560442738|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
155275865|NCT02718417|560442736|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
155275866|NCT02718417|560442737|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
155275867|NCT02718417|560442738|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
155275868|NCT02718417|560442736|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
155275869|NCT02718417|560442737|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
155275870|NCT02718417|560442738|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
155275871|NCT02718417|560442736|FG000|Observation Phase (OP)|Other|0|||
155726898|NCT03879772|562099810|FG000|Overall Study|Adverse Event|2|||
155275872|NCT02718417|560442737|FG001|Observation Phase (OP)|Other|0|||
155381942|NCT00598273|560833242|FG000|Overall Study|Physician Decision|0|||
155275873|NCT02718417|560442738|FG002|Observation Phase (OP)|Other|7|||
155275874|NCT02718417|560442736|FG000|Follow-up Phase|Adverse Event|3|||
155275875|NCT02718417|560442737|FG001|Follow-up Phase|Adverse Event|1|||
155275876|NCT02718417|560442738|FG002|Follow-up Phase|Adverse Event|1|||
155275877|NCT02718417|560442736|FG000|Follow-up Phase|Other|4|||
155275878|NCT02718417|560442737|FG001|Follow-up Phase|Other|6|||
155275879|NCT02718417|560442738|FG002|Follow-up Phase|Other|4|||
155275880|NCT02718417|560442736|FG000|Follow-up Phase|Withdrawal by Subject|19|||
155275881|NCT02718417|560442737|FG001|Follow-up Phase|Withdrawal by Subject|17|||
155275882|NCT02718417|560442738|FG002|Follow-up Phase|Withdrawal by Subject|5|||
155275883|NCT02718417|560442736|FG000|Follow-up Phase|Study terminated by sponsor|100|||
155275884|NCT02718417|560442737|FG001|Follow-up Phase|Study terminated by sponsor|138|||
155275885|NCT02718417|560442738|FG002|Follow-up Phase|Study terminated by sponsor|6|||
155275886|NCT02718417|560442736|FG000|Follow-up Phase|Lost to Follow-up|2|||
155275887|NCT02718417|560442737|FG001|Follow-up Phase|Lost to Follow-up|3|||
155275888|NCT02718417|560442738|FG002|Follow-up Phase|Lost to Follow-up|0|||
155275889|NCT02718417|560442736|FG000|Follow-up Phase|Death leading to discontinuation|7|||
155275890|NCT02718417|560442737|FG001|Follow-up Phase|Death leading to discontinuation|7|||
155275891|NCT02718417|560442738|FG002|Follow-up Phase|Death leading to discontinuation|3|||
155275892|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
155275893|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
155275894|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
155275895|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
155275896|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
155275897|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
155275898|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
155275899|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
155275900|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
155275901|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
155275902|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
155275903|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
155275904|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Other|0|||
155275905|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Other|2|||
155275906|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Other|0|||
155275907|NCT01023308|560442741|FG000|Overall Study|Abnormal test proceedure results|3|||
155275908|NCT01023308|560442742|FG001|Overall Study|Abnormal test proceedure results|8|||
155275909|NCT01023308|560442741|FG000|Overall Study|Administrative problems|2|||
155275910|NCT01023308|560442742|FG001|Overall Study|Administrative problems|1|||
155275911|NCT01023308|560442741|FG000|Overall Study|Adverse Event|130|||
155275912|NCT01023308|560442742|FG001|Overall Study|Adverse Event|66|||
155275913|NCT01023308|560442741|FG000|Overall Study|Death|21|||
155275914|NCT01023308|560442742|FG001|Overall Study|Death|17|||
155275915|NCT01023308|560442741|FG000|Overall Study|Disease progression|82|||
155275916|NCT01023308|560442742|FG001|Overall Study|Disease progression|153|||
155275917|NCT01023308|560442741|FG000|Overall Study|New Cancer therapy|4|||
155275918|NCT01023308|560442742|FG001|Overall Study|New Cancer therapy|7|||
155275919|NCT01023308|560442741|FG000|Overall Study|Protocol Violation|3|||
155275920|NCT01023308|560442742|FG001|Overall Study|Protocol Violation|4|||
155275921|NCT01023308|560442741|FG000|Overall Study|Untreated|5|||
155275922|NCT01023308|560442742|FG001|Overall Study|Untreated|5|||
155275923|NCT01023308|560442741|FG000|Overall Study|Lost to Follow-up|1|||
155275924|NCT01023308|560442742|FG001|Overall Study|Lost to Follow-up|0|||
155275925|NCT01023308|560442741|FG000|Overall Study|Withdrawal by Subject|34|||
155275926|NCT01023308|560442742|FG001|Overall Study|Withdrawal by Subject|18|||
155275927|NCT00551213|560442743|FG000|Overall Study|Adverse Event|6|||
155275928|NCT00551213|560442744|FG001|Overall Study|Adverse Event|3|||
155275929|NCT00551213|560442743|FG000|Overall Study|Progressive Disease|41|||
155275930|NCT00551213|560442744|FG001|Overall Study|Progressive Disease|12|||
155275931|NCT00551213|560442743|FG000|Overall Study|Withdrawal by Subject|2|||
155275932|NCT00551213|560442744|FG001|Overall Study|Withdrawal by Subject|0|||
155275933|NCT00551213|560442743|FG000|Overall Study|Not Treated|1|||
155275934|NCT00551213|560442744|FG001|Overall Study|Not Treated|2|||
155275935|NCT01890967|560442745|FG000|Overall Study|Adverse Event|3|||
155275936|NCT01890967|560442746|FG001|Overall Study|Adverse Event|3|||
155275937|NCT01890967|560442747|FG002|Overall Study|Adverse Event|3|||
155275938|NCT01890967|560442748|FG003|Overall Study|Adverse Event|2|||
155275939|NCT01890967|560442749|FG004|Overall Study|Adverse Event|1|||
155275940|NCT01890967|560442750|FG005|Overall Study|Adverse Event|7|||
155275941|NCT01890967|560442745|FG000|Overall Study|Death|1|||
155275942|NCT01890967|560442746|FG001|Overall Study|Death|0|||
155275943|NCT01890967|560442747|FG002|Overall Study|Death|0|||
155275944|NCT01890967|560442748|FG003|Overall Study|Death|0|||
155275945|NCT01890967|560442749|FG004|Overall Study|Death|0|||
155275946|NCT01890967|560442750|FG005|Overall Study|Death|0|||
155275947|NCT01890967|560442745|FG000|Overall Study|Lost to Follow-up|1|||
155275948|NCT01890967|560442746|FG001|Overall Study|Lost to Follow-up|1|||
155275949|NCT01890967|560442747|FG002|Overall Study|Lost to Follow-up|1|||
155275950|NCT01890967|560442748|FG003|Overall Study|Lost to Follow-up|1|||
155275951|NCT01890967|560442749|FG004|Overall Study|Lost to Follow-up|0|||
155275952|NCT01890967|560442750|FG005|Overall Study|Lost to Follow-up|1|||
155275953|NCT01890967|560442745|FG000|Overall Study|Protocol Violation|0|||
155275954|NCT01890967|560442746|FG001|Overall Study|Protocol Violation|3|||
155275955|NCT01890967|560442747|FG002|Overall Study|Protocol Violation|3|||
155275956|NCT01890967|560442748|FG003|Overall Study|Protocol Violation|2|||
155275957|NCT01890967|560442749|FG004|Overall Study|Protocol Violation|4|||
155275958|NCT01890967|560442750|FG005|Overall Study|Protocol Violation|1|||
155275959|NCT01890967|560442745|FG000|Overall Study|Sponsor Decision|2|||
155275960|NCT01890967|560442746|FG001|Overall Study|Sponsor Decision|0|||
155275961|NCT01890967|560442747|FG002|Overall Study|Sponsor Decision|1|||
155275962|NCT01890967|560442748|FG003|Overall Study|Sponsor Decision|3|||
155275963|NCT01890967|560442749|FG004|Overall Study|Sponsor Decision|2|||
155275964|NCT01890967|560442750|FG005|Overall Study|Sponsor Decision|3|||
155275965|NCT01890967|560442745|FG000|Overall Study|Withdrawal by Subject|3|||
155275966|NCT01890967|560442746|FG001|Overall Study|Withdrawal by Subject|4|||
155275967|NCT01890967|560442747|FG002|Overall Study|Withdrawal by Subject|2|||
155275968|NCT01890967|560442748|FG003|Overall Study|Withdrawal by Subject|3|||
155275969|NCT01890967|560442749|FG004|Overall Study|Withdrawal by Subject|3|||
155275970|NCT01890967|560442750|FG005|Overall Study|Withdrawal by Subject|1|||
155275971|NCT01383993|560442754|FG000|Overall Study|Adverse Event|1|||
155275972|NCT01383993|560442755|FG001|Overall Study|Adverse Event|1|||
155275973|NCT01383993|560442756|FG002|Overall Study|Adverse Event|0|||
155275974|NCT01383993|560442754|FG000|Overall Study|Withdrawal by Subject|0|||
155275975|NCT01383993|560442755|FG001|Overall Study|Withdrawal by Subject|0|||
155275976|NCT01383993|560442756|FG002|Overall Study|Withdrawal by Subject|1|||
155275977|NCT01383993|560442754|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
155275978|NCT01383993|560442755|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
155275979|NCT01383993|560442756|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
155275980|NCT01154036|560442769|FG000|Phase I|Physician Decision|0|||
155275981|NCT01154036|560442770|FG001|Phase I|Physician Decision|1|||
155275982|NCT01154036|560442771|FG002|Phase I|Physician Decision|0|||
155275983|NCT01154036|560442772|FG003|Phase I|Physician Decision|0|||
155275984|NCT01154036|560442773|FG004|Phase I|Physician Decision|0|||
155275985|NCT01154036|560442774|FG005|Phase I|Physician Decision|0|||
155275986|NCT01154036|560442775|FG006|Phase I|Physician Decision|0|||
155275987|NCT01154036|560442776|FG007|Phase I|Physician Decision|0|||
155275988|NCT01154036|560442769|FG000|Phase I|Lost to Follow-up|0|||
155275989|NCT01154036|560442770|FG001|Phase I|Lost to Follow-up|3|||
155275990|NCT01154036|560442771|FG002|Phase I|Lost to Follow-up|6|||
155275991|NCT01154036|560442772|FG003|Phase I|Lost to Follow-up|0|||
155275992|NCT01154036|560442773|FG004|Phase I|Lost to Follow-up|0|||
155275993|NCT01154036|560442774|FG005|Phase I|Lost to Follow-up|0|||
155275994|NCT01154036|560442775|FG006|Phase I|Lost to Follow-up|0|||
155275995|NCT01154036|560442776|FG007|Phase I|Lost to Follow-up|0|||
155275996|NCT01154036|560442769|FG000|Phase I|Protocol Violation|0|||
155275997|NCT01154036|560442770|FG001|Phase I|Protocol Violation|3|||
155275998|NCT01154036|560442771|FG002|Phase I|Protocol Violation|9|||
155275999|NCT01154036|560442772|FG003|Phase I|Protocol Violation|0|||
155276000|NCT01154036|560442773|FG004|Phase I|Protocol Violation|0|||
155276001|NCT01154036|560442774|FG005|Phase I|Protocol Violation|0|||
155276002|NCT01154036|560442775|FG006|Phase I|Protocol Violation|0|||
155276003|NCT01154036|560442776|FG007|Phase I|Protocol Violation|0|||
155276004|NCT01154036|560442769|FG000|Phase I|Withdrawal by Subject|2|||
155276005|NCT01154036|560442770|FG001|Phase I|Withdrawal by Subject|10|||
155276006|NCT01154036|560442771|FG002|Phase I|Withdrawal by Subject|29|||
155276007|NCT01154036|560442772|FG003|Phase I|Withdrawal by Subject|0|||
155276008|NCT01154036|560442773|FG004|Phase I|Withdrawal by Subject|0|||
155276009|NCT01154036|560442774|FG005|Phase I|Withdrawal by Subject|0|||
155276010|NCT01154036|560442775|FG006|Phase I|Withdrawal by Subject|0|||
155276011|NCT01154036|560442776|FG007|Phase I|Withdrawal by Subject|0|||
155276012|NCT01154036|560442769|FG000|Phase I|Adverse Event|1|||
155276013|NCT01154036|560442770|FG001|Phase I|Adverse Event|11|||
155276014|NCT01154036|560442771|FG002|Phase I|Adverse Event|12|||
155276015|NCT01154036|560442772|FG003|Phase I|Adverse Event|0|||
155276016|NCT01154036|560442773|FG004|Phase I|Adverse Event|0|||
155276017|NCT01154036|560442774|FG005|Phase I|Adverse Event|0|||
155276018|NCT01154036|560442775|FG006|Phase I|Adverse Event|0|||
155276019|NCT01154036|560442776|FG007|Phase I|Adverse Event|0|||
155276020|NCT01154036|560442769|FG000|Phase II|Adverse Event|0|||
155276021|NCT01154036|560442770|FG001|Phase II|Adverse Event|0|||
155276022|NCT01154036|560442771|FG002|Phase II|Adverse Event|0|||
155276023|NCT01154036|560442772|FG003|Phase II|Adverse Event|0|||
155276024|NCT01154036|560442773|FG004|Phase II|Adverse Event|1|||
155276025|NCT01154036|560442774|FG005|Phase II|Adverse Event|1|||
155276026|NCT01154036|560442775|FG006|Phase II|Adverse Event|1|||
155276027|NCT01154036|560442776|FG007|Phase II|Adverse Event|1|||
155276028|NCT01154036|560442769|FG000|Phase II|Physician Decision|0|||
155276029|NCT01154036|560442770|FG001|Phase II|Physician Decision|0|||
155276030|NCT01154036|560442771|FG002|Phase II|Physician Decision|0|||
155276031|NCT01154036|560442772|FG003|Phase II|Physician Decision|0|||
155276032|NCT01154036|560442773|FG004|Phase II|Physician Decision|0|||
155276033|NCT01154036|560442774|FG005|Phase II|Physician Decision|0|||
155276034|NCT01154036|560442775|FG006|Phase II|Physician Decision|1|||
155276035|NCT01154036|560442776|FG007|Phase II|Physician Decision|0|||
155276036|NCT01154036|560442769|FG000|Phase II|Lost to Follow-up|0|||
155276037|NCT01154036|560442770|FG001|Phase II|Lost to Follow-up|0|||
155276038|NCT01154036|560442771|FG002|Phase II|Lost to Follow-up|0|||
155276039|NCT01154036|560442772|FG003|Phase II|Lost to Follow-up|1|||
155276040|NCT01154036|560442773|FG004|Phase II|Lost to Follow-up|2|||
155276041|NCT01154036|560442774|FG005|Phase II|Lost to Follow-up|0|||
155276042|NCT01154036|560442775|FG006|Phase II|Lost to Follow-up|2|||
155276043|NCT01154036|560442776|FG007|Phase II|Lost to Follow-up|1|||
155276044|NCT01154036|560442769|FG000|Phase II|Protocol Violation|0|||
155276045|NCT01154036|560442770|FG001|Phase II|Protocol Violation|0|||
155276046|NCT01154036|560442771|FG002|Phase II|Protocol Violation|0|||
155276047|NCT01154036|560442772|FG003|Phase II|Protocol Violation|0|||
155276048|NCT01154036|560442773|FG004|Phase II|Protocol Violation|1|||
155276049|NCT01154036|560442774|FG005|Phase II|Protocol Violation|2|||
155276050|NCT01154036|560442775|FG006|Phase II|Protocol Violation|0|||
155276051|NCT01154036|560442776|FG007|Phase II|Protocol Violation|0|||
155276052|NCT01154036|560442769|FG000|Phase II|Withdrawal by Subject|0|||
155276053|NCT01154036|560442770|FG001|Phase II|Withdrawal by Subject|0|||
155276054|NCT01154036|560442771|FG002|Phase II|Withdrawal by Subject|0|||
155276055|NCT01154036|560442772|FG003|Phase II|Withdrawal by Subject|0|||
155276056|NCT01154036|560442773|FG004|Phase II|Withdrawal by Subject|4|||
155276057|NCT01154036|560442774|FG005|Phase II|Withdrawal by Subject|2|||
155276058|NCT01154036|560442775|FG006|Phase II|Withdrawal by Subject|5|||
155276059|NCT01154036|560442776|FG007|Phase II|Withdrawal by Subject|4|||
155276060|NCT02264574|560442777|FG000|Overall Study|Death|21|||
155276061|NCT02264574|560442778|FG001|Overall Study|Death|21|||
155276062|NCT02264574|560442777|FG000|Overall Study|Withdrawal by Subject|8|||
155276063|NCT02264574|560442778|FG001|Overall Study|Withdrawal by Subject|6|||
155276064|NCT02264574|560442777|FG000|Overall Study|Other, Not Specified|0|||
155276065|NCT02264574|560442778|FG001|Overall Study|Other, Not Specified|3|||
155276066|NCT00794820|560442783|FG000|Overall Study|Adverse Event|11|||
155276067|NCT00794820|560442783|FG000|Overall Study|Secondary Malignancies|2|||
155276068|NCT00794820|560442783|FG000|Overall Study|Resistant Disease|2|||
155276069|NCT00794820|560442783|FG000|Overall Study|Ineligible/Screen Failure|1|||
155276070|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
155276071|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276072|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276073|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276074|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276075|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
155276076|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276077|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276078|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
155276079|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
155276080|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155276081|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155276082|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
155276083|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
155276084|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155276085|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155276086|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
155276087|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
155276088|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
155276089|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
155276090|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
155276091|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
155276092|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
155276093|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
155276094|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
155276095|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276096|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276097|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276098|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
155276099|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
155276100|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
155276101|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
155276102|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155276103|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155276104|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
155276105|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
155276106|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276107|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276108|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
155276109|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276110|NCT00432679|560442792|FG000|Overall Study|Adverse Event|2|||
155276111|NCT00432679|560442793|FG001|Overall Study|Adverse Event|1|||
155276112|NCT00432679|560442792|FG000|Overall Study|Withdrawal by Subject|3|||
155276113|NCT00432679|560442793|FG001|Overall Study|Withdrawal by Subject|2|||
155276114|NCT04102540|560442794|FG000|Overall Study|Withdrawn by PI|2|||
155276115|NCT04102540|560442794|FG000|Overall Study|Lost to Follow-up|6|||
155276116|NCT00280293|560442795|FG000|Overall Study|Protocol Violation|3|||
155276117|NCT00280293|560442796|FG001|Overall Study|Protocol Violation|0|||
155276118|NCT00280293|560442795|FG000|Overall Study|Physician Decision|5|||
155276119|NCT00280293|560442796|FG001|Overall Study|Physician Decision|4|||
155276120|NCT00280293|560442795|FG000|Overall Study|Lost to Follow-up|14|||
155276121|NCT00280293|560442796|FG001|Overall Study|Lost to Follow-up|12|||
155276122|NCT00280293|560442795|FG000|Overall Study|Withdrawal by Subject|3|||
155276123|NCT00280293|560442796|FG001|Overall Study|Withdrawal by Subject|5|||
155276124|NCT00280293|560442795|FG000|Overall Study|Incarceration/Legal Reasons|1|||
155276125|NCT00280293|560442796|FG001|Overall Study|Incarceration/Legal Reasons|1|||
155276126|NCT00280293|560442795|FG000|Overall Study|Adverse Event|0|||
155276127|NCT00280293|560442796|FG001|Overall Study|Adverse Event|1|||
155276128|NCT00610675|560442801|FG000|Overall Study|Untreated|4|||
155276129|NCT00610675|560442801|FG000|Overall Study|Adverse Event|67|||
155276130|NCT00610675|560442801|FG000|Overall Study|Insufficient Effect|31|||
155276131|NCT00610675|560442801|FG000|Overall Study|Withdrawal by Subject|28|||
155276132|NCT00610675|560442801|FG000|Overall Study|Reasons unrelated to trial|27|||
155276133|NCT00610675|560442801|FG000|Overall Study|Lack of Compliance|7|||
155276134|NCT00610675|560442801|FG000|Overall Study|Lost to Follow-up|31|||
155276135|NCT00610675|560442801|FG000|Overall Study|Other reason (not specified)|25|||
155276136|NCT01458249|560442802|FG000|Overall Study|Not treated|1|||
155276137|NCT01458249|560442802|FG000|Overall Study|Adverse Event|4|||
155276138|NCT01458249|560442802|FG000|Overall Study|Other|2|||
155276139|NCT01458249|560442802|FG000|Overall Study|Ongoing|1|||
155276140|NCT02056119|560442805|FG000|Overall Study|Death|1|||
155276141|NCT02056119|560442806|FG001|Overall Study|Death|2|||
155276142|NCT02056119|560442805|FG000|Overall Study|Intubated for less than 24 hrs|2|||
155276143|NCT02056119|560442806|FG001|Overall Study|Intubated for less than 24 hrs|7|||
155276144|NCT02056119|560442805|FG000|Overall Study|No aerosol treatments were given.|3|||
155276145|NCT02056119|560442806|FG001|Overall Study|No aerosol treatments were given.|2|||
155276146|NCT02056119|560442805|FG000|Overall Study|Received Metaneb treatment|0|||
155276147|NCT02056119|560442806|FG001|Overall Study|Received Metaneb treatment|2|||
155276148|NCT02056119|560442805|FG000|Overall Study|Protocol Violation|4|||
155276149|NCT02056119|560442806|FG001|Overall Study|Protocol Violation|7|||
155276150|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276151|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
155276152|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276153|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
155276154|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276155|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
155276156|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
155276157|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
155276158|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276159|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
155276160|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276161|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
155276162|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276163|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
155276164|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276165|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276166|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276167|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276168|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
155276169|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276170|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276171|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276172|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276173|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
155276174|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276175|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155381943|NCT00598273|560833243|FG001|Overall Study|Physician Decision|0|||
155276176|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155381944|NCT00598273|560833244|FG002|Overall Study|Physician Decision|1|||
155276177|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276178|NCT03220737|560442807|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276179|NCT03220737|560442808|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276180|NCT03220737|560442809|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276181|NCT03220737|560442810|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276182|NCT03220737|560442811|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
155276183|NCT03220737|560442812|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276184|NCT03220737|560442813|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276185|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
155276186|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276187|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276188|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276189|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276190|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276191|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276192|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
155276193|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276194|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276195|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276196|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276197|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276198|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276199|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
155276200|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276201|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276202|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276203|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276204|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276205|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276206|NCT01686932|560442821|FG000|Period 1|Adverse Event|1|||
155276207|NCT01686932|560442822|FG001|Period 1|Adverse Event|1|||
155276208|NCT01313923|560442827|FG000|Overall Study|Physician Decision|3|||
155276209|NCT03358329|560442828|FG000|Overall Study|Lost to Follow-up|2|||
155276210|NCT03358329|560442828|FG000|Overall Study|Withdrawal by Subject|2|||
155276211|NCT02982720|560442829|FG000|Overall Study|Adverse Event|3|||
155276212|NCT02982720|560442829|FG000|Overall Study|Death|1|||
155276213|NCT03875911|560442830|FG000|Overall Study|Lost to Follow-up|3|||
155276214|NCT03875911|560442831|FG001|Overall Study|Lost to Follow-up|6|||
155276215|NCT03875911|560442832|FG002|Overall Study|Lost to Follow-up|2|||
155276216|NCT03875911|560442830|FG000|Overall Study|Surgery cancelled|1|||
155276217|NCT03875911|560442831|FG001|Overall Study|Surgery cancelled|0|||
155276218|NCT03875911|560442832|FG002|Overall Study|Surgery cancelled|1|||
155276219|NCT03875911|560442830|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
155276220|NCT03875911|560442831|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
155276221|NCT03875911|560442832|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
155276222|NCT01231503|560442833|FG000|Overall Study|Adverse Event|0|||
155276223|NCT01231503|560442834|FG001|Overall Study|Adverse Event|0|||
155276224|NCT01231503|560442835|FG002|Overall Study|Adverse Event|0|||
155276225|NCT01231503|560442836|FG003|Overall Study|Adverse Event|0|||
155276226|NCT01231503|560442837|FG004|Overall Study|Adverse Event|0|||
155276227|NCT01231503|560442838|FG005|Overall Study|Adverse Event|1|||
155276228|NCT01231503|560442839|FG006|Overall Study|Adverse Event|0|||
155276229|NCT01231503|560442840|FG007|Overall Study|Adverse Event|0|||
155276230|NCT01231503|560442833|FG000|Overall Study|Adverse event, serious fatal|0|||
155276231|NCT01231503|560442834|FG001|Overall Study|Adverse event, serious fatal|0|||
155276232|NCT01231503|560442835|FG002|Overall Study|Adverse event, serious fatal|1|||
155276233|NCT01231503|560442836|FG003|Overall Study|Adverse event, serious fatal|1|||
155276234|NCT01231503|560442837|FG004|Overall Study|Adverse event, serious fatal|0|||
155276235|NCT01231503|560442838|FG005|Overall Study|Adverse event, serious fatal|1|||
155276236|NCT01231503|560442839|FG006|Overall Study|Adverse event, serious fatal|0|||
155276237|NCT01231503|560442840|FG007|Overall Study|Adverse event, serious fatal|0|||
155276238|NCT01231503|560442833|FG000|Overall Study|Withdrawal by Subject|6|||
155276239|NCT01231503|560442834|FG001|Overall Study|Withdrawal by Subject|3|||
155276240|NCT01231503|560442835|FG002|Overall Study|Withdrawal by Subject|3|||
155276241|NCT01231503|560442836|FG003|Overall Study|Withdrawal by Subject|1|||
155276242|NCT01231503|560442837|FG004|Overall Study|Withdrawal by Subject|3|||
155381945|NCT00598273|560833242|FG000|Overall Study|Withdrawal by Subject|12|||
155276243|NCT01231503|560442838|FG005|Overall Study|Withdrawal by Subject|5|||
155276244|NCT01231503|560442839|FG006|Overall Study|Withdrawal by Subject|1|||
155276245|NCT01231503|560442840|FG007|Overall Study|Withdrawal by Subject|2|||
155276246|NCT01231503|560442833|FG000|Overall Study|Lost to Follow-up|8|||
155276247|NCT01231503|560442834|FG001|Overall Study|Lost to Follow-up|10|||
155276248|NCT01231503|560442835|FG002|Overall Study|Lost to Follow-up|8|||
155276249|NCT01231503|560442836|FG003|Overall Study|Lost to Follow-up|5|||
155276250|NCT01231503|560442837|FG004|Overall Study|Lost to Follow-up|7|||
155276251|NCT01231503|560442838|FG005|Overall Study|Lost to Follow-up|9|||
155276252|NCT01231503|560442839|FG006|Overall Study|Lost to Follow-up|6|||
155276253|NCT01231503|560442840|FG007|Overall Study|Lost to Follow-up|6|||
155276254|NCT01231503|560442833|FG000|Overall Study|Protocol Violation|0|||
155276255|NCT01231503|560442834|FG001|Overall Study|Protocol Violation|0|||
155276256|NCT01231503|560442835|FG002|Overall Study|Protocol Violation|0|||
155276257|NCT01231503|560442836|FG003|Overall Study|Protocol Violation|1|||
155276258|NCT01231503|560442837|FG004|Overall Study|Protocol Violation|0|||
155276259|NCT01231503|560442838|FG005|Overall Study|Protocol Violation|0|||
155276260|NCT01231503|560442839|FG006|Overall Study|Protocol Violation|0|||
155276261|NCT01231503|560442840|FG007|Overall Study|Protocol Violation|0|||
155276262|NCT00287469|560442841|FG000|Overall Study|serious adverse event|1|||
155276263|NCT00287469|560442842|FG001|Overall Study|serious adverse event|6|||
155276264|NCT00287469|560442841|FG000|Overall Study|Adverse Event|1|||
155276265|NCT00287469|560442842|FG001|Overall Study|Adverse Event|1|||
155276266|NCT00287469|560442841|FG000|Overall Study|moved from area|144|||
155276267|NCT00287469|560442842|FG001|Overall Study|moved from area|138|||
155276268|NCT00287469|560442841|FG000|Overall Study|Lost to Follow-up|74|||
155276269|NCT00287469|560442842|FG001|Overall Study|Lost to Follow-up|69|||
155276270|NCT02207374|560442846|FG000|Overall Study|Withdrawal by Subject|5|||
155276271|NCT02207374|560442847|FG001|Overall Study|Withdrawal by Subject|9|||
155276272|NCT02207374|560442848|FG002|Overall Study|Withdrawal by Subject|4|||
155276273|NCT02207374|560442846|FG000|Overall Study|Death|1|||
155276274|NCT02207374|560442847|FG001|Overall Study|Death|0|||
155276275|NCT02207374|560442848|FG002|Overall Study|Death|1|||
155276276|NCT02207374|560442846|FG000|Overall Study|Missing follow-up information|0|||
155276277|NCT02207374|560442847|FG001|Overall Study|Missing follow-up information|1|||
155276278|NCT02207374|560442848|FG002|Overall Study|Missing follow-up information|1|||
155276279|NCT02087150|560442849|FG000|Overall Study|Death|0|||
155276280|NCT02087150|560442850|FG001|Overall Study|Death|1|||
155276281|NCT02087150|560442851|FG002|Overall Study|Death|0|||
155276282|NCT02087150|560442849|FG000|Overall Study|Lost to Follow-up|6|||
155276283|NCT02087150|560442850|FG001|Overall Study|Lost to Follow-up|13|||
155276284|NCT02087150|560442851|FG002|Overall Study|Lost to Follow-up|7|||
155276285|NCT02087150|560442849|FG000|Overall Study|Withdrawal by Subject|2|||
155276286|NCT02087150|560442850|FG001|Overall Study|Withdrawal by Subject|5|||
155276287|NCT02087150|560442851|FG002|Overall Study|Withdrawal by Subject|3|||
155276288|NCT02087150|560442849|FG000|Overall Study|Physician Decision|0|||
155276289|NCT02087150|560442850|FG001|Overall Study|Physician Decision|1|||
155276290|NCT02087150|560442851|FG002|Overall Study|Physician Decision|0|||
155276291|NCT02087150|560442849|FG000|Overall Study|Procedure not done|1|||
155276292|NCT02087150|560442850|FG001|Overall Study|Procedure not done|13|||
155276293|NCT02087150|560442851|FG002|Overall Study|Procedure not done|0|||
155276294|NCT02087150|560442849|FG000|Overall Study|F/U not completed w/in study window|0|||
155276295|NCT02087150|560442850|FG001|Overall Study|F/U not completed w/in study window|0|||
155276296|NCT02087150|560442851|FG002|Overall Study|F/U not completed w/in study window|1|||
155276297|NCT02087150|560442849|FG000|Overall Study|Other|1|||
155276298|NCT02087150|560442850|FG001|Overall Study|Other|0|||
155276299|NCT02087150|560442851|FG002|Overall Study|Other|0|||
155276300|NCT02087150|560442849|FG000|Overall Study|Pt moved out of town|0|||
155276301|NCT02087150|560442850|FG001|Overall Study|Pt moved out of town|1|||
155276302|NCT02087150|560442851|FG002|Overall Study|Pt moved out of town|0|||
155276303|NCT00393094|560442855|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
155276304|NCT00393094|560442855|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
155276305|NCT02019602|560442856|FG000|Screening Period|Ineligibility|4|||
155276306|NCT02019602|560442857|FG001|Screening Period|Ineligibility|0|||
155276307|NCT02019602|560442856|FG000|Screening Period|Adverse Event|1|||
155381946|NCT00598273|560833243|FG001|Overall Study|Withdrawal by Subject|10|||
155276308|NCT02019602|560442857|FG001|Screening Period|Adverse Event|0|||
155276309|NCT03653416|560442860|FG000|Overall Study|Protocol Violation|6|||
155276310|NCT03653416|560442861|FG001|Overall Study|Protocol Violation|1|||
155276311|NCT02788006|560442862|FG000|Overall Study|Patient not treated|1|||
155276312|NCT01435798|560442865|FG000|Overall Study|Withdrawal by Subject|1|||
155276313|NCT01556763|560442868|FG000|Overall Study|Withdrawal by Subject|0|||
155276314|NCT01556763|560442869|FG001|Overall Study|Withdrawal by Subject|1|||
155276315|NCT01556763|560442870|FG002|Overall Study|Withdrawal by Subject|0|||
155276316|NCT02258464|560442871|FG000|Overall Study|Progressive disease (PD)|9|||
155276317|NCT02258464|560442872|FG001|Overall Study|Progressive disease (PD)|17|||
155276318|NCT02258464|560442871|FG000|Overall Study|Study drug never administered|1|||
155276319|NCT02258464|560442872|FG001|Overall Study|Study drug never administered|1|||
155276320|NCT02258464|560442871|FG000|Overall Study|AE not related to clinical PD|1|||
155276321|NCT02258464|560442872|FG001|Overall Study|AE not related to clinical PD|3|||
155276322|NCT02258464|560442871|FG000|Overall Study|Withdrawal by Subject|5|||
155276323|NCT02258464|560442872|FG001|Overall Study|Withdrawal by Subject|4|||
155276324|NCT02258464|560442871|FG000|Overall Study|AE related to clinical PD|1|||
155276325|NCT02258464|560442872|FG001|Overall Study|AE related to clinical PD|0|||
155276326|NCT00776100|560442873|FG000|Overall Study|Disease Progression|1|||
155276327|NCT00776100|560442874|FG001|Overall Study|Disease Progression|0|||
155276328|NCT03567993|560442875|FG000|Overall Study|Lost to Follow-up|4|||
155276329|NCT03567993|560442876|FG001|Overall Study|Lost to Follow-up|2|||
155276330|NCT03567993|560442875|FG000|Overall Study|Death|1|||
155276331|NCT03567993|560442876|FG001|Overall Study|Death|1|||
155276332|NCT03567993|560442875|FG000|Overall Study|Withdrawal by Subject|1|||
155276333|NCT03567993|560442876|FG001|Overall Study|Withdrawal by Subject|0|||
155276334|NCT00903786|560442877|FG000|Overall Study|Physician Decision|6|||
155276335|NCT00903786|560442877|FG000|Overall Study|Lack of Efficacy|5|||
155276336|NCT00903786|560442877|FG000|Overall Study|Reason other than lack of efficacy|4|||
155276337|NCT02285595|560442878|FG000|Overall Study|Lost to Follow-up|14|||
155276338|NCT02285595|560442878|FG000|Overall Study|Withdrawal by Subject|1|||
155276339|NCT01960790|560442879|FG000|Overall Study|Survey forms could not be recovered|3|||
155276340|NCT01960790|560442879|FG000|Overall Study|Treat with Humira outside survey period|3|||
155276341|NCT01960790|560442879|FG000|Overall Study|Transferred to another hospital|4|||
155276342|NCT01960790|560442879|FG000|Overall Study|Unevaluable for safety|1|||
155276343|NCT00064025|560442880|FG000|Overall Study|Ineligible|4|||
155276344|NCT00064025|560442880|FG000|Overall Study|Inevaluable|3|||
155276345|NCT01644474|560442881|FG000|Overall Study|Poor compliance to protocol|1|||
155276346|NCT01644474|560442882|FG001|Overall Study|Poor compliance to protocol|0|||
155276347|NCT01644474|560442881|FG000|Overall Study|Consent withdrawn by participant|0|||
155276348|NCT01644474|560442882|FG001|Overall Study|Consent withdrawn by participant|1|||
155276349|NCT01644474|560442881|FG000|Overall Study|Participant moved|0|||
155276350|NCT01644474|560442882|FG001|Overall Study|Participant moved|1|||
155276351|NCT01644474|560442881|FG000|Overall Study|Adverse Event|4|||
155276352|NCT01644474|560442882|FG001|Overall Study|Adverse Event|5|||
155276353|NCT01644474|560442881|FG000|Overall Study|Site scheduling error|1|||
155276354|NCT01644474|560442882|FG001|Overall Study|Site scheduling error|1|||
155276355|NCT01644474|560442881|FG000|Overall Study|Protocol Violation|1|||
155276356|NCT01644474|560442882|FG001|Overall Study|Protocol Violation|0|||
155276357|NCT02711995|560444637|FG000|Washout (90 Days)|Conflicting medication|1|||
155276358|NCT00322868|560444638|FG000|Overall Study|disease progression|1|||
155276359|NCT03615482|560444639|FG000|Overall Study|Death|1|||
155276360|NCT03615482|560444640|FG001|Overall Study|Death|0|||
155276361|NCT03615482|560444639|FG000|Overall Study|Lost to Follow-up|7|||
155276362|NCT03615482|560444640|FG001|Overall Study|Lost to Follow-up|7|||
155276363|NCT03615482|560444639|FG000|Overall Study|Physician Decision|2|||
155276364|NCT03615482|560444640|FG001|Overall Study|Physician Decision|3|||
155276365|NCT03615482|560444639|FG000|Overall Study|Withdrawal by Subject|7|||
155276366|NCT03615482|560444640|FG001|Overall Study|Withdrawal by Subject|7|||
155276367|NCT00590980|560444661|FG000|Overall Study|Did not meet all inclusion criteria|10|||
155276368|NCT00506285|560444662|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
155276369|NCT00506285|560444663|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
155276370|NCT00506285|560444662|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
155276371|NCT00506285|560444663|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
155276372|NCT00506285|560444662|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
155276373|NCT00506285|560444663|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
155276374|NCT00506285|560444662|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
155276375|NCT00506285|560444663|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
155276376|NCT00506285|560444662|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
155276377|NCT00506285|560444663|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
155276378|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
155276379|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
155276380|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
155276381|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
155276382|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
155276383|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
155276384|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
155276385|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
155276386|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155276387|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155619741|NCT01317641|561701345|FG005|Overall Study|Adverse Event|0|||
155619742|NCT01317641|561701346|FG006|Overall Study|Adverse Event|2|||
155619743|NCT01317641|561701347|FG007|Overall Study|Adverse Event|1|||
155276388|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
155276389|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
155276390|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
155276391|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
155276392|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
155619744|NCT01317641|561701348|FG008|Overall Study|Adverse Event|0|||
155619745|NCT01317641|561701340|FG000|Overall Study|Protocol Violation|1|||
155276393|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
155276394|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
155276395|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
155276396|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
155276397|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
155276398|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
155276399|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
155276400|NCT01489020|560444670|FG000|Overall Study|Withdrawal by Subject|1|||
155276401|NCT01489020|560444671|FG001|Overall Study|Withdrawal by Subject|0|||
155276402|NCT01489020|560444672|FG002|Overall Study|Withdrawal by Subject|0|||
155276403|NCT01489020|560444673|FG003|Overall Study|Withdrawal by Subject|0|||
155276404|NCT01489020|560444674|FG004|Overall Study|Withdrawal by Subject|0|||
155276405|NCT01489020|560444675|FG005|Overall Study|Withdrawal by Subject|0|||
155276406|NCT01489020|560444670|FG000|Overall Study|Adverse Event|0|||
155276407|NCT01489020|560444671|FG001|Overall Study|Adverse Event|0|||
155276408|NCT01489020|560444672|FG002|Overall Study|Adverse Event|3|||
155276409|NCT01489020|560444673|FG003|Overall Study|Adverse Event|0|||
155276410|NCT01489020|560444674|FG004|Overall Study|Adverse Event|3|||
155276411|NCT01489020|560444675|FG005|Overall Study|Adverse Event|0|||
155276412|NCT01489020|560444670|FG000|Overall Study|Concomitant disease|0|||
155276413|NCT01489020|560444671|FG001|Overall Study|Concomitant disease|0|||
155276414|NCT01489020|560444672|FG002|Overall Study|Concomitant disease|0|||
155276415|NCT01489020|560444673|FG003|Overall Study|Concomitant disease|0|||
155276416|NCT01489020|560444674|FG004|Overall Study|Concomitant disease|3|||
155276417|NCT01489020|560444675|FG005|Overall Study|Concomitant disease|0|||
155276418|NCT02892409|560444676|FG000|Overall Study|Adverse Event|1|||
155276419|NCT02892409|560444677|FG001|Overall Study|Adverse Event|0|||
155276420|NCT02892409|560444676|FG000|Overall Study|Withdrawal by Subject|2|||
155276421|NCT02892409|560444677|FG001|Overall Study|Withdrawal by Subject|1|||
155276422|NCT02451930|560444679|FG000|Overall Study|Death|0|||
155276423|NCT02451930|560444680|FG001|Overall Study|Death|15|||
155276424|NCT02451930|560444679|FG000|Overall Study|Lost to Follow-up|0|||
155276425|NCT02451930|560444680|FG001|Overall Study|Lost to Follow-up|3|||
155276426|NCT02451930|560444679|FG000|Overall Study|Sponsor Decision|2|||
155276427|NCT02451930|560444680|FG001|Overall Study|Sponsor Decision|10|||
155276428|NCT02451930|560444679|FG000|Overall Study|Withdrawal by Subject|0|||
155276429|NCT02451930|560444680|FG001|Overall Study|Withdrawal by Subject|1|||
155276430|NCT02451930|560444679|FG000|Overall Study|Other|0|||
155276431|NCT02451930|560444680|FG001|Overall Study|Other|1|||
155276432|NCT02485353|560444683|FG000|Overall Study|Death|1|||
155276433|NCT02485353|560444683|FG000|Overall Study|Disease Progression|1|||
155276434|NCT01950273|560444691|FG000|Overall Study|Protocol Violation|1|||
155276435|NCT01950273|560444692|FG001|Overall Study|Protocol Violation|0|||
155276436|NCT01950273|560444691|FG000|Overall Study|Withdrawal by Subject|2|||
155276437|NCT01950273|560444692|FG001|Overall Study|Withdrawal by Subject|0|||
155276438|NCT01950273|560444691|FG000|Overall Study|Other not defined above|1|||
155276439|NCT01950273|560444692|FG001|Overall Study|Other not defined above|0|||
155276440|NCT00472186|560444693|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
155276441|NCT00472186|560444694|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
155276442|NCT01254565|560444695|FG000|Overall Study|Non-compliance to Study Procedures|0|||
155276443|NCT01254565|560444696|FG001|Overall Study|Non-compliance to Study Procedures|0|||
155276444|NCT01254565|560444697|FG002|Overall Study|Non-compliance to Study Procedures|0|||
155276445|NCT01254565|560444698|FG003|Overall Study|Non-compliance to Study Procedures|0|||
155276446|NCT01254565|560444699|FG004|Overall Study|Non-compliance to Study Procedures|1|||
155276447|NCT01254565|560444700|FG005|Overall Study|Non-compliance to Study Procedures|0|||
155276448|NCT01254565|560444695|FG000|Overall Study|Did not Receive Treatment|1|||
155276449|NCT01254565|560444696|FG001|Overall Study|Did not Receive Treatment|1|||
155276450|NCT01254565|560444697|FG002|Overall Study|Did not Receive Treatment|0|||
155276451|NCT01254565|560444698|FG003|Overall Study|Did not Receive Treatment|0|||
155276452|NCT01254565|560444699|FG004|Overall Study|Did not Receive Treatment|3|||
155276453|NCT01254565|560444700|FG005|Overall Study|Did not Receive Treatment|4|||
155276454|NCT01254565|560444695|FG000|Overall Study|Other|0|||
155276455|NCT01254565|560444696|FG001|Overall Study|Other|0|||
155276456|NCT01254565|560444697|FG002|Overall Study|Other|0|||
155276457|NCT01254565|560444698|FG003|Overall Study|Other|1|||
155276458|NCT01254565|560444699|FG004|Overall Study|Other|0|||
155276459|NCT01254565|560444700|FG005|Overall Study|Other|0|||
155276460|NCT03354637|560444705|FG000|Double-blind Period|Protocol Violation|2|||
155276461|NCT03354637|560444706|FG001|Double-blind Period|Protocol Violation|0|||
155276462|NCT03354637|560444707|FG002|Double-blind Period|Protocol Violation|0|||
155276463|NCT03354637|560444705|FG000|Double-blind Period|Adverse Event|1|||
155276464|NCT03354637|560444706|FG001|Double-blind Period|Adverse Event|2|||
155276465|NCT03354637|560444707|FG002|Double-blind Period|Adverse Event|0|||
155276466|NCT03354637|560444705|FG000|Double-blind Period|Lost to Follow-up|3|||
155276467|NCT03354637|560444706|FG001|Double-blind Period|Lost to Follow-up|4|||
155276468|NCT03354637|560444707|FG002|Double-blind Period|Lost to Follow-up|3|||
155276469|NCT03354637|560444705|FG000|Double-blind Period|Withdrawal by Subject|10|||
155276470|NCT03354637|560444706|FG001|Double-blind Period|Withdrawal by Subject|6|||
155276471|NCT03354637|560444707|FG002|Double-blind Period|Withdrawal by Subject|4|||
155276472|NCT03354637|560444705|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
155276473|NCT03354637|560444706|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
155276474|NCT03354637|560444707|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
155276475|NCT03354637|560444705|FG000|Open Label Extension|Adverse Event|0|||
155276476|NCT03354637|560444706|FG001|Open Label Extension|Adverse Event|0|||
155276477|NCT03354637|560444707|FG002|Open Label Extension|Adverse Event|1|||
155276478|NCT03354637|560444705|FG000|Open Label Extension|Lost to Follow-up|0|||
155276479|NCT03354637|560444706|FG001|Open Label Extension|Lost to Follow-up|0|||
155276480|NCT03354637|560444707|FG002|Open Label Extension|Lost to Follow-up|2|||
155276481|NCT03354637|560444705|FG000|Open Label Extension|Withdrawal by Subject|0|||
155276482|NCT03354637|560444706|FG001|Open Label Extension|Withdrawal by Subject|0|||
155276483|NCT03354637|560444707|FG002|Open Label Extension|Withdrawal by Subject|5|||
155276484|NCT03354637|560444705|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
155276485|NCT03354637|560444706|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
155276486|NCT03354637|560444707|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
155276487|NCT03354637|560444705|FG000|Open Label Extension|Subject Noncompliance|0|||
155276488|NCT03354637|560444706|FG001|Open Label Extension|Subject Noncompliance|0|||
155276489|NCT03354637|560444707|FG002|Open Label Extension|Subject Noncompliance|1|||
155276490|NCT03354637|560444705|FG000|Open Label Extension|Lack of Efficacy|0|||
155276491|NCT03354637|560444706|FG001|Open Label Extension|Lack of Efficacy|0|||
155276492|NCT03354637|560444707|FG002|Open Label Extension|Lack of Efficacy|1|||
155276493|NCT03354637|560444705|FG000|Open Label Extension|Physician Decision|0|||
155276494|NCT03354637|560444706|FG001|Open Label Extension|Physician Decision|0|||
155276495|NCT03354637|560444707|FG002|Open Label Extension|Physician Decision|1|||
155276496|NCT02726399|560444708|FG000|Overall Study|Participant Non-Compliance|1|||
155276497|NCT02726399|560444708|FG000|Overall Study|Adverse Event|2|||
155276498|NCT02726399|560444708|FG000|Overall Study|Progression of disease|4|||
155276499|NCT04006366|560444709|FG000|Overall Study|Withdrawal by Subject|1|||
155276500|NCT00997243|560444713|FG000|Overall Study|Early termination of study by sponsor|7|||
155276501|NCT02086552|560444716|FG000|Overall Study|Withdrawal by Subject|1|||
155276502|NCT02206152|560444717|FG000|Pre-Randomization|Withdrawal by Subject|2|||
155276503|NCT00478608|560444718|FG000|Overall Study|Adverse Event|1|||
155276504|NCT00478608|560444718|FG000|Overall Study|Serious Adverse Event|14|||
155276505|NCT00478608|560444718|FG000|Overall Study|Withdrawal by Subject|2|||
155276506|NCT00478608|560444718|FG000|Overall Study|Protocol Violation|3|||
155276507|NCT02080520|560444719|FG000|Overall Study|Self-reported symptoms|5|||
155276508|NCT02080520|560444720|FG001|Overall Study|Self-reported symptoms|6|||
155276509|NCT02080520|560444719|FG000|Overall Study|Unable to contact|2|||
155276510|NCT02080520|560444720|FG001|Overall Study|Unable to contact|1|||
155276511|NCT02080520|560444719|FG000|Overall Study|Initiated aspirin|2|||
155276512|NCT02080520|560444720|FG001|Overall Study|Initiated aspirin|0|||
155276513|NCT02080520|560444719|FG000|Overall Study|Atrial fibrillation|1|||
155276514|NCT02080520|560444720|FG001|Overall Study|Atrial fibrillation|1|||
155276515|NCT02080520|560444719|FG000|Overall Study|Cancer|1|||
155276516|NCT02080520|560444720|FG001|Overall Study|Cancer|2|||
155276517|NCT02080520|560444719|FG000|Overall Study|Not interested in study|1|||
155619746|NCT01317641|561701341|FG001|Overall Study|Protocol Violation|0|||
155619747|NCT01317641|561701342|FG002|Overall Study|Protocol Violation|0|||
155619748|NCT01317641|561701343|FG003|Overall Study|Protocol Violation|0|||
155619749|NCT01317641|561701344|FG004|Overall Study|Protocol Violation|0|||
155619750|NCT01317641|561701345|FG005|Overall Study|Protocol Violation|0|||
155619751|NCT01317641|561701346|FG006|Overall Study|Protocol Violation|0|||
155619752|NCT01317641|561701347|FG007|Overall Study|Protocol Violation|0|||
155619753|NCT01317641|561701348|FG008|Overall Study|Protocol Violation|0|||
155619754|NCT01317641|561701340|FG000|Overall Study|Disease progression|0|||
155619755|NCT01317641|561701341|FG001|Overall Study|Disease progression|0|||
155619756|NCT01317641|561701342|FG002|Overall Study|Disease progression|0|||
155619757|NCT01317641|561701343|FG003|Overall Study|Disease progression|0|||
155619758|NCT01317641|561701344|FG004|Overall Study|Disease progression|0|||
155619759|NCT01317641|561701345|FG005|Overall Study|Disease progression|0|||
155619760|NCT01317641|561701346|FG006|Overall Study|Disease progression|0|||
155619761|NCT01317641|561701347|FG007|Overall Study|Disease progression|3|||
155619762|NCT01317641|561701348|FG008|Overall Study|Disease progression|4|||
155619763|NCT01317641|561701340|FG000|Overall Study|Withdrawal by Subject|0|||
155726899|NCT03879772|562099811|FG001|Overall Study|Adverse Event|2|||
155276518|NCT02080520|560444720|FG001|Overall Study|Not interested in study|3|||
155276519|NCT02080520|560444719|FG000|Overall Study|Too busy|1|||
155276520|NCT02080520|560444720|FG001|Overall Study|Too busy|1|||
155276521|NCT02080520|560444719|FG000|Overall Study|Work-related injury|1|||
155276522|NCT02080520|560444720|FG001|Overall Study|Work-related injury|0|||
155276523|NCT02080520|560444719|FG000|Overall Study|Personal reasons|0|||
155276524|NCT02080520|560444720|FG001|Overall Study|Personal reasons|3|||
155619764|NCT01317641|561701341|FG001|Overall Study|Withdrawal by Subject|0|||
155619765|NCT01317641|561701342|FG002|Overall Study|Withdrawal by Subject|0|||
155276525|NCT00390455|560444721|FG000|Overall Study|Adverse Event|17|||
155276526|NCT00390455|560444722|FG001|Overall Study|Adverse Event|3|||
155276527|NCT00390455|560444721|FG000|Overall Study|Withdrawal by Subject|8|||
155276528|NCT00390455|560444722|FG001|Overall Study|Withdrawal by Subject|8|||
155276529|NCT00390455|560444721|FG000|Overall Study|Alternate Treatment|0|||
155276530|NCT00390455|560444722|FG001|Overall Study|Alternate Treatment|1|||
155276531|NCT00390455|560444721|FG000|Overall Study|Other Medical Reasons|7|||
155276532|NCT00390455|560444722|FG001|Overall Study|Other Medical Reasons|11|||
155276533|NCT02406261|560444725|FG000|Period 1|Lost to Follow-up|2|||
155276534|NCT02406261|560444726|FG001|Period 1|Lost to Follow-up|0|||
155276535|NCT02406261|560444725|FG000|Period 1|Adverse Event|1|||
155276536|NCT02406261|560444726|FG001|Period 1|Adverse Event|0|||
155276537|NCT02406261|560444725|FG000|Period 2|Physician Decision|0|||
155276538|NCT02406261|560444726|FG001|Period 2|Physician Decision|1|||
155276539|NCT02406261|560444725|FG000|Period 2|Protocol Violation|0|||
155276540|NCT02406261|560444726|FG001|Period 2|Protocol Violation|1|||
155276541|NCT02406261|560444725|FG000|Period 2|Withdrawal by Subject|0|||
155276542|NCT02406261|560444726|FG001|Period 2|Withdrawal by Subject|1|||
155276543|NCT01591460|560444732|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
155276544|NCT01591460|560444732|FG000|Overall Study|Futility Rule (Week 12)|7|||
155276545|NCT01591460|560444732|FG000|Overall Study|Futility Rule (Week 24)|3|||
155276546|NCT01591460|560444732|FG000|Overall Study|Rebound or Breakthrough|3|||
155276547|NCT01591460|560444732|FG000|Overall Study|Treatment Discontinued by Error|1|||
155276548|NCT01591460|560444732|FG000|Overall Study|Lost to Follow-up|1|||
155276549|NCT01591460|560444732|FG000|Overall Study|Noncompliance|1|||
155276550|NCT01591460|560444732|FG000|Overall Study|Participant Refusal|3|||
155276551|NCT01591460|560444732|FG000|Overall Study|Withdrawal by Subject|1|||
155276552|NCT01591460|560444732|FG000|Overall Study|Protocol Violation|1|||
155276553|NCT01567163|560444736|FG000|Overall Study|Progressive Disease|2|||
155276554|NCT01567163|560444736|FG000|Overall Study|Lost to Follow-up|2|||
155276555|NCT03405662|560444738|FG000|Overall Study|COVID-19 restriction|1|||
155276556|NCT03405662|560444739|FG001|Overall Study|COVID-19 restriction|0|||
155276557|NCT03405662|560444738|FG000|Overall Study|unblinding|0|||
155276558|NCT03405662|560444739|FG001|Overall Study|unblinding|1|||
155276559|NCT03405662|560444738|FG000|Overall Study|placement in memory care facility|0|||
155276560|NCT03405662|560444739|FG001|Overall Study|placement in memory care facility|2|||
155276561|NCT01348854|560444740|FG000|Overall Study|Lost to Follow-up|2|||
155276562|NCT01348854|560444741|FG001|Overall Study|Lost to Follow-up|1|||
155276563|NCT01348854|560444740|FG000|Overall Study|Withdrawal by Subject|1|||
155276564|NCT01348854|560444741|FG001|Overall Study|Withdrawal by Subject|0|||
155276565|NCT01720797|560444742|FG000|Overall Study|Withdrawal by Subject|3|||
155276566|NCT01720797|560444743|FG001|Overall Study|Withdrawal by Subject|0|||
155276567|NCT00983619|560444744|FG000|Overall Study|Lost to Follow-up|0|||
155276568|NCT00983619|560444745|FG001|Overall Study|Lost to Follow-up|1|||
155276569|NCT00983619|560444746|FG002|Overall Study|Lost to Follow-up|0|||
155276570|NCT00983619|560444747|FG003|Overall Study|Lost to Follow-up|0|||
155276571|NCT00983619|560444748|FG004|Overall Study|Lost to Follow-up|0|||
155276572|NCT00983619|560444749|FG005|Overall Study|Lost to Follow-up|2|||
155276573|NCT00983619|560444750|FG006|Overall Study|Lost to Follow-up|0|||
155276574|NCT00983619|560444751|FG007|Overall Study|Lost to Follow-up|0|||
155276575|NCT00983619|560444752|FG008|Overall Study|Lost to Follow-up|0|||
155276576|NCT00983619|560444753|FG009|Overall Study|Lost to Follow-up|0|||
155276577|NCT00983619|560444754|FG010|Overall Study|Lost to Follow-up|0|||
155276578|NCT00983619|560444755|FG011|Overall Study|Lost to Follow-up|2|||
155276579|NCT00983619|560444744|FG000|Overall Study|Withdrawal by Subject|2|||
155276580|NCT00983619|560444745|FG001|Overall Study|Withdrawal by Subject|1|||
155276581|NCT00983619|560444746|FG002|Overall Study|Withdrawal by Subject|1|||
155276582|NCT00983619|560444747|FG003|Overall Study|Withdrawal by Subject|3|||
155276583|NCT00983619|560444748|FG004|Overall Study|Withdrawal by Subject|1|||
155276584|NCT00983619|560444749|FG005|Overall Study|Withdrawal by Subject|23|||
155276585|NCT00983619|560444750|FG006|Overall Study|Withdrawal by Subject|0|||
155276586|NCT00983619|560444751|FG007|Overall Study|Withdrawal by Subject|0|||
155276587|NCT00983619|560444752|FG008|Overall Study|Withdrawal by Subject|0|||
155276588|NCT00983619|560444753|FG009|Overall Study|Withdrawal by Subject|0|||
155276589|NCT00983619|560444754|FG010|Overall Study|Withdrawal by Subject|1|||
155276590|NCT00983619|560444755|FG011|Overall Study|Withdrawal by Subject|1|||
155276591|NCT00983619|560444744|FG000|Overall Study|Death|0|||
155276592|NCT00983619|560444745|FG001|Overall Study|Death|2|||
155276593|NCT00983619|560444746|FG002|Overall Study|Death|2|||
155276594|NCT00983619|560444747|FG003|Overall Study|Death|1|||
155276595|NCT00983619|560444748|FG004|Overall Study|Death|2|||
155276596|NCT00983619|560444749|FG005|Overall Study|Death|30|||
155276597|NCT00983619|560444750|FG006|Overall Study|Death|1|||
155276598|NCT00983619|560444751|FG007|Overall Study|Death|0|||
155276599|NCT00983619|560444752|FG008|Overall Study|Death|1|||
155276600|NCT00983619|560444753|FG009|Overall Study|Death|2|||
155276601|NCT00983619|560444754|FG010|Overall Study|Death|9|||
155276602|NCT00983619|560444755|FG011|Overall Study|Death|8|||
155276603|NCT00983619|560444744|FG000|Overall Study|Other|1|||
155276604|NCT00983619|560444745|FG001|Overall Study|Other|0|||
155276605|NCT00983619|560444746|FG002|Overall Study|Other|0|||
155276606|NCT00983619|560444747|FG003|Overall Study|Other|1|||
155276607|NCT00983619|560444748|FG004|Overall Study|Other|0|||
155276608|NCT00983619|560444749|FG005|Overall Study|Other|12|||
155276609|NCT00983619|560444750|FG006|Overall Study|Other|2|||
155276610|NCT00983619|560444751|FG007|Overall Study|Other|2|||
155276611|NCT00983619|560444752|FG008|Overall Study|Other|0|||
155276612|NCT00983619|560444753|FG009|Overall Study|Other|1|||
155276613|NCT00983619|560444754|FG010|Overall Study|Other|1|||
155276614|NCT00983619|560444755|FG011|Overall Study|Other|0|||
155276615|NCT00724061|560444756|FG000|Dose Escalation Phase|Adverse Event|2|||
155276616|NCT00724061|560444756|FG000|Dose Escalation Phase|Disease Progression|3|||
155276617|NCT04827134|560444759|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276618|NCT04827134|560444760|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276619|NCT04827134|560444761|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
155276620|NCT04827134|560444762|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276621|NCT00688259|560444767|FG000|Overall Study|Lost to Follow-up|2|||
155276622|NCT00688259|560444768|FG001|Overall Study|Lost to Follow-up|4|||
155276623|NCT00688259|560444767|FG000|Overall Study|Physician Decision|1|||
155276624|NCT00688259|560444768|FG001|Overall Study|Physician Decision|0|||
155276625|NCT00688259|560444767|FG000|Overall Study|Withdrawal by Subject|2|||
155276626|NCT00688259|560444768|FG001|Overall Study|Withdrawal by Subject|0|||
155276627|NCT00688259|560444767|FG000|Overall Study|Declined Interview|2|||
155276628|NCT00688259|560444768|FG001|Overall Study|Declined Interview|3|||
155276629|NCT00688259|560444767|FG000|Overall Study|Hospitalized at Follow-up|0|||
155276630|NCT00688259|560444768|FG001|Overall Study|Hospitalized at Follow-up|1|||
155276631|NCT02443103|560444769|FG000|Overall Study|Adverse Event|2|||
155276632|NCT02443103|560444769|FG000|Overall Study|Noncompliance|1|||
155276633|NCT03207711|560444776|FG000|Overall Study|Withdrawal by Subject|1|||
155276634|NCT03207711|560444777|FG001|Overall Study|Withdrawal by Subject|2|||
155276635|NCT01083160|560444781|FG000|Overall Study|Adverse Event|1|||
155276636|NCT01267253|560444783|FG000|Overall Study|Ineligible - required test not done|1|||
155276637|NCT01267253|560444783|FG000|Overall Study|Inevaluable-never received study treatme|2|||
155276638|NCT00547911|560444786|FG000|Overall Study|Adverse Event|0|||
155276639|NCT00547911|560444787|FG001|Overall Study|Adverse Event|0|||
155276640|NCT00547911|560444788|FG002|Overall Study|Adverse Event|0|||
155276641|NCT00547911|560444789|FG003|Overall Study|Adverse Event|1|||
155276642|NCT00547911|560444790|FG004|Overall Study|Adverse Event|0|||
155276643|NCT00547911|560444791|FG005|Overall Study|Adverse Event|0|||
155276644|NCT04129580|560446061|FG000|Overall Study|Lost to Follow-up|14|||
155276645|NCT04129580|560446062|FG001|Overall Study|Lost to Follow-up|25|||
155276646|NCT03699124|560446063|FG000|Overall Study|Adverse Event|6|||
155276647|NCT03699124|560446064|FG001|Overall Study|Adverse Event|5|||
155276648|NCT03699124|560446065|FG002|Overall Study|Adverse Event|2|||
155276649|NCT03699124|560446063|FG000|Overall Study|Death|0|||
155276650|NCT03699124|560446064|FG001|Overall Study|Death|2|||
155276651|NCT03699124|560446065|FG002|Overall Study|Death|0|||
155276652|NCT03699124|560446063|FG000|Overall Study|Lost to Follow-up|20|||
155276653|NCT03699124|560446064|FG001|Overall Study|Lost to Follow-up|16|||
155276654|NCT03699124|560446065|FG002|Overall Study|Lost to Follow-up|15|||
155276655|NCT03699124|560446063|FG000|Overall Study|Protocol Violation|1|||
155276656|NCT03699124|560446064|FG001|Overall Study|Protocol Violation|0|||
155276657|NCT03699124|560446065|FG002|Overall Study|Protocol Violation|0|||
155276658|NCT03699124|560446063|FG000|Overall Study|Withdrawal by Subject|13|||
155276659|NCT03699124|560446064|FG001|Overall Study|Withdrawal by Subject|14|||
155276660|NCT03699124|560446065|FG002|Overall Study|Withdrawal by Subject|13|||
155276661|NCT03699124|560446063|FG000|Overall Study|Other reasons|5|||
155276662|NCT03699124|560446064|FG001|Overall Study|Other reasons|3|||
155276663|NCT03699124|560446065|FG002|Overall Study|Other reasons|10|||
155276664|NCT03595683|560446066|FG000|Overall Study|Adverse Event|1|||
155276665|NCT03595683|560446067|FG001|Overall Study|Adverse Event|0|||
155276666|NCT03595683|560446066|FG000|Overall Study|Pursue alternative therapy|1|||
155276667|NCT03595683|560446067|FG001|Overall Study|Pursue alternative therapy|1|||
155276668|NCT03595683|560446066|FG000|Overall Study|Progressive disease|1|||
155276669|NCT03595683|560446067|FG001|Overall Study|Progressive disease|3|||
155276670|NCT02561455|560446068|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276671|NCT02561455|560446069|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276672|NCT02561455|560446070|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
155276673|NCT02561455|560446071|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276674|NCT02561455|560446068|FG000|Overall Study|Withdrawal by Subject|1|||
155276675|NCT02561455|560446069|FG001|Overall Study|Withdrawal by Subject|0|||
155276676|NCT02561455|560446070|FG002|Overall Study|Withdrawal by Subject|1|||
155276677|NCT02561455|560446071|FG003|Overall Study|Withdrawal by Subject|0|||
155276678|NCT02561455|560446068|FG000|Overall Study|Disease Progression|0|||
155276679|NCT02561455|560446069|FG001|Overall Study|Disease Progression|1|||
155276680|NCT02561455|560446070|FG002|Overall Study|Disease Progression|0|||
155276681|NCT02561455|560446071|FG003|Overall Study|Disease Progression|0|||
155276682|NCT01951092|560446077|FG000|Overall Study|Lost to Follow-up|10|||
155276683|NCT01951092|560446077|FG000|Overall Study|Incarceration|1|||
155276684|NCT01951092|560446077|FG000|Overall Study|Transfer of Care|1|||
155276685|NCT00136916|560446078|FG000|Overall Study|Never received study treatment|3|||
155276686|NCT00136916|560446079|FG001|Overall Study|Never received study treatment|5|||
155276687|NCT00136916|560446078|FG000|Overall Study|Death|1|||
155276688|NCT00136916|560446079|FG001|Overall Study|Death|3|||
155276689|NCT00136916|560446078|FG000|Overall Study|Adverse Event|27|||
155276690|NCT00136916|560446079|FG001|Overall Study|Adverse Event|8|||
155276691|NCT00136916|560446078|FG000|Overall Study|Laboratory abnormality|0|||
155276692|NCT00136916|560446079|FG001|Overall Study|Laboratory abnormality|1|||
155276693|NCT00136916|560446078|FG000|Overall Study|Lack of Efficacy|13|||
155276694|NCT00136916|560446079|FG001|Overall Study|Lack of Efficacy|3|||
155276695|NCT00136916|560446078|FG000|Overall Study|Lost to Follow-up|12|||
155276696|NCT00136916|560446079|FG001|Overall Study|Lost to Follow-up|14|||
155276697|NCT00136916|560446078|FG000|Overall Study|Withdrawal by Subject|44|||
155276698|NCT00136916|560446079|FG001|Overall Study|Withdrawal by Subject|46|||
155276699|NCT00136916|560446078|FG000|Overall Study|Other|22|||
155276700|NCT00136916|560446079|FG001|Overall Study|Other|24|||
155276701|NCT00136916|560446078|FG000|Overall Study|Discontinued in follow up period|3|||
155276702|NCT00136916|560446079|FG001|Overall Study|Discontinued in follow up period|0|||
155276703|NCT01991197|560446080|FG000|Overall Study|Lost to Follow-up|1|||
155276704|NCT01991197|560446081|FG001|Overall Study|Lost to Follow-up|1|||
155276705|NCT01991197|560446080|FG000|Overall Study|Physician Decision|0|||
155276706|NCT01991197|560446081|FG001|Overall Study|Physician Decision|2|||
155276707|NCT01991197|560446080|FG000|Overall Study|Withdrawal by Subject|2|||
155276708|NCT01991197|560446081|FG001|Overall Study|Withdrawal by Subject|0|||
155276709|NCT01010217|560446082|FG000|Overall Study|Lost to Follow-up|4|||
155276710|NCT01010217|560446083|FG001|Overall Study|Lost to Follow-up|5|||
155276711|NCT01010217|560446084|FG002|Overall Study|Lost to Follow-up|1|||
155276712|NCT01010217|560446085|FG003|Overall Study|Lost to Follow-up|0|||
155276713|NCT01010217|560446086|FG004|Overall Study|Lost to Follow-up|0|||
155276714|NCT01010217|560446082|FG000|Overall Study|Withdrawal by Subject|1|||
155276715|NCT01010217|560446083|FG001|Overall Study|Withdrawal by Subject|0|||
155276716|NCT01010217|560446084|FG002|Overall Study|Withdrawal by Subject|0|||
155276717|NCT01010217|560446085|FG003|Overall Study|Withdrawal by Subject|0|||
155276718|NCT01010217|560446086|FG004|Overall Study|Withdrawal by Subject|0|||
155276719|NCT01010217|560446082|FG000|Overall Study|Physician Decision|0|||
155276720|NCT01010217|560446083|FG001|Overall Study|Physician Decision|0|||
155276721|NCT01010217|560446084|FG002|Overall Study|Physician Decision|0|||
155276722|NCT01010217|560446085|FG003|Overall Study|Physician Decision|6|||
155276723|NCT01010217|560446086|FG004|Overall Study|Physician Decision|3|||
155276724|NCT00577720|560446094|FG000|Overall Study|Adverse Event|2|||
155276725|NCT00577720|560446095|FG001|Overall Study|Adverse Event|1|||
155276726|NCT00577720|560446096|FG002|Overall Study|Adverse Event|0|||
155276727|NCT00577720|560446097|FG003|Overall Study|Adverse Event|4|||
155276728|NCT00577720|560446094|FG000|Overall Study|Lost to Follow-up|0|||
155276729|NCT00577720|560446095|FG001|Overall Study|Lost to Follow-up|0|||
155276730|NCT00577720|560446096|FG002|Overall Study|Lost to Follow-up|1|||
155276731|NCT00577720|560446097|FG003|Overall Study|Lost to Follow-up|0|||
155276732|NCT00577720|560446094|FG000|Overall Study|Protocol Violation|0|||
155276733|NCT00577720|560446095|FG001|Overall Study|Protocol Violation|0|||
155276734|NCT00577720|560446096|FG002|Overall Study|Protocol Violation|0|||
155276735|NCT00577720|560446097|FG003|Overall Study|Protocol Violation|1|||
155276736|NCT00577720|560446094|FG000|Overall Study|Withdrawal by Subject|2|||
155276737|NCT00577720|560446095|FG001|Overall Study|Withdrawal by Subject|0|||
155276738|NCT00577720|560446096|FG002|Overall Study|Withdrawal by Subject|0|||
155276739|NCT00577720|560446097|FG003|Overall Study|Withdrawal by Subject|2|||
155276740|NCT03246672|560446098|FG000|Overall Study|Lost to Follow-up|2|||
155276741|NCT03260504|560446099|FG000|Overall Study|Adverse Event|0|||
155276742|NCT03260504|560446100|FG001|Overall Study|Adverse Event|1|||
155276743|NCT01932996|560446101|FG000|Overall Study|Protocol Violation|2|||
155276744|NCT01932996|560446102|FG001|Overall Study|Protocol Violation|0|||
155276745|NCT00846742|560446105|FG000|Overall Study|Withdrawal by Subject|1|||
155276746|NCT05868954|560446111|FG000|Overall Study|Lost to Follow-up|0|||
155276747|NCT05868954|560446112|FG001|Overall Study|Lost to Follow-up|1|||
155276748|NCT05868954|560446111|FG000|Overall Study|Withdrawal by Subject|2|||
155276749|NCT05868954|560446112|FG001|Overall Study|Withdrawal by Subject|2|||
155276750|NCT05868954|560446111|FG000|Overall Study|Participant delivered|1|||
155276751|NCT05868954|560446112|FG001|Overall Study|Participant delivered|1|||
155276752|NCT05868954|560446111|FG000|Overall Study|Miscarriage|0|||
155276753|NCT05868954|560446112|FG001|Overall Study|Miscarriage|1|||
155276754|NCT03257995|560446118|FG000|Overall Study|Adverse Event|0|||
155276755|NCT03257995|560446119|FG001|Overall Study|Adverse Event|1|||
155276756|NCT03257995|560446120|FG002|Overall Study|Adverse Event|0|||
155276757|NCT03257995|560446121|FG003|Overall Study|Adverse Event|0|||
155276758|NCT03257995|560446122|FG004|Overall Study|Adverse Event|0|||
155276759|NCT03257995|560446123|FG005|Overall Study|Adverse Event|0|||
155276760|NCT03257995|560446118|FG000|Overall Study|Protocol deviation|0|||
155276761|NCT03257995|560446119|FG001|Overall Study|Protocol deviation|0|||
155276762|NCT03257995|560446120|FG002|Overall Study|Protocol deviation|0|||
155276763|NCT03257995|560446121|FG003|Overall Study|Protocol deviation|0|||
155276764|NCT03257995|560446122|FG004|Overall Study|Protocol deviation|0|||
155276765|NCT03257995|560446123|FG005|Overall Study|Protocol deviation|2|||
155276766|NCT02275533|560446124|FG000|Overall Study|Protocol Violation|2|||
155276767|NCT02275533|560446125|FG001|Overall Study|Protocol Violation|0|||
155276768|NCT02275533|560446124|FG000|Overall Study|Never received study treatment|1|||
155276769|NCT02275533|560446125|FG001|Overall Study|Never received study treatment|0|||
155276770|NCT01570868|560446126|FG000|Overall Study|Adverse Event|8|||
155276771|NCT01570868|560446127|FG001|Overall Study|Adverse Event|1|||
155276772|NCT01570868|560446126|FG000|Overall Study|FDA Recommendation|23|||
155276773|NCT01570868|560446127|FG001|Overall Study|FDA Recommendation|3|||
155276774|NCT01570868|560446126|FG000|Overall Study|Physician Decision|10|||
155276775|NCT01570868|560446127|FG001|Overall Study|Physician Decision|4|||
155276776|NCT01570868|560446126|FG000|Overall Study|Lost to Follow-up|1|||
155276777|NCT01570868|560446127|FG001|Overall Study|Lost to Follow-up|0|||
155276778|NCT01570868|560446126|FG000|Overall Study|Withdrawal by Subject|1|||
155276779|NCT01570868|560446127|FG001|Overall Study|Withdrawal by Subject|0|||
155276780|NCT04936308|560446128|FG000|Overall Study|Death|0|||
155276781|NCT04936308|560446129|FG001|Overall Study|Death|0|||
155276782|NCT04936308|560446130|FG002|Overall Study|Death|1|||
155276783|NCT04936308|560446128|FG000|Overall Study|Withdrawal by Subject|6|||
155276784|NCT04936308|560446129|FG001|Overall Study|Withdrawal by Subject|3|||
155276785|NCT04936308|560446130|FG002|Overall Study|Withdrawal by Subject|0|||
155276786|NCT04936308|560446128|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
155276787|NCT04936308|560446129|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
155276788|NCT04936308|560446130|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
155276789|NCT04936308|560446128|FG000|Overall Study|Completed protocol-required follow-up|1|||
155276790|NCT04936308|560446129|FG001|Overall Study|Completed protocol-required follow-up|2|||
155276791|NCT04936308|560446130|FG002|Overall Study|Completed protocol-required follow-up|2|||
155276792|NCT04936308|560446128|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
155276793|NCT04936308|560446129|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
155276794|NCT04936308|560446130|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
155276795|NCT04936308|560446128|FG000|Overall Study|Other|3|||
155276796|NCT04936308|560446129|FG001|Overall Study|Other|0|||
155276797|NCT04936308|560446130|FG002|Overall Study|Other|2|||
155276798|NCT00932646|560446133|FG000|Overall Study|Adverse Event|2|||
155276799|NCT00932646|560446134|FG001|Overall Study|Adverse Event|1|||
155276800|NCT00932646|560446135|FG002|Overall Study|Adverse Event|1|||
155276801|NCT00932646|560446136|FG003|Overall Study|Adverse Event|1|||
155276802|NCT00932646|560446133|FG000|Overall Study|Lost to Follow-up|2|||
155276803|NCT00932646|560446134|FG001|Overall Study|Lost to Follow-up|1|||
155276804|NCT00932646|560446135|FG002|Overall Study|Lost to Follow-up|0|||
155276805|NCT00932646|560446136|FG003|Overall Study|Lost to Follow-up|0|||
155276806|NCT00932646|560446133|FG000|Overall Study|Withdrawal by Subject|1|||
155276807|NCT00932646|560446134|FG001|Overall Study|Withdrawal by Subject|1|||
155276808|NCT00932646|560446135|FG002|Overall Study|Withdrawal by Subject|3|||
155276809|NCT00932646|560446136|FG003|Overall Study|Withdrawal by Subject|0|||
155276810|NCT00653263|560446137|FG000|Overall Study|Withdrawal by Subject|1|||
155276811|NCT00653263|560446137|FG000|Overall Study|Physician Decision|1|||
155276812|NCT02611830|560446138|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
155276813|NCT02611830|560446139|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276814|NCT02611830|560446140|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276815|NCT02611830|560446141|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276816|NCT02611830|560446138|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
155276817|NCT02611830|560446139|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
155276818|NCT02611830|560446140|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
155276819|NCT02611830|560446141|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
155276820|NCT02611830|560446138|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
155276821|NCT02611830|560446139|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
155276822|NCT02611830|560446140|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
155276823|NCT02611830|560446141|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
155276824|NCT02611830|560446138|FG000|OL Induction Phase|Lack of Efficacy|9|||
155276825|NCT02611830|560446139|FG001|OL Induction Phase|Lack of Efficacy|0|||
155276826|NCT02611830|560446140|FG002|OL Induction Phase|Lack of Efficacy|0|||
155276827|NCT02611830|560446141|FG003|OL Induction Phase|Lack of Efficacy|0|||
155276828|NCT02611830|560446138|FG000|OL Induction Phase|Reason not specified|3|||
155276829|NCT02611830|560446139|FG001|OL Induction Phase|Reason not specified|0|||
155276830|NCT02611830|560446140|FG002|OL Induction Phase|Reason not specified|0|||
155276831|NCT02611830|560446141|FG003|OL Induction Phase|Reason not specified|0|||
155276832|NCT02611830|560446138|FG000|Maintenance Phase|Lack of Efficacy|0|||
155276833|NCT02611830|560446139|FG001|Maintenance Phase|Lack of Efficacy|29|||
155276834|NCT02611830|560446140|FG002|Maintenance Phase|Lack of Efficacy|18|||
155276835|NCT02611830|560446141|FG003|Maintenance Phase|Lack of Efficacy|6|||
155276836|NCT02611830|560446138|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155276837|NCT02611830|560446139|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
155276838|NCT02611830|560446140|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
155276839|NCT02611830|560446141|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
155276840|NCT02611830|560446138|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
155276841|NCT02611830|560446139|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
155276842|NCT02611830|560446140|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
155276843|NCT02611830|560446141|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
155276844|NCT02611830|560446138|FG000|Maintenance Phase|Lost to Follow-up|0|||
155276845|NCT02611830|560446139|FG001|Maintenance Phase|Lost to Follow-up|0|||
155276846|NCT02611830|560446140|FG002|Maintenance Phase|Lost to Follow-up|0|||
155276847|NCT02611830|560446141|FG003|Maintenance Phase|Lost to Follow-up|1|||
155276848|NCT02611830|560446138|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
155276849|NCT02611830|560446139|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
155276850|NCT02611830|560446140|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
155276851|NCT02611830|560446141|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
155276852|NCT02611830|560446138|FG000|Maintenance Phase|Pregnancy|0|||
155276853|NCT02611830|560446139|FG001|Maintenance Phase|Pregnancy|0|||
155276854|NCT02611830|560446140|FG002|Maintenance Phase|Pregnancy|1|||
155276855|NCT02611830|560446141|FG003|Maintenance Phase|Pregnancy|0|||
155276856|NCT02611830|560446138|FG000|Maintenance Phase|Reason not specified|0|||
155276857|NCT02611830|560446139|FG001|Maintenance Phase|Reason not specified|1|||
155276858|NCT02611830|560446140|FG002|Maintenance Phase|Reason not specified|4|||
155276859|NCT02611830|560446141|FG003|Maintenance Phase|Reason not specified|0|||
155276860|NCT04759885|560446146|FG000|Overall Study|Other|1|||
155276861|NCT04759885|560446147|FG001|Overall Study|Other|0|||
155276862|NCT04759885|560446148|FG002|Overall Study|Other|2|||
155276863|NCT04759885|560446149|FG003|Overall Study|Other|0|||
155276864|NCT04759885|560446150|FG004|Overall Study|Other|0|||
155276865|NCT04759885|560446146|FG000|Overall Study|Withdrawal by Subject|0|||
155276866|NCT04759885|560446147|FG001|Overall Study|Withdrawal by Subject|0|||
155276867|NCT04759885|560446148|FG002|Overall Study|Withdrawal by Subject|1|||
155276868|NCT04759885|560446149|FG003|Overall Study|Withdrawal by Subject|9|||
155276869|NCT04759885|560446150|FG004|Overall Study|Withdrawal by Subject|6|||
155276870|NCT04759885|560446146|FG000|Overall Study|Adverse Event|0|||
155276871|NCT04759885|560446147|FG001|Overall Study|Adverse Event|0|||
155276872|NCT04759885|560446148|FG002|Overall Study|Adverse Event|0|||
155276873|NCT04759885|560446149|FG003|Overall Study|Adverse Event|3|||
155276874|NCT04759885|560446150|FG004|Overall Study|Adverse Event|0|||
155276875|NCT04759885|560446146|FG000|Overall Study|Physician Decision|0|||
155276876|NCT04759885|560446147|FG001|Overall Study|Physician Decision|0|||
155276877|NCT04759885|560446148|FG002|Overall Study|Physician Decision|0|||
155276878|NCT04759885|560446149|FG003|Overall Study|Physician Decision|2|||
155276879|NCT04759885|560446150|FG004|Overall Study|Physician Decision|0|||
155276880|NCT00195715|560446151|FG000|Overall Study|Adverse Event|122|||
155276881|NCT00195715|560446151|FG000|Overall Study|Withdrawal by Subject|58|||
155276882|NCT00195715|560446151|FG000|Overall Study|Lost to Follow-up|27|||
155276883|NCT00195715|560446151|FG000|Overall Study|Protocol Violation|13|||
155276884|NCT00195715|560446151|FG000|Overall Study|Lack of Efficacy|93|||
155276885|NCT00195715|560446151|FG000|Overall Study|Pregnancy|14|||
155276886|NCT00195715|560446151|FG000|Overall Study|Investigative site closure|8|||
155276887|NCT00195715|560446151|FG000|Overall Study|Subject moved/relocated|7|||
155276888|NCT00195715|560446151|FG000|Overall Study|Subject non-compliance|6|||
155276889|NCT00195715|560446151|FG000|Overall Study|Subject started commercial Humira|5|||
155276890|NCT00195715|560446151|FG000|Overall Study|Subject choice|3|||
155276891|NCT00195715|560446151|FG000|Overall Study|Loss of response/no improvement|3|||
155619766|NCT01317641|561701343|FG003|Overall Study|Withdrawal by Subject|0|||
155619767|NCT01317641|561701344|FG004|Overall Study|Withdrawal by Subject|0|||
155619768|NCT01317641|561701345|FG005|Overall Study|Withdrawal by Subject|0|||
155619769|NCT01317641|561701346|FG006|Overall Study|Withdrawal by Subject|1|||
155619770|NCT01317641|561701347|FG007|Overall Study|Withdrawal by Subject|0|||
155619771|NCT01317641|561701348|FG008|Overall Study|Withdrawal by Subject|0|||
155619772|NCT04980014|561701349|FG000|Overall Study|Participants who are Duplicated|1|||
155619773|NCT04980014|561701349|FG000|Overall Study|Follow-up Failure|13|||
155619774|NCT04980014|561701349|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
155276892|NCT00195715|560446151|FG000|Overall Study|Sponsor stopped study|1|||
155276893|NCT00195715|560446151|FG000|Overall Study|Administrative reasons|2|||
155276894|NCT00195715|560446151|FG000|Overall Study|Investigator's decision|2|||
155276895|NCT00195715|560446151|FG000|Overall Study|Subject wants to get pregnant|4|||
155276896|NCT00195715|560446151|FG000|Overall Study|Use of prohibited medication|2|||
155276897|NCT00195715|560446151|FG000|Overall Study|Planned surgery|2|||
155276898|NCT00195715|560446151|FG000|Overall Study|Increased infection rate|1|||
155276899|NCT00195715|560446151|FG000|Overall Study|Ineligible|1|||
155276900|NCT00195715|560446151|FG000|Overall Study|Colonic stricture|1|||
155276901|NCT00195715|560446151|FG000|Overall Study|Sponsor discontinued trial|1|||
155276902|NCT00195715|560446151|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
155619775|NCT04980014|561701349|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
155619776|NCT04980014|561701349|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
155619777|NCT00715559|561701350|FG000|Overall Study|medication not tolerated - nausea|1|||
155619778|NCT01302418|561701351|FG000|Overall Study|Protocol Violation|9|||
155619779|NCT01302418|561701351|FG000|Overall Study|Non-evaluable|9|||
155619780|NCT02787304|561701356|FG000|Overall Study|Adverse Event|9|||
155619781|NCT02787304|561701357|FG001|Overall Study|Adverse Event|3|||
155619782|NCT02787304|561701358|FG002|Overall Study|Adverse Event|8|||
155619783|NCT02787304|561701359|FG003|Overall Study|Adverse Event|1|||
155619784|NCT02787304|561701356|FG000|Overall Study|Withdrawal by Subject|1|||
155619785|NCT02787304|561701357|FG001|Overall Study|Withdrawal by Subject|4|||
155619786|NCT02787304|561701358|FG002|Overall Study|Withdrawal by Subject|0|||
155619787|NCT02787304|561701359|FG003|Overall Study|Withdrawal by Subject|0|||
155619788|NCT02787304|561701356|FG000|Overall Study|Lost to Follow-up|1|||
155619789|NCT02787304|561701357|FG001|Overall Study|Lost to Follow-up|0|||
155619790|NCT02787304|561701358|FG002|Overall Study|Lost to Follow-up|0|||
155619791|NCT02787304|561701359|FG003|Overall Study|Lost to Follow-up|1|||
155619792|NCT02787304|561701356|FG000|Overall Study|Noncompliance with study drug|0|||
155619793|NCT02787304|561701357|FG001|Overall Study|Noncompliance with study drug|0|||
155619794|NCT02787304|561701358|FG002|Overall Study|Noncompliance with study drug|1|||
155619795|NCT02787304|561701359|FG003|Overall Study|Noncompliance with study drug|0|||
155619796|NCT02787304|561701356|FG000|Overall Study|Physician Decision|0|||
155619797|NCT02787304|561701357|FG001|Overall Study|Physician Decision|0|||
155619798|NCT02787304|561701358|FG002|Overall Study|Physician Decision|1|||
155619799|NCT02787304|561701359|FG003|Overall Study|Physician Decision|0|||
155619800|NCT02787304|561701356|FG000|Overall Study|Study terminated by sponsor|25|||
155619801|NCT02787304|561701357|FG001|Overall Study|Study terminated by sponsor|31|||
155619802|NCT02787304|561701358|FG002|Overall Study|Study terminated by sponsor|31|||
155619803|NCT02787304|561701359|FG003|Overall Study|Study terminated by sponsor|32|||
155619804|NCT04771013|561701363|FG000|Overall Study|Withdrawal by Subject|2|||
155619805|NCT04771013|561701364|FG001|Overall Study|Withdrawal by Subject|0|||
155619806|NCT04771013|561701363|FG000|Overall Study|Death|0|||
155619807|NCT04771013|561701364|FG001|Overall Study|Death|5|||
155619808|NCT04771013|561701363|FG000|Overall Study|Referred to another hospital before day 20|0|||
155619809|NCT04771013|561701364|FG001|Overall Study|Referred to another hospital before day 20|1|||
155619810|NCT01051921|561701366|FG000|Overall Study|Physician Decision|9|||
155276903|NCT05822921|560446156|FG000|Overall Study|Lost to Follow-up|1|||
155276904|NCT05822921|560446157|FG001|Overall Study|Lost to Follow-up|1|||
155276905|NCT00544544|560446158|FG000|Overall Study|Withdrawal by Subject|1|||
155276906|NCT00544544|560446158|FG000|Overall Study|Adverse Event|1|||
155276907|NCT00544544|560446158|FG000|Overall Study|Lost to Follow-up|1|||
155619811|NCT01051921|561701366|FG000|Overall Study|Adverse Event|8|||
155619812|NCT01051921|561701366|FG000|Overall Study|Withdrawal by Subject|7|||
155619813|NCT01051921|561701366|FG000|Overall Study|Lost to Follow-up|4|||
155619814|NCT01051921|561701366|FG000|Overall Study|virological failure|1|||
155619815|NCT01051921|561701366|FG000|Overall Study|patient moved|1|||
155619816|NCT00419757|561701367|FG000|Overall Study|Adverse Event|1|||
155619817|NCT00419757|561701368|FG001|Overall Study|Adverse Event|4|||
155619818|NCT00419757|561701367|FG000|Overall Study|Lost to Follow-up|1|||
155619819|NCT00419757|561701368|FG001|Overall Study|Lost to Follow-up|4|||
155619820|NCT00419757|561701367|FG000|Overall Study|Withdrawal by Subject|7|||
155619821|NCT00419757|561701368|FG001|Overall Study|Withdrawal by Subject|1|||
155619822|NCT00419757|561701367|FG000|Overall Study|Protocol Violation|2|||
155619823|NCT00419757|561701368|FG001|Overall Study|Protocol Violation|3|||
155619824|NCT00419757|561701367|FG000|Overall Study|Study specific discontinuation criteria|4|||
155619825|NCT00419757|561701368|FG001|Overall Study|Study specific discontinuation criteria|8|||
155619826|NCT00419757|561701367|FG000|Overall Study|Multiple reasons|3|||
155619827|NCT00419757|561701368|FG001|Overall Study|Multiple reasons|1|||
155619828|NCT00379834|561701373|FG000|Overall Study|Time constraints|2|||
155619829|NCT01519817|561701374|FG000|Overall Study|Withdrawal by Subject|1|||
155619830|NCT01519817|561701375|FG001|Overall Study|Withdrawal by Subject|0|||
155619831|NCT01519817|561701376|FG002|Overall Study|Withdrawal by Subject|0|||
155619832|NCT01519817|561701377|FG003|Overall Study|Withdrawal by Subject|0|||
155619833|NCT01519817|561701374|FG000|Overall Study|Off study due to infection|0|||
155619834|NCT01519817|561701375|FG001|Overall Study|Off study due to infection|0|||
155619835|NCT01519817|561701376|FG002|Overall Study|Off study due to infection|0|||
155619836|NCT01519817|561701377|FG003|Overall Study|Off study due to infection|1|||
155619837|NCT01325350|561701380|FG000|Overall Study|Adverse Event|3|||
155619838|NCT01325350|561701381|FG001|Overall Study|Adverse Event|3|||
155726900|NCT03879772|562099812|FG002|Overall Study|Adverse Event|3|||
155726901|NCT03879772|562099813|FG003|Overall Study|Adverse Event|4|||
155726902|NCT03879772|562099814|FG004|Overall Study|Adverse Event|3|||
155276908|NCT02036515|560446164|FG000|Overall Study|Adverse Event|1|||
155276909|NCT02036515|560446165|FG001|Overall Study|Adverse Event|1|||
155619839|NCT01325350|561701382|FG002|Overall Study|Adverse Event|3|||
155619840|NCT01325350|561701383|FG003|Overall Study|Adverse Event|1|||
155619841|NCT01325350|561701384|FG004|Overall Study|Adverse Event|2|||
155619842|NCT01325350|561701380|FG000|Overall Study|Pregnancy|0|||
155619843|NCT01325350|561701381|FG001|Overall Study|Pregnancy|0|||
155619844|NCT01325350|561701382|FG002|Overall Study|Pregnancy|1|||
155619845|NCT01325350|561701383|FG003|Overall Study|Pregnancy|0|||
155619846|NCT01325350|561701384|FG004|Overall Study|Pregnancy|1|||
155619847|NCT01325350|561701380|FG000|Overall Study|Lost to Follow-up|1|||
155619848|NCT01325350|561701381|FG001|Overall Study|Lost to Follow-up|0|||
155276910|NCT02036515|560446166|FG002|Overall Study|Adverse Event|2|||
155276911|NCT02036515|560446164|FG000|Overall Study|Lost to Follow-up|0|||
155276912|NCT02036515|560446165|FG001|Overall Study|Lost to Follow-up|2|||
155276913|NCT02036515|560446166|FG002|Overall Study|Lost to Follow-up|0|||
155276914|NCT02036515|560446164|FG000|Overall Study|Non-compliance with study drug|0|||
155276915|NCT02036515|560446165|FG001|Overall Study|Non-compliance with study drug|0|||
155276916|NCT02036515|560446166|FG002|Overall Study|Non-compliance with study drug|2|||
155276917|NCT02036515|560446164|FG000|Overall Study|Screen failure|0|||
155276918|NCT02036515|560446165|FG001|Overall Study|Screen failure|2|||
155276919|NCT02036515|560446166|FG002|Overall Study|Screen failure|0|||
155276920|NCT02036515|560446164|FG000|Overall Study|Withdrawal by Subject|4|||
155276921|NCT02036515|560446165|FG001|Overall Study|Withdrawal by Subject|7|||
155276922|NCT02036515|560446166|FG002|Overall Study|Withdrawal by Subject|9|||
155276923|NCT02036515|560446164|FG000|Overall Study|Hyperglycemia|0|||
155276924|NCT02036515|560446165|FG001|Overall Study|Hyperglycemia|0|||
155276925|NCT02036515|560446166|FG002|Overall Study|Hyperglycemia|1|||
155276926|NCT01671748|560446173|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
155276927|NCT01671748|560446174|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
155276928|NCT01671748|560446173|FG000|4 Week run-in Phase|Adverse Event|1|||
155276929|NCT01671748|560446174|FG001|4 Week run-in Phase|Adverse Event|0|||
155276930|NCT01671748|560446173|FG000|4 Week run-in Phase|Not eligible|9|||
155276931|NCT01671748|560446174|FG001|4 Week run-in Phase|Not eligible|0|||
155276932|NCT04145349|560447533|FG000|Overall Study|Withdrawal by Subject|3|||
155276933|NCT04145349|560447534|FG001|Overall Study|Withdrawal by Subject|0|||
155276934|NCT04145349|560447533|FG000|Overall Study|Lost to Follow-up|0|||
155276935|NCT04145349|560447534|FG001|Overall Study|Lost to Follow-up|1|||
155276936|NCT04145349|560447533|FG000|Overall Study|On study treatment (Ongoing)|0|||
155276937|NCT04145349|560447534|FG001|Overall Study|On study treatment (Ongoing)|1|||
155276938|NCT00513019|560447535|FG000|Overall Study|Adverse Event|1|||
155276939|NCT00513019|560447536|FG001|Overall Study|Adverse Event|0|||
155619849|NCT01325350|561701382|FG002|Overall Study|Lost to Follow-up|5|||
155619850|NCT01325350|561701383|FG003|Overall Study|Lost to Follow-up|1|||
155276940|NCT00513019|560447535|FG000|Overall Study|Withdrawal by Subject|4|||
155276941|NCT00513019|560447536|FG001|Overall Study|Withdrawal by Subject|5|||
155276942|NCT05675709|560447540|FG000|Overall Study|incomplete outcome data|2|||
155276943|NCT05675709|560447541|FG001|Overall Study|incomplete outcome data|8|||
155276944|NCT05876351|560447544|FG000|Overall Study|Other than specified|2|||
155276945|NCT05876351|560447544|FG000|Overall Study|Study specific discontinuation criteria|1|||
155276946|NCT04168385|560447546|FG000|Overall Study|Withdrawal by Subject|1|||
155276947|NCT04168385|560447547|FG001|Overall Study|Withdrawal by Subject|0|||
155276948|NCT04168385|560447546|FG000|Overall Study|Adverse Event|2|||
155276949|NCT04168385|560447547|FG001|Overall Study|Adverse Event|1|||
155276950|NCT04168385|560447546|FG000|Overall Study|Liver transplant|3|||
155276951|NCT04168385|560447547|FG001|Overall Study|Liver transplant|1|||
155276952|NCT04168385|560447546|FG000|Overall Study|Listed for liver transplant|1|||
155276953|NCT04168385|560447547|FG001|Overall Study|Listed for liver transplant|0|||
155276954|NCT02748512|560447548|FG000|Overall Study|Lost to Follow-up|1|||
155276955|NCT02748512|560447549|FG001|Overall Study|Lost to Follow-up|1|||
155276956|NCT03415022|560447556|FG000|Overall Study|Withdrawal by Subject|1|||
155619851|NCT01325350|561701384|FG004|Overall Study|Lost to Follow-up|5|||
155619852|NCT01325350|561701380|FG000|Overall Study|Personal Reasons|2|||
155619853|NCT01325350|561701381|FG001|Overall Study|Personal Reasons|1|||
155619854|NCT01325350|561701382|FG002|Overall Study|Personal Reasons|6|||
155619855|NCT01325350|561701383|FG003|Overall Study|Personal Reasons|5|||
155276957|NCT03415022|560447557|FG001|Overall Study|Withdrawal by Subject|2|||
155276958|NCT03415022|560447556|FG000|Overall Study|COVID-19 Suspension|2|||
155276959|NCT03415022|560447557|FG001|Overall Study|COVID-19 Suspension|3|||
155276960|NCT03415022|560447556|FG000|Overall Study|Lost to Follow-up|2|||
155276961|NCT03415022|560447557|FG001|Overall Study|Lost to Follow-up|0|||
155619856|NCT01325350|561701384|FG004|Overall Study|Personal Reasons|3|||
155726903|NCT03879772|562099810|FG000|Overall Study|Treatment Failure|1|||
155726904|NCT03879772|562099811|FG001|Overall Study|Treatment Failure|0|||
155726905|NCT03879772|562099812|FG002|Overall Study|Treatment Failure|0|||
155276962|NCT03583541|560447563|FG000|Overall Study|Lost to Follow-up|31|||
155276963|NCT03583541|560447564|FG001|Overall Study|Lost to Follow-up|65|||
155276964|NCT00884286|560447565|FG000|Overall Study|Progressive disease|21|||
155276965|NCT00884286|560447566|FG001|Overall Study|Progressive disease|28|||
155276966|NCT00884286|560447565|FG000|Overall Study|Toxicity|4|||
155276967|NCT00884286|560447566|FG001|Overall Study|Toxicity|1|||
155276968|NCT00884286|560447565|FG000|Overall Study|Death|2|||
155276969|NCT00884286|560447566|FG001|Overall Study|Death|2|||
155619857|NCT01325350|561701380|FG000|Overall Study|Protocol Violation|0|||
155619858|NCT01325350|561701381|FG001|Overall Study|Protocol Violation|0|||
155619859|NCT01325350|561701382|FG002|Overall Study|Protocol Violation|0|||
155619860|NCT01325350|561701383|FG003|Overall Study|Protocol Violation|1|||
155619861|NCT01325350|561701384|FG004|Overall Study|Protocol Violation|0|||
155619862|NCT01325350|561701380|FG000|Overall Study|Withdrawal by Subject|0|||
155619863|NCT01325350|561701381|FG001|Overall Study|Withdrawal by Subject|0|||
155619864|NCT01325350|561701382|FG002|Overall Study|Withdrawal by Subject|1|||
155619865|NCT01325350|561701383|FG003|Overall Study|Withdrawal by Subject|1|||
155619866|NCT01325350|561701384|FG004|Overall Study|Withdrawal by Subject|0|||
155619867|NCT01325350|561701380|FG000|Overall Study|Did Not Receive Treatment|0|||
155619868|NCT01325350|561701381|FG001|Overall Study|Did Not Receive Treatment|1|||
155619869|NCT01325350|561701382|FG002|Overall Study|Did Not Receive Treatment|1|||
155619870|NCT01325350|561701383|FG003|Overall Study|Did Not Receive Treatment|0|||
155619871|NCT01325350|561701384|FG004|Overall Study|Did Not Receive Treatment|1|||
155619872|NCT01716806|561701389|FG000|Overall Study|Patient withdrawal of consent|4|||
155619873|NCT01716806|561701390|FG001|Overall Study|Patient withdrawal of consent|2|||
155619874|NCT01716806|561701391|FG002|Overall Study|Patient withdrawal of consent|4|||
155619875|NCT01716806|561701392|FG003|Overall Study|Patient withdrawal of consent|3|||
155619876|NCT01716806|561701393|FG004|Overall Study|Patient withdrawal of consent|2|||
155619877|NCT01716806|561701394|FG005|Overall Study|Patient withdrawal of consent|0|||
155619878|NCT01716806|561701389|FG000|Overall Study|Lost to Follow-up|3|||
155619879|NCT01716806|561701390|FG001|Overall Study|Lost to Follow-up|3|||
155619880|NCT01716806|561701391|FG002|Overall Study|Lost to Follow-up|0|||
155619881|NCT01716806|561701392|FG003|Overall Study|Lost to Follow-up|2|||
155619882|NCT01716806|561701393|FG004|Overall Study|Lost to Follow-up|1|||
155619883|NCT01716806|561701394|FG005|Overall Study|Lost to Follow-up|0|||
155619884|NCT01716806|561701389|FG000|Overall Study|Death|13|||
155619885|NCT01716806|561701390|FG001|Overall Study|Death|9|||
155619886|NCT01716806|561701391|FG002|Overall Study|Death|12|||
155619887|NCT01716806|561701392|FG003|Overall Study|Death|4|||
155619888|NCT01716806|561701393|FG004|Overall Study|Death|10|||
155619889|NCT01716806|561701394|FG005|Overall Study|Death|5|||
155619890|NCT01716806|561701389|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155276970|NCT00884286|560447565|FG000|Overall Study|Physician Decision|1|||
155276971|NCT00884286|560447566|FG001|Overall Study|Physician Decision|0|||
155276972|NCT00884286|560447565|FG000|Overall Study|Septic shock|1|||
155276973|NCT00884286|560447566|FG001|Overall Study|Septic shock|0|||
155276974|NCT00884286|560447565|FG000|Overall Study|Thrombus in right auricle|1|||
155276975|NCT00884286|560447566|FG001|Overall Study|Thrombus in right auricle|0|||
155276976|NCT00884286|560447565|FG000|Overall Study|Not treated|2|||
155276977|NCT00884286|560447566|FG001|Overall Study|Not treated|1|||
155276978|NCT00884286|560447565|FG000|Overall Study|Comprised lung carcinoma|0|||
155276979|NCT00884286|560447566|FG001|Overall Study|Comprised lung carcinoma|1|||
155276980|NCT01196104|560447567|FG000|Overall Study|Lost to Follow-up|1|||
155276981|NCT01196104|560447568|FG001|Overall Study|Lost to Follow-up|0|||
155276982|NCT01196104|560447567|FG000|Overall Study|Physician Decision|0|||
155276983|NCT01196104|560447568|FG001|Overall Study|Physician Decision|1|||
155276984|NCT01196104|560447567|FG000|Overall Study|Withdrawal by Subject|3|||
155276985|NCT01196104|560447568|FG001|Overall Study|Withdrawal by Subject|3|||
155276986|NCT01196104|560447567|FG000|Overall Study|Various|0|||
155276987|NCT01196104|560447568|FG001|Overall Study|Various|1|||
155276988|NCT01094171|560447573|FG000|Overall Study|Lost to Follow-up|2|||
155276989|NCT01094171|560447573|FG000|Overall Study|Informed consent withdrawal|4|||
155276990|NCT01094171|560447573|FG000|Overall Study|Migration from the study area|3|||
155276991|NCT01094171|560447573|FG000|Overall Study|Other|1|||
155276992|NCT00594932|560447574|FG000|First 3 Months|Withdrawal by Subject|1|||
155276993|NCT00594932|560447575|FG001|First 3 Months|Withdrawal by Subject|3|||
155276994|NCT00594932|560447574|FG000|Final 3 Months|Withdrawal by Subject|4|||
155276995|NCT00594932|560447575|FG001|Final 3 Months|Withdrawal by Subject|3|||
155619891|NCT01716806|561701390|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155619892|NCT01716806|561701391|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155619893|NCT01716806|561701392|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155619894|NCT01716806|561701393|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
155619895|NCT01716806|561701394|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
155619896|NCT01716806|561701389|FG000|Overall Study|PI decision|0|||
155619897|NCT01716806|561701390|FG001|Overall Study|PI decision|0|||
155276996|NCT01536145|560447576|FG000|Overall Study|Progressive disease|3|||
155276997|NCT01536145|560447577|FG001|Overall Study|Progressive disease|4|||
155276998|NCT01536145|560447578|FG002|Overall Study|Progressive disease|1|||
155276999|NCT01536145|560447579|FG003|Overall Study|Progressive disease|2|||
155277000|NCT01536145|560447580|FG004|Overall Study|Progressive disease|1|||
155277001|NCT01536145|560447581|FG005|Overall Study|Progressive disease|2|||
155277002|NCT01536145|560447582|FG006|Overall Study|Progressive disease|1|||
155619898|NCT01716806|561701391|FG002|Overall Study|PI decision|0|||
155619899|NCT01716806|561701392|FG003|Overall Study|PI decision|0|||
155619900|NCT01716806|561701393|FG004|Overall Study|PI decision|1|||
155619901|NCT01716806|561701394|FG005|Overall Study|PI decision|0|||
155619902|NCT01716806|561701389|FG000|Overall Study|Change in performance status|1|||
155619903|NCT01716806|561701390|FG001|Overall Study|Change in performance status|0|||
155619904|NCT01716806|561701391|FG002|Overall Study|Change in performance status|0|||
155619905|NCT01716806|561701392|FG003|Overall Study|Change in performance status|0|||
155619906|NCT01716806|561701393|FG004|Overall Study|Change in performance status|0|||
155619907|NCT01716806|561701394|FG005|Overall Study|Change in performance status|0|||
155619908|NCT01716806|561701389|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
155619909|NCT01716806|561701390|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
155619910|NCT01716806|561701391|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
155619911|NCT01716806|561701392|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
155619912|NCT01716806|561701393|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
155619913|NCT01716806|561701394|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
155619914|NCT01716806|561701389|FG000|Overall Study|Sponsor direction|7|||
155619915|NCT01716806|561701390|FG001|Overall Study|Sponsor direction|8|||
155619916|NCT01716806|561701391|FG002|Overall Study|Sponsor direction|5|||
155619917|NCT01716806|561701392|FG003|Overall Study|Sponsor direction|12|||
155619918|NCT01716806|561701393|FG004|Overall Study|Sponsor direction|16|||
155619919|NCT01716806|561701394|FG005|Overall Study|Sponsor direction|1|||
155619920|NCT00956839|561701395|FG000|Overall Study|Lost to Follow-up|3|||
155619921|NCT00956839|561701396|FG001|Overall Study|Lost to Follow-up|0|||
155619922|NCT00956839|561701397|FG002|Overall Study|Lost to Follow-up|3|||
155277003|NCT01536145|560447583|FG007|Overall Study|Progressive disease|2|||
155277004|NCT01536145|560447584|FG008|Overall Study|Progressive disease|1|||
155277005|NCT01536145|560447585|FG009|Overall Study|Progressive disease|3|||
155277006|NCT01536145|560447586|FG010|Overall Study|Progressive disease|3|||
155277007|NCT01536145|560447576|FG000|Overall Study|Withdrawal by Subject|0|||
155277008|NCT01536145|560447577|FG001|Overall Study|Withdrawal by Subject|0|||
155277009|NCT01536145|560447578|FG002|Overall Study|Withdrawal by Subject|1|||
155277010|NCT01536145|560447579|FG003|Overall Study|Withdrawal by Subject|0|||
155277011|NCT01536145|560447580|FG004|Overall Study|Withdrawal by Subject|0|||
155277012|NCT01536145|560447581|FG005|Overall Study|Withdrawal by Subject|1|||
155277013|NCT01536145|560447582|FG006|Overall Study|Withdrawal by Subject|0|||
155277014|NCT01536145|560447583|FG007|Overall Study|Withdrawal by Subject|0|||
155277015|NCT01536145|560447584|FG008|Overall Study|Withdrawal by Subject|2|||
155277016|NCT01536145|560447585|FG009|Overall Study|Withdrawal by Subject|0|||
155277017|NCT01536145|560447586|FG010|Overall Study|Withdrawal by Subject|2|||
155277018|NCT01536145|560447576|FG000|Overall Study|Other|0|||
155277019|NCT01536145|560447577|FG001|Overall Study|Other|0|||
155277020|NCT01536145|560447578|FG002|Overall Study|Other|0|||
155277021|NCT01536145|560447579|FG003|Overall Study|Other|0|||
155277022|NCT01536145|560447580|FG004|Overall Study|Other|1|||
155277023|NCT01536145|560447581|FG005|Overall Study|Other|0|||
155277024|NCT01536145|560447582|FG006|Overall Study|Other|0|||
155277025|NCT01536145|560447583|FG007|Overall Study|Other|0|||
155277026|NCT01536145|560447584|FG008|Overall Study|Other|0|||
155277027|NCT01536145|560447585|FG009|Overall Study|Other|3|||
155277028|NCT01536145|560447586|FG010|Overall Study|Other|2|||
155277029|NCT01536145|560447576|FG000|Overall Study|Death|0|||
155277030|NCT01536145|560447577|FG001|Overall Study|Death|0|||
155277031|NCT01536145|560447578|FG002|Overall Study|Death|0|||
155277032|NCT01536145|560447579|FG003|Overall Study|Death|0|||
155277033|NCT01536145|560447580|FG004|Overall Study|Death|0|||
155277034|NCT01536145|560447581|FG005|Overall Study|Death|0|||
155277035|NCT01536145|560447582|FG006|Overall Study|Death|1|||
155277036|NCT01536145|560447583|FG007|Overall Study|Death|0|||
155277037|NCT01536145|560447584|FG008|Overall Study|Death|0|||
155619923|NCT02692586|561701398|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
155619924|NCT02692586|561701398|FG000|Overall Study|Received adjunctive thrombolytics|2|||
155619925|NCT03316586|561701402|FG000|Overall Study|Adverse Event|2|||
155619926|NCT03316586|561701402|FG000|Overall Study|Physician Decision|3|||
155277038|NCT01536145|560447585|FG009|Overall Study|Death|0|||
155277039|NCT01536145|560447586|FG010|Overall Study|Death|0|||
155277040|NCT01536145|560447576|FG000|Overall Study|Adverse Event|0|||
155277041|NCT01536145|560447577|FG001|Overall Study|Adverse Event|0|||
155277042|NCT01536145|560447578|FG002|Overall Study|Adverse Event|0|||
155619927|NCT03316586|561701402|FG000|Overall Study|Lack of Efficacy|10|||
155277043|NCT01536145|560447579|FG003|Overall Study|Adverse Event|0|||
155277044|NCT01536145|560447580|FG004|Overall Study|Adverse Event|0|||
155277045|NCT01536145|560447581|FG005|Overall Study|Adverse Event|0|||
155277046|NCT01536145|560447582|FG006|Overall Study|Adverse Event|0|||
155277047|NCT01536145|560447583|FG007|Overall Study|Adverse Event|2|||
155277048|NCT01536145|560447584|FG008|Overall Study|Adverse Event|0|||
155619928|NCT03316586|561701402|FG000|Overall Study|still on treatment|1|||
155619929|NCT03316586|561701402|FG000|Overall Study|Patient needed radiation therapy|1|||
155277049|NCT01536145|560447585|FG009|Overall Study|Adverse Event|0|||
155277050|NCT01536145|560447586|FG010|Overall Study|Adverse Event|3|||
155277051|NCT00088205|560447591|FG000|Overall Study|Adverse Event|4|||
155277052|NCT00088205|560447591|FG000|Overall Study|Progressive Disease|51|||
155277053|NCT00088205|560447591|FG000|Overall Study|Physician Decision|1|||
155619930|NCT03316586|561701402|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
155619931|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
155619932|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155619933|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155619934|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155619935|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155619936|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
155619937|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155619938|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155619939|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155619940|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155619941|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
155619942|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155619943|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155619944|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155619945|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155619946|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
155619947|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155619948|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155619949|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155619950|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155619951|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
155619952|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155619953|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155619954|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155619955|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155619956|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
155619957|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155619958|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155619959|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155619960|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155619961|NCT01111565|561701403|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
155619962|NCT01111565|561701404|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155619963|NCT01111565|561701405|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155619964|NCT01111565|561701406|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155619965|NCT01111565|561701407|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155619966|NCT01111565|561701403|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155619967|NCT01111565|561701404|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155619968|NCT01111565|561701405|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155619969|NCT01111565|561701406|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
155619970|NCT01111565|561701407|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155619971|NCT01111565|561701403|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155619972|NCT01111565|561701404|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155619973|NCT01111565|561701405|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
155619974|NCT01111565|561701406|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155619975|NCT01111565|561701407|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155619976|NCT01111565|561701403|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
155619977|NCT01111565|561701404|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
155619978|NCT01111565|561701405|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155619979|NCT01111565|561701406|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
155619980|NCT01111565|561701407|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155619981|NCT01111565|561701403|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155619982|NCT01111565|561701404|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155619983|NCT01111565|561701405|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155619984|NCT01111565|561701406|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
155619985|NCT01111565|561701407|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155619986|NCT01111565|561701403|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155619987|NCT01111565|561701404|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155619988|NCT01111565|561701405|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155619989|NCT01111565|561701406|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155619990|NCT01111565|561701407|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
155619991|NCT04131712|561701408|FG000|Overall Study|COVID related|0|||
155619992|NCT04131712|561701409|FG001|Overall Study|COVID related|0|||
155619993|NCT04131712|561701410|FG002|Overall Study|COVID related|2|||
155619994|NCT04131712|561701411|FG003|Overall Study|COVID related|0|||
155619995|NCT04131712|561701408|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155726906|NCT03879772|562099813|FG003|Overall Study|Treatment Failure|2|||
155619996|NCT04131712|561701409|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155619997|NCT04131712|561701410|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
155619998|NCT04131712|561701411|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155619999|NCT00766597|561701412|FG000|Overall Study|Unexpected closure of study|4|||
155620000|NCT00766597|561701412|FG000|Overall Study|Without CCR5-tropic virus|5|||
155620001|NCT01254656|561701413|FG000|Overall Study|Discontinued due to termination of study|40|||
155620002|NCT01254656|561701414|FG001|Overall Study|Discontinued due to termination of study|39|||
155620003|NCT01254656|561701415|FG002|Overall Study|Discontinued due to termination of study|13|||
155620004|NCT01254656|561701413|FG000|Overall Study|Lack of Efficacy|3|||
155620005|NCT01254656|561701414|FG001|Overall Study|Lack of Efficacy|0|||
155620006|NCT01254656|561701415|FG002|Overall Study|Lack of Efficacy|0|||
155620007|NCT01254656|561701413|FG000|Overall Study|Lost to Follow-up|1|||
155620008|NCT01254656|561701414|FG001|Overall Study|Lost to Follow-up|0|||
155620009|NCT01254656|561701415|FG002|Overall Study|Lost to Follow-up|2|||
155620010|NCT01254656|561701413|FG000|Overall Study|Withdrawal by Subject|2|||
155620011|NCT01254656|561701414|FG001|Overall Study|Withdrawal by Subject|2|||
155620012|NCT01254656|561701415|FG002|Overall Study|Withdrawal by Subject|1|||
155620013|NCT01254656|561701413|FG000|Overall Study|Pregnancy|0|||
155620014|NCT01254656|561701414|FG001|Overall Study|Pregnancy|0|||
155620015|NCT01254656|561701415|FG002|Overall Study|Pregnancy|2|||
155620016|NCT01254656|561701413|FG000|Overall Study|Adverse Event|1|||
155620017|NCT01254656|561701414|FG001|Overall Study|Adverse Event|1|||
155620018|NCT01254656|561701415|FG002|Overall Study|Adverse Event|0|||
155620019|NCT01254656|561701413|FG000|Overall Study|Death|0|||
155620020|NCT01254656|561701414|FG001|Overall Study|Death|1|||
155620021|NCT01254656|561701415|FG002|Overall Study|Death|0|||
155620022|NCT01265394|561701439|FG000|Overall Study|Subjects withdrawn|37|||
155620023|NCT00716456|561701441|FG000|Overall Study|Adverse Event|0|||
155620024|NCT00716456|561701442|FG001|Overall Study|Adverse Event|2|||
155620025|NCT00716456|561701443|FG002|Overall Study|Adverse Event|0|||
155620026|NCT04556760|561701444|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155620027|NCT04556760|561701445|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
155620028|NCT04556760|561701446|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155620029|NCT04556760|561701447|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155620030|NCT04556760|561701448|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155620031|NCT04556760|561701449|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155620032|NCT04556760|561701444|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155620033|NCT04556760|561701445|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155620034|NCT04556760|561701446|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155620035|NCT04556760|561701447|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
155620036|NCT04556760|561701448|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155620037|NCT04556760|561701449|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155620038|NCT02849743|561701451|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
155620039|NCT02849743|561701452|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
155620040|NCT02849743|561701451|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155620041|NCT02849743|561701452|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155620042|NCT02168491|561701459|FG000|Overall Study|Withdrawal by Subject|1|||
155620043|NCT00809445|561701460|FG000|1 Month Follow-up|Lost contact|1|||
155620044|NCT00809445|561701461|FG001|1 Month Follow-up|Lost contact|2|||
155620045|NCT00809445|561701462|FG002|1 Month Follow-up|Lost contact|1|||
155620046|NCT00809445|561701460|FG000|1 Month Follow-up|Withdrew consent|1|||
155620047|NCT00809445|561701461|FG001|1 Month Follow-up|Withdrew consent|1|||
155620048|NCT00809445|561701462|FG002|1 Month Follow-up|Withdrew consent|1|||
155620049|NCT00809445|561701460|FG000|1 Month Follow-up|Death|0|||
155620050|NCT00809445|561701461|FG001|1 Month Follow-up|Death|1|||
155620051|NCT00809445|561701462|FG002|1 Month Follow-up|Death|1|||
155620052|NCT00809445|561701460|FG000|1 Month Follow-up|Incarcerated|0|||
155620053|NCT00809445|561701461|FG001|1 Month Follow-up|Incarcerated|0|||
155620054|NCT00809445|561701462|FG002|1 Month Follow-up|Incarcerated|1|||
155620055|NCT00809445|561701460|FG000|6 Month Follow-up|Lost contact|16|||
155620056|NCT00809445|561701461|FG001|6 Month Follow-up|Lost contact|14|||
155620057|NCT00809445|561701462|FG002|6 Month Follow-up|Lost contact|14|||
155620058|NCT00809445|561701460|FG000|6 Month Follow-up|Death|2|||
155620059|NCT00809445|561701461|FG001|6 Month Follow-up|Death|1|||
155620060|NCT00809445|561701462|FG002|6 Month Follow-up|Death|1|||
155620061|NCT00809445|561701460|FG000|6 Month Follow-up|Incarcerated|6|||
155620062|NCT00809445|561701461|FG001|6 Month Follow-up|Incarcerated|8|||
155620063|NCT00809445|561701462|FG002|6 Month Follow-up|Incarcerated|8|||
155620064|NCT00809445|561701460|FG000|6 Month Follow-up|Withdrew consent|0|||
155620065|NCT00809445|561701461|FG001|6 Month Follow-up|Withdrew consent|0|||
155620066|NCT00809445|561701462|FG002|6 Month Follow-up|Withdrew consent|1|||
155620067|NCT03874013|561701463|FG000|Overall Study|Adverse Event|0|||
155620068|NCT03874013|561701464|FG001|Overall Study|Adverse Event|1|||
155726907|NCT03879772|562099814|FG004|Overall Study|Treatment Failure|1|||
155620069|NCT00661089|561701468|FG000|Overall Study|1 subject withdrawal|0|||
155620070|NCT00661089|561701469|FG001|Overall Study|1 subject withdrawal|1|||
155620071|NCT00661089|561701468|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
155620072|NCT00661089|561701469|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
155620073|NCT00321906|561701475|FG000|Overall Study|Adverse Event|36|||
155620074|NCT00321906|561701476|FG001|Overall Study|Adverse Event|44|||
155620075|NCT00321906|561701475|FG000|Overall Study|Death|9|||
155620076|NCT00321906|561701476|FG001|Overall Study|Death|6|||
155620077|NCT00321906|561701475|FG000|Overall Study|Lost to Follow-up|1|||
155620078|NCT00321906|561701476|FG001|Overall Study|Lost to Follow-up|2|||
155620079|NCT00321906|561701475|FG000|Overall Study|Withdrawal by Subject|0|||
155620080|NCT00321906|561701476|FG001|Overall Study|Withdrawal by Subject|4|||
155620081|NCT02899065|561701477|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
155620082|NCT02899065|561701478|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
155620083|NCT02899065|561701477|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
155620084|NCT02899065|561701478|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
155620085|NCT02899065|561701477|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
155620086|NCT02899065|561701478|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
155620087|NCT00186485|561701479|FG000|Overall Study|Lost to Follow-up|3|||
155620088|NCT03771963|561701486|FG000|Overall Study|Lost to Follow-up|22|||
155620089|NCT03771963|561701486|FG000|Overall Study|Withdrawal of Consent|10|||
155620090|NCT01026948|561701487|FG000|Overall Study|Physician Decision|8|||
155620091|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
155620092|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
155620093|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Adverse Event|57|||
155620094|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Adverse Event|49|||
155620095|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
155620096|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
155620097|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Site closure|3|||
155620098|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Site closure|2|||
155620099|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
155620100|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
155277054|NCT00088205|560447591|FG000|Overall Study|Death Due to Study Disease|4|||
155277055|NCT05199233|560447592|FG000|Overall Study|Lack of Efficacy|1|||
155277056|NCT02491892|560447597|FG000|Overall Study|Adverse Event|1|||
155277057|NCT02491892|560447598|FG001|Overall Study|Adverse Event|1|||
155277058|NCT02491892|560447597|FG000|Overall Study|Death|1|||
155277059|NCT02491892|560447598|FG001|Overall Study|Death|1|||
155277060|NCT02491892|560447597|FG000|Overall Study|Lack of Efficacy|37|||
155620101|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Physician Decision|48|||
155620102|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Physician Decision|38|||
155620103|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
155620104|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
155620105|NCT01705977|561701488|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
155620106|NCT01705977|561701489|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
155620107|NCT01705977|561701488|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
155620108|NCT01705977|561701489|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
155620109|NCT01705977|561701488|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
155620110|NCT01705977|561701489|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
155620111|NCT01705977|561701488|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
155620112|NCT01705977|561701489|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
155620113|NCT01705977|561701488|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
155620114|NCT01705977|561701489|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
155620115|NCT00520039|561701493|FG000|Overall Study|Exclusion criteria met at first visit|7|||
155620116|NCT00520039|561701494|FG001|Overall Study|Exclusion criteria met at first visit|5|||
155620117|NCT03560869|561701495|FG000|Overall Study|Withdrawal by Subject|3|||
155277061|NCT02491892|560447598|FG001|Overall Study|Lack of Efficacy|36|||
155620118|NCT03560869|561701496|FG001|Overall Study|Withdrawal by Subject|4|||
155620119|NCT03560869|561701495|FG000|Overall Study|Screening failure|4|||
155620120|NCT03560869|561701496|FG001|Overall Study|Screening failure|4|||
155620121|NCT03560869|561701495|FG000|Overall Study|Withdrawal by PI|0|||
155620122|NCT03560869|561701496|FG001|Overall Study|Withdrawal by PI|1|||
155620123|NCT00325819|561701497|FG000|Overall Study|Study product lost in mail|2|||
155620124|NCT00325819|561701498|FG001|Overall Study|Study product lost in mail|1|||
155620125|NCT00325819|561701497|FG000|Overall Study|Did not take a dose of study product|4|||
155620126|NCT00325819|561701498|FG001|Overall Study|Did not take a dose of study product|9|||
155620127|NCT00325819|561701497|FG000|Overall Study|Lost to Follow-up|3|||
155620128|NCT00325819|561701498|FG001|Overall Study|Lost to Follow-up|3|||
155620129|NCT03934216|561703226|FG000|Overall Study|Other Reasons|5|||
155620130|NCT03934216|561703227|FG001|Overall Study|Other Reasons|5|||
155620131|NCT03934216|561703226|FG000|Overall Study|Adverse Event|22|||
155277062|NCT02491892|560447597|FG000|Overall Study|Refused Treatment|1|||
155277063|NCT02491892|560447598|FG001|Overall Study|Refused Treatment|0|||
155277064|NCT02491892|560447597|FG000|Overall Study|Lost to Follow-up|1|||
155277065|NCT02491892|560447598|FG001|Overall Study|Lost to Follow-up|0|||
155277066|NCT01734850|560447599|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
155277067|NCT01734850|560447600|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
155277068|NCT01734850|560447601|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
155277069|NCT01734850|560447599|FG000|Overall Study|Not infused due to manufacturing failure|0|||
155277070|NCT01734850|560447600|FG001|Overall Study|Not infused due to manufacturing failure|0|||
155277071|NCT01734850|560447601|FG002|Overall Study|Not infused due to manufacturing failure|1|||
155277072|NCT03824938|560447602|FG000|Overall Study|Withdrawal by Subject|2|||
155277073|NCT03824938|560447603|FG001|Overall Study|Withdrawal by Subject|1|||
155277074|NCT03824938|560447604|FG002|Overall Study|Withdrawal by Subject|0|||
155277075|NCT03824938|560447605|FG003|Overall Study|Withdrawal by Subject|2|||
155277076|NCT03824938|560447606|FG004|Overall Study|Withdrawal by Subject|0|||
155277077|NCT03824938|560447607|FG005|Overall Study|Withdrawal by Subject|1|||
155277078|NCT03824938|560447602|FG000|Overall Study|Lost to Follow-up|0|||
155277079|NCT03824938|560447603|FG001|Overall Study|Lost to Follow-up|1|||
155277080|NCT03824938|560447604|FG002|Overall Study|Lost to Follow-up|0|||
155277081|NCT03824938|560447605|FG003|Overall Study|Lost to Follow-up|0|||
155277082|NCT03824938|560447606|FG004|Overall Study|Lost to Follow-up|1|||
155277083|NCT03824938|560447607|FG005|Overall Study|Lost to Follow-up|0|||
155277084|NCT00065468|560447611|FG000|Overall Study|Death|172|||
155277085|NCT00065468|560447612|FG001|Overall Study|Death|169|||
155277086|NCT00065468|560447613|FG002|Overall Study|Death|171|||
155277087|NCT00065468|560447611|FG000|Overall Study|Withdrawal by Subject|3|||
155277088|NCT00065468|560447612|FG001|Overall Study|Withdrawal by Subject|4|||
155277089|NCT00065468|560447613|FG002|Overall Study|Withdrawal by Subject|5|||
155277090|NCT00065468|560447611|FG000|Overall Study|Lost to Follow-up|5|||
155277091|NCT00065468|560447612|FG001|Overall Study|Lost to Follow-up|3|||
155277092|NCT00065468|560447613|FG002|Overall Study|Lost to Follow-up|2|||
155277093|NCT00065468|560447611|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
155277094|NCT00065468|560447612|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
155277095|NCT00065468|560447613|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
155277096|NCT00065468|560447611|FG000|Overall Study|Disease progression|0|||
155277097|NCT00065468|560447612|FG001|Overall Study|Disease progression|0|||
155277098|NCT00065468|560447613|FG002|Overall Study|Disease progression|1|||
155277099|NCT00065468|560447611|FG000|Overall Study|Other|14|||
155277100|NCT00065468|560447612|FG001|Overall Study|Other|24|||
155277101|NCT00065468|560447613|FG002|Overall Study|Other|18|||
155277102|NCT04496167|560447614|FG000|Overall Study|Adverse Event|6|||
155277103|NCT04496167|560447615|FG001|Overall Study|Adverse Event|2|||
155277104|NCT04496167|560447614|FG000|Overall Study|Withdrawal by Subject|7|||
155277105|NCT04496167|560447615|FG001|Overall Study|Withdrawal by Subject|6|||
155277106|NCT04496167|560447614|FG000|Overall Study|Lost to Follow-up|3|||
155277107|NCT04496167|560447615|FG001|Overall Study|Lost to Follow-up|5|||
155277108|NCT04496167|560447614|FG000|Overall Study|Not Treated|1|||
155277109|NCT04496167|560447615|FG001|Overall Study|Not Treated|2|||
155277110|NCT04496167|560447614|FG000|Overall Study|Other Than Specified|1|||
155277111|NCT04496167|560447615|FG001|Overall Study|Other Than Specified|1|||
155277112|NCT01058863|560447616|FG000|Overall Study|Lost to Follow-up|1|||
155277113|NCT01058863|560447616|FG000|Overall Study|Withdrawal by Subject|1|||
155277114|NCT01058863|560447616|FG000|Overall Study|Sponsor requested withdrawal|1|||
155277115|NCT01058863|560447616|FG000|Overall Study|Randomized in error|1|||
155277116|NCT03050398|560447621|FG000|Overall Study|Study terminated by sponsor|8|||
155277117|NCT05108649|560447622|FG000|Overall Study|Lost to Follow-up|0|||
155277118|NCT05108649|560447623|FG001|Overall Study|Lost to Follow-up|4|||
155277119|NCT05108649|560447624|FG002|Overall Study|Lost to Follow-up|3|||
155277120|NCT05108649|560447625|FG003|Overall Study|Lost to Follow-up|6|||
155620132|NCT03934216|561703227|FG001|Overall Study|Adverse Event|11|||
155620133|NCT03934216|561703226|FG000|Overall Study|Lack of Efficacy|8|||
155620134|NCT03934216|561703227|FG001|Overall Study|Lack of Efficacy|7|||
155277121|NCT05108649|560447622|FG000|Overall Study|Not Interested|1|||
155277122|NCT05108649|560447623|FG001|Overall Study|Not Interested|1|||
155277123|NCT05108649|560447624|FG002|Overall Study|Not Interested|0|||
155277124|NCT05108649|560447625|FG003|Overall Study|Not Interested|1|||
155277125|NCT05108649|560447622|FG000|Overall Study|Out of area|0|||
155277126|NCT05108649|560447623|FG001|Overall Study|Out of area|0|||
155277127|NCT05108649|560447624|FG002|Overall Study|Out of area|0|||
155277128|NCT05108649|560447625|FG003|Overall Study|Out of area|1|||
155277129|NCT05108649|560447622|FG000|Overall Study|PI decision|1|||
155277130|NCT05108649|560447623|FG001|Overall Study|PI decision|0|||
155277131|NCT05108649|560447624|FG002|Overall Study|PI decision|0|||
155620135|NCT03934216|561703226|FG000|Overall Study|Lost to Follow-up|2|||
155620136|NCT03934216|561703227|FG001|Overall Study|Lost to Follow-up|0|||
155277132|NCT05108649|560447625|FG003|Overall Study|PI decision|0|||
155277133|NCT05108649|560447622|FG000|Overall Study|Significant Non-Compliance|0|||
155277134|NCT05108649|560447623|FG001|Overall Study|Significant Non-Compliance|1|||
155277135|NCT05108649|560447624|FG002|Overall Study|Significant Non-Compliance|0|||
155277136|NCT05108649|560447625|FG003|Overall Study|Significant Non-Compliance|0|||
155277137|NCT05108649|560447622|FG000|Overall Study|Unable to adhere to study protocol|0|||
155620137|NCT03934216|561703226|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155620138|NCT03934216|561703227|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155620139|NCT03934216|561703226|FG000|Overall Study|Pregnancy|1|||
155620140|NCT03934216|561703227|FG001|Overall Study|Pregnancy|0|||
155620141|NCT03934216|561703226|FG000|Overall Study|Withdrawal by Subject|18|||
155620142|NCT03934216|561703227|FG001|Overall Study|Withdrawal by Subject|6|||
155620143|NCT03934216|561703226|FG000|Overall Study|Randomized but not treated|1|||
155620144|NCT03934216|561703227|FG001|Overall Study|Randomized but not treated|1|||
155620145|NCT00619827|561703233|FG000|Overall Study|Adverse Event|1|||
155620146|NCT00619827|561703234|FG001|Overall Study|Adverse Event|2|||
155620147|NCT00619827|561703233|FG000|Overall Study|Withdrawal by Subject|2|||
155620148|NCT00619827|561703234|FG001|Overall Study|Withdrawal by Subject|2|||
155620149|NCT01396083|561703236|FG000|Overall Study|Adverse Event|2|||
155620150|NCT01396083|561703237|FG001|Overall Study|Adverse Event|28|||
155620151|NCT01396083|561703236|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155620152|NCT01396083|561703237|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
155620153|NCT01396083|561703236|FG000|Overall Study|Consent withdrawn|4|||
155620154|NCT01396083|561703237|FG001|Overall Study|Consent withdrawn|5|||
155620155|NCT01396083|561703236|FG000|Overall Study|Protocol deviation(s)|0|||
155620156|NCT01396083|561703237|FG001|Overall Study|Protocol deviation(s)|1|||
155620157|NCT01396083|561703236|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155620158|NCT01396083|561703237|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155620159|NCT01396083|561703236|FG000|Overall Study|Administrative problems|1|||
155620160|NCT01396083|561703237|FG001|Overall Study|Administrative problems|0|||
155620161|NCT01396083|561703236|FG000|Overall Study|Lost to Follow-up|1|||
155620162|NCT01396083|561703237|FG001|Overall Study|Lost to Follow-up|0|||
155620163|NCT01063855|561703238|FG000|Overall Study|Adverse Event|4|||
155620164|NCT01063855|561703239|FG001|Overall Study|Adverse Event|4|||
155620165|NCT01063855|561703238|FG000|Overall Study|Death|0|||
155620166|NCT01063855|561703239|FG001|Overall Study|Death|1|||
155620167|NCT01063855|561703238|FG000|Overall Study|Lost to Follow-up|8|||
155620168|NCT01063855|561703239|FG001|Overall Study|Lost to Follow-up|4|||
155620169|NCT01063855|561703238|FG000|Overall Study|Pregnancy|1|||
155620170|NCT01063855|561703239|FG001|Overall Study|Pregnancy|0|||
155620171|NCT01063855|561703238|FG000|Overall Study|Lack of Efficacy|0|||
155620172|NCT01063855|561703239|FG001|Overall Study|Lack of Efficacy|1|||
155620173|NCT01063855|561703238|FG000|Overall Study|Withdrawal by Subject|11|||
155620174|NCT01063855|561703239|FG001|Overall Study|Withdrawal by Subject|8|||
155620175|NCT01063855|561703238|FG000|Overall Study|Reason not specified|13|||
155620176|NCT01063855|561703239|FG001|Overall Study|Reason not specified|11|||
155620177|NCT00735709|561703240|FG000|Overall Study|Adverse Event|2|||
155620178|NCT00735709|561703241|FG001|Overall Study|Adverse Event|3|||
155620179|NCT00735709|561703242|FG002|Overall Study|Adverse Event|1|||
155620180|NCT00735709|561703243|FG003|Overall Study|Adverse Event|5|||
155620181|NCT00735709|561703240|FG000|Overall Study|Lack of Efficacy|8|||
155620182|NCT00735709|561703241|FG001|Overall Study|Lack of Efficacy|4|||
155620183|NCT00735709|561703242|FG002|Overall Study|Lack of Efficacy|2|||
155620184|NCT00735709|561703243|FG003|Overall Study|Lack of Efficacy|3|||
155620185|NCT00735709|561703240|FG000|Overall Study|Noncompliance|0|||
155726908|NCT03879772|562099810|FG000|Overall Study|Lost to Follow-up|0|||
155726909|NCT03879772|562099811|FG001|Overall Study|Lost to Follow-up|0|||
155726910|NCT03879772|562099812|FG002|Overall Study|Lost to Follow-up|0|||
155620186|NCT00735709|561703241|FG001|Overall Study|Noncompliance|0|||
155620187|NCT00735709|561703242|FG002|Overall Study|Noncompliance|1|||
155620188|NCT00735709|561703243|FG003|Overall Study|Noncompliance|0|||
155620189|NCT00735709|561703240|FG000|Overall Study|Protocol deviations|1|||
155620190|NCT00735709|561703241|FG001|Overall Study|Protocol deviations|2|||
155620191|NCT00735709|561703242|FG002|Overall Study|Protocol deviations|1|||
155620192|NCT00735709|561703243|FG003|Overall Study|Protocol deviations|1|||
155620193|NCT00735709|561703240|FG000|Overall Study|Voluntary Withdrawal|1|||
155620194|NCT00735709|561703241|FG001|Overall Study|Voluntary Withdrawal|3|||
155620195|NCT00735709|561703242|FG002|Overall Study|Voluntary Withdrawal|5|||
155620196|NCT00735709|561703243|FG003|Overall Study|Voluntary Withdrawal|7|||
155620197|NCT00735709|561703240|FG000|Overall Study|Lost to Follow-up|0|||
155620198|NCT00735709|561703241|FG001|Overall Study|Lost to Follow-up|1|||
155620199|NCT00735709|561703242|FG002|Overall Study|Lost to Follow-up|1|||
155620200|NCT00735709|561703243|FG003|Overall Study|Lost to Follow-up|1|||
155620201|NCT00735709|561703240|FG000|Overall Study|Excluded medication|1|||
155620202|NCT00735709|561703241|FG001|Overall Study|Excluded medication|0|||
155620203|NCT00735709|561703242|FG002|Overall Study|Excluded medication|0|||
155620204|NCT00735709|561703243|FG003|Overall Study|Excluded medication|1|||
155726911|NCT03879772|562099813|FG003|Overall Study|Lost to Follow-up|0|||
155620205|NCT01165307|561703245|FG000|Overall Study|Lost to Follow-up|11|||
155620206|NCT01165307|561703246|FG001|Overall Study|Lost to Follow-up|3|||
155620207|NCT01165307|561703245|FG000|Overall Study|Withdrawal by Subject|2|||
155620208|NCT01165307|561703246|FG001|Overall Study|Withdrawal by Subject|0|||
155620209|NCT01165307|561703245|FG000|Overall Study|Subject not available for contact|1|||
155726912|NCT03879772|562099814|FG004|Overall Study|Lost to Follow-up|1|||
155620210|NCT01165307|561703246|FG001|Overall Study|Subject not available for contact|0|||
155620211|NCT03234036|561703247|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
155620212|NCT03234036|561703248|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
155620213|NCT03234036|561703249|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
155620214|NCT03234036|561703250|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
155620215|NCT02163395|561703255|FG000|Overall Study|Withdrawal by Subject|1|||
155620216|NCT02163395|561703255|FG000|Overall Study|Lost to Follow-up|3|||
155620217|NCT02163395|561703255|FG000|Overall Study|Adverse Event|1|||
155620218|NCT02683239|561703273|FG000|Overall Study|Protocol Violation|35|||
155620219|NCT02683239|561703274|FG001|Overall Study|Protocol Violation|23|||
155620220|NCT02683239|561703275|FG002|Overall Study|Protocol Violation|26|||
155620221|NCT02683239|561703276|FG003|Overall Study|Protocol Violation|4|||
155620222|NCT02683239|561703277|FG004|Overall Study|Protocol Violation|35|||
155620223|NCT02683239|561703278|FG005|Overall Study|Protocol Violation|4|||
155620224|NCT02683239|561703279|FG006|Overall Study|Protocol Violation|5|||
155620225|NCT02683239|561703273|FG000|Overall Study|Adverse Event|64|||
155620226|NCT02683239|561703274|FG001|Overall Study|Adverse Event|39|||
155620227|NCT02683239|561703275|FG002|Overall Study|Adverse Event|42|||
155620228|NCT02683239|561703276|FG003|Overall Study|Adverse Event|16|||
155620229|NCT02683239|561703277|FG004|Overall Study|Adverse Event|189|||
155620230|NCT02683239|561703278|FG005|Overall Study|Adverse Event|9|||
155620231|NCT02683239|561703279|FG006|Overall Study|Adverse Event|9|||
155620232|NCT02683239|561703273|FG000|Overall Study|Physician Decision|38|||
155620233|NCT02683239|561703274|FG001|Overall Study|Physician Decision|19|||
155620234|NCT02683239|561703275|FG002|Overall Study|Physician Decision|14|||
155620235|NCT02683239|561703276|FG003|Overall Study|Physician Decision|73|||
155620236|NCT02683239|561703277|FG004|Overall Study|Physician Decision|143|||
155620237|NCT02683239|561703278|FG005|Overall Study|Physician Decision|14|||
155620238|NCT02683239|561703279|FG006|Overall Study|Physician Decision|15|||
155620239|NCT02683239|561703273|FG000|Overall Study|Withdrawal by Subject|187|||
155620240|NCT02683239|561703274|FG001|Overall Study|Withdrawal by Subject|99|||
155620241|NCT02683239|561703275|FG002|Overall Study|Withdrawal by Subject|91|||
155620242|NCT02683239|561703276|FG003|Overall Study|Withdrawal by Subject|18|||
155620243|NCT02683239|561703277|FG004|Overall Study|Withdrawal by Subject|248|||
155620244|NCT02683239|561703278|FG005|Overall Study|Withdrawal by Subject|22|||
155620245|NCT02683239|561703279|FG006|Overall Study|Withdrawal by Subject|28|||
155620246|NCT02683239|561703273|FG000|Overall Study|Lost to Follow-up|77|||
155620247|NCT02683239|561703274|FG001|Overall Study|Lost to Follow-up|24|||
155620248|NCT02683239|561703275|FG002|Overall Study|Lost to Follow-up|25|||
155620249|NCT02683239|561703276|FG003|Overall Study|Lost to Follow-up|7|||
155620250|NCT02683239|561703277|FG004|Overall Study|Lost to Follow-up|88|||
155620251|NCT02683239|561703278|FG005|Overall Study|Lost to Follow-up|8|||
155620252|NCT02683239|561703279|FG006|Overall Study|Lost to Follow-up|11|||
155620253|NCT02683239|561703273|FG000|Overall Study|Death|9|||
155620254|NCT02683239|561703274|FG001|Overall Study|Death|5|||
155620255|NCT02683239|561703275|FG002|Overall Study|Death|8|||
155620256|NCT02683239|561703276|FG003|Overall Study|Death|0|||
155620257|NCT02683239|561703277|FG004|Overall Study|Death|12|||
155620258|NCT02683239|561703278|FG005|Overall Study|Death|1|||
155620259|NCT02683239|561703279|FG006|Overall Study|Death|0|||
155620260|NCT02683239|561703273|FG000|Overall Study|Lack of Efficacy|50|||
155620261|NCT02683239|561703274|FG001|Overall Study|Lack of Efficacy|23|||
155620262|NCT02683239|561703275|FG002|Overall Study|Lack of Efficacy|12|||
155620263|NCT02683239|561703276|FG003|Overall Study|Lack of Efficacy|2|||
155620264|NCT02683239|561703277|FG004|Overall Study|Lack of Efficacy|29|||
155620265|NCT02683239|561703278|FG005|Overall Study|Lack of Efficacy|2|||
155620266|NCT02683239|561703279|FG006|Overall Study|Lack of Efficacy|3|||
155620267|NCT02683239|561703273|FG000|Overall Study|Missing data|0|||
155620268|NCT02683239|561703274|FG001|Overall Study|Missing data|1|||
155620269|NCT02683239|561703275|FG002|Overall Study|Missing data|1|||
155620270|NCT02683239|561703276|FG003|Overall Study|Missing data|0|||
155620271|NCT02683239|561703277|FG004|Overall Study|Missing data|1|||
155620272|NCT02683239|561703278|FG005|Overall Study|Missing data|0|||
155620273|NCT02683239|561703279|FG006|Overall Study|Missing data|0|||
155620274|NCT00521365|561703282|FG000|Overall Study|Adverse Event|3|||
155620275|NCT00521365|561703282|FG000|Overall Study|Lost to Follow-up|6|||
155620276|NCT00521365|561703282|FG000|Overall Study|Protocol deviation|2|||
155620277|NCT00521365|561703282|FG000|Overall Study|Drug compliance|3|||
155620278|NCT00521365|561703282|FG000|Overall Study|Usage of not allowed drugs|6|||
155620279|NCT03627832|561703283|FG000|Overall Study|Withdrawal by Subject|10|||
155620280|NCT03627832|561703284|FG001|Overall Study|Withdrawal by Subject|1|||
155620281|NCT03150082|561703288|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
155620282|NCT03150082|561703289|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
155620283|NCT01718483|561703290|FG000|Overall Study|Withdrawal by Subject|14|||
155620284|NCT01718483|561703291|FG001|Overall Study|Withdrawal by Subject|12|||
155277138|NCT05108649|560447623|FG001|Overall Study|Unable to adhere to study protocol|2|||
155620285|NCT01718483|561703290|FG000|Overall Study|Adverse Event|5|||
155620286|NCT01718483|561703291|FG001|Overall Study|Adverse Event|12|||
155620287|NCT01718483|561703290|FG000|Overall Study|Lost to Follow-up|8|||
155620288|NCT01718483|561703291|FG001|Overall Study|Lost to Follow-up|3|||
155620289|NCT01718483|561703290|FG000|Overall Study|Protocol Violation|4|||
155620290|NCT01718483|561703291|FG001|Overall Study|Protocol Violation|2|||
155620291|NCT01718483|561703290|FG000|Overall Study|Other|1|||
155620292|NCT01718483|561703291|FG001|Overall Study|Other|4|||
155620293|NCT01718483|561703290|FG000|Overall Study|Pregnancy|1|||
155277139|NCT05108649|560447624|FG002|Overall Study|Unable to adhere to study protocol|0|||
155620294|NCT01718483|561703291|FG001|Overall Study|Pregnancy|1|||
155620295|NCT01718483|561703290|FG000|Overall Study|Lack of Efficacy|1|||
155620296|NCT01718483|561703291|FG001|Overall Study|Lack of Efficacy|0|||
155620297|NCT04547140|561703294|FG000|Overall Study|Adverse Event|0|||
155620298|NCT04547140|561703295|FG001|Overall Study|Adverse Event|1|||
155620299|NCT04547140|561703294|FG000|Overall Study|Withdrawal by Subject|0|||
155620300|NCT04547140|561703295|FG001|Overall Study|Withdrawal by Subject|1|||
155620301|NCT04547140|561703294|FG000|Overall Study|Lost to Follow-up|3|||
155620302|NCT04547140|561703295|FG001|Overall Study|Lost to Follow-up|1|||
155277140|NCT05108649|560447625|FG003|Overall Study|Unable to adhere to study protocol|0|||
155277141|NCT00918749|560447628|FG000|Overall Study|Adverse Event|1|||
155277142|NCT00918749|560447629|FG001|Overall Study|Adverse Event|0|||
155277143|NCT00918749|560447630|FG002|Overall Study|Adverse Event|1|||
155277144|NCT00918749|560447628|FG000|Overall Study|Lost to Follow-up|0|||
155277145|NCT00918749|560447629|FG001|Overall Study|Lost to Follow-up|0|||
155277146|NCT00918749|560447630|FG002|Overall Study|Lost to Follow-up|1|||
155277147|NCT00918749|560447628|FG000|Overall Study|Withdrawal by Subject|5|||
155277148|NCT00918749|560447629|FG001|Overall Study|Withdrawal by Subject|3|||
155277149|NCT00918749|560447630|FG002|Overall Study|Withdrawal by Subject|5|||
155277150|NCT00918749|560447628|FG000|Overall Study|No Study Medication Taken|1|||
155277151|NCT00918749|560447629|FG001|Overall Study|No Study Medication Taken|0|||
155277152|NCT00918749|560447630|FG002|Overall Study|No Study Medication Taken|0|||
155277153|NCT01712789|560447631|FG000|Overall Study|Lack of Efficacy|2|||
155277154|NCT01712789|560447631|FG000|Overall Study|Lost to Follow-up|1|||
155277155|NCT01712789|560447631|FG000|Overall Study|Progressive Disease|504|||
155277156|NCT01712789|560447631|FG000|Overall Study|Death|57|||
155277157|NCT01712789|560447631|FG000|Overall Study|Adverse Event|52|||
155277158|NCT01712789|560447631|FG000|Overall Study|Miscellaneous|31|||
155277159|NCT01712789|560447631|FG000|Overall Study|Withdrawal by Subject|21|||
155277160|NCT01712789|560447631|FG000|Overall Study|Transition to Commercial Treatment|8|||
155620303|NCT04547140|561703294|FG000|Overall Study|Death|2|||
155620304|NCT04547140|561703295|FG001|Overall Study|Death|1|||
155620305|NCT04547140|561703294|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
155620306|NCT04547140|561703295|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
155620307|NCT04547140|561703294|FG000|Overall Study|Pregnancy|1|||
155620308|NCT04547140|561703295|FG001|Overall Study|Pregnancy|0|||
155620309|NCT04547140|561703294|FG000|Overall Study|Reason Not Specified|4|||
155620310|NCT04547140|561703295|FG001|Overall Study|Reason Not Specified|1|||
155620311|NCT02119299|561703296|FG000|Overall Study|Withdrawal by Subject|7|||
155620312|NCT02119299|561703296|FG000|Overall Study|Lack of Efficacy|1|||
155620313|NCT02119299|561703296|FG000|Overall Study|Pregnancy|1|||
155620314|NCT04613739|561703299|FG000|Overall Study|Lost to Follow-up|6|||
155620315|NCT04613739|561703300|FG001|Overall Study|Lost to Follow-up|9|||
155277161|NCT01712789|560447631|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
155277162|NCT03018106|560447632|FG000|Overall Study|Lost to Follow-up|0|||
155277163|NCT03018106|560447633|FG001|Overall Study|Lost to Follow-up|1|||
155277164|NCT02213055|560447636|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
155277165|NCT02213055|560447637|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
155277166|NCT02213055|560447636|FG000|Overall Study|Protocol was not Followed during Study|1|||
155277167|NCT02213055|560447637|FG001|Overall Study|Protocol was not Followed during Study|0|||
155277168|NCT02213055|560447636|FG000|Overall Study|Documentation Issue at Enrollment|1|||
155277169|NCT02213055|560447637|FG001|Overall Study|Documentation Issue at Enrollment|0|||
155277170|NCT02213055|560447636|FG000|Overall Study|Documentation Issue during Study|10|||
155277171|NCT02213055|560447637|FG001|Overall Study|Documentation Issue during Study|0|||
155277172|NCT02213055|560447636|FG000|Overall Study|Did not have Live Lice|8|||
155277173|NCT02213055|560447637|FG001|Overall Study|Did not have Live Lice|0|||
155277174|NCT02213055|560447636|FG000|Overall Study|Had another Treatment during the Study|3|||
155277175|NCT02213055|560447637|FG001|Overall Study|Had another Treatment during the Study|0|||
155277176|NCT02213055|560447636|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
155277177|NCT02213055|560447637|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
155277178|NCT02213055|560447636|FG000|Overall Study|Did not Return to School|5|||
155277179|NCT02213055|560447637|FG001|Overall Study|Did not Return to School|0|||
155277180|NCT02025205|560447639|FG000|Overall Study|Withdrawal by Subject|1|||
155620316|NCT04613739|561703299|FG000|Overall Study|potentially duplicative/fraudulent|1|||
155620317|NCT04613739|561703300|FG001|Overall Study|potentially duplicative/fraudulent|3|||
155620318|NCT00735943|561703305|FG000|Overall Study|Lost to Follow-up|1|||
155620319|NCT00735943|561703305|FG000|Overall Study|Adverse Event|1|||
155620320|NCT00115778|561703308|FG000|Overall Study|Withdrawal by Subject|0|||
155726913|NCT03879772|562099810|FG000|Overall Study|Withdrawal by Subject|0|||
155277181|NCT02025205|560447640|FG001|Overall Study|Withdrawal by Subject|1|||
155277182|NCT02025205|560447639|FG000|Overall Study|Protocol Violation|2|||
155620321|NCT00115778|561703309|FG001|Overall Study|Withdrawal by Subject|1|||
155620322|NCT01607593|561703310|FG000|Overall Study|Adverse Event|15|||
155620323|NCT01607593|561703310|FG000|Overall Study|Lack of Efficacy|16|||
155620324|NCT01607593|561703310|FG000|Overall Study|Lost to Follow-up|25|||
155620325|NCT01607593|561703310|FG000|Overall Study|Continuation|33|||
155620326|NCT01607593|561703310|FG000|Overall Study|Other|4|||
155620327|NCT00528424|561703315|FG000|Overall Study|Lost to Follow-up|13|||
155620328|NCT00528424|561703315|FG000|Overall Study|Withdrew consent|2|||
155620329|NCT00528424|561703315|FG000|Overall Study|Administrative reason|2|||
155620330|NCT00528424|561703315|FG000|Overall Study|Other|12|||
155620331|NCT03713684|561703316|FG000|Overall Study|Adverse Event|1|||
155620332|NCT03713684|561703317|FG001|Overall Study|Adverse Event|3|||
155620333|NCT03713684|561703318|FG002|Overall Study|Adverse Event|1|||
155620334|NCT03713684|561703319|FG003|Overall Study|Adverse Event|0|||
155620335|NCT03713684|561703316|FG000|Overall Study|Poor compliance to protocol|2|||
155620336|NCT03713684|561703317|FG001|Overall Study|Poor compliance to protocol|1|||
155620337|NCT03713684|561703318|FG002|Overall Study|Poor compliance to protocol|0|||
155620338|NCT03713684|561703319|FG003|Overall Study|Poor compliance to protocol|1|||
155620339|NCT03713684|561703316|FG000|Overall Study|Withdrawal by Subject|14|||
155620340|NCT03713684|561703317|FG001|Overall Study|Withdrawal by Subject|6|||
155620341|NCT03713684|561703318|FG002|Overall Study|Withdrawal by Subject|14|||
155620342|NCT03713684|561703319|FG003|Overall Study|Withdrawal by Subject|16|||
155620343|NCT03713684|561703316|FG000|Overall Study|Other than specified|69|||
155620344|NCT03713684|561703317|FG001|Overall Study|Other than specified|77|||
155620345|NCT03713684|561703318|FG002|Overall Study|Other than specified|73|||
155620346|NCT03713684|561703319|FG003|Overall Study|Other than specified|70|||
155620347|NCT02515630|561703320|FG000|Overall Study|Withdrawal by Subject|5|||
155620348|NCT02515630|561703320|FG000|Overall Study|Adverse Event|4|||
155620349|NCT02515630|561703320|FG000|Overall Study|Physician Decision|4|||
155620350|NCT02515630|561703320|FG000|Overall Study|Death|2|||
155620351|NCT02515630|561703320|FG000|Overall Study|Disease Progression|1|||
155620352|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
155620353|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
155620354|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
155620355|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Death|0|||
155620356|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Death|1|||
155620357|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Death|0|||
155620358|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
155620359|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
155620360|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
155620361|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
155620362|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
155620363|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
155620364|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155620365|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155620366|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155620367|NCT01064414|561703323|FG000|Core Period: Baseline to Week 26|Other|4|||
155620368|NCT01064414|561703324|FG001|Core Period: Baseline to Week 26|Other|7|||
155620369|NCT01064414|561703325|FG002|Core Period: Baseline to Week 26|Other|2|||
155620370|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155620371|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155620372|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155620373|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Death|0|||
155620374|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Death|1|||
155620375|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Death|0|||
155620376|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
155620377|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155620378|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155620379|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
155620380|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155620381|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155620382|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155620383|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155620384|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155620385|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
155277183|NCT02025205|560447640|FG001|Overall Study|Protocol Violation|1|||
155277184|NCT02025205|560447639|FG000|Overall Study|Death|0|||
155277185|NCT02025205|560447640|FG001|Overall Study|Death|1|||
155620386|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155620387|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155620388|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155620389|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155620390|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155620391|NCT01064414|561703323|FG000|Extension Period: Week 26 to Week 52|Other|5|||
155620392|NCT01064414|561703324|FG001|Extension Period: Week 26 to Week 52|Other|2|||
155620393|NCT01064414|561703325|FG002|Extension Period: Week 26 to Week 52|Other|1|||
155620394|NCT02185417|561703326|FG000|Overall Study|Death|448|||
155620395|NCT02185417|561703327|FG001|Overall Study|Death|446|||
155620396|NCT02185417|561703328|FG002|Overall Study|Death|0|||
155620397|NCT02185417|561703326|FG000|Overall Study|Withdrawal by Subject|7|||
155620398|NCT02185417|561703327|FG001|Overall Study|Withdrawal by Subject|12|||
155620399|NCT02185417|561703328|FG002|Overall Study|Withdrawal by Subject|0|||
155620400|NCT02595502|561703331|FG000|Period 1|Adverse Event|0|||
155620401|NCT02595502|561703332|FG001|Period 1|Adverse Event|1|||
155620402|NCT02595502|561703331|FG000|Period 1|Withdrawal by Subject|1|||
155620403|NCT02595502|561703332|FG001|Period 1|Withdrawal by Subject|0|||
155620404|NCT02595502|561703331|FG000|Period 1|Lost to Follow-up|0|||
155620405|NCT02595502|561703332|FG001|Period 1|Lost to Follow-up|1|||
155620406|NCT02595502|561703331|FG000|Period 2|Adverse Event|1|||
155620407|NCT02595502|561703332|FG001|Period 2|Adverse Event|1|||
155620408|NCT02595502|561703331|FG000|Period 2|Received incorrect lens at Period 1|0|||
155620409|NCT02595502|561703332|FG001|Period 2|Received incorrect lens at Period 1|1|||
155620410|NCT02595502|561703331|FG000|Period 3|Protocol Violation|0|||
155620411|NCT02595502|561703332|FG001|Period 3|Protocol Violation|1|||
155620412|NCT02595502|561703331|FG000|Period 3|Lost to Follow-up|1|||
155620413|NCT02595502|561703332|FG001|Period 3|Lost to Follow-up|0|||
155620414|NCT02595502|561703331|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
155620415|NCT02595502|561703332|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
155620416|NCT00974311|561703333|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
155620417|NCT00974311|561703334|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
155620418|NCT00974311|561703333|FG000|DB Phase (up to 24 Months)|Death|561|||
155620419|NCT00974311|561703334|FG001|DB Phase (up to 24 Months)|Death|298|||
155620420|NCT00974311|561703333|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
155620421|NCT00974311|561703334|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
155620422|NCT00974311|561703333|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
155620423|NCT00974311|561703334|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
155620424|NCT00974311|561703333|FG000|DB Phase (up to 24 Months)|Other|1|||
155620425|NCT00974311|561703334|FG001|DB Phase (up to 24 Months)|Other|0|||
155620426|NCT00974311|561703333|FG000|OLE Phase (up to 77 Months)|Death|14|||
155620427|NCT00974311|561703334|FG001|OLE Phase (up to 77 Months)|Death|21|||
155620428|NCT00974311|561703333|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
155620429|NCT00974311|561703334|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
155620430|NCT00974311|561703333|FG000|OLE Phase (up to 77 Months)|Other|15|||
155620431|NCT00974311|561703334|FG001|OLE Phase (up to 77 Months)|Other|2|||
155620432|NCT00974311|561703333|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
155620433|NCT00974311|561703334|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
155620434|NCT03286218|561703335|FG000|Qualification Phase Period 1|Adverse Event|1|||
155620435|NCT03286218|561703336|FG001|Qualification Phase Period 1|Adverse Event|0|||
155620436|NCT03286218|561703337|FG002|Qualification Phase Period 1|Adverse Event|0|||
155620437|NCT03286218|561703338|FG003|Qualification Phase Period 1|Adverse Event|0|||
155620438|NCT03286218|561703339|FG004|Qualification Phase Period 1|Adverse Event|0|||
155620439|NCT03286218|561703340|FG005|Qualification Phase Period 1|Adverse Event|0|||
155620440|NCT03286218|561703341|FG006|Qualification Phase Period 1|Adverse Event|0|||
155620441|NCT03286218|561703342|FG007|Qualification Phase Period 1|Adverse Event|0|||
155620442|NCT03286218|561703343|FG008|Qualification Phase Period 1|Adverse Event|0|||
155620443|NCT03286218|561703344|FG009|Qualification Phase Period 1|Adverse Event|0|||
155620444|NCT03286218|561703345|FG010|Qualification Phase Period 1|Adverse Event|0|||
155277186|NCT02448719|560447643|FG000|Overall Study|Withdrawal by Subject|0|||
155277187|NCT02448719|560447644|FG001|Overall Study|Withdrawal by Subject|0|||
155277188|NCT02448719|560447645|FG002|Overall Study|Withdrawal by Subject|0|||
155277189|NCT02448719|560447646|FG003|Overall Study|Withdrawal by Subject|0|||
155277190|NCT02448719|560447647|FG004|Overall Study|Withdrawal by Subject|1|||
155277191|NCT02448719|560447648|FG005|Overall Study|Withdrawal by Subject|0|||
155277192|NCT02448719|560447649|FG006|Overall Study|Withdrawal by Subject|0|||
155277193|NCT02448719|560447650|FG007|Overall Study|Withdrawal by Subject|0|||
155277194|NCT02448719|560447651|FG008|Overall Study|Withdrawal by Subject|0|||
155277195|NCT02448719|560447652|FG009|Overall Study|Withdrawal by Subject|0|||
155277196|NCT02448719|560447653|FG010|Overall Study|Withdrawal by Subject|0|||
155620445|NCT03286218|561703346|FG011|Qualification Phase Period 1|Adverse Event|0|||
155620446|NCT03286218|561703335|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620447|NCT03286218|561703336|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
155620448|NCT03286218|561703337|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620449|NCT03286218|561703338|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620450|NCT03286218|561703339|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620451|NCT03286218|561703340|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620452|NCT03286218|561703341|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
155277197|NCT01024751|560447654|FG000|Enrolled Participants|Ineligible at baseline|3|||
155620453|NCT03286218|561703342|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620454|NCT03286218|561703343|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620455|NCT03286218|561703344|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620456|NCT03286218|561703345|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620457|NCT03286218|561703346|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
155620458|NCT03286218|561703335|FG000|Qualification Phase Period 2|Adverse Event|0|||
155620459|NCT03286218|561703336|FG001|Qualification Phase Period 2|Adverse Event|1|||
155620460|NCT03286218|561703337|FG002|Qualification Phase Period 2|Adverse Event|0|||
155620461|NCT03286218|561703338|FG003|Qualification Phase Period 2|Adverse Event|0|||
155620462|NCT03286218|561703339|FG004|Qualification Phase Period 2|Adverse Event|0|||
155620463|NCT03286218|561703340|FG005|Qualification Phase Period 2|Adverse Event|0|||
155620464|NCT03286218|561703341|FG006|Qualification Phase Period 2|Adverse Event|0|||
155620465|NCT03286218|561703342|FG007|Qualification Phase Period 2|Adverse Event|0|||
155620466|NCT03286218|561703343|FG008|Qualification Phase Period 2|Adverse Event|0|||
155620467|NCT03286218|561703344|FG009|Qualification Phase Period 2|Adverse Event|0|||
155620468|NCT03286218|561703345|FG010|Qualification Phase Period 2|Adverse Event|0|||
155620469|NCT03286218|561703346|FG011|Qualification Phase Period 2|Adverse Event|0|||
155620470|NCT03286218|561703335|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
155620471|NCT03286218|561703336|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
155620472|NCT03286218|561703337|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620473|NCT03286218|561703338|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620474|NCT03286218|561703339|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620475|NCT03286218|561703340|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620476|NCT03286218|561703341|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620477|NCT03286218|561703342|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620478|NCT03286218|561703343|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620479|NCT03286218|561703344|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620480|NCT03286218|561703345|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620481|NCT03286218|561703346|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155620482|NCT03286218|561703335|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
155620483|NCT03286218|561703336|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
155620484|NCT03286218|561703337|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
155620485|NCT03286218|561703338|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
155620486|NCT03286218|561703339|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
155620487|NCT03286218|561703340|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
155620488|NCT03286218|561703341|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
155620489|NCT03286218|561703342|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
155620490|NCT03286218|561703343|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
155620491|NCT03286218|561703344|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
155620492|NCT03286218|561703345|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
155620493|NCT03286218|561703346|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
155620494|NCT03286218|561703335|FG000|Qualification Phase Period 2|Protocol Violation|2|||
155620495|NCT03286218|561703336|FG001|Qualification Phase Period 2|Protocol Violation|0|||
155620496|NCT03286218|561703337|FG002|Qualification Phase Period 2|Protocol Violation|0|||
155620497|NCT03286218|561703338|FG003|Qualification Phase Period 2|Protocol Violation|0|||
155620498|NCT03286218|561703339|FG004|Qualification Phase Period 2|Protocol Violation|0|||
155620499|NCT03286218|561703340|FG005|Qualification Phase Period 2|Protocol Violation|0|||
155620500|NCT03286218|561703341|FG006|Qualification Phase Period 2|Protocol Violation|0|||
155620501|NCT03286218|561703342|FG007|Qualification Phase Period 2|Protocol Violation|0|||
155620502|NCT03286218|561703343|FG008|Qualification Phase Period 2|Protocol Violation|0|||
155620503|NCT03286218|561703344|FG009|Qualification Phase Period 2|Protocol Violation|0|||
155620504|NCT03286218|561703345|FG010|Qualification Phase Period 2|Protocol Violation|0|||
155620505|NCT03286218|561703346|FG011|Qualification Phase Period 2|Protocol Violation|0|||
155620506|NCT03286218|561703335|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
155620507|NCT03286218|561703336|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
155620508|NCT03286218|561703337|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620509|NCT03286218|561703338|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620510|NCT03286218|561703339|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620511|NCT03286218|561703340|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620512|NCT03286218|561703341|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620513|NCT03286218|561703342|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620514|NCT03286218|561703343|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620515|NCT03286218|561703344|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620516|NCT03286218|561703345|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620517|NCT03286218|561703346|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
155620518|NCT03286218|561703335|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620519|NCT03286218|561703336|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620520|NCT03286218|561703337|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
155620521|NCT03286218|561703338|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
155620522|NCT03286218|561703339|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620523|NCT03286218|561703340|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
155620524|NCT03286218|561703341|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620525|NCT03286218|561703342|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620526|NCT03286218|561703343|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620527|NCT03286218|561703344|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620528|NCT03286218|561703345|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
155620529|NCT03286218|561703346|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
155620530|NCT03286218|561703335|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620531|NCT03286218|561703336|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620532|NCT03286218|561703337|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620533|NCT03286218|561703338|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620534|NCT03286218|561703339|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620535|NCT03286218|561703340|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620536|NCT03286218|561703341|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620537|NCT03286218|561703342|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620538|NCT03286218|561703343|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620539|NCT03286218|561703344|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620540|NCT03286218|561703345|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
155620541|NCT03286218|561703346|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
155620542|NCT02346708|561703349|FG000|Overall Study|Adverse Event|2|||
155620543|NCT02346708|561703350|FG001|Overall Study|Adverse Event|0|||
155620544|NCT02346708|561703349|FG000|Overall Study|Protocol Violation|0|||
155620545|NCT02346708|561703350|FG001|Overall Study|Protocol Violation|1|||
155620546|NCT01781962|561703351|FG000|Overall Study|Other Miscellaneous Reasons|5|||
155620547|NCT02154139|561703355|FG000|Overall Study|Injection not administered|2|||
155620548|NCT02154139|561703355|FG000|Overall Study|Other|2|||
155620549|NCT02154139|561703355|FG000|Overall Study|Investigator transferred|3|||
155620550|NCT03075267|561703358|FG000|Overall Study|Protocol Violation|1|||
155620551|NCT03075267|561703359|FG001|Overall Study|Protocol Violation|0|||
155620552|NCT03075267|561703360|FG002|Overall Study|Protocol Violation|0|||
155620553|NCT01566604|561703361|FG000|Overall Study|Patient's inability to use the device|1|||
155620554|NCT01566604|561703362|FG001|Overall Study|Patient's inability to use the device|0|||
155620555|NCT01566604|561703361|FG000|Overall Study|Administrative problems|1|||
155620556|NCT01566604|561703362|FG001|Overall Study|Administrative problems|0|||
155620557|NCT01566604|561703361|FG000|Overall Study|Lack of Efficacy|1|||
155620558|NCT01566604|561703362|FG001|Overall Study|Lack of Efficacy|2|||
155620559|NCT01566604|561703361|FG000|Overall Study|Protocol deviation|2|||
155620560|NCT01566604|561703362|FG001|Overall Study|Protocol deviation|0|||
155620561|NCT01566604|561703361|FG000|Overall Study|Abnormal laboratory value|2|||
155620562|NCT01566604|561703362|FG001|Overall Study|Abnormal laboratory value|0|||
155620563|NCT01566604|561703361|FG000|Overall Study|Death|4|||
155620564|NCT01566604|561703362|FG001|Overall Study|Death|1|||
155620565|NCT01566604|561703361|FG000|Overall Study|Adverse Event|4|||
155620566|NCT01566604|561703362|FG001|Overall Study|Adverse Event|2|||
155620567|NCT01566604|561703361|FG000|Overall Study|Withdrawal by Subject|9|||
155620568|NCT01566604|561703362|FG001|Overall Study|Withdrawal by Subject|6|||
155620569|NCT03421379|561703366|FG000|Period 1|Withdrawal by Subject|0|||
155620570|NCT03421379|561703367|FG001|Period 1|Withdrawal by Subject|1|||
155620571|NCT03421379|561703366|FG000|Period 1|Physician Decision|1|||
155620572|NCT03421379|561703367|FG001|Period 1|Physician Decision|1|||
155620573|NCT03421379|561703366|FG000|Period 1|Did not receive treatment|1|||
155620574|NCT03421379|561703367|FG001|Period 1|Did not receive treatment|2|||
155620575|NCT01951417|561703368|FG000|Overall Study|Withdrawal by Subject|1|||
155620576|NCT01951417|561703368|FG000|Overall Study|Protocol Violation|2|||
155620577|NCT01951417|561703368|FG000|Overall Study|Lost to Follow-up|6|||
155620578|NCT02329327|561703370|FG000|Overall Study|Death|78|||
155620579|NCT02329327|561703371|FG001|Overall Study|Death|0|||
155620580|NCT02329327|561703370|FG000|Overall Study|Withdrawal by Subject|3|||
155620581|NCT02329327|561703371|FG001|Overall Study|Withdrawal by Subject|0|||
155620582|NCT02329327|561703370|FG000|Overall Study|Lost to Follow-up|4|||
155620583|NCT02329327|561703371|FG001|Overall Study|Lost to Follow-up|0|||
155620584|NCT01367249|561703372|FG000|Overall Study|Withdrawal by Subject|6|||
155620585|NCT01367249|561703373|FG001|Overall Study|Withdrawal by Subject|6|||
155620586|NCT01367249|561703372|FG000|Overall Study|Other|3|||
155620587|NCT01367249|561703373|FG001|Overall Study|Other|10|||
155620588|NCT03718429|561703374|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
155620589|NCT03718429|561703375|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
155620590|NCT03718429|561703376|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
155620591|NCT03718429|561703377|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
155620592|NCT00873730|561705046|FG000|Overall Study|Protocol Deviation|5|||
155620593|NCT00873730|561705047|FG001|Overall Study|Protocol Deviation|2|||
155620594|NCT00873730|561705046|FG000|Overall Study|Adverse Event|0|||
155620595|NCT00873730|561705047|FG001|Overall Study|Adverse Event|2|||
155620596|NCT00873730|561705046|FG000|Overall Study|Withdrawal by Subject|0|||
155620597|NCT00873730|561705047|FG001|Overall Study|Withdrawal by Subject|1|||
155620598|NCT00873730|561705046|FG000|Overall Study|Sponsor decision|1|||
155620599|NCT00873730|561705047|FG001|Overall Study|Sponsor decision|0|||
155620600|NCT00048035|561705050|FG000|Core Period|Early Withdrawals|4|||
155620601|NCT00048035|561705051|FG001|Core Period|Early Withdrawals|2|||
155620602|NCT00048035|561705052|FG002|Core Period|Early Withdrawals|1|||
155620603|NCT00048035|561705053|FG003|Core Period|Early Withdrawals|1|||
155620604|NCT00048035|561705054|FG004|Core Period|Early Withdrawals|1|||
155620605|NCT00048035|561705055|FG005|Core Period|Early Withdrawals|1|||
155620606|NCT00048035|561705056|FG006|Core Period|Early Withdrawals|0|||
155620607|NCT00048035|561705057|FG007|Core Period|Early Withdrawals|0|||
155620608|NCT00048035|561705050|FG000|Extension Year 1|Early Withdrawals|0|||
155620609|NCT00048035|561705051|FG001|Extension Year 1|Early Withdrawals|0|||
155620610|NCT00048035|561705052|FG002|Extension Year 1|Early Withdrawals|0|||
155620611|NCT00048035|561705053|FG003|Extension Year 1|Early Withdrawals|0|||
155620612|NCT00048035|561705054|FG004|Extension Year 1|Early Withdrawals|0|||
155620613|NCT00048035|561705055|FG005|Extension Year 1|Early Withdrawals|0|||
155620614|NCT00048035|561705056|FG006|Extension Year 1|Early Withdrawals|11|||
155620615|NCT00048035|561705057|FG007|Extension Year 1|Early Withdrawals|11|||
155620616|NCT00048035|561705050|FG000|Extension Year 2|Early Withdrawals|0|||
155620617|NCT00048035|561705051|FG001|Extension Year 2|Early Withdrawals|0|||
155620618|NCT00048035|561705052|FG002|Extension Year 2|Early Withdrawals|0|||
155620619|NCT00048035|561705053|FG003|Extension Year 2|Early Withdrawals|0|||
155620620|NCT00048035|561705054|FG004|Extension Year 2|Early Withdrawals|0|||
155620621|NCT00048035|561705055|FG005|Extension Year 2|Early Withdrawals|0|||
155620622|NCT00048035|561705056|FG006|Extension Year 2|Early Withdrawals|3|||
155620623|NCT00048035|561705057|FG007|Extension Year 2|Early Withdrawals|3|||
155620624|NCT04110314|561705058|FG000|Overall Study|Did not meet inclusion criteria|35255|||
155620625|NCT04110314|561705059|FG001|Overall Study|Did not meet inclusion criteria|35104|||
155620626|NCT04110314|561705060|FG002|Overall Study|Did not meet inclusion criteria|35636|||
155620627|NCT04110314|561705061|FG003|Overall Study|Did not meet inclusion criteria|35135|||
155620628|NCT04110314|561705062|FG004|Overall Study|Did not meet inclusion criteria|35247|||
155620629|NCT04110314|561705063|FG005|Overall Study|Did not meet inclusion criteria|35727|||
155620630|NCT05137717|561705068|FG000|Overall Study|Death|2|||
155620631|NCT05137717|561705068|FG000|Overall Study|Withdrawal by Subject|6|||
155620632|NCT02619617|561705069|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
155620633|NCT02619617|561705070|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
155620634|NCT02619617|561705069|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
155620635|NCT02619617|561705070|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
155620636|NCT00509899|561705072|FG000|Overall Study|Progressive disease|1|||
155620637|NCT00509899|561705073|FG001|Overall Study|Progressive disease|3|||
155620638|NCT00509899|561705074|FG002|Overall Study|Progressive disease|5|||
155620639|NCT00509899|561705075|FG003|Overall Study|Progressive disease|1|||
155620640|NCT00509899|561705076|FG004|Overall Study|Progressive disease|0|||
155620641|NCT00509899|561705077|FG005|Overall Study|Progressive disease|1|||
155620642|NCT00509899|561705078|FG006|Overall Study|Progressive disease|0|||
155620643|NCT00509899|561705079|FG007|Overall Study|Progressive disease|0|||
155620644|NCT00509899|561705072|FG000|Overall Study|Unacceptable Toxicity|1|||
155620645|NCT00509899|561705073|FG001|Overall Study|Unacceptable Toxicity|0|||
155620646|NCT00509899|561705074|FG002|Overall Study|Unacceptable Toxicity|0|||
155620647|NCT00509899|561705075|FG003|Overall Study|Unacceptable Toxicity|2|||
155620648|NCT00509899|561705076|FG004|Overall Study|Unacceptable Toxicity|0|||
155620649|NCT00509899|561705077|FG005|Overall Study|Unacceptable Toxicity|0|||
155620650|NCT00509899|561705078|FG006|Overall Study|Unacceptable Toxicity|0|||
155620651|NCT00509899|561705079|FG007|Overall Study|Unacceptable Toxicity|0|||
155620652|NCT00509899|561705072|FG000|Overall Study|Withdrawal by Subject|6|||
155620653|NCT00509899|561705073|FG001|Overall Study|Withdrawal by Subject|2|||
155620654|NCT00509899|561705074|FG002|Overall Study|Withdrawal by Subject|3|||
155620655|NCT00509899|561705075|FG003|Overall Study|Withdrawal by Subject|0|||
155620656|NCT00509899|561705076|FG004|Overall Study|Withdrawal by Subject|3|||
155620657|NCT00509899|561705077|FG005|Overall Study|Withdrawal by Subject|2|||
155620658|NCT00509899|561705078|FG006|Overall Study|Withdrawal by Subject|0|||
155620659|NCT00509899|561705079|FG007|Overall Study|Withdrawal by Subject|0|||
155620660|NCT00509899|561705072|FG000|Overall Study|Physician Decision|4|||
155620661|NCT00509899|561705073|FG001|Overall Study|Physician Decision|2|||
155620662|NCT00509899|561705074|FG002|Overall Study|Physician Decision|7|||
155620663|NCT00509899|561705075|FG003|Overall Study|Physician Decision|0|||
155620664|NCT00509899|561705076|FG004|Overall Study|Physician Decision|1|||
155620665|NCT00509899|561705077|FG005|Overall Study|Physician Decision|4|||
155620666|NCT00509899|561705078|FG006|Overall Study|Physician Decision|0|||
155620667|NCT00509899|561705079|FG007|Overall Study|Physician Decision|0|||
155620668|NCT00509899|561705072|FG000|Overall Study|Intercurrent Illness|1|||
155620669|NCT00509899|561705073|FG001|Overall Study|Intercurrent Illness|0|||
155620670|NCT00509899|561705074|FG002|Overall Study|Intercurrent Illness|0|||
155620671|NCT00509899|561705075|FG003|Overall Study|Intercurrent Illness|1|||
155620672|NCT00509899|561705076|FG004|Overall Study|Intercurrent Illness|0|||
155620673|NCT00509899|561705077|FG005|Overall Study|Intercurrent Illness|1|||
155620674|NCT00509899|561705078|FG006|Overall Study|Intercurrent Illness|0|||
155620675|NCT00509899|561705079|FG007|Overall Study|Intercurrent Illness|0|||
155620676|NCT00509899|561705072|FG000|Overall Study|Death|2|||
155620677|NCT00509899|561705073|FG001|Overall Study|Death|2|||
155620678|NCT00509899|561705074|FG002|Overall Study|Death|3|||
155620679|NCT00509899|561705075|FG003|Overall Study|Death|0|||
155620680|NCT00509899|561705076|FG004|Overall Study|Death|1|||
155620681|NCT00509899|561705077|FG005|Overall Study|Death|1|||
155620682|NCT00509899|561705078|FG006|Overall Study|Death|1|||
155620683|NCT00509899|561705079|FG007|Overall Study|Death|1|||
155620684|NCT00509899|561705072|FG000|Overall Study|Lack of Efficacy|1|||
155620685|NCT00509899|561705073|FG001|Overall Study|Lack of Efficacy|0|||
155620686|NCT00509899|561705074|FG002|Overall Study|Lack of Efficacy|2|||
155620687|NCT00509899|561705075|FG003|Overall Study|Lack of Efficacy|0|||
155620688|NCT00509899|561705076|FG004|Overall Study|Lack of Efficacy|0|||
155620689|NCT00509899|561705077|FG005|Overall Study|Lack of Efficacy|1|||
155620690|NCT00509899|561705078|FG006|Overall Study|Lack of Efficacy|0|||
155620691|NCT00509899|561705079|FG007|Overall Study|Lack of Efficacy|0|||
155620692|NCT01711983|561705082|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
155620693|NCT01711983|561705082|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
155620694|NCT01711983|561705082|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
155620695|NCT01711983|561705082|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
155620696|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620697|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
155620698|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
155620699|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620700|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620701|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620702|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620703|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620704|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620705|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620706|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620707|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620708|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620709|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620710|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155620711|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155620712|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
155620713|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620714|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620715|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620716|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620717|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620718|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620719|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620720|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620721|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620722|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620723|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620724|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620725|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155620726|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
155620727|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
155620728|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
155620729|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620730|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155726914|NCT03879772|562099811|FG001|Overall Study|Withdrawal by Subject|1|||
155726915|NCT03879772|562099812|FG002|Overall Study|Withdrawal by Subject|3|||
155620731|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620732|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620733|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620734|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620735|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620736|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620737|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155726916|NCT03879772|562099813|FG003|Overall Study|Withdrawal by Subject|1|||
155620738|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620739|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620740|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155620741|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620742|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620743|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
155620744|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620745|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620746|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620747|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620748|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620749|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620750|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620751|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620752|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620753|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620754|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620755|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155620756|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620757|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620758|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
155620759|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620760|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620761|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620762|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620763|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620764|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620765|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620766|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620767|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620768|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620769|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620770|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155620771|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620772|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620773|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
155620774|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620775|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620776|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620777|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620778|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620779|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620780|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620781|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620782|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620783|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620784|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620785|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155620786|NCT02326272|561705083|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620787|NCT02326272|561705084|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620788|NCT02326272|561705085|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
155620789|NCT02326272|561705086|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620790|NCT02326272|561705087|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620791|NCT02326272|561705088|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620792|NCT02326272|561705089|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620793|NCT02326272|561705090|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620794|NCT02326272|561705091|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620795|NCT02326272|561705092|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620796|NCT02326272|561705093|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620797|NCT02326272|561705094|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620798|NCT02326272|561705095|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620799|NCT02326272|561705096|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620800|NCT02326272|561705097|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155620801|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620802|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620803|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620804|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620805|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155620806|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
155620807|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
155620808|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155620809|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155620810|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620811|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620812|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620813|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620814|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620815|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155620816|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620817|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620818|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620819|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620820|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620821|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
155620822|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155620823|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620824|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155620825|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155620826|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620827|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620828|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620829|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620830|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155620831|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620832|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620833|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620834|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620835|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620836|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155620837|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620838|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155620839|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620840|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620841|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620842|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620843|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620844|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620845|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155620846|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620847|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620848|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620849|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155620850|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620851|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
155620852|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155620853|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155620854|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620855|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155620856|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620857|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620858|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620859|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620860|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155620861|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620862|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620863|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620864|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620865|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620866|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620867|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620868|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
155620869|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620870|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620871|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620872|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620873|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620874|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620875|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155620876|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620877|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620878|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620879|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620880|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620881|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620882|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
155620883|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620884|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620885|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620886|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620887|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620888|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620889|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620890|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155620891|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620892|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620893|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620894|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620895|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620896|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620897|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620898|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620899|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
155620900|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620901|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620902|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620903|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620904|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620905|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155620906|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620907|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620908|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620909|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620910|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620911|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
155620912|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
155620913|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
155620914|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
155277198|NCT01024751|560447655|FG001|Enrolled Participants|Ineligible at baseline|4|||
155277199|NCT01024751|560447654|FG000|Eligible Participants|Withdrawal by Subject|0|||
155277200|NCT01024751|560447655|FG001|Eligible Participants|Withdrawal by Subject|1|||
155277201|NCT01024751|560447654|FG000|Eligible Participants|Lost to Follow-up|0|||
155277202|NCT01024751|560447655|FG001|Eligible Participants|Lost to Follow-up|1|||
155277203|NCT01024751|560447654|FG000|Eligible Participants|Ineligible|0|||
155277204|NCT01024751|560447655|FG001|Eligible Participants|Ineligible|1|||
155277205|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277206|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277207|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277208|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277209|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277210|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
155277211|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277212|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277213|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277214|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277215|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277216|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
155277217|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277218|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277219|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277220|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277221|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277222|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
155277223|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277224|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277225|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277226|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277227|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277228|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277229|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
155277230|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277231|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277232|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277233|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277234|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277235|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277236|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277237|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277238|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
155277239|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277240|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
155277241|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277242|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277243|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
155277244|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277245|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277246|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277247|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277248|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277249|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277250|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277251|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277252|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277253|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277254|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277255|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277256|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277257|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277258|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
155620915|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620916|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620917|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620918|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620919|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620920|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155620921|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620922|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620923|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620924|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620925|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620926|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
155620927|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620928|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620929|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620930|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620931|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620932|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620933|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620934|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620935|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155620936|NCT02326272|561705083|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620937|NCT02326272|561705084|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620938|NCT02326272|561705085|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620939|NCT02326272|561705086|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620940|NCT02326272|561705087|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620941|NCT02326272|561705088|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620942|NCT02326272|561705089|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
155620943|NCT02326272|561705090|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620944|NCT02326272|561705091|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620945|NCT02326272|561705092|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620946|NCT02326272|561705093|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620947|NCT02326272|561705094|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620948|NCT02326272|561705095|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620949|NCT02326272|561705096|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620950|NCT02326272|561705097|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155620951|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
155620952|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
155620953|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
155620954|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
155620955|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
155620956|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
155620957|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
155620958|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
155620959|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
155620960|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
155620961|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
155620962|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
155620963|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
155620964|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
155620965|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
155620966|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620967|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620968|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620969|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620970|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620971|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620972|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620973|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620974|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620975|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620976|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
155620977|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
155620978|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155620979|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155620980|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
155620981|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620982|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620983|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620984|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620985|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620986|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620987|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620988|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620989|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620990|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620991|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155620992|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620993|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155620994|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620995|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155620996|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155620997|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155620998|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155620999|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621000|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621001|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621002|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621003|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621004|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621005|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621006|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621007|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
155621008|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621009|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621010|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155621011|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621012|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621013|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621014|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621015|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621016|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621017|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621018|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621019|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621020|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621021|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155621022|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621023|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155621024|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155621025|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155621026|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621027|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621028|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621029|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621030|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621031|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621032|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621033|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621034|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621035|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621036|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621037|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
155621038|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621039|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155621040|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
155621041|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621042|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621043|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621044|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621045|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621046|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621047|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621048|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621049|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621050|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621051|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621052|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
155621053|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155621054|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155621055|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155621056|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621057|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621058|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621059|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621060|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621061|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621062|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621063|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621064|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621065|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621066|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621067|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
155621068|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621069|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621070|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155621071|NCT02326272|561705083|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621072|NCT02326272|561705084|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621073|NCT02326272|561705085|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621074|NCT02326272|561705086|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621075|NCT02326272|561705087|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621076|NCT02326272|561705088|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621077|NCT02326272|561705089|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621078|NCT02326272|561705090|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621079|NCT02326272|561705091|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621080|NCT02326272|561705092|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621081|NCT02326272|561705093|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621082|NCT02326272|561705094|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621083|NCT02326272|561705095|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
155621084|NCT02326272|561705096|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621085|NCT02326272|561705097|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155621086|NCT00737100|561705098|FG000|Overall Study|Adverse Event|6|||
155621087|NCT00737100|561705099|FG001|Overall Study|Adverse Event|5|||
155621088|NCT00737100|561705100|FG002|Overall Study|Adverse Event|3|||
155621089|NCT00737100|561705098|FG000|Overall Study|Lost to Follow-up|0|||
155621090|NCT00737100|561705099|FG001|Overall Study|Lost to Follow-up|1|||
155621091|NCT00737100|561705100|FG002|Overall Study|Lost to Follow-up|0|||
155621092|NCT00737100|561705098|FG000|Overall Study|Withdrawal by Subject|0|||
155621093|NCT00737100|561705099|FG001|Overall Study|Withdrawal by Subject|0|||
155621094|NCT00737100|561705100|FG002|Overall Study|Withdrawal by Subject|3|||
155621095|NCT00737100|561705098|FG000|Overall Study|Reason discontinued not explained above|1|||
155621096|NCT00737100|561705099|FG001|Overall Study|Reason discontinued not explained above|1|||
155621097|NCT00737100|561705100|FG002|Overall Study|Reason discontinued not explained above|1|||
155621098|NCT03131167|561705101|FG000|Overall Study|Other (Unspecified)|0|||
155621099|NCT03131167|561705102|FG001|Overall Study|Other (Unspecified)|0|||
155621100|NCT03131167|561705103|FG002|Overall Study|Other (Unspecified)|0|||
155621101|NCT03131167|561705104|FG003|Overall Study|Other (Unspecified)|0|||
155621102|NCT03131167|561705105|FG004|Overall Study|Other (Unspecified)|0|||
155621103|NCT03131167|561705106|FG005|Overall Study|Other (Unspecified)|1|||
155621104|NCT03131167|561705107|FG006|Overall Study|Other (Unspecified)|0|||
155621105|NCT03131167|561705108|FG007|Overall Study|Other (Unspecified)|0|||
155621106|NCT03131167|561705109|FG008|Overall Study|Other (Unspecified)|0|||
155277259|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277260|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277261|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277262|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277263|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277264|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277265|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277266|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277267|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
155277268|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277269|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277270|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277271|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155621107|NCT03131167|561705110|FG009|Overall Study|Other (Unspecified)|0|||
155621108|NCT03131167|561705111|FG010|Overall Study|Other (Unspecified)|0|||
155621109|NCT03131167|561705112|FG011|Overall Study|Other (Unspecified)|0|||
155621110|NCT03131167|561705113|FG012|Overall Study|Other (Unspecified)|0|||
155621111|NCT00458003|561705116|FG000|Overall Study|Non protocol spinal anesthesia|1|||
155621112|NCT00458003|561705117|FG001|Overall Study|Non protocol spinal anesthesia|1|||
155621113|NCT00483652|561705120|FG000|Double-blind Treatment Period|Protocol Violation|2|||
155621114|NCT00483652|561705121|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155621115|NCT00483652|561705120|FG000|Double-blind Treatment Period|Adverse Event|3|||
155621116|NCT00483652|561705121|FG001|Double-blind Treatment Period|Adverse Event|4|||
155621117|NCT00483652|561705120|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
155621118|NCT00483652|561705121|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
155621119|NCT00483652|561705120|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
155621120|NCT00483652|561705121|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
155621121|NCT00928434|561705122|FG000|Overall Study|Adverse Event|14|||
155621122|NCT00928434|561705123|FG001|Overall Study|Adverse Event|5|||
155621123|NCT00928434|561705124|FG002|Overall Study|Adverse Event|18|||
155621124|NCT00928434|561705122|FG000|Overall Study|Protocol Violation|5|||
155621125|NCT00928434|561705123|FG001|Overall Study|Protocol Violation|0|||
155621126|NCT00928434|561705124|FG002|Overall Study|Protocol Violation|8|||
155621127|NCT00928434|561705122|FG000|Overall Study|Physician Decision|2|||
155621128|NCT00928434|561705123|FG001|Overall Study|Physician Decision|0|||
155621129|NCT00928434|561705124|FG002|Overall Study|Physician Decision|3|||
155621130|NCT00928434|561705122|FG000|Overall Study|Lost to Follow-up|1|||
155621131|NCT00928434|561705123|FG001|Overall Study|Lost to Follow-up|0|||
155621132|NCT00928434|561705124|FG002|Overall Study|Lost to Follow-up|3|||
155621133|NCT00928434|561705122|FG000|Overall Study|Withdrawal by Subject|5|||
155621134|NCT00928434|561705123|FG001|Overall Study|Withdrawal by Subject|3|||
155621135|NCT00928434|561705124|FG002|Overall Study|Withdrawal by Subject|2|||
155621136|NCT00928434|561705122|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
155621137|NCT00928434|561705123|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
155621138|NCT00928434|561705124|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
155621139|NCT00928434|561705122|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
155621140|NCT00928434|561705123|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
155621141|NCT00928434|561705124|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
155621142|NCT00928434|561705122|FG000|Overall Study|Other (not meeting above criteria)|5|||
155621143|NCT00928434|561705123|FG001|Overall Study|Other (not meeting above criteria)|1|||
155621144|NCT00928434|561705124|FG002|Overall Study|Other (not meeting above criteria)|2|||
155621145|NCT05417412|561705129|FG000|Overall Study|Lost to Follow-up|2|||
155621146|NCT04919317|561705133|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
155621147|NCT04919317|561705134|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
155621148|NCT04919317|561705133|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
155621149|NCT04919317|561705134|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
155621150|NCT01443858|561705137|FG000|Overall Study|Withdrawal by Subject|9|||
155621151|NCT01443858|561705138|FG001|Overall Study|Withdrawal by Subject|8|||
155621152|NCT01443858|561705139|FG002|Overall Study|Withdrawal by Subject|5|||
155621153|NCT01443858|561705137|FG000|Overall Study|Lack of Efficacy|1|||
155621154|NCT01443858|561705138|FG001|Overall Study|Lack of Efficacy|0|||
155621155|NCT01443858|561705139|FG002|Overall Study|Lack of Efficacy|0|||
155621156|NCT01443858|561705137|FG000|Overall Study|Lost to Follow-up|5|||
155621157|NCT01443858|561705138|FG001|Overall Study|Lost to Follow-up|5|||
155621158|NCT01443858|561705139|FG002|Overall Study|Lost to Follow-up|2|||
155621159|NCT01272908|561705142|FG000|Initial Treatment Period|Adverse Event|1|||
155621160|NCT01272908|561705142|FG000|Initial Treatment Period|Lack of Efficacy|5|||
155621161|NCT01272908|561705142|FG000|Initial Treatment Period|Protocol Violation|1|||
155621162|NCT01272908|561705142|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155621163|NCT01272908|561705142|FG000|Re-Treatment Period|Adverse Event|2|||
155621164|NCT01272908|561705142|FG000|Re-Treatment Period|Lack of Efficacy|3|||
155621165|NCT01272908|561705142|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
155621166|NCT02221648|561705143|FG000|Overall Study|Withdrawal by Subject|3|||
155621167|NCT02221648|561705144|FG001|Overall Study|Withdrawal by Subject|3|||
155621168|NCT00810069|561705146|FG000|Lead-in Period I|Adverse Event|43|||
155621169|NCT00810069|561705147|FG001|Lead-in Period I|Adverse Event|0|||
155621170|NCT00810069|561705148|FG002|Lead-in Period I|Adverse Event|0|||
155621171|NCT00810069|561705146|FG000|Lead-in Period I|Lack of Efficacy|1|||
155621172|NCT00810069|561705147|FG001|Lead-in Period I|Lack of Efficacy|0|||
155621173|NCT00810069|561705148|FG002|Lead-in Period I|Lack of Efficacy|0|||
155277272|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277273|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155621174|NCT00810069|561705146|FG000|Lead-in Period I|Lost to Follow-up|19|||
155621175|NCT00810069|561705147|FG001|Lead-in Period I|Lost to Follow-up|0|||
155621176|NCT00810069|561705148|FG002|Lead-in Period I|Lost to Follow-up|0|||
155621177|NCT00810069|561705146|FG000|Lead-in Period I|Physician Decision|1|||
155621178|NCT00810069|561705147|FG001|Lead-in Period I|Physician Decision|0|||
155621179|NCT00810069|561705148|FG002|Lead-in Period I|Physician Decision|0|||
155621180|NCT00810069|561705146|FG000|Lead-in Period I|Protocol Violation|1|||
155621181|NCT00810069|561705147|FG001|Lead-in Period I|Protocol Violation|0|||
155621182|NCT00810069|561705148|FG002|Lead-in Period I|Protocol Violation|0|||
155621183|NCT00810069|561705146|FG000|Lead-in Period I|Withdrawal by Subject|46|||
155621184|NCT00810069|561705147|FG001|Lead-in Period I|Withdrawal by Subject|0|||
155621185|NCT00810069|561705148|FG002|Lead-in Period I|Withdrawal by Subject|0|||
155621186|NCT00810069|561705146|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
155621187|NCT00810069|561705147|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
155621188|NCT00810069|561705148|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
155621189|NCT00810069|561705146|FG000|Lead-in Period I|Randomization criteria not met|158|||
155621190|NCT00810069|561705147|FG001|Lead-in Period I|Randomization criteria not met|0|||
155621191|NCT00810069|561705148|FG002|Lead-in Period I|Randomization criteria not met|0|||
155621192|NCT00810069|561705146|FG000|Double-Blind Period II|Adverse Event|0|||
155621193|NCT00810069|561705147|FG001|Double-Blind Period II|Adverse Event|9|||
155621194|NCT00810069|561705148|FG002|Double-Blind Period II|Adverse Event|8|||
155621195|NCT00810069|561705146|FG000|Double-Blind Period II|Lack of Efficacy|0|||
155621196|NCT00810069|561705147|FG001|Double-Blind Period II|Lack of Efficacy|7|||
155621197|NCT00810069|561705148|FG002|Double-Blind Period II|Lack of Efficacy|12|||
155621198|NCT00810069|561705146|FG000|Double-Blind Period II|Lost to Follow-up|0|||
155621199|NCT00810069|561705147|FG001|Double-Blind Period II|Lost to Follow-up|9|||
155621200|NCT00810069|561705148|FG002|Double-Blind Period II|Lost to Follow-up|9|||
155621201|NCT00810069|561705146|FG000|Double-Blind Period II|Physician Decision|0|||
155621202|NCT00810069|561705147|FG001|Double-Blind Period II|Physician Decision|0|||
155621203|NCT00810069|561705148|FG002|Double-Blind Period II|Physician Decision|1|||
155621204|NCT00810069|561705146|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
155621205|NCT00810069|561705147|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
155621206|NCT00810069|561705148|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
155621207|NCT00810069|561705146|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
155621208|NCT00810069|561705147|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
155621209|NCT00810069|561705148|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
155621210|NCT00810069|561705146|FG000|Double-Blind Period II|Clinical relapse|0|||
155621211|NCT00810069|561705147|FG001|Double-Blind Period II|Clinical relapse|3|||
155621212|NCT00810069|561705148|FG002|Double-Blind Period II|Clinical relapse|0|||
155621213|NCT00810069|561705146|FG000|Double-Blind Period II|Protocol Violation|0|||
155621214|NCT00810069|561705147|FG001|Double-Blind Period II|Protocol Violation|7|||
155621215|NCT00810069|561705148|FG002|Double-Blind Period II|Protocol Violation|6|||
155621216|NCT00905424|561705152|FG000|Overall Study|Lost to Follow-up|3|||
155621217|NCT00905424|561705153|FG001|Overall Study|Lost to Follow-up|3|||
155621218|NCT00905424|561705152|FG000|Overall Study|Withdrawal by Subject|1|||
155621219|NCT00905424|561705153|FG001|Overall Study|Withdrawal by Subject|2|||
155621220|NCT00905424|561705152|FG000|Overall Study|Adverse Event|4|||
155621221|NCT00905424|561705153|FG001|Overall Study|Adverse Event|2|||
155621222|NCT00905424|561705152|FG000|Overall Study|Non-compliance with study medication|2|||
155621223|NCT00905424|561705153|FG001|Overall Study|Non-compliance with study medication|0|||
155621224|NCT00905424|561705152|FG000|Overall Study|Sponsor decision|1|||
155621225|NCT00905424|561705153|FG001|Overall Study|Sponsor decision|0|||
155621226|NCT00905424|561705152|FG000|Overall Study|Positive urine drug screen|0|||
155621227|NCT00905424|561705153|FG001|Overall Study|Positive urine drug screen|1|||
155621228|NCT00905424|561705152|FG000|Overall Study|Non-adherence to visit schedule|0|||
155621229|NCT00905424|561705153|FG001|Overall Study|Non-adherence to visit schedule|1|||
155621230|NCT00426764|561705154|FG000|Overall Study|Protocol Violation|1|||
155621231|NCT00426764|561705154|FG000|Overall Study|Withdrawal by Subject|4|||
155621232|NCT00426764|561705154|FG000|Overall Study|Physician Decision|6|||
155621233|NCT00426764|561705154|FG000|Overall Study|Compassionate Use|1|||
155621234|NCT00426764|561705154|FG000|Overall Study|Progressive Disease|83|||
155621235|NCT00426764|561705154|FG000|Overall Study|Adverse Event|24|||
155621236|NCT00426764|561705154|FG000|Overall Study|Other|1|||
155621237|NCT00426764|561705154|FG000|Overall Study|Death|1|||
155621238|NCT00426764|561705154|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
155621239|NCT00379899|561705155|FG000|Overall Study|Adverse Event|7|||
155621240|NCT00379899|561705156|FG001|Overall Study|Adverse Event|3|||
155621241|NCT00379899|561705155|FG000|Overall Study|Death|10|||
155621242|NCT00379899|561705156|FG001|Overall Study|Death|10|||
155621243|NCT00379899|561705155|FG000|Overall Study|Lost to Follow-up|2|||
155621244|NCT00379899|561705156|FG001|Overall Study|Lost to Follow-up|4|||
155621245|NCT00379899|561705155|FG000|Overall Study|Physician Decision|3|||
155621246|NCT00379899|561705156|FG001|Overall Study|Physician Decision|4|||
155621247|NCT00379899|561705155|FG000|Overall Study|Withdrawal by Subject|5|||
155621248|NCT00379899|561705156|FG001|Overall Study|Withdrawal by Subject|5|||
155621249|NCT00379899|561705155|FG000|Overall Study|Ineligibility determined|0|||
155621250|NCT00379899|561705156|FG001|Overall Study|Ineligibility determined|1|||
155621251|NCT00379899|561705155|FG000|Overall Study|Noncompliance|1|||
155621252|NCT00379899|561705156|FG001|Overall Study|Noncompliance|1|||
155621253|NCT00379899|561705155|FG000|Overall Study|Parathyroidectomy|0|||
155621254|NCT00379899|561705156|FG001|Overall Study|Parathyroidectomy|2|||
155621255|NCT00379899|561705155|FG000|Overall Study|Renal transplantation|5|||
155621256|NCT00379899|561705156|FG001|Overall Study|Renal transplantation|4|||
155621257|NCT00379899|561705155|FG000|Overall Study|Coronary artery bypass graft|1|||
155621258|NCT00379899|561705156|FG001|Overall Study|Coronary artery bypass graft|1|||
155621259|NCT00379899|561705155|FG000|Overall Study|Other protocol-specified criteria|3|||
155621260|NCT00379899|561705156|FG001|Overall Study|Other protocol-specified criteria|4|||
155621261|NCT00379899|561705155|FG000|Overall Study|Other|3|||
155621262|NCT00379899|561705156|FG001|Overall Study|Other|1|||
155621263|NCT02417753|561705157|FG000|Overall Study|Death|1|||
155621264|NCT03113968|561705158|FG000|Overall Study|Withdrawal by Subject|31|||
155621265|NCT03113968|561705159|FG001|Overall Study|Withdrawal by Subject|4|||
155621266|NCT04805671|561705162|FG000|Overall Study|Death|2|||
155621267|NCT04805671|561705163|FG001|Overall Study|Death|7|||
155621268|NCT04805671|561705162|FG000|Overall Study|Lost to Follow-up|1|||
155621269|NCT04805671|561705163|FG001|Overall Study|Lost to Follow-up|0|||
155277274|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277275|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277276|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277277|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277278|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277279|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277280|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
155277281|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
155277282|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277283|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277284|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277285|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277286|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277287|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277288|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277289|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
155277290|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
155277291|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
155277292|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
155277293|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Other|0|||
155277294|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Other|0|||
155277295|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Other|0|||
155277296|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Other|0|||
155277297|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Other|0|||
155277298|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Other|0|||
155277299|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Other|0|||
155277300|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Other|0|||
155277301|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Other|2|||
155277302|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Other|2|||
155277303|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Other|0|||
155277304|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Death|0|||
155277305|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Death|0|||
155277306|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Death|0|||
155277307|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Death|0|||
155277308|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Death|0|||
155277309|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Death|0|||
155277310|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Death|0|||
155277311|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Death|0|||
155277312|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Death|1|||
155277313|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Death|0|||
155277314|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Death|0|||
155277315|NCT03038672|560449021|FG000|Initial Treatment|Unacceptable chemistry|0|||
155277316|NCT03038672|560449022|FG001|Initial Treatment|Unacceptable chemistry|1|||
155277317|NCT03038672|560449021|FG000|Initial Treatment|Progression prior to treatment|1|||
155277318|NCT03038672|560449022|FG001|Initial Treatment|Progression prior to treatment|0|||
155277319|NCT03038672|560449021|FG000|Initial Treatment|No treatment per protocol|1|||
155277320|NCT03038672|560449022|FG001|Initial Treatment|No treatment per protocol|0|||
155277321|NCT04423393|560449023|FG000|Overall Study|Withdrawal by Subject|0|||
155277322|NCT04423393|560449024|FG001|Overall Study|Withdrawal by Subject|0|||
155277323|NCT04423393|560449025|FG002|Overall Study|Withdrawal by Subject|0|||
155277324|NCT04423393|560449026|FG003|Overall Study|Withdrawal by Subject|0|||
155277325|NCT04423393|560449027|FG004|Overall Study|Withdrawal by Subject|0|||
155277326|NCT04423393|560449028|FG005|Overall Study|Withdrawal by Subject|1|||
155277327|NCT04423393|560449029|FG006|Overall Study|Withdrawal by Subject|0|||
155277328|NCT04423393|560449030|FG007|Overall Study|Withdrawal by Subject|0|||
155277329|NCT04423393|560449031|FG008|Overall Study|Withdrawal by Subject|0|||
155621270|NCT04805671|561705162|FG000|Overall Study|Withdrawal by Subject|9|||
155621271|NCT04805671|561705163|FG001|Overall Study|Withdrawal by Subject|7|||
155726917|NCT03879772|562099814|FG004|Overall Study|Withdrawal by Subject|1|||
155726918|NCT03879772|562099810|FG000|Overall Study|Protocol Violation|0|||
155621272|NCT04805671|561705162|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
155621273|NCT04805671|561705163|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
155621274|NCT03804268|561705164|FG000|Overall Study|Adverse Event|2|||
155621275|NCT03804268|561705165|FG001|Overall Study|Adverse Event|2|||
155621276|NCT03804268|561705164|FG000|Overall Study|Withdrawal by Subject|2|||
155621277|NCT03804268|561705165|FG001|Overall Study|Withdrawal by Subject|0|||
155621278|NCT03804268|561705164|FG000|Overall Study|Lost to Follow-up|1|||
155621279|NCT03804268|561705165|FG001|Overall Study|Lost to Follow-up|0|||
155621280|NCT03804268|561705164|FG000|Overall Study|Physician Decision|2|||
155621281|NCT03804268|561705165|FG001|Overall Study|Physician Decision|0|||
155621282|NCT02849587|561705166|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
155621283|NCT02849587|561705167|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
155621284|NCT02849587|561705168|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
155621285|NCT02849587|561705166|FG000|Overall Study|Withdrawal by Subject|0|||
155621286|NCT02849587|561705167|FG001|Overall Study|Withdrawal by Subject|1|||
155621287|NCT02849587|561705168|FG002|Overall Study|Withdrawal by Subject|0|||
155621288|NCT03380377|561705171|FG000|Overall Study|Physician Decision|1|||
155621289|NCT03380377|561705171|FG000|Overall Study|Withdrawal by Subject|1|||
155621290|NCT02716779|561705172|FG000|Monotherapy|Adverse Event|0|||
155621291|NCT02716779|561705173|FG001|Monotherapy|Adverse Event|1|||
155621292|NCT02716779|561705174|FG002|Monotherapy|Adverse Event|1|||
155621293|NCT02716779|561705172|FG000|Combination Therapy|Adverse Event|0|||
155621294|NCT02716779|561705173|FG001|Combination Therapy|Adverse Event|2|||
155621295|NCT02716779|561705174|FG002|Combination Therapy|Adverse Event|1|||
155621296|NCT00096538|561705176|FG000|Overall Study|Withdrawal by Subject|1|||
155621297|NCT02324361|561705180|FG000|Overall Study|Lost to Follow-up|5|||
155621298|NCT02324361|561705181|FG001|Overall Study|Lost to Follow-up|2|||
155621299|NCT00003471|561705187|FG000|Overall Study|Not evaluable|4|||
155621300|NCT00101868|561705188|FG000|Overall Study|Death|10|||
155621301|NCT00101868|561705189|FG001|Overall Study|Death|10|||
155621302|NCT00101868|561705188|FG000|Overall Study|Withdrawal by Subject|8|||
155621303|NCT00101868|561705189|FG001|Overall Study|Withdrawal by Subject|9|||
155621304|NCT00101868|561705188|FG000|Overall Study|Protocol Violation|3|||
155621305|NCT00101868|561705189|FG001|Overall Study|Protocol Violation|0|||
155621306|NCT00101868|561705188|FG000|Overall Study|Lost to Follow-up|8|||
155621307|NCT00101868|561705189|FG001|Overall Study|Lost to Follow-up|13|||
155621308|NCT04001803|561705190|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
155621309|NCT04001803|561705190|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
155621310|NCT04001803|561705190|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
155621311|NCT04001803|561705190|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
155621312|NCT04001803|561705190|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
155621313|NCT04001803|561705190|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
155621314|NCT04001803|561705190|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
155621315|NCT04001803|561705190|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
155621316|NCT04001803|561705190|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
155621317|NCT04001803|561705190|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
155621318|NCT02493517|561705191|FG000|Overall Study|Protocol Violation|1|||
155621319|NCT02493517|561705192|FG001|Overall Study|Protocol Violation|2|||
155621320|NCT02493517|561705191|FG000|Overall Study|Withdrawal by Subject|1|||
155621321|NCT02493517|561705192|FG001|Overall Study|Withdrawal by Subject|2|||
155621322|NCT02493517|561705191|FG000|Overall Study|Adverse Event|0|||
155621323|NCT02493517|561705192|FG001|Overall Study|Adverse Event|2|||
155621324|NCT02493517|561705191|FG000|Overall Study|Missed study visit|0|||
155621325|NCT02493517|561705192|FG001|Overall Study|Missed study visit|1|||
155621326|NCT05404711|561705194|FG000|Completed Study Visit|Withdrawal by Subject|1|||
155621327|NCT05404711|561705194|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
155621328|NCT05404711|561705194|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
155621329|NCT05404711|561705194|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
155621330|NCT05404711|561705194|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
155621331|NCT05404711|561705194|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
155621332|NCT01683604|561705197|FG000|Overall Study|Adverse Event|2|||
155621333|NCT01683604|561705197|FG000|Overall Study|Lack of Efficacy|1|||
155621334|NCT01683604|561705197|FG000|Overall Study|Other|2|||
155621335|NCT03430856|561705198|FG000|Overall Study|Adverse Event|0|||
155621336|NCT03430856|561705199|FG001|Overall Study|Adverse Event|1|||
155621337|NCT03430856|561705200|FG002|Overall Study|Adverse Event|0|||
155621338|NCT03430856|561705198|FG000|Overall Study|Rescue criteria|1|||
155621339|NCT03430856|561705199|FG001|Overall Study|Rescue criteria|1|||
155621340|NCT03430856|561705200|FG002|Overall Study|Rescue criteria|0|||
155621341|NCT03430856|561705198|FG000|Overall Study|Voluntary withdrawal of consent|1|||
155621342|NCT03430856|561705199|FG001|Overall Study|Voluntary withdrawal of consent|1|||
155621343|NCT03430856|561705200|FG002|Overall Study|Voluntary withdrawal of consent|1|||
155621344|NCT03877224|561705203|FG000|Overall Study|Death|3|||
155621345|NCT03877224|561705204|FG001|Overall Study|Death|2|||
155621346|NCT03877224|561705203|FG000|Overall Study|Withdrawal by Subject|1|||
155621347|NCT03877224|561705204|FG001|Overall Study|Withdrawal by Subject|6|||
155621348|NCT03877224|561705203|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
155621349|NCT03877224|561705204|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
155621350|NCT02481050|561707204|FG000|Overall Study|Adverse Event|1|||
155621351|NCT02481050|561707204|FG000|Overall Study|Disease Progression|47|||
155621352|NCT02481050|561707204|FG000|Overall Study|Withdrawal by Subject|7|||
155621353|NCT02481050|561707204|FG000|Overall Study|Other|3|||
155621354|NCT01386606|561707205|FG000|Overall Study|Adverse Event|0|||
155621355|NCT01386606|561707206|FG001|Overall Study|Adverse Event|1|||
155621356|NCT01386606|561707207|FG002|Overall Study|Adverse Event|0|||
155621357|NCT01386606|561707208|FG003|Overall Study|Adverse Event|0|||
155621358|NCT01386606|561707205|FG000|Overall Study|Withdrawal by Subject|0|||
155621359|NCT01386606|561707206|FG001|Overall Study|Withdrawal by Subject|1|||
155621360|NCT01386606|561707207|FG002|Overall Study|Withdrawal by Subject|1|||
155621361|NCT01386606|561707208|FG003|Overall Study|Withdrawal by Subject|0|||
155621362|NCT01386606|561707205|FG000|Overall Study|Protocol Violation|1|||
155621363|NCT01386606|561707206|FG001|Overall Study|Protocol Violation|0|||
155621364|NCT01386606|561707207|FG002|Overall Study|Protocol Violation|1|||
155621365|NCT01386606|561707208|FG003|Overall Study|Protocol Violation|1|||
155621366|NCT01386606|561707205|FG000|Overall Study|Lost to Follow-up|2|||
155621367|NCT01386606|561707206|FG001|Overall Study|Lost to Follow-up|0|||
155621368|NCT01386606|561707207|FG002|Overall Study|Lost to Follow-up|0|||
155621369|NCT01386606|561707208|FG003|Overall Study|Lost to Follow-up|0|||
155621370|NCT01386606|561707205|FG000|Overall Study|Subject incarcerated|0|||
155621371|NCT01386606|561707206|FG001|Overall Study|Subject incarcerated|1|||
155621372|NCT01386606|561707207|FG002|Overall Study|Subject incarcerated|0|||
155621373|NCT01386606|561707208|FG003|Overall Study|Subject incarcerated|0|||
155621374|NCT01386606|561707205|FG000|Overall Study|Unable to draw PK|1|||
155621375|NCT01386606|561707206|FG001|Overall Study|Unable to draw PK|0|||
155621376|NCT01386606|561707207|FG002|Overall Study|Unable to draw PK|0|||
155621377|NCT01386606|561707208|FG003|Overall Study|Unable to draw PK|0|||
155621378|NCT01386606|561707205|FG000|Overall Study|T levels too high|0|||
155621379|NCT01386606|561707206|FG001|Overall Study|T levels too high|1|||
155621380|NCT01386606|561707207|FG002|Overall Study|T levels too high|1|||
155621381|NCT01386606|561707208|FG003|Overall Study|T levels too high|0|||
155621382|NCT01548599|561707211|FG000|Overall Study|Lost to Follow-up|0|||
155621383|NCT01548599|561707212|FG001|Overall Study|Lost to Follow-up|1|||
155621384|NCT01548599|561707211|FG000|Overall Study|Withdrawal by Subject|4|||
155621385|NCT01548599|561707212|FG001|Overall Study|Withdrawal by Subject|0|||
155621386|NCT01548599|561707211|FG000|Overall Study|Death|2|||
155621387|NCT01548599|561707212|FG001|Overall Study|Death|1|||
155621388|NCT03638128|561707213|FG000|Overall Study|Withdrawal by Subject|1|||
155621389|NCT03638128|561707214|FG001|Overall Study|Withdrawal by Subject|7|||
155621390|NCT03638128|561707215|FG002|Overall Study|Withdrawal by Subject|6|||
155621391|NCT03638128|561707213|FG000|Overall Study|Sponsor Decision|15|||
155621392|NCT03638128|561707214|FG001|Overall Study|Sponsor Decision|12|||
155621393|NCT03638128|561707215|FG002|Overall Study|Sponsor Decision|19|||
155621394|NCT03638128|561707213|FG000|Overall Study|Lost to Follow-up|0|||
155621395|NCT03638128|561707214|FG001|Overall Study|Lost to Follow-up|0|||
155621396|NCT03638128|561707215|FG002|Overall Study|Lost to Follow-up|1|||
155621397|NCT00611806|561707216|FG000|Overall Study|Withdrawal by Subject|8|||
155621398|NCT00611806|561707217|FG001|Overall Study|Withdrawal by Subject|2|||
155621399|NCT00611806|561707216|FG000|Overall Study|Adverse Event|2|||
155621400|NCT00611806|561707217|FG001|Overall Study|Adverse Event|1|||
155621401|NCT00611806|561707216|FG000|Overall Study|Lost to Follow-up|6|||
155621402|NCT00611806|561707217|FG001|Overall Study|Lost to Follow-up|0|||
155621403|NCT04152200|561707219|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
155621404|NCT04152200|561707220|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
155621405|NCT04069715|561707221|FG000|Overall Study|Lost to Follow-up|1|||
155621406|NCT04069715|561707222|FG001|Overall Study|Lost to Follow-up|1|||
155621407|NCT04069715|561707221|FG000|Overall Study|Physician Decision|1|||
155621408|NCT04069715|561707222|FG001|Overall Study|Physician Decision|1|||
155621409|NCT04069715|561707221|FG000|Overall Study|Withdrawal by Subject|3|||
155621410|NCT04069715|561707222|FG001|Overall Study|Withdrawal by Subject|3|||
155621411|NCT02723188|561707223|FG000|Overall Study|Withdrawal by Subject|1|||
155621412|NCT02723188|561707224|FG001|Overall Study|Withdrawal by Subject|0|||
155621413|NCT02723188|561707225|FG002|Overall Study|Withdrawal by Subject|0|||
155621414|NCT03110354|561707226|FG000|Overall Study|Death|1|||
155621415|NCT03110354|561707227|FG001|Overall Study|Death|0|||
155621416|NCT03110354|561707228|FG002|Overall Study|Death|0|||
155621417|NCT03110354|561707229|FG003|Overall Study|Death|1|||
155621418|NCT03110354|561707230|FG004|Overall Study|Death|0|||
155621419|NCT03110354|561707226|FG000|Overall Study|Start of new therapy|0|||
155621420|NCT03110354|561707227|FG001|Overall Study|Start of new therapy|0|||
155621421|NCT03110354|561707228|FG002|Overall Study|Start of new therapy|0|||
155621422|NCT03110354|561707229|FG003|Overall Study|Start of new therapy|0|||
155621423|NCT03110354|561707230|FG004|Overall Study|Start of new therapy|1|||
155621424|NCT03110354|561707226|FG000|Overall Study|Failure to achieve response|2|||
155621425|NCT03110354|561707227|FG001|Overall Study|Failure to achieve response|3|||
155621426|NCT03110354|561707228|FG002|Overall Study|Failure to achieve response|0|||
155621427|NCT03110354|561707229|FG003|Overall Study|Failure to achieve response|2|||
155621428|NCT03110354|561707230|FG004|Overall Study|Failure to achieve response|1|||
155621429|NCT03110354|561707226|FG000|Overall Study|Progressive disease|1|||
155621430|NCT03110354|561707227|FG001|Overall Study|Progressive disease|1|||
155621431|NCT03110354|561707228|FG002|Overall Study|Progressive disease|3|||
155621432|NCT03110354|561707229|FG003|Overall Study|Progressive disease|4|||
155621433|NCT03110354|561707230|FG004|Overall Study|Progressive disease|2|||
155621434|NCT03110354|561707226|FG000|Overall Study|Adverse Event|0|||
155621435|NCT03110354|561707227|FG001|Overall Study|Adverse Event|0|||
155621436|NCT03110354|561707228|FG002|Overall Study|Adverse Event|0|||
155621437|NCT03110354|561707229|FG003|Overall Study|Adverse Event|2|||
155621438|NCT03110354|561707230|FG004|Overall Study|Adverse Event|2|||
155621439|NCT03110354|561707226|FG000|Overall Study|Other|0|||
155621440|NCT03110354|561707227|FG001|Overall Study|Other|0|||
155621441|NCT03110354|561707228|FG002|Overall Study|Other|0|||
155621442|NCT03110354|561707229|FG003|Overall Study|Other|1|||
155621443|NCT03110354|561707230|FG004|Overall Study|Other|1|||
155621444|NCT00165503|561707231|FG000|Overall Study|Death|1|||
155621445|NCT00165503|561707231|FG000|Overall Study|Lost to Follow-up|12|||
155621446|NCT00165503|561707231|FG000|Overall Study|Unresectable|3|||
155621447|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Death|20|||
155621448|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Death|26|||
155621449|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
155621450|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
155621451|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
155621452|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
155621453|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
155621454|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
155621455|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
155621456|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
155621457|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
155621458|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
155621459|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
155621460|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
155621461|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
155621462|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
155621463|NCT00643201|561707232|FG000|Randomized, Completed 6 Months of Study|Other|107|||
155621464|NCT00643201|561707233|FG001|Randomized, Completed 6 Months of Study|Other|107|||
155621465|NCT00643201|561707232|FG000|Completed Study Follow Up|Death|28|||
155621466|NCT00643201|561707233|FG001|Completed Study Follow Up|Death|34|||
155621467|NCT00643201|561707232|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
155621468|NCT00643201|561707233|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
155621469|NCT00643201|561707232|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
155621470|NCT00643201|561707233|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
155621471|NCT00643201|561707232|FG000|Completed Study Follow Up|non-specified|1|||
155621472|NCT00643201|561707233|FG001|Completed Study Follow Up|non-specified|0|||
155621473|NCT02976519|561707234|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621474|NCT02976519|561707235|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
155621475|NCT02976519|561707236|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621476|NCT02976519|561707237|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621477|NCT02976519|561707238|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621478|NCT02976519|561707239|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621479|NCT02976519|561707240|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155621480|NCT02976519|561707234|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621481|NCT02976519|561707235|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621482|NCT02976519|561707236|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621483|NCT02976519|561707237|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
155621484|NCT02976519|561707238|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621485|NCT02976519|561707239|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621486|NCT02976519|561707240|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155621487|NCT02976519|561707234|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621488|NCT02976519|561707235|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621489|NCT02976519|561707236|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621490|NCT02976519|561707237|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621491|NCT02976519|561707238|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621492|NCT02976519|561707239|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155621493|NCT02976519|561707240|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
155621494|NCT02976519|561707234|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621495|NCT02976519|561707235|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621496|NCT02976519|561707236|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621497|NCT02976519|561707237|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621498|NCT02976519|561707238|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621499|NCT02976519|561707239|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155621500|NCT02976519|561707240|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
155621501|NCT02976519|561707234|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621502|NCT02976519|561707235|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621503|NCT02976519|561707236|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621504|NCT02976519|561707237|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621505|NCT02976519|561707238|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621506|NCT02976519|561707239|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155621507|NCT02976519|561707240|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
155621508|NCT01278342|561707241|FG000|Overall Study|Physician Decision|0|||
155621509|NCT01278342|561707242|FG001|Overall Study|Physician Decision|1|||
155621510|NCT01278342|561707243|FG002|Overall Study|Physician Decision|0|||
155621511|NCT01278342|561707241|FG000|Overall Study|Lost to Follow-up|1|||
155621512|NCT01278342|561707242|FG001|Overall Study|Lost to Follow-up|0|||
155621513|NCT01278342|561707243|FG002|Overall Study|Lost to Follow-up|0|||
155621514|NCT01278342|561707241|FG000|Overall Study|Administrative problems|2|||
155621515|NCT01278342|561707242|FG001|Overall Study|Administrative problems|0|||
155621516|NCT01278342|561707243|FG002|Overall Study|Administrative problems|0|||
155621517|NCT01278342|561707241|FG000|Overall Study|Other|1|||
155621518|NCT01278342|561707242|FG001|Overall Study|Other|0|||
155621519|NCT01278342|561707243|FG002|Overall Study|Other|0|||
155621520|NCT00473655|561707249|FG000|Overall Study|Lost to Follow-up|9|||
155621521|NCT00473655|561707250|FG001|Overall Study|Lost to Follow-up|5|||
155621522|NCT00473655|561707251|FG002|Overall Study|Lost to Follow-up|8|||
155621523|NCT00891813|561707252|FG000|Overall Study|Adverse Event|3|||
155621524|NCT00891813|561707252|FG000|Overall Study|Withdrawal by Subject|1|||
155621525|NCT00891813|561707252|FG000|Overall Study|Patient Noncompliance|6|||
155621526|NCT00891813|561707252|FG000|Overall Study|Protocol Violation|2|||
155621527|NCT00243919|561707260|FG000|Overall Study|Death|3|||
155621528|NCT00243919|561707261|FG001|Overall Study|Death|4|||
155621529|NCT00243919|561707262|FG002|Overall Study|Death|6|||
155621530|NCT00243919|561707260|FG000|Overall Study|Withdrawal by Subject|6|||
155621531|NCT00243919|561707261|FG001|Overall Study|Withdrawal by Subject|6|||
155621532|NCT00243919|561707262|FG002|Overall Study|Withdrawal by Subject|2|||
155621533|NCT00243919|561707260|FG000|Overall Study|Lost to Follow-up|6|||
155621534|NCT00243919|561707261|FG001|Overall Study|Lost to Follow-up|7|||
155621535|NCT00243919|561707262|FG002|Overall Study|Lost to Follow-up|3|||
155621536|NCT00243919|561707260|FG000|Overall Study|Administrative Error|1|||
155621537|NCT00243919|561707261|FG001|Overall Study|Administrative Error|0|||
155621538|NCT00243919|561707262|FG002|Overall Study|Administrative Error|0|||
155621539|NCT00243919|561707260|FG000|Overall Study|Physician Decision|1|||
155621540|NCT00243919|561707261|FG001|Overall Study|Physician Decision|1|||
155621541|NCT00243919|561707262|FG002|Overall Study|Physician Decision|0|||
155621542|NCT02513550|561707263|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
155621543|NCT02513550|561707264|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
155621544|NCT02513550|561707265|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
155621545|NCT02513550|561707266|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
155621546|NCT02513550|561707267|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155621547|NCT02513550|561707268|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
155621548|NCT02513550|561707263|FG000|Double Blind Treatment Period|Adverse Event|5|||
155621549|NCT02513550|561707264|FG001|Double Blind Treatment Period|Adverse Event|13|||
155621550|NCT02513550|561707265|FG002|Double Blind Treatment Period|Adverse Event|17|||
155621551|NCT02513550|561707266|FG003|Double Blind Treatment Period|Adverse Event|0|||
155621552|NCT02513550|561707267|FG004|Double Blind Treatment Period|Adverse Event|1|||
155621553|NCT02513550|561707268|FG005|Double Blind Treatment Period|Adverse Event|0|||
155621554|NCT02513550|561707263|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
155621555|NCT02513550|561707264|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
155621556|NCT02513550|561707265|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
155621557|NCT02513550|561707266|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
155621558|NCT02513550|561707267|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
155621559|NCT02513550|561707268|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
155621560|NCT02513550|561707263|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
155621561|NCT02513550|561707264|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
155621562|NCT02513550|561707265|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
155621563|NCT02513550|561707266|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155621564|NCT02513550|561707267|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
155621565|NCT02513550|561707268|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
155621566|NCT02513550|561707263|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155621567|NCT02513550|561707264|FG001|Double Blind Treatment Period|Protocol Violation|1|||
155621568|NCT02513550|561707265|FG002|Double Blind Treatment Period|Protocol Violation|4|||
155621569|NCT02513550|561707266|FG003|Double Blind Treatment Period|Protocol Violation|0|||
155621570|NCT02513550|561707267|FG004|Double Blind Treatment Period|Protocol Violation|0|||
155621571|NCT02513550|561707268|FG005|Double Blind Treatment Period|Protocol Violation|0|||
155621572|NCT02513550|561707263|FG000|Double Blind Treatment Period|Physician Decision|2|||
155621573|NCT02513550|561707264|FG001|Double Blind Treatment Period|Physician Decision|0|||
155621574|NCT02513550|561707265|FG002|Double Blind Treatment Period|Physician Decision|4|||
155621575|NCT02513550|561707266|FG003|Double Blind Treatment Period|Physician Decision|0|||
155621576|NCT02513550|561707267|FG004|Double Blind Treatment Period|Physician Decision|0|||
155621577|NCT02513550|561707268|FG005|Double Blind Treatment Period|Physician Decision|0|||
155621578|NCT02513550|561707263|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
155621579|NCT02513550|561707264|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
155621580|NCT02513550|561707265|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
155621581|NCT02513550|561707266|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
155621582|NCT02513550|561707267|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
155621583|NCT02513550|561707268|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
155621584|NCT02513550|561707263|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155621585|NCT02513550|561707264|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155621586|NCT02513550|561707265|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
155621587|NCT02513550|561707266|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155621588|NCT02513550|561707267|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155621589|NCT02513550|561707268|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155621590|NCT02513550|561707263|FG000|Double Blind Treatment Period|Due to personal business|2|||
155621591|NCT02513550|561707264|FG001|Double Blind Treatment Period|Due to personal business|0|||
155621592|NCT02513550|561707265|FG002|Double Blind Treatment Period|Due to personal business|1|||
155621593|NCT02513550|561707266|FG003|Double Blind Treatment Period|Due to personal business|0|||
155621594|NCT02513550|561707267|FG004|Double Blind Treatment Period|Due to personal business|0|||
155621595|NCT02513550|561707268|FG005|Double Blind Treatment Period|Due to personal business|0|||
155621596|NCT02513550|561707263|FG000|Double Blind Treatment Period|Death|1|||
155621597|NCT02513550|561707264|FG001|Double Blind Treatment Period|Death|0|||
155621598|NCT02513550|561707265|FG002|Double Blind Treatment Period|Death|2|||
155621599|NCT02513550|561707266|FG003|Double Blind Treatment Period|Death|0|||
155621600|NCT02513550|561707267|FG004|Double Blind Treatment Period|Death|0|||
155621601|NCT02513550|561707268|FG005|Double Blind Treatment Period|Death|0|||
155621602|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
155621603|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
155621604|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
155621605|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155621606|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155621607|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155621608|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
155621609|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
155621610|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
155621611|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155621612|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155621613|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155621614|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
155621615|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
155621616|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
155621617|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155621618|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155621619|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155621620|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
155621621|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
155621622|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
155621623|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
155621624|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
155621625|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
155621626|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
155621627|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
155726919|NCT03879772|562099811|FG001|Overall Study|Protocol Violation|0|||
155726920|NCT03879772|562099812|FG002|Overall Study|Protocol Violation|3|||
155621628|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
155621629|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
155621630|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
155277330|NCT04423393|560449032|FG009|Overall Study|Withdrawal by Subject|0|||
155277331|NCT04423393|560449033|FG010|Overall Study|Withdrawal by Subject|0|||
155621631|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
155621632|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Death|0|||
155621633|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Death|0|||
155621634|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Death|1|||
155621635|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Death|0|||
155621636|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Death|0|||
155621637|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Death|0|||
155621638|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
155621639|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
155621640|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
155621641|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
155621642|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
155621643|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
155621644|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155621645|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155621646|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
155621647|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155621648|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155621649|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155621650|NCT02513550|561707263|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
155621651|NCT02513550|561707264|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
155621652|NCT02513550|561707265|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
155621653|NCT02513550|561707266|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
155621654|NCT02513550|561707267|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
155621655|NCT02513550|561707268|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
155621656|NCT04176939|561707273|FG000|Overall Study|Withdrawal by Subject|5|||
155621657|NCT04176939|561707273|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
155621658|NCT04176939|561707273|FG000|Overall Study|Lost to Follow-up|2|||
155621659|NCT04176939|561707273|FG000|Overall Study|Unspecified reason|4|||
155621660|NCT04176939|561707273|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
155621661|NCT02157519|561707274|FG000|Overall Study|Death|3|||
155621662|NCT02157519|561707275|FG001|Overall Study|Death|1|||
155621663|NCT02157519|561707274|FG000|Overall Study|Withdrawal by Subject|7|||
155621664|NCT02157519|561707275|FG001|Overall Study|Withdrawal by Subject|0|||
155621665|NCT02157519|561707274|FG000|Overall Study|Lost to Follow-up|1|||
155621666|NCT02157519|561707275|FG001|Overall Study|Lost to Follow-up|0|||
155621667|NCT01656395|561707276|FG000|Overall Study|Adverse Event|1|||
155621668|NCT01656395|561707277|FG001|Overall Study|Adverse Event|14|||
155621669|NCT01656395|561707278|FG002|Overall Study|Adverse Event|5|||
155621670|NCT01656395|561707279|FG003|Overall Study|Adverse Event|4|||
155621671|NCT01656395|561707280|FG004|Overall Study|Adverse Event|5|||
155621672|NCT01656395|561707281|FG005|Overall Study|Adverse Event|7|||
155621673|NCT01656395|561707282|FG006|Overall Study|Adverse Event|0|||
155621674|NCT01656395|561707283|FG007|Overall Study|Adverse Event|0|||
155621675|NCT01656395|561707276|FG000|Overall Study|Lack of Efficacy|1|||
155621676|NCT01656395|561707277|FG001|Overall Study|Lack of Efficacy|8|||
155621677|NCT01656395|561707278|FG002|Overall Study|Lack of Efficacy|6|||
155621678|NCT01656395|561707279|FG003|Overall Study|Lack of Efficacy|1|||
155621679|NCT01656395|561707280|FG004|Overall Study|Lack of Efficacy|1|||
155621680|NCT01656395|561707281|FG005|Overall Study|Lack of Efficacy|6|||
155621681|NCT01656395|561707282|FG006|Overall Study|Lack of Efficacy|0|||
155621682|NCT01656395|561707283|FG007|Overall Study|Lack of Efficacy|0|||
155621683|NCT01656395|561707276|FG000|Overall Study|Lost to Follow-up|1|||
155621684|NCT01656395|561707277|FG001|Overall Study|Lost to Follow-up|0|||
155621685|NCT01656395|561707278|FG002|Overall Study|Lost to Follow-up|0|||
155621686|NCT01656395|561707279|FG003|Overall Study|Lost to Follow-up|0|||
155621687|NCT01656395|561707280|FG004|Overall Study|Lost to Follow-up|0|||
155621688|NCT01656395|561707281|FG005|Overall Study|Lost to Follow-up|0|||
155621689|NCT01656395|561707282|FG006|Overall Study|Lost to Follow-up|0|||
155621690|NCT01656395|561707283|FG007|Overall Study|Lost to Follow-up|0|||
155621691|NCT01656395|561707276|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155621692|NCT01656395|561707277|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155621693|NCT01656395|561707278|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155621694|NCT01656395|561707279|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155621695|NCT01656395|561707280|FG004|Overall Study|Non-Compliance with Study Drug|1|||
155621696|NCT01656395|561707281|FG005|Overall Study|Non-Compliance with Study Drug|1|||
155621697|NCT01656395|561707282|FG006|Overall Study|Non-Compliance with Study Drug|0|||
155621698|NCT01656395|561707283|FG007|Overall Study|Non-Compliance with Study Drug|0|||
155621699|NCT01656395|561707276|FG000|Overall Study|Other|0|||
155621700|NCT01656395|561707277|FG001|Overall Study|Other|0|||
155621701|NCT01656395|561707278|FG002|Overall Study|Other|1|||
155621702|NCT01656395|561707279|FG003|Overall Study|Other|0|||
155621703|NCT01656395|561707280|FG004|Overall Study|Other|0|||
155621704|NCT01656395|561707281|FG005|Overall Study|Other|1|||
155621705|NCT01656395|561707282|FG006|Overall Study|Other|0|||
155621706|NCT01656395|561707283|FG007|Overall Study|Other|0|||
155621707|NCT01656395|561707276|FG000|Overall Study|Physician Decision|2|||
155621708|NCT01656395|561707277|FG001|Overall Study|Physician Decision|3|||
155621709|NCT01656395|561707278|FG002|Overall Study|Physician Decision|3|||
155621710|NCT01656395|561707279|FG003|Overall Study|Physician Decision|2|||
155621711|NCT01656395|561707280|FG004|Overall Study|Physician Decision|3|||
155621712|NCT01656395|561707281|FG005|Overall Study|Physician Decision|3|||
155621713|NCT01656395|561707282|FG006|Overall Study|Physician Decision|0|||
155621714|NCT01656395|561707283|FG007|Overall Study|Physician Decision|0|||
155621715|NCT01656395|561707276|FG000|Overall Study|Pregnancy|0|||
155621716|NCT01656395|561707277|FG001|Overall Study|Pregnancy|0|||
155621717|NCT01656395|561707278|FG002|Overall Study|Pregnancy|1|||
155621718|NCT01656395|561707279|FG003|Overall Study|Pregnancy|0|||
155621719|NCT01656395|561707280|FG004|Overall Study|Pregnancy|0|||
155621720|NCT01656395|561707281|FG005|Overall Study|Pregnancy|0|||
155621721|NCT01656395|561707282|FG006|Overall Study|Pregnancy|0|||
155621722|NCT01656395|561707283|FG007|Overall Study|Pregnancy|0|||
155621723|NCT01656395|561707276|FG000|Overall Study|Progressive Disease|0|||
155621724|NCT01656395|561707277|FG001|Overall Study|Progressive Disease|0|||
155621725|NCT01656395|561707278|FG002|Overall Study|Progressive Disease|0|||
155621726|NCT01656395|561707279|FG003|Overall Study|Progressive Disease|0|||
155621727|NCT01656395|561707280|FG004|Overall Study|Progressive Disease|0|||
155621728|NCT01656395|561707281|FG005|Overall Study|Progressive Disease|1|||
155621729|NCT01656395|561707282|FG006|Overall Study|Progressive Disease|0|||
155621730|NCT01656395|561707283|FG007|Overall Study|Progressive Disease|0|||
155621731|NCT01656395|561707276|FG000|Overall Study|Protocol Violation|6|||
155621732|NCT01656395|561707277|FG001|Overall Study|Protocol Violation|6|||
155621733|NCT01656395|561707278|FG002|Overall Study|Protocol Violation|9|||
155621734|NCT01656395|561707279|FG003|Overall Study|Protocol Violation|2|||
155621735|NCT01656395|561707280|FG004|Overall Study|Protocol Violation|4|||
155621736|NCT01656395|561707281|FG005|Overall Study|Protocol Violation|10|||
155621737|NCT01656395|561707282|FG006|Overall Study|Protocol Violation|0|||
155621738|NCT01656395|561707283|FG007|Overall Study|Protocol Violation|0|||
155621739|NCT01656395|561707276|FG000|Overall Study|Screen Failure|2|||
155621740|NCT01656395|561707277|FG001|Overall Study|Screen Failure|1|||
155621741|NCT01656395|561707278|FG002|Overall Study|Screen Failure|7|||
155621742|NCT01656395|561707279|FG003|Overall Study|Screen Failure|1|||
155621743|NCT01656395|561707280|FG004|Overall Study|Screen Failure|0|||
155621744|NCT01656395|561707281|FG005|Overall Study|Screen Failure|8|||
155621745|NCT01656395|561707282|FG006|Overall Study|Screen Failure|0|||
155621746|NCT01656395|561707283|FG007|Overall Study|Screen Failure|0|||
155621747|NCT01656395|561707276|FG000|Overall Study|Withdrawal by Subject|3|||
155621748|NCT01656395|561707277|FG001|Overall Study|Withdrawal by Subject|1|||
155621749|NCT01656395|561707278|FG002|Overall Study|Withdrawal by Subject|4|||
155621750|NCT01656395|561707279|FG003|Overall Study|Withdrawal by Subject|2|||
155621751|NCT01656395|561707280|FG004|Overall Study|Withdrawal by Subject|0|||
155621752|NCT01656395|561707281|FG005|Overall Study|Withdrawal by Subject|3|||
155621753|NCT01656395|561707282|FG006|Overall Study|Withdrawal by Subject|0|||
155621754|NCT01656395|561707283|FG007|Overall Study|Withdrawal by Subject|0|||
155621755|NCT00230048|561707288|FG000|Overall Study|Lost to Follow-up|13|||
155621756|NCT00230048|561707289|FG001|Overall Study|Lost to Follow-up|18|||
155621757|NCT00676403|561707290|FG000|Overall Study|Adverse Event|1|||
155621758|NCT00676403|561707291|FG001|Overall Study|Adverse Event|2|||
155621759|NCT00676403|561707292|FG002|Overall Study|Adverse Event|0|||
155621760|NCT00676403|561707293|FG003|Overall Study|Adverse Event|5|||
155621761|NCT00676403|561707294|FG004|Overall Study|Adverse Event|1|||
155621762|NCT00676403|561707295|FG005|Overall Study|Adverse Event|2|||
155621763|NCT00676403|561707290|FG000|Overall Study|Lost to Follow-up|0|||
155621764|NCT00676403|561707291|FG001|Overall Study|Lost to Follow-up|0|||
155621765|NCT00676403|561707292|FG002|Overall Study|Lost to Follow-up|0|||
155621766|NCT00676403|561707293|FG003|Overall Study|Lost to Follow-up|0|||
155621767|NCT00676403|561707294|FG004|Overall Study|Lost to Follow-up|0|||
155621768|NCT00676403|561707295|FG005|Overall Study|Lost to Follow-up|1|||
155621769|NCT00676403|561707290|FG000|Overall Study|Reason Unspecified|1|||
155621770|NCT00676403|561707291|FG001|Overall Study|Reason Unspecified|0|||
155621771|NCT00676403|561707292|FG002|Overall Study|Reason Unspecified|1|||
155621772|NCT00676403|561707293|FG003|Overall Study|Reason Unspecified|0|||
155621773|NCT00676403|561707294|FG004|Overall Study|Reason Unspecified|0|||
155621774|NCT00676403|561707295|FG005|Overall Study|Reason Unspecified|1|||
155621775|NCT00676403|561707290|FG000|Overall Study|Withdrawal by Subject|0|||
155621776|NCT00676403|561707291|FG001|Overall Study|Withdrawal by Subject|0|||
155621777|NCT00676403|561707292|FG002|Overall Study|Withdrawal by Subject|0|||
155621778|NCT00676403|561707293|FG003|Overall Study|Withdrawal by Subject|0|||
155621779|NCT00676403|561707294|FG004|Overall Study|Withdrawal by Subject|0|||
155621780|NCT00676403|561707295|FG005|Overall Study|Withdrawal by Subject|1|||
155621781|NCT03225170|561707296|FG000|Overall Study|Lost to Follow-up|4|||
155621782|NCT03225170|561707297|FG001|Overall Study|Lost to Follow-up|4|||
155621783|NCT03225170|561707298|FG002|Overall Study|Lost to Follow-up|0|||
155621784|NCT03225170|561707296|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
155621785|NCT03225170|561707297|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
155621786|NCT03225170|561707298|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
155621787|NCT00705757|561707301|FG000|Overall Study|Lack of Efficacy|5|||
155621788|NCT00705757|561707302|FG001|Overall Study|Lack of Efficacy|1|||
155621789|NCT00705757|561707303|FG002|Overall Study|Lack of Efficacy|3|||
155621790|NCT00705757|561707301|FG000|Overall Study|Lost to Follow-up|7|||
155621791|NCT00705757|561707302|FG001|Overall Study|Lost to Follow-up|6|||
155726921|NCT03879772|562099813|FG003|Overall Study|Protocol Violation|1|||
155726922|NCT03879772|562099814|FG004|Overall Study|Protocol Violation|2|||
155726923|NCT03879772|562099810|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
155726924|NCT03879772|562099811|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
155726925|NCT03879772|562099812|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
155726926|NCT03879772|562099813|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
155726927|NCT03879772|562099814|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
155726928|NCT01210313|562099819|FG000|Overall Study|Withdrawal by Subject|3|||
155726929|NCT01210313|562099819|FG000|Overall Study|Adverse Event|2|||
155726930|NCT01210313|562099819|FG000|Overall Study|Distant recurrence|4|||
155726931|NCT01210313|562099819|FG000|Overall Study|Non-compliance|7|||
155726932|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
155726933|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
155726934|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
155726935|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
155726936|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
155726937|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
155726938|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
155726939|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
155726940|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
155726941|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
155726942|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
155726943|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
155726944|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
155726945|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
155726946|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
155726947|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
155726948|NCT03773978|562099824|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
155726949|NCT03773978|562099825|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
155726950|NCT03773978|562099824|FG000|DBW Period|Adverse Event|2|||
155726951|NCT03773978|562099825|FG001|DBW Period|Adverse Event|2|||
155726952|NCT03773978|562099824|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
155726953|NCT03773978|562099825|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
155726954|NCT03773978|562099824|FG000|DBW Period|Withdrawal by Subject|2|||
155726955|NCT03773978|562099825|FG001|DBW Period|Withdrawal by Subject|1|||
155726956|NCT03773978|562099824|FG000|DBW Period|Due to epidemic or pandemic|5|||
155726957|NCT03773978|562099825|FG001|DBW Period|Due to epidemic or pandemic|6|||
155726958|NCT03773978|562099824|FG000|DBW Period|Study team decision|1|||
155726959|NCT03773978|562099825|FG001|DBW Period|Study team decision|0|||
155726960|NCT03113487|562099826|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
155726961|NCT03777982|562099827|FG000|Overall Study|Physician Decision|0|||
155726962|NCT03777982|562099828|FG001|Overall Study|Physician Decision|1|||
155726963|NCT04189952|562099831|FG000|Follow-up Period|Death|1|||
155726964|NCT04189952|562099831|FG000|Follow-up Period|Withdrawal by Subject|1|||
155726965|NCT00870740|562099832|FG000|Overall Study|Adverse Event|2|||
155726966|NCT00870740|562099833|FG001|Overall Study|Adverse Event|1|||
155726967|NCT00870740|562099834|FG002|Overall Study|Adverse Event|3|||
155726968|NCT00870740|562099835|FG003|Overall Study|Adverse Event|2|||
155726969|NCT00870740|562099836|FG004|Overall Study|Adverse Event|1|||
155726970|NCT00870740|562099837|FG005|Overall Study|Adverse Event|6|||
155726971|NCT00870740|562099832|FG000|Overall Study|Consent Withdrawn|6|||
155726972|NCT00870740|562099833|FG001|Overall Study|Consent Withdrawn|3|||
155726973|NCT00870740|562099834|FG002|Overall Study|Consent Withdrawn|4|||
155726974|NCT00870740|562099835|FG003|Overall Study|Consent Withdrawn|6|||
155726975|NCT00870740|562099836|FG004|Overall Study|Consent Withdrawn|6|||
155726976|NCT00870740|562099837|FG005|Overall Study|Consent Withdrawn|5|||
155726977|NCT00870740|562099832|FG000|Overall Study|Investigator Decision|2|||
155726978|NCT00870740|562099833|FG001|Overall Study|Investigator Decision|0|||
155726979|NCT00870740|562099834|FG002|Overall Study|Investigator Decision|1|||
155726980|NCT00870740|562099835|FG003|Overall Study|Investigator Decision|0|||
155726981|NCT00870740|562099836|FG004|Overall Study|Investigator Decision|0|||
155726982|NCT00870740|562099837|FG005|Overall Study|Investigator Decision|0|||
155726983|NCT00870740|562099832|FG000|Overall Study|Subject Non-compliance|0|||
155726984|NCT00870740|562099833|FG001|Overall Study|Subject Non-compliance|0|||
155621792|NCT00705757|561707303|FG002|Overall Study|Lost to Follow-up|6|||
155621793|NCT00705757|561707301|FG000|Overall Study|Withdrawal by Subject|1|||
155621794|NCT00705757|561707302|FG001|Overall Study|Withdrawal by Subject|1|||
155621795|NCT00705757|561707303|FG002|Overall Study|Withdrawal by Subject|2|||
155621796|NCT04742673|561707304|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
155621797|NCT04742673|561707305|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
155621798|NCT04073303|561707310|FG000|Overall Study|Adverse Event|0|||
155621799|NCT04073303|561707311|FG001|Overall Study|Adverse Event|2|||
155621800|NCT04073303|561707310|FG000|Overall Study|Withdrawal by Subject|16|||
155621801|NCT04073303|561707311|FG001|Overall Study|Withdrawal by Subject|36|||
155621802|NCT04073303|561707310|FG000|Overall Study|Lost to Follow-up|6|||
155621803|NCT04073303|561707311|FG001|Overall Study|Lost to Follow-up|1|||
155621804|NCT04073303|561707310|FG000|Overall Study|Protocol Deviation|0|||
155621805|NCT04073303|561707311|FG001|Overall Study|Protocol Deviation|4|||
155621806|NCT04073303|561707310|FG000|Overall Study|Other|1|||
155621807|NCT04073303|561707311|FG001|Overall Study|Other|1|||
155621808|NCT01158261|561707317|FG000|Overall Study|Lost to Follow-up|9|||
155621809|NCT01158261|561707317|FG000|Overall Study|Death|7|||
155621810|NCT01158261|561707317|FG000|Overall Study|Withdrawal by Subject|1|||
155621811|NCT00971867|561707318|FG000|Overall Study|Adverse Event|4|||
155621812|NCT00971867|561707318|FG000|Overall Study|Participant Withdrew Consent|1|||
155621813|NCT00971867|561707318|FG000|Overall Study|Disease Progression|6|||
155621814|NCT00227539|561707319|FG000|Overall Study|Protocol Violation|1|||
155621815|NCT01922258|561707323|FG000|Overall Study|Lost to Follow-up|1|||
155621816|NCT01922258|561707324|FG001|Overall Study|Lost to Follow-up|1|||
155621817|NCT01922258|561707323|FG000|Overall Study|Adverse Event|9|||
155621818|NCT01922258|561707324|FG001|Overall Study|Adverse Event|2|||
155621819|NCT01922258|561707323|FG000|Overall Study|Met Withdrawal Criteria|0|||
155621820|NCT01922258|561707324|FG001|Overall Study|Met Withdrawal Criteria|4|||
155621821|NCT01922258|561707323|FG000|Overall Study|Withdrawn by the Investigator|1|||
155621822|NCT01922258|561707324|FG001|Overall Study|Withdrawn by the Investigator|4|||
155621823|NCT01922258|561707323|FG000|Overall Study|Withdrawal by participant|5|||
155621824|NCT01922258|561707324|FG001|Overall Study|Withdrawal by participant|5|||
155621825|NCT00673257|561707325|FG000|Overall Study|Withdrawal by Subject|4|||
155621826|NCT00673257|561707325|FG000|Overall Study|Unable to obtain specimen|1|||
155621827|NCT01166750|561707332|FG000|Overall Study|Lost to Follow-up|1|||
155621828|NCT01166750|561707333|FG001|Overall Study|Lost to Follow-up|0|||
155621829|NCT05225389|561707334|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
155621830|NCT01585246|561707335|FG000|Overall Study|Lost to Follow-up|0|||
155621831|NCT01585246|561707336|FG001|Overall Study|Lost to Follow-up|0|||
155621832|NCT01585246|561707337|FG002|Overall Study|Lost to Follow-up|2|||
155621833|NCT01585246|561707338|FG003|Overall Study|Lost to Follow-up|1|||
155621834|NCT01585246|561707339|FG004|Overall Study|Lost to Follow-up|0|||
155621835|NCT01585246|561707335|FG000|Overall Study|Protocol Violation|0|||
155621836|NCT01585246|561707336|FG001|Overall Study|Protocol Violation|0|||
155621837|NCT01585246|561707337|FG002|Overall Study|Protocol Violation|0|||
155621838|NCT01585246|561707338|FG003|Overall Study|Protocol Violation|0|||
155621839|NCT01585246|561707339|FG004|Overall Study|Protocol Violation|1|||
155621840|NCT01585246|561707335|FG000|Overall Study|Withdrawal by Subject|0|||
155621841|NCT01585246|561707336|FG001|Overall Study|Withdrawal by Subject|0|||
155621842|NCT01585246|561707337|FG002|Overall Study|Withdrawal by Subject|1|||
155621843|NCT01585246|561707338|FG003|Overall Study|Withdrawal by Subject|2|||
155621844|NCT01585246|561707339|FG004|Overall Study|Withdrawal by Subject|1|||
155621845|NCT01585246|561707335|FG000|Overall Study|Other|0|||
155621846|NCT01585246|561707336|FG001|Overall Study|Other|1|||
155621847|NCT01585246|561707337|FG002|Overall Study|Other|1|||
155621848|NCT01585246|561707338|FG003|Overall Study|Other|1|||
155621849|NCT01585246|561707339|FG004|Overall Study|Other|0|||
155621850|NCT04396626|561707340|FG000|Overall Study|Premature termination of study|975|||
155621851|NCT02111174|561707343|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
155621852|NCT02111174|561707344|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
155621853|NCT02111174|561707343|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
155621854|NCT02111174|561707344|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
155621855|NCT02111174|561707343|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
155621856|NCT02111174|561707344|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
155621857|NCT02111174|561707343|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
155621858|NCT02111174|561707344|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
155621859|NCT04552132|561707345|FG000|Overall Study|Lost to Follow-up|4|||
155621860|NCT04552132|561707346|FG001|Overall Study|Lost to Follow-up|3|||
155621861|NCT04552132|561707345|FG000|Overall Study|Protocol Violation|1|||
155621862|NCT04552132|561707346|FG001|Overall Study|Protocol Violation|0|||
155621863|NCT01657162|561707347|FG000|Overall Study|Adverse Event|26|||
155621864|NCT01657162|561707348|FG001|Overall Study|Adverse Event|36|||
155621865|NCT01657162|561707347|FG000|Overall Study|Withdrawal by Subject|13|||
155621866|NCT01657162|561707348|FG001|Overall Study|Withdrawal by Subject|13|||
155621867|NCT01657162|561707347|FG000|Overall Study|Continuing Significant Deterioration|9|||
155621868|NCT01657162|561707348|FG001|Overall Study|Continuing Significant Deterioration|3|||
155621869|NCT01657162|561707347|FG000|Overall Study|Refusal of Treatment|4|||
155621870|NCT01657162|561707348|FG001|Overall Study|Refusal of Treatment|6|||
155621871|NCT01657162|561707347|FG000|Overall Study|Lost to Follow-up|3|||
155621872|NCT01657162|561707348|FG001|Overall Study|Lost to Follow-up|4|||
155621873|NCT01657162|561707347|FG000|Overall Study|Death|2|||
155621874|NCT01657162|561707348|FG001|Overall Study|Death|3|||
155621875|NCT01657162|561707347|FG000|Overall Study|Inability to Complete Study Procedures|1|||
155621876|NCT01657162|561707348|FG001|Overall Study|Inability to Complete Study Procedures|7|||
155621877|NCT01657162|561707347|FG000|Overall Study|Protocol Violation|1|||
155621878|NCT01657162|561707348|FG001|Overall Study|Protocol Violation|0|||
155621879|NCT01657162|561707347|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
155621880|NCT01657162|561707348|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
155621881|NCT01657162|561707347|FG000|Overall Study|Other than Specified|0|||
155621882|NCT01657162|561707348|FG001|Overall Study|Other than Specified|2|||
155621883|NCT00901342|561707349|FG000|Overall Study|Adverse Event|1|||
155621884|NCT00901342|561707349|FG000|Overall Study|Death|4|||
155621885|NCT00901342|561707349|FG000|Overall Study|Disease progression|1|||
155621886|NCT00901342|561707349|FG000|Overall Study|Withdrawal by Subject|9|||
155621887|NCT02600923|561707352|FG000|Overall Study|Death|10|||
155621888|NCT02600923|561707352|FG000|Overall Study|Adverse Event|3|||
155621889|NCT02600923|561707352|FG000|Overall Study|Global deterioration of health status|2|||
155621890|NCT02600923|561707352|FG000|Overall Study|Insufficient clinical response|6|||
155621891|NCT02600923|561707352|FG000|Overall Study|Lost to Follow-up|1|||
155621892|NCT02600923|561707352|FG000|Overall Study|Withdrawal by Subject|5|||
155621893|NCT02600923|561707352|FG000|Overall Study|Objective progression or relapse|50|||
155621894|NCT02600923|561707352|FG000|Overall Study|Study terminated by Sponsor|53|||
155621895|NCT02600923|561707352|FG000|Overall Study|Not treated|1|||
155621896|NCT00792909|561707353|FG000|Overall Study|Withdrawal by Subject|0|||
155621897|NCT00792909|561707354|FG001|Overall Study|Withdrawal by Subject|1|||
155621898|NCT00792909|561707355|FG002|Overall Study|Withdrawal by Subject|0|||
155621899|NCT00385918|561707361|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
155621900|NCT00385918|561707362|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
155726985|NCT00870740|562099834|FG002|Overall Study|Subject Non-compliance|0|||
155726986|NCT00870740|562099835|FG003|Overall Study|Subject Non-compliance|0|||
155726987|NCT00870740|562099836|FG004|Overall Study|Subject Non-compliance|0|||
155726988|NCT00870740|562099837|FG005|Overall Study|Subject Non-compliance|1|||
155726989|NCT00870740|562099832|FG000|Overall Study|Death|0|||
155726990|NCT00870740|562099833|FG001|Overall Study|Death|0|||
155726991|NCT00870740|562099834|FG002|Overall Study|Death|0|||
155726992|NCT00870740|562099835|FG003|Overall Study|Death|0|||
155726993|NCT00870740|562099836|FG004|Overall Study|Death|1|||
155726994|NCT00870740|562099837|FG005|Overall Study|Death|0|||
155726995|NCT00870740|562099832|FG000|Overall Study|Other|2|||
155726996|NCT00870740|562099833|FG001|Overall Study|Other|5|||
155726997|NCT00870740|562099834|FG002|Overall Study|Other|2|||
155726998|NCT00870740|562099835|FG003|Overall Study|Other|4|||
155726999|NCT00870740|562099836|FG004|Overall Study|Other|3|||
155727000|NCT00870740|562099837|FG005|Overall Study|Other|5|||
155727001|NCT04298697|562099845|FG000|Overall Study|Lost to Follow-up|5|||
155727002|NCT04298697|562099846|FG001|Overall Study|Lost to Follow-up|5|||
155727003|NCT04298697|562099847|FG002|Overall Study|Lost to Follow-up|1|||
155727004|NCT04298697|562099848|FG003|Overall Study|Lost to Follow-up|0|||
155727005|NCT04298697|562099845|FG000|Overall Study|Withdrawal by Subject|0|||
155727006|NCT04298697|562099846|FG001|Overall Study|Withdrawal by Subject|3|||
155727007|NCT04298697|562099847|FG002|Overall Study|Withdrawal by Subject|2|||
155727008|NCT04298697|562099848|FG003|Overall Study|Withdrawal by Subject|3|||
155727009|NCT03592186|562099849|FG000|Overall Study|Withdrawal by Subject|1|||
155727010|NCT03592186|562099850|FG001|Overall Study|Withdrawal by Subject|0|||
155727011|NCT03592186|562099849|FG000|Overall Study|Lost to Follow-up|16|||
155727012|NCT03592186|562099850|FG001|Overall Study|Lost to Follow-up|11|||
155727013|NCT01342211|562099854|FG000|Overall Study|Lost to Follow-up|0|||
155727014|NCT01342211|562099855|FG001|Overall Study|Lost to Follow-up|0|||
155727015|NCT01342211|562099856|FG002|Overall Study|Lost to Follow-up|0|||
155727016|NCT01342211|562099857|FG003|Overall Study|Lost to Follow-up|1|||
155727017|NCT01342211|562099858|FG004|Overall Study|Lost to Follow-up|0|||
155727018|NCT01342211|562099854|FG000|Overall Study|Adverse Event|0|||
155727019|NCT01342211|562099855|FG001|Overall Study|Adverse Event|0|||
155727020|NCT01342211|562099856|FG002|Overall Study|Adverse Event|0|||
155621901|NCT00385918|561707363|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
155621902|NCT00385918|561707361|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
155621903|NCT00385918|561707362|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
155621904|NCT00385918|561707363|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
155727021|NCT01342211|562099857|FG003|Overall Study|Adverse Event|0|||
155727022|NCT01342211|562099858|FG004|Overall Study|Adverse Event|1|||
155727023|NCT01342211|562099854|FG000|Overall Study|Withdrawal by Subject|0|||
155727024|NCT01342211|562099855|FG001|Overall Study|Withdrawal by Subject|0|||
155621905|NCT00385918|561707361|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
155621906|NCT00385918|561707362|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
155621907|NCT00385918|561707363|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
155621908|NCT00385918|561707361|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
155621909|NCT00385918|561707362|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
155621910|NCT00385918|561707363|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
155621911|NCT00385918|561707361|FG000|Intervention Phase After Randomization|Physician Decision|1|||
155621912|NCT00385918|561707362|FG001|Intervention Phase After Randomization|Physician Decision|0|||
155621913|NCT00385918|561707363|FG002|Intervention Phase After Randomization|Physician Decision|0|||
155621914|NCT00385918|561707361|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
155621915|NCT00385918|561707362|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
155621916|NCT00385918|561707363|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
155621917|NCT00128661|561707364|FG000|Overall Study|Adverse Event|14|||
155621918|NCT00128661|561707365|FG001|Overall Study|Adverse Event|11|||
155621919|NCT00128661|561707364|FG000|Overall Study|Lost to Follow-up|10|||
155621920|NCT00128661|561707365|FG001|Overall Study|Lost to Follow-up|7|||
155621921|NCT00128661|561707364|FG000|Overall Study|Withdrawal by Subject|243|||
155621922|NCT00128661|561707365|FG001|Overall Study|Withdrawal by Subject|232|||
155621923|NCT00128661|561707364|FG000|Overall Study|Other|7|||
155621924|NCT00128661|561707365|FG001|Overall Study|Other|8|||
155621925|NCT01261390|561707366|FG000|Overall Study|Significant Concurrent Illness|1|||
155621926|NCT01261390|561707367|FG001|Overall Study|Significant Concurrent Illness|0|||
155621927|NCT01261390|561707368|FG002|Overall Study|Significant Concurrent Illness|1|||
155621928|NCT01261390|561707369|FG003|Overall Study|Significant Concurrent Illness|0|||
155621929|NCT01261390|561707366|FG000|Overall Study|Dissatisfaction with Treatment|2|||
155621930|NCT01261390|561707367|FG001|Overall Study|Dissatisfaction with Treatment|1|||
155621931|NCT01261390|561707368|FG002|Overall Study|Dissatisfaction with Treatment|1|||
155621932|NCT01261390|561707369|FG003|Overall Study|Dissatisfaction with Treatment|2|||
155621933|NCT01261390|561707366|FG000|Overall Study|Relocation|0|||
155621934|NCT01261390|561707367|FG001|Overall Study|Relocation|1|||
155621935|NCT01261390|561707368|FG002|Overall Study|Relocation|0|||
155621936|NCT01261390|561707369|FG003|Overall Study|Relocation|0|||
155621937|NCT01261390|561707366|FG000|Overall Study|Loss of Interest in the Study|3|||
155621938|NCT01261390|561707367|FG001|Overall Study|Loss of Interest in the Study|1|||
155621939|NCT01261390|561707368|FG002|Overall Study|Loss of Interest in the Study|0|||
155621940|NCT01261390|561707369|FG003|Overall Study|Loss of Interest in the Study|0|||
155621941|NCT01261390|561707366|FG000|Overall Study|Lost to Follow-up|1|||
155621942|NCT01261390|561707367|FG001|Overall Study|Lost to Follow-up|6|||
155621943|NCT01261390|561707368|FG002|Overall Study|Lost to Follow-up|5|||
155621944|NCT01261390|561707369|FG003|Overall Study|Lost to Follow-up|6|||
155621945|NCT04010461|561707371|FG000|Overall Study|COVID based withdrawal|5|||
155621946|NCT04010461|561707371|FG000|Overall Study|Withdrawal by Subject|5|||
155621947|NCT04010461|561707371|FG000|Overall Study|Adverse Event|1|||
155621948|NCT04010461|561707371|FG000|Overall Study|No Motor Threshold obtainable|1|||
155621949|NCT04010461|561707371|FG000|Overall Study|Physician Decision|1|||
155621950|NCT00735007|561707376|FG000|Overall Study|Adverse Event|4|||
155621951|NCT00735007|561707376|FG000|Overall Study|Protocol Violation|1|||
155621952|NCT00715403|561707377|FG000|Overall Study|Progressive disease|0|||
155621953|NCT00715403|561707378|FG001|Overall Study|Progressive disease|1|||
155621954|NCT00715403|561707379|FG002|Overall Study|Progressive disease|3|||
155621955|NCT00715403|561707380|FG003|Overall Study|Progressive disease|9|||
155621956|NCT00715403|561707381|FG004|Overall Study|Progressive disease|5|||
155621957|NCT00715403|561707382|FG005|Overall Study|Progressive disease|14|||
155621958|NCT00715403|561707383|FG006|Overall Study|Progressive disease|1|||
155621959|NCT00715403|561707377|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621960|NCT00715403|561707378|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621961|NCT00715403|561707379|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621962|NCT00715403|561707380|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621963|NCT00715403|561707381|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621964|NCT00715403|561707382|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
155621965|NCT00715403|561707383|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
155621966|NCT00715403|561707377|FG000|Overall Study|Other Adverse Event than DLT|1|||
155621967|NCT00715403|561707378|FG001|Overall Study|Other Adverse Event than DLT|0|||
155621968|NCT00715403|561707379|FG002|Overall Study|Other Adverse Event than DLT|0|||
155621969|NCT00715403|561707380|FG003|Overall Study|Other Adverse Event than DLT|0|||
155727025|NCT01342211|562099856|FG002|Overall Study|Withdrawal by Subject|0|||
155727026|NCT01342211|562099857|FG003|Overall Study|Withdrawal by Subject|1|||
155621970|NCT00715403|561707381|FG004|Overall Study|Other Adverse Event than DLT|0|||
155621971|NCT00715403|561707382|FG005|Overall Study|Other Adverse Event than DLT|2|||
155621972|NCT00715403|561707383|FG006|Overall Study|Other Adverse Event than DLT|0|||
155621973|NCT00715403|561707377|FG000|Overall Study|Protocol Violation|0|||
155621974|NCT00715403|561707378|FG001|Overall Study|Protocol Violation|0|||
155621975|NCT00715403|561707379|FG002|Overall Study|Protocol Violation|0|||
155621976|NCT00715403|561707380|FG003|Overall Study|Protocol Violation|0|||
155621977|NCT00715403|561707381|FG004|Overall Study|Protocol Violation|0|||
155621978|NCT00715403|561707382|FG005|Overall Study|Protocol Violation|1|||
155621979|NCT00715403|561707383|FG006|Overall Study|Protocol Violation|0|||
155621980|NCT00715403|561707377|FG000|Overall Study|Other reason not defined above|0|||
155621981|NCT00715403|561707378|FG001|Overall Study|Other reason not defined above|0|||
155621982|NCT00715403|561707379|FG002|Overall Study|Other reason not defined above|1|||
155621983|NCT00715403|561707380|FG003|Overall Study|Other reason not defined above|0|||
155621984|NCT00715403|561707381|FG004|Overall Study|Other reason not defined above|1|||
155621985|NCT00715403|561707382|FG005|Overall Study|Other reason not defined above|1|||
155621986|NCT00715403|561707383|FG006|Overall Study|Other reason not defined above|0|||
155621987|NCT03839394|561707390|FG000|Overall Study|Lost to Follow-up|6|||
155621988|NCT03839394|561707391|FG001|Overall Study|Lost to Follow-up|8|||
155621989|NCT03839394|561707390|FG000|Overall Study|Withdrawal by Subject|0|||
155621990|NCT03839394|561707391|FG001|Overall Study|Withdrawal by Subject|2|||
155621991|NCT01931397|561707394|FG000|Overall Study|Physician Decision|2|||
155621992|NCT01931397|561707394|FG000|Overall Study|Withdrawal by Subject|8|||
155621993|NCT01931397|561707394|FG000|Overall Study|moved out of state|1|||
155621994|NCT02346877|561707398|FG000|Overall Study|Adverse Event|1|||
155621995|NCT02346877|561707399|FG001|Overall Study|Adverse Event|0|||
155621996|NCT02346877|561707398|FG000|Overall Study|Administrative Decision|1|||
155621997|NCT02346877|561707399|FG001|Overall Study|Administrative Decision|0|||
155621998|NCT02346877|561707398|FG000|Overall Study|Sponsor Decision|12|||
155621999|NCT02346877|561707399|FG001|Overall Study|Sponsor Decision|0|||
155622000|NCT02346877|561707398|FG000|Overall Study|Missing|5|||
155622001|NCT02346877|561707399|FG001|Overall Study|Missing|0|||
155622002|NCT00565604|561707400|FG000|Overall Study|Failure to treat|2|||
155622003|NCT00565604|561707400|FG000|Overall Study|Lost to Follow-up|2|||
155622004|NCT00329108|561709501|FG000|Overall Study|Adverse Event|2|||
155622005|NCT00329108|561709502|FG001|Overall Study|Adverse Event|2|||
155622006|NCT00329108|561709501|FG000|Overall Study|Lack of Efficacy|3|||
155622007|NCT00329108|561709502|FG001|Overall Study|Lack of Efficacy|3|||
155622008|NCT00329108|561709501|FG000|Overall Study|Withdrawal by Subject|0|||
155622009|NCT00329108|561709502|FG001|Overall Study|Withdrawal by Subject|2|||
155622010|NCT00329108|561709501|FG000|Overall Study|symptomatic deterioration|1|||
155622011|NCT00329108|561709502|FG001|Overall Study|symptomatic deterioration|1|||
155622012|NCT00329108|561709501|FG000|Overall Study|Subject no longer willing to participate|2|||
155622013|NCT00329108|561709502|FG001|Overall Study|Subject no longer willing to participate|2|||
155622014|NCT00329108|561709501|FG000|Overall Study|study terminated by sponsor|1|||
155622015|NCT00329108|561709502|FG001|Overall Study|study terminated by sponsor|0|||
155622016|NCT00329108|561709501|FG000|Overall Study|withdrew patient after SAE resolved|1|||
155622017|NCT00329108|561709502|FG001|Overall Study|withdrew patient after SAE resolved|0|||
155622018|NCT00329108|561709501|FG000|Overall Study|Protocol Violation|0|||
155622019|NCT00329108|561709502|FG001|Overall Study|Protocol Violation|2|||
155622020|NCT00754741|561709503|FG000|Overall Study|Died or disenrolled|57|||
155622021|NCT00754741|561709504|FG001|Overall Study|Died or disenrolled|69|||
155622022|NCT00754741|561709505|FG002|Overall Study|Died or disenrolled|54|||
155622023|NCT04969289|561709507|FG000|Overall Study|Lost to Follow-up|13|||
155622024|NCT04969289|561709508|FG001|Overall Study|Lost to Follow-up|9|||
155622025|NCT00593814|561709509|FG000|Overall Study|Death|7|||
155622026|NCT00593814|561709510|FG001|Overall Study|Death|0|||
155622027|NCT00593814|561709509|FG000|Overall Study|Withdrawal by Subject|7|||
155622028|NCT00593814|561709510|FG001|Overall Study|Withdrawal by Subject|0|||
155622029|NCT00593814|561709509|FG000|Overall Study|Lost to Follow-up|7|||
155622030|NCT00593814|561709510|FG001|Overall Study|Lost to Follow-up|0|||
155622031|NCT00593814|561709509|FG000|Overall Study|Physician Decision|3|||
155622032|NCT00593814|561709510|FG001|Overall Study|Physician Decision|0|||
155622033|NCT01921517|561709511|FG000|Overall Study|Lost to Follow-up|5|||
155622034|NCT01921517|561709512|FG001|Overall Study|Lost to Follow-up|0|||
155622035|NCT01921517|561709511|FG000|Overall Study|Newly diagnosed health concern|2|||
155622036|NCT01921517|561709512|FG001|Overall Study|Newly diagnosed health concern|0|||
155622037|NCT01921517|561709511|FG000|Overall Study|Physician Decision|0|||
155622038|NCT01921517|561709512|FG001|Overall Study|Physician Decision|2|||
155622039|NCT01921517|561709511|FG000|Overall Study|Withdrawal by Subject|7|||
155622040|NCT01921517|561709512|FG001|Overall Study|Withdrawal by Subject|3|||
155622041|NCT01921517|561709511|FG000|Overall Study|Subject missed final imaging|1|||
155622042|NCT01921517|561709512|FG001|Overall Study|Subject missed final imaging|4|||
155622043|NCT02486692|561709518|FG000|Overall Study|did not login for randomization|4|||
155622044|NCT02486692|561709519|FG001|Overall Study|did not login for randomization|7|||
155622045|NCT00116688|561709523|FG000|Overall Study|Protocol deviation|1|||
155622046|NCT00116688|561709524|FG001|Overall Study|Protocol deviation|0|||
155622047|NCT00116688|561709523|FG000|Overall Study|Noncompliance|3|||
155622048|NCT00116688|561709524|FG001|Overall Study|Noncompliance|1|||
155622049|NCT00116688|561709523|FG000|Overall Study|Adverse Event|11|||
155622050|NCT00116688|561709524|FG001|Overall Study|Adverse Event|0|||
155622051|NCT00116688|561709523|FG000|Overall Study|Withdrawal by Subject|26|||
155622052|NCT00116688|561709524|FG001|Overall Study|Withdrawal by Subject|2|||
155622053|NCT00116688|561709523|FG000|Overall Study|Requirement for alternative therapy|11|||
155622054|NCT00116688|561709524|FG001|Overall Study|Requirement for alternative therapy|1|||
155622055|NCT00116688|561709523|FG000|Overall Study|Physician Decision|7|||
155622056|NCT00116688|561709524|FG001|Overall Study|Physician Decision|0|||
155622057|NCT00116688|561709523|FG000|Overall Study|Lost to Follow-up|3|||
155622058|NCT00116688|561709524|FG001|Overall Study|Lost to Follow-up|0|||
155622059|NCT00116688|561709523|FG000|Overall Study|Death|15|||
155622060|NCT00116688|561709524|FG001|Overall Study|Death|0|||
155622061|NCT00116688|561709523|FG000|Overall Study|Protocol-specified criteria|3|||
155622062|NCT00116688|561709524|FG001|Overall Study|Protocol-specified criteria|0|||
155622063|NCT00116688|561709523|FG000|Overall Study|Pregnancy|1|||
155622064|NCT00116688|561709524|FG001|Overall Study|Pregnancy|0|||
155622065|NCT00116688|561709523|FG000|Overall Study|Other|11|||
155622066|NCT00116688|561709524|FG001|Overall Study|Other|0|||
155622067|NCT01775670|561709530|FG000|Overall Study|Lost to Follow-up|1|||
155622068|NCT01775670|561709531|FG001|Overall Study|Lost to Follow-up|1|||
155622069|NCT01298700|561709532|FG000|Overall Study|Adverse Event|50|||
155622070|NCT01298700|561709533|FG001|Overall Study|Adverse Event|51|||
155622071|NCT01298700|561709532|FG000|Overall Study|Lack of Efficacy|9|||
155622072|NCT01298700|561709533|FG001|Overall Study|Lack of Efficacy|14|||
155622073|NCT01298700|561709532|FG000|Overall Study|Lost to Follow-up|5|||
155622074|NCT01298700|561709533|FG001|Overall Study|Lost to Follow-up|2|||
155622075|NCT01298700|561709532|FG000|Overall Study|Withdrawal by Subject|12|||
155622076|NCT01298700|561709533|FG001|Overall Study|Withdrawal by Subject|9|||
155622077|NCT01298700|561709532|FG000|Overall Study|Protocol Violation|6|||
155622078|NCT01298700|561709533|FG001|Overall Study|Protocol Violation|4|||
155622079|NCT01298700|561709532|FG000|Overall Study|Other Miscellaneous Reasons|16|||
155622080|NCT01298700|561709533|FG001|Overall Study|Other Miscellaneous Reasons|15|||
155622081|NCT01298700|561709532|FG000|Overall Study|Did not Receive Study Drug|3|||
155622082|NCT01298700|561709533|FG001|Overall Study|Did not Receive Study Drug|5|||
155622083|NCT04006145|561709534|FG000|Overall Study|Lost to Follow-up|0|||
155622084|NCT04006145|561709535|FG001|Overall Study|Lost to Follow-up|1|||
155622085|NCT04006145|561709534|FG000|Overall Study|Other|1|||
155622086|NCT04006145|561709535|FG001|Overall Study|Other|2|||
155622087|NCT01001429|561709536|FG000|Overall Study|surgery cancelled|0|||
155622088|NCT01001429|561709537|FG001|Overall Study|surgery cancelled|1|||
155622089|NCT00010257|561709540|FG000|Overall Study|Withdrawal by Subject|1|||
155622090|NCT00010257|561709541|FG001|Overall Study|Withdrawal by Subject|0|||
155622091|NCT00643760|561709544|FG000|Overall Study|Adverse Event|11|||
155622092|NCT00643760|561709545|FG001|Overall Study|Adverse Event|5|||
155622093|NCT00643760|561709546|FG002|Overall Study|Adverse Event|12|||
155622094|NCT00643760|561709547|FG003|Overall Study|Adverse Event|21|||
155622095|NCT00643760|561709548|FG004|Overall Study|Adverse Event|6|||
155622096|NCT00643760|561709544|FG000|Overall Study|Lack of Efficacy|3|||
155622097|NCT00643760|561709545|FG001|Overall Study|Lack of Efficacy|1|||
155622098|NCT00643760|561709546|FG002|Overall Study|Lack of Efficacy|0|||
155622099|NCT00643760|561709547|FG003|Overall Study|Lack of Efficacy|4|||
155622100|NCT00643760|561709548|FG004|Overall Study|Lack of Efficacy|3|||
155622101|NCT00643760|561709544|FG000|Overall Study|Protocol Violation|7|||
155622102|NCT00643760|561709545|FG001|Overall Study|Protocol Violation|6|||
155622103|NCT00643760|561709546|FG002|Overall Study|Protocol Violation|4|||
155622104|NCT00643760|561709547|FG003|Overall Study|Protocol Violation|4|||
155622105|NCT00643760|561709548|FG004|Overall Study|Protocol Violation|6|||
155622106|NCT00643760|561709544|FG000|Overall Study|Lost to Follow-up|6|||
155622107|NCT00643760|561709545|FG001|Overall Study|Lost to Follow-up|2|||
155622108|NCT00643760|561709546|FG002|Overall Study|Lost to Follow-up|1|||
155622109|NCT00643760|561709547|FG003|Overall Study|Lost to Follow-up|3|||
155622110|NCT00643760|561709548|FG004|Overall Study|Lost to Follow-up|3|||
155622111|NCT00643760|561709544|FG000|Overall Study|Investigator Discretion|0|||
155622112|NCT00643760|561709545|FG001|Overall Study|Investigator Discretion|0|||
155622113|NCT00643760|561709546|FG002|Overall Study|Investigator Discretion|0|||
155622114|NCT00643760|561709547|FG003|Overall Study|Investigator Discretion|2|||
155622115|NCT00643760|561709548|FG004|Overall Study|Investigator Discretion|0|||
155622116|NCT00643760|561709544|FG000|Overall Study|Withdrawal by Subject|3|||
155622117|NCT00643760|561709545|FG001|Overall Study|Withdrawal by Subject|1|||
155622118|NCT00643760|561709546|FG002|Overall Study|Withdrawal by Subject|2|||
155622119|NCT00643760|561709547|FG003|Overall Study|Withdrawal by Subject|4|||
155622120|NCT00643760|561709548|FG004|Overall Study|Withdrawal by Subject|1|||
155622121|NCT02063672|561709552|FG000|Overall Study|Ongoing Follow-up|27|||
155622122|NCT02063672|561709553|FG001|Overall Study|Ongoing Follow-up|14|||
155622123|NCT02063672|561709552|FG000|Overall Study|Death|5|||
155622124|NCT02063672|561709553|FG001|Overall Study|Death|3|||
155622125|NCT02063672|561709552|FG000|Overall Study|Lost to Follow-up|1|||
155622126|NCT02063672|561709553|FG001|Overall Study|Lost to Follow-up|3|||
155622127|NCT02063672|561709552|FG000|Overall Study|Withdrawal by Subject|2|||
155622128|NCT02063672|561709553|FG001|Overall Study|Withdrawal by Subject|2|||
155622129|NCT01307787|561709554|FG000|Overall Study|Withdrawal by Subject|2|||
155622130|NCT01307787|561709555|FG001|Overall Study|Withdrawal by Subject|0|||
155622131|NCT03353792|561709560|FG000|Overall Study|Lost to Follow-up|1|||
155622132|NCT03353792|561709561|FG001|Overall Study|Lost to Follow-up|0|||
155622133|NCT03353792|561709560|FG000|Overall Study|Participant Unable to Manage Device|1|||
155622134|NCT03353792|561709561|FG001|Overall Study|Participant Unable to Manage Device|0|||
155622135|NCT00789321|561709562|FG000|Overall Study|Adverse Event|0|||
155622136|NCT00789321|561709563|FG001|Overall Study|Adverse Event|1|||
155622137|NCT01965327|561709564|FG000|Overall Study|Physician Decision|2|||
155622138|NCT00104052|561709565|FG000|Overall Study|Adverse Event|1|||
155622139|NCT00104052|561709565|FG000|Overall Study|Lack of Efficacy|26|||
155622140|NCT00104052|561709565|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
155622141|NCT02498678|561709568|FG000|Overall Study|interference from the surgical team|0|||
155622142|NCT02498678|561709569|FG001|Overall Study|interference from the surgical team|2|||
155622143|NCT03652818|561709571|FG000|Overall Study|Adverse Event|1|||
155622144|NCT03652818|561709572|FG001|Overall Study|Adverse Event|0|||
155622145|NCT03652818|561709573|FG002|Overall Study|Adverse Event|0|||
155622146|NCT03652818|561709574|FG003|Overall Study|Adverse Event|0|||
155622147|NCT03652818|561709575|FG004|Overall Study|Adverse Event|0|||
155622148|NCT03652818|561709571|FG000|Overall Study|Physician Decision|1|||
155622149|NCT03652818|561709572|FG001|Overall Study|Physician Decision|0|||
155622150|NCT03652818|561709573|FG002|Overall Study|Physician Decision|0|||
155622151|NCT03652818|561709574|FG003|Overall Study|Physician Decision|0|||
155622152|NCT03652818|561709575|FG004|Overall Study|Physician Decision|0|||
155622153|NCT03652818|561709571|FG000|Overall Study|Lost to Follow-up|0|||
155622154|NCT03652818|561709572|FG001|Overall Study|Lost to Follow-up|1|||
155622155|NCT03652818|561709573|FG002|Overall Study|Lost to Follow-up|2|||
155622156|NCT03652818|561709574|FG003|Overall Study|Lost to Follow-up|1|||
155622157|NCT03652818|561709575|FG004|Overall Study|Lost to Follow-up|1|||
155622158|NCT01294423|561709580|FG000|Overall Study|Adverse Event|1|||
155622159|NCT01294423|561709581|FG001|Overall Study|Adverse Event|2|||
155622160|NCT01294423|561709582|FG002|Overall Study|Adverse Event|3|||
155622161|NCT01294423|561709580|FG000|Overall Study|Withdrawal by Subject|1|||
155622162|NCT01294423|561709581|FG001|Overall Study|Withdrawal by Subject|2|||
155622163|NCT01294423|561709582|FG002|Overall Study|Withdrawal by Subject|2|||
155622164|NCT01294423|561709580|FG000|Overall Study|subject no longer meets study criteria|2|||
155622165|NCT01294423|561709581|FG001|Overall Study|subject no longer meets study criteria|5|||
155622166|NCT01294423|561709582|FG002|Overall Study|subject no longer meets study criteria|2|||
155622167|NCT01294423|561709580|FG000|Overall Study|poor/non-compliance|1|||
155622168|NCT01294423|561709581|FG001|Overall Study|poor/non-compliance|0|||
155622169|NCT01294423|561709582|FG002|Overall Study|poor/non-compliance|1|||
155622170|NCT01241279|561709583|FG000|Overall Study|Lost to Follow-up|0|||
155622171|NCT01241279|561709584|FG001|Overall Study|Lost to Follow-up|1|||
155622172|NCT01145482|561709585|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155622173|NCT01145482|561709586|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155622174|NCT01699750|561709591|FG000|Overall Study|Withdrew Consent|0|||
155622175|NCT01699750|561709592|FG001|Overall Study|Withdrew Consent|1|||
155622176|NCT01699750|561709591|FG000|Overall Study|Other|0|||
155622177|NCT01699750|561709592|FG001|Overall Study|Other|2|||
155622178|NCT01484951|561709593|FG000|Overall Study|Adverse Event|3|||
155622179|NCT01484951|561709593|FG000|Overall Study|Personal Reasons|1|||
155622180|NCT01484951|561709593|FG000|Overall Study|Non-Compliance|1|||
155622181|NCT02452047|561709594|FG000|Overall Study|Adverse Event|0|||
155622182|NCT02452047|561709595|FG001|Overall Study|Adverse Event|1|||
155622183|NCT02452047|561709596|FG002|Overall Study|Adverse Event|1|||
155622184|NCT02452047|561709594|FG000|Overall Study|Death|1|||
155622185|NCT02452047|561709595|FG001|Overall Study|Death|3|||
155622186|NCT02452047|561709596|FG002|Overall Study|Death|1|||
155622187|NCT02452047|561709594|FG000|Overall Study|Physician Decision|1|||
155622188|NCT02452047|561709595|FG001|Overall Study|Physician Decision|0|||
155622189|NCT02452047|561709596|FG002|Overall Study|Physician Decision|0|||
155622190|NCT02452047|561709594|FG000|Overall Study|Lost to Follow-up|1|||
155622191|NCT02452047|561709595|FG001|Overall Study|Lost to Follow-up|1|||
155622192|NCT02452047|561709596|FG002|Overall Study|Lost to Follow-up|0|||
155622193|NCT02452047|561709594|FG000|Overall Study|Withdrawal by Subject|1|||
155622194|NCT02452047|561709595|FG001|Overall Study|Withdrawal by Subject|0|||
155622195|NCT02452047|561709596|FG002|Overall Study|Withdrawal by Subject|0|||
155622196|NCT00917124|561709597|FG000|Overall Study|Protocol Violation|4|||
155622197|NCT00917124|561709598|FG001|Overall Study|Protocol Violation|6|||
155622198|NCT03933449|561709604|FG000|Overall Study|Adverse Event|6|||
155622199|NCT03933449|561709605|FG001|Overall Study|Adverse Event|4|||
155622200|NCT03933449|561709604|FG000|Overall Study|Death|55|||
155622201|NCT03933449|561709605|FG001|Overall Study|Death|57|||
155622202|NCT03933449|561709604|FG000|Overall Study|Sponsor Decision|1|||
155622203|NCT03933449|561709605|FG001|Overall Study|Sponsor Decision|0|||
155622204|NCT02087774|561709606|FG000|Overall Study|Were absent day of data collection|8|||
155622205|NCT02087774|561709607|FG001|Overall Study|Were absent day of data collection|20|||
155622206|NCT01529606|561709608|FG000|Overall Study|Lost to Follow-up|21|||
155622207|NCT01529606|561709609|FG001|Overall Study|Lost to Follow-up|18|||
155622208|NCT05209880|561709614|FG000|1-Month Follow-up|Spoke with Doctor|5|||
155622209|NCT05209880|561709615|FG001|1-Month Follow-up|Spoke with Doctor|5|||
155622210|NCT05209880|561709614|FG000|1-Month Follow-up|Lost to Follow-up|7|||
155622211|NCT05209880|561709615|FG001|1-Month Follow-up|Lost to Follow-up|9|||
155277332|NCT04423393|560449034|FG011|Overall Study|Withdrawal by Subject|0|||
155277333|NCT04423393|560449035|FG012|Overall Study|Withdrawal by Subject|0|||
155277334|NCT04423393|560449036|FG013|Overall Study|Withdrawal by Subject|1|||
155277335|NCT04423393|560449037|FG014|Overall Study|Withdrawal by Subject|0|||
155277336|NCT04423393|560449038|FG015|Overall Study|Withdrawal by Subject|0|||
155277337|NCT04423393|560449039|FG016|Overall Study|Withdrawal by Subject|0|||
155277338|NCT04423393|560449040|FG017|Overall Study|Withdrawal by Subject|0|||
155277339|NCT04423393|560449023|FG000|Overall Study|Sponsor Decision|0|||
155277340|NCT04423393|560449024|FG001|Overall Study|Sponsor Decision|0|||
155277341|NCT04423393|560449025|FG002|Overall Study|Sponsor Decision|0|||
155277342|NCT04423393|560449026|FG003|Overall Study|Sponsor Decision|0|||
155277343|NCT04423393|560449027|FG004|Overall Study|Sponsor Decision|0|||
155277344|NCT04423393|560449028|FG005|Overall Study|Sponsor Decision|0|||
155277345|NCT04423393|560449029|FG006|Overall Study|Sponsor Decision|0|||
155277346|NCT04423393|560449030|FG007|Overall Study|Sponsor Decision|0|||
155277347|NCT04423393|560449031|FG008|Overall Study|Sponsor Decision|0|||
155277348|NCT04423393|560449032|FG009|Overall Study|Sponsor Decision|0|||
155277349|NCT04423393|560449033|FG010|Overall Study|Sponsor Decision|0|||
155277350|NCT04423393|560449034|FG011|Overall Study|Sponsor Decision|0|||
155277351|NCT04423393|560449035|FG012|Overall Study|Sponsor Decision|0|||
155277352|NCT04423393|560449036|FG013|Overall Study|Sponsor Decision|1|||
155277353|NCT04423393|560449037|FG014|Overall Study|Sponsor Decision|0|||
155277354|NCT04423393|560449038|FG015|Overall Study|Sponsor Decision|0|||
155277355|NCT04423393|560449039|FG016|Overall Study|Sponsor Decision|0|||
155277356|NCT04423393|560449040|FG017|Overall Study|Sponsor Decision|0|||
155277357|NCT05220501|560449041|FG000|Overall Study|Withdrawal by Subject|11|||
155277358|NCT05220501|560449042|FG001|Overall Study|Withdrawal by Subject|21|||
155277359|NCT05220501|560449043|FG002|Overall Study|Withdrawal by Subject|32|||
155277360|NCT05220501|560449041|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
155277361|NCT05220501|560449042|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
155277362|NCT05220501|560449043|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
155277363|NCT01929993|560449044|FG000|Overall Study|Protocol Violation|4|||
155277364|NCT01929993|560449045|FG001|Overall Study|Protocol Violation|6|||
155277365|NCT01929993|560449044|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
155277366|NCT01929993|560449045|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
155277367|NCT01440049|560449050|FG000|Overall Study|Adverse Event|5|||
155277368|NCT02268552|560449051|FG000|Part 1|Death|1|||
155277369|NCT02268552|560449052|FG001|Part 1|Death|1|||
155277370|NCT02268552|560449053|FG002|Part 1|Death|1|||
155277371|NCT02268552|560449054|FG003|Part 1|Death|2|||
155277372|NCT02268552|560449055|FG004|Part 1|Death|0|||
155277373|NCT02268552|560449056|FG005|Part 1|Death|0|||
155277374|NCT02268552|560449057|FG006|Part 1|Death|0|||
155277375|NCT02268552|560449051|FG000|Part 1|Subject/guardian decision|0|||
155277376|NCT02268552|560449052|FG001|Part 1|Subject/guardian decision|0|||
155277377|NCT02268552|560449053|FG002|Part 1|Subject/guardian decision|0|||
155277378|NCT02268552|560449054|FG003|Part 1|Subject/guardian decision|1|||
155277379|NCT02268552|560449055|FG004|Part 1|Subject/guardian decision|0|||
155277380|NCT02268552|560449056|FG005|Part 1|Subject/guardian decision|0|||
155277381|NCT02268552|560449057|FG006|Part 1|Subject/guardian decision|0|||
155277382|NCT02268552|560449051|FG000|Part 2|Death|0|||
155277383|NCT02268552|560449052|FG001|Part 2|Death|0|||
155277384|NCT02268552|560449053|FG002|Part 2|Death|0|||
155277385|NCT02268552|560449054|FG003|Part 2|Death|0|||
155277386|NCT02268552|560449055|FG004|Part 2|Death|0|||
155277387|NCT02268552|560449056|FG005|Part 2|Death|0|||
155277388|NCT02268552|560449057|FG006|Part 2|Death|2|||
155277389|NCT02268552|560449051|FG000|Part 2|Subject/guardian decision|0|||
155277390|NCT02268552|560449052|FG001|Part 2|Subject/guardian decision|0|||
155277391|NCT02268552|560449053|FG002|Part 2|Subject/guardian decision|0|||
155277392|NCT02268552|560449054|FG003|Part 2|Subject/guardian decision|0|||
155277393|NCT02268552|560449055|FG004|Part 2|Subject/guardian decision|0|||
155277394|NCT02268552|560449056|FG005|Part 2|Subject/guardian decision|0|||
155277395|NCT02268552|560449057|FG006|Part 2|Subject/guardian decision|1|||
155277396|NCT02268552|560449051|FG000|Part 3 Extension|Death|0|||
155277397|NCT02268552|560449052|FG001|Part 3 Extension|Death|1|||
155622212|NCT05209880|561709614|FG000|1-Month Follow-up|Discontinued|0|||
155277398|NCT02268552|560449053|FG002|Part 3 Extension|Death|1|||
155277399|NCT02268552|560449054|FG003|Part 3 Extension|Death|1|||
155277400|NCT02268552|560449055|FG004|Part 3 Extension|Death|1|||
155277401|NCT02268552|560449056|FG005|Part 3 Extension|Death|1|||
155277402|NCT02268552|560449057|FG006|Part 3 Extension|Death|0|||
155277403|NCT02268552|560449051|FG000|Part 3 Extension|Early termination of trial|1|||
155277404|NCT02268552|560449052|FG001|Part 3 Extension|Early termination of trial|0|||
155277405|NCT02268552|560449053|FG002|Part 3 Extension|Early termination of trial|0|||
155277406|NCT02268552|560449054|FG003|Part 3 Extension|Early termination of trial|0|||
155277407|NCT02268552|560449055|FG004|Part 3 Extension|Early termination of trial|2|||
155277408|NCT02268552|560449056|FG005|Part 3 Extension|Early termination of trial|9|||
155622213|NCT05209880|561709615|FG001|1-Month Follow-up|Discontinued|1|||
155622214|NCT05209880|561709614|FG000|3-Month Follow-up|Spoke with Doctor|17|||
155622215|NCT05209880|561709615|FG001|3-Month Follow-up|Spoke with Doctor|7|||
155622216|NCT05209880|561709614|FG000|3-Month Follow-up|Lost to Follow-up|8|||
155622217|NCT05209880|561709615|FG001|3-Month Follow-up|Lost to Follow-up|10|||
155622218|NCT05209880|561709614|FG000|3-Month Follow-up|Discontinued|1|||
155622219|NCT05209880|561709615|FG001|3-Month Follow-up|Discontinued|3|||
155622220|NCT05209880|561709614|FG000|6-Month Follow-up|Spoke with Doctor|25|||
155622221|NCT05209880|561709615|FG001|6-Month Follow-up|Spoke with Doctor|14|||
155622222|NCT05209880|561709614|FG000|6-Month Follow-up|Lost to Follow-up|9|||
155622223|NCT05209880|561709615|FG001|6-Month Follow-up|Lost to Follow-up|14|||
155622224|NCT05209880|561709614|FG000|6-Month Follow-up|Discontinued|1|||
155622225|NCT05209880|561709615|FG001|6-Month Follow-up|Discontinued|3|||
155622226|NCT03143101|561709618|FG000|Overall Study|Withdrawal by Subject|0|||
155622227|NCT03143101|561709619|FG001|Overall Study|Withdrawal by Subject|1|||
155622228|NCT03143101|561709620|FG002|Overall Study|Withdrawal by Subject|0|||
155277409|NCT02268552|560449057|FG006|Part 3 Extension|Early termination of trial|11|||
155277410|NCT02268552|560449051|FG000|Part 3 Extension|Subject/guardian decision|0|||
155277411|NCT02268552|560449052|FG001|Part 3 Extension|Subject/guardian decision|0|||
155277412|NCT02268552|560449053|FG002|Part 3 Extension|Subject/guardian decision|0|||
155277413|NCT02268552|560449054|FG003|Part 3 Extension|Subject/guardian decision|0|||
155277414|NCT02268552|560449055|FG004|Part 3 Extension|Subject/guardian decision|0|||
155277415|NCT02268552|560449056|FG005|Part 3 Extension|Subject/guardian decision|0|||
155277416|NCT02268552|560449057|FG006|Part 3 Extension|Subject/guardian decision|1|||
155277417|NCT00661258|560449060|FG000|Overall Study|Death|1|||
155277418|NCT00661258|560449061|FG001|Overall Study|Death|0|||
155277419|NCT00661258|560449060|FG000|Overall Study|caught by police and in detox center|2|||
155277420|NCT00661258|560449061|FG001|Overall Study|caught by police and in detox center|1|||
155277421|NCT01708187|560449062|FG000|Overall Study|Lost to Follow-up|0|||
155277422|NCT01708187|560449063|FG001|Overall Study|Lost to Follow-up|1|||
155277423|NCT04242875|560449064|FG000|Overall Study|Adverse Event|2|||
155277424|NCT02408549|560449066|FG000|Overall Study|Adverse Event|15|||
155277425|NCT02408549|560449066|FG000|Overall Study|Death|4|||
155277426|NCT02408549|560449066|FG000|Overall Study|Lack of Efficacy|17|||
155277427|NCT02408549|560449066|FG000|Overall Study|Protocol Violation|4|||
155277428|NCT02408549|560449066|FG000|Overall Study|Lost to Follow-up|6|||
155277429|NCT02408549|560449066|FG000|Overall Study|Consent withdrawn|30|||
155277430|NCT02408549|560449066|FG000|Overall Study|Neurology research program closing at site|1|||
155277431|NCT02408549|560449066|FG000|Overall Study|Site closure|1|||
155277432|NCT02408549|560449066|FG000|Overall Study|Pregnancy|1|||
155277433|NCT02408549|560449066|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
155277434|NCT02408549|560449066|FG000|Overall Study|Subject moved to another place, far from site|1|||
155277435|NCT02408549|560449066|FG000|Overall Study|Study terminated at site|1|||
155277436|NCT00231894|560449067|FG000|Overall Study|Withdrawal by Subject|1|||
155277437|NCT00231894|560449068|FG001|Overall Study|Withdrawal by Subject|1|||
155277438|NCT01232556|560449071|FG000|Overall Study|Withdrawal by Subject|21|||
155277439|NCT01232556|560449072|FG001|Overall Study|Withdrawal by Subject|17|||
155277440|NCT01232556|560449071|FG000|Overall Study|Death|97|||
155277441|NCT01232556|560449072|FG001|Overall Study|Death|97|||
155277442|NCT01232556|560449071|FG000|Overall Study|Lost to Follow-up|0|||
155277443|NCT01232556|560449072|FG001|Overall Study|Lost to Follow-up|2|||
155277444|NCT01232556|560449071|FG000|Overall Study|Terminated by Sponsor|35|||
155277445|NCT01232556|560449072|FG001|Overall Study|Terminated by Sponsor|51|||
155277446|NCT01232556|560449071|FG000|Overall Study|Other|6|||
155277447|NCT01232556|560449072|FG001|Overall Study|Other|4|||
155277448|NCT01628510|560449073|FG000|Overall Study|Withdrawal by Subject|0|||
155277449|NCT01628510|560449074|FG001|Overall Study|Withdrawal by Subject|4|||
155277450|NCT01628510|560449073|FG000|Overall Study|Death|3|||
155277451|NCT01628510|560449074|FG001|Overall Study|Death|1|||
155277452|NCT04707391|560449075|FG000|Overall Study|Adverse Event|5|||
155277453|NCT04707391|560449076|FG001|Overall Study|Adverse Event|8|||
155277454|NCT04707391|560449075|FG000|Overall Study|Lost to Follow-up|44|||
155277455|NCT04707391|560449076|FG001|Overall Study|Lost to Follow-up|31|||
155622229|NCT03143101|561709618|FG000|Overall Study|Lost to Follow-up|2|||
155622230|NCT03143101|561709619|FG001|Overall Study|Lost to Follow-up|2|||
155622231|NCT03143101|561709620|FG002|Overall Study|Lost to Follow-up|0|||
155277456|NCT04707391|560449075|FG000|Overall Study|Protocol Violation|1|||
155277457|NCT04707391|560449076|FG001|Overall Study|Protocol Violation|5|||
155277458|NCT04707391|560449075|FG000|Overall Study|Withdrawal by Subject|27|||
155277459|NCT04707391|560449076|FG001|Overall Study|Withdrawal by Subject|25|||
155277460|NCT04707391|560449075|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
155277461|NCT04707391|560449076|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
155622232|NCT01601496|561709623|FG000|Overall Study|Physician Decision|1|||
155277462|NCT04707391|560449075|FG000|Overall Study|Other|0|||
155277463|NCT04707391|560449076|FG001|Overall Study|Other|2|||
155622233|NCT01601496|561709623|FG000|Overall Study|Withdrawal by Subject|1|||
155622234|NCT01601496|561709623|FG000|Overall Study|Lost to Follow-up|6|||
155622235|NCT01601496|561709623|FG000|Overall Study|Death|4|||
155622236|NCT01601496|561709623|FG000|Overall Study|Other: patient refusal to continue|3|||
155622237|NCT02689804|561709624|FG000|Overall Study|Withdrawal by Subject|2|||
155622238|NCT02689804|561709625|FG001|Overall Study|Withdrawal by Subject|0|||
155622239|NCT02782741|561709626|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
155622240|NCT02782741|561709627|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
155622241|NCT02782741|561709628|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
155622242|NCT02782741|561709626|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
155622243|NCT02782741|561709627|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
155622244|NCT02782741|561709628|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
155622245|NCT02782741|561709626|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
155622246|NCT02782741|561709627|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
155622247|NCT02782741|561709628|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
155622248|NCT02782741|561709626|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
155622249|NCT02782741|561709627|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
155622250|NCT02782741|561709628|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
155622251|NCT02782741|561709626|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
155622252|NCT02782741|561709627|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
155622253|NCT02782741|561709628|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
155622254|NCT04157088|561709629|FG000|Overall Study|Study terminated by sponsor|23|||
155622255|NCT04157088|561709629|FG000|Overall Study|Withdrawal by Subject|4|||
155622256|NCT04157088|561709629|FG000|Overall Study|Lost to Follow-up|2|||
155622257|NCT04157088|561709629|FG000|Overall Study|Death|1|||
155622258|NCT02421419|561709630|FG000|Overall Study|Physician Decision|0|||
155622259|NCT02421419|561709631|FG001|Overall Study|Physician Decision|0|||
155622260|NCT02421419|561709632|FG002|Overall Study|Physician Decision|1|||
155622261|NCT01676701|561709634|FG000|Overall Study|Protocol Violation|1|||
155622262|NCT01676701|561709635|FG001|Overall Study|Protocol Violation|0|||
155622263|NCT01676701|561709634|FG000|Overall Study|Sponsor Decision|3|||
155622264|NCT01676701|561709635|FG001|Overall Study|Sponsor Decision|4|||
155622265|NCT04863872|561709636|FG000|Overall Study|Withdrawal by Subject|4|||
155622266|NCT04863872|561709637|FG001|Overall Study|Withdrawal by Subject|15|||
155622267|NCT04863872|561709636|FG000|Overall Study|Death|5|||
155622268|NCT04863872|561709637|FG001|Overall Study|Death|2|||
155622269|NCT04863872|561709636|FG000|Overall Study|Lost to Follow-up|2|||
155622270|NCT04863872|561709637|FG001|Overall Study|Lost to Follow-up|1|||
155622271|NCT01497067|561709638|FG000|Overall Study|Lost to Follow-up|56|||
155622272|NCT01497067|561709638|FG000|Overall Study|Adverse Event|3|||
155622273|NCT01497067|561709638|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
155622274|NCT01497067|561709638|FG000|Overall Study|Other|13|||
155622275|NCT04058028|561709642|FG000|Overall Study|Withdrawal of Consent from Study|12|||
155622276|NCT04058028|561709643|FG001|Overall Study|Withdrawal of Consent from Study|8|||
155622277|NCT04058028|561709644|FG002|Overall Study|Withdrawal of Consent from Study|6|||
155622278|NCT04058028|561709645|FG003|Overall Study|Withdrawal of Consent from Study|7|||
155622279|NCT04058028|561709642|FG000|Overall Study|Decision by Sponsor|13|||
155622280|NCT04058028|561709643|FG001|Overall Study|Decision by Sponsor|4|||
155622281|NCT04058028|561709644|FG002|Overall Study|Decision by Sponsor|1|||
155622282|NCT04058028|561709645|FG003|Overall Study|Decision by Sponsor|35|||
155622283|NCT04058028|561709642|FG000|Overall Study|Lost to Follow-up|1|||
155622284|NCT04058028|561709643|FG001|Overall Study|Lost to Follow-up|1|||
155622285|NCT04058028|561709644|FG002|Overall Study|Lost to Follow-up|1|||
155622286|NCT04058028|561709645|FG003|Overall Study|Lost to Follow-up|0|||
155277464|NCT02500316|560449079|FG000|Overall Study|Adverse Event|3|||
155277465|NCT02500316|560449079|FG000|Overall Study|Lost to Follow-up|2|||
155622287|NCT04058028|561709642|FG000|Overall Study|Death|0|||
155622288|NCT04058028|561709643|FG001|Overall Study|Death|1|||
155622289|NCT04058028|561709644|FG002|Overall Study|Death|0|||
155622290|NCT04058028|561709645|FG003|Overall Study|Death|0|||
155622291|NCT02227784|561709646|FG000|Double-Blind Phase|Adverse Event|3|||
155622292|NCT02227784|561709647|FG001|Double-Blind Phase|Adverse Event|2|||
155622293|NCT02227784|561709648|FG002|Double-Blind Phase|Adverse Event|1|||
155277466|NCT02500316|560449079|FG000|Overall Study|Protocol Violation|1|||
155277467|NCT02500316|560449079|FG000|Overall Study|Withdrawal by Subject|15|||
155622294|NCT02227784|561709649|FG003|Double-Blind Phase|Adverse Event|3|||
155277468|NCT02500316|560449079|FG000|Overall Study|Final height achieved|5|||
155277469|NCT02500316|560449079|FG000|Overall Study|Due to war activity|1|||
155277470|NCT01406717|560449080|FG000|Overall Study|Subject non-compliance|4|||
155277471|NCT01406717|560449081|FG001|Overall Study|Subject non-compliance|3|||
155622295|NCT02227784|561709650|FG004|Double-Blind Phase|Adverse Event|0|||
155622296|NCT02227784|561709646|FG000|Double-Blind Phase|Physician Decision|1|||
155622297|NCT02227784|561709647|FG001|Double-Blind Phase|Physician Decision|0|||
155622298|NCT02227784|561709648|FG002|Double-Blind Phase|Physician Decision|0|||
155727027|NCT01342211|562099858|FG004|Overall Study|Withdrawal by Subject|0|||
155277472|NCT01406717|560449080|FG000|Overall Study|Protocol Violation|5|||
155622299|NCT02227784|561709649|FG003|Double-Blind Phase|Physician Decision|1|||
155622300|NCT02227784|561709650|FG004|Double-Blind Phase|Physician Decision|0|||
155622301|NCT02227784|561709646|FG000|Double-Blind Phase|Protocol Violation|0|||
155277473|NCT01406717|560449081|FG001|Overall Study|Protocol Violation|1|||
155277474|NCT01406717|560449080|FG000|Overall Study|Lost to Follow-up|14|||
155277475|NCT01406717|560449081|FG001|Overall Study|Lost to Follow-up|8|||
155277476|NCT01406717|560449080|FG000|Overall Study|Withdrawal by Subject|19|||
155277477|NCT01406717|560449081|FG001|Overall Study|Withdrawal by Subject|15|||
155277478|NCT01406717|560449080|FG000|Overall Study|Adverse Event|1|||
155277479|NCT01406717|560449081|FG001|Overall Study|Adverse Event|2|||
155277480|NCT01406717|560449080|FG000|Overall Study|Lack of Efficacy|0|||
155277481|NCT01406717|560449081|FG001|Overall Study|Lack of Efficacy|1|||
155277482|NCT01406717|560449080|FG000|Overall Study|Non-completion of visit activity|0|||
155277483|NCT01406717|560449081|FG001|Overall Study|Non-completion of visit activity|1|||
155277484|NCT02040090|560449082|FG000|Overall Study|Adverse Event|2|||
155277485|NCT02040090|560449083|FG001|Overall Study|Adverse Event|0|||
155277486|NCT02040090|560449082|FG000|Overall Study|Physician Decision|1|||
155277487|NCT02040090|560449083|FG001|Overall Study|Physician Decision|0|||
155277488|NCT02040090|560449082|FG000|Overall Study|Withdrawal by Subject|0|||
155277489|NCT02040090|560449083|FG001|Overall Study|Withdrawal by Subject|1|||
155277490|NCT02040090|560449082|FG000|Overall Study|Lost to Follow-up|0|||
155277491|NCT02040090|560449083|FG001|Overall Study|Lost to Follow-up|1|||
155277492|NCT03370276|560449086|FG000|Overall Study|Death|0|||
155277493|NCT03370276|560449087|FG001|Overall Study|Death|2|||
155277494|NCT03370276|560449088|FG002|Overall Study|Death|5|||
155277495|NCT02584855|560449092|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
155277496|NCT02584855|560449093|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155277497|NCT02584855|560449094|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155277498|NCT02584855|560449095|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
155277499|NCT02584855|560449096|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
155277500|NCT02584855|560449097|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
155277501|NCT02584855|560449092|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
155277502|NCT02584855|560449093|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277503|NCT02584855|560449094|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277504|NCT02584855|560449095|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277505|NCT02584855|560449096|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277506|NCT02584855|560449097|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277507|NCT02584855|560449092|FG000|Open-Label Treatment Period|Adverse Event|14|||
155277508|NCT02584855|560449093|FG001|Open-Label Treatment Period|Adverse Event|0|||
155277509|NCT02584855|560449094|FG002|Open-Label Treatment Period|Adverse Event|0|||
155277510|NCT02584855|560449095|FG003|Open-Label Treatment Period|Adverse Event|0|||
155277511|NCT02584855|560449096|FG004|Open-Label Treatment Period|Adverse Event|0|||
155277512|NCT02584855|560449097|FG005|Open-Label Treatment Period|Adverse Event|0|||
155622302|NCT02227784|561709647|FG001|Double-Blind Phase|Protocol Violation|0|||
155622303|NCT02227784|561709648|FG002|Double-Blind Phase|Protocol Violation|1|||
155622304|NCT02227784|561709649|FG003|Double-Blind Phase|Protocol Violation|1|||
155622305|NCT02227784|561709650|FG004|Double-Blind Phase|Protocol Violation|0|||
155622306|NCT02227784|561709646|FG000|Double-Blind Phase|Sponsor Decision|34|||
155622307|NCT02227784|561709647|FG001|Double-Blind Phase|Sponsor Decision|15|||
155622308|NCT02227784|561709648|FG002|Double-Blind Phase|Sponsor Decision|14|||
155622309|NCT02227784|561709649|FG003|Double-Blind Phase|Sponsor Decision|32|||
155622310|NCT02227784|561709650|FG004|Double-Blind Phase|Sponsor Decision|0|||
155622311|NCT02227784|561709646|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155622312|NCT02227784|561709647|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
155622313|NCT02227784|561709648|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
155622314|NCT02227784|561709649|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
155622315|NCT02227784|561709650|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155622316|NCT02227784|561709646|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155622317|NCT02227784|561709647|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155622318|NCT02227784|561709648|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155622319|NCT02227784|561709649|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155622320|NCT02227784|561709650|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
155622321|NCT02227784|561709646|FG000|Open-Label Extension Phase (OLE)|Death|0|||
155622322|NCT02227784|561709647|FG001|Open-Label Extension Phase (OLE)|Death|0|||
155277513|NCT02584855|560449092|FG000|Open-Label Treatment Period|Death|2|||
155277514|NCT02584855|560449093|FG001|Open-Label Treatment Period|Death|0|||
155277515|NCT02584855|560449094|FG002|Open-Label Treatment Period|Death|0|||
155277516|NCT02584855|560449095|FG003|Open-Label Treatment Period|Death|0|||
155277517|NCT02584855|560449096|FG004|Open-Label Treatment Period|Death|0|||
155277518|NCT02584855|560449097|FG005|Open-Label Treatment Period|Death|0|||
155381947|NCT00598273|560833244|FG002|Overall Study|Withdrawal by Subject|10|||
155277519|NCT02584855|560449092|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
155277520|NCT02584855|560449093|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
155277521|NCT02584855|560449094|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
155277522|NCT02584855|560449095|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
155622323|NCT02227784|561709648|FG002|Open-Label Extension Phase (OLE)|Death|0|||
155622324|NCT02227784|561709649|FG003|Open-Label Extension Phase (OLE)|Death|0|||
155622325|NCT02227784|561709650|FG004|Open-Label Extension Phase (OLE)|Death|1|||
155622326|NCT02227784|561709646|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155622327|NCT02227784|561709647|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155622328|NCT02227784|561709648|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155622329|NCT02227784|561709649|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155622330|NCT02227784|561709650|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
155622331|NCT02227784|561709646|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155622332|NCT02227784|561709647|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155622333|NCT02227784|561709648|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155622334|NCT02227784|561709649|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155622335|NCT02227784|561709650|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
155622342|NCT00102596|561709654|FG000|Part A|Screen failures|6|||
155622343|NCT00102596|561709655|FG001|Part A|Screen failures|0|||
155622344|NCT00102596|561709654|FG000|Part A|Adverse Event|1|||
155622345|NCT00102596|561709655|FG001|Part A|Adverse Event|0|||
155622346|NCT00248651|561709658|FG000|Overall Study|Withdrawal by Subject|28|||
155622347|NCT00248651|561709659|FG001|Overall Study|Withdrawal by Subject|40|||
155622348|NCT00248651|561709660|FG002|Overall Study|Withdrawal by Subject|32|||
155622349|NCT01275144|561709661|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
155622350|NCT01275144|561709662|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
155622351|NCT00828113|561709663|FG000|Overall Study|Withdrawal by Subject|27|||
155622352|NCT00828113|561709664|FG001|Overall Study|Withdrawal by Subject|26|||
155622353|NCT00828113|561709663|FG000|Overall Study|Lost to Follow-up|3|||
155622354|NCT00828113|561709664|FG001|Overall Study|Lost to Follow-up|5|||
155622355|NCT01365130|561709665|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
155622356|NCT05607576|561709666|FG000|Overall Study|immediate sensor error|2|||
155622357|NCT05607576|561709666|FG000|Overall Study|Physician Decision|2|||
155622358|NCT05116202|561709667|FG000|Overall Study|Study Terminated by Sponsor|21|||
155622359|NCT05116202|561709668|FG001|Overall Study|Study Terminated by Sponsor|38|||
155622360|NCT05116202|561709669|FG002|Overall Study|Study Terminated by Sponsor|17|||
155622361|NCT05116202|561709670|FG003|Overall Study|Study Terminated by Sponsor|18|||
155622362|NCT05116202|561709671|FG004|Overall Study|Study Terminated by Sponsor|0|||
155622363|NCT05116202|561709667|FG000|Overall Study|Withdrawal by Subject|0|||
155622364|NCT05116202|561709668|FG001|Overall Study|Withdrawal by Subject|1|||
155622365|NCT05116202|561709669|FG002|Overall Study|Withdrawal by Subject|1|||
155622366|NCT05116202|561709670|FG003|Overall Study|Withdrawal by Subject|1|||
155622367|NCT05116202|561709671|FG004|Overall Study|Withdrawal by Subject|1|||
155622368|NCT05116202|561709667|FG000|Overall Study|Lost to Follow-up|0|||
155622369|NCT05116202|561709668|FG001|Overall Study|Lost to Follow-up|0|||
155622370|NCT05116202|561709669|FG002|Overall Study|Lost to Follow-up|0|||
155622371|NCT05116202|561709670|FG003|Overall Study|Lost to Follow-up|0|||
155622372|NCT05116202|561709671|FG004|Overall Study|Lost to Follow-up|2|||
155622373|NCT05116202|561709667|FG000|Overall Study|Death|1|||
155622374|NCT05116202|561709668|FG001|Overall Study|Death|1|||
155622375|NCT05116202|561709669|FG002|Overall Study|Death|2|||
155622376|NCT05116202|561709670|FG003|Overall Study|Death|1|||
155622377|NCT05116202|561709671|FG004|Overall Study|Death|5|||
155622378|NCT05067972|561709672|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
155622379|NCT05067972|561709673|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
155622380|NCT05067972|561709674|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
155622381|NCT05067972|561709675|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
155622382|NCT05067972|561709676|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
155622383|NCT05067972|561709677|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
155622384|NCT05067972|561709678|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
155622385|NCT05067972|561709672|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
155622386|NCT05067972|561709673|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
155622387|NCT05067972|561709674|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
155622388|NCT05067972|561709675|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
155622389|NCT05067972|561709676|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
155622390|NCT05067972|561709677|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
155622391|NCT05067972|561709678|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
155622392|NCT05067972|561709672|FG000|Part 1: Treatment|Progressive Disease|3|||
155622393|NCT05067972|561709673|FG001|Part 1: Treatment|Progressive Disease|3|||
155622394|NCT05067972|561709674|FG002|Part 1: Treatment|Progressive Disease|4|||
155622395|NCT05067972|561709675|FG003|Part 1: Treatment|Progressive Disease|2|||
155622396|NCT05067972|561709676|FG004|Part 1: Treatment|Progressive Disease|3|||
155622397|NCT05067972|561709677|FG005|Part 1: Treatment|Progressive Disease|0|||
155622398|NCT05067972|561709678|FG006|Part 1: Treatment|Progressive Disease|2|||
155622399|NCT05067972|561709672|FG000|Part 1: Treatment|Physician Decision|0|||
155622400|NCT05067972|561709673|FG001|Part 1: Treatment|Physician Decision|0|||
155622401|NCT05067972|561709674|FG002|Part 1: Treatment|Physician Decision|0|||
155622402|NCT05067972|561709675|FG003|Part 1: Treatment|Physician Decision|1|||
155622403|NCT05067972|561709676|FG004|Part 1: Treatment|Physician Decision|0|||
155622404|NCT05067972|561709677|FG005|Part 1: Treatment|Physician Decision|0|||
155622405|NCT05067972|561709678|FG006|Part 1: Treatment|Physician Decision|0|||
155622406|NCT05067972|561709672|FG000|Part 1: Treatment|Death|0|||
155622407|NCT05067972|561709673|FG001|Part 1: Treatment|Death|0|||
155622408|NCT05067972|561709674|FG002|Part 1: Treatment|Death|0|||
155622409|NCT05067972|561709675|FG003|Part 1: Treatment|Death|2|||
155622410|NCT05067972|561709676|FG004|Part 1: Treatment|Death|0|||
155622411|NCT05067972|561709677|FG005|Part 1: Treatment|Death|0|||
155622412|NCT05067972|561709678|FG006|Part 1: Treatment|Death|0|||
155622413|NCT05067972|561709672|FG000|Part 1: Treatment|Adverse Event|0|||
155622414|NCT05067972|561709673|FG001|Part 1: Treatment|Adverse Event|0|||
155622415|NCT05067972|561709674|FG002|Part 1: Treatment|Adverse Event|0|||
155622416|NCT05067972|561709675|FG003|Part 1: Treatment|Adverse Event|0|||
155622417|NCT05067972|561709676|FG004|Part 1: Treatment|Adverse Event|0|||
155622418|NCT05067972|561709677|FG005|Part 1: Treatment|Adverse Event|2|||
155622419|NCT05067972|561709678|FG006|Part 1: Treatment|Adverse Event|1|||
155622420|NCT05067972|561709672|FG000|Part 1: Follow-up|Adverse Event|0|||
155622421|NCT05067972|561709673|FG001|Part 1: Follow-up|Adverse Event|0|||
155622422|NCT05067972|561709674|FG002|Part 1: Follow-up|Adverse Event|0|||
155622423|NCT05067972|561709675|FG003|Part 1: Follow-up|Adverse Event|0|||
155622424|NCT05067972|561709676|FG004|Part 1: Follow-up|Adverse Event|0|||
155622425|NCT05067972|561709677|FG005|Part 1: Follow-up|Adverse Event|1|||
155622426|NCT05067972|561709678|FG006|Part 1: Follow-up|Adverse Event|0|||
155622427|NCT05067972|561709672|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
155622428|NCT05067972|561709673|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
155622429|NCT05067972|561709674|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
155622430|NCT05067972|561709675|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
155622431|NCT05067972|561709676|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
155622432|NCT05067972|561709677|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
155622433|NCT05067972|561709678|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
155622434|NCT05067972|561709672|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622435|NCT05067972|561709673|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622436|NCT05067972|561709674|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622437|NCT05067972|561709675|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622438|NCT05067972|561709676|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622439|NCT05067972|561709677|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
155622440|NCT05067972|561709678|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155622441|NCT05067972|561709672|FG000|Part 1: Follow-up|Physician Decision|0|||
155622442|NCT05067972|561709673|FG001|Part 1: Follow-up|Physician Decision|0|||
155622443|NCT05067972|561709674|FG002|Part 1: Follow-up|Physician Decision|0|||
155622444|NCT05067972|561709675|FG003|Part 1: Follow-up|Physician Decision|1|||
155622445|NCT05067972|561709676|FG004|Part 1: Follow-up|Physician Decision|0|||
155622446|NCT05067972|561709677|FG005|Part 1: Follow-up|Physician Decision|0|||
155622447|NCT05067972|561709678|FG006|Part 1: Follow-up|Physician Decision|0|||
155622448|NCT05067972|561709672|FG000|Part 1: Follow-up|Death|1|||
155622449|NCT05067972|561709673|FG001|Part 1: Follow-up|Death|2|||
155622450|NCT05067972|561709674|FG002|Part 1: Follow-up|Death|1|||
155622451|NCT05067972|561709675|FG003|Part 1: Follow-up|Death|0|||
155622452|NCT05067972|561709676|FG004|Part 1: Follow-up|Death|1|||
155622453|NCT05067972|561709677|FG005|Part 1: Follow-up|Death|0|||
155622454|NCT05067972|561709678|FG006|Part 1: Follow-up|Death|1|||
155622455|NCT04888494|561709685|FG000|Overall Study|Lost to Follow-up|2|||
155622456|NCT04888494|561709686|FG001|Overall Study|Lost to Follow-up|3|||
155622457|NCT04888494|561709685|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
155622458|NCT04888494|561709686|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
155622459|NCT02357459|561711796|FG000|Overall Study|Adverse Event|0|||
155622460|NCT02357459|561711797|FG001|Overall Study|Adverse Event|1|||
155622461|NCT02357459|561711798|FG002|Overall Study|Adverse Event|1|||
155622462|NCT02357459|561711796|FG000|Overall Study|Withdrawal by Subject|5|||
155622463|NCT02357459|561711797|FG001|Overall Study|Withdrawal by Subject|3|||
155622464|NCT02357459|561711798|FG002|Overall Study|Withdrawal by Subject|3|||
155622465|NCT02357459|561711796|FG000|Overall Study|Physician Decision|0|||
155622466|NCT02357459|561711797|FG001|Overall Study|Physician Decision|2|||
155727028|NCT01342211|562099854|FG000|Overall Study|Randomized, but not Treated|0|||
155622467|NCT02357459|561711798|FG002|Overall Study|Physician Decision|0|||
155622468|NCT02357459|561711796|FG000|Overall Study|Protocol Violation|1|||
155622469|NCT02357459|561711797|FG001|Overall Study|Protocol Violation|1|||
155622470|NCT02357459|561711798|FG002|Overall Study|Protocol Violation|0|||
155622471|NCT02357459|561711796|FG000|Overall Study|Lost to Follow-up|1|||
155622472|NCT02357459|561711797|FG001|Overall Study|Lost to Follow-up|3|||
155622473|NCT02357459|561711798|FG002|Overall Study|Lost to Follow-up|0|||
155622474|NCT02357459|561711796|FG000|Overall Study|Lack of Efficacy|7|||
155622475|NCT02357459|561711797|FG001|Overall Study|Lack of Efficacy|4|||
155622476|NCT02357459|561711798|FG002|Overall Study|Lack of Efficacy|4|||
155622477|NCT02357459|561711796|FG000|Overall Study|Patient Relocated|2|||
155622478|NCT02357459|561711797|FG001|Overall Study|Patient Relocated|0|||
155622479|NCT02357459|561711798|FG002|Overall Study|Patient Relocated|0|||
155622480|NCT02357459|561711796|FG000|Overall Study|Instruction from PCP|1|||
155622481|NCT02357459|561711797|FG001|Overall Study|Instruction from PCP|0|||
155622482|NCT02357459|561711798|FG002|Overall Study|Instruction from PCP|0|||
155622483|NCT02357459|561711796|FG000|Overall Study|Incarceration|0|||
155622484|NCT02357459|561711797|FG001|Overall Study|Incarceration|0|||
155622485|NCT02357459|561711798|FG002|Overall Study|Incarceration|1|||
155622486|NCT02357459|561711796|FG000|Overall Study|Pre-planned Knee surgery|0|||
155622487|NCT02357459|561711797|FG001|Overall Study|Pre-planned Knee surgery|0|||
155622488|NCT02357459|561711798|FG002|Overall Study|Pre-planned Knee surgery|2|||
155622489|NCT02357459|561711796|FG000|Overall Study|Job Commitments|0|||
155622490|NCT02357459|561711797|FG001|Overall Study|Job Commitments|0|||
155622491|NCT02357459|561711798|FG002|Overall Study|Job Commitments|1|||
155622492|NCT03246347|561711799|FG000|Overall Study|On Study|23|||
155622493|NCT02188160|561711800|FG000|Overall Study|Adverse Event|1|||
155622494|NCT02188160|561711801|FG001|Overall Study|Adverse Event|0|||
155622495|NCT02188160|561711800|FG000|Overall Study|Use of an excluded medication|0|||
155622496|NCT02188160|561711801|FG001|Overall Study|Use of an excluded medication|1|||
155622497|NCT04113694|561711802|FG000|Overall Study|Adverse Event|2|||
155622498|NCT04113694|561711802|FG000|Overall Study|Lost to Follow-up|2|||
155622499|NCT04113694|561711802|FG000|Overall Study|Withdrawal by Subject|6|||
155622500|NCT04113694|561711802|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
155622501|NCT00916578|561711805|FG000|Overall Study|Physician Decision|2|||
155622502|NCT00916578|561711805|FG000|Overall Study|Withdrawal by Subject|3|||
155622503|NCT00916578|561711805|FG000|Overall Study|Insurance Denial|2|||
155622504|NCT03163446|561711808|FG000|Overall Study|Unable to return for Day 180 visit|2|||
155622505|NCT03163446|561711809|FG001|Overall Study|Unable to return for Day 180 visit|0|||
155622506|NCT03163446|561711808|FG000|Overall Study|Withdrawal by Subject|2|||
155622507|NCT03163446|561711809|FG001|Overall Study|Withdrawal by Subject|6|||
155622508|NCT03163446|561711808|FG000|Overall Study|Death|16|||
155622509|NCT03163446|561711809|FG001|Overall Study|Death|5|||
155622510|NCT03163446|561711808|FG000|Overall Study|Lost to Follow-up|6|||
155622511|NCT03163446|561711809|FG001|Overall Study|Lost to Follow-up|5|||
155622512|NCT03163446|561711808|FG000|Overall Study|Physician Decision|1|||
155622513|NCT03163446|561711809|FG001|Overall Study|Physician Decision|1|||
155622514|NCT03163446|561711808|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
155622515|NCT03163446|561711809|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
155622516|NCT01094288|561711810|FG000|Overall Study|Adverse Event|0|||
155622517|NCT01094288|561711811|FG001|Overall Study|Adverse Event|3|||
155622518|NCT01094288|561711812|FG002|Overall Study|Adverse Event|1|||
155622519|NCT01094288|561711813|FG003|Overall Study|Adverse Event|1|||
155622520|NCT01094288|561711814|FG004|Overall Study|Adverse Event|0|||
155622521|NCT01094288|561711815|FG005|Overall Study|Adverse Event|0|||
155622522|NCT01094288|561711816|FG006|Overall Study|Adverse Event|0|||
155622523|NCT01094288|561711817|FG007|Overall Study|Adverse Event|0|||
155622524|NCT01094288|561711810|FG000|Overall Study|Withdrawal by Subject|0|||
155622525|NCT01094288|561711811|FG001|Overall Study|Withdrawal by Subject|1|||
155622526|NCT01094288|561711812|FG002|Overall Study|Withdrawal by Subject|2|||
155622527|NCT01094288|561711813|FG003|Overall Study|Withdrawal by Subject|0|||
155622528|NCT01094288|561711814|FG004|Overall Study|Withdrawal by Subject|0|||
155622529|NCT01094288|561711815|FG005|Overall Study|Withdrawal by Subject|0|||
155622530|NCT01094288|561711816|FG006|Overall Study|Withdrawal by Subject|0|||
155622531|NCT01094288|561711817|FG007|Overall Study|Withdrawal by Subject|2|||
155622532|NCT01094288|561711810|FG000|Overall Study|Initiation of Alternative Therapy|0|||
155622533|NCT01094288|561711811|FG001|Overall Study|Initiation of Alternative Therapy|0|||
155622534|NCT01094288|561711812|FG002|Overall Study|Initiation of Alternative Therapy|1|||
155622535|NCT01094288|561711813|FG003|Overall Study|Initiation of Alternative Therapy|0|||
155622536|NCT01094288|561711814|FG004|Overall Study|Initiation of Alternative Therapy|0|||
155622537|NCT01094288|561711815|FG005|Overall Study|Initiation of Alternative Therapy|0|||
155622538|NCT01094288|561711816|FG006|Overall Study|Initiation of Alternative Therapy|0|||
155622539|NCT01094288|561711817|FG007|Overall Study|Initiation of Alternative Therapy|0|||
155622540|NCT01094288|561711810|FG000|Overall Study|Reason not Specified|2|||
155622541|NCT01094288|561711811|FG001|Overall Study|Reason not Specified|3|||
155622542|NCT01094288|561711812|FG002|Overall Study|Reason not Specified|0|||
155622543|NCT01094288|561711813|FG003|Overall Study|Reason not Specified|1|||
155622544|NCT01094288|561711814|FG004|Overall Study|Reason not Specified|0|||
155622545|NCT01094288|561711815|FG005|Overall Study|Reason not Specified|0|||
155622546|NCT01094288|561711816|FG006|Overall Study|Reason not Specified|0|||
155622547|NCT01094288|561711817|FG007|Overall Study|Reason not Specified|0|||
155622548|NCT01094288|561711810|FG000|Overall Study|Ongoing Participants|0|||
155622549|NCT01094288|561711811|FG001|Overall Study|Ongoing Participants|3|||
155622550|NCT01094288|561711812|FG002|Overall Study|Ongoing Participants|0|||
155622551|NCT01094288|561711813|FG003|Overall Study|Ongoing Participants|0|||
155622552|NCT01094288|561711814|FG004|Overall Study|Ongoing Participants|0|||
155622553|NCT01094288|561711815|FG005|Overall Study|Ongoing Participants|0|||
155622554|NCT01094288|561711816|FG006|Overall Study|Ongoing Participants|0|||
155622555|NCT01094288|561711817|FG007|Overall Study|Ongoing Participants|0|||
155622556|NCT02611882|561711818|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
155622557|NCT02611882|561711819|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
155622558|NCT02611882|561711820|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
155622559|NCT01228591|561711821|FG000|Baseline|Lack of Efficacy|1|||
155622560|NCT01228591|561711822|FG001|Baseline|Lack of Efficacy|2|||
155622561|NCT01389232|561711823|FG000|Overall Study|Had scaffold removed|15|||
155622562|NCT01389232|561711823|FG000|Overall Study|Personal reasons|2|||
155622563|NCT01389232|561711823|FG000|Overall Study|Adverse Event|1|||
155622564|NCT01389232|561711823|FG000|Overall Study|Death|1|||
155622565|NCT01317940|561711824|FG000|Overall Study|Death|1|||
155622566|NCT01317940|561711825|FG001|Overall Study|Death|0|||
155622567|NCT01317940|561711826|FG002|Overall Study|Death|1|||
155727029|NCT01342211|562099855|FG001|Overall Study|Randomized, but not Treated|2|||
155727030|NCT01342211|562099856|FG002|Overall Study|Randomized, but not Treated|0|||
155727031|NCT01342211|562099857|FG003|Overall Study|Randomized, but not Treated|0|||
155727032|NCT01342211|562099858|FG004|Overall Study|Randomized, but not Treated|1|||
155727033|NCT03205423|562099861|FG000|Overall Study|Personal|1|||
155727034|NCT03205423|562099862|FG001|Overall Study|Personal|1|||
155727035|NCT03205423|562099861|FG000|Overall Study|Physician Decision|0|||
155727036|NCT03205423|562099862|FG001|Overall Study|Physician Decision|2|||
155727037|NCT02749422|562099863|FG000|Overall Study|Lost to Follow-up|0|||
155727038|NCT02749422|562099864|FG001|Overall Study|Lost to Follow-up|2|||
155727039|NCT02749422|562099863|FG000|Overall Study|Ineligible|0|||
155727040|NCT02749422|562099864|FG001|Overall Study|Ineligible|1|||
155727041|NCT00911170|562099865|FG000|Treatment Period|Randomized in error|1|||
155727042|NCT00911170|562099866|FG001|Treatment Period|Randomized in error|1|||
155727043|NCT00911170|562099865|FG000|Treatment Period|Ineligibility determined|1|||
155727044|NCT00911170|562099866|FG001|Treatment Period|Ineligibility determined|3|||
155727045|NCT00911170|562099865|FG000|Treatment Period|Protocol deviation|1|||
155727046|NCT00911170|562099866|FG001|Treatment Period|Protocol deviation|2|||
155727047|NCT00911170|562099865|FG000|Treatment Period|Adverse Event|9|||
155727048|NCT00911170|562099866|FG001|Treatment Period|Adverse Event|10|||
155727049|NCT00911170|562099865|FG000|Treatment Period|Withdrawal by Subject|4|||
155727050|NCT00911170|562099866|FG001|Treatment Period|Withdrawal by Subject|4|||
155727051|NCT00911170|562099865|FG000|Treatment Period|Disease progression|0|||
155727052|NCT00911170|562099866|FG001|Treatment Period|Disease progression|2|||
155727053|NCT00911170|562099865|FG000|Treatment Period|Physician Decision|5|||
155727054|NCT00911170|562099866|FG001|Treatment Period|Physician Decision|5|||
155727055|NCT00911170|562099865|FG000|Treatment Period|Lost to Follow-up|0|||
155727056|NCT00911170|562099866|FG001|Treatment Period|Lost to Follow-up|1|||
155727057|NCT00911170|562099865|FG000|Treatment Period|Death|6|||
155727058|NCT00911170|562099866|FG001|Treatment Period|Death|9|||
155727059|NCT00911170|562099865|FG000|Long Term Follow-Up|Continuing in study|274|||
155727060|NCT00911170|562099866|FG001|Long Term Follow-Up|Continuing in study|269|||
155727061|NCT00911170|562099865|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
155727062|NCT00911170|562099866|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
155727063|NCT00911170|562099865|FG000|Long Term Follow-Up|Physician Decision|5|||
155727064|NCT00911170|562099866|FG001|Long Term Follow-Up|Physician Decision|4|||
155727065|NCT00911170|562099865|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
155727066|NCT00911170|562099866|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
155727067|NCT00911170|562099865|FG000|Long Term Follow-Up|Death|116|||
155727068|NCT00911170|562099866|FG001|Long Term Follow-Up|Death|121|||
155727069|NCT02594124|562099867|FG000|Overall Study|Adverse Event|0|||
155727070|NCT02594124|562099868|FG001|Overall Study|Adverse Event|5|||
155727071|NCT02594124|562099869|FG002|Overall Study|Adverse Event|8|||
155727072|NCT02594124|562099870|FG003|Overall Study|Adverse Event|1|||
155727073|NCT02594124|562099871|FG004|Overall Study|Adverse Event|0|||
155727074|NCT02594124|562099872|FG005|Overall Study|Adverse Event|0|||
155727075|NCT02594124|562099873|FG006|Overall Study|Adverse Event|2|||
155727076|NCT02594124|562099874|FG007|Overall Study|Adverse Event|2|||
155381948|NCT00598273|560833242|FG000|Overall Study|Noncompliance|3|||
155727077|NCT02594124|562099875|FG008|Overall Study|Adverse Event|0|||
155727078|NCT02594124|562099867|FG000|Overall Study|Withdrawal by Subject|2|||
155727079|NCT02594124|562099868|FG001|Overall Study|Withdrawal by Subject|3|||
155727080|NCT02594124|562099869|FG002|Overall Study|Withdrawal by Subject|5|||
155622568|NCT01317940|561711827|FG003|Overall Study|Death|0|||
155727081|NCT02594124|562099870|FG003|Overall Study|Withdrawal by Subject|1|||
155727082|NCT02594124|562099871|FG004|Overall Study|Withdrawal by Subject|8|||
155727083|NCT02594124|562099872|FG005|Overall Study|Withdrawal by Subject|4|||
155727084|NCT02594124|562099873|FG006|Overall Study|Withdrawal by Subject|13|||
155727085|NCT02594124|562099874|FG007|Overall Study|Withdrawal by Subject|19|||
155727086|NCT02594124|562099875|FG008|Overall Study|Withdrawal by Subject|0|||
155727087|NCT02594124|562099867|FG000|Overall Study|Physician Decision|0|||
155727088|NCT02594124|562099868|FG001|Overall Study|Physician Decision|2|||
155727089|NCT02594124|562099869|FG002|Overall Study|Physician Decision|0|||
155727090|NCT02594124|562099870|FG003|Overall Study|Physician Decision|0|||
155622569|NCT01317940|561711828|FG004|Overall Study|Death|0|||
155622570|NCT01317940|561711829|FG005|Overall Study|Death|0|||
155622571|NCT01317940|561711824|FG000|Overall Study|Lost to Follow-up|0|||
155622572|NCT01317940|561711825|FG001|Overall Study|Lost to Follow-up|0|||
155622573|NCT01317940|561711826|FG002|Overall Study|Lost to Follow-up|1|||
155622574|NCT01317940|561711827|FG003|Overall Study|Lost to Follow-up|1|||
155622575|NCT01317940|561711828|FG004|Overall Study|Lost to Follow-up|1|||
155622576|NCT01317940|561711829|FG005|Overall Study|Lost to Follow-up|0|||
155622577|NCT01317940|561711824|FG000|Overall Study|Change in therapy plan|0|||
155622578|NCT01317940|561711825|FG001|Overall Study|Change in therapy plan|0|||
155622579|NCT01317940|561711826|FG002|Overall Study|Change in therapy plan|3|||
155622580|NCT01317940|561711827|FG003|Overall Study|Change in therapy plan|0|||
155622581|NCT01317940|561711828|FG004|Overall Study|Change in therapy plan|0|||
155622582|NCT01317940|561711829|FG005|Overall Study|Change in therapy plan|0|||
155622583|NCT02371616|561711831|FG000|Overall Study|Protocol Violation|2|||
155622584|NCT02371616|561711832|FG001|Overall Study|Protocol Violation|1|||
155622585|NCT02371616|561711831|FG000|Overall Study|Adverse Event|0|||
155622586|NCT02371616|561711832|FG001|Overall Study|Adverse Event|1|||
155622587|NCT02371616|561711831|FG000|Overall Study|Withdrawal of Consent|1|||
155622588|NCT02371616|561711832|FG001|Overall Study|Withdrawal of Consent|0|||
155622589|NCT02371616|561711831|FG000|Overall Study|Other (Not specified)|1|||
155622590|NCT02371616|561711832|FG001|Overall Study|Other (Not specified)|5|||
155622591|NCT02699996|561711835|FG000|Overall Study|Withdrawal by Subject|5|||
155622592|NCT02699996|561711836|FG001|Overall Study|Withdrawal by Subject|2|||
155622593|NCT03205150|561711837|FG000|Overall Study|Protocol deviation|1|||
155622594|NCT03205150|561711838|FG001|Overall Study|Protocol deviation|3|||
155622595|NCT03205150|561711839|FG002|Overall Study|Protocol deviation|0|||
155622596|NCT03205150|561711837|FG000|Overall Study|Patient/guardian decision|0|||
155622597|NCT03205150|561711838|FG001|Overall Study|Patient/guardian decision|3|||
155622598|NCT03205150|561711839|FG002|Overall Study|Patient/guardian decision|0|||
155622599|NCT03205150|561711837|FG000|Overall Study|Adverse Event|1|||
155622600|NCT03205150|561711838|FG001|Overall Study|Adverse Event|1|||
155622601|NCT03205150|561711839|FG002|Overall Study|Adverse Event|1|||
155622602|NCT03205150|561711837|FG000|Overall Study|Lost to Follow-up|0|||
155622603|NCT03205150|561711838|FG001|Overall Study|Lost to Follow-up|0|||
155622604|NCT03205150|561711839|FG002|Overall Study|Lost to Follow-up|1|||
155622605|NCT01095835|561711840|FG000|Overall Study|Adverse Event|8|||
155622606|NCT01095835|561711841|FG001|Overall Study|Adverse Event|6|||
155622607|NCT01095835|561711842|FG002|Overall Study|Adverse Event|6|||
155622608|NCT01095835|561711840|FG000|Overall Study|Lack of Efficacy|0|||
155622609|NCT01095835|561711841|FG001|Overall Study|Lack of Efficacy|1|||
155622610|NCT01095835|561711842|FG002|Overall Study|Lack of Efficacy|0|||
155622611|NCT01095835|561711840|FG000|Overall Study|Physician Decision|0|||
155622612|NCT01095835|561711841|FG001|Overall Study|Physician Decision|0|||
155622613|NCT01095835|561711842|FG002|Overall Study|Physician Decision|1|||
155622614|NCT01095835|561711840|FG000|Overall Study|Withdrawal by Subject|1|||
155622615|NCT01095835|561711841|FG001|Overall Study|Withdrawal by Subject|3|||
155622616|NCT01095835|561711842|FG002|Overall Study|Withdrawal by Subject|0|||
155622617|NCT01095835|561711840|FG000|Overall Study|Non study compliance|0|||
155622618|NCT01095835|561711841|FG001|Overall Study|Non study compliance|0|||
155622619|NCT01095835|561711842|FG002|Overall Study|Non study compliance|1|||
155622620|NCT01095835|561711840|FG000|Overall Study|Protocol Violation|1|||
155622621|NCT01095835|561711841|FG001|Overall Study|Protocol Violation|2|||
155622622|NCT01095835|561711842|FG002|Overall Study|Protocol Violation|0|||
155622623|NCT01405560|561711851|FG000|Overall Study|Physician Decision|1|||
155622624|NCT02169505|561711853|FG000|Overall Study|Withdrawal by Subject|1|||
155622625|NCT05227118|561711862|FG000|Overall Study|Adverse Event|0|||
155622626|NCT05227118|561711863|FG001|Overall Study|Adverse Event|0|||
155622627|NCT05227118|561711864|FG002|Overall Study|Adverse Event|1|||
155622628|NCT05227118|561711865|FG003|Overall Study|Adverse Event|0|||
155622629|NCT05227118|561711862|FG000|Overall Study|Withdrawal by Subject|0|||
155622630|NCT05227118|561711863|FG001|Overall Study|Withdrawal by Subject|0|||
155622631|NCT05227118|561711864|FG002|Overall Study|Withdrawal by Subject|2|||
155622632|NCT05227118|561711865|FG003|Overall Study|Withdrawal by Subject|0|||
155622633|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
155622634|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
155622635|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
155622636|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
155622637|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
155622638|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
155622639|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
155622640|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
155622641|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
155622642|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
155622643|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
155622644|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
155622645|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
155622646|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155622647|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155622648|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155622649|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155622650|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155622651|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
155622652|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155622653|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155622654|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155622655|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155622656|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155622657|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
155622658|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622659|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622660|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622661|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622662|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622663|NCT01435759|561711866|FG000|Antidepressant Lead-in Phase|Other|119|||
155622664|NCT01435759|561711867|FG001|Antidepressant Lead-in Phase|Other|0|||
155622665|NCT01435759|561711868|FG002|Antidepressant Lead-in Phase|Other|0|||
155622666|NCT01435759|561711869|FG003|Antidepressant Lead-in Phase|Other|0|||
155622667|NCT01435759|561711870|FG004|Antidepressant Lead-in Phase|Other|0|||
155622668|NCT01435759|561711871|FG005|Antidepressant Lead-in Phase|Other|0|||
155622669|NCT01435759|561711866|FG000|Double-blind Phase|Adverse Event|7|||
155622670|NCT01435759|561711867|FG001|Double-blind Phase|Adverse Event|0|||
155622671|NCT01435759|561711868|FG002|Double-blind Phase|Adverse Event|1|||
155622672|NCT01435759|561711869|FG003|Double-blind Phase|Adverse Event|1|||
155622673|NCT01435759|561711870|FG004|Double-blind Phase|Adverse Event|1|||
155622674|NCT01435759|561711871|FG005|Double-blind Phase|Adverse Event|3|||
155622675|NCT01435759|561711866|FG000|Double-blind Phase|Protocol Violation|2|||
155622676|NCT01435759|561711867|FG001|Double-blind Phase|Protocol Violation|0|||
155622677|NCT01435759|561711868|FG002|Double-blind Phase|Protocol Violation|1|||
155622678|NCT01435759|561711869|FG003|Double-blind Phase|Protocol Violation|2|||
155622679|NCT01435759|561711870|FG004|Double-blind Phase|Protocol Violation|0|||
155622680|NCT01435759|561711871|FG005|Double-blind Phase|Protocol Violation|1|||
155622681|NCT01435759|561711866|FG000|Double-blind Phase|Withdrawal by Subject|17|||
155622682|NCT01435759|561711867|FG001|Double-blind Phase|Withdrawal by Subject|4|||
155622683|NCT01435759|561711868|FG002|Double-blind Phase|Withdrawal by Subject|3|||
155622684|NCT01435759|561711869|FG003|Double-blind Phase|Withdrawal by Subject|4|||
155622685|NCT01435759|561711870|FG004|Double-blind Phase|Withdrawal by Subject|2|||
155622686|NCT01435759|561711871|FG005|Double-blind Phase|Withdrawal by Subject|2|||
155622687|NCT01435759|561711866|FG000|Double-blind Phase|Lost to Follow-up|31|||
155622688|NCT01435759|561711867|FG001|Double-blind Phase|Lost to Follow-up|1|||
155622689|NCT01435759|561711868|FG002|Double-blind Phase|Lost to Follow-up|2|||
155622690|NCT01435759|561711869|FG003|Double-blind Phase|Lost to Follow-up|0|||
155622691|NCT01435759|561711870|FG004|Double-blind Phase|Lost to Follow-up|3|||
155622692|NCT01435759|561711871|FG005|Double-blind Phase|Lost to Follow-up|3|||
155622693|NCT01435759|561711866|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
155622694|NCT01435759|561711867|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622695|NCT01435759|561711868|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622696|NCT01435759|561711869|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622697|NCT01435759|561711870|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
155622698|NCT01435759|561711871|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155622699|NCT01435759|561711866|FG000|Double-blind Phase|Other|8|||
155622700|NCT01435759|561711867|FG001|Double-blind Phase|Other|2|||
155622701|NCT01435759|561711868|FG002|Double-blind Phase|Other|0|||
155622702|NCT01435759|561711869|FG003|Double-blind Phase|Other|2|||
155622703|NCT01435759|561711870|FG004|Double-blind Phase|Other|0|||
155622704|NCT01435759|561711871|FG005|Double-blind Phase|Other|0|||
155622705|NCT03727841|561711872|FG000|Overall Study|Physician Decision|3|||
155622706|NCT03727841|561711873|FG001|Overall Study|Physician Decision|1|||
155622707|NCT03126786|561711874|FG000|Overall Study|Adverse Event|3|||
155622708|NCT03126786|561711875|FG001|Overall Study|Adverse Event|0|||
155622709|NCT03126786|561711874|FG000|Overall Study|Lost to Follow-up|0|||
155622710|NCT03126786|561711875|FG001|Overall Study|Lost to Follow-up|1|||
155622711|NCT03126786|561711874|FG000|Overall Study|Withdrawal by Subject|3|||
155277523|NCT02584855|560449096|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
155622712|NCT03126786|561711875|FG001|Overall Study|Withdrawal by Subject|1|||
155622713|NCT03243305|561711876|FG000|Overall Study|Lost to Follow-up|250|||
155622714|NCT03243305|561711876|FG000|Overall Study|Withdrawal by Subject|170|||
155622715|NCT03243305|561711876|FG000|Overall Study|Pregnancy|104|||
155622716|NCT03243305|561711876|FG000|Overall Study|Non-Compliance with Study Drug|38|||
155622717|NCT03243305|561711876|FG000|Overall Study|Adverse Event|23|||
155622718|NCT03243305|561711876|FG000|Overall Study|No sexually active|26|||
155622719|NCT03243305|561711876|FG000|Overall Study|Physician Decision|22|||
155622720|NCT03243305|561711876|FG000|Overall Study|Protocol Violation|22|||
155622721|NCT03243305|561711876|FG000|Overall Study|Study method no longer primary method|12|||
155622722|NCT03243305|561711876|FG000|Overall Study|Study Terminated by Sponsor|1|||
155622723|NCT03243305|561711876|FG000|Overall Study|Early terminations|267|||
155622724|NCT01747499|561711879|FG000|Overall Study|Steroid refractory aGvHD|1|||
155622725|NCT01747499|561711880|FG001|Overall Study|Steroid refractory aGvHD|0|||
155622726|NCT01747499|561711881|FG002|Overall Study|Steroid refractory aGvHD|0|||
155622727|NCT01747499|561711882|FG003|Overall Study|Steroid refractory aGvHD|1|||
155622728|NCT01747499|561711883|FG004|Overall Study|Steroid refractory aGvHD|4|||
155622729|NCT01747499|561711879|FG000|Overall Study|Physician Decision|0|||
155622730|NCT01747499|561711880|FG001|Overall Study|Physician Decision|1|||
155622731|NCT01747499|561711881|FG002|Overall Study|Physician Decision|0|||
155622732|NCT01747499|561711882|FG003|Overall Study|Physician Decision|0|||
155622733|NCT01747499|561711883|FG004|Overall Study|Physician Decision|2|||
155622734|NCT01747499|561711879|FG000|Overall Study|Death|0|||
155622735|NCT01747499|561711880|FG001|Overall Study|Death|0|||
155622736|NCT01747499|561711881|FG002|Overall Study|Death|0|||
155622737|NCT01747499|561711882|FG003|Overall Study|Death|1|||
155622738|NCT01747499|561711883|FG004|Overall Study|Death|1|||
155622739|NCT01747499|561711879|FG000|Overall Study|Withdrawal by Subject|0|||
155622740|NCT01747499|561711880|FG001|Overall Study|Withdrawal by Subject|0|||
155622741|NCT01747499|561711881|FG002|Overall Study|Withdrawal by Subject|0|||
155622742|NCT01747499|561711882|FG003|Overall Study|Withdrawal by Subject|0|||
155622743|NCT01747499|561711883|FG004|Overall Study|Withdrawal by Subject|6|||
155622744|NCT01747499|561711879|FG000|Overall Study|Developed AML and death|0|||
155622745|NCT01747499|561711880|FG001|Overall Study|Developed AML and death|0|||
155622746|NCT01747499|561711881|FG002|Overall Study|Developed AML and death|0|||
155622747|NCT01747499|561711882|FG003|Overall Study|Developed AML and death|0|||
155622748|NCT01747499|561711883|FG004|Overall Study|Developed AML and death|1|||
155622749|NCT01747499|561711879|FG000|Overall Study|Determined not to be eligible|0|||
155622750|NCT01747499|561711880|FG001|Overall Study|Determined not to be eligible|0|||
155622751|NCT01747499|561711881|FG002|Overall Study|Determined not to be eligible|0|||
155622752|NCT01747499|561711882|FG003|Overall Study|Determined not to be eligible|0|||
155622753|NCT01747499|561711883|FG004|Overall Study|Determined not to be eligible|1|||
155622754|NCT02115607|561711884|FG000|Overall Study|Withdrawal by Subject|1|||
155622755|NCT00196105|561711888|FG000|Overall Study|Lost to Follow-up|4|||
155622756|NCT00196105|561711889|FG001|Overall Study|Lost to Follow-up|5|||
155622757|NCT00196105|561711890|FG002|Overall Study|Lost to Follow-up|7|||
155622758|NCT05616013|561711892|FG000|Overall Study|Adverse Event|6|||
155622759|NCT05616013|561711893|FG001|Overall Study|Adverse Event|12|||
155622760|NCT05616013|561711894|FG002|Overall Study|Adverse Event|8|||
155622761|NCT05616013|561711895|FG003|Overall Study|Adverse Event|4|||
155622762|NCT05616013|561711896|FG004|Overall Study|Adverse Event|6|||
155622763|NCT05616013|561711897|FG005|Overall Study|Adverse Event|8|||
155622764|NCT05616013|561711898|FG006|Overall Study|Adverse Event|3|||
155622765|NCT05616013|561711899|FG007|Overall Study|Adverse Event|6|||
155622766|NCT05616013|561711900|FG008|Overall Study|Adverse Event|1|||
155622767|NCT05616013|561711892|FG000|Overall Study|Lost to Follow-up|5|||
155622768|NCT05616013|561711893|FG001|Overall Study|Lost to Follow-up|4|||
155622769|NCT05616013|561711894|FG002|Overall Study|Lost to Follow-up|3|||
155622770|NCT05616013|561711895|FG003|Overall Study|Lost to Follow-up|2|||
155622771|NCT05616013|561711896|FG004|Overall Study|Lost to Follow-up|0|||
155622772|NCT05616013|561711897|FG005|Overall Study|Lost to Follow-up|5|||
155622773|NCT05616013|561711898|FG006|Overall Study|Lost to Follow-up|2|||
155622774|NCT05616013|561711899|FG007|Overall Study|Lost to Follow-up|1|||
155622775|NCT05616013|561711900|FG008|Overall Study|Lost to Follow-up|2|||
155622776|NCT05616013|561711892|FG000|Overall Study|Non-compliance with study requirements|2|||
155622777|NCT05616013|561711893|FG001|Overall Study|Non-compliance with study requirements|2|||
155622778|NCT05616013|561711894|FG002|Overall Study|Non-compliance with study requirements|2|||
155727091|NCT02594124|562099871|FG004|Overall Study|Physician Decision|0|||
155727092|NCT02594124|562099872|FG005|Overall Study|Physician Decision|0|||
155727093|NCT02594124|562099873|FG006|Overall Study|Physician Decision|0|||
155727094|NCT02594124|562099874|FG007|Overall Study|Physician Decision|1|||
155727095|NCT02594124|562099875|FG008|Overall Study|Physician Decision|0|||
155727096|NCT02594124|562099867|FG000|Overall Study|Commercial drug|0|||
155727097|NCT02594124|562099868|FG001|Overall Study|Commercial drug|1|||
155727098|NCT02594124|562099869|FG002|Overall Study|Commercial drug|6|||
155622779|NCT05616013|561711895|FG003|Overall Study|Non-compliance with study requirements|3|||
155622780|NCT05616013|561711896|FG004|Overall Study|Non-compliance with study requirements|0|||
155622781|NCT05616013|561711897|FG005|Overall Study|Non-compliance with study requirements|2|||
155622782|NCT05616013|561711898|FG006|Overall Study|Non-compliance with study requirements|1|||
155622783|NCT05616013|561711899|FG007|Overall Study|Non-compliance with study requirements|1|||
155622784|NCT05616013|561711900|FG008|Overall Study|Non-compliance with study requirements|4|||
155622785|NCT05616013|561711892|FG000|Overall Study|Withdrawal by Subject|11|||
155727099|NCT02594124|562099870|FG003|Overall Study|Commercial drug|3|||
155727100|NCT02594124|562099871|FG004|Overall Study|Commercial drug|0|||
155622786|NCT05616013|561711893|FG001|Overall Study|Withdrawal by Subject|9|||
155622787|NCT05616013|561711894|FG002|Overall Study|Withdrawal by Subject|8|||
155622788|NCT05616013|561711895|FG003|Overall Study|Withdrawal by Subject|6|||
155622789|NCT05616013|561711896|FG004|Overall Study|Withdrawal by Subject|3|||
155622790|NCT05616013|561711897|FG005|Overall Study|Withdrawal by Subject|4|||
155622791|NCT05616013|561711898|FG006|Overall Study|Withdrawal by Subject|6|||
155622792|NCT05616013|561711899|FG007|Overall Study|Withdrawal by Subject|5|||
155622793|NCT05616013|561711900|FG008|Overall Study|Withdrawal by Subject|4|||
155622794|NCT05616013|561711892|FG000|Overall Study|Physician Decision|0|||
155622795|NCT05616013|561711893|FG001|Overall Study|Physician Decision|0|||
155622796|NCT05616013|561711894|FG002|Overall Study|Physician Decision|1|||
155622797|NCT05616013|561711895|FG003|Overall Study|Physician Decision|0|||
155622798|NCT05616013|561711896|FG004|Overall Study|Physician Decision|0|||
155622799|NCT05616013|561711897|FG005|Overall Study|Physician Decision|1|||
155622800|NCT05616013|561711898|FG006|Overall Study|Physician Decision|3|||
155622801|NCT05616013|561711899|FG007|Overall Study|Physician Decision|0|||
155622802|NCT05616013|561711900|FG008|Overall Study|Physician Decision|0|||
155622803|NCT05616013|561711892|FG000|Overall Study|Protocol Violation|0|||
155622804|NCT05616013|561711893|FG001|Overall Study|Protocol Violation|0|||
155622805|NCT05616013|561711894|FG002|Overall Study|Protocol Violation|0|||
155622806|NCT05616013|561711895|FG003|Overall Study|Protocol Violation|0|||
155622807|NCT05616013|561711896|FG004|Overall Study|Protocol Violation|0|||
155622808|NCT05616013|561711897|FG005|Overall Study|Protocol Violation|0|||
155622809|NCT05616013|561711898|FG006|Overall Study|Protocol Violation|1|||
155622810|NCT05616013|561711899|FG007|Overall Study|Protocol Violation|0|||
155622811|NCT05616013|561711900|FG008|Overall Study|Protocol Violation|2|||
155622812|NCT05616013|561711892|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
155622813|NCT05616013|561711893|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622814|NCT05616013|561711894|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622815|NCT05616013|561711895|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622816|NCT05616013|561711896|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622817|NCT05616013|561711897|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622818|NCT05616013|561711898|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622819|NCT05616013|561711899|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622820|NCT05616013|561711900|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
155622821|NCT05616013|561711892|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
155622822|NCT05616013|561711893|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622823|NCT05616013|561711894|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622824|NCT05616013|561711895|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622825|NCT05616013|561711896|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622826|NCT05616013|561711897|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622827|NCT05616013|561711898|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622828|NCT05616013|561711899|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622829|NCT05616013|561711900|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155622830|NCT05616013|561711892|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
155622831|NCT05616013|561711893|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622832|NCT05616013|561711894|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622833|NCT05616013|561711895|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622834|NCT05616013|561711896|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622835|NCT05616013|561711897|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622836|NCT05616013|561711898|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622837|NCT05616013|561711899|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622838|NCT05616013|561711900|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155622839|NCT05616013|561711892|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622840|NCT05616013|561711893|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
155622841|NCT05616013|561711894|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622842|NCT05616013|561711895|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622843|NCT05616013|561711896|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622844|NCT05616013|561711897|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622845|NCT05616013|561711898|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622846|NCT05616013|561711899|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622847|NCT05616013|561711900|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155622848|NCT05616013|561711892|FG000|Overall Study|Participant Decision, Time Constraints|0|||
155622849|NCT05616013|561711893|FG001|Overall Study|Participant Decision, Time Constraints|1|||
155622850|NCT05616013|561711894|FG002|Overall Study|Participant Decision, Time Constraints|0|||
155622851|NCT05616013|561711895|FG003|Overall Study|Participant Decision, Time Constraints|0|||
155727101|NCT02594124|562099872|FG005|Overall Study|Commercial drug|0|||
155622852|NCT05616013|561711896|FG004|Overall Study|Participant Decision, Time Constraints|0|||
155622853|NCT05616013|561711897|FG005|Overall Study|Participant Decision, Time Constraints|0|||
155622854|NCT05616013|561711898|FG006|Overall Study|Participant Decision, Time Constraints|0|||
155622855|NCT05616013|561711899|FG007|Overall Study|Participant Decision, Time Constraints|0|||
155622856|NCT05616013|561711900|FG008|Overall Study|Participant Decision, Time Constraints|0|||
155622857|NCT05616013|561711892|FG000|Overall Study|Prohibited Concomitant Medication|0|||
155622858|NCT05616013|561711893|FG001|Overall Study|Prohibited Concomitant Medication|0|||
155622859|NCT05616013|561711894|FG002|Overall Study|Prohibited Concomitant Medication|1|||
155622860|NCT05616013|561711895|FG003|Overall Study|Prohibited Concomitant Medication|0|||
155622861|NCT05616013|561711896|FG004|Overall Study|Prohibited Concomitant Medication|0|||
155622862|NCT05616013|561711897|FG005|Overall Study|Prohibited Concomitant Medication|0|||
155622863|NCT05616013|561711898|FG006|Overall Study|Prohibited Concomitant Medication|0|||
155622864|NCT05616013|561711899|FG007|Overall Study|Prohibited Concomitant Medication|0|||
155622865|NCT05616013|561711900|FG008|Overall Study|Prohibited Concomitant Medication|0|||
155622866|NCT05616013|561711892|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622867|NCT05616013|561711893|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622868|NCT05616013|561711894|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
155622869|NCT05616013|561711895|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622870|NCT05616013|561711896|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622871|NCT05616013|561711897|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622872|NCT05616013|561711898|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622873|NCT05616013|561711899|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622874|NCT05616013|561711900|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
155622875|NCT05616013|561711892|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622876|NCT05616013|561711893|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622877|NCT05616013|561711894|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622878|NCT05616013|561711895|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
155622879|NCT05616013|561711896|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622880|NCT05616013|561711897|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622881|NCT05616013|561711898|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622882|NCT05616013|561711899|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622883|NCT05616013|561711900|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155622884|NCT05616013|561711892|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622885|NCT05616013|561711893|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622886|NCT05616013|561711894|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622887|NCT05616013|561711895|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622888|NCT05616013|561711896|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622889|NCT05616013|561711897|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622890|NCT05616013|561711898|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
155622891|NCT05616013|561711899|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622892|NCT05616013|561711900|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155622893|NCT05616013|561711892|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622894|NCT05616013|561711893|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622895|NCT05616013|561711894|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622896|NCT05616013|561711895|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622897|NCT05616013|561711896|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622898|NCT05616013|561711897|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622899|NCT05616013|561711898|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622900|NCT05616013|561711899|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155622901|NCT05616013|561711900|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
155622902|NCT05616013|561711892|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622903|NCT05616013|561711893|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622904|NCT05616013|561711894|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622905|NCT05616013|561711895|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622906|NCT05616013|561711896|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622907|NCT05616013|561711897|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622908|NCT05616013|561711898|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
155622909|NCT05616013|561711899|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
155727102|NCT02594124|562099873|FG006|Overall Study|Commercial drug|7|||
155622910|NCT05616013|561711900|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
155622911|NCT04391842|561711901|FG000|Overall Study|Withdrawal by Subject|2|||
155622912|NCT00810199|561711902|FG000|Overall Study|Adverse Event|24|||
155622913|NCT00810199|561711903|FG001|Overall Study|Adverse Event|26|||
155622914|NCT00810199|561711902|FG000|Overall Study|Death|4|||
155622915|NCT00810199|561711903|FG001|Overall Study|Death|6|||
155622916|NCT00810199|561711902|FG000|Overall Study|Withdrew consent|9|||
155622917|NCT00810199|561711903|FG001|Overall Study|Withdrew consent|12|||
155622918|NCT00810199|561711902|FG000|Overall Study|Insufficient therapeutic response|5|||
155622919|NCT00810199|561711903|FG001|Overall Study|Insufficient therapeutic response|14|||
155622920|NCT00810199|561711902|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
155622921|NCT00810199|561711903|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
155622922|NCT00810199|561711902|FG000|Overall Study|Administrative/Other|5|||
155622923|NCT00810199|561711903|FG001|Overall Study|Administrative/Other|6|||
155622924|NCT00810199|561711902|FG000|Overall Study|Protocol Violation|2|||
155622925|NCT00810199|561711903|FG001|Overall Study|Protocol Violation|6|||
155622926|NCT00810199|561711902|FG000|Overall Study|Failure to return|1|||
155622927|NCT00810199|561711903|FG001|Overall Study|Failure to return|4|||
155622928|NCT00810199|561711902|FG000|Overall Study|Did not receive study drug|2|||
155622929|NCT00810199|561711903|FG001|Overall Study|Did not receive study drug|1|||
155622930|NCT00992017|561711905|FG000|Overall Study|Lost to Follow-up|2|||
155622931|NCT00992017|561711905|FG000|Overall Study|Withdrawal by Subject|2|||
155622932|NCT00992017|561711905|FG000|Overall Study|Unable to get to clinic|5|||
155622933|NCT00992017|561711905|FG000|Overall Study|Not adhere to study requirements|1|||
155622934|NCT02864407|561711906|FG000|Overall Study|Protocol Violation|3|||
155622935|NCT02864407|561711906|FG000|Overall Study|Lost to Follow-up|115|||
155622936|NCT02864407|561711906|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
155622937|NCT02864407|561711906|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
155622938|NCT02864407|561711906|FG000|Overall Study|Consent prior to the contract date|1|||
155622939|NCT02686164|561711914|FG000|Overall Study|Adverse Event|1|||
155622940|NCT02686164|561711914|FG000|Overall Study|Withdrawal of consent|1|||
155622941|NCT02686164|561711914|FG000|Overall Study|Clinical progression|1|||
155622942|NCT01691378|561711915|FG000|Overall Study|Withdrawal by Subject|2|||
155622943|NCT01691378|561711916|FG001|Overall Study|Withdrawal by Subject|0|||
155622944|NCT01691378|561711915|FG000|Overall Study|Lost to Follow-up|5|||
155622945|NCT01691378|561711916|FG001|Overall Study|Lost to Follow-up|2|||
155622946|NCT01827592|561711919|FG000|Overall Study|Adverse Event|11|||
155622947|NCT01827592|561711920|FG001|Overall Study|Adverse Event|9|||
155622948|NCT01827592|561711921|FG002|Overall Study|Adverse Event|2|||
155622949|NCT01827592|561711919|FG000|Overall Study|Physician Decision|0|||
155622950|NCT01827592|561711920|FG001|Overall Study|Physician Decision|2|||
155622951|NCT01827592|561711921|FG002|Overall Study|Physician Decision|1|||
155622952|NCT01827592|561711919|FG000|Overall Study|Protocol Violation|2|||
155622953|NCT01827592|561711920|FG001|Overall Study|Protocol Violation|1|||
155622954|NCT01827592|561711921|FG002|Overall Study|Protocol Violation|0|||
155622955|NCT01827592|561711919|FG000|Overall Study|Lost to Follow-up|1|||
155622956|NCT01827592|561711920|FG001|Overall Study|Lost to Follow-up|2|||
155622957|NCT01827592|561711921|FG002|Overall Study|Lost to Follow-up|2|||
155622958|NCT01827592|561711919|FG000|Overall Study|Withdrawal by Subject|12|||
155622959|NCT01827592|561711920|FG001|Overall Study|Withdrawal by Subject|11|||
155622960|NCT01827592|561711921|FG002|Overall Study|Withdrawal by Subject|11|||
155622961|NCT01827592|561711919|FG000|Overall Study|Patient's substantial non-compliance|1|||
155622962|NCT01827592|561711920|FG001|Overall Study|Patient's substantial non-compliance|1|||
155622963|NCT01827592|561711921|FG002|Overall Study|Patient's substantial non-compliance|6|||
155622964|NCT01827592|561711919|FG000|Overall Study|Trial terminated by Sponsor|47|||
155622965|NCT01827592|561711920|FG001|Overall Study|Trial terminated by Sponsor|53|||
155622966|NCT01827592|561711921|FG002|Overall Study|Trial terminated by Sponsor|51|||
155622967|NCT01827592|561711919|FG000|Overall Study|Others|0|||
155622968|NCT01827592|561711920|FG001|Overall Study|Others|1|||
155622969|NCT01827592|561711921|FG002|Overall Study|Others|3|||
155622970|NCT02573259|561711935|FG000|Overall Study|Death|1|||
155622971|NCT02573259|561711936|FG001|Overall Study|Death|6|||
155622972|NCT02573259|561711937|FG002|Overall Study|Death|5|||
155622973|NCT02573259|561711938|FG003|Overall Study|Death|6|||
155622974|NCT02573259|561711939|FG004|Overall Study|Death|9|||
155622975|NCT02573259|561711940|FG005|Overall Study|Death|32|||
155622976|NCT02573259|561711941|FG006|Overall Study|Death|21|||
155622977|NCT02573259|561711935|FG000|Overall Study|Lost to Follow-up|0|||
155622978|NCT02573259|561711936|FG001|Overall Study|Lost to Follow-up|0|||
155727103|NCT02594124|562099874|FG007|Overall Study|Commercial drug|11|||
155622979|NCT02573259|561711937|FG002|Overall Study|Lost to Follow-up|0|||
155622980|NCT02573259|561711938|FG003|Overall Study|Lost to Follow-up|0|||
155622981|NCT02573259|561711939|FG004|Overall Study|Lost to Follow-up|0|||
155622982|NCT02573259|561711940|FG005|Overall Study|Lost to Follow-up|2|||
155622983|NCT02573259|561711941|FG006|Overall Study|Lost to Follow-up|1|||
155622984|NCT02573259|561711935|FG000|Overall Study|Participant refused further follow-up|0|||
155622985|NCT02573259|561711936|FG001|Overall Study|Participant refused further follow-up|2|||
155727104|NCT02594124|562099875|FG008|Overall Study|Commercial drug|2|||
155622986|NCT02573259|561711937|FG002|Overall Study|Participant refused further follow-up|1|||
155622987|NCT02573259|561711938|FG003|Overall Study|Participant refused further follow-up|0|||
155622988|NCT02573259|561711939|FG004|Overall Study|Participant refused further follow-up|3|||
155622989|NCT02573259|561711940|FG005|Overall Study|Participant refused further follow-up|20|||
155622990|NCT02573259|561711941|FG006|Overall Study|Participant refused further follow-up|7|||
155622991|NCT02573259|561711935|FG000|Overall Study|Other|0|||
155622992|NCT02573259|561711936|FG001|Overall Study|Other|0|||
155622993|NCT02573259|561711937|FG002|Overall Study|Other|0|||
155622994|NCT02573259|561711938|FG003|Overall Study|Other|0|||
155622995|NCT02573259|561711939|FG004|Overall Study|Other|1|||
155622996|NCT02573259|561711940|FG005|Overall Study|Other|4|||
155622997|NCT02573259|561711941|FG006|Overall Study|Other|5|||
155622998|NCT00751140|561711942|FG000|Overall Study|benign angioma excluded from analysis|1|||
155622999|NCT03160716|561711943|FG000|Overall Study|Lost to Follow-up|1|||
155623000|NCT01628848|561711944|FG000|Overall Study|Adverse Event|9|||
155623001|NCT01628848|561711945|FG001|Overall Study|Adverse Event|7|||
155623002|NCT01628848|561711944|FG000|Overall Study|Lack of Efficacy|0|||
155623003|NCT01628848|561711945|FG001|Overall Study|Lack of Efficacy|4|||
155623004|NCT01628848|561711944|FG000|Overall Study|Withdrawal by Subject|0|||
155623005|NCT01628848|561711945|FG001|Overall Study|Withdrawal by Subject|2|||
155623006|NCT01628848|561711944|FG000|Overall Study|Physician Decision|3|||
155623007|NCT01628848|561711945|FG001|Overall Study|Physician Decision|1|||
155623008|NCT00808067|561711947|FG000|Overall Study|Major/minor bleed|30|||
155623009|NCT00808067|561711948|FG001|Overall Study|Major/minor bleed|44|||
155623010|NCT00808067|561711947|FG000|Overall Study|Outcome event - other|33|||
155623011|NCT00808067|561711948|FG001|Overall Study|Outcome event - other|25|||
155623012|NCT00808067|561711947|FG000|Overall Study|Adverse Event|111|||
155623013|NCT00808067|561711948|FG001|Overall Study|Adverse Event|121|||
155623014|NCT00808067|561711947|FG000|Overall Study|Hospitalization (not including surgery)|18|||
155623015|NCT00808067|561711948|FG001|Overall Study|Hospitalization (not including surgery)|17|||
155623016|NCT00808067|561711947|FG000|Overall Study|Hospitalization due to surgery|37|||
155623017|NCT00808067|561711948|FG001|Overall Study|Hospitalization due to surgery|40|||
155623018|NCT00808067|561711947|FG000|Overall Study|Reduced creatinine clearance|53|||
155623019|NCT00808067|561711948|FG001|Overall Study|Reduced creatinine clearance|55|||
155623020|NCT00808067|561711947|FG000|Overall Study|Elevated LFT results|7|||
155623021|NCT00808067|561711948|FG001|Overall Study|Elevated LFT results|3|||
155623022|NCT00808067|561711947|FG000|Overall Study|Patient refused to take study medication|65|||
155623023|NCT00808067|561711948|FG001|Overall Study|Patient refused to take study medication|76|||
155623024|NCT00808067|561711947|FG000|Overall Study|Missing|1|||
155623025|NCT00808067|561711948|FG001|Overall Study|Missing|0|||
155623026|NCT00808067|561711947|FG000|Overall Study|Death|1|||
155623027|NCT00808067|561711948|FG001|Overall Study|Death|1|||
155623028|NCT00808067|561711947|FG000|Overall Study|Procedure|6|||
155623029|NCT00808067|561711948|FG001|Overall Study|Procedure|7|||
155623030|NCT00808067|561711947|FG000|Overall Study|Withdrawal by Subject|21|||
155623031|NCT00808067|561711948|FG001|Overall Study|Withdrawal by Subject|25|||
155623032|NCT00808067|561711947|FG000|Overall Study|Site closed|4|||
155623033|NCT00808067|561711948|FG001|Overall Study|Site closed|3|||
155623034|NCT00808067|561711947|FG000|Overall Study|Physician Decision|47|||
155623035|NCT00808067|561711948|FG001|Overall Study|Physician Decision|38|||
155623036|NCT00808067|561711947|FG000|Overall Study|Protocol Violation|3|||
155623037|NCT00808067|561711948|FG001|Overall Study|Protocol Violation|11|||
155623038|NCT00808067|561711947|FG000|Overall Study|Patient elected|7|||
155623039|NCT00808067|561711948|FG001|Overall Study|Patient elected|9|||
155623040|NCT00808067|561711947|FG000|Overall Study|Site closed for cause|19|||
155623041|NCT00808067|561711948|FG001|Overall Study|Site closed for cause|19|||
155623042|NCT00808067|561711947|FG000|Overall Study|Other reason not defined above|5|||
155623043|NCT00808067|561711948|FG001|Overall Study|Other reason not defined above|5|||
155623044|NCT00808067|561711947|FG000|Overall Study|Excluded from analysis|13|||
155623045|NCT00808067|561711948|FG001|Overall Study|Excluded from analysis|19|||
155623046|NCT00689338|561711949|FG000|Overall Study|Death|65|||
155623047|NCT00689338|561711949|FG000|Overall Study|Adverse Event|13|||
155623048|NCT00689338|561711949|FG000|Overall Study|Insufficient Clinical Response|1|||
155623049|NCT00689338|561711949|FG000|Overall Study|Lack of Efficacy|6|||
155623050|NCT00689338|561711949|FG000|Overall Study|Other|8|||
155623051|NCT00689338|561711949|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
155623052|NCT00689338|561711949|FG000|Overall Study|Lost to Follow-up|5|||
155623053|NCT00689338|561711949|FG000|Overall Study|Withdrawal by Subject|3|||
155623054|NCT00689338|561711949|FG000|Overall Study|Protocol Violation|15|||
155623055|NCT01939314|561711950|FG000|Overall Study|Withdrawal by Subject|3|||
155623056|NCT01939314|561711951|FG001|Overall Study|Withdrawal by Subject|1|||
155623057|NCT01939314|561711950|FG000|Overall Study|Protocol Violation|1|||
155623058|NCT01939314|561711951|FG001|Overall Study|Protocol Violation|0|||
155623059|NCT01939314|561711950|FG000|Overall Study|Pregnancy|0|||
155623060|NCT01939314|561711951|FG001|Overall Study|Pregnancy|1|||
155623061|NCT01939314|561711950|FG000|Overall Study|Lost to Follow-up|5|||
155623062|NCT01939314|561711951|FG001|Overall Study|Lost to Follow-up|6|||
155623063|NCT02104895|561711954|FG000|Overall Study|Withdrawal by Subject|0|||
155623064|NCT02104895|561711955|FG001|Overall Study|Withdrawal by Subject|14|||
155623065|NCT00969228|561711956|FG000|Overall Study|Adverse Event|1|||
155623066|NCT00969228|561711957|FG001|Overall Study|Adverse Event|0|||
155623067|NCT00969228|561711956|FG000|Overall Study|Withdrawal by Subject|4|||
155623068|NCT00969228|561711957|FG001|Overall Study|Withdrawal by Subject|0|||
155623069|NCT00969228|561711956|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
155623070|NCT00969228|561711957|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
155623071|NCT01107925|561711966|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
155623072|NCT01107925|561711967|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155623073|NCT01107925|561711968|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155623074|NCT01107925|561711969|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155623075|NCT01107925|561711970|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
155623076|NCT01107925|561711971|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155623077|NCT01107925|561711966|FG000|Period 2|Withdrawal by Subject|0|||
155623078|NCT01107925|561711967|FG001|Period 2|Withdrawal by Subject|1|||
155623079|NCT01107925|561711968|FG002|Period 2|Withdrawal by Subject|0|||
155623080|NCT01107925|561711969|FG003|Period 2|Withdrawal by Subject|0|||
155623081|NCT01107925|561711970|FG004|Period 2|Withdrawal by Subject|0|||
155623082|NCT01107925|561711971|FG005|Period 2|Withdrawal by Subject|1|||
155623083|NCT03311945|561711972|FG000|Overall Study|Adverse Event|2|||
155623084|NCT03311945|561711972|FG000|Overall Study|Lack of Efficacy|1|||
155623085|NCT04235504|561711973|FG000|Study Phase|Withdrawal by Subject|5|||
155623086|NCT04235504|561711974|FG001|Study Phase|Withdrawal by Subject|2|||
155623087|NCT04235504|561711975|FG002|Study Phase|Withdrawal by Subject|0|||
155623088|NCT04235504|561711976|FG003|Study Phase|Withdrawal by Subject|0|||
155623089|NCT04235504|561711973|FG000|Continuation Phase|Withdrawal by Subject|0|||
155623090|NCT04235504|561711974|FG001|Continuation Phase|Withdrawal by Subject|4|||
155623091|NCT04235504|561711975|FG002|Continuation Phase|Withdrawal by Subject|0|||
155623092|NCT04235504|561711976|FG003|Continuation Phase|Withdrawal by Subject|0|||
155623093|NCT04235504|561711973|FG000|Continuation Phase|Adverse Event|0|||
155623094|NCT04235504|561711974|FG001|Continuation Phase|Adverse Event|1|||
155623095|NCT04235504|561711975|FG002|Continuation Phase|Adverse Event|0|||
155623096|NCT04235504|561711976|FG003|Continuation Phase|Adverse Event|0|||
155623097|NCT04235504|561711973|FG000|Continuation Phase|Physician Decision|1|||
155727105|NCT02594124|562099867|FG000|Overall Study|Reason Not Specified|1|||
155727106|NCT02594124|562099868|FG001|Overall Study|Reason Not Specified|3|||
155727107|NCT02594124|562099869|FG002|Overall Study|Reason Not Specified|4|||
155727108|NCT02594124|562099870|FG003|Overall Study|Reason Not Specified|0|||
155727109|NCT02594124|562099871|FG004|Overall Study|Reason Not Specified|0|||
155727110|NCT02594124|562099872|FG005|Overall Study|Reason Not Specified|1|||
155727111|NCT02594124|562099873|FG006|Overall Study|Reason Not Specified|1|||
155727112|NCT02594124|562099874|FG007|Overall Study|Reason Not Specified|6|||
155727113|NCT02594124|562099875|FG008|Overall Study|Reason Not Specified|1|||
155727114|NCT01824836|562099876|FG000|Overall Study|Adverse Event|48|||
155727115|NCT01824836|562099876|FG000|Overall Study|Withdrawal by Subject|63|||
155727116|NCT01824836|562099876|FG000|Overall Study|Other complicating disease|116|||
155727117|NCT01824836|562099876|FG000|Overall Study|Disease progression|5|||
155727118|NCT01824836|562099876|FG000|Overall Study|Alternative therapy|2|||
155727119|NCT01824836|562099876|FG000|Overall Study|Depression|1|||
155727120|NCT01824836|562099876|FG000|Overall Study|Non-compliance|3|||
155727121|NCT01824836|562099876|FG000|Overall Study|Patient regained ovarian function|3|||
155727122|NCT01824836|562099876|FG000|Overall Study|Lost to Follow-up|8|||
155727123|NCT01824836|562099876|FG000|Overall Study|Physician Decision|2|||
155727124|NCT01824836|562099876|FG000|Overall Study|Research office was closed|3|||
155727125|NCT01824836|562099876|FG000|Overall Study|Relocation|3|||
155727126|NCT01824836|562099876|FG000|Overall Study|Insurance-related issue|1|||
155727127|NCT01824836|562099876|FG000|Overall Study|Transportation issue|1|||
155727128|NCT01824836|562099876|FG000|Overall Study|Patient transferred care|1|||
155727129|NCT01824836|562099876|FG000|Overall Study|Unknown reasons|4|||
155727130|NCT01824836|562099876|FG000|Overall Study|Never started treatment|16|||
155727131|NCT05523089|562099877|FG000|Overall Study|Withdrawal by Subject|1|||
155623098|NCT04235504|561711974|FG001|Continuation Phase|Physician Decision|2|||
155623099|NCT04235504|561711975|FG002|Continuation Phase|Physician Decision|1|||
155623100|NCT04235504|561711976|FG003|Continuation Phase|Physician Decision|0|||
155623101|NCT04877990|561711977|FG000|Treatment|Other reasons|3|||
155623102|NCT04877990|561711978|FG001|Treatment|Other reasons|1|||
155623103|NCT04877990|561711977|FG000|Treatment|Administrative reasons by sponsor|17|||
155623104|NCT04877990|561711978|FG001|Treatment|Administrative reasons by sponsor|33|||
155623105|NCT04877990|561711977|FG000|Treatment|Withdrawal by Subject|2|||
155623106|NCT04877990|561711978|FG001|Treatment|Withdrawal by Subject|6|||
155727132|NCT05523089|562099878|FG001|Overall Study|Withdrawal by Subject|0|||
155727133|NCT05523089|562099879|FG002|Overall Study|Withdrawal by Subject|0|||
155727134|NCT05523089|562099877|FG000|Overall Study|Lost to Follow-up|1|||
155727135|NCT05523089|562099878|FG001|Overall Study|Lost to Follow-up|0|||
155727136|NCT05523089|562099879|FG002|Overall Study|Lost to Follow-up|0|||
155727137|NCT02083354|562101936|FG000|Overall Study|Withdrawal by Subject|9|||
155623107|NCT04877990|561711977|FG000|Treatment|Adverse Event|2|||
155623108|NCT04877990|561711978|FG001|Treatment|Adverse Event|1|||
155623109|NCT02532283|561711980|FG000|Overall Study|Adverse Event|0|||
155623110|NCT02532283|561711981|FG001|Overall Study|Adverse Event|1|||
155623111|NCT02532283|561711980|FG000|Overall Study|Death|1|||
155623112|NCT02532283|561711981|FG001|Overall Study|Death|0|||
155623113|NCT02532283|561711980|FG000|Overall Study|Lost to Follow-up|0|||
155623114|NCT02532283|561711981|FG001|Overall Study|Lost to Follow-up|1|||
155623115|NCT02532283|561711980|FG000|Overall Study|Withdrawal by Subject|8|||
155623116|NCT02532283|561711981|FG001|Overall Study|Withdrawal by Subject|3|||
155623117|NCT01945944|561711984|FG000|Overall Study|Adverse Event|0|||
155623118|NCT01945944|561711985|FG001|Overall Study|Adverse Event|2|||
155623119|NCT01945944|561711984|FG000|Overall Study|Physician Decision|1|||
155623120|NCT01945944|561711985|FG001|Overall Study|Physician Decision|0|||
155623121|NCT01945944|561711984|FG000|Overall Study|Withdrawal by Subject|0|||
155623122|NCT01945944|561711985|FG001|Overall Study|Withdrawal by Subject|1|||
155623123|NCT01817075|561711986|FG000|Overall Study|Adverse Event|7|||
155623124|NCT01817075|561711987|FG001|Overall Study|Adverse Event|5|||
155623125|NCT01817075|561711986|FG000|Overall Study|Physician Decision|9|||
155623126|NCT01817075|561711987|FG001|Overall Study|Physician Decision|12|||
155623127|NCT01817075|561711986|FG000|Overall Study|Withdrawal by Subject|31|||
155623128|NCT01817075|561711987|FG001|Overall Study|Withdrawal by Subject|15|||
155623129|NCT01817075|561711986|FG000|Overall Study|Received Sorafenib after enrollment|0|||
155623130|NCT01817075|561711987|FG001|Overall Study|Received Sorafenib after enrollment|1|||
155623131|NCT01817075|561711986|FG000|Overall Study|Ineligible|0|||
155623132|NCT01817075|561711987|FG001|Overall Study|Ineligible|2|||
155623133|NCT04376515|561711990|FG000|Overall Study|Found to have been vaccinated before study start|6|||
155623134|NCT04376515|561711991|FG001|Overall Study|Found to have been vaccinated before study start|6|||
155623135|NCT03811821|561711992|FG000|Overall Study|Adverse Event|1|||
155623136|NCT03811821|561711993|FG001|Overall Study|Adverse Event|1|||
155623137|NCT03811821|561711992|FG000|Overall Study|Withdrawal by Subject|5|||
155623138|NCT03811821|561711993|FG001|Overall Study|Withdrawal by Subject|4|||
155623139|NCT03811821|561711992|FG000|Overall Study|Lost to Follow-up|2|||
155623140|NCT03811821|561711993|FG001|Overall Study|Lost to Follow-up|2|||
155623141|NCT03811821|561711992|FG000|Overall Study|Contraindication for treatment|0|||
155623142|NCT03811821|561711993|FG001|Overall Study|Contraindication for treatment|1|||
155623143|NCT03811821|561711992|FG000|Overall Study|Tolerability|0|||
155623144|NCT03811821|561711993|FG001|Overall Study|Tolerability|3|||
155623145|NCT03811821|561711992|FG000|Overall Study|Comorbidities|0|||
155623146|NCT03811821|561711993|FG001|Overall Study|Comorbidities|2|||
155623147|NCT01395810|561711996|FG000|Overall Study|Adverse Event|0|||
155623148|NCT01395810|561711997|FG001|Overall Study|Adverse Event|1|||
155623149|NCT01395810|561711998|FG002|Overall Study|Adverse Event|0|||
155623150|NCT01395810|561711999|FG003|Overall Study|Adverse Event|0|||
155623151|NCT01395810|561711996|FG000|Overall Study|Lack of Efficacy|0|||
155623152|NCT01395810|561711997|FG001|Overall Study|Lack of Efficacy|1|||
155623153|NCT01395810|561711998|FG002|Overall Study|Lack of Efficacy|0|||
155623154|NCT01395810|561711999|FG003|Overall Study|Lack of Efficacy|0|||
155623155|NCT01395810|561711996|FG000|Overall Study|Withdrawal criteria|0|||
155623156|NCT01395810|561711997|FG001|Overall Study|Withdrawal criteria|2|||
155623157|NCT01395810|561711998|FG002|Overall Study|Withdrawal criteria|0|||
155623158|NCT01395810|561711999|FG003|Overall Study|Withdrawal criteria|0|||
155623159|NCT01395810|561711996|FG000|Overall Study|Unclassified|2|||
155623160|NCT01395810|561711997|FG001|Overall Study|Unclassified|0|||
155623161|NCT01395810|561711998|FG002|Overall Study|Unclassified|0|||
155623162|NCT01395810|561711999|FG003|Overall Study|Unclassified|0|||
155623163|NCT05630196|561714158|FG000|Overall Study|Adverse Event|2|||
155623164|NCT05630196|561714159|FG001|Overall Study|Adverse Event|1|||
155623165|NCT05630196|561714158|FG000|Overall Study|Lost to Follow-up|1|||
155623166|NCT05630196|561714159|FG001|Overall Study|Lost to Follow-up|1|||
155623167|NCT05630196|561714158|FG000|Overall Study|Protocol Violation|2|||
155623168|NCT05630196|561714159|FG001|Overall Study|Protocol Violation|3|||
155623169|NCT05630196|561714158|FG000|Overall Study|Physician Decision|1|||
155623170|NCT05630196|561714159|FG001|Overall Study|Physician Decision|0|||
155623171|NCT05630196|561714158|FG000|Overall Study|Withdrawal by Subject|3|||
155623172|NCT05630196|561714159|FG001|Overall Study|Withdrawal by Subject|4|||
155623173|NCT01022203|561714165|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
155623174|NCT01022203|561714166|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
155623175|NCT01022203|561714165|FG000|Post Treatment Assessment|Physician Decision|2|||
155623176|NCT01022203|561714166|FG001|Post Treatment Assessment|Physician Decision|0|||
155623177|NCT01022203|561714165|FG000|Post Treatment Assessment|Adverse Event|0|||
155623178|NCT01022203|561714166|FG001|Post Treatment Assessment|Adverse Event|2|||
155623179|NCT01022203|561714165|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
155623180|NCT01022203|561714166|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
155623181|NCT00903201|561714167|FG000|Overall Study|Adverse Event|1|||
155623182|NCT00903201|561714168|FG001|Overall Study|Adverse Event|4|||
155623183|NCT00903201|561714169|FG002|Overall Study|Adverse Event|0|||
155623184|NCT00903201|561714167|FG000|Overall Study|Protocol Violation|2|||
155623185|NCT00903201|561714168|FG001|Overall Study|Protocol Violation|1|||
155623186|NCT00903201|561714169|FG002|Overall Study|Protocol Violation|0|||
155623187|NCT00903201|561714167|FG000|Overall Study|Lost to Follow-up|0|||
155623188|NCT00903201|561714168|FG001|Overall Study|Lost to Follow-up|1|||
155623189|NCT00903201|561714169|FG002|Overall Study|Lost to Follow-up|0|||
155623190|NCT00903201|561714167|FG000|Overall Study|Physician Decision|1|||
155623191|NCT00903201|561714168|FG001|Overall Study|Physician Decision|0|||
155623192|NCT00903201|561714169|FG002|Overall Study|Physician Decision|1|||
155623193|NCT00903201|561714167|FG000|Overall Study|Withdrawal by Subject|1|||
155623194|NCT00903201|561714168|FG001|Overall Study|Withdrawal by Subject|0|||
155623195|NCT00903201|561714169|FG002|Overall Study|Withdrawal by Subject|1|||
155623196|NCT00945243|561714172|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
155623197|NCT03256578|561714173|FG000|Overall Study|Excluded Post Randomization|66|||
155623198|NCT03256578|561714174|FG001|Overall Study|Excluded Post Randomization|56|||
155623199|NCT03028142|561714175|FG000|Overall Study|Adverse Event|1|||
155623200|NCT03028142|561714176|FG001|Overall Study|Adverse Event|1|||
155623201|NCT03028142|561714177|FG002|Overall Study|Adverse Event|0|||
155623202|NCT03028142|561714178|FG003|Overall Study|Adverse Event|0|||
155623203|NCT03028142|561714179|FG004|Overall Study|Adverse Event|0|||
155623204|NCT03028142|561714180|FG005|Overall Study|Adverse Event|1|||
155623205|NCT03028142|561714175|FG000|Overall Study|Withdrawal by Subject|0|||
155623206|NCT03028142|561714176|FG001|Overall Study|Withdrawal by Subject|0|||
155623207|NCT03028142|561714177|FG002|Overall Study|Withdrawal by Subject|0|||
155623208|NCT03028142|561714178|FG003|Overall Study|Withdrawal by Subject|0|||
155623209|NCT03028142|561714179|FG004|Overall Study|Withdrawal by Subject|1|||
155623210|NCT03028142|561714180|FG005|Overall Study|Withdrawal by Subject|0|||
155623211|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
155623212|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
155623213|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
155623214|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
155623215|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
155623216|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
155623217|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
155623218|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
155623219|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
155623220|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
155623221|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
155623222|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
155623223|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
155623224|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
155623225|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
155623226|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
155623227|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
155623228|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
155623229|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
155623230|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
155623231|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
155623232|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
155623233|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
155623234|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
155623235|NCT01198002|561714181|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
155623236|NCT01198002|561714182|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
155623237|NCT01198002|561714183|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
155623238|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
155623239|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
155623240|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
155623241|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
155623242|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
155623243|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
155623244|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
155623245|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
155623246|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
155623247|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
155623248|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
155623249|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
155623250|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
155623251|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
155623252|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
155623253|NCT01198002|561714181|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
155623254|NCT01198002|561714182|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
155623255|NCT01198002|561714183|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
155623256|NCT02812186|561714186|FG000|Period 1|Post randomization screen failure|5|||
155623257|NCT02812186|561714187|FG001|Period 1|Post randomization screen failure|9|||
155623258|NCT02812186|561714186|FG000|Period 1|nonevaluable data sets|6|||
155623259|NCT02812186|561714187|FG001|Period 1|nonevaluable data sets|6|||
155623260|NCT01162343|561714188|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
155623261|NCT01162343|561714188|FG000|Overall Study|Refused psychiatrist assessment|12|||
155623262|NCT03964207|561714189|FG000|First Treatment|Withdrawal by Subject|1|||
155623263|NCT03964207|561714190|FG001|First Treatment|Withdrawal by Subject|2|||
155623264|NCT03964207|561714189|FG000|First Treatment|Protocol Violation|1|||
155623265|NCT03964207|561714190|FG001|First Treatment|Protocol Violation|0|||
155623266|NCT03964207|561714189|FG000|First Treatment|Lost to Follow-up|1|||
155623267|NCT03964207|561714190|FG001|First Treatment|Lost to Follow-up|0|||
155623268|NCT03964207|561714189|FG000|Second Treatment|Lost to Follow-up|0|||
155623269|NCT03964207|561714190|FG001|Second Treatment|Lost to Follow-up|1|||
155623270|NCT03964207|561714189|FG000|Second Treatment|Adverse Event|1|||
155623271|NCT03964207|561714190|FG001|Second Treatment|Adverse Event|2|||
155623272|NCT00830219|561714193|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155623273|NCT00830219|561714194|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155623274|NCT01130272|561714195|FG000|Overall Study|Adverse Event|2|||
155623275|NCT01130272|561714196|FG001|Overall Study|Adverse Event|5|||
155623276|NCT01130272|561714197|FG002|Overall Study|Adverse Event|6|||
155623277|NCT01130272|561714198|FG003|Overall Study|Adverse Event|22|||
155623278|NCT01130272|561714199|FG004|Overall Study|Adverse Event|7|||
155623279|NCT01130272|561714195|FG000|Overall Study|IVRS-confirmed constipation|0|||
155623280|NCT01130272|561714196|FG001|Overall Study|IVRS-confirmed constipation|1|||
155623281|NCT01130272|561714197|FG002|Overall Study|IVRS-confirmed constipation|1|||
155623282|NCT01130272|561714198|FG003|Overall Study|IVRS-confirmed constipation|2|||
155623283|NCT01130272|561714199|FG004|Overall Study|IVRS-confirmed constipation|0|||
155623284|NCT01130272|561714195|FG000|Overall Study|Rescue medications due to diarrhea|3|||
155623285|NCT01130272|561714196|FG001|Overall Study|Rescue medications due to diarrhea|5|||
155623286|NCT01130272|561714197|FG002|Overall Study|Rescue medications due to diarrhea|8|||
155623287|NCT01130272|561714198|FG003|Overall Study|Rescue medications due to diarrhea|8|||
155623288|NCT01130272|561714199|FG004|Overall Study|Rescue medications due to diarrhea|6|||
155623289|NCT01130272|561714195|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
155623290|NCT01130272|561714196|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
155623291|NCT01130272|561714197|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
155623292|NCT01130272|561714198|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
155623293|NCT01130272|561714199|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
155623294|NCT01130272|561714195|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155623295|NCT01130272|561714196|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155623296|NCT01130272|561714197|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155623297|NCT01130272|561714198|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
155623298|NCT01130272|561714199|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155623299|NCT01130272|561714195|FG000|Overall Study|Protocol Violation|0|||
155623300|NCT01130272|561714196|FG001|Overall Study|Protocol Violation|0|||
155623301|NCT01130272|561714197|FG002|Overall Study|Protocol Violation|3|||
155623302|NCT01130272|561714198|FG003|Overall Study|Protocol Violation|5|||
155623303|NCT01130272|561714199|FG004|Overall Study|Protocol Violation|5|||
155277524|NCT02584855|560449097|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
155277525|NCT02584855|560449092|FG000|Open-Label Treatment Period|Protocol Violation|1|||
155623304|NCT01130272|561714195|FG000|Overall Study|Lost to Follow-up|4|||
155623305|NCT01130272|561714196|FG001|Overall Study|Lost to Follow-up|3|||
155623306|NCT01130272|561714197|FG002|Overall Study|Lost to Follow-up|4|||
155623307|NCT01130272|561714198|FG003|Overall Study|Lost to Follow-up|7|||
155623308|NCT01130272|561714199|FG004|Overall Study|Lost to Follow-up|6|||
155623309|NCT01130272|561714195|FG000|Overall Study|Withdrawal by Subject|4|||
155623310|NCT01130272|561714196|FG001|Overall Study|Withdrawal by Subject|11|||
155623311|NCT01130272|561714197|FG002|Overall Study|Withdrawal by Subject|10|||
155623312|NCT01130272|561714198|FG003|Overall Study|Withdrawal by Subject|9|||
155623313|NCT01130272|561714199|FG004|Overall Study|Withdrawal by Subject|8|||
155623314|NCT01130272|561714195|FG000|Overall Study|Physician Decision|1|||
155623315|NCT01130272|561714196|FG001|Overall Study|Physician Decision|1|||
155623316|NCT01130272|561714197|FG002|Overall Study|Physician Decision|0|||
155623317|NCT01130272|561714198|FG003|Overall Study|Physician Decision|1|||
155623318|NCT01130272|561714199|FG004|Overall Study|Physician Decision|2|||
155623319|NCT01130272|561714195|FG000|Overall Study|Sponsor decision|6|||
155623320|NCT01130272|561714196|FG001|Overall Study|Sponsor decision|15|||
155623321|NCT01130272|561714197|FG002|Overall Study|Sponsor decision|16|||
155277526|NCT02584855|560449093|FG001|Open-Label Treatment Period|Protocol Violation|0|||
155277527|NCT02584855|560449094|FG002|Open-Label Treatment Period|Protocol Violation|0|||
155277528|NCT02584855|560449095|FG003|Open-Label Treatment Period|Protocol Violation|0|||
155623322|NCT01130272|561714198|FG003|Overall Study|Sponsor decision|13|||
155623323|NCT01130272|561714199|FG004|Overall Study|Sponsor decision|16|||
155623324|NCT01130272|561714195|FG000|Overall Study|Study arm discontinued|38|||
155623325|NCT01130272|561714196|FG001|Overall Study|Study arm discontinued|0|||
155623326|NCT01130272|561714197|FG002|Overall Study|Study arm discontinued|0|||
155623327|NCT01130272|561714198|FG003|Overall Study|Study arm discontinued|0|||
155623328|NCT01130272|561714199|FG004|Overall Study|Study arm discontinued|0|||
155623329|NCT00239720|561714200|FG000|Overall Study|Adverse Event|1|||
155623330|NCT00239720|561714201|FG001|Overall Study|Adverse Event|0|||
155623331|NCT00239720|561714200|FG000|Overall Study|Lost to Follow-up|0|||
155623332|NCT00239720|561714201|FG001|Overall Study|Lost to Follow-up|1|||
155623333|NCT01783743|561714206|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
155623334|NCT01783743|561714207|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
155623335|NCT01783743|561714206|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
155623336|NCT01783743|561714207|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
155623337|NCT01783743|561714206|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
155623338|NCT01783743|561714207|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
155623339|NCT02771275|561714208|FG000|Overall Study|Reoperation|3|||
155623340|NCT02771275|561714208|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
155623341|NCT05556148|561714209|FG000|Overall Study|Early Termination|29|||
155623342|NCT05556148|561714209|FG000|Overall Study|Baseline Tasks Expired|4|||
155623343|NCT05556148|561714209|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
155623344|NCT05556148|561714209|FG000|Overall Study|No Longer Wished to Participate|1|||
155623345|NCT05556148|561714209|FG000|Overall Study|Bacterial Conjunctivitis|1|||
155623346|NCT00126594|561714223|FG000|Overall Study|Ineligible|2|||
155623347|NCT00126594|561714224|FG001|Overall Study|Ineligible|0|||
155623348|NCT00126594|561714223|FG000|Overall Study|Withdrawal by Subject|0|||
155623349|NCT00126594|561714224|FG001|Overall Study|Withdrawal by Subject|4|||
155623350|NCT00126594|561714223|FG000|Overall Study|Physician Decision|1|||
155623351|NCT00126594|561714224|FG001|Overall Study|Physician Decision|3|||
155623352|NCT00126594|561714223|FG000|Overall Study|Adverse Event|7|||
155623353|NCT00126594|561714224|FG001|Overall Study|Adverse Event|5|||
155623354|NCT00126594|561714223|FG000|Overall Study|Non-compliance|0|||
155623355|NCT00126594|561714224|FG001|Overall Study|Non-compliance|1|||
155623356|NCT00126594|561714223|FG000|Overall Study|Disease Progression|29|||
155623357|NCT00126594|561714224|FG001|Overall Study|Disease Progression|24|||
155623358|NCT00853762|561714225|FG000|Overall Study|Premature Termination|16|||
155623359|NCT00853762|561714226|FG001|Overall Study|Premature Termination|15|||
155623360|NCT00853762|561714227|FG002|Overall Study|Premature Termination|14|||
155623361|NCT00853762|561714228|FG003|Overall Study|Premature Termination|21|||
155623362|NCT00853762|561714225|FG000|Overall Study|Protocol Violation|0|||
155623363|NCT00853762|561714226|FG001|Overall Study|Protocol Violation|0|||
155623364|NCT00853762|561714227|FG002|Overall Study|Protocol Violation|0|||
155623365|NCT00853762|561714228|FG003|Overall Study|Protocol Violation|1|||
155623366|NCT00853762|561714225|FG000|Overall Study|Withdrawal by Subject|0|||
155623367|NCT00853762|561714226|FG001|Overall Study|Withdrawal by Subject|0|||
155623368|NCT00853762|561714227|FG002|Overall Study|Withdrawal by Subject|1|||
155623369|NCT00853762|561714228|FG003|Overall Study|Withdrawal by Subject|0|||
155623370|NCT00853762|561714225|FG000|Overall Study|Other|0|||
155623371|NCT00853762|561714226|FG001|Overall Study|Other|2|||
155623372|NCT00853762|561714227|FG002|Overall Study|Other|0|||
155623373|NCT00853762|561714228|FG003|Overall Study|Other|0|||
155623374|NCT00853762|561714225|FG000|Overall Study|Randomised but not Treated|0|||
155623375|NCT00853762|561714226|FG001|Overall Study|Randomised but not Treated|2|||
155623376|NCT00853762|561714227|FG002|Overall Study|Randomised but not Treated|2|||
155623377|NCT00853762|561714228|FG003|Overall Study|Randomised but not Treated|0|||
155623378|NCT02000921|561714229|FG000|Overall Study|Withdrawal by Subject|3|||
155623379|NCT02000921|561714230|FG001|Overall Study|Withdrawal by Subject|10|||
155623380|NCT02000921|561714231|FG002|Overall Study|Withdrawal by Subject|5|||
155623381|NCT02000921|561714229|FG000|Overall Study|Lost to Follow-up|2|||
155623382|NCT02000921|561714230|FG001|Overall Study|Lost to Follow-up|4|||
155623383|NCT02000921|561714231|FG002|Overall Study|Lost to Follow-up|5|||
155623384|NCT02000921|561714229|FG000|Overall Study|Physician Decision|0|||
155623385|NCT02000921|561714230|FG001|Overall Study|Physician Decision|2|||
155623386|NCT02000921|561714231|FG002|Overall Study|Physician Decision|0|||
155623387|NCT01290718|561714236|FG000|Overall Study|Early termination of the study|4|||
155623388|NCT02631941|561714239|FG000|Overall Study|Physician Decision|0|||
155623389|NCT02631941|561714240|FG001|Overall Study|Physician Decision|1|||
155623390|NCT02631941|561714241|FG002|Overall Study|Physician Decision|0|||
155623391|NCT02631941|561714242|FG003|Overall Study|Physician Decision|0|||
155623392|NCT02631941|561714243|FG004|Overall Study|Physician Decision|0|||
155623393|NCT02631941|561714244|FG005|Overall Study|Physician Decision|0|||
155623394|NCT02631941|561714245|FG006|Overall Study|Physician Decision|0|||
155623395|NCT02631941|561714246|FG007|Overall Study|Physician Decision|0|||
155623396|NCT02631941|561714247|FG008|Overall Study|Physician Decision|0|||
155623397|NCT02631941|561714248|FG009|Overall Study|Physician Decision|0|||
155727138|NCT02083354|562101936|FG000|Overall Study|Lost to Follow-up|1|||
155623398|NCT02631941|561714239|FG000|Overall Study|Adverse Event|0|||
155623399|NCT02631941|561714240|FG001|Overall Study|Adverse Event|1|||
155623400|NCT02631941|561714241|FG002|Overall Study|Adverse Event|0|||
155623401|NCT02631941|561714242|FG003|Overall Study|Adverse Event|0|||
155623402|NCT02631941|561714243|FG004|Overall Study|Adverse Event|0|||
155623403|NCT02631941|561714244|FG005|Overall Study|Adverse Event|0|||
155623404|NCT02631941|561714245|FG006|Overall Study|Adverse Event|0|||
155623405|NCT02631941|561714246|FG007|Overall Study|Adverse Event|0|||
155623406|NCT02631941|561714247|FG008|Overall Study|Adverse Event|0|||
155623407|NCT02631941|561714248|FG009|Overall Study|Adverse Event|0|||
155623408|NCT02631941|561714239|FG000|Overall Study|Withdrawal by Subject|0|||
155623409|NCT02631941|561714240|FG001|Overall Study|Withdrawal by Subject|0|||
155623410|NCT02631941|561714241|FG002|Overall Study|Withdrawal by Subject|0|||
155623411|NCT02631941|561714242|FG003|Overall Study|Withdrawal by Subject|0|||
155623412|NCT02631941|561714243|FG004|Overall Study|Withdrawal by Subject|1|||
155623413|NCT02631941|561714244|FG005|Overall Study|Withdrawal by Subject|0|||
155623414|NCT02631941|561714245|FG006|Overall Study|Withdrawal by Subject|0|||
155623415|NCT02631941|561714246|FG007|Overall Study|Withdrawal by Subject|1|||
155623416|NCT02631941|561714247|FG008|Overall Study|Withdrawal by Subject|0|||
155623417|NCT02631941|561714248|FG009|Overall Study|Withdrawal by Subject|0|||
155623418|NCT02631941|561714239|FG000|Overall Study|Lost to Follow-up|0|||
155623419|NCT02631941|561714240|FG001|Overall Study|Lost to Follow-up|0|||
155623420|NCT02631941|561714241|FG002|Overall Study|Lost to Follow-up|0|||
155623421|NCT02631941|561714242|FG003|Overall Study|Lost to Follow-up|0|||
155623422|NCT02631941|561714243|FG004|Overall Study|Lost to Follow-up|0|||
155623423|NCT02631941|561714244|FG005|Overall Study|Lost to Follow-up|0|||
155623424|NCT02631941|561714245|FG006|Overall Study|Lost to Follow-up|0|||
155623425|NCT02631941|561714246|FG007|Overall Study|Lost to Follow-up|0|||
155623426|NCT02631941|561714247|FG008|Overall Study|Lost to Follow-up|1|||
155623427|NCT02631941|561714248|FG009|Overall Study|Lost to Follow-up|0|||
155623428|NCT00719901|561714251|FG000|Overall Study|Adverse Event|5|||
155623429|NCT00719901|561714251|FG000|Overall Study|Withdrawal by Subject|1|||
155623430|NCT00719901|561714251|FG000|Overall Study|Alternate Treatment|1|||
155623431|NCT00719901|561714251|FG000|Overall Study|Disease Progression|3|||
155623432|NCT00719901|561714251|FG000|Overall Study|Availability of Study Drug|1|||
155623433|NCT04456686|561714254|FG000|Overall Study|Adverse Event|2|||
155623434|NCT04456686|561714255|FG001|Overall Study|Adverse Event|1|||
155623435|NCT04456686|561714254|FG000|Overall Study|Lack of Efficacy|3|||
155623436|NCT04456686|561714255|FG001|Overall Study|Lack of Efficacy|1|||
155623437|NCT04456686|561714254|FG000|Overall Study|Withdrew consent|3|||
155623438|NCT04456686|561714255|FG001|Overall Study|Withdrew consent|1|||
155623439|NCT04456686|561714254|FG000|Overall Study|Physician Decision|2|||
155623440|NCT04456686|561714255|FG001|Overall Study|Physician Decision|2|||
155623441|NCT04456686|561714254|FG000|Overall Study|Withdrawal by Subject|5|||
155623442|NCT04456686|561714255|FG001|Overall Study|Withdrawal by Subject|1|||
155623443|NCT04456686|561714254|FG000|Overall Study|Protocol Violation|0|||
155623444|NCT04456686|561714255|FG001|Overall Study|Protocol Violation|1|||
155623445|NCT02858401|561714258|FG000|Overall Study|Withdrew Consent|0|||
155623446|NCT02858401|561714259|FG001|Overall Study|Withdrew Consent|0|||
155623447|NCT02858401|561714260|FG002|Overall Study|Withdrew Consent|0|||
155623448|NCT02858401|561714261|FG003|Overall Study|Withdrew Consent|0|||
155623449|NCT02858401|561714262|FG004|Overall Study|Withdrew Consent|0|||
155623450|NCT02858401|561714263|FG005|Overall Study|Withdrew Consent|1|||
155623451|NCT02858401|561714264|FG006|Overall Study|Withdrew Consent|0|||
155623452|NCT02858401|561714258|FG000|Overall Study|Lost to Follow-up|0|||
155623453|NCT02858401|561714259|FG001|Overall Study|Lost to Follow-up|1|||
155623454|NCT02858401|561714260|FG002|Overall Study|Lost to Follow-up|0|||
155623455|NCT02858401|561714261|FG003|Overall Study|Lost to Follow-up|0|||
155623456|NCT02858401|561714262|FG004|Overall Study|Lost to Follow-up|0|||
155623457|NCT02858401|561714263|FG005|Overall Study|Lost to Follow-up|0|||
155623458|NCT02858401|561714264|FG006|Overall Study|Lost to Follow-up|0|||
155623459|NCT02869789|561714270|FG000|Overall Study|Disease progression|184|||
155623460|NCT02869789|561714271|FG001|Overall Study|Disease progression|109|||
155623461|NCT02869789|561714272|FG002|Overall Study|Disease progression|260|||
155623462|NCT02869789|561714273|FG003|Overall Study|Disease progression|19|||
155623463|NCT02869789|561714270|FG000|Overall Study|Study drug toxicity|90|||
155623464|NCT02869789|561714271|FG001|Overall Study|Study drug toxicity|32|||
155623465|NCT02869789|561714272|FG002|Overall Study|Study drug toxicity|55|||
155623466|NCT02869789|561714273|FG003|Overall Study|Study drug toxicity|14|||
155623467|NCT02869789|561714270|FG000|Overall Study|Death|7|||
155623468|NCT02869789|561714271|FG001|Overall Study|Death|3|||
155623469|NCT02869789|561714272|FG002|Overall Study|Death|5|||
155623470|NCT02869789|561714273|FG003|Overall Study|Death|1|||
155623471|NCT02869789|561714270|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
155623472|NCT02869789|561714271|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
155727139|NCT02083354|562101936|FG000|Overall Study|Adverse Event|3|||
155623473|NCT02869789|561714272|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
155623474|NCT02869789|561714273|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
155623475|NCT02869789|561714270|FG000|Overall Study|Participant request to discontinue study treatment|10|||
155623476|NCT02869789|561714271|FG001|Overall Study|Participant request to discontinue study treatment|5|||
155623477|NCT02869789|561714272|FG002|Overall Study|Participant request to discontinue study treatment|5|||
155623478|NCT02869789|561714273|FG003|Overall Study|Participant request to discontinue study treatment|3|||
155623479|NCT02869789|561714270|FG000|Overall Study|Withdrawal by Subject|5|||
155277529|NCT02584855|560449096|FG004|Open-Label Treatment Period|Protocol Violation|0|||
155277530|NCT02584855|560449097|FG005|Open-Label Treatment Period|Protocol Violation|0|||
155277531|NCT02584855|560449092|FG000|Open-Label Treatment Period|No PI Available|2|||
155277532|NCT02584855|560449093|FG001|Open-Label Treatment Period|No PI Available|0|||
155277533|NCT02584855|560449094|FG002|Open-Label Treatment Period|No PI Available|0|||
155277534|NCT02584855|560449095|FG003|Open-Label Treatment Period|No PI Available|0|||
155277535|NCT02584855|560449096|FG004|Open-Label Treatment Period|No PI Available|0|||
155277536|NCT02584855|560449097|FG005|Open-Label Treatment Period|No PI Available|0|||
155277537|NCT02584855|560449092|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
155277538|NCT02584855|560449093|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
155277539|NCT02584855|560449094|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
155277540|NCT02584855|560449095|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
155277541|NCT02584855|560449096|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
155277542|NCT02584855|560449097|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
155277543|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277544|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277545|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
155277546|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277547|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277548|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277549|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
155277550|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
155277551|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
155277552|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
155277553|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
155381949|NCT00598273|560833243|FG001|Overall Study|Noncompliance|2|||
155381950|NCT00598273|560833244|FG002|Overall Study|Noncompliance|3|||
155381951|NCT00598273|560833242|FG000|Overall Study|Relocation|0|||
155381952|NCT00598273|560833243|FG001|Overall Study|Relocation|2|||
155381953|NCT00598273|560833244|FG002|Overall Study|Relocation|4|||
155381954|NCT00598273|560833242|FG000|Overall Study|Renal transplant|1|||
155381955|NCT00598273|560833243|FG001|Overall Study|Renal transplant|0|||
155381956|NCT00598273|560833244|FG002|Overall Study|Renal transplant|1|||
155381957|NCT00598273|560833242|FG000|Overall Study|Site elected to close|1|||
155381958|NCT00598273|560833243|FG001|Overall Study|Site elected to close|0|||
155381959|NCT00598273|560833244|FG002|Overall Study|Site elected to close|0|||
155381960|NCT00598273|560833242|FG000|Overall Study|Started dialysis|6|||
155381961|NCT00598273|560833243|FG001|Overall Study|Started dialysis|4|||
155381962|NCT00598273|560833244|FG002|Overall Study|Started dialysis|5|||
155381963|NCT01590082|560833245|FG000|Overall Study|Withdrawal by Subject|1|||
155381964|NCT01590082|560833246|FG001|Overall Study|Withdrawal by Subject|0|||
155381965|NCT01590082|560833245|FG000|Overall Study|Ineligible|1|||
155381966|NCT01590082|560833246|FG001|Overall Study|Ineligible|0|||
155381967|NCT01210664|560833248|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381968|NCT01210664|560833249|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381969|NCT01210664|560833250|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
155381970|NCT01210664|560833251|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381971|NCT01210664|560833248|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381972|NCT01210664|560833249|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381973|NCT01210664|560833250|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
155381974|NCT01210664|560833251|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381975|NCT01210664|560833248|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381976|NCT01210664|560833249|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381977|NCT01210664|560833250|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381978|NCT01210664|560833251|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
155381979|NCT02891408|560833252|FG000|Overall Study|Lost to Follow-up|0|||
155381980|NCT02891408|560833253|FG001|Overall Study|Lost to Follow-up|0|||
155381981|NCT02891408|560833254|FG002|Overall Study|Lost to Follow-up|1|||
155381982|NCT02891408|560833255|FG003|Overall Study|Lost to Follow-up|0|||
155381983|NCT02891408|560833256|FG004|Overall Study|Lost to Follow-up|0|||
155381984|NCT02891408|560833257|FG005|Overall Study|Lost to Follow-up|0|||
155381985|NCT02891408|560833258|FG006|Overall Study|Lost to Follow-up|0|||
155381986|NCT02549196|560833259|FG000|Overall Study|Protocol Violation|0|||
155381987|NCT02549196|560833260|FG001|Overall Study|Protocol Violation|0|||
155381988|NCT02549196|560833261|FG002|Overall Study|Protocol Violation|0|||
155381989|NCT02549196|560833262|FG003|Overall Study|Protocol Violation|1|||
155381990|NCT02549196|560833259|FG000|Overall Study|Withdrawal by Subject|1|||
155623480|NCT02869789|561714271|FG001|Overall Study|Withdrawal by Subject|2|||
155623481|NCT02869789|561714272|FG002|Overall Study|Withdrawal by Subject|7|||
155623482|NCT02869789|561714273|FG003|Overall Study|Withdrawal by Subject|2|||
155277554|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
155277555|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155623483|NCT02869789|561714270|FG000|Overall Study|Lost to Follow-up|0|||
155623484|NCT02869789|561714271|FG001|Overall Study|Lost to Follow-up|0|||
155623485|NCT02869789|561714272|FG002|Overall Study|Lost to Follow-up|2|||
155623486|NCT02869789|561714273|FG003|Overall Study|Lost to Follow-up|0|||
155623487|NCT02869789|561714270|FG000|Overall Study|Maximum clinical benefit|5|||
155623488|NCT02869789|561714271|FG001|Overall Study|Maximum clinical benefit|2|||
155623489|NCT02869789|561714272|FG002|Overall Study|Maximum clinical benefit|1|||
155623490|NCT02869789|561714273|FG003|Overall Study|Maximum clinical benefit|0|||
155623491|NCT02869789|561714270|FG000|Overall Study|Poor/Non-compliance|0|||
155623492|NCT02869789|561714271|FG001|Overall Study|Poor/Non-compliance|2|||
155623493|NCT02869789|561714272|FG002|Overall Study|Poor/Non-compliance|1|||
155623494|NCT02869789|561714273|FG003|Overall Study|Poor/Non-compliance|0|||
155623495|NCT02869789|561714270|FG000|Overall Study|Participant no longer meets study criteria|0|||
155623496|NCT02869789|561714271|FG001|Overall Study|Participant no longer meets study criteria|1|||
155623497|NCT02869789|561714272|FG002|Overall Study|Participant no longer meets study criteria|1|||
155623498|NCT02869789|561714273|FG003|Overall Study|Participant no longer meets study criteria|0|||
155623499|NCT02869789|561714270|FG000|Overall Study|Administrative reason by sponsor|0|||
155623500|NCT02869789|561714271|FG001|Overall Study|Administrative reason by sponsor|0|||
155623501|NCT02869789|561714272|FG002|Overall Study|Administrative reason by sponsor|1|||
155623502|NCT02869789|561714273|FG003|Overall Study|Administrative reason by sponsor|0|||
155623503|NCT02869789|561714270|FG000|Overall Study|Other reasons|4|||
155623504|NCT02869789|561714271|FG001|Overall Study|Other reasons|8|||
155623505|NCT02869789|561714272|FG002|Overall Study|Other reasons|6|||
155623506|NCT02869789|561714273|FG003|Overall Study|Other reasons|0|||
155623507|NCT00297648|561714275|FG000|Overall Study|Adverse Event|13|||
155623508|NCT00297648|561714275|FG000|Overall Study|Lack of Efficacy|18|||
155623509|NCT00297648|561714275|FG000|Overall Study|Lost to Follow-up|1|||
155623510|NCT00297648|561714275|FG000|Overall Study|Withdrawal by Subject|3|||
155623511|NCT00297648|561714275|FG000|Overall Study|Other: Incompliance|1|||
155623512|NCT02048722|561714276|FG000|2 Cycles of Treatment|Adverse Event|2|||
155623513|NCT02048722|561714276|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
155623514|NCT02048722|561714276|FG000|2 Cycles of Treatment|Progressive Disease|2|||
155623515|NCT02048722|561714276|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
155623516|NCT02048722|561714276|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
155623517|NCT02048722|561714276|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
155623518|NCT01746862|561714278|FG000|Overall Study|Withdrawal by Subject|1|||
155623519|NCT01746862|561714279|FG001|Overall Study|Withdrawal by Subject|1|||
155623520|NCT01746862|561714278|FG000|Overall Study|Protocol Violation|1|||
155623521|NCT01746862|561714279|FG001|Overall Study|Protocol Violation|0|||
155623522|NCT01746862|561714278|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
155623523|NCT01746862|561714279|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
155623524|NCT01746862|561714278|FG000|Overall Study|Entered puberty during the study|1|||
155623525|NCT01746862|561714279|FG001|Overall Study|Entered puberty during the study|0|||
155623526|NCT00731822|561714283|FG000|Overall Study|Adverse Event|2|||
155623527|NCT00731822|561714284|FG001|Overall Study|Adverse Event|1|||
155623528|NCT00731822|561714283|FG000|Overall Study|Protocol Violation|1|||
155623529|NCT00731822|561714284|FG001|Overall Study|Protocol Violation|0|||
155623530|NCT00731822|561714283|FG000|Overall Study|Lost to Follow-up|1|||
155623531|NCT00731822|561714284|FG001|Overall Study|Lost to Follow-up|0|||
155623532|NCT02127658|561714288|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
155623533|NCT02127658|561714289|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
155623534|NCT02127658|561714288|FG000|Overall Study|Withdrawal by Subject|0|||
155623535|NCT02127658|561714289|FG001|Overall Study|Withdrawal by Subject|2|||
155623536|NCT02127658|561714288|FG000|Overall Study|Physician Decision|0|||
155623537|NCT02127658|561714289|FG001|Overall Study|Physician Decision|1|||
155623538|NCT03834493|561714290|FG000|Overall Study|Participants Ongoing|311|||
155623539|NCT03834493|561714291|FG001|Overall Study|Participants Ongoing|324|||
155623540|NCT03834493|561714290|FG000|Overall Study|Withdrawal by Subject|20|||
155623541|NCT03834493|561714291|FG001|Overall Study|Withdrawal by Subject|17|||
155623542|NCT03834493|561714290|FG000|Overall Study|Physician Decision|1|||
155623543|NCT03834493|561714291|FG001|Overall Study|Physician Decision|0|||
155623544|NCT03834493|561714290|FG000|Overall Study|Death|289|||
155623545|NCT03834493|561714291|FG001|Overall Study|Death|282|||
155623546|NCT04144322|561714295|FG000|Overall Study|Lack of Efficacy|2|||
155623547|NCT04144322|561714296|FG001|Overall Study|Lack of Efficacy|2|||
155623548|NCT02277028|561714297|FG000|Overall Study|Lost to Follow-up|1|||
155623549|NCT02277028|561714298|FG001|Overall Study|Lost to Follow-up|0|||
155623550|NCT02277028|561714297|FG000|Overall Study|Withdrawal by Subject|0|||
155623551|NCT02277028|561714298|FG001|Overall Study|Withdrawal by Subject|1|||
155623552|NCT02718911|561714299|FG000|Overall Study|Adverse Event|0|||
155623553|NCT02718911|561714300|FG001|Overall Study|Adverse Event|0|||
155623554|NCT02718911|561714301|FG002|Overall Study|Adverse Event|0|||
155623555|NCT02718911|561714302|FG003|Overall Study|Adverse Event|0|||
155623556|NCT02718911|561714303|FG004|Overall Study|Adverse Event|0|||
155623557|NCT02718911|561714304|FG005|Overall Study|Adverse Event|0|||
155623558|NCT02718911|561714305|FG006|Overall Study|Adverse Event|0|||
155623559|NCT02718911|561714306|FG007|Overall Study|Adverse Event|0|||
155623560|NCT02718911|561714307|FG008|Overall Study|Adverse Event|0|||
155623561|NCT02718911|561714308|FG009|Overall Study|Adverse Event|2|||
155623562|NCT02718911|561714299|FG000|Overall Study|Death|2|||
155623563|NCT02718911|561714300|FG001|Overall Study|Death|3|||
155623564|NCT02718911|561714301|FG002|Overall Study|Death|1|||
155623565|NCT02718911|561714302|FG003|Overall Study|Death|0|||
155277556|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
155277557|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277558|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277559|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277560|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277561|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277562|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
155277563|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277564|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277565|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277566|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277567|NCT02584855|560449092|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277568|NCT02584855|560449093|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277569|NCT02584855|560449094|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277570|NCT02584855|560449095|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277571|NCT02584855|560449096|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
155277572|NCT02584855|560449097|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277573|NCT02584855|560449092|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
155277574|NCT02584855|560449093|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
155277575|NCT02584855|560449094|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
155277576|NCT02584855|560449095|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
155277577|NCT02584855|560449096|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
155277578|NCT02584855|560449097|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
155277579|NCT02337478|560449098|FG000|Overall Study|Lack of Efficacy|5|||
155277580|NCT00895843|560449099|FG000|Overall Study|Protocol Violation|12|||
155277581|NCT00895843|560449100|FG001|Overall Study|Protocol Violation|12|||
155277582|NCT04963062|560449104|FG000|Overall Study|withdrew by the study team|4|||
155277583|NCT04963062|560449105|FG001|Overall Study|withdrew by the study team|2|||
155277584|NCT03500172|560449108|FG000|Period 1: Baseline Randomization|Death|0|||
155277585|NCT03500172|560449109|FG001|Period 1: Baseline Randomization|Death|0|||
155277586|NCT03500172|560449110|FG002|Period 1: Baseline Randomization|Death|0|||
155277587|NCT03500172|560449111|FG003|Period 1: Baseline Randomization|Death|0|||
155277588|NCT03500172|560449112|FG004|Period 1: Baseline Randomization|Death|0|||
155277589|NCT03500172|560449113|FG005|Period 1: Baseline Randomization|Death|0|||
155277590|NCT03500172|560449114|FG006|Period 1: Baseline Randomization|Death|0|||
155277591|NCT03500172|560449115|FG007|Period 1: Baseline Randomization|Death|0|||
155277592|NCT03500172|560449116|FG008|Period 1: Baseline Randomization|Death|0|||
155277593|NCT03500172|560449117|FG009|Period 1: Baseline Randomization|Death|2|||
155277594|NCT03500172|560449118|FG010|Period 1: Baseline Randomization|Death|0|||
155277595|NCT03500172|560449108|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
155277596|NCT03500172|560449109|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
155277597|NCT03500172|560449110|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
155277598|NCT03500172|560449111|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
155277599|NCT03500172|560449112|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
155277600|NCT03500172|560449113|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
155277601|NCT03500172|560449114|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
155277602|NCT03500172|560449115|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
155277603|NCT03500172|560449116|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
155277604|NCT03500172|560449117|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
155277605|NCT03500172|560449118|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
155277606|NCT03500172|560449108|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
155277607|NCT03500172|560449109|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
155277608|NCT03500172|560449110|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
155277609|NCT03500172|560449111|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
155277610|NCT03500172|560449112|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
155277611|NCT03500172|560449113|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
155277612|NCT03500172|560449114|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
155277613|NCT03500172|560449115|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
155277614|NCT03500172|560449116|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
155381991|NCT02549196|560833260|FG001|Overall Study|Withdrawal by Subject|0|||
155623566|NCT02718911|561714303|FG004|Overall Study|Death|1|||
155623567|NCT02718911|561714304|FG005|Overall Study|Death|3|||
155623568|NCT02718911|561714305|FG006|Overall Study|Death|1|||
155623569|NCT02718911|561714306|FG007|Overall Study|Death|1|||
155623570|NCT02718911|561714307|FG008|Overall Study|Death|4|||
155623571|NCT02718911|561714308|FG009|Overall Study|Death|3|||
155623572|NCT02718911|561714299|FG000|Overall Study|Lost to Follow-up|0|||
155623573|NCT02718911|561714300|FG001|Overall Study|Lost to Follow-up|0|||
155623574|NCT02718911|561714301|FG002|Overall Study|Lost to Follow-up|0|||
155623575|NCT02718911|561714302|FG003|Overall Study|Lost to Follow-up|0|||
155623576|NCT02718911|561714303|FG004|Overall Study|Lost to Follow-up|0|||
155623577|NCT02718911|561714304|FG005|Overall Study|Lost to Follow-up|0|||
155623578|NCT02718911|561714305|FG006|Overall Study|Lost to Follow-up|0|||
155623579|NCT02718911|561714306|FG007|Overall Study|Lost to Follow-up|0|||
155623580|NCT02718911|561714307|FG008|Overall Study|Lost to Follow-up|1|||
155623581|NCT02718911|561714308|FG009|Overall Study|Lost to Follow-up|0|||
155623582|NCT02718911|561714299|FG000|Overall Study|Physician Decision|2|||
155623583|NCT02718911|561714300|FG001|Overall Study|Physician Decision|0|||
155623584|NCT02718911|561714301|FG002|Overall Study|Physician Decision|1|||
155623585|NCT02718911|561714302|FG003|Overall Study|Physician Decision|1|||
155623586|NCT02718911|561714303|FG004|Overall Study|Physician Decision|0|||
155623587|NCT02718911|561714304|FG005|Overall Study|Physician Decision|0|||
155623588|NCT02718911|561714305|FG006|Overall Study|Physician Decision|0|||
155623589|NCT02718911|561714306|FG007|Overall Study|Physician Decision|1|||
155623590|NCT02718911|561714307|FG008|Overall Study|Physician Decision|2|||
155623591|NCT02718911|561714308|FG009|Overall Study|Physician Decision|1|||
155623592|NCT02718911|561714299|FG000|Overall Study|Withdrawal by Subject|0|||
155623593|NCT02718911|561714300|FG001|Overall Study|Withdrawal by Subject|0|||
155623594|NCT02718911|561714301|FG002|Overall Study|Withdrawal by Subject|0|||
155623595|NCT02718911|561714302|FG003|Overall Study|Withdrawal by Subject|0|||
155623596|NCT02718911|561714303|FG004|Overall Study|Withdrawal by Subject|1|||
155623597|NCT02718911|561714304|FG005|Overall Study|Withdrawal by Subject|0|||
155623598|NCT02718911|561714305|FG006|Overall Study|Withdrawal by Subject|0|||
155623599|NCT02718911|561714306|FG007|Overall Study|Withdrawal by Subject|0|||
155623600|NCT02718911|561714307|FG008|Overall Study|Withdrawal by Subject|1|||
155623601|NCT02718911|561714308|FG009|Overall Study|Withdrawal by Subject|4|||
155623602|NCT02718911|561714299|FG000|Overall Study|Reason Not Collected|0|||
155623603|NCT02718911|561714300|FG001|Overall Study|Reason Not Collected|0|||
155623604|NCT02718911|561714301|FG002|Overall Study|Reason Not Collected|1|||
155623605|NCT02718911|561714302|FG003|Overall Study|Reason Not Collected|0|||
155623606|NCT02718911|561714303|FG004|Overall Study|Reason Not Collected|0|||
155623607|NCT02718911|561714304|FG005|Overall Study|Reason Not Collected|0|||
155623608|NCT02718911|561714305|FG006|Overall Study|Reason Not Collected|2|||
155623609|NCT02718911|561714306|FG007|Overall Study|Reason Not Collected|1|||
155623610|NCT02718911|561714307|FG008|Overall Study|Reason Not Collected|4|||
155623611|NCT02718911|561714308|FG009|Overall Study|Reason Not Collected|9|||
155623612|NCT04817332|561714309|FG000|Overall Study|Lost to Follow-up|3|||
155623613|NCT04817332|561714310|FG001|Overall Study|Lost to Follow-up|3|||
155623614|NCT04817332|561714309|FG000|Overall Study|Protocol Violation|2|||
155623615|NCT04817332|561714310|FG001|Overall Study|Protocol Violation|0|||
155623616|NCT01867008|561714311|FG000|Overall Study|Withdrawal by Subject|1|||
155623617|NCT00983372|561714312|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
155623618|NCT00983372|561714312|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
155623619|NCT00983372|561714312|FG000|Diltiazem ER Alone|Adverse Event|1|||
155623620|NCT05635045|561714313|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155623621|NCT05635045|561714314|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155623622|NCT05635045|561714315|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
155623623|NCT05635045|561714316|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155623624|NCT00570401|561714329|FG000|Overall Study|Adverse Event|2|||
155623625|NCT00871234|561714330|FG000|Overall Study|Adverse Event|2|||
155623626|NCT00871234|561714330|FG000|Overall Study|Lost to Follow-up|3|||
155623627|NCT01710020|561714331|FG000|Period 1|Protocol Violation|1|||
155623628|NCT00427908|561714332|FG000|Primary Phase|Lost to Follow-up|4|||
155623629|NCT00427908|561714333|FG001|Primary Phase|Lost to Follow-up|0|||
155623630|NCT00427908|561714334|FG002|Primary Phase|Lost to Follow-up|2|||
155623631|NCT00427908|561714335|FG003|Primary Phase|Lost to Follow-up|0|||
155623632|NCT00427908|561714332|FG000|Primary Phase|Withdrawal by Subject|1|||
155623633|NCT00427908|561714333|FG001|Primary Phase|Withdrawal by Subject|2|||
155623634|NCT00427908|561714334|FG002|Primary Phase|Withdrawal by Subject|1|||
155623635|NCT00427908|561714335|FG003|Primary Phase|Withdrawal by Subject|0|||
155623636|NCT00427908|561714332|FG000|Primary Phase|Adverse Event|0|||
155623637|NCT00427908|561714333|FG001|Primary Phase|Adverse Event|1|||
155623638|NCT00427908|561714334|FG002|Primary Phase|Adverse Event|0|||
155623639|NCT00427908|561714335|FG003|Primary Phase|Adverse Event|0|||
155623640|NCT01764841|561714336|FG000|Overall Study|Logistical Difficulties|0|||
155623641|NCT01764841|561714337|FG001|Overall Study|Logistical Difficulties|1|||
155623642|NCT01764841|561714338|FG002|Overall Study|Logistical Difficulties|0|||
155623643|NCT01764841|561714339|FG003|Overall Study|Logistical Difficulties|0|||
155623644|NCT01764841|561714336|FG000|Overall Study|Death|3|||
155623645|NCT01764841|561714337|FG001|Overall Study|Death|0|||
155623646|NCT01764841|561714338|FG002|Overall Study|Death|1|||
155727140|NCT02083354|562101936|FG000|Overall Study|Disease progression|46|||
155623647|NCT01764841|561714339|FG003|Overall Study|Death|4|||
155623648|NCT01764841|561714336|FG000|Overall Study|No Follow Up|1|||
155623649|NCT01764841|561714337|FG001|Overall Study|No Follow Up|0|||
155623650|NCT01764841|561714338|FG002|Overall Study|No Follow Up|1|||
155623651|NCT01764841|561714339|FG003|Overall Study|No Follow Up|0|||
155623652|NCT01764841|561714336|FG000|Overall Study|Protocol Violation|0|||
155623653|NCT01764841|561714337|FG001|Overall Study|Protocol Violation|1|||
155623654|NCT01764841|561714338|FG002|Overall Study|Protocol Violation|0|||
155623655|NCT01764841|561714339|FG003|Overall Study|Protocol Violation|0|||
155623656|NCT01764841|561714336|FG000|Overall Study|Withdrawal by Subject|16|||
155623657|NCT01764841|561714337|FG001|Overall Study|Withdrawal by Subject|24|||
155623658|NCT01764841|561714338|FG002|Overall Study|Withdrawal by Subject|11|||
155623659|NCT01764841|561714339|FG003|Overall Study|Withdrawal by Subject|15|||
155623660|NCT01764841|561714336|FG000|Overall Study|Lost to Follow-up|3|||
155623661|NCT01764841|561714337|FG001|Overall Study|Lost to Follow-up|0|||
155623662|NCT01764841|561714338|FG002|Overall Study|Lost to Follow-up|1|||
155623663|NCT01764841|561714339|FG003|Overall Study|Lost to Follow-up|0|||
155277615|NCT03500172|560449117|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
155277616|NCT03500172|560449118|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
155277617|NCT03500172|560449108|FG000|Period 2: Re-Randomization|Death|0|||
155277618|NCT03500172|560449109|FG001|Period 2: Re-Randomization|Death|0|||
155277619|NCT03500172|560449110|FG002|Period 2: Re-Randomization|Death|0|||
155277620|NCT03500172|560449111|FG003|Period 2: Re-Randomization|Death|4|||
155277621|NCT03500172|560449112|FG004|Period 2: Re-Randomization|Death|2|||
155277622|NCT03500172|560449113|FG005|Period 2: Re-Randomization|Death|0|||
155277623|NCT03500172|560449114|FG006|Period 2: Re-Randomization|Death|5|||
155277624|NCT03500172|560449115|FG007|Period 2: Re-Randomization|Death|2|||
155277625|NCT03500172|560449116|FG008|Period 2: Re-Randomization|Death|0|||
155623664|NCT03973996|561715837|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155623665|NCT03973996|561715838|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155623666|NCT03973996|561715839|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155623667|NCT03973996|561715840|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
155623668|NCT04070989|561715841|FG000|Overall Study|Death|1|||
155623669|NCT04070989|561715842|FG001|Overall Study|Death|0|||
155623670|NCT04070989|561715843|FG002|Overall Study|Death|0|||
155623671|NCT04070989|561715841|FG000|Overall Study|Study Terminated by Sponsor|7|||
155623672|NCT04070989|561715842|FG001|Overall Study|Study Terminated by Sponsor|8|||
155623673|NCT04070989|561715843|FG002|Overall Study|Study Terminated by Sponsor|23|||
155623674|NCT04070989|561715841|FG000|Overall Study|Withdrawal by Subject|0|||
155623675|NCT04070989|561715842|FG001|Overall Study|Withdrawal by Subject|1|||
155623676|NCT04070989|561715843|FG002|Overall Study|Withdrawal by Subject|0|||
155623677|NCT04070989|561715841|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
155623678|NCT04070989|561715842|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
155623679|NCT04070989|561715843|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
155623680|NCT04070989|561715841|FG000|Overall Study|Other|1|||
155623681|NCT04070989|561715842|FG001|Overall Study|Other|1|||
155623682|NCT04070989|561715843|FG002|Overall Study|Other|0|||
155623683|NCT00641056|561715846|FG000|Overall Study|Adverse Event|12|||
155623684|NCT00641056|561715847|FG001|Overall Study|Adverse Event|2|||
155623685|NCT00641056|561715846|FG000|Overall Study|Lost to Follow-up|2|||
155623686|NCT00641056|561715847|FG001|Overall Study|Lost to Follow-up|1|||
155623687|NCT00641056|561715846|FG000|Overall Study|Physician Decision|3|||
155623688|NCT00641056|561715847|FG001|Overall Study|Physician Decision|1|||
155623689|NCT00641056|561715846|FG000|Overall Study|Protocol Violation|2|||
155623690|NCT00641056|561715847|FG001|Overall Study|Protocol Violation|0|||
155623691|NCT00641056|561715846|FG000|Overall Study|Entry Criteria Not Met|3|||
155623692|NCT00641056|561715847|FG001|Overall Study|Entry Criteria Not Met|0|||
155623693|NCT00641056|561715846|FG000|Overall Study|Subject Decision|6|||
155623694|NCT00641056|561715847|FG001|Overall Study|Subject Decision|19|||
155623695|NCT00641056|561715846|FG000|Overall Study|Sponsor Decision|1|||
155277626|NCT03500172|560449117|FG009|Period 2: Re-Randomization|Death|0|||
155277627|NCT03500172|560449118|FG010|Period 2: Re-Randomization|Death|0|||
155277628|NCT00996580|560449119|FG000|Overall Study|Adverse Event|466|||
155277629|NCT00996580|560449119|FG000|Overall Study|Lost to Follow-up|480|||
155623696|NCT00641056|561715847|FG001|Overall Study|Sponsor Decision|2|||
155623697|NCT01811732|561715849|FG000|Overall Study|Lost to Follow-up|24|||
155623698|NCT01811732|561715850|FG001|Overall Study|Lost to Follow-up|30|||
155623699|NCT01811732|561715849|FG000|Overall Study|Withdrawal by Subject|16|||
155623700|NCT01811732|561715850|FG001|Overall Study|Withdrawal by Subject|10|||
155623701|NCT01811732|561715849|FG000|Overall Study|Adverse Event|3|||
155623702|NCT01811732|561715850|FG001|Overall Study|Adverse Event|9|||
155623703|NCT01811732|561715849|FG000|Overall Study|Lack of Efficacy|3|||
155623704|NCT01811732|561715850|FG001|Overall Study|Lack of Efficacy|1|||
155623705|NCT01811732|561715849|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
155623706|NCT01811732|561715850|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
155623707|NCT01811732|561715849|FG000|Overall Study|Physician Decision|2|||
155623708|NCT01811732|561715850|FG001|Overall Study|Physician Decision|0|||
155623709|NCT01811732|561715849|FG000|Overall Study|Death|1|||
155623710|NCT01811732|561715850|FG001|Overall Study|Death|1|||
155623711|NCT01811732|561715849|FG000|Overall Study|Insufficient venous access|0|||
155623712|NCT01811732|561715850|FG001|Overall Study|Insufficient venous access|1|||
155623713|NCT01811732|561715849|FG000|Overall Study|Protocol Violation|0|||
155623714|NCT01811732|561715850|FG001|Overall Study|Protocol Violation|1|||
155623715|NCT01811732|561715849|FG000|Overall Study|Subject incarcerated|1|||
155623716|NCT01811732|561715850|FG001|Overall Study|Subject incarcerated|2|||
155623717|NCT01811732|561715849|FG000|Overall Study|Admitted to another facility|1|||
155623718|NCT01811732|561715850|FG001|Overall Study|Admitted to another facility|0|||
155623719|NCT01811732|561715849|FG000|Overall Study|Correct study drug not available on site|1|||
155623720|NCT01811732|561715850|FG001|Overall Study|Correct study drug not available on site|0|||
155623721|NCT02026141|561715855|FG000|Overall Study|Protocol Violation|0|||
155623722|NCT02026141|561715856|FG001|Overall Study|Protocol Violation|1|||
155623723|NCT01249417|561715857|FG000|Randomised Population|Study treatment not received|0|||
155623724|NCT01249417|561715858|FG001|Randomised Population|Study treatment not received|0|||
155623725|NCT01249417|561715859|FG002|Randomised Population|Study treatment not received|2|||
155623726|NCT01249417|561715857|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
155623727|NCT01249417|561715858|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
155623728|NCT01249417|561715859|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
155623729|NCT01249417|561715857|FG000|Treatment Phase - ITT Population|Other|0|||
155623730|NCT01249417|561715858|FG001|Treatment Phase - ITT Population|Other|0|||
155623731|NCT01249417|561715859|FG002|Treatment Phase - ITT Population|Other|1|||
155623732|NCT01249417|561715857|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
155623733|NCT01249417|561715858|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
155623734|NCT01249417|561715859|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
155623735|NCT01249417|561715857|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
155623736|NCT01249417|561715858|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
155623737|NCT01249417|561715859|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
155623738|NCT01249417|561715857|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
155623739|NCT01249417|561715858|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
155623740|NCT01249417|561715859|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
155623741|NCT01248455|561715860|FG000|Overall Study|switched to alternate treatment|1|||
155623742|NCT02035553|561715861|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
155623743|NCT02035553|561715862|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
155623744|NCT02035553|561715861|FG000|Overall Study|Adverse Event|10|||
155623745|NCT02035553|561715862|FG001|Overall Study|Adverse Event|6|||
155623746|NCT02035553|561715861|FG000|Overall Study|Physician Decision|3|||
155623747|NCT02035553|561715862|FG001|Overall Study|Physician Decision|2|||
155623748|NCT02035553|561715861|FG000|Overall Study|Lack of Efficacy|1|||
155623749|NCT02035553|561715862|FG001|Overall Study|Lack of Efficacy|1|||
155623750|NCT02035553|561715861|FG000|Overall Study|Withdrawal by Subject|4|||
155623751|NCT02035553|561715862|FG001|Overall Study|Withdrawal by Subject|7|||
155623752|NCT02035553|561715861|FG000|Overall Study|Non-compliance with Study Drug|0|||
155623753|NCT02035553|561715862|FG001|Overall Study|Non-compliance with Study Drug|1|||
155623754|NCT02035553|561715861|FG000|Overall Study|Lost to Follow-up|0|||
155623755|NCT02035553|561715862|FG001|Overall Study|Lost to Follow-up|1|||
155623756|NCT02035553|561715861|FG000|Overall Study|Other Reason|0|||
155623757|NCT02035553|561715862|FG001|Overall Study|Other Reason|4|||
155623758|NCT04539964|561715863|FG000|Overall Study|device malfunction|1|||
155623759|NCT04539964|561715864|FG001|Overall Study|device malfunction|0|||
155623760|NCT04539964|561715863|FG000|Overall Study|Withdrawal by Subject|1|||
155277630|NCT00996580|560449119|FG000|Overall Study|Noncompliance with the protocol|137|||
155277631|NCT00996580|560449119|FG000|Overall Study|Physician Decision|5|||
155277632|NCT00996580|560449119|FG000|Overall Study|Pregnancy|68|||
155277633|NCT00996580|560449119|FG000|Overall Study|Protocol Violation|16|||
155277634|NCT00996580|560449119|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
155277635|NCT00996580|560449119|FG000|Overall Study|Withdrawal by Subject|217|||
155277636|NCT00996580|560449119|FG000|Overall Study|Other|29|||
155277637|NCT02218489|560449120|FG000|Overall Study|Withdrawal by Subject|4|||
155277638|NCT02218489|560449121|FG001|Overall Study|Withdrawal by Subject|3|||
155277639|NCT02218489|560449120|FG000|Overall Study|Lost to Follow-up|1|||
155277640|NCT02218489|560449121|FG001|Overall Study|Lost to Follow-up|0|||
155277641|NCT01778062|560449122|FG000|Overall Study|Adverse Event|1|||
155277642|NCT01778062|560449123|FG001|Overall Study|Adverse Event|3|||
155277643|NCT01778062|560449122|FG000|Overall Study|Consent Withdrawal|1|||
155277644|NCT01778062|560449123|FG001|Overall Study|Consent Withdrawal|5|||
155277645|NCT01778062|560449122|FG000|Overall Study|major protocol deviation|4|||
155277646|NCT01778062|560449123|FG001|Overall Study|major protocol deviation|3|||
155623761|NCT04539964|561715864|FG001|Overall Study|Withdrawal by Subject|2|||
155623762|NCT04539964|561715863|FG000|Overall Study|Adverse Event|0|||
155623763|NCT04539964|561715864|FG001|Overall Study|Adverse Event|2|||
155623764|NCT02735980|561715865|FG000|Overall Study|Adverse Event|0|||
155623765|NCT02735980|561715866|FG001|Overall Study|Adverse Event|4|||
155623766|NCT02735980|561715867|FG002|Overall Study|Adverse Event|1|||
155623767|NCT02735980|561715865|FG000|Overall Study|Death|5|||
155381992|NCT02549196|560833261|FG002|Overall Study|Withdrawal by Subject|1|||
155623768|NCT02735980|561715866|FG001|Overall Study|Death|4|||
155623769|NCT02735980|561715867|FG002|Overall Study|Death|0|||
155623770|NCT02735980|561715865|FG000|Overall Study|Physician Decision|3|||
155623771|NCT02735980|561715866|FG001|Overall Study|Physician Decision|1|||
155623772|NCT02735980|561715867|FG002|Overall Study|Physician Decision|0|||
155623773|NCT02735980|561715865|FG000|Overall Study|Screen failure|1|||
155623774|NCT02735980|561715866|FG001|Overall Study|Screen failure|0|||
155623775|NCT02735980|561715867|FG002|Overall Study|Screen failure|0|||
155623776|NCT02735980|561715865|FG000|Overall Study|Withdrawal by Subject|1|||
155623777|NCT02735980|561715866|FG001|Overall Study|Withdrawal by Subject|2|||
155623778|NCT02735980|561715867|FG002|Overall Study|Withdrawal by Subject|0|||
155623779|NCT01854697|561715868|FG000|Overall Study|Adverse Event|1|||
155623780|NCT01854697|561715869|FG001|Overall Study|Adverse Event|0|||
155623781|NCT01854697|561715870|FG002|Overall Study|Adverse Event|0|||
155623782|NCT01854697|561715871|FG003|Overall Study|Adverse Event|0|||
155623783|NCT01854697|561715872|FG004|Overall Study|Adverse Event|1|||
155623784|NCT01854697|561715868|FG000|Overall Study|Lost to Follow-up|4|||
155623785|NCT01854697|561715869|FG001|Overall Study|Lost to Follow-up|1|||
155623786|NCT01854697|561715870|FG002|Overall Study|Lost to Follow-up|1|||
155623787|NCT01854697|561715871|FG003|Overall Study|Lost to Follow-up|2|||
155623788|NCT01854697|561715872|FG004|Overall Study|Lost to Follow-up|0|||
155623789|NCT01854697|561715868|FG000|Overall Study|To enter another AbbVie study|1|||
155623790|NCT01854697|561715869|FG001|Overall Study|To enter another AbbVie study|0|||
155623791|NCT01854697|561715870|FG002|Overall Study|To enter another AbbVie study|0|||
155623792|NCT01854697|561715871|FG003|Overall Study|To enter another AbbVie study|0|||
155623793|NCT01854697|561715872|FG004|Overall Study|To enter another AbbVie study|1|||
155623794|NCT01854697|561715868|FG000|Overall Study|Withdrew Consent|0|||
155623795|NCT01854697|561715869|FG001|Overall Study|Withdrew Consent|1|||
155623796|NCT01854697|561715870|FG002|Overall Study|Withdrew Consent|0|||
155623797|NCT01854697|561715871|FG003|Overall Study|Withdrew Consent|1|||
155623798|NCT01854697|561715872|FG004|Overall Study|Withdrew Consent|0|||
155623799|NCT01854697|561715868|FG000|Overall Study|Other|0|||
155623800|NCT01854697|561715869|FG001|Overall Study|Other|1|||
155623801|NCT01854697|561715870|FG002|Overall Study|Other|1|||
155623802|NCT01854697|561715871|FG003|Overall Study|Other|0|||
155623803|NCT01854697|561715872|FG004|Overall Study|Other|0|||
155623804|NCT00468585|561715875|FG000|Overall Study|Patient not treated|1|||
155623805|NCT00468585|561715876|FG001|Overall Study|Patient not treated|0|||
155623806|NCT00468585|561715877|FG002|Overall Study|Patient not treated|1|||
155623807|NCT00468585|561715878|FG003|Overall Study|Patient not treated|0|||
155623808|NCT00468585|561715875|FG000|Overall Study|Patient found to be ineligible|0|||
155623809|NCT00468585|561715876|FG001|Overall Study|Patient found to be ineligible|0|||
155623810|NCT00468585|561715877|FG002|Overall Study|Patient found to be ineligible|1|||
155623811|NCT00468585|561715878|FG003|Overall Study|Patient found to be ineligible|0|||
155623812|NCT00468585|561715875|FG000|Overall Study|Adverse Event|0|||
155623813|NCT00468585|561715876|FG001|Overall Study|Adverse Event|0|||
155623814|NCT00468585|561715877|FG002|Overall Study|Adverse Event|1|||
155623815|NCT00468585|561715878|FG003|Overall Study|Adverse Event|0|||
155623816|NCT00468585|561715875|FG000|Overall Study|Withdrawal by Subject|0|||
155623817|NCT00468585|561715876|FG001|Overall Study|Withdrawal by Subject|0|||
155623818|NCT00468585|561715877|FG002|Overall Study|Withdrawal by Subject|2|||
155623819|NCT00468585|561715878|FG003|Overall Study|Withdrawal by Subject|1|||
155623820|NCT01232790|561715879|FG000|Randomization|Withdrawal by Subject|2|||
155623821|NCT01232790|561715880|FG001|Randomization|Withdrawal by Subject|0|||
155623822|NCT01232790|561715879|FG000|Randomization|Protocol Violation|0|||
155623823|NCT01232790|561715880|FG001|Randomization|Protocol Violation|1|||
155623824|NCT01232790|561715879|FG000|Randomization|Physician Decision|0|||
155623825|NCT01232790|561715880|FG001|Randomization|Physician Decision|1|||
155623826|NCT01232790|561715879|FG000|Initial Assessment|Withdrawal by Subject|0|||
155623827|NCT01232790|561715880|FG001|Initial Assessment|Withdrawal by Subject|1|||
155623828|NCT01232790|561715879|FG000|First Crossover|Withdrawal by Subject|1|||
155623829|NCT01232790|561715880|FG001|First Crossover|Withdrawal by Subject|0|||
155727141|NCT02083354|562101936|FG000|Overall Study|Study closed/terminated|5|||
155727142|NCT03312634|562101937|FG000|Overall Study|Adverse Event|11|||
155727143|NCT03312634|562101938|FG001|Overall Study|Adverse Event|0|||
155623830|NCT01232790|561715879|FG000|Second Crossover|Withdrawal by Subject|1|||
155623831|NCT01232790|561715880|FG001|Second Crossover|Withdrawal by Subject|2|||
155623832|NCT03769649|561715881|FG000|Overall Study|Lost to Follow-up|4|||
155623833|NCT03322293|561715882|FG000|Overall Study|Lost to Follow-up|0|||
155623834|NCT03322293|561715883|FG001|Overall Study|Lost to Follow-up|0|||
155623835|NCT03322293|561715884|FG002|Overall Study|Lost to Follow-up|1|||
155623836|NCT00083915|561715887|FG000|Overall Study|Death|6|||
155381993|NCT02549196|560833262|FG003|Overall Study|Withdrawal by Subject|0|||
155623837|NCT00083915|561715888|FG001|Overall Study|Death|3|||
155623838|NCT00083915|561715887|FG000|Overall Study|Physician Decision|11|||
155623839|NCT00083915|561715888|FG001|Overall Study|Physician Decision|6|||
155727144|NCT03312634|562101937|FG000|Overall Study|Sponsor request|2|||
155381994|NCT01442779|560833263|FG000|Overall Study|Withdrawal by Subject|3|||
155381995|NCT01442779|560833263|FG000|Overall Study|Death|3|||
155381996|NCT01442779|560833263|FG000|Overall Study|Non-compliance|1|||
155381997|NCT05249829|560833264|FG000|Overall Study|Participant Relocation|0|||
155381998|NCT05249829|560833265|FG001|Overall Study|Participant Relocation|1|||
155381999|NCT05249829|560833266|FG002|Overall Study|Participant Relocation|2|||
155382000|NCT05249829|560833267|FG003|Overall Study|Participant Relocation|2|||
155382001|NCT05249829|560833264|FG000|Overall Study|Withdrawal by Subject|9|||
155382002|NCT05249829|560833265|FG001|Overall Study|Withdrawal by Subject|17|||
155382003|NCT05249829|560833266|FG002|Overall Study|Withdrawal by Subject|40|||
155382004|NCT05249829|560833267|FG003|Overall Study|Withdrawal by Subject|35|||
155623840|NCT00083915|561715887|FG000|Overall Study|Withdrawal by Subject|8|||
155623841|NCT00083915|561715888|FG001|Overall Study|Withdrawal by Subject|3|||
155623842|NCT00083915|561715887|FG000|Overall Study|disease progression|18|||
155623843|NCT00083915|561715888|FG001|Overall Study|disease progression|23|||
155623844|NCT00083915|561715887|FG000|Overall Study|Failure to collect|3|||
155623845|NCT00083915|561715888|FG001|Overall Study|Failure to collect|0|||
155727145|NCT03312634|562101938|FG001|Overall Study|Sponsor request|0|||
155727146|NCT03312634|562101937|FG000|Overall Study|Withdrawal by Subject|31|||
155727147|NCT03312634|562101938|FG001|Overall Study|Withdrawal by Subject|9|||
155727148|NCT03312634|562101937|FG000|Overall Study|Enrolled in an interventional study|0|||
155727149|NCT03312634|562101938|FG001|Overall Study|Enrolled in an interventional study|52|||
155727150|NCT03312634|562101937|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
155727151|NCT03312634|562101938|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
155727152|NCT03312634|562101937|FG000|Overall Study|Death|0|||
155727153|NCT03312634|562101938|FG001|Overall Study|Death|1|||
155727154|NCT03312634|562101937|FG000|Overall Study|Non-compliance|0|||
155727155|NCT03312634|562101938|FG001|Overall Study|Non-compliance|2|||
155727156|NCT03312634|562101937|FG000|Overall Study|Lost to Follow-up|0|||
155727157|NCT03312634|562101938|FG001|Overall Study|Lost to Follow-up|1|||
155727158|NCT03312634|562101937|FG000|Overall Study|Enrolled into non-interventional study|0|||
155727159|NCT03312634|562101938|FG001|Overall Study|Enrolled into non-interventional study|5|||
155727160|NCT03312634|562101937|FG000|Overall Study|Worsening clinical condition|0|||
155727161|NCT03312634|562101938|FG001|Overall Study|Worsening clinical condition|1|||
155727162|NCT03312634|562101937|FG000|Overall Study|Participant did not want to travel|0|||
155727163|NCT03312634|562101938|FG001|Overall Study|Participant did not want to travel|1|||
155727164|NCT03312634|562101937|FG000|Overall Study|Physician Decision|1|||
155727165|NCT03312634|562101938|FG001|Overall Study|Physician Decision|0|||
155727166|NCT03312634|562101937|FG000|Overall Study|Other|13|||
155727167|NCT03312634|562101938|FG001|Overall Study|Other|0|||
155727168|NCT01148979|562101947|FG000|Overall Study|Lost to Follow-up|0|||
155727169|NCT01148979|562101948|FG001|Overall Study|Lost to Follow-up|1|||
155727170|NCT00777153|562101949|FG000|Overall Study|Lost to Follow-up|1|||
155727171|NCT00777153|562101950|FG001|Overall Study|Lost to Follow-up|1|||
155727172|NCT00777153|562101951|FG002|Overall Study|Lost to Follow-up|0|||
155727173|NCT00777153|562101949|FG000|Overall Study|Death|85|||
155727174|NCT00777153|562101950|FG001|Overall Study|Death|73|||
155727175|NCT00777153|562101951|FG002|Overall Study|Death|33|||
155727176|NCT00777153|562101949|FG000|Overall Study|Withdrawal by Subject|3|||
155727177|NCT00777153|562101950|FG001|Overall Study|Withdrawal by Subject|4|||
155727178|NCT00777153|562101951|FG002|Overall Study|Withdrawal by Subject|3|||
155727179|NCT00777153|562101949|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
155727180|NCT00777153|562101950|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
155727181|NCT00777153|562101951|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
155727182|NCT00554216|562101955|FG000|Overall Study|Lost to Follow-up|92|||
155727183|NCT00554216|562101956|FG001|Overall Study|Lost to Follow-up|31|||
155727184|NCT00554216|562101957|FG002|Overall Study|Lost to Follow-up|63|||
155727185|NCT00554216|562101955|FG000|Overall Study|Adverse Event|16|||
155727186|NCT00554216|562101956|FG001|Overall Study|Adverse Event|16|||
155727187|NCT00554216|562101957|FG002|Overall Study|Adverse Event|36|||
155382005|NCT05249829|560833264|FG000|Overall Study|Physician Decision|1|||
155382006|NCT05249829|560833265|FG001|Overall Study|Physician Decision|0|||
155623846|NCT00083915|561715887|FG000|Overall Study|No response|3|||
155623847|NCT00083915|561715888|FG001|Overall Study|No response|1|||
155623848|NCT00083915|561715887|FG000|Overall Study|Insurance issues|1|||
155623849|NCT00083915|561715888|FG001|Overall Study|Insurance issues|1|||
155623850|NCT01239797|561715889|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
155623851|NCT01239797|561715890|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
155623852|NCT01239797|561715889|FG000|Randomized Participants|Participant withdrew consent|1|||
155623853|NCT01239797|561715890|FG001|Randomized Participants|Participant withdrew consent|7|||
155623854|NCT01239797|561715889|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
155623855|NCT01239797|561715890|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
155623856|NCT01239797|561715889|FG000|Treated Participants|Disease progression|185|||
155623857|NCT01239797|561715890|FG001|Treated Participants|Disease progression|185|||
155623858|NCT01239797|561715889|FG000|Treated Participants|Study drug toxicity|39|||
155727188|NCT00554216|562101955|FG000|Overall Study|Withdrawal by Subject|92|||
155623859|NCT01239797|561715890|FG001|Treated Participants|Study drug toxicity|45|||
155623860|NCT01239797|561715889|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
155623861|NCT01239797|561715890|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
155623862|NCT01239797|561715889|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
155277647|NCT03958630|560449124|FG000|Overall Study|Withdrawal by Subject|0|||
155277648|NCT03958630|560449125|FG001|Overall Study|Withdrawal by Subject|0|||
155277649|NCT03958630|560449126|FG002|Overall Study|Withdrawal by Subject|1|||
155277650|NCT03958630|560449124|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
155277651|NCT03958630|560449125|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
155277652|NCT03958630|560449126|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
155277653|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
155277654|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
155277655|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
155277656|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
155277657|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
155277658|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
155277659|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
155277660|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
155277661|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
155277662|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
155277663|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
155277664|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
155277665|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
155277666|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
155277667|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
155277668|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
155277669|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
155277670|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
155277671|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
155277672|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
155277673|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
155277674|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
155277675|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
155277676|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
155277677|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Death|1|||
155277678|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Death|0|||
155277679|NCT04039503|560449129|FG000|Overall Study|Adverse Event|3|||
155277680|NCT04039503|560449130|FG001|Overall Study|Adverse Event|0|||
155277681|NCT04039503|560449131|FG002|Overall Study|Adverse Event|2|||
155277682|NCT04039503|560449132|FG003|Overall Study|Adverse Event|0|||
155277683|NCT04039503|560449129|FG000|Overall Study|Lost to Follow-up|0|||
155277684|NCT04039503|560449130|FG001|Overall Study|Lost to Follow-up|0|||
155277685|NCT04039503|560449131|FG002|Overall Study|Lost to Follow-up|1|||
155277686|NCT04039503|560449132|FG003|Overall Study|Lost to Follow-up|0|||
155277687|NCT04039503|560449129|FG000|Overall Study|Protocol Violation|0|||
155277688|NCT04039503|560449130|FG001|Overall Study|Protocol Violation|1|||
155277689|NCT04039503|560449131|FG002|Overall Study|Protocol Violation|2|||
155277690|NCT04039503|560449132|FG003|Overall Study|Protocol Violation|1|||
155277691|NCT04039503|560449129|FG000|Overall Study|Withdrawal by Subject|4|||
155277692|NCT04039503|560449130|FG001|Overall Study|Withdrawal by Subject|3|||
155277693|NCT04039503|560449131|FG002|Overall Study|Withdrawal by Subject|5|||
155277694|NCT04039503|560449132|FG003|Overall Study|Withdrawal by Subject|2|||
155277695|NCT03387514|560449134|FG000|Overall Study|Withdrawal by Subject|2|||
155277696|NCT03387514|560449134|FG000|Overall Study|Physician Decision|1|||
155277697|NCT03387514|560449134|FG000|Overall Study|Lost to Follow-up|2|||
155277698|NCT04157686|560449141|FG000|Overall Study|Adverse Event|1|||
155277699|NCT04157686|560449142|FG001|Overall Study|Adverse Event|0|||
155277700|NCT04157686|560449143|FG002|Overall Study|Adverse Event|1|||
155277701|NCT04157686|560449144|FG003|Overall Study|Adverse Event|0|||
155277702|NCT04157686|560449145|FG004|Overall Study|Adverse Event|1|||
155277703|NCT04157686|560449146|FG005|Overall Study|Adverse Event|0|||
155277704|NCT04157686|560449147|FG006|Overall Study|Adverse Event|0|||
155277705|NCT04157686|560449148|FG007|Overall Study|Adverse Event|0|||
155277706|NCT04157686|560449141|FG000|Overall Study|Pregnancy|0|||
155277707|NCT04157686|560449142|FG001|Overall Study|Pregnancy|1|||
155277708|NCT04157686|560449143|FG002|Overall Study|Pregnancy|3|||
155277709|NCT04157686|560449144|FG003|Overall Study|Pregnancy|0|||
155277710|NCT04157686|560449145|FG004|Overall Study|Pregnancy|0|||
155277711|NCT04157686|560449146|FG005|Overall Study|Pregnancy|0|||
155277712|NCT04157686|560449147|FG006|Overall Study|Pregnancy|3|||
155277713|NCT04157686|560449148|FG007|Overall Study|Pregnancy|0|||
155277714|NCT04157686|560449141|FG000|Overall Study|Lost to Follow-up|1|||
155277715|NCT04157686|560449142|FG001|Overall Study|Lost to Follow-up|2|||
155277716|NCT04157686|560449143|FG002|Overall Study|Lost to Follow-up|8|||
155277717|NCT04157686|560449144|FG003|Overall Study|Lost to Follow-up|6|||
155277718|NCT04157686|560449145|FG004|Overall Study|Lost to Follow-up|6|||
155277719|NCT04157686|560449146|FG005|Overall Study|Lost to Follow-up|3|||
155277720|NCT04157686|560449147|FG006|Overall Study|Lost to Follow-up|7|||
155277721|NCT04157686|560449148|FG007|Overall Study|Lost to Follow-up|9|||
155277722|NCT04157686|560449141|FG000|Overall Study|Lack of Efficacy|0|||
155277723|NCT04157686|560449142|FG001|Overall Study|Lack of Efficacy|0|||
155277724|NCT04157686|560449143|FG002|Overall Study|Lack of Efficacy|0|||
155277725|NCT04157686|560449144|FG003|Overall Study|Lack of Efficacy|0|||
155277726|NCT04157686|560449145|FG004|Overall Study|Lack of Efficacy|0|||
155277727|NCT04157686|560449146|FG005|Overall Study|Lack of Efficacy|2|||
155277728|NCT04157686|560449147|FG006|Overall Study|Lack of Efficacy|0|||
155277729|NCT04157686|560449148|FG007|Overall Study|Lack of Efficacy|1|||
155277730|NCT04157686|560449141|FG000|Overall Study|Withdrawal by Subject|10|||
155277731|NCT04157686|560449142|FG001|Overall Study|Withdrawal by Subject|10|||
155277732|NCT04157686|560449143|FG002|Overall Study|Withdrawal by Subject|12|||
155277733|NCT04157686|560449144|FG003|Overall Study|Withdrawal by Subject|20|||
155277734|NCT04157686|560449145|FG004|Overall Study|Withdrawal by Subject|12|||
155277735|NCT04157686|560449146|FG005|Overall Study|Withdrawal by Subject|11|||
155277736|NCT04157686|560449147|FG006|Overall Study|Withdrawal by Subject|18|||
155277737|NCT04157686|560449148|FG007|Overall Study|Withdrawal by Subject|24|||
155277738|NCT04157686|560449141|FG000|Overall Study|Physician Decision|0|||
155277739|NCT04157686|560449142|FG001|Overall Study|Physician Decision|0|||
155277740|NCT04157686|560449143|FG002|Overall Study|Physician Decision|1|||
155277741|NCT04157686|560449144|FG003|Overall Study|Physician Decision|0|||
155277742|NCT04157686|560449145|FG004|Overall Study|Physician Decision|1|||
155277743|NCT04157686|560449146|FG005|Overall Study|Physician Decision|0|||
155277744|NCT04157686|560449147|FG006|Overall Study|Physician Decision|3|||
155277745|NCT04157686|560449148|FG007|Overall Study|Physician Decision|0|||
155277746|NCT04157686|560449141|FG000|Overall Study|Death|0|||
155277747|NCT04157686|560449142|FG001|Overall Study|Death|0|||
155277748|NCT04157686|560449143|FG002|Overall Study|Death|0|||
155277749|NCT04157686|560449144|FG003|Overall Study|Death|2|||
155277750|NCT04157686|560449145|FG004|Overall Study|Death|0|||
155277751|NCT04157686|560449146|FG005|Overall Study|Death|0|||
155277752|NCT04157686|560449147|FG006|Overall Study|Death|0|||
155277753|NCT04157686|560449148|FG007|Overall Study|Death|0|||
155277754|NCT04157686|560449141|FG000|Overall Study|Protocol Violation|0|||
155277755|NCT04157686|560449142|FG001|Overall Study|Protocol Violation|0|||
155277756|NCT04157686|560449143|FG002|Overall Study|Protocol Violation|0|||
155277757|NCT04157686|560449144|FG003|Overall Study|Protocol Violation|0|||
155277758|NCT04157686|560449145|FG004|Overall Study|Protocol Violation|1|||
155277759|NCT04157686|560449146|FG005|Overall Study|Protocol Violation|0|||
155277760|NCT04157686|560449147|FG006|Overall Study|Protocol Violation|0|||
155277761|NCT04157686|560449148|FG007|Overall Study|Protocol Violation|0|||
155277762|NCT04157686|560449141|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
155277763|NCT04157686|560449142|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
155277764|NCT04157686|560449143|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
155277765|NCT04157686|560449144|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
155277766|NCT04157686|560449145|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
155277767|NCT04157686|560449146|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
155277768|NCT04157686|560449147|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
155277769|NCT04157686|560449148|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
155277770|NCT01388543|560449153|FG000|Day 14|Adverse Event|1|||
155277771|NCT01388543|560449154|FG001|Day 14|Adverse Event|4|||
155277772|NCT01556243|560449155|FG000|Overall Study|Ineligible|34|||
155277773|NCT01556243|560449155|FG000|Overall Study|Converted to mastectomy|14|||
155277774|NCT01556243|560449155|FG000|Overall Study|Unable to achieve negative margins|2|||
155277775|NCT01556243|560449155|FG000|Overall Study|Withdrawal by Subject|16|||
155277776|NCT04684914|560449156|FG000|Overall Study|Withdrawal by Subject|1|||
155277777|NCT04684914|560449157|FG001|Overall Study|Withdrawal by Subject|0|||
155277778|NCT04684914|560449156|FG000|Overall Study|Discontinued before receiving study treatment|1|||
155277779|NCT04684914|560449157|FG001|Overall Study|Discontinued before receiving study treatment|2|||
155277780|NCT03872388|560449160|FG000|Overall Study|Disease Progression|0|||
155277781|NCT03872388|560449161|FG001|Overall Study|Disease Progression|0|||
155277782|NCT03872388|560449162|FG002|Overall Study|Disease Progression|0|||
155277783|NCT03872388|560449163|FG003|Overall Study|Disease Progression|0|||
155277784|NCT03872388|560449164|FG004|Overall Study|Disease Progression|0|||
155277785|NCT03872388|560449165|FG005|Overall Study|Disease Progression|0|||
155277786|NCT03872388|560449166|FG006|Overall Study|Disease Progression|1|||
155277787|NCT03872388|560449167|FG007|Overall Study|Disease Progression|1|||
155277788|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
155277789|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
155277790|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
155277791|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
155277792|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
155277793|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
155277794|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
155277795|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
155277796|NCT04191135|560449171|FG000|Induction Treatment|Not Treated|2|||
155277797|NCT04191135|560449172|FG001|Induction Treatment|Not Treated|0|||
155277798|NCT04191135|560449173|FG002|Induction Treatment|Not Treated|0|||
155277799|NCT04191135|560449171|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
155277800|NCT04191135|560449172|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
155277801|NCT04191135|560449173|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
155277802|NCT04191135|560449171|FG000|Induction Treatment|Adverse Event|25|||
155277803|NCT04191135|560449172|FG001|Induction Treatment|Adverse Event|0|||
155277804|NCT04191135|560449173|FG002|Induction Treatment|Adverse Event|0|||
155277805|NCT04191135|560449171|FG000|Induction Treatment|Clinical Progression|8|||
155277806|NCT04191135|560449172|FG001|Induction Treatment|Clinical Progression|0|||
155277807|NCT04191135|560449173|FG002|Induction Treatment|Clinical Progression|0|||
155277808|NCT04191135|560449171|FG000|Induction Treatment|Excluded Medication|1|||
155277809|NCT04191135|560449172|FG001|Induction Treatment|Excluded Medication|0|||
155277810|NCT04191135|560449173|FG002|Induction Treatment|Excluded Medication|0|||
155277811|NCT04191135|560449171|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
155277812|NCT04191135|560449172|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
155277813|NCT04191135|560449173|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
155277814|NCT04191135|560449171|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
155277815|NCT04191135|560449172|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
155277816|NCT04191135|560449173|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
155277817|NCT04191135|560449171|FG000|Induction Treatment|Physician Decision|2|||
155277818|NCT04191135|560449172|FG001|Induction Treatment|Physician Decision|0|||
155277819|NCT04191135|560449173|FG002|Induction Treatment|Physician Decision|0|||
155277820|NCT04191135|560449171|FG000|Induction Treatment|Progressive Disease|135|||
155277821|NCT04191135|560449172|FG001|Induction Treatment|Progressive Disease|0|||
155277822|NCT04191135|560449173|FG002|Induction Treatment|Progressive Disease|0|||
155277823|NCT04191135|560449171|FG000|Induction Treatment|Protocol Violation|10|||
155277824|NCT04191135|560449172|FG001|Induction Treatment|Protocol Violation|0|||
155277825|NCT04191135|560449173|FG002|Induction Treatment|Protocol Violation|0|||
155277826|NCT04191135|560449171|FG000|Induction Treatment|Withdrawal by Subject|4|||
155277827|NCT04191135|560449172|FG001|Induction Treatment|Withdrawal by Subject|0|||
155382007|NCT05249829|560833266|FG002|Overall Study|Physician Decision|0|||
155382008|NCT05249829|560833267|FG003|Overall Study|Physician Decision|0|||
155382009|NCT05249829|560833264|FG000|Overall Study|Lost to Follow-up|16|||
155623863|NCT01239797|561715890|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
155623864|NCT01239797|561715889|FG000|Treated Participants|Administrative reason by sponsor|13|||
155623865|NCT01239797|561715890|FG001|Treated Participants|Administrative reason by sponsor|4|||
155623866|NCT01239797|561715889|FG000|Treated Participants|Other reasons|14|||
155623867|NCT01239797|561715890|FG001|Treated Participants|Other reasons|14|||
155623868|NCT01239797|561715889|FG000|Treated Participants|Participant withdrew consent|6|||
155623869|NCT01239797|561715890|FG001|Treated Participants|Participant withdrew consent|11|||
155623870|NCT01239797|561715889|FG000|Treated Participants|Death|1|||
155623871|NCT01239797|561715890|FG001|Treated Participants|Death|1|||
155623872|NCT01239797|561715889|FG000|Treated Participants|Participant no longer meets study criteria|1|||
155623873|NCT01239797|561715890|FG001|Treated Participants|Participant no longer meets study criteria|1|||
155623874|NCT01239797|561715889|FG000|Treated Participants|Poor/non-compliance|0|||
155623875|NCT01239797|561715890|FG001|Treated Participants|Poor/non-compliance|1|||
155623876|NCT03722576|561715895|FG000|Overall Study|Withdrawal by Subject|3|||
155623877|NCT03722576|561715895|FG000|Overall Study|Adverse Event|2|||
155623878|NCT03722576|561715895|FG000|Overall Study|Physician Decision|1|||
155623879|NCT03722576|561715895|FG000|Overall Study|Lost to Follow-up|1|||
155623880|NCT01240382|561715896|FG000|Overall Study|Adverse Event|2|||
155623881|NCT01240382|561715897|FG001|Overall Study|Adverse Event|1|||
155623882|NCT01240382|561715896|FG000|Overall Study|Lack of Efficacy|0|||
155623883|NCT01240382|561715897|FG001|Overall Study|Lack of Efficacy|2|||
155623884|NCT01240382|561715896|FG000|Overall Study|Fear of adverse events|0|||
155623885|NCT01240382|561715897|FG001|Overall Study|Fear of adverse events|1|||
155623886|NCT02643693|561715898|FG000|Overall Study|Physician Decision|0|||
155623887|NCT02643693|561715899|FG001|Overall Study|Physician Decision|1|||
155623888|NCT02643693|561715900|FG002|Overall Study|Physician Decision|0|||
155623889|NCT02643693|561715901|FG003|Overall Study|Physician Decision|0|||
155623890|NCT02643693|561715902|FG004|Overall Study|Physician Decision|0|||
155277828|NCT04191135|560449173|FG002|Induction Treatment|Withdrawal by Subject|0|||
155277829|NCT04191135|560449171|FG000|Randomized Treatment|Death|0|||
155277830|NCT04191135|560449172|FG001|Randomized Treatment|Death|50|||
155277831|NCT04191135|560449173|FG002|Randomized Treatment|Death|54|||
155727189|NCT00554216|562101956|FG001|Overall Study|Withdrawal by Subject|31|||
155623891|NCT02643693|561715903|FG005|Overall Study|Physician Decision|0|||
155382010|NCT05249829|560833265|FG001|Overall Study|Lost to Follow-up|16|||
155382011|NCT05249829|560833266|FG002|Overall Study|Lost to Follow-up|57|||
155382012|NCT05249829|560833267|FG003|Overall Study|Lost to Follow-up|60|||
155382013|NCT05249829|560833264|FG000|Overall Study|Adverse Event|2|||
155382014|NCT05249829|560833265|FG001|Overall Study|Adverse Event|2|||
155382015|NCT05249829|560833266|FG002|Overall Study|Adverse Event|2|||
155382016|NCT05249829|560833267|FG003|Overall Study|Adverse Event|2|||
155382017|NCT05249829|560833264|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
155382018|NCT05249829|560833265|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
155382019|NCT05249829|560833266|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
155382020|NCT05249829|560833267|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
155382021|NCT05249829|560833264|FG000|Overall Study|Protocol Violation|2|||
155382022|NCT05249829|560833265|FG001|Overall Study|Protocol Violation|0|||
155382023|NCT05249829|560833266|FG002|Overall Study|Protocol Violation|5|||
155382024|NCT05249829|560833267|FG003|Overall Study|Protocol Violation|3|||
155382025|NCT05249829|560833264|FG000|Overall Study|Death|0|||
155382026|NCT05249829|560833265|FG001|Overall Study|Death|1|||
155382027|NCT05249829|560833266|FG002|Overall Study|Death|2|||
155382028|NCT05249829|560833267|FG003|Overall Study|Death|4|||
155382029|NCT00196976|560833269|FG000|Primary Study|Migrated from study area|0|||
155382030|NCT00196976|560833270|FG001|Primary Study|Migrated from study area|0|||
155382031|NCT00196976|560833271|FG002|Primary Study|Migrated from study area|0|||
155382032|NCT00196976|560833272|FG003|Primary Study|Migrated from study area|0|||
155623892|NCT02643693|561715898|FG000|Overall Study|Withdrawal by Subject|0|||
155623893|NCT02643693|561715899|FG001|Overall Study|Withdrawal by Subject|1|||
155623894|NCT02643693|561715900|FG002|Overall Study|Withdrawal by Subject|0|||
155623895|NCT02643693|561715901|FG003|Overall Study|Withdrawal by Subject|0|||
155623896|NCT02643693|561715902|FG004|Overall Study|Withdrawal by Subject|0|||
155623897|NCT02643693|561715903|FG005|Overall Study|Withdrawal by Subject|0|||
155623898|NCT02643693|561715898|FG000|Overall Study|Protocol Adherence Issues|2|||
155623899|NCT02643693|561715899|FG001|Overall Study|Protocol Adherence Issues|0|||
155623900|NCT02643693|561715900|FG002|Overall Study|Protocol Adherence Issues|1|||
155623901|NCT02643693|561715901|FG003|Overall Study|Protocol Adherence Issues|0|||
155623902|NCT02643693|561715902|FG004|Overall Study|Protocol Adherence Issues|0|||
155623903|NCT02643693|561715903|FG005|Overall Study|Protocol Adherence Issues|1|||
155727190|NCT00554216|562101957|FG002|Overall Study|Withdrawal by Subject|43|||
155277832|NCT04191135|560449171|FG000|Randomized Treatment|Lost to Follow-up|0|||
155277833|NCT04191135|560449172|FG001|Randomized Treatment|Lost to Follow-up|0|||
155277834|NCT04191135|560449173|FG002|Randomized Treatment|Lost to Follow-up|1|||
155277835|NCT04191135|560449171|FG000|Randomized Treatment|Withdrawal by Subject|0|||
155277836|NCT04191135|560449172|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155277837|NCT04191135|560449173|FG002|Randomized Treatment|Withdrawal by Subject|0|||
155277838|NCT04191135|560449171|FG000|Randomized Treatment|Ongoing in Trial|0|||
155277839|NCT04191135|560449172|FG001|Randomized Treatment|Ongoing in Trial|83|||
155277840|NCT04191135|560449173|FG002|Randomized Treatment|Ongoing in Trial|81|||
155277841|NCT00107380|560451010|FG000|Overall Study|Adverse Event|7|||
155277842|NCT00107380|560451010|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
155277843|NCT00107380|560451010|FG000|Overall Study|Progression/relapse|4|||
155277844|NCT00107380|560451010|FG000|Overall Study|Death|3|||
155277845|NCT00107380|560451010|FG000|Overall Study|Other - not protocol specified|7|||
155277846|NCT00107380|560451010|FG000|Overall Study|Ineligible|2|||
155277847|NCT03673098|560451011|FG000|Overall Study|Lost to Follow-up|2|||
155277848|NCT03673098|560451012|FG001|Overall Study|Lost to Follow-up|3|||
155277849|NCT03673098|560451011|FG000|Overall Study|Withdrawal by Subject|6|||
155277850|NCT03673098|560451012|FG001|Overall Study|Withdrawal by Subject|1|||
155277851|NCT03673098|560451011|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
155277852|NCT03673098|560451012|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
155277853|NCT01268059|560451013|FG000|Overall Study|Lost to Follow-up|0|||
155277854|NCT01268059|560451014|FG001|Overall Study|Lost to Follow-up|1|||
155277855|NCT01268059|560451015|FG002|Overall Study|Lost to Follow-up|0|||
155277856|NCT01268059|560451016|FG003|Overall Study|Lost to Follow-up|0|||
155277857|NCT01268059|560451013|FG000|Overall Study|Withdrawal by Subject|7|||
155382033|NCT00196976|560833273|FG004|Primary Study|Migrated from study area|0|||
155727191|NCT00554216|562101955|FG000|Overall Study|Non compliance|10|||
155382034|NCT00196976|560833274|FG005|Primary Study|Migrated from study area|0|||
155382035|NCT00196976|560833275|FG006|Primary Study|Migrated from study area|0|||
155382036|NCT00196976|560833276|FG007|Primary Study|Migrated from study area|1|||
155382037|NCT00196976|560833277|FG008|Primary Study|Migrated from study area|0|||
155382038|NCT00196976|560833278|FG009|Primary Study|Migrated from study area|0|||
155382039|NCT00196976|560833279|FG010|Primary Study|Migrated from study area|0|||
155623904|NCT02059239|561715904|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
155623905|NCT02059239|561715905|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
155623906|NCT02059239|561715904|FG000|Overall Study|Physician Decision|1|||
155277858|NCT01268059|560451014|FG001|Overall Study|Withdrawal by Subject|4|||
155277859|NCT01268059|560451015|FG002|Overall Study|Withdrawal by Subject|0|||
155277860|NCT01268059|560451016|FG003|Overall Study|Withdrawal by Subject|0|||
155623907|NCT02059239|561715905|FG001|Overall Study|Physician Decision|0|||
155623908|NCT01408706|561715907|FG000|Overall Study|Physician Decision|1|||
155623909|NCT01408706|561715908|FG001|Overall Study|Physician Decision|0|||
155623910|NCT01268267|561715909|FG000|Overall Study|Protocol Violation|1|||
155623911|NCT01222104|561715910|FG000|Overall Study|Lost to Follow-up|37|||
155623912|NCT01222104|561715910|FG000|Overall Study|Death|10|||
155623913|NCT00888654|561715912|FG000|Overall Study|Problems swallowing oral meds.|1|||
155623914|NCT00888654|561715912|FG000|Overall Study|Not enough oral meds before surgery|3|||
155623915|NCT00888654|561715912|FG000|Overall Study|Surgery aborted|2|||
155623916|NCT00888654|561715912|FG000|Overall Study|Withdrawal by Subject|1|||
155727192|NCT00554216|562101956|FG001|Overall Study|Non compliance|4|||
155277861|NCT01268059|560451013|FG000|Overall Study|Death|20|||
155277862|NCT01268059|560451014|FG001|Overall Study|Death|30|||
155277863|NCT01268059|560451015|FG002|Overall Study|Death|3|||
155277864|NCT01268059|560451016|FG003|Overall Study|Death|5|||
155277865|NCT01268059|560451013|FG000|Overall Study|Progression of disease|1|||
155277866|NCT01268059|560451014|FG001|Overall Study|Progression of disease|0|||
155277867|NCT01268059|560451015|FG002|Overall Study|Progression of disease|0|||
155277868|NCT01268059|560451016|FG003|Overall Study|Progression of disease|0|||
155277869|NCT03660943|560451017|FG000|Overall Study|Adverse Event|5|||
155277870|NCT03660943|560451018|FG001|Overall Study|Adverse Event|3|||
155277871|NCT03660943|560451017|FG000|Overall Study|Death|0|||
155277872|NCT03660943|560451018|FG001|Overall Study|Death|2|||
155277873|NCT03660943|560451017|FG000|Overall Study|Lost to Follow-up|7|||
155277874|NCT03660943|560451018|FG001|Overall Study|Lost to Follow-up|3|||
155277875|NCT03660943|560451017|FG000|Overall Study|Protocol Violation|3|||
155277876|NCT03660943|560451018|FG001|Overall Study|Protocol Violation|5|||
155277877|NCT03660943|560451017|FG000|Overall Study|Withdrawal by Subject|8|||
155277878|NCT03660943|560451018|FG001|Overall Study|Withdrawal by Subject|15|||
155277879|NCT03660943|560451017|FG000|Overall Study|Lack of Efficacy|9|||
155277880|NCT03660943|560451018|FG001|Overall Study|Lack of Efficacy|12|||
155277881|NCT03660943|560451017|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
155277882|NCT03660943|560451018|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
155277883|NCT01021878|560451019|FG000|Overall Study|Lost to Follow-up|4|||
155277884|NCT01021878|560451020|FG001|Overall Study|Lost to Follow-up|3|||
155277885|NCT01021878|560451019|FG000|Overall Study|Death|0|||
155277886|NCT01021878|560451020|FG001|Overall Study|Death|1|||
155277887|NCT01021878|560451019|FG000|Overall Study|Adverse Event|6|||
155277888|NCT01021878|560451020|FG001|Overall Study|Adverse Event|5|||
155277889|NCT01021878|560451019|FG000|Overall Study|Transplantation|6|||
155277890|NCT01021878|560451020|FG001|Overall Study|Transplantation|1|||
155277891|NCT01155726|560451021|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
155277892|NCT01155726|560451022|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
155277893|NCT01155726|560451023|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
155277894|NCT01155726|560451024|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
155277895|NCT00109928|560451037|FG000|Overall Study|Adverse Event|2|||
155277896|NCT00109928|560451037|FG000|Overall Study|Progression|6|||
155277897|NCT00109928|560451037|FG000|Overall Study|Death|2|||
155277898|NCT00109928|560451037|FG000|Overall Study|not protocol specified|2|||
155277899|NCT00109928|560451037|FG000|Overall Study|not eligible|1|||
155277900|NCT02411591|560451042|FG000|Overall Study|Adverse Event|0|||
155277901|NCT02411591|560451043|FG001|Overall Study|Adverse Event|4|||
155277902|NCT02411591|560451044|FG002|Overall Study|Adverse Event|2|||
155277903|NCT02411591|560451042|FG000|Overall Study|Withdrawal by Subject|0|||
155277904|NCT02411591|560451043|FG001|Overall Study|Withdrawal by Subject|3|||
155277905|NCT02411591|560451044|FG002|Overall Study|Withdrawal by Subject|0|||
155277906|NCT02411591|560451042|FG000|Overall Study|Physician Decision|0|||
155277907|NCT02411591|560451043|FG001|Overall Study|Physician Decision|3|||
155277908|NCT02411591|560451044|FG002|Overall Study|Physician Decision|1|||
155277909|NCT00598481|560451046|FG000|Treatment|Physician Decision|1|||
155277910|NCT01439711|560451047|FG000|Overall Study|Ineligible|13|||
155277911|NCT01439711|560451047|FG000|Overall Study|Cancel|3|||
155277912|NCT01439711|560451047|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
155277913|NCT01439711|560451047|FG000|Overall Study|Adverse Event|5|||
155277914|NCT01439711|560451047|FG000|Overall Study|Withdrawal by Subject|3|||
155277915|NCT01439711|560451047|FG000|Overall Study|Progression During Active Tx|3|||
155277916|NCT01439711|560451047|FG000|Overall Study|Noncompliance|3|||
155277917|NCT01439711|560451047|FG000|Overall Study|No MRI|9|||
155277918|NCT01603121|560451048|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
155727193|NCT00554216|562101957|FG002|Overall Study|Non compliance|5|||
155277919|NCT01603121|560451049|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
155277920|NCT00738530|560451050|FG000|Overall Study|Death|220|||
155277921|NCT00738530|560451051|FG001|Overall Study|Death|224|||
155727194|NCT00554216|562101955|FG000|Overall Study|Pregnancy|2|||
155277922|NCT00738530|560451050|FG000|Overall Study|Lost to Follow-up|8|||
155277923|NCT00738530|560451051|FG001|Overall Study|Lost to Follow-up|6|||
155623917|NCT00888654|561715912|FG000|Overall Study|Inelig. due to contraindication of med|1|||
155623918|NCT00888654|561715912|FG000|Overall Study|Change in surg date|1|||
155277924|NCT00738530|560451050|FG000|Overall Study|Withdrawal by Subject|6|||
155382040|NCT00196976|560833280|FG011|Primary Study|Migrated from study area|0|||
155382041|NCT00196976|560833281|FG012|Primary Study|Migrated from study area|0|||
155382042|NCT00196976|560833282|FG013|Primary Study|Migrated from study area|0|||
155382043|NCT00196976|560833269|FG000|Primary Study|Protocol Violation|0|||
155382044|NCT00196976|560833270|FG001|Primary Study|Protocol Violation|1|||
155382045|NCT00196976|560833271|FG002|Primary Study|Protocol Violation|1|||
155382046|NCT00196976|560833272|FG003|Primary Study|Protocol Violation|0|||
155382047|NCT00196976|560833273|FG004|Primary Study|Protocol Violation|0|||
155382048|NCT00196976|560833274|FG005|Primary Study|Protocol Violation|0|||
155382049|NCT00196976|560833275|FG006|Primary Study|Protocol Violation|0|||
155382050|NCT00196976|560833276|FG007|Primary Study|Protocol Violation|0|||
155382051|NCT00196976|560833277|FG008|Primary Study|Protocol Violation|0|||
155382052|NCT00196976|560833278|FG009|Primary Study|Protocol Violation|0|||
155382053|NCT00196976|560833279|FG010|Primary Study|Protocol Violation|0|||
155382054|NCT00196976|560833280|FG011|Primary Study|Protocol Violation|0|||
155382055|NCT00196976|560833281|FG012|Primary Study|Protocol Violation|0|||
155382056|NCT00196976|560833282|FG013|Primary Study|Protocol Violation|0|||
155382057|NCT00196976|560833269|FG000|Primary Study|Withdrawal by Subject|1|||
155382058|NCT00196976|560833270|FG001|Primary Study|Withdrawal by Subject|0|||
155382059|NCT00196976|560833271|FG002|Primary Study|Withdrawal by Subject|1|||
155382060|NCT00196976|560833272|FG003|Primary Study|Withdrawal by Subject|1|||
155382061|NCT00196976|560833273|FG004|Primary Study|Withdrawal by Subject|2|||
155382062|NCT00196976|560833274|FG005|Primary Study|Withdrawal by Subject|1|||
155382063|NCT00196976|560833275|FG006|Primary Study|Withdrawal by Subject|0|||
155623919|NCT00888654|561715912|FG000|Overall Study|Stopped meds due to headaches|1|||
155623920|NCT01418339|561715913|FG000|Overall Study|Adverse Event|5|||
155623921|NCT01418339|561715914|FG001|Overall Study|Adverse Event|2|||
155623922|NCT01418339|561715913|FG000|Overall Study|Subject Withdrew Consent|1|||
155623923|NCT01418339|561715914|FG001|Overall Study|Subject Withdrew Consent|2|||
155623924|NCT01418339|561715913|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
155623925|NCT01418339|561715914|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
155623926|NCT02204917|561715917|FG000|Overall Study|Protocol Violation|1|||
155623927|NCT02219685|561715918|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
155623928|NCT02219685|561715919|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
155623929|NCT02219685|561715918|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
155623930|NCT02219685|561715919|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
155623931|NCT00698815|561715920|FG000|Overall Study|Death|1|||
155623932|NCT00698815|561715921|FG001|Overall Study|Death|2|||
155623933|NCT00698815|561715922|FG002|Overall Study|Death|4|||
155623934|NCT00698815|561715920|FG000|Overall Study|Withdrawal by Subject|6|||
155623935|NCT00698815|561715921|FG001|Overall Study|Withdrawal by Subject|3|||
155623936|NCT00698815|561715922|FG002|Overall Study|Withdrawal by Subject|2|||
155623937|NCT00698815|561715920|FG000|Overall Study|MD discretion|2|||
155623938|NCT00698815|561715921|FG001|Overall Study|MD discretion|7|||
155623939|NCT00698815|561715922|FG002|Overall Study|MD discretion|2|||
155623940|NCT00698815|561715920|FG000|Overall Study|Did not receive protocol treatment|1|||
155623941|NCT00698815|561715921|FG001|Overall Study|Did not receive protocol treatment|2|||
155623942|NCT00698815|561715922|FG002|Overall Study|Did not receive protocol treatment|2|||
155623943|NCT04003103|561715927|FG000|Overall Study|Death|1|||
155623944|NCT04003103|561715928|FG001|Overall Study|Death|0|||
155623945|NCT04003103|561715929|FG002|Overall Study|Death|0|||
155623946|NCT04003103|561715927|FG000|Overall Study|Lost to Follow-up|4|||
155623947|NCT04003103|561715928|FG001|Overall Study|Lost to Follow-up|3|||
155623948|NCT04003103|561715929|FG002|Overall Study|Lost to Follow-up|2|||
155623949|NCT04003103|561715927|FG000|Overall Study|Withdrawal by Subject|10|||
155623950|NCT04003103|561715928|FG001|Overall Study|Withdrawal by Subject|1|||
155623951|NCT04003103|561715929|FG002|Overall Study|Withdrawal by Subject|1|||
155623952|NCT04003103|561715927|FG000|Overall Study|Status not recorded|0|||
155623953|NCT04003103|561715928|FG001|Overall Study|Status not recorded|2|||
155623954|NCT04003103|561715929|FG002|Overall Study|Status not recorded|0|||
155623955|NCT02131064|561715933|FG000|Overall Study|Death|5|||
155623956|NCT02131064|561715934|FG001|Overall Study|Death|6|||
155623957|NCT02131064|561715933|FG000|Overall Study|Lost to Follow-up|4|||
155623958|NCT02131064|561715934|FG001|Overall Study|Lost to Follow-up|8|||
155623959|NCT02131064|561715933|FG000|Overall Study|Withdrawal by Subject|14|||
155623960|NCT02131064|561715934|FG001|Overall Study|Withdrawal by Subject|18|||
155727195|NCT00554216|562101956|FG001|Overall Study|Pregnancy|1|||
155727196|NCT00554216|562101957|FG002|Overall Study|Pregnancy|14|||
155382064|NCT00196976|560833276|FG007|Primary Study|Withdrawal by Subject|0|||
155382065|NCT00196976|560833277|FG008|Primary Study|Withdrawal by Subject|0|||
155382066|NCT00196976|560833278|FG009|Primary Study|Withdrawal by Subject|1|||
155382067|NCT00196976|560833279|FG010|Primary Study|Withdrawal by Subject|0|||
155382068|NCT00196976|560833280|FG011|Primary Study|Withdrawal by Subject|0|||
155623961|NCT02131064|561715933|FG000|Overall Study|Other|2|||
155623962|NCT02131064|561715934|FG001|Overall Study|Other|2|||
155623963|NCT00593918|561715937|FG000|Overall Study|Withdrawal by Subject|5|||
155623964|NCT00593918|561715938|FG001|Overall Study|Withdrawal by Subject|24|||
155623965|NCT04202497|561715945|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
155382069|NCT00196976|560833281|FG012|Primary Study|Withdrawal by Subject|0|||
155382070|NCT00196976|560833282|FG013|Primary Study|Withdrawal by Subject|0|||
155382071|NCT00196976|560833269|FG000|Primary Study|Lost to Follow-up|0|||
155382072|NCT00196976|560833270|FG001|Primary Study|Lost to Follow-up|0|||
155382073|NCT00196976|560833271|FG002|Primary Study|Lost to Follow-up|0|||
155382074|NCT00196976|560833272|FG003|Primary Study|Lost to Follow-up|0|||
155382075|NCT00196976|560833273|FG004|Primary Study|Lost to Follow-up|1|||
155382076|NCT00196976|560833274|FG005|Primary Study|Lost to Follow-up|1|||
155382077|NCT00196976|560833275|FG006|Primary Study|Lost to Follow-up|0|||
155382078|NCT00196976|560833276|FG007|Primary Study|Lost to Follow-up|2|||
155382079|NCT00196976|560833277|FG008|Primary Study|Lost to Follow-up|0|||
155382080|NCT00196976|560833278|FG009|Primary Study|Lost to Follow-up|0|||
155382081|NCT00196976|560833279|FG010|Primary Study|Lost to Follow-up|0|||
155382082|NCT00196976|560833280|FG011|Primary Study|Lost to Follow-up|0|||
155382083|NCT00196976|560833281|FG012|Primary Study|Lost to Follow-up|0|||
155382084|NCT00196976|560833282|FG013|Primary Study|Lost to Follow-up|0|||
155382085|NCT00196976|560833269|FG000|Primary Study|Other|0|||
155382086|NCT00196976|560833270|FG001|Primary Study|Other|0|||
155382087|NCT00196976|560833271|FG002|Primary Study|Other|2|||
155382088|NCT00196976|560833272|FG003|Primary Study|Other|0|||
155382089|NCT00196976|560833273|FG004|Primary Study|Other|0|||
155382090|NCT00196976|560833274|FG005|Primary Study|Other|0|||
155382091|NCT00196976|560833275|FG006|Primary Study|Other|0|||
155382092|NCT00196976|560833276|FG007|Primary Study|Other|0|||
155382093|NCT00196976|560833277|FG008|Primary Study|Other|0|||
155382094|NCT00196976|560833278|FG009|Primary Study|Other|0|||
155382095|NCT00196976|560833279|FG010|Primary Study|Other|0|||
155382096|NCT00196976|560833280|FG011|Primary Study|Other|0|||
155382097|NCT00196976|560833281|FG012|Primary Study|Other|0|||
155382098|NCT00196976|560833282|FG013|Primary Study|Other|0|||
155382099|NCT00196976|560833269|FG000|Booster Study|Withdrawal by Subject|0|||
155382100|NCT00196976|560833270|FG001|Booster Study|Withdrawal by Subject|0|||
155382101|NCT00196976|560833271|FG002|Booster Study|Withdrawal by Subject|0|||
155382102|NCT00196976|560833272|FG003|Booster Study|Withdrawal by Subject|0|||
155382103|NCT00196976|560833273|FG004|Booster Study|Withdrawal by Subject|0|||
155382104|NCT00196976|560833274|FG005|Booster Study|Withdrawal by Subject|0|||
155382105|NCT00196976|560833275|FG006|Booster Study|Withdrawal by Subject|0|||
155382106|NCT00196976|560833276|FG007|Booster Study|Withdrawal by Subject|0|||
155382107|NCT00196976|560833277|FG008|Booster Study|Withdrawal by Subject|0|||
155382108|NCT00196976|560833278|FG009|Booster Study|Withdrawal by Subject|0|||
155623966|NCT04202497|561715946|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155623967|NCT04202497|561715947|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155623968|NCT04202497|561715948|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155623969|NCT02155699|561715949|FG000|Overall Study|Withdrawal by Subject|0|||
155623970|NCT02155699|561715950|FG001|Overall Study|Withdrawal by Subject|3|||
155623971|NCT02155699|561715951|FG002|Overall Study|Withdrawal by Subject|6|||
155623972|NCT02155699|561715952|FG003|Overall Study|Withdrawal by Subject|1|||
155623973|NCT02155699|561715949|FG000|Overall Study|Lost to Follow-up|0|||
155623974|NCT02155699|561715950|FG001|Overall Study|Lost to Follow-up|0|||
155623975|NCT02155699|561715951|FG002|Overall Study|Lost to Follow-up|0|||
155623976|NCT02155699|561715952|FG003|Overall Study|Lost to Follow-up|3|||
155623977|NCT02155699|561715949|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
155623978|NCT02155699|561715950|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
155623979|NCT02155699|561715951|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
155623980|NCT02155699|561715952|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
155623981|NCT05547386|561715953|FG000|Overall Study|Withdrawal by Subject|7|||
155623982|NCT03834506|561715954|FG000|Overall Study|Death|336|||
155623983|NCT03834506|561715955|FG001|Overall Study|Death|326|||
155623984|NCT03834506|561715954|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155623985|NCT03834506|561715955|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155382109|NCT00196976|560833279|FG010|Booster Study|Withdrawal by Subject|1|||
155382110|NCT00196976|560833280|FG011|Booster Study|Withdrawal by Subject|0|||
155623986|NCT03834506|561715954|FG000|Overall Study|Withdrawal by Subject|10|||
155623987|NCT03834506|561715955|FG001|Overall Study|Withdrawal by Subject|8|||
155727197|NCT00554216|562101955|FG000|Overall Study|Restricted med|3|||
155382111|NCT00196976|560833281|FG012|Booster Study|Withdrawal by Subject|0|||
155382112|NCT00196976|560833282|FG013|Booster Study|Withdrawal by Subject|0|||
155382113|NCT00196976|560833269|FG000|Booster Study|Lost to Follow-up|0|||
155382114|NCT00196976|560833270|FG001|Booster Study|Lost to Follow-up|0|||
155382115|NCT00196976|560833271|FG002|Booster Study|Lost to Follow-up|0|||
155382116|NCT00196976|560833272|FG003|Booster Study|Lost to Follow-up|0|||
155382117|NCT00196976|560833273|FG004|Booster Study|Lost to Follow-up|0|||
155382118|NCT00196976|560833274|FG005|Booster Study|Lost to Follow-up|0|||
155382119|NCT00196976|560833275|FG006|Booster Study|Lost to Follow-up|0|||
155382120|NCT00196976|560833276|FG007|Booster Study|Lost to Follow-up|0|||
155382121|NCT00196976|560833277|FG008|Booster Study|Lost to Follow-up|0|||
155382122|NCT00196976|560833278|FG009|Booster Study|Lost to Follow-up|0|||
155382123|NCT00196976|560833279|FG010|Booster Study|Lost to Follow-up|1|||
155382124|NCT00196976|560833280|FG011|Booster Study|Lost to Follow-up|2|||
155382125|NCT00196976|560833281|FG012|Booster Study|Lost to Follow-up|0|||
155382126|NCT00196976|560833282|FG013|Booster Study|Lost to Follow-up|0|||
155623988|NCT03834506|561715954|FG000|Overall Study|Sponsor decision|165|||
155623989|NCT03834506|561715955|FG001|Overall Study|Sponsor decision|178|||
155623990|NCT03834506|561715954|FG000|Overall Study|Physician Decision|3|||
155623991|NCT03834506|561715955|FG001|Overall Study|Physician Decision|1|||
155623992|NCT03834506|561715954|FG000|Overall Study|Lost to Follow-up|0|||
155623993|NCT03834506|561715955|FG001|Overall Study|Lost to Follow-up|1|||
155623994|NCT05502302|561715963|FG000|Overall Study|Lost to Follow-up|6|||
155623995|NCT05502302|561715963|FG000|Overall Study|Death|2|||
155623996|NCT02998151|561715964|FG000|Overall Study|Withdrawal by Subject|3|||
155623997|NCT02998151|561715964|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
155623998|NCT02998151|561715964|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
155623999|NCT02667301|561715965|FG000|Overall Study|Adverse Event|1|||
155624000|NCT02667301|561715965|FG000|Overall Study|Lack of Efficacy|1|||
155624001|NCT01619878|561715966|FG000|6 Week Follow-up Phase|Adverse Event|1|||
155624002|NCT01619878|561715966|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
155624003|NCT01619878|561715966|FG000|Follow-up at 12 Months of Age|Death|2|||
155624004|NCT02895295|561715967|FG000|Overall Study|Survey Non-response|71|||
155624005|NCT02895295|561715968|FG001|Overall Study|Survey Non-response|94|||
155624006|NCT02895295|561715969|FG002|Overall Study|Survey Non-response|92|||
155624007|NCT04414787|561715970|FG000|Overall Study|Patient Death|18|||
155624008|NCT04414787|561715971|FG001|Overall Study|Patient Death|18|||
155624009|NCT04414787|561715972|FG002|Overall Study|Patient Death|15|||
155624010|NCT04414787|561715973|FG003|Overall Study|Patient Death|15|||
155624011|NCT04414787|561715970|FG000|Overall Study|Patient Hospitalization|1|||
155624012|NCT04414787|561715971|FG001|Overall Study|Patient Hospitalization|1|||
155624013|NCT04414787|561715972|FG002|Overall Study|Patient Hospitalization|2|||
155624014|NCT04414787|561715973|FG003|Overall Study|Patient Hospitalization|2|||
155624015|NCT04414787|561715970|FG000|Overall Study|Lost to Follow-up|7|||
155624016|NCT04414787|561715971|FG001|Overall Study|Lost to Follow-up|7|||
155624017|NCT04414787|561715972|FG002|Overall Study|Lost to Follow-up|5|||
155624018|NCT04414787|561715973|FG003|Overall Study|Lost to Follow-up|5|||
155624019|NCT04414787|561715970|FG000|Overall Study|Residence in post-acute care facility|3|||
155624020|NCT04414787|561715971|FG001|Overall Study|Residence in post-acute care facility|3|||
155624021|NCT04414787|561715972|FG002|Overall Study|Residence in post-acute care facility|5|||
155624022|NCT04414787|561715973|FG003|Overall Study|Residence in post-acute care facility|5|||
155624023|NCT00447902|561715977|FG000|Overall Study|Adverse Event|0|||
155624024|NCT00447902|561715978|FG001|Overall Study|Adverse Event|3|||
155624025|NCT00447902|561715977|FG000|Overall Study|Protocol Violation|1|||
155624026|NCT00447902|561715978|FG001|Overall Study|Protocol Violation|0|||
155624027|NCT00447902|561715977|FG000|Overall Study|Withdrawal by Subject|0|||
155624028|NCT00447902|561715978|FG001|Overall Study|Withdrawal by Subject|1|||
155624029|NCT00447902|561715977|FG000|Overall Study|included patients who discontinued|1|||
155624030|NCT00447902|561715978|FG001|Overall Study|included patients who discontinued|1|||
155624031|NCT00447902|561715977|FG000|Overall Study|Lack of Efficacy|2|||
155624032|NCT00447902|561715978|FG001|Overall Study|Lack of Efficacy|1|||
155624033|NCT01496976|561717729|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
155624034|NCT04579380|561717730|FG000|Overall Study|Death|9|||
155624035|NCT04579380|561717731|FG001|Overall Study|Death|22|||
155624036|NCT04579380|561717732|FG002|Overall Study|Death|22|||
155624037|NCT04579380|561717733|FG003|Overall Study|Death|17|||
155624038|NCT04579380|561717734|FG004|Overall Study|Death|6|||
155624039|NCT04579380|561717735|FG005|Overall Study|Death|21|||
155624040|NCT04579380|561717736|FG006|Overall Study|Death|10|||
155624041|NCT04579380|561717737|FG007|Overall Study|Death|11|||
155624042|NCT04579380|561717738|FG008|Overall Study|Death|25|||
155624043|NCT04579380|561717730|FG000|Overall Study|Withdrawal by Subject|0|||
155624044|NCT04579380|561717731|FG001|Overall Study|Withdrawal by Subject|3|||
155624045|NCT04579380|561717732|FG002|Overall Study|Withdrawal by Subject|4|||
155624046|NCT04579380|561717733|FG003|Overall Study|Withdrawal by Subject|0|||
155727198|NCT00554216|562101956|FG001|Overall Study|Restricted med|1|||
155624047|NCT04579380|561717734|FG004|Overall Study|Withdrawal by Subject|1|||
155624048|NCT04579380|561717735|FG005|Overall Study|Withdrawal by Subject|2|||
155624049|NCT04579380|561717736|FG006|Overall Study|Withdrawal by Subject|0|||
155624050|NCT04579380|561717737|FG007|Overall Study|Withdrawal by Subject|1|||
155624051|NCT04579380|561717738|FG008|Overall Study|Withdrawal by Subject|2|||
155624052|NCT04579380|561717730|FG000|Overall Study|Ongoing|2|||
155624053|NCT04579380|561717731|FG001|Overall Study|Ongoing|6|||
155624054|NCT04579380|561717732|FG002|Overall Study|Ongoing|4|||
155624055|NCT04579380|561717733|FG003|Overall Study|Ongoing|8|||
155382127|NCT01535560|560833283|FG000|Overall Study|Adverse Event|12|||
155382128|NCT01535560|560833284|FG001|Overall Study|Adverse Event|7|||
155624056|NCT04579380|561717734|FG004|Overall Study|Ongoing|5|||
155624057|NCT04579380|561717735|FG005|Overall Study|Ongoing|8|||
155624058|NCT04579380|561717736|FG006|Overall Study|Ongoing|3|||
155277925|NCT00738530|560451051|FG001|Overall Study|Withdrawal by Subject|8|||
155277926|NCT04179461|560451052|FG000|Overall Study|Lost to Follow-up|4|||
155277927|NCT03785340|560451053|FG000|Overall Study|Lost to Follow-up|2|||
155277928|NCT03785340|560451054|FG001|Overall Study|Lost to Follow-up|0|||
155277929|NCT03785340|560451053|FG000|Overall Study|Adverse Event|1|||
155277930|NCT03785340|560451054|FG001|Overall Study|Adverse Event|0|||
155277931|NCT01848834|560451055|FG000|Overall Study|Adverse Event|3|||
155277932|NCT01848834|560451056|FG001|Overall Study|Adverse Event|11|||
155277933|NCT01848834|560451057|FG002|Overall Study|Adverse Event|3|||
155277934|NCT01848834|560451058|FG003|Overall Study|Adverse Event|5|||
155277935|NCT01848834|560451059|FG004|Overall Study|Adverse Event|9|||
155624059|NCT04579380|561717737|FG007|Overall Study|Ongoing|19|||
155624060|NCT04579380|561717738|FG008|Overall Study|Ongoing|6|||
155624061|NCT06088784|561717740|FG000|Overall Study|Adverse Event|0|||
155624062|NCT06088784|561717741|FG001|Overall Study|Adverse Event|0|||
155624063|NCT06088784|561717742|FG002|Overall Study|Adverse Event|0|||
155624064|NCT06088784|561717743|FG003|Overall Study|Adverse Event|0|||
155277936|NCT01848834|560451055|FG000|Overall Study|Death|2|||
155277937|NCT01848834|560451056|FG001|Overall Study|Death|11|||
155277938|NCT01848834|560451057|FG002|Overall Study|Death|1|||
155277939|NCT01848834|560451058|FG003|Overall Study|Death|8|||
155277940|NCT01848834|560451059|FG004|Overall Study|Death|27|||
155277941|NCT01848834|560451055|FG000|Overall Study|Excluded Medication|5|||
155277942|NCT01848834|560451056|FG001|Overall Study|Excluded Medication|4|||
155277943|NCT01848834|560451057|FG002|Overall Study|Excluded Medication|3|||
155277944|NCT01848834|560451058|FG003|Overall Study|Excluded Medication|6|||
155277945|NCT01848834|560451059|FG004|Overall Study|Excluded Medication|6|||
155277946|NCT01848834|560451055|FG000|Overall Study|Lost to Follow-up|5|||
155277947|NCT01848834|560451056|FG001|Overall Study|Lost to Follow-up|5|||
155277948|NCT01848834|560451057|FG002|Overall Study|Lost to Follow-up|3|||
155277949|NCT01848834|560451058|FG003|Overall Study|Lost to Follow-up|0|||
155277950|NCT01848834|560451059|FG004|Overall Study|Lost to Follow-up|3|||
155277951|NCT01848834|560451055|FG000|Overall Study|Physician Decision|1|||
155277952|NCT01848834|560451056|FG001|Overall Study|Physician Decision|3|||
155277953|NCT01848834|560451057|FG002|Overall Study|Physician Decision|4|||
155277954|NCT01848834|560451058|FG003|Overall Study|Physician Decision|0|||
155277955|NCT01848834|560451059|FG004|Overall Study|Physician Decision|11|||
155277956|NCT01848834|560451055|FG000|Overall Study|Protocol Violation|0|||
155277957|NCT01848834|560451056|FG001|Overall Study|Protocol Violation|0|||
155277958|NCT01848834|560451057|FG002|Overall Study|Protocol Violation|0|||
155277959|NCT01848834|560451058|FG003|Overall Study|Protocol Violation|0|||
155277960|NCT01848834|560451059|FG004|Overall Study|Protocol Violation|1|||
155277961|NCT01848834|560451055|FG000|Overall Study|Sponsor Decision|1|||
155277962|NCT01848834|560451056|FG001|Overall Study|Sponsor Decision|1|||
155277963|NCT01848834|560451057|FG002|Overall Study|Sponsor Decision|0|||
155277964|NCT01848834|560451058|FG003|Overall Study|Sponsor Decision|1|||
155277965|NCT01848834|560451059|FG004|Overall Study|Sponsor Decision|1|||
155277966|NCT01848834|560451055|FG000|Overall Study|Withdrawal by Subject|2|||
155277967|NCT01848834|560451056|FG001|Overall Study|Withdrawal by Subject|13|||
155277968|NCT01848834|560451057|FG002|Overall Study|Withdrawal by Subject|10|||
155277969|NCT01848834|560451058|FG003|Overall Study|Withdrawal by Subject|6|||
155277970|NCT01848834|560451059|FG004|Overall Study|Withdrawal by Subject|36|||
155277971|NCT01513967|560451074|FG000|Overall Study|Pregnancy|0|||
155277972|NCT01513967|560451075|FG001|Overall Study|Pregnancy|0|||
155277973|NCT01513967|560451076|FG002|Overall Study|Pregnancy|0|||
155624065|NCT06088784|561717744|FG004|Overall Study|Adverse Event|0|||
155624066|NCT06088784|561717745|FG005|Overall Study|Adverse Event|0|||
155624067|NCT06088784|561717746|FG006|Overall Study|Adverse Event|3|||
155624068|NCT06088784|561717747|FG007|Overall Study|Adverse Event|0|||
155624069|NCT06088784|561717748|FG008|Overall Study|Adverse Event|0|||
155624070|NCT06088784|561717749|FG009|Overall Study|Adverse Event|0|||
155624071|NCT06088784|561717750|FG010|Overall Study|Adverse Event|0|||
155624072|NCT06088784|561717751|FG011|Overall Study|Adverse Event|0|||
155624073|NCT06088784|561717740|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155277974|NCT01513967|560451077|FG003|Overall Study|Pregnancy|0|||
155277975|NCT01513967|560451078|FG004|Overall Study|Pregnancy|0|||
155277976|NCT01513967|560451079|FG005|Overall Study|Pregnancy|0|||
155277977|NCT01513967|560451080|FG006|Overall Study|Pregnancy|1|||
155277978|NCT01513967|560451081|FG007|Overall Study|Pregnancy|0|||
155277979|NCT01513967|560451074|FG000|Overall Study|missed a study visit|0|||
155277980|NCT01513967|560451075|FG001|Overall Study|missed a study visit|0|||
155624074|NCT06088784|561717741|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624075|NCT06088784|561717742|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155277981|NCT01513967|560451076|FG002|Overall Study|missed a study visit|0|||
155277982|NCT01513967|560451077|FG003|Overall Study|missed a study visit|0|||
155277983|NCT01513967|560451078|FG004|Overall Study|missed a study visit|0|||
155277984|NCT01513967|560451079|FG005|Overall Study|missed a study visit|0|||
155277985|NCT01513967|560451080|FG006|Overall Study|missed a study visit|1|||
155277986|NCT01513967|560451081|FG007|Overall Study|missed a study visit|0|||
155277987|NCT01513967|560451074|FG000|Overall Study|excluded due to positive drug screen|0|||
155727199|NCT00554216|562101957|FG002|Overall Study|Restricted med|1|||
155624076|NCT06088784|561717743|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624077|NCT06088784|561717744|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624078|NCT06088784|561717745|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624079|NCT06088784|561717746|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
155624080|NCT06088784|561717747|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624081|NCT06088784|561717748|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624082|NCT06088784|561717749|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624083|NCT06088784|561717750|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624084|NCT06088784|561717751|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155624085|NCT05556616|561717752|FG000|Overall Study|Withdrawal by Subject|1|||
155624086|NCT05556616|561717753|FG001|Overall Study|Withdrawal by Subject|0|||
155624087|NCT05556616|561717754|FG002|Overall Study|Withdrawal by Subject|0|||
155624088|NCT05556616|561717755|FG003|Overall Study|Withdrawal by Subject|0|||
155624089|NCT05556616|561717756|FG004|Overall Study|Withdrawal by Subject|0|||
155624090|NCT05556616|561717757|FG005|Overall Study|Withdrawal by Subject|0|||
155624091|NCT05556616|561717758|FG006|Overall Study|Withdrawal by Subject|0|||
155624092|NCT05556616|561717752|FG000|Overall Study|Death|0|||
155624093|NCT05556616|561717753|FG001|Overall Study|Death|0|||
155624094|NCT05556616|561717754|FG002|Overall Study|Death|2|||
155382129|NCT01535560|560833283|FG000|Overall Study|Lost to Follow-up|1|||
155382130|NCT01535560|560833284|FG001|Overall Study|Lost to Follow-up|3|||
155382131|NCT01535560|560833283|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
155382132|NCT01535560|560833284|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
155382133|NCT01535560|560833283|FG000|Overall Study|Treatment Failure|21|||
155382134|NCT01535560|560833284|FG001|Overall Study|Treatment Failure|83|||
155382135|NCT01535560|560833283|FG000|Overall Study|Other|0|||
155624095|NCT05556616|561717755|FG003|Overall Study|Death|1|||
155624096|NCT05556616|561717756|FG004|Overall Study|Death|0|||
155382136|NCT01535560|560833284|FG001|Overall Study|Other|1|||
155624097|NCT05556616|561717757|FG005|Overall Study|Death|0|||
155624098|NCT05556616|561717758|FG006|Overall Study|Death|0|||
155624099|NCT05556616|561717752|FG000|Overall Study|Study Terminated by Sponsor|0|||
155624100|NCT05556616|561717753|FG001|Overall Study|Study Terminated by Sponsor|3|||
155382137|NCT01535560|560833283|FG000|Overall Study|Randomized in Error|0|||
155382138|NCT01535560|560833284|FG001|Overall Study|Randomized in Error|1|||
155624101|NCT05556616|561717754|FG002|Overall Study|Study Terminated by Sponsor|0|||
155624102|NCT05556616|561717755|FG003|Overall Study|Study Terminated by Sponsor|0|||
155624103|NCT05556616|561717756|FG004|Overall Study|Study Terminated by Sponsor|0|||
155624104|NCT05556616|561717757|FG005|Overall Study|Study Terminated by Sponsor|0|||
155624105|NCT05556616|561717758|FG006|Overall Study|Study Terminated by Sponsor|0|||
155624106|NCT05428436|561717759|FG000|Period 1 - 2 washout|Adverse Event|1|||
155624107|NCT05428436|561717760|FG001|Period 1 - 2 washout|Adverse Event|0|||
155624108|NCT05428436|561717761|FG002|Period 1 - 2 washout|Adverse Event|0|||
155382139|NCT02009761|560833285|FG000|Overall Study|Adverse Event|4|||
155382140|NCT02842827|560833288|FG000|Overall Study|Adverse Event|0|||
155382141|NCT02842827|560833289|FG001|Overall Study|Adverse Event|1|||
155382142|NCT02842827|560833290|FG002|Overall Study|Adverse Event|0|||
155382143|NCT02842827|560833291|FG003|Overall Study|Adverse Event|1|||
155382144|NCT02842827|560833292|FG004|Overall Study|Adverse Event|0|||
155382145|NCT02842827|560833293|FG005|Overall Study|Adverse Event|1|||
155382146|NCT02842827|560833294|FG006|Overall Study|Adverse Event|0|||
155382147|NCT02842827|560833295|FG007|Overall Study|Adverse Event|0|||
155382148|NCT02842827|560833288|FG000|Overall Study|Death|1|||
155382149|NCT02842827|560833289|FG001|Overall Study|Death|0|||
155382150|NCT02842827|560833290|FG002|Overall Study|Death|2|||
155382151|NCT02842827|560833291|FG003|Overall Study|Death|3|||
155382152|NCT02842827|560833292|FG004|Overall Study|Death|2|||
155382153|NCT02842827|560833293|FG005|Overall Study|Death|1|||
155624109|NCT00896493|561717762|FG000|Overall Study|Early disease relapse|3|||
155624110|NCT01868646|561717765|FG000|Overall Study|Do not meet inclusion criteria|3|||
155624111|NCT01868646|561717766|FG001|Overall Study|Do not meet inclusion criteria|5|||
155624112|NCT01831427|561717767|FG000|Overall Study|Adverse Event|0|||
155624113|NCT01831427|561717768|FG001|Overall Study|Adverse Event|1|||
155624114|NCT01831427|561717769|FG002|Overall Study|Adverse Event|0|||
155624115|NCT01831427|561717770|FG003|Overall Study|Adverse Event|0|||
155727200|NCT00554216|562101955|FG000|Overall Study|Other|12|||
155624116|NCT01831427|561717771|FG004|Overall Study|Adverse Event|0|||
155382154|NCT02842827|560833294|FG006|Overall Study|Death|0|||
155382155|NCT02842827|560833295|FG007|Overall Study|Death|4|||
155624117|NCT01831427|561717772|FG005|Overall Study|Adverse Event|1|||
155382156|NCT02842827|560833288|FG000|Overall Study|Physician Decision|1|||
155382157|NCT02842827|560833289|FG001|Overall Study|Physician Decision|3|||
155382158|NCT02842827|560833290|FG002|Overall Study|Physician Decision|0|||
155382159|NCT02842827|560833291|FG003|Overall Study|Physician Decision|0|||
155382160|NCT02842827|560833292|FG004|Overall Study|Physician Decision|1|||
155382161|NCT02842827|560833293|FG005|Overall Study|Physician Decision|4|||
155624118|NCT01831427|561717773|FG006|Overall Study|Adverse Event|0|||
155624119|NCT01831427|561717774|FG007|Overall Study|Adverse Event|1|||
155624120|NCT01831427|561717775|FG008|Overall Study|Adverse Event|0|||
155382162|NCT02842827|560833294|FG006|Overall Study|Physician Decision|2|||
155382163|NCT02842827|560833295|FG007|Overall Study|Physician Decision|1|||
155382164|NCT02842827|560833288|FG000|Overall Study|Protocol Defined Disease Progression|0|||
155382165|NCT02842827|560833289|FG001|Overall Study|Protocol Defined Disease Progression|0|||
155382166|NCT02842827|560833290|FG002|Overall Study|Protocol Defined Disease Progression|0|||
155382167|NCT02842827|560833291|FG003|Overall Study|Protocol Defined Disease Progression|0|||
155382168|NCT02842827|560833292|FG004|Overall Study|Protocol Defined Disease Progression|0|||
155382169|NCT02842827|560833293|FG005|Overall Study|Protocol Defined Disease Progression|1|||
155382170|NCT02842827|560833294|FG006|Overall Study|Protocol Defined Disease Progression|0|||
155382171|NCT02842827|560833295|FG007|Overall Study|Protocol Defined Disease Progression|0|||
155382172|NCT02842827|560833288|FG000|Overall Study|Participant Withdrawal of Consent|1|||
155382173|NCT02842827|560833289|FG001|Overall Study|Participant Withdrawal of Consent|2|||
155382174|NCT02842827|560833290|FG002|Overall Study|Participant Withdrawal of Consent|2|||
155382175|NCT02842827|560833291|FG003|Overall Study|Participant Withdrawal of Consent|2|||
155382176|NCT02842827|560833292|FG004|Overall Study|Participant Withdrawal of Consent|2|||
155382177|NCT02842827|560833293|FG005|Overall Study|Participant Withdrawal of Consent|1|||
155382178|NCT02842827|560833294|FG006|Overall Study|Participant Withdrawal of Consent|2|||
155382179|NCT02842827|560833295|FG007|Overall Study|Participant Withdrawal of Consent|1|||
155382180|NCT00825825|560833296|FG000|First Medication Period (14 Days)|Adverse Event|1|||
155382181|NCT00825825|560833297|FG001|First Medication Period (14 Days)|Adverse Event|0|||
155382182|NCT00825825|560833298|FG002|First Medication Period (14 Days)|Adverse Event|0|||
155382183|NCT00825825|560833299|FG003|First Medication Period (14 Days)|Adverse Event|0|||
155382184|NCT00825825|560833300|FG004|First Medication Period (14 Days)|Adverse Event|0|||
155382185|NCT00825825|560833301|FG005|First Medication Period (14 Days)|Adverse Event|1|||
155382186|NCT00825825|560833296|FG000|First Medication Period (14 Days)|Physician Decision|2|||
155382187|NCT00825825|560833297|FG001|First Medication Period (14 Days)|Physician Decision|0|||
155382188|NCT00825825|560833298|FG002|First Medication Period (14 Days)|Physician Decision|1|||
155382189|NCT00825825|560833299|FG003|First Medication Period (14 Days)|Physician Decision|0|||
155382190|NCT00825825|560833300|FG004|First Medication Period (14 Days)|Physician Decision|0|||
155382191|NCT00825825|560833301|FG005|First Medication Period (14 Days)|Physician Decision|1|||
155382192|NCT00825825|560833296|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
155382193|NCT00825825|560833297|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
155382194|NCT00825825|560833298|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
155382195|NCT00825825|560833299|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
155382196|NCT00825825|560833300|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
155382197|NCT00825825|560833301|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
155382198|NCT00825825|560833296|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
155382199|NCT00825825|560833297|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
155382200|NCT00825825|560833298|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
155382201|NCT00825825|560833299|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
155382202|NCT00825825|560833300|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
155727201|NCT00554216|562101956|FG001|Overall Study|Other|7|||
155727202|NCT00554216|562101957|FG002|Overall Study|Other|10|||
155727203|NCT00554216|562101955|FG000|Overall Study|Lack of Efficacy|15|||
155727204|NCT00554216|562101956|FG001|Overall Study|Lack of Efficacy|3|||
155727205|NCT00554216|562101957|FG002|Overall Study|Lack of Efficacy|0|||
155727206|NCT01712399|562101977|FG000|Overall Study|Lost to Follow-up|1|||
155727207|NCT01712399|562101977|FG000|Overall Study|Withdrawal by Subject|39|||
155727208|NCT01712399|562101977|FG000|Overall Study|Death|1|||
155727209|NCT01712399|562101977|FG000|Overall Study|Adverse Event|11|||
155727210|NCT01712399|562101977|FG000|Overall Study|Study closure|345|||
155727211|NCT01357850|562101978|FG000|Overall Study|Lost to Follow-up|1|||
155382203|NCT00825825|560833301|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
155382204|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
155624121|NCT01831427|561717776|FG009|Overall Study|Adverse Event|0|||
155624122|NCT01831427|561717777|FG010|Overall Study|Adverse Event|2|||
155624123|NCT01831427|561717767|FG000|Overall Study|Investigator's Discretion|0|||
155624124|NCT01831427|561717768|FG001|Overall Study|Investigator's Discretion|0|||
155624125|NCT01831427|561717769|FG002|Overall Study|Investigator's Discretion|0|||
155624126|NCT01831427|561717770|FG003|Overall Study|Investigator's Discretion|1|||
155624127|NCT01831427|561717771|FG004|Overall Study|Investigator's Discretion|0|||
155624128|NCT01831427|561717772|FG005|Overall Study|Investigator's Discretion|0|||
155624129|NCT01831427|561717773|FG006|Overall Study|Investigator's Discretion|0|||
155624130|NCT01831427|561717774|FG007|Overall Study|Investigator's Discretion|0|||
155624131|NCT01831427|561717775|FG008|Overall Study|Investigator's Discretion|0|||
155382205|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
155624132|NCT01831427|561717776|FG009|Overall Study|Investigator's Discretion|0|||
155382206|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
155382207|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
155382208|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
155727212|NCT01357850|562101979|FG001|Overall Study|Lost to Follow-up|0|||
155624133|NCT01831427|561717777|FG010|Overall Study|Investigator's Discretion|0|||
155624134|NCT01831427|561717767|FG000|Overall Study|Withdrew Consent|0|||
155624135|NCT01831427|561717768|FG001|Overall Study|Withdrew Consent|0|||
155624136|NCT01831427|561717769|FG002|Overall Study|Withdrew Consent|0|||
155624137|NCT01831427|561717770|FG003|Overall Study|Withdrew Consent|0|||
155624138|NCT01831427|561717771|FG004|Overall Study|Withdrew Consent|0|||
155624139|NCT01831427|561717772|FG005|Overall Study|Withdrew Consent|0|||
155624140|NCT01831427|561717773|FG006|Overall Study|Withdrew Consent|2|||
155624141|NCT01831427|561717774|FG007|Overall Study|Withdrew Consent|0|||
155624142|NCT01831427|561717775|FG008|Overall Study|Withdrew Consent|0|||
155624143|NCT01831427|561717776|FG009|Overall Study|Withdrew Consent|1|||
155624144|NCT01831427|561717777|FG010|Overall Study|Withdrew Consent|1|||
155624145|NCT01171898|561717778|FG000|Overall Study|Death|0|||
155624146|NCT01171898|561717779|FG001|Overall Study|Death|0|||
155624147|NCT01171898|561717780|FG002|Overall Study|Death|2|||
155624148|NCT01171898|561717781|FG003|Overall Study|Death|0|||
155624149|NCT01171898|561717778|FG000|Overall Study|Lost to Follow-up|0|||
155624150|NCT01171898|561717779|FG001|Overall Study|Lost to Follow-up|1|||
155624151|NCT01171898|561717780|FG002|Overall Study|Lost to Follow-up|1|||
155624152|NCT01171898|561717781|FG003|Overall Study|Lost to Follow-up|1|||
155624153|NCT01171898|561717778|FG000|Overall Study|Withdrawal by Subject|1|||
155624154|NCT01171898|561717779|FG001|Overall Study|Withdrawal by Subject|4|||
155624155|NCT01171898|561717780|FG002|Overall Study|Withdrawal by Subject|6|||
155624156|NCT01171898|561717781|FG003|Overall Study|Withdrawal by Subject|3|||
155277988|NCT01513967|560451075|FG001|Overall Study|excluded due to positive drug screen|0|||
155277989|NCT01513967|560451076|FG002|Overall Study|excluded due to positive drug screen|0|||
155277990|NCT01513967|560451077|FG003|Overall Study|excluded due to positive drug screen|0|||
155277991|NCT01513967|560451078|FG004|Overall Study|excluded due to positive drug screen|0|||
155277992|NCT01513967|560451079|FG005|Overall Study|excluded due to positive drug screen|0|||
155277993|NCT01513967|560451080|FG006|Overall Study|excluded due to positive drug screen|0|||
155277994|NCT01513967|560451081|FG007|Overall Study|excluded due to positive drug screen|2|||
155624157|NCT01171898|561717778|FG000|Overall Study|Terminated by Sponsor|1|||
155624158|NCT01171898|561717779|FG001|Overall Study|Terminated by Sponsor|0|||
155624159|NCT01171898|561717780|FG002|Overall Study|Terminated by Sponsor|0|||
155624160|NCT01171898|561717781|FG003|Overall Study|Terminated by Sponsor|0|||
155624161|NCT01171898|561717778|FG000|Overall Study|Ongoing|1|||
155624162|NCT01171898|561717779|FG001|Overall Study|Ongoing|9|||
155624163|NCT01171898|561717780|FG002|Overall Study|Ongoing|3|||
155624164|NCT01171898|561717781|FG003|Overall Study|Ongoing|0|||
155624165|NCT01171898|561717778|FG000|Overall Study|Other|1|||
155624166|NCT01171898|561717779|FG001|Overall Study|Other|5|||
155624167|NCT01171898|561717780|FG002|Overall Study|Other|0|||
155624168|NCT01171898|561717781|FG003|Overall Study|Other|2|||
155624169|NCT03191799|561717782|FG000|Overall Study|Withdrawal by Subject|4|||
155624170|NCT03191799|561717782|FG000|Overall Study|Physician Decision|2|||
155277995|NCT01513967|560451074|FG000|Overall Study|Physician Decision|0|||
155277996|NCT01513967|560451075|FG001|Overall Study|Physician Decision|0|||
155624171|NCT03191799|561717782|FG000|Overall Study|Lost to Follow-up|1|||
155624172|NCT03191799|561717782|FG000|Overall Study|Death|2|||
155277997|NCT01513967|560451076|FG002|Overall Study|Physician Decision|0|||
155277998|NCT01513967|560451077|FG003|Overall Study|Physician Decision|0|||
155277999|NCT01513967|560451078|FG004|Overall Study|Physician Decision|0|||
155382209|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
155624173|NCT00902577|561717785|FG000|Overall Study|Withdrawal by Subject|6|||
155624174|NCT00902577|561717785|FG000|Overall Study|FMISO production failure|2|||
155624175|NCT01319565|561717786|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
155624176|NCT01319565|561717787|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
155624177|NCT01319565|561717788|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
155624178|NCT05953363|561717789|FG000|Overall Study|Screen Failure|2|||
155624179|NCT05953363|561717789|FG000|Overall Study|Withdrawal by Subject|3|||
155624180|NCT05953363|561717789|FG000|Overall Study|Surgery cancelled|2|||
155624181|NCT05953363|561717789|FG000|Overall Study|Adverse Event|1|||
155624182|NCT05696392|561717791|FG000|Overall Study|Lost to Follow-up|3|||
155624183|NCT05696392|561717791|FG000|Overall Study|Protocol Violation|1|||
155624184|NCT05696392|561717791|FG000|Overall Study|Withdrawal by Subject|1|||
155624185|NCT03904693|561717792|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155624186|NCT03904693|561717793|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155382210|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
155624187|NCT03904693|561717794|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
155624188|NCT03904693|561717795|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155624189|NCT03904693|561717796|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155624190|NCT03904693|561717797|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155624191|NCT03904693|561717792|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155624192|NCT03904693|561717793|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155624193|NCT03904693|561717794|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
155624194|NCT03904693|561717795|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155624195|NCT03904693|561717796|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155624196|NCT03904693|561717797|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155624197|NCT03904693|561717792|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155624198|NCT03904693|561717793|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
155624199|NCT03904693|561717794|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
155624200|NCT03904693|561717795|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155624201|NCT03904693|561717796|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155727213|NCT01357850|562101980|FG002|Overall Study|Lost to Follow-up|0|||
155727214|NCT01357850|562101981|FG003|Overall Study|Lost to Follow-up|0|||
155727215|NCT04610281|562101982|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
155727216|NCT04610281|562101983|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
155727217|NCT01803607|562101985|FG000|Overall Study|Adverse Event|5|||
155727218|NCT01803607|562101986|FG001|Overall Study|Adverse Event|3|||
155727219|NCT01803607|562101985|FG000|Overall Study|Lack of Efficacy|0|||
155727220|NCT01803607|562101986|FG001|Overall Study|Lack of Efficacy|1|||
155727221|NCT01803607|562101985|FG000|Overall Study|Protocol Violation|3|||
155624202|NCT03904693|561717797|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155624203|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155624204|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155624205|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155624206|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
155624207|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
155624208|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
155624209|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
155624210|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
155624211|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
155624212|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
155624213|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
155624214|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
155624215|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155624216|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155624217|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155624218|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
155624219|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155624220|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155624221|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155624222|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155624223|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155624224|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
155624225|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155624226|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155624227|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155624228|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155624229|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155624230|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155624231|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155624232|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
155624233|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155624234|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155624235|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155624236|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155727222|NCT01803607|562101986|FG001|Overall Study|Protocol Violation|2|||
155727223|NCT01803607|562101985|FG000|Overall Study|Study terminated by sponsor|54|||
155727224|NCT01803607|562101986|FG001|Overall Study|Study terminated by sponsor|56|||
155727225|NCT01803607|562101985|FG000|Overall Study|Withdrawal by Subject|6|||
155727226|NCT01803607|562101986|FG001|Overall Study|Withdrawal by Subject|5|||
155727227|NCT02266888|562101993|FG000|Overall Study|Death|2|||
155727228|NCT02266888|562101994|FG001|Overall Study|Death|2|||
155727229|NCT02266888|562101995|FG002|Overall Study|Death|4|||
155727230|NCT02266888|562101996|FG003|Overall Study|Death|2|||
155727231|NCT02266888|562101993|FG000|Overall Study|Physician Decision|0|||
155727232|NCT02266888|562101994|FG001|Overall Study|Physician Decision|1|||
155727233|NCT02266888|562101995|FG002|Overall Study|Physician Decision|2|||
155727234|NCT02266888|562101996|FG003|Overall Study|Physician Decision|2|||
155727235|NCT02266888|562101993|FG000|Overall Study|Study Terminated|5|||
155727236|NCT02266888|562101994|FG001|Overall Study|Study Terminated|1|||
155727237|NCT02266888|562101995|FG002|Overall Study|Study Terminated|0|||
155727238|NCT02266888|562101996|FG003|Overall Study|Study Terminated|0|||
155727239|NCT02266888|562101993|FG000|Overall Study|No Longer Eligible|0|||
155727240|NCT02266888|562101994|FG001|Overall Study|No Longer Eligible|0|||
155727241|NCT02266888|562101995|FG002|Overall Study|No Longer Eligible|0|||
155727242|NCT02266888|562101996|FG003|Overall Study|No Longer Eligible|2|||
155727243|NCT02266888|562101993|FG000|Overall Study|Randomization Closed|0|||
155727244|NCT02266888|562101994|FG001|Overall Study|Randomization Closed|0|||
155727245|NCT02266888|562101995|FG002|Overall Study|Randomization Closed|4|||
155727246|NCT02266888|562101996|FG003|Overall Study|Randomization Closed|0|||
155727247|NCT02266888|562101993|FG000|Overall Study|Personnel unavailable at transplant|0|||
155727248|NCT02266888|562101994|FG001|Overall Study|Personnel unavailable at transplant|0|||
155727249|NCT02266888|562101995|FG002|Overall Study|Personnel unavailable at transplant|0|||
155727250|NCT02266888|562101996|FG003|Overall Study|Personnel unavailable at transplant|1|||
155727251|NCT02266888|562101993|FG000|Overall Study|Transfer of care|0|||
155727252|NCT02266888|562101994|FG001|Overall Study|Transfer of care|0|||
155727253|NCT02266888|562101995|FG002|Overall Study|Transfer of care|1|||
155278000|NCT01513967|560451079|FG005|Overall Study|Physician Decision|1|||
155278001|NCT01513967|560451080|FG006|Overall Study|Physician Decision|0|||
155278002|NCT01513967|560451081|FG007|Overall Study|Physician Decision|0|||
155624237|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
155624238|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155624239|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155624240|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155624241|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155624242|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155624243|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155624244|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
155624245|NCT03904693|561717792|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155624246|NCT03904693|561717793|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155624247|NCT03904693|561717794|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155624248|NCT03904693|561717795|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155624249|NCT03904693|561717796|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155624250|NCT03904693|561717797|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
155624251|NCT03180736|561717798|FG000|Overall Study|Adverse Event|3|||
155624252|NCT03180736|561717799|FG001|Overall Study|Adverse Event|4|||
155624253|NCT03180736|561717798|FG000|Overall Study|Death|10|||
155624254|NCT03180736|561717799|FG001|Overall Study|Death|7|||
155624255|NCT03180736|561717798|FG000|Overall Study|Withdrawal by Subject|5|||
155624256|NCT03180736|561717799|FG001|Overall Study|Withdrawal by Subject|12|||
155624257|NCT03180736|561717798|FG000|Overall Study|Lost to Follow-up|1|||
155624258|NCT03180736|561717799|FG001|Overall Study|Lost to Follow-up|0|||
155624259|NCT03180736|561717798|FG000|Overall Study|Lack of Efficacy|66|||
155624260|NCT03180736|561717799|FG001|Overall Study|Lack of Efficacy|87|||
155624261|NCT03180736|561717798|FG000|Overall Study|Physician Decision|4|||
155624262|NCT03180736|561717799|FG001|Overall Study|Physician Decision|7|||
155624263|NCT03180736|561717798|FG000|Overall Study|randomized but not treated|2|||
155624264|NCT03180736|561717799|FG001|Overall Study|randomized but not treated|3|||
155624265|NCT03258593|561717800|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
155624266|NCT03258593|561717801|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
155624267|NCT03258593|561717802|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
155624268|NCT03258593|561717803|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
155624269|NCT03258593|561717800|FG000|Run-In Maintenance Phase|Disease progression|3|||
155624270|NCT03258593|561717801|FG001|Run-In Maintenance Phase|Disease progression|0|||
155624271|NCT03258593|561717802|FG002|Run-In Maintenance Phase|Disease progression|0|||
155624272|NCT03258593|561717803|FG003|Run-In Maintenance Phase|Disease progression|0|||
155624273|NCT03258593|561717800|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155624274|NCT03258593|561717801|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
155624275|NCT03258593|561717802|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155624276|NCT03258593|561717803|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155624277|NCT03258593|561717800|FG000|Expansion Maintenance Phase|Physician Decision|0|||
155624278|NCT03258593|561717801|FG001|Expansion Maintenance Phase|Physician Decision|1|||
155624279|NCT03258593|561717802|FG002|Expansion Maintenance Phase|Physician Decision|0|||
155624280|NCT03258593|561717803|FG003|Expansion Maintenance Phase|Physician Decision|0|||
155624281|NCT05457257|561717808|FG000|Overall Study|Withdrawal by Subject|0|||
155624282|NCT05457257|561717809|FG001|Overall Study|Withdrawal by Subject|2|||
155624283|NCT05457257|561717808|FG000|Overall Study|Death|10|||
155624284|NCT05457257|561717809|FG001|Overall Study|Death|3|||
155624285|NCT05457257|561717808|FG000|Overall Study|Ongoing|19|||
155624286|NCT05457257|561717809|FG001|Overall Study|Ongoing|9|||
155727254|NCT02266888|562101996|FG003|Overall Study|Transfer of care|0|||
155727255|NCT02351856|562102000|FG000|Overall Study|Adverse Event|2|||
155727256|NCT02351856|562102000|FG000|Overall Study|Physician Decision|5|||
155278003|NCT02906202|560451082|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
155624287|NCT04464707|561717810|FG000|Overall Study|Adverse Event|1|||
155624288|NCT04464707|561717811|FG001|Overall Study|Adverse Event|0|||
155624289|NCT04464707|561717812|FG002|Overall Study|Adverse Event|0|||
155624290|NCT04464707|561717810|FG000|Overall Study|Withdrawal by Subject|0|||
155624291|NCT04464707|561717811|FG001|Overall Study|Withdrawal by Subject|0|||
155624292|NCT04464707|561717812|FG002|Overall Study|Withdrawal by Subject|2|||
155624293|NCT04464707|561717810|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155624294|NCT04464707|561717811|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155624295|NCT04464707|561717812|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155624296|NCT04464707|561717810|FG000|Overall Study|Protocol Deviation|1|||
155624297|NCT04464707|561717811|FG001|Overall Study|Protocol Deviation|0|||
155278004|NCT01987830|560451083|FG000|Overall Study|Never received baseline scan|1|||
155278005|NCT01563978|560451086|FG000|Overall Study|Physician Decision|1|||
155278006|NCT01563978|560451087|FG001|Overall Study|Physician Decision|0|||
155278007|NCT01563978|560451086|FG000|Overall Study|Lost to Follow-up|1|||
155278008|NCT01563978|560451087|FG001|Overall Study|Lost to Follow-up|0|||
155278009|NCT01563978|560451086|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
155278010|NCT01563978|560451087|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
155278011|NCT01563978|560451086|FG000|Overall Study|Adverse Event|1|||
155278012|NCT01563978|560451087|FG001|Overall Study|Adverse Event|2|||
155278013|NCT05764239|560451088|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
155278014|NCT05764239|560451088|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
155278015|NCT05764239|560451088|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
155278016|NCT05764239|560451088|FG000|DEP (Part 1)|Adverse Event|1|||
155278017|NCT05764239|560451088|FG000|DEP (Part 1)|Lost to Follow-up|1|||
155278018|NCT05764239|560451088|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
155278019|NCT05764239|560451088|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
155278020|NCT05764239|560451088|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
155278021|NCT05764239|560451088|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
155278022|NCT00057811|560451090|FG000|Overall Study|Lack of Efficacy|1|||
155278023|NCT00057811|560451091|FG001|Overall Study|Lack of Efficacy|4|||
155278024|NCT00057811|560451090|FG000|Overall Study|Physician Decision|1|||
155278025|NCT00057811|560451091|FG001|Overall Study|Physician Decision|0|||
155278026|NCT00057811|560451090|FG000|Overall Study|Withdrawal by Subject|3|||
155278027|NCT00057811|560451091|FG001|Overall Study|Withdrawal by Subject|4|||
155278028|NCT00057811|560451090|FG000|Overall Study|Ineligible|4|||
155278029|NCT00057811|560451091|FG001|Overall Study|Ineligible|2|||
155278030|NCT00057811|560451090|FG000|Overall Study|Inevaluable|1|||
155278031|NCT00057811|560451091|FG001|Overall Study|Inevaluable|2|||
155278032|NCT00556374|560451092|FG000|Overall Study|Withdrawal by Subject|235|||
155278033|NCT00556374|560451093|FG001|Overall Study|Withdrawal by Subject|205|||
155278034|NCT00556374|560451092|FG000|Overall Study|Death|158|||
155278035|NCT00556374|560451093|FG001|Overall Study|Death|127|||
155278036|NCT00556374|560451092|FG000|Overall Study|Lost to Follow-up|24|||
155278037|NCT00556374|560451093|FG001|Overall Study|Lost to Follow-up|17|||
155278038|NCT00556374|560451092|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
155278039|NCT00556374|560451093|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
155278040|NCT04131907|560451094|FG000|Overall Study|Adverse Event|2|||
155278041|NCT04131907|560451095|FG001|Overall Study|Adverse Event|0|||
155278042|NCT04131907|560451096|FG002|Overall Study|Adverse Event|0|||
155278043|NCT04131907|560451094|FG000|Overall Study|Physician Decision|4|||
155278044|NCT04131907|560451095|FG001|Overall Study|Physician Decision|22|||
155278045|NCT04131907|560451096|FG002|Overall Study|Physician Decision|0|||
155278046|NCT04131907|560451094|FG000|Overall Study|Withdrawal by Subject|2|||
155278047|NCT04131907|560451095|FG001|Overall Study|Withdrawal by Subject|0|||
155278048|NCT04131907|560451096|FG002|Overall Study|Withdrawal by Subject|1|||
155278049|NCT04131907|560451094|FG000|Overall Study|Treatment failure|2|||
155278050|NCT04131907|560451095|FG001|Overall Study|Treatment failure|0|||
155727257|NCT02351856|562102000|FG000|Overall Study|Study terminated by sponsor|1|||
155727258|NCT01458392|562102007|FG000|Overall Study|Death|2|||
155624298|NCT04464707|561717812|FG002|Overall Study|Protocol Deviation|0|||
155624299|NCT04464707|561717810|FG000|Overall Study|Lost to Follow-up|2|||
155624300|NCT04464707|561717811|FG001|Overall Study|Lost to Follow-up|0|||
155727259|NCT01458392|562102008|FG001|Overall Study|Death|11|||
155727260|NCT01458392|562102009|FG002|Overall Study|Death|22|||
155727261|NCT01458392|562102007|FG000|Overall Study|At the discretion of the sponsor|0|||
155624301|NCT04464707|561717812|FG002|Overall Study|Lost to Follow-up|1|||
155727262|NCT01458392|562102008|FG001|Overall Study|At the discretion of the sponsor|2|||
155727263|NCT01458392|562102009|FG002|Overall Study|At the discretion of the sponsor|7|||
155278051|NCT04131907|560451096|FG002|Overall Study|Treatment failure|1|||
155278052|NCT05294419|560451097|FG000|Overall Study|Protocol Violation|4|||
155278053|NCT05294419|560451098|FG001|Overall Study|Protocol Violation|0|||
155278054|NCT05294419|560451099|FG002|Overall Study|Protocol Violation|0|||
155278055|NCT05294419|560451097|FG000|Overall Study|Lost to Follow-up|6|||
155278056|NCT05294419|560451098|FG001|Overall Study|Lost to Follow-up|0|||
155278057|NCT05294419|560451099|FG002|Overall Study|Lost to Follow-up|0|||
155278058|NCT05294419|560451097|FG000|Overall Study|Results voided after publishing|2|||
155278059|NCT05294419|560451098|FG001|Overall Study|Results voided after publishing|0|||
155624302|NCT04831138|561717813|FG000|Overall Study|Lost to Follow-up|2|||
155624303|NCT04831138|561717814|FG001|Overall Study|Lost to Follow-up|0|||
155624304|NCT04344301|561717816|FG000|Overall Study|Withdrawal by Subject|1|||
155624305|NCT04344301|561717817|FG001|Overall Study|Withdrawal by Subject|0|||
155624306|NCT04344301|561717816|FG000|Overall Study|Death|0|||
155624307|NCT04344301|561717817|FG001|Overall Study|Death|1|||
155624308|NCT00072410|561717818|FG000|Overall Study|Progressive disease|0|||
155624309|NCT00072410|561717819|FG001|Overall Study|Progressive disease|3|||
155624310|NCT05590377|561717822|FG000|Overall Study|Death|1|||
155624311|NCT05590377|561717823|FG001|Overall Study|Death|1|||
155624312|NCT05590377|561717824|FG002|Overall Study|Death|2|||
155624313|NCT05590377|561717825|FG003|Overall Study|Death|0|||
155624314|NCT05590377|561717826|FG004|Overall Study|Death|0|||
155624315|NCT05590377|561717822|FG000|Overall Study|Study Terminated by Sponsor|1|||
155624316|NCT05590377|561717823|FG001|Overall Study|Study Terminated by Sponsor|5|||
155624317|NCT05590377|561717824|FG002|Overall Study|Study Terminated by Sponsor|4|||
155624318|NCT05590377|561717825|FG003|Overall Study|Study Terminated by Sponsor|0|||
155624319|NCT05590377|561717826|FG004|Overall Study|Study Terminated by Sponsor|0|||
155624320|NCT05590377|561717822|FG000|Overall Study|Withdrawal by Subject|1|||
155624321|NCT05590377|561717823|FG001|Overall Study|Withdrawal by Subject|0|||
155624322|NCT05590377|561717824|FG002|Overall Study|Withdrawal by Subject|0|||
155624323|NCT05590377|561717825|FG003|Overall Study|Withdrawal by Subject|0|||
155624324|NCT05590377|561717826|FG004|Overall Study|Withdrawal by Subject|0|||
155624325|NCT03389620|561717827|FG000|Overall Study|Lost to Follow-up|5|||
155624326|NCT03389620|561717828|FG001|Overall Study|Lost to Follow-up|1|||
155624327|NCT00549549|561717829|FG000|Overall Study|Adverse Event|5|||
155624328|NCT00549549|561717830|FG001|Overall Study|Adverse Event|3|||
155624329|NCT00549549|561717831|FG002|Overall Study|Adverse Event|1|||
155624330|NCT00549549|561717832|FG003|Overall Study|Adverse Event|9|||
155624331|NCT00549549|561717829|FG000|Overall Study|Lack of Efficacy|9|||
155624332|NCT00549549|561717830|FG001|Overall Study|Lack of Efficacy|6|||
155624333|NCT00549549|561717831|FG002|Overall Study|Lack of Efficacy|4|||
155624334|NCT00549549|561717832|FG003|Overall Study|Lack of Efficacy|2|||
155624335|NCT00549549|561717829|FG000|Overall Study|Lost to Follow-up|1|||
155624336|NCT00549549|561717830|FG001|Overall Study|Lost to Follow-up|0|||
155624337|NCT00549549|561717831|FG002|Overall Study|Lost to Follow-up|1|||
155624338|NCT00549549|561717832|FG003|Overall Study|Lost to Follow-up|2|||
155624339|NCT00549549|561717829|FG000|Overall Study|Withdrawal by Subject|0|||
155624340|NCT00549549|561717830|FG001|Overall Study|Withdrawal by Subject|4|||
155624341|NCT00549549|561717831|FG002|Overall Study|Withdrawal by Subject|1|||
155624342|NCT00549549|561717832|FG003|Overall Study|Withdrawal by Subject|0|||
155624343|NCT00549549|561717829|FG000|Overall Study|Other|9|||
155624344|NCT00549549|561717830|FG001|Overall Study|Other|9|||
155624345|NCT00549549|561717831|FG002|Overall Study|Other|9|||
155624346|NCT00549549|561717832|FG003|Overall Study|Other|11|||
155624347|NCT00549549|561717829|FG000|Overall Study|Randomized but not treated|0|||
155624348|NCT00549549|561717830|FG001|Overall Study|Randomized but not treated|0|||
155624349|NCT00549549|561717831|FG002|Overall Study|Randomized but not treated|1|||
155624350|NCT00549549|561717832|FG003|Overall Study|Randomized but not treated|1|||
155624351|NCT05852353|561717833|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
155624352|NCT05852353|561717833|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
155624353|NCT05852353|561717833|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
155624354|NCT05852353|561717833|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
155624355|NCT03509467|561717834|FG000|Overall Study|Withdrawal by Subject|5|||
155624356|NCT03509467|561717835|FG001|Overall Study|Withdrawal by Subject|1|||
155624357|NCT03509467|561717836|FG002|Overall Study|Withdrawal by Subject|6|||
155624358|NCT03509467|561717837|FG003|Overall Study|Withdrawal by Subject|7|||
155624359|NCT03509467|561717838|FG004|Overall Study|Withdrawal by Subject|10|||
155624360|NCT03509467|561717839|FG005|Overall Study|Withdrawal by Subject|10|||
155624361|NCT03509467|561717840|FG006|Overall Study|Withdrawal by Subject|10|||
155624362|NCT03509467|561717841|FG007|Overall Study|Withdrawal by Subject|10|||
155624363|NCT03509467|561717834|FG000|Overall Study|Death|0|||
155624364|NCT03509467|561717835|FG001|Overall Study|Death|0|||
155624365|NCT03509467|561717836|FG002|Overall Study|Death|2|||
155624366|NCT03509467|561717837|FG003|Overall Study|Death|2|||
155624367|NCT03509467|561717838|FG004|Overall Study|Death|1|||
155624368|NCT03509467|561717839|FG005|Overall Study|Death|0|||
155624369|NCT03509467|561717840|FG006|Overall Study|Death|1|||
155624370|NCT03509467|561717841|FG007|Overall Study|Death|0|||
155624371|NCT03509467|561717834|FG000|Overall Study|Proxy Withdrawal|0|||
155624372|NCT03509467|561717835|FG001|Overall Study|Proxy Withdrawal|0|||
155624373|NCT03509467|561717836|FG002|Overall Study|Proxy Withdrawal|0|||
155624374|NCT03509467|561717837|FG003|Overall Study|Proxy Withdrawal|0|||
155624375|NCT03509467|561717838|FG004|Overall Study|Proxy Withdrawal|0|||
155624376|NCT03509467|561717839|FG005|Overall Study|Proxy Withdrawal|0|||
155624377|NCT03509467|561717840|FG006|Overall Study|Proxy Withdrawal|0|||
155624378|NCT03509467|561717841|FG007|Overall Study|Proxy Withdrawal|1|||
155624379|NCT01005745|561717842|FG000|Overall Study|No TIL growth|1|||
155727264|NCT01458392|562102007|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
155727265|NCT01458392|562102008|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
155727266|NCT01458392|562102009|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
155727267|NCT01281124|562102018|FG000|Overall Study|Death|1|||
155727268|NCT03038100|562102019|FG000|Overall Study|Death|289|||
155727269|NCT03038100|562102020|FG001|Overall Study|Death|272|||
155727270|NCT03038100|562102019|FG000|Overall Study|Lost to Follow-up|9|||
155727271|NCT03038100|562102020|FG001|Overall Study|Lost to Follow-up|10|||
155727272|NCT03038100|562102019|FG000|Overall Study|Protocol Deviation|1|||
155727273|NCT03038100|562102020|FG001|Overall Study|Protocol Deviation|4|||
155727274|NCT03038100|562102019|FG000|Overall Study|Withdrawal by Subject|45|||
155727275|NCT03038100|562102020|FG001|Overall Study|Withdrawal by Subject|51|||
155727276|NCT03038100|562102019|FG000|Overall Study|Study Terminated By Sponsor|305|||
155727277|NCT03038100|562102020|FG001|Overall Study|Study Terminated By Sponsor|311|||
155727278|NCT03038100|562102019|FG000|Overall Study|Physician Decision|1|||
155727279|NCT03038100|562102020|FG001|Overall Study|Physician Decision|3|||
155727280|NCT01198795|562102021|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
155727281|NCT01198795|562102021|FG000|Overall Study|Withdrawal by Subject|17|||
155727282|NCT01198795|562102021|FG000|Overall Study|Lost to Follow-up|15|||
155727283|NCT01198795|562102021|FG000|Overall Study|Adverse Event|9|||
155727284|NCT01198795|562102021|FG000|Overall Study|Lack of Efficacy|5|||
155727285|NCT01198795|562102021|FG000|Overall Study|Protocol Violation|2|||
155727286|NCT01198795|562102021|FG000|Overall Study|Other Reason|4|||
155727287|NCT00918255|562102022|FG000|Overall Study|Adverse Event|1|||
155727288|NCT00918255|562102023|FG001|Overall Study|Adverse Event|0|||
155727289|NCT00918255|562102024|FG002|Overall Study|Adverse Event|0|||
155727290|NCT00918255|562102022|FG000|Overall Study|Withdrawal by Subject|1|||
155727291|NCT00918255|562102023|FG001|Overall Study|Withdrawal by Subject|0|||
155727292|NCT00918255|562102024|FG002|Overall Study|Withdrawal by Subject|2|||
155727293|NCT00918255|562102022|FG000|Overall Study|Lack of Efficacy|1|||
155727294|NCT00918255|562102023|FG001|Overall Study|Lack of Efficacy|0|||
155727295|NCT00918255|562102024|FG002|Overall Study|Lack of Efficacy|0|||
155727296|NCT00918255|562102022|FG000|Overall Study|Lost to Follow-up|1|||
155727297|NCT00918255|562102023|FG001|Overall Study|Lost to Follow-up|0|||
155727298|NCT00918255|562102024|FG002|Overall Study|Lost to Follow-up|2|||
155727299|NCT00918255|562102022|FG000|Overall Study|Exceeded allowed number of interventions|0|||
155727300|NCT00918255|562102023|FG001|Overall Study|Exceeded allowed number of interventions|0|||
155727301|NCT00918255|562102024|FG002|Overall Study|Exceeded allowed number of interventions|1|||
155727302|NCT00918255|562102022|FG000|Overall Study|Non-compliance|1|||
155727303|NCT00918255|562102023|FG001|Overall Study|Non-compliance|0|||
155727304|NCT00918255|562102024|FG002|Overall Study|Non-compliance|0|||
155727305|NCT00918255|562102022|FG000|Overall Study|Investigator discretion|1|||
155727306|NCT00918255|562102023|FG001|Overall Study|Investigator discretion|0|||
155727307|NCT00918255|562102024|FG002|Overall Study|Investigator discretion|0|||
155727308|NCT02038933|562102057|FG000|Overall Study|Disease progression|104|||
155727309|NCT02038933|562102057|FG000|Overall Study|Study drug toxicity|6|||
155727310|NCT02038933|562102057|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155727311|NCT02038933|562102057|FG000|Overall Study|Participant request to discontinue treatment|2|||
155727312|NCT02038933|562102057|FG000|Overall Study|Lost to Follow-up|1|||
155727313|NCT02038933|562102057|FG000|Overall Study|Other reasons|2|||
155727314|NCT03250273|562102058|FG000|Overall Study|Disease Progression|2|||
155727315|NCT03250273|562102059|FG001|Overall Study|Disease Progression|11|||
155727316|NCT03250273|562102058|FG000|Overall Study|Death|0|||
155727317|NCT03250273|562102059|FG001|Overall Study|Death|1|||
155727318|NCT04154904|562102060|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
155727319|NCT04154904|562102061|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
155727320|NCT04154904|562102062|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
155727321|NCT00706238|562102063|FG000|Overall Study|Disease progression|4|||
155727322|NCT00706238|562102063|FG000|Overall Study|Other|1|||
155624380|NCT01005745|561717842|FG000|Overall Study|Disease progressed during TIL growth|3|||
155624381|NCT01005745|561717842|FG000|Overall Study|Death prior to treatment|1|||
155624382|NCT01005745|561717842|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
155624383|NCT02287038|561717843|FG000|Overall Study|Stopped attending appointments|3|||
155624384|NCT02287038|561717844|FG001|Overall Study|Stopped attending appointments|2|||
155624385|NCT02287038|561717843|FG000|Overall Study|Anxiety after starting medication|0|||
155624386|NCT02287038|561717844|FG001|Overall Study|Anxiety after starting medication|1|||
155727323|NCT00936715|562102064|FG000|Overall Study|Investigators Discretion|1|||
155727324|NCT00936715|562102064|FG000|Overall Study|Protocol Violation|1|||
155727325|NCT00936715|562102064|FG000|Overall Study|Safety or Tolerability Reasons|4|||
155624387|NCT02287038|561717843|FG000|Overall Study|Nausea after starting medication|1|||
155727326|NCT03877510|562102067|FG000|Overall Study|Death|6|||
155727327|NCT03877510|562102067|FG000|Overall Study|Lost to Follow-up|2|||
155727328|NCT03877510|562102067|FG000|Overall Study|Non-compliance with study drug|2|||
155727329|NCT03877510|562102067|FG000|Overall Study|Lack of Efficacy|14|||
155727330|NCT03877510|562102067|FG000|Overall Study|Adverse Event|20|||
155727331|NCT03877510|562102067|FG000|Overall Study|Withdrawal by Subject|22|||
155727332|NCT03877510|562102067|FG000|Overall Study|Miscellaneous|1|||
155727333|NCT01337960|562102068|FG000|Overall Study|Lost to Follow-up|1|||
155727334|NCT01337960|562102069|FG001|Overall Study|Lost to Follow-up|0|||
155727335|NCT01337960|562102070|FG002|Overall Study|Lost to Follow-up|0|||
155727336|NCT01337960|562102068|FG000|Overall Study|Withdrawal by Subject|1|||
155727337|NCT01337960|562102069|FG001|Overall Study|Withdrawal by Subject|0|||
155727338|NCT01337960|562102070|FG002|Overall Study|Withdrawal by Subject|0|||
155727339|NCT03763877|562102072|FG000|Overall Study|Withdrawal by Subject|3|||
155727340|NCT03763877|562102073|FG001|Overall Study|Withdrawal by Subject|1|||
155727341|NCT03763877|562102074|FG002|Overall Study|Withdrawal by Subject|3|||
155727342|NCT03763877|562102075|FG003|Overall Study|Withdrawal by Subject|4|||
155727343|NCT03763877|562102072|FG000|Overall Study|Adverse Event|1|||
155727344|NCT03763877|562102073|FG001|Overall Study|Adverse Event|1|||
155727345|NCT03763877|562102074|FG002|Overall Study|Adverse Event|3|||
155727346|NCT03763877|562102075|FG003|Overall Study|Adverse Event|1|||
155727347|NCT03763877|562102072|FG000|Overall Study|Protocol Violation|1|||
155624388|NCT02287038|561717844|FG001|Overall Study|Nausea after starting medication|0|||
155624389|NCT02287038|561717843|FG000|Overall Study|Abnormal ECG after starting medication|1|||
155624390|NCT02287038|561717844|FG001|Overall Study|Abnormal ECG after starting medication|0|||
155624391|NCT04037358|561717850|FG000|Overall Study|Patient withdrew before intervention|1|||
155624392|NCT04037358|561717851|FG001|Overall Study|Patient withdrew before intervention|0|||
155624393|NCT04157517|561717854|FG000|Overall Study|Death|1|||
155624394|NCT04157517|561717855|FG001|Overall Study|Death|2|||
155624395|NCT04157517|561717856|FG002|Overall Study|Death|2|||
155624396|NCT04157517|561717857|FG003|Overall Study|Death|3|||
155624397|NCT04157517|561717858|FG004|Overall Study|Death|3|||
155624398|NCT04157517|561717859|FG005|Overall Study|Death|4|||
155624399|NCT04157517|561717860|FG006|Overall Study|Death|1|||
155624400|NCT04157517|561717861|FG007|Overall Study|Death|2|||
155624401|NCT04157517|561717862|FG008|Overall Study|Death|4|||
155624402|NCT04157517|561717863|FG009|Overall Study|Death|0|||
155624403|NCT04157517|561717854|FG000|Overall Study|Withdrawal by Subject|1|||
155624404|NCT04157517|561717855|FG001|Overall Study|Withdrawal by Subject|1|||
155624405|NCT04157517|561717856|FG002|Overall Study|Withdrawal by Subject|1|||
155624406|NCT04157517|561717857|FG003|Overall Study|Withdrawal by Subject|0|||
155624407|NCT04157517|561717858|FG004|Overall Study|Withdrawal by Subject|0|||
155624408|NCT04157517|561717859|FG005|Overall Study|Withdrawal by Subject|1|||
155624409|NCT04157517|561717860|FG006|Overall Study|Withdrawal by Subject|0|||
155624410|NCT04157517|561717861|FG007|Overall Study|Withdrawal by Subject|0|||
155624411|NCT04157517|561717862|FG008|Overall Study|Withdrawal by Subject|1|||
155624412|NCT04157517|561717863|FG009|Overall Study|Withdrawal by Subject|0|||
155624413|NCT04157517|561717854|FG000|Overall Study|Other|1|||
155624414|NCT04157517|561717855|FG001|Overall Study|Other|0|||
155624415|NCT04157517|561717856|FG002|Overall Study|Other|0|||
155624416|NCT04157517|561717857|FG003|Overall Study|Other|0|||
155624417|NCT04157517|561717858|FG004|Overall Study|Other|0|||
155624418|NCT04157517|561717859|FG005|Overall Study|Other|1|||
155624419|NCT04157517|561717860|FG006|Overall Study|Other|2|||
155624420|NCT04157517|561717861|FG007|Overall Study|Other|7|||
155624421|NCT04157517|561717862|FG008|Overall Study|Other|7|||
155624422|NCT04157517|561717863|FG009|Overall Study|Other|0|||
155624423|NCT03433898|561717864|FG000|Overall Study|Progressive disease|6|||
155624424|NCT03433898|561717865|FG001|Overall Study|Progressive disease|3|||
155624425|NCT03433898|561717866|FG002|Overall Study|Progressive disease|3|||
155624426|NCT03433898|561717867|FG003|Overall Study|Progressive disease|2|||
155624427|NCT03433898|561717868|FG004|Overall Study|Progressive disease|30|||
155624428|NCT03433898|561717869|FG005|Overall Study|Progressive disease|29|||
155624429|NCT03433898|561717870|FG006|Overall Study|Progressive disease|17|||
155624430|NCT03433898|561717871|FG007|Overall Study|Progressive disease|30|||
155624431|NCT03433898|561717864|FG000|Overall Study|Not treated|1|||
155624432|NCT03433898|561717865|FG001|Overall Study|Not treated|0|||
155624433|NCT03433898|561717866|FG002|Overall Study|Not treated|0|||
155624434|NCT03433898|561717867|FG003|Overall Study|Not treated|0|||
155624435|NCT03433898|561717868|FG004|Overall Study|Not treated|1|||
155624436|NCT03433898|561717869|FG005|Overall Study|Not treated|0|||
155624437|NCT03433898|561717870|FG006|Overall Study|Not treated|0|||
155624438|NCT03433898|561717871|FG007|Overall Study|Not treated|0|||
155624439|NCT03433898|561717864|FG000|Overall Study|Death|0|||
155624440|NCT03433898|561717865|FG001|Overall Study|Death|0|||
155624441|NCT03433898|561717866|FG002|Overall Study|Death|0|||
155624442|NCT03433898|561717867|FG003|Overall Study|Death|0|||
155624443|NCT03433898|561717868|FG004|Overall Study|Death|0|||
155624444|NCT03433898|561717869|FG005|Overall Study|Death|0|||
155624445|NCT03433898|561717870|FG006|Overall Study|Death|1|||
155624446|NCT03433898|561717871|FG007|Overall Study|Death|1|||
155624447|NCT03433898|561717864|FG000|Overall Study|Withdrawal by Subject|0|||
155624448|NCT03433898|561717865|FG001|Overall Study|Withdrawal by Subject|0|||
155624449|NCT03433898|561717866|FG002|Overall Study|Withdrawal by Subject|0|||
155624450|NCT03433898|561717867|FG003|Overall Study|Withdrawal by Subject|0|||
155727348|NCT03763877|562102073|FG001|Overall Study|Protocol Violation|1|||
155727349|NCT03763877|562102074|FG002|Overall Study|Protocol Violation|0|||
155382211|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
155624451|NCT03433898|561717868|FG004|Overall Study|Withdrawal by Subject|2|||
155624452|NCT03433898|561717869|FG005|Overall Study|Withdrawal by Subject|0|||
155624453|NCT03433898|561717870|FG006|Overall Study|Withdrawal by Subject|0|||
155624454|NCT03433898|561717871|FG007|Overall Study|Withdrawal by Subject|0|||
155624455|NCT03433898|561717864|FG000|Overall Study|Adverse Event|0|||
155624456|NCT03433898|561717865|FG001|Overall Study|Adverse Event|0|||
155624457|NCT03433898|561717866|FG002|Overall Study|Adverse Event|0|||
155624458|NCT03433898|561717867|FG003|Overall Study|Adverse Event|0|||
155624459|NCT03433898|561717868|FG004|Overall Study|Adverse Event|0|||
155624460|NCT03433898|561717869|FG005|Overall Study|Adverse Event|5|||
155624461|NCT03433898|561717870|FG006|Overall Study|Adverse Event|2|||
155624462|NCT03433898|561717871|FG007|Overall Study|Adverse Event|2|||
155624463|NCT03433898|561717864|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624464|NCT03433898|561717865|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155727350|NCT03763877|562102075|FG003|Overall Study|Protocol Violation|0|||
155727351|NCT03763877|562102072|FG000|Overall Study|Lost to Follow-up|0|||
155727352|NCT03763877|562102073|FG001|Overall Study|Lost to Follow-up|1|||
155727353|NCT03763877|562102074|FG002|Overall Study|Lost to Follow-up|1|||
155727354|NCT03763877|562102075|FG003|Overall Study|Lost to Follow-up|0|||
155727355|NCT03040336|562102077|FG000|Overall Study|Death|1|||
155727356|NCT03040336|562102078|FG001|Overall Study|Death|0|||
155727357|NCT03040336|562102077|FG000|Overall Study|Withdrawal by Subject|2|||
155727358|NCT03040336|562102078|FG001|Overall Study|Withdrawal by Subject|3|||
155727359|NCT02282605|562102079|FG000|Overall Study|negative SA result on Day -1|3|||
155727360|NCT02282605|562102080|FG001|Overall Study|negative SA result on Day -1|0|||
155727361|NCT02282605|562102081|FG002|Overall Study|negative SA result on Day -1|0|||
155727362|NCT03938259|562102082|FG000|Overall Study|unable to establish baseline for ventilation|1|||
155727363|NCT03938259|562102083|FG001|Overall Study|unable to establish baseline for ventilation|1|||
155624465|NCT03433898|561717866|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624466|NCT03433898|561717867|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624467|NCT03433898|561717868|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
155624468|NCT03433898|561717869|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624469|NCT03433898|561717870|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624470|NCT03433898|561717871|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155624471|NCT05027815|561717872|FG000|Overall Study|Death|2|||
155624472|NCT05027815|561717873|FG001|Overall Study|Death|1|||
155624473|NCT00536510|561718559|FG000|Overall Study|Adverse Event|27|||
155624474|NCT00536510|561718560|FG001|Overall Study|Adverse Event|4|||
155624475|NCT00536510|561718559|FG000|Overall Study|Lost to Follow-up|11|||
155624476|NCT00536510|561718560|FG001|Overall Study|Lost to Follow-up|8|||
155624477|NCT00536510|561718559|FG000|Overall Study|Protocol Violation|4|||
155624478|NCT00536510|561718560|FG001|Overall Study|Protocol Violation|5|||
155624479|NCT00536510|561718559|FG000|Overall Study|Withdrawal by Subject|16|||
155624480|NCT00536510|561718560|FG001|Overall Study|Withdrawal by Subject|9|||
155624481|NCT00536510|561718559|FG000|Overall Study|Flushing with Product|20|||
155624482|NCT00536510|561718560|FG001|Overall Study|Flushing with Product|0|||
155624483|NCT00536510|561718559|FG000|Overall Study|Laboratory Adverse Event|2|||
155624484|NCT00536510|561718560|FG001|Overall Study|Laboratory Adverse Event|1|||
155624485|NCT00536510|561718559|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
155624486|NCT00536510|561718560|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
155624487|NCT02062437|561718561|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
155727364|NCT00763035|562102084|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
155727365|NCT00763035|562102085|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
155727366|NCT00763035|562102084|FG000|First Intervention|Adverse Event|0|||
155727367|NCT00763035|562102085|FG001|First Intervention|Adverse Event|1|||
155727368|NCT00763035|562102084|FG000|Second Intervention|Adverse Event|1|||
155727369|NCT00763035|562102085|FG001|Second Intervention|Adverse Event|0|||
155727370|NCT00763035|562102084|FG000|Second Intervention|Physician Decision|2|||
155727371|NCT00763035|562102085|FG001|Second Intervention|Physician Decision|0|||
155727372|NCT02435992|562102090|FG000|Overall Study|non compliance with protocol|2|||
155727373|NCT02435992|562102091|FG001|Overall Study|non compliance with protocol|0|||
155727374|NCT02435992|562102092|FG002|Overall Study|non compliance with protocol|1|||
155727375|NCT02435992|562102093|FG003|Overall Study|non compliance with protocol|0|||
155727376|NCT02435992|562102094|FG004|Overall Study|non compliance with protocol|0|||
155727377|NCT02435992|562102090|FG000|Overall Study|Adverse Event|11|||
155727378|NCT02435992|562102091|FG001|Overall Study|Adverse Event|6|||
155727379|NCT02435992|562102092|FG002|Overall Study|Adverse Event|12|||
155727380|NCT02435992|562102093|FG003|Overall Study|Adverse Event|0|||
155624488|NCT02062437|561718561|FG000|Overall Study|Patient not available for the 2y visit|18|||
155624489|NCT02062437|561718561|FG000|Overall Study|Death|2|||
155727381|NCT02435992|562102094|FG004|Overall Study|Adverse Event|0|||
155727382|NCT02435992|562102090|FG000|Overall Study|Lack of Efficacy|4|||
155727383|NCT02435992|562102091|FG001|Overall Study|Lack of Efficacy|10|||
155727384|NCT02435992|562102092|FG002|Overall Study|Lack of Efficacy|9|||
155624490|NCT02062437|561718561|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
155624491|NCT01674725|561718562|FG000|Overall Study|Adverse Event|1|||
155624492|NCT01674725|561718563|FG001|Overall Study|Adverse Event|0|||
155624493|NCT01674725|561718562|FG000|Overall Study|Did not receive study drug|1|||
155278060|NCT05294419|560451099|FG002|Overall Study|Results voided after publishing|0|||
155278061|NCT00847301|560451100|FG000|Overall Study|Adverse Event|35|||
155278062|NCT00847301|560451100|FG000|Overall Study|Switch to other anticoagulants|16|||
155278063|NCT00847301|560451100|FG000|Overall Study|Lost to Follow-up|1|||
155278064|NCT00847301|560451100|FG000|Overall Study|No prescription after hospital discharge|1|||
155278065|NCT00847301|560451100|FG000|Overall Study|Other reason not defined above|1|||
155278066|NCT05708846|560451101|FG000|Overall Study|Death|5|||
155278067|NCT05708846|560451101|FG000|Overall Study|Withdrawal by Subject|20|||
155278068|NCT03621982|560451102|FG000|Overall Study|Withdrawal by Subject|1|||
155624494|NCT01674725|561718563|FG001|Overall Study|Did not receive study drug|0|||
155624495|NCT01674725|561718562|FG000|Overall Study|Withdrawal by Subject|1|||
155624496|NCT01674725|561718563|FG001|Overall Study|Withdrawal by Subject|0|||
155624497|NCT01674725|561718562|FG000|Overall Study|Lost to Follow-up|0|||
155624498|NCT01674725|561718563|FG001|Overall Study|Lost to Follow-up|1|||
155624499|NCT03102762|561718564|FG000|Overall Study|Lost to Follow-up|1|||
155727385|NCT02435992|562102093|FG003|Overall Study|Lack of Efficacy|0|||
155278069|NCT03621982|560451103|FG001|Overall Study|Withdrawal by Subject|0|||
155278070|NCT03621982|560451104|FG002|Overall Study|Withdrawal by Subject|0|||
155278071|NCT03621982|560451105|FG003|Overall Study|Withdrawal by Subject|1|||
155278072|NCT03621982|560451106|FG004|Overall Study|Withdrawal by Subject|0|||
155278073|NCT03621982|560451107|FG005|Overall Study|Withdrawal by Subject|1|||
155278074|NCT03621982|560451108|FG006|Overall Study|Withdrawal by Subject|1|||
155278075|NCT03621982|560451109|FG007|Overall Study|Withdrawal by Subject|0|||
155278076|NCT03621982|560451110|FG008|Overall Study|Withdrawal by Subject|1|||
155278077|NCT03621982|560451111|FG009|Overall Study|Withdrawal by Subject|0|||
155278078|NCT03621982|560451112|FG010|Overall Study|Withdrawal by Subject|2|||
155278079|NCT03621982|560451113|FG011|Overall Study|Withdrawal by Subject|1|||
155278080|NCT03621982|560451114|FG012|Overall Study|Withdrawal by Subject|2|||
155278081|NCT03621982|560451115|FG013|Overall Study|Withdrawal by Subject|2|||
155278082|NCT03621982|560451102|FG000|Overall Study|Investigator/Sponsor decision|0|||
155278083|NCT03621982|560451103|FG001|Overall Study|Investigator/Sponsor decision|0|||
155278084|NCT03621982|560451104|FG002|Overall Study|Investigator/Sponsor decision|0|||
155278085|NCT03621982|560451105|FG003|Overall Study|Investigator/Sponsor decision|0|||
155278086|NCT03621982|560451106|FG004|Overall Study|Investigator/Sponsor decision|0|||
155278087|NCT03621982|560451107|FG005|Overall Study|Investigator/Sponsor decision|0|||
155278088|NCT03621982|560451108|FG006|Overall Study|Investigator/Sponsor decision|0|||
155278089|NCT03621982|560451109|FG007|Overall Study|Investigator/Sponsor decision|0|||
155278090|NCT03621982|560451110|FG008|Overall Study|Investigator/Sponsor decision|0|||
155278091|NCT03621982|560451111|FG009|Overall Study|Investigator/Sponsor decision|0|||
155278092|NCT03621982|560451112|FG010|Overall Study|Investigator/Sponsor decision|0|||
155278093|NCT03621982|560451113|FG011|Overall Study|Investigator/Sponsor decision|4|||
155278094|NCT03621982|560451114|FG012|Overall Study|Investigator/Sponsor decision|0|||
155278095|NCT03621982|560451115|FG013|Overall Study|Investigator/Sponsor decision|2|||
155278096|NCT03621982|560451102|FG000|Overall Study|Death|2|||
155278097|NCT03621982|560451103|FG001|Overall Study|Death|4|||
155278098|NCT03621982|560451104|FG002|Overall Study|Death|4|||
155278099|NCT03621982|560451105|FG003|Overall Study|Death|3|||
155278100|NCT03621982|560451106|FG004|Overall Study|Death|8|||
155278101|NCT03621982|560451107|FG005|Overall Study|Death|4|||
155278102|NCT03621982|560451108|FG006|Overall Study|Death|6|||
155278103|NCT03621982|560451109|FG007|Overall Study|Death|3|||
155278104|NCT03621982|560451110|FG008|Overall Study|Death|0|||
155278105|NCT03621982|560451111|FG009|Overall Study|Death|3|||
155278106|NCT03621982|560451112|FG010|Overall Study|Death|8|||
155278107|NCT03621982|560451113|FG011|Overall Study|Death|4|||
155278108|NCT03621982|560451114|FG012|Overall Study|Death|2|||
155278109|NCT03621982|560451115|FG013|Overall Study|Death|2|||
155278110|NCT03621982|560451102|FG000|Overall Study|Lost to Follow-up|0|||
155278111|NCT03621982|560451103|FG001|Overall Study|Lost to Follow-up|0|||
155278112|NCT03621982|560451104|FG002|Overall Study|Lost to Follow-up|1|||
155278113|NCT03621982|560451105|FG003|Overall Study|Lost to Follow-up|0|||
155278114|NCT03621982|560451106|FG004|Overall Study|Lost to Follow-up|0|||
155278115|NCT03621982|560451107|FG005|Overall Study|Lost to Follow-up|0|||
155278116|NCT03621982|560451108|FG006|Overall Study|Lost to Follow-up|1|||
155278117|NCT03621982|560451109|FG007|Overall Study|Lost to Follow-up|0|||
155278118|NCT03621982|560451110|FG008|Overall Study|Lost to Follow-up|0|||
155278119|NCT03621982|560451111|FG009|Overall Study|Lost to Follow-up|1|||
155278120|NCT03621982|560451112|FG010|Overall Study|Lost to Follow-up|0|||
155278121|NCT03621982|560451113|FG011|Overall Study|Lost to Follow-up|0|||
155278122|NCT03621982|560451114|FG012|Overall Study|Lost to Follow-up|0|||
155278123|NCT03621982|560451115|FG013|Overall Study|Lost to Follow-up|0|||
155278124|NCT00238420|560451116|FG000|Overall Study|Protocol Violation|1|||
155278125|NCT00238420|560451117|FG001|Overall Study|Protocol Violation|1|||
155727386|NCT02435992|562102094|FG004|Overall Study|Lack of Efficacy|0|||
155727387|NCT02435992|562102090|FG000|Overall Study|Withdrawal by Subject|10|||
155727388|NCT02435992|562102091|FG001|Overall Study|Withdrawal by Subject|8|||
155727389|NCT02435992|562102092|FG002|Overall Study|Withdrawal by Subject|20|||
155727390|NCT02435992|562102093|FG003|Overall Study|Withdrawal by Subject|0|||
155727391|NCT02435992|562102094|FG004|Overall Study|Withdrawal by Subject|0|||
155727392|NCT02435992|562102090|FG000|Overall Study|Other Reason|1|||
155727393|NCT02435992|562102091|FG001|Overall Study|Other Reason|0|||
155727394|NCT02435992|562102092|FG002|Overall Study|Other Reason|0|||
155727395|NCT02435992|562102093|FG003|Overall Study|Other Reason|0|||
155727396|NCT02435992|562102094|FG004|Overall Study|Other Reason|0|||
155727397|NCT02435992|562102090|FG000|Overall Study|Physician Decision|0|||
155727398|NCT02435992|562102091|FG001|Overall Study|Physician Decision|0|||
155727399|NCT02435992|562102092|FG002|Overall Study|Physician Decision|1|||
155727400|NCT02435992|562102093|FG003|Overall Study|Physician Decision|0|||
155727401|NCT02435992|562102094|FG004|Overall Study|Physician Decision|0|||
155727402|NCT00930046|562102095|FG000|Overall Study|Wound catheter malfunctioned|1|||
155727403|NCT00930046|562102096|FG001|Overall Study|Wound catheter malfunctioned|2|||
155727404|NCT01598532|562102097|FG000|Overall Study|Lost to Follow-up|3|||
155727405|NCT01598532|562102097|FG000|Overall Study|Did not meet inclusion criteria|8|||
155727406|NCT00912808|562102098|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
155727407|NCT00912808|562102099|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155727408|NCT00912808|562102098|FG000|Washout|Withdrawal by Subject|0|||
155727409|NCT00912808|562102099|FG001|Washout|Withdrawal by Subject|1|||
155727410|NCT00912808|562102098|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155727411|NCT00912808|562102099|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
155727412|NCT00912808|562102098|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
155727413|NCT00912808|562102099|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
155727414|NCT00702221|562102100|FG000|Overall Study|Adverse Event|4|||
155727415|NCT00702221|562102101|FG001|Overall Study|Adverse Event|3|||
155727416|NCT03345784|562102106|FG000|Overall Study|Withdrawal by Subject|2|||
155727417|NCT03345784|562102107|FG001|Overall Study|Withdrawal by Subject|1|||
155727418|NCT01249261|562102108|FG000|Overall Study|Withdrawal by Subject|1|||
155727419|NCT01249261|562102109|FG001|Overall Study|Withdrawal by Subject|0|||
155727420|NCT01055197|562102117|FG000|Overall Study|Protocol Violation|7|||
155727421|NCT01055197|562102118|FG001|Overall Study|Protocol Violation|2|||
155727422|NCT01055197|562102117|FG000|Overall Study|Withdrawal by Subject|2|||
155727423|NCT01055197|562102118|FG001|Overall Study|Withdrawal by Subject|0|||
155727424|NCT00389610|562102119|FG000|Overall Study|Disease Progression|0|||
155727425|NCT00389610|562102120|FG001|Overall Study|Disease Progression|19|||
155727426|NCT00389610|562102119|FG000|Overall Study|Death|0|||
155727427|NCT00389610|562102120|FG001|Overall Study|Death|1|||
155727428|NCT00389610|562102119|FG000|Overall Study|Physician Decision|0|||
155727429|NCT00389610|562102120|FG001|Overall Study|Physician Decision|1|||
155727430|NCT00389610|562102119|FG000|Overall Study|Withdrawal by Subject|0|||
155727431|NCT00389610|562102120|FG001|Overall Study|Withdrawal by Subject|1|||
155727432|NCT00538902|562102121|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
155727433|NCT00538902|562102122|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
155727434|NCT00538902|562102123|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
155727435|NCT00538902|562102121|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
155727436|NCT00538902|562102122|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
155727437|NCT00538902|562102123|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
155727438|NCT00538902|562102121|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
155727439|NCT00538902|562102122|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
155382212|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
155727440|NCT00538902|562102123|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
155727441|NCT00538902|562102121|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155727442|NCT00538902|562102122|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155727443|NCT00538902|562102123|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155727444|NCT00538902|562102121|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
155727445|NCT00538902|562102122|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
155727446|NCT00538902|562102123|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
155382213|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
155382214|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
155727447|NCT00538902|562102121|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
155727448|NCT00538902|562102122|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
155727449|NCT00538902|562102123|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
155727450|NCT00538902|562102121|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
155727451|NCT00538902|562102122|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
155727452|NCT00538902|562102123|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
155727453|NCT00538902|562102121|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
155727454|NCT00538902|562102122|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
155727455|NCT00538902|562102123|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
155727456|NCT01967940|562102128|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
155727457|NCT01967940|562102129|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
155727458|NCT01967940|562102130|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
155727459|NCT01967940|562102131|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
155727460|NCT01967940|562102128|FG000|Part 2|Adverse Event|0|||
155727461|NCT01967940|562102129|FG001|Part 2|Adverse Event|0|||
155727462|NCT01967940|562102130|FG002|Part 2|Adverse Event|0|||
155727463|NCT01967940|562102131|FG003|Part 2|Adverse Event|1|||
155727464|NCT01967940|562102128|FG000|Part 2|Unknown Reason|0|||
155727465|NCT01967940|562102129|FG001|Part 2|Unknown Reason|0|||
155727466|NCT01967940|562102130|FG002|Part 2|Unknown Reason|0|||
155727467|NCT01967940|562102131|FG003|Part 2|Unknown Reason|1|||
155727468|NCT04109547|562102132|FG000|Overall Study|Withdrawal by Subject|3|||
155727469|NCT04109547|562102133|FG001|Overall Study|Withdrawal by Subject|2|||
155727470|NCT04109547|562102134|FG002|Overall Study|Withdrawal by Subject|6|||
155727471|NCT04109547|562102135|FG003|Overall Study|Withdrawal by Subject|6|||
155727472|NCT04109547|562102132|FG000|Overall Study|Lost to Follow-up|0|||
155727473|NCT04109547|562102133|FG001|Overall Study|Lost to Follow-up|0|||
155727474|NCT04109547|562102134|FG002|Overall Study|Lost to Follow-up|0|||
155727475|NCT04109547|562102135|FG003|Overall Study|Lost to Follow-up|1|||
155727476|NCT04109547|562102132|FG000|Overall Study|Physician Decision|1|||
155727477|NCT04109547|562102133|FG001|Overall Study|Physician Decision|2|||
155727478|NCT04109547|562102134|FG002|Overall Study|Physician Decision|0|||
155727479|NCT04109547|562102135|FG003|Overall Study|Physician Decision|0|||
155727480|NCT01550003|562102136|FG000|Overall Study|Adverse Event|0|||
155727481|NCT01550003|562102137|FG001|Overall Study|Adverse Event|9|||
155727482|NCT01550003|562102138|FG002|Overall Study|Adverse Event|15|||
155727483|NCT01550003|562102136|FG000|Overall Study|Lack of Efficacy|4|||
155727484|NCT01550003|562102137|FG001|Overall Study|Lack of Efficacy|11|||
155727485|NCT01550003|562102138|FG002|Overall Study|Lack of Efficacy|15|||
155727486|NCT01550003|562102136|FG000|Overall Study|Protocol Violation|0|||
155727487|NCT01550003|562102137|FG001|Overall Study|Protocol Violation|3|||
155727488|NCT01550003|562102138|FG002|Overall Study|Protocol Violation|2|||
155727489|NCT01550003|562102136|FG000|Overall Study|Lost to Follow-up|1|||
155727490|NCT01550003|562102137|FG001|Overall Study|Lost to Follow-up|4|||
155727491|NCT01550003|562102138|FG002|Overall Study|Lost to Follow-up|8|||
155727492|NCT01550003|562102136|FG000|Overall Study|Consent withdrawn|2|||
155727493|NCT01550003|562102137|FG001|Overall Study|Consent withdrawn|11|||
155727494|NCT01550003|562102138|FG002|Overall Study|Consent withdrawn|23|||
155727495|NCT01550003|562102136|FG000|Overall Study|Missing|1|||
155727496|NCT01550003|562102137|FG001|Overall Study|Missing|0|||
155727497|NCT01550003|562102138|FG002|Overall Study|Missing|2|||
155727498|NCT01550003|562102136|FG000|Overall Study|Study closure as announced by sponsor|7|||
155727499|NCT01550003|562102137|FG001|Overall Study|Study closure as announced by sponsor|6|||
155727500|NCT01550003|562102138|FG002|Overall Study|Study closure as announced by sponsor|24|||
155727501|NCT01550003|562102136|FG000|Overall Study|Protocol Noncompliance|1|||
155727502|NCT01550003|562102137|FG001|Overall Study|Protocol Noncompliance|0|||
155382215|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
155382216|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|poor data quality|0|||
155382217|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|poor data quality|1|||
155624500|NCT03102762|561718565|FG001|Overall Study|Lost to Follow-up|0|||
155624501|NCT03074695|561718570|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
155624502|NCT03074695|561718571|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
155624503|NCT03074695|561718570|FG000|Overall Study|Research staff not available|1|||
155624504|NCT03074695|561718571|FG001|Overall Study|Research staff not available|2|||
155624505|NCT03074695|561718570|FG000|Overall Study|Did not receive neuraxial block|2|||
155624506|NCT03074695|561718571|FG001|Overall Study|Did not receive neuraxial block|2|||
155624507|NCT01774981|561718572|FG000|Overall Study|Adverse Event|0|||
155624508|NCT01774981|561718573|FG001|Overall Study|Adverse Event|0|||
155624509|NCT01774981|561718574|FG002|Overall Study|Adverse Event|0|||
155727503|NCT01550003|562102138|FG002|Overall Study|Protocol Noncompliance|0|||
155727504|NCT01550003|562102136|FG000|Overall Study|Study closure|0|||
155727505|NCT01550003|562102137|FG001|Overall Study|Study closure|1|||
155727506|NCT01550003|562102138|FG002|Overall Study|Study closure|1|||
155727507|NCT01550003|562102136|FG000|Overall Study|Patient reached adulthood|0|||
155727508|NCT01550003|562102137|FG001|Overall Study|Patient reached adulthood|1|||
155727509|NCT01550003|562102138|FG002|Overall Study|Patient reached adulthood|0|||
155727510|NCT01550003|562102136|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
155624510|NCT01774981|561718575|FG003|Overall Study|Adverse Event|0|||
155727511|NCT01550003|562102137|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
155727512|NCT01550003|562102138|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
155727513|NCT01550003|562102136|FG000|Overall Study|Sponsor's order|0|||
155727514|NCT01550003|562102137|FG001|Overall Study|Sponsor's order|3|||
155727515|NCT01550003|562102138|FG002|Overall Study|Sponsor's order|3|||
155727516|NCT01550003|562102136|FG000|Overall Study|Sponsor's decision|1|||
155727517|NCT01550003|562102137|FG001|Overall Study|Sponsor's decision|5|||
155727518|NCT01550003|562102138|FG002|Overall Study|Sponsor's decision|4|||
155727519|NCT01550003|562102136|FG000|Overall Study|Subject mother passed away|0|||
155727520|NCT01550003|562102137|FG001|Overall Study|Subject mother passed away|1|||
155727521|NCT01550003|562102138|FG002|Overall Study|Subject mother passed away|0|||
155727522|NCT01550003|562102136|FG000|Overall Study|Discontinuation|0|||
155727523|NCT01550003|562102137|FG001|Overall Study|Discontinuation|1|||
155727524|NCT01550003|562102138|FG002|Overall Study|Discontinuation|0|||
155727525|NCT01550003|562102136|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
155727526|NCT01550003|562102137|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
155727527|NCT01550003|562102138|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
155727528|NCT01550003|562102136|FG000|Overall Study|Site closure|0|||
155727529|NCT01550003|562102137|FG001|Overall Study|Site closure|2|||
155727530|NCT01550003|562102138|FG002|Overall Study|Site closure|0|||
155727531|NCT01550003|562102136|FG000|Overall Study|Pregnancy|0|||
155727532|NCT01550003|562102137|FG001|Overall Study|Pregnancy|1|||
155727533|NCT01550003|562102138|FG002|Overall Study|Pregnancy|0|||
155727534|NCT01550003|562102136|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
155727535|NCT01550003|562102137|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
155727536|NCT01550003|562102138|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
155727537|NCT01550003|562102136|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
155727538|NCT01550003|562102137|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
155727539|NCT01550003|562102138|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
155727540|NCT01550003|562102136|FG000|Overall Study|Switching to adult rheumatologist|0|||
155727541|NCT01550003|562102137|FG001|Overall Study|Switching to adult rheumatologist|0|||
155727542|NCT01550003|562102138|FG002|Overall Study|Switching to adult rheumatologist|1|||
155727543|NCT01550003|562102136|FG000|Overall Study|Patient transition to adult care|0|||
155727544|NCT01550003|562102137|FG001|Overall Study|Patient transition to adult care|0|||
155727545|NCT01550003|562102138|FG002|Overall Study|Patient transition to adult care|1|||
155727546|NCT01550003|562102136|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
155727547|NCT01550003|562102137|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
155727548|NCT01550003|562102138|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
155727549|NCT01550003|562102136|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
155727550|NCT01550003|562102137|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
155727551|NCT01550003|562102138|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
155727552|NCT01550003|562102136|FG000|Overall Study|Per Sponsor request|1|||
155727553|NCT01550003|562102137|FG001|Overall Study|Per Sponsor request|0|||
155727554|NCT01550003|562102138|FG002|Overall Study|Per Sponsor request|1|||
155727555|NCT01550003|562102136|FG000|Overall Study|Patient not compliance|0|||
155727556|NCT01550003|562102137|FG001|Overall Study|Patient not compliance|0|||
155727557|NCT01550003|562102138|FG002|Overall Study|Patient not compliance|1|||
155727558|NCT01550003|562102136|FG000|Overall Study|Non-compliance|0|||
155727559|NCT01550003|562102137|FG001|Overall Study|Non-compliance|0|||
155727560|NCT01550003|562102138|FG002|Overall Study|Non-compliance|1|||
155727561|NCT01550003|562102136|FG000|Overall Study|Study closed|0|||
155727562|NCT01550003|562102137|FG001|Overall Study|Study closed|1|||
155727563|NCT01550003|562102138|FG002|Overall Study|Study closed|0|||
155727564|NCT01550003|562102136|FG000|Overall Study|Transitioned to adult rheumatology|0|||
155727565|NCT01550003|562102137|FG001|Overall Study|Transitioned to adult rheumatology|0|||
155727566|NCT01550003|562102138|FG002|Overall Study|Transitioned to adult rheumatology|1|||
155727567|NCT05567783|562102139|FG000|Overall Study|Death|2|||
155727568|NCT05567783|562102140|FG001|Overall Study|Death|3|||
155727569|NCT05567783|562102141|FG002|Overall Study|Death|0|||
155727570|NCT05567783|562102139|FG000|Overall Study|Lost to Follow-up|25|||
155727571|NCT05567783|562102140|FG001|Overall Study|Lost to Follow-up|19|||
155727572|NCT05567783|562102141|FG002|Overall Study|Lost to Follow-up|17|||
155727573|NCT05567783|562102139|FG000|Overall Study|Physician Decision|10|||
155727574|NCT05567783|562102140|FG001|Overall Study|Physician Decision|7|||
155727575|NCT05567783|562102141|FG002|Overall Study|Physician Decision|9|||
155727576|NCT05567783|562102139|FG000|Overall Study|Study Terminated by Sponsor|924|||
155727577|NCT05567783|562102140|FG001|Overall Study|Study Terminated by Sponsor|937|||
155727578|NCT05567783|562102141|FG002|Overall Study|Study Terminated by Sponsor|941|||
155727579|NCT05567783|562102139|FG000|Overall Study|Withdrawal by Subject|23|||
155727580|NCT05567783|562102140|FG001|Overall Study|Withdrawal by Subject|27|||
155727581|NCT05567783|562102141|FG002|Overall Study|Withdrawal by Subject|24|||
155727582|NCT05567783|562102139|FG000|Overall Study|Incarcerated|1|||
155727583|NCT05567783|562102140|FG001|Overall Study|Incarcerated|0|||
155727584|NCT05567783|562102141|FG002|Overall Study|Incarcerated|0|||
155727585|NCT05567783|562102139|FG000|Overall Study|Participant randomized in error|4|||
155727586|NCT05567783|562102140|FG001|Overall Study|Participant randomized in error|2|||
155727587|NCT05567783|562102141|FG002|Overall Study|Participant randomized in error|2|||
155727588|NCT03675126|562102144|FG000|Overall Study|Study Terminated by Sponsor|9|||
155727589|NCT03675126|562102144|FG000|Overall Study|Death|2|||
155727590|NCT03675126|562102144|FG000|Overall Study|Withdrawal by Subject|4|||
155727591|NCT00001959|562102145|FG000|Overall Study|newly diagnosed colon cancer|1|||
155727592|NCT00001959|562102145|FG000|Overall Study|disabling sedation|1|||
155278126|NCT00641186|560451120|FG000|Overall Study|Adverse Event|3|||
155278127|NCT00442286|560451121|FG000|Overall Study|Death|2|||
155278128|NCT00442286|560451122|FG001|Overall Study|Death|2|||
155278129|NCT00442286|560451121|FG000|Overall Study|Lost to Follow-up|1|||
155278130|NCT00442286|560451122|FG001|Overall Study|Lost to Follow-up|0|||
155278131|NCT00442286|560451121|FG000|Overall Study|Withdrawal by Subject|2|||
155278132|NCT00442286|560451122|FG001|Overall Study|Withdrawal by Subject|0|||
155278133|NCT00442286|560451121|FG000|Overall Study|System explanted|1|||
155278134|NCT00442286|560451122|FG001|Overall Study|System explanted|0|||
155278135|NCT00442286|560451121|FG000|Overall Study|Patient Injury|1|||
155278136|NCT00442286|560451122|FG001|Overall Study|Patient Injury|0|||
155278137|NCT03428815|560451125|FG000|Overall Study|Lost to Follow-up|2|||
155278138|NCT03428815|560451126|FG001|Overall Study|Lost to Follow-up|2|||
155278139|NCT03428815|560451125|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
155278140|NCT03428815|560451126|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
155278141|NCT03428815|560451125|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
155278142|NCT03428815|560451126|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
155278143|NCT05221749|560451127|FG000|Overall Study|Lost to Follow-up|2|||
155278144|NCT05221749|560451128|FG001|Overall Study|Lost to Follow-up|3|||
155278145|NCT02404493|560451129|FG000|Overall Study|Adverse Event|1|||
155278146|NCT02404493|560451130|FG001|Overall Study|Adverse Event|1|||
155278147|NCT04140890|560451133|FG000|Overall Study|Withdrawal by Subject|0|||
155278148|NCT04140890|560451134|FG001|Overall Study|Withdrawal by Subject|1|||
155278149|NCT01700348|560451135|FG000|Overall Study|Withdrawal by Subject|22|||
155278150|NCT01700348|560451135|FG000|Overall Study|Lost to Follow-up|1|||
155278151|NCT02102464|560451136|FG000|Randomized Study|Withdrawal by Subject|0|||
155278152|NCT02102464|560451137|FG001|Randomized Study|Withdrawal by Subject|1|||
155278153|NCT02102464|560451138|FG002|Randomized Study|Withdrawal by Subject|0|||
155278154|NCT01824472|560451147|FG000|Overall Study|Lost to Follow-up|0|||
155278155|NCT01824472|560451148|FG001|Overall Study|Lost to Follow-up|0|||
155278156|NCT01824472|560451149|FG002|Overall Study|Lost to Follow-up|1|||
155278157|NCT01824472|560451147|FG000|Overall Study|Withdrawal by Subject|1|||
155278158|NCT01824472|560451148|FG001|Overall Study|Withdrawal by Subject|5|||
155278159|NCT01824472|560451149|FG002|Overall Study|Withdrawal by Subject|3|||
155278160|NCT01824472|560451147|FG000|Overall Study|Ineligible post randomization&screening|0|||
155278161|NCT01824472|560451148|FG001|Overall Study|Ineligible post randomization&screening|2|||
155278162|NCT01824472|560451149|FG002|Overall Study|Ineligible post randomization&screening|0|||
155278163|NCT03040687|560451150|FG000|Overall Study|Withdrawal by Subject|1|||
155278164|NCT03040687|560451151|FG001|Overall Study|Withdrawal by Subject|0|||
155278165|NCT03040687|560451152|FG002|Overall Study|Withdrawal by Subject|0|||
155278166|NCT03317379|560451153|FG000|Overall Study|Lost to Follow-up|0|||
155278167|NCT03317379|560451154|FG001|Overall Study|Lost to Follow-up|3|||
155278168|NCT03317379|560451155|FG002|Overall Study|Lost to Follow-up|2|||
155278169|NCT02846558|560451156|FG000|Overall Study|Adverse Event|1|||
155278170|NCT02846558|560451157|FG001|Overall Study|Adverse Event|0|||
155278171|NCT02846558|560451158|FG002|Overall Study|Adverse Event|0|||
155278172|NCT02846558|560451159|FG003|Overall Study|Adverse Event|0|||
155278173|NCT02846558|560451156|FG000|Overall Study|Withdrawal by Subject|5|||
155278174|NCT02846558|560451157|FG001|Overall Study|Withdrawal by Subject|4|||
155278175|NCT02846558|560451158|FG002|Overall Study|Withdrawal by Subject|2|||
155278176|NCT02846558|560451159|FG003|Overall Study|Withdrawal by Subject|2|||
155278177|NCT02846558|560451156|FG000|Overall Study|Lost to Follow-up|2|||
155278178|NCT02846558|560451157|FG001|Overall Study|Lost to Follow-up|0|||
155278179|NCT02846558|560451158|FG002|Overall Study|Lost to Follow-up|0|||
155278180|NCT02846558|560451159|FG003|Overall Study|Lost to Follow-up|0|||
155278181|NCT04445155|560451160|FG000|Overall Study|Lost to Follow-up|11|||
155278182|NCT04445155|560451161|FG001|Overall Study|Lost to Follow-up|2|||
155278183|NCT04445155|560451162|FG002|Overall Study|Lost to Follow-up|3|||
155278184|NCT04445155|560451163|FG003|Overall Study|Lost to Follow-up|0|||
155278185|NCT04445155|560451160|FG000|Overall Study|Withdrawal by Subject|8|||
155278186|NCT04445155|560451161|FG001|Overall Study|Withdrawal by Subject|0|||
155278187|NCT04445155|560451162|FG002|Overall Study|Withdrawal by Subject|0|||
155278188|NCT04445155|560451163|FG003|Overall Study|Withdrawal by Subject|0|||
155278189|NCT04445155|560451160|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
155278190|NCT04445155|560451161|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278191|NCT04445155|560451162|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278192|NCT04445155|560451163|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278193|NCT04445155|560451160|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
155278194|NCT04445155|560451161|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155278195|NCT04445155|560451162|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155278196|NCT04445155|560451163|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155382218|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|poor data quality|0|||
155727593|NCT00001959|562102145|FG000|Overall Study|non-compliance|1|||
155727594|NCT02638220|562102151|FG000|Overall Study|Lost to Follow-up|6|||
155727595|NCT02638220|562102151|FG000|Overall Study|Withdrawal by Subject|3|||
155727596|NCT02638220|562102151|FG000|Overall Study|Physician Decision|1|||
155727597|NCT02638220|562102151|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
155727598|NCT04323124|562102153|FG000|Overall Study|Adverse Event|0|||
155727599|NCT04323124|562102154|FG001|Overall Study|Adverse Event|0|||
155727600|NCT04323124|562102155|FG002|Overall Study|Adverse Event|0|||
155727601|NCT04323124|562102156|FG003|Overall Study|Adverse Event|0|||
155727602|NCT04323124|562102157|FG004|Overall Study|Adverse Event|0|||
155727603|NCT04323124|562102158|FG005|Overall Study|Adverse Event|1|||
155727604|NCT04323124|562102159|FG006|Overall Study|Adverse Event|0|||
155727605|NCT04323124|562102160|FG007|Overall Study|Adverse Event|1|||
155727606|NCT04323124|562102161|FG008|Overall Study|Adverse Event|1|||
155727607|NCT04323124|562102162|FG009|Overall Study|Adverse Event|0|||
155727608|NCT04323124|562102163|FG010|Overall Study|Adverse Event|0|||
155727609|NCT04323124|562102164|FG011|Overall Study|Adverse Event|0|||
155727610|NCT04323124|562102165|FG012|Overall Study|Adverse Event|0|||
155727611|NCT04323124|562102166|FG013|Overall Study|Adverse Event|0|||
155727612|NCT04323124|562102167|FG014|Overall Study|Adverse Event|0|||
155727613|NCT04323124|562102153|FG000|Overall Study|Other|0|||
155727614|NCT04323124|562102154|FG001|Overall Study|Other|0|||
155727615|NCT04323124|562102155|FG002|Overall Study|Other|0|||
155727616|NCT04323124|562102156|FG003|Overall Study|Other|0|||
155727617|NCT04323124|562102157|FG004|Overall Study|Other|1|||
155727618|NCT04323124|562102158|FG005|Overall Study|Other|0|||
155727619|NCT04323124|562102159|FG006|Overall Study|Other|0|||
155727620|NCT04323124|562102160|FG007|Overall Study|Other|0|||
155727621|NCT04323124|562102161|FG008|Overall Study|Other|1|||
155727622|NCT04323124|562102162|FG009|Overall Study|Other|0|||
155727623|NCT04323124|562102163|FG010|Overall Study|Other|0|||
155727624|NCT04323124|562102164|FG011|Overall Study|Other|0|||
155727625|NCT04323124|562102165|FG012|Overall Study|Other|0|||
155727626|NCT04323124|562102166|FG013|Overall Study|Other|0|||
155727627|NCT04323124|562102167|FG014|Overall Study|Other|0|||
155727628|NCT04323124|562102153|FG000|Overall Study|Coming from a red zone (COVID)|0|||
155727629|NCT04323124|562102154|FG001|Overall Study|Coming from a red zone (COVID)|0|||
155727630|NCT04323124|562102155|FG002|Overall Study|Coming from a red zone (COVID)|0|||
155727631|NCT04323124|562102156|FG003|Overall Study|Coming from a red zone (COVID)|0|||
155727632|NCT04323124|562102157|FG004|Overall Study|Coming from a red zone (COVID)|1|||
155727633|NCT04323124|562102158|FG005|Overall Study|Coming from a red zone (COVID)|1|||
155727634|NCT04323124|562102159|FG006|Overall Study|Coming from a red zone (COVID)|0|||
155727635|NCT04323124|562102160|FG007|Overall Study|Coming from a red zone (COVID)|0|||
155727636|NCT04323124|562102161|FG008|Overall Study|Coming from a red zone (COVID)|0|||
155727637|NCT04323124|562102162|FG009|Overall Study|Coming from a red zone (COVID)|0|||
155727638|NCT04323124|562102163|FG010|Overall Study|Coming from a red zone (COVID)|0|||
155727639|NCT04323124|562102164|FG011|Overall Study|Coming from a red zone (COVID)|0|||
155727640|NCT04323124|562102165|FG012|Overall Study|Coming from a red zone (COVID)|0|||
155727641|NCT04323124|562102166|FG013|Overall Study|Coming from a red zone (COVID)|0|||
155727642|NCT04323124|562102167|FG014|Overall Study|Coming from a red zone (COVID)|0|||
155727643|NCT04323124|562102153|FG000|Overall Study|No longer meets eligibility criteria|0|||
155727644|NCT04323124|562102154|FG001|Overall Study|No longer meets eligibility criteria|0|||
155727645|NCT04323124|562102155|FG002|Overall Study|No longer meets eligibility criteria|0|||
155727646|NCT04323124|562102156|FG003|Overall Study|No longer meets eligibility criteria|0|||
155727647|NCT04323124|562102157|FG004|Overall Study|No longer meets eligibility criteria|0|||
155727648|NCT04323124|562102158|FG005|Overall Study|No longer meets eligibility criteria|0|||
155727649|NCT04323124|562102159|FG006|Overall Study|No longer meets eligibility criteria|0|||
155727650|NCT04323124|562102160|FG007|Overall Study|No longer meets eligibility criteria|1|||
155727651|NCT04323124|562102161|FG008|Overall Study|No longer meets eligibility criteria|0|||
155727652|NCT04323124|562102162|FG009|Overall Study|No longer meets eligibility criteria|0|||
155727653|NCT04323124|562102163|FG010|Overall Study|No longer meets eligibility criteria|0|||
155727654|NCT04323124|562102164|FG011|Overall Study|No longer meets eligibility criteria|0|||
155727655|NCT04323124|562102165|FG012|Overall Study|No longer meets eligibility criteria|0|||
155727656|NCT04323124|562102166|FG013|Overall Study|No longer meets eligibility criteria|1|||
155727657|NCT04323124|562102167|FG014|Overall Study|No longer meets eligibility criteria|1|||
155727658|NCT04323124|562102153|FG000|Overall Study|Study terminated by sponsor|0|||
155727659|NCT04323124|562102154|FG001|Overall Study|Study terminated by sponsor|0|||
155727660|NCT04323124|562102155|FG002|Overall Study|Study terminated by sponsor|0|||
155727661|NCT04323124|562102156|FG003|Overall Study|Study terminated by sponsor|0|||
155727662|NCT04323124|562102157|FG004|Overall Study|Study terminated by sponsor|0|||
155727663|NCT04323124|562102158|FG005|Overall Study|Study terminated by sponsor|0|||
155727664|NCT04323124|562102159|FG006|Overall Study|Study terminated by sponsor|0|||
155727665|NCT04323124|562102160|FG007|Overall Study|Study terminated by sponsor|0|||
155727666|NCT04323124|562102161|FG008|Overall Study|Study terminated by sponsor|0|||
155727667|NCT04323124|562102162|FG009|Overall Study|Study terminated by sponsor|0|||
155624511|NCT01774981|561718576|FG004|Overall Study|Adverse Event|0|||
155727668|NCT04323124|562102163|FG010|Overall Study|Study terminated by sponsor|0|||
155727669|NCT04323124|562102164|FG011|Overall Study|Study terminated by sponsor|2|||
155727670|NCT04323124|562102165|FG012|Overall Study|Study terminated by sponsor|1|||
155727671|NCT04323124|562102166|FG013|Overall Study|Study terminated by sponsor|0|||
155727672|NCT04323124|562102167|FG014|Overall Study|Study terminated by sponsor|0|||
155727673|NCT03841604|562104137|FG000|Overall Study|Withdrawal by Subject|3|||
155727674|NCT03841604|562104138|FG001|Overall Study|Withdrawal by Subject|1|||
155727675|NCT03841604|562104137|FG000|Overall Study|Adverse Event|4|||
155727676|NCT03841604|562104138|FG001|Overall Study|Adverse Event|2|||
155727677|NCT03841604|562104137|FG000|Overall Study|Physician Decision|1|||
155727678|NCT03841604|562104138|FG001|Overall Study|Physician Decision|0|||
155727679|NCT01193244|562104139|FG000|Overall Study|Withdrawal by Subject|79|||
155727680|NCT01193244|562104140|FG001|Overall Study|Withdrawal by Subject|97|||
155727681|NCT01193244|562104139|FG000|Overall Study|Other|303|||
155727682|NCT01193244|562104140|FG001|Overall Study|Other|278|||
155727683|NCT01193244|562104139|FG000|Overall Study|Lost to Follow-up|6|||
155727684|NCT01193244|562104140|FG001|Overall Study|Lost to Follow-up|15|||
155727685|NCT01774721|562104147|FG000|Overall Study|Death|133|||
155727686|NCT01774721|562104148|FG001|Overall Study|Death|152|||
155727687|NCT01774721|562104147|FG000|Overall Study|Withdrawal by Subject|20|||
155727688|NCT01774721|562104148|FG001|Overall Study|Withdrawal by Subject|14|||
155727689|NCT01774721|562104147|FG000|Overall Study|Lost to Follow-up|6|||
155727690|NCT01774721|562104148|FG001|Overall Study|Lost to Follow-up|7|||
155727691|NCT01774721|562104147|FG000|Overall Study|Did not meet eligibility criteria|0|||
155727692|NCT01774721|562104148|FG001|Overall Study|Did not meet eligibility criteria|3|||
155727693|NCT01774721|562104147|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
155727694|NCT01774721|562104148|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
155727695|NCT01774721|562104147|FG000|Overall Study|Study terminated by sponsor|5|||
155727696|NCT01774721|562104148|FG001|Overall Study|Study terminated by sponsor|0|||
155727697|NCT01774721|562104147|FG000|Overall Study|Disease progression|5|||
155727698|NCT01774721|562104148|FG001|Overall Study|Disease progression|0|||
155727699|NCT01936870|562104149|FG000|Overall Study|No Visit After Treatment|176|||
155727700|NCT01936870|562104149|FG000|Overall Study|Protocol Violation|12|||
155727701|NCT01936870|562104149|FG000|Overall Study|No Drug Administration|1|||
155727702|NCT00248040|562104154|FG000|Overall Study|transplantectomy|2|||
155727703|NCT00248040|562104155|FG001|Overall Study|transplantectomy|1|||
155727704|NCT00248040|562104156|FG002|Overall Study|transplantectomy|3|||
155727705|NCT00248040|562104154|FG000|Overall Study|transplant cancelled post treat start|1|||
155727706|NCT00248040|562104155|FG001|Overall Study|transplant cancelled post treat start|0|||
155727707|NCT00248040|562104156|FG002|Overall Study|transplant cancelled post treat start|0|||
155727708|NCT00248040|562104154|FG000|Overall Study|Death|0|||
155727709|NCT00248040|562104155|FG001|Overall Study|Death|0|||
155727710|NCT00248040|562104156|FG002|Overall Study|Death|1|||
155727711|NCT00628108|562104164|FG000|Overall Study|Adverse Event|0|||
155727712|NCT00628108|562104165|FG001|Overall Study|Adverse Event|3|||
155727713|NCT00628108|562104164|FG000|Overall Study|Withdrawal by Subject|1|||
155727714|NCT00628108|562104165|FG001|Overall Study|Withdrawal by Subject|0|||
155727715|NCT03848832|562104166|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
155727716|NCT03848832|562104167|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
155727717|NCT03848832|562104168|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
155727718|NCT03848832|562104166|FG000|Overall Study|Withdrawal by Subject|0|||
155727719|NCT03848832|562104167|FG001|Overall Study|Withdrawal by Subject|0|||
155624512|NCT01774981|561718577|FG005|Overall Study|Adverse Event|1|||
155624513|NCT01774981|561718578|FG006|Overall Study|Adverse Event|0|||
155624514|NCT01774981|561718579|FG007|Overall Study|Adverse Event|0|||
155624515|NCT01774981|561718572|FG000|Overall Study|Withdrawal by Subject|0|||
155624516|NCT01774981|561718573|FG001|Overall Study|Withdrawal by Subject|0|||
155624517|NCT01774981|561718574|FG002|Overall Study|Withdrawal by Subject|0|||
155624518|NCT01774981|561718575|FG003|Overall Study|Withdrawal by Subject|0|||
155624519|NCT01774981|561718576|FG004|Overall Study|Withdrawal by Subject|0|||
155624520|NCT01774981|561718577|FG005|Overall Study|Withdrawal by Subject|0|||
155624521|NCT01774981|561718578|FG006|Overall Study|Withdrawal by Subject|0|||
155727720|NCT03848832|562104168|FG002|Overall Study|Withdrawal by Subject|1|||
155727721|NCT03848832|562104166|FG000|Overall Study|Withdrawal (Covid-19)|0|||
155727722|NCT03848832|562104167|FG001|Overall Study|Withdrawal (Covid-19)|2|||
155727723|NCT03848832|562104168|FG002|Overall Study|Withdrawal (Covid-19)|0|||
155624522|NCT01774981|561718579|FG007|Overall Study|Withdrawal by Subject|1|||
155727724|NCT03848832|562104166|FG000|Overall Study|Physician Decision|2|||
155727725|NCT03848832|562104167|FG001|Overall Study|Physician Decision|1|||
155727726|NCT03848832|562104168|FG002|Overall Study|Physician Decision|3|||
155727727|NCT03848832|562104166|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
155727728|NCT03848832|562104167|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
155727729|NCT03848832|562104168|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
155727730|NCT03848832|562104166|FG000|Overall Study|Adverse Event|1|||
155624523|NCT01774981|561718572|FG000|Overall Study|Death|0|||
155727731|NCT03848832|562104167|FG001|Overall Study|Adverse Event|0|||
155727732|NCT03848832|562104168|FG002|Overall Study|Adverse Event|0|||
155727733|NCT01760733|562104170|FG000|Waiting List|Death|18|||
155727734|NCT01760733|562104170|FG000|Waiting List|Removed from waiting list|41|||
155624524|NCT01774981|561718573|FG001|Overall Study|Death|0|||
155624525|NCT01774981|561718574|FG002|Overall Study|Death|0|||
155624526|NCT01774981|561718575|FG003|Overall Study|Death|0|||
155727735|NCT01760733|562104170|FG000|Waiting List|Not received a transplant yet|13|||
155727736|NCT01760733|562104170|FG000|Transplanted|Not reached 10 years post transplant|184|||
155727737|NCT01760733|562104170|FG000|Transplanted|Death|26|||
155727738|NCT01760733|562104170|FG000|Transplanted|Graft loss|7|||
155727739|NCT00815659|562104171|FG000|Overall Study|Adverse Event|9|||
155727740|NCT00815659|562104171|FG000|Overall Study|Withdrawal by Subject|9|||
155727741|NCT00815659|562104171|FG000|Overall Study|Lost to Follow-up|4|||
155727742|NCT00815659|562104171|FG000|Overall Study|Protocol Violation|1|||
155727743|NCT00719472|562104172|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
155727744|NCT00719472|562104172|FG000|Enrolled in Study|Subject decision to withdraw|8|||
155727745|NCT00719472|562104172|FG000|Enrolled in Study|Various Reasons|17|||
155727746|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
155727747|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Death|5|||
155727748|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
155727749|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
155727750|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
155727751|NCT00719472|562104172|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
155727752|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
155727753|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Death|6|||
155727754|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Disease progression|3|||
155727755|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
155727756|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
155727757|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
155727758|NCT00719472|562104172|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
155727759|NCT02395471|562104173|FG000|Overall Study|Lost to Follow-up|2|||
155727760|NCT02395471|562104174|FG001|Overall Study|Lost to Follow-up|0|||
155727761|NCT02395471|562104173|FG000|Overall Study|Withdrawal by Subject|2|||
155727762|NCT02395471|562104174|FG001|Overall Study|Withdrawal by Subject|1|||
155727763|NCT02395471|562104173|FG000|Overall Study|Physician Decision|1|||
155727764|NCT02395471|562104174|FG001|Overall Study|Physician Decision|0|||
155727765|NCT02395471|562104173|FG000|Overall Study|Protocol Violation|0|||
155727766|NCT02395471|562104174|FG001|Overall Study|Protocol Violation|1|||
155727767|NCT02395471|562104173|FG000|Overall Study|Failure to swollow sponge twice|1|||
155727768|NCT02395471|562104174|FG001|Overall Study|Failure to swollow sponge twice|0|||
155727769|NCT02395471|562104173|FG000|Overall Study|Patient did not return for procedure|0|||
155727770|NCT02395471|562104174|FG001|Overall Study|Patient did not return for procedure|1|||
155727771|NCT02395471|562104173|FG000|Overall Study|Subject not eligible|1|||
155624527|NCT01774981|561718576|FG004|Overall Study|Death|1|||
155624528|NCT01774981|561718577|FG005|Overall Study|Death|0|||
155624529|NCT01774981|561718578|FG006|Overall Study|Death|0|||
155624530|NCT01774981|561718579|FG007|Overall Study|Death|0|||
155624531|NCT00960193|561718580|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
155624532|NCT01324102|561718583|FG000|Overall Study|illness|1|||
155624533|NCT01324102|561718584|FG001|Overall Study|illness|6|||
155624534|NCT00728494|561718585|FG000|Overall Study|Adverse Event|7|||
155624535|NCT00728494|561718586|FG001|Overall Study|Adverse Event|0|||
155624536|NCT00728494|561718585|FG000|Overall Study|Withdrawal by Subject|0|||
155624537|NCT00728494|561718586|FG001|Overall Study|Withdrawal by Subject|2|||
155624538|NCT00728494|561718585|FG000|Overall Study|Lack of Efficacy|2|||
155624539|NCT00728494|561718586|FG001|Overall Study|Lack of Efficacy|4|||
155624540|NCT00728494|561718585|FG000|Overall Study|No data available|0|||
155624541|NCT00728494|561718586|FG001|Overall Study|No data available|1|||
155624542|NCT00001566|561718587|FG000|Overall Study|patients' choice to discontinue protocol|3|||
155624543|NCT00001566|561718587|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
155624544|NCT00001566|561718587|FG000|Overall Study|Death|13|||
155624545|NCT00001566|561718587|FG000|Overall Study|Lost to Follow-up|1|||
155624546|NCT00001566|561718587|FG000|Overall Study|unable to complete initial apheresis|1|||
155624547|NCT03669549|561718588|FG000|Overall Study|Adverse Event|4|||
155624548|NCT03669549|561718588|FG000|Overall Study|Withdrawal by Subject|1|||
155624549|NCT03669549|561718588|FG000|Overall Study|Study terminated by the Sponsor|1|||
155727772|NCT02395471|562104174|FG001|Overall Study|Subject not eligible|0|||
155727773|NCT03847896|562104175|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155727774|NCT03847896|562104176|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155727775|NCT03847896|562104177|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
155624550|NCT00909844|561718589|FG000|Overall Study|Adverse Event|1|||
155624551|NCT00909844|561718589|FG000|Overall Study|Withdrawal by Subject|1|||
155624552|NCT00909844|561718589|FG000|Overall Study|Lost to Follow-up|2|||
155624553|NCT00706004|561718591|FG000|Overall Study|Did not meet eligibility criteria|2|||
155727776|NCT03847896|562104178|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155727777|NCT03847896|562104179|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155727778|NCT03847896|562104175|FG000|Overall Study|Withdrawal by Subject|2|||
155727779|NCT03847896|562104176|FG001|Overall Study|Withdrawal by Subject|10|||
155727780|NCT03847896|562104177|FG002|Overall Study|Withdrawal by Subject|5|||
155727781|NCT03847896|562104178|FG003|Overall Study|Withdrawal by Subject|9|||
155727782|NCT03847896|562104179|FG004|Overall Study|Withdrawal by Subject|8|||
155727783|NCT03847896|562104175|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155727784|NCT03847896|562104176|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155727785|NCT03847896|562104177|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155727786|NCT03847896|562104178|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155727787|NCT03847896|562104179|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155727788|NCT03847896|562104175|FG000|Overall Study|Adverse Event|2|||
155727789|NCT03847896|562104176|FG001|Overall Study|Adverse Event|1|||
155727790|NCT03847896|562104177|FG002|Overall Study|Adverse Event|3|||
155727791|NCT03847896|562104178|FG003|Overall Study|Adverse Event|2|||
155727792|NCT03847896|562104179|FG004|Overall Study|Adverse Event|4|||
155727793|NCT03847896|562104175|FG000|Overall Study|A severe exacerbation event|0|||
155727794|NCT03847896|562104176|FG001|Overall Study|A severe exacerbation event|0|||
155624554|NCT03575702|561718593|FG000|Overall Study|Withdrawal by Subject|1|||
155278197|NCT00810641|560451166|FG000|Overall Study|Withdrawal by Subject|0|||
155278198|NCT00810641|560451167|FG001|Overall Study|Withdrawal by Subject|1|||
155278199|NCT00810641|560451168|FG002|Overall Study|Withdrawal by Subject|2|||
155278200|NCT02325713|560451171|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278201|NCT02325713|560451172|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278202|NCT02325713|560451173|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278203|NCT02325713|560451174|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278204|NCT02325713|560451175|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278205|NCT02325713|560451176|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278206|NCT02325713|560451177|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278207|NCT02325713|560451178|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155624555|NCT03575702|561718594|FG001|Overall Study|Withdrawal by Subject|1|||
155624556|NCT03575702|561718593|FG000|Overall Study|Lost to Follow-up|1|||
155624557|NCT03575702|561718594|FG001|Overall Study|Lost to Follow-up|2|||
155624558|NCT03575702|561718593|FG000|Overall Study|Protocol Violation|0|||
155624559|NCT03575702|561718594|FG001|Overall Study|Protocol Violation|1|||
155624560|NCT03575702|561718593|FG000|Overall Study|Patient non compliance|4|||
155624561|NCT03575702|561718594|FG001|Overall Study|Patient non compliance|0|||
155624562|NCT01701674|561718595|FG000|Overall Study|Unable to safely complete treatment|1|||
155624563|NCT05276973|561718596|FG000|Overall Study|Treated and DLT unevaluable|1|||
155624564|NCT05276973|561718597|FG001|Overall Study|Treated and DLT unevaluable|1|||
155624565|NCT05276973|561718598|FG002|Overall Study|Treated and DLT unevaluable|0|||
155624566|NCT01946204|561718599|FG000|Overall Study|Death|38|||
155624567|NCT01946204|561718600|FG001|Overall Study|Death|59|||
155624568|NCT01946204|561718599|FG000|Overall Study|Withdrawal by Subject|37|||
155624569|NCT01946204|561718600|FG001|Overall Study|Withdrawal by Subject|50|||
155624570|NCT01946204|561718599|FG000|Overall Study|Lost to Follow-up|3|||
155727795|NCT03847896|562104177|FG002|Overall Study|A severe exacerbation event|0|||
155727796|NCT03847896|562104178|FG003|Overall Study|A severe exacerbation event|0|||
155727797|NCT03847896|562104179|FG004|Overall Study|A severe exacerbation event|3|||
155727798|NCT03847896|562104175|FG000|Overall Study|Protocol Violation|0|||
155727799|NCT03847896|562104176|FG001|Overall Study|Protocol Violation|2|||
155727800|NCT03847896|562104177|FG002|Overall Study|Protocol Violation|1|||
155727801|NCT03847896|562104178|FG003|Overall Study|Protocol Violation|0|||
155727802|NCT03847896|562104179|FG004|Overall Study|Protocol Violation|2|||
155727803|NCT03847896|562104175|FG000|Overall Study|Lost to Follow-up|0|||
155727804|NCT03847896|562104176|FG001|Overall Study|Lost to Follow-up|0|||
155727805|NCT03847896|562104177|FG002|Overall Study|Lost to Follow-up|0|||
155727806|NCT03847896|562104178|FG003|Overall Study|Lost to Follow-up|1|||
155727807|NCT03847896|562104179|FG004|Overall Study|Lost to Follow-up|0|||
155727808|NCT03847896|562104175|FG000|Overall Study|Condition under investigation worsened|0|||
155278208|NCT02325713|560451179|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278209|NCT02325713|560451180|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278210|NCT02325713|560451181|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
155278211|NCT02325713|560451182|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155624571|NCT01946204|561718600|FG001|Overall Study|Lost to Follow-up|7|||
155624572|NCT01946204|561718599|FG000|Overall Study|Ongoing|316|||
155624573|NCT01946204|561718600|FG001|Overall Study|Ongoing|687|||
155624574|NCT01946204|561718599|FG000|Overall Study|Other|7|||
155624575|NCT01946204|561718600|FG001|Overall Study|Other|3|||
155624576|NCT04782180|561718601|FG000|Overall Study|Withdrawal by Subject|2|||
155727809|NCT03847896|562104176|FG001|Overall Study|Condition under investigation worsened|0|||
155727810|NCT03847896|562104177|FG002|Overall Study|Condition under investigation worsened|0|||
155624577|NCT04782180|561718601|FG000|Overall Study|Lost to Follow-up|2|||
155727811|NCT03847896|562104178|FG003|Overall Study|Condition under investigation worsened|1|||
155727812|NCT03847896|562104179|FG004|Overall Study|Condition under investigation worsened|1|||
155727813|NCT03847896|562104175|FG000|Overall Study|Lack of Efficacy|0|||
155727814|NCT03847896|562104176|FG001|Overall Study|Lack of Efficacy|0|||
155727815|NCT03847896|562104177|FG002|Overall Study|Lack of Efficacy|0|||
155727816|NCT03847896|562104178|FG003|Overall Study|Lack of Efficacy|2|||
155727817|NCT03847896|562104179|FG004|Overall Study|Lack of Efficacy|2|||
155727818|NCT03847896|562104175|FG000|Overall Study|Other reasons|3|||
155727819|NCT03847896|562104176|FG001|Overall Study|Other reasons|3|||
155727820|NCT03847896|562104177|FG002|Overall Study|Other reasons|1|||
155727821|NCT03847896|562104178|FG003|Overall Study|Other reasons|2|||
155727822|NCT03847896|562104179|FG004|Overall Study|Other reasons|1|||
155727823|NCT00118417|562104180|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
155727824|NCT00118417|562104181|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
155727825|NCT00118417|562104180|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
155727826|NCT00118417|562104181|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
155727827|NCT00118417|562104180|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
155727828|NCT00118417|562104181|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
155727829|NCT00118417|562104180|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
155727830|NCT00118417|562104181|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
155727831|NCT00118417|562104180|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
155727832|NCT00118417|562104181|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
155727833|NCT02978781|562104182|FG000|Part A|Adverse Event|1|||
155727834|NCT02978781|562104183|FG001|Part A|Adverse Event|1|||
155727835|NCT02978781|562104184|FG002|Part A|Adverse Event|0|||
155727836|NCT02978781|562104185|FG003|Part A|Adverse Event|0|||
155727837|NCT02978781|562104186|FG004|Part A|Adverse Event|0|||
155727838|NCT02978781|562104182|FG000|Part A|Withdrawal by Subject|0|||
155727839|NCT02978781|562104183|FG001|Part A|Withdrawal by Subject|1|||
155727840|NCT02978781|562104184|FG002|Part A|Withdrawal by Subject|0|||
155727841|NCT02978781|562104185|FG003|Part A|Withdrawal by Subject|0|||
155727842|NCT02978781|562104186|FG004|Part A|Withdrawal by Subject|0|||
155727843|NCT02978781|562104182|FG000|Part B|Withdrawal by Subject|0|||
155727844|NCT02978781|562104183|FG001|Part B|Withdrawal by Subject|0|||
155727845|NCT02978781|562104184|FG002|Part B|Withdrawal by Subject|0|||
155727846|NCT02978781|562104185|FG003|Part B|Withdrawal by Subject|1|||
155727847|NCT02978781|562104186|FG004|Part B|Withdrawal by Subject|0|||
155727848|NCT02978781|562104182|FG000|Part C|Adverse Event|0|||
155727849|NCT02978781|562104183|FG001|Part C|Adverse Event|0|||
155727850|NCT02978781|562104184|FG002|Part C|Adverse Event|0|||
155727851|NCT02978781|562104185|FG003|Part C|Adverse Event|0|||
155727852|NCT02978781|562104186|FG004|Part C|Adverse Event|2|||
155727853|NCT02978781|562104182|FG000|Part C|Withdrawal by Subject|0|||
155727854|NCT02978781|562104183|FG001|Part C|Withdrawal by Subject|0|||
155727855|NCT02978781|562104184|FG002|Part C|Withdrawal by Subject|0|||
155727856|NCT02978781|562104185|FG003|Part C|Withdrawal by Subject|0|||
155727857|NCT02978781|562104186|FG004|Part C|Withdrawal by Subject|1|||
155727858|NCT02978781|562104182|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
155727859|NCT02978781|562104183|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
155727860|NCT02978781|562104184|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
155727861|NCT02978781|562104185|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
155727862|NCT02978781|562104186|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
155727863|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
155727864|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
155727865|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Adverse Event|31|||
155727866|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Adverse Event|21|||
155727867|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
155727868|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
155727869|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
155727870|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
155727871|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
155727872|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
155727873|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
155727874|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
155727875|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Administrative problems|3|||
155727876|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Administrative problems|3|||
155727877|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Death|5|||
155727878|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Death|8|||
155727879|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Disease progression|139|||
155727880|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Disease progression|119|||
155727881|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
155727882|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
155727883|NCT00785785|562104187|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
155727884|NCT00785785|562104188|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
155727885|NCT00785785|562104187|FG000|Optional Extension Phase|Adverse Event|4|||
155624578|NCT06077773|561718604|FG000|Overall Study|Withdrawal by Subject|1|||
155624579|NCT06077773|561718605|FG001|Overall Study|Withdrawal by Subject|0|||
155624580|NCT06077773|561718606|FG002|Overall Study|Withdrawal by Subject|1|||
155624581|NCT06077773|561718604|FG000|Overall Study|Lost to Follow-up|0|||
155624582|NCT06077773|561718605|FG001|Overall Study|Lost to Follow-up|1|||
155624583|NCT06077773|561718606|FG002|Overall Study|Lost to Follow-up|0|||
155624584|NCT06077773|561718604|FG000|Overall Study|Adverse Event|0|||
155278212|NCT02325713|560451183|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278213|NCT02325713|560451184|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278214|NCT02325713|560451185|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278215|NCT02325713|560451186|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278216|NCT02325713|560451171|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
155278217|NCT02325713|560451172|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278218|NCT02325713|560451173|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278219|NCT02325713|560451174|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278220|NCT02325713|560451175|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278221|NCT02325713|560451176|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278222|NCT02325713|560451177|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278223|NCT02325713|560451178|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278224|NCT02325713|560451179|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278225|NCT02325713|560451180|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278226|NCT02325713|560451181|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278227|NCT02325713|560451182|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278228|NCT02325713|560451183|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278229|NCT02325713|560451184|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278230|NCT02325713|560451185|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278231|NCT02325713|560451186|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278232|NCT02325713|560451171|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278233|NCT02325713|560451172|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278234|NCT02325713|560451173|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278235|NCT02325713|560451174|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278236|NCT02325713|560451175|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278237|NCT02325713|560451176|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278238|NCT02325713|560451177|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278239|NCT02325713|560451178|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278240|NCT02325713|560451179|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278241|NCT02325713|560451180|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
155278242|NCT02325713|560451181|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278243|NCT02325713|560451182|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278244|NCT02325713|560451183|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278245|NCT02325713|560451184|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278246|NCT02325713|560451185|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278247|NCT02325713|560451186|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278248|NCT03363659|560451187|FG000|Overall Study|Adverse Event|1|||
155278249|NCT03363659|560451187|FG000|Overall Study|Screen fail|1|||
155278250|NCT03363659|560451187|FG000|Overall Study|Withdrawal by Subject|1|||
155278251|NCT01213173|560451189|FG000|Overall Study|Protocol Violation|2|||
155278252|NCT01213173|560451190|FG001|Overall Study|Protocol Violation|0|||
155278253|NCT01213173|560451189|FG000|Overall Study|Adverse Event|4|||
155278254|NCT01213173|560451190|FG001|Overall Study|Adverse Event|8|||
155278255|NCT01213173|560451189|FG000|Overall Study|Withdrawal by Subject|5|||
155278256|NCT01213173|560451190|FG001|Overall Study|Withdrawal by Subject|5|||
155278257|NCT01213173|560451189|FG000|Overall Study|Incorrect Enrollment|1|||
155278258|NCT01213173|560451190|FG001|Overall Study|Incorrect Enrollment|3|||
155278259|NCT02253316|560451191|FG000|Consolidation|Progression|4|||
155278260|NCT02253316|560451192|FG001|Consolidation|Progression|0|||
155278261|NCT02253316|560451193|FG002|Consolidation|Progression|0|||
155278262|NCT02253316|560451191|FG000|Consolidation|Non-Compliance|1|||
155278263|NCT02253316|560451192|FG001|Consolidation|Non-Compliance|0|||
155278264|NCT02253316|560451193|FG002|Consolidation|Non-Compliance|0|||
155278265|NCT02253316|560451191|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
155278266|NCT02253316|560451192|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
155278267|NCT02253316|560451193|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
155278268|NCT02253316|560451191|FG000|Consolidation|Secondary Malignancy|2|||
155278269|NCT02253316|560451192|FG001|Consolidation|Secondary Malignancy|0|||
155278270|NCT02253316|560451193|FG002|Consolidation|Secondary Malignancy|0|||
155278271|NCT02253316|560451191|FG000|Consolidation|Adverse Event|7|||
155278272|NCT02253316|560451192|FG001|Consolidation|Adverse Event|0|||
155278273|NCT02253316|560451193|FG002|Consolidation|Adverse Event|0|||
155278274|NCT02253316|560451191|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
155624585|NCT06077773|561718605|FG001|Overall Study|Adverse Event|0|||
155278275|NCT02253316|560451192|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
155278276|NCT02253316|560451193|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
155278277|NCT02253316|560451191|FG000|Maintenance|Physician Decision|0|||
155278278|NCT02253316|560451192|FG001|Maintenance|Physician Decision|7|||
155278279|NCT02253316|560451193|FG002|Maintenance|Physician Decision|16|||
155278280|NCT02253316|560451191|FG000|Maintenance|Non-Compliance|0|||
155278281|NCT02253316|560451192|FG001|Maintenance|Non-Compliance|1|||
155278282|NCT02253316|560451193|FG002|Maintenance|Non-Compliance|1|||
155278283|NCT02253316|560451191|FG000|Maintenance|Secondary Malignancy|0|||
155278284|NCT02253316|560451192|FG001|Maintenance|Secondary Malignancy|2|||
155278285|NCT02253316|560451193|FG002|Maintenance|Secondary Malignancy|6|||
155278286|NCT02253316|560451191|FG000|Maintenance|Adverse Event|0|||
155278287|NCT02253316|560451192|FG001|Maintenance|Adverse Event|8|||
155278288|NCT02253316|560451193|FG002|Maintenance|Adverse Event|12|||
155278289|NCT02253316|560451191|FG000|Maintenance|Still receiving active treatment|0|||
155278290|NCT02253316|560451192|FG001|Maintenance|Still receiving active treatment|4|||
155278291|NCT02253316|560451193|FG002|Maintenance|Still receiving active treatment|0|||
155278292|NCT02353832|560451194|FG000|Overall Study|Ineligible after enrollment|1|||
155278293|NCT02353832|560451194|FG000|Overall Study|Lost to Follow-up|1|||
155278294|NCT00904150|560451195|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
155278295|NCT00904150|560451196|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
155278296|NCT00904150|560451195|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
155278297|NCT00904150|560451196|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
155278298|NCT02692235|560453123|FG000|Overall Study|Withdrawal by Subject|2|||
155278299|NCT02692235|560453124|FG001|Overall Study|Withdrawal by Subject|1|||
155278300|NCT02692235|560453123|FG000|Overall Study|Adverse Event|1|||
155278301|NCT02692235|560453124|FG001|Overall Study|Adverse Event|2|||
155278302|NCT00802841|560453125|FG000|Overall Study|Administrative problems|1|||
155278303|NCT00802841|560453126|FG001|Overall Study|Administrative problems|0|||
155278304|NCT00802841|560453125|FG000|Overall Study|Lost to Follow-up|2|||
155624586|NCT06077773|561718606|FG002|Overall Study|Adverse Event|2|||
155624587|NCT04275973|561718607|FG000|Overall Study|Withdrawal by Subject|2|||
155624588|NCT04275973|561718608|FG001|Overall Study|Withdrawal by Subject|1|||
155624589|NCT06110754|561718609|FG000|Overall Study|Withdrawal by Subject|0|||
155624590|NCT06110754|561718610|FG001|Overall Study|Withdrawal by Subject|0|||
155624591|NCT06110754|561718611|FG002|Overall Study|Withdrawal by Subject|1|||
155624592|NCT06110754|561718612|FG003|Overall Study|Withdrawal by Subject|0|||
155624593|NCT02499146|561718615|FG000|Overall Study|Global deterioration of health status|1|||
155624594|NCT02499146|561718615|FG000|Overall Study|Objective progression or relapse|20|||
155624595|NCT02499146|561718615|FG000|Overall Study|Other|2|||
155624596|NCT02499146|561718615|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
155624597|NCT04325828|561718616|FG000|Overall Study|Ongoing|26|||
155624598|NCT05115630|561718617|FG000|Overall Study|Due to COVID19|1|||
155624599|NCT05115630|561718617|FG000|Overall Study|Due to Bacteremia|1|||
155624600|NCT05115630|561718617|FG000|Overall Study|Due to viral infection|1|||
155624601|NCT05093933|561718618|FG000|Overall Study|Death|372|||
155624602|NCT05093933|561718619|FG001|Overall Study|Death|434|||
155624603|NCT05093933|561718618|FG000|Overall Study|Lost to Follow-up|13|||
155624604|NCT05093933|561718619|FG001|Overall Study|Lost to Follow-up|16|||
155624605|NCT05093933|561718618|FG000|Overall Study|Physician Decision|0|||
155624606|NCT05093933|561718619|FG001|Overall Study|Physician Decision|2|||
155624607|NCT05093933|561718618|FG000|Overall Study|Sponsor Decision|1|||
155624608|NCT05093933|561718619|FG001|Overall Study|Sponsor Decision|3|||
155624609|NCT05093933|561718618|FG000|Overall Study|Withdrawal by Guardian|1|||
155624610|NCT05093933|561718619|FG001|Overall Study|Withdrawal by Guardian|1|||
155624611|NCT05093933|561718618|FG000|Overall Study|Withdrawal by Subject|18|||
155624612|NCT05093933|561718619|FG001|Overall Study|Withdrawal by Subject|25|||
155624613|NCT01949142|561718621|FG000|Overall Study|Withdrawal of consent|1|||
155624614|NCT01949142|561718622|FG001|Overall Study|Withdrawal of consent|0|||
155624615|NCT01949142|561718621|FG000|Overall Study|Lost to Follow-up|1|||
155624616|NCT01949142|561718622|FG001|Overall Study|Lost to Follow-up|1|||
155624617|NCT01949142|561718621|FG000|Overall Study|Parent changed their mind|1|||
155624618|NCT01949142|561718622|FG001|Overall Study|Parent changed their mind|0|||
155624619|NCT05069259|561718623|FG000|Overall Study|Withdrawal by Subject|1|||
155624620|NCT05069259|561718623|FG000|Overall Study|Sponsor decision|1|||
155624621|NCT00870727|561720037|FG000|Overall Study|Lost to Follow-up|0|||
155624622|NCT00870727|561720038|FG001|Overall Study|Lost to Follow-up|1|||
155624623|NCT00870727|561720037|FG000|Overall Study|Lack of Efficacy|1|||
155624624|NCT00870727|561720038|FG001|Overall Study|Lack of Efficacy|3|||
155624625|NCT00870727|561720037|FG000|Overall Study|Adverse Event|0|||
155278305|NCT00802841|560453126|FG001|Overall Study|Lost to Follow-up|1|||
155278306|NCT00802841|560453125|FG000|Overall Study|Death|1|||
155278307|NCT00802841|560453126|FG001|Overall Study|Death|2|||
155278308|NCT00802841|560453125|FG000|Overall Study|Adverse Event|8|||
155278309|NCT00802841|560453126|FG001|Overall Study|Adverse Event|2|||
155278310|NCT00802841|560453125|FG000|Overall Study|Disease progression|7|||
155624626|NCT00870727|561720038|FG001|Overall Study|Adverse Event|1|||
155727886|NCT00785785|562104188|FG001|Optional Extension Phase|Adverse Event|5|||
155727887|NCT00785785|562104187|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
155727888|NCT00785785|562104188|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
155727889|NCT00785785|562104187|FG000|Optional Extension Phase|Lost to Follow-up|1|||
155727890|NCT00785785|562104188|FG001|Optional Extension Phase|Lost to Follow-up|0|||
155727891|NCT00785785|562104187|FG000|Optional Extension Phase|Administrative problems|2|||
155727892|NCT00785785|562104188|FG001|Optional Extension Phase|Administrative problems|0|||
155727893|NCT00785785|562104187|FG000|Optional Extension Phase|Death|1|||
155727894|NCT00785785|562104188|FG001|Optional Extension Phase|Death|5|||
155727895|NCT00785785|562104187|FG000|Optional Extension Phase|Disease progression|22|||
155727896|NCT00785785|562104188|FG001|Optional Extension Phase|Disease progression|70|||
155727897|NCT00785785|562104187|FG000|Optional Extension Phase|Protocol deviation|0|||
155727898|NCT00785785|562104188|FG001|Optional Extension Phase|Protocol deviation|2|||
155727899|NCT00785785|562104187|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
155727900|NCT00785785|562104188|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
155727901|NCT02453321|562104189|FG000|Overall Study|Weakness|1|||
155727902|NCT02453321|562104190|FG001|Overall Study|Weakness|1|||
155727903|NCT02453321|562104191|FG002|Overall Study|Weakness|2|||
155727904|NCT02453321|562104189|FG000|Overall Study|Deep Venous Thrombosis|0|||
155727905|NCT02453321|562104190|FG001|Overall Study|Deep Venous Thrombosis|1|||
155727906|NCT02453321|562104191|FG002|Overall Study|Deep Venous Thrombosis|0|||
155727907|NCT01244893|562104192|FG000|Baseline|Protocol Violation|0|||
155727908|NCT01244893|562104193|FG001|Baseline|Protocol Violation|1|||
155727909|NCT01244893|562104192|FG000|1-Week Follow Up|Lost to Follow-up|1|||
155727910|NCT01244893|562104193|FG001|1-Week Follow Up|Lost to Follow-up|0|||
155727911|NCT00357552|562104194|FG000|Screening|Did not meet eligibility criteria|84|||
155727912|NCT00357552|562104194|FG000|Weeks 0 to 24|Death|1|||
155727913|NCT00357552|562104194|FG000|Weeks 24 to 104|Death|3|||
155727914|NCT00357552|562104194|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
155727915|NCT00711191|562104201|FG000|Overall Study|Adverse Event|1|||
155727916|NCT00711191|562104202|FG001|Overall Study|Adverse Event|1|||
155727917|NCT00711191|562104203|FG002|Overall Study|Adverse Event|2|||
155727918|NCT00711191|562104201|FG000|Overall Study|Objective progression or relapse|2|||
155727919|NCT00711191|562104202|FG001|Overall Study|Objective progression or relapse|3|||
155727920|NCT00711191|562104203|FG002|Overall Study|Objective progression or relapse|7|||
155727921|NCT00711191|562104201|FG000|Overall Study|Withdrawal by Subject|0|||
155727922|NCT00711191|562104202|FG001|Overall Study|Withdrawal by Subject|1|||
155727923|NCT00711191|562104203|FG002|Overall Study|Withdrawal by Subject|3|||
155727924|NCT03926611|562104204|FG000|Overall Study|Adverse Event|0|||
155727925|NCT03926611|562104205|FG001|Overall Study|Adverse Event|0|||
155727926|NCT03926611|562104206|FG002|Overall Study|Adverse Event|0|||
155727927|NCT03926611|562104207|FG003|Overall Study|Adverse Event|3|||
155727928|NCT03926611|562104208|FG004|Overall Study|Adverse Event|1|||
155727929|NCT03926611|562104209|FG005|Overall Study|Adverse Event|3|||
155727930|NCT03926611|562104210|FG006|Overall Study|Adverse Event|0|||
155727931|NCT03926611|562104204|FG000|Overall Study|Lack of Efficacy|1|||
155727932|NCT03926611|562104205|FG001|Overall Study|Lack of Efficacy|2|||
155727933|NCT03926611|562104206|FG002|Overall Study|Lack of Efficacy|0|||
155727934|NCT03926611|562104207|FG003|Overall Study|Lack of Efficacy|0|||
155727935|NCT03926611|562104208|FG004|Overall Study|Lack of Efficacy|1|||
155727936|NCT03926611|562104209|FG005|Overall Study|Lack of Efficacy|0|||
155727937|NCT03926611|562104210|FG006|Overall Study|Lack of Efficacy|1|||
155727938|NCT03926611|562104204|FG000|Overall Study|Physician Decision|0|||
155727939|NCT03926611|562104205|FG001|Overall Study|Physician Decision|0|||
155727940|NCT03926611|562104206|FG002|Overall Study|Physician Decision|0|||
155727941|NCT03926611|562104207|FG003|Overall Study|Physician Decision|0|||
155727942|NCT03926611|562104208|FG004|Overall Study|Physician Decision|0|||
155727943|NCT03926611|562104209|FG005|Overall Study|Physician Decision|1|||
155727944|NCT03926611|562104210|FG006|Overall Study|Physician Decision|0|||
155727945|NCT03926611|562104204|FG000|Overall Study|Protocol Violation|1|||
155727946|NCT03926611|562104205|FG001|Overall Study|Protocol Violation|0|||
155727947|NCT03926611|562104206|FG002|Overall Study|Protocol Violation|0|||
155727948|NCT03926611|562104207|FG003|Overall Study|Protocol Violation|1|||
155727949|NCT03926611|562104208|FG004|Overall Study|Protocol Violation|1|||
155727950|NCT03926611|562104209|FG005|Overall Study|Protocol Violation|1|||
155727951|NCT03926611|562104210|FG006|Overall Study|Protocol Violation|1|||
155727952|NCT03926611|562104204|FG000|Overall Study|Technical problems|0|||
155727953|NCT03926611|562104205|FG001|Overall Study|Technical problems|0|||
155727954|NCT03926611|562104206|FG002|Overall Study|Technical problems|0|||
155727955|NCT03926611|562104207|FG003|Overall Study|Technical problems|0|||
155727956|NCT03926611|562104208|FG004|Overall Study|Technical problems|0|||
155727957|NCT03926611|562104209|FG005|Overall Study|Technical problems|1|||
155727958|NCT03926611|562104210|FG006|Overall Study|Technical problems|0|||
155727959|NCT03926611|562104204|FG000|Overall Study|Withdrawal by Subject|1|||
155727960|NCT03926611|562104205|FG001|Overall Study|Withdrawal by Subject|1|||
155727961|NCT03926611|562104206|FG002|Overall Study|Withdrawal by Subject|1|||
155727962|NCT03926611|562104207|FG003|Overall Study|Withdrawal by Subject|0|||
155727963|NCT03926611|562104208|FG004|Overall Study|Withdrawal by Subject|0|||
155278311|NCT00802841|560453126|FG001|Overall Study|Disease progression|3|||
155624627|NCT01712516|561720039|FG000|Overall Study|Technical problems|0|||
155624628|NCT01712516|561720040|FG001|Overall Study|Technical problems|0|||
155624629|NCT01712516|561720041|FG002|Overall Study|Technical problems|0|||
155624630|NCT01712516|561720042|FG003|Overall Study|Technical problems|2|||
155624631|NCT01712516|561720039|FG000|Overall Study|Lost to Follow-up|0|||
155624632|NCT01712516|561720040|FG001|Overall Study|Lost to Follow-up|0|||
155624633|NCT01712516|561720041|FG002|Overall Study|Lost to Follow-up|2|||
155624634|NCT01712516|561720042|FG003|Overall Study|Lost to Follow-up|1|||
155624635|NCT01712516|561720039|FG000|Overall Study|Death|0|||
155624636|NCT01712516|561720040|FG001|Overall Study|Death|1|||
155624637|NCT01712516|561720041|FG002|Overall Study|Death|0|||
155624638|NCT01712516|561720042|FG003|Overall Study|Death|0|||
155624639|NCT01712516|561720039|FG000|Overall Study|Protocol deviation|1|||
155624640|NCT01712516|561720040|FG001|Overall Study|Protocol deviation|0|||
155624641|NCT01712516|561720041|FG002|Overall Study|Protocol deviation|1|||
155624642|NCT01712516|561720042|FG003|Overall Study|Protocol deviation|0|||
155624643|NCT01712516|561720039|FG000|Overall Study|Physician Decision|2|||
155624644|NCT01712516|561720040|FG001|Overall Study|Physician Decision|0|||
155624645|NCT01712516|561720041|FG002|Overall Study|Physician Decision|0|||
155624646|NCT01712516|561720042|FG003|Overall Study|Physician Decision|1|||
155624647|NCT01712516|561720039|FG000|Overall Study|Withdrawal by Subject|3|||
155624648|NCT01712516|561720040|FG001|Overall Study|Withdrawal by Subject|9|||
155624649|NCT01712516|561720041|FG002|Overall Study|Withdrawal by Subject|3|||
155624650|NCT01712516|561720042|FG003|Overall Study|Withdrawal by Subject|9|||
155624651|NCT01251952|561720043|FG000|Overall Study|Adverse Event|1|||
155624652|NCT00496769|561720044|FG000|Double Blind|>=1 reason assigned per patient|558|||
155624653|NCT00496769|561720045|FG001|Double Blind|>=1 reason assigned per patient|649|||
155624654|NCT00496769|561720046|FG002|Double Blind|>=1 reason assigned per patient|0|||
155624655|NCT00496769|561720044|FG000|Open Label|>=1 reason assigned per patient|0|||
155624656|NCT00496769|561720045|FG001|Open Label|>=1 reason assigned per patient|0|||
155624657|NCT00496769|561720046|FG002|Open Label|>=1 reason assigned per patient|1011|||
155624658|NCT02224625|561720052|FG000|Irritation|Adverse Event|6|||
155624659|NCT02224625|561720052|FG000|Sensitization|Adverse Event|55|||
155624660|NCT01433159|561720056|FG000|Overall Study|Adverse Event|1|||
155624661|NCT01433159|561720057|FG001|Overall Study|Adverse Event|0|||
155624662|NCT01433159|561720056|FG000|Overall Study|Physician Decision|1|||
155624663|NCT01433159|561720057|FG001|Overall Study|Physician Decision|0|||
155624664|NCT01433159|561720056|FG000|Overall Study|Protocol Violation|0|||
155624665|NCT01433159|561720057|FG001|Overall Study|Protocol Violation|1|||
155624666|NCT01100853|561720058|FG000|Overall Study|Lost to Follow-up|11|||
155624667|NCT01100853|561720059|FG001|Overall Study|Lost to Follow-up|6|||
155624668|NCT01100853|561720058|FG000|Overall Study|Received <4 study injections|10|||
155624669|NCT01100853|561720059|FG001|Overall Study|Received <4 study injections|13|||
155624670|NCT01100853|561720058|FG000|Overall Study|Withdrawal by Subject|6|||
155624671|NCT01100853|561720059|FG001|Overall Study|Withdrawal by Subject|4|||
155624672|NCT01384877|561720060|FG000|Treatment 2|Lost to Follow-up|2|||
155624673|NCT01384877|561720061|FG001|Treatment 2|Lost to Follow-up|2|||
155624674|NCT01548404|561720062|FG000|Overall Study|Adverse Event|3|||
155624675|NCT01548404|561720063|FG001|Overall Study|Adverse Event|1|||
155624676|NCT01548404|561720062|FG000|Overall Study|Physician Decision|2|||
155624677|NCT01548404|561720063|FG001|Overall Study|Physician Decision|1|||
155624678|NCT01548404|561720062|FG000|Overall Study|Inadequate response to study treatment|23|||
155624679|NCT01548404|561720063|FG001|Overall Study|Inadequate response to study treatment|7|||
155624680|NCT01548404|561720062|FG000|Overall Study|Lost to Follow-up|2|||
155624681|NCT01548404|561720063|FG001|Overall Study|Lost to Follow-up|0|||
155624682|NCT01548404|561720062|FG000|Overall Study|Withdrawal by Subject|0|||
155624683|NCT01548404|561720063|FG001|Overall Study|Withdrawal by Subject|3|||
155624684|NCT01548404|561720062|FG000|Overall Study|Other than specified above|0|||
155624685|NCT01548404|561720063|FG001|Overall Study|Other than specified above|2|||
155624686|NCT00426270|561720064|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
155624687|NCT00426270|561720064|FG000|Overall Study|Adverse Event|5|||
155624688|NCT01117870|561720065|FG000|Overall Study|Inability to place needle|1|||
155624689|NCT01117870|561720066|FG001|Overall Study|Inability to place needle|0|||
155624690|NCT00433836|561720069|FG000|Overall Study|Adverse Event|7|||
155624691|NCT00433836|561720070|FG001|Overall Study|Adverse Event|0|||
155624692|NCT00433836|561720069|FG000|Overall Study|Lost to Follow-up|3|||
155624693|NCT00433836|561720070|FG001|Overall Study|Lost to Follow-up|0|||
155624694|NCT00433836|561720069|FG000|Overall Study|Withdrawal by Subject|2|||
155624695|NCT00433836|561720070|FG001|Overall Study|Withdrawal by Subject|1|||
155624696|NCT00433836|561720069|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155624697|NCT00433836|561720070|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155624698|NCT00433836|561720069|FG000|Overall Study|Protocol Violation|0|||
155278312|NCT00802841|560453125|FG000|Overall Study|Withdrawal by Subject|9|||
155624699|NCT00433836|561720070|FG001|Overall Study|Protocol Violation|2|||
155624700|NCT00433836|561720069|FG000|Overall Study|Condition no longer requires study drug|0|||
155624701|NCT00433836|561720070|FG001|Overall Study|Condition no longer requires study drug|1|||
155624702|NCT00433836|561720069|FG000|Overall Study|Abnormal laboratory values|0|||
155624703|NCT00433836|561720070|FG001|Overall Study|Abnormal laboratory values|1|||
155727964|NCT03926611|562104209|FG005|Overall Study|Withdrawal by Subject|1|||
155727965|NCT03926611|562104210|FG006|Overall Study|Withdrawal by Subject|3|||
155727966|NCT03926611|562104204|FG000|Overall Study|Covid-19 pandemic|0|||
155727967|NCT03926611|562104205|FG001|Overall Study|Covid-19 pandemic|0|||
155727968|NCT03926611|562104206|FG002|Overall Study|Covid-19 pandemic|1|||
155727969|NCT03926611|562104207|FG003|Overall Study|Covid-19 pandemic|0|||
155727970|NCT03926611|562104208|FG004|Overall Study|Covid-19 pandemic|1|||
155727971|NCT03926611|562104209|FG005|Overall Study|Covid-19 pandemic|2|||
155727972|NCT03926611|562104210|FG006|Overall Study|Covid-19 pandemic|0|||
155727973|NCT00084136|562104211|FG000|PI Comparison|Death|10|||
155727974|NCT00084136|562104212|FG001|PI Comparison|Death|9|||
155727975|NCT00084136|562104213|FG002|PI Comparison|Death|0|||
155727976|NCT00084136|562104211|FG000|PI Comparison|Lost to Follow-up|11|||
155727977|NCT00084136|562104212|FG001|PI Comparison|Lost to Follow-up|8|||
155727978|NCT00084136|562104213|FG002|PI Comparison|Lost to Follow-up|0|||
155727979|NCT00084136|562104211|FG000|PI Comparison|Withdrawal by Subject|33|||
155727980|NCT00084136|562104212|FG001|PI Comparison|Withdrawal by Subject|30|||
155727981|NCT00084136|562104213|FG002|PI Comparison|Withdrawal by Subject|0|||
155727982|NCT00084136|562104211|FG000|PI Comparison|Clinic site closed|1|||
155624704|NCT00748241|561720071|FG000|Overall Study|Implant failure|1|||
155624705|NCT00748241|561720071|FG000|Overall Study|Lost to Follow-up|5|||
155624706|NCT00748241|561720071|FG000|Overall Study|Death|2|||
155624707|NCT02456727|561720072|FG000|Overall Study|Lost to Follow-up|63|||
155624708|NCT02456727|561720073|FG001|Overall Study|Lost to Follow-up|65|||
155624709|NCT02456727|561720072|FG000|Overall Study|Death|2|||
155624710|NCT02456727|561720073|FG001|Overall Study|Death|1|||
155624711|NCT02456727|561720072|FG000|Overall Study|Withdrawal by Subject|1|||
155624712|NCT02456727|561720073|FG001|Overall Study|Withdrawal by Subject|10|||
155624713|NCT02456727|561720072|FG000|Overall Study|Never Initiated Treatment|43|||
155624714|NCT02456727|561720073|FG001|Overall Study|Never Initiated Treatment|30|||
155624715|NCT00492297|561720074|FG000|Treatment|Death|2|||
155624716|NCT00492297|561720074|FG000|Treatment|Study terminated by sponsor|3|||
155624717|NCT00492297|561720074|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
155624718|NCT00492297|561720074|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
155624719|NCT00492297|561720074|FG000|Survival Only Follow-up|Death|46|||
155624720|NCT00492297|561720074|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
155624721|NCT00492297|561720074|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
155624722|NCT00113607|561720075|FG000|Overall Study|Adverse Event|40|||
155624723|NCT00113607|561720076|FG001|Overall Study|Adverse Event|71|||
155624724|NCT00113607|561720075|FG000|Overall Study|Death|8|||
155624725|NCT00113607|561720076|FG001|Overall Study|Death|8|||
155624726|NCT00113607|561720075|FG000|Overall Study|Withdrawal by Subject|50|||
155624727|NCT00113607|561720076|FG001|Overall Study|Withdrawal by Subject|58|||
155624728|NCT00113607|561720075|FG000|Overall Study|Lost to Follow-up|0|||
155624729|NCT00113607|561720076|FG001|Overall Study|Lost to Follow-up|2|||
155624730|NCT00113607|561720075|FG000|Overall Study|Disease Progression|180|||
155624731|NCT00113607|561720076|FG001|Overall Study|Disease Progression|142|||
155624732|NCT00113607|561720075|FG000|Overall Study|Complete Response (Confirmed)|14|||
155624733|NCT00113607|561720076|FG001|Overall Study|Complete Response (Confirmed)|24|||
155624734|NCT00113607|561720075|FG000|Overall Study|Other|43|||
155624735|NCT00113607|561720076|FG001|Overall Study|Other|32|||
155624736|NCT02974868|561720077|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
155624737|NCT02974868|561720078|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
155624738|NCT02974868|561720079|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
155624739|NCT02974868|561720080|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
155624740|NCT02974868|561720077|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
155624741|NCT02974868|561720078|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
155624742|NCT02974868|561720079|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
155624743|NCT02974868|561720080|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
155624744|NCT02974868|561720077|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
155624745|NCT02974868|561720078|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
155624746|NCT02974868|561720079|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
155624747|NCT02974868|561720080|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
155624748|NCT02974868|561720077|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
155624749|NCT02974868|561720078|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
155624750|NCT02974868|561720079|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
155624751|NCT02974868|561720080|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
155624752|NCT02674516|561720081|FG000|Overall Study|Lost to Follow-up|3|||
155624753|NCT02674516|561720082|FG001|Overall Study|Lost to Follow-up|0|||
155624754|NCT02674516|561720081|FG000|Overall Study|Protocol Violation|0|||
155624755|NCT02674516|561720082|FG001|Overall Study|Protocol Violation|4|||
155624756|NCT02674516|561720081|FG000|Overall Study|Knowledge of study hypothesis|1|||
155624757|NCT02674516|561720082|FG001|Overall Study|Knowledge of study hypothesis|0|||
155624758|NCT01064479|561720083|FG000|Overall Study|Death|10|||
155727983|NCT00084136|562104212|FG001|PI Comparison|Clinic site closed|0|||
155624759|NCT01064479|561720084|FG001|Overall Study|Death|11|||
155624760|NCT01064479|561720083|FG000|Overall Study|Withdrawal by Subject|2|||
155624761|NCT01064479|561720084|FG001|Overall Study|Withdrawal by Subject|2|||
155624762|NCT01064479|561720083|FG000|Overall Study|Disease progression|1|||
155624763|NCT01064479|561720084|FG001|Overall Study|Disease progression|1|||
155624764|NCT01064479|561720083|FG000|Overall Study|Toxicity|1|||
155624765|NCT01064479|561720084|FG001|Overall Study|Toxicity|1|||
155624766|NCT01064479|561720083|FG000|Overall Study|Other|1|||
155624767|NCT01064479|561720084|FG001|Overall Study|Other|2|||
155624768|NCT00749398|561720085|FG000|Overall Study|Lack of Efficacy|7|||
155624769|NCT00749398|561720085|FG000|Overall Study|Adverse Event|4|||
155624770|NCT00749398|561720085|FG000|Overall Study|Serious adverse event|11|||
155624771|NCT00749398|561720085|FG000|Overall Study|Withdrawal by Subject|17|||
155624772|NCT00749398|561720085|FG000|Overall Study|Lost to Follow-up|11|||
155624773|NCT00749398|561720085|FG000|Overall Study|Reason not specified|2|||
155624774|NCT00749398|561720085|FG000|Overall Study|Unknown reason|1|||
155624775|NCT01663402|561720091|FG000|Overall Study|Randomized but not treated|19|||
155624776|NCT01663402|561720092|FG001|Overall Study|Randomized but not treated|11|||
155624777|NCT01663402|561720091|FG000|Overall Study|Adverse Event|347|||
155624778|NCT01663402|561720092|FG001|Overall Study|Adverse Event|362|||
155624779|NCT01663402|561720091|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
155624780|NCT01663402|561720092|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
155624781|NCT01663402|561720091|FG000|Overall Study|Poor compliance to protocol|529|||
155624782|NCT01663402|561720092|FG001|Overall Study|Poor compliance to protocol|454|||
155624783|NCT01663402|561720091|FG000|Overall Study|Physician Decision|77|||
155624784|NCT01663402|561720092|FG001|Overall Study|Physician Decision|62|||
155624785|NCT01663402|561720091|FG000|Overall Study|Site terminated by sponsor|1|||
155624786|NCT01663402|561720092|FG001|Overall Study|Site terminated by sponsor|3|||
155624787|NCT01663402|561720091|FG000|Overall Study|Participant moved|139|||
155624788|NCT01663402|561720092|FG001|Overall Study|Participant moved|104|||
155624789|NCT01663402|561720091|FG000|Overall Study|Withdrawal by Subject|118|||
155624790|NCT01663402|561720092|FG001|Overall Study|Withdrawal by Subject|91|||
155624791|NCT01663402|561720091|FG000|Overall Study|Related to study drug administration|96|||
155624792|NCT01663402|561720092|FG001|Overall Study|Related to study drug administration|105|||
155624793|NCT01663402|561720091|FG000|Overall Study|Lost to Follow-up|17|||
155624794|NCT01663402|561720092|FG001|Overall Study|Lost to Follow-up|15|||
155624795|NCT01663402|561720091|FG000|Overall Study|Other than specified above|172|||
155624796|NCT01663402|561720092|FG001|Overall Study|Other than specified above|147|||
155624797|NCT03903172|561720095|FG000|Overall Study|screen fail|4|||
155624798|NCT03903172|561720096|FG001|Overall Study|screen fail|1|||
155624799|NCT01900444|561720097|FG000|Overall Study|Protocol Violation|2|||
155624800|NCT01900444|561720097|FG000|Overall Study|Lost to Follow-up|1|||
155624801|NCT00072384|561720098|FG000|Overall Study|Physician Decision|1|||
155624802|NCT00072384|561720098|FG000|Overall Study|Ineligible|8|||
155624803|NCT01825200|561720103|FG000|Overall Study|Lost to Follow-up|5|||
155624804|NCT01825200|561720104|FG001|Overall Study|Lost to Follow-up|6|||
155624805|NCT01825200|561720103|FG000|Overall Study|Withdrawal by Subject|0|||
155624806|NCT01825200|561720104|FG001|Overall Study|Withdrawal by Subject|1|||
155624807|NCT00490035|561720105|FG000|Overall Study|AE, non-serious non-fatal|3|||
155624808|NCT00490035|561720106|FG001|Overall Study|AE, non-serious non-fatal|4|||
155624809|NCT00490035|561720107|FG002|Overall Study|AE, non-serious non-fatal|4|||
155624810|NCT00490035|561720108|FG003|Overall Study|AE, non-serious non-fatal|5|||
155624811|NCT00490035|561720105|FG000|Overall Study|Lost to Follow-up|2|||
155624812|NCT00490035|561720106|FG001|Overall Study|Lost to Follow-up|0|||
155624813|NCT00490035|561720107|FG002|Overall Study|Lost to Follow-up|1|||
155624814|NCT00490035|561720108|FG003|Overall Study|Lost to Follow-up|0|||
155624815|NCT00490035|561720105|FG000|Overall Study|Withdrawal by Subject|2|||
155624816|NCT00490035|561720106|FG001|Overall Study|Withdrawal by Subject|1|||
155624817|NCT00490035|561720107|FG002|Overall Study|Withdrawal by Subject|1|||
155624818|NCT00490035|561720108|FG003|Overall Study|Withdrawal by Subject|0|||
155624819|NCT00490035|561720105|FG000|Overall Study|Other reason|0|||
155624820|NCT00490035|561720106|FG001|Overall Study|Other reason|1|||
155624821|NCT00490035|561720107|FG002|Overall Study|Other reason|3|||
155624822|NCT00490035|561720108|FG003|Overall Study|Other reason|1|||
155624823|NCT00490035|561720105|FG000|Overall Study|AE, serious fatal|1|||
155624824|NCT00490035|561720106|FG001|Overall Study|AE, serious fatal|0|||
155624825|NCT00490035|561720107|FG002|Overall Study|AE, serious fatal|0|||
155624826|NCT00490035|561720108|FG003|Overall Study|AE, serious fatal|0|||
155624827|NCT00490035|561720105|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155624828|NCT00490035|561720106|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155624829|NCT00490035|561720107|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
155624830|NCT00490035|561720108|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155624831|NCT00490035|561720105|FG000|Overall Study|AE of unknown type|0|||
155624832|NCT00490035|561720106|FG001|Overall Study|AE of unknown type|0|||
155624833|NCT00490035|561720107|FG002|Overall Study|AE of unknown type|2|||
155624834|NCT00490035|561720108|FG003|Overall Study|AE of unknown type|0|||
155624835|NCT06058390|561720109|FG000|Overall Study|Lost to Follow-up|0|||
155624836|NCT06058390|561720110|FG001|Overall Study|Lost to Follow-up|0|||
155624837|NCT06058390|561720111|FG002|Overall Study|Lost to Follow-up|2|||
155624838|NCT06058390|561720112|FG003|Overall Study|Lost to Follow-up|1|||
155624839|NCT06058390|561720109|FG000|Overall Study|Physician Decision|0|||
155624840|NCT06058390|561720110|FG001|Overall Study|Physician Decision|0|||
155624841|NCT06058390|561720111|FG002|Overall Study|Physician Decision|0|||
155624842|NCT06058390|561720112|FG003|Overall Study|Physician Decision|1|||
155624843|NCT06058390|561720109|FG000|Overall Study|Participants did not receive any study intervention|0|||
155624844|NCT06058390|561720110|FG001|Overall Study|Participants did not receive any study intervention|0|||
155624845|NCT06058390|561720111|FG002|Overall Study|Participants did not receive any study intervention|0|||
155624846|NCT06058390|561720112|FG003|Overall Study|Participants did not receive any study intervention|1|||
155624847|NCT03585270|561720115|FG000|Overall Study|Withdrawal by Subject|2|||
155624848|NCT03585270|561720116|FG001|Overall Study|Withdrawal by Subject|6|||
155624849|NCT03585270|561720115|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
155727984|NCT00084136|562104213|FG002|PI Comparison|Clinic site closed|0|||
155624850|NCT03585270|561720116|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
155624851|NCT03585270|561720115|FG000|Overall Study|Adverse Event|5|||
155624852|NCT03585270|561720116|FG001|Overall Study|Adverse Event|2|||
155624853|NCT03585270|561720115|FG000|Overall Study|Lost to Follow-up|1|||
155727985|NCT00084136|562104211|FG000|NRTI Comparison|Death|20|||
155727986|NCT00084136|562104212|FG001|NRTI Comparison|Death|0|||
155624854|NCT03585270|561720116|FG001|Overall Study|Lost to Follow-up|4|||
155624855|NCT03585270|561720115|FG000|Overall Study|Death|5|||
155624856|NCT03585270|561720116|FG001|Overall Study|Death|3|||
155624857|NCT03585270|561720115|FG000|Overall Study|Other reasons|2|||
155624858|NCT03585270|561720116|FG001|Overall Study|Other reasons|2|||
155624859|NCT05559905|561720117|FG000|Overall Study|Withdrawal by Subject|1|||
155624860|NCT05559905|561720118|FG001|Overall Study|Withdrawal by Subject|0|||
155624861|NCT05559905|561720119|FG002|Overall Study|Withdrawal by Subject|0|||
155624862|NCT05559905|561720117|FG000|Overall Study|Not Reported|1|||
155624863|NCT05559905|561720118|FG001|Overall Study|Not Reported|0|||
155727987|NCT00084136|562104213|FG002|NRTI Comparison|Death|18|||
155727988|NCT00084136|562104211|FG000|NRTI Comparison|Lost to Follow-up|14|||
155727989|NCT00084136|562104212|FG001|NRTI Comparison|Lost to Follow-up|0|||
155727990|NCT00084136|562104213|FG002|NRTI Comparison|Lost to Follow-up|12|||
155727991|NCT00084136|562104211|FG000|NRTI Comparison|Withdrawal by Subject|54|||
155727992|NCT00084136|562104212|FG001|NRTI Comparison|Withdrawal by Subject|0|||
155727993|NCT00084136|562104213|FG002|NRTI Comparison|Withdrawal by Subject|38|||
155727994|NCT00084136|562104211|FG000|NRTI Comparison|Clinic site closed|12|||
155727995|NCT00084136|562104212|FG001|NRTI Comparison|Clinic site closed|0|||
155727996|NCT00084136|562104213|FG002|NRTI Comparison|Clinic site closed|14|||
155727997|NCT00084136|562104211|FG000|NRTI Comparison|Not reason above|1|||
155727998|NCT00084136|562104212|FG001|NRTI Comparison|Not reason above|0|||
155727999|NCT00084136|562104213|FG002|NRTI Comparison|Not reason above|0|||
155728000|NCT01524796|562104214|FG000|Overall Study|Adverse Event|13|||
155728001|NCT01524796|562104214|FG000|Overall Study|Lack of Efficacy|3|||
155728002|NCT01524796|562104214|FG000|Overall Study|Lost to Follow-up|1|||
155728003|NCT01524796|562104214|FG000|Overall Study|The price|1|||
155728004|NCT01524796|562104214|FG000|Overall Study|Withdrawal by Subject|4|||
155728005|NCT01524796|562104214|FG000|Overall Study|Move|1|||
155728006|NCT01524796|562104214|FG000|Overall Study|Deterioration of pains|1|||
155728007|NCT01524796|562104214|FG000|Overall Study|Gall stone surgery|1|||
155728008|NCT01524796|562104214|FG000|Overall Study|Nervous about confidentiality|1|||
155728009|NCT01524796|562104214|FG000|Overall Study|Switch to carbamazapine|1|||
155728010|NCT01524796|562104214|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
155728011|NCT02612779|562104220|FG000|Overall Study|Administrative reason by sponsor|4|||
155728012|NCT02612779|562104221|FG001|Overall Study|Administrative reason by sponsor|1|||
155728013|NCT02612779|562104220|FG000|Overall Study|No longer meet study criteria|0|||
155728014|NCT02612779|562104221|FG001|Overall Study|No longer meet study criteria|1|||
155728015|NCT02612779|562104220|FG000|Overall Study|Disease progression|29|||
155728016|NCT02612779|562104221|FG001|Overall Study|Disease progression|2|||
155728017|NCT02612779|562104220|FG000|Overall Study|Study drug toxicity|10|||
155728018|NCT02612779|562104221|FG001|Overall Study|Study drug toxicity|1|||
155728019|NCT02612779|562104220|FG000|Overall Study|Death|1|||
155728020|NCT02612779|562104221|FG001|Overall Study|Death|0|||
155728021|NCT02612779|562104220|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155728022|NCT02612779|562104221|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155728023|NCT02612779|562104220|FG000|Overall Study|Participant withdrew consent|4|||
155728024|NCT02612779|562104221|FG001|Overall Study|Participant withdrew consent|0|||
155728025|NCT02612779|562104220|FG000|Overall Study|Lost to Follow-up|1|||
155728026|NCT02612779|562104221|FG001|Overall Study|Lost to Follow-up|0|||
155728027|NCT02612779|562104220|FG000|Overall Study|Maximum clinical benefit|10|||
155728028|NCT02612779|562104221|FG001|Overall Study|Maximum clinical benefit|1|||
155728029|NCT02612779|562104220|FG000|Overall Study|Other reasons|4|||
155728030|NCT02612779|562104221|FG001|Overall Study|Other reasons|0|||
155624864|NCT05559905|561720119|FG002|Overall Study|Not Reported|0|||
155624865|NCT00485069|561720130|FG000|Overall Study|Adverse Event|10|||
155624866|NCT00485069|561720131|FG001|Overall Study|Adverse Event|4|||
155624867|NCT00485069|561720130|FG000|Overall Study|Lack of Efficacy|2|||
155624868|NCT00485069|561720131|FG001|Overall Study|Lack of Efficacy|1|||
155624869|NCT00485069|561720130|FG000|Overall Study|Protocol Violation|0|||
155624870|NCT00485069|561720131|FG001|Overall Study|Protocol Violation|1|||
155624871|NCT00485069|561720130|FG000|Overall Study|Withdrawal by Subject|6|||
155624872|NCT00485069|561720131|FG001|Overall Study|Withdrawal by Subject|6|||
155624873|NCT00086190|561720132|FG000|Overall Study|Adverse Event|6|||
155624874|NCT00086190|561720133|FG001|Overall Study|Adverse Event|2|||
155624875|NCT00086190|561720134|FG002|Overall Study|Adverse Event|2|||
155624876|NCT00086190|561720132|FG000|Overall Study|Withdrawal by Subject|0|||
155624877|NCT00086190|561720133|FG001|Overall Study|Withdrawal by Subject|2|||
155624878|NCT00086190|561720134|FG002|Overall Study|Withdrawal by Subject|2|||
155624879|NCT00086190|561720132|FG000|Overall Study|Protocol Violation|1|||
155624880|NCT00086190|561720133|FG001|Overall Study|Protocol Violation|0|||
155624881|NCT00086190|561720134|FG002|Overall Study|Protocol Violation|0|||
155624882|NCT00086190|561720132|FG000|Overall Study|Moved|1|||
155624883|NCT00086190|561720133|FG001|Overall Study|Moved|0|||
155624884|NCT00086190|561720134|FG002|Overall Study|Moved|0|||
155624885|NCT00086190|561720132|FG000|Overall Study|Worsening depression|0|||
155624886|NCT00086190|561720133|FG001|Overall Study|Worsening depression|0|||
155624887|NCT00086190|561720134|FG002|Overall Study|Worsening depression|2|||
155624888|NCT00249834|561720135|FG000|Overall Study|Ovarian stimulation failed|1|||
155624889|NCT00249834|561720136|FG001|Overall Study|Ovarian stimulation failed|0|||
155278313|NCT00802841|560453126|FG001|Overall Study|Withdrawal by Subject|5|||
155624890|NCT00249834|561720137|FG002|Overall Study|Ovarian stimulation failed|0|||
155624891|NCT00249834|561720138|FG003|Overall Study|Ovarian stimulation failed|0|||
155624892|NCT00249834|561720139|FG004|Overall Study|Ovarian stimulation failed|0|||
155624893|NCT00249834|561720140|FG005|Overall Study|Ovarian stimulation failed|0|||
155278314|NCT00802841|560453125|FG000|Overall Study|Protocol deviation|2|||
155278315|NCT00802841|560453126|FG001|Overall Study|Protocol deviation|6|||
155278316|NCT00802841|560453125|FG000|Overall Study|Treatment duration completed|66|||
155278317|NCT00802841|560453126|FG001|Overall Study|Treatment duration completed|76|||
155278318|NCT00432159|560453127|FG000|Overall Study|Death|0|||
155278319|NCT00432159|560453128|FG001|Overall Study|Death|1|||
155278320|NCT00432159|560453129|FG002|Overall Study|Death|0|||
155278321|NCT00432159|560453130|FG003|Overall Study|Death|0|||
155278322|NCT00432159|560453131|FG004|Overall Study|Death|0|||
155278323|NCT00432159|560453127|FG000|Overall Study|Failure|9|||
155278324|NCT00432159|560453128|FG001|Overall Study|Failure|5|||
155278325|NCT00432159|560453129|FG002|Overall Study|Failure|3|||
155278326|NCT00432159|560453130|FG003|Overall Study|Failure|2|||
155278327|NCT00432159|560453131|FG004|Overall Study|Failure|3|||
155278328|NCT00432159|560453127|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
155278329|NCT00432159|560453128|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
155278330|NCT00432159|560453129|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
155278331|NCT00432159|560453130|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
155278332|NCT00432159|560453131|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
155278333|NCT03850444|560453138|FG000|Overall Study|Adverse Event|16|||
155278334|NCT03850444|560453139|FG001|Overall Study|Adverse Event|10|||
155278335|NCT03850444|560453138|FG000|Overall Study|Death|87|||
155278336|NCT03850444|560453139|FG001|Overall Study|Death|107|||
155278337|NCT03850444|560453138|FG000|Overall Study|Lost to Follow-up|1|||
155278338|NCT03850444|560453139|FG001|Overall Study|Lost to Follow-up|1|||
155278339|NCT03850444|560453138|FG000|Overall Study|Withdrawal by Subject|1|||
155278340|NCT03850444|560453139|FG001|Overall Study|Withdrawal by Subject|5|||
155278341|NCT03850444|560453138|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
155278342|NCT03850444|560453139|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
155278343|NCT01518257|560453140|FG000|Overall Study|Lost to Follow-up|1|||
155278344|NCT01518257|560453141|FG001|Overall Study|Lost to Follow-up|0|||
155278345|NCT01518257|560453140|FG000|Overall Study|Other Miscellaneous Reason|1|||
155278346|NCT01518257|560453141|FG001|Overall Study|Other Miscellaneous Reason|0|||
155278347|NCT02107274|560453142|FG000|Treatment vs. Placebo|Adverse Event|3|||
155278348|NCT02107274|560453143|FG001|Treatment vs. Placebo|Adverse Event|0|||
155278349|NCT02107274|560453142|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
155278350|NCT02107274|560453143|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
155278351|NCT02107274|560453142|FG000|Control Phase|Lost to Follow-up|1|||
155624894|NCT00249834|561720141|FG006|Overall Study|Ovarian stimulation failed|0|||
155624895|NCT00249834|561720142|FG007|Overall Study|Ovarian stimulation failed|0|||
155624896|NCT00249834|561720135|FG000|Overall Study|Failure of down-regulation|0|||
155624897|NCT00249834|561720136|FG001|Overall Study|Failure of down-regulation|0|||
155278352|NCT02107274|560453143|FG001|Control Phase|Lost to Follow-up|1|||
155278353|NCT02107274|560453142|FG000|Control Phase|Death|2|||
155278354|NCT02107274|560453143|FG001|Control Phase|Death|0|||
155278355|NCT02107274|560453142|FG000|Control Phase|Adverse Event|0|||
155278356|NCT02107274|560453143|FG001|Control Phase|Adverse Event|1|||
155278357|NCT03158948|560453147|FG000|Overall Study|Death|1|||
155278358|NCT03158948|560453148|FG001|Overall Study|Death|1|||
155278359|NCT03158948|560453149|FG002|Overall Study|Death|3|||
155624898|NCT00249834|561720137|FG002|Overall Study|Failure of down-regulation|0|||
155624899|NCT00249834|561720138|FG003|Overall Study|Failure of down-regulation|0|||
155624900|NCT00249834|561720139|FG004|Overall Study|Failure of down-regulation|0|||
155624901|NCT00249834|561720140|FG005|Overall Study|Failure of down-regulation|0|||
155624902|NCT00249834|561720141|FG006|Overall Study|Failure of down-regulation|1|||
155624903|NCT00249834|561720142|FG007|Overall Study|Failure of down-regulation|0|||
155624904|NCT00249834|561720135|FG000|Overall Study|Protocol Violation|0|||
155624905|NCT00249834|561720136|FG001|Overall Study|Protocol Violation|19|||
155624906|NCT00249834|561720137|FG002|Overall Study|Protocol Violation|14|||
155624907|NCT00249834|561720138|FG003|Overall Study|Protocol Violation|8|||
155624908|NCT00249834|561720139|FG004|Overall Study|Protocol Violation|5|||
155624909|NCT00249834|561720140|FG005|Overall Study|Protocol Violation|2|||
155624910|NCT00249834|561720141|FG006|Overall Study|Protocol Violation|0|||
155624911|NCT00249834|561720142|FG007|Overall Study|Protocol Violation|0|||
155624912|NCT02688933|561720143|FG000|Overall Study|Adverse Event|3|||
155624913|NCT02688933|561720144|FG001|Overall Study|Adverse Event|1|||
155624914|NCT02688933|561720143|FG000|Overall Study|Lack of Efficacy|2|||
155624915|NCT02688933|561720144|FG001|Overall Study|Lack of Efficacy|2|||
155624916|NCT02688933|561720143|FG000|Overall Study|Poor compliance to protocol|7|||
155624917|NCT02688933|561720144|FG001|Overall Study|Poor compliance to protocol|4|||
155624918|NCT02688933|561720143|FG000|Overall Study|Hypoglycemia|2|||
155624919|NCT02688933|561720144|FG001|Overall Study|Hypoglycemia|0|||
155624920|NCT02688933|561720143|FG000|Overall Study|Other than Specified|14|||
155624921|NCT02688933|561720144|FG001|Overall Study|Other than Specified|25|||
155624922|NCT02688933|561720143|FG000|Overall Study|Lost to Follow-up|1|||
155624923|NCT02688933|561720144|FG001|Overall Study|Lost to Follow-up|5|||
155624924|NCT04802161|561720156|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
155624925|NCT04802161|561720157|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
155624926|NCT04802161|561720158|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
155624927|NCT04802161|561720159|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
155624928|NCT04802161|561720156|FG000|Overall Study|Clinical Instability|0|||
155624929|NCT04802161|561720157|FG001|Overall Study|Clinical Instability|0|||
155624930|NCT04802161|561720158|FG002|Overall Study|Clinical Instability|1|||
155624931|NCT04802161|561720159|FG003|Overall Study|Clinical Instability|0|||
155624932|NCT04802161|561720156|FG000|Overall Study|Adverse Event|0|||
155624933|NCT04802161|561720157|FG001|Overall Study|Adverse Event|0|||
155624934|NCT04802161|561720158|FG002|Overall Study|Adverse Event|1|||
155624935|NCT04802161|561720159|FG003|Overall Study|Adverse Event|0|||
155624936|NCT04802161|561720156|FG000|Overall Study|Death|0|||
155624937|NCT04802161|561720157|FG001|Overall Study|Death|0|||
155624938|NCT04802161|561720158|FG002|Overall Study|Death|1|||
155624939|NCT04802161|561720159|FG003|Overall Study|Death|0|||
155624940|NCT07116759|561720165|FG000|Overall Study|Incompatibility with the RHMC device|2|||
155624941|NCT01655901|561721830|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155624942|NCT01655901|561721831|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155624943|NCT01655901|561721832|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155624944|NCT01655901|561721833|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
155624945|NCT01655901|561721834|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155624946|NCT01655901|561721835|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
155624947|NCT00352118|561721836|FG000|Overall Study|Physician Decision|4|||
155624948|NCT02997163|561721837|FG000|Overall Study|Adverse Event|1|||
155624949|NCT02997163|561721838|FG001|Overall Study|Adverse Event|0|||
155624950|NCT02997163|561721839|FG002|Overall Study|Adverse Event|0|||
155624951|NCT02997163|561721840|FG003|Overall Study|Adverse Event|1|||
155624952|NCT00922636|561721841|FG000|Overall Study|Adverse Event|3|||
155624953|NCT00922636|561721842|FG001|Overall Study|Adverse Event|3|||
155624954|NCT00922636|561721843|FG002|Overall Study|Adverse Event|2|||
155624955|NCT00922636|561721844|FG003|Overall Study|Adverse Event|3|||
155624956|NCT00922636|561721845|FG004|Overall Study|Adverse Event|2|||
155624957|NCT00922636|561721841|FG000|Overall Study|Lack of Efficacy|1|||
155624958|NCT00922636|561721842|FG001|Overall Study|Lack of Efficacy|7|||
155624959|NCT00922636|561721843|FG002|Overall Study|Lack of Efficacy|3|||
155624960|NCT00922636|561721844|FG003|Overall Study|Lack of Efficacy|2|||
155624961|NCT00922636|561721845|FG004|Overall Study|Lack of Efficacy|4|||
155624962|NCT00922636|561721841|FG000|Overall Study|Sponsor Decision|0|||
155624963|NCT00922636|561721842|FG001|Overall Study|Sponsor Decision|0|||
155624964|NCT00922636|561721843|FG002|Overall Study|Sponsor Decision|2|||
155624965|NCT00922636|561721844|FG003|Overall Study|Sponsor Decision|0|||
155624966|NCT00922636|561721845|FG004|Overall Study|Sponsor Decision|0|||
155624967|NCT00922636|561721841|FG000|Overall Study|Withdrawal by Subject|0|||
155624968|NCT00922636|561721842|FG001|Overall Study|Withdrawal by Subject|0|||
155624969|NCT00922636|561721843|FG002|Overall Study|Withdrawal by Subject|5|||
155624970|NCT00922636|561721844|FG003|Overall Study|Withdrawal by Subject|2|||
155624971|NCT00922636|561721845|FG004|Overall Study|Withdrawal by Subject|4|||
155624972|NCT00922636|561721841|FG000|Overall Study|Protocol Violation|0|||
155624973|NCT00922636|561721842|FG001|Overall Study|Protocol Violation|0|||
155624974|NCT00922636|561721843|FG002|Overall Study|Protocol Violation|2|||
155624975|NCT00922636|561721844|FG003|Overall Study|Protocol Violation|2|||
155624976|NCT00922636|561721845|FG004|Overall Study|Protocol Violation|0|||
155624977|NCT00922636|561721841|FG000|Overall Study|Entry Criteria Not Met|0|||
155624978|NCT00922636|561721842|FG001|Overall Study|Entry Criteria Not Met|0|||
155624979|NCT00922636|561721843|FG002|Overall Study|Entry Criteria Not Met|1|||
155624980|NCT00922636|561721844|FG003|Overall Study|Entry Criteria Not Met|1|||
155624981|NCT00922636|561721845|FG004|Overall Study|Entry Criteria Not Met|0|||
155624982|NCT00922636|561721841|FG000|Overall Study|Parent/Caregiver Decision|2|||
155624983|NCT00922636|561721842|FG001|Overall Study|Parent/Caregiver Decision|4|||
155624984|NCT00922636|561721843|FG002|Overall Study|Parent/Caregiver Decision|3|||
155624985|NCT00922636|561721844|FG003|Overall Study|Parent/Caregiver Decision|5|||
155624986|NCT00922636|561721845|FG004|Overall Study|Parent/Caregiver Decision|2|||
155624987|NCT00922636|561721841|FG000|Overall Study|Lost to Follow-up|1|||
155624988|NCT00922636|561721842|FG001|Overall Study|Lost to Follow-up|2|||
155624989|NCT00922636|561721843|FG002|Overall Study|Lost to Follow-up|2|||
155624990|NCT00922636|561721844|FG003|Overall Study|Lost to Follow-up|2|||
155624991|NCT00922636|561721845|FG004|Overall Study|Lost to Follow-up|4|||
155624992|NCT02308046|561721846|FG000|Overall Study|Negative yeast culture at Baseline|32|||
155624993|NCT02308046|561721847|FG001|Overall Study|Negative yeast culture at Baseline|33|||
155624994|NCT02308046|561721846|FG000|Overall Study|Positive for STD at Baseline|1|||
155624995|NCT02308046|561721847|FG001|Overall Study|Positive for STD at Baseline|2|||
155624996|NCT02308046|561721846|FG000|Overall Study|Lost to Follow-up|1|||
155624997|NCT02308046|561721847|FG001|Overall Study|Lost to Follow-up|3|||
155624998|NCT01181167|561721848|FG000|Overall Study|Adverse Event|11|||
155624999|NCT01181167|561721849|FG001|Overall Study|Adverse Event|21|||
155625000|NCT01181167|561721848|FG000|Overall Study|Lost to Follow-up|1|||
155625001|NCT01181167|561721849|FG001|Overall Study|Lost to Follow-up|0|||
155625002|NCT01181167|561721848|FG000|Overall Study|Physician Decision|2|||
155625003|NCT01181167|561721849|FG001|Overall Study|Physician Decision|3|||
155625004|NCT01181167|561721848|FG000|Overall Study|Protocol Violation|3|||
155625005|NCT01181167|561721849|FG001|Overall Study|Protocol Violation|0|||
155625006|NCT01181167|561721848|FG000|Overall Study|Withdrawal by Subject|6|||
155625007|NCT01181167|561721849|FG001|Overall Study|Withdrawal by Subject|8|||
155625008|NCT01573000|561721853|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
155625009|NCT01573000|561721854|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
155625010|NCT01573000|561721853|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
155625011|NCT01573000|561721854|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
155625012|NCT01573000|561721853|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
155625013|NCT01573000|561721854|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
155625014|NCT01573000|561721853|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
155625015|NCT01573000|561721854|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
155625016|NCT01573000|561721853|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
155625017|NCT01573000|561721854|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
155625018|NCT01573000|561721853|FG000|Crossover Phase|Lack of Efficacy|0|||
155625019|NCT01573000|561721854|FG001|Crossover Phase|Lack of Efficacy|13|||
155625020|NCT01573000|561721853|FG000|Crossover Phase|Lost to Follow-up|0|||
155625021|NCT01573000|561721854|FG001|Crossover Phase|Lost to Follow-up|2|||
155625022|NCT01573000|561721853|FG000|Crossover Phase|Death|0|||
155625023|NCT01573000|561721854|FG001|Crossover Phase|Death|3|||
155625024|NCT01573000|561721853|FG000|Long-Term Follow-Up|Death|3|||
155625025|NCT01573000|561721854|FG001|Long-Term Follow-Up|Death|0|||
155625026|NCT01573000|561721853|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
155625027|NCT01573000|561721854|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
155625028|NCT03885908|561721857|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
155625029|NCT03885908|561721858|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
155625030|NCT03885908|561721857|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
155625031|NCT03885908|561721858|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
155625032|NCT03885908|561721857|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
155625033|NCT03885908|561721858|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
155625034|NCT03885908|561721857|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
155728031|NCT02633306|562104224|FG000|Overall Study|Withdrawal by Subject|3|||
155728032|NCT01744977|562104225|FG000|Overall Study|Withdrawal by Subject|1|||
155728033|NCT01744977|562104226|FG001|Overall Study|Withdrawal by Subject|2|||
155728034|NCT01744977|562104225|FG000|Overall Study|Death|2|||
155728035|NCT01744977|562104226|FG001|Overall Study|Death|3|||
155728036|NCT01744977|562104225|FG000|Overall Study|Lost to Follow-up|2|||
155728037|NCT01744977|562104226|FG001|Overall Study|Lost to Follow-up|0|||
155728038|NCT01744977|562104225|FG000|Overall Study|No longer meets inclusion|6|||
155728039|NCT01744977|562104226|FG001|Overall Study|No longer meets inclusion|0|||
155728040|NCT03774576|562104229|FG000|Period 2|Adverse Event|1|||
155728041|NCT03041038|562104230|FG000|Overall Study|Withdrawal by Subject|4|||
155728042|NCT03041038|562104231|FG001|Overall Study|Withdrawal by Subject|0|||
155728043|NCT03041038|562104230|FG000|Overall Study|Lost to Follow-up|1|||
155728044|NCT03041038|562104231|FG001|Overall Study|Lost to Follow-up|1|||
155728045|NCT03041038|562104230|FG000|Overall Study|Protocol Violation|1|||
155728046|NCT03041038|562104231|FG001|Overall Study|Protocol Violation|1|||
155728047|NCT00803569|562104232|FG000|Overall Study|Progressive Disease|3|||
155625035|NCT03885908|561721858|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
155625036|NCT01545388|561721863|FG000|Overall Study|Adverse Event|2|||
155625037|NCT01545388|561721864|FG001|Overall Study|Adverse Event|4|||
155625038|NCT01545388|561721865|FG002|Overall Study|Adverse Event|1|||
155625039|NCT01545388|561721863|FG000|Overall Study|Lack of Efficacy|3|||
155625040|NCT01545388|561721864|FG001|Overall Study|Lack of Efficacy|2|||
155625041|NCT01545388|561721865|FG002|Overall Study|Lack of Efficacy|5|||
155625042|NCT01545388|561721863|FG000|Overall Study|Participant moved or relocated|1|||
155625043|NCT01545388|561721864|FG001|Overall Study|Participant moved or relocated|0|||
155625044|NCT01545388|561721865|FG002|Overall Study|Participant moved or relocated|0|||
155625045|NCT01545388|561721863|FG000|Overall Study|Withdrawal by Subject|1|||
155625046|NCT01545388|561721864|FG001|Overall Study|Withdrawal by Subject|4|||
155625047|NCT01545388|561721865|FG002|Overall Study|Withdrawal by Subject|2|||
155625048|NCT01545388|561721863|FG000|Overall Study|Other|1|||
155625049|NCT01545388|561721864|FG001|Overall Study|Other|1|||
155625050|NCT01545388|561721865|FG002|Overall Study|Other|0|||
155625051|NCT05002972|561721867|FG000|Overall Study|Withdrawal by Subject|2|||
155625052|NCT01664091|561721868|FG000|Overall Study|Death|1|||
155625053|NCT01664091|561721868|FG000|Overall Study|Disease Progression|2|||
155625054|NCT01664091|561721868|FG000|Overall Study|Lost to Follow-up|2|||
155625055|NCT01664091|561721868|FG000|Overall Study|Withdrawal by Subject|1|||
155625056|NCT01172873|561721872|FG000|Overall Study|Withdrawal by Subject|3|||
155625057|NCT01172873|561721873|FG001|Overall Study|Withdrawal by Subject|2|||
155625058|NCT05518539|561721877|FG000|Overall Study|Lost to Follow-up|6|||
155625059|NCT02053493|561721878|FG000|Overall Study|Withdrawal by Subject|1|||
155625060|NCT02053493|561721879|FG001|Overall Study|Withdrawal by Subject|1|||
155625061|NCT01619865|561721880|FG000|Overall Study|Adverse Event|1|||
155625062|NCT01619865|561721880|FG000|Overall Study|Death|2|||
155625063|NCT01619865|561721880|FG000|Overall Study|subject not able to comply|1|||
155625064|NCT01494818|561721881|FG000|Overall Study|Relocation|1|||
155625065|NCT01494818|561721882|FG001|Overall Study|Relocation|2|||
155625066|NCT01494818|561721881|FG000|Overall Study|Lost to Follow-up|1|||
155625067|NCT01494818|561721882|FG001|Overall Study|Lost to Follow-up|0|||
155625068|NCT01211145|561721883|FG000|Overall Study|Reason not specified|3|||
155625069|NCT01211145|561721884|FG001|Overall Study|Reason not specified|2|||
155625070|NCT01211145|561721885|FG002|Overall Study|Reason not specified|2|||
155625071|NCT01211145|561721886|FG003|Overall Study|Reason not specified|1|||
155625072|NCT01211145|561721883|FG000|Overall Study|Lost to Follow-up|3|||
155625073|NCT01211145|561721884|FG001|Overall Study|Lost to Follow-up|2|||
155728048|NCT00803569|562104232|FG000|Overall Study|Noncompliance|1|||
155728049|NCT02900378|562104233|FG000|Randomization (Visit 2)|Adverse Event|14|||
155728050|NCT02900378|562104234|FG001|Randomization (Visit 2)|Adverse Event|11|||
155728051|NCT02900378|562104233|FG000|Randomization (Visit 2)|Death|1|||
155728052|NCT02900378|562104234|FG001|Randomization (Visit 2)|Death|4|||
155728053|NCT02900378|562104233|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
155728054|NCT02900378|562104234|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
155728055|NCT02900378|562104233|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
155728056|NCT02900378|562104234|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
155728057|NCT02900378|562104233|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
155728058|NCT02900378|562104234|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
155728059|NCT02900378|562104233|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
155728060|NCT02900378|562104234|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
155728061|NCT02900378|562104233|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
155728062|NCT02900378|562104234|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
155728063|NCT01134055|562104237|FG000|Overall Study|Adverse Event|5|||
155728064|NCT01134055|562104238|FG001|Overall Study|Adverse Event|2|||
155728065|NCT01134055|562104239|FG002|Overall Study|Adverse Event|2|||
155728066|NCT01134055|562104240|FG003|Overall Study|Adverse Event|2|||
155728067|NCT01134055|562104241|FG004|Overall Study|Adverse Event|5|||
155728068|NCT01134055|562104242|FG005|Overall Study|Adverse Event|7|||
155728069|NCT01134055|562104243|FG006|Overall Study|Adverse Event|2|||
155728070|NCT01134055|562104237|FG000|Overall Study|Lost to Follow-up|0|||
155728071|NCT01134055|562104238|FG001|Overall Study|Lost to Follow-up|1|||
155728072|NCT01134055|562104239|FG002|Overall Study|Lost to Follow-up|0|||
155728073|NCT01134055|562104240|FG003|Overall Study|Lost to Follow-up|1|||
155728074|NCT01134055|562104241|FG004|Overall Study|Lost to Follow-up|0|||
155728075|NCT01134055|562104242|FG005|Overall Study|Lost to Follow-up|0|||
155728076|NCT01134055|562104243|FG006|Overall Study|Lost to Follow-up|0|||
155728077|NCT01134055|562104237|FG000|Overall Study|Withdrawal by Subject|3|||
155728078|NCT01134055|562104238|FG001|Overall Study|Withdrawal by Subject|3|||
155625074|NCT01211145|561721885|FG002|Overall Study|Lost to Follow-up|1|||
155625075|NCT01211145|561721886|FG003|Overall Study|Lost to Follow-up|2|||
155625076|NCT01211145|561721883|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155625077|NCT01211145|561721884|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155728079|NCT01134055|562104239|FG002|Overall Study|Withdrawal by Subject|1|||
155728080|NCT01134055|562104240|FG003|Overall Study|Withdrawal by Subject|2|||
155728081|NCT01134055|562104241|FG004|Overall Study|Withdrawal by Subject|0|||
155728082|NCT01134055|562104242|FG005|Overall Study|Withdrawal by Subject|0|||
155728083|NCT01134055|562104243|FG006|Overall Study|Withdrawal by Subject|8|||
155728084|NCT01134055|562104237|FG000|Overall Study|Protocol Violation|0|||
155728085|NCT01134055|562104238|FG001|Overall Study|Protocol Violation|0|||
155728086|NCT01134055|562104239|FG002|Overall Study|Protocol Violation|0|||
155728087|NCT01134055|562104240|FG003|Overall Study|Protocol Violation|1|||
155728088|NCT01134055|562104241|FG004|Overall Study|Protocol Violation|1|||
155728089|NCT01134055|562104242|FG005|Overall Study|Protocol Violation|0|||
155728090|NCT01134055|562104243|FG006|Overall Study|Protocol Violation|0|||
155728091|NCT01134055|562104237|FG000|Overall Study|Physician Decision|0|||
155728092|NCT01134055|562104238|FG001|Overall Study|Physician Decision|0|||
155728093|NCT01134055|562104239|FG002|Overall Study|Physician Decision|0|||
155728094|NCT01134055|562104240|FG003|Overall Study|Physician Decision|0|||
155728095|NCT01134055|562104241|FG004|Overall Study|Physician Decision|0|||
155728096|NCT01134055|562104242|FG005|Overall Study|Physician Decision|0|||
155728097|NCT01134055|562104243|FG006|Overall Study|Physician Decision|1|||
155728098|NCT04798196|562104245|FG000|Overall Study|Lost to Follow-up|3|||
155728099|NCT04798196|562104246|FG001|Overall Study|Lost to Follow-up|1|||
155728100|NCT04798196|562104247|FG002|Overall Study|Lost to Follow-up|3|||
155728101|NCT00734539|562104257|FG000|Main Study|Death|33|||
155728102|NCT00734539|562104258|FG001|Main Study|Death|32|||
155728103|NCT00734539|562104257|FG000|Main Study|Physician Decision|2|||
155728104|NCT00734539|562104258|FG001|Main Study|Physician Decision|0|||
155728105|NCT00734539|562104257|FG000|Main Study|Withdrawal by Subject|1|||
155728106|NCT00734539|562104258|FG001|Main Study|Withdrawal by Subject|3|||
155728107|NCT00734539|562104257|FG000|Main Study|Enrolled in error; ineligible|1|||
155728108|NCT00734539|562104258|FG001|Main Study|Enrolled in error; ineligible|0|||
155728109|NCT00705016|562104261|FG000|Overall Study|Adverse Event|6|||
155728110|NCT00705016|562104262|FG001|Overall Study|Adverse Event|11|||
155728111|NCT00705016|562104263|FG002|Overall Study|Adverse Event|10|||
155728112|NCT00705016|562104261|FG000|Overall Study|Death|5|||
155728113|NCT00705016|562104262|FG001|Overall Study|Death|7|||
155728114|NCT00705016|562104263|FG002|Overall Study|Death|5|||
155728115|NCT00705016|562104261|FG000|Overall Study|Protocol Violation|0|||
155728116|NCT00705016|562104262|FG001|Overall Study|Protocol Violation|1|||
155728117|NCT00705016|562104263|FG002|Overall Study|Protocol Violation|1|||
155728118|NCT00705016|562104261|FG000|Overall Study|Withdrawal by Subject|4|||
155728119|NCT00705016|562104262|FG001|Overall Study|Withdrawal by Subject|3|||
155728120|NCT00705016|562104263|FG002|Overall Study|Withdrawal by Subject|2|||
155728121|NCT00705016|562104261|FG000|Overall Study|Progressive Disease|33|||
155728122|NCT00705016|562104262|FG001|Overall Study|Progressive Disease|29|||
155728123|NCT00705016|562104263|FG002|Overall Study|Progressive Disease|33|||
155728124|NCT00705016|562104261|FG000|Overall Study|Symptomatic Deterioration|3|||
155728125|NCT00705016|562104262|FG001|Overall Study|Symptomatic Deterioration|1|||
155728126|NCT00705016|562104263|FG002|Overall Study|Symptomatic Deterioration|1|||
155728127|NCT00705016|562104261|FG000|Overall Study|Other|9|||
155728128|NCT00705016|562104262|FG001|Overall Study|Other|6|||
155728129|NCT00705016|562104263|FG002|Overall Study|Other|6|||
155728130|NCT00942604|562104266|FG000|Overall Study|Protocol Violation|1|||
155728131|NCT00942604|562104267|FG001|Overall Study|Protocol Violation|1|||
155728132|NCT00942604|562104266|FG000|Overall Study|Adverse Event|0|||
155728133|NCT00942604|562104267|FG001|Overall Study|Adverse Event|1|||
155728134|NCT00942604|562104266|FG000|Overall Study|Withdrawal by Subject|0|||
155728135|NCT00942604|562104267|FG001|Overall Study|Withdrawal by Subject|1|||
155728136|NCT00942604|562104266|FG000|Overall Study|Patient relocation|1|||
155728137|NCT00942604|562104267|FG001|Overall Study|Patient relocation|1|||
155728138|NCT01656408|562104268|FG000|Overall Study|Adverse Event|0|||
155728139|NCT01656408|562104269|FG001|Overall Study|Adverse Event|0|||
155728140|NCT01656408|562104270|FG002|Overall Study|Adverse Event|1|||
155728141|NCT01656408|562104271|FG003|Overall Study|Adverse Event|0|||
155728142|NCT01656408|562104272|FG004|Overall Study|Adverse Event|0|||
155728143|NCT01656408|562104273|FG005|Overall Study|Adverse Event|1|||
155728144|NCT01656408|562104274|FG006|Overall Study|Adverse Event|1|||
155728145|NCT01656408|562104275|FG007|Overall Study|Adverse Event|0|||
155728146|NCT01656408|562104276|FG008|Overall Study|Adverse Event|1|||
155728147|NCT01656408|562104277|FG009|Overall Study|Adverse Event|0|||
155728148|NCT01656408|562104268|FG000|Overall Study|Physician Decision|1|||
155728149|NCT01656408|562104269|FG001|Overall Study|Physician Decision|0|||
155728150|NCT01656408|562104270|FG002|Overall Study|Physician Decision|1|||
155728151|NCT01656408|562104271|FG003|Overall Study|Physician Decision|0|||
155728152|NCT01656408|562104272|FG004|Overall Study|Physician Decision|1|||
155728153|NCT01656408|562104273|FG005|Overall Study|Physician Decision|1|||
155728154|NCT01656408|562104274|FG006|Overall Study|Physician Decision|0|||
155728155|NCT01656408|562104275|FG007|Overall Study|Physician Decision|1|||
155728156|NCT01656408|562104276|FG008|Overall Study|Physician Decision|1|||
155728157|NCT01656408|562104277|FG009|Overall Study|Physician Decision|3|||
155728158|NCT00904982|562104283|FG000|Overall Study|Withdrawal by Subject|2|||
155728159|NCT00904982|562104284|FG001|Overall Study|Withdrawal by Subject|0|||
155728160|NCT00904982|562104285|FG002|Overall Study|Withdrawal by Subject|0|||
155728161|NCT00904982|562104286|FG003|Overall Study|Withdrawal by Subject|0|||
155728162|NCT04119414|562104290|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
155728163|NCT01929317|562104296|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
155728164|NCT01929317|562104297|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
155728165|NCT01929317|562104296|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
155728166|NCT01929317|562104297|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
155728167|NCT01929317|562104296|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
155728168|NCT01929317|562104297|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
155728169|NCT01929317|562104296|FG000|Long-term Phase|Adverse Event|5|||
155728170|NCT01929317|562104297|FG001|Long-term Phase|Adverse Event|1|||
155728171|NCT01929317|562104296|FG000|Long-term Phase|Physician Decision|3|||
155728172|NCT01929317|562104297|FG001|Long-term Phase|Physician Decision|0|||
155728173|NCT01929317|562104296|FG000|Long-term Phase|Withdrawal by Subject|4|||
155728174|NCT01929317|562104297|FG001|Long-term Phase|Withdrawal by Subject|0|||
155728175|NCT01929317|562104296|FG000|Long-term Phase|Protocol Violation|1|||
155728176|NCT01929317|562104297|FG001|Long-term Phase|Protocol Violation|0|||
155728177|NCT01929317|562104296|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
155728178|NCT01929317|562104297|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
155728179|NCT01929317|562104296|FG000|Long-term Phase|Study Closed/Terminated|5|||
155728180|NCT01929317|562104297|FG001|Long-term Phase|Study Closed/Terminated|3|||
155728181|NCT02514083|562104298|FG000|Overall Study|Adverse Event|1|||
155728182|NCT01899040|562104299|FG000|Overall Study|Randomized in error|0|||
155728183|NCT01899040|562104300|FG001|Overall Study|Randomized in error|1|||
155728184|NCT01899040|562104301|FG002|Overall Study|Randomized in error|1|||
155728185|NCT01899040|562104299|FG000|Overall Study|Adverse Event|3|||
155728186|NCT01899040|562104300|FG001|Overall Study|Adverse Event|1|||
155728187|NCT01899040|562104301|FG002|Overall Study|Adverse Event|2|||
155728188|NCT01899040|562104299|FG000|Overall Study|Unspecified reasons|4|||
155728189|NCT01899040|562104300|FG001|Overall Study|Unspecified reasons|4|||
155728190|NCT01899040|562104301|FG002|Overall Study|Unspecified reasons|0|||
155728191|NCT01899040|562104299|FG000|Overall Study|Compliance issues|1|||
155728192|NCT01899040|562104300|FG001|Overall Study|Compliance issues|2|||
155728193|NCT01899040|562104301|FG002|Overall Study|Compliance issues|0|||
155728194|NCT04586205|562104309|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
155728195|NCT04586205|562104310|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
155728196|NCT04040933|562106314|FG000|Overall Study|Protocol Violation|1|||
155728197|NCT04040933|562106314|FG000|Overall Study|Withdrawal by Subject|2|||
155728198|NCT02066181|562106315|FG000|Overall Study|Withdrawal by Subject|1|||
155728199|NCT02066181|562106316|FG001|Overall Study|Withdrawal by Subject|1|||
155728200|NCT00775190|562106317|FG000|Overall Study|Lost to Follow-up|2|||
155728201|NCT00775190|562106318|FG001|Overall Study|Lost to Follow-up|3|||
155728202|NCT00775190|562106317|FG000|Overall Study|Withdrawal by Subject|1|||
155728203|NCT00775190|562106318|FG001|Overall Study|Withdrawal by Subject|2|||
155728204|NCT00775190|562106317|FG000|Overall Study|Protocol Violation|1|||
155728205|NCT00775190|562106318|FG001|Overall Study|Protocol Violation|0|||
155728206|NCT02141295|562106319|FG000|Overall Study|Adverse Event|1|||
155728207|NCT02141295|562106320|FG001|Overall Study|Adverse Event|18|||
155728208|NCT02141295|562106321|FG002|Overall Study|Adverse Event|11|||
155278360|NCT03158948|560453150|FG003|Overall Study|Death|2|||
155278361|NCT03158948|560453147|FG000|Overall Study|Physician Decision|0|||
155278362|NCT03158948|560453148|FG001|Overall Study|Physician Decision|0|||
155278363|NCT03158948|560453149|FG002|Overall Study|Physician Decision|0|||
155278364|NCT03158948|560453150|FG003|Overall Study|Physician Decision|1|||
155278365|NCT05305040|560453151|FG000|Overall Study|Not Dosed|37|||
155278366|NCT05305040|560453152|FG001|Overall Study|Not Dosed|37|||
155278367|NCT05305040|560453151|FG000|Overall Study|Study Closure|34|||
155278368|NCT05305040|560453152|FG001|Overall Study|Study Closure|46|||
155278369|NCT05305040|560453151|FG000|Overall Study|Death|14|||
155278370|NCT05305040|560453152|FG001|Overall Study|Death|13|||
155278371|NCT05305040|560453151|FG000|Overall Study|Withdrawal by Subject|15|||
155278372|NCT05305040|560453152|FG001|Overall Study|Withdrawal by Subject|10|||
155278373|NCT05305040|560453151|FG000|Overall Study|Other|13|||
155278374|NCT05305040|560453152|FG001|Overall Study|Other|10|||
155278375|NCT05305040|560453151|FG000|Overall Study|Primary Malignancy Relapse|3|||
155728209|NCT02141295|562106319|FG000|Overall Study|Physician Decision|2|||
155278376|NCT05305040|560453152|FG001|Overall Study|Primary Malignancy Relapse|4|||
155728210|NCT02141295|562106320|FG001|Overall Study|Physician Decision|19|||
155728211|NCT02141295|562106321|FG002|Overall Study|Physician Decision|14|||
155278377|NCT05305040|560453151|FG000|Overall Study|Adverse Event|3|||
155278378|NCT05305040|560453152|FG001|Overall Study|Adverse Event|3|||
155728212|NCT02141295|562106319|FG000|Overall Study|Study terminated by sponsor|0|||
155728213|NCT02141295|562106320|FG001|Overall Study|Study terminated by sponsor|6|||
155728214|NCT02141295|562106321|FG002|Overall Study|Study terminated by sponsor|6|||
155728215|NCT02141295|562106319|FG000|Overall Study|Non-compliance|0|||
155278379|NCT05305040|560453151|FG000|Overall Study|Lost to Follow-up|2|||
155728216|NCT02141295|562106320|FG001|Overall Study|Non-compliance|1|||
155728217|NCT02141295|562106321|FG002|Overall Study|Non-compliance|0|||
155728218|NCT02141295|562106319|FG000|Overall Study|Progressive disease|3|||
155728219|NCT02141295|562106320|FG001|Overall Study|Progressive disease|32|||
155728220|NCT02141295|562106321|FG002|Overall Study|Progressive disease|50|||
155728221|NCT02141295|562106319|FG000|Overall Study|Reason not specified|0|||
155728222|NCT02141295|562106320|FG001|Overall Study|Reason not specified|9|||
155728223|NCT02141295|562106321|FG002|Overall Study|Reason not specified|10|||
155728224|NCT02141295|562106319|FG000|Overall Study|Withdrawal by Subject|0|||
155728225|NCT02141295|562106320|FG001|Overall Study|Withdrawal by Subject|9|||
155728226|NCT02141295|562106321|FG002|Overall Study|Withdrawal by Subject|4|||
155728227|NCT01710501|562106322|FG000|Overall Study|Lost to Follow-up|2|||
155728228|NCT01710501|562106323|FG001|Overall Study|Lost to Follow-up|0|||
155728229|NCT01710501|562106324|FG002|Overall Study|Lost to Follow-up|0|||
155728230|NCT01432730|562106331|FG000|Period 1|Adverse Event|2|||
155728231|NCT01432730|562106332|FG001|Period 1|Adverse Event|0|||
155625078|NCT01211145|561721885|FG002|Overall Study|Study-specific withdrawal criteria|0|||
155625079|NCT01211145|561721886|FG003|Overall Study|Study-specific withdrawal criteria|0|||
155625080|NCT01211145|561721883|FG000|Overall Study|Severe noncompliance to protocol|1|||
155625081|NCT01211145|561721884|FG001|Overall Study|Severe noncompliance to protocol|0|||
155625082|NCT01211145|561721885|FG002|Overall Study|Severe noncompliance to protocol|0|||
155625083|NCT01211145|561721886|FG003|Overall Study|Severe noncompliance to protocol|0|||
155625084|NCT01211145|561721883|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
155625085|NCT01211145|561721884|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
155625086|NCT01211145|561721885|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
155625087|NCT01211145|561721886|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
155625088|NCT01211145|561721883|FG000|Overall Study|Patient decision|2|||
155625089|NCT01211145|561721884|FG001|Overall Study|Patient decision|1|||
155625090|NCT01211145|561721885|FG002|Overall Study|Patient decision|0|||
155625091|NCT01211145|561721886|FG003|Overall Study|Patient decision|2|||
155625092|NCT00791999|561721887|FG000|Overall Study|Protocol planed withdrawal|14|||
155625093|NCT00791999|561721888|FG001|Overall Study|Protocol planed withdrawal|11|||
155625094|NCT00791999|561721889|FG002|Overall Study|Protocol planed withdrawal|11|||
155625095|NCT00791999|561721890|FG003|Overall Study|Protocol planed withdrawal|45|||
155625096|NCT00791999|561721887|FG000|Overall Study|Withdrawal by Subject|0|||
155625097|NCT00791999|561721888|FG001|Overall Study|Withdrawal by Subject|1|||
155625098|NCT00791999|561721889|FG002|Overall Study|Withdrawal by Subject|0|||
155625099|NCT00791999|561721890|FG003|Overall Study|Withdrawal by Subject|2|||
155625100|NCT00791999|561721887|FG000|Overall Study|Protocol Violation|3|||
155625101|NCT00791999|561721888|FG001|Overall Study|Protocol Violation|0|||
155625102|NCT00791999|561721889|FG002|Overall Study|Protocol Violation|1|||
155625103|NCT00791999|561721890|FG003|Overall Study|Protocol Violation|0|||
155625104|NCT00791999|561721887|FG000|Overall Study|Adverse Event|3|||
155625105|NCT00791999|561721888|FG001|Overall Study|Adverse Event|3|||
155625106|NCT00791999|561721889|FG002|Overall Study|Adverse Event|7|||
155625107|NCT00791999|561721890|FG003|Overall Study|Adverse Event|3|||
155625108|NCT00791999|561721887|FG000|Overall Study|Lack of Efficacy|0|||
155625109|NCT00791999|561721888|FG001|Overall Study|Lack of Efficacy|1|||
155625110|NCT00791999|561721889|FG002|Overall Study|Lack of Efficacy|0|||
155625111|NCT00791999|561721890|FG003|Overall Study|Lack of Efficacy|2|||
155728232|NCT01432730|562106331|FG000|Period 2|Adverse Event|0|||
155728233|NCT01432730|562106332|FG001|Period 2|Adverse Event|4|||
155728234|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
155728235|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
155728236|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
155728237|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
155728238|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
155728239|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
155728240|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
155728241|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
155728242|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
155728243|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
155728244|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
155625112|NCT00791999|561721887|FG000|Overall Study|Reason other than those above|1|||
155625113|NCT00791999|561721888|FG001|Overall Study|Reason other than those above|0|||
155625114|NCT00791999|561721889|FG002|Overall Study|Reason other than those above|1|||
155625115|NCT00791999|561721890|FG003|Overall Study|Reason other than those above|0|||
155625116|NCT00617357|561721891|FG000|Overall Study|Lost to Follow-up|7|||
155625117|NCT00617357|561721891|FG000|Overall Study|Death|5|||
155625118|NCT00617357|561721891|FG000|Overall Study|insurance concerns|2|||
155625119|NCT00617357|561721891|FG000|Overall Study|Withdrawal by Subject|1|||
155625120|NCT00617357|561721891|FG000|Overall Study|Physician Decision|1|||
155625121|NCT04622969|561721897|FG000|Overall Study|Withdrawal by Subject|2|||
155625122|NCT04622969|561721898|FG001|Overall Study|Withdrawal by Subject|3|||
155278380|NCT05305040|560453152|FG001|Overall Study|Lost to Follow-up|1|||
155625123|NCT04467515|561721899|FG000|Overall Study|Lost to Follow-up|1|||
155625124|NCT04467515|561721900|FG001|Overall Study|Lost to Follow-up|0|||
155625125|NCT04467515|561721901|FG002|Overall Study|Lost to Follow-up|0|||
155625126|NCT04467515|561721899|FG000|Overall Study|Withdrawal by Subject|1|||
155625127|NCT04467515|561721900|FG001|Overall Study|Withdrawal by Subject|0|||
155625128|NCT04467515|561721901|FG002|Overall Study|Withdrawal by Subject|1|||
155625129|NCT04467515|561721899|FG000|Overall Study|Progressive Disease|0|||
155625130|NCT04467515|561721900|FG001|Overall Study|Progressive Disease|1|||
155625131|NCT04467515|561721901|FG002|Overall Study|Progressive Disease|3|||
155625132|NCT04467515|561721899|FG000|Overall Study|Death|0|||
155625133|NCT04467515|561721900|FG001|Overall Study|Death|1|||
155625134|NCT04467515|561721901|FG002|Overall Study|Death|0|||
155625135|NCT02155985|561721907|FG000|Overall Study|Withdrawal by Subject|0|||
155625136|NCT02155985|561721908|FG001|Overall Study|Withdrawal by Subject|0|||
155625137|NCT02155985|561721909|FG002|Overall Study|Withdrawal by Subject|1|||
155625138|NCT02155985|561721907|FG000|Overall Study|Lost to Follow-up|1|||
155625139|NCT02155985|561721908|FG001|Overall Study|Lost to Follow-up|0|||
155625140|NCT02155985|561721909|FG002|Overall Study|Lost to Follow-up|0|||
155278381|NCT05305040|560453151|FG000|Overall Study|Graft versus host disease|2|||
155278382|NCT05305040|560453152|FG001|Overall Study|Graft versus host disease|0|||
155278383|NCT05305040|560453151|FG000|Overall Study|Investigator's Decision|1|||
155278384|NCT05305040|560453152|FG001|Overall Study|Investigator's Decision|1|||
155278385|NCT05305040|560453151|FG000|Overall Study|COVID-19 Reasons|1|||
155278386|NCT05305040|560453152|FG001|Overall Study|COVID-19 Reasons|0|||
155278387|NCT01195675|560453153|FG000|Overall Study|Adverse Event|1|||
155278388|NCT01195675|560453153|FG000|Overall Study|Withdrawal by Subject|2|||
155278389|NCT02424344|560453154|FG000|Overall Study|Lack of Efficacy|0|||
155278390|NCT02424344|560453155|FG001|Overall Study|Lack of Efficacy|1|||
155278391|NCT02424344|560453154|FG000|Overall Study|Withdrawal by Subject|2|||
155278392|NCT02424344|560453155|FG001|Overall Study|Withdrawal by Subject|1|||
155278393|NCT02424344|560453154|FG000|Overall Study|Lost to Follow-up|1|||
155278394|NCT02424344|560453155|FG001|Overall Study|Lost to Follow-up|0|||
155278395|NCT02424344|560453154|FG000|Overall Study|Adverse Event|4|||
155278396|NCT02424344|560453155|FG001|Overall Study|Adverse Event|8|||
155278397|NCT04730947|560453156|FG000|Overall Study|Withdrawal by Subject|0|||
155278398|NCT04730947|560453157|FG001|Overall Study|Withdrawal by Subject|1|||
155278399|NCT01174550|560453158|FG000|Overall Study|Death|75|||
155278400|NCT01174550|560453159|FG001|Overall Study|Death|74|||
155278401|NCT01174550|560453158|FG000|Overall Study|Lost to Follow-up|652|||
155278402|NCT01174550|560453159|FG001|Overall Study|Lost to Follow-up|510|||
155278403|NCT01174550|560453158|FG000|Overall Study|Withdrawal by Subject|543|||
155278404|NCT01174550|560453159|FG001|Overall Study|Withdrawal by Subject|289|||
155278405|NCT02123966|560453160|FG000|Overall Study|Intercurrent Illness|1|||
155278406|NCT01536262|560453161|FG000|Overall Study|Adverse Event|6|||
155278407|NCT01536262|560453162|FG001|Overall Study|Adverse Event|1|||
155278408|NCT01536262|560453163|FG002|Overall Study|Adverse Event|2|||
155625141|NCT04460326|561721914|FG000|Completed at Least 4 Meals|Early discharge|5|||
155625142|NCT04460326|561721915|FG001|Completed at Least 4 Meals|Early discharge|5|||
155625143|NCT04460326|561721914|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
155625144|NCT04460326|561721915|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
155625145|NCT04460326|561721914|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
155625146|NCT04460326|561721915|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
155625147|NCT04460326|561721914|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
155625148|NCT04460326|561721915|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
155625149|NCT04460326|561721914|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
155625150|NCT04460326|561721915|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
155625151|NCT04460326|561721914|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
155625152|NCT04460326|561721915|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
155625153|NCT04794751|561721918|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
155625154|NCT04794751|561721919|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
155625155|NCT04794751|561721918|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
155625156|NCT04794751|561721919|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
155625157|NCT04794751|561721918|FG000|Period 1|Protocol Violation|0|||
155625158|NCT04794751|561721919|FG001|Period 1|Protocol Violation|2|||
155625159|NCT04794751|561721918|FG000|Period 1|Withdrawal by Subject|0|||
155625160|NCT04794751|561721919|FG001|Period 1|Withdrawal by Subject|1|||
155625161|NCT04794751|561721918|FG000|Period 2|Withdrawal by Subject|0|||
155625162|NCT04794751|561721919|FG001|Period 2|Withdrawal by Subject|1|||
155625163|NCT04794751|561721918|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
155278409|NCT01536262|560453161|FG000|Overall Study|Withdrawal by Subject|1|||
155278410|NCT01536262|560453162|FG001|Overall Study|Withdrawal by Subject|1|||
155278411|NCT01536262|560453163|FG002|Overall Study|Withdrawal by Subject|0|||
155278412|NCT01536262|560453161|FG000|Overall Study|Other than stated above|1|||
155278413|NCT01536262|560453162|FG001|Overall Study|Other than stated above|0|||
155278414|NCT01536262|560453163|FG002|Overall Study|Other than stated above|0|||
155278415|NCT01460381|560453167|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
155278416|NCT01460381|560453168|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
155278417|NCT01097655|560453169|FG000|Overall Study|Withdrawal by Subject|1|||
155278418|NCT01097655|560453169|FG000|Overall Study|Subject Documented Twice|1|||
155278419|NCT01097655|560453169|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
155278420|NCT05257837|560453170|FG000|Overall Study|Excluded (did not find the guns)|4|||
155278421|NCT05257837|560453171|FG001|Overall Study|Excluded (did not find the guns)|2|||
155278422|NCT05257837|560453172|FG002|Overall Study|Excluded (did not find the guns)|4|||
155278423|NCT05257837|560453173|FG003|Overall Study|Excluded (did not find the guns)|0|||
155278424|NCT01033643|560453174|FG000|Overall Study|Withdrew Consent|0|||
155625164|NCT04794751|561721919|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
155625165|NCT04794751|561721918|FG000|Period 2|Protocol Violation|1|||
155625166|NCT04794751|561721919|FG001|Period 2|Protocol Violation|0|||
155625167|NCT01687218|561721920|FG000|Overall Study|Withdrawal by Subject|2|||
155625168|NCT01687218|561721921|FG001|Overall Study|Withdrawal by Subject|3|||
155625169|NCT01687218|561721922|FG002|Overall Study|Withdrawal by Subject|0|||
155625170|NCT01687218|561721923|FG003|Overall Study|Withdrawal by Subject|1|||
155625171|NCT01687218|561721924|FG004|Overall Study|Withdrawal by Subject|1|||
155625172|NCT01687218|561721925|FG005|Overall Study|Withdrawal by Subject|0|||
155625173|NCT01687218|561721920|FG000|Overall Study|Relocated, no follow-up planned|1|||
155625174|NCT01687218|561721921|FG001|Overall Study|Relocated, no follow-up planned|0|||
155625175|NCT01687218|561721922|FG002|Overall Study|Relocated, no follow-up planned|1|||
155625176|NCT01687218|561721923|FG003|Overall Study|Relocated, no follow-up planned|1|||
155625177|NCT01687218|561721924|FG004|Overall Study|Relocated, no follow-up planned|0|||
155625178|NCT01687218|561721925|FG005|Overall Study|Relocated, no follow-up planned|0|||
155625179|NCT03528551|561721931|FG000|Overall Study|Lost to Follow-up|0|||
155625180|NCT03528551|561721932|FG001|Overall Study|Lost to Follow-up|1|||
155625181|NCT03528551|561721933|FG002|Overall Study|Lost to Follow-up|0|||
155625182|NCT03528551|561721931|FG000|Overall Study|Transferred to other arm/group|2|||
155625183|NCT03528551|561721932|FG001|Overall Study|Transferred to other arm/group|3|||
155625184|NCT03528551|561721933|FG002|Overall Study|Transferred to other arm/group|0|||
155625185|NCT03528551|561721931|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155625186|NCT03528551|561721932|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155625187|NCT03528551|561721933|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155625188|NCT03528551|561721931|FG000|Overall Study|Protocol Violation|0|||
155625189|NCT03528551|561721932|FG001|Overall Study|Protocol Violation|3|||
155625190|NCT03528551|561721933|FG002|Overall Study|Protocol Violation|0|||
155625191|NCT03528551|561721931|FG000|Overall Study|Withdrawal by Subject|0|||
155625192|NCT03528551|561721932|FG001|Overall Study|Withdrawal by Subject|7|||
155625193|NCT03528551|561721933|FG002|Overall Study|Withdrawal by Subject|0|||
155625194|NCT00846586|561721936|FG000|Overall Study|Adverse Event|20|||
155625195|NCT00846586|561721937|FG001|Overall Study|Adverse Event|10|||
155625196|NCT00846586|561721936|FG000|Overall Study|Subject withdrew consent|8|||
155625197|NCT00846586|561721937|FG001|Overall Study|Subject withdrew consent|10|||
155625198|NCT00846586|561721936|FG000|Overall Study|Administrative problems|5|||
155625199|NCT00846586|561721937|FG001|Overall Study|Administrative problems|4|||
155625200|NCT00846586|561721936|FG000|Overall Study|Death|2|||
155625201|NCT00846586|561721937|FG001|Overall Study|Death|0|||
155625202|NCT00846586|561721936|FG000|Overall Study|Protocol deviation|2|||
155625203|NCT00846586|561721937|FG001|Overall Study|Protocol deviation|6|||
155625204|NCT00846586|561721936|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155625205|NCT00846586|561721937|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155625206|NCT00846586|561721936|FG000|Overall Study|Lost to Follow-up|1|||
155625207|NCT00846586|561721937|FG001|Overall Study|Lost to Follow-up|4|||
155625208|NCT00846586|561721936|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155625209|NCT00846586|561721937|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155625210|NCT01789047|561721940|FG000|Overall Study|Adverse Event|3|||
155625211|NCT01789047|561721941|FG001|Overall Study|Adverse Event|2|||
155625212|NCT01789047|561721940|FG000|Overall Study|Withdrawal by Subject|1|||
155625213|NCT01789047|561721941|FG001|Overall Study|Withdrawal by Subject|2|||
155625214|NCT03644017|561721942|FG000|Overall Study|Access Abandonment|5|||
155625215|NCT03644017|561721942|FG000|Overall Study|Kidney Transplant|2|||
155625216|NCT01204671|561721943|FG000|Overall Study|Adverse Event|4|||
155625217|NCT01204671|561721944|FG001|Overall Study|Adverse Event|3|||
155625218|NCT01204671|561721945|FG002|Overall Study|Adverse Event|3|||
155278425|NCT01033643|560453175|FG001|Overall Study|Withdrew Consent|3|||
155625219|NCT01204671|561721946|FG003|Overall Study|Adverse Event|3|||
155625220|NCT01204671|561721947|FG004|Overall Study|Adverse Event|1|||
155625221|NCT01204671|561721943|FG000|Overall Study|Withdrawal by Subject|2|||
155625222|NCT01204671|561721944|FG001|Overall Study|Withdrawal by Subject|3|||
155625223|NCT01204671|561721945|FG002|Overall Study|Withdrawal by Subject|4|||
155625224|NCT01204671|561721946|FG003|Overall Study|Withdrawal by Subject|5|||
155625225|NCT01204671|561721947|FG004|Overall Study|Withdrawal by Subject|3|||
155625226|NCT01204671|561721943|FG000|Overall Study|Lost to Follow-up|7|||
155625227|NCT01204671|561721944|FG001|Overall Study|Lost to Follow-up|8|||
155625228|NCT01204671|561721945|FG002|Overall Study|Lost to Follow-up|6|||
155625229|NCT01204671|561721946|FG003|Overall Study|Lost to Follow-up|4|||
155625230|NCT01204671|561721947|FG004|Overall Study|Lost to Follow-up|0|||
155625231|NCT01204671|561721943|FG000|Overall Study|Unknown Completion Status|1|||
155625232|NCT01204671|561721944|FG001|Overall Study|Unknown Completion Status|1|||
155625233|NCT01204671|561721945|FG002|Overall Study|Unknown Completion Status|0|||
155625234|NCT01204671|561721946|FG003|Overall Study|Unknown Completion Status|0|||
155625235|NCT01204671|561721947|FG004|Overall Study|Unknown Completion Status|0|||
155625236|NCT01204671|561721943|FG000|Overall Study|Physician Decision|0|||
155625237|NCT01204671|561721944|FG001|Overall Study|Physician Decision|0|||
155625238|NCT01204671|561721945|FG002|Overall Study|Physician Decision|0|||
155625239|NCT01204671|561721946|FG003|Overall Study|Physician Decision|1|||
155625240|NCT01204671|561721947|FG004|Overall Study|Physician Decision|0|||
155625241|NCT02700048|561721948|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
155625242|NCT02700048|561721949|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
155625243|NCT02175225|561721950|FG000|Overall Study|Withdrawal by Subject|1|||
155625244|NCT02175225|561721951|FG001|Overall Study|Withdrawal by Subject|2|||
155625245|NCT02175225|561721950|FG000|Overall Study|Lost to Follow-up|6|||
155625246|NCT02175225|561721951|FG001|Overall Study|Lost to Follow-up|7|||
155625247|NCT02175225|561721950|FG000|Overall Study|Study drug not administered|1|||
155625248|NCT02175225|561721951|FG001|Overall Study|Study drug not administered|2|||
155625249|NCT02340000|561721952|FG000|Time Period 1|Withdrawal by Subject|6|||
155625250|NCT02340000|561721953|FG001|Time Period 1|Withdrawal by Subject|8|||
155625251|NCT02340000|561721952|FG000|Time Period 1|Lost to Follow-up|6|||
155625252|NCT02340000|561721953|FG001|Time Period 1|Lost to Follow-up|7|||
155625253|NCT02340000|561721952|FG000|Time Period 2|Withdrawal by Subject|9|||
155625254|NCT02340000|561721953|FG001|Time Period 2|Withdrawal by Subject|7|||
155625255|NCT02340000|561721952|FG000|Time Period 2|Lost to Follow-up|10|||
155625256|NCT02340000|561721953|FG001|Time Period 2|Lost to Follow-up|8|||
155625257|NCT02668640|561721954|FG000|Overall Study|Lost to Follow-up|13|||
155625258|NCT02668640|561721954|FG000|Overall Study|Other, not specified|1|||
155625259|NCT01883895|561721956|FG000|Overall Study|Lost to Follow-up|2|||
155625260|NCT01526785|561721963|FG000|Overall Study|Study Terminated by Sponsor|8|||
155625261|NCT01526785|561721963|FG000|Overall Study|Death|2|||
155625262|NCT01526785|561721963|FG000|Overall Study|Physician Decision|1|||
155625263|NCT01526785|561721963|FG000|Overall Study|Withdrawal by Subject|2|||
155625264|NCT01121263|561721966|FG000|Overall Study|Death|3|||
155625265|NCT01121263|561721967|FG001|Overall Study|Death|2|||
155625266|NCT01121263|561721966|FG000|Overall Study|Lost to Follow-up|22|||
155625267|NCT01121263|561721967|FG001|Overall Study|Lost to Follow-up|12|||
155625268|NCT01121263|561721966|FG000|Overall Study|Withdrawal by Subject|0|||
155625269|NCT01121263|561721967|FG001|Overall Study|Withdrawal by Subject|1|||
155625270|NCT03810456|561721968|FG000|Treatment|Urgent Family Matters|3|||
155625271|NCT03810456|561721969|FG001|Treatment|Urgent Family Matters|0|||
155625272|NCT03810456|561721970|FG002|Treatment|Urgent Family Matters|0|||
155625273|NCT03810456|561721968|FG000|Treatment|Scheduling Conflicts|0|||
155625274|NCT03810456|561721969|FG001|Treatment|Scheduling Conflicts|11|||
155278426|NCT01033643|560453176|FG002|Overall Study|Withdrew Consent|0|||
155278427|NCT01033643|560453177|FG003|Overall Study|Withdrew Consent|0|||
155278428|NCT01033643|560453178|FG004|Overall Study|Withdrew Consent|0|||
155278429|NCT01033643|560453179|FG005|Overall Study|Withdrew Consent|1|||
155278430|NCT03639675|560453180|FG000|Overall Study|Withdrawal by Subject|1|||
155278431|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Death|0|||
155278432|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Death|2|||
155278433|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
155278434|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
155278435|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
155278436|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
155278437|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
155278438|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
155278439|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Death|2|||
155278440|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Death|1|||
155278441|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
155278442|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
155278443|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
155278444|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
155625275|NCT03810456|561721970|FG002|Treatment|Scheduling Conflicts|0|||
155625276|NCT03810456|561721968|FG000|Treatment|No Longer Interested|0|||
155625277|NCT03810456|561721969|FG001|Treatment|No Longer Interested|12|||
155625278|NCT03810456|561721970|FG002|Treatment|No Longer Interested|0|||
155278445|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Death|2|||
155625279|NCT03810456|561721968|FG000|Treatment|Transportation Issues|0|||
155625280|NCT03810456|561721969|FG001|Treatment|Transportation Issues|1|||
155625281|NCT03810456|561721970|FG002|Treatment|Transportation Issues|0|||
155625282|NCT03810456|561721968|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
155625283|NCT03810456|561721969|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
155625284|NCT03810456|561721970|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
155728245|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
155728246|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
155728247|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
155728248|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
155728249|NCT01235741|562106333|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
155728250|NCT01235741|562106334|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
155728251|NCT01235741|562106335|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
155728252|NCT01235741|562106333|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
155728253|NCT01235741|562106334|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
155728254|NCT01235741|562106335|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
155728255|NCT01235741|562106333|FG000|Randomized to Treatment|Adverse Event|0|||
155728256|NCT01235741|562106334|FG001|Randomized to Treatment|Adverse Event|1|||
155728257|NCT01235741|562106335|FG002|Randomized to Treatment|Adverse Event|1|||
155728258|NCT01235741|562106333|FG000|Randomized to Treatment|Sponsor terminated study|0|||
155728259|NCT01235741|562106334|FG001|Randomized to Treatment|Sponsor terminated study|35|||
155728260|NCT01235741|562106335|FG002|Randomized to Treatment|Sponsor terminated study|34|||
155728261|NCT01235741|562106333|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
155728262|NCT01235741|562106334|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
155728263|NCT01235741|562106335|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
155728264|NCT01235741|562106333|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
155728265|NCT01235741|562106334|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
155728266|NCT01235741|562106335|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
155728267|NCT01235741|562106333|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
155728268|NCT01235741|562106334|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
155728269|NCT01235741|562106335|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
155728270|NCT01421719|562106336|FG000|Overall Study|Withdrawal by Subject|4|||
155728271|NCT01942837|562106345|FG000|Overall Study|Death|1|||
155728272|NCT01942837|562106345|FG000|Overall Study|Symptomatic or radiographic progression|49|||
155728273|NCT01942837|562106345|FG000|Overall Study|Adverse Event|6|||
155728274|NCT01942837|562106345|FG000|Overall Study|Physician Decision|3|||
155728275|NCT01942837|562106345|FG000|Overall Study|Withdrawal by Subject|2|||
155728276|NCT01942837|562106345|FG000|Overall Study|Intercurrent Illness|1|||
155728277|NCT01942837|562106345|FG000|Overall Study|On treatment|3|||
155728278|NCT01942837|562106345|FG000|Overall Study|Never initiate the treatment|2|||
155728279|NCT01298648|562106346|FG000|Overall Study|Withdrawal by Subject|2|||
155728280|NCT01298648|562106346|FG000|Overall Study|Lost to Follow-up|21|||
155728281|NCT02392624|562106347|FG000|Overall Study|Withdrawal by Subject|15|||
155728282|NCT02392624|562106348|FG001|Overall Study|Withdrawal by Subject|12|||
155728283|NCT02392624|562106349|FG002|Overall Study|Withdrawal by Subject|9|||
155728284|NCT02392624|562106347|FG000|Overall Study|Adverse Event|4|||
155728285|NCT02392624|562106348|FG001|Overall Study|Adverse Event|1|||
155728286|NCT02392624|562106349|FG002|Overall Study|Adverse Event|2|||
155728287|NCT02392624|562106347|FG000|Overall Study|Pregnancy|1|||
155728288|NCT02392624|562106348|FG001|Overall Study|Pregnancy|0|||
155728289|NCT02392624|562106349|FG002|Overall Study|Pregnancy|0|||
155728290|NCT02392624|562106347|FG000|Overall Study|Protocol Violation|0|||
155728291|NCT02392624|562106348|FG001|Overall Study|Protocol Violation|0|||
155728292|NCT02392624|562106349|FG002|Overall Study|Protocol Violation|1|||
155728293|NCT02392624|562106347|FG000|Overall Study|Sponsor/Investigator Decision|2|||
155728294|NCT02392624|562106348|FG001|Overall Study|Sponsor/Investigator Decision|1|||
155728295|NCT02392624|562106349|FG002|Overall Study|Sponsor/Investigator Decision|0|||
155728296|NCT02392624|562106347|FG000|Overall Study|Other|49|||
155728297|NCT02392624|562106348|FG001|Overall Study|Other|1|||
155728298|NCT02392624|562106349|FG002|Overall Study|Other|1|||
155728299|NCT03819114|562106350|FG000|Overall Study|Protocol Violation|0|||
155728300|NCT03819114|562106351|FG001|Overall Study|Protocol Violation|1|||
155728301|NCT03819114|562106352|FG002|Overall Study|Protocol Violation|1|||
155728302|NCT03819114|562106353|FG003|Overall Study|Protocol Violation|0|||
155728303|NCT03819114|562106350|FG000|Overall Study|Lost to Follow-up|0|||
155728304|NCT03819114|562106351|FG001|Overall Study|Lost to Follow-up|0|||
155728305|NCT03819114|562106352|FG002|Overall Study|Lost to Follow-up|1|||
155728306|NCT03819114|562106353|FG003|Overall Study|Lost to Follow-up|0|||
155728307|NCT02492763|562106356|FG000|Overall Study|Withdrawal by Subject|0|||
155728308|NCT02492763|562106357|FG001|Overall Study|Withdrawal by Subject|2|||
155728309|NCT02492763|562106358|FG002|Overall Study|Withdrawal by Subject|1|||
155728310|NCT02492763|562106359|FG003|Overall Study|Withdrawal by Subject|0|||
155728311|NCT02492763|562106356|FG000|Overall Study|Adverse Event|3|||
155728312|NCT02492763|562106357|FG001|Overall Study|Adverse Event|1|||
155728313|NCT02492763|562106358|FG002|Overall Study|Adverse Event|1|||
155728314|NCT02492763|562106359|FG003|Overall Study|Adverse Event|2|||
155728315|NCT02492763|562106356|FG000|Overall Study|Death|0|||
155728316|NCT02492763|562106357|FG001|Overall Study|Death|0|||
155728317|NCT02492763|562106358|FG002|Overall Study|Death|1|||
155728318|NCT02492763|562106359|FG003|Overall Study|Death|0|||
155728319|NCT02492763|562106356|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155728320|NCT02492763|562106357|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
155728321|NCT02492763|562106358|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155728322|NCT02492763|562106359|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155728323|NCT02492763|562106356|FG000|Overall Study|Lost to Follow-up|0|||
155728324|NCT02492763|562106357|FG001|Overall Study|Lost to Follow-up|0|||
155728325|NCT02492763|562106358|FG002|Overall Study|Lost to Follow-up|1|||
155728326|NCT02492763|562106359|FG003|Overall Study|Lost to Follow-up|0|||
155728327|NCT02492763|562106356|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155728328|NCT02492763|562106357|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155728329|NCT02492763|562106358|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155728330|NCT02492763|562106359|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155728331|NCT02492763|562106356|FG000|Overall Study|Screen Failure|0|||
155728332|NCT02492763|562106357|FG001|Overall Study|Screen Failure|0|||
155728333|NCT02492763|562106358|FG002|Overall Study|Screen Failure|0|||
155728334|NCT02492763|562106359|FG003|Overall Study|Screen Failure|1|||
155728335|NCT02492763|562106356|FG000|Overall Study|Study Terminated by Sponsor|13|||
155728336|NCT02492763|562106357|FG001|Overall Study|Study Terminated by Sponsor|10|||
155728337|NCT02492763|562106358|FG002|Overall Study|Study Terminated by Sponsor|6|||
155728338|NCT02492763|562106359|FG003|Overall Study|Study Terminated by Sponsor|10|||
155728339|NCT01772316|562106360|FG000|Overall Study|Serious adverse event|1|||
155728340|NCT01772316|562106360|FG000|Overall Study|Inform consent withdrawn|1|||
155728341|NCT01772316|562106360|FG000|Overall Study|Withdrawn by sponsor decision|5|||
155728342|NCT02085161|562106361|FG000|Overall Study|Not Treated|1|||
155728343|NCT02085161|562106362|FG001|Overall Study|Not Treated|0|||
155728344|NCT02085161|562106363|FG002|Overall Study|Not Treated|0|||
155728345|NCT02085161|562106364|FG003|Overall Study|Not Treated|0|||
155728346|NCT02085161|562106361|FG000|Overall Study|Adverse Event|8|||
155728347|NCT02085161|562106362|FG001|Overall Study|Adverse Event|5|||
155728348|NCT02085161|562106363|FG002|Overall Study|Adverse Event|4|||
155625285|NCT03810456|561721968|FG000|1 Month Follow-Up|Relocated to Different State|1|||
155625286|NCT03810456|561721969|FG001|1 Month Follow-Up|Relocated to Different State|0|||
155625287|NCT03810456|561721970|FG002|1 Month Follow-Up|Relocated to Different State|1|||
155625288|NCT03810456|561721968|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
155625289|NCT03810456|561721969|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
155625290|NCT03810456|561721970|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
155625291|NCT03810456|561721968|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
155625292|NCT03810456|561721969|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
155625293|NCT03810456|561721970|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
155625294|NCT03810456|561721968|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
155625295|NCT03810456|561721969|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
155625296|NCT03810456|561721970|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
155625297|NCT03810456|561721968|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
155625298|NCT03810456|561721969|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
155625299|NCT03810456|561721970|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
155625300|NCT03810456|561721968|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
155625301|NCT03810456|561721969|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
155625302|NCT03810456|561721970|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
155625303|NCT02007720|561721972|FG000|Overall Study|Withdrawal by Subject|9|||
155625304|NCT02007720|561721973|FG001|Overall Study|Withdrawal by Subject|11|||
155625305|NCT02007720|561721972|FG000|Overall Study|study terminated by sponsor|58|||
155625306|NCT02007720|561721973|FG001|Overall Study|study terminated by sponsor|54|||
155625307|NCT02007720|561721972|FG000|Overall Study|technical problem|4|||
155625308|NCT02007720|561721973|FG001|Overall Study|technical problem|2|||
155625309|NCT02007720|561721972|FG000|Overall Study|patient followd less than 165 days|11|||
155625310|NCT02007720|561721973|FG001|Overall Study|patient followd less than 165 days|5|||
155625311|NCT00490919|561721976|FG000|Open-label Run-in Period|Adverse Event|239|||
155625312|NCT00490919|561721977|FG001|Open-label Run-in Period|Adverse Event|0|||
155625313|NCT00490919|561721978|FG002|Open-label Run-in Period|Adverse Event|0|||
155625314|NCT00490919|561721976|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
155625315|NCT00490919|561721977|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
155728349|NCT02085161|562106364|FG003|Overall Study|Adverse Event|5|||
155728350|NCT02085161|562106361|FG000|Overall Study|Protocol Violation|0|||
155728351|NCT02085161|562106362|FG001|Overall Study|Protocol Violation|1|||
155728352|NCT02085161|562106363|FG002|Overall Study|Protocol Violation|0|||
155728353|NCT02085161|562106364|FG003|Overall Study|Protocol Violation|1|||
155728354|NCT02085161|562106361|FG000|Overall Study|Withdrawal by Subject|2|||
155728355|NCT02085161|562106362|FG001|Overall Study|Withdrawal by Subject|4|||
155728356|NCT02085161|562106363|FG002|Overall Study|Withdrawal by Subject|0|||
155278446|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Death|0|||
155278447|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
155625316|NCT00490919|561721978|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
155625317|NCT00490919|561721976|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
155625318|NCT00490919|561721977|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
155625319|NCT00490919|561721978|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
155625320|NCT00490919|561721976|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
155625321|NCT00490919|561721977|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
155625322|NCT00490919|561721978|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
155625323|NCT00490919|561721976|FG000|Open-label Run-in Period|Administrative|40|||
155625324|NCT00490919|561721977|FG001|Open-label Run-in Period|Administrative|0|||
155625325|NCT00490919|561721978|FG002|Open-label Run-in Period|Administrative|0|||
155625326|NCT00490919|561721976|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
155625327|NCT00490919|561721977|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
155625328|NCT00490919|561721978|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
155625329|NCT00490919|561721976|FG000|Double-blind Phase|Adverse Event|0|||
155625330|NCT00490919|561721977|FG001|Double-blind Phase|Adverse Event|40|||
155625331|NCT00490919|561721978|FG002|Double-blind Phase|Adverse Event|20|||
155625332|NCT00490919|561721976|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155625333|NCT00490919|561721977|FG001|Double-blind Phase|Withdrawal by Subject|10|||
155625334|NCT00490919|561721978|FG002|Double-blind Phase|Withdrawal by Subject|11|||
155625335|NCT00490919|561721976|FG000|Double-blind Phase|Lost to Follow-up|0|||
155625336|NCT00490919|561721977|FG001|Double-blind Phase|Lost to Follow-up|8|||
155625337|NCT00490919|561721978|FG002|Double-blind Phase|Lost to Follow-up|11|||
155625338|NCT00490919|561721976|FG000|Double-blind Phase|Lack of Efficacy|0|||
155625339|NCT00490919|561721977|FG001|Double-blind Phase|Lack of Efficacy|22|||
155625340|NCT00490919|561721978|FG002|Double-blind Phase|Lack of Efficacy|36|||
155625341|NCT00490919|561721976|FG000|Double-blind Phase|Administrative|0|||
155625342|NCT00490919|561721977|FG001|Double-blind Phase|Administrative|6|||
155625343|NCT00490919|561721978|FG002|Double-blind Phase|Administrative|6|||
155625344|NCT04350827|561721981|FG000|Overall Study|Lost to Follow-up|1|||
155625345|NCT04350827|561721982|FG001|Overall Study|Lost to Follow-up|2|||
155625346|NCT01249131|561724074|FG000|Washout Period of 10 Days|Adverse Event|0|||
155625347|NCT01249131|561724075|FG001|Washout Period of 10 Days|Adverse Event|0|||
155625348|NCT01249131|561724076|FG002|Washout Period of 10 Days|Adverse Event|0|||
155625349|NCT01249131|561724077|FG003|Washout Period of 10 Days|Adverse Event|0|||
155625350|NCT01249131|561724078|FG004|Washout Period of 10 Days|Adverse Event|1|||
155625351|NCT01249131|561724079|FG005|Washout Period of 10 Days|Adverse Event|0|||
155625352|NCT02915835|561724080|FG000|Overall Study|Physician Decision|1|||
155625353|NCT02915835|561724081|FG001|Overall Study|Physician Decision|0|||
155625354|NCT02915835|561724080|FG000|Overall Study|Withdrawal by Subject|0|||
155625355|NCT02915835|561724081|FG001|Overall Study|Withdrawal by Subject|1|||
155625356|NCT03426345|561724082|FG000|Overall Study|Adverse Event|4|||
155625357|NCT03426345|561724083|FG001|Overall Study|Adverse Event|4|||
155625358|NCT03426345|561724082|FG000|Overall Study|Lack of Efficacy|1|||
155625359|NCT03426345|561724083|FG001|Overall Study|Lack of Efficacy|0|||
155625360|NCT03426345|561724082|FG000|Overall Study|Withdrawal by Subject|5|||
155625361|NCT03426345|561724083|FG001|Overall Study|Withdrawal by Subject|6|||
155625362|NCT03426345|561724082|FG000|Overall Study|Lost to Follow-up|3|||
155625363|NCT03426345|561724083|FG001|Overall Study|Lost to Follow-up|1|||
155625364|NCT03426345|561724082|FG000|Overall Study|Protocol Deviation|3|||
155625365|NCT03426345|561724083|FG001|Overall Study|Protocol Deviation|4|||
155625366|NCT03426345|561724082|FG000|Overall Study|Reason Not Specified|1|||
155625367|NCT03426345|561724083|FG001|Overall Study|Reason Not Specified|2|||
155625368|NCT03426345|561724082|FG000|Overall Study|Missing Completion Status|1|||
155625369|NCT03426345|561724083|FG001|Overall Study|Missing Completion Status|0|||
155625370|NCT02446691|561724090|FG000|Overall Study|Withdrawal by Subject|2|||
155625371|NCT02446691|561724090|FG000|Overall Study|Lost to Follow-up|8|||
155625372|NCT02446691|561724090|FG000|Overall Study|Protocol Violation|1|||
155625373|NCT00192114|561724091|FG000|Overall Study|Objective Tumor Progression|19|||
155625374|NCT00192114|561724091|FG000|Overall Study|Adverse Event|2|||
155625375|NCT00192114|561724091|FG000|Overall Study|Clinical Progression|2|||
155625376|NCT00192114|561724091|FG000|Overall Study|Death|1|||
155625377|NCT02666222|561724099|FG000|Overall Study|Death|2|||
155625378|NCT01474486|561724100|FG000|Overall Study|Death|2|||
155625379|NCT01474486|561724100|FG000|Overall Study|Withdrawal by Subject|4|||
155625380|NCT01474486|561724100|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
155625381|NCT01255163|561724101|FG000|Overall Study|Withdrawal by Subject|1|||
155625382|NCT01255163|561724102|FG001|Overall Study|Withdrawal by Subject|0|||
155625383|NCT01255163|561724101|FG000|Overall Study|Lost to Follow-up|2|||
155625384|NCT01255163|561724102|FG001|Overall Study|Lost to Follow-up|0|||
155625385|NCT01255163|561724101|FG000|Overall Study|Adverse Event|0|||
155625386|NCT01255163|561724102|FG001|Overall Study|Adverse Event|2|||
155625387|NCT01255163|561724101|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
155625388|NCT01255163|561724102|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
155625389|NCT03504917|561724107|FG000|Blinded Treatment Period|Protocol Violation|1|||
155625390|NCT03504917|561724108|FG001|Blinded Treatment Period|Protocol Violation|0|||
155625391|NCT03504917|561724107|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
155625392|NCT03504917|561724108|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
155625393|NCT03504917|561724107|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
155625394|NCT03504917|561724108|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
155625395|NCT03504917|561724107|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
155728357|NCT02085161|562106364|FG003|Overall Study|Withdrawal by Subject|3|||
155728358|NCT02085161|562106361|FG000|Overall Study|Other Reason|1|||
155728359|NCT02085161|562106362|FG001|Overall Study|Other Reason|0|||
155728360|NCT02085161|562106363|FG002|Overall Study|Other Reason|1|||
155728361|NCT02085161|562106364|FG003|Overall Study|Other Reason|1|||
155728362|NCT00068692|562106375|FG000|Step 1: Registration|Disese progression/relapse|5|||
155728363|NCT00068692|562106376|FG001|Step 1: Registration|Disese progression/relapse|0|||
155728364|NCT00068692|562106377|FG002|Step 1: Registration|Disese progression/relapse|0|||
155728365|NCT00068692|562106378|FG003|Step 1: Registration|Disese progression/relapse|0|||
155728366|NCT00068692|562106379|FG004|Step 1: Registration|Disese progression/relapse|0|||
155728367|NCT00068692|562106380|FG005|Step 1: Registration|Disese progression/relapse|0|||
155728368|NCT00068692|562106381|FG006|Step 1: Registration|Disese progression/relapse|0|||
155728369|NCT00068692|562106382|FG007|Step 1: Registration|Disese progression/relapse|0|||
155728370|NCT00068692|562106375|FG000|Step 1: Registration|Adverse Event|7|||
155728371|NCT00068692|562106376|FG001|Step 1: Registration|Adverse Event|0|||
155728372|NCT00068692|562106377|FG002|Step 1: Registration|Adverse Event|0|||
155728373|NCT00068692|562106378|FG003|Step 1: Registration|Adverse Event|0|||
155728374|NCT00068692|562106379|FG004|Step 1: Registration|Adverse Event|0|||
155728375|NCT00068692|562106380|FG005|Step 1: Registration|Adverse Event|0|||
155728376|NCT00068692|562106381|FG006|Step 1: Registration|Adverse Event|0|||
155728377|NCT00068692|562106382|FG007|Step 1: Registration|Adverse Event|0|||
155728378|NCT00068692|562106375|FG000|Step 1: Registration|Death|1|||
155728379|NCT00068692|562106376|FG001|Step 1: Registration|Death|0|||
155728380|NCT00068692|562106377|FG002|Step 1: Registration|Death|0|||
155728381|NCT00068692|562106378|FG003|Step 1: Registration|Death|0|||
155728382|NCT00068692|562106379|FG004|Step 1: Registration|Death|0|||
155728383|NCT00068692|562106380|FG005|Step 1: Registration|Death|0|||
155728384|NCT00068692|562106381|FG006|Step 1: Registration|Death|0|||
155728385|NCT00068692|562106382|FG007|Step 1: Registration|Death|0|||
155728386|NCT00068692|562106375|FG000|Step 1: Registration|Withdrawal by Subject|11|||
155728387|NCT00068692|562106376|FG001|Step 1: Registration|Withdrawal by Subject|0|||
155728388|NCT00068692|562106377|FG002|Step 1: Registration|Withdrawal by Subject|0|||
155728389|NCT00068692|562106378|FG003|Step 1: Registration|Withdrawal by Subject|0|||
155728390|NCT00068692|562106379|FG004|Step 1: Registration|Withdrawal by Subject|0|||
155728391|NCT00068692|562106380|FG005|Step 1: Registration|Withdrawal by Subject|0|||
155728392|NCT00068692|562106381|FG006|Step 1: Registration|Withdrawal by Subject|0|||
155728393|NCT00068692|562106382|FG007|Step 1: Registration|Withdrawal by Subject|0|||
155278448|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
155625396|NCT03504917|561724108|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
155625397|NCT03504917|561724107|FG000|Blinded Treatment Period|Adverse Event|4|||
155625398|NCT03504917|561724108|FG001|Blinded Treatment Period|Adverse Event|4|||
155625399|NCT03504917|561724107|FG000|Blinded Treatment Period|Physician Decision|1|||
155625400|NCT03504917|561724108|FG001|Blinded Treatment Period|Physician Decision|0|||
155625401|NCT03504917|561724107|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
155625402|NCT03504917|561724108|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
155625403|NCT03504917|561724107|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
155625404|NCT03504917|561724108|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
155625405|NCT03504917|561724107|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
155625406|NCT03504917|561724108|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
155625407|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
155625408|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
155625409|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
155625410|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
155625411|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
155625412|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
155625413|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
155625414|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
155625415|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
155625416|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
155625417|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
155625418|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
155625419|NCT03504917|561724107|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
155728394|NCT00068692|562106375|FG000|Step 1: Registration|Alternative therapy|2|||
155728395|NCT00068692|562106376|FG001|Step 1: Registration|Alternative therapy|0|||
155728396|NCT00068692|562106377|FG002|Step 1: Registration|Alternative therapy|0|||
155728397|NCT00068692|562106378|FG003|Step 1: Registration|Alternative therapy|0|||
155728398|NCT00068692|562106379|FG004|Step 1: Registration|Alternative therapy|0|||
155728399|NCT00068692|562106380|FG005|Step 1: Registration|Alternative therapy|0|||
155728400|NCT00068692|562106381|FG006|Step 1: Registration|Alternative therapy|0|||
155728401|NCT00068692|562106382|FG007|Step 1: Registration|Alternative therapy|0|||
155625420|NCT03504917|561724108|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
155625421|NCT04219189|561724109|FG000|Overall Study|Withdrawal by Subject|1|||
155625422|NCT04219189|561724110|FG001|Overall Study|Withdrawal by Subject|2|||
155625423|NCT04219189|561724109|FG000|Overall Study|Protocol Violation|0|||
155728402|NCT00068692|562106375|FG000|Step 1: Registration|Complicating disease|2|||
155728403|NCT00068692|562106376|FG001|Step 1: Registration|Complicating disease|0|||
155728404|NCT00068692|562106377|FG002|Step 1: Registration|Complicating disease|0|||
155278449|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
155278450|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
155278451|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
155625424|NCT04219189|561724110|FG001|Overall Study|Protocol Violation|1|||
155625425|NCT04219189|561724109|FG000|Overall Study|Lost to Follow-up|0|||
155625426|NCT04219189|561724110|FG001|Overall Study|Lost to Follow-up|1|||
155625427|NCT04219189|561724109|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
155625428|NCT04219189|561724110|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
155625429|NCT03863353|561724111|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
155625430|NCT03863353|561724112|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
155625431|NCT02495389|561724113|FG000|Overall Study|Withdrawal by Subject|40|||
155625432|NCT04079790|561724117|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
155625433|NCT04079790|561724118|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155625434|NCT04079790|561724119|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155625435|NCT04079790|561724120|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155625436|NCT04079790|561724117|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155625437|NCT04079790|561724118|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155625438|NCT04079790|561724119|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
155625439|NCT04079790|561724120|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155625440|NCT04079790|561724117|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155625441|NCT04079790|561724118|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155625442|NCT04079790|561724119|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
155625443|NCT04079790|561724120|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155625444|NCT01924533|561724122|FG000|Overall Study|Death|181|||
155625445|NCT01924533|561724123|FG001|Overall Study|Death|200|||
155625446|NCT01924533|561724122|FG000|Overall Study|Lost to Follow-up|0|||
155625447|NCT01924533|561724123|FG001|Overall Study|Lost to Follow-up|1|||
155625448|NCT01924533|561724122|FG000|Overall Study|Withdrawal by Subject|7|||
155625449|NCT01924533|561724123|FG001|Overall Study|Withdrawal by Subject|3|||
155625450|NCT01924533|561724122|FG000|Overall Study|Other Eligibility criteria|1|||
155625451|NCT01924533|561724123|FG001|Overall Study|Other Eligibility criteria|1|||
155625452|NCT05817669|561724124|FG000|Overall Study|Prohibited medication used|1|||
155278452|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
155278453|NCT01021332|560453185|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
155278454|NCT01021332|560453185|FG000|Overall Study|Adverse Event|43|||
155278455|NCT01021332|560453185|FG000|Overall Study|Lack of Efficacy|19|||
155278456|NCT01021332|560453185|FG000|Overall Study|Withdrawal of Consent|23|||
155278457|NCT01021332|560453185|FG000|Overall Study|Lost to Follow-up|4|||
155278458|NCT01021332|560453185|FG000|Overall Study|Protocol Violation|9|||
155278459|NCT01021332|560453185|FG000|Overall Study|Miscellaneous|3|||
155278460|NCT05343455|560453189|FG000|Overall Study|Withdrawal by Subject|4|||
155278461|NCT05343455|560453190|FG001|Overall Study|Withdrawal by Subject|9|||
155278462|NCT05343455|560453191|FG002|Overall Study|Withdrawal by Subject|7|||
155278463|NCT05343455|560453189|FG000|Overall Study|Adverse Event|2|||
155278464|NCT05343455|560453190|FG001|Overall Study|Adverse Event|1|||
155278465|NCT05343455|560453191|FG002|Overall Study|Adverse Event|2|||
155278466|NCT05343455|560453189|FG000|Overall Study|Lost to Follow-up|1|||
155278467|NCT05343455|560453190|FG001|Overall Study|Lost to Follow-up|1|||
155278468|NCT05343455|560453191|FG002|Overall Study|Lost to Follow-up|3|||
155278469|NCT05343455|560453189|FG000|Overall Study|Pregnancy|1|||
155278470|NCT05343455|560453190|FG001|Overall Study|Pregnancy|0|||
155278471|NCT05343455|560453191|FG002|Overall Study|Pregnancy|0|||
155278472|NCT05343455|560453189|FG000|Overall Study|Physician Decision|0|||
155278473|NCT05343455|560453190|FG001|Overall Study|Physician Decision|0|||
155278474|NCT05343455|560453191|FG002|Overall Study|Physician Decision|1|||
155278475|NCT05343455|560453189|FG000|Overall Study|Protocol Violation|0|||
155625453|NCT05817669|561724125|FG001|Overall Study|Prohibited medication used|2|||
155625454|NCT05817669|561724124|FG000|Overall Study|Adverse Event|1|||
155625455|NCT05817669|561724125|FG001|Overall Study|Adverse Event|0|||
155625456|NCT05817669|561724124|FG000|Overall Study|Withdrawal by Subject|1|||
155728405|NCT00068692|562106378|FG003|Step 1: Registration|Complicating disease|0|||
155278476|NCT05343455|560453190|FG001|Overall Study|Protocol Violation|1|||
155278477|NCT05343455|560453191|FG002|Overall Study|Protocol Violation|1|||
155278478|NCT00839917|560453192|FG000|Overall Study|Lost to Follow-up|1|||
155278479|NCT00839917|560453193|FG001|Overall Study|Lost to Follow-up|0|||
155278480|NCT00839917|560453192|FG000|Overall Study|Did not receive vaccine|0|||
155278481|NCT00839917|560453193|FG001|Overall Study|Did not receive vaccine|1|||
155625457|NCT05817669|561724125|FG001|Overall Study|Withdrawal by Subject|2|||
155625458|NCT04233879|561724126|FG000|Overall Study|Death|2|||
155625459|NCT04233879|561724127|FG001|Overall Study|Death|0|||
155625460|NCT04233879|561724126|FG000|Overall Study|Lost to Follow-up|3|||
155625461|NCT04233879|561724127|FG001|Overall Study|Lost to Follow-up|8|||
155625462|NCT04233879|561724126|FG000|Overall Study|Physician Decision|4|||
155625463|NCT04233879|561724127|FG001|Overall Study|Physician Decision|4|||
155625464|NCT04233879|561724126|FG000|Overall Study|Withdrawal by Subject|7|||
155625465|NCT04233879|561724127|FG001|Overall Study|Withdrawal by Subject|10|||
155625466|NCT04233879|561724126|FG000|Overall Study|Other|281|||
155625467|NCT04233879|561724127|FG001|Overall Study|Other|279|||
155625468|NCT03292016|561724130|FG000|Second Washout|Adverse Event|0|||
155625469|NCT03292016|561724131|FG001|Second Washout|Adverse Event|1|||
155625470|NCT03292016|561724132|FG002|Second Washout|Adverse Event|0|||
155625471|NCT03292016|561724133|FG003|Second Washout|Adverse Event|0|||
155625472|NCT03292016|561724134|FG004|Second Washout|Adverse Event|0|||
155625473|NCT03292016|561724135|FG005|Second Washout|Adverse Event|0|||
155625474|NCT01802385|561724137|FG000|Overall Study|Death|106|||
155625475|NCT01802385|561724138|FG001|Overall Study|Death|120|||
155625476|NCT03810183|561724139|FG000|Overall Study|Study terminated by Sponsor|2|||
155625477|NCT03810183|561724140|FG001|Overall Study|Study terminated by Sponsor|1|||
155625478|NCT00323063|561724142|FG000|Overall Study|Adverse Event|1|||
155625479|NCT00323063|561724143|FG001|Overall Study|Adverse Event|0|||
155625480|NCT00323063|561724142|FG000|Overall Study|brain mets discovered prior to treatment|1|||
155625481|NCT00323063|561724143|FG001|Overall Study|brain mets discovered prior to treatment|0|||
155625482|NCT04275336|561724146|FG000|Overall Study|First venipuncture failed|4|||
155625483|NCT04275336|561724147|FG001|Overall Study|First venipuncture failed|6|||
155625484|NCT04275336|561724148|FG002|Overall Study|First venipuncture failed|5|||
155625485|NCT04275336|561724146|FG000|Overall Study|Unscheduled venipuncture|9|||
155625486|NCT04275336|561724147|FG001|Overall Study|Unscheduled venipuncture|13|||
155625487|NCT04275336|561724148|FG002|Overall Study|Unscheduled venipuncture|7|||
155625488|NCT04275336|561724146|FG000|Overall Study|Failed specimen of saliva|4|||
155625489|NCT04275336|561724147|FG001|Overall Study|Failed specimen of saliva|3|||
155625490|NCT04275336|561724148|FG002|Overall Study|Failed specimen of saliva|4|||
155625491|NCT03055936|561724149|FG000|Overall Study|Adverse Event|0|||
155625492|NCT03055936|561724150|FG001|Overall Study|Adverse Event|1|||
155625493|NCT03055936|561724151|FG002|Overall Study|Adverse Event|1|||
155625494|NCT03055936|561724152|FG003|Overall Study|Adverse Event|1|||
155625495|NCT03055936|561724149|FG000|Overall Study|Personal reason|2|||
155625496|NCT03055936|561724150|FG001|Overall Study|Personal reason|0|||
155625497|NCT03055936|561724151|FG002|Overall Study|Personal reason|1|||
155625498|NCT03055936|561724152|FG003|Overall Study|Personal reason|0|||
155625499|NCT01909804|561724158|FG000|Overall Study|Randomized but Never Treated|0|||
155625500|NCT01909804|561724159|FG001|Overall Study|Randomized but Never Treated|0|||
155625501|NCT01909804|561724160|FG002|Overall Study|Randomized but Never Treated|0|||
155625502|NCT01909804|561724161|FG003|Overall Study|Randomized but Never Treated|0|||
155625503|NCT01909804|561724162|FG004|Overall Study|Randomized but Never Treated|0|||
155625504|NCT01909804|561724163|FG005|Overall Study|Randomized but Never Treated|0|||
155625505|NCT01909804|561724164|FG006|Overall Study|Randomized but Never Treated|1|||
155625506|NCT01909804|561724165|FG007|Overall Study|Randomized but Never Treated|0|||
155625507|NCT01909804|561724166|FG008|Overall Study|Randomized but Never Treated|0|||
155625508|NCT01909804|561724167|FG009|Overall Study|Randomized but Never Treated|0|||
155625509|NCT01909804|561724168|FG010|Overall Study|Randomized but Never Treated|0|||
155625510|NCT01909804|561724169|FG011|Overall Study|Randomized but Never Treated|1|||
155625511|NCT01909804|561724158|FG000|Overall Study|Death|0|||
155625512|NCT01909804|561724159|FG001|Overall Study|Death|0|||
155625513|NCT01909804|561724160|FG002|Overall Study|Death|0|||
155625514|NCT01909804|561724161|FG003|Overall Study|Death|0|||
155625515|NCT01909804|561724162|FG004|Overall Study|Death|0|||
155625516|NCT01909804|561724163|FG005|Overall Study|Death|0|||
155625517|NCT01909804|561724164|FG006|Overall Study|Death|0|||
155625518|NCT01909804|561724165|FG007|Overall Study|Death|0|||
155625519|NCT01909804|561724166|FG008|Overall Study|Death|0|||
155625520|NCT01909804|561724167|FG009|Overall Study|Death|0|||
155625521|NCT01909804|561724168|FG010|Overall Study|Death|1|||
155625522|NCT01909804|561724169|FG011|Overall Study|Death|0|||
155625523|NCT01909804|561724158|FG000|Overall Study|Lack of Efficacy|4|||
155625524|NCT01909804|561724159|FG001|Overall Study|Lack of Efficacy|1|||
155625525|NCT01909804|561724160|FG002|Overall Study|Lack of Efficacy|0|||
155625526|NCT01909804|561724161|FG003|Overall Study|Lack of Efficacy|0|||
155625527|NCT01909804|561724162|FG004|Overall Study|Lack of Efficacy|7|||
155625528|NCT01909804|561724163|FG005|Overall Study|Lack of Efficacy|3|||
155625529|NCT01909804|561724164|FG006|Overall Study|Lack of Efficacy|1|||
155625530|NCT01909804|561724165|FG007|Overall Study|Lack of Efficacy|1|||
155625531|NCT01909804|561724166|FG008|Overall Study|Lack of Efficacy|0|||
155625532|NCT01909804|561724167|FG009|Overall Study|Lack of Efficacy|1|||
155625533|NCT01909804|561724168|FG010|Overall Study|Lack of Efficacy|0|||
155625534|NCT01909804|561724169|FG011|Overall Study|Lack of Efficacy|1|||
155625535|NCT01909804|561724158|FG000|Overall Study|Withdrew Consent|0|||
155278482|NCT03468426|560453194|FG000|Overall Study|Progressive disease|3|||
155278483|NCT03468426|560453195|FG001|Overall Study|Progressive disease|0|||
155278484|NCT03468426|560453196|FG002|Overall Study|Progressive disease|4|||
155278485|NCT03468426|560453197|FG003|Overall Study|Progressive disease|20|||
155278486|NCT03468426|560453198|FG004|Overall Study|Progressive disease|23|||
155278487|NCT03468426|560453199|FG005|Overall Study|Progressive disease|15|||
155278488|NCT03468426|560453200|FG006|Overall Study|Progressive disease|24|||
155278489|NCT03468426|560453201|FG007|Overall Study|Progressive disease|27|||
155278490|NCT03468426|560453202|FG008|Overall Study|Progressive disease|13|||
155278491|NCT03468426|560453203|FG009|Overall Study|Progressive disease|13|||
155278492|NCT03468426|560453204|FG010|Overall Study|Progressive disease|0|||
155278493|NCT03468426|560453194|FG000|Overall Study|Other adverse event or clinical progression|0|||
155278494|NCT03468426|560453195|FG001|Overall Study|Other adverse event or clinical progression|1|||
155278495|NCT03468426|560453196|FG002|Overall Study|Other adverse event or clinical progression|3|||
155278496|NCT03468426|560453197|FG003|Overall Study|Other adverse event or clinical progression|14|||
155278497|NCT03468426|560453198|FG004|Overall Study|Other adverse event or clinical progression|10|||
155278498|NCT03468426|560453199|FG005|Overall Study|Other adverse event or clinical progression|8|||
155278499|NCT03468426|560453200|FG006|Overall Study|Other adverse event or clinical progression|5|||
155278500|NCT03468426|560453201|FG007|Overall Study|Other adverse event or clinical progression|4|||
155278501|NCT03468426|560453202|FG008|Overall Study|Other adverse event or clinical progression|6|||
155278502|NCT03468426|560453203|FG009|Overall Study|Other adverse event or clinical progression|11|||
155278503|NCT03468426|560453204|FG010|Overall Study|Other adverse event or clinical progression|0|||
155625536|NCT01909804|561724159|FG001|Overall Study|Withdrew Consent|0|||
155625537|NCT01909804|561724160|FG002|Overall Study|Withdrew Consent|0|||
155625538|NCT01909804|561724161|FG003|Overall Study|Withdrew Consent|0|||
155278504|NCT03468426|560453194|FG000|Overall Study|Refused to continue taking trial medication|0|||
155278505|NCT03468426|560453195|FG001|Overall Study|Refused to continue taking trial medication|0|||
155278506|NCT03468426|560453196|FG002|Overall Study|Refused to continue taking trial medication|0|||
155278507|NCT03468426|560453197|FG003|Overall Study|Refused to continue taking trial medication|2|||
155278508|NCT03468426|560453198|FG004|Overall Study|Refused to continue taking trial medication|0|||
155278509|NCT03468426|560453199|FG005|Overall Study|Refused to continue taking trial medication|3|||
155278510|NCT03468426|560453200|FG006|Overall Study|Refused to continue taking trial medication|0|||
155278511|NCT03468426|560453201|FG007|Overall Study|Refused to continue taking trial medication|0|||
155278512|NCT03468426|560453202|FG008|Overall Study|Refused to continue taking trial medication|1|||
155278513|NCT03468426|560453203|FG009|Overall Study|Refused to continue taking trial medication|0|||
155278514|NCT03468426|560453204|FG010|Overall Study|Refused to continue taking trial medication|0|||
155278515|NCT03468426|560453194|FG000|Overall Study|Other than listed|0|||
155278516|NCT03468426|560453195|FG001|Overall Study|Other than listed|1|||
155278517|NCT03468426|560453196|FG002|Overall Study|Other than listed|0|||
155278518|NCT03468426|560453197|FG003|Overall Study|Other than listed|0|||
155278519|NCT03468426|560453198|FG004|Overall Study|Other than listed|2|||
155278520|NCT03468426|560453199|FG005|Overall Study|Other than listed|2|||
155278521|NCT03468426|560453200|FG006|Overall Study|Other than listed|0|||
155278522|NCT03468426|560453201|FG007|Overall Study|Other than listed|0|||
155625539|NCT01909804|561724162|FG004|Overall Study|Withdrew Consent|1|||
155625540|NCT01909804|561724163|FG005|Overall Study|Withdrew Consent|1|||
155625541|NCT01909804|561724164|FG006|Overall Study|Withdrew Consent|0|||
155625542|NCT01909804|561724165|FG007|Overall Study|Withdrew Consent|0|||
155625543|NCT01909804|561724166|FG008|Overall Study|Withdrew Consent|0|||
155625544|NCT01909804|561724167|FG009|Overall Study|Withdrew Consent|0|||
155625545|NCT01909804|561724168|FG010|Overall Study|Withdrew Consent|0|||
155625546|NCT01909804|561724169|FG011|Overall Study|Withdrew Consent|0|||
155625547|NCT01909804|561724158|FG000|Overall Study|Protocol Violation|0|||
155625548|NCT01909804|561724159|FG001|Overall Study|Protocol Violation|0|||
155625549|NCT01909804|561724160|FG002|Overall Study|Protocol Violation|0|||
155625550|NCT01909804|561724161|FG003|Overall Study|Protocol Violation|0|||
155625551|NCT01909804|561724162|FG004|Overall Study|Protocol Violation|0|||
155625552|NCT01909804|561724163|FG005|Overall Study|Protocol Violation|0|||
155625553|NCT01909804|561724164|FG006|Overall Study|Protocol Violation|0|||
155625554|NCT01909804|561724165|FG007|Overall Study|Protocol Violation|0|||
155625555|NCT01909804|561724166|FG008|Overall Study|Protocol Violation|0|||
155625556|NCT01909804|561724167|FG009|Overall Study|Protocol Violation|0|||
155625557|NCT01909804|561724168|FG010|Overall Study|Protocol Violation|0|||
155625558|NCT01909804|561724169|FG011|Overall Study|Protocol Violation|1|||
155625559|NCT04613518|561724172|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
155625560|NCT04613518|561724173|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155625561|NCT04613518|561724174|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
155625562|NCT04613518|561724172|FG000|Double-Blind Treatment Period|Adverse Event|2|||
155278523|NCT03468426|560453202|FG008|Overall Study|Other than listed|4|||
155278524|NCT03468426|560453203|FG009|Overall Study|Other than listed|4|||
155278525|NCT03468426|560453204|FG010|Overall Study|Other than listed|1|||
155278526|NCT03468426|560453194|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278527|NCT03468426|560453195|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155625563|NCT04613518|561724173|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155625564|NCT04613518|561724174|FG002|Double-Blind Treatment Period|Adverse Event|1|||
155625565|NCT04613518|561724172|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
155625566|NCT04613518|561724173|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
155625567|NCT04613518|561724174|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
155625568|NCT04613518|561724172|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
155625569|NCT04613518|561724173|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
155625570|NCT04613518|561724174|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
155625571|NCT04613518|561724172|FG000|Double-Blind Treatment Period|Other Reasons|2|||
155625572|NCT04613518|561724173|FG001|Double-Blind Treatment Period|Other Reasons|0|||
155625573|NCT04613518|561724174|FG002|Double-Blind Treatment Period|Other Reasons|0|||
155625574|NCT04613518|561724172|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
155625575|NCT04613518|561724173|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
155625576|NCT04613518|561724174|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155625577|NCT04613518|561724172|FG000|Open-Label Treatment Period|Adverse Event|1|||
155625578|NCT04613518|561724173|FG001|Open-Label Treatment Period|Adverse Event|0|||
155625579|NCT04613518|561724174|FG002|Open-Label Treatment Period|Adverse Event|3|||
155625580|NCT04613518|561724172|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
155625581|NCT04613518|561724173|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
155625582|NCT04613518|561724174|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
155625583|NCT04613518|561724172|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
155625584|NCT04613518|561724173|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
155625585|NCT04613518|561724174|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
155625586|NCT04613518|561724172|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
155625587|NCT04613518|561724173|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
155625588|NCT04613518|561724174|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
155625589|NCT04613518|561724172|FG000|Open-Label Treatment Period|Other reasons|1|||
155625590|NCT04613518|561724173|FG001|Open-Label Treatment Period|Other reasons|0|||
155625591|NCT04613518|561724174|FG002|Open-Label Treatment Period|Other reasons|0|||
155625592|NCT03589807|561724175|FG000|Overall Study|Lost to Follow-up|0|||
155625593|NCT03589807|561724176|FG001|Overall Study|Lost to Follow-up|2|||
155625594|NCT03589807|561724177|FG002|Overall Study|Lost to Follow-up|2|||
155625595|NCT03589807|561724178|FG003|Overall Study|Lost to Follow-up|3|||
155625596|NCT03589807|561724179|FG004|Overall Study|Lost to Follow-up|1|||
155625597|NCT03589807|561724180|FG005|Overall Study|Lost to Follow-up|1|||
155625598|NCT03589807|561724175|FG000|Overall Study|Withdrawal by Subject|0|||
155625599|NCT03589807|561724176|FG001|Overall Study|Withdrawal by Subject|5|||
155625600|NCT03589807|561724177|FG002|Overall Study|Withdrawal by Subject|0|||
155625601|NCT03589807|561724178|FG003|Overall Study|Withdrawal by Subject|0|||
155625602|NCT03589807|561724179|FG004|Overall Study|Withdrawal by Subject|0|||
155625603|NCT03589807|561724180|FG005|Overall Study|Withdrawal by Subject|0|||
155625604|NCT03589807|561724175|FG000|Overall Study|Protocol Violation|0|||
155625605|NCT03589807|561724176|FG001|Overall Study|Protocol Violation|0|||
155625606|NCT03589807|561724177|FG002|Overall Study|Protocol Violation|0|||
155625607|NCT03589807|561724178|FG003|Overall Study|Protocol Violation|1|||
155625608|NCT03589807|561724179|FG004|Overall Study|Protocol Violation|0|||
155625609|NCT03589807|561724180|FG005|Overall Study|Protocol Violation|0|||
155625610|NCT03589807|561724175|FG000|Overall Study|Enrolled but treatment not administered|0|||
155625611|NCT03589807|561724176|FG001|Overall Study|Enrolled but treatment not administered|0|||
155625612|NCT03589807|561724177|FG002|Overall Study|Enrolled but treatment not administered|0|||
155625613|NCT03589807|561724178|FG003|Overall Study|Enrolled but treatment not administered|0|||
155625614|NCT03589807|561724179|FG004|Overall Study|Enrolled but treatment not administered|1|||
155625615|NCT03589807|561724180|FG005|Overall Study|Enrolled but treatment not administered|0|||
155625616|NCT01076543|561724182|FG000|Overall Study|Withdrawal by Subject|2|||
155625617|NCT01076543|561724183|FG001|Overall Study|Withdrawal by Subject|0|||
155625618|NCT01076543|561724184|FG002|Overall Study|Withdrawal by Subject|0|||
155625619|NCT01076543|561724185|FG003|Overall Study|Withdrawal by Subject|0|||
155625620|NCT01076543|561724186|FG004|Overall Study|Withdrawal by Subject|0|||
155625621|NCT01076543|561724187|FG005|Overall Study|Withdrawal by Subject|0|||
155625622|NCT00338741|561724188|FG000|Overall Study|Lost to Follow-up|2|||
155625623|NCT00338741|561724189|FG001|Overall Study|Lost to Follow-up|0|||
155625624|NCT01534273|561724190|FG000|Period 1|Physician Decision|0|||
155625625|NCT01534273|561724191|FG001|Period 1|Physician Decision|0|||
155625626|NCT01534273|561724192|FG002|Period 1|Physician Decision|0|||
155625627|NCT01534273|561724193|FG003|Period 1|Physician Decision|1|||
155625628|NCT01534273|561724194|FG004|Period 1|Physician Decision|0|||
155625629|NCT01534273|561724195|FG005|Period 1|Physician Decision|0|||
155625630|NCT01534273|561724196|FG006|Period 1|Physician Decision|0|||
155625631|NCT03586050|561724197|FG000|Overall Study|Death|3|||
155625632|NCT03586050|561724197|FG000|Overall Study|Withdrawal by Subject|2|||
155625633|NCT01791985|561724202|FG000|Overall Study|Adverse Event|7|||
155625634|NCT01791985|561724202|FG000|Overall Study|Withdrawal by Subject|1|||
155625635|NCT03902613|561724209|FG000|Overall Study|Physician Decision|1|||
155625636|NCT01091246|561724210|FG000|Overall Study|Lost to Follow-up|23|||
155625637|NCT01091246|561724211|FG001|Overall Study|Lost to Follow-up|11|||
155625638|NCT01091246|561724212|FG002|Overall Study|Lost to Follow-up|7|||
155625639|NCT01091246|561724210|FG000|Overall Study|Adverse Event|1|||
155625640|NCT01091246|561724211|FG001|Overall Study|Adverse Event|0|||
155625641|NCT01091246|561724212|FG002|Overall Study|Adverse Event|1|||
155625642|NCT01091246|561724210|FG000|Overall Study|Withdrawal by Subject|9|||
155625643|NCT01091246|561724211|FG001|Overall Study|Withdrawal by Subject|5|||
155625644|NCT01091246|561724212|FG002|Overall Study|Withdrawal by Subject|4|||
155625645|NCT01091246|561724210|FG000|Overall Study|Subject not dosed|2|||
155625646|NCT01091246|561724211|FG001|Overall Study|Subject not dosed|0|||
155625647|NCT01091246|561724212|FG002|Overall Study|Subject not dosed|1|||
155625648|NCT04577794|561724213|FG000|Overall Study|Adverse Event|1|||
155625649|NCT04577794|561724214|FG001|Overall Study|Adverse Event|1|||
155625650|NCT01676012|561724215|FG000|Overall Study|Adverse Event|2|||
155625651|NCT01676012|561724215|FG000|Overall Study|incomplete set of videos|1|||
155625652|NCT03372798|561724222|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
155625653|NCT03372798|561724223|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
155625654|NCT03372798|561724222|FG000|Overall Study|Failure of imaging probe|0|||
155625655|NCT03372798|561724223|FG001|Overall Study|Failure of imaging probe|1|||
155625656|NCT01405898|561724225|FG000|Overall Study|Withdrawal by Subject|2|||
155625657|NCT01405898|561724226|FG001|Overall Study|Withdrawal by Subject|2|||
155625658|NCT02283658|561724227|FG000|Overall Study|Withdrawal by Subject|1|||
155625659|NCT03608826|561724229|FG000|Overall Study|Death|3|||
155625660|NCT03608826|561724229|FG000|Overall Study|Heart Transplant|3|||
155625661|NCT03608826|561724229|FG000|Overall Study|Physician Decision|4|||
155625662|NCT00875810|561724230|FG000|Overall Study|Withdrawal by Subject|1|||
155625663|NCT00875810|561724230|FG000|Overall Study|Physician Decision|3|||
155625664|NCT00875810|561724230|FG000|Overall Study|Lost to Follow-up|39|||
155625665|NCT00875810|561724230|FG000|Overall Study|Patient enroled but not implanted|2|||
155625666|NCT00875810|561724230|FG000|Overall Study|Device explanted|1|||
155625667|NCT00780975|561724231|FG000|Overall Study|Progressive disease|3|||
155625668|NCT00780975|561724231|FG000|Overall Study|Toxicity|5|||
155625669|NCT01061606|561724232|FG000|Overall Study|Adverse Event|1|||
155625670|NCT01061606|561724232|FG000|Overall Study|Death|1|||
155625671|NCT01061606|561724232|FG000|Overall Study|Disease Progression|4|||
155625672|NCT01061606|561724232|FG000|Overall Study|alternative therapy|2|||
155625673|NCT01305564|561724233|FG000|Overall Study|Death|21|||
155625674|NCT01305564|561724233|FG000|Overall Study|Lost to Follow-up|12|||
155625675|NCT01305564|561724233|FG000|Overall Study|Withdrawal by Subject|1|||
155625676|NCT01305564|561724233|FG000|Overall Study|Physician Decision|3|||
155625677|NCT02322749|561724235|FG000|Period 2|Adverse Event|0|||
155625678|NCT02322749|561724236|FG001|Period 2|Adverse Event|0|||
155625679|NCT02322749|561724237|FG002|Period 2|Adverse Event|0|||
155625680|NCT02322749|561724238|FG003|Period 2|Adverse Event|1|||
155625681|NCT02322749|561724239|FG004|Period 2|Adverse Event|0|||
155625682|NCT02322749|561724240|FG005|Period 2|Adverse Event|0|||
155625683|NCT02322749|561724235|FG000|Period 2|Withdrawal by Subject|0|||
155625684|NCT02322749|561724236|FG001|Period 2|Withdrawal by Subject|0|||
155625685|NCT02322749|561724237|FG002|Period 2|Withdrawal by Subject|0|||
155625686|NCT02322749|561724238|FG003|Period 2|Withdrawal by Subject|1|||
155625687|NCT02322749|561724239|FG004|Period 2|Withdrawal by Subject|0|||
155625688|NCT02322749|561724240|FG005|Period 2|Withdrawal by Subject|0|||
155625689|NCT02322749|561724235|FG000|Period 3|Withdrawal by Subject|0|||
155625690|NCT02322749|561724236|FG001|Period 3|Withdrawal by Subject|0|||
155625691|NCT02322749|561724237|FG002|Period 3|Withdrawal by Subject|1|||
155625692|NCT02322749|561724238|FG003|Period 3|Withdrawal by Subject|0|||
155625693|NCT02322749|561724239|FG004|Period 3|Withdrawal by Subject|0|||
155625694|NCT02322749|561724240|FG005|Period 3|Withdrawal by Subject|0|||
155625695|NCT00073918|561724245|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
155625696|NCT00073918|561724245|FG000|Overall Study|Rapid disease progression|2|||
155625697|NCT00073918|561724245|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
155625698|NCT01190813|561724248|FG000|Overall Study|Lost to Follow-up|1|||
155625699|NCT01190813|561724249|FG001|Overall Study|Lost to Follow-up|2|||
155625700|NCT01190813|561724248|FG000|Overall Study|Withdrawal by Subject|2|||
155625701|NCT01190813|561724249|FG001|Overall Study|Withdrawal by Subject|1|||
155625702|NCT01190813|561724248|FG000|Overall Study|Refused study treatment after randomized|1|||
155278528|NCT03468426|560453196|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155278529|NCT03468426|560453197|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155625703|NCT01190813|561724249|FG001|Overall Study|Refused study treatment after randomized|0|||
155625704|NCT01190813|561724248|FG000|Overall Study|Adverse Event|0|||
155625705|NCT01190813|561724249|FG001|Overall Study|Adverse Event|1|||
155625706|NCT02033759|561724250|FG000|Overall Study|Withdrawal by Subject|2|||
155625707|NCT02033759|561724251|FG001|Overall Study|Withdrawal by Subject|1|||
155625708|NCT02033759|561724250|FG000|Overall Study|Protocol Violation|1|||
155278530|NCT03468426|560453198|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155625709|NCT02033759|561724251|FG001|Overall Study|Protocol Violation|1|||
155625710|NCT00807365|561724256|FG000|Overall Study|Study Terminated|5|||
155278531|NCT03468426|560453199|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278532|NCT03468426|560453200|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278533|NCT03468426|560453201|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278534|NCT03468426|560453202|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278535|NCT03468426|560453203|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155625711|NCT04821830|561724259|FG000|Overall Study|Withdrawal by Subject|1|||
155625712|NCT04821830|561724260|FG001|Overall Study|Withdrawal by Subject|0|||
155625713|NCT00919633|561724262|FG000|Overall Study|Adverse Event|1|||
155625714|NCT00919633|561724263|FG001|Overall Study|Adverse Event|9|||
155625715|NCT00919633|561724264|FG002|Overall Study|Adverse Event|12|||
155625716|NCT00919633|561724265|FG003|Overall Study|Adverse Event|10|||
155625717|NCT00919633|561724262|FG000|Overall Study|Death|0|||
155625718|NCT00919633|561724263|FG001|Overall Study|Death|0|||
155625719|NCT00919633|561724264|FG002|Overall Study|Death|2|||
155625720|NCT00919633|561724265|FG003|Overall Study|Death|0|||
155625721|NCT00919633|561724262|FG000|Overall Study|Lack of Efficacy|17|||
155625722|NCT00919633|561724263|FG001|Overall Study|Lack of Efficacy|3|||
155625723|NCT00919633|561724264|FG002|Overall Study|Lack of Efficacy|2|||
155625724|NCT00919633|561724265|FG003|Overall Study|Lack of Efficacy|3|||
155625725|NCT00919633|561724262|FG000|Overall Study|Withdrawal by Subject|1|||
155625726|NCT00919633|561724263|FG001|Overall Study|Withdrawal by Subject|2|||
155625727|NCT00919633|561724264|FG002|Overall Study|Withdrawal by Subject|4|||
155625728|NCT00919633|561724265|FG003|Overall Study|Withdrawal by Subject|3|||
155625729|NCT00919633|561724262|FG000|Overall Study|Lost to Follow-up|3|||
155625730|NCT00919633|561724263|FG001|Overall Study|Lost to Follow-up|1|||
155625731|NCT00919633|561724264|FG002|Overall Study|Lost to Follow-up|0|||
155625732|NCT00919633|561724265|FG003|Overall Study|Lost to Follow-up|2|||
155625733|NCT00919633|561724262|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
155625734|NCT00919633|561724263|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
155625735|NCT00919633|561724264|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
155625736|NCT00919633|561724265|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
155625737|NCT00919633|561724262|FG000|Overall Study|Protocol Violation|0|||
155625738|NCT00919633|561724263|FG001|Overall Study|Protocol Violation|0|||
155625739|NCT00919633|561724264|FG002|Overall Study|Protocol Violation|0|||
155625740|NCT00919633|561724265|FG003|Overall Study|Protocol Violation|1|||
155625741|NCT00919633|561724262|FG000|Overall Study|Physician Decision|0|||
155625742|NCT00919633|561724263|FG001|Overall Study|Physician Decision|0|||
155625743|NCT00919633|561724264|FG002|Overall Study|Physician Decision|0|||
155625744|NCT00919633|561724265|FG003|Overall Study|Physician Decision|1|||
155625745|NCT00919633|561724262|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
155625746|NCT00919633|561724263|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
155625747|NCT00919633|561724264|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
155625748|NCT00919633|561724265|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
155625749|NCT00919633|561724262|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
155625750|NCT00919633|561724263|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
155625751|NCT00919633|561724264|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
155625752|NCT00919633|561724265|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
155625753|NCT02100124|561724270|FG000|Overall Study|Lost to Follow-up|5|||
155625754|NCT02100124|561724271|FG001|Overall Study|Lost to Follow-up|11|||
155625755|NCT02100124|561724272|FG002|Overall Study|Lost to Follow-up|3|||
155625756|NCT02100124|561724270|FG000|Overall Study|Withdrawal by Subject|1|||
155625757|NCT02100124|561724271|FG001|Overall Study|Withdrawal by Subject|0|||
155625758|NCT02100124|561724272|FG002|Overall Study|Withdrawal by Subject|0|||
155625759|NCT04265261|561724273|FG000|Overall Study|Adverse Event|2|||
155625760|NCT04265261|561724274|FG001|Overall Study|Adverse Event|0|||
155625761|NCT04265261|561724275|FG002|Overall Study|Adverse Event|0|||
155625762|NCT04265261|561724273|FG000|Overall Study|Death|1|||
155625763|NCT04265261|561724274|FG001|Overall Study|Death|0|||
155625764|NCT04265261|561724275|FG002|Overall Study|Death|0|||
155625765|NCT04265261|561724273|FG000|Overall Study|Lost to Follow-up|4|||
155625766|NCT04265261|561724274|FG001|Overall Study|Lost to Follow-up|1|||
155625767|NCT04265261|561724275|FG002|Overall Study|Lost to Follow-up|3|||
155625768|NCT04265261|561724273|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155625769|NCT04265261|561724274|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155625770|NCT04265261|561724275|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155625771|NCT04265261|561724273|FG000|Overall Study|Physician Decision|0|||
155625772|NCT04265261|561724274|FG001|Overall Study|Physician Decision|0|||
155278536|NCT03468426|560453204|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278537|NCT03468426|560453194|FG000|Overall Study|missing reason|0|||
155625773|NCT04265261|561724275|FG002|Overall Study|Physician Decision|1|||
155625774|NCT04265261|561724273|FG000|Overall Study|Protocol Deviation|0|||
155625775|NCT04265261|561724274|FG001|Overall Study|Protocol Deviation|2|||
155625776|NCT04265261|561724275|FG002|Overall Study|Protocol Deviation|0|||
155625777|NCT04265261|561724273|FG000|Overall Study|Withdrawal by Subject|2|||
155625778|NCT04265261|561724274|FG001|Overall Study|Withdrawal by Subject|1|||
155625779|NCT04265261|561724275|FG002|Overall Study|Withdrawal by Subject|4|||
155728406|NCT00068692|562106379|FG004|Step 1: Registration|Complicating disease|0|||
155728407|NCT00068692|562106380|FG005|Step 1: Registration|Complicating disease|0|||
155728408|NCT00068692|562106381|FG006|Step 1: Registration|Complicating disease|0|||
155728409|NCT00068692|562106382|FG007|Step 1: Registration|Complicating disease|0|||
155728410|NCT00068692|562106375|FG000|Step 1: Registration|Protocol Violation|1|||
155728411|NCT00068692|562106376|FG001|Step 1: Registration|Protocol Violation|0|||
155728412|NCT00068692|562106377|FG002|Step 1: Registration|Protocol Violation|0|||
155728413|NCT00068692|562106378|FG003|Step 1: Registration|Protocol Violation|0|||
155728414|NCT00068692|562106379|FG004|Step 1: Registration|Protocol Violation|0|||
155728415|NCT00068692|562106380|FG005|Step 1: Registration|Protocol Violation|0|||
155728416|NCT00068692|562106381|FG006|Step 1: Registration|Protocol Violation|0|||
155728417|NCT00068692|562106382|FG007|Step 1: Registration|Protocol Violation|0|||
155728418|NCT00068692|562106375|FG000|Step 1: Registration|Not eligible|6|||
155728419|NCT00068692|562106376|FG001|Step 1: Registration|Not eligible|0|||
155728420|NCT00068692|562106377|FG002|Step 1: Registration|Not eligible|0|||
155728421|NCT00068692|562106378|FG003|Step 1: Registration|Not eligible|0|||
155728422|NCT00068692|562106379|FG004|Step 1: Registration|Not eligible|0|||
155728423|NCT00068692|562106380|FG005|Step 1: Registration|Not eligible|0|||
155728424|NCT00068692|562106381|FG006|Step 1: Registration|Not eligible|0|||
155728425|NCT00068692|562106382|FG007|Step 1: Registration|Not eligible|0|||
155728426|NCT00068692|562106375|FG000|Step 1: Registration|Other|2|||
155728427|NCT00068692|562106376|FG001|Step 1: Registration|Other|0|||
155728428|NCT00068692|562106377|FG002|Step 1: Registration|Other|0|||
155728429|NCT00068692|562106378|FG003|Step 1: Registration|Other|0|||
155728430|NCT00068692|562106379|FG004|Step 1: Registration|Other|0|||
155728431|NCT00068692|562106380|FG005|Step 1: Registration|Other|0|||
155728432|NCT00068692|562106381|FG006|Step 1: Registration|Other|0|||
155728433|NCT00068692|562106382|FG007|Step 1: Registration|Other|0|||
155728434|NCT00068692|562106375|FG000|Step 1: Registration|Not start protocol therapy|3|||
155728435|NCT00068692|562106376|FG001|Step 1: Registration|Not start protocol therapy|0|||
155728436|NCT00068692|562106377|FG002|Step 1: Registration|Not start protocol therapy|0|||
155728437|NCT00068692|562106378|FG003|Step 1: Registration|Not start protocol therapy|0|||
155728438|NCT00068692|562106379|FG004|Step 1: Registration|Not start protocol therapy|0|||
155728439|NCT00068692|562106380|FG005|Step 1: Registration|Not start protocol therapy|0|||
155728440|NCT00068692|562106381|FG006|Step 1: Registration|Not start protocol therapy|0|||
155728441|NCT00068692|562106382|FG007|Step 1: Registration|Not start protocol therapy|0|||
155728442|NCT00068692|562106375|FG000|Step 1: Registration|Registered but not randomized|0|||
155728443|NCT00068692|562106376|FG001|Step 1: Registration|Registered but not randomized|1|||
155728444|NCT00068692|562106377|FG002|Step 1: Registration|Registered but not randomized|0|||
155728445|NCT00068692|562106378|FG003|Step 1: Registration|Registered but not randomized|0|||
155728446|NCT00068692|562106379|FG004|Step 1: Registration|Registered but not randomized|0|||
155728447|NCT00068692|562106380|FG005|Step 1: Registration|Registered but not randomized|0|||
155728448|NCT00068692|562106381|FG006|Step 1: Registration|Registered but not randomized|0|||
155728449|NCT00068692|562106382|FG007|Step 1: Registration|Registered but not randomized|0|||
155728450|NCT00068692|562106375|FG000|Step 2: Randomization|Disesae progression/replase|0|||
155728451|NCT00068692|562106376|FG001|Step 2: Randomization|Disesae progression/replase|0|||
155728452|NCT00068692|562106377|FG002|Step 2: Randomization|Disesae progression/replase|1|||
155728453|NCT00068692|562106378|FG003|Step 2: Randomization|Disesae progression/replase|1|||
155728454|NCT00068692|562106379|FG004|Step 2: Randomization|Disesae progression/replase|0|||
155728455|NCT00068692|562106380|FG005|Step 2: Randomization|Disesae progression/replase|0|||
155728456|NCT00068692|562106381|FG006|Step 2: Randomization|Disesae progression/replase|0|||
155728457|NCT00068692|562106382|FG007|Step 2: Randomization|Disesae progression/replase|0|||
155728458|NCT00068692|562106375|FG000|Step 2: Randomization|Adverse Event|0|||
155728459|NCT00068692|562106376|FG001|Step 2: Randomization|Adverse Event|0|||
155728460|NCT00068692|562106377|FG002|Step 2: Randomization|Adverse Event|4|||
155728461|NCT00068692|562106378|FG003|Step 2: Randomization|Adverse Event|2|||
155728462|NCT00068692|562106379|FG004|Step 2: Randomization|Adverse Event|2|||
155728463|NCT00068692|562106380|FG005|Step 2: Randomization|Adverse Event|3|||
155728464|NCT00068692|562106381|FG006|Step 2: Randomization|Adverse Event|4|||
155728465|NCT00068692|562106382|FG007|Step 2: Randomization|Adverse Event|4|||
155728466|NCT00068692|562106375|FG000|Step 2: Randomization|Death|0|||
155728467|NCT00068692|562106376|FG001|Step 2: Randomization|Death|0|||
155728468|NCT00068692|562106377|FG002|Step 2: Randomization|Death|0|||
155728469|NCT00068692|562106378|FG003|Step 2: Randomization|Death|0|||
155728470|NCT00068692|562106379|FG004|Step 2: Randomization|Death|1|||
155728471|NCT00068692|562106380|FG005|Step 2: Randomization|Death|0|||
155728472|NCT00068692|562106381|FG006|Step 2: Randomization|Death|0|||
155728473|NCT00068692|562106382|FG007|Step 2: Randomization|Death|1|||
155728474|NCT00068692|562106375|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
155728475|NCT00068692|562106376|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
155728476|NCT00068692|562106377|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
155728477|NCT00068692|562106378|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
155728478|NCT00068692|562106379|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
155728479|NCT00068692|562106380|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
155728480|NCT00068692|562106381|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
155728481|NCT00068692|562106382|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
155625780|NCT00557466|561725978|FG000|Overall Study|Adverse Event|3|||
155625781|NCT00557466|561725979|FG001|Overall Study|Adverse Event|1|||
155625782|NCT00557466|561725980|FG002|Overall Study|Adverse Event|4|||
155625783|NCT00557466|561725981|FG003|Overall Study|Adverse Event|1|||
155625784|NCT00557466|561725982|FG004|Overall Study|Adverse Event|2|||
155625785|NCT00557466|561725983|FG005|Overall Study|Adverse Event|4|||
155625786|NCT00557466|561725978|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155625787|NCT00557466|561725979|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155625788|NCT00557466|561725980|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155625789|NCT00557466|561725981|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155625790|NCT00557466|561725982|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155625791|NCT00557466|561725983|FG005|Overall Study|Abnormal laboratory value(s)|0|||
155625792|NCT00557466|561725978|FG000|Overall Study|Protocol deviation|0|||
155625793|NCT00557466|561725979|FG001|Overall Study|Protocol deviation|1|||
155625794|NCT00557466|561725980|FG002|Overall Study|Protocol deviation|0|||
155625795|NCT00557466|561725981|FG003|Overall Study|Protocol deviation|2|||
155625796|NCT00557466|561725982|FG004|Overall Study|Protocol deviation|0|||
155728482|NCT00068692|562106375|FG000|Step 2: Randomization|alternative therapy|0|||
155728483|NCT00068692|562106376|FG001|Step 2: Randomization|alternative therapy|0|||
155728484|NCT00068692|562106377|FG002|Step 2: Randomization|alternative therapy|0|||
155728485|NCT00068692|562106378|FG003|Step 2: Randomization|alternative therapy|1|||
155728486|NCT00068692|562106379|FG004|Step 2: Randomization|alternative therapy|1|||
155728487|NCT00068692|562106380|FG005|Step 2: Randomization|alternative therapy|0|||
155728488|NCT00068692|562106381|FG006|Step 2: Randomization|alternative therapy|0|||
155728489|NCT00068692|562106382|FG007|Step 2: Randomization|alternative therapy|0|||
155728490|NCT00068692|562106375|FG000|Step 2: Randomization|Physician Decision|0|||
155728491|NCT00068692|562106376|FG001|Step 2: Randomization|Physician Decision|0|||
155728492|NCT00068692|562106377|FG002|Step 2: Randomization|Physician Decision|0|||
155728493|NCT00068692|562106378|FG003|Step 2: Randomization|Physician Decision|1|||
155728494|NCT00068692|562106379|FG004|Step 2: Randomization|Physician Decision|1|||
155728495|NCT00068692|562106380|FG005|Step 2: Randomization|Physician Decision|0|||
155728496|NCT00068692|562106381|FG006|Step 2: Randomization|Physician Decision|0|||
155728497|NCT00068692|562106382|FG007|Step 2: Randomization|Physician Decision|0|||
155728498|NCT00068692|562106375|FG000|Step 2: Randomization|Other|0|||
155728499|NCT00068692|562106376|FG001|Step 2: Randomization|Other|0|||
155728500|NCT00068692|562106377|FG002|Step 2: Randomization|Other|0|||
155728501|NCT00068692|562106378|FG003|Step 2: Randomization|Other|1|||
155625797|NCT00557466|561725983|FG005|Overall Study|Protocol deviation|0|||
155625798|NCT00557466|561725978|FG000|Overall Study|Subject withdrew consent|0|||
155625799|NCT00557466|561725979|FG001|Overall Study|Subject withdrew consent|0|||
155625800|NCT00557466|561725980|FG002|Overall Study|Subject withdrew consent|0|||
155625801|NCT00557466|561725981|FG003|Overall Study|Subject withdrew consent|0|||
155625802|NCT00557466|561725982|FG004|Overall Study|Subject withdrew consent|1|||
155625803|NCT00557466|561725983|FG005|Overall Study|Subject withdrew consent|2|||
155625804|NCT00557466|561725978|FG000|Overall Study|Administrative problems|0|||
155625805|NCT00557466|561725979|FG001|Overall Study|Administrative problems|1|||
155625806|NCT00557466|561725980|FG002|Overall Study|Administrative problems|1|||
155625807|NCT00557466|561725981|FG003|Overall Study|Administrative problems|0|||
155625808|NCT00557466|561725982|FG004|Overall Study|Administrative problems|0|||
155625809|NCT00557466|561725983|FG005|Overall Study|Administrative problems|0|||
155625810|NCT00557466|561725978|FG000|Overall Study|Abnormal test procedure results|0|||
155625811|NCT00557466|561725979|FG001|Overall Study|Abnormal test procedure results|0|||
155625812|NCT00557466|561725980|FG002|Overall Study|Abnormal test procedure results|1|||
155625813|NCT00557466|561725981|FG003|Overall Study|Abnormal test procedure results|0|||
155625814|NCT00557466|561725982|FG004|Overall Study|Abnormal test procedure results|0|||
155625815|NCT00557466|561725983|FG005|Overall Study|Abnormal test procedure results|0|||
155625816|NCT00557466|561725978|FG000|Overall Study|Lost to Follow-up|0|||
155625817|NCT00557466|561725979|FG001|Overall Study|Lost to Follow-up|0|||
155625818|NCT00557466|561725980|FG002|Overall Study|Lost to Follow-up|0|||
155625819|NCT00557466|561725981|FG003|Overall Study|Lost to Follow-up|1|||
155625820|NCT00557466|561725982|FG004|Overall Study|Lost to Follow-up|0|||
155625821|NCT00557466|561725983|FG005|Overall Study|Lost to Follow-up|0|||
155625822|NCT02810418|561725986|FG000|Arm A Dose Escalation|Adverse Event|2|||
155625823|NCT02810418|561725987|FG001|Arm A Dose Escalation|Adverse Event|1|||
155625824|NCT02810418|561725988|FG002|Arm A Dose Escalation|Adverse Event|0|||
155625825|NCT02810418|561725989|FG003|Arm A Dose Escalation|Adverse Event|0|||
155625826|NCT02810418|561725990|FG004|Arm A Dose Escalation|Adverse Event|0|||
155382219|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|poor data quality|0|||
155728502|NCT00068692|562106379|FG004|Step 2: Randomization|Other|0|||
155728503|NCT00068692|562106380|FG005|Step 2: Randomization|Other|1|||
155728504|NCT00068692|562106381|FG006|Step 2: Randomization|Other|0|||
155728505|NCT00068692|562106382|FG007|Step 2: Randomization|Other|0|||
155728506|NCT00068692|562106375|FG000|Step 2: Randomization|never start protocol therapy|0|||
155728507|NCT00068692|562106376|FG001|Step 2: Randomization|never start protocol therapy|0|||
155728508|NCT00068692|562106377|FG002|Step 2: Randomization|never start protocol therapy|1|||
155728509|NCT00068692|562106378|FG003|Step 2: Randomization|never start protocol therapy|0|||
155728510|NCT00068692|562106379|FG004|Step 2: Randomization|never start protocol therapy|1|||
155728511|NCT00068692|562106380|FG005|Step 2: Randomization|never start protocol therapy|0|||
155728512|NCT00068692|562106381|FG006|Step 2: Randomization|never start protocol therapy|0|||
155728513|NCT00068692|562106382|FG007|Step 2: Randomization|never start protocol therapy|0|||
155728514|NCT01600716|562106384|FG000|Overall Study|Other Reasons|3|||
155728515|NCT01600716|562106385|FG001|Overall Study|Other Reasons|1|||
155728516|NCT01600716|562106384|FG000|Overall Study|Personal Reasons|0|||
155728517|NCT01600716|562106385|FG001|Overall Study|Personal Reasons|2|||
155728518|NCT01600716|562106384|FG000|Overall Study|Lost to Follow-up|0|||
155728519|NCT01600716|562106385|FG001|Overall Study|Lost to Follow-up|2|||
155728520|NCT01600716|562106384|FG000|Overall Study|Pregnancy|1|||
155728521|NCT01600716|562106385|FG001|Overall Study|Pregnancy|0|||
155728522|NCT01600716|562106384|FG000|Overall Study|Lack of Efficacy|2|||
155728523|NCT01600716|562106385|FG001|Overall Study|Lack of Efficacy|1|||
155728524|NCT01600716|562106384|FG000|Overall Study|Adverse Event|1|||
155728525|NCT01600716|562106385|FG001|Overall Study|Adverse Event|1|||
155728526|NCT03557034|562106388|FG000|Overall Study|Withdrawal by Subject|1|||
155728527|NCT03557034|562106389|FG001|Overall Study|Withdrawal by Subject|0|||
155728528|NCT01759446|562106392|FG000|Overall Study|Protocol Violation|1|||
155728529|NCT01759446|562106393|FG001|Overall Study|Protocol Violation|0|||
155728530|NCT01759446|562106394|FG002|Overall Study|Protocol Violation|1|||
155728531|NCT01759446|562106395|FG003|Overall Study|Protocol Violation|0|||
155728532|NCT01759446|562106396|FG004|Overall Study|Protocol Violation|0|||
155728533|NCT01759446|562106392|FG000|Overall Study|Withdrawal by Subject|0|||
155728534|NCT01759446|562106393|FG001|Overall Study|Withdrawal by Subject|1|||
155728535|NCT01759446|562106394|FG002|Overall Study|Withdrawal by Subject|0|||
155728536|NCT01759446|562106395|FG003|Overall Study|Withdrawal by Subject|1|||
155728537|NCT01759446|562106396|FG004|Overall Study|Withdrawal by Subject|0|||
155728538|NCT00882557|562106397|FG000|Overall Study|Withdrawal by Subject|1|||
155728539|NCT00882557|562106398|FG001|Overall Study|Withdrawal by Subject|0|||
155728540|NCT00882557|562106397|FG000|Overall Study|Trouble with Vein Access|1|||
155728541|NCT00882557|562106398|FG001|Overall Study|Trouble with Vein Access|0|||
155728542|NCT00882557|562106397|FG000|Overall Study|Randomized Not Treated|0|||
155728543|NCT00882557|562106398|FG001|Overall Study|Randomized Not Treated|1|||
155728544|NCT01383356|562106399|FG000|Period 1|Adverse Event|5|||
155728545|NCT01383356|562106400|FG001|Period 1|Adverse Event|3|||
155728546|NCT01383356|562106399|FG000|Period 1|Non-compliance|3|||
155728547|NCT01383356|562106400|FG001|Period 1|Non-compliance|0|||
155728548|NCT01383356|562106399|FG000|Period 1|Out of Range Mid-study-Test|0|||
155728549|NCT01383356|562106400|FG001|Period 1|Out of Range Mid-study-Test|1|||
155728550|NCT01383356|562106399|FG000|Period 1|Personal|0|||
155728551|NCT01383356|562106400|FG001|Period 1|Personal|2|||
155728552|NCT02035267|562106401|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
155728553|NCT02035267|562106402|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
155625827|NCT02810418|561725991|FG005|Arm A Dose Escalation|Adverse Event|0|||
155625828|NCT02810418|561725992|FG006|Arm A Dose Escalation|Adverse Event|0|||
155625829|NCT02810418|561725986|FG000|Dose Expansion|Adverse Event|0|||
155625830|NCT02810418|561725987|FG001|Dose Expansion|Adverse Event|1|||
155625831|NCT02810418|561725988|FG002|Dose Expansion|Adverse Event|1|||
155625832|NCT02810418|561725989|FG003|Dose Expansion|Adverse Event|0|||
155625833|NCT02810418|561725990|FG004|Dose Expansion|Adverse Event|0|||
155625834|NCT02810418|561725991|FG005|Dose Expansion|Adverse Event|0|||
155625835|NCT02810418|561725992|FG006|Dose Expansion|Adverse Event|0|||
155625836|NCT02810418|561725986|FG000|Dose Expansion|Physician Decision|0|||
155625837|NCT02810418|561725987|FG001|Dose Expansion|Physician Decision|0|||
155625838|NCT02810418|561725988|FG002|Dose Expansion|Physician Decision|2|||
155625839|NCT02810418|561725989|FG003|Dose Expansion|Physician Decision|0|||
155728554|NCT02035267|562106403|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
155728555|NCT02035267|562106404|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
155728556|NCT02035267|562106401|FG000|Overall Study|Adverse Event|0|||
155728557|NCT02035267|562106402|FG001|Overall Study|Adverse Event|0|||
155728558|NCT02035267|562106403|FG002|Overall Study|Adverse Event|1|||
155728559|NCT02035267|562106404|FG003|Overall Study|Adverse Event|0|||
155728560|NCT02035267|562106401|FG000|Overall Study|Lost to Follow-up|0|||
155728561|NCT02035267|562106402|FG001|Overall Study|Lost to Follow-up|0|||
155728562|NCT02035267|562106403|FG002|Overall Study|Lost to Follow-up|0|||
155728563|NCT02035267|562106404|FG003|Overall Study|Lost to Follow-up|1|||
155728564|NCT02035267|562106401|FG000|Overall Study|Other unspecified|0|||
155728565|NCT02035267|562106402|FG001|Overall Study|Other unspecified|1|||
155728566|NCT02035267|562106403|FG002|Overall Study|Other unspecified|0|||
155728567|NCT02035267|562106404|FG003|Overall Study|Other unspecified|0|||
155728568|NCT03038880|562106411|FG000|Overall Study|Death|1|||
155728569|NCT03038880|562106412|FG001|Overall Study|Death|2|||
155625840|NCT02810418|561725990|FG004|Dose Expansion|Physician Decision|0|||
155625841|NCT02810418|561725991|FG005|Dose Expansion|Physician Decision|0|||
155625842|NCT02810418|561725992|FG006|Dose Expansion|Physician Decision|0|||
155625843|NCT02810418|561725986|FG000|Arm B Dose Escalation|Adverse Event|0|||
155625844|NCT02810418|561725987|FG001|Arm B Dose Escalation|Adverse Event|0|||
155625845|NCT02810418|561725988|FG002|Arm B Dose Escalation|Adverse Event|0|||
155625846|NCT02810418|561725989|FG003|Arm B Dose Escalation|Adverse Event|0|||
155625847|NCT02810418|561725990|FG004|Arm B Dose Escalation|Adverse Event|1|||
155625848|NCT02810418|561725991|FG005|Arm B Dose Escalation|Adverse Event|2|||
155625849|NCT02810418|561725992|FG006|Arm B Dose Escalation|Adverse Event|0|||
155625850|NCT03342001|561725993|FG000|Overall Study|Adverse Event|1|||
155625851|NCT03342001|561725993|FG000|Overall Study|Lost to Follow-up|1|||
155625852|NCT04161391|561725994|FG000|Overall Study|Adverse Event|0|||
155625853|NCT04161391|561725995|FG001|Overall Study|Adverse Event|1|||
155625854|NCT04161391|561725996|FG002|Overall Study|Adverse Event|0|||
155625855|NCT04161391|561725997|FG003|Overall Study|Adverse Event|1|||
155625856|NCT04161391|561725998|FG004|Overall Study|Adverse Event|0|||
155625857|NCT04161391|561725999|FG005|Overall Study|Adverse Event|0|||
155625858|NCT04161391|561726000|FG006|Overall Study|Adverse Event|0|||
155625859|NCT04161391|561726001|FG007|Overall Study|Adverse Event|3|||
155278538|NCT03468426|560453195|FG001|Overall Study|missing reason|0|||
155278539|NCT03468426|560453196|FG002|Overall Study|missing reason|0|||
155278540|NCT03468426|560453197|FG003|Overall Study|missing reason|0|||
155625860|NCT04161391|561726002|FG008|Overall Study|Adverse Event|0|||
155625861|NCT04161391|561725994|FG000|Overall Study|Death|0|||
155625862|NCT04161391|561725995|FG001|Overall Study|Death|0|||
155625863|NCT04161391|561725996|FG002|Overall Study|Death|0|||
155625864|NCT04161391|561725997|FG003|Overall Study|Death|0|||
155728570|NCT03038880|562106413|FG002|Overall Study|Death|0|||
155728571|NCT03038880|562106411|FG000|Overall Study|Physician Decision|2|||
155728572|NCT03038880|562106412|FG001|Overall Study|Physician Decision|1|||
155728573|NCT03038880|562106413|FG002|Overall Study|Physician Decision|0|||
155728574|NCT00956007|562106416|FG000|Overall Study|Protocol Violation|27|||
155728575|NCT00956007|562106417|FG001|Overall Study|Protocol Violation|23|||
155728576|NCT01746901|562106418|FG000|Naloxone Challenge Phase|Adverse Event|2|||
155728577|NCT01746901|562106419|FG001|Naloxone Challenge Phase|Adverse Event|0|||
155728578|NCT01746901|562106420|FG002|Naloxone Challenge Phase|Adverse Event|0|||
155728579|NCT01746901|562106421|FG003|Naloxone Challenge Phase|Adverse Event|0|||
155728580|NCT01746901|562106422|FG004|Naloxone Challenge Phase|Adverse Event|0|||
155728581|NCT01746901|562106423|FG005|Naloxone Challenge Phase|Adverse Event|0|||
155728582|NCT01746901|562106424|FG006|Naloxone Challenge Phase|Adverse Event|0|||
155728583|NCT01746901|562106425|FG007|Naloxone Challenge Phase|Adverse Event|0|||
155728584|NCT01746901|562106426|FG008|Naloxone Challenge Phase|Adverse Event|0|||
155728585|NCT01746901|562106418|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
155728586|NCT01746901|562106419|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728587|NCT01746901|562106420|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155625865|NCT04161391|561725998|FG004|Overall Study|Death|0|||
155625866|NCT04161391|561725999|FG005|Overall Study|Death|0|||
155625867|NCT04161391|561726000|FG006|Overall Study|Death|0|||
155625868|NCT04161391|561726001|FG007|Overall Study|Death|1|||
155728588|NCT01746901|562106421|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728589|NCT01746901|562106422|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155278541|NCT03468426|560453198|FG004|Overall Study|missing reason|0|||
155728590|NCT01746901|562106423|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728591|NCT01746901|562106424|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728592|NCT01746901|562106425|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728593|NCT01746901|562106426|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155728594|NCT01746901|562106418|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728595|NCT01746901|562106419|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
155278542|NCT03468426|560453199|FG005|Overall Study|missing reason|0|||
155278543|NCT03468426|560453200|FG006|Overall Study|missing reason|0|||
155278544|NCT03468426|560453201|FG007|Overall Study|missing reason|0|||
155278545|NCT03468426|560453202|FG008|Overall Study|missing reason|0|||
155278546|NCT03468426|560453203|FG009|Overall Study|missing reason|1|||
155278547|NCT03468426|560453204|FG010|Overall Study|missing reason|0|||
155278548|NCT02139982|560453205|FG000|Overall Study|Lack of Efficacy|0|||
155728596|NCT01746901|562106420|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728597|NCT01746901|562106421|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155278549|NCT02139982|560453206|FG001|Overall Study|Lack of Efficacy|1|||
155278550|NCT02139982|560453207|FG002|Overall Study|Lack of Efficacy|0|||
155278551|NCT02139982|560453208|FG003|Overall Study|Lack of Efficacy|1|||
155278552|NCT02139982|560453209|FG004|Overall Study|Lack of Efficacy|0|||
155625869|NCT04161391|561726002|FG008|Overall Study|Death|0|||
155625870|NCT04161391|561725994|FG000|Overall Study|Physician Decision|0|||
155625871|NCT04161391|561725995|FG001|Overall Study|Physician Decision|0|||
155625872|NCT04161391|561725996|FG002|Overall Study|Physician Decision|1|||
155625873|NCT04161391|561725997|FG003|Overall Study|Physician Decision|2|||
155625874|NCT04161391|561725998|FG004|Overall Study|Physician Decision|0|||
155625875|NCT04161391|561725999|FG005|Overall Study|Physician Decision|0|||
155625876|NCT04161391|561726000|FG006|Overall Study|Physician Decision|2|||
155625877|NCT04161391|561726001|FG007|Overall Study|Physician Decision|0|||
155728598|NCT01746901|562106422|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728599|NCT01746901|562106423|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728600|NCT01746901|562106424|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728601|NCT01746901|562106425|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728602|NCT01746901|562106426|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155728603|NCT01746901|562106418|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728604|NCT01746901|562106419|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
155728605|NCT01746901|562106420|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
155728606|NCT01746901|562106421|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728607|NCT01746901|562106422|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728608|NCT01746901|562106423|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728609|NCT01746901|562106424|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728610|NCT01746901|562106425|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728611|NCT01746901|562106426|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155728612|NCT01746901|562106418|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728613|NCT01746901|562106419|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
155728614|NCT01746901|562106420|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
155728615|NCT01746901|562106421|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728616|NCT01746901|562106422|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728617|NCT01746901|562106423|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728618|NCT01746901|562106424|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728619|NCT01746901|562106425|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728620|NCT01746901|562106426|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155728621|NCT01746901|562106418|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728622|NCT01746901|562106419|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
155728623|NCT01746901|562106420|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
155728624|NCT01746901|562106421|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728625|NCT01746901|562106422|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728626|NCT01746901|562106423|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728627|NCT01746901|562106424|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728628|NCT01746901|562106425|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728629|NCT01746901|562106426|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155728630|NCT01746901|562106418|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
155728631|NCT01746901|562106419|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
155728632|NCT01746901|562106420|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
155728633|NCT01746901|562106421|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
155728634|NCT01746901|562106422|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
155728635|NCT01746901|562106423|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
155728636|NCT01746901|562106424|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
155728637|NCT01746901|562106425|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
155728638|NCT01746901|562106426|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
155728639|NCT01746901|562106418|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728640|NCT01746901|562106419|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728641|NCT01746901|562106420|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728642|NCT01746901|562106421|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728643|NCT01746901|562106422|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728644|NCT01746901|562106423|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728645|NCT01746901|562106424|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728646|NCT01746901|562106425|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
155728647|NCT01746901|562106426|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155728648|NCT01746901|562106418|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728649|NCT01746901|562106419|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728650|NCT01746901|562106420|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728651|NCT01746901|562106421|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728652|NCT01746901|562106422|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728653|NCT01746901|562106423|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
155728654|NCT01746901|562106424|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
155728655|NCT01746901|562106425|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728656|NCT01746901|562106426|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
155728657|NCT01746901|562106418|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728658|NCT01746901|562106419|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728659|NCT01746901|562106420|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155278553|NCT02139982|560453210|FG005|Overall Study|Lack of Efficacy|0|||
155278554|NCT02139982|560453211|FG006|Overall Study|Lack of Efficacy|0|||
155278555|NCT02139982|560453212|FG007|Overall Study|Lack of Efficacy|0|||
155728660|NCT01746901|562106421|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
155728661|NCT01746901|562106422|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728662|NCT01746901|562106423|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728663|NCT01746901|562106424|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728664|NCT01746901|562106425|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728665|NCT01746901|562106426|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155728666|NCT01746901|562106418|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728667|NCT01746901|562106419|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728668|NCT01746901|562106420|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728669|NCT01746901|562106421|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155625878|NCT04161391|561726002|FG008|Overall Study|Physician Decision|0|||
155625879|NCT04161391|561725994|FG000|Overall Study|Progressive Disease|4|||
155625880|NCT04161391|561725995|FG001|Overall Study|Progressive Disease|3|||
155625881|NCT04161391|561725996|FG002|Overall Study|Progressive Disease|3|||
155625882|NCT04161391|561725997|FG003|Overall Study|Progressive Disease|5|||
155625883|NCT04161391|561725998|FG004|Overall Study|Progressive Disease|3|||
155625884|NCT04161391|561725999|FG005|Overall Study|Progressive Disease|3|||
155625885|NCT04161391|561726000|FG006|Overall Study|Progressive Disease|5|||
155625886|NCT04161391|561726001|FG007|Overall Study|Progressive Disease|2|||
155625887|NCT04161391|561726002|FG008|Overall Study|Progressive Disease|2|||
155625888|NCT02579629|561726020|FG000|Overall Study|Withdrawal by Subject|0|||
155625889|NCT02579629|561726021|FG001|Overall Study|Withdrawal by Subject|1|||
155625890|NCT02579629|561726022|FG002|Overall Study|Withdrawal by Subject|0|||
155728670|NCT01746901|562106422|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728671|NCT01746901|562106423|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
155728672|NCT01746901|562106424|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728673|NCT01746901|562106425|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155728674|NCT01746901|562106426|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
155728675|NCT01746901|562106418|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728676|NCT01746901|562106419|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728677|NCT01746901|562106420|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728678|NCT01746901|562106421|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728679|NCT01746901|562106422|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728680|NCT01746901|562106423|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728681|NCT01746901|562106424|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
155728682|NCT01746901|562106425|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155728683|NCT01746901|562106426|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
155728684|NCT01208207|562106427|FG000|Part I|Adverse Event|19|||
155728685|NCT01208207|562106428|FG001|Part I|Adverse Event|2|||
155728686|NCT01208207|562106429|FG002|Part I|Adverse Event|6|||
155728687|NCT01208207|562106430|FG003|Part I|Adverse Event|0|||
155728688|NCT01208207|562106431|FG004|Part I|Adverse Event|0|||
155728689|NCT01208207|562106432|FG005|Part I|Adverse Event|0|||
155728690|NCT01208207|562106433|FG006|Part I|Adverse Event|0|||
155728691|NCT01208207|562106427|FG000|Part I|Lack of Efficacy|21|||
155728692|NCT01208207|562106428|FG001|Part I|Lack of Efficacy|3|||
155728693|NCT01208207|562106429|FG002|Part I|Lack of Efficacy|2|||
155728694|NCT01208207|562106430|FG003|Part I|Lack of Efficacy|0|||
155728695|NCT01208207|562106431|FG004|Part I|Lack of Efficacy|0|||
155728696|NCT01208207|562106432|FG005|Part I|Lack of Efficacy|0|||
155728697|NCT01208207|562106433|FG006|Part I|Lack of Efficacy|0|||
155728698|NCT01208207|562106427|FG000|Part I|Lost to Follow-up|6|||
155728699|NCT01208207|562106428|FG001|Part I|Lost to Follow-up|1|||
155728700|NCT01208207|562106429|FG002|Part I|Lost to Follow-up|0|||
155728701|NCT01208207|562106430|FG003|Part I|Lost to Follow-up|0|||
155728702|NCT01208207|562106431|FG004|Part I|Lost to Follow-up|0|||
155728703|NCT01208207|562106432|FG005|Part I|Lost to Follow-up|0|||
155728704|NCT01208207|562106433|FG006|Part I|Lost to Follow-up|0|||
155728705|NCT01208207|562106427|FG000|Part I|Non-Compliance With Study Drug|1|||
155728706|NCT01208207|562106428|FG001|Part I|Non-Compliance With Study Drug|0|||
155728707|NCT01208207|562106429|FG002|Part I|Non-Compliance With Study Drug|1|||
155728708|NCT01208207|562106430|FG003|Part I|Non-Compliance With Study Drug|0|||
155728709|NCT01208207|562106431|FG004|Part I|Non-Compliance With Study Drug|0|||
155728710|NCT01208207|562106432|FG005|Part I|Non-Compliance With Study Drug|0|||
155728711|NCT01208207|562106433|FG006|Part I|Non-Compliance With Study Drug|0|||
155728712|NCT01208207|562106427|FG000|Part I|Physician Decision|0|||
155728713|NCT01208207|562106428|FG001|Part I|Physician Decision|1|||
155728714|NCT01208207|562106429|FG002|Part I|Physician Decision|0|||
155728715|NCT01208207|562106430|FG003|Part I|Physician Decision|0|||
155728716|NCT01208207|562106431|FG004|Part I|Physician Decision|0|||
155728717|NCT01208207|562106432|FG005|Part I|Physician Decision|0|||
155728718|NCT01208207|562106433|FG006|Part I|Physician Decision|0|||
155625891|NCT02579629|561726020|FG000|Overall Study|Screen Failure|2|||
155625892|NCT02579629|561726021|FG001|Overall Study|Screen Failure|0|||
155728719|NCT01208207|562106427|FG000|Part I|Progressive Disease|1|||
155728720|NCT01208207|562106428|FG001|Part I|Progressive Disease|0|||
155728721|NCT01208207|562106429|FG002|Part I|Progressive Disease|0|||
155728722|NCT01208207|562106430|FG003|Part I|Progressive Disease|0|||
155728723|NCT01208207|562106431|FG004|Part I|Progressive Disease|0|||
155728724|NCT01208207|562106432|FG005|Part I|Progressive Disease|0|||
155728725|NCT01208207|562106433|FG006|Part I|Progressive Disease|0|||
155728726|NCT01208207|562106427|FG000|Part I|Protocol Violation|8|||
155728727|NCT01208207|562106428|FG001|Part I|Protocol Violation|0|||
155728728|NCT01208207|562106429|FG002|Part I|Protocol Violation|2|||
155728729|NCT01208207|562106430|FG003|Part I|Protocol Violation|0|||
155728730|NCT01208207|562106431|FG004|Part I|Protocol Violation|0|||
155728731|NCT01208207|562106432|FG005|Part I|Protocol Violation|0|||
155728732|NCT01208207|562106433|FG006|Part I|Protocol Violation|0|||
155728733|NCT01208207|562106427|FG000|Part I|Withdrawal by Subject|14|||
155728734|NCT01208207|562106428|FG001|Part I|Withdrawal by Subject|4|||
155728735|NCT01208207|562106429|FG002|Part I|Withdrawal by Subject|4|||
155728736|NCT01208207|562106430|FG003|Part I|Withdrawal by Subject|0|||
155728737|NCT01208207|562106431|FG004|Part I|Withdrawal by Subject|0|||
155728738|NCT01208207|562106432|FG005|Part I|Withdrawal by Subject|0|||
155728739|NCT01208207|562106433|FG006|Part I|Withdrawal by Subject|0|||
155728740|NCT01208207|562106427|FG000|Part II|Withdrawal by Subject|0|||
155728741|NCT01208207|562106428|FG001|Part II|Withdrawal by Subject|0|||
155728742|NCT01208207|562106429|FG002|Part II|Withdrawal by Subject|0|||
155728743|NCT01208207|562106430|FG003|Part II|Withdrawal by Subject|10|||
155728744|NCT01208207|562106431|FG004|Part II|Withdrawal by Subject|9|||
155728745|NCT01208207|562106432|FG005|Part II|Withdrawal by Subject|3|||
155728746|NCT01208207|562106433|FG006|Part II|Withdrawal by Subject|5|||
155728747|NCT01208207|562106427|FG000|Part II|Adverse Event|0|||
155728748|NCT01208207|562106428|FG001|Part II|Adverse Event|0|||
155728749|NCT01208207|562106429|FG002|Part II|Adverse Event|0|||
155728750|NCT01208207|562106430|FG003|Part II|Adverse Event|5|||
155728751|NCT01208207|562106431|FG004|Part II|Adverse Event|9|||
155728752|NCT01208207|562106432|FG005|Part II|Adverse Event|4|||
155728753|NCT01208207|562106433|FG006|Part II|Adverse Event|2|||
155728754|NCT01208207|562106427|FG000|Part II|Lack of Efficacy|0|||
155728755|NCT01208207|562106428|FG001|Part II|Lack of Efficacy|0|||
155728756|NCT01208207|562106429|FG002|Part II|Lack of Efficacy|0|||
155728757|NCT01208207|562106430|FG003|Part II|Lack of Efficacy|6|||
155728758|NCT01208207|562106431|FG004|Part II|Lack of Efficacy|4|||
155728759|NCT01208207|562106432|FG005|Part II|Lack of Efficacy|3|||
155728760|NCT01208207|562106433|FG006|Part II|Lack of Efficacy|3|||
155728761|NCT01208207|562106427|FG000|Part II|Lost to Follow-up|0|||
155728762|NCT01208207|562106428|FG001|Part II|Lost to Follow-up|0|||
155728763|NCT01208207|562106429|FG002|Part II|Lost to Follow-up|0|||
155728764|NCT01208207|562106430|FG003|Part II|Lost to Follow-up|4|||
155728765|NCT01208207|562106431|FG004|Part II|Lost to Follow-up|0|||
155728766|NCT01208207|562106432|FG005|Part II|Lost to Follow-up|2|||
155728767|NCT01208207|562106433|FG006|Part II|Lost to Follow-up|1|||
155728768|NCT01208207|562106427|FG000|Part II|Non-Compliance With Study Drug|0|||
155728769|NCT01208207|562106428|FG001|Part II|Non-Compliance With Study Drug|0|||
155728770|NCT01208207|562106429|FG002|Part II|Non-Compliance With Study Drug|0|||
155728771|NCT01208207|562106430|FG003|Part II|Non-Compliance With Study Drug|4|||
155728772|NCT01208207|562106431|FG004|Part II|Non-Compliance With Study Drug|1|||
155728773|NCT01208207|562106432|FG005|Part II|Non-Compliance With Study Drug|1|||
155728774|NCT01208207|562106433|FG006|Part II|Non-Compliance With Study Drug|0|||
155728775|NCT01208207|562106427|FG000|Part II|Physician Decision|0|||
155728776|NCT01208207|562106428|FG001|Part II|Physician Decision|0|||
155728777|NCT01208207|562106429|FG002|Part II|Physician Decision|0|||
155728778|NCT01208207|562106430|FG003|Part II|Physician Decision|1|||
155728779|NCT01208207|562106431|FG004|Part II|Physician Decision|0|||
155728780|NCT01208207|562106432|FG005|Part II|Physician Decision|2|||
155728781|NCT01208207|562106433|FG006|Part II|Physician Decision|0|||
155728782|NCT01208207|562106427|FG000|Part II|Protocol Violation|0|||
155728783|NCT01208207|562106428|FG001|Part II|Protocol Violation|0|||
155728784|NCT01208207|562106429|FG002|Part II|Protocol Violation|0|||
155728785|NCT01208207|562106430|FG003|Part II|Protocol Violation|1|||
155382220|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|poor data quality|0|||
155382221|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|poor data quality|0|||
155382222|NCT01815138|560833302|FG000|Overall Study|Withdrawal by Subject|0|||
155382223|NCT01815138|560833303|FG001|Overall Study|Withdrawal by Subject|1|||
155728786|NCT01208207|562106431|FG004|Part II|Protocol Violation|0|||
155728787|NCT01208207|562106432|FG005|Part II|Protocol Violation|0|||
155728788|NCT01208207|562106433|FG006|Part II|Protocol Violation|0|||
155728789|NCT01208207|562106427|FG000|Part II|Technical Problems|0|||
155728790|NCT01208207|562106428|FG001|Part II|Technical Problems|0|||
155728791|NCT01208207|562106429|FG002|Part II|Technical Problems|0|||
155728792|NCT01208207|562106430|FG003|Part II|Technical Problems|1|||
155728793|NCT01208207|562106431|FG004|Part II|Technical Problems|0|||
155728794|NCT01208207|562106432|FG005|Part II|Technical Problems|1|||
155728795|NCT01208207|562106433|FG006|Part II|Technical Problems|0|||
155728796|NCT02177032|562106434|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
155728797|NCT02177032|562106435|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
155728798|NCT02177032|562106436|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
155728799|NCT02177032|562106437|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
155728800|NCT02177032|562106434|FG000|Overall Study|Lost to Follow-up|0|||
155278556|NCT02139982|560453213|FG008|Overall Study|Lack of Efficacy|0|||
155278557|NCT02139982|560453214|FG009|Overall Study|Lack of Efficacy|0|||
155278558|NCT04466618|560453226|FG000|Overall Study|Withdrawal by Subject|0|||
155278559|NCT04466618|560453227|FG001|Overall Study|Withdrawal by Subject|1|||
155278560|NCT01349907|560453228|FG000|Overall Study|Adverse Event|37|||
155278561|NCT01349907|560453229|FG001|Overall Study|Adverse Event|11|||
155278562|NCT01349907|560453228|FG000|Overall Study|Treatment failure|13|||
155278563|NCT01349907|560453229|FG001|Overall Study|Treatment failure|4|||
155278564|NCT01349907|560453228|FG000|Overall Study|Lost to Follow-up|25|||
155278565|NCT01349907|560453229|FG001|Overall Study|Lost to Follow-up|6|||
155278566|NCT01349907|560453228|FG000|Overall Study|Withdrawal by Subject|30|||
155278567|NCT01349907|560453229|FG001|Overall Study|Withdrawal by Subject|8|||
155278568|NCT01349907|560453228|FG000|Overall Study|Protocol Violation|33|||
155278569|NCT01349907|560453229|FG001|Overall Study|Protocol Violation|13|||
155278570|NCT01349907|560453228|FG000|Overall Study|Administrative|1|||
155278571|NCT01349907|560453229|FG001|Overall Study|Administrative|1|||
155278572|NCT02800928|560453232|FG000|Overall Study|Withdrawal by Subject|1|||
155278573|NCT02800928|560453233|FG001|Overall Study|Withdrawal by Subject|1|||
155278574|NCT02800928|560453232|FG000|Overall Study|Protocol Violation|1|||
155278575|NCT02800928|560453233|FG001|Overall Study|Protocol Violation|1|||
155278576|NCT02886728|560453234|FG000|Overall Study|Withdrew Consent|31|||
155278577|NCT02886728|560453235|FG001|Overall Study|Withdrew Consent|13|||
155278578|NCT02886728|560453236|FG002|Overall Study|Withdrew Consent|11|||
155278579|NCT02886728|560453237|FG003|Overall Study|Withdrew Consent|47|||
155278580|NCT02886728|560453234|FG000|Overall Study|Lost to Follow-up|12|||
155278581|NCT02886728|560453235|FG001|Overall Study|Lost to Follow-up|6|||
155278582|NCT02886728|560453236|FG002|Overall Study|Lost to Follow-up|13|||
155278583|NCT02886728|560453237|FG003|Overall Study|Lost to Follow-up|12|||
155278584|NCT02886728|560453234|FG000|Overall Study|Adverse Event|13|||
155278585|NCT02886728|560453235|FG001|Overall Study|Adverse Event|5|||
155278586|NCT02886728|560453236|FG002|Overall Study|Adverse Event|5|||
155278587|NCT02886728|560453237|FG003|Overall Study|Adverse Event|11|||
155278588|NCT02886728|560453234|FG000|Overall Study|Investigator's Discretion|11|||
155278589|NCT02886728|560453235|FG001|Overall Study|Investigator's Discretion|7|||
155278590|NCT02886728|560453236|FG002|Overall Study|Investigator's Discretion|5|||
155278591|NCT02886728|560453237|FG003|Overall Study|Investigator's Discretion|11|||
155278592|NCT02886728|560453234|FG000|Overall Study|Death|3|||
155278593|NCT02886728|560453235|FG001|Overall Study|Death|1|||
155278594|NCT02886728|560453236|FG002|Overall Study|Death|0|||
155278595|NCT02886728|560453237|FG003|Overall Study|Death|0|||
155278596|NCT02886728|560453234|FG000|Overall Study|Protocol Violation|0|||
155278597|NCT02886728|560453235|FG001|Overall Study|Protocol Violation|0|||
155278598|NCT02886728|560453236|FG002|Overall Study|Protocol Violation|0|||
155278599|NCT02886728|560453237|FG003|Overall Study|Protocol Violation|4|||
155278600|NCT02886728|560453234|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155278601|NCT02886728|560453235|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155278602|NCT02886728|560453236|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155278603|NCT02886728|560453237|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155278604|NCT02886728|560453234|FG000|Overall Study|Pregnancy|0|||
155278605|NCT02886728|560453235|FG001|Overall Study|Pregnancy|0|||
155278606|NCT02886728|560453236|FG002|Overall Study|Pregnancy|1|||
155278607|NCT02886728|560453237|FG003|Overall Study|Pregnancy|0|||
155278608|NCT02886728|560453234|FG000|Overall Study|Randomized but Not Dosed|1|||
155278609|NCT02886728|560453235|FG001|Overall Study|Randomized but Not Dosed|0|||
155278610|NCT02886728|560453236|FG002|Overall Study|Randomized but Not Dosed|0|||
155278611|NCT02886728|560453237|FG003|Overall Study|Randomized but Not Dosed|2|||
155278612|NCT01364727|560453242|FG000|Overall Study|Not Eligible|2|||
155278613|NCT01676220|560453243|FG000|Overall Study|Randomized But Not Treated|4|||
155382224|NCT01815138|560833302|FG000|Overall Study|Physician Decision|8|||
155278614|NCT01676220|560453244|FG001|Overall Study|Randomized But Not Treated|1|||
155278615|NCT01676220|560453243|FG000|Overall Study|Adverse Event|10|||
155278616|NCT01676220|560453244|FG001|Overall Study|Adverse Event|8|||
155278617|NCT01676220|560453243|FG000|Overall Study|Lack of Efficacy|2|||
155278618|NCT01676220|560453244|FG001|Overall Study|Lack of Efficacy|5|||
155278619|NCT01676220|560453243|FG000|Overall Study|Protocol Violation|11|||
155278620|NCT01676220|560453244|FG001|Overall Study|Protocol Violation|12|||
155278621|NCT01676220|560453243|FG000|Overall Study|Received Rescue Therapy|14|||
155278622|NCT01676220|560453244|FG001|Overall Study|Received Rescue Therapy|22|||
155278623|NCT01676220|560453243|FG000|Overall Study|Personal Reason|34|||
155278624|NCT01676220|560453244|FG001|Overall Study|Personal Reason|45|||
155278625|NCT01676220|560453243|FG000|Overall Study|Lost to Follow-up|11|||
155278626|NCT01676220|560453244|FG001|Overall Study|Lost to Follow-up|18|||
155278627|NCT01676220|560453243|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
155278628|NCT01676220|560453244|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
155278629|NCT01676220|560453243|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
155278630|NCT01676220|560453244|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
155278631|NCT01676220|560453243|FG000|Overall Study|Perceived Lack of Efficacy|3|||
155278632|NCT01676220|560453244|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155382225|NCT01815138|560833303|FG001|Overall Study|Physician Decision|5|||
155382226|NCT02649946|560833309|FG000|Overall Study|Withdrawal by Subject|1|||
155382227|NCT02649946|560833310|FG001|Overall Study|Withdrawal by Subject|1|||
155382228|NCT02649946|560833309|FG000|Overall Study|Death|7|||
155382229|NCT02649946|560833310|FG001|Overall Study|Death|9|||
155382230|NCT02649946|560833309|FG000|Overall Study|Physician Decision|1|||
155382231|NCT02649946|560833310|FG001|Overall Study|Physician Decision|0|||
155382232|NCT02649946|560833309|FG000|Overall Study|Lost to Follow-up|2|||
155382233|NCT02649946|560833310|FG001|Overall Study|Lost to Follow-up|1|||
155382234|NCT02649946|560833309|FG000|Overall Study|Erroneously enrolled|1|||
155382235|NCT02649946|560833310|FG001|Overall Study|Erroneously enrolled|0|||
155382236|NCT02649946|560833309|FG000|Overall Study|Missed 6-month follow-up visit|0|||
155382237|NCT02649946|560833310|FG001|Overall Study|Missed 6-month follow-up visit|4|||
155382238|NCT00950950|560833311|FG000|Overall Study|Adverse Event|1|||
155382239|NCT00950950|560833312|FG001|Overall Study|Adverse Event|0|||
155382240|NCT00950950|560833311|FG000|Overall Study|Withdrawal by Subject|0|||
155382241|NCT00950950|560833312|FG001|Overall Study|Withdrawal by Subject|1|||
155382242|NCT01047293|560833315|FG000|Overall Study|DLT criteria not fulfilled|1|||
155382243|NCT01047293|560833316|FG001|Overall Study|DLT criteria not fulfilled|1|||
155382244|NCT01047293|560833317|FG002|Overall Study|DLT criteria not fulfilled|0|||
155382245|NCT01047293|560833318|FG003|Overall Study|DLT criteria not fulfilled|0|||
155382246|NCT01920854|560833322|FG000|Overall Study|Withdrawal by Subject|1|||
155382247|NCT01920854|560833323|FG001|Overall Study|Withdrawal by Subject|0|||
155382248|NCT01920854|560833324|FG002|Overall Study|Withdrawal by Subject|0|||
155382249|NCT01920854|560833325|FG003|Overall Study|Withdrawal by Subject|0|||
155382250|NCT01920854|560833326|FG004|Overall Study|Withdrawal by Subject|1|||
155382251|NCT01920854|560833327|FG005|Overall Study|Withdrawal by Subject|0|||
155382252|NCT01920854|560833328|FG006|Overall Study|Withdrawal by Subject|1|||
155382253|NCT00757783|560833329|FG000|Overall Study|Adverse Event|0|||
155382254|NCT00757783|560833330|FG001|Overall Study|Adverse Event|2|||
155382255|NCT00757783|560833329|FG000|Overall Study|Lost to Follow-up|1|||
155382256|NCT00757783|560833330|FG001|Overall Study|Lost to Follow-up|1|||
155382257|NCT00757783|560833329|FG000|Overall Study|Protocol Violation|1|||
155382258|NCT00757783|560833330|FG001|Overall Study|Protocol Violation|0|||
155382259|NCT00757783|560833329|FG000|Overall Study|Withdrawal by Subject|2|||
155382260|NCT00757783|560833330|FG001|Overall Study|Withdrawal by Subject|1|||
155382261|NCT00757783|560833329|FG000|Overall Study|Other|1|||
155382262|NCT00757783|560833330|FG001|Overall Study|Other|2|||
155382263|NCT02372136|560833331|FG000|Overall Study|Death|3|||
155382264|NCT02372136|560833332|FG001|Overall Study|Death|1|||
155382265|NCT03265938|560833333|FG000|Overall Study|Withdrawal by Subject|1|||
155382266|NCT03265938|560833333|FG000|Overall Study|Physician Decision|1|||
155382267|NCT03265938|560833333|FG000|Overall Study|friable mass|6|||
155382268|NCT01588496|560833334|FG000|Overall Study|Withdrawal by Subject|0|||
155382269|NCT01588496|560833335|FG001|Overall Study|Withdrawal by Subject|1|||
155382270|NCT01588496|560833336|FG002|Overall Study|Withdrawal by Subject|0|||
155382271|NCT03143166|560833337|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
155382272|NCT05924945|560833338|FG000|Overall Study|Withdrawal by Subject|3|||
155382273|NCT05924945|560833339|FG001|Overall Study|Withdrawal by Subject|4|||
155382274|NCT02471833|560833340|FG000|Overall Study|Lost to Follow-up|1|||
155382275|NCT02471833|560833341|FG001|Overall Study|Lost to Follow-up|0|||
155382276|NCT02471833|560833342|FG002|Overall Study|Lost to Follow-up|0|||
155382277|NCT02471833|560833340|FG000|Overall Study|Withdrawal by Subject|2|||
155382278|NCT02471833|560833341|FG001|Overall Study|Withdrawal by Subject|1|||
155382279|NCT02471833|560833342|FG002|Overall Study|Withdrawal by Subject|5|||
155382280|NCT03683823|560833357|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
155382281|NCT03683823|560833358|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
155382282|NCT03683823|560833357|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
155382283|NCT03683823|560833358|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
155382284|NCT03683823|560833357|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
155382285|NCT03683823|560833358|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
155382286|NCT01946438|560833361|FG000|Overall Study|Adverse Event|0|||
155382287|NCT01946438|560833362|FG001|Overall Study|Adverse Event|0|||
155382288|NCT01946438|560833363|FG002|Overall Study|Adverse Event|0|||
155382289|NCT01946438|560833364|FG003|Overall Study|Adverse Event|1|||
155382290|NCT01946438|560833361|FG000|Overall Study|Serious Adverse event|1|||
155382291|NCT01946438|560833362|FG001|Overall Study|Serious Adverse event|0|||
155382292|NCT01946438|560833363|FG002|Overall Study|Serious Adverse event|0|||
155382293|NCT01946438|560833364|FG003|Overall Study|Serious Adverse event|0|||
155382294|NCT01946438|560833361|FG000|Overall Study|Protocol Violation|0|||
155382295|NCT01946438|560833362|FG001|Overall Study|Protocol Violation|0|||
155382296|NCT01946438|560833363|FG002|Overall Study|Protocol Violation|1|||
155382297|NCT01946438|560833364|FG003|Overall Study|Protocol Violation|0|||
155382298|NCT01946438|560833361|FG000|Overall Study|Withdrawal by Subject|1|||
155382299|NCT01946438|560833362|FG001|Overall Study|Withdrawal by Subject|0|||
155382300|NCT01946438|560833363|FG002|Overall Study|Withdrawal by Subject|0|||
155382301|NCT01946438|560833364|FG003|Overall Study|Withdrawal by Subject|0|||
155382302|NCT05195489|560835263|FG000|Overall Study|Lost to Follow-up|1|||
155382303|NCT05195489|560835264|FG001|Overall Study|Lost to Follow-up|0|||
155382304|NCT05195489|560835263|FG000|Overall Study|Protocol Violation|0|||
155382305|NCT05195489|560835264|FG001|Overall Study|Protocol Violation|2|||
155382306|NCT05195489|560835263|FG000|Overall Study|Withdrawal by Subject|1|||
155382307|NCT05195489|560835264|FG001|Overall Study|Withdrawal by Subject|1|||
155382308|NCT05195489|560835263|FG000|Overall Study|Removed|0|||
155382309|NCT05195489|560835264|FG001|Overall Study|Removed|1|||
155382310|NCT01328717|560835273|FG000|Overall Study|Adverse Event|1|||
155382311|NCT00346268|560835274|FG000|Overall Study|Adverse Event|1|||
155382312|NCT00346268|560835275|FG001|Overall Study|Adverse Event|0|||
155382313|NCT00346268|560835274|FG000|Overall Study|Protocol Violation|1|||
155382314|NCT00346268|560835275|FG001|Overall Study|Protocol Violation|0|||
155382315|NCT00346268|560835274|FG000|Overall Study|Participant refused|0|||
155382316|NCT00346268|560835275|FG001|Overall Study|Participant refused|3|||
155382317|NCT00031551|560835276|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
155382318|NCT00031551|560835277|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
155382319|NCT02164383|560835278|FG000|Overall Study|Lost to Follow-up|1|||
155382320|NCT02164383|560835279|FG001|Overall Study|Lost to Follow-up|0|||
155382321|NCT01036763|560835280|FG000|Overall Study|Adverse Event|25|||
155382322|NCT01036763|560835280|FG000|Overall Study|Lost to Follow-up|28|||
155382323|NCT01036763|560835280|FG000|Overall Study|Other reason (not specified)|40|||
155382324|NCT01672723|560835281|FG000|First Intervention|Adverse Event|3|||
155382325|NCT01672723|560835282|FG001|First Intervention|Adverse Event|0|||
155382326|NCT00743275|560835283|FG000|Overall Study|Protocol Violation|0|||
155382327|NCT00743275|560835284|FG001|Overall Study|Protocol Violation|1|||
155382328|NCT02831387|560835290|FG000|Overall Study|Withdrawal by Subject|1|||
155382329|NCT02831387|560835291|FG001|Overall Study|Withdrawal by Subject|1|||
155382330|NCT02831387|560835290|FG000|Overall Study|Discontinued due to stock recovery|0|||
155382331|NCT02831387|560835291|FG001|Overall Study|Discontinued due to stock recovery|1|||
155382332|NCT00192647|560835292|FG000|Overall Study|Death|1|||
155382333|NCT00192647|560835293|FG001|Overall Study|Death|1|||
155382334|NCT00192647|560835292|FG000|Overall Study|Adverse Event|35|||
155382335|NCT00192647|560835293|FG001|Overall Study|Adverse Event|29|||
155382336|NCT00192647|560835292|FG000|Overall Study|Laboratory Test Abnormality|4|||
155382337|NCT00192647|560835293|FG001|Overall Study|Laboratory Test Abnormality|2|||
155382338|NCT00192647|560835292|FG000|Overall Study|Insufficient Therapeutic Response|53|||
155382339|NCT00192647|560835293|FG001|Overall Study|Insufficient Therapeutic Response|83|||
155382340|NCT00192647|560835292|FG000|Overall Study|Entry Criteria Violation|6|||
155382341|NCT00192647|560835293|FG001|Overall Study|Entry Criteria Violation|6|||
155382342|NCT00192647|560835292|FG000|Overall Study|Protocol Violation|3|||
155382343|NCT00192647|560835293|FG001|Overall Study|Protocol Violation|1|||
155382344|NCT00192647|560835292|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
155382345|NCT00192647|560835293|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
155382346|NCT00192647|560835292|FG000|Overall Study|Failure to Return|11|||
155382347|NCT00192647|560835293|FG001|Overall Study|Failure to Return|13|||
155382348|NCT00192647|560835292|FG000|Overall Study|Other/Administrative|5|||
155382349|NCT00192647|560835293|FG001|Overall Study|Other/Administrative|3|||
155382350|NCT00876928|560835294|FG000|Overall Study|Lost to Follow-up|2|||
155382351|NCT00876928|560835295|FG001|Overall Study|Lost to Follow-up|5|||
155382352|NCT00876928|560835294|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
155382353|NCT00876928|560835295|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
155382354|NCT01016977|560835303|FG000|Overall Study|Lost to Follow-up|1|||
155382355|NCT01016977|560835304|FG001|Overall Study|Lost to Follow-up|0|||
155382356|NCT01016977|560835303|FG000|Overall Study|Withdrawal by Subject|2|||
155382357|NCT01016977|560835304|FG001|Overall Study|Withdrawal by Subject|2|||
155382358|NCT02080221|560835305|FG000|Overall Study|Withdrawal by Subject|1|||
155382359|NCT02080221|560835305|FG000|Overall Study|Clinical Progression of Disease|1|||
155382360|NCT03184870|560835311|FG000|Initial Treatment|Death|6|||
155382361|NCT03184870|560835312|FG001|Initial Treatment|Death|6|||
155382362|NCT03184870|560835313|FG002|Initial Treatment|Death|8|||
155382363|NCT03184870|560835314|FG003|Initial Treatment|Death|8|||
155382364|NCT03184870|560835315|FG004|Initial Treatment|Death|6|||
155382365|NCT03184870|560835316|FG005|Initial Treatment|Death|6|||
155382366|NCT03184870|560835317|FG006|Initial Treatment|Death|6|||
155382367|NCT03184870|560835318|FG007|Initial Treatment|Death|7|||
155382368|NCT03184870|560835319|FG008|Initial Treatment|Death|1|||
155382369|NCT03184870|560835320|FG009|Initial Treatment|Death|2|||
155382370|NCT03184870|560835321|FG010|Initial Treatment|Death|26|||
155382371|NCT03184870|560835322|FG011|Initial Treatment|Death|28|||
155382372|NCT03184870|560835323|FG012|Initial Treatment|Death|10|||
155382373|NCT03184870|560835324|FG013|Initial Treatment|Death|33|||
155382374|NCT03184870|560835325|FG014|Initial Treatment|Death|34|||
155382375|NCT03184870|560835326|FG015|Initial Treatment|Death|26|||
155382376|NCT03184870|560835327|FG016|Initial Treatment|Death|20|||
155382377|NCT03184870|560835328|FG017|Initial Treatment|Death|18|||
155382378|NCT03184870|560835311|FG000|Initial Treatment|Other Reasons|2|||
155382379|NCT03184870|560835312|FG001|Initial Treatment|Other Reasons|2|||
155382380|NCT03184870|560835313|FG002|Initial Treatment|Other Reasons|0|||
155382381|NCT03184870|560835314|FG003|Initial Treatment|Other Reasons|1|||
155382382|NCT03184870|560835315|FG004|Initial Treatment|Other Reasons|0|||
155382383|NCT03184870|560835316|FG005|Initial Treatment|Other Reasons|0|||
155382384|NCT03184870|560835317|FG006|Initial Treatment|Other Reasons|0|||
155382385|NCT03184870|560835318|FG007|Initial Treatment|Other Reasons|2|||
155382386|NCT03184870|560835319|FG008|Initial Treatment|Other Reasons|0|||
155382387|NCT03184870|560835320|FG009|Initial Treatment|Other Reasons|0|||
155382388|NCT03184870|560835321|FG010|Initial Treatment|Other Reasons|4|||
155382389|NCT03184870|560835322|FG011|Initial Treatment|Other Reasons|2|||
155382390|NCT03184870|560835323|FG012|Initial Treatment|Other Reasons|2|||
155382391|NCT03184870|560835324|FG013|Initial Treatment|Other Reasons|0|||
155278633|NCT01676220|560453243|FG000|Overall Study|Non Serious Hypoglycemia|2|||
155278634|NCT01676220|560453244|FG001|Overall Study|Non Serious Hypoglycemia|0|||
155278635|NCT01676220|560453243|FG000|Overall Study|No More Need of Insulin|1|||
155278636|NCT01676220|560453244|FG001|Overall Study|No More Need of Insulin|0|||
155278637|NCT04227340|560453245|FG000|Overall Study|Withdrawal by Subject|3|||
155278638|NCT00750893|560453248|FG000|Overall Study|Adverse Event|5|||
155278639|NCT00750893|560453248|FG000|Overall Study|Withdrawal by Subject|10|||
155278640|NCT00750893|560453248|FG000|Overall Study|Lost to Follow-up|510|||
155278641|NCT00750893|560453248|FG000|Overall Study|Other|17|||
155278642|NCT01628874|560453255|FG000|Overall Study|Physician Decision|1|||
155278643|NCT01628874|560453256|FG001|Overall Study|Physician Decision|1|||
155278644|NCT01628874|560453255|FG000|Overall Study|Age >4 months|4|||
155278645|NCT01628874|560453256|FG001|Overall Study|Age >4 months|2|||
155278646|NCT01152554|560453258|FG000|Overall Study|Withdrawal by Subject|73|||
155278647|NCT01152554|560453259|FG001|Overall Study|Withdrawal by Subject|28|||
155278648|NCT01152554|560453258|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
155278649|NCT01152554|560453259|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
155278650|NCT01152554|560453258|FG000|Overall Study|Adverse Event|67|||
155278651|NCT01152554|560453259|FG001|Overall Study|Adverse Event|14|||
155278652|NCT01152554|560453258|FG000|Overall Study|Severe non-compliance to protocol|36|||
155278653|NCT01152554|560453259|FG001|Overall Study|Severe non-compliance to protocol|14|||
155278654|NCT01152554|560453258|FG000|Overall Study|Condition under investigation worsened|5|||
155278655|NCT01152554|560453259|FG001|Overall Study|Condition under investigation worsened|2|||
155278656|NCT01152554|560453258|FG000|Overall Study|Lack of Efficacy|20|||
155278657|NCT01152554|560453259|FG001|Overall Study|Lack of Efficacy|3|||
155278658|NCT01152554|560453258|FG000|Overall Study|Study-specific withdrawal criteria|17|||
155278659|NCT01152554|560453259|FG001|Overall Study|Study-specific withdrawal criteria|8|||
155278660|NCT01152554|560453258|FG000|Overall Study|Lost to Follow-up|87|||
155278661|NCT01152554|560453259|FG001|Overall Study|Lost to Follow-up|32|||
155278662|NCT01152554|560453258|FG000|Overall Study|Other|28|||
155278663|NCT01152554|560453259|FG001|Overall Study|Other|8|||
155278664|NCT01152554|560453258|FG000|Overall Study|Death|1|||
155278665|NCT01152554|560453259|FG001|Overall Study|Death|1|||
155278666|NCT02397460|560453260|FG000|Treatment Period 2|Adverse Event|0|||
155278667|NCT02397460|560453261|FG001|Treatment Period 2|Adverse Event|0|||
155278668|NCT02397460|560453262|FG002|Treatment Period 2|Adverse Event|0|||
155278669|NCT02397460|560453263|FG003|Treatment Period 2|Adverse Event|0|||
155278670|NCT02397460|560453264|FG004|Treatment Period 2|Adverse Event|0|||
155278671|NCT02397460|560453265|FG005|Treatment Period 2|Adverse Event|0|||
155278672|NCT02397460|560453266|FG006|Treatment Period 2|Adverse Event|0|||
155278673|NCT02397460|560453267|FG007|Treatment Period 2|Adverse Event|1|||
155278674|NCT02397460|560453260|FG000|Treatment Period 4|Adverse Event|0|||
155278675|NCT02397460|560453261|FG001|Treatment Period 4|Adverse Event|1|||
155278676|NCT02397460|560453262|FG002|Treatment Period 4|Adverse Event|0|||
155278677|NCT02397460|560453263|FG003|Treatment Period 4|Adverse Event|0|||
155278678|NCT02397460|560453264|FG004|Treatment Period 4|Adverse Event|0|||
155278679|NCT02397460|560453265|FG005|Treatment Period 4|Adverse Event|0|||
155278680|NCT02397460|560453266|FG006|Treatment Period 4|Adverse Event|0|||
155278681|NCT02397460|560453267|FG007|Treatment Period 4|Adverse Event|0|||
155278682|NCT02397460|560453260|FG000|Treatment Period 4|Physician Decision|0|||
155278683|NCT02397460|560453261|FG001|Treatment Period 4|Physician Decision|0|||
155278684|NCT02397460|560453262|FG002|Treatment Period 4|Physician Decision|0|||
155278685|NCT02397460|560453263|FG003|Treatment Period 4|Physician Decision|0|||
155382392|NCT03184870|560835325|FG014|Initial Treatment|Other Reasons|0|||
155382393|NCT03184870|560835326|FG015|Initial Treatment|Other Reasons|1|||
155278686|NCT02397460|560453264|FG004|Treatment Period 4|Physician Decision|1|||
155278687|NCT02397460|560453265|FG005|Treatment Period 4|Physician Decision|0|||
155278688|NCT02397460|560453266|FG006|Treatment Period 4|Physician Decision|0|||
155278689|NCT02397460|560453267|FG007|Treatment Period 4|Physician Decision|0|||
155278690|NCT01767129|560453271|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155278691|NCT01767129|560453272|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155278692|NCT01473420|560453273|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
155278693|NCT01473420|560453274|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
155278694|NCT01473420|560453273|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
155278695|NCT01473420|560453274|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
155278696|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
155382394|NCT03184870|560835327|FG016|Initial Treatment|Other Reasons|0|||
155382395|NCT03184870|560835328|FG017|Initial Treatment|Other Reasons|2|||
155382396|NCT03184870|560835311|FG000|Initial Treatment|Lost to Follow-up|2|||
155382397|NCT03184870|560835312|FG001|Initial Treatment|Lost to Follow-up|0|||
155382398|NCT03184870|560835313|FG002|Initial Treatment|Lost to Follow-up|0|||
155382399|NCT03184870|560835314|FG003|Initial Treatment|Lost to Follow-up|1|||
155382400|NCT03184870|560835315|FG004|Initial Treatment|Lost to Follow-up|1|||
155382401|NCT03184870|560835316|FG005|Initial Treatment|Lost to Follow-up|1|||
155382402|NCT03184870|560835317|FG006|Initial Treatment|Lost to Follow-up|0|||
155382403|NCT03184870|560835318|FG007|Initial Treatment|Lost to Follow-up|2|||
155382404|NCT03184870|560835319|FG008|Initial Treatment|Lost to Follow-up|0|||
155382405|NCT03184870|560835320|FG009|Initial Treatment|Lost to Follow-up|0|||
155382406|NCT03184870|560835321|FG010|Initial Treatment|Lost to Follow-up|2|||
155382407|NCT03184870|560835322|FG011|Initial Treatment|Lost to Follow-up|0|||
155382408|NCT03184870|560835323|FG012|Initial Treatment|Lost to Follow-up|2|||
155382409|NCT03184870|560835324|FG013|Initial Treatment|Lost to Follow-up|2|||
155382410|NCT03184870|560835325|FG014|Initial Treatment|Lost to Follow-up|0|||
155382411|NCT03184870|560835326|FG015|Initial Treatment|Lost to Follow-up|0|||
155382412|NCT03184870|560835327|FG016|Initial Treatment|Lost to Follow-up|2|||
155382413|NCT03184870|560835328|FG017|Initial Treatment|Lost to Follow-up|2|||
155382414|NCT03184870|560835311|FG000|Initial Treatment|Withdrawal by Subject|0|||
155382415|NCT03184870|560835312|FG001|Initial Treatment|Withdrawal by Subject|0|||
155382416|NCT03184870|560835313|FG002|Initial Treatment|Withdrawal by Subject|2|||
155382417|NCT03184870|560835314|FG003|Initial Treatment|Withdrawal by Subject|1|||
155382418|NCT03184870|560835315|FG004|Initial Treatment|Withdrawal by Subject|1|||
155382419|NCT03184870|560835316|FG005|Initial Treatment|Withdrawal by Subject|0|||
155382420|NCT03184870|560835317|FG006|Initial Treatment|Withdrawal by Subject|1|||
155382421|NCT03184870|560835318|FG007|Initial Treatment|Withdrawal by Subject|0|||
155382422|NCT03184870|560835319|FG008|Initial Treatment|Withdrawal by Subject|0|||
155382423|NCT03184870|560835320|FG009|Initial Treatment|Withdrawal by Subject|0|||
155382424|NCT03184870|560835321|FG010|Initial Treatment|Withdrawal by Subject|0|||
155382425|NCT03184870|560835322|FG011|Initial Treatment|Withdrawal by Subject|2|||
155382426|NCT03184870|560835323|FG012|Initial Treatment|Withdrawal by Subject|3|||
155382427|NCT03184870|560835324|FG013|Initial Treatment|Withdrawal by Subject|0|||
155382428|NCT03184870|560835325|FG014|Initial Treatment|Withdrawal by Subject|1|||
155382429|NCT03184870|560835326|FG015|Initial Treatment|Withdrawal by Subject|5|||
155382430|NCT03184870|560835327|FG016|Initial Treatment|Withdrawal by Subject|2|||
155382431|NCT03184870|560835328|FG017|Initial Treatment|Withdrawal by Subject|2|||
155382432|NCT03184870|560835311|FG000|Initial Treatment|Moved to crossover treatment|0|||
155382433|NCT03184870|560835312|FG001|Initial Treatment|Moved to crossover treatment|0|||
155382434|NCT03184870|560835313|FG002|Initial Treatment|Moved to crossover treatment|0|||
155382435|NCT03184870|560835314|FG003|Initial Treatment|Moved to crossover treatment|0|||
155382436|NCT03184870|560835315|FG004|Initial Treatment|Moved to crossover treatment|0|||
155382437|NCT03184870|560835316|FG005|Initial Treatment|Moved to crossover treatment|0|||
155382438|NCT03184870|560835317|FG006|Initial Treatment|Moved to crossover treatment|0|||
155382439|NCT03184870|560835318|FG007|Initial Treatment|Moved to crossover treatment|0|||
155382440|NCT03184870|560835319|FG008|Initial Treatment|Moved to crossover treatment|0|||
155382441|NCT03184870|560835320|FG009|Initial Treatment|Moved to crossover treatment|0|||
155382442|NCT03184870|560835321|FG010|Initial Treatment|Moved to crossover treatment|0|||
155382443|NCT03184870|560835322|FG011|Initial Treatment|Moved to crossover treatment|0|||
155382444|NCT03184870|560835323|FG012|Initial Treatment|Moved to crossover treatment|9|||
155382445|NCT03184870|560835324|FG013|Initial Treatment|Moved to crossover treatment|0|||
155382446|NCT03184870|560835325|FG014|Initial Treatment|Moved to crossover treatment|0|||
155382447|NCT03184870|560835326|FG015|Initial Treatment|Moved to crossover treatment|0|||
155382448|NCT03184870|560835327|FG016|Initial Treatment|Moved to crossover treatment|0|||
155382449|NCT03184870|560835328|FG017|Initial Treatment|Moved to crossover treatment|0|||
155382450|NCT03184870|560835311|FG000|Crossover Treatment|Other reasons|0|||
155382451|NCT03184870|560835312|FG001|Crossover Treatment|Other reasons|0|||
155382452|NCT03184870|560835313|FG002|Crossover Treatment|Other reasons|0|||
155382453|NCT03184870|560835314|FG003|Crossover Treatment|Other reasons|0|||
155382454|NCT03184870|560835315|FG004|Crossover Treatment|Other reasons|0|||
155382455|NCT03184870|560835316|FG005|Crossover Treatment|Other reasons|0|||
155382456|NCT03184870|560835317|FG006|Crossover Treatment|Other reasons|0|||
155382457|NCT03184870|560835318|FG007|Crossover Treatment|Other reasons|0|||
155382458|NCT03184870|560835319|FG008|Crossover Treatment|Other reasons|0|||
155382459|NCT03184870|560835320|FG009|Crossover Treatment|Other reasons|0|||
155382460|NCT03184870|560835321|FG010|Crossover Treatment|Other reasons|0|||
155382461|NCT03184870|560835322|FG011|Crossover Treatment|Other reasons|0|||
155382462|NCT03184870|560835323|FG012|Crossover Treatment|Other reasons|0|||
155382463|NCT03184870|560835324|FG013|Crossover Treatment|Other reasons|0|||
155382464|NCT03184870|560835325|FG014|Crossover Treatment|Other reasons|0|||
155382465|NCT03184870|560835326|FG015|Crossover Treatment|Other reasons|0|||
155382466|NCT03184870|560835327|FG016|Crossover Treatment|Other reasons|0|||
155382467|NCT03184870|560835328|FG017|Crossover Treatment|Other reasons|2|||
155382468|NCT03184870|560835311|FG000|Crossover Treatment|Death|0|||
155382469|NCT03184870|560835312|FG001|Crossover Treatment|Death|0|||
155382470|NCT03184870|560835313|FG002|Crossover Treatment|Death|0|||
155382471|NCT03184870|560835314|FG003|Crossover Treatment|Death|0|||
155382472|NCT03184870|560835315|FG004|Crossover Treatment|Death|0|||
155382473|NCT03184870|560835316|FG005|Crossover Treatment|Death|0|||
155382474|NCT03184870|560835317|FG006|Crossover Treatment|Death|0|||
155382475|NCT03184870|560835318|FG007|Crossover Treatment|Death|0|||
155382476|NCT03184870|560835319|FG008|Crossover Treatment|Death|0|||
155382477|NCT03184870|560835320|FG009|Crossover Treatment|Death|0|||
155382478|NCT03184870|560835321|FG010|Crossover Treatment|Death|0|||
155382479|NCT03184870|560835322|FG011|Crossover Treatment|Death|0|||
155382480|NCT03184870|560835323|FG012|Crossover Treatment|Death|0|||
155382481|NCT03184870|560835324|FG013|Crossover Treatment|Death|0|||
155382482|NCT03184870|560835325|FG014|Crossover Treatment|Death|0|||
155382483|NCT03184870|560835326|FG015|Crossover Treatment|Death|0|||
155382484|NCT03184870|560835327|FG016|Crossover Treatment|Death|0|||
155382485|NCT03184870|560835328|FG017|Crossover Treatment|Death|7|||
155382486|NCT05081388|560835329|FG000|Overall Study|Adverse Event|1|||
155382487|NCT05081388|560835330|FG001|Overall Study|Adverse Event|0|||
155382488|NCT05081388|560835331|FG002|Overall Study|Adverse Event|0|||
155382489|NCT05081388|560835332|FG003|Overall Study|Adverse Event|0|||
155382490|NCT05081388|560835333|FG004|Overall Study|Adverse Event|0|||
155382491|NCT05081388|560835329|FG000|Overall Study|Lost to Follow-up|0|||
155382492|NCT05081388|560835330|FG001|Overall Study|Lost to Follow-up|1|||
155382493|NCT05081388|560835331|FG002|Overall Study|Lost to Follow-up|0|||
155382494|NCT05081388|560835332|FG003|Overall Study|Lost to Follow-up|0|||
155382495|NCT05081388|560835333|FG004|Overall Study|Lost to Follow-up|0|||
155382496|NCT05081388|560835329|FG000|Overall Study|Subject decision|0|||
155382497|NCT05081388|560835330|FG001|Overall Study|Subject decision|0|||
155382498|NCT05081388|560835331|FG002|Overall Study|Subject decision|0|||
155382499|NCT05081388|560835332|FG003|Overall Study|Subject decision|1|||
155382500|NCT05081388|560835333|FG004|Overall Study|Subject decision|0|||
155382501|NCT03786783|560835334|FG000|Overall Study|Death|1|||
155382502|NCT03786783|560835334|FG000|Overall Study|Physician Decision|6|||
155382503|NCT03786783|560835334|FG000|Overall Study|Withdrawal by Subject|2|||
155382504|NCT03786783|560835334|FG000|Overall Study|Disease Progression|7|||
155382505|NCT03786783|560835334|FG000|Overall Study|Patient/Parent Refusal|4|||
155382506|NCT01776541|560835335|FG000|Overall Study|Administrative Reason|6|||
155382507|NCT01776541|560835336|FG001|Overall Study|Administrative Reason|2|||
155382508|NCT01776541|560835335|FG000|Overall Study|Death|4|||
155625893|NCT02579629|561726022|FG002|Overall Study|Screen Failure|2|||
155625894|NCT01930539|561726023|FG000|Overall Study|Withdrawal by Subject|2|||
155625895|NCT01930539|561726024|FG001|Overall Study|Withdrawal by Subject|2|||
155625896|NCT02870868|561726025|FG000|Overall Study|Withdrawal by Subject|2|||
155625897|NCT02870868|561726026|FG001|Overall Study|Withdrawal by Subject|1|||
155625898|NCT00883181|561726028|FG000|Overall Study|Hematological Adverse Event|26|||
155625899|NCT00883181|561726028|FG000|Overall Study|Non-hematological Adverse Event|55|||
155625900|NCT00883181|561726028|FG000|Overall Study|Disease Progression|94|||
155625901|NCT00883181|561726028|FG000|Overall Study|Administrative Reason|24|||
155278697|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
155278698|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
155278699|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
155278700|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
155278701|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
155278702|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
155278703|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
155278704|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
155278705|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
155278706|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
155278707|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
155278708|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
155278709|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
155278710|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
155278711|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
155278712|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
155278713|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
155278714|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
155278715|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
155278716|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
155382509|NCT01776541|560835336|FG001|Overall Study|Death|0|||
155382510|NCT01776541|560835335|FG000|Overall Study|Lost to Follow-up|27|||
155382511|NCT01776541|560835336|FG001|Overall Study|Lost to Follow-up|48|||
155382512|NCT01776541|560835335|FG000|Overall Study|Unclassified|5|||
155382513|NCT01776541|560835336|FG001|Overall Study|Unclassified|4|||
155382514|NCT01776541|560835335|FG000|Overall Study|Protocol Violation|2|||
155382515|NCT01776541|560835336|FG001|Overall Study|Protocol Violation|1|||
155382516|NCT01776541|560835335|FG000|Overall Study|Withdrawal by Subject|12|||
155382517|NCT01776541|560835336|FG001|Overall Study|Withdrawal by Subject|20|||
155382518|NCT04279392|560835339|FG000|Overall Study|Physician Decision|1|||
155625902|NCT00883181|561726028|FG000|Overall Study|Withdrawal by Subject|4|||
155625903|NCT00883181|561726028|FG000|Overall Study|Death|31|||
155382519|NCT04279392|560835340|FG001|Overall Study|Physician Decision|0|||
155382520|NCT01171807|560835341|FG000|Overall Study|Treatment failure|2|||
155382521|NCT01171807|560835342|FG001|Overall Study|Treatment failure|4|||
155382522|NCT01171807|560835341|FG000|Overall Study|Non compliance|1|||
155382523|NCT01171807|560835342|FG001|Overall Study|Non compliance|0|||
155382524|NCT01171807|560835341|FG000|Overall Study|Lost to Follow-up|3|||
155382525|NCT01171807|560835342|FG001|Overall Study|Lost to Follow-up|0|||
155382526|NCT01901341|560835343|FG000|Overall Study|Adverse Event|4|||
155382527|NCT01901341|560835344|FG001|Overall Study|Adverse Event|2|||
155382528|NCT01901341|560835343|FG000|Overall Study|Lack of Efficacy|0|||
155382529|NCT01901341|560835344|FG001|Overall Study|Lack of Efficacy|2|||
155382530|NCT01901341|560835343|FG000|Overall Study|Lost to Follow-up|0|||
155382531|NCT01901341|560835344|FG001|Overall Study|Lost to Follow-up|1|||
155382532|NCT01901341|560835343|FG000|Overall Study|Protocol Violation|2|||
155728801|NCT02177032|562106435|FG001|Overall Study|Lost to Follow-up|2|||
155728802|NCT02177032|562106436|FG002|Overall Study|Lost to Follow-up|0|||
155728803|NCT02177032|562106437|FG003|Overall Study|Lost to Follow-up|0|||
155728804|NCT02177032|562106434|FG000|Overall Study|OTHER|2|||
155728805|NCT02177032|562106435|FG001|Overall Study|OTHER|0|||
155728806|NCT02177032|562106436|FG002|Overall Study|OTHER|1|||
155728807|NCT02177032|562106437|FG003|Overall Study|OTHER|0|||
155728808|NCT02177032|562106434|FG000|Overall Study|Withdrawal by Subject|1|||
155728809|NCT02177032|562106435|FG001|Overall Study|Withdrawal by Subject|0|||
155728810|NCT02177032|562106436|FG002|Overall Study|Withdrawal by Subject|1|||
155728811|NCT02177032|562106437|FG003|Overall Study|Withdrawal by Subject|0|||
155728812|NCT01605799|562106443|FG000|Overall Study|Withdrawal by Subject|2|||
155728813|NCT01605799|562106444|FG001|Overall Study|Withdrawal by Subject|1|||
155728814|NCT00686712|562106445|FG000|Overall Study|Protocol Violation|8|||
155728815|NCT00686712|562106446|FG001|Overall Study|Protocol Violation|8|||
155728816|NCT00686712|562106447|FG002|Overall Study|Protocol Violation|10|||
155728817|NCT00686712|562106445|FG000|Overall Study|Lost to Follow-up|1|||
155728818|NCT00686712|562106446|FG001|Overall Study|Lost to Follow-up|2|||
155728819|NCT00686712|562106447|FG002|Overall Study|Lost to Follow-up|3|||
155728820|NCT00686712|562106445|FG000|Overall Study|Adverse Event|1|||
155728821|NCT00686712|562106446|FG001|Overall Study|Adverse Event|1|||
155728822|NCT00686712|562106447|FG002|Overall Study|Adverse Event|0|||
155382533|NCT01901341|560835344|FG001|Overall Study|Protocol Violation|0|||
155382534|NCT01901341|560835343|FG000|Overall Study|Study Terminated by Sponsor|13|||
155382535|NCT01901341|560835344|FG001|Overall Study|Study Terminated by Sponsor|15|||
155382536|NCT01901341|560835343|FG000|Overall Study|Withdrawal by Subject|1|||
155382537|NCT01901341|560835344|FG001|Overall Study|Withdrawal by Subject|1|||
155382538|NCT04964388|560835345|FG000|Overall Study|Lost to Follow-up|3|||
155382539|NCT04964388|560835346|FG001|Overall Study|Lost to Follow-up|2|||
155382540|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
155382541|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
155382542|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
155382543|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
155382544|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
155382545|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
155382546|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
155382547|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
155382548|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
155382549|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
155382550|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
155382551|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
155382552|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
155382553|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
155382554|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
155382555|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
155382556|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
155382557|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
155382558|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
155728823|NCT01318915|562106450|FG000|Overall Study|Lost to Follow-up|1|||
155728824|NCT00926237|562106451|FG000|Overall Study|Withdrawal by Subject|2|||
155728825|NCT00926237|562106452|FG001|Overall Study|Withdrawal by Subject|1|||
155728826|NCT03815929|562106465|FG000|Overall Study|Lost to Follow-up|2|||
155728827|NCT03815929|562106466|FG001|Overall Study|Lost to Follow-up|1|||
155728828|NCT03815929|562106467|FG002|Overall Study|Lost to Follow-up|0|||
155728829|NCT03815929|562106465|FG000|Overall Study|Physician Decision|2|||
155382559|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
155382560|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
155382561|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
155382562|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
155728830|NCT03815929|562106466|FG001|Overall Study|Physician Decision|2|||
155728831|NCT03815929|562106467|FG002|Overall Study|Physician Decision|0|||
155728832|NCT03815929|562106465|FG000|Overall Study|Withdrawal by Subject|0|||
155728833|NCT03815929|562106466|FG001|Overall Study|Withdrawal by Subject|0|||
155728834|NCT03815929|562106467|FG002|Overall Study|Withdrawal by Subject|1|||
155728835|NCT03313037|562106468|FG000|Overall Study|Protocol Violation|4|||
155728836|NCT03313037|562106469|FG001|Overall Study|Protocol Violation|1|||
155728837|NCT03313037|562106468|FG000|Overall Study|Other|1|||
155728838|NCT03313037|562106469|FG001|Overall Study|Other|1|||
155382563|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
155382564|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
155382565|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
155382566|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
155382567|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
155382568|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
155382569|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
155382570|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
155382571|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
155382572|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
155382573|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
155382574|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
155382575|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
155382576|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
155382577|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
155382578|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
155382579|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
155382580|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
155382581|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
155382582|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
155382583|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
155382584|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
155382585|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
155382586|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
155382587|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
155382588|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
155382589|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
155382590|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
155382591|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
155382592|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
155382593|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
155382594|NCT02476279|560835351|FG000|Overall Study|Lost to Follow-up|1|||
155382595|NCT02476279|560835352|FG001|Overall Study|Lost to Follow-up|1|||
155382596|NCT02208999|560835353|FG000|Overall Study|Lost to Follow-up|1|||
155382597|NCT00319839|560835354|FG000|Overall Study|Adverse Event|5|||
155382598|NCT00319839|560835354|FG000|Overall Study|Withdrawal by Subject|1|||
155382599|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
155382600|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
155382601|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
155382602|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
155382603|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
155382604|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
155382605|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
155382606|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382607|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382608|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382609|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382610|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
155382611|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382612|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382613|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382614|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382615|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382616|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
155728839|NCT03313037|562106468|FG000|Overall Study|Withdrawal by Subject|4|||
155728840|NCT03313037|562106469|FG001|Overall Study|Withdrawal by Subject|3|||
155728841|NCT03313037|562106468|FG000|Overall Study|No longer meets eligibility criteria|1|||
155382617|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
155382618|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
155728842|NCT03313037|562106469|FG001|Overall Study|No longer meets eligibility criteria|7|||
155728843|NCT03313037|562106468|FG000|Overall Study|Lost to Follow-up|9|||
155728844|NCT03313037|562106469|FG001|Overall Study|Lost to Follow-up|8|||
155278717|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
155278718|NCT04172987|560453275|FG000|Lead In Period|Adverse Event|1|||
155278719|NCT04172987|560453275|FG000|Lead In Period|Protocol Violation|1|||
155278720|NCT04172987|560453275|FG000|Period 1|Physician Decision|1|||
155278721|NCT04172987|560453275|FG000|Period 2|Adverse Event|5|||
155278722|NCT04172987|560453275|FG000|Period 2|Dosing Termination by Sponsor|4|||
155625904|NCT00883181|561726028|FG000|Overall Study|Other|38|||
155625905|NCT00883181|561726028|FG000|Overall Study|Protocol Deviation|3|||
155625906|NCT00883181|561726028|FG000|Overall Study|Noncompliance|3|||
155625907|NCT04040439|561726029|FG000|Overall Study|Invalid registration|11|||
155625908|NCT04040439|561726029|FG000|Overall Study|No IC* on publication of study results|2|||
155625909|NCT01450813|561726034|FG000|Overall Study|Physician Decision|1|||
155625910|NCT01450813|561726035|FG001|Overall Study|Physician Decision|1|||
155625911|NCT01450813|561726036|FG002|Overall Study|Physician Decision|0|||
155625912|NCT01450813|561726037|FG003|Overall Study|Physician Decision|3|||
155625913|NCT01309386|561726038|FG000|Overall Study|Other|2|||
155625914|NCT01309386|561726039|FG001|Overall Study|Other|0|||
155625915|NCT01309386|561726038|FG000|Overall Study|Withdrawal by Subject|2|||
155625916|NCT01309386|561726039|FG001|Overall Study|Withdrawal by Subject|0|||
155625917|NCT01309386|561726038|FG000|Overall Study|Progressive disease|9|||
155625918|NCT01309386|561726039|FG001|Overall Study|Progressive disease|11|||
155625919|NCT01309386|561726038|FG000|Overall Study|Physician Decision|1|||
155625920|NCT01309386|561726039|FG001|Overall Study|Physician Decision|1|||
155625921|NCT01309386|561726038|FG000|Overall Study|Lack of Efficacy|3|||
155625922|NCT01309386|561726039|FG001|Overall Study|Lack of Efficacy|1|||
155625923|NCT01309386|561726038|FG000|Overall Study|Adverse Event|5|||
155625924|NCT01309386|561726039|FG001|Overall Study|Adverse Event|8|||
155625925|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
155625926|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155625927|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155625928|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155625929|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155625930|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
155625931|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155625932|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155625933|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155625934|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155625935|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
155625936|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155625937|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155625938|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155625939|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155625940|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
155625941|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155625942|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155625943|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155625944|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155625945|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
155625946|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155625947|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155625948|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155625949|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155625950|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
155625951|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155625952|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155625953|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155625954|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155625955|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
155625956|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155625957|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155625958|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155625959|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155625960|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
155625961|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155625962|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155625963|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155625964|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155625965|NCT02709746|561726040|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
155278723|NCT01656759|560453276|FG000|Overall Study|Protocol Violation|2|||
155728845|NCT03313037|562106468|FG000|Overall Study|Randomized but not treated|1|||
155728846|NCT03313037|562106469|FG001|Overall Study|Randomized but not treated|0|||
155728847|NCT02760498|562106470|FG000|Overall Study|Adverse Event|3|||
155728848|NCT02760498|562106471|FG001|Overall Study|Adverse Event|3|||
155728849|NCT02760498|562106472|FG002|Overall Study|Adverse Event|1|||
155728850|NCT02760498|562106473|FG003|Overall Study|Adverse Event|1|||
155728851|NCT02760498|562106474|FG004|Overall Study|Adverse Event|0|||
155728852|NCT02760498|562106475|FG005|Overall Study|Adverse Event|6|||
155728853|NCT02760498|562106470|FG000|Overall Study|Death|7|||
155728854|NCT02760498|562106471|FG001|Overall Study|Death|5|||
155728855|NCT02760498|562106472|FG002|Overall Study|Death|5|||
155728856|NCT02760498|562106473|FG003|Overall Study|Death|7|||
155728857|NCT02760498|562106474|FG004|Overall Study|Death|0|||
155728858|NCT02760498|562106475|FG005|Overall Study|Death|23|||
155728859|NCT02760498|562106470|FG000|Overall Study|Lost to Follow-up|0|||
155728860|NCT02760498|562106471|FG001|Overall Study|Lost to Follow-up|0|||
155728861|NCT02760498|562106472|FG002|Overall Study|Lost to Follow-up|0|||
155728862|NCT02760498|562106473|FG003|Overall Study|Lost to Follow-up|0|||
155728863|NCT02760498|562106474|FG004|Overall Study|Lost to Follow-up|0|||
155728864|NCT02760498|562106475|FG005|Overall Study|Lost to Follow-up|3|||
155728865|NCT02760498|562106470|FG000|Overall Study|Non-compliance with study drug|0|||
155728866|NCT02760498|562106471|FG001|Overall Study|Non-compliance with study drug|2|||
155728867|NCT02760498|562106472|FG002|Overall Study|Non-compliance with study drug|0|||
155728868|NCT02760498|562106473|FG003|Overall Study|Non-compliance with study drug|0|||
155728869|NCT02760498|562106474|FG004|Overall Study|Non-compliance with study drug|0|||
155728870|NCT02760498|562106475|FG005|Overall Study|Non-compliance with study drug|0|||
155728871|NCT02760498|562106470|FG000|Overall Study|Participant decision|1|||
155728872|NCT02760498|562106471|FG001|Overall Study|Participant decision|4|||
155728873|NCT02760498|562106472|FG002|Overall Study|Participant decision|2|||
155728874|NCT02760498|562106473|FG003|Overall Study|Participant decision|2|||
155728875|NCT02760498|562106474|FG004|Overall Study|Participant decision|1|||
155728876|NCT02760498|562106475|FG005|Overall Study|Participant decision|6|||
155728877|NCT02760498|562106470|FG000|Overall Study|Sponsor decision|0|||
155728878|NCT02760498|562106471|FG001|Overall Study|Sponsor decision|0|||
155728879|NCT02760498|562106472|FG002|Overall Study|Sponsor decision|0|||
155728880|NCT02760498|562106473|FG003|Overall Study|Sponsor decision|3|||
155728881|NCT02760498|562106474|FG004|Overall Study|Sponsor decision|0|||
155728882|NCT02760498|562106475|FG005|Overall Study|Sponsor decision|0|||
155728883|NCT02760498|562106470|FG000|Overall Study|Physician Decision|3|||
155728884|NCT02760498|562106471|FG001|Overall Study|Physician Decision|4|||
155728885|NCT02760498|562106472|FG002|Overall Study|Physician Decision|1|||
155728886|NCT02760498|562106473|FG003|Overall Study|Physician Decision|4|||
155728887|NCT02760498|562106474|FG004|Overall Study|Physician Decision|0|||
155728888|NCT02760498|562106475|FG005|Overall Study|Physician Decision|2|||
155728889|NCT02760498|562106470|FG000|Overall Study|Disease progression|21|||
155728890|NCT02760498|562106471|FG001|Overall Study|Disease progression|19|||
155728891|NCT02760498|562106472|FG002|Overall Study|Disease progression|20|||
155728892|NCT02760498|562106473|FG003|Overall Study|Disease progression|18|||
155728893|NCT02760498|562106474|FG004|Overall Study|Disease progression|4|||
155728894|NCT02760498|562106475|FG005|Overall Study|Disease progression|55|||
155728895|NCT02760498|562106470|FG000|Overall Study|Withdrawal by Subject|4|||
155728896|NCT02760498|562106471|FG001|Overall Study|Withdrawal by Subject|7|||
155728897|NCT02760498|562106472|FG002|Overall Study|Withdrawal by Subject|5|||
155728898|NCT02760498|562106473|FG003|Overall Study|Withdrawal by Subject|1|||
155728899|NCT02760498|562106474|FG004|Overall Study|Withdrawal by Subject|0|||
155728900|NCT02760498|562106475|FG005|Overall Study|Withdrawal by Subject|6|||
155728901|NCT02760498|562106470|FG000|Overall Study|Other than specified|1|||
155728902|NCT02760498|562106471|FG001|Overall Study|Other than specified|6|||
155728903|NCT02760498|562106472|FG002|Overall Study|Other than specified|0|||
155728904|NCT02760498|562106473|FG003|Overall Study|Other than specified|3|||
155728905|NCT02760498|562106474|FG004|Overall Study|Other than specified|1|||
155728906|NCT02760498|562106475|FG005|Overall Study|Other than specified|0|||
155728907|NCT02760498|562106470|FG000|Overall Study|Not treated|0|||
155728908|NCT02760498|562106471|FG001|Overall Study|Not treated|0|||
155728909|NCT02760498|562106472|FG002|Overall Study|Not treated|0|||
155728910|NCT02760498|562106473|FG003|Overall Study|Not treated|0|||
155728911|NCT02760498|562106474|FG004|Overall Study|Not treated|0|||
155728912|NCT02760498|562106475|FG005|Overall Study|Not treated|2|||
155728913|NCT02205736|562106476|FG000|Overall Study|Lost to Follow-up|106|||
155728914|NCT01198977|562106482|FG000|Overall Study|Lost to Follow-up|1|||
155728915|NCT01198977|562106483|FG001|Overall Study|Lost to Follow-up|0|||
155728916|NCT01588522|562106489|FG000|Overall Study|Withdrawal by Subject|1|||
155728917|NCT01588522|562106490|FG001|Overall Study|Withdrawal by Subject|5|||
155728918|NCT01588522|562106491|FG002|Overall Study|Withdrawal by Subject|3|||
155728919|NCT01588522|562106492|FG003|Overall Study|Withdrawal by Subject|1|||
155728920|NCT01588522|562106493|FG004|Overall Study|Withdrawal by Subject|2|||
155728921|NCT01588522|562106494|FG005|Overall Study|Withdrawal by Subject|0|||
155728922|NCT01588522|562106489|FG000|Overall Study|Lack of Efficacy|0|||
155728923|NCT01588522|562106490|FG001|Overall Study|Lack of Efficacy|0|||
155728924|NCT01588522|562106491|FG002|Overall Study|Lack of Efficacy|0|||
155728925|NCT01588522|562106492|FG003|Overall Study|Lack of Efficacy|0|||
155728926|NCT01588522|562106493|FG004|Overall Study|Lack of Efficacy|1|||
155382619|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382620|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382621|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382622|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382623|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
155382624|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
155382625|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382626|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382627|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382628|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382629|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382630|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382631|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382632|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382633|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382634|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382635|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382636|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382637|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382638|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
155382639|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382640|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382641|NCT04494256|560835355|FG000|Part 2: Open Label Period|Death|0|||
155382642|NCT04494256|560835356|FG001|Part 2: Open Label Period|Death|0|||
155382643|NCT04494256|560835357|FG002|Part 2: Open Label Period|Death|0|||
155382644|NCT04494256|560835358|FG003|Part 2: Open Label Period|Death|0|||
155382645|NCT04494256|560835359|FG004|Part 2: Open Label Period|Death|0|||
155382646|NCT04494256|560835360|FG005|Part 2: Open Label Period|Death|4|||
155382647|NCT04494256|560835361|FG006|Part 2: Open Label Period|Death|2|||
155382648|NCT04494256|560835355|FG000|Part 2: Open Label Period|Adverse Event|0|||
155382649|NCT04494256|560835356|FG001|Part 2: Open Label Period|Adverse Event|0|||
155382650|NCT04494256|560835357|FG002|Part 2: Open Label Period|Adverse Event|0|||
155382651|NCT04494256|560835358|FG003|Part 2: Open Label Period|Adverse Event|0|||
155382652|NCT04494256|560835359|FG004|Part 2: Open Label Period|Adverse Event|0|||
155382653|NCT04494256|560835360|FG005|Part 2: Open Label Period|Adverse Event|0|||
155382654|NCT04494256|560835361|FG006|Part 2: Open Label Period|Adverse Event|2|||
155382655|NCT04494256|560835355|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382656|NCT04494256|560835356|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382657|NCT04494256|560835357|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382658|NCT04494256|560835358|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382659|NCT04494256|560835359|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382660|NCT04494256|560835360|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
155382661|NCT04494256|560835361|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
155382662|NCT04494256|560835355|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382663|NCT04494256|560835356|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382664|NCT04494256|560835357|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382665|NCT04494256|560835358|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382666|NCT04494256|560835359|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382667|NCT04494256|560835360|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382668|NCT04494256|560835361|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
155382669|NCT04494256|560835355|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382670|NCT04494256|560835356|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382671|NCT04494256|560835357|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382672|NCT04494256|560835358|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382673|NCT04494256|560835359|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155728927|NCT01588522|562106494|FG005|Overall Study|Lack of Efficacy|0|||
155728928|NCT01588522|562106489|FG000|Overall Study|Adverse Event|0|||
155728929|NCT01588522|562106490|FG001|Overall Study|Adverse Event|0|||
155728930|NCT01588522|562106491|FG002|Overall Study|Adverse Event|0|||
155728931|NCT01588522|562106492|FG003|Overall Study|Adverse Event|1|||
155728932|NCT01588522|562106493|FG004|Overall Study|Adverse Event|0|||
155728933|NCT01588522|562106494|FG005|Overall Study|Adverse Event|0|||
155728934|NCT01588522|562106489|FG000|Overall Study|Grade 2 alopecia|1|||
155382674|NCT04494256|560835360|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
155382675|NCT04494256|560835361|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
155382676|NCT04494256|560835355|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382677|NCT04494256|560835356|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382678|NCT04494256|560835357|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382679|NCT04494256|560835358|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382680|NCT04494256|560835359|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382681|NCT04494256|560835360|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
155382682|NCT04494256|560835361|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
155382683|NCT04494256|560835355|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382684|NCT04494256|560835356|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382685|NCT04494256|560835357|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382686|NCT04494256|560835358|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382687|NCT04494256|560835359|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382688|NCT04494256|560835360|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
155382689|NCT04494256|560835361|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
155382690|NCT00262951|560835362|FG000|Overall Study|Progressive disease/relapse|3|||
155382691|NCT00262951|560835362|FG000|Overall Study|Adverse Event|7|||
155382692|NCT00262951|560835362|FG000|Overall Study|Death|1|||
155382693|NCT00262951|560835362|FG000|Overall Study|Withdrawal by Subject|1|||
155382694|NCT00262951|560835362|FG000|Overall Study|Alternative treatment|3|||
155382695|NCT00262951|560835362|FG000|Overall Study|Off treatment for other disease|1|||
155382696|NCT01778023|560835363|FG000|Overall Study|Withdrawal by Subject|0|||
155382697|NCT01778023|560835364|FG001|Overall Study|Withdrawal by Subject|3|||
155382698|NCT00903630|560835365|FG000|Phase 2|Adverse Event|0|||
155382699|NCT00903630|560835366|FG001|Phase 2|Adverse Event|0|||
155382700|NCT00903630|560835367|FG002|Phase 2|Adverse Event|1|||
155625966|NCT02709746|561726041|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155625967|NCT02709746|561726042|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155625968|NCT02709746|561726043|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155625969|NCT02709746|561726044|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155625970|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155625971|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
155625972|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155625973|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155625974|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
155625975|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
155625976|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
155625977|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
155625978|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
155625979|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
155625980|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
155625981|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
155625982|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
155625983|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
155625984|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
155625985|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
155625986|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
155625987|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
155625988|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
155625989|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
155625990|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
155625991|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
155625992|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
155625993|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
155625994|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
155625995|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
155625996|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155625997|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155625998|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155625999|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
155626000|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155626001|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155382701|NCT01249274|560835371|FG000|Overall Study|Lost to Follow-up|3|||
155382702|NCT01249274|560835372|FG001|Overall Study|Lost to Follow-up|4|||
155382703|NCT01249274|560835371|FG000|Overall Study|Received inpatient substance treatment|1|||
155382704|NCT01249274|560835372|FG001|Overall Study|Received inpatient substance treatment|2|||
155382705|NCT03451162|560835373|FG000|Overall Study|Lost to Follow-up|1|||
155382706|NCT03451162|560835374|FG001|Overall Study|Lost to Follow-up|0|||
155382707|NCT03451162|560835375|FG002|Overall Study|Lost to Follow-up|0|||
155382708|NCT03451162|560835376|FG003|Overall Study|Lost to Follow-up|0|||
155382709|NCT03451162|560835377|FG004|Overall Study|Lost to Follow-up|0|||
155382710|NCT03451162|560835373|FG000|Overall Study|Physician Decision|0|||
155382711|NCT03451162|560835374|FG001|Overall Study|Physician Decision|1|||
155382712|NCT03451162|560835375|FG002|Overall Study|Physician Decision|0|||
155382713|NCT03451162|560835376|FG003|Overall Study|Physician Decision|0|||
155382714|NCT03451162|560835377|FG004|Overall Study|Physician Decision|0|||
155382715|NCT03451162|560835373|FG000|Overall Study|Withdrawal by Subject|1|||
155382716|NCT03451162|560835374|FG001|Overall Study|Withdrawal by Subject|1|||
155382717|NCT03451162|560835375|FG002|Overall Study|Withdrawal by Subject|0|||
155382718|NCT03451162|560835376|FG003|Overall Study|Withdrawal by Subject|0|||
155382719|NCT03451162|560835377|FG004|Overall Study|Withdrawal by Subject|0|||
155382720|NCT03658668|560835378|FG000|Overall Study|Time Commitment|1|||
155382721|NCT03658668|560835379|FG001|Overall Study|Time Commitment|1|||
155382722|NCT04634825|560835380|FG000|Overall Study|Death|10|||
155382723|NCT04634825|560835381|FG001|Overall Study|Death|3|||
155382724|NCT04634825|560835380|FG000|Overall Study|Lost to Follow-up|1|||
155382725|NCT04634825|560835381|FG001|Overall Study|Lost to Follow-up|0|||
155382726|NCT04634825|560835380|FG000|Overall Study|Study terminated by sponsor|35|||
155382727|NCT04634825|560835381|FG001|Overall Study|Study terminated by sponsor|11|||
155382728|NCT04634825|560835380|FG000|Overall Study|Withdrawal by Subject|2|||
155382729|NCT04634825|560835381|FG001|Overall Study|Withdrawal by Subject|0|||
155382730|NCT00402597|560835384|FG000|Overall Study|Death|15|||
155382731|NCT00402597|560835385|FG001|Overall Study|Death|7|||
155382732|NCT00402597|560835386|FG002|Overall Study|Death|6|||
155382733|NCT00402597|560835387|FG003|Overall Study|Death|4|||
155382734|NCT00402597|560835388|FG004|Overall Study|Death|6|||
155382735|NCT00402597|560835384|FG000|Overall Study|Adverse Event|81|||
155382736|NCT00402597|560835385|FG001|Overall Study|Adverse Event|18|||
155382737|NCT00402597|560835386|FG002|Overall Study|Adverse Event|106|||
155382738|NCT00402597|560835387|FG003|Overall Study|Adverse Event|39|||
155382739|NCT00402597|560835388|FG004|Overall Study|Adverse Event|71|||
155382740|NCT00402597|560835384|FG000|Overall Study|Lost to Follow-up|8|||
155382741|NCT00402597|560835385|FG001|Overall Study|Lost to Follow-up|1|||
155382742|NCT00402597|560835386|FG002|Overall Study|Lost to Follow-up|8|||
155382743|NCT00402597|560835387|FG003|Overall Study|Lost to Follow-up|2|||
155382744|NCT00402597|560835388|FG004|Overall Study|Lost to Follow-up|3|||
155382745|NCT00402597|560835384|FG000|Overall Study|Withdrawal by Subject|57|||
155382746|NCT00402597|560835385|FG001|Overall Study|Withdrawal by Subject|16|||
155382747|NCT00402597|560835386|FG002|Overall Study|Withdrawal by Subject|65|||
155382748|NCT00402597|560835387|FG003|Overall Study|Withdrawal by Subject|15|||
155382749|NCT00402597|560835388|FG004|Overall Study|Withdrawal by Subject|24|||
155382750|NCT00402597|560835384|FG000|Overall Study|reason not specified|30|||
155382751|NCT00402597|560835385|FG001|Overall Study|reason not specified|4|||
155382752|NCT00402597|560835386|FG002|Overall Study|reason not specified|27|||
155382753|NCT00402597|560835387|FG003|Overall Study|reason not specified|14|||
155382754|NCT00402597|560835388|FG004|Overall Study|reason not specified|20|||
155382755|NCT01100034|560835389|FG000|Overall Study|Lost to Follow-up|11|||
155382756|NCT01100034|560835389|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
155382757|NCT01100034|560835389|FG000|Overall Study|Withdrawal by Subject|4|||
155382758|NCT01100034|560835389|FG000|Overall Study|Sponsor decision|21|||
155382759|NCT01100034|560835389|FG000|Overall Study|Participated in another clinical trial|1|||
155382760|NCT01100034|560835389|FG000|Overall Study|Participants moved to another hospital|4|||
155382761|NCT01100034|560835389|FG000|Overall Study|Site closed due to non-responsiveness|1|||
155382762|NCT01831856|560835390|FG000|Overall Study|Adverse Event|5|||
155382763|NCT01831856|560835391|FG001|Overall Study|Adverse Event|8|||
155382764|NCT01831856|560835390|FG000|Overall Study|Lack of Efficacy|13|||
155382765|NCT01831856|560835391|FG001|Overall Study|Lack of Efficacy|11|||
155382766|NCT01831856|560835390|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
155382767|NCT01831856|560835391|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
155382768|NCT00836095|560835393|FG000|Overall Study|Physician Decision|0|||
155382769|NCT00836095|560835394|FG001|Overall Study|Physician Decision|3|||
155382770|NCT01602562|560835396|FG000|Overall Study|Adverse Event|3|||
155382771|NCT01602562|560835397|FG001|Overall Study|Adverse Event|1|||
155382772|NCT01602562|560835396|FG000|Overall Study|Physician Decision|1|||
155382773|NCT01602562|560835397|FG001|Overall Study|Physician Decision|1|||
155382774|NCT01602562|560835396|FG000|Overall Study|Withdrawal by Subject|1|||
155382775|NCT01602562|560835397|FG001|Overall Study|Withdrawal by Subject|1|||
155382776|NCT02003573|560835401|FG000|Overall Study|Progressive disease|2|||
155382777|NCT02003573|560835402|FG001|Overall Study|Progressive disease|0|||
155382778|NCT02003573|560835403|FG002|Overall Study|Progressive disease|1|||
155382779|NCT02003573|560835401|FG000|Overall Study|Other Adverse event|0|||
155382780|NCT02003573|560835402|FG001|Overall Study|Other Adverse event|1|||
155382781|NCT02003573|560835403|FG002|Overall Study|Other Adverse event|1|||
155382782|NCT02003573|560835401|FG000|Overall Study|Refuse to take trial medication|0|||
155382783|NCT02003573|560835402|FG001|Overall Study|Refuse to take trial medication|1|||
155382784|NCT02003573|560835403|FG002|Overall Study|Refuse to take trial medication|1|||
155382785|NCT02003573|560835401|FG000|Overall Study|Other than specified|1|||
155382786|NCT02003573|560835402|FG001|Overall Study|Other than specified|2|||
155382787|NCT02003573|560835403|FG002|Overall Study|Other than specified|3|||
155382788|NCT05026710|560835410|FG000|Overall Study|No longer met eligibility criteria|3|||
155382789|NCT05026710|560835411|FG001|Overall Study|No longer met eligibility criteria|1|||
155382790|NCT00126503|560835414|FG000|Overall Study|disease progression|23|||
155382791|NCT00126503|560835415|FG001|Overall Study|disease progression|14|||
155382792|NCT00126503|560835414|FG000|Overall Study|Withdrawal by Subject|0|||
155382793|NCT00126503|560835415|FG001|Overall Study|Withdrawal by Subject|1|||
155626002|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
155626003|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155626004|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155626005|NCT02709746|561726040|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
155626006|NCT02709746|561726041|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
155626007|NCT02709746|561726042|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
155626008|NCT02709746|561726043|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
155626009|NCT02709746|561726044|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
155626010|NCT00752089|561726045|FG000|Overall Study|Adverse Event|1|||
155626011|NCT00752089|561726045|FG000|Overall Study|Protocol Deviation|2|||
155626012|NCT00752089|561726045|FG000|Overall Study|Could not attend visit 9|1|||
155626013|NCT00752089|561726045|FG000|Overall Study|Not capable of wearing partial denture|1|||
155626014|NCT00752089|561726045|FG000|Overall Study|Cannot continue the study|1|||
155626015|NCT02089347|561726046|FG000|Overall Study|Protocol Violation|1|||
155626016|NCT02089347|561726047|FG001|Overall Study|Protocol Violation|0|||
155626017|NCT02914834|561726051|FG000|Overall Study|Study halted due to COVID|1|||
155626018|NCT02914834|561726052|FG001|Overall Study|Study halted due to COVID|1|||
155626019|NCT02914834|561726051|FG000|Overall Study|1 subject withdrew|0|||
155626020|NCT02914834|561726052|FG001|Overall Study|1 subject withdrew|1|||
155626021|NCT00975416|561726059|FG000|Overall Study|early discharge from tx|3|||
155626022|NCT00975416|561726060|FG001|Overall Study|early discharge from tx|5|||
155626023|NCT01245101|561726061|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
155626024|NCT01245101|561726062|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
155626025|NCT01245101|561726061|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
155626026|NCT01245101|561726062|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
155626027|NCT01245101|561726061|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
155626028|NCT01245101|561726062|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
155626029|NCT01225549|561726063|FG000|Period 4 - Washout|Disallowed medication|0|||
155626030|NCT01225549|561726064|FG001|Period 4 - Washout|Disallowed medication|1|||
155626031|NCT01225549|561726065|FG002|Period 4 - Washout|Disallowed medication|0|||
155626032|NCT01225549|561726066|FG003|Period 4 - Washout|Disallowed medication|0|||
155626033|NCT01225549|561726067|FG004|Period 4 - Washout|Disallowed medication|0|||
155626034|NCT01225549|561726068|FG005|Period 4 - Washout|Disallowed medication|0|||
155626035|NCT01225549|561726069|FG006|Period 4 - Washout|Disallowed medication|0|||
155626036|NCT01225549|561726070|FG007|Period 4 - Washout|Disallowed medication|0|||
155626037|NCT01225549|561726071|FG008|Period 4 - Washout|Disallowed medication|0|||
155626038|NCT01225549|561726072|FG009|Period 4 - Washout|Disallowed medication|0|||
155626039|NCT01225549|561726063|FG000|Period 6 - Washout|Disallowed medication|0|||
155626040|NCT01225549|561726064|FG001|Period 6 - Washout|Disallowed medication|0|||
155626041|NCT01225549|561726065|FG002|Period 6 - Washout|Disallowed medication|0|||
155626042|NCT01225549|561726066|FG003|Period 6 - Washout|Disallowed medication|1|||
155626043|NCT01225549|561726067|FG004|Period 6 - Washout|Disallowed medication|0|||
155626044|NCT01225549|561726068|FG005|Period 6 - Washout|Disallowed medication|0|||
155626045|NCT01225549|561726069|FG006|Period 6 - Washout|Disallowed medication|0|||
155626046|NCT01225549|561726070|FG007|Period 6 - Washout|Disallowed medication|0|||
155626047|NCT01225549|561726071|FG008|Period 6 - Washout|Disallowed medication|0|||
155626048|NCT01225549|561726072|FG009|Period 6 - Washout|Disallowed medication|0|||
155626049|NCT00473083|561726075|FG000|Overall Study|Adverse Event|1|||
155626050|NCT00473083|561726076|FG001|Overall Study|Adverse Event|0|||
155626051|NCT00473083|561726077|FG002|Overall Study|Adverse Event|0|||
155382794|NCT00126503|560835414|FG000|Overall Study|alternative therapy|1|||
155382795|NCT00126503|560835415|FG001|Overall Study|alternative therapy|1|||
155626052|NCT01184872|561726078|FG000|Overall Study|Adverse Event|3|||
155626053|NCT01184872|561726079|FG001|Overall Study|Adverse Event|4|||
155626054|NCT01184872|561726078|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155626055|NCT01184872|561726079|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155626056|NCT01184872|561726078|FG000|Overall Study|Withdrawal by Subject|2|||
155626057|NCT01184872|561726079|FG001|Overall Study|Withdrawal by Subject|0|||
155626058|NCT01184872|561726078|FG000|Overall Study|Lost to Follow-up|0|||
155382796|NCT00126503|560835414|FG000|Overall Study|other complicating disease|4|||
155728935|NCT01588522|562106490|FG001|Overall Study|Grade 2 alopecia|0|||
155382797|NCT00126503|560835415|FG001|Overall Study|other complicating disease|1|||
155382798|NCT00126503|560835414|FG000|Overall Study|Death|3|||
155382799|NCT00126503|560835415|FG001|Overall Study|Death|0|||
155382800|NCT00126503|560835414|FG000|Overall Study|Adverse Event|13|||
155382801|NCT00126503|560835415|FG001|Overall Study|Adverse Event|3|||
155382802|NCT00126503|560835414|FG000|Overall Study|non-compliant|1|||
155382803|NCT00126503|560835415|FG001|Overall Study|non-compliant|0|||
155382804|NCT00126503|560835414|FG000|Overall Study|Physician Decision|2|||
155382805|NCT00126503|560835415|FG001|Overall Study|Physician Decision|1|||
155382806|NCT02523599|560835416|FG000|Overall Study|Adverse Event|1|||
155382807|NCT02523599|560835417|FG001|Overall Study|Adverse Event|0|||
155382808|NCT02523599|560835416|FG000|Overall Study|Physician Decision|1|||
155626059|NCT01184872|561726079|FG001|Overall Study|Lost to Follow-up|1|||
155626060|NCT01184872|561726078|FG000|Overall Study|Administrative problems|1|||
155626061|NCT01184872|561726079|FG001|Overall Study|Administrative problems|1|||
155626062|NCT01184872|561726078|FG000|Overall Study|Protocol deviation|1|||
155626063|NCT01184872|561726079|FG001|Overall Study|Protocol deviation|0|||
155626064|NCT05222880|561726083|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155626065|NCT05222880|561726083|FG000|Overall Study|Withdrew Consent during Study|1|||
155626066|NCT05222880|561726083|FG000|Overall Study|COVID-19 Related|1|||
155626067|NCT01077323|561726086|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
155626068|NCT01077323|561726087|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
155626069|NCT01077323|561726088|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
155626070|NCT01077323|561726086|FG000|Overall Study|Dispensing of drug in baseline period|0|||
155626071|NCT01077323|561726087|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
155626072|NCT01077323|561726088|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
155626073|NCT01077323|561726086|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
155626074|NCT01077323|561726087|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
155626075|NCT01077323|561726088|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
155626076|NCT02153918|561726089|FG000|Overall Study|Refused further treatment|1|||
155626077|NCT02144701|561726090|FG000|Overall Study|development of relapse, GVHD or death|9|||
155626078|NCT02144701|561726091|FG001|Overall Study|development of relapse, GVHD or death|3|||
155626079|NCT03327324|561726092|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626080|NCT03327324|561726093|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155626081|NCT03327324|561726094|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626082|NCT03327324|561726095|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155626083|NCT03327324|561726096|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626084|NCT03327324|561726097|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
155626085|NCT03327324|561726092|FG000|Baseline (Month 0-Month 3)|Refused|0|||
155626086|NCT03327324|561726093|FG001|Baseline (Month 0-Month 3)|Refused|0|||
155626087|NCT03327324|561726094|FG002|Baseline (Month 0-Month 3)|Refused|0|||
155626088|NCT03327324|561726095|FG003|Baseline (Month 0-Month 3)|Refused|0|||
155626089|NCT03327324|561726096|FG004|Baseline (Month 0-Month 3)|Refused|1|||
155626090|NCT03327324|561726097|FG005|Baseline (Month 0-Month 3)|Refused|0|||
155626091|NCT03327324|561726092|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155626092|NCT03327324|561726093|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
155626093|NCT03327324|561726094|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155626094|NCT03327324|561726095|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155626095|NCT03327324|561726096|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155626096|NCT03327324|561726097|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155626097|NCT03327324|561726092|FG000|Baseline (Month 0-Month 3)|Death|0|||
155626098|NCT03327324|561726093|FG001|Baseline (Month 0-Month 3)|Death|0|||
155626099|NCT03327324|561726094|FG002|Baseline (Month 0-Month 3)|Death|0|||
155626100|NCT03327324|561726095|FG003|Baseline (Month 0-Month 3)|Death|0|||
155626101|NCT03327324|561726096|FG004|Baseline (Month 0-Month 3)|Death|1|||
155626102|NCT03327324|561726097|FG005|Baseline (Month 0-Month 3)|Death|0|||
155626103|NCT03327324|561726092|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626104|NCT03327324|561726093|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626105|NCT03327324|561726094|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626106|NCT03327324|561726095|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155382809|NCT02523599|560835417|FG001|Overall Study|Physician Decision|0|||
155382810|NCT02523599|560835416|FG000|Overall Study|Lost to Follow-up|4|||
155626107|NCT03327324|561726096|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626108|NCT03327324|561726097|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
155382811|NCT02523599|560835417|FG001|Overall Study|Lost to Follow-up|1|||
155382812|NCT02523599|560835416|FG000|Overall Study|Did not return for Day 30 visit|2|||
155382813|NCT02523599|560835417|FG001|Overall Study|Did not return for Day 30 visit|0|||
155382814|NCT03519971|560835418|FG000|Overall Study|Death|142|||
155382815|NCT03519971|560835419|FG001|Overall Study|Death|69|||
155382816|NCT03519971|560835418|FG000|Overall Study|Lost to Follow-up|0|||
155382817|NCT03519971|560835419|FG001|Overall Study|Lost to Follow-up|1|||
155382818|NCT03519971|560835418|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
155382819|NCT03519971|560835419|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
155382820|NCT03519971|560835418|FG000|Overall Study|Withdrawal by Subject|3|||
155382821|NCT03519971|560835419|FG001|Overall Study|Withdrawal by Subject|2|||
155382822|NCT03519971|560835418|FG000|Overall Study|Other|1|||
155382823|NCT03519971|560835419|FG001|Overall Study|Other|0|||
155382824|NCT03141905|560835420|FG000|Overall Study|Death|3|||
155382825|NCT03141905|560835421|FG001|Overall Study|Death|2|||
155382826|NCT03141905|560835420|FG000|Overall Study|Withdrawal by Subject|1|||
155382827|NCT03141905|560835421|FG001|Overall Study|Withdrawal by Subject|0|||
155382828|NCT03141905|560835420|FG000|Overall Study|Lost to Follow-up|3|||
155382829|NCT03141905|560835421|FG001|Overall Study|Lost to Follow-up|7|||
155382830|NCT03141905|560835420|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
155382831|NCT03141905|560835421|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
155382832|NCT05180500|560835422|FG000|Overall Study|Adverse Event|1|||
155382833|NCT05180500|560835423|FG001|Overall Study|Adverse Event|0|||
155382834|NCT05180500|560835422|FG000|Overall Study|Withdrawal by Subject|2|||
155382835|NCT05180500|560835423|FG001|Overall Study|Withdrawal by Subject|0|||
155382836|NCT04134845|560835428|FG000|Overall Study|withdrawl by PI|12|||
155382837|NCT04134845|560835429|FG001|Overall Study|withdrawl by PI|5|||
155382838|NCT04927884|560835430|FG000|Overall Study|Progressive Disease|2|||
155382839|NCT01775124|560835431|FG000|Core Period|Disease Progression|0|||
155382840|NCT01775124|560835432|FG001|Core Period|Disease Progression|1|||
155382841|NCT01775124|560835431|FG000|Core Period|Physician Decision|1|||
155382842|NCT01775124|560835432|FG001|Core Period|Physician Decision|1|||
155382843|NCT01775124|560835431|FG000|Core Period|Death|0|||
155382844|NCT01775124|560835432|FG001|Core Period|Death|1|||
155382845|NCT01775124|560835431|FG000|Core Period|Administrative problems|1|||
155382846|NCT01775124|560835432|FG001|Core Period|Administrative problems|0|||
155382847|NCT01775124|560835431|FG000|Core Period|Withdrawal by Subject|4|||
155382848|NCT01775124|560835432|FG001|Core Period|Withdrawal by Subject|2|||
155382849|NCT01775124|560835431|FG000|Core Period|Adverse Event|5|||
155382850|NCT01775124|560835432|FG001|Core Period|Adverse Event|5|||
155382851|NCT01775124|560835431|FG000|Extension Period|Adverse Event|3|||
155382852|NCT01775124|560835432|FG001|Extension Period|Adverse Event|2|||
155382853|NCT01775124|560835431|FG000|Extension Period|Physician Decision|0|||
155382854|NCT01775124|560835432|FG001|Extension Period|Physician Decision|2|||
155382855|NCT01775124|560835431|FG000|Extension Period|Administrative problems|0|||
155382856|NCT01775124|560835432|FG001|Extension Period|Administrative problems|1|||
155382857|NCT01775124|560835431|FG000|Extension Period|Lost to Follow-up|0|||
155382858|NCT01775124|560835432|FG001|Extension Period|Lost to Follow-up|1|||
155382859|NCT01775124|560835431|FG000|Extension Period|Withdrawal by Subject|9|||
155382860|NCT01775124|560835432|FG001|Extension Period|Withdrawal by Subject|12|||
155382861|NCT00727311|560835433|FG000|Overall Study|Did not receive drug|316|||
155382862|NCT00727311|560835433|FG000|Overall Study|Missing end of therapy data|205|||
155626109|NCT03327324|561726092|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626110|NCT03327324|561726093|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626111|NCT03327324|561726094|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155626112|NCT03327324|561726095|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626113|NCT03327324|561726096|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626114|NCT03327324|561726097|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626115|NCT03327324|561726092|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
155626116|NCT03327324|561726093|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155626117|NCT03327324|561726094|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155626118|NCT03327324|561726095|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
155626119|NCT03327324|561726096|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155626120|NCT03327324|561726097|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
155382863|NCT00727311|560835433|FG000|Overall Study|Adverse Event|58|||
155382864|NCT00727311|560835433|FG000|Overall Study|Lack of Efficacy|242|||
155382865|NCT00727311|560835433|FG000|Overall Study|Lost to Follow-up|73|||
155382866|NCT00727311|560835433|FG000|Overall Study|Withdrawal by Subject|77|||
155382867|NCT00727311|560835433|FG000|Overall Study|Other|97|||
155382868|NCT00727311|560835433|FG000|Overall Study|Multiple reasons|39|||
155382869|NCT03992846|560835434|FG000|Overall Study|Adverse Event|8|||
155382870|NCT03992846|560835435|FG001|Overall Study|Adverse Event|6|||
155382871|NCT03992846|560835436|FG002|Overall Study|Adverse Event|3|||
155382872|NCT03992846|560835434|FG000|Overall Study|Lost to Follow-up|0|||
155382873|NCT03992846|560835435|FG001|Overall Study|Lost to Follow-up|1|||
155382874|NCT03992846|560835436|FG002|Overall Study|Lost to Follow-up|1|||
155382875|NCT03992846|560835434|FG000|Overall Study|Pregnancy|2|||
155382876|NCT03992846|560835435|FG001|Overall Study|Pregnancy|0|||
155382877|NCT03992846|560835436|FG002|Overall Study|Pregnancy|1|||
155382878|NCT03992846|560835434|FG000|Overall Study|Protocol Violation|1|||
155382879|NCT03992846|560835435|FG001|Overall Study|Protocol Violation|2|||
155382880|NCT03992846|560835436|FG002|Overall Study|Protocol Violation|0|||
155382881|NCT03992846|560835434|FG000|Overall Study|Withdrawal by Subject|8|||
155382882|NCT03992846|560835435|FG001|Overall Study|Withdrawal by Subject|10|||
155382883|NCT03992846|560835436|FG002|Overall Study|Withdrawal by Subject|20|||
155382884|NCT03992846|560835434|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
155382885|NCT03992846|560835435|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
155382886|NCT03992846|560835436|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
155382887|NCT01177722|560837407|FG000|Overall Study|Serious Adverse Event|0|||
155382888|NCT01177722|560837408|FG001|Overall Study|Serious Adverse Event|0|||
155382889|NCT01177722|560837409|FG002|Overall Study|Serious Adverse Event|1|||
155382890|NCT01177722|560837410|FG003|Overall Study|Serious Adverse Event|0|||
155382891|NCT01177722|560837407|FG000|Overall Study|Protocol Violation|0|||
155382892|NCT01177722|560837408|FG001|Overall Study|Protocol Violation|0|||
155382893|NCT01177722|560837409|FG002|Overall Study|Protocol Violation|1|||
155382894|NCT01177722|560837410|FG003|Overall Study|Protocol Violation|0|||
155382895|NCT01177722|560837407|FG000|Overall Study|Lost to Follow-up|3|||
155382896|NCT01177722|560837408|FG001|Overall Study|Lost to Follow-up|4|||
155382897|NCT01177722|560837409|FG002|Overall Study|Lost to Follow-up|3|||
155382898|NCT01177722|560837410|FG003|Overall Study|Lost to Follow-up|1|||
155382899|NCT01177722|560837407|FG000|Overall Study|Withdrawal by Subject|10|||
155382900|NCT01177722|560837408|FG001|Overall Study|Withdrawal by Subject|6|||
155382901|NCT01177722|560837409|FG002|Overall Study|Withdrawal by Subject|4|||
155382902|NCT01177722|560837410|FG003|Overall Study|Withdrawal by Subject|6|||
155382903|NCT00484289|560837416|FG000|Long Term Phase|Adverse Event|1|||
155382904|NCT00484289|560837417|FG001|Long Term Phase|Adverse Event|17|||
155382905|NCT00484289|560837418|FG002|Long Term Phase|Adverse Event|5|||
155382906|NCT00484289|560837416|FG000|Long Term Phase|Withdrawal by Subject|0|||
155382907|NCT00484289|560837417|FG001|Long Term Phase|Withdrawal by Subject|7|||
155382908|NCT00484289|560837418|FG002|Long Term Phase|Withdrawal by Subject|6|||
155382909|NCT00484289|560837416|FG000|Long Term Phase|Inadequate response|2|||
155382910|NCT00484289|560837417|FG001|Long Term Phase|Inadequate response|7|||
155382911|NCT00484289|560837418|FG002|Long Term Phase|Inadequate response|4|||
155382912|NCT00484289|560837416|FG000|Long Term Phase|Other Reason|0|||
155382913|NCT00484289|560837417|FG001|Long Term Phase|Other Reason|5|||
155382914|NCT00484289|560837418|FG002|Long Term Phase|Other Reason|1|||
155382915|NCT00484289|560837416|FG000|Post Marketing Phase|Adverse Event|0|||
155382916|NCT00484289|560837417|FG001|Post Marketing Phase|Adverse Event|1|||
155382917|NCT00484289|560837418|FG002|Post Marketing Phase|Adverse Event|0|||
155382918|NCT01828073|560837419|FG000|Overall Study|Lost to Follow-up|1|||
155382919|NCT01828073|560837420|FG001|Overall Study|Lost to Follow-up|2|||
155382920|NCT03057977|560837428|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
155382921|NCT03057977|560837429|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
155382922|NCT03057977|560837428|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
155382923|NCT03057977|560837429|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
155382924|NCT03057977|560837428|FG000|Discontinuation From Treatment|Protocol Violation|6|||
155382925|NCT03057977|560837429|FG001|Discontinuation From Treatment|Protocol Violation|5|||
155382926|NCT03057977|560837428|FG000|Discontinuation From Treatment|Not treated|4|||
155382927|NCT03057977|560837429|FG001|Discontinuation From Treatment|Not treated|0|||
155382928|NCT03057977|560837428|FG000|Discontinuation From Treatment|Adverse Event|343|||
155382929|NCT03057977|560837429|FG001|Discontinuation From Treatment|Adverse Event|337|||
155382930|NCT03057977|560837428|FG000|Discontinuation From Treatment|Reason Unknown|0|||
155382931|NCT03057977|560837429|FG001|Discontinuation From Treatment|Reason Unknown|1|||
155382932|NCT03057977|560837428|FG000|Discontinuation From Treatment|Personal Reasons|1|||
155382933|NCT03057977|560837429|FG001|Discontinuation From Treatment|Personal Reasons|1|||
155382934|NCT03057977|560837428|FG000|Discontinuation From Treatment|Unblinded medication|1|||
155382935|NCT03057977|560837429|FG001|Discontinuation From Treatment|Unblinded medication|0|||
155382936|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
155382937|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
155382938|NCT03057977|560837428|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
155382939|NCT03057977|560837429|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
155382940|NCT03057977|560837428|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
155382941|NCT03057977|560837429|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
155382942|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
155382943|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
155382944|NCT03057977|560837428|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
155382945|NCT03057977|560837429|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
155382946|NCT03057977|560837428|FG000|Discontinuation From Treatment|Not attending study visit|3|||
155382947|NCT03057977|560837429|FG001|Discontinuation From Treatment|Not attending study visit|10|||
155382948|NCT03057977|560837428|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
155382949|NCT03057977|560837429|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
155382950|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
155382951|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
155382952|NCT03057977|560837428|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
155382953|NCT03057977|560837429|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
155382954|NCT03057977|560837428|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
155382955|NCT03057977|560837429|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
155382956|NCT03057977|560837428|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
155382957|NCT03057977|560837429|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
155382958|NCT01201317|560837430|FG000|Overall Study|Withdrawal by Subject|5|||
155382959|NCT01201317|560837431|FG001|Overall Study|Withdrawal by Subject|0|||
155382960|NCT01201317|560837432|FG002|Overall Study|Withdrawal by Subject|3|||
155382961|NCT01201317|560837430|FG000|Overall Study|Adverse Event|2|||
155382962|NCT01201317|560837431|FG001|Overall Study|Adverse Event|2|||
155382963|NCT01201317|560837432|FG002|Overall Study|Adverse Event|2|||
155382964|NCT01201317|560837430|FG000|Overall Study|Screen failure|1|||
155382965|NCT01201317|560837431|FG001|Overall Study|Screen failure|1|||
155382966|NCT01201317|560837432|FG002|Overall Study|Screen failure|0|||
155382967|NCT01201317|560837430|FG000|Overall Study|Protocol Violation|0|||
155382968|NCT01201317|560837431|FG001|Overall Study|Protocol Violation|1|||
155382969|NCT01201317|560837432|FG002|Overall Study|Protocol Violation|1|||
155382970|NCT01201317|560837430|FG000|Overall Study|Death|0|||
155382971|NCT01201317|560837431|FG001|Overall Study|Death|1|||
155382972|NCT01201317|560837432|FG002|Overall Study|Death|0|||
155382973|NCT01201317|560837430|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155382974|NCT01201317|560837431|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155382975|NCT01201317|560837432|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155382976|NCT01201317|560837430|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
155382977|NCT01201317|560837431|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
155382978|NCT01201317|560837432|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
155382979|NCT01201317|560837430|FG000|Overall Study|Decrease in renal function|0|||
155382980|NCT01201317|560837431|FG001|Overall Study|Decrease in renal function|1|||
155382981|NCT01201317|560837432|FG002|Overall Study|Decrease in renal function|0|||
155382982|NCT01201317|560837430|FG000|Overall Study|Lack of Efficacy|1|||
155382983|NCT01201317|560837431|FG001|Overall Study|Lack of Efficacy|0|||
155382984|NCT01201317|560837432|FG002|Overall Study|Lack of Efficacy|0|||
155382985|NCT01201317|560837430|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
155382986|NCT01201317|560837431|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
155382987|NCT01201317|560837432|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
155382988|NCT01350336|560837433|FG000|Overall Study|Lost to Follow-up|31|||
155382989|NCT01350336|560837433|FG000|Overall Study|Withdrawal by Subject|14|||
155382990|NCT01350336|560837433|FG000|Overall Study|Physician Decision|8|||
155382991|NCT01350336|560837433|FG000|Overall Study|Death|4|||
155382992|NCT02795429|560837435|FG000|Overall Study|Adverse Event|1|||
155382993|NCT02795429|560837436|FG001|Overall Study|Adverse Event|2|||
155382994|NCT02795429|560837437|FG002|Overall Study|Adverse Event|1|||
155382995|NCT02795429|560837438|FG003|Overall Study|Adverse Event|2|||
155382996|NCT02795429|560837439|FG004|Overall Study|Adverse Event|1|||
155382997|NCT02795429|560837435|FG000|Overall Study|Death|1|||
155382998|NCT02795429|560837436|FG001|Overall Study|Death|0|||
155382999|NCT02795429|560837437|FG002|Overall Study|Death|1|||
155383000|NCT02795429|560837438|FG003|Overall Study|Death|2|||
155383001|NCT02795429|560837439|FG004|Overall Study|Death|1|||
155383002|NCT02795429|560837435|FG000|Overall Study|Physician Decision|0|||
155626121|NCT03327324|561726092|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
155626122|NCT03327324|561726093|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155626123|NCT03327324|561726094|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155626124|NCT03327324|561726095|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155626125|NCT03327324|561726096|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155626126|NCT03327324|561726097|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155626127|NCT03327324|561726092|FG000|Intervention (Month 3-Month 6)|Death|1|||
155626128|NCT03327324|561726093|FG001|Intervention (Month 3-Month 6)|Death|0|||
155626129|NCT03327324|561726094|FG002|Intervention (Month 3-Month 6)|Death|1|||
155626130|NCT03327324|561726095|FG003|Intervention (Month 3-Month 6)|Death|1|||
155626131|NCT03327324|561726096|FG004|Intervention (Month 3-Month 6)|Death|1|||
155626132|NCT03327324|561726097|FG005|Intervention (Month 3-Month 6)|Death|0|||
155626133|NCT03327324|561726092|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155383003|NCT02795429|560837436|FG001|Overall Study|Physician Decision|0|||
155650596|NCT00452530|561812516|FG001|Overall Study|Withdrawal by Subject|57|||
155728936|NCT01588522|562106491|FG002|Overall Study|Grade 2 alopecia|0|||
155278724|NCT01656759|560453277|FG001|Overall Study|Protocol Violation|3|||
155728937|NCT01588522|562106492|FG003|Overall Study|Grade 2 alopecia|0|||
155728938|NCT01588522|562106493|FG004|Overall Study|Grade 2 alopecia|0|||
155728939|NCT01588522|562106494|FG005|Overall Study|Grade 2 alopecia|0|||
155728940|NCT01588522|562106489|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
155728941|NCT01588522|562106490|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
155728942|NCT01588522|562106491|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
155728943|NCT01588522|562106492|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
155728944|NCT01588522|562106493|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
155728945|NCT01588522|562106494|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
155728946|NCT01588522|562106489|FG000|Overall Study|Taken off taxane-based regimen|0|||
155728947|NCT01588522|562106490|FG001|Overall Study|Taken off taxane-based regimen|0|||
155728948|NCT01588522|562106491|FG002|Overall Study|Taken off taxane-based regimen|0|||
155728949|NCT01588522|562106492|FG003|Overall Study|Taken off taxane-based regimen|1|||
155728950|NCT01588522|562106493|FG004|Overall Study|Taken off taxane-based regimen|0|||
155728951|NCT01588522|562106494|FG005|Overall Study|Taken off taxane-based regimen|0|||
155728952|NCT01588522|562106489|FG000|Overall Study|Did not initiate chemotherapy|0|||
155728953|NCT01588522|562106490|FG001|Overall Study|Did not initiate chemotherapy|0|||
155728954|NCT01588522|562106491|FG002|Overall Study|Did not initiate chemotherapy|0|||
155728955|NCT01588522|562106492|FG003|Overall Study|Did not initiate chemotherapy|0|||
155728956|NCT01588522|562106493|FG004|Overall Study|Did not initiate chemotherapy|1|||
155728957|NCT01588522|562106494|FG005|Overall Study|Did not initiate chemotherapy|0|||
155728958|NCT02855125|562106497|FG000|Overall Study|Withdrawal by Subject|2|||
155728959|NCT02855125|562106498|FG001|Overall Study|Withdrawal by Subject|2|||
155728960|NCT02855125|562106497|FG000|Overall Study|Clinical Disease Progression|5|||
155728961|NCT02855125|562106498|FG001|Overall Study|Clinical Disease Progression|4|||
155728962|NCT02855125|562106497|FG000|Overall Study|Radiologic Disease Progression|36|||
155728963|NCT02855125|562106498|FG001|Overall Study|Radiologic Disease Progression|39|||
155728964|NCT02855125|562106497|FG000|Overall Study|Adverse Event|11|||
155728965|NCT02855125|562106498|FG001|Overall Study|Adverse Event|7|||
155278725|NCT07083843|560453278|FG000|Intervention period.|Withdrawal by Subject|1|||
155278726|NCT07083843|560453279|FG001|Intervention period.|Withdrawal by Subject|0|||
155278727|NCT07083843|560453278|FG000|Intervention period.|Death|0|||
155278728|NCT07083843|560453279|FG001|Intervention period.|Death|1|||
155278729|NCT04988477|560453282|FG000|Overall Study|Death|1|||
155278730|NCT04988477|560453283|FG001|Overall Study|Death|0|||
155278731|NCT04988477|560453284|FG002|Overall Study|Death|0|||
155278732|NCT04988477|560453282|FG000|Overall Study|Lost to Follow-up|5|||
155278733|NCT04988477|560453283|FG001|Overall Study|Lost to Follow-up|2|||
155278734|NCT04988477|560453284|FG002|Overall Study|Lost to Follow-up|0|||
155278735|NCT04988477|560453282|FG000|Overall Study|Withdrawal by Subject|2|||
155278736|NCT04988477|560453283|FG001|Overall Study|Withdrawal by Subject|0|||
155278737|NCT04988477|560453284|FG002|Overall Study|Withdrawal by Subject|0|||
155278738|NCT05567952|560454675|FG000|Overall Study|Lost to Follow-up|3|||
155278739|NCT05567952|560454676|FG001|Overall Study|Lost to Follow-up|2|||
155278740|NCT05567952|560454675|FG000|Overall Study|Withdrawal by Subject|6|||
155278741|NCT05567952|560454676|FG001|Overall Study|Withdrawal by Subject|3|||
155278742|NCT05567952|560454675|FG000|Overall Study|Other|3|||
155278743|NCT05567952|560454676|FG001|Overall Study|Other|1|||
155278744|NCT03280563|560454678|FG000|Stage 1|Death|2|||
155278745|NCT03280563|560454679|FG001|Stage 1|Death|1|||
155278746|NCT03280563|560454680|FG002|Stage 1|Death|0|||
155278747|NCT03280563|560454681|FG003|Stage 1|Death|0|||
155278748|NCT03280563|560454682|FG004|Stage 1|Death|0|||
155278749|NCT03280563|560454683|FG005|Stage 1|Death|3|||
155278750|NCT03280563|560454684|FG006|Stage 1|Death|0|||
155278751|NCT03280563|560454685|FG007|Stage 1|Death|0|||
155278752|NCT03280563|560454686|FG008|Stage 1|Death|0|||
155278753|NCT03280563|560454678|FG000|Stage 1|Study Ended by Sponsor|0|||
155278754|NCT03280563|560454679|FG001|Stage 1|Study Ended by Sponsor|0|||
155278755|NCT03280563|560454680|FG002|Stage 1|Study Ended by Sponsor|1|||
155278756|NCT03280563|560454681|FG003|Stage 1|Study Ended by Sponsor|0|||
155278757|NCT03280563|560454682|FG004|Stage 1|Study Ended by Sponsor|0|||
155278758|NCT03280563|560454683|FG005|Stage 1|Study Ended by Sponsor|1|||
155278759|NCT03280563|560454684|FG006|Stage 1|Study Ended by Sponsor|0|||
155278760|NCT03280563|560454685|FG007|Stage 1|Study Ended by Sponsor|0|||
155728966|NCT02855125|562106497|FG000|Overall Study|Physician Decision|1|||
155728967|NCT02855125|562106498|FG001|Overall Study|Physician Decision|0|||
155728968|NCT02855125|562106497|FG000|Overall Study|On Treatment|9|||
155728969|NCT02855125|562106498|FG001|Overall Study|On Treatment|11|||
155728970|NCT02855125|562106497|FG000|Overall Study|Randomized but not treated|0|||
155728971|NCT02855125|562106498|FG001|Overall Study|Randomized but not treated|1|||
155728972|NCT04467905|562106499|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
155728973|NCT04467905|562106500|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
155278761|NCT03280563|560454686|FG008|Stage 1|Study Ended by Sponsor|0|||
155278762|NCT03280563|560454678|FG000|Stage 1|Withdrawal by Subject|5|||
155278763|NCT03280563|560454679|FG001|Stage 1|Withdrawal by Subject|1|||
155383004|NCT02795429|560837437|FG002|Overall Study|Physician Decision|2|||
155383005|NCT02795429|560837438|FG003|Overall Study|Physician Decision|1|||
155383006|NCT02795429|560837439|FG004|Overall Study|Physician Decision|5|||
155383007|NCT02795429|560837435|FG000|Overall Study|Progressive disease|3|||
155383008|NCT02795429|560837436|FG001|Overall Study|Progressive disease|7|||
155383009|NCT02795429|560837437|FG002|Overall Study|Progressive disease|6|||
155383010|NCT02795429|560837438|FG003|Overall Study|Progressive disease|26|||
155383011|NCT02795429|560837439|FG004|Overall Study|Progressive disease|20|||
155383012|NCT02795429|560837435|FG000|Overall Study|Subject/guardian decision|1|||
155383013|NCT02795429|560837436|FG001|Overall Study|Subject/guardian decision|1|||
155383014|NCT02795429|560837437|FG002|Overall Study|Subject/guardian decision|1|||
155383015|NCT02795429|560837438|FG003|Overall Study|Subject/guardian decision|1|||
155383016|NCT02795429|560837439|FG004|Overall Study|Subject/guardian decision|3|||
155383017|NCT02079610|560837440|FG000|Overall Study|Withdrawal by Subject|1|||
155383018|NCT02079610|560837441|FG001|Overall Study|Withdrawal by Subject|1|||
155383019|NCT05220254|560837442|FG000|Overall Study|Withdrawal by Subject|4|||
155383020|NCT05220254|560837442|FG000|Overall Study|Removed due to ineligibility|1|||
155383021|NCT05220254|560837442|FG000|Overall Study|Lost to Follow-up|7|||
155383022|NCT00250679|560837446|FG000|Overall Study|Adverse Event|12|||
155383023|NCT00250679|560837447|FG001|Overall Study|Adverse Event|15|||
155383024|NCT00250679|560837448|FG002|Overall Study|Adverse Event|16|||
155383025|NCT00250679|560837446|FG000|Overall Study|Protocol Violation|2|||
155383026|NCT00250679|560837447|FG001|Overall Study|Protocol Violation|4|||
155383027|NCT00250679|560837448|FG002|Overall Study|Protocol Violation|3|||
155383028|NCT00250679|560837446|FG000|Overall Study|Withdrawal by Subject|15|||
155383029|NCT00250679|560837447|FG001|Overall Study|Withdrawal by Subject|18|||
155383030|NCT00250679|560837448|FG002|Overall Study|Withdrawal by Subject|15|||
155383031|NCT00250679|560837446|FG000|Overall Study|Lost to Follow-up|3|||
155383032|NCT00250679|560837447|FG001|Overall Study|Lost to Follow-up|4|||
155383033|NCT00250679|560837448|FG002|Overall Study|Lost to Follow-up|2|||
155383034|NCT00250679|560837446|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
155383035|NCT00250679|560837447|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
155383036|NCT00250679|560837448|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
155383037|NCT00250679|560837446|FG000|Overall Study|Lack of Efficacy|0|||
155626134|NCT03327324|561726093|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626135|NCT03327324|561726094|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626136|NCT03327324|561726095|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626137|NCT03327324|561726096|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626138|NCT03327324|561726097|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
155626139|NCT03327324|561726092|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155626140|NCT03327324|561726093|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626141|NCT03327324|561726094|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626142|NCT03327324|561726095|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626143|NCT03327324|561726096|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626144|NCT03327324|561726097|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155626145|NCT03327324|561726092|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
155626146|NCT03327324|561726093|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
155626147|NCT03327324|561726094|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155626148|NCT03327324|561726095|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155626149|NCT03327324|561726096|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155626150|NCT03327324|561726097|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155626151|NCT03327324|561726092|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155626152|NCT03327324|561726093|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155626153|NCT03327324|561726094|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155626154|NCT03327324|561726095|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155626155|NCT03327324|561726096|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155626156|NCT03327324|561726097|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155728974|NCT04467905|562106501|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
155383038|NCT00250679|560837447|FG001|Overall Study|Lack of Efficacy|1|||
155383039|NCT00250679|560837448|FG002|Overall Study|Lack of Efficacy|3|||
155383040|NCT00250679|560837446|FG000|Overall Study|Technical Holter issues|1|||
155383041|NCT00250679|560837447|FG001|Overall Study|Technical Holter issues|0|||
155383042|NCT00250679|560837448|FG002|Overall Study|Technical Holter issues|2|||
155383043|NCT00250679|560837446|FG000|Overall Study|Moved|1|||
155383044|NCT00250679|560837447|FG001|Overall Study|Moved|1|||
155383045|NCT00250679|560837448|FG002|Overall Study|Moved|0|||
155626157|NCT03327324|561726092|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626158|NCT03327324|561726093|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626159|NCT03327324|561726094|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626160|NCT03327324|561726095|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
155626161|NCT03327324|561726096|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
155626162|NCT03327324|561726097|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155626163|NCT03327324|561726092|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
155626164|NCT03327324|561726093|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155626165|NCT03327324|561726094|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155626166|NCT03327324|561726095|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155626167|NCT03327324|561726096|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155626168|NCT03327324|561726097|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155626169|NCT03327324|561726092|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
155626170|NCT03327324|561726093|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155626171|NCT03327324|561726094|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155626172|NCT03327324|561726095|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155626173|NCT03327324|561726096|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155626174|NCT03327324|561726097|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155626175|NCT03886272|561726099|FG000|Period 1|Withdrawal by Subject|0|||
155626176|NCT03886272|561726100|FG001|Period 1|Withdrawal by Subject|0|||
155626177|NCT03886272|561726101|FG002|Period 1|Withdrawal by Subject|0|||
155626178|NCT03886272|561726102|FG003|Period 1|Withdrawal by Subject|0|||
155626179|NCT03886272|561726103|FG004|Period 1|Withdrawal by Subject|0|||
155626180|NCT03886272|561726104|FG005|Period 1|Withdrawal by Subject|1|||
155626181|NCT03886272|561726105|FG006|Period 1|Withdrawal by Subject|0|||
155626182|NCT03014206|561726106|FG000|Overall Study|Registration Violation|12|||
155626183|NCT03177148|561726107|FG000|Overall Study|Lost to Follow-up|50|||
155626184|NCT03177148|561726108|FG001|Overall Study|Lost to Follow-up|1|||
155626185|NCT03177148|561726107|FG000|Overall Study|Death|1|||
155626186|NCT03177148|561726108|FG001|Overall Study|Death|0|||
155626187|NCT02848664|561726112|FG000|Overall Study|Withdrawal by Subject|2|||
155626188|NCT02848664|561726112|FG000|Overall Study|Adverse Event|1|||
155626189|NCT02848664|561726112|FG000|Overall Study|no assistance for device training|1|||
155626190|NCT02849080|561726113|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
155626191|NCT02849080|561726114|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
155626192|NCT02849080|561726115|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
155626193|NCT02849080|561726116|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
155626194|NCT02849080|561726113|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
155626195|NCT02849080|561726114|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
155626196|NCT02849080|561726115|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
155278764|NCT03280563|560454680|FG002|Stage 1|Withdrawal by Subject|2|||
155278765|NCT03280563|560454681|FG003|Stage 1|Withdrawal by Subject|0|||
155278766|NCT03280563|560454682|FG004|Stage 1|Withdrawal by Subject|0|||
155278767|NCT03280563|560454683|FG005|Stage 1|Withdrawal by Subject|2|||
155278768|NCT03280563|560454684|FG006|Stage 1|Withdrawal by Subject|0|||
155278769|NCT03280563|560454685|FG007|Stage 1|Withdrawal by Subject|0|||
155278770|NCT03280563|560454686|FG008|Stage 1|Withdrawal by Subject|0|||
155278771|NCT03280563|560454678|FG000|Stage 1|Reason Not Specified|0|||
155278772|NCT03280563|560454679|FG001|Stage 1|Reason Not Specified|0|||
155278773|NCT03280563|560454680|FG002|Stage 1|Reason Not Specified|0|||
155278774|NCT03280563|560454681|FG003|Stage 1|Reason Not Specified|0|||
155278775|NCT03280563|560454682|FG004|Stage 1|Reason Not Specified|0|||
155278776|NCT03280563|560454683|FG005|Stage 1|Reason Not Specified|1|||
155278777|NCT03280563|560454684|FG006|Stage 1|Reason Not Specified|0|||
155278778|NCT03280563|560454685|FG007|Stage 1|Reason Not Specified|0|||
155278779|NCT03280563|560454686|FG008|Stage 1|Reason Not Specified|0|||
155278780|NCT03280563|560454678|FG000|Stage 1|Physician Decision|0|||
155278781|NCT03280563|560454679|FG001|Stage 1|Physician Decision|1|||
155278782|NCT03280563|560454680|FG002|Stage 1|Physician Decision|0|||
155278783|NCT03280563|560454681|FG003|Stage 1|Physician Decision|0|||
155278784|NCT03280563|560454682|FG004|Stage 1|Physician Decision|0|||
155278785|NCT03280563|560454683|FG005|Stage 1|Physician Decision|0|||
155278786|NCT03280563|560454684|FG006|Stage 1|Physician Decision|0|||
155278787|NCT03280563|560454685|FG007|Stage 1|Physician Decision|0|||
155278788|NCT03280563|560454686|FG008|Stage 1|Physician Decision|0|||
155278789|NCT03280563|560454678|FG000|Stage 2|Death|0|||
155278790|NCT03280563|560454679|FG001|Stage 2|Death|0|||
155278791|NCT03280563|560454680|FG002|Stage 2|Death|0|||
155278792|NCT03280563|560454681|FG003|Stage 2|Death|0|||
155278793|NCT03280563|560454682|FG004|Stage 2|Death|0|||
155278794|NCT03280563|560454683|FG005|Stage 2|Death|0|||
155278795|NCT03280563|560454684|FG006|Stage 2|Death|0|||
155278796|NCT03280563|560454685|FG007|Stage 2|Death|1|||
155728975|NCT04467905|562106499|FG000|Overall Study|Conversion to SR|0|||
155728976|NCT04467905|562106500|FG001|Overall Study|Conversion to SR|0|||
155728977|NCT04467905|562106501|FG002|Overall Study|Conversion to SR|3|||
155728978|NCT04467905|562106499|FG000|Overall Study|Technical issue with Holter ECG|0|||
155728979|NCT04467905|562106500|FG001|Overall Study|Technical issue with Holter ECG|0|||
155728980|NCT04467905|562106501|FG002|Overall Study|Technical issue with Holter ECG|3|||
155728981|NCT04467905|562106499|FG000|Overall Study|Hemodynamic instability|0|||
155728982|NCT04467905|562106500|FG001|Overall Study|Hemodynamic instability|0|||
155728983|NCT04467905|562106501|FG002|Overall Study|Hemodynamic instability|1|||
155728984|NCT04467905|562106499|FG000|Overall Study|Site misinterpretation of protocol|0|||
155728985|NCT04467905|562106500|FG001|Overall Study|Site misinterpretation of protocol|0|||
155728986|NCT04467905|562106501|FG002|Overall Study|Site misinterpretation of protocol|1|||
155728987|NCT01590888|562107998|FG000|Overall Study|Adverse Event|3|||
155728988|NCT01590888|562107999|FG001|Overall Study|Adverse Event|0|||
155728989|NCT01590888|562108000|FG002|Overall Study|Adverse Event|1|||
155728990|NCT01590888|562107998|FG000|Overall Study|Lost to Follow-up|1|||
155728991|NCT01590888|562107999|FG001|Overall Study|Lost to Follow-up|0|||
155728992|NCT01590888|562108000|FG002|Overall Study|Lost to Follow-up|0|||
155728993|NCT01705509|562108011|FG000|Inclusion CPET|Screen Failure|5|||
155728994|NCT01705509|562108011|FG000|Inclusion CPET|Withdrawal by Subject|2|||
155728995|NCT01705509|562108011|FG000|CPET w/ Ranexa|Screen Failure|2|||
155728996|NCT00904033|562108012|FG000|Overall Study|Withdrawal by Subject|1|||
155278797|NCT03280563|560454686|FG008|Stage 2|Death|0|||
155278798|NCT03280563|560454678|FG000|Stage 2|Progressive Disease|0|||
155278799|NCT03280563|560454679|FG001|Stage 2|Progressive Disease|0|||
155278800|NCT03280563|560454680|FG002|Stage 2|Progressive Disease|0|||
155278801|NCT03280563|560454681|FG003|Stage 2|Progressive Disease|0|||
155278802|NCT03280563|560454682|FG004|Stage 2|Progressive Disease|0|||
155383046|NCT00250679|560837446|FG000|Overall Study|Non-compliance|1|||
155728997|NCT00904033|562108013|FG001|Overall Study|Withdrawal by Subject|1|||
155728998|NCT00904033|562108014|FG002|Overall Study|Withdrawal by Subject|0|||
155728999|NCT00904033|562108015|FG003|Overall Study|Withdrawal by Subject|0|||
155729000|NCT00904033|562108012|FG000|Overall Study|Physician Decision|0|||
155729001|NCT00904033|562108013|FG001|Overall Study|Physician Decision|0|||
155729002|NCT00904033|562108014|FG002|Overall Study|Physician Decision|1|||
155729003|NCT00904033|562108015|FG003|Overall Study|Physician Decision|0|||
155729004|NCT00904033|562108012|FG000|Overall Study|Unable to obtain final blood draw|0|||
155729005|NCT00904033|562108013|FG001|Overall Study|Unable to obtain final blood draw|0|||
155729006|NCT00904033|562108014|FG002|Overall Study|Unable to obtain final blood draw|0|||
155729007|NCT00904033|562108015|FG003|Overall Study|Unable to obtain final blood draw|2|||
155729008|NCT02736890|562108016|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
155729009|NCT02736890|562108017|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
155729010|NCT02736890|562108016|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
155729011|NCT02736890|562108017|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
155729012|NCT03077412|562108019|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
155729013|NCT03077412|562108020|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
155729014|NCT03077412|562108021|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
155729015|NCT03077412|562108019|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
155729016|NCT03077412|562108020|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
155729017|NCT03077412|562108021|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
155729018|NCT03077412|562108019|FG000|Overall Study|Adverse Event|1|||
155729019|NCT03077412|562108020|FG001|Overall Study|Adverse Event|2|||
155729020|NCT03077412|562108021|FG002|Overall Study|Adverse Event|2|||
155729021|NCT03077412|562108019|FG000|Overall Study|Investigator's Discretion|0|||
155729022|NCT03077412|562108020|FG001|Overall Study|Investigator's Discretion|1|||
155729023|NCT03077412|562108021|FG002|Overall Study|Investigator's Discretion|1|||
155729024|NCT03077412|562108019|FG000|Overall Study|Withdrew Consent|0|||
155729025|NCT03077412|562108020|FG001|Overall Study|Withdrew Consent|2|||
155729026|NCT03077412|562108021|FG002|Overall Study|Withdrew Consent|0|||
155729027|NCT02904954|562108022|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
155729028|NCT02904954|562108023|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
155729029|NCT02904954|562108022|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
155729030|NCT02904954|562108023|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
155729031|NCT02904954|562108022|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
155278803|NCT03280563|560454683|FG005|Stage 2|Progressive Disease|0|||
155278804|NCT03280563|560454684|FG006|Stage 2|Progressive Disease|2|||
155729032|NCT02904954|562108023|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
155729033|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Recurrence|2|||
155729034|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Recurrence|0|||
155729035|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Adverse Event|2|||
155729036|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Adverse Event|6|||
155729037|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Participant wishes|12|||
155729038|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Participant wishes|7|||
155278805|NCT03280563|560454685|FG007|Stage 2|Progressive Disease|0|||
155729039|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Physician Decision|2|||
155729040|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Physician Decision|1|||
155729041|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
155729042|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
155383047|NCT00250679|560837447|FG001|Overall Study|Non-compliance|1|||
155383048|NCT00250679|560837448|FG002|Overall Study|Non-compliance|0|||
155729043|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Death|0|||
155729044|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Death|1|||
155729045|NCT02904954|562108022|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
155729046|NCT02904954|562108023|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
155729047|NCT00753506|562108024|FG000|Overall Study|Withdrawal by Subject|4|||
155729048|NCT00753506|562108025|FG001|Overall Study|Withdrawal by Subject|1|||
155278806|NCT03280563|560454686|FG008|Stage 2|Progressive Disease|0|||
155278807|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Death|10|||
155278808|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Death|14|||
155278809|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Death|15|||
155278810|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Death|3|||
155278811|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Death|6|||
155278812|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Death|18|||
155278813|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Death|11|||
155278814|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Death|1|||
155278815|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Death|3|||
155278816|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
155278817|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
155278818|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
155278819|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278820|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278821|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
155278822|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278823|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
155278824|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278825|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278826|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278827|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278828|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278829|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278830|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278831|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278832|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278833|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278834|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278835|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278836|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278837|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278838|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
155278839|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278840|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278841|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278842|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278843|NCT02065245|560454687|FG000|Infusion 1|Lost to Follow-up|0|||
155278844|NCT02065245|560454688|FG001|Infusion 1|Lost to Follow-up|0|||
155278845|NCT02065245|560454689|FG002|Infusion 1|Lost to Follow-up|0|||
155278846|NCT02065245|560454690|FG003|Infusion 1|Lost to Follow-up|0|||
155278847|NCT02065245|560454691|FG004|Infusion 1|Lost to Follow-up|0|||
155278848|NCT02065245|560454692|FG005|Infusion 1|Lost to Follow-up|0|||
155278849|NCT02065245|560454693|FG006|Infusion 1|Lost to Follow-up|1|||
155278850|NCT02065245|560454687|FG000|Infusion 1|Death|0|||
155278851|NCT02065245|560454688|FG001|Infusion 1|Death|0|||
155278852|NCT02065245|560454689|FG002|Infusion 1|Death|1|||
155278853|NCT02065245|560454690|FG003|Infusion 1|Death|0|||
155278854|NCT02065245|560454691|FG004|Infusion 1|Death|1|||
155278855|NCT02065245|560454692|FG005|Infusion 1|Death|0|||
155278856|NCT02065245|560454693|FG006|Infusion 1|Death|0|||
155278857|NCT02065245|560454687|FG000|Infusion 2|Death|0|||
155278858|NCT02065245|560454688|FG001|Infusion 2|Death|0|||
155278859|NCT02065245|560454689|FG002|Infusion 2|Death|0|||
155278860|NCT02065245|560454690|FG003|Infusion 2|Death|0|||
155278861|NCT02065245|560454691|FG004|Infusion 2|Death|0|||
155278862|NCT02065245|560454692|FG005|Infusion 2|Death|0|||
155278863|NCT02065245|560454693|FG006|Infusion 2|Death|1|||
155278864|NCT02065245|560454687|FG000|Infusion 3|Lost to Follow-up|1|||
155278865|NCT02065245|560454688|FG001|Infusion 3|Lost to Follow-up|1|||
155278866|NCT02065245|560454689|FG002|Infusion 3|Lost to Follow-up|0|||
155278867|NCT02065245|560454690|FG003|Infusion 3|Lost to Follow-up|0|||
155278868|NCT02065245|560454691|FG004|Infusion 3|Lost to Follow-up|0|||
155729049|NCT00753506|562108024|FG000|Overall Study|Lost to Follow-up|2|||
155729050|NCT00753506|562108025|FG001|Overall Study|Lost to Follow-up|0|||
155729051|NCT00753506|562108024|FG000|Overall Study|Other reason|1|||
155626197|NCT02849080|561726116|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
155626198|NCT02849080|561726113|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
155626199|NCT02849080|561726114|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
155626200|NCT02849080|561726115|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
155626201|NCT02849080|561726116|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
155626202|NCT02849080|561726113|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
155626203|NCT02849080|561726114|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155626204|NCT02849080|561726115|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155626205|NCT02849080|561726116|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155626206|NCT02849080|561726113|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
155626207|NCT02849080|561726114|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
155626208|NCT02849080|561726115|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
155626209|NCT02849080|561726116|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
155626210|NCT02849080|561726113|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
155626211|NCT02849080|561726114|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155626212|NCT02849080|561726115|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155626213|NCT02849080|561726116|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155626214|NCT01819727|561726119|FG000|Overall Study|Adverse Event|8|||
155626215|NCT01819727|561726120|FG001|Overall Study|Adverse Event|9|||
155626216|NCT01819727|561726119|FG000|Overall Study|Death|1|||
155626217|NCT01819727|561726120|FG001|Overall Study|Death|0|||
155626218|NCT01819727|561726119|FG000|Overall Study|Lost to Follow-up|1|||
155626219|NCT01819727|561726120|FG001|Overall Study|Lost to Follow-up|1|||
155626220|NCT01819727|561726119|FG000|Overall Study|Physician Decision|3|||
155626221|NCT01819727|561726120|FG001|Overall Study|Physician Decision|2|||
155626222|NCT01819727|561726119|FG000|Overall Study|Pregnancy|1|||
155626223|NCT01819727|561726120|FG001|Overall Study|Pregnancy|0|||
155626224|NCT01819727|561726119|FG000|Overall Study|Protocol Violation|0|||
155626225|NCT01819727|561726120|FG001|Overall Study|Protocol Violation|2|||
155626226|NCT01819727|561726119|FG000|Overall Study|Study Terminated by Sponsor|0|||
155626227|NCT01819727|561726120|FG001|Overall Study|Study Terminated by Sponsor|1|||
155626228|NCT01819727|561726119|FG000|Overall Study|Withdrawal by Subject|6|||
155626229|NCT01819727|561726120|FG001|Overall Study|Withdrawal by Subject|11|||
155626230|NCT01819727|561726119|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
155626231|NCT01819727|561726120|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
155626232|NCT01819727|561726119|FG000|Overall Study|Quit due to lack of health benifits|0|||
155626233|NCT01819727|561726120|FG001|Overall Study|Quit due to lack of health benifits|1|||
155626234|NCT00732069|561726123|FG000|Washout After First Study Drug|Adverse Event|1|||
155626235|NCT00732069|561726124|FG001|Washout After First Study Drug|Adverse Event|0|||
155626236|NCT00732069|561726125|FG002|Washout After First Study Drug|Adverse Event|0|||
155626237|NCT00732069|561726126|FG003|Washout After First Study Drug|Adverse Event|0|||
155626238|NCT00732069|561726127|FG004|Washout After First Study Drug|Adverse Event|0|||
155278869|NCT02065245|560454692|FG005|Infusion 3|Lost to Follow-up|0|||
155278870|NCT02065245|560454693|FG006|Infusion 3|Lost to Follow-up|0|||
155278871|NCT03531905|560454694|FG000|Overall Study|Withdrawal by Subject|3|||
155278872|NCT03531905|560454695|FG001|Overall Study|Withdrawal by Subject|3|||
155278873|NCT03531905|560454696|FG002|Overall Study|Withdrawal by Subject|2|||
155278874|NCT03531905|560454694|FG000|Overall Study|Lost to Follow-up|2|||
155278875|NCT03531905|560454695|FG001|Overall Study|Lost to Follow-up|2|||
155278876|NCT03531905|560454696|FG002|Overall Study|Lost to Follow-up|1|||
155278877|NCT03531905|560454694|FG000|Overall Study|Participant was out of town|1|||
155278878|NCT03531905|560454695|FG001|Overall Study|Participant was out of town|0|||
155278879|NCT03531905|560454696|FG002|Overall Study|Participant was out of town|0|||
155278880|NCT03531905|560454694|FG000|Overall Study|Could not speak with the participant|1|||
155278881|NCT03531905|560454695|FG001|Overall Study|Could not speak with the participant|0|||
155278882|NCT03531905|560454696|FG002|Overall Study|Could not speak with the participant|0|||
155278883|NCT03303105|560454701|FG000|Overall Study|Adverse Event|0|||
155278884|NCT03303105|560454702|FG001|Overall Study|Adverse Event|2|||
155278885|NCT03303105|560454701|FG000|Overall Study|Lack of Efficacy|1|||
155278886|NCT03303105|560454702|FG001|Overall Study|Lack of Efficacy|0|||
155278887|NCT03303105|560454701|FG000|Overall Study|Protocol Violation|1|||
155278888|NCT03303105|560454702|FG001|Overall Study|Protocol Violation|0|||
155278889|NCT03303105|560454701|FG000|Overall Study|Withdrawal by Subject|0|||
155626239|NCT00732069|561726128|FG005|Washout After First Study Drug|Adverse Event|0|||
155729052|NCT00753506|562108025|FG001|Overall Study|Other reason|1|||
155729053|NCT04226742|562108026|FG000|Overall Study|Lost to Follow-up|16|||
155626240|NCT00402727|561726129|FG000|Overall Study|Adverse Event|10|||
155626241|NCT00402727|561726130|FG001|Overall Study|Adverse Event|6|||
155729054|NCT04226742|562108027|FG001|Overall Study|Lost to Follow-up|13|||
155278890|NCT03303105|560454702|FG001|Overall Study|Withdrawal by Subject|2|||
155278891|NCT03527277|560454705|FG000|Overall Study|Withdrawal by Subject|5|||
155278892|NCT03527277|560454706|FG001|Overall Study|Withdrawal by Subject|0|||
155383049|NCT00250679|560837446|FG000|Overall Study|various single events: hip surgery,diary|3|||
155383050|NCT00250679|560837447|FG001|Overall Study|various single events: hip surgery,diary|1|||
155383051|NCT00250679|560837448|FG002|Overall Study|various single events: hip surgery,diary|1|||
155383052|NCT00448279|560837450|FG000|Overall Study|Lost to Follow-up|2|||
155383053|NCT00448279|560837451|FG001|Overall Study|Lost to Follow-up|2|||
155383054|NCT00448279|560837450|FG000|Overall Study|Adverse Event|1|||
155383055|NCT00448279|560837451|FG001|Overall Study|Adverse Event|1|||
155383056|NCT00448279|560837450|FG000|Overall Study|Disease progression|16|||
155383057|NCT00448279|560837451|FG001|Overall Study|Disease progression|18|||
155383058|NCT00448279|560837450|FG000|Overall Study|Withdrawal by Subject|4|||
155626242|NCT00402727|561726129|FG000|Overall Study|Death|1|||
155626243|NCT00402727|561726130|FG001|Overall Study|Death|0|||
155626244|NCT00402727|561726129|FG000|Overall Study|Lack of Efficacy|1|||
155626245|NCT00402727|561726130|FG001|Overall Study|Lack of Efficacy|3|||
155626246|NCT00402727|561726129|FG000|Overall Study|Lost to Follow-up|24|||
155626247|NCT00402727|561726130|FG001|Overall Study|Lost to Follow-up|11|||
155626248|NCT00402727|561726129|FG000|Overall Study|Physician Decision|1|||
155626249|NCT00402727|561726130|FG001|Overall Study|Physician Decision|1|||
155626250|NCT00402727|561726129|FG000|Overall Study|Protocol Violation|0|||
155626251|NCT00402727|561726130|FG001|Overall Study|Protocol Violation|4|||
155626252|NCT00402727|561726129|FG000|Overall Study|Withdrawal by Subject|3|||
155626253|NCT00402727|561726130|FG001|Overall Study|Withdrawal by Subject|7|||
155626254|NCT00402727|561726129|FG000|Overall Study|supply problems|2|||
155626255|NCT00402727|561726130|FG001|Overall Study|supply problems|1|||
155626256|NCT00402727|561726129|FG000|Overall Study|non-compliance|0|||
155626257|NCT00402727|561726130|FG001|Overall Study|non-compliance|1|||
155626258|NCT00577317|561726131|FG000|Overall Study|Study Terminated|0|||
155626259|NCT00577317|561726132|FG001|Overall Study|Study Terminated|2|||
155626260|NCT02008526|561726144|FG000|Overall Study|Death|0|||
155626261|NCT02008526|561726145|FG001|Overall Study|Death|2|||
155626262|NCT02008526|561726146|FG002|Overall Study|Death|1|||
155626263|NCT02008526|561726144|FG000|Overall Study|Withdrawal by Subject|3|||
155626264|NCT02008526|561726145|FG001|Overall Study|Withdrawal by Subject|3|||
155626265|NCT02008526|561726146|FG002|Overall Study|Withdrawal by Subject|2|||
155626266|NCT02008526|561726144|FG000|Overall Study|Lost to Follow-up|5|||
155626267|NCT02008526|561726145|FG001|Overall Study|Lost to Follow-up|9|||
155626268|NCT02008526|561726146|FG002|Overall Study|Lost to Follow-up|6|||
155626269|NCT00960804|561726151|FG000|Overall Study|Adverse Event|1|||
155626270|NCT00960804|561726152|FG001|Overall Study|Adverse Event|0|||
155626271|NCT00960804|561726153|FG002|Overall Study|Adverse Event|0|||
155626272|NCT00960804|561726151|FG000|Overall Study|Withdrawal by Subject|1|||
155626273|NCT00960804|561726152|FG001|Overall Study|Withdrawal by Subject|0|||
155626274|NCT00960804|561726153|FG002|Overall Study|Withdrawal by Subject|0|||
155626275|NCT00960804|561726151|FG000|Overall Study|Study terminated by the sponsor|5|||
155626276|NCT00960804|561726152|FG001|Overall Study|Study terminated by the sponsor|4|||
155626277|NCT00960804|561726153|FG002|Overall Study|Study terminated by the sponsor|10|||
155626278|NCT02337764|561728003|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
155626279|NCT02337764|561728003|FG000|Overall Study|Voluntary Withdrawal|12|||
155626280|NCT02337764|561728003|FG000|Overall Study|Lack of Efficacy|2|||
155626281|NCT02990000|561728004|FG000|Overall Study|Failed to provide data beyond baseline|36|||
155626282|NCT02990000|561728005|FG001|Overall Study|Failed to provide data beyond baseline|34|||
155626283|NCT00161213|561728020|FG000|Overall Study|Withdrawal by Subject|1|||
155626284|NCT00161213|561728020|FG000|Overall Study|Evaluable for toxicity but not response|1|||
155626285|NCT03103503|561728021|FG000|Overall Study|Death|64|||
155626286|NCT03103503|561728021|FG000|Overall Study|Physician Decision|57|||
155626287|NCT03103503|561728021|FG000|Overall Study|Withdrawal by Subject|10|||
155626288|NCT03103503|561728021|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
155626289|NCT03103503|561728021|FG000|Overall Study|Lost to Follow-up|3|||
155626290|NCT03103503|561728021|FG000|Overall Study|Study Closure|757|||
155626291|NCT01926028|561728026|FG000|Overall Study|Lost to Follow-up|7|||
155626292|NCT01926028|561728027|FG001|Overall Study|Lost to Follow-up|6|||
155626293|NCT01926028|561728028|FG002|Overall Study|Lost to Follow-up|0|||
155626294|NCT01926028|561728026|FG000|Overall Study|Physician Decision|1|||
155626295|NCT01926028|561728027|FG001|Overall Study|Physician Decision|5|||
155626296|NCT01926028|561728028|FG002|Overall Study|Physician Decision|0|||
155626297|NCT01926028|561728026|FG000|Overall Study|Withdrawal by Subject|9|||
155626298|NCT01926028|561728027|FG001|Overall Study|Withdrawal by Subject|9|||
155626299|NCT01926028|561728028|FG002|Overall Study|Withdrawal by Subject|2|||
155626300|NCT01926028|561728026|FG000|Overall Study|Non compliance or other reasons|4|||
155626301|NCT01926028|561728027|FG001|Overall Study|Non compliance or other reasons|2|||
155626302|NCT01926028|561728028|FG002|Overall Study|Non compliance or other reasons|0|||
155383059|NCT00448279|560837451|FG001|Overall Study|Withdrawal by Subject|3|||
155626303|NCT00301834|561728029|FG000|Overall Study|Death|1|||
155383060|NCT00448279|560837450|FG000|Overall Study|Other|6|||
155383061|NCT00448279|560837451|FG001|Overall Study|Other|4|||
155383062|NCT00448279|560837450|FG000|Overall Study|Protocol Violation|0|||
155626304|NCT00744939|561728030|FG000|Overall Study|Withdrawal by Subject|9|||
155626305|NCT00744939|561728030|FG000|Overall Study|Protocol Violation|13|||
155626306|NCT00744939|561728030|FG000|Overall Study|Death|24|||
155729055|NCT04226742|562108026|FG000|Overall Study|Withdrawal by Subject|5|||
155729056|NCT04226742|562108027|FG001|Overall Study|Withdrawal by Subject|3|||
155729057|NCT05097963|562108028|FG000|Overall Study|Protocol Violation|13|||
155729058|NCT05097963|562108028|FG000|Overall Study|Withdrawal by Subject|21|||
155729059|NCT01417377|562108031|FG000|Overall Study|Lost to Follow-up|12|||
155729060|NCT01417377|562108031|FG000|Overall Study|Enrolled, but not treated|1|||
155729061|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
155729062|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
155729063|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
155729064|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
155729065|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
155729066|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
155729067|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
155729068|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
155729069|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
155729070|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
155729071|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
155729072|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
155729073|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
155729074|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
155729075|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
155729076|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
155729077|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
155729078|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
155729079|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
155729080|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
155729081|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
155729082|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
155729083|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
155278893|NCT03527277|560454705|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
155278894|NCT03527277|560454706|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
155278895|NCT03527277|560454705|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
155278896|NCT03527277|560454706|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
155278897|NCT01781611|560454707|FG000|Overall Study|Adverse Event|4|||
155278898|NCT01781611|560454708|FG001|Overall Study|Adverse Event|0|||
155278899|NCT01333943|560454709|FG000|Overall Study|Known neuropathy|1|||
155278900|NCT01333943|560454710|FG001|Overall Study|Known neuropathy|0|||
155278901|NCT02652130|560454717|FG000|Overall Study|Death|1|||
155278902|NCT02028884|560454718|FG000|Double-blind Period|Adverse Event|5|||
155278903|NCT02028884|560454719|FG001|Double-blind Period|Adverse Event|3|||
155278904|NCT02028884|560454720|FG002|Double-blind Period|Adverse Event|0|||
155278905|NCT02028884|560454718|FG000|Double-blind Period|Eligibility Violation|1|||
155278906|NCT02028884|560454719|FG001|Double-blind Period|Eligibility Violation|0|||
155278907|NCT02028884|560454720|FG002|Double-blind Period|Eligibility Violation|0|||
155278908|NCT02028884|560454718|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
155278909|NCT02028884|560454719|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
155278910|NCT02028884|560454720|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
155278911|NCT02028884|560454718|FG000|Double-blind Period|Withdrawal by Subject|2|||
155278912|NCT02028884|560454719|FG001|Double-blind Period|Withdrawal by Subject|0|||
155278913|NCT02028884|560454720|FG002|Double-blind Period|Withdrawal by Subject|0|||
155278914|NCT02028884|560454718|FG000|Open-label Extension Period|Adverse Event|3|||
155278915|NCT02028884|560454719|FG001|Open-label Extension Period|Adverse Event|1|||
155278916|NCT02028884|560454720|FG002|Open-label Extension Period|Adverse Event|0|||
155278917|NCT02028884|560454718|FG000|Open-label Extension Period|Lack of Efficacy|3|||
155278918|NCT02028884|560454719|FG001|Open-label Extension Period|Lack of Efficacy|0|||
155278919|NCT02028884|560454720|FG002|Open-label Extension Period|Lack of Efficacy|0|||
155278920|NCT02028884|560454718|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155278921|NCT02028884|560454719|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
155278922|NCT02028884|560454720|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155278923|NCT02028884|560454718|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155729084|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
155729085|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
155729086|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
155729087|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
155278924|NCT02028884|560454719|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
155278925|NCT02028884|560454720|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
155278926|NCT02028884|560454718|FG000|Open-label Extension Period|Switched to another treatment option|3|||
155278927|NCT02028884|560454719|FG001|Open-label Extension Period|Switched to another treatment option|0|||
155729088|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
155729089|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729090|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729091|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383063|NCT00448279|560837451|FG001|Overall Study|Protocol Violation|1|||
155383064|NCT03907410|560837452|FG000|Overall Study|Lost to Follow-up|4|||
155383065|NCT03907410|560837453|FG001|Overall Study|Lost to Follow-up|1|||
155383066|NCT03907410|560837454|FG002|Overall Study|Lost to Follow-up|1|||
155383067|NCT03907410|560837452|FG000|Overall Study|Lost to follow-up and research burden|0|||
155383068|NCT03907410|560837453|FG001|Overall Study|Lost to follow-up and research burden|0|||
155383069|NCT03907410|560837454|FG002|Overall Study|Lost to follow-up and research burden|1|||
155383070|NCT01981473|560837455|FG000|Overall Study|Incorrect diagnosis of RA|0|||
155383071|NCT01981473|560837456|FG001|Overall Study|Incorrect diagnosis of RA|0|||
155383072|NCT01981473|560837457|FG002|Overall Study|Incorrect diagnosis of RA|1|||
155383073|NCT01981473|560837455|FG000|Overall Study|Received treatment for < 6 months|0|||
155383074|NCT01981473|560837456|FG001|Overall Study|Received treatment for < 6 months|0|||
155383075|NCT01981473|560837457|FG002|Overall Study|Received treatment for < 6 months|1|||
155383076|NCT01981473|560837455|FG000|Overall Study|Received treatment for >24 months|2|||
155383077|NCT01981473|560837456|FG001|Overall Study|Received treatment for >24 months|0|||
155383078|NCT01981473|560837457|FG002|Overall Study|Received treatment for >24 months|6|||
155383079|NCT04776148|560837458|FG000|Overall Study|Death|249|||
155383080|NCT04776148|560837459|FG001|Overall Study|Death|260|||
155383081|NCT04776148|560837458|FG000|Overall Study|Lost to Follow-up|0|||
155383082|NCT04776148|560837459|FG001|Overall Study|Lost to Follow-up|1|||
155383083|NCT04776148|560837458|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155383084|NCT04776148|560837459|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155383085|NCT04776148|560837458|FG000|Overall Study|Withdrawal by Subject|3|||
155383086|NCT04776148|560837459|FG001|Overall Study|Withdrawal by Subject|4|||
155383087|NCT04776148|560837458|FG000|Overall Study|Sponsor Decision|30|||
155383088|NCT04776148|560837459|FG001|Overall Study|Sponsor Decision|15|||
155383089|NCT00738582|560837460|FG000|Combination Therapy|Completed Combination Therapy|1|||
155383090|NCT00738582|560837461|FG001|Combination Therapy|Completed Combination Therapy|0|||
155383091|NCT00738582|560837460|FG000|Combination Therapy|Physician Decision|1|||
155383092|NCT00738582|560837461|FG001|Combination Therapy|Physician Decision|0|||
155383093|NCT00738582|560837460|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
155383094|NCT00738582|560837461|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
155383095|NCT00738582|560837460|FG000|Combination Therapy|Other|5|||
155383096|NCT00738582|560837461|FG001|Combination Therapy|Other|0|||
155383097|NCT00738582|560837460|FG000|Combination Therapy|Adverse Event|16|||
155383098|NCT00738582|560837461|FG001|Combination Therapy|Adverse Event|0|||
155383099|NCT00738582|560837460|FG000|Combination Therapy|Progressive Disease|9|||
155383100|NCT00738582|560837461|FG001|Combination Therapy|Progressive Disease|0|||
155383101|NCT00738582|560837460|FG000|Maintenance Therapy|Other|0|||
155383102|NCT00738582|560837461|FG001|Maintenance Therapy|Other|2|||
155383103|NCT00738582|560837460|FG000|Maintenance Therapy|Adverse Event|0|||
155383104|NCT00738582|560837461|FG001|Maintenance Therapy|Adverse Event|6|||
155383105|NCT00738582|560837460|FG000|Maintenance Therapy|Progressive Disease|0|||
155383106|NCT00738582|560837461|FG001|Maintenance Therapy|Progressive Disease|47|||
155383107|NCT00738582|560837460|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
155383108|NCT00738582|560837461|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
155383109|NCT02563522|560837462|FG000|Overall Study|Adverse Event|2|||
155383110|NCT02563522|560837463|FG001|Overall Study|Adverse Event|3|||
155383111|NCT02563522|560837462|FG000|Overall Study|Lost to Follow-up|1|||
155383112|NCT02563522|560837463|FG001|Overall Study|Lost to Follow-up|0|||
155383113|NCT02563522|560837462|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
155383114|NCT02563522|560837463|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
155383115|NCT01052103|560837464|FG000|Overall Study|Adverse Event|10|||
155383116|NCT01052103|560837465|FG001|Overall Study|Adverse Event|6|||
155383117|NCT01052103|560837464|FG000|Overall Study|Entry Criteria Not Met|3|||
155383118|NCT01052103|560837465|FG001|Overall Study|Entry Criteria Not Met|1|||
155383119|NCT01052103|560837464|FG000|Overall Study|Lost to Follow-up|3|||
155383120|NCT01052103|560837465|FG001|Overall Study|Lost to Follow-up|5|||
155383121|NCT01052103|560837464|FG000|Overall Study|Protocol Violation|10|||
155383122|NCT01052103|560837465|FG001|Overall Study|Protocol Violation|4|||
155383123|NCT01052103|560837464|FG000|Overall Study|Scheduling conflict|2|||
155383124|NCT01052103|560837465|FG001|Overall Study|Scheduling conflict|1|||
155383125|NCT01052103|560837464|FG000|Overall Study|Sponsor Decision|2|||
155383126|NCT01052103|560837465|FG001|Overall Study|Sponsor Decision|0|||
155383127|NCT01052103|560837464|FG000|Overall Study|Withdrawal by Subject|3|||
155383128|NCT01052103|560837465|FG001|Overall Study|Withdrawal by Subject|6|||
155729092|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383129|NCT01052103|560837464|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155383130|NCT01052103|560837465|FG001|Overall Study|Perceived Lack of Efficacy|0|||
155383131|NCT00799513|560837466|FG000|Overall Study|Physician Decision|1|||
155383132|NCT00799513|560837466|FG000|Overall Study|Adverse Event|1|||
155383133|NCT00666679|560837472|FG000|First Intervention|Lost to Follow-up|1|||
155383134|NCT00666679|560837473|FG001|First Intervention|Lost to Follow-up|0|||
155383135|NCT00666679|560837472|FG000|First Intervention|Protocol Violation|1|||
155729093|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383136|NCT00666679|560837473|FG001|First Intervention|Protocol Violation|0|||
155626307|NCT00744939|561728030|FG000|Overall Study|distance|4|||
155626308|NCT00744939|561728030|FG000|Overall Study|Lost to Follow-up|12|||
155626309|NCT00744939|561728030|FG000|Overall Study|Medical history exclusionary|1|||
155626310|NCT00744939|561728030|FG000|Overall Study|Did not receive Magnevist|7|||
155626311|NCT00744939|561728030|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
155626312|NCT00744939|561728030|FG000|Overall Study|coma|1|||
155626313|NCT00744939|561728030|FG000|Overall Study|incorrect race|1|||
155626314|NCT01739335|561728031|FG000|Overall Study|Lost to Follow-up|7|||
155626315|NCT01739335|561728032|FG001|Overall Study|Lost to Follow-up|4|||
155626316|NCT01739335|561728031|FG000|Overall Study|Ineligible patient randomized|0|||
155626317|NCT01739335|561728032|FG001|Overall Study|Ineligible patient randomized|1|||
155626318|NCT00288912|561728033|FG000|Overall Study|Developed exclusion criterion|4|||
155626319|NCT00288912|561728034|FG001|Overall Study|Developed exclusion criterion|6|||
155626320|NCT00288912|561728035|FG002|Overall Study|Developed exclusion criterion|7|||
155626321|NCT00288912|561728033|FG000|Overall Study|Lost to Follow-up|9|||
155626322|NCT00288912|561728034|FG001|Overall Study|Lost to Follow-up|6|||
155626323|NCT00288912|561728035|FG002|Overall Study|Lost to Follow-up|9|||
155626324|NCT00288912|561728033|FG000|Overall Study|Withdrawal by Subject|4|||
155626325|NCT00288912|561728034|FG001|Overall Study|Withdrawal by Subject|5|||
155626326|NCT00288912|561728035|FG002|Overall Study|Withdrawal by Subject|12|||
155626327|NCT00183430|561728038|FG000|Overall Study|Adverse Event|1|||
155626328|NCT00183430|561728039|FG001|Overall Study|Adverse Event|0|||
155626329|NCT00183430|561728038|FG000|Overall Study|Lost to Follow-up|3|||
155626330|NCT00183430|561728039|FG001|Overall Study|Lost to Follow-up|0|||
155626331|NCT00183430|561728038|FG000|Overall Study|did not meet inclusion criteria|1|||
155626332|NCT00183430|561728039|FG001|Overall Study|did not meet inclusion criteria|0|||
155626333|NCT00183430|561728038|FG000|Overall Study|Withdrawal by Subject|1|||
155626334|NCT00183430|561728039|FG001|Overall Study|Withdrawal by Subject|0|||
155626335|NCT01863771|561728048|FG000|Induction Phase|Adverse Event|9|||
155626336|NCT01863771|561728049|FG001|Induction Phase|Adverse Event|0|||
155626337|NCT01863771|561728050|FG002|Induction Phase|Adverse Event|0|||
155626338|NCT01863771|561728051|FG003|Induction Phase|Adverse Event|0|||
155626339|NCT01863771|561728048|FG000|Induction Phase|Lack of Efficacy|10|||
155626340|NCT01863771|561728049|FG001|Induction Phase|Lack of Efficacy|0|||
155626341|NCT01863771|561728050|FG002|Induction Phase|Lack of Efficacy|0|||
155626342|NCT01863771|561728051|FG003|Induction Phase|Lack of Efficacy|0|||
155626343|NCT01863771|561728048|FG000|Induction Phase|Withdrawal by Subject|2|||
155626344|NCT01863771|561728049|FG001|Induction Phase|Withdrawal by Subject|0|||
155626345|NCT01863771|561728050|FG002|Induction Phase|Withdrawal by Subject|0|||
155626346|NCT01863771|561728051|FG003|Induction Phase|Withdrawal by Subject|0|||
155626347|NCT01863771|561728048|FG000|Maintenance Phase|Adverse Event|0|||
155626348|NCT01863771|561728049|FG001|Maintenance Phase|Adverse Event|0|||
155626349|NCT01863771|561728050|FG002|Maintenance Phase|Adverse Event|1|||
155626350|NCT01863771|561728051|FG003|Maintenance Phase|Adverse Event|1|||
155626351|NCT01863771|561728048|FG000|Maintenance Phase|Lack of Efficacy|0|||
155626352|NCT01863771|561728049|FG001|Maintenance Phase|Lack of Efficacy|3|||
155626353|NCT01863771|561728050|FG002|Maintenance Phase|Lack of Efficacy|7|||
155626354|NCT01863771|561728051|FG003|Maintenance Phase|Lack of Efficacy|38|||
155626355|NCT01863771|561728048|FG000|Maintenance Phase|Physician Decision|0|||
155626356|NCT01863771|561728049|FG001|Maintenance Phase|Physician Decision|0|||
155626357|NCT01863771|561728050|FG002|Maintenance Phase|Physician Decision|2|||
155626358|NCT01863771|561728051|FG003|Maintenance Phase|Physician Decision|1|||
155626359|NCT01863771|561728048|FG000|Maintenance Phase|Pregnancy|0|||
155626360|NCT01863771|561728049|FG001|Maintenance Phase|Pregnancy|1|||
155278928|NCT02028884|560454720|FG002|Open-label Extension Period|Switched to another treatment option|0|||
155278929|NCT00354029|560454721|FG000|Overall Study|Protocol Violation|4|||
155278930|NCT00354029|560454722|FG001|Overall Study|Protocol Violation|2|||
155278931|NCT00826280|560454723|FG000|Overall Study|Randomized but drug not received|1|||
155278932|NCT00826280|560454724|FG001|Overall Study|Randomized but drug not received|0|||
155278933|NCT00826280|560454725|FG002|Overall Study|Randomized but drug not received|1|||
155278934|NCT00826280|560454723|FG000|Overall Study|Adverse Event|1|||
155278935|NCT00826280|560454724|FG001|Overall Study|Adverse Event|3|||
155278936|NCT00826280|560454725|FG002|Overall Study|Adverse Event|0|||
155626361|NCT01863771|561728050|FG002|Maintenance Phase|Pregnancy|0|||
155626362|NCT01863771|561728051|FG003|Maintenance Phase|Pregnancy|0|||
155626363|NCT01863771|561728048|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155626364|NCT01863771|561728049|FG001|Maintenance Phase|Withdrawal by Subject|1|||
155626365|NCT01863771|561728050|FG002|Maintenance Phase|Withdrawal by Subject|2|||
155626366|NCT01863771|561728051|FG003|Maintenance Phase|Withdrawal by Subject|3|||
155626367|NCT03636256|561728052|FG000|Overall Study|Lost to Follow-up|3|||
155626368|NCT03636256|561728053|FG001|Overall Study|Lost to Follow-up|0|||
155278937|NCT00826280|560454723|FG000|Overall Study|Lost to Follow-up|0|||
155278938|NCT00826280|560454724|FG001|Overall Study|Lost to Follow-up|1|||
155626369|NCT03636256|561728054|FG002|Overall Study|Lost to Follow-up|2|||
155626370|NCT03636256|561728055|FG003|Overall Study|Lost to Follow-up|1|||
155626371|NCT03636256|561728056|FG004|Overall Study|Lost to Follow-up|0|||
155626372|NCT03636256|561728057|FG005|Overall Study|Lost to Follow-up|4|||
155729094|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729095|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
155383137|NCT00666679|560837472|FG000|First Intervention|Withdrawal by Subject|1|||
155383138|NCT00666679|560837473|FG001|First Intervention|Withdrawal by Subject|0|||
155383139|NCT00666679|560837472|FG000|First Intervention|Randomized did not start treatment|1|||
155729096|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729097|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383140|NCT00666679|560837473|FG001|First Intervention|Randomized did not start treatment|1|||
155383141|NCT00666679|560837472|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
155383142|NCT00666679|560837473|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
155383143|NCT00666679|560837472|FG000|Washout Period of 1 Week|Protocol Violation|0|||
155383144|NCT00666679|560837473|FG001|Washout Period of 1 Week|Protocol Violation|1|||
155383145|NCT00666679|560837472|FG000|Second Intervention|Adverse Event|1|||
155383146|NCT00666679|560837473|FG001|Second Intervention|Adverse Event|0|||
155383147|NCT00666679|560837472|FG000|Second Intervention|Death|0|||
155383148|NCT00666679|560837473|FG001|Second Intervention|Death|1|||
155383149|NCT00903006|560837474|FG000|Overall Study|Withdrawal by Subject|2|||
155383150|NCT00903006|560837475|FG001|Overall Study|Withdrawal by Subject|0|||
155383151|NCT00903006|560837476|FG002|Overall Study|Withdrawal by Subject|0|||
155383152|NCT00903006|560837477|FG003|Overall Study|Withdrawal by Subject|0|||
155383153|NCT00903006|560837474|FG000|Overall Study|Progressive Disease|0|||
155383154|NCT00903006|560837475|FG001|Overall Study|Progressive Disease|3|||
155383155|NCT00903006|560837476|FG002|Overall Study|Progressive Disease|1|||
155383156|NCT00903006|560837477|FG003|Overall Study|Progressive Disease|0|||
155383157|NCT03405792|560837478|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
155383158|NCT03405792|560837479|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
155383159|NCT03405792|560837478|FG000|Overall Study|o Did not receive pembrolizumab|1|||
155383160|NCT03405792|560837479|FG001|Overall Study|o Did not receive pembrolizumab|0|||
155383161|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
155383162|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
155383163|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
155383164|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
155383165|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
155383166|NCT00918580|560837480|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
155383167|NCT00918580|560837480|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
155383168|NCT04882995|560837481|FG000|Overall Study|Withdrawal by Subject|1|||
155383169|NCT04882995|560837482|FG001|Overall Study|Withdrawal by Subject|2|||
155383170|NCT04882995|560837481|FG000|Overall Study|Protocol Violation|4|||
155383171|NCT04882995|560837482|FG001|Overall Study|Protocol Violation|4|||
155383172|NCT04882995|560837481|FG000|Overall Study|Surgery postponed due to COVID|1|||
155383173|NCT04882995|560837482|FG001|Overall Study|Surgery postponed due to COVID|1|||
155383174|NCT04371198|560837483|FG000|Overall Study|inadequate sample|4|||
155383175|NCT00372229|560837484|FG000|Study Phase|Graft loss|0|||
155383176|NCT00372229|560837485|FG001|Study Phase|Graft loss|3|||
155383177|NCT00372229|560837484|FG000|Study Phase|Protocol Violation|3|||
155383178|NCT00372229|560837485|FG001|Study Phase|Protocol Violation|4|||
155383179|NCT00372229|560837484|FG000|Study Phase|Consent withdrawn|16|||
155383180|NCT00372229|560837485|FG001|Study Phase|Consent withdrawn|14|||
155383181|NCT00372229|560837484|FG000|Study Phase|Refused treatment/did not cooperate|3|||
155383182|NCT00372229|560837485|FG001|Study Phase|Refused treatment/did not cooperate|1|||
155383183|NCT00372229|560837484|FG000|Study Phase|Death|3|||
155383184|NCT00372229|560837485|FG001|Study Phase|Death|2|||
155383185|NCT00372229|560837484|FG000|Study Phase|Reason not specified|3|||
155383186|NCT00372229|560837485|FG001|Study Phase|Reason not specified|2|||
155383187|NCT00372229|560837484|FG000|Study Phase|Lost to Follow-up|3|||
155383188|NCT00372229|560837485|FG001|Study Phase|Lost to Follow-up|3|||
155383189|NCT00372229|560837484|FG000|Follow-Up Phase|Graft loss|8|||
155383190|NCT00372229|560837485|FG001|Follow-Up Phase|Graft loss|7|||
155383191|NCT00372229|560837484|FG000|Follow-Up Phase|Consent withdrawn|13|||
155383192|NCT00372229|560837485|FG001|Follow-Up Phase|Consent withdrawn|19|||
155383193|NCT00372229|560837484|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
155729098|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383194|NCT00372229|560837485|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
155383195|NCT00372229|560837484|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
155729099|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729100|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729101|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155383196|NCT00372229|560837485|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
155383197|NCT00372229|560837484|FG000|Follow-Up Phase|Death|9|||
155383198|NCT00372229|560837485|FG001|Follow-Up Phase|Death|12|||
155383199|NCT00372229|560837484|FG000|Follow-Up Phase|Administrative|1|||
155383200|NCT00372229|560837485|FG001|Follow-Up Phase|Administrative|0|||
155383201|NCT00372229|560837484|FG000|Follow-Up Phase|Reason not specified|2|||
155383202|NCT00372229|560837485|FG001|Follow-Up Phase|Reason not specified|3|||
155383203|NCT00372229|560837484|FG000|Follow-Up Phase|Lost to Follow-up|12|||
155729102|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155729103|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Transplant|0|||
155729104|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Transplant|1|||
155729105|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Transplant|0|||
155729106|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Transplant|0|||
155729107|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Transplant|0|||
155729108|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Transplant|1|||
155729109|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Transplant|0|||
155383204|NCT00372229|560837485|FG001|Follow-Up Phase|Lost to Follow-up|10|||
155383205|NCT01347762|560837486|FG000|Overall Study|Lost to Follow-up|0|||
155383206|NCT01347762|560837487|FG001|Overall Study|Lost to Follow-up|1|||
155383207|NCT01347762|560837488|FG002|Overall Study|Lost to Follow-up|6|||
155383208|NCT01347762|560837489|FG003|Overall Study|Lost to Follow-up|5|||
155383209|NCT01347762|560837486|FG000|Overall Study|Withdrawal by Subject|4|||
155383210|NCT01347762|560837487|FG001|Overall Study|Withdrawal by Subject|1|||
155383211|NCT01347762|560837488|FG002|Overall Study|Withdrawal by Subject|3|||
155383212|NCT01347762|560837489|FG003|Overall Study|Withdrawal by Subject|3|||
155383213|NCT00701220|560837490|FG000|Overall Study|Withdrawal by Subject|0|||
155383214|NCT00701220|560837491|FG001|Overall Study|Withdrawal by Subject|2|||
155383215|NCT00701220|560837490|FG000|Overall Study|Protocol Violation|2|||
155383216|NCT00701220|560837491|FG001|Overall Study|Protocol Violation|0|||
155383217|NCT03235284|560837492|FG000|Overall Study|Adverse Event|1|||
155383218|NCT03235284|560837493|FG001|Overall Study|Adverse Event|2|||
155383219|NCT03235284|560837494|FG002|Overall Study|Adverse Event|1|||
155383220|NCT00690820|560837495|FG000|Period 1|Withdrawal by Subject|0|||
155383221|NCT00690820|560837496|FG001|Period 1|Withdrawal by Subject|1|||
155383222|NCT05208866|560837497|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
155383223|NCT04964414|560837500|FG000|Overall Study|Lost to Follow-up|10|||
155383224|NCT04964414|560837501|FG001|Overall Study|Lost to Follow-up|8|||
155383225|NCT04964414|560837500|FG000|Overall Study|Withdrawal by Subject|1|||
155383226|NCT04964414|560837501|FG001|Overall Study|Withdrawal by Subject|1|||
155383227|NCT03881553|560837502|FG000|Overall Study|Discharged prior to participation|1|||
155383228|NCT03881553|560837503|FG001|Overall Study|Discharged prior to participation|1|||
155383229|NCT03881553|560837504|FG002|Overall Study|Discharged prior to participation|0|||
155383230|NCT03881553|560837502|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
155383231|NCT03881553|560837503|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
155383232|NCT03881553|560837504|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
155383233|NCT02951767|560837507|FG000|Overall Study|Study Terminated By Sponsor|9|||
155383234|NCT02951767|560837507|FG000|Overall Study|Withdrawal by Subject|11|||
155383235|NCT02951767|560837507|FG000|Overall Study|Death|96|||
155383236|NCT02951767|560837507|FG000|Overall Study|Lost to Follow-up|2|||
155383237|NCT02951767|560837507|FG000|Overall Study|Physician Decision|1|||
155383238|NCT03426605|560837508|FG000|Overall Study|AML relapse or progression|2|||
155383239|NCT03426605|560837509|FG001|Overall Study|AML relapse or progression|1|||
155383240|NCT03426605|560837510|FG002|Overall Study|AML relapse or progression|2|||
155383241|NCT03426605|560837511|FG003|Overall Study|AML relapse or progression|2|||
155383242|NCT03426605|560837508|FG000|Overall Study|Treatment failure|3|||
155383243|NCT03426605|560837509|FG001|Overall Study|Treatment failure|2|||
155383244|NCT03426605|560837510|FG002|Overall Study|Treatment failure|0|||
155383245|NCT03426605|560837511|FG003|Overall Study|Treatment failure|0|||
155383246|NCT03426605|560837508|FG000|Overall Study|Adverse Event|1|||
155383247|NCT03426605|560837509|FG001|Overall Study|Adverse Event|0|||
155383248|NCT03426605|560837510|FG002|Overall Study|Adverse Event|1|||
155383249|NCT03426605|560837511|FG003|Overall Study|Adverse Event|1|||
155383250|NCT03426605|560837508|FG000|Overall Study|Withdrawal by Subject|0|||
155383251|NCT03426605|560837509|FG001|Overall Study|Withdrawal by Subject|0|||
155383252|NCT03426605|560837510|FG002|Overall Study|Withdrawal by Subject|1|||
155383253|NCT03426605|560837511|FG003|Overall Study|Withdrawal by Subject|1|||
155383254|NCT00609765|560837512|FG000|Overall Study|Study ended prior to 12 months|1|||
155383255|NCT02054520|560837513|FG000|Overall Study|Adverse Event|1|||
155383256|NCT02054520|560837514|FG001|Overall Study|Adverse Event|4|||
155729110|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Transplant|0|||
155729111|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Transplant|0|||
155383257|NCT02054520|560837515|FG002|Overall Study|Adverse Event|2|||
155383258|NCT02054520|560837516|FG003|Overall Study|Adverse Event|1|||
155383259|NCT02054520|560837517|FG004|Overall Study|Adverse Event|1|||
155383260|NCT02054520|560837518|FG005|Overall Study|Adverse Event|0|||
155383261|NCT02054520|560837513|FG000|Overall Study|Lack of Efficacy|7|||
155383262|NCT02054520|560837514|FG001|Overall Study|Lack of Efficacy|0|||
155383263|NCT02054520|560837515|FG002|Overall Study|Lack of Efficacy|2|||
155383264|NCT02054520|560837516|FG003|Overall Study|Lack of Efficacy|1|||
155383265|NCT02054520|560837517|FG004|Overall Study|Lack of Efficacy|3|||
155729112|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Transplant|0|||
155383266|NCT02054520|560837518|FG005|Overall Study|Lack of Efficacy|2|||
155383267|NCT02054520|560837513|FG000|Overall Study|Withdrawal by Subject|1|||
155626373|NCT03636256|561728058|FG006|Overall Study|Lost to Follow-up|2|||
155626374|NCT03636256|561728059|FG007|Overall Study|Lost to Follow-up|0|||
155626375|NCT03636256|561728060|FG008|Overall Study|Lost to Follow-up|4|||
155626376|NCT03636256|561728052|FG000|Overall Study|Withdrawal by Subject|0|||
155626377|NCT03636256|561728053|FG001|Overall Study|Withdrawal by Subject|0|||
155626378|NCT03636256|561728054|FG002|Overall Study|Withdrawal by Subject|0|||
155626379|NCT03636256|561728055|FG003|Overall Study|Withdrawal by Subject|0|||
155626380|NCT03636256|561728056|FG004|Overall Study|Withdrawal by Subject|0|||
155626381|NCT03636256|561728057|FG005|Overall Study|Withdrawal by Subject|0|||
155626382|NCT03636256|561728058|FG006|Overall Study|Withdrawal by Subject|0|||
155626383|NCT03636256|561728059|FG007|Overall Study|Withdrawal by Subject|0|||
155626384|NCT03636256|561728060|FG008|Overall Study|Withdrawal by Subject|1|||
155626385|NCT01218308|561728061|FG000|Overall Study|Adverse Event|1|||
155626386|NCT01218308|561728062|FG001|Overall Study|Adverse Event|2|||
155626387|NCT01218308|561728061|FG000|Overall Study|Protocol Violation|0|||
155626388|NCT01218308|561728062|FG001|Overall Study|Protocol Violation|2|||
155626389|NCT01218308|561728061|FG000|Overall Study|Withdrawal by Subject|61|||
155626390|NCT01218308|561728062|FG001|Overall Study|Withdrawal by Subject|64|||
155626391|NCT01218308|561728061|FG000|Overall Study|Lost to Follow-up|27|||
155626392|NCT01218308|561728062|FG001|Overall Study|Lost to Follow-up|31|||
155626393|NCT01218308|561728061|FG000|Overall Study|Other|14|||
155626394|NCT01218308|561728062|FG001|Overall Study|Other|21|||
155626395|NCT02426684|561728063|FG000|Overall Study|Physician Decision|1|||
155626396|NCT00723229|561728066|FG000|First Intervention|Lost to Follow-up|7|||
155626397|NCT00723229|561728067|FG001|First Intervention|Lost to Follow-up|3|||
155729113|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Transplant|0|||
155278939|NCT00826280|560454725|FG002|Overall Study|Lost to Follow-up|0|||
155278940|NCT00826280|560454723|FG000|Overall Study|Sponsor discontinued subject or study|1|||
155278941|NCT00826280|560454724|FG001|Overall Study|Sponsor discontinued subject or study|0|||
155278942|NCT00826280|560454725|FG002|Overall Study|Sponsor discontinued subject or study|0|||
155278943|NCT00826280|560454723|FG000|Overall Study|Reversible ischemic defect not present|43|||
155278944|NCT00826280|560454724|FG001|Overall Study|Reversible ischemic defect not present|40|||
155278945|NCT00826280|560454725|FG002|Overall Study|Reversible ischemic defect not present|44|||
155278946|NCT00826280|560454723|FG000|Overall Study|Interpretation Failure|1|||
155278947|NCT00826280|560454724|FG001|Overall Study|Interpretation Failure|0|||
155278948|NCT00826280|560454725|FG002|Overall Study|Interpretation Failure|0|||
155278949|NCT00826280|560454723|FG000|Overall Study|Machine Failure|1|||
155278950|NCT00826280|560454724|FG001|Overall Study|Machine Failure|1|||
155278951|NCT00826280|560454725|FG002|Overall Study|Machine Failure|0|||
155278952|NCT00826280|560454723|FG000|Overall Study|One or more non-interpretable scan|0|||
155278953|NCT00826280|560454724|FG001|Overall Study|One or more non-interpretable scan|1|||
155278954|NCT00826280|560454725|FG002|Overall Study|One or more non-interpretable scan|1|||
155278955|NCT01477749|560454733|FG000|Overall Study|Physician Decision|4|||
155278956|NCT04004208|560454738|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155278957|NCT04004208|560454739|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155278958|NCT04004208|560454738|FG000|Overall Study|Death|3|||
155278959|NCT04004208|560454739|FG001|Overall Study|Death|0|||
155278960|NCT04004208|560454738|FG000|Overall Study|COVID-19 pandemic|1|||
155278961|NCT04004208|560454739|FG001|Overall Study|COVID-19 pandemic|0|||
155278962|NCT04004208|560454738|FG000|Overall Study|Physician Decision|1|||
155278963|NCT04004208|560454739|FG001|Overall Study|Physician Decision|0|||
155278964|NCT04004208|560454738|FG000|Overall Study|Adverse Event|1|||
155278965|NCT04004208|560454739|FG001|Overall Study|Adverse Event|1|||
155278966|NCT01310868|560454741|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
155278967|NCT00873093|560454742|FG000|Overall Study|Adverse Event|0|||
155278968|NCT00873093|560454743|FG001|Overall Study|Adverse Event|2|||
155278969|NCT00873093|560454744|FG002|Overall Study|Adverse Event|0|||
155278970|NCT00873093|560454745|FG003|Overall Study|Adverse Event|0|||
155278971|NCT00873093|560454746|FG004|Overall Study|Adverse Event|0|||
155278972|NCT00873093|560454742|FG000|Overall Study|Death|0|||
155278973|NCT00873093|560454743|FG001|Overall Study|Death|3|||
155278974|NCT00873093|560454744|FG002|Overall Study|Death|2|||
155278975|NCT00873093|560454745|FG003|Overall Study|Death|0|||
155278976|NCT00873093|560454746|FG004|Overall Study|Death|0|||
155278977|NCT00873093|560454742|FG000|Overall Study|Physician Decision|0|||
155278978|NCT00873093|560454743|FG001|Overall Study|Physician Decision|17|||
155278979|NCT00873093|560454744|FG002|Overall Study|Physician Decision|10|||
155278980|NCT00873093|560454745|FG003|Overall Study|Physician Decision|10|||
155278981|NCT00873093|560454746|FG004|Overall Study|Physician Decision|2|||
155278982|NCT00873093|560454742|FG000|Overall Study|Withdrawal by Subject|1|||
155278983|NCT00873093|560454743|FG001|Overall Study|Withdrawal by Subject|4|||
155278984|NCT00873093|560454744|FG002|Overall Study|Withdrawal by Subject|4|||
155278985|NCT00873093|560454745|FG003|Overall Study|Withdrawal by Subject|0|||
155278986|NCT00873093|560454746|FG004|Overall Study|Withdrawal by Subject|0|||
155278987|NCT00873093|560454742|FG000|Overall Study|Ineligible|0|||
155278988|NCT00873093|560454743|FG001|Overall Study|Ineligible|1|||
155278989|NCT00873093|560454744|FG002|Overall Study|Ineligible|0|||
155626398|NCT00977197|561728068|FG000|Overall Study|Withdrawal by Subject|3|||
155383268|NCT02054520|560837514|FG001|Overall Study|Withdrawal by Subject|0|||
155383269|NCT02054520|560837515|FG002|Overall Study|Withdrawal by Subject|0|||
155383270|NCT02054520|560837516|FG003|Overall Study|Withdrawal by Subject|2|||
155383271|NCT02054520|560837517|FG004|Overall Study|Withdrawal by Subject|1|||
155383272|NCT02054520|560837518|FG005|Overall Study|Withdrawal by Subject|0|||
155383273|NCT02054520|560837513|FG000|Overall Study|Physician Decision|0|||
155383274|NCT02054520|560837514|FG001|Overall Study|Physician Decision|1|||
155383275|NCT02054520|560837515|FG002|Overall Study|Physician Decision|0|||
155383276|NCT02054520|560837516|FG003|Overall Study|Physician Decision|1|||
155383277|NCT02054520|560837517|FG004|Overall Study|Physician Decision|0|||
155383278|NCT02054520|560837518|FG005|Overall Study|Physician Decision|1|||
155383279|NCT02054520|560837513|FG000|Overall Study|Study terminated by Sponsor|0|||
155383280|NCT02054520|560837514|FG001|Overall Study|Study terminated by Sponsor|0|||
155383281|NCT02054520|560837515|FG002|Overall Study|Study terminated by Sponsor|2|||
155383282|NCT02054520|560837516|FG003|Overall Study|Study terminated by Sponsor|1|||
155383283|NCT02054520|560837517|FG004|Overall Study|Study terminated by Sponsor|0|||
155383284|NCT02054520|560837518|FG005|Overall Study|Study terminated by Sponsor|0|||
155383285|NCT01272804|560837519|FG000|Overall Study|Adverse Event|1|||
155383286|NCT01272804|560837520|FG001|Overall Study|Adverse Event|0|||
155383287|NCT01272804|560837521|FG002|Overall Study|Adverse Event|0|||
155383288|NCT01272804|560837522|FG003|Overall Study|Adverse Event|0|||
155383289|NCT01272804|560837523|FG004|Overall Study|Adverse Event|2|||
155383290|NCT01272804|560837524|FG005|Overall Study|Adverse Event|1|||
155383291|NCT02232243|560837525|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
155383292|NCT02232243|560837526|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
155383293|NCT02232243|560837527|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
155383294|NCT00490724|560837528|FG000|Period I|Physician Decision|0|||
155383295|NCT00490724|560837529|FG001|Period I|Physician Decision|0|||
155383296|NCT00490724|560837530|FG002|Period I|Physician Decision|1|||
155383297|NCT00490724|560837528|FG000|Period II|Treatment Discontinuation|3|||
155383298|NCT00490724|560837529|FG001|Period II|Treatment Discontinuation|1|||
155383299|NCT00490724|560837530|FG002|Period II|Treatment Discontinuation|3|||
155383300|NCT03218397|560837531|FG000|Overall Study|Prior positive blood culture|8|||
155383301|NCT03218397|560837532|FG001|Overall Study|Prior positive blood culture|13|||
155383302|NCT03218397|560837531|FG000|Overall Study|Comfort care|8|||
155383303|NCT03218397|560837532|FG001|Overall Study|Comfort care|5|||
155383304|NCT03218397|560837531|FG000|Overall Study|Comfort care and positive blood culture|1|||
155383305|NCT03218397|560837532|FG001|Overall Study|Comfort care and positive blood culture|0|||
155383306|NCT03218397|560837531|FG000|Overall Study|Comfort care and mixed culture|0|||
155383307|NCT03218397|560837532|FG001|Overall Study|Comfort care and mixed culture|1|||
155383308|NCT03218397|560837531|FG000|Overall Study|Mixed culture|2|||
155383309|NCT03218397|560837532|FG001|Overall Study|Mixed culture|2|||
155383310|NCT03218397|560837531|FG000|Overall Study|Inaccessible hospital records|2|||
155383311|NCT03218397|560837532|FG001|Overall Study|Inaccessible hospital records|5|||
155626399|NCT00977197|561728069|FG001|Overall Study|Withdrawal by Subject|4|||
155626400|NCT00977197|561728068|FG000|Overall Study|Adverse Event|3|||
155626401|NCT00977197|561728069|FG001|Overall Study|Adverse Event|1|||
155626402|NCT00977197|561728068|FG000|Overall Study|Lack of Efficacy|1|||
155626403|NCT00977197|561728069|FG001|Overall Study|Lack of Efficacy|0|||
155626404|NCT00977197|561728068|FG000|Overall Study|Lost to Follow-up|1|||
155626405|NCT00977197|561728069|FG001|Overall Study|Lost to Follow-up|3|||
155626406|NCT00977197|561728068|FG000|Overall Study|Nonadherence|1|||
155626407|NCT00977197|561728069|FG001|Overall Study|Nonadherence|1|||
155626408|NCT02900352|561728070|FG000|Overall Study|Lost to Follow-up|28|||
155626409|NCT02900352|561728071|FG001|Overall Study|Lost to Follow-up|17|||
155626410|NCT00386334|561728074|FG000|Double Blind Period|Adverse Event|9|||
155626411|NCT00386334|561728075|FG001|Double Blind Period|Adverse Event|14|||
155626412|NCT00386334|561728074|FG000|Double Blind Period|Protocol Violation|1|||
155626413|NCT00386334|561728075|FG001|Double Blind Period|Protocol Violation|1|||
155626414|NCT00386334|561728074|FG000|Double Blind Period|Withdrawal by Subject|9|||
155626415|NCT00386334|561728075|FG001|Double Blind Period|Withdrawal by Subject|13|||
155626416|NCT00386334|561728074|FG000|Double Blind Period|Lack of Efficacy|20|||
155383312|NCT03218397|560837531|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
155383313|NCT03218397|560837532|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
155383314|NCT03218397|560837531|FG000|Overall Study|Randomized during laboratory off hours|2|||
155383315|NCT03218397|560837532|FG001|Overall Study|Randomized during laboratory off hours|1|||
155383316|NCT01796548|560837533|FG000|Overall Study|Lost to Follow-up|1|||
155383317|NCT01796548|560837533|FG000|Overall Study|Other|2|||
155383318|NCT02457559|560837534|FG000|Overall Study|Progressive Disease|1|||
155383319|NCT02457559|560837535|FG001|Overall Study|Progressive Disease|2|||
155626417|NCT00386334|561728075|FG001|Double Blind Period|Lack of Efficacy|11|||
155626418|NCT00386334|561728074|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
155626419|NCT00386334|561728075|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
155626420|NCT00386334|561728074|FG000|Double Blind Period|Other|3|||
155626421|NCT00386334|561728075|FG001|Double Blind Period|Other|3|||
155626422|NCT00386334|561728074|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
155729114|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Transplant|0|||
155383320|NCT02457559|560837536|FG002|Overall Study|Progressive Disease|3|||
155383321|NCT02457559|560837537|FG003|Overall Study|Progressive Disease|0|||
155383322|NCT02457559|560837538|FG004|Overall Study|Progressive Disease|0|||
155383323|NCT02457559|560837539|FG005|Overall Study|Progressive Disease|2|||
155383324|NCT02457559|560837540|FG006|Overall Study|Progressive Disease|1|||
155383325|NCT02457559|560837541|FG007|Overall Study|Progressive Disease|0|||
155383326|NCT02457559|560837542|FG008|Overall Study|Progressive Disease|1|||
155383327|NCT02457559|560837543|FG009|Overall Study|Progressive Disease|1|||
155383328|NCT02457559|560837544|FG010|Overall Study|Progressive Disease|1|||
155383329|NCT02457559|560837534|FG000|Overall Study|Investigator's Discretion|0|||
155383330|NCT02457559|560837535|FG001|Overall Study|Investigator's Discretion|0|||
155383331|NCT02457559|560837536|FG002|Overall Study|Investigator's Discretion|2|||
155383332|NCT02457559|560837537|FG003|Overall Study|Investigator's Discretion|0|||
155383333|NCT02457559|560837538|FG004|Overall Study|Investigator's Discretion|1|||
155383334|NCT02457559|560837539|FG005|Overall Study|Investigator's Discretion|0|||
155383335|NCT02457559|560837540|FG006|Overall Study|Investigator's Discretion|1|||
155383336|NCT02457559|560837541|FG007|Overall Study|Investigator's Discretion|0|||
155383337|NCT02457559|560837542|FG008|Overall Study|Investigator's Discretion|1|||
155383338|NCT02457559|560837543|FG009|Overall Study|Investigator's Discretion|0|||
155383339|NCT02457559|560837544|FG010|Overall Study|Investigator's Discretion|1|||
155383340|NCT02457559|560837534|FG000|Overall Study|Adverse Event|0|||
155383341|NCT02457559|560837535|FG001|Overall Study|Adverse Event|1|||
155383342|NCT02457559|560837536|FG002|Overall Study|Adverse Event|2|||
155383343|NCT02457559|560837537|FG003|Overall Study|Adverse Event|0|||
155383344|NCT02457559|560837538|FG004|Overall Study|Adverse Event|0|||
155383345|NCT02457559|560837539|FG005|Overall Study|Adverse Event|0|||
155383346|NCT02457559|560837540|FG006|Overall Study|Adverse Event|0|||
155383347|NCT02457559|560837541|FG007|Overall Study|Adverse Event|0|||
155383348|NCT02457559|560837542|FG008|Overall Study|Adverse Event|0|||
155383349|NCT02457559|560837543|FG009|Overall Study|Adverse Event|0|||
155383350|NCT02457559|560837544|FG010|Overall Study|Adverse Event|0|||
155383351|NCT02457559|560837534|FG000|Overall Study|Reason not Specified|1|||
155383352|NCT02457559|560837535|FG001|Overall Study|Reason not Specified|0|||
155383353|NCT02457559|560837536|FG002|Overall Study|Reason not Specified|0|||
155383354|NCT02457559|560837537|FG003|Overall Study|Reason not Specified|0|||
155383355|NCT02457559|560837538|FG004|Overall Study|Reason not Specified|0|||
155383356|NCT02457559|560837539|FG005|Overall Study|Reason not Specified|0|||
155383357|NCT02457559|560837540|FG006|Overall Study|Reason not Specified|0|||
155383358|NCT02457559|560837541|FG007|Overall Study|Reason not Specified|0|||
155383359|NCT02457559|560837542|FG008|Overall Study|Reason not Specified|0|||
155383360|NCT02457559|560837543|FG009|Overall Study|Reason not Specified|2|||
155383361|NCT02457559|560837544|FG010|Overall Study|Reason not Specified|0|||
155383362|NCT02457559|560837534|FG000|Overall Study|Death|0|||
155383363|NCT02457559|560837535|FG001|Overall Study|Death|0|||
155383364|NCT02457559|560837536|FG002|Overall Study|Death|0|||
155383365|NCT02457559|560837537|FG003|Overall Study|Death|0|||
155383366|NCT02457559|560837538|FG004|Overall Study|Death|0|||
155383367|NCT02457559|560837539|FG005|Overall Study|Death|0|||
155383368|NCT02457559|560837540|FG006|Overall Study|Death|0|||
155383369|NCT02457559|560837541|FG007|Overall Study|Death|0|||
155626423|NCT00386334|561728075|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
155626424|NCT00785356|561728076|FG000|Overall Study|Study prematurely terminated|8|||
155626425|NCT04210986|561728080|FG000|Overall Study|Lost to Follow-up|5|||
155626426|NCT04210986|561728081|FG001|Overall Study|Lost to Follow-up|2|||
155626427|NCT04210986|561728080|FG000|Overall Study|Withdrawal by Subject|3|||
155626428|NCT04210986|561728081|FG001|Overall Study|Withdrawal by Subject|1|||
155626429|NCT04210986|561728080|FG000|Overall Study|Protocol Violation|1|||
155626430|NCT04210986|561728081|FG001|Overall Study|Protocol Violation|1|||
155626431|NCT04210986|561728080|FG000|Overall Study|Physician Decision|0|||
155626432|NCT04210986|561728081|FG001|Overall Study|Physician Decision|1|||
155626433|NCT02378662|561728082|FG000|Overall Study|Early Discontinuation|2|||
155626434|NCT02378662|561728083|FG001|Overall Study|Early Discontinuation|0|||
155626435|NCT02295644|561728084|FG000|Overall Study|Did not meet inclusion criterion|0|||
155626436|NCT02295644|561728085|FG001|Overall Study|Did not meet inclusion criterion|0|||
155626437|NCT02295644|561728086|FG002|Overall Study|Did not meet inclusion criterion|1|||
155626438|NCT02295644|561728087|FG003|Overall Study|Did not meet inclusion criterion|2|||
155626439|NCT03101020|561728088|FG000|Overall Study|Lack of time to participate|1|||
155383370|NCT02457559|560837542|FG008|Overall Study|Death|1|||
155383371|NCT02457559|560837543|FG009|Overall Study|Death|1|||
155383372|NCT02457559|560837544|FG010|Overall Study|Death|0|||
155383373|NCT03866473|560837549|FG000|Phase 1|Death|1|||
155383374|NCT03866473|560837550|FG001|Phase 1|Death|0|||
155383375|NCT03866473|560837549|FG000|Phase 2|Death|0|||
155383376|NCT03866473|560837550|FG001|Phase 2|Death|2|||
155383377|NCT03866473|560837549|FG000|Phase 2|Dropped|1|||
155383378|NCT03866473|560837550|FG001|Phase 2|Dropped|1|||
155383379|NCT03866473|560837549|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
155626440|NCT03101020|561728089|FG001|Overall Study|Lack of time to participate|0|||
155383380|NCT03866473|560837550|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
155383381|NCT02495792|560837551|FG000|Overall Study|Lost to Follow-up|5|||
155383382|NCT02495792|560837552|FG001|Overall Study|Lost to Follow-up|9|||
155383383|NCT02495792|560837551|FG000|Overall Study|Protocol Violation|32|||
155383384|NCT02495792|560837552|FG001|Overall Study|Protocol Violation|31|||
155383385|NCT05590884|560837553|FG000|Overall Study|Withdrawal by Subject|1|||
155383386|NCT05590884|560837554|FG001|Overall Study|Withdrawal by Subject|0|||
155383387|NCT05590884|560837555|FG002|Overall Study|Withdrawal by Subject|0|||
155383388|NCT04443153|560837560|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
155383389|NCT04443153|560837561|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
155383390|NCT04443153|560837560|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
155383391|NCT04443153|560837561|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
155383392|NCT04443153|560837560|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
155383393|NCT04443153|560837561|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
155383394|NCT04443153|560837560|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
155383395|NCT04443153|560837561|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
155383396|NCT03110224|560837565|FG000|Overall Study|Death|3|||
155383397|NCT03110224|560837565|FG000|Overall Study|Lost to Follow-up|132|||
155383398|NCT03110224|560837565|FG000|Overall Study|Physician Decision|2|||
155383399|NCT03110224|560837565|FG000|Overall Study|Site Closed by Physician|35|||
155383400|NCT03110224|560837565|FG000|Overall Study|Site Closed by Sponsor|202|||
155626441|NCT03101020|561728088|FG000|Overall Study|Ran over by a car|0|||
155626442|NCT03101020|561728089|FG001|Overall Study|Ran over by a car|1|||
155383401|NCT03110224|560837565|FG000|Overall Study|Withdrawal by Subject|9|||
155383402|NCT05328167|560837566|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
155383403|NCT05328167|560837566|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
155383404|NCT00409773|560839488|FG000|Overall Study|Adverse Event|3|||
155383405|NCT00409773|560839489|FG001|Overall Study|Adverse Event|4|||
155383406|NCT00409773|560839490|FG002|Overall Study|Adverse Event|4|||
155626443|NCT03101020|561728088|FG000|Overall Study|Withdrawal by Subject|0|||
155626444|NCT03101020|561728089|FG001|Overall Study|Withdrawal by Subject|2|||
155626445|NCT02616783|561728090|FG000|Overall Study|Randomized but Not Treated|1|||
155626446|NCT02616783|561728091|FG001|Overall Study|Randomized but Not Treated|0|||
155626447|NCT02616783|561728090|FG000|Overall Study|Adverse Event|1|||
155626448|NCT02616783|561728091|FG001|Overall Study|Adverse Event|0|||
155626449|NCT02616783|561728090|FG000|Overall Study|Death|1|||
155626450|NCT02616783|561728091|FG001|Overall Study|Death|0|||
155626451|NCT02616783|561728090|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155626452|NCT02616783|561728091|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155626453|NCT02616783|561728090|FG000|Overall Study|Protocol Violation|1|||
155626454|NCT02616783|561728091|FG001|Overall Study|Protocol Violation|1|||
155626455|NCT02616783|561728090|FG000|Overall Study|Withdrew Consent|1|||
155626456|NCT02616783|561728091|FG001|Overall Study|Withdrew Consent|1|||
155626457|NCT01103323|561728092|FG000|Without/Before Drug Switch|Adverse Event|50|||
155626458|NCT01103323|561728093|FG001|Without/Before Drug Switch|Adverse Event|7|||
155626459|NCT01103323|561728092|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
155626460|NCT01103323|561728093|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
155626461|NCT01103323|561728092|FG000|Without/Before Drug Switch|Protocol Violation|2|||
155626462|NCT01103323|561728093|FG001|Without/Before Drug Switch|Protocol Violation|0|||
155626463|NCT01103323|561728092|FG000|Without/Before Drug Switch|Physician Decision|2|||
155626464|NCT01103323|561728093|FG001|Without/Before Drug Switch|Physician Decision|0|||
155626465|NCT01103323|561728092|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
155626466|NCT01103323|561728093|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
155626467|NCT01103323|561728092|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
155626468|NCT01103323|561728093|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
155626469|NCT01103323|561728092|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
155626470|NCT01103323|561728093|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
155626471|NCT00372424|561728094|FG000|Overall Study|Adverse Event|2|||
155626472|NCT00372424|561728094|FG000|Overall Study|Withdrawal by Subject|1|||
155626473|NCT00372424|561728094|FG000|Overall Study|Death|1|||
155626474|NCT00372424|561728094|FG000|Overall Study|Objective Progression or Relapse|14|||
155626475|NCT00372424|561728094|FG000|Overall Study|Other|7|||
155626476|NCT00372424|561728094|FG000|Overall Study|Enrolled, Not Treated|1|||
155626477|NCT05214118|561728103|FG000|Overall Study|Lost to Follow-up|0|||
155626478|NCT05214118|561728104|FG001|Overall Study|Lost to Follow-up|2|||
155626479|NCT05214118|561728103|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
155626480|NCT05214118|561728104|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
155626481|NCT05214118|561728103|FG000|Overall Study|moved|1|||
155626482|NCT05214118|561728104|FG001|Overall Study|moved|0|||
155626483|NCT03797898|561728107|FG000|Overall Study|Lost to Follow-up|60|||
155626484|NCT03797898|561728108|FG001|Overall Study|Lost to Follow-up|69|||
155626485|NCT03797898|561728107|FG000|Overall Study|Withdrawal by Subject|9|||
155626486|NCT03797898|561728108|FG001|Overall Study|Withdrawal by Subject|7|||
155626487|NCT03797898|561728107|FG000|Overall Study|Became ineligible|5|||
155383407|NCT00409773|560839491|FG003|Overall Study|Adverse Event|2|||
155383408|NCT00409773|560839492|FG004|Overall Study|Adverse Event|6|||
155383409|NCT00409773|560839488|FG000|Overall Study|Lost to Follow-up|6|||
155383410|NCT00409773|560839489|FG001|Overall Study|Lost to Follow-up|1|||
155383411|NCT00409773|560839490|FG002|Overall Study|Lost to Follow-up|2|||
155383412|NCT00409773|560839491|FG003|Overall Study|Lost to Follow-up|3|||
155383413|NCT00409773|560839492|FG004|Overall Study|Lost to Follow-up|1|||
155383414|NCT00409773|560839488|FG000|Overall Study|Physician Decision|0|||
155383415|NCT00409773|560839489|FG001|Overall Study|Physician Decision|0|||
155383416|NCT00409773|560839490|FG002|Overall Study|Physician Decision|0|||
155383417|NCT00409773|560839491|FG003|Overall Study|Physician Decision|2|||
155383418|NCT00409773|560839492|FG004|Overall Study|Physician Decision|0|||
155383419|NCT00409773|560839488|FG000|Overall Study|Protocol Violation|0|||
155383420|NCT00409773|560839489|FG001|Overall Study|Protocol Violation|2|||
155383421|NCT00409773|560839490|FG002|Overall Study|Protocol Violation|3|||
155383422|NCT00409773|560839491|FG003|Overall Study|Protocol Violation|3|||
155383423|NCT00409773|560839492|FG004|Overall Study|Protocol Violation|1|||
155383424|NCT00409773|560839488|FG000|Overall Study|Withdrawal by Subject|0|||
155383425|NCT00409773|560839489|FG001|Overall Study|Withdrawal by Subject|0|||
155383426|NCT00409773|560839490|FG002|Overall Study|Withdrawal by Subject|0|||
155383427|NCT00409773|560839491|FG003|Overall Study|Withdrawal by Subject|2|||
155383428|NCT00409773|560839492|FG004|Overall Study|Withdrawal by Subject|1|||
155383429|NCT00409773|560839488|FG000|Overall Study|Lack of Eligibility|0|||
155383430|NCT00409773|560839489|FG001|Overall Study|Lack of Eligibility|0|||
155383431|NCT00409773|560839490|FG002|Overall Study|Lack of Eligibility|0|||
155383432|NCT00409773|560839491|FG003|Overall Study|Lack of Eligibility|0|||
155383433|NCT00409773|560839492|FG004|Overall Study|Lack of Eligibility|1|||
155383434|NCT01919814|560839493|FG000|Overall Study|Adverse Event|1|||
155383435|NCT01919814|560839494|FG001|Overall Study|Adverse Event|0|||
155383436|NCT01919814|560839493|FG000|Overall Study|Protocol Violation|1|||
155383437|NCT01919814|560839494|FG001|Overall Study|Protocol Violation|0|||
155383438|NCT01919814|560839493|FG000|Overall Study|Withdrawal by Subject|1|||
155383439|NCT01919814|560839494|FG001|Overall Study|Withdrawal by Subject|0|||
155383440|NCT01440374|560839495|FG000|Part 1: Open-label Phase|Adverse Event|5|||
155383441|NCT01440374|560839496|FG001|Part 1: Open-label Phase|Adverse Event|0|||
155383442|NCT01440374|560839497|FG002|Part 1: Open-label Phase|Adverse Event|0|||
155383443|NCT01440374|560839498|FG003|Part 1: Open-label Phase|Adverse Event|0|||
155383444|NCT01440374|560839495|FG000|Part 1: Open-label Phase|Physician Decision|1|||
155383445|NCT01440374|560839496|FG001|Part 1: Open-label Phase|Physician Decision|0|||
155383446|NCT01440374|560839497|FG002|Part 1: Open-label Phase|Physician Decision|0|||
155383447|NCT01440374|560839498|FG003|Part 1: Open-label Phase|Physician Decision|0|||
155383448|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
155383449|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
155383450|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
155383451|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
155383452|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
155383453|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
155383454|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
155383455|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
155383456|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
155383457|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
155383458|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
155383459|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
155626488|NCT03797898|561728108|FG001|Overall Study|Became ineligible|2|||
155626489|NCT02314728|561728109|FG000|Overall Study|Protocol Violation|1|||
155626490|NCT02314728|561728110|FG001|Overall Study|Protocol Violation|0|||
155626491|NCT02314728|561728109|FG000|Overall Study|Lost to Follow-up|0|||
155626492|NCT02314728|561728110|FG001|Overall Study|Lost to Follow-up|1|||
155626493|NCT03080935|561728111|FG000|Overall Study|Death|34|||
155626494|NCT03080935|561728112|FG001|Overall Study|Death|50|||
155626495|NCT03080935|561728111|FG000|Overall Study|Lost to Follow-up|5|||
155626496|NCT03080935|561728112|FG001|Overall Study|Lost to Follow-up|4|||
155626497|NCT03080935|561728111|FG000|Overall Study|Withdrawal by Subject|11|||
155626498|NCT03080935|561728112|FG001|Overall Study|Withdrawal by Subject|15|||
155626499|NCT03118934|561728113|FG000|Overall Study|Adverse Event|0|||
155626500|NCT03118934|561728114|FG001|Overall Study|Adverse Event|0|||
155626501|NCT03118934|561728115|FG002|Overall Study|Adverse Event|0|||
155626502|NCT03118934|561728116|FG003|Overall Study|Adverse Event|0|||
155626503|NCT03118934|561728117|FG004|Overall Study|Adverse Event|0|||
155626504|NCT03118934|561728118|FG005|Overall Study|Adverse Event|1|||
155626505|NCT03118934|561728113|FG000|Overall Study|Physician Decision|0|||
155626506|NCT03118934|561728114|FG001|Overall Study|Physician Decision|0|||
155626507|NCT03118934|561728115|FG002|Overall Study|Physician Decision|0|||
155626508|NCT03118934|561728116|FG003|Overall Study|Physician Decision|0|||
155626509|NCT03118934|561728117|FG004|Overall Study|Physician Decision|0|||
155626510|NCT03118934|561728118|FG005|Overall Study|Physician Decision|1|||
155626511|NCT03118934|561728113|FG000|Overall Study|Discontinued prior to exposure|0|||
155383460|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383461|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
155383462|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383463|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383464|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
155383465|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
155383466|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
155383467|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
155383468|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Not treated|0|||
155383469|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Not treated|0|||
155383470|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Not treated|1|||
155383471|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Not treated|0|||
155383472|NCT01440374|560839495|FG000|Part 3: Extension|Withdrawal by Subject|0|||
155383473|NCT01440374|560839496|FG001|Part 3: Extension|Withdrawal by Subject|0|||
155383474|NCT01440374|560839497|FG002|Part 3: Extension|Withdrawal by Subject|0|||
155383475|NCT01440374|560839498|FG003|Part 3: Extension|Withdrawal by Subject|5|||
155383476|NCT01440374|560839495|FG000|Part 3: Extension|Adverse Event|0|||
155383477|NCT01440374|560839496|FG001|Part 3: Extension|Adverse Event|0|||
155383478|NCT01440374|560839497|FG002|Part 3: Extension|Adverse Event|0|||
155383479|NCT01440374|560839498|FG003|Part 3: Extension|Adverse Event|13|||
155383480|NCT01440374|560839495|FG000|Part 3: Extension|Physician Decision|0|||
155383481|NCT01440374|560839496|FG001|Part 3: Extension|Physician Decision|0|||
155383482|NCT01440374|560839497|FG002|Part 3: Extension|Physician Decision|0|||
155383483|NCT01440374|560839498|FG003|Part 3: Extension|Physician Decision|14|||
155383484|NCT04812548|560839500|FG000|Overall Study|Adverse Event|2|||
155383485|NCT04812548|560839501|FG001|Overall Study|Adverse Event|7|||
155383486|NCT04812548|560839500|FG000|Overall Study|HSCT Planned|2|||
155383487|NCT04812548|560839501|FG001|Overall Study|HSCT Planned|3|||
155383488|NCT04812548|560839500|FG000|Overall Study|Progressive Disease|0|||
155383489|NCT04812548|560839501|FG001|Overall Study|Progressive Disease|2|||
155383490|NCT04812548|560839500|FG000|Overall Study|Death|0|||
155383491|NCT04812548|560839501|FG001|Overall Study|Death|1|||
155383492|NCT04812548|560839500|FG000|Overall Study|Post Study Access to Treatment|0|||
155383493|NCT04812548|560839501|FG001|Overall Study|Post Study Access to Treatment|1|||
155383494|NCT04812548|560839500|FG000|Overall Study|Withdrawal by Subject|0|||
155383495|NCT04812548|560839501|FG001|Overall Study|Withdrawal by Subject|1|||
155383496|NCT04812548|560839500|FG000|Overall Study|Physician Decision|1|||
155383497|NCT04812548|560839501|FG001|Overall Study|Physician Decision|0|||
155383498|NCT02141984|560839503|FG000|Overall Study|Lack of Efficacy|2|||
155383499|NCT01765192|560839506|FG000|Treatment Period 1|Adverse Event|0|||
155383500|NCT01765192|560839507|FG001|Treatment Period 1|Adverse Event|1|||
155383501|NCT01765192|560839506|FG000|Washout Period|Voluntary Withdrawal|1|||
155383502|NCT01765192|560839507|FG001|Washout Period|Voluntary Withdrawal|1|||
155383503|NCT01765192|560839506|FG000|Washout Period|Reason not specified|1|||
155383504|NCT01765192|560839507|FG001|Washout Period|Reason not specified|0|||
155383505|NCT01765192|560839506|FG000|Treatment Period 2|Reason not specified|0|||
155383506|NCT01765192|560839507|FG001|Treatment Period 2|Reason not specified|2|||
155383507|NCT01765192|560839506|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
155383508|NCT01765192|560839507|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
155626512|NCT03118934|561728114|FG001|Overall Study|Discontinued prior to exposure|1|||
155626513|NCT03118934|561728115|FG002|Overall Study|Discontinued prior to exposure|1|||
155626514|NCT03118934|561728116|FG003|Overall Study|Discontinued prior to exposure|1|||
155626515|NCT03118934|561728117|FG004|Overall Study|Discontinued prior to exposure|2|||
155626516|NCT03118934|561728118|FG005|Overall Study|Discontinued prior to exposure|0|||
155626517|NCT01614470|561728119|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
155626518|NCT01614470|561728120|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155626519|NCT01614470|561728121|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155626520|NCT01614470|561728119|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
155626521|NCT01614470|561728120|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
155626522|NCT01614470|561728121|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
155626523|NCT03217591|561728132|FG000|Overall Study|Adverse Event|1|||
155626524|NCT03217591|561728133|FG001|Overall Study|Adverse Event|2|||
155626525|NCT03217591|561728134|FG002|Overall Study|Adverse Event|6|||
155626526|NCT03217591|561728132|FG000|Overall Study|Withdrawal by Subject|0|||
155383509|NCT04874415|560839510|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383510|NCT04874415|560839511|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383511|NCT04874415|560839512|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383512|NCT04874415|560839513|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383513|NCT04874415|560839514|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383514|NCT04874415|560839515|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155626527|NCT03217591|561728133|FG001|Overall Study|Withdrawal by Subject|1|||
155626528|NCT03217591|561728134|FG002|Overall Study|Withdrawal by Subject|3|||
155626529|NCT03217591|561728132|FG000|Overall Study|Lost to Follow-up|1|||
155383515|NCT04874415|560839516|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383516|NCT04874415|560839517|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383517|NCT04874415|560839518|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
155383518|NCT04874415|560839519|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383519|NCT04874415|560839520|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383520|NCT04874415|560839521|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383521|NCT04874415|560839522|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383522|NCT04874415|560839523|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383523|NCT04874415|560839524|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
155383524|NCT04874415|560839525|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383525|NCT04874415|560839510|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383526|NCT04874415|560839511|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383527|NCT04874415|560839512|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383528|NCT04874415|560839513|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383529|NCT04874415|560839514|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383530|NCT04874415|560839515|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383531|NCT04874415|560839516|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383532|NCT04874415|560839517|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383533|NCT04874415|560839518|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383534|NCT04874415|560839519|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
155383535|NCT04874415|560839520|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383536|NCT04874415|560839521|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383537|NCT04874415|560839522|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383538|NCT04874415|560839523|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383539|NCT04874415|560839524|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383540|NCT04874415|560839525|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383541|NCT04874415|560839510|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383542|NCT04874415|560839511|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383543|NCT04874415|560839512|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383544|NCT04874415|560839513|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383545|NCT04874415|560839514|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
155383546|NCT04874415|560839515|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383547|NCT04874415|560839516|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383548|NCT04874415|560839517|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383549|NCT04874415|560839518|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383550|NCT04874415|560839519|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383551|NCT04874415|560839520|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383552|NCT04874415|560839521|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383553|NCT04874415|560839522|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383554|NCT04874415|560839523|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383555|NCT04874415|560839524|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383556|NCT04874415|560839525|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383557|NCT05062759|560839528|FG000|Overall Study|Death|0|||
155383558|NCT05062759|560839529|FG001|Overall Study|Death|1|||
155383559|NCT05062759|560839528|FG000|Overall Study|Lost to Follow-up|1|||
155383560|NCT05062759|560839529|FG001|Overall Study|Lost to Follow-up|0|||
155383561|NCT04981366|560839530|FG000|Overall Study|Withdrawal by Subject|5|||
155383562|NCT04981366|560839531|FG001|Overall Study|Withdrawal by Subject|4|||
155383563|NCT04981366|560839532|FG002|Overall Study|Withdrawal by Subject|8|||
155383564|NCT04981366|560839530|FG000|Overall Study|Health issues unrelated to the trial|1|||
155383565|NCT04981366|560839531|FG001|Overall Study|Health issues unrelated to the trial|2|||
155383566|NCT04981366|560839532|FG002|Overall Study|Health issues unrelated to the trial|0|||
155383567|NCT03214094|560839533|FG000|Overall Study|Case Report Forms Uncollected|14|||
155383568|NCT03214094|560839533|FG000|Overall Study|Protocol Deviation|46|||
155383569|NCT00310037|560839534|FG000|Overall Study|Adverse Event|7|||
155383570|NCT00310037|560839535|FG001|Overall Study|Adverse Event|14|||
155383571|NCT00310037|560839534|FG000|Overall Study|Withdrawal by Subject|4|||
155383572|NCT00310037|560839535|FG001|Overall Study|Withdrawal by Subject|3|||
155383573|NCT00310037|560839534|FG000|Overall Study|Progression|6|||
155383574|NCT00310037|560839535|FG001|Overall Study|Progression|0|||
155383575|NCT00310037|560839534|FG000|Overall Study|Non-protocol treatment|1|||
155626530|NCT03217591|561728133|FG001|Overall Study|Lost to Follow-up|0|||
155383576|NCT00310037|560839535|FG001|Overall Study|Non-protocol treatment|0|||
155383577|NCT00440999|560839546|FG000|Overall Study|Adverse Event|0|||
155383578|NCT00440999|560839547|FG001|Overall Study|Adverse Event|2|||
155383579|NCT00440999|560839546|FG000|Overall Study|Lack of Efficacy|6|||
155383580|NCT00440999|560839547|FG001|Overall Study|Lack of Efficacy|7|||
155383581|NCT00440999|560839546|FG000|Overall Study|Lost to Follow-up|19|||
155383582|NCT00440999|560839547|FG001|Overall Study|Lost to Follow-up|12|||
155383583|NCT00440999|560839546|FG000|Overall Study|Protocol Violation|1|||
155383584|NCT00440999|560839547|FG001|Overall Study|Protocol Violation|0|||
155383585|NCT00440999|560839546|FG000|Overall Study|Withdrawal by Subject|2|||
155383586|NCT00440999|560839547|FG001|Overall Study|Withdrawal by Subject|5|||
155383587|NCT00440999|560839546|FG000|Overall Study|Subjets missed the visit|1|||
155383588|NCT00440999|560839547|FG001|Overall Study|Subjets missed the visit|0|||
155383589|NCT00440999|560839546|FG000|Overall Study|Mixed infection at entry|1|||
155383590|NCT00440999|560839547|FG001|Overall Study|Mixed infection at entry|0|||
155383591|NCT00440999|560839546|FG000|Overall Study|P. falciparum malaria|5|||
155383592|NCT00440999|560839547|FG001|Overall Study|P. falciparum malaria|14|||
155383593|NCT00440999|560839546|FG000|Overall Study|Subj left hosp without inform staff|0|||
155383594|NCT00440999|560839547|FG001|Overall Study|Subj left hosp without inform staff|1|||
155383595|NCT05559099|560839550|FG000|Overall Study|Death|5|||
155383596|NCT05559099|560839551|FG001|Overall Study|Death|4|||
155383597|NCT05559099|560839550|FG000|Overall Study|Lost to Follow-up|0|||
155383598|NCT05559099|560839551|FG001|Overall Study|Lost to Follow-up|2|||
155383599|NCT05559099|560839550|FG000|Overall Study|Adverse Event|1|||
155383600|NCT05559099|560839551|FG001|Overall Study|Adverse Event|1|||
155383601|NCT04018092|560839552|FG000|Overall Study|Withdrawal by Subject|1|||
155383602|NCT04018092|560839553|FG001|Overall Study|Withdrawal by Subject|1|||
155383603|NCT04018092|560839552|FG000|Overall Study|Withdrawal by Subject|1|||
155383604|NCT04018092|560839553|FG001|Overall Study|Withdrawal by Subject|1|||
155383605|NCT06469242|560839554|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
155383606|NCT06469242|560839555|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
155383607|NCT06469242|560839554|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
155383608|NCT06469242|560839555|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
155383609|NCT05041101|560839556|FG000|Overall Study|Adverse Event|1|||
155383610|NCT05041101|560839557|FG001|Overall Study|Adverse Event|0|||
155383611|NCT05041101|560839558|FG002|Overall Study|Adverse Event|0|||
155383612|NCT05041101|560839556|FG000|Overall Study|Diease Progression|5|||
155383613|NCT05041101|560839557|FG001|Overall Study|Diease Progression|0|||
155383614|NCT05041101|560839558|FG002|Overall Study|Diease Progression|0|||
155383615|NCT00211185|560839559|FG000|Overall Study|Death|2|||
155383616|NCT00211185|560839559|FG000|Overall Study|Disease progression|7|||
155383617|NCT00211185|560839559|FG000|Overall Study|Withdrawal by Subject|6|||
155383618|NCT00211185|560839559|FG000|Overall Study|Physician Decision|5|||
155383619|NCT00249002|560839560|FG000|Overall Study|Adverse Event|2|||
155383620|NCT00249002|560839560|FG000|Overall Study|Study cancellation|3|||
155626531|NCT03217591|561728134|FG002|Overall Study|Lost to Follow-up|0|||
155626532|NCT03217591|561728132|FG000|Overall Study|Protocol Violation|1|||
155626533|NCT03217591|561728133|FG001|Overall Study|Protocol Violation|0|||
155626534|NCT03217591|561728134|FG002|Overall Study|Protocol Violation|1|||
155626535|NCT00069264|561728139|FG000|Overall Study|Adverse Event|3|||
155626536|NCT00069264|561728139|FG000|Overall Study|Progressive Disease|23|||
155626537|NCT00069264|561728139|FG000|Overall Study|Withdrawal by Subject|3|||
155626538|NCT00069264|561728139|FG000|Overall Study|Discon Therapy|3|||
155626539|NCT04249427|561728142|FG000|Overall Study|Adverse Event|3|||
155626540|NCT04249427|561728143|FG001|Overall Study|Adverse Event|1|||
155626541|NCT04249427|561728142|FG000|Overall Study|Lack of Efficacy|0|||
155626542|NCT04249427|561728143|FG001|Overall Study|Lack of Efficacy|1|||
155626543|NCT04249427|561728142|FG000|Overall Study|Withdrawal by Subject|1|||
155626544|NCT04249427|561728143|FG001|Overall Study|Withdrawal by Subject|2|||
155626545|NCT02895347|561728146|FG000|Overall Study|Withdrawal by Subject|3|||
155626546|NCT02895347|561728147|FG001|Overall Study|Withdrawal by Subject|1|||
155626547|NCT01673178|561728151|FG000|Overall Study|Lost to Follow-up|0|||
155383621|NCT00249002|560839560|FG000|Overall Study|Other|2|||
155383622|NCT00069108|560839561|FG000|Overall Study|Withdrawal by Subject|5|||
155383623|NCT00069108|560839562|FG001|Overall Study|Withdrawal by Subject|9|||
155383624|NCT00069108|560839561|FG000|Overall Study|Adverse Event|64|||
155626548|NCT01673178|561728152|FG001|Overall Study|Lost to Follow-up|1|||
155626549|NCT01673178|561728153|FG002|Overall Study|Lost to Follow-up|0|||
155626550|NCT01673178|561728154|FG003|Overall Study|Lost to Follow-up|0|||
155626551|NCT01673178|561728155|FG004|Overall Study|Lost to Follow-up|0|||
155626552|NCT01673178|561728151|FG000|Overall Study|Withdrawal by Subject|0|||
155626553|NCT01673178|561728152|FG001|Overall Study|Withdrawal by Subject|0|||
155626554|NCT01673178|561728153|FG002|Overall Study|Withdrawal by Subject|1|||
155383625|NCT00069108|560839562|FG001|Overall Study|Adverse Event|42|||
155383626|NCT00069108|560839561|FG000|Overall Study|Death|6|||
155383627|NCT00069108|560839562|FG001|Overall Study|Death|6|||
155626555|NCT01673178|561728154|FG003|Overall Study|Withdrawal by Subject|4|||
155626556|NCT01673178|561728155|FG004|Overall Study|Withdrawal by Subject|2|||
155626557|NCT01673178|561728151|FG000|Overall Study|Protocol Violation|1|||
155626558|NCT01673178|561728152|FG001|Overall Study|Protocol Violation|1|||
155383628|NCT00069108|560839561|FG000|Overall Study|Administration|15|||
155383629|NCT00069108|560839562|FG001|Overall Study|Administration|4|||
155383630|NCT00069108|560839561|FG000|Overall Study|Insufficient therapy|117|||
155729115|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Transplant|0|||
155729116|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Transplant|0|||
155729117|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
155729118|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
155729119|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
155729120|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
155729121|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
155729122|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
155729123|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
155729124|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
155729125|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
155729126|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
155729127|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
155729128|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
155729129|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
155729130|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
155729131|NCT02113982|562108033|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
155729132|NCT02113982|562108034|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
155278990|NCT00873093|560454745|FG003|Overall Study|Ineligible|1|||
155278991|NCT00873093|560454746|FG004|Overall Study|Ineligible|0|||
155278992|NCT00146640|560454749|FG000|Overall Study|Adverse Event|12|||
155278993|NCT00146640|560454750|FG001|Overall Study|Adverse Event|10|||
155278994|NCT00146640|560454749|FG000|Overall Study|Medical Reasons|3|||
155278995|NCT00146640|560454750|FG001|Overall Study|Medical Reasons|0|||
155278996|NCT00146640|560454749|FG000|Overall Study|Non-Medical Reasons|8|||
155278997|NCT00146640|560454750|FG001|Overall Study|Non-Medical Reasons|4|||
155278998|NCT02117544|560454751|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
155278999|NCT02117544|560454752|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
155279000|NCT02059161|560454753|FG000|Overall Study|Pregnancy|0|||
155279001|NCT02059161|560454754|FG001|Overall Study|Pregnancy|2|||
155279002|NCT02059161|560454753|FG000|Overall Study|Adverse Event|2|||
155279003|NCT02059161|560454754|FG001|Overall Study|Adverse Event|6|||
155279004|NCT02059161|560454753|FG000|Overall Study|Lost to Follow-up|20|||
155279005|NCT02059161|560454754|FG001|Overall Study|Lost to Follow-up|12|||
155279006|NCT02059161|560454753|FG000|Overall Study|Physician Decision|4|||
155279007|NCT02059161|560454754|FG001|Overall Study|Physician Decision|4|||
155279008|NCT02059161|560454753|FG000|Overall Study|Protocol Violation|1|||
155279009|NCT02059161|560454754|FG001|Overall Study|Protocol Violation|1|||
155279010|NCT02059161|560454753|FG000|Overall Study|Withdrawal by Subject|16|||
155279011|NCT02059161|560454754|FG001|Overall Study|Withdrawal by Subject|13|||
155279012|NCT02059161|560454753|FG000|Overall Study|Randomized in error, no study drug|0|||
155279013|NCT02059161|560454754|FG001|Overall Study|Randomized in error, no study drug|1|||
155279014|NCT02059161|560454753|FG000|Overall Study|Non-compliance with study drug|6|||
155279015|NCT02059161|560454754|FG001|Overall Study|Non-compliance with study drug|2|||
155279016|NCT03486899|560454755|FG000|Overall Study|Lost to Follow-up|4|||
155279017|NCT03486899|560454756|FG001|Overall Study|Lost to Follow-up|1|||
155279018|NCT03486899|560454757|FG002|Overall Study|Lost to Follow-up|4|||
155279019|NCT03486899|560454758|FG003|Overall Study|Lost to Follow-up|3|||
155279020|NCT03486899|560454755|FG000|Overall Study|Death|1|||
155279021|NCT03486899|560454756|FG001|Overall Study|Death|0|||
155279022|NCT03486899|560454757|FG002|Overall Study|Death|0|||
155279023|NCT03486899|560454758|FG003|Overall Study|Death|1|||
155279024|NCT03486899|560454755|FG000|Overall Study|Adverse Event|0|||
155279025|NCT03486899|560454756|FG001|Overall Study|Adverse Event|2|||
155279026|NCT03486899|560454757|FG002|Overall Study|Adverse Event|0|||
155279027|NCT03486899|560454758|FG003|Overall Study|Adverse Event|2|||
155279028|NCT03486899|560454755|FG000|Overall Study|Withdrawal by Subject|3|||
155279029|NCT03486899|560454756|FG001|Overall Study|Withdrawal by Subject|7|||
155279030|NCT03486899|560454757|FG002|Overall Study|Withdrawal by Subject|4|||
155279031|NCT03486899|560454758|FG003|Overall Study|Withdrawal by Subject|3|||
155279032|NCT03486899|560454755|FG000|Overall Study|Other Reasons|0|||
155279033|NCT03486899|560454756|FG001|Overall Study|Other Reasons|1|||
155279034|NCT03486899|560454757|FG002|Overall Study|Other Reasons|0|||
155279035|NCT03486899|560454758|FG003|Overall Study|Other Reasons|1|||
155279036|NCT01723826|560454759|FG000|Overall Study|Adverse Event|4|||
155279037|NCT01723826|560454760|FG001|Overall Study|Adverse Event|1|||
155279038|NCT01723826|560454761|FG002|Overall Study|Adverse Event|4|||
155279039|NCT01723826|560454762|FG003|Overall Study|Adverse Event|5|||
155279040|NCT01723826|560454759|FG000|Overall Study|Death according to AE eCRF|2|||
155279041|NCT01723826|560454760|FG001|Overall Study|Death according to AE eCRF|3|||
155279042|NCT01723826|560454761|FG002|Overall Study|Death according to AE eCRF|3|||
155279043|NCT01723826|560454762|FG003|Overall Study|Death according to AE eCRF|7|||
155279044|NCT01723826|560454759|FG000|Overall Study|Lost to Follow-up|1|||
155279045|NCT01723826|560454760|FG001|Overall Study|Lost to Follow-up|3|||
155279046|NCT01723826|560454761|FG002|Overall Study|Lost to Follow-up|1|||
155279047|NCT01723826|560454762|FG003|Overall Study|Lost to Follow-up|1|||
155279048|NCT01723826|560454759|FG000|Overall Study|Non-compliance|0|||
155279049|NCT01723826|560454760|FG001|Overall Study|Non-compliance|1|||
155383631|NCT00069108|560839562|FG001|Overall Study|Insufficient therapy|144|||
155383632|NCT00069108|560839561|FG000|Overall Study|Violation criteria|1|||
155383633|NCT00069108|560839562|FG001|Overall Study|Violation criteria|4|||
155383634|NCT00069108|560839561|FG000|Overall Study|Refused treatment|5|||
155383635|NCT00069108|560839562|FG001|Overall Study|Refused treatment|10|||
155383636|NCT00986674|560839563|FG000|Overall Study|Lack of Efficacy|28|||
155383637|NCT00986674|560839564|FG001|Overall Study|Lack of Efficacy|25|||
155383638|NCT00986674|560839565|FG002|Overall Study|Lack of Efficacy|23|||
155383639|NCT00986674|560839563|FG000|Overall Study|Adverse Event|4|||
155383640|NCT00986674|560839564|FG001|Overall Study|Adverse Event|8|||
155383641|NCT00986674|560839565|FG002|Overall Study|Adverse Event|9|||
155383642|NCT00986674|560839563|FG000|Overall Study|Death|5|||
155383643|NCT00986674|560839564|FG001|Overall Study|Death|0|||
155383644|NCT00986674|560839565|FG002|Overall Study|Death|4|||
155383645|NCT00986674|560839563|FG000|Overall Study|Withdrawal by Subject|6|||
155383646|NCT00986674|560839564|FG001|Overall Study|Withdrawal by Subject|2|||
155383647|NCT00986674|560839565|FG002|Overall Study|Withdrawal by Subject|1|||
155383648|NCT00986674|560839563|FG000|Overall Study|alternative therapy|0|||
155383649|NCT00986674|560839564|FG001|Overall Study|alternative therapy|0|||
155383650|NCT00986674|560839565|FG002|Overall Study|alternative therapy|1|||
155383651|NCT00986674|560839563|FG000|Overall Study|not start protocol therapy|4|||
155383652|NCT00986674|560839564|FG001|Overall Study|not start protocol therapy|3|||
155383653|NCT00986674|560839565|FG002|Overall Study|not start protocol therapy|1|||
155383654|NCT00986674|560839563|FG000|Overall Study|unknown/not specify|0|||
155383655|NCT00986674|560839564|FG001|Overall Study|unknown/not specify|7|||
155383656|NCT00986674|560839565|FG002|Overall Study|unknown/not specify|9|||
155383657|NCT00842985|560839566|FG000|Screening|Did not meet entrance requirements|27|||
155383658|NCT00842985|560839566|FG000|First Intervention|Withdrawal by Subject|3|||
155383659|NCT00842985|560839566|FG000|First Intervention|Protocol Violation|3|||
155383660|NCT00842985|560839566|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
155383661|NCT00842985|560839566|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
155383662|NCT01037244|560839567|FG000|Overall Study|Adverse Event|3|||
155383663|NCT01037244|560839568|FG001|Overall Study|Adverse Event|2|||
155626559|NCT01673178|561728153|FG002|Overall Study|Protocol Violation|0|||
155626560|NCT01673178|561728154|FG003|Overall Study|Protocol Violation|1|||
155383664|NCT01037244|560839569|FG002|Overall Study|Adverse Event|6|||
155383665|NCT01037244|560839570|FG003|Overall Study|Adverse Event|3|||
155626561|NCT01673178|561728155|FG004|Overall Study|Protocol Violation|0|||
155383666|NCT01037244|560839567|FG000|Overall Study|Lack of Efficacy|1|||
155626562|NCT01673178|561728151|FG000|Overall Study|Adverse Event|1|||
155626563|NCT01673178|561728152|FG001|Overall Study|Adverse Event|0|||
155626564|NCT01673178|561728153|FG002|Overall Study|Adverse Event|0|||
155626565|NCT01673178|561728154|FG003|Overall Study|Adverse Event|2|||
155626566|NCT01673178|561728155|FG004|Overall Study|Adverse Event|0|||
155626567|NCT01673178|561728151|FG000|Overall Study|Other|1|||
155626568|NCT01673178|561728152|FG001|Overall Study|Other|0|||
155626569|NCT01673178|561728153|FG002|Overall Study|Other|2|||
155626570|NCT01673178|561728154|FG003|Overall Study|Other|1|||
155626571|NCT01673178|561728155|FG004|Overall Study|Other|0|||
155626572|NCT02557399|561728156|FG000|Overall Study|Adverse Event|6|||
155626573|NCT02557399|561728157|FG001|Overall Study|Adverse Event|5|||
155626574|NCT02557399|561728156|FG000|Overall Study|Protocol Violation|0|||
155626575|NCT02557399|561728157|FG001|Overall Study|Protocol Violation|1|||
155626576|NCT02557399|561728156|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155626577|NCT02557399|561728157|FG001|Overall Study|Protocol-defined stopping criteria|1|||
155626578|NCT02557399|561728156|FG000|Overall Study|Withdrawal by Subject|1|||
155626579|NCT02557399|561728157|FG001|Overall Study|Withdrawal by Subject|1|||
155626580|NCT03106077|561728169|FG000|Overall Study|Screen Failure|94|||
155626581|NCT03106077|561728170|FG001|Overall Study|Screen Failure|0|||
155626582|NCT00606307|561728171|FG000|Overall Study|Adverse Event|2|||
155626583|NCT00606307|561728171|FG000|Overall Study|Withdrawal by Subject|2|||
155626584|NCT00606307|561728171|FG000|Overall Study|Disease progression|6|||
155626585|NCT00606307|561728171|FG000|Overall Study|QTc prolongation|1|||
155626586|NCT01274533|561728172|FG000|Overall Study|Withdrawal by Subject|1|||
155626587|NCT01274533|561728172|FG000|Overall Study|Non-compliance|1|||
155626588|NCT01274533|561728172|FG000|Overall Study|Disease progression|2|||
155626589|NCT02563899|561728173|FG000|Overall Study|Protocol Violation|1|||
155626590|NCT02563899|561728174|FG001|Overall Study|Protocol Violation|0|||
155383667|NCT01037244|560839568|FG001|Overall Study|Lack of Efficacy|1|||
155383668|NCT01037244|560839569|FG002|Overall Study|Lack of Efficacy|0|||
155626591|NCT02563899|561728175|FG002|Overall Study|Protocol Violation|0|||
155626592|NCT02563899|561728176|FG003|Overall Study|Protocol Violation|0|||
155626593|NCT02563899|561728173|FG000|Overall Study|Withdrawal by Subject|0|||
155626594|NCT02563899|561728174|FG001|Overall Study|Withdrawal by Subject|0|||
155626595|NCT02563899|561728175|FG002|Overall Study|Withdrawal by Subject|1|||
155626596|NCT02563899|561728176|FG003|Overall Study|Withdrawal by Subject|0|||
155626597|NCT03669588|561728177|FG000|Overall Study|Adverse Event|1|||
155626598|NCT03669588|561728178|FG001|Overall Study|Adverse Event|0|||
155383669|NCT01037244|560839570|FG003|Overall Study|Lack of Efficacy|1|||
155383670|NCT01037244|560839567|FG000|Overall Study|Lost to Follow-up|3|||
155383671|NCT01037244|560839568|FG001|Overall Study|Lost to Follow-up|3|||
155383672|NCT01037244|560839569|FG002|Overall Study|Lost to Follow-up|4|||
155383673|NCT01037244|560839570|FG003|Overall Study|Lost to Follow-up|4|||
155383674|NCT01037244|560839567|FG000|Overall Study|Withdrawal by Subject|1|||
155383675|NCT01037244|560839568|FG001|Overall Study|Withdrawal by Subject|5|||
155626599|NCT03669588|561728177|FG000|Overall Study|Physician Decision|0|||
155626600|NCT03669588|561728178|FG001|Overall Study|Physician Decision|1|||
155626601|NCT03669588|561728177|FG000|Overall Study|Protocol Violation|1|||
155626602|NCT03669588|561728178|FG001|Overall Study|Protocol Violation|0|||
155626603|NCT03669588|561728177|FG000|Overall Study|Sponsor Decision|1|||
155626604|NCT03669588|561728178|FG001|Overall Study|Sponsor Decision|1|||
155626605|NCT03669588|561728177|FG000|Overall Study|Withdrawal by Subject|1|||
155626606|NCT03669588|561728178|FG001|Overall Study|Withdrawal by Subject|4|||
155626607|NCT03669588|561728177|FG000|Overall Study|Rescue Therapy Needed|0|||
155626608|NCT03669588|561728178|FG001|Overall Study|Rescue Therapy Needed|1|||
155626609|NCT02949947|561728180|FG000|Overall Study|Non Compliance|0|||
155626610|NCT02949947|561728181|FG001|Overall Study|Non Compliance|1|||
155626611|NCT02949947|561728180|FG000|Overall Study|Insurance change|1|||
155626612|NCT02949947|561728181|FG001|Overall Study|Insurance change|0|||
155626613|NCT01973218|561728182|FG000|Overall Study|Adverse Event|1|||
155626614|NCT01973218|561728183|FG001|Overall Study|Adverse Event|0|||
155626615|NCT01973218|561728182|FG000|Overall Study|Withdrawal by Subject|1|||
155626616|NCT01973218|561728183|FG001|Overall Study|Withdrawal by Subject|0|||
155626617|NCT00492726|561728184|FG000|Overall Study|Adverse Event|10|||
155626618|NCT00492726|561728185|FG001|Overall Study|Adverse Event|6|||
155626619|NCT00492726|561728184|FG000|Overall Study|Death|7|||
155626620|NCT00492726|561728185|FG001|Overall Study|Death|2|||
155626621|NCT00492726|561728184|FG000|Overall Study|Lack of Efficacy|0|||
155626622|NCT00492726|561728185|FG001|Overall Study|Lack of Efficacy|2|||
155626623|NCT00492726|561728184|FG000|Overall Study|Lost to Follow-up|27|||
155626624|NCT00492726|561728185|FG001|Overall Study|Lost to Follow-up|19|||
155626625|NCT00492726|561728184|FG000|Overall Study|Physician Decision|0|||
155626626|NCT00492726|561728185|FG001|Overall Study|Physician Decision|1|||
155626627|NCT00492726|561728184|FG000|Overall Study|Withdrawal by Subject|6|||
155626628|NCT00492726|561728185|FG001|Overall Study|Withdrawal by Subject|3|||
155626629|NCT00492726|561728184|FG000|Overall Study|Non compliant with study medication|0|||
155626630|NCT00492726|561728185|FG001|Overall Study|Non compliant with study medication|3|||
155626631|NCT01100502|561728186|FG000|Overall Study|Withdrawal by Subject|18|||
155626632|NCT01100502|561728187|FG001|Overall Study|Withdrawal by Subject|25|||
155626633|NCT01100502|561728186|FG000|Overall Study|Lost to Follow-up|13|||
155626634|NCT01100502|561728187|FG001|Overall Study|Lost to Follow-up|28|||
155626635|NCT01100502|561728186|FG000|Overall Study|Site request to end participation in study|0|||
155626636|NCT01100502|561728187|FG001|Overall Study|Site request to end participation in study|1|||
155626637|NCT01100502|561728186|FG000|Overall Study|Death|45|||
155626638|NCT01100502|561728187|FG001|Overall Study|Death|40|||
155626639|NCT04386902|561728188|FG000|Overall Study|Withdrawal by Subject|5|||
155626640|NCT04386902|561728188|FG000|Overall Study|Technical problems in the recording|5|||
155626641|NCT01190891|561729985|FG000|Overall Study|Protocol Violation|1|||
155626642|NCT01190891|561729986|FG001|Overall Study|Protocol Violation|0|||
155626643|NCT01190891|561729985|FG000|Overall Study|Withdrawal by Subject|5|||
155626644|NCT01190891|561729986|FG001|Overall Study|Withdrawal by Subject|0|||
155626645|NCT00737048|561729987|FG000|Overall Study|Physician Decision|0|||
155626646|NCT00737048|561729988|FG001|Overall Study|Physician Decision|0|||
155626647|NCT00737048|561729989|FG002|Overall Study|Physician Decision|1|||
155626648|NCT00737048|561729987|FG000|Overall Study|Adverse Event|0|||
155626649|NCT00737048|561729988|FG001|Overall Study|Adverse Event|1|||
155626650|NCT00737048|561729989|FG002|Overall Study|Adverse Event|0|||
155626651|NCT00737048|561729987|FG000|Overall Study|Worsening of the symptoms|3|||
155626652|NCT00737048|561729988|FG001|Overall Study|Worsening of the symptoms|5|||
155626653|NCT00737048|561729989|FG002|Overall Study|Worsening of the symptoms|3|||
155626654|NCT04635839|561729990|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
155626655|NCT04635839|561729991|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
155626656|NCT02737358|561729992|FG000|Overall Study|Withdrawal by Subject|7|||
155626657|NCT02737358|561729993|FG001|Overall Study|Withdrawal by Subject|12|||
155626658|NCT02737358|561729992|FG000|Overall Study|Lost to Follow-up|2|||
155626659|NCT02737358|561729993|FG001|Overall Study|Lost to Follow-up|3|||
155383676|NCT01037244|560839569|FG002|Overall Study|Withdrawal by Subject|3|||
155626660|NCT03238417|561729995|FG000|Overall|non-response|955|||
155626661|NCT03238417|561729996|FG001|Overall|non-response|1920|||
155626662|NCT03238417|561729995|FG000|Overall|partial completion|48|||
155626663|NCT03238417|561729996|FG001|Overall|partial completion|68|||
155626664|NCT03238417|561729995|FG000|Baseline|Partial completion|17|||
155626665|NCT03238417|561729996|FG001|Baseline|Partial completion|48|||
155626666|NCT03238417|561729995|FG000|Baseline|non-response|372|||
155626667|NCT03238417|561729996|FG001|Baseline|non-response|669|||
155626668|NCT03238417|561729995|FG000|12-month|non-response|296|||
155626669|NCT03238417|561729996|FG001|12-month|non-response|669|||
155626670|NCT03238417|561729995|FG000|12-month|partial completion|23|||
155626671|NCT03238417|561729996|FG001|12-month|partial completion|37|||
155383677|NCT01037244|560839570|FG003|Overall Study|Withdrawal by Subject|5|||
155383678|NCT01037244|560839567|FG000|Overall Study|Partner Withdrew Consent|2|||
155383679|NCT01037244|560839568|FG001|Overall Study|Partner Withdrew Consent|1|||
155383680|NCT01037244|560839569|FG002|Overall Study|Partner Withdrew Consent|0|||
155383681|NCT01037244|560839570|FG003|Overall Study|Partner Withdrew Consent|0|||
155383682|NCT01037244|560839567|FG000|Overall Study|Various|3|||
155383683|NCT01037244|560839568|FG001|Overall Study|Various|2|||
155383684|NCT01037244|560839569|FG002|Overall Study|Various|1|||
155383685|NCT01037244|560839570|FG003|Overall Study|Various|1|||
155383686|NCT01411215|560839571|FG000|Overall Study|Adverse Event|1|||
155383687|NCT01411215|560839572|FG001|Overall Study|Adverse Event|2|||
155383688|NCT01411215|560839571|FG000|Overall Study|Lack of Efficacy|2|||
155383689|NCT01411215|560839572|FG001|Overall Study|Lack of Efficacy|4|||
155383690|NCT01411215|560839571|FG000|Overall Study|Lost to Follow-up|12|||
155383691|NCT01411215|560839572|FG001|Overall Study|Lost to Follow-up|18|||
155383692|NCT01411215|560839571|FG000|Overall Study|Did not meet entrance criteria|0|||
155383693|NCT01411215|560839572|FG001|Overall Study|Did not meet entrance criteria|1|||
155383694|NCT01411215|560839571|FG000|Overall Study|Study terminated by sponsor|2|||
155383695|NCT01411215|560839572|FG001|Overall Study|Study terminated by sponsor|15|||
155383696|NCT01411215|560839571|FG000|Overall Study|Protocol Violation|3|||
155383697|NCT01411215|560839572|FG001|Overall Study|Protocol Violation|5|||
155383698|NCT01411215|560839571|FG000|Overall Study|Withdrawal by Subject|34|||
155383699|NCT01411215|560839572|FG001|Overall Study|Withdrawal by Subject|21|||
155383700|NCT01411215|560839571|FG000|Overall Study|Other|12|||
155383701|NCT01411215|560839572|FG001|Overall Study|Other|17|||
155383702|NCT01411215|560839571|FG000|Overall Study|Screen failure|0|||
155383703|NCT01411215|560839572|FG001|Overall Study|Screen failure|1|||
155383704|NCT04025580|560839573|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
155383705|NCT04025580|560839574|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
155383706|NCT04025580|560839575|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
155383707|NCT03305731|560839577|FG000|Overall Study|Protocol Violation|1|||
155383708|NCT01952054|560839578|FG000|Overall Study|Physician Decision|1|||
155383709|NCT01718353|560839581|FG000|Overall Study|Lost to Follow-up|0|||
155383710|NCT01718353|560839582|FG001|Overall Study|Lost to Follow-up|1|||
155383711|NCT01718353|560839581|FG000|Overall Study|Principal Investigator's Decision|10|||
155383712|NCT01718353|560839582|FG001|Overall Study|Principal Investigator's Decision|4|||
155383713|NCT01718353|560839581|FG000|Overall Study|Randomized but not treated|2|||
155383714|NCT01718353|560839582|FG001|Overall Study|Randomized but not treated|0|||
155383715|NCT01959516|560839583|FG000|Epoch 1|Adverse Event|4|||
155383716|NCT01959516|560839584|FG001|Epoch 1|Adverse Event|1|||
155626672|NCT03238417|561729995|FG000|24-month|non-response|287|||
155626673|NCT03238417|561729996|FG001|24-month|non-response|594|||
155626674|NCT03238417|561729995|FG000|24-month|partial completion|8|||
155626675|NCT03238417|561729996|FG001|24-month|partial completion|31|||
155626676|NCT03439137|561730004|FG000|Overall Study|Adverse Event|16|||
155626677|NCT03439137|561730005|FG001|Overall Study|Adverse Event|12|||
155626678|NCT03439137|561730004|FG000|Overall Study|Physician Decision|0|||
155626679|NCT03439137|561730005|FG001|Overall Study|Physician Decision|5|||
155626680|NCT03439137|561730004|FG000|Overall Study|Withdrawal by Subject|14|||
155626681|NCT03439137|561730005|FG001|Overall Study|Withdrawal by Subject|4|||
155626682|NCT03439137|561730004|FG000|Overall Study|Conducting rescue therapy|2|||
155626683|NCT03439137|561730005|FG001|Overall Study|Conducting rescue therapy|1|||
155626684|NCT03439137|561730004|FG000|Overall Study|Difficult to control Hb|10|||
155626685|NCT03439137|561730005|FG001|Overall Study|Difficult to control Hb|2|||
155626686|NCT03439137|561730004|FG000|Overall Study|Initiation of a renal transplant|0|||
155626687|NCT03439137|561730005|FG001|Overall Study|Initiation of a renal transplant|2|||
155626688|NCT00106002|561730006|FG000|Overall Study|Did not take any study drug|1|||
155626689|NCT00106002|561730006|FG000|Overall Study|Ineligible after Registration|1|||
155626690|NCT01122173|561730012|FG000|Overall Study|Lost to Follow-up|3|||
155626691|NCT01122173|561730012|FG000|Overall Study|Withdrawal by Subject|3|||
155626692|NCT01122173|561730012|FG000|Overall Study|Left study for other reasons|3|||
155626693|NCT02265510|561730013|FG000|Overall Study|Withdrawal by Subject|1|||
155626694|NCT02265510|561730014|FG001|Overall Study|Withdrawal by Subject|1|||
155626695|NCT02265510|561730015|FG002|Overall Study|Withdrawal by Subject|2|||
155626696|NCT02265510|561730016|FG003|Overall Study|Withdrawal by Subject|1|||
155626697|NCT02265510|561730017|FG004|Overall Study|Withdrawal by Subject|0|||
155626698|NCT02265510|561730018|FG005|Overall Study|Withdrawal by Subject|2|||
155729133|NCT02113982|562108035|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
155383717|NCT01959516|560839583|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
155383718|NCT01959516|560839584|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
155383719|NCT01959516|560839583|FG000|Epoch 1|Subject withdrew consent|3|||
155383720|NCT01959516|560839584|FG001|Epoch 1|Subject withdrew consent|2|||
155626699|NCT02265510|561730019|FG006|Overall Study|Withdrawal by Subject|0|||
155626700|NCT02265510|561730020|FG007|Overall Study|Withdrawal by Subject|2|||
155626701|NCT02265510|561730021|FG008|Overall Study|Withdrawal by Subject|0|||
155626702|NCT02265510|561730022|FG009|Overall Study|Withdrawal by Subject|0|||
155383721|NCT01959516|560839583|FG000|Epoch 1|Administrative problems|1|||
155383722|NCT01959516|560839584|FG001|Epoch 1|Administrative problems|0|||
155383723|NCT01959516|560839583|FG000|Epoch 1|Use of prohibited treatment|1|||
155383724|NCT01959516|560839584|FG001|Epoch 1|Use of prohibited treatment|0|||
155383725|NCT01959516|560839583|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
155729134|NCT02113982|562108036|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
155729135|NCT02113982|562108037|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
155729136|NCT02113982|562108038|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
155729137|NCT02113982|562108039|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
155729138|NCT02113982|562108040|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
155729139|NCT02113982|562108041|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
155729140|NCT02113982|562108042|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
155729141|NCT02113982|562108043|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
155729142|NCT02113982|562108044|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
155729143|NCT02113982|562108045|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
155729144|NCT02113982|562108046|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
155279050|NCT01723826|560454761|FG002|Overall Study|Non-compliance|3|||
155279051|NCT01723826|560454762|FG003|Overall Study|Non-compliance|3|||
155279052|NCT01723826|560454759|FG000|Overall Study|Non-compliance With Study Drug|0|||
155279053|NCT01723826|560454760|FG001|Overall Study|Non-compliance With Study Drug|1|||
155279054|NCT01723826|560454761|FG002|Overall Study|Non-compliance With Study Drug|0|||
155279055|NCT01723826|560454762|FG003|Overall Study|Non-compliance With Study Drug|0|||
155279056|NCT01723826|560454759|FG000|Overall Study|Other Reason|8|||
155279057|NCT01723826|560454760|FG001|Overall Study|Other Reason|6|||
155279058|NCT01723826|560454761|FG002|Overall Study|Other Reason|12|||
155279059|NCT01723826|560454762|FG003|Overall Study|Other Reason|14|||
155279060|NCT01723826|560454759|FG000|Overall Study|Physician Decision|1|||
155279061|NCT01723826|560454760|FG001|Overall Study|Physician Decision|3|||
155279062|NCT01723826|560454761|FG002|Overall Study|Physician Decision|4|||
155279063|NCT01723826|560454762|FG003|Overall Study|Physician Decision|11|||
155279064|NCT01723826|560454759|FG000|Overall Study|Protocol Violation|1|||
155279065|NCT01723826|560454760|FG001|Overall Study|Protocol Violation|1|||
155279066|NCT01723826|560454761|FG002|Overall Study|Protocol Violation|3|||
155279067|NCT01723826|560454762|FG003|Overall Study|Protocol Violation|1|||
155279068|NCT01723826|560454759|FG000|Overall Study|Withdrawal by Subject|10|||
155279069|NCT01723826|560454760|FG001|Overall Study|Withdrawal by Subject|17|||
155279070|NCT01723826|560454761|FG002|Overall Study|Withdrawal by Subject|27|||
155279071|NCT01723826|560454762|FG003|Overall Study|Withdrawal by Subject|48|||
155279072|NCT03100838|560454773|FG000|Overall Study|Adverse Event|1|||
155279073|NCT03100838|560454774|FG001|Overall Study|Adverse Event|0|||
155279074|NCT03100838|560454775|FG002|Overall Study|Adverse Event|0|||
155279075|NCT03100838|560454776|FG003|Overall Study|Adverse Event|0|||
155279076|NCT03100838|560454773|FG000|Overall Study|Physician Decision|1|||
155279077|NCT03100838|560454774|FG001|Overall Study|Physician Decision|1|||
155279078|NCT03100838|560454775|FG002|Overall Study|Physician Decision|1|||
155279079|NCT03100838|560454776|FG003|Overall Study|Physician Decision|1|||
155279080|NCT03100838|560454773|FG000|Overall Study|Pregnancy|0|||
155279081|NCT03100838|560454774|FG001|Overall Study|Pregnancy|1|||
155279082|NCT03100838|560454775|FG002|Overall Study|Pregnancy|0|||
155279083|NCT03100838|560454776|FG003|Overall Study|Pregnancy|0|||
155279084|NCT03100838|560454773|FG000|Overall Study|Lost to Follow-up|0|||
155279085|NCT03100838|560454774|FG001|Overall Study|Lost to Follow-up|0|||
155279086|NCT03100838|560454775|FG002|Overall Study|Lost to Follow-up|1|||
155279087|NCT03100838|560454776|FG003|Overall Study|Lost to Follow-up|0|||
155279088|NCT01347645|560454777|FG000|Overall Study|Death|1|||
155279089|NCT01347645|560454778|FG001|Overall Study|Death|5|||
155279090|NCT01347645|560454779|FG002|Overall Study|Death|2|||
155279091|NCT01347645|560454780|FG003|Overall Study|Death|7|||
155279092|NCT01347645|560454781|FG004|Overall Study|Death|7|||
155279093|NCT01347645|560454777|FG000|Overall Study|Lost to Follow-up|1|||
155279094|NCT01347645|560454778|FG001|Overall Study|Lost to Follow-up|1|||
155279095|NCT01347645|560454779|FG002|Overall Study|Lost to Follow-up|0|||
155279096|NCT01347645|560454780|FG003|Overall Study|Lost to Follow-up|1|||
155383726|NCT01959516|560839584|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
155279097|NCT01347645|560454781|FG004|Overall Study|Lost to Follow-up|1|||
155279098|NCT01347645|560454777|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
155279099|NCT01347645|560454778|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
155279100|NCT01347645|560454779|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
155279101|NCT01347645|560454780|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
155279102|NCT01347645|560454781|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
155279103|NCT01347645|560454777|FG000|Overall Study|Other|1|||
155383727|NCT01959516|560839583|FG000|Epoch 1|Protocol deviation|0|||
155279104|NCT01347645|560454778|FG001|Overall Study|Other|0|||
155279105|NCT01347645|560454779|FG002|Overall Study|Other|0|||
155279106|NCT01347645|560454780|FG003|Overall Study|Other|0|||
155729145|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
155383728|NCT01959516|560839584|FG001|Epoch 1|Protocol deviation|1|||
155383729|NCT01959516|560839583|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
155383730|NCT01959516|560839584|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
155383731|NCT01959516|560839583|FG000|Epoch 2|Subject withdrew consent|1|||
155383732|NCT01959516|560839584|FG001|Epoch 2|Subject withdrew consent|0|||
155383733|NCT01959516|560839583|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
155383734|NCT01959516|560839584|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
155383735|NCT00455325|560839585|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
155383736|NCT00455325|560839586|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
155383737|NCT00455325|560839587|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
155383738|NCT00455325|560839588|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
155383739|NCT00455325|560839585|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
155383740|NCT00455325|560839586|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383741|NCT00455325|560839587|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383742|NCT00455325|560839588|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383743|NCT00455325|560839585|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
155383744|NCT00455325|560839586|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
155383745|NCT00455325|560839587|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
155383746|NCT00455325|560839588|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
155383747|NCT00455325|560839585|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
155383748|NCT00455325|560839586|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383749|NCT00455325|560839587|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383750|NCT00455325|560839588|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383751|NCT00455325|560839585|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
155383752|NCT00455325|560839586|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383753|NCT00455325|560839587|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383754|NCT00455325|560839588|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383755|NCT00455325|560839585|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383756|NCT00455325|560839586|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
155383757|NCT00455325|560839587|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383758|NCT00455325|560839588|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383759|NCT00455325|560839585|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383760|NCT00455325|560839586|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383761|NCT00455325|560839587|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
155383762|NCT00455325|560839588|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383763|NCT02745392|560839595|FG000|Overall Study|Lost to Follow-up|0|||
155383764|NCT02745392|560839596|FG001|Overall Study|Lost to Follow-up|1|||
155383765|NCT02745392|560839597|FG002|Overall Study|Lost to Follow-up|0|||
155383766|NCT02745392|560839598|FG003|Overall Study|Lost to Follow-up|0|||
155383767|NCT02004353|560839600|FG000|Overall Study|Voluntary participation|1334|||
155383768|NCT01691768|560839601|FG000|Overall Study|Death|0|||
155383769|NCT01691768|560839602|FG001|Overall Study|Death|2|||
155383770|NCT01691768|560839601|FG000|Overall Study|Lost to Follow-up|4|||
155383771|NCT01691768|560839602|FG001|Overall Study|Lost to Follow-up|3|||
155383772|NCT01691768|560839601|FG000|Overall Study|Withdrawal by Subject|10|||
155383773|NCT01691768|560839602|FG001|Overall Study|Withdrawal by Subject|9|||
155383774|NCT01691768|560839601|FG000|Overall Study|Relocated|0|||
155383775|NCT01691768|560839602|FG001|Overall Study|Relocated|1|||
155383776|NCT01691768|560839601|FG000|Overall Study|Investigator decision|1|||
155383777|NCT01691768|560839602|FG001|Overall Study|Investigator decision|1|||
155626703|NCT02265510|561730023|FG010|Overall Study|Withdrawal by Subject|0|||
155626704|NCT02265510|561730024|FG011|Overall Study|Withdrawal by Subject|0|||
155626705|NCT02265510|561730025|FG012|Overall Study|Withdrawal by Subject|1|||
155626706|NCT02265510|561730026|FG013|Overall Study|Withdrawal by Subject|0|||
155626707|NCT02265510|561730013|FG000|Overall Study|Disease Progression|0|||
155626708|NCT02265510|561730014|FG001|Overall Study|Disease Progression|1|||
155626709|NCT02265510|561730015|FG002|Overall Study|Disease Progression|2|||
155626710|NCT02265510|561730016|FG003|Overall Study|Disease Progression|1|||
155626711|NCT02265510|561730017|FG004|Overall Study|Disease Progression|1|||
155626712|NCT02265510|561730018|FG005|Overall Study|Disease Progression|0|||
155626713|NCT02265510|561730019|FG006|Overall Study|Disease Progression|0|||
155383778|NCT01759368|560839603|FG000|Overall Study|Lost to Follow-up|1|||
155383779|NCT01759368|560839604|FG001|Overall Study|Lost to Follow-up|0|||
155383780|NCT00336895|560839611|FG000|Overall Study|diarrhea|1|||
155383781|NCT00336895|560839611|FG000|Overall Study|nausea and upset stomach|1|||
155383782|NCT00336895|560839611|FG000|Overall Study|Physician Decision|1|||
155383783|NCT00336895|560839611|FG000|Overall Study|screen failed|1|||
155383784|NCT01959334|560839612|FG000|Second Dose|Adverse Event|1|||
155383785|NCT01959334|560839613|FG001|Second Dose|Adverse Event|0|||
155383786|NCT01959334|560839612|FG000|Third Dose|Adverse Event|0|||
155383787|NCT01959334|560839613|FG001|Third Dose|Adverse Event|1|||
155383788|NCT01768637|560839615|FG000|Overall Study|Lost to Follow-up|2|||
155383789|NCT01768637|560839616|FG001|Overall Study|Lost to Follow-up|7|||
155626714|NCT02265510|561730020|FG007|Overall Study|Disease Progression|0|||
155626715|NCT02265510|561730021|FG008|Overall Study|Disease Progression|0|||
155383790|NCT01768637|560839615|FG000|Overall Study|Difficult blood draw|1|||
155383791|NCT01768637|560839616|FG001|Overall Study|Difficult blood draw|0|||
155383792|NCT01007448|560839617|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
155729146|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
155729147|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
155729148|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
155729149|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
155729150|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
155729151|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
155729152|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
155729153|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
155729154|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
155729155|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
155729156|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
155729157|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
155729158|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
155729159|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
155729160|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
155729161|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
155729162|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
155729163|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
155729164|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
155729165|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
155729166|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
155729167|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
155729168|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
155729169|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
155729170|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
155729171|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
155729172|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
155729173|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729174|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
155383793|NCT01007448|560839618|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
155383794|NCT01007448|560839617|FG000|Overall Study|Staph Skin Infection Flare|1|||
155383795|NCT01007448|560839618|FG001|Overall Study|Staph Skin Infection Flare|0|||
155383796|NCT01007448|560839617|FG000|Overall Study|Participant Leaving the Country|1|||
155383797|NCT01007448|560839618|FG001|Overall Study|Participant Leaving the Country|0|||
155383798|NCT01007448|560839617|FG000|Overall Study|Participant Given Prohibited Medication|1|||
155383799|NCT01007448|560839618|FG001|Overall Study|Participant Given Prohibited Medication|0|||
155383800|NCT01007448|560839617|FG000|Overall Study|Progressive Disease|1|||
155383801|NCT01007448|560839618|FG001|Overall Study|Progressive Disease|2|||
155383802|NCT01007448|560839617|FG000|Overall Study|Lack of Efficacy|2|||
155383803|NCT01007448|560839618|FG001|Overall Study|Lack of Efficacy|0|||
155383804|NCT01007448|560839617|FG000|Overall Study|Withdrawal by Subject|2|||
155383805|NCT01007448|560839618|FG001|Overall Study|Withdrawal by Subject|3|||
155383806|NCT01007448|560839617|FG000|Overall Study|Adverse Event|1|||
155383807|NCT01007448|560839618|FG001|Overall Study|Adverse Event|4|||
155383808|NCT01054170|560839619|FG000|Overall Study|Protocol Violation|1|||
155383809|NCT01054170|560839620|FG001|Overall Study|Protocol Violation|0|||
155383810|NCT01054170|560839619|FG000|Overall Study|Withdrawal by Subject|3|||
155383811|NCT01054170|560839620|FG001|Overall Study|Withdrawal by Subject|2|||
155383812|NCT01054170|560839619|FG000|Overall Study|Adverse Event|0|||
155383813|NCT01054170|560839620|FG001|Overall Study|Adverse Event|4|||
155383814|NCT02751320|560839621|FG000|Overall Study|Adverse Event|2|||
155383815|NCT02751320|560839621|FG000|Overall Study|Withdrawal by Subject|1|||
155383816|NCT01337115|560839625|FG000|Overall Study|Protocol Violation|2|||
155383817|NCT01337115|560839626|FG001|Overall Study|Protocol Violation|0|||
155383818|NCT03426267|560839633|FG000|Overall Study|Physician Decision|1|||
155383819|NCT03426267|560839634|FG001|Overall Study|Physician Decision|4|||
155383820|NCT03426267|560839633|FG000|Overall Study|Lost to Follow-up|1|||
155383821|NCT03426267|560839634|FG001|Overall Study|Lost to Follow-up|0|||
155383822|NCT03426267|560839633|FG000|Overall Study|Withdrawal by Subject|4|||
155729175|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729176|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729177|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729178|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
155383823|NCT03426267|560839634|FG001|Overall Study|Withdrawal by Subject|10|||
155383824|NCT03426267|560839633|FG000|Overall Study|Protocol Violation|1|||
155383825|NCT03426267|560839634|FG001|Overall Study|Protocol Violation|3|||
155383826|NCT03426267|560839633|FG000|Overall Study|Adverse Event|9|||
155383827|NCT03426267|560839634|FG001|Overall Study|Adverse Event|27|||
155383828|NCT03426267|560839633|FG000|Overall Study|Prohibited Treatment Intake|2|||
155383829|NCT03426267|560839634|FG001|Overall Study|Prohibited Treatment Intake|3|||
155383830|NCT03426267|560839633|FG000|Overall Study|Lack of Efficacy|0|||
155383831|NCT03426267|560839634|FG001|Overall Study|Lack of Efficacy|25|||
155383832|NCT03426267|560839633|FG000|Overall Study|other|3|||
155383833|NCT03426267|560839634|FG001|Overall Study|other|0|||
155383834|NCT03801915|560839640|FG000|Overall Study|Screen failure|0|||
155383835|NCT03801915|560839641|FG001|Overall Study|Screen failure|0|||
155383836|NCT03801915|560839642|FG002|Overall Study|Screen failure|1|||
155383837|NCT03801915|560839640|FG000|Overall Study|Ineligible|1|||
155383838|NCT03801915|560839641|FG001|Overall Study|Ineligible|0|||
155383839|NCT03801915|560839642|FG002|Overall Study|Ineligible|0|||
155383840|NCT03801915|560839640|FG000|Overall Study|Physician Decision|2|||
155383841|NCT03801915|560839641|FG001|Overall Study|Physician Decision|1|||
155383842|NCT03801915|560839642|FG002|Overall Study|Physician Decision|0|||
155383843|NCT02308020|560839643|FG000|Overall Study|Lost to Follow-up|1|||
155383844|NCT02308020|560839644|FG001|Overall Study|Lost to Follow-up|7|||
155383845|NCT02308020|560839645|FG002|Overall Study|Lost to Follow-up|0|||
155383846|NCT02308020|560839646|FG003|Overall Study|Lost to Follow-up|0|||
155383847|NCT02308020|560839647|FG004|Overall Study|Lost to Follow-up|1|||
155383848|NCT02308020|560839648|FG005|Overall Study|Lost to Follow-up|2|||
155383849|NCT02308020|560839643|FG000|Overall Study|Sponsor Decision|0|||
155383850|NCT02308020|560839644|FG001|Overall Study|Sponsor Decision|8|||
155383851|NCT02308020|560839645|FG002|Overall Study|Sponsor Decision|0|||
155383852|NCT02308020|560839646|FG003|Overall Study|Sponsor Decision|2|||
155383853|NCT02308020|560839647|FG004|Overall Study|Sponsor Decision|2|||
155383854|NCT02308020|560839648|FG005|Overall Study|Sponsor Decision|1|||
155383855|NCT02308020|560839643|FG000|Overall Study|Withdrawal by Subject|3|||
155383856|NCT02308020|560839644|FG001|Overall Study|Withdrawal by Subject|5|||
155383857|NCT02308020|560839645|FG002|Overall Study|Withdrawal by Subject|3|||
155383858|NCT02308020|560839646|FG003|Overall Study|Withdrawal by Subject|2|||
155383859|NCT02308020|560839647|FG004|Overall Study|Withdrawal by Subject|1|||
155383860|NCT02308020|560839648|FG005|Overall Study|Withdrawal by Subject|2|||
155383861|NCT01211288|560839649|FG000|Overall Study|Lost to Follow-up|1|||
155383862|NCT01211288|560839650|FG001|Overall Study|Lost to Follow-up|1|||
155383863|NCT01270971|560839651|FG000|Overall Study|Withdrawal by Subject|24|||
155383864|NCT01270971|560839652|FG001|Overall Study|Withdrawal by Subject|11|||
155383865|NCT01270971|560839651|FG000|Overall Study|Lost to Follow-up|18|||
155383866|NCT01270971|560839652|FG001|Overall Study|Lost to Follow-up|5|||
155383867|NCT01270971|560839651|FG000|Overall Study|Adverse Event|1|||
155383868|NCT01270971|560839652|FG001|Overall Study|Adverse Event|2|||
155383869|NCT01270971|560839651|FG000|Overall Study|Non compliance|2|||
155383870|NCT01270971|560839652|FG001|Overall Study|Non compliance|2|||
155383871|NCT01270971|560839651|FG000|Overall Study|Non-specific|7|||
155383872|NCT01270971|560839652|FG001|Overall Study|Non-specific|3|||
155383873|NCT03333837|560839654|FG000|Overall Study|Adverse Event|2|||
155383874|NCT03333837|560839655|FG001|Overall Study|Adverse Event|1|||
155383875|NCT03333837|560839656|FG002|Overall Study|Adverse Event|1|||
155383876|NCT03333837|560839657|FG003|Overall Study|Adverse Event|1|||
155383877|NCT03333837|560839658|FG004|Overall Study|Adverse Event|0|||
155383878|NCT03333837|560839654|FG000|Overall Study|Caregiver withdrew|0|||
155383879|NCT03333837|560839655|FG001|Overall Study|Caregiver withdrew|2|||
155383880|NCT03333837|560839656|FG002|Overall Study|Caregiver withdrew|1|||
155383881|NCT03333837|560839657|FG003|Overall Study|Caregiver withdrew|0|||
155383882|NCT03333837|560839658|FG004|Overall Study|Caregiver withdrew|0|||
155383883|NCT03333837|560839654|FG000|Overall Study|Withdrawal by Subject|0|||
155383884|NCT03333837|560839655|FG001|Overall Study|Withdrawal by Subject|0|||
155383885|NCT03333837|560839656|FG002|Overall Study|Withdrawal by Subject|1|||
155383886|NCT03333837|560839657|FG003|Overall Study|Withdrawal by Subject|1|||
155383887|NCT03333837|560839658|FG004|Overall Study|Withdrawal by Subject|3|||
155383888|NCT03333837|560839654|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383889|NCT03333837|560839655|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383890|NCT03333837|560839656|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
155383891|NCT03333837|560839657|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383892|NCT03333837|560839658|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383893|NCT01551212|560839659|FG000|Overall Study|Graft loss/Retransplantation|0|||
155626716|NCT02265510|561730022|FG009|Overall Study|Disease Progression|0|||
155626717|NCT02265510|561730023|FG010|Overall Study|Disease Progression|0|||
155626718|NCT02265510|561730024|FG011|Overall Study|Disease Progression|0|||
155626719|NCT02265510|561730025|FG012|Overall Study|Disease Progression|0|||
155626720|NCT02265510|561730026|FG013|Overall Study|Disease Progression|0|||
155626721|NCT02265510|561730013|FG000|Overall Study|Death|2|||
155383894|NCT01551212|560839660|FG001|Overall Study|Graft loss/Retransplantation|1|||
155383895|NCT01551212|560839659|FG000|Overall Study|Administrative problems|1|||
155383896|NCT01551212|560839660|FG001|Overall Study|Administrative problems|2|||
155626722|NCT02265510|561730014|FG001|Overall Study|Death|0|||
155626723|NCT02265510|561730015|FG002|Overall Study|Death|2|||
155383897|NCT01551212|560839659|FG000|Overall Study|Lost to Follow-up|0|||
155383898|NCT01551212|560839660|FG001|Overall Study|Lost to Follow-up|1|||
155383899|NCT01551212|560839659|FG000|Overall Study|Protocol Violation|0|||
155626724|NCT02265510|561730016|FG003|Overall Study|Death|2|||
155626725|NCT02265510|561730017|FG004|Overall Study|Death|1|||
155626726|NCT02265510|561730018|FG005|Overall Study|Death|3|||
155626727|NCT02265510|561730019|FG006|Overall Study|Death|2|||
155626728|NCT02265510|561730020|FG007|Overall Study|Death|1|||
155626729|NCT02265510|561730021|FG008|Overall Study|Death|3|||
155626730|NCT02265510|561730022|FG009|Overall Study|Death|3|||
155626731|NCT02265510|561730023|FG010|Overall Study|Death|4|||
155626732|NCT02265510|561730024|FG011|Overall Study|Death|12|||
155626733|NCT02265510|561730025|FG012|Overall Study|Death|7|||
155626734|NCT02265510|561730026|FG013|Overall Study|Death|6|||
155626735|NCT02265510|561730013|FG000|Overall Study|Lost to Follow-up|0|||
155626736|NCT02265510|561730014|FG001|Overall Study|Lost to Follow-up|0|||
155626737|NCT02265510|561730015|FG002|Overall Study|Lost to Follow-up|0|||
155626738|NCT02265510|561730016|FG003|Overall Study|Lost to Follow-up|0|||
155729179|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
155279107|NCT01347645|560454781|FG004|Overall Study|Other|1|||
155279108|NCT01347645|560454777|FG000|Overall Study|Withdrawal by Subject|0|||
155279109|NCT01347645|560454778|FG001|Overall Study|Withdrawal by Subject|0|||
155279110|NCT01347645|560454779|FG002|Overall Study|Withdrawal by Subject|0|||
155279111|NCT01347645|560454780|FG003|Overall Study|Withdrawal by Subject|3|||
155279112|NCT01347645|560454781|FG004|Overall Study|Withdrawal by Subject|3|||
155279113|NCT01347645|560454777|FG000|Overall Study|Physician Decision|0|||
155279114|NCT01347645|560454778|FG001|Overall Study|Physician Decision|0|||
155279115|NCT01347645|560454779|FG002|Overall Study|Physician Decision|0|||
155279116|NCT01347645|560454780|FG003|Overall Study|Physician Decision|0|||
155279117|NCT01347645|560454781|FG004|Overall Study|Physician Decision|1|||
155279118|NCT01347645|560454777|FG000|Overall Study|Adverse Event|0|||
155279119|NCT01347645|560454778|FG001|Overall Study|Adverse Event|0|||
155279120|NCT01347645|560454779|FG002|Overall Study|Adverse Event|0|||
155279121|NCT01347645|560454780|FG003|Overall Study|Adverse Event|1|||
155279122|NCT01347645|560454781|FG004|Overall Study|Adverse Event|1|||
155279123|NCT01141660|560454784|FG000|Overall Study|Physician Decision|0|||
155626739|NCT02265510|561730017|FG004|Overall Study|Lost to Follow-up|1|||
155626740|NCT02265510|561730018|FG005|Overall Study|Lost to Follow-up|0|||
155729180|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
155729181|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729182|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
155729183|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
155729184|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729185|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729186|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
155729187|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729188|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729189|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729190|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729191|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729192|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729193|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729194|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
155729195|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729196|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
155729197|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729198|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729199|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729200|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155729201|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729202|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729203|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729204|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729205|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729206|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729207|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729208|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
155729209|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729210|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729211|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729212|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729213|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155729214|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155279124|NCT01141660|560454785|FG001|Overall Study|Physician Decision|12|||
155279125|NCT00209027|560454787|FG000|Overall Study|study terminated|10|||
155279126|NCT00209027|560454788|FG001|Overall Study|study terminated|0|||
155626741|NCT02265510|561730019|FG006|Overall Study|Lost to Follow-up|0|||
155626742|NCT02265510|561730020|FG007|Overall Study|Lost to Follow-up|0|||
155626743|NCT02265510|561730021|FG008|Overall Study|Lost to Follow-up|0|||
155626744|NCT02265510|561730022|FG009|Overall Study|Lost to Follow-up|2|||
155383900|NCT01551212|560839660|FG001|Overall Study|Protocol Violation|1|||
155383901|NCT01551212|560839659|FG000|Overall Study|Withdrawal by Subject|0|||
155383902|NCT01551212|560839660|FG001|Overall Study|Withdrawal by Subject|7|||
155383903|NCT01551212|560839659|FG000|Overall Study|Death|2|||
155383904|NCT01551212|560839660|FG001|Overall Study|Death|4|||
155383905|NCT01551212|560839659|FG000|Overall Study|Never Received Study Treatment|2|||
155383906|NCT01551212|560839660|FG001|Overall Study|Never Received Study Treatment|4|||
155383907|NCT04217590|560839661|FG000|Overall Study|Other|1|||
155383908|NCT04217590|560839662|FG001|Overall Study|Other|1|||
155383909|NCT04217590|560839661|FG000|Overall Study|Withdrawal by Subject|3|||
155383910|NCT04217590|560839662|FG001|Overall Study|Withdrawal by Subject|1|||
155383911|NCT04217590|560839661|FG000|Overall Study|Death|0|||
155383912|NCT04217590|560839662|FG001|Overall Study|Death|1|||
155383913|NCT01013285|560839663|FG000|Overall Study|Death|48|||
155383914|NCT01013285|560839664|FG001|Overall Study|Death|89|||
155383915|NCT00704405|560839665|FG000|Overall Study (NC Population)|Adverse Event|1|||
155383916|NCT00704405|560839666|FG001|Overall Study (NC Population)|Adverse Event|0|||
155383917|NCT00704405|560839667|FG002|Overall Study (NC Population)|Adverse Event|0|||
155383918|NCT00704405|560839668|FG003|Overall Study (NC Population)|Adverse Event|0|||
155383919|NCT00704405|560839669|FG004|Overall Study (NC Population)|Adverse Event|0|||
155383920|NCT00704405|560839665|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
155383921|NCT00704405|560839666|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
155383922|NCT00704405|560839667|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
155383923|NCT00704405|560839668|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
155383924|NCT00704405|560839669|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
155383925|NCT00704405|560839665|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383926|NCT00704405|560839666|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
155383927|NCT00704405|560839667|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383928|NCT00704405|560839668|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383929|NCT00704405|560839669|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383930|NCT00704405|560839665|FG000|Overall Study (NC Population)|Other|0|||
155383931|NCT00704405|560839666|FG001|Overall Study (NC Population)|Other|0|||
155383932|NCT00704405|560839667|FG002|Overall Study (NC Population)|Other|0|||
155383933|NCT00704405|560839668|FG003|Overall Study (NC Population)|Other|0|||
155383934|NCT00704405|560839669|FG004|Overall Study (NC Population)|Other|1|||
155383935|NCT00704405|560839665|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
155383936|NCT00704405|560839666|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
155383937|NCT00704405|560839667|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
155383938|NCT00704405|560839668|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
155383939|NCT00704405|560839669|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
155383940|NCT00704405|560839665|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
155383941|NCT00704405|560839666|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
155383942|NCT00704405|560839667|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
155383943|NCT00704405|560839668|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
155383944|NCT00704405|560839669|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
155383945|NCT01395888|560839670|FG000|2-week Run-in Period|Adverse Event|2|||
155383946|NCT01395888|560839671|FG001|2-week Run-in Period|Adverse Event|0|||
155383947|NCT01395888|560839672|FG002|2-week Run-in Period|Adverse Event|0|||
155383948|NCT01395888|560839670|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
155383949|NCT01395888|560839671|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155383950|NCT01395888|560839672|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155383951|NCT01395888|560839670|FG000|2-week Run-in Period|Lost to Follow-up|1|||
155383952|NCT01395888|560839671|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155383953|NCT01395888|560839672|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155383954|NCT01395888|560839670|FG000|2-week Run-in Period|Protocol Violation|2|||
155383955|NCT01395888|560839671|FG001|2-week Run-in Period|Protocol Violation|0|||
155383956|NCT01395888|560839672|FG002|2-week Run-in Period|Protocol Violation|0|||
155383957|NCT01395888|560839670|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
155383958|NCT01395888|560839671|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155383959|NCT01395888|560839672|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155383960|NCT01395888|560839670|FG000|Treatment Period (TP)|Adverse Event|0|||
155383961|NCT01395888|560839671|FG001|Treatment Period (TP)|Adverse Event|7|||
155383962|NCT01395888|560839672|FG002|Treatment Period (TP)|Adverse Event|6|||
155383963|NCT01395888|560839670|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
155383964|NCT01395888|560839671|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
155383965|NCT01395888|560839672|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
155383966|NCT01395888|560839670|FG000|Treatment Period (TP)|Protocol Violation|0|||
155383967|NCT01395888|560839671|FG001|Treatment Period (TP)|Protocol Violation|1|||
155383968|NCT01395888|560839672|FG002|Treatment Period (TP)|Protocol Violation|5|||
155383969|NCT01395888|560839670|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
155383970|NCT01395888|560839671|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
155383971|NCT01395888|560839672|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
155383972|NCT01395888|560839670|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
155383973|NCT01395888|560839671|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
155383974|NCT01395888|560839672|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
155383975|NCT02641496|560839673|FG000|Overall Study|Lost to Follow-up|13|||
155383976|NCT02641496|560839674|FG001|Overall Study|Lost to Follow-up|12|||
155383977|NCT02641496|560839673|FG000|Overall Study|Withdrawal by Subject|1|||
155383978|NCT02641496|560839674|FG001|Overall Study|Withdrawal by Subject|0|||
155383979|NCT03035201|560839675|FG000|Overall Study|Death|9|||
155383980|NCT03035201|560839676|FG001|Overall Study|Death|12|||
155383981|NCT03035201|560839677|FG002|Overall Study|Death|9|||
155383982|NCT03035201|560839678|FG003|Overall Study|Death|10|||
155383983|NCT03035201|560839675|FG000|Overall Study|Withdrawal by Subject|51|||
155383984|NCT03035201|560839676|FG001|Overall Study|Withdrawal by Subject|49|||
155383985|NCT03035201|560839677|FG002|Overall Study|Withdrawal by Subject|37|||
155383986|NCT03035201|560839678|FG003|Overall Study|Withdrawal by Subject|46|||
155383987|NCT03035201|560839675|FG000|Overall Study|Lost to Follow-up|67|||
155383988|NCT03035201|560839676|FG001|Overall Study|Lost to Follow-up|51|||
155383989|NCT03035201|560839677|FG002|Overall Study|Lost to Follow-up|64|||
155383990|NCT03035201|560839678|FG003|Overall Study|Lost to Follow-up|69|||
155383991|NCT03727438|560839685|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
155383992|NCT03727438|560839686|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
155383993|NCT03727438|560839685|FG000|Intervention Period|Excluded (health)|1|||
155383994|NCT03727438|560839686|FG001|Intervention Period|Excluded (health)|0|||
155383995|NCT03727438|560839685|FG000|Intervention Period|Withdrawal by Subject|3|||
155383996|NCT03727438|560839686|FG001|Intervention Period|Withdrawal by Subject|1|||
155383997|NCT03727438|560839685|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
155383998|NCT03727438|560839686|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
155383999|NCT03727438|560839685|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
155384000|NCT03727438|560839686|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
155384001|NCT03727438|560839685|FG000|8 Week Assessment|Withdrawal by Subject|6|||
155626745|NCT02265510|561730023|FG010|Overall Study|Lost to Follow-up|0|||
155626746|NCT02265510|561730024|FG011|Overall Study|Lost to Follow-up|0|||
155626747|NCT02265510|561730025|FG012|Overall Study|Lost to Follow-up|0|||
155626748|NCT02265510|561730026|FG013|Overall Study|Lost to Follow-up|2|||
155626749|NCT02265510|561730013|FG000|Overall Study|Other|0|||
155626750|NCT02265510|561730014|FG001|Overall Study|Other|1|||
155626751|NCT02265510|561730015|FG002|Overall Study|Other|0|||
155626752|NCT02265510|561730016|FG003|Overall Study|Other|0|||
155626753|NCT02265510|561730017|FG004|Overall Study|Other|0|||
155626754|NCT02265510|561730018|FG005|Overall Study|Other|0|||
155626755|NCT02265510|561730019|FG006|Overall Study|Other|0|||
155626756|NCT02265510|561730020|FG007|Overall Study|Other|0|||
155626757|NCT02265510|561730021|FG008|Overall Study|Other|0|||
155626758|NCT02265510|561730022|FG009|Overall Study|Other|0|||
155626759|NCT02265510|561730023|FG010|Overall Study|Other|0|||
155626760|NCT02265510|561730024|FG011|Overall Study|Other|0|||
155626761|NCT02265510|561730025|FG012|Overall Study|Other|0|||
155626762|NCT02265510|561730026|FG013|Overall Study|Other|0|||
155626763|NCT02265510|561730013|FG000|Overall Study|Study Terminated by Sponsor|0|||
155626764|NCT02265510|561730014|FG001|Overall Study|Study Terminated by Sponsor|0|||
155626765|NCT02265510|561730015|FG002|Overall Study|Study Terminated by Sponsor|0|||
155626766|NCT02265510|561730016|FG003|Overall Study|Study Terminated by Sponsor|0|||
155626767|NCT02265510|561730017|FG004|Overall Study|Study Terminated by Sponsor|0|||
155626768|NCT02265510|561730018|FG005|Overall Study|Study Terminated by Sponsor|1|||
155626769|NCT02265510|561730019|FG006|Overall Study|Study Terminated by Sponsor|1|||
155626770|NCT02265510|561730020|FG007|Overall Study|Study Terminated by Sponsor|1|||
155626771|NCT02265510|561730021|FG008|Overall Study|Study Terminated by Sponsor|1|||
155626772|NCT02265510|561730022|FG009|Overall Study|Study Terminated by Sponsor|2|||
155626773|NCT02265510|561730023|FG010|Overall Study|Study Terminated by Sponsor|1|||
155626774|NCT02265510|561730024|FG011|Overall Study|Study Terminated by Sponsor|4|||
155626775|NCT02265510|561730025|FG012|Overall Study|Study Terminated by Sponsor|1|||
155626776|NCT02265510|561730026|FG013|Overall Study|Study Terminated by Sponsor|2|||
155626777|NCT02530385|561730027|FG000|Overall Study|Withdrawal by Subject|0|||
155626778|NCT02530385|561730028|FG001|Overall Study|Withdrawal by Subject|1|||
155626779|NCT00116142|561730033|FG000|Overall Study|Adverse Event|8|||
155626780|NCT00116142|561730034|FG001|Overall Study|Adverse Event|7|||
155626781|NCT00116142|561730033|FG000|Overall Study|Protocol Violation|2|||
155626782|NCT00116142|561730034|FG001|Overall Study|Protocol Violation|1|||
155384002|NCT03727438|560839686|FG001|8 Week Assessment|Withdrawal by Subject|1|||
155384003|NCT03727438|560839685|FG000|6 mo Assessment|did not complete assessment|10|||
155384004|NCT03727438|560839686|FG001|6 mo Assessment|did not complete assessment|11|||
155384005|NCT06729606|560839687|FG000|Overall Study|Adverse Event|0|||
155626783|NCT00116142|561730033|FG000|Overall Study|Withdrawal by Subject|5|||
155626784|NCT00116142|561730034|FG001|Overall Study|Withdrawal by Subject|5|||
155626785|NCT00116142|561730033|FG000|Overall Study|Physician Decision|3|||
155626786|NCT00116142|561730034|FG001|Overall Study|Physician Decision|1|||
155626787|NCT00116142|561730033|FG000|Overall Study|Delayed Radiation Therapy|1|||
155729215|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Transplant|0|||
155729216|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Transplant|0|||
155384006|NCT06729606|560839688|FG001|Overall Study|Adverse Event|2|||
155384007|NCT06729606|560839687|FG000|Overall Study|Death|1|||
155729217|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Transplant|0|||
155729218|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Transplant|0|||
155729219|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Transplant|0|||
155384008|NCT06729606|560839688|FG001|Overall Study|Death|0|||
155384009|NCT06729606|560839687|FG000|Overall Study|Physician Decision|0|||
155384010|NCT06729606|560839688|FG001|Overall Study|Physician Decision|1|||
155384011|NCT06729606|560839687|FG000|Overall Study|Withdrawal by Subject|2|||
155729220|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Transplant|0|||
155729221|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Transplant|0|||
155729222|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Transplant|0|||
155729223|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Transplant|0|||
155729224|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Transplant|4|||
155729225|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Transplant|2|||
155729226|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Transplant|0|||
155384012|NCT06729606|560839688|FG001|Overall Study|Withdrawal by Subject|4|||
155384013|NCT01201343|560841546|FG000|Overall Study|Adverse Event|6|||
155384014|NCT01201343|560841546|FG000|Overall Study|Withdrawal by Subject|5|||
155384015|NCT01201343|560841546|FG000|Overall Study|Lost to Follow-up|2|||
155384016|NCT01201343|560841546|FG000|Overall Study|Lack of Efficacy|2|||
155384017|NCT01201343|560841546|FG000|Overall Study|Participant wrongly included in trial|1|||
155384018|NCT01201343|560841546|FG000|Overall Study|Randomized, not treated|3|||
155384019|NCT01716117|560841547|FG000|Overall Study|Death|5|||
155729227|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Transplant|0|||
155729228|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Transplant|0|||
155729229|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
155384020|NCT01716117|560841548|FG001|Overall Study|Death|2|||
155729230|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
155729231|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
155384021|NCT01716117|560841547|FG000|Overall Study|Withdrawal by Subject|2|||
155384022|NCT01716117|560841548|FG001|Overall Study|Withdrawal by Subject|0|||
155384023|NCT01557283|560841549|FG000|Overall Study|Lost to Follow-up|7|||
155384024|NCT01557283|560841549|FG000|Overall Study|Non-responder|19|||
155384025|NCT01557283|560841549|FG000|Overall Study|Adverse Event|7|||
155384026|NCT01557283|560841549|FG000|Overall Study|Lack of Efficacy|1|||
155384027|NCT01557283|560841549|FG000|Overall Study|Non-compliance|1|||
155384028|NCT01557283|560841549|FG000|Overall Study|Withdrawal by Subject|1|||
155384029|NCT01557283|560841549|FG000|Overall Study|Participant's weight too high for dose|1|||
155384030|NCT01557283|560841549|FG000|Overall Study|Worsening of psoriasis|1|||
155384031|NCT01557283|560841549|FG000|Overall Study|Other|6|||
155384032|NCT03645057|560841550|FG000|Randomization to Baseline|Lost to Follow-up|1|||
155384033|NCT03645057|560841551|FG001|Randomization to Baseline|Lost to Follow-up|0|||
155384034|NCT03645057|560841552|FG002|Randomization to Baseline|Lost to Follow-up|1|||
155384035|NCT03645057|560841553|FG003|Randomization to Baseline|Lost to Follow-up|0|||
155384036|NCT03645057|560841550|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
155384037|NCT03645057|560841551|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
155384038|NCT03645057|560841552|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
155384039|NCT03645057|560841553|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
155384040|NCT03645057|560841550|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
155384041|NCT03645057|560841551|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
155384042|NCT03645057|560841552|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
155384043|NCT03645057|560841553|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
155384044|NCT03645057|560841550|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
155384045|NCT03645057|560841551|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
155384046|NCT03645057|560841552|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
155384047|NCT03645057|560841553|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
155384048|NCT01873495|560841554|FG000|Overall Study|Withdrawal by Subject|1|||
155384049|NCT01873495|560841554|FG000|Overall Study|Physician Decision|3|||
155384050|NCT01873495|560841554|FG000|Overall Study|Adverse Event|1|||
155384051|NCT01873495|560841554|FG000|Overall Study|Removed for Transplantation|1|||
155729232|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
155384052|NCT01873495|560841554|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
155384053|NCT04363801|560841556|FG000|Overall Study|Death|18|||
155384054|NCT04363801|560841557|FG001|Overall Study|Death|14|||
155384055|NCT04363801|560841558|FG002|Overall Study|Death|16|||
155384056|NCT04363801|560841559|FG003|Overall Study|Death|48|||
155384057|NCT04363801|560841560|FG004|Overall Study|Death|38|||
155384058|NCT04363801|560841556|FG000|Overall Study|Withdrawal by Subject|1|||
155384059|NCT04363801|560841557|FG001|Overall Study|Withdrawal by Subject|6|||
155384060|NCT04363801|560841558|FG002|Overall Study|Withdrawal by Subject|1|||
155384061|NCT04363801|560841559|FG003|Overall Study|Withdrawal by Subject|4|||
155384062|NCT04363801|560841560|FG004|Overall Study|Withdrawal by Subject|14|||
155729233|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
155384063|NCT04363801|560841556|FG000|Overall Study|Sponsor Decision|6|||
155384064|NCT04363801|560841557|FG001|Overall Study|Sponsor Decision|4|||
155384065|NCT04363801|560841558|FG002|Overall Study|Sponsor Decision|10|||
155384066|NCT04363801|560841559|FG003|Overall Study|Sponsor Decision|33|||
155384067|NCT04363801|560841560|FG004|Overall Study|Sponsor Decision|32|||
155384068|NCT04363801|560841556|FG000|Overall Study|Lost to Follow-up|0|||
155384069|NCT04363801|560841557|FG001|Overall Study|Lost to Follow-up|0|||
155384070|NCT04363801|560841558|FG002|Overall Study|Lost to Follow-up|1|||
155384071|NCT04363801|560841559|FG003|Overall Study|Lost to Follow-up|0|||
155384072|NCT04363801|560841560|FG004|Overall Study|Lost to Follow-up|1|||
155384073|NCT03864146|560841561|FG000|Overall Study|Lost to Follow-up|14|||
155384074|NCT03864146|560841562|FG001|Overall Study|Lost to Follow-up|23|||
155384075|NCT03864146|560841561|FG000|Overall Study|Withdrawal by Subject|3|||
155384076|NCT03864146|560841562|FG001|Overall Study|Withdrawal by Subject|2|||
155384077|NCT01112306|560841563|FG000|Overall Study|Death|175|||
155384078|NCT01112306|560841563|FG000|Overall Study|Lost to Follow-up|9|||
155384079|NCT01112306|560841563|FG000|Overall Study|Withdrawal by Subject|31|||
155384080|NCT01112306|560841563|FG000|Overall Study|Other|70|||
155384081|NCT00881608|560841564|FG000|Overall Study|Study prematurely terminated|11|||
155384082|NCT00655486|560841570|FG000|Overall Study|Adverse Event|10|||
155384083|NCT00655486|560841570|FG000|Overall Study|Lack of Efficacy|8|||
155384084|NCT00655486|560841570|FG000|Overall Study|Withdrawal by Subject|4|||
155384085|NCT00655486|560841570|FG000|Overall Study|Protocol Violation|1|||
155384086|NCT00655486|560841570|FG000|Overall Study|Unsatisfactory compliance|2|||
155384087|NCT00655486|560841570|FG000|Overall Study|Other: Pregnancy|1|||
155384088|NCT00655486|560841570|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
155384089|NCT00655486|560841570|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
155384090|NCT04218084|560841571|FG000|Overall Study|Adverse Event|7|||
155384091|NCT04218084|560841572|FG001|Overall Study|Adverse Event|2|||
155384092|NCT04218084|560841571|FG000|Overall Study|Withdrawal of Consent|4|||
155384093|NCT04218084|560841572|FG001|Overall Study|Withdrawal of Consent|5|||
155384094|NCT04218084|560841571|FG000|Overall Study|Physician Decision|1|||
155384095|NCT04218084|560841572|FG001|Overall Study|Physician Decision|1|||
155384096|NCT04218084|560841571|FG000|Overall Study|Lost to Follow-up|1|||
155384097|NCT04218084|560841572|FG001|Overall Study|Lost to Follow-up|1|||
155384098|NCT04218084|560841571|FG000|Overall Study|Non-compliance with study drug|1|||
155384099|NCT04218084|560841572|FG001|Overall Study|Non-compliance with study drug|1|||
155384100|NCT04218084|560841571|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
155384101|NCT04218084|560841572|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
155384102|NCT04218084|560841571|FG000|Overall Study|Other|0|||
155384103|NCT04218084|560841572|FG001|Overall Study|Other|1|||
155384104|NCT04218084|560841571|FG000|Overall Study|Ongoing at data cut-off date|62|||
155384105|NCT04218084|560841572|FG001|Overall Study|Ongoing at data cut-off date|58|||
155384106|NCT01205152|560841573|FG000|Overall Study|Death|1|||
155384107|NCT02783768|560841574|FG000|Overall Study|Lost to Follow-up|1|||
155384108|NCT02783768|560841575|FG001|Overall Study|Lost to Follow-up|0|||
155384109|NCT01853137|560841576|FG000|Overall Study|Lost to Follow-up|4|||
155384110|NCT01853137|560841577|FG001|Overall Study|Lost to Follow-up|1|||
155384111|NCT03401229|560841578|FG000|Overall Study|Lost to Follow-up|2|||
155384112|NCT03401229|560841579|FG001|Overall Study|Lost to Follow-up|1|||
155384113|NCT03401229|560841578|FG000|Overall Study|Other|1|||
155384114|NCT03401229|560841579|FG001|Overall Study|Other|3|||
155384115|NCT03401229|560841578|FG000|Overall Study|Adverse Event|8|||
155384116|NCT03401229|560841579|FG001|Overall Study|Adverse Event|6|||
155384117|NCT03401229|560841578|FG000|Overall Study|Withdrawal by Subject|29|||
155384118|NCT03401229|560841579|FG001|Overall Study|Withdrawal by Subject|26|||
155384119|NCT03401229|560841578|FG000|Overall Study|COVID-19|0|||
155384120|NCT03401229|560841579|FG001|Overall Study|COVID-19|1|||
155384121|NCT05333224|560841580|FG000|Overall Study - Infants|Lost to Follow-up|1|||
155384122|NCT05333224|560841581|FG001|Overall Study - Infants|Lost to Follow-up|1|||
155384123|NCT00848926|560841583|FG000|Treatment Period|Progressive disease|45|||
155626788|NCT00116142|561730034|FG001|Overall Study|Delayed Radiation Therapy|0|||
155384124|NCT00848926|560841583|FG000|Treatment Period|Adverse Event|20|||
155384125|NCT00848926|560841583|FG000|Treatment Period|Physician Decision|12|||
155384126|NCT00848926|560841583|FG000|Treatment Period|Withdrawal by Subject|7|||
155626789|NCT00116142|561730033|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
155626790|NCT00116142|561730034|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
155626791|NCT00116142|561730033|FG000|Overall Study|Patient stopped due to depression|0|||
155626792|NCT00116142|561730034|FG001|Overall Study|Patient stopped due to depression|1|||
155384127|NCT00848926|560841583|FG000|Follow-up Period|Lost to Follow-up|7|||
155384128|NCT00848926|560841583|FG000|Follow-up Period|Withdrawal by Subject|3|||
155384129|NCT00848926|560841583|FG000|Follow-up Period|Other|2|||
155384130|NCT00966277|560841585|FG000|Overall Study|Withdrawal by Subject|3|||
155384131|NCT00966277|560841586|FG001|Overall Study|Withdrawal by Subject|0|||
155384132|NCT00966277|560841585|FG000|Overall Study|Ineligible|1|||
155384133|NCT00966277|560841586|FG001|Overall Study|Ineligible|3|||
155384134|NCT00966277|560841585|FG000|Overall Study|Treatment Plan Changed|0|||
155384135|NCT00966277|560841586|FG001|Overall Study|Treatment Plan Changed|1|||
155384136|NCT01127139|560841588|FG000|Overall Study|Adverse Event|40|||
155384137|NCT01127139|560841588|FG000|Overall Study|Incompliance|12|||
155384138|NCT01127139|560841588|FG000|Overall Study|Lack of Efficacy|4|||
155384139|NCT01127139|560841588|FG000|Overall Study|Reason not specified|1|||
155384140|NCT01136772|560841589|FG000|Overall Study|Adverse Event|15|||
155384141|NCT01136772|560841590|FG001|Overall Study|Adverse Event|14|||
155384142|NCT01136772|560841589|FG000|Overall Study|Lack of Efficacy|42|||
155384143|NCT01136772|560841590|FG001|Overall Study|Lack of Efficacy|39|||
155384144|NCT01136772|560841589|FG000|Overall Study|Administrative|14|||
155384145|NCT01136772|560841590|FG001|Overall Study|Administrative|12|||
155384146|NCT01136772|560841589|FG000|Overall Study|Withdrawal by Subject|33|||
155384147|NCT01136772|560841590|FG001|Overall Study|Withdrawal by Subject|36|||
155384148|NCT01136772|560841589|FG000|Overall Study|Did not receive injection|10|||
155384149|NCT01136772|560841590|FG001|Overall Study|Did not receive injection|7|||
155384150|NCT01136772|560841589|FG000|Overall Study|Did not follow up after first injection|2|||
155384151|NCT01136772|560841590|FG001|Overall Study|Did not follow up after first injection|2|||
155384152|NCT01498653|560841591|FG000|Overall Study|Adverse Event|2|||
155384153|NCT01498653|560841592|FG001|Overall Study|Adverse Event|2|||
155384154|NCT01498653|560841591|FG000|Overall Study|Lack of Efficacy|12|||
155384155|NCT01498653|560841592|FG001|Overall Study|Lack of Efficacy|26|||
155384156|NCT01498653|560841591|FG000|Overall Study|Protocol Violation|0|||
155384157|NCT01498653|560841592|FG001|Overall Study|Protocol Violation|4|||
155384158|NCT01498653|560841591|FG000|Overall Study|Lost to Follow-up|1|||
155384159|NCT01498653|560841592|FG001|Overall Study|Lost to Follow-up|0|||
155384160|NCT01498653|560841591|FG000|Overall Study|Physician Decision|2|||
155384161|NCT01498653|560841592|FG001|Overall Study|Physician Decision|0|||
155384162|NCT01498653|560841591|FG000|Overall Study|Withdrawal by Subject|2|||
155384163|NCT01498653|560841592|FG001|Overall Study|Withdrawal by Subject|3|||
155384164|NCT03421431|560841596|FG000|Overall Study|Adverse Event|2|||
155384165|NCT03421431|560841597|FG001|Overall Study|Adverse Event|1|||
155384166|NCT03421431|560841598|FG002|Overall Study|Adverse Event|12|||
155384167|NCT03421431|560841596|FG000|Overall Study|Lost to Follow-up|1|||
155384168|NCT03421431|560841597|FG001|Overall Study|Lost to Follow-up|1|||
155384169|NCT03421431|560841598|FG002|Overall Study|Lost to Follow-up|1|||
155384170|NCT03421431|560841596|FG000|Overall Study|Withdrawal by Subject|3|||
155384171|NCT03421431|560841597|FG001|Overall Study|Withdrawal by Subject|2|||
155384172|NCT03421431|560841598|FG002|Overall Study|Withdrawal by Subject|1|||
155384173|NCT03421431|560841596|FG000|Overall Study|Protocol Violation|0|||
155384174|NCT03421431|560841597|FG001|Overall Study|Protocol Violation|1|||
155384175|NCT03421431|560841598|FG002|Overall Study|Protocol Violation|0|||
155384176|NCT03421431|560841596|FG000|Overall Study|Participant met Stopping Rules|0|||
155384177|NCT03421431|560841597|FG001|Overall Study|Participant met Stopping Rules|1|||
155384178|NCT03421431|560841598|FG002|Overall Study|Participant met Stopping Rules|0|||
155384179|NCT02216357|560841600|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
155384180|NCT02216357|560841601|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
155384181|NCT00141726|560841605|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
155384182|NCT00235326|560841610|FG000|Overall Study|Lost to Follow-up|746|||
155384183|NCT00235326|560841611|FG001|Overall Study|Lost to Follow-up|1400|||
155384184|NCT01477333|560841614|FG000|Overall Study|Adverse Event|1|||
155384185|NCT01477333|560841614|FG000|Overall Study|Withdrawal by Subject|1|||
155384186|NCT01477333|560841614|FG000|Overall Study|Clinical Deterioration|1|||
155384187|NCT01178671|560841615|FG000|Overall Study|Adverse Event|4|||
155384188|NCT01178671|560841616|FG001|Overall Study|Adverse Event|6|||
155384189|NCT01178671|560841615|FG000|Overall Study|Protocol Violation|1|||
155384190|NCT01178671|560841616|FG001|Overall Study|Protocol Violation|1|||
155384191|NCT01178671|560841615|FG000|Overall Study|Lack of Efficacy|0|||
155384192|NCT01178671|560841616|FG001|Overall Study|Lack of Efficacy|1|||
155384193|NCT01178671|560841615|FG000|Overall Study|Lost to Follow-up|3|||
155384194|NCT01178671|560841616|FG001|Overall Study|Lost to Follow-up|1|||
155384195|NCT01178671|560841615|FG000|Overall Study|Physician Decision|4|||
155384196|NCT01178671|560841616|FG001|Overall Study|Physician Decision|6|||
155384197|NCT02435966|560841617|FG000|Overall Study|Withdrawal by Subject|0|||
155384198|NCT02435966|560841618|FG001|Overall Study|Withdrawal by Subject|1|||
155384199|NCT02435966|560841619|FG002|Overall Study|Withdrawal by Subject|0|||
155384200|NCT04620811|560841620|FG000|Overall Study|Withdrawal by Subject|18|||
155384201|NCT04620811|560841621|FG001|Overall Study|Withdrawal by Subject|15|||
155384202|NCT04620811|560841620|FG000|Overall Study|Adverse Event|6|||
155384203|NCT04620811|560841621|FG001|Overall Study|Adverse Event|11|||
155384204|NCT04620811|560841620|FG000|Overall Study|Lost to Follow-up|4|||
155384205|NCT04620811|560841621|FG001|Overall Study|Lost to Follow-up|8|||
155384206|NCT04620811|560841620|FG000|Overall Study|Physician Decision|1|||
155384207|NCT04620811|560841621|FG001|Overall Study|Physician Decision|4|||
155384208|NCT04620811|560841620|FG000|Overall Study|Sponsor Decision|0|||
155384209|NCT04620811|560841621|FG001|Overall Study|Sponsor Decision|1|||
155384210|NCT04620811|560841620|FG000|Overall Study|Elevation of ALT or AST|1|||
155384211|NCT04620811|560841621|FG001|Overall Study|Elevation of ALT or AST|0|||
155384212|NCT04620811|560841620|FG000|Overall Study|Other|3|||
155384213|NCT04620811|560841621|FG001|Overall Study|Other|5|||
155384214|NCT01078675|560841623|FG000|Overall Study|Withdrawal by Subject|7|||
155384215|NCT01078675|560841624|FG001|Overall Study|Withdrawal by Subject|3|||
155384216|NCT01078675|560841623|FG000|Overall Study|Protocol Violation|56|||
155384217|NCT01078675|560841624|FG001|Overall Study|Protocol Violation|0|||
155384218|NCT01078675|560841623|FG000|Overall Study|Provided in CRF for specific reasons|2|||
155384219|NCT01078675|560841624|FG001|Overall Study|Provided in CRF for specific reasons|3|||
155384220|NCT01078675|560841623|FG000|Overall Study|Adverse Event|3|||
155384221|NCT01078675|560841624|FG001|Overall Study|Adverse Event|0|||
155384222|NCT00928746|560841627|FG000|Overall Study|Adverse Event|2|||
155384223|NCT00928746|560841627|FG000|Overall Study|Protocol Violation|1|||
155384224|NCT00928746|560841627|FG000|Overall Study|Withdrawal by Subject|1|||
155384225|NCT00928746|560841627|FG000|Overall Study|Other|2|||
155384226|NCT02513303|560841632|FG000|Overall Study|Withdrawal by Subject|9|||
155384227|NCT02513303|560841633|FG001|Overall Study|Withdrawal by Subject|7|||
155384228|NCT02513303|560841634|FG002|Overall Study|Withdrawal by Subject|2|||
155384229|NCT02513303|560841632|FG000|Overall Study|Lost to Follow-up|2|||
155384230|NCT02513303|560841633|FG001|Overall Study|Lost to Follow-up|4|||
155384231|NCT02513303|560841634|FG002|Overall Study|Lost to Follow-up|0|||
155384232|NCT02513303|560841632|FG000|Overall Study|Adverse Event|0|||
155384233|NCT02513303|560841633|FG001|Overall Study|Adverse Event|1|||
155384234|NCT02513303|560841634|FG002|Overall Study|Adverse Event|0|||
155384235|NCT02513303|560841632|FG000|Overall Study|Physician Decision|1|||
155384236|NCT02513303|560841633|FG001|Overall Study|Physician Decision|1|||
155384237|NCT02513303|560841634|FG002|Overall Study|Physician Decision|0|||
155729234|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
155729235|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
155729236|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
155729237|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
155729238|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
155729239|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
155729240|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
155729241|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
155729242|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
155729243|NCT02113982|562108033|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
155729244|NCT02113982|562108034|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
155729245|NCT02113982|562108035|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
155729246|NCT02113982|562108036|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
155729247|NCT02113982|562108037|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
155729248|NCT02113982|562108038|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
155729249|NCT02113982|562108039|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
155384238|NCT02513303|560841632|FG000|Overall Study|Death|8|||
155384239|NCT02513303|560841633|FG001|Overall Study|Death|4|||
155384240|NCT02513303|560841634|FG002|Overall Study|Death|2|||
155384241|NCT02581631|560841638|FG000|Overall Study|Disease progression|29|||
155384242|NCT02581631|560841639|FG001|Overall Study|Disease progression|19|||
155384243|NCT02581631|560841640|FG002|Overall Study|Disease progression|13|||
155384244|NCT02581631|560841641|FG003|Overall Study|Disease progression|5|||
155384245|NCT02581631|560841642|FG004|Overall Study|Disease progression|8|||
155384246|NCT02581631|560841638|FG000|Overall Study|Study drug toxicity|4|||
155384247|NCT02581631|560841639|FG001|Overall Study|Study drug toxicity|6|||
155384248|NCT02581631|560841640|FG002|Overall Study|Study drug toxicity|7|||
155384249|NCT02581631|560841641|FG003|Overall Study|Study drug toxicity|0|||
155384250|NCT02581631|560841642|FG004|Overall Study|Study drug toxicity|3|||
155384251|NCT02581631|560841638|FG000|Overall Study|AE unrelated to study drug|3|||
155384252|NCT02581631|560841639|FG001|Overall Study|AE unrelated to study drug|1|||
155384253|NCT02581631|560841640|FG002|Overall Study|AE unrelated to study drug|1|||
155384254|NCT02581631|560841641|FG003|Overall Study|AE unrelated to study drug|0|||
155384255|NCT02581631|560841642|FG004|Overall Study|AE unrelated to study drug|2|||
155384256|NCT02581631|560841638|FG000|Overall Study|Request to discontinue|1|||
155384257|NCT02581631|560841639|FG001|Overall Study|Request to discontinue|0|||
155384258|NCT02581631|560841640|FG002|Overall Study|Request to discontinue|3|||
155384259|NCT02581631|560841641|FG003|Overall Study|Request to discontinue|0|||
155384260|NCT02581631|560841642|FG004|Overall Study|Request to discontinue|1|||
155384261|NCT02581631|560841638|FG000|Overall Study|participant withdrew consent|3|||
155384262|NCT02581631|560841639|FG001|Overall Study|participant withdrew consent|0|||
155384263|NCT02581631|560841640|FG002|Overall Study|participant withdrew consent|1|||
155384264|NCT02581631|560841641|FG003|Overall Study|participant withdrew consent|0|||
155384265|NCT02581631|560841642|FG004|Overall Study|participant withdrew consent|0|||
155384266|NCT02581631|560841638|FG000|Overall Study|Maximum clinical benefit|1|||
155384267|NCT02581631|560841639|FG001|Overall Study|Maximum clinical benefit|7|||
155384268|NCT02581631|560841640|FG002|Overall Study|Maximum clinical benefit|1|||
155384269|NCT02581631|560841641|FG003|Overall Study|Maximum clinical benefit|3|||
155384270|NCT02581631|560841642|FG004|Overall Study|Maximum clinical benefit|13|||
155384271|NCT02581631|560841638|FG000|Overall Study|Other Reasons|1|||
155384272|NCT02581631|560841639|FG001|Overall Study|Other Reasons|0|||
155384273|NCT02581631|560841640|FG002|Overall Study|Other Reasons|2|||
155384274|NCT02581631|560841641|FG003|Overall Study|Other Reasons|2|||
155384275|NCT02581631|560841642|FG004|Overall Study|Other Reasons|3|||
155384276|NCT02581631|560841638|FG000|Overall Study|Poor/Non-Compliance|0|||
155384277|NCT02581631|560841639|FG001|Overall Study|Poor/Non-Compliance|0|||
155384278|NCT02581631|560841640|FG002|Overall Study|Poor/Non-Compliance|1|||
155384279|NCT02581631|560841641|FG003|Overall Study|Poor/Non-Compliance|0|||
155384280|NCT02581631|560841642|FG004|Overall Study|Poor/Non-Compliance|0|||
155384281|NCT01191268|560841646|FG000|Overall Study|Withdrawal by Subject|19|||
155384282|NCT01191268|560841647|FG001|Overall Study|Withdrawal by Subject|25|||
155384283|NCT01191268|560841648|FG002|Overall Study|Withdrawal by Subject|21|||
155384284|NCT01191268|560841646|FG000|Overall Study|Adverse Event|21|||
155384285|NCT01191268|560841647|FG001|Overall Study|Adverse Event|13|||
155384286|NCT01191268|560841648|FG002|Overall Study|Adverse Event|8|||
155384287|NCT01191268|560841646|FG000|Overall Study|Physician Decision|6|||
155384288|NCT01191268|560841647|FG001|Overall Study|Physician Decision|8|||
155384289|NCT01191268|560841648|FG002|Overall Study|Physician Decision|9|||
155384290|NCT01191268|560841646|FG000|Overall Study|Lost to Follow-up|8|||
155384291|NCT01191268|560841647|FG001|Overall Study|Lost to Follow-up|5|||
155384292|NCT01191268|560841648|FG002|Overall Study|Lost to Follow-up|9|||
155384293|NCT01191268|560841646|FG000|Overall Study|Entry Criteria Not Met|3|||
155384294|NCT01191268|560841647|FG001|Overall Study|Entry Criteria Not Met|1|||
155384295|NCT01191268|560841648|FG002|Overall Study|Entry Criteria Not Met|1|||
155384296|NCT01191268|560841646|FG000|Overall Study|Death|0|||
155384297|NCT01191268|560841647|FG001|Overall Study|Death|1|||
155384298|NCT01191268|560841648|FG002|Overall Study|Death|3|||
155384299|NCT01191268|560841646|FG000|Overall Study|Protocol Violation|1|||
155384300|NCT01191268|560841647|FG001|Overall Study|Protocol Violation|0|||
155384301|NCT01191268|560841648|FG002|Overall Study|Protocol Violation|1|||
155384302|NCT01191268|560841646|FG000|Overall Study|Sponsor Decision|0|||
155384303|NCT01191268|560841647|FG001|Overall Study|Sponsor Decision|2|||
155384304|NCT01191268|560841648|FG002|Overall Study|Sponsor Decision|0|||
155384305|NCT01313689|560841649|FG000|24-Week Randomization 1|Adverse Event|10|||
155384306|NCT01313689|560841650|FG001|24-Week Randomization 1|Adverse Event|5|||
155384307|NCT01313689|560841651|FG002|24-Week Randomization 1|Adverse Event|0|||
155384308|NCT01313689|560841652|FG003|24-Week Randomization 1|Adverse Event|0|||
155384309|NCT01313689|560841653|FG004|24-Week Randomization 1|Adverse Event|0|||
155384310|NCT01313689|560841649|FG000|24-Week Randomization 1|Physician Decision|4|||
155384311|NCT01313689|560841650|FG001|24-Week Randomization 1|Physician Decision|5|||
155384312|NCT01313689|560841651|FG002|24-Week Randomization 1|Physician Decision|0|||
155384313|NCT01313689|560841652|FG003|24-Week Randomization 1|Physician Decision|0|||
155384314|NCT01313689|560841653|FG004|24-Week Randomization 1|Physician Decision|0|||
155384315|NCT01313689|560841649|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
155384316|NCT01313689|560841650|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
155384317|NCT01313689|560841651|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
155626793|NCT00116142|561730033|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
155626794|NCT00116142|561730034|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
155626795|NCT00116142|561730033|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
155626796|NCT00116142|561730034|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
155626797|NCT00116142|561730033|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
155626798|NCT00116142|561730034|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
155626799|NCT00644059|561730035|FG000|Overall Study|Lost to Follow-up|37|||
155626800|NCT00644059|561730036|FG001|Overall Study|Lost to Follow-up|34|||
155626801|NCT00644059|561730037|FG002|Overall Study|Lost to Follow-up|16|||
155626802|NCT00644059|561730035|FG000|Overall Study|Withdrawal by Subject|52|||
155626803|NCT00644059|561730036|FG001|Overall Study|Withdrawal by Subject|60|||
155626804|NCT00644059|561730037|FG002|Overall Study|Withdrawal by Subject|30|||
155626805|NCT00644059|561730035|FG000|Overall Study|Adverse Event|8|||
155626806|NCT00644059|561730036|FG001|Overall Study|Adverse Event|5|||
155626807|NCT00644059|561730037|FG002|Overall Study|Adverse Event|1|||
155626808|NCT00644059|561730035|FG000|Overall Study|Inappropriate Enrollment|1|||
155626809|NCT00644059|561730036|FG001|Overall Study|Inappropriate Enrollment|3|||
155626810|NCT00644059|561730037|FG002|Overall Study|Inappropriate Enrollment|0|||
155626811|NCT00644059|561730035|FG000|Overall Study|Protocol Deviation/violation|20|||
155626812|NCT00644059|561730036|FG001|Overall Study|Protocol Deviation/violation|19|||
155626813|NCT00644059|561730037|FG002|Overall Study|Protocol Deviation/violation|15|||
155626814|NCT00644059|561730035|FG000|Overall Study|Unable to classify|6|||
155384318|NCT01313689|560841652|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
155384319|NCT01313689|560841653|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
155384320|NCT01313689|560841649|FG000|24-Week Randomization 2|Adverse Event|0|||
155384321|NCT01313689|560841650|FG001|24-Week Randomization 2|Adverse Event|0|||
155384322|NCT01313689|560841651|FG002|24-Week Randomization 2|Adverse Event|2|||
155384323|NCT01313689|560841652|FG003|24-Week Randomization 2|Adverse Event|0|||
155384324|NCT01313689|560841653|FG004|24-Week Randomization 2|Adverse Event|8|||
155384325|NCT01313689|560841649|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
155384326|NCT01313689|560841650|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
155384327|NCT01313689|560841651|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
155384328|NCT01313689|560841652|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
155384329|NCT01313689|560841653|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
155384330|NCT01313689|560841649|FG000|24-Week Randomization 2|Physician Decision|0|||
155384331|NCT01313689|560841650|FG001|24-Week Randomization 2|Physician Decision|0|||
155384332|NCT01313689|560841651|FG002|24-Week Randomization 2|Physician Decision|0|||
155384333|NCT01313689|560841652|FG003|24-Week Randomization 2|Physician Decision|0|||
155384334|NCT01313689|560841653|FG004|24-Week Randomization 2|Physician Decision|4|||
155384335|NCT02481947|560841654|FG000|Overall Study|Withdrawal by Subject|24|||
155384336|NCT02481947|560841655|FG001|Overall Study|Withdrawal by Subject|10|||
155384337|NCT02481947|560841654|FG000|Overall Study|Lost to Follow-up|11|||
155384338|NCT02481947|560841655|FG001|Overall Study|Lost to Follow-up|5|||
155384339|NCT02481947|560841654|FG000|Overall Study|Adverse Event|6|||
155384340|NCT02481947|560841655|FG001|Overall Study|Adverse Event|11|||
155384341|NCT02481947|560841654|FG000|Overall Study|Physician Decision|4|||
155384342|NCT02481947|560841655|FG001|Overall Study|Physician Decision|5|||
155384343|NCT02481947|560841654|FG000|Overall Study|Protocol Violation|1|||
155384344|NCT02481947|560841655|FG001|Overall Study|Protocol Violation|5|||
155384345|NCT00551460|560841656|FG000|Overall Study|Adverse Event|1|||
155384346|NCT00551460|560841656|FG000|Overall Study|Withdrawal by Subject|1|||
155384347|NCT00551460|560841656|FG000|Overall Study|Physician Decision|1|||
155384348|NCT00551460|560841656|FG000|Overall Study|Death|7|||
155384349|NCT00551460|560841656|FG000|Overall Study|Ineligible|4|||
155384350|NCT00551460|560841656|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
155384351|NCT02027623|560841658|FG000|Overall Study|Lost to Follow-up|3|||
155384352|NCT02027623|560841659|FG001|Overall Study|Lost to Follow-up|3|||
155384353|NCT02027623|560841658|FG000|Overall Study|Withdrawal by Subject|6|||
155384354|NCT02027623|560841659|FG001|Overall Study|Withdrawal by Subject|9|||
155384355|NCT01886378|560841662|FG000|Overall Study|Adverse Event|1|||
155384356|NCT01886378|560841662|FG000|Overall Study|Withdrawal by Subject|4|||
155384357|NCT01740323|560841668|FG000|Overall Study|Adverse Event|1|||
155384358|NCT01740323|560841669|FG001|Overall Study|Adverse Event|0|||
155384359|NCT01740323|560841668|FG000|Overall Study|Randomized but did not take study drug|1|||
155384360|NCT01740323|560841669|FG001|Overall Study|Randomized but did not take study drug|0|||
155384361|NCT02112708|560841675|FG000|Baseline|Physician Decision|16|||
155384362|NCT02112708|560841676|FG001|Baseline|Physician Decision|11|||
155384363|NCT02112708|560841675|FG000|Baseline|Lost to Follow-up|12|||
155384364|NCT02112708|560841676|FG001|Baseline|Lost to Follow-up|0|||
155384365|NCT02112708|560841675|FG000|4 Month|Death|0|||
155384366|NCT02112708|560841676|FG001|4 Month|Death|1|||
155384367|NCT02112708|560841675|FG000|4 Month|Withdrawal by Subject|12|||
155384368|NCT02112708|560841676|FG001|4 Month|Withdrawal by Subject|0|||
155384369|NCT02374671|560841677|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
155384370|NCT02374671|560841678|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
155384371|NCT02374671|560841679|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
155384372|NCT02374671|560841677|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
155384373|NCT02374671|560841678|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
155384374|NCT02374671|560841679|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
155384375|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
155384376|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
155384377|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
155384378|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
155384379|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
155384380|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
155384381|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
155384382|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
155384383|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
155384384|NCT00903682|560841680|FG000|Overall Study|Adverse Event|6|||
155384385|NCT00903682|560841681|FG001|Overall Study|Adverse Event|13|||
155384386|NCT00903682|560841680|FG000|Overall Study|Lost to Follow-up|1|||
155384387|NCT00903682|560841681|FG001|Overall Study|Lost to Follow-up|0|||
155384388|NCT00903682|560841680|FG000|Overall Study|Withdrawal by Subject|5|||
155384389|NCT00903682|560841681|FG001|Overall Study|Withdrawal by Subject|0|||
155384390|NCT00903682|560841680|FG000|Overall Study|Pregnancy|0|||
155384391|NCT00903682|560841681|FG001|Overall Study|Pregnancy|1|||
155384392|NCT00903682|560841680|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
155384393|NCT00903682|560841681|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
155384394|NCT00903682|560841680|FG000|Overall Study|Subject Non-Compliant|1|||
155384395|NCT00903682|560841681|FG001|Overall Study|Subject Non-Compliant|0|||
155384396|NCT00903682|560841680|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
155384397|NCT00903682|560841681|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
155384398|NCT00903682|560841680|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
155384399|NCT00903682|560841681|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
155384400|NCT03169101|560841682|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
155626815|NCT00644059|561730036|FG001|Overall Study|Unable to classify|2|||
155626816|NCT00644059|561730037|FG002|Overall Study|Unable to classify|3|||
155626817|NCT02133508|561730038|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
155626818|NCT02133508|561730038|FG000|Overall Study|Death|12|||
155626819|NCT02133508|561730038|FG000|Overall Study|Lost to Follow-up|2|||
155626820|NCT01026493|561730040|FG000|Overall Study|Protocol Violation|0|||
155626821|NCT01026493|561730041|FG001|Overall Study|Protocol Violation|1|||
155626822|NCT01026493|561730042|FG002|Overall Study|Protocol Violation|0|||
155626823|NCT01026493|561730043|FG003|Overall Study|Protocol Violation|0|||
155626824|NCT01026493|561730044|FG004|Overall Study|Protocol Violation|2|||
155626825|NCT01026493|561730045|FG005|Overall Study|Protocol Violation|3|||
155626826|NCT01026493|561730046|FG006|Overall Study|Protocol Violation|4|||
155626827|NCT01026493|561730047|FG007|Overall Study|Protocol Violation|1|||
155626828|NCT03167242|561730055|FG000|Overall Study|Patient/Guardian Decision|0|||
155626829|NCT03167242|561730056|FG001|Overall Study|Patient/Guardian Decision|1|||
155626830|NCT03167242|561730057|FG002|Overall Study|Patient/Guardian Decision|2|||
155626831|NCT03167242|561730058|FG003|Overall Study|Patient/Guardian Decision|1|||
155626832|NCT03167242|561730059|FG004|Overall Study|Patient/Guardian Decision|1|||
155626833|NCT03167242|561730060|FG005|Overall Study|Patient/Guardian Decision|1|||
155626834|NCT03167242|561730061|FG006|Overall Study|Patient/Guardian Decision|0|||
155626835|NCT03167242|561730062|FG007|Overall Study|Patient/Guardian Decision|0|||
155626836|NCT03167242|561730063|FG008|Overall Study|Patient/Guardian Decision|0|||
155626837|NCT03167242|561730064|FG009|Overall Study|Patient/Guardian Decision|0|||
155626838|NCT03167242|561730065|FG010|Overall Study|Patient/Guardian Decision|1|||
155626839|NCT03167242|561730066|FG011|Overall Study|Patient/Guardian Decision|0|||
155626840|NCT03167242|561730055|FG000|Overall Study|Lost to Follow-up|0|||
155626841|NCT03167242|561730056|FG001|Overall Study|Lost to Follow-up|0|||
155626842|NCT03167242|561730057|FG002|Overall Study|Lost to Follow-up|1|||
155626843|NCT03167242|561730058|FG003|Overall Study|Lost to Follow-up|0|||
155626844|NCT03167242|561730059|FG004|Overall Study|Lost to Follow-up|0|||
155626845|NCT03167242|561730060|FG005|Overall Study|Lost to Follow-up|1|||
155626846|NCT03167242|561730061|FG006|Overall Study|Lost to Follow-up|2|||
155626847|NCT03167242|561730062|FG007|Overall Study|Lost to Follow-up|1|||
155626848|NCT03167242|561730063|FG008|Overall Study|Lost to Follow-up|0|||
155626849|NCT03167242|561730064|FG009|Overall Study|Lost to Follow-up|0|||
155626850|NCT03167242|561730065|FG010|Overall Study|Lost to Follow-up|1|||
155626851|NCT03167242|561730066|FG011|Overall Study|Lost to Follow-up|1|||
155626852|NCT03167242|561730055|FG000|Overall Study|Reason not provided|0|||
155626853|NCT03167242|561730056|FG001|Overall Study|Reason not provided|0|||
155626854|NCT03167242|561730057|FG002|Overall Study|Reason not provided|0|||
155626855|NCT03167242|561730058|FG003|Overall Study|Reason not provided|0|||
155626856|NCT03167242|561730059|FG004|Overall Study|Reason not provided|0|||
155626857|NCT03167242|561730060|FG005|Overall Study|Reason not provided|0|||
155626858|NCT03167242|561730061|FG006|Overall Study|Reason not provided|0|||
155626859|NCT03167242|561730062|FG007|Overall Study|Reason not provided|0|||
155626860|NCT03167242|561730063|FG008|Overall Study|Reason not provided|1|||
155626861|NCT03167242|561730064|FG009|Overall Study|Reason not provided|0|||
155626862|NCT03167242|561730065|FG010|Overall Study|Reason not provided|0|||
155626863|NCT03167242|561730066|FG011|Overall Study|Reason not provided|0|||
155626864|NCT03786380|561730067|FG000|Overall Study|Adverse Event|1|||
155626865|NCT03786380|561730068|FG001|Overall Study|Adverse Event|0|||
155626866|NCT03786380|561730069|FG002|Overall Study|Adverse Event|0|||
155626867|NCT03786380|561730070|FG003|Overall Study|Adverse Event|3|||
155626868|NCT03786380|561730071|FG004|Overall Study|Adverse Event|1|||
155626869|NCT03786380|561730067|FG000|Overall Study|Lack of Efficacy|0|||
155626870|NCT03786380|561730068|FG001|Overall Study|Lack of Efficacy|0|||
155626871|NCT03786380|561730069|FG002|Overall Study|Lack of Efficacy|0|||
155626872|NCT03786380|561730070|FG003|Overall Study|Lack of Efficacy|0|||
155626873|NCT03786380|561730071|FG004|Overall Study|Lack of Efficacy|1|||
155626874|NCT03786380|561730067|FG000|Overall Study|Withdrawal by Subject|1|||
155626875|NCT03786380|561730068|FG001|Overall Study|Withdrawal by Subject|2|||
155626876|NCT03786380|561730069|FG002|Overall Study|Withdrawal by Subject|2|||
155626877|NCT03786380|561730070|FG003|Overall Study|Withdrawal by Subject|1|||
155626878|NCT03786380|561730071|FG004|Overall Study|Withdrawal by Subject|2|||
155626879|NCT03786380|561730067|FG000|Overall Study|Lost to Follow-up|3|||
155626880|NCT03786380|561730068|FG001|Overall Study|Lost to Follow-up|0|||
155626881|NCT03786380|561730069|FG002|Overall Study|Lost to Follow-up|1|||
155626882|NCT03786380|561730070|FG003|Overall Study|Lost to Follow-up|2|||
155626883|NCT03786380|561730071|FG004|Overall Study|Lost to Follow-up|0|||
155626884|NCT03786380|561730067|FG000|Overall Study|Physician Decision|0|||
155626885|NCT03786380|561730068|FG001|Overall Study|Physician Decision|0|||
155626886|NCT03786380|561730069|FG002|Overall Study|Physician Decision|1|||
155626887|NCT03786380|561730070|FG003|Overall Study|Physician Decision|0|||
155626888|NCT03786380|561730071|FG004|Overall Study|Physician Decision|0|||
155626889|NCT03786380|561730067|FG000|Overall Study|Study Terminated by the Sponsor|30|||
155626890|NCT03786380|561730068|FG001|Overall Study|Study Terminated by the Sponsor|20|||
155626891|NCT03786380|561730069|FG002|Overall Study|Study Terminated by the Sponsor|50|||
155626892|NCT03786380|561730070|FG003|Overall Study|Study Terminated by the Sponsor|57|||
155626893|NCT03786380|561730071|FG004|Overall Study|Study Terminated by the Sponsor|23|||
155384401|NCT03169101|560841683|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
155384402|NCT03169101|560841684|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
155384403|NCT03169101|560841685|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
155384404|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
155384405|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
155384406|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
155384407|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
155384408|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
155384409|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
155384410|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
155384411|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
155384412|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
155384413|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
155384414|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
155384415|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
155384416|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
155384417|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
155384418|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
155384419|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
155384420|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
155384421|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
155384422|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
155384423|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
155384424|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
155384425|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
155384426|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
155384427|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
155384428|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
155384429|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
155384430|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
155384431|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
155384432|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Death|1|||
155384433|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Death|1|||
155384434|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
155384435|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
155384436|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
155384437|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
155384438|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
155384439|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
155384440|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
155384441|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
155384442|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
155384443|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
155384444|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
155384445|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
155384446|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
155384447|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
155384448|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Death|1|||
155384449|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Death|0|||
155384450|NCT01028027|560841690|FG000|Overall Study|Lost to Follow-up|4|||
155384451|NCT01028027|560841691|FG001|Overall Study|Lost to Follow-up|1|||
155384452|NCT01028027|560841690|FG000|Overall Study|Withdrawal by Subject|5|||
155384453|NCT01028027|560841691|FG001|Overall Study|Withdrawal by Subject|3|||
155384454|NCT01028027|560841690|FG000|Overall Study|Adverse Event|4|||
155384455|NCT01028027|560841691|FG001|Overall Study|Adverse Event|7|||
155384456|NCT01028027|560841690|FG000|Overall Study|Protocol Violation|3|||
155384457|NCT01028027|560841691|FG001|Overall Study|Protocol Violation|1|||
155384458|NCT01028027|560841690|FG000|Overall Study|Lack of Efficacy|0|||
155384459|NCT01028027|560841691|FG001|Overall Study|Lack of Efficacy|1|||
155384460|NCT02572843|560841698|FG000|Accrual|Brain metastasis retrospectively detected|1|||
155384461|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
155384462|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
155384463|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
155384464|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
155384465|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
155384466|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
155384467|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
155384468|NCT02572843|560841698|FG000|Surgery|lost to follow up|7|||
155384469|NCT02572843|560841698|FG000|Surgery|Death|1|||
155384470|NCT01078454|560841699|FG000|Overall Study|Adverse Event|1|||
155384471|NCT01078454|560841700|FG001|Overall Study|Adverse Event|1|||
155384472|NCT01078454|560841699|FG000|Overall Study|Death|0|||
155384473|NCT01078454|560841700|FG001|Overall Study|Death|1|||
155384474|NCT03440320|560843620|FG000|Overall Study|Withdrawal by Subject|0|||
155384475|NCT03440320|560843621|FG001|Overall Study|Withdrawal by Subject|1|||
155384476|NCT01912456|560843622|FG000|Period 1|Physician Decision|0|||
155384477|NCT01912456|560843623|FG001|Period 1|Physician Decision|0|||
155384478|NCT01912456|560843624|FG002|Period 1|Physician Decision|1|||
155384479|NCT01912456|560843625|FG003|Period 1|Physician Decision|0|||
155384480|NCT01912456|560843622|FG000|Period 1|non-compliance|1|||
155384481|NCT01912456|560843623|FG001|Period 1|non-compliance|0|||
155384482|NCT01912456|560843624|FG002|Period 1|non-compliance|0|||
155384483|NCT01912456|560843625|FG003|Period 1|non-compliance|1|||
155384484|NCT01912456|560843622|FG000|Period 1|Adverse Event|1|||
155384485|NCT01912456|560843623|FG001|Period 1|Adverse Event|0|||
155384486|NCT01912456|560843624|FG002|Period 1|Adverse Event|0|||
155384487|NCT01912456|560843625|FG003|Period 1|Adverse Event|1|||
155384488|NCT01912456|560843622|FG000|Period 1|Withdrawal by Subject|0|||
155384489|NCT01912456|560843623|FG001|Period 1|Withdrawal by Subject|1|||
155384490|NCT01912456|560843624|FG002|Period 1|Withdrawal by Subject|1|||
155384491|NCT01912456|560843625|FG003|Period 1|Withdrawal by Subject|1|||
155384492|NCT01912456|560843622|FG000|Period 2|Lack of Efficacy|0|||
155384493|NCT01912456|560843623|FG001|Period 2|Lack of Efficacy|2|||
155384494|NCT01912456|560843624|FG002|Period 2|Lack of Efficacy|0|||
155384495|NCT01912456|560843625|FG003|Period 2|Lack of Efficacy|0|||
155384496|NCT01912456|560843622|FG000|Period 2|Adverse Event|0|||
155384497|NCT01912456|560843623|FG001|Period 2|Adverse Event|0|||
155384498|NCT01912456|560843624|FG002|Period 2|Adverse Event|0|||
155384499|NCT01912456|560843625|FG003|Period 2|Adverse Event|1|||
155384500|NCT00001962|560843631|FG000|Overall Study|Lack of Efficacy|18|||
155384501|NCT00001962|560843631|FG000|Overall Study|Lack of Accrual|6|||
155384502|NCT00001962|560843631|FG000|Overall Study|Death|1|||
155384503|NCT00001962|560843631|FG000|Overall Study|Lost to Follow-up|2|||
155384504|NCT00001962|560843631|FG000|Overall Study|Adverse Event|1|||
155384505|NCT00171704|560843632|FG000|Overall Study|Adverse Event|24|||
155384506|NCT00171704|560843633|FG001|Overall Study|Adverse Event|33|||
155384507|NCT00171704|560843632|FG000|Overall Study|Disease Progression|14|||
155384508|NCT00171704|560843633|FG001|Overall Study|Disease Progression|9|||
155384509|NCT00171704|560843632|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
155384510|NCT00171704|560843633|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
155384511|NCT00171704|560843632|FG000|Overall Study|Administrative Problems|2|||
155384512|NCT00171704|560843633|FG001|Overall Study|Administrative Problems|1|||
155384513|NCT00171704|560843632|FG000|Overall Study|Death|2|||
155384514|NCT00171704|560843633|FG001|Overall Study|Death|2|||
155384515|NCT00171704|560843632|FG000|Overall Study|Withdrawal by Subject|1|||
155384516|NCT00171704|560843633|FG001|Overall Study|Withdrawal by Subject|3|||
155384517|NCT00171704|560843632|FG000|Overall Study|Protocol Violation|0|||
155384518|NCT00171704|560843633|FG001|Overall Study|Protocol Violation|1|||
155384519|NCT00320541|560843636|FG000|Overall Study|Adverse Event|21|||
155384520|NCT00320541|560843637|FG001|Overall Study|Adverse Event|19|||
155384521|NCT00320541|560843636|FG000|Overall Study|Protocol Violation|0|||
155384522|NCT00320541|560843637|FG001|Overall Study|Protocol Violation|1|||
155384523|NCT00320541|560843636|FG000|Overall Study|Withdrawal by Subject|12|||
155384524|NCT00320541|560843637|FG001|Overall Study|Withdrawal by Subject|16|||
155384525|NCT00320541|560843636|FG000|Overall Study|Physician Decision|9|||
155384526|NCT00320541|560843637|FG001|Overall Study|Physician Decision|13|||
155384527|NCT00320541|560843636|FG000|Overall Study|Other|3|||
155384528|NCT00320541|560843637|FG001|Overall Study|Other|4|||
155384529|NCT00320541|560843636|FG000|Overall Study|Sponsor Decision|2|||
155384530|NCT00320541|560843637|FG001|Overall Study|Sponsor Decision|1|||
155384531|NCT00320541|560843636|FG000|Overall Study|Death due to Study Disease|1|||
155384532|NCT00320541|560843637|FG001|Overall Study|Death due to Study Disease|3|||
155384533|NCT00320541|560843636|FG000|Overall Study|Death due to Adverse Event(s)|1|||
155384534|NCT00320541|560843637|FG001|Overall Study|Death due to Adverse Event(s)|0|||
155384535|NCT00320541|560843636|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
155384536|NCT00320541|560843637|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
155384537|NCT04281004|560843640|FG000|Overall Study|Physician Decision|1|||
155384538|NCT04281004|560843641|FG001|Overall Study|Physician Decision|0|||
155384539|NCT00701779|560843642|FG000|Overall Study|Adverse Event|6|||
155384540|NCT00701779|560843642|FG000|Overall Study|Lost to Follow-up|1|||
155384541|NCT00701779|560843642|FG000|Overall Study|Withdrawal by Subject|2|||
155384542|NCT02245672|560843643|FG000|Overall Study|Adverse Event|4|||
155384543|NCT02245672|560843644|FG001|Overall Study|Adverse Event|4|||
155384544|NCT02245672|560843645|FG002|Overall Study|Adverse Event|4|||
155384545|NCT02245672|560843643|FG000|Overall Study|Lost to Follow-up|3|||
155384546|NCT02245672|560843644|FG001|Overall Study|Lost to Follow-up|5|||
155384547|NCT02245672|560843645|FG002|Overall Study|Lost to Follow-up|1|||
155384548|NCT02245672|560843643|FG000|Overall Study|Withdrawal by Subject|6|||
155384549|NCT02245672|560843644|FG001|Overall Study|Withdrawal by Subject|3|||
155626894|NCT03786380|561730067|FG000|Overall Study|Reason Not Specified|0|||
155626895|NCT03786380|561730068|FG001|Overall Study|Reason Not Specified|0|||
155626896|NCT03786380|561730069|FG002|Overall Study|Reason Not Specified|0|||
155626897|NCT03786380|561730070|FG003|Overall Study|Reason Not Specified|0|||
155626898|NCT03786380|561730071|FG004|Overall Study|Reason Not Specified|1|||
155626899|NCT01038687|561730074|FG000|Overall Study|Adverse Event|0|||
155626900|NCT01038687|561730075|FG001|Overall Study|Adverse Event|2|||
155626901|NCT01038687|561730076|FG002|Overall Study|Adverse Event|1|||
155626902|NCT05401565|561730077|FG000|Overall Study|Lost to Follow-up|1|||
155626903|NCT05401565|561730078|FG001|Overall Study|Lost to Follow-up|0|||
155626904|NCT05401565|561730077|FG000|Overall Study|Adverse Event|2|||
155626905|NCT05401565|561730078|FG001|Overall Study|Adverse Event|0|||
155626906|NCT02984982|561730079|FG000|Overall Study|Adverse Event|2|||
155626907|NCT02984982|561730080|FG001|Overall Study|Adverse Event|5|||
155626908|NCT02984982|561730079|FG000|Overall Study|Poor Compliance to Protocol|4|||
155626909|NCT02984982|561730080|FG001|Overall Study|Poor Compliance to Protocol|4|||
155626910|NCT02984982|561730079|FG000|Overall Study|Withdrawal by Subject|2|||
155626911|NCT02984982|561730080|FG001|Overall Study|Withdrawal by Subject|0|||
155626912|NCT02984982|561730079|FG000|Overall Study|Randomized but not treated|0|||
155626913|NCT02984982|561730080|FG001|Overall Study|Randomized but not treated|1|||
155626914|NCT02175121|561730082|FG000|Overall Study|Lack of Efficacy|1|||
155626915|NCT02175121|561730083|FG001|Overall Study|Lack of Efficacy|0|||
155626916|NCT02175121|561730084|FG002|Overall Study|Lack of Efficacy|0|||
155626917|NCT02175121|561730085|FG003|Overall Study|Lack of Efficacy|0|||
155626918|NCT02175121|561730086|FG004|Overall Study|Lack of Efficacy|0|||
155626919|NCT02175121|561730082|FG000|Overall Study|Lost to Follow-up|0|||
155626920|NCT02175121|561730083|FG001|Overall Study|Lost to Follow-up|1|||
155626921|NCT02175121|561730084|FG002|Overall Study|Lost to Follow-up|0|||
155626922|NCT02175121|561730085|FG003|Overall Study|Lost to Follow-up|1|||
155626923|NCT02175121|561730086|FG004|Overall Study|Lost to Follow-up|0|||
155626924|NCT02175121|561730082|FG000|Overall Study|Personal emergency|0|||
155626925|NCT02175121|561730083|FG001|Overall Study|Personal emergency|0|||
155626926|NCT02175121|561730084|FG002|Overall Study|Personal emergency|0|||
155626927|NCT02175121|561730085|FG003|Overall Study|Personal emergency|0|||
155626928|NCT02175121|561730086|FG004|Overall Study|Personal emergency|1|||
155626929|NCT02175121|561730082|FG000|Overall Study|Schedule conflict|0|||
155626930|NCT02175121|561730083|FG001|Overall Study|Schedule conflict|0|||
155626931|NCT02175121|561730084|FG002|Overall Study|Schedule conflict|1|||
155626932|NCT02175121|561730085|FG003|Overall Study|Schedule conflict|0|||
155626933|NCT02175121|561730086|FG004|Overall Study|Schedule conflict|0|||
155626934|NCT02175121|561730082|FG000|Overall Study|Time issues|0|||
155626935|NCT02175121|561730083|FG001|Overall Study|Time issues|0|||
155626936|NCT02175121|561730084|FG002|Overall Study|Time issues|1|||
155626937|NCT02175121|561730085|FG003|Overall Study|Time issues|0|||
155626938|NCT02175121|561730086|FG004|Overall Study|Time issues|0|||
155626939|NCT00931632|561730091|FG000|Overall Study|Withdrawal by Subject|2|||
155626940|NCT00931632|561730092|FG001|Overall Study|Withdrawal by Subject|3|||
155626941|NCT00931632|561730091|FG000|Overall Study|Adverse Event|19|||
155626942|NCT00931632|561730092|FG001|Overall Study|Adverse Event|15|||
155626943|NCT01419314|561730093|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
155626944|NCT01419314|561730094|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
155626945|NCT01419314|561730093|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
155626946|NCT01419314|561730094|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
155626947|NCT01419314|561730093|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
155626948|NCT01419314|561730094|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
155626949|NCT03139552|561730098|FG000|Overall Study|unable to attend tasting due to schedule|3|||
155626950|NCT00887484|561730108|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
155626951|NCT00887484|561730108|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
155626952|NCT00887484|561730108|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
155626953|NCT03044314|561730114|FG000|Overall Study|Physician Decision|2|||
155626954|NCT03044314|561730114|FG000|Overall Study|Withdrawal by Subject|1|||
155626955|NCT03044314|561730114|FG000|Overall Study|Connector tubing not available|1|||
155626956|NCT03122171|561730115|FG000|Overall Study|Withdrawal by Subject|1|||
155626957|NCT01316224|561730116|FG000|Overall Study|Protocol Violation|3|||
155626958|NCT01316224|561730116|FG000|Overall Study|Adverse Event|3|||
155626959|NCT01316224|561730116|FG000|Overall Study|Lack of Efficacy|1|||
155729250|NCT02113982|562108040|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
155729251|NCT02113982|562108041|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
155279127|NCT02335268|560454789|FG000|Overall Study|Physician Decision|5|||
155626960|NCT01316224|561730116|FG000|Overall Study|Withdrawal by Subject|1|||
155626961|NCT01316224|561730116|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
155626962|NCT01316224|561730116|FG000|Overall Study|Other|1|||
155626963|NCT00264147|561730117|FG000|Treatment I Period|Adverse Event|3|||
155626964|NCT00264147|561730118|FG001|Treatment I Period|Adverse Event|6|||
155626965|NCT00264147|561730119|FG002|Treatment I Period|Adverse Event|3|||
155626966|NCT00264147|561730120|FG003|Treatment I Period|Adverse Event|5|||
155626967|NCT00264147|561730121|FG004|Treatment I Period|Adverse Event|7|||
155729252|NCT02113982|562108042|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
155384550|NCT02245672|560843645|FG002|Overall Study|Withdrawal by Subject|0|||
155384551|NCT02245672|560843643|FG000|Overall Study|Randomized in error (not treated)|0|||
155384552|NCT02245672|560843644|FG001|Overall Study|Randomized in error (not treated)|1|||
155384553|NCT02245672|560843645|FG002|Overall Study|Randomized in error (not treated)|0|||
155384554|NCT01640054|560843646|FG000|Overall Study|Study-specific disc criteria|1|||
155384555|NCT01640054|560843646|FG000|Overall Study|Lack of Efficacy|3|||
155384556|NCT01640054|560843646|FG000|Overall Study|Adverse Event|2|||
155384557|NCT01620255|560843648|FG000|Overall Study|Withdrawal by Subject|4|||
155384558|NCT01620255|560843649|FG001|Overall Study|Withdrawal by Subject|1|||
155384559|NCT01620255|560843650|FG002|Overall Study|Withdrawal by Subject|1|||
155384560|NCT01620255|560843651|FG003|Overall Study|Withdrawal by Subject|2|||
155384561|NCT01620255|560843652|FG004|Overall Study|Withdrawal by Subject|4|||
155384562|NCT01620255|560843648|FG000|Overall Study|Participant underwent fecal transplant|0|||
155384563|NCT01620255|560843649|FG001|Overall Study|Participant underwent fecal transplant|0|||
155384564|NCT01620255|560843650|FG002|Overall Study|Participant underwent fecal transplant|1|||
155384565|NCT01620255|560843651|FG003|Overall Study|Participant underwent fecal transplant|0|||
155384566|NCT01620255|560843652|FG004|Overall Study|Participant underwent fecal transplant|0|||
155384567|NCT01620255|560843648|FG000|Overall Study|Non-compliance|0|||
155384568|NCT01620255|560843649|FG001|Overall Study|Non-compliance|1|||
155384569|NCT01620255|560843650|FG002|Overall Study|Non-compliance|0|||
155384570|NCT01620255|560843651|FG003|Overall Study|Non-compliance|0|||
155384571|NCT01620255|560843652|FG004|Overall Study|Non-compliance|0|||
155384572|NCT01620255|560843648|FG000|Overall Study|Adverse Event|0|||
155384573|NCT01620255|560843649|FG001|Overall Study|Adverse Event|4|||
155384574|NCT01620255|560843650|FG002|Overall Study|Adverse Event|0|||
155384575|NCT01620255|560843651|FG003|Overall Study|Adverse Event|1|||
155384576|NCT01620255|560843652|FG004|Overall Study|Adverse Event|1|||
155384577|NCT01620255|560843648|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
155384578|NCT01620255|560843649|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
155384579|NCT01620255|560843650|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
155384580|NCT01620255|560843651|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
155384581|NCT01620255|560843652|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
155384582|NCT01146054|560843655|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
155384583|NCT01146054|560843655|FG000|Overall Study|Rapid tumor progression|2|||
155384584|NCT01146054|560843655|FG000|Overall Study|Other illness precluded treatment|2|||
155384585|NCT01146054|560843655|FG000|Overall Study|Lost to Follow-up|1|||
155384586|NCT01155375|560843656|FG000|Overall Study|Adverse Event|1|||
155384587|NCT01155375|560843657|FG001|Overall Study|Adverse Event|0|||
155384588|NCT04335812|560843658|FG000|Overall Study|Withdrawal by Subject|1|||
155384589|NCT04335812|560843659|FG001|Overall Study|Withdrawal by Subject|3|||
155384590|NCT04335812|560843658|FG000|Overall Study|Lost to Follow-up|12|||
155384591|NCT04335812|560843659|FG001|Overall Study|Lost to Follow-up|12|||
155384592|NCT04335812|560843658|FG000|Overall Study|Did not engage in the intervention|22|||
155384593|NCT04335812|560843659|FG001|Overall Study|Did not engage in the intervention|18|||
155384594|NCT02901041|560843660|FG000|Overall Study|Withdrawal by PI|4|||
155384595|NCT02901041|560843661|FG001|Overall Study|Withdrawal by PI|8|||
155384596|NCT02901041|560843660|FG000|Overall Study|Withdrawal by Subject|7|||
155384597|NCT02901041|560843661|FG001|Overall Study|Withdrawal by Subject|3|||
155384598|NCT00975507|560843665|FG000|Overall Study|Adverse Event|1|||
155384599|NCT00975507|560843666|FG001|Overall Study|Adverse Event|0|||
155384600|NCT00975507|560843665|FG000|Overall Study|Lost to Follow-up|7|||
155384601|NCT00975507|560843666|FG001|Overall Study|Lost to Follow-up|1|||
155384602|NCT00975507|560843665|FG000|Overall Study|Protocol Violation|2|||
155384603|NCT00975507|560843666|FG001|Overall Study|Protocol Violation|0|||
155384604|NCT00975507|560843665|FG000|Overall Study|Withdrawal by Subject|10|||
155384605|NCT00975507|560843666|FG001|Overall Study|Withdrawal by Subject|3|||
155384606|NCT03818204|560843667|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384607|NCT03818204|560843668|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384608|NCT03818204|560843669|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384609|NCT03818204|560843670|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384610|NCT03818204|560843671|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
155384611|NCT03818204|560843672|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384612|NCT03818204|560843673|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384613|NCT03818204|560843674|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384614|NCT03818204|560843675|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384615|NCT03818204|560843676|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384616|NCT03818204|560843677|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384617|NCT03818204|560843678|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384618|NCT03818204|560843679|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384619|NCT03818204|560843680|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
155384620|NCT03818204|560843681|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155626968|NCT00264147|561730122|FG005|Treatment I Period|Adverse Event|0|||
155626969|NCT00264147|561730117|FG000|Treatment I Period|Laboratory Adverse Event|0|||
155626970|NCT00264147|561730118|FG001|Treatment I Period|Laboratory Adverse Event|0|||
155626971|NCT00264147|561730119|FG002|Treatment I Period|Laboratory Adverse Event|0|||
155626972|NCT00264147|561730120|FG003|Treatment I Period|Laboratory Adverse Event|1|||
155626973|NCT00264147|561730121|FG004|Treatment I Period|Laboratory Adverse Event|0|||
155626974|NCT00264147|561730122|FG005|Treatment I Period|Laboratory Adverse Event|0|||
155626975|NCT00264147|561730117|FG000|Treatment I Period|Lack of Efficacy|6|||
155626976|NCT00264147|561730118|FG001|Treatment I Period|Lack of Efficacy|2|||
155626977|NCT00264147|561730119|FG002|Treatment I Period|Lack of Efficacy|8|||
155626978|NCT00264147|561730120|FG003|Treatment I Period|Lack of Efficacy|0|||
155626979|NCT00264147|561730121|FG004|Treatment I Period|Lack of Efficacy|1|||
155626980|NCT00264147|561730122|FG005|Treatment I Period|Lack of Efficacy|0|||
155626981|NCT00264147|561730117|FG000|Treatment I Period|Lost to Follow-up|1|||
155626982|NCT00264147|561730118|FG001|Treatment I Period|Lost to Follow-up|0|||
155626983|NCT00264147|561730119|FG002|Treatment I Period|Lost to Follow-up|0|||
155626984|NCT00264147|561730120|FG003|Treatment I Period|Lost to Follow-up|1|||
155626985|NCT00264147|561730121|FG004|Treatment I Period|Lost to Follow-up|1|||
155626986|NCT00264147|561730122|FG005|Treatment I Period|Lost to Follow-up|0|||
155626987|NCT00264147|561730117|FG000|Treatment I Period|Protocol Violation|2|||
155626988|NCT00264147|561730118|FG001|Treatment I Period|Protocol Violation|2|||
155626989|NCT00264147|561730119|FG002|Treatment I Period|Protocol Violation|0|||
155626990|NCT00264147|561730120|FG003|Treatment I Period|Protocol Violation|0|||
155626991|NCT00264147|561730121|FG004|Treatment I Period|Protocol Violation|0|||
155626992|NCT00264147|561730122|FG005|Treatment I Period|Protocol Violation|0|||
155626993|NCT00264147|561730117|FG000|Treatment I Period|Withdrawal by Subject|2|||
155626994|NCT00264147|561730118|FG001|Treatment I Period|Withdrawal by Subject|0|||
155626995|NCT00264147|561730119|FG002|Treatment I Period|Withdrawal by Subject|0|||
155626996|NCT00264147|561730120|FG003|Treatment I Period|Withdrawal by Subject|2|||
155626997|NCT00264147|561730121|FG004|Treatment I Period|Withdrawal by Subject|2|||
155626998|NCT00264147|561730122|FG005|Treatment I Period|Withdrawal by Subject|0|||
155626999|NCT00264147|561730117|FG000|Treatment I Period|Patient out of town for an extended time|0|||
155627000|NCT00264147|561730118|FG001|Treatment I Period|Patient out of town for an extended time|1|||
155627001|NCT00264147|561730119|FG002|Treatment I Period|Patient out of town for an extended time|0|||
155627002|NCT00264147|561730120|FG003|Treatment I Period|Patient out of town for an extended time|0|||
155627003|NCT00264147|561730121|FG004|Treatment I Period|Patient out of town for an extended time|0|||
155627004|NCT00264147|561730122|FG005|Treatment I Period|Patient out of town for an extended time|0|||
155627005|NCT00264147|561730117|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155627006|NCT00264147|561730118|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155627007|NCT00264147|561730119|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
155627008|NCT00264147|561730120|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155627009|NCT00264147|561730121|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155627010|NCT00264147|561730122|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155627011|NCT00264147|561730117|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
155627012|NCT00264147|561730118|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
155627013|NCT00264147|561730119|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
155627014|NCT00264147|561730120|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
155627015|NCT00264147|561730121|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
155627016|NCT00264147|561730122|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
155627017|NCT00264147|561730117|FG000|Treatment II Period|Adverse Event|0|||
155627018|NCT00264147|561730118|FG001|Treatment II Period|Adverse Event|0|||
155627019|NCT00264147|561730119|FG002|Treatment II Period|Adverse Event|0|||
155627020|NCT00264147|561730120|FG003|Treatment II Period|Adverse Event|0|||
155627021|NCT00264147|561730121|FG004|Treatment II Period|Adverse Event|9|||
155627022|NCT00264147|561730122|FG005|Treatment II Period|Adverse Event|9|||
155279128|NCT02335268|560454790|FG001|Overall Study|Physician Decision|1|||
155279129|NCT02335268|560454789|FG000|Overall Study|Lack of Efficacy|2|||
155279130|NCT02335268|560454790|FG001|Overall Study|Lack of Efficacy|1|||
155279131|NCT02335268|560454789|FG000|Overall Study|Adverse Event|5|||
155279132|NCT02335268|560454790|FG001|Overall Study|Adverse Event|2|||
155279133|NCT02335268|560454789|FG000|Overall Study|increase blasts|2|||
155279134|NCT02335268|560454790|FG001|Overall Study|increase blasts|0|||
155279135|NCT02335268|560454789|FG000|Overall Study|Withdrawal by Subject|3|||
155279136|NCT02335268|560454790|FG001|Overall Study|Withdrawal by Subject|2|||
155279137|NCT03160079|560454799|FG000|Overall Study|Adverse Event|2|||
155279138|NCT03160079|560454800|FG001|Overall Study|Adverse Event|0|||
155279139|NCT03160079|560454799|FG000|Overall Study|Disease Progression|1|||
155279140|NCT03160079|560454800|FG001|Overall Study|Disease Progression|0|||
155279141|NCT03160079|560454799|FG000|Overall Study|Physician Decision|1|||
155279142|NCT03160079|560454800|FG001|Overall Study|Physician Decision|0|||
155279143|NCT01923428|560454811|FG000|Overall Study|Adverse Event|8|||
155279144|NCT01923428|560454812|FG001|Overall Study|Adverse Event|6|||
155279145|NCT01923428|560454813|FG002|Overall Study|Adverse Event|3|||
155384621|NCT03818204|560843682|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384622|NCT03818204|560843683|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384623|NCT03818204|560843684|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384624|NCT03818204|560843685|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384625|NCT03818204|560843667|FG000|Overall Study|Physician Decision|0|||
155384626|NCT03818204|560843668|FG001|Overall Study|Physician Decision|0|||
155384627|NCT03818204|560843669|FG002|Overall Study|Physician Decision|0|||
155384628|NCT03818204|560843670|FG003|Overall Study|Physician Decision|0|||
155384629|NCT03818204|560843671|FG004|Overall Study|Physician Decision|0|||
155384630|NCT03818204|560843672|FG005|Overall Study|Physician Decision|0|||
155384631|NCT03818204|560843673|FG006|Overall Study|Physician Decision|0|||
155384632|NCT03818204|560843674|FG007|Overall Study|Physician Decision|0|||
155384633|NCT03818204|560843675|FG008|Overall Study|Physician Decision|0|||
155384634|NCT03818204|560843676|FG009|Overall Study|Physician Decision|0|||
155384635|NCT03818204|560843677|FG010|Overall Study|Physician Decision|0|||
155384636|NCT03818204|560843678|FG011|Overall Study|Physician Decision|0|||
155384637|NCT03818204|560843679|FG012|Overall Study|Physician Decision|0|||
155384638|NCT03818204|560843680|FG013|Overall Study|Physician Decision|0|||
155384639|NCT03818204|560843681|FG014|Overall Study|Physician Decision|1|||
155384640|NCT03818204|560843682|FG015|Overall Study|Physician Decision|0|||
155384641|NCT03818204|560843683|FG016|Overall Study|Physician Decision|0|||
155384642|NCT03818204|560843684|FG017|Overall Study|Physician Decision|0|||
155384643|NCT03818204|560843685|FG018|Overall Study|Physician Decision|0|||
155384644|NCT00887250|560843686|FG000|Overall Study|Adverse Event|3|||
155384645|NCT00887250|560843687|FG001|Overall Study|Adverse Event|0|||
155384646|NCT00887250|560843688|FG002|Overall Study|Adverse Event|7|||
155384647|NCT00887250|560843686|FG000|Overall Study|Lack of Efficacy|9|||
155384648|NCT00887250|560843687|FG001|Overall Study|Lack of Efficacy|6|||
155384649|NCT00887250|560843688|FG002|Overall Study|Lack of Efficacy|1|||
155384650|NCT00887250|560843686|FG000|Overall Study|Lost to Follow-up|2|||
155384651|NCT00887250|560843687|FG001|Overall Study|Lost to Follow-up|3|||
155384652|NCT00887250|560843688|FG002|Overall Study|Lost to Follow-up|1|||
155384653|NCT00887250|560843686|FG000|Overall Study|Protocol Violation|2|||
155384654|NCT00887250|560843687|FG001|Overall Study|Protocol Violation|2|||
155384655|NCT00887250|560843688|FG002|Overall Study|Protocol Violation|1|||
155384656|NCT00887250|560843686|FG000|Overall Study|Withdrawal by Subject|2|||
155384657|NCT00887250|560843687|FG001|Overall Study|Withdrawal by Subject|1|||
155384658|NCT00887250|560843688|FG002|Overall Study|Withdrawal by Subject|2|||
155384659|NCT00887250|560843686|FG000|Overall Study|Patient uncooperative|0|||
155384660|NCT00887250|560843687|FG001|Overall Study|Patient uncooperative|0|||
155384661|NCT00887250|560843688|FG002|Overall Study|Patient uncooperative|1|||
155384662|NCT05754333|560843689|FG000|Overall Study|Miscellaneous|3|||
155384663|NCT05754333|560843690|FG001|Overall Study|Miscellaneous|0|||
155384664|NCT05754333|560843691|FG002|Overall Study|Miscellaneous|0|||
155384665|NCT05754333|560843692|FG003|Overall Study|Miscellaneous|0|||
155384666|NCT05754333|560843689|FG000|Overall Study|Lost to Follow-up|2|||
155384667|NCT05754333|560843690|FG001|Overall Study|Lost to Follow-up|1|||
155384668|NCT05754333|560843691|FG002|Overall Study|Lost to Follow-up|0|||
155384669|NCT05754333|560843692|FG003|Overall Study|Lost to Follow-up|1|||
155384670|NCT02070588|560843700|FG000|Overall Study|Withdrawal by Subject|29|||
155384671|NCT02070588|560843701|FG001|Overall Study|Withdrawal by Subject|1|||
155384672|NCT02070588|560843702|FG002|Overall Study|Withdrawal by Subject|0|||
155384673|NCT02070588|560843700|FG000|Overall Study|Writhdrawal due to early termination|9|||
155384674|NCT02070588|560843701|FG001|Overall Study|Writhdrawal due to early termination|0|||
155384675|NCT02070588|560843702|FG002|Overall Study|Writhdrawal due to early termination|0|||
155384676|NCT02070588|560843700|FG000|Overall Study|Adverse Event|1|||
155384677|NCT02070588|560843701|FG001|Overall Study|Adverse Event|0|||
155384678|NCT02070588|560843702|FG002|Overall Study|Adverse Event|0|||
155384679|NCT00819390|560843703|FG000|Overall Study|Lost to Follow-up|1|||
155384680|NCT00819390|560843704|FG001|Overall Study|Lost to Follow-up|1|||
155384681|NCT00819390|560843705|FG002|Overall Study|Lost to Follow-up|0|||
155384682|NCT00819390|560843706|FG003|Overall Study|Lost to Follow-up|0|||
155384683|NCT00819390|560843703|FG000|Overall Study|Withdrawal by Subject|2|||
155384684|NCT00819390|560843704|FG001|Overall Study|Withdrawal by Subject|0|||
155384685|NCT00819390|560843705|FG002|Overall Study|Withdrawal by Subject|0|||
155384686|NCT00819390|560843706|FG003|Overall Study|Withdrawal by Subject|0|||
155384687|NCT00819390|560843703|FG000|Overall Study|Adverse Event|0|||
155384688|NCT00819390|560843704|FG001|Overall Study|Adverse Event|0|||
155384689|NCT00819390|560843705|FG002|Overall Study|Adverse Event|1|||
155384690|NCT00819390|560843706|FG003|Overall Study|Adverse Event|0|||
155384691|NCT01209780|560843707|FG000|Overall Study|Adverse Event|0|||
155384692|NCT01209780|560843708|FG001|Overall Study|Adverse Event|1|||
155384693|NCT01209780|560843709|FG002|Overall Study|Adverse Event|0|||
155384694|NCT01209780|560843710|FG003|Overall Study|Adverse Event|0|||
155384695|NCT01209780|560843711|FG004|Overall Study|Adverse Event|0|||
155384696|NCT01209780|560843707|FG000|Overall Study|Withdrawal by Subject|9|||
155384697|NCT01209780|560843708|FG001|Overall Study|Withdrawal by Subject|2|||
155384698|NCT01209780|560843709|FG002|Overall Study|Withdrawal by Subject|1|||
155384699|NCT01209780|560843710|FG003|Overall Study|Withdrawal by Subject|1|||
155384700|NCT01209780|560843711|FG004|Overall Study|Withdrawal by Subject|0|||
155384701|NCT01209780|560843707|FG000|Overall Study|Lost to Follow-up|17|||
155384702|NCT01209780|560843708|FG001|Overall Study|Lost to Follow-up|12|||
155384703|NCT01209780|560843709|FG002|Overall Study|Lost to Follow-up|3|||
155384704|NCT01209780|560843710|FG003|Overall Study|Lost to Follow-up|9|||
155384705|NCT01209780|560843711|FG004|Overall Study|Lost to Follow-up|4|||
155384706|NCT01209780|560843707|FG000|Overall Study|Protocol Violation|0|||
155384707|NCT01209780|560843708|FG001|Overall Study|Protocol Violation|1|||
155384708|NCT01209780|560843709|FG002|Overall Study|Protocol Violation|0|||
155384709|NCT01209780|560843710|FG003|Overall Study|Protocol Violation|0|||
155384710|NCT01209780|560843711|FG004|Overall Study|Protocol Violation|0|||
155384711|NCT01209780|560843707|FG000|Overall Study|Inappropriate enrollment|0|||
155384712|NCT01209780|560843708|FG001|Overall Study|Inappropriate enrollment|2|||
155384713|NCT01209780|560843709|FG002|Overall Study|Inappropriate enrollment|0|||
155384714|NCT01209780|560843710|FG003|Overall Study|Inappropriate enrollment|0|||
155384715|NCT01209780|560843711|FG004|Overall Study|Inappropriate enrollment|1|||
155384716|NCT02709096|560843712|FG000|Overall Study|non-compliance|1|||
155384717|NCT02709096|560843713|FG001|Overall Study|non-compliance|1|||
155384718|NCT00818649|560843714|FG000|Overall Study|Declining performance status|2|||
155384719|NCT00818649|560843714|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
155384720|NCT00818649|560843714|FG000|Overall Study|Adverse Event|1|||
155384721|NCT00505284|560843715|FG000|Overall Study|Adverse Event|3|||
155384722|NCT00505284|560843716|FG001|Overall Study|Adverse Event|7|||
155384723|NCT00505284|560843717|FG002|Overall Study|Adverse Event|9|||
155384724|NCT00505284|560843718|FG003|Overall Study|Adverse Event|14|||
155384725|NCT00505284|560843719|FG004|Overall Study|Adverse Event|22|||
155384726|NCT00505284|560843715|FG000|Overall Study|Protocol Violation|0|||
155384727|NCT00505284|560843716|FG001|Overall Study|Protocol Violation|1|||
155384728|NCT00505284|560843717|FG002|Overall Study|Protocol Violation|1|||
155384729|NCT00505284|560843718|FG003|Overall Study|Protocol Violation|0|||
155384730|NCT00505284|560843719|FG004|Overall Study|Protocol Violation|0|||
155384731|NCT00505284|560843715|FG000|Overall Study|Withdrawal by Subject|2|||
155384732|NCT00505284|560843716|FG001|Overall Study|Withdrawal by Subject|6|||
155384733|NCT00505284|560843717|FG002|Overall Study|Withdrawal by Subject|1|||
155384734|NCT00505284|560843718|FG003|Overall Study|Withdrawal by Subject|0|||
155384735|NCT00505284|560843719|FG004|Overall Study|Withdrawal by Subject|6|||
155384736|NCT00505284|560843715|FG000|Overall Study|Lack of Efficacy|0|||
155384737|NCT00505284|560843716|FG001|Overall Study|Lack of Efficacy|1|||
155384738|NCT00505284|560843717|FG002|Overall Study|Lack of Efficacy|1|||
155384739|NCT00505284|560843718|FG003|Overall Study|Lack of Efficacy|1|||
155384740|NCT00505284|560843719|FG004|Overall Study|Lack of Efficacy|1|||
155384741|NCT00505284|560843715|FG000|Overall Study|Physician Decision|0|||
155384742|NCT00505284|560843716|FG001|Overall Study|Physician Decision|1|||
155384743|NCT00505284|560843717|FG002|Overall Study|Physician Decision|0|||
155384744|NCT00505284|560843718|FG003|Overall Study|Physician Decision|0|||
155384745|NCT00505284|560843719|FG004|Overall Study|Physician Decision|0|||
155384746|NCT00505284|560843715|FG000|Overall Study|Other|5|||
155384747|NCT00505284|560843716|FG001|Overall Study|Other|0|||
155384748|NCT00505284|560843717|FG002|Overall Study|Other|0|||
155384749|NCT00505284|560843718|FG003|Overall Study|Other|4|||
155384750|NCT00505284|560843719|FG004|Overall Study|Other|4|||
155384751|NCT03513588|560843720|FG000|Overall Study|Lost to Follow-up|0|||
155384752|NCT03513588|560843721|FG001|Overall Study|Lost to Follow-up|1|||
155384753|NCT03513588|560843722|FG002|Overall Study|Lost to Follow-up|1|||
155384754|NCT03513588|560843720|FG000|Overall Study|Study dosing paused by sponsor|1|||
155384755|NCT03513588|560843721|FG001|Overall Study|Study dosing paused by sponsor|1|||
155384756|NCT03513588|560843722|FG002|Overall Study|Study dosing paused by sponsor|0|||
155384757|NCT03513588|560843720|FG000|Overall Study|Death|0|||
155384758|NCT03513588|560843721|FG001|Overall Study|Death|0|||
155384759|NCT03513588|560843722|FG002|Overall Study|Death|1|||
155384760|NCT01275131|560843723|FG000|Period 1|Withdrawal by Subject|1|||
155384761|NCT01275131|560843724|FG001|Period 1|Withdrawal by Subject|0|||
155384762|NCT01275131|560843725|FG002|Period 1|Withdrawal by Subject|3|||
155384763|NCT01275131|560843726|FG003|Period 1|Withdrawal by Subject|2|||
155384764|NCT01275131|560843723|FG000|Period 1|Physician Decision|1|||
155627023|NCT00264147|561730117|FG000|Treatment II Period|Laboratory Adverse Event|0|||
155627024|NCT00264147|561730118|FG001|Treatment II Period|Laboratory Adverse Event|0|||
155384765|NCT01275131|560843724|FG001|Period 1|Physician Decision|0|||
155384766|NCT01275131|560843725|FG002|Period 1|Physician Decision|0|||
155384767|NCT01275131|560843726|FG003|Period 1|Physician Decision|0|||
155384768|NCT01275131|560843723|FG000|Period 2 (Crossover)|Adverse Event|0|||
155384769|NCT01275131|560843724|FG001|Period 2 (Crossover)|Adverse Event|1|||
155384770|NCT01275131|560843725|FG002|Period 2 (Crossover)|Adverse Event|0|||
155384771|NCT01275131|560843726|FG003|Period 2 (Crossover)|Adverse Event|0|||
155384772|NCT01275131|560843723|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
155384773|NCT01275131|560843724|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
155384774|NCT01275131|560843725|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
155384775|NCT01275131|560843726|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
155384776|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
155384777|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
155384778|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
155384779|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
155384780|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
155384781|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
155384782|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
155384783|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
155384784|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
155384785|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
155384786|NCT00953745|560843729|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
155384787|NCT00953745|560843730|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
155384788|NCT03075410|560843732|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
155384789|NCT03075410|560843733|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384790|NCT03075410|560843734|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
155384791|NCT03075410|560843735|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384792|NCT03075410|560843736|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384793|NCT03075410|560843737|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384794|NCT03075410|560843738|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384795|NCT03075410|560843739|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384796|NCT03075410|560843740|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384797|NCT03075410|560843732|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
155384798|NCT03075410|560843733|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384799|NCT03075410|560843734|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384800|NCT03075410|560843735|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384801|NCT03075410|560843736|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384802|NCT03075410|560843737|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384803|NCT03075410|560843738|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384804|NCT03075410|560843739|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384805|NCT03075410|560843740|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384806|NCT02053792|560843741|FG000|Overall Study|Physician Decision|0|||
155384807|NCT02053792|560843742|FG001|Overall Study|Physician Decision|1|||
155384808|NCT02053792|560843741|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
155384809|NCT02053792|560843742|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
155384810|NCT02053792|560843741|FG000|Overall Study|Lack of Efficacy|1|||
155627025|NCT00264147|561730119|FG002|Treatment II Period|Laboratory Adverse Event|0|||
155627026|NCT00264147|561730120|FG003|Treatment II Period|Laboratory Adverse Event|0|||
155627027|NCT00264147|561730121|FG004|Treatment II Period|Laboratory Adverse Event|0|||
155627028|NCT00264147|561730122|FG005|Treatment II Period|Laboratory Adverse Event|1|||
155627029|NCT00264147|561730117|FG000|Treatment II Period|Lack of Efficacy|0|||
155627030|NCT00264147|561730118|FG001|Treatment II Period|Lack of Efficacy|0|||
155627031|NCT00264147|561730119|FG002|Treatment II Period|Lack of Efficacy|0|||
155627032|NCT00264147|561730120|FG003|Treatment II Period|Lack of Efficacy|0|||
155627033|NCT00264147|561730121|FG004|Treatment II Period|Lack of Efficacy|20|||
155627034|NCT00264147|561730122|FG005|Treatment II Period|Lack of Efficacy|19|||
155627035|NCT00264147|561730117|FG000|Treatment II Period|Lost to Follow-up|0|||
155627036|NCT00264147|561730118|FG001|Treatment II Period|Lost to Follow-up|0|||
155627037|NCT00264147|561730119|FG002|Treatment II Period|Lost to Follow-up|0|||
155627038|NCT00264147|561730120|FG003|Treatment II Period|Lost to Follow-up|0|||
155627039|NCT00264147|561730121|FG004|Treatment II Period|Lost to Follow-up|1|||
155627040|NCT00264147|561730122|FG005|Treatment II Period|Lost to Follow-up|1|||
155627041|NCT00264147|561730117|FG000|Treatment II Period|Withdrawal by Subject|0|||
155627042|NCT00264147|561730118|FG001|Treatment II Period|Withdrawal by Subject|0|||
155627043|NCT00264147|561730119|FG002|Treatment II Period|Withdrawal by Subject|0|||
155627044|NCT00264147|561730120|FG003|Treatment II Period|Withdrawal by Subject|0|||
155627045|NCT00264147|561730121|FG004|Treatment II Period|Withdrawal by Subject|3|||
155627046|NCT00264147|561730122|FG005|Treatment II Period|Withdrawal by Subject|2|||
155627047|NCT00264147|561730117|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
155627048|NCT00264147|561730118|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
155627049|NCT00264147|561730119|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
155627050|NCT00264147|561730120|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
155627051|NCT00264147|561730121|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
155627052|NCT00264147|561730122|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
155627053|NCT03234465|561730123|FG000|Overall Study|Adverse Event|4|||
155627054|NCT03234465|561730124|FG001|Overall Study|Adverse Event|2|||
155627055|NCT03234465|561730123|FG000|Overall Study|Death|0|||
155627056|NCT03234465|561730124|FG001|Overall Study|Death|1|||
155627057|NCT03234465|561730123|FG000|Overall Study|Lost to Follow-up|1|||
155627058|NCT03234465|561730124|FG001|Overall Study|Lost to Follow-up|1|||
155627059|NCT03234465|561730123|FG000|Overall Study|Withdrawal by Subject|12|||
155279146|NCT01923428|560454814|FG003|Overall Study|Adverse Event|3|||
155279147|NCT01923428|560454811|FG000|Overall Study|Withdrawal by Subject|5|||
155279148|NCT01923428|560454812|FG001|Overall Study|Withdrawal by Subject|3|||
155279149|NCT01923428|560454813|FG002|Overall Study|Withdrawal by Subject|0|||
155279150|NCT01923428|560454814|FG003|Overall Study|Withdrawal by Subject|4|||
155279151|NCT01923428|560454811|FG000|Overall Study|Lost to Follow-up|2|||
155279152|NCT01923428|560454812|FG001|Overall Study|Lost to Follow-up|1|||
155279153|NCT01923428|560454813|FG002|Overall Study|Lost to Follow-up|5|||
155279154|NCT01923428|560454814|FG003|Overall Study|Lost to Follow-up|0|||
155279155|NCT01923428|560454811|FG000|Overall Study|Protocol Violation|3|||
155279156|NCT01923428|560454812|FG001|Overall Study|Protocol Violation|0|||
155279157|NCT01923428|560454813|FG002|Overall Study|Protocol Violation|2|||
155279158|NCT01923428|560454814|FG003|Overall Study|Protocol Violation|1|||
155279159|NCT01923428|560454811|FG000|Overall Study|Non Compliance to treatment|1|||
155279160|NCT01923428|560454812|FG001|Overall Study|Non Compliance to treatment|2|||
155279161|NCT01923428|560454813|FG002|Overall Study|Non Compliance to treatment|0|||
155279162|NCT01923428|560454814|FG003|Overall Study|Non Compliance to treatment|1|||
155279163|NCT01923428|560454811|FG000|Overall Study|Lack of Efficacy|0|||
155279164|NCT01923428|560454812|FG001|Overall Study|Lack of Efficacy|0|||
155279165|NCT01923428|560454813|FG002|Overall Study|Lack of Efficacy|1|||
155279166|NCT01923428|560454814|FG003|Overall Study|Lack of Efficacy|1|||
155279167|NCT00946647|560454818|FG000|Phase 1 Part|Adverse Event|2|||
155279168|NCT00946647|560454819|FG001|Phase 1 Part|Adverse Event|5|||
155279169|NCT00946647|560454820|FG002|Phase 1 Part|Adverse Event|3|||
155279170|NCT00946647|560454821|FG003|Phase 1 Part|Adverse Event|0|||
155279171|NCT00946647|560454822|FG004|Phase 1 Part|Adverse Event|0|||
155279172|NCT00946647|560454818|FG000|Phase 1 Part|Disease progression|3|||
155279173|NCT00946647|560454819|FG001|Phase 1 Part|Disease progression|6|||
155279174|NCT00946647|560454820|FG002|Phase 1 Part|Disease progression|1|||
155279175|NCT00946647|560454821|FG003|Phase 1 Part|Disease progression|0|||
155279176|NCT00946647|560454822|FG004|Phase 1 Part|Disease progression|0|||
155279177|NCT00946647|560454818|FG000|Phase 1 Part|Withdrawal by Subject|1|||
155279178|NCT00946647|560454819|FG001|Phase 1 Part|Withdrawal by Subject|4|||
155279179|NCT00946647|560454820|FG002|Phase 1 Part|Withdrawal by Subject|3|||
155279180|NCT00946647|560454821|FG003|Phase 1 Part|Withdrawal by Subject|0|||
155279181|NCT00946647|560454822|FG004|Phase 1 Part|Withdrawal by Subject|0|||
155279182|NCT00946647|560454818|FG000|Phase 1 Part|Abnormal values|0|||
155279183|NCT00946647|560454819|FG001|Phase 1 Part|Abnormal values|2|||
155279184|NCT00946647|560454820|FG002|Phase 1 Part|Abnormal values|0|||
155279185|NCT00946647|560454821|FG003|Phase 1 Part|Abnormal values|0|||
155279186|NCT00946647|560454822|FG004|Phase 1 Part|Abnormal values|0|||
155279187|NCT00946647|560454818|FG000|Phase 1 Part|Reason missing|0|||
155279188|NCT00946647|560454819|FG001|Phase 1 Part|Reason missing|1|||
155279189|NCT00946647|560454820|FG002|Phase 1 Part|Reason missing|0|||
155279190|NCT00946647|560454821|FG003|Phase 1 Part|Reason missing|0|||
155279191|NCT00946647|560454822|FG004|Phase 1 Part|Reason missing|0|||
155279192|NCT00946647|560454818|FG000|Phase ll Part|Untreated|0|||
155279193|NCT00946647|560454819|FG001|Phase ll Part|Untreated|0|||
155279194|NCT00946647|560454820|FG002|Phase ll Part|Untreated|0|||
155279195|NCT00946647|560454821|FG003|Phase ll Part|Untreated|0|||
155279196|NCT00946647|560454822|FG004|Phase ll Part|Untreated|2|||
155279197|NCT00946647|560454818|FG000|Phase ll Part|Adverse Event|0|||
155279198|NCT00946647|560454819|FG001|Phase ll Part|Adverse Event|0|||
155279199|NCT00946647|560454820|FG002|Phase ll Part|Adverse Event|0|||
155279200|NCT00946647|560454821|FG003|Phase ll Part|Adverse Event|10|||
155279201|NCT00946647|560454822|FG004|Phase ll Part|Adverse Event|6|||
155279202|NCT00946647|560454818|FG000|Phase ll Part|Withdrawal by Subject|0|||
155279203|NCT00946647|560454819|FG001|Phase ll Part|Withdrawal by Subject|0|||
155279204|NCT00946647|560454820|FG002|Phase ll Part|Withdrawal by Subject|0|||
155279205|NCT00946647|560454821|FG003|Phase ll Part|Withdrawal by Subject|8|||
155279206|NCT00946647|560454822|FG004|Phase ll Part|Withdrawal by Subject|6|||
155279207|NCT00946647|560454818|FG000|Phase ll Part|Administrative problems|0|||
155279208|NCT00946647|560454819|FG001|Phase ll Part|Administrative problems|0|||
155279209|NCT00946647|560454820|FG002|Phase ll Part|Administrative problems|0|||
155279210|NCT00946647|560454821|FG003|Phase ll Part|Administrative problems|3|||
155279211|NCT00946647|560454822|FG004|Phase ll Part|Administrative problems|8|||
155279212|NCT00946647|560454818|FG000|Phase ll Part|Death|0|||
155279213|NCT00946647|560454819|FG001|Phase ll Part|Death|0|||
155279214|NCT00946647|560454820|FG002|Phase ll Part|Death|0|||
155279215|NCT00946647|560454821|FG003|Phase ll Part|Death|7|||
155279216|NCT00946647|560454822|FG004|Phase ll Part|Death|4|||
155279217|NCT00946647|560454818|FG000|Phase ll Part|Disease progression|0|||
155279218|NCT00946647|560454819|FG001|Phase ll Part|Disease progression|0|||
155279219|NCT00946647|560454820|FG002|Phase ll Part|Disease progression|0|||
155279220|NCT00946647|560454821|FG003|Phase ll Part|Disease progression|6|||
155279221|NCT00946647|560454822|FG004|Phase ll Part|Disease progression|14|||
155279222|NCT00946647|560454818|FG000|Phase ll Part|Protocol Violation|0|||
155279223|NCT00946647|560454819|FG001|Phase ll Part|Protocol Violation|0|||
155279224|NCT00946647|560454820|FG002|Phase ll Part|Protocol Violation|0|||
155279225|NCT00946647|560454821|FG003|Phase ll Part|Protocol Violation|4|||
155384811|NCT02053792|560843742|FG001|Overall Study|Lack of Efficacy|0|||
155384812|NCT02053792|560843741|FG000|Overall Study|Adverse Event|1|||
155384813|NCT02053792|560843742|FG001|Overall Study|Adverse Event|0|||
155384814|NCT02053792|560843741|FG000|Overall Study|Withdrawal by Subject|2|||
155384815|NCT02053792|560843742|FG001|Overall Study|Withdrawal by Subject|2|||
155384816|NCT02053792|560843741|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
155384817|NCT02053792|560843742|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
155384818|NCT02053792|560843741|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
155384819|NCT02053792|560843742|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
155384820|NCT01427751|560843743|FG000|Overall Study|Adverse Event|18|||
155384821|NCT01427751|560843744|FG001|Overall Study|Adverse Event|2|||
155384822|NCT01427751|560843743|FG000|Overall Study|No further treatment benefit expected|5|||
155384823|NCT01427751|560843744|FG001|Overall Study|No further treatment benefit expected|1|||
155384824|NCT01427751|560843743|FG000|Overall Study|Lost to Follow-up|3|||
155384825|NCT01427751|560843744|FG001|Overall Study|Lost to Follow-up|1|||
155384826|NCT01427751|560843743|FG000|Overall Study|Withdrawal of consent|2|||
155384827|NCT01427751|560843744|FG001|Overall Study|Withdrawal of consent|2|||
155384828|NCT01427751|560843743|FG000|Overall Study|Protocol Violation|6|||
155384829|NCT01427751|560843744|FG001|Overall Study|Protocol Violation|4|||
155384830|NCT01427751|560843743|FG000|Overall Study|Death|2|||
155384831|NCT01427751|560843744|FG001|Overall Study|Death|0|||
155384832|NCT01427751|560843743|FG000|Overall Study|Other miscellaneous reasons|6|||
155384833|NCT01427751|560843744|FG001|Overall Study|Other miscellaneous reasons|4|||
155384834|NCT00368992|560843751|FG000|Overall Study|Ineligible|5|||
155384835|NCT00368992|560843751|FG000|Overall Study|Refused treatment|3|||
155384836|NCT00368992|560843751|FG000|Overall Study|Lack of Efficacy|63|||
155384837|NCT00368992|560843751|FG000|Overall Study|Adverse Event|26|||
155384838|NCT00368992|560843751|FG000|Overall Study|Death|4|||
155384839|NCT00368992|560843751|FG000|Overall Study|Other|9|||
155384840|NCT00790751|560843752|FG000|Overall Study|Protocol non-compliance|16|||
155384841|NCT00790751|560843753|FG001|Overall Study|Protocol non-compliance|16|||
155384842|NCT00790751|560843754|FG002|Overall Study|Protocol non-compliance|10|||
155384843|NCT00790751|560843755|FG003|Overall Study|Protocol non-compliance|11|||
155384844|NCT00790751|560843752|FG000|Overall Study|Lost to Follow-up|4|||
155384845|NCT00790751|560843753|FG001|Overall Study|Lost to Follow-up|9|||
155384846|NCT00790751|560843754|FG002|Overall Study|Lost to Follow-up|4|||
155384847|NCT00790751|560843755|FG003|Overall Study|Lost to Follow-up|5|||
155384848|NCT00790751|560843752|FG000|Overall Study|Adverse Event|5|||
155384849|NCT00790751|560843753|FG001|Overall Study|Adverse Event|3|||
155384850|NCT00790751|560843754|FG002|Overall Study|Adverse Event|5|||
155384851|NCT00790751|560843755|FG003|Overall Study|Adverse Event|4|||
155384852|NCT00790751|560843752|FG000|Overall Study|Requirement for restricted medication|0|||
155384853|NCT00790751|560843753|FG001|Overall Study|Requirement for restricted medication|2|||
155384854|NCT00790751|560843754|FG002|Overall Study|Requirement for restricted medication|0|||
155384855|NCT00790751|560843755|FG003|Overall Study|Requirement for restricted medication|0|||
155384856|NCT00790751|560843752|FG000|Overall Study|Death|0|||
155384857|NCT00790751|560843753|FG001|Overall Study|Death|0|||
155384858|NCT00790751|560843754|FG002|Overall Study|Death|1|||
155384859|NCT00790751|560843755|FG003|Overall Study|Death|0|||
155384860|NCT00790751|560843752|FG000|Overall Study|Physician Decision|0|||
155384861|NCT00790751|560843753|FG001|Overall Study|Physician Decision|0|||
155384862|NCT00790751|560843754|FG002|Overall Study|Physician Decision|0|||
155384863|NCT00790751|560843755|FG003|Overall Study|Physician Decision|1|||
155384864|NCT02427464|560843756|FG000|Overall Study|Adverse Event|6|||
155384865|NCT02427464|560843757|FG001|Overall Study|Adverse Event|1|||
155384866|NCT02427464|560843756|FG000|Overall Study|Lost to Follow-up|16|||
155384867|NCT02427464|560843757|FG001|Overall Study|Lost to Follow-up|5|||
155384868|NCT02427464|560843756|FG000|Overall Study|Physician Decision|2|||
155384869|NCT02427464|560843757|FG001|Overall Study|Physician Decision|0|||
155384870|NCT02427464|560843756|FG000|Overall Study|Withdrawal by Subject|10|||
155384871|NCT02427464|560843757|FG001|Overall Study|Withdrawal by Subject|8|||
155384872|NCT02427464|560843756|FG000|Overall Study|Noncompliance|16|||
155384873|NCT02427464|560843757|FG001|Overall Study|Noncompliance|10|||
155384874|NCT05330312|560843761|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
155384875|NCT05330312|560843762|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
155384876|NCT05330312|560843763|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
155384877|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
155384878|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
155729253|NCT02113982|562108043|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
155384879|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
155384880|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
155384881|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
155384882|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
155384883|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Death|1|||
155384884|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Death|4|||
155384885|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Death|0|||
155384886|NCT05227703|560843767|FG000|Overall Study|Adverse Event|2|||
155384887|NCT05227703|560843768|FG001|Overall Study|Adverse Event|6|||
155384888|NCT05227703|560843769|FG002|Overall Study|Adverse Event|4|||
155384889|NCT05227703|560843767|FG000|Overall Study|Lack of Efficacy|4|||
155384890|NCT05227703|560843768|FG001|Overall Study|Lack of Efficacy|0|||
155279226|NCT00946647|560454822|FG004|Phase ll Part|Protocol Violation|2|||
155279227|NCT00946647|560454818|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
155279228|NCT00946647|560454819|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
155279229|NCT00946647|560454820|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
155279230|NCT00946647|560454821|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
155279231|NCT00946647|560454822|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
155279232|NCT01368211|560454823|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
155279233|NCT01368211|560454824|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
155279234|NCT03990363|560454825|FG000|Overall Study|Withdrawal by Subject|10|||
155279235|NCT03990363|560454826|FG001|Overall Study|Withdrawal by Subject|9|||
155279236|NCT03990363|560454827|FG002|Overall Study|Withdrawal by Subject|18|||
155279237|NCT03990363|560454828|FG003|Overall Study|Withdrawal by Subject|11|||
155279238|NCT03990363|560454829|FG004|Overall Study|Withdrawal by Subject|9|||
155279239|NCT03990363|560454825|FG000|Overall Study|Physician Decision|1|||
155279240|NCT03990363|560454826|FG001|Overall Study|Physician Decision|0|||
155279241|NCT03990363|560454827|FG002|Overall Study|Physician Decision|0|||
155279242|NCT03990363|560454828|FG003|Overall Study|Physician Decision|0|||
155279243|NCT03990363|560454829|FG004|Overall Study|Physician Decision|0|||
155279244|NCT03990363|560454825|FG000|Overall Study|Adverse Event|1|||
155279245|NCT03990363|560454826|FG001|Overall Study|Adverse Event|3|||
155279246|NCT03990363|560454827|FG002|Overall Study|Adverse Event|2|||
155279247|NCT03990363|560454828|FG003|Overall Study|Adverse Event|2|||
155279248|NCT03990363|560454829|FG004|Overall Study|Adverse Event|0|||
155279249|NCT03990363|560454825|FG000|Overall Study|Death|14|||
155279250|NCT03990363|560454826|FG001|Overall Study|Death|8|||
155279251|NCT03990363|560454827|FG002|Overall Study|Death|14|||
155279252|NCT03990363|560454828|FG003|Overall Study|Death|10|||
155279253|NCT03990363|560454829|FG004|Overall Study|Death|11|||
155279254|NCT03990363|560454825|FG000|Overall Study|Failure to meet randomization criteria|0|||
155279255|NCT03990363|560454826|FG001|Overall Study|Failure to meet randomization criteria|1|||
155279256|NCT03990363|560454827|FG002|Overall Study|Failure to meet randomization criteria|1|||
155279257|NCT03990363|560454828|FG003|Overall Study|Failure to meet randomization criteria|0|||
155279258|NCT03990363|560454829|FG004|Overall Study|Failure to meet randomization criteria|0|||
155279259|NCT03990363|560454825|FG000|Overall Study|Lost to Follow-up|0|||
155279260|NCT03990363|560454826|FG001|Overall Study|Lost to Follow-up|0|||
155279261|NCT03990363|560454827|FG002|Overall Study|Lost to Follow-up|0|||
155279262|NCT03990363|560454828|FG003|Overall Study|Lost to Follow-up|1|||
155279263|NCT03990363|560454829|FG004|Overall Study|Lost to Follow-up|2|||
155279264|NCT03990363|560454825|FG000|Overall Study|Non-compliance with study drug|2|||
155279265|NCT03990363|560454826|FG001|Overall Study|Non-compliance with study drug|1|||
155279266|NCT03990363|560454827|FG002|Overall Study|Non-compliance with study drug|2|||
155279267|NCT03990363|560454828|FG003|Overall Study|Non-compliance with study drug|0|||
155279268|NCT03990363|560454829|FG004|Overall Study|Non-compliance with study drug|0|||
155279269|NCT03990363|560454825|FG000|Overall Study|Study terminated by sponsor|0|||
155279270|NCT03990363|560454826|FG001|Overall Study|Study terminated by sponsor|1|||
155279271|NCT03990363|560454827|FG002|Overall Study|Study terminated by sponsor|0|||
155279272|NCT03990363|560454828|FG003|Overall Study|Study terminated by sponsor|0|||
155279273|NCT03990363|560454829|FG004|Overall Study|Study terminated by sponsor|0|||
155279274|NCT03990363|560454825|FG000|Overall Study|Site terminated by sponsor|2|||
155279275|NCT03990363|560454826|FG001|Overall Study|Site terminated by sponsor|1|||
155279276|NCT03990363|560454827|FG002|Overall Study|Site terminated by sponsor|2|||
155279277|NCT03990363|560454828|FG003|Overall Study|Site terminated by sponsor|0|||
155279278|NCT03990363|560454829|FG004|Overall Study|Site terminated by sponsor|2|||
155279279|NCT03990363|560454825|FG000|Overall Study|Not categorized|5|||
155279280|NCT03990363|560454826|FG001|Overall Study|Not categorized|5|||
155279281|NCT03990363|560454827|FG002|Overall Study|Not categorized|3|||
155279282|NCT03990363|560454828|FG003|Overall Study|Not categorized|2|||
155279283|NCT03990363|560454829|FG004|Overall Study|Not categorized|2|||
155279284|NCT01349660|560454832|FG000|Overall Study|Still Receiving Study Treatment|0|||
155279285|NCT01349660|560454833|FG001|Overall Study|Still Receiving Study Treatment|0|||
155279286|NCT01349660|560454834|FG002|Overall Study|Still Receiving Study Treatment|1|||
155279287|NCT01349660|560454832|FG000|Overall Study|Disease Progression|2|||
155279288|NCT01349660|560454833|FG001|Overall Study|Disease Progression|4|||
155279289|NCT01349660|560454834|FG002|Overall Study|Disease Progression|50|||
155384891|NCT05227703|560843769|FG002|Overall Study|Lack of Efficacy|1|||
155384892|NCT05227703|560843767|FG000|Overall Study|Physician Decision|2|||
155279290|NCT01349660|560454832|FG000|Overall Study|Adverse Event|1|||
155279291|NCT01349660|560454833|FG001|Overall Study|Adverse Event|1|||
155279292|NCT01349660|560454834|FG002|Overall Study|Adverse Event|12|||
155279293|NCT01349660|560454832|FG000|Overall Study|Withdrawal by Subject|2|||
155384893|NCT05227703|560843768|FG001|Overall Study|Physician Decision|2|||
155384894|NCT05227703|560843769|FG002|Overall Study|Physician Decision|1|||
155384895|NCT05227703|560843767|FG000|Overall Study|Protocol Violation|2|||
155384896|NCT05227703|560843768|FG001|Overall Study|Protocol Violation|1|||
155384897|NCT05227703|560843769|FG002|Overall Study|Protocol Violation|0|||
155384898|NCT05227703|560843767|FG000|Overall Study|Withdrawal by Subject|17|||
155384899|NCT05227703|560843768|FG001|Overall Study|Withdrawal by Subject|26|||
155384900|NCT05227703|560843769|FG002|Overall Study|Withdrawal by Subject|32|||
155384901|NCT05227703|560843767|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
155384902|NCT05227703|560843768|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
155384903|NCT05227703|560843769|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
155384904|NCT05227703|560843767|FG000|Overall Study|Other|1|||
155384905|NCT05227703|560843768|FG001|Overall Study|Other|1|||
155384906|NCT05227703|560843769|FG002|Overall Study|Other|0|||
155384907|NCT03756129|560843774|FG000|Overall Study|Adverse Event|1|||
155384908|NCT03756129|560843775|FG001|Overall Study|Adverse Event|1|||
155384909|NCT03756129|560843776|FG002|Overall Study|Adverse Event|0|||
155384910|NCT03756129|560843777|FG003|Overall Study|Adverse Event|2|||
155384911|NCT03756129|560843778|FG004|Overall Study|Adverse Event|0|||
155384912|NCT03756129|560843779|FG005|Overall Study|Adverse Event|0|||
155384913|NCT03756129|560843774|FG000|Overall Study|Withdrawal by Subject|2|||
155384914|NCT03756129|560843775|FG001|Overall Study|Withdrawal by Subject|1|||
155384915|NCT03756129|560843776|FG002|Overall Study|Withdrawal by Subject|3|||
155384916|NCT03756129|560843777|FG003|Overall Study|Withdrawal by Subject|1|||
155384917|NCT03756129|560843778|FG004|Overall Study|Withdrawal by Subject|1|||
155384918|NCT03756129|560843779|FG005|Overall Study|Withdrawal by Subject|3|||
155384919|NCT03756129|560843774|FG000|Overall Study|Lost to Follow-up|0|||
155384920|NCT03756129|560843775|FG001|Overall Study|Lost to Follow-up|0|||
155384921|NCT03756129|560843776|FG002|Overall Study|Lost to Follow-up|0|||
155384922|NCT03756129|560843777|FG003|Overall Study|Lost to Follow-up|0|||
155384923|NCT03756129|560843778|FG004|Overall Study|Lost to Follow-up|0|||
155384924|NCT03756129|560843779|FG005|Overall Study|Lost to Follow-up|1|||
155384925|NCT03756129|560843774|FG000|Overall Study|Physician Decision|0|||
155384926|NCT03756129|560843775|FG001|Overall Study|Physician Decision|0|||
155384927|NCT03756129|560843776|FG002|Overall Study|Physician Decision|0|||
155384928|NCT03756129|560843777|FG003|Overall Study|Physician Decision|0|||
155384929|NCT03756129|560843778|FG004|Overall Study|Physician Decision|0|||
155384930|NCT03756129|560843779|FG005|Overall Study|Physician Decision|1|||
155384931|NCT03464097|560843782|FG000|Overall Study|Withdrawal by Subject|15|||
155384932|NCT03464097|560843783|FG001|Overall Study|Withdrawal by Subject|13|||
155384933|NCT03464097|560843784|FG002|Overall Study|Withdrawal by Subject|11|||
155384934|NCT03464097|560843782|FG000|Overall Study|Study terminated by sponsor|47|||
155384935|NCT03464097|560843783|FG001|Overall Study|Study terminated by sponsor|44|||
155384936|NCT03464097|560843784|FG002|Overall Study|Study terminated by sponsor|40|||
155384937|NCT03464097|560843782|FG000|Overall Study|Pregnancy|0|||
155384938|NCT03464097|560843783|FG001|Overall Study|Pregnancy|1|||
155384939|NCT03464097|560843784|FG002|Overall Study|Pregnancy|0|||
155384940|NCT03464097|560843782|FG000|Overall Study|Other reasons|5|||
155384941|NCT03464097|560843783|FG001|Overall Study|Other reasons|12|||
155384942|NCT03464097|560843784|FG002|Overall Study|Other reasons|14|||
155384943|NCT03464097|560843782|FG000|Overall Study|Lost to Follow-up|0|||
155384944|NCT03464097|560843783|FG001|Overall Study|Lost to Follow-up|1|||
155384945|NCT03464097|560843784|FG002|Overall Study|Lost to Follow-up|1|||
155384946|NCT03464097|560843782|FG000|Overall Study|Lack of Efficacy|11|||
155384947|NCT03464097|560843783|FG001|Overall Study|Lack of Efficacy|18|||
155384948|NCT03464097|560843784|FG002|Overall Study|Lack of Efficacy|30|||
155384949|NCT03464097|560843782|FG000|Overall Study|Death|1|||
155384950|NCT03464097|560843783|FG001|Overall Study|Death|0|||
155384951|NCT03464097|560843784|FG002|Overall Study|Death|0|||
155384952|NCT03464097|560843782|FG000|Overall Study|Adverse Event|13|||
155384953|NCT03464097|560843783|FG001|Overall Study|Adverse Event|6|||
155384954|NCT03464097|560843784|FG002|Overall Study|Adverse Event|8|||
155384955|NCT05572021|560843785|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
155384956|NCT05572021|560843786|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
155384957|NCT03432260|560843787|FG000|Overall Study|Lost to Follow-up|1|||
155384958|NCT03432260|560843788|FG001|Overall Study|Lost to Follow-up|1|||
155729254|NCT02113982|562108044|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
155384959|NCT03432260|560843789|FG002|Overall Study|Lost to Follow-up|0|||
155384960|NCT03432260|560843790|FG003|Overall Study|Lost to Follow-up|0|||
155384961|NCT03432260|560843791|FG004|Overall Study|Lost to Follow-up|1|||
155384962|NCT02186847|560843792|FG000|Overall Study|Protocol Violation|3|||
155384963|NCT02186847|560843793|FG001|Overall Study|Protocol Violation|0|||
155384964|NCT03319849|560843794|FG000|Overall Study|Adverse Event|1|||
155384965|NCT03319849|560843795|FG001|Overall Study|Adverse Event|0|||
155384966|NCT03319849|560843794|FG000|Overall Study|Physician Decision|0|||
155384967|NCT03319849|560843795|FG001|Overall Study|Physician Decision|1|||
155384968|NCT03319849|560843794|FG000|Overall Study|Withdrawal by Subject|0|||
155384969|NCT03319849|560843795|FG001|Overall Study|Withdrawal by Subject|1|||
155384970|NCT03319849|560843794|FG000|Overall Study|COVID-19|0|||
155384971|NCT03319849|560843795|FG001|Overall Study|COVID-19|1|||
155384972|NCT03319849|560843794|FG000|Overall Study|Other|1|||
155384973|NCT03319849|560843795|FG001|Overall Study|Other|2|||
155384974|NCT03319849|560843794|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
155384975|NCT03319849|560843795|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
155384976|NCT03319849|560843794|FG000|Overall Study|Lost to Follow-up|0|||
155384977|NCT03319849|560843795|FG001|Overall Study|Lost to Follow-up|2|||
155384978|NCT00112047|560843796|FG000|Randomized Phase|Lost to Follow-up|26|||
155384979|NCT00112047|560843797|FG001|Randomized Phase|Lost to Follow-up|33|||
155384980|NCT00112047|560843796|FG000|Randomized Phase|Adverse Event|10|||
155384981|NCT00112047|560843797|FG001|Randomized Phase|Adverse Event|10|||
155384982|NCT00112047|560843796|FG000|Randomized Phase|Withrawal of consent|10|||
155384983|NCT00112047|560843797|FG001|Randomized Phase|Withrawal of consent|18|||
155384984|NCT00112047|560843796|FG000|Randomized Phase|Sub-optimal virological response|3|||
155384985|NCT00112047|560843797|FG001|Randomized Phase|Sub-optimal virological response|13|||
155279294|NCT01349660|560454833|FG001|Overall Study|Withdrawal by Subject|0|||
155279295|NCT01349660|560454834|FG002|Overall Study|Withdrawal by Subject|9|||
155279296|NCT01349660|560454832|FG000|Overall Study|Death|1|||
155279297|NCT01349660|560454833|FG001|Overall Study|Death|1|||
155279298|NCT01349660|560454834|FG002|Overall Study|Death|0|||
155279299|NCT01349660|560454832|FG000|Overall Study|Non-Permitted Interventions|0|||
155279300|NCT01349660|560454833|FG001|Overall Study|Non-Permitted Interventions|0|||
155279301|NCT01349660|560454834|FG002|Overall Study|Non-Permitted Interventions|2|||
155279302|NCT01349660|560454832|FG000|Overall Study|Study Compliance|0|||
155279303|NCT01349660|560454833|FG001|Overall Study|Study Compliance|0|||
155279304|NCT01349660|560454834|FG002|Overall Study|Study Compliance|1|||
155279305|NCT01349660|560454832|FG000|Overall Study|Declining Performance Status|0|||
155279306|NCT01349660|560454833|FG001|Overall Study|Declining Performance Status|0|||
155279307|NCT01349660|560454834|FG002|Overall Study|Declining Performance Status|1|||
155279308|NCT04630756|560454835|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
155279309|NCT04630756|560454836|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
155279310|NCT04630756|560454837|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
155279311|NCT02388074|560454838|FG000|Overall Study|Lost in Transit|2|||
155279312|NCT02388074|560454838|FG000|Overall Study|Sample Not Returned|1|||
155279313|NCT01939158|560456206|FG000|Overall Study|Adverse Event|1|||
155279314|NCT01939158|560456207|FG001|Overall Study|Adverse Event|0|||
155279315|NCT01939158|560456208|FG002|Overall Study|Adverse Event|0|||
155279316|NCT01939158|560456209|FG003|Overall Study|Adverse Event|0|||
155279317|NCT01939158|560456206|FG000|Overall Study|Withdrawal by Subject|22|||
155279318|NCT01939158|560456207|FG001|Overall Study|Withdrawal by Subject|25|||
155279319|NCT01939158|560456208|FG002|Overall Study|Withdrawal by Subject|15|||
155279320|NCT01939158|560456209|FG003|Overall Study|Withdrawal by Subject|17|||
155279321|NCT01939158|560456206|FG000|Overall Study|Migrated/moved from study area|5|||
155279322|NCT01939158|560456207|FG001|Overall Study|Migrated/moved from study area|7|||
155279323|NCT01939158|560456208|FG002|Overall Study|Migrated/moved from study area|3|||
155279324|NCT01939158|560456209|FG003|Overall Study|Migrated/moved from study area|6|||
155279325|NCT01939158|560456206|FG000|Overall Study|Lost to Follow-up|18|||
155279326|NCT01939158|560456207|FG001|Overall Study|Lost to Follow-up|17|||
155279327|NCT01939158|560456208|FG002|Overall Study|Lost to Follow-up|17|||
155279328|NCT01939158|560456209|FG003|Overall Study|Lost to Follow-up|17|||
155279329|NCT01939158|560456206|FG000|Overall Study|Death|0|||
155279330|NCT01939158|560456207|FG001|Overall Study|Death|0|||
155279331|NCT01939158|560456208|FG002|Overall Study|Death|1|||
155279332|NCT01939158|560456209|FG003|Overall Study|Death|1|||
155279333|NCT01939158|560456206|FG000|Overall Study|No longer meets eligibility criteria|0|||
155279334|NCT01939158|560456207|FG001|Overall Study|No longer meets eligibility criteria|0|||
155279335|NCT01939158|560456208|FG002|Overall Study|No longer meets eligibility criteria|1|||
155279336|NCT01939158|560456209|FG003|Overall Study|No longer meets eligibility criteria|0|||
155279337|NCT01939158|560456206|FG000|Overall Study|Other|1|||
155279338|NCT01939158|560456207|FG001|Overall Study|Other|3|||
155279339|NCT01939158|560456208|FG002|Overall Study|Other|4|||
155279340|NCT01939158|560456209|FG003|Overall Study|Other|3|||
155279341|NCT05310084|560456210|FG000|Overall Study|Withdrawal by Subject|2|||
155279342|NCT05310084|560456211|FG001|Overall Study|Withdrawal by Subject|3|||
155279343|NCT05310084|560456210|FG000|Overall Study|Participant availability|0|||
155279344|NCT05310084|560456211|FG001|Overall Study|Participant availability|4|||
155279345|NCT05310084|560456210|FG000|Overall Study|Lost to Follow-up|1|||
155279346|NCT05310084|560456211|FG001|Overall Study|Lost to Follow-up|1|||
155279347|NCT05310084|560456210|FG000|Overall Study|Adverse Event|1|||
155279348|NCT05310084|560456211|FG001|Overall Study|Adverse Event|1|||
155279349|NCT05310084|560456210|FG000|Overall Study|Randomized but not vaccinated|4|||
155384986|NCT00112047|560843796|FG000|Randomized Phase|Noncompliance|8|||
155384987|NCT00112047|560843797|FG001|Randomized Phase|Noncompliance|4|||
155384988|NCT00112047|560843796|FG000|Randomized Phase|Protocol Violation|2|||
155384989|NCT00112047|560843797|FG001|Randomized Phase|Protocol Violation|0|||
155384990|NCT00112047|560843796|FG000|Randomized Phase|Pregnancy|3|||
155384991|NCT00112047|560843797|FG001|Randomized Phase|Pregnancy|1|||
155384992|NCT00112047|560843796|FG000|Randomized Phase|Death|1|||
155384993|NCT00112047|560843797|FG001|Randomized Phase|Death|3|||
155384994|NCT00112047|560843796|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
155384995|NCT00112047|560843797|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
155384996|NCT00112047|560843796|FG000|Randomized Phase|Inability to swallow pills|0|||
155384997|NCT00112047|560843797|FG001|Randomized Phase|Inability to swallow pills|1|||
155384998|NCT00112047|560843796|FG000|Randomized Phase|Incarceration|3|||
155384999|NCT00112047|560843797|FG001|Randomized Phase|Incarceration|2|||
155385000|NCT00112047|560843796|FG000|Randomized Phase|Moved out of State|0|||
155385001|NCT00112047|560843797|FG001|Randomized Phase|Moved out of State|1|||
155385002|NCT00112047|560843796|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
155385003|NCT00112047|560843797|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
155385004|NCT00112047|560843796|FG000|Randomized Phase|High Hepatitis B DNA|0|||
155385005|NCT00112047|560843797|FG001|Randomized Phase|High Hepatitis B DNA|1|||
155385006|NCT00112047|560843796|FG000|Atripla Phase|Adverse Event|2|||
155385007|NCT00112047|560843797|FG001|Atripla Phase|Adverse Event|1|||
155385008|NCT00112047|560843796|FG000|Atripla Phase|Lost to Follow-up|5|||
155385009|NCT00112047|560843797|FG001|Atripla Phase|Lost to Follow-up|7|||
155385010|NCT00112047|560843796|FG000|Atripla Phase|Pregnancy|0|||
155385011|NCT00112047|560843797|FG001|Atripla Phase|Pregnancy|1|||
155385012|NCT00112047|560843796|FG000|Atripla Phase|Death|0|||
155385013|NCT00112047|560843797|FG001|Atripla Phase|Death|2|||
155385014|NCT00112047|560843796|FG000|Atripla Phase|Withdrew consent|7|||
155385015|NCT00112047|560843797|FG001|Atripla Phase|Withdrew consent|7|||
155385016|NCT00112047|560843796|FG000|Atripla Phase|Sub-optimal virological response|0|||
155385017|NCT00112047|560843797|FG001|Atripla Phase|Sub-optimal virological response|1|||
155385018|NCT00112047|560843796|FG000|Atripla Phase|Non-compliance|1|||
155385019|NCT00112047|560843797|FG001|Atripla Phase|Non-compliance|0|||
155385020|NCT00112047|560843796|FG000|Atripla Phase|Other|3|||
155385021|NCT00112047|560843797|FG001|Atripla Phase|Other|1|||
155385022|NCT01307579|560843798|FG000|Overall Study|Death|3|||
155385023|NCT01307579|560843799|FG001|Overall Study|Death|6|||
155385024|NCT01307579|560843798|FG000|Overall Study|Physician Decision|26|||
155385025|NCT01307579|560843799|FG001|Overall Study|Physician Decision|29|||
155385026|NCT01307579|560843798|FG000|Overall Study|Withdrawal by Subject|7|||
155385027|NCT01307579|560843799|FG001|Overall Study|Withdrawal by Subject|3|||
155385028|NCT01307579|560843798|FG000|Overall Study|Institutional diagnosis of IFD|21|||
155385029|NCT01307579|560843799|FG001|Overall Study|Institutional diagnosis of IFD|36|||
155385030|NCT01307579|560843798|FG000|Overall Study|Begin conditioning for HSCT|42|||
155385031|NCT01307579|560843799|FG001|Overall Study|Begin conditioning for HSCT|44|||
155385032|NCT01307579|560843798|FG000|Overall Study|Refractory or relapsed AML|38|||
155385033|NCT01307579|560843799|FG001|Overall Study|Refractory or relapsed AML|23|||
155385034|NCT01307579|560843798|FG000|Overall Study|Ineligible|3|||
155385035|NCT01307579|560843799|FG001|Overall Study|Ineligible|4|||
155385036|NCT03170349|560843802|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
155385037|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
155385038|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
155385039|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
155385040|NCT03170349|560843802|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
155385041|NCT03170349|560843802|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
155385042|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
155385043|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
155385044|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
155385045|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
155385046|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
155385047|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
155385048|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
155385049|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
155385050|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
155385051|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
155385052|NCT03938545|560845017|FG000|Overall Study|Lost to Follow-up|0|||
155385053|NCT03938545|560845018|FG001|Overall Study|Lost to Follow-up|0|||
155627060|NCT03234465|561730124|FG001|Overall Study|Withdrawal by Subject|27|||
155627061|NCT03234465|561730123|FG000|Overall Study|Symptomatic deterioration|0|||
155627062|NCT03234465|561730124|FG001|Overall Study|Symptomatic deterioration|1|||
155627063|NCT03234465|561730123|FG000|Overall Study|Non-compliance|2|||
155627064|NCT03234465|561730124|FG001|Overall Study|Non-compliance|0|||
155627065|NCT03234465|561730123|FG000|Overall Study|Other|14|||
155385054|NCT03938545|560845019|FG002|Overall Study|Lost to Follow-up|0|||
155385055|NCT03938545|560845020|FG003|Overall Study|Lost to Follow-up|1|||
155385056|NCT03938545|560845017|FG000|Overall Study|Non-compliance with study drug|0|||
155627066|NCT03234465|561730124|FG001|Overall Study|Other|8|||
155627067|NCT00449163|561730127|FG000|Overall Study|Physician Decision|3|||
155385057|NCT03938545|560845018|FG001|Overall Study|Non-compliance with study drug|0|||
155385058|NCT03938545|560845019|FG002|Overall Study|Non-compliance with study drug|1|||
155385059|NCT03938545|560845020|FG003|Overall Study|Non-compliance with study drug|0|||
155385060|NCT03938545|560845017|FG000|Overall Study|Pregnancy|1|||
155385061|NCT03938545|560845018|FG001|Overall Study|Pregnancy|0|||
155385062|NCT03938545|560845019|FG002|Overall Study|Pregnancy|0|||
155385063|NCT03938545|560845020|FG003|Overall Study|Pregnancy|0|||
155385064|NCT03938545|560845017|FG000|Overall Study|Study terminated by sponsor|6|||
155385065|NCT03938545|560845018|FG001|Overall Study|Study terminated by sponsor|4|||
155385066|NCT03938545|560845019|FG002|Overall Study|Study terminated by sponsor|2|||
155385067|NCT03938545|560845020|FG003|Overall Study|Study terminated by sponsor|4|||
155385068|NCT03938545|560845017|FG000|Overall Study|Withdrawal by Subject|0|||
155385069|NCT03938545|560845018|FG001|Overall Study|Withdrawal by Subject|1|||
155385070|NCT03938545|560845019|FG002|Overall Study|Withdrawal by Subject|0|||
155385071|NCT03938545|560845020|FG003|Overall Study|Withdrawal by Subject|0|||
155385072|NCT03938545|560845017|FG000|Overall Study|Adverse Event|1|||
155385073|NCT03938545|560845018|FG001|Overall Study|Adverse Event|0|||
155385074|NCT03938545|560845019|FG002|Overall Study|Adverse Event|0|||
155385075|NCT03938545|560845020|FG003|Overall Study|Adverse Event|0|||
155385076|NCT01060540|560845021|FG000|Overall Study|Withdrawal by Subject|10|||
155385077|NCT01060540|560845022|FG001|Overall Study|Withdrawal by Subject|20|||
155385078|NCT01060540|560845021|FG000|Overall Study|Lost to Follow-up|52|||
155385079|NCT01060540|560845022|FG001|Overall Study|Lost to Follow-up|43|||
155385080|NCT01060540|560845021|FG000|Overall Study|Death|2|||
155385081|NCT01060540|560845022|FG001|Overall Study|Death|1|||
155385082|NCT01060540|560845021|FG000|Overall Study|Physician Decision|0|||
155385083|NCT01060540|560845022|FG001|Overall Study|Physician Decision|1|||
155385084|NCT01222507|560845026|FG000|Overall Study|Physician Decision|1|||
155385085|NCT01222507|560845026|FG000|Overall Study|Withdrawal by Subject|1|||
155385086|NCT02647320|560845027|FG000|Overall Study|Adverse Event|0|||
155385087|NCT02647320|560845028|FG001|Overall Study|Adverse Event|1|||
155385088|NCT02647320|560845029|FG002|Overall Study|Adverse Event|3|||
155385089|NCT02647320|560845030|FG003|Overall Study|Adverse Event|2|||
155385090|NCT02647320|560845031|FG004|Overall Study|Adverse Event|1|||
155385091|NCT02647320|560845027|FG000|Overall Study|Protocol Violation|0|||
155385092|NCT02647320|560845028|FG001|Overall Study|Protocol Violation|0|||
155385093|NCT02647320|560845029|FG002|Overall Study|Protocol Violation|3|||
155385094|NCT02647320|560845030|FG003|Overall Study|Protocol Violation|0|||
155385095|NCT02647320|560845031|FG004|Overall Study|Protocol Violation|0|||
155385096|NCT02647320|560845027|FG000|Overall Study|Withdrawal by Subject|7|||
155385097|NCT02647320|560845028|FG001|Overall Study|Withdrawal by Subject|4|||
155385098|NCT02647320|560845029|FG002|Overall Study|Withdrawal by Subject|2|||
155385099|NCT02647320|560845030|FG003|Overall Study|Withdrawal by Subject|2|||
155385100|NCT02647320|560845031|FG004|Overall Study|Withdrawal by Subject|7|||
155385101|NCT02647320|560845027|FG000|Overall Study|Persistent hyperglycemia|0|||
155385102|NCT02647320|560845028|FG001|Overall Study|Persistent hyperglycemia|1|||
155385103|NCT02647320|560845029|FG002|Overall Study|Persistent hyperglycemia|1|||
155385104|NCT02647320|560845030|FG003|Overall Study|Persistent hyperglycemia|1|||
155385105|NCT02647320|560845031|FG004|Overall Study|Persistent hyperglycemia|1|||
155385106|NCT02647320|560845027|FG000|Overall Study|Study terminated by sponsor|1|||
155385107|NCT02647320|560845028|FG001|Overall Study|Study terminated by sponsor|1|||
155385108|NCT02647320|560845029|FG002|Overall Study|Study terminated by sponsor|1|||
155385109|NCT02647320|560845030|FG003|Overall Study|Study terminated by sponsor|1|||
155385110|NCT02647320|560845031|FG004|Overall Study|Study terminated by sponsor|2|||
155385111|NCT02647320|560845027|FG000|Overall Study|Reason not provided|0|||
155385112|NCT02647320|560845028|FG001|Overall Study|Reason not provided|0|||
155385113|NCT02647320|560845029|FG002|Overall Study|Reason not provided|1|||
155385114|NCT02647320|560845030|FG003|Overall Study|Reason not provided|0|||
155385115|NCT02647320|560845031|FG004|Overall Study|Reason not provided|2|||
155385116|NCT02647320|560845027|FG000|Overall Study|Lost to Follow-up|1|||
155385117|NCT02647320|560845028|FG001|Overall Study|Lost to Follow-up|1|||
155385118|NCT02647320|560845029|FG002|Overall Study|Lost to Follow-up|0|||
155385119|NCT02647320|560845030|FG003|Overall Study|Lost to Follow-up|0|||
155385120|NCT02647320|560845031|FG004|Overall Study|Lost to Follow-up|0|||
155385121|NCT02647320|560845027|FG000|Overall Study|Develop anemia|1|||
155385122|NCT02647320|560845028|FG001|Overall Study|Develop anemia|0|||
155385123|NCT02647320|560845029|FG002|Overall Study|Develop anemia|0|||
155385124|NCT02647320|560845030|FG003|Overall Study|Develop anemia|0|||
155385125|NCT02647320|560845031|FG004|Overall Study|Develop anemia|0|||
155385126|NCT02647320|560845027|FG000|Overall Study|Lack of Efficacy|0|||
155385127|NCT02647320|560845028|FG001|Overall Study|Lack of Efficacy|0|||
155385128|NCT02647320|560845029|FG002|Overall Study|Lack of Efficacy|0|||
155385129|NCT02647320|560845030|FG003|Overall Study|Lack of Efficacy|1|||
155385130|NCT02647320|560845031|FG004|Overall Study|Lack of Efficacy|0|||
155385131|NCT02647320|560845027|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
155385132|NCT02647320|560845028|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
155385133|NCT02647320|560845029|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
155385134|NCT02647320|560845030|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
155385135|NCT02647320|560845031|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
155385136|NCT00596427|560845032|FG000|Overall Study|Withdrawal by Subject|2|||
155385137|NCT00596427|560845033|FG001|Overall Study|Withdrawal by Subject|2|||
155385138|NCT00596427|560845032|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
155385139|NCT00596427|560845033|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
155385140|NCT00596427|560845032|FG000|Overall Study|Protocol Violation|1|||
155385141|NCT00596427|560845033|FG001|Overall Study|Protocol Violation|0|||
155385142|NCT02401867|560845038|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
155385143|NCT02401867|560845038|FG000|Analysis|Cervical assay could not be conducted|9|||
155385144|NCT01650246|560845039|FG000|Overall Study|Adverse Event|23|||
155385145|NCT01650246|560845039|FG000|Overall Study|Protocol Violation|5|||
155385146|NCT01650246|560845039|FG000|Overall Study|Sponsor terminated study|53|||
155385147|NCT01650246|560845039|FG000|Overall Study|Lost to Follow-up|5|||
155385148|NCT01650246|560845039|FG000|Overall Study|Withdrawal by Subject|26|||
155385149|NCT01650246|560845039|FG000|Overall Study|Death|1|||
155385150|NCT01650246|560845039|FG000|Overall Study|Lack of Efficacy|30|||
155385151|NCT00081770|560845040|FG000|Overall Study|Adverse Event|130|||
155385152|NCT00081770|560845041|FG001|Overall Study|Adverse Event|98|||
155385153|NCT00081770|560845042|FG002|Overall Study|Adverse Event|136|||
155385154|NCT00081770|560845040|FG000|Overall Study|Lack of Efficacy|262|||
155385155|NCT00081770|560845041|FG001|Overall Study|Lack of Efficacy|357|||
155385156|NCT00081770|560845042|FG002|Overall Study|Lack of Efficacy|211|||
155385157|NCT00081770|560845040|FG000|Overall Study|Lost to Follow-up|45|||
155385158|NCT00081770|560845041|FG001|Overall Study|Lost to Follow-up|34|||
155385159|NCT00081770|560845042|FG002|Overall Study|Lost to Follow-up|45|||
155385160|NCT00081770|560845040|FG000|Overall Study|Protocol Violation|15|||
155385161|NCT00081770|560845041|FG001|Overall Study|Protocol Violation|10|||
155385162|NCT00081770|560845042|FG002|Overall Study|Protocol Violation|10|||
155385163|NCT00081770|560845040|FG000|Overall Study|Withdrawal by Subject|45|||
155385164|NCT00081770|560845041|FG001|Overall Study|Withdrawal by Subject|40|||
155385165|NCT00081770|560845042|FG002|Overall Study|Withdrawal by Subject|42|||
155385166|NCT00081770|560845040|FG000|Overall Study|Did not meet protocol eligibility|2|||
155385167|NCT00081770|560845041|FG001|Overall Study|Did not meet protocol eligibility|0|||
155385168|NCT00081770|560845042|FG002|Overall Study|Did not meet protocol eligibility|3|||
155385169|NCT00081770|560845040|FG000|Overall Study|Administrative|1|||
155385170|NCT00081770|560845041|FG001|Overall Study|Administrative|0|||
155385171|NCT00081770|560845042|FG002|Overall Study|Administrative|1|||
155385172|NCT00081770|560845040|FG000|Overall Study|Other|2|||
155385173|NCT00081770|560845041|FG001|Overall Study|Other|7|||
155385174|NCT00081770|560845042|FG002|Overall Study|Other|8|||
155385175|NCT03435497|560845044|FG000|Overall Study|Lost to Follow-up|1|||
155385176|NCT03435497|560845045|FG001|Overall Study|Lost to Follow-up|0|||
155385177|NCT03435497|560845044|FG000|Overall Study|Death|1|||
155385178|NCT03435497|560845045|FG001|Overall Study|Death|0|||
155385179|NCT03435497|560845044|FG000|Overall Study|Withdrawal by Subject|0|||
155385180|NCT03435497|560845045|FG001|Overall Study|Withdrawal by Subject|4|||
155385181|NCT03435497|560845044|FG000|Overall Study|Wrong survey administered|0|||
155385182|NCT03435497|560845045|FG001|Overall Study|Wrong survey administered|2|||
155385183|NCT01614197|560845054|FG000|Overall Study|Withdrawal by Subject|0|||
155385184|NCT01614197|560845055|FG001|Overall Study|Withdrawal by Subject|1|||
155385185|NCT01614197|560845056|FG002|Overall Study|Withdrawal by Subject|0|||
155385186|NCT01614197|560845057|FG003|Overall Study|Withdrawal by Subject|0|||
155385187|NCT03628898|560845059|FG000|Overall Study|Device deficiency|1|||
155385188|NCT03442985|560845060|FG000|Overall Study|Sponsor Request|55|||
155385189|NCT03442985|560845061|FG001|Overall Study|Sponsor Request|60|||
155385190|NCT03442985|560845062|FG002|Overall Study|Sponsor Request|54|||
155385191|NCT03442985|560845060|FG000|Overall Study|Lost to Follow-up|5|||
155385192|NCT03442985|560845061|FG001|Overall Study|Lost to Follow-up|2|||
155385193|NCT03442985|560845062|FG002|Overall Study|Lost to Follow-up|7|||
155385194|NCT03442985|560845060|FG000|Overall Study|Withdrawal by Subject|2|||
155385195|NCT03442985|560845061|FG001|Overall Study|Withdrawal by Subject|3|||
155385196|NCT03442985|560845062|FG002|Overall Study|Withdrawal by Subject|4|||
155385197|NCT03442985|560845060|FG000|Overall Study|Adverse Event|0|||
155385198|NCT03442985|560845061|FG001|Overall Study|Adverse Event|1|||
155385199|NCT03442985|560845062|FG002|Overall Study|Adverse Event|0|||
155385200|NCT01217957|560845065|FG000|Phase 1|Withdrawal by Patient|1|||
155385201|NCT01217957|560845066|FG001|Phase 1|Withdrawal by Patient|0|||
155385202|NCT01217957|560845067|FG002|Phase 1|Withdrawal by Patient|1|||
155729255|NCT02113982|562108045|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
155729256|NCT02113982|562108046|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
155385203|NCT01217957|560845068|FG003|Phase 1|Withdrawal by Patient|1|||
155385204|NCT01217957|560845069|FG004|Phase 1|Withdrawal by Patient|0|||
155385205|NCT01217957|560845065|FG000|Phase 2|Withdrawal by Patient|0|||
155385206|NCT01217957|560845066|FG001|Phase 2|Withdrawal by Patient|0|||
155385207|NCT01217957|560845067|FG002|Phase 2|Withdrawal by Patient|0|||
155385208|NCT01217957|560845068|FG003|Phase 2|Withdrawal by Patient|0|||
155385209|NCT01217957|560845069|FG004|Phase 2|Withdrawal by Patient|1|||
155385210|NCT00971932|560845070|FG000|Overall Study|Withdrawal by Subject|1|||
155385211|NCT00971932|560845070|FG000|Overall Study|Investigator's decision|2|||
155385212|NCT00971932|560845070|FG000|Overall Study|Ongoing|4|||
155385213|NCT01206777|560845074|FG000|Overall Study|Death|1|||
155385214|NCT01206777|560845074|FG000|Overall Study|Adverse Event|1|||
155385215|NCT00824161|560845083|FG000|Overall Study|Withdrawal by Subject|1|||
155385216|NCT00824161|560845083|FG000|Overall Study|Screen Failure|1|||
155385217|NCT04754477|560845084|FG000|Overall Study|Withdrawal by Subject|1|||
155385218|NCT00655863|560845085|FG000|Overall Study|Lost to Follow-up|0|||
155385219|NCT00655863|560845086|FG001|Overall Study|Lost to Follow-up|0|||
155385220|NCT00655863|560845087|FG002|Overall Study|Lost to Follow-up|1|||
155385221|NCT02203695|560845092|FG000|Overall Study|Patient withdrew consent|1|||
155385222|NCT02203695|560845093|FG001|Overall Study|Patient withdrew consent|1|||
155385223|NCT02203695|560845092|FG000|Overall Study|Started non-study treatment|1|||
155385224|NCT02203695|560845093|FG001|Overall Study|Started non-study treatment|0|||
155385225|NCT01122862|560845094|FG000|Period 1|Protocol Violation|0|||
155385226|NCT01122862|560845095|FG001|Period 1|Protocol Violation|1|||
155385227|NCT01122862|560845096|FG002|Period 1|Protocol Violation|0|||
155385228|NCT01122862|560845094|FG000|Period 2|Adverse Event|0|||
155385229|NCT01122862|560845095|FG001|Period 2|Adverse Event|0|||
155385230|NCT01122862|560845096|FG002|Period 2|Adverse Event|1|||
155385231|NCT00846391|560845097|FG000|Overall Study|Physician Decision|0|||
155385232|NCT00846391|560845098|FG001|Overall Study|Physician Decision|0|||
155385233|NCT00846391|560845099|FG002|Overall Study|Physician Decision|1|||
155385234|NCT00846391|560845097|FG000|Overall Study|Study Terminated by Sponsor|1|||
155385235|NCT00846391|560845098|FG001|Overall Study|Study Terminated by Sponsor|2|||
155385236|NCT00846391|560845099|FG002|Overall Study|Study Terminated by Sponsor|2|||
155385237|NCT01790126|560845103|FG000|Overall Study|PSA Progression|12|||
155385238|NCT01790126|560845104|FG001|Overall Study|PSA Progression|16|||
155385239|NCT01790126|560845105|FG002|Overall Study|PSA Progression|16|||
155385240|NCT01790126|560845103|FG000|Overall Study|Other|5|||
155385241|NCT01790126|560845104|FG001|Overall Study|Other|4|||
155385242|NCT01790126|560845105|FG002|Overall Study|Other|8|||
155385243|NCT01790126|560845103|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
155385244|NCT01790126|560845104|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
155385245|NCT01790126|560845105|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
155385246|NCT01790126|560845103|FG000|Overall Study|Withdrawal by Physician|1|||
155385247|NCT01790126|560845104|FG001|Overall Study|Withdrawal by Physician|1|||
155385248|NCT01790126|560845105|FG002|Overall Study|Withdrawal by Physician|2|||
155385249|NCT01790126|560845103|FG000|Overall Study|Withdrawal by Subject|3|||
155385250|NCT01790126|560845104|FG001|Overall Study|Withdrawal by Subject|1|||
155385251|NCT01790126|560845105|FG002|Overall Study|Withdrawal by Subject|2|||
155385252|NCT01790126|560845103|FG000|Overall Study|Lost to Follow-up|1|||
155385253|NCT01790126|560845104|FG001|Overall Study|Lost to Follow-up|0|||
155385254|NCT01790126|560845105|FG002|Overall Study|Lost to Follow-up|1|||
155385255|NCT01790126|560845103|FG000|Overall Study|Adverse Event|0|||
155385256|NCT01790126|560845104|FG001|Overall Study|Adverse Event|2|||
155385257|NCT01790126|560845105|FG002|Overall Study|Adverse Event|0|||
155385258|NCT01790126|560845103|FG000|Overall Study|Death|2|||
155385259|NCT01790126|560845104|FG001|Overall Study|Death|0|||
155385260|NCT01790126|560845105|FG002|Overall Study|Death|0|||
155385261|NCT01790126|560845103|FG000|Overall Study|Radiographic Progression|3|||
155385262|NCT01790126|560845104|FG001|Overall Study|Radiographic Progression|1|||
155385263|NCT01790126|560845105|FG002|Overall Study|Radiographic Progression|0|||
155385264|NCT01636960|560845108|FG000|Induction Phase|Adverse Event|2|||
155385265|NCT01636960|560845108|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
155385266|NCT01636960|560845108|FG000|Maintenance Phase|Adverse Event|3|||
155385267|NCT01636960|560845108|FG000|Maintenance Phase|Progressive disease|1|||
155385268|NCT01580969|560845109|FG000|Overall Study|Physician Decision|3|||
155385269|NCT01580969|560845110|FG001|Overall Study|Physician Decision|0|||
155385270|NCT01580969|560845111|FG002|Overall Study|Physician Decision|0|||
155385271|NCT01745848|560845112|FG000|Overall Study|Adverse Event|6|||
155385272|NCT06338462|560845116|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
155385273|NCT01001832|560845120|FG000|Short-term Period|Adverse Event|2|||
155385274|NCT01001832|560845121|FG001|Short-term Period|Adverse Event|3|||
155385275|NCT01001832|560845120|FG000|Long-term Period|Adverse Event|2|||
155385276|NCT01001832|560845121|FG001|Long-term Period|Adverse Event|1|||
155385277|NCT01001832|560845120|FG000|Long-term Period|Withdrawal by Subject|1|||
155385278|NCT01001832|560845121|FG001|Long-term Period|Withdrawal by Subject|0|||
155385279|NCT01001832|560845120|FG000|Long-term Period|Lack of Efficacy|0|||
155385280|NCT01001832|560845121|FG001|Long-term Period|Lack of Efficacy|2|||
155385281|NCT01001832|560845120|FG000|Long-term Period|Other|1|||
155385282|NCT01001832|560845121|FG001|Long-term Period|Other|2|||
155385283|NCT01001832|560845120|FG000|Follow-up Period|Withdrawal by Subject|1|||
155627068|NCT03368807|561730138|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
155627069|NCT03368807|561730138|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
155385284|NCT01001832|560845121|FG001|Follow-up Period|Withdrawal by Subject|0|||
155385285|NCT01001832|560845120|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
155385286|NCT01001832|560845121|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
155385287|NCT01001832|560845120|FG000|Follow-up Period|Other|2|||
155385288|NCT01001832|560845121|FG001|Follow-up Period|Other|1|||
155385289|NCT03581825|560845130|FG000|Period 1|Lens Discomfort|1|||
155385290|NCT03581825|560845131|FG001|Period 1|Lens Discomfort|0|||
155385291|NCT03581825|560845130|FG000|Period 2|Unsatisfactory Vision to Test|0|||
155385292|NCT03581825|560845131|FG001|Period 2|Unsatisfactory Vision to Test|1|||
155385293|NCT03110185|560845133|FG000|Overall Study|Death|0|||
155385294|NCT03110185|560845134|FG001|Overall Study|Death|1|||
155385295|NCT03110185|560845133|FG000|Overall Study|Withdrawal by Subject|2|||
155385296|NCT03110185|560845134|FG001|Overall Study|Withdrawal by Subject|7|||
155385297|NCT03110185|560845133|FG000|Overall Study|Time Constraints|0|||
155385298|NCT03110185|560845134|FG001|Overall Study|Time Constraints|6|||
155385299|NCT03110185|560845133|FG000|Overall Study|Conflict with care|5|||
155385300|NCT03110185|560845134|FG001|Overall Study|Conflict with care|12|||
155385301|NCT03110185|560845133|FG000|Overall Study|Protocol Violation|1|||
155385302|NCT03110185|560845134|FG001|Overall Study|Protocol Violation|4|||
155385303|NCT03110185|560845133|FG000|Overall Study|MRI Incompatible|2|||
155385304|NCT03110185|560845134|FG001|Overall Study|MRI Incompatible|0|||
155385305|NCT03110185|560845133|FG000|Overall Study|Patient Refusal|0|||
155385306|NCT03110185|560845134|FG001|Overall Study|Patient Refusal|1|||
155279350|NCT05310084|560456211|FG001|Overall Study|Randomized but not vaccinated|2|||
155279351|NCT00924664|560456213|FG000|Overall Study|Adverse Event|23|||
155279352|NCT00924664|560456214|FG001|Overall Study|Adverse Event|39|||
155279353|NCT00924664|560456213|FG000|Overall Study|Lack of Efficacy|10|||
155279354|NCT00924664|560456214|FG001|Overall Study|Lack of Efficacy|15|||
155279355|NCT00924664|560456213|FG000|Overall Study|Lost to Follow-up|10|||
155279356|NCT00924664|560456214|FG001|Overall Study|Lost to Follow-up|12|||
155279357|NCT00924664|560456213|FG000|Overall Study|Withdrawal by Subject|47|||
155279358|NCT00924664|560456214|FG001|Overall Study|Withdrawal by Subject|71|||
155279359|NCT00924664|560456213|FG000|Overall Study|Protocol Violation|2|||
155279360|NCT00924664|560456214|FG001|Overall Study|Protocol Violation|5|||
155279361|NCT00924664|560456213|FG000|Overall Study|Pregnancy|1|||
155279362|NCT00924664|560456214|FG001|Overall Study|Pregnancy|1|||
155279363|NCT00924664|560456213|FG000|Overall Study|Death|0|||
155279364|NCT00924664|560456214|FG001|Overall Study|Death|2|||
155279365|NCT00924664|560456213|FG000|Overall Study|Study terminated by sponsor|199|||
155279366|NCT00924664|560456214|FG001|Overall Study|Study terminated by sponsor|330|||
155279367|NCT00924664|560456213|FG000|Overall Study|Other|29|||
155279368|NCT00924664|560456214|FG001|Overall Study|Other|52|||
155279369|NCT00924664|560456213|FG000|Overall Study|Randomized but not Treated|1|||
155279370|NCT00924664|560456214|FG001|Overall Study|Randomized but not Treated|0|||
155279371|NCT01598987|560456215|FG000|Baseline to Month 12|Administrative problems|2|||
155279372|NCT01598987|560456215|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
155279373|NCT01598987|560456215|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
155279374|NCT01598987|560456215|FG000|Baseline to 24 Month|Administrative problems|2|||
155279375|NCT01598987|560456215|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
155279376|NCT02724020|560456225|FG000|Overall Study|Death|16|||
155279377|NCT02724020|560456226|FG001|Overall Study|Death|18|||
155279378|NCT02724020|560456227|FG002|Overall Study|Death|19|||
155279379|NCT02724020|560456225|FG000|Overall Study|Lost to Follow-up|0|||
155279380|NCT02724020|560456226|FG001|Overall Study|Lost to Follow-up|3|||
155279381|NCT02724020|560456227|FG002|Overall Study|Lost to Follow-up|0|||
155279382|NCT02724020|560456225|FG000|Overall Study|Site Terminated by Sponsor|15|||
155279383|NCT02724020|560456226|FG001|Overall Study|Site Terminated by Sponsor|8|||
155279384|NCT02724020|560456227|FG002|Overall Study|Site Terminated by Sponsor|8|||
155279385|NCT02724020|560456225|FG000|Overall Study|Withdrawal by Subject|1|||
155279386|NCT02724020|560456226|FG001|Overall Study|Withdrawal by Subject|3|||
155279387|NCT02724020|560456227|FG002|Overall Study|Withdrawal by Subject|5|||
155279388|NCT00425503|560456228|FG000|Overall Study|Adverse Event|2|||
155279389|NCT00425503|560456228|FG000|Overall Study|Protocol Violation|1|||
155279390|NCT01925170|560456229|FG000|Overall Study|Unverified cancer status|53|||
155279391|NCT02839681|560456232|FG000|Overall Study|Death|2|||
155279392|NCT01653847|560456233|FG000|Overall Study|Withdrawal by Subject|1|||
155279393|NCT01653847|560456234|FG001|Overall Study|Withdrawal by Subject|0|||
155279394|NCT00801242|560456239|FG000|Overall Study|Adverse Event|10|||
155279395|NCT00801242|560456239|FG000|Overall Study|Withdrawal by Subject|13|||
155279396|NCT00801242|560456239|FG000|Overall Study|Protocol Violation|5|||
155279397|NCT00801242|560456239|FG000|Overall Study|Physician Decision|3|||
155385307|NCT04737187|560845142|FG000|Overall Study|Switched to marketed drug|32|||
155385308|NCT04737187|560845143|FG001|Overall Study|Switched to marketed drug|4|||
155385309|NCT04737187|560845142|FG000|Overall Study|Radiological Progressive Disease|145|||
155385310|NCT04737187|560845143|FG001|Overall Study|Radiological Progressive Disease|146|||
155385311|NCT04737187|560845142|FG000|Overall Study|Clinical Progressive Disease|20|||
155385312|NCT04737187|560845143|FG001|Overall Study|Clinical Progressive Disease|20|||
155279398|NCT00801242|560456239|FG000|Overall Study|Lost to Follow-up|1|||
155279399|NCT00801242|560456239|FG000|Overall Study|Miscellaneous reasons|20|||
155279400|NCT02554513|560456240|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
155279401|NCT02554513|560456241|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
155279402|NCT00184028|560456242|FG000|Overall Study|Death|1|||
155385313|NCT04737187|560845142|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
155385314|NCT04737187|560845143|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
155385315|NCT04737187|560845142|FG000|Overall Study|Adverse Event|16|||
155385316|NCT04737187|560845143|FG001|Overall Study|Adverse Event|16|||
155385317|NCT04737187|560845142|FG000|Overall Study|Physician Decision|2|||
155385318|NCT04737187|560845143|FG001|Overall Study|Physician Decision|0|||
155385319|NCT04737187|560845142|FG000|Overall Study|Withdrawal by Subject|5|||
155385320|NCT04737187|560845143|FG001|Overall Study|Withdrawal by Subject|8|||
155385321|NCT00345293|560845144|FG000|Overall Study|Unable to access line for sample|1|||
155385322|NCT00345293|560845145|FG001|Overall Study|Unable to access line for sample|0|||
155385323|NCT00345293|560845144|FG000|Overall Study|Withdrawal by Subject|1|||
155385324|NCT00345293|560845145|FG001|Overall Study|Withdrawal by Subject|0|||
155385325|NCT04873232|560845147|FG000|Overall Study|Lost to Follow-up|1|||
155385326|NCT04873232|560845148|FG001|Overall Study|Lost to Follow-up|4|||
155385327|NCT04873232|560845147|FG000|Overall Study|Withdrawal by Subject|1|||
155385328|NCT04873232|560845148|FG001|Overall Study|Withdrawal by Subject|0|||
155385329|NCT01340196|560847075|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
155385330|NCT00604279|560847080|FG000|Overall Study|Lack of Efficacy|22|||
155385331|NCT00604279|560847081|FG001|Overall Study|Lack of Efficacy|9|||
155385332|NCT00604279|560847080|FG000|Overall Study|Lost to Follow-up|9|||
155385333|NCT00604279|560847081|FG001|Overall Study|Lost to Follow-up|14|||
155385334|NCT00604279|560847080|FG000|Overall Study|Pregnancy|2|||
155385335|NCT00604279|560847081|FG001|Overall Study|Pregnancy|0|||
155385336|NCT00604279|560847080|FG000|Overall Study|Protocol Violation|3|||
155385337|NCT00604279|560847081|FG001|Overall Study|Protocol Violation|1|||
155385338|NCT00604279|560847080|FG000|Overall Study|Withdrawal by Subject|16|||
155385339|NCT00604279|560847081|FG001|Overall Study|Withdrawal by Subject|5|||
155385340|NCT00604279|560847080|FG000|Overall Study|Adverse Event|4|||
155385341|NCT00604279|560847081|FG001|Overall Study|Adverse Event|5|||
155385342|NCT00604279|560847080|FG000|Overall Study|Other|8|||
155385343|NCT00604279|560847081|FG001|Overall Study|Other|4|||
155385344|NCT00355056|560847082|FG000|Randomization Period|Early Termination|4|||
155385345|NCT00355056|560847083|FG001|Randomization Period|Early Termination|6|||
155385346|NCT00816400|560847084|FG000|Overall Study|Death|2|||
155385347|NCT00816400|560847085|FG001|Overall Study|Death|3|||
155385348|NCT00816400|560847086|FG002|Overall Study|Death|3|||
155385349|NCT00816400|560847087|FG003|Overall Study|Death|3|||
155385350|NCT00816400|560847088|FG004|Overall Study|Death|2|||
155385351|NCT00816400|560847089|FG005|Overall Study|Death|3|||
155385352|NCT00816400|560847090|FG006|Overall Study|Death|2|||
155385353|NCT00816400|560847091|FG007|Overall Study|Death|5|||
155385354|NCT00816400|560847092|FG008|Overall Study|Death|6|||
155385355|NCT00816400|560847084|FG000|Overall Study|In hospice care at the end of the study|0|||
155385356|NCT00816400|560847085|FG001|Overall Study|In hospice care at the end of the study|0|||
155385357|NCT00816400|560847086|FG002|Overall Study|In hospice care at the end of the study|2|||
155385358|NCT00816400|560847087|FG003|Overall Study|In hospice care at the end of the study|0|||
155385359|NCT00816400|560847088|FG004|Overall Study|In hospice care at the end of the study|0|||
155385360|NCT00816400|560847089|FG005|Overall Study|In hospice care at the end of the study|0|||
155385361|NCT00816400|560847090|FG006|Overall Study|In hospice care at the end of the study|0|||
155650597|NCT00452530|561812515|FG000|Overall Study|Lost to Follow-up|1|||
155650598|NCT00452530|561812516|FG001|Overall Study|Lost to Follow-up|0|||
155650599|NCT00452530|561812515|FG000|Overall Study|Poor compliance/noncompliance|1|||
155650600|NCT00452530|561812516|FG001|Overall Study|Poor compliance/noncompliance|2|||
155650601|NCT00452530|561812515|FG000|Overall Study|No longer met study criteria|18|||
155650602|NCT00452530|561812516|FG001|Overall Study|No longer met study criteria|22|||
155650603|NCT00452530|561812515|FG000|Overall Study|Other|7|||
155650604|NCT00452530|561812516|FG001|Overall Study|Other|11|||
155650605|NCT00468546|561812519|FG000|Week 24 Analysis|Lack of Efficacy|83|||
155650606|NCT00468546|561812520|FG001|Week 24 Analysis|Lack of Efficacy|37|||
155650607|NCT00468546|561812519|FG000|Week 24 Analysis|Refused treatment|5|||
155650608|NCT00468546|561812520|FG001|Week 24 Analysis|Refused treatment|5|||
155650609|NCT00468546|561812519|FG000|Week 24 Analysis|Adverse Event|1|||
155650610|NCT00468546|561812520|FG001|Week 24 Analysis|Adverse Event|8|||
155650611|NCT00468546|561812519|FG000|Week 24 Analysis|Failure to return|3|||
155650612|NCT00468546|561812520|FG001|Week 24 Analysis|Failure to return|4|||
155650613|NCT00468546|561812519|FG000|Week 24 Analysis|Rescue therapy|2|||
155650614|NCT00468546|561812520|FG001|Week 24 Analysis|Rescue therapy|0|||
155650615|NCT00468546|561812519|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
155650616|NCT00468546|561812520|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
155650617|NCT00468546|561812519|FG000|Week 24 Analysis|Due to clinical hold|1|||
155650618|NCT00468546|561812520|FG001|Week 24 Analysis|Due to clinical hold|0|||
155650619|NCT00468546|561812519|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
155650620|NCT00468546|561812520|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
155650621|NCT00468546|561812519|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
155650622|NCT00468546|561812520|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
155279403|NCT00184028|560456242|FG000|Overall Study|Lack of Efficacy|4|||
155279404|NCT00184028|560456242|FG000|Overall Study|Adverse Event|2|||
155279405|NCT00184028|560456242|FG000|Overall Study|Withdrawal by Subject|1|||
155279406|NCT00184028|560456242|FG000|Overall Study|Non-compliance|2|||
155279407|NCT00388362|560456243|FG000|Enrolled|Ineligible|1|||
155279408|NCT00388362|560456243|FG000|Enrolled|Adverse Event|9|||
155279409|NCT00388362|560456243|FG000|Enrolled|Death|1|||
155279410|NCT00388362|560456243|FG000|Enrolled|Loss insurance|1|||
155279411|NCT00388362|560456243|FG000|Enrolled|Withdrawal by Subject|1|||
155279412|NCT00388362|560456243|FG000|Remained on Study Median of 514 Days|Death|2|||
155279413|NCT03259373|560456246|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
155279414|NCT03259373|560456247|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
155279415|NCT03259373|560456246|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
155279416|NCT03259373|560456247|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
155279417|NCT03259373|560456246|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
155279418|NCT03259373|560456247|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
155279419|NCT03259373|560456246|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
155279420|NCT03259373|560456247|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
155279421|NCT03259373|560456246|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
155279422|NCT03259373|560456247|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
155627070|NCT03368807|561730138|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
155627071|NCT03368807|561730138|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
155627072|NCT00369343|561730153|FG000|Double-blind Phase|Adverse Event|19|||
155627073|NCT00369343|561730154|FG001|Double-blind Phase|Adverse Event|4|||
155627074|NCT00369343|561730153|FG000|Double-blind Phase|Failed to return|2|||
155627075|NCT00369343|561730154|FG001|Double-blind Phase|Failed to return|0|||
155627076|NCT00369343|561730153|FG000|Double-blind Phase|Lost to Follow-up|9|||
155627077|NCT00369343|561730154|FG001|Double-blind Phase|Lost to Follow-up|2|||
155627078|NCT00369343|561730153|FG000|Double-blind Phase|Protocol Violation|2|||
155627079|NCT00369343|561730154|FG001|Double-blind Phase|Protocol Violation|0|||
155627080|NCT00369343|561730153|FG000|Double-blind Phase|Withdrawal by Subject|8|||
155627081|NCT00369343|561730154|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155627082|NCT00369343|561730153|FG000|Double-blind Phase|Lack of Efficacy|0|||
155627083|NCT00369343|561730154|FG001|Double-blind Phase|Lack of Efficacy|4|||
155627084|NCT00369343|561730153|FG000|Double-blind Phase|Protocol deviation|4|||
155627085|NCT00369343|561730154|FG001|Double-blind Phase|Protocol deviation|0|||
155627086|NCT00369343|561730153|FG000|Open-label Phase|Adverse Event|19|||
155627087|NCT00369343|561730154|FG001|Open-label Phase|Adverse Event|7|||
155627088|NCT00369343|561730153|FG000|Open-label Phase|Failed to return|4|||
155627089|NCT00369343|561730154|FG001|Open-label Phase|Failed to return|0|||
155627090|NCT00369343|561730153|FG000|Open-label Phase|Physician Decision|2|||
155627091|NCT00369343|561730154|FG001|Open-label Phase|Physician Decision|0|||
155627092|NCT00369343|561730153|FG000|Open-label Phase|Lost to Follow-up|5|||
155627093|NCT00369343|561730154|FG001|Open-label Phase|Lost to Follow-up|3|||
155627094|NCT00369343|561730153|FG000|Open-label Phase|inadvertently reported study completers|3|||
155627095|NCT00369343|561730154|FG001|Open-label Phase|inadvertently reported study completers|2|||
155627096|NCT00369343|561730153|FG000|Open-label Phase|Protocol Violation|1|||
155627097|NCT00369343|561730154|FG001|Open-label Phase|Protocol Violation|3|||
155627098|NCT00369343|561730153|FG000|Open-label Phase|Withdrawal by Subject|15|||
155627099|NCT00369343|561730154|FG001|Open-label Phase|Withdrawal by Subject|6|||
155627100|NCT00369343|561730153|FG000|Open-label Phase|Lack of Efficacy|4|||
155627101|NCT00369343|561730154|FG001|Open-label Phase|Lack of Efficacy|3|||
155627102|NCT00369343|561730153|FG000|Open-label Phase|Lack of continuance tolerability|3|||
155627103|NCT00369343|561730154|FG001|Open-label Phase|Lack of continuance tolerability|4|||
155627104|NCT00369343|561730153|FG000|Open-label Phase|did not take study drug|1|||
155627105|NCT00369343|561730154|FG001|Open-label Phase|did not take study drug|2|||
155627106|NCT02247466|561730155|FG000|Overall Study|Procedure changed to open surgery|0|||
155627107|NCT02247466|561730156|FG001|Overall Study|Procedure changed to open surgery|3|||
155627108|NCT04356937|561730157|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
155627109|NCT04356937|561730158|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
155627110|NCT00617279|561730159|FG000|Overall Study|Study terminated by Sponsor|10|||
155627111|NCT00617279|561730160|FG001|Overall Study|Study terminated by Sponsor|15|||
155627112|NCT00617279|561730159|FG000|Overall Study|Graft abandonment|2|||
155627113|NCT00617279|561730160|FG001|Overall Study|Graft abandonment|0|||
155627114|NCT00617279|561730159|FG000|Overall Study|Lost to Follow-up|1|||
155627115|NCT00617279|561730160|FG001|Overall Study|Lost to Follow-up|0|||
155627116|NCT00617279|561730159|FG000|Overall Study|Death|1|||
155627117|NCT00617279|561730160|FG001|Overall Study|Death|2|||
155627118|NCT02351934|561732337|FG000|Allocation|POD weight<pre-op weight|3|||
155627119|NCT02351934|561732338|FG001|Allocation|POD weight<pre-op weight|0|||
155729257|NCT02113982|562108033|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
155385362|NCT00816400|560847091|FG007|Overall Study|In hospice care at the end of the study|0|||
155385363|NCT00816400|560847092|FG008|Overall Study|In hospice care at the end of the study|0|||
155385364|NCT01072877|560847096|FG000|Overall Study|Lost to Follow-up|1|||
155385365|NCT01072877|560847097|FG001|Overall Study|Lost to Follow-up|1|||
155385366|NCT01072877|560847098|FG002|Overall Study|Lost to Follow-up|0|||
155385367|NCT01072877|560847099|FG003|Overall Study|Lost to Follow-up|2|||
155385368|NCT01072877|560847100|FG004|Overall Study|Lost to Follow-up|0|||
155385369|NCT00601419|560847101|FG000|Overall Study|Lost to Follow-up|3|||
155385370|NCT00601419|560847101|FG000|Overall Study|Missed Visits|1|||
155385371|NCT01786174|560847102|FG000|Overall Study|Discontinued Study Drug|2|||
155385372|NCT01786174|560847103|FG001|Overall Study|Discontinued Study Drug|0|||
155385373|NCT00995020|560847104|FG000|Overall Study|margin analysis not performed|2|||
155385374|NCT00995020|560847105|FG001|Overall Study|margin analysis not performed|5|||
155385375|NCT00995020|560847104|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
155385376|NCT00995020|560847105|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
155385377|NCT00876694|560847111|FG000|Overall Study|Adverse Event|10|||
155385378|NCT00876694|560847112|FG001|Overall Study|Adverse Event|7|||
155385379|NCT00876694|560847111|FG000|Overall Study|Subject withdrew consent|6|||
155385380|NCT00876694|560847112|FG001|Overall Study|Subject withdrew consent|4|||
155385381|NCT00876694|560847111|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155385382|NCT00876694|560847112|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155385383|NCT00876694|560847111|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155385384|NCT00876694|560847112|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155385385|NCT00876694|560847111|FG000|Overall Study|Administrative problems|1|||
155385386|NCT00876694|560847112|FG001|Overall Study|Administrative problems|1|||
155385387|NCT00876694|560847111|FG000|Overall Study|Death|1|||
155385388|NCT00876694|560847112|FG001|Overall Study|Death|0|||
155385389|NCT00288509|560847113|FG000|Treatment Cycle 1|Adverse Event|1|||
155385390|NCT00288509|560847113|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
155385391|NCT00288509|560847113|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
155385392|NCT00288509|560847113|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
155385393|NCT00288509|560847113|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
155385394|NCT00288509|560847113|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
155385395|NCT00288509|560847113|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
155385396|NCT00288509|560847113|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
155385397|NCT00288509|560847113|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
155385398|NCT00288509|560847113|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
155385399|NCT00288509|560847113|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
155385400|NCT00288509|560847113|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
155385401|NCT00288509|560847113|FG000|Treatment Cycle 4|Physician Decision|4|||
155385402|NCT00288509|560847113|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
155385403|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
155385404|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
155385405|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
155385406|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
155385407|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
155385408|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
155385409|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
155385410|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
155385411|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
155385412|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
155385413|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Death|4|||
155385414|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Death|0|||
155385415|NCT02382016|560847114|FG000|OL Extension Period|Physician Decision|3|||
155385416|NCT02382016|560847115|FG001|OL Extension Period|Physician Decision|0|||
155385417|NCT02382016|560847114|FG000|OL Extension Period|Death|2|||
155385418|NCT02382016|560847115|FG001|OL Extension Period|Death|0|||
155385419|NCT02382016|560847114|FG000|OL Extension Period|Withdrawal by Subject|1|||
155385420|NCT02382016|560847115|FG001|OL Extension Period|Withdrawal by Subject|0|||
155385421|NCT00084266|560847116|FG000|Overall Study|Death|42|||
155385422|NCT00084266|560847117|FG001|Overall Study|Death|39|||
155385423|NCT00084266|560847116|FG000|Overall Study|Adverse Event|8|||
155385424|NCT00084266|560847117|FG001|Overall Study|Adverse Event|5|||
155385425|NCT00084266|560847116|FG000|Overall Study|Lack of Efficacy|2|||
155385426|NCT00084266|560847117|FG001|Overall Study|Lack of Efficacy|4|||
155385427|NCT00084266|560847116|FG000|Overall Study|Lost to Follow-up|5|||
155385428|NCT00084266|560847117|FG001|Overall Study|Lost to Follow-up|3|||
155385429|NCT00084266|560847116|FG000|Overall Study|Participant not willing to participate|3|||
155385430|NCT00084266|560847117|FG001|Overall Study|Participant not willing to participate|8|||
155385431|NCT00084266|560847116|FG000|Overall Study|Other|360|||
155385432|NCT00084266|560847117|FG001|Overall Study|Other|344|||
155385433|NCT00084266|560847116|FG000|Overall Study|Randomized not treated|21|||
155385434|NCT00084266|560847117|FG001|Overall Study|Randomized not treated|20|||
155385435|NCT00730171|560847118|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
155385436|NCT00730171|560847118|FG000|Overall Study|Adverse Event|193|||
155385437|NCT00730171|560847118|FG000|Overall Study|Protocol Violation|48|||
155385438|NCT00730171|560847118|FG000|Overall Study|Withdrawal by Subject|202|||
155385439|NCT00730171|560847118|FG000|Overall Study|Lost to Follow-up|121|||
155385440|NCT00730171|560847118|FG000|Overall Study|Insufficient Therapeutic Response|141|||
155385441|NCT00730171|560847118|FG000|Overall Study|Other|61|||
155385442|NCT01215422|560847119|FG000|Overall Study|Relocation|1|||
155385443|NCT01215422|560847120|FG001|Overall Study|Relocation|0|||
155385444|NCT01215422|560847121|FG002|Overall Study|Relocation|0|||
155385445|NCT01215422|560847122|FG003|Overall Study|Relocation|0|||
155385446|NCT01215422|560847119|FG000|Overall Study|Failed intubations|0|||
155385447|NCT01215422|560847120|FG001|Overall Study|Failed intubations|0|||
155385448|NCT01215422|560847121|FG002|Overall Study|Failed intubations|3|||
155385449|NCT01215422|560847122|FG003|Overall Study|Failed intubations|8|||
155385450|NCT01215422|560847119|FG000|Overall Study|Did not complete all intubations|7|||
155385451|NCT01215422|560847120|FG001|Overall Study|Did not complete all intubations|0|||
155385452|NCT01215422|560847121|FG002|Overall Study|Did not complete all intubations|0|||
155385453|NCT01215422|560847122|FG003|Overall Study|Did not complete all intubations|0|||
155385454|NCT01729156|560847123|FG000|Overall Study|Withdrawal by Subject|1|||
155385455|NCT01729156|560847124|FG001|Overall Study|Withdrawal by Subject|0|||
155385456|NCT01729156|560847125|FG002|Overall Study|Withdrawal by Subject|0|||
155385457|NCT01386788|560847130|FG000|Overall Study|Lost to Follow-up|2|||
155385458|NCT00462865|560847133|FG000|Overall Study|Adverse Event|1|||
155385459|NCT02120625|560847134|FG000|Overall Study|Physician Decision|2|||
155385460|NCT00120406|560847135|FG000|Overall Study|Death|9|||
155385461|NCT00120406|560847136|FG001|Overall Study|Death|4|||
155385462|NCT00120406|560847135|FG000|Overall Study|Withdrawal by Subject|5|||
155385463|NCT00120406|560847136|FG001|Overall Study|Withdrawal by Subject|7|||
155385464|NCT00120406|560847135|FG000|Overall Study|Lost to Follow-up|5|||
155385465|NCT00120406|560847136|FG001|Overall Study|Lost to Follow-up|2|||
155385466|NCT00120406|560847135|FG000|Overall Study|received non-study stent|0|||
155385467|NCT00120406|560847136|FG001|Overall Study|received non-study stent|2|||
155385468|NCT00120406|560847135|FG000|Overall Study|patient moved but has not withdrawn|0|||
155385469|NCT00120406|560847136|FG001|Overall Study|patient moved but has not withdrawn|1|||
155385470|NCT06336603|560847137|FG000|Overall Study|Withdrawal by Subject|1|||
155385471|NCT06336603|560847137|FG000|Overall Study|Lost to Follow-up|2|||
155385472|NCT00762970|560847143|FG000|Overall Study|Withdrawal by Subject|7|||
155385473|NCT00762970|560847144|FG001|Overall Study|Withdrawal by Subject|4|||
155385474|NCT00762970|560847145|FG002|Overall Study|Withdrawal by Subject|0|||
155385475|NCT00762970|560847143|FG000|Overall Study|Protocol Violation|3|||
155385476|NCT00762970|560847144|FG001|Overall Study|Protocol Violation|1|||
155385477|NCT00762970|560847145|FG002|Overall Study|Protocol Violation|1|||
155385478|NCT00762970|560847143|FG000|Overall Study|Lost to Follow-up|1|||
155385479|NCT00762970|560847144|FG001|Overall Study|Lost to Follow-up|2|||
155385480|NCT00762970|560847145|FG002|Overall Study|Lost to Follow-up|0|||
155385481|NCT00762970|560847143|FG000|Overall Study|Difficulty of handling lens|1|||
155385482|NCT00762970|560847144|FG001|Overall Study|Difficulty of handling lens|2|||
155385483|NCT00762970|560847145|FG002|Overall Study|Difficulty of handling lens|0|||
155385484|NCT01295034|560847146|FG000|Overall Study|Lost to Follow-up|5|||
155385485|NCT01295034|560847147|FG001|Overall Study|Lost to Follow-up|5|||
155385486|NCT00879762|560847148|FG000|Overall Study|Lost to Follow-up|3|||
155385487|NCT00879762|560847149|FG001|Overall Study|Lost to Follow-up|1|||
155385488|NCT01313637|560847154|FG000|Overall Study|Adverse Event|17|||
155385489|NCT01313637|560847155|FG001|Overall Study|Adverse Event|24|||
155385490|NCT01313637|560847156|FG002|Overall Study|Adverse Event|25|||
155385491|NCT01313637|560847157|FG003|Overall Study|Adverse Event|18|||
155385492|NCT01313637|560847154|FG000|Overall Study|Lack of Efficacy|44|||
155385493|NCT01313637|560847155|FG001|Overall Study|Lack of Efficacy|38|||
155385494|NCT01313637|560847156|FG002|Overall Study|Lack of Efficacy|37|||
155385495|NCT01313637|560847157|FG003|Overall Study|Lack of Efficacy|24|||
155385496|NCT01313637|560847154|FG000|Overall Study|Protocol Violation|4|||
155385497|NCT01313637|560847155|FG001|Overall Study|Protocol Violation|3|||
155385498|NCT01313637|560847156|FG002|Overall Study|Protocol Violation|11|||
155385499|NCT01313637|560847157|FG003|Overall Study|Protocol Violation|5|||
155385500|NCT01313637|560847154|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
155385501|NCT01313637|560847155|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
155385502|NCT01313637|560847156|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
155385503|NCT01313637|560847157|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
155385504|NCT01313637|560847154|FG000|Overall Study|Lost to Follow-up|0|||
155385505|NCT01313637|560847155|FG001|Overall Study|Lost to Follow-up|2|||
155385506|NCT01313637|560847156|FG002|Overall Study|Lost to Follow-up|1|||
155385507|NCT01313637|560847157|FG003|Overall Study|Lost to Follow-up|3|||
155385508|NCT01313637|560847154|FG000|Overall Study|Withdrawal by Subject|11|||
155385509|NCT01313637|560847155|FG001|Overall Study|Withdrawal by Subject|13|||
155385510|NCT01313637|560847156|FG002|Overall Study|Withdrawal by Subject|18|||
155385511|NCT01313637|560847157|FG003|Overall Study|Withdrawal by Subject|15|||
155385512|NCT00795951|560847163|FG000|Overall Study|Lost to Follow-up|1|||
155385513|NCT00795951|560847163|FG000|Overall Study|Withdrawal by Subject|1|||
155279423|NCT03259373|560456246|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
155279424|NCT03259373|560456247|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
155279425|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
155279426|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
155279427|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
155279428|NCT05893797|560456248|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
155279429|NCT04770220|560456249|FG000|Overall Study|Adverse Event|2|||
155279430|NCT04770220|560456250|FG001|Overall Study|Adverse Event|11|||
155279431|NCT04770220|560456249|FG000|Overall Study|Withdrawal by Subject|5|||
155279432|NCT04770220|560456250|FG001|Overall Study|Withdrawal by Subject|11|||
155279433|NCT04770220|560456249|FG000|Overall Study|Lost to Follow-up|4|||
155279434|NCT04770220|560456250|FG001|Overall Study|Lost to Follow-up|3|||
155279435|NCT04770220|560456249|FG000|Overall Study|not otherwise specified|2|||
155279436|NCT04770220|560456250|FG001|Overall Study|not otherwise specified|3|||
155279437|NCT04770220|560456249|FG000|Overall Study|Physician Decision|1|||
155279438|NCT04770220|560456250|FG001|Overall Study|Physician Decision|3|||
155279439|NCT04894903|560456252|FG000|Overall Study|Death|1|||
155279440|NCT04894903|560456253|FG001|Overall Study|Death|0|||
155279441|NCT04894903|560456252|FG000|Overall Study|Pregnancy|1|||
155279442|NCT04894903|560456253|FG001|Overall Study|Pregnancy|0|||
155279443|NCT04894903|560456252|FG000|Overall Study|Withdrawal by Subject|1|||
155279444|NCT04894903|560456253|FG001|Overall Study|Withdrawal by Subject|1|||
155279445|NCT04894903|560456252|FG000|Overall Study|moved or exited health system|1|||
155279446|NCT04894903|560456253|FG001|Overall Study|moved or exited health system|3|||
155279447|NCT01822353|560456254|FG000|Overall Study|Adverse Event|1|||
155279448|NCT01822353|560456255|FG001|Overall Study|Adverse Event|3|||
155279449|NCT01822353|560456256|FG002|Overall Study|Adverse Event|1|||
155279450|NCT01822353|560456254|FG000|Overall Study|Pregnancy|0|||
155279451|NCT01822353|560456255|FG001|Overall Study|Pregnancy|1|||
155279452|NCT01822353|560456256|FG002|Overall Study|Pregnancy|0|||
155279453|NCT01822353|560456254|FG000|Overall Study|Withdrawal by Subject|3|||
155279454|NCT01822353|560456255|FG001|Overall Study|Withdrawal by Subject|1|||
155279455|NCT01822353|560456256|FG002|Overall Study|Withdrawal by Subject|0|||
155279456|NCT04320615|560456257|FG000|Overall Study|Withdrawal by Subject|4|||
155279457|NCT04320615|560456258|FG001|Overall Study|Withdrawal by Subject|10|||
155279458|NCT04320615|560456257|FG000|Overall Study|Physician Decision|2|||
155279459|NCT04320615|560456258|FG001|Overall Study|Physician Decision|0|||
155279460|NCT04320615|560456257|FG000|Overall Study|Other|2|||
155279461|NCT04320615|560456258|FG001|Overall Study|Other|0|||
155279462|NCT04320615|560456257|FG000|Overall Study|Lost to Follow-up|5|||
155279463|NCT04320615|560456258|FG001|Overall Study|Lost to Follow-up|23|||
155279464|NCT04320615|560456257|FG000|Overall Study|Death|35|||
155279465|NCT04320615|560456258|FG001|Overall Study|Death|71|||
155279466|NCT01857323|560456260|FG000|Overall Study|Adverse Event|1|||
155279467|NCT01857323|560456260|FG000|Overall Study|Withdrawal by Subject|3|||
155279468|NCT01857323|560456260|FG000|Overall Study|Non-compliance|1|||
155279469|NCT01857323|560456260|FG000|Overall Study|Protocol Violation|6|||
155279470|NCT01857323|560456260|FG000|Overall Study|Lost to Follow-up|1|||
155279471|NCT01857323|560456260|FG000|Overall Study|Other|4|||
155279472|NCT01857323|560456260|FG000|Overall Study|Did not complete 180 doses|48|||
155279473|NCT03873246|560456261|FG000|Overall Study|Adverse Event|1|||
155279474|NCT03873246|560456262|FG001|Overall Study|Adverse Event|3|||
155279475|NCT03873246|560456263|FG002|Overall Study|Adverse Event|3|||
155279476|NCT03873246|560456261|FG000|Overall Study|Lost to Follow-up|4|||
155279477|NCT03873246|560456262|FG001|Overall Study|Lost to Follow-up|4|||
155279478|NCT03873246|560456263|FG002|Overall Study|Lost to Follow-up|5|||
155279479|NCT03873246|560456261|FG000|Overall Study|Protocol Violation|0|||
155279480|NCT03873246|560456262|FG001|Overall Study|Protocol Violation|1|||
155279481|NCT03873246|560456263|FG002|Overall Study|Protocol Violation|0|||
155279482|NCT03873246|560456261|FG000|Overall Study|Withdrawal by Subject|0|||
155279483|NCT03873246|560456262|FG001|Overall Study|Withdrawal by Subject|4|||
155279484|NCT03873246|560456263|FG002|Overall Study|Withdrawal by Subject|1|||
155279485|NCT02107443|560456264|FG000|Overall Study|Death|42|||
155279486|NCT02107443|560456265|FG001|Overall Study|Death|30|||
155279487|NCT02107443|560456264|FG000|Overall Study|Study Protocol Violation|3|||
155279488|NCT02107443|560456265|FG001|Overall Study|Study Protocol Violation|1|||
155279489|NCT02107443|560456264|FG000|Overall Study|Registered but Not Eligible|0|||
155279490|NCT02107443|560456265|FG001|Overall Study|Registered but Not Eligible|1|||
155279491|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
155279492|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
155279493|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
155279494|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
155279495|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Changed Mind|2|||
155279496|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Changed Mind|0|||
155279497|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
155279498|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
155279499|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
155385514|NCT04572841|560847164|FG000|Overall Study|Adverse Event|1|||
155385515|NCT04572841|560847165|FG001|Overall Study|Adverse Event|1|||
155385516|NCT04572841|560847164|FG000|Overall Study|Withdrawal by Subject|2|||
155385517|NCT04572841|560847165|FG001|Overall Study|Withdrawal by Subject|1|||
155385518|NCT01323647|560847168|FG000|Overall Study|Migrated/moved from study area|2|||
155385519|NCT01323647|560847169|FG001|Overall Study|Migrated/moved from study area|0|||
155385520|NCT01323647|560847168|FG000|Overall Study|Withdrawal by Subject|5|||
155385521|NCT01323647|560847169|FG001|Overall Study|Withdrawal by Subject|0|||
155385522|NCT01323647|560847168|FG000|Overall Study|Lost to Follow-up|2|||
155385523|NCT01323647|560847169|FG001|Overall Study|Lost to Follow-up|0|||
155385524|NCT00712673|560847170|FG000|Overall Study|Adverse Event|3|||
155385525|NCT00712673|560847171|FG001|Overall Study|Adverse Event|3|||
155385526|NCT00712673|560847172|FG002|Overall Study|Adverse Event|21|||
155385527|NCT00712673|560847173|FG003|Overall Study|Adverse Event|26|||
155385528|NCT00712673|560847170|FG000|Overall Study|Lack of Efficacy|2|||
155385529|NCT00712673|560847171|FG001|Overall Study|Lack of Efficacy|8|||
155385530|NCT00712673|560847172|FG002|Overall Study|Lack of Efficacy|8|||
155385531|NCT00712673|560847173|FG003|Overall Study|Lack of Efficacy|6|||
155385532|NCT00712673|560847170|FG000|Overall Study|Poor Compliance to Protocol|3|||
155385533|NCT00712673|560847171|FG001|Overall Study|Poor Compliance to Protocol|3|||
155385534|NCT00712673|560847172|FG002|Overall Study|Poor Compliance to Protocol|4|||
155385535|NCT00712673|560847173|FG003|Overall Study|Poor Compliance to Protocol|16|||
155385536|NCT00712673|560847170|FG000|Overall Study|Lost to Follow-up|1|||
155385537|NCT00712673|560847171|FG001|Overall Study|Lost to Follow-up|0|||
155385538|NCT00712673|560847172|FG002|Overall Study|Lost to Follow-up|2|||
155385539|NCT00712673|560847173|FG003|Overall Study|Lost to Follow-up|0|||
155385540|NCT00712673|560847170|FG000|Overall Study|Withdrawal by Subject|6|||
155385541|NCT00712673|560847171|FG001|Overall Study|Withdrawal by Subject|7|||
155385542|NCT00712673|560847172|FG002|Overall Study|Withdrawal by Subject|15|||
155385543|NCT00712673|560847173|FG003|Overall Study|Withdrawal by Subject|20|||
155385544|NCT00712673|560847170|FG000|Overall Study|Familial and Personal Reasons|5|||
155385545|NCT00712673|560847171|FG001|Overall Study|Familial and Personal Reasons|0|||
155385546|NCT00712673|560847172|FG002|Overall Study|Familial and Personal Reasons|5|||
155385547|NCT00712673|560847173|FG003|Overall Study|Familial and Personal Reasons|2|||
155385548|NCT00712673|560847170|FG000|Overall Study|Investigator's Decision|1|||
155385549|NCT00712673|560847171|FG001|Overall Study|Investigator's Decision|0|||
155385550|NCT00712673|560847172|FG002|Overall Study|Investigator's Decision|0|||
155385551|NCT00712673|560847173|FG003|Overall Study|Investigator's Decision|0|||
155385552|NCT00712673|560847170|FG000|Overall Study|Protocol Violation|0|||
155385553|NCT00712673|560847171|FG001|Overall Study|Protocol Violation|0|||
155385554|NCT00712673|560847172|FG002|Overall Study|Protocol Violation|2|||
155385555|NCT00712673|560847173|FG003|Overall Study|Protocol Violation|0|||
155385556|NCT01774110|560847174|FG000|Overall Study|Lost to Follow-up|7|||
155385557|NCT00640016|560847175|FG000|Overall Study|Withdrawal by Subject|0|||
155385558|NCT00640016|560847176|FG001|Overall Study|Withdrawal by Subject|1|||
155385559|NCT00640016|560847177|FG002|Overall Study|Withdrawal by Subject|0|||
155385560|NCT00640016|560847178|FG003|Overall Study|Withdrawal by Subject|0|||
155385561|NCT00640016|560847175|FG000|Overall Study|Study termination|2|||
155385562|NCT00640016|560847176|FG001|Overall Study|Study termination|1|||
155385563|NCT00640016|560847177|FG002|Overall Study|Study termination|3|||
155385564|NCT00640016|560847178|FG003|Overall Study|Study termination|2|||
155385565|NCT00640016|560847175|FG000|Overall Study|Adverse Event|0|||
155385566|NCT00640016|560847176|FG001|Overall Study|Adverse Event|0|||
155385567|NCT00640016|560847177|FG002|Overall Study|Adverse Event|0|||
155385568|NCT00640016|560847178|FG003|Overall Study|Adverse Event|1|||
155385569|NCT02924064|560847180|FG000|Overall Study|Adverse Event|2|||
155385570|NCT02924064|560847181|FG001|Overall Study|Adverse Event|2|||
155385571|NCT02924064|560847180|FG000|Overall Study|Lost to Follow-up|0|||
155385572|NCT02924064|560847181|FG001|Overall Study|Lost to Follow-up|2|||
155385573|NCT02924064|560847180|FG000|Overall Study|Physician Decision|0|||
155385574|NCT02924064|560847181|FG001|Overall Study|Physician Decision|2|||
155385575|NCT02924064|560847180|FG000|Overall Study|Protocol Violation|1|||
155385576|NCT02924064|560847181|FG001|Overall Study|Protocol Violation|3|||
155385577|NCT02924064|560847180|FG000|Overall Study|Withdrawal by Subject|4|||
155385578|NCT02924064|560847181|FG001|Overall Study|Withdrawal by Subject|5|||
155385579|NCT02924064|560847180|FG000|Overall Study|Other|17|||
155385580|NCT02924064|560847181|FG001|Overall Study|Other|29|||
155385581|NCT02699983|560847182|FG000|Overall Study|Withdrawal by Subject|1|||
155385582|NCT02699983|560847183|FG001|Overall Study|Withdrawal by Subject|0|||
155385583|NCT03575143|560847184|FG000|Overall Study|Lost to Follow-up|0|||
155385584|NCT03575143|560847185|FG001|Overall Study|Lost to Follow-up|0|||
155385585|NCT03575143|560847186|FG002|Overall Study|Lost to Follow-up|4|||
155385586|NCT03575143|560847184|FG000|Overall Study|Withdrawal by Subject|0|||
155385587|NCT03575143|560847185|FG001|Overall Study|Withdrawal by Subject|0|||
155385588|NCT03575143|560847186|FG002|Overall Study|Withdrawal by Subject|5|||
155385589|NCT03575143|560847184|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
155385590|NCT03575143|560847185|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
155385591|NCT03575143|560847186|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
155385592|NCT00261846|560847189|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
155385593|NCT00261846|560847190|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
155385594|NCT00261846|560847191|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
155385595|NCT00261846|560847192|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385596|NCT00261846|560847193|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385597|NCT00261846|560847194|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385598|NCT00261846|560847195|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385599|NCT00261846|560847196|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385600|NCT00261846|560847197|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385601|NCT00261846|560847198|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385602|NCT00261846|560847199|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385603|NCT00261846|560847200|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385604|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385605|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385606|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385607|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
155385608|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385609|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385610|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385611|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385612|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
155385613|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385614|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385615|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385616|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385617|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385618|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385619|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
155385620|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
155385621|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
155385622|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
155385623|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
155385624|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385625|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
155385626|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385627|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385628|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385629|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385630|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385631|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
155385632|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385633|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385634|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385635|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385636|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
155385637|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385638|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385639|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385640|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
155385641|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
155385642|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
155385643|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
155385644|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
155385645|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
155385646|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
155385647|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
155385648|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
155385649|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
155385650|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
155385651|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
155385652|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
155385653|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
155385654|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
155385655|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
155729258|NCT02113982|562108034|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729259|NCT02113982|562108035|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729260|NCT02113982|562108036|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729261|NCT02113982|562108037|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729262|NCT02113982|562108038|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
155385656|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
155385657|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
155385658|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
155385659|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
155385660|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
155385661|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
155385662|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
155385663|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
155385664|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385665|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385666|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385667|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
155385668|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
155385669|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385670|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
155385671|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
155385672|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
155385673|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
155385674|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
155385675|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
155385676|NCT02294227|560847201|FG000|Overall Study|Death|0|||
155385677|NCT02294227|560847202|FG001|Overall Study|Death|0|||
155385678|NCT02294227|560847203|FG002|Overall Study|Death|1|||
155385679|NCT02294227|560847201|FG000|Overall Study|Subject/Guardian Decision|6|||
155385680|NCT02294227|560847202|FG001|Overall Study|Subject/Guardian Decision|3|||
155385681|NCT02294227|560847203|FG002|Overall Study|Subject/Guardian Decision|7|||
155385682|NCT02294227|560847201|FG000|Overall Study|Physician Decision|1|||
155385683|NCT02294227|560847202|FG001|Overall Study|Physician Decision|2|||
155385684|NCT02294227|560847203|FG002|Overall Study|Physician Decision|1|||
155385685|NCT02294227|560847201|FG000|Overall Study|Lost to Follow-up|1|||
155385686|NCT02294227|560847202|FG001|Overall Study|Lost to Follow-up|0|||
155385687|NCT02294227|560847203|FG002|Overall Study|Lost to Follow-up|0|||
155385688|NCT02294227|560847201|FG000|Overall Study|Lack of Efficacy|11|||
155385689|NCT02294227|560847202|FG001|Overall Study|Lack of Efficacy|12|||
155385690|NCT02294227|560847203|FG002|Overall Study|Lack of Efficacy|8|||
155385691|NCT02294227|560847201|FG000|Overall Study|Adverse Event|6|||
155385692|NCT02294227|560847202|FG001|Overall Study|Adverse Event|8|||
155385693|NCT02294227|560847203|FG002|Overall Study|Adverse Event|2|||
155385694|NCT00887432|560847206|FG000|Overall Study|Start Excluded Therapy|3|||
155385695|NCT00887432|560847207|FG001|Overall Study|Start Excluded Therapy|0|||
155385696|NCT00887432|560847206|FG000|Overall Study|Did not complete treatment|6|||
155385697|NCT00887432|560847207|FG001|Overall Study|Did not complete treatment|8|||
155385698|NCT00887432|560847206|FG000|Overall Study|Protocol Violation|2|||
155385699|NCT00887432|560847207|FG001|Overall Study|Protocol Violation|3|||
155385700|NCT00887432|560847206|FG000|Overall Study|Withdrawal by Subject|3|||
155385701|NCT00887432|560847207|FG001|Overall Study|Withdrawal by Subject|2|||
155385702|NCT00887432|560847206|FG000|Overall Study|Lost to Follow-up|1|||
155385703|NCT00887432|560847207|FG001|Overall Study|Lost to Follow-up|0|||
155385704|NCT00887432|560847206|FG000|Overall Study|No reason provided|0|||
155385705|NCT00887432|560847207|FG001|Overall Study|No reason provided|1|||
155385706|NCT00899548|560847208|FG000|Overall Study|Physician Decision|3|||
155385707|NCT04781387|560847212|FG000|Overall Study|Withdrawal by Subject|1|||
155385708|NCT04781387|560847213|FG001|Overall Study|Withdrawal by Subject|0|||
155385709|NCT04781387|560847214|FG002|Overall Study|Withdrawal by Subject|1|||
155385710|NCT04781387|560847212|FG000|Overall Study|Lost to Follow-up|1|||
155385711|NCT04781387|560847213|FG001|Overall Study|Lost to Follow-up|0|||
155385712|NCT04781387|560847214|FG002|Overall Study|Lost to Follow-up|0|||
155385713|NCT00679627|560847215|FG000|Overall Study|Death|41|||
155385714|NCT00679627|560847216|FG001|Overall Study|Death|29|||
155385715|NCT00679627|560847215|FG000|Overall Study|Adverse Event|43|||
155385716|NCT00679627|560847216|FG001|Overall Study|Adverse Event|53|||
155385717|NCT00679627|560847215|FG000|Overall Study|Withdrawal by Subject|168|||
155385718|NCT00679627|560847216|FG001|Overall Study|Withdrawal by Subject|172|||
155385719|NCT00679627|560847215|FG000|Overall Study|Lost to Follow-up|22|||
155385720|NCT00679627|560847216|FG001|Overall Study|Lost to Follow-up|26|||
155385721|NCT00679627|560847215|FG000|Overall Study|Early Study Closure|425|||
155385722|NCT00679627|560847216|FG001|Overall Study|Early Study Closure|405|||
155385723|NCT00448123|560847217|FG000|Overall Study|Lost to Follow-up|9|||
155385724|NCT00448123|560847218|FG001|Overall Study|Lost to Follow-up|6|||
155385725|NCT00448123|560847217|FG000|Overall Study|Physician Decision|6|||
155385726|NCT00448123|560847218|FG001|Overall Study|Physician Decision|6|||
155385727|NCT02318797|560847219|FG000|Overall Study|Death|3|||
155385728|NCT02318797|560847220|FG001|Overall Study|Death|6|||
155385729|NCT02318797|560847219|FG000|Overall Study|Lost to Follow-up|85|||
155385730|NCT02318797|560847220|FG001|Overall Study|Lost to Follow-up|96|||
155385731|NCT01079741|560847226|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385732|NCT01079741|560847227|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
155385733|NCT01079741|560847228|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385734|NCT01079741|560847229|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385735|NCT01079741|560847230|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385736|NCT01079741|560847226|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385737|NCT01079741|560847227|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385738|NCT01079741|560847228|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385739|NCT01079741|560847229|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385740|NCT01079741|560847230|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
155385741|NCT00511472|560847231|FG000|Overall Study|Clinical Adverse Event|1|||
155385742|NCT00511472|560847232|FG001|Overall Study|Clinical Adverse Event|2|||
155385743|NCT00511472|560847231|FG000|Overall Study|Laboratory Adverse Event|0|||
155385744|NCT00511472|560847232|FG001|Overall Study|Laboratory Adverse Event|2|||
155385745|NCT00511472|560847231|FG000|Overall Study|Not reported|2|||
155385746|NCT00511472|560847232|FG001|Overall Study|Not reported|2|||
155385747|NCT00446992|560847233|FG000|Overall Study|Adverse Event|11|||
155385748|NCT00446992|560847233|FG000|Overall Study|Lost to Follow-up|5|||
155385749|NCT00406653|560847234|FG000|Induction Period|Adverse Event|1|||
155385750|NCT00406653|560847235|FG001|Induction Period|Adverse Event|10|||
155385751|NCT00406653|560847236|FG002|Induction Period|Adverse Event|4|||
155385752|NCT00406653|560847237|FG003|Induction Period|Adverse Event|11|||
155385753|NCT00406653|560847238|FG004|Induction Period|Adverse Event|0|||
155385754|NCT00406653|560847239|FG005|Induction Period|Adverse Event|0|||
155385755|NCT00406653|560847240|FG006|Induction Period|Adverse Event|0|||
155385756|NCT00406653|560847234|FG000|Induction Period|Lack of Efficacy|11|||
155385757|NCT00406653|560847235|FG001|Induction Period|Lack of Efficacy|14|||
155385758|NCT00406653|560847236|FG002|Induction Period|Lack of Efficacy|8|||
155385759|NCT00406653|560847237|FG003|Induction Period|Lack of Efficacy|10|||
155385760|NCT00406653|560847238|FG004|Induction Period|Lack of Efficacy|0|||
155385761|NCT00406653|560847239|FG005|Induction Period|Lack of Efficacy|0|||
155385762|NCT00406653|560847240|FG006|Induction Period|Lack of Efficacy|0|||
155385763|NCT00406653|560847234|FG000|Induction Period|Lost to Follow-up|0|||
155385764|NCT00406653|560847235|FG001|Induction Period|Lost to Follow-up|2|||
155385765|NCT00406653|560847236|FG002|Induction Period|Lost to Follow-up|0|||
155385766|NCT00406653|560847237|FG003|Induction Period|Lost to Follow-up|0|||
155385767|NCT00406653|560847238|FG004|Induction Period|Lost to Follow-up|0|||
155385768|NCT00406653|560847239|FG005|Induction Period|Lost to Follow-up|0|||
155385769|NCT00406653|560847240|FG006|Induction Period|Lost to Follow-up|0|||
155385770|NCT00406653|560847234|FG000|Induction Period|Withdrawal of Consent|2|||
155385771|NCT00406653|560847235|FG001|Induction Period|Withdrawal of Consent|5|||
155385772|NCT00406653|560847236|FG002|Induction Period|Withdrawal of Consent|1|||
155385773|NCT00406653|560847237|FG003|Induction Period|Withdrawal of Consent|2|||
155385774|NCT00406653|560847238|FG004|Induction Period|Withdrawal of Consent|0|||
155385775|NCT00406653|560847239|FG005|Induction Period|Withdrawal of Consent|0|||
155385776|NCT00406653|560847240|FG006|Induction Period|Withdrawal of Consent|0|||
155385777|NCT00406653|560847234|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385778|NCT00406653|560847235|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385779|NCT00406653|560847236|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385780|NCT00406653|560847237|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
155385781|NCT00406653|560847238|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385782|NCT00406653|560847239|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385783|NCT00406653|560847240|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385784|NCT00406653|560847234|FG000|Induction Period|Pregnancy|1|||
155385785|NCT00406653|560847235|FG001|Induction Period|Pregnancy|0|||
155385786|NCT00406653|560847236|FG002|Induction Period|Pregnancy|0|||
155385787|NCT00406653|560847237|FG003|Induction Period|Pregnancy|0|||
155385788|NCT00406653|560847238|FG004|Induction Period|Pregnancy|0|||
155385789|NCT00406653|560847239|FG005|Induction Period|Pregnancy|0|||
155385790|NCT00406653|560847240|FG006|Induction Period|Pregnancy|0|||
155385791|NCT00406653|560847234|FG000|Induction Period|Declined participation but followup done|0|||
155385792|NCT00406653|560847235|FG001|Induction Period|Declined participation but followup done|2|||
155385793|NCT00406653|560847236|FG002|Induction Period|Declined participation but followup done|1|||
155385794|NCT00406653|560847237|FG003|Induction Period|Declined participation but followup done|1|||
155385795|NCT00406653|560847238|FG004|Induction Period|Declined participation but followup done|0|||
155385796|NCT00406653|560847239|FG005|Induction Period|Declined participation but followup done|0|||
155385797|NCT00406653|560847240|FG006|Induction Period|Declined participation but followup done|0|||
155385798|NCT00406653|560847234|FG000|Induction Period|Given prohibited drug|0|||
155385799|NCT00406653|560847235|FG001|Induction Period|Given prohibited drug|1|||
155385800|NCT00406653|560847236|FG002|Induction Period|Given prohibited drug|2|||
155385801|NCT00406653|560847237|FG003|Induction Period|Given prohibited drug|0|||
155385802|NCT00406653|560847238|FG004|Induction Period|Given prohibited drug|0|||
155385803|NCT00406653|560847239|FG005|Induction Period|Given prohibited drug|0|||
155385804|NCT00406653|560847240|FG006|Induction Period|Given prohibited drug|0|||
155385805|NCT00406653|560847234|FG000|Induction Period|Incarcerated|0|||
155385806|NCT00406653|560847235|FG001|Induction Period|Incarcerated|0|||
155385807|NCT00406653|560847236|FG002|Induction Period|Incarcerated|1|||
155385808|NCT00406653|560847237|FG003|Induction Period|Incarcerated|0|||
155279500|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
155279501|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
155279502|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
155279503|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
155279504|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
155279505|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Other Medical|9|||
155279506|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Other Medical|5|||
155279507|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Disease Progression|4|||
155279508|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Disease Progression|2|||
155279509|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Personal Issues|0|||
155279510|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Personal Issues|3|||
155279511|NCT00885495|560456266|FG000|Overall Study|Adverse Event|1|||
155279512|NCT00885495|560456267|FG001|Overall Study|Adverse Event|2|||
155279513|NCT00885495|560456266|FG000|Overall Study|Protocol Violation|0|||
155279514|NCT00885495|560456267|FG001|Overall Study|Protocol Violation|1|||
155279515|NCT00885495|560456266|FG000|Overall Study|Withdrawal by Subject|1|||
155279516|NCT00885495|560456267|FG001|Overall Study|Withdrawal by Subject|0|||
155279517|NCT01400893|560456268|FG000|Overall Study|Death|27|||
155279518|NCT01400893|560456269|FG001|Overall Study|Death|21|||
155279519|NCT01400893|560456268|FG000|Overall Study|Lost to Follow-up|0|||
155279520|NCT01400893|560456269|FG001|Overall Study|Lost to Follow-up|6|||
155279521|NCT00519636|560456270|FG000|Treatment Period 1|Adverse Event|1|||
155279522|NCT00519636|560456271|FG001|Treatment Period 1|Adverse Event|0|||
155279523|NCT00519636|560456272|FG002|Treatment Period 1|Adverse Event|1|||
155279524|NCT00519636|560456273|FG003|Treatment Period 1|Adverse Event|0|||
155279525|NCT00519636|560456270|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
155279526|NCT00519636|560456271|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
155279527|NCT00519636|560456272|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
155279528|NCT00519636|560456273|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
155279529|NCT00519636|560456270|FG000|Washout Period|Adverse Event|2|||
155279530|NCT00519636|560456271|FG001|Washout Period|Adverse Event|1|||
155279531|NCT00519636|560456272|FG002|Washout Period|Adverse Event|1|||
155279532|NCT00519636|560456273|FG003|Washout Period|Adverse Event|0|||
155279533|NCT00519636|560456270|FG000|Washout Period|Lost to Follow-up|1|||
155279534|NCT00519636|560456271|FG001|Washout Period|Lost to Follow-up|0|||
155279535|NCT00519636|560456272|FG002|Washout Period|Lost to Follow-up|0|||
155279536|NCT00519636|560456273|FG003|Washout Period|Lost to Follow-up|0|||
155279537|NCT00519636|560456270|FG000|Washout Period|Protocol Violation|0|||
155279538|NCT00519636|560456271|FG001|Washout Period|Protocol Violation|0|||
155279539|NCT00519636|560456272|FG002|Washout Period|Protocol Violation|1|||
155279540|NCT00519636|560456273|FG003|Washout Period|Protocol Violation|2|||
155279541|NCT00519636|560456270|FG000|Washout Period|Withdrawal by Subject|1|||
155279542|NCT00519636|560456271|FG001|Washout Period|Withdrawal by Subject|0|||
155279543|NCT00519636|560456272|FG002|Washout Period|Withdrawal by Subject|1|||
155279544|NCT00519636|560456273|FG003|Washout Period|Withdrawal by Subject|0|||
155279545|NCT00519636|560456270|FG000|Washout Period|Failed to meet continuation criteria|14|||
155279546|NCT00519636|560456271|FG001|Washout Period|Failed to meet continuation criteria|11|||
155279547|NCT00519636|560456272|FG002|Washout Period|Failed to meet continuation criteria|9|||
155279548|NCT00519636|560456273|FG003|Washout Period|Failed to meet continuation criteria|3|||
155279549|NCT00519636|560456270|FG000|Washout Period|Out of pollen area > 48 hours|1|||
155279550|NCT00519636|560456271|FG001|Washout Period|Out of pollen area > 48 hours|0|||
155279551|NCT00519636|560456272|FG002|Washout Period|Out of pollen area > 48 hours|0|||
155279552|NCT00519636|560456273|FG003|Washout Period|Out of pollen area > 48 hours|0|||
155279553|NCT00519636|560456270|FG000|Washout Period|Participating in study at another site|1|||
155279554|NCT00519636|560456271|FG001|Washout Period|Participating in study at another site|0|||
155279555|NCT00519636|560456272|FG002|Washout Period|Participating in study at another site|0|||
155279556|NCT00519636|560456273|FG003|Washout Period|Participating in study at another site|0|||
155279557|NCT00519636|560456270|FG000|Washout Period|Non-compliant|0|||
155279558|NCT00519636|560456271|FG001|Washout Period|Non-compliant|1|||
155279559|NCT00519636|560456272|FG002|Washout Period|Non-compliant|0|||
155279560|NCT00519636|560456273|FG003|Washout Period|Non-compliant|0|||
155279561|NCT00519636|560456270|FG000|Washout Period|Per doctors request|0|||
155279562|NCT00519636|560456271|FG001|Washout Period|Per doctors request|1|||
155279563|NCT00519636|560456272|FG002|Washout Period|Per doctors request|0|||
155279564|NCT00519636|560456273|FG003|Washout Period|Per doctors request|0|||
155279565|NCT00519636|560456270|FG000|Washout Period|Subject randomized in error|0|||
155279566|NCT00519636|560456271|FG001|Washout Period|Subject randomized in error|0|||
155279567|NCT00519636|560456272|FG002|Washout Period|Subject randomized in error|1|||
155279568|NCT00519636|560456273|FG003|Washout Period|Subject randomized in error|0|||
155279569|NCT00519636|560456270|FG000|Washout Period|Prohibited medications|0|||
155279570|NCT00519636|560456271|FG001|Washout Period|Prohibited medications|0|||
155279571|NCT00519636|560456272|FG002|Washout Period|Prohibited medications|1|||
155279572|NCT00519636|560456273|FG003|Washout Period|Prohibited medications|0|||
155279573|NCT00519636|560456270|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155385809|NCT00406653|560847238|FG004|Induction Period|Incarcerated|0|||
155385810|NCT00406653|560847239|FG005|Induction Period|Incarcerated|0|||
155385811|NCT00406653|560847240|FG006|Induction Period|Incarcerated|0|||
155385812|NCT00406653|560847234|FG000|Induction Period|Patient relocated|0|||
155385813|NCT00406653|560847235|FG001|Induction Period|Patient relocated|0|||
155385814|NCT00406653|560847236|FG002|Induction Period|Patient relocated|1|||
155385815|NCT00406653|560847237|FG003|Induction Period|Patient relocated|0|||
155385816|NCT00406653|560847238|FG004|Induction Period|Patient relocated|0|||
155385817|NCT00406653|560847239|FG005|Induction Period|Patient relocated|0|||
155385818|NCT00406653|560847240|FG006|Induction Period|Patient relocated|0|||
155385819|NCT00406653|560847234|FG000|Maintenance Period|Adverse Event|0|||
155385820|NCT00406653|560847235|FG001|Maintenance Period|Adverse Event|0|||
155385821|NCT00406653|560847236|FG002|Maintenance Period|Adverse Event|0|||
155385822|NCT00406653|560847237|FG003|Maintenance Period|Adverse Event|0|||
155385823|NCT00406653|560847238|FG004|Maintenance Period|Adverse Event|1|||
155385824|NCT00406653|560847239|FG005|Maintenance Period|Adverse Event|1|||
155385825|NCT00406653|560847240|FG006|Maintenance Period|Adverse Event|0|||
155385826|NCT00406653|560847234|FG000|Maintenance Period|Lack of Efficacy|0|||
155385827|NCT00406653|560847235|FG001|Maintenance Period|Lack of Efficacy|0|||
155385828|NCT00406653|560847236|FG002|Maintenance Period|Lack of Efficacy|0|||
155385829|NCT00406653|560847237|FG003|Maintenance Period|Lack of Efficacy|0|||
155385830|NCT00406653|560847238|FG004|Maintenance Period|Lack of Efficacy|20|||
155385831|NCT00406653|560847239|FG005|Maintenance Period|Lack of Efficacy|26|||
155385832|NCT00406653|560847240|FG006|Maintenance Period|Lack of Efficacy|0|||
155385833|NCT00406653|560847234|FG000|Maintenance Period|Lost to Follow-up|0|||
155385834|NCT00406653|560847235|FG001|Maintenance Period|Lost to Follow-up|0|||
155385835|NCT00406653|560847236|FG002|Maintenance Period|Lost to Follow-up|0|||
155385836|NCT00406653|560847237|FG003|Maintenance Period|Lost to Follow-up|0|||
155385837|NCT00406653|560847238|FG004|Maintenance Period|Lost to Follow-up|2|||
155385838|NCT00406653|560847239|FG005|Maintenance Period|Lost to Follow-up|1|||
155385839|NCT00406653|560847240|FG006|Maintenance Period|Lost to Follow-up|0|||
155385840|NCT00406653|560847234|FG000|Maintenance Period|Withdrawal of Consent|0|||
155385841|NCT00406653|560847235|FG001|Maintenance Period|Withdrawal of Consent|0|||
155385842|NCT00406653|560847236|FG002|Maintenance Period|Withdrawal of Consent|0|||
155385843|NCT00406653|560847237|FG003|Maintenance Period|Withdrawal of Consent|0|||
155385844|NCT00406653|560847238|FG004|Maintenance Period|Withdrawal of Consent|2|||
155385845|NCT00406653|560847239|FG005|Maintenance Period|Withdrawal of Consent|0|||
155385846|NCT00406653|560847240|FG006|Maintenance Period|Withdrawal of Consent|0|||
155385847|NCT00406653|560847234|FG000|Maintenance Period|Pregnancy|0|||
155385848|NCT00406653|560847235|FG001|Maintenance Period|Pregnancy|0|||
155385849|NCT00406653|560847236|FG002|Maintenance Period|Pregnancy|0|||
155385850|NCT00406653|560847237|FG003|Maintenance Period|Pregnancy|0|||
155385851|NCT00406653|560847238|FG004|Maintenance Period|Pregnancy|0|||
155385852|NCT00406653|560847239|FG005|Maintenance Period|Pregnancy|1|||
155385853|NCT00406653|560847240|FG006|Maintenance Period|Pregnancy|0|||
155385854|NCT00406653|560847234|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
155385855|NCT00406653|560847235|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
155385856|NCT00406653|560847236|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
155385857|NCT00406653|560847237|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
155385858|NCT00406653|560847238|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
155385859|NCT00406653|560847239|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
155385860|NCT00406653|560847240|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
155385861|NCT00406653|560847234|FG000|Maintenance Period|Error in disease score evaluation|0|||
155385862|NCT00406653|560847235|FG001|Maintenance Period|Error in disease score evaluation|0|||
155385863|NCT00406653|560847236|FG002|Maintenance Period|Error in disease score evaluation|0|||
155385864|NCT00406653|560847237|FG003|Maintenance Period|Error in disease score evaluation|0|||
155385865|NCT00406653|560847238|FG004|Maintenance Period|Error in disease score evaluation|1|||
155385866|NCT00406653|560847239|FG005|Maintenance Period|Error in disease score evaluation|0|||
155385867|NCT00406653|560847240|FG006|Maintenance Period|Error in disease score evaluation|0|||
155385868|NCT00406653|560847234|FG000|Open-Label Period|Death|0|||
155385869|NCT00406653|560847235|FG001|Open-Label Period|Death|0|||
155385870|NCT00406653|560847236|FG002|Open-Label Period|Death|0|||
155385871|NCT00406653|560847237|FG003|Open-Label Period|Death|0|||
155385872|NCT00406653|560847238|FG004|Open-Label Period|Death|0|||
155385873|NCT00406653|560847239|FG005|Open-Label Period|Death|0|||
155385874|NCT00406653|560847240|FG006|Open-Label Period|Death|1|||
155385875|NCT00406653|560847234|FG000|Open-Label Period|Adverse Event|0|||
155385876|NCT00406653|560847235|FG001|Open-Label Period|Adverse Event|0|||
155385877|NCT00406653|560847236|FG002|Open-Label Period|Adverse Event|0|||
155385878|NCT00406653|560847237|FG003|Open-Label Period|Adverse Event|0|||
155385879|NCT00406653|560847238|FG004|Open-Label Period|Adverse Event|0|||
155385880|NCT00406653|560847239|FG005|Open-Label Period|Adverse Event|0|||
155385881|NCT00406653|560847240|FG006|Open-Label Period|Adverse Event|18|||
155385882|NCT00406653|560847234|FG000|Open-Label Period|Lack of Efficacy|0|||
155385883|NCT00406653|560847235|FG001|Open-Label Period|Lack of Efficacy|0|||
155385884|NCT00406653|560847236|FG002|Open-Label Period|Lack of Efficacy|0|||
155385885|NCT00406653|560847237|FG003|Open-Label Period|Lack of Efficacy|0|||
155385886|NCT00406653|560847238|FG004|Open-Label Period|Lack of Efficacy|0|||
155385887|NCT00406653|560847239|FG005|Open-Label Period|Lack of Efficacy|0|||
155385888|NCT00406653|560847240|FG006|Open-Label Period|Lack of Efficacy|160|||
155385889|NCT00406653|560847234|FG000|Open-Label Period|Lost to Follow-up|0|||
155385890|NCT00406653|560847235|FG001|Open-Label Period|Lost to Follow-up|0|||
155385891|NCT00406653|560847236|FG002|Open-Label Period|Lost to Follow-up|0|||
155385892|NCT00406653|560847237|FG003|Open-Label Period|Lost to Follow-up|0|||
155385893|NCT00406653|560847238|FG004|Open-Label Period|Lost to Follow-up|0|||
155385894|NCT00406653|560847239|FG005|Open-Label Period|Lost to Follow-up|0|||
155385895|NCT00406653|560847240|FG006|Open-Label Period|Lost to Follow-up|6|||
155385896|NCT00406653|560847234|FG000|Open-Label Period|Withdrawal of Consent|0|||
155385897|NCT00406653|560847235|FG001|Open-Label Period|Withdrawal of Consent|0|||
155385898|NCT00406653|560847236|FG002|Open-Label Period|Withdrawal of Consent|0|||
155385899|NCT00406653|560847237|FG003|Open-Label Period|Withdrawal of Consent|0|||
155385900|NCT00406653|560847238|FG004|Open-Label Period|Withdrawal of Consent|0|||
155385901|NCT00406653|560847239|FG005|Open-Label Period|Withdrawal of Consent|0|||
155385902|NCT00406653|560847240|FG006|Open-Label Period|Withdrawal of Consent|11|||
155385903|NCT00406653|560847234|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385904|NCT00406653|560847235|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385905|NCT00406653|560847236|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385906|NCT00406653|560847237|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385907|NCT00406653|560847238|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385908|NCT00406653|560847239|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385909|NCT00406653|560847240|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
155385910|NCT00406653|560847234|FG000|Open-Label Period|Pregnancy|0|||
155385911|NCT00406653|560847235|FG001|Open-Label Period|Pregnancy|0|||
155385912|NCT00406653|560847236|FG002|Open-Label Period|Pregnancy|0|||
155385913|NCT00406653|560847237|FG003|Open-Label Period|Pregnancy|0|||
155385914|NCT00406653|560847238|FG004|Open-Label Period|Pregnancy|0|||
155385915|NCT00406653|560847239|FG005|Open-Label Period|Pregnancy|0|||
155385916|NCT00406653|560847240|FG006|Open-Label Period|Pregnancy|2|||
155385917|NCT00406653|560847234|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
155385918|NCT00406653|560847235|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
155385919|NCT00406653|560847236|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
155385920|NCT00406653|560847237|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
155385921|NCT00406653|560847238|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
155385922|NCT00406653|560847239|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
155385923|NCT00406653|560847240|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
155385924|NCT00406653|560847234|FG000|Open-Label Period|Declined participation but followup done|0|||
155385925|NCT00406653|560847235|FG001|Open-Label Period|Declined participation but followup done|0|||
155385926|NCT00406653|560847236|FG002|Open-Label Period|Declined participation but followup done|0|||
155385927|NCT00406653|560847237|FG003|Open-Label Period|Declined participation but followup done|0|||
155385928|NCT00406653|560847238|FG004|Open-Label Period|Declined participation but followup done|0|||
155385929|NCT00406653|560847239|FG005|Open-Label Period|Declined participation but followup done|0|||
155385930|NCT00406653|560847240|FG006|Open-Label Period|Declined participation but followup done|8|||
155385931|NCT00406653|560847234|FG000|Open-Label Period|Discontinued by Sponsor|0|||
155385932|NCT00406653|560847235|FG001|Open-Label Period|Discontinued by Sponsor|0|||
155385933|NCT00406653|560847236|FG002|Open-Label Period|Discontinued by Sponsor|0|||
155385934|NCT00406653|560847237|FG003|Open-Label Period|Discontinued by Sponsor|0|||
155385935|NCT00406653|560847238|FG004|Open-Label Period|Discontinued by Sponsor|0|||
155385936|NCT00406653|560847239|FG005|Open-Label Period|Discontinued by Sponsor|0|||
155385937|NCT00406653|560847240|FG006|Open-Label Period|Discontinued by Sponsor|1|||
155385938|NCT00406653|560847234|FG000|Open-Label Period|Refused followup|0|||
155385939|NCT00406653|560847235|FG001|Open-Label Period|Refused followup|0|||
155385940|NCT00406653|560847236|FG002|Open-Label Period|Refused followup|0|||
155385941|NCT00406653|560847237|FG003|Open-Label Period|Refused followup|0|||
155385942|NCT00406653|560847238|FG004|Open-Label Period|Refused followup|0|||
155385943|NCT00406653|560847239|FG005|Open-Label Period|Refused followup|0|||
155385944|NCT00406653|560847240|FG006|Open-Label Period|Refused followup|1|||
155385945|NCT00940108|560847241|FG000|Overall Study|Adverse Event|2|||
155385946|NCT00940108|560847242|FG001|Overall Study|Adverse Event|4|||
155385947|NCT00940108|560847243|FG002|Overall Study|Adverse Event|0|||
155385948|NCT00940108|560847244|FG003|Overall Study|Adverse Event|2|||
155385949|NCT00940108|560847241|FG000|Overall Study|Withdrew Consent|2|||
155385950|NCT00940108|560847242|FG001|Overall Study|Withdrew Consent|1|||
155385951|NCT00940108|560847243|FG002|Overall Study|Withdrew Consent|0|||
155385952|NCT00940108|560847244|FG003|Overall Study|Withdrew Consent|1|||
155385953|NCT00940108|560847241|FG000|Overall Study|Dose 2 contraindicated|1|||
155385954|NCT00940108|560847242|FG001|Overall Study|Dose 2 contraindicated|1|||
155385955|NCT00940108|560847243|FG002|Overall Study|Dose 2 contraindicated|0|||
155385956|NCT00940108|560847244|FG003|Overall Study|Dose 2 contraindicated|1|||
155385957|NCT00940108|560847241|FG000|Overall Study|Declined further vaccination|0|||
155385958|NCT00940108|560847242|FG001|Overall Study|Declined further vaccination|1|||
155385959|NCT00940108|560847243|FG002|Overall Study|Declined further vaccination|3|||
155385960|NCT00940108|560847244|FG003|Overall Study|Declined further vaccination|0|||
155385961|NCT00940108|560847241|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
155385962|NCT00940108|560847242|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
155385963|NCT00940108|560847243|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
155385964|NCT00940108|560847244|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
155385965|NCT00940108|560847241|FG000|Overall Study|Viral illness after Dose 1|0|||
155385966|NCT00940108|560847242|FG001|Overall Study|Viral illness after Dose 1|1|||
155385967|NCT00940108|560847243|FG002|Overall Study|Viral illness after Dose 1|0|||
155385968|NCT00940108|560847244|FG003|Overall Study|Viral illness after Dose 1|0|||
155385969|NCT00940108|560847241|FG000|Overall Study|Diagnosed with H1N1|0|||
155385970|NCT00940108|560847242|FG001|Overall Study|Diagnosed with H1N1|0|||
155385971|NCT00940108|560847243|FG002|Overall Study|Diagnosed with H1N1|0|||
155385972|NCT00940108|560847244|FG003|Overall Study|Diagnosed with H1N1|1|||
155385973|NCT01668667|560847245|FG000|Overall Study|Adverse Event|3|||
155385974|NCT01668667|560847246|FG001|Overall Study|Adverse Event|6|||
155385975|NCT01668667|560847247|FG002|Overall Study|Adverse Event|4|||
155385976|NCT01668667|560847248|FG003|Overall Study|Adverse Event|4|||
155385977|NCT01668667|560847245|FG000|Overall Study|Lack of Efficacy|3|||
155385978|NCT01668667|560847246|FG001|Overall Study|Lack of Efficacy|2|||
155385979|NCT01668667|560847247|FG002|Overall Study|Lack of Efficacy|2|||
155385980|NCT01668667|560847248|FG003|Overall Study|Lack of Efficacy|3|||
155385981|NCT01668667|560847245|FG000|Overall Study|Protocol Violation|6|||
155385982|NCT01668667|560847246|FG001|Overall Study|Protocol Violation|10|||
155385983|NCT01668667|560847247|FG002|Overall Study|Protocol Violation|12|||
155385984|NCT01668667|560847248|FG003|Overall Study|Protocol Violation|5|||
155385985|NCT01668667|560847245|FG000|Overall Study|Lost to Follow-up|9|||
155385986|NCT01668667|560847246|FG001|Overall Study|Lost to Follow-up|4|||
155385987|NCT01668667|560847247|FG002|Overall Study|Lost to Follow-up|7|||
155385988|NCT01668667|560847248|FG003|Overall Study|Lost to Follow-up|6|||
155385989|NCT01668667|560847245|FG000|Overall Study|Physician Decision|3|||
155385990|NCT01668667|560847246|FG001|Overall Study|Physician Decision|0|||
155385991|NCT01668667|560847247|FG002|Overall Study|Physician Decision|1|||
155385992|NCT01668667|560847248|FG003|Overall Study|Physician Decision|0|||
155385993|NCT01668667|560847245|FG000|Overall Study|Withdrawal by Subject|7|||
155385994|NCT01668667|560847246|FG001|Overall Study|Withdrawal by Subject|4|||
155385995|NCT01668667|560847247|FG002|Overall Study|Withdrawal by Subject|5|||
155385996|NCT01668667|560847248|FG003|Overall Study|Withdrawal by Subject|5|||
155385997|NCT04576455|560847249|FG000|Overall Study|Ongoing in the Study|48|||
155385998|NCT04576455|560847250|FG001|Overall Study|Ongoing in the Study|58|||
155385999|NCT04576455|560847249|FG000|Overall Study|Death|83|||
155386000|NCT04576455|560847250|FG001|Overall Study|Death|77|||
155386001|NCT04576455|560847249|FG000|Overall Study|Lost to Follow-up|4|||
155386002|NCT04576455|560847250|FG001|Overall Study|Lost to Follow-up|5|||
155386003|NCT04576455|560847249|FG000|Overall Study|Withdrawal by Subject|16|||
155386004|NCT04576455|560847250|FG001|Overall Study|Withdrawal by Subject|12|||
155386005|NCT01256658|560849010|FG000|Period 1|Lost to Follow-up|837|||
155386006|NCT01256658|560849011|FG001|Period 1|Lost to Follow-up|661|||
155386007|NCT01256658|560849010|FG000|Period 1|Withdrawal by Subject|35|||
155386008|NCT01256658|560849011|FG001|Period 1|Withdrawal by Subject|43|||
155386009|NCT01256658|560849010|FG000|Period 1|Death|48|||
155386010|NCT01256658|560849011|FG001|Period 1|Death|44|||
155386011|NCT00719563|560849016|FG000|Overall Study|Adverse Event|16|||
155386012|NCT00719563|560849017|FG001|Overall Study|Adverse Event|13|||
155386013|NCT00719563|560849016|FG000|Overall Study|Medical condition changed|3|||
155386014|NCT00719563|560849017|FG001|Overall Study|Medical condition changed|5|||
155386015|NCT00719563|560849016|FG000|Overall Study|Lack of Efficacy|3|||
155386016|NCT00719563|560849017|FG001|Overall Study|Lack of Efficacy|7|||
155386017|NCT00719563|560849016|FG000|Overall Study|Personal reasons|6|||
155386018|NCT00719563|560849017|FG001|Overall Study|Personal reasons|7|||
155729263|NCT02113982|562108039|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
155386019|NCT00719563|560849016|FG000|Overall Study|Unknown reasons|4|||
155386020|NCT00719563|560849017|FG001|Overall Study|Unknown reasons|6|||
155386021|NCT00719563|560849016|FG000|Overall Study|Noncompliant|1|||
155386022|NCT00719563|560849017|FG001|Overall Study|Noncompliant|1|||
155386023|NCT00719563|560849016|FG000|Overall Study|Lost to Follow-up|5|||
155386024|NCT00719563|560849017|FG001|Overall Study|Lost to Follow-up|3|||
155386025|NCT02986334|560849019|FG000|Overall Study|Withdrawal by Subject|0|||
155386026|NCT02986334|560849020|FG001|Overall Study|Withdrawal by Subject|1|||
155386027|NCT02986334|560849021|FG002|Overall Study|Withdrawal by Subject|2|||
155386028|NCT02986334|560849019|FG000|Overall Study|Lost to Follow-up|1|||
155386029|NCT02986334|560849020|FG001|Overall Study|Lost to Follow-up|2|||
155386030|NCT02986334|560849021|FG002|Overall Study|Lost to Follow-up|1|||
155386031|NCT02986334|560849019|FG000|Overall Study|Adverse Event|0|||
155386032|NCT02986334|560849020|FG001|Overall Study|Adverse Event|2|||
155386033|NCT02986334|560849021|FG002|Overall Study|Adverse Event|1|||
155386034|NCT02986334|560849019|FG000|Overall Study|non compliance in phone ratings|2|||
155386035|NCT02986334|560849020|FG001|Overall Study|non compliance in phone ratings|1|||
155386036|NCT02986334|560849021|FG002|Overall Study|non compliance in phone ratings|2|||
155386037|NCT02986334|560849019|FG000|Overall Study|undisclosed comorbidities|0|||
155386038|NCT02986334|560849020|FG001|Overall Study|undisclosed comorbidities|1|||
155386039|NCT02986334|560849021|FG002|Overall Study|undisclosed comorbidities|1|||
155386040|NCT04142450|560849022|FG000|Overall Study|Screen Failure|1|||
155386041|NCT04142450|560849022|FG000|Overall Study|Lost to Follow-up|1|||
155386042|NCT01480674|560849023|FG000|Overall Study|Death|23|||
155386043|NCT01480674|560849023|FG000|Overall Study|Lost to Follow-up|2|||
155386044|NCT01480674|560849023|FG000|Overall Study|visit not done|10|||
155386045|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
155386046|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
155386047|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
155386048|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
155386049|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
155386050|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
155386051|NCT03249714|560849024|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
155386052|NCT03249714|560849025|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
155386053|NCT01138007|560849029|FG000|Overall Study|Adverse Event|4|||
155386054|NCT01138007|560849030|FG001|Overall Study|Adverse Event|12|||
155386055|NCT01138007|560849031|FG002|Overall Study|Adverse Event|9|||
155386056|NCT01138007|560849029|FG000|Overall Study|Lack of Efficacy|2|||
155386057|NCT01138007|560849030|FG001|Overall Study|Lack of Efficacy|0|||
155386058|NCT01138007|560849031|FG002|Overall Study|Lack of Efficacy|6|||
155386059|NCT01138007|560849029|FG000|Overall Study|Protocol Violation|2|||
155386060|NCT01138007|560849030|FG001|Overall Study|Protocol Violation|3|||
155386061|NCT01138007|560849031|FG002|Overall Study|Protocol Violation|2|||
155386062|NCT01138007|560849029|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
155386063|NCT01138007|560849030|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
155386064|NCT01138007|560849031|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
155386065|NCT01138007|560849029|FG000|Overall Study|Lost to Follow-up|3|||
155386066|NCT01138007|560849030|FG001|Overall Study|Lost to Follow-up|3|||
155386067|NCT01138007|560849031|FG002|Overall Study|Lost to Follow-up|5|||
155386068|NCT01138007|560849029|FG000|Overall Study|Physician Decision|0|||
155386069|NCT01138007|560849030|FG001|Overall Study|Physician Decision|5|||
155386070|NCT01138007|560849031|FG002|Overall Study|Physician Decision|3|||
155386071|NCT01138007|560849029|FG000|Overall Study|Withdrawal by Subject|5|||
155386072|NCT01138007|560849030|FG001|Overall Study|Withdrawal by Subject|6|||
155386073|NCT01138007|560849031|FG002|Overall Study|Withdrawal by Subject|15|||
155386074|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
155386075|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
155386076|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
155386077|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
155386078|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
155386079|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
155386080|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
155386081|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
155386082|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
155386083|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
155386084|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
155386085|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
155386086|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
155386087|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
155386088|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
155386089|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
155386090|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
155386091|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
155386092|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
155386093|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
155386094|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
155386095|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
155386096|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
155386097|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
155386098|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
155386099|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
155386100|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
155386101|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
155386102|NCT04661878|560849034|FG000|Overall Study|Lost to Follow-up|6|||
155386103|NCT04661878|560849035|FG001|Overall Study|Lost to Follow-up|5|||
155386104|NCT05580588|560849036|FG000|Overall Study|Lack of Efficacy|12|||
155386105|NCT03603028|560849039|FG000|Overall Study|Withdrawal by Subject|1|||
155386106|NCT02768870|560849042|FG000|Overall Study|Death|1|||
155386107|NCT02768870|560849042|FG000|Overall Study|Reoperation|6|||
155386108|NCT02768870|560849042|FG000|Overall Study|Lost to Follow-up|1|||
155386109|NCT02768870|560849042|FG000|Overall Study|Exit|4|||
155386110|NCT02963610|560849043|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
155279574|NCT00519636|560456271|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155279575|NCT00519636|560456272|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155279576|NCT00519636|560456273|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
155279577|NCT00519636|560456270|FG000|Treatment Period 2|Subject randomized in error|0|||
155279578|NCT00519636|560456271|FG001|Treatment Period 2|Subject randomized in error|1|||
155279579|NCT00519636|560456272|FG002|Treatment Period 2|Subject randomized in error|0|||
155279580|NCT00519636|560456273|FG003|Treatment Period 2|Subject randomized in error|0|||
155279581|NCT00519636|560456270|FG000|Treatment Period 2|Per doctors request|0|||
155386111|NCT00063154|560849044|FG000|Overall Study|Disease progression|27|||
155386112|NCT00063154|560849044|FG000|Overall Study|Adverse Event|2|||
155386113|NCT00063154|560849044|FG000|Overall Study|Physician Decision|10|||
155386114|NCT00063154|560849044|FG000|Overall Study|Death|3|||
155386115|NCT00063154|560849044|FG000|Overall Study|Reason unspecified|1|||
155386116|NCT00063154|560849044|FG000|Overall Study|Did not receive treatment|8|||
155386117|NCT01287065|560849045|FG000|Treatment Period 1|Adverse Event|0|||
155386118|NCT01287065|560849046|FG001|Treatment Period 1|Adverse Event|0|||
155386119|NCT01287065|560849047|FG002|Treatment Period 1|Adverse Event|0|||
155386120|NCT01287065|560849048|FG003|Treatment Period 1|Adverse Event|0|||
155386121|NCT01287065|560849049|FG004|Treatment Period 1|Adverse Event|1|||
155386122|NCT01287065|560849050|FG005|Treatment Period 1|Adverse Event|0|||
155386123|NCT01287065|560849045|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155386124|NCT01287065|560849046|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155386125|NCT01287065|560849047|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155386126|NCT01287065|560849048|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155386127|NCT01287065|560849049|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155386128|NCT01287065|560849050|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155386129|NCT02875977|560849051|FG000|Overall Study|Lost to Follow-up|42|||
155386130|NCT02875977|560849052|FG001|Overall Study|Lost to Follow-up|29|||
155386131|NCT01259726|560849053|FG000|Overall Study|Death|1|||
155386132|NCT01259726|560849054|FG001|Overall Study|Death|0|||
155386133|NCT01259726|560849055|FG002|Overall Study|Death|0|||
155386134|NCT01259726|560849056|FG003|Overall Study|Death|0|||
155386135|NCT01259726|560849053|FG000|Overall Study|Physician Decision|2|||
155386136|NCT01259726|560849054|FG001|Overall Study|Physician Decision|0|||
155386137|NCT01259726|560849055|FG002|Overall Study|Physician Decision|1|||
155386138|NCT01259726|560849056|FG003|Overall Study|Physician Decision|1|||
155386139|NCT01259726|560849053|FG000|Overall Study|Withdrawal by Subject|1|||
155386140|NCT01259726|560849054|FG001|Overall Study|Withdrawal by Subject|3|||
155386141|NCT01259726|560849055|FG002|Overall Study|Withdrawal by Subject|2|||
155386142|NCT01259726|560849056|FG003|Overall Study|Withdrawal by Subject|1|||
155386143|NCT01259726|560849053|FG000|Overall Study|Lost to Follow-up|1|||
155386144|NCT01259726|560849054|FG001|Overall Study|Lost to Follow-up|1|||
155386145|NCT01259726|560849055|FG002|Overall Study|Lost to Follow-up|1|||
155386146|NCT01259726|560849056|FG003|Overall Study|Lost to Follow-up|3|||
155386147|NCT01211197|560849058|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155279582|NCT00519636|560456271|FG001|Treatment Period 2|Per doctors request|0|||
155279583|NCT00519636|560456272|FG002|Treatment Period 2|Per doctors request|1|||
155279584|NCT00519636|560456273|FG003|Treatment Period 2|Per doctors request|0|||
155279585|NCT00519636|560456270|FG000|Treatment Period 2|Subject misrandomized|0|||
155279586|NCT00519636|560456271|FG001|Treatment Period 2|Subject misrandomized|0|||
155279587|NCT00519636|560456272|FG002|Treatment Period 2|Subject misrandomized|0|||
155279588|NCT00519636|560456273|FG003|Treatment Period 2|Subject misrandomized|1|||
155279589|NCT00519636|560456270|FG000|Post Study Period|Subject randomized in error|0|||
155386148|NCT01211197|560849059|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386149|NCT01211197|560849060|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155627120|NCT02351934|561732337|FG000|Allocation|Hypotension preventing administration|2|||
155627121|NCT02351934|561732338|FG001|Allocation|Hypotension preventing administration|0|||
155627122|NCT02351934|561732337|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
155627123|NCT02351934|561732338|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
155627124|NCT02351934|561732337|FG000|Follow-Up|POD weight<pre-op weight|3|||
155279590|NCT00519636|560456271|FG001|Post Study Period|Subject randomized in error|0|||
155279591|NCT00519636|560456272|FG002|Post Study Period|Subject randomized in error|0|||
155386150|NCT01211197|560849061|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386151|NCT01211197|560849062|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386152|NCT01211197|560849063|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386153|NCT01211197|560849058|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
155386154|NCT01211197|560849059|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
155386155|NCT01211197|560849060|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
155386156|NCT01211197|560849061|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
155386157|NCT01211197|560849062|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
155386158|NCT01211197|560849063|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
155627125|NCT02351934|561732338|FG001|Follow-Up|POD weight<pre-op weight|0|||
155386159|NCT01776424|560849066|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
155386160|NCT01776424|560849067|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
155386161|NCT01776424|560849068|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
155386162|NCT01776424|560849066|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
155386163|NCT01776424|560849067|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
155386164|NCT01776424|560849068|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
155386165|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
155386166|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
155386167|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
155386168|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Refused|5|||
155386169|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Refused|2|||
155386170|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Refused|11|||
155386171|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
155279592|NCT00519636|560456273|FG003|Post Study Period|Subject randomized in error|1|||
155279593|NCT04504916|560456274|FG000|Overall Study|Study terminated|7|||
155279594|NCT04504916|560456275|FG001|Overall Study|Study terminated|8|||
155279595|NCT04504916|560456274|FG000|Overall Study|Death|54|||
155279596|NCT04504916|560456275|FG001|Overall Study|Death|18|||
155279597|NCT04504916|560456274|FG000|Overall Study|Lost to Follow-up|1|||
155279598|NCT04504916|560456275|FG001|Overall Study|Lost to Follow-up|1|||
155279599|NCT04504916|560456274|FG000|Overall Study|Withdrawal by Subject|8|||
155279600|NCT04504916|560456275|FG001|Overall Study|Withdrawal by Subject|4|||
155279601|NCT04504916|560456274|FG000|Overall Study|Did not agree to follow-up|0|||
155279602|NCT04504916|560456275|FG001|Overall Study|Did not agree to follow-up|1|||
155279603|NCT03057834|560456278|FG000|Overall Study|Withdrawal by Subject|25|||
155279604|NCT03057834|560456279|FG001|Overall Study|Withdrawal by Subject|29|||
155279605|NCT00003509|560456280|FG000|Overall Study|Not evaluable|5|||
155279606|NCT05593211|560456289|FG000|Overall Study|Withdrawal by Subject|1|||
155279607|NCT03077620|560456293|FG000|Overall Study|Unable to place lumbar catheter|1|||
155279608|NCT03077620|560456294|FG001|Overall Study|Unable to place lumbar catheter|0|||
155279609|NCT03077620|560456295|FG002|Overall Study|Unable to place lumbar catheter|1|||
155279610|NCT03077620|560456296|FG003|Overall Study|Unable to place lumbar catheter|0|||
155279611|NCT03077620|560456293|FG000|Overall Study|Withdrawal by Subject|0|||
155279612|NCT03077620|560456294|FG001|Overall Study|Withdrawal by Subject|1|||
155279613|NCT03077620|560456295|FG002|Overall Study|Withdrawal by Subject|0|||
155279614|NCT03077620|560456296|FG003|Overall Study|Withdrawal by Subject|0|||
155279615|NCT03077620|560456293|FG000|Overall Study|Physician Decision|0|||
155279616|NCT03077620|560456294|FG001|Overall Study|Physician Decision|0|||
155279617|NCT03077620|560456295|FG002|Overall Study|Physician Decision|1|||
155279618|NCT03077620|560456296|FG003|Overall Study|Physician Decision|0|||
155279619|NCT03225846|560456297|FG000|Overall Study|Adverse Event|0|||
155279620|NCT03225846|560456298|FG001|Overall Study|Adverse Event|0|||
155279621|NCT03225846|560456299|FG002|Overall Study|Adverse Event|0|||
155279622|NCT03225846|560456300|FG003|Overall Study|Adverse Event|0|||
155279623|NCT03225846|560456301|FG004|Overall Study|Adverse Event|0|||
155279624|NCT03225846|560456302|FG005|Overall Study|Adverse Event|0|||
155279625|NCT03225846|560456303|FG006|Overall Study|Adverse Event|6|||
155279626|NCT03225846|560456297|FG000|Overall Study|Withdrawal by Subject|0|||
155279627|NCT03225846|560456298|FG001|Overall Study|Withdrawal by Subject|1|||
155279628|NCT03225846|560456299|FG002|Overall Study|Withdrawal by Subject|0|||
155279629|NCT03225846|560456300|FG003|Overall Study|Withdrawal by Subject|0|||
155279630|NCT03225846|560456301|FG004|Overall Study|Withdrawal by Subject|0|||
155279631|NCT03225846|560456302|FG005|Overall Study|Withdrawal by Subject|0|||
155279632|NCT03225846|560456303|FG006|Overall Study|Withdrawal by Subject|0|||
155279633|NCT03225846|560456297|FG000|Overall Study|Death|0|||
155279634|NCT03225846|560456298|FG001|Overall Study|Death|1|||
155279635|NCT03225846|560456299|FG002|Overall Study|Death|0|||
155279636|NCT03225846|560456300|FG003|Overall Study|Death|0|||
155279637|NCT03225846|560456301|FG004|Overall Study|Death|0|||
155279638|NCT03225846|560456302|FG005|Overall Study|Death|0|||
155279639|NCT03225846|560456303|FG006|Overall Study|Death|0|||
155279640|NCT03225846|560456297|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279641|NCT03225846|560456298|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279642|NCT03225846|560456299|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
155279643|NCT03225846|560456300|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279644|NCT03225846|560456301|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279645|NCT03225846|560456302|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279646|NCT03225846|560456303|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279647|NCT03225846|560456297|FG000|Overall Study|Patient decision|0|||
155279648|NCT03225846|560456298|FG001|Overall Study|Patient decision|0|||
155386172|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
155386173|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
155386174|NCT02019927|560849071|FG000|Overall Study|Lost to Follow-up|2|||
155386175|NCT02019927|560849072|FG001|Overall Study|Lost to Follow-up|4|||
155279649|NCT03225846|560456299|FG002|Overall Study|Patient decision|0|||
155279650|NCT03225846|560456300|FG003|Overall Study|Patient decision|0|||
155627126|NCT02351934|561732337|FG000|Follow-Up|Acute Kidney Injury|1|||
155627127|NCT02351934|561732338|FG001|Follow-Up|Acute Kidney Injury|0|||
155279651|NCT03225846|560456301|FG004|Overall Study|Patient decision|0|||
155279652|NCT03225846|560456302|FG005|Overall Study|Patient decision|0|||
155279653|NCT03225846|560456303|FG006|Overall Study|Patient decision|1|||
155279654|NCT04248465|560456304|FG000|Randomized-Controlled Period|Death|12|||
155279655|NCT04248465|560456305|FG001|Randomized-Controlled Period|Death|5|||
155279656|NCT04248465|560456304|FG000|Randomized-Controlled Period|Adverse Event|2|||
155279657|NCT04248465|560456305|FG001|Randomized-Controlled Period|Adverse Event|0|||
155279658|NCT04248465|560456304|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
155279659|NCT04248465|560456305|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
155279660|NCT04248465|560456304|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
155279661|NCT04248465|560456305|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
155279662|NCT04248465|560456304|FG000|Randomized-Controlled Period|Physician Decision|1|||
155279663|NCT04248465|560456305|FG001|Randomized-Controlled Period|Physician Decision|1|||
155279664|NCT04248465|560456304|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
155279665|NCT04248465|560456305|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
155279666|NCT04248465|560456304|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
155279667|NCT04248465|560456305|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
155279668|NCT04248465|560456304|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155279669|NCT04248465|560456305|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
155279670|NCT01254890|560456306|FG000|Overall Study|Ineligible|0|||
155279671|NCT01254890|560456307|FG001|Overall Study|Ineligible|3|||
155279672|NCT01254890|560456306|FG000|Overall Study|Withdrawal by Subject|1|||
155279673|NCT01254890|560456307|FG001|Overall Study|Withdrawal by Subject|2|||
155279674|NCT01254890|560456306|FG000|Overall Study|Disease Progression|0|||
155279675|NCT01254890|560456307|FG001|Overall Study|Disease Progression|5|||
155279676|NCT00245011|560456311|FG000|Overall Study|Lack of Efficacy|1|||
155279677|NCT00550173|560456312|FG000|Overall Study|Death|45|||
155279678|NCT00550173|560456313|FG001|Overall Study|Death|38|||
155279679|NCT00550173|560456314|FG002|Overall Study|Death|50|||
155279680|NCT00550173|560456312|FG000|Overall Study|Physician Decision|1|||
155279681|NCT00550173|560456313|FG001|Overall Study|Physician Decision|2|||
155279682|NCT00550173|560456314|FG002|Overall Study|Physician Decision|2|||
155279683|NCT00550173|560456312|FG000|Overall Study|Withdrawal by Subject|9|||
155279684|NCT00550173|560456313|FG001|Overall Study|Withdrawal by Subject|12|||
155279685|NCT00550173|560456314|FG002|Overall Study|Withdrawal by Subject|17|||
155279686|NCT00550173|560456312|FG000|Overall Study|Sponsor Decision|13|||
155279687|NCT00550173|560456313|FG001|Overall Study|Sponsor Decision|7|||
155279688|NCT00550173|560456314|FG002|Overall Study|Sponsor Decision|1|||
155279689|NCT00550173|560456312|FG000|Overall Study|Lost to Follow-up|4|||
155279690|NCT00550173|560456313|FG001|Overall Study|Lost to Follow-up|4|||
155279691|NCT00550173|560456314|FG002|Overall Study|Lost to Follow-up|3|||
155279692|NCT02419755|560456318|FG000|Overall Study|Death|1|||
155279693|NCT02419755|560456319|FG001|Overall Study|Death|3|||
155279694|NCT02419755|560456318|FG000|Overall Study|Relapse|0|||
155279695|NCT02419755|560456319|FG001|Overall Study|Relapse|1|||
155279696|NCT02419755|560456318|FG000|Overall Study|Ineligible|1|||
155279697|NCT02419755|560456319|FG001|Overall Study|Ineligible|0|||
155279698|NCT02419755|560456318|FG000|Overall Study|Withdrawal by Subject|1|||
155279699|NCT02419755|560456319|FG001|Overall Study|Withdrawal by Subject|0|||
155279700|NCT06403605|560456323|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
155279701|NCT06403605|560456324|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
155279702|NCT06403605|560456323|FG000|Follow-up|Adverse Event|4|||
155279703|NCT06403605|560456324|FG001|Follow-up|Adverse Event|2|||
155279704|NCT06403605|560456323|FG000|Follow-up|Withdrawal by Subject|2|||
155279705|NCT06403605|560456324|FG001|Follow-up|Withdrawal by Subject|3|||
155279706|NCT06403605|560456323|FG000|Follow-up|Lost to Follow-up|1|||
155279707|NCT06403605|560456324|FG001|Follow-up|Lost to Follow-up|0|||
155279708|NCT06403605|560456323|FG000|Follow-up|Death|1|||
155279709|NCT06403605|560456324|FG001|Follow-up|Death|0|||
155279710|NCT06403605|560456323|FG000|Follow-up|Other reasons|0|||
155279711|NCT06403605|560456324|FG001|Follow-up|Other reasons|4|||
155279712|NCT04213846|560457728|FG000|Overall Study|Withdrawal by Subject|7|||
155279713|NCT04213846|560457729|FG001|Overall Study|Withdrawal by Subject|6|||
155279714|NCT04213846|560457728|FG000|Overall Study|Lost to Follow-up|15|||
155279715|NCT04213846|560457729|FG001|Overall Study|Lost to Follow-up|21|||
155279716|NCT04096365|560457742|FG000|Overall Study|Adverse Event|1|||
155279717|NCT02401529|560457743|FG000|Overall Study|Lost to Follow-up|2|||
155279718|NCT02401529|560457744|FG001|Overall Study|Lost to Follow-up|1|||
155279719|NCT02401529|560457743|FG000|Overall Study|Physician Decision|2|||
155279720|NCT02401529|560457744|FG001|Overall Study|Physician Decision|6|||
155279721|NCT02401529|560457743|FG000|Overall Study|Protocol Violation|5|||
155279722|NCT02401529|560457744|FG001|Overall Study|Protocol Violation|0|||
155279723|NCT02491411|560457747|FG000|Overall Study|Physician Decision|4|||
155279724|NCT01036087|560457749|FG000|Overall Study|Adverse Event|2|||
155279725|NCT01036087|560457749|FG000|Overall Study|Lack of Efficacy|1|||
155279726|NCT02206685|560457751|FG000|Overall Study|Surgery cancelled/changed|2|||
155386176|NCT02019927|560849073|FG002|Overall Study|Lost to Follow-up|1|||
155386177|NCT02019927|560849074|FG003|Overall Study|Lost to Follow-up|2|||
155729264|NCT02113982|562108040|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729265|NCT02113982|562108041|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729266|NCT02113982|562108042|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729267|NCT02113982|562108043|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
155729268|NCT02113982|562108044|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
155729269|NCT02113982|562108045|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
155279727|NCT02206685|560457752|FG001|Overall Study|Surgery cancelled/changed|3|||
155279728|NCT02206685|560457751|FG000|Overall Study|Withdrawal by Subject|1|||
155279729|NCT02206685|560457752|FG001|Overall Study|Withdrawal by Subject|2|||
155279730|NCT02206685|560457751|FG000|Overall Study|Protocol Violation|2|||
155279731|NCT02206685|560457752|FG001|Overall Study|Protocol Violation|2|||
155279732|NCT01616563|560457753|FG000|Overall Study|Lost to Follow-up|40|||
155279733|NCT00072475|560457754|FG000|Overall Study|Adverse Event|44|||
155279734|NCT00072475|560457754|FG000|Overall Study|Death|3|||
155279735|NCT00072475|560457754|FG000|Overall Study|Withdrawal by Subject|46|||
155279736|NCT00072475|560457754|FG000|Overall Study|Patient/Investigator Decision|4|||
155279737|NCT01450943|560457757|FG000|Overall Study|Screen failure, loss to follow-up|2|||
155279738|NCT01450943|560457758|FG001|Overall Study|Screen failure, loss to follow-up|7|||
155279739|NCT01450943|560457759|FG002|Overall Study|Screen failure, loss to follow-up|6|||
155279740|NCT04822298|560457761|FG000|Overall Study|Death|3|||
155279741|NCT00465361|560457762|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
155279742|NCT01625338|560457766|FG000|Overall Study|Enrolled but not Treated|0|||
155279743|NCT01625338|560457767|FG001|Overall Study|Enrolled but not Treated|0|||
155279744|NCT01625338|560457768|FG002|Overall Study|Enrolled but not Treated|1|||
155279745|NCT01625338|560457766|FG000|Overall Study|Efficacy Failure|27|||
155279746|NCT01625338|560457767|FG001|Overall Study|Efficacy Failure|39|||
155279747|NCT01625338|560457768|FG002|Overall Study|Efficacy Failure|31|||
155279748|NCT01625338|560457766|FG000|Overall Study|Lost to Follow-up|3|||
155279749|NCT01625338|560457767|FG001|Overall Study|Lost to Follow-up|3|||
155279750|NCT01625338|560457768|FG002|Overall Study|Lost to Follow-up|2|||
155279751|NCT01625338|560457766|FG000|Overall Study|Investigator Decision|0|||
155279752|NCT01625338|560457767|FG001|Overall Study|Investigator Decision|2|||
155279753|NCT01625338|560457768|FG002|Overall Study|Investigator Decision|1|||
155279754|NCT01625338|560457766|FG000|Overall Study|Subject Withdrew Consent|1|||
155279755|NCT01625338|560457767|FG001|Overall Study|Subject Withdrew Consent|0|||
155279756|NCT01625338|560457768|FG002|Overall Study|Subject Withdrew Consent|2|||
155279757|NCT01625338|560457766|FG000|Overall Study|Adverse Event|1|||
155279758|NCT01625338|560457767|FG001|Overall Study|Adverse Event|0|||
155279759|NCT01625338|560457768|FG002|Overall Study|Adverse Event|1|||
155279760|NCT01625338|560457766|FG000|Overall Study|Study Discontinued by Sponsor|0|||
155279761|NCT01625338|560457767|FG001|Overall Study|Study Discontinued by Sponsor|0|||
155279762|NCT01625338|560457768|FG002|Overall Study|Study Discontinued by Sponsor|1|||
155279763|NCT01789203|560457769|FG000|Overall Study|Adverse Event|2|||
155279764|NCT01789203|560457770|FG001|Overall Study|Adverse Event|2|||
155279765|NCT01789203|560457769|FG000|Overall Study|Withdrawal by Subject|1|||
155279766|NCT01789203|560457770|FG001|Overall Study|Withdrawal by Subject|0|||
155279767|NCT01789203|560457769|FG000|Overall Study|Death|1|||
155279768|NCT01789203|560457770|FG001|Overall Study|Death|0|||
155279769|NCT01789203|560457769|FG000|Overall Study|Protocol Violation|2|||
155279770|NCT01789203|560457770|FG001|Overall Study|Protocol Violation|1|||
155279771|NCT01789203|560457769|FG000|Overall Study|Other|1|||
155279772|NCT01789203|560457770|FG001|Overall Study|Other|1|||
155279773|NCT01789203|560457769|FG000|Overall Study|patient non-adherent|2|||
155279774|NCT01789203|560457770|FG001|Overall Study|patient non-adherent|0|||
155279775|NCT02403674|560457777|FG000|Base Study|Death|1|||
155279776|NCT02403674|560457778|FG001|Base Study|Death|4|||
155279777|NCT02403674|560457777|FG000|Base Study|Adverse Event|11|||
155279778|NCT02403674|560457778|FG001|Base Study|Adverse Event|26|||
155279779|NCT02403674|560457777|FG000|Base Study|Lack of Efficacy|31|||
155279780|NCT02403674|560457778|FG001|Base Study|Lack of Efficacy|23|||
155279781|NCT02403674|560457777|FG000|Base Study|Lost to Follow-up|6|||
155279782|NCT02403674|560457778|FG001|Base Study|Lost to Follow-up|8|||
155729270|NCT02113982|562108046|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
155279783|NCT02403674|560457777|FG000|Base Study|Withdrawal by Subject|10|||
155386178|NCT02019927|560849075|FG004|Overall Study|Lost to Follow-up|3|||
155279784|NCT02403674|560457778|FG001|Base Study|Withdrawal by Subject|17|||
155279785|NCT02403674|560457777|FG000|Base Study|Physician Decision|2|||
155279786|NCT02403674|560457778|FG001|Base Study|Physician Decision|2|||
155279787|NCT02403674|560457777|FG000|Base Study|Pregnancy|2|||
155279788|NCT02403674|560457778|FG001|Base Study|Pregnancy|2|||
155279789|NCT02403674|560457777|FG000|Base Study|Protocol Violation|8|||
155279790|NCT02403674|560457778|FG001|Base Study|Protocol Violation|4|||
155279791|NCT02403674|560457777|FG000|Base Study|Non-Compliance with study drug|1|||
155279792|NCT02403674|560457778|FG001|Base Study|Non-Compliance with study drug|4|||
155279793|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
155279794|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
155279795|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
155279796|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
155279797|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
155279798|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
155279799|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
155279800|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
155279801|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
155279802|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
155279803|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
155279804|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
155279805|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Death|1|||
155279806|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Death|0|||
155279807|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
155279808|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
155279809|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
155279810|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
155279811|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
155279812|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
155279813|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
155279814|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
155279815|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
155279816|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
155279817|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
155279818|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
155279819|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
155279820|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
155279821|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Death|2|||
155279822|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Death|2|||
155279823|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
155279824|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
155279825|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
155279826|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
155279827|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
155279828|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
155279829|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
155279830|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
155279831|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
155279832|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
155279833|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
155279834|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
155279835|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
155279836|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
155279837|NCT03487666|560457780|FG000|Overall Study|Disease progression|4|||
155279838|NCT03487666|560457781|FG001|Overall Study|Disease progression|2|||
155279839|NCT03487666|560457782|FG002|Overall Study|Disease progression|0|||
155279840|NCT03487666|560457780|FG000|Overall Study|Adverse Event|0|||
155279841|NCT03487666|560457781|FG001|Overall Study|Adverse Event|0|||
155279842|NCT03487666|560457782|FG002|Overall Study|Adverse Event|1|||
155279843|NCT03201757|560457783|FG000|Overall Study|Withdrawal by Subject|133|||
155279844|NCT03201757|560457783|FG000|Overall Study|Adverse Event|44|||
155279845|NCT03201757|560457783|FG000|Overall Study|Lost to Follow-up|37|||
155279846|NCT03201757|560457783|FG000|Overall Study|Pregnancy|2|||
155279847|NCT03201757|560457783|FG000|Overall Study|Lack of Efficacy|1|||
155279848|NCT03201757|560457783|FG000|Overall Study|Protocol Violation|20|||
155279849|NCT03201757|560457783|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
155279850|NCT03201757|560457783|FG000|Overall Study|Not Yet Determined|5|||
155279851|NCT03201757|560457783|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
155279852|NCT03201757|560457783|FG000|Overall Study|Other|20|||
155279853|NCT01254305|560457784|FG000|Overall Study|Adverse Event|6|||
155279854|NCT01254305|560457785|FG001|Overall Study|Adverse Event|3|||
155279855|NCT01254305|560457786|FG002|Overall Study|Adverse Event|2|||
155279856|NCT01254305|560457784|FG000|Overall Study|Lack of Efficacy|1|||
155279857|NCT01254305|560457785|FG001|Overall Study|Lack of Efficacy|0|||
155279858|NCT01254305|560457786|FG002|Overall Study|Lack of Efficacy|1|||
155279859|NCT01254305|560457784|FG000|Overall Study|Protocol Violation|1|||
155279860|NCT01254305|560457785|FG001|Overall Study|Protocol Violation|7|||
155279861|NCT01254305|560457786|FG002|Overall Study|Protocol Violation|3|||
155279862|NCT01254305|560457784|FG000|Overall Study|Withdrawal by Subject|4|||
155279863|NCT01254305|560457785|FG001|Overall Study|Withdrawal by Subject|2|||
155279864|NCT01254305|560457786|FG002|Overall Study|Withdrawal by Subject|4|||
155279865|NCT01254305|560457784|FG000|Overall Study|Lost to Follow-up|10|||
155279866|NCT01254305|560457785|FG001|Overall Study|Lost to Follow-up|6|||
155279867|NCT01254305|560457786|FG002|Overall Study|Lost to Follow-up|5|||
155386179|NCT02019927|560849076|FG005|Overall Study|Lost to Follow-up|1|||
155386180|NCT00928447|560849085|FG000|Overall Study|Withdrawal by Subject|1|||
155386181|NCT00928447|560849085|FG000|Overall Study|Investigator's decision|1|||
155386182|NCT01259284|560849086|FG000|Overall Study|Study Termination|2|||
155386183|NCT01259284|560849087|FG001|Overall Study|Study Termination|0|||
155386184|NCT01259284|560849088|FG002|Overall Study|Study Termination|0|||
155386185|NCT00069238|560849089|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
155386186|NCT00069238|560849090|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
155386187|NCT00069238|560849091|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
155386188|NCT00069238|560849089|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
155386189|NCT00069238|560849090|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
155386190|NCT00069238|560849091|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
155386191|NCT00069238|560849089|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
155386192|NCT00069238|560849090|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
155386193|NCT00069238|560849091|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
155386194|NCT00926211|560849093|FG000|Overall Study|Lost to Follow-up|1|||
155386195|NCT01032382|560849094|FG000|Overall Study|Disease dissemination|1|||
155386196|NCT01032382|560849095|FG001|Overall Study|Disease dissemination|1|||
155386197|NCT01032382|560849094|FG000|Overall Study|Treatment failure|3|||
155386198|NCT01032382|560849095|FG001|Overall Study|Treatment failure|1|||
155386199|NCT01032382|560849094|FG000|Overall Study|Index lesion relapse|1|||
155386200|NCT01032382|560849095|FG001|Overall Study|Index lesion relapse|3|||
155386201|NCT04508023|560849096|FG000|Overall Study|Withdrawal by Subject|1|||
155386202|NCT04508023|560849097|FG001|Overall Study|Withdrawal by Subject|2|||
155386203|NCT02988622|560849098|FG000|Overall Study|Lost to Follow-up|17|||
155386204|NCT03261700|560849099|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
155386205|NCT03261700|560849100|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
155386206|NCT00983931|560849101|FG000|14 Day Washout Period|Physician Decision|1|||
155386207|NCT01281969|560849104|FG000|Overall Study|not randomized didn't meet criteria|0|||
155386208|NCT01281969|560849105|FG001|Overall Study|not randomized didn't meet criteria|0|||
155386209|NCT01281969|560849106|FG002|Overall Study|not randomized didn't meet criteria|7|||
155386210|NCT01281969|560849104|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
155386211|NCT01281969|560849105|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
155386212|NCT01281969|560849106|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
155386213|NCT01281969|560849104|FG000|Overall Study|not randomized, child consent not given|0|||
155386214|NCT01281969|560849105|FG001|Overall Study|not randomized, child consent not given|0|||
155386215|NCT01281969|560849106|FG002|Overall Study|not randomized, child consent not given|2|||
155386216|NCT01723254|560849108|FG000|Overall Study|Conflict with work schedule|0|||
155386217|NCT01723254|560849109|FG001|Overall Study|Conflict with work schedule|0|||
155386218|NCT01723254|560849110|FG002|Overall Study|Conflict with work schedule|0|||
155386219|NCT01723254|560849111|FG003|Overall Study|Conflict with work schedule|0|||
155386220|NCT01723254|560849112|FG004|Overall Study|Conflict with work schedule|0|||
155386221|NCT01723254|560849113|FG005|Overall Study|Conflict with work schedule|0|||
155386222|NCT01723254|560849114|FG006|Overall Study|Conflict with work schedule|0|||
155386223|NCT01723254|560849115|FG007|Overall Study|Conflict with work schedule|1|||
155386224|NCT01723254|560849108|FG000|Overall Study|Personal issues|0|||
155386225|NCT01723254|560849109|FG001|Overall Study|Personal issues|0|||
155386226|NCT01723254|560849110|FG002|Overall Study|Personal issues|0|||
155386227|NCT01723254|560849111|FG003|Overall Study|Personal issues|0|||
155386228|NCT01723254|560849112|FG004|Overall Study|Personal issues|0|||
155386229|NCT01723254|560849113|FG005|Overall Study|Personal issues|1|||
155386230|NCT01723254|560849114|FG006|Overall Study|Personal issues|0|||
155386231|NCT01723254|560849115|FG007|Overall Study|Personal issues|0|||
155386232|NCT01723254|560849108|FG000|Overall Study|No longer have time to participate|0|||
155386233|NCT01723254|560849109|FG001|Overall Study|No longer have time to participate|0|||
155386234|NCT01723254|560849110|FG002|Overall Study|No longer have time to participate|0|||
155386235|NCT01723254|560849111|FG003|Overall Study|No longer have time to participate|1|||
155386236|NCT01723254|560849112|FG004|Overall Study|No longer have time to participate|0|||
155386237|NCT01723254|560849113|FG005|Overall Study|No longer have time to participate|0|||
155386238|NCT01723254|560849114|FG006|Overall Study|No longer have time to participate|0|||
155386239|NCT01723254|560849115|FG007|Overall Study|No longer have time to participate|0|||
155386240|NCT01723254|560849108|FG000|Overall Study|Move/Left to another country/city|0|||
155386241|NCT01723254|560849109|FG001|Overall Study|Move/Left to another country/city|0|||
155386242|NCT01723254|560849110|FG002|Overall Study|Move/Left to another country/city|2|||
155386243|NCT01723254|560849111|FG003|Overall Study|Move/Left to another country/city|1|||
155386244|NCT01723254|560849112|FG004|Overall Study|Move/Left to another country/city|1|||
155386245|NCT01723254|560849113|FG005|Overall Study|Move/Left to another country/city|0|||
155386246|NCT01723254|560849114|FG006|Overall Study|Move/Left to another country/city|0|||
155386247|NCT01723254|560849115|FG007|Overall Study|Move/Left to another country/city|0|||
155386248|NCT01723254|560849108|FG000|Overall Study|Protocol Violation|0|||
155386249|NCT01723254|560849109|FG001|Overall Study|Protocol Violation|1|||
155386250|NCT01723254|560849110|FG002|Overall Study|Protocol Violation|0|||
155386251|NCT01723254|560849111|FG003|Overall Study|Protocol Violation|0|||
155627128|NCT02351934|561732337|FG000|Follow-Up|Early dismissal|3|||
155279868|NCT01254305|560457784|FG000|Overall Study|Other Reasons|0|||
155279869|NCT01254305|560457785|FG001|Overall Study|Other Reasons|0|||
155279870|NCT01254305|560457786|FG002|Overall Study|Other Reasons|2|||
155279871|NCT02297503|560457787|FG000|Overall Study|Withdrawal by Subject|1|||
155279872|NCT02297503|560457788|FG001|Overall Study|Withdrawal by Subject|1|||
155279873|NCT02297503|560457787|FG000|Overall Study|Protocol Violation|1|||
155279874|NCT02297503|560457788|FG001|Overall Study|Protocol Violation|0|||
155279875|NCT02297503|560457787|FG000|Overall Study|Pregnancy|0|||
155279876|NCT02297503|560457788|FG001|Overall Study|Pregnancy|1|||
155279877|NCT02297503|560457787|FG000|Overall Study|Lost to Follow-up|0|||
155279878|NCT02297503|560457788|FG001|Overall Study|Lost to Follow-up|1|||
155279879|NCT02297503|560457787|FG000|Overall Study|Medical reason|0|||
155279880|NCT02297503|560457788|FG001|Overall Study|Medical reason|1|||
155279881|NCT00765362|560457789|FG000|Overall Study|Death|9|||
155279882|NCT00765362|560457789|FG000|Overall Study|Adverse Event|2|||
155279883|NCT00765362|560457789|FG000|Overall Study|Protocol Violation|18|||
155279884|NCT00765362|560457789|FG000|Overall Study|Withdrawal by Subject|13|||
155279885|NCT00765362|560457789|FG000|Overall Study|Lost to Follow-up|95|||
155279886|NCT03930186|560457790|FG000|Weeks 0 to 16|Adverse Event|6|||
155279887|NCT03930186|560457790|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
155279888|NCT03930186|560457790|FG000|Weeks 16 to 32|Adverse Event|1|||
155279889|NCT03930186|560457790|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
155279890|NCT03019458|560457795|FG000|Overall Study|Death|0|||
155279891|NCT03019458|560457796|FG001|Overall Study|Death|1|||
155279892|NCT00557505|560457797|FG000|Overall Study|Death|0|||
155279893|NCT00557505|560457798|FG001|Overall Study|Death|0|||
155279894|NCT00557505|560457799|FG002|Overall Study|Death|0|||
155279895|NCT00557505|560457800|FG003|Overall Study|Death|0|||
155279896|NCT00557505|560457801|FG004|Overall Study|Death|0|||
155279897|NCT00557505|560457802|FG005|Overall Study|Death|0|||
155279898|NCT00557505|560457803|FG006|Overall Study|Death|0|||
155279899|NCT00557505|560457804|FG007|Overall Study|Death|0|||
155279900|NCT00557505|560457805|FG008|Overall Study|Death|1|||
155279901|NCT00557505|560457797|FG000|Overall Study|Adverse Event|0|||
155279902|NCT00557505|560457798|FG001|Overall Study|Adverse Event|0|||
155279903|NCT00557505|560457799|FG002|Overall Study|Adverse Event|1|||
155279904|NCT00557505|560457800|FG003|Overall Study|Adverse Event|0|||
155279905|NCT00557505|560457801|FG004|Overall Study|Adverse Event|0|||
155279906|NCT00557505|560457802|FG005|Overall Study|Adverse Event|0|||
155279907|NCT00557505|560457803|FG006|Overall Study|Adverse Event|1|||
155279908|NCT00557505|560457804|FG007|Overall Study|Adverse Event|0|||
155279909|NCT00557505|560457805|FG008|Overall Study|Adverse Event|0|||
155279910|NCT00557505|560457797|FG000|Overall Study|Global deterioration of health|1|||
155279911|NCT00557505|560457798|FG001|Overall Study|Global deterioration of health|0|||
155279912|NCT00557505|560457799|FG002|Overall Study|Global deterioration of health|0|||
155279913|NCT00557505|560457800|FG003|Overall Study|Global deterioration of health|0|||
155279914|NCT00557505|560457801|FG004|Overall Study|Global deterioration of health|0|||
155279915|NCT00557505|560457802|FG005|Overall Study|Global deterioration of health|0|||
155279916|NCT00557505|560457803|FG006|Overall Study|Global deterioration of health|0|||
155279917|NCT00557505|560457804|FG007|Overall Study|Global deterioration of health|0|||
155279918|NCT00557505|560457805|FG008|Overall Study|Global deterioration of health|0|||
155279919|NCT00557505|560457797|FG000|Overall Study|Objective progression or relapse|2|||
155279920|NCT00557505|560457798|FG001|Overall Study|Objective progression or relapse|3|||
155279921|NCT00557505|560457799|FG002|Overall Study|Objective progression or relapse|3|||
155279922|NCT00557505|560457800|FG003|Overall Study|Objective progression or relapse|2|||
155279923|NCT00557505|560457801|FG004|Overall Study|Objective progression or relapse|2|||
155279924|NCT00557505|560457802|FG005|Overall Study|Objective progression or relapse|3|||
155279925|NCT00557505|560457803|FG006|Overall Study|Objective progression or relapse|2|||
155279926|NCT00557505|560457804|FG007|Overall Study|Objective progression or relapse|5|||
155279927|NCT00557505|560457805|FG008|Overall Study|Objective progression or relapse|15|||
155279928|NCT00557505|560457797|FG000|Overall Study|Withdrawal by Subject|0|||
155279929|NCT00557505|560457798|FG001|Overall Study|Withdrawal by Subject|0|||
155279930|NCT00557505|560457799|FG002|Overall Study|Withdrawal by Subject|0|||
155279931|NCT00557505|560457800|FG003|Overall Study|Withdrawal by Subject|1|||
155279932|NCT00557505|560457801|FG004|Overall Study|Withdrawal by Subject|0|||
155279933|NCT00557505|560457802|FG005|Overall Study|Withdrawal by Subject|0|||
155279934|NCT00557505|560457803|FG006|Overall Study|Withdrawal by Subject|0|||
155279935|NCT00557505|560457804|FG007|Overall Study|Withdrawal by Subject|0|||
155279936|NCT00557505|560457805|FG008|Overall Study|Withdrawal by Subject|1|||
155279937|NCT00031447|560457806|FG000|Overall Study|Lost to Follow-up|0|||
155279938|NCT00031447|560457807|FG001|Overall Study|Lost to Follow-up|1|||
155279939|NCT00031447|560457806|FG000|Overall Study|Non-compliant|1|||
155279940|NCT00031447|560457807|FG001|Overall Study|Non-compliant|1|||
155279941|NCT00031447|560457806|FG000|Overall Study|Re-activation of Disease|2|||
155279942|NCT00031447|560457807|FG001|Overall Study|Re-activation of Disease|1|||
155279943|NCT00031447|560457806|FG000|Overall Study|Disruption of blinded study drug supply|7|||
155279944|NCT00031447|560457807|FG001|Overall Study|Disruption of blinded study drug supply|4|||
155386252|NCT01723254|560849112|FG004|Overall Study|Protocol Violation|0|||
155386253|NCT01723254|560849113|FG005|Overall Study|Protocol Violation|0|||
155386254|NCT01723254|560849114|FG006|Overall Study|Protocol Violation|0|||
155386255|NCT01723254|560849115|FG007|Overall Study|Protocol Violation|0|||
155386256|NCT01723254|560849108|FG000|Overall Study|Withdrawal by Subject|1|||
155386257|NCT01723254|560849109|FG001|Overall Study|Withdrawal by Subject|2|||
155386258|NCT01723254|560849110|FG002|Overall Study|Withdrawal by Subject|1|||
155386259|NCT01723254|560849111|FG003|Overall Study|Withdrawal by Subject|0|||
155386260|NCT01723254|560849112|FG004|Overall Study|Withdrawal by Subject|1|||
155386261|NCT01723254|560849113|FG005|Overall Study|Withdrawal by Subject|1|||
155386262|NCT01723254|560849114|FG006|Overall Study|Withdrawal by Subject|1|||
155386263|NCT01723254|560849115|FG007|Overall Study|Withdrawal by Subject|2|||
155386264|NCT04640077|560849119|FG000|Period 1|Withdrawal by Subject|4|||
155386265|NCT04640077|560849120|FG001|Period 1|Withdrawal by Subject|5|||
155386266|NCT04640077|560849121|FG002|Period 1|Withdrawal by Subject|0|||
155386267|NCT04640077|560849119|FG000|Period 1|Adverse Event|1|||
155386268|NCT04640077|560849120|FG001|Period 1|Adverse Event|1|||
155386269|NCT04640077|560849121|FG002|Period 1|Adverse Event|0|||
155386270|NCT04640077|560849119|FG000|Period 1|Screen Failure|2|||
155386271|NCT04640077|560849120|FG001|Period 1|Screen Failure|0|||
155386272|NCT04640077|560849121|FG002|Period 1|Screen Failure|0|||
155386273|NCT04640077|560849119|FG000|Period 2|Withdrawal by Subject|0|||
155386274|NCT04640077|560849120|FG001|Period 2|Withdrawal by Subject|0|||
155386275|NCT04640077|560849121|FG002|Period 2|Withdrawal by Subject|18|||
155386276|NCT04640077|560849119|FG000|Period 2|Adverse Event|0|||
155386277|NCT04640077|560849120|FG001|Period 2|Adverse Event|0|||
155386278|NCT04640077|560849121|FG002|Period 2|Adverse Event|6|||
155386279|NCT04640077|560849119|FG000|Period 2|Lost to Follow-up|0|||
155386280|NCT04640077|560849120|FG001|Period 2|Lost to Follow-up|0|||
155386281|NCT04640077|560849121|FG002|Period 2|Lost to Follow-up|2|||
155386282|NCT04640077|560849119|FG000|Period 2|Death|0|||
155386283|NCT04640077|560849120|FG001|Period 2|Death|0|||
155386284|NCT04640077|560849121|FG002|Period 2|Death|2|||
155386285|NCT04640077|560849119|FG000|Period 2|Progressive Disease|0|||
155386286|NCT04640077|560849120|FG001|Period 2|Progressive Disease|0|||
155386287|NCT04640077|560849121|FG002|Period 2|Progressive Disease|1|||
155386288|NCT04640077|560849119|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
155386289|NCT04640077|560849120|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
155386290|NCT04640077|560849121|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
155386291|NCT01257425|560849122|FG000|Overall Study|Lack of Efficacy|3|||
155386292|NCT01257425|560849123|FG001|Overall Study|Lack of Efficacy|3|||
155386293|NCT01257425|560849122|FG000|Overall Study|Adverse Event|1|||
155386294|NCT01257425|560849123|FG001|Overall Study|Adverse Event|1|||
155386295|NCT01257425|560849122|FG000|Overall Study|Protocol Violation|1|||
155386296|NCT01257425|560849123|FG001|Overall Study|Protocol Violation|1|||
155386297|NCT01257425|560849122|FG000|Overall Study|Withdrawal by Subject|0|||
155386298|NCT01257425|560849123|FG001|Overall Study|Withdrawal by Subject|1|||
155386299|NCT01257425|560849122|FG000|Overall Study|Death|1|||
155386300|NCT01257425|560849123|FG001|Overall Study|Death|0|||
155386301|NCT02409368|560849125|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
155386302|NCT02409368|560849126|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
155386303|NCT02409368|560849127|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
155386304|NCT02409368|560849128|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
155386305|NCT02409368|560849125|FG000|ECOG Reclassification|Death|1|||
155386306|NCT02409368|560849126|FG001|ECOG Reclassification|Death|5|||
155386307|NCT02409368|560849127|FG002|ECOG Reclassification|Death|0|||
155386308|NCT02409368|560849128|FG003|ECOG Reclassification|Death|0|||
155386309|NCT02409368|560849125|FG000|ECOG Reclassification|Disease Progression|113|||
155386310|NCT02409368|560849126|FG001|ECOG Reclassification|Disease Progression|382|||
155386311|NCT02409368|560849127|FG002|ECOG Reclassification|Disease Progression|70|||
155386312|NCT02409368|560849128|FG003|ECOG Reclassification|Disease Progression|1|||
155386313|NCT02409368|560849125|FG000|ECOG Reclassification|Lost to Follow-up|1|||
155386314|NCT02409368|560849126|FG001|ECOG Reclassification|Lost to Follow-up|5|||
155386315|NCT02409368|560849127|FG002|ECOG Reclassification|Lost to Follow-up|0|||
155386316|NCT02409368|560849128|FG003|ECOG Reclassification|Lost to Follow-up|0|||
155386317|NCT02409368|560849125|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
155386318|NCT02409368|560849126|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
155386319|NCT02409368|560849127|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
155386320|NCT02409368|560849128|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
155386321|NCT02409368|560849125|FG000|ECOG Reclassification|Poor/non-compliance|0|||
155386322|NCT02409368|560849126|FG001|ECOG Reclassification|Poor/non-compliance|3|||
155386323|NCT02409368|560849127|FG002|ECOG Reclassification|Poor/non-compliance|2|||
155386324|NCT02409368|560849128|FG003|ECOG Reclassification|Poor/non-compliance|0|||
155386325|NCT02409368|560849125|FG000|ECOG Reclassification|Study drug toxicity|17|||
155386326|NCT02409368|560849126|FG001|ECOG Reclassification|Study drug toxicity|42|||
155386327|NCT02409368|560849127|FG002|ECOG Reclassification|Study drug toxicity|7|||
155386328|NCT02409368|560849128|FG003|ECOG Reclassification|Study drug toxicity|0|||
155386329|NCT02409368|560849125|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
155386330|NCT02409368|560849126|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
155386331|NCT02409368|560849127|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
155386332|NCT02409368|560849128|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
155386333|NCT02409368|560849125|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
155386334|NCT02409368|560849126|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
155386335|NCT02409368|560849127|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
155386336|NCT02409368|560849128|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
155386337|NCT02409368|560849125|FG000|ECOG Reclassification|Participant withdrew consent|2|||
155386338|NCT02409368|560849126|FG001|ECOG Reclassification|Participant withdrew consent|3|||
155386339|NCT02409368|560849127|FG002|ECOG Reclassification|Participant withdrew consent|4|||
155386340|NCT02409368|560849128|FG003|ECOG Reclassification|Participant withdrew consent|0|||
155386341|NCT02409368|560849125|FG000|ECOG Reclassification|Other Reasons|5|||
155386342|NCT02409368|560849126|FG001|ECOG Reclassification|Other Reasons|26|||
155386343|NCT02409368|560849127|FG002|ECOG Reclassification|Other Reasons|2|||
155386344|NCT02409368|560849128|FG003|ECOG Reclassification|Other Reasons|0|||
155386345|NCT02409368|560849125|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
155386346|NCT02409368|560849126|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
155386347|NCT02409368|560849127|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
155386348|NCT02409368|560849128|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
155386349|NCT02240693|560849130|FG000|Overall Study|Adverse Event|0|||
155386350|NCT02240693|560849131|FG001|Overall Study|Adverse Event|0|||
155386351|NCT02240693|560849132|FG002|Overall Study|Adverse Event|0|||
155386352|NCT02240693|560849133|FG003|Overall Study|Adverse Event|0|||
155386353|NCT02240693|560849134|FG004|Overall Study|Adverse Event|1|||
155386354|NCT02240693|560849130|FG000|Overall Study|Withdrawal by Subject|0|||
155386355|NCT02240693|560849131|FG001|Overall Study|Withdrawal by Subject|0|||
155386356|NCT02240693|560849132|FG002|Overall Study|Withdrawal by Subject|2|||
155386357|NCT02240693|560849133|FG003|Overall Study|Withdrawal by Subject|1|||
155386358|NCT02240693|560849134|FG004|Overall Study|Withdrawal by Subject|0|||
155386359|NCT02240693|560849130|FG000|Overall Study|Other than specified|0|||
155386360|NCT02240693|560849131|FG001|Overall Study|Other than specified|0|||
155386361|NCT02240693|560849132|FG002|Overall Study|Other than specified|2|||
155386362|NCT02240693|560849133|FG003|Overall Study|Other than specified|0|||
155386363|NCT02240693|560849134|FG004|Overall Study|Other than specified|0|||
155386364|NCT03343301|560849135|FG000|Overall Study|Withdrawal by Subject|1|||
155386365|NCT03343301|560849136|FG001|Overall Study|Withdrawal by Subject|1|||
155386366|NCT03343301|560849135|FG000|Overall Study|Death|0|||
155386367|NCT03343301|560849136|FG001|Overall Study|Death|2|||
155386368|NCT03343301|560849135|FG000|Overall Study|Other|0|||
155386369|NCT03343301|560849136|FG001|Overall Study|Other|6|||
155386370|NCT03343301|560849135|FG000|Overall Study|Missing|2|||
155386371|NCT03343301|560849136|FG001|Overall Study|Missing|0|||
155386372|NCT02668185|560849137|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
155386373|NCT02668185|560849138|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
155386374|NCT02668185|560849137|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
155386375|NCT02668185|560849138|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
155386376|NCT02668185|560849137|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
155386377|NCT02668185|560849138|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
155386378|NCT02668185|560849137|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
155386379|NCT02668185|560849138|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
155386380|NCT01013597|560849139|FG000|Overall Study|Withdrawal by Subject|1|||
155386381|NCT00427895|560849140|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386382|NCT00427895|560849141|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386383|NCT00427895|560849142|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386384|NCT00427895|560849143|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
155386385|NCT00427895|560849144|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386386|NCT00427895|560849145|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386387|NCT00427895|560849146|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386388|NCT00427895|560849147|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386389|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386390|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386391|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386392|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386393|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386394|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386395|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386396|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
155386397|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386398|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386399|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386400|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
155279945|NCT00519779|560457813|FG000|Overall Study|Withdrawal by Subject|0|||
155279946|NCT00519779|560457814|FG001|Overall Study|Withdrawal by Subject|1|||
155279947|NCT01561079|560457815|FG000|Overall Study|Physician Decision|17|||
155279948|NCT01561079|560457815|FG000|Overall Study|Withdrawal by Subject|59|||
155279949|NCT01561079|560457815|FG000|Overall Study|Protocol Violation|2|||
155279950|NCT01123161|560457818|FG000|Overall Study|Lost to Follow-up|1|||
155279951|NCT01123161|560457819|FG001|Overall Study|Lost to Follow-up|0|||
155279952|NCT01123161|560457818|FG000|Overall Study|Withdrawal by Subject|1|||
155279953|NCT01123161|560457819|FG001|Overall Study|Withdrawal by Subject|0|||
155279954|NCT00664521|560457820|FG000|Overall Study|Adverse Event|4|||
155279955|NCT00664521|560457821|FG001|Overall Study|Adverse Event|1|||
155279956|NCT00664521|560457820|FG000|Overall Study|Lost to Follow-up|1|||
155279957|NCT00664521|560457821|FG001|Overall Study|Lost to Follow-up|0|||
155279958|NCT00664521|560457820|FG000|Overall Study|Other|1|||
155279959|NCT00664521|560457821|FG001|Overall Study|Other|0|||
155279960|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
155279961|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155279962|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155279963|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155279964|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155279965|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
155279966|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155279967|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
155279968|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
155279969|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
155279970|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155279971|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
155279972|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155279973|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155279974|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279975|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279976|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279977|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155279978|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279979|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279980|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279981|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279982|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
155279983|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279984|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279985|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279986|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279987|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279988|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155279989|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279990|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
155279991|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155279992|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155279993|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155279994|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
155279995|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155279996|NCT01323660|560457822|FG000|Washout Period (14 Days)|Adverse Event|0|||
155279997|NCT01323660|560457823|FG001|Washout Period (14 Days)|Adverse Event|0|||
155279998|NCT01323660|560457824|FG002|Washout Period (14 Days)|Adverse Event|0|||
155279999|NCT01323660|560457825|FG003|Washout Period (14 Days)|Adverse Event|0|||
155280000|NCT01323660|560457826|FG004|Washout Period (14 Days)|Adverse Event|1|||
155280001|NCT01323660|560457827|FG005|Washout Period (14 Days)|Adverse Event|0|||
155280002|NCT01323660|560457822|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
155280003|NCT01323660|560457823|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
155280004|NCT01323660|560457824|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
155280005|NCT01323660|560457825|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
155280006|NCT01323660|560457826|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
155280007|NCT01323660|560457827|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
155280008|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280009|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155280010|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155280011|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280012|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280013|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
155280014|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
155729271|NCT02113982|562108033|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
155386401|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386402|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386403|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386404|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
155386405|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
155386406|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
155386407|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
155386408|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
155386409|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
155386410|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
155386411|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
155386412|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
155386413|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386414|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
155386415|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
155386416|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
155386417|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386418|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386419|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386420|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386421|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
155386422|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386423|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
155386424|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
155386425|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386426|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386427|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386428|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386429|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
155386430|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
155386431|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386432|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386433|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386434|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386435|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386436|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386437|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
155386438|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
155386439|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
155386440|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
155386441|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386442|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386443|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386444|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386445|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386446|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386447|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386448|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
155386449|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155627129|NCT02351934|561732338|FG001|Follow-Up|Early dismissal|0|||
155627130|NCT02351934|561732337|FG000|Follow-Up|Hypotension|3|||
155627131|NCT02351934|561732338|FG001|Follow-Up|Hypotension|0|||
155627132|NCT02351934|561732337|FG000|Follow-Up|No documentation|2|||
155627133|NCT02351934|561732338|FG001|Follow-Up|No documentation|0|||
155627134|NCT02351934|561732337|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
155280015|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155280016|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155280017|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155280018|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155280019|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
155280020|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280021|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280022|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280023|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280024|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280025|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
155280026|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155280027|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280028|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155386450|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386451|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386452|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386453|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
155386454|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
155386455|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
155386456|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
155386457|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386458|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386459|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386460|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386461|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386462|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386463|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
155386464|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
155386465|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386466|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386467|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386468|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386469|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386470|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
155386471|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
155386472|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
155386473|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386474|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386475|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386476|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386477|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
155386478|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
155386479|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386480|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
155386481|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386482|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386483|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386484|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386485|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
155386486|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
155386487|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
155386488|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
155386489|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386490|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386491|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386492|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386493|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386494|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
155386495|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386496|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386497|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386498|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386499|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386500|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386501|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Death|1|||
155386502|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Death|0|||
155386503|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Death|0|||
155386504|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Death|0|||
155386505|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Death|0|||
155386506|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Death|0|||
155386507|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Death|0|||
155386508|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Death|0|||
155386509|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386510|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386511|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
155386512|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
155386513|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386514|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386515|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386516|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386517|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Other|0|||
155386518|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Other|0|||
155627135|NCT02351934|561732338|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
155386519|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Other|0|||
155386520|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Other|2|||
155386521|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Other|0|||
155386522|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Other|0|||
155386523|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Other|0|||
155386524|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Other|0|||
155386525|NCT00427895|560849140|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
155386526|NCT00427895|560849141|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
155386527|NCT00427895|560849142|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
155386528|NCT00427895|560849143|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
155386529|NCT00427895|560849144|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386530|NCT00427895|560849145|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386531|NCT00427895|560849146|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386532|NCT00427895|560849147|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386533|NCT00585195|560849149|FG000|Overall Study|Adverse Event|0|||
155386534|NCT00585195|560849150|FG001|Overall Study|Adverse Event|0|||
155386535|NCT00585195|560849151|FG002|Overall Study|Adverse Event|0|||
155386536|NCT00585195|560849152|FG003|Overall Study|Adverse Event|0|||
155386537|NCT00585195|560849153|FG004|Overall Study|Adverse Event|2|||
155386538|NCT00585195|560849154|FG005|Overall Study|Adverse Event|1|||
155386539|NCT00585195|560849155|FG006|Overall Study|Adverse Event|0|||
155386540|NCT00585195|560849156|FG007|Overall Study|Adverse Event|1|||
155386541|NCT00585195|560849157|FG008|Overall Study|Adverse Event|0|||
155386542|NCT00585195|560849158|FG009|Overall Study|Adverse Event|0|||
155386543|NCT00585195|560849159|FG010|Overall Study|Adverse Event|3|||
155386544|NCT00585195|560849160|FG011|Overall Study|Adverse Event|0|||
155386545|NCT00585195|560849161|FG012|Overall Study|Adverse Event|8|||
155386546|NCT00585195|560849162|FG013|Overall Study|Adverse Event|6|||
155386547|NCT00585195|560849163|FG014|Overall Study|Adverse Event|4|||
155386548|NCT00585195|560849164|FG015|Overall Study|Adverse Event|1|||
155386549|NCT00585195|560849165|FG016|Overall Study|Adverse Event|14|||
155386550|NCT00585195|560849166|FG017|Overall Study|Adverse Event|9|||
155386551|NCT00585195|560849167|FG018|Overall Study|Adverse Event|2|||
155386552|NCT00585195|560849168|FG019|Overall Study|Adverse Event|3|||
155386553|NCT00585195|560849169|FG020|Overall Study|Adverse Event|1|||
155386554|NCT00585195|560849149|FG000|Overall Study|Progressive Disease|2|||
155386555|NCT00585195|560849150|FG001|Overall Study|Progressive Disease|2|||
155386556|NCT00585195|560849151|FG002|Overall Study|Progressive Disease|5|||
155386557|NCT00585195|560849152|FG003|Overall Study|Progressive Disease|4|||
155386558|NCT00585195|560849153|FG004|Overall Study|Progressive Disease|6|||
155386559|NCT00585195|560849154|FG005|Overall Study|Progressive Disease|4|||
155386560|NCT00585195|560849155|FG006|Overall Study|Progressive Disease|6|||
155386561|NCT00585195|560849156|FG007|Overall Study|Progressive Disease|3|||
155386562|NCT00585195|560849157|FG008|Overall Study|Progressive Disease|0|||
155386563|NCT00585195|560849158|FG009|Overall Study|Progressive Disease|5|||
155386564|NCT00585195|560849159|FG010|Overall Study|Progressive Disease|2|||
155386565|NCT00585195|560849160|FG011|Overall Study|Progressive Disease|25|||
155386566|NCT00585195|560849161|FG012|Overall Study|Progressive Disease|29|||
155386567|NCT00585195|560849162|FG013|Overall Study|Progressive Disease|26|||
155386568|NCT00585195|560849163|FG014|Overall Study|Progressive Disease|21|||
155386569|NCT00585195|560849164|FG015|Overall Study|Progressive Disease|12|||
155386570|NCT00585195|560849165|FG016|Overall Study|Progressive Disease|94|||
155386571|NCT00585195|560849166|FG017|Overall Study|Progressive Disease|42|||
155386572|NCT00585195|560849167|FG018|Overall Study|Progressive Disease|4|||
155386573|NCT00585195|560849168|FG019|Overall Study|Progressive Disease|9|||
155386574|NCT00585195|560849169|FG020|Overall Study|Progressive Disease|8|||
155386575|NCT00585195|560849149|FG000|Overall Study|Withdrawal by Subject|1|||
155386576|NCT00585195|560849150|FG001|Overall Study|Withdrawal by Subject|1|||
155386577|NCT00585195|560849151|FG002|Overall Study|Withdrawal by Subject|2|||
155386578|NCT00585195|560849152|FG003|Overall Study|Withdrawal by Subject|2|||
155386579|NCT00585195|560849153|FG004|Overall Study|Withdrawal by Subject|0|||
155386580|NCT00585195|560849154|FG005|Overall Study|Withdrawal by Subject|0|||
155386581|NCT00585195|560849155|FG006|Overall Study|Withdrawal by Subject|0|||
155386582|NCT00585195|560849156|FG007|Overall Study|Withdrawal by Subject|1|||
155386583|NCT00585195|560849157|FG008|Overall Study|Withdrawal by Subject|0|||
155386584|NCT00585195|560849158|FG009|Overall Study|Withdrawal by Subject|0|||
155386585|NCT00585195|560849159|FG010|Overall Study|Withdrawal by Subject|3|||
155386586|NCT00585195|560849160|FG011|Overall Study|Withdrawal by Subject|8|||
155386587|NCT00585195|560849161|FG012|Overall Study|Withdrawal by Subject|15|||
155386588|NCT00585195|560849162|FG013|Overall Study|Withdrawal by Subject|0|||
155386589|NCT00585195|560849163|FG014|Overall Study|Withdrawal by Subject|3|||
155386590|NCT00585195|560849164|FG015|Overall Study|Withdrawal by Subject|0|||
155386591|NCT00585195|560849165|FG016|Overall Study|Withdrawal by Subject|7|||
155386592|NCT00585195|560849166|FG017|Overall Study|Withdrawal by Subject|1|||
155386593|NCT00585195|560849167|FG018|Overall Study|Withdrawal by Subject|2|||
155386594|NCT00585195|560849168|FG019|Overall Study|Withdrawal by Subject|2|||
155386595|NCT00585195|560849169|FG020|Overall Study|Withdrawal by Subject|0|||
155386596|NCT00585195|560849149|FG000|Overall Study|Other|0|||
155386597|NCT00585195|560849150|FG001|Overall Study|Other|1|||
155386598|NCT00585195|560849151|FG002|Overall Study|Other|1|||
155280029|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280030|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280031|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155280032|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280033|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280034|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280035|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155280036|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
155280037|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155280038|NCT00751790|560457831|FG000|Overall Study|Lost to Follow-up|1|||
155280039|NCT00751790|560457831|FG000|Overall Study|Death|3|||
155280040|NCT00751790|560457831|FG000|Overall Study|Withdrawal by Subject|1|||
155280041|NCT01106976|560457835|FG000|Overall Study|Lost to Follow-up|8|||
155280042|NCT00051311|560457852|FG000|Overall Study|Starting new study|0|||
155280043|NCT00051311|560457853|FG001|Overall Study|Starting new study|1|||
155280044|NCT00051311|560457852|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
155280045|NCT00051311|560457853|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
155280046|NCT00051311|560457852|FG000|Overall Study|Death of recipient|8|||
155280047|NCT00051311|560457853|FG001|Overall Study|Death of recipient|8|||
155280048|NCT00051311|560457852|FG000|Overall Study|Recipient taken off study|4|||
155280049|NCT00051311|560457853|FG001|Overall Study|Recipient taken off study|4|||
155280050|NCT04990440|560457854|FG000|Overall Study|Sponsor's Decision|0|||
155280051|NCT04990440|560457855|FG001|Overall Study|Sponsor's Decision|0|||
155280052|NCT04990440|560457856|FG002|Overall Study|Sponsor's Decision|1|||
155280053|NCT04170023|560457857|FG000|LTE Period|Withdrawal by Subject|1|||
155280054|NCT04170023|560457858|FG001|LTE Period|Withdrawal by Subject|0|||
155280055|NCT04170023|560457859|FG002|LTE Period|Withdrawal by Subject|0|||
155280056|NCT04170023|560457857|FG000|LTE Period|Study Termination|11|||
155280057|NCT04170023|560457858|FG001|LTE Period|Study Termination|11|||
155280058|NCT04170023|560457859|FG002|LTE Period|Study Termination|5|||
155280059|NCT03712098|560457860|FG000|Overall Study|Lost to Follow-up|3|||
155280060|NCT03712098|560457861|FG001|Overall Study|Lost to Follow-up|7|||
155280061|NCT03712098|560457860|FG000|Overall Study|Withdrawal by Subject|9|||
155280062|NCT03712098|560457861|FG001|Overall Study|Withdrawal by Subject|4|||
155280063|NCT03712098|560457860|FG000|Overall Study|Protocol Violation|2|||
155280064|NCT03712098|560457861|FG001|Overall Study|Protocol Violation|1|||
155280065|NCT03566680|560457862|FG000|Overall Study|Pregnancy|1|||
155280066|NCT03566680|560457862|FG000|Overall Study|Lost to Follow-up|13|||
155280067|NCT03566680|560457862|FG000|Overall Study|Withdrawal by Subject|3|||
155280068|NCT03836664|560457866|FG000|Overall Study|Didn't complete forms and lost drug|3|||
155280069|NCT03836664|560457867|FG001|Overall Study|Didn't complete forms and lost drug|3|||
155280070|NCT02550873|560457869|FG000|Randomized Double Blind|Adverse Event|3|||
155280071|NCT02550873|560457870|FG001|Randomized Double Blind|Adverse Event|1|||
155280072|NCT02550873|560457871|FG002|Randomized Double Blind|Adverse Event|0|||
155280073|NCT02550873|560457869|FG000|Randomized Double Blind|Disease progression|1|||
155280074|NCT02550873|560457870|FG001|Randomized Double Blind|Disease progression|1|||
155280075|NCT02550873|560457871|FG002|Randomized Double Blind|Disease progression|0|||
155280076|NCT02550873|560457869|FG000|Open Label Extension|Study ongoing|0|||
155280077|NCT02550873|560457870|FG001|Open Label Extension|Study ongoing|0|||
155280078|NCT02550873|560457871|FG002|Open Label Extension|Study ongoing|111|||
155280079|NCT02684903|560457875|FG000|Overall Study|COVID-19 shutdown of lab|4|||
155280080|NCT02684903|560457876|FG001|Overall Study|COVID-19 shutdown of lab|6|||
155280081|NCT02684903|560457875|FG000|Overall Study|Lost to Follow-up|31|||
155280082|NCT02684903|560457876|FG001|Overall Study|Lost to Follow-up|41|||
155280083|NCT00394095|560459727|FG000|Screening|Withdrawal by Subject|1|||
155280084|NCT00394095|560459728|FG001|Screening|Withdrawal by Subject|0|||
155280085|NCT00394095|560459727|FG000|Randomized|Withdrawal by Subject|5|||
155280086|NCT00394095|560459728|FG001|Randomized|Withdrawal by Subject|1|||
155280087|NCT00394095|560459727|FG000|Randomized|Adverse Event|1|||
155280088|NCT00394095|560459728|FG001|Randomized|Adverse Event|1|||
155280089|NCT00394095|560459727|FG000|Randomized|Overdose|1|||
155280090|NCT00394095|560459728|FG001|Randomized|Overdose|0|||
155280091|NCT00394095|560459727|FG000|Randomized|Lost to Follow-up|1|||
155280092|NCT00394095|560459728|FG001|Randomized|Lost to Follow-up|2|||
155280093|NCT01106287|560459729|FG000|Overall Study|Adverse Event|1|||
155280094|NCT01106287|560459730|FG001|Overall Study|Adverse Event|0|||
155280095|NCT01106287|560459731|FG002|Overall Study|Adverse Event|0|||
155280096|NCT01106287|560459732|FG003|Overall Study|Adverse Event|0|||
155280097|NCT05406791|560459735|FG000|Overall Study|Lost to Follow-up|13|||
155280098|NCT05406791|560459736|FG001|Overall Study|Lost to Follow-up|10|||
155280099|NCT00515086|560459737|FG000|Overall Study|Adverse Event|1|||
155280100|NCT00515086|560459738|FG001|Overall Study|Adverse Event|1|||
155280101|NCT00515086|560459739|FG002|Overall Study|Adverse Event|2|||
155280102|NCT00515086|560459740|FG003|Overall Study|Adverse Event|3|||
155280103|NCT00515086|560459737|FG000|Overall Study|Administrative|1|||
155280104|NCT00515086|560459738|FG001|Overall Study|Administrative|1|||
155280105|NCT00515086|560459739|FG002|Overall Study|Administrative|0|||
155386599|NCT00585195|560849152|FG003|Overall Study|Other|1|||
155386600|NCT00585195|560849153|FG004|Overall Study|Other|0|||
155386601|NCT00585195|560849154|FG005|Overall Study|Other|1|||
155386602|NCT00585195|560849155|FG006|Overall Study|Other|0|||
155386603|NCT00585195|560849156|FG007|Overall Study|Other|0|||
155386604|NCT00585195|560849157|FG008|Overall Study|Other|2|||
155386605|NCT00585195|560849158|FG009|Overall Study|Other|1|||
155386606|NCT00585195|560849159|FG010|Overall Study|Other|0|||
155386607|NCT00585195|560849160|FG011|Overall Study|Other|19|||
155386608|NCT00585195|560849161|FG012|Overall Study|Other|24|||
155386609|NCT00585195|560849162|FG013|Overall Study|Other|7|||
155386610|NCT00585195|560849163|FG014|Overall Study|Other|11|||
155386611|NCT00585195|560849164|FG015|Overall Study|Other|3|||
155386612|NCT00585195|560849165|FG016|Overall Study|Other|28|||
155386613|NCT00585195|560849166|FG017|Overall Study|Other|12|||
155386614|NCT00585195|560849167|FG018|Overall Study|Other|10|||
155386615|NCT00585195|560849168|FG019|Overall Study|Other|4|||
155386616|NCT00585195|560849169|FG020|Overall Study|Other|2|||
155386617|NCT00585195|560849149|FG000|Overall Study|Randomized not treated|0|||
155386618|NCT00585195|560849150|FG001|Overall Study|Randomized not treated|0|||
155386619|NCT00585195|560849151|FG002|Overall Study|Randomized not treated|1|||
155386620|NCT00585195|560849152|FG003|Overall Study|Randomized not treated|0|||
155386621|NCT00585195|560849153|FG004|Overall Study|Randomized not treated|1|||
155386622|NCT00585195|560849154|FG005|Overall Study|Randomized not treated|0|||
155386623|NCT00585195|560849155|FG006|Overall Study|Randomized not treated|1|||
155386624|NCT00585195|560849156|FG007|Overall Study|Randomized not treated|0|||
155386625|NCT00585195|560849157|FG008|Overall Study|Randomized not treated|0|||
155386626|NCT00585195|560849158|FG009|Overall Study|Randomized not treated|0|||
155386627|NCT00585195|560849159|FG010|Overall Study|Randomized not treated|2|||
155386628|NCT00585195|560849160|FG011|Overall Study|Randomized not treated|0|||
155386629|NCT00585195|560849161|FG012|Overall Study|Randomized not treated|0|||
155386630|NCT00585195|560849162|FG013|Overall Study|Randomized not treated|0|||
155386631|NCT00585195|560849163|FG014|Overall Study|Randomized not treated|0|||
155386632|NCT00585195|560849164|FG015|Overall Study|Randomized not treated|1|||
155386633|NCT00585195|560849165|FG016|Overall Study|Randomized not treated|0|||
155386634|NCT00585195|560849166|FG017|Overall Study|Randomized not treated|1|||
155386635|NCT00585195|560849167|FG018|Overall Study|Randomized not treated|3|||
155386636|NCT00585195|560849168|FG019|Overall Study|Randomized not treated|0|||
155386637|NCT00585195|560849169|FG020|Overall Study|Randomized not treated|2|||
155386638|NCT00585195|560849149|FG000|Overall Study|Death|0|||
155386639|NCT00585195|560849150|FG001|Overall Study|Death|0|||
155386640|NCT00585195|560849151|FG002|Overall Study|Death|0|||
155386641|NCT00585195|560849152|FG003|Overall Study|Death|0|||
155386642|NCT00585195|560849153|FG004|Overall Study|Death|0|||
155386643|NCT00585195|560849154|FG005|Overall Study|Death|0|||
155386644|NCT00585195|560849155|FG006|Overall Study|Death|0|||
155386645|NCT00585195|560849156|FG007|Overall Study|Death|0|||
155386646|NCT00585195|560849157|FG008|Overall Study|Death|1|||
155386647|NCT00585195|560849158|FG009|Overall Study|Death|0|||
155386648|NCT00585195|560849159|FG010|Overall Study|Death|1|||
155386649|NCT00585195|560849160|FG011|Overall Study|Death|1|||
155386650|NCT00585195|560849161|FG012|Overall Study|Death|7|||
155386651|NCT00585195|560849162|FG013|Overall Study|Death|2|||
155386652|NCT00585195|560849163|FG014|Overall Study|Death|8|||
155386653|NCT00585195|560849164|FG015|Overall Study|Death|2|||
155386654|NCT00585195|560849165|FG016|Overall Study|Death|11|||
155386655|NCT00585195|560849166|FG017|Overall Study|Death|0|||
155729272|NCT02113982|562108034|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729273|NCT02113982|562108035|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
155386656|NCT00585195|560849167|FG018|Overall Study|Death|0|||
155386657|NCT00585195|560849168|FG019|Overall Study|Death|0|||
155386658|NCT00585195|560849169|FG020|Overall Study|Death|1|||
155386659|NCT00585195|560849149|FG000|Overall Study|Lost to Follow-up|0|||
155386660|NCT00585195|560849150|FG001|Overall Study|Lost to Follow-up|0|||
155386661|NCT00585195|560849151|FG002|Overall Study|Lost to Follow-up|0|||
155386662|NCT00585195|560849152|FG003|Overall Study|Lost to Follow-up|0|||
155386663|NCT00585195|560849153|FG004|Overall Study|Lost to Follow-up|0|||
155386664|NCT00585195|560849154|FG005|Overall Study|Lost to Follow-up|0|||
155386665|NCT00585195|560849155|FG006|Overall Study|Lost to Follow-up|0|||
155386666|NCT00585195|560849156|FG007|Overall Study|Lost to Follow-up|0|||
155386667|NCT00585195|560849157|FG008|Overall Study|Lost to Follow-up|0|||
155386668|NCT00585195|560849158|FG009|Overall Study|Lost to Follow-up|0|||
155386669|NCT00585195|560849159|FG010|Overall Study|Lost to Follow-up|0|||
155386670|NCT00585195|560849160|FG011|Overall Study|Lost to Follow-up|0|||
155386671|NCT00585195|560849161|FG012|Overall Study|Lost to Follow-up|1|||
155386672|NCT00585195|560849162|FG013|Overall Study|Lost to Follow-up|0|||
155386673|NCT00585195|560849163|FG014|Overall Study|Lost to Follow-up|0|||
155386674|NCT00585195|560849164|FG015|Overall Study|Lost to Follow-up|0|||
155386675|NCT00585195|560849165|FG016|Overall Study|Lost to Follow-up|0|||
155386676|NCT00585195|560849166|FG017|Overall Study|Lost to Follow-up|2|||
155386677|NCT00585195|560849167|FG018|Overall Study|Lost to Follow-up|0|||
155386678|NCT00585195|560849168|FG019|Overall Study|Lost to Follow-up|0|||
155280106|NCT00515086|560459740|FG003|Overall Study|Administrative|0|||
155280107|NCT00515086|560459737|FG000|Overall Study|Withdrawal by Subject|1|||
155280108|NCT00515086|560459738|FG001|Overall Study|Withdrawal by Subject|0|||
155280109|NCT00515086|560459739|FG002|Overall Study|Withdrawal by Subject|0|||
155280110|NCT00515086|560459740|FG003|Overall Study|Withdrawal by Subject|1|||
155280111|NCT00515086|560459737|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
155280112|NCT00515086|560459738|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155280113|NCT00515086|560459739|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
155280114|NCT00515086|560459740|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155280115|NCT00515086|560459737|FG000|Overall Study|Lost to Follow-up|1|||
155280116|NCT00515086|560459738|FG001|Overall Study|Lost to Follow-up|0|||
155280117|NCT00515086|560459739|FG002|Overall Study|Lost to Follow-up|0|||
155280118|NCT00515086|560459740|FG003|Overall Study|Lost to Follow-up|0|||
155280119|NCT00515086|560459737|FG000|Overall Study|Study drug no longer required|0|||
155280120|NCT00515086|560459738|FG001|Overall Study|Study drug no longer required|1|||
155280121|NCT00515086|560459739|FG002|Overall Study|Study drug no longer required|0|||
155280122|NCT00515086|560459740|FG003|Overall Study|Study drug no longer required|0|||
155280123|NCT00515086|560459737|FG000|Overall Study|Death|2|||
155280124|NCT00515086|560459738|FG001|Overall Study|Death|0|||
155280125|NCT00515086|560459739|FG002|Overall Study|Death|0|||
155280126|NCT00515086|560459740|FG003|Overall Study|Death|0|||
155280127|NCT01636362|560459741|FG000|Overall Study|Physician Decision|6|||
155280128|NCT01636362|560459741|FG000|Overall Study|Subject healed, not returning|1|||
155280129|NCT01636362|560459741|FG000|Overall Study|Withdrawal by Subject|1|||
155280130|NCT03330119|560459742|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
155280131|NCT03330119|560459743|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
155280132|NCT00550732|560459747|FG000|Overall Study|Death|4|||
155280133|NCT00550732|560459747|FG000|Overall Study|Withdrawal by Subject|2|||
155280134|NCT00550732|560459747|FG000|Overall Study|Physician Decision|2|||
155280135|NCT00550732|560459747|FG000|Overall Study|Lost to Follow-up|1|||
155280136|NCT00550732|560459747|FG000|Overall Study|Palliative care|1|||
155280137|NCT00550732|560459747|FG000|Overall Study|Adverse Event|1|||
155280138|NCT00926393|560459749|FG000|Overall Study|Withdrawal by Subject|1|||
155280139|NCT00926393|560459750|FG001|Overall Study|Withdrawal by Subject|2|||
155280140|NCT00926393|560459749|FG000|Overall Study|Adverse Event|1|||
155280141|NCT00926393|560459750|FG001|Overall Study|Adverse Event|1|||
155280142|NCT01403987|560459752|FG000|Overall Study|Residents forgot their secret PIN|18|||
155280143|NCT01403987|560459753|FG001|Overall Study|Residents forgot their secret PIN|17|||
155280144|NCT01403987|560459754|FG002|Overall Study|Residents forgot their secret PIN|18|||
155280145|NCT00180674|560459756|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
155280146|NCT00180674|560459756|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
155280147|NCT03302910|560459757|FG000|Overall Study|Protocol Violation|1|||
155280148|NCT03302910|560459758|FG001|Overall Study|Protocol Violation|0|||
155280149|NCT00953160|560459760|FG000|Overall Study|Lost to Follow-up|23|||
155280150|NCT00953160|560459760|FG000|Overall Study|Withdrawal by Subject|4|||
155280151|NCT02179918|560459761|FG000|Overall Study|Death|0|||
155280152|NCT02179918|560459762|FG001|Overall Study|Death|0|||
155280153|NCT02179918|560459763|FG002|Overall Study|Death|0|||
155280154|NCT02179918|560459764|FG003|Overall Study|Death|1|||
155280155|NCT02179918|560459765|FG004|Overall Study|Death|0|||
155280156|NCT02179918|560459761|FG000|Overall Study|Lost to Follow-up|0|||
155280157|NCT02179918|560459762|FG001|Overall Study|Lost to Follow-up|0|||
155280158|NCT02179918|560459763|FG002|Overall Study|Lost to Follow-up|1|||
155280159|NCT02179918|560459764|FG003|Overall Study|Lost to Follow-up|0|||
155280160|NCT02179918|560459765|FG004|Overall Study|Lost to Follow-up|0|||
155280161|NCT02179918|560459761|FG000|Overall Study|Progressive Disease|4|||
155280162|NCT02179918|560459762|FG001|Overall Study|Progressive Disease|1|||
155280163|NCT02179918|560459763|FG002|Overall Study|Progressive Disease|1|||
155280164|NCT02179918|560459764|FG003|Overall Study|Progressive Disease|2|||
155280165|NCT02179918|560459765|FG004|Overall Study|Progressive Disease|6|||
155280166|NCT02179918|560459761|FG000|Overall Study|Other|0|||
155280167|NCT02179918|560459762|FG001|Overall Study|Other|1|||
155280168|NCT02179918|560459763|FG002|Overall Study|Other|0|||
155280169|NCT02179918|560459764|FG003|Overall Study|Other|0|||
155280170|NCT02179918|560459765|FG004|Overall Study|Other|1|||
155280171|NCT02179918|560459761|FG000|Overall Study|Subject refused further follow-up|0|||
155280172|NCT02179918|560459762|FG001|Overall Study|Subject refused further follow-up|1|||
155280173|NCT02179918|560459763|FG002|Overall Study|Subject refused further follow-up|0|||
155280174|NCT02179918|560459764|FG003|Overall Study|Subject refused further follow-up|0|||
155280175|NCT02179918|560459765|FG004|Overall Study|Subject refused further follow-up|1|||
155280176|NCT02118714|560459770|FG000|Overall Study|Lost to Follow-up|2|||
155280177|NCT02118714|560459770|FG000|Overall Study|Protocol Violation|1|||
155280178|NCT02954575|560459771|FG000|Overall Study|Withdrawal by Subject|2|||
155280179|NCT02954575|560459771|FG000|Overall Study|Adverse Event|1|||
155280180|NCT00570661|560459773|FG000|Overall Study|Disease worsening|5|||
155280181|NCT00570661|560459773|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
155280182|NCT00570661|560459773|FG000|Overall Study|Adverse Event|1|||
155280183|NCT01066156|560459774|FG000|Overall Study|ineligible|2|||
155280184|NCT01066156|560459774|FG000|Overall Study|Lost to Follow-up|7|||
155280185|NCT01066156|560459774|FG000|Overall Study|Withdrawal by Subject|1|||
155280186|NCT01734382|560459778|FG000|Part 1|Adverse Event|2|||
155280187|NCT01734382|560459779|FG001|Part 1|Adverse Event|0|||
155280188|NCT01734382|560459780|FG002|Part 1|Adverse Event|0|||
155280189|NCT01734382|560459778|FG000|Part 2|Adverse Event|0|||
155280190|NCT01734382|560459779|FG001|Part 2|Adverse Event|0|||
155280191|NCT01734382|560459780|FG002|Part 2|Adverse Event|1|||
155280192|NCT01734382|560459778|FG000|Part 2|Lack of Efficacy|0|||
155280193|NCT01734382|560459779|FG001|Part 2|Lack of Efficacy|1|||
155280194|NCT01734382|560459780|FG002|Part 2|Lack of Efficacy|1|||
155280195|NCT01734382|560459778|FG000|Part 2|Other|0|||
155280196|NCT01734382|560459779|FG001|Part 2|Other|0|||
155280197|NCT01734382|560459780|FG002|Part 2|Other|1|||
155280198|NCT01734382|560459778|FG000|Part 2|Physician Decision|0|||
155280199|NCT01734382|560459779|FG001|Part 2|Physician Decision|0|||
155280200|NCT01734382|560459780|FG002|Part 2|Physician Decision|3|||
155280201|NCT01734382|560459778|FG000|Part 2|Protocol Violation|0|||
155280202|NCT01734382|560459779|FG001|Part 2|Protocol Violation|1|||
155280203|NCT01734382|560459780|FG002|Part 2|Protocol Violation|0|||
155280204|NCT01734382|560459778|FG000|Part 2|Withdrawal by Subject|0|||
155280205|NCT01734382|560459779|FG001|Part 2|Withdrawal by Subject|0|||
155280206|NCT01734382|560459780|FG002|Part 2|Withdrawal by Subject|1|||
155280207|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
155280208|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
155280209|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
155280210|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
155280211|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
155280212|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
155280213|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
155280214|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
155280215|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
155280216|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
155280217|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
155280218|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
155280219|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
155280220|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
155280221|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
155280222|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
155280223|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
155280224|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
155280225|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
155280226|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
155280227|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
155280228|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
155280229|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
155280230|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
155280231|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
155280232|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280233|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280234|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280235|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280236|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
155280237|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280238|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280239|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280240|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
155280241|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280242|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280243|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
155280244|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
155280245|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
155280246|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
155280247|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
155280248|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
155280249|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
155280250|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
155280251|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155280252|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155386679|NCT00585195|560849169|FG020|Overall Study|Lost to Follow-up|0|||
155386680|NCT00585195|560849149|FG000|Overall Study|Site Terminated by Sponsor|0|||
155386681|NCT00585195|560849150|FG001|Overall Study|Site Terminated by Sponsor|0|||
155386682|NCT00585195|560849151|FG002|Overall Study|Site Terminated by Sponsor|0|||
155386683|NCT00585195|560849152|FG003|Overall Study|Site Terminated by Sponsor|0|||
155386684|NCT00585195|560849153|FG004|Overall Study|Site Terminated by Sponsor|0|||
155386685|NCT00585195|560849154|FG005|Overall Study|Site Terminated by Sponsor|0|||
155386686|NCT00585195|560849155|FG006|Overall Study|Site Terminated by Sponsor|0|||
155386687|NCT00585195|560849156|FG007|Overall Study|Site Terminated by Sponsor|0|||
155386688|NCT00585195|560849157|FG008|Overall Study|Site Terminated by Sponsor|0|||
155386689|NCT00585195|560849158|FG009|Overall Study|Site Terminated by Sponsor|0|||
155386690|NCT00585195|560849159|FG010|Overall Study|Site Terminated by Sponsor|0|||
155386691|NCT00585195|560849160|FG011|Overall Study|Site Terminated by Sponsor|0|||
155386692|NCT00585195|560849161|FG012|Overall Study|Site Terminated by Sponsor|1|||
155386693|NCT00585195|560849162|FG013|Overall Study|Site Terminated by Sponsor|0|||
155386694|NCT00585195|560849163|FG014|Overall Study|Site Terminated by Sponsor|0|||
155386695|NCT00585195|560849164|FG015|Overall Study|Site Terminated by Sponsor|0|||
155386696|NCT00585195|560849165|FG016|Overall Study|Site Terminated by Sponsor|0|||
155386697|NCT00585195|560849166|FG017|Overall Study|Site Terminated by Sponsor|0|||
155386698|NCT00585195|560849167|FG018|Overall Study|Site Terminated by Sponsor|0|||
155386699|NCT00585195|560849168|FG019|Overall Study|Site Terminated by Sponsor|0|||
155386700|NCT00585195|560849169|FG020|Overall Study|Site Terminated by Sponsor|0|||
155386701|NCT00585195|560849149|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
155386702|NCT00585195|560849150|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
155386703|NCT00585195|560849151|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
155386704|NCT00585195|560849152|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
155386705|NCT00585195|560849153|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
155386706|NCT00585195|560849154|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
155386707|NCT00585195|560849155|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
155386708|NCT00585195|560849156|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
155386709|NCT00585195|560849157|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
155386710|NCT00585195|560849158|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
155386711|NCT00585195|560849159|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
155386712|NCT00585195|560849160|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
155386713|NCT00585195|560849161|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
155386714|NCT00585195|560849162|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
155386715|NCT00585195|560849163|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
155386716|NCT00585195|560849164|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
155386717|NCT00585195|560849165|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
155386718|NCT00585195|560849166|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
155386719|NCT00585195|560849167|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
155386720|NCT00585195|560849168|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
155386721|NCT00585195|560849169|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
155386722|NCT00770341|560849170|FG000|Overall Study|Did not meet eligibility criteria|1|||
155386723|NCT00770341|560849171|FG001|Overall Study|Did not meet eligibility criteria|0|||
155386724|NCT00770341|560849172|FG002|Overall Study|Did not meet eligibility criteria|0|||
155386725|NCT00770341|560849170|FG000|Overall Study|Withdrawal by Subject|0|||
155386726|NCT00770341|560849171|FG001|Overall Study|Withdrawal by Subject|1|||
155386727|NCT00770341|560849172|FG002|Overall Study|Withdrawal by Subject|0|||
155386728|NCT00770341|560849170|FG000|Overall Study|Clinical Adverse Event|3|||
155386729|NCT00770341|560849171|FG001|Overall Study|Clinical Adverse Event|1|||
155386730|NCT00770341|560849172|FG002|Overall Study|Clinical Adverse Event|2|||
155386731|NCT00770341|560849170|FG000|Overall Study|Laboratory adverse event|3|||
155386732|NCT00770341|560849171|FG001|Overall Study|Laboratory adverse event|3|||
155386733|NCT00770341|560849172|FG002|Overall Study|Laboratory adverse event|0|||
155386734|NCT00770341|560849170|FG000|Overall Study|Lack of Efficacy|3|||
155386735|NCT00770341|560849171|FG001|Overall Study|Lack of Efficacy|0|||
155386736|NCT00770341|560849172|FG002|Overall Study|Lack of Efficacy|1|||
155386737|NCT00770341|560849170|FG000|Overall Study|Other|1|||
155386738|NCT00770341|560849171|FG001|Overall Study|Other|0|||
155386739|NCT00770341|560849172|FG002|Overall Study|Other|0|||
155386740|NCT00770341|560849170|FG000|Overall Study|Not treated|1|||
155386741|NCT00770341|560849171|FG001|Overall Study|Not treated|0|||
155386742|NCT00770341|560849172|FG002|Overall Study|Not treated|0|||
155386743|NCT02796560|560849178|FG000|Overall Study|Adverse Event|2|||
155386744|NCT02796560|560849179|FG001|Overall Study|Adverse Event|0|||
155386745|NCT02796560|560849178|FG000|Overall Study|Withdrawal by Subject|2|||
155386746|NCT02796560|560849179|FG001|Overall Study|Withdrawal by Subject|2|||
155386747|NCT02533570|560849181|FG000|Overall Study|Adverse Event|0|||
155386748|NCT02533570|560849182|FG001|Overall Study|Adverse Event|1|||
155386749|NCT02533570|560849183|FG002|Overall Study|Adverse Event|1|||
155386750|NCT00529958|560849184|FG000|2-Year Follow-up|Lost to Follow-up|1|||
155386751|NCT00529958|560849185|FG001|2-Year Follow-up|Lost to Follow-up|2|||
155386752|NCT00529958|560849186|FG002|2-Year Follow-up|Lost to Follow-up|2|||
155386753|NCT00529958|560849184|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
155386754|NCT00529958|560849185|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
155729274|NCT02113982|562108036|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729275|NCT02113982|562108037|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729276|NCT02113982|562108038|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
155280253|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155280254|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
155280255|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280256|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280257|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
155280258|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280259|NCT04537949|560459785|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
155280260|NCT04537949|560459786|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
155280261|NCT04537949|560459787|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
155280262|NCT04537949|560459788|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
155280263|NCT04537949|560459789|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
155280264|NCT04537949|560459790|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
155280265|NCT04537949|560459791|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
155280266|NCT04537949|560459792|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
155280267|NCT04537949|560459785|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
155280268|NCT04537949|560459786|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280269|NCT04537949|560459787|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
155280270|NCT04537949|560459788|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
155280271|NCT04537949|560459789|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280272|NCT04537949|560459790|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280273|NCT04537949|560459791|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
155280274|NCT04537949|560459792|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
155280275|NCT04537949|560459785|FG000|Follow-up Phase|Lost to Follow-up|0|||
155280276|NCT04537949|560459786|FG001|Follow-up Phase|Lost to Follow-up|3|||
155280277|NCT04537949|560459787|FG002|Follow-up Phase|Lost to Follow-up|0|||
155280278|NCT04537949|560459788|FG003|Follow-up Phase|Lost to Follow-up|0|||
155280279|NCT04537949|560459789|FG004|Follow-up Phase|Lost to Follow-up|0|||
155280280|NCT04537949|560459790|FG005|Follow-up Phase|Lost to Follow-up|0|||
155280281|NCT04537949|560459791|FG006|Follow-up Phase|Lost to Follow-up|0|||
155280282|NCT04537949|560459792|FG007|Follow-up Phase|Lost to Follow-up|0|||
155280283|NCT04537949|560459785|FG000|Follow-up Phase|personal reasons|0|||
155280284|NCT04537949|560459786|FG001|Follow-up Phase|personal reasons|0|||
155280285|NCT04537949|560459787|FG002|Follow-up Phase|personal reasons|0|||
155280286|NCT04537949|560459788|FG003|Follow-up Phase|personal reasons|1|||
155280287|NCT04537949|560459789|FG004|Follow-up Phase|personal reasons|1|||
155280288|NCT04537949|560459790|FG005|Follow-up Phase|personal reasons|0|||
155280289|NCT04537949|560459791|FG006|Follow-up Phase|personal reasons|0|||
155280290|NCT04537949|560459792|FG007|Follow-up Phase|personal reasons|0|||
155280291|NCT04537949|560459785|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155280292|NCT04537949|560459786|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155280293|NCT04537949|560459787|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155280294|NCT04537949|560459788|FG003|Follow-up Phase|Withdrawal by Subject|0|||
155280295|NCT04537949|560459789|FG004|Follow-up Phase|Withdrawal by Subject|1|||
155280296|NCT04537949|560459790|FG005|Follow-up Phase|Withdrawal by Subject|0|||
155280297|NCT04537949|560459791|FG006|Follow-up Phase|Withdrawal by Subject|0|||
155280298|NCT04537949|560459792|FG007|Follow-up Phase|Withdrawal by Subject|0|||
155280299|NCT04003974|560459793|FG000|Overall Study|Missing|1|||
155280300|NCT04003974|560459794|FG001|Overall Study|Missing|0|||
155280301|NCT04003974|560459793|FG000|Overall Study|Withdrawal by Subject|0|||
155280302|NCT04003974|560459794|FG001|Overall Study|Withdrawal by Subject|2|||
155280303|NCT02400307|560459795|FG000|Overall Study|Enrolled and Never Dosed|1|||
155280304|NCT02400307|560459796|FG001|Overall Study|Enrolled and Never Dosed|0|||
155280305|NCT01052662|560459799|FG000|Overall Study|Lost to Follow-up|15|||
155280306|NCT01052662|560459800|FG001|Overall Study|Lost to Follow-up|13|||
155280307|NCT01052662|560459801|FG002|Overall Study|Lost to Follow-up|18|||
155280308|NCT01052662|560459799|FG000|Overall Study|Withdrawal by Subject|3|||
155280309|NCT01052662|560459800|FG001|Overall Study|Withdrawal by Subject|2|||
155280310|NCT01052662|560459801|FG002|Overall Study|Withdrawal by Subject|1|||
155280311|NCT01052662|560459799|FG000|Overall Study|Pharmacy issue|1|||
155280312|NCT01052662|560459800|FG001|Overall Study|Pharmacy issue|3|||
155280313|NCT01052662|560459801|FG002|Overall Study|Pharmacy issue|3|||
155280314|NCT01052662|560459799|FG000|Overall Study|Adverse Event|1|||
155280315|NCT01052662|560459800|FG001|Overall Study|Adverse Event|1|||
155280316|NCT01052662|560459801|FG002|Overall Study|Adverse Event|0|||
155280317|NCT01052662|560459799|FG000|Overall Study|Legal Problem|2|||
155280318|NCT01052662|560459800|FG001|Overall Study|Legal Problem|0|||
155280319|NCT01052662|560459801|FG002|Overall Study|Legal Problem|0|||
155280320|NCT01052662|560459799|FG000|Overall Study|Administrative|0|||
155280321|NCT01052662|560459800|FG001|Overall Study|Administrative|3|||
155280322|NCT01052662|560459801|FG002|Overall Study|Administrative|0|||
155386755|NCT00529958|560849186|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
155386756|NCT00529958|560849184|FG000|5-Year Follow-up|Lost to Follow-up|2|||
155729277|NCT02113982|562108039|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
155280323|NCT00479674|560459804|FG000|Overall Study|Adverse Event|18|||
155280324|NCT00479674|560459804|FG000|Overall Study|Withdrawal by Subject|6|||
155280325|NCT00479674|560459804|FG000|Overall Study|Physician Decision|14|||
155280326|NCT00479674|560459804|FG000|Overall Study|none provided|3|||
155280327|NCT02478359|560459806|FG000|Overall Study|Disenrolled from health plan|106|||
155280328|NCT02478359|560459807|FG001|Overall Study|Disenrolled from health plan|65|||
155280329|NCT03293485|560459811|FG000|Overall Study|Death|1|||
155280330|NCT03293485|560459811|FG000|Overall Study|Screen Failure|2|||
155280331|NCT03293485|560459811|FG000|Overall Study|Withdrawal by Subject|2|||
155280332|NCT03023332|560459812|FG000|Overall Study|Withdrawal by Subject|10|||
155280333|NCT03023332|560459813|FG001|Overall Study|Withdrawal by Subject|5|||
155280334|NCT03023332|560459814|FG002|Overall Study|Withdrawal by Subject|4|||
155280335|NCT03023332|560459815|FG003|Overall Study|Withdrawal by Subject|7|||
155280336|NCT03023332|560459812|FG000|Overall Study|Lost to Follow-up|13|||
155280337|NCT03023332|560459813|FG001|Overall Study|Lost to Follow-up|16|||
155280338|NCT03023332|560459814|FG002|Overall Study|Lost to Follow-up|8|||
155280339|NCT03023332|560459815|FG003|Overall Study|Lost to Follow-up|13|||
155280340|NCT03023332|560459812|FG000|Overall Study|Death|1|||
155280341|NCT03023332|560459813|FG001|Overall Study|Death|0|||
155280342|NCT03023332|560459814|FG002|Overall Study|Death|0|||
155280343|NCT03023332|560459815|FG003|Overall Study|Death|0|||
155280344|NCT02013687|560459816|FG000|Overall Study|Lost to Follow-up|0|||
155280345|NCT02013687|560459817|FG001|Overall Study|Lost to Follow-up|0|||
155280346|NCT02013687|560459818|FG002|Overall Study|Lost to Follow-up|1|||
155280347|NCT02013687|560459819|FG003|Overall Study|Lost to Follow-up|0|||
155280348|NCT02013687|560459816|FG000|Overall Study|Protocol Violation|0|||
155280349|NCT02013687|560459817|FG001|Overall Study|Protocol Violation|0|||
155280350|NCT02013687|560459818|FG002|Overall Study|Protocol Violation|0|||
155280351|NCT02013687|560459819|FG003|Overall Study|Protocol Violation|1|||
155280352|NCT02013687|560459816|FG000|Overall Study|Withdrawal by Subject|0|||
155280353|NCT02013687|560459817|FG001|Overall Study|Withdrawal by Subject|0|||
155280354|NCT02013687|560459818|FG002|Overall Study|Withdrawal by Subject|0|||
155280355|NCT02013687|560459819|FG003|Overall Study|Withdrawal by Subject|1|||
155280356|NCT02013687|560459816|FG000|Overall Study|Missed visits due to patient travel|0|||
155280357|NCT02013687|560459817|FG001|Overall Study|Missed visits due to patient travel|0|||
155280358|NCT02013687|560459818|FG002|Overall Study|Missed visits due to patient travel|1|||
155280359|NCT02013687|560459819|FG003|Overall Study|Missed visits due to patient travel|0|||
155280360|NCT01782326|560459820|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
155280361|NCT01782326|560459821|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
155280362|NCT01782326|560459820|FG000|Planned Treatment Epoch|Death|29|||
155280363|NCT01782326|560459821|FG001|Planned Treatment Epoch|Death|30|||
155280364|NCT01782326|560459820|FG000|Planned Treatment Epoch|Physician Decision|18|||
155280365|NCT01782326|560459821|FG001|Planned Treatment Epoch|Physician Decision|16|||
155280366|NCT01782326|560459820|FG000|Planned Treatment Epoch|Protocol deviation|2|||
155280367|NCT01782326|560459821|FG001|Planned Treatment Epoch|Protocol deviation|3|||
155280368|NCT01782326|560459820|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
155280369|NCT01782326|560459821|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
155280370|NCT01782326|560459820|FG000|Planned Treatment Epoch|Technical problems|0|||
155280371|NCT01782326|560459821|FG001|Planned Treatment Epoch|Technical problems|4|||
155280372|NCT01782326|560459820|FG000|Double-blind Treatment|Adverse Event|129|||
155280373|NCT01782326|560459821|FG001|Double-blind Treatment|Adverse Event|145|||
155280374|NCT01782326|560459820|FG000|Double-blind Treatment|Subject/guardian decision|111|||
155280375|NCT01782326|560459821|FG001|Double-blind Treatment|Subject/guardian decision|125|||
155280376|NCT01782326|560459820|FG000|Double-blind Treatment|Lack of Efficacy|17|||
155280377|NCT01782326|560459821|FG001|Double-blind Treatment|Lack of Efficacy|22|||
155280378|NCT01782326|560459820|FG000|Double-blind Treatment|Physician Decision|13|||
155280379|NCT01782326|560459821|FG001|Double-blind Treatment|Physician Decision|16|||
155280380|NCT01782326|560459820|FG000|Double-blind Treatment|Protocol deviation|8|||
155280381|NCT01782326|560459821|FG001|Double-blind Treatment|Protocol deviation|7|||
155280382|NCT01782326|560459820|FG000|Double-blind Treatment|Technical problems|0|||
155280383|NCT01782326|560459821|FG001|Double-blind Treatment|Technical problems|5|||
155280384|NCT03633903|560459822|FG000|Overall Study|Withdrawal by Subject|1|||
155280385|NCT03633903|560459823|FG001|Overall Study|Withdrawal by Subject|2|||
155280386|NCT03633903|560459822|FG000|Overall Study|Lost to Follow-up|5|||
155280387|NCT03633903|560459823|FG001|Overall Study|Lost to Follow-up|5|||
155280388|NCT05968482|560459824|FG000|First Crossover Period|Withdrawal by Subject|0|||
155280389|NCT05968482|560459825|FG001|First Crossover Period|Withdrawal by Subject|0|||
155280390|NCT05968482|560459826|FG002|First Crossover Period|Withdrawal by Subject|1|||
155280391|NCT05968482|560459827|FG003|First Crossover Period|Withdrawal by Subject|0|||
155280392|NCT05968482|560459828|FG004|First Crossover Period|Withdrawal by Subject|0|||
155280393|NCT05968482|560459829|FG005|First Crossover Period|Withdrawal by Subject|0|||
155280394|NCT05968482|560459824|FG000|First Crossover Period|Adverse Event|0|||
155280395|NCT05968482|560459825|FG001|First Crossover Period|Adverse Event|0|||
155280396|NCT05968482|560459826|FG002|First Crossover Period|Adverse Event|0|||
155280397|NCT05968482|560459827|FG003|First Crossover Period|Adverse Event|0|||
155280398|NCT05968482|560459828|FG004|First Crossover Period|Adverse Event|0|||
155280399|NCT05968482|560459829|FG005|First Crossover Period|Adverse Event|1|||
155280400|NCT05968482|560459824|FG000|Second Crossover Period|Withdrawal by Subject|0|||
155280401|NCT05968482|560459825|FG001|Second Crossover Period|Withdrawal by Subject|0|||
155280402|NCT05968482|560459826|FG002|Second Crossover Period|Withdrawal by Subject|0|||
155280403|NCT05968482|560459827|FG003|Second Crossover Period|Withdrawal by Subject|0|||
155280404|NCT05968482|560459828|FG004|Second Crossover Period|Withdrawal by Subject|1|||
155280405|NCT05968482|560459829|FG005|Second Crossover Period|Withdrawal by Subject|0|||
155280406|NCT05968482|560459824|FG000|Third Crossover Period|Adverse Event|0|||
155280407|NCT05968482|560459825|FG001|Third Crossover Period|Adverse Event|0|||
155280408|NCT05968482|560459826|FG002|Third Crossover Period|Adverse Event|0|||
155280409|NCT05968482|560459827|FG003|Third Crossover Period|Adverse Event|0|||
155280410|NCT05968482|560459828|FG004|Third Crossover Period|Adverse Event|1|||
155280411|NCT05968482|560459829|FG005|Third Crossover Period|Adverse Event|0|||
155280412|NCT05968482|560459824|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
155280413|NCT05968482|560459825|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
155280414|NCT05968482|560459826|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
155280415|NCT05968482|560459827|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
155280416|NCT05968482|560459828|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
155280417|NCT05968482|560459829|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
155280418|NCT02559817|560459830|FG000|Treatment Period|Adverse Event|1|||
155280419|NCT02559817|560459831|FG001|Treatment Period|Adverse Event|0|||
155280420|NCT02559817|560459832|FG002|Treatment Period|Adverse Event|1|||
155280421|NCT02559817|560459833|FG003|Treatment Period|Adverse Event|0|||
155280422|NCT02559817|560459834|FG004|Treatment Period|Adverse Event|0|||
155280423|NCT02559817|560459830|FG000|Treatment Period|Lack of Efficacy|0|||
155280424|NCT02559817|560459831|FG001|Treatment Period|Lack of Efficacy|1|||
155280425|NCT02559817|560459832|FG002|Treatment Period|Lack of Efficacy|0|||
155280426|NCT02559817|560459833|FG003|Treatment Period|Lack of Efficacy|0|||
155280427|NCT02559817|560459834|FG004|Treatment Period|Lack of Efficacy|0|||
155280428|NCT02559817|560459830|FG000|Treatment Period|Lost to Follow-up|0|||
155280429|NCT02559817|560459831|FG001|Treatment Period|Lost to Follow-up|1|||
155280430|NCT02559817|560459832|FG002|Treatment Period|Lost to Follow-up|0|||
155280431|NCT02559817|560459833|FG003|Treatment Period|Lost to Follow-up|1|||
155280432|NCT02559817|560459834|FG004|Treatment Period|Lost to Follow-up|0|||
155280433|NCT02559817|560459830|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
155280434|NCT02559817|560459831|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
155280435|NCT02559817|560459832|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
155280436|NCT02559817|560459833|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
155280437|NCT02559817|560459834|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
155280438|NCT02559817|560459830|FG000|Treatment Period|Protocol Violation|0|||
155280439|NCT02559817|560459831|FG001|Treatment Period|Protocol Violation|0|||
155280440|NCT02559817|560459832|FG002|Treatment Period|Protocol Violation|0|||
155280441|NCT02559817|560459833|FG003|Treatment Period|Protocol Violation|1|||
155280442|NCT02559817|560459834|FG004|Treatment Period|Protocol Violation|0|||
155280443|NCT01657682|560459835|FG000|Overall Study|Lost to Follow-up|1|||
155280444|NCT01657682|560459836|FG001|Overall Study|Lost to Follow-up|0|||
155280445|NCT01657682|560459837|FG002|Overall Study|Lost to Follow-up|0|||
155280446|NCT01657682|560459835|FG000|Overall Study|Withdrawal by Subject|0|||
155280447|NCT01657682|560459836|FG001|Overall Study|Withdrawal by Subject|1|||
155280448|NCT01657682|560459837|FG002|Overall Study|Withdrawal by Subject|1|||
155280449|NCT01657682|560459835|FG000|Overall Study|Adverse Event|0|||
155280450|NCT01657682|560459836|FG001|Overall Study|Adverse Event|1|||
155280451|NCT01657682|560459837|FG002|Overall Study|Adverse Event|0|||
155280452|NCT03389893|560459838|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
155280453|NCT03389893|560459839|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280454|NCT03389893|560459840|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280455|NCT03389893|560459841|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280456|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
155280457|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
155280458|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
155280459|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
155280460|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
155386757|NCT00529958|560849185|FG001|5-Year Follow-up|Lost to Follow-up|3|||
155280461|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
155280462|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
155280463|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
155280464|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
155386758|NCT00529958|560849186|FG002|5-Year Follow-up|Lost to Follow-up|1|||
155386759|NCT00529958|560849184|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
155386760|NCT00529958|560849185|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
155386761|NCT00529958|560849186|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
155386762|NCT03816332|560849187|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
155386763|NCT03816332|560849187|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
155386764|NCT03534284|560849190|FG000|Overall Study|Death|2|||
155386765|NCT03534284|560849191|FG001|Overall Study|Death|3|||
155386766|NCT03534284|560849192|FG002|Overall Study|Death|3|||
155386767|NCT03534284|560849190|FG000|Overall Study|Withdrawal by Subject|5|||
155386768|NCT03534284|560849191|FG001|Overall Study|Withdrawal by Subject|0|||
155386769|NCT03534284|560849192|FG002|Overall Study|Withdrawal by Subject|0|||
155386770|NCT03316300|560849193|FG000|Overall Study|Withdrawal by Subject|3|||
155386771|NCT03316300|560849194|FG001|Overall Study|Withdrawal by Subject|2|||
155386772|NCT03316300|560849193|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
155386773|NCT03316300|560849194|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
155386774|NCT03316300|560849193|FG000|Overall Study|Adverse Event|1|||
155386775|NCT03316300|560849194|FG001|Overall Study|Adverse Event|0|||
155386776|NCT03316300|560849193|FG000|Overall Study|COVID-19|0|||
155386777|NCT03316300|560849194|FG001|Overall Study|COVID-19|1|||
155386778|NCT03164564|560849195|FG000|Overall Study|Death|3|||
155386779|NCT03164564|560849196|FG001|Overall Study|Death|0|||
155386780|NCT03164564|560849195|FG000|Overall Study|Withdrawal by Subject|20|||
155386781|NCT03164564|560849196|FG001|Overall Study|Withdrawal by Subject|15|||
155386782|NCT03164564|560849195|FG000|Overall Study|Lost to Follow-up|2|||
155386783|NCT03164564|560849196|FG001|Overall Study|Lost to Follow-up|0|||
155386784|NCT03164564|560849195|FG000|Overall Study|Physician Decision|0|||
155386785|NCT03164564|560849196|FG001|Overall Study|Physician Decision|1|||
155386786|NCT03164564|560849195|FG000|Overall Study|Adverse Event|0|||
155386787|NCT03164564|560849196|FG001|Overall Study|Adverse Event|1|||
155386788|NCT03164564|560849195|FG000|Overall Study|Ongoing|1586|||
155386789|NCT03164564|560849196|FG001|Overall Study|Ongoing|1586|||
155386790|NCT00294554|560851534|FG000|Overall Study|Lack of Efficacy|0|||
155386791|NCT00294554|560851535|FG001|Overall Study|Lack of Efficacy|1|||
155386792|NCT00294554|560851534|FG000|Overall Study|Physician Decision|0|||
155386793|NCT00294554|560851535|FG001|Overall Study|Physician Decision|1|||
155386794|NCT02544217|560851536|FG000|Overall Study|Withdrawal by Subject|1|||
155386795|NCT02544217|560851537|FG001|Overall Study|Withdrawal by Subject|1|||
155386796|NCT02544217|560851538|FG002|Overall Study|Withdrawal by Subject|0|||
155386797|NCT02544217|560851539|FG003|Overall Study|Withdrawal by Subject|0|||
155386798|NCT02544217|560851540|FG004|Overall Study|Withdrawal by Subject|0|||
155386799|NCT02544217|560851541|FG005|Overall Study|Withdrawal by Subject|0|||
155386800|NCT00887679|560851542|FG000|Overall Study|Withdrawal by Subject|1|||
155386801|NCT00887679|560851542|FG000|Overall Study|Lost to Follow-up|4|||
155386802|NCT00887679|560851542|FG000|Overall Study|Physician Decision|5|||
155386803|NCT02683941|560851543|FG000|Double-blind Phase|Adverse Event|0|||
155386804|NCT02683941|560851544|FG001|Double-blind Phase|Adverse Event|1|||
155386805|NCT02683941|560851543|FG000|Double-blind Phase|Withdrawal by Subject|4|||
155627136|NCT02351934|561732337|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
155627137|NCT02351934|561732338|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
155280465|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
155280466|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
155280467|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
155280468|NCT01719861|560459845|FG000|Cycle 1|Death|4|||
155280469|NCT01719861|560459845|FG000|Cycle 2|Death|1|||
155280470|NCT02034435|560459856|FG000|Overall Study|Withdrawal by Subject|1|||
155280471|NCT02034435|560459857|FG001|Overall Study|Withdrawal by Subject|0|||
155280472|NCT02034435|560459858|FG002|Overall Study|Withdrawal by Subject|0|||
155280473|NCT02034435|560459859|FG003|Overall Study|Withdrawal by Subject|0|||
155280474|NCT02034435|560459856|FG000|Overall Study|Illness|0|||
155280475|NCT02034435|560459857|FG001|Overall Study|Illness|2|||
155280476|NCT02034435|560459858|FG002|Overall Study|Illness|0|||
155280477|NCT02034435|560459859|FG003|Overall Study|Illness|0|||
155280478|NCT02034435|560459856|FG000|Overall Study|Inadequate IV access|1|||
155280479|NCT02034435|560459857|FG001|Overall Study|Inadequate IV access|0|||
155280480|NCT02034435|560459858|FG002|Overall Study|Inadequate IV access|0|||
155280481|NCT02034435|560459859|FG003|Overall Study|Inadequate IV access|1|||
155280482|NCT00772928|560459860|FG000|Overall Study|Lost to Follow-up|9|||
155280483|NCT00772928|560459861|FG001|Overall Study|Lost to Follow-up|6|||
155280484|NCT00772928|560459860|FG000|Overall Study|Protocol Violation|10|||
155280485|NCT00772928|560459861|FG001|Overall Study|Protocol Violation|12|||
155386806|NCT02683941|560851544|FG001|Double-blind Phase|Withdrawal by Subject|2|||
155386807|NCT02683941|560851543|FG000|Double-blind Phase|Lost to Follow-up|1|||
155386808|NCT02683941|560851544|FG001|Double-blind Phase|Lost to Follow-up|0|||
155280486|NCT00772928|560459860|FG000|Overall Study|Withdrawal by Subject|25|||
155280487|NCT00772928|560459861|FG001|Overall Study|Withdrawal by Subject|22|||
155280488|NCT00772928|560459860|FG000|Overall Study|Did not receive vaccine|0|||
155386809|NCT02683941|560851543|FG000|Double-blind Phase|Disease Progression|5|||
155386810|NCT02683941|560851544|FG001|Double-blind Phase|Disease Progression|2|||
155386811|NCT02683941|560851543|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
155386812|NCT02683941|560851544|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
155386813|NCT02683941|560851543|FG000|Open-label Treatment Phase|Disease Progression|1|||
155386814|NCT02683941|560851544|FG001|Open-label Treatment Phase|Disease Progression|2|||
155386815|NCT02683941|560851543|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
155386816|NCT02683941|560851544|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
155386817|NCT02683941|560851543|FG000|Open-label Treatment Phase|Other|1|||
155386818|NCT02683941|560851544|FG001|Open-label Treatment Phase|Other|0|||
155386819|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
155386820|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
155386821|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
155386822|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
155386823|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
155280489|NCT00772928|560459861|FG001|Overall Study|Did not receive vaccine|1|||
155280490|NCT04955626|560459867|FG000|Blinded Period|Lost to Follow-up|28|||
155280491|NCT04955626|560459868|FG001|Blinded Period|Lost to Follow-up|28|||
155280492|NCT04955626|560459869|FG002|Blinded Period|Lost to Follow-up|7|||
155280493|NCT04955626|560459870|FG003|Blinded Period|Lost to Follow-up|14|||
155280494|NCT04955626|560459871|FG004|Blinded Period|Lost to Follow-up|3|||
155280495|NCT04955626|560459872|FG005|Blinded Period|Lost to Follow-up|2|||
155280496|NCT04955626|560459873|FG006|Blinded Period|Lost to Follow-up|6|||
155280497|NCT04955626|560459874|FG007|Blinded Period|Lost to Follow-up|4|||
155280498|NCT04955626|560459875|FG008|Blinded Period|Lost to Follow-up|5|||
155280499|NCT04955626|560459876|FG009|Blinded Period|Lost to Follow-up|8|||
155280500|NCT04955626|560459877|FG010|Blinded Period|Lost to Follow-up|10|||
155280501|NCT04955626|560459878|FG011|Blinded Period|Lost to Follow-up|32|||
155280502|NCT04955626|560459879|FG012|Blinded Period|Lost to Follow-up|0|||
155280503|NCT04955626|560459880|FG013|Blinded Period|Lost to Follow-up|0|||
155280504|NCT04955626|560459881|FG014|Blinded Period|Lost to Follow-up|0|||
155280505|NCT04955626|560459882|FG015|Blinded Period|Lost to Follow-up|12|||
155280506|NCT04955626|560459883|FG016|Blinded Period|Lost to Follow-up|2|||
155280507|NCT04955626|560459884|FG017|Blinded Period|Lost to Follow-up|5|||
155280508|NCT04955626|560459885|FG018|Blinded Period|Lost to Follow-up|0|||
155280509|NCT04955626|560459886|FG019|Blinded Period|Lost to Follow-up|0|||
155280510|NCT04955626|560459887|FG020|Blinded Period|Lost to Follow-up|0|||
155280511|NCT04955626|560459888|FG021|Blinded Period|Lost to Follow-up|0|||
155280512|NCT04955626|560459889|FG022|Blinded Period|Lost to Follow-up|0|||
155280513|NCT04955626|560459890|FG023|Blinded Period|Lost to Follow-up|0|||
155280514|NCT04955626|560459891|FG024|Blinded Period|Lost to Follow-up|3|||
155280515|NCT04955626|560459892|FG025|Blinded Period|Lost to Follow-up|1|||
155280516|NCT04955626|560459893|FG026|Blinded Period|Lost to Follow-up|2|||
155280517|NCT04955626|560459894|FG027|Blinded Period|Lost to Follow-up|2|||
155280518|NCT04955626|560459895|FG028|Blinded Period|Lost to Follow-up|2|||
155280519|NCT04955626|560459896|FG029|Blinded Period|Lost to Follow-up|0|||
155280520|NCT04955626|560459897|FG030|Blinded Period|Lost to Follow-up|0|||
155280521|NCT04955626|560459898|FG031|Blinded Period|Lost to Follow-up|0|||
155280522|NCT04955626|560459899|FG032|Blinded Period|Lost to Follow-up|0|||
155280523|NCT04955626|560459900|FG033|Blinded Period|Lost to Follow-up|0|||
155280524|NCT04955626|560459901|FG034|Blinded Period|Lost to Follow-up|0|||
155280525|NCT04955626|560459902|FG035|Blinded Period|Lost to Follow-up|0|||
155280526|NCT04955626|560459867|FG000|Blinded Period|Protocol Violation|5|||
155280527|NCT04955626|560459868|FG001|Blinded Period|Protocol Violation|14|||
155280528|NCT04955626|560459869|FG002|Blinded Period|Protocol Violation|0|||
155280529|NCT04955626|560459870|FG003|Blinded Period|Protocol Violation|1|||
155280530|NCT04955626|560459871|FG004|Blinded Period|Protocol Violation|2|||
155280531|NCT04955626|560459872|FG005|Blinded Period|Protocol Violation|2|||
155280532|NCT04955626|560459873|FG006|Blinded Period|Protocol Violation|0|||
155280533|NCT04955626|560459874|FG007|Blinded Period|Protocol Violation|0|||
155280534|NCT04955626|560459875|FG008|Blinded Period|Protocol Violation|0|||
155280535|NCT04955626|560459876|FG009|Blinded Period|Protocol Violation|4|||
155280536|NCT04955626|560459877|FG010|Blinded Period|Protocol Violation|6|||
155280537|NCT04955626|560459878|FG011|Blinded Period|Protocol Violation|1|||
155280538|NCT04955626|560459879|FG012|Blinded Period|Protocol Violation|0|||
155280539|NCT04955626|560459880|FG013|Blinded Period|Protocol Violation|0|||
155280540|NCT04955626|560459881|FG014|Blinded Period|Protocol Violation|2|||
155280541|NCT04955626|560459882|FG015|Blinded Period|Protocol Violation|6|||
155280542|NCT04955626|560459883|FG016|Blinded Period|Protocol Violation|4|||
155280543|NCT04955626|560459884|FG017|Blinded Period|Protocol Violation|6|||
155280544|NCT04955626|560459885|FG018|Blinded Period|Protocol Violation|0|||
155280545|NCT04955626|560459886|FG019|Blinded Period|Protocol Violation|1|||
155280546|NCT04955626|560459887|FG020|Blinded Period|Protocol Violation|0|||
155280547|NCT04955626|560459888|FG021|Blinded Period|Protocol Violation|1|||
155280548|NCT04955626|560459889|FG022|Blinded Period|Protocol Violation|0|||
155280549|NCT04955626|560459890|FG023|Blinded Period|Protocol Violation|0|||
155280550|NCT04955626|560459891|FG024|Blinded Period|Protocol Violation|4|||
155280551|NCT04955626|560459892|FG025|Blinded Period|Protocol Violation|6|||
155280552|NCT04955626|560459893|FG026|Blinded Period|Protocol Violation|5|||
155280553|NCT04955626|560459894|FG027|Blinded Period|Protocol Violation|3|||
155280554|NCT04955626|560459895|FG028|Blinded Period|Protocol Violation|4|||
155386824|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
155386825|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Other|8|||
155386826|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Other|1|||
155386827|NCT02075541|560851546|FG000|Overall Study|Serious Adverse Event|1|||
155386828|NCT02075541|560851547|FG001|Overall Study|Serious Adverse Event|4|||
155386829|NCT02075541|560851546|FG000|Overall Study|Protocol Violation|1|||
155386830|NCT02075541|560851547|FG001|Overall Study|Protocol Violation|0|||
155386831|NCT02075541|560851546|FG000|Overall Study|Withdrawal by Subject|1|||
155386832|NCT02075541|560851547|FG001|Overall Study|Withdrawal by Subject|3|||
155386833|NCT02075541|560851546|FG000|Overall Study|Sponsor study termination|0|||
155386834|NCT02075541|560851547|FG001|Overall Study|Sponsor study termination|1|||
155386835|NCT02075541|560851546|FG000|Overall Study|Other- unable to perform study procedure|1|||
155386836|NCT02075541|560851547|FG001|Overall Study|Other- unable to perform study procedure|0|||
155386837|NCT02434939|560851548|FG000|Overall Study|Lack of Efficacy|34|||
155386838|NCT02434939|560851549|FG001|Overall Study|Lack of Efficacy|48|||
155386839|NCT02434939|560851548|FG000|Overall Study|Withdrawal by Subject|3|||
155386840|NCT02434939|560851549|FG001|Overall Study|Withdrawal by Subject|0|||
155386841|NCT02434939|560851548|FG000|Overall Study|Adverse Event|0|||
155386842|NCT02434939|560851549|FG001|Overall Study|Adverse Event|1|||
155386843|NCT03181451|560851550|FG000|Overall Study|Adverse Event|0|||
155386844|NCT03181451|560851551|FG001|Overall Study|Adverse Event|1|||
155386845|NCT03181451|560851552|FG002|Overall Study|Adverse Event|0|||
155386846|NCT03181451|560851550|FG000|Overall Study|Withdrawal by Subject|0|||
155386847|NCT03181451|560851551|FG001|Overall Study|Withdrawal by Subject|1|||
155386848|NCT03181451|560851552|FG002|Overall Study|Withdrawal by Subject|0|||
155386849|NCT01326533|560851553|FG000|Overall Study|Lost to Follow-up|2|||
155386850|NCT01326533|560851554|FG001|Overall Study|Lost to Follow-up|0|||
155386851|NCT01326533|560851553|FG000|Overall Study|Withdrawal by Subject|1|||
155386852|NCT01326533|560851554|FG001|Overall Study|Withdrawal by Subject|0|||
155386853|NCT01326533|560851553|FG000|Overall Study|Adverse Event|1|||
155386854|NCT01326533|560851554|FG001|Overall Study|Adverse Event|0|||
155386855|NCT04079803|560851555|FG000|Overall Study|Withdrawal by Subject|0|||
155386856|NCT04079803|560851556|FG001|Overall Study|Withdrawal by Subject|0|||
155386857|NCT04079803|560851557|FG002|Overall Study|Withdrawal by Subject|1|||
155386858|NCT00807235|560851565|FG000|Overall Study|Adverse Event|1|||
155386859|NCT00807235|560851566|FG001|Overall Study|Adverse Event|0|||
155386860|NCT01242800|560851569|FG000|Overall Study|Patient refusal|0|||
155386861|NCT01242800|560851570|FG001|Overall Study|Patient refusal|10|||
155386862|NCT01242800|560851569|FG000|Overall Study|Physician Decision|0|||
155386863|NCT01242800|560851570|FG001|Overall Study|Physician Decision|1|||
155386864|NCT01242800|560851569|FG000|Overall Study|Disease progression|0|||
155386865|NCT01242800|560851570|FG001|Overall Study|Disease progression|3|||
155386866|NCT01242800|560851569|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
155386867|NCT01242800|560851570|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
155386868|NCT01242800|560851569|FG000|Overall Study|Reasons not reported|0|||
155386869|NCT01242800|560851570|FG001|Overall Study|Reasons not reported|4|||
155386870|NCT00511901|560851579|FG000|Overall Study|Withdrawal by Subject|1|||
155386871|NCT00511901|560851580|FG001|Overall Study|Withdrawal by Subject|3|||
155386872|NCT02447172|560851581|FG000|Overall Study|Adverse Event|11|||
155386873|NCT02447172|560851582|FG001|Overall Study|Adverse Event|8|||
155386874|NCT02447172|560851583|FG002|Overall Study|Adverse Event|7|||
155386875|NCT02447172|560851581|FG000|Overall Study|Death|3|||
155386876|NCT02447172|560851582|FG001|Overall Study|Death|1|||
155386877|NCT02447172|560851583|FG002|Overall Study|Death|0|||
155386878|NCT02447172|560851581|FG000|Overall Study|Protocol Violation|2|||
155386879|NCT02447172|560851582|FG001|Overall Study|Protocol Violation|1|||
155386880|NCT02447172|560851583|FG002|Overall Study|Protocol Violation|2|||
155386881|NCT02447172|560851581|FG000|Overall Study|Lost to Follow-up|7|||
155386882|NCT02447172|560851582|FG001|Overall Study|Lost to Follow-up|4|||
155386883|NCT02447172|560851583|FG002|Overall Study|Lost to Follow-up|4|||
155386884|NCT02447172|560851581|FG000|Overall Study|Withdrawal by Subject|5|||
155386885|NCT02447172|560851582|FG001|Overall Study|Withdrawal by Subject|1|||
155386886|NCT02447172|560851583|FG002|Overall Study|Withdrawal by Subject|3|||
155386887|NCT02447172|560851581|FG000|Overall Study|protocol specific treatment unrelated|3|||
155386888|NCT02447172|560851582|FG001|Overall Study|protocol specific treatment unrelated|0|||
155386889|NCT02447172|560851583|FG002|Overall Study|protocol specific treatment unrelated|2|||
155386890|NCT01204398|560851587|FG000|Overall Study|Adverse Event|1|||
155386891|NCT03562247|560851588|FG000|Overall Study|Lost to Follow-up|3|||
155386892|NCT03562247|560851589|FG001|Overall Study|Lost to Follow-up|1|||
155386893|NCT03562247|560851590|FG002|Overall Study|Lost to Follow-up|1|||
155386894|NCT01296347|560851591|FG000|Allocation|Withdrawal by Subject|1|||
155386895|NCT01296347|560851592|FG001|Allocation|Withdrawal by Subject|2|||
155386896|NCT01296347|560851591|FG000|Allocation|Lack of Efficacy|1|||
155386897|NCT01296347|560851592|FG001|Allocation|Lack of Efficacy|2|||
155386898|NCT01296347|560851591|FG000|Allocation|not received infusion|1|||
155386899|NCT01296347|560851592|FG001|Allocation|not received infusion|0|||
155386900|NCT01296347|560851591|FG000|6 Week Follow up|Death|0|||
155386901|NCT01296347|560851592|FG001|6 Week Follow up|Death|1|||
155386902|NCT01296347|560851591|FG000|3 Month Follow up|Death|1|||
155386903|NCT01296347|560851592|FG001|3 Month Follow up|Death|0|||
155386904|NCT01296347|560851591|FG000|3 Month Follow up|Lost to Follow-up|0|||
155386905|NCT01296347|560851592|FG001|3 Month Follow up|Lost to Follow-up|1|||
155386906|NCT01296347|560851591|FG000|6 Month Follow up|Death|2|||
155386907|NCT01296347|560851592|FG001|6 Month Follow up|Death|1|||
155386908|NCT01296347|560851591|FG000|6 Month Follow up|Lost to Follow-up|0|||
155386909|NCT01296347|560851592|FG001|6 Month Follow up|Lost to Follow-up|1|||
155386910|NCT01296347|560851591|FG000|12 Month Follow up|Lost to Follow-up|3|||
155386911|NCT01296347|560851592|FG001|12 Month Follow up|Lost to Follow-up|1|||
155386912|NCT01296347|560851591|FG000|12 Month Follow up|Death|1|||
155386913|NCT01296347|560851592|FG001|12 Month Follow up|Death|1|||
155386914|NCT01296347|560851591|FG000|12 Month Follow up|Withdrawal by Subject|0|||
155386915|NCT01296347|560851592|FG001|12 Month Follow up|Withdrawal by Subject|1|||
155386916|NCT01163916|560851595|FG000|Overall Study|Withdrawal by Subject|2|||
155386917|NCT01163916|560851596|FG001|Overall Study|Withdrawal by Subject|0|||
155386918|NCT01163916|560851597|FG002|Overall Study|Withdrawal by Subject|2|||
155386919|NCT01163916|560851595|FG000|Overall Study|Adverse Event|2|||
155386920|NCT01163916|560851596|FG001|Overall Study|Adverse Event|0|||
155386921|NCT01163916|560851597|FG002|Overall Study|Adverse Event|1|||
155386922|NCT01163916|560851595|FG000|Overall Study|Lack of Efficacy|2|||
155386923|NCT01163916|560851596|FG001|Overall Study|Lack of Efficacy|0|||
155386924|NCT01163916|560851597|FG002|Overall Study|Lack of Efficacy|1|||
155386925|NCT01163916|560851595|FG000|Overall Study|Other|24|||
155386926|NCT01163916|560851596|FG001|Overall Study|Other|4|||
155386927|NCT01163916|560851597|FG002|Overall Study|Other|16|||
155627138|NCT02683109|561732339|FG000|Overall Study|Adverse Event|1|||
155627139|NCT02683109|561732340|FG001|Overall Study|Adverse Event|0|||
155627140|NCT03312738|561732343|FG000|Overall Study|Progressive disease|58|||
155627141|NCT03312738|561732344|FG001|Overall Study|Progressive disease|67|||
155627142|NCT03312738|561732343|FG000|Overall Study|Patient/guardian decision|13|||
155627143|NCT03312738|561732344|FG001|Overall Study|Patient/guardian decision|5|||
155627144|NCT03312738|561732343|FG000|Overall Study|Adverse Event|5|||
155627145|NCT03312738|561732344|FG001|Overall Study|Adverse Event|3|||
155280555|NCT04955626|560459896|FG029|Blinded Period|Protocol Violation|3|||
155280556|NCT04955626|560459897|FG030|Blinded Period|Protocol Violation|0|||
155280557|NCT04955626|560459898|FG031|Blinded Period|Protocol Violation|0|||
155280558|NCT04955626|560459899|FG032|Blinded Period|Protocol Violation|0|||
155280559|NCT04955626|560459900|FG033|Blinded Period|Protocol Violation|0|||
155280560|NCT04955626|560459901|FG034|Blinded Period|Protocol Violation|0|||
155280561|NCT04955626|560459902|FG035|Blinded Period|Protocol Violation|0|||
155280562|NCT04955626|560459867|FG000|Blinded Period|Death|0|||
155280563|NCT04955626|560459868|FG001|Blinded Period|Death|2|||
155280564|NCT04955626|560459869|FG002|Blinded Period|Death|0|||
155280565|NCT04955626|560459870|FG003|Blinded Period|Death|0|||
155280566|NCT04955626|560459871|FG004|Blinded Period|Death|0|||
155280567|NCT04955626|560459872|FG005|Blinded Period|Death|0|||
155280568|NCT04955626|560459873|FG006|Blinded Period|Death|0|||
155280569|NCT04955626|560459874|FG007|Blinded Period|Death|2|||
155280570|NCT04955626|560459875|FG008|Blinded Period|Death|1|||
155280571|NCT04955626|560459876|FG009|Blinded Period|Death|1|||
155280572|NCT04955626|560459877|FG010|Blinded Period|Death|0|||
155280573|NCT04955626|560459878|FG011|Blinded Period|Death|2|||
155280574|NCT04955626|560459879|FG012|Blinded Period|Death|0|||
155280575|NCT04955626|560459880|FG013|Blinded Period|Death|0|||
155280576|NCT04955626|560459881|FG014|Blinded Period|Death|0|||
155280577|NCT04955626|560459882|FG015|Blinded Period|Death|0|||
155280578|NCT04955626|560459883|FG016|Blinded Period|Death|0|||
155280579|NCT04955626|560459884|FG017|Blinded Period|Death|0|||
155280580|NCT04955626|560459885|FG018|Blinded Period|Death|0|||
155280581|NCT04955626|560459886|FG019|Blinded Period|Death|0|||
155280582|NCT04955626|560459887|FG020|Blinded Period|Death|0|||
155280583|NCT04955626|560459888|FG021|Blinded Period|Death|0|||
155280584|NCT04955626|560459889|FG022|Blinded Period|Death|0|||
155280585|NCT04955626|560459890|FG023|Blinded Period|Death|1|||
155280586|NCT04955626|560459891|FG024|Blinded Period|Death|0|||
155280587|NCT04955626|560459892|FG025|Blinded Period|Death|0|||
155280588|NCT04955626|560459893|FG026|Blinded Period|Death|1|||
155280589|NCT04955626|560459894|FG027|Blinded Period|Death|1|||
155280590|NCT04955626|560459895|FG028|Blinded Period|Death|0|||
155386928|NCT00423930|560851598|FG000|Overall Study|Withdrawal by Subject|2|||
155627146|NCT03312738|561732343|FG000|Overall Study|Protocol deviation|2|||
155627147|NCT03312738|561732344|FG001|Overall Study|Protocol deviation|0|||
155280591|NCT04955626|560459896|FG029|Blinded Period|Death|1|||
155386929|NCT04002401|560851599|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
155386930|NCT04002401|560851599|FG000|Overall Study|Death|10|||
155386931|NCT04002401|560851599|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
155386932|NCT04002401|560851599|FG000|Overall Study|Enrolled but Never Treated|1|||
155386933|NCT04002401|560851599|FG000|Overall Study|Lost to Follow-up|1|||
155386934|NCT02337751|560851600|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
155280592|NCT04955626|560459897|FG030|Blinded Period|Death|0|||
155280593|NCT04955626|560459898|FG031|Blinded Period|Death|0|||
155627148|NCT03312738|561732343|FG000|Overall Study|Technical problems|0|||
155386935|NCT02337751|560851601|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
155386936|NCT02337751|560851600|FG000|Overall Study|Voluntary Withdrawal|6|||
155386937|NCT02337751|560851601|FG001|Overall Study|Voluntary Withdrawal|8|||
155386938|NCT02337751|560851600|FG000|Overall Study|Lack of Efficacy|2|||
155386939|NCT02337751|560851601|FG001|Overall Study|Lack of Efficacy|5|||
155386940|NCT02337751|560851600|FG000|Overall Study|Investigator's Judgement|1|||
155386941|NCT02337751|560851601|FG001|Overall Study|Investigator's Judgement|0|||
155386942|NCT01910181|560851602|FG000|Overall Study|Death|37|||
155386943|NCT01910181|560851602|FG000|Overall Study|Lost to Follow-up|3|||
155386944|NCT01910181|560851602|FG000|Overall Study|Study Terminated by Sponsor|6|||
155386945|NCT02656823|560851603|FG000|Overall Study|Adverse Event|3|||
155386946|NCT02656823|560851603|FG000|Overall Study|Lost to Follow-up|2|||
155386947|NCT01340651|560851607|FG000|Overall Study|Adverse Event|3|||
155386948|NCT01340651|560851607|FG000|Overall Study|Consent Withdrawn|2|||
155386949|NCT01340651|560851607|FG000|Overall Study|Commercial Supply per Sponsor|12|||
155386950|NCT01315353|560851608|FG000|Overall Study|Death|2|||
155386951|NCT01315353|560851609|FG001|Overall Study|Death|1|||
155386952|NCT01315353|560851610|FG002|Overall Study|Death|0|||
155386953|NCT01315353|560851608|FG000|Overall Study|Withdrawal by Subject|2|||
155386954|NCT01315353|560851609|FG001|Overall Study|Withdrawal by Subject|6|||
155386955|NCT01315353|560851610|FG002|Overall Study|Withdrawal by Subject|1|||
155386956|NCT01315353|560851608|FG000|Overall Study|Lost to Follow-up|13|||
155386957|NCT01315353|560851609|FG001|Overall Study|Lost to Follow-up|6|||
155386958|NCT01315353|560851610|FG002|Overall Study|Lost to Follow-up|6|||
155386959|NCT01315353|560851608|FG000|Overall Study|Unwilling to adhere to requirements|5|||
155386960|NCT01315353|560851609|FG001|Overall Study|Unwilling to adhere to requirements|5|||
155386961|NCT01315353|560851610|FG002|Overall Study|Unwilling to adhere to requirements|4|||
155386962|NCT01315353|560851608|FG000|Overall Study|Site closing|7|||
155386963|NCT01315353|560851609|FG001|Overall Study|Site closing|4|||
155386964|NCT01315353|560851610|FG002|Overall Study|Site closing|0|||
155386965|NCT01315353|560851608|FG000|Overall Study|Taken off study by site in error|0|||
155386966|NCT01315353|560851609|FG001|Overall Study|Taken off study by site in error|1|||
155386967|NCT01315353|560851610|FG002|Overall Study|Taken off study by site in error|0|||
155386968|NCT01315353|560851608|FG000|Overall Study|Inadvertent randomization/assignment|0|||
155386969|NCT01315353|560851609|FG001|Overall Study|Inadvertent randomization/assignment|0|||
155386970|NCT01315353|560851610|FG002|Overall Study|Inadvertent randomization/assignment|2|||
155386971|NCT03567434|560851611|FG000|Overall Study|Lost to Follow-up|1|||
155386972|NCT03567434|560851612|FG001|Overall Study|Lost to Follow-up|3|||
155386973|NCT01009580|560851613|FG000|Overall Study|Adverse Event|4|||
155386974|NCT01009580|560851614|FG001|Overall Study|Adverse Event|4|||
155386975|NCT01009580|560851613|FG000|Overall Study|Lack of Efficacy|0|||
155386976|NCT01009580|560851614|FG001|Overall Study|Lack of Efficacy|1|||
155386977|NCT01009580|560851613|FG000|Overall Study|Protocol Violation|2|||
155386978|NCT01009580|560851614|FG001|Overall Study|Protocol Violation|3|||
155386979|NCT01009580|560851613|FG000|Overall Study|Withdrawal Criteria|4|||
155386980|NCT01009580|560851614|FG001|Overall Study|Withdrawal Criteria|6|||
155386981|NCT01009580|560851613|FG000|Overall Study|Unclassified|17|||
155386982|NCT01009580|560851614|FG001|Overall Study|Unclassified|21|||
155386983|NCT04469270|560851617|FG000|Overall Study|Adverse Event|2|||
155386984|NCT04469270|560851618|FG001|Overall Study|Adverse Event|0|||
155386985|NCT04469270|560851617|FG000|Overall Study|Lost to Follow-up|4|||
155386986|NCT04469270|560851618|FG001|Overall Study|Lost to Follow-up|3|||
155386987|NCT04469270|560851617|FG000|Overall Study|Withdrawal by Subject|7|||
155386988|NCT04469270|560851618|FG001|Overall Study|Withdrawal by Subject|3|||
155386989|NCT04469270|560851617|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
155386990|NCT04469270|560851618|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
155386991|NCT04469270|560851617|FG000|Overall Study|missing|1|||
155386992|NCT04469270|560851618|FG001|Overall Study|missing|0|||
155386993|NCT05269355|560851626|FG000|Overall Study|Progressive Disease|104|||
155386994|NCT05269355|560851627|FG001|Overall Study|Progressive Disease|68|||
155386995|NCT05269355|560851626|FG000|Overall Study|Study Terminated by Sponsor|87|||
155386996|NCT05269355|560851627|FG001|Overall Study|Study Terminated by Sponsor|29|||
155386997|NCT05269355|560851626|FG000|Overall Study|Adverse Event|15|||
155386998|NCT05269355|560851627|FG001|Overall Study|Adverse Event|8|||
155386999|NCT05269355|560851626|FG000|Overall Study|Withdrawal by Subject|18|||
155387000|NCT05269355|560851627|FG001|Overall Study|Withdrawal by Subject|5|||
155387001|NCT05269355|560851626|FG000|Overall Study|Physician Decision|6|||
155387002|NCT05269355|560851627|FG001|Overall Study|Physician Decision|4|||
155387003|NCT05269355|560851626|FG000|Overall Study|Death|3|||
155387004|NCT05269355|560851627|FG001|Overall Study|Death|5|||
155387005|NCT05269355|560851626|FG000|Overall Study|Other Than Specified|5|||
155387006|NCT05269355|560851627|FG001|Overall Study|Other Than Specified|1|||
155387007|NCT05269355|560851626|FG000|Overall Study|Randomized But Not Treated|1|||
155387008|NCT05269355|560851627|FG001|Overall Study|Randomized But Not Treated|0|||
155387009|NCT03705832|560851628|FG000|Overall Study|Physician Decision|0|||
155387010|NCT03705832|560851629|FG001|Overall Study|Physician Decision|1|||
155387011|NCT03705832|560851628|FG000|Overall Study|Withdrawal by Subject|1|||
155387012|NCT03705832|560851629|FG001|Overall Study|Withdrawal by Subject|0|||
155387013|NCT01050790|560851630|FG000|Overall Study|Adverse Event|1|||
155387014|NCT01880528|560851631|FG000|Overall Study|Other|1|||
155387015|NCT01880528|560851632|FG001|Overall Study|Other|1|||
155387016|NCT00081497|560851633|FG000|Overall Study|Adverse Event|2|||
155387017|NCT00081497|560851634|FG001|Overall Study|Adverse Event|0|||
155387018|NCT00081497|560851633|FG000|Overall Study|Death|0|||
155387019|NCT00081497|560851634|FG001|Overall Study|Death|1|||
155387020|NCT00081497|560851633|FG000|Overall Study|Withdrawal by Subject|1|||
155387021|NCT00081497|560851634|FG001|Overall Study|Withdrawal by Subject|0|||
155387022|NCT00081497|560851633|FG000|Overall Study|Non-compliance|0|||
155387023|NCT00081497|560851634|FG001|Overall Study|Non-compliance|1|||
155387024|NCT01439360|560851635|FG000|Overall Study|Adverse Event|4|||
155387025|NCT01439360|560851636|FG001|Overall Study|Adverse Event|16|||
155387026|NCT01439360|560851635|FG000|Overall Study|Lost to Follow-up|43|||
155387027|NCT01439360|560851636|FG001|Overall Study|Lost to Follow-up|58|||
155387028|NCT01439360|560851635|FG000|Overall Study|Others|10|||
155387029|NCT01439360|560851636|FG001|Overall Study|Others|5|||
155387030|NCT01439360|560851635|FG000|Overall Study|Protocol Violation|1|||
155387031|NCT01439360|560851636|FG001|Overall Study|Protocol Violation|0|||
155387032|NCT01439360|560851635|FG000|Overall Study|Withdrawal by Subject|140|||
155387033|NCT01439360|560851636|FG001|Overall Study|Withdrawal by Subject|129|||
155387034|NCT02390245|560851638|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
155387035|NCT02390245|560851639|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
155387036|NCT02390245|560851640|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
155387037|NCT02390245|560851638|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
155387038|NCT02390245|560851639|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
155387039|NCT02390245|560851640|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
155387040|NCT05437510|560851643|FG000|Overall Study|Adverse Event|2|||
155387041|NCT05437510|560851644|FG001|Overall Study|Adverse Event|1|||
155387042|NCT05437510|560851643|FG000|Overall Study|Protocol Deviation|1|||
155387043|NCT05437510|560851644|FG001|Overall Study|Protocol Deviation|6|||
155387044|NCT05437510|560851643|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
155387045|NCT05437510|560851644|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
155387046|NCT05437510|560851643|FG000|Overall Study|Lost to Follow-up|265|||
155387047|NCT05437510|560851644|FG001|Overall Study|Lost to Follow-up|358|||
155387048|NCT03573401|560851645|FG000|Overall Study|Withdrawal by Subject|2|||
155387049|NCT03573401|560851646|FG001|Overall Study|Withdrawal by Subject|0|||
155387050|NCT03573401|560851645|FG000|Overall Study|Subject non-compliance with study schedule|1|||
155387051|NCT03573401|560851646|FG001|Overall Study|Subject non-compliance with study schedule|0|||
155387052|NCT03573401|560851645|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
155387053|NCT03573401|560851646|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
155387054|NCT03573401|560851645|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
155387055|NCT03573401|560851646|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
155387056|NCT05677893|560852934|FG000|Overall Study|Withdrawal by Subject|0|||
155387057|NCT05677893|560852935|FG001|Overall Study|Withdrawal by Subject|0|||
155387058|NCT05677893|560852936|FG002|Overall Study|Withdrawal by Subject|0|||
155387059|NCT05677893|560852937|FG003|Overall Study|Withdrawal by Subject|0|||
155387060|NCT05677893|560852938|FG004|Overall Study|Withdrawal by Subject|1|||
155387061|NCT05677893|560852939|FG005|Overall Study|Withdrawal by Subject|1|||
155387062|NCT05677893|560852940|FG006|Overall Study|Withdrawal by Subject|0|||
155387063|NCT05677893|560852934|FG000|Overall Study|Others|1|||
155387064|NCT05677893|560852935|FG001|Overall Study|Others|0|||
155387065|NCT05677893|560852936|FG002|Overall Study|Others|0|||
155387066|NCT05677893|560852937|FG003|Overall Study|Others|0|||
155387067|NCT05677893|560852938|FG004|Overall Study|Others|0|||
155387068|NCT05677893|560852939|FG005|Overall Study|Others|0|||
155387069|NCT05677893|560852940|FG006|Overall Study|Others|0|||
155387070|NCT03217266|560852941|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
155387071|NCT03217266|560852942|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387072|NCT03217266|560852943|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387073|NCT03217266|560852944|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387074|NCT03217266|560852941|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
155387075|NCT03217266|560852942|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
155387076|NCT03217266|560852943|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
155387077|NCT03217266|560852944|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
155387078|NCT03217266|560852941|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
155387079|NCT03217266|560852942|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
155387080|NCT03217266|560852943|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
155387081|NCT03217266|560852944|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
155387082|NCT02101034|560852945|FG000|Overall Study|Enrolled but did not start treatment|0|||
155387083|NCT02101034|560852946|FG001|Overall Study|Enrolled but did not start treatment|0|||
155387084|NCT02101034|560852947|FG002|Overall Study|Enrolled but did not start treatment|1|||
155627149|NCT03312738|561732344|FG001|Overall Study|Technical problems|1|||
155627150|NCT03312738|561732343|FG000|Overall Study|Physician Decision|2|||
155627151|NCT03312738|561732344|FG001|Overall Study|Physician Decision|3|||
155627152|NCT02669849|561732352|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155627153|NCT02669849|561732353|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155627154|NCT02669849|561732354|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
155627155|NCT02669849|561732352|FG000|Overall Study|Lost to Follow-up|1|||
155627156|NCT02669849|561732353|FG001|Overall Study|Lost to Follow-up|0|||
155627157|NCT02669849|561732354|FG002|Overall Study|Lost to Follow-up|3|||
155627158|NCT02669849|561732352|FG000|Overall Study|Death|1|||
155627159|NCT02669849|561732353|FG001|Overall Study|Death|1|||
155627160|NCT02669849|561732354|FG002|Overall Study|Death|2|||
155627161|NCT02669849|561732352|FG000|Overall Study|Study terminated by sponsor|16|||
155627162|NCT02669849|561732353|FG001|Overall Study|Study terminated by sponsor|1|||
155627163|NCT02669849|561732354|FG002|Overall Study|Study terminated by sponsor|14|||
155627164|NCT02669849|561732352|FG000|Overall Study|Other|0|||
155627165|NCT02669849|561732353|FG001|Overall Study|Other|0|||
155627166|NCT02669849|561732354|FG002|Overall Study|Other|2|||
155627167|NCT03408899|561732355|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
155280594|NCT04955626|560459899|FG032|Blinded Period|Death|0|||
155627168|NCT00606008|561732356|FG000|Overall Study|Adverse Event|1|||
155627169|NCT00606008|561732356|FG000|Overall Study|Withdrawal by Subject|4|||
155627170|NCT04745351|561732357|FG000|Overall Study|Death|51|||
155627171|NCT04745351|561732358|FG001|Overall Study|Death|25|||
155627172|NCT04745351|561732357|FG000|Overall Study|Lost to Follow-up|9|||
155627173|NCT04745351|561732358|FG001|Overall Study|Lost to Follow-up|3|||
155627174|NCT04745351|561732357|FG000|Overall Study|Randomized but Never Treated|3|||
155627175|NCT04745351|561732358|FG001|Overall Study|Randomized but Never Treated|3|||
155627176|NCT04745351|561732357|FG000|Overall Study|Adverse Event|4|||
155627177|NCT04745351|561732358|FG001|Overall Study|Adverse Event|0|||
155627178|NCT04745351|561732357|FG000|Overall Study|Withdrew Consent|1|||
155627179|NCT04745351|561732358|FG001|Overall Study|Withdrew Consent|2|||
155627180|NCT04745351|561732357|FG000|Overall Study|Investigator's Discretion|2|||
155627181|NCT04745351|561732358|FG001|Overall Study|Investigator's Discretion|0|||
155627182|NCT04745351|561732357|FG000|Overall Study|Protocol Violation|1|||
155280595|NCT04955626|560459900|FG033|Blinded Period|Death|0|||
155280596|NCT04955626|560459901|FG034|Blinded Period|Death|0|||
155280597|NCT04955626|560459902|FG035|Blinded Period|Death|0|||
155280598|NCT04955626|560459867|FG000|Blinded Period|Adverse Event|0|||
155280599|NCT04955626|560459868|FG001|Blinded Period|Adverse Event|1|||
155280600|NCT04955626|560459869|FG002|Blinded Period|Adverse Event|1|||
155280601|NCT04955626|560459870|FG003|Blinded Period|Adverse Event|1|||
155280602|NCT04955626|560459871|FG004|Blinded Period|Adverse Event|0|||
155280603|NCT04955626|560459872|FG005|Blinded Period|Adverse Event|0|||
155280604|NCT04955626|560459873|FG006|Blinded Period|Adverse Event|0|||
155280605|NCT04955626|560459874|FG007|Blinded Period|Adverse Event|0|||
155280606|NCT04955626|560459875|FG008|Blinded Period|Adverse Event|0|||
155280607|NCT04955626|560459876|FG009|Blinded Period|Adverse Event|1|||
155280608|NCT04955626|560459877|FG010|Blinded Period|Adverse Event|1|||
155280609|NCT04955626|560459878|FG011|Blinded Period|Adverse Event|0|||
155280610|NCT04955626|560459879|FG012|Blinded Period|Adverse Event|0|||
155280611|NCT04955626|560459880|FG013|Blinded Period|Adverse Event|0|||
155280612|NCT04955626|560459881|FG014|Blinded Period|Adverse Event|0|||
155280613|NCT04955626|560459882|FG015|Blinded Period|Adverse Event|0|||
155280614|NCT04955626|560459883|FG016|Blinded Period|Adverse Event|0|||
155280615|NCT04955626|560459884|FG017|Blinded Period|Adverse Event|0|||
155280616|NCT04955626|560459885|FG018|Blinded Period|Adverse Event|1|||
155280617|NCT04955626|560459886|FG019|Blinded Period|Adverse Event|0|||
155280618|NCT04955626|560459887|FG020|Blinded Period|Adverse Event|0|||
155280619|NCT04955626|560459888|FG021|Blinded Period|Adverse Event|0|||
155280620|NCT04955626|560459889|FG022|Blinded Period|Adverse Event|0|||
155280621|NCT04955626|560459890|FG023|Blinded Period|Adverse Event|0|||
155280622|NCT04955626|560459891|FG024|Blinded Period|Adverse Event|0|||
155280623|NCT04955626|560459892|FG025|Blinded Period|Adverse Event|0|||
155280624|NCT04955626|560459893|FG026|Blinded Period|Adverse Event|1|||
155280625|NCT04955626|560459894|FG027|Blinded Period|Adverse Event|0|||
155280626|NCT04955626|560459895|FG028|Blinded Period|Adverse Event|0|||
155280627|NCT04955626|560459896|FG029|Blinded Period|Adverse Event|0|||
155280628|NCT04955626|560459897|FG030|Blinded Period|Adverse Event|0|||
155627183|NCT04745351|561732358|FG001|Overall Study|Protocol Violation|0|||
155627184|NCT02014272|561732362|FG000|Intervention Period 1|Withdrawal by Subject|1|||
155627185|NCT02014272|561732363|FG001|Intervention Period 1|Withdrawal by Subject|0|||
155627186|NCT02014272|561732362|FG000|Intervention Period 1|Adverse Event|0|||
155627187|NCT02014272|561732363|FG001|Intervention Period 1|Adverse Event|1|||
155627188|NCT03499795|561732364|FG000|Overall Study|Adverse Event|1|||
155627189|NCT03499795|561732364|FG000|Overall Study|Lost to Follow-up|1|||
155280629|NCT04955626|560459898|FG031|Blinded Period|Adverse Event|0|||
155280630|NCT04955626|560459899|FG032|Blinded Period|Adverse Event|0|||
155280631|NCT04955626|560459900|FG033|Blinded Period|Adverse Event|0|||
155280632|NCT04955626|560459901|FG034|Blinded Period|Adverse Event|0|||
155280633|NCT04955626|560459902|FG035|Blinded Period|Adverse Event|0|||
155387085|NCT02101034|560852948|FG003|Overall Study|Enrolled but did not start treatment|0|||
155387086|NCT02101034|560852949|FG004|Overall Study|Enrolled but did not start treatment|0|||
155387087|NCT01390181|560852950|FG000|Overall Study|Lost to Follow-up|1|||
155387088|NCT01390181|560852950|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
155387089|NCT01101477|560852951|FG000|Overall Study|Protocol Violation|5|||
155387090|NCT01101477|560852952|FG001|Overall Study|Protocol Violation|3|||
155387091|NCT01101477|560852953|FG002|Overall Study|Protocol Violation|1|||
155387092|NCT00720941|560852954|FG000|Overall Study|Protocol Violation|1|||
155387093|NCT00720941|560852955|FG001|Overall Study|Protocol Violation|2|||
155387094|NCT00720941|560852954|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
155387095|NCT00720941|560852955|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
155387096|NCT00720941|560852954|FG000|Overall Study|Lost to Follow-up|20|||
155387097|NCT00720941|560852955|FG001|Overall Study|Lost to Follow-up|15|||
155387098|NCT00720941|560852954|FG000|Overall Study|Physician Decision|14|||
155387099|NCT00720941|560852955|FG001|Overall Study|Physician Decision|12|||
155387100|NCT00720941|560852954|FG000|Overall Study|Withdrawal by Subject|29|||
155387101|NCT00720941|560852955|FG001|Overall Study|Withdrawal by Subject|36|||
155387102|NCT01717989|560852960|FG000|Overall Study|Ineligibility determined|6|||
155387103|NCT01717989|560852960|FG000|Overall Study|Protocol deviation|6|||
155387104|NCT01717989|560852960|FG000|Overall Study|Withdrawal by Subject|11|||
155387105|NCT01717989|560852960|FG000|Overall Study|Physician Decision|2|||
155387106|NCT01717989|560852960|FG000|Overall Study|Lost to Follow-up|11|||
155387107|NCT01717989|560852960|FG000|Overall Study|Death|439|||
155387108|NCT01717989|560852960|FG000|Overall Study|Protocol-specified criteria|551|||
155387109|NCT01717989|560852960|FG000|Overall Study|Other|40|||
155387110|NCT03224325|560852961|FG000|Overall Study|Adverse Event|1|||
155387111|NCT03224325|560852962|FG001|Overall Study|Adverse Event|0|||
155387112|NCT03224325|560852963|FG002|Overall Study|Adverse Event|0|||
155387113|NCT03224325|560852964|FG003|Overall Study|Adverse Event|0|||
155387114|NCT03224325|560852965|FG004|Overall Study|Adverse Event|0|||
155387115|NCT03224325|560852966|FG005|Overall Study|Adverse Event|0|||
155387116|NCT03224325|560852967|FG006|Overall Study|Adverse Event|1|||
155387117|NCT03224325|560852961|FG000|Overall Study|Withdrawal by Subject|0|||
155387118|NCT03224325|560852962|FG001|Overall Study|Withdrawal by Subject|0|||
155387119|NCT03224325|560852963|FG002|Overall Study|Withdrawal by Subject|0|||
155387120|NCT03224325|560852964|FG003|Overall Study|Withdrawal by Subject|1|||
155387121|NCT03224325|560852965|FG004|Overall Study|Withdrawal by Subject|0|||
155387122|NCT03224325|560852966|FG005|Overall Study|Withdrawal by Subject|0|||
155387123|NCT03224325|560852967|FG006|Overall Study|Withdrawal by Subject|0|||
155387124|NCT02598557|560852968|FG000|Overall Study|Withdrawal by Subject|1|||
155387125|NCT02598557|560852969|FG001|Overall Study|Withdrawal by Subject|0|||
155387126|NCT02598557|560852970|FG002|Overall Study|Withdrawal by Subject|1|||
155387127|NCT02598557|560852968|FG000|Overall Study|Participant did not start treatment|2|||
155387128|NCT02598557|560852969|FG001|Overall Study|Participant did not start treatment|1|||
155387129|NCT02598557|560852970|FG002|Overall Study|Participant did not start treatment|1|||
155387130|NCT02598557|560852968|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
155387131|NCT02598557|560852969|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
155387132|NCT02598557|560852970|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
155387133|NCT02598557|560852968|FG000|Overall Study|Adverse Event|1|||
155387134|NCT02598557|560852969|FG001|Overall Study|Adverse Event|1|||
155387135|NCT02598557|560852970|FG002|Overall Study|Adverse Event|0|||
155387136|NCT02864381|560852971|FG000|Overall Study|Death|58|||
155387137|NCT02864381|560852972|FG001|Overall Study|Death|61|||
155387138|NCT02864381|560852971|FG000|Overall Study|Withdrew Consent|5|||
155387139|NCT02864381|560852972|FG001|Overall Study|Withdrew Consent|6|||
155387140|NCT02864381|560852971|FG000|Overall Study|Reason Unknown|7|||
155387141|NCT02864381|560852972|FG001|Overall Study|Reason Unknown|3|||
155387142|NCT02864381|560852971|FG000|Overall Study|Lost to Follow-up|1|||
155387143|NCT02864381|560852972|FG001|Overall Study|Lost to Follow-up|1|||
155387144|NCT02864381|560852971|FG000|Overall Study|Investigator's Discretion|1|||
155387145|NCT02864381|560852972|FG001|Overall Study|Investigator's Discretion|0|||
155387146|NCT02864381|560852971|FG000|Overall Study|Protocol Violation|0|||
155387147|NCT02864381|560852972|FG001|Overall Study|Protocol Violation|1|||
155387148|NCT00667355|560852973|FG000|Overall Study|Adverse Event|5|||
155387149|NCT00667355|560852973|FG000|Overall Study|Lost to Follow-up|1|||
155387150|NCT00667355|560852973|FG000|Overall Study|Other reason was not specified|5|||
155387151|NCT00687973|560852976|FG000|Overall Study|Adverse Event|18|||
155387152|NCT00687973|560852977|FG001|Overall Study|Adverse Event|28|||
155387153|NCT00687973|560852976|FG000|Overall Study|Lack of Efficacy|2|||
155387154|NCT00687973|560852977|FG001|Overall Study|Lack of Efficacy|3|||
155387155|NCT00687973|560852976|FG000|Overall Study|Protocol Violation|1|||
155387156|NCT00687973|560852977|FG001|Overall Study|Protocol Violation|2|||
155387157|NCT00687973|560852976|FG000|Overall Study|Administrative Reasons|0|||
155387158|NCT00687973|560852977|FG001|Overall Study|Administrative Reasons|2|||
155387159|NCT00687973|560852976|FG000|Overall Study|Withdrawal by Subject|3|||
155387160|NCT00687973|560852977|FG001|Overall Study|Withdrawal by Subject|3|||
155387161|NCT00731120|560852979|FG000|Overall Study|Adverse Event|7|||
155387162|NCT00731120|560852980|FG001|Overall Study|Adverse Event|6|||
155387163|NCT00731120|560852981|FG002|Overall Study|Adverse Event|8|||
155387164|NCT00731120|560852979|FG000|Overall Study|Lack of Efficacy|4|||
155387165|NCT00731120|560852980|FG001|Overall Study|Lack of Efficacy|5|||
155387166|NCT00731120|560852981|FG002|Overall Study|Lack of Efficacy|4|||
155387167|NCT00731120|560852979|FG000|Overall Study|Noncompliance with Study Drug|3|||
155387168|NCT00731120|560852980|FG001|Overall Study|Noncompliance with Study Drug|3|||
155387169|NCT00731120|560852981|FG002|Overall Study|Noncompliance with Study Drug|1|||
155387170|NCT00731120|560852979|FG000|Overall Study|Protocol Deviations|1|||
155387171|NCT00731120|560852980|FG001|Overall Study|Protocol Deviations|6|||
155387172|NCT00731120|560852981|FG002|Overall Study|Protocol Deviations|1|||
155387173|NCT00731120|560852979|FG000|Overall Study|Withdrawal of Consent|13|||
155387174|NCT00731120|560852980|FG001|Overall Study|Withdrawal of Consent|8|||
155387175|NCT00731120|560852981|FG002|Overall Study|Withdrawal of Consent|4|||
155387176|NCT00731120|560852979|FG000|Overall Study|Lost to Follow-up|10|||
155387177|NCT00731120|560852980|FG001|Overall Study|Lost to Follow-up|15|||
155387178|NCT00731120|560852981|FG002|Overall Study|Lost to Follow-up|17|||
155387179|NCT00731120|560852979|FG000|Overall Study|Other|4|||
155387180|NCT00731120|560852980|FG001|Overall Study|Other|0|||
155387181|NCT00731120|560852981|FG002|Overall Study|Other|1|||
155387182|NCT01012713|560852990|FG000|Overall Study|Lack of Efficacy|3|||
155387183|NCT00985153|560852991|FG000|Overall Study|Lost to Follow-up|16|||
155387184|NCT00985153|560852992|FG001|Overall Study|Lost to Follow-up|19|||
155387185|NCT00985153|560852993|FG002|Overall Study|Lost to Follow-up|17|||
155387186|NCT00985153|560852994|FG003|Overall Study|Lost to Follow-up|20|||
155387187|NCT00985153|560852991|FG000|Overall Study|Protocol Violation|3|||
155387188|NCT00985153|560852992|FG001|Overall Study|Protocol Violation|2|||
155387189|NCT00985153|560852993|FG002|Overall Study|Protocol Violation|4|||
155387190|NCT00985153|560852994|FG003|Overall Study|Protocol Violation|3|||
155387191|NCT00985153|560852991|FG000|Overall Study|Withdrawal by Subject|6|||
155387192|NCT00985153|560852992|FG001|Overall Study|Withdrawal by Subject|11|||
155387193|NCT00985153|560852993|FG002|Overall Study|Withdrawal by Subject|11|||
155387194|NCT00985153|560852994|FG003|Overall Study|Withdrawal by Subject|10|||
155387195|NCT00985153|560852991|FG000|Overall Study|Missed One or More Bleeds|7|||
155387196|NCT00985153|560852992|FG001|Overall Study|Missed One or More Bleeds|7|||
155387197|NCT00985153|560852993|FG002|Overall Study|Missed One or More Bleeds|8|||
155387198|NCT00985153|560852994|FG003|Overall Study|Missed One or More Bleeds|10|||
155387199|NCT00985153|560852991|FG000|Overall Study|Incomplete Safety Follow-up|3|||
155387200|NCT00985153|560852992|FG001|Overall Study|Incomplete Safety Follow-up|5|||
155387201|NCT00985153|560852993|FG002|Overall Study|Incomplete Safety Follow-up|4|||
155387202|NCT00985153|560852994|FG003|Overall Study|Incomplete Safety Follow-up|4|||
155387203|NCT03370471|560852995|FG000|Overall Study|Withdrawal by Subject|6|||
155729278|NCT02113982|562108040|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729279|NCT02113982|562108041|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729280|NCT02113982|562108042|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729281|NCT02113982|562108043|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729282|NCT02113982|562108044|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
155729283|NCT02113982|562108045|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729284|NCT02113982|562108046|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
155729285|NCT02113982|562108033|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729286|NCT02113982|562108034|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729287|NCT02113982|562108035|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729288|NCT02113982|562108036|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729289|NCT02113982|562108037|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729290|NCT02113982|562108038|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729291|NCT02113982|562108039|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729292|NCT02113982|562108040|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729293|NCT02113982|562108041|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729294|NCT02113982|562108042|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729295|NCT02113982|562108043|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729296|NCT02113982|562108044|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
155387204|NCT03370471|560852996|FG001|Overall Study|Withdrawal by Subject|1|||
155387205|NCT03370471|560852995|FG000|Overall Study|Unable to access veins for blood draw|0|||
155387206|NCT03370471|560852996|FG001|Overall Study|Unable to access veins for blood draw|1|||
155387207|NCT03370471|560852995|FG000|Overall Study|Screen fail|1|||
155387208|NCT03370471|560852996|FG001|Overall Study|Screen fail|0|||
155387209|NCT00561951|560852998|FG000|Overall Study|Adverse Event|11|||
155729297|NCT02113982|562108045|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729298|NCT02113982|562108046|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155729299|NCT02113982|562108033|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
155387210|NCT00561951|560852999|FG001|Overall Study|Adverse Event|14|||
155387211|NCT00561951|560853000|FG002|Overall Study|Adverse Event|14|||
155387212|NCT00561951|560852998|FG000|Overall Study|Lack of Efficacy|5|||
155387213|NCT00561951|560852999|FG001|Overall Study|Lack of Efficacy|3|||
155387214|NCT00561951|560853000|FG002|Overall Study|Lack of Efficacy|2|||
155387215|NCT00561951|560852998|FG000|Overall Study|Lost to Follow-up|1|||
155387216|NCT00561951|560852999|FG001|Overall Study|Lost to Follow-up|1|||
155387217|NCT00561951|560853000|FG002|Overall Study|Lost to Follow-up|0|||
155387218|NCT00561951|560852998|FG000|Overall Study|Withdrawal by Subject|10|||
155387219|NCT00561951|560852999|FG001|Overall Study|Withdrawal by Subject|9|||
155387220|NCT00561951|560853000|FG002|Overall Study|Withdrawal by Subject|10|||
155387221|NCT00561951|560852998|FG000|Overall Study|Protocol Violation|4|||
155387222|NCT00561951|560852999|FG001|Overall Study|Protocol Violation|3|||
155387223|NCT00561951|560853000|FG002|Overall Study|Protocol Violation|4|||
155387224|NCT00561951|560852998|FG000|Overall Study|Physician Decision|1|||
155387225|NCT00561951|560852999|FG001|Overall Study|Physician Decision|0|||
155387226|NCT00561951|560853000|FG002|Overall Study|Physician Decision|0|||
155387227|NCT00561951|560852998|FG000|Overall Study|Pregnancy|0|||
155387228|NCT00561951|560852999|FG001|Overall Study|Pregnancy|1|||
155387229|NCT00561951|560853000|FG002|Overall Study|Pregnancy|0|||
155387230|NCT00561951|560852998|FG000|Overall Study|Meet Withdrawal Criterion|0|||
155387231|NCT00561951|560852999|FG001|Overall Study|Meet Withdrawal Criterion|1|||
155387232|NCT00561951|560853000|FG002|Overall Study|Meet Withdrawal Criterion|1|||
155387233|NCT00561951|560852998|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
155387234|NCT00561951|560852999|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
155387235|NCT00561951|560853000|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
155387236|NCT01765179|560853001|FG000|Overall Study|Adverse Event|3|||
155387237|NCT01765179|560853001|FG000|Overall Study|Lost to Follow-up|5|||
155387238|NCT01765179|560853001|FG000|Overall Study|Non-compliance with study drug|2|||
155387239|NCT01765179|560853001|FG000|Overall Study|Protocol Violation|1|||
155387240|NCT01765179|560853001|FG000|Overall Study|Withdrawal by Subject|8|||
155387241|NCT01765179|560853001|FG000|Overall Study|Hematocrit >54%|3|||
155387242|NCT01765179|560853001|FG000|Overall Study|prohibited med|1|||
155387243|NCT01765179|560853001|FG000|Overall Study|Out of country unable to finish study|1|||
155387244|NCT01765179|560853001|FG000|Overall Study|lack of venous access|1|||
155387245|NCT01765179|560853001|FG000|Overall Study|work conflict|1|||
155387246|NCT01765179|560853001|FG000|Overall Study|Ca elevated 10.6|1|||
155387247|NCT02640157|560853002|FG000|Overall Study|Adverse Event|2|||
155387248|NCT02640157|560853003|FG001|Overall Study|Adverse Event|2|||
155387249|NCT02640157|560853004|FG002|Overall Study|Adverse Event|1|||
155387250|NCT02640157|560853002|FG000|Overall Study|Withdrew consent|2|||
155387251|NCT02640157|560853003|FG001|Overall Study|Withdrew consent|0|||
155387252|NCT02640157|560853004|FG002|Overall Study|Withdrew consent|2|||
155387253|NCT02640157|560853002|FG000|Overall Study|Lost to Follow-up|9|||
155387254|NCT02640157|560853003|FG001|Overall Study|Lost to Follow-up|2|||
155387255|NCT02640157|560853004|FG002|Overall Study|Lost to Follow-up|7|||
155387256|NCT02640157|560853002|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
155387257|NCT02640157|560853003|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
155387258|NCT02640157|560853004|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
155387259|NCT01596621|560853005|FG000|Overall Study|Death|4|||
155387260|NCT01596621|560853005|FG000|Overall Study|Withdrawal by Subject|9|||
155387261|NCT01596621|560853005|FG000|Overall Study|Disease Progression|49|||
155387262|NCT01596621|560853005|FG000|Overall Study|Lost to Follow-up|3|||
155387263|NCT01596621|560853005|FG000|Overall Study|Other than specified|13|||
155387264|NCT00710021|560853006|FG000|Overall Study|Lost to Follow-up|1|||
155387265|NCT00710021|560853007|FG001|Overall Study|Lost to Follow-up|0|||
155387266|NCT00710021|560853008|FG002|Overall Study|Lost to Follow-up|0|||
155387267|NCT00710021|560853006|FG000|Overall Study|Subject's Decision|0|||
155387268|NCT00710021|560853007|FG001|Overall Study|Subject's Decision|1|||
155387269|NCT00710021|560853008|FG002|Overall Study|Subject's Decision|0|||
155387270|NCT00710021|560853006|FG000|Overall Study|Subject misrandomized|0|||
155387271|NCT00710021|560853007|FG001|Overall Study|Subject misrandomized|1|||
155387272|NCT00710021|560853008|FG002|Overall Study|Subject misrandomized|1|||
155387273|NCT00710021|560853006|FG000|Overall Study|Physician Decision|0|||
155387274|NCT00710021|560853007|FG001|Overall Study|Physician Decision|1|||
155387275|NCT00710021|560853008|FG002|Overall Study|Physician Decision|0|||
155387276|NCT01679405|560853009|FG000|Overall Study|Death|2|||
155387277|NCT01679405|560853010|FG001|Overall Study|Death|5|||
155627190|NCT00547339|561732365|FG000|Overall Study|Physician Decision|0|||
155627191|NCT00547339|561732366|FG001|Overall Study|Physician Decision|0|||
155627192|NCT00547339|561732367|FG002|Overall Study|Physician Decision|1|||
155627193|NCT00547339|561732368|FG003|Overall Study|Physician Decision|0|||
155627194|NCT03736967|561732369|FG000|Overall Study|Withdrawal by Subject|26|||
155627195|NCT03736967|561732370|FG001|Overall Study|Withdrawal by Subject|25|||
155627196|NCT03736967|561732371|FG002|Overall Study|Withdrawal by Subject|23|||
155627197|NCT03736967|561732372|FG003|Overall Study|Withdrawal by Subject|26|||
155627198|NCT03736967|561732369|FG000|Overall Study|Lost to Follow-up|3|||
155387278|NCT04677179|560853011|FG000|Induction Treatment Period|Adverse Event|1|||
155387279|NCT04677179|560853012|FG001|Induction Treatment Period|Adverse Event|0|||
155387280|NCT04677179|560853013|FG002|Induction Treatment Period|Adverse Event|0|||
155387281|NCT04677179|560853014|FG003|Induction Treatment Period|Adverse Event|0|||
155387282|NCT04677179|560853015|FG004|Induction Treatment Period|Adverse Event|0|||
155387283|NCT04677179|560853016|FG005|Induction Treatment Period|Adverse Event|0|||
155280634|NCT04955626|560459867|FG000|Blinded Period|No longer meets eligibility criteria|1|||
155280635|NCT04955626|560459868|FG001|Blinded Period|No longer meets eligibility criteria|2|||
155280636|NCT04955626|560459869|FG002|Blinded Period|No longer meets eligibility criteria|0|||
155280637|NCT04955626|560459870|FG003|Blinded Period|No longer meets eligibility criteria|1|||
155280638|NCT04955626|560459871|FG004|Blinded Period|No longer meets eligibility criteria|0|||
155280639|NCT04955626|560459872|FG005|Blinded Period|No longer meets eligibility criteria|0|||
155280640|NCT04955626|560459873|FG006|Blinded Period|No longer meets eligibility criteria|0|||
155280641|NCT04955626|560459874|FG007|Blinded Period|No longer meets eligibility criteria|0|||
155280642|NCT04955626|560459875|FG008|Blinded Period|No longer meets eligibility criteria|1|||
155280643|NCT04955626|560459876|FG009|Blinded Period|No longer meets eligibility criteria|0|||
155280644|NCT04955626|560459877|FG010|Blinded Period|No longer meets eligibility criteria|1|||
155280645|NCT04955626|560459878|FG011|Blinded Period|No longer meets eligibility criteria|1|||
155280646|NCT04955626|560459879|FG012|Blinded Period|No longer meets eligibility criteria|0|||
155280647|NCT04955626|560459880|FG013|Blinded Period|No longer meets eligibility criteria|0|||
155280648|NCT04955626|560459881|FG014|Blinded Period|No longer meets eligibility criteria|0|||
155280649|NCT04955626|560459882|FG015|Blinded Period|No longer meets eligibility criteria|3|||
155280650|NCT04955626|560459883|FG016|Blinded Period|No longer meets eligibility criteria|0|||
155280651|NCT04955626|560459884|FG017|Blinded Period|No longer meets eligibility criteria|2|||
155280652|NCT04955626|560459885|FG018|Blinded Period|No longer meets eligibility criteria|0|||
155280653|NCT04955626|560459886|FG019|Blinded Period|No longer meets eligibility criteria|0|||
155280654|NCT04955626|560459887|FG020|Blinded Period|No longer meets eligibility criteria|0|||
155280655|NCT04955626|560459888|FG021|Blinded Period|No longer meets eligibility criteria|0|||
155280656|NCT04955626|560459889|FG022|Blinded Period|No longer meets eligibility criteria|0|||
155280657|NCT04955626|560459890|FG023|Blinded Period|No longer meets eligibility criteria|0|||
155280658|NCT04955626|560459891|FG024|Blinded Period|No longer meets eligibility criteria|1|||
155280659|NCT04955626|560459892|FG025|Blinded Period|No longer meets eligibility criteria|0|||
155280660|NCT04955626|560459893|FG026|Blinded Period|No longer meets eligibility criteria|0|||
155280661|NCT04955626|560459894|FG027|Blinded Period|No longer meets eligibility criteria|1|||
155280662|NCT04955626|560459895|FG028|Blinded Period|No longer meets eligibility criteria|0|||
155280663|NCT04955626|560459896|FG029|Blinded Period|No longer meets eligibility criteria|0|||
155280664|NCT04955626|560459897|FG030|Blinded Period|No longer meets eligibility criteria|0|||
155627199|NCT03736967|561732370|FG001|Overall Study|Lost to Follow-up|2|||
155627200|NCT03736967|561732371|FG002|Overall Study|Lost to Follow-up|1|||
155627201|NCT03736967|561732372|FG003|Overall Study|Lost to Follow-up|1|||
155627202|NCT03736967|561732369|FG000|Overall Study|Physician Decision|1|||
155627203|NCT03736967|561732370|FG001|Overall Study|Physician Decision|0|||
155627204|NCT03736967|561732371|FG002|Overall Study|Physician Decision|0|||
155627205|NCT03736967|561732372|FG003|Overall Study|Physician Decision|1|||
155627206|NCT03736967|561732369|FG000|Overall Study|Adverse Event|0|||
155627207|NCT03736967|561732370|FG001|Overall Study|Adverse Event|1|||
155627208|NCT03736967|561732371|FG002|Overall Study|Adverse Event|0|||
155627209|NCT03736967|561732372|FG003|Overall Study|Adverse Event|1|||
155627210|NCT03736967|561732369|FG000|Overall Study|Death|0|||
155627211|NCT03736967|561732370|FG001|Overall Study|Death|0|||
155627212|NCT03736967|561732371|FG002|Overall Study|Death|0|||
155627213|NCT03736967|561732372|FG003|Overall Study|Death|1|||
155627214|NCT03736967|561732369|FG000|Overall Study|Randomized but never treated|1|||
155627215|NCT03736967|561732370|FG001|Overall Study|Randomized but never treated|0|||
155627216|NCT03736967|561732371|FG002|Overall Study|Randomized but never treated|0|||
155627217|NCT03736967|561732372|FG003|Overall Study|Randomized but never treated|0|||
155627218|NCT02369653|561732373|FG000|Overall Study|Lost to Follow-up|0|||
155627219|NCT02369653|561732374|FG001|Overall Study|Lost to Follow-up|1|||
155627220|NCT02369653|561732373|FG000|Overall Study|Administrative reason by sponsor|0|||
155627221|NCT02369653|561732374|FG001|Overall Study|Administrative reason by sponsor|1|||
155627222|NCT02369653|561732373|FG000|Overall Study|Death|1|||
155627223|NCT02369653|561732374|FG001|Overall Study|Death|2|||
155627224|NCT02369653|561732373|FG000|Overall Study|Participant withdrew consent|13|||
155627225|NCT02369653|561732374|FG001|Overall Study|Participant withdrew consent|3|||
155627226|NCT03587636|561732375|FG000|Overall Study|Lost to Follow-up|2|||
155627227|NCT03587636|561732376|FG001|Overall Study|Lost to Follow-up|5|||
155627228|NCT01587885|561732377|FG000|Treatment Period 1|Failure to Return|0|||
155627229|NCT01587885|561732378|FG001|Treatment Period 1|Failure to Return|1|||
155627230|NCT01587885|561732377|FG000|Treatment Period 1|Protocol Violation|0|||
155627231|NCT01587885|561732378|FG001|Treatment Period 1|Protocol Violation|2|||
155627232|NCT01458587|561732379|FG000|Overall Study|Withdrawal by Subject|1|||
155627233|NCT01458587|561732380|FG001|Overall Study|Withdrawal by Subject|0|||
155627234|NCT01603602|561732381|FG000|Overall Study|Adverse Event|1|||
155627235|NCT01603602|561732382|FG001|Overall Study|Adverse Event|0|||
155627236|NCT01603602|561732383|FG002|Overall Study|Adverse Event|0|||
155627237|NCT01603602|561732381|FG000|Overall Study|Personal Reasons|1|||
155627238|NCT01603602|561732382|FG001|Overall Study|Personal Reasons|0|||
155387284|NCT04677179|560853017|FG006|Induction Treatment Period|Adverse Event|0|||
155387285|NCT04677179|560853018|FG007|Induction Treatment Period|Adverse Event|0|||
155387286|NCT04677179|560853019|FG008|Induction Treatment Period|Adverse Event|0|||
155387287|NCT04677179|560853020|FG009|Induction Treatment Period|Adverse Event|0|||
155387288|NCT04677179|560853011|FG000|Induction Treatment Period|Physician Decision|1|||
155387289|NCT04677179|560853012|FG001|Induction Treatment Period|Physician Decision|0|||
155387290|NCT04677179|560853013|FG002|Induction Treatment Period|Physician Decision|1|||
155387291|NCT04677179|560853014|FG003|Induction Treatment Period|Physician Decision|0|||
155387292|NCT04677179|560853015|FG004|Induction Treatment Period|Physician Decision|0|||
155387293|NCT04677179|560853016|FG005|Induction Treatment Period|Physician Decision|0|||
155387294|NCT04677179|560853017|FG006|Induction Treatment Period|Physician Decision|0|||
155387295|NCT04677179|560853018|FG007|Induction Treatment Period|Physician Decision|0|||
155387296|NCT04677179|560853019|FG008|Induction Treatment Period|Physician Decision|0|||
155387297|NCT04677179|560853020|FG009|Induction Treatment Period|Physician Decision|0|||
155387298|NCT04677179|560853011|FG000|Induction Treatment Period|Protocol Violation|0|||
155627239|NCT01603602|561732383|FG002|Overall Study|Personal Reasons|1|||
155627240|NCT04748718|561732387|FG000|Overall Study|Lost to Follow-up|50|||
155627241|NCT00316004|561732388|FG000|Overall Study|Subject was not given study fluid.|14|||
155627242|NCT00316004|561732389|FG001|Overall Study|Subject was not given study fluid.|14|||
155627243|NCT00316004|561732390|FG002|Overall Study|Subject was not given study fluid.|21|||
155627244|NCT01118299|561732391|FG000|Overall Study|Death|7|||
155627245|NCT01118299|561732392|FG001|Overall Study|Death|5|||
155627246|NCT01118299|561732391|FG000|Overall Study|Withdrawal by Subject|8|||
155627247|NCT01118299|561732392|FG001|Overall Study|Withdrawal by Subject|8|||
155627248|NCT01118299|561732391|FG000|Overall Study|Lost to Follow-up|2|||
155627249|NCT01118299|561732392|FG001|Overall Study|Lost to Follow-up|1|||
155627250|NCT01118299|561732391|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
155627251|NCT01118299|561732392|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
155627252|NCT01935089|561732394|FG000|Overall Study|Adverse Event|2|||
155627253|NCT01935089|561732394|FG000|Overall Study|Withdrawal by Subject|1|||
155627254|NCT02932943|561732395|FG000|Overall Study|Lost to Follow-up|0|||
155627255|NCT02932943|561732396|FG001|Overall Study|Lost to Follow-up|2|||
155627256|NCT02932943|561732395|FG000|Overall Study|Adverse Event|2|||
155627257|NCT02932943|561732396|FG001|Overall Study|Adverse Event|2|||
155627258|NCT02932943|561732395|FG000|Overall Study|Withdrawal by Subject|3|||
155627259|NCT02932943|561732396|FG001|Overall Study|Withdrawal by Subject|3|||
155627260|NCT02665117|561732399|FG000|Overall Study|Physician Decision|1|||
155627261|NCT02665117|561732400|FG001|Overall Study|Physician Decision|0|||
155627262|NCT02337491|561732404|FG000|Overall Study|Death|1|||
155627263|NCT02337491|561732405|FG001|Overall Study|Death|1|||
155627264|NCT02337491|561732404|FG000|Overall Study|Adverse Event|0|||
155627265|NCT02337491|561732405|FG001|Overall Study|Adverse Event|1|||
155627266|NCT02337491|561732404|FG000|Overall Study|Withdrawal by Subject|3|||
155627267|NCT02337491|561732405|FG001|Overall Study|Withdrawal by Subject|0|||
155627268|NCT02337491|561732404|FG000|Overall Study|Progressive Disease|44|||
155627269|NCT02337491|561732405|FG001|Overall Study|Progressive Disease|28|||
155627270|NCT02337491|561732404|FG000|Overall Study|On Treatment|2|||
155627271|NCT02337491|561732405|FG001|Overall Study|On Treatment|0|||
155627272|NCT01432951|561732406|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
155627273|NCT01079780|561732410|FG000|Overall Study|Disease progression|43|||
155627274|NCT01079780|561732411|FG001|Overall Study|Disease progression|7|||
155627275|NCT01079780|561732412|FG002|Overall Study|Disease progression|31|||
155627276|NCT01079780|561732410|FG000|Overall Study|Adverse Event|13|||
155627277|NCT01079780|561732411|FG001|Overall Study|Adverse Event|5|||
155627278|NCT01079780|561732412|FG002|Overall Study|Adverse Event|7|||
155627279|NCT01079780|561732410|FG000|Overall Study|Death|2|||
155627280|NCT01079780|561732411|FG001|Overall Study|Death|0|||
155627281|NCT01079780|561732412|FG002|Overall Study|Death|2|||
155627282|NCT01079780|561732410|FG000|Overall Study|Withdrawal by Subject|6|||
155627283|NCT01079780|561732411|FG001|Overall Study|Withdrawal by Subject|4|||
155627284|NCT01079780|561732412|FG002|Overall Study|Withdrawal by Subject|4|||
155627285|NCT01079780|561732410|FG000|Overall Study|Alternative therapy|2|||
155627286|NCT01079780|561732411|FG001|Overall Study|Alternative therapy|0|||
155627287|NCT01079780|561732412|FG002|Overall Study|Alternative therapy|2|||
155387299|NCT04677179|560853012|FG001|Induction Treatment Period|Protocol Violation|1|||
155387300|NCT04677179|560853013|FG002|Induction Treatment Period|Protocol Violation|0|||
155627288|NCT01079780|561732410|FG000|Overall Study|Physician Decision|1|||
155627289|NCT01079780|561732411|FG001|Overall Study|Physician Decision|0|||
155627290|NCT01079780|561732412|FG002|Overall Study|Physician Decision|1|||
155627291|NCT01079780|561732410|FG000|Overall Study|Error made in lesion measurement|1|||
155627292|NCT01079780|561732411|FG001|Overall Study|Error made in lesion measurement|0|||
155627293|NCT01079780|561732412|FG002|Overall Study|Error made in lesion measurement|0|||
155627294|NCT01079780|561732410|FG000|Overall Study|Patient had surgery|1|||
155627295|NCT01079780|561732411|FG001|Overall Study|Patient had surgery|0|||
155627296|NCT01079780|561732412|FG002|Overall Study|Patient had surgery|0|||
155627297|NCT01079780|561732410|FG000|Overall Study|Treatment cycle delay|0|||
155627298|NCT01079780|561732411|FG001|Overall Study|Treatment cycle delay|0|||
155280665|NCT04955626|560459898|FG031|Blinded Period|No longer meets eligibility criteria|0|||
155280666|NCT04955626|560459899|FG032|Blinded Period|No longer meets eligibility criteria|0|||
155280667|NCT04955626|560459900|FG033|Blinded Period|No longer meets eligibility criteria|0|||
155280668|NCT04955626|560459901|FG034|Blinded Period|No longer meets eligibility criteria|0|||
155280669|NCT04955626|560459902|FG035|Blinded Period|No longer meets eligibility criteria|0|||
155280670|NCT04955626|560459867|FG000|Blinded Period|Other|54|||
155280671|NCT04955626|560459868|FG001|Blinded Period|Other|3|||
155280672|NCT04955626|560459869|FG002|Blinded Period|Other|4|||
155280673|NCT04955626|560459870|FG003|Blinded Period|Other|2|||
155280674|NCT04955626|560459871|FG004|Blinded Period|Other|0|||
155280675|NCT04955626|560459872|FG005|Blinded Period|Other|0|||
155280676|NCT04955626|560459873|FG006|Blinded Period|Other|2|||
155280677|NCT04955626|560459874|FG007|Blinded Period|Other|2|||
155280678|NCT04955626|560459875|FG008|Blinded Period|Other|1|||
155280679|NCT04955626|560459876|FG009|Blinded Period|Other|0|||
155280680|NCT04955626|560459877|FG010|Blinded Period|Other|1|||
155280681|NCT04955626|560459878|FG011|Blinded Period|Other|1|||
155280682|NCT04955626|560459879|FG012|Blinded Period|Other|0|||
155280683|NCT04955626|560459880|FG013|Blinded Period|Other|0|||
155280684|NCT04955626|560459881|FG014|Blinded Period|Other|0|||
155280685|NCT04955626|560459882|FG015|Blinded Period|Other|0|||
155280686|NCT04955626|560459883|FG016|Blinded Period|Other|0|||
155280687|NCT04955626|560459884|FG017|Blinded Period|Other|1|||
155280688|NCT04955626|560459885|FG018|Blinded Period|Other|0|||
155280689|NCT04955626|560459886|FG019|Blinded Period|Other|0|||
155280690|NCT04955626|560459887|FG020|Blinded Period|Other|0|||
155280691|NCT04955626|560459888|FG021|Blinded Period|Other|0|||
155280692|NCT04955626|560459889|FG022|Blinded Period|Other|0|||
155280693|NCT04955626|560459890|FG023|Blinded Period|Other|0|||
155280694|NCT04955626|560459891|FG024|Blinded Period|Other|0|||
155280695|NCT04955626|560459892|FG025|Blinded Period|Other|0|||
155280696|NCT04955626|560459893|FG026|Blinded Period|Other|2|||
155280697|NCT04955626|560459894|FG027|Blinded Period|Other|0|||
155280698|NCT04955626|560459895|FG028|Blinded Period|Other|0|||
155280699|NCT04955626|560459896|FG029|Blinded Period|Other|0|||
155280700|NCT04955626|560459897|FG030|Blinded Period|Other|0|||
155280701|NCT04955626|560459898|FG031|Blinded Period|Other|0|||
155280702|NCT04955626|560459899|FG032|Blinded Period|Other|0|||
155280703|NCT04955626|560459900|FG033|Blinded Period|Other|0|||
155280704|NCT04955626|560459901|FG034|Blinded Period|Other|0|||
155280705|NCT04955626|560459902|FG035|Blinded Period|Other|0|||
155280706|NCT04955626|560459867|FG000|Blinded Period|Physician Decision|1|||
155280707|NCT04955626|560459868|FG001|Blinded Period|Physician Decision|1|||
155280708|NCT04955626|560459869|FG002|Blinded Period|Physician Decision|0|||
155280709|NCT04955626|560459870|FG003|Blinded Period|Physician Decision|3|||
155280710|NCT04955626|560459871|FG004|Blinded Period|Physician Decision|0|||
155280711|NCT04955626|560459872|FG005|Blinded Period|Physician Decision|0|||
155280712|NCT04955626|560459873|FG006|Blinded Period|Physician Decision|1|||
155280713|NCT04955626|560459874|FG007|Blinded Period|Physician Decision|1|||
155280714|NCT04955626|560459875|FG008|Blinded Period|Physician Decision|0|||
155280715|NCT04955626|560459876|FG009|Blinded Period|Physician Decision|0|||
155280716|NCT04955626|560459877|FG010|Blinded Period|Physician Decision|0|||
155280717|NCT04955626|560459878|FG011|Blinded Period|Physician Decision|5|||
155280718|NCT04955626|560459879|FG012|Blinded Period|Physician Decision|0|||
155280719|NCT04955626|560459880|FG013|Blinded Period|Physician Decision|0|||
155280720|NCT04955626|560459881|FG014|Blinded Period|Physician Decision|0|||
155280721|NCT04955626|560459882|FG015|Blinded Period|Physician Decision|0|||
155280722|NCT04955626|560459883|FG016|Blinded Period|Physician Decision|0|||
155280723|NCT04955626|560459884|FG017|Blinded Period|Physician Decision|0|||
155280724|NCT04955626|560459885|FG018|Blinded Period|Physician Decision|0|||
155280725|NCT04955626|560459886|FG019|Blinded Period|Physician Decision|0|||
155280726|NCT04955626|560459887|FG020|Blinded Period|Physician Decision|0|||
155280727|NCT04955626|560459888|FG021|Blinded Period|Physician Decision|0|||
155280728|NCT04955626|560459889|FG022|Blinded Period|Physician Decision|0|||
155280729|NCT04955626|560459890|FG023|Blinded Period|Physician Decision|0|||
155280730|NCT04955626|560459891|FG024|Blinded Period|Physician Decision|0|||
155280731|NCT04955626|560459892|FG025|Blinded Period|Physician Decision|0|||
155280732|NCT04955626|560459893|FG026|Blinded Period|Physician Decision|0|||
155280733|NCT04955626|560459894|FG027|Blinded Period|Physician Decision|0|||
155280734|NCT04955626|560459895|FG028|Blinded Period|Physician Decision|0|||
155280735|NCT04955626|560459896|FG029|Blinded Period|Physician Decision|0|||
155280736|NCT04955626|560459897|FG030|Blinded Period|Physician Decision|0|||
155280737|NCT04955626|560459898|FG031|Blinded Period|Physician Decision|0|||
155280738|NCT04955626|560459899|FG032|Blinded Period|Physician Decision|0|||
155280739|NCT04955626|560459900|FG033|Blinded Period|Physician Decision|0|||
155280740|NCT04955626|560459901|FG034|Blinded Period|Physician Decision|0|||
155280741|NCT04955626|560459902|FG035|Blinded Period|Physician Decision|0|||
155280742|NCT04955626|560459867|FG000|Blinded Period|Withdrawal by Subject|26|||
155280743|NCT04955626|560459868|FG001|Blinded Period|Withdrawal by Subject|62|||
155280744|NCT04955626|560459869|FG002|Blinded Period|Withdrawal by Subject|14|||
155280745|NCT04955626|560459870|FG003|Blinded Period|Withdrawal by Subject|16|||
155280746|NCT04955626|560459871|FG004|Blinded Period|Withdrawal by Subject|1|||
155387301|NCT04677179|560853014|FG003|Induction Treatment Period|Protocol Violation|0|||
155387302|NCT04677179|560853015|FG004|Induction Treatment Period|Protocol Violation|0|||
155387303|NCT04677179|560853016|FG005|Induction Treatment Period|Protocol Violation|0|||
155387304|NCT04677179|560853017|FG006|Induction Treatment Period|Protocol Violation|0|||
155387305|NCT04677179|560853018|FG007|Induction Treatment Period|Protocol Violation|0|||
155387306|NCT04677179|560853019|FG008|Induction Treatment Period|Protocol Violation|0|||
155387307|NCT04677179|560853020|FG009|Induction Treatment Period|Protocol Violation|0|||
155387308|NCT04677179|560853011|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
155387309|NCT04677179|560853012|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
155387310|NCT04677179|560853013|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
155387311|NCT04677179|560853014|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
155387312|NCT04677179|560853015|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
155387313|NCT04677179|560853016|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
155387314|NCT04677179|560853017|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
155387315|NCT04677179|560853018|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
155387316|NCT04677179|560853019|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
155387317|NCT04677179|560853020|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
155387318|NCT04677179|560853011|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
155387319|NCT04677179|560853012|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
155387320|NCT04677179|560853013|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
155387321|NCT04677179|560853014|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
155387322|NCT04677179|560853015|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
155387323|NCT04677179|560853016|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
155387324|NCT04677179|560853017|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
155387325|NCT04677179|560853018|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
155387326|NCT04677179|560853019|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
155387327|NCT04677179|560853020|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
155387328|NCT04677179|560853011|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
155387329|NCT04677179|560853012|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
155387330|NCT04677179|560853013|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
155387331|NCT04677179|560853014|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
155387332|NCT04677179|560853015|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
155387333|NCT04677179|560853016|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
155387334|NCT04677179|560853017|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
155387335|NCT04677179|560853018|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
155387336|NCT04677179|560853019|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
155387337|NCT04677179|560853020|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
155387338|NCT04677179|560853011|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387339|NCT04677179|560853012|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387340|NCT04677179|560853013|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387341|NCT04677179|560853014|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
155387342|NCT04677179|560853015|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387343|NCT04677179|560853016|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387344|NCT04677179|560853017|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387345|NCT04677179|560853018|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387346|NCT04677179|560853019|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387347|NCT04677179|560853020|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387348|NCT04677179|560853011|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387349|NCT04677179|560853012|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387350|NCT04677179|560853013|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387351|NCT04677179|560853014|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
155387352|NCT04677179|560853015|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
155387353|NCT04677179|560853016|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
155387354|NCT04677179|560853017|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387355|NCT04677179|560853018|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387356|NCT04677179|560853019|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387357|NCT04677179|560853020|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387358|NCT04677179|560853011|FG000|Extension Treatment Period|Lack of Efficacy|0|||
155387359|NCT04677179|560853012|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155387360|NCT04677179|560853013|FG002|Extension Treatment Period|Lack of Efficacy|0|||
155387361|NCT04677179|560853014|FG003|Extension Treatment Period|Lack of Efficacy|0|||
155387362|NCT04677179|560853015|FG004|Extension Treatment Period|Lack of Efficacy|0|||
155387363|NCT04677179|560853016|FG005|Extension Treatment Period|Lack of Efficacy|0|||
155387364|NCT04677179|560853017|FG006|Extension Treatment Period|Lack of Efficacy|6|||
155387365|NCT04677179|560853018|FG007|Extension Treatment Period|Lack of Efficacy|0|||
155387366|NCT04677179|560853019|FG008|Extension Treatment Period|Lack of Efficacy|0|||
155387367|NCT04677179|560853020|FG009|Extension Treatment Period|Lack of Efficacy|0|||
155387368|NCT04677179|560853011|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155387369|NCT04677179|560853012|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155387370|NCT04677179|560853013|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155387371|NCT04677179|560853014|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
155387372|NCT04677179|560853015|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
155387373|NCT04677179|560853016|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
155387374|NCT04677179|560853017|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
155387375|NCT04677179|560853018|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
155387376|NCT04677179|560853019|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
155387377|NCT04677179|560853020|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
155387378|NCT04677179|560853011|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
155387379|NCT04677179|560853012|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
155387380|NCT04677179|560853013|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
155387381|NCT04677179|560853014|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
155387382|NCT04677179|560853015|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
155387383|NCT04677179|560853016|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
155387384|NCT04677179|560853017|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
155387385|NCT04677179|560853018|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
155387386|NCT04677179|560853019|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
155387387|NCT04677179|560853020|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
155387388|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
155387389|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
155387390|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
155387391|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
155387392|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
155387393|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
155387394|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
155387395|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
155387396|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
155387397|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
155387398|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387399|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387400|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387401|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387402|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387403|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387404|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387405|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
155387406|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
155387407|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387408|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387409|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387410|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387411|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387412|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387413|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387414|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387415|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
155387416|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387417|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387418|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387419|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387420|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387421|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387422|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387423|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155729300|NCT02113982|562108034|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
155387424|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387425|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
155387426|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
155387427|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387428|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387429|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387430|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387431|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387432|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387433|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387434|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155729301|NCT02113982|562108035|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
155729302|NCT02113982|562108036|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
155729303|NCT02113982|562108037|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
155729304|NCT02113982|562108038|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
155729305|NCT02113982|562108039|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
155729306|NCT02113982|562108040|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
155729307|NCT02113982|562108041|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
155729308|NCT02113982|562108042|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
155729309|NCT02113982|562108043|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
155729310|NCT02113982|562108044|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
155729311|NCT02113982|562108045|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
155280747|NCT04955626|560459872|FG005|Blinded Period|Withdrawal by Subject|2|||
155280748|NCT04955626|560459873|FG006|Blinded Period|Withdrawal by Subject|9|||
155280749|NCT04955626|560459874|FG007|Blinded Period|Withdrawal by Subject|5|||
155280750|NCT04955626|560459875|FG008|Blinded Period|Withdrawal by Subject|3|||
155280751|NCT04955626|560459876|FG009|Blinded Period|Withdrawal by Subject|15|||
155280752|NCT04955626|560459877|FG010|Blinded Period|Withdrawal by Subject|11|||
155280753|NCT04955626|560459878|FG011|Blinded Period|Withdrawal by Subject|7|||
155280754|NCT04955626|560459879|FG012|Blinded Period|Withdrawal by Subject|2|||
155280755|NCT04955626|560459880|FG013|Blinded Period|Withdrawal by Subject|0|||
155280756|NCT04955626|560459881|FG014|Blinded Period|Withdrawal by Subject|1|||
155280757|NCT04955626|560459882|FG015|Blinded Period|Withdrawal by Subject|11|||
155280758|NCT04955626|560459883|FG016|Blinded Period|Withdrawal by Subject|2|||
155280759|NCT04955626|560459884|FG017|Blinded Period|Withdrawal by Subject|5|||
155280760|NCT04955626|560459885|FG018|Blinded Period|Withdrawal by Subject|0|||
155280761|NCT04955626|560459886|FG019|Blinded Period|Withdrawal by Subject|0|||
155280762|NCT04955626|560459887|FG020|Blinded Period|Withdrawal by Subject|1|||
155280763|NCT04955626|560459888|FG021|Blinded Period|Withdrawal by Subject|0|||
155280764|NCT04955626|560459889|FG022|Blinded Period|Withdrawal by Subject|0|||
155280765|NCT04955626|560459890|FG023|Blinded Period|Withdrawal by Subject|0|||
155280766|NCT04955626|560459891|FG024|Blinded Period|Withdrawal by Subject|5|||
155280767|NCT04955626|560459892|FG025|Blinded Period|Withdrawal by Subject|1|||
155280768|NCT04955626|560459893|FG026|Blinded Period|Withdrawal by Subject|5|||
155280769|NCT04955626|560459894|FG027|Blinded Period|Withdrawal by Subject|1|||
155280770|NCT04955626|560459895|FG028|Blinded Period|Withdrawal by Subject|4|||
155280771|NCT04955626|560459896|FG029|Blinded Period|Withdrawal by Subject|2|||
155280772|NCT04955626|560459897|FG030|Blinded Period|Withdrawal by Subject|0|||
155280773|NCT04955626|560459898|FG031|Blinded Period|Withdrawal by Subject|0|||
155280774|NCT04955626|560459899|FG032|Blinded Period|Withdrawal by Subject|0|||
155280775|NCT04955626|560459900|FG033|Blinded Period|Withdrawal by Subject|0|||
155280776|NCT04955626|560459901|FG034|Blinded Period|Withdrawal by Subject|0|||
155280777|NCT04955626|560459902|FG035|Blinded Period|Withdrawal by Subject|0|||
155280778|NCT04955626|560459867|FG000|Blinded Period|Refused further study procedures|0|||
155280779|NCT04955626|560459868|FG001|Blinded Period|Refused further study procedures|0|||
155280780|NCT04955626|560459869|FG002|Blinded Period|Refused further study procedures|0|||
155280781|NCT04955626|560459870|FG003|Blinded Period|Refused further study procedures|0|||
155280782|NCT04955626|560459871|FG004|Blinded Period|Refused further study procedures|0|||
155280783|NCT04955626|560459872|FG005|Blinded Period|Refused further study procedures|0|||
155280784|NCT04955626|560459873|FG006|Blinded Period|Refused further study procedures|1|||
155280785|NCT04955626|560459874|FG007|Blinded Period|Refused further study procedures|0|||
155280786|NCT04955626|560459875|FG008|Blinded Period|Refused further study procedures|0|||
155280787|NCT04955626|560459876|FG009|Blinded Period|Refused further study procedures|0|||
155280788|NCT04955626|560459877|FG010|Blinded Period|Refused further study procedures|0|||
155280789|NCT04955626|560459878|FG011|Blinded Period|Refused further study procedures|2|||
155280790|NCT04955626|560459879|FG012|Blinded Period|Refused further study procedures|0|||
155280791|NCT04955626|560459880|FG013|Blinded Period|Refused further study procedures|0|||
155280792|NCT04955626|560459881|FG014|Blinded Period|Refused further study procedures|0|||
155280793|NCT04955626|560459882|FG015|Blinded Period|Refused further study procedures|0|||
155280794|NCT04955626|560459883|FG016|Blinded Period|Refused further study procedures|0|||
155280795|NCT04955626|560459884|FG017|Blinded Period|Refused further study procedures|0|||
155280796|NCT04955626|560459885|FG018|Blinded Period|Refused further study procedures|0|||
155280797|NCT04955626|560459886|FG019|Blinded Period|Refused further study procedures|0|||
155280798|NCT04955626|560459887|FG020|Blinded Period|Refused further study procedures|0|||
155280799|NCT04955626|560459888|FG021|Blinded Period|Refused further study procedures|0|||
155280800|NCT04955626|560459889|FG022|Blinded Period|Refused further study procedures|0|||
155280801|NCT04955626|560459890|FG023|Blinded Period|Refused further study procedures|0|||
155280802|NCT04955626|560459891|FG024|Blinded Period|Refused further study procedures|0|||
155280803|NCT04955626|560459892|FG025|Blinded Period|Refused further study procedures|0|||
155280804|NCT04955626|560459893|FG026|Blinded Period|Refused further study procedures|0|||
155280805|NCT04955626|560459894|FG027|Blinded Period|Refused further study procedures|0|||
155280806|NCT04955626|560459895|FG028|Blinded Period|Refused further study procedures|0|||
155280807|NCT04955626|560459896|FG029|Blinded Period|Refused further study procedures|0|||
155280808|NCT04955626|560459897|FG030|Blinded Period|Refused further study procedures|0|||
155729312|NCT02113982|562108046|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
155387435|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
155387436|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
155387437|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
155387438|NCT01536015|560853021|FG000|Overall Study|Adverse Event|1|||
155387439|NCT01536015|560853022|FG001|Overall Study|Adverse Event|4|||
155387440|NCT01536015|560853021|FG000|Overall Study|Lost to Follow-up|0|||
155387441|NCT01536015|560853022|FG001|Overall Study|Lost to Follow-up|1|||
155387442|NCT01536015|560853021|FG000|Overall Study|Inclusion Criterion not met|2|||
155387443|NCT01536015|560853022|FG001|Overall Study|Inclusion Criterion not met|0|||
155387444|NCT01536015|560853021|FG000|Overall Study|Study closure|5|||
155387445|NCT01536015|560853022|FG001|Overall Study|Study closure|5|||
155387446|NCT01201265|560853025|FG000|Overall Study|Death|14|||
155387447|NCT01201265|560853025|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155387448|NCT01201265|560853025|FG000|Overall Study|Lost to Follow-up|10|||
155387449|NCT01201265|560853025|FG000|Overall Study|Withdrawal by Subject|7|||
155387450|NCT01201265|560853025|FG000|Overall Study|Disease Progression|4|||
155387451|NCT02041520|560853026|FG000|Overall Study|Adverse Event|2|||
155387452|NCT02041520|560853027|FG001|Overall Study|Adverse Event|1|||
155387453|NCT02041520|560853026|FG000|Overall Study|Withdrawal by Subject|3|||
155387454|NCT02041520|560853027|FG001|Overall Study|Withdrawal by Subject|4|||
155387455|NCT02041520|560853026|FG000|Overall Study|Protocol Violation|1|||
155387456|NCT02041520|560853027|FG001|Overall Study|Protocol Violation|0|||
155387457|NCT02041520|560853026|FG000|Overall Study|Lost to Follow-up|0|||
155387458|NCT02041520|560853027|FG001|Overall Study|Lost to Follow-up|1|||
155387459|NCT02041520|560853026|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
155387460|NCT02041520|560853027|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
155387461|NCT00413972|560853028|FG000|Overall Study|Adverse Event|2|||
155387462|NCT00413972|560853029|FG001|Overall Study|Adverse Event|1|||
155387463|NCT00413972|560853030|FG002|Overall Study|Adverse Event|0|||
155387464|NCT00413972|560853031|FG003|Overall Study|Adverse Event|0|||
155387465|NCT00413972|560853028|FG000|Overall Study|Lost to Follow-up|1|||
155387466|NCT00413972|560853029|FG001|Overall Study|Lost to Follow-up|2|||
155387467|NCT00413972|560853030|FG002|Overall Study|Lost to Follow-up|1|||
155387468|NCT00413972|560853031|FG003|Overall Study|Lost to Follow-up|0|||
155387469|NCT00413972|560853028|FG000|Overall Study|Withdrawal by Subject|4|||
155387470|NCT00413972|560853029|FG001|Overall Study|Withdrawal by Subject|5|||
155627299|NCT01079780|561732412|FG002|Overall Study|Treatment cycle delay|1|||
155627300|NCT01079780|561732410|FG000|Overall Study|Never started treatment|1|||
155627301|NCT01079780|561732411|FG001|Overall Study|Never started treatment|0|||
155627302|NCT01079780|561732412|FG002|Overall Study|Never started treatment|2|||
155627303|NCT02783066|561732413|FG000|Overall Study|Withdrawal by Subject|13|||
155627304|NCT03712280|561732414|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
155627305|NCT03712280|561732415|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
155627306|NCT03712280|561732416|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
155627307|NCT03712280|561732417|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
155627308|NCT03712280|561732414|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
155627309|NCT03712280|561732415|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
155627310|NCT03712280|561732416|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
155627311|NCT03712280|561732417|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
155627312|NCT03712280|561732414|FG000|Overall Study|Adverse Event|0|||
155627313|NCT03712280|561732415|FG001|Overall Study|Adverse Event|0|||
155627314|NCT03712280|561732416|FG002|Overall Study|Adverse Event|1|||
155627315|NCT03712280|561732417|FG003|Overall Study|Adverse Event|0|||
155627316|NCT00551369|561732418|FG000|Overall Study|Protocol Violation|5|||
155627317|NCT00551369|561732418|FG000|Overall Study|Withdrawal by Subject|1|||
155627318|NCT00551369|561732418|FG000|Overall Study|Not treated per protocol and re|1|||
155627319|NCT01663623|561732419|FG000|Overall Study|Adverse Event|3|||
155627320|NCT01663623|561732420|FG001|Overall Study|Adverse Event|7|||
155627321|NCT01663623|561732419|FG000|Overall Study|Lack of Efficacy|5|||
155627322|NCT01663623|561732420|FG001|Overall Study|Lack of Efficacy|6|||
155627323|NCT01663623|561732419|FG000|Overall Study|Protocol Violation|0|||
155627324|NCT01663623|561732420|FG001|Overall Study|Protocol Violation|1|||
155627325|NCT01663623|561732419|FG000|Overall Study|Other-Study closed/terminated|1|||
155627326|NCT01663623|561732420|FG001|Overall Study|Other-Study closed/terminated|1|||
155729313|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155627327|NCT01663623|561732419|FG000|Overall Study|Physician Decision|1|||
155387471|NCT00413972|560853030|FG002|Overall Study|Withdrawal by Subject|7|||
155387472|NCT00413972|560853031|FG003|Overall Study|Withdrawal by Subject|2|||
155387473|NCT00413972|560853028|FG000|Overall Study|Protocol Violation|0|||
155387474|NCT00413972|560853029|FG001|Overall Study|Protocol Violation|0|||
155387475|NCT00413972|560853030|FG002|Overall Study|Protocol Violation|2|||
155387476|NCT00413972|560853031|FG003|Overall Study|Protocol Violation|0|||
155387477|NCT00413972|560853028|FG000|Overall Study|Other|0|||
155387478|NCT00413972|560853029|FG001|Overall Study|Other|0|||
155387479|NCT00413972|560853030|FG002|Overall Study|Other|0|||
155387480|NCT00413972|560853031|FG003|Overall Study|Other|1|||
155729314|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729315|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729316|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729317|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729318|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155280809|NCT04955626|560459898|FG031|Blinded Period|Refused further study procedures|0|||
155280810|NCT04955626|560459899|FG032|Blinded Period|Refused further study procedures|0|||
155280811|NCT04955626|560459900|FG033|Blinded Period|Refused further study procedures|0|||
155280812|NCT04955626|560459901|FG034|Blinded Period|Refused further study procedures|0|||
155280813|NCT04955626|560459902|FG035|Blinded Period|Refused further study procedures|0|||
155280814|NCT04955626|560459867|FG000|Blinded Period|Participants entered open label period|4544|||
155280815|NCT04955626|560459868|FG001|Blinded Period|Participants entered open label period|4906|||
155280816|NCT04955626|560459869|FG002|Blinded Period|Participants entered open label period|0|||
155280817|NCT04955626|560459870|FG003|Blinded Period|Participants entered open label period|0|||
155280818|NCT04955626|560459871|FG004|Blinded Period|Participants entered open label period|0|||
155280819|NCT04955626|560459872|FG005|Blinded Period|Participants entered open label period|0|||
155280820|NCT04955626|560459873|FG006|Blinded Period|Participants entered open label period|0|||
155280821|NCT04955626|560459874|FG007|Blinded Period|Participants entered open label period|0|||
155280822|NCT04955626|560459875|FG008|Blinded Period|Participants entered open label period|0|||
155280823|NCT04955626|560459876|FG009|Blinded Period|Participants entered open label period|0|||
155280824|NCT04955626|560459877|FG010|Blinded Period|Participants entered open label period|0|||
155280825|NCT04955626|560459878|FG011|Blinded Period|Participants entered open label period|0|||
155280826|NCT04955626|560459879|FG012|Blinded Period|Participants entered open label period|0|||
155280827|NCT04955626|560459880|FG013|Blinded Period|Participants entered open label period|0|||
155280828|NCT04955626|560459881|FG014|Blinded Period|Participants entered open label period|0|||
155280829|NCT04955626|560459882|FG015|Blinded Period|Participants entered open label period|0|||
155280830|NCT04955626|560459883|FG016|Blinded Period|Participants entered open label period|0|||
155280831|NCT04955626|560459884|FG017|Blinded Period|Participants entered open label period|0|||
155280832|NCT04955626|560459885|FG018|Blinded Period|Participants entered open label period|0|||
155280833|NCT04955626|560459886|FG019|Blinded Period|Participants entered open label period|0|||
155280834|NCT04955626|560459887|FG020|Blinded Period|Participants entered open label period|0|||
155280835|NCT04955626|560459888|FG021|Blinded Period|Participants entered open label period|0|||
155280836|NCT04955626|560459889|FG022|Blinded Period|Participants entered open label period|0|||
155280837|NCT04955626|560459890|FG023|Blinded Period|Participants entered open label period|0|||
155280838|NCT04955626|560459891|FG024|Blinded Period|Participants entered open label period|0|||
155280839|NCT04955626|560459892|FG025|Blinded Period|Participants entered open label period|0|||
155280840|NCT04955626|560459893|FG026|Blinded Period|Participants entered open label period|0|||
155280841|NCT04955626|560459894|FG027|Blinded Period|Participants entered open label period|0|||
155280842|NCT04955626|560459895|FG028|Blinded Period|Participants entered open label period|0|||
155280843|NCT04955626|560459896|FG029|Blinded Period|Participants entered open label period|0|||
155280844|NCT04955626|560459897|FG030|Blinded Period|Participants entered open label period|0|||
155280845|NCT04955626|560459898|FG031|Blinded Period|Participants entered open label period|0|||
155280846|NCT04955626|560459899|FG032|Blinded Period|Participants entered open label period|0|||
155280847|NCT04955626|560459900|FG033|Blinded Period|Participants entered open label period|0|||
155280848|NCT04955626|560459901|FG034|Blinded Period|Participants entered open label period|0|||
155280849|NCT04955626|560459902|FG035|Blinded Period|Participants entered open label period|0|||
155280850|NCT04955626|560459867|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
155280851|NCT04955626|560459868|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
155280852|NCT04955626|560459869|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
155280853|NCT04955626|560459870|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
155280854|NCT04955626|560459871|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
155280855|NCT04955626|560459872|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
155280856|NCT04955626|560459873|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
155280857|NCT04955626|560459874|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
155280858|NCT04955626|560459875|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
155280859|NCT04955626|560459876|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
155280860|NCT04955626|560459877|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
155280861|NCT04955626|560459878|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
155280862|NCT04955626|560459879|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
155280863|NCT04955626|560459880|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
155280864|NCT04955626|560459881|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
155387481|NCT01898923|560853034|FG000|Overall Study|Lack of Efficacy|5|||
155280865|NCT04955626|560459882|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
155280866|NCT04955626|560459883|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
155280867|NCT04955626|560459884|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
155280868|NCT04955626|560459885|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
155387482|NCT01898923|560853035|FG001|Overall Study|Lack of Efficacy|6|||
155387483|NCT01898923|560853034|FG000|Overall Study|Adverse Event|3|||
155729319|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729320|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729321|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729322|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729323|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729324|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155280869|NCT04955626|560459886|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
155280870|NCT04955626|560459887|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
155280871|NCT04955626|560459888|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
155280872|NCT04955626|560459889|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
155280873|NCT04955626|560459890|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
155280874|NCT04955626|560459891|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
155280875|NCT04955626|560459892|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
155280876|NCT04955626|560459893|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
155280877|NCT04955626|560459894|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
155280878|NCT04955626|560459895|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
155280879|NCT04955626|560459896|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
155280880|NCT04955626|560459897|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
155280881|NCT04955626|560459898|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
155280882|NCT04955626|560459899|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
155280883|NCT04955626|560459900|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
155280884|NCT04955626|560459901|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
155280885|NCT04955626|560459902|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
155280886|NCT04955626|560459867|FG000|Blinded Period|Medication error|0|||
155280887|NCT04955626|560459868|FG001|Blinded Period|Medication error|0|||
155280888|NCT04955626|560459869|FG002|Blinded Period|Medication error|0|||
155280889|NCT04955626|560459870|FG003|Blinded Period|Medication error|0|||
155280890|NCT04955626|560459871|FG004|Blinded Period|Medication error|0|||
155280891|NCT04955626|560459872|FG005|Blinded Period|Medication error|0|||
155280892|NCT04955626|560459873|FG006|Blinded Period|Medication error|0|||
155280893|NCT04955626|560459874|FG007|Blinded Period|Medication error|0|||
155280894|NCT04955626|560459875|FG008|Blinded Period|Medication error|0|||
155280895|NCT04955626|560459876|FG009|Blinded Period|Medication error|0|||
155280896|NCT04955626|560459877|FG010|Blinded Period|Medication error|2|||
155280897|NCT04955626|560459878|FG011|Blinded Period|Medication error|0|||
155280898|NCT04955626|560459879|FG012|Blinded Period|Medication error|0|||
155280899|NCT04955626|560459880|FG013|Blinded Period|Medication error|0|||
155280900|NCT04955626|560459881|FG014|Blinded Period|Medication error|0|||
155280901|NCT04955626|560459882|FG015|Blinded Period|Medication error|0|||
155280902|NCT04955626|560459883|FG016|Blinded Period|Medication error|0|||
155280903|NCT04955626|560459884|FG017|Blinded Period|Medication error|0|||
155280904|NCT04955626|560459885|FG018|Blinded Period|Medication error|0|||
155280905|NCT04955626|560459886|FG019|Blinded Period|Medication error|0|||
155280906|NCT04955626|560459887|FG020|Blinded Period|Medication error|0|||
155280907|NCT04955626|560459888|FG021|Blinded Period|Medication error|0|||
155280908|NCT04955626|560459889|FG022|Blinded Period|Medication error|0|||
155280909|NCT04955626|560459890|FG023|Blinded Period|Medication error|0|||
155280910|NCT04955626|560459891|FG024|Blinded Period|Medication error|0|||
155280911|NCT04955626|560459892|FG025|Blinded Period|Medication error|0|||
155280912|NCT04955626|560459893|FG026|Blinded Period|Medication error|0|||
155280913|NCT04955626|560459894|FG027|Blinded Period|Medication error|0|||
155627328|NCT01663623|561732420|FG001|Overall Study|Physician Decision|4|||
155627329|NCT01663623|561732419|FG000|Overall Study|Withdrawal by Subject|2|||
155627330|NCT01663623|561732420|FG001|Overall Study|Withdrawal by Subject|1|||
155627331|NCT02251275|561732421|FG000|Overall Study|Adverse Event|23|||
155627332|NCT02251275|561732422|FG001|Overall Study|Adverse Event|60|||
155627333|NCT02251275|561732423|FG002|Overall Study|Adverse Event|28|||
155627334|NCT02251275|561732424|FG003|Overall Study|Adverse Event|0|||
155627335|NCT02251275|561732425|FG004|Overall Study|Adverse Event|0|||
155627336|NCT02251275|561732421|FG000|Overall Study|Lost to Follow-up|5|||
155627337|NCT02251275|561732422|FG001|Overall Study|Lost to Follow-up|6|||
155627338|NCT02251275|561732423|FG002|Overall Study|Lost to Follow-up|4|||
155627339|NCT02251275|561732424|FG003|Overall Study|Lost to Follow-up|0|||
155627340|NCT02251275|561732425|FG004|Overall Study|Lost to Follow-up|0|||
155627341|NCT02251275|561732421|FG000|Overall Study|Physician Decision|19|||
155627342|NCT02251275|561732422|FG001|Overall Study|Physician Decision|30|||
155280914|NCT04955626|560459895|FG028|Blinded Period|Medication error|4|||
155280915|NCT04955626|560459896|FG029|Blinded Period|Medication error|0|||
155280916|NCT04955626|560459897|FG030|Blinded Period|Medication error|0|||
155280917|NCT04955626|560459898|FG031|Blinded Period|Medication error|0|||
155280918|NCT04955626|560459899|FG032|Blinded Period|Medication error|0|||
155280919|NCT04955626|560459900|FG033|Blinded Period|Medication error|0|||
155627343|NCT02251275|561732423|FG002|Overall Study|Physician Decision|26|||
155627344|NCT02251275|561732424|FG003|Overall Study|Physician Decision|0|||
155627345|NCT02251275|561732425|FG004|Overall Study|Physician Decision|1|||
155627346|NCT02251275|561732421|FG000|Overall Study|Protocol Deviation|0|||
155627347|NCT02251275|561732422|FG001|Overall Study|Protocol Deviation|0|||
155387484|NCT01898923|560853035|FG001|Overall Study|Adverse Event|1|||
155387485|NCT01898923|560853034|FG000|Overall Study|Lost to Follow-up|0|||
155387486|NCT01898923|560853035|FG001|Overall Study|Lost to Follow-up|1|||
155387487|NCT01898923|560853034|FG000|Overall Study|Withdrawal by Subject|4|||
155387488|NCT01898923|560853035|FG001|Overall Study|Withdrawal by Subject|7|||
155387489|NCT01898923|560853034|FG000|Overall Study|Physician Decision|3|||
155387490|NCT01898923|560853035|FG001|Overall Study|Physician Decision|4|||
155387491|NCT01898923|560853034|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
155387492|NCT01898923|560853035|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
155387493|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
155387494|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
155387495|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
155387496|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
155387497|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
155387498|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
155387499|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
155387500|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
155387501|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
155387502|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
155387503|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
155387504|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
155387505|NCT00723021|560853042|FG000|Intervention Period 4|Adverse Event|0|||
155387506|NCT00723021|560853043|FG001|Intervention Period 4|Adverse Event|0|||
155387507|NCT00723021|560853044|FG002|Intervention Period 4|Adverse Event|0|||
155387508|NCT00723021|560853045|FG003|Intervention Period 4|Adverse Event|0|||
155387509|NCT00723021|560853046|FG004|Intervention Period 4|Adverse Event|1|||
155387510|NCT02739360|560853048|FG000|Overall Study|Adverse Event|1|||
155387511|NCT02739360|560853048|FG000|Overall Study|Study terminated by Sponsor|2|||
155387512|NCT00026208|560853051|FG000|Overall Study|Complications of auto accident|1|||
155387513|NCT00026208|560853052|FG001|Overall Study|Complications of auto accident|0|||
155387514|NCT02881957|560853061|FG000|Overall Study|Comfort care|0|||
155387515|NCT02881957|560853062|FG001|Overall Study|Comfort care|1|||
155627348|NCT02251275|561732423|FG002|Overall Study|Protocol Deviation|1|||
155627349|NCT02251275|561732424|FG003|Overall Study|Protocol Deviation|0|||
155627350|NCT02251275|561732425|FG004|Overall Study|Protocol Deviation|0|||
155627351|NCT02251275|561732421|FG000|Overall Study|Withdrawal by Subject|25|||
155627352|NCT02251275|561732422|FG001|Overall Study|Withdrawal by Subject|51|||
155627353|NCT02251275|561732423|FG002|Overall Study|Withdrawal by Subject|35|||
155627354|NCT02251275|561732424|FG003|Overall Study|Withdrawal by Subject|1|||
155627355|NCT02251275|561732425|FG004|Overall Study|Withdrawal by Subject|0|||
155627356|NCT01004614|561732426|FG000|Washout|Withdrawal by Subject|0|||
155627357|NCT01004614|561732427|FG001|Washout|Withdrawal by Subject|1|||
155627358|NCT01004614|561732428|FG002|Washout|Withdrawal by Subject|0|||
155627359|NCT01004614|561732429|FG003|Washout|Withdrawal by Subject|0|||
155627360|NCT01569022|561732431|FG000|First Intervention|Lost to Follow-up|2|||
155627361|NCT01569022|561732432|FG001|First Intervention|Lost to Follow-up|1|||
155627362|NCT01569022|561732431|FG000|Second Intervention|Lost to Follow-up|2|||
155627363|NCT01569022|561732432|FG001|Second Intervention|Lost to Follow-up|2|||
155627364|NCT02111083|561732433|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
155627365|NCT02111083|561732434|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
155627366|NCT01302899|561732435|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
155627367|NCT01302899|561732436|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
155627368|NCT01302899|561732435|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
155627369|NCT01302899|561732436|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
155627370|NCT02834975|561732437|FG000|Overall Study|Physician Decision|2|||
155627371|NCT02834975|561732437|FG000|Overall Study|Adverse Event|1|||
155627372|NCT02834975|561732437|FG000|Overall Study|Withdrawal by Subject|1|||
155627373|NCT02834975|561732437|FG000|Overall Study|Lack of Efficacy|1|||
155627374|NCT03482024|561732439|FG000|Overall Study|Physician Decision|1|||
155627375|NCT03482024|561732440|FG001|Overall Study|Physician Decision|0|||
155627376|NCT03482024|561732441|FG002|Overall Study|Physician Decision|0|||
155627377|NCT03482024|561732442|FG003|Overall Study|Physician Decision|0|||
155627378|NCT03482024|561732443|FG004|Overall Study|Physician Decision|0|||
155627379|NCT00472420|561732444|FG000|Induction Treatment Period|Physician Decision|9|||
155627380|NCT00472420|561732444|FG000|Induction Treatment Period|Adverse Event|3|||
155627381|NCT00472420|561732444|FG000|Induction Treatment Period|Non-compliance|1|||
155627382|NCT00472420|561732444|FG000|Induction Treatment Period|Death|3|||
155627383|NCT00472420|561732444|FG000|Follow-up Period|Death|5|||
155627384|NCT00472420|561732444|FG000|Follow-up Period|Physician Decision|9|||
155627385|NCT00472420|561732444|FG000|Follow-up Period|Lost to Follow-up|2|||
155627386|NCT00472420|561732444|FG000|Follow-up Period|Protocol Violation|1|||
155387516|NCT02881957|560853061|FG000|Overall Study|Concurrent trial enrollment|0|||
155387517|NCT02881957|560853062|FG001|Overall Study|Concurrent trial enrollment|1|||
155387518|NCT02881957|560853061|FG000|Overall Study|Discharged within 48 hours|0|||
155387519|NCT02881957|560853062|FG001|Overall Study|Discharged within 48 hours|1|||
155387520|NCT02881957|560853061|FG000|Overall Study|Withdrawal by Subject|2|||
155387521|NCT02881957|560853062|FG001|Overall Study|Withdrawal by Subject|1|||
155387522|NCT02881957|560853061|FG000|Overall Study|Protocol Violation|1|||
155387523|NCT02881957|560853062|FG001|Overall Study|Protocol Violation|0|||
155387524|NCT02254278|560853063|FG000|Overall Study|Protocol Violation|1|||
155387525|NCT02254278|560853064|FG001|Overall Study|Protocol Violation|1|||
155387526|NCT00826111|560854878|FG000|Overall Study|Lost to Follow-up|0|||
155387527|NCT00826111|560854879|FG001|Overall Study|Lost to Follow-up|1|||
155387528|NCT00826111|560854878|FG000|Overall Study|Protocol Violation|1|||
155387529|NCT00826111|560854879|FG001|Overall Study|Protocol Violation|0|||
155387530|NCT00826111|560854878|FG000|Overall Study|Withdrawal by Subject|5|||
155387531|NCT00826111|560854879|FG001|Overall Study|Withdrawal by Subject|0|||
155387532|NCT00826111|560854878|FG000|Overall Study|Physician Decision|1|||
155387533|NCT00826111|560854879|FG001|Overall Study|Physician Decision|1|||
155387534|NCT02805725|560854880|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387535|NCT02805725|560854881|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387536|NCT02805725|560854882|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
155387537|NCT02805725|560854883|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387538|NCT02805725|560854884|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387539|NCT02805725|560854880|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387540|NCT02805725|560854881|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387541|NCT02805725|560854882|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
155387542|NCT02805725|560854883|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
155387543|NCT02805725|560854884|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387544|NCT02805725|560854880|FG000|Phase II|Protocol Violation|0|||
155387545|NCT02805725|560854881|FG001|Phase II|Protocol Violation|0|||
155387546|NCT02805725|560854882|FG002|Phase II|Protocol Violation|0|||
155387547|NCT02805725|560854883|FG003|Phase II|Protocol Violation|0|||
155387548|NCT02805725|560854884|FG004|Phase II|Protocol Violation|6|||
155387549|NCT01195545|560854885|FG000|Overall Study|Protocol Violation|4|||
155387550|NCT03511053|560854889|FG000|Overall Study|Withdrawal by Subject|1|||
155387551|NCT02425644|560854890|FG000|Overall Study|Lost to Follow-up|2|||
155387552|NCT02425644|560854891|FG001|Overall Study|Lost to Follow-up|3|||
155387553|NCT02425644|560854890|FG000|Overall Study|Withdrawal by Subject|41|||
155387554|NCT02425644|560854891|FG001|Overall Study|Withdrawal by Subject|36|||
155387555|NCT02425644|560854890|FG000|Overall Study|Lack of Efficacy|3|||
155387556|NCT02425644|560854891|FG001|Overall Study|Lack of Efficacy|10|||
155387557|NCT02425644|560854890|FG000|Overall Study|Adverse Event|13|||
155387558|NCT02425644|560854891|FG001|Overall Study|Adverse Event|3|||
155387559|NCT02425644|560854890|FG000|Overall Study|Death|0|||
155387560|NCT02425644|560854891|FG001|Overall Study|Death|2|||
155387561|NCT02425644|560854890|FG000|Overall Study|Other|18|||
155387562|NCT02425644|560854891|FG001|Overall Study|Other|17|||
155387563|NCT02720536|560854892|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
155387564|NCT02720536|560854892|FG000|Overall Study|PR - pregnancy|2|||
155387565|NCT02720536|560854892|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
155387566|NCT02720536|560854892|FG000|Overall Study|PR - death|1|||
155387567|NCT02720536|560854892|FG000|Overall Study|PR - adverse event|1|||
155387568|NCT02720536|560854892|FG000|Overall Study|PR - abnormal lab value(s)|1|||
155387569|NCT02720536|560854892|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
155387570|NCT01028222|560854893|FG000|Overall Study|Protocol deviation|1|||
155387571|NCT01028222|560854894|FG001|Overall Study|Protocol deviation|0|||
155387572|NCT01028222|560854893|FG000|Overall Study|Disease progression|33|||
155387573|NCT01028222|560854894|FG001|Overall Study|Disease progression|9|||
155387574|NCT01028222|560854893|FG000|Overall Study|Administrative problems|1|||
155387575|NCT01028222|560854894|FG001|Overall Study|Administrative problems|1|||
155387576|NCT01028222|560854893|FG000|Overall Study|Lost to Follow-up|0|||
155387577|NCT01028222|560854894|FG001|Overall Study|Lost to Follow-up|1|||
155387578|NCT01028222|560854893|FG000|Overall Study|Withdrawal by Subject|1|||
155387579|NCT01028222|560854894|FG001|Overall Study|Withdrawal by Subject|0|||
155387580|NCT01028222|560854893|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
155387581|NCT01028222|560854894|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
155387582|NCT01028222|560854893|FG000|Overall Study|Adverse Event|2|||
155387583|NCT01028222|560854894|FG001|Overall Study|Adverse Event|0|||
155387584|NCT00146328|560854895|FG000|Overall Study|Adverse Event|39|||
155387585|NCT00146328|560854896|FG001|Overall Study|Adverse Event|48|||
155387586|NCT00146328|560854897|FG002|Overall Study|Adverse Event|79|||
155387587|NCT00146328|560854895|FG000|Overall Study|Protocol Violation|11|||
155387588|NCT00146328|560854896|FG001|Overall Study|Protocol Violation|6|||
155387589|NCT00146328|560854897|FG002|Overall Study|Protocol Violation|12|||
155387590|NCT00146328|560854895|FG000|Overall Study|Lost to Follow-up|7|||
155387591|NCT00146328|560854896|FG001|Overall Study|Lost to Follow-up|4|||
155387592|NCT00146328|560854897|FG002|Overall Study|Lost to Follow-up|7|||
155387593|NCT00146328|560854895|FG000|Overall Study|Withdrawal by Subject|16|||
155387594|NCT00146328|560854896|FG001|Overall Study|Withdrawal by Subject|16|||
155627387|NCT00686972|561732446|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
155387595|NCT00146328|560854897|FG002|Overall Study|Withdrawal by Subject|22|||
155387596|NCT00146328|560854895|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
155387597|NCT00146328|560854896|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
155387598|NCT00146328|560854897|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
155387599|NCT00146328|560854895|FG000|Overall Study|Trial ended/site closed|8|||
155387600|NCT00146328|560854896|FG001|Overall Study|Trial ended/site closed|2|||
155387601|NCT00146328|560854897|FG002|Overall Study|Trial ended/site closed|19|||
155387602|NCT00146328|560854895|FG000|Overall Study|Patient decision to end|0|||
155627388|NCT03093181|561732447|FG000|Overall Study|Withdrawal by Subject|2|||
155627389|NCT03093181|561732448|FG001|Overall Study|Withdrawal by Subject|1|||
155627390|NCT03093181|561732449|FG002|Overall Study|Withdrawal by Subject|2|||
155627391|NCT03093181|561732447|FG000|Overall Study|Other (Not specified)|1|||
155627392|NCT03093181|561732448|FG001|Overall Study|Other (Not specified)|0|||
155627393|NCT03093181|561732449|FG002|Overall Study|Other (Not specified)|0|||
155627394|NCT03093181|561732447|FG000|Overall Study|Adverse Event|0|||
155627395|NCT03093181|561732448|FG001|Overall Study|Adverse Event|1|||
155627396|NCT03093181|561732449|FG002|Overall Study|Adverse Event|0|||
155627397|NCT03093181|561732447|FG000|Overall Study|Other (Protocol violation)|0|||
155627398|NCT03093181|561732448|FG001|Overall Study|Other (Protocol violation)|0|||
155627399|NCT03093181|561732449|FG002|Overall Study|Other (Protocol violation)|1|||
155627400|NCT03154086|561732450|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627401|NCT03154086|561732451|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627402|NCT03154086|561732452|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627403|NCT03154086|561732453|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
155627404|NCT03154086|561732454|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627405|NCT03154086|561732455|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627406|NCT03154086|561732456|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627407|NCT03154086|561732457|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627408|NCT03154086|561732458|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627409|NCT03154086|561732459|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627410|NCT03154086|561732460|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627411|NCT03154086|561732461|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627412|NCT03154086|561732462|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627413|NCT03154086|561732463|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627414|NCT03154086|561732464|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155627415|NCT03154086|561732450|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627416|NCT03154086|561732451|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
155627417|NCT03154086|561732452|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627418|NCT03154086|561732453|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627419|NCT03154086|561732454|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627420|NCT03154086|561732455|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627421|NCT03154086|561732456|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627422|NCT03154086|561732457|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627423|NCT03154086|561732458|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627424|NCT03154086|561732459|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627425|NCT03154086|561732460|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627426|NCT03154086|561732461|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627427|NCT03154086|561732462|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627428|NCT03154086|561732463|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627429|NCT03154086|561732464|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155627430|NCT03154086|561732450|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627431|NCT03154086|561732451|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627432|NCT03154086|561732452|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
155627433|NCT03154086|561732453|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627434|NCT03154086|561732454|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627435|NCT03154086|561732455|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627436|NCT03154086|561732456|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627437|NCT03154086|561732457|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627438|NCT03154086|561732458|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627439|NCT03154086|561732459|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627440|NCT03154086|561732460|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627441|NCT03154086|561732461|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627442|NCT03154086|561732462|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627443|NCT03154086|561732463|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627444|NCT03154086|561732464|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155627445|NCT03154086|561732450|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
155387603|NCT00146328|560854896|FG001|Overall Study|Patient decision to end|1|||
155387604|NCT00146328|560854897|FG002|Overall Study|Patient decision to end|6|||
155387605|NCT00146328|560854895|FG000|Overall Study|Enroll into other trial|2|||
155387606|NCT00146328|560854896|FG001|Overall Study|Enroll into other trial|4|||
155387607|NCT00146328|560854897|FG002|Overall Study|Enroll into other trial|2|||
155387608|NCT00146328|560854895|FG000|Overall Study|Death|0|||
155387609|NCT00146328|560854896|FG001|Overall Study|Death|1|||
155387610|NCT00146328|560854897|FG002|Overall Study|Death|1|||
155387611|NCT00146328|560854895|FG000|Overall Study|Moved|2|||
155387612|NCT00146328|560854896|FG001|Overall Study|Moved|0|||
155387613|NCT00146328|560854897|FG002|Overall Study|Moved|0|||
155387614|NCT00146328|560854895|FG000|Overall Study|Interaction with other medication|2|||
155387615|NCT00146328|560854896|FG001|Overall Study|Interaction with other medication|0|||
155387616|NCT00146328|560854897|FG002|Overall Study|Interaction with other medication|1|||
155387617|NCT00300781|560854898|FG000|Overall Study|Disease Progression|55|||
155387618|NCT00300781|560854899|FG001|Overall Study|Disease Progression|52|||
155387619|NCT00300781|560854898|FG000|Overall Study|Adverse Event|5|||
155387620|NCT00300781|560854899|FG001|Overall Study|Adverse Event|6|||
155387621|NCT00300781|560854898|FG000|Overall Study|Withdrawal by Subject|1|||
155387622|NCT00300781|560854899|FG001|Overall Study|Withdrawal by Subject|2|||
155387623|NCT00300781|560854898|FG000|Overall Study|Physician Decision|1|||
155387624|NCT00300781|560854899|FG001|Overall Study|Physician Decision|0|||
155387625|NCT00300781|560854898|FG000|Overall Study|Not Recorded|0|||
155387626|NCT00300781|560854899|FG001|Overall Study|Not Recorded|1|||
155387627|NCT00300781|560854898|FG000|Overall Study|Symptomatic Deterioration|1|||
155387628|NCT00300781|560854899|FG001|Overall Study|Symptomatic Deterioration|0|||
155387629|NCT00300781|560854898|FG000|Overall Study|Lost to Follow-up|0|||
155387630|NCT00300781|560854899|FG001|Overall Study|Lost to Follow-up|1|||
155387631|NCT00792805|560854900|FG000|Overall Study|Adverse Event|12|||
155387632|NCT00792805|560854901|FG001|Overall Study|Adverse Event|10|||
155387633|NCT00792805|560854902|FG002|Overall Study|Adverse Event|10|||
155387634|NCT00792805|560854900|FG000|Overall Study|Subject withdrew consent|5|||
155387635|NCT00792805|560854901|FG001|Overall Study|Subject withdrew consent|6|||
155387636|NCT00792805|560854902|FG002|Overall Study|Subject withdrew consent|5|||
155387637|NCT00792805|560854900|FG000|Overall Study|Administrative problems|2|||
155387638|NCT00792805|560854901|FG001|Overall Study|Administrative problems|0|||
155387639|NCT00792805|560854902|FG002|Overall Study|Administrative problems|4|||
155387640|NCT00792805|560854900|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155387641|NCT00792805|560854901|FG001|Overall Study|Abnormal test procedure result(s)|2|||
155387642|NCT00792805|560854902|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155387643|NCT00792805|560854900|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155387644|NCT00792805|560854901|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155387645|NCT00792805|560854902|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155387646|NCT00792805|560854900|FG000|Overall Study|Lost to Follow-up|1|||
155387647|NCT00792805|560854901|FG001|Overall Study|Lost to Follow-up|1|||
155387648|NCT00792805|560854902|FG002|Overall Study|Lost to Follow-up|6|||
155387649|NCT00792805|560854900|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155387650|NCT00792805|560854901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155387651|NCT00792805|560854902|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155387652|NCT00792805|560854900|FG000|Overall Study|Protocol deviation|0|||
155280920|NCT04955626|560459901|FG034|Blinded Period|Medication error|0|||
155280921|NCT04955626|560459902|FG035|Blinded Period|Medication error|0|||
155280922|NCT04955626|560459867|FG000|Open-Label Period|Lost to Follow-up|109|||
155280923|NCT04955626|560459868|FG001|Open-Label Period|Lost to Follow-up|41|||
155280924|NCT04955626|560459869|FG002|Open-Label Period|Lost to Follow-up|0|||
155280925|NCT04955626|560459870|FG003|Open-Label Period|Lost to Follow-up|0|||
155280926|NCT04955626|560459871|FG004|Open-Label Period|Lost to Follow-up|0|||
155280927|NCT04955626|560459872|FG005|Open-Label Period|Lost to Follow-up|0|||
155280928|NCT04955626|560459873|FG006|Open-Label Period|Lost to Follow-up|0|||
155280929|NCT04955626|560459874|FG007|Open-Label Period|Lost to Follow-up|0|||
155387653|NCT00792805|560854901|FG001|Overall Study|Protocol deviation|1|||
155280930|NCT04955626|560459875|FG008|Open-Label Period|Lost to Follow-up|0|||
155280931|NCT04955626|560459876|FG009|Open-Label Period|Lost to Follow-up|0|||
155280932|NCT04955626|560459877|FG010|Open-Label Period|Lost to Follow-up|0|||
155280933|NCT04955626|560459878|FG011|Open-Label Period|Lost to Follow-up|0|||
155280934|NCT04955626|560459879|FG012|Open-Label Period|Lost to Follow-up|0|||
155387654|NCT00792805|560854902|FG002|Overall Study|Protocol deviation|1|||
155387655|NCT02072434|560854906|FG000|Overall Study|Protocol Violation|10|||
155387656|NCT02072434|560854907|FG001|Overall Study|Protocol Violation|9|||
155387657|NCT02072434|560854906|FG000|Overall Study|Physician Decision|5|||
155387658|NCT02072434|560854907|FG001|Overall Study|Physician Decision|10|||
155387659|NCT02072434|560854906|FG000|Overall Study|Adverse event, serious fatal|1|||
155387660|NCT02072434|560854907|FG001|Overall Study|Adverse event, serious fatal|6|||
155387661|NCT02072434|560854906|FG000|Overall Study|Adverse Event|7|||
155387662|NCT02072434|560854907|FG001|Overall Study|Adverse Event|6|||
155387663|NCT02072434|560854906|FG000|Overall Study|Withdrawal by Subject|17|||
155627446|NCT03154086|561732451|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627447|NCT03154086|561732452|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155387664|NCT02072434|560854907|FG001|Overall Study|Withdrawal by Subject|29|||
155729325|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
155729326|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155729327|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729328|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155387665|NCT02072434|560854906|FG000|Overall Study|Other|14|||
155387666|NCT02072434|560854907|FG001|Overall Study|Other|29|||
155387667|NCT02072434|560854906|FG000|Overall Study|Lost to Follow-up|0|||
155387668|NCT02072434|560854907|FG001|Overall Study|Lost to Follow-up|1|||
155387669|NCT02525861|560854910|FG000|Overall Study|Adverse Event|1|||
155387670|NCT02525861|560854911|FG001|Overall Study|Adverse Event|0|||
155387671|NCT02525861|560854910|FG000|Overall Study|Withdrawal by Subject|0|||
155387672|NCT02525861|560854911|FG001|Overall Study|Withdrawal by Subject|1|||
155387673|NCT02525861|560854910|FG000|Overall Study|Physician Decision|0|||
155387674|NCT02525861|560854911|FG001|Overall Study|Physician Decision|1|||
155387675|NCT00888433|560854912|FG000|Overall Study|Withdrawal by Subject|1|||
155387676|NCT00888433|560854913|FG001|Overall Study|Withdrawal by Subject|2|||
155387677|NCT00888433|560854912|FG000|Overall Study|Missed Visit|2|||
155387678|NCT00888433|560854913|FG001|Overall Study|Missed Visit|1|||
155387679|NCT00402363|560854916|FG000|Overall Study|Adverse Event|9|||
155387680|NCT00402363|560854917|FG001|Overall Study|Adverse Event|14|||
155387681|NCT00402363|560854918|FG002|Overall Study|Adverse Event|2|||
155387682|NCT00402363|560854919|FG003|Overall Study|Adverse Event|2|||
155387683|NCT00402363|560854916|FG000|Overall Study|Withdrew Consent|10|||
155387684|NCT00402363|560854917|FG001|Overall Study|Withdrew Consent|5|||
155387685|NCT00402363|560854918|FG002|Overall Study|Withdrew Consent|2|||
155387686|NCT00402363|560854919|FG003|Overall Study|Withdrew Consent|1|||
155387687|NCT00402363|560854916|FG000|Overall Study|Protocol Violation|3|||
155387688|NCT00402363|560854917|FG001|Overall Study|Protocol Violation|5|||
155387689|NCT00402363|560854918|FG002|Overall Study|Protocol Violation|0|||
155387690|NCT00402363|560854919|FG003|Overall Study|Protocol Violation|3|||
155387691|NCT00402363|560854916|FG000|Overall Study|Lost to Follow-up|5|||
155387692|NCT00402363|560854917|FG001|Overall Study|Lost to Follow-up|4|||
155387693|NCT00402363|560854918|FG002|Overall Study|Lost to Follow-up|0|||
155387694|NCT00402363|560854919|FG003|Overall Study|Lost to Follow-up|2|||
155729329|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729330|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729331|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155387695|NCT00402363|560854916|FG000|Overall Study|"Captured as Other"|6|||
155387696|NCT00402363|560854917|FG001|Overall Study|"Captured as Other"|2|||
155387697|NCT00402363|560854918|FG002|Overall Study|"Captured as Other"|2|||
155387698|NCT00402363|560854919|FG003|Overall Study|"Captured as Other"|2|||
155387699|NCT00937833|560854929|FG000|Overall Study|Protocol Violation|1|||
155387700|NCT00937833|560854930|FG001|Overall Study|Protocol Violation|2|||
155387701|NCT00937833|560854929|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
155387702|NCT00937833|560854930|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
155387703|NCT00937833|560854929|FG000|Overall Study|Lost to Follow-up|10|||
155387704|NCT00937833|560854930|FG001|Overall Study|Lost to Follow-up|8|||
155387705|NCT00937833|560854929|FG000|Overall Study|Withdrawal by Subject|4|||
155729332|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729333|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729334|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729335|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729336|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729337|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729338|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155729339|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
155729340|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
155729341|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729342|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729343|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729344|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729345|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729346|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729347|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729348|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729349|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155387706|NCT00937833|560854930|FG001|Overall Study|Withdrawal by Subject|6|||
155387707|NCT03278106|560854932|FG000|Overall Study|No protocol treatment|1|||
155387708|NCT02175004|560854933|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
155387709|NCT02175004|560854934|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
155387710|NCT02175004|560854933|FG000|Overall Study|Investigator Judgment|1|||
155387711|NCT02175004|560854934|FG001|Overall Study|Investigator Judgment|4|||
155627448|NCT03154086|561732453|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627449|NCT03154086|561732454|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627450|NCT03154086|561732455|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627451|NCT03154086|561732456|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627452|NCT03154086|561732457|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627453|NCT03154086|561732458|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627454|NCT03154086|561732459|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155729350|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729351|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729352|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155729353|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
155387712|NCT02175004|560854933|FG000|Overall Study|Voluntary Withdrawal|6|||
155387713|NCT02175004|560854934|FG001|Overall Study|Voluntary Withdrawal|19|||
155387714|NCT02175004|560854933|FG000|Overall Study|Liver Transplant|1|||
155387715|NCT02175004|560854934|FG001|Overall Study|Liver Transplant|0|||
155387716|NCT02175004|560854933|FG000|Overall Study|Disease Progression|1|||
155387717|NCT02175004|560854934|FG001|Overall Study|Disease Progression|0|||
155387718|NCT02175004|560854933|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
155387719|NCT02175004|560854934|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
155387720|NCT01607554|560854935|FG000|Overall Study|Disease progression|2|||
155387721|NCT00162032|560854936|FG000|Overall Study|Lost to Follow-up|4|||
155387722|NCT00162032|560854937|FG001|Overall Study|Lost to Follow-up|2|||
155387723|NCT00162032|560854936|FG000|Overall Study|Reason not specified|1|||
155387724|NCT00162032|560854937|FG001|Overall Study|Reason not specified|0|||
155387725|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
155387726|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
155387727|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
155387728|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
155387729|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
155387730|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
155387731|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
155387732|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
155387733|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
155387734|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
155387735|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
155387736|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
155387737|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
155387738|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
155387739|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
155387740|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
155387741|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
155387742|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
155387743|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Other|16|||
155387744|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Other|13|||
155387745|NCT01137955|560854940|FG000|Overall Study|Withdrawal by Subject|5|||
155387746|NCT01137955|560854941|FG001|Overall Study|Withdrawal by Subject|4|||
155387747|NCT02027701|560854942|FG000|Overall Study|Adverse Event|3|||
155387748|NCT02027701|560854942|FG000|Overall Study|Lack of Efficacy|8|||
155387749|NCT02027701|560854942|FG000|Overall Study|Physician Decision|2|||
155387750|NCT02027701|560854942|FG000|Overall Study|Withdrawal by Subject|3|||
155387751|NCT00756470|560854943|FG000|Overall Study|Withdrawal by Subject|1|||
155387752|NCT00756470|560854943|FG000|Overall Study|Adverse Event|4|||
155387753|NCT00820027|560854944|FG000|Overall Study|Adverse Event|15|||
155387754|NCT00820027|560854945|FG001|Overall Study|Adverse Event|8|||
155387755|NCT00820027|560854946|FG002|Overall Study|Adverse Event|10|||
155387756|NCT00820027|560854947|FG003|Overall Study|Adverse Event|5|||
155627455|NCT03154086|561732460|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627456|NCT03154086|561732461|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627457|NCT03154086|561732462|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627458|NCT03154086|561732463|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627459|NCT03154086|561732464|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155627460|NCT03154086|561732450|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627461|NCT03154086|561732451|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627462|NCT03154086|561732452|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627463|NCT03154086|561732453|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627464|NCT03154086|561732454|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627465|NCT03154086|561732455|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627466|NCT03154086|561732456|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155729354|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
155627467|NCT03154086|561732457|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627468|NCT03154086|561732458|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
155627469|NCT03154086|561732459|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627470|NCT03154086|561732460|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627471|NCT03154086|561732461|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627472|NCT03154086|561732462|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627473|NCT03154086|561732463|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627474|NCT03154086|561732464|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155627475|NCT03154086|561732450|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627476|NCT03154086|561732451|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627477|NCT03154086|561732452|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627478|NCT03154086|561732453|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627479|NCT03154086|561732454|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627480|NCT03154086|561732455|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627481|NCT03154086|561732456|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627482|NCT03154086|561732457|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
155627483|NCT03154086|561732458|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627484|NCT03154086|561732459|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627485|NCT03154086|561732460|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627486|NCT03154086|561732461|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627487|NCT03154086|561732462|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627488|NCT03154086|561732463|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627489|NCT03154086|561732464|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155627490|NCT03154086|561732450|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
155627491|NCT03154086|561732451|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
155627492|NCT03154086|561732452|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
155627493|NCT03154086|561732453|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
155627494|NCT03154086|561732454|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
155627495|NCT03154086|561732455|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
155627496|NCT03154086|561732456|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
155627497|NCT03154086|561732457|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
155627498|NCT03154086|561732458|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
155627499|NCT03154086|561732459|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
155627500|NCT03154086|561732460|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
155627501|NCT03154086|561732461|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
155627502|NCT03154086|561732462|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
155627503|NCT03154086|561732463|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
155627504|NCT03154086|561732464|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
155627505|NCT04076917|561732465|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
155627506|NCT04076917|561732465|FG000|Overall Study|Study closure|13|||
155627507|NCT04076917|561732465|FG000|Overall Study|Physician Decision|3|||
155627508|NCT04076917|561732465|FG000|Overall Study|Death|1|||
155627509|NCT04076917|561732465|FG000|Overall Study|Lost to Follow-up|1|||
155627510|NCT04076917|561732465|FG000|Overall Study|Withdrawal by Subject|1|||
155627511|NCT04076917|561732465|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
155627512|NCT01701245|561732468|FG000|Overall Study|Protocol Violation|1|||
155627513|NCT01701245|561732469|FG001|Overall Study|Protocol Violation|3|||
155627514|NCT01701245|561732468|FG000|Overall Study|Did not complete the open label period|11|||
155627515|NCT01701245|561732469|FG001|Overall Study|Did not complete the open label period|12|||
155627516|NCT01774591|561732470|FG000|Overall Study|Physician Decision|1|||
155627517|NCT01774591|561732471|FG001|Overall Study|Physician Decision|1|||
155627518|NCT01774591|561732470|FG000|Overall Study|Withdrawal by Subject|0|||
155627519|NCT01774591|561732471|FG001|Overall Study|Withdrawal by Subject|1|||
155627520|NCT01774591|561732470|FG000|Overall Study|Adverse Event|0|||
155627521|NCT01774591|561732471|FG001|Overall Study|Adverse Event|2|||
155627522|NCT01159574|561732472|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
155627523|NCT01159574|561732472|FG000|Treatment Phase|Adverse Event|3|||
155627524|NCT01159574|561732472|FG000|Treatment Phase|Death|6|||
155627525|NCT01159574|561732472|FG000|Treatment Phase|Physician Decision|2|||
155627526|NCT01159574|561732472|FG000|Treatment Phase|Withdrawal by Subject|7|||
155627527|NCT01159574|561732472|FG000|Treatment Phase|still on treatment|2|||
155627528|NCT01159574|561732472|FG000|Follow Up Phase|Lost to Follow-up|2|||
155627529|NCT01159574|561732472|FG000|Follow Up Phase|still being followed for overall surviva|18|||
155627530|NCT01787552|561732475|FG000|Overall Study|Withdrawal by Subject|2|||
155627531|NCT01787552|561732476|FG001|Overall Study|Withdrawal by Subject|0|||
155627532|NCT01787552|561732477|FG002|Overall Study|Withdrawal by Subject|0|||
155627533|NCT01787552|561732478|FG003|Overall Study|Withdrawal by Subject|4|||
155627534|NCT01787552|561732475|FG000|Overall Study|Physician Decision|2|||
155627535|NCT01787552|561732476|FG001|Overall Study|Physician Decision|2|||
155627536|NCT01787552|561732477|FG002|Overall Study|Physician Decision|1|||
155387757|NCT00820027|560854944|FG000|Overall Study|Lack of Efficacy|2|||
155280935|NCT04955626|560459880|FG013|Open-Label Period|Lost to Follow-up|0|||
155280936|NCT04955626|560459881|FG014|Open-Label Period|Lost to Follow-up|0|||
155280937|NCT04955626|560459882|FG015|Open-Label Period|Lost to Follow-up|0|||
155280938|NCT04955626|560459883|FG016|Open-Label Period|Lost to Follow-up|0|||
155280939|NCT04955626|560459884|FG017|Open-Label Period|Lost to Follow-up|0|||
155280940|NCT04955626|560459885|FG018|Open-Label Period|Lost to Follow-up|0|||
155280941|NCT04955626|560459886|FG019|Open-Label Period|Lost to Follow-up|0|||
155280942|NCT04955626|560459887|FG020|Open-Label Period|Lost to Follow-up|0|||
155280943|NCT04955626|560459888|FG021|Open-Label Period|Lost to Follow-up|0|||
155280944|NCT04955626|560459889|FG022|Open-Label Period|Lost to Follow-up|0|||
155280945|NCT04955626|560459890|FG023|Open-Label Period|Lost to Follow-up|0|||
155280946|NCT04955626|560459891|FG024|Open-Label Period|Lost to Follow-up|0|||
155280947|NCT04955626|560459892|FG025|Open-Label Period|Lost to Follow-up|0|||
155280948|NCT04955626|560459893|FG026|Open-Label Period|Lost to Follow-up|0|||
155280949|NCT04955626|560459894|FG027|Open-Label Period|Lost to Follow-up|0|||
155280950|NCT04955626|560459895|FG028|Open-Label Period|Lost to Follow-up|0|||
155280951|NCT04955626|560459896|FG029|Open-Label Period|Lost to Follow-up|0|||
155280952|NCT04955626|560459897|FG030|Open-Label Period|Lost to Follow-up|0|||
155280953|NCT04955626|560459898|FG031|Open-Label Period|Lost to Follow-up|0|||
155280954|NCT04955626|560459899|FG032|Open-Label Period|Lost to Follow-up|0|||
155280955|NCT04955626|560459900|FG033|Open-Label Period|Lost to Follow-up|0|||
155280956|NCT04955626|560459901|FG034|Open-Label Period|Lost to Follow-up|0|||
155280957|NCT04955626|560459902|FG035|Open-Label Period|Lost to Follow-up|0|||
155280958|NCT04955626|560459867|FG000|Open-Label Period|Protocol Violation|377|||
155280959|NCT04955626|560459868|FG001|Open-Label Period|Protocol Violation|48|||
155280960|NCT04955626|560459869|FG002|Open-Label Period|Protocol Violation|0|||
155280961|NCT04955626|560459870|FG003|Open-Label Period|Protocol Violation|0|||
155280962|NCT04955626|560459871|FG004|Open-Label Period|Protocol Violation|0|||
155280963|NCT04955626|560459872|FG005|Open-Label Period|Protocol Violation|0|||
155280964|NCT04955626|560459873|FG006|Open-Label Period|Protocol Violation|0|||
155280965|NCT04955626|560459874|FG007|Open-Label Period|Protocol Violation|0|||
155280966|NCT04955626|560459875|FG008|Open-Label Period|Protocol Violation|0|||
155280967|NCT04955626|560459876|FG009|Open-Label Period|Protocol Violation|0|||
155280968|NCT04955626|560459877|FG010|Open-Label Period|Protocol Violation|0|||
155280969|NCT04955626|560459878|FG011|Open-Label Period|Protocol Violation|0|||
155280970|NCT04955626|560459879|FG012|Open-Label Period|Protocol Violation|0|||
155280971|NCT04955626|560459880|FG013|Open-Label Period|Protocol Violation|0|||
155280972|NCT04955626|560459881|FG014|Open-Label Period|Protocol Violation|0|||
155280973|NCT04955626|560459882|FG015|Open-Label Period|Protocol Violation|0|||
155280974|NCT04955626|560459883|FG016|Open-Label Period|Protocol Violation|0|||
155280975|NCT04955626|560459884|FG017|Open-Label Period|Protocol Violation|0|||
155280976|NCT04955626|560459885|FG018|Open-Label Period|Protocol Violation|0|||
155280977|NCT04955626|560459886|FG019|Open-Label Period|Protocol Violation|0|||
155280978|NCT04955626|560459887|FG020|Open-Label Period|Protocol Violation|0|||
155280979|NCT04955626|560459888|FG021|Open-Label Period|Protocol Violation|0|||
155280980|NCT04955626|560459889|FG022|Open-Label Period|Protocol Violation|0|||
155280981|NCT04955626|560459890|FG023|Open-Label Period|Protocol Violation|0|||
155280982|NCT04955626|560459891|FG024|Open-Label Period|Protocol Violation|0|||
155280983|NCT04955626|560459892|FG025|Open-Label Period|Protocol Violation|0|||
155280984|NCT04955626|560459893|FG026|Open-Label Period|Protocol Violation|0|||
155280985|NCT04955626|560459894|FG027|Open-Label Period|Protocol Violation|0|||
155280986|NCT04955626|560459895|FG028|Open-Label Period|Protocol Violation|0|||
155280987|NCT04955626|560459896|FG029|Open-Label Period|Protocol Violation|0|||
155280988|NCT04955626|560459897|FG030|Open-Label Period|Protocol Violation|0|||
155280989|NCT04955626|560459898|FG031|Open-Label Period|Protocol Violation|0|||
155280990|NCT04955626|560459899|FG032|Open-Label Period|Protocol Violation|0|||
155280991|NCT04955626|560459900|FG033|Open-Label Period|Protocol Violation|0|||
155280992|NCT04955626|560459901|FG034|Open-Label Period|Protocol Violation|0|||
155280993|NCT04955626|560459902|FG035|Open-Label Period|Protocol Violation|0|||
155280994|NCT04955626|560459867|FG000|Open-Label Period|Death|5|||
155280995|NCT04955626|560459868|FG001|Open-Label Period|Death|5|||
155280996|NCT04955626|560459869|FG002|Open-Label Period|Death|0|||
155280997|NCT04955626|560459870|FG003|Open-Label Period|Death|0|||
155280998|NCT04955626|560459871|FG004|Open-Label Period|Death|0|||
155280999|NCT04955626|560459872|FG005|Open-Label Period|Death|0|||
155281000|NCT04955626|560459873|FG006|Open-Label Period|Death|0|||
155281001|NCT04955626|560459874|FG007|Open-Label Period|Death|0|||
155281002|NCT04955626|560459875|FG008|Open-Label Period|Death|0|||
155627537|NCT01787552|561732478|FG003|Overall Study|Physician Decision|2|||
155281003|NCT04955626|560459876|FG009|Open-Label Period|Death|0|||
155281004|NCT04955626|560459877|FG010|Open-Label Period|Death|0|||
155281005|NCT04955626|560459878|FG011|Open-Label Period|Death|0|||
155387758|NCT00820027|560854945|FG001|Overall Study|Lack of Efficacy|1|||
155281006|NCT04955626|560459879|FG012|Open-Label Period|Death|0|||
155281007|NCT04955626|560459880|FG013|Open-Label Period|Death|0|||
155281008|NCT04955626|560459881|FG014|Open-Label Period|Death|0|||
155281009|NCT04955626|560459882|FG015|Open-Label Period|Death|0|||
155281010|NCT04955626|560459883|FG016|Open-Label Period|Death|0|||
155387759|NCT00820027|560854946|FG002|Overall Study|Lack of Efficacy|2|||
155387760|NCT00820027|560854947|FG003|Overall Study|Lack of Efficacy|2|||
155387761|NCT00820027|560854944|FG000|Overall Study|Physician Decision|0|||
155387762|NCT00820027|560854945|FG001|Overall Study|Physician Decision|1|||
155387763|NCT00820027|560854946|FG002|Overall Study|Physician Decision|1|||
155387764|NCT00820027|560854947|FG003|Overall Study|Physician Decision|0|||
155387765|NCT00820027|560854944|FG000|Overall Study|Protocol Violation|3|||
155387766|NCT00820027|560854945|FG001|Overall Study|Protocol Violation|0|||
155387767|NCT00820027|560854946|FG002|Overall Study|Protocol Violation|4|||
155387768|NCT00820027|560854947|FG003|Overall Study|Protocol Violation|0|||
155387769|NCT00820027|560854944|FG000|Overall Study|Withdrawal by Subject|6|||
155387770|NCT00820027|560854945|FG001|Overall Study|Withdrawal by Subject|4|||
155387771|NCT00820027|560854946|FG002|Overall Study|Withdrawal by Subject|4|||
155387772|NCT00820027|560854947|FG003|Overall Study|Withdrawal by Subject|6|||
155387773|NCT02604433|560854948|FG000|Overall Study|Withdrawal by Subject|37|||
155387774|NCT02604433|560854949|FG001|Overall Study|Withdrawal by Subject|16|||
155387775|NCT02604433|560854948|FG000|Overall Study|Adverse Event|4|||
155387776|NCT02604433|560854949|FG001|Overall Study|Adverse Event|0|||
155387777|NCT02604433|560854948|FG000|Overall Study|Other reasons|3|||
155387778|NCT02604433|560854949|FG001|Overall Study|Other reasons|5|||
155387779|NCT02604433|560854948|FG000|Overall Study|Death|4|||
155387780|NCT02604433|560854949|FG001|Overall Study|Death|1|||
155387781|NCT02604433|560854948|FG000|Overall Study|Transition to Rollover Protocol|169|||
155387782|NCT02604433|560854949|FG001|Overall Study|Transition to Rollover Protocol|82|||
155387783|NCT02604433|560854948|FG000|Overall Study|Physician Decision|1|||
155387784|NCT02604433|560854949|FG001|Overall Study|Physician Decision|1|||
155387785|NCT02604433|560854948|FG000|Overall Study|Lack of Efficacy|0|||
155387786|NCT02604433|560854949|FG001|Overall Study|Lack of Efficacy|1|||
155387787|NCT03285178|560854950|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
155387788|NCT03285178|560854951|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387789|NCT03285178|560854952|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387790|NCT03285178|560854953|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387791|NCT03285178|560854954|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387792|NCT03285178|560854955|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387793|NCT03285178|560854956|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387794|NCT03285178|560854950|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
155387795|NCT03285178|560854951|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387796|NCT03285178|560854952|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387797|NCT03285178|560854953|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387798|NCT03285178|560854954|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387799|NCT03285178|560854955|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387800|NCT03285178|560854956|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387801|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
155387802|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
155387803|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
155387804|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
155387805|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
155387806|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
155387807|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
155387808|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
155387809|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387810|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387811|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387812|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387813|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387814|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387815|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Physician Decision|2|||
155387816|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Physician Decision|0|||
155387817|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Physician Decision|0|||
155387818|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Physician Decision|0|||
155387819|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Physician Decision|0|||
155387820|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Physician Decision|0|||
155387821|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Physician Decision|0|||
155387822|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387823|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
155387824|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
155387825|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387826|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387827|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387828|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387829|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155387830|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155387831|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155387832|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155387833|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Adverse Event|0|||
155387834|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Adverse Event|0|||
155387835|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Adverse Event|2|||
155387836|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387837|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155387838|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387839|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387840|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
155387841|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387842|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387843|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387844|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387845|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387846|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387847|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387848|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155387849|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387850|NCT03285178|560854950|FG000|Double-Blind Treatment Period|COVID-19|0|||
155387851|NCT03285178|560854951|FG001|Double-Blind Treatment Period|COVID-19|0|||
155387852|NCT03285178|560854952|FG002|Double-Blind Treatment Period|COVID-19|1|||
155387853|NCT03285178|560854953|FG003|Double-Blind Treatment Period|COVID-19|0|||
155387854|NCT03285178|560854954|FG004|Double-Blind Treatment Period|COVID-19|0|||
155387855|NCT03285178|560854955|FG005|Double-Blind Treatment Period|COVID-19|0|||
155387856|NCT03285178|560854956|FG006|Double-Blind Treatment Period|COVID-19|0|||
155387857|NCT01128738|560854957|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
155387858|NCT01128738|560854958|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
155387859|NCT01128738|560854957|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
155387860|NCT01128738|560854958|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
155387861|NCT01128738|560854957|FG000|Second TP|Lost to Follow-up|0|||
155387862|NCT01128738|560854958|FG001|Second TP|Lost to Follow-up|1|||
155387863|NCT01128738|560854957|FG000|Second TP|Withdrawal by Subject|0|||
155387864|NCT01128738|560854958|FG001|Second TP|Withdrawal by Subject|2|||
155387865|NCT00325039|560854961|FG000|Overall Study|Lost to Follow-up|18|||
155387866|NCT00325039|560854962|FG001|Overall Study|Lost to Follow-up|14|||
155387867|NCT01009203|560854964|FG000|Overall Study|Withdrawal by Subject|1|||
155387868|NCT01009203|560854964|FG000|Overall Study|Adverse Event|5|||
155387869|NCT01009203|560854964|FG000|Overall Study|Treatment-unrelated death|1|||
155387870|NCT00892723|560854968|FG000|Overall Study|Lost to Follow-up|1|||
155387871|NCT00892723|560854969|FG001|Overall Study|Lost to Follow-up|3|||
155387872|NCT00892723|560854970|FG002|Overall Study|Lost to Follow-up|1|||
155387873|NCT00892723|560854968|FG000|Overall Study|Withdrawal by Subject|1|||
155387874|NCT00892723|560854969|FG001|Overall Study|Withdrawal by Subject|1|||
155387875|NCT00892723|560854970|FG002|Overall Study|Withdrawal by Subject|1|||
155387876|NCT02974088|560854971|FG000|Overall Study|Lost to Follow-up|0|||
155387877|NCT02974088|560854972|FG001|Overall Study|Lost to Follow-up|2|||
155387878|NCT02974088|560854971|FG000|Overall Study|Adverse Event|0|||
155387879|NCT02974088|560854972|FG001|Overall Study|Adverse Event|1|||
155387880|NCT00150969|560854975|FG000|24 Month Main Study|Adverse Event|3|||
155387881|NCT00150969|560854976|FG001|24 Month Main Study|Adverse Event|4|||
155387882|NCT00150969|560854975|FG000|24 Month Main Study|Death|1|||
155387883|NCT00150969|560854976|FG001|24 Month Main Study|Death|1|||
155387884|NCT00150969|560854975|FG000|24 Month Main Study|Lack of Efficacy|1|||
155387885|NCT00150969|560854976|FG001|24 Month Main Study|Lack of Efficacy|8|||
155387886|NCT00150969|560854975|FG000|24 Month Main Study|Lost to Follow-up|3|||
155387887|NCT00150969|560854976|FG001|24 Month Main Study|Lost to Follow-up|2|||
155387888|NCT00150969|560854975|FG000|24 Month Main Study|Protocol Violation|4|||
155387889|NCT00150969|560854976|FG001|24 Month Main Study|Protocol Violation|2|||
155387890|NCT00150969|560854975|FG000|24 Month Main Study|Withdrawal by Subject|7|||
155387891|NCT00150969|560854976|FG001|24 Month Main Study|Withdrawal by Subject|4|||
155387892|NCT00150969|560854975|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
155387893|NCT00150969|560854976|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
155387894|NCT00150969|560854975|FG000|24-48 Month Extension|Lack of Efficacy|0|||
155387895|NCT00150969|560854976|FG001|24-48 Month Extension|Lack of Efficacy|1|||
155627538|NCT01787552|561732475|FG000|Overall Study|Death|0|||
155729355|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729356|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729357|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729358|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729359|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729360|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729361|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729362|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155281011|NCT04955626|560459884|FG017|Open-Label Period|Death|0|||
155281012|NCT04955626|560459885|FG018|Open-Label Period|Death|0|||
155281013|NCT04955626|560459886|FG019|Open-Label Period|Death|0|||
155281014|NCT04955626|560459887|FG020|Open-Label Period|Death|0|||
155281015|NCT04955626|560459888|FG021|Open-Label Period|Death|0|||
155281016|NCT04955626|560459889|FG022|Open-Label Period|Death|0|||
155281017|NCT04955626|560459890|FG023|Open-Label Period|Death|0|||
155281018|NCT04955626|560459891|FG024|Open-Label Period|Death|0|||
155281019|NCT04955626|560459892|FG025|Open-Label Period|Death|0|||
155281020|NCT04955626|560459893|FG026|Open-Label Period|Death|0|||
155281021|NCT04955626|560459894|FG027|Open-Label Period|Death|0|||
155281022|NCT04955626|560459895|FG028|Open-Label Period|Death|0|||
155281023|NCT04955626|560459896|FG029|Open-Label Period|Death|0|||
155281024|NCT04955626|560459897|FG030|Open-Label Period|Death|0|||
155281025|NCT04955626|560459898|FG031|Open-Label Period|Death|0|||
155281026|NCT04955626|560459899|FG032|Open-Label Period|Death|0|||
155281027|NCT04955626|560459900|FG033|Open-Label Period|Death|0|||
155281028|NCT04955626|560459901|FG034|Open-Label Period|Death|0|||
155281029|NCT04955626|560459902|FG035|Open-Label Period|Death|0|||
155281030|NCT04955626|560459867|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
155281031|NCT04955626|560459868|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
155281032|NCT04955626|560459869|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
155281033|NCT04955626|560459870|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
155281034|NCT04955626|560459871|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
155281035|NCT04955626|560459872|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
155281036|NCT04955626|560459873|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
155281037|NCT04955626|560459874|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
155281038|NCT04955626|560459875|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
155281039|NCT04955626|560459876|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
155281040|NCT04955626|560459877|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
155281041|NCT04955626|560459878|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
155281042|NCT04955626|560459879|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
155281043|NCT04955626|560459880|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
155281044|NCT04955626|560459881|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
155281045|NCT04955626|560459882|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
155281046|NCT04955626|560459883|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
155281047|NCT04955626|560459884|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
155281048|NCT04955626|560459885|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
155281049|NCT04955626|560459886|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
155281050|NCT04955626|560459887|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
155281051|NCT04955626|560459888|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
155281052|NCT04955626|560459889|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
155281053|NCT04955626|560459890|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
155281054|NCT04955626|560459891|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
155281055|NCT04955626|560459892|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
155281056|NCT04955626|560459893|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
155281057|NCT04955626|560459894|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
155281058|NCT04955626|560459895|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
155281059|NCT04955626|560459896|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
155281060|NCT04955626|560459897|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
155281061|NCT04955626|560459898|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
155281062|NCT04955626|560459899|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
155281063|NCT04955626|560459900|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
155729363|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155281064|NCT04955626|560459901|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
155281065|NCT04955626|560459902|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
155281066|NCT04955626|560459867|FG000|Open-Label Period|Other|621|||
155281067|NCT04955626|560459868|FG001|Open-Label Period|Other|429|||
155281068|NCT04955626|560459869|FG002|Open-Label Period|Other|0|||
155281069|NCT04955626|560459870|FG003|Open-Label Period|Other|0|||
155281070|NCT04955626|560459871|FG004|Open-Label Period|Other|0|||
155281071|NCT04955626|560459872|FG005|Open-Label Period|Other|0|||
155281072|NCT04955626|560459873|FG006|Open-Label Period|Other|0|||
155281073|NCT04955626|560459874|FG007|Open-Label Period|Other|0|||
155281074|NCT04955626|560459875|FG008|Open-Label Period|Other|0|||
155729364|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729365|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729366|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155729367|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
155729368|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
155729369|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729370|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729371|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729372|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729373|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729374|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729375|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729376|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729377|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729378|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729379|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729380|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155729381|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
155729382|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155627539|NCT01787552|561732476|FG001|Overall Study|Death|0|||
155627540|NCT01787552|561732477|FG002|Overall Study|Death|0|||
155729383|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729384|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729385|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729386|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729387|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729388|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729389|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729390|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729391|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729392|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729393|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729394|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729395|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
155729396|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155729397|NCT02113982|562108033|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729398|NCT02113982|562108034|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729399|NCT02113982|562108035|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729400|NCT02113982|562108036|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729401|NCT02113982|562108037|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729402|NCT02113982|562108038|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729403|NCT02113982|562108039|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729404|NCT02113982|562108040|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729405|NCT02113982|562108041|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729406|NCT02113982|562108042|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729407|NCT02113982|562108043|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155627541|NCT01787552|561732478|FG003|Overall Study|Death|1|||
155627542|NCT01787552|561732475|FG000|Overall Study|Adverse Event|2|||
155627543|NCT01787552|561732476|FG001|Overall Study|Adverse Event|5|||
155627544|NCT01787552|561732477|FG002|Overall Study|Adverse Event|2|||
155627545|NCT01787552|561732478|FG003|Overall Study|Adverse Event|16|||
155627546|NCT01787552|561732475|FG000|Overall Study|Study terminated by Sponsor|0|||
155627547|NCT01787552|561732476|FG001|Overall Study|Study terminated by Sponsor|0|||
155627548|NCT01787552|561732477|FG002|Overall Study|Study terminated by Sponsor|1|||
155627549|NCT01787552|561732478|FG003|Overall Study|Study terminated by Sponsor|3|||
155627550|NCT01787552|561732475|FG000|Overall Study|Progressive Disease|2|||
155627551|NCT01787552|561732476|FG001|Overall Study|Progressive Disease|2|||
155627552|NCT01787552|561732477|FG002|Overall Study|Progressive Disease|1|||
155627553|NCT01787552|561732478|FG003|Overall Study|Progressive Disease|1|||
155627554|NCT00630916|561732479|FG000|Overall Study|Death|110|||
155627555|NCT00630916|561732479|FG000|Overall Study|Explant|8|||
155627556|NCT00630916|561732479|FG000|Overall Study|Lost to Follow-up|5|||
155627557|NCT00630916|561732479|FG000|Overall Study|Withdrawal by Subject|30|||
155627558|NCT00630916|561732479|FG000|Overall Study|Protocol Violation|7|||
155627559|NCT00630916|561732479|FG000|Overall Study|Physician Decision|47|||
155627560|NCT00630916|561732479|FG000|Overall Study|Lack of Efficacy|3|||
155627561|NCT02147626|561732480|FG000|Overall Study|Lost to Follow-up|4|||
155627562|NCT02147626|561732481|FG001|Overall Study|Lost to Follow-up|4|||
155729408|NCT02113982|562108044|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155281075|NCT04955626|560459876|FG009|Open-Label Period|Other|0|||
155281076|NCT04955626|560459877|FG010|Open-Label Period|Other|0|||
155627563|NCT02147626|561732480|FG000|Overall Study|Pregnancy|1|||
155729409|NCT02113982|562108045|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
155729410|NCT02113982|562108046|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155729411|NCT03349034|562108047|FG000|Overall Study|catheters dislodged during transport|2|||
155729412|NCT03349034|562108048|FG001|Overall Study|catheters dislodged during transport|0|||
155729413|NCT03349034|562108047|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
155729414|NCT03349034|562108048|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
155729415|NCT03349034|562108047|FG000|Overall Study|soft tissue flap used|1|||
155729416|NCT03349034|562108048|FG001|Overall Study|soft tissue flap used|0|||
155729417|NCT03349034|562108047|FG000|Overall Study|Other|0|||
155729418|NCT03349034|562108048|FG001|Overall Study|Other|1|||
155729419|NCT00865566|562108049|FG000|Overall Study|Death|1|||
155729420|NCT00865566|562108050|FG001|Overall Study|Death|11|||
155729421|NCT00865566|562108049|FG000|Overall Study|Lost to Follow-up|314|||
155729422|NCT00865566|562108050|FG001|Overall Study|Lost to Follow-up|315|||
155729423|NCT00865566|562108049|FG000|Overall Study|Withdrawal by Subject|45|||
155729424|NCT00865566|562108050|FG001|Overall Study|Withdrawal by Subject|65|||
155729425|NCT00865566|562108049|FG000|Overall Study|Physician Decision|0|||
155729426|NCT00865566|562108050|FG001|Overall Study|Physician Decision|1|||
155729427|NCT00865566|562108049|FG000|Overall Study|Participant relocated|78|||
155729428|NCT00865566|562108050|FG001|Overall Study|Participant relocated|107|||
155729429|NCT00865566|562108049|FG000|Overall Study|Participant unable to adhere|27|||
155729430|NCT00865566|562108050|FG001|Overall Study|Participant unable to adhere|42|||
155729431|NCT00865566|562108049|FG000|Overall Study|Other; N=245 due to early study closure|154|||
155729432|NCT00865566|562108050|FG001|Overall Study|Other; N=245 due to early study closure|139|||
155729433|NCT00865566|562108049|FG000|Overall Study|HIV infection|5|||
155729434|NCT00865566|562108050|FG001|Overall Study|HIV infection|7|||
155729435|NCT01039376|562108053|FG000|Overall Study|Lost to Follow-up|5|||
155729436|NCT01039376|562108054|FG001|Overall Study|Lost to Follow-up|12|||
155729437|NCT01039376|562108053|FG000|Overall Study|Physician Decision|15|||
155729438|NCT01039376|562108054|FG001|Overall Study|Physician Decision|10|||
155729439|NCT01039376|562108053|FG000|Overall Study|Withdrawal by Subject|20|||
155729440|NCT01039376|562108054|FG001|Overall Study|Withdrawal by Subject|32|||
155729441|NCT01039376|562108053|FG000|Overall Study|Study terminated by Sponsor|90|||
155729442|NCT01039376|562108054|FG001|Overall Study|Study terminated by Sponsor|72|||
155729443|NCT03252925|562108055|FG000|Overall Study|Withdrawal by Subject|1|||
155729444|NCT03252925|562108056|FG001|Overall Study|Withdrawal by Subject|0|||
155729445|NCT03252925|562108055|FG000|Overall Study|Protocol Violation|6|||
155729446|NCT03252925|562108056|FG001|Overall Study|Protocol Violation|0|||
155729447|NCT03252925|562108055|FG000|Overall Study|Adverse Event|1|||
155729448|NCT03252925|562108056|FG001|Overall Study|Adverse Event|0|||
155729449|NCT03252925|562108055|FG000|Overall Study|Lost to Follow-up|6|||
155729450|NCT03252925|562108056|FG001|Overall Study|Lost to Follow-up|6|||
155729451|NCT00123422|562108057|FG000|Overall Study|Physician Decision|2|||
155729452|NCT00123422|562108058|FG001|Overall Study|Physician Decision|2|||
155729453|NCT00123422|562108059|FG002|Overall Study|Physician Decision|6|||
155729454|NCT00123422|562108057|FG000|Overall Study|Withdrawal by Subject|1|||
155729455|NCT00123422|562108058|FG001|Overall Study|Withdrawal by Subject|2|||
155729456|NCT00123422|562108059|FG002|Overall Study|Withdrawal by Subject|2|||
155729457|NCT00123422|562108057|FG000|Overall Study|Lost to Follow-up|1|||
155729458|NCT00123422|562108058|FG001|Overall Study|Lost to Follow-up|2|||
155729459|NCT00123422|562108059|FG002|Overall Study|Lost to Follow-up|2|||
155729460|NCT00521404|562108060|FG000|Overall Study|Adverse Event|13|||
155729461|NCT00521404|562108060|FG000|Overall Study|Disease Progression|33|||
155729462|NCT00521404|562108060|FG000|Overall Study|Investigator decision|5|||
155729463|NCT00521404|562108060|FG000|Overall Study|Withdrawal of consent|3|||
155729464|NCT00521404|562108060|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
155729465|NCT00521404|562108060|FG000|Overall Study|Other|7|||
155729466|NCT04555616|562108061|FG000|Overall Study|Death|1|||
155729467|NCT04555616|562108062|FG001|Overall Study|Death|0|||
155729468|NCT04555616|562108063|FG002|Overall Study|Death|1|||
155729469|NCT04555616|562108061|FG000|Overall Study|Withdrawal by Subject|2|||
155729470|NCT04555616|562108062|FG001|Overall Study|Withdrawal by Subject|1|||
155729471|NCT04555616|562108063|FG002|Overall Study|Withdrawal by Subject|0|||
155729472|NCT01750229|562108066|FG000|Randomized Crossover Phase|Adverse Event|1|||
155729473|NCT01750229|562108066|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
155729474|NCT01750229|562108066|FG000|Long-term Follow-up Phase|Adverse Event|2|||
155729475|NCT01750229|562108066|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
155729476|NCT03594110|562108070|FG000|Interventional Part|Participant concerned about study treatment|23|||
155729477|NCT03594110|562108071|FG001|Interventional Part|Participant concerned about study treatment|28|||
155729478|NCT03594110|562108070|FG000|Interventional Part|Doctor advice|38|||
155729479|NCT03594110|562108071|FG001|Interventional Part|Doctor advice|40|||
155729480|NCT03594110|562108070|FG000|Interventional Part|Participants' wish|89|||
155729481|NCT03594110|562108071|FG001|Interventional Part|Participants' wish|68|||
155729482|NCT03594110|562108070|FG000|Interventional Part|Adverse event-non-fatal events|119|||
155729483|NCT03594110|562108071|FG001|Interventional Part|Adverse event-non-fatal events|116|||
155729484|NCT03594110|562108070|FG000|Interventional Part|Study drug stopped, reason missing|336|||
155627564|NCT02147626|561732481|FG001|Overall Study|Pregnancy|2|||
155627565|NCT02147626|561732480|FG000|Overall Study|Withdrawal by Subject|0|||
155627566|NCT02147626|561732481|FG001|Overall Study|Withdrawal by Subject|1|||
155627567|NCT00572832|561732482|FG000|Overall Study|Lost to Follow-up|0|||
155627568|NCT00572832|561732483|FG001|Overall Study|Lost to Follow-up|11|||
155627569|NCT00572832|561732482|FG000|Overall Study|Pregnancy|0|||
155627570|NCT00572832|561732483|FG001|Overall Study|Pregnancy|1|||
155627571|NCT00324155|561732484|FG000|Enrolled and Randomized|No longer met study criteria|3|||
155627572|NCT00324155|561732485|FG001|Enrolled and Randomized|No longer met study criteria|0|||
155627573|NCT00324155|561732484|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
155627574|NCT00324155|561732485|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
155627575|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
155627576|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
155627577|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
155627578|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
155627579|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Death|8|||
155627580|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Death|15|||
155627581|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
155627582|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
155627583|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
155627584|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
155627585|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
155627586|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
155627587|NCT00324155|561732484|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
155627588|NCT00324155|561732485|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
155627589|NCT00324155|561732484|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
155627590|NCT00324155|561732485|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
155627591|NCT00324155|561732484|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
155627592|NCT00324155|561732485|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
155627593|NCT00324155|561732484|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
155627594|NCT00324155|561732485|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
155627595|NCT00324155|561732484|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
155627596|NCT00324155|561732485|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
155627597|NCT00324155|561732484|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
155627598|NCT00324155|561732485|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
155627599|NCT00324155|561732484|FG000|Follow-up Phase|On-going participants still on drug|11|||
155627600|NCT00324155|561732485|FG001|Follow-up Phase|On-going participants still on drug|6|||
155627601|NCT00390689|561732486|FG000|Overall Study|Adverse Event|2|||
155627602|NCT00390689|561732487|FG001|Overall Study|Adverse Event|5|||
155627603|NCT00390689|561732488|FG002|Overall Study|Adverse Event|2|||
155627604|NCT00390689|561732486|FG000|Overall Study|Lack of Efficacy|0|||
155627605|NCT00390689|561732487|FG001|Overall Study|Lack of Efficacy|0|||
155627606|NCT00390689|561732488|FG002|Overall Study|Lack of Efficacy|1|||
155627607|NCT00390689|561732486|FG000|Overall Study|Protocol Violation|1|||
155627608|NCT00390689|561732487|FG001|Overall Study|Protocol Violation|0|||
155627609|NCT00390689|561732488|FG002|Overall Study|Protocol Violation|0|||
155627610|NCT00390689|561732486|FG000|Overall Study|Investigator's judgement|2|||
155627611|NCT00390689|561732487|FG001|Overall Study|Investigator's judgement|0|||
155627612|NCT00390689|561732488|FG002|Overall Study|Investigator's judgement|0|||
155627613|NCT01253161|561732489|FG000|Overall Study|Adverse Event|1|||
155627614|NCT00843492|561732493|FG000|Overall Study|Adverse Event|0|||
155627615|NCT00843492|561732494|FG001|Overall Study|Adverse Event|3|||
155627616|NCT00843492|561732493|FG000|Overall Study|Lost to Follow-up|4|||
155627617|NCT00843492|561732494|FG001|Overall Study|Lost to Follow-up|4|||
155627618|NCT00843492|561732493|FG000|Overall Study|Withdrawal by Subject|0|||
155627619|NCT00843492|561732494|FG001|Overall Study|Withdrawal by Subject|4|||
155627620|NCT00843492|561732493|FG000|Overall Study|Immobilization Stopped|1|||
155627621|NCT00843492|561732494|FG001|Overall Study|Immobilization Stopped|0|||
155627622|NCT00843492|561732493|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
155627623|NCT00843492|561732494|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
155627624|NCT00843492|561732493|FG000|Overall Study|Orthopedic Surgery|0|||
155627625|NCT00843492|561732494|FG001|Overall Study|Orthopedic Surgery|2|||
155627626|NCT00843492|561732493|FG000|Overall Study|Visit Not Performed|1|||
155627627|NCT00843492|561732494|FG001|Overall Study|Visit Not Performed|0|||
155627628|NCT00843492|561732493|FG000|Overall Study|Deep-vein Thrombosis|1|||
155627629|NCT00843492|561732494|FG001|Overall Study|Deep-vein Thrombosis|0|||
155627630|NCT00720499|561732495|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
155627631|NCT00720499|561732496|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155627632|NCT00720499|561732495|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
155627633|NCT00720499|561732496|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
155627634|NCT00720499|561732495|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
155729485|NCT03594110|562108071|FG001|Interventional Part|Study drug stopped, reason missing|294|||
155729486|NCT03594110|562108070|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
155729487|NCT03594110|562108071|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
155729488|NCT03594110|562108070|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
155729489|NCT03594110|562108071|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
155729490|NCT03594110|562108070|FG000|Interventional Part|Contraindicated drug started|32|||
155729491|NCT03594110|562108071|FG001|Interventional Part|Contraindicated drug started|18|||
155729492|NCT03594110|562108070|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
155729493|NCT03594110|562108071|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
155729494|NCT03594110|562108070|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
155729495|NCT03594110|562108071|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
155729496|NCT03594110|562108070|FG000|Non-interventional Part|Withdrawal by Subject|3|||
155729497|NCT03594110|562108071|FG001|Non-interventional Part|Withdrawal by Subject|4|||
155729498|NCT03594110|562108070|FG000|Non-interventional Part|Lost to Follow-up|45|||
155729499|NCT03594110|562108071|FG001|Non-interventional Part|Lost to Follow-up|41|||
155729500|NCT02085460|562108074|FG000|Overall Study|Adverse Event|2|||
155729501|NCT02085460|562108075|FG001|Overall Study|Adverse Event|2|||
155729502|NCT02085460|562108076|FG002|Overall Study|Adverse Event|1|||
155729503|NCT02085460|562108074|FG000|Overall Study|Physician Decision|1|||
155729504|NCT02085460|562108075|FG001|Overall Study|Physician Decision|1|||
155729505|NCT02085460|562108076|FG002|Overall Study|Physician Decision|2|||
155729506|NCT02085460|562108074|FG000|Overall Study|Withdrawal by Subject|11|||
155729507|NCT02085460|562108075|FG001|Overall Study|Withdrawal by Subject|5|||
155729508|NCT02085460|562108076|FG002|Overall Study|Withdrawal by Subject|7|||
155729509|NCT02351817|562108077|FG000|Period 1|Adverse Event|1|||
155729510|NCT02351817|562108078|FG001|Period 1|Adverse Event|2|||
155729511|NCT02351817|562108077|FG000|Period 1|Lack of Efficacy|0|||
155729512|NCT02351817|562108078|FG001|Period 1|Lack of Efficacy|1|||
155729513|NCT02351817|562108077|FG000|Period 2|Adverse Event|0|||
155729514|NCT02351817|562108078|FG001|Period 2|Adverse Event|2|||
155729515|NCT02351817|562108077|FG000|Period 2|Protocol Violation|1|||
155729516|NCT02351817|562108078|FG001|Period 2|Protocol Violation|0|||
155729517|NCT00891904|562108085|FG000|Overall Study|Death|1|||
155729518|NCT00891904|562108085|FG000|Overall Study|Adverse Event|1|||
155729519|NCT01046396|562108086|FG000|Overall Study|Withdrawal by Subject|5|||
155729520|NCT04041414|562108089|FG000|Overall Study|Lost to Follow-up|1|||
155729521|NCT04041414|562108090|FG001|Overall Study|Lost to Follow-up|2|||
155729522|NCT00665652|562108091|FG000|Overall Study|Adverse Event|4|||
155729523|NCT00665652|562108091|FG000|Overall Study|Death|1|||
155729524|NCT00665652|562108091|FG000|Overall Study|No longer met inclusion criteria.|1|||
155729525|NCT02161016|562108092|FG000|Overall Study|withdrawn by IRB|1|||
155729526|NCT00380367|562108101|FG000|Overall Study|Lost to Follow-up|1|||
155729527|NCT00380367|562108101|FG000|Overall Study|Withdrawal by Subject|1|||
155729528|NCT02504151|562108106|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
155729529|NCT02504151|562108107|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
155729530|NCT02504151|562108106|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155729531|NCT02504151|562108107|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155729532|NCT02504151|562108106|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155729533|NCT02504151|562108107|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155729534|NCT02504151|562108106|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
155729535|NCT02504151|562108107|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
155729536|NCT05038982|562108108|FG000|Overall Study|Withdrawal by Subject|0|||
155729537|NCT05038982|562108109|FG001|Overall Study|Withdrawal by Subject|2|||
155729538|NCT01454102|562108113|FG000|Overall Study|Continuing in the treatment period|0|||
155729539|NCT01454102|562108114|FG001|Overall Study|Continuing in the treatment period|0|||
155729540|NCT01454102|562108115|FG002|Overall Study|Continuing in the treatment period|0|||
155281077|NCT04955626|560459878|FG011|Open-Label Period|Other|0|||
155729541|NCT01454102|562108116|FG003|Overall Study|Continuing in the treatment period|0|||
155729542|NCT01454102|562108117|FG004|Overall Study|Continuing in the treatment period|3|||
155729543|NCT01454102|562108118|FG005|Overall Study|Continuing in the treatment period|3|||
155729544|NCT01454102|562108119|FG006|Overall Study|Continuing in the treatment period|2|||
155729545|NCT01454102|562108120|FG007|Overall Study|Continuing in the treatment period|0|||
155729546|NCT01454102|562108121|FG008|Overall Study|Continuing in the treatment period|1|||
155729547|NCT01454102|562108122|FG009|Overall Study|Continuing in the treatment period|0|||
155729548|NCT01454102|562108123|FG010|Overall Study|Continuing in the treatment period|0|||
155729549|NCT01454102|562108124|FG011|Overall Study|Continuing in the treatment period|4|||
155729550|NCT01454102|562108125|FG012|Overall Study|Continuing in the treatment period|7|||
155281078|NCT04955626|560459879|FG012|Open-Label Period|Other|0|||
155281079|NCT04955626|560459880|FG013|Open-Label Period|Other|0|||
155729551|NCT01454102|562108126|FG013|Overall Study|Continuing in the treatment period|4|||
155729552|NCT01454102|562108127|FG014|Overall Study|Continuing in the treatment period|3|||
155281080|NCT04955626|560459881|FG014|Open-Label Period|Other|0|||
155281081|NCT04955626|560459882|FG015|Open-Label Period|Other|0|||
155729553|NCT01454102|562108128|FG015|Overall Study|Continuing in the treatment period|1|||
155729554|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
155729555|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
155729556|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
155729557|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155729558|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155729559|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155729560|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
155729561|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
155729562|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
155729563|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155729564|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155729565|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
155729566|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
155729567|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
155729568|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
155729569|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
155729570|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
155729571|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
155729572|NCT03739203|562108131|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
155729573|NCT03739203|562108132|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
155729574|NCT03739203|562108133|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
155729575|NCT03739203|562108131|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
155729576|NCT03739203|562108132|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
155729577|NCT03739203|562108133|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
155729578|NCT03739203|562108131|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
155729579|NCT03739203|562108132|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
155729580|NCT03739203|562108133|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
155729581|NCT03739203|562108131|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
155729582|NCT03739203|562108132|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
155729583|NCT03739203|562108133|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
155729584|NCT03739203|562108131|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
155729585|NCT03739203|562108132|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
155729586|NCT03739203|562108133|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
155729587|NCT01782378|562108134|FG000|First Series|Lost to Follow-up|7|||
155729588|NCT01782378|562108135|FG001|First Series|Lost to Follow-up|8|||
155729589|NCT01782378|562108134|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
155729590|NCT01782378|562108135|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
155729591|NCT01782378|562108134|FG000|Second Series|Lost to Follow-up|8|||
155729592|NCT01782378|562108135|FG001|Second Series|Lost to Follow-up|7|||
155729593|NCT01782378|562108134|FG000|Second Series|Did not choose to complete S2 Optional|18|||
155729594|NCT01782378|562108135|FG001|Second Series|Did not choose to complete S2 Optional|0|||
155729595|NCT00830440|562108136|FG000|Overall Study|Protocol Violation|1|||
155729596|NCT00830440|562108137|FG001|Overall Study|Protocol Violation|0|||
155729597|NCT00830440|562108136|FG000|Overall Study|Withdrawal by Subject|1|||
155729598|NCT00830440|562108137|FG001|Overall Study|Withdrawal by Subject|0|||
155729599|NCT00830440|562108136|FG000|Overall Study|unsuccessful procedure|4|||
155729600|NCT00830440|562108137|FG001|Overall Study|unsuccessful procedure|0|||
155729601|NCT00830440|562108136|FG000|Overall Study|Adverse Event|2|||
155729602|NCT00830440|562108137|FG001|Overall Study|Adverse Event|0|||
155729603|NCT02592798|562108138|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
155729604|NCT02592798|562108139|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
155729605|NCT02592798|562108138|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
155729606|NCT02592798|562108139|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
155729607|NCT02592798|562108138|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
155729608|NCT02592798|562108139|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
155729609|NCT02592798|562108138|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
155729610|NCT02592798|562108139|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
155729611|NCT02592798|562108138|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
155729612|NCT02592798|562108139|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
155729613|NCT02592798|562108138|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
155387896|NCT00150969|560854975|FG000|24-48 Month Extension|Adverse Event|1|||
155729614|NCT02592798|562108139|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
155729615|NCT02592798|562108138|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
155729616|NCT02592798|562108139|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
155729617|NCT02592798|562108138|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
155387897|NCT00150969|560854976|FG001|24-48 Month Extension|Adverse Event|3|||
155729618|NCT02592798|562108139|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
155729619|NCT02592798|562108138|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
155729620|NCT02592798|562108139|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
155729621|NCT02592798|562108138|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
155729622|NCT02592798|562108139|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
155729623|NCT02592798|562108138|FG000|Transition From DB2 to OLE|Other reasons|1|||
155729624|NCT02592798|562108139|FG001|Transition From DB2 to OLE|Other reasons|0|||
155729625|NCT02592798|562108138|FG000|Open Label Period (OLE)|Other reasons|0|||
155729626|NCT02592798|562108139|FG001|Open Label Period (OLE)|Other reasons|2|||
155729627|NCT02592798|562108138|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
155729628|NCT02592798|562108139|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
155729629|NCT02592798|562108138|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
155729630|NCT02592798|562108139|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
155729631|NCT02592798|562108138|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
155729632|NCT02592798|562108139|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
155729633|NCT02592798|562108138|FG000|Open Label Period (OLE)|Adverse Event|0|||
155729634|NCT02592798|562108139|FG001|Open Label Period (OLE)|Adverse Event|1|||
155729635|NCT01188343|562108140|FG000|Overall Study|Not vaccinated|0|||
155729636|NCT01188343|562108141|FG001|Overall Study|Not vaccinated|2|||
155729637|NCT01188343|562108142|FG002|Overall Study|Not vaccinated|1|||
155729638|NCT01188343|562108140|FG000|Overall Study|Withdrawal by Subject|1|||
155729639|NCT01188343|562108141|FG001|Overall Study|Withdrawal by Subject|24|||
155729640|NCT01188343|562108142|FG002|Overall Study|Withdrawal by Subject|0|||
155729641|NCT01143246|562108143|FG000|Overall Study|Adverse Event|24|||
155729642|NCT01143246|562108144|FG001|Overall Study|Adverse Event|28|||
155729643|NCT01143246|562108143|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
155729644|NCT01143246|562108144|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
155729645|NCT01143246|562108143|FG000|Overall Study|Lost to Follow-up|0|||
155729646|NCT01143246|562108144|FG001|Overall Study|Lost to Follow-up|1|||
155729647|NCT01143246|562108143|FG000|Overall Study|Death|16|||
155729648|NCT01143246|562108144|FG001|Overall Study|Death|15|||
155729649|NCT01143246|562108143|FG000|Overall Study|Reason not Specified|3|||
155729650|NCT01143246|562108144|FG001|Overall Study|Reason not Specified|5|||
155729651|NCT01663103|562108145|FG000|Overall Study|Withdrawal by Subject|1|||
155729652|NCT01663103|562108146|FG001|Overall Study|Withdrawal by Subject|2|||
155729653|NCT01663103|562108145|FG000|Overall Study|Adverse Event|1|||
155729654|NCT01663103|562108146|FG001|Overall Study|Adverse Event|0|||
155729655|NCT01663103|562108145|FG000|Overall Study|dog bite|1|||
155729656|NCT01663103|562108146|FG001|Overall Study|dog bite|0|||
155729657|NCT00363480|562108147|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
155729658|NCT00363480|562108147|FG000|Overall Study|Adverse Event|4|||
155729659|NCT00363480|562108147|FG000|Overall Study|Lost to Follow-up|5|||
155729660|NCT00363480|562108147|FG000|Overall Study|Withdrawal by Subject|5|||
155729661|NCT00363480|562108147|FG000|Overall Study|Non-compliance of subject|1|||
155729662|NCT00363480|562108147|FG000|Overall Study|Participant discontinued on its own|1|||
155729663|NCT04634253|562108150|FG000|Overall Study|Adverse Event|1|||
155729664|NCT04634253|562108151|FG001|Overall Study|Adverse Event|1|||
155729665|NCT04634253|562108152|FG002|Overall Study|Adverse Event|0|||
155729666|NCT04634253|562108150|FG000|Overall Study|Physician Decision|0|||
155729667|NCT04634253|562108151|FG001|Overall Study|Physician Decision|1|||
155729668|NCT04634253|562108152|FG002|Overall Study|Physician Decision|0|||
155729669|NCT04634253|562108150|FG000|Overall Study|Withdrawal by Subject|1|||
155729670|NCT04634253|562108151|FG001|Overall Study|Withdrawal by Subject|0|||
155729671|NCT04634253|562108152|FG002|Overall Study|Withdrawal by Subject|3|||
155729672|NCT01457703|562108159|FG000|Overall Study|Screen Failure|5|||
155729673|NCT01457703|562108160|FG001|Overall Study|Screen Failure|7|||
155729674|NCT01457703|562108159|FG000|Overall Study|Withdrawal by Subject|1|||
155729675|NCT01457703|562108160|FG001|Overall Study|Withdrawal by Subject|4|||
155729676|NCT01658436|562108161|FG000|Overall Study|Adverse Event|6|||
155729677|NCT01658436|562108162|FG001|Overall Study|Adverse Event|5|||
155729678|NCT01658436|562108161|FG000|Overall Study|Physician Decision|1|||
155729679|NCT01658436|562108162|FG001|Overall Study|Physician Decision|0|||
155729680|NCT01658436|562108161|FG000|Overall Study|Progressive disease|12|||
155729681|NCT01658436|562108162|FG001|Overall Study|Progressive disease|4|||
155729682|NCT01658436|562108161|FG000|Overall Study|Study terminated by sponsor|0|||
155729683|NCT01658436|562108162|FG001|Overall Study|Study terminated by sponsor|1|||
155729684|NCT01658436|562108161|FG000|Overall Study|Subject/guardian decision|0|||
155729685|NCT01658436|562108162|FG001|Overall Study|Subject/guardian decision|1|||
155729686|NCT01658436|562108161|FG000|Overall Study|Death|1|||
155729687|NCT01658436|562108162|FG001|Overall Study|Death|0|||
155729688|NCT03987503|562108163|FG000|Overall Study|Lost to Follow-up|20|||
155729689|NCT03987503|562108163|FG000|Overall Study|Withdrawal by Subject|2|||
155729690|NCT00888940|562108167|FG000|Overall Study|Adverse Event|12|||
155729691|NCT00888940|562108168|FG001|Overall Study|Adverse Event|3|||
155729692|NCT00888940|562108167|FG000|Overall Study|Lost to Follow-up|5|||
155729693|NCT00888940|562108168|FG001|Overall Study|Lost to Follow-up|5|||
155729694|NCT00888940|562108167|FG000|Overall Study|Randomized Not Treated|11|||
155387898|NCT00150969|560854975|FG000|24-48 Month Extension|Other Reason|81|||
155387899|NCT00150969|560854976|FG001|24-48 Month Extension|Other Reason|91|||
155387900|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
155387901|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
155627635|NCT00720499|561732496|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
155627636|NCT00828711|561732497|FG000|Overall Study|Lost to Follow-up|1|||
155627637|NCT00828711|561732498|FG001|Overall Study|Lost to Follow-up|0|||
155627638|NCT00828711|561732499|FG002|Overall Study|Lost to Follow-up|0|||
155627639|NCT01618968|561732500|FG000|Overall Study|Adverse Event|1|||
155627640|NCT01618968|561732501|FG001|Overall Study|Adverse Event|0|||
155627641|NCT01618968|561732502|FG002|Overall Study|Adverse Event|0|||
155627642|NCT01618968|561732503|FG003|Overall Study|Adverse Event|0|||
155627643|NCT01618968|561732500|FG000|Overall Study|Death|0|||
155627644|NCT01618968|561732501|FG001|Overall Study|Death|0|||
155627645|NCT01618968|561732502|FG002|Overall Study|Death|0|||
155627646|NCT01618968|561732503|FG003|Overall Study|Death|1|||
155627647|NCT00721799|561732509|FG000|Overall Study|Withdrawal by Subject|7|||
155627648|NCT00721799|561732509|FG000|Overall Study|withdraw by subject after scan 1|1|||
155627649|NCT01441973|561732510|FG000|Overall Study|Disease progression|8|||
155627650|NCT01441973|561732511|FG001|Overall Study|Disease progression|6|||
155627651|NCT01441973|561732510|FG000|Overall Study|Adverse event unrelated to study drug|3|||
155627652|NCT01441973|561732511|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155627653|NCT01441973|561732510|FG000|Overall Study|Participant request to discontinue|1|||
155627654|NCT01441973|561732511|FG001|Overall Study|Participant request to discontinue|1|||
155627655|NCT01441973|561732510|FG000|Overall Study|Poor compliance/noncompliance|0|||
155627656|NCT01441973|561732511|FG001|Overall Study|Poor compliance/noncompliance|1|||
155387902|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
155627657|NCT01441973|561732510|FG000|Overall Study|Administrative reason by sponsor|3|||
155627658|NCT01441973|561732511|FG001|Overall Study|Administrative reason by sponsor|5|||
155627659|NCT01441973|561732510|FG000|Overall Study|Participant withdrew consent|0|||
155627660|NCT01441973|561732511|FG001|Overall Study|Participant withdrew consent|1|||
155627661|NCT02873689|561734073|FG000|Overall Study|Lack of Efficacy|1|||
155627662|NCT02873689|561734074|FG001|Overall Study|Lack of Efficacy|0|||
155627663|NCT02873689|561734073|FG000|Overall Study|Withdrawal by Subject|2|||
155627664|NCT02873689|561734074|FG001|Overall Study|Withdrawal by Subject|2|||
155627665|NCT02873689|561734073|FG000|Overall Study|Protocol Violation|1|||
155627666|NCT02873689|561734074|FG001|Overall Study|Protocol Violation|0|||
155627667|NCT02873689|561734073|FG000|Overall Study|Adverse Event|2|||
155627668|NCT02873689|561734074|FG001|Overall Study|Adverse Event|2|||
155627669|NCT02873689|561734073|FG000|Overall Study|Randomized but not Treated|1|||
155627670|NCT02873689|561734074|FG001|Overall Study|Randomized but not Treated|1|||
155627671|NCT00350545|561734075|FG000|Overall Study|Withdrawal by Subject|2|||
155627672|NCT00434252|561734076|FG000|Overall Study|Lack of Efficacy|50|||
155627673|NCT00434252|561734077|FG001|Overall Study|Lack of Efficacy|100|||
155627674|NCT00434252|561734076|FG000|Overall Study|Adverse Event|6|||
155627675|NCT00434252|561734077|FG001|Overall Study|Adverse Event|13|||
155627676|NCT00434252|561734076|FG000|Overall Study|Death|1|||
155627677|NCT00434252|561734077|FG001|Overall Study|Death|2|||
155627678|NCT00434252|561734076|FG000|Overall Study|Lost to Follow-up|0|||
155627679|NCT00434252|561734077|FG001|Overall Study|Lost to Follow-up|1|||
155627680|NCT00434252|561734076|FG000|Overall Study|Physician Decision|4|||
155627681|NCT00434252|561734077|FG001|Overall Study|Physician Decision|8|||
155627682|NCT00434252|561734076|FG000|Overall Study|Withdrawal by Subject|3|||
155627683|NCT00434252|561734077|FG001|Overall Study|Withdrawal by Subject|7|||
155627684|NCT00750269|561734089|FG000|Overall Study|Protocol Violation|0|||
155627685|NCT00750269|561734090|FG001|Overall Study|Protocol Violation|1|||
155627686|NCT00750269|561734091|FG002|Overall Study|Protocol Violation|1|||
155627687|NCT00750269|561734092|FG003|Overall Study|Protocol Violation|2|||
155627688|NCT00750269|561734093|FG004|Overall Study|Protocol Violation|4|||
155627689|NCT00750269|561734089|FG000|Overall Study|Withdrawal by Subject|0|||
155627690|NCT00750269|561734090|FG001|Overall Study|Withdrawal by Subject|0|||
155627691|NCT00750269|561734091|FG002|Overall Study|Withdrawal by Subject|2|||
155627692|NCT00750269|561734092|FG003|Overall Study|Withdrawal by Subject|2|||
155627693|NCT00750269|561734093|FG004|Overall Study|Withdrawal by Subject|2|||
155627694|NCT00750269|561734089|FG000|Overall Study|Physician Decision|0|||
155627695|NCT00750269|561734090|FG001|Overall Study|Physician Decision|0|||
155627696|NCT00750269|561734091|FG002|Overall Study|Physician Decision|0|||
155627697|NCT00750269|561734092|FG003|Overall Study|Physician Decision|0|||
155627698|NCT00750269|561734093|FG004|Overall Study|Physician Decision|2|||
155627699|NCT00750269|561734089|FG000|Overall Study|Patient too large for positioning|0|||
155627700|NCT00750269|561734090|FG001|Overall Study|Patient too large for positioning|0|||
155627701|NCT00750269|561734091|FG002|Overall Study|Patient too large for positioning|1|||
155627702|NCT00750269|561734092|FG003|Overall Study|Patient too large for positioning|0|||
155627703|NCT00750269|561734093|FG004|Overall Study|Patient too large for positioning|0|||
155627704|NCT00750269|561734089|FG000|Overall Study|Site error|0|||
155627705|NCT00750269|561734090|FG001|Overall Study|Site error|0|||
155627706|NCT00750269|561734091|FG002|Overall Study|Site error|0|||
155627707|NCT00750269|561734092|FG003|Overall Study|Site error|1|||
155627708|NCT00750269|561734093|FG004|Overall Study|Site error|0|||
155627709|NCT00750269|561734089|FG000|Overall Study|SBRT plan could not be drawn|0|||
155627710|NCT00750269|561734090|FG001|Overall Study|SBRT plan could not be drawn|0|||
155627711|NCT00750269|561734091|FG002|Overall Study|SBRT plan could not be drawn|0|||
155627712|NCT00750269|561734092|FG003|Overall Study|SBRT plan could not be drawn|0|||
155627713|NCT00750269|561734093|FG004|Overall Study|SBRT plan could not be drawn|1|||
155627714|NCT00750269|561734089|FG000|Overall Study|Fiducials could not be placed|0|||
155627715|NCT00750269|561734090|FG001|Overall Study|Fiducials could not be placed|0|||
155627716|NCT00750269|561734091|FG002|Overall Study|Fiducials could not be placed|0|||
155627717|NCT00750269|561734092|FG003|Overall Study|Fiducials could not be placed|0|||
155627718|NCT00750269|561734093|FG004|Overall Study|Fiducials could not be placed|1|||
155627719|NCT03630393|561734095|FG000|Overall Study|Death|1|||
155627720|NCT03630393|561734096|FG001|Overall Study|Death|0|||
155627721|NCT00408499|561734097|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155627722|NCT00408499|561734098|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155627723|NCT00408499|561734099|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
155627724|NCT00408499|561734100|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155627725|NCT00408499|561734101|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155627726|NCT00408499|561734097|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
155627727|NCT00408499|561734098|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
155627728|NCT00408499|561734099|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155627729|NCT00408499|561734100|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155627730|NCT00408499|561734101|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155627731|NCT00408499|561734097|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
155627732|NCT00408499|561734098|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
155627733|NCT00408499|561734099|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155627734|NCT00408499|561734100|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155627735|NCT00408499|561734101|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155627736|NCT00408499|561734097|FG000|Phase II- MTD Expansion|Adverse Event|0|||
155627737|NCT00408499|561734098|FG001|Phase II- MTD Expansion|Adverse Event|0|||
155627738|NCT00408499|561734099|FG002|Phase II- MTD Expansion|Adverse Event|0|||
155627739|NCT00408499|561734100|FG003|Phase II- MTD Expansion|Adverse Event|0|||
155627740|NCT00408499|561734101|FG004|Phase II- MTD Expansion|Adverse Event|9|||
155627741|NCT00408499|561734097|FG000|Phase II- MTD Expansion|Death|0|||
155627742|NCT00408499|561734098|FG001|Phase II- MTD Expansion|Death|0|||
155627743|NCT00408499|561734099|FG002|Phase II- MTD Expansion|Death|0|||
155627744|NCT00408499|561734100|FG003|Phase II- MTD Expansion|Death|0|||
155627745|NCT00408499|561734101|FG004|Phase II- MTD Expansion|Death|2|||
155627746|NCT00408499|561734097|FG000|Phase II- MTD Expansion|Physician Decision|0|||
155627747|NCT00408499|561734098|FG001|Phase II- MTD Expansion|Physician Decision|0|||
155627748|NCT00408499|561734099|FG002|Phase II- MTD Expansion|Physician Decision|0|||
155627749|NCT00408499|561734100|FG003|Phase II- MTD Expansion|Physician Decision|0|||
155627750|NCT00408499|561734101|FG004|Phase II- MTD Expansion|Physician Decision|1|||
155627751|NCT00408499|561734097|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155627752|NCT00408499|561734098|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155627753|NCT00408499|561734099|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155627754|NCT00408499|561734100|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155627755|NCT00408499|561734101|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
155627756|NCT00408499|561734097|FG000|Phase II- MTD Expansion|treatment delay|0|||
155627757|NCT00408499|561734098|FG001|Phase II- MTD Expansion|treatment delay|0|||
155627758|NCT00408499|561734099|FG002|Phase II- MTD Expansion|treatment delay|0|||
155627759|NCT00408499|561734100|FG003|Phase II- MTD Expansion|treatment delay|0|||
155627760|NCT00408499|561734101|FG004|Phase II- MTD Expansion|treatment delay|3|||
155627761|NCT01586195|561734103|FG000|Overall Study|Death|11|||
155627762|NCT01586195|561734103|FG000|Overall Study|Withdrawal of Consent|5|||
155627763|NCT01586195|561734103|FG000|Overall Study|Started new anti-melanoma therapy|1|||
155627764|NCT01586195|561734103|FG000|Overall Study|Reason not specified|9|||
155627765|NCT00997334|561734104|FG000|Overall Study|still on therapy|12|||
155627766|NCT00997334|561734104|FG000|Overall Study|Adverse Event|3|||
155627767|NCT00997334|561734104|FG000|Overall Study|Patient non-compliance|1|||
155387903|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
155627768|NCT00997334|561734104|FG000|Overall Study|Withdrawal by Subject|3|||
155627769|NCT00997334|561734104|FG000|Overall Study|Death|2|||
155627770|NCT00997334|561734104|FG000|Overall Study|Urgent Palliative Care|2|||
155627771|NCT00997334|561734104|FG000|Overall Study|No lesion amenable|1|||
155627772|NCT00997334|561734104|FG000|Overall Study|Ineligible|1|||
155627773|NCT01855958|561734105|FG000|Overall Study|Withdrawal by Subject|1|||
155627774|NCT01855958|561734106|FG001|Overall Study|Withdrawal by Subject|0|||
155627775|NCT01483118|561734112|FG000|Overall Study|Lost to Follow-up|12|||
155627776|NCT01483118|561734113|FG001|Overall Study|Lost to Follow-up|16|||
155627777|NCT01178294|561734114|FG000|Overall Study|Adverse Event|4|||
155627778|NCT01178294|561734114|FG000|Overall Study|Lost to Follow-up|2|||
155627779|NCT01178294|561734114|FG000|Overall Study|Lack of Efficacy|1|||
155627780|NCT01178294|561734114|FG000|Overall Study|Death|1|||
155627781|NCT01178294|561734114|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
155627782|NCT01178294|561734114|FG000|Overall Study|Subject status is terminal|1|||
155627783|NCT01178294|561734114|FG000|Overall Study|Completion status could not be verified|1|||
155627784|NCT05379920|561734116|FG000|Overall Study|Lost to Follow-up|0|||
155627785|NCT05379920|561734117|FG001|Overall Study|Lost to Follow-up|5|||
155627786|NCT05379920|561734118|FG002|Overall Study|Lost to Follow-up|0|||
155627787|NCT05379920|561734119|FG003|Overall Study|Lost to Follow-up|0|||
155627788|NCT03176771|561734122|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
155627789|NCT03176771|561734123|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
155627790|NCT03176771|561734124|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
155627791|NCT03176771|561734125|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
155627792|NCT03176771|561734126|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
155627793|NCT03176771|561734122|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155627794|NCT03176771|561734123|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
155627795|NCT03176771|561734124|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155627796|NCT03176771|561734125|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155627797|NCT03176771|561734126|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155627798|NCT03176771|561734122|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
155627799|NCT03176771|561734123|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
155627800|NCT03176771|561734124|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
155627801|NCT03176771|561734125|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
155627802|NCT03176771|561734126|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
155627803|NCT03176771|561734122|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155627804|NCT03176771|561734123|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155627805|NCT03176771|561734124|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
155627806|NCT03176771|561734125|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155627807|NCT03176771|561734126|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155627808|NCT03176771|561734122|FG000|Double-Blind Extension Period|Adverse Event|0|||
155627809|NCT03176771|561734123|FG001|Double-Blind Extension Period|Adverse Event|0|||
155627810|NCT03176771|561734124|FG002|Double-Blind Extension Period|Adverse Event|0|||
155627811|NCT03176771|561734125|FG003|Double-Blind Extension Period|Adverse Event|15|||
155627812|NCT03176771|561734126|FG004|Double-Blind Extension Period|Adverse Event|18|||
155627813|NCT03176771|561734122|FG000|Double-Blind Extension Period|Death|0|||
155627814|NCT03176771|561734123|FG001|Double-Blind Extension Period|Death|0|||
155627815|NCT03176771|561734124|FG002|Double-Blind Extension Period|Death|0|||
155627816|NCT03176771|561734125|FG003|Double-Blind Extension Period|Death|3|||
155627817|NCT03176771|561734126|FG004|Double-Blind Extension Period|Death|4|||
155627818|NCT03176771|561734122|FG000|Double-Blind Extension Period|Physician Decision|0|||
155627819|NCT03176771|561734123|FG001|Double-Blind Extension Period|Physician Decision|0|||
155627820|NCT03176771|561734124|FG002|Double-Blind Extension Period|Physician Decision|0|||
155627821|NCT03176771|561734125|FG003|Double-Blind Extension Period|Physician Decision|3|||
155627822|NCT03176771|561734126|FG004|Double-Blind Extension Period|Physician Decision|1|||
155627823|NCT03176771|561734122|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
155627824|NCT03176771|561734123|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
155627825|NCT03176771|561734124|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
155627826|NCT03176771|561734125|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
155627827|NCT03176771|561734126|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
155627828|NCT03530293|561734127|FG000|Pre-randomization|Adverse Event|12|||
155627829|NCT03530293|561734128|FG001|Pre-randomization|Adverse Event|0|||
155627830|NCT03530293|561734129|FG002|Pre-randomization|Adverse Event|0|||
155627831|NCT03530293|561734127|FG000|Pre-randomization|Protocol Violation|2|||
155627832|NCT03530293|561734128|FG001|Pre-randomization|Protocol Violation|0|||
155627833|NCT03530293|561734129|FG002|Pre-randomization|Protocol Violation|0|||
155627834|NCT03530293|561734127|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
155627835|NCT03530293|561734128|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
155627836|NCT03530293|561734129|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
155627837|NCT03530293|561734127|FG000|Pre-randomization|Withdrawal by Subject|5|||
155627838|NCT03530293|561734128|FG001|Pre-randomization|Withdrawal by Subject|0|||
155627839|NCT03530293|561734129|FG002|Pre-randomization|Withdrawal by Subject|0|||
155627840|NCT03530293|561734127|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
155627841|NCT03530293|561734128|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
155627842|NCT03530293|561734129|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
155627843|NCT03530293|561734127|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
155627844|NCT03530293|561734128|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
155627845|NCT03530293|561734129|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
155627846|NCT03530293|561734127|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
155627847|NCT03530293|561734128|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
155729695|NCT00888940|562108168|FG001|Overall Study|Randomized Not Treated|13|||
155729696|NCT02202759|562109823|FG000|Overall Study|Study Terminated by Sponsor|3|||
155627848|NCT03530293|561734129|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
155627849|NCT03530293|561734127|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
155627850|NCT03530293|561734128|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
155627851|NCT03530293|561734129|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
155627852|NCT03530293|561734127|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
155627853|NCT03530293|561734128|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
155627854|NCT03530293|561734129|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
155627855|NCT02152007|561734131|FG000|Overall Study|Withdrawal by Subject|1|||
155627856|NCT02497469|561734136|FG000|Overall Study|Randomized but not Treated|0|||
155627857|NCT02497469|561734137|FG001|Overall Study|Randomized but not Treated|2|||
155627858|NCT02497469|561734136|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
155627859|NCT02497469|561734137|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
155627860|NCT02497469|561734136|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
155627861|NCT02497469|561734137|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
155627862|NCT02497469|561734136|FG000|Overall Study|Significant Protocol Deviation|4|||
155627863|NCT02497469|561734137|FG001|Overall Study|Significant Protocol Deviation|5|||
155627864|NCT02497469|561734136|FG000|Overall Study|Lost to Follow-up|14|||
155627865|NCT02497469|561734137|FG001|Overall Study|Lost to Follow-up|4|||
155627866|NCT02497469|561734136|FG000|Overall Study|Voluntary Withdrawal|39|||
155627867|NCT02497469|561734137|FG001|Overall Study|Voluntary Withdrawal|41|||
155627868|NCT02497469|561734136|FG000|Overall Study|Pregnancy|1|||
155627869|NCT02497469|561734137|FG001|Overall Study|Pregnancy|1|||
155627870|NCT02497469|561734136|FG000|Overall Study|Lack of Efficacy|86|||
155627871|NCT02497469|561734137|FG001|Overall Study|Lack of Efficacy|40|||
155627872|NCT02497469|561734136|FG000|Overall Study|Reason not Specified|6|||
155627873|NCT02497469|561734137|FG001|Overall Study|Reason not Specified|6|||
155627874|NCT03558516|561734138|FG000|Overall Study|Protocol Violation|2|||
155627875|NCT03558516|561734139|FG001|Overall Study|Protocol Violation|2|||
155627876|NCT02714153|561734140|FG000|Overall Study|Death|1|||
155627877|NCT01901185|561734141|FG000|Overall Study|Withdrawal by Subject|2|||
155627878|NCT02065557|561734144|FG000|Induction Period|Withdrawal by Subject|2|||
155627879|NCT02065557|561734145|FG001|Induction Period|Withdrawal by Subject|1|||
155627880|NCT02065557|561734146|FG002|Induction Period|Withdrawal by Subject|0|||
155627881|NCT02065557|561734147|FG003|Induction Period|Withdrawal by Subject|0|||
155627882|NCT02065557|561734148|FG004|Induction Period|Withdrawal by Subject|0|||
155627883|NCT02065557|561734149|FG005|Induction Period|Withdrawal by Subject|0|||
155627884|NCT02065557|561734144|FG000|Induction Period|Lack of Efficacy|2|||
155627885|NCT02065557|561734145|FG001|Induction Period|Lack of Efficacy|1|||
155627886|NCT02065557|561734146|FG002|Induction Period|Lack of Efficacy|1|||
155627887|NCT02065557|561734147|FG003|Induction Period|Lack of Efficacy|0|||
155627888|NCT02065557|561734148|FG004|Induction Period|Lack of Efficacy|0|||
155627889|NCT02065557|561734149|FG005|Induction Period|Lack of Efficacy|0|||
155627890|NCT02065557|561734144|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155627891|NCT02065557|561734145|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155627892|NCT02065557|561734146|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155627893|NCT02065557|561734147|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155627894|NCT02065557|561734148|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155627895|NCT02065557|561734149|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155627896|NCT02065557|561734144|FG000|Induction Period|Non-Responder at Week 8|4|||
155627897|NCT02065557|561734145|FG001|Induction Period|Non-Responder at Week 8|4|||
155627898|NCT02065557|561734146|FG002|Induction Period|Non-Responder at Week 8|0|||
155627899|NCT02065557|561734147|FG003|Induction Period|Non-Responder at Week 8|0|||
155627900|NCT02065557|561734148|FG004|Induction Period|Non-Responder at Week 8|0|||
155627901|NCT02065557|561734149|FG005|Induction Period|Non-Responder at Week 8|0|||
155627902|NCT02065557|561734144|FG000|Induction Period|Adverse Event|1|||
155627903|NCT02065557|561734145|FG001|Induction Period|Adverse Event|1|||
155627904|NCT02065557|561734146|FG002|Induction Period|Adverse Event|0|||
155627905|NCT02065557|561734147|FG003|Induction Period|Adverse Event|0|||
155627906|NCT02065557|561734148|FG004|Induction Period|Adverse Event|0|||
155627907|NCT02065557|561734149|FG005|Induction Period|Adverse Event|0|||
155627908|NCT02065557|561734144|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155729697|NCT02202759|562109824|FG001|Overall Study|Study Terminated by Sponsor|3|||
155729698|NCT02202759|562109825|FG002|Overall Study|Study Terminated by Sponsor|3|||
155729699|NCT02202759|562109823|FG000|Overall Study|Withdrawal by Subject|2|||
155729700|NCT02202759|562109824|FG001|Overall Study|Withdrawal by Subject|1|||
155627909|NCT02065557|561734145|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155627910|NCT02065557|561734146|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155627911|NCT02065557|561734147|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
155729701|NCT02202759|562109825|FG002|Overall Study|Withdrawal by Subject|1|||
155729702|NCT02202759|562109823|FG000|Overall Study|Reason not Specified|4|||
155729703|NCT02202759|562109824|FG001|Overall Study|Reason not Specified|11|||
155627912|NCT02065557|561734148|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
155627913|NCT02065557|561734149|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155627914|NCT02065557|561734144|FG000|Maintenance Period|Withdrawal by Subject|0|||
155627915|NCT02065557|561734145|FG001|Maintenance Period|Withdrawal by Subject|0|||
155627916|NCT02065557|561734146|FG002|Maintenance Period|Withdrawal by Subject|0|||
155627917|NCT02065557|561734147|FG003|Maintenance Period|Withdrawal by Subject|0|||
155627918|NCT02065557|561734148|FG004|Maintenance Period|Withdrawal by Subject|2|||
155627919|NCT02065557|561734149|FG005|Maintenance Period|Withdrawal by Subject|1|||
155627920|NCT02065557|561734144|FG000|Maintenance Period|Lack of Efficacy|0|||
155627921|NCT02065557|561734145|FG001|Maintenance Period|Lack of Efficacy|0|||
155627922|NCT02065557|561734146|FG002|Maintenance Period|Lack of Efficacy|0|||
155627923|NCT02065557|561734147|FG003|Maintenance Period|Lack of Efficacy|0|||
155627924|NCT02065557|561734148|FG004|Maintenance Period|Lack of Efficacy|5|||
155627925|NCT02065557|561734149|FG005|Maintenance Period|Lack of Efficacy|2|||
155627926|NCT02065557|561734144|FG000|Maintenance Period|Subject Non-Compliance|0|||
155627927|NCT02065557|561734145|FG001|Maintenance Period|Subject Non-Compliance|0|||
155627928|NCT02065557|561734146|FG002|Maintenance Period|Subject Non-Compliance|0|||
155627929|NCT02065557|561734147|FG003|Maintenance Period|Subject Non-Compliance|0|||
155627930|NCT02065557|561734148|FG004|Maintenance Period|Subject Non-Compliance|0|||
155627931|NCT02065557|561734149|FG005|Maintenance Period|Subject Non-Compliance|1|||
155627932|NCT01462942|561734152|FG000|Overall Study|Adverse Event|7|||
155627933|NCT01462942|561734153|FG001|Overall Study|Adverse Event|12|||
155627934|NCT01462942|561734154|FG002|Overall Study|Adverse Event|10|||
155627935|NCT01462942|561734155|FG003|Overall Study|Adverse Event|11|||
155627936|NCT01462942|561734156|FG004|Overall Study|Adverse Event|11|||
155627937|NCT01462942|561734152|FG000|Overall Study|Other, including COPD exacerbation|3|||
155627938|NCT01462942|561734153|FG001|Overall Study|Other, including COPD exacerbation|5|||
155627939|NCT01462942|561734154|FG002|Overall Study|Other, including COPD exacerbation|2|||
155627940|NCT01462942|561734155|FG003|Overall Study|Other, including COPD exacerbation|8|||
155627941|NCT01462942|561734156|FG004|Overall Study|Other, including COPD exacerbation|5|||
155627942|NCT01462942|561734152|FG000|Overall Study|Withdrawal by Subject|14|||
155627943|NCT01462942|561734153|FG001|Overall Study|Withdrawal by Subject|10|||
155627944|NCT01462942|561734154|FG002|Overall Study|Withdrawal by Subject|14|||
155627945|NCT01462942|561734155|FG003|Overall Study|Withdrawal by Subject|16|||
155627946|NCT01462942|561734156|FG004|Overall Study|Withdrawal by Subject|19|||
155627947|NCT01462942|561734152|FG000|Overall Study|Lack of Efficacy|6|||
155627948|NCT01462942|561734153|FG001|Overall Study|Lack of Efficacy|0|||
155627949|NCT01462942|561734154|FG002|Overall Study|Lack of Efficacy|4|||
155627950|NCT01462942|561734155|FG003|Overall Study|Lack of Efficacy|5|||
155627951|NCT01462942|561734156|FG004|Overall Study|Lack of Efficacy|3|||
155627952|NCT01462942|561734152|FG000|Overall Study|Lost to Follow-up|0|||
155627953|NCT01462942|561734153|FG001|Overall Study|Lost to Follow-up|1|||
155627954|NCT01462942|561734154|FG002|Overall Study|Lost to Follow-up|1|||
155627955|NCT01462942|561734155|FG003|Overall Study|Lost to Follow-up|1|||
155627956|NCT01462942|561734156|FG004|Overall Study|Lost to Follow-up|1|||
155627957|NCT01462942|561734152|FG000|Overall Study|Protocol Violation|4|||
155627958|NCT01462942|561734153|FG001|Overall Study|Protocol Violation|6|||
155627959|NCT01462942|561734154|FG002|Overall Study|Protocol Violation|9|||
155627960|NCT01462942|561734155|FG003|Overall Study|Protocol Violation|9|||
155627961|NCT01462942|561734156|FG004|Overall Study|Protocol Violation|6|||
155627962|NCT02737722|561734159|FG000|Overall Study|Physician Decision|0|||
155627963|NCT02737722|561734160|FG001|Overall Study|Physician Decision|0|||
155627964|NCT02737722|561734161|FG002|Overall Study|Physician Decision|1|||
155627965|NCT02737722|561734162|FG003|Overall Study|Physician Decision|0|||
155627966|NCT02662569|561734163|FG000|Overall Study|Withdrawal by Subject|6|||
155627967|NCT02662569|561734164|FG001|Overall Study|Withdrawal by Subject|1|||
155627968|NCT02662569|561734165|FG002|Overall Study|Withdrawal by Subject|6|||
155627969|NCT02662569|561734166|FG003|Overall Study|Withdrawal by Subject|4|||
155627970|NCT02662569|561734163|FG000|Overall Study|Lost to Follow-up|1|||
155729704|NCT02202759|562109825|FG002|Overall Study|Reason not Specified|10|||
155729705|NCT01987453|562109826|FG000|Overall Study|Death|0|||
155627971|NCT02662569|561734164|FG001|Overall Study|Lost to Follow-up|0|||
155627972|NCT02662569|561734165|FG002|Overall Study|Lost to Follow-up|0|||
155627973|NCT02662569|561734166|FG003|Overall Study|Lost to Follow-up|0|||
155627974|NCT03555149|561734174|FG000|Overall Study|Death|18|||
155627975|NCT03555149|561734175|FG001|Overall Study|Death|15|||
155627976|NCT03555149|561734176|FG002|Overall Study|Death|15|||
155627977|NCT03555149|561734177|FG003|Overall Study|Death|4|||
155627978|NCT03555149|561734178|FG004|Overall Study|Death|4|||
155627979|NCT03555149|561734179|FG005|Overall Study|Death|11|||
155627980|NCT03555149|561734180|FG006|Overall Study|Death|12|||
155627981|NCT03555149|561734181|FG007|Overall Study|Death|1|||
155627982|NCT03555149|561734174|FG000|Overall Study|Lost to Follow-up|1|||
155627983|NCT03555149|561734175|FG001|Overall Study|Lost to Follow-up|0|||
155627984|NCT03555149|561734176|FG002|Overall Study|Lost to Follow-up|0|||
155627985|NCT03555149|561734177|FG003|Overall Study|Lost to Follow-up|0|||
155627986|NCT03555149|561734178|FG004|Overall Study|Lost to Follow-up|0|||
155627987|NCT03555149|561734179|FG005|Overall Study|Lost to Follow-up|1|||
155387904|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
155387905|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
155387906|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
155387907|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
155387908|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
155387909|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
155387910|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
155387911|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
155387912|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
155387913|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
155387914|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
155627988|NCT03555149|561734180|FG006|Overall Study|Lost to Follow-up|0|||
155627989|NCT03555149|561734181|FG007|Overall Study|Lost to Follow-up|0|||
155627990|NCT03555149|561734174|FG000|Overall Study|Physician Decision|1|||
155627991|NCT03555149|561734175|FG001|Overall Study|Physician Decision|0|||
155627992|NCT03555149|561734176|FG002|Overall Study|Physician Decision|0|||
155627993|NCT03555149|561734177|FG003|Overall Study|Physician Decision|0|||
155627994|NCT03555149|561734178|FG004|Overall Study|Physician Decision|0|||
155627995|NCT03555149|561734179|FG005|Overall Study|Physician Decision|0|||
155627996|NCT03555149|561734180|FG006|Overall Study|Physician Decision|0|||
155627997|NCT03555149|561734181|FG007|Overall Study|Physician Decision|0|||
155627998|NCT03555149|561734174|FG000|Overall Study|Study Terminated By Sponsor|1|||
155627999|NCT03555149|561734175|FG001|Overall Study|Study Terminated By Sponsor|0|||
155628000|NCT03555149|561734176|FG002|Overall Study|Study Terminated By Sponsor|0|||
155628001|NCT03555149|561734177|FG003|Overall Study|Study Terminated By Sponsor|0|||
155628002|NCT03555149|561734178|FG004|Overall Study|Study Terminated By Sponsor|0|||
155628003|NCT03555149|561734179|FG005|Overall Study|Study Terminated By Sponsor|2|||
155628004|NCT03555149|561734180|FG006|Overall Study|Study Terminated By Sponsor|3|||
155628005|NCT03555149|561734181|FG007|Overall Study|Study Terminated By Sponsor|1|||
155628006|NCT03555149|561734174|FG000|Overall Study|Withdrawal by Subject|3|||
155628007|NCT03555149|561734175|FG001|Overall Study|Withdrawal by Subject|0|||
155628008|NCT03555149|561734176|FG002|Overall Study|Withdrawal by Subject|0|||
155628009|NCT03555149|561734177|FG003|Overall Study|Withdrawal by Subject|2|||
155628010|NCT03555149|561734178|FG004|Overall Study|Withdrawal by Subject|0|||
155628011|NCT03555149|561734179|FG005|Overall Study|Withdrawal by Subject|1|||
155628012|NCT03555149|561734180|FG006|Overall Study|Withdrawal by Subject|0|||
155628013|NCT03555149|561734181|FG007|Overall Study|Withdrawal by Subject|0|||
155628014|NCT02785939|561734195|FG000|Overall Study|Progression|25|||
155628015|NCT02785939|561734196|FG001|Overall Study|Progression|8|||
155628016|NCT02785939|561734195|FG000|Overall Study|Adverse Event|3|||
155628017|NCT02785939|561734196|FG001|Overall Study|Adverse Event|1|||
155628018|NCT02785939|561734195|FG000|Overall Study|Death|1|||
155628019|NCT02785939|561734196|FG001|Overall Study|Death|0|||
155628020|NCT02785939|561734195|FG000|Overall Study|Refusal|1|||
155628021|NCT02785939|561734196|FG001|Overall Study|Refusal|0|||
155628022|NCT02785939|561734195|FG000|Overall Study|Deteriorating health|1|||
155628023|NCT02785939|561734196|FG001|Overall Study|Deteriorating health|0|||
155628024|NCT02785939|561734195|FG000|Overall Study|Not protocol specified|0|||
155628025|NCT02785939|561734196|FG001|Overall Study|Not protocol specified|1|||
155628026|NCT04465422|561734197|FG000|Overall Study|Lost to Follow-up|0|||
155628027|NCT04465422|561734198|FG001|Overall Study|Lost to Follow-up|2|||
155628028|NCT01299584|561734204|FG000|Overall Study|Protocol Violation|9|||
155628029|NCT05412134|561734206|FG000|Overall Study|Lost to Follow-up|2|||
155628030|NCT05412134|561734207|FG001|Overall Study|Lost to Follow-up|0|||
155628031|NCT03444584|561734210|FG000|Overall Study|Withdrawal by Subject|0|||
155628032|NCT03444584|561734211|FG001|Overall Study|Withdrawal by Subject|1|||
155628033|NCT03444584|561734210|FG000|Overall Study|Other|0|||
155628034|NCT03444584|561734211|FG001|Overall Study|Other|1|||
155628035|NCT00423046|561734214|FG000|Overall Study|Other|340|||
155628036|NCT00423046|561734215|FG001|Overall Study|Other|345|||
155628037|NCT01604785|561734216|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
155628038|NCT01604785|561734217|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
155628039|NCT02783911|561734224|FG000|Overall Study|Lost to Follow-up|3|||
155628040|NCT02783911|561734225|FG001|Overall Study|Lost to Follow-up|32|||
155628041|NCT00467519|561734226|FG000|Overall Study|Protocol Violation|8|||
155628042|NCT00467519|561734227|FG001|Overall Study|Protocol Violation|4|||
155628043|NCT00467519|561734226|FG000|Overall Study|Lost to Follow-up|2|||
155628044|NCT00467519|561734227|FG001|Overall Study|Lost to Follow-up|9|||
155628045|NCT00467519|561734226|FG000|Overall Study|Withdrawal by Subject|4|||
155628046|NCT00467519|561734227|FG001|Overall Study|Withdrawal by Subject|10|||
155628047|NCT01118052|561734229|FG000|Overall Study|Never treated|2|||
155628048|NCT01677741|561734231|FG000|Overall Study|Death|0|||
155628049|NCT01677741|561734232|FG001|Overall Study|Death|0|||
155628050|NCT01677741|561734233|FG002|Overall Study|Death|0|||
155628051|NCT01677741|561734234|FG003|Overall Study|Death|1|||
155628052|NCT01677741|561734235|FG004|Overall Study|Death|0|||
155628053|NCT01677741|561734236|FG005|Overall Study|Death|1|||
155628054|NCT01677741|561734237|FG006|Overall Study|Death|0|||
155628055|NCT01677741|561734238|FG007|Overall Study|Death|0|||
155628056|NCT01677741|561734231|FG000|Overall Study|Withdrawal by Subject|2|||
155628057|NCT01677741|561734232|FG001|Overall Study|Withdrawal by Subject|7|||
155628058|NCT01677741|561734233|FG002|Overall Study|Withdrawal by Subject|5|||
155628059|NCT01677741|561734234|FG003|Overall Study|Withdrawal by Subject|4|||
155628060|NCT01677741|561734235|FG004|Overall Study|Withdrawal by Subject|11|||
155628061|NCT01677741|561734236|FG005|Overall Study|Withdrawal by Subject|20|||
155628062|NCT01677741|561734237|FG006|Overall Study|Withdrawal by Subject|4|||
155628063|NCT01677741|561734238|FG007|Overall Study|Withdrawal by Subject|2|||
155628064|NCT01677741|561734231|FG000|Overall Study|Enrolled in a rollover study|0|||
155628065|NCT01677741|561734232|FG001|Overall Study|Enrolled in a rollover study|3|||
155628066|NCT01677741|561734233|FG002|Overall Study|Enrolled in a rollover study|2|||
155628067|NCT01677741|561734234|FG003|Overall Study|Enrolled in a rollover study|1|||
155628068|NCT01677741|561734235|FG004|Overall Study|Enrolled in a rollover study|6|||
155628069|NCT01677741|561734236|FG005|Overall Study|Enrolled in a rollover study|6|||
155628070|NCT01677741|561734237|FG006|Overall Study|Enrolled in a rollover study|7|||
155628071|NCT01677741|561734238|FG007|Overall Study|Enrolled in a rollover study|0|||
155628072|NCT01677741|561734231|FG000|Overall Study|Progressive disease|1|||
155628073|NCT01677741|561734232|FG001|Overall Study|Progressive disease|0|||
155628074|NCT01677741|561734233|FG002|Overall Study|Progressive disease|1|||
155628075|NCT01677741|561734234|FG003|Overall Study|Progressive disease|0|||
155628076|NCT01677741|561734235|FG004|Overall Study|Progressive disease|0|||
155628077|NCT01677741|561734236|FG005|Overall Study|Progressive disease|1|||
155628078|NCT01677741|561734237|FG006|Overall Study|Progressive disease|0|||
155628079|NCT01677741|561734238|FG007|Overall Study|Progressive disease|0|||
155628080|NCT00794664|561734239|FG000|Treatment Period|Withdrawal by Subject|0|||
155628081|NCT00794664|561734240|FG001|Treatment Period|Withdrawal by Subject|2|||
155628082|NCT00794664|561734239|FG000|Treatment Period|Protocol non-compliance|0|||
155628083|NCT00794664|561734240|FG001|Treatment Period|Protocol non-compliance|1|||
155628084|NCT00794664|561734239|FG000|Treatment Period|Other|0|||
155628085|NCT00794664|561734240|FG001|Treatment Period|Other|1|||
155628086|NCT00794664|561734239|FG000|Treatment Period|Adverse Event|1|||
155628087|NCT00794664|561734240|FG001|Treatment Period|Adverse Event|8|||
155628088|NCT00794664|561734239|FG000|Follow-up Period|Other|1|||
155628089|NCT00794664|561734240|FG001|Follow-up Period|Other|2|||
155628090|NCT00794664|561734239|FG000|Follow-up Period|Withdrawal by Subject|0|||
155628091|NCT00794664|561734240|FG001|Follow-up Period|Withdrawal by Subject|2|||
155628092|NCT00794664|561734239|FG000|Follow-up Period|Protocol non-compliance|0|||
155628093|NCT00794664|561734240|FG001|Follow-up Period|Protocol non-compliance|1|||
155628094|NCT02230891|561734243|FG000|Baseline|Did not meet inclusion|0|||
155628095|NCT02230891|561734244|FG001|Baseline|Did not meet inclusion|1|||
155628096|NCT02230891|561734245|FG002|Baseline|Did not meet inclusion|1|||
155628097|NCT02230891|561734243|FG000|2 Week|Withdrawal by Subject|2|||
155628098|NCT02230891|561734244|FG001|2 Week|Withdrawal by Subject|2|||
155628099|NCT02230891|561734245|FG002|2 Week|Withdrawal by Subject|0|||
155628100|NCT02230891|561734243|FG000|2 Week|Consent withdrawn|1|||
155628101|NCT02230891|561734244|FG001|2 Week|Consent withdrawn|0|||
155628102|NCT02230891|561734245|FG002|2 Week|Consent withdrawn|0|||
155628103|NCT02230891|561734243|FG000|6 Month|Withdrawal by Subject|1|||
155628104|NCT02230891|561734244|FG001|6 Month|Withdrawal by Subject|1|||
155628105|NCT02230891|561734245|FG002|6 Month|Withdrawal by Subject|1|||
155628106|NCT02230891|561734243|FG000|6 Month|Physician Decision|0|||
155628107|NCT02230891|561734244|FG001|6 Month|Physician Decision|2|||
155628108|NCT02230891|561734245|FG002|6 Month|Physician Decision|0|||
155628109|NCT02230891|561734243|FG000|12 Month|Death|1|||
155628110|NCT02230891|561734244|FG001|12 Month|Death|0|||
155628111|NCT02230891|561734245|FG002|12 Month|Death|0|||
155628112|NCT02230891|561734243|FG000|12 Month|Lost to Follow-up|0|||
155628113|NCT02230891|561734244|FG001|12 Month|Lost to Follow-up|1|||
155628114|NCT02230891|561734245|FG002|12 Month|Lost to Follow-up|0|||
155281082|NCT04955626|560459883|FG016|Open-Label Period|Other|0|||
155628115|NCT02230891|561734243|FG000|12 Month|Withdrawal by Subject|0|||
155628116|NCT02230891|561734244|FG001|12 Month|Withdrawal by Subject|2|||
155628117|NCT02230891|561734245|FG002|12 Month|Withdrawal by Subject|0|||
155628118|NCT02230891|561734243|FG000|18 Month End of Study|Death|0|||
155628119|NCT02230891|561734244|FG001|18 Month End of Study|Death|0|||
155628120|NCT02230891|561734245|FG002|18 Month End of Study|Death|1|||
155628121|NCT02230891|561734243|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
155628122|NCT02230891|561734244|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
155628123|NCT02230891|561734245|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
155628124|NCT03087058|561734247|FG000|Overall Study|Withdrawal by Subject|2|||
155628125|NCT03087058|561734248|FG001|Overall Study|Withdrawal by Subject|0|||
155628126|NCT03087058|561734249|FG002|Overall Study|Withdrawal by Subject|0|||
155628127|NCT05158140|561734250|FG000|Overall Study|Death|0|||
155628128|NCT05158140|561734251|FG001|Overall Study|Death|0|||
155628129|NCT05158140|561734252|FG002|Overall Study|Death|0|||
155628130|NCT05158140|561734253|FG003|Overall Study|Death|1|||
155628131|NCT05158140|561734250|FG000|Overall Study|Lost to Follow-up|3|||
155387915|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
155387916|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
155387917|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
155387918|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
155387919|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
155387920|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
155387921|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
155387922|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
155387923|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
155387924|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
155387925|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
155387926|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
155628132|NCT05158140|561734251|FG001|Overall Study|Lost to Follow-up|6|||
155628133|NCT05158140|561734252|FG002|Overall Study|Lost to Follow-up|4|||
155628134|NCT05158140|561734253|FG003|Overall Study|Lost to Follow-up|3|||
155628135|NCT05158140|561734250|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155628136|NCT05158140|561734251|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155628137|NCT05158140|561734252|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
155628138|NCT05158140|561734253|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155628139|NCT05158140|561734250|FG000|Overall Study|Withdrawal by Subject|3|||
155628140|NCT05158140|561734251|FG001|Overall Study|Withdrawal by Subject|7|||
155628141|NCT05158140|561734252|FG002|Overall Study|Withdrawal by Subject|3|||
155628142|NCT05158140|561734253|FG003|Overall Study|Withdrawal by Subject|7|||
155628143|NCT00921024|561734254|FG000|Overall Study|Lost to Follow-up|2|||
155628144|NCT00921024|561734255|FG001|Overall Study|Lost to Follow-up|0|||
155628145|NCT00921024|561734254|FG000|Overall Study|Received concomittant therapy|2|||
155628146|NCT00921024|561734255|FG001|Overall Study|Received concomittant therapy|0|||
155628147|NCT00921024|561734254|FG000|Overall Study|Withdrawal by Subject|0|||
155628148|NCT00921024|561734255|FG001|Overall Study|Withdrawal by Subject|3|||
155628149|NCT01898078|561735815|FG000|Overall Study|Progressive Disease|1|||
155628150|NCT01898078|561735816|FG001|Overall Study|Progressive Disease|5|||
155628151|NCT01898078|561735815|FG000|Overall Study|Adverse Event|2|||
155628152|NCT01898078|561735816|FG001|Overall Study|Adverse Event|1|||
155628153|NCT01898078|561735815|FG000|Overall Study|Withdrawal by Subject|1|||
155628154|NCT01898078|561735816|FG001|Overall Study|Withdrawal by Subject|1|||
155628155|NCT01898078|561735815|FG000|Overall Study|Symptomatic Deterioration|2|||
155628156|NCT01898078|561735816|FG001|Overall Study|Symptomatic Deterioration|0|||
155628157|NCT01898078|561735815|FG000|Overall Study|Reason not Specified|0|||
155628158|NCT01898078|561735816|FG001|Overall Study|Reason not Specified|1|||
155628159|NCT00720278|561735823|FG000|Overall Study|Adverse Event|5|||
155628160|NCT00720278|561735824|FG001|Overall Study|Adverse Event|3|||
155628161|NCT00720278|561735825|FG002|Overall Study|Adverse Event|4|||
155628162|NCT00720278|561735823|FG000|Overall Study|Withdrawal by Subject|0|||
155628163|NCT00720278|561735824|FG001|Overall Study|Withdrawal by Subject|1|||
155628164|NCT00720278|561735825|FG002|Overall Study|Withdrawal by Subject|0|||
155628165|NCT00720278|561735823|FG000|Overall Study|Lost to Follow-up|0|||
155628166|NCT00720278|561735824|FG001|Overall Study|Lost to Follow-up|0|||
155628167|NCT00720278|561735825|FG002|Overall Study|Lost to Follow-up|1|||
155628168|NCT00720278|561735823|FG000|Overall Study|Non-compliance|1|||
155628169|NCT00720278|561735824|FG001|Overall Study|Non-compliance|0|||
155628170|NCT00720278|561735825|FG002|Overall Study|Non-compliance|0|||
155628171|NCT00720278|561735823|FG000|Overall Study|eligibility criteria violation|1|||
155628172|NCT00720278|561735824|FG001|Overall Study|eligibility criteria violation|0|||
155628173|NCT00720278|561735825|FG002|Overall Study|eligibility criteria violation|1|||
155628174|NCT00266708|561735828|FG000|Overall Study|No renal function|1|||
155628175|NCT00266708|561735829|FG001|Overall Study|No renal function|1|||
155628176|NCT00266708|561735828|FG000|Overall Study|Refused biopsy|3|||
155628177|NCT00266708|561735829|FG001|Overall Study|Refused biopsy|6|||
155628178|NCT00266708|561735828|FG000|Overall Study|Asthma|0|||
155387927|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
155387928|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
155387929|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
155387930|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Other|10|||
155387931|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Other|7|||
155387932|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Other|8|||
155628179|NCT00266708|561735829|FG001|Overall Study|Asthma|2|||
155628180|NCT02791269|561735830|FG000|Overall Study|Lost to Follow-up|0|||
155628181|NCT02791269|561735831|FG001|Overall Study|Lost to Follow-up|1|||
155628182|NCT00368251|561735832|FG000|Overall Study|SAE, non-fatal|1|||
155628183|NCT00368251|561735833|FG001|Overall Study|SAE, non-fatal|0|||
155628184|NCT00368251|561735834|FG002|Overall Study|SAE, non-fatal|0|||
155628185|NCT00368251|561735832|FG000|Overall Study|AE, non-serious non-fatal|0|||
155628186|NCT00368251|561735833|FG001|Overall Study|AE, non-serious non-fatal|0|||
155628187|NCT00368251|561735834|FG002|Overall Study|AE, non-serious non-fatal|1|||
155729706|NCT01987453|562109827|FG001|Overall Study|Death|0|||
155729707|NCT01987453|562109828|FG002|Overall Study|Death|1|||
155729708|NCT01987453|562109826|FG000|Overall Study|Lack of Efficacy|1|||
155729709|NCT01987453|562109827|FG001|Overall Study|Lack of Efficacy|12|||
155729710|NCT01987453|562109828|FG002|Overall Study|Lack of Efficacy|0|||
155729711|NCT04953728|562109829|FG000|Overall Study|Withdrawal by Subject|3|||
155729712|NCT04953728|562109829|FG000|Overall Study|Physician Decision|1|||
155729713|NCT01646125|562109830|FG000|Overall Study|Untreated|2|||
155729714|NCT01646125|562109831|FG001|Overall Study|Untreated|5|||
155729715|NCT01646125|562109830|FG000|Overall Study|Adverse Event|2|||
155729716|NCT01646125|562109831|FG001|Overall Study|Adverse Event|1|||
155729717|NCT01646125|562109830|FG000|Overall Study|Death|1|||
155729718|NCT01646125|562109831|FG001|Overall Study|Death|1|||
155729719|NCT01646125|562109830|FG000|Overall Study|Physician Decision|1|||
155729720|NCT01646125|562109831|FG001|Overall Study|Physician Decision|3|||
155729721|NCT01646125|562109830|FG000|Overall Study|Progressive disease|22|||
155729722|NCT01646125|562109831|FG001|Overall Study|Progressive disease|16|||
155729723|NCT01646125|562109830|FG000|Overall Study|Study terminated by sponsor|2|||
155729724|NCT01646125|562109831|FG001|Overall Study|Study terminated by sponsor|1|||
155729725|NCT01646125|562109830|FG000|Overall Study|Subject/Guardian decision|1|||
155729726|NCT01646125|562109831|FG001|Overall Study|Subject/Guardian decision|1|||
155729727|NCT02105662|562109832|FG000|Overall Study|Lost to Follow-up|5|||
155729728|NCT02105662|562109832|FG000|Overall Study|Withdrawal by Subject|1|||
155729729|NCT02331277|562109833|FG000|Overall Study|Withdrawal by Subject|1|||
155729730|NCT02331277|562109834|FG001|Overall Study|Withdrawal by Subject|0|||
155729731|NCT01376804|562109836|FG000|Treatment Period|Withdrawal by Subject|1|||
155729732|NCT01376804|562109836|FG000|Treatment Period|Adverse Event|6|||
155729733|NCT01376804|562109836|FG000|Treatment Period|Patient did not receive study drug|1|||
155729734|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
155729735|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
155729736|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Patient requirement|20|||
155729737|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Death|5|||
155729738|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Change of therapy|6|||
155729739|NCT01071798|562109837|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
155729740|NCT01071798|562109837|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
155729741|NCT01071798|562109837|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
155729742|NCT01071798|562109837|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
155729743|NCT01071798|562109837|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
155729744|NCT01528969|562109841|FG000|Overall Study|absent from the school at baseline|2|||
155729745|NCT01528969|562109842|FG001|Overall Study|absent from the school at baseline|0|||
155729746|NCT03584789|562109845|FG000|Overall Study|refused EHR permission|19|||
155729747|NCT03584789|562109846|FG001|Overall Study|refused EHR permission|28|||
155729748|NCT03584789|562109847|FG002|Overall Study|refused EHR permission|23|||
155729749|NCT03584789|562109845|FG000|Overall Study|patients tied to a provider who retired|0|||
155729750|NCT03584789|562109846|FG001|Overall Study|patients tied to a provider who retired|0|||
155729751|NCT03584789|562109847|FG002|Overall Study|patients tied to a provider who retired|3|||
155729752|NCT04646044|562109849|FG000|Overall Study|Lost to Follow-up|0|||
155729753|NCT04646044|562109850|FG001|Overall Study|Lost to Follow-up|0|||
155729754|NCT04646044|562109851|FG002|Overall Study|Lost to Follow-up|1|||
155729755|NCT04646044|562109852|FG003|Overall Study|Lost to Follow-up|0|||
155729756|NCT04646044|562109849|FG000|Overall Study|Withdrawal by Subject|0|||
155729757|NCT04646044|562109850|FG001|Overall Study|Withdrawal by Subject|1|||
155729758|NCT04646044|562109851|FG002|Overall Study|Withdrawal by Subject|0|||
155729759|NCT04646044|562109852|FG003|Overall Study|Withdrawal by Subject|0|||
155729760|NCT00602472|562109853|FG000|Overall Study|Adverse Event|5|||
155729761|NCT00602472|562109854|FG001|Overall Study|Adverse Event|23|||
155729762|NCT00602472|562109853|FG000|Overall Study|Protocol Violation|4|||
155729763|NCT00602472|562109854|FG001|Overall Study|Protocol Violation|19|||
155729764|NCT00602472|562109853|FG000|Overall Study|Withdrawal by Subject|8|||
155729765|NCT00602472|562109854|FG001|Overall Study|Withdrawal by Subject|14|||
155729766|NCT00602472|562109853|FG000|Overall Study|Other incl. lack of efficacy|4|||
155729767|NCT00602472|562109854|FG001|Overall Study|Other incl. lack of efficacy|2|||
155281083|NCT04955626|560459884|FG017|Open-Label Period|Other|0|||
155729768|NCT01938716|562109855|FG000|Overall Study|Physician Decision|2|||
155729769|NCT01938716|562109855|FG000|Overall Study|Withdrawal by Subject|2|||
155729770|NCT02803580|562109856|FG000|Overall Study|Death|13|||
155729771|NCT02803580|562109856|FG000|Overall Study|Lost to Follow-up|19|||
155729772|NCT02803580|562109856|FG000|Overall Study|Withdrawal by Subject|3|||
155729773|NCT02803580|562109856|FG000|Overall Study|Inclusion in clinical trial|1|||
155729774|NCT02054104|562109861|FG000|Overall Study|Did not want to continue due to college classes|1|||
155729775|NCT02054104|562109862|FG001|Overall Study|Did not want to continue due to college classes|0|||
155729776|NCT02054104|562109861|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
155729777|NCT02054104|562109862|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
155729778|NCT02054104|562109861|FG000|Overall Study|No evidence of immunologic response|2|||
155729779|NCT02054104|562109862|FG001|Overall Study|No evidence of immunologic response|2|||
155729780|NCT02054104|562109861|FG000|Overall Study|Disease Progression On Study|4|||
155729781|NCT02054104|562109862|FG001|Overall Study|Disease Progression On Study|5|||
155729782|NCT02054104|562109861|FG000|Overall Study|Diagnosis of lymphoma|0|||
155729783|NCT02054104|562109862|FG001|Overall Study|Diagnosis of lymphoma|1|||
155729784|NCT02054104|562109861|FG000|Overall Study|Inconclusive response|0|||
155729785|NCT02054104|562109862|FG001|Overall Study|Inconclusive response|1|||
155729786|NCT01908803|562109863|FG000|Overall Study|Adverse Event|1|||
155729787|NCT01908803|562109864|FG001|Overall Study|Adverse Event|0|||
155729788|NCT01908803|562109863|FG000|Overall Study|Physician Decision|0|||
155729789|NCT01908803|562109864|FG001|Overall Study|Physician Decision|1|||
155729790|NCT01908803|562109863|FG000|Overall Study|Withdrawal by Subject|1|||
155729791|NCT01908803|562109864|FG001|Overall Study|Withdrawal by Subject|0|||
155729792|NCT01908803|562109863|FG000|Overall Study|Randomization Error|1|||
155729793|NCT01908803|562109864|FG001|Overall Study|Randomization Error|0|||
155729794|NCT01908803|562109863|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
155729795|NCT01908803|562109864|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
155729796|NCT02404025|562109865|FG000|Overall Study|Adverse Event|1|||
155729797|NCT02404025|562109865|FG000|Overall Study|Lack of Efficacy|3|||
155729798|NCT00823615|562109866|FG000|Period 2|Lost to Follow-up|2|||
155729799|NCT00823615|562109867|FG001|Period 2|Lost to Follow-up|0|||
155729800|NCT00823615|562109866|FG000|Period 2|Time/Job Conflict|1|||
155729801|NCT00823615|562109867|FG001|Period 2|Time/Job Conflict|2|||
155729802|NCT00098813|562109868|FG000|Overall Study|Death|8|||
155729803|NCT00098813|562109868|FG000|Overall Study|Protocol Violation|1|||
155729804|NCT00098813|562109868|FG000|Overall Study|Withdrawal by Subject|7|||
155729805|NCT00098813|562109868|FG000|Overall Study|Progression of Disease|1|||
155729806|NCT00098813|562109868|FG000|Overall Study|Other complicating disease|1|||
155729807|NCT00098813|562109868|FG000|Overall Study|Reversal of RAI resistance|1|||
155729808|NCT02230670|562109870|FG000|Overall Study|Adverse Event|1|||
155729809|NCT02230670|562109871|FG001|Overall Study|Adverse Event|2|||
155729810|NCT02230670|562109870|FG000|Overall Study|Withdrawal by Subject|2|||
155729811|NCT02230670|562109871|FG001|Overall Study|Withdrawal by Subject|2|||
155729812|NCT02230670|562109870|FG000|Overall Study|Physician Decision|0|||
155729813|NCT02230670|562109871|FG001|Overall Study|Physician Decision|1|||
155729814|NCT02230670|562109870|FG000|Overall Study|Protocol Violation|0|||
155729815|NCT02230670|562109871|FG001|Overall Study|Protocol Violation|1|||
155729816|NCT02230670|562109870|FG000|Overall Study|Progression to Child-Pugh C|1|||
155729817|NCT02230670|562109871|FG001|Overall Study|Progression to Child-Pugh C|2|||
155729818|NCT01907854|562109876|FG000|Overall Study|Protocol Violation|1|||
155729819|NCT01907854|562109877|FG001|Overall Study|Protocol Violation|1|||
155729820|NCT01907854|562109876|FG000|Overall Study|Withdrawal by Subject|9|||
155729821|NCT01907854|562109877|FG001|Overall Study|Withdrawal by Subject|7|||
155729822|NCT01907854|562109876|FG000|Overall Study|Lost to Follow-up|2|||
155729823|NCT01907854|562109877|FG001|Overall Study|Lost to Follow-up|2|||
155729824|NCT01907854|562109876|FG000|Overall Study|Unclassified|4|||
155729825|NCT01907854|562109877|FG001|Overall Study|Unclassified|3|||
155729826|NCT02215252|562109878|FG000|Overall Study|Adverse Event|1|||
155729827|NCT02215252|562109879|FG001|Overall Study|Adverse Event|5|||
155729828|NCT02215252|562109880|FG002|Overall Study|Adverse Event|2|||
155729829|NCT02215252|562109878|FG000|Overall Study|Lost to Follow-up|0|||
155729830|NCT02215252|562109879|FG001|Overall Study|Lost to Follow-up|0|||
155729831|NCT02215252|562109880|FG002|Overall Study|Lost to Follow-up|1|||
155729832|NCT02215252|562109878|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
155729833|NCT02215252|562109879|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
155729834|NCT02215252|562109880|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
155729835|NCT02215252|562109878|FG000|Overall Study|Protocol Violation|0|||
155729836|NCT02215252|562109879|FG001|Overall Study|Protocol Violation|1|||
155729837|NCT02215252|562109880|FG002|Overall Study|Protocol Violation|0|||
155729838|NCT02215252|562109878|FG000|Overall Study|Withdrawal by Subject|1|||
155729839|NCT02215252|562109879|FG001|Overall Study|Withdrawal by Subject|0|||
155729840|NCT02215252|562109880|FG002|Overall Study|Withdrawal by Subject|0|||
155729841|NCT02215252|562109878|FG000|Overall Study|Other|0|||
155729842|NCT02215252|562109879|FG001|Overall Study|Other|1|||
155729843|NCT02215252|562109880|FG002|Overall Study|Other|1|||
155729844|NCT02118961|562109881|FG000|Overall Study|Withdrawal by Subject|1|||
155729845|NCT02118961|562109882|FG001|Overall Study|Withdrawal by Subject|0|||
155729846|NCT00892099|562109884|FG000|Overall Study|Death|1|||
155729847|NCT00892099|562109885|FG001|Overall Study|Death|0|||
155729848|NCT00892099|562109886|FG002|Overall Study|Death|1|||
155729849|NCT00892099|562109884|FG000|Overall Study|Adverse Event|1|||
155729850|NCT00892099|562109885|FG001|Overall Study|Adverse Event|0|||
155729851|NCT00892099|562109886|FG002|Overall Study|Adverse Event|0|||
155729852|NCT00892099|562109884|FG000|Overall Study|replocated|1|||
155729853|NCT00892099|562109885|FG001|Overall Study|replocated|0|||
155729854|NCT00892099|562109886|FG002|Overall Study|replocated|2|||
155729855|NCT00892099|562109884|FG000|Overall Study|Prolonged hospitalization|1|||
155729856|NCT00892099|562109885|FG001|Overall Study|Prolonged hospitalization|0|||
155729857|NCT00892099|562109886|FG002|Overall Study|Prolonged hospitalization|1|||
155628188|NCT00499122|561735835|FG000|Overall Study|Withdrawal by Subject|2|||
155628189|NCT04539275|561735841|FG000|Overall Study|Death|2|||
155628190|NCT04539275|561735842|FG001|Overall Study|Death|4|||
155628191|NCT04539275|561735841|FG000|Overall Study|Lost to Follow-up|1|||
155628192|NCT04539275|561735842|FG001|Overall Study|Lost to Follow-up|1|||
155628193|NCT04539275|561735841|FG000|Overall Study|Withdrawal by Subject|3|||
155628194|NCT04539275|561735842|FG001|Overall Study|Withdrawal by Subject|0|||
155628195|NCT02466399|561735843|FG000|Overall Study|Adverse Event|1|||
155628196|NCT02466399|561735844|FG001|Overall Study|Adverse Event|0|||
155628197|NCT02466399|561735843|FG000|Overall Study|Early exit due to family emergency|1|||
155628198|NCT02466399|561735844|FG001|Overall Study|Early exit due to family emergency|0|||
155628199|NCT01715831|561735847|FG000|Overall Study|Adverse Event|1|||
155628200|NCT00900562|561735848|FG000|Overall Study|Progressive disease|9|||
155628201|NCT00900562|561735849|FG001|Overall Study|Progressive disease|5|||
155628202|NCT00900562|561735848|FG000|Overall Study|Toxicity|1|||
155628203|NCT00900562|561735849|FG001|Overall Study|Toxicity|0|||
155628204|NCT00900562|561735848|FG000|Overall Study|Death|1|||
155628205|NCT00900562|561735849|FG001|Overall Study|Death|1|||
155628206|NCT00900562|561735848|FG000|Overall Study|Withdrawal by Subject|0|||
155628207|NCT00900562|561735849|FG001|Overall Study|Withdrawal by Subject|1|||
155628208|NCT00900562|561735848|FG000|Overall Study|Unrelated adverse event|1|||
155628209|NCT00900562|561735849|FG001|Overall Study|Unrelated adverse event|0|||
155628210|NCT01516216|561735852|FG000|Overall Study|Adverse Event|2|||
155628211|NCT01516216|561735853|FG001|Overall Study|Adverse Event|4|||
155628212|NCT01516216|561735852|FG000|Overall Study|Disease Progression|38|||
155628213|NCT01516216|561735853|FG001|Overall Study|Disease Progression|34|||
155628214|NCT01516216|561735852|FG000|Overall Study|Withdrawal by Subject|9|||
155628215|NCT01516216|561735853|FG001|Overall Study|Withdrawal by Subject|11|||
155628216|NCT01516216|561735852|FG000|Overall Study|Potentially Curative Resection|6|||
155628217|NCT01516216|561735853|FG001|Overall Study|Potentially Curative Resection|12|||
155628218|NCT01516216|561735852|FG000|Overall Study|Nonadherence|2|||
155628219|NCT01516216|561735853|FG001|Overall Study|Nonadherence|3|||
155628220|NCT01516216|561735852|FG000|Overall Study|Physician Decision|6|||
155628221|NCT01516216|561735853|FG001|Overall Study|Physician Decision|3|||
155628222|NCT01516216|561735852|FG000|Overall Study|Prolonged Treatment Delay|5|||
155628223|NCT01516216|561735853|FG001|Overall Study|Prolonged Treatment Delay|1|||
155628224|NCT01516216|561735852|FG000|Overall Study|Intercurrent Illness|1|||
155628225|NCT01516216|561735853|FG001|Overall Study|Intercurrent Illness|0|||
155628226|NCT01516216|561735852|FG000|Overall Study|Death|1|||
155628227|NCT01516216|561735853|FG001|Overall Study|Death|1|||
155628228|NCT03098979|561735854|FG000|Overall Study|Adverse Event|1|||
155628229|NCT03098979|561735855|FG001|Overall Study|Adverse Event|0|||
155628230|NCT03098979|561735856|FG002|Overall Study|Adverse Event|1|||
155628231|NCT03098979|561735857|FG003|Overall Study|Adverse Event|4|||
155628232|NCT03098979|561735858|FG004|Overall Study|Adverse Event|6|||
155628233|NCT03098979|561735859|FG005|Overall Study|Adverse Event|1|||
155628234|NCT03098979|561735854|FG000|Overall Study|Withdrawal by Subject|2|||
155628235|NCT03098979|561735855|FG001|Overall Study|Withdrawal by Subject|1|||
155628236|NCT03098979|561735856|FG002|Overall Study|Withdrawal by Subject|1|||
155628237|NCT03098979|561735857|FG003|Overall Study|Withdrawal by Subject|1|||
155628238|NCT03098979|561735858|FG004|Overall Study|Withdrawal by Subject|2|||
155628239|NCT03098979|561735859|FG005|Overall Study|Withdrawal by Subject|1|||
155628240|NCT03098979|561735854|FG000|Overall Study|Death|1|||
155628241|NCT03098979|561735855|FG001|Overall Study|Death|0|||
155628242|NCT03098979|561735856|FG002|Overall Study|Death|2|||
155628243|NCT03098979|561735857|FG003|Overall Study|Death|0|||
155628244|NCT03098979|561735858|FG004|Overall Study|Death|1|||
155628245|NCT03098979|561735859|FG005|Overall Study|Death|0|||
155628246|NCT03098979|561735854|FG000|Overall Study|Physician Decision|2|||
155628247|NCT03098979|561735855|FG001|Overall Study|Physician Decision|1|||
155628248|NCT03098979|561735856|FG002|Overall Study|Physician Decision|0|||
155628249|NCT03098979|561735857|FG003|Overall Study|Physician Decision|0|||
155628250|NCT03098979|561735858|FG004|Overall Study|Physician Decision|0|||
155628251|NCT03098979|561735859|FG005|Overall Study|Physician Decision|0|||
155628252|NCT03098979|561735854|FG000|Overall Study|Non-compliance|0|||
155628253|NCT03098979|561735855|FG001|Overall Study|Non-compliance|0|||
155281084|NCT04955626|560459885|FG018|Open-Label Period|Other|0|||
155281085|NCT04955626|560459886|FG019|Open-Label Period|Other|0|||
155281086|NCT04955626|560459887|FG020|Open-Label Period|Other|0|||
155281087|NCT04955626|560459888|FG021|Open-Label Period|Other|0|||
155281088|NCT04955626|560459889|FG022|Open-Label Period|Other|0|||
155281089|NCT04955626|560459890|FG023|Open-Label Period|Other|0|||
155628254|NCT03098979|561735856|FG002|Overall Study|Non-compliance|0|||
155628255|NCT03098979|561735857|FG003|Overall Study|Non-compliance|0|||
155628256|NCT03098979|561735858|FG004|Overall Study|Non-compliance|0|||
155628257|NCT03098979|561735859|FG005|Overall Study|Non-compliance|1|||
155628258|NCT03098979|561735854|FG000|Overall Study|Protocol Violation|0|||
155628259|NCT03098979|561735855|FG001|Overall Study|Protocol Violation|0|||
155628260|NCT03098979|561735856|FG002|Overall Study|Protocol Violation|0|||
155628261|NCT03098979|561735857|FG003|Overall Study|Protocol Violation|0|||
155628262|NCT03098979|561735858|FG004|Overall Study|Protocol Violation|0|||
155628263|NCT03098979|561735859|FG005|Overall Study|Protocol Violation|1|||
155628264|NCT02419807|561735860|FG000|Overall Study|Withdrawal by Subject|4|||
155628265|NCT02419807|561735860|FG000|Overall Study|Physician Decision|1|||
155628266|NCT02419807|561735860|FG000|Overall Study|Protocol Violation|5|||
155628267|NCT01006629|561735861|FG000|Overall Study|Adverse Event|1|||
155628268|NCT01006629|561735861|FG000|Overall Study|Parent refused to continue participation|1|||
155628269|NCT01006629|561735861|FG000|Overall Study|Parent unable to perform site visit|4|||
155628270|NCT01065818|561735862|FG000|Overall Study|Withdrawal by Subject|1|||
155628271|NCT01065818|561735862|FG000|Overall Study|Not a candidate for surgery|1|||
155628272|NCT03157089|561735865|FG000|Overall Study|Treated only with pembrolizumab|1|||
155628273|NCT03157089|561735866|FG001|Overall Study|Treated only with pembrolizumab|0|||
155628274|NCT03157089|561735865|FG000|Overall Study|Adverse Event|5|||
155628275|NCT03157089|561735866|FG001|Overall Study|Adverse Event|4|||
155628276|NCT03157089|561735865|FG000|Overall Study|Progressive disease|6|||
155628277|NCT03157089|561735866|FG001|Overall Study|Progressive disease|8|||
155628278|NCT00784875|561735867|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
155628279|NCT00784875|561735868|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
155628280|NCT00784875|561735869|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
155628281|NCT00784875|561735870|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
155628282|NCT00784875|561735867|FG000|Period A - Baseline|Adverse Event|0|||
155628283|NCT00784875|561735868|FG001|Period A - Baseline|Adverse Event|0|||
155628284|NCT00784875|561735869|FG002|Period A - Baseline|Adverse Event|0|||
155628285|NCT00784875|561735870|FG003|Period A - Baseline|Adverse Event|8|||
155628286|NCT00784875|561735867|FG000|Period A - Baseline|Protocol Violation|0|||
155628287|NCT00784875|561735868|FG001|Period A - Baseline|Protocol Violation|0|||
155628288|NCT00784875|561735869|FG002|Period A - Baseline|Protocol Violation|0|||
155628289|NCT00784875|561735870|FG003|Period A - Baseline|Protocol Violation|25|||
155628290|NCT00784875|561735867|FG000|Period A - Baseline|Withdrawal by Subject|0|||
155628291|NCT00784875|561735868|FG001|Period A - Baseline|Withdrawal by Subject|0|||
155628292|NCT00784875|561735869|FG002|Period A - Baseline|Withdrawal by Subject|0|||
155628293|NCT00784875|561735870|FG003|Period A - Baseline|Withdrawal by Subject|27|||
155628294|NCT00784875|561735867|FG000|Period A - Baseline|Physician Decision|0|||
155628295|NCT00784875|561735868|FG001|Period A - Baseline|Physician Decision|0|||
155628296|NCT00784875|561735869|FG002|Period A - Baseline|Physician Decision|0|||
155628297|NCT00784875|561735870|FG003|Period A - Baseline|Physician Decision|2|||
155628298|NCT00784875|561735867|FG000|Period A - Baseline|Sponsor Decision|0|||
155628299|NCT00784875|561735868|FG001|Period A - Baseline|Sponsor Decision|0|||
155628300|NCT00784875|561735869|FG002|Period A - Baseline|Sponsor Decision|0|||
155628301|NCT00784875|561735870|FG003|Period A - Baseline|Sponsor Decision|113|||
155628302|NCT00784875|561735867|FG000|Period A - Baseline|Lost to Follow-up|0|||
155729858|NCT00892099|562109884|FG000|Overall Study|no further details|1|||
155729859|NCT00892099|562109885|FG001|Overall Study|no further details|0|||
155729860|NCT00892099|562109886|FG002|Overall Study|no further details|1|||
155729861|NCT00892099|562109884|FG000|Overall Study|kidney function recovered|0|||
155729862|NCT00892099|562109885|FG001|Overall Study|kidney function recovered|1|||
155387933|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Other|8|||
155387934|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Other|0|||
155387935|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
155387936|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
155387937|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
155387938|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
155387939|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
155387940|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
155387941|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387942|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387943|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387944|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387945|NCT01630434|560854982|FG000|Overall Study|Donor lungs turned down|1|||
155387946|NCT01630434|560854983|FG001|Overall Study|Donor lungs turned down|0|||
155387947|NCT01630434|560854982|FG000|Overall Study|Protocol Violation|9|||
155387948|NCT01630434|560854983|FG001|Overall Study|Protocol Violation|4|||
155387949|NCT01630434|560854982|FG000|Overall Study|Death|20|||
155729863|NCT00892099|562109886|FG002|Overall Study|kidney function recovered|0|||
155729864|NCT00892099|562109884|FG000|Overall Study|investigator decision|0|||
155628303|NCT00784875|561735868|FG001|Period A - Baseline|Lost to Follow-up|0|||
155628304|NCT00784875|561735869|FG002|Period A - Baseline|Lost to Follow-up|0|||
155628305|NCT00784875|561735870|FG003|Period A - Baseline|Lost to Follow-up|2|||
155628306|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
155628307|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
155729865|NCT00892099|562109885|FG001|Overall Study|investigator decision|0|||
155628308|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
155628309|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
155628310|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
155387950|NCT01630434|560854983|FG001|Overall Study|Death|26|||
155387951|NCT02121834|560854985|FG000|Overall Study|Protocol Violation|0|||
155387952|NCT02121834|560854986|FG001|Overall Study|Protocol Violation|1|||
155387953|NCT02121834|560854987|FG002|Overall Study|Protocol Violation|0|||
155387954|NCT02121834|560854988|FG003|Overall Study|Protocol Violation|0|||
155387955|NCT02121834|560854989|FG004|Overall Study|Protocol Violation|0|||
155387956|NCT02121834|560854990|FG005|Overall Study|Protocol Violation|0|||
155387957|NCT02121834|560854991|FG006|Overall Study|Protocol Violation|0|||
155387958|NCT02121834|560854985|FG000|Overall Study|Withdrawal by Subject|0|||
155387959|NCT02121834|560854986|FG001|Overall Study|Withdrawal by Subject|1|||
155387960|NCT02121834|560854987|FG002|Overall Study|Withdrawal by Subject|1|||
155387961|NCT02121834|560854988|FG003|Overall Study|Withdrawal by Subject|0|||
155387962|NCT02121834|560854989|FG004|Overall Study|Withdrawal by Subject|0|||
155387963|NCT02121834|560854990|FG005|Overall Study|Withdrawal by Subject|0|||
155387964|NCT02121834|560854991|FG006|Overall Study|Withdrawal by Subject|0|||
155387965|NCT02121834|560854985|FG000|Overall Study|Lost to Follow-up|0|||
155387966|NCT02121834|560854986|FG001|Overall Study|Lost to Follow-up|0|||
155387967|NCT02121834|560854987|FG002|Overall Study|Lost to Follow-up|1|||
155387968|NCT02121834|560854988|FG003|Overall Study|Lost to Follow-up|0|||
155387969|NCT02121834|560854989|FG004|Overall Study|Lost to Follow-up|0|||
155387970|NCT02121834|560854990|FG005|Overall Study|Lost to Follow-up|0|||
155387971|NCT02121834|560854991|FG006|Overall Study|Lost to Follow-up|0|||
155387972|NCT02578862|560854992|FG000|Overall Study|Withdrawal by Subject|0|||
155387973|NCT02578862|560854993|FG001|Overall Study|Withdrawal by Subject|1|||
155387974|NCT02578862|560854992|FG000|Overall Study|Unplanned unilateral procedure|0|||
155387975|NCT02578862|560854993|FG001|Overall Study|Unplanned unilateral procedure|1|||
155387976|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
155387977|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
155387978|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Death|0|||
155387979|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Death|2|||
155387980|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155387981|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
155387982|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
155387983|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
155387984|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
155387985|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
155387986|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
155387987|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
155387988|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
155387989|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
155387990|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
155387991|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
155387992|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
155387993|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
155387994|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
155387995|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
155387996|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Death|3|||
155387997|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Death|3|||
155387998|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155387999|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155388000|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
155388001|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
155388002|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
155388003|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
155388004|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
155388005|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
155388006|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
155388007|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
155388008|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
155388009|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
155388010|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
155388011|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
155388012|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
155388013|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
155388014|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Death|4|||
155628311|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
155628312|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
155388015|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Death|5|||
155628313|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
155388016|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
155388017|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155729866|NCT00892099|562109886|FG002|Overall Study|investigator decision|1|||
155729867|NCT00892099|562109884|FG000|Overall Study|Lost to Follow-up|0|||
155729868|NCT00892099|562109885|FG001|Overall Study|Lost to Follow-up|0|||
155729869|NCT00892099|562109886|FG002|Overall Study|Lost to Follow-up|1|||
155729870|NCT01657019|562109887|FG000|Overall Study|Withdrawal by Subject|65|||
155729871|NCT01657019|562109887|FG000|Overall Study|Adverse Event|55|||
155729872|NCT01657019|562109887|FG000|Overall Study|Lost to Follow-up|48|||
155729873|NCT01657019|562109887|FG000|Overall Study|Protocol Violation|6|||
155729874|NCT01657019|562109887|FG000|Overall Study|Lack of Efficacy|3|||
155729875|NCT01657019|562109887|FG000|Overall Study|Other|58|||
155729876|NCT03910244|562109888|FG000|Overall Study|Adverse Event|14|||
155729877|NCT03910244|562109889|FG001|Overall Study|Adverse Event|0|||
155729878|NCT03910244|562109888|FG000|Overall Study|Death|1|||
155729879|NCT03910244|562109889|FG001|Overall Study|Death|0|||
155729880|NCT03910244|562109888|FG000|Overall Study|Lost to Follow-up|0|||
155729881|NCT03910244|562109889|FG001|Overall Study|Lost to Follow-up|2|||
155729882|NCT03910244|562109888|FG000|Overall Study|Joint withdrawal decision|1|||
155729883|NCT03910244|562109889|FG001|Overall Study|Joint withdrawal decision|0|||
155628314|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
155628315|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
155628316|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
155628317|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
155628318|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155628319|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
155628320|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155628321|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155628322|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
155628323|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
155628324|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
155628325|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
155628326|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
155628327|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
155628328|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
155628329|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
155628330|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
155628331|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
155628332|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
155628333|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
155628334|NCT00784875|561735867|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155628335|NCT00784875|561735868|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155628336|NCT00784875|561735869|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
155628337|NCT00784875|561735870|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155628338|NCT00784875|561735867|FG000|Period C|Adverse Event|1|||
155628339|NCT00784875|561735868|FG001|Period C|Adverse Event|0|||
155628340|NCT00784875|561735869|FG002|Period C|Adverse Event|4|||
155628341|NCT00784875|561735870|FG003|Period C|Adverse Event|2|||
155628342|NCT00784875|561735867|FG000|Period C|Protocol Violation|0|||
155628343|NCT00784875|561735868|FG001|Period C|Protocol Violation|0|||
155628344|NCT00784875|561735869|FG002|Period C|Protocol Violation|1|||
155628345|NCT00784875|561735870|FG003|Period C|Protocol Violation|2|||
155628346|NCT00784875|561735867|FG000|Period C|Lack of Efficacy|0|||
155628347|NCT00784875|561735868|FG001|Period C|Lack of Efficacy|0|||
155628348|NCT00784875|561735869|FG002|Period C|Lack of Efficacy|1|||
155628349|NCT00784875|561735870|FG003|Period C|Lack of Efficacy|0|||
155628350|NCT00784875|561735867|FG000|Period C|Withdrawal by Subject|1|||
155628351|NCT00784875|561735868|FG001|Period C|Withdrawal by Subject|1|||
155628352|NCT00784875|561735869|FG002|Period C|Withdrawal by Subject|2|||
155628353|NCT00784875|561735870|FG003|Period C|Withdrawal by Subject|0|||
155628354|NCT00784875|561735867|FG000|Period C|Physician Decision|0|||
155628355|NCT00784875|561735868|FG001|Period C|Physician Decision|0|||
155628356|NCT00784875|561735869|FG002|Period C|Physician Decision|1|||
155628357|NCT00784875|561735870|FG003|Period C|Physician Decision|1|||
155628358|NCT00784875|561735867|FG000|Period C|Sponsor Decision|5|||
155729884|NCT03910244|562109888|FG000|Overall Study|Study Terminated by Sponsor|7|||
155388018|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
155628359|NCT00784875|561735868|FG001|Period C|Sponsor Decision|5|||
155628360|NCT00784875|561735869|FG002|Period C|Sponsor Decision|4|||
155729885|NCT03910244|562109889|FG001|Overall Study|Study Terminated by Sponsor|4|||
155729886|NCT03910244|562109888|FG000|Overall Study|Physician Decision|1|||
155729887|NCT03910244|562109889|FG001|Overall Study|Physician Decision|0|||
155729888|NCT03910244|562109888|FG000|Overall Study|Protocol Violation|1|||
155628361|NCT00784875|561735870|FG003|Period C|Sponsor Decision|2|||
155628362|NCT00784875|561735867|FG000|Period D|Adverse Event|0|||
155628363|NCT00784875|561735868|FG001|Period D|Adverse Event|2|||
155628364|NCT00784875|561735869|FG002|Period D|Adverse Event|2|||
155628365|NCT00784875|561735870|FG003|Period D|Adverse Event|0|||
155628366|NCT00784875|561735867|FG000|Period D|Protocol Violation|1|||
155729889|NCT03910244|562109889|FG001|Overall Study|Protocol Violation|0|||
155388019|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
155388020|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
155628367|NCT00784875|561735868|FG001|Period D|Protocol Violation|0|||
155628368|NCT00784875|561735869|FG002|Period D|Protocol Violation|0|||
155628369|NCT00784875|561735870|FG003|Period D|Protocol Violation|0|||
155628370|NCT00784875|561735867|FG000|Period D|Withdrawal by Subject|2|||
155628371|NCT00784875|561735868|FG001|Period D|Withdrawal by Subject|0|||
155628372|NCT00784875|561735869|FG002|Period D|Withdrawal by Subject|2|||
155628373|NCT00784875|561735870|FG003|Period D|Withdrawal by Subject|0|||
155628374|NCT00784875|561735867|FG000|Period D|Physician Decision|0|||
155628375|NCT00784875|561735868|FG001|Period D|Physician Decision|1|||
155628376|NCT00784875|561735869|FG002|Period D|Physician Decision|0|||
155628377|NCT00784875|561735870|FG003|Period D|Physician Decision|0|||
155628378|NCT00784875|561735867|FG000|Period D|Sponsor Decision|1|||
155628379|NCT00784875|561735868|FG001|Period D|Sponsor Decision|1|||
155628380|NCT00784875|561735869|FG002|Period D|Sponsor Decision|1|||
155628381|NCT00784875|561735870|FG003|Period D|Sponsor Decision|0|||
155628382|NCT00784875|561735867|FG000|Period D|Lost to Follow-up|1|||
155628383|NCT00784875|561735868|FG001|Period D|Lost to Follow-up|0|||
155628384|NCT00784875|561735869|FG002|Period D|Lost to Follow-up|1|||
155628385|NCT00784875|561735870|FG003|Period D|Lost to Follow-up|1|||
155628386|NCT00958074|561735871|FG000|Overall Study|Withdrawal by Subject|0|||
155628387|NCT00958074|561735872|FG001|Overall Study|Withdrawal by Subject|1|||
155628388|NCT00941928|561735877|FG000|Overall Study|Withdrawal by Subject|1|||
155628389|NCT00941928|561735877|FG000|Overall Study|Disease Progression|1|||
155628390|NCT02300610|561735880|FG000|Overall Study|Withdrawal by Subject|1|||
155628391|NCT02300610|561735881|FG001|Overall Study|Withdrawal by Subject|0|||
155628392|NCT02300610|561735882|FG002|Overall Study|Withdrawal by Subject|1|||
155628393|NCT00095979|561735883|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
155628394|NCT01829347|561735884|FG000|VTI-210|Death|5|||
155628395|NCT01829347|561735885|FG001|VTI-210|Death|3|||
155628396|NCT01829347|561735884|FG000|VTI-210|Withdrawal by Subject|1|||
155628397|NCT01829347|561735885|FG001|VTI-210|Withdrawal by Subject|0|||
155628398|NCT01829347|561735884|FG000|VTI-210E|Death|2|||
155628399|NCT01829347|561735885|FG001|VTI-210E|Death|1|||
155628400|NCT01829347|561735884|FG000|VTI-210E|Study terminated prematurely|1|||
155628401|NCT01829347|561735885|FG001|VTI-210E|Study terminated prematurely|5|||
155628402|NCT02051296|561735889|FG000|Overall Study|Lost to Follow-up|1|||
155628403|NCT02051296|561735890|FG001|Overall Study|Lost to Follow-up|2|||
155628404|NCT02051296|561735889|FG000|Overall Study|withdraw prior to treatment|7|||
155628405|NCT02051296|561735890|FG001|Overall Study|withdraw prior to treatment|7|||
155628406|NCT00706797|561735895|FG000|Overall Study|Lack of Efficacy|3|||
155628407|NCT00706797|561735896|FG001|Overall Study|Lack of Efficacy|0|||
155628408|NCT00706797|561735895|FG000|Overall Study|Adverse Event|0|||
155628409|NCT00706797|561735896|FG001|Overall Study|Adverse Event|3|||
155628410|NCT00706797|561735895|FG000|Overall Study|Withdrawal by Subject|8|||
155628411|NCT00706797|561735896|FG001|Overall Study|Withdrawal by Subject|1|||
155628412|NCT00706797|561735895|FG000|Overall Study|Death|1|||
155628413|NCT00706797|561735896|FG001|Overall Study|Death|0|||
155281090|NCT04955626|560459891|FG024|Open-Label Period|Other|0|||
155281091|NCT04955626|560459892|FG025|Open-Label Period|Other|0|||
155281092|NCT04955626|560459893|FG026|Open-Label Period|Other|0|||
155281093|NCT04955626|560459894|FG027|Open-Label Period|Other|0|||
155281094|NCT04955626|560459895|FG028|Open-Label Period|Other|0|||
155281095|NCT04955626|560459896|FG029|Open-Label Period|Other|0|||
155281096|NCT04955626|560459897|FG030|Open-Label Period|Other|0|||
155281097|NCT04955626|560459898|FG031|Open-Label Period|Other|0|||
155281098|NCT04955626|560459899|FG032|Open-Label Period|Other|0|||
155281099|NCT04955626|560459900|FG033|Open-Label Period|Other|0|||
155281100|NCT04955626|560459901|FG034|Open-Label Period|Other|0|||
155281101|NCT04955626|560459902|FG035|Open-Label Period|Other|0|||
155281102|NCT04955626|560459867|FG000|Open-Label Period|Physician Decision|2|||
155281103|NCT04955626|560459868|FG001|Open-Label Period|Physician Decision|0|||
155388021|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
155388022|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
155628414|NCT00706797|561735895|FG000|Overall Study|Discontinuation of study by sponsor|52|||
155628415|NCT00706797|561735896|FG001|Overall Study|Discontinuation of study by sponsor|63|||
155628416|NCT00706797|561735895|FG000|Overall Study|Protocol Violation|3|||
155628417|NCT00706797|561735896|FG001|Overall Study|Protocol Violation|2|||
155628418|NCT00706797|561735895|FG000|Overall Study|Lost to Follow-up|1|||
155628419|NCT00706797|561735896|FG001|Overall Study|Lost to Follow-up|2|||
155628420|NCT00706797|561735895|FG000|Overall Study|Other|1|||
155281104|NCT04955626|560459869|FG002|Open-Label Period|Physician Decision|0|||
155281105|NCT04955626|560459870|FG003|Open-Label Period|Physician Decision|0|||
155628421|NCT00706797|561735896|FG001|Overall Study|Other|0|||
155628422|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
155628423|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155628424|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155628425|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155281106|NCT04955626|560459871|FG004|Open-Label Period|Physician Decision|0|||
155729890|NCT03910244|562109888|FG000|Overall Study|Withdrawal by Subject|7|||
155729891|NCT03910244|562109889|FG001|Overall Study|Withdrawal by Subject|2|||
155388023|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
155388024|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
155388025|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
155388026|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
155388027|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
155388028|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
155388029|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
155388030|NCT00394953|560855004|FG000|First Treatment Period|Adverse Event|1|||
155388031|NCT00394953|560855005|FG001|First Treatment Period|Adverse Event|2|||
155388032|NCT00394953|560855004|FG000|First Treatment Period|Death|6|||
155388033|NCT00394953|560855005|FG001|First Treatment Period|Death|7|||
155729892|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
155729893|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
155729894|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
155729895|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155729896|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155729897|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
155729898|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
155729899|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
155729900|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
155729901|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
155729902|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
155729903|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
155729904|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
155729905|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
155729906|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
155729907|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155729908|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155729909|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155729910|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
155729911|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155729912|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155729913|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
155729914|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155729915|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155729916|NCT01106690|562109890|FG000|Core Period: Baseline to Week 26|Other|10|||
155729917|NCT01106690|562109891|FG001|Core Period: Baseline to Week 26|Other|2|||
155729918|NCT01106690|562109892|FG002|Core Period: Baseline to Week 26|Other|6|||
155729919|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155729920|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155729921|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155729922|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155729923|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155729924|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155729925|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155729926|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155729927|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155729928|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155729929|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155729930|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
155729931|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155729932|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155729933|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155729934|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Other|8|||
155729935|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Other|3|||
155729936|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Other|4|||
155729937|NCT01106690|562109890|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
155729938|NCT01106690|562109891|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155729939|NCT01106690|562109892|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155388034|NCT00394953|560855004|FG000|First Treatment Period|Lack of Efficacy|1|||
155388035|NCT00394953|560855005|FG001|First Treatment Period|Lack of Efficacy|1|||
155388036|NCT00394953|560855004|FG000|First Treatment Period|Withdrawal by Subject|6|||
155388037|NCT00394953|560855005|FG001|First Treatment Period|Withdrawal by Subject|3|||
155388038|NCT00394953|560855004|FG000|First Treatment Period|Lost to Follow-up|0|||
155388039|NCT00394953|560855005|FG001|First Treatment Period|Lost to Follow-up|1|||
155388040|NCT00394953|560855004|FG000|First Treatment Period|Renal transplant|11|||
155388041|NCT00394953|560855005|FG001|First Treatment Period|Renal transplant|7|||
155388042|NCT00394953|560855004|FG000|First Treatment Period|Not defined|4|||
155388043|NCT00394953|560855005|FG001|First Treatment Period|Not defined|1|||
155388044|NCT00394953|560855004|FG000|Second Treatment Period|Adverse Event|2|||
155388045|NCT00394953|560855005|FG001|Second Treatment Period|Adverse Event|5|||
155388046|NCT00394953|560855004|FG000|Second Treatment Period|Death|8|||
155628426|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155628427|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155628428|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155628429|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
155628430|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628431|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628432|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628433|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628434|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628435|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155628436|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628437|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
155628438|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628439|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628440|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628441|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628442|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155628443|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628444|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628445|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
155628446|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628447|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628448|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628449|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155628450|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628451|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628452|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
155628453|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628454|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628455|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628456|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155628457|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628458|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628459|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
155628460|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628461|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628462|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628463|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155628464|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628465|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628466|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628467|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
155628468|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628469|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628470|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155628471|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628472|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628473|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628474|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
155628475|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628476|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628477|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155628478|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155628479|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155628480|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155388047|NCT00394953|560855005|FG001|Second Treatment Period|Death|4|||
155729940|NCT02346721|562109893|FG000|Overall Study|Withdrew Consent|3|||
155729941|NCT02346721|562109893|FG000|Overall Study|Lack of Efficacy|1|||
155729942|NCT04455815|562109894|FG000|Randomisation Phase|Adverse Event|1|||
155729943|NCT04455815|562109895|FG001|Randomisation Phase|Adverse Event|0|||
155729944|NCT04455815|562109894|FG000|Treatment Phase|Adverse Event|0|||
155729945|NCT04455815|562109895|FG001|Treatment Phase|Adverse Event|1|||
155729946|NCT04455815|562109894|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
155729947|NCT04455815|562109895|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
155729948|NCT04455815|562109894|FG000|Treatment Phase|Withdrawal by Subject|1|||
155729949|NCT04455815|562109895|FG001|Treatment Phase|Withdrawal by Subject|1|||
155729950|NCT02106390|562109896|FG000|Overall Study|Withdrawal by Subject|15|||
155729951|NCT02106390|562109897|FG001|Overall Study|Withdrawal by Subject|16|||
155729952|NCT02106390|562109898|FG002|Overall Study|Withdrawal by Subject|15|||
155729953|NCT02106390|562109896|FG000|Overall Study|Lost to Follow-up|25|||
155729954|NCT02106390|562109897|FG001|Overall Study|Lost to Follow-up|20|||
155729955|NCT02106390|562109898|FG002|Overall Study|Lost to Follow-up|13|||
155729956|NCT02106390|562109896|FG000|Overall Study|Other: Administrative Reason|8|||
155729957|NCT02106390|562109897|FG001|Overall Study|Other: Administrative Reason|5|||
155729958|NCT02106390|562109898|FG002|Overall Study|Other: Administrative Reason|12|||
155729959|NCT02106390|562109896|FG000|Overall Study|Other: Unspecified|1|||
155729960|NCT02106390|562109897|FG001|Overall Study|Other: Unspecified|4|||
155729961|NCT02106390|562109898|FG002|Overall Study|Other: Unspecified|2|||
155729962|NCT02106390|562109896|FG000|Overall Study|Adverse Event|0|||
155729963|NCT02106390|562109897|FG001|Overall Study|Adverse Event|2|||
155729964|NCT02106390|562109898|FG002|Overall Study|Adverse Event|1|||
155729965|NCT02106390|562109896|FG000|Overall Study|Protocol Violation|0|||
155729966|NCT02106390|562109897|FG001|Overall Study|Protocol Violation|1|||
155729967|NCT02106390|562109898|FG002|Overall Study|Protocol Violation|0|||
155729968|NCT03219528|562109899|FG000|Overall Study|Lost to Follow-up|5|||
155729969|NCT03219528|562109900|FG001|Overall Study|Lost to Follow-up|4|||
155729970|NCT03219528|562109899|FG000|Overall Study|Withdrawal by Subject|4|||
155729971|NCT03219528|562109900|FG001|Overall Study|Withdrawal by Subject|4|||
155729972|NCT00790842|562109901|FG000|Dose Level 1|Adverse Event|1|||
155729973|NCT00790842|562109902|FG001|Dose Level 1|Adverse Event|0|||
155729974|NCT00790842|562109903|FG002|Dose Level 1|Adverse Event|0|||
155729975|NCT00790842|562109904|FG003|Dose Level 1|Adverse Event|2|||
155729976|NCT00790842|562109905|FG004|Dose Level 1|Adverse Event|0|||
155729977|NCT00790842|562109906|FG005|Dose Level 1|Adverse Event|0|||
155729978|NCT00790842|562109907|FG006|Dose Level 1|Adverse Event|0|||
155729979|NCT00790842|562109908|FG007|Dose Level 1|Adverse Event|1|||
155729980|NCT00790842|562109909|FG008|Dose Level 1|Adverse Event|0|||
155729981|NCT00790842|562109910|FG009|Dose Level 1|Adverse Event|0|||
155729982|NCT00790842|562109911|FG010|Dose Level 1|Adverse Event|0|||
155729983|NCT00790842|562109901|FG000|Dose Level 1|Physician Decision|1|||
155729984|NCT00790842|562109902|FG001|Dose Level 1|Physician Decision|0|||
155729985|NCT00790842|562109903|FG002|Dose Level 1|Physician Decision|0|||
155729986|NCT00790842|562109904|FG003|Dose Level 1|Physician Decision|0|||
155729987|NCT00790842|562109905|FG004|Dose Level 1|Physician Decision|0|||
155729988|NCT00790842|562109906|FG005|Dose Level 1|Physician Decision|0|||
155729989|NCT00790842|562109907|FG006|Dose Level 1|Physician Decision|0|||
155729990|NCT00790842|562109908|FG007|Dose Level 1|Physician Decision|1|||
155729991|NCT00790842|562109909|FG008|Dose Level 1|Physician Decision|0|||
155729992|NCT00790842|562109910|FG009|Dose Level 1|Physician Decision|0|||
155729993|NCT00790842|562109911|FG010|Dose Level 1|Physician Decision|0|||
155729994|NCT00790842|562109901|FG000|Dose Level 1|Withdrawal by Subject|1|||
155281107|NCT04955626|560459872|FG005|Open-Label Period|Physician Decision|0|||
155281108|NCT04955626|560459873|FG006|Open-Label Period|Physician Decision|0|||
155281109|NCT04955626|560459874|FG007|Open-Label Period|Physician Decision|0|||
155281110|NCT04955626|560459875|FG008|Open-Label Period|Physician Decision|0|||
155281111|NCT04955626|560459876|FG009|Open-Label Period|Physician Decision|0|||
155281112|NCT04955626|560459877|FG010|Open-Label Period|Physician Decision|0|||
155281113|NCT04955626|560459878|FG011|Open-Label Period|Physician Decision|0|||
155281114|NCT04955626|560459879|FG012|Open-Label Period|Physician Decision|0|||
155281115|NCT04955626|560459880|FG013|Open-Label Period|Physician Decision|0|||
155281116|NCT04955626|560459881|FG014|Open-Label Period|Physician Decision|0|||
155729995|NCT00790842|562109902|FG001|Dose Level 1|Withdrawal by Subject|0|||
155729996|NCT00790842|562109903|FG002|Dose Level 1|Withdrawal by Subject|0|||
155729997|NCT00790842|562109904|FG003|Dose Level 1|Withdrawal by Subject|0|||
155729998|NCT00790842|562109905|FG004|Dose Level 1|Withdrawal by Subject|0|||
155729999|NCT00790842|562109906|FG005|Dose Level 1|Withdrawal by Subject|0|||
155730000|NCT00790842|562109907|FG006|Dose Level 1|Withdrawal by Subject|0|||
155730001|NCT00790842|562109908|FG007|Dose Level 1|Withdrawal by Subject|0|||
155730002|NCT00790842|562109909|FG008|Dose Level 1|Withdrawal by Subject|0|||
155730003|NCT00790842|562109910|FG009|Dose Level 1|Withdrawal by Subject|0|||
155730004|NCT00790842|562109911|FG010|Dose Level 1|Withdrawal by Subject|0|||
155730005|NCT00790842|562109901|FG000|Dose Level 2|Death|0|||
155730006|NCT00790842|562109902|FG001|Dose Level 2|Death|1|||
155730007|NCT00790842|562109903|FG002|Dose Level 2|Death|0|||
155730008|NCT00790842|562109904|FG003|Dose Level 2|Death|0|||
155730009|NCT00790842|562109905|FG004|Dose Level 2|Death|1|||
155730010|NCT00790842|562109906|FG005|Dose Level 2|Death|0|||
155730011|NCT00790842|562109907|FG006|Dose Level 2|Death|0|||
155730012|NCT00790842|562109908|FG007|Dose Level 2|Death|0|||
155730013|NCT00790842|562109909|FG008|Dose Level 2|Death|0|||
155730014|NCT00790842|562109910|FG009|Dose Level 2|Death|0|||
155730015|NCT00790842|562109911|FG010|Dose Level 2|Death|0|||
155730016|NCT00790842|562109901|FG000|Dose Level 2|Physician Decision|0|||
155730017|NCT00790842|562109902|FG001|Dose Level 2|Physician Decision|1|||
155730018|NCT00790842|562109903|FG002|Dose Level 2|Physician Decision|0|||
155730019|NCT00790842|562109904|FG003|Dose Level 2|Physician Decision|0|||
155730020|NCT00790842|562109905|FG004|Dose Level 2|Physician Decision|0|||
155730021|NCT00790842|562109906|FG005|Dose Level 2|Physician Decision|0|||
155730022|NCT00790842|562109907|FG006|Dose Level 2|Physician Decision|0|||
155730023|NCT00790842|562109908|FG007|Dose Level 2|Physician Decision|0|||
155730024|NCT00790842|562109909|FG008|Dose Level 2|Physician Decision|0|||
155730025|NCT00790842|562109910|FG009|Dose Level 2|Physician Decision|0|||
155730026|NCT00790842|562109911|FG010|Dose Level 2|Physician Decision|0|||
155730027|NCT00790842|562109901|FG000|Dose Level 2|Withdrawal by Subject|0|||
155730028|NCT00790842|562109902|FG001|Dose Level 2|Withdrawal by Subject|1|||
155730029|NCT00790842|562109903|FG002|Dose Level 2|Withdrawal by Subject|0|||
155730030|NCT00790842|562109904|FG003|Dose Level 2|Withdrawal by Subject|0|||
155730031|NCT00790842|562109905|FG004|Dose Level 2|Withdrawal by Subject|0|||
155730032|NCT00790842|562109906|FG005|Dose Level 2|Withdrawal by Subject|0|||
155730033|NCT00790842|562109907|FG006|Dose Level 2|Withdrawal by Subject|0|||
155730034|NCT00790842|562109908|FG007|Dose Level 2|Withdrawal by Subject|0|||
155730035|NCT00790842|562109909|FG008|Dose Level 2|Withdrawal by Subject|0|||
155730036|NCT00790842|562109910|FG009|Dose Level 2|Withdrawal by Subject|0|||
155730037|NCT00790842|562109911|FG010|Dose Level 2|Withdrawal by Subject|0|||
155730038|NCT00790842|562109901|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730039|NCT00790842|562109902|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730040|NCT00790842|562109903|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730041|NCT00790842|562109904|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730042|NCT00790842|562109905|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730043|NCT00790842|562109906|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730044|NCT00790842|562109907|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155281117|NCT04955626|560459882|FG015|Open-Label Period|Physician Decision|0|||
155281118|NCT04955626|560459883|FG016|Open-Label Period|Physician Decision|0|||
155281119|NCT04955626|560459884|FG017|Open-Label Period|Physician Decision|0|||
155281120|NCT04955626|560459885|FG018|Open-Label Period|Physician Decision|0|||
155281121|NCT04955626|560459886|FG019|Open-Label Period|Physician Decision|0|||
155281122|NCT04955626|560459887|FG020|Open-Label Period|Physician Decision|0|||
155281123|NCT04955626|560459888|FG021|Open-Label Period|Physician Decision|0|||
155281124|NCT04955626|560459889|FG022|Open-Label Period|Physician Decision|0|||
155281125|NCT04955626|560459890|FG023|Open-Label Period|Physician Decision|0|||
155281126|NCT04955626|560459891|FG024|Open-Label Period|Physician Decision|0|||
155281127|NCT04955626|560459892|FG025|Open-Label Period|Physician Decision|0|||
155281128|NCT04955626|560459893|FG026|Open-Label Period|Physician Decision|0|||
155281129|NCT04955626|560459894|FG027|Open-Label Period|Physician Decision|0|||
155281130|NCT04955626|560459895|FG028|Open-Label Period|Physician Decision|0|||
155281131|NCT04955626|560459896|FG029|Open-Label Period|Physician Decision|0|||
155281132|NCT04955626|560459897|FG030|Open-Label Period|Physician Decision|0|||
155281133|NCT04955626|560459898|FG031|Open-Label Period|Physician Decision|0|||
155281134|NCT04955626|560459899|FG032|Open-Label Period|Physician Decision|0|||
155281135|NCT04955626|560459900|FG033|Open-Label Period|Physician Decision|0|||
155281136|NCT04955626|560459901|FG034|Open-Label Period|Physician Decision|0|||
155281137|NCT04955626|560459902|FG035|Open-Label Period|Physician Decision|0|||
155281138|NCT04955626|560459867|FG000|Open-Label Period|Withdrawal by Subject|135|||
155281139|NCT04955626|560459868|FG001|Open-Label Period|Withdrawal by Subject|25|||
155281140|NCT04955626|560459869|FG002|Open-Label Period|Withdrawal by Subject|0|||
155281141|NCT04955626|560459870|FG003|Open-Label Period|Withdrawal by Subject|0|||
155281142|NCT04955626|560459871|FG004|Open-Label Period|Withdrawal by Subject|0|||
155281143|NCT04955626|560459872|FG005|Open-Label Period|Withdrawal by Subject|0|||
155281144|NCT04955626|560459873|FG006|Open-Label Period|Withdrawal by Subject|0|||
155281145|NCT04955626|560459874|FG007|Open-Label Period|Withdrawal by Subject|0|||
155281146|NCT04955626|560459875|FG008|Open-Label Period|Withdrawal by Subject|0|||
155281147|NCT04955626|560459876|FG009|Open-Label Period|Withdrawal by Subject|0|||
155281148|NCT04955626|560459877|FG010|Open-Label Period|Withdrawal by Subject|0|||
155388048|NCT00394953|560855004|FG000|Second Treatment Period|Lack of Efficacy|9|||
155730045|NCT00790842|562109908|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155388049|NCT00394953|560855005|FG001|Second Treatment Period|Lack of Efficacy|47|||
155730046|NCT00790842|562109909|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
155730047|NCT00790842|562109910|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730048|NCT00790842|562109911|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155730049|NCT00790842|562109901|FG000|Dose Level 3|Adverse Event|0|||
155628481|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155628482|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
155628483|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155628484|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155628485|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628486|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628487|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628488|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628489|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
155281149|NCT04955626|560459878|FG011|Open-Label Period|Withdrawal by Subject|0|||
155281150|NCT04955626|560459879|FG012|Open-Label Period|Withdrawal by Subject|0|||
155281151|NCT04955626|560459880|FG013|Open-Label Period|Withdrawal by Subject|0|||
155281152|NCT04955626|560459881|FG014|Open-Label Period|Withdrawal by Subject|0|||
155281153|NCT04955626|560459882|FG015|Open-Label Period|Withdrawal by Subject|0|||
155281154|NCT04955626|560459883|FG016|Open-Label Period|Withdrawal by Subject|0|||
155281155|NCT04955626|560459884|FG017|Open-Label Period|Withdrawal by Subject|0|||
155281156|NCT04955626|560459885|FG018|Open-Label Period|Withdrawal by Subject|0|||
155281157|NCT04955626|560459886|FG019|Open-Label Period|Withdrawal by Subject|0|||
155281158|NCT04955626|560459887|FG020|Open-Label Period|Withdrawal by Subject|0|||
155281159|NCT04955626|560459888|FG021|Open-Label Period|Withdrawal by Subject|0|||
155281160|NCT04955626|560459889|FG022|Open-Label Period|Withdrawal by Subject|0|||
155281161|NCT04955626|560459890|FG023|Open-Label Period|Withdrawal by Subject|0|||
155281162|NCT04955626|560459891|FG024|Open-Label Period|Withdrawal by Subject|0|||
155281163|NCT04955626|560459892|FG025|Open-Label Period|Withdrawal by Subject|0|||
155281164|NCT04955626|560459893|FG026|Open-Label Period|Withdrawal by Subject|0|||
155281165|NCT04955626|560459894|FG027|Open-Label Period|Withdrawal by Subject|0|||
155281166|NCT04955626|560459895|FG028|Open-Label Period|Withdrawal by Subject|0|||
155281167|NCT04955626|560459896|FG029|Open-Label Period|Withdrawal by Subject|0|||
155281168|NCT04955626|560459897|FG030|Open-Label Period|Withdrawal by Subject|0|||
155281169|NCT04955626|560459898|FG031|Open-Label Period|Withdrawal by Subject|0|||
155281170|NCT04955626|560459899|FG032|Open-Label Period|Withdrawal by Subject|0|||
155281171|NCT04955626|560459900|FG033|Open-Label Period|Withdrawal by Subject|0|||
155281172|NCT04955626|560459901|FG034|Open-Label Period|Withdrawal by Subject|0|||
155281173|NCT04955626|560459902|FG035|Open-Label Period|Withdrawal by Subject|0|||
155281174|NCT04955626|560459867|FG000|Open-Label Period|Refused further study procedures|1|||
155281175|NCT04955626|560459868|FG001|Open-Label Period|Refused further study procedures|0|||
155281176|NCT04955626|560459869|FG002|Open-Label Period|Refused further study procedures|0|||
155281177|NCT04955626|560459870|FG003|Open-Label Period|Refused further study procedures|0|||
155281178|NCT04955626|560459871|FG004|Open-Label Period|Refused further study procedures|0|||
155281179|NCT04955626|560459872|FG005|Open-Label Period|Refused further study procedures|0|||
155281180|NCT04955626|560459873|FG006|Open-Label Period|Refused further study procedures|0|||
155281181|NCT04955626|560459874|FG007|Open-Label Period|Refused further study procedures|0|||
155281182|NCT04955626|560459875|FG008|Open-Label Period|Refused further study procedures|0|||
155281183|NCT04955626|560459876|FG009|Open-Label Period|Refused further study procedures|0|||
155281184|NCT04955626|560459877|FG010|Open-Label Period|Refused further study procedures|0|||
155281185|NCT04955626|560459878|FG011|Open-Label Period|Refused further study procedures|0|||
155281186|NCT04955626|560459879|FG012|Open-Label Period|Refused further study procedures|0|||
155281187|NCT04955626|560459880|FG013|Open-Label Period|Refused further study procedures|0|||
155281188|NCT04955626|560459881|FG014|Open-Label Period|Refused further study procedures|0|||
155281189|NCT04955626|560459882|FG015|Open-Label Period|Refused further study procedures|0|||
155281190|NCT04955626|560459883|FG016|Open-Label Period|Refused further study procedures|0|||
155281191|NCT04955626|560459884|FG017|Open-Label Period|Refused further study procedures|0|||
155281192|NCT04955626|560459885|FG018|Open-Label Period|Refused further study procedures|0|||
155281193|NCT04955626|560459886|FG019|Open-Label Period|Refused further study procedures|0|||
155281194|NCT04955626|560459887|FG020|Open-Label Period|Refused further study procedures|0|||
155281195|NCT04955626|560459888|FG021|Open-Label Period|Refused further study procedures|0|||
155281196|NCT04955626|560459889|FG022|Open-Label Period|Refused further study procedures|0|||
155281197|NCT04955626|560459890|FG023|Open-Label Period|Refused further study procedures|0|||
155281198|NCT04955626|560459891|FG024|Open-Label Period|Refused further study procedures|0|||
155281199|NCT04955626|560459892|FG025|Open-Label Period|Refused further study procedures|0|||
155281200|NCT04955626|560459893|FG026|Open-Label Period|Refused further study procedures|0|||
155281201|NCT04955626|560459894|FG027|Open-Label Period|Refused further study procedures|0|||
155281202|NCT04955626|560459895|FG028|Open-Label Period|Refused further study procedures|0|||
155281203|NCT04955626|560459896|FG029|Open-Label Period|Refused further study procedures|0|||
155281204|NCT04955626|560459897|FG030|Open-Label Period|Refused further study procedures|0|||
155281205|NCT04955626|560459898|FG031|Open-Label Period|Refused further study procedures|0|||
155281206|NCT04955626|560459899|FG032|Open-Label Period|Refused further study procedures|0|||
155281207|NCT04955626|560459900|FG033|Open-Label Period|Refused further study procedures|0|||
155730050|NCT00790842|562109902|FG001|Dose Level 3|Adverse Event|0|||
155730051|NCT00790842|562109903|FG002|Dose Level 3|Adverse Event|1|||
155730052|NCT00790842|562109904|FG003|Dose Level 3|Adverse Event|0|||
155730053|NCT00790842|562109905|FG004|Dose Level 3|Adverse Event|0|||
155730054|NCT00790842|562109906|FG005|Dose Level 3|Adverse Event|0|||
155730055|NCT00790842|562109907|FG006|Dose Level 3|Adverse Event|0|||
155730056|NCT00790842|562109908|FG007|Dose Level 3|Adverse Event|0|||
155730057|NCT00790842|562109909|FG008|Dose Level 3|Adverse Event|0|||
155730058|NCT00790842|562109910|FG009|Dose Level 3|Adverse Event|0|||
155730059|NCT00790842|562109911|FG010|Dose Level 3|Adverse Event|0|||
155730060|NCT00790842|562109901|FG000|Dose Level 3|Withdrawal by Subject|0|||
155730061|NCT00790842|562109902|FG001|Dose Level 3|Withdrawal by Subject|0|||
155730062|NCT00790842|562109903|FG002|Dose Level 3|Withdrawal by Subject|3|||
155730063|NCT00790842|562109904|FG003|Dose Level 3|Withdrawal by Subject|0|||
155730064|NCT00790842|562109905|FG004|Dose Level 3|Withdrawal by Subject|0|||
155730065|NCT00790842|562109906|FG005|Dose Level 3|Withdrawal by Subject|0|||
155730066|NCT00790842|562109907|FG006|Dose Level 3|Withdrawal by Subject|0|||
155730067|NCT00790842|562109908|FG007|Dose Level 3|Withdrawal by Subject|0|||
155730068|NCT00790842|562109909|FG008|Dose Level 3|Withdrawal by Subject|0|||
155730069|NCT00790842|562109910|FG009|Dose Level 3|Withdrawal by Subject|2|||
155730070|NCT00790842|562109911|FG010|Dose Level 3|Withdrawal by Subject|0|||
155730071|NCT00790842|562109901|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730072|NCT00790842|562109902|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730073|NCT00790842|562109903|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730074|NCT00790842|562109904|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730075|NCT00790842|562109905|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730076|NCT00790842|562109906|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
155730077|NCT00790842|562109907|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730078|NCT00790842|562109908|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730079|NCT00790842|562109909|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730080|NCT00790842|562109910|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730081|NCT00790842|562109911|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155730082|NCT00790842|562109901|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730083|NCT00790842|562109902|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730084|NCT00790842|562109903|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
155730085|NCT00790842|562109904|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155281208|NCT04955626|560459901|FG034|Open-Label Period|Refused further study procedures|0|||
155281209|NCT04955626|560459902|FG035|Open-Label Period|Refused further study procedures|0|||
155281210|NCT04955626|560459867|FG000|Open-Label Period|Adverse Event|1|||
155281211|NCT04955626|560459868|FG001|Open-Label Period|Adverse Event|0|||
155281212|NCT04955626|560459869|FG002|Open-Label Period|Adverse Event|0|||
155281213|NCT04955626|560459870|FG003|Open-Label Period|Adverse Event|0|||
155281214|NCT04955626|560459871|FG004|Open-Label Period|Adverse Event|0|||
155281215|NCT04955626|560459872|FG005|Open-Label Period|Adverse Event|0|||
155281216|NCT04955626|560459873|FG006|Open-Label Period|Adverse Event|0|||
155281217|NCT04955626|560459874|FG007|Open-Label Period|Adverse Event|0|||
155281218|NCT04955626|560459875|FG008|Open-Label Period|Adverse Event|0|||
155281219|NCT04955626|560459876|FG009|Open-Label Period|Adverse Event|0|||
155281220|NCT04955626|560459877|FG010|Open-Label Period|Adverse Event|0|||
155281221|NCT04955626|560459878|FG011|Open-Label Period|Adverse Event|0|||
155281222|NCT04955626|560459879|FG012|Open-Label Period|Adverse Event|0|||
155281223|NCT04955626|560459880|FG013|Open-Label Period|Adverse Event|0|||
155281224|NCT04955626|560459881|FG014|Open-Label Period|Adverse Event|0|||
155281225|NCT04955626|560459882|FG015|Open-Label Period|Adverse Event|0|||
155281226|NCT04955626|560459883|FG016|Open-Label Period|Adverse Event|0|||
155281227|NCT04955626|560459884|FG017|Open-Label Period|Adverse Event|0|||
155281228|NCT04955626|560459885|FG018|Open-Label Period|Adverse Event|0|||
155281229|NCT04955626|560459886|FG019|Open-Label Period|Adverse Event|0|||
155281230|NCT04955626|560459887|FG020|Open-Label Period|Adverse Event|0|||
155281231|NCT04955626|560459888|FG021|Open-Label Period|Adverse Event|0|||
155281232|NCT04955626|560459889|FG022|Open-Label Period|Adverse Event|0|||
155281233|NCT04955626|560459890|FG023|Open-Label Period|Adverse Event|0|||
155388050|NCT00394953|560855004|FG000|Second Treatment Period|Withdrawal by Subject|3|||
155388051|NCT00394953|560855005|FG001|Second Treatment Period|Withdrawal by Subject|3|||
155388052|NCT00394953|560855004|FG000|Second Treatment Period|Lost to Follow-up|0|||
155730086|NCT00790842|562109905|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730087|NCT00790842|562109906|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730088|NCT00790842|562109907|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730089|NCT00790842|562109908|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730090|NCT00790842|562109909|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155281234|NCT04955626|560459891|FG024|Open-Label Period|Adverse Event|0|||
155281235|NCT04955626|560459892|FG025|Open-Label Period|Adverse Event|0|||
155281236|NCT04955626|560459893|FG026|Open-Label Period|Adverse Event|0|||
155281237|NCT04955626|560459894|FG027|Open-Label Period|Adverse Event|0|||
155281238|NCT04955626|560459895|FG028|Open-Label Period|Adverse Event|0|||
155628490|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628491|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155628492|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628493|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628494|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628495|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628496|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
155628497|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628498|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155628499|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628500|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628501|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628502|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628503|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
155628504|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628505|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155628506|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628507|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628508|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628509|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628510|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628511|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
155628512|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155628513|NCT01791595|561735900|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628514|NCT01791595|561735901|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628515|NCT01791595|561735902|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628516|NCT01791595|561735903|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628517|NCT01791595|561735904|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628518|NCT01791595|561735905|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
155628519|NCT01791595|561735906|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155628520|NCT01791595|561735900|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628521|NCT01791595|561735901|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628522|NCT01791595|561735902|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628523|NCT01791595|561735903|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628524|NCT01791595|561735904|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628525|NCT01791595|561735905|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155628526|NCT01791595|561735906|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
155628527|NCT01791595|561735900|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628528|NCT01791595|561735901|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628529|NCT01791595|561735902|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628530|NCT01791595|561735903|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628531|NCT01791595|561735904|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628532|NCT01791595|561735905|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155628533|NCT01791595|561735906|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
155628534|NCT01791595|561735900|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628535|NCT01791595|561735901|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628536|NCT01791595|561735902|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628537|NCT01791595|561735903|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628538|NCT01791595|561735904|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628539|NCT01791595|561735905|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155628540|NCT01791595|561735906|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
155628541|NCT01791595|561735900|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628542|NCT01791595|561735901|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628543|NCT01791595|561735902|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628544|NCT01791595|561735903|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628545|NCT01791595|561735904|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628546|NCT01791595|561735905|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155628547|NCT01791595|561735906|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
155628548|NCT01776554|561735907|FG000|Overall Study|Adverse Event|1|||
155628549|NCT01776554|561735908|FG001|Overall Study|Adverse Event|0|||
155628550|NCT01776554|561735907|FG000|Overall Study|Withdrawal by Subject|3|||
155628551|NCT01776554|561735908|FG001|Overall Study|Withdrawal by Subject|8|||
155628552|NCT01776554|561735907|FG000|Overall Study|Lost to Follow-up|6|||
155628553|NCT01776554|561735908|FG001|Overall Study|Lost to Follow-up|9|||
155628554|NCT01776554|561735907|FG000|Overall Study|Administrative Reason|2|||
155628555|NCT01776554|561735908|FG001|Overall Study|Administrative Reason|5|||
155628556|NCT01776554|561735907|FG000|Overall Study|Protocol Violation|1|||
155628557|NCT01776554|561735908|FG001|Overall Study|Protocol Violation|0|||
155628558|NCT01776554|561735907|FG000|Overall Study|Unclassified|4|||
155628559|NCT01776554|561735908|FG001|Overall Study|Unclassified|1|||
155628560|NCT01041859|561735909|FG000|Open-Label Titration|Adverse Event|69|||
155628561|NCT01041859|561735910|FG001|Open-Label Titration|Adverse Event|0|||
155628562|NCT01041859|561735911|FG002|Open-Label Titration|Adverse Event|0|||
155628563|NCT01041859|561735909|FG000|Open-Label Titration|Lack of Efficacy|3|||
155628564|NCT01041859|561735910|FG001|Open-Label Titration|Lack of Efficacy|0|||
155628565|NCT01041859|561735911|FG002|Open-Label Titration|Lack of Efficacy|0|||
155628566|NCT01041859|561735909|FG000|Open-Label Titration|Lost to Follow-up|1|||
155628567|NCT01041859|561735910|FG001|Open-Label Titration|Lost to Follow-up|0|||
155628568|NCT01041859|561735911|FG002|Open-Label Titration|Lost to Follow-up|0|||
155628569|NCT01041859|561735909|FG000|Open-Label Titration|Physician Decision|1|||
155628570|NCT01041859|561735910|FG001|Open-Label Titration|Physician Decision|0|||
155628571|NCT01041859|561735911|FG002|Open-Label Titration|Physician Decision|0|||
155628572|NCT01041859|561735909|FG000|Open-Label Titration|Protocol Violation|1|||
155628573|NCT01041859|561735910|FG001|Open-Label Titration|Protocol Violation|0|||
155628574|NCT01041859|561735911|FG002|Open-Label Titration|Protocol Violation|0|||
155628575|NCT01041859|561735909|FG000|Open-Label Titration|Other|7|||
155628576|NCT01041859|561735910|FG001|Open-Label Titration|Other|0|||
155628577|NCT01041859|561735911|FG002|Open-Label Titration|Other|0|||
155628578|NCT01041859|561735909|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
155628579|NCT01041859|561735910|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
155628580|NCT01041859|561735911|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
155628581|NCT01041859|561735909|FG000|Open-Label Titration|Withdrawal by Subject|11|||
155628582|NCT01041859|561735910|FG001|Open-Label Titration|Withdrawal by Subject|0|||
155628583|NCT01041859|561735911|FG002|Open-Label Titration|Withdrawal by Subject|0|||
155628584|NCT01041859|561735909|FG000|Double-Blind Maintenance|Adverse Event|0|||
155628585|NCT01041859|561735910|FG001|Double-Blind Maintenance|Adverse Event|23|||
155628586|NCT01041859|561735911|FG002|Double-Blind Maintenance|Adverse Event|13|||
155628587|NCT01041859|561735909|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
155628588|NCT01041859|561735910|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
155628589|NCT01041859|561735911|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
155628590|NCT01041859|561735909|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
155628591|NCT01041859|561735910|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
155628592|NCT01041859|561735911|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
155628593|NCT01041859|561735909|FG000|Double-Blind Maintenance|Physician Decision|0|||
155628594|NCT01041859|561735910|FG001|Double-Blind Maintenance|Physician Decision|2|||
155628595|NCT01041859|561735911|FG002|Double-Blind Maintenance|Physician Decision|1|||
155628596|NCT01041859|561735909|FG000|Double-Blind Maintenance|Protocol Violation|0|||
155628597|NCT01041859|561735910|FG001|Double-Blind Maintenance|Protocol Violation|1|||
155628598|NCT01041859|561735911|FG002|Double-Blind Maintenance|Protocol Violation|3|||
155628599|NCT01041859|561735909|FG000|Double-Blind Maintenance|Other|0|||
155628600|NCT01041859|561735910|FG001|Double-Blind Maintenance|Other|6|||
155628601|NCT01041859|561735911|FG002|Double-Blind Maintenance|Other|2|||
155628602|NCT01041859|561735909|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
155628603|NCT01041859|561735910|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
155628604|NCT01041859|561735911|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
155628605|NCT01041859|561735909|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
155628606|NCT01041859|561735910|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
155628607|NCT01041859|561735911|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
155628608|NCT03329885|561735912|FG000|Overall Study|Sponsor discontinued the study early|0|||
155628609|NCT03329885|561735913|FG001|Overall Study|Sponsor discontinued the study early|0|||
155628610|NCT03329885|561735914|FG002|Overall Study|Sponsor discontinued the study early|0|||
155628611|NCT03329885|561735915|FG003|Overall Study|Sponsor discontinued the study early|0|||
155628612|NCT03329885|561735916|FG004|Overall Study|Sponsor discontinued the study early|0|||
155628613|NCT03329885|561735917|FG005|Overall Study|Sponsor discontinued the study early|0|||
155628614|NCT03329885|561735918|FG006|Overall Study|Sponsor discontinued the study early|1|||
155628615|NCT03329885|561735919|FG007|Overall Study|Sponsor discontinued the study early|1|||
155628616|NCT03329885|561735920|FG008|Overall Study|Sponsor discontinued the study early|0|||
155628617|NCT01991795|561735921|FG000|Overall Study|Lost to Follow-up|6|||
155628618|NCT01991795|561735922|FG001|Overall Study|Lost to Follow-up|4|||
155628619|NCT01991795|561735921|FG000|Overall Study|Withdrawal by Subject|117|||
155628620|NCT01991795|561735922|FG001|Overall Study|Withdrawal by Subject|94|||
155628621|NCT01991795|561735921|FG000|Overall Study|Site prematurely closed by sponsor|26|||
155281239|NCT04955626|560459896|FG029|Open-Label Period|Adverse Event|0|||
155281240|NCT04955626|560459897|FG030|Open-Label Period|Adverse Event|0|||
155281241|NCT04955626|560459898|FG031|Open-Label Period|Adverse Event|0|||
155281242|NCT04955626|560459899|FG032|Open-Label Period|Adverse Event|0|||
155281243|NCT04955626|560459900|FG033|Open-Label Period|Adverse Event|0|||
155281244|NCT04955626|560459901|FG034|Open-Label Period|Adverse Event|0|||
155281245|NCT04955626|560459902|FG035|Open-Label Period|Adverse Event|0|||
155730091|NCT00790842|562109910|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730092|NCT00790842|562109911|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155730093|NCT00790842|562109901|FG000|Dose Level 4|Adverse Event|0|||
155730094|NCT00790842|562109902|FG001|Dose Level 4|Adverse Event|0|||
155730095|NCT00790842|562109903|FG002|Dose Level 4|Adverse Event|0|||
155730096|NCT00790842|562109904|FG003|Dose Level 4|Adverse Event|0|||
155730097|NCT00790842|562109905|FG004|Dose Level 4|Adverse Event|0|||
155730098|NCT00790842|562109906|FG005|Dose Level 4|Adverse Event|0|||
155730099|NCT00790842|562109907|FG006|Dose Level 4|Adverse Event|1|||
155730100|NCT00790842|562109908|FG007|Dose Level 4|Adverse Event|0|||
155730101|NCT00790842|562109909|FG008|Dose Level 4|Adverse Event|0|||
155730102|NCT00790842|562109910|FG009|Dose Level 4|Adverse Event|0|||
155730103|NCT00790842|562109911|FG010|Dose Level 4|Adverse Event|0|||
155730104|NCT00790842|562109901|FG000|Dose Level 4|Physician Decision|0|||
155730105|NCT00790842|562109902|FG001|Dose Level 4|Physician Decision|0|||
155730106|NCT00790842|562109903|FG002|Dose Level 4|Physician Decision|0|||
155730107|NCT00790842|562109904|FG003|Dose Level 4|Physician Decision|0|||
155388053|NCT00394953|560855005|FG001|Second Treatment Period|Lost to Follow-up|1|||
155388054|NCT00394953|560855004|FG000|Second Treatment Period|Renal transplant|4|||
155388055|NCT00394953|560855005|FG001|Second Treatment Period|Renal transplant|6|||
155388056|NCT00394953|560855004|FG000|Second Treatment Period|Not defined|3|||
155388057|NCT00394953|560855005|FG001|Second Treatment Period|Not defined|8|||
155388058|NCT03021954|560855013|FG000|Overall Study|Lost to Follow-up|10|||
155388059|NCT03021954|560855014|FG001|Overall Study|Lost to Follow-up|43|||
155388060|NCT03021954|560855013|FG000|Overall Study|Subjects had avulsion trauma|4|||
155388061|NCT03021954|560855014|FG001|Overall Study|Subjects had avulsion trauma|1|||
155388062|NCT02196714|560855017|FG000|Overall Study|Protocol Violation|0|||
155388063|NCT02196714|560855018|FG001|Overall Study|Protocol Violation|0|||
155388064|NCT02196714|560855019|FG002|Overall Study|Protocol Violation|1|||
155388065|NCT02196714|560855020|FG003|Overall Study|Protocol Violation|0|||
155388066|NCT01592864|560855022|FG000|Overall Study|Withdrawal by Subject|0|||
155388067|NCT01592864|560855023|FG001|Overall Study|Withdrawal by Subject|1|||
155388068|NCT03353350|560855028|FG000|30-week Core Treatment Period|Protocol Violation|1|||
155388069|NCT03353350|560855029|FG001|30-week Core Treatment Period|Protocol Violation|1|||
155388070|NCT03353350|560855030|FG002|30-week Core Treatment Period|Protocol Violation|1|||
155388071|NCT03353350|560855031|FG003|30-week Core Treatment Period|Protocol Violation|0|||
155388072|NCT03353350|560855028|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388073|NCT03353350|560855029|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388074|NCT03353350|560855030|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388075|NCT03353350|560855031|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
155388076|NCT03353350|560855028|FG000|30-week Core Treatment Period|Adverse Event|0|||
155388077|NCT03353350|560855029|FG001|30-week Core Treatment Period|Adverse Event|4|||
155730108|NCT00790842|562109905|FG004|Dose Level 4|Physician Decision|0|||
155730109|NCT00790842|562109906|FG005|Dose Level 4|Physician Decision|0|||
155730110|NCT00790842|562109907|FG006|Dose Level 4|Physician Decision|1|||
155730111|NCT00790842|562109908|FG007|Dose Level 4|Physician Decision|0|||
155730112|NCT00790842|562109909|FG008|Dose Level 4|Physician Decision|0|||
155730113|NCT00790842|562109910|FG009|Dose Level 4|Physician Decision|0|||
155730114|NCT00790842|562109911|FG010|Dose Level 4|Physician Decision|1|||
155281246|NCT04955626|560459867|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
155281247|NCT04955626|560459868|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
155281248|NCT04955626|560459869|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
155281249|NCT04955626|560459870|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
155281250|NCT04955626|560459871|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
155281251|NCT04955626|560459872|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
155281252|NCT04955626|560459873|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
155281253|NCT04955626|560459874|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
155281254|NCT04955626|560459875|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
155281255|NCT04955626|560459876|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
155281256|NCT04955626|560459877|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
155281257|NCT04955626|560459878|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
155281258|NCT04955626|560459879|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
155281259|NCT04955626|560459880|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
155281260|NCT04955626|560459881|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
155281261|NCT04955626|560459882|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
155281262|NCT04955626|560459883|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
155281263|NCT04955626|560459884|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
155281264|NCT04955626|560459885|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
155281265|NCT04955626|560459886|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
155281266|NCT04955626|560459887|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
155281267|NCT04955626|560459888|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
155281268|NCT04955626|560459889|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
155730115|NCT00790842|562109901|FG000|Dose Level 4|Withdrawal by Subject|0|||
155730116|NCT00790842|562109902|FG001|Dose Level 4|Withdrawal by Subject|0|||
155628622|NCT01991795|561735922|FG001|Overall Study|Site prematurely closed by sponsor|25|||
155628623|NCT02027025|561735923|FG000|Overall Study|Adverse Event|0|||
155628624|NCT02027025|561735924|FG001|Overall Study|Adverse Event|1|||
155628625|NCT02027025|561735925|FG002|Overall Study|Adverse Event|1|||
155628626|NCT02027025|561735923|FG000|Overall Study|Protocol Violation|1|||
155628627|NCT02027025|561735924|FG001|Overall Study|Protocol Violation|0|||
155628628|NCT02027025|561735925|FG002|Overall Study|Protocol Violation|0|||
155628629|NCT02027025|561735923|FG000|Overall Study|Lost to Follow-up|0|||
155628630|NCT02027025|561735924|FG001|Overall Study|Lost to Follow-up|2|||
155628631|NCT02027025|561735925|FG002|Overall Study|Lost to Follow-up|0|||
155628632|NCT02027025|561735923|FG000|Overall Study|Withdrawal by Subject|0|||
155628633|NCT02027025|561735924|FG001|Overall Study|Withdrawal by Subject|1|||
155628634|NCT02027025|561735925|FG002|Overall Study|Withdrawal by Subject|0|||
155628635|NCT02027025|561735923|FG000|Overall Study|Sponsor's decision|0|||
155628636|NCT02027025|561735924|FG001|Overall Study|Sponsor's decision|1|||
155628637|NCT02027025|561735925|FG002|Overall Study|Sponsor's decision|0|||
155628638|NCT03883386|561735927|FG000|First Assignment|Lost to Follow-up|1|||
155628639|NCT03883386|561735928|FG001|First Assignment|Lost to Follow-up|0|||
155628640|NCT03883386|561735927|FG000|First Assignment|Withdrawal by Subject|1|||
155628641|NCT03883386|561735928|FG001|First Assignment|Withdrawal by Subject|1|||
155628642|NCT01326871|561735929|FG000|Overall Study|Major surgery|0|||
155628643|NCT01326871|561735930|FG001|Overall Study|Major surgery|1|||
155628644|NCT01326871|561735931|FG002|Overall Study|Major surgery|0|||
155628645|NCT01326871|561735929|FG000|Overall Study|SAE and death|0|||
155628646|NCT01326871|561735930|FG001|Overall Study|SAE and death|2|||
155628647|NCT01326871|561735931|FG002|Overall Study|SAE and death|0|||
155628648|NCT01326871|561735929|FG000|Overall Study|Physician decision and decreased performance status|0|||
155628649|NCT01326871|561735930|FG001|Overall Study|Physician decision and decreased performance status|1|||
155628650|NCT01326871|561735931|FG002|Overall Study|Physician decision and decreased performance status|0|||
155628651|NCT01326871|561735929|FG000|Overall Study|Disease progression|0|||
155628652|NCT01326871|561735930|FG001|Overall Study|Disease progression|11|||
155628653|NCT01326871|561735931|FG002|Overall Study|Disease progression|5|||
155628654|NCT01326871|561735929|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
155628655|NCT01326871|561735930|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
155628656|NCT01326871|561735931|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
155628657|NCT01326871|561735929|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
155628658|NCT01326871|561735930|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
155628659|NCT01326871|561735931|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
155628660|NCT01326871|561735929|FG000|Overall Study|Withdrawal by Subject|0|||
155628661|NCT01326871|561735930|FG001|Overall Study|Withdrawal by Subject|1|||
155628662|NCT01326871|561735931|FG002|Overall Study|Withdrawal by Subject|0|||
155628663|NCT01326871|561735929|FG000|Overall Study|DLT|0|||
155628664|NCT01326871|561735930|FG001|Overall Study|DLT|2|||
155628665|NCT01326871|561735931|FG002|Overall Study|DLT|0|||
155628666|NCT01326871|561735929|FG000|Overall Study|SAE, disease progression and subject decision|0|||
155628667|NCT01326871|561735930|FG001|Overall Study|SAE, disease progression and subject decision|1|||
155628668|NCT01326871|561735931|FG002|Overall Study|SAE, disease progression and subject decision|0|||
155628669|NCT01326871|561735929|FG000|Overall Study|Death|0|||
155628670|NCT01326871|561735930|FG001|Overall Study|Death|1|||
155628671|NCT01326871|561735931|FG002|Overall Study|Death|0|||
155628672|NCT01326871|561735929|FG000|Overall Study|Other|0|||
155628673|NCT01326871|561735930|FG001|Overall Study|Other|3|||
155628674|NCT01326871|561735931|FG002|Overall Study|Other|0|||
155628675|NCT01326871|561735929|FG000|Overall Study|SAE and disease progression|0|||
155628676|NCT01326871|561735930|FG001|Overall Study|SAE and disease progression|0|||
155628677|NCT01326871|561735931|FG002|Overall Study|SAE and disease progression|1|||
155628678|NCT01326871|561735929|FG000|Overall Study|SAE and physician decision|0|||
155628679|NCT01326871|561735930|FG001|Overall Study|SAE and physician decision|0|||
155628680|NCT01326871|561735931|FG002|Overall Study|SAE and physician decision|1|||
155628681|NCT01326871|561735929|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
155628682|NCT01326871|561735930|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
155628683|NCT01326871|561735931|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
155628684|NCT01326871|561735929|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
155730117|NCT00790842|562109903|FG002|Dose Level 4|Withdrawal by Subject|0|||
155628685|NCT01326871|561735930|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
155628686|NCT01326871|561735931|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
155628687|NCT01326871|561735929|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
155628688|NCT01326871|561735930|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
155628689|NCT01326871|561735931|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
155628690|NCT01326871|561735929|FG000|Overall Study|Physician Decision|0|||
155628691|NCT01326871|561735930|FG001|Overall Study|Physician Decision|0|||
155730118|NCT00790842|562109904|FG003|Dose Level 4|Withdrawal by Subject|0|||
155730119|NCT00790842|562109905|FG004|Dose Level 4|Withdrawal by Subject|0|||
155730120|NCT00790842|562109906|FG005|Dose Level 4|Withdrawal by Subject|0|||
155730121|NCT00790842|562109907|FG006|Dose Level 4|Withdrawal by Subject|0|||
155730122|NCT00790842|562109908|FG007|Dose Level 4|Withdrawal by Subject|0|||
155730123|NCT00790842|562109909|FG008|Dose Level 4|Withdrawal by Subject|0|||
155730124|NCT00790842|562109910|FG009|Dose Level 4|Withdrawal by Subject|0|||
155730125|NCT00790842|562109911|FG010|Dose Level 4|Withdrawal by Subject|1|||
155730126|NCT00790842|562109901|FG000|Expansion Cohort|Adverse Event|0|||
155730127|NCT00790842|562109902|FG001|Expansion Cohort|Adverse Event|0|||
155730128|NCT00790842|562109903|FG002|Expansion Cohort|Adverse Event|0|||
155730129|NCT00790842|562109904|FG003|Expansion Cohort|Adverse Event|0|||
155730130|NCT00790842|562109905|FG004|Expansion Cohort|Adverse Event|0|||
155730131|NCT00790842|562109906|FG005|Expansion Cohort|Adverse Event|0|||
155730132|NCT00790842|562109907|FG006|Expansion Cohort|Adverse Event|1|||
155730133|NCT00790842|562109908|FG007|Expansion Cohort|Adverse Event|0|||
155730134|NCT00790842|562109909|FG008|Expansion Cohort|Adverse Event|0|||
155730135|NCT00790842|562109910|FG009|Expansion Cohort|Adverse Event|0|||
155730136|NCT00790842|562109911|FG010|Expansion Cohort|Adverse Event|0|||
155730137|NCT00790842|562109901|FG000|Expansion Cohort|Death|0|||
155730138|NCT00790842|562109902|FG001|Expansion Cohort|Death|0|||
155730139|NCT00790842|562109903|FG002|Expansion Cohort|Death|2|||
155730140|NCT00790842|562109904|FG003|Expansion Cohort|Death|0|||
155730141|NCT00790842|562109905|FG004|Expansion Cohort|Death|0|||
155730142|NCT00790842|562109906|FG005|Expansion Cohort|Death|0|||
155730143|NCT00790842|562109907|FG006|Expansion Cohort|Death|0|||
155730144|NCT00790842|562109908|FG007|Expansion Cohort|Death|0|||
155730145|NCT00790842|562109909|FG008|Expansion Cohort|Death|0|||
155730146|NCT00790842|562109910|FG009|Expansion Cohort|Death|0|||
155730147|NCT00790842|562109911|FG010|Expansion Cohort|Death|0|||
155730148|NCT00790842|562109901|FG000|Expansion Cohort|Physician Decision|0|||
155730149|NCT00790842|562109902|FG001|Expansion Cohort|Physician Decision|0|||
155730150|NCT00790842|562109903|FG002|Expansion Cohort|Physician Decision|1|||
155730151|NCT00790842|562109904|FG003|Expansion Cohort|Physician Decision|0|||
155730152|NCT00790842|562109905|FG004|Expansion Cohort|Physician Decision|0|||
155730153|NCT00790842|562109906|FG005|Expansion Cohort|Physician Decision|0|||
155730154|NCT00790842|562109907|FG006|Expansion Cohort|Physician Decision|0|||
155730155|NCT00790842|562109908|FG007|Expansion Cohort|Physician Decision|0|||
155730156|NCT00790842|562109909|FG008|Expansion Cohort|Physician Decision|0|||
155730157|NCT00790842|562109910|FG009|Expansion Cohort|Physician Decision|0|||
155730158|NCT00790842|562109911|FG010|Expansion Cohort|Physician Decision|0|||
155730159|NCT00790842|562109901|FG000|Expansion Cohort|Withdrawal by Subject|0|||
155730160|NCT00790842|562109902|FG001|Expansion Cohort|Withdrawal by Subject|0|||
155730161|NCT00790842|562109903|FG002|Expansion Cohort|Withdrawal by Subject|3|||
155730162|NCT00790842|562109904|FG003|Expansion Cohort|Withdrawal by Subject|0|||
155730163|NCT00790842|562109905|FG004|Expansion Cohort|Withdrawal by Subject|0|||
155730164|NCT00790842|562109906|FG005|Expansion Cohort|Withdrawal by Subject|0|||
155730165|NCT00790842|562109907|FG006|Expansion Cohort|Withdrawal by Subject|0|||
155730166|NCT00790842|562109908|FG007|Expansion Cohort|Withdrawal by Subject|0|||
155730167|NCT00790842|562109909|FG008|Expansion Cohort|Withdrawal by Subject|0|||
155730168|NCT00790842|562109910|FG009|Expansion Cohort|Withdrawal by Subject|0|||
155730169|NCT00790842|562109911|FG010|Expansion Cohort|Withdrawal by Subject|0|||
155730170|NCT00790842|562109901|FG000|Expansion Cohort|Study Closure|0|||
155730171|NCT00790842|562109902|FG001|Expansion Cohort|Study Closure|0|||
155730172|NCT00790842|562109903|FG002|Expansion Cohort|Study Closure|1|||
155730173|NCT00790842|562109904|FG003|Expansion Cohort|Study Closure|0|||
155730174|NCT00790842|562109905|FG004|Expansion Cohort|Study Closure|0|||
155730175|NCT00790842|562109906|FG005|Expansion Cohort|Study Closure|0|||
155730176|NCT00790842|562109907|FG006|Expansion Cohort|Study Closure|0|||
155730177|NCT00790842|562109908|FG007|Expansion Cohort|Study Closure|0|||
155730178|NCT00790842|562109909|FG008|Expansion Cohort|Study Closure|0|||
155730179|NCT00790842|562109910|FG009|Expansion Cohort|Study Closure|0|||
155730180|NCT00790842|562109911|FG010|Expansion Cohort|Study Closure|0|||
155730181|NCT02968004|562109912|FG000|Main Study Phase|Adverse Event|1|||
155281269|NCT04955626|560459890|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
155281270|NCT04955626|560459891|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
155281271|NCT04955626|560459892|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
155730182|NCT02968004|562109913|FG001|Main Study Phase|Adverse Event|0|||
155730183|NCT02968004|562109912|FG000|Main Study Phase|Withdrawal by Subject|0|||
155730184|NCT02968004|562109913|FG001|Main Study Phase|Withdrawal by Subject|1|||
155730185|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
155730186|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
155730187|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
155730188|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
155730189|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
155730190|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
155730191|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
155730192|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
155730193|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
155730194|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
155730195|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
155730196|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
155730197|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
155730198|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
155730199|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
155730200|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
155730201|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
155730202|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
155730203|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
155730204|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
155730205|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
155730206|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
155730207|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
155730208|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
155730209|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
155628692|NCT01326871|561735931|FG002|Overall Study|Physician Decision|1|||
155628693|NCT01326871|561735929|FG000|Overall Study|SAE|0|||
155628694|NCT01326871|561735930|FG001|Overall Study|SAE|0|||
155628695|NCT01326871|561735931|FG002|Overall Study|SAE|1|||
155628696|NCT01326871|561735929|FG000|Overall Study|Disease progression and death|0|||
155628697|NCT01326871|561735930|FG001|Overall Study|Disease progression and death|0|||
155628698|NCT01326871|561735931|FG002|Overall Study|Disease progression and death|1|||
155628699|NCT01326871|561735929|FG000|Overall Study|Subject decision|0|||
155628700|NCT01326871|561735930|FG001|Overall Study|Subject decision|0|||
155628701|NCT01326871|561735931|FG002|Overall Study|Subject decision|1|||
155628702|NCT01387269|561735935|FG000|Overall Study|Death|38|||
155628703|NCT01387269|561735936|FG001|Overall Study|Death|20|||
155628704|NCT01387269|561735935|FG000|Overall Study|Other|8|||
155628705|NCT01387269|561735936|FG001|Overall Study|Other|7|||
155628706|NCT01387269|561735935|FG000|Overall Study|Unrelated AE|12|||
155628707|NCT01387269|561735936|FG001|Overall Study|Unrelated AE|3|||
155628708|NCT01387269|561735935|FG000|Overall Study|Withdrawal by patient|32|||
155628709|NCT01387269|561735936|FG001|Overall Study|Withdrawal by patient|10|||
155628710|NCT01387269|561735935|FG000|Overall Study|Study drug-related AE|1|||
155628711|NCT01387269|561735936|FG001|Overall Study|Study drug-related AE|0|||
155628712|NCT01387269|561735935|FG000|Overall Study|Lost to Follow-up|1|||
155628713|NCT01387269|561735936|FG001|Overall Study|Lost to Follow-up|0|||
155628714|NCT01200329|561735937|FG000|Overall Study|Lack of financial coverage|2|||
155628715|NCT01200329|561735937|FG000|Overall Study|Progressive disease|1|||
155628716|NCT04158219|561735950|FG000|Overall Study|Lost to Follow-up|1|||
155628717|NCT01814007|561735952|FG000|Overall Study|Withdrawal by Subject|1|||
155730210|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
155281272|NCT04955626|560459893|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
155281273|NCT04955626|560459894|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
155281274|NCT04955626|560459895|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
155281275|NCT04955626|560459896|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
155281276|NCT04955626|560459897|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
155281277|NCT04955626|560459898|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
155281278|NCT04955626|560459899|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
155281279|NCT04955626|560459900|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
155281280|NCT04955626|560459901|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
155281281|NCT04955626|560459902|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
155281282|NCT04955626|560459867|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281283|NCT04955626|560459868|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
155281284|NCT04955626|560459869|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281285|NCT04955626|560459870|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281286|NCT04955626|560459871|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281287|NCT04955626|560459872|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281288|NCT04955626|560459873|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281289|NCT04955626|560459874|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281290|NCT04955626|560459875|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281291|NCT04955626|560459876|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281292|NCT04955626|560459877|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281293|NCT04955626|560459878|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281294|NCT04955626|560459879|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155628718|NCT01324947|561735953|FG000|Overall Study|Adverse Event|7|||
155628719|NCT01324947|561735953|FG000|Overall Study|Death|10|||
155628720|NCT01324947|561735953|FG000|Overall Study|Other|3|||
155628721|NCT01324947|561735953|FG000|Overall Study|Progressive Disease|50|||
155730211|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
155730212|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
155730213|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
155730214|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
155730215|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
155730216|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
155730217|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
155730218|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
155730219|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
155730220|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
155730221|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
155730222|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
155730223|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
155730224|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
155730225|NCT02968004|562109912|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
155730226|NCT02968004|562109913|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
155730227|NCT05029362|562109914|FG000|Overall Study|Lost to Follow-up|9|||
155730228|NCT00419952|562109916|FG000|Overall Study|Adverse Event|8|||
155730229|NCT00419952|562109917|FG001|Overall Study|Adverse Event|10|||
155730230|NCT00419952|562109916|FG000|Overall Study|Withdrawal by Subject|44|||
155730231|NCT00419952|562109917|FG001|Overall Study|Withdrawal by Subject|43|||
155730232|NCT00419952|562109916|FG000|Overall Study|Lost to Follow-up|43|||
155730233|NCT00419952|562109917|FG001|Overall Study|Lost to Follow-up|34|||
155730234|NCT00419952|562109916|FG000|Overall Study|Protocol Violation|32|||
155730235|NCT00419952|562109917|FG001|Overall Study|Protocol Violation|24|||
155730236|NCT00419952|562109916|FG000|Overall Study|Pregnancy|4|||
155730237|NCT00419952|562109917|FG001|Overall Study|Pregnancy|2|||
155730238|NCT00419952|562109916|FG000|Overall Study|Physician Decision|1|||
155730239|NCT00419952|562109917|FG001|Overall Study|Physician Decision|3|||
155730240|NCT00419952|562109916|FG000|Overall Study|Incorrectly enrolled|10|||
155730241|NCT00419952|562109917|FG001|Overall Study|Incorrectly enrolled|3|||
155730242|NCT00419952|562109916|FG000|Overall Study|Intake of prohibited medication|2|||
155730243|NCT00419952|562109917|FG001|Overall Study|Intake of prohibited medication|2|||
155730244|NCT00419952|562109916|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
155730245|NCT00419952|562109917|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
155730246|NCT00419952|562109916|FG000|Overall Study|Diary or medication non-compliance|2|||
155730247|NCT00419952|562109917|FG001|Overall Study|Diary or medication non-compliance|4|||
155730248|NCT00419952|562109916|FG000|Overall Study|Abnormal ECG|1|||
155730249|NCT00419952|562109917|FG001|Overall Study|Abnormal ECG|0|||
155730250|NCT03126591|562109918|FG000|Overall Study|Death|6|||
155730251|NCT03126591|562109919|FG001|Overall Study|Death|3|||
155730252|NCT03126591|562109920|FG002|Overall Study|Death|17|||
155730253|NCT03126591|562109918|FG000|Overall Study|Progressive Disease|0|||
155730254|NCT03126591|562109919|FG001|Overall Study|Progressive Disease|1|||
155730255|NCT03126591|562109920|FG002|Overall Study|Progressive Disease|2|||
155730256|NCT03126591|562109918|FG000|Overall Study|Terminated by Sponsor|0|||
155730257|NCT03126591|562109919|FG001|Overall Study|Terminated by Sponsor|1|||
155730258|NCT03126591|562109920|FG002|Overall Study|Terminated by Sponsor|4|||
155730259|NCT03126591|562109918|FG000|Overall Study|Withdrawal by Subject|1|||
155730260|NCT03126591|562109919|FG001|Overall Study|Withdrawal by Subject|1|||
155730261|NCT03126591|562109920|FG002|Overall Study|Withdrawal by Subject|4|||
155730262|NCT03722238|562109923|FG000|Overall Study|Protocol Violation|1|||
155730263|NCT03722238|562109924|FG001|Overall Study|Protocol Violation|0|||
155730264|NCT03722238|562109923|FG000|Overall Study|Physician Decision|1|||
155730265|NCT03722238|562109924|FG001|Overall Study|Physician Decision|0|||
155730266|NCT03722238|562109923|FG000|Overall Study|Death|1|||
155730267|NCT03722238|562109924|FG001|Overall Study|Death|0|||
155730268|NCT03722238|562109923|FG000|Overall Study|Lost to Follow-up|6|||
155281295|NCT04955626|560459880|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281296|NCT04955626|560459881|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281297|NCT04955626|560459882|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281298|NCT04955626|560459883|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281299|NCT04955626|560459884|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730269|NCT03722238|562109924|FG001|Overall Study|Lost to Follow-up|0|||
155730270|NCT03722238|562109923|FG000|Overall Study|Partial missing data|44|||
155730271|NCT03722238|562109924|FG001|Overall Study|Partial missing data|1|||
155730272|NCT03722238|562109923|FG000|Overall Study|Withdrawal by Subject|2|||
155730273|NCT03722238|562109924|FG001|Overall Study|Withdrawal by Subject|0|||
155730274|NCT03722238|562109923|FG000|Overall Study|Other|4|||
155730275|NCT03722238|562109924|FG001|Overall Study|Other|0|||
155730276|NCT03722238|562109923|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
155281300|NCT04955626|560459885|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730277|NCT03722238|562109924|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
155730278|NCT03722238|562109923|FG000|Overall Study|Did not meet risk classification group criteria|90|||
155730279|NCT03722238|562109924|FG001|Overall Study|Did not meet risk classification group criteria|0|||
155730280|NCT03722238|562109923|FG000|Overall Study|Did not sign consent|17|||
155730281|NCT03722238|562109924|FG001|Overall Study|Did not sign consent|0|||
155730282|NCT03722238|562109923|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
155730283|NCT03722238|562109924|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
155730284|NCT03722238|562109923|FG000|Overall Study|Not willing to purchase study medication|142|||
155730285|NCT03722238|562109924|FG001|Overall Study|Not willing to purchase study medication|0|||
155730286|NCT03722238|562109923|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
155730287|NCT03722238|562109924|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
155730288|NCT01285323|562109925|FG000|Overall Study|Adverse Event|9|||
155730289|NCT01285323|562109926|FG001|Overall Study|Adverse Event|8|||
155730290|NCT01285323|562109925|FG000|Overall Study|Lack of Efficacy|4|||
155730291|NCT01285323|562109926|FG001|Overall Study|Lack of Efficacy|2|||
155730292|NCT01285323|562109925|FG000|Overall Study|Withdrawal by Subject|15|||
155730293|NCT01285323|562109926|FG001|Overall Study|Withdrawal by Subject|11|||
155730294|NCT01285323|562109925|FG000|Overall Study|Protocol Violation|1|||
155730295|NCT01285323|562109926|FG001|Overall Study|Protocol Violation|2|||
155730296|NCT01285323|562109925|FG000|Overall Study|Non-compliance with study procedures|2|||
155730297|NCT01285323|562109926|FG001|Overall Study|Non-compliance with study procedures|3|||
155730298|NCT01285323|562109925|FG000|Overall Study|Lost to Follow-up|1|||
155730299|NCT01285323|562109926|FG001|Overall Study|Lost to Follow-up|1|||
155730300|NCT01285323|562109925|FG000|Overall Study|Other|1|||
155730301|NCT01285323|562109926|FG001|Overall Study|Other|3|||
155730302|NCT02606643|562109927|FG000|Overall Study|did not meet inclusion criteria|1|||
155730303|NCT02606643|562109928|FG001|Overall Study|did not meet inclusion criteria|3|||
155730304|NCT02158546|562109936|FG000|Overall Study|Physician Decision|0|||
155730305|NCT02158546|562109937|FG001|Overall Study|Physician Decision|1|||
155730306|NCT02158546|562109938|FG002|Overall Study|Physician Decision|0|||
155730307|NCT02158546|562109939|FG003|Overall Study|Physician Decision|0|||
155730308|NCT02158546|562109936|FG000|Overall Study|Non-compliance|0|||
155730309|NCT02158546|562109937|FG001|Overall Study|Non-compliance|1|||
155730310|NCT02158546|562109938|FG002|Overall Study|Non-compliance|0|||
155730311|NCT02158546|562109939|FG003|Overall Study|Non-compliance|1|||
155730312|NCT02158546|562109936|FG000|Overall Study|Failure to meet eligibility criteria|0|||
155730313|NCT02158546|562109937|FG001|Overall Study|Failure to meet eligibility criteria|1|||
155730314|NCT02158546|562109938|FG002|Overall Study|Failure to meet eligibility criteria|0|||
155730315|NCT02158546|562109939|FG003|Overall Study|Failure to meet eligibility criteria|0|||
155730316|NCT02158546|562109936|FG000|Overall Study|Lack of Efficacy|1|||
155730317|NCT02158546|562109937|FG001|Overall Study|Lack of Efficacy|1|||
155730318|NCT02158546|562109938|FG002|Overall Study|Lack of Efficacy|0|||
155730319|NCT02158546|562109939|FG003|Overall Study|Lack of Efficacy|0|||
155730320|NCT02158546|562109936|FG000|Overall Study|Adverse Event|2|||
155730321|NCT02158546|562109937|FG001|Overall Study|Adverse Event|2|||
155730322|NCT02158546|562109938|FG002|Overall Study|Adverse Event|0|||
155730323|NCT02158546|562109939|FG003|Overall Study|Adverse Event|0|||
155730324|NCT02158546|562109936|FG000|Overall Study|Withdrawal by Subject|6|||
155730325|NCT02158546|562109937|FG001|Overall Study|Withdrawal by Subject|2|||
155730326|NCT02158546|562109938|FG002|Overall Study|Withdrawal by Subject|1|||
155730327|NCT02158546|562109939|FG003|Overall Study|Withdrawal by Subject|0|||
155730328|NCT02158546|562109936|FG000|Overall Study|Lost to Follow-up|5|||
155730329|NCT02158546|562109937|FG001|Overall Study|Lost to Follow-up|4|||
155730330|NCT02158546|562109938|FG002|Overall Study|Lost to Follow-up|0|||
155730331|NCT02158546|562109939|FG003|Overall Study|Lost to Follow-up|1|||
155730332|NCT02158546|562109936|FG000|Overall Study|Site Excluded|5|||
155730333|NCT02158546|562109937|FG001|Overall Study|Site Excluded|5|||
155730334|NCT02158546|562109938|FG002|Overall Study|Site Excluded|3|||
155730335|NCT02158546|562109939|FG003|Overall Study|Site Excluded|4|||
155730336|NCT02488915|562109943|FG000|Overall Study|Death|21|||
155388078|NCT03353350|560855030|FG002|30-week Core Treatment Period|Adverse Event|2|||
155388079|NCT03353350|560855031|FG003|30-week Core Treatment Period|Adverse Event|3|||
155388080|NCT03353350|560855028|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
155730337|NCT02488915|562109943|FG000|Overall Study|Lost to Follow-up|4|||
155730338|NCT02488915|562109943|FG000|Overall Study|Withdrawal by Subject|1|||
155730339|NCT00885170|562109946|FG000|Overall Study|Adverse Event|12|||
155730340|NCT00885170|562109947|FG001|Overall Study|Adverse Event|4|||
155730341|NCT00885170|562109946|FG000|Overall Study|Excessive bone loss|6|||
155730342|NCT00885170|562109947|FG001|Overall Study|Excessive bone loss|3|||
155730343|NCT00885170|562109946|FG000|Overall Study|Lost to Follow-up|2|||
155730344|NCT00885170|562109947|FG001|Overall Study|Lost to Follow-up|1|||
155730345|NCT00885170|562109946|FG000|Overall Study|Physician Decision|2|||
155730346|NCT00885170|562109947|FG001|Overall Study|Physician Decision|1|||
155730347|NCT00885170|562109946|FG000|Overall Study|Protocol Violation|3|||
155388081|NCT03353350|560855029|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
155388082|NCT03353350|560855030|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
155388083|NCT03353350|560855031|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
155388084|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
155388085|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
155388086|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
155388087|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
155388088|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
155388089|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
155388090|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
155730348|NCT00885170|562109947|FG001|Overall Study|Protocol Violation|1|||
155730349|NCT00885170|562109946|FG000|Overall Study|Withdrawal by Subject|13|||
155730350|NCT00885170|562109947|FG001|Overall Study|Withdrawal by Subject|13|||
155730351|NCT03771664|562109948|FG000|Overall Study|Adverse Event|1|||
155730352|NCT03771664|562109949|FG001|Overall Study|Adverse Event|0|||
155730353|NCT03771664|562109948|FG000|Overall Study|Lost to Follow-up|1|||
155730354|NCT03771664|562109949|FG001|Overall Study|Lost to Follow-up|0|||
155730355|NCT03771664|562109948|FG000|Overall Study|Withdrawal by Participant|1|||
155730356|NCT03771664|562109949|FG001|Overall Study|Withdrawal by Participant|4|||
155730357|NCT03771664|562109948|FG000|Overall Study|Randomized but not Treated|0|||
155730358|NCT03771664|562109949|FG001|Overall Study|Randomized but not Treated|1|||
155730359|NCT02120898|562109950|FG000|Overall Study|Withdrawal by Subject|4|||
155730360|NCT02120898|562109951|FG001|Overall Study|Withdrawal by Subject|2|||
155730361|NCT02120898|562109952|FG002|Overall Study|Withdrawal by Subject|2|||
155388091|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
155628722|NCT01324947|561735953|FG000|Overall Study|Withdrawal by Subject|3|||
155628723|NCT01324947|561735953|FG000|Overall Study|1 discontinued before starting drug|1|||
155628724|NCT01296412|561735954|FG000|Overall Study|Adverse Event|8|||
155628725|NCT01296412|561735955|FG001|Overall Study|Adverse Event|29|||
155628726|NCT01296412|561735954|FG000|Overall Study|Lack of Efficacy|1|||
155628727|NCT01296412|561735955|FG001|Overall Study|Lack of Efficacy|0|||
155628728|NCT01296412|561735954|FG000|Overall Study|Lost to Follow-up|10|||
155628729|NCT01296412|561735955|FG001|Overall Study|Lost to Follow-up|7|||
155628730|NCT01296412|561735954|FG000|Overall Study|Non-compliance with study drug|1|||
155628731|NCT01296412|561735955|FG001|Overall Study|Non-compliance with study drug|2|||
155628732|NCT01296412|561735954|FG000|Overall Study|Other reason not specified|20|||
155628733|NCT01296412|561735955|FG001|Overall Study|Other reason not specified|15|||
155628734|NCT01296412|561735954|FG000|Overall Study|Physician Decision|1|||
155628735|NCT01296412|561735955|FG001|Overall Study|Physician Decision|3|||
155628736|NCT01296412|561735954|FG000|Overall Study|Pregnancy|0|||
155628737|NCT01296412|561735955|FG001|Overall Study|Pregnancy|1|||
155628738|NCT01296412|561735954|FG000|Overall Study|Withdrawal by Subject|10|||
155628739|NCT01296412|561735955|FG001|Overall Study|Withdrawal by Subject|13|||
155628740|NCT02160626|561735956|FG000|Overall Study|Adverse Event|1|||
155628741|NCT02160626|561735957|FG001|Overall Study|Adverse Event|0|||
155628742|NCT02160626|561735958|FG002|Overall Study|Adverse Event|0|||
155628743|NCT02160626|561735956|FG000|Overall Study|Schedule not conducive to study visits|0|||
155628744|NCT02160626|561735957|FG001|Overall Study|Schedule not conducive to study visits|0|||
155628745|NCT02160626|561735958|FG002|Overall Study|Schedule not conducive to study visits|1|||
155628746|NCT02160626|561735956|FG000|Overall Study|Withdrawal by Subject|0|||
155628747|NCT02160626|561735957|FG001|Overall Study|Withdrawal by Subject|1|||
155628748|NCT02160626|561735958|FG002|Overall Study|Withdrawal by Subject|0|||
155628749|NCT04194814|561735964|FG000|Overall Study|Physician Decision|3|||
155628750|NCT04194814|561735965|FG001|Overall Study|Physician Decision|0|||
155628751|NCT04194814|561735964|FG000|Overall Study|Withdrawal by Subject|0|||
155628752|NCT04194814|561735965|FG001|Overall Study|Withdrawal by Subject|2|||
155628753|NCT01113749|561737751|FG000|Overall Study|Lost to Follow-up|1|||
155628754|NCT01113749|561737752|FG001|Overall Study|Lost to Follow-up|2|||
155628755|NCT02034006|561737753|FG000|Overall Study|Withdrawal by Subject|7|||
155628756|NCT02034006|561737753|FG000|Overall Study|Lost to Follow-up|5|||
155628757|NCT02034006|561737753|FG000|Overall Study|Death|1|||
155628758|NCT02034006|561737753|FG000|Overall Study|Pregnancy|1|||
155628759|NCT02934178|561737754|FG000|Received Vaccination 2|Death|0|||
155628760|NCT02934178|561737755|FG001|Received Vaccination 2|Death|1|||
155628761|NCT02934178|561737754|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
155628762|NCT02934178|561737755|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
155628763|NCT01075048|561737758|FG000|Overall Study|Death|4|||
155628764|NCT01075048|561737759|FG001|Overall Study|Death|17|||
155730362|NCT02120898|562109950|FG000|Overall Study|Non-compliance with study drug|3|||
155730363|NCT02120898|562109951|FG001|Overall Study|Non-compliance with study drug|0|||
155730364|NCT02120898|562109952|FG002|Overall Study|Non-compliance with study drug|0|||
155628765|NCT01075048|561737760|FG002|Overall Study|Death|12|||
155628766|NCT01075048|561737758|FG000|Overall Study|Start of other or new therapy|4|||
155628767|NCT01075048|561737759|FG001|Overall Study|Start of other or new therapy|36|||
155628768|NCT01075048|561737760|FG002|Overall Study|Start of other or new therapy|46|||
155628769|NCT01075048|561737758|FG000|Overall Study|Withdrawal by Subject|1|||
155730365|NCT02120898|562109950|FG000|Overall Study|Adverse Event|1|||
155730366|NCT02120898|562109951|FG001|Overall Study|Adverse Event|2|||
155730367|NCT02120898|562109952|FG002|Overall Study|Adverse Event|1|||
155730368|NCT02120898|562109950|FG000|Overall Study|Protocol Violation|1|||
155730369|NCT02120898|562109951|FG001|Overall Study|Protocol Violation|2|||
155730370|NCT02120898|562109952|FG002|Overall Study|Protocol Violation|0|||
155730371|NCT02120898|562109950|FG000|Overall Study|Lost to Follow-up|0|||
155730372|NCT02120898|562109951|FG001|Overall Study|Lost to Follow-up|0|||
155730373|NCT02120898|562109952|FG002|Overall Study|Lost to Follow-up|1|||
155730374|NCT00561925|562109953|FG000|14 Day Lead-In Period|Adverse Event|38|||
155730375|NCT00561925|562109954|FG001|14 Day Lead-In Period|Adverse Event|0|||
155730376|NCT00561925|562109955|FG002|14 Day Lead-In Period|Adverse Event|0|||
155730377|NCT00561925|562109956|FG003|14 Day Lead-In Period|Adverse Event|0|||
155730378|NCT00561925|562109957|FG004|14 Day Lead-In Period|Adverse Event|0|||
155730379|NCT00561925|562109953|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
155730380|NCT00561925|562109954|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
155730381|NCT00561925|562109955|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
155730382|NCT00561925|562109956|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
155730383|NCT00561925|562109957|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
155730384|NCT00561925|562109953|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
155730385|NCT00561925|562109954|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
155730386|NCT00561925|562109955|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
155730387|NCT00561925|562109956|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
155730388|NCT00561925|562109957|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
155730389|NCT00561925|562109953|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
155730390|NCT00561925|562109954|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
155730391|NCT00561925|562109955|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
155730392|NCT00561925|562109956|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
155730393|NCT00561925|562109957|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
155730394|NCT00561925|562109953|FG000|14 Day Lead-In Period|Other|5|||
155730395|NCT00561925|562109954|FG001|14 Day Lead-In Period|Other|0|||
155730396|NCT00561925|562109955|FG002|14 Day Lead-In Period|Other|0|||
155730397|NCT00561925|562109956|FG003|14 Day Lead-In Period|Other|0|||
155730398|NCT00561925|562109957|FG004|14 Day Lead-In Period|Other|0|||
155730399|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
155730400|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
155730401|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
155730402|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
155730403|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
155730404|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155730405|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
155730406|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
155730407|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155730408|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155730409|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155730410|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
155730411|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
155730412|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155730413|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155730414|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155730415|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
155730416|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
155730417|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155730418|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155730419|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155730420|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
155281301|NCT04955626|560459886|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281302|NCT04955626|560459887|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281303|NCT04955626|560459888|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281304|NCT04955626|560459889|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281305|NCT04955626|560459890|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730421|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
155730422|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155730423|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155730424|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
155730425|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
155730426|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
155730427|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
155730428|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
155281306|NCT04955626|560459891|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730429|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Death|0|||
155730430|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Death|6|||
155730431|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Death|3|||
155730432|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Death|0|||
155730433|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Death|0|||
155730434|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155730435|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
155730436|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155730437|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155730438|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155730439|NCT00561925|562109953|FG000|144-week Double-blind, Double-dummy|Other|0|||
155730440|NCT00561925|562109954|FG001|144-week Double-blind, Double-dummy|Other|8|||
155730441|NCT00561925|562109955|FG002|144-week Double-blind, Double-dummy|Other|11|||
155730442|NCT00561925|562109956|FG003|144-week Double-blind, Double-dummy|Other|0|||
155730443|NCT00561925|562109957|FG004|144-week Double-blind, Double-dummy|Other|0|||
155730444|NCT00561925|562109953|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
155730445|NCT00561925|562109954|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
155730446|NCT00561925|562109955|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
155730447|NCT00561925|562109956|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
155730448|NCT00561925|562109957|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
155730449|NCT00684021|562109958|FG000|Overall Study|MRI Contraindicated|1|||
155730450|NCT00684021|562109959|FG001|Overall Study|MRI Contraindicated|1|||
155730451|NCT00684021|562109960|FG002|Overall Study|MRI Contraindicated|1|||
155730452|NCT00684021|562109961|FG003|Overall Study|MRI Contraindicated|0|||
155730453|NCT00684021|562109958|FG000|Overall Study|MRI not performed|0|||
155730454|NCT00684021|562109959|FG001|Overall Study|MRI not performed|1|||
155730455|NCT00684021|562109960|FG002|Overall Study|MRI not performed|1|||
155730456|NCT00684021|562109961|FG003|Overall Study|MRI not performed|2|||
155730457|NCT00684021|562109958|FG000|Overall Study|Death|1|||
155730458|NCT00684021|562109959|FG001|Overall Study|Death|0|||
155730459|NCT00684021|562109960|FG002|Overall Study|Death|0|||
155730460|NCT00684021|562109961|FG003|Overall Study|Death|0|||
155730461|NCT02556177|562109962|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
155730462|NCT02556177|562109963|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
155730463|NCT03818321|562109965|FG000|Overall Study|Withdrawal by Subject|1|||
155730464|NCT03818321|562109966|FG001|Overall Study|Withdrawal by Subject|2|||
155730465|NCT01285557|562109968|FG000|Overall Study|Death|173|||
155730466|NCT01285557|562109969|FG001|Overall Study|Death|90|||
155730467|NCT01285557|562109968|FG000|Overall Study|Lost to Follow-up|6|||
155730468|NCT01285557|562109969|FG001|Overall Study|Lost to Follow-up|2|||
155730469|NCT01285557|562109968|FG000|Overall Study|Withdrew Consent|6|||
155730470|NCT01285557|562109969|FG001|Overall Study|Withdrew Consent|1|||
155730471|NCT01285557|562109968|FG000|Overall Study|Sponsor Study Termination|23|||
155730472|NCT01285557|562109969|FG001|Overall Study|Sponsor Study Termination|13|||
155730473|NCT01285557|562109968|FG000|Overall Study|Randomized but not treated|1|||
155730474|NCT01285557|562109969|FG001|Overall Study|Randomized but not treated|1|||
155730475|NCT01285557|562109968|FG000|Overall Study|Study follow-up ongoing|28|||
155730476|NCT01285557|562109969|FG001|Overall Study|Study follow-up ongoing|14|||
155730477|NCT01285557|562109968|FG000|Overall Study|Sponsor Decision|2|||
155730478|NCT01285557|562109969|FG001|Overall Study|Sponsor Decision|1|||
155628770|NCT01075048|561737759|FG001|Overall Study|Withdrawal by Subject|6|||
155628771|NCT01075048|561737760|FG002|Overall Study|Withdrawal by Subject|3|||
155628772|NCT01075048|561737758|FG000|Overall Study|Lost to Follow-up|0|||
155628773|NCT01075048|561737759|FG001|Overall Study|Lost to Follow-up|1|||
155628774|NCT01075048|561737760|FG002|Overall Study|Lost to Follow-up|1|||
155628775|NCT03944616|561737761|FG000|Overall Study|Lost to Follow-up|0|||
155628776|NCT03944616|561737762|FG001|Overall Study|Lost to Follow-up|2|||
155628777|NCT01287936|561737767|FG000|Overall Study|Lost to Follow-up|0|||
155628778|NCT01287936|561737768|FG001|Overall Study|Lost to Follow-up|1|||
155628779|NCT01287936|561737769|FG002|Overall Study|Lost to Follow-up|1|||
155628780|NCT00296244|561737770|FG000|Overall Study|Underwent retransplant|0|||
155628781|NCT00296244|561737771|FG001|Overall Study|Underwent retransplant|1|||
155628782|NCT00761319|561737772|FG000|Overall Study|Protocol Violation|21|||
155730479|NCT05786651|562109971|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
155730480|NCT03207763|562111605|FG000|Overall Study|Lost to Follow-up|1|||
155730481|NCT03207763|562111606|FG001|Overall Study|Lost to Follow-up|0|||
155628783|NCT00761319|561737773|FG001|Overall Study|Protocol Violation|14|||
155628784|NCT00761319|561737772|FG000|Overall Study|Adverse Event|11|||
155628785|NCT00761319|561737773|FG001|Overall Study|Adverse Event|7|||
155628786|NCT00761319|561737772|FG000|Overall Study|Withdrawal by Subject|8|||
155730482|NCT00990704|562111607|FG000|Overall Study|Adverse Event|1|||
155730483|NCT00990704|562111608|FG001|Overall Study|Adverse Event|1|||
155730484|NCT00990704|562111607|FG000|Overall Study|Physician Decision|0|||
155730485|NCT00990704|562111608|FG001|Overall Study|Physician Decision|1|||
155730486|NCT01002339|562111611|FG000|Overall Study|Withdrawal by Subject|0|||
155730487|NCT01002339|562111612|FG001|Overall Study|Withdrawal by Subject|1|||
155730488|NCT01002339|562111613|FG002|Overall Study|Withdrawal by Subject|0|||
155730489|NCT01002339|562111611|FG000|Overall Study|Incorrect treatment assignment|0|||
155730490|NCT01002339|562111612|FG001|Overall Study|Incorrect treatment assignment|0|||
155730491|NCT01002339|562111613|FG002|Overall Study|Incorrect treatment assignment|1|||
155730492|NCT01002339|562111611|FG000|Overall Study|Protocol Violation|0|||
155730493|NCT01002339|562111612|FG001|Overall Study|Protocol Violation|0|||
155730494|NCT01002339|562111613|FG002|Overall Study|Protocol Violation|2|||
155730495|NCT01002339|562111611|FG000|Overall Study|Lung cancer detected before transplant|0|||
155730496|NCT01002339|562111612|FG001|Overall Study|Lung cancer detected before transplant|0|||
155730497|NCT01002339|562111613|FG002|Overall Study|Lung cancer detected before transplant|1|||
155730498|NCT01002339|562111611|FG000|Overall Study|Randomized. Not transplanted|0|||
155730499|NCT01002339|562111612|FG001|Overall Study|Randomized. Not transplanted|0|||
155730500|NCT01002339|562111613|FG002|Overall Study|Randomized. Not transplanted|1|||
155730501|NCT01519921|562111620|FG000|Overall Study|Adverse Event|10|||
155730502|NCT01519921|562111621|FG001|Overall Study|Adverse Event|9|||
155730503|NCT01519921|562111620|FG000|Overall Study|Lack of Efficacy|4|||
155730504|NCT01519921|562111621|FG001|Overall Study|Lack of Efficacy|3|||
155730505|NCT01519921|562111620|FG000|Overall Study|Withdrawal by Subject|3|||
155730506|NCT01519921|562111621|FG001|Overall Study|Withdrawal by Subject|0|||
155730507|NCT01519921|562111620|FG000|Overall Study|Lost to Follow-up|2|||
155730508|NCT01519921|562111621|FG001|Overall Study|Lost to Follow-up|1|||
155730509|NCT01519921|562111620|FG000|Overall Study|Treatment refusal|2|||
155730510|NCT01519921|562111621|FG001|Overall Study|Treatment refusal|1|||
155730511|NCT01519921|562111620|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
155730512|NCT01519921|562111621|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
155730513|NCT01721044|562111624|FG000|Treatment Period|Adverse Event|7|||
155730514|NCT01721044|562111625|FG001|Treatment Period|Adverse Event|7|||
155730515|NCT01721044|562111626|FG002|Treatment Period|Adverse Event|10|||
155730516|NCT01721044|562111624|FG000|Treatment Period|Death|0|||
155730517|NCT01721044|562111625|FG001|Treatment Period|Death|0|||
155730518|NCT01721044|562111626|FG002|Treatment Period|Death|1|||
155730519|NCT01721044|562111624|FG000|Treatment Period|Lack of Efficacy|16|||
155730520|NCT01721044|562111625|FG001|Treatment Period|Lack of Efficacy|4|||
155730521|NCT01721044|562111626|FG002|Treatment Period|Lack of Efficacy|4|||
155730522|NCT01721044|562111624|FG000|Treatment Period|Lost to Follow-up|0|||
155730523|NCT01721044|562111625|FG001|Treatment Period|Lost to Follow-up|0|||
155730524|NCT01721044|562111626|FG002|Treatment Period|Lost to Follow-up|1|||
155730525|NCT01721044|562111624|FG000|Treatment Period|Physician Decision|1|||
155730526|NCT01721044|562111625|FG001|Treatment Period|Physician Decision|0|||
155730527|NCT01721044|562111626|FG002|Treatment Period|Physician Decision|2|||
155730528|NCT01721044|562111624|FG000|Treatment Period|Protocol Violation|1|||
155730529|NCT01721044|562111625|FG001|Treatment Period|Protocol Violation|0|||
155730530|NCT01721044|562111626|FG002|Treatment Period|Protocol Violation|0|||
155730531|NCT01721044|562111624|FG000|Treatment Period|Withdrawal by Subject|7|||
155730532|NCT01721044|562111625|FG001|Treatment Period|Withdrawal by Subject|6|||
155730533|NCT01721044|562111626|FG002|Treatment Period|Withdrawal by Subject|1|||
155730534|NCT01499355|562111629|FG000|Run-In Period|Study Termination|15|||
155730535|NCT01499355|562111630|FG001|Run-In Period|Study Termination|0|||
155730536|NCT01499355|562111631|FG002|Run-In Period|Study Termination|0|||
155730537|NCT01499355|562111632|FG003|Run-In Period|Study Termination|0|||
155730538|NCT01499355|562111629|FG000|Run-In Period|Other|3|||
155730539|NCT01499355|562111630|FG001|Run-In Period|Other|0|||
155730540|NCT01499355|562111631|FG002|Run-In Period|Other|0|||
155730541|NCT01499355|562111632|FG003|Run-In Period|Other|0|||
155730542|NCT01499355|562111629|FG000|Run-In Period|Death|2|||
155730543|NCT01499355|562111630|FG001|Run-In Period|Death|0|||
155730544|NCT01499355|562111631|FG002|Run-In Period|Death|0|||
155730545|NCT01499355|562111632|FG003|Run-In Period|Death|0|||
155730546|NCT01499355|562111629|FG000|Run-In Period|Investigator Decision|2|||
155730547|NCT01499355|562111630|FG001|Run-In Period|Investigator Decision|0|||
155730548|NCT01499355|562111631|FG002|Run-In Period|Investigator Decision|0|||
155730549|NCT01499355|562111632|FG003|Run-In Period|Investigator Decision|0|||
155730550|NCT01499355|562111629|FG000|Run-In Period|Consent Withdrawn|1|||
155730551|NCT01499355|562111630|FG001|Run-In Period|Consent Withdrawn|0|||
155730552|NCT01499355|562111631|FG002|Run-In Period|Consent Withdrawn|0|||
155730553|NCT01499355|562111632|FG003|Run-In Period|Consent Withdrawn|0|||
155730554|NCT01499355|562111629|FG000|Run-In Period|Adverse Event|8|||
155730555|NCT01499355|562111630|FG001|Run-In Period|Adverse Event|0|||
155730556|NCT01499355|562111631|FG002|Run-In Period|Adverse Event|0|||
155730557|NCT01499355|562111632|FG003|Run-In Period|Adverse Event|0|||
155730558|NCT01499355|562111629|FG000|Double-Blind Period|Adverse Event|0|||
155730559|NCT01499355|562111630|FG001|Double-Blind Period|Adverse Event|2|||
155730560|NCT01499355|562111631|FG002|Double-Blind Period|Adverse Event|3|||
155281307|NCT04955626|560459892|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730561|NCT01499355|562111632|FG003|Double-Blind Period|Adverse Event|2|||
155730562|NCT01499355|562111629|FG000|Double-Blind Period|Study Termination|0|||
155730563|NCT01499355|562111630|FG001|Double-Blind Period|Study Termination|18|||
155730564|NCT01499355|562111631|FG002|Double-Blind Period|Study Termination|16|||
155388092|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Adverse Event|1|||
155628787|NCT00761319|561737773|FG001|Overall Study|Withdrawal by Subject|7|||
155628788|NCT00761319|561737772|FG000|Overall Study|Noncompliance|4|||
155628789|NCT00761319|561737773|FG001|Overall Study|Noncompliance|3|||
155628790|NCT00761319|561737772|FG000|Overall Study|Lost to Follow-up|1|||
155628791|NCT00761319|561737773|FG001|Overall Study|Lost to Follow-up|1|||
155628792|NCT00761319|561737772|FG000|Overall Study|Nonspecified|2|||
155628793|NCT00761319|561737773|FG001|Overall Study|Nonspecified|2|||
155628794|NCT00761319|561737772|FG000|Overall Study|Missing|1|||
155628795|NCT00761319|561737773|FG001|Overall Study|Missing|0|||
155628796|NCT00607893|561737774|FG000|Overall Study|Lost to Follow-up|4|||
155628797|NCT00607893|561737775|FG001|Overall Study|Lost to Follow-up|0|||
155628798|NCT00607893|561737774|FG000|Overall Study|withdrew due to loss of interest|0|||
155628799|NCT00607893|561737775|FG001|Overall Study|withdrew due to loss of interest|1|||
155628800|NCT00607893|561737774|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
155628801|NCT00607893|561737775|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
155628802|NCT00607893|561737774|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
155628803|NCT00607893|561737775|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
155628804|NCT00607893|561737774|FG000|Overall Study|Declined to be treated|1|||
155628805|NCT00607893|561737775|FG001|Overall Study|Declined to be treated|0|||
155628806|NCT00607893|561737774|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
155628807|NCT00607893|561737775|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
155628808|NCT01373164|561737776|FG000|Overall Study|Lost to Follow-up|0|||
155628809|NCT01373164|561737777|FG001|Overall Study|Lost to Follow-up|0|||
155628810|NCT01373164|561737778|FG002|Overall Study|Lost to Follow-up|1|||
155628811|NCT01373164|561737779|FG003|Overall Study|Lost to Follow-up|2|||
155628812|NCT01373164|561737780|FG004|Overall Study|Lost to Follow-up|0|||
155628813|NCT01373164|561737776|FG000|Overall Study|Withdrawal by Subject|0|||
155628814|NCT01373164|561737777|FG001|Overall Study|Withdrawal by Subject|1|||
155628815|NCT01373164|561737778|FG002|Overall Study|Withdrawal by Subject|0|||
155628816|NCT01373164|561737779|FG003|Overall Study|Withdrawal by Subject|10|||
155628817|NCT01373164|561737780|FG004|Overall Study|Withdrawal by Subject|2|||
155628818|NCT01799941|561737781|FG000|Overall Study|Adverse Event|34|||
155628819|NCT01799941|561737781|FG000|Overall Study|Withdrawal by Subject|21|||
155628820|NCT01799941|561737781|FG000|Overall Study|Death|2|||
155628821|NCT01799941|561737781|FG000|Overall Study|Investigator Decision|4|||
155628822|NCT01799941|561737781|FG000|Overall Study|Lack of Efficacy|3|||
155628823|NCT01799941|561737781|FG000|Overall Study|Lost to Follow-up|17|||
155628824|NCT01799941|561737781|FG000|Overall Study|Other|15|||
155628825|NCT03617588|561737795|FG000|Overall Study|Withdrawal by Subject|1|||
155628826|NCT03617588|561737796|FG001|Overall Study|Withdrawal by Subject|0|||
155628827|NCT01499511|561737797|FG000|Overall Study|Death|1|||
155628828|NCT01499511|561737798|FG001|Overall Study|Death|0|||
155628829|NCT04459338|561737800|FG000|Overall Study|Loss of IV during study|1|||
155628830|NCT04459338|561737801|FG001|Overall Study|Loss of IV during study|0|||
155628831|NCT00853385|561737802|FG000|Overall Study|Death|0|||
155628832|NCT00853385|561737803|FG001|Overall Study|Death|0|||
155628833|NCT00853385|561737804|FG002|Overall Study|Death|0|||
155628834|NCT00853385|561737805|FG003|Overall Study|Death|0|||
155628835|NCT00853385|561737806|FG004|Overall Study|Death|1|||
155628836|NCT00853385|561737802|FG000|Overall Study|Adverse Event|24|||
155628837|NCT00853385|561737803|FG001|Overall Study|Adverse Event|24|||
155628838|NCT00853385|561737804|FG002|Overall Study|Adverse Event|2|||
155628839|NCT00853385|561737805|FG003|Overall Study|Adverse Event|5|||
155628840|NCT00853385|561737806|FG004|Overall Study|Adverse Event|22|||
155628841|NCT00853385|561737802|FG000|Overall Study|Lack of Efficacy|6|||
155628842|NCT00853385|561737803|FG001|Overall Study|Lack of Efficacy|7|||
155628843|NCT00853385|561737804|FG002|Overall Study|Lack of Efficacy|3|||
155388093|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Adverse Event|0|||
155388094|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Adverse Event|0|||
155628844|NCT00853385|561737805|FG003|Overall Study|Lack of Efficacy|3|||
155628845|NCT00853385|561737806|FG004|Overall Study|Lack of Efficacy|6|||
155628846|NCT00853385|561737802|FG000|Overall Study|Lost to Follow-up|2|||
155628847|NCT00853385|561737803|FG001|Overall Study|Lost to Follow-up|1|||
155628848|NCT00853385|561737804|FG002|Overall Study|Lost to Follow-up|0|||
155628849|NCT00853385|561737805|FG003|Overall Study|Lost to Follow-up|0|||
155730565|NCT01499355|562111632|FG003|Double-Blind Period|Study Termination|14|||
155628850|NCT00853385|561737806|FG004|Overall Study|Lost to Follow-up|0|||
155628851|NCT00853385|561737802|FG000|Overall Study|Withdrawal by Subject|4|||
155628852|NCT00853385|561737803|FG001|Overall Study|Withdrawal by Subject|2|||
155628853|NCT00853385|561737804|FG002|Overall Study|Withdrawal by Subject|0|||
155628854|NCT00853385|561737805|FG003|Overall Study|Withdrawal by Subject|1|||
155628855|NCT00853385|561737806|FG004|Overall Study|Withdrawal by Subject|1|||
155628856|NCT00853385|561737802|FG000|Overall Study|Other|18|||
155628857|NCT00853385|561737803|FG001|Overall Study|Other|9|||
155628858|NCT00853385|561737804|FG002|Overall Study|Other|4|||
155628859|NCT00853385|561737805|FG003|Overall Study|Other|4|||
155628860|NCT00853385|561737806|FG004|Overall Study|Other|12|||
155628861|NCT02515227|561737809|FG000|Overall Study|Adverse Event|0|||
155730566|NCT01499355|562111629|FG000|Double-Blind Period|Other|0|||
155730567|NCT01499355|562111630|FG001|Double-Blind Period|Other|1|||
155730568|NCT01499355|562111631|FG002|Double-Blind Period|Other|2|||
155730569|NCT01499355|562111632|FG003|Double-Blind Period|Other|2|||
155730570|NCT01499355|562111629|FG000|Double-Blind Period|Death|0|||
155730571|NCT01499355|562111630|FG001|Double-Blind Period|Death|1|||
155730572|NCT01499355|562111631|FG002|Double-Blind Period|Death|0|||
155730573|NCT01499355|562111632|FG003|Double-Blind Period|Death|0|||
155730574|NCT01499355|562111629|FG000|Double-Blind Period|Investigator Decision|0|||
155730575|NCT01499355|562111630|FG001|Double-Blind Period|Investigator Decision|0|||
155730576|NCT01499355|562111631|FG002|Double-Blind Period|Investigator Decision|3|||
155730577|NCT01499355|562111632|FG003|Double-Blind Period|Investigator Decision|3|||
155730578|NCT01499355|562111629|FG000|Double-Blind Period|Consent Withdrawn|0|||
155730579|NCT01499355|562111630|FG001|Double-Blind Period|Consent Withdrawn|0|||
155730580|NCT01499355|562111631|FG002|Double-Blind Period|Consent Withdrawn|1|||
155730581|NCT01499355|562111632|FG003|Double-Blind Period|Consent Withdrawn|2|||
155730582|NCT01499355|562111629|FG000|Double-Blind Period|Lost to Follow-up|0|||
155730583|NCT01499355|562111630|FG001|Double-Blind Period|Lost to Follow-up|1|||
155730584|NCT01499355|562111631|FG002|Double-Blind Period|Lost to Follow-up|0|||
155730585|NCT01499355|562111632|FG003|Double-Blind Period|Lost to Follow-up|0|||
155730586|NCT02420821|562111634|FG000|Overall Study|Lost to Follow-up|6|||
155730587|NCT02420821|562111635|FG001|Overall Study|Lost to Follow-up|6|||
155730588|NCT02420821|562111634|FG000|Overall Study|Non-compliance|0|||
155730589|NCT02420821|562111635|FG001|Overall Study|Non-compliance|2|||
155730590|NCT02420821|562111634|FG000|Overall Study|Physician Decision|6|||
155730591|NCT02420821|562111635|FG001|Overall Study|Physician Decision|2|||
155730592|NCT02420821|562111634|FG000|Overall Study|Withdrawal by Subject|32|||
155730593|NCT02420821|562111635|FG001|Overall Study|Withdrawal by Subject|25|||
155730594|NCT02420821|562111634|FG000|Overall Study|Death|270|||
155730595|NCT02420821|562111635|FG001|Overall Study|Death|263|||
155730596|NCT02420821|562111634|FG000|Overall Study|Study Terminated By Sponsor|145|||
155730597|NCT02420821|562111635|FG001|Overall Study|Study Terminated By Sponsor|149|||
155730598|NCT02420821|562111634|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
155730599|NCT02420821|562111635|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
155730600|NCT02420821|562111634|FG000|Overall Study|Adverse Event|0|||
155730601|NCT02420821|562111635|FG001|Overall Study|Adverse Event|1|||
155628862|NCT02515227|561737810|FG001|Overall Study|Adverse Event|2|||
155628863|NCT02515227|561737809|FG000|Overall Study|Progressive disease|2|||
155628864|NCT02515227|561737810|FG001|Overall Study|Progressive disease|9|||
155628865|NCT03451071|561737815|FG000|First Vaccine|Withdrawal by Subject|1|||
155628866|NCT03451071|561737815|FG000|Second Vaccine|Lost to Follow-up|19|||
155628867|NCT03451071|561737815|FG000|Third Vaccine|Lost to Follow-up|22|||
155628868|NCT03451071|561737815|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
155628869|NCT03363906|561737820|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
155628870|NCT03363906|561737821|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
155628871|NCT03363906|561737820|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
155628872|NCT03363906|561737821|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
155628873|NCT03363906|561737820|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
155628874|NCT03363906|561737821|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
155628875|NCT03363906|561737820|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
155628876|NCT03363906|561737821|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
155628877|NCT00676143|561737822|FG000|Overall Study|Adverse Event|34|||
155628878|NCT00676143|561737823|FG001|Overall Study|Adverse Event|60|||
155628879|NCT00676143|561737822|FG000|Overall Study|Death|4|||
155628880|NCT00676143|561737823|FG001|Overall Study|Death|4|||
155628881|NCT00676143|561737822|FG000|Overall Study|Lack of Efficacy|0|||
155628882|NCT00676143|561737823|FG001|Overall Study|Lack of Efficacy|6|||
155628883|NCT00676143|561737822|FG000|Overall Study|Lost to Follow-up|0|||
155628884|NCT00676143|561737823|FG001|Overall Study|Lost to Follow-up|13|||
155628885|NCT00676143|561737822|FG000|Overall Study|Physician Decision|5|||
155628886|NCT00676143|561737823|FG001|Overall Study|Physician Decision|8|||
155628887|NCT00676143|561737822|FG000|Overall Study|Protocol Violation|4|||
155628888|NCT00676143|561737823|FG001|Overall Study|Protocol Violation|8|||
155628889|NCT00676143|561737822|FG000|Overall Study|Withdrawal by Subject|24|||
155730602|NCT02420821|562111634|FG000|Overall Study|Protinuria|0|||
155730603|NCT02420821|562111635|FG001|Overall Study|Protinuria|1|||
155730604|NCT02420821|562111634|FG000|Overall Study|Progressive Disease|1|||
155730605|NCT02420821|562111635|FG001|Overall Study|Progressive Disease|1|||
155730606|NCT02420821|562111634|FG000|Overall Study|Disease Progression|0|||
155730607|NCT02420821|562111635|FG001|Overall Study|Disease Progression|1|||
155730608|NCT02420821|562111634|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
155730609|NCT02420821|562111635|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
155730610|NCT03133793|562111644|FG000|Overall Study|Withdrawal by Subject|0|||
155628890|NCT00676143|561737823|FG001|Overall Study|Withdrawal by Subject|42|||
155628891|NCT00676143|561737822|FG000|Overall Study|Discontinuation of study by sponsor|65|||
155628892|NCT00676143|561737823|FG001|Overall Study|Discontinuation of study by sponsor|88|||
155628893|NCT00676143|561737822|FG000|Overall Study|Failed to return|2|||
155628894|NCT00676143|561737823|FG001|Overall Study|Failed to return|1|||
155628895|NCT00676143|561737822|FG000|Overall Study|Loss of caregiver|5|||
155628896|NCT00676143|561737823|FG001|Overall Study|Loss of caregiver|3|||
155628897|NCT00676143|561737822|FG000|Overall Study|Other|11|||
155628898|NCT00676143|561737823|FG001|Overall Study|Other|20|||
155628899|NCT00676143|561737822|FG000|Overall Study|Participant participation unknown|1|||
155628900|NCT00676143|561737823|FG001|Overall Study|Participant participation unknown|4|||
155628901|NCT00676143|561737822|FG000|Overall Study|Vasogenic edema recurrence|1|||
155628902|NCT00676143|561737823|FG001|Overall Study|Vasogenic edema recurrence|3|||
155628903|NCT00929669|561737824|FG000|Overall Study|elevated glucose levels|1|||
155628904|NCT00250588|561737825|FG000|Overall Study|Withdrawal by Subject|3|||
155628905|NCT00250588|561737826|FG001|Overall Study|Withdrawal by Subject|6|||
155628906|NCT00250588|561737827|FG002|Overall Study|Withdrawal by Subject|0|||
155628907|NCT00250588|561737825|FG000|Overall Study|Lost to Follow-up|6|||
155628908|NCT00250588|561737826|FG001|Overall Study|Lost to Follow-up|13|||
155628909|NCT00250588|561737827|FG002|Overall Study|Lost to Follow-up|13|||
155628910|NCT03502798|561737828|FG000|Overall Study|equipment failure|0|||
155628911|NCT03502798|561737829|FG001|Overall Study|equipment failure|7|||
155628912|NCT01027845|561737831|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
155628913|NCT01027845|561737832|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
155628914|NCT01027845|561737833|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
155628915|NCT01027845|561737834|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
155628916|NCT01027845|561737831|FG000|Primary Vaccination Phase|Adverse Event|1|||
155628917|NCT01027845|561737832|FG001|Primary Vaccination Phase|Adverse Event|0|||
155628918|NCT01027845|561737833|FG002|Primary Vaccination Phase|Adverse Event|0|||
155628919|NCT01027845|561737834|FG003|Primary Vaccination Phase|Adverse Event|0|||
155628920|NCT01027845|561737831|FG000|Primary Vaccination Phase|Protocol Violation|1|||
155628921|NCT01027845|561737832|FG001|Primary Vaccination Phase|Protocol Violation|0|||
155628922|NCT01027845|561737833|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155628923|NCT01027845|561737834|FG003|Primary Vaccination Phase|Protocol Violation|0|||
155628924|NCT01027845|561737831|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
155628925|NCT01027845|561737832|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
155628926|NCT01027845|561737833|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
155628927|NCT01027845|561737834|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
155628928|NCT01027845|561737831|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
155628929|NCT01027845|561737832|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155628930|NCT01027845|561737833|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
155628931|NCT01027845|561737834|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
155628932|NCT01027845|561737831|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
155628933|NCT01027845|561737832|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
155628934|NCT01027845|561737833|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
155628935|NCT01027845|561737834|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
155628936|NCT01670292|561737836|FG000|Overall Study|Lost to Follow-up|14|||
155628937|NCT01603277|561737839|FG000|Overall Study|Adverse Event|1|||
155628938|NCT01603277|561737840|FG001|Overall Study|Adverse Event|2|||
155628939|NCT01603277|561737839|FG000|Overall Study|Physician Decision|0|||
155628940|NCT01603277|561737840|FG001|Overall Study|Physician Decision|1|||
155628941|NCT01603277|561737839|FG000|Overall Study|Protocol Violation|6|||
155628942|NCT01603277|561737840|FG001|Overall Study|Protocol Violation|10|||
155628943|NCT01603277|561737839|FG000|Overall Study|Withdrawal by Subject|5|||
155628944|NCT01603277|561737840|FG001|Overall Study|Withdrawal by Subject|4|||
155628945|NCT01603277|561737839|FG000|Overall Study|Non-Compliance|2|||
155628946|NCT01603277|561737840|FG001|Overall Study|Non-Compliance|1|||
155628947|NCT00087178|561737841|FG000|Overall Study|No follow up data|5|||
155628948|NCT00087178|561737842|FG001|Overall Study|No follow up data|15|||
155628949|NCT00087178|561737841|FG000|Overall Study|No clinical assessment|1|||
155628950|NCT00087178|561737842|FG001|Overall Study|No clinical assessment|2|||
155628951|NCT00087178|561737841|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
155628952|NCT00087178|561737842|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
155628953|NCT01692119|561737845|FG000|Overall Study|Protocol Violation|3|||
155628954|NCT01692119|561737846|FG001|Overall Study|Protocol Violation|1|||
155628955|NCT01692119|561737845|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
155628956|NCT01692119|561737846|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
155628957|NCT01192815|561737856|FG000|Overall Study|Withdrawal by Subject|1|||
155388095|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Adverse Event|1|||
155628958|NCT01192815|561737856|FG000|Overall Study|Lack of Efficacy|1|||
155628959|NCT03451045|561737857|FG000|Overall Study|Lack of Efficacy|3|||
155628960|NCT03451045|561737858|FG001|Overall Study|Lack of Efficacy|2|||
155628961|NCT03451045|561737859|FG002|Overall Study|Lack of Efficacy|2|||
155628962|NCT03451045|561737857|FG000|Overall Study|Physician Decision|1|||
155628963|NCT03451045|561737858|FG001|Overall Study|Physician Decision|1|||
155628964|NCT03451045|561737859|FG002|Overall Study|Physician Decision|1|||
155628965|NCT03451045|561737857|FG000|Overall Study|Withdrawal by Subject|4|||
155628966|NCT03451045|561737858|FG001|Overall Study|Withdrawal by Subject|0|||
155730611|NCT03133793|562111645|FG001|Overall Study|Withdrawal by Subject|4|||
155730612|NCT03133793|562111646|FG002|Overall Study|Withdrawal by Subject|2|||
155730613|NCT03133793|562111647|FG003|Overall Study|Withdrawal by Subject|4|||
155730614|NCT03133793|562111644|FG000|Overall Study|Lost to Follow-up|1|||
155730615|NCT03133793|562111645|FG001|Overall Study|Lost to Follow-up|0|||
155730616|NCT03133793|562111646|FG002|Overall Study|Lost to Follow-up|2|||
155730617|NCT03133793|562111647|FG003|Overall Study|Lost to Follow-up|0|||
155730618|NCT03133793|562111644|FG000|Overall Study|Death|0|||
155730619|NCT03133793|562111645|FG001|Overall Study|Death|0|||
155730620|NCT03133793|562111646|FG002|Overall Study|Death|0|||
155730621|NCT03133793|562111647|FG003|Overall Study|Death|1|||
155730622|NCT03486834|562111648|FG000|Overall Study|Withdrawal by Subject|46|||
155730623|NCT03486834|562111649|FG001|Overall Study|Withdrawal by Subject|46|||
155730624|NCT03486834|562111650|FG002|Overall Study|Withdrawal by Subject|52|||
155730625|NCT03486834|562111648|FG000|Overall Study|Adverse Event|8|||
155730626|NCT03486834|562111649|FG001|Overall Study|Adverse Event|7|||
155730627|NCT03486834|562111650|FG002|Overall Study|Adverse Event|0|||
155730628|NCT03486834|562111648|FG000|Overall Study|Lost to Follow-up|41|||
155730629|NCT03486834|562111649|FG001|Overall Study|Lost to Follow-up|24|||
155730630|NCT03486834|562111650|FG002|Overall Study|Lost to Follow-up|39|||
155730631|NCT03486834|562111648|FG000|Overall Study|Non-compliance with Study Drug|2|||
155730632|NCT03486834|562111649|FG001|Overall Study|Non-compliance with Study Drug|2|||
155730633|NCT03486834|562111650|FG002|Overall Study|Non-compliance with Study Drug|0|||
155730634|NCT03486834|562111648|FG000|Overall Study|Physician Decision|5|||
155730635|NCT03486834|562111649|FG001|Overall Study|Physician Decision|2|||
155730636|NCT03486834|562111650|FG002|Overall Study|Physician Decision|3|||
155730637|NCT03486834|562111648|FG000|Overall Study|Pregnancy|10|||
155730638|NCT03486834|562111649|FG001|Overall Study|Pregnancy|12|||
155730639|NCT03486834|562111650|FG002|Overall Study|Pregnancy|12|||
155730640|NCT03486834|562111648|FG000|Overall Study|Protocol Deviation|2|||
155730641|NCT03486834|562111649|FG001|Overall Study|Protocol Deviation|3|||
155730642|NCT03486834|562111650|FG002|Overall Study|Protocol Deviation|3|||
155730643|NCT03486834|562111648|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155730644|NCT03486834|562111649|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155730645|NCT03486834|562111650|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155730646|NCT03486834|562111648|FG000|Overall Study|Randomized but not treated|4|||
155730647|NCT03486834|562111649|FG001|Overall Study|Randomized but not treated|4|||
155730648|NCT03486834|562111650|FG002|Overall Study|Randomized but not treated|1|||
155730649|NCT02745119|562111652|FG000|Overall Study|Adverse Event|1|||
155730650|NCT02745119|562111653|FG001|Overall Study|Adverse Event|0|||
155730651|NCT02745119|562111654|FG002|Overall Study|Adverse Event|1|||
155730652|NCT02745119|562111655|FG003|Overall Study|Adverse Event|3|||
155730653|NCT02745119|562111652|FG000|Overall Study|Death|3|||
155730654|NCT02745119|562111653|FG001|Overall Study|Death|3|||
155730655|NCT02745119|562111654|FG002|Overall Study|Death|0|||
155730656|NCT02745119|562111655|FG003|Overall Study|Death|4|||
155730657|NCT02745119|562111652|FG000|Overall Study|Lost to Follow-up|0|||
155730658|NCT02745119|562111653|FG001|Overall Study|Lost to Follow-up|0|||
155730659|NCT02745119|562111654|FG002|Overall Study|Lost to Follow-up|0|||
155730660|NCT02745119|562111655|FG003|Overall Study|Lost to Follow-up|1|||
155730661|NCT02745119|562111652|FG000|Overall Study|Protocol Deviation|0|||
155730662|NCT02745119|562111653|FG001|Overall Study|Protocol Deviation|0|||
155730663|NCT02745119|562111654|FG002|Overall Study|Protocol Deviation|0|||
155730664|NCT02745119|562111655|FG003|Overall Study|Protocol Deviation|1|||
155730665|NCT02745119|562111652|FG000|Overall Study|Withdrawal by Subject|7|||
155730666|NCT02745119|562111653|FG001|Overall Study|Withdrawal by Subject|15|||
155730667|NCT02745119|562111654|FG002|Overall Study|Withdrawal by Subject|8|||
155730668|NCT02745119|562111655|FG003|Overall Study|Withdrawal by Subject|14|||
155730669|NCT02745119|562111652|FG000|Overall Study|Study Terminated by Sponsor|134|||
155730670|NCT02745119|562111653|FG001|Overall Study|Study Terminated by Sponsor|252|||
155730671|NCT02745119|562111654|FG002|Overall Study|Study Terminated by Sponsor|135|||
155730672|NCT02745119|562111655|FG003|Overall Study|Study Terminated by Sponsor|251|||
155730673|NCT02745119|562111652|FG000|Overall Study|Physician Decision|0|||
155730674|NCT02745119|562111653|FG001|Overall Study|Physician Decision|2|||
155730675|NCT02745119|562111654|FG002|Overall Study|Physician Decision|2|||
155730676|NCT02745119|562111655|FG003|Overall Study|Physician Decision|2|||
155730677|NCT02745119|562111652|FG000|Overall Study|Reason Not Specified|0|||
155730678|NCT02745119|562111653|FG001|Overall Study|Reason Not Specified|2|||
155730679|NCT02745119|562111654|FG002|Overall Study|Reason Not Specified|0|||
155730680|NCT02745119|562111655|FG003|Overall Study|Reason Not Specified|1|||
155730681|NCT00960999|562111656|FG000|Overall Study|Withdrawal by Subject|1|||
155730682|NCT00960999|562111657|FG001|Overall Study|Withdrawal by Subject|0|||
155730683|NCT00960999|562111656|FG000|Overall Study|Protocol Violation|5|||
155730684|NCT00960999|562111657|FG001|Overall Study|Protocol Violation|2|||
155730685|NCT00960999|562111656|FG000|Overall Study|RT dose constraints not met|2|||
155730686|NCT00960999|562111657|FG001|Overall Study|RT dose constraints not met|0|||
155730687|NCT00432172|562111658|FG000|Overall Study|Physician Decision|0|||
155730688|NCT00432172|562111659|FG001|Overall Study|Physician Decision|0|||
155730689|NCT00432172|562111660|FG002|Overall Study|Physician Decision|2|||
155730690|NCT00432172|562111661|FG003|Overall Study|Physician Decision|0|||
155388096|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
155388097|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
155388098|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
155388099|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
155388100|NCT03037619|560855032|FG000|Overall Study|Lost to Follow-up|0|||
155388101|NCT03037619|560855033|FG001|Overall Study|Lost to Follow-up|1|||
155388102|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
155388103|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
155388104|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
155388105|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
155388106|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
155388107|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
155388108|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
155388109|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
155388110|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
155388111|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
155388112|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
155388113|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
155388114|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
155388115|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
155388116|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
155388117|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
155388118|NCT01294683|560855036|FG000|Post Crossover (Period III)|Adverse Event|6|||
155388119|NCT01294683|560855037|FG001|Post Crossover (Period III)|Adverse Event|6|||
155628967|NCT03451045|561737859|FG002|Overall Study|Withdrawal by Subject|5|||
155628968|NCT03451045|561737857|FG000|Overall Study|Pregnancy|0|||
155628969|NCT03451045|561737858|FG001|Overall Study|Pregnancy|0|||
155628970|NCT03451045|561737859|FG002|Overall Study|Pregnancy|2|||
155628971|NCT03451045|561737857|FG000|Overall Study|Adverse Event|7|||
155628972|NCT03451045|561737858|FG001|Overall Study|Adverse Event|1|||
155628973|NCT03451045|561737859|FG002|Overall Study|Adverse Event|3|||
155628974|NCT03451045|561737857|FG000|Overall Study|Non-compliance with study|2|||
155628975|NCT03451045|561737858|FG001|Overall Study|Non-compliance with study|0|||
155628976|NCT03451045|561737859|FG002|Overall Study|Non-compliance with study|1|||
155628977|NCT03451045|561737857|FG000|Overall Study|any other reason|10|||
155628978|NCT03451045|561737858|FG001|Overall Study|any other reason|2|||
155628979|NCT03451045|561737859|FG002|Overall Study|any other reason|13|||
155628980|NCT04142242|561737860|FG000|Stage I|Non-compliance with the protocol|1|||
155628981|NCT04142242|561737861|FG001|Stage I|Non-compliance with the protocol|0|||
155628982|NCT04142242|561737862|FG002|Stage I|Non-compliance with the protocol|0|||
155628983|NCT04142242|561737863|FG003|Stage I|Non-compliance with the protocol|0|||
155628984|NCT04142242|561737864|FG004|Stage I|Non-compliance with the protocol|0|||
155628985|NCT04142242|561737865|FG005|Stage I|Non-compliance with the protocol|1|||
155628986|NCT04142242|561737860|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155628987|NCT04142242|561737861|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
155628988|NCT04142242|561737862|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155628989|NCT04142242|561737863|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155628990|NCT04142242|561737864|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155628991|NCT04142242|561737865|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155628992|NCT04142242|561737860|FG000|Stage II|Non-compliance with the protocol|0|||
155628993|NCT04142242|561737861|FG001|Stage II|Non-compliance with the protocol|0|||
155628994|NCT04142242|561737862|FG002|Stage II|Non-compliance with the protocol|0|||
155628995|NCT04142242|561737863|FG003|Stage II|Non-compliance with the protocol|2|||
155628996|NCT04142242|561737864|FG004|Stage II|Non-compliance with the protocol|0|||
155628997|NCT04142242|561737865|FG005|Stage II|Non-compliance with the protocol|0|||
155628998|NCT04142242|561737860|FG000|Stage II|Lost to Follow-up|0|||
155628999|NCT04142242|561737861|FG001|Stage II|Lost to Follow-up|0|||
155629000|NCT04142242|561737862|FG002|Stage II|Lost to Follow-up|1|||
155629001|NCT04142242|561737863|FG003|Stage II|Lost to Follow-up|2|||
155629002|NCT04142242|561737864|FG004|Stage II|Lost to Follow-up|0|||
155629003|NCT04142242|561737865|FG005|Stage II|Lost to Follow-up|0|||
155629004|NCT04142242|561737860|FG000|Stage II|Withdrawal by Subject|0|||
155629005|NCT04142242|561737861|FG001|Stage II|Withdrawal by Subject|0|||
155629006|NCT04142242|561737862|FG002|Stage II|Withdrawal by Subject|5|||
155629007|NCT04142242|561737863|FG003|Stage II|Withdrawal by Subject|9|||
155730691|NCT00432172|562111658|FG000|Overall Study|Adverse Event|4|||
155629008|NCT04142242|561737864|FG004|Stage II|Withdrawal by Subject|0|||
155629009|NCT04142242|561737865|FG005|Stage II|Withdrawal by Subject|0|||
155629010|NCT05063448|561737871|FG000|Overall Study|Withdrawal by Subject|1|||
155629011|NCT02475369|561737872|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
155629012|NCT02475369|561737873|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
155629013|NCT04798027|561737882|FG000|Overall Study|Protocol Violation|0|||
155730692|NCT00432172|562111659|FG001|Overall Study|Adverse Event|2|||
155730693|NCT00432172|562111660|FG002|Overall Study|Adverse Event|4|||
155730694|NCT00432172|562111661|FG003|Overall Study|Adverse Event|3|||
155730695|NCT00432172|562111658|FG000|Overall Study|Disease progression|0|||
155730696|NCT00432172|562111659|FG001|Overall Study|Disease progression|2|||
155730697|NCT00432172|562111660|FG002|Overall Study|Disease progression|5|||
155730698|NCT00432172|562111661|FG003|Overall Study|Disease progression|1|||
155730699|NCT00432172|562111658|FG000|Overall Study|Withdrawal by Subject|0|||
155730700|NCT00432172|562111659|FG001|Overall Study|Withdrawal by Subject|1|||
155730701|NCT00432172|562111660|FG002|Overall Study|Withdrawal by Subject|0|||
155730702|NCT00432172|562111661|FG003|Overall Study|Withdrawal by Subject|2|||
155730703|NCT00432172|562111658|FG000|Overall Study|No treatment received|2|||
155730704|NCT00432172|562111659|FG001|Overall Study|No treatment received|2|||
155730705|NCT00432172|562111660|FG002|Overall Study|No treatment received|0|||
155730706|NCT00432172|562111661|FG003|Overall Study|No treatment received|1|||
155730707|NCT02536963|562111662|FG000|Overall Study|Withdrawal by Subject|18|||
155730708|NCT02668393|562111663|FG000|Overall Study|Progressive disease|6|||
155730709|NCT02668393|562111664|FG001|Overall Study|Progressive disease|3|||
155730710|NCT02668393|562111663|FG000|Overall Study|Adverse Event|0|||
155730711|NCT02668393|562111664|FG001|Overall Study|Adverse Event|2|||
155730712|NCT02668393|562111663|FG000|Overall Study|Withdrawal from the trial|0|||
155730713|NCT02668393|562111664|FG001|Overall Study|Withdrawal from the trial|1|||
155730714|NCT02668393|562111663|FG000|Overall Study|Lack of benefit and side effects|1|||
155730715|NCT02668393|562111664|FG001|Overall Study|Lack of benefit and side effects|0|||
155730716|NCT02141204|562111665|FG000|Overall Study|Lost to Follow-up|2|||
155730717|NCT02141204|562111666|FG001|Overall Study|Lost to Follow-up|1|||
155730718|NCT02141204|562111665|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
155730719|NCT02141204|562111666|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
155730720|NCT02141204|562111665|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155730721|NCT02141204|562111666|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
155730722|NCT02141204|562111665|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
155730723|NCT02141204|562111666|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
155730724|NCT00515619|562111669|FG000|Overall Study|Adverse Event|34|||
155730725|NCT00515619|562111669|FG000|Overall Study|Lack of Efficacy|92|||
155730726|NCT00515619|562111669|FG000|Overall Study|Withdrawal by Subject|66|||
155730727|NCT00515619|562111669|FG000|Overall Study|Protocol Violation|3|||
155730728|NCT00515619|562111669|FG000|Overall Study|Lost to Follow-up|4|||
155730729|NCT00515619|562111669|FG000|Overall Study|Unsatisfactory compliance|6|||
155730730|NCT00515619|562111669|FG000|Overall Study|Other: Site discontinuing trials|2|||
155730731|NCT00515619|562111669|FG000|Overall Study|Other: Subject cannot attend visits|2|||
155730732|NCT00515619|562111669|FG000|Overall Study|Other: Subject required surgery|1|||
155730733|NCT00515619|562111669|FG000|Overall Study|Other: Subject moved to another country|1|||
155730734|NCT00515619|562111669|FG000|Overall Study|Other: Investigator decision|1|||
155730735|NCT00515619|562111669|FG000|Overall Study|Other: Subject became pregnant|1|||
155730736|NCT00515619|562111669|FG000|Overall Study|Other: Request from sponsor|1|||
155730737|NCT00515619|562111669|FG000|Overall Study|Other: Drug available on license|1|||
155730738|NCT00515619|562111669|FG000|Overall Study|Other: Subject interested in other AED|1|||
155730739|NCT02379091|562111670|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155730740|NCT02379091|562111671|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155730741|NCT02379091|562111672|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155730742|NCT02379091|562111673|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155730743|NCT02379091|562111670|FG000|Overall Study|Principal Investigator Discretion|0|||
155730744|NCT02379091|562111671|FG001|Overall Study|Principal Investigator Discretion|1|||
155730745|NCT02379091|562111672|FG002|Overall Study|Principal Investigator Discretion|0|||
155730746|NCT02379091|562111673|FG003|Overall Study|Principal Investigator Discretion|0|||
155730747|NCT02379091|562111670|FG000|Overall Study|Lost to Follow-up|0|||
155730748|NCT02379091|562111671|FG001|Overall Study|Lost to Follow-up|0|||
155730749|NCT02379091|562111672|FG002|Overall Study|Lost to Follow-up|0|||
155730750|NCT02379091|562111673|FG003|Overall Study|Lost to Follow-up|1|||
155730751|NCT02379091|562111670|FG000|Overall Study|Voluntary Withdrawal|2|||
155730752|NCT02379091|562111671|FG001|Overall Study|Voluntary Withdrawal|5|||
155730753|NCT02379091|562111672|FG002|Overall Study|Voluntary Withdrawal|2|||
155730754|NCT02379091|562111673|FG003|Overall Study|Voluntary Withdrawal|4|||
155730755|NCT02379091|562111670|FG000|Overall Study|Study Termination|7|||
155730756|NCT02379091|562111671|FG001|Overall Study|Study Termination|2|||
155730757|NCT02379091|562111672|FG002|Overall Study|Study Termination|5|||
155730758|NCT02379091|562111673|FG003|Overall Study|Study Termination|8|||
155730759|NCT02379091|562111670|FG000|Overall Study|Lack of Efficacy|3|||
155730760|NCT02379091|562111671|FG001|Overall Study|Lack of Efficacy|0|||
155730761|NCT02379091|562111672|FG002|Overall Study|Lack of Efficacy|0|||
155730762|NCT02379091|562111673|FG003|Overall Study|Lack of Efficacy|0|||
155730763|NCT03326713|562111675|FG000|Overall Study|Death|2|||
155730764|NCT03326713|562111676|FG001|Overall Study|Death|1|||
155730765|NCT03326713|562111677|FG002|Overall Study|Death|0|||
155730766|NCT03326713|562111675|FG000|Overall Study|Lost to Follow-up|20|||
155730767|NCT03326713|562111676|FG001|Overall Study|Lost to Follow-up|21|||
155730768|NCT03326713|562111677|FG002|Overall Study|Lost to Follow-up|33|||
155730769|NCT03326713|562111675|FG000|Overall Study|Withdrawal by Subject|1|||
155730770|NCT03326713|562111676|FG001|Overall Study|Withdrawal by Subject|2|||
155730771|NCT03326713|562111677|FG002|Overall Study|Withdrawal by Subject|11|||
155730772|NCT03326713|562111675|FG000|Overall Study|Found Ineligible|11|||
155730773|NCT03326713|562111676|FG001|Overall Study|Found Ineligible|11|||
155730774|NCT03326713|562111677|FG002|Overall Study|Found Ineligible|8|||
155730775|NCT00771758|562111678|FG000|Overall Study|Adverse Event|2|||
155730776|NCT00771758|562111679|FG001|Overall Study|Adverse Event|8|||
155730777|NCT00771758|562111680|FG002|Overall Study|Adverse Event|1|||
155730778|NCT00771758|562111678|FG000|Overall Study|Lack of Efficacy|0|||
155730779|NCT00771758|562111679|FG001|Overall Study|Lack of Efficacy|2|||
155730780|NCT00771758|562111680|FG002|Overall Study|Lack of Efficacy|1|||
155730781|NCT00771758|562111678|FG000|Overall Study|Lost to Follow-up|1|||
155730782|NCT00771758|562111679|FG001|Overall Study|Lost to Follow-up|0|||
155730783|NCT00771758|562111680|FG002|Overall Study|Lost to Follow-up|0|||
155730784|NCT00771758|562111678|FG000|Overall Study|Protocol Violation|1|||
155730785|NCT00771758|562111679|FG001|Overall Study|Protocol Violation|0|||
155730786|NCT00771758|562111680|FG002|Overall Study|Protocol Violation|0|||
155730787|NCT00771758|562111678|FG000|Overall Study|Withdrawal by Subject|1|||
155730788|NCT00771758|562111679|FG001|Overall Study|Withdrawal by Subject|0|||
155730789|NCT00771758|562111680|FG002|Overall Study|Withdrawal by Subject|0|||
155730790|NCT00771758|562111678|FG000|Overall Study|Other|3|||
155730791|NCT00771758|562111679|FG001|Overall Study|Other|2|||
155730792|NCT00771758|562111680|FG002|Overall Study|Other|0|||
155730793|NCT03067077|562111681|FG000|Overall Study|Did not receive surgery|4|||
155730794|NCT03067077|562111682|FG001|Overall Study|Did not receive surgery|5|||
155730795|NCT03067077|562111681|FG000|Overall Study|Lost to Follow-up|3|||
155730796|NCT03067077|562111682|FG001|Overall Study|Lost to Follow-up|2|||
155730797|NCT00935584|562111683|FG000|Overall Study|Withdrawal by Subject|9|||
155730798|NCT00935584|562111684|FG001|Overall Study|Withdrawal by Subject|0|||
155730799|NCT00935584|562111683|FG000|Overall Study|Death|3|||
155730800|NCT00935584|562111684|FG001|Overall Study|Death|0|||
155730801|NCT00935584|562111683|FG000|Overall Study|Lost to Follow-up|8|||
155730802|NCT00935584|562111684|FG001|Overall Study|Lost to Follow-up|0|||
155730803|NCT00935584|562111683|FG000|Overall Study|No show|9|||
155730804|NCT00935584|562111684|FG001|Overall Study|No show|0|||
155730805|NCT00935584|562111683|FG000|Overall Study|Relocated|3|||
155730806|NCT00935584|562111684|FG001|Overall Study|Relocated|0|||
155730807|NCT00935584|562111683|FG000|Overall Study|Patient changed provider|3|||
155730808|NCT00935584|562111684|FG001|Overall Study|Patient changed provider|0|||
155730809|NCT00935584|562111683|FG000|Overall Study|Provider dropped out of study|14|||
155730810|NCT00935584|562111684|FG001|Overall Study|Provider dropped out of study|4|||
155730811|NCT00687193|562111685|FG000|Overall Study|Adverse Event|0|||
155730812|NCT00687193|562111686|FG001|Overall Study|Adverse Event|1|||
155730813|NCT00687193|562111687|FG002|Overall Study|Adverse Event|2|||
155730814|NCT00687193|562111688|FG003|Overall Study|Adverse Event|3|||
155730815|NCT00687193|562111689|FG004|Overall Study|Adverse Event|0|||
155730816|NCT00687193|562111690|FG005|Overall Study|Adverse Event|2|||
155730817|NCT00687193|562111685|FG000|Overall Study|Lack of Efficacy|1|||
155730818|NCT00687193|562111686|FG001|Overall Study|Lack of Efficacy|1|||
155730819|NCT00687193|562111687|FG002|Overall Study|Lack of Efficacy|0|||
155730820|NCT00687193|562111688|FG003|Overall Study|Lack of Efficacy|0|||
155730821|NCT00687193|562111689|FG004|Overall Study|Lack of Efficacy|0|||
155730822|NCT00687193|562111690|FG005|Overall Study|Lack of Efficacy|2|||
155730823|NCT00687193|562111685|FG000|Overall Study|Protocol Violation|1|||
155730824|NCT00687193|562111686|FG001|Overall Study|Protocol Violation|2|||
155730825|NCT00687193|562111687|FG002|Overall Study|Protocol Violation|0|||
155730826|NCT00687193|562111688|FG003|Overall Study|Protocol Violation|1|||
155730827|NCT00687193|562111689|FG004|Overall Study|Protocol Violation|2|||
155730828|NCT00687193|562111690|FG005|Overall Study|Protocol Violation|0|||
155730829|NCT02129699|562111691|FG000|Overall Study|Did not start treatment|3|||
155730830|NCT02129699|562111692|FG001|Overall Study|Did not start treatment|2|||
155730831|NCT01394016|562111693|FG000|Overall Study|Progressive Disease|2|||
155730832|NCT01394016|562111694|FG001|Overall Study|Progressive Disease|0|||
155730833|NCT01394016|562111695|FG002|Overall Study|Progressive Disease|0|||
155730834|NCT01394016|562111696|FG003|Overall Study|Progressive Disease|0|||
155730835|NCT01394016|562111697|FG004|Overall Study|Progressive Disease|0|||
155730836|NCT01394016|562111698|FG005|Overall Study|Progressive Disease|0|||
155730837|NCT01394016|562111699|FG006|Overall Study|Progressive Disease|0|||
155730838|NCT01394016|562111700|FG007|Overall Study|Progressive Disease|0|||
155730839|NCT01394016|562111701|FG008|Overall Study|Progressive Disease|0|||
155730840|NCT01394016|562111702|FG009|Overall Study|Progressive Disease|0|||
155730841|NCT01394016|562111703|FG010|Overall Study|Progressive Disease|0|||
155730842|NCT01394016|562111704|FG011|Overall Study|Progressive Disease|0|||
155730843|NCT01394016|562111705|FG012|Overall Study|Progressive Disease|0|||
155730844|NCT01394016|562111706|FG013|Overall Study|Progressive Disease|0|||
155730845|NCT01394016|562111707|FG014|Overall Study|Progressive Disease|0|||
155730846|NCT01394016|562111708|FG015|Overall Study|Progressive Disease|0|||
155730847|NCT01394016|562111709|FG016|Overall Study|Progressive Disease|0|||
155730848|NCT01394016|562111710|FG017|Overall Study|Progressive Disease|0|||
155730849|NCT01394016|562111711|FG018|Overall Study|Progressive Disease|0|||
155730850|NCT01394016|562111693|FG000|Overall Study|Withdrawal by Subject|0|||
155730851|NCT01394016|562111694|FG001|Overall Study|Withdrawal by Subject|0|||
155730852|NCT01394016|562111695|FG002|Overall Study|Withdrawal by Subject|0|||
155730853|NCT01394016|562111696|FG003|Overall Study|Withdrawal by Subject|0|||
155730854|NCT01394016|562111697|FG004|Overall Study|Withdrawal by Subject|0|||
155730855|NCT01394016|562111698|FG005|Overall Study|Withdrawal by Subject|0|||
155730856|NCT01394016|562111699|FG006|Overall Study|Withdrawal by Subject|0|||
155730857|NCT01394016|562111700|FG007|Overall Study|Withdrawal by Subject|1|||
155730858|NCT01394016|562111701|FG008|Overall Study|Withdrawal by Subject|1|||
155730859|NCT01394016|562111702|FG009|Overall Study|Withdrawal by Subject|1|||
155730860|NCT01394016|562111703|FG010|Overall Study|Withdrawal by Subject|4|||
155730861|NCT01394016|562111704|FG011|Overall Study|Withdrawal by Subject|0|||
155730862|NCT01394016|562111705|FG012|Overall Study|Withdrawal by Subject|0|||
155730863|NCT01394016|562111706|FG013|Overall Study|Withdrawal by Subject|3|||
155730864|NCT01394016|562111707|FG014|Overall Study|Withdrawal by Subject|1|||
155730865|NCT01394016|562111708|FG015|Overall Study|Withdrawal by Subject|3|||
155730866|NCT01394016|562111709|FG016|Overall Study|Withdrawal by Subject|1|||
155730867|NCT01394016|562111710|FG017|Overall Study|Withdrawal by Subject|1|||
155730868|NCT01394016|562111711|FG018|Overall Study|Withdrawal by Subject|2|||
155730869|NCT01394016|562111693|FG000|Overall Study|Adverse Event|0|||
155730870|NCT01394016|562111694|FG001|Overall Study|Adverse Event|0|||
155730871|NCT01394016|562111695|FG002|Overall Study|Adverse Event|0|||
155730872|NCT01394016|562111696|FG003|Overall Study|Adverse Event|0|||
155730873|NCT01394016|562111697|FG004|Overall Study|Adverse Event|0|||
155730874|NCT01394016|562111698|FG005|Overall Study|Adverse Event|0|||
155730875|NCT01394016|562111699|FG006|Overall Study|Adverse Event|0|||
155730876|NCT01394016|562111700|FG007|Overall Study|Adverse Event|0|||
155730877|NCT01394016|562111701|FG008|Overall Study|Adverse Event|0|||
155730878|NCT01394016|562111702|FG009|Overall Study|Adverse Event|1|||
155730879|NCT01394016|562111703|FG010|Overall Study|Adverse Event|0|||
155730880|NCT01394016|562111704|FG011|Overall Study|Adverse Event|0|||
155730881|NCT01394016|562111705|FG012|Overall Study|Adverse Event|0|||
155730882|NCT01394016|562111706|FG013|Overall Study|Adverse Event|0|||
155730883|NCT01394016|562111707|FG014|Overall Study|Adverse Event|0|||
155730884|NCT01394016|562111708|FG015|Overall Study|Adverse Event|0|||
155730885|NCT01394016|562111709|FG016|Overall Study|Adverse Event|1|||
155730886|NCT01394016|562111710|FG017|Overall Study|Adverse Event|1|||
155730887|NCT01394016|562111711|FG018|Overall Study|Adverse Event|0|||
155730888|NCT01394016|562111693|FG000|Overall Study|Sponsor Decision|0|||
155730889|NCT01394016|562111694|FG001|Overall Study|Sponsor Decision|0|||
155730890|NCT01394016|562111695|FG002|Overall Study|Sponsor Decision|0|||
155730891|NCT01394016|562111696|FG003|Overall Study|Sponsor Decision|0|||
155730892|NCT01394016|562111697|FG004|Overall Study|Sponsor Decision|0|||
155730893|NCT01394016|562111698|FG005|Overall Study|Sponsor Decision|0|||
155730894|NCT01394016|562111699|FG006|Overall Study|Sponsor Decision|0|||
155730895|NCT01394016|562111700|FG007|Overall Study|Sponsor Decision|0|||
155730896|NCT01394016|562111701|FG008|Overall Study|Sponsor Decision|0|||
155730897|NCT01394016|562111702|FG009|Overall Study|Sponsor Decision|0|||
155730898|NCT01394016|562111703|FG010|Overall Study|Sponsor Decision|0|||
155730899|NCT01394016|562111704|FG011|Overall Study|Sponsor Decision|0|||
155730900|NCT01394016|562111705|FG012|Overall Study|Sponsor Decision|1|||
155730901|NCT01394016|562111706|FG013|Overall Study|Sponsor Decision|0|||
155730902|NCT01394016|562111707|FG014|Overall Study|Sponsor Decision|0|||
155730903|NCT01394016|562111708|FG015|Overall Study|Sponsor Decision|0|||
155730904|NCT01394016|562111709|FG016|Overall Study|Sponsor Decision|0|||
155730905|NCT01394016|562111710|FG017|Overall Study|Sponsor Decision|0|||
155281308|NCT04955626|560459893|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281309|NCT04955626|560459894|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281310|NCT04955626|560459895|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730906|NCT01394016|562111711|FG018|Overall Study|Sponsor Decision|0|||
155730907|NCT01394016|562111693|FG000|Overall Study|Lost to Follow-up|0|||
155730908|NCT01394016|562111694|FG001|Overall Study|Lost to Follow-up|0|||
155730909|NCT01394016|562111695|FG002|Overall Study|Lost to Follow-up|0|||
155730910|NCT01394016|562111696|FG003|Overall Study|Lost to Follow-up|0|||
155730911|NCT01394016|562111697|FG004|Overall Study|Lost to Follow-up|0|||
155730912|NCT01394016|562111698|FG005|Overall Study|Lost to Follow-up|0|||
155730913|NCT01394016|562111699|FG006|Overall Study|Lost to Follow-up|0|||
155730914|NCT01394016|562111700|FG007|Overall Study|Lost to Follow-up|0|||
155730915|NCT01394016|562111701|FG008|Overall Study|Lost to Follow-up|0|||
155730916|NCT01394016|562111702|FG009|Overall Study|Lost to Follow-up|0|||
155730917|NCT01394016|562111703|FG010|Overall Study|Lost to Follow-up|0|||
155730918|NCT01394016|562111704|FG011|Overall Study|Lost to Follow-up|0|||
155730919|NCT01394016|562111705|FG012|Overall Study|Lost to Follow-up|0|||
155730920|NCT01394016|562111706|FG013|Overall Study|Lost to Follow-up|0|||
155730921|NCT01394016|562111707|FG014|Overall Study|Lost to Follow-up|0|||
155730922|NCT01394016|562111708|FG015|Overall Study|Lost to Follow-up|0|||
155730923|NCT01394016|562111709|FG016|Overall Study|Lost to Follow-up|0|||
155629014|NCT04798027|561737883|FG001|Overall Study|Protocol Violation|0|||
155629015|NCT04798027|561737884|FG002|Overall Study|Protocol Violation|0|||
155629016|NCT04798027|561737885|FG003|Overall Study|Protocol Violation|0|||
155629017|NCT04798027|561737886|FG004|Overall Study|Protocol Violation|1|||
155629018|NCT04798027|561737887|FG005|Overall Study|Protocol Violation|0|||
155629019|NCT04798027|561737888|FG006|Overall Study|Protocol Violation|0|||
155629020|NCT04798027|561737889|FG007|Overall Study|Protocol Violation|1|||
155629021|NCT04798027|561737890|FG008|Overall Study|Protocol Violation|0|||
155629022|NCT04798027|561737882|FG000|Overall Study|Withdrawal by Subject|1|||
155629023|NCT04798027|561737883|FG001|Overall Study|Withdrawal by Subject|0|||
155629024|NCT04798027|561737884|FG002|Overall Study|Withdrawal by Subject|1|||
155629025|NCT04798027|561737885|FG003|Overall Study|Withdrawal by Subject|1|||
155629026|NCT04798027|561737886|FG004|Overall Study|Withdrawal by Subject|1|||
155629027|NCT04798027|561737887|FG005|Overall Study|Withdrawal by Subject|1|||
155629028|NCT04798027|561737888|FG006|Overall Study|Withdrawal by Subject|3|||
155629029|NCT04798027|561737889|FG007|Overall Study|Withdrawal by Subject|2|||
155629030|NCT04798027|561737890|FG008|Overall Study|Withdrawal by Subject|2|||
155629031|NCT04798027|561737882|FG000|Overall Study|Lost to Follow-up|1|||
155629032|NCT04798027|561737883|FG001|Overall Study|Lost to Follow-up|3|||
155629033|NCT04798027|561737884|FG002|Overall Study|Lost to Follow-up|0|||
155629034|NCT04798027|561737885|FG003|Overall Study|Lost to Follow-up|0|||
155629035|NCT04798027|561737886|FG004|Overall Study|Lost to Follow-up|0|||
155629036|NCT04798027|561737887|FG005|Overall Study|Lost to Follow-up|1|||
155629037|NCT04798027|561737888|FG006|Overall Study|Lost to Follow-up|0|||
155629038|NCT04798027|561737889|FG007|Overall Study|Lost to Follow-up|0|||
155629039|NCT04798027|561737890|FG008|Overall Study|Lost to Follow-up|1|||
155629040|NCT04798027|561737882|FG000|Overall Study|Withdrawal by Sponsor|8|||
155629041|NCT04798027|561737883|FG001|Overall Study|Withdrawal by Sponsor|22|||
155629042|NCT04798027|561737884|FG002|Overall Study|Withdrawal by Sponsor|9|||
155629043|NCT04798027|561737885|FG003|Overall Study|Withdrawal by Sponsor|26|||
155629044|NCT04798027|561737886|FG004|Overall Study|Withdrawal by Sponsor|24|||
155629045|NCT04798027|561737887|FG005|Overall Study|Withdrawal by Sponsor|11|||
155629046|NCT04798027|561737888|FG006|Overall Study|Withdrawal by Sponsor|25|||
155629047|NCT04798027|561737889|FG007|Overall Study|Withdrawal by Sponsor|26|||
155629048|NCT04798027|561737890|FG008|Overall Study|Withdrawal by Sponsor|11|||
155629049|NCT03210714|561737891|FG000|Overall Study|Adverse Event|6|||
155629050|NCT03210714|561737891|FG000|Overall Study|Physician Decision|1|||
155629051|NCT03210714|561737891|FG000|Overall Study|Progressive disease|11|||
155629052|NCT03210714|561737891|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
155629053|NCT00803179|561737892|FG000|Overall Study|Lost to Follow-up|3|||
155629054|NCT04609514|561737893|FG000|Overall Study|Lost to Follow-up|5|||
155629055|NCT04609514|561737894|FG001|Overall Study|Lost to Follow-up|4|||
155629056|NCT04609514|561737893|FG000|Overall Study|Withdrawal by PI|0|||
155629057|NCT04609514|561737894|FG001|Overall Study|Withdrawal by PI|2|||
155629058|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
155629059|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
155629060|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
155629061|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
155629062|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
155629063|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
155629064|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
155629065|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155629066|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155629067|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155629068|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
155629069|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
155629070|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155629071|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155629072|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155629073|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
155629074|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
155629075|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155730924|NCT01394016|562111710|FG017|Overall Study|Lost to Follow-up|0|||
155281311|NCT04955626|560459896|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155629076|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155629077|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155629078|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
155629079|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
155629080|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155629081|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155629082|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155629083|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
155730925|NCT01394016|562111711|FG018|Overall Study|Lost to Follow-up|1|||
155730926|NCT03534804|562111712|FG000|Overall Study|Withdrawal by Subject|1|||
155730927|NCT00174187|562111716|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
155730928|NCT00174187|562111717|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
155730929|NCT00174187|562111718|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
155730930|NCT00174187|562111716|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
155730931|NCT00174187|562111717|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
155730932|NCT00174187|562111718|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
155730933|NCT00174187|562111716|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
155730934|NCT00174187|562111717|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
155730935|NCT00174187|562111718|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
155730936|NCT00174187|562111716|FG000|Period 1 (up to 3 Years)|Other|0|||
155730937|NCT00174187|562111717|FG001|Period 1 (up to 3 Years)|Other|1|||
155730938|NCT00174187|562111718|FG002|Period 1 (up to 3 Years)|Other|0|||
155730939|NCT00174187|562111716|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
155730940|NCT00174187|562111717|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
155730941|NCT00174187|562111718|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
155730942|NCT00174187|562111716|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
155730943|NCT00174187|562111717|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
155730944|NCT00174187|562111718|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
155730945|NCT00174187|562111716|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
155730946|NCT00174187|562111717|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
155730947|NCT00174187|562111718|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
155730948|NCT00174187|562111716|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
155730949|NCT00174187|562111717|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
155730950|NCT00174187|562111718|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
155730951|NCT00174187|562111716|FG000|Period 2 (After 3 Years)|Other|0|||
155730952|NCT00174187|562111717|FG001|Period 2 (After 3 Years)|Other|0|||
155730953|NCT00174187|562111718|FG002|Period 2 (After 3 Years)|Other|5|||
155730954|NCT04161157|562111719|FG000|Overall Study|Lost to Follow-up|4|||
155730955|NCT04161157|562111719|FG000|Overall Study|Death|3|||
155730956|NCT04161157|562111719|FG000|Overall Study|Ineligible|2|||
155730957|NCT04161157|562111719|FG000|Overall Study|Withdrawal by Subject|4|||
155730958|NCT02991768|562111728|FG000|Overall Study|Physician Decision|4|||
155730959|NCT04922216|562111732|FG000|Overall Study|Withdrawal by Subject|0|||
155730960|NCT04922216|562111733|FG001|Overall Study|Withdrawal by Subject|1|||
155730961|NCT04922216|562111734|FG002|Overall Study|Withdrawal by Subject|0|||
155730962|NCT04922216|562111735|FG003|Overall Study|Withdrawal by Subject|0|||
155730963|NCT04922216|562111736|FG004|Overall Study|Withdrawal by Subject|0|||
155730964|NCT04922216|562111737|FG005|Overall Study|Withdrawal by Subject|0|||
155730965|NCT04922216|562111738|FG006|Overall Study|Withdrawal by Subject|0|||
155730966|NCT04922216|562111739|FG007|Overall Study|Withdrawal by Subject|2|||
155730967|NCT04922216|562111740|FG008|Overall Study|Withdrawal by Subject|0|||
155730968|NCT04922216|562111741|FG009|Overall Study|Withdrawal by Subject|0|||
155730969|NCT04922216|562111742|FG010|Overall Study|Withdrawal by Subject|0|||
155730970|NCT04922216|562111743|FG011|Overall Study|Withdrawal by Subject|0|||
155730971|NCT04922216|562111744|FG012|Overall Study|Withdrawal by Subject|1|||
155730972|NCT04922216|562111745|FG013|Overall Study|Withdrawal by Subject|1|||
155730973|NCT04922216|562111746|FG014|Overall Study|Withdrawal by Subject|1|||
155730974|NCT04922216|562111747|FG015|Overall Study|Withdrawal by Subject|0|||
155730975|NCT04922216|562111748|FG016|Overall Study|Withdrawal by Subject|0|||
155730976|NCT04922216|562111749|FG017|Overall Study|Withdrawal by Subject|1|||
155730977|NCT04922216|562111750|FG018|Overall Study|Withdrawal by Subject|1|||
155730978|NCT04922216|562111751|FG019|Overall Study|Withdrawal by Subject|1|||
155730979|NCT04922216|562111752|FG020|Overall Study|Withdrawal by Subject|1|||
155730980|NCT04922216|562111753|FG021|Overall Study|Withdrawal by Subject|0|||
155730981|NCT04922216|562111754|FG022|Overall Study|Withdrawal by Subject|0|||
155730982|NCT04922216|562111755|FG023|Overall Study|Withdrawal by Subject|2|||
155730983|NCT04922216|562111756|FG024|Overall Study|Withdrawal by Subject|0|||
155730984|NCT04922216|562111757|FG025|Overall Study|Withdrawal by Subject|0|||
155730985|NCT04922216|562111758|FG026|Overall Study|Withdrawal by Subject|1|||
155730986|NCT04922216|562111759|FG027|Overall Study|Withdrawal by Subject|0|||
155730987|NCT04922216|562111760|FG028|Overall Study|Withdrawal by Subject|0|||
155730988|NCT04922216|562111761|FG029|Overall Study|Withdrawal by Subject|0|||
155730989|NCT04922216|562111762|FG030|Overall Study|Withdrawal by Subject|1|||
155730990|NCT04922216|562111763|FG031|Overall Study|Withdrawal by Subject|0|||
155730991|NCT04922216|562111732|FG000|Overall Study|Lost to Follow-up|1|||
155730992|NCT04922216|562111733|FG001|Overall Study|Lost to Follow-up|0|||
155281312|NCT04955626|560459897|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155730993|NCT04922216|562111734|FG002|Overall Study|Lost to Follow-up|2|||
155730994|NCT04922216|562111735|FG003|Overall Study|Lost to Follow-up|0|||
155730995|NCT04922216|562111736|FG004|Overall Study|Lost to Follow-up|0|||
155730996|NCT04922216|562111737|FG005|Overall Study|Lost to Follow-up|2|||
155730997|NCT04922216|562111738|FG006|Overall Study|Lost to Follow-up|0|||
155730998|NCT04922216|562111739|FG007|Overall Study|Lost to Follow-up|1|||
155730999|NCT04922216|562111740|FG008|Overall Study|Lost to Follow-up|1|||
155731000|NCT04922216|562111741|FG009|Overall Study|Lost to Follow-up|2|||
155731001|NCT04922216|562111742|FG010|Overall Study|Lost to Follow-up|2|||
155731002|NCT04922216|562111743|FG011|Overall Study|Lost to Follow-up|1|||
155731003|NCT04922216|562111744|FG012|Overall Study|Lost to Follow-up|1|||
155731004|NCT04922216|562111745|FG013|Overall Study|Lost to Follow-up|0|||
155731005|NCT04922216|562111746|FG014|Overall Study|Lost to Follow-up|1|||
155731006|NCT04922216|562111747|FG015|Overall Study|Lost to Follow-up|0|||
155731007|NCT04922216|562111748|FG016|Overall Study|Lost to Follow-up|0|||
155731008|NCT04922216|562111749|FG017|Overall Study|Lost to Follow-up|2|||
155731009|NCT04922216|562111750|FG018|Overall Study|Lost to Follow-up|1|||
155731010|NCT04922216|562111751|FG019|Overall Study|Lost to Follow-up|0|||
155731011|NCT04922216|562111752|FG020|Overall Study|Lost to Follow-up|1|||
155731012|NCT04922216|562111753|FG021|Overall Study|Lost to Follow-up|0|||
155731013|NCT04922216|562111754|FG022|Overall Study|Lost to Follow-up|2|||
155731014|NCT04922216|562111755|FG023|Overall Study|Lost to Follow-up|1|||
155731015|NCT04922216|562111756|FG024|Overall Study|Lost to Follow-up|0|||
155731016|NCT04922216|562111757|FG025|Overall Study|Lost to Follow-up|2|||
155731017|NCT04922216|562111758|FG026|Overall Study|Lost to Follow-up|0|||
155731018|NCT04922216|562111759|FG027|Overall Study|Lost to Follow-up|0|||
155731019|NCT04922216|562111760|FG028|Overall Study|Lost to Follow-up|1|||
155731020|NCT04922216|562111761|FG029|Overall Study|Lost to Follow-up|0|||
155731021|NCT04922216|562111762|FG030|Overall Study|Lost to Follow-up|2|||
155731022|NCT04922216|562111763|FG031|Overall Study|Lost to Follow-up|1|||
155731023|NCT03278249|562111764|FG000|Overall Study|Withdrawal by Subject|2|||
155731024|NCT03278249|562111764|FG000|Overall Study|Lost to Follow-up|1|||
155731025|NCT02017405|562111765|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155731026|NCT02017405|562111766|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155731027|NCT02017405|562111767|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155731028|NCT02017405|562111768|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155731029|NCT02017405|562111769|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155281313|NCT04955626|560459898|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281314|NCT04955626|560459899|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281315|NCT04955626|560459900|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281316|NCT04955626|560459901|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281317|NCT04955626|560459902|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281318|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
155281319|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
155281320|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
155731030|NCT02017405|562111770|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
155731031|NCT02017405|562111765|FG000|Open-label Phase|Adverse Event|1|||
155731032|NCT02017405|562111766|FG001|Open-label Phase|Adverse Event|1|||
155731033|NCT02017405|562111767|FG002|Open-label Phase|Adverse Event|0|||
155731034|NCT02017405|562111768|FG003|Open-label Phase|Adverse Event|0|||
155731035|NCT02017405|562111769|FG004|Open-label Phase|Adverse Event|0|||
155731036|NCT02017405|562111770|FG005|Open-label Phase|Adverse Event|0|||
155731037|NCT01399372|562113012|FG000|Overall Study|Protocol Violation|3|||
155731038|NCT01399372|562113013|FG001|Overall Study|Protocol Violation|1|||
155731039|NCT01177397|562113017|FG000|Overall Study|Protocol Violation|0|||
155731040|NCT01177397|562113018|FG001|Overall Study|Protocol Violation|0|||
155731041|NCT01177397|562113019|FG002|Overall Study|Protocol Violation|0|||
155731042|NCT01177397|562113020|FG003|Overall Study|Protocol Violation|0|||
155281321|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
155281322|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
155281323|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
155731043|NCT01177397|562113021|FG004|Overall Study|Protocol Violation|0|||
155731044|NCT01177397|562113022|FG005|Overall Study|Protocol Violation|1|||
155731045|NCT01177397|562113023|FG006|Overall Study|Protocol Violation|0|||
155731046|NCT01177397|562113024|FG007|Overall Study|Protocol Violation|0|||
155731047|NCT01177397|562113025|FG008|Overall Study|Protocol Violation|0|||
155731048|NCT01177397|562113026|FG009|Overall Study|Protocol Violation|0|||
155731049|NCT01177397|562113027|FG010|Overall Study|Protocol Violation|0|||
155731050|NCT01177397|562113028|FG011|Overall Study|Protocol Violation|0|||
155731051|NCT01177397|562113017|FG000|Overall Study|Lost to Follow-up|0|||
155731052|NCT01177397|562113018|FG001|Overall Study|Lost to Follow-up|0|||
155731053|NCT01177397|562113019|FG002|Overall Study|Lost to Follow-up|0|||
155731054|NCT01177397|562113020|FG003|Overall Study|Lost to Follow-up|0|||
155731055|NCT01177397|562113021|FG004|Overall Study|Lost to Follow-up|1|||
155731056|NCT01177397|562113022|FG005|Overall Study|Lost to Follow-up|0|||
155731057|NCT01177397|562113023|FG006|Overall Study|Lost to Follow-up|0|||
155731058|NCT01177397|562113024|FG007|Overall Study|Lost to Follow-up|2|||
155731059|NCT01177397|562113025|FG008|Overall Study|Lost to Follow-up|0|||
155731060|NCT01177397|562113026|FG009|Overall Study|Lost to Follow-up|0|||
155731061|NCT01177397|562113027|FG010|Overall Study|Lost to Follow-up|0|||
155731062|NCT01177397|562113028|FG011|Overall Study|Lost to Follow-up|0|||
155731063|NCT01177397|562113017|FG000|Overall Study|Death|0|||
155731064|NCT01177397|562113018|FG001|Overall Study|Death|0|||
155731065|NCT01177397|562113019|FG002|Overall Study|Death|1|||
155731066|NCT01177397|562113020|FG003|Overall Study|Death|1|||
155731067|NCT01177397|562113021|FG004|Overall Study|Death|0|||
155731068|NCT01177397|562113022|FG005|Overall Study|Death|0|||
155731069|NCT01177397|562113023|FG006|Overall Study|Death|0|||
155731070|NCT01177397|562113024|FG007|Overall Study|Death|5|||
155731071|NCT01177397|562113025|FG008|Overall Study|Death|2|||
155731072|NCT01177397|562113026|FG009|Overall Study|Death|1|||
155731073|NCT01177397|562113027|FG010|Overall Study|Death|0|||
155731074|NCT01177397|562113028|FG011|Overall Study|Death|0|||
155731075|NCT01177397|562113017|FG000|Overall Study|Withdrawal by Subject|0|||
155731076|NCT01177397|562113018|FG001|Overall Study|Withdrawal by Subject|0|||
155731077|NCT01177397|562113019|FG002|Overall Study|Withdrawal by Subject|1|||
155731078|NCT01177397|562113020|FG003|Overall Study|Withdrawal by Subject|1|||
155731079|NCT01177397|562113021|FG004|Overall Study|Withdrawal by Subject|1|||
155731080|NCT01177397|562113022|FG005|Overall Study|Withdrawal by Subject|2|||
155731081|NCT01177397|562113023|FG006|Overall Study|Withdrawal by Subject|0|||
155731082|NCT01177397|562113024|FG007|Overall Study|Withdrawal by Subject|5|||
155731083|NCT01177397|562113025|FG008|Overall Study|Withdrawal by Subject|9|||
155731084|NCT01177397|562113026|FG009|Overall Study|Withdrawal by Subject|1|||
155731085|NCT01177397|562113027|FG010|Overall Study|Withdrawal by Subject|1|||
155731086|NCT01177397|562113028|FG011|Overall Study|Withdrawal by Subject|0|||
155731087|NCT01177397|562113017|FG000|Overall Study|Adverse Event|0|||
155731088|NCT01177397|562113018|FG001|Overall Study|Adverse Event|0|||
155731089|NCT01177397|562113019|FG002|Overall Study|Adverse Event|1|||
155731090|NCT01177397|562113020|FG003|Overall Study|Adverse Event|2|||
155731091|NCT01177397|562113021|FG004|Overall Study|Adverse Event|0|||
155731092|NCT01177397|562113022|FG005|Overall Study|Adverse Event|12|||
155731093|NCT01177397|562113023|FG006|Overall Study|Adverse Event|1|||
155731094|NCT01177397|562113024|FG007|Overall Study|Adverse Event|14|||
155731095|NCT01177397|562113025|FG008|Overall Study|Adverse Event|8|||
155731096|NCT01177397|562113026|FG009|Overall Study|Adverse Event|6|||
155731097|NCT01177397|562113027|FG010|Overall Study|Adverse Event|3|||
155731098|NCT01177397|562113028|FG011|Overall Study|Adverse Event|7|||
155731099|NCT01177397|562113017|FG000|Overall Study|Disease progression|1|||
155731100|NCT01177397|562113018|FG001|Overall Study|Disease progression|2|||
155731101|NCT01177397|562113019|FG002|Overall Study|Disease progression|5|||
155731102|NCT01177397|562113020|FG003|Overall Study|Disease progression|5|||
155731103|NCT01177397|562113021|FG004|Overall Study|Disease progression|4|||
155731104|NCT01177397|562113022|FG005|Overall Study|Disease progression|10|||
155731105|NCT01177397|562113023|FG006|Overall Study|Disease progression|10|||
155731106|NCT01177397|562113024|FG007|Overall Study|Disease progression|21|||
155731107|NCT01177397|562113025|FG008|Overall Study|Disease progression|18|||
155731108|NCT01177397|562113026|FG009|Overall Study|Disease progression|12|||
155731109|NCT01177397|562113027|FG010|Overall Study|Disease progression|10|||
155281324|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
155281325|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
155281326|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
155281327|NCT05194735|560461541|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
155281328|NCT05194735|560461542|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
155281329|NCT05194735|560461543|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
155281330|NCT00731042|560461544|FG000|Second Intervention|Did not meet inclusion criteria|0|||
155281331|NCT00731042|560461545|FG001|Second Intervention|Did not meet inclusion criteria|2|||
155281332|NCT01256476|560461546|FG000|Overall Study|Adverse Event|2|||
155281333|NCT01256476|560461547|FG001|Overall Study|Adverse Event|1|||
155281334|NCT01256476|560461546|FG000|Overall Study|Withdrawal by Subject|2|||
155281335|NCT01256476|560461547|FG001|Overall Study|Withdrawal by Subject|1|||
155281336|NCT01256476|560461546|FG000|Overall Study|Lost to Follow-up|1|||
155281337|NCT01256476|560461547|FG001|Overall Study|Lost to Follow-up|2|||
155281338|NCT01256476|560461546|FG000|Overall Study|Persistent ALT or AST elevation|1|||
155731110|NCT01177397|562113028|FG011|Overall Study|Disease progression|8|||
155731111|NCT01177397|562113017|FG000|Overall Study|Other reasons|0|||
155731112|NCT01177397|562113018|FG001|Overall Study|Other reasons|0|||
155731113|NCT01177397|562113019|FG002|Overall Study|Other reasons|1|||
155731114|NCT01177397|562113020|FG003|Overall Study|Other reasons|0|||
155731115|NCT01177397|562113021|FG004|Overall Study|Other reasons|1|||
155731116|NCT01177397|562113022|FG005|Overall Study|Other reasons|1|||
155731117|NCT01177397|562113023|FG006|Overall Study|Other reasons|2|||
155731118|NCT01177397|562113024|FG007|Overall Study|Other reasons|6|||
155731119|NCT01177397|562113025|FG008|Overall Study|Other reasons|10|||
155731120|NCT01177397|562113026|FG009|Overall Study|Other reasons|8|||
155731121|NCT01177397|562113027|FG010|Overall Study|Other reasons|0|||
155731122|NCT01177397|562113028|FG011|Overall Study|Other reasons|2|||
155731123|NCT01358721|562113029|FG000|Overall Study|Withdrawal by Subject|0|||
155731124|NCT01358721|562113030|FG001|Overall Study|Withdrawal by Subject|0|||
155731125|NCT01358721|562113031|FG002|Overall Study|Withdrawal by Subject|0|||
155731126|NCT01358721|562113032|FG003|Overall Study|Withdrawal by Subject|1|||
155731127|NCT01358721|562113029|FG000|Overall Study|Death|0|||
155731128|NCT01358721|562113030|FG001|Overall Study|Death|2|||
155731129|NCT01358721|562113031|FG002|Overall Study|Death|0|||
155731130|NCT01358721|562113032|FG003|Overall Study|Death|0|||
155731131|NCT01358721|562113029|FG000|Overall Study|Study Drug Toxicity|1|||
155731132|NCT01358721|562113030|FG001|Overall Study|Study Drug Toxicity|3|||
155731133|NCT01358721|562113031|FG002|Overall Study|Study Drug Toxicity|4|||
155731134|NCT01358721|562113032|FG003|Overall Study|Study Drug Toxicity|5|||
155731135|NCT01358721|562113029|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
155731136|NCT01358721|562113030|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
155731137|NCT01358721|562113031|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
155731138|NCT01358721|562113032|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
155731139|NCT01358721|562113029|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155731140|NCT01358721|562113030|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
155731141|NCT01358721|562113031|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
155731142|NCT01358721|562113032|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
155731143|NCT01358721|562113029|FG000|Overall Study|Adverse Event related to study drug|1|||
155731144|NCT01358721|562113030|FG001|Overall Study|Adverse Event related to study drug|0|||
155731145|NCT01358721|562113031|FG002|Overall Study|Adverse Event related to study drug|0|||
155731146|NCT01358721|562113032|FG003|Overall Study|Adverse Event related to study drug|1|||
155731147|NCT01358721|562113029|FG000|Overall Study|Disease Progression|19|||
155731148|NCT01358721|562113030|FG001|Overall Study|Disease Progression|15|||
155731149|NCT01358721|562113031|FG002|Overall Study|Disease Progression|17|||
155731150|NCT01358721|562113032|FG003|Overall Study|Disease Progression|15|||
155731151|NCT01358721|562113029|FG000|Overall Study|Out of State/Unmet Criteria|0|||
155731152|NCT01358721|562113030|FG001|Overall Study|Out of State/Unmet Criteria|0|||
155731153|NCT01358721|562113031|FG002|Overall Study|Out of State/Unmet Criteria|1|||
155731154|NCT01358721|562113032|FG003|Overall Study|Out of State/Unmet Criteria|0|||
155731155|NCT02446899|562113037|FG000|Overall Study|Adverse Event|4|||
155731156|NCT02446899|562113038|FG001|Overall Study|Adverse Event|7|||
155731157|NCT02446899|562113037|FG000|Overall Study|Condition Under Investigation Worsened|1|||
155731158|NCT02446899|562113038|FG001|Overall Study|Condition Under Investigation Worsened|4|||
155731159|NCT02446899|562113037|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
155731160|NCT02446899|562113038|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
155731161|NCT02446899|562113037|FG000|Overall Study|Lack of Efficacy|2|||
155731162|NCT02446899|562113038|FG001|Overall Study|Lack of Efficacy|8|||
155731163|NCT02446899|562113037|FG000|Overall Study|Lost to Follow-up|1|||
155731164|NCT02446899|562113038|FG001|Overall Study|Lost to Follow-up|3|||
155731165|NCT02446899|562113037|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
155731166|NCT02446899|562113038|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
155731167|NCT02446899|562113037|FG000|Overall Study|Withdrawal by Subject|11|||
155731168|NCT02446899|562113038|FG001|Overall Study|Withdrawal by Subject|19|||
155731169|NCT02446899|562113037|FG000|Overall Study|Miscellaneous|5|||
155731170|NCT02446899|562113038|FG001|Overall Study|Miscellaneous|4|||
155731171|NCT02446899|562113037|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155731172|NCT02446899|562113038|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155731173|NCT01554241|562113039|FG000|Overall Study|Death|3|||
155731174|NCT01554241|562113040|FG001|Overall Study|Death|1|||
155731175|NCT01554241|562113041|FG002|Overall Study|Death|1|||
155629084|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
155629085|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155629086|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155629087|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155629088|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
155629089|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
155629090|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155629091|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155629092|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155629093|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
155731176|NCT01554241|562113042|FG003|Overall Study|Death|0|||
155731177|NCT01554241|562113039|FG000|Overall Study|protocol specified renal stone|0|||
155731178|NCT01554241|562113040|FG001|Overall Study|protocol specified renal stone|0|||
155731179|NCT01554241|562113041|FG002|Overall Study|protocol specified renal stone|0|||
155731180|NCT01554241|562113042|FG003|Overall Study|protocol specified renal stone|1|||
155731181|NCT01554241|562113039|FG000|Overall Study|protocol specified change in eGFR|0|||
155731182|NCT01554241|562113040|FG001|Overall Study|protocol specified change in eGFR|0|||
155731183|NCT01554241|562113041|FG002|Overall Study|protocol specified change in eGFR|1|||
155731184|NCT01554241|562113042|FG003|Overall Study|protocol specified change in eGFR|0|||
155731185|NCT01554241|562113039|FG000|Overall Study|Withdrawal by Subject|0|||
155731186|NCT01554241|562113040|FG001|Overall Study|Withdrawal by Subject|0|||
155731187|NCT01554241|562113041|FG002|Overall Study|Withdrawal by Subject|2|||
155731188|NCT01554241|562113042|FG003|Overall Study|Withdrawal by Subject|0|||
155731189|NCT00742235|562113043|FG000|Overall Study|Lost to Follow-up|0|||
155731190|NCT00742235|562113044|FG001|Overall Study|Lost to Follow-up|31|||
155731191|NCT00433004|562113045|FG000|Overall Study|Lost to Follow-up|5|||
155731192|NCT00433004|562113046|FG001|Overall Study|Lost to Follow-up|7|||
155731193|NCT05661409|562113048|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
155731194|NCT05661409|562113049|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
155731195|NCT05661409|562113050|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
155731196|NCT05661409|562113051|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
155731197|NCT05661409|562113052|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
155731198|NCT05661409|562113053|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
155731199|NCT05661409|562113048|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
155731200|NCT05661409|562113049|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
155731201|NCT05661409|562113050|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
155731202|NCT05661409|562113051|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
155731203|NCT05661409|562113052|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
155731204|NCT05661409|562113053|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
155731205|NCT05661409|562113048|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155731206|NCT05661409|562113049|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155731207|NCT05661409|562113050|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155731208|NCT05661409|562113051|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
155388120|NCT01294683|560855036|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
155388121|NCT01294683|560855037|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
155388122|NCT01294683|560855036|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
155388123|NCT01294683|560855037|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
155388124|NCT01294683|560855036|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
155388125|NCT01294683|560855037|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
155388126|NCT01881750|560855038|FG000|Overall Study|Changes in concomitant therapies|2|||
155388127|NCT01881750|560855039|FG001|Overall Study|Changes in concomitant therapies|3|||
155388128|NCT01881750|560855038|FG000|Overall Study|Lost to Follow-up|0|||
155388129|NCT01881750|560855039|FG001|Overall Study|Lost to Follow-up|1|||
155388130|NCT00307125|560855040|FG000|Screening Phase|Adverse Event|1|||
155388131|NCT00307125|560855041|FG001|Screening Phase|Adverse Event|0|||
155731209|NCT05661409|562113052|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
155731210|NCT05661409|562113053|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
155731211|NCT05661409|562113048|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
155731212|NCT05661409|562113049|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
155731213|NCT05661409|562113050|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
155731214|NCT05661409|562113051|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
155388132|NCT00307125|560855042|FG002|Screening Phase|Adverse Event|0|||
155388133|NCT00307125|560855040|FG000|Screening Phase|Protocol Violation|27|||
155388134|NCT00307125|560855041|FG001|Screening Phase|Protocol Violation|0|||
155629094|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
155629095|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155629096|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155629097|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155629098|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
155629099|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155629100|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155629101|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155629102|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155629103|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
155629104|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
155629105|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
155629106|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
155629107|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
155629108|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
155629109|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
155731215|NCT05661409|562113052|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
155731216|NCT05661409|562113053|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
155731217|NCT05661409|562113048|FG000|Overall Study|Miscommu-nication about administration|0|||
155388135|NCT00307125|560855042|FG002|Screening Phase|Protocol Violation|0|||
155388136|NCT00307125|560855040|FG000|Screening Phase|Lost to Follow-up|87|||
155388137|NCT00307125|560855041|FG001|Screening Phase|Lost to Follow-up|0|||
155388138|NCT00307125|560855042|FG002|Screening Phase|Lost to Follow-up|0|||
155731218|NCT05661409|562113049|FG001|Overall Study|Miscommu-nication about administration|0|||
155731219|NCT05661409|562113050|FG002|Overall Study|Miscommu-nication about administration|0|||
155731220|NCT05661409|562113051|FG003|Overall Study|Miscommu-nication about administration|0|||
155731221|NCT05661409|562113052|FG004|Overall Study|Miscommu-nication about administration|0|||
155731222|NCT05661409|562113053|FG005|Overall Study|Miscommu-nication about administration|1|||
155731223|NCT04730271|562113056|FG000|Overall Study|Adverse Event|0|||
155731224|NCT04730271|562113057|FG001|Overall Study|Adverse Event|2|||
155388139|NCT00307125|560855040|FG000|Screening Phase|Death|10|||
155731225|NCT04730271|562113056|FG000|Overall Study|Withdrawal by Subject|1|||
155731226|NCT04730271|562113057|FG001|Overall Study|Withdrawal by Subject|1|||
155731227|NCT04730271|562113056|FG000|Overall Study|Protocol Violation|7|||
155731228|NCT04730271|562113057|FG001|Overall Study|Protocol Violation|13|||
155731229|NCT04730271|562113056|FG000|Overall Study|Lost to Follow-up|3|||
155731230|NCT04730271|562113057|FG001|Overall Study|Lost to Follow-up|3|||
155731231|NCT04730271|562113056|FG000|Overall Study|Death|1|||
155731232|NCT04730271|562113057|FG001|Overall Study|Death|0|||
155731233|NCT00998296|562113058|FG000|Overall Study|Progressive disease|0|||
155731234|NCT00998296|562113059|FG001|Overall Study|Progressive disease|1|||
155731235|NCT00998296|562113060|FG002|Overall Study|Progressive disease|0|||
155731236|NCT00998296|562113061|FG003|Overall Study|Progressive disease|0|||
155731237|NCT00998296|562113062|FG004|Overall Study|Progressive disease|0|||
155731238|NCT00998296|562113063|FG005|Overall Study|Progressive disease|0|||
155731239|NCT00998296|562113064|FG006|Overall Study|Progressive disease|1|||
155731240|NCT00998296|562113065|FG007|Overall Study|Progressive disease|0|||
155731241|NCT00998296|562113066|FG008|Overall Study|Progressive disease|0|||
155731242|NCT00998296|562113067|FG009|Overall Study|Progressive disease|14|||
155731243|NCT00998296|562113068|FG010|Overall Study|Progressive disease|5|||
155731244|NCT00998296|562113058|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731245|NCT00998296|562113059|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731246|NCT00998296|562113060|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731247|NCT00998296|562113061|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731248|NCT00998296|562113062|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
155731249|NCT00998296|562113063|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731250|NCT00998296|562113064|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731251|NCT00998296|562113065|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
155731252|NCT00998296|562113066|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
155731253|NCT00998296|562113067|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731254|NCT00998296|562113068|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
155731255|NCT00998296|562113058|FG000|Overall Study|Other adverse event|0|||
155731256|NCT00998296|562113059|FG001|Overall Study|Other adverse event|0|||
155731257|NCT00998296|562113060|FG002|Overall Study|Other adverse event|0|||
155731258|NCT00998296|562113061|FG003|Overall Study|Other adverse event|0|||
155731259|NCT00998296|562113062|FG004|Overall Study|Other adverse event|1|||
155731260|NCT00998296|562113063|FG005|Overall Study|Other adverse event|0|||
155731261|NCT00998296|562113064|FG006|Overall Study|Other adverse event|0|||
155731262|NCT00998296|562113065|FG007|Overall Study|Other adverse event|0|||
155731263|NCT00998296|562113066|FG008|Overall Study|Other adverse event|0|||
155731264|NCT00998296|562113067|FG009|Overall Study|Other adverse event|1|||
155731265|NCT00998296|562113068|FG010|Overall Study|Other adverse event|2|||
155731266|NCT00998296|562113058|FG000|Overall Study|Refused to continue taking trial med.|0|||
155388140|NCT00307125|560855041|FG001|Screening Phase|Death|0|||
155388141|NCT00307125|560855042|FG002|Screening Phase|Death|0|||
155388142|NCT00307125|560855040|FG000|Screening Phase|Withdrawal by Subject|77|||
155388143|NCT00307125|560855041|FG001|Screening Phase|Withdrawal by Subject|0|||
155388144|NCT00307125|560855042|FG002|Screening Phase|Withdrawal by Subject|0|||
155388145|NCT00307125|560855040|FG000|Screening Phase|Physician Decision|26|||
155388146|NCT00307125|560855041|FG001|Screening Phase|Physician Decision|0|||
155388147|NCT00307125|560855042|FG002|Screening Phase|Physician Decision|0|||
155388148|NCT00307125|560855040|FG000|Screening Phase|Sponsor Decision|4|||
155388149|NCT00307125|560855041|FG001|Screening Phase|Sponsor Decision|0|||
155388150|NCT00307125|560855042|FG002|Screening Phase|Sponsor Decision|0|||
155388151|NCT00307125|560855040|FG000|Screening Phase|Study Terminated|17|||
155388152|NCT00307125|560855041|FG001|Screening Phase|Study Terminated|0|||
155731267|NCT00998296|562113059|FG001|Overall Study|Refused to continue taking trial med.|0|||
155731268|NCT00998296|562113060|FG002|Overall Study|Refused to continue taking trial med.|0|||
155388153|NCT00307125|560855042|FG002|Screening Phase|Study Terminated|0|||
155731269|NCT00998296|562113061|FG003|Overall Study|Refused to continue taking trial med.|0|||
155731270|NCT00998296|562113062|FG004|Overall Study|Refused to continue taking trial med.|0|||
155731271|NCT00998296|562113063|FG005|Overall Study|Refused to continue taking trial med.|0|||
155731272|NCT00998296|562113064|FG006|Overall Study|Refused to continue taking trial med.|0|||
155731273|NCT00998296|562113065|FG007|Overall Study|Refused to continue taking trial med.|0|||
155731274|NCT00998296|562113066|FG008|Overall Study|Refused to continue taking trial med.|0|||
155731275|NCT00998296|562113067|FG009|Overall Study|Refused to continue taking trial med.|2|||
155388154|NCT00307125|560855040|FG000|Screening Phase|Graft Loss|3|||
155388155|NCT00307125|560855041|FG001|Screening Phase|Graft Loss|0|||
155731276|NCT00998296|562113068|FG010|Overall Study|Refused to continue taking trial med.|0|||
155731277|NCT00998296|562113058|FG000|Overall Study|Reason other than those specified above|0|||
155731278|NCT00998296|562113059|FG001|Overall Study|Reason other than those specified above|0|||
155731279|NCT00998296|562113060|FG002|Overall Study|Reason other than those specified above|0|||
155731280|NCT00998296|562113061|FG003|Overall Study|Reason other than those specified above|0|||
155731281|NCT00998296|562113062|FG004|Overall Study|Reason other than those specified above|0|||
155731282|NCT00998296|562113063|FG005|Overall Study|Reason other than those specified above|0|||
155731283|NCT00998296|562113064|FG006|Overall Study|Reason other than those specified above|0|||
155731284|NCT00998296|562113065|FG007|Overall Study|Reason other than those specified above|0|||
155731285|NCT00998296|562113066|FG008|Overall Study|Reason other than those specified above|0|||
155731286|NCT00998296|562113067|FG009|Overall Study|Reason other than those specified above|1|||
155731287|NCT00998296|562113068|FG010|Overall Study|Reason other than those specified above|0|||
155731288|NCT04396639|562113069|FG000|Overall Study|Withdrawal by Subject|1|||
155731289|NCT04396639|562113069|FG000|Overall Study|Other|1|||
155731290|NCT01544335|562113070|FG000|Overall Study|Lost to Follow-up|27|||
155731291|NCT01544335|562113070|FG000|Overall Study|Death|4|||
155731292|NCT01544335|562113070|FG000|Overall Study|Disease progression|3|||
155731293|NCT01544335|562113070|FG000|Overall Study|Baseline Measurements not Available|19|||
155731294|NCT02223858|562113071|FG000|Overall Study|Death|1|||
155731295|NCT02223858|562113072|FG001|Overall Study|Death|1|||
155731296|NCT02223858|562113071|FG000|Overall Study|Lost to Follow-up|6|||
155731297|NCT02223858|562113072|FG001|Overall Study|Lost to Follow-up|11|||
155731298|NCT02223858|562113071|FG000|Overall Study|Withdrawal by Subject|8|||
155731299|NCT02223858|562113072|FG001|Overall Study|Withdrawal by Subject|5|||
155731300|NCT02223858|562113071|FG000|Overall Study|Refused|9|||
155731301|NCT02223858|562113072|FG001|Overall Study|Refused|9|||
155731302|NCT03198507|562113075|FG000|Overall Study|Withdrawal by Subject|1|||
155731303|NCT03198507|562113076|FG001|Overall Study|Withdrawal by Subject|0|||
155731304|NCT00241839|562113083|FG000|Overall Study|Withdrawal by Subject|18|||
155731305|NCT00241839|562113084|FG001|Overall Study|Withdrawal by Subject|17|||
155731306|NCT00241839|562113083|FG000|Overall Study|Adverse Event|1|||
155731307|NCT00241839|562113084|FG001|Overall Study|Adverse Event|1|||
155731308|NCT03809104|562113085|FG000|Overall Study|Withdrawal by Subject|3|||
155731309|NCT01532986|562113090|FG000|Overall Study|Death|9|||
155731310|NCT01532986|562113091|FG001|Overall Study|Death|9|||
155731311|NCT01532986|562113090|FG000|Overall Study|Withdrawal by Subject|7|||
155731312|NCT01532986|562113091|FG001|Overall Study|Withdrawal by Subject|10|||
155731313|NCT01532986|562113090|FG000|Overall Study|Physician Decision|7|||
155731314|NCT01532986|562113091|FG001|Overall Study|Physician Decision|5|||
155731315|NCT00831181|562113092|FG000|Overall Study|Adverse Event|12|||
155731316|NCT04313244|562113093|FG000|Overall Study|Withdrawal of Consent|3|||
155731317|NCT04313244|562113094|FG001|Overall Study|Withdrawal of Consent|3|||
155731318|NCT04313244|562113093|FG000|Overall Study|Met Exclusion Criteria|1|||
155731319|NCT04313244|562113094|FG001|Overall Study|Met Exclusion Criteria|0|||
155731320|NCT04313244|562113093|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
155731321|NCT04313244|562113094|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
155731322|NCT00927953|562113095|FG000|Overall Study|Death|2|||
155731323|NCT00927953|562113096|FG001|Overall Study|Death|1|||
155731324|NCT02976038|562113097|FG000|Overall Study|Physician Decision|22|||
155731325|NCT02976038|562113097|FG000|Overall Study|Withdrawal by Subject|3|||
155731326|NCT02976038|562113097|FG000|Overall Study|Lost to Follow-up|2|||
155731327|NCT02976038|562113097|FG000|Overall Study|Adverse Event|1|||
155731328|NCT00724698|562113098|FG000|Overall Study|Adverse Event|9|||
155731329|NCT00724698|562113098|FG000|Overall Study|Failure of Therapy|4|||
155731330|NCT00724698|562113098|FG000|Overall Study|Poor Compliance|16|||
155731331|NCT00724698|562113098|FG000|Overall Study|Lost to Follow-up|36|||
155731332|NCT00724698|562113098|FG000|Overall Study|No Info|25|||
155731333|NCT05021978|562113101|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
155731334|NCT05021978|562113102|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155731335|NCT05021978|562113103|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155731336|NCT05021978|562113104|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155731337|NCT05021978|562113101|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155731338|NCT05021978|562113102|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
155731339|NCT05021978|562113103|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155731340|NCT05021978|562113104|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155731341|NCT00196313|562113105|FG000|Overall Study|Protocol Violation|2|||
155731342|NCT00196313|562113106|FG001|Overall Study|Protocol Violation|3|||
155731343|NCT00196313|562113105|FG000|Overall Study|Withdrawal by Subject|3|||
155731344|NCT00196313|562113106|FG001|Overall Study|Withdrawal by Subject|1|||
155731345|NCT00196313|562113105|FG000|Overall Study|Adverse Event|3|||
155731346|NCT00196313|562113106|FG001|Overall Study|Adverse Event|1|||
155731347|NCT00196313|562113105|FG000|Overall Study|Subject Pregnant|1|||
155731348|NCT00196313|562113106|FG001|Overall Study|Subject Pregnant|1|||
155731349|NCT00196313|562113105|FG000|Overall Study|Lost to Follow-up|2|||
155731350|NCT00196313|562113106|FG001|Overall Study|Lost to Follow-up|2|||
155731351|NCT00043979|562113107|FG000|Period 1|recipient with progressive disease|7|||
155731352|NCT00043979|562113108|FG001|Period 1|recipient with progressive disease|4|||
155731353|NCT00043979|562113109|FG002|Period 1|recipient with progressive disease|3|||
155731354|NCT03096288|562113111|FG000|Overall Study|Withdrawal by Subject|0|||
155731355|NCT03096288|562113112|FG001|Overall Study|Withdrawal by Subject|1|||
155731356|NCT03096288|562113113|FG002|Overall Study|Withdrawal by Subject|0|||
155731357|NCT03096288|562113114|FG003|Overall Study|Withdrawal by Subject|1|||
155731358|NCT01411891|562113120|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
155731359|NCT01411891|562113121|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
155731360|NCT01995838|562113122|FG000|Overall Study|Lost to Follow-up|0|||
155731361|NCT01995838|562113123|FG001|Overall Study|Lost to Follow-up|1|||
155731362|NCT01995838|562113124|FG002|Overall Study|Lost to Follow-up|0|||
155731363|NCT01995838|562113125|FG003|Overall Study|Lost to Follow-up|0|||
155731364|NCT01995838|562113126|FG004|Overall Study|Lost to Follow-up|0|||
155731365|NCT01995838|562113127|FG005|Overall Study|Lost to Follow-up|0|||
155731366|NCT01995838|562113128|FG006|Overall Study|Lost to Follow-up|1|||
155731367|NCT01995838|562113122|FG000|Overall Study|Participant choice|2|||
155731368|NCT01995838|562113123|FG001|Overall Study|Participant choice|0|||
155731369|NCT01995838|562113124|FG002|Overall Study|Participant choice|0|||
155731370|NCT01995838|562113125|FG003|Overall Study|Participant choice|0|||
155731371|NCT01995838|562113126|FG004|Overall Study|Participant choice|0|||
155731372|NCT01995838|562113127|FG005|Overall Study|Participant choice|1|||
155731373|NCT01995838|562113128|FG006|Overall Study|Participant choice|1|||
155731374|NCT01995838|562113122|FG000|Overall Study|Adverse Event|0|||
155731375|NCT01995838|562113123|FG001|Overall Study|Adverse Event|0|||
155731376|NCT01995838|562113124|FG002|Overall Study|Adverse Event|0|||
155731377|NCT01995838|562113125|FG003|Overall Study|Adverse Event|0|||
155731378|NCT01995838|562113126|FG004|Overall Study|Adverse Event|0|||
155731379|NCT01995838|562113127|FG005|Overall Study|Adverse Event|0|||
155731380|NCT01995838|562113128|FG006|Overall Study|Adverse Event|1|||
155731381|NCT01995838|562113122|FG000|Overall Study|Withdrawal by Subject|0|||
155731382|NCT01995838|562113123|FG001|Overall Study|Withdrawal by Subject|0|||
155731383|NCT01995838|562113124|FG002|Overall Study|Withdrawal by Subject|0|||
155731384|NCT01995838|562113125|FG003|Overall Study|Withdrawal by Subject|0|||
155731385|NCT01995838|562113126|FG004|Overall Study|Withdrawal by Subject|1|||
155731386|NCT01995838|562113127|FG005|Overall Study|Withdrawal by Subject|0|||
155731387|NCT01995838|562113128|FG006|Overall Study|Withdrawal by Subject|0|||
155731388|NCT01995838|562113122|FG000|Overall Study|Other|3|||
155731389|NCT01995838|562113123|FG001|Overall Study|Other|1|||
155731390|NCT01995838|562113124|FG002|Overall Study|Other|0|||
155731391|NCT01995838|562113125|FG003|Overall Study|Other|2|||
155731392|NCT01995838|562113126|FG004|Overall Study|Other|1|||
155731393|NCT01995838|562113127|FG005|Overall Study|Other|1|||
155731394|NCT01995838|562113128|FG006|Overall Study|Other|2|||
155731395|NCT03196349|562113129|FG000|Overall Study|Did not receive study drug|0|||
155731396|NCT03196349|562113130|FG001|Overall Study|Did not receive study drug|1|||
155731397|NCT03196349|562113131|FG002|Overall Study|Did not receive study drug|2|||
155731398|NCT03196349|562113129|FG000|Overall Study|No data entered|2|||
155731399|NCT03196349|562113130|FG001|Overall Study|No data entered|4|||
155731400|NCT03196349|562113131|FG002|Overall Study|No data entered|0|||
155731401|NCT03196349|562113129|FG000|Overall Study|Study Terminated early|15|||
155731402|NCT03196349|562113130|FG001|Overall Study|Study Terminated early|9|||
155731403|NCT03196349|562113131|FG002|Overall Study|Study Terminated early|11|||
155731404|NCT02819804|562113132|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
155731405|NCT03967444|562113133|FG000|Overall Study|Lost to Follow-up|1|||
155731406|NCT03967444|562113134|FG001|Overall Study|Lost to Follow-up|2|||
155731407|NCT01821118|562113141|FG000|Overall Study|Death|0|||
155731408|NCT01821118|562113142|FG001|Overall Study|Death|1|||
155731409|NCT00318643|562113143|FG000|Overall Study|Adverse Event|0|||
155731410|NCT00318643|562113144|FG001|Overall Study|Adverse Event|0|||
155731411|NCT00318643|562113145|FG002|Overall Study|Adverse Event|0|||
155731412|NCT00318643|562113146|FG003|Overall Study|Adverse Event|0|||
155731413|NCT00318643|562113147|FG004|Overall Study|Adverse Event|1|||
155731414|NCT00318643|562113143|FG000|Overall Study|Participant's Decision|0|||
155731415|NCT00318643|562113144|FG001|Overall Study|Participant's Decision|0|||
155731416|NCT00318643|562113145|FG002|Overall Study|Participant's Decision|0|||
155731417|NCT00318643|562113146|FG003|Overall Study|Participant's Decision|0|||
155731418|NCT00318643|562113147|FG004|Overall Study|Participant's Decision|1|||
155731419|NCT00318643|562113143|FG000|Overall Study|Investigator's Decision|0|||
155731420|NCT00318643|562113144|FG001|Overall Study|Investigator's Decision|0|||
155731421|NCT00318643|562113145|FG002|Overall Study|Investigator's Decision|0|||
155731422|NCT00318643|562113146|FG003|Overall Study|Investigator's Decision|0|||
155731423|NCT00318643|562113147|FG004|Overall Study|Investigator's Decision|1|||
155731424|NCT01812252|562113148|FG000|Overall Study|Persistent Disease|1|||
155731425|NCT01812252|562113149|FG001|Overall Study|Persistent Disease|0|||
155731426|NCT01812252|562113148|FG000|Overall Study|Not transplanted|11|||
155731427|NCT01812252|562113149|FG001|Overall Study|Not transplanted|11|||
155731428|NCT01812252|562113148|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
155731429|NCT01812252|562113149|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
155731430|NCT01812252|562113148|FG000|Overall Study|Withdrawal by Subject|1|||
155731431|NCT01812252|562113149|FG001|Overall Study|Withdrawal by Subject|1|||
155731432|NCT01812252|562113148|FG000|Overall Study|Screen Failure|1|||
155731433|NCT01812252|562113149|FG001|Overall Study|Screen Failure|0|||
155731434|NCT01216189|562113150|FG000|Overall Study|Lost to Follow-up|21|||
155731435|NCT01216189|562113151|FG001|Overall Study|Lost to Follow-up|3|||
155731436|NCT01216189|562113150|FG000|Overall Study|Death|4|||
155731437|NCT01216189|562113151|FG001|Overall Study|Death|2|||
155731438|NCT03467750|562113152|FG000|Overall Study|Surgery canceled|1|||
155731439|NCT03467750|562113153|FG001|Overall Study|Surgery canceled|0|||
155731440|NCT03467750|562113152|FG000|Overall Study|Protocol Violation|1|||
155731441|NCT03467750|562113153|FG001|Overall Study|Protocol Violation|1|||
155731442|NCT03467750|562113152|FG000|Overall Study|Withdrawal by Subject|0|||
155731443|NCT03467750|562113153|FG001|Overall Study|Withdrawal by Subject|1|||
155731444|NCT05673876|562113154|FG000|Overall Study|Death|3|||
155731445|NCT05673876|562113155|FG001|Overall Study|Death|1|||
155731446|NCT05673876|562113154|FG000|Overall Study|Study Terminated by Sponsor|0|||
155731447|NCT05673876|562113155|FG001|Overall Study|Study Terminated by Sponsor|1|||
155731448|NCT05673876|562113154|FG000|Overall Study|Physician Decision|0|||
155731449|NCT05673876|562113155|FG001|Overall Study|Physician Decision|1|||
155731450|NCT03529422|562113156|FG000|Overall Study|Withdrawal by Subject|1|||
155731451|NCT03529422|562113156|FG000|Overall Study|Protocol Violation|1|||
155731452|NCT03529422|562113156|FG000|Overall Study|Disease progression|2|||
155731453|NCT05006573|562113159|FG000|Double-blind Treatment Period|Physician Decision|2|||
155731454|NCT05006573|562113160|FG001|Double-blind Treatment Period|Physician Decision|0|||
155731455|NCT05006573|562113159|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
155731456|NCT05006573|562113160|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
155731457|NCT05006573|562113159|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
155731458|NCT05006573|562113160|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155731459|NCT05006573|562113159|FG000|Double-blind Treatment Period|Protocol Violation|2|||
155731460|NCT05006573|562113160|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155731461|NCT05006573|562113159|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
155731462|NCT05006573|562113160|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
155731463|NCT05006573|562113159|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
155731464|NCT05006573|562113160|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
155731465|NCT00414596|562114893|FG000|Overall Study|Protocol Violation|2|||
155731466|NCT04639258|562114894|FG000|Overall Study|Screen failure|5|||
155731467|NCT04639258|562114894|FG000|Overall Study|Physician Decision|2|||
155731468|NCT04639258|562114894|FG000|Overall Study|Early study termination|3|||
155731469|NCT04639258|562114894|FG000|Overall Study|Withdrawal by Subject|1|||
155731470|NCT04614974|562114895|FG000|Overall Study|Lost to Follow-up|14|||
155731471|NCT04614974|562114896|FG001|Overall Study|Lost to Follow-up|11|||
155731472|NCT01635153|562114897|FG000|Overall Study|Lost to Follow-up|40|||
155731473|NCT01635153|562114898|FG001|Overall Study|Lost to Follow-up|43|||
155731474|NCT00658359|562114900|FG000|Overall Study|Death|3|||
155731475|NCT00658359|562114901|FG001|Overall Study|Death|1|||
155731476|NCT00658359|562114902|FG002|Overall Study|Death|2|||
155731477|NCT00658359|562114900|FG000|Overall Study|Adverse Event|13|||
155731478|NCT00658359|562114901|FG001|Overall Study|Adverse Event|6|||
155731479|NCT00658359|562114902|FG002|Overall Study|Adverse Event|9|||
155731480|NCT00658359|562114900|FG000|Overall Study|Protocol Violation|1|||
155731481|NCT00658359|562114901|FG001|Overall Study|Protocol Violation|0|||
155731482|NCT00658359|562114902|FG002|Overall Study|Protocol Violation|0|||
155731483|NCT00658359|562114900|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
155731484|NCT00658359|562114901|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
155731485|NCT00658359|562114902|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
155731486|NCT00658359|562114900|FG000|Overall Study|Withdrawal by Subject|7|||
155731487|NCT00658359|562114901|FG001|Overall Study|Withdrawal by Subject|4|||
155281339|NCT01256476|560461547|FG001|Overall Study|Persistent ALT or AST elevation|0|||
155281340|NCT01256476|560461546|FG000|Overall Study|Physician Decision|0|||
155281341|NCT01256476|560461547|FG001|Overall Study|Physician Decision|1|||
155281342|NCT01256476|560461546|FG000|Overall Study|Subject non-compliance|0|||
155281343|NCT01256476|560461547|FG001|Overall Study|Subject non-compliance|1|||
155731488|NCT00658359|562114902|FG002|Overall Study|Withdrawal by Subject|2|||
155281344|NCT01256476|560461546|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
155281345|NCT01256476|560461547|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
155281346|NCT04034238|560461550|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
155281347|NCT04034238|560461551|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155731489|NCT00658359|562114900|FG000|Overall Study|Lost to Follow-up|2|||
155731490|NCT00658359|562114901|FG001|Overall Study|Lost to Follow-up|2|||
155731491|NCT00658359|562114902|FG002|Overall Study|Lost to Follow-up|4|||
155731492|NCT00658359|562114900|FG000|Overall Study|Lack of Efficacy|0|||
155731493|NCT00658359|562114901|FG001|Overall Study|Lack of Efficacy|1|||
155731494|NCT00658359|562114902|FG002|Overall Study|Lack of Efficacy|0|||
155731495|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Adverse Event|9|||
155281348|NCT04034238|560461552|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155281349|NCT04034238|560461553|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155281350|NCT04034238|560461550|FG000|Dose Escalation Phase|Screen failures|0|||
155281351|NCT04034238|560461551|FG001|Dose Escalation Phase|Screen failures|0|||
155281352|NCT04034238|560461552|FG002|Dose Escalation Phase|Screen failures|0|||
155731496|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Adverse Event|3|||
155731497|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Death|7|||
155731498|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Death|7|||
155731499|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
155731500|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
155731501|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Physician Decision|1|||
155731502|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Physician Decision|0|||
155731503|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
155731504|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
155731505|NCT02558296|562114903|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
155731506|NCT02558296|562114904|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
155731507|NCT02558296|562114903|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
155731508|NCT02558296|562114904|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
155731509|NCT02558296|562114903|FG000|Completed the Study|Adverse Event|14|||
155731510|NCT02558296|562114904|FG001|Completed the Study|Adverse Event|5|||
155731511|NCT02558296|562114903|FG000|Completed the Study|Death|39|||
155731512|NCT02558296|562114904|FG001|Completed the Study|Death|25|||
155731513|NCT02558296|562114903|FG000|Completed the Study|Lost to Follow-up|31|||
155731514|NCT02558296|562114904|FG001|Completed the Study|Lost to Follow-up|23|||
155731515|NCT02558296|562114903|FG000|Completed the Study|Physician Decision|6|||
155731516|NCT02558296|562114904|FG001|Completed the Study|Physician Decision|0|||
155731517|NCT02558296|562114903|FG000|Completed the Study|Protocol Violation|2|||
155731518|NCT02558296|562114904|FG001|Completed the Study|Protocol Violation|1|||
155731519|NCT02558296|562114903|FG000|Completed the Study|Withdrawal by Subject|53|||
155731520|NCT02558296|562114904|FG001|Completed the Study|Withdrawal by Subject|31|||
155731521|NCT02558296|562114903|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
155731522|NCT02558296|562114904|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
155731523|NCT02919995|562114907|FG000|Overall Study|Adverse Event|0|||
155731524|NCT02919995|562114908|FG001|Overall Study|Adverse Event|0|||
155731525|NCT02919995|562114909|FG002|Overall Study|Adverse Event|0|||
155731526|NCT02919995|562114910|FG003|Overall Study|Adverse Event|0|||
155731527|NCT02919995|562114911|FG004|Overall Study|Adverse Event|0|||
155731528|NCT02919995|562114912|FG005|Overall Study|Adverse Event|1|||
155731529|NCT00275509|562114913|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
155731530|NCT00275509|562114914|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
155731531|NCT03388164|562114919|FG000|Overall Study|Withdrawal by Subject|3|||
155731532|NCT03388164|562114920|FG001|Overall Study|Withdrawal by Subject|1|||
155731533|NCT00345358|562114921|FG000|Primary Vaccination Phase|Other|0|||
155731534|NCT00345358|562114922|FG001|Primary Vaccination Phase|Other|1|||
155731535|NCT00345358|562114923|FG002|Primary Vaccination Phase|Other|1|||
155731536|NCT00345358|562114924|FG003|Primary Vaccination Phase|Other|0|||
155731537|NCT00345358|562114921|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
155731538|NCT00345358|562114922|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
155731539|NCT00345358|562114923|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
155731540|NCT00345358|562114924|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
155731541|NCT00345358|562114921|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
155731542|NCT00345358|562114922|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
155731543|NCT00345358|562114923|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
155731544|NCT00345358|562114924|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
155731545|NCT00345358|562114921|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
155731546|NCT00345358|562114922|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
155731547|NCT00345358|562114923|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
155731548|NCT00345358|562114924|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
155731549|NCT00345358|562114921|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
155731550|NCT00345358|562114922|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155731551|NCT00345358|562114923|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
155731552|NCT00345358|562114924|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
155731553|NCT00345358|562114921|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
155731554|NCT00345358|562114922|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
155731555|NCT00345358|562114923|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
155731556|NCT00345358|562114924|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
155731557|NCT00346697|562114926|FG000|Overall Study|Lost to Follow-up|0|||
155731558|NCT00346697|562114927|FG001|Overall Study|Lost to Follow-up|1|||
155731559|NCT00499083|562114928|FG000|Overall Study|Not evaluable|3|||
155731560|NCT00686686|562114929|FG000|Overall Study|Non-compliance|1|||
155281353|NCT04034238|560461553|FG003|Dose Escalation Phase|Screen failures|2|||
155281354|NCT04034238|560461550|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
155731561|NCT00686686|562114929|FG000|Overall Study|Adverse Event|2|||
155731562|NCT00686686|562114929|FG000|Overall Study|Lost to Follow-up|3|||
155731563|NCT01012440|562114930|FG000|Overall Study|Withdrawal by Subject|2|||
155731564|NCT00477386|562114934|FG000|Overall Study|Adverse Event|4|||
155731565|NCT00477386|562114935|FG001|Overall Study|Adverse Event|8|||
155731566|NCT00477386|562114934|FG000|Overall Study|Disease progression, relapse|3|||
155731567|NCT00477386|562114935|FG001|Overall Study|Disease progression, relapse|4|||
155731568|NCT00477386|562114934|FG000|Overall Study|Disease progression, refractory|1|||
155731569|NCT00477386|562114935|FG001|Overall Study|Disease progression, refractory|3|||
155388156|NCT00307125|560855042|FG002|Screening Phase|Graft Loss|0|||
155388157|NCT00307125|560855040|FG000|Screening Phase|Graft Failure|8|||
155388158|NCT00307125|560855041|FG001|Screening Phase|Graft Failure|0|||
155388159|NCT00307125|560855042|FG002|Screening Phase|Graft Failure|0|||
155388160|NCT00307125|560855040|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
155388161|NCT00307125|560855041|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
155388162|NCT00307125|560855042|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
155388163|NCT00307125|560855040|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
155388164|NCT00307125|560855041|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
155388165|NCT00307125|560855042|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
155388166|NCT00307125|560855040|FG000|Screening Phase|Moved or transferred facilities|34|||
155388167|NCT00307125|560855041|FG001|Screening Phase|Moved or transferred facilities|0|||
155388168|NCT00307125|560855042|FG002|Screening Phase|Moved or transferred facilities|0|||
155388169|NCT00307125|560855040|FG000|Screening Phase|Received Pancreas Transplant|8|||
155388170|NCT00307125|560855041|FG001|Screening Phase|Received Pancreas Transplant|0|||
155388171|NCT00307125|560855042|FG002|Screening Phase|Received Pancreas Transplant|0|||
155388172|NCT00307125|560855040|FG000|Screening Phase|Ineligible for pilot|4|||
155388173|NCT00307125|560855041|FG001|Screening Phase|Ineligible for pilot|0|||
155388174|NCT00307125|560855042|FG002|Screening Phase|Ineligible for pilot|0|||
155388175|NCT00307125|560855040|FG000|Screening Phase|Try to get pregnant|1|||
155388176|NCT00307125|560855041|FG001|Screening Phase|Try to get pregnant|0|||
155388177|NCT00307125|560855042|FG002|Screening Phase|Try to get pregnant|0|||
155388178|NCT00307125|560855040|FG000|Screening Phase|Developed acute leukemia|1|||
155388179|NCT00307125|560855041|FG001|Screening Phase|Developed acute leukemia|0|||
155388180|NCT00307125|560855042|FG002|Screening Phase|Developed acute leukemia|0|||
155388181|NCT00307125|560855040|FG000|Screening Phase|Metastatic colon cancer|1|||
155388182|NCT00307125|560855041|FG001|Screening Phase|Metastatic colon cancer|0|||
155388183|NCT00307125|560855042|FG002|Screening Phase|Metastatic colon cancer|0|||
155388184|NCT00307125|560855040|FG000|Screening Phase|Malignancy|1|||
155388185|NCT00307125|560855041|FG001|Screening Phase|Malignancy|0|||
155388186|NCT00307125|560855042|FG002|Screening Phase|Malignancy|0|||
155388187|NCT00307125|560855040|FG000|Screening Phase|PAK|1|||
155388188|NCT00307125|560855041|FG001|Screening Phase|PAK|0|||
155388189|NCT00307125|560855042|FG002|Screening Phase|PAK|0|||
155388190|NCT00307125|560855040|FG000|Screening Phase|Ineligible|1|||
155388191|NCT00307125|560855041|FG001|Screening Phase|Ineligible|0|||
155388192|NCT00307125|560855042|FG002|Screening Phase|Ineligible|0|||
155388193|NCT00307125|560855040|FG000|Screening Phase|Screen Error|1|||
155388194|NCT00307125|560855041|FG001|Screening Phase|Screen Error|0|||
155388195|NCT00307125|560855042|FG002|Screening Phase|Screen Error|0|||
155388196|NCT00307125|560855040|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
155388197|NCT00307125|560855041|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
155388198|NCT00307125|560855042|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
155388199|NCT00307125|560855040|FG000|Screening Phase|AMR and treated with rituximab|1|||
155388200|NCT00307125|560855041|FG001|Screening Phase|AMR and treated with rituximab|0|||
155388201|NCT00307125|560855042|FG002|Screening Phase|AMR and treated with rituximab|0|||
155388202|NCT00307125|560855040|FG000|Screening Phase|Coronary artery bypass|1|||
155388203|NCT00307125|560855041|FG001|Screening Phase|Coronary artery bypass|0|||
155388204|NCT00307125|560855042|FG002|Screening Phase|Coronary artery bypass|0|||
155388205|NCT00307125|560855040|FG000|Pilot Phase|Lost to Follow-up|0|||
155388206|NCT00307125|560855041|FG001|Pilot Phase|Lost to Follow-up|1|||
155388207|NCT00307125|560855042|FG002|Pilot Phase|Lost to Follow-up|0|||
155388208|NCT00307125|560855040|FG000|Pilot Phase|Withdrawal by Subject|0|||
155388209|NCT00307125|560855041|FG001|Pilot Phase|Withdrawal by Subject|1|||
155388210|NCT00307125|560855042|FG002|Pilot Phase|Withdrawal by Subject|1|||
155388211|NCT00051363|560855043|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
155388212|NCT00051363|560855044|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
155388213|NCT00051363|560855043|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
155388214|NCT00051363|560855044|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
155388215|NCT00051363|560855043|FG000|Overall Study|Death|2|||
155388216|NCT00051363|560855044|FG001|Overall Study|Death|2|||
155731570|NCT00477386|562114934|FG000|Overall Study|Other|1|||
155388217|NCT00051363|560855043|FG000|Overall Study|Excluded Pre-Randomization|2|||
155731571|NCT00477386|562114935|FG001|Overall Study|Other|2|||
155731572|NCT00477386|562114934|FG000|Overall Study|Physician Decision|1|||
155731573|NCT00477386|562114935|FG001|Overall Study|Physician Decision|0|||
155731574|NCT00477386|562114934|FG000|Overall Study|Withdrawal by Subject|1|||
155388218|NCT00051363|560855044|FG001|Overall Study|Excluded Pre-Randomization|5|||
155388219|NCT01290601|560855045|FG000|Overall Study|Adverse Event|0|||
155388220|NCT01290601|560855046|FG001|Overall Study|Adverse Event|2|||
155388221|NCT01290601|560855047|FG002|Overall Study|Adverse Event|0|||
155388222|NCT01290601|560855048|FG003|Overall Study|Adverse Event|0|||
155388223|NCT01290601|560855045|FG000|Overall Study|Lack of Efficacy|2|||
155388224|NCT01290601|560855046|FG001|Overall Study|Lack of Efficacy|1|||
155388225|NCT01290601|560855047|FG002|Overall Study|Lack of Efficacy|0|||
155388226|NCT01290601|560855048|FG003|Overall Study|Lack of Efficacy|0|||
155629110|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
155629111|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
155629112|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
155629113|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
155629114|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155629115|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155629116|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155629117|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155629118|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
155629119|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155629120|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155629121|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155629122|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155629123|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155629124|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
155629125|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155629126|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155629127|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155629128|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
155629129|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
155629130|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
155629131|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
155629132|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
155629133|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155629134|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
155629135|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155629136|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155629137|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155629138|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
155629139|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155629140|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155629141|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155629142|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155629143|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155629144|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
155629145|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155629146|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155629147|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155629148|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
155629149|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155629150|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155629151|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155629152|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155629153|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155629154|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
155629155|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155629156|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155629157|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155629158|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
155629159|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155629160|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155629161|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155388227|NCT01290601|560855045|FG000|Overall Study|Lost to Follow-up|7|||
155388228|NCT01290601|560855046|FG001|Overall Study|Lost to Follow-up|2|||
155388229|NCT01290601|560855047|FG002|Overall Study|Lost to Follow-up|0|||
155388230|NCT01290601|560855048|FG003|Overall Study|Lost to Follow-up|0|||
155388231|NCT01290601|560855045|FG000|Overall Study|Other|1|||
155388232|NCT01290601|560855046|FG001|Overall Study|Other|0|||
155629162|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155629163|NCT02717195|561737896|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
155629164|NCT02717195|561737897|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155629165|NCT02717195|561737898|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155629166|NCT02717195|561737899|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155629167|NCT02717195|561737900|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155629168|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
155629169|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
155629170|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
155629171|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
155629172|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
155629173|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
155629174|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
155629175|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
155629176|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
155629177|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
155629178|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
155629179|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
155629180|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
155629181|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
155629182|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
155629183|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155629184|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155629185|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
155629186|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155629187|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
155629188|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155629189|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155629190|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
155629191|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
155629192|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
155629193|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155629194|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155629195|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155629196|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
155629197|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
155629198|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155629199|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155629200|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
155629201|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155629202|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155629203|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
155629204|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
155629205|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
155629206|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
155629207|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
155629208|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155629209|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155629210|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155629211|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
155629212|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
155629213|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155629214|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155629215|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155629216|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155629217|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
155629218|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
155629219|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
155731575|NCT00477386|562114935|FG001|Overall Study|Withdrawal by Subject|0|||
155388233|NCT01290601|560855047|FG002|Overall Study|Other|0|||
155388234|NCT01290601|560855048|FG003|Overall Study|Other|0|||
155388235|NCT01290601|560855045|FG000|Overall Study|Protocol Violation|1|||
155388236|NCT01290601|560855046|FG001|Overall Study|Protocol Violation|0|||
155731576|NCT01254422|562114936|FG000|Overall Study|Protocol Violation|1|||
155731577|NCT01254422|562114937|FG001|Overall Study|Protocol Violation|0|||
155731578|NCT01254422|562114936|FG000|Overall Study|Adverse Event|1|||
155731579|NCT01254422|562114937|FG001|Overall Study|Adverse Event|0|||
155731580|NCT01254422|562114936|FG000|Overall Study|Serious adverse event|0|||
155731581|NCT01254422|562114937|FG001|Overall Study|Serious adverse event|1|||
155731582|NCT01254422|562114936|FG000|Overall Study|Lost to Follow-up|1|||
155731583|NCT01254422|562114937|FG001|Overall Study|Lost to Follow-up|0|||
155731584|NCT00643162|562114938|FG000|Overall Study|Withdrawal by Subject|1|||
155731585|NCT00643162|562114939|FG001|Overall Study|Withdrawal by Subject|1|||
155731586|NCT02691507|562114945|FG000|Overall Study|Missed Visit 3|0|||
155731587|NCT02691507|562114946|FG001|Overall Study|Missed Visit 3|1|||
155731588|NCT02557139|562114947|FG000|Overall Study|Significant liver elevation|1|||
155731589|NCT02557139|562114948|FG001|Overall Study|Significant liver elevation|0|||
155731590|NCT02557139|562114949|FG002|Overall Study|Significant liver elevation|1|||
155731591|NCT02557139|562114947|FG000|Overall Study|Withdrawal by Subject|1|||
155731592|NCT02557139|562114948|FG001|Overall Study|Withdrawal by Subject|0|||
155731593|NCT02557139|562114949|FG002|Overall Study|Withdrawal by Subject|0|||
155731594|NCT02557139|562114947|FG000|Overall Study|Illness of prohibited medication|0|||
155731595|NCT02557139|562114948|FG001|Overall Study|Illness of prohibited medication|0|||
155731596|NCT02557139|562114949|FG002|Overall Study|Illness of prohibited medication|1|||
155731597|NCT03023397|562114951|FG000|Run-In|Failed screening allergen challenge|1|||
155731598|NCT03023397|562114952|FG001|Run-In|Failed screening allergen challenge|0|||
155731599|NCT03023397|562114953|FG002|Run-In|Failed screening allergen challenge|0|||
155731600|NCT03023397|562114951|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
155731601|NCT03023397|562114952|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
155731602|NCT03023397|562114953|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
155731603|NCT01146795|562114957|FG000|Overall Study|Withdrawal by Subject|4|||
155731604|NCT01146795|562114957|FG000|Overall Study|Adverse Event|6|||
155731605|NCT01146795|562114957|FG000|Overall Study|Still in treatment at study closure|10|||
155731606|NCT05375760|562114958|FG000|Overall Study|Adverse Event|1|||
155731607|NCT05375760|562114959|FG001|Overall Study|Adverse Event|0|||
155731608|NCT05375760|562114958|FG000|Overall Study|Death|0|||
155731609|NCT05375760|562114959|FG001|Overall Study|Death|1|||
155731610|NCT05375760|562114958|FG000|Overall Study|Lost to Follow-up|6|||
155731611|NCT05375760|562114959|FG001|Overall Study|Lost to Follow-up|6|||
155731612|NCT05375760|562114958|FG000|Overall Study|Withdrawal by Subject|17|||
155731613|NCT05375760|562114959|FG001|Overall Study|Withdrawal by Subject|19|||
155731614|NCT05375760|562114958|FG000|Overall Study|Dosing halted by FDA|96|||
155731615|NCT05375760|562114959|FG001|Overall Study|Dosing halted by FDA|100|||
155731616|NCT05375760|562114958|FG000|Overall Study|Not compliant with study visit|2|||
155731617|NCT05375760|562114959|FG001|Overall Study|Not compliant with study visit|0|||
155731618|NCT05375760|562114958|FG000|Overall Study|Physician Decision|1|||
155731619|NCT05375760|562114959|FG001|Overall Study|Physician Decision|0|||
155731620|NCT05375760|562114958|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
155731621|NCT05375760|562114959|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
155731622|NCT05375760|562114958|FG000|Overall Study|Participant moved|1|||
155731623|NCT05375760|562114959|FG001|Overall Study|Participant moved|0|||
155731624|NCT03853109|562114960|FG000|Overall Study|Withdrawal by Subject|0|||
155731625|NCT03853109|562114961|FG001|Overall Study|Withdrawal by Subject|0|||
155731626|NCT03853109|562114962|FG002|Overall Study|Withdrawal by Subject|1|||
155731627|NCT03853109|562114963|FG003|Overall Study|Withdrawal by Subject|2|||
155731628|NCT03853109|562114964|FG004|Overall Study|Withdrawal by Subject|1|||
155731629|NCT03853109|562114965|FG005|Overall Study|Withdrawal by Subject|4|||
155731630|NCT03853109|562114966|FG006|Overall Study|Withdrawal by Subject|5|||
155731631|NCT03853109|562114967|FG007|Overall Study|Withdrawal by Subject|3|||
155731632|NCT03853109|562114960|FG000|Overall Study|Decision by Sponsor|0|||
155731633|NCT03853109|562114961|FG001|Overall Study|Decision by Sponsor|0|||
155731634|NCT03853109|562114962|FG002|Overall Study|Decision by Sponsor|1|||
155731635|NCT03853109|562114963|FG003|Overall Study|Decision by Sponsor|0|||
155731636|NCT03853109|562114964|FG004|Overall Study|Decision by Sponsor|1|||
155731637|NCT03853109|562114965|FG005|Overall Study|Decision by Sponsor|1|||
155731638|NCT03853109|562114966|FG006|Overall Study|Decision by Sponsor|10|||
155731639|NCT03853109|562114967|FG007|Overall Study|Decision by Sponsor|2|||
155731640|NCT03853109|562114960|FG000|Overall Study|Lost to Follow-up|0|||
155731641|NCT03853109|562114961|FG001|Overall Study|Lost to Follow-up|0|||
155731642|NCT03853109|562114962|FG002|Overall Study|Lost to Follow-up|0|||
155731643|NCT03853109|562114963|FG003|Overall Study|Lost to Follow-up|0|||
155731644|NCT03853109|562114964|FG004|Overall Study|Lost to Follow-up|1|||
155731645|NCT03853109|562114965|FG005|Overall Study|Lost to Follow-up|3|||
155388237|NCT01290601|560855047|FG002|Overall Study|Protocol Violation|0|||
155388238|NCT01290601|560855048|FG003|Overall Study|Protocol Violation|0|||
155731646|NCT03853109|562114966|FG006|Overall Study|Lost to Follow-up|0|||
155731647|NCT03853109|562114967|FG007|Overall Study|Lost to Follow-up|0|||
155731648|NCT03853109|562114960|FG000|Overall Study|Death|2|||
155731649|NCT03853109|562114961|FG001|Overall Study|Death|5|||
155731650|NCT03853109|562114962|FG002|Overall Study|Death|8|||
155731651|NCT03853109|562114963|FG003|Overall Study|Death|10|||
155731652|NCT03853109|562114964|FG004|Overall Study|Death|3|||
155731653|NCT03853109|562114965|FG005|Overall Study|Death|20|||
155731654|NCT03853109|562114966|FG006|Overall Study|Death|10|||
155731655|NCT03853109|562114967|FG007|Overall Study|Death|5|||
155731656|NCT04032093|562114968|FG000|Overall Study|Lost to Follow-up|7|||
155731657|NCT04032093|562114969|FG001|Overall Study|Lost to Follow-up|7|||
155731658|NCT04032093|562114970|FG002|Overall Study|Lost to Follow-up|6|||
155731659|NCT04032093|562114971|FG003|Overall Study|Lost to Follow-up|10|||
155731660|NCT04032093|562114972|FG004|Overall Study|Lost to Follow-up|13|||
155731661|NCT04032093|562114973|FG005|Overall Study|Lost to Follow-up|7|||
155731662|NCT04032093|562114974|FG006|Overall Study|Lost to Follow-up|7|||
155731663|NCT04032093|562114975|FG007|Overall Study|Lost to Follow-up|5|||
155731664|NCT04032093|562114976|FG008|Overall Study|Lost to Follow-up|9|||
155731665|NCT04032093|562114977|FG009|Overall Study|Lost to Follow-up|12|||
155731666|NCT04032093|562114968|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731667|NCT04032093|562114969|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731668|NCT04032093|562114970|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731669|NCT04032093|562114971|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
155281355|NCT04034238|560461551|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
155281356|NCT04034238|560461552|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
155281357|NCT04034238|560461553|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
155281358|NCT04034238|560461550|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281359|NCT04034238|560461551|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281360|NCT04034238|560461552|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
155281361|NCT04034238|560461553|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281362|NCT01345292|560461554|FG000|Overall Study|Withdrawal by Subject|2|||
155281363|NCT01345292|560461555|FG001|Overall Study|Withdrawal by Subject|0|||
155281364|NCT01345292|560461556|FG002|Overall Study|Withdrawal by Subject|1|||
155281365|NCT01244763|560461562|FG000|Overall Study|Adverse Event|1|||
155281366|NCT01244763|560461563|FG001|Overall Study|Adverse Event|0|||
155281367|NCT01244763|560461564|FG002|Overall Study|Adverse Event|0|||
155281368|NCT01244763|560461565|FG003|Overall Study|Adverse Event|0|||
155281369|NCT01244763|560461566|FG004|Overall Study|Adverse Event|0|||
155281370|NCT01244763|560461567|FG005|Overall Study|Adverse Event|1|||
155281371|NCT01244763|560461562|FG000|Overall Study|Death|1|||
155281372|NCT01244763|560461563|FG001|Overall Study|Death|0|||
155281373|NCT01244763|560461564|FG002|Overall Study|Death|1|||
155281374|NCT01244763|560461565|FG003|Overall Study|Death|0|||
155281375|NCT01244763|560461566|FG004|Overall Study|Death|2|||
155281376|NCT01244763|560461567|FG005|Overall Study|Death|0|||
155281377|NCT01244763|560461562|FG000|Overall Study|Physician Decision|0|||
155281378|NCT01244763|560461563|FG001|Overall Study|Physician Decision|0|||
155281379|NCT01244763|560461564|FG002|Overall Study|Physician Decision|1|||
155281380|NCT01244763|560461565|FG003|Overall Study|Physician Decision|0|||
155281381|NCT01244763|560461566|FG004|Overall Study|Physician Decision|0|||
155281382|NCT01244763|560461567|FG005|Overall Study|Physician Decision|0|||
155281383|NCT01244763|560461562|FG000|Overall Study|Withdrawal by Subject|1|||
155281384|NCT01244763|560461563|FG001|Overall Study|Withdrawal by Subject|2|||
155281385|NCT01244763|560461564|FG002|Overall Study|Withdrawal by Subject|0|||
155281386|NCT01244763|560461565|FG003|Overall Study|Withdrawal by Subject|1|||
155281387|NCT01244763|560461566|FG004|Overall Study|Withdrawal by Subject|1|||
155281388|NCT01244763|560461567|FG005|Overall Study|Withdrawal by Subject|2|||
155281389|NCT01244763|560461562|FG000|Overall Study|Lost to Follow-up|0|||
155281390|NCT01244763|560461563|FG001|Overall Study|Lost to Follow-up|1|||
155281391|NCT01244763|560461564|FG002|Overall Study|Lost to Follow-up|0|||
155281392|NCT01244763|560461565|FG003|Overall Study|Lost to Follow-up|0|||
155281393|NCT01244763|560461566|FG004|Overall Study|Lost to Follow-up|0|||
155281394|NCT01244763|560461567|FG005|Overall Study|Lost to Follow-up|0|||
155281395|NCT01244763|560461562|FG000|Overall Study|Enrolled into the Extension Study|0|||
155281396|NCT01244763|560461563|FG001|Overall Study|Enrolled into the Extension Study|0|||
155281397|NCT01244763|560461564|FG002|Overall Study|Enrolled into the Extension Study|0|||
155281398|NCT01244763|560461565|FG003|Overall Study|Enrolled into the Extension Study|0|||
155281399|NCT01244763|560461566|FG004|Overall Study|Enrolled into the Extension Study|0|||
155281400|NCT01244763|560461567|FG005|Overall Study|Enrolled into the Extension Study|1|||
155281401|NCT02271594|560461568|FG000|Overall Study|Study closed; recruiting failure|19|||
155281402|NCT02271594|560461569|FG001|Overall Study|Study closed; recruiting failure|12|||
155281403|NCT02015663|560461580|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
155281404|NCT02015663|560461581|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
155281405|NCT02015663|560461580|FG000|Overall Study|Withdrawal by Subject|1|||
155731670|NCT04032093|562114972|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
155731671|NCT04032093|562114973|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731672|NCT04032093|562114974|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731673|NCT04032093|562114975|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155731674|NCT04032093|562114976|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
155731675|NCT04032093|562114977|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
155731676|NCT04032093|562114968|FG000|Overall Study|Other|1|||
155731677|NCT04032093|562114969|FG001|Overall Study|Other|0|||
155731678|NCT04032093|562114970|FG002|Overall Study|Other|0|||
155731679|NCT04032093|562114971|FG003|Overall Study|Other|1|||
155731680|NCT04032093|562114972|FG004|Overall Study|Other|1|||
155731681|NCT04032093|562114973|FG005|Overall Study|Other|0|||
155731682|NCT04032093|562114974|FG006|Overall Study|Other|0|||
155731683|NCT04032093|562114975|FG007|Overall Study|Other|0|||
155731684|NCT04032093|562114976|FG008|Overall Study|Other|0|||
155731685|NCT04032093|562114977|FG009|Overall Study|Other|1|||
155731686|NCT04032093|562114968|FG000|Overall Study|Withdrawal by Subject|1|||
155731687|NCT04032093|562114969|FG001|Overall Study|Withdrawal by Subject|3|||
155731688|NCT04032093|562114970|FG002|Overall Study|Withdrawal by Subject|2|||
155731689|NCT04032093|562114971|FG003|Overall Study|Withdrawal by Subject|2|||
155731690|NCT04032093|562114972|FG004|Overall Study|Withdrawal by Subject|3|||
155731691|NCT04032093|562114973|FG005|Overall Study|Withdrawal by Subject|0|||
155731692|NCT04032093|562114974|FG006|Overall Study|Withdrawal by Subject|0|||
155731693|NCT04032093|562114975|FG007|Overall Study|Withdrawal by Subject|0|||
155731694|NCT04032093|562114976|FG008|Overall Study|Withdrawal by Subject|0|||
155731695|NCT04032093|562114977|FG009|Overall Study|Withdrawal by Subject|0|||
155731696|NCT04032093|562114968|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155731697|NCT04032093|562114969|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155731698|NCT04032093|562114970|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155731699|NCT04032093|562114971|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155731700|NCT04032093|562114972|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155731701|NCT04032093|562114973|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155731702|NCT04032093|562114974|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
155731703|NCT04032093|562114975|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
155731704|NCT04032093|562114976|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
155731705|NCT04032093|562114977|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
155731706|NCT04032093|562114968|FG000|Overall Study|Adverse Event|0|||
155731707|NCT04032093|562114969|FG001|Overall Study|Adverse Event|0|||
155731708|NCT04032093|562114970|FG002|Overall Study|Adverse Event|0|||
155731709|NCT04032093|562114971|FG003|Overall Study|Adverse Event|0|||
155731710|NCT04032093|562114972|FG004|Overall Study|Adverse Event|0|||
155731711|NCT04032093|562114973|FG005|Overall Study|Adverse Event|0|||
155731712|NCT04032093|562114974|FG006|Overall Study|Adverse Event|0|||
155731713|NCT04032093|562114975|FG007|Overall Study|Adverse Event|0|||
155731714|NCT04032093|562114976|FG008|Overall Study|Adverse Event|0|||
155731715|NCT04032093|562114977|FG009|Overall Study|Adverse Event|1|||
155281406|NCT02015663|560461581|FG001|Overall Study|Withdrawal by Subject|0|||
155281407|NCT02015663|560461580|FG000|Overall Study|Protocol Violation|0|||
155281408|NCT02015663|560461581|FG001|Overall Study|Protocol Violation|1|||
155281409|NCT02015663|560461580|FG000|Overall Study|Adverse Event|3|||
155281410|NCT02015663|560461581|FG001|Overall Study|Adverse Event|0|||
155281411|NCT02015663|560461580|FG000|Overall Study|Administrative problems|10|||
155281412|NCT02015663|560461581|FG001|Overall Study|Administrative problems|11|||
155281413|NCT01818700|560461582|FG000|Overall Study|Adverse Event|67|||
155281414|NCT01818700|560461582|FG000|Overall Study|Lack of Efficacy|2|||
155281415|NCT01818700|560461582|FG000|Overall Study|Lost to Follow-up|5|||
155281416|NCT01818700|560461582|FG000|Overall Study|Withdrawal by Subject|27|||
155281417|NCT01818700|560461582|FG000|Overall Study|Protocol Violation|2|||
155281418|NCT01818700|560461582|FG000|Overall Study|Other|1|||
155281419|NCT02412761|560461583|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281420|NCT02412761|560461584|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281421|NCT02412761|560461585|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281422|NCT02412761|560461586|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281423|NCT02412761|560461587|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281424|NCT02412761|560461588|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281425|NCT01627340|560461591|FG000|Overall Study|Adverse Event|1|||
155281426|NCT01627340|560461592|FG001|Overall Study|Adverse Event|0|||
155281427|NCT01627340|560461591|FG000|Overall Study|Lost to Follow-up|8|||
155281428|NCT01627340|560461592|FG001|Overall Study|Lost to Follow-up|4|||
155281429|NCT01627340|560461591|FG000|Overall Study|Pregnancy|1|||
155281430|NCT01627340|560461592|FG001|Overall Study|Pregnancy|0|||
155731716|NCT04032093|562114968|FG000|Overall Study|Physician Decision|0|||
155731717|NCT04032093|562114969|FG001|Overall Study|Physician Decision|0|||
155731718|NCT04032093|562114970|FG002|Overall Study|Physician Decision|0|||
155731719|NCT04032093|562114971|FG003|Overall Study|Physician Decision|0|||
155731720|NCT04032093|562114972|FG004|Overall Study|Physician Decision|0|||
155731721|NCT04032093|562114973|FG005|Overall Study|Physician Decision|1|||
155731722|NCT04032093|562114974|FG006|Overall Study|Physician Decision|0|||
155731723|NCT04032093|562114975|FG007|Overall Study|Physician Decision|0|||
155731724|NCT04032093|562114976|FG008|Overall Study|Physician Decision|0|||
155731725|NCT04032093|562114977|FG009|Overall Study|Physician Decision|0|||
155731726|NCT02377817|562114978|FG000|Overall Study|Transportation/childcare barriers.|2|||
155731727|NCT02377817|562114979|FG001|Overall Study|Transportation/childcare barriers.|0|||
155731728|NCT02377817|562114978|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
155731729|NCT02377817|562114979|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
155731730|NCT01696188|562114997|FG000|Overall Study|Protocol Violation|1|||
155731731|NCT01696188|562114998|FG001|Overall Study|Protocol Violation|1|||
155731732|NCT02447003|562114999|FG000|Overall Study|Other|0|||
155731733|NCT02447003|562115000|FG001|Overall Study|Other|4|||
155731734|NCT02447003|562114999|FG000|Overall Study|Site discontinued|0|||
155731735|NCT02447003|562115000|FG001|Overall Study|Site discontinued|2|||
155731736|NCT02447003|562114999|FG000|Overall Study|Physician Decision|0|||
155731737|NCT02447003|562115000|FG001|Overall Study|Physician Decision|1|||
155731738|NCT02447003|562114999|FG000|Overall Study|Withdrawal by Subject|4|||
155731739|NCT02447003|562115000|FG001|Overall Study|Withdrawal by Subject|3|||
155731740|NCT02447003|562114999|FG000|Overall Study|Sponsor Decision|6|||
155731741|NCT02447003|562115000|FG001|Overall Study|Sponsor Decision|11|||
155731742|NCT02447003|562114999|FG000|Overall Study|Progressive Disease|1|||
155731743|NCT02447003|562115000|FG001|Overall Study|Progressive Disease|0|||
155731744|NCT02447003|562114999|FG000|Overall Study|Lost to Follow-up|5|||
155731745|NCT02447003|562115000|FG001|Overall Study|Lost to Follow-up|0|||
155731746|NCT02447003|562114999|FG000|Overall Study|Death|154|||
155731747|NCT02447003|562115000|FG001|Overall Study|Death|63|||
155731748|NCT03848728|562115001|FG000|Overall Study|Death|16|||
155731749|NCT03848728|562115002|FG001|Overall Study|Death|13|||
155731750|NCT03848728|562115001|FG000|Overall Study|Outmigrated to non-study community|98|||
155731751|NCT03848728|562115002|FG001|Overall Study|Outmigrated to non-study community|106|||
155731752|NCT03848728|562115001|FG000|Overall Study|Transfered to non-study clinic|32|||
155731753|NCT03848728|562115002|FG001|Overall Study|Transfered to non-study clinic|48|||
155731754|NCT03848728|562115001|FG000|Overall Study|Withdrawal by Subject|1|||
155731755|NCT03848728|562115002|FG001|Overall Study|Withdrawal by Subject|0|||
155731756|NCT00536744|562115005|FG000|Overall Study|Adverse Event|13|||
155731757|NCT00536744|562115006|FG001|Overall Study|Adverse Event|10|||
155731758|NCT00536744|562115005|FG000|Overall Study|Death|2|||
155731759|NCT00536744|562115006|FG001|Overall Study|Death|1|||
155731760|NCT00536744|562115005|FG000|Overall Study|Physician Decision|3|||
155731761|NCT00536744|562115006|FG001|Overall Study|Physician Decision|1|||
155731762|NCT00536744|562115005|FG000|Overall Study|Lost to Follow-up|3|||
155731763|NCT00536744|562115006|FG001|Overall Study|Lost to Follow-up|5|||
155731764|NCT00536744|562115005|FG000|Overall Study|Withdrawal by Subject|7|||
155731765|NCT00536744|562115006|FG001|Overall Study|Withdrawal by Subject|8|||
155731766|NCT00536744|562115005|FG000|Overall Study|PI tried alternative treatment|1|||
155731767|NCT00536744|562115006|FG001|Overall Study|PI tried alternative treatment|3|||
155731768|NCT02581410|562115007|FG000|Vaccination Phase|Adverse Event|2|||
155731769|NCT02581410|562115008|FG001|Vaccination Phase|Adverse Event|1|||
155731770|NCT02581410|562115007|FG000|Vaccination Phase|Withdrawal by Subject|0|||
155731771|NCT02581410|562115008|FG001|Vaccination Phase|Withdrawal by Subject|1|||
155731772|NCT02581410|562115007|FG000|Vaccination Phase|Migrated/moved from study area|0|||
155731773|NCT02581410|562115008|FG001|Vaccination Phase|Migrated/moved from study area|1|||
155731774|NCT02581410|562115007|FG000|End of Study Phase|Adverse Event|4|||
155731775|NCT02581410|562115008|FG001|End of Study Phase|Adverse Event|3|||
155731776|NCT02581410|562115007|FG000|End of Study Phase|Withdrawal by Subject|1|||
155731777|NCT02581410|562115008|FG001|End of Study Phase|Withdrawal by Subject|2|||
155731778|NCT02581410|562115007|FG000|End of Study Phase|Migrated/moved from study area|0|||
155731779|NCT02581410|562115008|FG001|End of Study Phase|Migrated/moved from study area|3|||
155731780|NCT02581410|562115007|FG000|End of Study Phase|Lost to Follow-up|0|||
155731781|NCT02581410|562115008|FG001|End of Study Phase|Lost to Follow-up|2|||
155731782|NCT02581410|562115007|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
155731783|NCT02581410|562115008|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
155731784|NCT02908672|562115010|FG000|Run-in Period|Death|12|||
155731785|NCT02908672|562115011|FG001|Run-in Period|Death|10|||
155731786|NCT02908672|562115012|FG002|Run-in Period|Death|0|||
155731787|NCT02908672|562115013|FG003|Run-in Period|Death|0|||
155731788|NCT02908672|562115010|FG000|Run-in Period|Lost to Follow-up|1|||
155731789|NCT02908672|562115011|FG001|Run-in Period|Lost to Follow-up|1|||
155731790|NCT02908672|562115012|FG002|Run-in Period|Lost to Follow-up|0|||
155731791|NCT02908672|562115013|FG003|Run-in Period|Lost to Follow-up|0|||
155731792|NCT02908672|562115010|FG000|Run-in Period|Reason Not Specified|2|||
155731793|NCT02908672|562115011|FG001|Run-in Period|Reason Not Specified|0|||
155731794|NCT02908672|562115012|FG002|Run-in Period|Reason Not Specified|0|||
155731795|NCT02908672|562115013|FG003|Run-in Period|Reason Not Specified|0|||
155731796|NCT02908672|562115010|FG000|Run-in Period|Protocol Violation|1|||
155731797|NCT02908672|562115011|FG001|Run-in Period|Protocol Violation|1|||
155731798|NCT02908672|562115012|FG002|Run-in Period|Protocol Violation|0|||
155731799|NCT02908672|562115013|FG003|Run-in Period|Protocol Violation|0|||
155731800|NCT02908672|562115010|FG000|Run-in Period|Study Ended by Sponsor|5|||
155731801|NCT02908672|562115011|FG001|Run-in Period|Study Ended by Sponsor|1|||
155731802|NCT02908672|562115012|FG002|Run-in Period|Study Ended by Sponsor|0|||
155731803|NCT02908672|562115013|FG003|Run-in Period|Study Ended by Sponsor|0|||
155388239|NCT02571049|560855049|FG000|Screening|Did not meet entry criteria|2|||
155629220|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
155629221|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
155629222|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
155629223|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155629224|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155629225|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155629226|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155629227|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
155629228|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155629229|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155629230|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
155629231|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155629232|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155629233|NCT02717195|561737896|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155629234|NCT02717195|561737897|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155629235|NCT02717195|561737898|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155629236|NCT02717195|561737899|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
155629237|NCT02717195|561737900|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
155629238|NCT02577029|561737903|FG000|Overall Study|Adverse Event|1|||
155629239|NCT02577029|561737904|FG001|Overall Study|Adverse Event|0|||
155629240|NCT02577029|561737905|FG002|Overall Study|Adverse Event|2|||
155629241|NCT02577029|561737906|FG003|Overall Study|Adverse Event|0|||
155629242|NCT02577029|561737907|FG004|Overall Study|Adverse Event|1|||
155629243|NCT02577029|561737908|FG005|Overall Study|Adverse Event|0|||
155629244|NCT02577029|561737909|FG006|Overall Study|Adverse Event|0|||
155629245|NCT02577029|561737910|FG007|Overall Study|Adverse Event|0|||
155629246|NCT02577029|561737903|FG000|Overall Study|Withdrawal by Subject|0|||
155629247|NCT02577029|561737904|FG001|Overall Study|Withdrawal by Subject|0|||
155629248|NCT02577029|561737905|FG002|Overall Study|Withdrawal by Subject|0|||
155629249|NCT02577029|561737906|FG003|Overall Study|Withdrawal by Subject|0|||
155629250|NCT02577029|561737907|FG004|Overall Study|Withdrawal by Subject|0|||
155629251|NCT02577029|561737908|FG005|Overall Study|Withdrawal by Subject|1|||
155629252|NCT02577029|561737909|FG006|Overall Study|Withdrawal by Subject|0|||
155629253|NCT02577029|561737910|FG007|Overall Study|Withdrawal by Subject|0|||
155629254|NCT02577029|561737903|FG000|Overall Study|Sponsor Termination of the Study|9|||
155629255|NCT02577029|561737904|FG001|Overall Study|Sponsor Termination of the Study|2|||
155629256|NCT02577029|561737905|FG002|Overall Study|Sponsor Termination of the Study|5|||
155629257|NCT02577029|561737906|FG003|Overall Study|Sponsor Termination of the Study|12|||
155629258|NCT02577029|561737907|FG004|Overall Study|Sponsor Termination of the Study|10|||
155629259|NCT02577029|561737908|FG005|Overall Study|Sponsor Termination of the Study|12|||
155629260|NCT02577029|561737909|FG006|Overall Study|Sponsor Termination of the Study|12|||
155629261|NCT02577029|561737910|FG007|Overall Study|Sponsor Termination of the Study|12|||
155629262|NCT02078817|561737911|FG000|Overall Study|Withdrawal by Subject|1|||
155629263|NCT01274351|561737912|FG000|Overall Study|Lost to Follow-up|1|||
155629264|NCT01274351|561737912|FG000|Overall Study|patient not compliant with the protocol|1|||
155629265|NCT01274351|561737912|FG000|Overall Study|Pregnancy|1|||
155629266|NCT01274351|561737912|FG000|Overall Study|Death|2|||
155629267|NCT01274351|561737912|FG000|Overall Study|Withdrawal by Subject|3|||
155629268|NCT01274351|561737912|FG000|Overall Study|Adverse Event|8|||
155629269|NCT01274351|561737912|FG000|Overall Study|progression of disease|3|||
155629270|NCT01274351|561737912|FG000|Overall Study|hospitalization|1|||
155629271|NCT00959751|561739818|FG000|Overall Study|Lost to Follow-up|2|||
155629272|NCT00959751|561739819|FG001|Overall Study|Lost to Follow-up|3|||
155629273|NCT00959751|561739818|FG000|Overall Study|Consent Withdrawn|0|||
155629274|NCT00959751|561739819|FG001|Overall Study|Consent Withdrawn|1|||
155629275|NCT00959751|561739818|FG000|Overall Study|Non-compliance to Study Procedures|0|||
155629276|NCT00959751|561739819|FG001|Overall Study|Non-compliance to Study Procedures|1|||
155629277|NCT00959751|561739818|FG000|Overall Study|No migraine headache without aura|7|||
155281431|NCT01627340|560461591|FG000|Overall Study|Withdrawal by Subject|2|||
155281432|NCT01627340|560461592|FG001|Overall Study|Withdrawal by Subject|0|||
155281433|NCT01272011|560461593|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
155281434|NCT01272011|560461594|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
155281435|NCT01272011|560461595|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
155281436|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
155281437|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
155281438|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
155281439|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
155281440|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
155629278|NCT00959751|561739819|FG001|Overall Study|No migraine headache without aura|7|||
155629279|NCT03737994|561739820|FG000|Overall Study|Withdrawal by Subject|0|||
155388240|NCT02571049|560855050|FG001|Screening|Did not meet entry criteria|2|||
155388241|NCT02571049|560855049|FG000|Randomization|No migraine attack|0|||
155388242|NCT02571049|560855050|FG001|Randomization|No migraine attack|1|||
155388243|NCT02571049|560855049|FG000|Randomization|Adverse Event|0|||
155388244|NCT02571049|560855050|FG001|Randomization|Adverse Event|1|||
155388245|NCT00973362|560856170|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
155388246|NCT00973362|560856171|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
155629280|NCT03737994|561739821|FG001|Overall Study|Withdrawal by Subject|0|||
155629281|NCT03737994|561739822|FG002|Overall Study|Withdrawal by Subject|0|||
155629282|NCT03737994|561739823|FG003|Overall Study|Withdrawal by Subject|0|||
155629283|NCT03737994|561739824|FG004|Overall Study|Withdrawal by Subject|0|||
155629284|NCT03737994|561739825|FG005|Overall Study|Withdrawal by Subject|0|||
155629285|NCT03737994|561739826|FG006|Overall Study|Withdrawal by Subject|1|||
155629286|NCT03861039|561739829|FG000|Overall Study|Adverse Event|2|||
155629287|NCT03861039|561739830|FG001|Overall Study|Adverse Event|5|||
155629288|NCT03861039|561739831|FG002|Overall Study|Adverse Event|11|||
155629289|NCT03861039|561739829|FG000|Overall Study|Withdrawal by Subject|1|||
155629290|NCT03861039|561739830|FG001|Overall Study|Withdrawal by Subject|3|||
155629291|NCT03861039|561739831|FG002|Overall Study|Withdrawal by Subject|4|||
155629292|NCT03427892|561739832|FG000|Overall Study|Lost to Follow-up|2|||
155629293|NCT03255187|561739833|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
155629294|NCT03255187|561739834|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
155629295|NCT03255187|561739833|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
155629296|NCT03255187|561739834|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
155629297|NCT03261401|561739839|FG000|Overall Study|Withdrawal by Subject|0|||
155629298|NCT03261401|561739840|FG001|Overall Study|Withdrawal by Subject|0|||
155629299|NCT03261401|561739841|FG002|Overall Study|Withdrawal by Subject|0|||
155629300|NCT03261401|561739842|FG003|Overall Study|Withdrawal by Subject|0|||
155629301|NCT03261401|561739843|FG004|Overall Study|Withdrawal by Subject|0|||
155629302|NCT03261401|561739844|FG005|Overall Study|Withdrawal by Subject|1|||
155629303|NCT03261401|561739845|FG006|Overall Study|Withdrawal by Subject|0|||
155629304|NCT03261401|561739846|FG007|Overall Study|Withdrawal by Subject|0|||
155629305|NCT03261401|561739847|FG008|Overall Study|Withdrawal by Subject|0|||
155629306|NCT03261401|561739848|FG009|Overall Study|Withdrawal by Subject|0|||
155629307|NCT03261401|561739849|FG010|Overall Study|Withdrawal by Subject|0|||
155629308|NCT03261401|561739850|FG011|Overall Study|Withdrawal by Subject|0|||
155629309|NCT03261401|561739851|FG012|Overall Study|Withdrawal by Subject|0|||
155629310|NCT03261401|561739839|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
155629311|NCT03261401|561739840|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
155629312|NCT03261401|561739841|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
155629313|NCT03261401|561739842|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
155629314|NCT03261401|561739843|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
155629315|NCT03261401|561739844|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
155629316|NCT03261401|561739845|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
155629317|NCT03261401|561739846|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
155629318|NCT03261401|561739847|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
155629319|NCT03261401|561739848|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
155629320|NCT03261401|561739849|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
155629321|NCT03261401|561739850|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
155731804|NCT02908672|562115010|FG000|Run-in Period|Withdrawal by Subject|3|||
155731805|NCT02908672|562115011|FG001|Run-in Period|Withdrawal by Subject|9|||
155731806|NCT02908672|562115012|FG002|Run-in Period|Withdrawal by Subject|0|||
155731807|NCT02908672|562115013|FG003|Run-in Period|Withdrawal by Subject|0|||
155388247|NCT00973362|560856170|FG000|Baseline Evaluation|No colposcopy visit|62|||
155388248|NCT00973362|560856171|FG001|Baseline Evaluation|No colposcopy visit|0|||
155388249|NCT00973362|560856170|FG000|Baseline Evaluation|Inevaluable|686|||
155388250|NCT00973362|560856171|FG001|Baseline Evaluation|Inevaluable|223|||
155388251|NCT00973362|560856170|FG000|3-Year Follow-up|Lost to Follow-up|17|||
155388252|NCT00973362|560856171|FG001|3-Year Follow-up|Lost to Follow-up|0|||
155388253|NCT05116046|560856172|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155388254|NCT05116046|560856173|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155388255|NCT05116046|560856174|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155388256|NCT05116046|560856172|FG000|Overall Study|Study terminated by sponsor|14|||
155388257|NCT05116046|560856173|FG001|Overall Study|Study terminated by sponsor|16|||
155388258|NCT05116046|560856174|FG002|Overall Study|Study terminated by sponsor|1|||
155388259|NCT00146757|560856175|FG000|Overall Study|Death|1|||
155388260|NCT00146757|560856176|FG001|Overall Study|Death|0|||
155388261|NCT00146757|560856175|FG000|Overall Study|Adverse Event|1|||
155629322|NCT03261401|561739851|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
155629323|NCT00296335|561739857|FG000|Overall Study|Recurrence|3|||
155629324|NCT00296335|561739858|FG001|Overall Study|Recurrence|51|||
155388262|NCT00146757|560856176|FG001|Overall Study|Adverse Event|0|||
155629325|NCT00296335|561739857|FG000|Overall Study|Adverse Event|17|||
155629326|NCT00296335|561739858|FG001|Overall Study|Adverse Event|27|||
155629327|NCT00296335|561739857|FG000|Overall Study|Lost to Follow-up|7|||
155629328|NCT00296335|561739858|FG001|Overall Study|Lost to Follow-up|33|||
155629329|NCT00296335|561739857|FG000|Overall Study|Physician Decision|3|||
155629330|NCT00296335|561739858|FG001|Overall Study|Physician Decision|11|||
155629331|NCT01142336|561739859|FG000|Overall Study|Adverse Event|1|||
155629332|NCT01142336|561739860|FG001|Overall Study|Adverse Event|1|||
155629333|NCT01142336|561739859|FG000|Overall Study|Lost to Follow-up|0|||
155629334|NCT01142336|561739860|FG001|Overall Study|Lost to Follow-up|1|||
155629335|NCT01704261|561739861|FG000|Overall Study|Withdrawal by Subject|12|||
155629336|NCT01704261|561739862|FG001|Overall Study|Withdrawal by Subject|15|||
155629337|NCT01704261|561739861|FG000|Overall Study|Lost to Follow-up|1|||
155629338|NCT01704261|561739862|FG001|Overall Study|Lost to Follow-up|0|||
155629339|NCT02722967|561739863|FG000|Overall Study|Adverse Event|1|||
155629340|NCT02722967|561739864|FG001|Overall Study|Adverse Event|0|||
155629341|NCT02722967|561739865|FG002|Overall Study|Adverse Event|0|||
155629342|NCT02722967|561739863|FG000|Overall Study|Lost to Follow-up|0|||
155629343|NCT02722967|561739864|FG001|Overall Study|Lost to Follow-up|1|||
155629344|NCT02722967|561739865|FG002|Overall Study|Lost to Follow-up|0|||
155629345|NCT02722967|561739863|FG000|Overall Study|Non-compliance with patch wearing|2|||
155629346|NCT02722967|561739864|FG001|Overall Study|Non-compliance with patch wearing|1|||
155629347|NCT02722967|561739865|FG002|Overall Study|Non-compliance with patch wearing|1|||
155629348|NCT02722967|561739863|FG000|Overall Study|Withdrawal by Subject|1|||
155629349|NCT02722967|561739864|FG001|Overall Study|Withdrawal by Subject|0|||
155629350|NCT02722967|561739865|FG002|Overall Study|Withdrawal by Subject|1|||
155629351|NCT02722967|561739863|FG000|Overall Study|Physician Decision|1|||
155629352|NCT02722967|561739864|FG001|Overall Study|Physician Decision|0|||
155629353|NCT02722967|561739865|FG002|Overall Study|Physician Decision|0|||
155629354|NCT02722967|561739863|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
155629355|NCT02722967|561739864|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
155629356|NCT02722967|561739865|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
155629357|NCT02391337|561739866|FG000|6 Months Follow-up|Death|5|||
155629358|NCT02391337|561739867|FG001|6 Months Follow-up|Death|4|||
155629359|NCT02391337|561739866|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
155629360|NCT02391337|561739867|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
155629361|NCT02391337|561739866|FG000|12 Months Follow-up|Death|2|||
155629362|NCT02391337|561739867|FG001|12 Months Follow-up|Death|0|||
155629363|NCT02391337|561739866|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
155629364|NCT02391337|561739867|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
155629365|NCT02391337|561739866|FG000|12 Months Follow-up|Lost to Follow-up|0|||
155629366|NCT02391337|561739867|FG001|12 Months Follow-up|Lost to Follow-up|2|||
155629367|NCT00830128|561739871|FG000|Overall Study|Adverse Event|5|||
155629368|NCT00830128|561739871|FG000|Overall Study|Lack of Efficacy|7|||
155629369|NCT00830128|561739871|FG000|Overall Study|Protocol Violation|1|||
155629370|NCT00830128|561739871|FG000|Overall Study|Withdrawal by Subject|2|||
155629371|NCT00830128|561739871|FG000|Overall Study|Family obligation|1|||
155629372|NCT00830128|561739871|FG000|Overall Study|Relocation|1|||
155629373|NCT00830128|561739871|FG000|Overall Study|Work obligation|1|||
155629374|NCT00830128|561739871|FG000|Overall Study|Operating a vehicle|1|||
155629375|NCT00846053|561739874|FG000|Overall Study|Physician Decision|3|||
155629376|NCT00846053|561739875|FG001|Overall Study|Physician Decision|0|||
155629377|NCT01123655|561739879|FG000|Overall Study|Medication for RA had to be changed|1|||
155629378|NCT01123655|561739880|FG001|Overall Study|Medication for RA had to be changed|0|||
155629379|NCT01123655|561739881|FG002|Overall Study|Medication for RA had to be changed|0|||
155629380|NCT01123655|561739879|FG000|Overall Study|new illness|0|||
155629381|NCT01123655|561739880|FG001|Overall Study|new illness|1|||
155629382|NCT01123655|561739881|FG002|Overall Study|new illness|0|||
155629383|NCT01123655|561739879|FG000|Overall Study|began prohibitive drug|0|||
155629384|NCT01123655|561739880|FG001|Overall Study|began prohibitive drug|0|||
155629385|NCT01123655|561739881|FG002|Overall Study|began prohibitive drug|1|||
155629386|NCT00062166|561739882|FG000|Overall Study|Withdrawal by Subject|6|||
155629387|NCT04158648|561739887|FG000|Overall Study|Ongoing in the Study|69|||
155629388|NCT04158648|561739887|FG000|Overall Study|Withdrawal by Subject|4|||
155629389|NCT02121210|561739888|FG000|Overall Study|Adverse Event|5|||
155281441|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
155629390|NCT02121210|561739889|FG001|Overall Study|Adverse Event|7|||
155629391|NCT02121210|561739888|FG000|Overall Study|Lack of Efficacy|2|||
155629392|NCT02121210|561739889|FG001|Overall Study|Lack of Efficacy|0|||
155629393|NCT02121210|561739888|FG000|Overall Study|Other than specified above|0|||
155629394|NCT02121210|561739889|FG001|Overall Study|Other than specified above|2|||
155629395|NCT00885118|561739890|FG000|Overall Study|Adverse Event|1|||
155629396|NCT00885118|561739891|FG001|Overall Study|Adverse Event|0|||
155629397|NCT00885118|561739892|FG002|Overall Study|Adverse Event|0|||
155629398|NCT00885118|561739893|FG003|Overall Study|Adverse Event|0|||
155629399|NCT00885118|561739894|FG004|Overall Study|Adverse Event|0|||
155629400|NCT00885118|561739890|FG000|Overall Study|Withdrawal by Subject|0|||
155629401|NCT00885118|561739891|FG001|Overall Study|Withdrawal by Subject|0|||
155629402|NCT00885118|561739892|FG002|Overall Study|Withdrawal by Subject|0|||
155388263|NCT02076178|560856180|FG000|Oral Phase|Adverse Event|0|||
155388264|NCT02076178|560856181|FG001|Oral Phase|Adverse Event|7|||
155388265|NCT02076178|560856180|FG000|Oral Phase|Withdrawal by Subject|0|||
155388266|NCT02076178|560856181|FG001|Oral Phase|Withdrawal by Subject|4|||
155388267|NCT02076178|560856180|FG000|Oral Phase|Physician Decision|0|||
155388268|NCT02076178|560856181|FG001|Oral Phase|Physician Decision|1|||
155388269|NCT02076178|560856180|FG000|Injection Phase|Protocol defined stopping criteria|1|||
155388270|NCT02076178|560856181|FG001|Injection Phase|Protocol defined stopping criteria|0|||
155388271|NCT02076178|560856180|FG000|Injection Phase|Withdrawal by Subject|0|||
155388272|NCT02076178|560856181|FG001|Injection Phase|Withdrawal by Subject|3|||
155388273|NCT02076178|560856180|FG000|Injection Phase|Physician Decision|0|||
155731808|NCT02908672|562115010|FG000|Triple Combination Period|Death|0|||
155731809|NCT02908672|562115011|FG001|Triple Combination Period|Death|0|||
155731810|NCT02908672|562115012|FG002|Triple Combination Period|Death|150|||
155731811|NCT02908672|562115013|FG003|Triple Combination Period|Death|127|||
155731812|NCT02908672|562115010|FG000|Triple Combination Period|Lost to Follow-up|0|||
155731813|NCT02908672|562115011|FG001|Triple Combination Period|Lost to Follow-up|0|||
155731814|NCT02908672|562115012|FG002|Triple Combination Period|Lost to Follow-up|6|||
155731815|NCT02908672|562115013|FG003|Triple Combination Period|Lost to Follow-up|8|||
155731816|NCT02908672|562115010|FG000|Triple Combination Period|Reason Not Specified|0|||
155731817|NCT02908672|562115011|FG001|Triple Combination Period|Reason Not Specified|0|||
155731818|NCT02908672|562115012|FG002|Triple Combination Period|Reason Not Specified|0|||
155731819|NCT02908672|562115013|FG003|Triple Combination Period|Reason Not Specified|1|||
155731820|NCT02908672|562115010|FG000|Triple Combination Period|Physician Decision|0|||
155731821|NCT02908672|562115011|FG001|Triple Combination Period|Physician Decision|0|||
155731822|NCT02908672|562115012|FG002|Triple Combination Period|Physician Decision|1|||
155388274|NCT02076178|560856181|FG001|Injection Phase|Physician Decision|3|||
155388275|NCT02076178|560856180|FG000|Injection Phase|Lost to Follow-up|0|||
155388276|NCT02076178|560856181|FG001|Injection Phase|Lost to Follow-up|1|||
155388277|NCT01026454|560856182|FG000|Second Intervention|Pregnancy|1|||
155388278|NCT01026454|560856183|FG001|Second Intervention|Pregnancy|1|||
155388279|NCT02893930|560856184|FG000|Overall Study|Adverse Event|3|||
155388280|NCT02893930|560856184|FG000|Overall Study|Death|1|||
155388281|NCT02893930|560856184|FG000|Overall Study|Disease progression|5|||
155388282|NCT02893930|560856184|FG000|Overall Study|Withdrawal by Subject|2|||
155388283|NCT02893930|560856184|FG000|Overall Study|Physician Decision|1|||
155388284|NCT02893930|560856184|FG000|Overall Study|Ineligible|1|||
155388285|NCT01142596|560856185|FG000|Overall Study|Withdrawal by Subject|9|||
155388286|NCT01142596|560856186|FG001|Overall Study|Withdrawal by Subject|35|||
155388287|NCT01142596|560856185|FG000|Overall Study|Adverse Event|8|||
155388288|NCT01142596|560856186|FG001|Overall Study|Adverse Event|35|||
155388289|NCT01142596|560856185|FG000|Overall Study|Lack of Efficacy|5|||
155388290|NCT01142596|560856186|FG001|Overall Study|Lack of Efficacy|9|||
155388291|NCT01142596|560856185|FG000|Overall Study|Lost to Follow-up|2|||
155388292|NCT01142596|560856186|FG001|Overall Study|Lost to Follow-up|3|||
155388293|NCT01142596|560856185|FG000|Overall Study|Other reason (not specified)|5|||
155388294|NCT01142596|560856186|FG001|Overall Study|Other reason (not specified)|4|||
155388295|NCT02349360|560856187|FG000|Overall Study|Withdrawal by Subject|0|||
155388296|NCT02349360|560856188|FG001|Overall Study|Withdrawal by Subject|1|||
155388297|NCT01054846|560856189|FG000|Overall Study|Lost to Follow-up|76|||
155388298|NCT01054846|560856190|FG001|Overall Study|Lost to Follow-up|17|||
155388299|NCT02446886|560856199|FG000|Overall Study|Adverse Event|1|||
155388300|NCT02446886|560856200|FG001|Overall Study|Adverse Event|3|||
155388301|NCT02446886|560856199|FG000|Overall Study|Withdrawal by Subject|1|||
155388302|NCT02446886|560856200|FG001|Overall Study|Withdrawal by Subject|1|||
155388303|NCT01971203|560856203|FG000|Overall Study|Protocol Violation|3|||
155388304|NCT01971203|560856204|FG001|Overall Study|Protocol Violation|2|||
155388305|NCT01971203|560856203|FG000|Overall Study|Withdrawal by Subject|5|||
155629403|NCT00885118|561739893|FG003|Overall Study|Withdrawal by Subject|0|||
155629404|NCT00885118|561739894|FG004|Overall Study|Withdrawal by Subject|1|||
155629405|NCT00885118|561739890|FG000|Overall Study|Other reason not defined above|0|||
155629406|NCT00885118|561739891|FG001|Overall Study|Other reason not defined above|0|||
155629407|NCT00885118|561739892|FG002|Overall Study|Other reason not defined above|1|||
155629408|NCT00885118|561739893|FG003|Overall Study|Other reason not defined above|0|||
155629409|NCT00885118|561739894|FG004|Overall Study|Other reason not defined above|0|||
155629410|NCT00251758|561739901|FG000|Overall Study|Adverse Event|7|||
155629411|NCT00251758|561739902|FG001|Overall Study|Adverse Event|9|||
155629412|NCT00251758|561739903|FG002|Overall Study|Adverse Event|11|||
155629413|NCT00251758|561739901|FG000|Overall Study|Lost to Follow-up|4|||
155731823|NCT02908672|562115013|FG003|Triple Combination Period|Physician Decision|1|||
155731824|NCT02908672|562115010|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
155388306|NCT01971203|560856204|FG001|Overall Study|Withdrawal by Subject|6|||
155388307|NCT01971203|560856203|FG000|Overall Study|Adverse Event|1|||
155388308|NCT01971203|560856204|FG001|Overall Study|Adverse Event|0|||
155629414|NCT00251758|561739902|FG001|Overall Study|Lost to Follow-up|2|||
155731825|NCT02908672|562115011|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
155388309|NCT00775450|560856211|FG000|Overall Study|Serious Adverse Event|2|||
155388310|NCT00775450|560856212|FG001|Overall Study|Serious Adverse Event|0|||
155629415|NCT00251758|561739903|FG002|Overall Study|Lost to Follow-up|5|||
155629416|NCT00251758|561739901|FG000|Overall Study|Withdrawal by Subject|13|||
155629417|NCT00251758|561739902|FG001|Overall Study|Withdrawal by Subject|7|||
155629418|NCT00251758|561739903|FG002|Overall Study|Withdrawal by Subject|3|||
155629419|NCT00251758|561739901|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155629420|NCT00251758|561739902|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
155629421|NCT00251758|561739903|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
155629422|NCT00251758|561739901|FG000|Overall Study|Lack of Efficacy|3|||
155629423|NCT00251758|561739902|FG001|Overall Study|Lack of Efficacy|0|||
155629424|NCT00251758|561739903|FG002|Overall Study|Lack of Efficacy|0|||
155629425|NCT00251758|561739901|FG000|Overall Study|Noncompliant|0|||
155629426|NCT00251758|561739902|FG001|Overall Study|Noncompliant|2|||
155629427|NCT00251758|561739903|FG002|Overall Study|Noncompliant|2|||
155629428|NCT00251758|561739901|FG000|Overall Study|Pregnancy|0|||
155629429|NCT00251758|561739902|FG001|Overall Study|Pregnancy|1|||
155629430|NCT00251758|561739903|FG002|Overall Study|Pregnancy|0|||
155629431|NCT00251758|561739901|FG000|Overall Study|Per Subject Request|0|||
155629432|NCT00251758|561739902|FG001|Overall Study|Per Subject Request|0|||
155629433|NCT00251758|561739903|FG002|Overall Study|Per Subject Request|1|||
155629434|NCT00251758|561739901|FG000|Overall Study|Per Investigator Request|1|||
155629435|NCT00251758|561739902|FG001|Overall Study|Per Investigator Request|0|||
155629436|NCT00251758|561739903|FG002|Overall Study|Per Investigator Request|0|||
155629437|NCT01981616|561739906|FG000|Overall Study|Adverse Event|0|||
155629438|NCT01981616|561739907|FG001|Overall Study|Adverse Event|1|||
155629439|NCT01981616|561739906|FG000|Overall Study|Protocol Violation|1|||
155629440|NCT01981616|561739907|FG001|Overall Study|Protocol Violation|0|||
155629441|NCT02404545|561739908|FG000|Overall Study|Sponsor Termination|6|||
155629442|NCT02404545|561739909|FG001|Overall Study|Sponsor Termination|6|||
155629443|NCT03641508|561739910|FG000|First Injection|Lost to Follow-up|2|||
155629444|NCT03641508|561739911|FG001|First Injection|Lost to Follow-up|0|||
155629445|NCT03642990|561739912|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
155629446|NCT03642990|561739912|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
155629447|NCT00094445|561739913|FG000|Overall Study|Withdrawal by Subject|3|||
155629448|NCT00094445|561739913|FG000|Overall Study|Lost to Follow-up|1|||
155629449|NCT00094445|561739913|FG000|Overall Study|Progressive Disease|2|||
155629450|NCT00855218|561739914|FG000|Overall Study|Adverse Event|43|||
155629451|NCT00855218|561739915|FG001|Overall Study|Adverse Event|27|||
155629452|NCT00855218|561739914|FG000|Overall Study|Withdrawal by Subject|10|||
155629453|NCT00855218|561739915|FG001|Overall Study|Withdrawal by Subject|6|||
155629454|NCT00855218|561739914|FG000|Overall Study|Physician Decision|18|||
155629455|NCT00855218|561739915|FG001|Overall Study|Physician Decision|11|||
155629456|NCT00855218|561739914|FG000|Overall Study|Lost to Follow-up|0|||
155629457|NCT00855218|561739915|FG001|Overall Study|Lost to Follow-up|1|||
155629458|NCT00855218|561739914|FG000|Overall Study|Protocol Violation|5|||
155629459|NCT00855218|561739915|FG001|Overall Study|Protocol Violation|9|||
155629460|NCT00855218|561739914|FG000|Overall Study|non-compliant with study drug|3|||
155629461|NCT00855218|561739915|FG001|Overall Study|non-compliant with study drug|1|||
155629462|NCT00855218|561739914|FG000|Overall Study|patient convenience|2|||
155629463|NCT00855218|561739915|FG001|Overall Study|patient convenience|0|||
155629464|NCT00855218|561739914|FG000|Overall Study|technical problems|2|||
155629465|NCT00855218|561739915|FG001|Overall Study|technical problems|1|||
155629466|NCT00855218|561739914|FG000|Overall Study|Still treated with study medication|0|||
155629467|NCT00855218|561739915|FG001|Overall Study|Still treated with study medication|1|||
155629468|NCT00855218|561739914|FG000|Overall Study|Untreatable disease progression|54|||
155629469|NCT00855218|561739915|FG001|Overall Study|Untreatable disease progression|67|||
155629470|NCT00855218|561739914|FG000|Overall Study|Second malignancy|0|||
155629471|NCT00855218|561739915|FG001|Overall Study|Second malignancy|1|||
155629472|NCT00855218|561739914|FG000|Overall Study|Progression measurement proven|7|||
155629473|NCT00855218|561739915|FG001|Overall Study|Progression measurement proven|15|||
155629474|NCT00855218|561739914|FG000|Overall Study|Clinical endpoint reached|10|||
155629475|NCT00855218|561739915|FG001|Overall Study|Clinical endpoint reached|13|||
155629476|NCT00769561|561739917|FG000|Overall Study|Withdrawal by Subject|2|||
155629477|NCT00769561|561739918|FG001|Overall Study|Withdrawal by Subject|2|||
155629478|NCT00769561|561739917|FG000|Overall Study|Lost to Follow-up|1|||
155629479|NCT00769561|561739918|FG001|Overall Study|Lost to Follow-up|3|||
155629480|NCT03191552|561739926|FG000|Overall Study|Lost to Follow-up|1|||
155629481|NCT03191552|561739927|FG001|Overall Study|Lost to Follow-up|0|||
155629482|NCT03191552|561739928|FG002|Overall Study|Lost to Follow-up|0|||
155629483|NCT03191552|561739926|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
155388311|NCT00775450|560856213|FG002|Overall Study|Serious Adverse Event|0|||
155629484|NCT03191552|561739927|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
155629485|NCT03191552|561739928|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
155629486|NCT02370511|561739931|FG000|Overall Study|Death|10|||
155629487|NCT02370511|561739932|FG001|Overall Study|Death|7|||
155629488|NCT02370511|561739933|FG002|Overall Study|Death|1|||
155629489|NCT02370511|561739931|FG000|Overall Study|Withdrawal by Subject|2|||
155731826|NCT02908672|562115012|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
155731827|NCT02908672|562115013|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
155731828|NCT02908672|562115010|FG000|Triple Combination Period|Withdrawal by Subject|0|||
155731829|NCT02908672|562115011|FG001|Triple Combination Period|Withdrawal by Subject|0|||
155731830|NCT02908672|562115012|FG002|Triple Combination Period|Withdrawal by Subject|13|||
155731831|NCT02908672|562115013|FG003|Triple Combination Period|Withdrawal by Subject|16|||
155731832|NCT00670748|562115014|FG000|Overall Study|Death during treatment|1|||
155731833|NCT00670748|562115015|FG001|Overall Study|Death during treatment|1|||
155731834|NCT00670748|562115016|FG002|Overall Study|Death during treatment|1|||
155731835|NCT00670748|562115017|FG003|Overall Study|Death during treatment|0|||
155731836|NCT00670748|562115014|FG000|Overall Study|Not off study|2|||
155731837|NCT00670748|562115015|FG001|Overall Study|Not off study|1|||
155731838|NCT00670748|562115016|FG002|Overall Study|Not off study|1|||
155731839|NCT00670748|562115017|FG003|Overall Study|Not off study|1|||
155731840|NCT01185080|562115021|FG000|Overall Study|Adverse Event|1|||
155731841|NCT01185080|562115022|FG001|Overall Study|Adverse Event|1|||
155731842|NCT01185080|562115023|FG002|Overall Study|Adverse Event|0|||
155731843|NCT01185080|562115021|FG000|Overall Study|Personal reasons|0|||
155731844|NCT01185080|562115022|FG001|Overall Study|Personal reasons|0|||
155731845|NCT01185080|562115023|FG002|Overall Study|Personal reasons|1|||
155731846|NCT02876601|562115024|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155731847|NCT02876601|562115025|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155731848|NCT02876601|562115026|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
155731849|NCT02876601|562115027|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155731850|NCT03863080|562115028|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155731851|NCT03863080|562115029|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155731852|NCT03863080|562115030|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
155731853|NCT03863080|562115031|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155731854|NCT03863080|562115028|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155731855|NCT03863080|562115029|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155731856|NCT03863080|562115030|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155731857|NCT03863080|562115031|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
155731858|NCT03863080|562115028|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155731859|NCT03863080|562115029|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155731860|NCT03863080|562115030|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155731861|NCT03863080|562115031|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
155731862|NCT06083506|562115033|FG000|Overall Study|Physician Decision|2|||
155731863|NCT06083506|562115033|FG000|Overall Study|Lack of Efficacy|1|||
155731864|NCT01648751|562115045|FG000|Overall Study|Withdrawal by Subject|2|||
155731865|NCT01648751|562115046|FG001|Overall Study|Withdrawal by Subject|3|||
155731866|NCT02000115|562115048|FG000|Overall Study|Death|56|||
155731867|NCT02000115|562115049|FG001|Overall Study|Death|45|||
155731868|NCT02000115|562115050|FG002|Overall Study|Death|0|||
155731869|NCT02000115|562115051|FG003|Overall Study|Death|0|||
155731870|NCT02000115|562115048|FG000|Overall Study|Missed Visit|6|||
155731871|NCT02000115|562115049|FG001|Overall Study|Missed Visit|8|||
155731872|NCT02000115|562115050|FG002|Overall Study|Missed Visit|1|||
155731873|NCT02000115|562115051|FG003|Overall Study|Missed Visit|0|||
155731874|NCT02000115|562115048|FG000|Overall Study|Protocol Violation|2|||
155731875|NCT02000115|562115049|FG001|Overall Study|Protocol Violation|1|||
155731876|NCT02000115|562115050|FG002|Overall Study|Protocol Violation|0|||
155731877|NCT02000115|562115051|FG003|Overall Study|Protocol Violation|0|||
155731878|NCT02000115|562115048|FG000|Overall Study|Physician Decision|2|||
155731879|NCT02000115|562115049|FG001|Overall Study|Physician Decision|0|||
155731880|NCT02000115|562115050|FG002|Overall Study|Physician Decision|0|||
155731881|NCT02000115|562115051|FG003|Overall Study|Physician Decision|0|||
155731882|NCT02000115|562115048|FG000|Overall Study|Withdrawal by Subject|11|||
155731883|NCT02000115|562115049|FG001|Overall Study|Withdrawal by Subject|11|||
155731884|NCT02000115|562115050|FG002|Overall Study|Withdrawal by Subject|0|||
155731885|NCT02000115|562115051|FG003|Overall Study|Withdrawal by Subject|0|||
155731886|NCT02000115|562115048|FG000|Overall Study|Lost to Follow-up|0|||
155731887|NCT02000115|562115049|FG001|Overall Study|Lost to Follow-up|1|||
155731888|NCT02000115|562115050|FG002|Overall Study|Lost to Follow-up|0|||
155731889|NCT02000115|562115051|FG003|Overall Study|Lost to Follow-up|0|||
155731890|NCT02000115|562115048|FG000|Overall Study|Non-compliance|2|||
155731891|NCT02000115|562115049|FG001|Overall Study|Non-compliance|1|||
155731892|NCT02000115|562115050|FG002|Overall Study|Non-compliance|0|||
155731893|NCT02000115|562115051|FG003|Overall Study|Non-compliance|0|||
155731894|NCT02000115|562115048|FG000|Overall Study|Withdrawn on day of randomization|0|||
155731895|NCT02000115|562115049|FG001|Overall Study|Withdrawn on day of randomization|1|||
155731896|NCT02000115|562115050|FG002|Overall Study|Withdrawn on day of randomization|0|||
155731897|NCT02000115|562115051|FG003|Overall Study|Withdrawn on day of randomization|0|||
155731898|NCT02000115|562115048|FG000|Overall Study|Still on Study|0|||
155731899|NCT02000115|562115049|FG001|Overall Study|Still on Study|0|||
155731900|NCT02000115|562115050|FG002|Overall Study|Still on Study|0|||
155388312|NCT00775450|560856214|FG003|Overall Study|Serious Adverse Event|0|||
155388313|NCT00775450|560856215|FG004|Overall Study|Serious Adverse Event|0|||
155731901|NCT02000115|562115051|FG003|Overall Study|Still on Study|53|||
155731902|NCT01967238|562115054|FG000|Overall Study|Adverse Event|1|||
155731903|NCT01967238|562115055|FG001|Overall Study|Adverse Event|1|||
155731904|NCT01967238|562115056|FG002|Overall Study|Adverse Event|0|||
155731905|NCT01967238|562115054|FG000|Overall Study|Lost to Follow-up|1|||
155731906|NCT01967238|562115055|FG001|Overall Study|Lost to Follow-up|0|||
155731907|NCT01967238|562115056|FG002|Overall Study|Lost to Follow-up|1|||
155731908|NCT01967238|562115054|FG000|Overall Study|Withdrawal by Subject|0|||
155731909|NCT01967238|562115055|FG001|Overall Study|Withdrawal by Subject|0|||
155731910|NCT01967238|562115056|FG002|Overall Study|Withdrawal by Subject|1|||
155731911|NCT02484391|562115057|FG000|Overall Study|Lack of Efficacy|15|||
155731912|NCT02484391|562115058|FG001|Overall Study|Lack of Efficacy|14|||
155731913|NCT02484391|562115059|FG002|Overall Study|Lack of Efficacy|3|||
155731914|NCT02484391|562115057|FG000|Overall Study|Lost to Follow-up|0|||
155731915|NCT02484391|562115058|FG001|Overall Study|Lost to Follow-up|0|||
155731916|NCT02484391|562115059|FG002|Overall Study|Lost to Follow-up|2|||
155731917|NCT02484391|562115057|FG000|Overall Study|Physician Decision|1|||
155731918|NCT02484391|562115058|FG001|Overall Study|Physician Decision|3|||
155731919|NCT02484391|562115059|FG002|Overall Study|Physician Decision|0|||
155731920|NCT02484391|562115057|FG000|Overall Study|Went to Transplant|5|||
155731921|NCT02484391|562115058|FG001|Overall Study|Went to Transplant|3|||
155731922|NCT02484391|562115059|FG002|Overall Study|Went to Transplant|2|||
155731923|NCT04949490|562115065|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155731924|NCT04949490|562115066|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155731925|NCT04949490|562115067|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155731926|NCT04949490|562115068|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
155731927|NCT04949490|562115069|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155731928|NCT04949490|562115070|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155731929|NCT04949490|562115065|FG000|Group A and Group B|Withdrawal by Subject|0|||
155388314|NCT00775450|560856211|FG000|Overall Study|Protocol Violation|0|||
155388315|NCT00775450|560856212|FG001|Overall Study|Protocol Violation|0|||
155388316|NCT00775450|560856213|FG002|Overall Study|Protocol Violation|0|||
155388317|NCT00775450|560856214|FG003|Overall Study|Protocol Violation|0|||
155388318|NCT00775450|560856215|FG004|Overall Study|Protocol Violation|1|||
155388319|NCT00775450|560856211|FG000|Overall Study|Withdrawal by Subject|1|||
155388320|NCT00775450|560856212|FG001|Overall Study|Withdrawal by Subject|0|||
155388321|NCT00775450|560856213|FG002|Overall Study|Withdrawal by Subject|0|||
155388322|NCT00775450|560856214|FG003|Overall Study|Withdrawal by Subject|0|||
155388323|NCT00775450|560856215|FG004|Overall Study|Withdrawal by Subject|1|||
155388324|NCT01055262|560856225|FG000|Overall Study|Adverse Event|5|||
155388325|NCT01055262|560856225|FG000|Overall Study|Protocol Violation|3|||
155388326|NCT01055262|560856225|FG000|Overall Study|Uncooperativeness|1|||
155388327|NCT00752622|560856226|FG000|Induction Phase|Adverse Event|3|||
155388328|NCT00752622|560856226|FG000|Induction Phase|Other|3|||
155388329|NCT00752622|560856226|FG000|Induction Phase|Non-responder|14|||
155629490|NCT02370511|561739932|FG001|Overall Study|Withdrawal by Subject|0|||
155629491|NCT02370511|561739933|FG002|Overall Study|Withdrawal by Subject|0|||
155629492|NCT02370511|561739931|FG000|Overall Study|Lost to Follow-up|0|||
155629493|NCT02370511|561739932|FG001|Overall Study|Lost to Follow-up|4|||
155629494|NCT02370511|561739933|FG002|Overall Study|Lost to Follow-up|0|||
155629495|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
155629496|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155629497|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155629498|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155629499|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
155629500|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155629501|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155629502|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155629503|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
155629504|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155629505|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155629506|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155731930|NCT04949490|562115066|FG001|Group A and Group B|Withdrawal by Subject|0|||
155388330|NCT00752622|560856226|FG000|Induction Phase|Withdrawal by Subject|1|||
155388331|NCT00752622|560856226|FG000|Induction Phase|Premature study termination|14|||
155388332|NCT00752622|560856226|FG000|Observational Phase|Premature Study Termination|36|||
155388333|NCT00752622|560856226|FG000|Observational Phase|Non-responder|2|||
155731931|NCT04949490|562115067|FG002|Group A and Group B|Withdrawal by Subject|1|||
155731932|NCT04949490|562115068|FG003|Group A and Group B|Withdrawal by Subject|0|||
155731933|NCT04949490|562115069|FG004|Group A and Group B|Withdrawal by Subject|0|||
155731934|NCT04949490|562115070|FG005|Group A and Group B|Withdrawal by Subject|0|||
155731935|NCT04949490|562115065|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155731936|NCT04949490|562115066|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155388334|NCT00752622|560856226|FG000|Observational Phase|Withdrawal by Subject|2|||
155388335|NCT00752622|560856226|FG000|Observational Phase|Adverse Event|1|||
155388336|NCT00752622|560856226|FG000|Observational Phase|Other|2|||
155388337|NCT00752622|560856226|FG000|Interventional Phase|Non-responder|2|||
155388338|NCT00752622|560856226|FG000|Interventional Phase|Physician Decision|1|||
155388339|NCT00752622|560856226|FG000|Interventional Phase|Premature Study Termination|5|||
155388340|NCT00392327|560856229|FG000|Overall Study|Death|1|||
155388341|NCT00392327|560856230|FG001|Overall Study|Death|0|||
155388342|NCT00392327|560856231|FG002|Overall Study|Death|1|||
155388343|NCT00392327|560856232|FG003|Overall Study|Death|0|||
155388344|NCT00392327|560856233|FG004|Overall Study|Death|0|||
155388345|NCT00392327|560856234|FG005|Overall Study|Death|0|||
155388346|NCT00392327|560856235|FG006|Overall Study|Death|0|||
155388347|NCT00392327|560856236|FG007|Overall Study|Death|0|||
155388348|NCT00392327|560856229|FG000|Overall Study|Lack of Efficacy|8|||
155388349|NCT00392327|560856230|FG001|Overall Study|Lack of Efficacy|8|||
155388350|NCT00392327|560856231|FG002|Overall Study|Lack of Efficacy|9|||
155388351|NCT00392327|560856232|FG003|Overall Study|Lack of Efficacy|6|||
155388352|NCT00392327|560856233|FG004|Overall Study|Lack of Efficacy|3|||
155388353|NCT00392327|560856234|FG005|Overall Study|Lack of Efficacy|3|||
155388354|NCT00392327|560856235|FG006|Overall Study|Lack of Efficacy|3|||
155388355|NCT00392327|560856236|FG007|Overall Study|Lack of Efficacy|3|||
155388356|NCT00392327|560856229|FG000|Overall Study|Physician Decision|3|||
155388357|NCT00392327|560856230|FG001|Overall Study|Physician Decision|5|||
155388358|NCT00392327|560856231|FG002|Overall Study|Physician Decision|2|||
155388359|NCT00392327|560856232|FG003|Overall Study|Physician Decision|2|||
155388360|NCT00392327|560856233|FG004|Overall Study|Physician Decision|0|||
155388361|NCT00392327|560856234|FG005|Overall Study|Physician Decision|1|||
155388362|NCT00392327|560856235|FG006|Overall Study|Physician Decision|5|||
155388363|NCT00392327|560856236|FG007|Overall Study|Physician Decision|3|||
155388364|NCT00392327|560856229|FG000|Overall Study|Protocol Violation|0|||
155388365|NCT00392327|560856230|FG001|Overall Study|Protocol Violation|0|||
155388366|NCT00392327|560856231|FG002|Overall Study|Protocol Violation|1|||
155388367|NCT00392327|560856232|FG003|Overall Study|Protocol Violation|0|||
155388368|NCT00392327|560856233|FG004|Overall Study|Protocol Violation|0|||
155388369|NCT00392327|560856234|FG005|Overall Study|Protocol Violation|0|||
155388370|NCT00392327|560856235|FG006|Overall Study|Protocol Violation|0|||
155388371|NCT00392327|560856236|FG007|Overall Study|Protocol Violation|0|||
155388372|NCT00392327|560856229|FG000|Overall Study|Withdrawal by Subject|3|||
155388373|NCT00392327|560856230|FG001|Overall Study|Withdrawal by Subject|2|||
155388374|NCT00392327|560856231|FG002|Overall Study|Withdrawal by Subject|4|||
155388375|NCT00392327|560856232|FG003|Overall Study|Withdrawal by Subject|6|||
155388376|NCT00392327|560856233|FG004|Overall Study|Withdrawal by Subject|0|||
155388377|NCT00392327|560856234|FG005|Overall Study|Withdrawal by Subject|1|||
155629507|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
155629508|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
155629509|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
155629510|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
155629511|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
155629512|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155629513|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155629514|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155629515|NCT01149655|561739934|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
155629516|NCT01149655|561739935|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155629517|NCT01149655|561739936|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155629518|NCT01149655|561739937|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155629519|NCT01149655|561739934|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155629520|NCT01149655|561739935|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
155629521|NCT01149655|561739936|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155629522|NCT01149655|561739937|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155731937|NCT04949490|562115067|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155731938|NCT04949490|562115068|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155731939|NCT04949490|562115069|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155388378|NCT00392327|560856235|FG006|Overall Study|Withdrawal by Subject|1|||
155388379|NCT00392327|560856236|FG007|Overall Study|Withdrawal by Subject|5|||
155388380|NCT00392327|560856229|FG000|Overall Study|Ineligible|0|||
155388381|NCT00392327|560856230|FG001|Overall Study|Ineligible|4|||
155388382|NCT00392327|560856231|FG002|Overall Study|Ineligible|3|||
155388383|NCT00392327|560856232|FG003|Overall Study|Ineligible|2|||
155388384|NCT00392327|560856233|FG004|Overall Study|Ineligible|0|||
155388385|NCT00392327|560856234|FG005|Overall Study|Ineligible|0|||
155388386|NCT00392327|560856235|FG006|Overall Study|Ineligible|0|||
155388387|NCT00392327|560856236|FG007|Overall Study|Ineligible|0|||
155388388|NCT00178126|560856237|FG000|Overall Study|Lost to Follow-up|21|||
155388389|NCT00178126|560856238|FG001|Overall Study|Lost to Follow-up|21|||
155388390|NCT00178126|560856237|FG000|Overall Study|did not receive intervention|4|||
155731940|NCT04949490|562115070|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
155731941|NCT04949490|562115065|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155731942|NCT04949490|562115066|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155731943|NCT04949490|562115067|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155731944|NCT04949490|562115068|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155731945|NCT04949490|562115069|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
155731946|NCT04949490|562115070|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155731947|NCT04721977|562115071|FG000|Overall Study|Death|15|||
155731948|NCT04721977|562115071|FG000|Overall Study|Ongoing|51|||
155731949|NCT02864394|562115072|FG000|Overall Study|Death|184|||
155731950|NCT02864394|562115073|FG001|Overall Study|Death|189|||
155731951|NCT02864394|562115072|FG000|Overall Study|Lost to Follow-up|0|||
155731952|NCT02864394|562115073|FG001|Overall Study|Lost to Follow-up|2|||
155731953|NCT02864394|562115072|FG000|Overall Study|Sponsor Decision|26|||
155731954|NCT02864394|562115073|FG001|Overall Study|Sponsor Decision|11|||
155731955|NCT02864394|562115072|FG000|Overall Study|Withdrawal by Subject|3|||
155731956|NCT02864394|562115073|FG001|Overall Study|Withdrawal by Subject|10|||
155731957|NCT02605122|562116613|FG000|Overall Study|Withdrawal by Subject|4|||
155731958|NCT02605122|562116614|FG001|Overall Study|Withdrawal by Subject|1|||
155731959|NCT02605122|562116613|FG000|Overall Study|Lost to Follow-up|1|||
155731960|NCT02605122|562116614|FG001|Overall Study|Lost to Follow-up|1|||
155731961|NCT02273596|562116618|FG000|24-Week Treatment Period|Adverse Event|3|||
155731962|NCT02273596|562116618|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
155731963|NCT02273596|562116618|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
155731964|NCT02273596|562116618|FG000|24-Week Treatment Period|Physician Decision|1|||
155731965|NCT02273596|562116618|FG000|24-Week Treatment Period|Protocol Deviation|1|||
155731966|NCT02273596|562116618|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
155731967|NCT02273596|562116618|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
155731968|NCT02273596|562116618|FG000|Extension Period|Lost to Follow-up|1|||
155731969|NCT02273596|562116618|FG000|Extension Period|Protocol Deviation|1|||
155731970|NCT02741518|562116619|FG000|Overall Study|Withdrawal by Subject|1|||
155731971|NCT02741518|562116620|FG001|Overall Study|Withdrawal by Subject|1|||
155731972|NCT00476008|562116623|FG000|Overall Study|Adverse Event|4|||
155731973|NCT00476008|562116624|FG001|Overall Study|Adverse Event|4|||
155731974|NCT00476008|562116623|FG000|Overall Study|Placebo concerns|2|||
155731975|NCT00476008|562116624|FG001|Overall Study|Placebo concerns|2|||
155731976|NCT00476008|562116623|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
155731977|NCT00476008|562116624|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
155731978|NCT00476008|562116623|FG000|Overall Study|Withdrawal by Subject|0|||
155731979|NCT00476008|562116624|FG001|Overall Study|Withdrawal by Subject|1|||
155731980|NCT00476008|562116623|FG000|Overall Study|Death|1|||
155731981|NCT00476008|562116624|FG001|Overall Study|Death|0|||
155731982|NCT01227018|562116625|FG000|Overall Study|Disease progression|9|||
155731983|NCT01227018|562116625|FG000|Overall Study|Toxicity|2|||
155731984|NCT01227018|562116625|FG000|Overall Study|Withdrew after beginning treatment|4|||
155731985|NCT02873702|562116628|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
155731986|NCT02873702|562116629|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
155731987|NCT02873702|562116630|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
155731988|NCT02873702|562116631|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
155731989|NCT02873702|562116628|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155731990|NCT02873702|562116629|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
155731991|NCT02873702|562116630|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155731992|NCT02873702|562116631|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155731993|NCT02873702|562116628|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
155731994|NCT02873702|562116629|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
155731995|NCT02873702|562116630|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
155731996|NCT02873702|562116631|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
155731997|NCT02873702|562116628|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
155731998|NCT02873702|562116629|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
155731999|NCT02873702|562116630|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
155281442|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
155281443|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
155732000|NCT02873702|562116631|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
155281444|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
155281445|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281446|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281447|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281448|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
155732001|NCT02873702|562116628|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
155732002|NCT02873702|562116629|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
155732003|NCT02873702|562116630|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
155388391|NCT00178126|560856238|FG001|Overall Study|did not receive intervention|6|||
155388392|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
155388393|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
155388394|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
155388395|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
155388396|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
155388397|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
155388398|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
155388399|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
155388400|NCT00421707|560856239|FG000|Period 2: Washout|Adverse Event|1|||
155388401|NCT00421707|560856240|FG001|Period 2: Washout|Adverse Event|1|||
155388402|NCT00421707|560856239|FG000|Period 2: Washout|Withdrawal by Subject|0|||
155388403|NCT00421707|560856240|FG001|Period 2: Washout|Withdrawal by Subject|1|||
155388404|NCT00421707|560856239|FG000|Period 2: Washout|Lost to Follow-up|0|||
155388405|NCT00421707|560856240|FG001|Period 2: Washout|Lost to Follow-up|1|||
155388406|NCT00421707|560856239|FG000|Period 2: Washout|Other: Pregnancy|0|||
155629523|NCT01149655|561739934|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155629524|NCT01149655|561739935|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
155629525|NCT01149655|561739936|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155629526|NCT01149655|561739937|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155629527|NCT01149655|561739934|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
155629528|NCT01149655|561739935|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
155629529|NCT01149655|561739936|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
155629530|NCT01149655|561739937|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
155629531|NCT01149655|561739934|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155629532|NCT01149655|561739935|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
155629533|NCT01149655|561739936|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155629534|NCT01149655|561739937|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155629535|NCT01149655|561739934|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155629536|NCT01149655|561739935|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
155629537|NCT01149655|561739936|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155629538|NCT01149655|561739937|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155629539|NCT01149655|561739934|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
155629540|NCT01149655|561739935|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
155629541|NCT01149655|561739936|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
155629542|NCT01149655|561739937|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
155629543|NCT01149655|561739934|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
155629544|NCT01149655|561739935|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
155629545|NCT01149655|561739936|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
155629546|NCT01149655|561739937|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
155629547|NCT01149655|561739934|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
155629548|NCT01149655|561739935|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
155629549|NCT01149655|561739936|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
155629550|NCT01149655|561739937|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
155629551|NCT01149655|561739934|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
155629552|NCT01149655|561739935|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
155629553|NCT01149655|561739936|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
155629554|NCT01149655|561739937|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
155629555|NCT01149655|561739934|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
155629556|NCT01149655|561739935|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
155629557|NCT01149655|561739936|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
155629558|NCT01149655|561739937|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
155629559|NCT01265498|561739940|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
155629560|NCT01265498|561739941|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
155629561|NCT03092752|561739942|FG000|Overall Study|Aged <40 years|14209|||
155629562|NCT03092752|561739942|FG000|Overall Study|At least one claim with T2DM|61299|||
155629563|NCT03092752|561739942|FG000|Overall Study|Having no claim of study drugs|29282|||
155629564|NCT03092752|561739942|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
155629565|NCT03092752|561739942|FG000|Overall Study|<6 month history|245900|||
155629566|NCT03882918|561739946|FG000|Overall Study|Study terminated by sponsor|98|||
155629567|NCT03882918|561739946|FG000|Overall Study|Protocol Violation|1|||
155629568|NCT03882918|561739946|FG000|Overall Study|Other|9|||
155629569|NCT03882918|561739946|FG000|Overall Study|Lack of Efficacy|14|||
155388407|NCT00421707|560856240|FG001|Period 2: Washout|Other: Pregnancy|1|||
155629570|NCT03882918|561739946|FG000|Overall Study|Adverse Event|13|||
155629571|NCT03882918|561739946|FG000|Overall Study|Withdrawal by Subject|5|||
155650623|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
155388408|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
155388409|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
155732004|NCT02873702|562116631|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
155732005|NCT01229267|562116636|FG000|Overall Study|Adverse Event|4|||
155732006|NCT01229267|562116637|FG001|Overall Study|Adverse Event|6|||
155732007|NCT01229267|562116638|FG002|Overall Study|Adverse Event|3|||
155732008|NCT01229267|562116639|FG003|Overall Study|Adverse Event|2|||
155732009|NCT01229267|562116640|FG004|Overall Study|Adverse Event|10|||
155732010|NCT01229267|562116636|FG000|Overall Study|Death|40|||
155732011|NCT01229267|562116637|FG001|Overall Study|Death|37|||
155732012|NCT01229267|562116638|FG002|Overall Study|Death|35|||
155732013|NCT01229267|562116639|FG003|Overall Study|Death|13|||
155732014|NCT01229267|562116640|FG004|Overall Study|Death|103|||
155732015|NCT01229267|562116636|FG000|Overall Study|Withdrawal by Subject|23|||
155732016|NCT01229267|562116637|FG001|Overall Study|Withdrawal by Subject|22|||
155732017|NCT01229267|562116638|FG002|Overall Study|Withdrawal by Subject|32|||
155732018|NCT01229267|562116639|FG003|Overall Study|Withdrawal by Subject|14|||
155732019|NCT01229267|562116640|FG004|Overall Study|Withdrawal by Subject|59|||
155732020|NCT01229267|562116636|FG000|Overall Study|Protocol Violation|0|||
155732021|NCT01229267|562116637|FG001|Overall Study|Protocol Violation|1|||
155732022|NCT01229267|562116638|FG002|Overall Study|Protocol Violation|0|||
155732023|NCT01229267|562116639|FG003|Overall Study|Protocol Violation|0|||
155732024|NCT01229267|562116640|FG004|Overall Study|Protocol Violation|0|||
155732025|NCT01229267|562116636|FG000|Overall Study|Progressive disease|0|||
155732026|NCT01229267|562116637|FG001|Overall Study|Progressive disease|0|||
155732027|NCT01229267|562116638|FG002|Overall Study|Progressive disease|0|||
155732028|NCT01229267|562116639|FG003|Overall Study|Progressive disease|0|||
155732029|NCT01229267|562116640|FG004|Overall Study|Progressive disease|1|||
155732030|NCT01229267|562116636|FG000|Overall Study|Physician Decision|8|||
155732031|NCT01229267|562116637|FG001|Overall Study|Physician Decision|11|||
155732032|NCT01229267|562116638|FG002|Overall Study|Physician Decision|8|||
155732033|NCT01229267|562116639|FG003|Overall Study|Physician Decision|3|||
155732034|NCT01229267|562116640|FG004|Overall Study|Physician Decision|25|||
155732035|NCT01229267|562116636|FG000|Overall Study|Lost to Follow-up|6|||
155732036|NCT01229267|562116637|FG001|Overall Study|Lost to Follow-up|5|||
155732037|NCT01229267|562116638|FG002|Overall Study|Lost to Follow-up|8|||
155732038|NCT01229267|562116639|FG003|Overall Study|Lost to Follow-up|3|||
155732039|NCT01229267|562116640|FG004|Overall Study|Lost to Follow-up|22|||
155732040|NCT03085797|562116643|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
155732041|NCT03085797|562116644|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
155732042|NCT03085797|562116643|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
155732043|NCT03085797|562116644|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
155281449|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
155281450|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
155281451|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
155281452|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
155281453|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281454|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281455|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281456|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
155281457|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
155281458|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
155281459|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
155281460|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281461|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281462|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
155281463|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281464|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281465|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281466|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
155281467|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281468|NCT01657032|560461602|FG000|Overall Study|Lost to Follow-up|0|||
155281469|NCT01657032|560461603|FG001|Overall Study|Lost to Follow-up|7|||
155281470|NCT00958009|560461611|FG000|Overall Study|Adverse Event|1|||
155281471|NCT00958009|560461611|FG000|Overall Study|Subject found device difficult to use|1|||
155281472|NCT00087490|560461612|FG000|Overall Study|Death|6|||
155281473|NCT00087490|560461613|FG001|Overall Study|Death|4|||
155281474|NCT00087490|560461612|FG000|Overall Study|Adverse Event|3|||
155281475|NCT00087490|560461613|FG001|Overall Study|Adverse Event|8|||
155281476|NCT00087490|560461612|FG000|Overall Study|Lack of Efficacy|0|||
155281477|NCT00087490|560461613|FG001|Overall Study|Lack of Efficacy|2|||
155281478|NCT00087490|560461612|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
155281479|NCT00087490|560461613|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
155281480|NCT00087490|560461612|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
155732044|NCT03085797|562116643|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
155732045|NCT03085797|562116644|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
155732046|NCT04050202|562116645|FG000|Overall Study|Lost to Follow-up|2|||
155732047|NCT00001213|562116646|FG000|Overall Study|Death|18|||
155732048|NCT02636595|562116647|FG000|Overall Study|Lost to Follow-up|1|||
155732049|NCT02636595|562116647|FG000|Overall Study|Other|1|||
155732050|NCT05782179|562116651|FG000|Overall Study|Adverse Event|0|||
155732051|NCT05782179|562116652|FG001|Overall Study|Adverse Event|0|||
155732052|NCT05782179|562116653|FG002|Overall Study|Adverse Event|2|||
155732053|NCT05782179|562116654|FG003|Overall Study|Adverse Event|0|||
155732054|NCT05782179|562116655|FG004|Overall Study|Adverse Event|0|||
155732055|NCT05782179|562116656|FG005|Overall Study|Adverse Event|0|||
155732056|NCT06170242|562116657|FG000|Overall Study|Lost to Follow-up|0|||
155732057|NCT06170242|562116658|FG001|Overall Study|Lost to Follow-up|0|||
155732058|NCT06170242|562116659|FG002|Overall Study|Lost to Follow-up|1|||
155732059|NCT06170242|562116660|FG003|Overall Study|Lost to Follow-up|1|||
155732060|NCT02004093|562116661|FG000|Overall Study|Death|2|||
155732061|NCT02004093|562116662|FG001|Overall Study|Death|1|||
155732062|NCT02004093|562116661|FG000|Overall Study|Lack of Efficacy|66|||
155732063|NCT02004093|562116662|FG001|Overall Study|Lack of Efficacy|62|||
155732064|NCT02004093|562116661|FG000|Overall Study|Protocol Violation|0|||
155732065|NCT02004093|562116662|FG001|Overall Study|Protocol Violation|1|||
155732066|NCT02004093|562116661|FG000|Overall Study|Lost to Follow-up|0|||
155732067|NCT02004093|562116662|FG001|Overall Study|Lost to Follow-up|1|||
155732068|NCT02004093|562116661|FG000|Overall Study|Withdrawal by Subject|3|||
155732069|NCT02004093|562116662|FG001|Overall Study|Withdrawal by Subject|7|||
155732070|NCT02004093|562116661|FG000|Overall Study|Other|3|||
155732071|NCT02004093|562116662|FG001|Overall Study|Other|1|||
155732072|NCT04085289|562116663|FG000|Overall Study|Withdrawal by Subject|0|||
155732073|NCT04085289|562116664|FG001|Overall Study|Withdrawal by Subject|0|||
155732074|NCT04085289|562116665|FG002|Overall Study|Withdrawal by Subject|1|||
155732075|NCT02754440|562116667|FG000|Overall Study|Protocol Violation|3|||
155732076|NCT02754440|562116668|FG001|Overall Study|Protocol Violation|2|||
155732077|NCT02754440|562116669|FG002|Overall Study|Protocol Violation|2|||
155732078|NCT02754440|562116670|FG003|Overall Study|Protocol Violation|6|||
155732079|NCT02754440|562116667|FG000|Overall Study|Adverse Event|3|||
155732080|NCT02754440|562116668|FG001|Overall Study|Adverse Event|1|||
155732081|NCT02754440|562116669|FG002|Overall Study|Adverse Event|0|||
155732082|NCT02754440|562116670|FG003|Overall Study|Adverse Event|9|||
155732083|NCT02754440|562116667|FG000|Overall Study|Withdrawal by Subject|0|||
155732084|NCT02754440|562116668|FG001|Overall Study|Withdrawal by Subject|0|||
155732085|NCT02754440|562116669|FG002|Overall Study|Withdrawal by Subject|0|||
155732086|NCT02754440|562116670|FG003|Overall Study|Withdrawal by Subject|1|||
155732087|NCT02754440|562116667|FG000|Overall Study|Equipment failure|0|||
155732088|NCT02754440|562116668|FG001|Overall Study|Equipment failure|5|||
155732089|NCT02754440|562116669|FG002|Overall Study|Equipment failure|5|||
155732090|NCT02754440|562116670|FG003|Overall Study|Equipment failure|7|||
155281481|NCT00087490|560461613|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
155281482|NCT00087490|560461612|FG000|Overall Study|Randomized but not treated|7|||
155281483|NCT00087490|560461613|FG001|Overall Study|Randomized but not treated|18|||
155281484|NCT00761774|560461614|FG000|Overall Study|Adverse Event|17|||
155281485|NCT00761774|560461614|FG000|Overall Study|Lack of Efficacy|37|||
155281486|NCT00761774|560461614|FG000|Overall Study|Lost to Follow-up|2|||
155281487|NCT00761774|560461614|FG000|Overall Study|Withdrawal by Subject|9|||
155281488|NCT00761774|560461614|FG000|Overall Study|Non-compliance|4|||
155281489|NCT00761774|560461614|FG000|Overall Study|End of study|2|||
155281490|NCT00761774|560461614|FG000|Overall Study|Reclassification of seizures|1|||
155281491|NCT00761774|560461614|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
155281492|NCT00761774|560461614|FG000|Overall Study|Sponsor decision|1|||
155281493|NCT00761774|560461614|FG000|Overall Study|Investigator clinical judgement|1|||
155281494|NCT00761774|560461614|FG000|Overall Study|Patient moved out of study area|1|||
155281495|NCT00761774|560461614|FG000|Overall Study|Coordinator leaving site|1|||
155281496|NCT00761774|560461614|FG000|Overall Study|Subject IP non-compliance|1|||
155281497|NCT00761774|560461614|FG000|Overall Study|IP stopped by hospital physician|1|||
155281498|NCT01077024|560461615|FG000|Overall Study|Lost to Follow-up|20|||
155732091|NCT02754440|562116667|FG000|Overall Study|Subject issues not resulting in AE|0|||
155732092|NCT02754440|562116668|FG001|Overall Study|Subject issues not resulting in AE|0|||
155732093|NCT02754440|562116669|FG002|Overall Study|Subject issues not resulting in AE|0|||
155732094|NCT02754440|562116670|FG003|Overall Study|Subject issues not resulting in AE|12|||
155281499|NCT01077024|560461616|FG001|Overall Study|Lost to Follow-up|14|||
155732095|NCT02560558|562116671|FG000|Overall Study|Adverse Event|1|||
155732096|NCT02560558|562116672|FG001|Overall Study|Adverse Event|0|||
155732097|NCT02560558|562116671|FG000|Overall Study|Death|0|||
155732098|NCT02560558|562116672|FG001|Overall Study|Death|2|||
155732099|NCT02560558|562116671|FG000|Overall Study|Lost to Follow-up|0|||
155281500|NCT01077024|560461615|FG000|Overall Study|Withdrawal by Subject|0|||
155732100|NCT02560558|562116672|FG001|Overall Study|Lost to Follow-up|4|||
155732101|NCT02560558|562116671|FG000|Overall Study|Protocol Violation|3|||
155732102|NCT02560558|562116672|FG001|Overall Study|Protocol Violation|0|||
155732103|NCT02560558|562116671|FG000|Overall Study|Withdrawal by Subject|3|||
155732104|NCT02560558|562116672|FG001|Overall Study|Withdrawal by Subject|0|||
155732105|NCT01263197|562116688|FG000|First Intervention (Period 1)|Adverse Event|0|||
155732106|NCT01263197|562116689|FG001|First Intervention (Period 1)|Adverse Event|0|||
155732107|NCT01263197|562116690|FG002|First Intervention (Period 1)|Adverse Event|0|||
155732108|NCT01263197|562116691|FG003|First Intervention (Period 1)|Adverse Event|0|||
155732109|NCT01263197|562116692|FG004|First Intervention (Period 1)|Adverse Event|0|||
155732110|NCT01263197|562116693|FG005|First Intervention (Period 1)|Adverse Event|1|||
155732111|NCT01263197|562116688|FG000|Washout Period 1|Protocol Violation|0|||
155732112|NCT01263197|562116689|FG001|Washout Period 1|Protocol Violation|0|||
155732113|NCT01263197|562116690|FG002|Washout Period 1|Protocol Violation|0|||
155732114|NCT01263197|562116691|FG003|Washout Period 1|Protocol Violation|0|||
155732115|NCT01263197|562116692|FG004|Washout Period 1|Protocol Violation|1|||
155732116|NCT01263197|562116693|FG005|Washout Period 1|Protocol Violation|0|||
155732117|NCT01263197|562116688|FG000|Washout Period 2|Physician Decision|0|||
155732118|NCT01263197|562116689|FG001|Washout Period 2|Physician Decision|0|||
155732119|NCT01263197|562116690|FG002|Washout Period 2|Physician Decision|0|||
155732120|NCT01263197|562116691|FG003|Washout Period 2|Physician Decision|0|||
155732121|NCT01263197|562116692|FG004|Washout Period 2|Physician Decision|0|||
155732122|NCT01263197|562116693|FG005|Washout Period 2|Physician Decision|1|||
155732123|NCT01263197|562116688|FG000|Washout Period 2|Protocol Violation|0|||
155732124|NCT01263197|562116689|FG001|Washout Period 2|Protocol Violation|0|||
155732125|NCT01263197|562116690|FG002|Washout Period 2|Protocol Violation|0|||
155732126|NCT01263197|562116691|FG003|Washout Period 2|Protocol Violation|1|||
155732127|NCT01263197|562116692|FG004|Washout Period 2|Protocol Violation|0|||
155732128|NCT01263197|562116693|FG005|Washout Period 2|Protocol Violation|0|||
155732129|NCT01263197|562116688|FG000|Third Intervention (Period 3)|Adverse Event|0|||
155732130|NCT01263197|562116689|FG001|Third Intervention (Period 3)|Adverse Event|1|||
155732131|NCT01263197|562116690|FG002|Third Intervention (Period 3)|Adverse Event|0|||
155732132|NCT01263197|562116691|FG003|Third Intervention (Period 3)|Adverse Event|0|||
155732133|NCT01263197|562116692|FG004|Third Intervention (Period 3)|Adverse Event|0|||
155732134|NCT01263197|562116693|FG005|Third Intervention (Period 3)|Adverse Event|0|||
155732135|NCT01967576|562116698|FG000|Overall Study|Withdrawal by Subject|3|||
155732136|NCT01967576|562116698|FG000|Overall Study|Progressed/Removed from treatment|1|||
155732137|NCT01967576|562116698|FG000|Overall Study|Study closing at site|1|||
155732138|NCT01967576|562116698|FG000|Overall Study|Adverse Event|1|||
155732139|NCT01967576|562116698|FG000|Overall Study|Refused further treatment|1|||
155732140|NCT02892448|562116701|FG000|Overall Study|Screening failure|2|||
155732141|NCT02892448|562116702|FG001|Overall Study|Screening failure|2|||
155732142|NCT02892448|562116703|FG002|Overall Study|Screening failure|1|||
155732143|NCT00131248|562116704|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
155732144|NCT00131248|562116705|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
155732145|NCT02284243|562116706|FG000|Overall Study|Lack of Efficacy|3|||
155732146|NCT02284243|562116707|FG001|Overall Study|Lack of Efficacy|3|||
155732147|NCT02284243|562116706|FG000|Overall Study|Adverse Event|1|||
155732148|NCT02284243|562116707|FG001|Overall Study|Adverse Event|0|||
155732149|NCT04269889|562116709|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
155732150|NCT01654302|562116714|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
155281501|NCT01077024|560461616|FG001|Overall Study|Withdrawal by Subject|2|||
155281502|NCT01077024|560461615|FG000|Overall Study|Incarcerated|7|||
155281503|NCT01077024|560461616|FG001|Overall Study|Incarcerated|8|||
155281504|NCT01077024|560461615|FG000|Overall Study|Other|4|||
155281505|NCT01077024|560461616|FG001|Overall Study|Other|4|||
155281506|NCT03379233|560461617|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
155281507|NCT03379233|560461618|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
155281508|NCT02300311|560461619|FG000|Overall Study|Other than the reason specified|1|||
155281509|NCT02300311|560461620|FG001|Overall Study|Other than the reason specified|0|||
155281510|NCT02300311|560461619|FG000|Overall Study|Refused to continue taking medication|18|||
155281511|NCT02300311|560461620|FG001|Overall Study|Refused to continue taking medication|0|||
155281512|NCT02687919|560461621|FG000|Overall Study|Withdrawal by Subject|6|||
155281513|NCT02687919|560461622|FG001|Overall Study|Withdrawal by Subject|6|||
155281514|NCT02687919|560461621|FG000|Overall Study|Protocol Violation|2|||
155281515|NCT02687919|560461622|FG001|Overall Study|Protocol Violation|0|||
155281516|NCT00848211|560461623|FG000|Overall Study|Protocol Violation|0|||
155281517|NCT00848211|560461624|FG001|Overall Study|Protocol Violation|1|||
155281518|NCT00848211|560461625|FG002|Overall Study|Protocol Violation|1|||
155281519|NCT00848211|560461626|FG003|Overall Study|Protocol Violation|0|||
155281520|NCT00848211|560461623|FG000|Overall Study|Adverse Event|0|||
155281521|NCT00848211|560461624|FG001|Overall Study|Adverse Event|0|||
155281522|NCT00848211|560461625|FG002|Overall Study|Adverse Event|0|||
155281523|NCT00848211|560461626|FG003|Overall Study|Adverse Event|0|||
155281524|NCT00419003|560461627|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
155281525|NCT00419003|560461628|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
155281526|NCT00419003|560461627|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
155732151|NCT01654302|562116715|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
155732152|NCT02699749|562116721|FG000|Overall Study|Other|0|||
155732153|NCT02699749|562116722|FG001|Overall Study|Other|0|||
155281527|NCT00419003|560461628|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
155629572|NCT06996301|561739947|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
155629573|NCT06996301|561739948|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
155629574|NCT06996301|561739947|FG000|Overall Study|Patients with discordant diagnostic results|107|||
155629575|NCT06996301|561739948|FG001|Overall Study|Patients with discordant diagnostic results|90|||
155629576|NCT06996301|561739947|FG000|Overall Study|Lost to Follow-up|31|||
155629577|NCT06996301|561739948|FG001|Overall Study|Lost to Follow-up|56|||
155629578|NCT06996301|561739947|FG000|Overall Study|Withdrawal by Subject|12|||
155629579|NCT06996301|561739948|FG001|Overall Study|Withdrawal by Subject|7|||
155629580|NCT04030598|561739949|FG000|Overall Study|Voluntary Withdrawal|0|||
155629581|NCT04030598|561739950|FG001|Overall Study|Voluntary Withdrawal|1|||
155629582|NCT04030598|561739951|FG002|Overall Study|Voluntary Withdrawal|0|||
155629583|NCT05117060|561739954|FG000|Overall Study|Adverse Event|3|||
155629584|NCT05117060|561739955|FG001|Overall Study|Adverse Event|5|||
155629585|NCT05117060|561739956|FG002|Overall Study|Adverse Event|6|||
155629586|NCT05117060|561739957|FG003|Overall Study|Adverse Event|1|||
155629587|NCT05117060|561739954|FG000|Overall Study|Lost to Follow-up|0|||
155629588|NCT05117060|561739955|FG001|Overall Study|Lost to Follow-up|0|||
155629589|NCT05117060|561739956|FG002|Overall Study|Lost to Follow-up|0|||
155629590|NCT05117060|561739957|FG003|Overall Study|Lost to Follow-up|1|||
155629591|NCT05117060|561739954|FG000|Overall Study|Lack of Efficacy|4|||
155629592|NCT05117060|561739955|FG001|Overall Study|Lack of Efficacy|5|||
155629593|NCT05117060|561739956|FG002|Overall Study|Lack of Efficacy|2|||
155629594|NCT05117060|561739957|FG003|Overall Study|Lack of Efficacy|6|||
155629595|NCT05117060|561739954|FG000|Overall Study|Withdrawal by Subject|8|||
155629596|NCT05117060|561739955|FG001|Overall Study|Withdrawal by Subject|5|||
155629597|NCT05117060|561739956|FG002|Overall Study|Withdrawal by Subject|5|||
155629598|NCT05117060|561739957|FG003|Overall Study|Withdrawal by Subject|6|||
155629599|NCT05117060|561739954|FG000|Overall Study|Other|2|||
155629600|NCT05117060|561739955|FG001|Overall Study|Other|1|||
155629601|NCT05117060|561739956|FG002|Overall Study|Other|3|||
155629602|NCT05117060|561739957|FG003|Overall Study|Other|1|||
155629603|NCT03141359|561739958|FG000|Overall Study|Death|32|||
155629604|NCT03141359|561739958|FG000|Overall Study|Still On Study (in follow up)|29|||
155629605|NCT05079321|561739959|FG000|Overall Study|Withdrawal by Subject|2|||
155629606|NCT05079321|561739960|FG001|Overall Study|Withdrawal by Subject|2|||
155629607|NCT05079321|561739959|FG000|Overall Study|Lost to Follow-up|0|||
155629608|NCT05079321|561739960|FG001|Overall Study|Lost to Follow-up|1|||
155629609|NCT02097823|561739961|FG000|Overall Study|Withdrawal by Subject|1|||
155629610|NCT02097823|561739962|FG001|Overall Study|Withdrawal by Subject|1|||
155629611|NCT01081626|561739963|FG000|Overall Study|Dosing error|1|||
155629612|NCT01081626|561739964|FG001|Overall Study|Dosing error|1|||
155629613|NCT01081626|561739963|FG000|Overall Study|Missing Estradiol|25|||
155629614|NCT01081626|561739964|FG001|Overall Study|Missing Estradiol|28|||
155629615|NCT01081626|561739963|FG000|Overall Study|Low antral follicle count|1|||
155629616|NCT01081626|561739964|FG001|Overall Study|Low antral follicle count|0|||
155629617|NCT01081626|561739963|FG000|Overall Study|Overstimulation|0|||
155629618|NCT01081626|561739964|FG001|Overall Study|Overstimulation|1|||
155629619|NCT01081626|561739963|FG000|Overall Study|Lost to Follow-up|0|||
155629620|NCT01081626|561739964|FG001|Overall Study|Lost to Follow-up|1|||
155281528|NCT02531438|560461629|FG000|Overall Study|Adverse Event|7|||
155281529|NCT02531438|560461630|FG001|Overall Study|Adverse Event|9|||
155281530|NCT02531438|560461629|FG000|Overall Study|Lost to Follow-up|0|||
155281531|NCT02531438|560461630|FG001|Overall Study|Lost to Follow-up|3|||
155281532|NCT02531438|560461629|FG000|Overall Study|Withdrawal by Subject|7|||
155281533|NCT02531438|560461630|FG001|Overall Study|Withdrawal by Subject|8|||
155281534|NCT02531438|560461629|FG000|Overall Study|Physician Decision|0|||
155281535|NCT02531438|560461630|FG001|Overall Study|Physician Decision|1|||
155281536|NCT02531438|560461629|FG000|Overall Study|Death|6|||
155281537|NCT02531438|560461630|FG001|Overall Study|Death|3|||
155281538|NCT02531438|560461629|FG000|Overall Study|Randomized, but Not Treated|4|||
155281539|NCT02531438|560461630|FG001|Overall Study|Randomized, but Not Treated|0|||
155281540|NCT02531438|560461629|FG000|Overall Study|Missed EOT/PTE Visit|5|||
155281541|NCT02531438|560461630|FG001|Overall Study|Missed EOT/PTE Visit|2|||
155281542|NCT02531438|560461629|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
155629621|NCT01081626|561739963|FG000|Overall Study|Other|33|||
155629622|NCT01081626|561739964|FG001|Overall Study|Other|30|||
155629623|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Other than specified|2|||
155629624|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Other than specified|4|||
155629625|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
155629626|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
155629627|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Pregnancy|0|||
155629628|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Pregnancy|2|||
155629629|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Physician Decision|1|||
155629630|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Physician Decision|1|||
155732154|NCT02699749|562116723|FG002|Overall Study|Other|2|||
155281543|NCT02531438|560461630|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
155732155|NCT02699749|562116724|FG003|Overall Study|Other|0|||
155732156|NCT02699749|562116725|FG004|Overall Study|Other|0|||
155732157|NCT02699749|562116726|FG005|Overall Study|Other|1|||
155732158|NCT02699749|562116727|FG006|Overall Study|Other|1|||
155732159|NCT02699749|562116728|FG007|Overall Study|Other|0|||
155732160|NCT02699749|562116729|FG008|Overall Study|Other|0|||
155732161|NCT02699749|562116730|FG009|Overall Study|Other|0|||
155732162|NCT02699749|562116731|FG010|Overall Study|Other|1|||
155732163|NCT02699749|562116732|FG011|Overall Study|Other|0|||
155732164|NCT02699749|562116733|FG012|Overall Study|Other|0|||
155732165|NCT02699749|562116734|FG013|Overall Study|Other|0|||
155732166|NCT02699749|562116721|FG000|Overall Study|Progressive Disease|3|||
155732167|NCT02699749|562116722|FG001|Overall Study|Progressive Disease|3|||
155732168|NCT02699749|562116723|FG002|Overall Study|Progressive Disease|14|||
155732169|NCT02699749|562116724|FG003|Overall Study|Progressive Disease|3|||
155732170|NCT02699749|562116725|FG004|Overall Study|Progressive Disease|3|||
155732171|NCT02699749|562116726|FG005|Overall Study|Progressive Disease|7|||
155732172|NCT02699749|562116727|FG006|Overall Study|Progressive Disease|5|||
155732173|NCT02699749|562116728|FG007|Overall Study|Progressive Disease|5|||
155732174|NCT02699749|562116729|FG008|Overall Study|Progressive Disease|6|||
155732175|NCT02699749|562116730|FG009|Overall Study|Progressive Disease|6|||
155732176|NCT02699749|562116731|FG010|Overall Study|Progressive Disease|5|||
155732177|NCT02699749|562116732|FG011|Overall Study|Progressive Disease|4|||
155732178|NCT02699749|562116733|FG012|Overall Study|Progressive Disease|3|||
155732179|NCT02699749|562116734|FG013|Overall Study|Progressive Disease|5|||
155732180|NCT02699749|562116721|FG000|Overall Study|Death|0|||
155732181|NCT02699749|562116722|FG001|Overall Study|Death|0|||
155732182|NCT02699749|562116723|FG002|Overall Study|Death|0|||
155732183|NCT02699749|562116724|FG003|Overall Study|Death|0|||
155732184|NCT02699749|562116725|FG004|Overall Study|Death|0|||
155732185|NCT02699749|562116726|FG005|Overall Study|Death|0|||
155732186|NCT02699749|562116727|FG006|Overall Study|Death|0|||
155732187|NCT02699749|562116728|FG007|Overall Study|Death|0|||
155732188|NCT02699749|562116729|FG008|Overall Study|Death|0|||
155732189|NCT02699749|562116730|FG009|Overall Study|Death|0|||
155732190|NCT02699749|562116731|FG010|Overall Study|Death|0|||
155732191|NCT02699749|562116732|FG011|Overall Study|Death|0|||
155732192|NCT02699749|562116733|FG012|Overall Study|Death|0|||
155732193|NCT02699749|562116734|FG013|Overall Study|Death|1|||
155732194|NCT02699749|562116721|FG000|Overall Study|Lost to Follow-up|0|||
155732195|NCT02699749|562116722|FG001|Overall Study|Lost to Follow-up|0|||
155732196|NCT02699749|562116723|FG002|Overall Study|Lost to Follow-up|0|||
155732197|NCT02699749|562116724|FG003|Overall Study|Lost to Follow-up|0|||
155732198|NCT02699749|562116725|FG004|Overall Study|Lost to Follow-up|0|||
155732199|NCT02699749|562116726|FG005|Overall Study|Lost to Follow-up|1|||
155732200|NCT02699749|562116727|FG006|Overall Study|Lost to Follow-up|0|||
155732201|NCT02699749|562116728|FG007|Overall Study|Lost to Follow-up|1|||
155732202|NCT02699749|562116729|FG008|Overall Study|Lost to Follow-up|0|||
155732203|NCT02699749|562116730|FG009|Overall Study|Lost to Follow-up|0|||
155732204|NCT02699749|562116731|FG010|Overall Study|Lost to Follow-up|0|||
155732205|NCT02699749|562116732|FG011|Overall Study|Lost to Follow-up|0|||
155732206|NCT02699749|562116733|FG012|Overall Study|Lost to Follow-up|0|||
155732207|NCT02699749|562116734|FG013|Overall Study|Lost to Follow-up|0|||
155732208|NCT04139018|562116735|FG000|Overall Study|Screen fail|1|||
155732209|NCT04139018|562116736|FG001|Overall Study|Screen fail|0|||
155732210|NCT04139018|562116735|FG000|Overall Study|Withdrawal by Subject|2|||
155732211|NCT04139018|562116736|FG001|Overall Study|Withdrawal by Subject|0|||
155732212|NCT04139018|562116735|FG000|Overall Study|Lost to Follow-up|0|||
155732213|NCT04139018|562116736|FG001|Overall Study|Lost to Follow-up|1|||
155732214|NCT02565108|562116737|FG000|Overall Study|Adverse Event|1|||
155732215|NCT02565108|562116738|FG001|Overall Study|Adverse Event|0|||
155732216|NCT02565108|562116737|FG000|Overall Study|Withdrew Consent|1|||
155732217|NCT02565108|562116738|FG001|Overall Study|Withdrew Consent|0|||
155732218|NCT01310075|562116739|FG000|Overall Study|Lost to Follow-up|1|||
155732219|NCT01310075|562116740|FG001|Overall Study|Lost to Follow-up|0|||
155732220|NCT01310075|562116739|FG000|Overall Study|Physician Decision|10|||
155732221|NCT01310075|562116740|FG001|Overall Study|Physician Decision|7|||
155732222|NCT01310075|562116739|FG000|Overall Study|Protocol Violation|2|||
155732223|NCT01310075|562116740|FG001|Overall Study|Protocol Violation|2|||
155732224|NCT01310075|562116739|FG000|Overall Study|Withdrawal by Subject|1|||
155732225|NCT01310075|562116740|FG001|Overall Study|Withdrawal by Subject|1|||
155732226|NCT04500158|562116741|FG000|Overall Study|Physician Decision|17|||
155732227|NCT04500158|562116742|FG001|Overall Study|Physician Decision|11|||
155732228|NCT04774094|562116747|FG000|Overall Study|Other|2|||
155732229|NCT04774094|562116747|FG000|Overall Study|Withdrawal by Subject|9|||
155732230|NCT04774094|562116747|FG000|Overall Study|Lost to Follow-up|7|||
155732231|NCT04774094|562116747|FG000|Overall Study|Lack of Efficacy|5|||
155732232|NCT04774094|562116747|FG000|Overall Study|Death|17|||
155732233|NCT04774094|562116747|FG000|Overall Study|Adverse Event|4|||
155732234|NCT02374450|562116748|FG000|Overall Study|Protocol Violation|0|||
155732235|NCT02374450|562116749|FG001|Overall Study|Protocol Violation|1|||
155732236|NCT02374450|562116750|FG002|Overall Study|Protocol Violation|0|||
155732237|NCT02374450|562116748|FG000|Overall Study|Withdrawal by Subject|91|||
155732238|NCT02374450|562116749|FG001|Overall Study|Withdrawal by Subject|110|||
155732239|NCT02374450|562116750|FG002|Overall Study|Withdrawal by Subject|4|||
155732240|NCT02374450|562116748|FG000|Overall Study|Lost to Follow-up|168|||
155732241|NCT02374450|562116749|FG001|Overall Study|Lost to Follow-up|194|||
155732242|NCT02374450|562116750|FG002|Overall Study|Lost to Follow-up|138|||
155732243|NCT02374450|562116748|FG000|Overall Study|Death|173|||
155732244|NCT02374450|562116749|FG001|Overall Study|Death|185|||
155732245|NCT02374450|562116750|FG002|Overall Study|Death|81|||
155732246|NCT02374450|562116748|FG000|Overall Study|Migrated from the study area|538|||
155732247|NCT02374450|562116749|FG001|Overall Study|Migrated from the study area|648|||
155732248|NCT02374450|562116750|FG002|Overall Study|Migrated from the study area|181|||
155732249|NCT02374450|562116748|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
155732250|NCT02374450|562116749|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
155732251|NCT02374450|562116750|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
155732252|NCT02374450|562116748|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
155732253|NCT02374450|562116749|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
155732254|NCT02374450|562116750|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
155732255|NCT02374450|562116748|FG000|Overall Study|Other|0|||
155732256|NCT02374450|562116749|FG001|Overall Study|Other|21|||
155732257|NCT02374450|562116750|FG002|Overall Study|Other|79|||
155732258|NCT05232682|562116753|FG000|Overall Study|Lost to Follow-up|2|||
155732259|NCT01442103|562118277|FG000|Overall Study|Lost to Follow-up|2|||
155732260|NCT02102204|562118280|FG000|Overall Study|Withdrawal by Subject|137|||
155732261|NCT02102204|562118280|FG000|Overall Study|Death|92|||
155732262|NCT02102204|562118280|FG000|Overall Study|Lost to Follow-up|65|||
155732263|NCT02102204|562118280|FG000|Overall Study|Sponsor Decision|5|||
155732264|NCT02102204|562118280|FG000|Overall Study|Ongoing|5|||
155732265|NCT03751657|562118281|FG000|Overall Study|Physician Decision|0|||
155732266|NCT03751657|562118282|FG001|Overall Study|Physician Decision|1|||
155732267|NCT03751657|562118281|FG000|Overall Study|Withdrawal by Subject|1|||
155732268|NCT03751657|562118282|FG001|Overall Study|Withdrawal by Subject|1|||
155732269|NCT03751657|562118281|FG000|Overall Study|Lost to Follow-up|2|||
155732270|NCT03751657|562118282|FG001|Overall Study|Lost to Follow-up|1|||
155732271|NCT00807001|562118291|FG000|Overall Study|Non-compliance|0|||
155732272|NCT00807001|562118292|FG001|Overall Study|Non-compliance|1|||
155732273|NCT00807001|562118293|FG002|Overall Study|Non-compliance|0|||
155732274|NCT00807001|562118294|FG003|Overall Study|Non-compliance|0|||
155732275|NCT00807001|562118295|FG004|Overall Study|Non-compliance|0|||
155732276|NCT02269267|562118296|FG000|Overall Study|Death|5|||
155732277|NCT03773796|562118297|FG000|Overall Study|Adverse Event|1|||
155732278|NCT03773796|562118297|FG000|Overall Study|Withdrawal by Subject|1|||
155732279|NCT03773796|562118297|FG000|Overall Study|Lack of Efficacy|1|||
155732280|NCT03805659|562118298|FG000|Overall Study|Withdrawal by Subject|0|||
155732281|NCT03805659|562118299|FG001|Overall Study|Withdrawal by Subject|1|||
155732282|NCT02604160|562118302|FG000|Overall Study|Protocol Violation|0|||
155732283|NCT02604160|562118303|FG001|Overall Study|Protocol Violation|1|||
155732284|NCT02604160|562118302|FG000|Overall Study|Physician Decision|0|||
155732285|NCT02604160|562118303|FG001|Overall Study|Physician Decision|1|||
155732286|NCT02139592|562118304|FG000|Overall Study|Case Report Forms Uncollected|8|||
155732287|NCT01069900|562118308|FG000|Overall Study|Technical problems|0|||
155732288|NCT01069900|562118309|FG001|Overall Study|Technical problems|1|||
155732289|NCT01069900|562118308|FG000|Overall Study|Lost to Follow-up|7|||
155732290|NCT01069900|562118309|FG001|Overall Study|Lost to Follow-up|1|||
155732291|NCT01069900|562118308|FG000|Overall Study|Withdrawal by Subject|6|||
155732292|NCT01069900|562118309|FG001|Overall Study|Withdrawal by Subject|1|||
155732293|NCT01069900|562118308|FG000|Overall Study|Protocol Violation|4|||
155732294|NCT01069900|562118309|FG001|Overall Study|Protocol Violation|1|||
155732295|NCT01069900|562118308|FG000|Overall Study|Insufficient Therapeutic effect|1|||
155732296|NCT01069900|562118309|FG001|Overall Study|Insufficient Therapeutic effect|0|||
155732297|NCT00145158|562118310|FG000|Overall Study|premature withdrawal|2|||
155732298|NCT00145158|562118311|FG001|Overall Study|premature withdrawal|3|||
155732299|NCT03682770|562118316|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732300|NCT03682770|562118317|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
155732301|NCT03682770|562118318|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732302|NCT03682770|562118319|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732303|NCT03682770|562118320|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732304|NCT03682770|562118321|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732305|NCT03682770|562118322|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155732306|NCT03682770|562118316|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
155732307|NCT03682770|562118317|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
155281544|NCT01653743|560461631|FG000|Overall Study|Withdrawal by Subject|1|||
155732308|NCT03682770|562118318|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155281545|NCT01653743|560461632|FG001|Overall Study|Withdrawal by Subject|0|||
155281546|NCT01653743|560461631|FG000|Overall Study|Investigator discretion|3|||
155732309|NCT03682770|562118319|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155388410|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
155388411|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
155388412|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
155388413|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
155388414|NCT05056987|560856241|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
155388415|NCT05056987|560856242|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
155388416|NCT05056987|560856241|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
155388417|NCT05056987|560856242|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
155388418|NCT01575028|560856243|FG000|Overall Study|Physician Decision|0|||
155388419|NCT01575028|560856244|FG001|Overall Study|Physician Decision|1|||
155388420|NCT01182194|560856245|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155388421|NCT01182194|560856246|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
155388422|NCT01948908|560856247|FG000|Overall Study|Protocol Violation|1|||
155388423|NCT01948908|560856248|FG001|Overall Study|Protocol Violation|0|||
155388424|NCT01948908|560856249|FG002|Overall Study|Protocol Violation|2|||
155388425|NCT01585987|560856250|FG000|Randomized|Withdrawal by Subject|0|||
155388426|NCT01585987|560856251|FG001|Randomized|Withdrawal by Subject|4|||
155388427|NCT01585987|560856250|FG000|Randomized|No longer met criteria|0|||
155388428|NCT01585987|560856251|FG001|Randomized|No longer met criteria|2|||
155388429|NCT01585987|560856250|FG000|Treated|Disease Progression|39|||
155388430|NCT01585987|560856251|FG001|Treated|Disease Progression|36|||
155388431|NCT01585987|560856250|FG000|Treated|Study Drug Toxicity|9|||
155388432|NCT01585987|560856251|FG001|Treated|Study Drug Toxicity|5|||
155388433|NCT01585987|560856250|FG000|Treated|Adverse Event|3|||
155388434|NCT01585987|560856251|FG001|Treated|Adverse Event|0|||
155388435|NCT01585987|560856250|FG000|Treated|Withdrawal by Subject|1|||
155388436|NCT01585987|560856251|FG001|Treated|Withdrawal by Subject|2|||
155388437|NCT01585987|560856250|FG000|Treated|Death|1|||
155388438|NCT01585987|560856251|FG001|Treated|Death|0|||
155388439|NCT01585987|560856250|FG000|Treated|Lost to Follow-up|0|||
155388440|NCT01585987|560856251|FG001|Treated|Lost to Follow-up|1|||
155388441|NCT01585987|560856250|FG000|Treated|Maximum Clinical Benefit|0|||
155388442|NCT01585987|560856251|FG001|Treated|Maximum Clinical Benefit|1|||
155388443|NCT01585987|560856250|FG000|Treated|Non-Specified|1|||
155388444|NCT01585987|560856251|FG001|Treated|Non-Specified|2|||
155388445|NCT01585987|560856250|FG000|Treated|Subject Request|0|||
155629631|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
155629632|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
155629633|NCT02003144|561739965|FG000|Open Label Maintenance Phase|Adverse Event|2|||
155629634|NCT02003144|561739966|FG001|Open Label Maintenance Phase|Adverse Event|1|||
155629635|NCT01419535|561739968|FG000|Overall Study|could not maintain iv line|1|||
155629636|NCT01419535|561739969|FG001|Overall Study|could not maintain iv line|1|||
155629637|NCT01419535|561739968|FG000|Overall Study|Withdrawal by Subject|0|||
155629638|NCT01419535|561739969|FG001|Overall Study|Withdrawal by Subject|1|||
155629639|NCT05965752|561739976|FG000|Overall Study|Adverse Event|0|||
155629640|NCT05965752|561739977|FG001|Overall Study|Adverse Event|1|||
155629641|NCT05965752|561739978|FG002|Overall Study|Adverse Event|0|||
155629642|NCT05965752|561739979|FG003|Overall Study|Adverse Event|1|||
155629643|NCT05965752|561739980|FG004|Overall Study|Adverse Event|3|||
155629644|NCT05965752|561739976|FG000|Overall Study|Lost to Follow-up|2|||
155629645|NCT05965752|561739977|FG001|Overall Study|Lost to Follow-up|0|||
155629646|NCT05965752|561739978|FG002|Overall Study|Lost to Follow-up|1|||
155629647|NCT05965752|561739979|FG003|Overall Study|Lost to Follow-up|1|||
155629648|NCT05965752|561739980|FG004|Overall Study|Lost to Follow-up|1|||
155629649|NCT05965752|561739976|FG000|Overall Study|Withdrawal by Subject|2|||
155629650|NCT05965752|561739977|FG001|Overall Study|Withdrawal by Subject|2|||
155629651|NCT05965752|561739978|FG002|Overall Study|Withdrawal by Subject|1|||
155629652|NCT05965752|561739979|FG003|Overall Study|Withdrawal by Subject|5|||
155629653|NCT05965752|561739980|FG004|Overall Study|Withdrawal by Subject|0|||
155629654|NCT05965752|561739976|FG000|Overall Study|Disease Relapse|1|||
155629655|NCT05965752|561739977|FG001|Overall Study|Disease Relapse|0|||
155629656|NCT05965752|561739978|FG002|Overall Study|Disease Relapse|1|||
155629657|NCT05965752|561739979|FG003|Overall Study|Disease Relapse|0|||
155388446|NCT01585987|560856251|FG001|Treated|Subject Request|1|||
155388447|NCT01585987|560856250|FG000|Treated|Poor/Non-Compliance|0|||
155388448|NCT01585987|560856251|FG001|Treated|Poor/Non-Compliance|1|||
155388449|NCT03291587|560856252|FG000|Overall Study|Lost to Follow-up|62|||
155388450|NCT03291587|560856253|FG001|Overall Study|Lost to Follow-up|43|||
155388451|NCT03291587|560856252|FG000|Overall Study|Refused to Answer|5|||
155629658|NCT05965752|561739980|FG004|Overall Study|Disease Relapse|0|||
155629659|NCT05965752|561739976|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155629660|NCT05965752|561739977|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155629661|NCT05965752|561739978|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155629662|NCT05965752|561739979|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
155388452|NCT03291587|560856253|FG001|Overall Study|Refused to Answer|2|||
155388453|NCT03291587|560856252|FG000|Overall Study|Death|2|||
155388454|NCT03291587|560856253|FG001|Overall Study|Death|4|||
155388455|NCT03291587|560856252|FG000|Overall Study|Not interested in participating|8|||
155732310|NCT03682770|562118320|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155732311|NCT03682770|562118321|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155732312|NCT03682770|562118322|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155732313|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155732314|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155732315|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
155732316|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
155732317|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155732318|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155732319|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155732320|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732321|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732322|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732323|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
155732324|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732325|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732326|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155732327|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155732328|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155732329|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
155732330|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
155732331|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155732332|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155732333|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155732334|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732335|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732336|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
155732337|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732338|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732339|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732340|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155732341|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732342|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732343|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
155732344|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732345|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732346|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732347|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155732348|NCT03682770|562118316|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732349|NCT03682770|562118317|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732350|NCT03682770|562118318|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732351|NCT03682770|562118319|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
155732352|NCT03682770|562118320|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732353|NCT03682770|562118321|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732354|NCT03682770|562118322|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155732355|NCT03682770|562118316|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155732356|NCT03682770|562118317|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155732357|NCT03682770|562118318|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155732358|NCT03682770|562118319|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155732359|NCT03682770|562118320|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
155732360|NCT03682770|562118321|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
155732361|NCT03682770|562118322|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
155732362|NCT03682770|562118316|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732363|NCT03682770|562118317|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732364|NCT03682770|562118318|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732365|NCT03682770|562118319|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732366|NCT03682770|562118320|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
155732367|NCT03682770|562118321|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732368|NCT03682770|562118322|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155732369|NCT03682770|562118316|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155732370|NCT03682770|562118317|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155732371|NCT03682770|562118318|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155281547|NCT01653743|560461632|FG001|Overall Study|Investigator discretion|0|||
155281548|NCT01318811|560461635|FG000|Overall Study|Physician Decision|1|||
155388456|NCT03291587|560856253|FG001|Overall Study|Not interested in participating|6|||
155388457|NCT03291587|560856252|FG000|Overall Study|Too busy to participate|4|||
155388458|NCT03291587|560856253|FG001|Overall Study|Too busy to participate|2|||
155388459|NCT00796120|560856255|FG000|Overall Study|Death|3|||
155388460|NCT00796120|560856256|FG001|Overall Study|Death|0|||
155388461|NCT00796120|560856255|FG000|Overall Study|Adverse Event|11|||
155388462|NCT00796120|560856256|FG001|Overall Study|Adverse Event|6|||
155388463|NCT00796120|560856255|FG000|Overall Study|Progressive disease|22|||
155388464|NCT00796120|560856256|FG001|Overall Study|Progressive disease|13|||
155388465|NCT00796120|560856255|FG000|Overall Study|Participant refusal|3|||
155388466|NCT00796120|560856256|FG001|Overall Study|Participant refusal|4|||
155388467|NCT00796120|560856255|FG000|Overall Study|Other|6|||
155388468|NCT00796120|560856256|FG001|Overall Study|Other|17|||
155388469|NCT00796120|560856255|FG000|Overall Study|Physician Decision|16|||
155388470|NCT00796120|560856256|FG001|Overall Study|Physician Decision|17|||
155388471|NCT00796120|560856255|FG000|Overall Study|Randomized but not treated|0|||
155388472|NCT00796120|560856256|FG001|Overall Study|Randomized but not treated|3|||
155388473|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
155388474|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
155388475|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
155388476|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388477|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388478|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388479|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
155388480|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
155388481|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
155388482|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
155388483|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
155388484|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
155388485|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
155629663|NCT05965752|561739980|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
155629664|NCT05965752|561739976|FG000|Overall Study|Unable to Return for Study Visits|0|||
155629665|NCT05965752|561739977|FG001|Overall Study|Unable to Return for Study Visits|1|||
155629666|NCT05965752|561739978|FG002|Overall Study|Unable to Return for Study Visits|0|||
155629667|NCT05965752|561739979|FG003|Overall Study|Unable to Return for Study Visits|3|||
155629668|NCT05965752|561739980|FG004|Overall Study|Unable to Return for Study Visits|1|||
155629669|NCT05965752|561739976|FG000|Overall Study|Early Termination|0|||
155629670|NCT05965752|561739977|FG001|Overall Study|Early Termination|0|||
155629671|NCT05965752|561739978|FG002|Overall Study|Early Termination|1|||
155629672|NCT05965752|561739979|FG003|Overall Study|Early Termination|0|||
155629673|NCT05965752|561739980|FG004|Overall Study|Early Termination|0|||
155629674|NCT05965752|561739976|FG000|Overall Study|Reported Unwanted Symptoms|0|||
155629675|NCT05965752|561739977|FG001|Overall Study|Reported Unwanted Symptoms|0|||
155629676|NCT05965752|561739978|FG002|Overall Study|Reported Unwanted Symptoms|0|||
155629677|NCT05965752|561739979|FG003|Overall Study|Reported Unwanted Symptoms|0|||
155629678|NCT05965752|561739980|FG004|Overall Study|Reported Unwanted Symptoms|1|||
155629679|NCT05965752|561739976|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155629680|NCT05965752|561739977|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155629681|NCT05965752|561739978|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155629682|NCT05965752|561739979|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155629683|NCT05965752|561739980|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
155629684|NCT04239924|561739984|FG000|Overall Study|Lost to Follow-up|2|||
155629685|NCT02839707|561739985|FG000|Phase I|Not eligible for analysis|9|||
155629686|NCT02839707|561739986|FG001|Phase I|Not eligible for analysis|0|||
155629687|NCT02839707|561739987|FG002|Phase I|Not eligible for analysis|0|||
155629688|NCT02839707|561739985|FG000|Phase II|Not treated according to protocol|4|||
155629689|NCT02839707|561739986|FG001|Phase II|Not treated according to protocol|0|||
155629690|NCT02839707|561739987|FG002|Phase II|Not treated according to protocol|2|||
155629691|NCT02839707|561739985|FG000|Phase III|Not treated according to protocol|0|||
155629692|NCT02839707|561739986|FG001|Phase III|Not treated according to protocol|0|||
155629693|NCT02839707|561739987|FG002|Phase III|Not treated according to protocol|4|||
155629694|NCT00703534|561741293|FG000|Overall Study|Adverse Event|14|||
155388486|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
155388487|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
155388488|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
155388489|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
155629695|NCT00703534|561741294|FG001|Overall Study|Adverse Event|3|||
155629696|NCT00703534|561741293|FG000|Overall Study|Withdrawal by Subject|8|||
155629697|NCT00703534|561741294|FG001|Overall Study|Withdrawal by Subject|7|||
155629698|NCT00703534|561741293|FG000|Overall Study|Incorrect Enrollment|6|||
155629699|NCT00703534|561741294|FG001|Overall Study|Incorrect Enrollment|6|||
155629700|NCT00703534|561741293|FG000|Overall Study|Lost to Follow-up|1|||
155388490|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
155388491|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
155388492|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
155388493|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
155388494|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
155388495|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
155388496|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
155388497|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
155388498|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
155388499|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
155388500|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
155388501|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
155388502|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
155388503|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
155388504|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
155388505|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
155388506|NCT03737474|560856262|FG000|Overall Study|Adverse Event|18|||
155388507|NCT03737474|560856263|FG001|Overall Study|Adverse Event|48|||
155388508|NCT03737474|560856262|FG000|Overall Study|Lack of Efficacy|1|||
155388509|NCT03737474|560856263|FG001|Overall Study|Lack of Efficacy|3|||
155388510|NCT03737474|560856262|FG000|Overall Study|Protocol Violation|0|||
155388511|NCT03737474|560856263|FG001|Overall Study|Protocol Violation|8|||
155388512|NCT03737474|560856262|FG000|Overall Study|Withdrawal by Subject|5|||
155388513|NCT03737474|560856263|FG001|Overall Study|Withdrawal by Subject|20|||
155388514|NCT03737474|560856262|FG000|Overall Study|Non-compliance With Study Drug|0|||
155388515|NCT03737474|560856263|FG001|Overall Study|Non-compliance With Study Drug|1|||
155388516|NCT03737474|560856262|FG000|Overall Study|Physician Decision|1|||
155388517|NCT03737474|560856263|FG001|Overall Study|Physician Decision|4|||
155388518|NCT01139658|560856266|FG000|Overall Study|Adverse Event|10|||
155388519|NCT01139658|560856267|FG001|Overall Study|Adverse Event|27|||
155388520|NCT01139658|560856266|FG000|Overall Study|Lack of Efficacy|15|||
155388521|NCT01139658|560856267|FG001|Overall Study|Lack of Efficacy|7|||
155388522|NCT01139658|560856266|FG000|Overall Study|Withdrawal by Subject|2|||
155388523|NCT01139658|560856267|FG001|Overall Study|Withdrawal by Subject|4|||
155388524|NCT01139658|560856266|FG000|Overall Study|No documentation of treatment|1|||
155388525|NCT01139658|560856267|FG001|Overall Study|No documentation of treatment|0|||
155388526|NCT01139658|560856266|FG000|Overall Study|Other|28|||
155388527|NCT01139658|560856267|FG001|Overall Study|Other|75|||
155388528|NCT00971243|560856268|FG000|Double Blind Period|Adverse Event|2|||
155388529|NCT00971243|560856269|FG001|Double Blind Period|Adverse Event|3|||
155388530|NCT00971243|560856270|FG002|Double Blind Period|Adverse Event|2|||
155388531|NCT00971243|560856271|FG003|Double Blind Period|Adverse Event|2|||
155388532|NCT00971243|560856272|FG004|Double Blind Period|Adverse Event|3|||
155388533|NCT00971243|560856268|FG000|Double Blind Period|Lost to Follow-up|0|||
155388534|NCT00971243|560856269|FG001|Double Blind Period|Lost to Follow-up|1|||
155388535|NCT00971243|560856270|FG002|Double Blind Period|Lost to Follow-up|1|||
155388536|NCT00971243|560856271|FG003|Double Blind Period|Lost to Follow-up|0|||
155388537|NCT00971243|560856272|FG004|Double Blind Period|Lost to Follow-up|1|||
155388538|NCT00971243|560856268|FG000|Double Blind Period|Physician Decision|10|||
155388539|NCT00971243|560856269|FG001|Double Blind Period|Physician Decision|6|||
155388540|NCT00971243|560856270|FG002|Double Blind Period|Physician Decision|7|||
155388541|NCT00971243|560856271|FG003|Double Blind Period|Physician Decision|6|||
155388542|NCT00971243|560856272|FG004|Double Blind Period|Physician Decision|7|||
155388543|NCT00971243|560856268|FG000|Double Blind Period|Protocol Violation|2|||
155388544|NCT00971243|560856269|FG001|Double Blind Period|Protocol Violation|0|||
155388545|NCT00971243|560856270|FG002|Double Blind Period|Protocol Violation|3|||
155388546|NCT00971243|560856271|FG003|Double Blind Period|Protocol Violation|2|||
155388547|NCT00971243|560856272|FG004|Double Blind Period|Protocol Violation|2|||
155388548|NCT00971243|560856268|FG000|Double Blind Period|Withdrawal by Subject|4|||
155388549|NCT00971243|560856269|FG001|Double Blind Period|Withdrawal by Subject|1|||
155388550|NCT00971243|560856270|FG002|Double Blind Period|Withdrawal by Subject|4|||
155388551|NCT00971243|560856271|FG003|Double Blind Period|Withdrawal by Subject|4|||
155388552|NCT00971243|560856272|FG004|Double Blind Period|Withdrawal by Subject|4|||
155388553|NCT00971243|560856268|FG000|Double Blind Period|Other reasons|1|||
155388554|NCT00971243|560856269|FG001|Double Blind Period|Other reasons|0|||
155388555|NCT00971243|560856270|FG002|Double Blind Period|Other reasons|2|||
155388556|NCT00971243|560856271|FG003|Double Blind Period|Other reasons|0|||
155388557|NCT00971243|560856272|FG004|Double Blind Period|Other reasons|1|||
155388558|NCT00971243|560856268|FG000|Open-label Period|Adverse Event|1|||
155388559|NCT00971243|560856269|FG001|Open-label Period|Adverse Event|0|||
155388560|NCT00971243|560856270|FG002|Open-label Period|Adverse Event|1|||
155388561|NCT00971243|560856271|FG003|Open-label Period|Adverse Event|1|||
155388562|NCT00971243|560856272|FG004|Open-label Period|Adverse Event|0|||
155388563|NCT00971243|560856268|FG000|Open-label Period|Physician Decision|5|||
155732372|NCT03682770|562118319|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155732373|NCT03682770|562118320|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155732374|NCT03682770|562118321|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
155732375|NCT03682770|562118322|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155732376|NCT03682770|562118316|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155732377|NCT03682770|562118317|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155732378|NCT03682770|562118318|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155732379|NCT03682770|562118319|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155732380|NCT03682770|562118320|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155732381|NCT03682770|562118321|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
155732382|NCT03682770|562118322|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
155732383|NCT02863419|562118323|FG000|Overall Study|Lost to Follow-up|0|||
155732384|NCT02863419|562118324|FG001|Overall Study|Lost to Follow-up|1|||
155732385|NCT02863419|562118325|FG002|Overall Study|Lost to Follow-up|4|||
155732386|NCT02863419|562118323|FG000|Overall Study|Withdrawal by Subject|5|||
155732387|NCT02863419|562118324|FG001|Overall Study|Withdrawal by Subject|5|||
155732388|NCT02863419|562118325|FG002|Overall Study|Withdrawal by Subject|3|||
155732389|NCT02863419|562118323|FG000|Overall Study|Died|3|||
155732390|NCT02863419|562118324|FG001|Overall Study|Died|4|||
155732391|NCT02863419|562118325|FG002|Overall Study|Died|1|||
155732392|NCT02362282|562118326|FG000|Overall Study|Withdrawal by Subject|1|||
155732393|NCT02362282|562118327|FG001|Overall Study|Withdrawal by Subject|0|||
155732394|NCT01189032|562118328|FG000|Overall Study|Adverse Event|1|||
155732395|NCT01189032|562118329|FG001|Overall Study|Adverse Event|3|||
155732396|NCT01189032|562118330|FG002|Overall Study|Adverse Event|4|||
155732397|NCT01189032|562118328|FG000|Overall Study|Lack of Efficacy|2|||
155732398|NCT01189032|562118329|FG001|Overall Study|Lack of Efficacy|3|||
155732399|NCT01189032|562118330|FG002|Overall Study|Lack of Efficacy|0|||
155732400|NCT01189032|562118328|FG000|Overall Study|Withdrawal by Subject|1|||
155732401|NCT01189032|562118329|FG001|Overall Study|Withdrawal by Subject|0|||
155388564|NCT00971243|560856269|FG001|Open-label Period|Physician Decision|9|||
155388565|NCT00971243|560856270|FG002|Open-label Period|Physician Decision|3|||
155388566|NCT00971243|560856271|FG003|Open-label Period|Physician Decision|7|||
155388567|NCT00971243|560856272|FG004|Open-label Period|Physician Decision|2|||
155388568|NCT00971243|560856268|FG000|Open-label Period|Protocol Violation|1|||
155388569|NCT00971243|560856269|FG001|Open-label Period|Protocol Violation|1|||
155388570|NCT00971243|560856270|FG002|Open-label Period|Protocol Violation|1|||
155388571|NCT00971243|560856271|FG003|Open-label Period|Protocol Violation|0|||
155388572|NCT00971243|560856272|FG004|Open-label Period|Protocol Violation|1|||
155388573|NCT00971243|560856268|FG000|Open-label Period|Withdrawal by Subject|1|||
155388574|NCT00971243|560856269|FG001|Open-label Period|Withdrawal by Subject|0|||
155388575|NCT00971243|560856270|FG002|Open-label Period|Withdrawal by Subject|0|||
155388576|NCT00971243|560856271|FG003|Open-label Period|Withdrawal by Subject|2|||
155388577|NCT00971243|560856272|FG004|Open-label Period|Withdrawal by Subject|1|||
155388578|NCT00971243|560856268|FG000|Open-label Period|Other reason|0|||
155388579|NCT00971243|560856269|FG001|Open-label Period|Other reason|0|||
155388580|NCT00971243|560856270|FG002|Open-label Period|Other reason|0|||
155388581|NCT00971243|560856271|FG003|Open-label Period|Other reason|0|||
155388582|NCT00971243|560856272|FG004|Open-label Period|Other reason|2|||
155388583|NCT00803270|560856273|FG000|Overall Study|Lost to Follow-up|1|||
155388584|NCT00803270|560856274|FG001|Overall Study|Lost to Follow-up|2|||
155388585|NCT02903368|560856277|FG000|Part 1|Adverse Event|3|||
155388586|NCT02903368|560856278|FG001|Part 1|Adverse Event|0|||
155388587|NCT02903368|560856279|FG002|Part 1|Adverse Event|0|||
155388588|NCT02903368|560856280|FG003|Part 1|Adverse Event|0|||
155388589|NCT02903368|560856277|FG000|Part 1|Withdrawal by Subject|1|||
155388590|NCT02903368|560856278|FG001|Part 1|Withdrawal by Subject|0|||
155388591|NCT02903368|560856279|FG002|Part 1|Withdrawal by Subject|0|||
155388592|NCT02903368|560856280|FG003|Part 1|Withdrawal by Subject|0|||
155388593|NCT02903368|560856277|FG000|Part 2|Adverse Event|0|||
155388594|NCT02903368|560856278|FG001|Part 2|Adverse Event|0|||
155388595|NCT02903368|560856279|FG002|Part 2|Adverse Event|5|||
155388596|NCT02903368|560856280|FG003|Part 2|Adverse Event|0|||
155388597|NCT02903368|560856277|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388598|NCT02903368|560856278|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388599|NCT02903368|560856279|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
155388600|NCT02903368|560856280|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388601|NCT02903368|560856277|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
155732402|NCT01189032|562118330|FG002|Overall Study|Withdrawal by Subject|1|||
155732403|NCT01189032|562118328|FG000|Overall Study|Protocol Violation|1|||
155732404|NCT01189032|562118329|FG001|Overall Study|Protocol Violation|1|||
155732405|NCT01189032|562118330|FG002|Overall Study|Protocol Violation|1|||
155732406|NCT01733680|562118331|FG000|Overall Study|Withdrawal by Subject|0|||
155388602|NCT02903368|560856278|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
155629701|NCT00703534|561741294|FG001|Overall Study|Lost to Follow-up|4|||
155629702|NCT00703534|561741293|FG000|Overall Study|Severe Non Compliance|1|||
155629703|NCT00703534|561741294|FG001|Overall Study|Severe Non Compliance|5|||
155629704|NCT00427934|561741295|FG000|Overall Study|Adverse Event|1|||
155629705|NCT00427934|561741296|FG001|Overall Study|Adverse Event|0|||
155629706|NCT00427934|561741297|FG002|Overall Study|Adverse Event|5|||
155629707|NCT00427934|561741298|FG003|Overall Study|Adverse Event|4|||
155629708|NCT00427934|561741295|FG000|Overall Study|Lack of Efficacy|0|||
155629709|NCT00427934|561741296|FG001|Overall Study|Lack of Efficacy|0|||
155629710|NCT00427934|561741297|FG002|Overall Study|Lack of Efficacy|5|||
155629711|NCT00427934|561741298|FG003|Overall Study|Lack of Efficacy|2|||
155629712|NCT00427934|561741295|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
155629713|NCT00427934|561741296|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
155629714|NCT00427934|561741297|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
155629715|NCT00427934|561741298|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
155629716|NCT00427934|561741295|FG000|Overall Study|Other|0|||
155629717|NCT00427934|561741296|FG001|Overall Study|Other|0|||
155629718|NCT00427934|561741297|FG002|Overall Study|Other|11|||
155629719|NCT00427934|561741298|FG003|Overall Study|Other|5|||
155629720|NCT00427934|561741295|FG000|Overall Study|Withdrawal by Subject|0|||
155629721|NCT00427934|561741296|FG001|Overall Study|Withdrawal by Subject|0|||
155629722|NCT00427934|561741297|FG002|Overall Study|Withdrawal by Subject|1|||
155629723|NCT00427934|561741298|FG003|Overall Study|Withdrawal by Subject|3|||
155629724|NCT02058095|561741299|FG000|Overall Study|Adverse Event|1|||
155629725|NCT02058095|561741300|FG001|Overall Study|Adverse Event|0|||
155629726|NCT00998946|561741303|FG000|Overall Study|Lost to Follow-up|1|||
155629727|NCT00998946|561741303|FG000|Overall Study|Withdrawal by Subject|1|||
155629728|NCT00998946|561741303|FG000|Overall Study|Death|2|||
155629729|NCT00998946|561741303|FG000|Overall Study|Reason Unspecified|3|||
155629730|NCT00998946|561741303|FG000|Overall Study|Enrolled but not Dosed|2|||
155629731|NCT00915525|561741309|FG000|Overall Study|Protocol Violation|9|||
155629732|NCT00915525|561741310|FG001|Overall Study|Protocol Violation|4|||
155629733|NCT00915525|561741309|FG000|Overall Study|Withdrawal by Subject|59|||
155629734|NCT00915525|561741310|FG001|Overall Study|Withdrawal by Subject|21|||
155629735|NCT00915525|561741309|FG000|Overall Study|Lost to Follow-up|27|||
155629736|NCT00915525|561741310|FG001|Overall Study|Lost to Follow-up|16|||
155629737|NCT00915525|561741309|FG000|Overall Study|Pregnancy|2|||
155629738|NCT00915525|561741310|FG001|Overall Study|Pregnancy|0|||
155629739|NCT00915525|561741309|FG000|Overall Study|Lack of Efficacy|15|||
155629740|NCT00915525|561741310|FG001|Overall Study|Lack of Efficacy|32|||
155629741|NCT00915525|561741309|FG000|Overall Study|Adverse Event|29|||
155629742|NCT00915525|561741310|FG001|Overall Study|Adverse Event|13|||
155629743|NCT00915525|561741309|FG000|Overall Study|Missing|12|||
155629744|NCT00915525|561741310|FG001|Overall Study|Missing|1|||
155629745|NCT00915525|561741309|FG000|Overall Study|Other Reason|35|||
155629746|NCT00915525|561741310|FG001|Overall Study|Other Reason|12|||
155629747|NCT00915525|561741309|FG000|Overall Study|Site Closed|27|||
155629748|NCT00915525|561741310|FG001|Overall Study|Site Closed|9|||
155629749|NCT00915525|561741309|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
155629750|NCT00915525|561741310|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
155629751|NCT00915525|561741309|FG000|Overall Study|Study Burden|28|||
155629752|NCT00915525|561741310|FG001|Overall Study|Study Burden|12|||
155629753|NCT00915525|561741309|FG000|Overall Study|Non-Compliance|3|||
155629754|NCT00915525|561741310|FG001|Overall Study|Non-Compliance|1|||
155629755|NCT00915525|561741309|FG000|Overall Study|Patient Moved|15|||
155629756|NCT00915525|561741310|FG001|Overall Study|Patient Moved|9|||
155629757|NCT00577408|561741311|FG000|Overall Study|Stopped attending study visits|9|||
155629758|NCT00577408|561741312|FG001|Overall Study|Stopped attending study visits|11|||
155629759|NCT00577408|561741311|FG000|Overall Study|Continued opioid use|3|||
155629760|NCT00577408|561741312|FG001|Overall Study|Continued opioid use|2|||
155629761|NCT00577408|561741311|FG000|Overall Study|Non-compliance with study meds|0|||
155629762|NCT00577408|561741312|FG001|Overall Study|Non-compliance with study meds|3|||
155629763|NCT00577408|561741311|FG000|Overall Study|Refused Oral Naltrexone|0|||
155629764|NCT00577408|561741312|FG001|Overall Study|Refused Oral Naltrexone|1|||
155629765|NCT00577408|561741311|FG000|Overall Study|Moved out of state|0|||
155629766|NCT00577408|561741312|FG001|Overall Study|Moved out of state|1|||
155732407|NCT01733680|562118332|FG001|Overall Study|Withdrawal by Subject|1|||
155732408|NCT01932437|562118333|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155629767|NCT00577408|561741311|FG000|Overall Study|Scheduling Issues|0|||
155629768|NCT00577408|561741312|FG001|Overall Study|Scheduling Issues|3|||
155629769|NCT00577408|561741311|FG000|Overall Study|Death|0|||
155732409|NCT01932437|562118334|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155629770|NCT00577408|561741312|FG001|Overall Study|Death|1|||
155629771|NCT00577408|561741311|FG000|Overall Study|Psychiatric hospitalization|0|||
155629772|NCT00577408|561741312|FG001|Overall Study|Psychiatric hospitalization|1|||
155732410|NCT01932437|562118335|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155629773|NCT02765035|561741318|FG000|First Intervention (90 Days)|Adverse Event|1|||
155629774|NCT02765035|561741319|FG001|First Intervention (90 Days)|Adverse Event|1|||
155732411|NCT01932437|562118336|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155732412|NCT01932437|562118337|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155732413|NCT01932437|562118338|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
155732414|NCT01526733|562118340|FG000|Phase 1|Protocol Violation|1|||
155732415|NCT01526733|562118341|FG001|Phase 1|Protocol Violation|0|||
155732416|NCT01526733|562118340|FG000|Phase 1|Withdrawal by Subject|1|||
155732417|NCT01526733|562118341|FG001|Phase 1|Withdrawal by Subject|1|||
155732418|NCT02839200|562118342|FG000|Overall Study|Withdrawal by Subject|2|||
155732419|NCT02839200|562118343|FG001|Overall Study|Withdrawal by Subject|0|||
155732420|NCT02839200|562118344|FG002|Overall Study|Withdrawal by Subject|1|||
155732421|NCT02839200|562118345|FG003|Overall Study|Withdrawal by Subject|0|||
155732422|NCT02839200|562118346|FG004|Overall Study|Withdrawal by Subject|0|||
155732423|NCT02839200|562118347|FG005|Overall Study|Withdrawal by Subject|1|||
155732424|NCT02839200|562118342|FG000|Overall Study|Lost to Follow-up|2|||
155732425|NCT02839200|562118343|FG001|Overall Study|Lost to Follow-up|0|||
155732426|NCT02839200|562118344|FG002|Overall Study|Lost to Follow-up|0|||
155732427|NCT02839200|562118345|FG003|Overall Study|Lost to Follow-up|0|||
155732428|NCT02839200|562118346|FG004|Overall Study|Lost to Follow-up|1|||
155732429|NCT02839200|562118347|FG005|Overall Study|Lost to Follow-up|0|||
155388603|NCT02903368|560856279|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
155388604|NCT02903368|560856280|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
155388605|NCT02903368|560856277|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
155388606|NCT02903368|560856278|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
155388607|NCT02903368|560856279|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
155388608|NCT02903368|560856280|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
155388609|NCT06515483|560856281|FG000|Overall Study|Subject withdraw due to family issues|1|||
155388610|NCT06515483|560856282|FG001|Overall Study|Subject withdraw due to family issues|0|||
155388611|NCT00147823|560856288|FG000|Overall Study|Lost to Follow-up|6|||
155388612|NCT00147823|560856289|FG001|Overall Study|Lost to Follow-up|12|||
155388613|NCT00147823|560856288|FG000|Overall Study|Physician Decision|1|||
155388614|NCT00147823|560856289|FG001|Overall Study|Physician Decision|0|||
155388615|NCT00147823|560856288|FG000|Overall Study|Withdrawal by Subject|0|||
155388616|NCT00147823|560856289|FG001|Overall Study|Withdrawal by Subject|1|||
155388617|NCT00147823|560856288|FG000|Overall Study|Did not receive vitoss due to infection|6|||
155388618|NCT00147823|560856289|FG001|Overall Study|Did not receive vitoss due to infection|2|||
155388619|NCT03769181|560858644|FG000|Overall Study|Adverse Event|1|||
155388620|NCT03769181|560858645|FG001|Overall Study|Adverse Event|0|||
155388621|NCT03769181|560858646|FG002|Overall Study|Adverse Event|2|||
155388622|NCT03769181|560858647|FG003|Overall Study|Adverse Event|4|||
155388623|NCT03769181|560858644|FG000|Overall Study|Withdrawal by Subject|1|||
155388624|NCT03769181|560858645|FG001|Overall Study|Withdrawal by Subject|0|||
155388625|NCT03769181|560858646|FG002|Overall Study|Withdrawal by Subject|2|||
155388626|NCT03769181|560858647|FG003|Overall Study|Withdrawal by Subject|1|||
155388627|NCT03769181|560858644|FG000|Overall Study|Progressive disease|9|||
155388628|NCT03769181|560858645|FG001|Overall Study|Progressive disease|7|||
155388629|NCT03769181|560858646|FG002|Overall Study|Progressive disease|13|||
155388630|NCT03769181|560858647|FG003|Overall Study|Progressive disease|6|||
155388631|NCT03769181|560858644|FG000|Overall Study|Other - Unspecified|2|||
155388632|NCT03769181|560858645|FG001|Overall Study|Other - Unspecified|1|||
155388633|NCT03769181|560858646|FG002|Overall Study|Other - Unspecified|0|||
155388634|NCT03769181|560858647|FG003|Overall Study|Other - Unspecified|0|||
155388635|NCT01485354|560858648|FG000|Overall Study|Withdrawal by Subject|5|||
155388636|NCT03566810|560858649|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388637|NCT03566810|560858650|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
155388638|NCT03566810|560858651|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388639|NCT03566810|560858652|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388640|NCT03338192|560858654|FG000|Year One to Year Two|High Blood Pressure|7|||
155388641|NCT03338192|560858655|FG001|Year One to Year Two|High Blood Pressure|1|||
155388642|NCT03338192|560858654|FG000|Year One to Year Two|HIV +|1|||
155388643|NCT03338192|560858655|FG001|Year One to Year Two|HIV +|0|||
155732430|NCT02839200|562118342|FG000|Overall Study|Adverse Event|0|||
155732431|NCT02839200|562118343|FG001|Overall Study|Adverse Event|0|||
155732432|NCT02839200|562118344|FG002|Overall Study|Adverse Event|0|||
155732433|NCT02839200|562118345|FG003|Overall Study|Adverse Event|0|||
155732434|NCT02839200|562118346|FG004|Overall Study|Adverse Event|1|||
155732435|NCT02839200|562118347|FG005|Overall Study|Adverse Event|0|||
155732436|NCT02839200|562118342|FG000|Overall Study|Randomized in error|0|||
155732437|NCT02839200|562118343|FG001|Overall Study|Randomized in error|1|||
155388644|NCT03338192|560858654|FG000|Year Two to Year Four|High Blood Pressure|1|||
155732438|NCT02839200|562118344|FG002|Overall Study|Randomized in error|0|||
155732439|NCT02839200|562118345|FG003|Overall Study|Randomized in error|0|||
155732440|NCT02839200|562118346|FG004|Overall Study|Randomized in error|0|||
155732441|NCT02839200|562118347|FG005|Overall Study|Randomized in error|0|||
155732442|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
155388645|NCT03338192|560858655|FG001|Year Two to Year Four|High Blood Pressure|0|||
155388646|NCT03338192|560858654|FG000|Year Two to Year Four|HIV +|2|||
155388647|NCT03338192|560858655|FG001|Year Two to Year Four|HIV +|0|||
155388648|NCT03338192|560858654|FG000|Year Four to Year Six|High Blood Pressure|2|||
155388649|NCT03338192|560858655|FG001|Year Four to Year Six|High Blood Pressure|1|||
155388650|NCT00985166|560858658|FG000|Overall Study|Lost to Follow-up|3|||
155388651|NCT00985166|560858659|FG001|Overall Study|Lost to Follow-up|2|||
155388652|NCT00985166|560858660|FG002|Overall Study|Lost to Follow-up|2|||
155388653|NCT00985166|560858658|FG000|Overall Study|Withdrawal by Subject|3|||
155388654|NCT00985166|560858659|FG001|Overall Study|Withdrawal by Subject|2|||
155388655|NCT00985166|560858660|FG002|Overall Study|Withdrawal by Subject|0|||
155388656|NCT00985166|560858658|FG000|Overall Study|Test not done|2|||
155388657|NCT00985166|560858659|FG001|Overall Study|Test not done|0|||
155388658|NCT00985166|560858660|FG002|Overall Study|Test not done|4|||
155388659|NCT00985166|560858658|FG000|Overall Study|Other|1|||
155388660|NCT00985166|560858659|FG001|Overall Study|Other|0|||
155388661|NCT00985166|560858660|FG002|Overall Study|Other|1|||
155388662|NCT00567268|560858661|FG000|Overall Study|Protocol Violation|7|||
155629775|NCT02765035|561741318|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
155629776|NCT02765035|561741319|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
155629777|NCT02732639|561741323|FG000|Overall Study|Lost to Follow-up|1|||
155629778|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
155629779|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155629780|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155629781|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155629782|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
155629783|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155629784|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155629785|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155629786|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
155629787|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
155629788|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
155629789|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
155629790|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
155629791|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155629792|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155629793|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155629794|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
155629795|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
155629796|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
155629797|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
155629798|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
155629799|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155629800|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155629801|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155629802|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
155629803|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155629804|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155629805|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155629806|NCT01668797|561741324|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
155629807|NCT01668797|561741325|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155629808|NCT01668797|561741326|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155629809|NCT01668797|561741327|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155629810|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155629811|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
155629812|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155629813|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155629814|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155629815|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
155629816|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155629817|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155629818|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
155629819|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
155629820|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
155629821|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
155629822|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155629823|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
155732443|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
155732444|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
155388663|NCT00567268|560858661|FG000|Overall Study|Lost to Follow-up|36|||
155732445|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
155732446|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
155732447|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
155732448|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
155732449|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
155732450|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
155732451|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
155732452|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
155732453|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
155732454|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
155732455|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
155732456|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
155732457|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
155732458|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
155732459|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
155732460|NCT02952820|562118348|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155732461|NCT02952820|562118349|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155732462|NCT02952820|562118350|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155732463|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
155732464|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
155732465|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
155732466|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
155732467|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
155732468|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
155732469|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
155732470|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
155732471|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
155732472|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
155732473|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
155732474|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
155732475|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
155732476|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
155281549|NCT01318811|560461636|FG001|Overall Study|Physician Decision|1|||
155281550|NCT01318811|560461635|FG000|Overall Study|CRRT stopped for head CT|0|||
155281551|NCT01318811|560461636|FG001|Overall Study|CRRT stopped for head CT|1|||
155281552|NCT01318811|560461635|FG000|Overall Study|Death|0|||
155281553|NCT01318811|560461636|FG001|Overall Study|Death|1|||
155281554|NCT01318811|560461635|FG000|Overall Study|CRRT stopped for head MRI|0|||
155281555|NCT01318811|560461636|FG001|Overall Study|CRRT stopped for head MRI|1|||
155281556|NCT00811187|560461637|FG000|Overall Study|Unable to place device / procedure abort|3|||
155281557|NCT00811187|560461638|FG001|Overall Study|Unable to place device / procedure abort|3|||
155281558|NCT00131911|560461639|FG000|Overall Study|Withdrawal by Subject|1|||
155281559|NCT00131911|560461640|FG001|Overall Study|Withdrawal by Subject|0|||
155281560|NCT02825043|560461641|FG000|Overall Study|Lost to Follow-up|4|||
155281561|NCT00329303|560461642|FG000|Overall Study|Lack of Efficacy|1|||
155281562|NCT00329303|560461643|FG001|Overall Study|Lack of Efficacy|0|||
155281563|NCT00329303|560461642|FG000|Overall Study|Decision of the sponsor|0|||
155281564|NCT00329303|560461643|FG001|Overall Study|Decision of the sponsor|1|||
155281565|NCT00329303|560461642|FG000|Overall Study|Patient no longer available|1|||
155281566|NCT00329303|560461643|FG001|Overall Study|Patient no longer available|0|||
155281567|NCT00329303|560461642|FG000|Overall Study|Patient relocated|0|||
155281568|NCT00329303|560461643|FG001|Overall Study|Patient relocated|1|||
155281569|NCT03582137|560461647|FG000|Overall Study|Adverse Event|1|||
155281570|NCT03582137|560461648|FG001|Overall Study|Adverse Event|0|||
155281571|NCT03704298|560461650|FG000|Overall Study|Death|3|||
155281572|NCT03704298|560461651|FG001|Overall Study|Death|1|||
155281573|NCT03704298|560461652|FG002|Overall Study|Death|1|||
155281574|NCT03704298|560461653|FG003|Overall Study|Death|0|||
155281575|NCT03704298|560461650|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
155281576|NCT03704298|560461651|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
155281577|NCT03704298|560461652|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
155281578|NCT03704298|560461653|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
155281579|NCT03704298|560461650|FG000|Overall Study|Withdrawal by Subject|1|||
155281580|NCT03704298|560461651|FG001|Overall Study|Withdrawal by Subject|0|||
155281581|NCT03704298|560461652|FG002|Overall Study|Withdrawal by Subject|0|||
155281582|NCT03704298|560461653|FG003|Overall Study|Withdrawal by Subject|0|||
155281583|NCT03704298|560461650|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155281584|NCT03704298|560461651|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
155281585|NCT03704298|560461652|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155388664|NCT00567268|560858661|FG000|Overall Study|No Visit After First Day of Treatment|2|||
155388665|NCT00567268|560858661|FG000|Overall Study|No Drug Administration|4|||
155388666|NCT00567268|560858661|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
155388667|NCT01117454|560858662|FG000|Overall Study|Pregnancy|0|||
155388668|NCT01117454|560858663|FG001|Overall Study|Pregnancy|1|||
155388669|NCT02276872|560858666|FG000|Overall Study|Adverse Event|1|||
155388670|NCT02276872|560858667|FG001|Overall Study|Adverse Event|0|||
155388671|NCT02276872|560858668|FG002|Overall Study|Adverse Event|0|||
155388672|NCT04175808|560858669|FG000|Part A|Miscellaneous|2|||
155388673|NCT04175808|560858670|FG001|Part A|Miscellaneous|0|||
155388674|NCT04175808|560858671|FG002|Part A|Miscellaneous|0|||
155388675|NCT04175808|560858672|FG003|Part A|Miscellaneous|0|||
155388676|NCT04175808|560858673|FG004|Part A|Miscellaneous|0|||
155388677|NCT04175808|560858674|FG005|Part A|Miscellaneous|0|||
155388678|NCT04175808|560858675|FG006|Part A|Miscellaneous|0|||
155388679|NCT00818389|560858677|FG000|Overall Study|Death|1|||
155388680|NCT00818389|560858678|FG001|Overall Study|Death|3|||
155388681|NCT00818389|560858677|FG000|Overall Study|ALS Disease Progression|1|||
155388682|NCT00818389|560858678|FG001|Overall Study|ALS Disease Progression|0|||
155388683|NCT00818389|560858677|FG000|Overall Study|Withdrawal by Subject|2|||
155388684|NCT00818389|560858678|FG001|Overall Study|Withdrawal by Subject|2|||
155388685|NCT00818389|560858677|FG000|Overall Study|Adverse Event|0|||
155388686|NCT00818389|560858678|FG001|Overall Study|Adverse Event|1|||
155388687|NCT04263909|560858679|FG000|Overall Study|Physician Decision|1|||
155388688|NCT04263909|560858680|FG001|Overall Study|Physician Decision|0|||
155388689|NCT04263909|560858681|FG002|Overall Study|Physician Decision|0|||
155388690|NCT04263909|560858679|FG000|Overall Study|Adverse Event|3|||
155388691|NCT04263909|560858680|FG001|Overall Study|Adverse Event|0|||
155388692|NCT04263909|560858681|FG002|Overall Study|Adverse Event|0|||
155388693|NCT04263909|560858679|FG000|Overall Study|Protocol Violation|5|||
155388694|NCT04263909|560858680|FG001|Overall Study|Protocol Violation|0|||
155388695|NCT04263909|560858681|FG002|Overall Study|Protocol Violation|0|||
155388696|NCT00068588|560858682|FG000|Overall Study|Adverse Event|0|||
155388697|NCT00068588|560858683|FG001|Overall Study|Adverse Event|0|||
155388698|NCT00068588|560858684|FG002|Overall Study|Adverse Event|2|||
155388699|NCT00068588|560858682|FG000|Overall Study|Withdrawal by Subject|0|||
155388700|NCT00068588|560858683|FG001|Overall Study|Withdrawal by Subject|0|||
155388701|NCT00068588|560858684|FG002|Overall Study|Withdrawal by Subject|1|||
155629824|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155629825|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155629826|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
155629827|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
155629828|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
155629829|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
155629830|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
155629831|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
155629832|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
155629833|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
155629834|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155629835|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
155629836|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155629837|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155629838|NCT01668797|561741324|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155629839|NCT01668797|561741325|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
155629840|NCT01668797|561741326|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155629841|NCT01668797|561741327|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155629842|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
155629843|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
155629844|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
155388702|NCT00068588|560858682|FG000|Overall Study|Poor KPS|0|||
155388703|NCT00068588|560858683|FG001|Overall Study|Poor KPS|0|||
155388704|NCT00068588|560858684|FG002|Overall Study|Poor KPS|1|||
155388705|NCT03840486|560858685|FG000|Overall Study|Withdrawal by Subject|0|||
155388706|NCT03840486|560858686|FG001|Overall Study|Withdrawal by Subject|1|||
155388707|NCT03840486|560858687|FG002|Overall Study|Withdrawal by Subject|0|||
155388708|NCT03840486|560858688|FG003|Overall Study|Withdrawal by Subject|0|||
155388709|NCT03840486|560858689|FG004|Overall Study|Withdrawal by Subject|0|||
155388710|NCT03840486|560858690|FG005|Overall Study|Withdrawal by Subject|0|||
155388711|NCT03840486|560858691|FG006|Overall Study|Withdrawal by Subject|0|||
155388712|NCT03840486|560858692|FG007|Overall Study|Withdrawal by Subject|0|||
155388713|NCT03840486|560858693|FG008|Overall Study|Withdrawal by Subject|0|||
155388714|NCT03840486|560858694|FG009|Overall Study|Withdrawal by Subject|0|||
155388715|NCT03840486|560858695|FG010|Overall Study|Withdrawal by Subject|0|||
155388716|NCT03840486|560858696|FG011|Overall Study|Withdrawal by Subject|0|||
155388717|NCT01978262|560858697|FG000|Overall Study|Withdrawal by Subject|9|||
155388718|NCT01978262|560858697|FG000|Overall Study|Lost to Follow-up|2|||
155388719|NCT02982187|560858698|FG000|Overall Study|Withdrawal by Subject|0|||
155388720|NCT02982187|560858699|FG001|Overall Study|Withdrawal by Subject|0|||
155388721|NCT02982187|560858700|FG002|Overall Study|Withdrawal by Subject|0|||
155388722|NCT02982187|560858701|FG003|Overall Study|Withdrawal by Subject|0|||
155388723|NCT02982187|560858702|FG004|Overall Study|Withdrawal by Subject|0|||
155388724|NCT02982187|560858703|FG005|Overall Study|Withdrawal by Subject|0|||
155388725|NCT02982187|560858704|FG006|Overall Study|Withdrawal by Subject|1|||
155388726|NCT02982187|560858705|FG007|Overall Study|Withdrawal by Subject|0|||
155388727|NCT01128894|560858706|FG000|Overall Study|Adverse Event|31|||
155388728|NCT01128894|560858707|FG001|Overall Study|Adverse Event|41|||
155388729|NCT01128894|560858706|FG000|Overall Study|Protocol Violation|2|||
155388730|NCT01128894|560858707|FG001|Overall Study|Protocol Violation|1|||
155388731|NCT01128894|560858706|FG000|Overall Study|Noncompliance|4|||
155388732|NCT01128894|560858707|FG001|Overall Study|Noncompliance|5|||
155388733|NCT01128894|560858706|FG000|Overall Study|Lost to Follow-up|8|||
155388734|NCT01128894|560858707|FG001|Overall Study|Lost to Follow-up|8|||
155388735|NCT01128894|560858706|FG000|Overall Study|Withdrawal by Subject|10|||
155388736|NCT01128894|560858707|FG001|Overall Study|Withdrawal by Subject|12|||
155388737|NCT01128894|560858706|FG000|Overall Study|Physician Decision|2|||
155388738|NCT01128894|560858707|FG001|Overall Study|Physician Decision|1|||
155388739|NCT01128894|560858706|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
155388740|NCT01128894|560858707|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
155388741|NCT03437278|560858708|FG000|Overall Study|Adverse Event|0|||
155388742|NCT03437278|560858709|FG001|Overall Study|Adverse Event|0|||
155388743|NCT03437278|560858710|FG002|Overall Study|Adverse Event|1|||
155388744|NCT03437278|560858708|FG000|Overall Study|Progressive disease|1|||
155388745|NCT03437278|560858709|FG001|Overall Study|Progressive disease|0|||
155388746|NCT03437278|560858710|FG002|Overall Study|Progressive disease|0|||
155388747|NCT03437278|560858708|FG000|Overall Study|Physician Decision|1|||
155388748|NCT03437278|560858709|FG001|Overall Study|Physician Decision|0|||
155388749|NCT03437278|560858710|FG002|Overall Study|Physician Decision|1|||
155388750|NCT02202551|560858711|FG000|Overall Study|Adverse Event|8|||
155388751|NCT02202551|560858712|FG001|Overall Study|Adverse Event|19|||
155388752|NCT02202551|560858713|FG002|Overall Study|Adverse Event|5|||
155388753|NCT02202551|560858714|FG003|Overall Study|Adverse Event|9|||
155388754|NCT02202551|560858711|FG000|Overall Study|Death|3|||
155388755|NCT02202551|560858712|FG001|Overall Study|Death|2|||
155388756|NCT02202551|560858713|FG002|Overall Study|Death|1|||
155388757|NCT02202551|560858714|FG003|Overall Study|Death|1|||
155388758|NCT02202551|560858711|FG000|Overall Study|Lost to Follow-up|0|||
155388759|NCT02202551|560858712|FG001|Overall Study|Lost to Follow-up|1|||
155388760|NCT02202551|560858713|FG002|Overall Study|Lost to Follow-up|0|||
155388761|NCT02202551|560858714|FG003|Overall Study|Lost to Follow-up|1|||
155388762|NCT02202551|560858711|FG000|Overall Study|Needed to take excluded medication|0|||
155388763|NCT02202551|560858712|FG001|Overall Study|Needed to take excluded medication|2|||
155388764|NCT02202551|560858713|FG002|Overall Study|Needed to take excluded medication|0|||
155388765|NCT02202551|560858714|FG003|Overall Study|Needed to take excluded medication|1|||
155388766|NCT02202551|560858711|FG000|Overall Study|Subject moved away|0|||
155388767|NCT02202551|560858712|FG001|Overall Study|Subject moved away|1|||
155629845|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
155629846|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
155629847|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
155629848|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
155629849|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
155629850|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
155629851|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
155629852|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
155629853|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
155629854|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
155629855|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
155629856|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
155629857|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
155732477|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
155388768|NCT02202551|560858713|FG002|Overall Study|Subject moved away|0|||
155388769|NCT02202551|560858714|FG003|Overall Study|Subject moved away|0|||
155388770|NCT02202551|560858711|FG000|Overall Study|DBS surgery|3|||
155732478|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
155388771|NCT02202551|560858712|FG001|Overall Study|DBS surgery|0|||
155388772|NCT02202551|560858713|FG002|Overall Study|DBS surgery|0|||
155388773|NCT02202551|560858714|FG003|Overall Study|DBS surgery|0|||
155388774|NCT02202551|560858711|FG000|Overall Study|Dyskinesia upon taper|1|||
155388775|NCT02202551|560858712|FG001|Overall Study|Dyskinesia upon taper|0|||
155388776|NCT02202551|560858713|FG002|Overall Study|Dyskinesia upon taper|0|||
155629858|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155629859|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155629860|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
155629861|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155629862|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
155629863|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
155629864|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
155629865|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
155629866|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
155629867|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
155629868|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
155629869|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
155629870|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
155629871|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
155629872|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
155629873|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
155629874|NCT01668797|561741324|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
155629875|NCT01668797|561741325|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
155629876|NCT01668797|561741326|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
155629877|NCT01668797|561741327|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
155629878|NCT00827567|561741328|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
155629879|NCT01259245|561741331|FG000|Overall Study|Withdrawal by Subject|27|||
155629880|NCT01259245|561741332|FG001|Overall Study|Withdrawal by Subject|24|||
155629881|NCT01259245|561741331|FG000|Overall Study|Death|1|||
155629882|NCT01259245|561741332|FG001|Overall Study|Death|2|||
155629883|NCT01206764|561741339|FG000|Overall Study|Adverse Event|20|||
155629884|NCT01206764|561741339|FG000|Overall Study|Abnormal laboratory value|2|||
155629885|NCT01206764|561741339|FG000|Overall Study|Abnormal test procedure result|1|||
155629886|NCT01206764|561741339|FG000|Overall Study|Patient withdrew consent|5|||
155629887|NCT01206764|561741339|FG000|Overall Study|Lost to Follow-up|6|||
155629888|NCT01206764|561741339|FG000|Overall Study|Death|11|||
155629889|NCT01206764|561741339|FG000|Overall Study|New cancer therapy|2|||
155629890|NCT01206764|561741339|FG000|Overall Study|Disease progression|88|||
155629891|NCT01206764|561741339|FG000|Overall Study|Protocol deviation|3|||
155629892|NCT04494646|561741340|FG000|Overall Study|Adverse Event|0|||
155629893|NCT04494646|561741341|FG001|Overall Study|Adverse Event|1|||
155629894|NCT04494646|561741340|FG000|Overall Study|Withdrawal by Subject|0|||
155629895|NCT04494646|561741341|FG001|Overall Study|Withdrawal by Subject|1|||
155629896|NCT05569174|561741344|FG000|Overall Study|Adverse Event|0|||
155629897|NCT05569174|561741345|FG001|Overall Study|Adverse Event|1|||
155629898|NCT05569174|561741344|FG000|Overall Study|Lack of compliance|0|||
155629899|NCT05569174|561741345|FG001|Overall Study|Lack of compliance|1|||
155629900|NCT05569174|561741344|FG000|Overall Study|Withdrawal of consent|0|||
155629901|NCT05569174|561741345|FG001|Overall Study|Withdrawal of consent|1|||
155629902|NCT05569174|561741344|FG000|Overall Study|Participant wish|0|||
155629903|NCT05569174|561741345|FG001|Overall Study|Participant wish|1|||
155629904|NCT05569174|561741344|FG000|Overall Study|Lost to Follow-up|0|||
155629905|NCT05569174|561741345|FG001|Overall Study|Lost to Follow-up|1|||
155629906|NCT00112957|561741346|FG000|Overall Study|Progressive disease|18|||
155629907|NCT00112957|561741346|FG000|Overall Study|Physician Decision|1|||
155629908|NCT00961415|561741347|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
155629909|NCT00961415|561741348|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
155629910|NCT00961415|561741349|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
155629911|NCT00961415|561741347|FG000|Induction Treatment Phase|Death|77|||
155629912|NCT00961415|561741348|FG001|Induction Treatment Phase|Death|0|||
155629913|NCT00961415|561741349|FG002|Induction Treatment Phase|Death|0|||
155629914|NCT00961415|561741347|FG000|Induction Treatment Phase|Protocol Violation|1|||
155629915|NCT00961415|561741348|FG001|Induction Treatment Phase|Protocol Violation|0|||
155629916|NCT00961415|561741349|FG002|Induction Treatment Phase|Protocol Violation|0|||
155629917|NCT00961415|561741347|FG000|Induction Treatment Phase|Physician Decision|2|||
155629918|NCT00961415|561741348|FG001|Induction Treatment Phase|Physician Decision|0|||
155629919|NCT00961415|561741349|FG002|Induction Treatment Phase|Physician Decision|0|||
155629920|NCT00961415|561741347|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
155629921|NCT00961415|561741348|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
155629922|NCT00961415|561741349|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
155732479|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
155629923|NCT00961415|561741347|FG000|Induction Treatment Phase|Other Reason|5|||
155629924|NCT00961415|561741348|FG001|Induction Treatment Phase|Other Reason|0|||
155629925|NCT00961415|561741349|FG002|Induction Treatment Phase|Other Reason|0|||
155629926|NCT00961415|561741347|FG000|Maintenance Treatment Phase|Death|0|||
155732480|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
155732481|NCT02952820|562118348|FG000|Active Treatment Period (6 Months)|Not treated|0|||
155732482|NCT02952820|562118349|FG001|Active Treatment Period (6 Months)|Not treated|0|||
155732483|NCT02952820|562118350|FG002|Active Treatment Period (6 Months)|Not treated|1|||
155732484|NCT03614156|562118351|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
155732485|NCT03614156|562118352|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155732486|NCT03614156|562118353|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155732487|NCT03614156|562118354|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155732488|NCT03614156|562118351|FG000|Open-Label Treatment Period|Adverse Event|7|||
155732489|NCT03614156|562118352|FG001|Open-Label Treatment Period|Adverse Event|0|||
155732490|NCT03614156|562118353|FG002|Open-Label Treatment Period|Adverse Event|0|||
155732491|NCT03614156|562118354|FG003|Open-Label Treatment Period|Adverse Event|0|||
155732492|NCT03614156|562118351|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
155732493|NCT03614156|562118352|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155732494|NCT03614156|562118353|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155732495|NCT03614156|562118354|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
155732496|NCT03614156|562118351|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
155732497|NCT03614156|562118352|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
155732498|NCT03614156|562118353|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
155732499|NCT03614156|562118354|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
155732500|NCT03614156|562118351|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
155732501|NCT03614156|562118352|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
155732502|NCT03614156|562118353|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
155732503|NCT03614156|562118354|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
155732504|NCT03614156|562118351|FG000|Open-Label Treatment Period|Protocol Violation|2|||
155732505|NCT03614156|562118352|FG001|Open-Label Treatment Period|Protocol Violation|0|||
155388777|NCT02202551|560858714|FG003|Overall Study|Dyskinesia upon taper|0|||
155388778|NCT02202551|560858711|FG000|Overall Study|Lack of Efficacy|0|||
155388779|NCT02202551|560858712|FG001|Overall Study|Lack of Efficacy|1|||
155388780|NCT02202551|560858713|FG002|Overall Study|Lack of Efficacy|0|||
155629927|NCT00961415|561741348|FG001|Maintenance Treatment Phase|Death|42|||
155629928|NCT00961415|561741349|FG002|Maintenance Treatment Phase|Death|34|||
155629929|NCT00961415|561741347|FG000|Maintenance Treatment Phase|Investigators decision|0|||
155629930|NCT00961415|561741348|FG001|Maintenance Treatment Phase|Investigators decision|2|||
155629931|NCT00961415|561741349|FG002|Maintenance Treatment Phase|Investigators decision|0|||
155629932|NCT00961415|561741347|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155629933|NCT00961415|561741348|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
155629934|NCT00961415|561741349|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
155629935|NCT00961415|561741347|FG000|Maintenance Treatment Phase|Other reason|0|||
155629936|NCT00961415|561741348|FG001|Maintenance Treatment Phase|Other reason|1|||
155629937|NCT00961415|561741349|FG002|Maintenance Treatment Phase|Other reason|3|||
155629938|NCT02309359|561741350|FG000|Overall Study|Adverse Event|4|||
155629939|NCT02309359|561741351|FG001|Overall Study|Adverse Event|5|||
155629940|NCT02309359|561741352|FG002|Overall Study|Adverse Event|5|||
155629941|NCT02309359|561741353|FG003|Overall Study|Adverse Event|4|||
155629942|NCT02309359|561741354|FG004|Overall Study|Adverse Event|4|||
155629943|NCT02309359|561741350|FG000|Overall Study|Death|1|||
155629944|NCT02309359|561741351|FG001|Overall Study|Death|0|||
155629945|NCT02309359|561741352|FG002|Overall Study|Death|0|||
155629946|NCT02309359|561741353|FG003|Overall Study|Death|0|||
155629947|NCT02309359|561741354|FG004|Overall Study|Death|0|||
155629948|NCT02309359|561741350|FG000|Overall Study|Withdrawal by Subject|2|||
155629949|NCT02309359|561741351|FG001|Overall Study|Withdrawal by Subject|2|||
155629950|NCT02309359|561741352|FG002|Overall Study|Withdrawal by Subject|4|||
155629951|NCT02309359|561741353|FG003|Overall Study|Withdrawal by Subject|4|||
155629952|NCT02309359|561741354|FG004|Overall Study|Withdrawal by Subject|0|||
155629953|NCT02309359|561741350|FG000|Overall Study|Lack of Efficacy|3|||
155629954|NCT02309359|561741351|FG001|Overall Study|Lack of Efficacy|1|||
155629955|NCT02309359|561741352|FG002|Overall Study|Lack of Efficacy|0|||
155629956|NCT02309359|561741353|FG003|Overall Study|Lack of Efficacy|0|||
155629957|NCT02309359|561741354|FG004|Overall Study|Lack of Efficacy|3|||
155629958|NCT02309359|561741350|FG000|Overall Study|Lost to Follow-up|0|||
155629959|NCT02309359|561741351|FG001|Overall Study|Lost to Follow-up|0|||
155629960|NCT02309359|561741352|FG002|Overall Study|Lost to Follow-up|0|||
155629961|NCT02309359|561741353|FG003|Overall Study|Lost to Follow-up|1|||
155629962|NCT02309359|561741354|FG004|Overall Study|Lost to Follow-up|0|||
155629963|NCT02309359|561741350|FG000|Overall Study|Other|2|||
155629964|NCT02309359|561741351|FG001|Overall Study|Other|0|||
155629965|NCT02309359|561741352|FG002|Overall Study|Other|2|||
155629966|NCT02309359|561741353|FG003|Overall Study|Other|3|||
155732506|NCT03614156|562118353|FG002|Open-Label Treatment Period|Protocol Violation|0|||
155732507|NCT03614156|562118354|FG003|Open-Label Treatment Period|Protocol Violation|0|||
155629967|NCT02309359|561741354|FG004|Overall Study|Other|2|||
155629968|NCT03895086|561741359|FG000|Overall Study|Early termination study|1|||
155629969|NCT03895086|561741360|FG001|Overall Study|Early termination study|0|||
155629970|NCT04656652|561741361|FG000|Overall Study|Lost to Follow-up|2|||
155629971|NCT04656652|561741362|FG001|Overall Study|Lost to Follow-up|2|||
155629972|NCT04656652|561741361|FG000|Overall Study|Death|213|||
155629973|NCT04656652|561741362|FG001|Overall Study|Death|212|||
155629974|NCT04656652|561741361|FG000|Overall Study|Other|1|||
155629975|NCT04656652|561741362|FG001|Overall Study|Other|0|||
155629976|NCT04656652|561741361|FG000|Overall Study|Withdrawal by Subject|15|||
155629977|NCT04656652|561741362|FG001|Overall Study|Withdrawal by Subject|29|||
155629978|NCT03307174|561741363|FG000|Overall Study|Unplanned ICU Administrion|5|||
155629979|NCT03307174|561741364|FG001|Overall Study|Unplanned ICU Administrion|3|||
155629980|NCT03307174|561741363|FG000|Overall Study|Aborted Surgery|1|||
155629981|NCT03307174|561741364|FG001|Overall Study|Aborted Surgery|2|||
155629982|NCT03307174|561741363|FG000|Overall Study|Hypotension|6|||
155629983|NCT03307174|561741364|FG001|Overall Study|Hypotension|0|||
155629984|NCT03307174|561741363|FG000|Overall Study|Nonfunctional epidural|1|||
155629985|NCT03307174|561741364|FG001|Overall Study|Nonfunctional epidural|1|||
155629986|NCT03307174|561741363|FG000|Overall Study|Planned epidural removal|1|||
155629987|NCT03307174|561741364|FG001|Overall Study|Planned epidural removal|0|||
155629988|NCT03307174|561741363|FG000|Overall Study|Intrathecal catheter placement|0|||
155629989|NCT03307174|561741364|FG001|Overall Study|Intrathecal catheter placement|1|||
155629990|NCT00863707|561741365|FG000|Overall Study|Randomized, but drug not received|4|||
155629991|NCT00863707|561741366|FG001|Overall Study|Randomized, but drug not received|3|||
155629992|NCT03704064|561741367|FG000|Overall Study|Lost to Follow-up|8|||
155629993|NCT03704064|561741368|FG001|Overall Study|Lost to Follow-up|4|||
155629994|NCT03704064|561741367|FG000|Overall Study|Withdrawal by Subject|1|||
155629995|NCT03704064|561741368|FG001|Overall Study|Withdrawal by Subject|1|||
155629996|NCT03704064|561741367|FG000|Overall Study|No longer available for study visits|0|||
155629997|NCT03704064|561741368|FG001|Overall Study|No longer available for study visits|1|||
155629998|NCT03704064|561741367|FG000|Overall Study|Censoring event|1|||
155629999|NCT03704064|561741368|FG001|Overall Study|Censoring event|0|||
155630000|NCT01286129|561741369|FG000|Overall Study|Withdrawal by Subject|4|||
155630001|NCT01286129|561741370|FG001|Overall Study|Withdrawal by Subject|1|||
155630002|NCT01286129|561741369|FG000|Overall Study|Could not comply with study requirements|4|||
155630003|NCT01286129|561741370|FG001|Overall Study|Could not comply with study requirements|4|||
155630004|NCT03040726|561741377|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
155630005|NCT03040726|561741378|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
155630006|NCT03040726|561741377|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
155630007|NCT03040726|561741378|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
155630008|NCT03040726|561741377|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
155630009|NCT03040726|561741378|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
155630010|NCT03040726|561741377|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
155630011|NCT03040726|561741378|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
155630012|NCT03040726|561741377|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
155630013|NCT03040726|561741378|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
155630014|NCT03025035|561741379|FG000|Overall Study|Death|2|||
155630015|NCT03025035|561741379|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
155630016|NCT01218802|561741380|FG000|Overall Study|Lost to Follow-up|5|||
155630017|NCT01218802|561741381|FG001|Overall Study|Lost to Follow-up|6|||
155630018|NCT01218802|561741380|FG000|Overall Study|Withdrawal by Subject|3|||
155630019|NCT01218802|561741381|FG001|Overall Study|Withdrawal by Subject|10|||
155630020|NCT01218802|561741380|FG000|Overall Study|Adverse Event|0|||
155630021|NCT01218802|561741381|FG001|Overall Study|Adverse Event|2|||
155630022|NCT01218802|561741380|FG000|Overall Study|Incarcerated|2|||
155281586|NCT03704298|560461653|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155281587|NCT00558753|560461654|FG000|Overall Study|Lost to Follow-up|5|||
155281588|NCT00558753|560461655|FG001|Overall Study|Lost to Follow-up|7|||
155281589|NCT01670500|560461661|FG000|Overall Study|Withdrawal by Subject|1|||
155281590|NCT01670500|560461662|FG001|Overall Study|Withdrawal by Subject|0|||
155281591|NCT03658811|560461664|FG000|Overall Study|Lost to Follow-up|3|||
155281592|NCT04951479|560461667|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
155281593|NCT04209790|560461668|FG000|Overall Study|Physician Decision|1|||
155281594|NCT04060680|560461670|FG000|Overall Study|Unsuccessful implant|17|||
155281595|NCT04060680|560461671|FG001|Overall Study|Unsuccessful implant|2|||
155281596|NCT04060680|560461670|FG000|Overall Study|Adverse Event|3|||
155281597|NCT04060680|560461671|FG001|Overall Study|Adverse Event|0|||
155281598|NCT04060680|560461670|FG000|Overall Study|Death|2|||
155281599|NCT04060680|560461671|FG001|Overall Study|Death|0|||
155281600|NCT04060680|560461670|FG000|Overall Study|Study product no longer in use|1|||
155281601|NCT04060680|560461671|FG001|Overall Study|Study product no longer in use|0|||
155281602|NCT04060680|560461670|FG000|Overall Study|Withdrawal by Subject|1|||
155630023|NCT01218802|561741381|FG001|Overall Study|Incarcerated|0|||
155630024|NCT03104374|561741384|FG000|Period 1|Adverse Event|7|||
155630025|NCT03104374|561741385|FG001|Period 1|Adverse Event|7|||
155732508|NCT03614156|562118351|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
155732509|NCT03614156|562118352|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
155732510|NCT03614156|562118353|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
155732511|NCT03614156|562118354|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
155388781|NCT02202551|560858714|FG003|Overall Study|Lack of Efficacy|0|||
155388782|NCT02202551|560858711|FG000|Overall Study|Physician Decision|1|||
155388783|NCT02202551|560858712|FG001|Overall Study|Physician Decision|0|||
155388784|NCT02202551|560858713|FG002|Overall Study|Physician Decision|0|||
155388785|NCT02202551|560858714|FG003|Overall Study|Physician Decision|0|||
155732512|NCT03614156|562118351|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
155732513|NCT03614156|562118352|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
155732514|NCT03614156|562118353|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
155732515|NCT03614156|562118354|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
155732516|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
155732517|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
155732518|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
155732519|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
155732520|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155732521|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
155732522|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155732523|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155732524|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155732525|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155732526|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
155732527|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
155732528|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
155732529|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155732530|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155732531|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155732532|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
155732533|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
155732534|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
155732535|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
155732536|NCT03614156|562118351|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155732537|NCT03614156|562118352|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
155732538|NCT03614156|562118353|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155732539|NCT03614156|562118354|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155732540|NCT03614156|562118351|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
155732541|NCT03614156|562118352|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155732542|NCT03614156|562118353|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155732543|NCT03614156|562118354|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155732544|NCT03614156|562118351|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
155732545|NCT03614156|562118352|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
155732546|NCT03614156|562118353|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
155732547|NCT03614156|562118354|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
155732548|NCT03614156|562118351|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
155732549|NCT03614156|562118352|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
155732550|NCT03614156|562118353|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
155732551|NCT03614156|562118354|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
155732552|NCT03857867|562118355|FG000|Overall Study|Physician Decision|1|||
155732553|NCT03070964|562118356|FG000|Overall Study|Progressive disease|8|||
155732554|NCT03070964|562118356|FG000|Overall Study|Treatment-unrelated adverse event|2|||
155732555|NCT03070964|562118356|FG000|Overall Study|Never treated|1|||
155732556|NCT03070964|562118356|FG000|Overall Study|Physician Decision|1|||
155732557|NCT03070964|562118356|FG000|Overall Study|Withdrawal by Subject|1|||
155732558|NCT03070964|562118356|FG000|Overall Study|Adverse Event|1|||
155732559|NCT01094119|562118357|FG000|Overall Study|Lack of Efficacy|2|||
155732560|NCT01094119|562118358|FG001|Overall Study|Lack of Efficacy|4|||
155732561|NCT01626872|562118359|FG000|Overall Study|Physician Decision|13|||
155732562|NCT01626872|562118360|FG001|Overall Study|Physician Decision|9|||
155732563|NCT01626872|562118361|FG002|Overall Study|Physician Decision|6|||
155732564|NCT01626872|562118359|FG000|Overall Study|Withdrawal by Subject|19|||
155732565|NCT01626872|562118360|FG001|Overall Study|Withdrawal by Subject|27|||
155732566|NCT01626872|562118361|FG002|Overall Study|Withdrawal by Subject|8|||
155732567|NCT01626872|562118359|FG000|Overall Study|Adverse Event (including Death)|20|||
155732568|NCT01626872|562118360|FG001|Overall Study|Adverse Event (including Death)|28|||
155388786|NCT02202551|560858711|FG000|Overall Study|Site closure|3|||
155388787|NCT02202551|560858712|FG001|Overall Study|Site closure|0|||
155388788|NCT02202551|560858713|FG002|Overall Study|Site closure|0|||
155388789|NCT02202551|560858714|FG003|Overall Study|Site closure|1|||
155388790|NCT02202551|560858711|FG000|Overall Study|Unable to complete visits per protocol|1|||
155388791|NCT02202551|560858712|FG001|Overall Study|Unable to complete visits per protocol|0|||
155388792|NCT02202551|560858713|FG002|Overall Study|Unable to complete visits per protocol|0|||
155388793|NCT02202551|560858714|FG003|Overall Study|Unable to complete visits per protocol|0|||
155388794|NCT02202551|560858711|FG000|Overall Study|Worsening Dyskinesia|0|||
155630026|NCT03104374|561741386|FG002|Period 1|Adverse Event|12|||
155630027|NCT03104374|561741387|FG003|Period 1|Adverse Event|14|||
155630028|NCT03104374|561741384|FG000|Period 1|Withdrawal by Subject|18|||
155630029|NCT03104374|561741385|FG001|Period 1|Withdrawal by Subject|9|||
155630030|NCT03104374|561741386|FG002|Period 1|Withdrawal by Subject|10|||
155630031|NCT03104374|561741387|FG003|Period 1|Withdrawal by Subject|17|||
155630032|NCT03104374|561741384|FG000|Period 1|Lost to Follow-up|4|||
155630033|NCT03104374|561741385|FG001|Period 1|Lost to Follow-up|4|||
155630034|NCT03104374|561741386|FG002|Period 1|Lost to Follow-up|6|||
155630035|NCT03104374|561741387|FG003|Period 1|Lost to Follow-up|8|||
155630036|NCT03104374|561741384|FG000|Period 1|Lack of Efficacy|6|||
155630037|NCT03104374|561741385|FG001|Period 1|Lack of Efficacy|7|||
155630038|NCT03104374|561741386|FG002|Period 1|Lack of Efficacy|12|||
155630039|NCT03104374|561741387|FG003|Period 1|Lack of Efficacy|6|||
155630040|NCT03104374|561741384|FG000|Period 1|Other|2|||
155630041|NCT03104374|561741385|FG001|Period 1|Other|2|||
155630042|NCT03104374|561741386|FG002|Period 1|Other|4|||
155630043|NCT03104374|561741387|FG003|Period 1|Other|7|||
155630044|NCT03104374|561741384|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155630045|NCT03104374|561741385|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155630046|NCT03104374|561741386|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155630047|NCT03104374|561741387|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
155630048|NCT03104374|561741384|FG000|Period 2|Adverse Event|4|||
155630049|NCT03104374|561741385|FG001|Period 2|Adverse Event|7|||
155630050|NCT03104374|561741386|FG002|Period 2|Adverse Event|10|||
155630051|NCT03104374|561741387|FG003|Period 2|Adverse Event|10|||
155630052|NCT03104374|561741384|FG000|Period 2|Withdrawal by Subject|3|||
155630053|NCT03104374|561741385|FG001|Period 2|Withdrawal by Subject|7|||
155630054|NCT03104374|561741386|FG002|Period 2|Withdrawal by Subject|13|||
155630055|NCT03104374|561741387|FG003|Period 2|Withdrawal by Subject|16|||
155630056|NCT03104374|561741384|FG000|Period 2|Lost to Follow-up|2|||
155630057|NCT03104374|561741385|FG001|Period 2|Lost to Follow-up|2|||
155630058|NCT03104374|561741386|FG002|Period 2|Lost to Follow-up|3|||
155630059|NCT03104374|561741387|FG003|Period 2|Lost to Follow-up|5|||
155630060|NCT03104374|561741384|FG000|Period 2|Lack of Efficacy|2|||
155630061|NCT03104374|561741385|FG001|Period 2|Lack of Efficacy|4|||
155630062|NCT03104374|561741386|FG002|Period 2|Lack of Efficacy|7|||
155630063|NCT03104374|561741387|FG003|Period 2|Lack of Efficacy|4|||
155630064|NCT03104374|561741384|FG000|Period 2|COVID-19 Infection|0|||
155630065|NCT03104374|561741385|FG001|Period 2|COVID-19 Infection|0|||
155630066|NCT03104374|561741386|FG002|Period 2|COVID-19 Infection|1|||
155630067|NCT03104374|561741387|FG003|Period 2|COVID-19 Infection|0|||
155630068|NCT03104374|561741384|FG000|Period 2|Other|3|||
155630069|NCT03104374|561741385|FG001|Period 2|Other|2|||
155630070|NCT03104374|561741386|FG002|Period 2|Other|2|||
155630071|NCT03104374|561741387|FG003|Period 2|Other|4|||
155630072|NCT01884597|561741392|FG000|Overall Study|Adverse Event|0|||
155630073|NCT01884597|561741393|FG001|Overall Study|Adverse Event|0|||
155630074|NCT01884597|561741394|FG002|Overall Study|Adverse Event|1|||
155630075|NCT01884597|561741392|FG000|Overall Study|Lack of Efficacy|1|||
155630076|NCT01884597|561741393|FG001|Overall Study|Lack of Efficacy|0|||
155630077|NCT01884597|561741394|FG002|Overall Study|Lack of Efficacy|0|||
155630078|NCT01884597|561741392|FG000|Overall Study|Death|0|||
155630079|NCT01884597|561741393|FG001|Overall Study|Death|1|||
155630080|NCT01884597|561741394|FG002|Overall Study|Death|0|||
155630081|NCT02074514|561741395|FG000|Overall Study|Lack of Efficacy|3|||
155630082|NCT02074514|561741396|FG001|Overall Study|Lack of Efficacy|2|||
155630083|NCT02074514|561741395|FG000|Overall Study|Lost to Follow-up|0|||
155388795|NCT02202551|560858712|FG001|Overall Study|Worsening Dyskinesia|0|||
155630084|NCT02074514|561741396|FG001|Overall Study|Lost to Follow-up|1|||
155630085|NCT02074514|561741395|FG000|Overall Study|Withdrew Consent|0|||
155630086|NCT02074514|561741396|FG001|Overall Study|Withdrew Consent|1|||
155388796|NCT02202551|560858713|FG002|Overall Study|Worsening Dyskinesia|0|||
155388797|NCT02202551|560858714|FG003|Overall Study|Worsening Dyskinesia|1|||
155630087|NCT00666237|561741397|FG000|Overall Study|Death|5|||
155630088|NCT00666237|561741398|FG001|Overall Study|Death|5|||
155630089|NCT00666237|561741397|FG000|Overall Study|Lost to Follow-up|29|||
155630090|NCT00666237|561741398|FG001|Overall Study|Lost to Follow-up|25|||
155630091|NCT03759379|561743019|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
155630092|NCT03759379|561743020|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
155630093|NCT03759379|561743019|FG000|Treatment Period|Death|2|||
155630094|NCT03759379|561743020|FG001|Treatment Period|Death|3|||
155630095|NCT03759379|561743019|FG000|Treatment Period|Lost to Follow-up|1|||
155732569|NCT01626872|562118361|FG002|Overall Study|Adverse Event (including Death)|8|||
155732570|NCT01626872|562118359|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
155732571|NCT01626872|562118360|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
155732572|NCT01626872|562118361|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
155732573|NCT01587924|562118362|FG000|Overall Study|Adverse Event|0|||
155732574|NCT01587924|562118363|FG001|Overall Study|Adverse Event|2|||
155732575|NCT01587924|562118364|FG002|Overall Study|Adverse Event|0|||
155732576|NCT01587924|562118365|FG003|Overall Study|Adverse Event|0|||
155732577|NCT01587924|562118362|FG000|Overall Study|Protocol Violation|2|||
155732578|NCT01587924|562118363|FG001|Overall Study|Protocol Violation|1|||
155732579|NCT01587924|562118364|FG002|Overall Study|Protocol Violation|2|||
155732580|NCT01587924|562118365|FG003|Overall Study|Protocol Violation|1|||
155732581|NCT01587924|562118362|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
155732582|NCT01587924|562118363|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
155732583|NCT01587924|562118364|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
155732584|NCT01587924|562118365|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
155732585|NCT01587924|562118362|FG000|Overall Study|Withdrawal by Subject|0|||
155732586|NCT01587924|562118363|FG001|Overall Study|Withdrawal by Subject|1|||
155732587|NCT01587924|562118364|FG002|Overall Study|Withdrawal by Subject|1|||
155732588|NCT01587924|562118365|FG003|Overall Study|Withdrawal by Subject|0|||
155732589|NCT01578486|562118366|FG000|Overall Study|Physician Decision|3|||
155732590|NCT01578486|562118366|FG000|Overall Study|Withdrawal by Subject|2|||
155732591|NCT02425943|562118367|FG000|Overall Study|Adverse Event|3|||
155732592|NCT02425943|562118368|FG001|Overall Study|Adverse Event|1|||
155732593|NCT02425943|562118367|FG000|Overall Study|Lost to Follow-up|59|||
155732594|NCT02425943|562118368|FG001|Overall Study|Lost to Follow-up|37|||
155732595|NCT02425943|562118367|FG000|Overall Study|Protocol Violation|4|||
155732596|NCT02425943|562118368|FG001|Overall Study|Protocol Violation|1|||
155732597|NCT02425943|562118367|FG000|Overall Study|Withdrawal by Subject|64|||
155732598|NCT02425943|562118368|FG001|Overall Study|Withdrawal by Subject|31|||
155732599|NCT02425943|562118367|FG000|Overall Study|Other|6|||
155732600|NCT02425943|562118368|FG001|Overall Study|Other|0|||
155732601|NCT01106248|562118370|FG000|Overall Study|Adverse Event|1|||
155732602|NCT01106248|562118370|FG000|Overall Study|Administrative|2|||
155732603|NCT00357903|562118371|FG000|Overall Study|Adverse Event|87|||
155732604|NCT00357903|562118372|FG001|Overall Study|Adverse Event|4|||
155732605|NCT00357903|562118371|FG000|Overall Study|Death|33|||
155732606|NCT00357903|562118372|FG001|Overall Study|Death|0|||
155732607|NCT00357903|562118371|FG000|Overall Study|Lost to Follow-up|23|||
155732608|NCT00357903|562118372|FG001|Overall Study|Lost to Follow-up|4|||
155732609|NCT00357903|562118371|FG000|Overall Study|Physician Decision|39|||
155732610|NCT00357903|562118372|FG001|Overall Study|Physician Decision|5|||
155732611|NCT00357903|562118371|FG000|Overall Study|Withdrawal by Subject|57|||
155732612|NCT00357903|562118372|FG001|Overall Study|Withdrawal by Subject|7|||
155732613|NCT00357903|562118371|FG000|Overall Study|Completed month 12 only|0|||
155732614|NCT00357903|562118372|FG001|Overall Study|Completed month 12 only|1|||
155732615|NCT00357903|562118371|FG000|Overall Study|Protocol issues|14|||
155732616|NCT00357903|562118372|FG001|Overall Study|Protocol issues|3|||
155732617|NCT00357903|562118371|FG000|Overall Study|Response status|61|||
155732618|NCT00357903|562118372|FG001|Overall Study|Response status|9|||
155732619|NCT00357903|562118371|FG000|Overall Study|Other|49|||
155732620|NCT00357903|562118372|FG001|Overall Study|Other|10|||
155732621|NCT03181529|562118373|FG000|Overall Study|Withdrawal by Subject|1|||
155732622|NCT03181529|562118374|FG001|Overall Study|Withdrawal by Subject|1|||
155732623|NCT03181529|562118373|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
155732624|NCT03181529|562118374|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
155732625|NCT01209325|562118377|FG000|Overall Study|Lost to Follow-up|24|||
155732626|NCT01209325|562118377|FG000|Overall Study|Adverse Event|1|||
155732627|NCT01209325|562118377|FG000|Overall Study|Relocated|3|||
155732628|NCT01209325|562118377|FG000|Overall Study|Refusal after starting therapy|8|||
155732629|NCT01209325|562118377|FG000|Overall Study|Protocol Violation|4|||
155732630|NCT01209325|562118377|FG000|Overall Study|Refusal prior to therapy|1|||
155732631|NCT01209325|562118377|FG000|Overall Study|Incarceration|2|||
155732632|NCT00607373|562118378|FG000|Treatment Period|Adverse Event|0|||
155732633|NCT00607373|562118379|FG001|Treatment Period|Adverse Event|4|||
155732634|NCT00607373|562118378|FG000|Treatment Period|Physician Decision|0|||
155732635|NCT00607373|562118379|FG001|Treatment Period|Physician Decision|1|||
155732636|NCT00607373|562118378|FG000|Treatment Period|Withdrawal by Subject|0|||
155732637|NCT00607373|562118379|FG001|Treatment Period|Withdrawal by Subject|1|||
155732638|NCT00607373|562118378|FG000|Follow-up Period|Other|0|||
155732639|NCT00607373|562118379|FG001|Follow-up Period|Other|1|||
155732640|NCT00607373|562118378|FG000|Follow-up Period|Protocol Violation|0|||
155732641|NCT00607373|562118379|FG001|Follow-up Period|Protocol Violation|1|||
155732642|NCT00607373|562118378|FG000|Follow-up Period|Withdrawal by Subject|1|||
155732643|NCT00607373|562118379|FG001|Follow-up Period|Withdrawal by Subject|3|||
155732644|NCT01918306|562118380|FG000|Overall Study|progresive disease|4|||
155732645|NCT01918306|562118381|FG001|Overall Study|progresive disease|0|||
155388798|NCT02202551|560858711|FG000|Overall Study|Protocol Violation|0|||
155388799|NCT02202551|560858712|FG001|Overall Study|Protocol Violation|1|||
155388800|NCT02202551|560858713|FG002|Overall Study|Protocol Violation|0|||
155388801|NCT02202551|560858714|FG003|Overall Study|Protocol Violation|0|||
155732646|NCT01918306|562118382|FG002|Overall Study|progresive disease|1|||
155732647|NCT01918306|562118383|FG003|Overall Study|progresive disease|1|||
155732648|NCT01918306|562118380|FG000|Overall Study|Withdrawal by Subject|0|||
155732649|NCT01918306|562118381|FG001|Overall Study|Withdrawal by Subject|0|||
155732650|NCT01918306|562118382|FG002|Overall Study|Withdrawal by Subject|0|||
155732651|NCT01918306|562118383|FG003|Overall Study|Withdrawal by Subject|2|||
155732652|NCT01918306|562118380|FG000|Overall Study|neutropenia|1|||
155732653|NCT01918306|562118381|FG001|Overall Study|neutropenia|0|||
155732654|NCT01918306|562118382|FG002|Overall Study|neutropenia|0|||
155732655|NCT01918306|562118383|FG003|Overall Study|neutropenia|0|||
155732656|NCT01918306|562118380|FG000|Overall Study|Lack of Efficacy|1|||
155732657|NCT01918306|562118381|FG001|Overall Study|Lack of Efficacy|0|||
155732658|NCT01918306|562118382|FG002|Overall Study|Lack of Efficacy|0|||
155732659|NCT01918306|562118383|FG003|Overall Study|Lack of Efficacy|0|||
155732660|NCT01918306|562118380|FG000|Overall Study|progress disease, crossover|0|||
155732661|NCT01918306|562118381|FG001|Overall Study|progress disease, crossover|0|||
155732662|NCT01918306|562118382|FG002|Overall Study|progress disease, crossover|1|||
155732663|NCT01918306|562118383|FG003|Overall Study|progress disease, crossover|0|||
155732664|NCT01160822|562118388|FG000|Overall Study|Adverse Event|0|||
155732665|NCT01160822|562118389|FG001|Overall Study|Adverse Event|0|||
155732666|NCT01160822|562118390|FG002|Overall Study|Adverse Event|0|||
155732667|NCT01160822|562118391|FG003|Overall Study|Adverse Event|0|||
155732668|NCT01160822|562118392|FG004|Overall Study|Adverse Event|1|||
155732669|NCT01160822|562118393|FG005|Overall Study|Adverse Event|2|||
155732670|NCT01160822|562118394|FG006|Overall Study|Adverse Event|5|||
155732671|NCT01160822|562118388|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155732672|NCT01160822|562118389|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155732673|NCT01160822|562118390|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155732674|NCT01160822|562118391|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155732675|NCT01160822|562118392|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
155732676|NCT01160822|562118393|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
155732677|NCT01160822|562118394|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
155732678|NCT01160822|562118388|FG000|Overall Study|Withdrawal by Subject|0|||
155732679|NCT01160822|562118389|FG001|Overall Study|Withdrawal by Subject|0|||
155732680|NCT01160822|562118390|FG002|Overall Study|Withdrawal by Subject|0|||
155732681|NCT01160822|562118391|FG003|Overall Study|Withdrawal by Subject|0|||
155732682|NCT01160822|562118392|FG004|Overall Study|Withdrawal by Subject|0|||
155732683|NCT01160822|562118393|FG005|Overall Study|Withdrawal by Subject|0|||
155732684|NCT01160822|562118394|FG006|Overall Study|Withdrawal by Subject|1|||
155732685|NCT01160822|562118388|FG000|Overall Study|Lost to Follow-up|0|||
155732686|NCT01160822|562118389|FG001|Overall Study|Lost to Follow-up|0|||
155732687|NCT01160822|562118390|FG002|Overall Study|Lost to Follow-up|0|||
155732688|NCT01160822|562118391|FG003|Overall Study|Lost to Follow-up|0|||
155732689|NCT01160822|562118392|FG004|Overall Study|Lost to Follow-up|1|||
155732690|NCT01160822|562118393|FG005|Overall Study|Lost to Follow-up|0|||
155732691|NCT01160822|562118394|FG006|Overall Study|Lost to Follow-up|0|||
155732692|NCT01160822|562118388|FG000|Overall Study|Administrative problems|0|||
155732693|NCT01160822|562118389|FG001|Overall Study|Administrative problems|0|||
155732694|NCT01160822|562118390|FG002|Overall Study|Administrative problems|0|||
155732695|NCT01160822|562118391|FG003|Overall Study|Administrative problems|0|||
155732696|NCT01160822|562118392|FG004|Overall Study|Administrative problems|1|||
155732697|NCT01160822|562118393|FG005|Overall Study|Administrative problems|0|||
155732698|NCT01160822|562118394|FG006|Overall Study|Administrative problems|0|||
155732699|NCT01160822|562118388|FG000|Overall Study|Protocol deviation|0|||
155732700|NCT01160822|562118389|FG001|Overall Study|Protocol deviation|0|||
155388802|NCT02202551|560858711|FG000|Overall Study|Sponsor's decision|2|||
155732701|NCT01160822|562118390|FG002|Overall Study|Protocol deviation|0|||
155388803|NCT02202551|560858712|FG001|Overall Study|Sponsor's decision|0|||
155732702|NCT01160822|562118391|FG003|Overall Study|Protocol deviation|0|||
155732703|NCT01160822|562118392|FG004|Overall Study|Protocol deviation|2|||
155732704|NCT01160822|562118393|FG005|Overall Study|Protocol deviation|0|||
155732705|NCT01160822|562118394|FG006|Overall Study|Protocol deviation|0|||
155388804|NCT02202551|560858713|FG002|Overall Study|Sponsor's decision|0|||
155388805|NCT02202551|560858714|FG003|Overall Study|Sponsor's decision|0|||
155388806|NCT02202551|560858711|FG000|Overall Study|Subject unwilling to proceed|1|||
155388807|NCT02202551|560858712|FG001|Overall Study|Subject unwilling to proceed|5|||
155388808|NCT02202551|560858713|FG002|Overall Study|Subject unwilling to proceed|3|||
155388809|NCT02202551|560858714|FG003|Overall Study|Subject unwilling to proceed|5|||
155732706|NCT00314795|562118398|FG000|Overall Study|Adverse Event|8|||
155732707|NCT00314795|562118398|FG000|Overall Study|Death|4|||
155732708|NCT00314795|562118398|FG000|Overall Study|Reason not Specified|3|||
155732709|NCT00314795|562118398|FG000|Overall Study|Renal Transplant|3|||
155732710|NCT00314795|562118398|FG000|Overall Study|Participants Withdrew Consent|2|||
155732711|NCT02170077|562118403|FG000|Overall Study|Withdrawal by Subject|3|||
155732712|NCT02170077|562118404|FG001|Overall Study|Withdrawal by Subject|4|||
155732713|NCT02170077|562118405|FG002|Overall Study|Withdrawal by Subject|2|||
155732714|NCT02170077|562118403|FG000|Overall Study|Adverse Event|4|||
155732715|NCT02170077|562118404|FG001|Overall Study|Adverse Event|4|||
155732716|NCT02170077|562118405|FG002|Overall Study|Adverse Event|4|||
155732717|NCT02170077|562118403|FG000|Overall Study|Lost to Follow-up|0|||
155732718|NCT02170077|562118404|FG001|Overall Study|Lost to Follow-up|1|||
155732719|NCT02170077|562118405|FG002|Overall Study|Lost to Follow-up|0|||
155732720|NCT02170077|562118403|FG000|Overall Study|Exclusion criteria|2|||
155732721|NCT02170077|562118404|FG001|Overall Study|Exclusion criteria|2|||
155732722|NCT02170077|562118405|FG002|Overall Study|Exclusion criteria|5|||
155732723|NCT02170077|562118403|FG000|Overall Study|Exacerbation of seizures|0|||
155732724|NCT02170077|562118404|FG001|Overall Study|Exacerbation of seizures|2|||
155732725|NCT02170077|562118405|FG002|Overall Study|Exacerbation of seizures|1|||
155732726|NCT01780974|562118410|FG000|Overall Study|Death|1|||
155732727|NCT01780974|562118411|FG001|Overall Study|Death|0|||
155732728|NCT01780974|562118410|FG000|Overall Study|Adverse Event|1|||
155732729|NCT01780974|562118411|FG001|Overall Study|Adverse Event|3|||
155732730|NCT00525161|562118412|FG000|Overall Study|Adverse Event|1|||
155732731|NCT01076361|562118416|FG000|Overall Study|22 leads were excluded from analysis|21|||
155732732|NCT00750438|562118421|FG000|Overall Study|Protocol Violation|4|||
155732733|NCT00750438|562118422|FG001|Overall Study|Protocol Violation|1|||
155732734|NCT00750438|562118421|FG000|Overall Study|Physician Decision|2|||
155732735|NCT00750438|562118422|FG001|Overall Study|Physician Decision|2|||
155732736|NCT00750438|562118421|FG000|Overall Study|Withdrawal by Subject|1|||
155732737|NCT00750438|562118422|FG001|Overall Study|Withdrawal by Subject|1|||
155732738|NCT00787644|562118423|FG000|Overall Study|Lost to Follow-up|1|||
155732739|NCT00787644|562118424|FG001|Overall Study|Lost to Follow-up|1|||
155732740|NCT00787644|562118423|FG000|Overall Study|Withdrawal by Subject|1|||
155732741|NCT00787644|562118424|FG001|Overall Study|Withdrawal by Subject|1|||
155732742|NCT01108185|562118428|FG000|Overall Study|Non-compliance|15|||
155732743|NCT01108185|562118428|FG000|Overall Study|Lost to Follow-up|12|||
155732744|NCT05615922|562118435|FG000|Overall Study|Lost to Follow-up|1|||
155732745|NCT00905164|562118436|FG000|Period 1|Protocol Violation|0|||
155732746|NCT00905164|562118437|FG001|Period 1|Protocol Violation|1|||
155732747|NCT04730804|562118438|FG000|Overall Study|Physician Decision|0|||
155732748|NCT04730804|562118439|FG001|Overall Study|Physician Decision|0|||
155732749|NCT04730804|562118440|FG002|Overall Study|Physician Decision|0|||
155732750|NCT04730804|562118441|FG003|Overall Study|Physician Decision|0|||
155732751|NCT04730804|562118442|FG004|Overall Study|Physician Decision|0|||
155732752|NCT04730804|562118443|FG005|Overall Study|Physician Decision|1|||
155732753|NCT04730804|562118438|FG000|Overall Study|Withdrawal by Subject|0|||
155732754|NCT04730804|562118439|FG001|Overall Study|Withdrawal by Subject|0|||
155732755|NCT04730804|562118440|FG002|Overall Study|Withdrawal by Subject|0|||
155732756|NCT04730804|562118441|FG003|Overall Study|Withdrawal by Subject|0|||
155732757|NCT04730804|562118442|FG004|Overall Study|Withdrawal by Subject|1|||
155732758|NCT04730804|562118443|FG005|Overall Study|Withdrawal by Subject|2|||
155732759|NCT03894813|562119977|FG000|Overall Study|Adverse Event|1|||
155732760|NCT03894813|562119978|FG001|Overall Study|Adverse Event|1|||
155732761|NCT03894813|562119977|FG000|Overall Study|Lack of Efficacy|3|||
155732762|NCT03894813|562119978|FG001|Overall Study|Lack of Efficacy|3|||
155732763|NCT03894813|562119977|FG000|Overall Study|Lost to Follow-up|1|||
155732764|NCT03894813|562119978|FG001|Overall Study|Lost to Follow-up|0|||
155732765|NCT03894813|562119977|FG000|Overall Study|Pregnancy|2|||
155732766|NCT03894813|562119978|FG001|Overall Study|Pregnancy|1|||
155732767|NCT03894813|562119977|FG000|Overall Study|Protocol Violation|3|||
155732768|NCT03894813|562119978|FG001|Overall Study|Protocol Violation|7|||
155732769|NCT03894813|562119977|FG000|Overall Study|Withdrawal by Subject|1|||
155732770|NCT03894813|562119978|FG001|Overall Study|Withdrawal by Subject|3|||
155732771|NCT03894813|562119977|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
155732772|NCT03894813|562119978|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
155732773|NCT00499616|562119979|FG000|Overall Study|Death|1|||
155732774|NCT00499616|562119980|FG001|Overall Study|Death|5|||
155732775|NCT00499616|562119981|FG002|Overall Study|Death|3|||
155732776|NCT00499616|562119982|FG003|Overall Study|Death|1|||
155732777|NCT00499616|562119979|FG000|Overall Study|Lack of Efficacy|5|||
155732778|NCT00499616|562119980|FG001|Overall Study|Lack of Efficacy|0|||
155732779|NCT00499616|562119981|FG002|Overall Study|Lack of Efficacy|19|||
155732780|NCT00499616|562119982|FG003|Overall Study|Lack of Efficacy|0|||
155732781|NCT00499616|562119979|FG000|Overall Study|Lost to Follow-up|0|||
155732782|NCT00499616|562119980|FG001|Overall Study|Lost to Follow-up|0|||
155732783|NCT00499616|562119981|FG002|Overall Study|Lost to Follow-up|1|||
155732784|NCT00499616|562119982|FG003|Overall Study|Lost to Follow-up|0|||
155732785|NCT00499616|562119979|FG000|Overall Study|Physician Decision|6|||
155732786|NCT00499616|562119980|FG001|Overall Study|Physician Decision|16|||
155732787|NCT00499616|562119981|FG002|Overall Study|Physician Decision|9|||
155732788|NCT00499616|562119982|FG003|Overall Study|Physician Decision|0|||
155732789|NCT00499616|562119979|FG000|Overall Study|Withdrawal by Subject|1|||
155732790|NCT00499616|562119980|FG001|Overall Study|Withdrawal by Subject|0|||
155388810|NCT02202551|560858711|FG000|Overall Study|Subject consent withdrawn|0|||
155388811|NCT02202551|560858712|FG001|Overall Study|Subject consent withdrawn|3|||
155630096|NCT03759379|561743020|FG001|Treatment Period|Lost to Follow-up|0|||
155630097|NCT03759379|561743019|FG000|Treatment Period|Physician Decision|0|||
155630098|NCT03759379|561743020|FG001|Treatment Period|Physician Decision|1|||
155630099|NCT05399680|561743021|FG000|Overall Study|Lost to Follow-up|1|||
155630100|NCT05399680|561743022|FG001|Overall Study|Lost to Follow-up|0|||
155630101|NCT05399680|561743021|FG000|Overall Study|Death|0|||
155630102|NCT05399680|561743022|FG001|Overall Study|Death|1|||
155630103|NCT02659865|561743023|FG000|Period 1|Withdrawal by Subject|1|||
155630104|NCT02659865|561743024|FG001|Period 1|Withdrawal by Subject|0|||
155630105|NCT02659865|561743025|FG002|Period 1|Withdrawal by Subject|0|||
155630106|NCT02659865|561743026|FG003|Period 1|Withdrawal by Subject|0|||
155630107|NCT02659865|561743027|FG004|Period 1|Withdrawal by Subject|0|||
155630108|NCT02659865|561743023|FG000|Period 1|Adverse Event|0|||
155630109|NCT02659865|561743024|FG001|Period 1|Adverse Event|0|||
155630110|NCT02659865|561743025|FG002|Period 1|Adverse Event|0|||
155630111|NCT02659865|561743026|FG003|Period 1|Adverse Event|0|||
155630112|NCT02659865|561743027|FG004|Period 1|Adverse Event|1|||
155630113|NCT03675308|561743028|FG000|Overall Study|Adverse Event|3|||
155630114|NCT03675308|561743029|FG001|Overall Study|Adverse Event|2|||
155630115|NCT03675308|561743028|FG000|Overall Study|Withdrawal by Subject|6|||
155630116|NCT03675308|561743029|FG001|Overall Study|Withdrawal by Subject|4|||
155630117|NCT03675308|561743028|FG000|Overall Study|Lost to Follow-up|3|||
155630118|NCT03675308|561743029|FG001|Overall Study|Lost to Follow-up|0|||
155630119|NCT03675308|561743028|FG000|Overall Study|Lack of Efficacy|1|||
155630120|NCT03675308|561743029|FG001|Overall Study|Lack of Efficacy|1|||
155630121|NCT03675308|561743028|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
155630122|NCT03675308|561743029|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
155630123|NCT03675308|561743028|FG000|Overall Study|Other|0|||
155630124|NCT03675308|561743029|FG001|Overall Study|Other|1|||
155630125|NCT02325414|561743030|FG000|Overall Study|Withdrawal by Subject|3|||
155630126|NCT02325414|561743031|FG001|Overall Study|Withdrawal by Subject|1|||
155630127|NCT02325414|561743030|FG000|Overall Study|Lost to Follow-up|5|||
155630128|NCT02325414|561743031|FG001|Overall Study|Lost to Follow-up|5|||
155630129|NCT05722522|561743032|FG000|Overall Study|Adverse Event|0|||
155630130|NCT05722522|561743033|FG001|Overall Study|Adverse Event|1|||
155630131|NCT02775851|561743035|FG000|Overall Study|Adverse Event|1|||
155630132|NCT02775851|561743036|FG001|Overall Study|Adverse Event|10|||
155630133|NCT02775851|561743035|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
155630134|NCT02775851|561743036|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
155630135|NCT02775851|561743035|FG000|Overall Study|Progression/Relapse|0|||
155630136|NCT02775851|561743036|FG001|Overall Study|Progression/Relapse|4|||
155630137|NCT02775851|561743035|FG000|Overall Study|Other - Not Protocol Specified|0|||
155630138|NCT02775851|561743036|FG001|Overall Study|Other - Not Protocol Specified|7|||
155630139|NCT02775851|561743035|FG000|Overall Study|Withdrawal by Subject|1|||
155630140|NCT02775851|561743036|FG001|Overall Study|Withdrawal by Subject|0|||
155630141|NCT02194465|561743037|FG000|Overall Study|Adverse Event|6|||
155630142|NCT02194465|561743038|FG001|Overall Study|Adverse Event|1|||
155630143|NCT02194465|561743039|FG002|Overall Study|Adverse Event|4|||
155630144|NCT02194465|561743040|FG003|Overall Study|Adverse Event|4|||
155630145|NCT02194465|561743041|FG004|Overall Study|Adverse Event|4|||
155630146|NCT02194465|561743042|FG005|Overall Study|Adverse Event|2|||
155630147|NCT02194465|561743043|FG006|Overall Study|Adverse Event|0|||
155630148|NCT02194465|561743037|FG000|Overall Study|Lost to Follow-up|0|||
155630149|NCT02194465|561743038|FG001|Overall Study|Lost to Follow-up|0|||
155630150|NCT02194465|561743039|FG002|Overall Study|Lost to Follow-up|0|||
155630151|NCT02194465|561743040|FG003|Overall Study|Lost to Follow-up|1|||
155630152|NCT02194465|561743041|FG004|Overall Study|Lost to Follow-up|0|||
155630153|NCT02194465|561743042|FG005|Overall Study|Lost to Follow-up|1|||
155630154|NCT02194465|561743043|FG006|Overall Study|Lost to Follow-up|0|||
155630155|NCT02194465|561743037|FG000|Overall Study|Physician Decision|1|||
155630156|NCT02194465|561743038|FG001|Overall Study|Physician Decision|0|||
155630157|NCT02194465|561743039|FG002|Overall Study|Physician Decision|0|||
155630158|NCT02194465|561743040|FG003|Overall Study|Physician Decision|0|||
155630159|NCT02194465|561743041|FG004|Overall Study|Physician Decision|0|||
155630160|NCT02194465|561743042|FG005|Overall Study|Physician Decision|0|||
155630161|NCT02194465|561743043|FG006|Overall Study|Physician Decision|0|||
155630162|NCT02194465|561743037|FG000|Overall Study|Protocol Violation|1|||
155630163|NCT02194465|561743038|FG001|Overall Study|Protocol Violation|1|||
155630164|NCT02194465|561743039|FG002|Overall Study|Protocol Violation|2|||
155630165|NCT02194465|561743040|FG003|Overall Study|Protocol Violation|1|||
155732791|NCT00499616|562119981|FG002|Overall Study|Withdrawal by Subject|1|||
155630166|NCT02194465|561743041|FG004|Overall Study|Protocol Violation|1|||
155630167|NCT02194465|561743042|FG005|Overall Study|Protocol Violation|0|||
155630168|NCT02194465|561743043|FG006|Overall Study|Protocol Violation|0|||
155630169|NCT02194465|561743037|FG000|Overall Study|Withdrawal by Subject|1|||
155630170|NCT02194465|561743038|FG001|Overall Study|Withdrawal by Subject|3|||
155630171|NCT02194465|561743039|FG002|Overall Study|Withdrawal by Subject|1|||
155732792|NCT00499616|562119982|FG003|Overall Study|Withdrawal by Subject|0|||
155732793|NCT00499616|562119979|FG000|Overall Study|Ineligible|1|||
155732794|NCT00499616|562119980|FG001|Overall Study|Ineligible|2|||
155732795|NCT00499616|562119981|FG002|Overall Study|Ineligible|0|||
155732796|NCT00499616|562119982|FG003|Overall Study|Ineligible|15|||
155732797|NCT00499616|562119979|FG000|Overall Study|Not evaluable|0|||
155732798|NCT00499616|562119980|FG001|Overall Study|Not evaluable|0|||
155732799|NCT00499616|562119981|FG002|Overall Study|Not evaluable|0|||
155732800|NCT00499616|562119982|FG003|Overall Study|Not evaluable|41|||
155732801|NCT00499616|562119979|FG000|Overall Study|Patient/Parent Refusal|1|||
155732802|NCT00499616|562119980|FG001|Overall Study|Patient/Parent Refusal|5|||
155732803|NCT00499616|562119981|FG002|Overall Study|Patient/Parent Refusal|3|||
155732804|NCT00499616|562119982|FG003|Overall Study|Patient/Parent Refusal|0|||
155732805|NCT04816669|562119983|FG000|Part 1|Adverse Event|1|||
155732806|NCT04816669|562119984|FG001|Part 1|Adverse Event|1|||
155732807|NCT04816669|562119985|FG002|Part 1|Adverse Event|0|||
155732808|NCT04816669|562119986|FG003|Part 1|Adverse Event|0|||
155732809|NCT04816669|562119983|FG000|Part 1|Lost to Follow-up|2|||
155732810|NCT04816669|562119984|FG001|Part 1|Lost to Follow-up|2|||
155732811|NCT04816669|562119985|FG002|Part 1|Lost to Follow-up|0|||
155732812|NCT04816669|562119986|FG003|Part 1|Lost to Follow-up|0|||
155732813|NCT04816669|562119983|FG000|Part 1|Protocol Violation|0|||
155732814|NCT04816669|562119984|FG001|Part 1|Protocol Violation|1|||
155732815|NCT04816669|562119985|FG002|Part 1|Protocol Violation|0|||
155732816|NCT04816669|562119986|FG003|Part 1|Protocol Violation|0|||
155732817|NCT04816669|562119983|FG000|Part 1|Withdrawal by Subject|1|||
155732818|NCT04816669|562119984|FG001|Part 1|Withdrawal by Subject|2|||
155732819|NCT04816669|562119985|FG002|Part 1|Withdrawal by Subject|0|||
155732820|NCT04816669|562119986|FG003|Part 1|Withdrawal by Subject|0|||
155732821|NCT04816669|562119983|FG000|Part 2|Other|0|||
155732822|NCT04816669|562119984|FG001|Part 2|Other|0|||
155732823|NCT04816669|562119985|FG002|Part 2|Other|1|||
155732824|NCT04816669|562119986|FG003|Part 2|Other|0|||
155732825|NCT04816669|562119983|FG000|Part 2|Withdrawal by Subject|0|||
155732826|NCT04816669|562119984|FG001|Part 2|Withdrawal by Subject|0|||
155732827|NCT04816669|562119985|FG002|Part 2|Withdrawal by Subject|0|||
155732828|NCT04816669|562119986|FG003|Part 2|Withdrawal by Subject|1|||
155732829|NCT04816669|562119983|FG000|Part 2|Lost to Follow-up|0|||
155732830|NCT04816669|562119984|FG001|Part 2|Lost to Follow-up|0|||
155732831|NCT04816669|562119985|FG002|Part 2|Lost to Follow-up|1|||
155732832|NCT04816669|562119986|FG003|Part 2|Lost to Follow-up|0|||
155732833|NCT00867815|562119992|FG000|Overall Study|Lost to Follow-up|1|||
155732834|NCT01499277|562119995|FG000|Overall Study|Adverse Event|3|||
155732835|NCT01499277|562119996|FG001|Overall Study|Adverse Event|6|||
155732836|NCT01499277|562119995|FG000|Overall Study|Death|3|||
155732837|NCT01499277|562119996|FG001|Overall Study|Death|2|||
155732838|NCT01499277|562119995|FG000|Overall Study|Lost to Follow-up|15|||
155732839|NCT01499277|562119996|FG001|Overall Study|Lost to Follow-up|8|||
155732840|NCT01499277|562119995|FG000|Overall Study|Protocol Violation|2|||
155732841|NCT01499277|562119996|FG001|Overall Study|Protocol Violation|3|||
155732842|NCT01499277|562119995|FG000|Overall Study|Withdrawal by Subject|16|||
155732843|NCT01499277|562119996|FG001|Overall Study|Withdrawal by Subject|6|||
155732844|NCT01499277|562119995|FG000|Overall Study|Lack of therapeutic response and other|8|||
155732845|NCT01499277|562119996|FG001|Overall Study|Lack of therapeutic response and other|7|||
155732846|NCT00790088|562119999|FG000|Overall Study|Protocol Violation|11|||
155732847|NCT00790088|562119999|FG000|Overall Study|Withdrawal by Subject|17|||
155732848|NCT00790088|562119999|FG000|Overall Study|Lost to Follow-up|7|||
155732849|NCT00790088|562119999|FG000|Overall Study|Physician Decision|4|||
155732850|NCT02015637|562120000|FG000|Overall Study|Lost to Follow-up|3|||
155732851|NCT02015637|562120001|FG001|Overall Study|Lost to Follow-up|5|||
155732852|NCT02015637|562120000|FG000|Overall Study|Adverse Event|3|||
155732853|NCT02015637|562120001|FG001|Overall Study|Adverse Event|0|||
155732854|NCT02015637|562120000|FG000|Overall Study|Did not take study drug|2|||
155281603|NCT04060680|560461671|FG001|Overall Study|Withdrawal by Subject|0|||
155281604|NCT05617040|560461672|FG000|Overall Study|Adverse Event|0|||
155732855|NCT02015637|562120001|FG001|Overall Study|Did not take study drug|0|||
155732856|NCT01491607|562120004|FG000|Overall Study|Lost to Follow-up|7|||
155732857|NCT01491607|562120004|FG000|Overall Study|Withdrawal by Subject|3|||
155732858|NCT01317277|562120005|FG000|Overall Study|Lost to Follow-up|3|||
155732859|NCT01317277|562120006|FG001|Overall Study|Lost to Follow-up|1|||
155732860|NCT01317277|562120005|FG000|Overall Study|Lost MEMS|1|||
155732861|NCT01317277|562120006|FG001|Overall Study|Lost MEMS|1|||
155732862|NCT01317277|562120005|FG000|Overall Study|Unable to comply with intervention|1|||
155732863|NCT01317277|562120006|FG001|Overall Study|Unable to comply with intervention|0|||
155732864|NCT01317277|562120005|FG000|Overall Study|Withdrawal by Subject|1|||
155732865|NCT01317277|562120006|FG001|Overall Study|Withdrawal by Subject|0|||
155732866|NCT01317277|562120005|FG000|Overall Study|Adverse Event|1|||
155732867|NCT01317277|562120006|FG001|Overall Study|Adverse Event|0|||
155732868|NCT00774566|562120007|FG000|Overall Study|Protocol Violation|18|||
155732869|NCT00774566|562120008|FG001|Overall Study|Protocol Violation|15|||
155732870|NCT04896073|562120015|FG000|Overall Study|Screen failure|0|||
155732871|NCT04896073|562120016|FG001|Overall Study|Screen failure|2|||
155388812|NCT02202551|560858713|FG002|Overall Study|Subject consent withdrawn|1|||
155388813|NCT02202551|560858714|FG003|Overall Study|Subject consent withdrawn|2|||
155388814|NCT02202551|560858711|FG000|Overall Study|eGFR<50mL/min/m2|2|||
155388815|NCT02202551|560858712|FG001|Overall Study|eGFR<50mL/min/m2|2|||
155388816|NCT02202551|560858713|FG002|Overall Study|eGFR<50mL/min/m2|0|||
155388817|NCT02202551|560858714|FG003|Overall Study|eGFR<50mL/min/m2|1|||
155388818|NCT02349451|560858715|FG000|Overall Study|Withdrawal by Subject|0|||
155388819|NCT02349451|560858716|FG001|Overall Study|Withdrawal by Subject|1|||
155388820|NCT02349451|560858717|FG002|Overall Study|Withdrawal by Subject|2|||
155388821|NCT02349451|560858718|FG003|Overall Study|Withdrawal by Subject|1|||
155388822|NCT02168842|560858719|FG000|Overall Study|Withdrawal by Subject|5|||
155388823|NCT02168842|560858720|FG001|Overall Study|Withdrawal by Subject|3|||
155388824|NCT02168842|560858719|FG000|Overall Study|Lost to Follow-up|0|||
155388825|NCT02168842|560858720|FG001|Overall Study|Lost to Follow-up|2|||
155388826|NCT02168842|560858719|FG000|Overall Study|Death|2|||
155388827|NCT02168842|560858720|FG001|Overall Study|Death|1|||
155388828|NCT02168842|560858719|FG000|Overall Study|Physician Decision|1|||
155388829|NCT02168842|560858720|FG001|Overall Study|Physician Decision|2|||
155388830|NCT02147353|560858721|FG000|Overall Study|Lost to Follow-up|2|||
155388831|NCT02147353|560858722|FG001|Overall Study|Lost to Follow-up|0|||
155388832|NCT02147353|560858721|FG000|Overall Study|unable to make visits|4|||
155388833|NCT02147353|560858722|FG001|Overall Study|unable to make visits|0|||
155388834|NCT02147353|560858721|FG000|Overall Study|medication noncompliance|3|||
155388835|NCT02147353|560858722|FG001|Overall Study|medication noncompliance|0|||
155388836|NCT01794923|560858738|FG000|Overall Study|Adverse Event|0|||
155388837|NCT01794923|560858739|FG001|Overall Study|Adverse Event|0|||
155388838|NCT01794923|560858740|FG002|Overall Study|Adverse Event|1|||
155388839|NCT01749540|560858741|FG000|Overall Study|Protocol Violation|0|||
155388840|NCT01749540|560858742|FG001|Overall Study|Protocol Violation|0|||
155388841|NCT01749540|560858743|FG002|Overall Study|Protocol Violation|0|||
155388842|NCT01749540|560858744|FG003|Overall Study|Protocol Violation|0|||
155388843|NCT01749540|560858745|FG004|Overall Study|Protocol Violation|0|||
155388844|NCT01749540|560858746|FG005|Overall Study|Protocol Violation|1|||
155388845|NCT01749540|560858747|FG006|Overall Study|Protocol Violation|1|||
155388846|NCT01749540|560858741|FG000|Overall Study|Withdrawal by Subject|0|||
155388847|NCT01749540|560858742|FG001|Overall Study|Withdrawal by Subject|0|||
155388848|NCT01749540|560858743|FG002|Overall Study|Withdrawal by Subject|0|||
155388849|NCT01749540|560858744|FG003|Overall Study|Withdrawal by Subject|1|||
155388850|NCT01749540|560858745|FG004|Overall Study|Withdrawal by Subject|0|||
155388851|NCT01749540|560858746|FG005|Overall Study|Withdrawal by Subject|0|||
155388852|NCT01749540|560858747|FG006|Overall Study|Withdrawal by Subject|0|||
155388853|NCT01749540|560858741|FG000|Overall Study|Initiated into extension study A536-06|0|||
155388854|NCT01749540|560858742|FG001|Overall Study|Initiated into extension study A536-06|0|||
155388855|NCT01749540|560858743|FG002|Overall Study|Initiated into extension study A536-06|0|||
155388856|NCT01749540|560858744|FG003|Overall Study|Initiated into extension study A536-06|0|||
155388857|NCT01749540|560858745|FG004|Overall Study|Initiated into extension study A536-06|0|||
155388858|NCT01749540|560858746|FG005|Overall Study|Initiated into extension study A536-06|2|||
155388859|NCT01749540|560858747|FG006|Overall Study|Initiated into extension study A536-06|24|||
155388860|NCT00576836|560858759|FG000|Overall Study|Death|0|||
155388861|NCT00576836|560858760|FG001|Overall Study|Death|1|||
155388862|NCT00576836|560858759|FG000|Overall Study|Physician Decision|0|||
155388863|NCT00576836|560858760|FG001|Overall Study|Physician Decision|1|||
155388864|NCT00894686|560858761|FG000|Overall Study|Withdrawal by Subject|50|||
155388865|NCT00894686|560858761|FG000|Overall Study|Physician Decision|1|||
155388866|NCT00894686|560858761|FG000|Overall Study|Other|5|||
155388867|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
155388868|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
155388869|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388870|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388871|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388872|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388873|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388874|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
155388875|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388876|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388877|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388878|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388879|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388880|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
155388881|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388882|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388883|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155630172|NCT02194465|561743040|FG003|Overall Study|Withdrawal by Subject|2|||
155630173|NCT02194465|561743041|FG004|Overall Study|Withdrawal by Subject|2|||
155630174|NCT02194465|561743042|FG005|Overall Study|Withdrawal by Subject|1|||
155630175|NCT02194465|561743043|FG006|Overall Study|Withdrawal by Subject|2|||
155630176|NCT02194465|561743037|FG000|Overall Study|Discontinued follow-up period|0|||
155630177|NCT02194465|561743038|FG001|Overall Study|Discontinued follow-up period|2|||
155630178|NCT02194465|561743039|FG002|Overall Study|Discontinued follow-up period|1|||
155630179|NCT02194465|561743040|FG003|Overall Study|Discontinued follow-up period|0|||
155630180|NCT02194465|561743041|FG004|Overall Study|Discontinued follow-up period|2|||
155630181|NCT02194465|561743042|FG005|Overall Study|Discontinued follow-up period|0|||
155630182|NCT02194465|561743043|FG006|Overall Study|Discontinued follow-up period|0|||
155630183|NCT01125930|561743044|FG000|Overall Study|Adverse Event|0|||
155630184|NCT01125930|561743045|FG001|Overall Study|Adverse Event|1|||
155630185|NCT01125930|561743044|FG000|Overall Study|Withdrawal by Subject|1|||
155630186|NCT01125930|561743045|FG001|Overall Study|Withdrawal by Subject|6|||
155630187|NCT01125930|561743044|FG000|Overall Study|Protocol Violation|0|||
155630188|NCT01125930|561743045|FG001|Overall Study|Protocol Violation|1|||
155630189|NCT01125930|561743044|FG000|Overall Study|Lost to Follow-up|0|||
155630190|NCT01125930|561743045|FG001|Overall Study|Lost to Follow-up|2|||
155630191|NCT01715298|561743046|FG000|Overall Study|Lost to Follow-up|0|||
155630192|NCT01715298|561743047|FG001|Overall Study|Lost to Follow-up|2|||
155630193|NCT01715298|561743046|FG000|Overall Study|Patient/guardian decision|7|||
155630194|NCT01715298|561743047|FG001|Overall Study|Patient/guardian decision|9|||
155630195|NCT01454284|561743048|FG000|Overall Study|Adverse Event|20|||
155630196|NCT01454284|561743049|FG001|Overall Study|Adverse Event|7|||
155630197|NCT01454284|561743048|FG000|Overall Study|Death|0|||
155281605|NCT05617040|560461673|FG001|Overall Study|Adverse Event|1|||
155281606|NCT05617040|560461674|FG002|Overall Study|Adverse Event|0|||
155281607|NCT05617040|560461672|FG000|Overall Study|Death|0|||
155281608|NCT05617040|560461673|FG001|Overall Study|Death|0|||
155281609|NCT05617040|560461674|FG002|Overall Study|Death|1|||
155281610|NCT02711826|560461675|FG000|Overall Study|Physician Decision|0|||
155281611|NCT02711826|560461676|FG001|Overall Study|Physician Decision|0|||
155281612|NCT02711826|560461677|FG002|Overall Study|Physician Decision|0|||
155281613|NCT02711826|560461678|FG003|Overall Study|Physician Decision|1|||
155281614|NCT02711826|560461679|FG004|Overall Study|Physician Decision|0|||
155281615|NCT02711826|560461675|FG000|Overall Study|Withdrawal by Subject|0|||
155281616|NCT02711826|560461676|FG001|Overall Study|Withdrawal by Subject|1|||
155281617|NCT02711826|560461677|FG002|Overall Study|Withdrawal by Subject|0|||
155281618|NCT02711826|560461678|FG003|Overall Study|Withdrawal by Subject|4|||
155281619|NCT02711826|560461679|FG004|Overall Study|Withdrawal by Subject|0|||
155281620|NCT02711826|560461675|FG000|Overall Study|Failure to manufacture cellular product|0|||
155281621|NCT02711826|560461676|FG001|Overall Study|Failure to manufacture cellular product|0|||
155281622|NCT02711826|560461677|FG002|Overall Study|Failure to manufacture cellular product|5|||
155281623|NCT02711826|560461678|FG003|Overall Study|Failure to manufacture cellular product|0|||
155281624|NCT02711826|560461679|FG004|Overall Study|Failure to manufacture cellular product|0|||
155281625|NCT02711826|560461675|FG000|Overall Study|Infusion canceled for active infection|0|||
155281626|NCT02711826|560461676|FG001|Overall Study|Infusion canceled for active infection|1|||
155281627|NCT02711826|560461677|FG002|Overall Study|Infusion canceled for active infection|0|||
155281628|NCT02711826|560461678|FG003|Overall Study|Infusion canceled for active infection|0|||
155281629|NCT02711826|560461679|FG004|Overall Study|Infusion canceled for active infection|0|||
155281630|NCT02711826|560461675|FG000|Overall Study|Screen failures|0|||
155281631|NCT02711826|560461676|FG001|Overall Study|Screen failures|0|||
155281632|NCT02711826|560461677|FG002|Overall Study|Screen failures|0|||
155281633|NCT02711826|560461678|FG003|Overall Study|Screen failures|4|||
155281634|NCT02711826|560461679|FG004|Overall Study|Screen failures|0|||
155281635|NCT00729690|560461680|FG000|Overall Study|IT Catheter Malfunction|0|||
155281636|NCT00729690|560461681|FG001|Overall Study|IT Catheter Malfunction|2|||
155281637|NCT00729690|560461682|FG002|Overall Study|IT Catheter Malfunction|2|||
155281638|NCT02169219|560461683|FG000|Overall Study|Lack of Efficacy|6|||
155281639|NCT02507219|560461687|FG000|Overall Study|Physician Decision|1|||
155281640|NCT02507219|560461688|FG001|Overall Study|Physician Decision|0|||
155281641|NCT02507219|560461689|FG002|Overall Study|Physician Decision|0|||
155281642|NCT02507219|560461690|FG003|Overall Study|Physician Decision|0|||
155281643|NCT02507219|560461691|FG004|Overall Study|Physician Decision|0|||
155281644|NCT02507219|560461692|FG005|Overall Study|Physician Decision|0|||
155281645|NCT02507219|560461687|FG000|Overall Study|Withdrawal by Subject|0|||
155388884|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155630198|NCT01454284|561743049|FG001|Overall Study|Death|3|||
155630199|NCT01454284|561743048|FG000|Overall Study|Lost to Follow-up|13|||
155630200|NCT01454284|561743049|FG001|Overall Study|Lost to Follow-up|8|||
155630201|NCT01454284|561743048|FG000|Overall Study|Protocol Violation|9|||
155630202|NCT01454284|561743049|FG001|Overall Study|Protocol Violation|6|||
155630203|NCT01454284|561743048|FG000|Overall Study|Withdrawal by Subject|58|||
155281646|NCT02507219|560461688|FG001|Overall Study|Withdrawal by Subject|0|||
155281647|NCT02507219|560461689|FG002|Overall Study|Withdrawal by Subject|0|||
155732872|NCT04896073|562120015|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
155732873|NCT04896073|562120016|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
155732874|NCT00297258|562120017|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
155732875|NCT00297258|562120017|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
155732876|NCT00297258|562120017|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
155732877|NCT00297258|562120017|FG000|Overall Study|Intercurrent Illness|3|||
155732878|NCT00297258|562120017|FG000|Overall Study|Intercurrent Death|2|||
155732879|NCT00297258|562120017|FG000|Overall Study|Deteriorization of General Condition|1|||
155732880|NCT00297258|562120017|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
155732881|NCT00297258|562120017|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
155732882|NCT00297258|562120017|FG000|Overall Study|Switch to Commercial Treatment|1|||
155732883|NCT00297258|562120017|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
155732884|NCT02454517|562120019|FG000|Overall Study|Withdrawal by Subject|3|||
155732885|NCT02454517|562120020|FG001|Overall Study|Withdrawal by Subject|0|||
155732886|NCT02454517|562120019|FG000|Overall Study|Lost to Follow-up|4|||
155732887|NCT02454517|562120020|FG001|Overall Study|Lost to Follow-up|7|||
155732888|NCT02454517|562120019|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
155732889|NCT02454517|562120020|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
155732890|NCT00473382|562120021|FG000|Core Study|Adverse Event|3|||
155732891|NCT00473382|562120022|FG001|Core Study|Adverse Event|1|||
155732892|NCT00473382|562120023|FG002|Core Study|Adverse Event|1|||
155732893|NCT00473382|562120021|FG000|Core Study|Death|3|||
155732894|NCT00473382|562120022|FG001|Core Study|Death|5|||
155732895|NCT00473382|562120023|FG002|Core Study|Death|10|||
155732896|NCT00473382|562120021|FG000|Core Study|Lost to Follow-up|3|||
155732897|NCT00473382|562120022|FG001|Core Study|Lost to Follow-up|3|||
155732898|NCT00473382|562120023|FG002|Core Study|Lost to Follow-up|3|||
155732899|NCT00473382|562120021|FG000|Core Study|Physician Decision|1|||
155732900|NCT00473382|562120022|FG001|Core Study|Physician Decision|2|||
155732901|NCT00473382|562120023|FG002|Core Study|Physician Decision|2|||
155732902|NCT00473382|562120021|FG000|Core Study|Subject non-compliance|5|||
155732903|NCT00473382|562120022|FG001|Core Study|Subject non-compliance|2|||
155732904|NCT00473382|562120023|FG002|Core Study|Subject non-compliance|1|||
155732905|NCT00473382|562120021|FG000|Core Study|Subject needed other treatment|1|||
155732906|NCT00473382|562120022|FG001|Core Study|Subject needed other treatment|3|||
155732907|NCT00473382|562120023|FG002|Core Study|Subject needed other treatment|2|||
155732908|NCT00473382|562120021|FG000|Core Study|Subject's decision|12|||
155732909|NCT00473382|562120022|FG001|Core Study|Subject's decision|11|||
155732910|NCT00473382|562120023|FG002|Core Study|Subject's decision|10|||
155732911|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
155732912|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
155732913|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
155732914|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Death|1|||
155732915|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Death|3|||
155732916|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Death|3|||
155732917|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
155732918|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
155732919|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
155732920|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
155732921|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
155732922|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
155732923|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
155732924|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
155732925|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
155732926|NCT00473382|562120021|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
155732927|NCT00473382|562120022|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
155732928|NCT00473382|562120023|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
155732929|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
155732930|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
155732931|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
155732932|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Death|1|||
155732933|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Death|7|||
155732934|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Death|4|||
155732935|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
155732936|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
155732937|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
155732938|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
155732939|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
155732940|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
155281648|NCT02507219|560461690|FG003|Overall Study|Withdrawal by Subject|0|||
155732941|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
155732942|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
155732943|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
155732944|NCT00473382|562120021|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
155732945|NCT00473382|562120022|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
155732946|NCT00473382|562120023|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
155732947|NCT03565497|562120024|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
155732948|NCT03565497|562120025|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
155732949|NCT03565497|562120026|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
155732950|NCT03565497|562120024|FG000|Overall Study|Lost to Follow-up|1|||
155732951|NCT03565497|562120025|FG001|Overall Study|Lost to Follow-up|1|||
155732952|NCT03565497|562120026|FG002|Overall Study|Lost to Follow-up|2|||
155732953|NCT03565497|562120024|FG000|Overall Study|Withdrawal by Subject|1|||
155732954|NCT03565497|562120025|FG001|Overall Study|Withdrawal by Subject|1|||
155732955|NCT03565497|562120026|FG002|Overall Study|Withdrawal by Subject|1|||
155732956|NCT02999672|562120027|FG000|Overall Study|Death|0|||
155732957|NCT02999672|562120028|FG001|Overall Study|Death|1|||
155732958|NCT02999672|562120027|FG000|Overall Study|Study Terminated by Sponsor|0|||
155732959|NCT02999672|562120028|FG001|Overall Study|Study Terminated by Sponsor|1|||
155732960|NCT02999672|562120027|FG000|Overall Study|Progressive Disease|9|||
155732961|NCT02999672|562120028|FG001|Overall Study|Progressive Disease|5|||
155732962|NCT02999672|562120027|FG000|Overall Study|Adverse Event|4|||
155732963|NCT02999672|562120028|FG001|Overall Study|Adverse Event|0|||
155732964|NCT01470326|562120029|FG000|Overall Study|Protocol Violation|32|||
155732965|NCT01470326|562120029|FG000|Overall Study|No Drug Administration Information|2|||
155732966|NCT01470326|562120029|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
155732967|NCT01166282|562120030|FG000|Open-label Period|Adverse Event|0|||
155732968|NCT01166282|562120031|FG001|Open-label Period|Adverse Event|0|||
155732969|NCT01166282|562120032|FG002|Open-label Period|Adverse Event|6|||
155732970|NCT01166282|562120030|FG000|Open-label Period|Withdrawal by Subject|0|||
155732971|NCT01166282|562120031|FG001|Open-label Period|Withdrawal by Subject|0|||
155732972|NCT01166282|562120032|FG002|Open-label Period|Withdrawal by Subject|4|||
155388885|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
155388886|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
155388887|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388888|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388889|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388890|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388891|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388892|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388893|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388894|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
155388895|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
155388896|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388897|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388898|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388899|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
155388900|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
155388901|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
155388902|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388903|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
155388904|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
155388905|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
155388906|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388907|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388908|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388909|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
155388910|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
155388911|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
155732973|NCT01166282|562120030|FG000|Open-label Period|Lack of Efficacy|0|||
155732974|NCT01166282|562120031|FG001|Open-label Period|Lack of Efficacy|0|||
155732975|NCT01166282|562120032|FG002|Open-label Period|Lack of Efficacy|2|||
155388912|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
155388913|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
155388914|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
155732976|NCT01166282|562120030|FG000|Open-label Period|Remission|0|||
155732977|NCT01166282|562120031|FG001|Open-label Period|Remission|0|||
155732978|NCT01166282|562120032|FG002|Open-label Period|Remission|4|||
155630204|NCT01454284|561743049|FG001|Overall Study|Withdrawal by Subject|36|||
155630205|NCT01454284|561743048|FG000|Overall Study|Physician Decision|16|||
155630206|NCT01454284|561743049|FG001|Overall Study|Physician Decision|11|||
155630207|NCT01454284|561743048|FG000|Overall Study|Sponsor Decision|0|||
155630208|NCT01454284|561743049|FG001|Overall Study|Sponsor Decision|2|||
155630209|NCT02842866|561743050|FG000|Overall Study|Serious Adverse Event|0|||
155630210|NCT02842866|561743051|FG001|Overall Study|Serious Adverse Event|1|||
155630211|NCT02842866|561743050|FG000|Overall Study|Protocol Violation|4|||
155630212|NCT02842866|561743051|FG001|Overall Study|Protocol Violation|2|||
155630213|NCT02842866|561743050|FG000|Overall Study|Lost to Follow-up|2|||
155630214|NCT02842866|561743051|FG001|Overall Study|Lost to Follow-up|0|||
155630215|NCT02842866|561743050|FG000|Overall Study|Withdrawal by Subject|1|||
155630216|NCT02842866|561743051|FG001|Overall Study|Withdrawal by Subject|0|||
155630217|NCT01432327|561743052|FG000|Posttest 3 Months|depression|3|||
155630218|NCT01432327|561743053|FG001|Posttest 3 Months|depression|0|||
155630219|NCT01432327|561743054|FG002|Posttest 3 Months|depression|0|||
155630220|NCT01432327|561743055|FG003|Posttest 3 Months|depression|0|||
155630221|NCT01432327|561743052|FG000|Posttest 3 Months|Lost to Follow-up|1|||
155630222|NCT01432327|561743053|FG001|Posttest 3 Months|Lost to Follow-up|0|||
155630223|NCT01432327|561743054|FG002|Posttest 3 Months|Lost to Follow-up|2|||
155630224|NCT01432327|561743055|FG003|Posttest 3 Months|Lost to Follow-up|1|||
155630225|NCT01432327|561743052|FG000|Posttest 3 Months|Allergic reaction|0|||
155630226|NCT01432327|561743053|FG001|Posttest 3 Months|Allergic reaction|2|||
155630227|NCT01432327|561743054|FG002|Posttest 3 Months|Allergic reaction|0|||
155630228|NCT01432327|561743055|FG003|Posttest 3 Months|Allergic reaction|0|||
155630229|NCT01432327|561743052|FG000|Posttest 6 Months|Lost to Follow-up|0|||
155630230|NCT01432327|561743053|FG001|Posttest 6 Months|Lost to Follow-up|0|||
155630231|NCT01432327|561743054|FG002|Posttest 6 Months|Lost to Follow-up|3|||
155630232|NCT01432327|561743055|FG003|Posttest 6 Months|Lost to Follow-up|2|||
155630233|NCT01432327|561743052|FG000|Posttest 6 Months|Allergic reaction|0|||
155630234|NCT01432327|561743053|FG001|Posttest 6 Months|Allergic reaction|0|||
155630235|NCT01432327|561743054|FG002|Posttest 6 Months|Allergic reaction|1|||
155630236|NCT01432327|561743055|FG003|Posttest 6 Months|Allergic reaction|0|||
155630237|NCT01432327|561743052|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
155630238|NCT01432327|561743053|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
155630239|NCT01432327|561743054|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
155630240|NCT01432327|561743055|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
155630241|NCT01432327|561743052|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
155630242|NCT01432327|561743053|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
155630243|NCT01432327|561743054|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
155630244|NCT01432327|561743055|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
155630245|NCT01432327|561743052|FG000|Posttest 1 Year|Lost to Follow-up|0|||
155630246|NCT01432327|561743053|FG001|Posttest 1 Year|Lost to Follow-up|0|||
155630247|NCT01432327|561743054|FG002|Posttest 1 Year|Lost to Follow-up|4|||
155630248|NCT01432327|561743055|FG003|Posttest 1 Year|Lost to Follow-up|2|||
155630249|NCT01432327|561743052|FG000|Posttest 1 Year|Allergic reaction|0|||
155630250|NCT01432327|561743053|FG001|Posttest 1 Year|Allergic reaction|0|||
155630251|NCT01432327|561743054|FG002|Posttest 1 Year|Allergic reaction|1|||
155630252|NCT01432327|561743055|FG003|Posttest 1 Year|Allergic reaction|1|||
155630253|NCT03248037|561743056|FG000|Overall Study|Withdrawal by Subject|6|||
155630254|NCT03248037|561743057|FG001|Overall Study|Withdrawal by Subject|9|||
155630255|NCT03248037|561743056|FG000|Overall Study|Adverse Event|15|||
155630256|NCT03248037|561743057|FG001|Overall Study|Adverse Event|0|||
155630257|NCT02897349|561743061|FG000|Overall Study|Lost to Follow-up|2|||
155630258|NCT02897349|561743062|FG001|Overall Study|Lost to Follow-up|2|||
155630259|NCT02897349|561743061|FG000|Overall Study|Adverse Event|3|||
155630260|NCT02897349|561743062|FG001|Overall Study|Adverse Event|3|||
155630261|NCT02897349|561743061|FG000|Overall Study|Other than listed above|0|||
155630262|NCT02897349|561743062|FG001|Overall Study|Other than listed above|1|||
155630263|NCT03055013|561743064|FG000|Overall Study|Adverse Event|78|||
155630264|NCT03055013|561743065|FG001|Overall Study|Adverse Event|0|||
155281649|NCT02507219|560461691|FG004|Overall Study|Withdrawal by Subject|1|||
155630265|NCT03055013|561743064|FG000|Overall Study|Death|6|||
155630266|NCT03055013|561743065|FG001|Overall Study|Death|0|||
155630267|NCT03055013|561743064|FG000|Overall Study|Disease relapse|33|||
155281650|NCT02507219|560461692|FG005|Overall Study|Withdrawal by Subject|0|||
155281651|NCT02886936|560461693|FG000|Overall Study|Lost to Follow-up|4|||
155281652|NCT02886936|560461694|FG001|Overall Study|Lost to Follow-up|3|||
155281653|NCT02886936|560461695|FG002|Overall Study|Lost to Follow-up|0|||
155281654|NCT04562779|560461696|FG000|Overall Study|Lost to Follow-up|7|||
155281655|NCT04562779|560461697|FG001|Overall Study|Lost to Follow-up|5|||
155281656|NCT04562779|560461698|FG002|Overall Study|Lost to Follow-up|10|||
155281657|NCT04562779|560461696|FG000|Overall Study|Protocol Violation|2|||
155281658|NCT04562779|560461697|FG001|Overall Study|Protocol Violation|2|||
155281659|NCT04562779|560461698|FG002|Overall Study|Protocol Violation|0|||
155281660|NCT02320721|560461699|FG000|Overall Study|Adverse Event|6|||
155281661|NCT02320721|560461700|FG001|Overall Study|Adverse Event|6|||
155281662|NCT02320721|560461699|FG000|Overall Study|Lack of Efficacy|2|||
155732979|NCT01166282|562120030|FG000|Open-label Period|Irregular Compliance|0|||
155732980|NCT01166282|562120031|FG001|Open-label Period|Irregular Compliance|0|||
155732981|NCT01166282|562120032|FG002|Open-label Period|Irregular Compliance|1|||
155732982|NCT02577718|562120033|FG000|Overall Study|Death|6|||
155732983|NCT02577718|562120033|FG000|Overall Study|Withdrawal by Subject|2|||
155732984|NCT01075685|562120034|FG000|Overall Study|Protocol Violation|9|||
155732985|NCT01075685|562120035|FG001|Overall Study|Protocol Violation|1|||
155388915|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388916|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388917|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
155388918|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
155388919|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388920|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
155388921|NCT01074216|560858768|FG000|Overall Study|Physician Decision|1|||
155388922|NCT01074216|560858768|FG000|Overall Study|Not Treated|12|||
155388923|NCT01323634|560858769|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
155388924|NCT01323634|560858770|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
155388925|NCT01323634|560858771|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
155388926|NCT01323634|560858769|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
155388927|NCT01323634|560858770|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
155388928|NCT01323634|560858771|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
155388929|NCT01323634|560858769|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
155388930|NCT01323634|560858770|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155388931|NCT01323634|560858771|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155388932|NCT01323634|560858769|FG000|2-week Run-in Period|Physician Decision|5|||
155388933|NCT01323634|560858770|FG001|2-week Run-in Period|Physician Decision|0|||
155388934|NCT01323634|560858771|FG002|2-week Run-in Period|Physician Decision|0|||
155388935|NCT01323634|560858769|FG000|2-week Run-in Period|Protocol Violation|1|||
155388936|NCT01323634|560858770|FG001|2-week Run-in Period|Protocol Violation|0|||
155388937|NCT01323634|560858771|FG002|2-week Run-in Period|Protocol Violation|0|||
155388938|NCT01323634|560858769|FG000|2-week Run-in Period|Adverse Event|1|||
155388939|NCT01323634|560858770|FG001|2-week Run-in Period|Adverse Event|0|||
155388940|NCT01323634|560858771|FG002|2-week Run-in Period|Adverse Event|0|||
155388941|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155388942|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
155388943|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
155388944|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155388945|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155388946|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
155388947|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155630268|NCT03055013|561743065|FG001|Overall Study|Disease relapse|0|||
155630269|NCT03055013|561743064|FG000|Overall Study|Withdrawal by Subject|28|||
155630270|NCT03055013|561743065|FG001|Overall Study|Withdrawal by Subject|0|||
155630271|NCT03055013|561743064|FG000|Overall Study|Other complicating disease|5|||
155630272|NCT03055013|561743065|FG001|Overall Study|Other complicating disease|0|||
155630273|NCT03055013|561743064|FG000|Overall Study|Physician Decision|1|||
155630274|NCT03055013|561743065|FG001|Overall Study|Physician Decision|0|||
155630275|NCT03055013|561743064|FG000|Overall Study|Benign mass/non-RCC|4|||
155630276|NCT03055013|561743065|FG001|Overall Study|Benign mass/non-RCC|0|||
155630277|NCT03055013|561743064|FG000|Overall Study|Enrolled in another trial|1|||
155630278|NCT03055013|561743065|FG001|Overall Study|Enrolled in another trial|0|||
155630279|NCT03055013|561743064|FG000|Overall Study|Non-protocol therapy|1|||
155630280|NCT03055013|561743065|FG001|Overall Study|Non-protocol therapy|0|||
155630281|NCT03055013|561743064|FG000|Overall Study|Incompliance|1|||
155630282|NCT03055013|561743065|FG001|Overall Study|Incompliance|0|||
155630283|NCT03055013|561743064|FG000|Overall Study|Insurance issues|1|||
155630284|NCT03055013|561743065|FG001|Overall Study|Insurance issues|0|||
155630285|NCT03055013|561743064|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
155630286|NCT03055013|561743065|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
155630287|NCT03055013|561743064|FG000|Overall Study|Did not receive nivolumab|10|||
155630288|NCT03055013|561743065|FG001|Overall Study|Did not receive nivolumab|0|||
155630289|NCT03055013|561743064|FG000|Overall Study|Did not receive surgery|0|||
155630290|NCT03055013|561743065|FG001|Overall Study|Did not receive surgery|28|||
155732986|NCT01075685|562120034|FG000|Overall Study|Withdrawal by Subject|20|||
155388948|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
155388949|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
155388950|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155388951|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155630291|NCT03435055|561743066|FG000|Screening|Physician Decision|2|||
155630292|NCT03435055|561743066|FG000|Received Intervention|Did not complete nitrous administration|3|||
155630293|NCT03817528|561743067|FG000|Overall Study|Withdrawal by Subject|1|||
155732987|NCT01075685|562120035|FG001|Overall Study|Withdrawal by Subject|5|||
155732988|NCT01075685|562120034|FG000|Overall Study|Lost to Follow-up|563|||
155732989|NCT01075685|562120035|FG001|Overall Study|Lost to Follow-up|220|||
155732990|NCT02858362|562120038|FG000|Overall Study|Protocol Violation|0|||
155732991|NCT02858362|562120039|FG001|Overall Study|Protocol Violation|1|||
155732992|NCT02858362|562120040|FG002|Overall Study|Protocol Violation|0|||
155732993|NCT02858362|562120038|FG000|Overall Study|Withdrawal by Subject|1|||
155732994|NCT02858362|562120039|FG001|Overall Study|Withdrawal by Subject|0|||
155732995|NCT02858362|562120040|FG002|Overall Study|Withdrawal by Subject|0|||
155732996|NCT02858362|562120038|FG000|Overall Study|Early Study Termination|0|||
155732997|NCT02858362|562120039|FG001|Overall Study|Early Study Termination|0|||
155732998|NCT02858362|562120040|FG002|Overall Study|Early Study Termination|3|||
155732999|NCT02858362|562120038|FG000|Overall Study|Lost to Follow-up|1|||
155733000|NCT02858362|562120039|FG001|Overall Study|Lost to Follow-up|0|||
155733001|NCT02858362|562120040|FG002|Overall Study|Lost to Follow-up|0|||
155733002|NCT02194985|562120042|FG000|Overall Study|Adverse Event|1|||
155733003|NCT02194985|562120042|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
155733004|NCT02194985|562120042|FG000|Overall Study|Physician Decision|4|||
155733005|NCT02194985|562120042|FG000|Overall Study|Lost to Follow-up|1|||
155733006|NCT02194985|562120042|FG000|Overall Study|Withdrawal by Subject|2|||
155733007|NCT02561832|562120051|FG000|Overall Study|Withdrawal by Subject|1|||
155733008|NCT02561832|562120052|FG001|Overall Study|Withdrawal by Subject|1|||
155733009|NCT02561832|562120051|FG000|Overall Study|Adverse Event|3|||
155733010|NCT02561832|562120052|FG001|Overall Study|Adverse Event|0|||
155733011|NCT02561832|562120051|FG000|Overall Study|Disease progression|3|||
155733012|NCT02561832|562120052|FG001|Overall Study|Disease progression|3|||
155733013|NCT02304367|562120053|FG000|Overall Study|Lack of Response to Bruosumab|1|||
155733014|NCT02304367|562120053|FG000|Overall Study|Sponsor Decision|3|||
155733015|NCT02304367|562120053|FG000|Overall Study|Death|2|||
155733016|NCT02304367|562120053|FG000|Overall Study|Physician Decision|1|||
155733017|NCT02304367|562120053|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
155733018|NCT00594815|562120054|FG000|Overall Study|Never Treated|3|||
155733019|NCT00594815|562120054|FG000|Overall Study|Withdrawal by Subject|2|||
155733020|NCT00594815|562120054|FG000|Overall Study|Toxicity|4|||
155733021|NCT03527732|562120055|FG000|Overall Study|Lost to Follow-up|21|||
155733022|NCT03527732|562120056|FG001|Overall Study|Lost to Follow-up|23|||
155733023|NCT03527732|562120057|FG002|Overall Study|Lost to Follow-up|80|||
155733024|NCT03527732|562120058|FG003|Overall Study|Lost to Follow-up|62|||
155733025|NCT03527732|562120059|FG004|Overall Study|Lost to Follow-up|12|||
155733026|NCT03527732|562120060|FG005|Overall Study|Lost to Follow-up|20|||
155733027|NCT03599089|562120061|FG000|Overall Study|Lost to Follow-up|1|||
155733028|NCT03599089|562120062|FG001|Overall Study|Lost to Follow-up|0|||
155733029|NCT03599089|562120063|FG002|Overall Study|Lost to Follow-up|0|||
155733030|NCT03599089|562120064|FG003|Overall Study|Lost to Follow-up|0|||
155733031|NCT03599089|562120061|FG000|Overall Study|Withdrawal by Subject|2|||
155733032|NCT03599089|562120062|FG001|Overall Study|Withdrawal by Subject|1|||
155733033|NCT03599089|562120063|FG002|Overall Study|Withdrawal by Subject|0|||
155733034|NCT03599089|562120064|FG003|Overall Study|Withdrawal by Subject|0|||
155733035|NCT03599089|562120061|FG000|Overall Study|Lack of Efficacy|0|||
155733036|NCT03599089|562120062|FG001|Overall Study|Lack of Efficacy|0|||
155733037|NCT03599089|562120063|FG002|Overall Study|Lack of Efficacy|1|||
155733038|NCT03599089|562120064|FG003|Overall Study|Lack of Efficacy|2|||
155733039|NCT03214666|562120065|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155733040|NCT03214666|562120066|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155733041|NCT03214666|562120067|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155733042|NCT03214666|562120068|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155733043|NCT03214666|562120069|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
155733044|NCT03214666|562120070|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155733045|NCT02207088|562120076|FG000|Overall Study|Adverse Event|2|||
155733046|NCT00541385|562120086|FG000|Overall Study|Adverse Event|6|||
155733047|NCT00541385|562120087|FG001|Overall Study|Adverse Event|3|||
155733048|NCT00541385|562120086|FG000|Overall Study|Withdrawal by Subject|2|||
155733049|NCT00541385|562120087|FG001|Overall Study|Withdrawal by Subject|2|||
155733050|NCT00541385|562120086|FG000|Overall Study|Lost to Follow-up|6|||
155733051|NCT00541385|562120087|FG001|Overall Study|Lost to Follow-up|1|||
155733052|NCT00541385|562120086|FG000|Overall Study|Parasite reappearance/malaria|67|||
155733053|NCT00541385|562120087|FG001|Overall Study|Parasite reappearance/malaria|32|||
155733054|NCT03155841|562120088|FG000|Overall Study|Protocol Violation|3|||
155733055|NCT03155841|562120089|FG001|Overall Study|Protocol Violation|4|||
155733056|NCT04411667|562120090|FG000|Overall Study|Physician Decision|1|||
155733057|NCT04411667|562120091|FG001|Overall Study|Physician Decision|0|||
155733058|NCT00949702|562120092|FG000|Overall Study|Death|40|||
155733059|NCT00949702|562120092|FG000|Overall Study|Disease progression|7|||
155388952|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155733060|NCT00949702|562120092|FG000|Overall Study|Withdrawal of consent|1|||
155733061|NCT03399552|562120093|FG000|Overall Study|No evidence of disease|1|||
155733062|NCT03399552|562120093|FG000|Overall Study|Unevaluable|1|||
155733063|NCT01286480|562120095|FG000|Overall Study|Withdrawal by Subject|5|||
155733064|NCT01286480|562120096|FG001|Overall Study|Withdrawal by Subject|3|||
155733065|NCT00834093|562120097|FG000|Overall Study|Progressive Disease|3|||
155733066|NCT00834093|562120097|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
155733067|NCT00606593|562120098|FG000|Overall Study|Adverse Event|0|||
155733068|NCT00606593|562120099|FG001|Overall Study|Adverse Event|0|||
155733069|NCT00606593|562120100|FG002|Overall Study|Adverse Event|0|||
155733070|NCT00606593|562120101|FG003|Overall Study|Adverse Event|1|||
155733071|NCT00606593|562120102|FG004|Overall Study|Adverse Event|1|||
155733072|NCT00606593|562120103|FG005|Overall Study|Adverse Event|0|||
155733073|NCT00606593|562120104|FG006|Overall Study|Adverse Event|1|||
155733074|NCT00606593|562120105|FG007|Overall Study|Adverse Event|2|||
155733075|NCT00606593|562120106|FG008|Overall Study|Adverse Event|1|||
155733076|NCT00606593|562120107|FG009|Overall Study|Adverse Event|0|||
155733077|NCT00606593|562120098|FG000|Overall Study|Withdrawal of consent|1|||
155733078|NCT00606593|562120099|FG001|Overall Study|Withdrawal of consent|0|||
155733079|NCT00606593|562120100|FG002|Overall Study|Withdrawal of consent|1|||
155733080|NCT00606593|562120101|FG003|Overall Study|Withdrawal of consent|0|||
155733081|NCT00606593|562120102|FG004|Overall Study|Withdrawal of consent|0|||
155733082|NCT00606593|562120103|FG005|Overall Study|Withdrawal of consent|0|||
155733083|NCT00606593|562120104|FG006|Overall Study|Withdrawal of consent|0|||
155733084|NCT00606593|562120105|FG007|Overall Study|Withdrawal of consent|0|||
155733085|NCT00606593|562120106|FG008|Overall Study|Withdrawal of consent|0|||
155733086|NCT00606593|562120107|FG009|Overall Study|Withdrawal of consent|0|||
155733087|NCT00606593|562120098|FG000|Overall Study|Administrative/Other|0|||
155733088|NCT00606593|562120099|FG001|Overall Study|Administrative/Other|0|||
155733089|NCT00606593|562120100|FG002|Overall Study|Administrative/Other|1|||
155733090|NCT00606593|562120101|FG003|Overall Study|Administrative/Other|0|||
155733091|NCT00606593|562120102|FG004|Overall Study|Administrative/Other|0|||
155733092|NCT00606593|562120103|FG005|Overall Study|Administrative/Other|0|||
155733093|NCT00606593|562120104|FG006|Overall Study|Administrative/Other|0|||
155733094|NCT00606593|562120105|FG007|Overall Study|Administrative/Other|0|||
155733095|NCT00606593|562120106|FG008|Overall Study|Administrative/Other|0|||
155733096|NCT00606593|562120107|FG009|Overall Study|Administrative/Other|0|||
155733097|NCT01724346|562120108|FG000|Overall Study|Death|42|||
155733098|NCT01724346|562120109|FG001|Overall Study|Death|42|||
155733099|NCT01724346|562120108|FG000|Overall Study|Lost to Follow-up|5|||
155733100|NCT01724346|562120109|FG001|Overall Study|Lost to Follow-up|1|||
155733101|NCT01724346|562120108|FG000|Overall Study|Withdrawal by Subject|27|||
155733102|NCT01724346|562120109|FG001|Overall Study|Withdrawal by Subject|19|||
155733103|NCT01724346|562120108|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
155733104|NCT01724346|562120109|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
155733105|NCT01642589|562120110|FG000|Overall Study|Withdrawal by Subject|1|||
155733106|NCT01642589|562120111|FG001|Overall Study|Withdrawal by Subject|1|||
155733107|NCT00759941|562120116|FG000|Overall Study|Use of medication|1|||
155733108|NCT00759941|562120117|FG001|Overall Study|Use of medication|0|||
155733109|NCT00759941|562120116|FG000|Overall Study|Adverse Event|1|||
155733110|NCT00759941|562120117|FG001|Overall Study|Adverse Event|0|||
155733111|NCT00759941|562120116|FG000|Overall Study|Exited in error by site|1|||
155733112|NCT00759941|562120117|FG001|Overall Study|Exited in error by site|1|||
155733113|NCT02736578|562120118|FG000|Overall Study|Adverse Event|1|||
155733114|NCT02736578|562120119|FG001|Overall Study|Adverse Event|0|||
155733115|NCT00802945|562120120|FG000|Overall Study|Death|27|||
155281663|NCT02320721|560461700|FG001|Overall Study|Lack of Efficacy|0|||
155281664|NCT02320721|560461699|FG000|Overall Study|Poor compliance to protocol|3|||
155281665|NCT02320721|560461700|FG001|Overall Study|Poor compliance to protocol|7|||
155281666|NCT02320721|560461699|FG000|Overall Study|Randomized but not treated|0|||
155281667|NCT02320721|560461700|FG001|Overall Study|Randomized but not treated|1|||
155281668|NCT02320721|560461699|FG000|Overall Study|Hypoglycemia|1|||
155281669|NCT02320721|560461700|FG001|Overall Study|Hypoglycemia|0|||
155281670|NCT02320721|560461699|FG000|Overall Study|Other than specified above|15|||
155281671|NCT02320721|560461700|FG001|Overall Study|Other than specified above|20|||
155281672|NCT03173248|560461701|FG000|Overall Study|Death|28|||
155281673|NCT03173248|560461702|FG001|Overall Study|Death|46|||
155281674|NCT03173248|560461701|FG000|Overall Study|Lost to Follow-up|0|||
155281675|NCT03173248|560461702|FG001|Overall Study|Lost to Follow-up|1|||
155281676|NCT03173248|560461701|FG000|Overall Study|Withdrawal by Subject|6|||
155281677|NCT03173248|560461702|FG001|Overall Study|Withdrawal by Subject|4|||
155281678|NCT03173248|560461701|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
155281679|NCT03173248|560461702|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
155281680|NCT01544582|560461703|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
155281681|NCT01544582|560461704|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281682|NCT01544582|560461705|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281683|NCT01544582|560461706|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281684|NCT01544582|560461703|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
155281685|NCT01544582|560461704|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155281686|NCT01544582|560461705|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155281687|NCT01544582|560461706|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155388953|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
155388954|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
155388955|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
155388956|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155388957|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
155388958|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
155630294|NCT03817528|561743067|FG000|Overall Study|Adverse Event|2|||
155630295|NCT00671749|561743073|FG000|Overall Study|Adverse Event|2|||
155630296|NCT00671749|561743073|FG000|Overall Study|Withdrawal by Subject|4|||
155630297|NCT00671749|561743073|FG000|Overall Study|Protocol Violation|1|||
155630298|NCT00671749|561743073|FG000|Overall Study|Lost to Follow-up|1|||
155630299|NCT03937778|561743079|FG000|Overall Study|Withdrawal by Subject|1|||
155630300|NCT03937778|561743079|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
155630301|NCT01200355|561743080|FG000|Overall Study|Death|7|||
155630302|NCT01200355|561743081|FG001|Overall Study|Death|2|||
155630303|NCT00485303|561743082|FG000|Overall Study|Adverse Event|5|||
155630304|NCT00485303|561743082|FG000|Overall Study|Progressive Disease|44|||
155630305|NCT00485303|561743082|FG000|Overall Study|Other|3|||
155630306|NCT00485303|561743082|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
155630307|NCT00485303|561743082|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
155630308|NCT01281306|561743084|FG000|Overall Study|Lack of Efficacy|0|||
155630309|NCT01281306|561743085|FG001|Overall Study|Lack of Efficacy|1|||
155630310|NCT01281306|561743086|FG002|Overall Study|Lack of Efficacy|3|||
155630311|NCT01281306|561743087|FG003|Overall Study|Lack of Efficacy|0|||
155630312|NCT01281306|561743088|FG004|Overall Study|Lack of Efficacy|2|||
155630313|NCT01281306|561743089|FG005|Overall Study|Lack of Efficacy|0|||
155630314|NCT01281306|561743090|FG006|Overall Study|Lack of Efficacy|1|||
155630315|NCT01281306|561743084|FG000|Overall Study|Withdrawal by Subject|1|||
155630316|NCT01281306|561743085|FG001|Overall Study|Withdrawal by Subject|0|||
155630317|NCT01281306|561743086|FG002|Overall Study|Withdrawal by Subject|2|||
155630318|NCT01281306|561743087|FG003|Overall Study|Withdrawal by Subject|4|||
155630319|NCT01281306|561743088|FG004|Overall Study|Withdrawal by Subject|1|||
155630320|NCT01281306|561743089|FG005|Overall Study|Withdrawal by Subject|3|||
155630321|NCT01281306|561743090|FG006|Overall Study|Withdrawal by Subject|1|||
155630322|NCT01281306|561743084|FG000|Overall Study|Protocol deviation|0|||
155630323|NCT01281306|561743085|FG001|Overall Study|Protocol deviation|1|||
155630324|NCT01281306|561743086|FG002|Overall Study|Protocol deviation|1|||
155630325|NCT01281306|561743087|FG003|Overall Study|Protocol deviation|1|||
155630326|NCT01281306|561743088|FG004|Overall Study|Protocol deviation|1|||
155630327|NCT01281306|561743089|FG005|Overall Study|Protocol deviation|0|||
155630328|NCT01281306|561743090|FG006|Overall Study|Protocol deviation|0|||
155630329|NCT01281306|561743084|FG000|Overall Study|Condition no longer requires study drug|1|||
155630330|NCT01281306|561743085|FG001|Overall Study|Condition no longer requires study drug|0|||
155630331|NCT01281306|561743086|FG002|Overall Study|Condition no longer requires study drug|0|||
155630332|NCT01281306|561743087|FG003|Overall Study|Condition no longer requires study drug|0|||
155630333|NCT01281306|561743088|FG004|Overall Study|Condition no longer requires study drug|0|||
155630334|NCT01281306|561743089|FG005|Overall Study|Condition no longer requires study drug|1|||
155630335|NCT01281306|561743090|FG006|Overall Study|Condition no longer requires study drug|1|||
155630336|NCT01281306|561743084|FG000|Overall Study|Lost to Follow-up|1|||
155630337|NCT01281306|561743085|FG001|Overall Study|Lost to Follow-up|0|||
155630338|NCT01281306|561743086|FG002|Overall Study|Lost to Follow-up|0|||
155630339|NCT01281306|561743087|FG003|Overall Study|Lost to Follow-up|2|||
155630340|NCT01281306|561743088|FG004|Overall Study|Lost to Follow-up|0|||
155630341|NCT01281306|561743089|FG005|Overall Study|Lost to Follow-up|0|||
155630342|NCT01281306|561743090|FG006|Overall Study|Lost to Follow-up|1|||
155630343|NCT01281306|561743084|FG000|Overall Study|Death|1|||
155630344|NCT01281306|561743085|FG001|Overall Study|Death|0|||
155630345|NCT01281306|561743086|FG002|Overall Study|Death|0|||
155630346|NCT01281306|561743087|FG003|Overall Study|Death|0|||
155630347|NCT01281306|561743088|FG004|Overall Study|Death|0|||
155630348|NCT01281306|561743089|FG005|Overall Study|Death|0|||
155630349|NCT01281306|561743090|FG006|Overall Study|Death|0|||
155630350|NCT01281306|561743084|FG000|Overall Study|Adverse Event|3|||
155388959|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
155630351|NCT01281306|561743085|FG001|Overall Study|Adverse Event|2|||
155630352|NCT01281306|561743086|FG002|Overall Study|Adverse Event|2|||
155630353|NCT01281306|561743087|FG003|Overall Study|Adverse Event|3|||
155630354|NCT01281306|561743088|FG004|Overall Study|Adverse Event|5|||
155630355|NCT01281306|561743089|FG005|Overall Study|Adverse Event|3|||
155630356|NCT01281306|561743090|FG006|Overall Study|Adverse Event|3|||
155630357|NCT01281306|561743084|FG000|Overall Study|Randomized in error|1|||
155630358|NCT01281306|561743085|FG001|Overall Study|Randomized in error|0|||
155630359|NCT01281306|561743086|FG002|Overall Study|Randomized in error|0|||
155630360|NCT01281306|561743087|FG003|Overall Study|Randomized in error|1|||
155630361|NCT01281306|561743088|FG004|Overall Study|Randomized in error|0|||
155630362|NCT01281306|561743089|FG005|Overall Study|Randomized in error|0|||
155630363|NCT01281306|561743090|FG006|Overall Study|Randomized in error|0|||
155630364|NCT02410629|561743091|FG000|Overall Study|Family cannot commit to the study|2|||
155630365|NCT02410629|561743092|FG001|Overall Study|Family cannot commit to the study|1|||
155630366|NCT02410629|561743091|FG000|Overall Study|Subject returned to work|1|||
155630367|NCT02410629|561743092|FG001|Overall Study|Subject returned to work|0|||
155630368|NCT02410629|561743091|FG000|Overall Study|Subject moved back to home country|0|||
155630369|NCT02410629|561743092|FG001|Overall Study|Subject moved back to home country|1|||
155630370|NCT02410629|561743091|FG000|Overall Study|Subject underwent heart surgery|0|||
155630371|NCT02410629|561743092|FG001|Overall Study|Subject underwent heart surgery|1|||
155630372|NCT06129149|561743093|FG000|Overall Study|Death|1|||
155630373|NCT04649359|561743094|FG000|Overall Study|Withdrawal by Subject|7|||
155630374|NCT04649359|561743095|FG001|Overall Study|Withdrawal by Subject|7|||
155630375|NCT04649359|561743094|FG000|Overall Study|Death|41|||
155630376|NCT04649359|561743095|FG001|Overall Study|Death|26|||
155630377|NCT04649359|561743094|FG000|Overall Study|Ongoing in the study|75|||
155630378|NCT04649359|561743095|FG001|Overall Study|Ongoing in the study|31|||
155630379|NCT05911841|561743096|FG000|Induction Period|Study Terminated by Sponsor|2|||
155630380|NCT05911841|561743097|FG001|Induction Period|Study Terminated by Sponsor|0|||
155630381|NCT05911841|561743098|FG002|Induction Period|Study Terminated by Sponsor|14|||
155630382|NCT05911841|561743099|FG003|Induction Period|Study Terminated by Sponsor|6|||
155630383|NCT05911841|561743100|FG004|Induction Period|Study Terminated by Sponsor|0|||
155630384|NCT05911841|561743101|FG005|Induction Period|Study Terminated by Sponsor|0|||
155630385|NCT05911841|561743102|FG006|Induction Period|Study Terminated by Sponsor|0|||
155630386|NCT05911841|561743103|FG007|Induction Period|Study Terminated by Sponsor|0|||
155630387|NCT05911841|561743104|FG008|Induction Period|Study Terminated by Sponsor|0|||
155630388|NCT05911841|561743105|FG009|Induction Period|Study Terminated by Sponsor|0|||
155630389|NCT05911841|561743096|FG000|Induction Period|Withdrawal by Subject|4|||
155630390|NCT05911841|561743097|FG001|Induction Period|Withdrawal by Subject|3|||
155630391|NCT05911841|561743098|FG002|Induction Period|Withdrawal by Subject|4|||
155630392|NCT05911841|561743099|FG003|Induction Period|Withdrawal by Subject|6|||
155630393|NCT05911841|561743100|FG004|Induction Period|Withdrawal by Subject|0|||
155630394|NCT05911841|561743101|FG005|Induction Period|Withdrawal by Subject|0|||
155630395|NCT05911841|561743102|FG006|Induction Period|Withdrawal by Subject|0|||
155630396|NCT05911841|561743103|FG007|Induction Period|Withdrawal by Subject|0|||
155630397|NCT05911841|561743104|FG008|Induction Period|Withdrawal by Subject|0|||
155630398|NCT05911841|561743105|FG009|Induction Period|Withdrawal by Subject|0|||
155630399|NCT05911841|561743096|FG000|Induction Period|Lack of Efficacy|3|||
155630400|NCT05911841|561743097|FG001|Induction Period|Lack of Efficacy|0|||
155630401|NCT05911841|561743098|FG002|Induction Period|Lack of Efficacy|3|||
155630402|NCT05911841|561743099|FG003|Induction Period|Lack of Efficacy|3|||
155630403|NCT05911841|561743100|FG004|Induction Period|Lack of Efficacy|0|||
155630404|NCT05911841|561743101|FG005|Induction Period|Lack of Efficacy|0|||
155630405|NCT05911841|561743102|FG006|Induction Period|Lack of Efficacy|0|||
155630406|NCT05911841|561743103|FG007|Induction Period|Lack of Efficacy|0|||
155630407|NCT05911841|561743104|FG008|Induction Period|Lack of Efficacy|0|||
155630408|NCT05911841|561743105|FG009|Induction Period|Lack of Efficacy|0|||
155630409|NCT05911841|561743096|FG000|Induction Period|Adverse Event|3|||
155630410|NCT05911841|561743097|FG001|Induction Period|Adverse Event|1|||
155630411|NCT05911841|561743098|FG002|Induction Period|Adverse Event|2|||
155630412|NCT05911841|561743099|FG003|Induction Period|Adverse Event|0|||
155630413|NCT05911841|561743100|FG004|Induction Period|Adverse Event|0|||
155630414|NCT05911841|561743101|FG005|Induction Period|Adverse Event|0|||
155630415|NCT05911841|561743102|FG006|Induction Period|Adverse Event|0|||
155630416|NCT05911841|561743103|FG007|Induction Period|Adverse Event|0|||
155630417|NCT05911841|561743104|FG008|Induction Period|Adverse Event|0|||
155630418|NCT05911841|561743105|FG009|Induction Period|Adverse Event|0|||
155630419|NCT05911841|561743096|FG000|Induction Period|Assigned Treatment by Mistake|0|||
155630420|NCT05911841|561743097|FG001|Induction Period|Assigned Treatment by Mistake|1|||
155630421|NCT05911841|561743098|FG002|Induction Period|Assigned Treatment by Mistake|0|||
155630422|NCT05911841|561743099|FG003|Induction Period|Assigned Treatment by Mistake|1|||
155630423|NCT05911841|561743100|FG004|Induction Period|Assigned Treatment by Mistake|0|||
155630424|NCT05911841|561743101|FG005|Induction Period|Assigned Treatment by Mistake|0|||
155630425|NCT05911841|561743102|FG006|Induction Period|Assigned Treatment by Mistake|0|||
155630426|NCT05911841|561743103|FG007|Induction Period|Assigned Treatment by Mistake|0|||
155630427|NCT05911841|561743104|FG008|Induction Period|Assigned Treatment by Mistake|0|||
155630428|NCT05911841|561743105|FG009|Induction Period|Assigned Treatment by Mistake|0|||
155630429|NCT05911841|561743096|FG000|Induction Period|Lost to Follow-up|0|||
155630430|NCT05911841|561743097|FG001|Induction Period|Lost to Follow-up|0|||
155630431|NCT05911841|561743098|FG002|Induction Period|Lost to Follow-up|1|||
155733116|NCT00802945|562120121|FG001|Overall Study|Death|23|||
155733117|NCT00802945|562120120|FG000|Overall Study|Terminated by sponsor|8|||
155733118|NCT00802945|562120121|FG001|Overall Study|Terminated by sponsor|12|||
155630432|NCT05911841|561743099|FG003|Induction Period|Lost to Follow-up|1|||
155630433|NCT05911841|561743100|FG004|Induction Period|Lost to Follow-up|0|||
155630434|NCT05911841|561743101|FG005|Induction Period|Lost to Follow-up|0|||
155630435|NCT05911841|561743102|FG006|Induction Period|Lost to Follow-up|0|||
155733119|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155733120|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
155733121|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155733122|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155733123|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155733124|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
155733125|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155733126|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155733127|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
155733128|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
155733129|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
155733130|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
155733131|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
155733132|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
155733133|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
155733134|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
155733135|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155733136|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
155733137|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155733138|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155733139|NCT05307692|562120122|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
155733140|NCT05307692|562120123|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
155733141|NCT05307692|562120124|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
155733142|NCT05307692|562120125|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
155733143|NCT05307692|562120122|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155733144|NCT05307692|562120123|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155733145|NCT05307692|562120124|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155733146|NCT05307692|562120125|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
155733147|NCT05307692|562120122|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155733148|NCT05307692|562120123|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155733149|NCT05307692|562120124|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155733150|NCT05307692|562120125|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
155733151|NCT02656693|562122010|FG000|Overall Study|Pregnancy|1|||
155733152|NCT02656693|562122011|FG001|Overall Study|Pregnancy|1|||
155733153|NCT02656693|562122012|FG002|Overall Study|Pregnancy|1|||
155733154|NCT02656693|562122010|FG000|Overall Study|Bariatric surgery|0|||
155733155|NCT02656693|562122011|FG001|Overall Study|Bariatric surgery|1|||
155733156|NCT02656693|562122012|FG002|Overall Study|Bariatric surgery|2|||
155733157|NCT01596062|562122013|FG000|Overall Study|Adverse Event|1|||
155733158|NCT01596062|562122014|FG001|Overall Study|Adverse Event|0|||
155733159|NCT01596062|562122015|FG002|Overall Study|Adverse Event|2|||
155733160|NCT01596062|562122013|FG000|Overall Study|Lack of Efficacy|0|||
155733161|NCT01596062|562122014|FG001|Overall Study|Lack of Efficacy|0|||
155733162|NCT01596062|562122015|FG002|Overall Study|Lack of Efficacy|1|||
155733163|NCT02255435|562122016|FG000|Overall Study|Patient's Limited Time Availability|0|||
155733164|NCT02255435|562122017|FG001|Overall Study|Patient's Limited Time Availability|0|||
155733165|NCT02255435|562122018|FG002|Overall Study|Patient's Limited Time Availability|0|||
155733166|NCT02255435|562122019|FG003|Overall Study|Patient's Limited Time Availability|0|||
155733167|NCT02255435|562122020|FG004|Overall Study|Patient's Limited Time Availability|0|||
155733168|NCT02255435|562122021|FG005|Overall Study|Patient's Limited Time Availability|0|||
155733169|NCT02255435|562122022|FG006|Overall Study|Patient's Limited Time Availability|0|||
155733170|NCT02255435|562122023|FG007|Overall Study|Patient's Limited Time Availability|1|||
155733171|NCT02255435|562122024|FG008|Overall Study|Patient's Limited Time Availability|0|||
155733172|NCT02255435|562122025|FG009|Overall Study|Patient's Limited Time Availability|0|||
155733173|NCT02255435|562122016|FG000|Overall Study|Withdrawal by Subject|0|||
155733174|NCT02255435|562122017|FG001|Overall Study|Withdrawal by Subject|0|||
155733175|NCT02255435|562122018|FG002|Overall Study|Withdrawal by Subject|0|||
155733176|NCT02255435|562122019|FG003|Overall Study|Withdrawal by Subject|0|||
155733177|NCT02255435|562122020|FG004|Overall Study|Withdrawal by Subject|0|||
155733178|NCT02255435|562122021|FG005|Overall Study|Withdrawal by Subject|0|||
155733179|NCT02255435|562122022|FG006|Overall Study|Withdrawal by Subject|0|||
155733180|NCT02255435|562122023|FG007|Overall Study|Withdrawal by Subject|0|||
155733181|NCT02255435|562122024|FG008|Overall Study|Withdrawal by Subject|1|||
155733182|NCT02255435|562122025|FG009|Overall Study|Withdrawal by Subject|4|||
155733183|NCT02255435|562122016|FG000|Overall Study|Administrative reasons|0|||
155733184|NCT02255435|562122017|FG001|Overall Study|Administrative reasons|0|||
155733185|NCT02255435|562122018|FG002|Overall Study|Administrative reasons|0|||
155733186|NCT02255435|562122019|FG003|Overall Study|Administrative reasons|0|||
155733187|NCT02255435|562122020|FG004|Overall Study|Administrative reasons|0|||
155733188|NCT02255435|562122021|FG005|Overall Study|Administrative reasons|0|||
155733189|NCT02255435|562122022|FG006|Overall Study|Administrative reasons|0|||
155733190|NCT02255435|562122023|FG007|Overall Study|Administrative reasons|0|||
155733191|NCT02255435|562122024|FG008|Overall Study|Administrative reasons|0|||
155733192|NCT02255435|562122025|FG009|Overall Study|Administrative reasons|2|||
155733193|NCT01788358|562122026|FG000|Overall Study|Other|11|||
155733194|NCT01788358|562122026|FG000|Overall Study|Logistical difficulties|1|||
155733195|NCT01788358|562122026|FG000|Overall Study|Lost to Follow-up|5|||
155733196|NCT01788358|562122026|FG000|Overall Study|Protocol Violation|3|||
155733197|NCT01788358|562122026|FG000|Overall Study|Withdrawal by Subject|26|||
155733198|NCT01788358|562122026|FG000|Overall Study|Lack of Efficacy|1|||
155733199|NCT01788358|562122026|FG000|Overall Study|Adverse Event|51|||
155733200|NCT01168219|562122027|FG000|Overall Study|off study before starting treatment|2|||
155733201|NCT01168219|562122027|FG000|Overall Study|withdrew before transplant|1|||
155733202|NCT01168219|562122027|FG000|Overall Study|ineligible due to CML|2|||
155733203|NCT01027273|562122028|FG000|Overall Study|Lost to Follow-up|57|||
155733204|NCT01027273|562122029|FG001|Overall Study|Lost to Follow-up|31|||
155733205|NCT01027273|562122028|FG000|Overall Study|Death|2|||
155733206|NCT01027273|562122029|FG001|Overall Study|Death|2|||
155733207|NCT02948634|562122033|FG000|Overall Study|Lack of efficacy and study suspended|10|||
155733208|NCT02948634|562122034|FG001|Overall Study|Lack of efficacy and study suspended|2|||
155733209|NCT01413204|562122039|FG000|Overall Study|Adverse Event|1|||
155733210|NCT01413204|562122040|FG001|Overall Study|Adverse Event|2|||
155733211|NCT01413204|562122041|FG002|Overall Study|Adverse Event|2|||
155733212|NCT01413204|562122039|FG000|Overall Study|Physician Decision|3|||
155733213|NCT01413204|562122040|FG001|Overall Study|Physician Decision|0|||
155733214|NCT01413204|562122041|FG002|Overall Study|Physician Decision|2|||
155733215|NCT01413204|562122039|FG000|Overall Study|Withdrawal by Subject|1|||
155733216|NCT01413204|562122040|FG001|Overall Study|Withdrawal by Subject|4|||
155733217|NCT01413204|562122041|FG002|Overall Study|Withdrawal by Subject|4|||
155733218|NCT01413204|562122039|FG000|Overall Study|Clearly not eligible for the study|0|||
155733219|NCT01413204|562122040|FG001|Overall Study|Clearly not eligible for the study|0|||
155733220|NCT01413204|562122041|FG002|Overall Study|Clearly not eligible for the study|1|||
155733221|NCT01413204|562122039|FG000|Overall Study|Fasting plasma glucose level increased|1|||
155733222|NCT01413204|562122040|FG001|Overall Study|Fasting plasma glucose level increased|0|||
155733223|NCT01413204|562122041|FG002|Overall Study|Fasting plasma glucose level increased|10|||
155733224|NCT01255436|562122042|FG000|Overall Study|Lost to Follow-up|178|||
155733225|NCT01255436|562122043|FG001|Overall Study|Lost to Follow-up|191|||
155733226|NCT01255436|562122042|FG000|Overall Study|Death, stroke, or MI|4|||
155733227|NCT01255436|562122043|FG001|Overall Study|Death, stroke, or MI|3|||
155733228|NCT01237899|562122044|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
155733229|NCT01237899|562122045|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
155733230|NCT01237899|562122046|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
155733231|NCT01237899|562122047|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
155733232|NCT01237899|562122048|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
155733233|NCT01237899|562122049|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
155733234|NCT01237899|562122050|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
155733235|NCT01237899|562122051|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
155733236|NCT01237899|562122052|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
155733237|NCT01237899|562122053|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
155733238|NCT01237899|562122054|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
155733239|NCT00859456|562122055|FG000|Overall Study|Adverse Event|3|||
155733240|NCT00859456|562122055|FG000|Overall Study|Progressive disease|2|||
155733241|NCT00859456|562122055|FG000|Overall Study|Non-compliance|3|||
155733242|NCT02910986|562122059|FG000|Overall Study|non-Latina|14|||
155733243|NCT02910986|562122060|FG001|Overall Study|non-Latina|13|||
155733244|NCT02910986|562122061|FG002|Overall Study|non-Latina|12|||
155733245|NCT02910986|562122059|FG000|Overall Study|Failure to return T! survey|72|||
155733246|NCT02910986|562122060|FG001|Overall Study|Failure to return T! survey|84|||
155733247|NCT02910986|562122061|FG002|Overall Study|Failure to return T! survey|72|||
155733248|NCT02910986|562122059|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
155733249|NCT02910986|562122060|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
155733250|NCT02910986|562122061|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
155733251|NCT02910986|562122059|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
155733252|NCT02910986|562122060|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
155733253|NCT02910986|562122061|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
155733254|NCT02500797|562122065|FG000|Overall Study|Cancel (rapid disease progression)|0|||
155733255|NCT02500797|562122066|FG001|Overall Study|Cancel (rapid disease progression)|0|||
155733256|NCT02500797|562122067|FG002|Overall Study|Cancel (rapid disease progression)|0|||
155733257|NCT02500797|562122068|FG003|Overall Study|Cancel (rapid disease progression)|0|||
155733258|NCT02500797|562122069|FG004|Overall Study|Cancel (rapid disease progression)|1|||
155733259|NCT02500797|562122070|FG005|Overall Study|Cancel (rapid disease progression)|1|||
155733260|NCT02500797|562122071|FG006|Overall Study|Cancel (rapid disease progression)|0|||
155733261|NCT02500797|562122072|FG007|Overall Study|Cancel (rapid disease progression)|0|||
155630436|NCT05911841|561743103|FG007|Induction Period|Lost to Follow-up|0|||
155630437|NCT05911841|561743104|FG008|Induction Period|Lost to Follow-up|0|||
155630438|NCT05911841|561743105|FG009|Induction Period|Lost to Follow-up|0|||
155630439|NCT05911841|561743096|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
155630440|NCT05911841|561743097|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
155630441|NCT05911841|561743098|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
155630442|NCT05911841|561743099|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
155630443|NCT05911841|561743100|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
155630444|NCT05911841|561743101|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
155630445|NCT05911841|561743102|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
155630446|NCT05911841|561743103|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
155630447|NCT05911841|561743104|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
155630448|NCT05911841|561743105|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
155630449|NCT05911841|561743096|FG000|Maintenance Period|Lack of Efficacy|0|||
155630450|NCT05911841|561743097|FG001|Maintenance Period|Lack of Efficacy|0|||
155630451|NCT05911841|561743098|FG002|Maintenance Period|Lack of Efficacy|0|||
155630452|NCT05911841|561743099|FG003|Maintenance Period|Lack of Efficacy|0|||
155630453|NCT05911841|561743100|FG004|Maintenance Period|Lack of Efficacy|1|||
155630454|NCT05911841|561743101|FG005|Maintenance Period|Lack of Efficacy|0|||
155630455|NCT05911841|561743102|FG006|Maintenance Period|Lack of Efficacy|1|||
155630456|NCT05911841|561743103|FG007|Maintenance Period|Lack of Efficacy|0|||
155630457|NCT05911841|561743104|FG008|Maintenance Period|Lack of Efficacy|0|||
155630458|NCT05911841|561743105|FG009|Maintenance Period|Lack of Efficacy|0|||
155630459|NCT05911841|561743096|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
155630460|NCT05911841|561743097|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
155630461|NCT05911841|561743098|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
155630462|NCT05911841|561743099|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
155630463|NCT05911841|561743100|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
155630464|NCT05911841|561743101|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
155630465|NCT05911841|561743102|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
155630466|NCT05911841|561743103|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
155630467|NCT05911841|561743104|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
155630468|NCT05911841|561743105|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
155630469|NCT05911841|561743096|FG000|Maintenance Period|Withdrawal by Subject|0|||
155630470|NCT05911841|561743097|FG001|Maintenance Period|Withdrawal by Subject|0|||
155630471|NCT05911841|561743098|FG002|Maintenance Period|Withdrawal by Subject|0|||
155630472|NCT05911841|561743099|FG003|Maintenance Period|Withdrawal by Subject|0|||
155630473|NCT05911841|561743100|FG004|Maintenance Period|Withdrawal by Subject|0|||
155630474|NCT05911841|561743101|FG005|Maintenance Period|Withdrawal by Subject|1|||
155630475|NCT05911841|561743102|FG006|Maintenance Period|Withdrawal by Subject|0|||
155630476|NCT05911841|561743103|FG007|Maintenance Period|Withdrawal by Subject|1|||
155630477|NCT05911841|561743104|FG008|Maintenance Period|Withdrawal by Subject|0|||
155630478|NCT05911841|561743105|FG009|Maintenance Period|Withdrawal by Subject|0|||
155630479|NCT05911841|561743096|FG000|Maintenance Period|Adverse Event|0|||
155630480|NCT05911841|561743097|FG001|Maintenance Period|Adverse Event|0|||
155630481|NCT05911841|561743098|FG002|Maintenance Period|Adverse Event|0|||
155630482|NCT05911841|561743099|FG003|Maintenance Period|Adverse Event|0|||
155630483|NCT05911841|561743100|FG004|Maintenance Period|Adverse Event|0|||
155630484|NCT05911841|561743101|FG005|Maintenance Period|Adverse Event|0|||
155630485|NCT05911841|561743102|FG006|Maintenance Period|Adverse Event|0|||
155630486|NCT05911841|561743103|FG007|Maintenance Period|Adverse Event|1|||
155630487|NCT05911841|561743104|FG008|Maintenance Period|Adverse Event|0|||
155630488|NCT05911841|561743105|FG009|Maintenance Period|Adverse Event|0|||
155630489|NCT05911841|561743096|FG000|Escape Period|Adverse Event|0|||
155630490|NCT05911841|561743097|FG001|Escape Period|Adverse Event|0|||
155630491|NCT05911841|561743098|FG002|Escape Period|Adverse Event|0|||
155630492|NCT05911841|561743099|FG003|Escape Period|Adverse Event|0|||
155630493|NCT05911841|561743100|FG004|Escape Period|Adverse Event|0|||
155630494|NCT05911841|561743101|FG005|Escape Period|Adverse Event|0|||
155630495|NCT05911841|561743102|FG006|Escape Period|Adverse Event|0|||
155630496|NCT05911841|561743103|FG007|Escape Period|Adverse Event|0|||
155630497|NCT05911841|561743104|FG008|Escape Period|Adverse Event|0|||
155281688|NCT01544582|560461703|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
155630498|NCT05911841|561743105|FG009|Escape Period|Adverse Event|1|||
155630499|NCT05911841|561743096|FG000|Escape Period|Lack of Efficacy|0|||
155630500|NCT05911841|561743097|FG001|Escape Period|Lack of Efficacy|0|||
155630501|NCT05911841|561743098|FG002|Escape Period|Lack of Efficacy|0|||
155630502|NCT05911841|561743099|FG003|Escape Period|Lack of Efficacy|0|||
155630503|NCT05911841|561743100|FG004|Escape Period|Lack of Efficacy|0|||
155630504|NCT05911841|561743101|FG005|Escape Period|Lack of Efficacy|0|||
155630505|NCT05911841|561743102|FG006|Escape Period|Lack of Efficacy|0|||
155630506|NCT05911841|561743103|FG007|Escape Period|Lack of Efficacy|0|||
155630507|NCT05911841|561743104|FG008|Escape Period|Lack of Efficacy|0|||
155630508|NCT05911841|561743105|FG009|Escape Period|Lack of Efficacy|31|||
155630509|NCT05911841|561743096|FG000|Escape Period|Lost to Follow-up|0|||
155630510|NCT05911841|561743097|FG001|Escape Period|Lost to Follow-up|0|||
155630511|NCT05911841|561743098|FG002|Escape Period|Lost to Follow-up|0|||
155388960|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
155388961|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
155388962|NCT01759407|560858772|FG000|Overall Study|Protocol Violation|0|||
155388963|NCT01759407|560858773|FG001|Overall Study|Protocol Violation|2|||
155388964|NCT02092220|560858778|FG000|Period 1|Unrelated Illness|0|||
155388965|NCT02092220|560858779|FG001|Period 1|Unrelated Illness|2|||
155388966|NCT02092220|560858778|FG000|Period 2|Severe Hypoglycaemia|1|||
155630512|NCT05911841|561743099|FG003|Escape Period|Lost to Follow-up|0|||
155630513|NCT05911841|561743100|FG004|Escape Period|Lost to Follow-up|0|||
155630514|NCT05911841|561743101|FG005|Escape Period|Lost to Follow-up|0|||
155630515|NCT05911841|561743102|FG006|Escape Period|Lost to Follow-up|0|||
155630516|NCT05911841|561743103|FG007|Escape Period|Lost to Follow-up|0|||
155630517|NCT05911841|561743104|FG008|Escape Period|Lost to Follow-up|0|||
155630518|NCT05911841|561743105|FG009|Escape Period|Lost to Follow-up|1|||
155630519|NCT05911841|561743096|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630520|NCT05911841|561743097|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630521|NCT05911841|561743098|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630522|NCT05911841|561743099|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630523|NCT05911841|561743100|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630524|NCT05911841|561743101|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630525|NCT05911841|561743102|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630526|NCT05911841|561743103|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630527|NCT05911841|561743104|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155630528|NCT05911841|561743105|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
155630529|NCT05911841|561743096|FG000|Escape Period|Site Terminated by Sponsor|0|||
155630530|NCT05911841|561743097|FG001|Escape Period|Site Terminated by Sponsor|0|||
155630531|NCT05911841|561743098|FG002|Escape Period|Site Terminated by Sponsor|0|||
155630532|NCT05911841|561743099|FG003|Escape Period|Site Terminated by Sponsor|0|||
155630533|NCT05911841|561743100|FG004|Escape Period|Site Terminated by Sponsor|0|||
155630534|NCT05911841|561743101|FG005|Escape Period|Site Terminated by Sponsor|0|||
155630535|NCT05911841|561743102|FG006|Escape Period|Site Terminated by Sponsor|0|||
155630536|NCT05911841|561743103|FG007|Escape Period|Site Terminated by Sponsor|0|||
155630537|NCT05911841|561743104|FG008|Escape Period|Site Terminated by Sponsor|0|||
155630538|NCT05911841|561743105|FG009|Escape Period|Site Terminated by Sponsor|1|||
155630539|NCT05911841|561743096|FG000|Escape Period|Study Terminated by Sponsor|0|||
155630540|NCT05911841|561743097|FG001|Escape Period|Study Terminated by Sponsor|0|||
155630541|NCT05911841|561743098|FG002|Escape Period|Study Terminated by Sponsor|0|||
155630542|NCT05911841|561743099|FG003|Escape Period|Study Terminated by Sponsor|0|||
155630543|NCT05911841|561743100|FG004|Escape Period|Study Terminated by Sponsor|0|||
155630544|NCT05911841|561743101|FG005|Escape Period|Study Terminated by Sponsor|0|||
155630545|NCT05911841|561743102|FG006|Escape Period|Study Terminated by Sponsor|0|||
155630546|NCT05911841|561743103|FG007|Escape Period|Study Terminated by Sponsor|0|||
155630547|NCT05911841|561743104|FG008|Escape Period|Study Terminated by Sponsor|0|||
155630548|NCT05911841|561743105|FG009|Escape Period|Study Terminated by Sponsor|34|||
155630549|NCT05911841|561743096|FG000|Escape Period|Withdrawal by Subject|0|||
155630550|NCT05911841|561743097|FG001|Escape Period|Withdrawal by Subject|0|||
155630551|NCT05911841|561743098|FG002|Escape Period|Withdrawal by Subject|0|||
155630552|NCT05911841|561743099|FG003|Escape Period|Withdrawal by Subject|0|||
155630553|NCT05911841|561743100|FG004|Escape Period|Withdrawal by Subject|0|||
155630554|NCT05911841|561743101|FG005|Escape Period|Withdrawal by Subject|0|||
155630555|NCT05911841|561743102|FG006|Escape Period|Withdrawal by Subject|0|||
155630556|NCT05911841|561743103|FG007|Escape Period|Withdrawal by Subject|0|||
155630557|NCT05911841|561743104|FG008|Escape Period|Withdrawal by Subject|0|||
155630558|NCT05911841|561743105|FG009|Escape Period|Withdrawal by Subject|10|||
155630559|NCT05595369|561743106|FG000|Overall Study|Adverse Event|2|||
155630560|NCT05595369|561743107|FG001|Overall Study|Adverse Event|0|||
155630561|NCT05595369|561743108|FG002|Overall Study|Adverse Event|0|||
155630562|NCT05595369|561743106|FG000|Overall Study|Lost to Follow-up|11|||
155630563|NCT05595369|561743107|FG001|Overall Study|Lost to Follow-up|10|||
155630564|NCT05595369|561743108|FG002|Overall Study|Lost to Follow-up|10|||
155630565|NCT05595369|561743106|FG000|Overall Study|Physician Decision|1|||
155630566|NCT05595369|561743107|FG001|Overall Study|Physician Decision|0|||
155630567|NCT05595369|561743108|FG002|Overall Study|Physician Decision|0|||
155630568|NCT05595369|561743106|FG000|Overall Study|Withdrawal by Subject|5|||
155630569|NCT05595369|561743107|FG001|Overall Study|Withdrawal by Subject|7|||
155630570|NCT05595369|561743108|FG002|Overall Study|Withdrawal by Subject|6|||
155630571|NCT05595369|561743106|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155630572|NCT05595369|561743107|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
155630573|NCT05595369|561743108|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
155630574|NCT05595369|561743106|FG000|Overall Study|Study Drug Non-compliance|0|||
155630575|NCT05595369|561743107|FG001|Overall Study|Study Drug Non-compliance|1|||
155630576|NCT05595369|561743108|FG002|Overall Study|Study Drug Non-compliance|0|||
155630577|NCT05595369|561743106|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
155733262|NCT02500797|562122065|FG000|Overall Study|Withdrawal by Subject|1|||
155733263|NCT02500797|562122066|FG001|Overall Study|Withdrawal by Subject|0|||
155733264|NCT02500797|562122067|FG002|Overall Study|Withdrawal by Subject|0|||
155733265|NCT02500797|562122068|FG003|Overall Study|Withdrawal by Subject|0|||
155733266|NCT02500797|562122069|FG004|Overall Study|Withdrawal by Subject|0|||
155733267|NCT02500797|562122070|FG005|Overall Study|Withdrawal by Subject|0|||
155733268|NCT02500797|562122071|FG006|Overall Study|Withdrawal by Subject|0|||
155733269|NCT02500797|562122072|FG007|Overall Study|Withdrawal by Subject|0|||
155733270|NCT03339219|562122077|FG000|Overall Study|Death|12|||
155733271|NCT03339219|562122077|FG000|Overall Study|Site Terminated by Sponsor|22|||
155733272|NCT03339219|562122077|FG000|Overall Study|Withdrawal by Subject|1|||
155733273|NCT01469377|562122080|FG000|Overall Study|Protocol Deviation|7|||
155733274|NCT01469377|562122081|FG001|Overall Study|Protocol Deviation|10|||
155630578|NCT05595369|561743107|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
155630579|NCT05595369|561743108|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
155630580|NCT00111761|561743115|FG000|Part 1|Physician Decision|0|||
155630581|NCT00111761|561743116|FG001|Part 1|Physician Decision|1|||
155630582|NCT00111761|561743115|FG000|Part 1|Death|0|||
155630583|NCT00111761|561743116|FG001|Part 1|Death|2|||
155630584|NCT00111761|561743115|FG000|Part 1|Other|0|||
155630585|NCT00111761|561743116|FG001|Part 1|Other|1|||
155630586|NCT00111761|561743115|FG000|Part 1|Withdrawal by Subject|0|||
155630587|NCT00111761|561743116|FG001|Part 1|Withdrawal by Subject|1|||
155630588|NCT00111761|561743115|FG000|Part 2|Adverse Event|1|||
155630589|NCT00111761|561743116|FG001|Part 2|Adverse Event|0|||
155630590|NCT00111761|561743115|FG000|Part 2|Physician Decision|1|||
155630591|NCT00111761|561743116|FG001|Part 2|Physician Decision|0|||
155630592|NCT00111761|561743115|FG000|Part 2|Death|1|||
155630593|NCT00111761|561743116|FG001|Part 2|Death|0|||
155630594|NCT00111761|561743115|FG000|Part 2|Disease progression|3|||
155630595|NCT00111761|561743116|FG001|Part 2|Disease progression|0|||
155630596|NCT00111761|561743115|FG000|Part 2|Protocol-specified criteria|1|||
155630597|NCT00111761|561743116|FG001|Part 2|Protocol-specified criteria|0|||
155630598|NCT00111761|561743115|FG000|Part 2|Other|1|||
155630599|NCT00111761|561743116|FG001|Part 2|Other|0|||
155630600|NCT00471497|561743119|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
155630601|NCT00471497|561743120|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
155630602|NCT00471497|561743121|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
155630603|NCT00471497|561743119|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
155630604|NCT00471497|561743120|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
155630605|NCT00471497|561743121|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
155630606|NCT00471497|561743119|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
155630607|NCT00471497|561743120|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
155630608|NCT00471497|561743121|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
155630609|NCT00471497|561743119|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
155630610|NCT00471497|561743120|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
155630611|NCT00471497|561743121|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
155630612|NCT00471497|561743119|FG000|Core Treatment Phase|Lost to Follow-up|6|||
155630613|NCT00471497|561743120|FG001|Core Treatment Phase|Lost to Follow-up|6|||
155630614|NCT00471497|561743121|FG002|Core Treatment Phase|Lost to Follow-up|3|||
155630615|NCT00471497|561743119|FG000|Core Treatment Phase|Death|3|||
155630616|NCT00471497|561743120|FG001|Core Treatment Phase|Death|9|||
155630617|NCT00471497|561743121|FG002|Core Treatment Phase|Death|3|||
155630618|NCT00471497|561743119|FG000|Core Treatment Phase|Disease Progression|10|||
155630619|NCT00471497|561743120|FG001|Core Treatment Phase|Disease Progression|2|||
155630620|NCT00471497|561743121|FG002|Core Treatment Phase|Disease Progression|4|||
155630621|NCT00471497|561743119|FG000|Core Treatment Phase|Protocol Violation|6|||
155630622|NCT00471497|561743120|FG001|Core Treatment Phase|Protocol Violation|15|||
155630623|NCT00471497|561743121|FG002|Core Treatment Phase|Protocol Violation|11|||
155630624|NCT00471497|561743119|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
155630625|NCT00471497|561743120|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
155630626|NCT00471497|561743121|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
155630627|NCT00471497|561743119|FG000|Core Treatment Phase|Administrative problems|14|||
155630628|NCT00471497|561743120|FG001|Core Treatment Phase|Administrative problems|14|||
155630629|NCT00471497|561743121|FG002|Core Treatment Phase|Administrative problems|12|||
155630630|NCT00471497|561743119|FG000|Core Treatment Phase|Adverse Event|43|||
155630631|NCT00471497|561743120|FG001|Core Treatment Phase|Adverse Event|53|||
155630632|NCT00471497|561743121|FG002|Core Treatment Phase|Adverse Event|89|||
155630633|NCT00471497|561743119|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
155630634|NCT00471497|561743120|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
155733275|NCT01469377|562122082|FG002|Overall Study|Protocol Deviation|10|||
155733276|NCT01469377|562122080|FG000|Overall Study|Lost to Follow-up|3|||
155630635|NCT00471497|561743121|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
155630636|NCT00471497|561743119|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
155630637|NCT00471497|561743120|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
155733277|NCT01469377|562122081|FG001|Overall Study|Lost to Follow-up|2|||
155733278|NCT01469377|562122082|FG002|Overall Study|Lost to Follow-up|5|||
155733279|NCT01469377|562122080|FG000|Overall Study|Withdrawal of Consent|12|||
155733280|NCT01469377|562122081|FG001|Overall Study|Withdrawal of Consent|14|||
155733281|NCT01469377|562122082|FG002|Overall Study|Withdrawal of Consent|15|||
155733282|NCT01469377|562122080|FG000|Overall Study|Adverse Event|8|||
155733283|NCT01469377|562122081|FG001|Overall Study|Adverse Event|18|||
155733284|NCT01469377|562122082|FG002|Overall Study|Adverse Event|36|||
155733285|NCT01469377|562122080|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155733286|NCT01469377|562122081|FG001|Overall Study|Insufficient Therapeutic Response|4|||
155733287|NCT01469377|562122082|FG002|Overall Study|Insufficient Therapeutic Response|0|||
155733288|NCT01469377|562122080|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155733289|NCT01469377|562122081|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155733290|NCT01469377|562122082|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155733291|NCT00074490|562122083|FG000|Overall Study|Progressive malignancy|0|||
155733292|NCT00074490|562122084|FG001|Overall Study|Progressive malignancy|7|||
155733293|NCT00074490|562122085|FG002|Overall Study|Progressive malignancy|0|||
155733294|NCT00074490|562122086|FG003|Overall Study|Progressive malignancy|0|||
155733295|NCT00074490|562122087|FG004|Overall Study|Progressive malignancy|3|||
155733296|NCT00074490|562122088|FG005|Overall Study|Progressive malignancy|0|||
155733297|NCT04139798|562122093|FG000|Overall Study|Withdrawal by Subject|6|||
155733298|NCT04139798|562122094|FG001|Overall Study|Withdrawal by Subject|5|||
155733299|NCT04139798|562122093|FG000|Overall Study|Lost to Follow-up|2|||
155733300|NCT04139798|562122094|FG001|Overall Study|Lost to Follow-up|5|||
155733301|NCT04139798|562122093|FG000|Overall Study|Discontinued|4|||
155733302|NCT04139798|562122094|FG001|Overall Study|Discontinued|2|||
155733303|NCT04139798|562122093|FG000|Overall Study|Adverse Event|1|||
155733304|NCT04139798|562122094|FG001|Overall Study|Adverse Event|3|||
155733305|NCT04139798|562122093|FG000|Overall Study|Protocol Violation|1|||
155733306|NCT04139798|562122094|FG001|Overall Study|Protocol Violation|0|||
155733307|NCT04939415|562122095|FG000|Overall Study|Withdrawal by Subject|1|||
155733308|NCT04939415|562122096|FG001|Overall Study|Withdrawal by Subject|3|||
155733309|NCT04939415|562122095|FG000|Overall Study|Lost to Follow-up|0|||
155733310|NCT04939415|562122096|FG001|Overall Study|Lost to Follow-up|2|||
155733311|NCT04308291|562122097|FG000|Run-In Phase|Withdrawal by Subject|4|||
155733312|NCT04308291|562122097|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
155733313|NCT04308291|562122097|FG000|Study Phase 6-M|Physician Decision|2|||
155733314|NCT04308291|562122097|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
155733315|NCT04308291|562122097|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
155733316|NCT04308291|562122097|FG000|Study Phase 12-M|Physician Decision|2|||
155733317|NCT04308291|562122097|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
155733318|NCT02357368|562122101|FG000|Overall Study|Lost to Follow-up|0|||
155733319|NCT02357368|562122102|FG001|Overall Study|Lost to Follow-up|0|||
155733320|NCT02357368|562122103|FG002|Overall Study|Lost to Follow-up|0|||
155733321|NCT02357368|562122104|FG003|Overall Study|Lost to Follow-up|1|||
155733322|NCT02357368|562122101|FG000|Overall Study|Pregnancy|3|||
155733323|NCT02357368|562122102|FG001|Overall Study|Pregnancy|2|||
155733324|NCT02357368|562122103|FG002|Overall Study|Pregnancy|0|||
155733325|NCT02357368|562122104|FG003|Overall Study|Pregnancy|0|||
155733326|NCT02357368|562122101|FG000|Overall Study|Withdrawal by Subject|3|||
155733327|NCT02357368|562122102|FG001|Overall Study|Withdrawal by Subject|1|||
155733328|NCT02357368|562122103|FG002|Overall Study|Withdrawal by Subject|1|||
155733329|NCT02357368|562122104|FG003|Overall Study|Withdrawal by Subject|2|||
155733330|NCT01931566|562122105|FG000|Overall Study|Randomized But Not Treated|6|||
155733331|NCT01931566|562122106|FG001|Overall Study|Randomized But Not Treated|9|||
155733332|NCT01931566|562122107|FG002|Overall Study|Randomized But Not Treated|14|||
155733333|NCT01931566|562122105|FG000|Overall Study|Adverse Event|37|||
155733334|NCT01931566|562122106|FG001|Overall Study|Adverse Event|167|||
155733335|NCT01931566|562122107|FG002|Overall Study|Adverse Event|132|||
155733336|NCT01931566|562122105|FG000|Overall Study|Major Protocol Deviation|5|||
155388967|NCT02092220|560858779|FG001|Period 2|Severe Hypoglycaemia|0|||
155388968|NCT02092220|560858778|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
155388969|NCT02092220|560858779|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
155388970|NCT00960531|560858780|FG000|Overall Study|Lack of Efficacy|1|||
155388971|NCT00960531|560858781|FG001|Overall Study|Lack of Efficacy|0|||
155733337|NCT01931566|562122106|FG001|Overall Study|Major Protocol Deviation|14|||
155733338|NCT01931566|562122107|FG002|Overall Study|Major Protocol Deviation|21|||
155733339|NCT01931566|562122105|FG000|Overall Study|Lost to Follow-up|3|||
155733340|NCT01931566|562122106|FG001|Overall Study|Lost to Follow-up|26|||
155733341|NCT01931566|562122107|FG002|Overall Study|Lost to Follow-up|23|||
155733342|NCT01931566|562122105|FG000|Overall Study|Voluntary Withdrawal|78|||
155733343|NCT01931566|562122106|FG001|Overall Study|Voluntary Withdrawal|245|||
155733344|NCT01931566|562122107|FG002|Overall Study|Voluntary Withdrawal|225|||
155733345|NCT01931566|562122105|FG000|Overall Study|Study Termination|289|||
155733346|NCT01931566|562122106|FG001|Overall Study|Study Termination|968|||
155733347|NCT01931566|562122107|FG002|Overall Study|Study Termination|1037|||
155733348|NCT01931566|562122105|FG000|Overall Study|Reason Not Specified|11|||
155733349|NCT01931566|562122106|FG001|Overall Study|Reason Not Specified|47|||
155388972|NCT00960531|560858782|FG002|Overall Study|Lack of Efficacy|0|||
155388973|NCT00960531|560858783|FG003|Overall Study|Lack of Efficacy|0|||
155388974|NCT00960531|560858784|FG004|Overall Study|Lack of Efficacy|0|||
155388975|NCT00960531|560858785|FG005|Overall Study|Lack of Efficacy|0|||
155388976|NCT00960531|560858786|FG006|Overall Study|Lack of Efficacy|0|||
155388977|NCT00960531|560858787|FG007|Overall Study|Lack of Efficacy|0|||
155388978|NCT00960531|560858788|FG008|Overall Study|Lack of Efficacy|0|||
155388979|NCT00960531|560858789|FG009|Overall Study|Lack of Efficacy|0|||
155388980|NCT00960531|560858780|FG000|Overall Study|Withdrawal by Subject|1|||
155388981|NCT00960531|560858781|FG001|Overall Study|Withdrawal by Subject|0|||
155388982|NCT00960531|560858782|FG002|Overall Study|Withdrawal by Subject|5|||
155388983|NCT00960531|560858783|FG003|Overall Study|Withdrawal by Subject|2|||
155388984|NCT00960531|560858784|FG004|Overall Study|Withdrawal by Subject|0|||
155388985|NCT00960531|560858785|FG005|Overall Study|Withdrawal by Subject|0|||
155388986|NCT00960531|560858786|FG006|Overall Study|Withdrawal by Subject|2|||
155388987|NCT00960531|560858787|FG007|Overall Study|Withdrawal by Subject|0|||
155388988|NCT00960531|560858788|FG008|Overall Study|Withdrawal by Subject|1|||
155388989|NCT00960531|560858789|FG009|Overall Study|Withdrawal by Subject|0|||
155388990|NCT00960531|560858780|FG000|Overall Study|Caregiver Request|2|||
155388991|NCT00960531|560858781|FG001|Overall Study|Caregiver Request|0|||
155388992|NCT00960531|560858782|FG002|Overall Study|Caregiver Request|6|||
155388993|NCT00960531|560858783|FG003|Overall Study|Caregiver Request|5|||
155630638|NCT00471497|561743121|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
155630639|NCT00471497|561743119|FG000|Extension Phase|Adverse Event|9|||
155630640|NCT00471497|561743120|FG001|Extension Phase|Adverse Event|5|||
155630641|NCT00471497|561743121|FG002|Extension Phase|Adverse Event|1|||
155630642|NCT00471497|561743119|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
155630643|NCT00471497|561743120|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
155630644|NCT00471497|561743121|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
155630645|NCT00471497|561743119|FG000|Extension Phase|Withdrawal by Subject|3|||
155630646|NCT00471497|561743120|FG001|Extension Phase|Withdrawal by Subject|1|||
155630647|NCT00471497|561743121|FG002|Extension Phase|Withdrawal by Subject|0|||
155630648|NCT00471497|561743119|FG000|Extension Phase|Lost to Follow-up|2|||
155630649|NCT00471497|561743120|FG001|Extension Phase|Lost to Follow-up|0|||
155630650|NCT00471497|561743121|FG002|Extension Phase|Lost to Follow-up|0|||
155630651|NCT00471497|561743119|FG000|Extension Phase|Death|1|||
155630652|NCT00471497|561743120|FG001|Extension Phase|Death|0|||
155630653|NCT00471497|561743121|FG002|Extension Phase|Death|0|||
155630654|NCT00471497|561743119|FG000|Extension Phase|Disease progression|2|||
155630655|NCT00471497|561743120|FG001|Extension Phase|Disease progression|0|||
155630656|NCT00471497|561743121|FG002|Extension Phase|Disease progression|0|||
155630657|NCT00471497|561743119|FG000|Extension Phase|Protocol Violation|2|||
155630658|NCT00471497|561743120|FG001|Extension Phase|Protocol Violation|2|||
155630659|NCT00471497|561743121|FG002|Extension Phase|Protocol Violation|0|||
155630660|NCT04004000|561743122|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
155630661|NCT06121609|561743123|FG000|Overall Study|Lack of Efficacy|0|||
155630662|NCT06121609|561743124|FG001|Overall Study|Lack of Efficacy|0|||
155630663|NCT06121609|561743125|FG002|Overall Study|Lack of Efficacy|45|||
155630664|NCT06494761|561743126|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
155630665|NCT06494761|561743126|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
155630666|NCT04865289|561743128|FG000|Overall Study|Death|34|||
155630667|NCT04865289|561743129|FG001|Overall Study|Death|25|||
155630668|NCT04865289|561743128|FG000|Overall Study|Physician Decision|27|||
155630669|NCT04865289|561743129|FG001|Overall Study|Physician Decision|27|||
155630670|NCT04865289|561743128|FG000|Overall Study|Sponsor Decision|11|||
155630671|NCT04865289|561743129|FG001|Overall Study|Sponsor Decision|1|||
155630672|NCT04865289|561743128|FG000|Overall Study|Withdrawal by Subject|2|||
155630673|NCT04865289|561743129|FG001|Overall Study|Withdrawal by Subject|3|||
155630674|NCT02867592|561743130|FG000|Overall Study|Adverse Event|3|||
155630675|NCT02867592|561743131|FG001|Overall Study|Adverse Event|0|||
155630676|NCT02867592|561743132|FG002|Overall Study|Adverse Event|2|||
155630677|NCT02867592|561743133|FG003|Overall Study|Adverse Event|1|||
155630678|NCT02867592|561743134|FG004|Overall Study|Adverse Event|1|||
155630679|NCT02867592|561743135|FG005|Overall Study|Adverse Event|5|||
155630680|NCT02867592|561743130|FG000|Overall Study|Death|0|||
155630681|NCT02867592|561743131|FG001|Overall Study|Death|0|||
155630682|NCT02867592|561743132|FG002|Overall Study|Death|0|||
155630683|NCT02867592|561743133|FG003|Overall Study|Death|1|||
155630684|NCT02867592|561743134|FG004|Overall Study|Death|0|||
155630685|NCT02867592|561743135|FG005|Overall Study|Death|1|||
155630686|NCT02867592|561743130|FG000|Overall Study|Lack of Efficacy|8|||
155630687|NCT02867592|561743131|FG001|Overall Study|Lack of Efficacy|10|||
155630688|NCT02867592|561743132|FG002|Overall Study|Lack of Efficacy|8|||
155630689|NCT02867592|561743133|FG003|Overall Study|Lack of Efficacy|8|||
155630690|NCT02867592|561743134|FG004|Overall Study|Lack of Efficacy|12|||
155630691|NCT02867592|561743135|FG005|Overall Study|Lack of Efficacy|17|||
155630692|NCT02867592|561743130|FG000|Overall Study|Physician Decision|1|||
155630693|NCT02867592|561743131|FG001|Overall Study|Physician Decision|2|||
155630694|NCT02867592|561743132|FG002|Overall Study|Physician Decision|2|||
155630695|NCT02867592|561743133|FG003|Overall Study|Physician Decision|0|||
155630696|NCT02867592|561743134|FG004|Overall Study|Physician Decision|5|||
155630697|NCT02867592|561743135|FG005|Overall Study|Physician Decision|1|||
155630698|NCT02867592|561743130|FG000|Overall Study|Protocol Violation|0|||
155630699|NCT02867592|561743131|FG001|Overall Study|Protocol Violation|0|||
155630700|NCT02867592|561743132|FG002|Overall Study|Protocol Violation|0|||
155630701|NCT02867592|561743133|FG003|Overall Study|Protocol Violation|0|||
155630702|NCT02867592|561743134|FG004|Overall Study|Protocol Violation|1|||
155630703|NCT02867592|561743135|FG005|Overall Study|Protocol Violation|1|||
155630704|NCT02867592|561743130|FG000|Overall Study|Withdrawal by Subject|0|||
155630705|NCT02867592|561743131|FG001|Overall Study|Withdrawal by Subject|1|||
155630706|NCT02867592|561743132|FG002|Overall Study|Withdrawal by Subject|0|||
155630707|NCT02867592|561743133|FG003|Overall Study|Withdrawal by Subject|1|||
155630708|NCT02867592|561743134|FG004|Overall Study|Withdrawal by Subject|3|||
155630709|NCT02867592|561743135|FG005|Overall Study|Withdrawal by Subject|3|||
155630710|NCT02867592|561743130|FG000|Overall Study|Ineligible|1|||
155630711|NCT02867592|561743131|FG001|Overall Study|Ineligible|1|||
155630712|NCT02867592|561743132|FG002|Overall Study|Ineligible|0|||
155630713|NCT02867592|561743133|FG003|Overall Study|Ineligible|0|||
155630714|NCT02867592|561743134|FG004|Overall Study|Ineligible|2|||
155630715|NCT02867592|561743135|FG005|Overall Study|Ineligible|0|||
155630716|NCT02867592|561743130|FG000|Overall Study|No Treatment|1|||
155630717|NCT02867592|561743131|FG001|Overall Study|No Treatment|0|||
155630718|NCT02867592|561743132|FG002|Overall Study|No Treatment|0|||
155630719|NCT02867592|561743133|FG003|Overall Study|No Treatment|0|||
155630720|NCT02867592|561743134|FG004|Overall Study|No Treatment|0|||
155630721|NCT02867592|561743135|FG005|Overall Study|No Treatment|0|||
155630722|NCT02867592|561743130|FG000|Overall Study|Still on Therapy|0|||
155630723|NCT02867592|561743131|FG001|Overall Study|Still on Therapy|0|||
155630724|NCT02867592|561743132|FG002|Overall Study|Still on Therapy|0|||
155630725|NCT02867592|561743133|FG003|Overall Study|Still on Therapy|0|||
155630726|NCT02867592|561743134|FG004|Overall Study|Still on Therapy|1|||
155630727|NCT02867592|561743135|FG005|Overall Study|Still on Therapy|0|||
155630728|NCT02867592|561743130|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155630729|NCT02867592|561743131|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155630730|NCT02867592|561743132|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155630731|NCT02867592|561743133|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155630732|NCT02867592|561743134|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155630733|NCT02867592|561743135|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
155630734|NCT02867592|561743130|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
155630735|NCT02867592|561743131|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155630736|NCT02867592|561743132|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
155630737|NCT02867592|561743133|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
155630738|NCT02867592|561743134|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155630739|NCT02867592|561743135|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155630740|NCT00909870|561743136|FG000|Overall Study|Adverse Event|13|||
155630741|NCT00909870|561743137|FG001|Overall Study|Adverse Event|7|||
155630742|NCT00909870|561743136|FG000|Overall Study|Protocol Violation|1|||
155630743|NCT00909870|561743137|FG001|Overall Study|Protocol Violation|2|||
155630744|NCT00909870|561743136|FG000|Overall Study|Withdrawal by Subject|5|||
155630745|NCT00909870|561743137|FG001|Overall Study|Withdrawal by Subject|8|||
155630746|NCT00909870|561743136|FG000|Overall Study|Lost to Follow-up|3|||
155630747|NCT00909870|561743137|FG001|Overall Study|Lost to Follow-up|3|||
155630748|NCT00909870|561743136|FG000|Overall Study|Physician Decision|0|||
155630749|NCT00909870|561743137|FG001|Overall Study|Physician Decision|2|||
155630750|NCT00909870|561743136|FG000|Overall Study|Other|1|||
155630751|NCT00909870|561743137|FG001|Overall Study|Other|5|||
155630752|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
155630753|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
155630754|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630755|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630756|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630757|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630758|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630759|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630760|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630761|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155630762|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
155733350|NCT01931566|562122107|FG002|Overall Study|Reason Not Specified|53|||
155733351|NCT01931566|562122105|FG000|Overall Study|Missing|0|||
155388994|NCT00960531|560858784|FG004|Overall Study|Caregiver Request|0|||
155388995|NCT00960531|560858785|FG005|Overall Study|Caregiver Request|2|||
155388996|NCT00960531|560858786|FG006|Overall Study|Caregiver Request|3|||
155388997|NCT00960531|560858787|FG007|Overall Study|Caregiver Request|1|||
155388998|NCT00960531|560858788|FG008|Overall Study|Caregiver Request|3|||
155388999|NCT00960531|560858789|FG009|Overall Study|Caregiver Request|0|||
155389000|NCT00960531|560858780|FG000|Overall Study|Investigator Request|0|||
155389001|NCT00960531|560858781|FG001|Overall Study|Investigator Request|0|||
155389002|NCT00960531|560858782|FG002|Overall Study|Investigator Request|1|||
155389003|NCT00960531|560858783|FG003|Overall Study|Investigator Request|0|||
155389004|NCT00960531|560858784|FG004|Overall Study|Investigator Request|0|||
155389005|NCT00960531|560858785|FG005|Overall Study|Investigator Request|0|||
155389006|NCT00960531|560858786|FG006|Overall Study|Investigator Request|0|||
155389007|NCT00960531|560858787|FG007|Overall Study|Investigator Request|0|||
155389008|NCT00960531|560858788|FG008|Overall Study|Investigator Request|0|||
155389009|NCT00960531|560858789|FG009|Overall Study|Investigator Request|0|||
155389010|NCT00960531|560858780|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155389011|NCT00960531|560858781|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155389012|NCT00960531|560858782|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155389013|NCT00960531|560858783|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155389014|NCT00960531|560858784|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155389015|NCT00960531|560858785|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155389016|NCT00960531|560858786|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
155389017|NCT00960531|560858787|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
155389018|NCT00960531|560858788|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
155389019|NCT00960531|560858789|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
155389020|NCT00960531|560858780|FG000|Overall Study|Lost to Follow-up|0|||
155389021|NCT00960531|560858781|FG001|Overall Study|Lost to Follow-up|0|||
155389022|NCT00960531|560858782|FG002|Overall Study|Lost to Follow-up|1|||
155389023|NCT00960531|560858783|FG003|Overall Study|Lost to Follow-up|0|||
155389024|NCT00960531|560858784|FG004|Overall Study|Lost to Follow-up|0|||
155389025|NCT00960531|560858785|FG005|Overall Study|Lost to Follow-up|0|||
155389026|NCT00960531|560858786|FG006|Overall Study|Lost to Follow-up|1|||
155389027|NCT00960531|560858787|FG007|Overall Study|Lost to Follow-up|0|||
155389028|NCT00960531|560858788|FG008|Overall Study|Lost to Follow-up|0|||
155389029|NCT00960531|560858789|FG009|Overall Study|Lost to Follow-up|0|||
155389030|NCT00960531|560858780|FG000|Overall Study|Failed to Return|2|||
155389031|NCT00960531|560858781|FG001|Overall Study|Failed to Return|0|||
155389032|NCT00960531|560858782|FG002|Overall Study|Failed to Return|0|||
155389033|NCT00960531|560858783|FG003|Overall Study|Failed to Return|0|||
155630763|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
155630764|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630765|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630766|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630767|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630768|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630769|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630770|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630771|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155630772|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
155630773|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630774|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630775|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630776|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630777|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630778|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630779|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630780|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630781|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155630782|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
155389034|NCT00960531|560858784|FG004|Overall Study|Failed to Return|0|||
155389035|NCT00960531|560858785|FG005|Overall Study|Failed to Return|0|||
155389036|NCT00960531|560858786|FG006|Overall Study|Failed to Return|0|||
155389037|NCT00960531|560858787|FG007|Overall Study|Failed to Return|2|||
155389038|NCT00960531|560858788|FG008|Overall Study|Failed to Return|0|||
155389039|NCT00960531|560858789|FG009|Overall Study|Failed to Return|0|||
155389040|NCT00960531|560858780|FG000|Overall Study|Adverse Event (AE)|2|||
155389041|NCT00960531|560858781|FG001|Overall Study|Adverse Event (AE)|0|||
155389042|NCT00960531|560858782|FG002|Overall Study|Adverse Event (AE)|0|||
155389043|NCT00960531|560858783|FG003|Overall Study|Adverse Event (AE)|0|||
155389044|NCT00960531|560858784|FG004|Overall Study|Adverse Event (AE)|0|||
155389045|NCT00960531|560858785|FG005|Overall Study|Adverse Event (AE)|1|||
155630783|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
155630784|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630785|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630786|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630787|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630788|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630789|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630790|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630791|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155630792|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
155630793|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
155630794|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630795|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630796|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630797|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630798|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630799|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630800|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630801|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155630802|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
155630803|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
155630804|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630805|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630806|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630807|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630808|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630809|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630810|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630811|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155630812|NCT01232283|561743140|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
155630813|NCT01232283|561743141|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
155630814|NCT01232283|561743142|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630815|NCT01232283|561743143|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630816|NCT01232283|561743144|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630817|NCT01232283|561743145|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630818|NCT01232283|561743146|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630819|NCT01232283|561743147|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630820|NCT01232283|561743148|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630821|NCT01232283|561743149|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155630822|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630823|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630824|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
155630825|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
155630826|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630827|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630828|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630829|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630830|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630831|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155630832|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155281689|NCT01544582|560461704|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
155281690|NCT01544582|560461705|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
155281691|NCT01544582|560461706|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
155281692|NCT01544582|560461703|FG000|Analysis Population|Physician Decision|0|||
155281693|NCT01544582|560461704|FG001|Analysis Population|Physician Decision|13|||
155281694|NCT01544582|560461705|FG002|Analysis Population|Physician Decision|10|||
155281695|NCT01544582|560461706|FG003|Analysis Population|Physician Decision|9|||
155281696|NCT01544582|560461703|FG000|Analysis Population|Safety Reason|0|||
155281697|NCT01544582|560461704|FG001|Analysis Population|Safety Reason|33|||
155281698|NCT01544582|560461705|FG002|Analysis Population|Safety Reason|31|||
155281699|NCT01544582|560461706|FG003|Analysis Population|Safety Reason|8|||
155281700|NCT01544582|560461703|FG000|Analysis Population|Effectiveness Reason|0|||
155281701|NCT01544582|560461704|FG001|Analysis Population|Effectiveness Reason|48|||
155281702|NCT01544582|560461705|FG002|Analysis Population|Effectiveness Reason|29|||
155281703|NCT01544582|560461706|FG003|Analysis Population|Effectiveness Reason|12|||
155281704|NCT01544582|560461703|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
155281705|NCT01544582|560461704|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
155281706|NCT01544582|560461705|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
155733352|NCT01931566|562122106|FG001|Overall Study|Missing|0|||
155733353|NCT01931566|562122107|FG002|Overall Study|Missing|1|||
155733354|NCT00611026|562122109|FG000|Randomized to Double-blind Treatment|Not treated|2|||
155733355|NCT00611026|562122110|FG001|Randomized to Double-blind Treatment|Not treated|1|||
155733356|NCT00611026|562122111|FG002|Randomized to Double-blind Treatment|Not treated|3|||
155733357|NCT00611026|562122109|FG000|Double-blind Treatment Period|Death|1|||
155733358|NCT00611026|562122110|FG001|Double-blind Treatment Period|Death|0|||
155733359|NCT00611026|562122111|FG002|Double-blind Treatment Period|Death|0|||
155733360|NCT00611026|562122109|FG000|Double-blind Treatment Period|Adverse Event|9|||
155733361|NCT00611026|562122110|FG001|Double-blind Treatment Period|Adverse Event|28|||
155733362|NCT00611026|562122111|FG002|Double-blind Treatment Period|Adverse Event|46|||
155733363|NCT00611026|562122109|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
155733364|NCT00611026|562122110|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
155733365|NCT00611026|562122111|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
155733366|NCT00611026|562122109|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
155733367|NCT00611026|562122110|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
155733368|NCT00611026|562122111|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
155733369|NCT00611026|562122109|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
155733370|NCT00611026|562122110|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
155733371|NCT00611026|562122111|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
155733372|NCT00611026|562122109|FG000|Double-blind Treatment Period|Other|13|||
155733373|NCT00611026|562122110|FG001|Double-blind Treatment Period|Other|20|||
155733374|NCT00611026|562122111|FG002|Double-blind Treatment Period|Other|18|||
155733375|NCT00760617|562122112|FG000|Overall Study|Adverse Event|5|||
155733376|NCT00760617|562122113|FG001|Overall Study|Adverse Event|2|||
155733377|NCT00760617|562122114|FG002|Overall Study|Adverse Event|0|||
155733378|NCT00760617|562122112|FG000|Overall Study|Lost to Follow-up|0|||
155733379|NCT00760617|562122113|FG001|Overall Study|Lost to Follow-up|0|||
155733380|NCT00760617|562122114|FG002|Overall Study|Lost to Follow-up|5|||
155733381|NCT01147874|562122117|FG000|Overall Study|Adverse Event|5|||
155733382|NCT01147874|562122117|FG000|Overall Study|Investigator's Request|1|||
155733383|NCT01147874|562122117|FG000|Overall Study|Lost to Follow-up|25|||
155733384|NCT01147874|562122117|FG000|Overall Study|Other|5|||
155733385|NCT01147874|562122117|FG000|Overall Study|Protocol Violation|5|||
155733386|NCT01147874|562122117|FG000|Overall Study|Sponsor's Decision|2|||
155733387|NCT01147874|562122117|FG000|Overall Study|Withdrawal by Subject|24|||
155733388|NCT04625101|562122119|FG000|Overall Study|Withdrawal by Subject|0|||
155733389|NCT04625101|562122120|FG001|Overall Study|Withdrawal by Subject|1|||
155733390|NCT04625101|562122119|FG000|Overall Study|Protocol Deviation|1|||
155733391|NCT04625101|562122120|FG001|Overall Study|Protocol Deviation|0|||
155733392|NCT02991040|562122121|FG000|Overall Study|Withdrawal by Subject|2|||
155733393|NCT02991040|562122121|FG000|Overall Study|Lost to Follow-up|2|||
155733394|NCT04287517|562122122|FG000|Overall Study|Withdrawal by Subject|1|||
155733395|NCT04287517|562122123|FG001|Overall Study|Withdrawal by Subject|1|||
155733396|NCT01869764|562122130|FG000|Overall Study|Withdrawal by Subject|0|||
155733397|NCT01869764|562122131|FG001|Overall Study|Withdrawal by Subject|2|||
155733398|NCT02175030|562122132|FG000|Overall Study|Failed screen after consent|7|||
155733399|NCT02175030|562122133|FG001|Overall Study|Failed screen after consent|6|||
155733400|NCT02175030|562122132|FG000|Overall Study|Failed IUD Insertion|20|||
155733401|NCT02175030|562122133|FG001|Overall Study|Failed IUD Insertion|21|||
155733402|NCT02175030|562122132|FG000|Overall Study|Physician Decision|1|||
155733403|NCT02175030|562122133|FG001|Overall Study|Physician Decision|1|||
155733404|NCT02175030|562122132|FG000|Overall Study|Lost to Follow-up|6|||
155733405|NCT02175030|562122133|FG001|Overall Study|Lost to Follow-up|6|||
155733406|NCT02175030|562122132|FG000|Overall Study|Withdrawal by Subject|1|||
155733407|NCT02175030|562122133|FG001|Overall Study|Withdrawal by Subject|4|||
155733408|NCT02533453|562122134|FG000|Overall Study|Adverse Event|6|||
155733409|NCT02533453|562122134|FG000|Overall Study|Protocol Violation|1|||
155733410|NCT02533453|562122134|FG000|Overall Study|Withdrawal by Subject|2|||
155733411|NCT00885534|562122135|FG000|Overall Study|Patient deemed ineligible|1|||
155733412|NCT02453711|562122136|FG000|Overall Study|Withdrawal by Subject|5|||
155389046|NCT00960531|560858786|FG006|Overall Study|Adverse Event (AE)|2|||
155389047|NCT00960531|560858787|FG007|Overall Study|Adverse Event (AE)|0|||
155389048|NCT00960531|560858788|FG008|Overall Study|Adverse Event (AE)|2|||
155389049|NCT00960531|560858789|FG009|Overall Study|Adverse Event (AE)|0|||
155733413|NCT02453711|562122137|FG001|Overall Study|Withdrawal by Subject|4|||
155733414|NCT02453711|562122138|FG002|Overall Study|Withdrawal by Subject|6|||
155733415|NCT02453711|562122139|FG003|Overall Study|Withdrawal by Subject|4|||
155389050|NCT00960531|560858780|FG000|Overall Study|Reason not Specified|2|||
155733416|NCT02453711|562122140|FG004|Overall Study|Withdrawal by Subject|1|||
155733417|NCT02453711|562122141|FG005|Overall Study|Withdrawal by Subject|1|||
155733418|NCT02453711|562122142|FG006|Overall Study|Withdrawal by Subject|0|||
155733419|NCT02453711|562122143|FG007|Overall Study|Withdrawal by Subject|1|||
155733420|NCT02453711|562122144|FG008|Overall Study|Withdrawal by Subject|7|||
155389051|NCT00960531|560858781|FG001|Overall Study|Reason not Specified|1|||
155389052|NCT00960531|560858782|FG002|Overall Study|Reason not Specified|13|||
155733421|NCT02453711|562122136|FG000|Overall Study|Lost to Follow-up|5|||
155733422|NCT02453711|562122137|FG001|Overall Study|Lost to Follow-up|3|||
155733423|NCT02453711|562122138|FG002|Overall Study|Lost to Follow-up|2|||
155733424|NCT02453711|562122139|FG003|Overall Study|Lost to Follow-up|3|||
155733425|NCT02453711|562122140|FG004|Overall Study|Lost to Follow-up|1|||
155733426|NCT02453711|562122141|FG005|Overall Study|Lost to Follow-up|5|||
155733427|NCT02453711|562122142|FG006|Overall Study|Lost to Follow-up|2|||
155733428|NCT02453711|562122143|FG007|Overall Study|Lost to Follow-up|6|||
155733429|NCT02453711|562122144|FG008|Overall Study|Lost to Follow-up|6|||
155733430|NCT02453711|562122136|FG000|Overall Study|Death|0|||
155733431|NCT02453711|562122137|FG001|Overall Study|Death|0|||
155733432|NCT02453711|562122138|FG002|Overall Study|Death|0|||
155733433|NCT02453711|562122139|FG003|Overall Study|Death|0|||
155733434|NCT02453711|562122140|FG004|Overall Study|Death|0|||
155733435|NCT02453711|562122141|FG005|Overall Study|Death|0|||
155733436|NCT02453711|562122142|FG006|Overall Study|Death|1|||
155733437|NCT02453711|562122143|FG007|Overall Study|Death|0|||
155733438|NCT02453711|562122144|FG008|Overall Study|Death|0|||
155733439|NCT02453711|562122136|FG000|Overall Study|Unclassified|1|||
155733440|NCT02453711|562122137|FG001|Overall Study|Unclassified|0|||
155733441|NCT02453711|562122138|FG002|Overall Study|Unclassified|1|||
155733442|NCT02453711|562122139|FG003|Overall Study|Unclassified|0|||
155733443|NCT02453711|562122140|FG004|Overall Study|Unclassified|0|||
155733444|NCT02453711|562122141|FG005|Overall Study|Unclassified|0|||
155733445|NCT02453711|562122142|FG006|Overall Study|Unclassified|0|||
155733446|NCT02453711|562122143|FG007|Overall Study|Unclassified|0|||
155733447|NCT02453711|562122144|FG008|Overall Study|Unclassified|0|||
155733448|NCT03695367|562122147|FG000|Overall Study|Missed the Day 28 visit.|1|||
155733449|NCT03695367|562122148|FG001|Overall Study|Missed the Day 28 visit.|0|||
155733450|NCT03695367|562122147|FG000|Overall Study|Lost to Follow-up|0|||
155733451|NCT03695367|562122148|FG001|Overall Study|Lost to Follow-up|1|||
155733452|NCT03695367|562122147|FG000|Overall Study|Withdrawal by Subject|0|||
155733453|NCT03695367|562122148|FG001|Overall Study|Withdrawal by Subject|1|||
155733454|NCT03695367|562122147|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
155733455|NCT03695367|562122148|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
155733456|NCT02506244|562122149|FG000|Overall Study|Did not undergo active monitoring|458|||
155733457|NCT02506244|562122150|FG001|Overall Study|Did not undergo active monitoring|459|||
155733458|NCT02506244|562122151|FG002|Overall Study|Did not undergo active monitoring|0|||
155733459|NCT01958164|562122153|FG000|Overall Study|Adverse Event|0|||
155733460|NCT01958164|562122154|FG001|Overall Study|Adverse Event|2|||
155733461|NCT01958164|562122153|FG000|Overall Study|Lost to Follow-up|2|||
155733462|NCT01958164|562122154|FG001|Overall Study|Lost to Follow-up|3|||
155733463|NCT00740857|562122156|FG000|Overall Study|Withdrawal by Subject|1|||
155733464|NCT00740857|562122157|FG001|Overall Study|Withdrawal by Subject|0|||
155733465|NCT00740857|562122158|FG002|Overall Study|Withdrawal by Subject|0|||
155733466|NCT02963506|562122159|FG000|Double-Blind Period|Adverse Event|0|||
155733467|NCT02963506|562122160|FG001|Double-Blind Period|Adverse Event|0|||
155733468|NCT02963506|562122161|FG002|Double-Blind Period|Adverse Event|1|||
155733469|NCT02963506|562122162|FG003|Double-Blind Period|Adverse Event|0|||
155733470|NCT02963506|562122163|FG004|Double-Blind Period|Adverse Event|0|||
155733471|NCT02963506|562122164|FG005|Double-Blind Period|Adverse Event|0|||
155733472|NCT02963506|562122165|FG006|Double-Blind Period|Adverse Event|0|||
155733473|NCT02963506|562122166|FG007|Double-Blind Period|Adverse Event|0|||
155733474|NCT02963506|562122167|FG008|Double-Blind Period|Adverse Event|0|||
155733475|NCT02963506|562122168|FG009|Double-Blind Period|Adverse Event|0|||
155733476|NCT02963506|562122169|FG010|Double-Blind Period|Adverse Event|0|||
155733477|NCT02963506|562122170|FG011|Double-Blind Period|Adverse Event|0|||
155733478|NCT02963506|562122171|FG012|Double-Blind Period|Adverse Event|0|||
155733479|NCT02963506|562122159|FG000|Double-Blind Period|Death|0|||
155733480|NCT02963506|562122160|FG001|Double-Blind Period|Death|0|||
155733481|NCT02963506|562122161|FG002|Double-Blind Period|Death|0|||
155733482|NCT02963506|562122162|FG003|Double-Blind Period|Death|1|||
155733483|NCT02963506|562122163|FG004|Double-Blind Period|Death|0|||
155733484|NCT02963506|562122164|FG005|Double-Blind Period|Death|0|||
155281707|NCT01544582|560461706|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
155733485|NCT02963506|562122165|FG006|Double-Blind Period|Death|0|||
155733486|NCT02963506|562122166|FG007|Double-Blind Period|Death|0|||
155733487|NCT02963506|562122167|FG008|Double-Blind Period|Death|0|||
155733488|NCT02963506|562122168|FG009|Double-Blind Period|Death|0|||
155281708|NCT01544582|560461703|FG000|Analysis Population|Lost to Follow-up|0|||
155733489|NCT02963506|562122169|FG010|Double-Blind Period|Death|0|||
155733490|NCT02963506|562122170|FG011|Double-Blind Period|Death|0|||
155733491|NCT02963506|562122171|FG012|Double-Blind Period|Death|0|||
155281709|NCT01544582|560461704|FG001|Analysis Population|Lost to Follow-up|6|||
155281710|NCT01544582|560461705|FG002|Analysis Population|Lost to Follow-up|6|||
155733492|NCT02963506|562122159|FG000|Double-Blind Period|Lost to Follow-up|0|||
155733493|NCT02963506|562122160|FG001|Double-Blind Period|Lost to Follow-up|1|||
155733494|NCT02963506|562122161|FG002|Double-Blind Period|Lost to Follow-up|0|||
155733495|NCT02963506|562122162|FG003|Double-Blind Period|Lost to Follow-up|0|||
155733496|NCT02963506|562122163|FG004|Double-Blind Period|Lost to Follow-up|0|||
155389053|NCT00960531|560858783|FG003|Overall Study|Reason not Specified|1|||
155389054|NCT00960531|560858784|FG004|Overall Study|Reason not Specified|2|||
155389055|NCT00960531|560858785|FG005|Overall Study|Reason not Specified|0|||
155389056|NCT00960531|560858786|FG006|Overall Study|Reason not Specified|16|||
155389057|NCT00960531|560858787|FG007|Overall Study|Reason not Specified|0|||
155389058|NCT00960531|560858788|FG008|Overall Study|Reason not Specified|8|||
155389059|NCT00960531|560858789|FG009|Overall Study|Reason not Specified|1|||
155389060|NCT00593957|560858790|FG000|Overall Study|Physician Decision|0|||
155389061|NCT00593957|560858791|FG001|Overall Study|Physician Decision|1|||
155389062|NCT00593957|560858792|FG002|Overall Study|Physician Decision|2|||
155389063|NCT02411578|560858793|FG000|Crossover Trial Phase|Pregnancy|0|||
155389064|NCT02411578|560858794|FG001|Crossover Trial Phase|Pregnancy|1|||
155389065|NCT00494481|560858795|FG000|Overall Study|Condition under investigation worsened|11|||
155389066|NCT00494481|560858796|FG001|Overall Study|Condition under investigation worsened|13|||
155389067|NCT00494481|560858795|FG000|Overall Study|Adverse Event|15|||
155389068|NCT00494481|560858796|FG001|Overall Study|Adverse Event|11|||
155389069|NCT00494481|560858795|FG000|Overall Study|Other|1|||
155389070|NCT00494481|560858796|FG001|Overall Study|Other|0|||
155389071|NCT00494481|560858795|FG000|Overall Study|Never received IP|2|||
155389072|NCT00494481|560858796|FG001|Overall Study|Never received IP|0|||
155389073|NCT00332189|560858797|FG000|Overall Study|Adverse Event|3|||
155389074|NCT00332189|560858797|FG000|Overall Study|Uncooperative/Noncompliant|3|||
155630833|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630834|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
155630835|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
155630836|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630837|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630838|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630839|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630840|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630841|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155630842|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630843|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630844|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
155630845|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630846|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630847|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630848|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630849|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630850|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630851|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155630852|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630853|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630854|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
155630855|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
155630856|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630857|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630858|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630859|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630860|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630861|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155630862|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630863|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630864|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
155630865|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
155630866|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630867|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630868|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630869|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630870|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630871|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155630872|NCT01232283|561743140|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
155630873|NCT01232283|561743141|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
155630874|NCT01232283|561743142|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
155630875|NCT01232283|561743143|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
155630876|NCT01232283|561743144|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
155389075|NCT00332189|560858797|FG000|Overall Study|Withdrawal by Subject|9|||
155389076|NCT00332189|560858797|FG000|Overall Study|Lack of Efficacy|4|||
155389077|NCT00332189|560858797|FG000|Overall Study|Moved out of country|2|||
155389078|NCT02370043|560858798|FG000|Overall Study|Withdrawal by Subject|0|||
155389079|NCT02370043|560858799|FG001|Overall Study|Withdrawal by Subject|0|||
155630877|NCT01232283|561743145|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
155630878|NCT01232283|561743146|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
155630879|NCT01232283|561743147|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
155630880|NCT01232283|561743148|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
155630881|NCT01232283|561743149|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
155630882|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630883|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630884|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630885|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630886|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
155630887|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
155630888|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630889|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
155630890|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630891|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155630892|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630893|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630894|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630895|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630896|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
155630897|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630898|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
155630899|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
155630900|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630901|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155630902|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630903|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630904|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630905|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630906|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155630907|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155630908|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155630909|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
155630910|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630911|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155630912|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630913|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630914|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630915|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630916|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
155630917|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630918|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630919|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630920|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630921|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155630922|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630923|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630924|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630925|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630926|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
155630927|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630928|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
155630929|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
155630930|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630931|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155630932|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630933|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630934|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630935|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630936|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630937|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630938|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155281711|NCT01544582|560461706|FG003|Analysis Population|Lost to Follow-up|5|||
155281712|NCT01544582|560461703|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
155281713|NCT01544582|560461704|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
155733497|NCT02963506|562122164|FG005|Double-Blind Period|Lost to Follow-up|0|||
155733498|NCT02963506|562122165|FG006|Double-Blind Period|Lost to Follow-up|0|||
155733499|NCT02963506|562122166|FG007|Double-Blind Period|Lost to Follow-up|0|||
155733500|NCT02963506|562122167|FG008|Double-Blind Period|Lost to Follow-up|0|||
155733501|NCT02963506|562122168|FG009|Double-Blind Period|Lost to Follow-up|0|||
155733502|NCT02963506|562122169|FG010|Double-Blind Period|Lost to Follow-up|0|||
155733503|NCT02963506|562122170|FG011|Double-Blind Period|Lost to Follow-up|0|||
155733504|NCT02963506|562122171|FG012|Double-Blind Period|Lost to Follow-up|0|||
155733505|NCT02963506|562122159|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155733506|NCT02963506|562122160|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155733507|NCT02963506|562122161|FG002|Double-Blind Period|Withdrawal by Subject|1|||
155733508|NCT02963506|562122162|FG003|Double-Blind Period|Withdrawal by Subject|1|||
155733509|NCT02963506|562122163|FG004|Double-Blind Period|Withdrawal by Subject|0|||
155733510|NCT02963506|562122164|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155733511|NCT02963506|562122165|FG006|Double-Blind Period|Withdrawal by Subject|0|||
155733512|NCT02963506|562122166|FG007|Double-Blind Period|Withdrawal by Subject|0|||
155733513|NCT02963506|562122167|FG008|Double-Blind Period|Withdrawal by Subject|0|||
155733514|NCT02963506|562122168|FG009|Double-Blind Period|Withdrawal by Subject|0|||
155733515|NCT02963506|562122169|FG010|Double-Blind Period|Withdrawal by Subject|0|||
155733516|NCT02963506|562122170|FG011|Double-Blind Period|Withdrawal by Subject|0|||
155733517|NCT02963506|562122171|FG012|Double-Blind Period|Withdrawal by Subject|0|||
155733518|NCT02963506|562122159|FG000|Double-Blind Period|No compliance|0|||
155733519|NCT02963506|562122160|FG001|Double-Blind Period|No compliance|1|||
155733520|NCT02963506|562122161|FG002|Double-Blind Period|No compliance|0|||
155733521|NCT02963506|562122162|FG003|Double-Blind Period|No compliance|0|||
155733522|NCT02963506|562122163|FG004|Double-Blind Period|No compliance|0|||
155733523|NCT02963506|562122164|FG005|Double-Blind Period|No compliance|0|||
155733524|NCT02963506|562122165|FG006|Double-Blind Period|No compliance|0|||
155733525|NCT02963506|562122166|FG007|Double-Blind Period|No compliance|0|||
155733526|NCT02963506|562122167|FG008|Double-Blind Period|No compliance|0|||
155733527|NCT02963506|562122168|FG009|Double-Blind Period|No compliance|0|||
155733528|NCT02963506|562122169|FG010|Double-Blind Period|No compliance|0|||
155733529|NCT02963506|562122170|FG011|Double-Blind Period|No compliance|0|||
155733530|NCT02963506|562122171|FG012|Double-Blind Period|No compliance|0|||
155733531|NCT02963506|562122159|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733532|NCT02963506|562122160|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
155733533|NCT02963506|562122161|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733534|NCT02963506|562122162|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733535|NCT02963506|562122163|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733536|NCT02963506|562122164|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733537|NCT02963506|562122165|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733538|NCT02963506|562122166|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733539|NCT02963506|562122167|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733540|NCT02963506|562122168|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733541|NCT02963506|562122169|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733542|NCT02963506|562122170|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733543|NCT02963506|562122171|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155733544|NCT02963506|562122159|FG000|Dose-Blind Period|Adverse Event|0|||
155733545|NCT02963506|562122160|FG001|Dose-Blind Period|Adverse Event|0|||
155733546|NCT02963506|562122161|FG002|Dose-Blind Period|Adverse Event|0|||
155733547|NCT02963506|562122162|FG003|Dose-Blind Period|Adverse Event|0|||
155733548|NCT02963506|562122163|FG004|Dose-Blind Period|Adverse Event|0|||
155733549|NCT02963506|562122164|FG005|Dose-Blind Period|Adverse Event|1|||
155733550|NCT02963506|562122165|FG006|Dose-Blind Period|Adverse Event|3|||
155733551|NCT02963506|562122166|FG007|Dose-Blind Period|Adverse Event|2|||
155733552|NCT02963506|562122167|FG008|Dose-Blind Period|Adverse Event|2|||
155733553|NCT02963506|562122168|FG009|Dose-Blind Period|Adverse Event|2|||
155733554|NCT02963506|562122169|FG010|Dose-Blind Period|Adverse Event|1|||
155733555|NCT02963506|562122170|FG011|Dose-Blind Period|Adverse Event|1|||
155733556|NCT02963506|562122171|FG012|Dose-Blind Period|Adverse Event|6|||
155733557|NCT02963506|562122159|FG000|Dose-Blind Period|Lack of Efficacy|0|||
155733558|NCT02963506|562122160|FG001|Dose-Blind Period|Lack of Efficacy|0|||
155733559|NCT02963506|562122161|FG002|Dose-Blind Period|Lack of Efficacy|0|||
155733560|NCT02963506|562122162|FG003|Dose-Blind Period|Lack of Efficacy|0|||
155733561|NCT02963506|562122163|FG004|Dose-Blind Period|Lack of Efficacy|0|||
155733562|NCT02963506|562122164|FG005|Dose-Blind Period|Lack of Efficacy|0|||
155733563|NCT02963506|562122165|FG006|Dose-Blind Period|Lack of Efficacy|0|||
155733564|NCT02963506|562122166|FG007|Dose-Blind Period|Lack of Efficacy|1|||
155733565|NCT02963506|562122167|FG008|Dose-Blind Period|Lack of Efficacy|0|||
155733566|NCT02963506|562122168|FG009|Dose-Blind Period|Lack of Efficacy|1|||
155733567|NCT02963506|562122169|FG010|Dose-Blind Period|Lack of Efficacy|0|||
155733568|NCT02963506|562122170|FG011|Dose-Blind Period|Lack of Efficacy|0|||
155733569|NCT02963506|562122171|FG012|Dose-Blind Period|Lack of Efficacy|0|||
155733570|NCT02963506|562122159|FG000|Dose-Blind Period|Lost to Follow-up|0|||
155733571|NCT02963506|562122160|FG001|Dose-Blind Period|Lost to Follow-up|0|||
155389080|NCT02370043|560858800|FG002|Overall Study|Withdrawal by Subject|0|||
155389081|NCT02370043|560858801|FG003|Overall Study|Withdrawal by Subject|0|||
155389082|NCT02370043|560858802|FG004|Overall Study|Withdrawal by Subject|1|||
155389083|NCT02370043|560858803|FG005|Overall Study|Withdrawal by Subject|1|||
155389084|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
155389085|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
155389086|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
155389087|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
155389088|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
155389089|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
155389090|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
155389091|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
155389092|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
155389093|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
155389094|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
155389095|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
155389096|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
155389097|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
155389098|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
155389099|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
155389100|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
155389101|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
155389102|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
155389103|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
155389104|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
155630939|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
155630940|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630941|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155630942|NCT01232283|561743140|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630943|NCT01232283|561743141|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630944|NCT01232283|561743142|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630945|NCT01232283|561743143|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630946|NCT01232283|561743144|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630947|NCT01232283|561743145|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
155630948|NCT01232283|561743146|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630949|NCT01232283|561743147|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630950|NCT01232283|561743148|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630951|NCT01232283|561743149|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155630952|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630953|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630954|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630955|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155733572|NCT02963506|562122161|FG002|Dose-Blind Period|Lost to Follow-up|0|||
155733573|NCT02963506|562122162|FG003|Dose-Blind Period|Lost to Follow-up|0|||
155733574|NCT02963506|562122163|FG004|Dose-Blind Period|Lost to Follow-up|0|||
155281714|NCT01544582|560461705|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
155281715|NCT01544582|560461706|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
155281716|NCT01544582|560461703|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281717|NCT01544582|560461704|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281718|NCT01544582|560461705|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
155281719|NCT01544582|560461706|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281720|NCT01544582|560461703|FG000|Analysis Population|Intolerance|0|||
155281721|NCT01544582|560461704|FG001|Analysis Population|Intolerance|1|||
155281722|NCT01544582|560461705|FG002|Analysis Population|Intolerance|0|||
155281723|NCT01544582|560461706|FG003|Analysis Population|Intolerance|0|||
155281724|NCT01544582|560461703|FG000|Analysis Population|Liver Transplantation|0|||
155281725|NCT01544582|560461704|FG001|Analysis Population|Liver Transplantation|0|||
155281726|NCT01544582|560461705|FG002|Analysis Population|Liver Transplantation|1|||
155281727|NCT01544582|560461706|FG003|Analysis Population|Liver Transplantation|0|||
155281728|NCT01544582|560461703|FG000|Analysis Population|No Social Insurance|0|||
155281729|NCT01544582|560461704|FG001|Analysis Population|No Social Insurance|0|||
155281730|NCT01544582|560461705|FG002|Analysis Population|No Social Insurance|1|||
155281731|NCT01544582|560461706|FG003|Analysis Population|No Social Insurance|0|||
155281732|NCT01544582|560461703|FG000|Analysis Population|Poor Adherence|0|||
155281733|NCT01544582|560461704|FG001|Analysis Population|Poor Adherence|0|||
155281734|NCT01544582|560461705|FG002|Analysis Population|Poor Adherence|1|||
155281735|NCT01544582|560461706|FG003|Analysis Population|Poor Adherence|0|||
155389105|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
155389106|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
155389107|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
155389108|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
155389109|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
155389110|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
155389111|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
155389112|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
155389113|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
155389114|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
155389115|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
155389116|NCT05266586|560858808|FG000|Overall Study|Adverse Event|2|||
155389117|NCT05266586|560858809|FG001|Overall Study|Adverse Event|2|||
155389118|NCT05266586|560858810|FG002|Overall Study|Adverse Event|1|||
155389119|NCT05266586|560858808|FG000|Overall Study|Withdrawal by Subject|1|||
155389120|NCT05266586|560858809|FG001|Overall Study|Withdrawal by Subject|0|||
155389121|NCT05266586|560858810|FG002|Overall Study|Withdrawal by Subject|1|||
155389122|NCT05266586|560858808|FG000|Overall Study|Non-compliance with study drug|0|||
155389123|NCT05266586|560858809|FG001|Overall Study|Non-compliance with study drug|1|||
155389124|NCT05266586|560858810|FG002|Overall Study|Non-compliance with study drug|0|||
155389125|NCT05266586|560858808|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
155389126|NCT05266586|560858809|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
155389127|NCT05266586|560858810|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
155389128|NCT02225353|560858811|FG000|Overall Study|Lost to Follow-up|0|||
155389129|NCT02225353|560858812|FG001|Overall Study|Lost to Follow-up|1|||
155389130|NCT02225353|560858813|FG002|Overall Study|Lost to Follow-up|3|||
155389131|NCT02225353|560858811|FG000|Overall Study|Protocol Violation|4|||
155389132|NCT02225353|560858812|FG001|Overall Study|Protocol Violation|5|||
155389133|NCT02225353|560858813|FG002|Overall Study|Protocol Violation|12|||
155389134|NCT03707925|560858814|FG000|Overall Study|Inevaluable|1|||
155389135|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Other|1|||
155630956|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630957|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630958|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630959|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155630960|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
155630961|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
155630962|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630963|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630964|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630965|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630966|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630967|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630968|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630969|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155630970|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
155630971|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
155630972|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630973|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630974|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630975|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630976|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630977|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630978|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630979|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155630980|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
155630981|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
155630982|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630983|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630984|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630985|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630986|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630987|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630988|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155389136|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Other|0|||
155389137|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
155389138|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
155630989|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155630990|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
155630991|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
155630992|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630993|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630994|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630995|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630996|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630997|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630998|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155630999|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155631000|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
155631001|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
155631002|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631003|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631004|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631005|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631006|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631007|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631008|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631009|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631010|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
155631011|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155631012|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631013|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631014|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631015|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631016|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631017|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631018|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631019|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631020|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
155631021|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155631022|NCT01232283|561743140|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631023|NCT01232283|561743141|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631024|NCT01232283|561743142|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631025|NCT01232283|561743143|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631026|NCT01232283|561743144|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631027|NCT01232283|561743145|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631028|NCT01232283|561743146|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631029|NCT01232283|561743147|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155631030|NCT01232283|561743148|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
155631031|NCT01232283|561743149|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
155631032|NCT03824561|561743150|FG000|Overall Study|Protocol Violation|19|||
155631033|NCT01773928|561743152|FG000|Overall Study|Adverse Event|0|||
155631034|NCT01773928|561743153|FG001|Overall Study|Adverse Event|0|||
155631035|NCT01773928|561743154|FG002|Overall Study|Adverse Event|0|||
155631036|NCT01773928|561743155|FG003|Overall Study|Adverse Event|0|||
155631037|NCT01773928|561743156|FG004|Overall Study|Adverse Event|0|||
155631038|NCT01773928|561743157|FG005|Overall Study|Adverse Event|0|||
155631039|NCT01773928|561743158|FG006|Overall Study|Adverse Event|0|||
155631040|NCT01773928|561743159|FG007|Overall Study|Adverse Event|1|||
155631041|NCT01773928|561743160|FG008|Overall Study|Adverse Event|0|||
155631042|NCT01773928|561743152|FG000|Overall Study|Physician Decision|0|||
155631043|NCT01773928|561743153|FG001|Overall Study|Physician Decision|0|||
155631044|NCT01773928|561743154|FG002|Overall Study|Physician Decision|0|||
155631045|NCT01773928|561743155|FG003|Overall Study|Physician Decision|1|||
155631046|NCT01773928|561743156|FG004|Overall Study|Physician Decision|0|||
155631047|NCT01773928|561743157|FG005|Overall Study|Physician Decision|0|||
155631048|NCT01773928|561743158|FG006|Overall Study|Physician Decision|0|||
155631049|NCT01773928|561743159|FG007|Overall Study|Physician Decision|0|||
155631050|NCT01773928|561743160|FG008|Overall Study|Physician Decision|0|||
155631051|NCT01773928|561743152|FG000|Overall Study|Withdrawal by Subject|5|||
155631052|NCT01773928|561743153|FG001|Overall Study|Withdrawal by Subject|4|||
155631053|NCT01773928|561743154|FG002|Overall Study|Withdrawal by Subject|4|||
155631054|NCT01773928|561743155|FG003|Overall Study|Withdrawal by Subject|4|||
155631055|NCT01773928|561743156|FG004|Overall Study|Withdrawal by Subject|7|||
155631056|NCT01773928|561743157|FG005|Overall Study|Withdrawal by Subject|1|||
155631057|NCT01773928|561743158|FG006|Overall Study|Withdrawal by Subject|0|||
155389139|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
155389140|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
155389141|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
155389142|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
155389143|NCT01117857|560858817|FG000|Overall Study|Lost to Follow-up|4|||
155389144|NCT01117857|560858817|FG000|Overall Study|Withdrawal by Subject|4|||
155389145|NCT01117857|560858817|FG000|Overall Study|Physician Decision|1|||
155631058|NCT01773928|561743159|FG007|Overall Study|Withdrawal by Subject|0|||
155631059|NCT01773928|561743160|FG008|Overall Study|Withdrawal by Subject|1|||
155631060|NCT01773928|561743152|FG000|Overall Study|Lost to Follow-up|0|||
155631061|NCT01773928|561743153|FG001|Overall Study|Lost to Follow-up|0|||
155631062|NCT01773928|561743154|FG002|Overall Study|Lost to Follow-up|0|||
155631063|NCT01773928|561743155|FG003|Overall Study|Lost to Follow-up|0|||
155631064|NCT01773928|561743156|FG004|Overall Study|Lost to Follow-up|0|||
155631065|NCT01773928|561743157|FG005|Overall Study|Lost to Follow-up|1|||
155631066|NCT01773928|561743158|FG006|Overall Study|Lost to Follow-up|0|||
155631067|NCT01773928|561743159|FG007|Overall Study|Lost to Follow-up|0|||
155631068|NCT01773928|561743160|FG008|Overall Study|Lost to Follow-up|0|||
155631069|NCT01773928|561743152|FG000|Overall Study|Subject misrepresented age|0|||
155631070|NCT01773928|561743153|FG001|Overall Study|Subject misrepresented age|1|||
155631071|NCT01773928|561743154|FG002|Overall Study|Subject misrepresented age|0|||
155631072|NCT01773928|561743155|FG003|Overall Study|Subject misrepresented age|0|||
155631073|NCT01773928|561743156|FG004|Overall Study|Subject misrepresented age|0|||
155631074|NCT01773928|561743157|FG005|Overall Study|Subject misrepresented age|0|||
155631075|NCT01773928|561743158|FG006|Overall Study|Subject misrepresented age|0|||
155631076|NCT01773928|561743159|FG007|Overall Study|Subject misrepresented age|0|||
155631077|NCT01773928|561743160|FG008|Overall Study|Subject misrepresented age|0|||
155631078|NCT01773928|561743152|FG000|Overall Study|Subject met exclusion criteria|0|||
155631079|NCT01773928|561743153|FG001|Overall Study|Subject met exclusion criteria|0|||
155631080|NCT01773928|561743154|FG002|Overall Study|Subject met exclusion criteria|0|||
155631081|NCT01773928|561743155|FG003|Overall Study|Subject met exclusion criteria|0|||
155631082|NCT01773928|561743156|FG004|Overall Study|Subject met exclusion criteria|0|||
155631083|NCT01773928|561743157|FG005|Overall Study|Subject met exclusion criteria|0|||
155631084|NCT01773928|561743158|FG006|Overall Study|Subject met exclusion criteria|0|||
155631085|NCT01773928|561743159|FG007|Overall Study|Subject met exclusion criteria|0|||
155631086|NCT01773928|561743160|FG008|Overall Study|Subject met exclusion criteria|1|||
155631087|NCT01773928|561743152|FG000|Overall Study|Randomized, had to leave, never returned|0|||
155631088|NCT01773928|561743153|FG001|Overall Study|Randomized, had to leave, never returned|0|||
155631089|NCT01773928|561743154|FG002|Overall Study|Randomized, had to leave, never returned|0|||
155631090|NCT01773928|561743155|FG003|Overall Study|Randomized, had to leave, never returned|1|||
155631091|NCT01773928|561743156|FG004|Overall Study|Randomized, had to leave, never returned|0|||
155631092|NCT01773928|561743157|FG005|Overall Study|Randomized, had to leave, never returned|0|||
155631093|NCT01773928|561743158|FG006|Overall Study|Randomized, had to leave, never returned|0|||
155631094|NCT01773928|561743159|FG007|Overall Study|Randomized, had to leave, never returned|0|||
155631095|NCT01773928|561743160|FG008|Overall Study|Randomized, had to leave, never returned|0|||
155631096|NCT01773928|561743152|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
155631097|NCT01773928|561743153|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
155631098|NCT01773928|561743154|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
155631099|NCT01773928|561743155|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
155631100|NCT01773928|561743156|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
155631101|NCT01773928|561743157|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
155631102|NCT01773928|561743158|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
155631103|NCT01773928|561743159|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
155631104|NCT01773928|561743160|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
155631105|NCT03054428|561743161|FG000|Overall Study|Physician Decision|0|||
155631106|NCT03054428|561743162|FG001|Overall Study|Physician Decision|1|||
155631107|NCT03054428|561743163|FG002|Overall Study|Physician Decision|1|||
155631108|NCT03054428|561743161|FG000|Overall Study|Lack of Efficacy|3|||
155631109|NCT03054428|561743162|FG001|Overall Study|Lack of Efficacy|1|||
155631110|NCT03054428|561743163|FG002|Overall Study|Lack of Efficacy|0|||
155631111|NCT03054428|561743161|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
155631112|NCT03054428|561743162|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
155631113|NCT03054428|561743163|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
155389146|NCT04683731|560858818|FG000|Overall Study|Withdrawal by Subject|1|||
155389147|NCT04683731|560858819|FG001|Overall Study|Withdrawal by Subject|0|||
155389148|NCT04683731|560858820|FG002|Overall Study|Withdrawal by Subject|3|||
155389149|NCT04683731|560858821|FG003|Overall Study|Withdrawal by Subject|2|||
155631114|NCT03054428|561743161|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
155631115|NCT03054428|561743162|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
155631116|NCT03054428|561743163|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
155631117|NCT03054428|561743161|FG000|Overall Study|Transitioned to OLE study|76|||
155631118|NCT03054428|561743162|FG001|Overall Study|Transitioned to OLE study|76|||
155631119|NCT03054428|561743163|FG002|Overall Study|Transitioned to OLE study|73|||
155631120|NCT03054428|561743161|FG000|Overall Study|Withdrawal by Subject|3|||
155281736|NCT01544582|560461703|FG000|Analysis Population|Poor Participant Compliance|0|||
155631121|NCT03054428|561743162|FG001|Overall Study|Withdrawal by Subject|2|||
155631122|NCT03054428|561743163|FG002|Overall Study|Withdrawal by Subject|3|||
155631123|NCT03054428|561743161|FG000|Overall Study|Lost to Follow-up|0|||
155631124|NCT03054428|561743162|FG001|Overall Study|Lost to Follow-up|0|||
155631125|NCT03054428|561743163|FG002|Overall Study|Lost to Follow-up|1|||
155631126|NCT03225287|561743164|FG000|Overall Study|Adverse Event|0|||
155631127|NCT03225287|561743165|FG001|Overall Study|Adverse Event|0|||
155631128|NCT03225287|561743166|FG002|Overall Study|Adverse Event|1|||
155631129|NCT03225287|561743164|FG000|Overall Study|Protocol non-compliance|0|||
155631130|NCT03225287|561743165|FG001|Overall Study|Protocol non-compliance|0|||
155631131|NCT03225287|561743166|FG002|Overall Study|Protocol non-compliance|1|||
155631132|NCT03225287|561743164|FG000|Overall Study|Subject withdraws consent|3|||
155631133|NCT03225287|561743165|FG001|Overall Study|Subject withdraws consent|0|||
155631134|NCT03225287|561743166|FG002|Overall Study|Subject withdraws consent|0|||
155631135|NCT03225287|561743164|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
155631136|NCT03225287|561743165|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
155631137|NCT03225287|561743166|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
155631138|NCT03225287|561743164|FG000|Overall Study|Trial drug not effective|0|||
155631139|NCT03225287|561743165|FG001|Overall Study|Trial drug not effective|1|||
155631140|NCT03225287|561743166|FG002|Overall Study|Trial drug not effective|0|||
155631141|NCT03225287|561743164|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
155631142|NCT03225287|561743165|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
155631143|NCT03225287|561743166|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
155631144|NCT03225287|561743164|FG000|Overall Study|Stem cell transplantation|0|||
155733575|NCT02963506|562122164|FG005|Dose-Blind Period|Lost to Follow-up|1|||
155281737|NCT01544582|560461704|FG001|Analysis Population|Poor Participant Compliance|1|||
155281738|NCT01544582|560461705|FG002|Analysis Population|Poor Participant Compliance|0|||
155281739|NCT01544582|560461706|FG003|Analysis Population|Poor Participant Compliance|0|||
155281740|NCT01544582|560461703|FG000|Analysis Population|Programmed Surgery|0|||
155281741|NCT01544582|560461704|FG001|Analysis Population|Programmed Surgery|1|||
155281742|NCT01544582|560461705|FG002|Analysis Population|Programmed Surgery|0|||
155281743|NCT01544582|560461706|FG003|Analysis Population|Programmed Surgery|0|||
155281744|NCT01544582|560461703|FG000|Analysis Population|Participant in Jail|0|||
155281745|NCT01544582|560461704|FG001|Analysis Population|Participant in Jail|0|||
155281746|NCT01544582|560461705|FG002|Analysis Population|Participant in Jail|1|||
155281747|NCT01544582|560461706|FG003|Analysis Population|Participant in Jail|0|||
155281748|NCT02624778|560463919|FG000|Overall Study|Lost to Follow-up|0|||
155281749|NCT02624778|560463920|FG001|Overall Study|Lost to Follow-up|0|||
155281750|NCT02624778|560463921|FG002|Overall Study|Lost to Follow-up|1|||
155281751|NCT02624778|560463922|FG003|Overall Study|Lost to Follow-up|0|||
155281752|NCT02624778|560463923|FG004|Overall Study|Lost to Follow-up|0|||
155281753|NCT02624778|560463924|FG005|Overall Study|Lost to Follow-up|0|||
155281754|NCT02624778|560463925|FG006|Overall Study|Lost to Follow-up|0|||
155281755|NCT02624778|560463926|FG007|Overall Study|Lost to Follow-up|0|||
155281756|NCT02624778|560463927|FG008|Overall Study|Lost to Follow-up|0|||
155281757|NCT02624778|560463919|FG000|Overall Study|Withdrawal by Subject|0|||
155281758|NCT02624778|560463920|FG001|Overall Study|Withdrawal by Subject|1|||
155281759|NCT02624778|560463921|FG002|Overall Study|Withdrawal by Subject|0|||
155281760|NCT02624778|560463922|FG003|Overall Study|Withdrawal by Subject|0|||
155281761|NCT02624778|560463923|FG004|Overall Study|Withdrawal by Subject|0|||
155281762|NCT02624778|560463924|FG005|Overall Study|Withdrawal by Subject|1|||
155281763|NCT02624778|560463925|FG006|Overall Study|Withdrawal by Subject|1|||
155281764|NCT02624778|560463926|FG007|Overall Study|Withdrawal by Subject|1|||
155281765|NCT02624778|560463927|FG008|Overall Study|Withdrawal by Subject|1|||
155281766|NCT02624778|560463919|FG000|Overall Study|Adverse Event|0|||
155281767|NCT02624778|560463920|FG001|Overall Study|Adverse Event|0|||
155281768|NCT02624778|560463921|FG002|Overall Study|Adverse Event|0|||
155281769|NCT02624778|560463922|FG003|Overall Study|Adverse Event|0|||
155281770|NCT02624778|560463923|FG004|Overall Study|Adverse Event|0|||
155281771|NCT02624778|560463924|FG005|Overall Study|Adverse Event|0|||
155281772|NCT02624778|560463925|FG006|Overall Study|Adverse Event|0|||
155281773|NCT02624778|560463926|FG007|Overall Study|Adverse Event|0|||
155281774|NCT02624778|560463927|FG008|Overall Study|Adverse Event|2|||
155281775|NCT02624778|560463919|FG000|Overall Study|Death|0|||
155281776|NCT02624778|560463920|FG001|Overall Study|Death|0|||
155281777|NCT02624778|560463921|FG002|Overall Study|Death|0|||
155281778|NCT02624778|560463922|FG003|Overall Study|Death|0|||
155281779|NCT02624778|560463923|FG004|Overall Study|Death|0|||
155281780|NCT02624778|560463924|FG005|Overall Study|Death|0|||
155281781|NCT02624778|560463925|FG006|Overall Study|Death|1|||
155281782|NCT02624778|560463926|FG007|Overall Study|Death|0|||
155631145|NCT03225287|561743165|FG001|Overall Study|Stem cell transplantation|1|||
155631146|NCT03225287|561743166|FG002|Overall Study|Stem cell transplantation|0|||
155631147|NCT01499810|561743168|FG000|Overall Study|Lost to Follow-up|10|||
155389150|NCT04683731|560858818|FG000|Overall Study|Determined patient was not eligible|3|||
155389151|NCT04683731|560858819|FG001|Overall Study|Determined patient was not eligible|3|||
155389152|NCT04683731|560858820|FG002|Overall Study|Determined patient was not eligible|12|||
155389153|NCT04683731|560858821|FG003|Overall Study|Determined patient was not eligible|3|||
155733576|NCT02963506|562122165|FG006|Dose-Blind Period|Lost to Follow-up|0|||
155733577|NCT02963506|562122166|FG007|Dose-Blind Period|Lost to Follow-up|0|||
155733578|NCT02963506|562122167|FG008|Dose-Blind Period|Lost to Follow-up|1|||
155733579|NCT02963506|562122168|FG009|Dose-Blind Period|Lost to Follow-up|0|||
155733580|NCT02963506|562122169|FG010|Dose-Blind Period|Lost to Follow-up|0|||
155733581|NCT02963506|562122170|FG011|Dose-Blind Period|Lost to Follow-up|1|||
155733582|NCT02963506|562122171|FG012|Dose-Blind Period|Lost to Follow-up|0|||
155733583|NCT02963506|562122159|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
155733584|NCT02963506|562122160|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
155733585|NCT02963506|562122161|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
155733586|NCT02963506|562122162|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
155733587|NCT02963506|562122163|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
155733588|NCT02963506|562122164|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
155733589|NCT02963506|562122165|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
155733590|NCT02963506|562122166|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
155733591|NCT02963506|562122167|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
155733592|NCT02963506|562122168|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
155733593|NCT02963506|562122169|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
155733594|NCT02963506|562122170|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
155733595|NCT02963506|562122171|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
155733596|NCT02963506|562122159|FG000|Dose-Blind Period|Sponsor decision|0|||
155733597|NCT02963506|562122160|FG001|Dose-Blind Period|Sponsor decision|0|||
155733598|NCT02963506|562122161|FG002|Dose-Blind Period|Sponsor decision|0|||
155733599|NCT02963506|562122162|FG003|Dose-Blind Period|Sponsor decision|0|||
155733600|NCT02963506|562122163|FG004|Dose-Blind Period|Sponsor decision|0|||
155733601|NCT02963506|562122164|FG005|Dose-Blind Period|Sponsor decision|1|||
155733602|NCT02963506|562122165|FG006|Dose-Blind Period|Sponsor decision|0|||
155733603|NCT02963506|562122166|FG007|Dose-Blind Period|Sponsor decision|0|||
155733604|NCT02963506|562122167|FG008|Dose-Blind Period|Sponsor decision|0|||
155733605|NCT02963506|562122168|FG009|Dose-Blind Period|Sponsor decision|0|||
155733606|NCT02963506|562122169|FG010|Dose-Blind Period|Sponsor decision|0|||
155733607|NCT02963506|562122170|FG011|Dose-Blind Period|Sponsor decision|0|||
155733608|NCT02963506|562122171|FG012|Dose-Blind Period|Sponsor decision|0|||
155733609|NCT02963506|562122159|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733610|NCT02963506|562122160|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733611|NCT02963506|562122161|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733612|NCT02963506|562122162|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733613|NCT02963506|562122163|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733614|NCT02963506|562122164|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733615|NCT02963506|562122165|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733616|NCT02963506|562122166|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733617|NCT02963506|562122167|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733618|NCT02963506|562122168|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733619|NCT02963506|562122169|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733620|NCT02963506|562122170|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155733621|NCT02963506|562122171|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
155733622|NCT00354432|562122174|FG000|Overall Study|Adverse Event|3|||
155733623|NCT00354432|562122175|FG001|Overall Study|Adverse Event|1|||
155733624|NCT00354432|562122176|FG002|Overall Study|Adverse Event|5|||
155733625|NCT00354432|562122177|FG003|Overall Study|Adverse Event|5|||
155733626|NCT00354432|562122174|FG000|Overall Study|Off/Toxicity|3|||
155733627|NCT00354432|562122175|FG001|Overall Study|Off/Toxicity|7|||
155733628|NCT00354432|562122176|FG002|Overall Study|Off/Toxicity|5|||
155733629|NCT00354432|562122177|FG003|Overall Study|Off/Toxicity|5|||
155733630|NCT03843541|562122178|FG000|Overall Study|Adverse Event|4|||
155733631|NCT03843541|562122179|FG001|Overall Study|Adverse Event|2|||
155389154|NCT01411839|560858822|FG000|Overall Study|Lost to Follow-up|4|||
155733632|NCT03843541|562122180|FG002|Overall Study|Adverse Event|3|||
155733633|NCT03843541|562122178|FG000|Overall Study|Death|1|||
155733634|NCT03843541|562122179|FG001|Overall Study|Death|0|||
155733635|NCT03843541|562122180|FG002|Overall Study|Death|0|||
155733636|NCT03843541|562122178|FG000|Overall Study|Lack of adherence to study medication|0|||
155733637|NCT03843541|562122179|FG001|Overall Study|Lack of adherence to study medication|0|||
155733638|NCT03843541|562122180|FG002|Overall Study|Lack of adherence to study medication|1|||
155733639|NCT03843541|562122178|FG000|Overall Study|Physician Decision|1|||
155733640|NCT03843541|562122179|FG001|Overall Study|Physician Decision|2|||
155389155|NCT01411839|560858823|FG001|Overall Study|Lost to Follow-up|3|||
155733641|NCT03843541|562122180|FG002|Overall Study|Physician Decision|2|||
155733642|NCT03843541|562122178|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
155733643|NCT03843541|562122179|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
155389156|NCT03282240|560858824|FG000|Overall Study|Adverse Event|2|||
155389157|NCT03282240|560858825|FG001|Overall Study|Adverse Event|2|||
155389158|NCT03282240|560858826|FG002|Overall Study|Adverse Event|0|||
155389159|NCT03282240|560858824|FG000|Overall Study|Lost to Follow-up|3|||
155389160|NCT03282240|560858825|FG001|Overall Study|Lost to Follow-up|0|||
155389161|NCT03282240|560858826|FG002|Overall Study|Lost to Follow-up|0|||
155389162|NCT03282240|560858824|FG000|Overall Study|Protocol Deviation|4|||
155389163|NCT03282240|560858825|FG001|Overall Study|Protocol Deviation|1|||
155389164|NCT03282240|560858826|FG002|Overall Study|Protocol Deviation|2|||
155389165|NCT03282240|560858824|FG000|Overall Study|Withdrawal by Subject|1|||
155389166|NCT03282240|560858825|FG001|Overall Study|Withdrawal by Subject|0|||
155389167|NCT03282240|560858826|FG002|Overall Study|Withdrawal by Subject|1|||
155389168|NCT01675479|560858827|FG000|Overall Study|Lost to Follow-up|11|||
155389169|NCT02910739|560858828|FG000|Overall Study|Adverse Event|1|||
155389170|NCT02910739|560858829|FG001|Overall Study|Adverse Event|0|||
155389171|NCT02910739|560858830|FG002|Overall Study|Adverse Event|0|||
155389172|NCT02910739|560858831|FG003|Overall Study|Adverse Event|0|||
155389173|NCT01572922|560858832|FG000|Overall Study|Adverse Event|1|||
155389174|NCT01572922|560858832|FG000|Overall Study|Protocol Violation|1|||
155389175|NCT01572922|560858832|FG000|Overall Study|Death|1|||
155389176|NCT00959647|560858834|FG000|Overall Study|Adverse Event|2|||
155389177|NCT00959647|560858834|FG000|Overall Study|Progressive disease|6|||
155389178|NCT00959647|560858834|FG000|Overall Study|Study terminated by sponsor|4|||
155389179|NCT00959647|560858834|FG000|Overall Study|Withdrawal by Subject|7|||
155389180|NCT05959629|560858837|FG000|Overall Study|partially necrotic/technical issues|2|||
155389181|NCT05959629|560858838|FG001|Overall Study|partially necrotic/technical issues|2|||
155389182|NCT04751656|560860037|FG000|Overall Study|Lost to Follow-up|1|||
155389183|NCT01103245|560860040|FG000|Overall Study|Withdrawal by Subject|1|||
155389184|NCT01103245|560860041|FG001|Overall Study|Withdrawal by Subject|0|||
155389185|NCT01103245|560860042|FG002|Overall Study|Withdrawal by Subject|3|||
155389186|NCT01103245|560860043|FG003|Overall Study|Withdrawal by Subject|0|||
155389187|NCT01103245|560860040|FG000|Overall Study|Inadequate IV access|1|||
155389188|NCT01103245|560860041|FG001|Overall Study|Inadequate IV access|0|||
155389189|NCT01103245|560860042|FG002|Overall Study|Inadequate IV access|0|||
155389190|NCT01103245|560860043|FG003|Overall Study|Inadequate IV access|0|||
155389191|NCT01103245|560860040|FG000|Overall Study|Adverse Event|0|||
155389192|NCT01103245|560860041|FG001|Overall Study|Adverse Event|2|||
155389193|NCT01103245|560860042|FG002|Overall Study|Adverse Event|1|||
155389194|NCT01103245|560860043|FG003|Overall Study|Adverse Event|0|||
155389195|NCT01103245|560860040|FG000|Overall Study|Physician Decision|1|||
155389196|NCT01103245|560860041|FG001|Overall Study|Physician Decision|0|||
155389197|NCT01103245|560860042|FG002|Overall Study|Physician Decision|0|||
155389198|NCT01103245|560860043|FG003|Overall Study|Physician Decision|0|||
155389199|NCT01444651|560860045|FG000|Overall Study|Adverse Event|3|||
155389200|NCT01444651|560860046|FG001|Overall Study|Adverse Event|2|||
155389201|NCT01444651|560860045|FG000|Overall Study|Lost to Follow-up|5|||
155389202|NCT01444651|560860046|FG001|Overall Study|Lost to Follow-up|5|||
155389203|NCT01444651|560860045|FG000|Overall Study|Non-fasting|2|||
155389204|NCT01444651|560860046|FG001|Overall Study|Non-fasting|1|||
155389205|NCT01444651|560860045|FG000|Overall Study|Missing data|1|||
155389206|NCT01444651|560860046|FG001|Overall Study|Missing data|1|||
155389207|NCT01929980|560860047|FG000|Overall Study|Physician Decision|1|||
155389208|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
155631148|NCT01499810|561743168|FG000|Overall Study|Protocol Violation|1|||
155631149|NCT01499810|561743168|FG000|Overall Study|Withdrawal by Subject|1|||
155631150|NCT03834961|561744263|FG000|Overall Study|Lack of Efficacy|1|||
155631151|NCT03834961|561744264|FG001|Overall Study|Lack of Efficacy|1|||
155631152|NCT03834961|561744265|FG002|Overall Study|Lack of Efficacy|0|||
155631153|NCT03834961|561744263|FG000|Overall Study|Physician Decision|0|||
155631154|NCT03834961|561744264|FG001|Overall Study|Physician Decision|1|||
155631155|NCT03834961|561744265|FG002|Overall Study|Physician Decision|0|||
155733644|NCT03843541|562122180|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
155389209|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
155389210|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
155389211|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
155389212|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
155389213|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
155733645|NCT03843541|562122178|FG000|Overall Study|Withdrawal by Subject|6|||
155733646|NCT03843541|562122179|FG001|Overall Study|Withdrawal by Subject|9|||
155389214|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
155389215|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
155389216|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
155389217|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
155389218|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
155389219|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
155631156|NCT04736199|561744268|FG000|Overall Study|Adverse Event|28|||
155631157|NCT04736199|561744269|FG001|Overall Study|Adverse Event|22|||
155733647|NCT03843541|562122180|FG002|Overall Study|Withdrawal by Subject|7|||
155733648|NCT03843541|562122178|FG000|Overall Study|Administration of rescue mucolytic|0|||
155733649|NCT03843541|562122179|FG001|Overall Study|Administration of rescue mucolytic|0|||
155733650|NCT03843541|562122180|FG002|Overall Study|Administration of rescue mucolytic|1|||
155733651|NCT03843541|562122178|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
155733652|NCT03843541|562122179|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
155733653|NCT03843541|562122180|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
155733654|NCT02930018|562122182|FG000|Overall Study|Lost to Follow-up|1|||
155389220|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Death|3|||
155389221|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Death|1|||
155389222|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
155733655|NCT02930018|562122183|FG001|Overall Study|Lost to Follow-up|1|||
155733656|NCT02930018|562122182|FG000|Overall Study|Withdrawal by Subject|5|||
155733657|NCT02930018|562122183|FG001|Overall Study|Withdrawal by Subject|2|||
155733658|NCT03493464|562122184|FG000|Overall Study|Surgery not performed|1|||
155733659|NCT02807402|562122185|FG000|Overall Study|Failure to Return|1|||
155733660|NCT02807402|562122185|FG000|Overall Study|Death|3|||
155733661|NCT02807402|562122185|FG000|Overall Study|Other|2|||
155733662|NCT01006291|562123716|FG000|Overall Study|Adverse Event|2|||
155733663|NCT01006291|562123717|FG001|Overall Study|Adverse Event|1|||
155733664|NCT01006291|562123718|FG002|Overall Study|Adverse Event|2|||
155733665|NCT01006291|562123716|FG000|Overall Study|Lack of Efficacy|2|||
155733666|NCT01006291|562123717|FG001|Overall Study|Lack of Efficacy|2|||
155733667|NCT01006291|562123718|FG002|Overall Study|Lack of Efficacy|1|||
155733668|NCT01006291|562123716|FG000|Overall Study|Protocol Violation|3|||
155389223|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
155389224|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Adverse Event|7|||
155389225|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Adverse Event|8|||
155389226|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Captured as Other|1|||
155389227|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Captured as Other|2|||
155389228|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
155389229|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
155389230|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
155389231|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
155389232|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
155389233|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
155389234|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Death|0|||
155389235|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Death|1|||
155389236|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
155389237|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
155389238|NCT01676909|560860054|FG000|Overall Study|Withdrawal by Subject|3|||
155389239|NCT01676909|560860055|FG001|Overall Study|Withdrawal by Subject|5|||
155389240|NCT01676909|560860054|FG000|Overall Study|Lost to Follow-up|15|||
155389241|NCT01676909|560860055|FG001|Overall Study|Lost to Follow-up|9|||
155389242|NCT04615247|560860056|FG000|Overall Study|Adverse Event|0|||
155389243|NCT04615247|560860057|FG001|Overall Study|Adverse Event|2|||
155389244|NCT04615247|560860056|FG000|Overall Study|Withdrawal by Subject|1|||
155389245|NCT04615247|560860057|FG001|Overall Study|Withdrawal by Subject|1|||
155389246|NCT00823901|560860060|FG000|Overall Study|Adverse Event|1|||
155389247|NCT00823901|560860061|FG001|Overall Study|Adverse Event|1|||
155389248|NCT00823901|560860060|FG000|Overall Study|Lack of Efficacy|1|||
155389249|NCT00823901|560860061|FG001|Overall Study|Lack of Efficacy|0|||
155389250|NCT00823901|560860060|FG000|Overall Study|Lost to Follow-up|2|||
155389251|NCT00823901|560860061|FG001|Overall Study|Lost to Follow-up|1|||
155389252|NCT01369511|560860062|FG000|Overall Study|Adverse Event|1|||
155389253|NCT01369511|560860063|FG001|Overall Study|Adverse Event|1|||
155389254|NCT01369511|560860064|FG002|Overall Study|Adverse Event|5|||
155389255|NCT01369511|560860065|FG003|Overall Study|Adverse Event|0|||
155389256|NCT01369511|560860062|FG000|Overall Study|Entry criteria not met|2|||
155389257|NCT01369511|560860063|FG001|Overall Study|Entry criteria not met|0|||
155389258|NCT01369511|560860064|FG002|Overall Study|Entry criteria not met|0|||
155389259|NCT01369511|560860065|FG003|Overall Study|Entry criteria not met|1|||
155389260|NCT01369511|560860062|FG000|Overall Study|Lost to Follow-up|0|||
155389261|NCT01369511|560860063|FG001|Overall Study|Lost to Follow-up|1|||
155389262|NCT01369511|560860064|FG002|Overall Study|Lost to Follow-up|1|||
155389263|NCT01369511|560860065|FG003|Overall Study|Lost to Follow-up|2|||
155733669|NCT01006291|562123717|FG001|Overall Study|Protocol Violation|3|||
155733670|NCT01006291|562123718|FG002|Overall Study|Protocol Violation|3|||
155733671|NCT01006291|562123716|FG000|Overall Study|Withdrawal criteria|5|||
155733672|NCT01006291|562123717|FG001|Overall Study|Withdrawal criteria|4|||
155389264|NCT01369511|560860062|FG000|Overall Study|Protocol Violation|0|||
155389265|NCT01369511|560860063|FG001|Overall Study|Protocol Violation|1|||
155389266|NCT01369511|560860064|FG002|Overall Study|Protocol Violation|0|||
155389267|NCT01369511|560860065|FG003|Overall Study|Protocol Violation|2|||
155389268|NCT01369511|560860062|FG000|Overall Study|Physician Decision|3|||
155389269|NCT01369511|560860063|FG001|Overall Study|Physician Decision|4|||
155389270|NCT01369511|560860064|FG002|Overall Study|Physician Decision|0|||
155389271|NCT01369511|560860065|FG003|Overall Study|Physician Decision|0|||
155389272|NCT01369511|560860062|FG000|Overall Study|Sponsor decision|2|||
155389273|NCT01369511|560860063|FG001|Overall Study|Sponsor decision|0|||
155389274|NCT01369511|560860064|FG002|Overall Study|Sponsor decision|1|||
155389275|NCT01369511|560860065|FG003|Overall Study|Sponsor decision|0|||
155389276|NCT01369511|560860062|FG000|Overall Study|Withdrawal by Subject|5|||
155389277|NCT01369511|560860063|FG001|Overall Study|Withdrawal by Subject|6|||
155389278|NCT01369511|560860064|FG002|Overall Study|Withdrawal by Subject|4|||
155389279|NCT01369511|560860065|FG003|Overall Study|Withdrawal by Subject|6|||
155389280|NCT01376349|560860067|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
155389281|NCT01376349|560860068|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
155389282|NCT01376349|560860069|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
155389283|NCT01376349|560860067|FG000|Raondomized Treatment|Adverse Event|13|||
155389284|NCT01376349|560860068|FG001|Raondomized Treatment|Adverse Event|17|||
155389285|NCT01376349|560860069|FG002|Raondomized Treatment|Adverse Event|14|||
155389286|NCT01376349|560860067|FG000|Raondomized Treatment|Unkown|1|||
155389287|NCT01376349|560860068|FG001|Raondomized Treatment|Unkown|2|||
155389288|NCT01376349|560860069|FG002|Raondomized Treatment|Unkown|1|||
155389289|NCT01376349|560860067|FG000|Raondomized Treatment|Alternative Treatment|0|||
155389290|NCT01376349|560860068|FG001|Raondomized Treatment|Alternative Treatment|0|||
155389291|NCT01376349|560860069|FG002|Raondomized Treatment|Alternative Treatment|1|||
155389292|NCT00718640|560860070|FG000|Overall Study|Adverse Event|4|||
155389293|NCT00718640|560860070|FG000|Overall Study|Death|1|||
155389294|NCT00718640|560860070|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
155389295|NCT05193500|560860073|FG000|Overall Study|Withdrawal by Subject|7|||
155389296|NCT05193500|560860074|FG001|Overall Study|Withdrawal by Subject|4|||
155389297|NCT05193500|560860075|FG002|Overall Study|Withdrawal by Subject|3|||
155389298|NCT05193500|560860076|FG003|Overall Study|Withdrawal by Subject|5|||
155389299|NCT01176773|560860078|FG000|Overall Study|Screen Failure|2|||
155389300|NCT01176773|560860078|FG000|Overall Study|Withdrew consent|1|||
155389301|NCT01498289|560860083|FG000|Overall Study|Adverse Event|16|||
155389302|NCT01498289|560860084|FG001|Overall Study|Adverse Event|18|||
155389303|NCT01498289|560860083|FG000|Overall Study|Death|6|||
155389304|NCT01498289|560860084|FG001|Overall Study|Death|8|||
155389305|NCT01498289|560860083|FG000|Overall Study|Withdrawal unrelated to AE|16|||
155389306|NCT01498289|560860084|FG001|Overall Study|Withdrawal unrelated to AE|16|||
155389307|NCT01498289|560860083|FG000|Overall Study|Progression/relapse|53|||
155389308|NCT01498289|560860084|FG001|Overall Study|Progression/relapse|59|||
155389309|NCT01498289|560860083|FG000|Overall Study|Not protocol specified|7|||
155389310|NCT01498289|560860084|FG001|Overall Study|Not protocol specified|2|||
155389311|NCT01498289|560860083|FG000|Overall Study|Reason under review|0|||
155389312|NCT01498289|560860084|FG001|Overall Study|Reason under review|1|||
155389313|NCT01423253|560860085|FG000|Overall Study|Adverse Event|2|||
155389314|NCT01423253|560860085|FG000|Overall Study|Lack of Efficacy|2|||
155389315|NCT01423253|560860085|FG000|Overall Study|Lost to Follow-up|1|||
155389316|NCT01423253|560860085|FG000|Overall Study|Protocol Violation|2|||
155389317|NCT01423253|560860085|FG000|Overall Study|Withdrawal by Subject|2|||
155389318|NCT02804178|560860089|FG000|Overall Study|Adverse Event|1|||
155389319|NCT02513745|560860094|FG000|Overall Study|Criteria at time of surgery not met.|3|||
155389320|NCT02513745|560860095|FG001|Overall Study|Criteria at time of surgery not met.|3|||
155389321|NCT01116882|560860096|FG000|30-day|Lost to Follow-up|50|||
155389322|NCT01116882|560860097|FG001|30-day|Lost to Follow-up|21|||
155389323|NCT01116882|560860096|FG000|30-day|Withdrawal by Subject|2|||
155733673|NCT01006291|562123718|FG002|Overall Study|Withdrawal criteria|4|||
155733674|NCT01006291|562123716|FG000|Overall Study|Other|14|||
155733675|NCT01006291|562123717|FG001|Overall Study|Other|14|||
155733676|NCT01006291|562123718|FG002|Overall Study|Other|17|||
155733677|NCT00684060|562123719|FG000|Overall Study|Lost to Follow-up|1|||
155733678|NCT00684060|562123720|FG001|Overall Study|Lost to Follow-up|0|||
155733679|NCT00684060|562123719|FG000|Overall Study|New stenosis identified|1|||
155733680|NCT00684060|562123720|FG001|Overall Study|New stenosis identified|0|||
155733681|NCT00684060|562123719|FG000|Overall Study|Unable to collect MRI|1|||
155389324|NCT01116882|560860097|FG001|30-day|Withdrawal by Subject|4|||
155389325|NCT01116882|560860096|FG000|30-day|Other Reasons|16|||
155389326|NCT01116882|560860097|FG001|30-day|Other Reasons|6|||
155389327|NCT01116882|560860096|FG000|12-month|Lost to Follow-up|111|||
155389328|NCT01116882|560860097|FG001|12-month|Lost to Follow-up|42|||
155389329|NCT01116882|560860096|FG000|12-month|Other Reasons|151|||
155389330|NCT01116882|560860097|FG001|12-month|Other Reasons|49|||
155389331|NCT01116882|560860096|FG000|12-month|Withdrawal by Subject|5|||
155389332|NCT01116882|560860097|FG001|12-month|Withdrawal by Subject|8|||
155733682|NCT00684060|562123720|FG001|Overall Study|Unable to collect MRI|2|||
155733683|NCT00684060|562123719|FG000|Overall Study|Death|0|||
155389333|NCT00547365|560860098|FG000|Overall Study|Physician Decision|1|||
155389334|NCT00547365|560860098|FG000|Overall Study|Lost to Follow-up|1|||
155389335|NCT00547365|560860098|FG000|Overall Study|Protocol Violation|2|||
155733684|NCT00684060|562123720|FG001|Overall Study|Death|1|||
155733685|NCT00702715|562123721|FG000|Overall Study|Lost to Follow-up|1|||
155733686|NCT00702715|562123722|FG001|Overall Study|Lost to Follow-up|0|||
155733687|NCT01677377|562123727|FG000|Overall Study|Protocol Violation|1|||
155733688|NCT01677377|562123728|FG001|Overall Study|Protocol Violation|0|||
155733689|NCT01677377|562123729|FG002|Overall Study|Protocol Violation|0|||
155733690|NCT01677377|562123727|FG000|Overall Study|Lost to Follow-up|0|||
155733691|NCT01677377|562123728|FG001|Overall Study|Lost to Follow-up|1|||
155733692|NCT01677377|562123729|FG002|Overall Study|Lost to Follow-up|1|||
155733693|NCT01677377|562123727|FG000|Overall Study|Withdrawal by Subject|0|||
155733694|NCT01677377|562123728|FG001|Overall Study|Withdrawal by Subject|0|||
155733695|NCT01677377|562123729|FG002|Overall Study|Withdrawal by Subject|3|||
155733696|NCT01677377|562123727|FG000|Overall Study|Lack of Efficacy|0|||
155733697|NCT01677377|562123728|FG001|Overall Study|Lack of Efficacy|0|||
155733698|NCT01677377|562123729|FG002|Overall Study|Lack of Efficacy|1|||
155733699|NCT01677377|562123727|FG000|Overall Study|Pregnancy|0|||
155733700|NCT01677377|562123728|FG001|Overall Study|Pregnancy|0|||
155733701|NCT01677377|562123729|FG002|Overall Study|Pregnancy|1|||
155733702|NCT02260180|562123730|FG000|Overall Study|Adverse Event|2|||
155733703|NCT02260180|562123731|FG001|Overall Study|Adverse Event|0|||
155733704|NCT02260180|562123732|FG002|Overall Study|Adverse Event|1|||
155733705|NCT03180840|562123733|FG000|Overall Study|Withdrawal by Subject|1|||
155733706|NCT00753649|562123744|FG000|Overall Study|Migrated/moved from study area|1|||
155733707|NCT00753649|562123745|FG001|Overall Study|Migrated/moved from study area|0|||
155733708|NCT00753649|562123744|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
155733709|NCT00753649|562123745|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
155733710|NCT00753649|562123744|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
155733711|NCT00753649|562123745|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
155733712|NCT00753649|562123744|FG000|Overall Study|Protocol Violation|2|||
155733713|NCT00753649|562123745|FG001|Overall Study|Protocol Violation|0|||
155733714|NCT03544333|562123746|FG000|Overall Study|Withdrawal by Subject|1|||
155733715|NCT03544333|562123747|FG001|Overall Study|Withdrawal by Subject|0|||
155733716|NCT00808080|562123751|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
155733717|NCT00423917|562123752|FG000|Overall Study|Cancel|2|||
155733718|NCT00423917|562123752|FG000|Overall Study|Ineligible|1|||
155733719|NCT01837823|562123753|FG000|Overall Study|Lost to Follow-up|6|||
155733720|NCT03052400|562123754|FG000|Overall Study|Lost to Follow-up|1|||
155733721|NCT03052400|562123755|FG001|Overall Study|Lost to Follow-up|0|||
155733722|NCT03052400|562123754|FG000|Overall Study|Withdrawal by Subject|0|||
155733723|NCT03052400|562123755|FG001|Overall Study|Withdrawal by Subject|1|||
155733724|NCT00555061|562123756|FG000|Overall Study|Adverse Event|3|||
155733725|NCT00555061|562123756|FG000|Overall Study|Protocol Violation|1|||
155733726|NCT00555061|562123756|FG000|Overall Study|Lost to Follow-up|2|||
155733727|NCT00555061|562123756|FG000|Overall Study|Withdrawal by Subject|2|||
155733728|NCT00555061|562123756|FG000|Overall Study|Participant enrolled, but never treated|1|||
155733729|NCT00475306|562123757|FG000|Overall Study|Protocol Violation|1|||
155733730|NCT00475306|562123758|FG001|Overall Study|Protocol Violation|1|||
155733731|NCT00475306|562123759|FG002|Overall Study|Protocol Violation|0|||
155733732|NCT00475306|562123760|FG003|Overall Study|Protocol Violation|1|||
155733733|NCT02405442|562123762|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
155733734|NCT02405442|562123763|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
155733735|NCT02405442|562123764|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
155733736|NCT02405442|562123765|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
155733737|NCT02405442|562123762|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
155733738|NCT02405442|562123763|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
155733739|NCT02405442|562123764|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
155733740|NCT02405442|562123765|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
155733741|NCT02405442|562123762|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
155733742|NCT02405442|562123763|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
155733743|NCT02405442|562123764|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
155733744|NCT02405442|562123765|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
155733745|NCT02405442|562123762|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155733746|NCT02405442|562123763|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
155733747|NCT02405442|562123764|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155733748|NCT02405442|562123765|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155733749|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
155733750|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
155733751|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
155733752|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
155281783|NCT02624778|560463927|FG008|Overall Study|Death|0|||
155281784|NCT02624778|560463919|FG000|Overall Study|Physician Decision|0|||
155733753|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
155733754|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
155389336|NCT00547365|560860098|FG000|Overall Study|death (not related to study)|4|||
155389337|NCT00504881|560860101|FG000|Overall Study|Lack of Efficacy|1|||
155389338|NCT00504881|560860102|FG001|Overall Study|Lack of Efficacy|5|||
155389339|NCT00504881|560860101|FG000|Overall Study|Lost to Follow-up|0|||
155733755|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
155733756|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
155733757|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
155733758|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
155733759|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
155733760|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
155733761|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
155733762|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
155733763|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
155733764|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
155733765|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
155733766|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
155733767|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
155733768|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
155733769|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155733770|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
155733771|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155733772|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155733773|NCT02405442|562123762|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155733774|NCT02405442|562123763|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
155733775|NCT02405442|562123764|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155733776|NCT02405442|562123765|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155733777|NCT02405442|562123762|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155733778|NCT02405442|562123763|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
155733779|NCT02405442|562123764|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155733780|NCT02405442|562123765|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155733781|NCT02405442|562123762|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155733782|NCT02405442|562123763|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
155733783|NCT02405442|562123764|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155733784|NCT02405442|562123765|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155733785|NCT02405442|562123762|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
155733786|NCT02405442|562123763|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
155733787|NCT02405442|562123764|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
155733788|NCT02405442|562123765|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
155733789|NCT03830892|562123767|FG000|Overall Study|Physician Decision|2|||
155733790|NCT03830892|562123768|FG001|Overall Study|Physician Decision|3|||
155733791|NCT03830892|562123767|FG000|Overall Study|Study terminated due to COVID|4|||
155733792|NCT03830892|562123768|FG001|Overall Study|Study terminated due to COVID|0|||
155733793|NCT03830892|562123767|FG000|Overall Study|Protocol Violation|0|||
155733794|NCT03830892|562123768|FG001|Overall Study|Protocol Violation|1|||
155733795|NCT03830892|562123767|FG000|Overall Study|Withdrawal by Subject|0|||
155733796|NCT03830892|562123768|FG001|Overall Study|Withdrawal by Subject|2|||
155733797|NCT00975689|562123769|FG000|Overall Study|Adverse Event|0|||
155733798|NCT00975689|562123770|FG001|Overall Study|Adverse Event|3|||
155733799|NCT00975689|562123769|FG000|Overall Study|Withdrawal by Subject|1|||
155733800|NCT00975689|562123770|FG001|Overall Study|Withdrawal by Subject|0|||
155733801|NCT00975689|562123769|FG000|Overall Study|Physician Decision|1|||
155733802|NCT00975689|562123770|FG001|Overall Study|Physician Decision|0|||
155733803|NCT00372593|562123771|FG000|Overall Study|Adverse Event|43|||
155733804|NCT00372593|562123772|FG001|Overall Study|Adverse Event|45|||
155733805|NCT00372593|562123773|FG002|Overall Study|Adverse Event|0|||
155733806|NCT00372593|562123771|FG000|Overall Study|Death|16|||
155733807|NCT00372593|562123772|FG001|Overall Study|Death|20|||
155733808|NCT00372593|562123773|FG002|Overall Study|Death|1|||
155733809|NCT00372593|562123771|FG000|Overall Study|Lack of Efficacy|82|||
155389340|NCT00504881|560860102|FG001|Overall Study|Lost to Follow-up|2|||
155389341|NCT00504881|560860101|FG000|Overall Study|Withdrawal by Subject|1|||
155733810|NCT00372593|562123772|FG001|Overall Study|Lack of Efficacy|71|||
155733811|NCT00372593|562123773|FG002|Overall Study|Lack of Efficacy|2|||
155733812|NCT00372593|562123771|FG000|Overall Study|Lost to Follow-up|1|||
155733813|NCT00372593|562123772|FG001|Overall Study|Lost to Follow-up|0|||
155733814|NCT00372593|562123773|FG002|Overall Study|Lost to Follow-up|0|||
155733815|NCT00372593|562123771|FG000|Overall Study|Physician Decision|42|||
155733816|NCT00372593|562123772|FG001|Overall Study|Physician Decision|41|||
155733817|NCT00372593|562123773|FG002|Overall Study|Physician Decision|0|||
155733818|NCT00372593|562123771|FG000|Overall Study|Ineligible|20|||
155389342|NCT00504881|560860102|FG001|Overall Study|Withdrawal by Subject|4|||
155733819|NCT00372593|562123772|FG001|Overall Study|Ineligible|21|||
155733820|NCT00372593|562123773|FG002|Overall Study|Ineligible|1|||
155733821|NCT02974543|562123774|FG000|Overall Study|Withdrawal by Subject|1|||
155733822|NCT02974543|562123775|FG001|Overall Study|Withdrawal by Subject|0|||
155733823|NCT03534180|562123776|FG000|Overall Study|Withdrawal by Subject|1|||
155733824|NCT00220636|562123777|FG000|Overall Study|Withdrawal by Subject|4|||
155733825|NCT00330967|562123778|FG000|Overall Study|Withdrawal by Subject|0|||
155733826|NCT00330967|562123779|FG001|Overall Study|Withdrawal by Subject|5|||
155733827|NCT00330967|562123778|FG000|Overall Study|Physician Decision|0|||
155733828|NCT00330967|562123779|FG001|Overall Study|Physician Decision|9|||
155733829|NCT00337675|562123782|FG000|Overall Study|Adverse Event|10|||
155733830|NCT00337675|562123783|FG001|Overall Study|Adverse Event|9|||
155733831|NCT00337675|562123784|FG002|Overall Study|Adverse Event|19|||
155733832|NCT00337675|562123782|FG000|Overall Study|Lack of Efficacy|10|||
155733833|NCT00337675|562123783|FG001|Overall Study|Lack of Efficacy|7|||
155733834|NCT00337675|562123784|FG002|Overall Study|Lack of Efficacy|9|||
155733835|NCT00337675|562123782|FG000|Overall Study|Lost to Follow-up|22|||
155733836|NCT00337675|562123783|FG001|Overall Study|Lost to Follow-up|19|||
155733837|NCT00337675|562123784|FG002|Overall Study|Lost to Follow-up|17|||
155733838|NCT00337675|562123782|FG000|Overall Study|Physician Decision|9|||
155733839|NCT00337675|562123783|FG001|Overall Study|Physician Decision|17|||
155733840|NCT00337675|562123784|FG002|Overall Study|Physician Decision|14|||
155733841|NCT00337675|562123782|FG000|Overall Study|Protocol Violation|21|||
155733842|NCT00337675|562123783|FG001|Overall Study|Protocol Violation|24|||
155733843|NCT00337675|562123784|FG002|Overall Study|Protocol Violation|19|||
155733844|NCT00337675|562123782|FG000|Overall Study|Withdrawal by Subject|25|||
155733845|NCT00337675|562123783|FG001|Overall Study|Withdrawal by Subject|25|||
155733846|NCT00337675|562123784|FG002|Overall Study|Withdrawal by Subject|19|||
155733847|NCT00337675|562123782|FG000|Overall Study|Progressive Disease|0|||
155733848|NCT00337675|562123783|FG001|Overall Study|Progressive Disease|2|||
155733849|NCT00337675|562123784|FG002|Overall Study|Progressive Disease|0|||
155733850|NCT00337675|562123782|FG000|Overall Study|Trial Terminated|0|||
155733851|NCT00337675|562123783|FG001|Overall Study|Trial Terminated|0|||
155733852|NCT00337675|562123784|FG002|Overall Study|Trial Terminated|2|||
155733853|NCT04269265|562123785|FG000|Overall Study|Physician Decision|1|||
155733854|NCT04269265|562123785|FG000|Overall Study|Withdrawal by Subject|1|||
155733855|NCT04269265|562123785|FG000|Overall Study|Overenrolled (sample size reached)|4|||
155733856|NCT04439136|562123786|FG000|Overall Study|Ineligible|1|||
155733857|NCT04439136|562123786|FG000|Overall Study|Never Started Treatment|2|||
155733858|NCT04439136|562123786|FG000|Overall Study|Adverse Event|4|||
155733859|NCT04439136|562123786|FG000|Overall Study|Death|3|||
155733860|NCT04439136|562123786|FG000|Overall Study|Disease Progression|27|||
155733861|NCT04439136|562123786|FG000|Overall Study|Alternative Therapy|1|||
155733862|NCT04439136|562123786|FG000|Overall Study|Increased Tumor Burden|1|||
155733863|NCT04439136|562123786|FG000|Overall Study|Symptomatic Detrioration|1|||
155733864|NCT04693234|562123787|FG000|Overall Study|Death|79|||
155733865|NCT04693234|562123788|FG001|Overall Study|Death|19|||
155733866|NCT04693234|562123787|FG000|Overall Study|Sponsor Ended Study|47|||
155733867|NCT04693234|562123788|FG001|Overall Study|Sponsor Ended Study|18|||
155733868|NCT04693234|562123787|FG000|Overall Study|Withdrawal by Subject|10|||
155733869|NCT04693234|562123788|FG001|Overall Study|Withdrawal by Subject|2|||
155733870|NCT04693234|562123787|FG000|Overall Study|Lost to Follow-up|2|||
155733871|NCT04693234|562123788|FG001|Overall Study|Lost to Follow-up|1|||
155733872|NCT02578706|562123791|FG000|Overall Study|Withdrawal by Subject|1|||
155733873|NCT02578706|562123792|FG001|Overall Study|Withdrawal by Subject|0|||
155733874|NCT02578706|562123793|FG002|Overall Study|Withdrawal by Subject|0|||
155733875|NCT02578706|562123791|FG000|Overall Study|Lost to Follow-up|0|||
155733876|NCT02578706|562123792|FG001|Overall Study|Lost to Follow-up|4|||
155733877|NCT02578706|562123793|FG002|Overall Study|Lost to Follow-up|0|||
155389343|NCT00504881|560860101|FG000|Overall Study|Non-Compliance|1|||
155389344|NCT00504881|560860102|FG001|Overall Study|Non-Compliance|0|||
155389345|NCT00504881|560860101|FG000|Overall Study|No Birth Control|0|||
155389346|NCT00504881|560860102|FG001|Overall Study|No Birth Control|1|||
155389347|NCT00504881|560860101|FG000|Overall Study|Safety Visit not performed|0|||
155733878|NCT02578706|562123791|FG000|Overall Study|Physician Decision|0|||
155733879|NCT02578706|562123792|FG001|Overall Study|Physician Decision|1|||
155733880|NCT02578706|562123793|FG002|Overall Study|Physician Decision|0|||
155733881|NCT04849559|562123794|FG000|Overall Study|Withdrawal by Subject|2|||
155733882|NCT04849559|562123795|FG001|Overall Study|Withdrawal by Subject|1|||
155733883|NCT00357006|562123807|FG000|Overall Study|Lost to Follow-up|1|||
155733884|NCT00357006|562123808|FG001|Overall Study|Lost to Follow-up|2|||
155733885|NCT00357006|562123809|FG002|Overall Study|Lost to Follow-up|1|||
155733886|NCT00357006|562123807|FG000|Overall Study|Withdrawal by Subject|1|||
155733887|NCT00357006|562123808|FG001|Overall Study|Withdrawal by Subject|3|||
155733888|NCT00357006|562123809|FG002|Overall Study|Withdrawal by Subject|2|||
155389348|NCT00504881|560860102|FG001|Overall Study|Safety Visit not performed|1|||
155389349|NCT00504881|560860101|FG000|Overall Study|AE, serious fatal|0|||
155733889|NCT03710161|562123810|FG000|Overall Study|Study halted due to COVID pandemic|3|||
155733890|NCT03710161|562123811|FG001|Overall Study|Study halted due to COVID pandemic|2|||
155389350|NCT00504881|560860102|FG001|Overall Study|AE, serious fatal|1|||
155389351|NCT00504881|560860101|FG000|Overall Study|SAE, non-fatal|2|||
155389352|NCT00504881|560860102|FG001|Overall Study|SAE, non-fatal|6|||
155389353|NCT00504881|560860101|FG000|Overall Study|AE, non-serious non-fatal|4|||
155389354|NCT00504881|560860102|FG001|Overall Study|AE, non-serious non-fatal|14|||
155389355|NCT00504881|560860101|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155389356|NCT00504881|560860102|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
155389357|NCT00504881|560860101|FG000|Overall Study|AE of unknown type|1|||
155389358|NCT00504881|560860102|FG001|Overall Study|AE of unknown type|0|||
155389359|NCT01777269|560860103|FG000|Overall Study|Adverse Event|24|||
155389360|NCT01777269|560860104|FG001|Overall Study|Adverse Event|33|||
155389361|NCT01777269|560860103|FG000|Overall Study|Lack of Efficacy|8|||
155389362|NCT01777269|560860104|FG001|Overall Study|Lack of Efficacy|10|||
155389363|NCT01777269|560860103|FG000|Overall Study|Protocol Violation|4|||
155389364|NCT01777269|560860104|FG001|Overall Study|Protocol Violation|4|||
155389365|NCT01777269|560860103|FG000|Overall Study|Participants reached stopping criteria|1|||
155389366|NCT01777269|560860104|FG001|Overall Study|Participants reached stopping criteria|1|||
155389367|NCT01777269|560860103|FG000|Overall Study|Lost to Follow-up|4|||
155389368|NCT01777269|560860104|FG001|Overall Study|Lost to Follow-up|0|||
155389369|NCT01777269|560860103|FG000|Overall Study|Physician Decision|5|||
155389370|NCT01777269|560860104|FG001|Overall Study|Physician Decision|2|||
155389371|NCT01777269|560860103|FG000|Overall Study|Withdrawal by Subject|9|||
155389372|NCT01777269|560860104|FG001|Overall Study|Withdrawal by Subject|9|||
155389373|NCT00753272|560860112|FG000|Overall Study|Adverse Event|878|||
155389374|NCT00753272|560860113|FG001|Overall Study|Adverse Event|869|||
155389375|NCT00753272|560860112|FG000|Overall Study|Protocol Violation|28|||
155389376|NCT00753272|560860113|FG001|Overall Study|Protocol Violation|46|||
155389377|NCT00753272|560860112|FG000|Overall Study|Withdrawal by Subject|2481|||
155389378|NCT00753272|560860113|FG001|Overall Study|Withdrawal by Subject|2407|||
155389379|NCT00753272|560860112|FG000|Overall Study|Lost to Follow-up|491|||
155389380|NCT00753272|560860113|FG001|Overall Study|Lost to Follow-up|497|||
155389381|NCT00753272|560860112|FG000|Overall Study|Other|1104|||
155389382|NCT00753272|560860113|FG001|Overall Study|Other|1088|||
155389383|NCT01193920|560860114|FG000|Overall Study|Withdrawal by Subject|1|||
155389384|NCT01193920|560860115|FG001|Overall Study|Withdrawal by Subject|0|||
155389385|NCT01193920|560860116|FG002|Overall Study|Withdrawal by Subject|5|||
155389386|NCT01193920|560860117|FG003|Overall Study|Withdrawal by Subject|1|||
155389387|NCT01193920|560860118|FG004|Overall Study|Withdrawal by Subject|3|||
155389388|NCT01193920|560860119|FG005|Overall Study|Withdrawal by Subject|1|||
155389389|NCT01193920|560860120|FG006|Overall Study|Withdrawal by Subject|3|||
155389390|NCT01193920|560860121|FG007|Overall Study|Withdrawal by Subject|0|||
155389391|NCT01193920|560860122|FG008|Overall Study|Withdrawal by Subject|1|||
155389392|NCT01193920|560860123|FG009|Overall Study|Withdrawal by Subject|0|||
155389393|NCT01193920|560860114|FG000|Overall Study|Lost to Follow-up|1|||
155389394|NCT01193920|560860115|FG001|Overall Study|Lost to Follow-up|0|||
155389395|NCT01193920|560860116|FG002|Overall Study|Lost to Follow-up|1|||
155733891|NCT02637037|562123814|FG000|Overall Study|Positive drug screen at admission|1|||
155733892|NCT02637037|562123815|FG001|Overall Study|Positive drug screen at admission|0|||
155733893|NCT02637037|562123814|FG000|Overall Study|Withdrawal by Subject|2|||
155733894|NCT02637037|562123815|FG001|Overall Study|Withdrawal by Subject|1|||
155733895|NCT02637037|562123814|FG000|Overall Study|Adverse Event|1|||
155733896|NCT02637037|562123815|FG001|Overall Study|Adverse Event|0|||
155733897|NCT02023697|562123817|FG000|Treatment Period|Radiological progression|13|||
155733898|NCT02023697|562123818|FG001|Treatment Period|Radiological progression|17|||
155733899|NCT02023697|562123819|FG002|Treatment Period|Radiological progression|26|||
155733900|NCT02023697|562123817|FG000|Treatment Period|Never Treated|5|||
155733901|NCT02023697|562123818|FG001|Treatment Period|Never Treated|6|||
155733902|NCT02023697|562123819|FG002|Treatment Period|Never Treated|10|||
155733903|NCT02023697|562123817|FG000|Treatment Period|Adverse Event|13|||
155733904|NCT02023697|562123818|FG001|Treatment Period|Adverse Event|25|||
155733905|NCT02023697|562123819|FG002|Treatment Period|Adverse Event|23|||
155733906|NCT02023697|562123817|FG000|Treatment Period|Logistical difficulties|1|||
155389396|NCT01193920|560860117|FG003|Overall Study|Lost to Follow-up|1|||
155389397|NCT01193920|560860118|FG004|Overall Study|Lost to Follow-up|3|||
155733907|NCT02023697|562123818|FG001|Treatment Period|Logistical difficulties|1|||
155389398|NCT01193920|560860119|FG005|Overall Study|Lost to Follow-up|3|||
155733908|NCT02023697|562123819|FG002|Treatment Period|Logistical difficulties|1|||
155733909|NCT02023697|562123817|FG000|Treatment Period|Clinical progression|10|||
155389399|NCT01193920|560860120|FG006|Overall Study|Lost to Follow-up|1|||
155389400|NCT01193920|560860121|FG007|Overall Study|Lost to Follow-up|0|||
155389401|NCT01193920|560860122|FG008|Overall Study|Lost to Follow-up|2|||
155733910|NCT02023697|562123818|FG001|Treatment Period|Clinical progression|8|||
155733911|NCT02023697|562123819|FG002|Treatment Period|Clinical progression|28|||
155733912|NCT02023697|562123817|FG000|Treatment Period|Withdrawal by Subject|4|||
155733913|NCT02023697|562123818|FG001|Treatment Period|Withdrawal by Subject|5|||
155389402|NCT01193920|560860123|FG009|Overall Study|Lost to Follow-up|3|||
155389403|NCT01193920|560860114|FG000|Overall Study|Protocol Violation|1|||
155389404|NCT01193920|560860115|FG001|Overall Study|Protocol Violation|0|||
155389405|NCT01193920|560860116|FG002|Overall Study|Protocol Violation|0|||
155389406|NCT01193920|560860117|FG003|Overall Study|Protocol Violation|0|||
155389407|NCT01193920|560860118|FG004|Overall Study|Protocol Violation|0|||
155389408|NCT01193920|560860119|FG005|Overall Study|Protocol Violation|0|||
155389409|NCT01193920|560860120|FG006|Overall Study|Protocol Violation|0|||
155389410|NCT01193920|560860121|FG007|Overall Study|Protocol Violation|0|||
155389411|NCT01193920|560860122|FG008|Overall Study|Protocol Violation|0|||
155389412|NCT01193920|560860123|FG009|Overall Study|Protocol Violation|0|||
155389413|NCT01193920|560860114|FG000|Overall Study|Death|0|||
155389414|NCT01193920|560860115|FG001|Overall Study|Death|0|||
155389415|NCT01193920|560860116|FG002|Overall Study|Death|0|||
155389416|NCT01193920|560860117|FG003|Overall Study|Death|1|||
155389417|NCT01193920|560860118|FG004|Overall Study|Death|0|||
155389418|NCT01193920|560860119|FG005|Overall Study|Death|0|||
155389419|NCT01193920|560860120|FG006|Overall Study|Death|2|||
155389420|NCT01193920|560860121|FG007|Overall Study|Death|3|||
155389421|NCT01193920|560860122|FG008|Overall Study|Death|2|||
155389422|NCT01193920|560860123|FG009|Overall Study|Death|4|||
155389423|NCT01193920|560860114|FG000|Overall Study|Unable to classify|0|||
155389424|NCT01193920|560860115|FG001|Overall Study|Unable to classify|0|||
155389425|NCT01193920|560860116|FG002|Overall Study|Unable to classify|0|||
155389426|NCT01193920|560860117|FG003|Overall Study|Unable to classify|1|||
155389427|NCT01193920|560860118|FG004|Overall Study|Unable to classify|0|||
155389428|NCT01193920|560860119|FG005|Overall Study|Unable to classify|0|||
155389429|NCT01193920|560860120|FG006|Overall Study|Unable to classify|0|||
155389430|NCT01193920|560860121|FG007|Overall Study|Unable to classify|1|||
155389431|NCT01193920|560860122|FG008|Overall Study|Unable to classify|0|||
155389432|NCT01193920|560860123|FG009|Overall Study|Unable to classify|0|||
155389433|NCT00883051|560860127|FG000|Overall Study|Lost to Follow-up|0|||
155631158|NCT04736199|561744268|FG000|Overall Study|Death|9|||
155631159|NCT04736199|561744269|FG001|Overall Study|Death|3|||
155631160|NCT04736199|561744268|FG000|Overall Study|Lost to Follow-up|4|||
155631161|NCT04736199|561744269|FG001|Overall Study|Lost to Follow-up|1|||
155631162|NCT04736199|561744268|FG000|Overall Study|Physician Decision|5|||
155631163|NCT04736199|561744269|FG001|Overall Study|Physician Decision|9|||
155631164|NCT04736199|561744268|FG000|Overall Study|Withdrawal by Subject|21|||
155631165|NCT04736199|561744269|FG001|Overall Study|Withdrawal by Subject|9|||
155631166|NCT04736199|561744268|FG000|Overall Study|Progressive disease|120|||
155631167|NCT04736199|561744269|FG001|Overall Study|Progressive disease|101|||
155631168|NCT04736199|561744268|FG000|Overall Study|Subject decision|13|||
155631169|NCT04736199|561744269|FG001|Overall Study|Subject decision|13|||
155631170|NCT04736199|561744268|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
155631171|NCT04736199|561744269|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
155631172|NCT04736199|561744268|FG000|Overall Study|Additional primary malignancy|1|||
155631173|NCT04736199|561744269|FG001|Overall Study|Additional primary malignancy|0|||
155631174|NCT04736199|561744268|FG000|Overall Study|Non-compliance with study drug|0|||
155631175|NCT04736199|561744269|FG001|Overall Study|Non-compliance with study drug|1|||
155631176|NCT04736199|561744268|FG000|Overall Study|Other reason|0|||
155631177|NCT04736199|561744269|FG001|Overall Study|Other reason|1|||
155631178|NCT04736199|561744268|FG000|Overall Study|Ongoing with study drug|240|||
155631179|NCT04736199|561744269|FG001|Overall Study|Ongoing with study drug|63|||
155631180|NCT04736199|561744268|FG000|Overall Study|Study drug never administered|3|||
155631181|NCT04736199|561744269|FG001|Overall Study|Study drug never administered|0|||
155631182|NCT03370172|561744270|FG000|Overall Study|Withdrawal by Subject|0|||
155631183|NCT03370172|561744271|FG001|Overall Study|Withdrawal by Subject|1|||
155631184|NCT05918055|561744272|FG000|Phase I - Dose Level 1|Ineligible|0|||
155631185|NCT05918055|561744273|FG001|Phase I - Dose Level 1|Ineligible|0|||
155631186|NCT05918055|561744274|FG002|Phase I - Dose Level 1|Ineligible|1|||
155631187|NCT05918055|561744272|FG000|Phase I - Dose Level -1|Physician Decision|1|||
155631188|NCT05918055|561744273|FG001|Phase I - Dose Level -1|Physician Decision|0|||
155631189|NCT05918055|561744274|FG002|Phase I - Dose Level -1|Physician Decision|0|||
155631190|NCT05610605|561744277|FG000|6-month Assessment|Death|1|||
155631191|NCT05610605|561744278|FG001|6-month Assessment|Death|1|||
155631192|NCT05610605|561744277|FG000|6-month Assessment|Lost to Follow-up|20|||
155631193|NCT05610605|561744278|FG001|6-month Assessment|Lost to Follow-up|0|||
155631194|NCT05610605|561744277|FG000|6-month Assessment|Institutionalized|1|||
155631195|NCT05610605|561744278|FG001|6-month Assessment|Institutionalized|2|||
155631196|NCT05610605|561744277|FG000|12-month Assessment|Death|2|||
155631197|NCT05610605|561744278|FG001|12-month Assessment|Death|1|||
155631198|NCT05610605|561744277|FG000|12-month Assessment|Lost to Follow-up|1|||
155389434|NCT00883051|560860128|FG001|Overall Study|Lost to Follow-up|0|||
155389435|NCT00883051|560860129|FG002|Overall Study|Lost to Follow-up|0|||
155389436|NCT00883051|560860130|FG003|Overall Study|Lost to Follow-up|0|||
155389437|NCT00883051|560860131|FG004|Overall Study|Lost to Follow-up|1|||
155389438|NCT00883051|560860127|FG000|Overall Study|Did not use study medication|24|||
155389439|NCT00883051|560860128|FG001|Overall Study|Did not use study medication|22|||
155389440|NCT00883051|560860129|FG002|Overall Study|Did not use study medication|29|||
155631199|NCT05610605|561744278|FG001|12-month Assessment|Lost to Follow-up|4|||
155631200|NCT05610605|561744277|FG000|12-month Assessment|Institutionalized|2|||
155389441|NCT00883051|560860130|FG003|Overall Study|Did not use study medication|29|||
155733914|NCT02023697|562123819|FG002|Treatment Period|Withdrawal by Subject|13|||
155733915|NCT02023697|562123817|FG000|Treatment Period|Safety outcome reached|0|||
155733916|NCT02023697|562123818|FG001|Treatment Period|Safety outcome reached|1|||
155733917|NCT02023697|562123819|FG002|Treatment Period|Safety outcome reached|0|||
155389442|NCT00883051|560860131|FG004|Overall Study|Did not use study medication|17|||
155389443|NCT01335009|560860134|FG000|Overall Study|Too ill to travel to study sites|1|||
155389444|NCT01335009|560860135|FG001|Overall Study|Too ill to travel to study sites|0|||
155389445|NCT01335009|560860134|FG000|Overall Study|Death|28|||
155389446|NCT01335009|560860135|FG001|Overall Study|Death|32|||
155389447|NCT01335009|560860134|FG000|Overall Study|Withdrawal by Subject|1|||
155389448|NCT01335009|560860135|FG001|Overall Study|Withdrawal by Subject|1|||
155389449|NCT01335009|560860134|FG000|Overall Study|Lost to Follow-up|1|||
155389450|NCT01335009|560860135|FG001|Overall Study|Lost to Follow-up|0|||
155389451|NCT04824521|560860136|FG000|Overall Study|Lost to Follow-up|1|||
155389452|NCT01598311|560860137|FG000|Overall Study|Physician Decision|4|||
155389453|NCT01598311|560860138|FG001|Overall Study|Physician Decision|5|||
155389454|NCT01598311|560860137|FG000|Overall Study|Adverse Event|9|||
155389455|NCT01598311|560860138|FG001|Overall Study|Adverse Event|13|||
155389456|NCT01598311|560860137|FG000|Overall Study|Lost to Follow-up|7|||
155389457|NCT01598311|560860138|FG001|Overall Study|Lost to Follow-up|12|||
155389458|NCT01598311|560860137|FG000|Overall Study|Withdrawal by Subject|9|||
155389459|NCT01598311|560860138|FG001|Overall Study|Withdrawal by Subject|13|||
155389460|NCT01598311|560860137|FG000|Overall Study|No reason provided.|0|||
155389461|NCT01598311|560860138|FG001|Overall Study|No reason provided.|5|||
155389462|NCT01598311|560860137|FG000|Overall Study|Randomized but never treated|8|||
155389463|NCT01598311|560860138|FG001|Overall Study|Randomized but never treated|5|||
155389464|NCT01598311|560860137|FG000|Overall Study|Treated but no confirmed CDAD|9|||
155389465|NCT01598311|560860138|FG001|Overall Study|Treated but no confirmed CDAD|8|||
155389466|NCT01598311|560860137|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
155389467|NCT01598311|560860138|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
155733918|NCT02023697|562123817|FG000|Treatment Period|Physician Decision|0|||
155733919|NCT02023697|562123818|FG001|Treatment Period|Physician Decision|0|||
155733920|NCT02023697|562123819|FG002|Treatment Period|Physician Decision|1|||
155733921|NCT02023697|562123817|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
155733922|NCT02023697|562123818|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
155733923|NCT02023697|562123819|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
155733924|NCT02023697|562123817|FG000|Active Follow-up Period|Lost to Follow-up|1|||
155733925|NCT02023697|562123818|FG001|Active Follow-up Period|Lost to Follow-up|1|||
155733926|NCT02023697|562123819|FG002|Active Follow-up Period|Lost to Follow-up|1|||
155733927|NCT02023697|562123817|FG000|Active Follow-up Period|Deterioration of general condition|1|||
155733928|NCT02023697|562123818|FG001|Active Follow-up Period|Deterioration of general condition|1|||
155733929|NCT02023697|562123819|FG002|Active Follow-up Period|Deterioration of general condition|1|||
155733930|NCT02023697|562123817|FG000|Active Follow-up Period|Other unspecified|2|||
155733931|NCT02023697|562123818|FG001|Active Follow-up Period|Other unspecified|0|||
155733932|NCT02023697|562123819|FG002|Active Follow-up Period|Other unspecified|1|||
155733933|NCT02023697|562123817|FG000|Active Follow-up Period|Clinical progression|0|||
155733934|NCT02023697|562123818|FG001|Active Follow-up Period|Clinical progression|2|||
155733935|NCT02023697|562123819|FG002|Active Follow-up Period|Clinical progression|1|||
155733936|NCT02023697|562123817|FG000|Active Follow-up Period|Radiological progression|0|||
155733937|NCT02023697|562123818|FG001|Active Follow-up Period|Radiological progression|0|||
155733938|NCT02023697|562123819|FG002|Active Follow-up Period|Radiological progression|1|||
155733939|NCT02023697|562123817|FG000|Active Follow-up Period|Death|83|||
155733940|NCT02023697|562123818|FG001|Active Follow-up Period|Death|82|||
155733941|NCT02023697|562123819|FG002|Active Follow-up Period|Death|87|||
155733942|NCT02023697|562123817|FG000|Long-term Follow-up Period|Death|9|||
155389468|NCT00688103|560860139|FG000|Overall Study|Adverse Event|4|||
155389469|NCT00688103|560860140|FG001|Overall Study|Adverse Event|1|||
155389470|NCT00688103|560860139|FG000|Overall Study|Lack of Efficacy|11|||
155389471|NCT00688103|560860140|FG001|Overall Study|Lack of Efficacy|1|||
155389472|NCT00688103|560860139|FG000|Overall Study|Withdrawal by Subject|4|||
155389473|NCT00688103|560860140|FG001|Overall Study|Withdrawal by Subject|2|||
155389474|NCT00688103|560860139|FG000|Overall Study|complex reasons|11|||
155389475|NCT00688103|560860140|FG001|Overall Study|complex reasons|9|||
155733943|NCT02023697|562123818|FG001|Long-term Follow-up Period|Death|6|||
155733944|NCT02023697|562123819|FG002|Long-term Follow-up Period|Death|4|||
155389476|NCT03144804|560860141|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
155733945|NCT02023697|562123817|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
155733946|NCT02023697|562123818|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
155733947|NCT02023697|562123819|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
155389477|NCT04223856|560860142|FG000|Overall Study|Progressive disease|153|||
155389478|NCT04223856|560860143|FG001|Overall Study|Progressive disease|73|||
155389479|NCT04223856|560860142|FG000|Overall Study|Adverse Event|97|||
155389480|NCT04223856|560860143|FG001|Overall Study|Adverse Event|62|||
155733948|NCT02023697|562123817|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
155733949|NCT02023697|562123818|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
155733950|NCT02023697|562123819|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
155733951|NCT02023697|562123817|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
155733952|NCT02023697|562123818|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
155733953|NCT02023697|562123819|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
155733954|NCT02023697|562123817|FG000|Long-term Follow-up Period|Technical problems|0|||
155733955|NCT02023697|562123818|FG001|Long-term Follow-up Period|Technical problems|0|||
155733956|NCT02023697|562123819|FG002|Long-term Follow-up Period|Technical problems|1|||
155733957|NCT02023697|562123817|FG000|Long-term Follow-up Period|Other unspecified|6|||
155733958|NCT02023697|562123818|FG001|Long-term Follow-up Period|Other unspecified|3|||
155389481|NCT04223856|560860142|FG000|Overall Study|Physician Decision|9|||
155389482|NCT04223856|560860143|FG001|Overall Study|Physician Decision|28|||
155389483|NCT04223856|560860142|FG000|Overall Study|Withdrawal by Subject|22|||
155389484|NCT04223856|560860143|FG001|Overall Study|Withdrawal by Subject|24|||
155389485|NCT04223856|560860142|FG000|Overall Study|Other|7|||
155389486|NCT04223856|560860143|FG001|Overall Study|Other|2|||
155389487|NCT04223856|560860142|FG000|Overall Study|Randomized but not treated|2|||
155389488|NCT04223856|560860143|FG001|Overall Study|Randomized but not treated|11|||
155389489|NCT04223856|560860142|FG000|Overall Study|On-treatment|144|||
155389490|NCT04223856|560860143|FG001|Overall Study|On-treatment|0|||
155389491|NCT03078907|560862526|FG000|Overall Study|Adverse Event|2|||
155389492|NCT03078907|560862527|FG001|Overall Study|Adverse Event|0|||
155389493|NCT03078907|560862526|FG000|Overall Study|Other|1|||
155389494|NCT03078907|560862527|FG001|Overall Study|Other|0|||
155389495|NCT03078907|560862526|FG000|Overall Study|Protocol Violation|0|||
155389496|NCT03078907|560862527|FG001|Overall Study|Protocol Violation|1|||
155389497|NCT01955122|560862528|FG000|Overall Study|Physician Decision|5|||
155389498|NCT01955122|560862529|FG001|Overall Study|Physician Decision|5|||
155389499|NCT01672788|560862530|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
155733959|NCT02023697|562123819|FG002|Long-term Follow-up Period|Other unspecified|5|||
155733960|NCT00478023|562123825|FG000|Overall Study|Adverse Event|11|||
155733961|NCT00478023|562123826|FG001|Overall Study|Adverse Event|7|||
155733962|NCT00478023|562123827|FG002|Overall Study|Adverse Event|8|||
155733963|NCT00478023|562123828|FG003|Overall Study|Adverse Event|14|||
155733964|NCT00478023|562123829|FG004|Overall Study|Adverse Event|6|||
155733965|NCT00478023|562123825|FG000|Overall Study|Death|1|||
155733966|NCT00478023|562123826|FG001|Overall Study|Death|0|||
155733967|NCT00478023|562123827|FG002|Overall Study|Death|0|||
155733968|NCT00478023|562123828|FG003|Overall Study|Death|0|||
155733969|NCT00478023|562123829|FG004|Overall Study|Death|0|||
155733970|NCT00478023|562123825|FG000|Overall Study|Lack of Efficacy|11|||
155733971|NCT00478023|562123826|FG001|Overall Study|Lack of Efficacy|10|||
155733972|NCT00478023|562123827|FG002|Overall Study|Lack of Efficacy|4|||
155733973|NCT00478023|562123828|FG003|Overall Study|Lack of Efficacy|5|||
155733974|NCT00478023|562123829|FG004|Overall Study|Lack of Efficacy|41|||
155733975|NCT00478023|562123825|FG000|Overall Study|Lost to Follow-up|3|||
155733976|NCT00478023|562123826|FG001|Overall Study|Lost to Follow-up|1|||
155733977|NCT00478023|562123827|FG002|Overall Study|Lost to Follow-up|1|||
155733978|NCT00478023|562123828|FG003|Overall Study|Lost to Follow-up|1|||
155733979|NCT00478023|562123829|FG004|Overall Study|Lost to Follow-up|0|||
155733980|NCT00478023|562123825|FG000|Overall Study|Withdrawal by Subject|2|||
155733981|NCT00478023|562123826|FG001|Overall Study|Withdrawal by Subject|3|||
155733982|NCT00478023|562123827|FG002|Overall Study|Withdrawal by Subject|2|||
155733983|NCT00478023|562123828|FG003|Overall Study|Withdrawal by Subject|4|||
155733984|NCT00478023|562123829|FG004|Overall Study|Withdrawal by Subject|5|||
155733985|NCT00478023|562123825|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
155733986|NCT00478023|562123826|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
155733987|NCT00478023|562123827|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
155389500|NCT01672788|560862531|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
155389501|NCT01672788|560862532|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
155389502|NCT01672788|560862533|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
155389503|NCT03329196|560862538|FG000|Overall Study|Adverse Event|10|||
155389504|NCT03329196|560862539|FG001|Overall Study|Adverse Event|5|||
155389505|NCT03329196|560862538|FG000|Overall Study|Physician Decision|2|||
155389506|NCT03329196|560862539|FG001|Overall Study|Physician Decision|2|||
155733988|NCT00478023|562123828|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
155733989|NCT00478023|562123829|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
155733990|NCT03895840|562123830|FG000|Overall Study|Withdrawal by Subject|21|||
155733991|NCT02395081|562123831|FG000|Overall Study|Withdrawal by Subject|1|||
155733992|NCT02395081|562123832|FG001|Overall Study|Withdrawal by Subject|1|||
155733993|NCT02395081|562123833|FG002|Overall Study|Withdrawal by Subject|0|||
155389507|NCT03329196|560862538|FG000|Overall Study|Withdrawal by Subject|11|||
155389508|NCT03329196|560862539|FG001|Overall Study|Withdrawal by Subject|3|||
155389509|NCT03329196|560862538|FG000|Overall Study|Hepatic function abnormalities|0|||
155389510|NCT03329196|560862539|FG001|Overall Study|Hepatic function abnormalities|1|||
155389511|NCT03329196|560862538|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
155389512|NCT03329196|560862539|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
155389513|NCT03329196|560862538|FG000|Overall Study|Difficult to control Hb|2|||
155389514|NCT03329196|560862539|FG001|Overall Study|Difficult to control Hb|3|||
155389515|NCT03329196|560862538|FG000|Overall Study|Dialysis or renal transplant|13|||
155389516|NCT03329196|560862539|FG001|Overall Study|Dialysis or renal transplant|15|||
155733994|NCT02395081|562123831|FG000|Overall Study|Moved where blood couldn't be collected|4|||
155733995|NCT02395081|562123832|FG001|Overall Study|Moved where blood couldn't be collected|1|||
155389517|NCT02464228|560862540|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
155389518|NCT02464228|560862541|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
155389519|NCT02464228|560862542|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
155389520|NCT02464228|560862543|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
155389521|NCT02464228|560862540|FG000|Overall Study|Physician Decision|2|||
155733996|NCT02395081|562123833|FG002|Overall Study|Moved where blood couldn't be collected|3|||
155733997|NCT02395081|562123831|FG000|Overall Study|Fetal Loss|2|||
155733998|NCT02395081|562123832|FG001|Overall Study|Fetal Loss|3|||
155733999|NCT02395081|562123833|FG002|Overall Study|Fetal Loss|1|||
155734000|NCT00068419|562123836|FG000|Overall Study|Adverse Event|3|||
155734001|NCT00068419|562123836|FG000|Overall Study|Lack of Efficacy|24|||
155734002|NCT00068419|562123836|FG000|Overall Study|Lost to Follow-up|1|||
155734003|NCT00068419|562123836|FG000|Overall Study|Physician Decision|7|||
155734004|NCT00068419|562123836|FG000|Overall Study|Withdrawal by Subject|14|||
155734005|NCT00068419|562123836|FG000|Overall Study|Ineligible|11|||
155734006|NCT00256997|562123844|FG000|Overall Study|Protocol Violation|1|||
155734007|NCT00256997|562123845|FG001|Overall Study|Protocol Violation|4|||
155734008|NCT00256997|562123844|FG000|Overall Study|Lack of Efficacy|1|||
155734009|NCT00256997|562123845|FG001|Overall Study|Lack of Efficacy|4|||
155734010|NCT00256997|562123844|FG000|Overall Study|Death|2|||
155734011|NCT00256997|562123845|FG001|Overall Study|Death|0|||
155734012|NCT00256997|562123844|FG000|Overall Study|Adverse Event|4|||
155734013|NCT00256997|562123845|FG001|Overall Study|Adverse Event|0|||
155734014|NCT00256997|562123844|FG000|Overall Study|Lost to Follow-up|3|||
155734015|NCT00256997|562123845|FG001|Overall Study|Lost to Follow-up|5|||
155734016|NCT00256997|562123844|FG000|Overall Study|Withdrawal by Subject|13|||
155734017|NCT00256997|562123845|FG001|Overall Study|Withdrawal by Subject|3|||
155734018|NCT00256997|562123844|FG000|Overall Study|Started but not treated|2|||
155734019|NCT00256997|562123845|FG001|Overall Study|Started but not treated|0|||
155734020|NCT00256997|562123844|FG000|Overall Study|Other|5|||
155734021|NCT00256997|562123845|FG001|Overall Study|Other|8|||
155734022|NCT00256997|562123844|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
155734023|NCT00256997|562123845|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
155734024|NCT00256997|562123844|FG000|Overall Study|Participant Non-compliant|3|||
155734025|NCT00256997|562123845|FG001|Overall Study|Participant Non-compliant|6|||
155734026|NCT00256997|562123844|FG000|Overall Study|Investigator Withdrew Participant|2|||
155734027|NCT00256997|562123845|FG001|Overall Study|Investigator Withdrew Participant|1|||
155734028|NCT01287741|562123846|FG000|Overall Study|Withdrawal by Subject|35|||
155734029|NCT01287741|562123847|FG001|Overall Study|Withdrawal by Subject|38|||
155734030|NCT01287741|562123846|FG000|Overall Study|Protocol Violation|2|||
155734031|NCT01287741|562123847|FG001|Overall Study|Protocol Violation|0|||
155389522|NCT02464228|560862541|FG001|Overall Study|Physician Decision|0|||
155389523|NCT02464228|560862542|FG002|Overall Study|Physician Decision|1|||
155389524|NCT02464228|560862543|FG003|Overall Study|Physician Decision|0|||
155389525|NCT02464228|560862540|FG000|Overall Study|Miscellaneous|1|||
155389526|NCT02464228|560862541|FG001|Overall Study|Miscellaneous|0|||
155389527|NCT02464228|560862542|FG002|Overall Study|Miscellaneous|1|||
155389528|NCT02464228|560862543|FG003|Overall Study|Miscellaneous|0|||
155389529|NCT02464228|560862540|FG000|Overall Study|Adverse Event|9|||
155389530|NCT02464228|560862541|FG001|Overall Study|Adverse Event|0|||
155389531|NCT02464228|560862542|FG002|Overall Study|Adverse Event|3|||
155389532|NCT02464228|560862543|FG003|Overall Study|Adverse Event|0|||
155389533|NCT02464228|560862540|FG000|Overall Study|Withdrawal by Subject|1|||
155389534|NCT02464228|560862541|FG001|Overall Study|Withdrawal by Subject|1|||
155734032|NCT01287741|562123846|FG000|Overall Study|Physician Decision|15|||
155734033|NCT01287741|562123847|FG001|Overall Study|Physician Decision|23|||
155734034|NCT01287741|562123846|FG000|Overall Study|Non-compliance|8|||
155734035|NCT01287741|562123847|FG001|Overall Study|Non-compliance|6|||
155734036|NCT01287741|562123846|FG000|Overall Study|Lost to Follow-up|10|||
155389535|NCT02464228|560862542|FG002|Overall Study|Withdrawal by Subject|1|||
155734037|NCT01287741|562123847|FG001|Overall Study|Lost to Follow-up|8|||
155734038|NCT01287741|562123846|FG000|Overall Study|Death|32|||
155734039|NCT01287741|562123847|FG001|Overall Study|Death|44|||
155734040|NCT01287741|562123846|FG000|Overall Study|Adverse Event|4|||
155389536|NCT02464228|560862543|FG003|Overall Study|Withdrawal by Subject|0|||
155389537|NCT02464228|560862540|FG000|Overall Study|Disease Progression|22|||
155389538|NCT02464228|560862541|FG001|Overall Study|Disease Progression|12|||
155389539|NCT02464228|560862542|FG002|Overall Study|Disease Progression|5|||
155734041|NCT01287741|562123847|FG001|Overall Study|Adverse Event|6|||
155734042|NCT01287741|562123846|FG000|Overall Study|Study terminated by Sponsor|307|||
155631201|NCT05610605|561744278|FG001|12-month Assessment|Institutionalized|1|||
155631202|NCT00753519|561744279|FG000|Overall Study|Withdrawal by Subject|0|||
155631203|NCT00753519|561744280|FG001|Overall Study|Withdrawal by Subject|2|||
155631204|NCT01171534|561744281|FG000|Overall Study|Lost to Follow-up|0|||
155631205|NCT01171534|561744282|FG001|Overall Study|Lost to Follow-up|2|||
155631206|NCT01171534|561744281|FG000|Overall Study|screen failure|0|||
155631207|NCT01171534|561744282|FG001|Overall Study|screen failure|1|||
155631208|NCT00548327|561744283|FG000|Overall Study|Adverse Event|0|||
155631209|NCT00548327|561744284|FG001|Overall Study|Adverse Event|1|||
155631210|NCT02100631|561744285|FG000|Overall Study|Withdrawal by Subject|1|||
155631211|NCT02100631|561744286|FG001|Overall Study|Withdrawal by Subject|0|||
155631212|NCT02100631|561744287|FG002|Overall Study|Withdrawal by Subject|0|||
155631213|NCT02100631|561744285|FG000|Overall Study|Lost to Follow-up|3|||
155631214|NCT02100631|561744286|FG001|Overall Study|Lost to Follow-up|4|||
155631215|NCT02100631|561744287|FG002|Overall Study|Lost to Follow-up|0|||
155631216|NCT02100631|561744285|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
155631217|NCT02100631|561744286|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
155631218|NCT02100631|561744287|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
155631219|NCT01316614|561744288|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
155631220|NCT01316614|561744288|FG000|Overall Study|Cytology slides not available for review|4|||
155631221|NCT01316614|561744288|FG000|Overall Study|Cystic lesion|5|||
155631222|NCT01316614|561744288|FG000|Overall Study|Inadequate number of passes|2|||
155631223|NCT01316614|561744288|FG000|Overall Study|Medically unstable|1|||
155631224|NCT00089648|561744289|FG000|Overall Study|Adverse Event|7|||
155631225|NCT00089648|561744289|FG000|Overall Study|Withdrawal by Subject|1|||
155631226|NCT00089648|561744289|FG000|Overall Study|Lack of Efficacy|33|||
155631227|NCT00420745|561744290|FG000|Overall Study|Adverse Event|2|||
155631228|NCT00420745|561744291|FG001|Overall Study|Adverse Event|2|||
155631229|NCT00420745|561744290|FG000|Overall Study|Lost to Follow-up|10|||
155631230|NCT00420745|561744291|FG001|Overall Study|Lost to Follow-up|2|||
155631231|NCT00420745|561744290|FG000|Overall Study|Protocol Violation|1|||
155631232|NCT00420745|561744291|FG001|Overall Study|Protocol Violation|0|||
155631233|NCT00420745|561744290|FG000|Overall Study|Physician Decision|1|||
155631234|NCT00420745|561744291|FG001|Overall Study|Physician Decision|1|||
155631235|NCT00420745|561744290|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
155631236|NCT00420745|561744291|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
155631237|NCT00420745|561744290|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
155631238|NCT00420745|561744291|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
155631239|NCT00423605|561744292|FG000|Overall Study|Adverse Event|129|||
155631240|NCT00423605|561744292|FG000|Overall Study|Withdrawal by Subject|36|||
155631241|NCT00423605|561744292|FG000|Overall Study|Lost to Follow-up|15|||
155631242|NCT00423605|561744292|FG000|Overall Study|Lack of Efficacy|38|||
155631243|NCT00423605|561744292|FG000|Overall Study|Sponsor Decision|3|||
155631244|NCT00423605|561744292|FG000|Overall Study|Physician Decision|8|||
155631245|NCT00423605|561744292|FG000|Overall Study|Protocol Violation|7|||
155631246|NCT00423605|561744292|FG000|Overall Study|Not one of the pre-specified options|5|||
155631247|NCT00726453|561744294|FG000|Primary Enrollment Group|Death|18|||
155631248|NCT00726453|561744295|FG001|Primary Enrollment Group|Death|0|||
155631249|NCT00726453|561744294|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
155631250|NCT00726453|561744295|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
155631251|NCT00726453|561744294|FG000|38 mm Length Group|Death|0|||
155631252|NCT00726453|561744295|FG001|38 mm Length Group|Death|3|||
155631253|NCT01588509|561744297|FG000|Overall Study|Lost to Follow-up|1|||
155631254|NCT01588509|561744298|FG001|Overall Study|Lost to Follow-up|0|||
155631255|NCT00368550|561744303|FG000|Overall Study|Adverse Event|7|||
155631256|NCT00368550|561744304|FG001|Overall Study|Adverse Event|4|||
155631257|NCT00368550|561744303|FG000|Overall Study|Lack of Efficacy|4|||
155631258|NCT00368550|561744304|FG001|Overall Study|Lack of Efficacy|9|||
155631259|NCT00368550|561744303|FG000|Overall Study|Withdrawal by Subject|17|||
155631260|NCT00368550|561744304|FG001|Overall Study|Withdrawal by Subject|10|||
155631261|NCT01401322|561744305|FG000|Overall Study|Withdrawal by Subject|1|||
155631262|NCT01401322|561744305|FG000|Overall Study|Physician Decision|1|||
155631263|NCT05282823|561744307|FG000|Overall Study|Withdrawal by Subject|9|||
155631264|NCT05282823|561744307|FG000|Overall Study|Adverse Event|1|||
155631265|NCT05282823|561744307|FG000|Overall Study|did not meet protocol criteria|2|||
155631266|NCT05282823|561744307|FG000|Overall Study|Withdrawal by Subject|7|||
155631267|NCT00997893|561744308|FG000|Overall Study|Adverse Event|1|||
155631268|NCT00997893|561744309|FG001|Overall Study|Adverse Event|0|||
155631269|NCT00997893|561744310|FG002|Overall Study|Adverse Event|0|||
155631270|NCT00997893|561744308|FG000|Overall Study|Unable to meet study timelines|1|||
155734043|NCT01287741|562123847|FG001|Overall Study|Study terminated by Sponsor|315|||
155631271|NCT00997893|561744309|FG001|Overall Study|Unable to meet study timelines|0|||
155631272|NCT00997893|561744310|FG002|Overall Study|Unable to meet study timelines|0|||
155631273|NCT00997893|561744308|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
155631274|NCT00997893|561744309|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
155389540|NCT02464228|560862543|FG003|Overall Study|Disease Progression|2|||
155389541|NCT02952001|560862546|FG000|Overall Study|Adverse Event|3|||
155389542|NCT02952001|560862547|FG001|Overall Study|Adverse Event|0|||
155631275|NCT00997893|561744310|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
155631276|NCT04108468|561744313|FG000|Overall Study|Physician Decision|0|||
155631277|NCT04108468|561744314|FG001|Overall Study|Physician Decision|1|||
155631278|NCT04108468|561744313|FG000|Overall Study|Lost to Follow-up|0|||
155631279|NCT04108468|561744314|FG001|Overall Study|Lost to Follow-up|1|||
155631280|NCT04108468|561744313|FG000|Overall Study|Non-compliance|1|||
155631281|NCT04108468|561744314|FG001|Overall Study|Non-compliance|1|||
155631282|NCT04108468|561744313|FG000|Overall Study|Unable to attend final visit|2|||
155631283|NCT04108468|561744314|FG001|Overall Study|Unable to attend final visit|0|||
155631284|NCT04108468|561744313|FG000|Overall Study|Missed study medication|0|||
155631285|NCT04108468|561744314|FG001|Overall Study|Missed study medication|1|||
155631286|NCT00848497|561744318|FG000|Overall Study|Screen failure|2|||
155631287|NCT00848497|561744319|FG001|Overall Study|Screen failure|0|||
155631288|NCT00848497|561744318|FG000|Overall Study|Withdrawal by Subject|0|||
155631289|NCT00848497|561744319|FG001|Overall Study|Withdrawal by Subject|1|||
155631290|NCT01420536|561744329|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
155631291|NCT01420536|561744330|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
155631292|NCT04711005|561744331|FG000|Overall Study|Withdrawal by Subject|0|||
155631293|NCT04711005|561744332|FG001|Overall Study|Withdrawal by Subject|0|||
155631294|NCT04711005|561744333|FG002|Overall Study|Withdrawal by Subject|0|||
155631295|NCT04711005|561744334|FG003|Overall Study|Withdrawal by Subject|0|||
155631296|NCT04711005|561744335|FG004|Overall Study|Withdrawal by Subject|0|||
155631297|NCT04711005|561744336|FG005|Overall Study|Withdrawal by Subject|0|||
155631298|NCT04711005|561744337|FG006|Overall Study|Withdrawal by Subject|0|||
155631299|NCT04711005|561744338|FG007|Overall Study|Withdrawal by Subject|1|||
155631300|NCT04711005|561744339|FG008|Overall Study|Withdrawal by Subject|0|||
155631301|NCT04711005|561744340|FG009|Overall Study|Withdrawal by Subject|0|||
155631302|NCT04711005|561744331|FG000|Overall Study|Physician Decision|0|||
155631303|NCT04711005|561744332|FG001|Overall Study|Physician Decision|0|||
155631304|NCT04711005|561744333|FG002|Overall Study|Physician Decision|0|||
155631305|NCT04711005|561744334|FG003|Overall Study|Physician Decision|0|||
155631306|NCT04711005|561744335|FG004|Overall Study|Physician Decision|0|||
155631307|NCT04711005|561744336|FG005|Overall Study|Physician Decision|0|||
155631308|NCT04711005|561744337|FG006|Overall Study|Physician Decision|0|||
155631309|NCT04711005|561744338|FG007|Overall Study|Physician Decision|2|||
155631310|NCT04711005|561744339|FG008|Overall Study|Physician Decision|1|||
155631311|NCT04711005|561744340|FG009|Overall Study|Physician Decision|0|||
155631312|NCT00764790|561744341|FG000|Overall Study|Protocol Violation|0|||
155631313|NCT00764790|561744342|FG001|Overall Study|Protocol Violation|0|||
155631314|NCT00764790|561744343|FG002|Overall Study|Protocol Violation|1|||
155631315|NCT00764790|561744341|FG000|Overall Study|Withdrawal by Subject|10|||
155631316|NCT00764790|561744342|FG001|Overall Study|Withdrawal by Subject|12|||
155631317|NCT00764790|561744343|FG002|Overall Study|Withdrawal by Subject|6|||
155631318|NCT00764790|561744341|FG000|Overall Study|Lost to Follow-up|28|||
155631319|NCT00764790|561744342|FG001|Overall Study|Lost to Follow-up|29|||
155631320|NCT00764790|561744343|FG002|Overall Study|Lost to Follow-up|23|||
155631321|NCT04935879|561744344|FG000|Overall Study|Adverse Event|2|||
155631322|NCT04935879|561744345|FG001|Overall Study|Adverse Event|1|||
155631323|NCT04935879|561744344|FG000|Overall Study|Lost to Follow-up|1|||
155631324|NCT04935879|561744345|FG001|Overall Study|Lost to Follow-up|1|||
155631325|NCT04935879|561744344|FG000|Overall Study|Pregnancy|2|||
155631326|NCT04935879|561744345|FG001|Overall Study|Pregnancy|3|||
155631327|NCT04935879|561744344|FG000|Overall Study|Withdrawal by Subject|8|||
155631328|NCT04935879|561744345|FG001|Overall Study|Withdrawal by Subject|6|||
155631329|NCT04935879|561744344|FG000|Overall Study|Other|3|||
155631330|NCT04935879|561744345|FG001|Overall Study|Other|3|||
155631331|NCT01652690|561744346|FG000|Overall Study|Withdrawal by Subject|16|||
155389543|NCT02952001|560862546|FG000|Overall Study|Prohibited therapy|10|||
155389544|NCT02952001|560862547|FG001|Overall Study|Prohibited therapy|3|||
155631332|NCT01652690|561744347|FG001|Overall Study|Withdrawal by Subject|4|||
155631333|NCT01652690|561744346|FG000|Overall Study|Other|8|||
155631334|NCT01652690|561744347|FG001|Overall Study|Other|9|||
155631335|NCT01652690|561744346|FG000|Overall Study|Lost to Follow-up|6|||
155631336|NCT01652690|561744347|FG001|Overall Study|Lost to Follow-up|6|||
155631337|NCT01652690|561744346|FG000|Overall Study|Death|5|||
155631338|NCT01652690|561744347|FG001|Overall Study|Death|2|||
155631339|NCT03533751|561744348|FG000|Overall Study|Withdrawal by Subject|12|||
155631340|NCT03533751|561744349|FG001|Overall Study|Withdrawal by Subject|6|||
155631341|NCT03533751|561744350|FG002|Overall Study|Withdrawal by Subject|11|||
155631342|NCT03533751|561744351|FG003|Overall Study|Withdrawal by Subject|9|||
155631343|NCT03533751|561744352|FG004|Overall Study|Withdrawal by Subject|10|||
155631344|NCT03533751|561744348|FG000|Overall Study|Adverse Event|4|||
155389545|NCT02952001|560862546|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
155631345|NCT03533751|561744349|FG001|Overall Study|Adverse Event|7|||
155631346|NCT03533751|561744350|FG002|Overall Study|Adverse Event|2|||
155631347|NCT03533751|561744351|FG003|Overall Study|Adverse Event|4|||
155734044|NCT01287741|562123846|FG000|Overall Study|Progressive disease|190|||
155734045|NCT01287741|562123847|FG001|Overall Study|Progressive disease|166|||
155734046|NCT01287741|562123846|FG000|Overall Study|Reason not specified|23|||
155734047|NCT01287741|562123847|FG001|Overall Study|Reason not specified|9|||
155734048|NCT04163016|562123849|FG000|Enrollment|Adverse Event|1|||
155734049|NCT04163016|562123850|FG001|Enrollment|Adverse Event|0|||
155734050|NCT04163016|562123851|FG002|Enrollment|Adverse Event|0|||
155734051|NCT04163016|562123852|FG003|Enrollment|Adverse Event|0|||
155734052|NCT04163016|562123849|FG000|Treatment|Adverse Event|0|||
155734053|NCT04163016|562123850|FG001|Treatment|Adverse Event|1|||
155734054|NCT04163016|562123851|FG002|Treatment|Adverse Event|0|||
155734055|NCT04163016|562123852|FG003|Treatment|Adverse Event|0|||
155734056|NCT04163016|562123849|FG000|Treatment|Withdrawal by Subject|0|||
155734057|NCT04163016|562123850|FG001|Treatment|Withdrawal by Subject|2|||
155734058|NCT04163016|562123851|FG002|Treatment|Withdrawal by Subject|0|||
155734059|NCT04163016|562123852|FG003|Treatment|Withdrawal by Subject|0|||
155734060|NCT04163016|562123849|FG000|Treatment|Indeterminate TB-test|0|||
155734061|NCT04163016|562123850|FG001|Treatment|Indeterminate TB-test|0|||
155734062|NCT04163016|562123851|FG002|Treatment|Indeterminate TB-test|0|||
155734063|NCT04163016|562123852|FG003|Treatment|Indeterminate TB-test|1|||
155734064|NCT04163016|562123849|FG000|Treatment|Participant did not want to continue in study|0|||
155734065|NCT04163016|562123850|FG001|Treatment|Participant did not want to continue in study|0|||
155734066|NCT04163016|562123851|FG002|Treatment|Participant did not want to continue in study|0|||
155734067|NCT04163016|562123852|FG003|Treatment|Participant did not want to continue in study|1|||
155734068|NCT04193189|562123853|FG000|Overall Study|Lost to Follow-up|9|||
155734069|NCT04193189|562123854|FG001|Overall Study|Lost to Follow-up|7|||
155734070|NCT04193189|562123855|FG002|Overall Study|Lost to Follow-up|9|||
155734071|NCT04193189|562123856|FG003|Overall Study|Lost to Follow-up|0|||
155734072|NCT04193189|562123853|FG000|Overall Study|Withdrawal by Subject|1|||
155734073|NCT04193189|562123854|FG001|Overall Study|Withdrawal by Subject|2|||
155734074|NCT04193189|562123855|FG002|Overall Study|Withdrawal by Subject|2|||
155734075|NCT04193189|562123856|FG003|Overall Study|Withdrawal by Subject|0|||
155734076|NCT04193189|562123853|FG000|Overall Study|Death|1|||
155734077|NCT04193189|562123854|FG001|Overall Study|Death|1|||
155734078|NCT04193189|562123855|FG002|Overall Study|Death|0|||
155734079|NCT04193189|562123856|FG003|Overall Study|Death|0|||
155734080|NCT04193189|562123853|FG000|Overall Study|Protocol Violation|0|||
155734081|NCT04193189|562123854|FG001|Overall Study|Protocol Violation|0|||
155734082|NCT04193189|562123855|FG002|Overall Study|Protocol Violation|0|||
155734083|NCT04193189|562123856|FG003|Overall Study|Protocol Violation|1|||
155734084|NCT01077050|562124960|FG000|Overall Study|Subjects signed ICF could not be located|1|||
155734085|NCT01077050|562124960|FG000|Overall Study|Screen failure|8|||
155734086|NCT02565784|562124964|FG000|First Treatment|Adverse Event|1|||
155734087|NCT02565784|562124964|FG000|First Treatment|Withdrawal by Subject|1|||
155734088|NCT02565784|562124964|FG000|Second Treatment|Withdrawal by Subject|2|||
155734089|NCT01193257|562124968|FG000|Overall Study|Death|202|||
155734090|NCT01193257|562124969|FG001|Overall Study|Death|391|||
155734091|NCT01193257|562124968|FG000|Overall Study|Study termination by sponsor|0|||
155734092|NCT01193257|562124969|FG001|Overall Study|Study termination by sponsor|3|||
155734093|NCT01193257|562124968|FG000|Overall Study|Withdrawal by Subject|26|||
155734094|NCT01193257|562124969|FG001|Overall Study|Withdrawal by Subject|86|||
155734095|NCT01193257|562124968|FG000|Overall Study|Lost to Follow-up|2|||
155734096|NCT01193257|562124969|FG001|Overall Study|Lost to Follow-up|3|||
155734097|NCT01193257|562124968|FG000|Overall Study|Unblinded due to futility|135|||
155734098|NCT01193257|562124969|FG001|Overall Study|Unblinded due to futility|251|||
155734099|NCT03126344|562124983|FG000|Overall Study|Lost to Follow-up|0|||
155734100|NCT03126344|562124984|FG001|Overall Study|Lost to Follow-up|0|||
155734101|NCT03126344|562124985|FG002|Overall Study|Lost to Follow-up|5|||
155734102|NCT01715857|562124986|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
155734103|NCT02563067|562124988|FG000|Overall Study|Subject/guardian decision|14|||
155734104|NCT02563067|562124989|FG001|Overall Study|Subject/guardian decision|20|||
155734105|NCT02563067|562124990|FG002|Overall Study|Subject/guardian decision|16|||
155734106|NCT02563067|562124988|FG000|Overall Study|Physician Decision|0|||
155734107|NCT02563067|562124989|FG001|Overall Study|Physician Decision|1|||
155734108|NCT02563067|562124990|FG002|Overall Study|Physician Decision|3|||
155734109|NCT02563067|562124988|FG000|Overall Study|Lost to Follow-up|1|||
155734110|NCT02563067|562124989|FG001|Overall Study|Lost to Follow-up|2|||
155734111|NCT02563067|562124990|FG002|Overall Study|Lost to Follow-up|0|||
155734112|NCT02563067|562124988|FG000|Overall Study|Technical problems|0|||
155734113|NCT02563067|562124989|FG001|Overall Study|Technical problems|1|||
155389546|NCT02952001|560862547|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
155389547|NCT01794520|560862552|FG000|Overall Study|Adverse events- related to progression|0|||
155734114|NCT02563067|562124990|FG002|Overall Study|Technical problems|0|||
155734115|NCT02563067|562124988|FG000|Overall Study|Lack of Efficacy|1|||
155734116|NCT02563067|562124989|FG001|Overall Study|Lack of Efficacy|0|||
155734117|NCT02563067|562124990|FG002|Overall Study|Lack of Efficacy|0|||
155734118|NCT02563067|562124988|FG000|Overall Study|Death|0|||
155734119|NCT02563067|562124989|FG001|Overall Study|Death|1|||
155734120|NCT02563067|562124990|FG002|Overall Study|Death|1|||
155389548|NCT01794520|560862553|FG001|Overall Study|Adverse events- related to progression|0|||
155389549|NCT01794520|560862554|FG002|Overall Study|Adverse events- related to progression|1|||
155389550|NCT01794520|560862555|FG003|Overall Study|Adverse events- related to progression|2|||
155389551|NCT01794520|560862556|FG004|Overall Study|Adverse events- related to progression|0|||
155389552|NCT01794520|560862557|FG005|Overall Study|Adverse events- related to progression|1|||
155389553|NCT01794520|560862558|FG006|Overall Study|Adverse events- related to progression|0|||
155734121|NCT02563067|562124988|FG000|Overall Study|Adverse Event|2|||
155734122|NCT02563067|562124989|FG001|Overall Study|Adverse Event|1|||
155734123|NCT02563067|562124990|FG002|Overall Study|Adverse Event|0|||
155734124|NCT02563067|562124988|FG000|Overall Study|Death post Treatment/safety period|1|||
155734125|NCT02563067|562124989|FG001|Overall Study|Death post Treatment/safety period|0|||
155734126|NCT02563067|562124990|FG002|Overall Study|Death post Treatment/safety period|0|||
155734127|NCT01039519|562125000|FG000|Treatment|Progressive disease|20|||
155734128|NCT01039519|562125000|FG000|Treatment|Treatment failure|2|||
155734129|NCT01039519|562125000|FG000|Treatment|Adverse Event|3|||
155734130|NCT01039519|562125000|FG000|Treatment|Physician Decision|2|||
155734131|NCT01039519|562125000|FG000|Survival Follow-up|Death|23|||
155734132|NCT01039519|562125000|FG000|Survival Follow-up|Sponsor decision|4|||
155734133|NCT01330108|562125004|FG000|Overall Study|Withdrawal by Subject|4|||
155734134|NCT01662102|562125007|FG000|Overall Study|Sponsor's decision|1|||
155734135|NCT01662102|562125008|FG001|Overall Study|Sponsor's decision|0|||
155734136|NCT00392769|562125009|FG000|Overall Study|Clinical Deterioration|9|||
155734137|NCT00392769|562125009|FG000|Overall Study|Adverse Event|1|||
155734138|NCT00439517|562125011|FG000|Overall Study|Subject on treatment|1|||
155734139|NCT00439517|562125012|FG001|Overall Study|Subject on treatment|0|||
155734140|NCT00439517|562125011|FG000|Overall Study|Subject in survival follow-up|1|||
155734141|NCT00439517|562125012|FG001|Overall Study|Subject in survival follow-up|0|||
155734142|NCT01262989|562125015|FG000|Period 1|Lost to Follow-up|1|||
155734143|NCT01262989|562125016|FG001|Period 1|Lost to Follow-up|1|||
155734144|NCT01262989|562125015|FG000|Period 1|Intercurrent disease|0|||
155734145|NCT01262989|562125016|FG001|Period 1|Intercurrent disease|1|||
155734146|NCT01262989|562125015|FG000|Period 1|Positive answer for exclusion criteria|0|||
155734147|NCT01262989|562125016|FG001|Period 1|Positive answer for exclusion criteria|1|||
155734148|NCT01262989|562125015|FG000|Period 2|Intercurrent disease|0|||
155734149|NCT01262989|562125016|FG001|Period 2|Intercurrent disease|1|||
155734150|NCT00470275|562125017|FG000|Overall Study|Death|1|||
155734151|NCT00470275|562125017|FG000|Overall Study|Lack of Efficacy|7|||
155734152|NCT00470275|562125017|FG000|Overall Study|Withdrawal by Subject|2|||
155734153|NCT00526071|562125018|FG000|Overall Study|Adverse Event|1|||
155734154|NCT00526071|562125018|FG000|Overall Study|Withdrawal by Subject|1|||
155734155|NCT00526071|562125018|FG000|Overall Study|Lack of Response to Study Drug|4|||
155734156|NCT00459186|562125019|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
155734157|NCT00459186|562125019|FG000|PET Imaging and Assessment|Adverse Event|3|||
155734158|NCT02920242|562125020|FG000|Overall Study|Withdrawal by Subject|1|||
155734159|NCT02920242|562125021|FG001|Overall Study|Withdrawal by Subject|0|||
155734160|NCT02920242|562125022|FG002|Overall Study|Withdrawal by Subject|1|||
155734161|NCT02920242|562125020|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
155734162|NCT02920242|562125021|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
155734163|NCT02920242|562125022|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
155734164|NCT00634101|562125023|FG000|Overall Study|Study Terminated|3|||
155734165|NCT00634101|562125024|FG001|Overall Study|Study Terminated|3|||
155734166|NCT00634101|562125023|FG000|Overall Study|Lost to Follow-up|2|||
155734167|NCT00634101|562125024|FG001|Overall Study|Lost to Follow-up|0|||
155734168|NCT03306173|562125026|FG000|Overall Study|Lost to Follow-up|16|||
155734169|NCT03306173|562125027|FG001|Overall Study|Lost to Follow-up|23|||
155734170|NCT03306173|562125026|FG000|Overall Study|Withdrawal by Subject|4|||
155734171|NCT03306173|562125027|FG001|Overall Study|Withdrawal by Subject|3|||
155734172|NCT03306173|562125026|FG000|Overall Study|Discontinued|4|||
155734173|NCT03306173|562125027|FG001|Overall Study|Discontinued|4|||
155734174|NCT00573144|562125028|FG000|Overall Study|Withdrawal by Subject|2|||
155734175|NCT00573144|562125029|FG001|Overall Study|Withdrawal by Subject|3|||
155734176|NCT03051178|562125030|FG000|Overall Study|Withdrawal by Subject|5|||
155734177|NCT02813577|562125031|FG000|Overall Study|Study terminated|4|||
155389554|NCT01794520|560862552|FG000|Overall Study|Adverse event- not related to progression|1|||
155734178|NCT00060840|562125032|FG000|Overall Study|Change in surgical plan|2|||
155734179|NCT00060840|562125033|FG001|Overall Study|Change in surgical plan|6|||
155734180|NCT00060840|562125032|FG000|Overall Study|Death|0|||
155734181|NCT00060840|562125033|FG001|Overall Study|Death|1|||
155734182|NCT00060840|562125032|FG000|Overall Study|Withdrawal by Subject|0|||
155734183|NCT00060840|562125033|FG001|Overall Study|Withdrawal by Subject|1|||
155734184|NCT00060840|562125032|FG000|Overall Study|Subinvestigator unavailable|0|||
155734185|NCT00060840|562125033|FG001|Overall Study|Subinvestigator unavailable|1|||
155734186|NCT00060840|562125032|FG000|Overall Study|Physician Decision|1|||
155734187|NCT00060840|562125033|FG001|Overall Study|Physician Decision|0|||
155734188|NCT00060840|562125032|FG000|Overall Study|Other|1|||
155734189|NCT00060840|562125033|FG001|Overall Study|Other|0|||
155734190|NCT01415882|562125034|FG000|Overall Study|Ineligible|1|||
155389555|NCT01794520|560862553|FG001|Overall Study|Adverse event- not related to progression|1|||
155389556|NCT01794520|560862554|FG002|Overall Study|Adverse event- not related to progression|0|||
155389557|NCT01794520|560862555|FG003|Overall Study|Adverse event- not related to progression|0|||
155389558|NCT01794520|560862556|FG004|Overall Study|Adverse event- not related to progression|2|||
155389559|NCT01794520|560862557|FG005|Overall Study|Adverse event- not related to progression|0|||
155389560|NCT01794520|560862558|FG006|Overall Study|Adverse event- not related to progression|0|||
155389561|NCT01794520|560862552|FG000|Overall Study|Progressive disease|5|||
155389562|NCT01794520|560862553|FG001|Overall Study|Progressive disease|6|||
155389563|NCT01794520|560862554|FG002|Overall Study|Progressive disease|2|||
155389564|NCT01794520|560862555|FG003|Overall Study|Progressive disease|5|||
155389565|NCT01794520|560862556|FG004|Overall Study|Progressive disease|27|||
155389566|NCT01794520|560862557|FG005|Overall Study|Progressive disease|18|||
155389567|NCT01794520|560862558|FG006|Overall Study|Progressive disease|0|||
155389568|NCT01794520|560862552|FG000|Overall Study|Withdrew consent|0|||
155389569|NCT01794520|560862553|FG001|Overall Study|Withdrew consent|0|||
155389570|NCT01794520|560862554|FG002|Overall Study|Withdrew consent|1|||
155389571|NCT01794520|560862555|FG003|Overall Study|Withdrew consent|1|||
155389572|NCT01794520|560862556|FG004|Overall Study|Withdrew consent|0|||
155389573|NCT01794520|560862557|FG005|Overall Study|Withdrew consent|0|||
155389574|NCT01794520|560862558|FG006|Overall Study|Withdrew consent|0|||
155389575|NCT01794520|560862552|FG000|Overall Study|Lost to Follow-up|0|||
155389576|NCT01794520|560862553|FG001|Overall Study|Lost to Follow-up|0|||
155389577|NCT01794520|560862554|FG002|Overall Study|Lost to Follow-up|0|||
155389578|NCT01794520|560862555|FG003|Overall Study|Lost to Follow-up|0|||
155389579|NCT01794520|560862556|FG004|Overall Study|Lost to Follow-up|1|||
155389580|NCT01794520|560862557|FG005|Overall Study|Lost to Follow-up|0|||
155389581|NCT01794520|560862558|FG006|Overall Study|Lost to Follow-up|0|||
155389582|NCT01794520|560862552|FG000|Overall Study|Toxicity|0|||
155389583|NCT01794520|560862553|FG001|Overall Study|Toxicity|2|||
155389584|NCT01794520|560862554|FG002|Overall Study|Toxicity|0|||
155389585|NCT01794520|560862555|FG003|Overall Study|Toxicity|0|||
155389586|NCT01794520|560862556|FG004|Overall Study|Toxicity|0|||
155389587|NCT01794520|560862557|FG005|Overall Study|Toxicity|0|||
155389588|NCT01794520|560862558|FG006|Overall Study|Toxicity|0|||
155389589|NCT01794520|560862552|FG000|Overall Study|Study terminated by sponsor|0|||
155389590|NCT01794520|560862553|FG001|Overall Study|Study terminated by sponsor|0|||
155389591|NCT01794520|560862554|FG002|Overall Study|Study terminated by sponsor|1|||
155389592|NCT01794520|560862555|FG003|Overall Study|Study terminated by sponsor|0|||
155389593|NCT01794520|560862556|FG004|Overall Study|Study terminated by sponsor|1|||
155389594|NCT01794520|560862557|FG005|Overall Study|Study terminated by sponsor|0|||
155389595|NCT01794520|560862558|FG006|Overall Study|Study terminated by sponsor|7|||
155389596|NCT01794520|560862552|FG000|Overall Study|Death|0|||
155389597|NCT01794520|560862553|FG001|Overall Study|Death|0|||
155389598|NCT01794520|560862554|FG002|Overall Study|Death|0|||
155389599|NCT01794520|560862555|FG003|Overall Study|Death|0|||
155389600|NCT01794520|560862556|FG004|Overall Study|Death|1|||
155389601|NCT01794520|560862557|FG005|Overall Study|Death|0|||
155389602|NCT01794520|560862558|FG006|Overall Study|Death|22|||
155389603|NCT01794520|560862552|FG000|Overall Study|Other, not specified|0|||
155389604|NCT01794520|560862553|FG001|Overall Study|Other, not specified|0|||
155389605|NCT01794520|560862554|FG002|Overall Study|Other, not specified|1|||
155389606|NCT01794520|560862555|FG003|Overall Study|Other, not specified|1|||
155389607|NCT01794520|560862556|FG004|Overall Study|Other, not specified|4|||
155389608|NCT01794520|560862557|FG005|Overall Study|Other, not specified|1|||
155389609|NCT01794520|560862558|FG006|Overall Study|Other, not specified|2|||
155389610|NCT04796896|560862560|FG000|Overall Study|Adverse Event|1|||
155631348|NCT03533751|561744352|FG004|Overall Study|Adverse Event|5|||
155631349|NCT03533751|561744348|FG000|Overall Study|Physician Decision|0|||
155631350|NCT03533751|561744349|FG001|Overall Study|Physician Decision|2|||
155631351|NCT03533751|561744350|FG002|Overall Study|Physician Decision|1|||
155631352|NCT03533751|561744351|FG003|Overall Study|Physician Decision|2|||
155631353|NCT03533751|561744352|FG004|Overall Study|Physician Decision|1|||
155631354|NCT03533751|561744348|FG000|Overall Study|Sponsor Decision|0|||
155631355|NCT03533751|561744349|FG001|Overall Study|Sponsor Decision|0|||
155631356|NCT03533751|561744350|FG002|Overall Study|Sponsor Decision|1|||
155631357|NCT03533751|561744351|FG003|Overall Study|Sponsor Decision|1|||
155631358|NCT03533751|561744352|FG004|Overall Study|Sponsor Decision|0|||
155631359|NCT03533751|561744348|FG000|Overall Study|Lost to Follow-up|3|||
155631360|NCT03533751|561744349|FG001|Overall Study|Lost to Follow-up|7|||
155631361|NCT03533751|561744350|FG002|Overall Study|Lost to Follow-up|6|||
155631362|NCT03533751|561744351|FG003|Overall Study|Lost to Follow-up|4|||
155631363|NCT03533751|561744352|FG004|Overall Study|Lost to Follow-up|3|||
155631364|NCT03533751|561744348|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
155734191|NCT01415882|562125035|FG001|Overall Study|Ineligible|0|||
155389611|NCT04796896|560862561|FG001|Overall Study|Adverse Event|0|||
155631365|NCT03533751|561744349|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
155631366|NCT03533751|561744350|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
155631367|NCT03533751|561744351|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
155389612|NCT04796896|560862562|FG002|Overall Study|Adverse Event|0|||
155734192|NCT01415882|562125036|FG002|Overall Study|Ineligible|0|||
155734193|NCT01415882|562125037|FG003|Overall Study|Ineligible|3|||
155734194|NCT01415882|562125038|FG004|Overall Study|Ineligible|0|||
155734195|NCT01415882|562125034|FG000|Overall Study|Withdrawal by Subject|0|||
155734196|NCT01415882|562125035|FG001|Overall Study|Withdrawal by Subject|1|||
155734197|NCT01415882|562125036|FG002|Overall Study|Withdrawal by Subject|0|||
155734198|NCT01415882|562125037|FG003|Overall Study|Withdrawal by Subject|1|||
155734199|NCT01415882|562125038|FG004|Overall Study|Withdrawal by Subject|0|||
155734200|NCT00976560|562125039|FG000|Overall Study|Adverse Event|5|||
155734201|NCT00976560|562125040|FG001|Overall Study|Adverse Event|5|||
155734202|NCT00976560|562125039|FG000|Overall Study|Lack of Efficacy|3|||
155734203|NCT00976560|562125040|FG001|Overall Study|Lack of Efficacy|5|||
155734204|NCT00976560|562125039|FG000|Overall Study|Protocol Violation|1|||
155734205|NCT00976560|562125040|FG001|Overall Study|Protocol Violation|0|||
155734206|NCT00976560|562125039|FG000|Overall Study|Lost to Follow-up|1|||
155734207|NCT00976560|562125040|FG001|Overall Study|Lost to Follow-up|0|||
155734208|NCT00976560|562125039|FG000|Overall Study|Physician Decision|2|||
155734209|NCT00976560|562125040|FG001|Overall Study|Physician Decision|0|||
155734210|NCT00976560|562125039|FG000|Overall Study|Withdrawal by Subject|2|||
155734211|NCT00976560|562125040|FG001|Overall Study|Withdrawal by Subject|3|||
155734212|NCT00125164|562125041|FG000|Overall Study|Adverse Event|0|||
155734213|NCT00125164|562125042|FG001|Overall Study|Adverse Event|0|||
155734214|NCT00125164|562125043|FG002|Overall Study|Adverse Event|2|||
155734215|NCT00125164|562125044|FG003|Overall Study|Adverse Event|4|||
155734216|NCT00125164|562125041|FG000|Overall Study|Lost to Follow-up|0|||
155734217|NCT00125164|562125042|FG001|Overall Study|Lost to Follow-up|0|||
155734218|NCT00125164|562125043|FG002|Overall Study|Lost to Follow-up|1|||
155734219|NCT00125164|562125044|FG003|Overall Study|Lost to Follow-up|1|||
155734220|NCT00125164|562125041|FG000|Overall Study|Withdrawal by Subject|2|||
155734221|NCT00125164|562125042|FG001|Overall Study|Withdrawal by Subject|0|||
155734222|NCT00125164|562125043|FG002|Overall Study|Withdrawal by Subject|1|||
155734223|NCT00125164|562125044|FG003|Overall Study|Withdrawal by Subject|1|||
155734224|NCT01339052|562125048|FG000|Overall Study|Disease progression|13|||
155734225|NCT01339052|562125049|FG001|Overall Study|Disease progression|46|||
155734226|NCT01339052|562125048|FG000|Overall Study|Adverse Event|1|||
155734227|NCT01339052|562125049|FG001|Overall Study|Adverse Event|1|||
155734228|NCT01339052|562125048|FG000|Overall Study|Withdrawal by Subject|0|||
155734229|NCT01339052|562125049|FG001|Overall Study|Withdrawal by Subject|3|||
155734230|NCT01339052|562125048|FG000|Overall Study|Physician Decision|1|||
155734231|NCT01339052|562125049|FG001|Overall Study|Physician Decision|0|||
155734232|NCT02722499|562125050|FG000|Overall Study|Lost to Follow-up|2|||
155734233|NCT02722499|562125051|FG001|Overall Study|Lost to Follow-up|0|||
155734234|NCT02722499|562125052|FG002|Overall Study|Lost to Follow-up|1|||
155734235|NCT01599637|562125055|FG000|Overall Study|administrative problems|0|||
155734236|NCT01599637|562125056|FG001|Overall Study|administrative problems|2|||
155734237|NCT01599637|562125057|FG002|Overall Study|administrative problems|0|||
155734238|NCT01599637|562125055|FG000|Overall Study|Adverse Event|1|||
155734239|NCT01599637|562125056|FG001|Overall Study|Adverse Event|0|||
155734240|NCT01599637|562125057|FG002|Overall Study|Adverse Event|0|||
155734241|NCT04476797|562125060|FG000|Overall Study|Withdrawal by Subject|1|||
155734242|NCT04476797|562125061|FG001|Overall Study|Withdrawal by Subject|0|||
155734243|NCT04476797|562125062|FG002|Overall Study|Withdrawal by Subject|0|||
155734244|NCT04476797|562125060|FG000|Overall Study|Death|0|||
155734245|NCT04476797|562125061|FG001|Overall Study|Death|1|||
155734246|NCT04476797|562125062|FG002|Overall Study|Death|2|||
155734247|NCT04476797|562125060|FG000|Overall Study|Sponsor Terminated Study|0|||
155734248|NCT04476797|562125061|FG001|Overall Study|Sponsor Terminated Study|18|||
155734249|NCT04476797|562125062|FG002|Overall Study|Sponsor Terminated Study|17|||
155734250|NCT00396253|562125064|FG000|Overall Study|Protocol Violation|1|||
155734251|NCT00396253|562125064|FG000|Overall Study|Withdrawal by Subject|7|||
155734252|NCT00396253|562125064|FG000|Overall Study|Death|3|||
155734253|NCT00396253|562125064|FG000|Overall Study|Physician Decision|1|||
155734254|NCT00396253|562125064|FG000|Overall Study|Change in eligibility status|1|||
155734255|NCT05340478|562125065|FG000|Overall Study|Scheduling Issues|10|||
155734256|NCT05340478|562125066|FG001|Overall Study|Scheduling Issues|4|||
155734257|NCT05340478|562125065|FG000|Overall Study|Neither member of dyad started treatment|2|||
155734258|NCT05340478|562125066|FG001|Overall Study|Neither member of dyad started treatment|2|||
155734259|NCT05340478|562125065|FG000|Overall Study|Withdrawn from study|2|||
155734260|NCT05340478|562125066|FG001|Overall Study|Withdrawn from study|2|||
155734261|NCT05340478|562125065|FG000|Overall Study|Lost to Follow-up|1|||
155734262|NCT05340478|562125066|FG001|Overall Study|Lost to Follow-up|4|||
155734263|NCT00092443|562125069|FG000|Overall Study|Adverse Event|9|||
155734264|NCT00092443|562125070|FG001|Overall Study|Adverse Event|13|||
155734265|NCT00092443|562125069|FG000|Overall Study|Lost to Follow-up|7|||
155734266|NCT00092443|562125070|FG001|Overall Study|Lost to Follow-up|3|||
155734267|NCT00092443|562125069|FG000|Overall Study|Protocol Violation|11|||
155734268|NCT00092443|562125070|FG001|Overall Study|Protocol Violation|9|||
155734269|NCT00092443|562125069|FG000|Overall Study|Withdrawal by Subject|9|||
155734270|NCT00092443|562125070|FG001|Overall Study|Withdrawal by Subject|11|||
155389613|NCT04796896|560862563|FG003|Overall Study|Adverse Event|0|||
155389614|NCT04796896|560862564|FG004|Overall Study|Adverse Event|0|||
155389615|NCT04796896|560862565|FG005|Overall Study|Adverse Event|1|||
155389616|NCT04796896|560862566|FG006|Overall Study|Adverse Event|1|||
155389617|NCT04796896|560862567|FG007|Overall Study|Adverse Event|0|||
155389618|NCT04796896|560862568|FG008|Overall Study|Adverse Event|1|||
155389619|NCT04796896|560862569|FG009|Overall Study|Adverse Event|1|||
155389620|NCT04796896|560862570|FG010|Overall Study|Adverse Event|1|||
155389621|NCT04796896|560862571|FG011|Overall Study|Adverse Event|0|||
155389622|NCT04796896|560862560|FG000|Overall Study|Lost to Follow-up|24|||
155389623|NCT04796896|560862561|FG001|Overall Study|Lost to Follow-up|15|||
155389624|NCT04796896|560862562|FG002|Overall Study|Lost to Follow-up|6|||
155389625|NCT04796896|560862563|FG003|Overall Study|Lost to Follow-up|4|||
155389626|NCT04796896|560862564|FG004|Overall Study|Lost to Follow-up|21|||
155389627|NCT04796896|560862565|FG005|Overall Study|Lost to Follow-up|55|||
155389628|NCT04796896|560862566|FG006|Overall Study|Lost to Follow-up|237|||
155389629|NCT04796896|560862567|FG007|Overall Study|Lost to Follow-up|52|||
155389630|NCT04796896|560862568|FG008|Overall Study|Lost to Follow-up|221|||
155389631|NCT04796896|560862569|FG009|Overall Study|Lost to Follow-up|43|||
155389632|NCT04796896|560862570|FG010|Overall Study|Lost to Follow-up|142|||
155389633|NCT04796896|560862571|FG011|Overall Study|Lost to Follow-up|18|||
155389634|NCT04796896|560862560|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
155389635|NCT04796896|560862561|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
155389636|NCT04796896|560862562|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
155389637|NCT04796896|560862563|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
155389638|NCT04796896|560862564|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
155389639|NCT04796896|560862565|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
155389640|NCT04796896|560862566|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
155389641|NCT04796896|560862567|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
155389642|NCT04796896|560862568|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
155389643|NCT04796896|560862569|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
155389644|NCT04796896|560862570|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
155389645|NCT04796896|560862571|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
155389646|NCT04796896|560862560|FG000|Overall Study|Physician Decision|1|||
155389647|NCT04796896|560862561|FG001|Overall Study|Physician Decision|0|||
155389648|NCT04796896|560862562|FG002|Overall Study|Physician Decision|0|||
155389649|NCT04796896|560862563|FG003|Overall Study|Physician Decision|0|||
155389650|NCT04796896|560862564|FG004|Overall Study|Physician Decision|0|||
155389651|NCT04796896|560862565|FG005|Overall Study|Physician Decision|3|||
155389652|NCT04796896|560862566|FG006|Overall Study|Physician Decision|18|||
155389653|NCT04796896|560862567|FG007|Overall Study|Physician Decision|1|||
155389654|NCT04796896|560862568|FG008|Overall Study|Physician Decision|7|||
155389655|NCT04796896|560862569|FG009|Overall Study|Physician Decision|0|||
155389656|NCT04796896|560862570|FG010|Overall Study|Physician Decision|5|||
155389657|NCT04796896|560862571|FG011|Overall Study|Physician Decision|0|||
155389658|NCT04796896|560862560|FG000|Overall Study|Withdrawal by Subject|36|||
155389659|NCT04796896|560862561|FG001|Overall Study|Withdrawal by Subject|31|||
155389660|NCT04796896|560862562|FG002|Overall Study|Withdrawal by Subject|11|||
155389661|NCT04796896|560862563|FG003|Overall Study|Withdrawal by Subject|8|||
155389662|NCT04796896|560862564|FG004|Overall Study|Withdrawal by Subject|16|||
155389663|NCT04796896|560862565|FG005|Overall Study|Withdrawal by Subject|162|||
155389664|NCT04796896|560862566|FG006|Overall Study|Withdrawal by Subject|299|||
155389665|NCT04796896|560862567|FG007|Overall Study|Withdrawal by Subject|149|||
155389666|NCT04796896|560862568|FG008|Overall Study|Withdrawal by Subject|303|||
155389667|NCT04796896|560862569|FG009|Overall Study|Withdrawal by Subject|94|||
155389668|NCT04796896|560862570|FG010|Overall Study|Withdrawal by Subject|192|||
155389669|NCT04796896|560862571|FG011|Overall Study|Withdrawal by Subject|16|||
155389670|NCT04796896|560862560|FG000|Overall Study|Other Than Specified|6|||
155389671|NCT04796896|560862561|FG001|Overall Study|Other Than Specified|5|||
155389672|NCT04796896|560862562|FG002|Overall Study|Other Than Specified|3|||
155389673|NCT04796896|560862563|FG003|Overall Study|Other Than Specified|2|||
155389674|NCT04796896|560862564|FG004|Overall Study|Other Than Specified|6|||
155389675|NCT04796896|560862565|FG005|Overall Study|Other Than Specified|31|||
155389676|NCT04796896|560862566|FG006|Overall Study|Other Than Specified|86|||
155389677|NCT04796896|560862567|FG007|Overall Study|Other Than Specified|66|||
155389678|NCT04796896|560862568|FG008|Overall Study|Other Than Specified|388|||
155389679|NCT04796896|560862569|FG009|Overall Study|Other Than Specified|48|||
155389680|NCT04796896|560862570|FG010|Overall Study|Other Than Specified|258|||
155389681|NCT04796896|560862571|FG011|Overall Study|Other Than Specified|4|||
155389682|NCT04796896|560862560|FG000|Overall Study|Protocol Deviation|0|||
155389683|NCT04796896|560862561|FG001|Overall Study|Protocol Deviation|0|||
155389684|NCT04796896|560862562|FG002|Overall Study|Protocol Deviation|0|||
155389685|NCT04796896|560862563|FG003|Overall Study|Protocol Deviation|1|||
155389686|NCT04796896|560862564|FG004|Overall Study|Protocol Deviation|1|||
155389687|NCT04796896|560862565|FG005|Overall Study|Protocol Deviation|2|||
155389688|NCT04796896|560862566|FG006|Overall Study|Protocol Deviation|2|||
155389689|NCT04796896|560862567|FG007|Overall Study|Protocol Deviation|2|||
155389690|NCT04796896|560862568|FG008|Overall Study|Protocol Deviation|2|||
155389691|NCT04796896|560862569|FG009|Overall Study|Protocol Deviation|1|||
155389692|NCT04796896|560862570|FG010|Overall Study|Protocol Deviation|0|||
155389693|NCT04796896|560862571|FG011|Overall Study|Protocol Deviation|0|||
155389694|NCT04796896|560862560|FG000|Overall Study|Missing|0|||
155389695|NCT04796896|560862561|FG001|Overall Study|Missing|0|||
155389696|NCT04796896|560862562|FG002|Overall Study|Missing|0|||
155389697|NCT04796896|560862563|FG003|Overall Study|Missing|0|||
155389698|NCT04796896|560862564|FG004|Overall Study|Missing|0|||
155389699|NCT04796896|560862565|FG005|Overall Study|Missing|0|||
155389700|NCT04796896|560862566|FG006|Overall Study|Missing|2|||
155389701|NCT04796896|560862567|FG007|Overall Study|Missing|1|||
155389702|NCT04796896|560862568|FG008|Overall Study|Missing|2|||
155389703|NCT04796896|560862569|FG009|Overall Study|Missing|1|||
155389704|NCT04796896|560862570|FG010|Overall Study|Missing|1|||
155389705|NCT04796896|560862571|FG011|Overall Study|Missing|0|||
155389706|NCT04796896|560862560|FG000|Overall Study|Death|0|||
155389707|NCT04796896|560862561|FG001|Overall Study|Death|0|||
155389708|NCT04796896|560862562|FG002|Overall Study|Death|0|||
155389709|NCT04796896|560862563|FG003|Overall Study|Death|0|||
155389710|NCT04796896|560862564|FG004|Overall Study|Death|0|||
155389711|NCT04796896|560862565|FG005|Overall Study|Death|0|||
155389712|NCT04796896|560862566|FG006|Overall Study|Death|0|||
155389713|NCT04796896|560862567|FG007|Overall Study|Death|0|||
155389714|NCT04796896|560862568|FG008|Overall Study|Death|1|||
155389715|NCT04796896|560862569|FG009|Overall Study|Death|0|||
155389716|NCT04796896|560862570|FG010|Overall Study|Death|0|||
155389717|NCT04796896|560862571|FG011|Overall Study|Death|0|||
155389718|NCT02021292|560862572|FG000|Overall Study|Physician Decision|0|||
155389719|NCT02021292|560862573|FG001|Overall Study|Physician Decision|1|||
155389720|NCT02021292|560862572|FG000|Overall Study|Lost to Follow-up|0|||
155389721|NCT02021292|560862573|FG001|Overall Study|Lost to Follow-up|1|||
155389722|NCT02021292|560862572|FG000|Overall Study|Death|0|||
155389723|NCT02021292|560862573|FG001|Overall Study|Death|1|||
155389724|NCT05972733|560862576|FG000|Overall Study|Lost to Follow-up|2|||
155389725|NCT05972733|560862576|FG000|Overall Study|Withdrawal by Subject|1|||
155389726|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
155389727|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
155389728|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
155389729|NCT01637623|560862578|FG000|Overall Study|Lost to Follow-up|0|||
155389730|NCT01637623|560862579|FG001|Overall Study|Lost to Follow-up|0|||
155389731|NCT01637623|560862580|FG002|Overall Study|Lost to Follow-up|2|||
155389732|NCT01637623|560862578|FG000|Overall Study|Physician Decision|1|||
155389733|NCT01637623|560862579|FG001|Overall Study|Physician Decision|0|||
155389734|NCT01637623|560862580|FG002|Overall Study|Physician Decision|1|||
155389735|NCT02824263|560862581|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
155389736|NCT02824263|560862582|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
155389737|NCT02824263|560862581|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
155389738|NCT02824263|560862582|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
155389739|NCT00568321|560862583|FG000|Overall Study|Adverse Event|1|||
155631368|NCT03533751|561744352|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
155631369|NCT03533751|561744348|FG000|Overall Study|Other|0|||
155631370|NCT03533751|561744349|FG001|Overall Study|Other|2|||
155631371|NCT03533751|561744350|FG002|Overall Study|Other|1|||
155631372|NCT03533751|561744351|FG003|Overall Study|Other|0|||
155631373|NCT03533751|561744352|FG004|Overall Study|Other|3|||
155631374|NCT06070610|561744356|FG000|Washout period|Adverse Event|1|||
155631375|NCT06070610|561744356|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
155631376|NCT02634710|561744361|FG000|Overall Study|Death|4|||
155631377|NCT04530630|561745807|FG000|Overall Study|Physician Decision|1|||
155389740|NCT00568321|560862584|FG001|Overall Study|Adverse Event|0|||
155389741|NCT00568321|560862585|FG002|Overall Study|Adverse Event|0|||
155389742|NCT00568321|560862583|FG000|Overall Study|Lack of Efficacy|8|||
155389743|NCT00568321|560862584|FG001|Overall Study|Lack of Efficacy|5|||
155389744|NCT00568321|560862585|FG002|Overall Study|Lack of Efficacy|6|||
155389745|NCT00568321|560862583|FG000|Overall Study|Lost to Follow-up|0|||
155389746|NCT00568321|560862584|FG001|Overall Study|Lost to Follow-up|0|||
155389747|NCT00568321|560862585|FG002|Overall Study|Lost to Follow-up|1|||
155631378|NCT06125964|561745808|FG000|Overall Study|Lost to Follow-up|0|||
155631379|NCT06125964|561745809|FG001|Overall Study|Lost to Follow-up|1|||
155389748|NCT00568321|560862583|FG000|Overall Study|Withdrawal by Subject|2|||
155389749|NCT00568321|560862584|FG001|Overall Study|Withdrawal by Subject|0|||
155389750|NCT00568321|560862585|FG002|Overall Study|Withdrawal by Subject|0|||
155389751|NCT00568321|560862583|FG000|Overall Study|Protocol Violation|0|||
155389752|NCT00568321|560862584|FG001|Overall Study|Protocol Violation|0|||
155389753|NCT00568321|560862585|FG002|Overall Study|Protocol Violation|1|||
155389754|NCT00568321|560862583|FG000|Overall Study|Randomized, not treated|2|||
155389755|NCT00568321|560862584|FG001|Overall Study|Randomized, not treated|0|||
155389756|NCT00568321|560862585|FG002|Overall Study|Randomized, not treated|1|||
155631380|NCT06125964|561745810|FG002|Overall Study|Lost to Follow-up|0|||
155389757|NCT01180998|560862588|FG000|Overall Study|Poor Vision|0|||
155389758|NCT01180998|560862589|FG001|Overall Study|Poor Vision|2|||
155389759|NCT01180998|560862590|FG002|Overall Study|Poor Vision|2|||
155389760|NCT01180998|560862588|FG000|Overall Study|Lost to Follow-up|0|||
155389761|NCT01180998|560862589|FG001|Overall Study|Lost to Follow-up|0|||
155389762|NCT01180998|560862590|FG002|Overall Study|Lost to Follow-up|1|||
155389763|NCT01180998|560862588|FG000|Overall Study|Protocol Violation|1|||
155389764|NCT01180998|560862589|FG001|Overall Study|Protocol Violation|2|||
155389765|NCT01180998|560862590|FG002|Overall Study|Protocol Violation|0|||
155389766|NCT01180998|560862588|FG000|Overall Study|Withdrawal by Subject|0|||
155389767|NCT01180998|560862589|FG001|Overall Study|Withdrawal by Subject|0|||
155389768|NCT01180998|560862590|FG002|Overall Study|Withdrawal by Subject|1|||
155389769|NCT01180998|560862588|FG000|Overall Study|Poor comfort|3|||
155389770|NCT01180998|560862589|FG001|Overall Study|Poor comfort|0|||
155389771|NCT01180998|560862590|FG002|Overall Study|Poor comfort|4|||
155389772|NCT01180998|560862588|FG000|Overall Study|Poor lens handling|0|||
155389773|NCT01180998|560862589|FG001|Overall Study|Poor lens handling|0|||
155389774|NCT01180998|560862590|FG002|Overall Study|Poor lens handling|2|||
155389775|NCT01176968|560862591|FG000|Overall Study|Adverse Event|10|||
155389776|NCT01176968|560862592|FG001|Overall Study|Adverse Event|11|||
155389777|NCT01176968|560862591|FG000|Overall Study|Death|2|||
155389778|NCT01176968|560862592|FG001|Overall Study|Death|3|||
155389779|NCT01176968|560862591|FG000|Overall Study|Lack of Efficacy|0|||
155389780|NCT01176968|560862592|FG001|Overall Study|Lack of Efficacy|1|||
155389781|NCT01176968|560862591|FG000|Overall Study|Lost to Follow-up|16|||
155389782|NCT01176968|560862592|FG001|Overall Study|Lost to Follow-up|14|||
155389783|NCT01176968|560862591|FG000|Overall Study|Withdrawal by Subject|48|||
155389784|NCT01176968|560862592|FG001|Overall Study|Withdrawal by Subject|48|||
155389785|NCT01176968|560862591|FG000|Overall Study|Protocol Violation|2|||
155389786|NCT01176968|560862592|FG001|Overall Study|Protocol Violation|1|||
155389787|NCT01176968|560862591|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155389788|NCT01176968|560862592|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
155389789|NCT01176968|560862591|FG000|Overall Study|Study terminated by sponsor|0|||
155389790|NCT01176968|560862592|FG001|Overall Study|Study terminated by sponsor|1|||
155389791|NCT01176968|560862591|FG000|Overall Study|Reason not defined|5|||
155389792|NCT01176968|560862592|FG001|Overall Study|Reason not defined|3|||
155389793|NCT04658186|560862593|FG000|Overall Study|Adverse Event|4|||
155389794|NCT04658186|560862594|FG001|Overall Study|Adverse Event|18|||
155389795|NCT04658186|560862595|FG002|Overall Study|Adverse Event|15|||
155389796|NCT04658186|560862593|FG000|Overall Study|Lack of Efficacy|1|||
155389797|NCT04658186|560862594|FG001|Overall Study|Lack of Efficacy|1|||
155389798|NCT04658186|560862595|FG002|Overall Study|Lack of Efficacy|0|||
155389799|NCT04658186|560862593|FG000|Overall Study|Protocol Violation|0|||
155389800|NCT04658186|560862594|FG001|Overall Study|Protocol Violation|0|||
155389801|NCT04658186|560862595|FG002|Overall Study|Protocol Violation|1|||
155389802|NCT04658186|560862593|FG000|Overall Study|Lost to Follow-up|0|||
155389803|NCT04658186|560862594|FG001|Overall Study|Lost to Follow-up|0|||
155389804|NCT04658186|560862595|FG002|Overall Study|Lost to Follow-up|2|||
155389805|NCT04658186|560862593|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
155389806|NCT04658186|560862594|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
155389807|NCT04658186|560862595|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
155389808|NCT04658186|560862593|FG000|Overall Study|Participant is Moving in Another Province|0|||
155389809|NCT04658186|560862594|FG001|Overall Study|Participant is Moving in Another Province|1|||
155389810|NCT04658186|560862595|FG002|Overall Study|Participant is Moving in Another Province|0|||
155389811|NCT04658186|560862593|FG000|Overall Study|Non-Compliance|0|||
155389812|NCT04658186|560862594|FG001|Overall Study|Non-Compliance|1|||
155389813|NCT04658186|560862595|FG002|Overall Study|Non-Compliance|1|||
155389814|NCT04658186|560862593|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
155389815|NCT04658186|560862594|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
155389816|NCT04658186|560862595|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
155389817|NCT04658186|560862593|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
155631381|NCT06125964|561745811|FG003|Overall Study|Lost to Follow-up|0|||
155389818|NCT04658186|560862594|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
155389819|NCT04658186|560862595|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
155389820|NCT04658186|560862593|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
155389821|NCT04658186|560862594|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
155389822|NCT04658186|560862595|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
155389823|NCT04658186|560862593|FG000|Overall Study|PI Decision due to Participant Safety|0|||
155389824|NCT04658186|560862594|FG001|Overall Study|PI Decision due to Participant Safety|0|||
155389825|NCT04658186|560862595|FG002|Overall Study|PI Decision due to Participant Safety|1|||
155389826|NCT04658186|560862593|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
155389827|NCT04658186|560862594|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
155389828|NCT04658186|560862595|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
155389829|NCT04098068|560862596|FG000|Overall Study|Disease Progression|7|||
155631382|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
155389830|NCT04098068|560862596|FG000|Overall Study|Withdrawal by Subject|2|||
155389831|NCT04098068|560862596|FG000|Overall Study|New Cancer Diagnosis|1|||
155389832|NCT03871829|560862597|FG000|Overall Study|Lost to Follow-up|0|||
155389833|NCT03871829|560862598|FG001|Overall Study|Lost to Follow-up|1|||
155389834|NCT03871829|560862597|FG000|Overall Study|Withdrawal by Subject|1|||
155389835|NCT03871829|560862598|FG001|Overall Study|Withdrawal by Subject|1|||
155389836|NCT03871829|560862597|FG000|Overall Study|Death|12|||
155389837|NCT03871829|560862598|FG001|Overall Study|Death|8|||
155389838|NCT03871829|560862597|FG000|Overall Study|Study terminated by sponsor|31|||
155389839|NCT03871829|560862598|FG001|Overall Study|Study terminated by sponsor|34|||
155389840|NCT02993523|560862599|FG000|Overall Study|Withdrew Consent|0|||
155389841|NCT02993523|560862600|FG001|Overall Study|Withdrew Consent|0|||
155389842|NCT02993523|560862601|FG002|Overall Study|Withdrew Consent|2|||
155389843|NCT02993523|560862602|FG003|Overall Study|Withdrew Consent|9|||
155389844|NCT02993523|560862603|FG004|Overall Study|Withdrew Consent|0|||
155389845|NCT02993523|560862599|FG000|Overall Study|Lost to Follow-up|0|||
155389846|NCT02993523|560862600|FG001|Overall Study|Lost to Follow-up|0|||
155389847|NCT02993523|560862601|FG002|Overall Study|Lost to Follow-up|3|||
155389848|NCT02993523|560862602|FG003|Overall Study|Lost to Follow-up|6|||
155389849|NCT02993523|560862603|FG004|Overall Study|Lost to Follow-up|0|||
155389850|NCT02993523|560862599|FG000|Overall Study|Death|1|||
155389851|NCT02993523|560862600|FG001|Overall Study|Death|1|||
155389852|NCT02993523|560862601|FG002|Overall Study|Death|138|||
155389853|NCT02993523|560862602|FG003|Overall Study|Death|222|||
155389854|NCT02993523|560862603|FG004|Overall Study|Death|6|||
155389855|NCT02993523|560862599|FG000|Overall Study|Reason not Specified|0|||
155389856|NCT02993523|560862600|FG001|Overall Study|Reason not Specified|0|||
155389857|NCT02993523|560862601|FG002|Overall Study|Reason not Specified|1|||
155389858|NCT02993523|560862602|FG003|Overall Study|Reason not Specified|1|||
155389859|NCT02993523|560862603|FG004|Overall Study|Reason not Specified|0|||
155389860|NCT03694418|560862604|FG000|Overall Study|Lost to Follow-up|115|||
155389861|NCT03694418|560862605|FG001|Overall Study|Lost to Follow-up|23|||
155389862|NCT03694418|560862606|FG002|Overall Study|Lost to Follow-up|12|||
155389863|NCT03694418|560862607|FG003|Overall Study|Lost to Follow-up|12|||
155389864|NCT03694418|560862608|FG004|Overall Study|Lost to Follow-up|13|||
155389865|NCT04288778|560862625|FG000|Overall Study|Withdrawal by Subject|2|||
155389866|NCT04288778|560862625|FG000|Overall Study|Adverse Event|5|||
155389867|NCT04288778|560862625|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155389868|NCT04288778|560862625|FG000|Overall Study|Other|1|||
155389869|NCT04288778|560862625|FG000|Overall Study|Started but not treated|2|||
155389870|NCT04485104|560862626|FG000|Overall Study|Physician Decision|2|||
155389871|NCT04485104|560862627|FG001|Overall Study|Physician Decision|0|||
155389872|NCT04485104|560862626|FG000|Overall Study|Decision by sponsor|0|||
155389873|NCT04485104|560862627|FG001|Overall Study|Decision by sponsor|1|||
155389874|NCT04442737|560862628|FG000|Overall Study|Lost to Follow-up|1|||
155389875|NCT04442737|560862629|FG001|Overall Study|Lost to Follow-up|3|||
155389876|NCT04442737|560862628|FG000|Overall Study|Withdrawal by Subject|3|||
155389877|NCT04442737|560862629|FG001|Overall Study|Withdrawal by Subject|2|||
155389878|NCT04442737|560862628|FG000|Overall Study|Adverse Event|3|||
155389879|NCT04442737|560862629|FG001|Overall Study|Adverse Event|2|||
155389880|NCT04442737|560862628|FG000|Overall Study|Death|0|||
155389881|NCT04442737|560862629|FG001|Overall Study|Death|1|||
155389882|NCT04442737|560862628|FG000|Overall Study|Protocol Violation|0|||
155389883|NCT04442737|560862629|FG001|Overall Study|Protocol Violation|2|||
155389884|NCT04442737|560862628|FG000|Overall Study|Other|1|||
155389885|NCT04442737|560862629|FG001|Overall Study|Other|1|||
155389886|NCT00744523|560862630|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
155389887|NCT00744523|560862631|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
155389888|NCT01139021|560862632|FG000|Overall Study|Adverse Event|0|||
155389889|NCT01139021|560862633|FG001|Overall Study|Adverse Event|0|||
155389890|NCT01139021|560862634|FG002|Overall Study|Adverse Event|0|||
155389891|NCT01139021|560862635|FG003|Overall Study|Adverse Event|0|||
155389892|NCT01139021|560862636|FG004|Overall Study|Adverse Event|1|||
155389893|NCT01139021|560862637|FG005|Overall Study|Adverse Event|0|||
155389894|NCT01139021|560862632|FG000|Overall Study|Lost to Follow-up|0|||
155389895|NCT01139021|560862633|FG001|Overall Study|Lost to Follow-up|0|||
155389896|NCT01139021|560862634|FG002|Overall Study|Lost to Follow-up|0|||
155389897|NCT01139021|560862635|FG003|Overall Study|Lost to Follow-up|0|||
155389898|NCT01139021|560862636|FG004|Overall Study|Lost to Follow-up|2|||
155389899|NCT01139021|560862637|FG005|Overall Study|Lost to Follow-up|0|||
155389900|NCT01139021|560862632|FG000|Overall Study|Protocol Violation|1|||
155389901|NCT01139021|560862633|FG001|Overall Study|Protocol Violation|0|||
155389902|NCT01139021|560862634|FG002|Overall Study|Protocol Violation|0|||
155389903|NCT01139021|560862635|FG003|Overall Study|Protocol Violation|0|||
155389904|NCT01139021|560862636|FG004|Overall Study|Protocol Violation|2|||
155389905|NCT01139021|560862637|FG005|Overall Study|Protocol Violation|0|||
155389906|NCT01139021|560862632|FG000|Overall Study|Withdrawal by Subject|0|||
155389907|NCT01139021|560862633|FG001|Overall Study|Withdrawal by Subject|0|||
155389908|NCT01139021|560862634|FG002|Overall Study|Withdrawal by Subject|0|||
155389909|NCT01139021|560862635|FG003|Overall Study|Withdrawal by Subject|1|||
155389910|NCT01139021|560862636|FG004|Overall Study|Withdrawal by Subject|4|||
155389911|NCT01139021|560862637|FG005|Overall Study|Withdrawal by Subject|0|||
155389912|NCT05057247|560862642|FG000|Overall Study|Death|4|||
155389913|NCT05057247|560862642|FG000|Overall Study|Physician Decision|3|||
155389914|NCT05057247|560862642|FG000|Overall Study|Progressive Disease|7|||
155389915|NCT05057247|560862642|FG000|Overall Study|Withdrawal by Subject|3|||
155389916|NCT05057247|560862642|FG000|Overall Study|Adverse Event|6|||
155389917|NCT05057247|560862642|FG000|Overall Study|Subject Non-Compliance|1|||
155389918|NCT05057247|560862642|FG000|Overall Study|On treatment|2|||
155389919|NCT00784693|560862644|FG000|Overall Study|Lost to Follow-up|0|||
155389920|NCT00784693|560862645|FG001|Overall Study|Lost to Follow-up|1|||
155389921|NCT00784693|560862644|FG000|Overall Study|Lack of Efficacy|1|||
155389922|NCT00784693|560862645|FG001|Overall Study|Lack of Efficacy|1|||
155389923|NCT00784693|560862644|FG000|Overall Study|Withdrawal by Subject|0|||
155389924|NCT00784693|560862645|FG001|Overall Study|Withdrawal by Subject|4|||
155389925|NCT00784693|560862644|FG000|Overall Study|Randomized but not Treated|1|||
155389926|NCT00784693|560862645|FG001|Overall Study|Randomized but not Treated|0|||
155389927|NCT00784693|560862644|FG000|Overall Study|Other|1|||
155389928|NCT00784693|560862645|FG001|Overall Study|Other|0|||
155389929|NCT05458479|560862646|FG000|Overall Study|Lost to Follow-up|1|||
155389930|NCT03588728|560862649|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
155389931|NCT03588728|560862650|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
155389932|NCT03588728|560862651|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
155389933|NCT03588728|560862652|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
155389934|NCT03588728|560862649|FG000|Overall Study|Lab shut down due to COVID-19|0|||
155389935|NCT03588728|560862650|FG001|Overall Study|Lab shut down due to COVID-19|0|||
155389936|NCT03588728|560862651|FG002|Overall Study|Lab shut down due to COVID-19|0|||
155389937|NCT03588728|560862652|FG003|Overall Study|Lab shut down due to COVID-19|1|||
155389938|NCT03588728|560862649|FG000|Overall Study|multiple technical issues|1|||
155389939|NCT03588728|560862650|FG001|Overall Study|multiple technical issues|0|||
155389940|NCT03588728|560862651|FG002|Overall Study|multiple technical issues|0|||
155389941|NCT03588728|560862652|FG003|Overall Study|multiple technical issues|0|||
155389942|NCT03588728|560862649|FG000|Overall Study|Hospitalized for COVID|1|||
155389943|NCT03588728|560862650|FG001|Overall Study|Hospitalized for COVID|0|||
155389944|NCT03588728|560862651|FG002|Overall Study|Hospitalized for COVID|0|||
155389945|NCT03588728|560862652|FG003|Overall Study|Hospitalized for COVID|0|||
155389946|NCT03588728|560862649|FG000|Overall Study|Schedule change unable to attend sessions|1|||
155389947|NCT03588728|560862650|FG001|Overall Study|Schedule change unable to attend sessions|0|||
155389948|NCT03588728|560862651|FG002|Overall Study|Schedule change unable to attend sessions|0|||
155389949|NCT03588728|560862652|FG003|Overall Study|Schedule change unable to attend sessions|0|||
155389950|NCT01388790|560862653|FG000|Overall Study|Ongoing at data cut-off date|8|||
155389951|NCT00908232|560862654|FG000|Cycle 1 to 4|Death|5|||
155389952|NCT00908232|560862655|FG001|Cycle 1 to 4|Death|0|||
155389953|NCT00908232|560862656|FG002|Cycle 1 to 4|Death|0|||
155389954|NCT00908232|560862657|FG003|Cycle 1 to 4|Death|0|||
155389955|NCT00908232|560862654|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
155389956|NCT00908232|560862655|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
155389957|NCT00908232|560862656|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
155389958|NCT00908232|560862657|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
155389959|NCT00908232|560862654|FG000|Cycle 1 to 4|Progressive Disease|6|||
155389960|NCT00908232|560862655|FG001|Cycle 1 to 4|Progressive Disease|0|||
155389961|NCT00908232|560862656|FG002|Cycle 1 to 4|Progressive Disease|0|||
155389962|NCT00908232|560862657|FG003|Cycle 1 to 4|Progressive Disease|0|||
155389963|NCT00908232|560862654|FG000|Cycle 1 to 4|Adverse Event|12|||
155389964|NCT00908232|560862655|FG001|Cycle 1 to 4|Adverse Event|0|||
155389965|NCT00908232|560862656|FG002|Cycle 1 to 4|Adverse Event|0|||
155389966|NCT00908232|560862657|FG003|Cycle 1 to 4|Adverse Event|0|||
155389967|NCT00908232|560862654|FG000|Cycle 1 to 4|Other|1|||
155389968|NCT00908232|560862655|FG001|Cycle 1 to 4|Other|0|||
155389969|NCT00908232|560862656|FG002|Cycle 1 to 4|Other|0|||
155389970|NCT00908232|560862657|FG003|Cycle 1 to 4|Other|0|||
155389971|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
155389972|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389973|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389974|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389975|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
155389976|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389977|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389978|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389979|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
155389980|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389981|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389982|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389983|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
155734271|NCT00092443|562125069|FG000|Overall Study|Moved|5|||
155734272|NCT00092443|562125070|FG001|Overall Study|Moved|5|||
155734273|NCT00092443|562125069|FG000|Overall Study|Other|17|||
155734274|NCT00092443|562125070|FG001|Overall Study|Other|13|||
155389984|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
155389985|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
155389986|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
155389987|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
155389988|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
155389989|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
155389990|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
155389991|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
155389992|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389993|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389994|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389995|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
155389996|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
155389997|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
155389998|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
155389999|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
155390000|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390001|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390002|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390003|NCT03153137|560862658|FG000|Overall Study|Lost to Follow-up|1|||
155390004|NCT03153137|560862659|FG001|Overall Study|Lost to Follow-up|0|||
155390005|NCT03153137|560862658|FG000|Overall Study|Withdrawal by Subject|2|||
155390006|NCT03153137|560862659|FG001|Overall Study|Withdrawal by Subject|1|||
155390007|NCT03153137|560862658|FG000|Overall Study|Physician Decision|0|||
155390008|NCT03153137|560862659|FG001|Overall Study|Physician Decision|3|||
155390009|NCT00195507|560862663|FG000|Overall Study|Adverse Event|24|||
155390010|NCT00195507|560862664|FG001|Overall Study|Adverse Event|13|||
155390011|NCT00195507|560862663|FG000|Overall Study|Death|0|||
155390012|NCT00195507|560862664|FG001|Overall Study|Death|1|||
155390013|NCT00195507|560862663|FG000|Overall Study|Failed to Return|4|||
155390014|NCT00195507|560862664|FG001|Overall Study|Failed to Return|3|||
155390015|NCT00195507|560862663|FG000|Overall Study|Physician Decision|1|||
155390016|NCT00195507|560862664|FG001|Overall Study|Physician Decision|2|||
155390017|NCT00195507|560862663|FG000|Overall Study|Lost to Follow-up|3|||
155390018|NCT00195507|560862664|FG001|Overall Study|Lost to Follow-up|2|||
155390019|NCT00195507|560862663|FG000|Overall Study|Protocol Violation|5|||
155390020|NCT00195507|560862664|FG001|Overall Study|Protocol Violation|4|||
155390021|NCT00195507|560862663|FG000|Overall Study|Lack of Efficacy|40|||
155390022|NCT00195507|560862664|FG001|Overall Study|Lack of Efficacy|67|||
155390023|NCT00195507|560862663|FG000|Overall Study|Withdrawal by Subject|16|||
155390024|NCT00195507|560862664|FG001|Overall Study|Withdrawal by Subject|23|||
155390025|NCT00195507|560862663|FG000|Overall Study|Protocol Deviation|6|||
155390026|NCT00195507|560862664|FG001|Overall Study|Protocol Deviation|3|||
155390027|NCT00528866|560862665|FG000|Overall Study|Protocol Violation|6|||
155390028|NCT00993915|560862669|FG000|Overall Study|Insufficient clinical response|3|||
155390029|NCT00993915|560862669|FG000|Overall Study|Withdrawal by Subject|2|||
155390030|NCT00993915|560862669|FG000|Overall Study|Other|1|||
155390031|NCT00993915|560862669|FG000|Overall Study|Ongoing|3|||
155390032|NCT01386658|560862670|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
155390033|NCT01386658|560862671|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
155390034|NCT01386658|560862670|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
155390035|NCT01386658|560862671|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
155390036|NCT02465463|560862677|FG000|Overall Study|Lost to Follow-up|2|||
155390037|NCT02465463|560862678|FG001|Overall Study|Lost to Follow-up|1|||
155390038|NCT02465463|560862677|FG000|Overall Study|Death|1|||
155734275|NCT04717336|562125071|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
155734276|NCT04717336|562125072|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
155734277|NCT04717336|562125071|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
155734278|NCT04717336|562125072|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
155734279|NCT02039843|562125073|FG000|Randomization and Observation Period|Adverse Event|2|||
155734280|NCT02039843|562125074|FG001|Randomization and Observation Period|Adverse Event|0|||
155390039|NCT02465463|560862678|FG001|Overall Study|Death|0|||
155390040|NCT02465463|560862677|FG000|Overall Study|Protocol Violation|1|||
155390041|NCT02465463|560862678|FG001|Overall Study|Protocol Violation|0|||
155390042|NCT01067326|560862681|FG000|Overall Study|Adverse Event|0|||
155390043|NCT01067326|560862682|FG001|Overall Study|Adverse Event|2|||
155390044|NCT01067326|560862681|FG000|Overall Study|Withdrawal by Subject|1|||
155734281|NCT02039843|562125073|FG000|Randomization and Observation Period|Death|1|||
155390045|NCT01067326|560862682|FG001|Overall Study|Withdrawal by Subject|0|||
155390046|NCT01067326|560862681|FG000|Overall Study|Early Study Termination|1|||
155390047|NCT01067326|560862682|FG001|Overall Study|Early Study Termination|1|||
155390048|NCT01230788|560862687|FG000|Overall Study|Prescribed exclusion drug|1|||
155390049|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
155390050|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
155390051|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Death|0|||
155390052|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Death|1|||
155390053|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
155390054|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
155390055|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
155390056|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
155390057|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
155390058|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
155390059|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
155390060|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
155390061|NCT00323297|560862688|FG000|Part B (Open-label)|Death|0|||
155390062|NCT00323297|560862689|FG001|Part B (Open-label)|Death|1|||
155390063|NCT00323297|560862688|FG000|Part B (Open-label)|Reason unspecified|0|||
155390064|NCT00323297|560862689|FG001|Part B (Open-label)|Reason unspecified|1|||
155390065|NCT00323297|560862688|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
155390066|NCT00323297|560862689|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
155390067|NCT00323297|560862688|FG000|Part B (Open-label)|Lack of Efficacy|3|||
155390068|NCT00323297|560862689|FG001|Part B (Open-label)|Lack of Efficacy|1|||
155390069|NCT00323297|560862688|FG000|Part B (Open-label)|Adverse Event|5|||
155390070|NCT00323297|560862689|FG001|Part B (Open-label)|Adverse Event|5|||
155390071|NCT00323297|560862688|FG000|Part B (Open-label)|Protocol Violation|0|||
155390072|NCT00323297|560862689|FG001|Part B (Open-label)|Protocol Violation|1|||
155390073|NCT00564018|560862690|FG000|Overall Study|Withdrawal by Subject|2|||
155390074|NCT00564018|560862691|FG001|Overall Study|Withdrawal by Subject|3|||
155390075|NCT00564018|560862692|FG002|Overall Study|Withdrawal by Subject|1|||
155390076|NCT00986440|560862693|FG000|Overall Study|Progressive disease|27|||
155390077|NCT00986440|560862694|FG001|Overall Study|Progressive disease|37|||
155734282|NCT02039843|562125074|FG001|Randomization and Observation Period|Death|0|||
155390078|NCT00986440|560862693|FG000|Overall Study|Serious adverse event or adverse event|9|||
155734283|NCT02039843|562125073|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
155734284|NCT02039843|562125074|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
155734285|NCT02039843|562125073|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
155734286|NCT02039843|562125074|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
155734287|NCT02039843|562125073|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
155734288|NCT02039843|562125074|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
155734289|NCT02039843|562125073|FG000|Pairing With a Study Dog|Death|1|||
155734290|NCT02039843|562125074|FG001|Pairing With a Study Dog|Death|0|||
155390079|NCT00986440|560862694|FG001|Overall Study|Serious adverse event or adverse event|2|||
155390080|NCT00986440|560862693|FG000|Overall Study|Withdrawal by Subject|1|||
155390081|NCT00986440|560862694|FG001|Overall Study|Withdrawal by Subject|2|||
155390082|NCT00986440|560862693|FG000|Overall Study|Screen failure (not dosed)|4|||
155390083|NCT00986440|560862694|FG001|Overall Study|Screen failure (not dosed)|2|||
155390084|NCT00954421|560862702|FG000|Screening|screen failures|3|||
155390085|NCT00954421|560862702|FG000|6 Months of DBS|Withdrawal by Subject|1|||
155390086|NCT00954421|560862702|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
155390087|NCT03231943|560862705|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390088|NCT03231943|560862706|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
155390089|NCT03231943|560862707|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
155390090|NCT03231943|560862708|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390091|NCT03231943|560862709|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390092|NCT03231943|560862710|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390093|NCT03231943|560862711|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390094|NCT03231943|560862712|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390095|NCT03231943|560862713|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390096|NCT03231943|560862714|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390097|NCT03231943|560862715|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390098|NCT03231943|560862716|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390099|NCT03231943|560862717|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390100|NCT03231943|560862705|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155734291|NCT02039843|562125073|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
155390101|NCT03231943|560862706|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
155390102|NCT03231943|560862707|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390103|NCT03231943|560862708|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390104|NCT03231943|560862709|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390105|NCT03231943|560862710|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390106|NCT03231943|560862711|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155734292|NCT02039843|562125074|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
155734293|NCT02039843|562125073|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
155390107|NCT03231943|560862712|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390108|NCT03231943|560862713|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390109|NCT03231943|560862714|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390110|NCT03231943|560862715|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390111|NCT03231943|560862716|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390112|NCT03231943|560862717|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390113|NCT03231943|560862705|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
155390114|NCT03231943|560862706|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390115|NCT03231943|560862707|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390116|NCT03231943|560862708|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390117|NCT03231943|560862709|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390118|NCT03231943|560862710|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390119|NCT03231943|560862711|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390120|NCT03231943|560862712|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390121|NCT03231943|560862713|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390122|NCT03231943|560862714|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390123|NCT03231943|560862715|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390124|NCT03231943|560862716|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390125|NCT03231943|560862717|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390126|NCT03231943|560862705|FG000|Part 2|Adverse Event|0|||
155390127|NCT03231943|560862706|FG001|Part 2|Adverse Event|0|||
155390128|NCT03231943|560862707|FG002|Part 2|Adverse Event|0|||
155390129|NCT03231943|560862708|FG003|Part 2|Adverse Event|0|||
155390130|NCT03231943|560862709|FG004|Part 2|Adverse Event|0|||
155390131|NCT03231943|560862710|FG005|Part 2|Adverse Event|0|||
155390132|NCT03231943|560862711|FG006|Part 2|Adverse Event|0|||
155390133|NCT03231943|560862712|FG007|Part 2|Adverse Event|0|||
155390134|NCT03231943|560862713|FG008|Part 2|Adverse Event|0|||
155390135|NCT03231943|560862714|FG009|Part 2|Adverse Event|0|||
155390136|NCT03231943|560862715|FG010|Part 2|Adverse Event|1|||
155390137|NCT03231943|560862716|FG011|Part 2|Adverse Event|0|||
155390138|NCT03231943|560862717|FG012|Part 2|Adverse Event|0|||
155390139|NCT03231943|560862705|FG000|Part 2|Withdrawal by Subject|0|||
155390140|NCT03231943|560862706|FG001|Part 2|Withdrawal by Subject|0|||
155390141|NCT03231943|560862707|FG002|Part 2|Withdrawal by Subject|0|||
155390142|NCT03231943|560862708|FG003|Part 2|Withdrawal by Subject|0|||
155390143|NCT03231943|560862709|FG004|Part 2|Withdrawal by Subject|0|||
155390144|NCT03231943|560862710|FG005|Part 2|Withdrawal by Subject|0|||
155390145|NCT03231943|560862711|FG006|Part 2|Withdrawal by Subject|0|||
155390146|NCT03231943|560862712|FG007|Part 2|Withdrawal by Subject|0|||
155390147|NCT03231943|560862713|FG008|Part 2|Withdrawal by Subject|0|||
155390148|NCT03231943|560862714|FG009|Part 2|Withdrawal by Subject|0|||
155390149|NCT03231943|560862715|FG010|Part 2|Withdrawal by Subject|0|||
155390150|NCT03231943|560862716|FG011|Part 2|Withdrawal by Subject|1|||
155390151|NCT03231943|560862717|FG012|Part 2|Withdrawal by Subject|0|||
155631383|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
155631384|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
155631385|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Death|1|||
155631386|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Death|1|||
155631387|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Death|0|||
155631388|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
155631389|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
155631390|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
155631391|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
155631392|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
155631393|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
155631394|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
155631395|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
155631396|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
155631397|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
155631398|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
155631399|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
155631400|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
155390152|NCT00658684|560862718|FG000|Overall Study|Adverse Event|10|||
155390153|NCT00658684|560862719|FG001|Overall Study|Adverse Event|8|||
155390154|NCT00658684|560862720|FG002|Overall Study|Adverse Event|2|||
155390155|NCT00658684|560862721|FG003|Overall Study|Adverse Event|0|||
155390156|NCT00658684|560862718|FG000|Overall Study|Withdrawal by Subject|6|||
155390157|NCT00658684|560862719|FG001|Overall Study|Withdrawal by Subject|4|||
155631401|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
155631402|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
155631403|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
155390158|NCT00658684|560862720|FG002|Overall Study|Withdrawal by Subject|1|||
155390159|NCT00658684|560862721|FG003|Overall Study|Withdrawal by Subject|1|||
155390160|NCT00658684|560862718|FG000|Overall Study|Lack of Efficacy|1|||
155734294|NCT02039843|562125074|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
155734295|NCT02039843|562125073|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
155734296|NCT02039843|562125074|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
155734297|NCT01500720|562125078|FG000|Overall Study|Randomized But Not Treated|1|||
155734298|NCT01500720|562125079|FG001|Overall Study|Randomized But Not Treated|1|||
155734299|NCT01500720|562125078|FG000|Overall Study|Other|4|||
155734300|NCT01500720|562125079|FG001|Overall Study|Other|8|||
155734301|NCT00630838|562125082|FG000|Overall Study|Death|0|||
155734302|NCT00630838|562125083|FG001|Overall Study|Death|1|||
155734303|NCT00630838|562125082|FG000|Overall Study|Lost to Follow-up|0|||
155734304|NCT00630838|562125083|FG001|Overall Study|Lost to Follow-up|1|||
155734305|NCT00928408|562125084|FG000|Overall Study|Other|2|||
155734306|NCT00928408|562125084|FG000|Overall Study|Withdrawal by Subject|4|||
155390161|NCT00658684|560862719|FG001|Overall Study|Lack of Efficacy|1|||
155390162|NCT00658684|560862720|FG002|Overall Study|Lack of Efficacy|0|||
155390163|NCT00658684|560862721|FG003|Overall Study|Lack of Efficacy|0|||
155390164|NCT00658684|560862718|FG000|Overall Study|Protocol Violation|1|||
155390165|NCT00658684|560862719|FG001|Overall Study|Protocol Violation|1|||
155390166|NCT00658684|560862720|FG002|Overall Study|Protocol Violation|0|||
155390167|NCT00658684|560862721|FG003|Overall Study|Protocol Violation|0|||
155390168|NCT00658684|560862718|FG000|Overall Study|Pregnancy|1|||
155390169|NCT00658684|560862719|FG001|Overall Study|Pregnancy|1|||
155390170|NCT00658684|560862720|FG002|Overall Study|Pregnancy|0|||
155390171|NCT00658684|560862721|FG003|Overall Study|Pregnancy|0|||
155390172|NCT03226275|560862724|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390173|NCT03226275|560862725|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390174|NCT03226275|560862726|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
155390175|NCT03226275|560862727|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390176|NCT03226275|560862724|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390177|NCT03226275|560862725|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390178|NCT03226275|560862726|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390179|NCT03226275|560862727|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
155390180|NCT03442114|560862728|FG000|Overall Study|Lost to Follow-up|13|||
155390181|NCT03442114|560862729|FG001|Overall Study|Lost to Follow-up|13|||
155390182|NCT03442114|560862728|FG000|Overall Study|Physician Decision|2|||
155390183|NCT03442114|560862729|FG001|Overall Study|Physician Decision|2|||
155390184|NCT03442114|560862728|FG000|Overall Study|Protocol Violation|0|||
155390185|NCT03442114|560862729|FG001|Overall Study|Protocol Violation|2|||
155390186|NCT03442114|560862728|FG000|Overall Study|Withdrawal by Subject|1|||
155390187|NCT03442114|560862729|FG001|Overall Study|Withdrawal by Subject|3|||
155390188|NCT03442114|560862728|FG000|Overall Study|Guardianship Change|0|||
155390189|NCT03442114|560862729|FG001|Overall Study|Guardianship Change|1|||
155390190|NCT01128361|560864259|FG000|Overall Study|Lost to Follow-up|0|||
155390191|NCT01128361|560864260|FG001|Overall Study|Lost to Follow-up|1|||
155390192|NCT01128361|560864259|FG000|Overall Study|Withdrawal by Subject|5|||
155390193|NCT01128361|560864260|FG001|Overall Study|Withdrawal by Subject|2|||
155390194|NCT01681628|560864263|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
155390195|NCT01681628|560864264|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
155390196|NCT01681628|560864263|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
155390197|NCT01681628|560864264|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
155390198|NCT01681628|560864263|FG000|19 Months Follow-up|Death|1|||
155390199|NCT01681628|560864264|FG001|19 Months Follow-up|Death|0|||
155390200|NCT01681628|560864263|FG000|19 Months Follow-up|Lost to Follow-up|61|||
155390201|NCT01681628|560864264|FG001|19 Months Follow-up|Lost to Follow-up|43|||
155390202|NCT04356183|560864277|FG000|Overall Study|Lost to Follow-up|1|||
155390203|NCT04356183|560864278|FG001|Overall Study|Lost to Follow-up|0|||
155390204|NCT04356183|560864277|FG000|Overall Study|Withdrawal by Subject|1|||
155390205|NCT04356183|560864278|FG001|Overall Study|Withdrawal by Subject|1|||
155734307|NCT00928408|562125084|FG000|Overall Study|Death|5|||
155734308|NCT00928408|562125084|FG000|Overall Study|Lost to Follow-up|12|||
155390206|NCT05736211|560864279|FG000|Overall Study|Lost to Follow-up|6|||
155390207|NCT05736211|560864280|FG001|Overall Study|Lost to Follow-up|0|||
155390208|NCT02634346|560864283|FG000|Overall Study|Withdrawal by Subject|8|||
155390209|NCT02634346|560864284|FG001|Overall Study|Withdrawal by Subject|9|||
155390210|NCT02634346|560864285|FG002|Overall Study|Withdrawal by Subject|8|||
155390211|NCT02634346|560864283|FG000|Overall Study|Adverse Event|2|||
155390212|NCT02634346|560864284|FG001|Overall Study|Adverse Event|2|||
155390213|NCT02634346|560864285|FG002|Overall Study|Adverse Event|7|||
155390214|NCT02634346|560864283|FG000|Overall Study|Lack of Efficacy|1|||
155390215|NCT02634346|560864284|FG001|Overall Study|Lack of Efficacy|2|||
155390216|NCT02634346|560864285|FG002|Overall Study|Lack of Efficacy|8|||
155390217|NCT02634346|560864283|FG000|Overall Study|Lost to Follow-up|1|||
155390218|NCT02634346|560864284|FG001|Overall Study|Lost to Follow-up|0|||
155390219|NCT02634346|560864285|FG002|Overall Study|Lost to Follow-up|0|||
155734309|NCT01104311|562125095|FG000|Overall Study|Withdrawal by Subject|6|||
155734310|NCT01104311|562125096|FG001|Overall Study|Withdrawal by Subject|6|||
155390220|NCT02634346|560864283|FG000|Overall Study|Protocol Violation|0|||
155390221|NCT02634346|560864284|FG001|Overall Study|Protocol Violation|1|||
155390222|NCT02634346|560864285|FG002|Overall Study|Protocol Violation|0|||
155390223|NCT00992511|560864286|FG000|Overall Study|Migrated/moved from study area|1|||
155390224|NCT00992511|560864287|FG001|Overall Study|Migrated/moved from study area|0|||
155390225|NCT00992511|560864288|FG002|Overall Study|Migrated/moved from study area|1|||
155390226|NCT00992511|560864289|FG003|Overall Study|Migrated/moved from study area|2|||
155390227|NCT00992511|560864286|FG000|Overall Study|Lost to Follow-up|1|||
155390228|NCT00992511|560864287|FG001|Overall Study|Lost to Follow-up|0|||
155390229|NCT00992511|560864288|FG002|Overall Study|Lost to Follow-up|0|||
155390230|NCT00992511|560864289|FG003|Overall Study|Lost to Follow-up|2|||
155390231|NCT00992511|560864286|FG000|Overall Study|Withdrawal by Subject|0|||
155390232|NCT00992511|560864287|FG001|Overall Study|Withdrawal by Subject|0|||
155390233|NCT00992511|560864288|FG002|Overall Study|Withdrawal by Subject|1|||
155390234|NCT00992511|560864289|FG003|Overall Study|Withdrawal by Subject|1|||
155390235|NCT02076113|560864292|FG000|Overall Study|Lost to Follow-up|4|||
155390236|NCT02076113|560864293|FG001|Overall Study|Lost to Follow-up|1|||
155390237|NCT02076113|560864292|FG000|Overall Study|Withdrawal by Subject|2|||
155390238|NCT02076113|560864293|FG001|Overall Study|Withdrawal by Subject|3|||
155390239|NCT02076113|560864292|FG000|Overall Study|Death|1|||
155390240|NCT02076113|560864293|FG001|Overall Study|Death|3|||
155390241|NCT00769860|560864301|FG000|Overall Study|Withdrawal by Subject|2|||
155390242|NCT00769860|560864302|FG001|Overall Study|Withdrawal by Subject|0|||
155390243|NCT00412971|560864308|FG000|Overall Study|Lost to Follow-up|17|||
155390244|NCT00412971|560864309|FG001|Overall Study|Lost to Follow-up|9|||
155390245|NCT00412971|560864308|FG000|Overall Study|Protocol Violation|13|||
155390246|NCT00412971|560864309|FG001|Overall Study|Protocol Violation|1|||
155390247|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
155390248|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
155390249|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
155390250|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
155390251|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
155390252|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
155390253|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
155390254|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
155390255|NCT02430051|560864313|FG000|Overall Study|Withdrawal by Subject|6|||
155390256|NCT02430051|560864314|FG001|Overall Study|Withdrawal by Subject|3|||
155390257|NCT02430051|560864313|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
155390258|NCT02430051|560864314|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
155390259|NCT02430051|560864313|FG000|Overall Study|Protocol Violation|1|||
155390260|NCT02430051|560864314|FG001|Overall Study|Protocol Violation|0|||
155390261|NCT02030405|560864320|FG000|Overall Study|Withdrawal by Subject|1|||
155390262|NCT02030405|560864320|FG000|Overall Study|Lost to Follow-up|1|||
155390263|NCT00132496|560864321|FG000|Overall Study|Withdrawal by Subject|1|||
155390264|NCT00132496|560864322|FG001|Overall Study|Withdrawal by Subject|2|||
155390265|NCT00132496|560864321|FG000|Overall Study|Physician Decision|1|||
155390266|NCT00132496|560864322|FG001|Overall Study|Physician Decision|0|||
155390267|NCT00388154|560864325|FG000|Overall Study|Withdrawal by Subject|1|||
155390268|NCT04526197|560864329|FG000|Period 1|Adverse Event|0|||
155390269|NCT04526197|560864330|FG001|Period 1|Adverse Event|1|||
155390270|NCT04526197|560864329|FG000|Period 1|Withdrawal by Subject|1|||
155390271|NCT04526197|560864330|FG001|Period 1|Withdrawal by Subject|0|||
155390272|NCT04526197|560864329|FG000|Period 2|Adverse Event|0|||
155390273|NCT04526197|560864330|FG001|Period 2|Adverse Event|1|||
155390274|NCT04526197|560864329|FG000|Period 2|Withdrawal by Subject|0|||
155390275|NCT04526197|560864330|FG001|Period 2|Withdrawal by Subject|1|||
155734311|NCT01104311|562125095|FG000|Overall Study|Protocol Violation|0|||
155734312|NCT01104311|562125096|FG001|Overall Study|Protocol Violation|1|||
155734313|NCT01104311|562125095|FG000|Overall Study|Physician Decision|2|||
155734314|NCT01104311|562125096|FG001|Overall Study|Physician Decision|2|||
155734315|NCT01104311|562125095|FG000|Overall Study|low compliance|1|||
155734316|NCT01104311|562125096|FG001|Overall Study|low compliance|1|||
155734317|NCT01104311|562125095|FG000|Overall Study|Adverse Event|1|||
155734318|NCT01104311|562125096|FG001|Overall Study|Adverse Event|2|||
155390276|NCT01209143|560864331|FG000|Overall Study|Adverse Event|2|||
155390277|NCT01209143|560864332|FG001|Overall Study|Adverse Event|1|||
155390278|NCT01209143|560864331|FG000|Overall Study|Death|0|||
155390279|NCT01209143|560864332|FG001|Overall Study|Death|1|||
155390280|NCT01209143|560864331|FG000|Overall Study|Physician Decision|3|||
155390281|NCT01209143|560864332|FG001|Overall Study|Physician Decision|1|||
155390282|NCT01209143|560864331|FG000|Overall Study|Lost to Follow-up|1|||
155390283|NCT01209143|560864332|FG001|Overall Study|Lost to Follow-up|0|||
155390284|NCT01209143|560864331|FG000|Overall Study|Withdrawal by Subject|2|||
155390285|NCT01209143|560864332|FG001|Overall Study|Withdrawal by Subject|1|||
155390286|NCT01209143|560864331|FG000|Overall Study|Disease progression|11|||
155390287|NCT01209143|560864332|FG001|Overall Study|Disease progression|16|||
155734319|NCT01864603|562127074|FG000|Stage 2|DSMB design modification|86056|||
155390288|NCT00381303|560864335|FG000|Overall Study|Lost to Follow-up|25|||
155390289|NCT00381303|560864336|FG001|Overall Study|Lost to Follow-up|9|||
155390290|NCT00381303|560864335|FG000|Overall Study|AE/HIV-related event|22|||
155390291|NCT00381303|560864336|FG001|Overall Study|AE/HIV-related event|6|||
155390292|NCT00381303|560864335|FG000|Overall Study|Non-Adherence|13|||
155390293|NCT00381303|560864336|FG001|Overall Study|Non-Adherence|6|||
155390294|NCT00381303|560864335|FG000|Overall Study|Withdrawal by Subject|13|||
155390295|NCT00381303|560864336|FG001|Overall Study|Withdrawal by Subject|6|||
155390296|NCT00381303|560864335|FG000|Overall Study|Virologic failure|6|||
155631404|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
155631405|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
155631406|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
155631407|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
155631408|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
155631409|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
155631410|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
155631411|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
155631412|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Other|10|||
155631413|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Other|4|||
155631414|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Other|0|||
155631415|NCT04006457|561745812|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
155631416|NCT04006457|561745813|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
155631417|NCT04006457|561745814|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
155631418|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
155631419|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
155631420|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
155631421|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
155631422|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
155631423|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
155631424|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
155631425|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
155631426|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
155631427|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
155631428|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
155631429|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
155631430|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
155631431|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
155631432|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
155631433|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Other|2|||
155631434|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Other|3|||
155631435|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Other|0|||
155631436|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
155631437|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
155631438|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
155631439|NCT04006457|561745812|FG000|Main Study: Treatment Period 2|Ongoing|86|||
155631440|NCT04006457|561745813|FG001|Main Study: Treatment Period 2|Ongoing|96|||
155631441|NCT04006457|561745814|FG002|Main Study: Treatment Period 2|Ongoing|0|||
155631442|NCT04006457|561745812|FG000|Main Study Observation Period|Adverse Event|1|||
155631443|NCT04006457|561745813|FG001|Main Study Observation Period|Adverse Event|1|||
155631444|NCT04006457|561745814|FG002|Main Study Observation Period|Adverse Event|0|||
155631445|NCT04006457|561745812|FG000|Main Study Observation Period|Lost to Follow-up|0|||
155631446|NCT04006457|561745813|FG001|Main Study Observation Period|Lost to Follow-up|1|||
155631447|NCT04006457|561745814|FG002|Main Study Observation Period|Lost to Follow-up|0|||
155631448|NCT04006457|561745812|FG000|Main Study Observation Period|Pregnancy|1|||
155631449|NCT04006457|561745813|FG001|Main Study Observation Period|Pregnancy|0|||
155631450|NCT04006457|561745814|FG002|Main Study Observation Period|Pregnancy|0|||
155631451|NCT04006457|561745812|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
155631452|NCT04006457|561745813|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
155631453|NCT04006457|561745814|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
155631454|NCT04006457|561745812|FG000|Main Study Observation Period|Other|8|||
155631455|NCT04006457|561745813|FG001|Main Study Observation Period|Other|16|||
155734320|NCT01864603|562127075|FG001|Stage 2|DSMB design modification|92558|||
155631456|NCT04006457|561745814|FG002|Main Study Observation Period|Other|0|||
155631457|NCT04006457|561745812|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
155631458|NCT04006457|561745813|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
155631459|NCT04006457|561745814|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
155390297|NCT00381303|560864336|FG001|Overall Study|Virologic failure|4|||
155390298|NCT00381303|560864335|FG000|Overall Study|Ineligible to continue the trial|2|||
155390299|NCT00381303|560864336|FG001|Overall Study|Ineligible to continue the trial|1|||
155390300|NCT00381303|560864335|FG000|Overall Study|Pregnancy|2|||
155390301|NCT00381303|560864336|FG001|Overall Study|Pregnancy|0|||
155390302|NCT00381303|560864335|FG000|Overall Study|Physician Decision|1|||
155390303|NCT00381303|560864336|FG001|Overall Study|Physician Decision|0|||
155390304|NCT00381303|560864335|FG000|Overall Study|Physician's decision to close the site|3|||
155390305|NCT00381303|560864336|FG001|Overall Study|Physician's decision to close the site|1|||
155390306|NCT00381303|560864335|FG000|Overall Study|Subject moved out of state|2|||
155390307|NCT00381303|560864336|FG001|Overall Study|Subject moved out of state|0|||
155390308|NCT00381303|560864335|FG000|Overall Study|Subject taking too many different meds|1|||
155390309|NCT00381303|560864336|FG001|Overall Study|Subject taking too many different meds|0|||
155390310|NCT00381303|560864335|FG000|Overall Study|No virologic response by week 12|1|||
155390311|NCT00381303|560864336|FG001|Overall Study|No virologic response by week 12|0|||
155390312|NCT00381303|560864335|FG000|Overall Study|Subject was too busy for appointments|1|||
155390313|NCT00381303|560864336|FG001|Overall Study|Subject was too busy for appointments|0|||
155390314|NCT00381303|560864335|FG000|Overall Study|Subject did not continue visits|1|||
155390315|NCT00381303|560864336|FG001|Overall Study|Subject did not continue visits|0|||
155390316|NCT00381303|560864335|FG000|Overall Study|Subject primary physician's decision|1|||
155390317|NCT00381303|560864336|FG001|Overall Study|Subject primary physician's decision|0|||
155390318|NCT01136811|560864337|FG000|Overall Study|Physician Decision|11|||
155390319|NCT01211522|560864338|FG000|Overall Study|Withdrawal by Subject|3|||
155390320|NCT01211522|560864339|FG001|Overall Study|Withdrawal by Subject|7|||
155390321|NCT01211522|560864340|FG002|Overall Study|Withdrawal by Subject|5|||
155390322|NCT01145755|560864342|FG000|Overall Study|Adverse Event|2|||
155390323|NCT01145755|560864343|FG001|Overall Study|Adverse Event|4|||
155390324|NCT01145755|560864344|FG002|Overall Study|Adverse Event|2|||
155390325|NCT01145755|560864342|FG000|Overall Study|Withdrawal by Subject|2|||
155390326|NCT01145755|560864343|FG001|Overall Study|Withdrawal by Subject|2|||
155390327|NCT01145755|560864344|FG002|Overall Study|Withdrawal by Subject|2|||
155390328|NCT01145755|560864342|FG000|Overall Study|Lost to Follow-up|2|||
155390329|NCT01145755|560864343|FG001|Overall Study|Lost to Follow-up|3|||
155390330|NCT01145755|560864344|FG002|Overall Study|Lost to Follow-up|1|||
155390331|NCT01145755|560864342|FG000|Overall Study|Protocol Violation|0|||
155390332|NCT01145755|560864343|FG001|Overall Study|Protocol Violation|3|||
155390333|NCT01145755|560864344|FG002|Overall Study|Protocol Violation|1|||
155390334|NCT01145755|560864342|FG000|Overall Study|Study Closure|14|||
155390335|NCT01145755|560864343|FG001|Overall Study|Study Closure|14|||
155390336|NCT01145755|560864344|FG002|Overall Study|Study Closure|17|||
155390337|NCT01145755|560864342|FG000|Overall Study|Lack of Efficacy|0|||
155390338|NCT01145755|560864343|FG001|Overall Study|Lack of Efficacy|1|||
155390339|NCT01145755|560864344|FG002|Overall Study|Lack of Efficacy|0|||
155390340|NCT01145755|560864342|FG000|Overall Study|Patient could not swollow medication|0|||
155390341|NCT01145755|560864343|FG001|Overall Study|Patient could not swollow medication|0|||
155390342|NCT01145755|560864344|FG002|Overall Study|Patient could not swollow medication|1|||
155390343|NCT01145755|560864342|FG000|Overall Study|Withdrawal by Subject|0|||
155390344|NCT01145755|560864343|FG001|Overall Study|Withdrawal by Subject|0|||
155390345|NCT01145755|560864344|FG002|Overall Study|Withdrawal by Subject|1|||
155390346|NCT01145755|560864342|FG000|Overall Study|Positive urine ethanol|0|||
155390347|NCT01145755|560864343|FG001|Overall Study|Positive urine ethanol|1|||
155390348|NCT01145755|560864344|FG002|Overall Study|Positive urine ethanol|0|||
155390349|NCT00372385|560864350|FG000|Overall Study|Adverse Event|6|||
155390350|NCT00372385|560864351|FG001|Overall Study|Adverse Event|11|||
155390351|NCT00372385|560864352|FG002|Overall Study|Adverse Event|9|||
155390352|NCT00372385|560864353|FG003|Overall Study|Adverse Event|7|||
155390353|NCT00372385|560864350|FG000|Overall Study|Noncompliance|0|||
155390354|NCT00372385|560864351|FG001|Overall Study|Noncompliance|1|||
155390355|NCT00372385|560864352|FG002|Overall Study|Noncompliance|1|||
155390356|NCT00372385|560864353|FG003|Overall Study|Noncompliance|1|||
155390357|NCT00372385|560864350|FG000|Overall Study|Physician Decision|1|||
155390358|NCT00372385|560864351|FG001|Overall Study|Physician Decision|0|||
155390359|NCT00372385|560864352|FG002|Overall Study|Physician Decision|0|||
155390360|NCT00372385|560864353|FG003|Overall Study|Physician Decision|0|||
155631460|NCT04006457|561745812|FG000|Main Study Observation Period|Ongoing|2|||
155631461|NCT04006457|561745813|FG001|Main Study Observation Period|Ongoing|1|||
155390361|NCT00372385|560864350|FG000|Overall Study|Lost to Follow-up|2|||
155390362|NCT00372385|560864351|FG001|Overall Study|Lost to Follow-up|0|||
155390363|NCT00372385|560864352|FG002|Overall Study|Lost to Follow-up|0|||
155390364|NCT00372385|560864353|FG003|Overall Study|Lost to Follow-up|0|||
155390365|NCT00372385|560864350|FG000|Overall Study|Withdrawal by Subject|2|||
155390366|NCT00372385|560864351|FG001|Overall Study|Withdrawal by Subject|1|||
155390367|NCT00372385|560864352|FG002|Overall Study|Withdrawal by Subject|0|||
155390368|NCT00372385|560864353|FG003|Overall Study|Withdrawal by Subject|0|||
155390369|NCT00372385|560864350|FG000|Overall Study|Refusal of Treatment|3|||
155390370|NCT00372385|560864351|FG001|Overall Study|Refusal of Treatment|6|||
155390371|NCT00372385|560864352|FG002|Overall Study|Refusal of Treatment|0|||
155390372|NCT00372385|560864353|FG003|Overall Study|Refusal of Treatment|0|||
155390373|NCT00372385|560864350|FG000|Overall Study|No Response|1|||
155390374|NCT00372385|560864351|FG001|Overall Study|No Response|1|||
155390375|NCT00372385|560864352|FG002|Overall Study|No Response|0|||
155390376|NCT00372385|560864353|FG003|Overall Study|No Response|0|||
155390377|NCT00372385|560864350|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
155390378|NCT00372385|560864351|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390379|NCT00372385|560864352|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390380|NCT00372385|560864353|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390381|NCT00372385|560864350|FG000|Overall Study|Virologic Stopping Rule|17|||
155390382|NCT00372385|560864351|FG001|Overall Study|Virologic Stopping Rule|0|||
155390383|NCT00372385|560864352|FG002|Overall Study|Virologic Stopping Rule|0|||
155390384|NCT00372385|560864353|FG003|Overall Study|Virologic Stopping Rule|0|||
155390385|NCT01966471|560864354|FG000|Overall Study|Death|44|||
155390386|NCT01966471|560864355|FG001|Overall Study|Death|56|||
155390387|NCT01966471|560864354|FG000|Overall Study|Lost to Follow-up|46|||
155390388|NCT01966471|560864355|FG001|Overall Study|Lost to Follow-up|39|||
155390389|NCT01966471|560864354|FG000|Overall Study|Various reasons|4|||
155390390|NCT01966471|560864355|FG001|Overall Study|Various reasons|4|||
155390391|NCT01966471|560864354|FG000|Overall Study|Physician Decision|7|||
155390392|NCT01966471|560864355|FG001|Overall Study|Physician Decision|5|||
155390393|NCT01966471|560864354|FG000|Overall Study|Study Terminated By Sponsor|758|||
155390394|NCT01966471|560864355|FG001|Overall Study|Study Terminated By Sponsor|773|||
155390395|NCT01966471|560864354|FG000|Overall Study|Withdrawal by Subject|59|||
155390396|NCT01966471|560864355|FG001|Overall Study|Withdrawal by Subject|51|||
155390397|NCT01030198|560864360|FG000|Overall Study|Could not measure efficacy accurately|0|||
155390398|NCT01030198|560864361|FG001|Overall Study|Could not measure efficacy accurately|7|||
155390399|NCT02279862|560864362|FG000|Overall Study|Study drug toxicity|3|||
155390400|NCT02279862|560864363|FG001|Overall Study|Study drug toxicity|6|||
155390401|NCT02279862|560864362|FG000|Overall Study|No longer meets criteria|0|||
155390402|NCT02279862|560864363|FG001|Overall Study|No longer meets criteria|1|||
155390403|NCT02279862|560864362|FG000|Overall Study|Administrative reason by sponsor|0|||
155390404|NCT02279862|560864363|FG001|Overall Study|Administrative reason by sponsor|1|||
155390405|NCT02279862|560864362|FG000|Overall Study|Disease progression|5|||
155390406|NCT02279862|560864363|FG001|Overall Study|Disease progression|2|||
155390407|NCT02279862|560864362|FG000|Overall Study|Study closed by sponsor|16|||
155390408|NCT02279862|560864363|FG001|Overall Study|Study closed by sponsor|13|||
155390409|NCT02279862|560864362|FG000|Overall Study|Other|1|||
155390410|NCT02279862|560864363|FG001|Overall Study|Other|2|||
155390411|NCT02279862|560864362|FG000|Overall Study|Withdrawal by Subject|1|||
155390412|NCT02279862|560864363|FG001|Overall Study|Withdrawal by Subject|0|||
155390413|NCT03431857|560864364|FG000|Overall Study|Death|6|||
155390414|NCT03431857|560864364|FG000|Overall Study|Lost to Follow-up|41|||
155390415|NCT03431857|560864364|FG000|Overall Study|Adverse Event|6|||
155390416|NCT03431857|560864364|FG000|Overall Study|Withdrawal by Subject|1|||
155390417|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
155390418|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
155390419|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
155734321|NCT02881567|562127079|FG000|Overall Study|Adverse Event|1|||
155734322|NCT02881567|562127079|FG000|Overall Study|Lost to Follow-up|3|||
155734323|NCT02881567|562127079|FG000|Overall Study|Consent withdrawn|1|||
155734324|NCT02881567|562127079|FG000|Overall Study|Investigator decision|1|||
155734325|NCT02881567|562127079|FG000|Overall Study|Study terminated by sponsor|9|||
155734326|NCT02881567|562127079|FG000|Overall Study|Reason not Specified|3|||
155734327|NCT00373113|562127081|FG000|Overall Study|Death|1|||
155734328|NCT00373113|562127082|FG001|Overall Study|Death|7|||
155734329|NCT00373113|562127081|FG000|Overall Study|Adverse Event|38|||
155734330|NCT00373113|562127082|FG001|Overall Study|Adverse Event|24|||
155734331|NCT00373113|562127081|FG000|Overall Study|Study terminated by sponsor|9|||
155734332|NCT00373113|562127082|FG001|Overall Study|Study terminated by sponsor|1|||
155390420|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
155390421|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
155734333|NCT00373113|562127081|FG000|Overall Study|Global deterioration of health status|10|||
155734334|NCT00373113|562127082|FG001|Overall Study|Global deterioration of health status|7|||
155734335|NCT00373113|562127081|FG000|Overall Study|Lost to Follow-up|1|||
155734336|NCT00373113|562127082|FG001|Overall Study|Lost to Follow-up|3|||
155734337|NCT00373113|562127081|FG000|Overall Study|Objective progression or relapse|150|||
155734338|NCT00373113|562127082|FG001|Overall Study|Objective progression or relapse|169|||
155390422|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
155390423|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
155390424|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
155390425|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
155390426|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
155390427|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
155734339|NCT00373113|562127081|FG000|Overall Study|Other|14|||
155734340|NCT00373113|562127082|FG001|Overall Study|Other|17|||
155734341|NCT00373113|562127081|FG000|Overall Study|Protocol Violation|5|||
155281785|NCT02624778|560463920|FG001|Overall Study|Physician Decision|0|||
155281786|NCT02624778|560463921|FG002|Overall Study|Physician Decision|0|||
155281787|NCT02624778|560463922|FG003|Overall Study|Physician Decision|0|||
155281788|NCT02624778|560463923|FG004|Overall Study|Physician Decision|0|||
155281789|NCT02624778|560463924|FG005|Overall Study|Physician Decision|0|||
155281790|NCT02624778|560463925|FG006|Overall Study|Physician Decision|0|||
155281791|NCT02624778|560463926|FG007|Overall Study|Physician Decision|3|||
155281792|NCT02624778|560463927|FG008|Overall Study|Physician Decision|3|||
155281793|NCT05296629|560463928|FG000|Overall Study|Withdrawal by Subject|3|||
155281794|NCT05296629|560463929|FG001|Overall Study|Withdrawal by Subject|10|||
155281795|NCT05296629|560463930|FG002|Overall Study|Withdrawal by Subject|4|||
155281796|NCT05296629|560463928|FG000|Overall Study|Lost to Follow-up|2|||
155281797|NCT05296629|560463929|FG001|Overall Study|Lost to Follow-up|7|||
155281798|NCT05296629|560463930|FG002|Overall Study|Lost to Follow-up|1|||
155281799|NCT05296629|560463928|FG000|Overall Study|Adverse Event|0|||
155281800|NCT05296629|560463929|FG001|Overall Study|Adverse Event|4|||
155281801|NCT05296629|560463930|FG002|Overall Study|Adverse Event|2|||
155281802|NCT05296629|560463928|FG000|Overall Study|Protocol Violation|0|||
155281803|NCT05296629|560463929|FG001|Overall Study|Protocol Violation|2|||
155281804|NCT05296629|560463930|FG002|Overall Study|Protocol Violation|0|||
155281805|NCT00231179|560463931|FG000|Overall Study|Lost to Follow-up|21|||
155281806|NCT00231179|560463932|FG001|Overall Study|Lost to Follow-up|21|||
155281807|NCT00231179|560463931|FG000|Overall Study|Withdrawal by Subject|3|||
155281808|NCT00231179|560463932|FG001|Overall Study|Withdrawal by Subject|3|||
155281809|NCT04610684|560463935|FG000|Study Treatment|Withdrawal by Subject|1|||
155281810|NCT04610684|560463935|FG000|Study Treatment|Disease Progression|2|||
155281811|NCT04610684|560463935|FG000|Follow up|Death|2|||
155281812|NCT04610684|560463935|FG000|Follow up|Withdrawal by Subject|1|||
155281813|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
155281814|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
155281815|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
155281816|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
155281817|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
155281818|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
155281819|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
155281820|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
155281821|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
155281822|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
155281823|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
155281824|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
155281825|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
155281826|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
155281827|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
155281828|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
155281829|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
155281830|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
155281831|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
155631462|NCT04006457|561745814|FG002|Main Study Observation Period|Ongoing|0|||
155631463|NCT04006457|561745812|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
155631464|NCT04006457|561745813|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
155631465|NCT04006457|561745814|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
155631466|NCT04780659|561745815|FG000|Overall Study|Adverse event, serious fatal|3|||
155631467|NCT04780659|561745816|FG001|Overall Study|Adverse event, serious fatal|0|||
155631468|NCT04780659|561745815|FG000|Overall Study|Withdrawal by Subject|3|||
155631469|NCT04780659|561745816|FG001|Overall Study|Withdrawal by Subject|0|||
155631470|NCT04780659|561745815|FG000|Overall Study|Physician Decision|1|||
155631471|NCT04780659|561745816|FG001|Overall Study|Physician Decision|0|||
155631472|NCT04780659|561745815|FG000|Overall Study|Died in original disease|2|||
155631473|NCT04780659|561745816|FG001|Overall Study|Died in original disease|0|||
155631474|NCT04780659|561745815|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
155631475|NCT04780659|561745816|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
155631476|NCT05507437|561745817|FG000|Overall Study|Withdrawal by Subject|1|||
155631477|NCT05507437|561745818|FG001|Overall Study|Withdrawal by Subject|1|||
155631478|NCT05507437|561745817|FG000|Overall Study|Death|3|||
155631479|NCT05507437|561745818|FG001|Overall Study|Death|0|||
155631480|NCT06583096|561745819|FG000|Overall Study|Lost to Follow-up|4|||
155631481|NCT06583096|561745820|FG001|Overall Study|Lost to Follow-up|10|||
155631482|NCT06583096|561745819|FG000|Overall Study|Withdrawal by Subject|0|||
155631483|NCT06583096|561745820|FG001|Overall Study|Withdrawal by Subject|2|||
155631484|NCT03729362|561745821|FG000|Overall Study|Withdrawal by Subject|2|||
155631485|NCT03729362|561745822|FG001|Overall Study|Withdrawal by Subject|0|||
155631486|NCT03729362|561745821|FG000|Overall Study|Physician Decision|1|||
155631487|NCT03729362|561745822|FG001|Overall Study|Physician Decision|0|||
155631488|NCT03729362|561745821|FG000|Overall Study|COVID-19 Pandemic|1|||
155390428|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
155390429|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
155390430|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
155390431|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
155390432|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
155390433|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
155390434|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
155390435|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
155390436|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
155390437|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
155390438|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
155390439|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
155390440|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
155390441|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
155390442|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
155390443|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
155390444|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155390445|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155390446|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155390447|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
155390448|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
155390449|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
155390450|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155390451|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
155390452|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
155390453|NCT01119001|560864368|FG000|Overall Study|Withdrawal by Subject|2|||
155390454|NCT04343248|560864369|FG000|Overall Study|Withdrawal by Subject|5|||
155631489|NCT03729362|561745822|FG001|Overall Study|COVID-19 Pandemic|0|||
155631490|NCT03729362|561745821|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
155631491|NCT03729362|561745822|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
155631492|NCT03729362|561745821|FG000|Overall Study|Adverse Event|0|||
155631493|NCT03729362|561745822|FG001|Overall Study|Adverse Event|1|||
155631494|NCT03729362|561745821|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
155631495|NCT03729362|561745822|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
155631496|NCT03405870|561745823|FG000|Overall Study|Withdrawal|1|||
155631497|NCT03405870|561745824|FG001|Overall Study|Withdrawal|0|||
155631498|NCT03405870|561745825|FG002|Overall Study|Withdrawal|1|||
155631499|NCT03405870|561745826|FG003|Overall Study|Withdrawal|0|||
155631500|NCT03405870|561745827|FG004|Overall Study|Withdrawal|0|||
155631501|NCT03405870|561745828|FG005|Overall Study|Withdrawal|0|||
155631502|NCT03405870|561745829|FG006|Overall Study|Withdrawal|1|||
155631503|NCT03405870|561745830|FG007|Overall Study|Withdrawal|0|||
155631504|NCT05172609|561745831|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
155631505|NCT05172609|561745832|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
155631506|NCT05172609|561745831|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
155631507|NCT05172609|561745832|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
155631508|NCT05172609|561745831|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
155631509|NCT05172609|561745832|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
155631510|NCT00109343|561745833|FG000|Overall Study|Adverse Event|1|||
155631511|NCT00109343|561745834|FG001|Overall Study|Adverse Event|0|||
155631512|NCT00109343|561745835|FG002|Overall Study|Adverse Event|2|||
155631513|NCT00109343|561745833|FG000|Overall Study|Lack of Efficacy|1|||
155631514|NCT00109343|561745834|FG001|Overall Study|Lack of Efficacy|0|||
155631515|NCT00109343|561745835|FG002|Overall Study|Lack of Efficacy|0|||
155631516|NCT00109343|561745833|FG000|Overall Study|Lost to Follow-up|35|||
155631517|NCT00109343|561745834|FG001|Overall Study|Lost to Follow-up|20|||
155631518|NCT00109343|561745835|FG002|Overall Study|Lost to Follow-up|14|||
155631519|NCT00109343|561745833|FG000|Overall Study|Protocol Violation|1|||
155631520|NCT00109343|561745834|FG001|Overall Study|Protocol Violation|2|||
155631521|NCT00109343|561745835|FG002|Overall Study|Protocol Violation|2|||
155631522|NCT00109343|561745833|FG000|Overall Study|Withdrawal by Subject|15|||
155631523|NCT00109343|561745834|FG001|Overall Study|Withdrawal by Subject|11|||
155734342|NCT00373113|562127082|FG001|Overall Study|Protocol Violation|1|||
155734343|NCT00373113|562127081|FG000|Overall Study|Withdrawal by Subject|10|||
155734344|NCT00373113|562127082|FG001|Overall Study|Withdrawal by Subject|15|||
155734345|NCT03275350|562127083|FG000|Overall Study|Lost to Follow-up|4|||
155734346|NCT03275350|562127084|FG001|Overall Study|Lost to Follow-up|6|||
155734347|NCT03275350|562127083|FG000|Overall Study|Death|2|||
155734348|NCT03275350|562127084|FG001|Overall Study|Death|1|||
155734349|NCT03275350|562127083|FG000|Overall Study|Physician Decision|1|||
155390455|NCT04343248|560864370|FG001|Overall Study|Withdrawal by Subject|6|||
155734350|NCT03275350|562127084|FG001|Overall Study|Physician Decision|0|||
155390456|NCT04343248|560864369|FG000|Overall Study|Death|1|||
155390457|NCT04343248|560864370|FG001|Overall Study|Death|2|||
155390458|NCT04343248|560864369|FG000|Overall Study|Lost to Follow-up|9|||
155390459|NCT04343248|560864370|FG001|Overall Study|Lost to Follow-up|6|||
155390460|NCT04343248|560864369|FG000|Overall Study|Physician Decision|0|||
155390461|NCT04343248|560864370|FG001|Overall Study|Physician Decision|1|||
155390462|NCT04343248|560864369|FG000|Overall Study|Adverse Event|1|||
155390463|NCT04343248|560864370|FG001|Overall Study|Adverse Event|0|||
155390464|NCT05245097|560864375|FG000|Overall Study|Adverse Event|13|||
155390465|NCT05245097|560864376|FG001|Overall Study|Adverse Event|2|||
155390466|NCT05245097|560864375|FG000|Overall Study|Protocol Violation|8|||
155390467|NCT05245097|560864376|FG001|Overall Study|Protocol Violation|6|||
155390468|NCT05245097|560864375|FG000|Overall Study|Withdrawal by Subject|18|||
155390469|NCT05245097|560864376|FG001|Overall Study|Withdrawal by Subject|0|||
155390470|NCT05245097|560864375|FG000|Overall Study|Death|6|||
155390471|NCT05245097|560864376|FG001|Overall Study|Death|7|||
155390472|NCT05245097|560864375|FG000|Overall Study|Physician Decision|6|||
155390473|NCT05245097|560864376|FG001|Overall Study|Physician Decision|0|||
155390474|NCT05245097|560864375|FG000|Overall Study|Relocation|4|||
155390475|NCT05245097|560864376|FG001|Overall Study|Relocation|3|||
155390476|NCT03604523|560864381|FG000|Overall Study|Physician Decision|1|||
155390477|NCT03604523|560864382|FG001|Overall Study|Physician Decision|0|||
155390478|NCT00458341|560864383|FG000|Cycle 1|Adverse Event|1|||
155390479|NCT00458341|560864384|FG001|Cycle 1|Adverse Event|0|||
155390480|NCT05461794|560864385|FG000|Overall Study|Withdrawal by Subject|1|||
155390481|NCT05461794|560864386|FG001|Overall Study|Withdrawal by Subject|1|||
155390482|NCT05461794|560864387|FG002|Overall Study|Withdrawal by Subject|3|||
155390483|NCT05461794|560864385|FG000|Overall Study|Study Terminated By Sponsor|18|||
155390484|NCT05461794|560864386|FG001|Overall Study|Study Terminated By Sponsor|13|||
155390485|NCT05461794|560864387|FG002|Overall Study|Study Terminated By Sponsor|16|||
155390486|NCT05461794|560864385|FG000|Overall Study|Death|20|||
155390487|NCT05461794|560864386|FG001|Overall Study|Death|5|||
155390488|NCT05461794|560864387|FG002|Overall Study|Death|19|||
155390489|NCT02730598|560864394|FG000|Overall Study|Withdrawal by Subject|3|||
155390490|NCT02730598|560864395|FG001|Overall Study|Withdrawal by Subject|3|||
155390491|NCT02730598|560864394|FG000|Overall Study|Protocol Violation|0|||
155390492|NCT02730598|560864395|FG001|Overall Study|Protocol Violation|1|||
155390493|NCT02730598|560864394|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
155390494|NCT02730598|560864395|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
155390495|NCT00810394|560864396|FG000|Overall Study|Withdrawal by Subject|3|||
155390496|NCT03254485|560864397|FG000|Overall Study|Adverse Event|3|||
155390497|NCT03254485|560864398|FG001|Overall Study|Adverse Event|0|||
155390498|NCT03254485|560864399|FG002|Overall Study|Adverse Event|0|||
155390499|NCT03254485|560864400|FG003|Overall Study|Adverse Event|6|||
155390500|NCT03254485|560864397|FG000|Overall Study|Protocol Violation|6|||
155390501|NCT03254485|560864398|FG001|Overall Study|Protocol Violation|0|||
155734351|NCT03275350|562127083|FG000|Overall Study|Incarcerated|1|||
155734352|NCT03275350|562127084|FG001|Overall Study|Incarcerated|1|||
155734353|NCT04661579|562127087|FG000|Overall Study|Lost to Follow-up|19|||
155734354|NCT04661579|562127088|FG001|Overall Study|Lost to Follow-up|10|||
155734355|NCT04661579|562127089|FG002|Overall Study|Lost to Follow-up|2|||
155734356|NCT04661579|562127090|FG003|Overall Study|Lost to Follow-up|7|||
155734357|NCT04661579|562127091|FG004|Overall Study|Lost to Follow-up|11|||
155734358|NCT04661579|562127087|FG000|Overall Study|Physician Decision|2|||
155734359|NCT04661579|562127088|FG001|Overall Study|Physician Decision|0|||
155734360|NCT04661579|562127089|FG002|Overall Study|Physician Decision|0|||
155734361|NCT04661579|562127090|FG003|Overall Study|Physician Decision|1|||
155734362|NCT04661579|562127091|FG004|Overall Study|Physician Decision|0|||
155390502|NCT03254485|560864399|FG002|Overall Study|Protocol Violation|0|||
155390503|NCT03254485|560864400|FG003|Overall Study|Protocol Violation|2|||
155390504|NCT03254485|560864397|FG000|Overall Study|Withdrawal by Subject|1|||
155390505|NCT03254485|560864398|FG001|Overall Study|Withdrawal by Subject|0|||
155390506|NCT03254485|560864399|FG002|Overall Study|Withdrawal by Subject|0|||
155390507|NCT03254485|560864400|FG003|Overall Study|Withdrawal by Subject|4|||
155390508|NCT03254485|560864397|FG000|Overall Study|Death|0|||
155390509|NCT03254485|560864398|FG001|Overall Study|Death|0|||
155390510|NCT03254485|560864399|FG002|Overall Study|Death|0|||
155390511|NCT03254485|560864400|FG003|Overall Study|Death|1|||
155390512|NCT03254485|560864397|FG000|Overall Study|Lost to Follow-up|1|||
155390513|NCT03254485|560864398|FG001|Overall Study|Lost to Follow-up|0|||
155390514|NCT03254485|560864399|FG002|Overall Study|Lost to Follow-up|0|||
155390515|NCT03254485|560864400|FG003|Overall Study|Lost to Follow-up|0|||
155734363|NCT04661579|562127087|FG000|Overall Study|Withdrawal by Subject|1|||
155734364|NCT04661579|562127088|FG001|Overall Study|Withdrawal by Subject|4|||
155390516|NCT03254485|560864397|FG000|Overall Study|Other|1|||
155390517|NCT03254485|560864398|FG001|Overall Study|Other|0|||
155390518|NCT03254485|560864399|FG002|Overall Study|Other|0|||
155390519|NCT03254485|560864400|FG003|Overall Study|Other|2|||
155734365|NCT04661579|562127089|FG002|Overall Study|Withdrawal by Subject|0|||
155734366|NCT04661579|562127090|FG003|Overall Study|Withdrawal by Subject|2|||
155281832|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
155281833|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
155281834|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
155281835|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
155281836|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
155281837|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
155281838|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
155281839|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
155281840|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
155281841|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
155281842|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
155281843|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
155281844|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
155281845|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
155281846|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
155281847|NCT02949271|560463938|FG000|Overall Study|Lack of Efficacy|5|||
155281848|NCT02949271|560463939|FG001|Overall Study|Lack of Efficacy|4|||
155281849|NCT02949271|560463938|FG000|Overall Study|Lost to Follow-up|3|||
155281850|NCT02949271|560463939|FG001|Overall Study|Lost to Follow-up|6|||
155281851|NCT02949271|560463938|FG000|Overall Study|Physician Decision|5|||
155281852|NCT02949271|560463939|FG001|Overall Study|Physician Decision|5|||
155281853|NCT02949271|560463938|FG000|Overall Study|Protocol Violation|6|||
155281854|NCT02949271|560463939|FG001|Overall Study|Protocol Violation|3|||
155281855|NCT02949271|560463938|FG000|Overall Study|Withdrawal by Subject|1|||
155281856|NCT02949271|560463939|FG001|Overall Study|Withdrawal by Subject|0|||
155281857|NCT02949271|560463938|FG000|Overall Study|Delivered prior to intervention|7|||
155281858|NCT02949271|560463939|FG001|Overall Study|Delivered prior to intervention|9|||
155281859|NCT02949271|560463938|FG000|Overall Study|Outside the window for cervical dilation|2|||
155281860|NCT02949271|560463939|FG001|Overall Study|Outside the window for cervical dilation|3|||
155281861|NCT02373813|560463942|FG000|Run-In Period|Other, Not Specified|5|||
155281862|NCT02373813|560463943|FG001|Run-In Period|Other, Not Specified|0|||
155281863|NCT02373813|560463944|FG002|Run-In Period|Other, Not Specified|0|||
155281864|NCT02373813|560463945|FG003|Run-In Period|Other, Not Specified|0|||
155281865|NCT02373813|560463942|FG000|Run-In Period|Withdrawal by Subject|16|||
155281866|NCT02373813|560463943|FG001|Run-In Period|Withdrawal by Subject|0|||
155281867|NCT02373813|560463944|FG002|Run-In Period|Withdrawal by Subject|0|||
155281868|NCT02373813|560463945|FG003|Run-In Period|Withdrawal by Subject|0|||
155281869|NCT02373813|560463942|FG000|Run-In Period|Decision by Sponsor|11|||
155281870|NCT02373813|560463943|FG001|Run-In Period|Decision by Sponsor|0|||
155281871|NCT02373813|560463944|FG002|Run-In Period|Decision by Sponsor|0|||
155281872|NCT02373813|560463945|FG003|Run-In Period|Decision by Sponsor|0|||
155281873|NCT02373813|560463942|FG000|Run-In Period|Protocol Violation|75|||
155281874|NCT02373813|560463943|FG001|Run-In Period|Protocol Violation|0|||
155281875|NCT02373813|560463944|FG002|Run-In Period|Protocol Violation|0|||
155281876|NCT02373813|560463945|FG003|Run-In Period|Protocol Violation|0|||
155281877|NCT02373813|560463942|FG000|Run-In Period|Lost to Follow-up|2|||
155281878|NCT02373813|560463943|FG001|Run-In Period|Lost to Follow-up|0|||
155281879|NCT02373813|560463944|FG002|Run-In Period|Lost to Follow-up|0|||
155281880|NCT02373813|560463945|FG003|Run-In Period|Lost to Follow-up|0|||
155281881|NCT02373813|560463942|FG000|Run-In Period|Adverse Event|3|||
155281882|NCT02373813|560463943|FG001|Run-In Period|Adverse Event|0|||
155281883|NCT02373813|560463944|FG002|Run-In Period|Adverse Event|0|||
155281884|NCT02373813|560463945|FG003|Run-In Period|Adverse Event|0|||
155281885|NCT02373813|560463942|FG000|Run-In Period|Noncompliance|1|||
155281886|NCT02373813|560463943|FG001|Run-In Period|Noncompliance|0|||
155281887|NCT02373813|560463944|FG002|Run-In Period|Noncompliance|0|||
155281888|NCT02373813|560463945|FG003|Run-In Period|Noncompliance|0|||
155281889|NCT02373813|560463942|FG000|Run-In Period|Ineligibility Determined|3|||
155281890|NCT02373813|560463943|FG001|Run-In Period|Ineligibility Determined|0|||
155281891|NCT02373813|560463944|FG002|Run-In Period|Ineligibility Determined|0|||
155281892|NCT02373813|560463945|FG003|Run-In Period|Ineligibility Determined|0|||
155281893|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
155281894|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
155281895|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
155281896|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
155281897|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155281898|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
155281899|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
155281900|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
155281901|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155281902|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155281903|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
155281904|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
155390520|NCT00467285|560864401|FG000|Overall Study|Lost to Follow-up|4|||
155390521|NCT00467285|560864402|FG001|Overall Study|Lost to Follow-up|4|||
155734367|NCT04661579|562127091|FG004|Overall Study|Withdrawal by Subject|0|||
155390522|NCT03891524|560864403|FG000|Overall Study|Death|0|||
155390523|NCT03891524|560864404|FG001|Overall Study|Death|0|||
155390524|NCT03891524|560864405|FG002|Overall Study|Death|0|||
155390525|NCT03891524|560864406|FG003|Overall Study|Death|0|||
155390526|NCT03891524|560864407|FG004|Overall Study|Death|0|||
155390527|NCT03891524|560864408|FG005|Overall Study|Death|0|||
155390528|NCT03891524|560864409|FG006|Overall Study|Death|0|||
155390529|NCT03891524|560864410|FG007|Overall Study|Death|1|||
155390530|NCT03891524|560864403|FG000|Overall Study|Withdrawal by Subject|0|||
155390531|NCT03891524|560864404|FG001|Overall Study|Withdrawal by Subject|1|||
155390532|NCT03891524|560864405|FG002|Overall Study|Withdrawal by Subject|2|||
155390533|NCT03891524|560864406|FG003|Overall Study|Withdrawal by Subject|1|||
155390534|NCT03891524|560864407|FG004|Overall Study|Withdrawal by Subject|2|||
155390535|NCT03891524|560864408|FG005|Overall Study|Withdrawal by Subject|2|||
155390536|NCT03891524|560864409|FG006|Overall Study|Withdrawal by Subject|2|||
155390537|NCT03891524|560864410|FG007|Overall Study|Withdrawal by Subject|1|||
155390538|NCT02958267|560864412|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
155390539|NCT02958267|560864413|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
155734368|NCT04661579|562127087|FG000|Overall Study|Death|1|||
155734369|NCT04661579|562127088|FG001|Overall Study|Death|0|||
155734370|NCT04661579|562127089|FG002|Overall Study|Death|0|||
155390540|NCT02958267|560864412|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
155390541|NCT02958267|560864413|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
155390542|NCT02958267|560864412|FG000|Follow-up Visits|Additional treatment pursued|2|||
155390543|NCT02958267|560864413|FG001|Follow-up Visits|Additional treatment pursued|1|||
155390544|NCT00475033|560864414|FG000|Infant Series|Failed to return|3|||
155390545|NCT00475033|560864415|FG001|Infant Series|Failed to return|4|||
155390546|NCT00475033|560864414|FG000|Infant Series|Parent or legal guardian request|1|||
155390547|NCT00475033|560864415|FG001|Infant Series|Parent or legal guardian request|5|||
155390548|NCT00475033|560864414|FG000|Infant Series|Protocol Violation|1|||
155390549|NCT00475033|560864415|FG001|Infant Series|Protocol Violation|2|||
155390550|NCT00475033|560864414|FG000|Infant Series|Lost to Follow-up|2|||
155390551|NCT00475033|560864415|FG001|Infant Series|Lost to Follow-up|0|||
155390552|NCT00475033|560864414|FG000|Infant Series|Adverse Event|0|||
155390553|NCT00475033|560864415|FG001|Infant Series|Adverse Event|2|||
155390554|NCT00475033|560864414|FG000|After the Infant Series|Adverse Event|0|||
155390555|NCT00475033|560864415|FG001|After the Infant Series|Adverse Event|4|||
155390556|NCT00475033|560864414|FG000|After the Infant Series|Parent or legal guardian request|2|||
155390557|NCT00475033|560864415|FG001|After the Infant Series|Parent or legal guardian request|2|||
155390558|NCT00475033|560864414|FG000|After the Infant Series|Failed to return|2|||
155390559|NCT00475033|560864415|FG001|After the Infant Series|Failed to return|1|||
155390560|NCT00475033|560864414|FG000|After the Infant Series|Protocol Violation|1|||
155390561|NCT00475033|560864415|FG001|After the Infant Series|Protocol Violation|0|||
155390562|NCT00475033|560864414|FG000|After the Infant Series|Lost to Follow-up|1|||
155390563|NCT00475033|560864415|FG001|After the Infant Series|Lost to Follow-up|0|||
155390564|NCT00475033|560864414|FG000|After the Infant Series|Other|0|||
155390565|NCT00475033|560864415|FG001|After the Infant Series|Other|1|||
155390566|NCT00475033|560864414|FG000|Toddler Dose|Parent or legal guardian request|2|||
155390567|NCT00475033|560864415|FG001|Toddler Dose|Parent or legal guardian request|0|||
155390568|NCT00475033|560864414|FG000|Toddler Dose|Failed to return|1|||
155390569|NCT00475033|560864415|FG001|Toddler Dose|Failed to return|0|||
155390570|NCT00475033|560864414|FG000|Toddler Dose|Lost to Follow-up|1|||
155390571|NCT00475033|560864415|FG001|Toddler Dose|Lost to Follow-up|0|||
155390572|NCT00047320|560864416|FG000|Overall Study|Lack of Efficacy|8|||
155390573|NCT00047320|560864416|FG000|Overall Study|Lost to Follow-up|1|||
155390574|NCT00047320|560864416|FG000|Overall Study|Physician Decision|8|||
155390575|NCT00047320|560864416|FG000|Overall Study|Withdrawal by Subject|9|||
155390576|NCT00047320|560864416|FG000|Overall Study|Ineligible|2|||
155390577|NCT04821869|560864417|FG000|Overall Study|Adverse Event|4|||
155390578|NCT04821869|560864417|FG000|Overall Study|Withdrawal by Subject|2|||
155390579|NCT04821869|560864417|FG000|Overall Study|Did not meet FEV1 criteria|1|||
155390580|NCT04614662|560865766|FG000|Overall Study|Withdrawal by Subject|0|||
155390581|NCT04614662|560865767|FG001|Overall Study|Withdrawal by Subject|1|||
155390582|NCT01603082|560865768|FG000|Overall Study|Adverse Event|0|||
155390583|NCT01603082|560865769|FG001|Overall Study|Adverse Event|1|||
155734371|NCT04661579|562127090|FG003|Overall Study|Death|0|||
155390584|NCT01603082|560865768|FG000|Overall Study|Withdrawal by Subject|1|||
155734372|NCT04661579|562127091|FG004|Overall Study|Death|0|||
155390585|NCT01603082|560865769|FG001|Overall Study|Withdrawal by Subject|0|||
155390586|NCT01603082|560865768|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
155390587|NCT01603082|560865769|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
155390588|NCT01862640|560865778|FG000|Overall Study|Adverse Event|4|||
155390589|NCT01862640|560865779|FG001|Overall Study|Adverse Event|10|||
155390590|NCT01862640|560865780|FG002|Overall Study|Adverse Event|6|||
155734373|NCT04661579|562127087|FG000|Overall Study|Other|1|||
155734374|NCT04661579|562127088|FG001|Overall Study|Other|2|||
155734375|NCT04661579|562127089|FG002|Overall Study|Other|1|||
155734376|NCT04661579|562127090|FG003|Overall Study|Other|1|||
155734377|NCT04661579|562127091|FG004|Overall Study|Other|1|||
155734378|NCT04661579|562127087|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
155734379|NCT04661579|562127088|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
155734380|NCT04661579|562127089|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
155734381|NCT04661579|562127090|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
155734382|NCT04661579|562127091|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
155734383|NCT03656562|562127092|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
155734384|NCT03656562|562127093|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
155734385|NCT03656562|562127094|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
155734386|NCT03656562|562127095|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
155734387|NCT03656562|562127092|FG000|Overall Study|Physician Decision|1|||
155734388|NCT03656562|562127093|FG001|Overall Study|Physician Decision|2|||
155734389|NCT03656562|562127094|FG002|Overall Study|Physician Decision|0|||
155390591|NCT01862640|560865781|FG003|Overall Study|Adverse Event|8|||
155390592|NCT01862640|560865778|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155734390|NCT03656562|562127095|FG003|Overall Study|Physician Decision|0|||
155734391|NCT03656562|562127092|FG000|Overall Study|Subject Decision|3|||
155734392|NCT03656562|562127093|FG001|Overall Study|Subject Decision|5|||
155734393|NCT03656562|562127094|FG002|Overall Study|Subject Decision|0|||
155734394|NCT03656562|562127095|FG003|Overall Study|Subject Decision|2|||
155734395|NCT04335136|562127096|FG000|Overall Study|Death|8|||
155734396|NCT04335136|562127097|FG001|Overall Study|Death|4|||
155734397|NCT04335136|562127096|FG000|Overall Study|Lost to Follow-up|2|||
155734398|NCT04335136|562127097|FG001|Overall Study|Lost to Follow-up|0|||
155734399|NCT04335136|562127096|FG000|Overall Study|Protocol Violation|1|||
155734400|NCT04335136|562127097|FG001|Overall Study|Protocol Violation|0|||
155390593|NCT01862640|560865779|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
155390594|NCT01862640|560865780|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
155390595|NCT01862640|560865781|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155390596|NCT01862640|560865778|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
155390597|NCT01862640|560865779|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
155390598|NCT01862640|560865780|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
155390599|NCT01862640|560865781|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
155390600|NCT01862640|560865778|FG000|Overall Study|Withdrawal by Subject|2|||
155390601|NCT01862640|560865779|FG001|Overall Study|Withdrawal by Subject|4|||
155390602|NCT01862640|560865780|FG002|Overall Study|Withdrawal by Subject|8|||
155390603|NCT01862640|560865781|FG003|Overall Study|Withdrawal by Subject|5|||
155390604|NCT01862640|560865778|FG000|Overall Study|Protocol Deviation|0|||
155390605|NCT01862640|560865779|FG001|Overall Study|Protocol Deviation|0|||
155390606|NCT01862640|560865780|FG002|Overall Study|Protocol Deviation|1|||
155390607|NCT01862640|560865781|FG003|Overall Study|Protocol Deviation|0|||
155390608|NCT05085665|560865782|FG000|Overall Study|Physician Decision|2|||
155390609|NCT01774084|560865783|FG000|Overall Study|Personal reasons|1|||
155390610|NCT01774084|560865784|FG001|Overall Study|Personal reasons|0|||
155390611|NCT03026127|560865785|FG000|CRISP R61|Adverse Event|5|||
155390612|NCT03026127|560865786|FG001|CRISP R61|Adverse Event|0|||
155390613|NCT03026127|560865787|FG002|CRISP R61|Adverse Event|0|||
155390614|NCT03026127|560865785|FG000|CRISP R61|Lost to Follow-up|2|||
155390615|NCT03026127|560865786|FG001|CRISP R61|Lost to Follow-up|0|||
155390616|NCT03026127|560865787|FG002|CRISP R61|Lost to Follow-up|0|||
155390617|NCT03026127|560865785|FG000|CRISP R61|Dropped before therapy|5|||
155734401|NCT04335136|562127096|FG000|Overall Study|Withdrawal by Subject|1|||
155734402|NCT04335136|562127097|FG001|Overall Study|Withdrawal by Subject|1|||
155734403|NCT04335136|562127096|FG000|Overall Study|Health-threatening condition|0|||
155734404|NCT04335136|562127097|FG001|Overall Study|Health-threatening condition|1|||
155734405|NCT04335136|562127096|FG000|Overall Study|Adverse Event|0|||
155734406|NCT04335136|562127097|FG001|Overall Study|Adverse Event|1|||
155281905|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155281906|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
155281907|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
155281908|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
155281909|NCT01511536|560463947|FG000|Phase 1|Other|0|||
155281910|NCT01511536|560463948|FG001|Phase 1|Other|1|||
155281911|NCT01511536|560463949|FG002|Phase 1|Other|0|||
155281912|NCT01511536|560463947|FG000|Phase 2|Other|0|||
155281913|NCT01511536|560463948|FG001|Phase 2|Other|0|||
155281914|NCT01511536|560463949|FG002|Phase 2|Other|9|||
155281915|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
155390618|NCT03026127|560865786|FG001|CRISP R61|Dropped before therapy|0|||
155390619|NCT03026127|560865787|FG002|CRISP R61|Dropped before therapy|0|||
155390620|NCT03026127|560865785|FG000|CRISP R33|Lost to Follow-up|0|||
155390621|NCT03026127|560865786|FG001|CRISP R33|Lost to Follow-up|5|||
155390622|NCT03026127|560865787|FG002|CRISP R33|Lost to Follow-up|4|||
155390623|NCT03026127|560865785|FG000|CRISP R33|Adverse Event|0|||
155390624|NCT03026127|560865786|FG001|CRISP R33|Adverse Event|9|||
155390625|NCT03026127|560865787|FG002|CRISP R33|Adverse Event|5|||
155390626|NCT03026127|560865785|FG000|CRISP R33|Withdrawal by Subject|0|||
155390627|NCT03026127|560865786|FG001|CRISP R33|Withdrawal by Subject|9|||
155390628|NCT03026127|560865787|FG002|CRISP R33|Withdrawal by Subject|1|||
155631524|NCT00109343|561745835|FG002|Overall Study|Withdrawal by Subject|10|||
155631525|NCT00109343|561745833|FG000|Overall Study|Subject Moved|6|||
155631526|NCT00109343|561745834|FG001|Overall Study|Subject Moved|2|||
155631527|NCT00109343|561745835|FG002|Overall Study|Subject Moved|1|||
155631528|NCT00109343|561745833|FG000|Overall Study|Other|5|||
155631529|NCT00109343|561745834|FG001|Overall Study|Other|2|||
155631530|NCT00109343|561745835|FG002|Overall Study|Other|1|||
155631531|NCT01721798|561745838|FG000|Overall Study|Death|0|||
155631532|NCT01721798|561745839|FG001|Overall Study|Death|0|||
155631533|NCT01721798|561745840|FG002|Overall Study|Death|1|||
155631534|NCT01721798|561745841|FG003|Overall Study|Death|1|||
155631535|NCT01721798|561745838|FG000|Overall Study|Lost to Follow-up|2|||
155631536|NCT01721798|561745839|FG001|Overall Study|Lost to Follow-up|2|||
155631537|NCT01721798|561745840|FG002|Overall Study|Lost to Follow-up|9|||
155631538|NCT01721798|561745841|FG003|Overall Study|Lost to Follow-up|9|||
155631539|NCT01721798|561745838|FG000|Overall Study|Pregnancy|0|||
155631540|NCT01721798|561745839|FG001|Overall Study|Pregnancy|0|||
155631541|NCT01721798|561745840|FG002|Overall Study|Pregnancy|1|||
155631542|NCT01721798|561745841|FG003|Overall Study|Pregnancy|1|||
155631543|NCT01721798|561745838|FG000|Overall Study|Withdrawal by Subject|1|||
155631544|NCT01721798|561745839|FG001|Overall Study|Withdrawal by Subject|0|||
155631545|NCT01721798|561745840|FG002|Overall Study|Withdrawal by Subject|2|||
155631546|NCT01721798|561745841|FG003|Overall Study|Withdrawal by Subject|1|||
155631547|NCT01721798|561745838|FG000|Overall Study|Not eligible for 24 month visit|1|||
155631548|NCT01721798|561745839|FG001|Overall Study|Not eligible for 24 month visit|0|||
155631549|NCT01721798|561745840|FG002|Overall Study|Not eligible for 24 month visit|8|||
155631550|NCT01721798|561745841|FG003|Overall Study|Not eligible for 24 month visit|7|||
155631551|NCT00715208|561745842|FG000|Overall Study|Withdrawal by Subject|1|||
155631552|NCT00715208|561745843|FG001|Overall Study|Withdrawal by Subject|1|||
155631553|NCT00715208|561745842|FG000|Overall Study|Adverse Event|0|||
155631554|NCT00715208|561745843|FG001|Overall Study|Adverse Event|6|||
155631555|NCT00715208|561745842|FG000|Overall Study|Lack of Efficacy|0|||
155631556|NCT00715208|561745843|FG001|Overall Study|Lack of Efficacy|2|||
155631557|NCT00076570|561745844|FG000|Overall Study|Drug intolerance|8|||
155631558|NCT00076570|561745845|FG001|Overall Study|Drug intolerance|8|||
155631559|NCT00903968|561745846|FG000|Overall Study|Adverse Event|0|||
155631560|NCT00903968|561745847|FG001|Overall Study|Adverse Event|0|||
155631561|NCT00903968|561745848|FG002|Overall Study|Adverse Event|0|||
155631562|NCT00903968|561745849|FG003|Overall Study|Adverse Event|0|||
155631563|NCT00903968|561745850|FG004|Overall Study|Adverse Event|0|||
155631564|NCT00903968|561745851|FG005|Overall Study|Adverse Event|0|||
155631565|NCT00903968|561745852|FG006|Overall Study|Adverse Event|1|||
155631566|NCT00903968|561745853|FG007|Overall Study|Adverse Event|8|||
155631567|NCT00903968|561745846|FG000|Overall Study|DLT|0|||
155631568|NCT00903968|561745847|FG001|Overall Study|DLT|0|||
155631569|NCT00903968|561745848|FG002|Overall Study|DLT|0|||
155631570|NCT00903968|561745849|FG003|Overall Study|DLT|0|||
155631571|NCT00903968|561745850|FG004|Overall Study|DLT|0|||
155631572|NCT00903968|561745851|FG005|Overall Study|DLT|0|||
155631573|NCT00903968|561745852|FG006|Overall Study|DLT|2|||
155631574|NCT00903968|561745853|FG007|Overall Study|DLT|0|||
155631575|NCT00903968|561745846|FG000|Overall Study|Withdrawal by Subject|1|||
155631576|NCT00903968|561745847|FG001|Overall Study|Withdrawal by Subject|0|||
155631577|NCT00903968|561745848|FG002|Overall Study|Withdrawal by Subject|1|||
155631578|NCT00903968|561745849|FG003|Overall Study|Withdrawal by Subject|0|||
155631579|NCT00903968|561745850|FG004|Overall Study|Withdrawal by Subject|1|||
155631580|NCT00903968|561745851|FG005|Overall Study|Withdrawal by Subject|1|||
155631581|NCT00903968|561745852|FG006|Overall Study|Withdrawal by Subject|0|||
155631582|NCT00903968|561745853|FG007|Overall Study|Withdrawal by Subject|4|||
155631583|NCT00903968|561745846|FG000|Overall Study|Non-Compliance|0|||
155631584|NCT00903968|561745847|FG001|Overall Study|Non-Compliance|0|||
155631585|NCT00903968|561745848|FG002|Overall Study|Non-Compliance|0|||
155631586|NCT00903968|561745849|FG003|Overall Study|Non-Compliance|0|||
155631587|NCT00903968|561745850|FG004|Overall Study|Non-Compliance|0|||
155631588|NCT00903968|561745851|FG005|Overall Study|Non-Compliance|1|||
155390629|NCT03026127|560865785|FG000|CRISP R33|Lack of Efficacy|0|||
155631589|NCT00903968|561745852|FG006|Overall Study|Non-Compliance|0|||
155631590|NCT00903968|561745853|FG007|Overall Study|Non-Compliance|0|||
155390630|NCT03026127|560865786|FG001|CRISP R33|Lack of Efficacy|3|||
155390631|NCT03026127|560865787|FG002|CRISP R33|Lack of Efficacy|2|||
155631591|NCT00903968|561745846|FG000|Overall Study|Physician Decision|0|||
155631592|NCT00903968|561745847|FG001|Overall Study|Physician Decision|0|||
155631593|NCT00903968|561745848|FG002|Overall Study|Physician Decision|0|||
155631594|NCT00903968|561745849|FG003|Overall Study|Physician Decision|0|||
155631595|NCT00903968|561745850|FG004|Overall Study|Physician Decision|0|||
155390632|NCT03026127|560865785|FG000|CRISP R33|Physician Decision|0|||
155390633|NCT03026127|560865786|FG001|CRISP R33|Physician Decision|3|||
155390634|NCT03026127|560865787|FG002|CRISP R33|Physician Decision|1|||
155390635|NCT03026127|560865785|FG000|CRISP R33|Transportation|0|||
155390636|NCT03026127|560865786|FG001|CRISP R33|Transportation|2|||
155390637|NCT03026127|560865787|FG002|CRISP R33|Transportation|1|||
155390638|NCT03027557|560865788|FG000|Overall Study|Adverse Event|1|||
155390639|NCT03027557|560865789|FG001|Overall Study|Adverse Event|0|||
155390640|NCT03027557|560865790|FG002|Overall Study|Adverse Event|0|||
155390641|NCT01699789|560865793|FG000|Overall Study|Withdrawal by Subject|18|||
155390642|NCT01699789|560865794|FG001|Overall Study|Withdrawal by Subject|23|||
155390643|NCT01699789|560865793|FG000|Overall Study|Death|1|||
155390644|NCT01699789|560865794|FG001|Overall Study|Death|2|||
155390645|NCT01699789|560865793|FG000|Overall Study|Lost to Follow-up|83|||
155390646|NCT01699789|560865794|FG001|Overall Study|Lost to Follow-up|101|||
155390647|NCT04226833|560865797|FG000|Overall Study|Death|0|||
155390648|NCT04226833|560865798|FG001|Overall Study|Death|0|||
155390649|NCT04226833|560865799|FG002|Overall Study|Death|1|||
155390650|NCT04226833|560865800|FG003|Overall Study|Death|0|||
155390651|NCT00364156|560865803|FG000|Overall Study|Withdrawal by Subject|73|||
155390652|NCT00364156|560865804|FG001|Overall Study|Withdrawal by Subject|80|||
155390653|NCT00364156|560865803|FG000|Overall Study|Protocol Violation|6|||
155390654|NCT00364156|560865804|FG001|Overall Study|Protocol Violation|1|||
155390655|NCT01050205|560865805|FG000|Overall Study|Lost to Follow-up|7|||
155390656|NCT01050205|560865806|FG001|Overall Study|Lost to Follow-up|1|||
155390657|NCT01050205|560865805|FG000|Overall Study|Withdrawal by Subject|1|||
155390658|NCT01050205|560865806|FG001|Overall Study|Withdrawal by Subject|1|||
155390659|NCT01050205|560865805|FG000|Overall Study|Relocated from area|1|||
155390660|NCT01050205|560865806|FG001|Overall Study|Relocated from area|2|||
155390661|NCT01050205|560865805|FG000|Overall Study|Discontinued Intervention|2|||
155390662|NCT01050205|560865806|FG001|Overall Study|Discontinued Intervention|0|||
155390663|NCT00403754|560865809|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
155390664|NCT00403754|560865810|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
155390665|NCT00403754|560865811|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
155390666|NCT00403754|560865812|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
155390667|NCT00403754|560865809|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
155390668|NCT00403754|560865810|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
155390669|NCT00403754|560865811|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
155390670|NCT00403754|560865812|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
155390671|NCT01891721|560865817|FG000|Overall Study|Lost to Follow-up|10|||
155390672|NCT01891721|560865818|FG001|Overall Study|Lost to Follow-up|5|||
155390673|NCT01891721|560865819|FG002|Overall Study|Lost to Follow-up|1|||
155390674|NCT00633061|560865820|FG000|Overall Study|Study closed|86|||
155390675|NCT00633061|560865821|FG001|Overall Study|Study closed|0|||
155390676|NCT02000427|560865822|FG000|Overall Study|Death|22|||
155390677|NCT02708095|560865823|FG000|Overall Study|Adverse Event|4|||
155390678|NCT02708095|560865824|FG001|Overall Study|Adverse Event|10|||
155390679|NCT02708095|560865825|FG002|Overall Study|Adverse Event|11|||
155390680|NCT02708095|560865823|FG000|Overall Study|Lack of Efficacy|9|||
155390681|NCT02708095|560865824|FG001|Overall Study|Lack of Efficacy|3|||
155390682|NCT02708095|560865825|FG002|Overall Study|Lack of Efficacy|0|||
155390683|NCT02708095|560865823|FG000|Overall Study|Lost to Follow-up|2|||
155390684|NCT02708095|560865824|FG001|Overall Study|Lost to Follow-up|0|||
155390685|NCT02708095|560865825|FG002|Overall Study|Lost to Follow-up|0|||
155390686|NCT02708095|560865823|FG000|Overall Study|Physician Decision|2|||
155390687|NCT02708095|560865824|FG001|Overall Study|Physician Decision|3|||
155390688|NCT02708095|560865825|FG002|Overall Study|Physician Decision|2|||
155390689|NCT02708095|560865823|FG000|Overall Study|Protocol Violation|0|||
155390690|NCT02708095|560865824|FG001|Overall Study|Protocol Violation|0|||
155390691|NCT02708095|560865825|FG002|Overall Study|Protocol Violation|1|||
155390692|NCT02708095|560865823|FG000|Overall Study|Withdrawal by Subject|5|||
155390693|NCT02708095|560865824|FG001|Overall Study|Withdrawal by Subject|3|||
155631596|NCT00903968|561745851|FG005|Overall Study|Physician Decision|1|||
155631597|NCT00903968|561745852|FG006|Overall Study|Physician Decision|0|||
155631598|NCT00903968|561745853|FG007|Overall Study|Physician Decision|0|||
155631599|NCT00903968|561745846|FG000|Overall Study|Progressive Disease|2|||
155390694|NCT02708095|560865825|FG002|Overall Study|Withdrawal by Subject|4|||
155390695|NCT05125679|560865826|FG000|Overall Study|Study Terminated by Sponsor|2|||
155390696|NCT05125679|560865827|FG001|Overall Study|Study Terminated by Sponsor|5|||
155390697|NCT03829319|560865840|FG000|Overall Study|Sponsor's Decision|4|||
155390698|NCT03829319|560865841|FG001|Overall Study|Sponsor's Decision|90|||
155390699|NCT03829319|560865842|FG002|Overall Study|Sponsor's Decision|102|||
155390700|NCT03829319|560865840|FG000|Overall Study|Withdrawal by Subject|1|||
155390701|NCT03829319|560865841|FG001|Overall Study|Withdrawal by Subject|5|||
155390702|NCT03829319|560865842|FG002|Overall Study|Withdrawal by Subject|4|||
155390703|NCT03829319|560865840|FG000|Overall Study|Physician Decision|0|||
155390704|NCT03829319|560865841|FG001|Overall Study|Physician Decision|3|||
155390705|NCT03829319|560865842|FG002|Overall Study|Physician Decision|0|||
155390706|NCT03829319|560865840|FG000|Overall Study|Lost to Follow-up|0|||
155390707|NCT03829319|560865841|FG001|Overall Study|Lost to Follow-up|0|||
155281916|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
155281917|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
155281918|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
155281919|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
155281920|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
155281921|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
155281922|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
155281923|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
155281924|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
155281925|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
155281926|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
155281927|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
155281928|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
155281929|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
155281930|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
155281931|NCT02703532|560463956|FG000|Overall Study|Withdrawal by Subject|0|||
155281932|NCT02703532|560463957|FG001|Overall Study|Withdrawal by Subject|1|||
155281933|NCT02703532|560463958|FG002|Overall Study|Withdrawal by Subject|0|||
155281934|NCT02703532|560463959|FG003|Overall Study|Withdrawal by Subject|1|||
155281935|NCT02703532|560463956|FG000|Overall Study|Lost to Follow-up|2|||
155281936|NCT02703532|560463957|FG001|Overall Study|Lost to Follow-up|0|||
155631600|NCT00903968|561745847|FG001|Overall Study|Progressive Disease|3|||
155631601|NCT00903968|561745848|FG002|Overall Study|Progressive Disease|2|||
155631602|NCT00903968|561745849|FG003|Overall Study|Progressive Disease|3|||
155631603|NCT00903968|561745850|FG004|Overall Study|Progressive Disease|3|||
155631604|NCT00903968|561745851|FG005|Overall Study|Progressive Disease|3|||
155631605|NCT00903968|561745852|FG006|Overall Study|Progressive Disease|0|||
155631606|NCT00903968|561745853|FG007|Overall Study|Progressive Disease|18|||
155631607|NCT00903968|561745846|FG000|Overall Study|Lack of Efficacy|0|||
155631608|NCT00903968|561745847|FG001|Overall Study|Lack of Efficacy|0|||
155631609|NCT00903968|561745848|FG002|Overall Study|Lack of Efficacy|0|||
155631610|NCT00903968|561745849|FG003|Overall Study|Lack of Efficacy|0|||
155631611|NCT00903968|561745850|FG004|Overall Study|Lack of Efficacy|0|||
155631612|NCT00903968|561745851|FG005|Overall Study|Lack of Efficacy|0|||
155631613|NCT00903968|561745852|FG006|Overall Study|Lack of Efficacy|0|||
155631614|NCT00903968|561745853|FG007|Overall Study|Lack of Efficacy|3|||
155631615|NCT01983930|561745859|FG000|Overall Study|Withdrawal by Subject|9|||
155631616|NCT01983930|561745860|FG001|Overall Study|Withdrawal by Subject|8|||
155631617|NCT01983930|561745859|FG000|Overall Study|Adverse Event|0|||
155631618|NCT01983930|561745860|FG001|Overall Study|Adverse Event|1|||
155631619|NCT00393367|561745861|FG000|Overall Study|Protocol Violation|2|||
155631620|NCT00393367|561745862|FG001|Overall Study|Protocol Violation|5|||
155631621|NCT00393367|561745861|FG000|Overall Study|Withdrawal by Subject|0|||
155631622|NCT00393367|561745862|FG001|Overall Study|Withdrawal by Subject|2|||
155631623|NCT01027949|561745865|FG000|Overall Study|Death|174|||
155281937|NCT02703532|560463958|FG002|Overall Study|Lost to Follow-up|2|||
155281938|NCT02703532|560463959|FG003|Overall Study|Lost to Follow-up|0|||
155281939|NCT03738241|560463960|FG000|Overall Study|Withdrawal by Subject|0|||
155281940|NCT03738241|560463961|FG001|Overall Study|Withdrawal by Subject|0|||
155281941|NCT03738241|560463962|FG002|Overall Study|Withdrawal by Subject|0|||
155281942|NCT03738241|560463963|FG003|Overall Study|Withdrawal by Subject|0|||
155281943|NCT03738241|560463964|FG004|Overall Study|Withdrawal by Subject|0|||
155281944|NCT03738241|560463965|FG005|Overall Study|Withdrawal by Subject|0|||
155281945|NCT03738241|560463966|FG006|Overall Study|Withdrawal by Subject|0|||
155281946|NCT03738241|560463967|FG007|Overall Study|Withdrawal by Subject|0|||
155281947|NCT03738241|560463968|FG008|Overall Study|Withdrawal by Subject|0|||
155281948|NCT03738241|560463969|FG009|Overall Study|Withdrawal by Subject|1|||
155281949|NCT03738241|560463960|FG000|Overall Study|Physician Decision|0|||
155281950|NCT03738241|560463961|FG001|Overall Study|Physician Decision|0|||
155281951|NCT03738241|560463962|FG002|Overall Study|Physician Decision|0|||
155281952|NCT03738241|560463963|FG003|Overall Study|Physician Decision|0|||
155281953|NCT03738241|560463964|FG004|Overall Study|Physician Decision|0|||
155281954|NCT03738241|560463965|FG005|Overall Study|Physician Decision|0|||
155281955|NCT03738241|560463966|FG006|Overall Study|Physician Decision|0|||
155281956|NCT03738241|560463967|FG007|Overall Study|Physician Decision|0|||
155281957|NCT03738241|560463968|FG008|Overall Study|Physician Decision|1|||
155281958|NCT03738241|560463969|FG009|Overall Study|Physician Decision|0|||
155281959|NCT03738241|560463960|FG000|Overall Study|Adverse Event|1|||
155281960|NCT03738241|560463961|FG001|Overall Study|Adverse Event|0|||
155390708|NCT03829319|560865842|FG002|Overall Study|Lost to Follow-up|1|||
155631624|NCT01027949|561745865|FG000|Overall Study|Progressive Disease|163|||
155631625|NCT01027949|561745865|FG000|Overall Study|Adverse Event|172|||
155281961|NCT03738241|560463962|FG002|Overall Study|Adverse Event|0|||
155631626|NCT01027949|561745865|FG000|Overall Study|Withdrawal by Subject|113|||
155734407|NCT04335136|562127096|FG000|Overall Study|Erroneously randomized|2|||
155390709|NCT03829319|560865840|FG000|Overall Study|Death|8|||
155390710|NCT03829319|560865841|FG001|Overall Study|Death|277|||
155390711|NCT03829319|560865842|FG002|Overall Study|Death|266|||
155390712|NCT01210118|560865847|FG000|Overall Study|Lost to Follow-up|1|||
155390713|NCT01210118|560865848|FG001|Overall Study|Lost to Follow-up|1|||
155390714|NCT01210118|560865847|FG000|Overall Study|Protocol Violation|1|||
155734408|NCT04335136|562127097|FG001|Overall Study|Erroneously randomized|0|||
155734409|NCT01396447|562127098|FG000|Overall Study|Did Not Receive Treatment|3|||
155734410|NCT01396447|562127099|FG001|Overall Study|Did Not Receive Treatment|2|||
155734411|NCT01396447|562127100|FG002|Overall Study|Did Not Receive Treatment|1|||
155734412|NCT01396447|562127101|FG003|Overall Study|Did Not Receive Treatment|0|||
155734413|NCT01396447|562127098|FG000|Overall Study|Adverse Event|15|||
155734414|NCT01396447|562127099|FG001|Overall Study|Adverse Event|12|||
155734415|NCT01396447|562127100|FG002|Overall Study|Adverse Event|12|||
155734416|NCT01396447|562127101|FG003|Overall Study|Adverse Event|17|||
155734417|NCT01396447|562127098|FG000|Overall Study|Insufficient Therapeutic Response|5|||
155734418|NCT01396447|562127099|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155734419|NCT01396447|562127100|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155734420|NCT01396447|562127101|FG003|Overall Study|Insufficient Therapeutic Response|4|||
155734421|NCT01396447|562127098|FG000|Overall Study|Protocol Violation|5|||
155734422|NCT01396447|562127099|FG001|Overall Study|Protocol Violation|2|||
155734423|NCT01396447|562127100|FG002|Overall Study|Protocol Violation|3|||
155734424|NCT01396447|562127101|FG003|Overall Study|Protocol Violation|7|||
155734425|NCT01396447|562127098|FG000|Overall Study|Withdrawal of Consent|11|||
155734426|NCT01396447|562127099|FG001|Overall Study|Withdrawal of Consent|9|||
155734427|NCT01396447|562127100|FG002|Overall Study|Withdrawal of Consent|4|||
155390715|NCT01210118|560865848|FG001|Overall Study|Protocol Violation|1|||
155390716|NCT01210118|560865847|FG000|Overall Study|Spontaneous abortion|1|||
155390717|NCT01210118|560865848|FG001|Overall Study|Spontaneous abortion|3|||
155390718|NCT00777946|560865849|FG000|Overall Study|Adverse Event|11|||
155390719|NCT00777946|560865850|FG001|Overall Study|Adverse Event|1|||
155390720|NCT00777946|560865851|FG002|Overall Study|Adverse Event|3|||
155390721|NCT00777946|560865849|FG000|Overall Study|Lack of Efficacy|0|||
155390722|NCT00777946|560865850|FG001|Overall Study|Lack of Efficacy|0|||
155390723|NCT00777946|560865851|FG002|Overall Study|Lack of Efficacy|9|||
155390724|NCT00777946|560865849|FG000|Overall Study|Condition no longer required study drug|1|||
155390725|NCT00777946|560865850|FG001|Overall Study|Condition no longer required study drug|0|||
155390726|NCT00777946|560865851|FG002|Overall Study|Condition no longer required study drug|0|||
155390727|NCT00777946|560865849|FG000|Overall Study|Patient withdrew consent|3|||
155390728|NCT00777946|560865850|FG001|Overall Study|Patient withdrew consent|2|||
155390729|NCT00777946|560865851|FG002|Overall Study|Patient withdrew consent|3|||
155390730|NCT00777946|560865849|FG000|Overall Study|Lost to Follow-up|3|||
155390731|NCT00777946|560865850|FG001|Overall Study|Lost to Follow-up|1|||
155390732|NCT00777946|560865851|FG002|Overall Study|Lost to Follow-up|0|||
155390733|NCT00777946|560865849|FG000|Overall Study|Protocol deviation|2|||
155390734|NCT00777946|560865850|FG001|Overall Study|Protocol deviation|1|||
155390735|NCT00777946|560865851|FG002|Overall Study|Protocol deviation|1|||
155390736|NCT00777946|560865849|FG000|Overall Study|Randomized in error|1|||
155390737|NCT00777946|560865850|FG001|Overall Study|Randomized in error|1|||
155390738|NCT00777946|560865851|FG002|Overall Study|Randomized in error|0|||
155390739|NCT01079130|560865852|FG000|Overall Study|Adverse Event|1|||
155390740|NCT01079130|560865853|FG001|Overall Study|Adverse Event|1|||
155390741|NCT01079130|560865854|FG002|Overall Study|Adverse Event|0|||
155390742|NCT01079130|560865855|FG003|Overall Study|Adverse Event|1|||
155390743|NCT01079130|560865856|FG004|Overall Study|Adverse Event|5|||
155390744|NCT01079130|560865857|FG005|Overall Study|Adverse Event|1|||
155390745|NCT01079130|560865852|FG000|Overall Study|Administrative problems|1|||
155390746|NCT01079130|560865853|FG001|Overall Study|Administrative problems|3|||
155390747|NCT01079130|560865854|FG002|Overall Study|Administrative problems|0|||
155390748|NCT01079130|560865855|FG003|Overall Study|Administrative problems|0|||
155390749|NCT01079130|560865856|FG004|Overall Study|Administrative problems|0|||
155734428|NCT01396447|562127101|FG003|Overall Study|Withdrawal of Consent|15|||
155390750|NCT01079130|560865857|FG005|Overall Study|Administrative problems|1|||
155390751|NCT01079130|560865852|FG000|Overall Study|Withdrawal by Subject|0|||
155390752|NCT01079130|560865853|FG001|Overall Study|Withdrawal by Subject|1|||
155390753|NCT01079130|560865854|FG002|Overall Study|Withdrawal by Subject|0|||
155734429|NCT01396447|562127098|FG000|Overall Study|Lost to Follow-up|4|||
155734430|NCT01396447|562127099|FG001|Overall Study|Lost to Follow-up|8|||
155734431|NCT01396447|562127100|FG002|Overall Study|Lost to Follow-up|7|||
155734432|NCT01396447|562127101|FG003|Overall Study|Lost to Follow-up|9|||
155734433|NCT01396447|562127098|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155390754|NCT01079130|560865855|FG003|Overall Study|Withdrawal by Subject|0|||
155390755|NCT01079130|560865856|FG004|Overall Study|Withdrawal by Subject|1|||
155390756|NCT01079130|560865857|FG005|Overall Study|Withdrawal by Subject|3|||
155390757|NCT01079130|560865852|FG000|Overall Study|Protocol deviation|0|||
155390758|NCT01079130|560865853|FG001|Overall Study|Protocol deviation|2|||
155390759|NCT01079130|560865854|FG002|Overall Study|Protocol deviation|1|||
155390760|NCT01079130|560865855|FG003|Overall Study|Protocol deviation|2|||
155631627|NCT01027949|561745865|FG000|Overall Study|Lost to Follow-up|17|||
155631628|NCT01027949|561745865|FG000|Overall Study|Protocol Violation|13|||
155631629|NCT01027949|561745865|FG000|Overall Study|PI Decision|8|||
155631630|NCT01027949|561745865|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
155631631|NCT01027949|561745865|FG000|Overall Study|Non-compliance with Study Procedures|7|||
155631632|NCT01027949|561745865|FG000|Overall Study|Lung Transplant|5|||
155281962|NCT03738241|560463963|FG003|Overall Study|Adverse Event|0|||
155281963|NCT03738241|560463964|FG004|Overall Study|Adverse Event|0|||
155281964|NCT03738241|560463965|FG005|Overall Study|Adverse Event|0|||
155281965|NCT03738241|560463966|FG006|Overall Study|Adverse Event|0|||
155281966|NCT03738241|560463967|FG007|Overall Study|Adverse Event|0|||
155281967|NCT03738241|560463968|FG008|Overall Study|Adverse Event|0|||
155281968|NCT03738241|560463969|FG009|Overall Study|Adverse Event|0|||
155281969|NCT03169361|560463970|FG000|Overall Study|Protocol Violation|32|||
155281970|NCT02788656|560463971|FG000|Overall Study|Withdrawal by Subject|1|||
155281971|NCT02788656|560463972|FG001|Overall Study|Withdrawal by Subject|0|||
155281972|NCT00495469|560463977|FG000|Overall Study|Adverse Event|0|||
155281973|NCT00495469|560463978|FG001|Overall Study|Adverse Event|1|||
155281974|NCT00495469|560463979|FG002|Overall Study|Adverse Event|3|||
155281975|NCT00495469|560463980|FG003|Overall Study|Adverse Event|0|||
155281976|NCT00495469|560463981|FG004|Overall Study|Adverse Event|1|||
155281977|NCT00495469|560463982|FG005|Overall Study|Adverse Event|1|||
155281978|NCT00495469|560463983|FG006|Overall Study|Adverse Event|1|||
155281979|NCT00495469|560463977|FG000|Overall Study|Lost to Follow-up|1|||
155281980|NCT00495469|560463978|FG001|Overall Study|Lost to Follow-up|1|||
155281981|NCT00495469|560463979|FG002|Overall Study|Lost to Follow-up|3|||
155281982|NCT00495469|560463980|FG003|Overall Study|Lost to Follow-up|1|||
155281983|NCT00495469|560463981|FG004|Overall Study|Lost to Follow-up|0|||
155281984|NCT00495469|560463982|FG005|Overall Study|Lost to Follow-up|0|||
155281985|NCT00495469|560463983|FG006|Overall Study|Lost to Follow-up|0|||
155281986|NCT00495469|560463977|FG000|Overall Study|Protocol Violation|0|||
155281987|NCT00495469|560463978|FG001|Overall Study|Protocol Violation|0|||
155281988|NCT00495469|560463979|FG002|Overall Study|Protocol Violation|0|||
155281989|NCT00495469|560463980|FG003|Overall Study|Protocol Violation|0|||
155281990|NCT00495469|560463981|FG004|Overall Study|Protocol Violation|1|||
155281991|NCT00495469|560463982|FG005|Overall Study|Protocol Violation|2|||
155281992|NCT00495469|560463983|FG006|Overall Study|Protocol Violation|0|||
155281993|NCT00495469|560463977|FG000|Overall Study|Withdrawal by Subject|5|||
155281994|NCT00495469|560463978|FG001|Overall Study|Withdrawal by Subject|3|||
155281995|NCT00495469|560463979|FG002|Overall Study|Withdrawal by Subject|1|||
155281996|NCT00495469|560463980|FG003|Overall Study|Withdrawal by Subject|3|||
155281997|NCT00495469|560463981|FG004|Overall Study|Withdrawal by Subject|3|||
155281998|NCT00495469|560463982|FG005|Overall Study|Withdrawal by Subject|2|||
155281999|NCT00495469|560463983|FG006|Overall Study|Withdrawal by Subject|3|||
155282000|NCT00495469|560463977|FG000|Overall Study|Lack of Efficacy|0|||
155282001|NCT00495469|560463978|FG001|Overall Study|Lack of Efficacy|0|||
155282002|NCT00495469|560463979|FG002|Overall Study|Lack of Efficacy|0|||
155282003|NCT00495469|560463980|FG003|Overall Study|Lack of Efficacy|0|||
155282004|NCT00495469|560463981|FG004|Overall Study|Lack of Efficacy|0|||
155282005|NCT00495469|560463982|FG005|Overall Study|Lack of Efficacy|0|||
155282006|NCT00495469|560463983|FG006|Overall Study|Lack of Efficacy|1|||
155282007|NCT00495469|560463977|FG000|Overall Study|Liver function test abnormality|0|||
155282008|NCT00495469|560463978|FG001|Overall Study|Liver function test abnormality|1|||
155282009|NCT00495469|560463979|FG002|Overall Study|Liver function test abnormality|0|||
155282010|NCT00495469|560463980|FG003|Overall Study|Liver function test abnormality|0|||
155282011|NCT00495469|560463981|FG004|Overall Study|Liver function test abnormality|0|||
155282012|NCT00495469|560463982|FG005|Overall Study|Liver function test abnormality|0|||
155282013|NCT00495469|560463983|FG006|Overall Study|Liver function test abnormality|0|||
155282014|NCT00495469|560463977|FG000|Overall Study|ST depression at randomisation in ECG|0|||
155282015|NCT00495469|560463978|FG001|Overall Study|ST depression at randomisation in ECG|1|||
155282016|NCT00495469|560463979|FG002|Overall Study|ST depression at randomisation in ECG|0|||
155282017|NCT00495469|560463980|FG003|Overall Study|ST depression at randomisation in ECG|0|||
155282018|NCT00495469|560463981|FG004|Overall Study|ST depression at randomisation in ECG|0|||
155282019|NCT00495469|560463982|FG005|Overall Study|ST depression at randomisation in ECG|0|||
155282020|NCT00495469|560463983|FG006|Overall Study|ST depression at randomisation in ECG|0|||
155282021|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
155282022|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
155282023|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
155282024|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
155282025|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
155282026|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
155282027|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
155282028|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
155631633|NCT01027949|561745865|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
155282029|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
155390761|NCT01079130|560865856|FG004|Overall Study|Protocol deviation|0|||
155390762|NCT01079130|560865857|FG005|Overall Study|Protocol deviation|0|||
155390763|NCT01079130|560865852|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155390764|NCT01079130|560865853|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155390765|NCT01079130|560865854|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155390766|NCT01079130|560865855|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155390767|NCT01079130|560865856|FG004|Overall Study|Abnormal test procedure result(s)|1|||
155390768|NCT01079130|560865857|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155390769|NCT01079130|560865852|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155390770|NCT01079130|560865853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155390771|NCT01079130|560865854|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155390772|NCT01079130|560865855|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155390773|NCT01079130|560865856|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
155390774|NCT01079130|560865857|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
155390775|NCT01079130|560865852|FG000|Overall Study|Lost to Follow-up|0|||
155390776|NCT01079130|560865853|FG001|Overall Study|Lost to Follow-up|0|||
155390777|NCT01079130|560865854|FG002|Overall Study|Lost to Follow-up|0|||
155390778|NCT01079130|560865855|FG003|Overall Study|Lost to Follow-up|0|||
155390779|NCT01079130|560865856|FG004|Overall Study|Lost to Follow-up|1|||
155390780|NCT01079130|560865857|FG005|Overall Study|Lost to Follow-up|0|||
155390781|NCT01696942|560865878|FG000|Overall Study|Withdrawal by Subject|1|||
155390782|NCT01696942|560865879|FG001|Overall Study|Withdrawal by Subject|0|||
155390783|NCT01696942|560865878|FG000|Overall Study|Protocol Violation|1|||
155390784|NCT01696942|560865879|FG001|Overall Study|Protocol Violation|2|||
155390785|NCT01696942|560865878|FG000|Overall Study|screen failure|0|||
155390786|NCT01696942|560865879|FG001|Overall Study|screen failure|1|||
155390787|NCT01422850|560865880|FG000|Overall Study|Physician Decision|3|||
155390788|NCT04484831|560865881|FG000|Overall Study|Withdrawal by Subject|1|||
155390789|NCT04484831|560865882|FG001|Overall Study|Withdrawal by Subject|0|||
155390790|NCT02244996|560865884|FG000|Overall Study|Lack of Efficacy|2|||
155390791|NCT02244996|560865885|FG001|Overall Study|Lack of Efficacy|6|||
155390792|NCT00174265|560865886|FG000|Overall Study|Adverse Event|7|||
155390793|NCT00174265|560865887|FG001|Overall Study|Adverse Event|4|||
155390794|NCT00174265|560865886|FG000|Overall Study|Lack of Efficacy|2|||
155390795|NCT00174265|560865887|FG001|Overall Study|Lack of Efficacy|2|||
155390796|NCT00174265|560865886|FG000|Overall Study|Withdrawal by Subject|3|||
155390797|NCT00174265|560865887|FG001|Overall Study|Withdrawal by Subject|5|||
155390798|NCT00174265|560865886|FG000|Overall Study|Lost to Follow-up|1|||
155390799|NCT00174265|560865887|FG001|Overall Study|Lost to Follow-up|0|||
155390800|NCT00174265|560865886|FG000|Overall Study|Other (Not specified)|16|||
155390801|NCT00174265|560865887|FG001|Overall Study|Other (Not specified)|10|||
155390802|NCT03471871|560865889|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390803|NCT03471871|560865890|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390804|NCT03471871|560865891|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
155390805|NCT03471871|560865892|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390806|NCT03471871|560865893|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390807|NCT03471871|560865889|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390808|NCT03471871|560865890|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390809|NCT03471871|560865891|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390810|NCT03471871|560865892|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
155390811|NCT03471871|560865893|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
155390812|NCT03471871|560865889|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390813|NCT03471871|560865890|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390814|NCT03471871|560865891|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155631634|NCT01027949|561745865|FG000|Overall Study|Use of Excluded Medication|2|||
155631635|NCT01027949|561745865|FG000|Overall Study|Patient Self-discontinuation|1|||
155631636|NCT01027949|561745865|FG000|Overall Study|Pregnancy|1|||
155631637|NCT01027949|561745865|FG000|Overall Study|Surgery|1|||
155631638|NCT00091819|561745870|FG000|Overall Study|Adverse Event|1|||
155631639|NCT00091819|561745871|FG001|Overall Study|Adverse Event|1|||
155631640|NCT00091819|561745870|FG000|Overall Study|Death|4|||
155631641|NCT00091819|561745871|FG001|Overall Study|Death|5|||
155631642|NCT00091819|561745870|FG000|Overall Study|Lost to Follow-up|26|||
155631643|NCT00091819|561745871|FG001|Overall Study|Lost to Follow-up|23|||
155631644|NCT00091819|561745870|FG000|Overall Study|Withdrawal by Subject|5|||
155390815|NCT03471871|560865892|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390816|NCT03471871|560865893|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
155631645|NCT00091819|561745871|FG001|Overall Study|Withdrawal by Subject|8|||
155631646|NCT00091819|561745870|FG000|Overall Study|Protocol Violation|1|||
155390817|NCT03471871|560865889|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390818|NCT03471871|560865890|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390819|NCT03471871|560865891|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155631647|NCT00091819|561745871|FG001|Overall Study|Protocol Violation|2|||
155390820|NCT03471871|560865892|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390821|NCT03471871|560865893|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
155390822|NCT03471871|560865889|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390823|NCT03471871|560865890|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390824|NCT03471871|560865891|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390825|NCT03471871|560865892|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
155390826|NCT03471871|560865893|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390827|NCT03040622|560865894|FG000|Overall Study|unable to implant device|3|||
155390828|NCT02818920|560865895|FG000|Overall Study|Unresectable|4|||
155390829|NCT02818920|560865895|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
155390830|NCT02818920|560865895|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
155390831|NCT02818920|560865895|FG000|Overall Study|Adverse Event|3|||
155390832|NCT02818920|560865895|FG000|Overall Study|Developed Other Disease|1|||
155390833|NCT02818920|560865895|FG000|Overall Study|Refused Further Treatment|1|||
155390834|NCT00445068|560865896|FG000|Overall Study|Disease progression|26|||
155390835|NCT00445068|560865896|FG000|Overall Study|Adverse Event|5|||
155390836|NCT00445068|560865896|FG000|Overall Study|Abnormal laboratory value|2|||
155390837|NCT00445068|560865896|FG000|Overall Study|Withdrawal by Subject|2|||
155390838|NCT00445068|560865896|FG000|Overall Study|Death|1|||
155390839|NCT02673619|560865897|FG000|Overall Study|Lost to Follow-up|1|||
155390840|NCT02673619|560865898|FG001|Overall Study|Lost to Follow-up|0|||
155390841|NCT02673619|560865899|FG002|Overall Study|Lost to Follow-up|0|||
155390842|NCT02673619|560865900|FG003|Overall Study|Lost to Follow-up|0|||
155390843|NCT02673619|560865897|FG000|Overall Study|Withdrawal by Subject|1|||
155390844|NCT02673619|560865898|FG001|Overall Study|Withdrawal by Subject|1|||
155390845|NCT02673619|560865899|FG002|Overall Study|Withdrawal by Subject|1|||
155390846|NCT02673619|560865900|FG003|Overall Study|Withdrawal by Subject|0|||
155390847|NCT02673619|560865897|FG000|Overall Study|Adverse Event|0|||
155390848|NCT02673619|560865898|FG001|Overall Study|Adverse Event|0|||
155390849|NCT02673619|560865899|FG002|Overall Study|Adverse Event|1|||
155390850|NCT02673619|560865900|FG003|Overall Study|Adverse Event|0|||
155390851|NCT02673619|560865897|FG000|Overall Study|Lack of Efficacy|0|||
155390852|NCT02673619|560865898|FG001|Overall Study|Lack of Efficacy|0|||
155631648|NCT00091819|561745870|FG000|Overall Study|Other|2|||
155631649|NCT00091819|561745871|FG001|Overall Study|Other|3|||
155631650|NCT00091819|561745870|FG000|Overall Study|Never received study treatment|3|||
155631651|NCT00091819|561745871|FG001|Overall Study|Never received study treatment|4|||
155631652|NCT00856180|561745872|FG000|Overall Study|Adverse Event|4|||
155631653|NCT00856180|561745872|FG000|Overall Study|Progressive Disease|16|||
155631654|NCT00481676|561745873|FG000|Overall Study|Adverse Event|0|||
155631655|NCT00481676|561745874|FG001|Overall Study|Adverse Event|1|||
155631656|NCT00481676|561745873|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155631657|NCT00481676|561745874|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155631658|NCT00481676|561745873|FG000|Overall Study|Administrative problem|1|||
155631659|NCT00481676|561745874|FG001|Overall Study|Administrative problem|0|||
155631660|NCT02911116|561745875|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155631661|NCT02911116|561745876|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155631662|NCT02911116|561745875|FG000|Overall Study|Lost to Follow-up|0|||
155631663|NCT02911116|561745876|FG001|Overall Study|Lost to Follow-up|1|||
155631664|NCT04796415|561745877|FG000|Overall Study|not interested|12|||
155631665|NCT04796415|561745877|FG000|Overall Study|health issue|8|||
155631666|NCT04796415|561745877|FG000|Overall Study|Other|4|||
155631667|NCT04796415|561745877|FG000|Overall Study|discharged from home health service|3|||
155631668|NCT04796415|561745877|FG000|Overall Study|re-hospitalization|2|||
155631669|NCT04796415|561745877|FG000|Overall Study|moving to nursing home|1|||
155631670|NCT04796415|561745877|FG000|Overall Study|lost contact|1|||
155631671|NCT01513590|561745878|FG000|Overall Study|Adverse Event|2|||
155631672|NCT01513590|561745879|FG001|Overall Study|Adverse Event|3|||
155390853|NCT02673619|560865899|FG002|Overall Study|Lack of Efficacy|1|||
155390854|NCT02673619|560865900|FG003|Overall Study|Lack of Efficacy|0|||
155631673|NCT01513590|561745878|FG000|Overall Study|Withdrawal Criteria|3|||
155631674|NCT01513590|561745879|FG001|Overall Study|Withdrawal Criteria|0|||
155631675|NCT01513590|561745878|FG000|Overall Study|Unclassified|5|||
155631676|NCT01513590|561745879|FG001|Overall Study|Unclassified|10|||
155631677|NCT04810962|561745880|FG000|Overall Study|Adverse Event|0|||
155631678|NCT04810962|561745881|FG001|Overall Study|Adverse Event|1|||
155631679|NCT04810962|561745880|FG000|Overall Study|Lost to Follow-up|2|||
155390855|NCT03444324|560865901|FG000|Overall Study|Withdrawal by Subject|0|||
155390856|NCT03444324|560865902|FG001|Overall Study|Withdrawal by Subject|1|||
155631680|NCT04810962|561745881|FG001|Overall Study|Lost to Follow-up|1|||
155631681|NCT04810962|561745880|FG000|Overall Study|Physician Decision|1|||
155631682|NCT04810962|561745881|FG001|Overall Study|Physician Decision|0|||
155631683|NCT04810962|561745880|FG000|Overall Study|Withdrawal by Subject|1|||
155631684|NCT04810962|561745881|FG001|Overall Study|Withdrawal by Subject|3|||
155650624|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
155650625|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Death|1|||
155734434|NCT01396447|562127099|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155734435|NCT01396447|562127100|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155734436|NCT01396447|562127101|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155734437|NCT01402102|562127103|FG000|Overall Study|Protocol Violation|1|||
155734438|NCT01402102|562127104|FG001|Overall Study|Protocol Violation|0|||
155734439|NCT01402102|562127103|FG000|Overall Study|Insufficiency of compliance|1|||
155734440|NCT01402102|562127104|FG001|Overall Study|Insufficiency of compliance|1|||
155734441|NCT01402102|562127103|FG000|Overall Study|Withdrawal by Subject|0|||
155734442|NCT01402102|562127104|FG001|Overall Study|Withdrawal by Subject|2|||
155734443|NCT00905645|562127105|FG000|Overall Study|Death (not device related)|10|||
155734444|NCT00905645|562127106|FG001|Overall Study|Death (not device related)|4|||
155734445|NCT00905645|562127107|FG002|Overall Study|Death (not device related)|15|||
155734446|NCT00905645|562127108|FG003|Overall Study|Death (not device related)|8|||
155734447|NCT00905645|562127105|FG000|Overall Study|Explantation of study device(s)|78|||
155734448|NCT00905645|562127106|FG001|Overall Study|Explantation of study device(s)|47|||
155734449|NCT00905645|562127107|FG002|Overall Study|Explantation of study device(s)|28|||
155734450|NCT00905645|562127108|FG003|Overall Study|Explantation of study device(s)|21|||
155734451|NCT00905645|562127105|FG000|Overall Study|Subject Request|41|||
155734452|NCT00905645|562127106|FG001|Overall Study|Subject Request|17|||
155734453|NCT00905645|562127107|FG002|Overall Study|Subject Request|13|||
155390857|NCT03444324|560865901|FG000|Overall Study|Lost to Follow-up|4|||
155390858|NCT03444324|560865902|FG001|Overall Study|Lost to Follow-up|2|||
155390859|NCT03444324|560865901|FG000|Overall Study|Protocol Violation|0|||
155390860|NCT03444324|560865902|FG001|Overall Study|Protocol Violation|1|||
155390861|NCT03444324|560865901|FG000|Overall Study|Lack of Trial Compliance|1|||
155390862|NCT03444324|560865902|FG001|Overall Study|Lack of Trial Compliance|1|||
155390863|NCT03444324|560865901|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
155390864|NCT03444324|560865902|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
155390865|NCT06071754|560865906|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
155390866|NCT00234494|560867839|FG000|Overall Study|Protocol Violation|2|||
155390867|NCT00293722|560867842|FG000|Overall Study|Other|427|||
155390868|NCT04498169|560867846|FG000|Study Completion|Adverse Event|1|||
155390869|NCT04498169|560867847|FG001|Study Completion|Adverse Event|1|||
155390870|NCT06069778|560867848|FG000|Overall Study|Withdrawal by Subject|1|||
155390871|NCT03801902|560867849|FG000|Overall Study|Did not receive protocol treatment.|1|||
155390872|NCT03801902|560867850|FG001|Overall Study|Did not receive protocol treatment.|0|||
155390873|NCT03801902|560867851|FG002|Overall Study|Did not receive protocol treatment.|0|||
155390874|NCT03801902|560867852|FG003|Overall Study|Did not receive protocol treatment.|0|||
155390875|NCT02260882|560867853|FG000|Overall Study|Protocol Violation|0|||
155390876|NCT02260882|560867854|FG001|Overall Study|Protocol Violation|1|||
155390877|NCT02119325|560867855|FG000|Washout Period 1|Adverse Event|0|||
155390878|NCT02119325|560867856|FG001|Washout Period 1|Adverse Event|1|||
155390879|NCT00954174|560867865|FG000|Overall Study|Adverse Event|28|||
155390880|NCT00954174|560867866|FG001|Overall Study|Adverse Event|23|||
155390881|NCT00954174|560867867|FG002|Overall Study|Adverse Event|4|||
155390882|NCT00954174|560867868|FG003|Overall Study|Adverse Event|9|||
155390883|NCT00954174|560867865|FG000|Overall Study|Death|4|||
155390884|NCT00954174|560867866|FG001|Overall Study|Death|2|||
155390885|NCT00954174|560867867|FG002|Overall Study|Death|0|||
155390886|NCT00954174|560867868|FG003|Overall Study|Death|0|||
155390887|NCT00954174|560867865|FG000|Overall Study|Lack of Efficacy|32|||
155390888|NCT00954174|560867866|FG001|Overall Study|Lack of Efficacy|22|||
155390889|NCT00954174|560867867|FG002|Overall Study|Lack of Efficacy|8|||
155390890|NCT00954174|560867868|FG003|Overall Study|Lack of Efficacy|6|||
155390891|NCT00954174|560867865|FG000|Overall Study|Withdrawal by Subject|14|||
155390892|NCT00954174|560867866|FG001|Overall Study|Withdrawal by Subject|10|||
155390893|NCT00954174|560867867|FG002|Overall Study|Withdrawal by Subject|4|||
155390894|NCT00954174|560867868|FG003|Overall Study|Withdrawal by Subject|3|||
155390895|NCT00954174|560867865|FG000|Overall Study|Medical Reason|4|||
155390896|NCT00954174|560867866|FG001|Overall Study|Medical Reason|2|||
155390897|NCT00954174|560867867|FG002|Overall Study|Medical Reason|1|||
155734454|NCT00905645|562127108|FG003|Overall Study|Subject Request|11|||
155734455|NCT00905645|562127105|FG000|Overall Study|Lost to Follow-up|299|||
155390898|NCT00954174|560867868|FG003|Overall Study|Medical Reason|0|||
155390899|NCT00954174|560867865|FG000|Overall Study|Ineligible|40|||
155390900|NCT00954174|560867866|FG001|Overall Study|Ineligible|47|||
155734456|NCT00905645|562127106|FG001|Overall Study|Lost to Follow-up|103|||
155734457|NCT00905645|562127107|FG002|Overall Study|Lost to Follow-up|51|||
155734458|NCT00905645|562127108|FG003|Overall Study|Lost to Follow-up|12|||
155734459|NCT04881942|562127110|FG000|Overall Study|Adverse Event|0|||
155390901|NCT00954174|560867867|FG002|Overall Study|Ineligible|7|||
155390902|NCT00954174|560867868|FG003|Overall Study|Ineligible|4|||
155390903|NCT00954174|560867865|FG000|Overall Study|Never Treated|4|||
155390904|NCT00954174|560867866|FG001|Overall Study|Never Treated|17|||
155390905|NCT00954174|560867867|FG002|Overall Study|Never Treated|0|||
155390906|NCT00954174|560867868|FG003|Overall Study|Never Treated|3|||
155390907|NCT02234323|560867869|FG000|All Enrolled|Not Treated: Completed study in database|2|||
155282030|NCT02459964|560463992|FG000|Overall Study|Withdrawal by Subject|0|||
155282031|NCT02459964|560463993|FG001|Overall Study|Withdrawal by Subject|0|||
155282032|NCT02459964|560463994|FG002|Overall Study|Withdrawal by Subject|1|||
155282033|NCT02459964|560463992|FG000|Overall Study|Abnormal EKG changes|0|||
155282034|NCT02459964|560463993|FG001|Overall Study|Abnormal EKG changes|0|||
155282035|NCT02459964|560463994|FG002|Overall Study|Abnormal EKG changes|1|||
155282036|NCT02256969|560464002|FG000|Overall Study|Screenfailed or withdrew|2|||
155282037|NCT02256969|560464003|FG001|Overall Study|Screenfailed or withdrew|1|||
155282038|NCT02256969|560464004|FG002|Overall Study|Screenfailed or withdrew|1|||
155631685|NCT04810962|561745880|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
155631686|NCT04810962|561745881|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
155631687|NCT00486044|561745882|FG000|Overall Study|Withdrawal by Subject|2|||
155631688|NCT00486044|561745883|FG001|Overall Study|Withdrawal by Subject|1|||
155282039|NCT01427907|560464008|FG000|Overall Study|Withdrawal by Subject|3|||
155282040|NCT01427907|560464009|FG001|Overall Study|Withdrawal by Subject|4|||
155282041|NCT01813422|560464013|FG000|Overall Study|Withdrawal by Subject|14|||
155282042|NCT01813422|560464014|FG001|Overall Study|Withdrawal by Subject|8|||
155282043|NCT01813422|560464013|FG000|Overall Study|Death|2|||
155282044|NCT01813422|560464014|FG001|Overall Study|Death|3|||
155282045|NCT01813422|560464013|FG000|Overall Study|Sponsor Decision|2|||
155282046|NCT01813422|560464014|FG001|Overall Study|Sponsor Decision|1|||
155631689|NCT00486044|561745882|FG000|Overall Study|Adverse Event|0|||
155631690|NCT00486044|561745883|FG001|Overall Study|Adverse Event|1|||
155631691|NCT00486044|561745882|FG000|Overall Study|Lost to Follow-up|0|||
155631692|NCT00486044|561745883|FG001|Overall Study|Lost to Follow-up|1|||
155631693|NCT03466346|561745886|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155631694|NCT03466346|561745887|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
155631695|NCT03466346|561745888|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155631696|NCT03466346|561745889|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155631697|NCT03466346|561745890|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155282047|NCT01813422|560464013|FG000|Overall Study|Lost to Follow-up|2|||
155282048|NCT01813422|560464014|FG001|Overall Study|Lost to Follow-up|4|||
155282049|NCT02015195|560464015|FG000|Overall Study|Adverse Event|0|||
155282050|NCT02015195|560464016|FG001|Overall Study|Adverse Event|0|||
155282051|NCT02015195|560464017|FG002|Overall Study|Adverse Event|0|||
155390908|NCT02234323|560867869|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
155390909|NCT02234323|560867869|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
155390910|NCT02234323|560867869|FG000|All Treated|Death|1|||
155390911|NCT02234323|560867869|FG000|All Treated|Physician Decision|5|||
155390912|NCT02234323|560867869|FG000|All Treated|Lack of Efficacy|3|||
155390913|NCT02234323|560867869|FG000|All Treated|Exceeded lab value limit|2|||
155390914|NCT02234323|560867869|FG000|All Treated|Other|7|||
155390915|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
155390916|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
155390917|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
155390918|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
155390919|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
155390920|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
155390921|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
155631698|NCT03466346|561745886|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
155631699|NCT03466346|561745887|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
155631700|NCT03466346|561745888|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155631701|NCT03466346|561745889|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155631702|NCT03466346|561745890|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155631703|NCT03466346|561745886|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
155631704|NCT03466346|561745887|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
155631705|NCT03466346|561745888|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155631706|NCT03466346|561745889|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155631707|NCT03466346|561745890|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155631708|NCT03466346|561745886|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
155631709|NCT03466346|561745887|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
155631710|NCT03466346|561745888|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155631711|NCT03466346|561745889|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155631712|NCT03466346|561745890|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155631713|NCT03466346|561745886|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
155631714|NCT03466346|561745887|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
155282052|NCT02015195|560464018|FG003|Overall Study|Adverse Event|1|||
155282053|NCT02015195|560464019|FG004|Overall Study|Adverse Event|0|||
155282054|NCT02015195|560464020|FG005|Overall Study|Adverse Event|0|||
155282055|NCT02015195|560464021|FG006|Overall Study|Adverse Event|0|||
155282056|NCT02303574|560464029|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155390922|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
155390923|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Death|1|||
155390924|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Death|1|||
155390925|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
155390926|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
155390927|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
155390928|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
155390929|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
155390930|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
155390931|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
155390932|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
155390933|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
155390934|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
155390935|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
155390936|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
155390937|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
155390938|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
155390939|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
155390940|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
155390941|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
155390942|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
155390943|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
155390944|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
155390945|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
155390946|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
155390947|NCT00559585|560867870|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
155390948|NCT00559585|560867871|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
155390949|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
155390950|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
155390951|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
155390952|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
155390953|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
155390954|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
155390955|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
155390956|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
155390957|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
155390958|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
155390959|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
155390960|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
155390961|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
155390962|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
155390963|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
155390964|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
155390965|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
155390966|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
155390967|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
155390968|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
155390969|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
155390970|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
155390971|NCT04209621|560867872|FG000|Overall Study|Death|1|||
155390972|NCT04209621|560867872|FG000|Overall Study|Study Terminated Early|2|||
155390973|NCT02249767|560867873|FG000|Overall Study|Did not use medication|8|||
155390974|NCT02249767|560867874|FG001|Overall Study|Did not use medication|9|||
155390975|NCT02249767|560867875|FG002|Overall Study|Did not use medication|8|||
155390976|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390977|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390978|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390979|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390980|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390981|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390982|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390983|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390984|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390985|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
155390986|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390987|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390988|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390989|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390990|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
155390991|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390992|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390993|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390994|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390995|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390996|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
155390997|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390998|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390999|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155391000|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391001|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391002|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391003|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391004|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391005|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391006|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
155391007|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391008|NCT01372410|560867876|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
155391009|NCT01372410|560867877|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391010|NCT01372410|560867878|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391011|NCT01372410|560867879|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391012|NCT01372410|560867880|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391013|NCT01372410|560867881|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391014|NCT01372410|560867882|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391015|NCT01372410|560867883|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
155391016|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391017|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391018|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391019|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391020|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
155391021|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391022|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391023|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391024|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391025|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391026|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391027|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391028|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391029|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391030|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391031|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391032|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391033|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391034|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391035|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391036|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391037|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391038|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391039|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
155391040|NCT01372410|560867876|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391041|NCT01372410|560867877|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391042|NCT01372410|560867878|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
155391043|NCT01372410|560867879|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391044|NCT01372410|560867880|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391045|NCT01372410|560867881|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391046|NCT01372410|560867882|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391047|NCT01372410|560867883|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391048|NCT01372410|560867876|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391049|NCT01372410|560867877|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391050|NCT01372410|560867878|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391051|NCT01372410|560867879|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391052|NCT01372410|560867880|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391053|NCT01372410|560867881|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
155391054|NCT01372410|560867882|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391055|NCT01372410|560867883|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391056|NCT02644941|560867884|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
155391057|NCT02644941|560867885|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
155391058|NCT04585646|560867886|FG000|First Intervention|Physician Decision|1|||
155391059|NCT04585646|560867887|FG001|First Intervention|Physician Decision|0|||
155391060|NCT04585646|560867886|FG000|First Intervention|Lost to Follow-up|0|||
155391061|NCT04585646|560867887|FG001|First Intervention|Lost to Follow-up|3|||
155391062|NCT04585646|560867886|FG000|First Intervention|Withdrawal by Subject|0|||
155391063|NCT04585646|560867887|FG001|First Intervention|Withdrawal by Subject|1|||
155391064|NCT01145495|560867888|FG000|Overall Study|Adverse Event|6|||
155391065|NCT01145495|560867888|FG000|Overall Study|Withdrawal by Subject|6|||
155391066|NCT01145495|560867888|FG000|Overall Study|Disease progression after respone|2|||
155391067|NCT01886313|560867891|FG000|Overall Study|Adverse Event|1|||
155391068|NCT01886313|560867892|FG001|Overall Study|Adverse Event|1|||
155391069|NCT03294109|560867899|FG000|Overall Study|Withdrawal by Subject|6|||
155391070|NCT03294109|560867900|FG001|Overall Study|Withdrawal by Subject|5|||
155391071|NCT01717768|560867903|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391072|NCT01717768|560867904|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
155391073|NCT01717768|560867905|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391074|NCT01717768|560867906|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391075|NCT01717768|560867907|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391076|NCT01717768|560867908|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391077|NCT01717768|560867909|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391078|NCT01717768|560867910|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391079|NCT01717768|560867911|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391080|NCT01717768|560867912|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391081|NCT01717768|560867913|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391082|NCT01717768|560867914|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391083|NCT01717768|560867903|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391084|NCT01717768|560867904|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391085|NCT01717768|560867905|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391086|NCT01717768|560867906|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391087|NCT01717768|560867907|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391088|NCT01717768|560867908|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391089|NCT01717768|560867909|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391090|NCT01717768|560867910|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391091|NCT01717768|560867911|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391092|NCT01717768|560867912|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391093|NCT01717768|560867913|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391094|NCT01717768|560867914|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
155391095|NCT01717768|560867903|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391096|NCT01717768|560867904|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391097|NCT01717768|560867905|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391098|NCT01717768|560867906|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391099|NCT01717768|560867907|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391100|NCT01717768|560867908|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391101|NCT01717768|560867909|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391102|NCT01717768|560867910|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
155391103|NCT01717768|560867911|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391104|NCT01717768|560867912|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391105|NCT01717768|560867913|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391106|NCT01717768|560867914|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391107|NCT01717768|560867903|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391108|NCT01717768|560867904|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155631715|NCT03466346|561745888|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
155631716|NCT03466346|561745889|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
155631717|NCT03466346|561745890|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
155631718|NCT03466346|561745886|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155631719|NCT03466346|561745887|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155631720|NCT03466346|561745888|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155631721|NCT03466346|561745889|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
155631722|NCT03466346|561745890|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
155631723|NCT03466346|561745886|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
155631724|NCT03466346|561745887|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
155391109|NCT01717768|560867905|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391110|NCT01717768|560867906|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391111|NCT01717768|560867907|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391112|NCT01717768|560867908|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391113|NCT01717768|560867909|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391114|NCT01717768|560867910|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391115|NCT01717768|560867911|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391116|NCT01717768|560867912|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
155734460|NCT04881942|562127111|FG001|Overall Study|Adverse Event|0|||
155734461|NCT04881942|562127112|FG002|Overall Study|Adverse Event|0|||
155734462|NCT04881942|562127113|FG003|Overall Study|Adverse Event|0|||
155734463|NCT04881942|562127114|FG004|Overall Study|Adverse Event|1|||
155734464|NCT04881942|562127110|FG000|Overall Study|Alternates|0|||
155734465|NCT04881942|562127111|FG001|Overall Study|Alternates|0|||
155734466|NCT04881942|562127112|FG002|Overall Study|Alternates|0|||
155734467|NCT04881942|562127113|FG003|Overall Study|Alternates|0|||
155734468|NCT04881942|562127114|FG004|Overall Study|Alternates|2|||
155734469|NCT02423902|562127115|FG000|Overall Study|Disease progression|1|||
155734470|NCT02423902|562127116|FG001|Overall Study|Disease progression|4|||
155734471|NCT02136069|562127117|FG000|Overall Study|UC flare-up|1|||
155734472|NCT02136069|562127118|FG001|Overall Study|UC flare-up|0|||
155734473|NCT02136069|562127117|FG000|Overall Study|Adverse Event|6|||
155734474|NCT02136069|562127118|FG001|Overall Study|Adverse Event|8|||
155734475|NCT02136069|562127117|FG000|Overall Study|Death|0|||
155734476|NCT02136069|562127118|FG001|Overall Study|Death|1|||
155734477|NCT02136069|562127117|FG000|Overall Study|Lack of Efficacy|10|||
155734478|NCT02136069|562127118|FG001|Overall Study|Lack of Efficacy|4|||
155734479|NCT02136069|562127117|FG000|Overall Study|Lost to Follow-up|1|||
155734480|NCT02136069|562127118|FG001|Overall Study|Lost to Follow-up|0|||
155734481|NCT02136069|562127117|FG000|Overall Study|Non-Compliance|1|||
155734482|NCT02136069|562127118|FG001|Overall Study|Non-Compliance|0|||
155734483|NCT02136069|562127117|FG000|Overall Study|Physician Decision|5|||
155734484|NCT02136069|562127118|FG001|Overall Study|Physician Decision|4|||
155734485|NCT02136069|562127117|FG000|Overall Study|Withdrawal by Subject|10|||
155734486|NCT02136069|562127118|FG001|Overall Study|Withdrawal by Subject|11|||
155734487|NCT04838626|562127119|FG000|Overall Study|Adverse Event|2|||
155391117|NCT01717768|560867913|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391118|NCT01717768|560867914|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391119|NCT00448435|560867915|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
155391120|NCT00448435|560867916|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155391121|NCT04195581|560867919|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
155391122|NCT04195581|560867919|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
155391123|NCT04195581|560867919|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
155391124|NCT04195581|560867919|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
155391125|NCT04195581|560867919|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
155391126|NCT04195581|560867919|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
155391127|NCT00821431|560867920|FG000|Overall Study|Adverse Event|6|||
155391128|NCT00821431|560867921|FG001|Overall Study|Adverse Event|3|||
155391129|NCT00821431|560867920|FG000|Overall Study|Withdrawal by Subject|5|||
155391130|NCT00821431|560867921|FG001|Overall Study|Withdrawal by Subject|0|||
155391131|NCT00821431|560867920|FG000|Overall Study|Lost to Follow-up|1|||
155391132|NCT00821431|560867921|FG001|Overall Study|Lost to Follow-up|0|||
155391133|NCT00821431|560867920|FG000|Overall Study|Protocol Violation|3|||
155391134|NCT00821431|560867921|FG001|Overall Study|Protocol Violation|1|||
155391135|NCT00821431|560867920|FG000|Overall Study|Physician Decision|0|||
155391136|NCT00821431|560867921|FG001|Overall Study|Physician Decision|1|||
155391137|NCT01387230|560867922|FG000|Overall Study|Adverse Event|0|||
155391138|NCT01387230|560867923|FG001|Overall Study|Adverse Event|1|||
155391139|NCT01387230|560867924|FG002|Overall Study|Adverse Event|3|||
155391140|NCT01387230|560867922|FG000|Overall Study|Lack of Efficacy|8|||
155391141|NCT01387230|560867923|FG001|Overall Study|Lack of Efficacy|5|||
155391142|NCT01387230|560867924|FG002|Overall Study|Lack of Efficacy|4|||
155391143|NCT01387230|560867922|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
155391144|NCT01387230|560867923|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
155391145|NCT01387230|560867924|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
155391146|NCT01387230|560867922|FG000|Overall Study|Lost to Follow-up|0|||
155391147|NCT01387230|560867923|FG001|Overall Study|Lost to Follow-up|0|||
155391148|NCT01387230|560867924|FG002|Overall Study|Lost to Follow-up|1|||
155391149|NCT01387230|560867922|FG000|Overall Study|Withdrawal by Subject|4|||
155391150|NCT01387230|560867923|FG001|Overall Study|Withdrawal by Subject|1|||
155391151|NCT01387230|560867924|FG002|Overall Study|Withdrawal by Subject|0|||
155391152|NCT01182766|560867930|FG000|Overall Study|Lost to Follow-up|32|||
155734488|NCT04838626|562127119|FG000|Overall Study|Physician Decision|6|||
155734489|NCT04838626|562127119|FG000|Overall Study|Protocol Violation|3|||
155734490|NCT04838626|562127119|FG000|Overall Study|Withdrawal by Subject|9|||
155734491|NCT04838626|562127119|FG000|Overall Study|Technical Problems|2|||
155734492|NCT03901469|562127122|FG000|Overall Study|Radiographic Progression|4|||
155734493|NCT03901469|562127123|FG001|Overall Study|Radiographic Progression|6|||
155391153|NCT01182766|560867931|FG001|Overall Study|Lost to Follow-up|36|||
155734494|NCT03901469|562127124|FG002|Overall Study|Radiographic Progression|3|||
155391154|NCT01182766|560867932|FG002|Overall Study|Lost to Follow-up|29|||
155391155|NCT01182766|560867930|FG000|Overall Study|Withdrawal by Subject|14|||
155391156|NCT01182766|560867931|FG001|Overall Study|Withdrawal by Subject|3|||
155391157|NCT01182766|560867932|FG002|Overall Study|Withdrawal by Subject|6|||
155391158|NCT01182766|560867930|FG000|Overall Study|Physician Decision|1|||
155391159|NCT01182766|560867931|FG001|Overall Study|Physician Decision|0|||
155391160|NCT01182766|560867932|FG002|Overall Study|Physician Decision|0|||
155391161|NCT01182766|560867930|FG000|Overall Study|Non-compliance|1|||
155391162|NCT01182766|560867931|FG001|Overall Study|Non-compliance|1|||
155391163|NCT01182766|560867932|FG002|Overall Study|Non-compliance|1|||
155391164|NCT01009554|560867935|FG000|Overall Study|Adverse Event|1|||
155391165|NCT01009554|560867936|FG001|Overall Study|Adverse Event|1|||
155391166|NCT01009554|560867935|FG000|Overall Study|Withdrawal by Subject|1|||
155391167|NCT01009554|560867936|FG001|Overall Study|Withdrawal by Subject|3|||
155391168|NCT01009554|560867935|FG000|Overall Study|Noncompliant with Study Product|0|||
155391169|NCT01009554|560867936|FG001|Overall Study|Noncompliant with Study Product|3|||
155391170|NCT01605253|560867937|FG000|Overall Study|Physician Decision|3|||
155391171|NCT01605253|560867938|FG001|Overall Study|Physician Decision|2|||
155391172|NCT01605253|560867937|FG000|Overall Study|Lost to Follow-up|3|||
155391173|NCT01605253|560867938|FG001|Overall Study|Lost to Follow-up|1|||
155391174|NCT02554903|560867939|FG000|Overall Study|Death|1|||
155391175|NCT02554903|560867940|FG001|Overall Study|Death|1|||
155391176|NCT02554903|560867939|FG000|Overall Study|Physician Decision|2|||
155391177|NCT02554903|560867940|FG001|Overall Study|Physician Decision|2|||
155391178|NCT02554903|560867939|FG000|Overall Study|Heart Transplant|1|||
155391179|NCT02554903|560867940|FG001|Overall Study|Heart Transplant|2|||
155391180|NCT02973048|560867941|FG000|Overall Study|Epidural catheter insertion failure|1|||
155391181|NCT02973048|560867942|FG001|Overall Study|Epidural catheter insertion failure|0|||
155391182|NCT02973048|560867941|FG000|Overall Study|Withdrawal by Subject|0|||
155391183|NCT02973048|560867942|FG001|Overall Study|Withdrawal by Subject|3|||
155391184|NCT04427501|560867946|FG000|Overall Study|Death|0|||
155391185|NCT04427501|560867947|FG001|Overall Study|Death|0|||
155391186|NCT04427501|560867948|FG002|Overall Study|Death|0|||
155391187|NCT04427501|560867949|FG003|Overall Study|Death|0|||
155391188|NCT04427501|560867950|FG004|Overall Study|Death|0|||
155391189|NCT04427501|560867951|FG005|Overall Study|Death|15|||
155391190|NCT04427501|560867952|FG006|Overall Study|Death|0|||
155391191|NCT04427501|560867953|FG007|Overall Study|Death|0|||
155391192|NCT04427501|560867954|FG008|Overall Study|Death|0|||
155631725|NCT03466346|561745888|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
155631726|NCT03466346|561745889|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
155631727|NCT03466346|561745890|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
155631728|NCT02701634|561745895|FG000|Overall Study|Adverse Event|2|||
155631729|NCT02701634|561745896|FG001|Overall Study|Adverse Event|3|||
155631730|NCT02701634|561745895|FG000|Overall Study|Death|1|||
155631731|NCT02701634|561745896|FG001|Overall Study|Death|0|||
155631732|NCT02701634|561745895|FG000|Overall Study|Investigator's Discretion|7|||
155631733|NCT02701634|561745896|FG001|Overall Study|Investigator's Discretion|4|||
155631734|NCT02701634|561745895|FG000|Overall Study|Study terminated by Sponsor|15|||
155631735|NCT02701634|561745896|FG001|Overall Study|Study terminated by Sponsor|17|||
155631736|NCT02701634|561745895|FG000|Overall Study|Withdrew Consent|6|||
155631737|NCT02701634|561745896|FG001|Overall Study|Withdrew Consent|7|||
155631738|NCT02701634|561745895|FG000|Overall Study|Randomized but not treated|1|||
155631739|NCT02701634|561745896|FG001|Overall Study|Randomized but not treated|0|||
155631740|NCT00537277|561745897|FG000|Overall Study|Adverse Event|1|||
155631741|NCT00537277|561745897|FG000|Overall Study|Lack of Efficacy|2|||
155631742|NCT00537277|561745897|FG000|Overall Study|Lost to Follow-up|12|||
155631743|NCT00537277|561745897|FG000|Overall Study|Protocol Violation|11|||
155631744|NCT00537277|561745897|FG000|Overall Study|Unclassified|4|||
155631745|NCT00537277|561745897|FG000|Overall Study|Inability to tolerate trial medication|4|||
155631746|NCT00537277|561745897|FG000|Overall Study|Non-compliance with trial procedures|15|||
155631747|NCT03620162|561745898|FG000|Overall Study|Physician Decision|4|||
155631748|NCT03620162|561745899|FG001|Overall Study|Physician Decision|0|||
155631749|NCT03620162|561745900|FG002|Overall Study|Physician Decision|1|||
155631750|NCT03620162|561745901|FG003|Overall Study|Physician Decision|0|||
155391193|NCT04427501|560867955|FG009|Overall Study|Death|0|||
155391194|NCT04427501|560867956|FG010|Overall Study|Death|0|||
155391195|NCT04427501|560867957|FG011|Overall Study|Death|0|||
155631751|NCT03620162|561745902|FG004|Overall Study|Physician Decision|2|||
155631752|NCT03620162|561745898|FG000|Overall Study|Lost to Follow-up|2|||
155631753|NCT03620162|561745899|FG001|Overall Study|Lost to Follow-up|6|||
155391196|NCT04427501|560867946|FG000|Overall Study|Lost to Follow-up|5|||
155391197|NCT04427501|560867947|FG001|Overall Study|Lost to Follow-up|1|||
155391198|NCT04427501|560867948|FG002|Overall Study|Lost to Follow-up|2|||
155631754|NCT03620162|561745900|FG002|Overall Study|Lost to Follow-up|7|||
155631755|NCT03620162|561745901|FG003|Overall Study|Lost to Follow-up|3|||
155391199|NCT04427501|560867949|FG003|Overall Study|Lost to Follow-up|0|||
155391200|NCT04427501|560867950|FG004|Overall Study|Lost to Follow-up|2|||
155391201|NCT04427501|560867951|FG005|Overall Study|Lost to Follow-up|11|||
155631756|NCT03620162|561745902|FG004|Overall Study|Lost to Follow-up|2|||
155631757|NCT03620162|561745898|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
155631758|NCT03620162|561745899|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
155631759|NCT03620162|561745900|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
155631760|NCT03620162|561745901|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
155631761|NCT03620162|561745902|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
155631762|NCT04530552|561745909|FG000|Overall Study|Physician Decision|0|||
155631763|NCT04530552|561745910|FG001|Overall Study|Physician Decision|1|||
155631764|NCT04530552|561745909|FG000|Overall Study|Withdrawal by Subject|0|||
155631765|NCT04530552|561745910|FG001|Overall Study|Withdrawal by Subject|1|||
155631766|NCT04530552|561745909|FG000|Overall Study|Adverse Event|0|||
155631767|NCT04530552|561745910|FG001|Overall Study|Adverse Event|1|||
155631768|NCT04530552|561745909|FG000|Overall Study|No surgery|0|||
155631769|NCT04530552|561745910|FG001|Overall Study|No surgery|1|||
155631770|NCT00071981|561745911|FG000|Overall Study|Lack of Efficacy|37|||
155631771|NCT00071981|561745912|FG001|Overall Study|Lack of Efficacy|29|||
155631772|NCT00071981|561745913|FG002|Overall Study|Lack of Efficacy|30|||
155631773|NCT00071981|561745914|FG003|Overall Study|Lack of Efficacy|43|||
155631774|NCT00071981|561745911|FG000|Overall Study|Adverse Event|4|||
155631775|NCT00071981|561745912|FG001|Overall Study|Adverse Event|4|||
155631776|NCT00071981|561745913|FG002|Overall Study|Adverse Event|3|||
155631777|NCT00071981|561745914|FG003|Overall Study|Adverse Event|1|||
155631778|NCT00071981|561745911|FG000|Overall Study|Death|0|||
155631779|NCT00071981|561745912|FG001|Overall Study|Death|0|||
155631780|NCT00071981|561745913|FG002|Overall Study|Death|1|||
155631781|NCT00071981|561745914|FG003|Overall Study|Death|1|||
155631782|NCT00071981|561745911|FG000|Overall Study|Withdrawal by Subject|3|||
155631783|NCT00071981|561745912|FG001|Overall Study|Withdrawal by Subject|1|||
155631784|NCT00071981|561745913|FG002|Overall Study|Withdrawal by Subject|0|||
155631785|NCT00071981|561745914|FG003|Overall Study|Withdrawal by Subject|0|||
155631786|NCT00071981|561745911|FG000|Overall Study|No protocol therapy|2|||
155631787|NCT00071981|561745912|FG001|Overall Study|No protocol therapy|5|||
155631788|NCT00071981|561745913|FG002|Overall Study|No protocol therapy|1|||
155631789|NCT00071981|561745914|FG003|Overall Study|No protocol therapy|0|||
155631790|NCT00071981|561745911|FG000|Overall Study|others (not specified in the study)|0|||
155631791|NCT00071981|561745912|FG001|Overall Study|others (not specified in the study)|2|||
155631792|NCT00071981|561745913|FG002|Overall Study|others (not specified in the study)|2|||
155631793|NCT00071981|561745914|FG003|Overall Study|others (not specified in the study)|0|||
155631794|NCT00465179|561745917|FG000|Overall Study|Adverse Event|4|||
155631795|NCT00465179|561745917|FG000|Overall Study|Withdrawal by Subject|2|||
155631796|NCT00465179|561745917|FG000|Overall Study|Progression of Disease|47|||
155631797|NCT00833755|561745921|FG000|Overall Study|Physician Decision|4|||
155631798|NCT00833755|561745922|FG001|Overall Study|Physician Decision|4|||
155631799|NCT00833755|561745923|FG002|Overall Study|Physician Decision|2|||
155631800|NCT00833755|561745924|FG003|Overall Study|Physician Decision|6|||
155631801|NCT00833755|561745921|FG000|Overall Study|Subject had scheduling issues|0|||
155631802|NCT00833755|561745922|FG001|Overall Study|Subject had scheduling issues|1|||
155631803|NCT00833755|561745923|FG002|Overall Study|Subject had scheduling issues|0|||
155631804|NCT00833755|561745924|FG003|Overall Study|Subject had scheduling issues|0|||
155631805|NCT00262925|561745925|FG000|Overall Study|Lack of Efficacy|3|||
155631806|NCT00262925|561745925|FG000|Overall Study|Adverse Event|4|||
155631807|NCT00262925|561745925|FG000|Overall Study|Death|2|||
155631808|NCT00262925|561745925|FG000|Overall Study|alternative therapy|1|||
155631809|NCT00262925|561745925|FG000|Overall Study|Other|1|||
155631810|NCT00560404|561745926|FG000|Overall Study|Adverse Event|2|||
155631811|NCT00560404|561745927|FG001|Overall Study|Adverse Event|3|||
155631812|NCT00560404|561745926|FG000|Overall Study|Death|3|||
155631813|NCT00560404|561745927|FG001|Overall Study|Death|3|||
155631814|NCT00560404|561745926|FG000|Overall Study|Protocol Violation|12|||
155631815|NCT00560404|561745927|FG001|Overall Study|Protocol Violation|7|||
155631816|NCT00560404|561745926|FG000|Overall Study|Administrative Reasons|1|||
155631817|NCT00560404|561745927|FG001|Overall Study|Administrative Reasons|1|||
155631818|NCT00560404|561745926|FG000|Overall Study|Withdrew Consent|4|||
155631819|NCT00560404|561745927|FG001|Overall Study|Withdrew Consent|0|||
155631820|NCT00560404|561745926|FG000|Overall Study|Failure to return|1|||
155631821|NCT00560404|561745927|FG001|Overall Study|Failure to return|2|||
155631822|NCT00560404|561745926|FG000|Overall Study|Other withdrawal reason|13|||
155631823|NCT00560404|561745927|FG001|Overall Study|Other withdrawal reason|5|||
155631824|NCT03260023|561745928|FG000|Overall Study|Adverse Event|0|||
155391202|NCT04427501|560867952|FG006|Overall Study|Lost to Follow-up|10|||
155631825|NCT03260023|561745929|FG001|Overall Study|Adverse Event|0|||
155631826|NCT03260023|561745930|FG002|Overall Study|Adverse Event|4|||
155631827|NCT03260023|561745931|FG003|Overall Study|Adverse Event|4|||
155631828|NCT03260023|561745932|FG004|Overall Study|Adverse Event|4|||
155631829|NCT03260023|561745933|FG005|Overall Study|Adverse Event|1|||
155631830|NCT03260023|561745934|FG006|Overall Study|Adverse Event|2|||
155631831|NCT03260023|561745928|FG000|Overall Study|Clinical Progression|0|||
155631832|NCT03260023|561745929|FG001|Overall Study|Clinical Progression|1|||
155391203|NCT04427501|560867953|FG007|Overall Study|Lost to Follow-up|10|||
155391204|NCT04427501|560867954|FG008|Overall Study|Lost to Follow-up|2|||
155391205|NCT04427501|560867955|FG009|Overall Study|Lost to Follow-up|5|||
155391206|NCT04427501|560867956|FG010|Overall Study|Lost to Follow-up|2|||
155391207|NCT04427501|560867957|FG011|Overall Study|Lost to Follow-up|0|||
155391208|NCT04427501|560867946|FG000|Overall Study|Physician Decision|0|||
155391209|NCT04427501|560867947|FG001|Overall Study|Physician Decision|3|||
155391210|NCT04427501|560867948|FG002|Overall Study|Physician Decision|0|||
155391211|NCT04427501|560867949|FG003|Overall Study|Physician Decision|0|||
155391212|NCT04427501|560867950|FG004|Overall Study|Physician Decision|0|||
155391213|NCT04427501|560867951|FG005|Overall Study|Physician Decision|0|||
155391214|NCT04427501|560867952|FG006|Overall Study|Physician Decision|2|||
155391215|NCT04427501|560867953|FG007|Overall Study|Physician Decision|0|||
155391216|NCT04427501|560867954|FG008|Overall Study|Physician Decision|0|||
155391217|NCT04427501|560867955|FG009|Overall Study|Physician Decision|0|||
155391218|NCT04427501|560867956|FG010|Overall Study|Physician Decision|0|||
155391219|NCT04427501|560867957|FG011|Overall Study|Physician Decision|0|||
155391220|NCT04427501|560867946|FG000|Overall Study|Withdrawal by Subject|9|||
155391221|NCT04427501|560867947|FG001|Overall Study|Withdrawal by Subject|2|||
155391222|NCT04427501|560867948|FG002|Overall Study|Withdrawal by Subject|2|||
155391223|NCT04427501|560867949|FG003|Overall Study|Withdrawal by Subject|3|||
155391224|NCT04427501|560867950|FG004|Overall Study|Withdrawal by Subject|7|||
155391225|NCT04427501|560867951|FG005|Overall Study|Withdrawal by Subject|25|||
155391226|NCT04427501|560867952|FG006|Overall Study|Withdrawal by Subject|15|||
155391227|NCT04427501|560867953|FG007|Overall Study|Withdrawal by Subject|7|||
155391228|NCT04427501|560867954|FG008|Overall Study|Withdrawal by Subject|4|||
155391229|NCT04427501|560867955|FG009|Overall Study|Withdrawal by Subject|1|||
155391230|NCT04427501|560867956|FG010|Overall Study|Withdrawal by Subject|4|||
155391231|NCT04427501|560867957|FG011|Overall Study|Withdrawal by Subject|0|||
155391232|NCT04427501|560867946|FG000|Overall Study|Other - as reported by the investigator|1|||
155391233|NCT04427501|560867947|FG001|Overall Study|Other - as reported by the investigator|0|||
155391234|NCT04427501|560867948|FG002|Overall Study|Other - as reported by the investigator|0|||
155391235|NCT04427501|560867949|FG003|Overall Study|Other - as reported by the investigator|0|||
155391236|NCT04427501|560867950|FG004|Overall Study|Other - as reported by the investigator|0|||
155391237|NCT04427501|560867951|FG005|Overall Study|Other - as reported by the investigator|6|||
155391238|NCT04427501|560867952|FG006|Overall Study|Other - as reported by the investigator|6|||
155391239|NCT04427501|560867953|FG007|Overall Study|Other - as reported by the investigator|0|||
155391240|NCT04427501|560867954|FG008|Overall Study|Other - as reported by the investigator|0|||
155391241|NCT04427501|560867955|FG009|Overall Study|Other - as reported by the investigator|0|||
155391242|NCT04427501|560867956|FG010|Overall Study|Other - as reported by the investigator|0|||
155391243|NCT04427501|560867957|FG011|Overall Study|Other - as reported by the investigator|0|||
155391244|NCT04427501|560867946|FG000|Overall Study|Other|0|||
155391245|NCT04427501|560867947|FG001|Overall Study|Other|0|||
155391246|NCT04427501|560867948|FG002|Overall Study|Other|0|||
155391247|NCT04427501|560867949|FG003|Overall Study|Other|0|||
155391248|NCT04427501|560867950|FG004|Overall Study|Other|0|||
155391249|NCT04427501|560867951|FG005|Overall Study|Other|0|||
155391250|NCT04427501|560867952|FG006|Overall Study|Other|0|||
155391251|NCT04427501|560867953|FG007|Overall Study|Other|0|||
155391252|NCT04427501|560867954|FG008|Overall Study|Other|0|||
155391253|NCT04427501|560867955|FG009|Overall Study|Other|0|||
155391254|NCT04427501|560867956|FG010|Overall Study|Other|0|||
155391255|NCT04427501|560867957|FG011|Overall Study|Other|1|||
155391256|NCT03170154|560867958|FG000|Overall Study|Lost to Follow-up|4|||
155391257|NCT03170154|560867958|FG000|Overall Study|Death|2|||
155391258|NCT03170154|560867958|FG000|Overall Study|Withdrawal by Subject|2|||
155734495|NCT03901469|562127125|FG003|Overall Study|Radiographic Progression|30|||
155734496|NCT03901469|562127126|FG004|Overall Study|Radiographic Progression|7|||
155734497|NCT03901469|562127127|FG005|Overall Study|Radiographic Progression|2|||
155734498|NCT03901469|562127128|FG006|Overall Study|Radiographic Progression|11|||
155391259|NCT01906346|560867959|FG000|Overall Study|AEs|1|||
155391260|NCT04936841|560867962|FG000|Overall Study|Death|1|||
155391261|NCT00639223|560867963|FG000|Overall Study|Lost to Follow-up|0|||
155391262|NCT00639223|560867964|FG001|Overall Study|Lost to Follow-up|2|||
155391263|NCT01163721|560867966|FG000|Overall Study|Adverse Event|5|||
155391264|NCT01163721|560867967|FG001|Overall Study|Adverse Event|6|||
155391265|NCT01163721|560867966|FG000|Overall Study|Withdrawal by Subject|3|||
155391266|NCT01163721|560867967|FG001|Overall Study|Withdrawal by Subject|4|||
155391267|NCT01163721|560867966|FG000|Overall Study|Lost to Follow-up|0|||
155391268|NCT01163721|560867967|FG001|Overall Study|Lost to Follow-up|1|||
155391269|NCT01163721|560867966|FG000|Overall Study|Physician Decision|0|||
155391270|NCT01163721|560867967|FG001|Overall Study|Physician Decision|1|||
155391271|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391272|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391273|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391274|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
155391275|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391276|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391277|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391278|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391279|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
155391280|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391281|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391282|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391283|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391284|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
155391285|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391286|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391287|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391288|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391289|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
155391290|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391291|NCT04484259|560867975|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391292|NCT04484259|560867976|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391293|NCT04484259|560867977|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391294|NCT04484259|560867978|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391295|NCT04484259|560867979|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
155391296|NCT04484259|560867975|FG000|Randomized Treatment|Withdrawal by Subject|1|||
155391297|NCT04484259|560867976|FG001|Randomized Treatment|Withdrawal by Subject|0|||
155391298|NCT04484259|560867977|FG002|Randomized Treatment|Withdrawal by Subject|0|||
155391299|NCT04484259|560867978|FG003|Randomized Treatment|Withdrawal by Subject|0|||
155391300|NCT04484259|560867979|FG004|Randomized Treatment|Withdrawal by Subject|0|||
155391301|NCT03951220|560867980|FG000|Overall Study|Withdrawal by Subject|9|||
155391302|NCT03951220|560867981|FG001|Overall Study|Withdrawal by Subject|2|||
155391303|NCT03951220|560867982|FG002|Overall Study|Withdrawal by Subject|0|||
155391304|NCT04498832|560867983|FG000|Overall Study|Adverse Event|1|||
155391305|NCT04498832|560867984|FG001|Overall Study|Adverse Event|3|||
155391306|NCT04498832|560867983|FG000|Overall Study|Withdrawal by Subject|0|||
155391307|NCT04498832|560867984|FG001|Overall Study|Withdrawal by Subject|1|||
155391308|NCT06268288|560867989|FG000|Overall Study|Withdrawal by Subject|1|||
155391309|NCT06268288|560867990|FG001|Overall Study|Withdrawal by Subject|2|||
155391310|NCT02146326|560867993|FG000|Overall Study|Lost to Follow-up|3|||
155391311|NCT02146326|560867994|FG001|Overall Study|Lost to Follow-up|3|||
155391312|NCT02146326|560867995|FG002|Overall Study|Lost to Follow-up|11|||
155391313|NCT02146326|560867996|FG003|Overall Study|Lost to Follow-up|19|||
155391314|NCT02146326|560867993|FG000|Overall Study|Withdrawal by Subject|2|||
155391315|NCT02146326|560867994|FG001|Overall Study|Withdrawal by Subject|1|||
155391316|NCT02146326|560867995|FG002|Overall Study|Withdrawal by Subject|15|||
155391317|NCT02146326|560867996|FG003|Overall Study|Withdrawal by Subject|11|||
155391318|NCT02146326|560867993|FG000|Overall Study|Separated from mental health center|23|||
155391319|NCT02146326|560867994|FG001|Overall Study|Separated from mental health center|33|||
155391320|NCT02146326|560867995|FG002|Overall Study|Separated from mental health center|0|||
155391321|NCT02146326|560867996|FG003|Overall Study|Separated from mental health center|0|||
155391322|NCT02146326|560867993|FG000|Overall Study|Incarcerated|0|||
155391323|NCT02146326|560867994|FG001|Overall Study|Incarcerated|0|||
155391324|NCT02146326|560867995|FG002|Overall Study|Incarcerated|3|||
155391325|NCT02146326|560867996|FG003|Overall Study|Incarcerated|8|||
155391326|NCT02146326|560867993|FG000|Overall Study|Death|0|||
155391327|NCT02146326|560867994|FG001|Overall Study|Death|0|||
155391328|NCT02146326|560867995|FG002|Overall Study|Death|4|||
155391329|NCT02146326|560867996|FG003|Overall Study|Death|4|||
155391330|NCT02146326|560867993|FG000|Overall Study|Unable to complete interview|0|||
155391331|NCT02146326|560867994|FG001|Overall Study|Unable to complete interview|0|||
155391332|NCT02146326|560867995|FG002|Overall Study|Unable to complete interview|10|||
155631833|NCT03260023|561745930|FG002|Overall Study|Clinical Progression|3|||
155631834|NCT03260023|561745931|FG003|Overall Study|Clinical Progression|1|||
155631835|NCT03260023|561745932|FG004|Overall Study|Clinical Progression|0|||
155391333|NCT02146326|560867996|FG003|Overall Study|Unable to complete interview|6|||
155391334|NCT03153111|560867997|FG000|Overall Study|Death|2|||
155391335|NCT03153111|560867998|FG001|Overall Study|Death|5|||
155391336|NCT03153111|560867997|FG000|Overall Study|Lost to Follow-up|1|||
155391337|NCT03153111|560867998|FG001|Overall Study|Lost to Follow-up|0|||
155391338|NCT03153111|560867997|FG000|Overall Study|Physician Decision|5|||
155391339|NCT03153111|560867998|FG001|Overall Study|Physician Decision|1|||
155391340|NCT03153111|560867997|FG000|Overall Study|Withdrawal by Subject|3|||
155391341|NCT03153111|560867998|FG001|Overall Study|Withdrawal by Subject|3|||
155391342|NCT05066724|560867999|FG000|Overall Study|Adverse Event|1|||
155391343|NCT05066724|560867999|FG000|Overall Study|Non-Compliance With Study Drug|5|||
155391344|NCT05066724|560867999|FG000|Overall Study|Withdrawal by Subject|6|||
155391345|NCT05066724|560867999|FG000|Overall Study|Physician Decision|2|||
155391346|NCT01313117|560868000|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
155391347|NCT01313117|560868000|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
155391348|NCT03602261|560868005|FG000|Overall Study|Adverse Event|5|||
155391349|NCT03602261|560868006|FG001|Overall Study|Adverse Event|1|||
155391350|NCT03602261|560868005|FG000|Overall Study|Physician Decision|1|||
155631836|NCT03260023|561745933|FG005|Overall Study|Clinical Progression|0|||
155631837|NCT03260023|561745934|FG006|Overall Study|Clinical Progression|0|||
155631838|NCT03260023|561745928|FG000|Overall Study|Physician Decision|0|||
155631839|NCT03260023|561745929|FG001|Overall Study|Physician Decision|0|||
155631840|NCT03260023|561745930|FG002|Overall Study|Physician Decision|0|||
155631841|NCT03260023|561745931|FG003|Overall Study|Physician Decision|1|||
155631842|NCT03260023|561745932|FG004|Overall Study|Physician Decision|1|||
155631843|NCT03260023|561745933|FG005|Overall Study|Physician Decision|0|||
155631844|NCT03260023|561745934|FG006|Overall Study|Physician Decision|0|||
155631845|NCT03260023|561745928|FG000|Overall Study|Withdrawal by Subject|0|||
155631846|NCT03260023|561745929|FG001|Overall Study|Withdrawal by Subject|0|||
155631847|NCT03260023|561745930|FG002|Overall Study|Withdrawal by Subject|0|||
155631848|NCT03260023|561745931|FG003|Overall Study|Withdrawal by Subject|0|||
155631849|NCT03260023|561745932|FG004|Overall Study|Withdrawal by Subject|3|||
155631850|NCT03260023|561745933|FG005|Overall Study|Withdrawal by Subject|0|||
155631851|NCT03260023|561745934|FG006|Overall Study|Withdrawal by Subject|0|||
155631852|NCT03260023|561745928|FG000|Overall Study|Under trial intervention|0|||
155631853|NCT03260023|561745929|FG001|Overall Study|Under trial intervention|0|||
155631854|NCT03260023|561745930|FG002|Overall Study|Under trial intervention|2|||
155631855|NCT03260023|561745931|FG003|Overall Study|Under trial intervention|5|||
155631856|NCT03260023|561745932|FG004|Overall Study|Under trial intervention|3|||
155631857|NCT03260023|561745933|FG005|Overall Study|Under trial intervention|0|||
155631858|NCT03260023|561745934|FG006|Overall Study|Under trial intervention|0|||
155631859|NCT05035407|561745935|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
155631860|NCT05035407|561745936|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155631861|NCT05035407|561745937|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155631862|NCT05035407|561745938|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155631863|NCT05035407|561745939|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155631864|NCT05035407|561745940|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155631865|NCT04220021|561745941|FG000|Overall Study|Withdrawal by Subject|11|||
155631866|NCT04220021|561745941|FG000|Overall Study|Physician Decision|2|||
155631867|NCT04220021|561745941|FG000|Overall Study|Non-study related illness|5|||
155631868|NCT04513366|561745942|FG000|Treatment Phase|Withdrawal by Subject|6|||
155631869|NCT04513366|561745943|FG001|Treatment Phase|Withdrawal by Subject|8|||
155631870|NCT04513366|561745944|FG002|Treatment Phase|Withdrawal by Subject|3|||
155631871|NCT04513366|561745942|FG000|Treatment Phase|Lost to Follow-up|1|||
155631872|NCT04513366|561745943|FG001|Treatment Phase|Lost to Follow-up|2|||
155631873|NCT04513366|561745944|FG002|Treatment Phase|Lost to Follow-up|5|||
155631874|NCT04513366|561745942|FG000|Treatment Phase|Other than Specified|1|||
155631875|NCT04513366|561745943|FG001|Treatment Phase|Other than Specified|0|||
155631876|NCT04513366|561745944|FG002|Treatment Phase|Other than Specified|2|||
155631877|NCT04513366|561745942|FG000|Treatment Phase|Physician Decision|2|||
155631878|NCT04513366|561745943|FG001|Treatment Phase|Physician Decision|0|||
155631879|NCT04513366|561745944|FG002|Treatment Phase|Physician Decision|0|||
155631880|NCT04513366|561745942|FG000|Treatment Phase|Adverse Event|0|||
155631881|NCT04513366|561745943|FG001|Treatment Phase|Adverse Event|1|||
155631882|NCT04513366|561745944|FG002|Treatment Phase|Adverse Event|1|||
155631883|NCT04513366|561745942|FG000|Extension Phase|Withdrawal by Subject|3|||
155631884|NCT04513366|561745943|FG001|Extension Phase|Withdrawal by Subject|1|||
155631885|NCT04513366|561745944|FG002|Extension Phase|Withdrawal by Subject|1|||
155631886|NCT04513366|561745942|FG000|Extension Phase|Other than Specified|4|||
155631887|NCT04513366|561745943|FG001|Extension Phase|Other than Specified|0|||
155631888|NCT04513366|561745944|FG002|Extension Phase|Other than Specified|1|||
155631889|NCT04513366|561745942|FG000|Extension Phase|Lost to Follow-up|1|||
155631890|NCT04513366|561745943|FG001|Extension Phase|Lost to Follow-up|1|||
155631891|NCT04513366|561745944|FG002|Extension Phase|Lost to Follow-up|1|||
155631892|NCT04513366|561745942|FG000|Extension Phase|Sponsor Decision|0|||
155631893|NCT04513366|561745943|FG001|Extension Phase|Sponsor Decision|1|||
155631894|NCT04513366|561745944|FG002|Extension Phase|Sponsor Decision|0|||
155631895|NCT04513366|561745942|FG000|Extension Phase|Death|0|||
155631896|NCT04513366|561745943|FG001|Extension Phase|Death|1|||
155631897|NCT04513366|561745944|FG002|Extension Phase|Death|0|||
155631898|NCT04513366|561745942|FG000|Extension Phase|Adverse Event|0|||
155391351|NCT03602261|560868006|FG001|Overall Study|Physician Decision|0|||
155391352|NCT03602261|560868005|FG000|Overall Study|Withdrawal by Subject|1|||
155391353|NCT03602261|560868006|FG001|Overall Study|Withdrawal by Subject|1|||
155391354|NCT03602261|560868005|FG000|Overall Study|Lack of Efficacy|0|||
155391355|NCT03602261|560868006|FG001|Overall Study|Lack of Efficacy|1|||
155391356|NCT03602261|560868005|FG000|Overall Study|Subject moving out of state|1|||
155391357|NCT03602261|560868006|FG001|Overall Study|Subject moving out of state|0|||
155391358|NCT01306890|560869440|FG000|Overall Study|Adverse Event|2|||
155391359|NCT01306890|560869440|FG000|Overall Study|Death|1223|||
155391360|NCT01306890|560869440|FG000|Overall Study|Lost to Follow-up|58|||
155391361|NCT01306890|560869440|FG000|Overall Study|Withdrawal by Subject|88|||
155391362|NCT01306890|560869440|FG000|Overall Study|Unspecified reasons|104|||
155391363|NCT01306890|560869440|FG000|Overall Study|Study Termination|3|||
155391364|NCT01306890|560869440|FG000|Overall Study|No discontinuation documentation|41|||
155391365|NCT02217436|560869441|FG000|Overall Study|Protocol Violation|1|||
155391366|NCT02217436|560869442|FG001|Overall Study|Protocol Violation|1|||
155391367|NCT02217436|560869441|FG000|Overall Study|Incomplete data|0|||
155391368|NCT02217436|560869442|FG001|Overall Study|Incomplete data|1|||
155391369|NCT04641299|560869457|FG000|Overall Study|Adverse Event|0|||
155391370|NCT04641299|560869458|FG001|Overall Study|Adverse Event|0|||
155391371|NCT04641299|560869459|FG002|Overall Study|Adverse Event|2|||
155391372|NCT04641299|560869460|FG003|Overall Study|Adverse Event|0|||
155391373|NCT04641299|560869457|FG000|Overall Study|Lost to Follow-up|0|||
155391374|NCT04641299|560869458|FG001|Overall Study|Lost to Follow-up|1|||
155391375|NCT04641299|560869459|FG002|Overall Study|Lost to Follow-up|0|||
155391376|NCT04641299|560869460|FG003|Overall Study|Lost to Follow-up|0|||
155391377|NCT04641299|560869457|FG000|Overall Study|Withdrawal by Subject|1|||
155391378|NCT04641299|560869458|FG001|Overall Study|Withdrawal by Subject|0|||
155391379|NCT04641299|560869459|FG002|Overall Study|Withdrawal by Subject|0|||
155391380|NCT04641299|560869460|FG003|Overall Study|Withdrawal by Subject|0|||
155391381|NCT04641299|560869457|FG000|Overall Study|Reason not given|1|||
155391382|NCT04641299|560869458|FG001|Overall Study|Reason not given|0|||
155391383|NCT04641299|560869459|FG002|Overall Study|Reason not given|0|||
155391384|NCT04641299|560869460|FG003|Overall Study|Reason not given|0|||
155391385|NCT01890148|560869464|FG000|Overall Study|Adverse Event|1|||
155391386|NCT01215175|560869465|FG000|Overall Study|Lost to Follow-up|0|||
155391387|NCT01215175|560869466|FG001|Overall Study|Lost to Follow-up|1|||
155391388|NCT01215175|560869467|FG002|Overall Study|Lost to Follow-up|0|||
155391389|NCT01215175|560869468|FG003|Overall Study|Lost to Follow-up|1|||
155391390|NCT01215175|560869469|FG004|Overall Study|Lost to Follow-up|0|||
155391391|NCT01920594|560869470|FG000|Overall Study|Adverse Event|4|||
155391392|NCT01920594|560869471|FG001|Overall Study|Adverse Event|2|||
155391393|NCT01920594|560869470|FG000|Overall Study|Lost to Follow-up|1|||
155391394|NCT01920594|560869471|FG001|Overall Study|Lost to Follow-up|0|||
155391395|NCT01920594|560869470|FG000|Overall Study|Recovery|2|||
155391396|NCT01920594|560869471|FG001|Overall Study|Recovery|0|||
155391397|NCT01920594|560869470|FG000|Overall Study|Investigator discretion|0|||
155391398|NCT01920594|560869471|FG001|Overall Study|Investigator discretion|1|||
155391399|NCT00929656|560869472|FG000|Overall Study|Lost to Follow-up|0|||
155391400|NCT00929656|560869473|FG001|Overall Study|Lost to Follow-up|1|||
155391401|NCT01990534|560869474|FG000|Overall Study|Death|22|||
155391402|NCT01990534|560869474|FG000|Overall Study|Progressive disease|3|||
155391403|NCT01990534|560869474|FG000|Overall Study|Protocol Violation|1|||
155391404|NCT01990534|560869474|FG000|Overall Study|Withdrawal of Informed Consent|2|||
155391405|NCT01990534|560869474|FG000|Overall Study|Symptomatic Deterioration|1|||
155391406|NCT01990534|560869474|FG000|Overall Study|Withdrawal by Subject|3|||
155391407|NCT01990534|560869474|FG000|Overall Study|Reason not Specified|2|||
155391408|NCT01990534|560869474|FG000|Overall Study|Lost to Follow-up|1|||
155391409|NCT01831544|560869475|FG000|Overall Study|Death|1|||
155391410|NCT01831544|560869475|FG000|Overall Study|Still on original MVAD device|2|||
155391411|NCT03422172|560869476|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
155391412|NCT03422172|560869476|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
155391413|NCT03422172|560869476|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
155391414|NCT04147234|560869477|FG000|Overall Study|Clinical deterioration|0|||
155391415|NCT04147234|560869478|FG001|Overall Study|Clinical deterioration|0|||
155391416|NCT04147234|560869479|FG002|Overall Study|Clinical deterioration|1|||
155391417|NCT04147234|560869480|FG003|Overall Study|Clinical deterioration|0|||
155391418|NCT04147234|560869481|FG004|Overall Study|Clinical deterioration|0|||
155391419|NCT04147234|560869482|FG005|Overall Study|Clinical deterioration|0|||
155391420|NCT04147234|560869483|FG006|Overall Study|Clinical deterioration|0|||
155391421|NCT04147234|560869477|FG000|Overall Study|Withdrawal by Subject|0|||
155391422|NCT04147234|560869478|FG001|Overall Study|Withdrawal by Subject|1|||
155391423|NCT04147234|560869479|FG002|Overall Study|Withdrawal by Subject|1|||
155391424|NCT04147234|560869480|FG003|Overall Study|Withdrawal by Subject|0|||
155391425|NCT04147234|560869481|FG004|Overall Study|Withdrawal by Subject|0|||
155391426|NCT04147234|560869482|FG005|Overall Study|Withdrawal by Subject|0|||
155391427|NCT04147234|560869483|FG006|Overall Study|Withdrawal by Subject|0|||
155391428|NCT04147234|560869477|FG000|Overall Study|Clinical disease progression|1|||
155391429|NCT04147234|560869478|FG001|Overall Study|Clinical disease progression|3|||
155391430|NCT04147234|560869479|FG002|Overall Study|Clinical disease progression|1|||
155391431|NCT04147234|560869480|FG003|Overall Study|Clinical disease progression|1|||
155391432|NCT04147234|560869481|FG004|Overall Study|Clinical disease progression|0|||
155391433|NCT04147234|560869482|FG005|Overall Study|Clinical disease progression|1|||
155391434|NCT04147234|560869483|FG006|Overall Study|Clinical disease progression|0|||
155391435|NCT04147234|560869477|FG000|Overall Study|Objective disease progression|6|||
155391436|NCT04147234|560869478|FG001|Overall Study|Objective disease progression|4|||
155391437|NCT04147234|560869479|FG002|Overall Study|Objective disease progression|3|||
155391438|NCT04147234|560869480|FG003|Overall Study|Objective disease progression|3|||
155734499|NCT03901469|562127122|FG000|Overall Study|Clinical Progression|0|||
155734500|NCT03901469|562127123|FG001|Overall Study|Clinical Progression|2|||
155734501|NCT03901469|562127124|FG002|Overall Study|Clinical Progression|0|||
155734502|NCT03901469|562127125|FG003|Overall Study|Clinical Progression|7|||
155734503|NCT03901469|562127126|FG004|Overall Study|Clinical Progression|6|||
155734504|NCT03901469|562127127|FG005|Overall Study|Clinical Progression|0|||
155734505|NCT03901469|562127128|FG006|Overall Study|Clinical Progression|2|||
155734506|NCT03901469|562127122|FG000|Overall Study|Adverse Event|1|||
155734507|NCT03901469|562127123|FG001|Overall Study|Adverse Event|0|||
155734508|NCT03901469|562127124|FG002|Overall Study|Adverse Event|0|||
155734509|NCT03901469|562127125|FG003|Overall Study|Adverse Event|0|||
155734510|NCT03901469|562127126|FG004|Overall Study|Adverse Event|0|||
155734511|NCT03901469|562127127|FG005|Overall Study|Adverse Event|0|||
155734512|NCT03901469|562127128|FG006|Overall Study|Adverse Event|9|||
155734513|NCT03901469|562127122|FG000|Overall Study|Physician Decision|0|||
155734514|NCT03901469|562127123|FG001|Overall Study|Physician Decision|0|||
155734515|NCT03901469|562127124|FG002|Overall Study|Physician Decision|0|||
155734516|NCT03901469|562127125|FG003|Overall Study|Physician Decision|1|||
155734517|NCT03901469|562127126|FG004|Overall Study|Physician Decision|0|||
155734518|NCT03901469|562127127|FG005|Overall Study|Physician Decision|0|||
155734519|NCT03901469|562127128|FG006|Overall Study|Physician Decision|0|||
155734520|NCT03901469|562127122|FG000|Overall Study|Withdrawal by Subject|0|||
155734521|NCT03901469|562127123|FG001|Overall Study|Withdrawal by Subject|0|||
155734522|NCT03901469|562127124|FG002|Overall Study|Withdrawal by Subject|0|||
155734523|NCT03901469|562127125|FG003|Overall Study|Withdrawal by Subject|0|||
155734524|NCT03901469|562127126|FG004|Overall Study|Withdrawal by Subject|2|||
155734525|NCT03901469|562127127|FG005|Overall Study|Withdrawal by Subject|0|||
155734526|NCT03901469|562127128|FG006|Overall Study|Withdrawal by Subject|8|||
155734527|NCT03901469|562127122|FG000|Overall Study|Death|0|||
155734528|NCT03901469|562127123|FG001|Overall Study|Death|0|||
155734529|NCT03901469|562127124|FG002|Overall Study|Death|0|||
155734530|NCT03901469|562127125|FG003|Overall Study|Death|3|||
155734531|NCT03901469|562127126|FG004|Overall Study|Death|5|||
155734532|NCT03901469|562127127|FG005|Overall Study|Death|0|||
155734533|NCT03901469|562127128|FG006|Overall Study|Death|1|||
155734534|NCT03901469|562127122|FG000|Overall Study|Termination of study by sponsor|0|||
155391439|NCT04147234|560869481|FG004|Overall Study|Objective disease progression|5|||
155734535|NCT03901469|562127123|FG001|Overall Study|Termination of study by sponsor|0|||
155734536|NCT03901469|562127124|FG002|Overall Study|Termination of study by sponsor|0|||
155734537|NCT03901469|562127125|FG003|Overall Study|Termination of study by sponsor|0|||
155734538|NCT03901469|562127126|FG004|Overall Study|Termination of study by sponsor|1|||
155734539|NCT03901469|562127127|FG005|Overall Study|Termination of study by sponsor|1|||
155734540|NCT03901469|562127128|FG006|Overall Study|Termination of study by sponsor|0|||
155734541|NCT03901469|562127122|FG000|Overall Study|Not Reported|1|||
155734542|NCT03901469|562127123|FG001|Overall Study|Not Reported|0|||
155734543|NCT03901469|562127124|FG002|Overall Study|Not Reported|0|||
155734544|NCT03901469|562127125|FG003|Overall Study|Not Reported|1|||
155734545|NCT03901469|562127126|FG004|Overall Study|Not Reported|0|||
155734546|NCT03901469|562127127|FG005|Overall Study|Not Reported|0|||
155734547|NCT03901469|562127128|FG006|Overall Study|Not Reported|1|||
155734548|NCT02586207|562127129|FG000|Overall Study|Physician Decision|1|||
155734549|NCT02586207|562127129|FG000|Overall Study|Withdrawal by Subject|1|||
155734550|NCT03048578|562127130|FG000|Overall Study|Withdrawal by Subject|5|||
155734551|NCT03048578|562127131|FG001|Overall Study|Withdrawal by Subject|6|||
155734552|NCT03048578|562127130|FG000|Overall Study|Lost to Follow-up|22|||
155734553|NCT03048578|562127131|FG001|Overall Study|Lost to Follow-up|10|||
155734554|NCT03048578|562127130|FG000|Overall Study|Adverse Event|1|||
155391440|NCT04147234|560869482|FG005|Overall Study|Objective disease progression|2|||
155391441|NCT04147234|560869483|FG006|Overall Study|Objective disease progression|3|||
155391442|NCT04147234|560869477|FG000|Overall Study|Adverse Event|0|||
155391443|NCT04147234|560869478|FG001|Overall Study|Adverse Event|0|||
155734555|NCT03048578|562127131|FG001|Overall Study|Adverse Event|2|||
155734556|NCT03048578|562127130|FG000|Overall Study|Terminated|3|||
155734557|NCT03048578|562127131|FG001|Overall Study|Terminated|2|||
155734558|NCT01409811|562127132|FG000|Overall Study|Insurance denial|1|||
155391444|NCT04147234|560869479|FG002|Overall Study|Adverse Event|0|||
155391445|NCT04147234|560869480|FG003|Overall Study|Adverse Event|0|||
155734559|NCT00441064|562127135|FG000|Overall Study|Adverse Event|1|||
155734560|NCT00441064|562127136|FG001|Overall Study|Adverse Event|0|||
155734561|NCT00441064|562127135|FG000|Overall Study|Abnormal laboratory values|0|||
155734562|NCT00441064|562127136|FG001|Overall Study|Abnormal laboratory values|2|||
155734563|NCT00441064|562127135|FG000|Overall Study|Abnormal test procedure results|0|||
155734564|NCT00441064|562127136|FG001|Overall Study|Abnormal test procedure results|1|||
155391446|NCT04147234|560869481|FG004|Overall Study|Adverse Event|1|||
155391447|NCT04147234|560869482|FG005|Overall Study|Adverse Event|0|||
155391448|NCT04147234|560869483|FG006|Overall Study|Adverse Event|0|||
155391449|NCT05104476|560869494|FG000|Overall Study|Randomized But Not Treated|1|||
155391450|NCT05104476|560869495|FG001|Overall Study|Randomized But Not Treated|2|||
155391451|NCT05104476|560869494|FG000|Overall Study|Adverse Event|2|||
155391452|NCT05104476|560869495|FG001|Overall Study|Adverse Event|2|||
155391453|NCT05104476|560869494|FG000|Overall Study|Withdrawal by Subject|3|||
155391454|NCT05104476|560869495|FG001|Overall Study|Withdrawal by Subject|3|||
155391455|NCT05104476|560869494|FG000|Overall Study|Other Than Specified|0|||
155391456|NCT05104476|560869495|FG001|Overall Study|Other Than Specified|3|||
155391457|NCT02170389|560869498|FG000|Overall Study|Study terminated prior to start of treat|1|||
155391458|NCT02596620|560869501|FG000|Overall Study|Lost to Follow-up|1|||
155391459|NCT02596620|560869502|FG001|Overall Study|Lost to Follow-up|1|||
155391460|NCT01054144|560869503|FG000|Overall Study|Death|2|||
155391461|NCT02310672|560869507|FG000|Overall Study|Death|1|||
155391462|NCT02310672|560869507|FG000|Overall Study|Lost to Follow-up|1|||
155391463|NCT02310672|560869507|FG000|Overall Study|Withdrawal by Subject|1|||
155391464|NCT02310672|560869507|FG000|Overall Study|Sponsor's decision|12|||
155391465|NCT04704336|560869511|FG000|Overall Study|Death|2|||
155391466|NCT04704336|560869512|FG001|Overall Study|Death|2|||
155391467|NCT04704336|560869511|FG000|Overall Study|Lost to Follow-up|33|||
155391468|NCT04704336|560869512|FG001|Overall Study|Lost to Follow-up|40|||
155391469|NCT03118674|560869513|FG000|Overall Study|Lost to Follow-up|2|||
155391470|NCT03118674|560869513|FG000|Overall Study|Screen Faliure|8|||
155391471|NCT03118674|560869513|FG000|Overall Study|Withdrawal by Subject|5|||
155391472|NCT00867113|560869514|FG000|Treatment Period|Adverse Event|15|||
155391473|NCT00867113|560869514|FG000|Treatment Period|Death|2|||
155391474|NCT00867113|560869514|FG000|Treatment Period|Withdrawal by Subject|19|||
155391475|NCT00867113|560869514|FG000|Treatment Period|Lost to Follow-up|3|||
155391476|NCT00867113|560869514|FG000|Treatment Period|Administrative problems|1|||
155391477|NCT00867113|560869514|FG000|Treatment Period|Disease progression/relapse|1|||
155391478|NCT00867113|560869514|FG000|Treatment Period|Protocol Violation|4|||
155391479|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Death|1|||
155391480|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
155391481|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
155391482|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
155391483|NCT02178553|560869516|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
155391484|NCT02178553|560869517|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
155391485|NCT02178553|560869516|FG000|Overall Study|Physician Decision|0|||
155391486|NCT02178553|560869517|FG001|Overall Study|Physician Decision|4|||
155391487|NCT02178553|560869516|FG000|Overall Study|Technical problem with injection|1|||
155391488|NCT02178553|560869517|FG001|Overall Study|Technical problem with injection|3|||
155391489|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391490|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391491|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
155391492|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391493|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
155391494|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
155391495|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
155391496|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
155391497|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
155391498|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
155391499|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
155391500|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
155391501|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
155631899|NCT04513366|561745943|FG001|Extension Phase|Adverse Event|0|||
155631900|NCT04513366|561745944|FG002|Extension Phase|Adverse Event|1|||
155631901|NCT02187783|561745945|FG000|Overall Study|Adverse Event|8|||
155631902|NCT02187783|561745945|FG000|Overall Study|Death|3|||
155631903|NCT02187783|561745945|FG000|Overall Study|Progressive disease|80|||
155631904|NCT02187783|561745945|FG000|Overall Study|Protocol Violation|3|||
155631905|NCT02187783|561745945|FG000|Overall Study|Physician Decision|2|||
155631906|NCT02187783|561745945|FG000|Overall Study|Withdrawal by Subject|9|||
155734565|NCT00441064|562127135|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155391502|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
155734566|NCT00441064|562127136|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155734567|NCT00441064|562127135|FG000|Overall Study|Protocol Deviation|3|||
155631907|NCT02187783|561745945|FG000|Overall Study|Study terminated by sponsor|1|||
155391503|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
155734568|NCT00441064|562127136|FG001|Overall Study|Protocol Deviation|2|||
155391504|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
155391505|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
155391506|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
155391507|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
155391508|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
155391509|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
155391510|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
155391511|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
155391512|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
155391513|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
155391514|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
155391515|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
155391516|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
155391517|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391518|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
155391519|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391520|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391521|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
155391522|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
155391523|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
155391524|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
155391525|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
155391526|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
155391527|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
155391528|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
155391529|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
155391530|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
155391531|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
155391532|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
155391533|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
155391534|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
155391535|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
155391536|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
155391537|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
155391538|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
155391539|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
155391540|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
155391541|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
155391542|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
155391543|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
155391544|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
155391545|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
155391546|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
155391547|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
155391548|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
155391549|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
155391550|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
155391551|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
155391552|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
155391553|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
155391554|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
155391555|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
155391556|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
155391557|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
155391558|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
155391559|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
155391560|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
155391561|NCT00651157|560869528|FG000|Overall Study|Death|1|||
155391562|NCT00651157|560869528|FG000|Overall Study|Protocol Violation|1|||
155391563|NCT00688181|560869530|FG000|Overall Study|Lost to Follow-up|17|||
155391564|NCT00688181|560869530|FG000|Overall Study|Unknown Reason|4|||
155391565|NCT00688181|560869530|FG000|Overall Study|Non-clinical Reason|2|||
155391566|NCT01472380|560869534|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
155391567|NCT01472380|560869534|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
155391568|NCT02511678|560869535|FG000|Overall Study|Withdrawal by Subject|2|||
155391569|NCT02511678|560869535|FG000|Overall Study|Lost to Follow-up|4|||
155391570|NCT02511678|560869535|FG000|Overall Study|Death|19|||
155391571|NCT02511678|560869535|FG000|Overall Study|Adverse Event|1|||
155391572|NCT02511678|560869535|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
155391573|NCT02511678|560869535|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
155631908|NCT00171249|561745946|FG000|Overall Study|Withdrawal by Subject|2|||
155631909|NCT00171249|561745947|FG001|Overall Study|Withdrawal by Subject|0|||
155631910|NCT00171249|561745948|FG002|Overall Study|Withdrawal by Subject|0|||
155631911|NCT00171249|561745949|FG003|Overall Study|Withdrawal by Subject|6|||
155631912|NCT00171249|561745950|FG004|Overall Study|Withdrawal by Subject|0|||
155631913|NCT00171249|561745951|FG005|Overall Study|Withdrawal by Subject|0|||
155631914|NCT00171249|561745952|FG006|Overall Study|Withdrawal by Subject|0|||
155631915|NCT00171249|561745946|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
155631916|NCT00171249|561745947|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155631917|NCT00171249|561745948|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
155631918|NCT00171249|561745949|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
155631919|NCT00171249|561745950|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155631920|NCT00171249|561745951|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
155631921|NCT00171249|561745952|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155631922|NCT00171249|561745946|FG000|Overall Study|Death|7|||
155631923|NCT00171249|561745947|FG001|Overall Study|Death|1|||
155631924|NCT00171249|561745948|FG002|Overall Study|Death|0|||
155631925|NCT00171249|561745949|FG003|Overall Study|Death|4|||
155631926|NCT00171249|561745950|FG004|Overall Study|Death|0|||
155631927|NCT00171249|561745951|FG005|Overall Study|Death|3|||
155631928|NCT00171249|561745952|FG006|Overall Study|Death|1|||
155631929|NCT00171249|561745946|FG000|Overall Study|Other|10|||
155631930|NCT00171249|561745947|FG001|Overall Study|Other|0|||
155631931|NCT00171249|561745948|FG002|Overall Study|Other|0|||
155631932|NCT00171249|561745949|FG003|Overall Study|Other|43|||
155631933|NCT00171249|561745950|FG004|Overall Study|Other|0|||
155631934|NCT00171249|561745951|FG005|Overall Study|Other|2|||
155631935|NCT00171249|561745952|FG006|Overall Study|Other|0|||
155631936|NCT00171249|561745946|FG000|Overall Study|No Longer Requires Study Drug|4|||
155631937|NCT00171249|561745947|FG001|Overall Study|No Longer Requires Study Drug|0|||
155631938|NCT00171249|561745948|FG002|Overall Study|No Longer Requires Study Drug|0|||
155631939|NCT00171249|561745949|FG003|Overall Study|No Longer Requires Study Drug|3|||
155631940|NCT00171249|561745950|FG004|Overall Study|No Longer Requires Study Drug|0|||
155631941|NCT00171249|561745951|FG005|Overall Study|No Longer Requires Study Drug|5|||
155631942|NCT00171249|561745952|FG006|Overall Study|No Longer Requires Study Drug|0|||
155631943|NCT00171249|561745946|FG000|Overall Study|Administrative Problems|1|||
155631944|NCT00171249|561745947|FG001|Overall Study|Administrative Problems|0|||
155631945|NCT00171249|561745948|FG002|Overall Study|Administrative Problems|0|||
155631946|NCT00171249|561745949|FG003|Overall Study|Administrative Problems|2|||
155631947|NCT00171249|561745950|FG004|Overall Study|Administrative Problems|0|||
155631948|NCT00171249|561745951|FG005|Overall Study|Administrative Problems|0|||
155631949|NCT00171249|561745952|FG006|Overall Study|Administrative Problems|0|||
155631950|NCT00171249|561745946|FG000|Overall Study|Adverse Event|3|||
155631951|NCT00171249|561745947|FG001|Overall Study|Adverse Event|1|||
155631952|NCT00171249|561745948|FG002|Overall Study|Adverse Event|0|||
155631953|NCT00171249|561745949|FG003|Overall Study|Adverse Event|15|||
155631954|NCT00171249|561745950|FG004|Overall Study|Adverse Event|0|||
155631955|NCT00171249|561745951|FG005|Overall Study|Adverse Event|2|||
155631956|NCT00171249|561745952|FG006|Overall Study|Adverse Event|0|||
155631957|NCT00171249|561745946|FG000|Overall Study|Lost to Follow-up|5|||
155631958|NCT00171249|561745947|FG001|Overall Study|Lost to Follow-up|0|||
155631959|NCT00171249|561745948|FG002|Overall Study|Lost to Follow-up|0|||
155631960|NCT00171249|561745949|FG003|Overall Study|Lost to Follow-up|9|||
155631961|NCT00171249|561745950|FG004|Overall Study|Lost to Follow-up|0|||
155631962|NCT00171249|561745951|FG005|Overall Study|Lost to Follow-up|0|||
155631963|NCT00171249|561745952|FG006|Overall Study|Lost to Follow-up|0|||
155631964|NCT02908347|561745953|FG000|Overall Study|Adverse Event|0|||
155631965|NCT02908347|561745954|FG001|Overall Study|Adverse Event|1|||
155631966|NCT02908347|561745953|FG000|Overall Study|Lost to Follow-up|1|||
155631967|NCT02908347|561745954|FG001|Overall Study|Lost to Follow-up|0|||
155631968|NCT03082729|561745957|FG000|Overall Study|Lost to Follow-up|7|||
155631969|NCT03082729|561745957|FG000|Overall Study|Physician Decision|2|||
155631970|NCT03082729|561745957|FG000|Overall Study|Withdrawal by Subject|1|||
155631971|NCT03082729|561745957|FG000|Overall Study|Lack of Efficacy|9|||
155631972|NCT03082729|561745957|FG000|Overall Study|Adverse Event|4|||
155631973|NCT03082729|561745957|FG000|Overall Study|Protocol Violation|6|||
155734569|NCT00441064|562127135|FG000|Overall Study|Patient withdrew consent|5|||
155631974|NCT03082729|561745957|FG000|Overall Study|Fear of study procedure|1|||
155631975|NCT03082729|561745957|FG000|Overall Study|Scheduling conflict|1|||
155631976|NCT00042289|561747631|FG000|Overall Study|Lost to Follow-up|3|||
155631977|NCT00042289|561747632|FG001|Overall Study|Lost to Follow-up|0|||
155631978|NCT00042289|561747633|FG002|Overall Study|Lost to Follow-up|0|||
155631979|NCT00042289|561747634|FG003|Overall Study|Lost to Follow-up|1|||
155631980|NCT00042289|561747635|FG004|Overall Study|Lost to Follow-up|3|||
155631981|NCT00042289|561747636|FG005|Overall Study|Lost to Follow-up|3|||
155631982|NCT00042289|561747637|FG006|Overall Study|Lost to Follow-up|6|||
155734570|NCT00441064|562127136|FG001|Overall Study|Patient withdrew consent|2|||
155631983|NCT00042289|561747638|FG007|Overall Study|Lost to Follow-up|1|||
155631984|NCT00042289|561747639|FG008|Overall Study|Lost to Follow-up|1|||
155391574|NCT02511678|560869535|FG000|Overall Study|Required Radiofrequency Ablation|1|||
155391575|NCT02511678|560869535|FG000|Overall Study|Biopsy was Negative|1|||
155391576|NCT02511678|560869535|FG000|Overall Study|Protocol Violation|1|||
155391577|NCT02511678|560869535|FG000|Overall Study|Received Radiation Treatment|1|||
155391578|NCT01295281|560869536|FG000|First Intervention (7 Days)|Death|0|||
155391579|NCT01295281|560869537|FG001|First Intervention (7 Days)|Death|1|||
155391580|NCT00292461|560869538|FG000|Overall Study|Adverse Event|4|||
155391581|NCT00292461|560869539|FG001|Overall Study|Adverse Event|2|||
155391582|NCT00292461|560869538|FG000|Overall Study|Lack of Efficacy|1|||
155391583|NCT00292461|560869539|FG001|Overall Study|Lack of Efficacy|0|||
155391584|NCT00292461|560869538|FG000|Overall Study|Withdrawal by Subject|0|||
155391585|NCT00292461|560869539|FG001|Overall Study|Withdrawal by Subject|1|||
155391586|NCT00292461|560869538|FG000|Overall Study|Protocol Violation|4|||
155391587|NCT00292461|560869539|FG001|Overall Study|Protocol Violation|3|||
155391588|NCT00292461|560869538|FG000|Overall Study|Lost to Follow-up|1|||
155391589|NCT00292461|560869539|FG001|Overall Study|Lost to Follow-up|0|||
155391590|NCT03049735|560869541|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
155391591|NCT03049735|560869542|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
155391592|NCT03049735|560869543|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
155391593|NCT03049735|560869541|FG000|Overall Study|Other|5|||
155391594|NCT03049735|560869542|FG001|Overall Study|Other|3|||
155391595|NCT03049735|560869543|FG002|Overall Study|Other|1|||
155391596|NCT03049735|560869541|FG000|Overall Study|Lack of Efficacy|4|||
155391597|NCT03049735|560869542|FG001|Overall Study|Lack of Efficacy|0|||
155391598|NCT03049735|560869543|FG002|Overall Study|Lack of Efficacy|3|||
155391599|NCT03049735|560869541|FG000|Overall Study|Protocol deviation|1|||
155391600|NCT03049735|560869542|FG001|Overall Study|Protocol deviation|0|||
155391601|NCT03049735|560869543|FG002|Overall Study|Protocol deviation|0|||
155391602|NCT03049735|560869541|FG000|Overall Study|Pregnancy|0|||
155391603|NCT03049735|560869542|FG001|Overall Study|Pregnancy|0|||
155391604|NCT03049735|560869543|FG002|Overall Study|Pregnancy|1|||
155391605|NCT03049735|560869541|FG000|Overall Study|Adverse Event|7|||
155391606|NCT03049735|560869542|FG001|Overall Study|Adverse Event|18|||
155391607|NCT03049735|560869543|FG002|Overall Study|Adverse Event|5|||
155391608|NCT03049735|560869541|FG000|Overall Study|Withdrawal by Subject|10|||
155391609|NCT03049735|560869542|FG001|Overall Study|Withdrawal by Subject|3|||
155391610|NCT03049735|560869543|FG002|Overall Study|Withdrawal by Subject|7|||
155391611|NCT03049735|560869541|FG000|Overall Study|Lost to Follow-up|1|||
155391612|NCT03049735|560869542|FG001|Overall Study|Lost to Follow-up|5|||
155391613|NCT03049735|560869543|FG002|Overall Study|Lost to Follow-up|5|||
155391614|NCT02684357|560869546|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
155391615|NCT02684357|560869547|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
155391616|NCT02684357|560869548|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
155391617|NCT02684357|560869549|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
155391618|NCT02684357|560869550|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
155391619|NCT02684357|560869551|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
155391620|NCT02684357|560869546|FG000|Part A|Lost to Follow-up|0|||
155391621|NCT02684357|560869547|FG001|Part A|Lost to Follow-up|2|||
155391622|NCT02684357|560869548|FG002|Part A|Lost to Follow-up|2|||
155391623|NCT02684357|560869549|FG003|Part A|Lost to Follow-up|0|||
155391624|NCT02684357|560869550|FG004|Part A|Lost to Follow-up|0|||
155391625|NCT02684357|560869551|FG005|Part A|Lost to Follow-up|0|||
155391626|NCT02684357|560869546|FG000|Part A|Withdrawal by Subject|3|||
155391627|NCT02684357|560869547|FG001|Part A|Withdrawal by Subject|0|||
155391628|NCT02684357|560869548|FG002|Part A|Withdrawal by Subject|0|||
155391629|NCT02684357|560869549|FG003|Part A|Withdrawal by Subject|0|||
155391630|NCT02684357|560869550|FG004|Part A|Withdrawal by Subject|0|||
155391631|NCT02684357|560869551|FG005|Part A|Withdrawal by Subject|0|||
155391632|NCT02684357|560869546|FG000|Part A|Other|0|||
155391633|NCT02684357|560869547|FG001|Part A|Other|1|||
155391634|NCT02684357|560869548|FG002|Part A|Other|0|||
155391635|NCT02684357|560869549|FG003|Part A|Other|0|||
155391636|NCT02684357|560869550|FG004|Part A|Other|0|||
155391637|NCT02684357|560869551|FG005|Part A|Other|0|||
155391638|NCT02684357|560869546|FG000|Part B|Adverse Event (Other)|0|||
155734571|NCT00953056|562127137|FG000|Overall Study|Withdrew Consent|0|||
155734572|NCT00953056|562127138|FG001|Overall Study|Withdrew Consent|0|||
155391639|NCT02684357|560869547|FG001|Part B|Adverse Event (Other)|0|||
155391640|NCT02684357|560869548|FG002|Part B|Adverse Event (Other)|0|||
155391641|NCT02684357|560869549|FG003|Part B|Adverse Event (Other)|1|||
155391642|NCT02684357|560869550|FG004|Part B|Adverse Event (Other)|1|||
155391643|NCT02684357|560869551|FG005|Part B|Adverse Event (Other)|1|||
155391644|NCT02684357|560869546|FG000|Part B|Lost to Follow-up|0|||
155391645|NCT02684357|560869547|FG001|Part B|Lost to Follow-up|0|||
155391646|NCT02684357|560869548|FG002|Part B|Lost to Follow-up|0|||
155391647|NCT02684357|560869549|FG003|Part B|Lost to Follow-up|1|||
155391648|NCT02684357|560869550|FG004|Part B|Lost to Follow-up|1|||
155391649|NCT02684357|560869551|FG005|Part B|Lost to Follow-up|7|||
155391650|NCT02684357|560869546|FG000|Part B|Withdrawal by Subject|0|||
155391651|NCT02684357|560869547|FG001|Part B|Withdrawal by Subject|0|||
155391652|NCT02684357|560869548|FG002|Part B|Withdrawal by Subject|0|||
155734573|NCT00953056|562127139|FG002|Overall Study|Withdrew Consent|0|||
155734574|NCT00953056|562127140|FG003|Overall Study|Withdrew Consent|0|||
155734575|NCT00953056|562127141|FG004|Overall Study|Withdrew Consent|2|||
155734576|NCT00953056|562127142|FG005|Overall Study|Withdrew Consent|3|||
155734577|NCT00953056|562127137|FG000|Overall Study|Serious Adverse Event|0|||
155734578|NCT00953056|562127138|FG001|Overall Study|Serious Adverse Event|0|||
155734579|NCT00953056|562127139|FG002|Overall Study|Serious Adverse Event|0|||
155734580|NCT00953056|562127140|FG003|Overall Study|Serious Adverse Event|0|||
155734581|NCT00953056|562127141|FG004|Overall Study|Serious Adverse Event|0|||
155734582|NCT00953056|562127142|FG005|Overall Study|Serious Adverse Event|1|||
155734583|NCT01077076|562127143|FG000|First Intervention|Withdrawal by Subject|1|||
155734584|NCT01077076|562127144|FG001|First Intervention|Withdrawal by Subject|0|||
155734585|NCT01077076|562127145|FG002|First Intervention|Withdrawal by Subject|0|||
155282057|NCT02303574|560464030|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282058|NCT02303574|560464031|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
155282059|NCT02303574|560464032|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155631985|NCT00042289|561747640|FG009|Overall Study|Lost to Follow-up|0|||
155631986|NCT00042289|561747641|FG010|Overall Study|Lost to Follow-up|0|||
155631987|NCT00042289|561747642|FG011|Overall Study|Lost to Follow-up|0|||
155631988|NCT00042289|561747643|FG012|Overall Study|Lost to Follow-up|0|||
155631989|NCT00042289|561747644|FG013|Overall Study|Lost to Follow-up|0|||
155631990|NCT00042289|561747645|FG014|Overall Study|Lost to Follow-up|0|||
155631991|NCT00042289|561747646|FG015|Overall Study|Lost to Follow-up|1|||
155631992|NCT00042289|561747647|FG016|Overall Study|Lost to Follow-up|1|||
155631993|NCT00042289|561747648|FG017|Overall Study|Lost to Follow-up|0|||
155631994|NCT00042289|561747649|FG018|Overall Study|Lost to Follow-up|3|||
155631995|NCT00042289|561747650|FG019|Overall Study|Lost to Follow-up|2|||
155631996|NCT00042289|561747651|FG020|Overall Study|Lost to Follow-up|0|||
155631997|NCT00042289|561747652|FG021|Overall Study|Lost to Follow-up|0|||
155631998|NCT00042289|561747653|FG022|Overall Study|Lost to Follow-up|0|||
155631999|NCT00042289|561747654|FG023|Overall Study|Lost to Follow-up|0|||
155632000|NCT00042289|561747655|FG024|Overall Study|Lost to Follow-up|0|||
155632001|NCT00042289|561747656|FG025|Overall Study|Lost to Follow-up|0|||
155632002|NCT00042289|561747657|FG026|Overall Study|Lost to Follow-up|2|||
155632003|NCT00042289|561747658|FG027|Overall Study|Lost to Follow-up|2|||
155632004|NCT00042289|561747659|FG028|Overall Study|Lost to Follow-up|2|||
155632005|NCT00042289|561747660|FG029|Overall Study|Lost to Follow-up|0|||
155632006|NCT00042289|561747661|FG030|Overall Study|Lost to Follow-up|0|||
155632007|NCT00042289|561747662|FG031|Overall Study|Lost to Follow-up|2|||
155632008|NCT00042289|561747663|FG032|Overall Study|Lost to Follow-up|1|||
155632009|NCT00042289|561747664|FG033|Overall Study|Lost to Follow-up|1|||
155632010|NCT00042289|561747665|FG034|Overall Study|Lost to Follow-up|1|||
155632011|NCT00042289|561747666|FG035|Overall Study|Lost to Follow-up|2|||
155632012|NCT00042289|561747667|FG036|Overall Study|Lost to Follow-up|1|||
155632013|NCT00042289|561747668|FG037|Overall Study|Lost to Follow-up|1|||
155632014|NCT00042289|561747669|FG038|Overall Study|Lost to Follow-up|0|||
155632015|NCT00042289|561747670|FG039|Overall Study|Lost to Follow-up|5|||
155632016|NCT00042289|561747671|FG040|Overall Study|Lost to Follow-up|0|||
155632017|NCT00042289|561747672|FG041|Overall Study|Lost to Follow-up|2|||
155632018|NCT00042289|561747673|FG042|Overall Study|Lost to Follow-up|2|||
155632019|NCT00042289|561747674|FG043|Overall Study|Lost to Follow-up|0|||
155632020|NCT00042289|561747675|FG044|Overall Study|Lost to Follow-up|0|||
155632021|NCT00042289|561747676|FG045|Overall Study|Lost to Follow-up|1|||
155632022|NCT00042289|561747677|FG046|Overall Study|Lost to Follow-up|0|||
155632023|NCT00042289|561747631|FG000|Overall Study|Other reason|0|||
155632024|NCT00042289|561747632|FG001|Overall Study|Other reason|0|||
155632025|NCT00042289|561747633|FG002|Overall Study|Other reason|0|||
155632026|NCT00042289|561747634|FG003|Overall Study|Other reason|2|||
155632027|NCT00042289|561747635|FG004|Overall Study|Other reason|0|||
155632028|NCT00042289|561747636|FG005|Overall Study|Other reason|0|||
155632029|NCT00042289|561747637|FG006|Overall Study|Other reason|0|||
155632030|NCT00042289|561747638|FG007|Overall Study|Other reason|0|||
155632031|NCT00042289|561747639|FG008|Overall Study|Other reason|0|||
155632032|NCT00042289|561747640|FG009|Overall Study|Other reason|0|||
155632033|NCT00042289|561747641|FG010|Overall Study|Other reason|0|||
155632034|NCT00042289|561747642|FG011|Overall Study|Other reason|0|||
155734586|NCT01077076|562127146|FG003|First Intervention|Withdrawal by Subject|0|||
155734587|NCT01077076|562127147|FG004|First Intervention|Withdrawal by Subject|0|||
155282060|NCT02303574|560464033|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282061|NCT02303574|560464034|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282062|NCT02303574|560464035|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155632035|NCT00042289|561747643|FG012|Overall Study|Other reason|0|||
155632036|NCT00042289|561747644|FG013|Overall Study|Other reason|0|||
155632037|NCT00042289|561747645|FG014|Overall Study|Other reason|0|||
155632038|NCT00042289|561747646|FG015|Overall Study|Other reason|0|||
155632039|NCT00042289|561747647|FG016|Overall Study|Other reason|0|||
155632040|NCT00042289|561747648|FG017|Overall Study|Other reason|0|||
155632041|NCT00042289|561747649|FG018|Overall Study|Other reason|1|||
155632042|NCT00042289|561747650|FG019|Overall Study|Other reason|0|||
155734588|NCT01077076|562127148|FG005|First Intervention|Withdrawal by Subject|0|||
155734589|NCT01077076|562127143|FG000|Third Intervention|Death in the participant's family|0|||
155734590|NCT01077076|562127144|FG001|Third Intervention|Death in the participant's family|0|||
155734591|NCT01077076|562127145|FG002|Third Intervention|Death in the participant's family|0|||
155734592|NCT01077076|562127146|FG003|Third Intervention|Death in the participant's family|0|||
155734593|NCT01077076|562127147|FG004|Third Intervention|Death in the participant's family|0|||
155734594|NCT01077076|562127148|FG005|Third Intervention|Death in the participant's family|1|||
155734595|NCT01388335|562127151|FG000|Period 1|Progressive Disease|1|||
155734596|NCT01388335|562127151|FG000|Period 2|Progressive Disease|2|||
155734597|NCT01388335|562127151|FG000|Period 2|Sponsor Decision|1|||
155282063|NCT02303574|560464036|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282064|NCT02303574|560464037|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282065|NCT02303574|560464038|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282066|NCT02303574|560464029|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282067|NCT02303574|560464030|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282068|NCT02303574|560464031|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282069|NCT02303574|560464032|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282070|NCT02303574|560464033|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282071|NCT02303574|560464034|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282072|NCT02303574|560464035|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282073|NCT02303574|560464036|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
155282074|NCT02303574|560464037|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282075|NCT02303574|560464038|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282076|NCT00994279|560464043|FG000|Overall Study|Withdrawal by Subject|2|||
155391653|NCT02684357|560869549|FG003|Part B|Withdrawal by Subject|0|||
155632043|NCT00042289|561747651|FG020|Overall Study|Other reason|0|||
155734598|NCT01388335|562127151|FG000|Safety Extension|Progressive Disease|7|||
155734599|NCT01301027|562127156|FG000|Overall Study|Physician Decision|2|||
155734600|NCT01301027|562127157|FG001|Overall Study|Physician Decision|0|||
155734601|NCT01301027|562127156|FG000|Overall Study|Withdrawal by Subject|2|||
155734602|NCT01301027|562127157|FG001|Overall Study|Withdrawal by Subject|3|||
155734603|NCT01301027|562127156|FG000|Overall Study|Adverse Event|0|||
155734604|NCT01301027|562127157|FG001|Overall Study|Adverse Event|2|||
155734605|NCT01301027|562127156|FG000|Overall Study|Fracture|1|||
155734606|NCT01301027|562127157|FG001|Overall Study|Fracture|3|||
155734607|NCT01301027|562127156|FG000|Overall Study|Transplant|0|||
155734608|NCT01301027|562127157|FG001|Overall Study|Transplant|2|||
155734609|NCT01301027|562127156|FG000|Overall Study|Volume Overload|3|||
155734610|NCT01301027|562127157|FG001|Overall Study|Volume Overload|0|||
155734611|NCT00845897|562127158|FG000|Overall Study|Lost to Follow-up|1|||
155734612|NCT00845897|562127159|FG001|Overall Study|Lost to Follow-up|1|||
155734613|NCT00845897|562127160|FG002|Overall Study|Lost to Follow-up|0|||
155734614|NCT00845897|562127158|FG000|Overall Study|Withdrawal by Subject|0|||
155734615|NCT00845897|562127159|FG001|Overall Study|Withdrawal by Subject|3|||
155734616|NCT00845897|562127160|FG002|Overall Study|Withdrawal by Subject|2|||
155734617|NCT00845897|562127158|FG000|Overall Study|Ulcer did not heal|1|||
155734618|NCT00845897|562127159|FG001|Overall Study|Ulcer did not heal|0|||
155734619|NCT00845897|562127160|FG002|Overall Study|Ulcer did not heal|1|||
155734620|NCT00845897|562127158|FG000|Overall Study|Too ill to participate|0|||
155734621|NCT00845897|562127159|FG001|Overall Study|Too ill to participate|1|||
155734622|NCT00845897|562127160|FG002|Overall Study|Too ill to participate|0|||
155734623|NCT03566485|562127169|FG000|Overall Study|Disease progression|5|||
155734624|NCT03566485|562127170|FG001|Overall Study|Disease progression|4|||
155734625|NCT03566485|562127169|FG000|Overall Study|Clinical progression|0|||
155734626|NCT03566485|562127170|FG001|Overall Study|Clinical progression|1|||
155734627|NCT03566485|562127169|FG000|Overall Study|Toxicity|0|||
155734628|NCT03566485|562127170|FG001|Overall Study|Toxicity|2|||
155734629|NCT03610269|562127171|FG000|Overall Study|Physician Decision|10|||
155734630|NCT03610269|562127171|FG000|Overall Study|Protocol Violation|1|||
155282077|NCT00994279|560464044|FG001|Overall Study|Withdrawal by Subject|2|||
155282078|NCT00994279|560464043|FG000|Overall Study|Toxicity|1|||
155632044|NCT00042289|561747652|FG021|Overall Study|Other reason|0|||
155632045|NCT00042289|561747653|FG022|Overall Study|Other reason|0|||
155632046|NCT00042289|561747654|FG023|Overall Study|Other reason|1|||
155632047|NCT00042289|561747655|FG024|Overall Study|Other reason|0|||
155632048|NCT00042289|561747656|FG025|Overall Study|Other reason|0|||
155632049|NCT00042289|561747657|FG026|Overall Study|Other reason|1|||
155632050|NCT00042289|561747658|FG027|Overall Study|Other reason|0|||
155632051|NCT00042289|561747659|FG028|Overall Study|Other reason|3|||
155632052|NCT00042289|561747660|FG029|Overall Study|Other reason|0|||
155632053|NCT00042289|561747661|FG030|Overall Study|Other reason|0|||
155632054|NCT00042289|561747662|FG031|Overall Study|Other reason|1|||
155632055|NCT00042289|561747663|FG032|Overall Study|Other reason|0|||
155632056|NCT00042289|561747664|FG033|Overall Study|Other reason|1|||
155632057|NCT00042289|561747665|FG034|Overall Study|Other reason|0|||
155632058|NCT00042289|561747666|FG035|Overall Study|Other reason|2|||
155734631|NCT03610269|562127171|FG000|Overall Study|Unable to draw blood|1|||
155734632|NCT03610269|562127171|FG000|Overall Study|Screen fail|4|||
155734633|NCT01354314|562127172|FG000|Overall Study|Lost to Follow-up|1|||
155734634|NCT01354314|562127173|FG001|Overall Study|Lost to Follow-up|0|||
155734635|NCT01354314|562127174|FG002|Overall Study|Lost to Follow-up|1|||
155734636|NCT01354314|562127175|FG003|Overall Study|Lost to Follow-up|1|||
155734637|NCT01354314|562127172|FG000|Overall Study|Withdrawal by Subject|0|||
155734638|NCT01354314|562127173|FG001|Overall Study|Withdrawal by Subject|0|||
155734639|NCT01354314|562127174|FG002|Overall Study|Withdrawal by Subject|1|||
155734640|NCT01354314|562127175|FG003|Overall Study|Withdrawal by Subject|0|||
155734641|NCT01354314|562127172|FG000|Overall Study|Adverse Event|0|||
155734642|NCT01354314|562127173|FG001|Overall Study|Adverse Event|0|||
155734643|NCT01354314|562127174|FG002|Overall Study|Adverse Event|0|||
155734644|NCT01354314|562127175|FG003|Overall Study|Adverse Event|1|||
155734645|NCT01354314|562127172|FG000|Overall Study|Protocol Violation|1|||
155391654|NCT02684357|560869550|FG004|Part B|Withdrawal by Subject|2|||
155391655|NCT02684357|560869551|FG005|Part B|Withdrawal by Subject|4|||
155391656|NCT02684357|560869546|FG000|Part B|Other|0|||
155391657|NCT02684357|560869547|FG001|Part B|Other|0|||
155391658|NCT02684357|560869548|FG002|Part B|Other|0|||
155391659|NCT02684357|560869549|FG003|Part B|Other|1|||
155391660|NCT02684357|560869550|FG004|Part B|Other|0|||
155391661|NCT02684357|560869551|FG005|Part B|Other|1|||
155391662|NCT01853982|560869552|FG000|Overall Study|Withdrawal by Subject|1|||
155391663|NCT01853982|560869553|FG001|Overall Study|Withdrawal by Subject|0|||
155734646|NCT01354314|562127173|FG001|Overall Study|Protocol Violation|1|||
155734647|NCT01354314|562127174|FG002|Overall Study|Protocol Violation|0|||
155734648|NCT01354314|562127175|FG003|Overall Study|Protocol Violation|0|||
155734649|NCT01354314|562127172|FG000|Overall Study|Less than 90% Adherence|4|||
155734650|NCT01354314|562127173|FG001|Overall Study|Less than 90% Adherence|2|||
155734651|NCT01354314|562127174|FG002|Overall Study|Less than 90% Adherence|6|||
155734652|NCT01354314|562127175|FG003|Overall Study|Less than 90% Adherence|4|||
155734653|NCT00369265|562127176|FG000|Overall Study|Study terminated|4|||
155734654|NCT00369265|562127177|FG001|Overall Study|Study terminated|7|||
155734655|NCT00714870|562127178|FG000|Overall Study|Lost to Follow-up|22|||
155734656|NCT00714870|562127179|FG001|Overall Study|Lost to Follow-up|5|||
155734657|NCT00714870|562127178|FG000|Overall Study|patient unable to come b/c back pain|1|||
155734658|NCT00714870|562127179|FG001|Overall Study|patient unable to come b/c back pain|0|||
155734659|NCT00714870|562127178|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
155734660|NCT00714870|562127179|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
155734661|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
155734662|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
155734663|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
155734664|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
155734665|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734666|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734667|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734668|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155734669|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155734670|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734671|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
155734672|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734673|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734674|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734675|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
155734676|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
155734677|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
155734678|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
155734679|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734680|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734681|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734682|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
155734683|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155734684|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
155734685|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155734686|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155734687|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155734688|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155734689|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
155734690|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
155391664|NCT01853982|560869552|FG000|Overall Study|Death|1|||
155391665|NCT01853982|560869553|FG001|Overall Study|Death|0|||
155391666|NCT01853982|560869552|FG000|Overall Study|Lost to Follow-up|0|||
155391667|NCT01853982|560869553|FG001|Overall Study|Lost to Follow-up|1|||
155391668|NCT00390910|560869554|FG000|Overall Study|Adverse Event|1|||
155391669|NCT00390910|560869555|FG001|Overall Study|Adverse Event|0|||
155734691|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
155391670|NCT00390910|560869556|FG002|Overall Study|Adverse Event|0|||
155391671|NCT00390910|560869554|FG000|Overall Study|Lost to Follow-up|0|||
155391672|NCT00390910|560869555|FG001|Overall Study|Lost to Follow-up|1|||
155391673|NCT00390910|560869556|FG002|Overall Study|Lost to Follow-up|5|||
155734692|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
155734693|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
155734694|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
155734695|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
155282079|NCT00994279|560464044|FG001|Overall Study|Toxicity|0|||
155282080|NCT00994279|560464043|FG000|Overall Study|Multiple reasons|1|||
155282081|NCT00994279|560464044|FG001|Overall Study|Multiple reasons|3|||
155282082|NCT01606189|560464045|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282083|NCT01606189|560464046|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282084|NCT01606189|560464047|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282085|NCT01606189|560464048|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282086|NCT01606189|560464049|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282087|NCT01606189|560464050|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
155282088|NCT01606189|560464045|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282089|NCT01606189|560464046|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282090|NCT01606189|560464047|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282091|NCT01606189|560464048|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282092|NCT01606189|560464049|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282093|NCT01606189|560464050|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
155282094|NCT00859014|560464051|FG000|Overall Study|Death|4|||
155282095|NCT00859014|560464051|FG000|Overall Study|Lost to Follow-up|1|||
155282096|NCT00162942|560464052|FG000|Overall Study|Adverse Event|10|||
155282097|NCT00162942|560464053|FG001|Overall Study|Adverse Event|6|||
155282098|NCT00162942|560464052|FG000|Overall Study|Death|1|||
155282099|NCT00162942|560464053|FG001|Overall Study|Death|0|||
155282100|NCT00162942|560464052|FG000|Overall Study|Withdrawal by Subject|3|||
155282101|NCT00162942|560464053|FG001|Overall Study|Withdrawal by Subject|6|||
155282102|NCT00162942|560464052|FG000|Overall Study|Physician Decision|1|||
155282103|NCT00162942|560464053|FG001|Overall Study|Physician Decision|0|||
155282104|NCT00162942|560464052|FG000|Overall Study|Enter Open-Label Study|76|||
155282105|NCT00162942|560464053|FG001|Overall Study|Enter Open-Label Study|35|||
155282106|NCT00162942|560464052|FG000|Overall Study|Alternate Therapy|6|||
155282107|NCT00162942|560464053|FG001|Overall Study|Alternate Therapy|2|||
155282108|NCT00162942|560464052|FG000|Overall Study|Lack of Efficacy|1|||
155282109|NCT00162942|560464053|FG001|Overall Study|Lack of Efficacy|0|||
155282110|NCT00162942|560464052|FG000|Overall Study|Flare During Active Treatment|7|||
155282111|NCT00162942|560464053|FG001|Overall Study|Flare During Active Treatment|3|||
155282112|NCT00162942|560464052|FG000|Overall Study|2 or more consecutive treatments missed|1|||
155282113|NCT00162942|560464053|FG001|Overall Study|2 or more consecutive treatments missed|0|||
155282114|NCT01354938|560464054|FG000|Overall Study|Lost to Follow-up|1|||
155282115|NCT01167023|560464055|FG000|Overall Study|Lost to Follow-up|0|||
155282116|NCT01167023|560464056|FG001|Overall Study|Lost to Follow-up|1|||
155282117|NCT01167023|560464057|FG002|Overall Study|Lost to Follow-up|1|||
155282118|NCT01167023|560464055|FG000|Overall Study|Screen Failure|0|||
155282119|NCT01167023|560464056|FG001|Overall Study|Screen Failure|1|||
155282120|NCT01167023|560464057|FG002|Overall Study|Screen Failure|0|||
155282121|NCT01167023|560464055|FG000|Overall Study|Sponsor Decision|0|||
155282122|NCT01167023|560464056|FG001|Overall Study|Sponsor Decision|1|||
155282123|NCT01167023|560464057|FG002|Overall Study|Sponsor Decision|0|||
155282124|NCT01167023|560464055|FG000|Overall Study|Withdrawal by Subject|0|||
155282125|NCT01167023|560464056|FG001|Overall Study|Withdrawal by Subject|0|||
155282126|NCT01167023|560464057|FG002|Overall Study|Withdrawal by Subject|1|||
155282127|NCT00410384|560464058|FG000|Overall Study|Withdrawal by Subject|28|||
155282128|NCT00410384|560464059|FG001|Overall Study|Withdrawal by Subject|17|||
155282129|NCT00410384|560464060|FG002|Overall Study|Withdrawal by Subject|20|||
155282130|NCT00410384|560464058|FG000|Overall Study|Adverse Event|23|||
155282131|NCT00410384|560464059|FG001|Overall Study|Adverse Event|18|||
155282132|NCT00410384|560464060|FG002|Overall Study|Adverse Event|23|||
155282133|NCT00410384|560464058|FG000|Overall Study|Lack of Efficacy|20|||
155282134|NCT00410384|560464059|FG001|Overall Study|Lack of Efficacy|12|||
155391674|NCT00390910|560869554|FG000|Overall Study|Withdrawal by Subject|1|||
155391675|NCT00390910|560869555|FG001|Overall Study|Withdrawal by Subject|3|||
155282135|NCT00410384|560464060|FG002|Overall Study|Lack of Efficacy|17|||
155282136|NCT00410384|560464058|FG000|Overall Study|Lack of Compliance|2|||
155282137|NCT00410384|560464059|FG001|Overall Study|Lack of Compliance|2|||
155282138|NCT00410384|560464060|FG002|Overall Study|Lack of Compliance|2|||
155391676|NCT00390910|560869556|FG002|Overall Study|Withdrawal by Subject|2|||
155391677|NCT00390910|560869554|FG000|Overall Study|Migrated/moved from study area|0|||
155391678|NCT00390910|560869555|FG001|Overall Study|Migrated/moved from study area|0|||
155391679|NCT00390910|560869556|FG002|Overall Study|Migrated/moved from study area|3|||
155391680|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
155391681|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391682|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391683|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391684|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391685|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391686|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
155391687|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
155391688|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391689|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391690|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391691|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391692|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391693|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
155391694|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391695|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391696|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391697|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391698|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
155391699|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391700|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391701|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391702|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391703|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155632059|NCT00042289|561747667|FG036|Overall Study|Other reason|0|||
155632060|NCT00042289|561747668|FG037|Overall Study|Other reason|0|||
155632061|NCT00042289|561747669|FG038|Overall Study|Other reason|0|||
155632062|NCT00042289|561747670|FG039|Overall Study|Other reason|0|||
155632063|NCT00042289|561747671|FG040|Overall Study|Other reason|0|||
155632064|NCT00042289|561747672|FG041|Overall Study|Other reason|0|||
155632065|NCT00042289|561747673|FG042|Overall Study|Other reason|0|||
155632066|NCT00042289|561747674|FG043|Overall Study|Other reason|1|||
155632067|NCT00042289|561747675|FG044|Overall Study|Other reason|0|||
155632068|NCT00042289|561747676|FG045|Overall Study|Other reason|0|||
155632069|NCT00042289|561747677|FG046|Overall Study|Other reason|0|||
155632070|NCT00042289|561747631|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155632071|NCT00042289|561747632|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155632072|NCT00042289|561747633|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155632073|NCT00042289|561747634|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155632074|NCT00042289|561747635|FG004|Overall Study|Severe debilitation, unable to continue|0|||
155632075|NCT00042289|561747636|FG005|Overall Study|Severe debilitation, unable to continue|0|||
155632076|NCT00042289|561747637|FG006|Overall Study|Severe debilitation, unable to continue|0|||
155632077|NCT00042289|561747638|FG007|Overall Study|Severe debilitation, unable to continue|0|||
155632078|NCT00042289|561747639|FG008|Overall Study|Severe debilitation, unable to continue|0|||
155632079|NCT00042289|561747640|FG009|Overall Study|Severe debilitation, unable to continue|0|||
155632080|NCT00042289|561747641|FG010|Overall Study|Severe debilitation, unable to continue|0|||
155632081|NCT00042289|561747642|FG011|Overall Study|Severe debilitation, unable to continue|0|||
155632082|NCT00042289|561747643|FG012|Overall Study|Severe debilitation, unable to continue|0|||
155632083|NCT00042289|561747644|FG013|Overall Study|Severe debilitation, unable to continue|0|||
155632084|NCT00042289|561747645|FG014|Overall Study|Severe debilitation, unable to continue|0|||
155632085|NCT00042289|561747646|FG015|Overall Study|Severe debilitation, unable to continue|0|||
155632086|NCT00042289|561747647|FG016|Overall Study|Severe debilitation, unable to continue|0|||
155632087|NCT00042289|561747648|FG017|Overall Study|Severe debilitation, unable to continue|0|||
155632088|NCT00042289|561747649|FG018|Overall Study|Severe debilitation, unable to continue|0|||
155632089|NCT00042289|561747650|FG019|Overall Study|Severe debilitation, unable to continue|0|||
155632090|NCT00042289|561747651|FG020|Overall Study|Severe debilitation, unable to continue|0|||
155632091|NCT00042289|561747652|FG021|Overall Study|Severe debilitation, unable to continue|1|||
155632092|NCT00042289|561747653|FG022|Overall Study|Severe debilitation, unable to continue|0|||
155632093|NCT00042289|561747654|FG023|Overall Study|Severe debilitation, unable to continue|1|||
155632094|NCT00042289|561747655|FG024|Overall Study|Severe debilitation, unable to continue|0|||
155632095|NCT00042289|561747656|FG025|Overall Study|Severe debilitation, unable to continue|0|||
155632096|NCT00042289|561747657|FG026|Overall Study|Severe debilitation, unable to continue|0|||
155632097|NCT00042289|561747658|FG027|Overall Study|Severe debilitation, unable to continue|1|||
155632098|NCT00042289|561747659|FG028|Overall Study|Severe debilitation, unable to continue|0|||
155734696|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
155734697|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734698|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734699|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734700|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734701|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734702|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734703|NCT05019521|562127180|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155734704|NCT05019521|562127181|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734705|NCT05019521|562127182|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155734706|NCT05019521|562127183|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
155734707|NCT05019521|562127184|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734708|NCT05019521|562127185|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734709|NCT05019521|562127186|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734710|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
155734711|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
155734712|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
155734713|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734714|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734715|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155734716|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
155734717|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155734718|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
155734719|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155734720|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734721|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734722|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155734723|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155734724|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
155734725|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734726|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734727|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155734728|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
155734729|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
155734730|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
155734731|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155734732|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
155734733|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
155734734|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155734735|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155734736|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155734737|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155734738|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
155734739|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
155734740|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
155734741|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
155734742|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
155734743|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
155734744|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
155734745|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734746|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734747|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734748|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734749|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734750|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
155734751|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155734752|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155391704|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
155391705|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
155391706|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
155391707|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
155391708|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
155734753|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
155391709|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
155734754|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155734755|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734756|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155734757|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
155734758|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155391710|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
155391711|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
155391712|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
155734759|NCT05019521|562127180|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
155734760|NCT05019521|562127181|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
155734761|NCT05019521|562127182|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
155734762|NCT05019521|562127183|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
155391713|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
155391714|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
155391715|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
155391716|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391717|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391718|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
155391719|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391720|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
155391721|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391722|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391723|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391724|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391725|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
155391726|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
155391727|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
155391728|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
155391729|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
155391730|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
155391731|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
155391732|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
155391733|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
155391734|NCT03872453|560871124|FG000|Overall Study|Adverse Event|1|||
155391735|NCT03872453|560871125|FG001|Overall Study|Adverse Event|1|||
155391736|NCT03872453|560871126|FG002|Overall Study|Adverse Event|0|||
155391737|NCT03872453|560871127|FG003|Overall Study|Adverse Event|0|||
155391738|NCT03872453|560871124|FG000|Overall Study|Lost to Follow-up|8|||
155391739|NCT03872453|560871125|FG001|Overall Study|Lost to Follow-up|7|||
155391740|NCT03872453|560871126|FG002|Overall Study|Lost to Follow-up|4|||
155391741|NCT03872453|560871127|FG003|Overall Study|Lost to Follow-up|4|||
155391742|NCT03872453|560871124|FG000|Overall Study|Never Treated Migraine|19|||
155391743|NCT03872453|560871125|FG001|Overall Study|Never Treated Migraine|17|||
155391744|NCT03872453|560871126|FG002|Overall Study|Never Treated Migraine|13|||
155391745|NCT03872453|560871127|FG003|Overall Study|Never Treated Migraine|12|||
155391746|NCT03872453|560871124|FG000|Overall Study|Pregnancy|1|||
155391747|NCT03872453|560871125|FG001|Overall Study|Pregnancy|0|||
155391748|NCT03872453|560871126|FG002|Overall Study|Pregnancy|0|||
155734763|NCT05019521|562127184|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
155734764|NCT05019521|562127185|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
155734765|NCT05019521|562127186|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
155391749|NCT03872453|560871127|FG003|Overall Study|Pregnancy|0|||
155391750|NCT03872453|560871124|FG000|Overall Study|Protocol Deviation|2|||
155391751|NCT03872453|560871125|FG001|Overall Study|Protocol Deviation|0|||
155391752|NCT03872453|560871126|FG002|Overall Study|Protocol Deviation|0|||
155391753|NCT03872453|560871127|FG003|Overall Study|Protocol Deviation|2|||
155391754|NCT03872453|560871124|FG000|Overall Study|Withdrawal by Subject|0|||
155391755|NCT03872453|560871125|FG001|Overall Study|Withdrawal by Subject|1|||
155734766|NCT02721966|562127187|FG000|Overall Study|Protocol Violation|1|||
155734767|NCT02721966|562127188|FG001|Overall Study|Protocol Violation|0|||
155734768|NCT02721966|562127189|FG002|Overall Study|Protocol Violation|0|||
155391756|NCT03872453|560871126|FG002|Overall Study|Withdrawal by Subject|2|||
155391757|NCT03872453|560871127|FG003|Overall Study|Withdrawal by Subject|0|||
155391758|NCT03872453|560871124|FG000|Overall Study|Other Than Specified|1|||
155391759|NCT03872453|560871125|FG001|Overall Study|Other Than Specified|0|||
155391760|NCT03872453|560871126|FG002|Overall Study|Other Than Specified|0|||
155391761|NCT03872453|560871127|FG003|Overall Study|Other Than Specified|0|||
155391762|NCT00352885|560871128|FG000|Overall Study|Withdrawal by Subject|0|||
155391763|NCT00352885|560871129|FG001|Overall Study|Withdrawal by Subject|3|||
155391764|NCT00352885|560871128|FG000|Overall Study|Development of major depression|0|||
155391765|NCT00352885|560871129|FG001|Overall Study|Development of major depression|1|||
155391766|NCT00352885|560871128|FG000|Overall Study|Progression of metastatic melanoma|5|||
155391767|NCT00352885|560871129|FG001|Overall Study|Progression of metastatic melanoma|3|||
155391768|NCT00352885|560871128|FG000|Overall Study|Side effects of IL-2 administration|1|||
155391769|NCT00352885|560871129|FG001|Overall Study|Side effects of IL-2 administration|0|||
155391770|NCT01678209|560871130|FG000|Overall Study|could not scan twice|1|||
155391771|NCT01678209|560871131|FG001|Overall Study|could not scan twice|1|||
155391772|NCT01678209|560871132|FG002|Overall Study|could not scan twice|1|||
155391773|NCT01678209|560871130|FG000|Overall Study|scheduling conflicts|0|||
155391774|NCT01678209|560871131|FG001|Overall Study|scheduling conflicts|0|||
155391775|NCT01678209|560871132|FG002|Overall Study|scheduling conflicts|1|||
155391776|NCT01678209|560871130|FG000|Overall Study|screen fail|16|||
155391777|NCT01678209|560871131|FG001|Overall Study|screen fail|17|||
155391778|NCT01678209|560871132|FG002|Overall Study|screen fail|16|||
155391779|NCT03756350|560871136|FG000|Overall Study|Lost to Follow-up|1|||
155391780|NCT00928564|560871140|FG000|Overall Study|Lost to Follow-up|6|||
155391781|NCT00928564|560871141|FG001|Overall Study|Lost to Follow-up|0|||
155391782|NCT03434353|560871144|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
155391783|NCT03434353|560871145|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
155391784|NCT03434353|560871146|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
155391785|NCT03434353|560871147|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
155391786|NCT03434353|560871148|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
155391787|NCT03434353|560871144|FG000|Overall Study|Withdrew consent|1|||
155391788|NCT03434353|560871145|FG001|Overall Study|Withdrew consent|0|||
155391789|NCT03434353|560871146|FG002|Overall Study|Withdrew consent|3|||
155391790|NCT03434353|560871147|FG003|Overall Study|Withdrew consent|0|||
155391791|NCT03434353|560871148|FG004|Overall Study|Withdrew consent|0|||
155391792|NCT03434353|560871144|FG000|Overall Study|Adverse Event|1|||
155391793|NCT03434353|560871145|FG001|Overall Study|Adverse Event|0|||
155391794|NCT03434353|560871146|FG002|Overall Study|Adverse Event|0|||
155391795|NCT03434353|560871147|FG003|Overall Study|Adverse Event|0|||
155391796|NCT03434353|560871148|FG004|Overall Study|Adverse Event|1|||
155391797|NCT03434353|560871144|FG000|Overall Study|Lost to Follow-up|2|||
155391798|NCT03434353|560871145|FG001|Overall Study|Lost to Follow-up|0|||
155391799|NCT03434353|560871146|FG002|Overall Study|Lost to Follow-up|0|||
155391800|NCT03434353|560871147|FG003|Overall Study|Lost to Follow-up|0|||
155391801|NCT03434353|560871148|FG004|Overall Study|Lost to Follow-up|0|||
155391802|NCT03739762|560871149|FG000|Overall Study|Lost to Follow-up|1|||
155391803|NCT03739762|560871150|FG001|Overall Study|Lost to Follow-up|1|||
155391804|NCT03739762|560871149|FG000|Overall Study|Withdrawal by Subject|2|||
155391805|NCT03739762|560871150|FG001|Overall Study|Withdrawal by Subject|6|||
155391806|NCT01521897|560871153|FG000|Overall Study|Protocol Violation|18|||
155391807|NCT01521897|560871153|FG000|Overall Study|Lost to Follow-up|5|||
155391808|NCT00385203|560871154|FG000|Overall Study|Adverse Event|5|||
155391809|NCT00385203|560871155|FG001|Overall Study|Adverse Event|4|||
155391810|NCT00385203|560871154|FG000|Overall Study|Death|1|||
155391811|NCT00385203|560871155|FG001|Overall Study|Death|0|||
155391812|NCT00385203|560871154|FG000|Overall Study|Condition under investigation worsened|18|||
155391813|NCT00385203|560871155|FG001|Overall Study|Condition under investigation worsened|3|||
155391814|NCT00385203|560871154|FG000|Overall Study|Incorrect enrollment|2|||
155391815|NCT00385203|560871155|FG001|Overall Study|Incorrect enrollment|0|||
155391816|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
155391817|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
155391818|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
155391819|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
155391820|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
155391821|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
155391822|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
155391823|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
155391824|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
155391825|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
155391826|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391827|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
155391828|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391829|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391830|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391831|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
155391832|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
155391833|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155391834|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155734769|NCT02721966|562127190|FG003|Overall Study|Protocol Violation|0|||
155734770|NCT02721966|562127191|FG004|Overall Study|Protocol Violation|0|||
155734771|NCT02721966|562127187|FG000|Overall Study|Withdrawal by Subject|9|||
155734772|NCT02721966|562127188|FG001|Overall Study|Withdrawal by Subject|2|||
155734773|NCT02721966|562127189|FG002|Overall Study|Withdrawal by Subject|3|||
155734774|NCT02721966|562127190|FG003|Overall Study|Withdrawal by Subject|7|||
155734775|NCT02721966|562127191|FG004|Overall Study|Withdrawal by Subject|0|||
155734776|NCT02721966|562127187|FG000|Overall Study|Adverse Event|4|||
155734777|NCT02721966|562127188|FG001|Overall Study|Adverse Event|4|||
155734778|NCT02721966|562127189|FG002|Overall Study|Adverse Event|3|||
155734779|NCT02721966|562127190|FG003|Overall Study|Adverse Event|0|||
155734780|NCT02721966|562127191|FG004|Overall Study|Adverse Event|0|||
155734781|NCT02721966|562127187|FG000|Overall Study|Death|1|||
155734782|NCT02721966|562127188|FG001|Overall Study|Death|0|||
155734783|NCT02721966|562127189|FG002|Overall Study|Death|0|||
155734784|NCT02721966|562127190|FG003|Overall Study|Death|0|||
155734785|NCT02721966|562127191|FG004|Overall Study|Death|0|||
155734786|NCT02721966|562127187|FG000|Overall Study|Lack of Efficacy|7|||
155734787|NCT02721966|562127188|FG001|Overall Study|Lack of Efficacy|4|||
155734788|NCT02721966|562127189|FG002|Overall Study|Lack of Efficacy|0|||
155734789|NCT02721966|562127190|FG003|Overall Study|Lack of Efficacy|0|||
155734790|NCT02721966|562127191|FG004|Overall Study|Lack of Efficacy|0|||
155734791|NCT02721966|562127187|FG000|Overall Study|Lost to Follow-up|0|||
155734792|NCT02721966|562127188|FG001|Overall Study|Lost to Follow-up|0|||
155734793|NCT02721966|562127189|FG002|Overall Study|Lost to Follow-up|3|||
155734794|NCT02721966|562127190|FG003|Overall Study|Lost to Follow-up|0|||
155734795|NCT02721966|562127191|FG004|Overall Study|Lost to Follow-up|0|||
155734796|NCT02721966|562127187|FG000|Overall Study|Physician Decision|1|||
155734797|NCT02721966|562127188|FG001|Overall Study|Physician Decision|1|||
155734798|NCT02721966|562127189|FG002|Overall Study|Physician Decision|0|||
155734799|NCT02721966|562127190|FG003|Overall Study|Physician Decision|0|||
155734800|NCT02721966|562127191|FG004|Overall Study|Physician Decision|0|||
155734801|NCT02721966|562127187|FG000|Overall Study|Pregnancy|1|||
155734802|NCT02721966|562127188|FG001|Overall Study|Pregnancy|0|||
155734803|NCT02721966|562127189|FG002|Overall Study|Pregnancy|0|||
155734804|NCT02721966|562127190|FG003|Overall Study|Pregnancy|0|||
155282139|NCT00410384|560464058|FG000|Overall Study|Lost to Follow-up|4|||
155282140|NCT00410384|560464059|FG001|Overall Study|Lost to Follow-up|6|||
155282141|NCT00410384|560464060|FG002|Overall Study|Lost to Follow-up|6|||
155282142|NCT00410384|560464058|FG000|Overall Study|Protocol Violation|6|||
155282143|NCT00410384|560464059|FG001|Overall Study|Protocol Violation|6|||
155282144|NCT00410384|560464060|FG002|Overall Study|Protocol Violation|6|||
155282145|NCT00410384|560464058|FG000|Overall Study|Physician Decision|3|||
155282146|NCT00410384|560464059|FG001|Overall Study|Physician Decision|3|||
155282147|NCT00410384|560464060|FG002|Overall Study|Physician Decision|4|||
155282148|NCT00410384|560464058|FG000|Overall Study|Other|3|||
155282149|NCT00410384|560464059|FG001|Overall Study|Other|8|||
155282150|NCT00410384|560464060|FG002|Overall Study|Other|4|||
155282151|NCT00577629|560464063|FG000|Treatment Period|Death|1|||
155282152|NCT00577629|560464063|FG000|Long Term Follow-Up|Death|15|||
155282153|NCT00577629|560464063|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
155282154|NCT00577629|560464063|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
155282155|NCT00577629|560464063|FG000|Long Term Follow-Up|Physician Decision|1|||
155282156|NCT01027871|560464064|FG000|Overall Study|Physician Decision|1|||
155282157|NCT01027871|560464065|FG001|Overall Study|Physician Decision|5|||
155282158|NCT01027871|560464066|FG002|Overall Study|Physician Decision|0|||
155282159|NCT01027871|560464064|FG000|Overall Study|Protocol Violation|0|||
155282160|NCT01027871|560464065|FG001|Overall Study|Protocol Violation|2|||
155282161|NCT01027871|560464066|FG002|Overall Study|Protocol Violation|2|||
155282162|NCT01027871|560464064|FG000|Overall Study|Withdrawal by Subject|1|||
155282163|NCT01027871|560464065|FG001|Overall Study|Withdrawal by Subject|2|||
155282164|NCT01027871|560464066|FG002|Overall Study|Withdrawal by Subject|2|||
155282165|NCT01027871|560464064|FG000|Overall Study|Adverse Event|0|||
155282166|NCT01027871|560464065|FG001|Overall Study|Adverse Event|2|||
155282167|NCT01027871|560464066|FG002|Overall Study|Adverse Event|2|||
155282168|NCT01027871|560464064|FG000|Overall Study|Sponsor Decision|0|||
155734805|NCT02721966|562127191|FG004|Overall Study|Pregnancy|0|||
155734806|NCT02721966|562127187|FG000|Overall Study|Did not continue to period 2|5|||
155734807|NCT02721966|562127188|FG001|Overall Study|Did not continue to period 2|12|||
155734808|NCT02721966|562127189|FG002|Overall Study|Did not continue to period 2|0|||
155734809|NCT02721966|562127190|FG003|Overall Study|Did not continue to period 2|0|||
155734810|NCT02721966|562127191|FG004|Overall Study|Did not continue to period 2|5|||
155282169|NCT01027871|560464065|FG001|Overall Study|Sponsor Decision|2|||
155282170|NCT01027871|560464066|FG002|Overall Study|Sponsor Decision|0|||
155282171|NCT01027871|560464064|FG000|Overall Study|Discontinued Prior to Treatment|0|||
155282172|NCT01027871|560464065|FG001|Overall Study|Discontinued Prior to Treatment|0|||
155734811|NCT01192191|562127192|FG000|Overall Study|Adverse Event|7|||
155734812|NCT01192191|562127193|FG001|Overall Study|Adverse Event|12|||
155734813|NCT01192191|562127192|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
155734814|NCT01192191|562127193|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
155391835|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155391836|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391837|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391838|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391839|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
155391840|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391841|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391842|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391843|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391844|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
155391845|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391846|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391847|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391848|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391849|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
155391850|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391851|NCT01131351|560871161|FG000|Overall Study|Adverse Event|0|||
155391852|NCT01131351|560871162|FG001|Overall Study|Adverse Event|2|||
155391853|NCT01131351|560871161|FG000|Overall Study|Protocol Deviation|0|||
155391854|NCT01131351|560871162|FG001|Overall Study|Protocol Deviation|1|||
155391855|NCT02194062|560871163|FG000|Overall Study|Lost to Follow-up|2|||
155391856|NCT02194062|560871164|FG001|Overall Study|Lost to Follow-up|2|||
155391857|NCT02194062|560871165|FG002|Overall Study|Lost to Follow-up|5|||
155391858|NCT01008696|560871169|FG000|Overall Study|Participant's evasion of hospital visit|5|||
155391859|NCT01008696|560871170|FG001|Overall Study|Participant's evasion of hospital visit|4|||
155391860|NCT01008696|560871169|FG000|Overall Study|Withdrawal by Subject|2|||
155391861|NCT01008696|560871170|FG001|Overall Study|Withdrawal by Subject|4|||
155391862|NCT01008696|560871169|FG000|Overall Study|Physician Decision|5|||
155391863|NCT01008696|560871170|FG001|Overall Study|Physician Decision|1|||
155391864|NCT01008696|560871169|FG000|Overall Study|Adverse Event|1|||
155391865|NCT01008696|560871170|FG001|Overall Study|Adverse Event|0|||
155391866|NCT01008696|560871169|FG000|Overall Study|Participants' non-cooperation|2|||
155391867|NCT01008696|560871170|FG001|Overall Study|Participants' non-cooperation|3|||
155391868|NCT01008696|560871169|FG000|Overall Study|Other|2|||
155391869|NCT01008696|560871170|FG001|Overall Study|Other|3|||
155391870|NCT01008696|560871169|FG000|Overall Study|Other|0|||
155391871|NCT01008696|560871170|FG001|Overall Study|Other|2|||
155391872|NCT04964960|560871171|FG000|Overall Study|Withdrawal by Subject|1|||
155391873|NCT04964960|560871171|FG000|Overall Study|Did not complete cycles|1|||
155391874|NCT02960854|560871172|FG000|Overall Study|Not Disclosed|2|||
155391875|NCT02960854|560871173|FG001|Overall Study|Not Disclosed|2|||
155391876|NCT02960854|560871172|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
155391877|NCT02960854|560871173|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
155391878|NCT02960854|560871172|FG000|Overall Study|Subject Withdrew Consent|0|||
155391879|NCT02960854|560871173|FG001|Overall Study|Subject Withdrew Consent|1|||
155391880|NCT02960854|560871172|FG000|Overall Study|Death|4|||
155391881|NCT02960854|560871173|FG001|Overall Study|Death|6|||
155391882|NCT00221195|560871174|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
155391883|NCT00221195|560871175|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
155391884|NCT00221195|560871174|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
155391885|NCT00221195|560871175|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
155391886|NCT00221195|560871174|FG000|Washout Period (Months 7-9)|Death|0|||
155391887|NCT00221195|560871175|FG001|Washout Period (Months 7-9)|Death|1|||
155632099|NCT00042289|561747660|FG029|Overall Study|Severe debilitation, unable to continue|0|||
155632100|NCT00042289|561747661|FG030|Overall Study|Severe debilitation, unable to continue|0|||
155632101|NCT00042289|561747662|FG031|Overall Study|Severe debilitation, unable to continue|1|||
155632102|NCT00042289|561747663|FG032|Overall Study|Severe debilitation, unable to continue|1|||
155632103|NCT00042289|561747664|FG033|Overall Study|Severe debilitation, unable to continue|0|||
155632104|NCT00042289|561747665|FG034|Overall Study|Severe debilitation, unable to continue|0|||
155632105|NCT00042289|561747666|FG035|Overall Study|Severe debilitation, unable to continue|0|||
155632106|NCT00042289|561747667|FG036|Overall Study|Severe debilitation, unable to continue|0|||
155391888|NCT00221195|560871174|FG000|Therapy 2 (Months 10-15)|Death|1|||
155632107|NCT00042289|561747668|FG037|Overall Study|Severe debilitation, unable to continue|0|||
155391889|NCT00221195|560871175|FG001|Therapy 2 (Months 10-15)|Death|0|||
155391890|NCT00221195|560871174|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
155391891|NCT00221195|560871175|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
155391892|NCT00833911|560871177|FG000|Titration|Adverse Event|18|||
155391893|NCT00833911|560871177|FG000|Titration|Withdrawal by Subject|3|||
155391894|NCT00833911|560871177|FG000|Maintenance Phase I|Adverse Event|73|||
155391895|NCT00833911|560871177|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
155391896|NCT00833911|560871177|FG000|Maintenance Phase I|Physician Decision|10|||
155391897|NCT00833911|560871177|FG000|Maintenance Phase I|Lack of Efficacy|4|||
155391898|NCT00833911|560871177|FG000|Maintenance Phase II|Adverse Event|6|||
155391899|NCT00833911|560871177|FG000|Maintenance Phase II|Physician Decision|2|||
155391900|NCT00833911|560871177|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
155391901|NCT00833911|560871177|FG000|Maintenance Phase II|Lack of Efficacy|1|||
155391902|NCT01383161|560871178|FG000|Overall Study|Adverse Event|5|||
155391903|NCT01383161|560871179|FG001|Overall Study|Adverse Event|1|||
155391904|NCT01383161|560871178|FG000|Overall Study|Withdrawal by Subject|0|||
155391905|NCT01383161|560871179|FG001|Overall Study|Withdrawal by Subject|2|||
155391906|NCT01383161|560871178|FG000|Overall Study|Lack of Efficacy|0|||
155391907|NCT01383161|560871179|FG001|Overall Study|Lack of Efficacy|1|||
155391908|NCT01423812|560871188|FG000|Overall Study|Lost to Follow-up|2|||
155391909|NCT01423812|560871189|FG001|Overall Study|Lost to Follow-up|2|||
155391910|NCT01423812|560871188|FG000|Overall Study|Withdrawal by Subject|1|||
155391911|NCT01423812|560871189|FG001|Overall Study|Withdrawal by Subject|2|||
155391912|NCT03942406|560871190|FG000|Overall Study|Lost to Follow-up|4|||
155391913|NCT03942406|560871191|FG001|Overall Study|Lost to Follow-up|5|||
155391914|NCT03942406|560871192|FG002|Overall Study|Lost to Follow-up|3|||
155391915|NCT03942406|560871193|FG003|Overall Study|Lost to Follow-up|7|||
155391916|NCT03942406|560871194|FG004|Overall Study|Lost to Follow-up|1|||
155391917|NCT03942406|560871195|FG005|Overall Study|Lost to Follow-up|0|||
155391918|NCT03942406|560871196|FG006|Overall Study|Lost to Follow-up|0|||
155391919|NCT03942406|560871190|FG000|Overall Study|Withdrawal by Subject|3|||
155391920|NCT03942406|560871191|FG001|Overall Study|Withdrawal by Subject|1|||
155391921|NCT03942406|560871192|FG002|Overall Study|Withdrawal by Subject|1|||
155391922|NCT03942406|560871193|FG003|Overall Study|Withdrawal by Subject|3|||
155391923|NCT03942406|560871194|FG004|Overall Study|Withdrawal by Subject|0|||
155391924|NCT03942406|560871195|FG005|Overall Study|Withdrawal by Subject|0|||
155391925|NCT03942406|560871196|FG006|Overall Study|Withdrawal by Subject|0|||
155391926|NCT03942406|560871190|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
155391927|NCT03942406|560871191|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
155391928|NCT03942406|560871192|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
155391929|NCT03942406|560871193|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
155391930|NCT03942406|560871194|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
155391931|NCT03942406|560871195|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
155391932|NCT03942406|560871196|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
155391933|NCT01207596|560871197|FG000|Overall Study|Physician Decision|4|||
155391934|NCT01207596|560871197|FG000|Overall Study|Lack of Efficacy|1|||
155391935|NCT01207596|560871197|FG000|Overall Study|Adverse Event|3|||
155391936|NCT01207596|560871197|FG000|Overall Study|Withdrawal by Subject|1|||
155391937|NCT00216203|560871198|FG000|Overall Study|Withdrawal by Subject|2|||
155391938|NCT03155373|560871208|FG000|Overall Study|No longer required surgery|1|||
155391939|NCT03155373|560871208|FG000|Overall Study|Protocol Violation|1|||
155391940|NCT03155373|560871208|FG000|Overall Study|Death|2|||
155391941|NCT03155373|560871208|FG000|Overall Study|Withdrawal by Subject|3|||
155391942|NCT02616614|560871209|FG000|Overall Study|Withdrawal by Subject|10|||
155391943|NCT02616614|560871210|FG001|Overall Study|Withdrawal by Subject|5|||
155391944|NCT02616614|560871211|FG002|Overall Study|Withdrawal by Subject|6|||
155391945|NCT02616614|560871209|FG000|Overall Study|Physician Decision|2|||
155391946|NCT02616614|560871210|FG001|Overall Study|Physician Decision|1|||
155391947|NCT02616614|560871211|FG002|Overall Study|Physician Decision|0|||
155391948|NCT02616614|560871209|FG000|Overall Study|Adverse Event|1|||
155391949|NCT02616614|560871210|FG001|Overall Study|Adverse Event|4|||
155391950|NCT02616614|560871211|FG002|Overall Study|Adverse Event|1|||
155391951|NCT02616614|560871209|FG000|Overall Study|Protocol Violation|0|||
155391952|NCT02616614|560871210|FG001|Overall Study|Protocol Violation|3|||
155391953|NCT02616614|560871211|FG002|Overall Study|Protocol Violation|1|||
155391954|NCT02616614|560871209|FG000|Overall Study|Prohibited Medication|12|||
155391955|NCT02616614|560871210|FG001|Overall Study|Prohibited Medication|9|||
155391956|NCT02616614|560871211|FG002|Overall Study|Prohibited Medication|5|||
155391957|NCT02616614|560871209|FG000|Overall Study|More than 3 applications missed|6|||
155632108|NCT00042289|561747669|FG038|Overall Study|Severe debilitation, unable to continue|0|||
155632109|NCT00042289|561747670|FG039|Overall Study|Severe debilitation, unable to continue|0|||
155632110|NCT00042289|561747671|FG040|Overall Study|Severe debilitation, unable to continue|0|||
155632111|NCT00042289|561747672|FG041|Overall Study|Severe debilitation, unable to continue|0|||
155632112|NCT00042289|561747673|FG042|Overall Study|Severe debilitation, unable to continue|0|||
155632113|NCT00042289|561747674|FG043|Overall Study|Severe debilitation, unable to continue|0|||
155391958|NCT02616614|560871210|FG001|Overall Study|More than 3 applications missed|8|||
155391959|NCT02616614|560871211|FG002|Overall Study|More than 3 applications missed|1|||
155632114|NCT00042289|561747675|FG044|Overall Study|Severe debilitation, unable to continue|0|||
155632115|NCT00042289|561747676|FG045|Overall Study|Severe debilitation, unable to continue|0|||
155632116|NCT00042289|561747677|FG046|Overall Study|Severe debilitation, unable to continue|0|||
155391960|NCT02616614|560871209|FG000|Overall Study|Lost to Follow-up|31|||
155391961|NCT02616614|560871210|FG001|Overall Study|Lost to Follow-up|28|||
155391962|NCT02616614|560871211|FG002|Overall Study|Lost to Follow-up|13|||
155391963|NCT02616614|560871209|FG000|Overall Study|Pregnancy|2|||
155391964|NCT02616614|560871210|FG001|Overall Study|Pregnancy|0|||
155632117|NCT00042289|561747631|FG000|Overall Study|Site closed|0|||
155632118|NCT00042289|561747632|FG001|Overall Study|Site closed|0|||
155632119|NCT00042289|561747633|FG002|Overall Study|Site closed|0|||
155632120|NCT00042289|561747634|FG003|Overall Study|Site closed|0|||
155632121|NCT00042289|561747635|FG004|Overall Study|Site closed|0|||
155632122|NCT00042289|561747636|FG005|Overall Study|Site closed|0|||
155632123|NCT00042289|561747637|FG006|Overall Study|Site closed|0|||
155632124|NCT00042289|561747638|FG007|Overall Study|Site closed|0|||
155282173|NCT01027871|560464066|FG002|Overall Study|Discontinued Prior to Treatment|1|||
155282174|NCT03782727|560464067|FG000|Overall Study|Lost to Follow-up|32|||
155282175|NCT04887285|560464070|FG000|Overall Study|Lost to Follow-up|0|||
155282176|NCT04887285|560464071|FG001|Overall Study|Lost to Follow-up|2|||
155282177|NCT04887285|560464072|FG002|Overall Study|Lost to Follow-up|3|||
155282178|NCT04640571|560464073|FG000|Overall Study|Withdrawal by Subject|0|||
155282179|NCT04640571|560464074|FG001|Overall Study|Withdrawal by Subject|0|||
155282180|NCT04640571|560464075|FG002|Overall Study|Withdrawal by Subject|0|||
155282181|NCT04640571|560464076|FG003|Overall Study|Withdrawal by Subject|0|||
155282182|NCT04640571|560464077|FG004|Overall Study|Withdrawal by Subject|0|||
155282183|NCT04640571|560464078|FG005|Overall Study|Withdrawal by Subject|2|||
155282184|NCT02820051|560464079|FG000|Overall Study|Lost to Follow-up|7|||
155282185|NCT02820051|560464080|FG001|Overall Study|Lost to Follow-up|4|||
155282186|NCT02338609|560464081|FG000|Overall Study|Physician Decision|1|||
155282187|NCT02338609|560464081|FG000|Overall Study|Death|1|||
155282188|NCT00832780|560464082|FG000|Overall Study|Death|16|||
155282189|NCT00832780|560464082|FG000|Overall Study|Lost to Follow-up|4|||
155282190|NCT00832780|560464082|FG000|Overall Study|no reason given|2|||
155282191|NCT00832780|560464082|FG000|Overall Study|other complicating condition|2|||
155282192|NCT00832780|560464082|FG000|Overall Study|Physician Decision|1|||
155282193|NCT05705167|560464085|FG000|Overall Study|Randomised but not Treated|0|||
155282194|NCT05705167|560464086|FG001|Overall Study|Randomised but not Treated|2|||
155282195|NCT05705167|560464087|FG002|Overall Study|Randomised but not Treated|0|||
155282196|NCT05705167|560464088|FG003|Overall Study|Randomised but not Treated|7|||
155282197|NCT05705167|560464089|FG004|Overall Study|Randomised but not Treated|0|||
155282198|NCT05705167|560464090|FG005|Overall Study|Randomised but not Treated|0|||
155282199|NCT05705167|560464091|FG006|Overall Study|Randomised but not Treated|0|||
155282200|NCT05705167|560464085|FG000|Overall Study|Death|0|||
155282201|NCT05705167|560464086|FG001|Overall Study|Death|0|||
155282202|NCT05705167|560464087|FG002|Overall Study|Death|3|||
155282203|NCT05705167|560464088|FG003|Overall Study|Death|0|||
155282204|NCT05705167|560464089|FG004|Overall Study|Death|1|||
155282205|NCT05705167|560464090|FG005|Overall Study|Death|1|||
155282206|NCT05705167|560464091|FG006|Overall Study|Death|1|||
155282207|NCT05705167|560464085|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282208|NCT05705167|560464086|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282209|NCT05705167|560464087|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282210|NCT05705167|560464088|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282211|NCT05705167|560464089|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282212|NCT05705167|560464090|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282213|NCT05705167|560464091|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282214|NCT04736056|560464092|FG000|Overall Study|Death|0|||
155282215|NCT04736056|560464093|FG001|Overall Study|Death|0|||
155282216|NCT04736056|560464094|FG002|Overall Study|Death|0|||
155282217|NCT04736056|560464095|FG003|Overall Study|Death|1|||
155282218|NCT04736056|560464092|FG000|Overall Study|Lost to Follow-up|1|||
155282219|NCT04736056|560464093|FG001|Overall Study|Lost to Follow-up|0|||
155282220|NCT04736056|560464094|FG002|Overall Study|Lost to Follow-up|1|||
155282221|NCT04736056|560464095|FG003|Overall Study|Lost to Follow-up|1|||
155282222|NCT04736056|560464092|FG000|Overall Study|Withdrawal by Subject|2|||
155282223|NCT04736056|560464093|FG001|Overall Study|Withdrawal by Subject|0|||
155282224|NCT04736056|560464094|FG002|Overall Study|Withdrawal by Subject|0|||
155282225|NCT04736056|560464095|FG003|Overall Study|Withdrawal by Subject|0|||
155282226|NCT04736056|560464092|FG000|Overall Study|Physician Decision|1|||
155282227|NCT04736056|560464093|FG001|Overall Study|Physician Decision|0|||
155282228|NCT04736056|560464094|FG002|Overall Study|Physician Decision|1|||
155282229|NCT04736056|560464095|FG003|Overall Study|Physician Decision|0|||
155282230|NCT04529538|560464096|FG000|Overall Study|Lost to Follow-up|3|||
155282231|NCT04529538|560464097|FG001|Overall Study|Lost to Follow-up|2|||
155282232|NCT04529538|560464098|FG002|Overall Study|Lost to Follow-up|1|||
155282233|NCT04529538|560464099|FG003|Overall Study|Lost to Follow-up|0|||
155282234|NCT04529538|560464100|FG004|Overall Study|Lost to Follow-up|1|||
155282235|NCT04529538|560464101|FG005|Overall Study|Lost to Follow-up|1|||
155282236|NCT04529538|560464102|FG006|Overall Study|Lost to Follow-up|2|||
155282237|NCT04529538|560464103|FG007|Overall Study|Lost to Follow-up|0|||
155282238|NCT04529538|560464096|FG000|Overall Study|Not eligible at enrollment|0|||
155282239|NCT04529538|560464097|FG001|Overall Study|Not eligible at enrollment|1|||
155282240|NCT04529538|560464098|FG002|Overall Study|Not eligible at enrollment|2|||
155282241|NCT04529538|560464099|FG003|Overall Study|Not eligible at enrollment|1|||
155632125|NCT00042289|561747639|FG008|Overall Study|Site closed|0|||
155632126|NCT00042289|561747640|FG009|Overall Study|Site closed|0|||
155734815|NCT01192191|562127192|FG000|Overall Study|Lost to Follow-up|0|||
155734816|NCT01192191|562127193|FG001|Overall Study|Lost to Follow-up|1|||
155734817|NCT01192191|562127192|FG000|Overall Study|Withdrawal by Subject|1|||
155734818|NCT01192191|562127193|FG001|Overall Study|Withdrawal by Subject|6|||
155734819|NCT00467753|562127194|FG000|Overall Study|Lost to Follow-up|1|||
155734820|NCT00467753|562127195|FG001|Overall Study|Lost to Follow-up|2|||
155734821|NCT00467753|562127194|FG000|Overall Study|Adverse Event|2|||
155734822|NCT00467753|562127195|FG001|Overall Study|Adverse Event|0|||
155391965|NCT02616614|560871211|FG002|Overall Study|Pregnancy|1|||
155391966|NCT02616614|560871209|FG000|Overall Study|Other|1|||
155391967|NCT02616614|560871210|FG001|Overall Study|Other|2|||
155391968|NCT02616614|560871211|FG002|Overall Study|Other|1|||
155391969|NCT02748018|560871212|FG000|Study Period|Adverse Event|1|||
155391970|NCT02748018|560871213|FG001|Study Period|Adverse Event|3|||
155391971|NCT02748018|560871214|FG002|Study Period|Adverse Event|4|||
155391972|NCT02748018|560871215|FG003|Study Period|Adverse Event|0|||
155391973|NCT02748018|560871216|FG004|Study Period|Adverse Event|3|||
155391974|NCT02748018|560871217|FG005|Study Period|Adverse Event|3|||
155391975|NCT02748018|560871212|FG000|Study Period|Withdrawal by Subject|7|||
155391976|NCT02748018|560871213|FG001|Study Period|Withdrawal by Subject|4|||
155391977|NCT02748018|560871214|FG002|Study Period|Withdrawal by Subject|4|||
155391978|NCT02748018|560871215|FG003|Study Period|Withdrawal by Subject|11|||
155391979|NCT02748018|560871216|FG004|Study Period|Withdrawal by Subject|12|||
155391980|NCT02748018|560871217|FG005|Study Period|Withdrawal by Subject|10|||
155391981|NCT02748018|560871212|FG000|Study Period|Pregnancy|0|||
155391982|NCT02748018|560871213|FG001|Study Period|Pregnancy|1|||
155391983|NCT02748018|560871214|FG002|Study Period|Pregnancy|0|||
155391984|NCT02748018|560871215|FG003|Study Period|Pregnancy|0|||
155391985|NCT02748018|560871216|FG004|Study Period|Pregnancy|1|||
155391986|NCT02748018|560871217|FG005|Study Period|Pregnancy|0|||
155391987|NCT02748018|560871212|FG000|Study Period|Physician Decision|2|||
155391988|NCT02748018|560871213|FG001|Study Period|Physician Decision|2|||
155391989|NCT02748018|560871214|FG002|Study Period|Physician Decision|1|||
155391990|NCT02748018|560871215|FG003|Study Period|Physician Decision|0|||
155391991|NCT02748018|560871216|FG004|Study Period|Physician Decision|2|||
155391992|NCT02748018|560871217|FG005|Study Period|Physician Decision|0|||
155391993|NCT02748018|560871212|FG000|Study Period|Lost to Follow-up|0|||
155391994|NCT02748018|560871213|FG001|Study Period|Lost to Follow-up|0|||
155391995|NCT02748018|560871214|FG002|Study Period|Lost to Follow-up|0|||
155391996|NCT02748018|560871215|FG003|Study Period|Lost to Follow-up|2|||
155391997|NCT02748018|560871216|FG004|Study Period|Lost to Follow-up|0|||
155391998|NCT02748018|560871217|FG005|Study Period|Lost to Follow-up|1|||
155391999|NCT02748018|560871212|FG000|Continuation Period|Adverse Event|2|||
155392000|NCT02748018|560871213|FG001|Continuation Period|Adverse Event|0|||
155392001|NCT02748018|560871214|FG002|Continuation Period|Adverse Event|1|||
155392002|NCT02748018|560871215|FG003|Continuation Period|Adverse Event|1|||
155392003|NCT02748018|560871216|FG004|Continuation Period|Adverse Event|1|||
155392004|NCT02748018|560871217|FG005|Continuation Period|Adverse Event|4|||
155392005|NCT02748018|560871212|FG000|Continuation Period|Withdrawal by Subject|3|||
155392006|NCT02748018|560871213|FG001|Continuation Period|Withdrawal by Subject|5|||
155392007|NCT02748018|560871214|FG002|Continuation Period|Withdrawal by Subject|3|||
155392008|NCT02748018|560871215|FG003|Continuation Period|Withdrawal by Subject|9|||
155392009|NCT02748018|560871216|FG004|Continuation Period|Withdrawal by Subject|11|||
155392010|NCT02748018|560871217|FG005|Continuation Period|Withdrawal by Subject|1|||
155392011|NCT02748018|560871212|FG000|Continuation Period|Lost to Follow-up|0|||
155392012|NCT02748018|560871213|FG001|Continuation Period|Lost to Follow-up|2|||
155392013|NCT02748018|560871214|FG002|Continuation Period|Lost to Follow-up|1|||
155392014|NCT02748018|560871215|FG003|Continuation Period|Lost to Follow-up|0|||
155392015|NCT02748018|560871216|FG004|Continuation Period|Lost to Follow-up|1|||
155392016|NCT02748018|560871217|FG005|Continuation Period|Lost to Follow-up|0|||
155392017|NCT02748018|560871212|FG000|Continuation Period|Pregnancy|1|||
155392018|NCT02748018|560871213|FG001|Continuation Period|Pregnancy|2|||
155392019|NCT02748018|560871214|FG002|Continuation Period|Pregnancy|0|||
155392020|NCT02748018|560871215|FG003|Continuation Period|Pregnancy|0|||
155392021|NCT02748018|560871216|FG004|Continuation Period|Pregnancy|0|||
155734823|NCT01047553|562127196|FG000|Overall Study|Adverse Event|10|||
155734824|NCT01047553|562127197|FG001|Overall Study|Adverse Event|5|||
155734825|NCT01047553|562127196|FG000|Overall Study|Withdrawal by Subject|4|||
155734826|NCT01047553|562127197|FG001|Overall Study|Withdrawal by Subject|2|||
155734827|NCT01047553|562127196|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
155734828|NCT01047553|562127197|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
155734829|NCT01047553|562127196|FG000|Overall Study|Lost to Follow-up|1|||
155734830|NCT01047553|562127197|FG001|Overall Study|Lost to Follow-up|0|||
155392022|NCT02748018|560871217|FG005|Continuation Period|Pregnancy|0|||
155392023|NCT02748018|560871212|FG000|Continuation Period|Physician Decision|0|||
155392024|NCT02748018|560871213|FG001|Continuation Period|Physician Decision|1|||
155392025|NCT02748018|560871214|FG002|Continuation Period|Physician Decision|2|||
155392026|NCT02748018|560871215|FG003|Continuation Period|Physician Decision|0|||
155392027|NCT02748018|560871216|FG004|Continuation Period|Physician Decision|2|||
155392028|NCT02748018|560871217|FG005|Continuation Period|Physician Decision|1|||
155392029|NCT02748018|560871212|FG000|Continuation Period|Protocol Violation|0|||
155392030|NCT02748018|560871213|FG001|Continuation Period|Protocol Violation|1|||
155392031|NCT02748018|560871214|FG002|Continuation Period|Protocol Violation|0|||
155392032|NCT02748018|560871215|FG003|Continuation Period|Protocol Violation|0|||
155392033|NCT02748018|560871216|FG004|Continuation Period|Protocol Violation|0|||
155392034|NCT02748018|560871217|FG005|Continuation Period|Protocol Violation|0|||
155392035|NCT02856893|560871218|FG000|Overall Study|Lack of Efficacy|27|||
155392036|NCT02856893|560871219|FG001|Overall Study|Lack of Efficacy|15|||
155392037|NCT02856893|560871220|FG002|Overall Study|Lack of Efficacy|19|||
155392038|NCT02856893|560871218|FG000|Overall Study|Death|1|||
155392039|NCT02856893|560871219|FG001|Overall Study|Death|0|||
155392040|NCT02856893|560871220|FG002|Overall Study|Death|0|||
155392041|NCT02856893|560871218|FG000|Overall Study|Adverse Event|2|||
155392042|NCT02856893|560871219|FG001|Overall Study|Adverse Event|0|||
155392043|NCT02856893|560871220|FG002|Overall Study|Adverse Event|0|||
155392044|NCT02856893|560871218|FG000|Overall Study|Physician Decision|0|||
155392045|NCT02856893|560871219|FG001|Overall Study|Physician Decision|2|||
155392046|NCT02856893|560871220|FG002|Overall Study|Physician Decision|3|||
155392047|NCT02856893|560871218|FG000|Overall Study|Withdrawal by Subject|1|||
155392048|NCT02856893|560871219|FG001|Overall Study|Withdrawal by Subject|1|||
155392049|NCT02856893|560871220|FG002|Overall Study|Withdrawal by Subject|0|||
155392050|NCT02856893|560871218|FG000|Overall Study|Other reasons|2|||
155392051|NCT02856893|560871219|FG001|Overall Study|Other reasons|1|||
155392052|NCT02856893|560871220|FG002|Overall Study|Other reasons|2|||
155392053|NCT01324323|560871228|FG000|Overall Study|Withdrawal by Subject|1|||
155392054|NCT00537485|560871229|FG000|Overall Study|Adverse Event|10|||
155392055|NCT00537485|560871230|FG001|Overall Study|Adverse Event|5|||
155392056|NCT00537485|560871229|FG000|Overall Study|Withdrawal by Subject|3|||
155392057|NCT00537485|560871230|FG001|Overall Study|Withdrawal by Subject|2|||
155392058|NCT00537485|560871229|FG000|Overall Study|Withdrawal by Subject|1|||
155392059|NCT00537485|560871230|FG001|Overall Study|Withdrawal by Subject|3|||
155392060|NCT00537485|560871229|FG000|Overall Study|Physician Decision|1|||
155392061|NCT00537485|560871230|FG001|Overall Study|Physician Decision|0|||
155392062|NCT01601847|560871234|FG000|Overall Study|Death|1|||
155392063|NCT01601847|560871235|FG001|Overall Study|Death|0|||
155392064|NCT01601847|560871234|FG000|Overall Study|Withdrawal by Subject|11|||
155392065|NCT01601847|560871235|FG001|Overall Study|Withdrawal by Subject|7|||
155392066|NCT01601847|560871234|FG000|Overall Study|Lost to Follow-up|1|||
155392067|NCT01601847|560871235|FG001|Overall Study|Lost to Follow-up|3|||
155392068|NCT00631189|560871236|FG000|Initial Phase|Protocol Violation|347|||
155392069|NCT00631189|560871237|FG001|Initial Phase|Protocol Violation|0|||
155392070|NCT00631189|560871238|FG002|Initial Phase|Protocol Violation|0|||
155392071|NCT00631189|560871239|FG003|Initial Phase|Protocol Violation|0|||
155392072|NCT00631189|560871236|FG000|Initial Phase|Withdrawal by Subject|4|||
155392073|NCT00631189|560871237|FG001|Initial Phase|Withdrawal by Subject|0|||
155392074|NCT00631189|560871238|FG002|Initial Phase|Withdrawal by Subject|0|||
155392075|NCT00631189|560871239|FG003|Initial Phase|Withdrawal by Subject|0|||
155392076|NCT00631189|560871236|FG000|Treatment Phase|Withdrawal by Subject|0|||
155392077|NCT00631189|560871237|FG001|Treatment Phase|Withdrawal by Subject|2|||
155392078|NCT00631189|560871238|FG002|Treatment Phase|Withdrawal by Subject|1|||
155392079|NCT00631189|560871239|FG003|Treatment Phase|Withdrawal by Subject|1|||
155392080|NCT00631189|560871236|FG000|Treatment Phase|Protocol Violation|0|||
155392081|NCT00631189|560871237|FG001|Treatment Phase|Protocol Violation|1|||
155392082|NCT00631189|560871238|FG002|Treatment Phase|Protocol Violation|6|||
155392083|NCT00631189|560871239|FG003|Treatment Phase|Protocol Violation|2|||
155392084|NCT00631189|560871236|FG000|Treatment Phase|Adverse Event|0|||
155392085|NCT00631189|560871237|FG001|Treatment Phase|Adverse Event|3|||
155392086|NCT00631189|560871238|FG002|Treatment Phase|Adverse Event|2|||
155392087|NCT00631189|560871239|FG003|Treatment Phase|Adverse Event|4|||
155632127|NCT00042289|561747641|FG010|Overall Study|Site closed|0|||
155632128|NCT00042289|561747642|FG011|Overall Study|Site closed|0|||
155632129|NCT00042289|561747643|FG012|Overall Study|Site closed|0|||
155632130|NCT00042289|561747644|FG013|Overall Study|Site closed|0|||
155392088|NCT00631189|560871236|FG000|Treatment Phase|Lost to Follow-up|0|||
155392089|NCT00631189|560871237|FG001|Treatment Phase|Lost to Follow-up|1|||
155392090|NCT00631189|560871238|FG002|Treatment Phase|Lost to Follow-up|0|||
155392091|NCT00631189|560871239|FG003|Treatment Phase|Lost to Follow-up|0|||
155392092|NCT00631189|560871236|FG000|Treatment Phase|Pregnancy|0|||
155392093|NCT00631189|560871237|FG001|Treatment Phase|Pregnancy|0|||
155392094|NCT00631189|560871238|FG002|Treatment Phase|Pregnancy|1|||
155392095|NCT00631189|560871239|FG003|Treatment Phase|Pregnancy|0|||
155392096|NCT00631189|560871236|FG000|Treatment Phase|patient did not take pravastatin|0|||
155392097|NCT00631189|560871237|FG001|Treatment Phase|patient did not take pravastatin|0|||
155392098|NCT00631189|560871238|FG002|Treatment Phase|patient did not take pravastatin|1|||
155632131|NCT00042289|561747645|FG014|Overall Study|Site closed|0|||
155632132|NCT00042289|561747646|FG015|Overall Study|Site closed|0|||
155392099|NCT00631189|560871239|FG003|Treatment Phase|patient did not take pravastatin|0|||
155632133|NCT00042289|561747647|FG016|Overall Study|Site closed|0|||
155632134|NCT00042289|561747648|FG017|Overall Study|Site closed|0|||
155392100|NCT04464265|560871240|FG000|Overall Study|Physician Decision|2|||
155392101|NCT01284062|560871241|FG000|Overall Study|Adverse Event|4|||
155392102|NCT01284062|560871242|FG001|Overall Study|Adverse Event|5|||
155392103|NCT01284062|560871243|FG002|Overall Study|Adverse Event|0|||
155392104|NCT01284062|560871244|FG003|Overall Study|Adverse Event|5|||
155392105|NCT01284062|560871241|FG000|Overall Study|Lack of Efficacy|3|||
155392106|NCT01284062|560871242|FG001|Overall Study|Lack of Efficacy|2|||
155392107|NCT01284062|560871243|FG002|Overall Study|Lack of Efficacy|2|||
155392108|NCT01284062|560871244|FG003|Overall Study|Lack of Efficacy|1|||
155392109|NCT01284062|560871241|FG000|Overall Study|Medication error without adverse event|0|||
155392110|NCT01284062|560871242|FG001|Overall Study|Medication error without adverse event|0|||
155392111|NCT01284062|560871243|FG002|Overall Study|Medication error without adverse event|1|||
155392112|NCT01284062|560871244|FG003|Overall Study|Medication error without adverse event|0|||
155392113|NCT01284062|560871241|FG000|Overall Study|Protocol Violation|1|||
155392114|NCT01284062|560871242|FG001|Overall Study|Protocol Violation|0|||
155392115|NCT01284062|560871243|FG002|Overall Study|Protocol Violation|0|||
155392116|NCT01284062|560871244|FG003|Overall Study|Protocol Violation|2|||
155392117|NCT01284062|560871241|FG000|Overall Study|Withdrawal by Subject|3|||
155392118|NCT01284062|560871242|FG001|Overall Study|Withdrawal by Subject|1|||
155392119|NCT01284062|560871243|FG002|Overall Study|Withdrawal by Subject|2|||
155392120|NCT01284062|560871244|FG003|Overall Study|Withdrawal by Subject|5|||
155392121|NCT01284062|560871241|FG000|Overall Study|Other|0|||
155392122|NCT01284062|560871242|FG001|Overall Study|Other|0|||
155392123|NCT01284062|560871243|FG002|Overall Study|Other|0|||
155392124|NCT01284062|560871244|FG003|Overall Study|Other|1|||
155392125|NCT01284062|560871241|FG000|Overall Study|Site Closed|0|||
155392126|NCT01284062|560871242|FG001|Overall Study|Site Closed|0|||
155392127|NCT01284062|560871243|FG002|Overall Study|Site Closed|1|||
155392128|NCT01284062|560871244|FG003|Overall Study|Site Closed|0|||
155392129|NCT00974090|560871245|FG000|Period 1: Double Blind Period|Adverse Event|2|||
155392130|NCT00974090|560871246|FG001|Period 1: Double Blind Period|Adverse Event|1|||
155392131|NCT00974090|560871245|FG000|Period 1: Double Blind Period|Physician Decision|1|||
155392132|NCT00974090|560871246|FG001|Period 1: Double Blind Period|Physician Decision|0|||
155392133|NCT00974090|560871245|FG000|Period 2: Open-label Period|Adverse Event|4|||
155392134|NCT00974090|560871246|FG001|Period 2: Open-label Period|Adverse Event|6|||
155392135|NCT00974090|560871245|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
155392136|NCT00974090|560871246|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
155392137|NCT00974090|560871245|FG000|Period 2: Open-label Period|Physician Decision|0|||
155392138|NCT00974090|560871246|FG001|Period 2: Open-label Period|Physician Decision|3|||
155392139|NCT00974090|560871245|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
155392140|NCT00974090|560871246|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
155392141|NCT01026142|560871251|FG000|Overall Study|Death|136|||
155392142|NCT01026142|560871252|FG001|Overall Study|Death|134|||
155392143|NCT01026142|560871251|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
155392144|NCT01026142|560871252|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
155392145|NCT00634010|560871253|FG000|Overall Study|Adverse Event|2|||
155392146|NCT00634010|560871254|FG001|Overall Study|Adverse Event|5|||
155392147|NCT00634010|560871253|FG000|Overall Study|Withdrawal by Subject|5|||
155392148|NCT00634010|560871254|FG001|Overall Study|Withdrawal by Subject|6|||
155392149|NCT00634010|560871253|FG000|Overall Study|Physician Decision|1|||
155392150|NCT00634010|560871254|FG001|Overall Study|Physician Decision|1|||
155392151|NCT00634010|560871253|FG000|Overall Study|Disease Progression|1|||
155392152|NCT00634010|560871254|FG001|Overall Study|Disease Progression|1|||
155392153|NCT00634010|560871253|FG000|Overall Study|Non-Compliant|1|||
155392154|NCT00634010|560871254|FG001|Overall Study|Non-Compliant|1|||
155392155|NCT01019317|560871255|FG000|Overall Study|Not Eligible|4|||
155392156|NCT01012739|560871256|FG000|Treatment Period 1|Adverse Event|0|||
155392157|NCT01012739|560871257|FG001|Treatment Period 1|Adverse Event|0|||
155392158|NCT01012739|560871258|FG002|Treatment Period 1|Adverse Event|0|||
155392159|NCT01012739|560871259|FG003|Treatment Period 1|Adverse Event|1|||
155392160|NCT01012739|560871256|FG000|Treatment Period 2|Abnormal test procedure results|0|||
155392161|NCT01012739|560871257|FG001|Treatment Period 2|Abnormal test procedure results|0|||
155392162|NCT01012739|560871258|FG002|Treatment Period 2|Abnormal test procedure results|0|||
155392163|NCT01012739|560871259|FG003|Treatment Period 2|Abnormal test procedure results|1|||
155392164|NCT04540133|560871260|FG000|Overall Study|Lost to Follow-up|1|||
155392165|NCT04540133|560871261|FG001|Overall Study|Lost to Follow-up|0|||
155392166|NCT04029480|560871262|FG000|Overall Study|Physician Decision|0|||
155392167|NCT04029480|560871263|FG001|Overall Study|Physician Decision|0|||
155734831|NCT01047553|562127196|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
155392168|NCT04029480|560871264|FG002|Overall Study|Physician Decision|2|||
155392169|NCT04029480|560871265|FG003|Overall Study|Physician Decision|1|||
155392170|NCT04029480|560871262|FG000|Overall Study|Withdrawal by Subject|2|||
155392171|NCT04029480|560871263|FG001|Overall Study|Withdrawal by Subject|0|||
155392172|NCT04029480|560871264|FG002|Overall Study|Withdrawal by Subject|1|||
155392173|NCT04029480|560871265|FG003|Overall Study|Withdrawal by Subject|1|||
155392174|NCT04786119|560871266|FG000|Overall Study|Withdrawal by Subject|4|||
155392175|NCT04786119|560871267|FG001|Overall Study|Withdrawal by Subject|5|||
155392176|NCT04786119|560871266|FG000|Overall Study|Lost to Follow-up|5|||
155392177|NCT04786119|560871267|FG001|Overall Study|Lost to Follow-up|5|||
155392178|NCT04786119|560871266|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
155392179|NCT04786119|560871267|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
155392180|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
155392181|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
155392182|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
155392183|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
155392184|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
155392185|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
155392186|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
155392187|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
155392188|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
155392189|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
155392190|NCT01658826|560871278|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
155392191|NCT01658826|560871279|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
155392192|NCT01658826|560871278|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
155392193|NCT01658826|560871279|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
155392194|NCT01658826|560871278|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
155392195|NCT01658826|560871279|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
155392196|NCT01658826|560871278|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
155392197|NCT01658826|560871279|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
155392198|NCT00866697|560871283|FG000|Overall Study|Study closed/terminated|156|||
155392199|NCT00866697|560871284|FG001|Overall Study|Study closed/terminated|138|||
155392200|NCT00866697|560871283|FG000|Overall Study|Lost to Follow-up|22|||
155392201|NCT00866697|560871284|FG001|Overall Study|Lost to Follow-up|28|||
155392202|NCT00866697|560871283|FG000|Overall Study|Physician Decision|3|||
155392203|NCT00866697|560871284|FG001|Overall Study|Physician Decision|5|||
155392204|NCT00866697|560871283|FG000|Overall Study|Withdrawal by Subject|33|||
155392205|NCT00866697|560871284|FG001|Overall Study|Withdrawal by Subject|57|||
155392206|NCT00447382|560871285|FG000|Overall Study|Adverse Event|1|||
155392207|NCT00447382|560871286|FG001|Overall Study|Adverse Event|1|||
155392208|NCT00447382|560871285|FG000|Overall Study|Lack of Efficacy|1|||
155392209|NCT00447382|560871286|FG001|Overall Study|Lack of Efficacy|0|||
155392210|NCT00447382|560871285|FG000|Overall Study|Protocol Violation|2|||
155392211|NCT00447382|560871286|FG001|Overall Study|Protocol Violation|0|||
155392212|NCT00447382|560871285|FG000|Overall Study|Unclassified|2|||
155392213|NCT00447382|560871286|FG001|Overall Study|Unclassified|5|||
155392214|NCT02408861|560871287|FG000|Overall Study|Death|0|||
155392215|NCT02408861|560871288|FG001|Overall Study|Death|3|||
155392216|NCT02408861|560871289|FG002|Overall Study|Death|1|||
155392217|NCT02408861|560871290|FG003|Overall Study|Death|2|||
155392218|NCT02408861|560871291|FG004|Overall Study|Death|4|||
155392219|NCT02408861|560871292|FG005|Overall Study|Death|1|||
155392220|NCT02408861|560871293|FG006|Overall Study|Death|0|||
155392221|NCT02408861|560871287|FG000|Overall Study|Lost to Follow-up|0|||
155392222|NCT02408861|560871288|FG001|Overall Study|Lost to Follow-up|0|||
155392223|NCT02408861|560871289|FG002|Overall Study|Lost to Follow-up|1|||
155392224|NCT02408861|560871290|FG003|Overall Study|Lost to Follow-up|1|||
155392225|NCT02408861|560871291|FG004|Overall Study|Lost to Follow-up|4|||
155392226|NCT02408861|560871292|FG005|Overall Study|Lost to Follow-up|2|||
155392227|NCT02408861|560871293|FG006|Overall Study|Lost to Follow-up|1|||
155392228|NCT02408861|560871287|FG000|Overall Study|Disease Progression|0|||
155392229|NCT02408861|560871288|FG001|Overall Study|Disease Progression|0|||
155392230|NCT02408861|560871289|FG002|Overall Study|Disease Progression|1|||
155392231|NCT02408861|560871290|FG003|Overall Study|Disease Progression|0|||
155632135|NCT00042289|561747649|FG018|Overall Study|Site closed|0|||
155632136|NCT00042289|561747650|FG019|Overall Study|Site closed|0|||
155632137|NCT00042289|561747651|FG020|Overall Study|Site closed|0|||
155632138|NCT00042289|561747652|FG021|Overall Study|Site closed|0|||
155632139|NCT00042289|561747653|FG022|Overall Study|Site closed|0|||
155392232|NCT02408861|560871291|FG004|Overall Study|Disease Progression|3|||
155392233|NCT02408861|560871292|FG005|Overall Study|Disease Progression|1|||
155392234|NCT02408861|560871293|FG006|Overall Study|Disease Progression|1|||
155392235|NCT02408861|560871287|FG000|Overall Study|Adverse Event|1|||
155392236|NCT02408861|560871288|FG001|Overall Study|Adverse Event|0|||
155392237|NCT02408861|560871289|FG002|Overall Study|Adverse Event|1|||
155392238|NCT02408861|560871290|FG003|Overall Study|Adverse Event|0|||
155392239|NCT02408861|560871291|FG004|Overall Study|Adverse Event|2|||
155392240|NCT02408861|560871292|FG005|Overall Study|Adverse Event|0|||
155392241|NCT02408861|560871293|FG006|Overall Study|Adverse Event|0|||
155392242|NCT02408861|560871287|FG000|Overall Study|Physician Decision|1|||
155632140|NCT00042289|561747654|FG023|Overall Study|Site closed|0|||
155392243|NCT02408861|560871288|FG001|Overall Study|Physician Decision|1|||
155392244|NCT02408861|560871289|FG002|Overall Study|Physician Decision|1|||
155392245|NCT02408861|560871290|FG003|Overall Study|Physician Decision|0|||
155392246|NCT02408861|560871291|FG004|Overall Study|Physician Decision|0|||
155392247|NCT02408861|560871292|FG005|Overall Study|Physician Decision|1|||
155392248|NCT02408861|560871293|FG006|Overall Study|Physician Decision|0|||
155392249|NCT02408861|560871287|FG000|Overall Study|Protocol Violation|1|||
155392250|NCT02408861|560871288|FG001|Overall Study|Protocol Violation|0|||
155392251|NCT02408861|560871289|FG002|Overall Study|Protocol Violation|0|||
155392252|NCT02408861|560871290|FG003|Overall Study|Protocol Violation|0|||
155392253|NCT02408861|560871291|FG004|Overall Study|Protocol Violation|0|||
155392254|NCT02408861|560871292|FG005|Overall Study|Protocol Violation|0|||
155392255|NCT02408861|560871293|FG006|Overall Study|Protocol Violation|0|||
155392256|NCT02408861|560871287|FG000|Overall Study|Withdrawal by Subject|0|||
155392257|NCT02408861|560871288|FG001|Overall Study|Withdrawal by Subject|0|||
155392258|NCT02408861|560871289|FG002|Overall Study|Withdrawal by Subject|0|||
155392259|NCT02408861|560871290|FG003|Overall Study|Withdrawal by Subject|0|||
155392260|NCT02408861|560871291|FG004|Overall Study|Withdrawal by Subject|1|||
155392261|NCT02408861|560871292|FG005|Overall Study|Withdrawal by Subject|1|||
155392262|NCT02408861|560871293|FG006|Overall Study|Withdrawal by Subject|0|||
155392263|NCT02408861|560871287|FG000|Overall Study|Other Treatment|0|||
155392264|NCT02408861|560871288|FG001|Overall Study|Other Treatment|0|||
155392265|NCT02408861|560871289|FG002|Overall Study|Other Treatment|0|||
155392266|NCT02408861|560871290|FG003|Overall Study|Other Treatment|0|||
155392267|NCT02408861|560871291|FG004|Overall Study|Other Treatment|0|||
155392268|NCT02408861|560871292|FG005|Overall Study|Other Treatment|1|||
155392269|NCT02408861|560871293|FG006|Overall Study|Other Treatment|1|||
155392270|NCT04567615|560871294|FG000|Randomization|Participant withdrew consent|1|||
155392271|NCT04567615|560871295|FG001|Randomization|Participant withdrew consent|0|||
155392272|NCT04567615|560871296|FG002|Randomization|Participant withdrew consent|0|||
155392273|NCT04567615|560871294|FG000|Randomization|Adverse event unrelated to study drug|0|||
155392274|NCT04567615|560871295|FG001|Randomization|Adverse event unrelated to study drug|1|||
155392275|NCT04567615|560871296|FG002|Randomization|Adverse event unrelated to study drug|0|||
155392276|NCT04567615|560871294|FG000|Treatment Period|Participant Withdrew Consent|2|||
155392277|NCT04567615|560871295|FG001|Treatment Period|Participant Withdrew Consent|5|||
155392278|NCT04567615|560871296|FG002|Treatment Period|Participant Withdrew Consent|1|||
155392279|NCT04567615|560871294|FG000|Treatment Period|Death|1|||
155392280|NCT04567615|560871295|FG001|Treatment Period|Death|2|||
155392281|NCT04567615|560871296|FG002|Treatment Period|Death|0|||
155392282|NCT04567615|560871294|FG000|Treatment Period|Lost to Follow-up|0|||
155392283|NCT04567615|560871295|FG001|Treatment Period|Lost to Follow-up|1|||
155392284|NCT04567615|560871296|FG002|Treatment Period|Lost to Follow-up|0|||
155392285|NCT04567615|560871294|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155392286|NCT04567615|560871295|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155392287|NCT04567615|560871296|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155392288|NCT04567615|560871294|FG000|Treatment Period|Disease Progression|85|||
155392289|NCT04567615|560871295|FG001|Treatment Period|Disease Progression|63|||
155392290|NCT04567615|560871296|FG002|Treatment Period|Disease Progression|16|||
155392291|NCT04567615|560871294|FG000|Treatment Period|Study Drug Toxicity|3|||
155392292|NCT04567615|560871295|FG001|Treatment Period|Study Drug Toxicity|10|||
155392293|NCT04567615|560871296|FG002|Treatment Period|Study Drug Toxicity|4|||
155392294|NCT04567615|560871294|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
155392295|NCT04567615|560871295|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
155392296|NCT04567615|560871296|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
155392297|NCT04567615|560871294|FG000|Treatment Period|Other Reasons|1|||
155392298|NCT04567615|560871295|FG001|Treatment Period|Other Reasons|2|||
155392299|NCT04567615|560871296|FG002|Treatment Period|Other Reasons|0|||
155392300|NCT04567615|560871294|FG000|Treatment Period|Still On-going Treatment|21|||
155392301|NCT04567615|560871295|FG001|Treatment Period|Still On-going Treatment|22|||
155392302|NCT04567615|560871296|FG002|Treatment Period|Still On-going Treatment|2|||
155392303|NCT05028517|560871297|FG000|Overall Study|Lost to Follow-up|13|||
155392304|NCT05028517|560871298|FG001|Overall Study|Lost to Follow-up|20|||
155392305|NCT05028517|560871299|FG002|Overall Study|Lost to Follow-up|12|||
155392306|NCT05028517|560871297|FG000|Overall Study|Withdrawal by Subject|0|||
155392307|NCT05028517|560871298|FG001|Overall Study|Withdrawal by Subject|0|||
155392308|NCT05028517|560871299|FG002|Overall Study|Withdrawal by Subject|1|||
155392309|NCT04890054|560872875|FG000|Overall Study|Lost to Follow-up|202|||
155392310|NCT04890054|560872876|FG001|Overall Study|Lost to Follow-up|219|||
155392311|NCT00523718|560872879|FG000|Overall Study|Withdrawal by Subject|1|||
155392312|NCT00523718|560872880|FG001|Overall Study|Withdrawal by Subject|0|||
155734832|NCT01047553|562127197|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
155392313|NCT00523718|560872879|FG000|Overall Study|Protocol Violation|2|||
155392314|NCT00523718|560872880|FG001|Overall Study|Protocol Violation|0|||
155392315|NCT01436071|560872881|FG000|Overall Study|Adverse Event|1|||
155392316|NCT01436071|560872882|FG001|Overall Study|Adverse Event|0|||
155392317|NCT01436071|560872881|FG000|Overall Study|Lack of Efficacy|16|||
155734833|NCT01047553|562127196|FG000|Overall Study|PI's decision|0|||
155734834|NCT01047553|562127197|FG001|Overall Study|PI's decision|1|||
155734835|NCT02817464|562127203|FG000|Overall Study|Lost to Follow-up|1|||
155734836|NCT02817464|562127204|FG001|Overall Study|Lost to Follow-up|0|||
155734837|NCT02817464|562127203|FG000|Overall Study|Discontinued early due to personal decision|1|||
155734838|NCT02817464|562127204|FG001|Overall Study|Discontinued early due to personal decision|1|||
155734839|NCT01273519|562127206|FG000|Overall Study|Adverse Event|3|||
155734840|NCT01273519|562127207|FG001|Overall Study|Adverse Event|0|||
155734841|NCT01273519|562127208|FG002|Overall Study|Adverse Event|0|||
155734842|NCT01273519|562127206|FG000|Overall Study|Lost to Follow-up|2|||
155734843|NCT01273519|562127207|FG001|Overall Study|Lost to Follow-up|1|||
155734844|NCT01273519|562127208|FG002|Overall Study|Lost to Follow-up|3|||
155734845|NCT01273519|562127206|FG000|Overall Study|Lack of Efficacy|8|||
155734846|NCT01273519|562127207|FG001|Overall Study|Lack of Efficacy|3|||
155734847|NCT01273519|562127208|FG002|Overall Study|Lack of Efficacy|4|||
155734848|NCT01273519|562127206|FG000|Overall Study|Other|6|||
155734849|NCT01273519|562127207|FG001|Overall Study|Other|1|||
155734850|NCT01273519|562127208|FG002|Overall Study|Other|1|||
155734851|NCT04292899|562127209|FG000|Overall Study|Death|21|||
155734852|NCT04292899|562127210|FG001|Overall Study|Death|28|||
155734853|NCT04292899|562127211|FG002|Overall Study|Death|188|||
155734854|NCT04292899|562127212|FG003|Overall Study|Death|371|||
155282242|NCT04529538|560464100|FG004|Overall Study|Not eligible at enrollment|0|||
155282243|NCT04529538|560464101|FG005|Overall Study|Not eligible at enrollment|0|||
155282244|NCT04529538|560464102|FG006|Overall Study|Not eligible at enrollment|0|||
155282245|NCT04529538|560464103|FG007|Overall Study|Not eligible at enrollment|1|||
155282246|NCT04529538|560464096|FG000|Overall Study|Withdrawal by Subject|0|||
155282247|NCT04529538|560464097|FG001|Overall Study|Withdrawal by Subject|1|||
155282248|NCT04529538|560464098|FG002|Overall Study|Withdrawal by Subject|1|||
155282249|NCT04529538|560464099|FG003|Overall Study|Withdrawal by Subject|2|||
155282250|NCT04529538|560464100|FG004|Overall Study|Withdrawal by Subject|0|||
155282251|NCT04529538|560464101|FG005|Overall Study|Withdrawal by Subject|2|||
155282252|NCT04529538|560464102|FG006|Overall Study|Withdrawal by Subject|3|||
155282253|NCT04529538|560464103|FG007|Overall Study|Withdrawal by Subject|0|||
155282254|NCT04529538|560464096|FG000|Overall Study|Other|0|||
155282255|NCT04529538|560464097|FG001|Overall Study|Other|1|||
155282256|NCT04529538|560464098|FG002|Overall Study|Other|0|||
155282257|NCT04529538|560464099|FG003|Overall Study|Other|0|||
155282258|NCT04529538|560464100|FG004|Overall Study|Other|0|||
155282259|NCT04529538|560464101|FG005|Overall Study|Other|0|||
155282260|NCT04529538|560464102|FG006|Overall Study|Other|0|||
155282261|NCT04529538|560464103|FG007|Overall Study|Other|0|||
155282262|NCT04529538|560464096|FG000|Overall Study|Adverse Event|0|||
155282263|NCT04529538|560464097|FG001|Overall Study|Adverse Event|0|||
155282264|NCT04529538|560464098|FG002|Overall Study|Adverse Event|0|||
155282265|NCT04529538|560464099|FG003|Overall Study|Adverse Event|1|||
155282266|NCT04529538|560464100|FG004|Overall Study|Adverse Event|0|||
155282267|NCT04529538|560464101|FG005|Overall Study|Adverse Event|0|||
155282268|NCT04529538|560464102|FG006|Overall Study|Adverse Event|0|||
155282269|NCT04529538|560464103|FG007|Overall Study|Adverse Event|0|||
155282270|NCT04529538|560464096|FG000|Overall Study|Protocol Deviation|0|||
155282271|NCT04529538|560464097|FG001|Overall Study|Protocol Deviation|0|||
155282272|NCT04529538|560464098|FG002|Overall Study|Protocol Deviation|0|||
155282273|NCT04529538|560464099|FG003|Overall Study|Protocol Deviation|1|||
155282274|NCT04529538|560464100|FG004|Overall Study|Protocol Deviation|0|||
155282275|NCT04529538|560464101|FG005|Overall Study|Protocol Deviation|0|||
155282276|NCT04529538|560464102|FG006|Overall Study|Protocol Deviation|0|||
155282277|NCT04529538|560464103|FG007|Overall Study|Protocol Deviation|0|||
155282278|NCT04529538|560464096|FG000|Overall Study|Physician Decision|0|||
155282279|NCT04529538|560464097|FG001|Overall Study|Physician Decision|0|||
155282280|NCT04529538|560464098|FG002|Overall Study|Physician Decision|0|||
155282281|NCT04529538|560464099|FG003|Overall Study|Physician Decision|0|||
155282282|NCT04529538|560464100|FG004|Overall Study|Physician Decision|0|||
155282283|NCT04529538|560464101|FG005|Overall Study|Physician Decision|1|||
155282284|NCT04529538|560464102|FG006|Overall Study|Physician Decision|0|||
155282285|NCT04529538|560464103|FG007|Overall Study|Physician Decision|1|||
155282286|NCT00114959|560464106|FG000|Overall Study|Lack of Efficacy|6|||
155734855|NCT04292899|562127209|FG000|Overall Study|Lost to Follow-up|8|||
155734856|NCT04292899|562127210|FG001|Overall Study|Lost to Follow-up|4|||
155734857|NCT04292899|562127211|FG002|Overall Study|Lost to Follow-up|22|||
155734858|NCT04292899|562127212|FG003|Overall Study|Lost to Follow-up|235|||
155734859|NCT04292899|562127209|FG000|Overall Study|Withdrew consent|1|||
155734860|NCT04292899|562127210|FG001|Overall Study|Withdrew consent|0|||
155282287|NCT00114959|560464106|FG000|Overall Study|Physician Decision|1|||
155282288|NCT00114959|560464106|FG000|Overall Study|Death|1|||
155282289|NCT03706690|560464107|FG000|Overall Study|Withdrawal by Subject|8|||
155282290|NCT03706690|560464108|FG001|Overall Study|Withdrawal by Subject|8|||
155282291|NCT03706690|560464107|FG000|Overall Study|Death|143|||
155282292|NCT03706690|560464108|FG001|Overall Study|Death|75|||
155282293|NCT03706690|560464107|FG000|Overall Study|Ongoing at DCO|121|||
155734861|NCT04292899|562127211|FG002|Overall Study|Withdrew consent|11|||
155392318|NCT01436071|560872882|FG001|Overall Study|Lack of Efficacy|7|||
155392319|NCT01436071|560872881|FG000|Overall Study|Protocol Violation|0|||
155392320|NCT01436071|560872882|FG001|Overall Study|Protocol Violation|1|||
155392321|NCT01436071|560872881|FG000|Overall Study|Lost to Follow-up|3|||
155392322|NCT01436071|560872882|FG001|Overall Study|Lost to Follow-up|1|||
155392323|NCT01436071|560872881|FG000|Overall Study|Physician Decision|1|||
155392324|NCT01436071|560872882|FG001|Overall Study|Physician Decision|0|||
155392325|NCT01436071|560872881|FG000|Overall Study|Withdrawal by Subject|2|||
155392326|NCT01436071|560872882|FG001|Overall Study|Withdrawal by Subject|2|||
155632141|NCT00042289|561747655|FG024|Overall Study|Site closed|0|||
155632142|NCT00042289|561747656|FG025|Overall Study|Site closed|0|||
155632143|NCT00042289|561747657|FG026|Overall Study|Site closed|0|||
155632144|NCT00042289|561747658|FG027|Overall Study|Site closed|0|||
155632145|NCT00042289|561747659|FG028|Overall Study|Site closed|0|||
155632146|NCT00042289|561747660|FG029|Overall Study|Site closed|0|||
155632147|NCT00042289|561747661|FG030|Overall Study|Site closed|0|||
155632148|NCT00042289|561747662|FG031|Overall Study|Site closed|3|||
155632149|NCT00042289|561747663|FG032|Overall Study|Site closed|0|||
155632150|NCT00042289|561747664|FG033|Overall Study|Site closed|0|||
155632151|NCT00042289|561747665|FG034|Overall Study|Site closed|0|||
155632152|NCT00042289|561747666|FG035|Overall Study|Site closed|0|||
155632153|NCT00042289|561747667|FG036|Overall Study|Site closed|1|||
155632154|NCT00042289|561747668|FG037|Overall Study|Site closed|0|||
155632155|NCT00042289|561747669|FG038|Overall Study|Site closed|0|||
155632156|NCT00042289|561747670|FG039|Overall Study|Site closed|0|||
155632157|NCT00042289|561747671|FG040|Overall Study|Site closed|0|||
155632158|NCT00042289|561747672|FG041|Overall Study|Site closed|0|||
155632159|NCT00042289|561747673|FG042|Overall Study|Site closed|1|||
155632160|NCT00042289|561747674|FG043|Overall Study|Site closed|0|||
155632161|NCT00042289|561747675|FG044|Overall Study|Site closed|0|||
155632162|NCT00042289|561747676|FG045|Overall Study|Site closed|0|||
155632163|NCT00042289|561747677|FG046|Overall Study|Site closed|0|||
155632164|NCT00042289|561747631|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
155632165|NCT00042289|561747632|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
155632166|NCT00042289|561747633|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
155632167|NCT00042289|561747634|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
155632168|NCT00042289|561747635|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
155632169|NCT00042289|561747636|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
155632170|NCT00042289|561747637|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
155632171|NCT00042289|561747638|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
155632172|NCT00042289|561747639|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
155632173|NCT00042289|561747640|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
155632174|NCT00042289|561747641|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
155632175|NCT00042289|561747642|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
155632176|NCT00042289|561747643|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
155632177|NCT00042289|561747644|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
155632178|NCT00042289|561747645|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
155632179|NCT00042289|561747646|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
155632180|NCT00042289|561747647|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
155632181|NCT00042289|561747648|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
155632182|NCT00042289|561747649|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
155632183|NCT00042289|561747650|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
155632184|NCT00042289|561747651|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
155632185|NCT00042289|561747652|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
155632186|NCT00042289|561747653|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
155632187|NCT00042289|561747654|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
155632188|NCT00042289|561747655|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
155632189|NCT00042289|561747656|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
155632190|NCT00042289|561747657|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
155632191|NCT00042289|561747658|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
155632192|NCT00042289|561747659|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
155632193|NCT00042289|561747660|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
155632194|NCT00042289|561747661|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
155632195|NCT00042289|561747662|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
155632196|NCT00042289|561747663|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
155734862|NCT04292899|562127212|FG003|Overall Study|Withdrew consent|32|||
155392327|NCT01436071|560872881|FG000|Overall Study|Did Not Receive Trial Medication|3|||
155392328|NCT01436071|560872882|FG001|Overall Study|Did Not Receive Trial Medication|3|||
155392329|NCT03808688|560872885|FG000|Overall Study|Adverse Event|13|||
155734863|NCT04292899|562127209|FG000|Overall Study|Adverse Event|2|||
155392330|NCT03808688|560872886|FG001|Overall Study|Adverse Event|17|||
155392331|NCT03808688|560872885|FG000|Overall Study|Lack of Efficacy|2|||
155392332|NCT03808688|560872886|FG001|Overall Study|Lack of Efficacy|0|||
155392333|NCT03808688|560872885|FG000|Overall Study|Lost to Follow-up|0|||
155392334|NCT03808688|560872886|FG001|Overall Study|Lost to Follow-up|2|||
155392335|NCT03808688|560872885|FG000|Overall Study|Withdrawal by Subject|1|||
155392336|NCT03808688|560872886|FG001|Overall Study|Withdrawal by Subject|0|||
155392337|NCT03808688|560872885|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
155392338|NCT03808688|560872886|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
155392339|NCT03808688|560872885|FG000|Overall Study|IOP Too High|1|||
155392340|NCT03808688|560872886|FG001|Overall Study|IOP Too High|1|||
155392341|NCT03808688|560872885|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
155392342|NCT03808688|560872886|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
155392343|NCT03808688|560872885|FG000|Overall Study|Visit Out of Window|0|||
155392344|NCT03808688|560872886|FG001|Overall Study|Visit Out of Window|1|||
155392345|NCT03808688|560872885|FG000|Overall Study|Medication Non-Compliance|0|||
155392346|NCT03808688|560872886|FG001|Overall Study|Medication Non-Compliance|1|||
155392347|NCT01940354|560872887|FG000|Overall Study|Withdrawal by Subject|4|||
155392348|NCT01940354|560872888|FG001|Overall Study|Withdrawal by Subject|2|||
155392349|NCT01096342|560872889|FG000|Overall Study|Protocol Violation|1|||
155392350|NCT00909792|560872890|FG000|Period 1|Did not meet inclusion criteria|0|||
155392351|NCT00909792|560872891|FG001|Period 1|Did not meet inclusion criteria|1|||
155392352|NCT00909792|560872890|FG000|Period 2|Biomicroscopy|1|||
155392353|NCT00909792|560872891|FG001|Period 2|Biomicroscopy|0|||
155392354|NCT00909792|560872890|FG000|Period 2|Lost to Follow-up|0|||
155392355|NCT00909792|560872891|FG001|Period 2|Lost to Follow-up|1|||
155392356|NCT01448213|560872896|FG000|Overall Study|Lost to Follow-up|12|||
155392357|NCT01448213|560872897|FG001|Overall Study|Lost to Follow-up|10|||
155392358|NCT01448213|560872896|FG000|Overall Study|Adverse Event|4|||
155392359|NCT01448213|560872897|FG001|Overall Study|Adverse Event|10|||
155392360|NCT01448213|560872896|FG000|Overall Study|Protocol Violation|1|||
155392361|NCT01448213|560872897|FG001|Overall Study|Protocol Violation|2|||
155392362|NCT04906616|560872902|FG000|Overall Study|Divorce|3|||
155392363|NCT04906616|560872903|FG001|Overall Study|Divorce|2|||
155392364|NCT00607880|560872904|FG000|Overall Study|Unable to place port due to occlusion|1|||
155392365|NCT00607880|560872905|FG001|Overall Study|Unable to place port due to occlusion|0|||
155392366|NCT04606771|560872907|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
155392367|NCT04606771|560872908|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
155392368|NCT04606771|560872907|FG000|Overall Study|Death|5|||
155392369|NCT04606771|560872908|FG001|Overall Study|Death|6|||
155392370|NCT04606771|560872907|FG000|Overall Study|Wrong randomisation|0|||
155392371|NCT04606771|560872908|FG001|Overall Study|Wrong randomisation|1|||
155632197|NCT00042289|561747664|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
155632198|NCT00042289|561747665|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
155632199|NCT00042289|561747666|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
155632200|NCT00042289|561747667|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
155632201|NCT00042289|561747668|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
155632202|NCT00042289|561747669|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
155632203|NCT00042289|561747670|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
155632204|NCT00042289|561747671|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
155632205|NCT00042289|561747672|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
155632206|NCT00042289|561747673|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
155632207|NCT00042289|561747674|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
155632208|NCT00042289|561747675|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
155632209|NCT00042289|561747676|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
155632210|NCT00042289|561747677|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
155632211|NCT00042289|561747631|FG000|Overall Study|Protocol Violation|0|||
155632212|NCT00042289|561747632|FG001|Overall Study|Protocol Violation|0|||
155632213|NCT00042289|561747633|FG002|Overall Study|Protocol Violation|0|||
155632214|NCT00042289|561747634|FG003|Overall Study|Protocol Violation|0|||
155632215|NCT00042289|561747635|FG004|Overall Study|Protocol Violation|0|||
155632216|NCT00042289|561747636|FG005|Overall Study|Protocol Violation|1|||
155392372|NCT01754857|560872910|FG000|Overall Study|Adverse Event|7|||
155392373|NCT01754857|560872910|FG000|Overall Study|Disease progression|3|||
155392374|NCT01754857|560872910|FG000|Overall Study|Physician Decision|2|||
155392375|NCT01754857|560872910|FG000|Overall Study|Withdrawal by Subject|3|||
155392376|NCT01754857|560872910|FG000|Overall Study|other complicating disease|1|||
155392377|NCT01754857|560872910|FG000|Overall Study|ineligible to continue onto maintenance|1|||
155392378|NCT01754857|560872910|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
155392379|NCT01754857|560872910|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
155392380|NCT03083847|560872913|FG000|Main|Physician Decision|0|||
155392381|NCT03083847|560872914|FG001|Main|Physician Decision|0|||
155392382|NCT03083847|560872915|FG002|Main|Physician Decision|0|||
155392383|NCT03083847|560872916|FG003|Main|Physician Decision|0|||
155392384|NCT03083847|560872917|FG004|Main|Physician Decision|0|||
155392385|NCT03083847|560872918|FG005|Main|Physician Decision|1|||
155392386|NCT03083847|560872919|FG006|Main|Physician Decision|0|||
155392387|NCT03083847|560872920|FG007|Main|Physician Decision|0|||
155392388|NCT03083847|560872921|FG008|Main|Physician Decision|0|||
155392389|NCT03083847|560872922|FG009|Main|Physician Decision|0|||
155392390|NCT03083847|560872913|FG000|Main|Pregnancy|0|||
155392391|NCT03083847|560872914|FG001|Main|Pregnancy|0|||
155392392|NCT03083847|560872915|FG002|Main|Pregnancy|0|||
155392393|NCT03083847|560872916|FG003|Main|Pregnancy|0|||
155392394|NCT03083847|560872917|FG004|Main|Pregnancy|0|||
155392395|NCT03083847|560872918|FG005|Main|Pregnancy|0|||
155392396|NCT03083847|560872919|FG006|Main|Pregnancy|0|||
155392397|NCT03083847|560872920|FG007|Main|Pregnancy|1|||
155392398|NCT03083847|560872921|FG008|Main|Pregnancy|0|||
155392399|NCT03083847|560872922|FG009|Main|Pregnancy|0|||
155392400|NCT03083847|560872913|FG000|Main|Adverse Event|0|||
155392401|NCT03083847|560872914|FG001|Main|Adverse Event|0|||
155392402|NCT03083847|560872915|FG002|Main|Adverse Event|0|||
155392403|NCT03083847|560872916|FG003|Main|Adverse Event|0|||
155392404|NCT03083847|560872917|FG004|Main|Adverse Event|0|||
155392405|NCT03083847|560872918|FG005|Main|Adverse Event|0|||
155392406|NCT03083847|560872919|FG006|Main|Adverse Event|0|||
155392407|NCT03083847|560872920|FG007|Main|Adverse Event|2|||
155392408|NCT03083847|560872921|FG008|Main|Adverse Event|0|||
155392409|NCT03083847|560872922|FG009|Main|Adverse Event|0|||
155392410|NCT03083847|560872913|FG000|Main|Withdrawal by Subject|0|||
155392411|NCT03083847|560872914|FG001|Main|Withdrawal by Subject|0|||
155392412|NCT03083847|560872915|FG002|Main|Withdrawal by Subject|0|||
155392413|NCT03083847|560872916|FG003|Main|Withdrawal by Subject|0|||
155392414|NCT03083847|560872917|FG004|Main|Withdrawal by Subject|0|||
155392415|NCT03083847|560872918|FG005|Main|Withdrawal by Subject|0|||
155392416|NCT03083847|560872919|FG006|Main|Withdrawal by Subject|1|||
155392417|NCT03083847|560872920|FG007|Main|Withdrawal by Subject|1|||
155392418|NCT03083847|560872921|FG008|Main|Withdrawal by Subject|0|||
155392419|NCT03083847|560872922|FG009|Main|Withdrawal by Subject|0|||
155392420|NCT01214187|560872923|FG000|Overall Study|Adverse Event|6|||
155392421|NCT01214187|560872924|FG001|Overall Study|Adverse Event|2|||
155392422|NCT01214187|560872923|FG000|Overall Study|Death|1|||
155392423|NCT01214187|560872924|FG001|Overall Study|Death|1|||
155392424|NCT01214187|560872923|FG000|Overall Study|Withdrawal by Subject|0|||
155392425|NCT01214187|560872924|FG001|Overall Study|Withdrawal by Subject|3|||
155392426|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Death|1|||
155392427|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Death|0|||
155392428|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Death|0|||
155392429|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Death|0|||
155392430|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
155392431|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
155392432|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
155392433|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
155392434|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
155392435|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
155392436|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
155392437|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
155392438|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
155392439|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
155632217|NCT00042289|561747637|FG006|Overall Study|Protocol Violation|0|||
155632218|NCT00042289|561747638|FG007|Overall Study|Protocol Violation|1|||
155632219|NCT00042289|561747639|FG008|Overall Study|Protocol Violation|0|||
155632220|NCT00042289|561747640|FG009|Overall Study|Protocol Violation|0|||
155632221|NCT00042289|561747641|FG010|Overall Study|Protocol Violation|0|||
155632222|NCT00042289|561747642|FG011|Overall Study|Protocol Violation|0|||
155632223|NCT00042289|561747643|FG012|Overall Study|Protocol Violation|0|||
155632224|NCT00042289|561747644|FG013|Overall Study|Protocol Violation|0|||
155632225|NCT00042289|561747645|FG014|Overall Study|Protocol Violation|0|||
155392440|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
155392441|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
155392442|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
155392443|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
155392444|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
155392445|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
155392446|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Other|3|||
155392447|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Other|0|||
155392448|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Other|0|||
155392449|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Other|3|||
155392450|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
155392451|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
155392452|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
155392453|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
155392454|NCT03189862|560872934|FG000|Overall Study|Withdrawal by Subject|1|||
155392455|NCT03189862|560872935|FG001|Overall Study|Withdrawal by Subject|0|||
155392456|NCT03189862|560872934|FG000|Overall Study|Lost to Follow-up|54|||
155392457|NCT03189862|560872935|FG001|Overall Study|Lost to Follow-up|62|||
155392458|NCT02545322|560872936|FG000|Overall Study|Withdrawal by Subject|3|||
155392459|NCT03690141|560872937|FG000|Overall Study|Adverse Event|5|||
155392460|NCT03690141|560872937|FG000|Overall Study|Withdrawal by Subject|3|||
155392461|NCT03690141|560872937|FG000|Overall Study|Physician Decision|4|||
155734864|NCT04292899|562127210|FG001|Overall Study|Adverse Event|1|||
155734865|NCT04292899|562127211|FG002|Overall Study|Adverse Event|2|||
155734866|NCT04292899|562127212|FG003|Overall Study|Adverse Event|2|||
155734867|NCT04292899|562127209|FG000|Overall Study|Investigator's Discretion|0|||
155734868|NCT04292899|562127210|FG001|Overall Study|Investigator's Discretion|0|||
155734869|NCT04292899|562127211|FG002|Overall Study|Investigator's Discretion|0|||
155734870|NCT04292899|562127212|FG003|Overall Study|Investigator's Discretion|3|||
155734871|NCT04292899|562127209|FG000|Overall Study|Non-compliance With Study Drug|0|||
155734872|NCT04292899|562127210|FG001|Overall Study|Non-compliance With Study Drug|0|||
155734873|NCT04292899|562127211|FG002|Overall Study|Non-compliance With Study Drug|0|||
155734874|NCT04292899|562127212|FG003|Overall Study|Non-compliance With Study Drug|1|||
155734875|NCT04292899|562127209|FG000|Overall Study|Protocol Violation|0|||
155632226|NCT00042289|561747646|FG015|Overall Study|Protocol Violation|0|||
155632227|NCT00042289|561747647|FG016|Overall Study|Protocol Violation|0|||
155632228|NCT00042289|561747648|FG017|Overall Study|Protocol Violation|0|||
155632229|NCT00042289|561747649|FG018|Overall Study|Protocol Violation|0|||
155632230|NCT00042289|561747650|FG019|Overall Study|Protocol Violation|0|||
155632231|NCT00042289|561747651|FG020|Overall Study|Protocol Violation|0|||
155632232|NCT00042289|561747652|FG021|Overall Study|Protocol Violation|0|||
155632233|NCT00042289|561747653|FG022|Overall Study|Protocol Violation|0|||
155734876|NCT04292899|562127210|FG001|Overall Study|Protocol Violation|0|||
155734877|NCT04292899|562127211|FG002|Overall Study|Protocol Violation|0|||
155734878|NCT04292899|562127212|FG003|Overall Study|Protocol Violation|1|||
155734879|NCT00948441|562127213|FG000|Overall Study|no longer meet inclusion criteria|1|||
155734880|NCT00948441|562127214|FG001|Overall Study|no longer meet inclusion criteria|4|||
155734881|NCT03532451|562127219|FG000|Overall Study|Withdrawal by Subject|0|||
155734882|NCT03532451|562127220|FG001|Overall Study|Withdrawal by Subject|1|||
155734883|NCT03532451|562127219|FG000|Overall Study|Did not undergo surgery|1|||
155392462|NCT03690141|560872937|FG000|Overall Study|Disease progression|4|||
155392463|NCT00041067|560872938|FG000|Overall Study|Adverse Event|20|||
155392464|NCT00041067|560872938|FG000|Overall Study|Progression|19|||
155392465|NCT00041067|560872938|FG000|Overall Study|Patient refusal|12|||
155392466|NCT00041067|560872938|FG000|Overall Study|Other reasons|23|||
155392467|NCT00041067|560872938|FG000|Overall Study|Ineligible|2|||
155392468|NCT00778622|560872939|FG000|Overall Study|Adverse Event|5|||
155392469|NCT00778622|560872940|FG001|Overall Study|Adverse Event|4|||
155392470|NCT00778622|560872941|FG002|Overall Study|Adverse Event|7|||
155392471|NCT00778622|560872939|FG000|Overall Study|Withdrawal by Subject|4|||
155392472|NCT00778622|560872940|FG001|Overall Study|Withdrawal by Subject|5|||
155392473|NCT00778622|560872941|FG002|Overall Study|Withdrawal by Subject|5|||
155392474|NCT00778622|560872939|FG000|Overall Study|Lost to Follow-up|3|||
155392475|NCT00778622|560872940|FG001|Overall Study|Lost to Follow-up|3|||
155392476|NCT00778622|560872941|FG002|Overall Study|Lost to Follow-up|2|||
155392477|NCT00778622|560872939|FG000|Overall Study|Protocol Violation|0|||
155392478|NCT00778622|560872940|FG001|Overall Study|Protocol Violation|3|||
155392479|NCT00778622|560872941|FG002|Overall Study|Protocol Violation|0|||
155392480|NCT00778622|560872939|FG000|Overall Study|Lack of Efficacy|2|||
155392481|NCT00778622|560872940|FG001|Overall Study|Lack of Efficacy|0|||
155392482|NCT00778622|560872941|FG002|Overall Study|Lack of Efficacy|0|||
155392483|NCT00778622|560872939|FG000|Overall Study|immigration|1|||
155632234|NCT00042289|561747654|FG023|Overall Study|Protocol Violation|1|||
155632235|NCT00042289|561747655|FG024|Overall Study|Protocol Violation|1|||
155632236|NCT00042289|561747656|FG025|Overall Study|Protocol Violation|0|||
155632237|NCT00042289|561747657|FG026|Overall Study|Protocol Violation|2|||
155734884|NCT03532451|562127220|FG001|Overall Study|Did not undergo surgery|1|||
155392484|NCT00778622|560872940|FG001|Overall Study|immigration|0|||
155734885|NCT02527421|562127221|FG000|Overall Study|Withdrawal by Subject|1|||
155734886|NCT02527421|562127222|FG001|Overall Study|Withdrawal by Subject|0|||
155734887|NCT04200352|562127223|FG000|Overall Study|Death|1|||
155734888|NCT04200352|562127223|FG000|Overall Study|Adverse Event|6|||
155392485|NCT00778622|560872941|FG002|Overall Study|immigration|0|||
155392486|NCT00778622|560872939|FG000|Overall Study|Other|1|||
155392487|NCT00778622|560872940|FG001|Overall Study|Other|0|||
155392488|NCT00778622|560872941|FG002|Overall Study|Other|1|||
155734889|NCT04200352|562127223|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155392489|NCT04744285|560872942|FG000|Overall Study|Withdrawal by Subject|1|||
155392490|NCT04744285|560872943|FG001|Overall Study|Withdrawal by Subject|1|||
155392491|NCT04744285|560872944|FG002|Overall Study|Withdrawal by Subject|2|||
155632238|NCT00042289|561747658|FG027|Overall Study|Protocol Violation|0|||
155632239|NCT00042289|561747659|FG028|Overall Study|Protocol Violation|0|||
155632240|NCT00042289|561747660|FG029|Overall Study|Protocol Violation|0|||
155734890|NCT04200352|562127223|FG000|Overall Study|Lack of Efficacy|1|||
155734891|NCT04200352|562127223|FG000|Overall Study|Other than specified|6|||
155734892|NCT02541604|562127224|FG000|Overall Study|Death|6|||
155734893|NCT02541604|562127225|FG001|Overall Study|Death|5|||
155734894|NCT02541604|562127226|FG002|Overall Study|Death|7|||
155734895|NCT02541604|562127227|FG003|Overall Study|Death|2|||
155734896|NCT02541604|562127228|FG004|Overall Study|Death|9|||
155734897|NCT02541604|562127229|FG005|Overall Study|Death|8|||
155734898|NCT02541604|562127230|FG006|Overall Study|Death|9|||
155734899|NCT02541604|562127231|FG007|Overall Study|Death|9|||
155734900|NCT02541604|562127232|FG008|Overall Study|Death|3|||
155734901|NCT02541604|562127233|FG009|Overall Study|Death|4|||
155734902|NCT02541604|562127234|FG010|Overall Study|Death|2|||
155734903|NCT02541604|562127235|FG011|Overall Study|Death|3|||
155734904|NCT02541604|562127224|FG000|Overall Study|Lost to Follow-up|2|||
155734905|NCT02541604|562127225|FG001|Overall Study|Lost to Follow-up|0|||
155734906|NCT02541604|562127226|FG002|Overall Study|Lost to Follow-up|1|||
155392492|NCT04744285|560872945|FG003|Overall Study|Withdrawal by Subject|1|||
155392493|NCT01822522|560872946|FG000|Overall Study|Adverse Event|1|||
155392494|NCT01822522|560872947|FG001|Overall Study|Adverse Event|1|||
155392495|NCT01822522|560872948|FG002|Overall Study|Adverse Event|1|||
155392496|NCT01822522|560872949|FG003|Overall Study|Adverse Event|0|||
155392497|NCT01822522|560872950|FG004|Overall Study|Adverse Event|0|||
155392498|NCT01822522|560872951|FG005|Overall Study|Adverse Event|1|||
155392499|NCT01822522|560872946|FG000|Overall Study|Death|3|||
155392500|NCT01822522|560872947|FG001|Overall Study|Death|0|||
155392501|NCT01822522|560872948|FG002|Overall Study|Death|2|||
155392502|NCT01822522|560872949|FG003|Overall Study|Death|0|||
155392503|NCT01822522|560872950|FG004|Overall Study|Death|0|||
155392504|NCT01822522|560872951|FG005|Overall Study|Death|0|||
155392505|NCT01822522|560872946|FG000|Overall Study|Lost to Follow-up|0|||
155392506|NCT01822522|560872947|FG001|Overall Study|Lost to Follow-up|0|||
155392507|NCT01822522|560872948|FG002|Overall Study|Lost to Follow-up|1|||
155392508|NCT01822522|560872949|FG003|Overall Study|Lost to Follow-up|1|||
155392509|NCT01822522|560872950|FG004|Overall Study|Lost to Follow-up|0|||
155392510|NCT01822522|560872951|FG005|Overall Study|Lost to Follow-up|1|||
155392511|NCT01822522|560872946|FG000|Overall Study|Withdrawal by Subject|0|||
155392512|NCT01822522|560872947|FG001|Overall Study|Withdrawal by Subject|0|||
155392513|NCT01822522|560872948|FG002|Overall Study|Withdrawal by Subject|0|||
155392514|NCT01822522|560872949|FG003|Overall Study|Withdrawal by Subject|1|||
155392515|NCT01822522|560872950|FG004|Overall Study|Withdrawal by Subject|0|||
155392516|NCT01822522|560872951|FG005|Overall Study|Withdrawal by Subject|0|||
155392517|NCT01822522|560872946|FG000|Overall Study|Lack of Efficacy|0|||
155392518|NCT01822522|560872947|FG001|Overall Study|Lack of Efficacy|0|||
155392519|NCT01822522|560872948|FG002|Overall Study|Lack of Efficacy|0|||
155392520|NCT01822522|560872949|FG003|Overall Study|Lack of Efficacy|0|||
155392521|NCT01822522|560872950|FG004|Overall Study|Lack of Efficacy|0|||
155392522|NCT01822522|560872951|FG005|Overall Study|Lack of Efficacy|2|||
155392523|NCT01807923|560872952|FG000|Overall Study|Adverse Event|2|||
155392524|NCT01807923|560872953|FG001|Overall Study|Adverse Event|1|||
155392525|NCT01807923|560872954|FG002|Overall Study|Adverse Event|2|||
155392526|NCT01807923|560872952|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155392527|NCT01807923|560872953|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
155392528|NCT01807923|560872954|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
155392529|NCT01807923|560872952|FG000|Overall Study|Physician Decision|0|||
155392530|NCT01807923|560872953|FG001|Overall Study|Physician Decision|0|||
155392531|NCT01807923|560872954|FG002|Overall Study|Physician Decision|1|||
155392532|NCT01807923|560872952|FG000|Overall Study|Not Eligible (Genotype)|0|||
155392533|NCT01807923|560872953|FG001|Overall Study|Not Eligible (Genotype)|0|||
155392534|NCT01807923|560872954|FG002|Overall Study|Not Eligible (Genotype)|1|||
155734907|NCT02541604|562127227|FG003|Overall Study|Lost to Follow-up|0|||
155734908|NCT02541604|562127228|FG004|Overall Study|Lost to Follow-up|0|||
155392535|NCT01807923|560872952|FG000|Overall Study|Randomized But Not Treated|3|||
155392536|NCT01807923|560872953|FG001|Overall Study|Randomized But Not Treated|2|||
155392537|NCT01807923|560872954|FG002|Overall Study|Randomized But Not Treated|5|||
155392538|NCT03836807|560872960|FG000|Overall Study|Physician Decision|1|||
155392539|NCT03836807|560872961|FG001|Overall Study|Physician Decision|0|||
155392540|NCT00685685|560872962|FG000|Washout Period of 7 Days|Adverse Event|2|||
155734909|NCT02541604|562127229|FG005|Overall Study|Lost to Follow-up|1|||
155734910|NCT02541604|562127230|FG006|Overall Study|Lost to Follow-up|1|||
155392541|NCT00685685|560872963|FG001|Washout Period of 7 Days|Adverse Event|0|||
155392542|NCT00685685|560872962|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155392543|NCT00685685|560872963|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155392544|NCT04029116|560872964|FG000|Overall Study|Adverse Event|0|||
155392545|NCT04029116|560872965|FG001|Overall Study|Adverse Event|2|||
155392546|NCT04029116|560872964|FG000|Overall Study|Lost to Follow-up|3|||
155734911|NCT02541604|562127231|FG007|Overall Study|Lost to Follow-up|0|||
155734912|NCT02541604|562127232|FG008|Overall Study|Lost to Follow-up|0|||
155734913|NCT02541604|562127233|FG009|Overall Study|Lost to Follow-up|0|||
155734914|NCT02541604|562127234|FG010|Overall Study|Lost to Follow-up|0|||
155392547|NCT04029116|560872965|FG001|Overall Study|Lost to Follow-up|5|||
155392548|NCT04029116|560872964|FG000|Overall Study|Physician Decision|2|||
155392549|NCT04029116|560872965|FG001|Overall Study|Physician Decision|0|||
155392550|NCT04029116|560872964|FG000|Overall Study|Pregnancy|1|||
155392551|NCT04029116|560872965|FG001|Overall Study|Pregnancy|2|||
155392552|NCT04029116|560872964|FG000|Overall Study|Withdrawal by Subject|4|||
155392553|NCT04029116|560872965|FG001|Overall Study|Withdrawal by Subject|6|||
155392554|NCT04029116|560872964|FG000|Overall Study|Other|2|||
155392555|NCT04029116|560872965|FG001|Overall Study|Other|1|||
155392556|NCT02469896|560872968|FG000|Overall Study|Withdrawal by Subject|2|||
155392557|NCT02469896|560872969|FG001|Overall Study|Withdrawal by Subject|0|||
155392558|NCT02510560|560872970|FG000|Overall Study|Discontinued from Treatment|27|||
155392559|NCT02510560|560872971|FG001|Overall Study|Discontinued from Treatment|18|||
155392560|NCT02510560|560872972|FG002|Overall Study|Discontinued from Treatment|19|||
155392561|NCT02510560|560872970|FG000|Overall Study|Other|4|||
155392562|NCT02510560|560872971|FG001|Overall Study|Other|4|||
155392563|NCT02510560|560872972|FG002|Overall Study|Other|3|||
155392564|NCT00882310|560872973|FG000|Overall Study|Screen Failure|10|||
155392565|NCT00882310|560872973|FG000|Overall Study|Never received treatment|1|||
155392566|NCT00882310|560872973|FG000|Overall Study|Death|6|||
155392567|NCT00882310|560872973|FG000|Overall Study|Progression of disease|4|||
155392568|NCT00882310|560872973|FG000|Overall Study|Adverse Event|1|||
155392569|NCT04233164|560872978|FG000|Overall Study|Unable to obtain specimen|0|||
155392570|NCT04233164|560872979|FG001|Overall Study|Unable to obtain specimen|1|||
155392571|NCT02014740|560872980|FG000|Overall Study|Lost to Follow-up|4|||
155392572|NCT02014740|560872981|FG001|Overall Study|Lost to Follow-up|4|||
155392573|NCT02014740|560872980|FG000|Overall Study|Withdrawal by Subject|2|||
155392574|NCT02014740|560872981|FG001|Overall Study|Withdrawal by Subject|1|||
155392575|NCT03684642|560872982|FG000|Overall Study|Adverse Event|6|||
155392576|NCT03684642|560872983|FG001|Overall Study|Adverse Event|15|||
155392577|NCT03684642|560872984|FG002|Overall Study|Adverse Event|11|||
155392578|NCT03684642|560872982|FG000|Overall Study|Withdrawal by Subject|35|||
155392579|NCT03684642|560872983|FG001|Overall Study|Withdrawal by Subject|53|||
155392580|NCT03684642|560872984|FG002|Overall Study|Withdrawal by Subject|23|||
155392581|NCT03684642|560872982|FG000|Overall Study|Lack of Efficacy|0|||
155392582|NCT03684642|560872983|FG001|Overall Study|Lack of Efficacy|0|||
155392583|NCT03684642|560872984|FG002|Overall Study|Lack of Efficacy|1|||
155392584|NCT03684642|560872982|FG000|Overall Study|Poor compliance to protocol|0|||
155392585|NCT03684642|560872983|FG001|Overall Study|Poor compliance to protocol|4|||
155392586|NCT03684642|560872984|FG002|Overall Study|Poor compliance to protocol|1|||
155392587|NCT03684642|560872982|FG000|Overall Study|Other than specified|62|||
155392588|NCT03684642|560872983|FG001|Overall Study|Other than specified|60|||
155392589|NCT03684642|560872984|FG002|Overall Study|Other than specified|67|||
155392590|NCT03684642|560872982|FG000|Overall Study|Randomized and not treated|0|||
155392591|NCT03684642|560872983|FG001|Overall Study|Randomized and not treated|0|||
155392592|NCT03684642|560872984|FG002|Overall Study|Randomized and not treated|1|||
155392593|NCT03684642|560872982|FG000|Overall Study|Missing completion status but alive at last contact|0|||
155392594|NCT03684642|560872983|FG001|Overall Study|Missing completion status but alive at last contact|1|||
155392595|NCT03684642|560872984|FG002|Overall Study|Missing completion status but alive at last contact|2|||
155392596|NCT01843218|560872987|FG000|Overall Study|Withdrawal by Subject|5|||
155392597|NCT01431534|560872988|FG000|Treatment Phase|Adverse Event|0|||
155392598|NCT01431534|560872989|FG001|Treatment Phase|Adverse Event|0|||
155392599|NCT01431534|560872990|FG002|Treatment Phase|Adverse Event|1|||
155392600|NCT01431534|560872988|FG000|Treatment Phase|Progressive Disease|4|||
155392601|NCT01431534|560872989|FG001|Treatment Phase|Progressive Disease|3|||
155392602|NCT01431534|560872990|FG002|Treatment Phase|Progressive Disease|10|||
155392603|NCT04201821|560872993|FG000|Overall Study|Withdrawal by Subject|2|||
155392604|NCT01395316|560872994|FG000|Overall Study|Lost to Follow-up|2|||
155392605|NCT01395316|560872994|FG000|Overall Study|poor MRI quality|1|||
155392606|NCT02540538|560872995|FG000|Overall Study|Pregnancy|0|||
155392607|NCT02540538|560872996|FG001|Overall Study|Pregnancy|1|||
155392608|NCT02540538|560872997|FG002|Overall Study|Pregnancy|0|||
155392609|NCT02846532|560872998|FG000|Overall Study|Lost to Follow-up|0|||
155632241|NCT00042289|561747661|FG030|Overall Study|Protocol Violation|1|||
155632242|NCT00042289|561747662|FG031|Overall Study|Protocol Violation|0|||
155392610|NCT02846532|560872999|FG001|Overall Study|Lost to Follow-up|1|||
155392611|NCT02846532|560873000|FG002|Overall Study|Lost to Follow-up|1|||
155392612|NCT02846532|560872998|FG000|Overall Study|Withdrawal by Subject|1|||
155392613|NCT02846532|560872999|FG001|Overall Study|Withdrawal by Subject|2|||
155392614|NCT02846532|560873000|FG002|Overall Study|Withdrawal by Subject|0|||
155392615|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
155392616|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
155392617|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
155392618|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
155392619|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
155392620|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
155435854|NCT01476787|561022966|FG000|Treatment|Voluntary treatment discontinuation|8|||
155392621|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
155392622|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
155392623|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
155392624|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
155392625|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
155392626|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
155392627|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
155392628|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
155392629|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
155392630|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
155392631|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
155392632|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
155392633|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
155392634|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
155392635|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
155392636|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
155392637|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
155392638|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
155392639|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
155392640|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
155392641|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
155392642|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
155392643|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
155392644|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
155392645|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
155392646|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
155392647|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
155392648|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392649|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392650|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392651|NCT04598477|560873006|FG000|Overall Study|Adverse Event|2|||
155392652|NCT04598477|560873007|FG001|Overall Study|Adverse Event|0|||
155392653|NCT04598477|560873006|FG000|Overall Study|Death|0|||
155392654|NCT04598477|560873007|FG001|Overall Study|Death|1|||
155392655|NCT04598477|560873006|FG000|Overall Study|Lost to Follow-up|1|||
155392656|NCT04598477|560873007|FG001|Overall Study|Lost to Follow-up|0|||
155392657|NCT04598477|560873006|FG000|Overall Study|Physician Decision|7|||
155392658|NCT04598477|560873007|FG001|Overall Study|Physician Decision|2|||
155392659|NCT04598477|560873006|FG000|Overall Study|Pregnancy|0|||
155392660|NCT04598477|560873007|FG001|Overall Study|Pregnancy|1|||
155392661|NCT04598477|560873006|FG000|Overall Study|Requires Prohibited Medication|0|||
155392662|NCT04598477|560873007|FG001|Overall Study|Requires Prohibited Medication|1|||
155392663|NCT04598477|560873006|FG000|Overall Study|Study Terminated by Sponsor|18|||
155392664|NCT04598477|560873007|FG001|Overall Study|Study Terminated by Sponsor|12|||
155392665|NCT04598477|560873006|FG000|Overall Study|Withdrawal by Subject|16|||
155392666|NCT04598477|560873007|FG001|Overall Study|Withdrawal by Subject|12|||
155392667|NCT04598477|560873006|FG000|Overall Study|Other|15|||
155392668|NCT04598477|560873007|FG001|Overall Study|Other|8|||
155392669|NCT05359003|560873008|FG000|Overall Study|Withdrawal by Subject|1|||
155392670|NCT05359003|560873009|FG001|Overall Study|Withdrawal by Subject|3|||
155392671|NCT05579990|560873015|FG000|Overall Study|Lost to Follow-up|3|||
155392672|NCT00607022|560873016|FG000|Overall Study|Withdrawal by Subject|1|||
155392673|NCT00607022|560873017|FG001|Overall Study|Withdrawal by Subject|0|||
155392674|NCT00607022|560873018|FG002|Overall Study|Withdrawal by Subject|0|||
155392675|NCT01313650|560873019|FG000|Overall Study|Adverse Event|9|||
155392676|NCT01313650|560873020|FG001|Overall Study|Adverse Event|34|||
155392677|NCT01313650|560873021|FG002|Overall Study|Adverse Event|24|||
155392678|NCT01313650|560873022|FG003|Overall Study|Adverse Event|23|||
155392679|NCT01313650|560873019|FG000|Overall Study|Lack of Efficacy|37|||
155392680|NCT01313650|560873020|FG001|Overall Study|Lack of Efficacy|20|||
155392681|NCT01313650|560873021|FG002|Overall Study|Lack of Efficacy|32|||
155392682|NCT01313650|560873022|FG003|Overall Study|Lack of Efficacy|20|||
155392683|NCT01313650|560873019|FG000|Overall Study|Lost to Follow-up|1|||
155392684|NCT01313650|560873020|FG001|Overall Study|Lost to Follow-up|0|||
155392685|NCT01313650|560873021|FG002|Overall Study|Lost to Follow-up|3|||
155392686|NCT01313650|560873022|FG003|Overall Study|Lost to Follow-up|2|||
155392687|NCT01313650|560873019|FG000|Overall Study|Withdrawal by Subject|16|||
155734915|NCT02541604|562127235|FG011|Overall Study|Lost to Follow-up|0|||
155734916|NCT02541604|562127224|FG000|Overall Study|Withdrawal by Subject|2|||
155734917|NCT02541604|562127225|FG001|Overall Study|Withdrawal by Subject|0|||
155392688|NCT01313650|560873020|FG001|Overall Study|Withdrawal by Subject|20|||
155392689|NCT01313650|560873021|FG002|Overall Study|Withdrawal by Subject|15|||
155392690|NCT01313650|560873022|FG003|Overall Study|Withdrawal by Subject|15|||
155392691|NCT01313650|560873019|FG000|Overall Study|Protocol Violation|4|||
155392692|NCT01313650|560873020|FG001|Overall Study|Protocol Violation|7|||
155392693|NCT01313650|560873021|FG002|Overall Study|Protocol Violation|5|||
155392694|NCT01313650|560873022|FG003|Overall Study|Protocol Violation|6|||
155392695|NCT01313650|560873019|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
155392696|NCT01313650|560873020|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
155392697|NCT01313650|560873021|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
155392698|NCT01313650|560873022|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
155392699|NCT04313153|560874767|FG000|Overall Study|Adverse Event (includes Death)|14|||
155392700|NCT04313153|560874768|FG001|Overall Study|Adverse Event (includes Death)|19|||
155392701|NCT04313153|560874769|FG002|Overall Study|Adverse Event (includes Death)|10|||
155392702|NCT04313153|560874767|FG000|Overall Study|Physician Decision|4|||
155392703|NCT04313153|560874768|FG001|Overall Study|Physician Decision|2|||
155392704|NCT04313153|560874769|FG002|Overall Study|Physician Decision|1|||
155392705|NCT04313153|560874767|FG000|Overall Study|Withdrawal by Subject|7|||
155392706|NCT04313153|560874768|FG001|Overall Study|Withdrawal by Subject|6|||
155392707|NCT04313153|560874769|FG002|Overall Study|Withdrawal by Subject|2|||
155392708|NCT04313153|560874767|FG000|Overall Study|Lack of Efficacy|3|||
155392709|NCT04313153|560874768|FG001|Overall Study|Lack of Efficacy|3|||
155392710|NCT04313153|560874769|FG002|Overall Study|Lack of Efficacy|0|||
155392711|NCT04313153|560874767|FG000|Overall Study|Lost to Follow-up|1|||
155392712|NCT04313153|560874768|FG001|Overall Study|Lost to Follow-up|0|||
155392713|NCT04313153|560874769|FG002|Overall Study|Lost to Follow-up|2|||
155392714|NCT04313153|560874767|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
155392715|NCT04313153|560874768|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
155392716|NCT04313153|560874769|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
155392717|NCT04313153|560874767|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
155392718|NCT04313153|560874768|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
155392719|NCT04313153|560874769|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
155392720|NCT04313153|560874767|FG000|Overall Study|Change in Dialysis Modality|0|||
155392721|NCT04313153|560874768|FG001|Overall Study|Change in Dialysis Modality|1|||
155392722|NCT04313153|560874769|FG002|Overall Study|Change in Dialysis Modality|2|||
155392723|NCT04313153|560874767|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
155392724|NCT04313153|560874768|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
155392725|NCT04313153|560874769|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
155392726|NCT04313153|560874767|FG000|Overall Study|Other|5|||
155392727|NCT04313153|560874768|FG001|Overall Study|Other|3|||
155392728|NCT04313153|560874769|FG002|Overall Study|Other|2|||
155392729|NCT05586269|560874770|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
155392730|NCT05586269|560874771|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
155392731|NCT05586269|560874772|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
155392732|NCT05586269|560874773|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
155392733|NCT05586269|560874770|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
155392734|NCT05586269|560874771|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
155392735|NCT05586269|560874772|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
155392736|NCT05586269|560874773|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
155392737|NCT04752475|560874774|FG000|Overall Study|Withdrawal by Subject|1|||
155392738|NCT04752475|560874775|FG001|Overall Study|Withdrawal by Subject|1|||
155392739|NCT03335163|560874785|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
155392740|NCT03335163|560874785|FG000|Overall Study|Withdrawal by Subject|18|||
155392741|NCT02020863|560874789|FG000|Overall Study|Discovery of Metastatic disease|4|||
155392742|NCT02020863|560874789|FG000|Overall Study|Team chose not to place an a line|1|||
155392743|NCT01016964|560874790|FG000|Overall Study|Lost to Follow-up|3|||
155392744|NCT01016964|560874791|FG001|Overall Study|Lost to Follow-up|3|||
155392745|NCT00702845|560874793|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
155392746|NCT00702845|560874794|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
155392747|NCT00702845|560874793|FG000|Overall Study|Too high ovarian response|5|||
155392748|NCT00702845|560874794|FG001|Overall Study|Too high ovarian response|1|||
155392749|NCT00702845|560874793|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
155392750|NCT00702845|560874794|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
155392751|NCT00702845|560874793|FG000|Overall Study|Insufficient ovarian response|1|||
155392752|NCT00702845|560874794|FG001|Overall Study|Insufficient ovarian response|0|||
155392753|NCT00702845|560874793|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
155392754|NCT00702845|560874794|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
155392755|NCT00702845|560874793|FG000|Overall Study|No or abnormal fertilization|4|||
155392756|NCT00702845|560874794|FG001|Overall Study|No or abnormal fertilization|2|||
155392757|NCT00702845|560874793|FG000|Overall Study|Patient's decision|2|||
155392758|NCT00702845|560874794|FG001|Overall Study|Patient's decision|1|||
155392759|NCT00702845|560874793|FG000|Overall Study|Not randomized|0|||
155392760|NCT00702845|560874794|FG001|Overall Study|Not randomized|1|||
155392761|NCT00440700|560874795|FG000|Overall Study|Withdrawal by Subject|8|||
155392762|NCT00440700|560874796|FG001|Overall Study|Withdrawal by Subject|8|||
155392763|NCT00440700|560874797|FG002|Overall Study|Withdrawal by Subject|4|||
155392764|NCT01524133|560874800|FG000|Treatment Phase|Withdrawal by Subject|13|||
155392765|NCT01524133|560874801|FG001|Treatment Phase|Withdrawal by Subject|28|||
155392766|NCT01524133|560874802|FG002|Treatment Phase|Withdrawal by Subject|31|||
155392767|NCT01524133|560874800|FG000|Treatment Phase|Physician Decision|6|||
155392768|NCT01524133|560874801|FG001|Treatment Phase|Physician Decision|3|||
155392769|NCT01524133|560874802|FG002|Treatment Phase|Physician Decision|3|||
155392770|NCT01524133|560874800|FG000|Treatment Phase|Lost to Follow-up|0|||
155392771|NCT01524133|560874801|FG001|Treatment Phase|Lost to Follow-up|1|||
155392772|NCT01524133|560874802|FG002|Treatment Phase|Lost to Follow-up|2|||
155392773|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
155392774|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
155392775|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
155392776|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Physician Decision|1|||
155392777|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Physician Decision|0|||
155392778|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Physician Decision|2|||
155392779|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
155392780|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
155734918|NCT02541604|562127226|FG002|Overall Study|Withdrawal by Subject|1|||
155734919|NCT02541604|562127227|FG003|Overall Study|Withdrawal by Subject|0|||
155734920|NCT02541604|562127228|FG004|Overall Study|Withdrawal by Subject|1|||
155734921|NCT02541604|562127229|FG005|Overall Study|Withdrawal by Subject|1|||
155734922|NCT02541604|562127230|FG006|Overall Study|Withdrawal by Subject|0|||
155734923|NCT02541604|562127231|FG007|Overall Study|Withdrawal by Subject|0|||
155734924|NCT02541604|562127232|FG008|Overall Study|Withdrawal by Subject|1|||
155734925|NCT02541604|562127233|FG009|Overall Study|Withdrawal by Subject|0|||
155734926|NCT02541604|562127234|FG010|Overall Study|Withdrawal by Subject|0|||
155734927|NCT02541604|562127235|FG011|Overall Study|Withdrawal by Subject|0|||
155734928|NCT02541604|562127224|FG000|Overall Study|Study Terminated by Sponsor|1|||
155734929|NCT02541604|562127225|FG001|Overall Study|Study Terminated by Sponsor|4|||
155734930|NCT02541604|562127226|FG002|Overall Study|Study Terminated by Sponsor|2|||
155734931|NCT02541604|562127227|FG003|Overall Study|Study Terminated by Sponsor|1|||
155734932|NCT02541604|562127228|FG004|Overall Study|Study Terminated by Sponsor|0|||
155734933|NCT02541604|562127229|FG005|Overall Study|Study Terminated by Sponsor|0|||
155734934|NCT02541604|562127230|FG006|Overall Study|Study Terminated by Sponsor|0|||
155734935|NCT02541604|562127231|FG007|Overall Study|Study Terminated by Sponsor|0|||
155734936|NCT02541604|562127232|FG008|Overall Study|Study Terminated by Sponsor|0|||
155734937|NCT02541604|562127233|FG009|Overall Study|Study Terminated by Sponsor|0|||
155734938|NCT02541604|562127234|FG010|Overall Study|Study Terminated by Sponsor|0|||
155734939|NCT02541604|562127235|FG011|Overall Study|Study Terminated by Sponsor|0|||
155734940|NCT02541604|562127224|FG000|Overall Study|Medical condition may jeopardize safety|0|||
155734941|NCT02541604|562127225|FG001|Overall Study|Medical condition may jeopardize safety|0|||
155392781|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
155392782|NCT00056862|560874811|FG000|Overall Study|Protocol Violation|1|||
155392783|NCT00056862|560874812|FG001|Overall Study|Protocol Violation|0|||
155392784|NCT03974334|560874818|FG000|Overall Study|Lost to Follow-up|1|||
155392785|NCT00931944|560874820|FG000|Overall Study|Adverse Event|4|||
155392786|NCT00931944|560874820|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
155392787|NCT00931944|560874820|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
155392788|NCT00931944|560874820|FG000|Overall Study|Death|28|||
155392789|NCT00931944|560874820|FG000|Overall Study|Other|2|||
155392790|NCT01109173|560874821|FG000|Overall Study|Adverse Event|15|||
155392791|NCT01109173|560874822|FG001|Overall Study|Adverse Event|17|||
155392792|NCT01109173|560874823|FG002|Overall Study|Adverse Event|9|||
155392793|NCT01109173|560874824|FG003|Overall Study|Adverse Event|6|||
155392794|NCT01109173|560874821|FG000|Overall Study|Lost to Follow-up|0|||
155392795|NCT01109173|560874822|FG001|Overall Study|Lost to Follow-up|1|||
155392796|NCT01109173|560874823|FG002|Overall Study|Lost to Follow-up|0|||
155392797|NCT01109173|560874824|FG003|Overall Study|Lost to Follow-up|0|||
155392798|NCT01109173|560874821|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
155392799|NCT01109173|560874822|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
155392800|NCT01109173|560874823|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
155392801|NCT01109173|560874824|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
155734942|NCT02541604|562127226|FG002|Overall Study|Medical condition may jeopardize safety|0|||
155734943|NCT02541604|562127227|FG003|Overall Study|Medical condition may jeopardize safety|0|||
155734944|NCT02541604|562127228|FG004|Overall Study|Medical condition may jeopardize safety|0|||
155392802|NCT01109173|560874821|FG000|Overall Study|Noncompliance|0|||
155392803|NCT01109173|560874822|FG001|Overall Study|Noncompliance|1|||
155392804|NCT01109173|560874823|FG002|Overall Study|Noncompliance|0|||
155392805|NCT01109173|560874824|FG003|Overall Study|Noncompliance|0|||
155392806|NCT01109173|560874821|FG000|Overall Study|Treatment Failure|25|||
155392807|NCT01109173|560874822|FG001|Overall Study|Treatment Failure|32|||
155392808|NCT01109173|560874823|FG002|Overall Study|Treatment Failure|69|||
155392809|NCT01109173|560874824|FG003|Overall Study|Treatment Failure|64|||
155392810|NCT01109173|560874821|FG000|Overall Study|Protocol Violation|4|||
155392811|NCT01109173|560874822|FG001|Overall Study|Protocol Violation|5|||
155392812|NCT01109173|560874823|FG002|Overall Study|Protocol Violation|1|||
155392813|NCT01109173|560874824|FG003|Overall Study|Protocol Violation|2|||
155392814|NCT01109173|560874821|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
155392815|NCT01109173|560874822|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
155392816|NCT01109173|560874823|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
155392817|NCT01109173|560874824|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
155392818|NCT01109173|560874821|FG000|Overall Study|Not Specifiied|5|||
155392819|NCT01109173|560874822|FG001|Overall Study|Not Specifiied|4|||
155392820|NCT01109173|560874823|FG002|Overall Study|Not Specifiied|9|||
155392821|NCT01109173|560874824|FG003|Overall Study|Not Specifiied|14|||
155392822|NCT04178967|560874830|FG000|Induction Period|Adverse Event|4|||
155392823|NCT04178967|560874831|FG001|Induction Period|Adverse Event|6|||
155392824|NCT04178967|560874832|FG002|Induction Period|Adverse Event|0|||
155392825|NCT04178967|560874833|FG003|Induction Period|Adverse Event|0|||
155392826|NCT04178967|560874834|FG004|Induction Period|Adverse Event|0|||
155392827|NCT04178967|560874835|FG005|Induction Period|Adverse Event|0|||
155392828|NCT04178967|560874836|FG006|Induction Period|Adverse Event|0|||
155392829|NCT04178967|560874837|FG007|Induction Period|Adverse Event|0|||
155392830|NCT04178967|560874838|FG008|Induction Period|Adverse Event|0|||
155392831|NCT04178967|560874839|FG009|Induction Period|Adverse Event|0|||
155392832|NCT04178967|560874840|FG010|Induction Period|Adverse Event|0|||
155392833|NCT04178967|560874830|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
155392834|NCT04178967|560874831|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
155392835|NCT04178967|560874832|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
155392836|NCT04178967|560874833|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
155392837|NCT04178967|560874834|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
155392838|NCT04178967|560874835|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
155392839|NCT04178967|560874836|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
155392840|NCT04178967|560874837|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
155392841|NCT04178967|560874838|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
155392842|NCT04178967|560874839|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
155392843|NCT04178967|560874840|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
155392844|NCT04178967|560874830|FG000|Induction Period|Lack of Efficacy|4|||
155392845|NCT04178967|560874831|FG001|Induction Period|Lack of Efficacy|1|||
155392846|NCT04178967|560874832|FG002|Induction Period|Lack of Efficacy|0|||
155392847|NCT04178967|560874833|FG003|Induction Period|Lack of Efficacy|0|||
155392848|NCT04178967|560874834|FG004|Induction Period|Lack of Efficacy|0|||
155392849|NCT04178967|560874835|FG005|Induction Period|Lack of Efficacy|0|||
155392850|NCT04178967|560874836|FG006|Induction Period|Lack of Efficacy|0|||
155632243|NCT00042289|561747663|FG032|Overall Study|Protocol Violation|0|||
155632244|NCT00042289|561747664|FG033|Overall Study|Protocol Violation|0|||
155632245|NCT00042289|561747665|FG034|Overall Study|Protocol Violation|0|||
155632246|NCT00042289|561747666|FG035|Overall Study|Protocol Violation|0|||
155632247|NCT00042289|561747667|FG036|Overall Study|Protocol Violation|0|||
155632248|NCT00042289|561747668|FG037|Overall Study|Protocol Violation|0|||
155632249|NCT00042289|561747669|FG038|Overall Study|Protocol Violation|0|||
155632250|NCT00042289|561747670|FG039|Overall Study|Protocol Violation|0|||
155632251|NCT00042289|561747671|FG040|Overall Study|Protocol Violation|0|||
155632252|NCT00042289|561747672|FG041|Overall Study|Protocol Violation|1|||
155632253|NCT00042289|561747673|FG042|Overall Study|Protocol Violation|1|||
155632254|NCT00042289|561747674|FG043|Overall Study|Protocol Violation|1|||
155632255|NCT00042289|561747675|FG044|Overall Study|Protocol Violation|0|||
155632256|NCT00042289|561747676|FG045|Overall Study|Protocol Violation|0|||
155632257|NCT00042289|561747677|FG046|Overall Study|Protocol Violation|0|||
155632258|NCT00042289|561747631|FG000|Overall Study|Withdrawal by Subject|4|||
155632259|NCT00042289|561747632|FG001|Overall Study|Withdrawal by Subject|1|||
155632260|NCT00042289|561747633|FG002|Overall Study|Withdrawal by Subject|0|||
155392851|NCT04178967|560874837|FG007|Induction Period|Lack of Efficacy|0|||
155392852|NCT04178967|560874838|FG008|Induction Period|Lack of Efficacy|0|||
155392853|NCT04178967|560874839|FG009|Induction Period|Lack of Efficacy|0|||
155392854|NCT04178967|560874840|FG010|Induction Period|Lack of Efficacy|0|||
155392855|NCT04178967|560874830|FG000|Induction Period|Protocol Violation|0|||
155392856|NCT04178967|560874831|FG001|Induction Period|Protocol Violation|6|||
155392857|NCT04178967|560874832|FG002|Induction Period|Protocol Violation|0|||
155392858|NCT04178967|560874833|FG003|Induction Period|Protocol Violation|0|||
155392859|NCT04178967|560874834|FG004|Induction Period|Protocol Violation|0|||
155632261|NCT00042289|561747634|FG003|Overall Study|Withdrawal by Subject|2|||
155632262|NCT00042289|561747635|FG004|Overall Study|Withdrawal by Subject|0|||
155632263|NCT00042289|561747636|FG005|Overall Study|Withdrawal by Subject|2|||
155392860|NCT04178967|560874835|FG005|Induction Period|Protocol Violation|0|||
155392861|NCT04178967|560874836|FG006|Induction Period|Protocol Violation|0|||
155392862|NCT04178967|560874837|FG007|Induction Period|Protocol Violation|0|||
155632264|NCT00042289|561747637|FG006|Overall Study|Withdrawal by Subject|0|||
155632265|NCT00042289|561747638|FG007|Overall Study|Withdrawal by Subject|0|||
155632266|NCT00042289|561747639|FG008|Overall Study|Withdrawal by Subject|0|||
155632267|NCT00042289|561747640|FG009|Overall Study|Withdrawal by Subject|1|||
155632268|NCT00042289|561747641|FG010|Overall Study|Withdrawal by Subject|0|||
155632269|NCT00042289|561747642|FG011|Overall Study|Withdrawal by Subject|0|||
155632270|NCT00042289|561747643|FG012|Overall Study|Withdrawal by Subject|2|||
155632271|NCT00042289|561747644|FG013|Overall Study|Withdrawal by Subject|0|||
155632272|NCT00042289|561747645|FG014|Overall Study|Withdrawal by Subject|0|||
155632273|NCT00042289|561747646|FG015|Overall Study|Withdrawal by Subject|0|||
155632274|NCT00042289|561747647|FG016|Overall Study|Withdrawal by Subject|0|||
155632275|NCT00042289|561747648|FG017|Overall Study|Withdrawal by Subject|0|||
155632276|NCT00042289|561747649|FG018|Overall Study|Withdrawal by Subject|0|||
155632277|NCT00042289|561747650|FG019|Overall Study|Withdrawal by Subject|0|||
155632278|NCT00042289|561747651|FG020|Overall Study|Withdrawal by Subject|0|||
155282294|NCT03706690|560464108|FG001|Overall Study|Ongoing at DCO|52|||
155282295|NCT03803774|560464109|FG000|Dose Escalation|Withdrawal by Subject|0|||
155282296|NCT03803774|560464110|FG001|Dose Escalation|Withdrawal by Subject|0|||
155282297|NCT03803774|560464111|FG002|Dose Escalation|Withdrawal by Subject|0|||
155282298|NCT03803774|560464112|FG003|Dose Escalation|Withdrawal by Subject|1|||
155282299|NCT03803774|560464113|FG004|Dose Escalation|Withdrawal by Subject|0|||
155282300|NCT04482855|560464117|FG000|Overall Study|Lost to Follow-up|1|||
155282301|NCT04482855|560464118|FG001|Overall Study|Lost to Follow-up|0|||
155282302|NCT04482855|560464117|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
155282303|NCT04482855|560464118|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
155282304|NCT04482855|560464117|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
155282305|NCT04482855|560464118|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
155282306|NCT03212365|560464123|FG000|Overall Study|Discharged prior to Xa level|12|||
155282307|NCT03212365|560464124|FG001|Overall Study|Discharged prior to Xa level|8|||
155282308|NCT03212365|560464123|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
155282309|NCT03212365|560464124|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
155282310|NCT03212365|560464123|FG000|Overall Study|Refused study medication|3|||
155282311|NCT03212365|560464124|FG001|Overall Study|Refused study medication|0|||
155282312|NCT03212365|560464123|FG000|Overall Study|Initiated heparin infusion on floor|1|||
155282313|NCT03212365|560464124|FG001|Overall Study|Initiated heparin infusion on floor|1|||
155282314|NCT03212365|560464123|FG000|Overall Study|Unexpected return to OR|1|||
155282315|NCT03212365|560464124|FG001|Overall Study|Unexpected return to OR|1|||
155282316|NCT03212365|560464123|FG000|Overall Study|Medication distribution error|1|||
155282317|NCT03212365|560464124|FG001|Overall Study|Medication distribution error|0|||
155282318|NCT03212365|560464123|FG000|Overall Study|Required epidural placement|1|||
155282319|NCT03212365|560464124|FG001|Overall Study|Required epidural placement|0|||
155282320|NCT03212365|560464123|FG000|Overall Study|Withdrawal by Subject|0|||
155282321|NCT03212365|560464124|FG001|Overall Study|Withdrawal by Subject|1|||
155282322|NCT03212365|560464123|FG000|Overall Study|developed acute renal failure|0|||
155282323|NCT03212365|560464124|FG001|Overall Study|developed acute renal failure|1|||
155282324|NCT00665561|560464125|FG000|Overall Study|Death recorded on subject summary pages|75|||
155282325|NCT00665561|560464126|FG001|Overall Study|Death recorded on subject summary pages|75|||
155282326|NCT00665561|560464125|FG000|Overall Study|Does not meet entrance criteria|19|||
155282327|NCT00665561|560464126|FG001|Overall Study|Does not meet entrance criteria|21|||
155282328|NCT00665561|560464125|FG000|Overall Study|Lost to Follow-up|203|||
155282329|NCT00665561|560464126|FG001|Overall Study|Lost to Follow-up|264|||
155282330|NCT00665561|560464125|FG000|Overall Study|Withdrawal by Subject|74|||
155282331|NCT00665561|560464126|FG001|Overall Study|Withdrawal by Subject|65|||
155282332|NCT00665561|560464125|FG000|Overall Study|Other|123|||
155282333|NCT00665561|560464126|FG001|Overall Study|Other|108|||
155282334|NCT00665561|560464125|FG000|Overall Study|Site closed|8|||
155282335|NCT00665561|560464126|FG001|Overall Study|Site closed|0|||
155282336|NCT00665561|560464125|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155282337|NCT00665561|560464126|FG001|Overall Study|Withdrawn due to pregnancy|1|||
155282338|NCT02337361|560464127|FG000|3-month Follow-up|Lost to Follow-up|19|||
155282339|NCT02337361|560464128|FG001|3-month Follow-up|Lost to Follow-up|14|||
155282340|NCT02337361|560464127|FG000|6-month Follow-up|Lost to Follow-up|2|||
155282341|NCT02337361|560464128|FG001|6-month Follow-up|Lost to Follow-up|4|||
155282342|NCT00701311|560464131|FG000|Overall Study|Lack of Efficacy|3|||
155282343|NCT00701311|560464131|FG000|Overall Study|Adverse Event|3|||
155282344|NCT00701311|560464131|FG000|Overall Study|Withdrawal by Subject|2|||
155632279|NCT00042289|561747652|FG021|Overall Study|Withdrawal by Subject|1|||
155632280|NCT00042289|561747653|FG022|Overall Study|Withdrawal by Subject|1|||
155282345|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
155282346|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
155282347|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
155282348|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
155632281|NCT00042289|561747654|FG023|Overall Study|Withdrawal by Subject|1|||
155632282|NCT00042289|561747655|FG024|Overall Study|Withdrawal by Subject|0|||
155632283|NCT00042289|561747656|FG025|Overall Study|Withdrawal by Subject|0|||
155632284|NCT00042289|561747657|FG026|Overall Study|Withdrawal by Subject|1|||
155632285|NCT00042289|561747658|FG027|Overall Study|Withdrawal by Subject|0|||
155632286|NCT00042289|561747659|FG028|Overall Study|Withdrawal by Subject|2|||
155632287|NCT00042289|561747660|FG029|Overall Study|Withdrawal by Subject|0|||
155632288|NCT00042289|561747661|FG030|Overall Study|Withdrawal by Subject|0|||
155632289|NCT00042289|561747662|FG031|Overall Study|Withdrawal by Subject|1|||
155632290|NCT00042289|561747663|FG032|Overall Study|Withdrawal by Subject|2|||
155632291|NCT00042289|561747664|FG033|Overall Study|Withdrawal by Subject|1|||
155632292|NCT00042289|561747665|FG034|Overall Study|Withdrawal by Subject|0|||
155632293|NCT00042289|561747666|FG035|Overall Study|Withdrawal by Subject|0|||
155632294|NCT00042289|561747667|FG036|Overall Study|Withdrawal by Subject|0|||
155632295|NCT00042289|561747668|FG037|Overall Study|Withdrawal by Subject|1|||
155632296|NCT00042289|561747669|FG038|Overall Study|Withdrawal by Subject|0|||
155632297|NCT00042289|561747670|FG039|Overall Study|Withdrawal by Subject|0|||
155632298|NCT00042289|561747671|FG040|Overall Study|Withdrawal by Subject|0|||
155632299|NCT00042289|561747672|FG041|Overall Study|Withdrawal by Subject|0|||
155632300|NCT00042289|561747673|FG042|Overall Study|Withdrawal by Subject|1|||
155632301|NCT00042289|561747674|FG043|Overall Study|Withdrawal by Subject|0|||
155282349|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
155282350|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
155282351|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
155282352|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
155282353|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
155282354|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
155282355|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
155282356|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
155282357|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
155282358|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
155282359|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
155282360|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
155282361|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
155282362|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
155282363|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
155282364|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
155282365|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
155282366|NCT02153788|560465753|FG000|Overall Study|Physician Decision|2|||
155282367|NCT02153788|560465754|FG001|Overall Study|Physician Decision|1|||
155282368|NCT05458102|560465761|FG000|Overall Study|Withdrew consent|2|||
155282369|NCT05458102|560465762|FG001|Overall Study|Withdrew consent|0|||
155282370|NCT05458102|560465761|FG000|Overall Study|Adverse Event|1|||
155282371|NCT05458102|560465762|FG001|Overall Study|Adverse Event|0|||
155282372|NCT05458102|560465761|FG000|Overall Study|Enrolled but never treated|1|||
155282373|NCT05458102|560465762|FG001|Overall Study|Enrolled but never treated|0|||
155282374|NCT05458102|560465761|FG000|Overall Study|Protocol Violation|1|||
155282375|NCT05458102|560465762|FG001|Overall Study|Protocol Violation|0|||
155282376|NCT03239210|560465765|FG000|Overall Study|Lost to Follow-up|2|||
155282377|NCT03239210|560465766|FG001|Overall Study|Lost to Follow-up|2|||
155282378|NCT03239210|560465765|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
155282379|NCT03239210|560465766|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
155282380|NCT03239210|560465765|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
155282381|NCT03239210|560465766|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
155282382|NCT01575860|560465767|FG000|Overall Study|Withdrawal by Subject|1|||
155282383|NCT01575860|560465767|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
155282384|NCT00278564|560465769|FG000|Overall Study|Lack of Efficacy|4|||
155282385|NCT01094743|560465770|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
155282386|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
155282387|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
155282388|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
155282389|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
155282390|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
155282391|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
155282392|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
155282393|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
155282394|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
155282395|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
155282396|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
155282397|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
155734945|NCT02541604|562127229|FG005|Overall Study|Medical condition may jeopardize safety|0|||
155392863|NCT04178967|560874838|FG008|Induction Period|Protocol Violation|0|||
155392864|NCT04178967|560874839|FG009|Induction Period|Protocol Violation|0|||
155392865|NCT04178967|560874840|FG010|Induction Period|Protocol Violation|0|||
155392866|NCT04178967|560874830|FG000|Induction Period|Withdrawal by Subject|6|||
155392867|NCT04178967|560874831|FG001|Induction Period|Withdrawal by Subject|4|||
155392868|NCT04178967|560874832|FG002|Induction Period|Withdrawal by Subject|0|||
155392869|NCT04178967|560874833|FG003|Induction Period|Withdrawal by Subject|0|||
155392870|NCT04178967|560874834|FG004|Induction Period|Withdrawal by Subject|0|||
155392871|NCT04178967|560874835|FG005|Induction Period|Withdrawal by Subject|0|||
155392872|NCT04178967|560874836|FG006|Induction Period|Withdrawal by Subject|0|||
155392873|NCT04178967|560874837|FG007|Induction Period|Withdrawal by Subject|0|||
155392874|NCT04178967|560874838|FG008|Induction Period|Withdrawal by Subject|0|||
155392875|NCT04178967|560874839|FG009|Induction Period|Withdrawal by Subject|0|||
155392876|NCT04178967|560874840|FG010|Induction Period|Withdrawal by Subject|0|||
155392877|NCT04178967|560874830|FG000|Induction Period|Lost to Follow-up|2|||
155392878|NCT04178967|560874831|FG001|Induction Period|Lost to Follow-up|0|||
155392879|NCT04178967|560874832|FG002|Induction Period|Lost to Follow-up|0|||
155392880|NCT04178967|560874833|FG003|Induction Period|Lost to Follow-up|0|||
155392881|NCT04178967|560874834|FG004|Induction Period|Lost to Follow-up|0|||
155392882|NCT04178967|560874835|FG005|Induction Period|Lost to Follow-up|0|||
155392883|NCT04178967|560874836|FG006|Induction Period|Lost to Follow-up|0|||
155392884|NCT04178967|560874837|FG007|Induction Period|Lost to Follow-up|0|||
155392885|NCT04178967|560874838|FG008|Induction Period|Lost to Follow-up|0|||
155392886|NCT04178967|560874839|FG009|Induction Period|Lost to Follow-up|0|||
155392887|NCT04178967|560874840|FG010|Induction Period|Lost to Follow-up|0|||
155392888|NCT04178967|560874830|FG000|Induction Period|Participant Missed Study Visits|0|||
155392889|NCT04178967|560874831|FG001|Induction Period|Participant Missed Study Visits|1|||
155392890|NCT04178967|560874832|FG002|Induction Period|Participant Missed Study Visits|0|||
155392891|NCT04178967|560874833|FG003|Induction Period|Participant Missed Study Visits|0|||
155392892|NCT04178967|560874834|FG004|Induction Period|Participant Missed Study Visits|0|||
155392893|NCT04178967|560874835|FG005|Induction Period|Participant Missed Study Visits|0|||
155392894|NCT04178967|560874836|FG006|Induction Period|Participant Missed Study Visits|0|||
155392895|NCT04178967|560874837|FG007|Induction Period|Participant Missed Study Visits|0|||
155392896|NCT04178967|560874838|FG008|Induction Period|Participant Missed Study Visits|0|||
155392897|NCT04178967|560874839|FG009|Induction Period|Participant Missed Study Visits|0|||
155392898|NCT04178967|560874840|FG010|Induction Period|Participant Missed Study Visits|0|||
155392899|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392900|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392901|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392902|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392903|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392904|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
155392905|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
155392906|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
155632302|NCT00042289|561747675|FG044|Overall Study|Withdrawal by Subject|0|||
155632303|NCT00042289|561747676|FG045|Overall Study|Withdrawal by Subject|0|||
155632304|NCT00042289|561747677|FG046|Overall Study|Withdrawal by Subject|0|||
155632305|NCT01673386|561747684|FG000|Overall Study|Study terminated by sponsor|16|||
155632306|NCT01673386|561747685|FG001|Overall Study|Study terminated by sponsor|22|||
155632307|NCT01673386|561747684|FG000|Overall Study|Adverse Event|5|||
155632308|NCT01673386|561747685|FG001|Overall Study|Adverse Event|2|||
155632309|NCT01673386|561747684|FG000|Overall Study|Progressive disease|4|||
155632310|NCT01673386|561747685|FG001|Overall Study|Progressive disease|1|||
155632311|NCT01673386|561747684|FG000|Overall Study|Withdrawal by Subject|0|||
155632312|NCT01673386|561747685|FG001|Overall Study|Withdrawal by Subject|2|||
155632313|NCT01140906|561747689|FG000|Overall Study|Adverse Event|7|||
155632314|NCT01140906|561747690|FG001|Overall Study|Adverse Event|10|||
155632315|NCT01140906|561747691|FG002|Overall Study|Adverse Event|17|||
155632316|NCT01140906|561747692|FG003|Overall Study|Adverse Event|7|||
155632317|NCT01140906|561747689|FG000|Overall Study|Lack of Efficacy|6|||
155632318|NCT01140906|561747690|FG001|Overall Study|Lack of Efficacy|8|||
155632319|NCT01140906|561747691|FG002|Overall Study|Lack of Efficacy|2|||
155632320|NCT01140906|561747692|FG003|Overall Study|Lack of Efficacy|1|||
155734946|NCT02541604|562127230|FG006|Overall Study|Medical condition may jeopardize safety|0|||
155734947|NCT02541604|562127231|FG007|Overall Study|Medical condition may jeopardize safety|1|||
155392907|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392908|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392909|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392910|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155632321|NCT01140906|561747689|FG000|Overall Study|Non-compliance|0|||
155632322|NCT01140906|561747690|FG001|Overall Study|Non-compliance|1|||
155734948|NCT02541604|562127232|FG008|Overall Study|Medical condition may jeopardize safety|0|||
155392911|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392912|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392913|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392914|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392915|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
155392916|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392917|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392918|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392919|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392920|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392921|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392922|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392923|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392924|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
155392925|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392926|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392927|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155734949|NCT02541604|562127233|FG009|Overall Study|Medical condition may jeopardize safety|0|||
155392928|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392929|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392930|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392931|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392932|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392933|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392934|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392935|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392936|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392937|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392938|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
155392939|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392940|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392941|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392942|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392943|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392944|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392945|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392946|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392947|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
155392948|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
155392949|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392950|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
155392951|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392952|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392953|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392954|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392955|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392956|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392957|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392958|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392959|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392960|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
155392961|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
155392962|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392963|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392964|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392965|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392966|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392967|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392968|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
155734950|NCT02541604|562127234|FG010|Overall Study|Medical condition may jeopardize safety|0|||
155734951|NCT02541604|562127235|FG011|Overall Study|Medical condition may jeopardize safety|0|||
155734952|NCT00828204|562127236|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
155734953|NCT00828204|562127237|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
155734954|NCT00828204|562127236|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
155392969|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392970|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
155392971|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
155392972|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
155392973|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392974|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392975|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392976|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392977|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392978|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392979|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392980|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392981|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392982|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392983|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392984|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
155392985|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
155392986|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392987|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392988|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392989|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392990|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392991|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392992|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392993|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392994|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392995|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
155392996|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
155392997|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
155392998|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155392999|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393000|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393001|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393002|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393003|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393004|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393005|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393006|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393007|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
155393008|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393009|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393010|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393011|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393012|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393013|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393014|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393015|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393016|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393017|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
155393018|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
155393019|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
155393020|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393021|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393022|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155632323|NCT01140906|561747691|FG002|Overall Study|Non-compliance|0|||
155632324|NCT01140906|561747692|FG003|Overall Study|Non-compliance|1|||
155632325|NCT01140906|561747689|FG000|Overall Study|Protocol Violation|5|||
155632326|NCT01140906|561747690|FG001|Overall Study|Protocol Violation|3|||
155632327|NCT01140906|561747691|FG002|Overall Study|Protocol Violation|2|||
155632328|NCT01140906|561747692|FG003|Overall Study|Protocol Violation|1|||
155632329|NCT01140906|561747689|FG000|Overall Study|Withdrawal of consent|6|||
155632330|NCT01140906|561747690|FG001|Overall Study|Withdrawal of consent|6|||
155632331|NCT01140906|561747691|FG002|Overall Study|Withdrawal of consent|2|||
155632332|NCT01140906|561747692|FG003|Overall Study|Withdrawal of consent|2|||
155632333|NCT01140906|561747689|FG000|Overall Study|Lost to Follow-up|1|||
155632334|NCT01140906|561747690|FG001|Overall Study|Lost to Follow-up|1|||
155632335|NCT01140906|561747691|FG002|Overall Study|Lost to Follow-up|0|||
155632336|NCT01140906|561747692|FG003|Overall Study|Lost to Follow-up|2|||
155632337|NCT01140906|561747689|FG000|Overall Study|Administrative or other reason|0|||
155632338|NCT01140906|561747690|FG001|Overall Study|Administrative or other reason|5|||
155282398|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282399|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
155282400|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282401|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282402|NCT02851511|560465771|FG000|Phase I|Physician Decision|0|||
155282403|NCT02851511|560465772|FG001|Phase I|Physician Decision|0|||
155282404|NCT02851511|560465773|FG002|Phase I|Physician Decision|0|||
155282405|NCT02851511|560465774|FG003|Phase I|Physician Decision|1|||
155282406|NCT02851511|560465771|FG000|Phase I|Withdrawal by Subject|2|||
155282407|NCT02851511|560465772|FG001|Phase I|Withdrawal by Subject|1|||
155282408|NCT02851511|560465773|FG002|Phase I|Withdrawal by Subject|0|||
155282409|NCT02851511|560465774|FG003|Phase I|Withdrawal by Subject|3|||
155282410|NCT02851511|560465771|FG000|Phase II|Physician Decision|18|||
155282411|NCT02851511|560465772|FG001|Phase II|Physician Decision|16|||
155282412|NCT02851511|560465773|FG002|Phase II|Physician Decision|0|||
155282413|NCT02851511|560465774|FG003|Phase II|Physician Decision|0|||
155282414|NCT02851511|560465771|FG000|Phase II|Withdrawal by Subject|18|||
155282415|NCT02851511|560465772|FG001|Phase II|Withdrawal by Subject|16|||
155282416|NCT02851511|560465773|FG002|Phase II|Withdrawal by Subject|0|||
155282417|NCT02851511|560465774|FG003|Phase II|Withdrawal by Subject|0|||
155282418|NCT02851511|560465771|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
155282419|NCT02851511|560465772|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
155282420|NCT02851511|560465773|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
155282421|NCT02851511|560465774|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
155282422|NCT02851511|560465771|FG000|Phase II|Lost to Follow-up|0|||
155282423|NCT02851511|560465772|FG001|Phase II|Lost to Follow-up|1|||
155282424|NCT02851511|560465773|FG002|Phase II|Lost to Follow-up|0|||
155282425|NCT02851511|560465774|FG003|Phase II|Lost to Follow-up|0|||
155282426|NCT00372567|560465775|FG000|Phase 3 Study|Adverse Event|5|||
155282427|NCT00372567|560465776|FG001|Phase 3 Study|Adverse Event|1|||
155282428|NCT00372567|560465777|FG002|Phase 3 Study|Adverse Event|1|||
155282429|NCT00372567|560465775|FG000|Phase 3 Study|Death|1|||
155282430|NCT00372567|560465776|FG001|Phase 3 Study|Death|1|||
155282431|NCT00372567|560465777|FG002|Phase 3 Study|Death|0|||
155282432|NCT00372567|560465775|FG000|Phase 3 Study|Protocol Violation|0|||
155282433|NCT00372567|560465776|FG001|Phase 3 Study|Protocol Violation|0|||
155282434|NCT00372567|560465777|FG002|Phase 3 Study|Protocol Violation|1|||
155282435|NCT00372567|560465775|FG000|Phase 3 Study|Objective progression or relapse|10|||
155282436|NCT00372567|560465776|FG001|Phase 3 Study|Objective progression or relapse|13|||
155282437|NCT00372567|560465777|FG002|Phase 3 Study|Objective progression or relapse|4|||
155282438|NCT00372567|560465775|FG000|Phase 3 Study|Global deterioration of health status|0|||
155282439|NCT00372567|560465776|FG001|Phase 3 Study|Global deterioration of health status|1|||
155282440|NCT00372567|560465777|FG002|Phase 3 Study|Global deterioration of health status|0|||
155282441|NCT00372567|560465775|FG000|Phase 3 Study|Other|2|||
155282442|NCT00372567|560465776|FG001|Phase 3 Study|Other|2|||
155282443|NCT00372567|560465777|FG002|Phase 3 Study|Other|1|||
155282444|NCT00372567|560465775|FG000|Phase 3 Study|study terminated by sponsor|13|||
155282445|NCT00372567|560465776|FG001|Phase 3 Study|study terminated by sponsor|8|||
155282446|NCT00372567|560465777|FG002|Phase 3 Study|study terminated by sponsor|5|||
155282447|NCT03278028|560465781|FG000|Overall Study|Lost to Follow-up|1|||
155282448|NCT03278028|560465782|FG001|Overall Study|Lost to Follow-up|0|||
155282449|NCT03278028|560465781|FG000|Overall Study|Withdrawal by Subject|3|||
155282450|NCT03278028|560465782|FG001|Overall Study|Withdrawal by Subject|1|||
155282451|NCT03278028|560465781|FG000|Overall Study|Pregnancy|0|||
155282452|NCT03278028|560465782|FG001|Overall Study|Pregnancy|1|||
155282453|NCT00372528|560465784|FG000|Overall Study|Lack of Efficacy|1|||
155282454|NCT00372528|560465784|FG000|Overall Study|Adverse Event|1|||
155282455|NCT00372528|560465784|FG000|Overall Study|Study Terminated by Sponsor|18|||
155282456|NCT00372528|560465784|FG000|Overall Study|Other|1|||
155282457|NCT01417000|560465785|FG000|Overall Study|Death|59|||
155282458|NCT01417000|560465786|FG001|Overall Study|Death|28|||
155282459|NCT01417000|560465785|FG000|Overall Study|Lost to Follow-up|1|||
155282460|NCT01417000|560465786|FG001|Overall Study|Lost to Follow-up|0|||
155282461|NCT01417000|560465785|FG000|Overall Study|Study Terminated by Sponsor|1|||
155282462|NCT01417000|560465786|FG001|Overall Study|Study Terminated by Sponsor|1|||
155282463|NCT00562965|560465787|FG000|Overall Study|Withdrawal by Subject|0|||
155282464|NCT00562965|560465788|FG001|Overall Study|Withdrawal by Subject|1|||
155282465|NCT00562965|560465787|FG000|Overall Study|Death|2|||
155282466|NCT00562965|560465788|FG001|Overall Study|Death|4|||
155282467|NCT00562965|560465787|FG000|Overall Study|Lost to Follow-up|1|||
155282468|NCT00562965|560465788|FG001|Overall Study|Lost to Follow-up|0|||
155282469|NCT00562965|560465787|FG000|Overall Study|Other|0|||
155282470|NCT00562965|560465788|FG001|Overall Study|Other|1|||
155282471|NCT00965484|560465791|FG000|Overall Study|Protocol Violation|1|||
155282472|NCT00965484|560465791|FG000|Overall Study|Withdrawal by Subject|1|||
155282473|NCT01124617|560465792|FG000|Overall Study|Adverse Event|5|||
155282474|NCT01124617|560465793|FG001|Overall Study|Adverse Event|2|||
155282475|NCT01124617|560465792|FG000|Overall Study|Lack of Efficacy|2|||
155282476|NCT01124617|560465793|FG001|Overall Study|Lack of Efficacy|1|||
155734955|NCT00828204|562127237|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
155734956|NCT00828204|562127236|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
155734957|NCT00828204|562127237|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
155734958|NCT00828204|562127236|FG000|Main Study: After Study Restart|Adverse Event|0|||
155734959|NCT00828204|562127237|FG001|Main Study: After Study Restart|Adverse Event|2|||
155734960|NCT00828204|562127236|FG000|Main Study: After Study Restart|Noncompliance|0|||
155734961|NCT00828204|562127237|FG001|Main Study: After Study Restart|Noncompliance|1|||
155734962|NCT00828204|562127236|FG000|Extension Study|Lost to Follow-up|0|||
155734963|NCT00828204|562127237|FG001|Extension Study|Lost to Follow-up|1|||
155734964|NCT00828204|562127236|FG000|Extension Study|Physician Decision|0|||
155734965|NCT00828204|562127237|FG001|Extension Study|Physician Decision|2|||
155282477|NCT01124617|560465792|FG000|Overall Study|Protocol Violation|1|||
155282478|NCT01124617|560465793|FG001|Overall Study|Protocol Violation|1|||
155282479|NCT01124617|560465792|FG000|Overall Study|Withdrawal by Subject|9|||
155282480|NCT01124617|560465793|FG001|Overall Study|Withdrawal by Subject|1|||
155282481|NCT01124617|560465792|FG000|Overall Study|Other|2|||
155282482|NCT01124617|560465793|FG001|Overall Study|Other|1|||
155282483|NCT00945477|560465794|FG000|Overall Study|Adverse Event|3|||
155282484|NCT00945477|560465794|FG000|Overall Study|Lack of Efficacy|2|||
155282485|NCT00945477|560465794|FG000|Overall Study|Withdrawal by Subject|1|||
155282486|NCT04796935|560465799|FG000|Overall Study|Withdrawal by Subject|0|||
155282487|NCT04796935|560465800|FG001|Overall Study|Withdrawal by Subject|1|||
155282488|NCT04796935|560465799|FG000|Overall Study|Physician Decision|0|||
155282489|NCT04796935|560465800|FG001|Overall Study|Physician Decision|1|||
155282490|NCT04796935|560465799|FG000|Overall Study|Device not available|1|||
155282491|NCT04796935|560465800|FG001|Overall Study|Device not available|0|||
155282492|NCT04796935|560465799|FG000|Overall Study|Trained provider not available|1|||
155282493|NCT04796935|560465800|FG001|Overall Study|Trained provider not available|0|||
155282494|NCT01253200|560465801|FG000|Overall Study|Death|1|||
155282495|NCT01253200|560465802|FG001|Overall Study|Death|0|||
155282496|NCT01253200|560465803|FG002|Overall Study|Death|0|||
155282497|NCT01253200|560465804|FG003|Overall Study|Death|0|||
155282498|NCT01253200|560465805|FG004|Overall Study|Death|0|||
155282499|NCT01253200|560465801|FG000|Overall Study|Lost to Follow-up|1|||
155282500|NCT01253200|560465802|FG001|Overall Study|Lost to Follow-up|1|||
155282501|NCT01253200|560465803|FG002|Overall Study|Lost to Follow-up|0|||
155282502|NCT01253200|560465804|FG003|Overall Study|Lost to Follow-up|0|||
155282503|NCT01253200|560465805|FG004|Overall Study|Lost to Follow-up|0|||
155282504|NCT01253200|560465801|FG000|Overall Study|Withdrawal by Subject|2|||
155282505|NCT01253200|560465802|FG001|Overall Study|Withdrawal by Subject|0|||
155282506|NCT01253200|560465803|FG002|Overall Study|Withdrawal by Subject|0|||
155282507|NCT01253200|560465804|FG003|Overall Study|Withdrawal by Subject|0|||
155282508|NCT01253200|560465805|FG004|Overall Study|Withdrawal by Subject|0|||
155282509|NCT01253200|560465801|FG000|Overall Study|Protocol Violation|1|||
155282510|NCT01253200|560465802|FG001|Overall Study|Protocol Violation|4|||
155282511|NCT01253200|560465803|FG002|Overall Study|Protocol Violation|0|||
155282512|NCT01253200|560465804|FG003|Overall Study|Protocol Violation|0|||
155282513|NCT01253200|560465805|FG004|Overall Study|Protocol Violation|5|||
155282514|NCT01253200|560465801|FG000|Overall Study|intents|10|||
155282515|NCT01253200|560465802|FG001|Overall Study|intents|10|||
155282516|NCT01253200|560465803|FG002|Overall Study|intents|1|||
155282517|NCT01253200|560465804|FG003|Overall Study|intents|3|||
155282518|NCT01253200|560465805|FG004|Overall Study|intents|0|||
155282519|NCT01253200|560465801|FG000|Overall Study|Attempts|6|||
155282520|NCT01253200|560465802|FG001|Overall Study|Attempts|4|||
155282521|NCT01253200|560465803|FG002|Overall Study|Attempts|1|||
155282522|NCT01253200|560465804|FG003|Overall Study|Attempts|2|||
155282523|NCT01253200|560465805|FG004|Overall Study|Attempts|0|||
155282524|NCT02049437|560465806|FG000|Period 1|Adverse Event|1|||
155282525|NCT02049437|560465807|FG001|Period 1|Adverse Event|1|||
155282526|NCT02049437|560465806|FG000|Period 1|Adverse Event|1|||
155282527|NCT02049437|560465807|FG001|Period 1|Adverse Event|0|||
155282528|NCT00783718|560465808|FG000|Induction Phase|Adverse Event|4|||
155282529|NCT00783718|560465809|FG001|Induction Phase|Adverse Event|0|||
155282530|NCT00783718|560465810|FG002|Induction Phase|Adverse Event|7|||
155282531|NCT00783718|560465811|FG003|Induction Phase|Adverse Event|0|||
155282532|NCT00783718|560465812|FG004|Induction Phase|Adverse Event|0|||
155282533|NCT00783718|560465813|FG005|Induction Phase|Adverse Event|0|||
155282534|NCT00783718|560465814|FG006|Induction Phase|Adverse Event|0|||
155282535|NCT00783718|560465808|FG000|Induction Phase|Protocol Violation|1|||
155734966|NCT02840461|562127239|FG000|Overall Study|Adverse Event|1|||
155282536|NCT00783718|560465809|FG001|Induction Phase|Protocol Violation|1|||
155282537|NCT00783718|560465810|FG002|Induction Phase|Protocol Violation|6|||
155282538|NCT00783718|560465811|FG003|Induction Phase|Protocol Violation|0|||
155282539|NCT00783718|560465812|FG004|Induction Phase|Protocol Violation|0|||
155282540|NCT00783718|560465813|FG005|Induction Phase|Protocol Violation|0|||
155282541|NCT00783718|560465814|FG006|Induction Phase|Protocol Violation|0|||
155282542|NCT00783718|560465808|FG000|Induction Phase|Lack of Efficacy|5|||
155734967|NCT02840461|562127240|FG001|Overall Study|Adverse Event|5|||
155282543|NCT00783718|560465809|FG001|Induction Phase|Lack of Efficacy|2|||
155282544|NCT00783718|560465810|FG002|Induction Phase|Lack of Efficacy|14|||
155282545|NCT00783718|560465811|FG003|Induction Phase|Lack of Efficacy|0|||
155282546|NCT00783718|560465812|FG004|Induction Phase|Lack of Efficacy|0|||
155282547|NCT00783718|560465813|FG005|Induction Phase|Lack of Efficacy|0|||
155282548|NCT00783718|560465814|FG006|Induction Phase|Lack of Efficacy|0|||
155282549|NCT00783718|560465808|FG000|Induction Phase|Withdrawal by Subject|3|||
155282550|NCT00783718|560465809|FG001|Induction Phase|Withdrawal by Subject|4|||
155282551|NCT00783718|560465810|FG002|Induction Phase|Withdrawal by Subject|8|||
155282552|NCT00783718|560465811|FG003|Induction Phase|Withdrawal by Subject|0|||
155282553|NCT00783718|560465812|FG004|Induction Phase|Withdrawal by Subject|0|||
155282554|NCT00783718|560465813|FG005|Induction Phase|Withdrawal by Subject|0|||
155282555|NCT00783718|560465814|FG006|Induction Phase|Withdrawal by Subject|0|||
155282556|NCT00783718|560465808|FG000|Induction Phase|Lost to Follow-up|1|||
155282557|NCT00783718|560465809|FG001|Induction Phase|Lost to Follow-up|0|||
155282558|NCT00783718|560465810|FG002|Induction Phase|Lost to Follow-up|1|||
155282559|NCT00783718|560465811|FG003|Induction Phase|Lost to Follow-up|0|||
155282560|NCT00783718|560465812|FG004|Induction Phase|Lost to Follow-up|0|||
155282561|NCT00783718|560465813|FG005|Induction Phase|Lost to Follow-up|0|||
155282562|NCT00783718|560465814|FG006|Induction Phase|Lost to Follow-up|0|||
155282563|NCT00783718|560465808|FG000|Maintenance Phase|Adverse Event|12|||
155282564|NCT00783718|560465809|FG001|Maintenance Phase|Adverse Event|0|||
155282565|NCT00783718|560465810|FG002|Maintenance Phase|Adverse Event|0|||
155282566|NCT00783718|560465811|FG003|Maintenance Phase|Adverse Event|15|||
155282567|NCT00783718|560465812|FG004|Maintenance Phase|Adverse Event|7|||
155282568|NCT00783718|560465813|FG005|Maintenance Phase|Adverse Event|6|||
155282569|NCT00783718|560465814|FG006|Maintenance Phase|Adverse Event|16|||
155282570|NCT00783718|560465808|FG000|Maintenance Phase|Protocol Violation|1|||
155282571|NCT00783718|560465809|FG001|Maintenance Phase|Protocol Violation|0|||
155282572|NCT00783718|560465810|FG002|Maintenance Phase|Protocol Violation|0|||
155282573|NCT00783718|560465811|FG003|Maintenance Phase|Protocol Violation|0|||
155282574|NCT00783718|560465812|FG004|Maintenance Phase|Protocol Violation|0|||
155282575|NCT00783718|560465813|FG005|Maintenance Phase|Protocol Violation|0|||
155282576|NCT00783718|560465814|FG006|Maintenance Phase|Protocol Violation|2|||
155282577|NCT00783718|560465808|FG000|Maintenance Phase|Lack of Efficacy|83|||
155282578|NCT00783718|560465809|FG001|Maintenance Phase|Lack of Efficacy|0|||
155282579|NCT00783718|560465810|FG002|Maintenance Phase|Lack of Efficacy|0|||
155282580|NCT00783718|560465811|FG003|Maintenance Phase|Lack of Efficacy|61|||
155282581|NCT00783718|560465812|FG004|Maintenance Phase|Lack of Efficacy|31|||
155282582|NCT00783718|560465813|FG005|Maintenance Phase|Lack of Efficacy|33|||
155282583|NCT00783718|560465814|FG006|Maintenance Phase|Lack of Efficacy|155|||
155282584|NCT00783718|560465808|FG000|Maintenance Phase|Withdrawal by Subject|6|||
155282585|NCT00783718|560465809|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155282586|NCT00783718|560465810|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155282587|NCT00783718|560465811|FG003|Maintenance Phase|Withdrawal by Subject|2|||
155282588|NCT00783718|560465812|FG004|Maintenance Phase|Withdrawal by Subject|5|||
155282589|NCT00783718|560465813|FG005|Maintenance Phase|Withdrawal by Subject|2|||
155282590|NCT00783718|560465814|FG006|Maintenance Phase|Withdrawal by Subject|20|||
155282591|NCT00783718|560465808|FG000|Maintenance Phase|Lost to Follow-up|3|||
155282592|NCT00783718|560465809|FG001|Maintenance Phase|Lost to Follow-up|0|||
155282593|NCT00783718|560465810|FG002|Maintenance Phase|Lost to Follow-up|0|||
155282594|NCT00783718|560465811|FG003|Maintenance Phase|Lost to Follow-up|0|||
155282595|NCT00783718|560465812|FG004|Maintenance Phase|Lost to Follow-up|2|||
155282596|NCT00783718|560465813|FG005|Maintenance Phase|Lost to Follow-up|0|||
155282597|NCT00783718|560465814|FG006|Maintenance Phase|Lost to Follow-up|2|||
155282598|NCT01163149|560465820|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
155282599|NCT01163149|560465821|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155282600|NCT01163149|560465822|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
155282601|NCT01163149|560465820|FG000|Extension Treatment Period|Adverse Event|0|||
155282602|NCT01163149|560465821|FG001|Extension Treatment Period|Adverse Event|1|||
155282603|NCT01163149|560465822|FG002|Extension Treatment Period|Adverse Event|0|||
155282604|NCT01163149|560465820|FG000|Extension Treatment Period|Noncompliance|0|||
155282605|NCT01163149|560465821|FG001|Extension Treatment Period|Noncompliance|0|||
155282606|NCT01163149|560465822|FG002|Extension Treatment Period|Noncompliance|1|||
155282607|NCT01192295|560465823|FG000|Overall Study|Adverse Event|3|||
155282608|NCT01192295|560465824|FG001|Overall Study|Adverse Event|7|||
155282609|NCT01192295|560465823|FG000|Overall Study|Withdrawal by Subject|3|||
155282610|NCT01192295|560465824|FG001|Overall Study|Withdrawal by Subject|4|||
155282611|NCT01192295|560465823|FG000|Overall Study|Lost to Follow-up|0|||
155282612|NCT01192295|560465824|FG001|Overall Study|Lost to Follow-up|1|||
155282613|NCT01192295|560465823|FG000|Overall Study|Lack of Efficacy|0|||
155282614|NCT01192295|560465824|FG001|Overall Study|Lack of Efficacy|5|||
155282615|NCT01192295|560465823|FG000|Overall Study|Administrative|4|||
155282616|NCT01192295|560465824|FG001|Overall Study|Administrative|6|||
155282617|NCT00630539|560465825|FG000|Overall Study|Adverse Event|1|||
155282618|NCT00630539|560465826|FG001|Overall Study|Adverse Event|3|||
155282619|NCT00630539|560465827|FG002|Overall Study|Adverse Event|1|||
155632339|NCT01140906|561747691|FG002|Overall Study|Administrative or other reason|3|||
155632340|NCT01140906|561747692|FG003|Overall Study|Administrative or other reason|2|||
155632341|NCT00336544|561747693|FG000|Overall Study|Lack of Efficacy|8|||
155632342|NCT00336544|561747694|FG001|Overall Study|Lack of Efficacy|5|||
155632343|NCT00336544|561747693|FG000|Overall Study|Adverse Event|4|||
155632344|NCT00336544|561747694|FG001|Overall Study|Adverse Event|9|||
155632345|NCT00336544|561747693|FG000|Overall Study|Withdrawal by Subject|4|||
155632346|NCT00336544|561747694|FG001|Overall Study|Withdrawal by Subject|3|||
155734968|NCT02840461|562127241|FG002|Overall Study|Adverse Event|3|||
155734969|NCT02840461|562127239|FG000|Overall Study|Lost to Follow-up|10|||
155734970|NCT02840461|562127240|FG001|Overall Study|Lost to Follow-up|7|||
155734971|NCT02840461|562127241|FG002|Overall Study|Lost to Follow-up|6|||
155734972|NCT02840461|562127239|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
155734973|NCT02840461|562127240|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
155734974|NCT02840461|562127241|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
155734975|NCT02840461|562127239|FG000|Overall Study|Protocol Violation|2|||
155734976|NCT02840461|562127240|FG001|Overall Study|Protocol Violation|3|||
155734977|NCT02840461|562127241|FG002|Overall Study|Protocol Violation|1|||
155734978|NCT02840461|562127239|FG000|Overall Study|Withdrawal by Subject|10|||
155734979|NCT02840461|562127240|FG001|Overall Study|Withdrawal by Subject|6|||
155282620|NCT00630539|560465828|FG003|Overall Study|Adverse Event|2|||
155282621|NCT00630539|560465825|FG000|Overall Study|Withdrawal by Subject|0|||
155282622|NCT00630539|560465826|FG001|Overall Study|Withdrawal by Subject|1|||
155282623|NCT00630539|560465827|FG002|Overall Study|Withdrawal by Subject|0|||
155282624|NCT00630539|560465828|FG003|Overall Study|Withdrawal by Subject|1|||
155282625|NCT01700530|560465831|FG000|Overall Study|Withdrawal by Subject|0|||
155282626|NCT01700530|560465832|FG001|Overall Study|Withdrawal by Subject|3|||
155282627|NCT01700530|560465833|FG002|Overall Study|Withdrawal by Subject|1|||
155282628|NCT04159896|560465837|FG000|Overall Study|Lack of Efficacy|7|||
155282629|NCT04159896|560465837|FG000|Overall Study|Withdrawal by Subject|1|||
155282630|NCT04159896|560465837|FG000|Overall Study|Adverse Event|1|||
155282631|NCT04159896|560465837|FG000|Overall Study|A transient ischaemic attack|1|||
155282632|NCT01449721|560465838|FG000|Overall Study|Physician Decision|0|||
155282633|NCT01449721|560465839|FG001|Overall Study|Physician Decision|1|||
155282634|NCT01449721|560465838|FG000|Overall Study|Physician Decision|0|||
155282635|NCT01449721|560465839|FG001|Overall Study|Physician Decision|1|||
155282636|NCT01342887|560465841|FG000|Overall Study|Death|2|||
155282637|NCT02698436|560465846|FG000|Overall Study|Adverse Event|1|||
155282638|NCT02698436|560465847|FG001|Overall Study|Adverse Event|0|||
155282639|NCT02698436|560465846|FG000|Overall Study|Withdrawal by Subject|3|||
155282640|NCT02698436|560465847|FG001|Overall Study|Withdrawal by Subject|3|||
155282641|NCT02698436|560465846|FG000|Overall Study|Lost to Follow-up|2|||
155282642|NCT02698436|560465847|FG001|Overall Study|Lost to Follow-up|4|||
155282643|NCT02698436|560465846|FG000|Overall Study|Non-compliance with study regimen|1|||
155282644|NCT02698436|560465847|FG001|Overall Study|Non-compliance with study regimen|0|||
155282645|NCT00097370|560465852|FG000|Stage 1|Adverse Event|3|||
155282646|NCT00097370|560465852|FG000|Stage 1|Withdrawal by Subject|1|||
155282647|NCT00097370|560465852|FG000|Stage 1|Lack of Efficacy|2|||
155282648|NCT00097370|560465852|FG000|Stage 2|Adverse Event|5|||
155282649|NCT00097370|560465852|FG000|Stage 2|Withdrawal by Subject|1|||
155282650|NCT00097370|560465852|FG000|Stage 2|Lack of Efficacy|3|||
155282651|NCT00097370|560465852|FG000|Stage 2|Pregnancy|1|||
155282652|NCT00097370|560465852|FG000|Stage 2|Sponsor Terminated Study|2|||
155282653|NCT00097370|560465852|FG000|Stage 2|Lost to Follow-up|1|||
155282654|NCT00097370|560465852|FG000|Stage 3|Adverse Event|2|||
155282655|NCT00097370|560465852|FG000|Stage 3|Withdrawal by Subject|3|||
155282656|NCT00097370|560465852|FG000|Stage 3|Lack of Efficacy|1|||
155282657|NCT00097370|560465852|FG000|Stage 3|Sponsor Terminated Study|52|||
155282658|NCT00097370|560465852|FG000|Stage 3|Lost to Follow-up|1|||
155282659|NCT01394991|560465853|FG000|Overall Study|Adverse Event|0|||
155282660|NCT01394991|560465854|FG001|Overall Study|Adverse Event|4|||
155282661|NCT01394991|560465853|FG000|Overall Study|Lack of Efficacy|5|||
155282662|NCT01394991|560465854|FG001|Overall Study|Lack of Efficacy|7|||
155282663|NCT01394991|560465853|FG000|Overall Study|Lost to Follow-up|6|||
155282664|NCT01394991|560465854|FG001|Overall Study|Lost to Follow-up|8|||
155282665|NCT01394991|560465853|FG000|Overall Study|Physician Decision|1|||
155282666|NCT01394991|560465854|FG001|Overall Study|Physician Decision|3|||
155282667|NCT01394991|560465853|FG000|Overall Study|Protocol Violation|1|||
155282668|NCT01394991|560465854|FG001|Overall Study|Protocol Violation|1|||
155282669|NCT01394991|560465853|FG000|Overall Study|Withdrawal by Subject|20|||
155282670|NCT01394991|560465854|FG001|Overall Study|Withdrawal by Subject|17|||
155282671|NCT01394991|560465853|FG000|Overall Study|Chemotherapy Termination|10|||
155282672|NCT01394991|560465854|FG001|Overall Study|Chemotherapy Termination|15|||
155282673|NCT01394991|560465853|FG000|Overall Study|Disease Progression|7|||
155282674|NCT01394991|560465854|FG001|Overall Study|Disease Progression|7|||
155282675|NCT01394991|560465853|FG000|Overall Study|Prematurely Termination of Trial|9|||
155282676|NCT01394991|560465854|FG001|Overall Study|Prematurely Termination of Trial|10|||
155734980|NCT02840461|562127241|FG002|Overall Study|Withdrawal by Subject|2|||
155734981|NCT02840461|562127239|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
155393023|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393024|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393025|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393026|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393027|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393028|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393029|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
155393030|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393031|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393032|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393033|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393034|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393035|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393036|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393037|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393038|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393039|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393040|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
155393041|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393042|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
155393043|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
155393044|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
155393045|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
155393046|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
155393047|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
155393048|NCT05211739|560874841|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
155393049|NCT05211739|560874842|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
155632347|NCT00336544|561747693|FG000|Overall Study|Other|3|||
155632348|NCT00336544|561747694|FG001|Overall Study|Other|5|||
155632349|NCT01649765|561747695|FG000|Overall Study|Adverse Event|5|||
155632350|NCT01649765|561747696|FG001|Overall Study|Adverse Event|3|||
155632351|NCT01649765|561747695|FG000|Overall Study|Lack of Efficacy|1|||
155632352|NCT01649765|561747696|FG001|Overall Study|Lack of Efficacy|1|||
155632353|NCT01649765|561747695|FG000|Overall Study|Physician Decision|0|||
155632354|NCT01649765|561747696|FG001|Overall Study|Physician Decision|3|||
155632355|NCT01649765|561747695|FG000|Overall Study|Protocol Violation|1|||
155632356|NCT01649765|561747696|FG001|Overall Study|Protocol Violation|0|||
155632357|NCT01649765|561747695|FG000|Overall Study|Withdrawal by Subject|2|||
155632358|NCT01649765|561747696|FG001|Overall Study|Withdrawal by Subject|1|||
155632359|NCT00961064|561747697|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
155632360|NCT00961064|561747697|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
155632361|NCT00961064|561747697|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
155632362|NCT00961064|561747697|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
155632363|NCT00961064|561747697|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
155632364|NCT00961064|561747697|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
155632365|NCT00961064|561747697|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
155632366|NCT00961064|561747697|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
155632367|NCT01408641|561747698|FG000|Overall Study|Physician Decision|1|||
155632368|NCT01408641|561747699|FG001|Overall Study|Physician Decision|0|||
155632369|NCT00576758|561747700|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
155632370|NCT00576758|561747701|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
155632371|NCT00576758|561747700|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
155632372|NCT00576758|561747701|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
155632373|NCT00576758|561747700|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
155632374|NCT00576758|561747701|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
155632375|NCT00576758|561747700|FG000|Induction Treatment Period|Death|1|||
155632376|NCT00576758|561747701|FG001|Induction Treatment Period|Death|0|||
155632377|NCT00576758|561747700|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
155632378|NCT00576758|561747701|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
155632379|NCT00576758|561747700|FG000|Induction Treatment Period|Withdrew consent|1|||
155632380|NCT00576758|561747701|FG001|Induction Treatment Period|Withdrew consent|0|||
155734982|NCT02840461|562127240|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
155734983|NCT02840461|562127241|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
155393050|NCT00628251|560874843|FG000|Randomised Part|Withdrawal by Subject|0|||
155393051|NCT00628251|560874844|FG001|Randomised Part|Withdrawal by Subject|0|||
155632381|NCT00576758|561747700|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
155632382|NCT00576758|561747701|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
155393052|NCT00628251|560874845|FG002|Randomised Part|Withdrawal by Subject|1|||
155393053|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
155393054|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
155393055|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
155393056|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
155393057|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
155393058|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
155393059|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
155393060|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
155393061|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
155393062|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
155393063|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
155393064|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
155393065|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
155393066|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
155393067|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
155393068|NCT00728481|560874846|FG000|Overall Study|Withdrawal by Subject|0|||
155393069|NCT00728481|560874847|FG001|Overall Study|Withdrawal by Subject|1|||
155393070|NCT00728481|560874846|FG000|Overall Study|Adverse Event|0|||
155393071|NCT00728481|560874847|FG001|Overall Study|Adverse Event|1|||
155393072|NCT00728481|560874846|FG000|Overall Study|Study medication non-compliance|0|||
155393073|NCT00728481|560874847|FG001|Overall Study|Study medication non-compliance|2|||
155393074|NCT00728481|560874846|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
155393075|NCT00728481|560874847|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
155393076|NCT01251120|560874851|FG000|Overall Study|Lack of Efficacy|0|||
155393077|NCT01251120|560874852|FG001|Overall Study|Lack of Efficacy|1|||
155393078|NCT01968070|560874853|FG000|Period 1|Withdrawal by Subject|0|||
155393079|NCT01968070|560874854|FG001|Period 1|Withdrawal by Subject|1|||
155393080|NCT01968070|560874855|FG002|Period 1|Withdrawal by Subject|0|||
155393081|NCT01968070|560874856|FG003|Period 1|Withdrawal by Subject|0|||
155393082|NCT01968070|560874857|FG004|Period 1|Withdrawal by Subject|0|||
155393083|NCT01968070|560874858|FG005|Period 1|Withdrawal by Subject|0|||
155393084|NCT01968070|560874859|FG006|Period 1|Withdrawal by Subject|1|||
155393085|NCT01968070|560874860|FG007|Period 1|Withdrawal by Subject|0|||
155393086|NCT01968070|560874861|FG008|Period 1|Withdrawal by Subject|0|||
155393087|NCT01968070|560874862|FG009|Period 1|Withdrawal by Subject|0|||
155632383|NCT00576758|561747700|FG000|Extension Treatment Period|Death|1|||
155632384|NCT00576758|561747701|FG001|Extension Treatment Period|Death|1|||
155632385|NCT00576758|561747700|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
155632386|NCT00576758|561747701|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
155632387|NCT00576758|561747700|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
155632388|NCT00576758|561747701|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
155632389|NCT00576758|561747700|FG000|Extension Treatment Period|Administrative/Other|3|||
155632390|NCT00576758|561747701|FG001|Extension Treatment Period|Administrative/Other|1|||
155632391|NCT00576758|561747700|FG000|Follow-up Period|Administrative/Other|6|||
155632392|NCT00576758|561747701|FG001|Follow-up Period|Administrative/Other|8|||
155632393|NCT00576758|561747700|FG000|Follow-up Period|Death|3|||
155632394|NCT00576758|561747701|FG001|Follow-up Period|Death|3|||
155632395|NCT00576758|561747700|FG000|Follow-up Period|Insufficient therapeutic response|16|||
155632396|NCT00576758|561747701|FG001|Follow-up Period|Insufficient therapeutic response|5|||
155632397|NCT00576758|561747700|FG000|Follow-up Period|Withdrew consent|2|||
155632398|NCT00576758|561747701|FG001|Follow-up Period|Withdrew consent|1|||
155632399|NCT01648764|561747702|FG000|Overall Study|Progressive Disease|0|||
155632400|NCT01648764|561747703|FG001|Overall Study|Progressive Disease|1|||
155632401|NCT01648764|561747704|FG002|Overall Study|Progressive Disease|0|||
155632402|NCT01648764|561747705|FG003|Overall Study|Progressive Disease|0|||
155632403|NCT01648764|561747706|FG004|Overall Study|Progressive Disease|0|||
155632404|NCT01648764|561747707|FG005|Overall Study|Progressive Disease|1|||
155632405|NCT01648764|561747708|FG006|Overall Study|Progressive Disease|1|||
155632406|NCT01648764|561747709|FG007|Overall Study|Progressive Disease|0|||
155632407|NCT01648764|561747710|FG008|Overall Study|Progressive Disease|0|||
155632408|NCT01648764|561747711|FG009|Overall Study|Progressive Disease|2|||
155632409|NCT01648764|561747712|FG010|Overall Study|Progressive Disease|0|||
155632410|NCT01648764|561747713|FG011|Overall Study|Progressive Disease|1|||
155632411|NCT01648764|561747714|FG012|Overall Study|Progressive Disease|2|||
155632412|NCT01648764|561747715|FG013|Overall Study|Progressive Disease|1|||
155632413|NCT01648764|561747702|FG000|Overall Study|Adverse Event|0|||
155632414|NCT01648764|561747703|FG001|Overall Study|Adverse Event|0|||
155632415|NCT01648764|561747704|FG002|Overall Study|Adverse Event|0|||
155632416|NCT01648764|561747705|FG003|Overall Study|Adverse Event|0|||
155632417|NCT01648764|561747706|FG004|Overall Study|Adverse Event|0|||
155632418|NCT01648764|561747707|FG005|Overall Study|Adverse Event|1|||
155393088|NCT01968070|560874863|FG010|Period 1|Withdrawal by Subject|0|||
155632419|NCT01648764|561747708|FG006|Overall Study|Adverse Event|0|||
155393089|NCT01968070|560874864|FG011|Period 1|Withdrawal by Subject|0|||
155393090|NCT01968070|560874865|FG012|Period 1|Withdrawal by Subject|0|||
155393091|NCT01968070|560874866|FG013|Period 1|Withdrawal by Subject|0|||
155393092|NCT01968070|560874867|FG014|Period 1|Withdrawal by Subject|0|||
155393093|NCT01968070|560874868|FG015|Period 1|Withdrawal by Subject|1|||
155393094|NCT01968070|560874869|FG016|Period 1|Withdrawal by Subject|0|||
155393095|NCT01968070|560874870|FG017|Period 1|Withdrawal by Subject|0|||
155393096|NCT01968070|560874853|FG000|Period 1|Protocol Violation|0|||
155393097|NCT01968070|560874854|FG001|Period 1|Protocol Violation|0|||
155393098|NCT01968070|560874855|FG002|Period 1|Protocol Violation|0|||
155393099|NCT01968070|560874856|FG003|Period 1|Protocol Violation|1|||
155393100|NCT01968070|560874857|FG004|Period 1|Protocol Violation|1|||
155393101|NCT01968070|560874858|FG005|Period 1|Protocol Violation|0|||
155393102|NCT01968070|560874859|FG006|Period 1|Protocol Violation|0|||
155393103|NCT01968070|560874860|FG007|Period 1|Protocol Violation|0|||
155393104|NCT01968070|560874861|FG008|Period 1|Protocol Violation|0|||
155393105|NCT01968070|560874862|FG009|Period 1|Protocol Violation|0|||
155393106|NCT01968070|560874863|FG010|Period 1|Protocol Violation|0|||
155393107|NCT01968070|560874864|FG011|Period 1|Protocol Violation|0|||
155393108|NCT01968070|560874865|FG012|Period 1|Protocol Violation|0|||
155393109|NCT01968070|560874866|FG013|Period 1|Protocol Violation|0|||
155393110|NCT01968070|560874867|FG014|Period 1|Protocol Violation|0|||
155393111|NCT01968070|560874868|FG015|Period 1|Protocol Violation|0|||
155393112|NCT01968070|560874869|FG016|Period 1|Protocol Violation|0|||
155393113|NCT01968070|560874870|FG017|Period 1|Protocol Violation|0|||
155393114|NCT01968070|560874853|FG000|Period 1|Lost to Follow-up|0|||
155393115|NCT01968070|560874854|FG001|Period 1|Lost to Follow-up|0|||
155393116|NCT01968070|560874855|FG002|Period 1|Lost to Follow-up|0|||
155393117|NCT01968070|560874856|FG003|Period 1|Lost to Follow-up|1|||
155393118|NCT01968070|560874857|FG004|Period 1|Lost to Follow-up|0|||
155393119|NCT01968070|560874858|FG005|Period 1|Lost to Follow-up|0|||
155393120|NCT01968070|560874859|FG006|Period 1|Lost to Follow-up|0|||
155393121|NCT01968070|560874860|FG007|Period 1|Lost to Follow-up|0|||
155393122|NCT01968070|560874861|FG008|Period 1|Lost to Follow-up|0|||
155393123|NCT01968070|560874862|FG009|Period 1|Lost to Follow-up|0|||
155393124|NCT01968070|560874863|FG010|Period 1|Lost to Follow-up|0|||
155393125|NCT01968070|560874864|FG011|Period 1|Lost to Follow-up|0|||
155393126|NCT01968070|560874865|FG012|Period 1|Lost to Follow-up|0|||
155393127|NCT01968070|560874866|FG013|Period 1|Lost to Follow-up|0|||
155393128|NCT01968070|560874867|FG014|Period 1|Lost to Follow-up|0|||
155393129|NCT01968070|560874868|FG015|Period 1|Lost to Follow-up|0|||
155393130|NCT01968070|560874869|FG016|Period 1|Lost to Follow-up|0|||
155393131|NCT01968070|560874870|FG017|Period 1|Lost to Follow-up|0|||
155393132|NCT01968070|560874853|FG000|Period 1|Adverse Event|0|||
155393133|NCT01968070|560874854|FG001|Period 1|Adverse Event|0|||
155393134|NCT01968070|560874855|FG002|Period 1|Adverse Event|0|||
155393135|NCT01968070|560874856|FG003|Period 1|Adverse Event|0|||
155393136|NCT01968070|560874857|FG004|Period 1|Adverse Event|0|||
155393137|NCT01968070|560874858|FG005|Period 1|Adverse Event|0|||
155393138|NCT01968070|560874859|FG006|Period 1|Adverse Event|1|||
155393139|NCT01968070|560874860|FG007|Period 1|Adverse Event|0|||
155393140|NCT01968070|560874861|FG008|Period 1|Adverse Event|0|||
155393141|NCT01968070|560874862|FG009|Period 1|Adverse Event|0|||
155393142|NCT01968070|560874863|FG010|Period 1|Adverse Event|0|||
155393143|NCT01968070|560874864|FG011|Period 1|Adverse Event|0|||
155393144|NCT01968070|560874865|FG012|Period 1|Adverse Event|0|||
155393145|NCT01968070|560874866|FG013|Period 1|Adverse Event|0|||
155393146|NCT01968070|560874867|FG014|Period 1|Adverse Event|0|||
155393147|NCT01968070|560874868|FG015|Period 1|Adverse Event|0|||
155393148|NCT01968070|560874869|FG016|Period 1|Adverse Event|0|||
155393149|NCT01968070|560874870|FG017|Period 1|Adverse Event|0|||
155393150|NCT01968070|560874853|FG000|Period 1|Physician Decision|0|||
155393151|NCT01968070|560874854|FG001|Period 1|Physician Decision|0|||
155393152|NCT01968070|560874855|FG002|Period 1|Physician Decision|0|||
155393153|NCT01968070|560874856|FG003|Period 1|Physician Decision|0|||
155393154|NCT01968070|560874857|FG004|Period 1|Physician Decision|0|||
155393155|NCT01968070|560874858|FG005|Period 1|Physician Decision|0|||
155393156|NCT01968070|560874859|FG006|Period 1|Physician Decision|0|||
155393157|NCT01968070|560874860|FG007|Period 1|Physician Decision|0|||
155393158|NCT01968070|560874861|FG008|Period 1|Physician Decision|0|||
155632420|NCT01648764|561747709|FG007|Overall Study|Adverse Event|0|||
155632421|NCT01648764|561747710|FG008|Overall Study|Adverse Event|0|||
155632422|NCT01648764|561747711|FG009|Overall Study|Adverse Event|1|||
155393159|NCT01968070|560874862|FG009|Period 1|Physician Decision|0|||
155393160|NCT01968070|560874863|FG010|Period 1|Physician Decision|0|||
155393161|NCT01968070|560874864|FG011|Period 1|Physician Decision|1|||
155393162|NCT01968070|560874865|FG012|Period 1|Physician Decision|0|||
155393163|NCT01968070|560874866|FG013|Period 1|Physician Decision|0|||
155393164|NCT01968070|560874867|FG014|Period 1|Physician Decision|0|||
155393165|NCT01968070|560874868|FG015|Period 1|Physician Decision|0|||
155393166|NCT01968070|560874869|FG016|Period 1|Physician Decision|0|||
155393167|NCT01968070|560874870|FG017|Period 1|Physician Decision|0|||
155632423|NCT01648764|561747712|FG010|Overall Study|Adverse Event|0|||
155632424|NCT01648764|561747713|FG011|Overall Study|Adverse Event|3|||
155632425|NCT01648764|561747714|FG012|Overall Study|Adverse Event|1|||
155632426|NCT01648764|561747715|FG013|Overall Study|Adverse Event|1|||
155632427|NCT01648764|561747702|FG000|Overall Study|Death|0|||
155282677|NCT03073005|560465856|FG000|Overall Study|Death|6|||
155282678|NCT03073005|560465857|FG001|Overall Study|Death|0|||
155282679|NCT03073005|560465858|FG002|Overall Study|Death|7|||
155282680|NCT03073005|560465859|FG003|Overall Study|Death|0|||
155282681|NCT03073005|560465856|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
155282682|NCT03073005|560465857|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
155282683|NCT03073005|560465858|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
155282684|NCT03073005|560465859|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
155282685|NCT03073005|560465856|FG000|Overall Study|Lost to Follow-up|2|||
155282686|NCT03073005|560465857|FG001|Overall Study|Lost to Follow-up|2|||
155282687|NCT03073005|560465858|FG002|Overall Study|Lost to Follow-up|1|||
155282688|NCT03073005|560465859|FG003|Overall Study|Lost to Follow-up|2|||
155282689|NCT03073005|560465856|FG000|Overall Study|Withdrawal by Subject|0|||
155282690|NCT03073005|560465857|FG001|Overall Study|Withdrawal by Subject|4|||
155282691|NCT03073005|560465858|FG002|Overall Study|Withdrawal by Subject|4|||
155282692|NCT03073005|560465859|FG003|Overall Study|Withdrawal by Subject|4|||
155282693|NCT01734811|560465860|FG000|Overall Study|Lost to Follow-up|2|||
155282694|NCT01734811|560465861|FG001|Overall Study|Lost to Follow-up|3|||
155282695|NCT01734811|560465860|FG000|Overall Study|Withdrawal by Subject|2|||
155282696|NCT01734811|560465861|FG001|Overall Study|Withdrawal by Subject|0|||
155282697|NCT02427646|560465862|FG000|Overall Study|Lack of Efficacy|2|||
155282698|NCT02427646|560465863|FG001|Overall Study|Lack of Efficacy|3|||
155282699|NCT02427646|560465862|FG000|Overall Study|Physician Decision|1|||
155282700|NCT02427646|560465863|FG001|Overall Study|Physician Decision|4|||
155282701|NCT02427646|560465862|FG000|Overall Study|Protocol Violation|3|||
155282702|NCT02427646|560465863|FG001|Overall Study|Protocol Violation|3|||
155282703|NCT02427646|560465862|FG000|Overall Study|Bothersome hand weakness|2|||
155282704|NCT02427646|560465863|FG001|Overall Study|Bothersome hand weakness|4|||
155282705|NCT03824236|560465864|FG000|Overall Study|Lost to Follow-up|0|||
155282706|NCT03824236|560465865|FG001|Overall Study|Lost to Follow-up|0|||
155282707|NCT03824236|560465866|FG002|Overall Study|Lost to Follow-up|1|||
155282708|NCT01290094|560465867|FG000|Overall Study|Withdrawal by Subject|1|||
155282709|NCT01290094|560465867|FG000|Overall Study|Lost to Follow-up|5|||
155282710|NCT01101542|560465868|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
155282711|NCT01101542|560465868|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
155282712|NCT01101542|560465868|FG000|Year 4 Surveillance Period|Other|287|||
155282713|NCT01101542|560465868|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
155282714|NCT01101542|560465868|FG000|Year 5 Surveillance Period|Pregnancy|1|||
155282715|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
155282716|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Pregnancy|1|||
155282717|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
155282718|NCT00814489|560465894|FG000|Overall Study|Other|2|||
155282719|NCT00814489|560465895|FG001|Overall Study|Other|0|||
155282720|NCT00814489|560465896|FG002|Overall Study|Other|1|||
155282721|NCT04880161|560465897|FG000|Overall Study|Withdrawal by Subject|1|||
155282722|NCT04880161|560465898|FG001|Overall Study|Withdrawal by Subject|0|||
155282723|NCT04880161|560465897|FG000|Overall Study|Lack of Compliance|1|||
155282724|NCT04880161|560465898|FG001|Overall Study|Lack of Compliance|1|||
155282725|NCT04880161|560465897|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
155282726|NCT04880161|560465898|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
155282727|NCT04880161|560465897|FG000|Overall Study|Screen Failure|0|||
155282728|NCT04880161|560465898|FG001|Overall Study|Screen Failure|1|||
155282729|NCT01354106|560465899|FG000|Overall Study|Withdrawal by Subject|2|||
155282730|NCT00901485|560465900|FG000|Overall Study|Lack of Efficacy|0|||
155282731|NCT00901485|560465901|FG001|Overall Study|Lack of Efficacy|2|||
155282732|NCT00901485|560465900|FG000|Overall Study|Withdrawal by Subject|1|||
155282733|NCT00901485|560465901|FG001|Overall Study|Withdrawal by Subject|2|||
155282734|NCT01871285|560465902|FG000|First Intervention (1 Day)|Adverse Event|1|||
155282735|NCT01871285|560465903|FG001|First Intervention (1 Day)|Adverse Event|0|||
155282736|NCT01871285|560465904|FG002|First Intervention (1 Day)|Adverse Event|0|||
155282737|NCT01871285|560465905|FG003|First Intervention (1 Day)|Adverse Event|0|||
155282738|NCT01871285|560465902|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
155282739|NCT01871285|560465903|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
155282740|NCT01871285|560465904|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
155282741|NCT01871285|560465905|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
155282742|NCT03015740|560465906|FG000|Overall Study|Adverse Event|1|||
155282743|NCT03015740|560465907|FG001|Overall Study|Adverse Event|0|||
155282744|NCT03015740|560465908|FG002|Overall Study|Adverse Event|0|||
155282745|NCT03015740|560465906|FG000|Overall Study|Death|3|||
155282746|NCT03015740|560465907|FG001|Overall Study|Death|5|||
155282747|NCT03015740|560465908|FG002|Overall Study|Death|0|||
155393168|NCT01968070|560874853|FG000|Period 2|Withdrawal by Subject|0|||
155282748|NCT03015740|560465906|FG000|Overall Study|Withdrawal by Subject|2|||
155632428|NCT01648764|561747703|FG001|Overall Study|Death|0|||
155393169|NCT01968070|560874854|FG001|Period 2|Withdrawal by Subject|0|||
155393170|NCT01968070|560874855|FG002|Period 2|Withdrawal by Subject|0|||
155393171|NCT01968070|560874856|FG003|Period 2|Withdrawal by Subject|0|||
155393172|NCT01968070|560874857|FG004|Period 2|Withdrawal by Subject|1|||
155393173|NCT01968070|560874858|FG005|Period 2|Withdrawal by Subject|0|||
155393174|NCT01968070|560874859|FG006|Period 2|Withdrawal by Subject|0|||
155393175|NCT01968070|560874860|FG007|Period 2|Withdrawal by Subject|0|||
155393176|NCT01968070|560874861|FG008|Period 2|Withdrawal by Subject|0|||
155393177|NCT01968070|560874862|FG009|Period 2|Withdrawal by Subject|0|||
155393178|NCT01968070|560874863|FG010|Period 2|Withdrawal by Subject|0|||
155393179|NCT01968070|560874864|FG011|Period 2|Withdrawal by Subject|0|||
155393180|NCT01968070|560874865|FG012|Period 2|Withdrawal by Subject|0|||
155393181|NCT01968070|560874866|FG013|Period 2|Withdrawal by Subject|0|||
155393182|NCT01968070|560874867|FG014|Period 2|Withdrawal by Subject|0|||
155393183|NCT01968070|560874868|FG015|Period 2|Withdrawal by Subject|0|||
155393184|NCT01968070|560874869|FG016|Period 2|Withdrawal by Subject|0|||
155393185|NCT01968070|560874870|FG017|Period 2|Withdrawal by Subject|0|||
155393186|NCT00890929|560874873|FG000|Overall Study|Death before treatment|2|||
155393187|NCT00890929|560874873|FG000|Overall Study|Withdrawal by Subject|3|||
155393188|NCT00890929|560874873|FG000|Overall Study|Physician Decision|1|||
155393189|NCT00108069|560874874|FG000|Overall Study|Never rec'd study drug|0|||
155393190|NCT00108069|560874875|FG001|Overall Study|Never rec'd study drug|1|||
155393191|NCT00108069|560874874|FG000|Overall Study|Adverse Event|1|||
155393192|NCT00108069|560874875|FG001|Overall Study|Adverse Event|1|||
155393193|NCT00108069|560874874|FG000|Overall Study|Withdrawal by Subject|1|||
155393194|NCT00108069|560874875|FG001|Overall Study|Withdrawal by Subject|0|||
155393195|NCT00108069|560874874|FG000|Overall Study|Death|1|||
155393196|NCT00108069|560874875|FG001|Overall Study|Death|0|||
155393197|NCT00108069|560874874|FG000|Overall Study|Progessive disease|27|||
155393198|NCT00108069|560874875|FG001|Overall Study|Progessive disease|11|||
155393199|NCT01237340|560874877|FG000|Overall Study|Adverse Event|3|||
155393200|NCT01237340|560874877|FG000|Overall Study|Withdrawal by Subject|1|||
155393201|NCT01237340|560874877|FG000|Overall Study|Early termination of the trial|36|||
155393202|NCT01272947|560874878|FG000|Overall Study|Abnormal Laboratory Value|2|||
155393203|NCT01272947|560874879|FG001|Overall Study|Abnormal Laboratory Value|2|||
155393204|NCT02019420|560874880|FG000|Overall Study|Did not receive study drug|2|||
155393205|NCT02019420|560874881|FG001|Overall Study|Did not receive study drug|2|||
155393206|NCT02019420|560874880|FG000|Overall Study|Withdrawal by Subject|1|||
155393207|NCT02019420|560874881|FG001|Overall Study|Withdrawal by Subject|3|||
155393208|NCT02019420|560874880|FG000|Overall Study|At request of sponsor or investigator|0|||
155393209|NCT02019420|560874881|FG001|Overall Study|At request of sponsor or investigator|1|||
155393210|NCT02019420|560874880|FG000|Overall Study|Death|104|||
155393211|NCT02019420|560874881|FG001|Overall Study|Death|99|||
155393212|NCT02019420|560874880|FG000|Overall Study|Transferred to other care facility|1|||
155393213|NCT02019420|560874881|FG001|Overall Study|Transferred to other care facility|1|||
155393214|NCT02401412|560874882|FG000|Overall Study|Lost to Follow-up|1|||
155393215|NCT02401412|560874883|FG001|Overall Study|Lost to Follow-up|0|||
155393216|NCT02401412|560874882|FG000|Overall Study|Discontinued Intervention|15|||
155393217|NCT02401412|560874883|FG001|Overall Study|Discontinued Intervention|21|||
155393218|NCT02401412|560874882|FG000|Overall Study|Withdrawal by Subject|4|||
155393219|NCT02401412|560874883|FG001|Overall Study|Withdrawal by Subject|4|||
155393220|NCT02401412|560874882|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
155393221|NCT02401412|560874883|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
155393222|NCT02401412|560874882|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
155393223|NCT02401412|560874883|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
155393224|NCT02742766|560874892|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393225|NCT02742766|560874893|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393226|NCT02742766|560874894|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393227|NCT02742766|560874895|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393228|NCT02742766|560874896|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155632429|NCT01648764|561747704|FG002|Overall Study|Death|0|||
155632430|NCT01648764|561747705|FG003|Overall Study|Death|0|||
155632431|NCT01648764|561747706|FG004|Overall Study|Death|0|||
155632432|NCT01648764|561747707|FG005|Overall Study|Death|0|||
155632433|NCT01648764|561747708|FG006|Overall Study|Death|1|||
155632434|NCT01648764|561747709|FG007|Overall Study|Death|0|||
155632435|NCT01648764|561747710|FG008|Overall Study|Death|0|||
155632436|NCT01648764|561747711|FG009|Overall Study|Death|0|||
155632437|NCT01648764|561747712|FG010|Overall Study|Death|0|||
155393229|NCT02742766|560874897|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155734984|NCT04672655|562127245|FG000|Overall Study|Lost to Follow-up|12|||
155393230|NCT02742766|560874898|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393231|NCT02742766|560874899|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155632438|NCT01648764|561747713|FG011|Overall Study|Death|0|||
155393232|NCT02742766|560874900|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393233|NCT02742766|560874901|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155632439|NCT01648764|561747714|FG012|Overall Study|Death|0|||
155734985|NCT04672655|562127246|FG001|Overall Study|Lost to Follow-up|17|||
155632440|NCT01648764|561747715|FG013|Overall Study|Death|1|||
155632441|NCT01648764|561747702|FG000|Overall Study|Withdrawal by Subject|0|||
155632442|NCT01648764|561747703|FG001|Overall Study|Withdrawal by Subject|0|||
155632443|NCT01648764|561747704|FG002|Overall Study|Withdrawal by Subject|0|||
155632444|NCT01648764|561747705|FG003|Overall Study|Withdrawal by Subject|0|||
155632445|NCT01648764|561747706|FG004|Overall Study|Withdrawal by Subject|0|||
155632446|NCT01648764|561747707|FG005|Overall Study|Withdrawal by Subject|0|||
155632447|NCT01648764|561747708|FG006|Overall Study|Withdrawal by Subject|2|||
155282749|NCT03015740|560465907|FG001|Overall Study|Withdrawal by Subject|0|||
155282750|NCT03015740|560465908|FG002|Overall Study|Withdrawal by Subject|0|||
155282751|NCT03253653|560465909|FG000|Overall Study|Withdrawal by Subject|4|||
155282752|NCT03253653|560465910|FG001|Overall Study|Withdrawal by Subject|1|||
155282753|NCT03253653|560465909|FG000|Overall Study|Protocol Violation|0|||
155282754|NCT03253653|560465910|FG001|Overall Study|Protocol Violation|5|||
155282755|NCT02263885|560468086|FG000|Overall Study|Withdrawal by Subject|7|||
155282756|NCT02263885|560468086|FG000|Overall Study|Alternative Treatment|3|||
155282757|NCT04531540|560468089|FG000|Overall Study|Adverse Event|1|||
155282758|NCT04531540|560468089|FG000|Overall Study|Protocol Violation|3|||
155282759|NCT04531540|560468089|FG000|Overall Study|Withdrawal by Subject|4|||
155282760|NCT04531540|560468089|FG000|Overall Study|Found to be Ineligible|1|||
155282761|NCT00003377|560468090|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
155282762|NCT00003377|560468091|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
155282763|NCT00003377|560468092|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
155282764|NCT00003377|560468093|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
155282765|NCT00003377|560468094|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
155282766|NCT00003377|560468090|FG000|Period II|Ureteral stent complications|0|||
155282767|NCT00003377|560468091|FG001|Period II|Ureteral stent complications|0|||
155282768|NCT00003377|560468092|FG002|Period II|Ureteral stent complications|0|||
155282769|NCT00003377|560468093|FG003|Period II|Ureteral stent complications|0|||
155282770|NCT00003377|560468094|FG004|Period II|Ureteral stent complications|1|||
155282771|NCT00582790|560468097|FG000|Overall Study|Rapid progression of disease|1|||
155282772|NCT00480441|560468102|FG000|Screening|Not Eligible|37|||
155282773|NCT00480441|560468103|FG001|Screening|Not Eligible|0|||
155282774|NCT00480441|560468104|FG002|Screening|Not Eligible|0|||
155282775|NCT00480441|560468102|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
155282776|NCT00480441|560468103|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
155282777|NCT00480441|560468104|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
155282778|NCT00480441|560468102|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
155282779|NCT00480441|560468103|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
155282780|NCT00480441|560468104|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
155282781|NCT00480441|560468102|FG000|Baseline Functional MRI|physical contraindication|4|||
155282782|NCT00480441|560468103|FG001|Baseline Functional MRI|physical contraindication|0|||
155282783|NCT00480441|560468104|FG002|Baseline Functional MRI|physical contraindication|0|||
155282784|NCT00480441|560468102|FG000|Randomization|Lost to Follow-up|0|||
155282785|NCT00480441|560468103|FG001|Randomization|Lost to Follow-up|7|||
155282786|NCT00480441|560468104|FG002|Randomization|Lost to Follow-up|2|||
155282787|NCT02374957|560468105|FG000|Overall Study|Patient did not complete forms correctly|1|||
155282788|NCT02374957|560468106|FG001|Overall Study|Patient did not complete forms correctly|0|||
155282789|NCT00748969|560468107|FG000|Overall Study|Withdrawal by Subject|1|||
155282790|NCT00748969|560468108|FG001|Overall Study|Withdrawal by Subject|0|||
155282791|NCT00748969|560468107|FG000|Overall Study|Withdrawal by Subject|0|||
155282792|NCT00748969|560468108|FG001|Overall Study|Withdrawal by Subject|1|||
155282793|NCT03532178|560468109|FG000|First Period|Withdrawal by Subject|1|||
155282794|NCT03532178|560468110|FG001|First Period|Withdrawal by Subject|3|||
155282795|NCT03532178|560468109|FG000|First Period|technical issues in data collection Technical issues|0|||
155282796|NCT03532178|560468110|FG001|First Period|technical issues in data collection Technical issues|1|||
155282797|NCT03532178|560468109|FG000|Second Period|Withdrawal by Subject|1|||
155282798|NCT03532178|560468110|FG001|Second Period|Withdrawal by Subject|1|||
155282799|NCT03532178|560468109|FG000|Second Period|Technical issues|0|||
155282800|NCT03532178|560468110|FG001|Second Period|Technical issues|1|||
155282801|NCT01113463|560468114|FG000|Overall Study|Physician Decision|5|||
155282802|NCT00578227|560468119|FG000|Overall Study|Lost to Follow-up|0|||
155282803|NCT00578227|560468120|FG001|Overall Study|Lost to Follow-up|1|||
155282804|NCT00578227|560468121|FG002|Overall Study|Lost to Follow-up|1|||
155282805|NCT00578227|560468119|FG000|Overall Study|Withdrawal by Subject|5|||
155282806|NCT00578227|560468120|FG001|Overall Study|Withdrawal by Subject|1|||
155282807|NCT00578227|560468121|FG002|Overall Study|Withdrawal by Subject|3|||
155282808|NCT00916006|560468130|FG000|Overall Study|Adverse Event|1|||
155282809|NCT00916006|560468131|FG001|Overall Study|Adverse Event|1|||
155282810|NCT00916006|560468130|FG000|Overall Study|Withdrawal by Subject|2|||
155282811|NCT00916006|560468131|FG001|Overall Study|Withdrawal by Subject|5|||
155282812|NCT00916006|560468130|FG000|Overall Study|Protocol Violation|0|||
155282813|NCT00916006|560468131|FG001|Overall Study|Protocol Violation|1|||
155282814|NCT01605136|560468136|FG000|Study Period|Withdrawal by Subject|2|||
155282815|NCT01605136|560468137|FG001|Study Period|Withdrawal by Subject|0|||
155282816|NCT01605136|560468136|FG000|Study Period|Physician Decision|1|||
155282817|NCT01605136|560468137|FG001|Study Period|Physician Decision|1|||
155282818|NCT01605136|560468136|FG000|Study Period|Lost to Follow-up|0|||
155282819|NCT01605136|560468137|FG001|Study Period|Lost to Follow-up|2|||
155282820|NCT01605136|560468136|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
155282821|NCT01605136|560468137|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
155282822|NCT01072929|560468138|FG000|Overall Study|Adverse Event|8|||
155282823|NCT01072929|560468139|FG001|Overall Study|Adverse Event|11|||
155282824|NCT01072929|560468140|FG002|Overall Study|Adverse Event|2|||
155282825|NCT01072929|560468138|FG000|Overall Study|Lack of Efficacy|7|||
155282826|NCT01072929|560468139|FG001|Overall Study|Lack of Efficacy|4|||
155282827|NCT01072929|560468140|FG002|Overall Study|Lack of Efficacy|0|||
155282828|NCT01072929|560468138|FG000|Overall Study|Withdrawal by Subject|7|||
155282829|NCT01072929|560468139|FG001|Overall Study|Withdrawal by Subject|15|||
155282830|NCT01072929|560468140|FG002|Overall Study|Withdrawal by Subject|3|||
155282831|NCT01072929|560468138|FG000|Overall Study|Protocol Violation|13|||
155282832|NCT01072929|560468139|FG001|Overall Study|Protocol Violation|11|||
155282833|NCT01072929|560468140|FG002|Overall Study|Protocol Violation|2|||
155282834|NCT01072929|560468138|FG000|Overall Study|Lost to Follow-up|8|||
155282835|NCT01072929|560468139|FG001|Overall Study|Lost to Follow-up|4|||
155282836|NCT01072929|560468140|FG002|Overall Study|Lost to Follow-up|1|||
155282837|NCT01072929|560468138|FG000|Overall Study|Noncompliance with study medication|0|||
155282838|NCT01072929|560468139|FG001|Overall Study|Noncompliance with study medication|3|||
155282839|NCT01072929|560468140|FG002|Overall Study|Noncompliance with study medication|0|||
155282840|NCT01072929|560468138|FG000|Overall Study|Noncompliance with study procedures|1|||
155282841|NCT01072929|560468139|FG001|Overall Study|Noncompliance with study procedures|0|||
155282842|NCT01072929|560468140|FG002|Overall Study|Noncompliance with study procedures|1|||
155282843|NCT01072929|560468138|FG000|Overall Study|Other|0|||
155282844|NCT01072929|560468139|FG001|Overall Study|Other|3|||
155282845|NCT01072929|560468140|FG002|Overall Study|Other|0|||
155282846|NCT02929108|560468141|FG000|Overall Study|Hospice patient death|100|||
155282847|NCT02929108|560468142|FG001|Overall Study|Hospice patient death|64|||
155282848|NCT02929108|560468143|FG002|Overall Study|Hospice patient death|28|||
155282849|NCT02929108|560468144|FG003|Overall Study|Hospice patient death|46|||
155282850|NCT02929108|560468145|FG004|Overall Study|Hospice patient death|55|||
155282851|NCT02929108|560468146|FG005|Overall Study|Hospice patient death|28|||
155282852|NCT02929108|560468147|FG006|Overall Study|Hospice patient death|78|||
155282853|NCT00052962|560468148|FG000|Overall Study|Not evaluable|0|||
155282854|NCT00052962|560468149|FG001|Overall Study|Not evaluable|2|||
155282855|NCT00052962|560468148|FG000|Overall Study|Not randomized/not evaluable|1|||
155282856|NCT00052962|560468149|FG001|Overall Study|Not randomized/not evaluable|0|||
155282857|NCT01414166|560468150|FG000|Overall Study|Adverse Event|10|||
155282858|NCT01414166|560468151|FG001|Overall Study|Adverse Event|2|||
155282859|NCT01414166|560468150|FG000|Overall Study|Lost to Follow-up|4|||
155282860|NCT01414166|560468151|FG001|Overall Study|Lost to Follow-up|1|||
155282861|NCT01414166|560468150|FG000|Overall Study|Non-compliance with study drug|2|||
155282862|NCT01414166|560468151|FG001|Overall Study|Non-compliance with study drug|0|||
155282863|NCT01414166|560468150|FG000|Overall Study|Physician Decision|2|||
155282864|NCT01414166|560468151|FG001|Overall Study|Physician Decision|0|||
155282865|NCT01414166|560468150|FG000|Overall Study|Protocol Violation|2|||
155282866|NCT01414166|560468151|FG001|Overall Study|Protocol Violation|0|||
155282867|NCT01414166|560468150|FG000|Overall Study|Study terminated by Sponsor|68|||
155282868|NCT01414166|560468151|FG001|Overall Study|Study terminated by Sponsor|75|||
155282869|NCT01414166|560468150|FG000|Overall Study|Withdrawal by Subject|3|||
155282870|NCT01414166|560468151|FG001|Overall Study|Withdrawal by Subject|5|||
155282871|NCT02806336|560468152|FG000|Overall Study|Physician Decision|1|||
155282872|NCT02806336|560468153|FG001|Overall Study|Physician Decision|0|||
155282873|NCT02806336|560468152|FG000|Overall Study|Withdrawal by Subject|2|||
155282874|NCT02806336|560468153|FG001|Overall Study|Withdrawal by Subject|4|||
155282875|NCT02806336|560468152|FG000|Overall Study|COVID-19 research shut down|3|||
155282876|NCT02806336|560468153|FG001|Overall Study|COVID-19 research shut down|4|||
155282877|NCT02806336|560468152|FG000|Overall Study|Lack of Efficacy|0|||
155282878|NCT02806336|560468153|FG001|Overall Study|Lack of Efficacy|1|||
155282879|NCT03682536|560468154|FG000|Randomization|Withdrawal by Subject|0|||
155282880|NCT03682536|560468155|FG001|Randomization|Withdrawal by Subject|2|||
155282881|NCT03682536|560468154|FG000|Treatment|Other Reasons|8|||
155282882|NCT03682536|560468155|FG001|Treatment|Other Reasons|7|||
155282883|NCT03682536|560468154|FG000|Treatment|Physician Decision|5|||
155282884|NCT03682536|560468155|FG001|Treatment|Physician Decision|5|||
155282885|NCT03682536|560468154|FG000|Treatment|Protocol Violation|1|||
155282886|NCT03682536|560468155|FG001|Treatment|Protocol Violation|0|||
155282887|NCT03682536|560468154|FG000|Treatment|Study Terminated by Sponsor|1|||
155282888|NCT03682536|560468155|FG001|Treatment|Study Terminated by Sponsor|2|||
155282889|NCT03682536|560468154|FG000|Treatment|Lost to Follow-up|0|||
155282890|NCT03682536|560468155|FG001|Treatment|Lost to Follow-up|1|||
155282891|NCT03682536|560468154|FG000|Treatment|Withdrawal by Subject|16|||
155282892|NCT03682536|560468155|FG001|Treatment|Withdrawal by Subject|18|||
155282893|NCT03682536|560468154|FG000|Treatment|Lack of Efficacy|41|||
155393234|NCT02742766|560874902|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393235|NCT02742766|560874903|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393236|NCT02742766|560874904|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393237|NCT02742766|560874905|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
155393238|NCT02742766|560874906|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393239|NCT02742766|560874907|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393240|NCT02742766|560874908|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393241|NCT02742766|560874909|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393242|NCT02742766|560874910|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393243|NCT02742766|560874892|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393244|NCT02742766|560874893|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393245|NCT02742766|560874894|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393246|NCT02742766|560874895|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393247|NCT02742766|560874896|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393248|NCT02742766|560874897|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393249|NCT02742766|560874898|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393250|NCT02742766|560874899|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393251|NCT02742766|560874900|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393252|NCT02742766|560874901|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393253|NCT02742766|560874902|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393254|NCT02742766|560874903|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393255|NCT02742766|560874904|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
155393256|NCT02742766|560874905|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
155393257|NCT02742766|560874906|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393258|NCT02742766|560874907|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
155393259|NCT02742766|560874908|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393260|NCT02742766|560874909|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393261|NCT02742766|560874910|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393262|NCT05118204|560874914|FG000|Overall Study|Lost to Follow-up|3|||
155393263|NCT05118204|560874915|FG001|Overall Study|Lost to Follow-up|2|||
155393264|NCT05118204|560874914|FG000|Overall Study|Withdrawal by Subject|0|||
155393265|NCT05118204|560874915|FG001|Overall Study|Withdrawal by Subject|2|||
155393266|NCT05393037|560874919|FG000|Part A|Death|1|||
155393267|NCT05393037|560874920|FG001|Part A|Death|0|||
155393268|NCT05393037|560874919|FG000|Part A|Lost to Follow-up|1|||
155393269|NCT05393037|560874920|FG001|Part A|Lost to Follow-up|1|||
155393270|NCT05393037|560874919|FG000|Part A|Withdrawal by Subject|2|||
155393271|NCT05393037|560874920|FG001|Part A|Withdrawal by Subject|4|||
155393272|NCT05393037|560874919|FG000|Part B|Lost to Follow-up|1|||
155393273|NCT05393037|560874920|FG001|Part B|Lost to Follow-up|0|||
155393274|NCT02593786|560874921|FG000|Overall Study|Disease progression|12|||
155393275|NCT02593786|560874922|FG001|Overall Study|Disease progression|16|||
155393276|NCT02593786|560874923|FG002|Overall Study|Disease progression|10|||
155393277|NCT02593786|560874924|FG003|Overall Study|Disease progression|7|||
155393278|NCT02593786|560874921|FG000|Overall Study|Study drug toxicity|1|||
155393279|NCT02593786|560874922|FG001|Overall Study|Study drug toxicity|0|||
155393280|NCT02593786|560874923|FG002|Overall Study|Study drug toxicity|0|||
155393281|NCT02593786|560874924|FG003|Overall Study|Study drug toxicity|0|||
155393282|NCT02593786|560874921|FG000|Overall Study|Adverse event unrelated to study drug|1|||
155393283|NCT02593786|560874922|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155393284|NCT02593786|560874923|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155393285|NCT02593786|560874924|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155393286|NCT02593786|560874921|FG000|Overall Study|Participant request to discontinue study therapy|0|||
155393287|NCT02593786|560874922|FG001|Overall Study|Participant request to discontinue study therapy|2|||
155393288|NCT02593786|560874923|FG002|Overall Study|Participant request to discontinue study therapy|0|||
155393289|NCT02593786|560874924|FG003|Overall Study|Participant request to discontinue study therapy|0|||
155393290|NCT02593786|560874921|FG000|Overall Study|Other reasons|1|||
155393291|NCT02593786|560874922|FG001|Overall Study|Other reasons|1|||
155393292|NCT02593786|560874923|FG002|Overall Study|Other reasons|0|||
155393293|NCT02593786|560874924|FG003|Overall Study|Other reasons|5|||
155393294|NCT00708175|560874937|FG000|Overall Study|Adverse Event|4|||
155393295|NCT00708175|560874938|FG001|Overall Study|Adverse Event|5|||
155393296|NCT00708175|560874937|FG000|Overall Study|Protocol Violation|2|||
155393297|NCT00708175|560874938|FG001|Overall Study|Protocol Violation|3|||
155393298|NCT00708175|560874937|FG000|Overall Study|Lost to Follow-up|5|||
155393299|NCT00708175|560874938|FG001|Overall Study|Lost to Follow-up|3|||
155393300|NCT00708175|560874937|FG000|Overall Study|Withdrawal by Subject|5|||
155393301|NCT00708175|560874938|FG001|Overall Study|Withdrawal by Subject|7|||
155393302|NCT00708175|560874937|FG000|Overall Study|BMD loss >7%|2|||
155393303|NCT00708175|560874938|FG001|Overall Study|BMD loss >7%|3|||
155393304|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
155393305|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
155393306|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393307|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393308|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393309|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393310|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
155393311|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393312|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393313|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393314|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393315|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393316|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
155393317|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
155393318|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393319|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393320|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393321|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393322|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393323|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393324|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
155393325|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
155393326|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
155393327|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393328|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393329|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393330|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
155393331|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393332|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393333|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393334|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393335|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393336|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
155393337|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
155393338|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
155393339|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393340|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393341|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393342|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393343|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393344|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393345|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
155393346|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393347|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393348|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155734986|NCT04672655|562127245|FG000|Overall Study|Withdrawal by Subject|1|||
155734987|NCT04672655|562127246|FG001|Overall Study|Withdrawal by Subject|0|||
155734988|NCT04672655|562127245|FG000|Overall Study|Withdrawal by Study|1|||
155734989|NCT04672655|562127246|FG001|Overall Study|Withdrawal by Study|0|||
155734990|NCT00560352|562127250|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155734991|NCT00560352|562127251|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155734992|NCT00560352|562127252|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155734993|NCT00560352|562127250|FG000|Overall Study|Study drug toxicity|3|||
155734994|NCT00560352|562127251|FG001|Overall Study|Study drug toxicity|0|||
155734995|NCT00560352|562127252|FG002|Overall Study|Study drug toxicity|1|||
155734996|NCT00560352|562127250|FG000|Overall Study|Disease progression|0|||
155734997|NCT00560352|562127251|FG001|Overall Study|Disease progression|1|||
155734998|NCT00560352|562127252|FG002|Overall Study|Disease progression|1|||
155734999|NCT00560352|562127250|FG000|Overall Study|Withdrawal by Subject|1|||
155735000|NCT00560352|562127251|FG001|Overall Study|Withdrawal by Subject|1|||
155735001|NCT00560352|562127252|FG002|Overall Study|Withdrawal by Subject|1|||
155735002|NCT00560352|562127250|FG000|Overall Study|Maximum clinical benefit|1|||
155735003|NCT00560352|562127251|FG001|Overall Study|Maximum clinical benefit|0|||
155735004|NCT00560352|562127252|FG002|Overall Study|Maximum clinical benefit|0|||
155735005|NCT03892967|562127256|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
155735006|NCT03892967|562127257|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
155735007|NCT03892967|562127258|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
155735008|NCT03892967|562127259|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
155735009|NCT03892967|562127260|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
155282894|NCT03682536|560468155|FG001|Treatment|Lack of Efficacy|68|||
155282895|NCT03682536|560468154|FG000|Treatment|Disease Progression|9|||
155282896|NCT03682536|560468155|FG001|Treatment|Disease Progression|7|||
155282897|NCT03682536|560468154|FG000|Treatment|Adverse Event|9|||
155282898|NCT03682536|560468155|FG001|Treatment|Adverse Event|5|||
155282899|NCT03682536|560468154|FG000|Treatment|Death|14|||
155282900|NCT03682536|560468155|FG001|Treatment|Death|13|||
155282901|NCT05489224|560468156|FG000|Treatment Period I|Withdrawal by Subject|6|||
155282902|NCT05489224|560468157|FG001|Treatment Period I|Withdrawal by Subject|5|||
155282903|NCT05489224|560468158|FG002|Treatment Period I|Withdrawal by Subject|0|||
155282904|NCT05489224|560468156|FG000|Treatment Period I|Adverse Event|3|||
155282905|NCT05489224|560468157|FG001|Treatment Period I|Adverse Event|11|||
155282906|NCT05489224|560468158|FG002|Treatment Period I|Adverse Event|0|||
155282907|NCT05489224|560468156|FG000|Treatment Period I|Lost to Follow-up|0|||
155282908|NCT05489224|560468157|FG001|Treatment Period I|Lost to Follow-up|1|||
155282909|NCT05489224|560468158|FG002|Treatment Period I|Lost to Follow-up|0|||
155282910|NCT05489224|560468156|FG000|Treatment Period I|Physician Decision|0|||
155282911|NCT05489224|560468157|FG001|Treatment Period I|Physician Decision|1|||
155282912|NCT05489224|560468158|FG002|Treatment Period I|Physician Decision|0|||
155282913|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Ongoing|222|||
155282914|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Ongoing|107|||
155282915|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Ongoing|107|||
155282916|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
155282917|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
155282918|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
155282919|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
155282920|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
155282921|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
155282922|NCT03008122|560468167|FG000|Overall Study|Physician Decision|3|||
155282923|NCT03008122|560468168|FG001|Overall Study|Physician Decision|2|||
155282924|NCT03008122|560468169|FG002|Overall Study|Physician Decision|0|||
155282925|NCT03008122|560468167|FG000|Overall Study|Withdrawal by Subject|1|||
155282926|NCT03008122|560468168|FG001|Overall Study|Withdrawal by Subject|3|||
155282927|NCT03008122|560468169|FG002|Overall Study|Withdrawal by Subject|0|||
155282928|NCT03008122|560468167|FG000|Overall Study|Lost to Follow-up|4|||
155282929|NCT03008122|560468168|FG001|Overall Study|Lost to Follow-up|8|||
155282930|NCT03008122|560468169|FG002|Overall Study|Lost to Follow-up|3|||
155282931|NCT03008122|560468167|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
155282932|NCT03008122|560468168|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155282933|NCT03008122|560468169|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155282934|NCT03008122|560468167|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
155282935|NCT03008122|560468168|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
155282936|NCT03008122|560468169|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
155282937|NCT03008122|560468167|FG000|Overall Study|Death|0|||
155282938|NCT03008122|560468168|FG001|Overall Study|Death|0|||
155282939|NCT03008122|560468169|FG002|Overall Study|Death|1|||
155282940|NCT01222247|560468171|FG000|Overall Study|Lost to Follow-up|2|||
155282941|NCT01222247|560468172|FG001|Overall Study|Lost to Follow-up|2|||
155282942|NCT02084082|560468173|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
155282943|NCT02084082|560468174|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
155282944|NCT02084082|560468175|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
155282945|NCT02084082|560468176|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
155282946|NCT02084082|560468173|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282947|NCT02084082|560468174|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282948|NCT02084082|560468175|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282949|NCT02084082|560468176|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
155282950|NCT02223182|560468181|FG000|Double-Blind Period|Adverse Event|0|||
155282951|NCT02223182|560468182|FG001|Double-Blind Period|Adverse Event|2|||
155282952|NCT02223182|560468183|FG002|Double-Blind Period|Adverse Event|1|||
155282953|NCT02223182|560468184|FG003|Double-Blind Period|Adverse Event|0|||
155282954|NCT02223182|560468181|FG000|Double-Blind Period|Withdrawal by Subject|1|||
155282955|NCT02223182|560468182|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155282956|NCT02223182|560468183|FG002|Double-Blind Period|Withdrawal by Subject|1|||
155282957|NCT02223182|560468184|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155282958|NCT02223182|560468181|FG000|Double-Blind Period|Lost to Follow-up|0|||
155282959|NCT02223182|560468182|FG001|Double-Blind Period|Lost to Follow-up|1|||
155282960|NCT02223182|560468183|FG002|Double-Blind Period|Lost to Follow-up|0|||
155282961|NCT02223182|560468184|FG003|Double-Blind Period|Lost to Follow-up|0|||
155282962|NCT02223182|560468181|FG000|Double-Blind Period|Non Compliance|0|||
155282963|NCT02223182|560468182|FG001|Double-Blind Period|Non Compliance|0|||
155282964|NCT02223182|560468183|FG002|Double-Blind Period|Non Compliance|0|||
155282965|NCT02223182|560468184|FG003|Double-Blind Period|Non Compliance|1|||
155282966|NCT02223182|560468181|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
155282967|NCT02223182|560468182|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282968|NCT02223182|560468183|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282969|NCT02223182|560468184|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282970|NCT02223182|560468181|FG000|Open-Label 500 Period|Adverse Event|1|||
155282971|NCT02223182|560468182|FG001|Open-Label 500 Period|Adverse Event|0|||
155282972|NCT02223182|560468183|FG002|Open-Label 500 Period|Adverse Event|2|||
155282973|NCT02223182|560468184|FG003|Open-Label 500 Period|Adverse Event|1|||
155282974|NCT02223182|560468181|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
155282975|NCT02223182|560468182|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
155282976|NCT02223182|560468183|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
155282977|NCT02223182|560468184|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
155282978|NCT02223182|560468181|FG000|Open-Label 500 Period|Physician Decision|0|||
155282979|NCT02223182|560468182|FG001|Open-Label 500 Period|Physician Decision|0|||
155282980|NCT02223182|560468183|FG002|Open-Label 500 Period|Physician Decision|0|||
155282981|NCT02223182|560468184|FG003|Open-Label 500 Period|Physician Decision|1|||
155282982|NCT02223182|560468181|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282983|NCT02223182|560468182|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282984|NCT02223182|560468183|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
155282985|NCT02223182|560468184|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282986|NCT02223182|560468181|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
155282987|NCT02223182|560468182|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
155282988|NCT02223182|560468183|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
155282989|NCT02223182|560468184|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
155282990|NCT02223182|560468181|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
155282991|NCT02223182|560468182|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
155282992|NCT02223182|560468183|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
155282993|NCT02223182|560468184|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
155282994|NCT02223182|560468181|FG000|Open-Label 300 Period|Non Compliance|0|||
155282995|NCT02223182|560468182|FG001|Open-Label 300 Period|Non Compliance|2|||
155282996|NCT02223182|560468183|FG002|Open-Label 300 Period|Non Compliance|1|||
155282997|NCT02223182|560468184|FG003|Open-Label 300 Period|Non Compliance|0|||
155282998|NCT04956692|560468191|FG000|Overall Study|Death|115|||
155282999|NCT04956692|560468192|FG001|Overall Study|Death|47|||
155283000|NCT04956692|560468191|FG000|Overall Study|Lost to Follow-up|0|||
155283001|NCT04956692|560468192|FG001|Overall Study|Lost to Follow-up|1|||
155283002|NCT04956692|560468191|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155283003|NCT04956692|560468192|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155283004|NCT04956692|560468191|FG000|Overall Study|Withdrawal by Subject|5|||
155283005|NCT04956692|560468192|FG001|Overall Study|Withdrawal by Subject|2|||
155283006|NCT04956692|560468191|FG000|Overall Study|Ongoing in Study|236|||
155283007|NCT04956692|560468192|FG001|Overall Study|Ongoing in Study|123|||
155283008|NCT02099539|560468197|FG000|Overall Study|Progressive Disease|3|||
155283009|NCT02099539|560468198|FG001|Overall Study|Progressive Disease|2|||
155283010|NCT02099539|560468199|FG002|Overall Study|Progressive Disease|2|||
155283011|NCT02099539|560468200|FG003|Overall Study|Progressive Disease|1|||
155283012|NCT02099539|560468201|FG004|Overall Study|Progressive Disease|4|||
155283013|NCT02099539|560468202|FG005|Overall Study|Progressive Disease|2|||
155283014|NCT02099539|560468203|FG006|Overall Study|Progressive Disease|0|||
155283015|NCT02099539|560468197|FG000|Overall Study|Adverse Event|0|||
155283016|NCT02099539|560468198|FG001|Overall Study|Adverse Event|0|||
155283017|NCT02099539|560468199|FG002|Overall Study|Adverse Event|1|||
155283018|NCT02099539|560468200|FG003|Overall Study|Adverse Event|1|||
155283019|NCT02099539|560468201|FG004|Overall Study|Adverse Event|0|||
155283020|NCT02099539|560468202|FG005|Overall Study|Adverse Event|0|||
155283021|NCT02099539|560468203|FG006|Overall Study|Adverse Event|0|||
155283022|NCT02099539|560468197|FG000|Overall Study|Physician Decision|0|||
155283023|NCT02099539|560468198|FG001|Overall Study|Physician Decision|0|||
155283024|NCT02099539|560468199|FG002|Overall Study|Physician Decision|0|||
155283025|NCT02099539|560468200|FG003|Overall Study|Physician Decision|0|||
155283026|NCT02099539|560468201|FG004|Overall Study|Physician Decision|0|||
155283027|NCT02099539|560468202|FG005|Overall Study|Physician Decision|1|||
155283028|NCT02099539|560468203|FG006|Overall Study|Physician Decision|0|||
155283029|NCT03473756|560468205|FG000|Overall Study|Withdrawal by Subject|1|||
155283030|NCT03473756|560468206|FG001|Overall Study|Withdrawal by Subject|4|||
155283031|NCT03473756|560468205|FG000|Overall Study|Adverse Event|6|||
155283032|NCT03473756|560468206|FG001|Overall Study|Adverse Event|7|||
155283033|NCT03473756|560468205|FG000|Overall Study|Lack of Efficacy|3|||
155283034|NCT03473756|560468206|FG001|Overall Study|Lack of Efficacy|10|||
155283035|NCT03473756|560468205|FG000|Overall Study|Physician Decision|0|||
155283036|NCT03473756|560468206|FG001|Overall Study|Physician Decision|2|||
155283037|NCT03473756|560468205|FG000|Overall Study|End of study treatment|0|||
155283038|NCT03473756|560468206|FG001|Overall Study|End of study treatment|2|||
155283039|NCT03473756|560468205|FG000|Overall Study|Lost to Follow-up|0|||
155283040|NCT03473756|560468206|FG001|Overall Study|Lost to Follow-up|1|||
155283041|NCT03714022|560468207|FG000|Overall Study|Adverse Event|1|||
155283042|NCT03714022|560468208|FG001|Overall Study|Adverse Event|0|||
155283043|NCT03714022|560468207|FG000|Overall Study|Consent withdrawal|0|||
155283044|NCT03714022|560468208|FG001|Overall Study|Consent withdrawal|1|||
155283045|NCT03714022|560468207|FG000|Overall Study|Lost to Follow-up|3|||
155283046|NCT03714022|560468208|FG001|Overall Study|Lost to Follow-up|2|||
155283047|NCT02148718|560468211|FG000|Overall Study|Protocol Violation|26|||
155283048|NCT02148718|560468211|FG000|Overall Study|Discontinued Study Prematurely|5|||
155283049|NCT02487446|560468215|FG000|Period 1|Physician Decision|0|||
155283050|NCT02487446|560468216|FG001|Period 1|Physician Decision|1|||
155283051|NCT02487446|560468215|FG000|Period 1|Lack of Efficacy|1|||
155283052|NCT02487446|560468216|FG001|Period 1|Lack of Efficacy|0|||
155283053|NCT02487446|560468215|FG000|Period 1|Protocol deviation|3|||
155283054|NCT02487446|560468216|FG001|Period 1|Protocol deviation|2|||
155283055|NCT02487446|560468215|FG000|Period 1|Lost to Follow-up|2|||
155283056|NCT02487446|560468216|FG001|Period 1|Lost to Follow-up|0|||
155283057|NCT02487446|560468215|FG000|Period 1|Withdrawal by Subject|2|||
155283058|NCT02487446|560468216|FG001|Period 1|Withdrawal by Subject|0|||
155283059|NCT02487446|560468215|FG000|Period 1|Adverse Event|5|||
155283060|NCT02487446|560468216|FG001|Period 1|Adverse Event|5|||
155283061|NCT02487446|560468215|FG000|Washout|Lost to Follow-up|0|||
155283062|NCT02487446|560468216|FG001|Washout|Lost to Follow-up|2|||
155283063|NCT02487446|560468215|FG000|Washout|Withdrawal by Subject|1|||
155283064|NCT02487446|560468216|FG001|Washout|Withdrawal by Subject|4|||
155283065|NCT02487446|560468215|FG000|Washout|Adverse Event|2|||
155283066|NCT02487446|560468216|FG001|Washout|Adverse Event|2|||
155283067|NCT02487446|560468215|FG000|Period 2|Protocol deviation|0|||
155283068|NCT02487446|560468216|FG001|Period 2|Protocol deviation|1|||
155283069|NCT02487446|560468215|FG000|Period 2|Lost to Follow-up|1|||
155283070|NCT02487446|560468216|FG001|Period 2|Lost to Follow-up|1|||
155283071|NCT02487446|560468215|FG000|Period 2|Withdrawal by Subject|1|||
155283072|NCT02487446|560468216|FG001|Period 2|Withdrawal by Subject|1|||
155283073|NCT02487446|560468215|FG000|Period 2|Adverse Event|6|||
155283074|NCT02487446|560468216|FG001|Period 2|Adverse Event|2|||
155283075|NCT02234310|560468217|FG000|Overall Study|Physician Decision|1|||
155283076|NCT02234310|560468217|FG000|Overall Study|Adverse Event|1|||
155283077|NCT02234310|560468217|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
155283078|NCT02234310|560468217|FG000|Overall Study|Withdrawal by Subject|2|||
155283079|NCT03289455|560468218|FG000|Overall Study|Death|1|||
155283080|NCT03289455|560468219|FG001|Overall Study|Death|0|||
155283081|NCT03289455|560468220|FG002|Overall Study|Death|0|||
155283082|NCT03289455|560468218|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
155283083|NCT03289455|560468219|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
155283084|NCT03289455|560468220|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
155283085|NCT03289455|560468218|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
155283086|NCT03289455|560468219|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
155283087|NCT03289455|560468220|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
155283088|NCT03289455|560468218|FG000|Overall Study|Progressive disease|3|||
155283089|NCT03289455|560468219|FG001|Overall Study|Progressive disease|4|||
155283090|NCT03289455|560468220|FG002|Overall Study|Progressive disease|5|||
155283091|NCT01822821|560468221|FG000|Overall Study|Eligible surgery cancelled|1|||
155283092|NCT01822821|560468222|FG001|Overall Study|Eligible surgery cancelled|1|||
155283093|NCT01822821|560468221|FG000|Overall Study|Other reasons|1|||
155283094|NCT01822821|560468222|FG001|Overall Study|Other reasons|0|||
155283095|NCT00333788|560468223|FG000|Overall Study|Adverse Event|44|||
155283096|NCT00333788|560468223|FG000|Overall Study|Lack of Efficacy|80|||
155283097|NCT00333788|560468223|FG000|Overall Study|Lost to Follow-up|2|||
155283098|NCT00333788|560468223|FG000|Overall Study|Withdrawal by Subject|24|||
155283099|NCT00333788|560468223|FG000|Overall Study|Other: Non-compliance|2|||
155283100|NCT00333788|560468223|FG000|Overall Study|Other: Moved|2|||
155283101|NCT00333788|560468223|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
155283102|NCT00333788|560468223|FG000|Overall Study|Other: Investigator decision|1|||
155283103|NCT00333788|560468223|FG000|Overall Study|Other: Quality of life concern|1|||
155283104|NCT00333788|560468223|FG000|Overall Study|Other: Sponsor decision|1|||
155283105|NCT00333788|560468223|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
155283106|NCT00333788|560468223|FG000|Overall Study|Other: Medical monitor decision|1|||
155283107|NCT00333788|560468223|FG000|Overall Study|Other: Physician decision|1|||
155283108|NCT00333788|560468223|FG000|Overall Study|Other: Signed consent for another study|1|||
155283109|NCT03251378|560468224|FG000|Overall Study|Death|3|||
155283110|NCT03251378|560468225|FG001|Overall Study|Death|2|||
155283111|NCT03251378|560468226|FG002|Overall Study|Death|3|||
155283112|NCT03251378|560468227|FG003|Overall Study|Death|30|||
155283113|NCT03251378|560468228|FG004|Overall Study|Death|24|||
155283114|NCT03251378|560468229|FG005|Overall Study|Death|12|||
155283115|NCT03251378|560468230|FG006|Overall Study|Death|12|||
155283116|NCT03251378|560468224|FG000|Overall Study|Lost to Follow-up|0|||
155393349|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393350|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393351|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
155393352|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393353|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393354|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393355|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393356|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393357|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
155393358|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393359|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393360|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393361|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393362|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393363|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
155393364|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393365|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393366|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393367|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393368|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393369|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
155393370|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393371|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393372|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393373|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393374|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393375|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
155393376|NCT02383589|560874945|FG000|Treatment Period|Adverse Event|1|||
155393377|NCT02383589|560874946|FG001|Treatment Period|Adverse Event|3|||
155393378|NCT02383589|560874945|FG000|Treatment Period|Lost to Follow-up|0|||
155393379|NCT02383589|560874946|FG001|Treatment Period|Lost to Follow-up|1|||
155393380|NCT02383589|560874945|FG000|Treatment Period|Withdrawal by Subject|0|||
155393381|NCT02383589|560874946|FG001|Treatment Period|Withdrawal by Subject|5|||
155393382|NCT02383589|560874945|FG000|Treatment Period|Non-compliance with study drug|0|||
155393383|NCT02383589|560874946|FG001|Treatment Period|Non-compliance with study drug|1|||
155632448|NCT01648764|561747709|FG007|Overall Study|Withdrawal by Subject|0|||
155632449|NCT01648764|561747710|FG008|Overall Study|Withdrawal by Subject|0|||
155735010|NCT03892967|562127256|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
155735011|NCT03892967|562127257|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
155735012|NCT03892967|562127258|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
155735013|NCT03892967|562127259|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
155735014|NCT03892967|562127260|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
155735015|NCT03892967|562127256|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
155735016|NCT03892967|562127257|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
155735017|NCT03892967|562127258|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
155735018|NCT03892967|562127259|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
155735019|NCT03892967|562127260|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
155735020|NCT03892967|562127256|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
155735021|NCT03892967|562127257|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
155735022|NCT03892967|562127258|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
155632450|NCT01648764|561747711|FG009|Overall Study|Withdrawal by Subject|0|||
155632451|NCT01648764|561747712|FG010|Overall Study|Withdrawal by Subject|0|||
155632452|NCT01648764|561747713|FG011|Overall Study|Withdrawal by Subject|0|||
155632453|NCT01648764|561747714|FG012|Overall Study|Withdrawal by Subject|1|||
155632454|NCT01648764|561747715|FG013|Overall Study|Withdrawal by Subject|0|||
155632455|NCT01648764|561747702|FG000|Overall Study|Investigator Decision|0|||
155632456|NCT01648764|561747703|FG001|Overall Study|Investigator Decision|0|||
155632457|NCT01648764|561747704|FG002|Overall Study|Investigator Decision|0|||
155632458|NCT01648764|561747705|FG003|Overall Study|Investigator Decision|0|||
155632459|NCT01648764|561747706|FG004|Overall Study|Investigator Decision|0|||
155632460|NCT01648764|561747707|FG005|Overall Study|Investigator Decision|0|||
155632461|NCT01648764|561747708|FG006|Overall Study|Investigator Decision|1|||
155735023|NCT03892967|562127259|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
155735024|NCT03892967|562127260|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
155735025|NCT03892967|562127256|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
155735026|NCT03892967|562127257|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
155735027|NCT03892967|562127258|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
155735028|NCT03892967|562127259|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
155735029|NCT03892967|562127260|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
155735030|NCT03892967|562127256|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
155735031|NCT03892967|562127257|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
155735032|NCT03892967|562127258|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
155735033|NCT03892967|562127259|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
155735034|NCT03892967|562127260|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
155735035|NCT04434937|562127261|FG000|Overall Study|Death|4|||
155735036|NCT04434937|562127261|FG000|Overall Study|Withdrawal by Subject|1|||
155735037|NCT04434937|562127261|FG000|Overall Study|Transitioned to Rollover Study|19|||
155735038|NCT04434937|562127261|FG000|Overall Study|Progressive Disease|18|||
155735039|NCT03079102|562129239|FG000|Overall Study|Physician Decision|0|||
155735040|NCT03079102|562129240|FG001|Overall Study|Physician Decision|1|||
155735041|NCT02923921|562129241|FG000|Overall Study|Sponsor Decision|39|||
155735042|NCT02923921|562129242|FG001|Overall Study|Sponsor Decision|38|||
155735043|NCT02923921|562129241|FG000|Overall Study|Lost to Follow-up|1|||
155735044|NCT02923921|562129242|FG001|Overall Study|Lost to Follow-up|0|||
155735045|NCT02923921|562129241|FG000|Overall Study|Withdrawal by Subject|6|||
155735046|NCT02923921|562129242|FG001|Overall Study|Withdrawal by Subject|13|||
155735047|NCT02923921|562129241|FG000|Overall Study|Unknown, Not Collected|7|||
155735048|NCT02923921|562129242|FG001|Overall Study|Unknown, Not Collected|6|||
155735049|NCT00479687|562129243|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
155735050|NCT00479687|562129244|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
155735051|NCT00479687|562129245|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
155735052|NCT00479687|562129243|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
155735053|NCT00479687|562129244|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
155735054|NCT00479687|562129245|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
155735055|NCT00479687|562129243|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
155735056|NCT00479687|562129244|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
155735057|NCT00479687|562129245|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
155735058|NCT00479687|562129243|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
155735059|NCT00479687|562129244|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
155735060|NCT00479687|562129245|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
155735061|NCT00479687|562129243|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
155735062|NCT00479687|562129244|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
155735063|NCT00479687|562129245|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
155735064|NCT00479687|562129243|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
155735065|NCT00479687|562129244|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
155735066|NCT00479687|562129245|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
155735067|NCT00479687|562129243|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
155735068|NCT00479687|562129244|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
155735069|NCT00479687|562129245|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
155735070|NCT00479687|562129243|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
155735071|NCT00479687|562129244|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
155735072|NCT00479687|562129245|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
155735073|NCT00479687|562129243|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
155735074|NCT00479687|562129244|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
155735075|NCT00479687|562129245|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
155393384|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
155632462|NCT01648764|561747709|FG007|Overall Study|Investigator Decision|0|||
155632463|NCT01648764|561747710|FG008|Overall Study|Investigator Decision|0|||
155632464|NCT01648764|561747711|FG009|Overall Study|Investigator Decision|0|||
155632465|NCT01648764|561747712|FG010|Overall Study|Investigator Decision|0|||
155632466|NCT01648764|561747713|FG011|Overall Study|Investigator Decision|1|||
155632467|NCT01648764|561747714|FG012|Overall Study|Investigator Decision|0|||
155632468|NCT01648764|561747715|FG013|Overall Study|Investigator Decision|0|||
155632469|NCT03427411|561747716|FG000|Overall Study|Screen failure - platelets too low|0|||
155632470|NCT03427411|561747717|FG001|Overall Study|Screen failure - platelets too low|1|||
155735076|NCT01474239|562129246|FG000|Overall Study|Disease Progression|37|||
155735077|NCT01474239|562129247|FG001|Overall Study|Disease Progression|25|||
155735078|NCT01474239|562129246|FG000|Overall Study|Adverse Event|12|||
155735079|NCT01474239|562129247|FG001|Overall Study|Adverse Event|3|||
155735080|NCT01474239|562129246|FG000|Overall Study|Withdrawal by Subject|1|||
155735081|NCT01474239|562129247|FG001|Overall Study|Withdrawal by Subject|2|||
155735082|NCT01474239|562129246|FG000|Overall Study|Death|1|||
155735083|NCT01474239|562129247|FG001|Overall Study|Death|1|||
155735084|NCT01474239|562129246|FG000|Overall Study|Clinical Disease Progression|7|||
155735085|NCT01474239|562129247|FG001|Overall Study|Clinical Disease Progression|1|||
155735086|NCT01474239|562129246|FG000|Overall Study|Withdrawal for Economic Reason|1|||
155735087|NCT01474239|562129247|FG001|Overall Study|Withdrawal for Economic Reason|0|||
155735088|NCT00854113|562129251|FG000|Overall Study|Adverse Event|0|||
155735089|NCT00854113|562129252|FG001|Overall Study|Adverse Event|0|||
155735090|NCT00854113|562129253|FG002|Overall Study|Adverse Event|0|||
155735091|NCT00854113|562129254|FG003|Overall Study|Adverse Event|0|||
155735092|NCT00854113|562129255|FG004|Overall Study|Adverse Event|0|||
155735093|NCT00854113|562129256|FG005|Overall Study|Adverse Event|0|||
155735094|NCT00854113|562129257|FG006|Overall Study|Adverse Event|0|||
155735095|NCT00854113|562129258|FG007|Overall Study|Adverse Event|2|||
155735096|NCT00854113|562129259|FG008|Overall Study|Adverse Event|0|||
155735097|NCT00854113|562129260|FG009|Overall Study|Adverse Event|0|||
155735098|NCT00854113|562129261|FG010|Overall Study|Adverse Event|0|||
155735099|NCT00854113|562129251|FG000|Overall Study|Withdrawal by Subject|0|||
155735100|NCT00854113|562129252|FG001|Overall Study|Withdrawal by Subject|0|||
155735101|NCT00854113|562129253|FG002|Overall Study|Withdrawal by Subject|0|||
155735102|NCT00854113|562129254|FG003|Overall Study|Withdrawal by Subject|0|||
155735103|NCT00854113|562129255|FG004|Overall Study|Withdrawal by Subject|0|||
155735104|NCT00854113|562129256|FG005|Overall Study|Withdrawal by Subject|0|||
155632471|NCT01294046|561747718|FG000|Overall Study|Infection and surgical explant|1|||
155632472|NCT01294046|561747718|FG000|Overall Study|Eligibility criteria expanded|1|||
155632473|NCT01294046|561747718|FG000|Overall Study|Stimulation response inadqequate|1|||
155632474|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
155632475|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
155632476|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
155632477|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
155632478|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
155632479|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
155632480|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
155632481|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
155632482|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
155632483|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
155632484|NCT03979313|561747719|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
155632485|NCT03979313|561747720|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
155632486|NCT03979313|561747719|FG000|All Subjects|Any Other Reason|16|||
155632487|NCT03979313|561747720|FG001|All Subjects|Any Other Reason|23|||
155632488|NCT03979313|561747719|FG000|All Subjects|Covid-19|1|||
155632489|NCT03979313|561747720|FG001|All Subjects|Covid-19|3|||
155632490|NCT03979313|561747719|FG000|All Subjects|Withdrawal by Subject|35|||
155632491|NCT03979313|561747720|FG001|All Subjects|Withdrawal by Subject|44|||
155632492|NCT03979313|561747719|FG000|All Subjects|Death|0|||
155632493|NCT03979313|561747720|FG001|All Subjects|Death|5|||
155632494|NCT03979313|561747719|FG000|All Subjects|Lost to Follow-up|28|||
155632495|NCT03979313|561747720|FG001|All Subjects|Lost to Follow-up|61|||
155632496|NCT03183908|561747721|FG000|Overall Study|Missing Symptom Diary Data|0|||
155632497|NCT03183908|561747722|FG001|Overall Study|Missing Symptom Diary Data|2|||
155632498|NCT03738696|561747723|FG000|Overall Study|Withdrawal by Subject|0|||
155632499|NCT03738696|561747724|FG001|Overall Study|Withdrawal by Subject|1|||
155632500|NCT03738696|561747723|FG000|Overall Study|Lost to Follow-up|8|||
155632501|NCT03738696|561747724|FG001|Overall Study|Lost to Follow-up|14|||
155632502|NCT01712178|561747725|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
155632503|NCT01712178|561747726|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
155735105|NCT00854113|562129257|FG006|Overall Study|Withdrawal by Subject|0|||
155735106|NCT00854113|562129258|FG007|Overall Study|Withdrawal by Subject|1|||
155632504|NCT01712178|561747725|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
155632505|NCT01712178|561747726|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
155735107|NCT00854113|562129259|FG008|Overall Study|Withdrawal by Subject|1|||
155735108|NCT00854113|562129260|FG009|Overall Study|Withdrawal by Subject|0|||
155735109|NCT00854113|562129261|FG010|Overall Study|Withdrawal by Subject|0|||
155735110|NCT00796419|562129263|FG000|Overall Study|Death|0|||
155735111|NCT00796419|562129264|FG001|Overall Study|Death|1|||
155735112|NCT00539864|562129265|FG000|Overall Study|Lost to Follow-up|0|||
155735113|NCT00539864|562129266|FG001|Overall Study|Lost to Follow-up|1|||
155735114|NCT00539864|562129265|FG000|Overall Study|Withdrawal by Subject|1|||
155735115|NCT00539864|562129266|FG001|Overall Study|Withdrawal by Subject|1|||
155632506|NCT01712178|561747725|FG000|Overall Study|Lost to Follow-up|0|||
155735116|NCT01250145|562129267|FG000|Overall Study|Adverse Event|2|||
155735117|NCT01250145|562129268|FG001|Overall Study|Adverse Event|1|||
155735118|NCT01250145|562129267|FG000|Overall Study|Withdrawal by Subject|0|||
155735119|NCT01250145|562129268|FG001|Overall Study|Withdrawal by Subject|4|||
155735120|NCT02840799|562129271|FG000|Phase 1|Physician Decision|1|||
155735121|NCT02840799|562129272|FG001|Phase 1|Physician Decision|3|||
155735122|NCT02840799|562129271|FG000|Phase 1|Withdrawal by Subject|4|||
155735123|NCT02840799|562129272|FG001|Phase 1|Withdrawal by Subject|0|||
155735124|NCT02840799|562129271|FG000|Phase 2 (Crossover)|Adverse Event|0|||
155735125|NCT02840799|562129272|FG001|Phase 2 (Crossover)|Adverse Event|1|||
155735126|NCT02840799|562129271|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
155735127|NCT02840799|562129272|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
155735128|NCT02687191|562129276|FG000|Overall Study|Death|0|||
155735129|NCT02687191|562129277|FG001|Overall Study|Death|1|||
155735130|NCT02687191|562129278|FG002|Overall Study|Death|1|||
155735131|NCT02687191|562129279|FG003|Overall Study|Death|0|||
155735132|NCT02687191|562129280|FG004|Overall Study|Death|1|||
155735133|NCT02687191|562129281|FG005|Overall Study|Death|1|||
155735134|NCT02687191|562129276|FG000|Overall Study|Withdrawal by Subject|0|||
155735135|NCT02687191|562129277|FG001|Overall Study|Withdrawal by Subject|0|||
155735136|NCT02687191|562129278|FG002|Overall Study|Withdrawal by Subject|0|||
155735137|NCT02687191|562129279|FG003|Overall Study|Withdrawal by Subject|1|||
155735138|NCT02687191|562129280|FG004|Overall Study|Withdrawal by Subject|0|||
155735139|NCT02687191|562129281|FG005|Overall Study|Withdrawal by Subject|0|||
155735140|NCT00943072|562129282|FG000|Overall Study|Adverse Event|0|||
155735141|NCT00943072|562129283|FG001|Overall Study|Adverse Event|3|||
155735142|NCT00943072|562129282|FG000|Overall Study|Death|0|||
155735143|NCT00943072|562129283|FG001|Overall Study|Death|2|||
155735144|NCT00943072|562129282|FG000|Overall Study|Withdrawal by Subject|3|||
155735145|NCT00943072|562129283|FG001|Overall Study|Withdrawal by Subject|1|||
155735146|NCT00943072|562129282|FG000|Overall Study|Protocol Violation|0|||
155735147|NCT00943072|562129283|FG001|Overall Study|Protocol Violation|1|||
155735148|NCT00943072|562129282|FG000|Overall Study|Lost to Follow-up|1|||
155735149|NCT00943072|562129283|FG001|Overall Study|Lost to Follow-up|2|||
155632507|NCT01712178|561747726|FG001|Overall Study|Lost to Follow-up|1|||
155632508|NCT05001620|561747727|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
155632509|NCT05001620|561747728|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
155632510|NCT00819039|561747729|FG000|Overall Study|Physician Decision|1|||
155632511|NCT00819039|561747730|FG001|Overall Study|Physician Decision|0|||
155632512|NCT00819039|561747731|FG002|Overall Study|Physician Decision|1|||
155632513|NCT00819039|561747729|FG000|Overall Study|Protocol Violation|1|||
155632514|NCT00819039|561747730|FG001|Overall Study|Protocol Violation|0|||
155632515|NCT00819039|561747731|FG002|Overall Study|Protocol Violation|0|||
155632516|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
155632517|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
155632518|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
155632519|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
155632520|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
155632521|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
155632522|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
155632523|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
155632524|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
155632525|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
155632526|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Death|3|||
155632527|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Death|1|||
155632528|NCT01056276|561747732|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
155632529|NCT01056276|561747733|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
155632530|NCT01056276|561747732|FG000|Maintenance Therapy|Toxicity|0|||
155632531|NCT01056276|561747733|FG001|Maintenance Therapy|Toxicity|2|||
155632532|NCT01056276|561747732|FG000|Maintenance Therapy|Progressive Disease|0|||
155632533|NCT01056276|561747733|FG001|Maintenance Therapy|Progressive Disease|9|||
155632534|NCT01056276|561747732|FG000|Maintenance Therapy|Physician Decision|0|||
155632535|NCT01056276|561747733|FG001|Maintenance Therapy|Physician Decision|1|||
155632536|NCT01056276|561747732|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
155632537|NCT01056276|561747733|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
155632538|NCT01056276|561747732|FG000|Maintenance Therapy|Intercurrent Illness|0|||
155632539|NCT01056276|561747733|FG001|Maintenance Therapy|Intercurrent Illness|1|||
155632540|NCT01056276|561747732|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
155735150|NCT00943072|562129282|FG000|Overall Study|Lack of Efficacy|0|||
155735151|NCT00943072|562129283|FG001|Overall Study|Lack of Efficacy|4|||
155735152|NCT00943072|562129282|FG000|Overall Study|Other|1|||
155735153|NCT00943072|562129283|FG001|Overall Study|Other|1|||
155735154|NCT01349049|562129284|FG000|Overall Study|Disease progression|3|||
155735155|NCT01349049|562129285|FG001|Overall Study|Disease progression|5|||
155735156|NCT01349049|562129286|FG002|Overall Study|Disease progression|3|||
155735157|NCT01349049|562129287|FG003|Overall Study|Disease progression|2|||
155735158|NCT01349049|562129288|FG004|Overall Study|Disease progression|2|||
155735159|NCT01349049|562129289|FG005|Overall Study|Disease progression|2|||
155735160|NCT01349049|562129290|FG006|Overall Study|Disease progression|3|||
155735161|NCT01349049|562129291|FG007|Overall Study|Disease progression|2|||
155735162|NCT01349049|562129292|FG008|Overall Study|Disease progression|33|||
155735163|NCT01349049|562129284|FG000|Overall Study|Adverse Event|0|||
155735164|NCT01349049|562129285|FG001|Overall Study|Adverse Event|1|||
155735165|NCT01349049|562129286|FG002|Overall Study|Adverse Event|0|||
155735166|NCT01349049|562129287|FG003|Overall Study|Adverse Event|0|||
155735167|NCT01349049|562129288|FG004|Overall Study|Adverse Event|0|||
155735168|NCT01349049|562129289|FG005|Overall Study|Adverse Event|3|||
155735169|NCT01349049|562129290|FG006|Overall Study|Adverse Event|1|||
155735170|NCT01349049|562129291|FG007|Overall Study|Adverse Event|0|||
155735171|NCT01349049|562129292|FG008|Overall Study|Adverse Event|4|||
155735172|NCT01349049|562129284|FG000|Overall Study|Physician Decision|0|||
155735173|NCT01349049|562129285|FG001|Overall Study|Physician Decision|1|||
155735174|NCT01349049|562129286|FG002|Overall Study|Physician Decision|0|||
155735175|NCT01349049|562129287|FG003|Overall Study|Physician Decision|0|||
155735176|NCT01349049|562129288|FG004|Overall Study|Physician Decision|0|||
155735177|NCT01349049|562129289|FG005|Overall Study|Physician Decision|0|||
155735178|NCT01349049|562129290|FG006|Overall Study|Physician Decision|0|||
155735179|NCT01349049|562129291|FG007|Overall Study|Physician Decision|0|||
155735180|NCT01349049|562129292|FG008|Overall Study|Physician Decision|2|||
155735181|NCT01349049|562129284|FG000|Overall Study|Protocol Violation|0|||
155735182|NCT01349049|562129285|FG001|Overall Study|Protocol Violation|0|||
155735183|NCT01349049|562129286|FG002|Overall Study|Protocol Violation|0|||
155735184|NCT01349049|562129287|FG003|Overall Study|Protocol Violation|0|||
155735185|NCT01349049|562129288|FG004|Overall Study|Protocol Violation|0|||
155735186|NCT01349049|562129289|FG005|Overall Study|Protocol Violation|0|||
155735187|NCT01349049|562129290|FG006|Overall Study|Protocol Violation|0|||
155735188|NCT01349049|562129291|FG007|Overall Study|Protocol Violation|0|||
155735189|NCT01349049|562129292|FG008|Overall Study|Protocol Violation|1|||
155735190|NCT01349049|562129284|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
155735191|NCT01349049|562129285|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
155735192|NCT01349049|562129286|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
155735193|NCT01349049|562129287|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
155735194|NCT01349049|562129288|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
155735195|NCT01349049|562129289|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
155735196|NCT01349049|562129290|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
155735197|NCT01349049|562129291|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
155735198|NCT01349049|562129292|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
155735199|NCT01349049|562129284|FG000|Overall Study|Other|0|||
155735200|NCT01349049|562129285|FG001|Overall Study|Other|0|||
155735201|NCT01349049|562129286|FG002|Overall Study|Other|0|||
155735202|NCT01349049|562129287|FG003|Overall Study|Other|0|||
155735203|NCT01349049|562129288|FG004|Overall Study|Other|0|||
155735204|NCT01349049|562129289|FG005|Overall Study|Other|1|||
155735205|NCT01349049|562129290|FG006|Overall Study|Other|0|||
155735206|NCT01349049|562129291|FG007|Overall Study|Other|0|||
155735207|NCT01349049|562129292|FG008|Overall Study|Other|4|||
155735208|NCT01349049|562129284|FG000|Overall Study|Death|0|||
155735209|NCT01349049|562129285|FG001|Overall Study|Death|0|||
155735210|NCT01349049|562129286|FG002|Overall Study|Death|0|||
155735211|NCT01349049|562129287|FG003|Overall Study|Death|0|||
155735212|NCT01349049|562129288|FG004|Overall Study|Death|0|||
155735213|NCT01349049|562129289|FG005|Overall Study|Death|0|||
155735214|NCT01349049|562129290|FG006|Overall Study|Death|0|||
155735215|NCT01349049|562129291|FG007|Overall Study|Death|1|||
155735216|NCT01349049|562129292|FG008|Overall Study|Death|5|||
155735217|NCT01349049|562129284|FG000|Overall Study|Non-compliance|0|||
155735218|NCT01349049|562129285|FG001|Overall Study|Non-compliance|0|||
155735219|NCT01349049|562129286|FG002|Overall Study|Non-compliance|0|||
155735220|NCT01349049|562129287|FG003|Overall Study|Non-compliance|1|||
155735221|NCT01349049|562129288|FG004|Overall Study|Non-compliance|0|||
155735222|NCT01349049|562129289|FG005|Overall Study|Non-compliance|0|||
155735223|NCT01349049|562129290|FG006|Overall Study|Non-compliance|0|||
155735224|NCT01349049|562129291|FG007|Overall Study|Non-compliance|0|||
155735225|NCT01349049|562129292|FG008|Overall Study|Non-compliance|0|||
155735226|NCT01349049|562129284|FG000|Overall Study|Withdrawal by Subject|0|||
155735227|NCT01349049|562129285|FG001|Overall Study|Withdrawal by Subject|0|||
155735228|NCT01349049|562129286|FG002|Overall Study|Withdrawal by Subject|0|||
155735229|NCT01349049|562129287|FG003|Overall Study|Withdrawal by Subject|0|||
155735230|NCT01349049|562129288|FG004|Overall Study|Withdrawal by Subject|0|||
155735231|NCT01349049|562129289|FG005|Overall Study|Withdrawal by Subject|0|||
155735232|NCT01349049|562129290|FG006|Overall Study|Withdrawal by Subject|0|||
155735233|NCT01349049|562129291|FG007|Overall Study|Withdrawal by Subject|0|||
155735234|NCT01349049|562129292|FG008|Overall Study|Withdrawal by Subject|6|||
155735235|NCT01675544|562129295|FG000|Overall Study|Withdrawal by Subject|2|||
155735236|NCT00505778|562129296|FG000|Overall Study|Adverse Event|2|||
155735237|NCT00505778|562129297|FG001|Overall Study|Adverse Event|7|||
155735238|NCT00505778|562129296|FG000|Overall Study|Physician Decision|8|||
155393385|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
155393386|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
155393387|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
155393388|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
155393389|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
155393390|NCT02906787|560874949|FG000|Overall Study|Withdrawal by Subject|12|||
155393391|NCT02906787|560874950|FG001|Overall Study|Withdrawal by Subject|10|||
155393392|NCT02906787|560874949|FG000|Overall Study|Missed|24|||
155393393|NCT02906787|560874950|FG001|Overall Study|Missed|22|||
155393394|NCT03901053|560874955|FG000|Overall Study|Lost to Follow-up|6|||
155393395|NCT03901053|560874956|FG001|Overall Study|Lost to Follow-up|2|||
155393396|NCT03901053|560874955|FG000|Overall Study|Withdrawal by Subject|4|||
155393397|NCT03901053|560874956|FG001|Overall Study|Withdrawal by Subject|3|||
155393398|NCT03901053|560874955|FG000|Overall Study|Unsatisfactory Device|1|||
155393399|NCT03901053|560874956|FG001|Overall Study|Unsatisfactory Device|2|||
155393400|NCT03901053|560874955|FG000|Overall Study|No longer meets study criteria|1|||
155393401|NCT03901053|560874956|FG001|Overall Study|No longer meets study criteria|3|||
155393402|NCT03901053|560874955|FG000|Overall Study|Subject's Medical Status|0|||
155393403|NCT03901053|560874956|FG001|Overall Study|Subject's Medical Status|1|||
155393404|NCT03901053|560874955|FG000|Overall Study|Screening Failure|1|||
155393405|NCT03901053|560874956|FG001|Overall Study|Screening Failure|0|||
155393406|NCT02113579|560876726|FG000|Overall Study|Adverse Event|1|||
155393407|NCT02113579|560876727|FG001|Overall Study|Adverse Event|0|||
155393408|NCT02113579|560876726|FG000|Overall Study|Withdrawal by Subject|3|||
155393409|NCT02113579|560876727|FG001|Overall Study|Withdrawal by Subject|2|||
155632541|NCT01056276|561747733|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
155632542|NCT04154956|561747738|FG000|Overall Study|Death|109|||
155632543|NCT04154956|561747739|FG001|Overall Study|Death|110|||
155632544|NCT04154956|561747738|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
155632545|NCT04154956|561747739|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
155632546|NCT04154956|561747738|FG000|Overall Study|Withdrawal by Subject|1|||
155632547|NCT04154956|561747739|FG001|Overall Study|Withdrawal by Subject|7|||
155632548|NCT04154956|561747738|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
155632549|NCT04154956|561747739|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
155632550|NCT04424901|561747740|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
155632551|NCT04424901|561747741|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
155632552|NCT00147238|561747742|FG000|Overall Study|Inevaluable|8|||
155632553|NCT01348269|561747743|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
155632554|NCT01348269|561747744|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
155632555|NCT01348269|561747743|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
155632556|NCT01348269|561747744|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
155632557|NCT01348269|561747743|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
155632558|NCT01348269|561747744|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
155632559|NCT00805532|561747745|FG000|Overall Study|invalid data|0|||
155632560|NCT00805532|561747746|FG001|Overall Study|invalid data|1|||
155632561|NCT01859741|561747747|FG000|Overall Study|Death|3|||
155632562|NCT01859741|561747748|FG001|Overall Study|Death|2|||
155632563|NCT01859741|561747749|FG002|Overall Study|Death|4|||
155632564|NCT01859741|561747750|FG003|Overall Study|Death|3|||
155632565|NCT01859741|561747751|FG004|Overall Study|Death|5|||
155632566|NCT01859741|561747752|FG005|Overall Study|Death|4|||
155632567|NCT01859741|561747753|FG006|Overall Study|Death|51|||
155632568|NCT01859741|561747754|FG007|Overall Study|Death|51|||
155632569|NCT01859741|561747747|FG000|Overall Study|Lost to Follow-up|0|||
155632570|NCT01859741|561747748|FG001|Overall Study|Lost to Follow-up|0|||
155632571|NCT01859741|561747749|FG002|Overall Study|Lost to Follow-up|0|||
155632572|NCT01859741|561747750|FG003|Overall Study|Lost to Follow-up|0|||
155632573|NCT01859741|561747751|FG004|Overall Study|Lost to Follow-up|0|||
155632574|NCT01859741|561747752|FG005|Overall Study|Lost to Follow-up|1|||
155632575|NCT01859741|561747753|FG006|Overall Study|Lost to Follow-up|0|||
155632576|NCT01859741|561747754|FG007|Overall Study|Lost to Follow-up|4|||
155632577|NCT01859741|561747747|FG000|Overall Study|Withdrawal by Subject|0|||
155632578|NCT01859741|561747748|FG001|Overall Study|Withdrawal by Subject|1|||
155632579|NCT01859741|561747749|FG002|Overall Study|Withdrawal by Subject|2|||
155632580|NCT01859741|561747750|FG003|Overall Study|Withdrawal by Subject|0|||
155632581|NCT01859741|561747751|FG004|Overall Study|Withdrawal by Subject|0|||
155632582|NCT01859741|561747752|FG005|Overall Study|Withdrawal by Subject|1|||
155632583|NCT01859741|561747753|FG006|Overall Study|Withdrawal by Subject|1|||
155632584|NCT01859741|561747754|FG007|Overall Study|Withdrawal by Subject|1|||
155632585|NCT01859741|561747747|FG000|Overall Study|Study Terminated by Sponsor|0|||
155632586|NCT01859741|561747748|FG001|Overall Study|Study Terminated by Sponsor|0|||
155632587|NCT01859741|561747749|FG002|Overall Study|Study Terminated by Sponsor|0|||
155632588|NCT01859741|561747750|FG003|Overall Study|Study Terminated by Sponsor|0|||
155632589|NCT01859741|561747751|FG004|Overall Study|Study Terminated by Sponsor|1|||
155632590|NCT01859741|561747752|FG005|Overall Study|Study Terminated by Sponsor|0|||
155393410|NCT02113579|560876726|FG000|Overall Study|Lost to Follow-up|6|||
155393411|NCT02113579|560876727|FG001|Overall Study|Lost to Follow-up|2|||
155393412|NCT00726622|560876728|FG000|Overall Study|Withdrawal by Subject|16|||
155393413|NCT00726622|560876729|FG001|Overall Study|Withdrawal by Subject|2|||
155393414|NCT00726622|560876728|FG000|Overall Study|Physician Decision|0|||
155393415|NCT00726622|560876729|FG001|Overall Study|Physician Decision|1|||
155393416|NCT00726622|560876728|FG000|Overall Study|Metastasis|2|||
155393417|NCT00726622|560876729|FG001|Overall Study|Metastasis|0|||
155393418|NCT02462928|560876730|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155393419|NCT02462928|560876731|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155393420|NCT02462928|560876732|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
155393421|NCT02462928|560876730|FG000|Overall Study|Adverse Event|47|||
155393422|NCT02462928|560876731|FG001|Overall Study|Adverse Event|51|||
155393423|NCT02462928|560876732|FG002|Overall Study|Adverse Event|25|||
155393424|NCT02462928|560876730|FG000|Overall Study|Lack of Efficacy|3|||
155393425|NCT02462928|560876731|FG001|Overall Study|Lack of Efficacy|8|||
155393426|NCT02462928|560876732|FG002|Overall Study|Lack of Efficacy|3|||
155393427|NCT02462928|560876730|FG000|Overall Study|Lost to Follow-up|4|||
155393428|NCT02462928|560876731|FG001|Overall Study|Lost to Follow-up|4|||
155393429|NCT02462928|560876732|FG002|Overall Study|Lost to Follow-up|1|||
155393430|NCT02462928|560876730|FG000|Overall Study|Withdrawal by Patient|31|||
155393431|NCT02462928|560876731|FG001|Overall Study|Withdrawal by Patient|21|||
155393432|NCT02462928|560876732|FG002|Overall Study|Withdrawal by Patient|21|||
155393433|NCT02462928|560876730|FG000|Overall Study|Protocol Violation|0|||
155393434|NCT02462928|560876731|FG001|Overall Study|Protocol Violation|1|||
155393435|NCT02462928|560876732|FG002|Overall Study|Protocol Violation|0|||
155393436|NCT02462928|560876730|FG000|Overall Study|Reason not Specified|4|||
155393437|NCT02462928|560876731|FG001|Overall Study|Reason not Specified|6|||
155393438|NCT02462928|560876732|FG002|Overall Study|Reason not Specified|5|||
155393439|NCT00395863|560876733|FG000|Overall Study|Patients did not complete both exams|2|||
155393440|NCT00395863|560876734|FG001|Overall Study|Patients did not complete both exams|3|||
155393441|NCT03873493|560876735|FG000|Overall Study|Withdrawal by Subject|1|||
155393442|NCT03873493|560876735|FG000|Overall Study|Death|9|||
155393443|NCT03873493|560876735|FG000|Overall Study|Lost to Follow-up|1|||
155393444|NCT03873493|560876735|FG000|Overall Study|Study Terminated by Sponsor|1|||
155393445|NCT03873493|560876735|FG000|Overall Study|Other|2|||
155393446|NCT02973425|560876742|FG000|Overall Study|Lost to Follow-up|49|||
155393447|NCT02973425|560876743|FG001|Overall Study|Lost to Follow-up|53|||
155393448|NCT03503513|560876744|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
155393449|NCT03503513|560876744|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
155393450|NCT03503513|560876744|FG000|Overall Study|Physician Decision|3|||
155393451|NCT03503513|560876744|FG000|Overall Study|Withdrawal by Subject|2|||
155393452|NCT03503513|560876744|FG000|Overall Study|Lost to Follow-up|1|||
155393453|NCT01170039|560876745|FG000|Overall Study|Withdrawal by Subject|5|||
155393454|NCT01170039|560876746|FG001|Overall Study|Withdrawal by Subject|3|||
155393455|NCT01170039|560876745|FG000|Overall Study|Lack of funding, drug not available|3|||
155393456|NCT01170039|560876746|FG001|Overall Study|Lack of funding, drug not available|3|||
155393457|NCT02366728|560876749|FG000|Overall Study|Death|0|||
155393458|NCT02366728|560876750|FG001|Overall Study|Death|0|||
155393459|NCT02366728|560876751|FG002|Overall Study|Death|1|||
155393460|NCT02366728|560876749|FG000|Overall Study|Adverse Event|1|||
155393461|NCT02366728|560876750|FG001|Overall Study|Adverse Event|0|||
155393462|NCT02366728|560876751|FG002|Overall Study|Adverse Event|0|||
155393463|NCT02366728|560876749|FG000|Overall Study|Screen Failure|2|||
155393464|NCT02366728|560876750|FG001|Overall Study|Screen Failure|1|||
155393465|NCT02366728|560876751|FG002|Overall Study|Screen Failure|0|||
155393466|NCT02366728|560876749|FG000|Overall Study|Only yielded 2 vaccines|1|||
155393467|NCT02366728|560876750|FG001|Overall Study|Only yielded 2 vaccines|0|||
155393468|NCT02366728|560876751|FG002|Overall Study|Only yielded 2 vaccines|0|||
155393469|NCT00059839|560876754|FG000|Overall Study|Death|1|||
155393470|NCT00059839|560876755|FG001|Overall Study|Death|1|||
155393471|NCT00059839|560876754|FG000|Overall Study|Lack of Efficacy|6|||
155393472|NCT00059839|560876755|FG001|Overall Study|Lack of Efficacy|5|||
155393473|NCT00059839|560876754|FG000|Overall Study|Lost to Follow-up|2|||
155393474|NCT00059839|560876755|FG001|Overall Study|Lost to Follow-up|0|||
155393475|NCT00059839|560876754|FG000|Overall Study|Physician Decision|1|||
155735239|NCT00505778|562129297|FG001|Overall Study|Physician Decision|14|||
155735240|NCT00505778|562129296|FG000|Overall Study|Lost to Follow-up|17|||
155735241|NCT00505778|562129297|FG001|Overall Study|Lost to Follow-up|23|||
155735242|NCT00505778|562129296|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
155735243|NCT00505778|562129297|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
155735244|NCT00505778|562129296|FG000|Overall Study|Protocol Violation|7|||
155735245|NCT00505778|562129297|FG001|Overall Study|Protocol Violation|9|||
155735246|NCT00505778|562129296|FG000|Overall Study|Withdrawal by Subject|29|||
155735247|NCT00505778|562129297|FG001|Overall Study|Withdrawal by Subject|14|||
155393476|NCT00059839|560876755|FG001|Overall Study|Physician Decision|2|||
155735248|NCT00505778|562129296|FG000|Overall Study|Relapse|65|||
155735249|NCT00505778|562129297|FG001|Overall Study|Relapse|65|||
155393477|NCT00059839|560876754|FG000|Overall Study|Withdrawal by Subject|1|||
155393478|NCT00059839|560876755|FG001|Overall Study|Withdrawal by Subject|6|||
155393479|NCT00059839|560876754|FG000|Overall Study|Ineligible|1|||
155393480|NCT00059839|560876755|FG001|Overall Study|Ineligible|3|||
155393481|NCT01187550|560876756|FG000|Overall Study|Protocol Violation|3|||
155632591|NCT01859741|561747753|FG006|Overall Study|Study Terminated by Sponsor|16|||
155632592|NCT01859741|561747754|FG007|Overall Study|Study Terminated by Sponsor|14|||
155632593|NCT01859741|561747747|FG000|Overall Study|Other|0|||
155632594|NCT01859741|561747748|FG001|Overall Study|Other|0|||
155632595|NCT01859741|561747749|FG002|Overall Study|Other|0|||
155632596|NCT01859741|561747750|FG003|Overall Study|Other|0|||
155632597|NCT01859741|561747751|FG004|Overall Study|Other|0|||
155632598|NCT01859741|561747752|FG005|Overall Study|Other|0|||
155632599|NCT01859741|561747753|FG006|Overall Study|Other|2|||
155632600|NCT01859741|561747754|FG007|Overall Study|Other|0|||
155632601|NCT02412657|561747755|FG000|Overall Study|Lost to Follow-up|1|||
155632602|NCT02412657|561747756|FG001|Overall Study|Lost to Follow-up|0|||
155632603|NCT02412657|561747757|FG002|Overall Study|Lost to Follow-up|0|||
155632604|NCT02412657|561747755|FG000|Overall Study|Protocol Violation|0|||
155632605|NCT02412657|561747756|FG001|Overall Study|Protocol Violation|2|||
155632606|NCT02412657|561747757|FG002|Overall Study|Protocol Violation|3|||
155632607|NCT03185208|561747761|FG000|Overall Study|Did not start study medication|0|||
155632608|NCT03185208|561747762|FG001|Overall Study|Did not start study medication|3|||
155632609|NCT03834350|561747763|FG000|Overall Study|Withdrawal by Subject|1|||
155632610|NCT04009837|561747764|FG000|Overall Study|Withdrawal by Subject|5|||
155632611|NCT04009837|561747765|FG001|Overall Study|Withdrawal by Subject|4|||
155632612|NCT04009837|561747764|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
155632613|NCT04009837|561747765|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
155632614|NCT05352815|561747767|FG000|Overall Study|Withdrawal by Subject|28|||
155632615|NCT05352815|561747768|FG001|Overall Study|Withdrawal by Subject|24|||
155632616|NCT05352815|561747767|FG000|Overall Study|Lost to Follow-up|4|||
155632617|NCT05352815|561747768|FG001|Overall Study|Lost to Follow-up|7|||
155632618|NCT05352815|561747767|FG000|Overall Study|Death|2|||
155632619|NCT05352815|561747768|FG001|Overall Study|Death|3|||
155632620|NCT05352815|561747767|FG000|Overall Study|Site closure|1|||
155632621|NCT05352815|561747768|FG001|Overall Study|Site closure|0|||
155632622|NCT00226655|561747769|FG000|Overall Study|Death|13|||
155632623|NCT00226655|561747769|FG000|Overall Study|Withdrawal by Subject|15|||
155632624|NCT00226655|561747769|FG000|Overall Study|Adverse Event|35|||
155632625|NCT00226655|561747769|FG000|Overall Study|Physician Decision|6|||
155632626|NCT00226655|561747769|FG000|Overall Study|Clinical deterioration|10|||
155632627|NCT05144945|561747770|FG000|Overall Study|Withdrawal by Subject|1|||
155632628|NCT05144945|561747771|FG001|Overall Study|Withdrawal by Subject|0|||
155632629|NCT02855268|561747772|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
155632630|NCT02855268|561747773|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
155632631|NCT02855268|561747772|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
155632632|NCT02855268|561747773|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
155632633|NCT02855268|561747772|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
155632634|NCT02855268|561747773|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
155632635|NCT02855268|561747772|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
155632636|NCT02855268|561747773|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
155632637|NCT02855268|561747772|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
155632638|NCT02855268|561747773|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
155632639|NCT02855268|561747772|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
155632640|NCT02855268|561747773|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
155632641|NCT00465517|561747774|FG000|Overall Study|Adverse Event|7|||
155632642|NCT00465517|561747775|FG001|Overall Study|Adverse Event|3|||
155632643|NCT00465517|561747774|FG000|Overall Study|Lost to Follow-up|1|||
155632644|NCT00465517|561747775|FG001|Overall Study|Lost to Follow-up|0|||
155632645|NCT00465517|561747774|FG000|Overall Study|Withdrawal by Subject|4|||
155632646|NCT00465517|561747775|FG001|Overall Study|Withdrawal by Subject|1|||
155632647|NCT00289276|561747788|FG000|Second Part of FAST Study (Expansion)|Death|0|||
155632648|NCT00289276|561747789|FG001|Second Part of FAST Study (Expansion)|Death|2|||
155632649|NCT00289276|561747788|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
155632650|NCT00289276|561747789|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
155632651|NCT00726609|561747790|FG000|Overall Study|Adverse Event|10|||
155632652|NCT00726609|561747790|FG000|Overall Study|Withdrawal by Subject|2|||
155632653|NCT00726609|561747790|FG000|Overall Study|Lack of Efficacy|25|||
155632654|NCT00726609|561747790|FG000|Overall Study|Other|16|||
155632655|NCT00726609|561747790|FG000|Overall Study|Missing|42|||
155632656|NCT00726609|561747790|FG000|Overall Study|Other|3|||
155632657|NCT00746551|561747796|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
155632658|NCT00746551|561747797|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
155632659|NCT00746551|561747796|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
155632660|NCT00746551|561747797|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
155632661|NCT00746551|561747796|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
155735250|NCT00505778|562129296|FG000|Overall Study|Took No Study Drug|2|||
155735251|NCT00505778|562129297|FG001|Overall Study|Took No Study Drug|2|||
155735252|NCT03790696|562129299|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
155735253|NCT03790696|562129300|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
155735254|NCT00243269|562129305|FG000|Overall Study|Protocol Violation|2|||
155735255|NCT00243269|562129306|FG001|Overall Study|Protocol Violation|1|||
155735256|NCT00243269|562129307|FG002|Overall Study|Protocol Violation|0|||
155735257|NCT00243269|562129308|FG003|Overall Study|Protocol Violation|1|||
155735258|NCT00243269|562129305|FG000|Overall Study|Lost to Follow-up|1|||
155735259|NCT00243269|562129306|FG001|Overall Study|Lost to Follow-up|0|||
155735260|NCT00243269|562129307|FG002|Overall Study|Lost to Follow-up|1|||
155735261|NCT00243269|562129308|FG003|Overall Study|Lost to Follow-up|3|||
155735262|NCT00485134|562129311|FG000|Overall Study|Lost to Follow-up|1|||
155735263|NCT00485134|562129312|FG001|Overall Study|Lost to Follow-up|0|||
155735264|NCT00485134|562129313|FG002|Overall Study|Lost to Follow-up|0|||
155735265|NCT00485134|562129314|FG003|Overall Study|Lost to Follow-up|0|||
155735266|NCT00485134|562129315|FG004|Overall Study|Lost to Follow-up|0|||
155735267|NCT00485134|562129316|FG005|Overall Study|Lost to Follow-up|0|||
155735268|NCT00485134|562129317|FG006|Overall Study|Lost to Follow-up|0|||
155735269|NCT00485134|562129318|FG007|Overall Study|Lost to Follow-up|0|||
155735270|NCT00485134|562129311|FG000|Overall Study|Withdrawal by Subject|0|||
155735271|NCT00485134|562129312|FG001|Overall Study|Withdrawal by Subject|1|||
155735272|NCT00485134|562129313|FG002|Overall Study|Withdrawal by Subject|0|||
155735273|NCT00485134|562129314|FG003|Overall Study|Withdrawal by Subject|0|||
155735274|NCT00485134|562129315|FG004|Overall Study|Withdrawal by Subject|0|||
155735275|NCT00485134|562129316|FG005|Overall Study|Withdrawal by Subject|0|||
155735276|NCT00485134|562129317|FG006|Overall Study|Withdrawal by Subject|0|||
155735277|NCT00485134|562129318|FG007|Overall Study|Withdrawal by Subject|0|||
155735278|NCT00485134|562129311|FG000|Overall Study|Change in health status|0|||
155735279|NCT00485134|562129312|FG001|Overall Study|Change in health status|1|||
155735280|NCT00485134|562129313|FG002|Overall Study|Change in health status|2|||
155735281|NCT00485134|562129314|FG003|Overall Study|Change in health status|1|||
155735282|NCT00485134|562129315|FG004|Overall Study|Change in health status|0|||
155735283|NCT00485134|562129316|FG005|Overall Study|Change in health status|1|||
155735284|NCT00485134|562129317|FG006|Overall Study|Change in health status|0|||
155735285|NCT00485134|562129318|FG007|Overall Study|Change in health status|0|||
155735286|NCT00485134|562129311|FG000|Overall Study|Withdrew for adverse event|0|||
155735287|NCT00485134|562129312|FG001|Overall Study|Withdrew for adverse event|0|||
155735288|NCT00485134|562129313|FG002|Overall Study|Withdrew for adverse event|1|||
155735289|NCT00485134|562129314|FG003|Overall Study|Withdrew for adverse event|0|||
155735290|NCT00485134|562129315|FG004|Overall Study|Withdrew for adverse event|0|||
155735291|NCT00485134|562129316|FG005|Overall Study|Withdrew for adverse event|0|||
155735292|NCT00485134|562129317|FG006|Overall Study|Withdrew for adverse event|0|||
155735293|NCT00485134|562129318|FG007|Overall Study|Withdrew for adverse event|0|||
155735294|NCT00485134|562129311|FG000|Overall Study|Positive drug test|0|||
155735295|NCT00485134|562129312|FG001|Overall Study|Positive drug test|0|||
155735296|NCT00485134|562129313|FG002|Overall Study|Positive drug test|0|||
155735297|NCT00485134|562129314|FG003|Overall Study|Positive drug test|0|||
155735298|NCT00485134|562129315|FG004|Overall Study|Positive drug test|2|||
155735299|NCT00485134|562129316|FG005|Overall Study|Positive drug test|1|||
155735300|NCT00485134|562129317|FG006|Overall Study|Positive drug test|0|||
155735301|NCT00485134|562129318|FG007|Overall Study|Positive drug test|0|||
155735302|NCT00485134|562129311|FG000|Overall Study|Non-compliance|0|||
155735303|NCT00485134|562129312|FG001|Overall Study|Non-compliance|0|||
155735304|NCT00485134|562129313|FG002|Overall Study|Non-compliance|0|||
155735305|NCT00485134|562129314|FG003|Overall Study|Non-compliance|0|||
155735306|NCT00485134|562129315|FG004|Overall Study|Non-compliance|1|||
155735307|NCT00485134|562129316|FG005|Overall Study|Non-compliance|2|||
155735308|NCT00485134|562129317|FG006|Overall Study|Non-compliance|2|||
155735309|NCT00485134|562129318|FG007|Overall Study|Non-compliance|0|||
155735310|NCT00485134|562129311|FG000|Overall Study|Unable to comply with study schedule|0|||
155735311|NCT00485134|562129312|FG001|Overall Study|Unable to comply with study schedule|0|||
155735312|NCT00485134|562129313|FG002|Overall Study|Unable to comply with study schedule|0|||
155735313|NCT00485134|562129314|FG003|Overall Study|Unable to comply with study schedule|0|||
155735314|NCT00485134|562129315|FG004|Overall Study|Unable to comply with study schedule|0|||
155735315|NCT00485134|562129316|FG005|Overall Study|Unable to comply with study schedule|0|||
155735316|NCT00485134|562129317|FG006|Overall Study|Unable to comply with study schedule|0|||
155735317|NCT00485134|562129318|FG007|Overall Study|Unable to comply with study schedule|1|||
155735318|NCT00485134|562129311|FG000|Overall Study|Pregnancy|0|||
155735319|NCT00485134|562129312|FG001|Overall Study|Pregnancy|0|||
155735320|NCT00485134|562129313|FG002|Overall Study|Pregnancy|0|||
155735321|NCT00485134|562129314|FG003|Overall Study|Pregnancy|0|||
155735322|NCT00485134|562129315|FG004|Overall Study|Pregnancy|0|||
155735323|NCT00485134|562129316|FG005|Overall Study|Pregnancy|0|||
155735324|NCT00485134|562129317|FG006|Overall Study|Pregnancy|1|||
155735325|NCT00485134|562129318|FG007|Overall Study|Pregnancy|0|||
155735326|NCT00970684|562129319|FG000|Overall Study|Lack of Efficacy|5|||
155735327|NCT00970684|562129319|FG000|Overall Study|Adverse Event|4|||
155735328|NCT00970684|562129319|FG000|Overall Study|Withdrawal by Subject|1|||
155735329|NCT01175083|562129320|FG000|Primary Epoch|Withdrawal by Subject|0|||
155735330|NCT01175083|562129321|FG001|Primary Epoch|Withdrawal by Subject|0|||
155735331|NCT01175083|562129322|FG002|Primary Epoch|Withdrawal by Subject|0|||
155735332|NCT01175083|562129323|FG003|Primary Epoch|Withdrawal by Subject|0|||
155735333|NCT01175083|562129324|FG004|Primary Epoch|Withdrawal by Subject|0|||
155735334|NCT01175083|562129325|FG005|Primary Epoch|Withdrawal by Subject|2|||
155735335|NCT01175083|562129320|FG000|Primary Epoch|Lost to Follow-up|0|||
155735336|NCT01175083|562129321|FG001|Primary Epoch|Lost to Follow-up|0|||
155735337|NCT01175083|562129322|FG002|Primary Epoch|Lost to Follow-up|0|||
155735338|NCT01175083|562129323|FG003|Primary Epoch|Lost to Follow-up|0|||
155735339|NCT01175083|562129324|FG004|Primary Epoch|Lost to Follow-up|0|||
155735340|NCT01175083|562129325|FG005|Primary Epoch|Lost to Follow-up|1|||
155735341|NCT01175083|562129320|FG000|Booster Epoch|Death|0|||
155735342|NCT01175083|562129321|FG001|Booster Epoch|Death|0|||
155393482|NCT01187550|560876757|FG001|Overall Study|Protocol Violation|1|||
155393483|NCT01187550|560876756|FG000|Overall Study|Other|3|||
155393484|NCT01187550|560876757|FG001|Overall Study|Other|0|||
155393485|NCT01187550|560876756|FG000|Overall Study|Randomized but not treated|8|||
155393486|NCT01187550|560876757|FG001|Overall Study|Randomized but not treated|0|||
155393487|NCT00733304|560876758|FG000|Overall Study|Adverse Event|3|||
155632662|NCT00746551|561747797|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
155393488|NCT00733304|560876759|FG001|Overall Study|Adverse Event|0|||
155393489|NCT00733304|560876760|FG002|Overall Study|Adverse Event|0|||
155393490|NCT00733304|560876758|FG000|Overall Study|Lack of Efficacy|0|||
155393491|NCT00733304|560876759|FG001|Overall Study|Lack of Efficacy|0|||
155393492|NCT00733304|560876760|FG002|Overall Study|Lack of Efficacy|2|||
155393493|NCT00733304|560876758|FG000|Overall Study|Lost to Follow-up|0|||
155393494|NCT00733304|560876759|FG001|Overall Study|Lost to Follow-up|1|||
155393495|NCT00733304|560876760|FG002|Overall Study|Lost to Follow-up|0|||
155393496|NCT00733304|560876758|FG000|Overall Study|Physician Decision|3|||
155393497|NCT00733304|560876759|FG001|Overall Study|Physician Decision|1|||
155393498|NCT00733304|560876760|FG002|Overall Study|Physician Decision|3|||
155393499|NCT00733304|560876758|FG000|Overall Study|Withdrawal by Subject|1|||
155393500|NCT00733304|560876759|FG001|Overall Study|Withdrawal by Subject|1|||
155393501|NCT00733304|560876760|FG002|Overall Study|Withdrawal by Subject|0|||
155393502|NCT01330914|560876763|FG000|Overall Study|Withdrawal by Subject|4|||
155632663|NCT02029417|561747800|FG000|Overall Study|Death|1|||
155632664|NCT02029417|561747800|FG000|Overall Study|Adverse Event|1|||
155632665|NCT04458922|561747801|FG000|Overall Study|Withdrawal by Subject|1|||
155735343|NCT01175083|562129322|FG002|Booster Epoch|Death|1|||
155735344|NCT01175083|562129323|FG003|Booster Epoch|Death|0|||
155735345|NCT01175083|562129324|FG004|Booster Epoch|Death|0|||
155735346|NCT01175083|562129325|FG005|Booster Epoch|Death|0|||
155735347|NCT01175083|562129320|FG000|Booster Epoch|Withdrawal by Subject|0|||
155735348|NCT01175083|562129321|FG001|Booster Epoch|Withdrawal by Subject|0|||
155735349|NCT01175083|562129322|FG002|Booster Epoch|Withdrawal by Subject|0|||
155735350|NCT01175083|562129323|FG003|Booster Epoch|Withdrawal by Subject|1|||
155735351|NCT01175083|562129324|FG004|Booster Epoch|Withdrawal by Subject|0|||
155735352|NCT01175083|562129325|FG005|Booster Epoch|Withdrawal by Subject|0|||
155735353|NCT00481091|562129326|FG000|Overall Study|Withdrawal by Subject|0|||
155735354|NCT00481091|562129327|FG001|Overall Study|Withdrawal by Subject|1|||
155735355|NCT00481091|562129328|FG002|Overall Study|Withdrawal by Subject|1|||
155735356|NCT00481091|562129329|FG003|Overall Study|Withdrawal by Subject|0|||
155735357|NCT00481091|562129330|FG004|Overall Study|Withdrawal by Subject|0|||
155735358|NCT00481091|562129331|FG005|Overall Study|Withdrawal by Subject|0|||
155735359|NCT00481091|562129332|FG006|Overall Study|Withdrawal by Subject|0|||
155632666|NCT04458922|561747802|FG001|Overall Study|Withdrawal by Subject|0|||
155632667|NCT04458922|561747803|FG002|Overall Study|Withdrawal by Subject|2|||
155632668|NCT04458922|561747801|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
155632669|NCT04458922|561747802|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
155632670|NCT04458922|561747803|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
155632671|NCT04458922|561747801|FG000|Overall Study|Adverse Event|1|||
155632672|NCT04458922|561747802|FG001|Overall Study|Adverse Event|0|||
155632673|NCT04458922|561747803|FG002|Overall Study|Adverse Event|0|||
155735360|NCT00481091|562129333|FG007|Overall Study|Withdrawal by Subject|0|||
155393503|NCT01330914|560876763|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
155393504|NCT05352048|560876766|FG000|Overall Study|Lost to Follow-up|1|||
155735361|NCT00481091|562129334|FG008|Overall Study|Withdrawal by Subject|1|||
155735362|NCT00481091|562129335|FG009|Overall Study|Withdrawal by Subject|6|||
155735363|NCT00481091|562129326|FG000|Overall Study|Other, Not Specified|0|||
155735364|NCT00481091|562129327|FG001|Overall Study|Other, Not Specified|1|||
155735365|NCT00481091|562129328|FG002|Overall Study|Other, Not Specified|1|||
155735366|NCT00481091|562129329|FG003|Overall Study|Other, Not Specified|0|||
155735367|NCT00481091|562129330|FG004|Overall Study|Other, Not Specified|0|||
155735368|NCT00481091|562129331|FG005|Overall Study|Other, Not Specified|1|||
155735369|NCT00481091|562129332|FG006|Overall Study|Other, Not Specified|0|||
155735370|NCT00481091|562129333|FG007|Overall Study|Other, Not Specified|0|||
155735371|NCT00481091|562129334|FG008|Overall Study|Other, Not Specified|0|||
155735372|NCT00481091|562129335|FG009|Overall Study|Other, Not Specified|4|||
155735373|NCT00481091|562129326|FG000|Overall Study|Adverse Event|1|||
155735374|NCT00481091|562129327|FG001|Overall Study|Adverse Event|2|||
155735375|NCT00481091|562129328|FG002|Overall Study|Adverse Event|0|||
155735376|NCT00481091|562129329|FG003|Overall Study|Adverse Event|1|||
155393505|NCT05352048|560876766|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
155735377|NCT00481091|562129330|FG004|Overall Study|Adverse Event|1|||
155735378|NCT00481091|562129331|FG005|Overall Study|Adverse Event|1|||
155393506|NCT02308007|560876777|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
155393507|NCT02308007|560876778|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
155735379|NCT00481091|562129332|FG006|Overall Study|Adverse Event|2|||
155735380|NCT00481091|562129333|FG007|Overall Study|Adverse Event|1|||
155735381|NCT00481091|562129334|FG008|Overall Study|Adverse Event|1|||
155735382|NCT00481091|562129335|FG009|Overall Study|Adverse Event|6|||
155735383|NCT00481091|562129326|FG000|Overall Study|Progressive disease clinical|0|||
155735384|NCT00481091|562129327|FG001|Overall Study|Progressive disease clinical|0|||
155735385|NCT00481091|562129328|FG002|Overall Study|Progressive disease clinical|0|||
155735386|NCT00481091|562129329|FG003|Overall Study|Progressive disease clinical|0|||
155735387|NCT00481091|562129330|FG004|Overall Study|Progressive disease clinical|0|||
155735388|NCT00481091|562129331|FG005|Overall Study|Progressive disease clinical|0|||
155735389|NCT00481091|562129332|FG006|Overall Study|Progressive disease clinical|0|||
155735390|NCT00481091|562129333|FG007|Overall Study|Progressive disease clinical|0|||
155735391|NCT00481091|562129334|FG008|Overall Study|Progressive disease clinical|1|||
155735392|NCT00481091|562129335|FG009|Overall Study|Progressive disease clinical|7|||
155735393|NCT00481091|562129326|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155735394|NCT00481091|562129327|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155735395|NCT00481091|562129328|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735396|NCT00481091|562129329|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735397|NCT00481091|562129330|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735398|NCT00481091|562129331|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155735399|NCT00481091|562129332|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735400|NCT00481091|562129333|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735401|NCT00481091|562129334|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735402|NCT00481091|562129335|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155735403|NCT00481091|562129326|FG000|Overall Study|Progressive disease other|1|||
155735404|NCT00481091|562129327|FG001|Overall Study|Progressive disease other|1|||
155735405|NCT00481091|562129328|FG002|Overall Study|Progressive disease other|0|||
155735406|NCT00481091|562129329|FG003|Overall Study|Progressive disease other|1|||
155735407|NCT00481091|562129330|FG004|Overall Study|Progressive disease other|1|||
155735408|NCT00481091|562129331|FG005|Overall Study|Progressive disease other|1|||
155735409|NCT00481091|562129332|FG006|Overall Study|Progressive disease other|0|||
155735410|NCT00481091|562129333|FG007|Overall Study|Progressive disease other|2|||
155735411|NCT00481091|562129334|FG008|Overall Study|Progressive disease other|0|||
155735412|NCT00481091|562129335|FG009|Overall Study|Progressive disease other|0|||
155735413|NCT00481091|562129326|FG000|Overall Study|No reason given|0|||
155735414|NCT00481091|562129327|FG001|Overall Study|No reason given|0|||
155735415|NCT00481091|562129328|FG002|Overall Study|No reason given|1|||
155735416|NCT00481091|562129329|FG003|Overall Study|No reason given|1|||
155735417|NCT00481091|562129330|FG004|Overall Study|No reason given|1|||
155735418|NCT00481091|562129331|FG005|Overall Study|No reason given|0|||
155735419|NCT00481091|562129332|FG006|Overall Study|No reason given|1|||
155735420|NCT00481091|562129333|FG007|Overall Study|No reason given|1|||
155735421|NCT00481091|562129334|FG008|Overall Study|No reason given|1|||
155735422|NCT00481091|562129335|FG009|Overall Study|No reason given|4|||
155735423|NCT04294680|562129336|FG000|Overall Study|Withdrawal by Subject|2|||
155735424|NCT04294680|562129337|FG001|Overall Study|Withdrawal by Subject|1|||
155735425|NCT04294680|562129336|FG000|Overall Study|Follow-up visits completed outside of window|1|||
155735426|NCT04294680|562129337|FG001|Overall Study|Follow-up visits completed outside of window|0|||
155735427|NCT01386970|562129339|FG000|Overall Study|Withdrawal by Subject|0|||
155735428|NCT01386970|562129340|FG001|Overall Study|Withdrawal by Subject|1|||
155735429|NCT01386970|562129339|FG000|Overall Study|Adverse Event|4|||
155735430|NCT01386970|562129340|FG001|Overall Study|Adverse Event|1|||
155735431|NCT00578292|562129341|FG000|Overall Study|Death|1|||
155735432|NCT00578292|562129341|FG000|Overall Study|Graft failure|2|||
155735433|NCT02675634|562129342|FG000|Test Period 1|Adverse Event|0|||
155735434|NCT02675634|562129343|FG001|Test Period 1|Adverse Event|1|||
155735435|NCT02675634|562129344|FG002|Test Period 1|Adverse Event|0|||
155735436|NCT02675634|562129345|FG003|Test Period 1|Adverse Event|1|||
155735437|NCT02675634|562129346|FG004|Test Period 1|Adverse Event|0|||
155735438|NCT02675634|562129347|FG005|Test Period 1|Adverse Event|0|||
155632674|NCT04458922|561747801|FG000|Overall Study|Started new study|0|||
155632675|NCT04458922|561747802|FG001|Overall Study|Started new study|0|||
155632676|NCT04458922|561747803|FG002|Overall Study|Started new study|1|||
155632677|NCT04458922|561747801|FG000|Overall Study|Progressive disease|6|||
155632678|NCT04458922|561747802|FG001|Overall Study|Progressive disease|8|||
155632679|NCT04458922|561747803|FG002|Overall Study|Progressive disease|2|||
155632680|NCT04458922|561747801|FG000|Overall Study|Death|1|||
155632681|NCT04458922|561747802|FG001|Overall Study|Death|0|||
155632682|NCT04458922|561747803|FG002|Overall Study|Death|2|||
155632683|NCT04458922|561747801|FG000|Overall Study|Participant started chemotherapy|0|||
155632684|NCT04458922|561747802|FG001|Overall Study|Participant started chemotherapy|1|||
155632685|NCT04458922|561747803|FG002|Overall Study|Participant started chemotherapy|0|||
155632686|NCT04682301|561747805|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
155632687|NCT04682301|561747805|FG000|Overall Study|Death|2|||
155632688|NCT05219162|561747806|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
155632689|NCT05219162|561747806|FG000|Overall Study|Withdrawal by Subject|23|||
155632690|NCT02642042|561747813|FG000|Overall Study|Adverse Event|22|||
155632691|NCT02642042|561747813|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155632692|NCT02642042|561747813|FG000|Overall Study|Progression/Relapse|28|||
155632693|NCT02642042|561747813|FG000|Overall Study|Death|1|||
155632694|NCT02642042|561747813|FG000|Overall Study|Not Protocol Specified|2|||
155632695|NCT00392223|561747816|FG000|Overall Study|Adverse Event|5|||
155632696|NCT00392223|561747817|FG001|Overall Study|Adverse Event|4|||
155632697|NCT00392223|561747816|FG000|Overall Study|Lost to Follow-up|1|||
155632698|NCT00392223|561747817|FG001|Overall Study|Lost to Follow-up|4|||
155632699|NCT00392223|561747816|FG000|Overall Study|Protocol Violation|0|||
155632700|NCT00392223|561747817|FG001|Overall Study|Protocol Violation|3|||
155632701|NCT00392223|561747816|FG000|Overall Study|Withdrawal by Subject|3|||
155632702|NCT00392223|561747817|FG001|Overall Study|Withdrawal by Subject|2|||
155632703|NCT03344757|561747818|FG000|Overall Study|Withdrawal by Subject|18|||
155632704|NCT03344757|561747819|FG001|Overall Study|Withdrawal by Subject|16|||
155632705|NCT03344757|561747818|FG000|Overall Study|Lost to Follow-up|0|||
155632706|NCT03344757|561747819|FG001|Overall Study|Lost to Follow-up|2|||
155632707|NCT01316575|561747820|FG000|Overall Study|Withdrawal by Subject|2|||
155632708|NCT01316575|561747821|FG001|Overall Study|Withdrawal by Subject|0|||
155735439|NCT02675634|562129342|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
155735440|NCT02675634|562129343|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
155735441|NCT02675634|562129344|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
155735442|NCT02675634|562129345|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
155735443|NCT02675634|562129346|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
155735444|NCT02675634|562129347|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
155735445|NCT02675634|562129342|FG000|Test Period 2|Lack of Efficacy|1|||
155735446|NCT02675634|562129343|FG001|Test Period 2|Lack of Efficacy|0|||
155735447|NCT02675634|562129344|FG002|Test Period 2|Lack of Efficacy|0|||
155735448|NCT02675634|562129345|FG003|Test Period 2|Lack of Efficacy|0|||
155735449|NCT02675634|562129346|FG004|Test Period 2|Lack of Efficacy|0|||
155735450|NCT02675634|562129347|FG005|Test Period 2|Lack of Efficacy|0|||
155735451|NCT02675634|562129342|FG000|Test Period 2|Adverse Event|0|||
155735452|NCT02675634|562129343|FG001|Test Period 2|Adverse Event|0|||
155735453|NCT02675634|562129344|FG002|Test Period 2|Adverse Event|0|||
155735454|NCT02675634|562129345|FG003|Test Period 2|Adverse Event|0|||
155735455|NCT02675634|562129346|FG004|Test Period 2|Adverse Event|0|||
155735456|NCT02675634|562129347|FG005|Test Period 2|Adverse Event|1|||
155735457|NCT04380519|562129348|FG000|Overall Study|Withdrawal by Subject|4|||
155735458|NCT04380519|562129349|FG001|Overall Study|Withdrawal by Subject|0|||
155735459|NCT04380519|562129350|FG002|Overall Study|Withdrawal by Subject|1|||
155735460|NCT04380519|562129348|FG000|Overall Study|Death|14|||
155735461|NCT04380519|562129349|FG001|Overall Study|Death|9|||
155735462|NCT04380519|562129350|FG002|Overall Study|Death|6|||
155735463|NCT04380519|562129348|FG000|Overall Study|Adverse Event|0|||
155735464|NCT04380519|562129349|FG001|Overall Study|Adverse Event|1|||
155735465|NCT04380519|562129350|FG002|Overall Study|Adverse Event|0|||
155735466|NCT04380519|562129348|FG000|Overall Study|relatives' decision|0|||
155735467|NCT04380519|562129349|FG001|Overall Study|relatives' decision|1|||
155735468|NCT04380519|562129350|FG002|Overall Study|relatives' decision|0|||
155735469|NCT05300763|562129353|FG000|Overall Study|Adverse Event|0|||
155735470|NCT05300763|562129354|FG001|Overall Study|Adverse Event|1|||
155735471|NCT05300763|562129353|FG000|Overall Study|Major Protocol Deviation|1|||
155735472|NCT05300763|562129354|FG001|Overall Study|Major Protocol Deviation|0|||
155735473|NCT05300763|562129353|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
155735474|NCT05300763|562129354|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155735475|NCT01485172|562129355|FG000|Overall Study|Adverse Event|2|||
155735476|NCT01485172|562129356|FG001|Overall Study|Adverse Event|1|||
155735477|NCT01485172|562129357|FG002|Overall Study|Adverse Event|2|||
155735478|NCT01485172|562129358|FG003|Overall Study|Adverse Event|2|||
155735479|NCT01485172|562129359|FG004|Overall Study|Adverse Event|1|||
155735480|NCT01485172|562129360|FG005|Overall Study|Adverse Event|2|||
155735481|NCT01485172|562129355|FG000|Overall Study|Lack of Efficacy|2|||
155283117|NCT03251378|560468225|FG001|Overall Study|Lost to Follow-up|0|||
155283118|NCT03251378|560468226|FG002|Overall Study|Lost to Follow-up|1|||
155283119|NCT03251378|560468227|FG003|Overall Study|Lost to Follow-up|3|||
155283120|NCT03251378|560468228|FG004|Overall Study|Lost to Follow-up|0|||
155283121|NCT03251378|560468229|FG005|Overall Study|Lost to Follow-up|0|||
155283122|NCT03251378|560468230|FG006|Overall Study|Lost to Follow-up|0|||
155283123|NCT03251378|560468224|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283124|NCT03251378|560468225|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283125|NCT03251378|560468226|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283126|NCT03251378|560468227|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
155283127|NCT03251378|560468228|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
155283128|NCT03251378|560468229|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
155283129|NCT03251378|560468230|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
155283130|NCT03251378|560468224|FG000|Overall Study|Progressive disease|2|||
155283131|NCT03251378|560468225|FG001|Overall Study|Progressive disease|0|||
155283132|NCT03251378|560468226|FG002|Overall Study|Progressive disease|0|||
155283133|NCT03251378|560468227|FG003|Overall Study|Progressive disease|1|||
155283134|NCT03251378|560468228|FG004|Overall Study|Progressive disease|0|||
155283135|NCT03251378|560468229|FG005|Overall Study|Progressive disease|0|||
155283136|NCT03251378|560468230|FG006|Overall Study|Progressive disease|0|||
155283137|NCT03251378|560468224|FG000|Overall Study|Physician Decision|0|||
155632709|NCT01316575|561747820|FG000|Overall Study|Required alternate treatment|0|||
155632710|NCT01316575|561747821|FG001|Overall Study|Required alternate treatment|1|||
155632711|NCT02792504|561747824|FG000|Overall Study|Lost to Follow-up|24|||
155632712|NCT02792504|561747824|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
155632713|NCT01832766|561747831|FG000|Washout|Lost to Follow-up|0|||
155632714|NCT01832766|561747832|FG001|Washout|Lost to Follow-up|1|||
155632715|NCT01114724|561747833|FG000|Overall Study|Death|8|||
155632716|NCT01114724|561747833|FG000|Overall Study|Lost to Follow-up|1|||
155632717|NCT01114724|561747833|FG000|Overall Study|Withdrawal by Subject|1|||
155632718|NCT02814526|561747834|FG000|Overall Study|Adverse Event|4|||
155632719|NCT02814526|561747835|FG001|Overall Study|Adverse Event|3|||
155632720|NCT02814526|561747834|FG000|Overall Study|Death|1|||
155632721|NCT02814526|561747835|FG001|Overall Study|Death|1|||
155632722|NCT02814526|561747834|FG000|Overall Study|Lost to Follow-up|3|||
155632723|NCT02814526|561747835|FG001|Overall Study|Lost to Follow-up|4|||
155632724|NCT02814526|561747834|FG000|Overall Study|non site physician decision|1|||
155632725|NCT02814526|561747835|FG001|Overall Study|non site physician decision|0|||
155632726|NCT02814526|561747834|FG000|Overall Study|participant noncompliance|1|||
155632727|NCT02814526|561747835|FG001|Overall Study|participant noncompliance|1|||
155632728|NCT02814526|561747834|FG000|Overall Study|Withdrawal by Subject|20|||
155632729|NCT02814526|561747835|FG001|Overall Study|Withdrawal by Subject|14|||
155632730|NCT02814526|561747834|FG000|Overall Study|safety risk|2|||
155632731|NCT02814526|561747835|FG001|Overall Study|safety risk|1|||
155632732|NCT02814526|561747834|FG000|Overall Study|early termination-study terminated|1|||
155632733|NCT02814526|561747835|FG001|Overall Study|early termination-study terminated|2|||
155632734|NCT02814526|561747834|FG000|Overall Study|Other|0|||
155632735|NCT02814526|561747835|FG001|Overall Study|Other|4|||
155632736|NCT04585893|561747836|FG000|Overall Study|Death|1|||
155632737|NCT04585893|561747837|FG001|Overall Study|Death|0|||
155632738|NCT02485860|561747839|FG000|Overall Study|Lost to Follow-up|4|||
155632739|NCT02485860|561747840|FG001|Overall Study|Lost to Follow-up|1|||
155632740|NCT02485860|561747839|FG000|Overall Study|Physician Decision|1|||
155632741|NCT02485860|561747840|FG001|Overall Study|Physician Decision|2|||
155632742|NCT02485860|561747839|FG000|Overall Study|Health context (COVID-19)|1|||
155632743|NCT02485860|561747840|FG001|Overall Study|Health context (COVID-19)|0|||
155632744|NCT03454555|561749269|FG000|Overall Study|Death|6|||
155632745|NCT03454555|561749270|FG001|Overall Study|Death|6|||
155632746|NCT03454555|561749269|FG000|Overall Study|Lost to Follow-up|31|||
155632747|NCT03454555|561749270|FG001|Overall Study|Lost to Follow-up|12|||
155632748|NCT03454555|561749269|FG000|Overall Study|Physician Decision|2|||
155632749|NCT03454555|561749270|FG001|Overall Study|Physician Decision|6|||
155632750|NCT03454555|561749269|FG000|Overall Study|Withdrawal by Subject|34|||
155632751|NCT03454555|561749270|FG001|Overall Study|Withdrawal by Subject|5|||
155632752|NCT03454555|561749269|FG000|Overall Study|Ineligible|1|||
155632753|NCT03454555|561749270|FG001|Overall Study|Ineligible|5|||
155632754|NCT04770753|561749277|FG000|Overall Study|Randomized, never treated|1|||
155632755|NCT04770753|561749278|FG001|Overall Study|Randomized, never treated|1|||
155632756|NCT04770753|561749277|FG000|Overall Study|Withdrawal by Subject|3|||
155632757|NCT04770753|561749278|FG001|Overall Study|Withdrawal by Subject|1|||
155632758|NCT04770753|561749277|FG000|Overall Study|Adverse Event|2|||
155632759|NCT04770753|561749278|FG001|Overall Study|Adverse Event|0|||
155632760|NCT04770753|561749277|FG000|Overall Study|Pregnancy|1|||
155632761|NCT04770753|561749278|FG001|Overall Study|Pregnancy|0|||
155632762|NCT04770753|561749277|FG000|Overall Study|Other un-specified|1|||
155632763|NCT04770753|561749278|FG001|Overall Study|Other un-specified|0|||
155735482|NCT01485172|562129356|FG001|Overall Study|Lack of Efficacy|0|||
155632764|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
155632765|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
155632766|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
155632767|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
155632768|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
155632769|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
155632770|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
155632771|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
155632772|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
155632773|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
155632774|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
155632775|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
155632776|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
155632777|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
155632778|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
155632779|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
155632780|NCT00849056|561749281|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155632781|NCT00849056|561749282|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
155632782|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155632783|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
155632784|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
155632785|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
155632786|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
155632787|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
155632788|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
155632789|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
155632790|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155632791|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155632792|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
155632793|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
155632794|NCT00849056|561749281|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
155632795|NCT00849056|561749282|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
155632796|NCT04588259|561749283|FG000|Run-in period|Run-in failure|0|||
155632797|NCT04588259|561749284|FG001|Run-in period|Run-in failure|23|||
155632798|NCT04588259|561749283|FG000|Run-in period|Withdrawn before randomisation|0|||
155632799|NCT04588259|561749284|FG001|Run-in period|Withdrawn before randomisation|8|||
155632800|NCT04588259|561749283|FG000|Treatment period|Withdrawal by Subject|6|||
155632801|NCT04588259|561749284|FG001|Treatment period|Withdrawal by Subject|6|||
155632802|NCT00274456|561749285|FG000|Overall Study|Still on treatment|2|||
155632803|NCT00274456|561749286|FG001|Overall Study|Still on treatment|3|||
155632804|NCT00274456|561749287|FG002|Overall Study|Still on treatment|5|||
155632805|NCT00274456|561749288|FG003|Overall Study|Still on treatment|1|||
155632806|NCT00274456|561749285|FG000|Overall Study|Unacceptable toxicity|10|||
155632807|NCT00274456|561749286|FG001|Overall Study|Unacceptable toxicity|5|||
155632808|NCT00274456|561749287|FG002|Overall Study|Unacceptable toxicity|12|||
155632809|NCT00274456|561749288|FG003|Overall Study|Unacceptable toxicity|16|||
155632810|NCT00274456|561749285|FG000|Overall Study|Adverse Event|0|||
155632811|NCT00274456|561749286|FG001|Overall Study|Adverse Event|1|||
155632812|NCT00274456|561749287|FG002|Overall Study|Adverse Event|2|||
155632813|NCT00274456|561749288|FG003|Overall Study|Adverse Event|2|||
155632814|NCT00274456|561749285|FG000|Overall Study|Physician Decision|7|||
155632815|NCT00274456|561749286|FG001|Overall Study|Physician Decision|5|||
155632816|NCT00274456|561749287|FG002|Overall Study|Physician Decision|6|||
155632817|NCT00274456|561749288|FG003|Overall Study|Physician Decision|13|||
155632818|NCT00274456|561749285|FG000|Overall Study|Lost to Follow-up|0|||
155632819|NCT00274456|561749286|FG001|Overall Study|Lost to Follow-up|0|||
155632820|NCT00274456|561749287|FG002|Overall Study|Lost to Follow-up|1|||
155632821|NCT00274456|561749288|FG003|Overall Study|Lost to Follow-up|0|||
155632822|NCT00274456|561749285|FG000|Overall Study|Withdrawal by Subject|18|||
155632823|NCT00274456|561749286|FG001|Overall Study|Withdrawal by Subject|13|||
155632824|NCT00274456|561749287|FG002|Overall Study|Withdrawal by Subject|9|||
155632825|NCT00274456|561749288|FG003|Overall Study|Withdrawal by Subject|13|||
155735483|NCT01485172|562129357|FG002|Overall Study|Lack of Efficacy|0|||
155735484|NCT01485172|562129358|FG003|Overall Study|Lack of Efficacy|0|||
155735485|NCT01485172|562129359|FG004|Overall Study|Lack of Efficacy|0|||
155735486|NCT01485172|562129360|FG005|Overall Study|Lack of Efficacy|0|||
155735487|NCT01485172|562129355|FG000|Overall Study|Protocol Violation|0|||
155735488|NCT01485172|562129356|FG001|Overall Study|Protocol Violation|0|||
155735489|NCT01485172|562129357|FG002|Overall Study|Protocol Violation|4|||
155735490|NCT01485172|562129358|FG003|Overall Study|Protocol Violation|5|||
155735491|NCT01485172|562129359|FG004|Overall Study|Protocol Violation|1|||
155735492|NCT01485172|562129360|FG005|Overall Study|Protocol Violation|0|||
155735493|NCT01485172|562129355|FG000|Overall Study|Protocol defined stopping criteria|1|||
155735494|NCT01485172|562129356|FG001|Overall Study|Protocol defined stopping criteria|0|||
155735495|NCT01485172|562129357|FG002|Overall Study|Protocol defined stopping criteria|0|||
155735496|NCT01485172|562129358|FG003|Overall Study|Protocol defined stopping criteria|0|||
155735497|NCT01485172|562129359|FG004|Overall Study|Protocol defined stopping criteria|1|||
155735498|NCT01485172|562129360|FG005|Overall Study|Protocol defined stopping criteria|0|||
155735499|NCT01485172|562129355|FG000|Overall Study|Lost to Follow-up|0|||
155735500|NCT01485172|562129356|FG001|Overall Study|Lost to Follow-up|0|||
155735501|NCT01485172|562129357|FG002|Overall Study|Lost to Follow-up|1|||
155735502|NCT01485172|562129358|FG003|Overall Study|Lost to Follow-up|0|||
155735503|NCT01485172|562129359|FG004|Overall Study|Lost to Follow-up|0|||
155735504|NCT01485172|562129360|FG005|Overall Study|Lost to Follow-up|1|||
155735505|NCT01485172|562129355|FG000|Overall Study|Physician Decision|0|||
155735506|NCT01485172|562129356|FG001|Overall Study|Physician Decision|0|||
155735507|NCT01485172|562129357|FG002|Overall Study|Physician Decision|0|||
155735508|NCT01485172|562129358|FG003|Overall Study|Physician Decision|0|||
155735509|NCT01485172|562129359|FG004|Overall Study|Physician Decision|1|||
155735510|NCT01485172|562129360|FG005|Overall Study|Physician Decision|0|||
155735511|NCT01485172|562129355|FG000|Overall Study|Withdrawal by Subject|2|||
155735512|NCT01485172|562129356|FG001|Overall Study|Withdrawal by Subject|0|||
155735513|NCT01485172|562129357|FG002|Overall Study|Withdrawal by Subject|0|||
155735514|NCT01485172|562129358|FG003|Overall Study|Withdrawal by Subject|1|||
155735515|NCT01485172|562129359|FG004|Overall Study|Withdrawal by Subject|1|||
155735516|NCT01485172|562129360|FG005|Overall Study|Withdrawal by Subject|1|||
155735517|NCT04995419|562129366|FG000|Overall Study|Withdrawal by Subject|3|||
155735518|NCT04995419|562129366|FG000|Overall Study|Progressive Disease|19|||
155735519|NCT04995419|562129366|FG000|Overall Study|Adverse Event|2|||
155735520|NCT04995419|562129366|FG000|Overall Study|Ongoing|16|||
155735521|NCT02948088|562129367|FG000|Overall Study|Lost to Follow-up|8|||
155735522|NCT02948088|562129367|FG000|Overall Study|Death|1|||
155735523|NCT02948088|562129367|FG000|Overall Study|Withdrawal by Subject|4|||
155735524|NCT02948088|562129367|FG000|Overall Study|Other|2|||
155735525|NCT00838513|562129368|FG000|Screening Period|Screen Failure|3|||
155735526|NCT00838513|562129368|FG000|Extension Treatment Period|Death|1|||
155735527|NCT00838513|562129368|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
155735528|NCT00139477|562129372|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
155735529|NCT00139477|562129373|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
155735530|NCT00139477|562129372|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
155735531|NCT00139477|562129373|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
155735532|NCT00139477|562129372|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
155735533|NCT00139477|562129373|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
155735534|NCT00139477|562129372|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
155735535|NCT00139477|562129373|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
155735536|NCT00139477|562129372|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
155735537|NCT00139477|562129373|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
155735538|NCT00139477|562129372|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
155735539|NCT00139477|562129373|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
155735540|NCT00139477|562129372|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
155735541|NCT00139477|562129373|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
155735542|NCT00975780|562129374|FG000|Follow Up|Death|88|||
155735543|NCT00975780|562129375|FG001|Follow Up|Death|122|||
155735544|NCT00975780|562129374|FG000|Follow Up|Facility Withdrawal|7|||
155735545|NCT00975780|562129375|FG001|Follow Up|Facility Withdrawal|23|||
155735546|NCT00975780|562129374|FG000|Follow Up|Discharged from Facility|7|||
155735547|NCT00975780|562129375|FG001|Follow Up|Discharged from Facility|12|||
155735548|NCT00670306|562129376|FG000|Overall Study|Adverse Event|8|||
155735549|NCT00670306|562129376|FG000|Overall Study|Lack of Efficacy|10|||
155735550|NCT00670306|562129376|FG000|Overall Study|Withdrawal by Subject|9|||
155735551|NCT00670306|562129376|FG000|Overall Study|Physician Decision|1|||
155735552|NCT00670306|562129376|FG000|Overall Study|Lost to Follow-up|8|||
155735553|NCT00670306|562129376|FG000|Overall Study|incl/excl criterias did not meet|19|||
155735554|NCT00067002|562129378|FG000|Overall Study|Early Death|1|||
155735555|NCT00067002|562129379|FG001|Overall Study|Early Death|2|||
155735556|NCT00067002|562129378|FG000|Overall Study|Delayed|1|||
155735557|NCT00067002|562129379|FG001|Overall Study|Delayed|1|||
155735558|NCT00067002|562129378|FG000|Overall Study|Graft Failure|5|||
155735559|NCT00067002|562129379|FG001|Overall Study|Graft Failure|6|||
155735560|NCT01026324|562129383|FG000|Follow up/Survival|Withdrawal by Subject|1|||
155735561|NCT01026324|562129384|FG001|Follow up/Survival|Withdrawal by Subject|0|||
155735562|NCT01026324|562129385|FG002|Follow up/Survival|Withdrawal by Subject|0|||
155735563|NCT01032889|562129386|FG000|Overall Study|Adverse Event|2|||
155735564|NCT01032889|562129387|FG001|Overall Study|Adverse Event|2|||
155735565|NCT01032889|562129388|FG002|Overall Study|Adverse Event|0|||
155735566|NCT01032889|562129386|FG000|Overall Study|Withdrawal of Consent|1|||
155735567|NCT01032889|562129387|FG001|Overall Study|Withdrawal of Consent|2|||
155735568|NCT01032889|562129388|FG002|Overall Study|Withdrawal of Consent|1|||
155735569|NCT01032889|562129386|FG000|Overall Study|Patient Request|0|||
155735570|NCT01032889|562129387|FG001|Overall Study|Patient Request|1|||
155735571|NCT01032889|562129388|FG002|Overall Study|Patient Request|0|||
155735572|NCT01032889|562129386|FG000|Overall Study|Lost to Follow-up|1|||
155735573|NCT01032889|562129387|FG001|Overall Study|Lost to Follow-up|1|||
155735574|NCT01032889|562129388|FG002|Overall Study|Lost to Follow-up|0|||
155735575|NCT01032889|562129386|FG000|Overall Study|Lack of Submental Fat|2|||
155735576|NCT01032889|562129387|FG001|Overall Study|Lack of Submental Fat|8|||
155735577|NCT01032889|562129388|FG002|Overall Study|Lack of Submental Fat|1|||
155735578|NCT01032889|562129386|FG000|Overall Study|Miscellaneous Reasons|2|||
155735579|NCT01032889|562129387|FG001|Overall Study|Miscellaneous Reasons|1|||
155735580|NCT01032889|562129388|FG002|Overall Study|Miscellaneous Reasons|1|||
155735581|NCT02442804|562129389|FG000|Overall Study|Withdrawal by Subject|0|||
155735582|NCT02442804|562129390|FG001|Overall Study|Withdrawal by Subject|1|||
155735583|NCT02442804|562129389|FG000|Overall Study|Adverse Event|1|||
155735584|NCT02442804|562129390|FG001|Overall Study|Adverse Event|0|||
155735585|NCT02624986|562129397|FG000|Overall Study|Death|0|||
155735586|NCT02624986|562129398|FG001|Overall Study|Death|1|||
155735587|NCT02624986|562129399|FG002|Overall Study|Death|2|||
155735588|NCT02624986|562129400|FG003|Overall Study|Death|2|||
155735589|NCT02624986|562129401|FG004|Overall Study|Death|2|||
155735590|NCT02624986|562129402|FG005|Overall Study|Death|0|||
155735591|NCT02624986|562129403|FG006|Overall Study|Death|0|||
155735592|NCT02624986|562129404|FG007|Overall Study|Death|1|||
155735593|NCT02624986|562129397|FG000|Overall Study|Study Terminated by Sponsor|1|||
155735594|NCT02624986|562129398|FG001|Overall Study|Study Terminated by Sponsor|1|||
155735595|NCT02624986|562129399|FG002|Overall Study|Study Terminated by Sponsor|0|||
155735596|NCT02624986|562129400|FG003|Overall Study|Study Terminated by Sponsor|1|||
155735597|NCT02624986|562129401|FG004|Overall Study|Study Terminated by Sponsor|2|||
155735598|NCT02624986|562129402|FG005|Overall Study|Study Terminated by Sponsor|2|||
155735599|NCT02624986|562129403|FG006|Overall Study|Study Terminated by Sponsor|4|||
155735600|NCT02624986|562129404|FG007|Overall Study|Study Terminated by Sponsor|3|||
155735601|NCT02624986|562129397|FG000|Overall Study|Progressive Disease|0|||
155735602|NCT02624986|562129398|FG001|Overall Study|Progressive Disease|1|||
155735603|NCT02624986|562129399|FG002|Overall Study|Progressive Disease|0|||
155735604|NCT02624986|562129400|FG003|Overall Study|Progressive Disease|0|||
155735605|NCT02624986|562129401|FG004|Overall Study|Progressive Disease|0|||
155735606|NCT02624986|562129402|FG005|Overall Study|Progressive Disease|0|||
155735607|NCT02624986|562129403|FG006|Overall Study|Progressive Disease|0|||
155735608|NCT02624986|562129404|FG007|Overall Study|Progressive Disease|0|||
155735609|NCT02624986|562129397|FG000|Overall Study|Protocol Violation|1|||
155735610|NCT02624986|562129398|FG001|Overall Study|Protocol Violation|0|||
155735611|NCT02624986|562129399|FG002|Overall Study|Protocol Violation|0|||
155735612|NCT02624986|562129400|FG003|Overall Study|Protocol Violation|0|||
155735613|NCT02624986|562129401|FG004|Overall Study|Protocol Violation|0|||
155735614|NCT02624986|562129402|FG005|Overall Study|Protocol Violation|0|||
155735615|NCT02624986|562129403|FG006|Overall Study|Protocol Violation|0|||
155735616|NCT02624986|562129404|FG007|Overall Study|Protocol Violation|0|||
155735617|NCT02624986|562129397|FG000|Overall Study|Withdrawal by Subject|0|||
155735618|NCT02624986|562129398|FG001|Overall Study|Withdrawal by Subject|0|||
155735619|NCT02624986|562129399|FG002|Overall Study|Withdrawal by Subject|0|||
155735620|NCT02624986|562129400|FG003|Overall Study|Withdrawal by Subject|0|||
155735621|NCT02624986|562129401|FG004|Overall Study|Withdrawal by Subject|0|||
155735622|NCT02624986|562129402|FG005|Overall Study|Withdrawal by Subject|0|||
155735623|NCT02624986|562129403|FG006|Overall Study|Withdrawal by Subject|0|||
155735624|NCT02624986|562129404|FG007|Overall Study|Withdrawal by Subject|1|||
155735625|NCT02116205|562129408|FG000|Overall Study|Withdrawal by Subject|2|||
155735626|NCT02116205|562129409|FG001|Overall Study|Withdrawal by Subject|4|||
155735627|NCT02116205|562129410|FG002|Overall Study|Withdrawal by Subject|1|||
155735628|NCT02116205|562129411|FG003|Overall Study|Withdrawal by Subject|3|||
155735629|NCT02116205|562129408|FG000|Overall Study|Lost to Follow-up|0|||
155735630|NCT02116205|562129409|FG001|Overall Study|Lost to Follow-up|2|||
155735631|NCT02116205|562129410|FG002|Overall Study|Lost to Follow-up|1|||
155735632|NCT02116205|562129411|FG003|Overall Study|Lost to Follow-up|2|||
155735633|NCT02116205|562129408|FG000|Overall Study|Physician Decision|0|||
155735634|NCT02116205|562129409|FG001|Overall Study|Physician Decision|1|||
155735635|NCT02116205|562129410|FG002|Overall Study|Physician Decision|1|||
155735636|NCT02116205|562129411|FG003|Overall Study|Physician Decision|1|||
155735637|NCT02116205|562129408|FG000|Overall Study|Exclusion criteria|0|||
155735638|NCT02116205|562129409|FG001|Overall Study|Exclusion criteria|0|||
155735639|NCT02116205|562129410|FG002|Overall Study|Exclusion criteria|1|||
155735640|NCT02116205|562129411|FG003|Overall Study|Exclusion criteria|0|||
155735641|NCT00993148|562129417|FG000|Overall Study|Lost to Follow-up|2|||
155735642|NCT00993148|562129417|FG000|Overall Study|never initiated treatment|1|||
155735643|NCT00806819|562129418|FG000|Overall Study|progressive disease (modified RECIST )|217|||
155735644|NCT00806819|562129419|FG001|Overall Study|progressive disease (modified RECIST )|216|||
155735645|NCT00806819|562129418|FG000|Overall Study|Worsening or AE of underlying disease|18|||
155735646|NCT00806819|562129419|FG001|Overall Study|Worsening or AE of underlying disease|25|||
155735647|NCT00806819|562129418|FG000|Overall Study|Other AE|38|||
155735648|NCT00806819|562129419|FG001|Overall Study|Other AE|40|||
155735649|NCT00806819|562129418|FG000|Overall Study|Protocol Violation|9|||
155735650|NCT00806819|562129419|FG001|Overall Study|Protocol Violation|4|||
155735651|NCT00806819|562129418|FG000|Overall Study|Lost to Follow-up|1|||
155735652|NCT00806819|562129419|FG001|Overall Study|Lost to Follow-up|0|||
155735653|NCT00806819|562129418|FG000|Overall Study|Withdrawal by Subject|32|||
155735654|NCT00806819|562129419|FG001|Overall Study|Withdrawal by Subject|29|||
155735655|NCT00806819|562129418|FG000|Overall Study|Not treated|6|||
155735656|NCT00806819|562129419|FG001|Overall Study|Not treated|3|||
155735657|NCT00806819|562129418|FG000|Overall Study|Reasons other than stated above|25|||
155735658|NCT00806819|562129419|FG001|Overall Study|Reasons other than stated above|41|||
155735659|NCT01737502|562129424|FG000|Phase I|Disease progression|2|||
155735660|NCT01737502|562129425|FG001|Phase I|Disease progression|3|||
155735661|NCT01737502|562129424|FG000|Phase I|Complicating disease|1|||
155735662|NCT01737502|562129425|FG001|Phase I|Complicating disease|0|||
155735663|NCT01737502|562129424|FG000|Phase II|Adverse Event|0|||
155735664|NCT01737502|562129425|FG001|Phase II|Adverse Event|3|||
155735665|NCT01737502|562129424|FG000|Phase II|Disease progression|0|||
155735666|NCT01737502|562129425|FG001|Phase II|Disease progression|18|||
155735667|NCT01737502|562129424|FG000|Phase II|Death|0|||
155735668|NCT01737502|562129425|FG001|Phase II|Death|1|||
155735669|NCT01737502|562129424|FG000|Phase II|Transition to hospice care|0|||
155735670|NCT01737502|562129425|FG001|Phase II|Transition to hospice care|1|||
155735671|NCT01326104|562129427|FG000|Overall Study|progressed prior to vaccine|0|||
155735672|NCT01326104|562129428|FG001|Overall Study|progressed prior to vaccine|2|||
155735673|NCT01326104|562129427|FG000|Overall Study|unable to make vaccine|0|||
155735674|NCT01326104|562129428|FG001|Overall Study|unable to make vaccine|2|||
155735675|NCT05064358|562129429|FG000|Overall Study|Death|23|||
155735676|NCT05064358|562129430|FG001|Overall Study|Death|23|||
155393508|NCT02308007|560876779|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
155393509|NCT02308007|560876777|FG000|Overall Study|Positive for STD at Baseline|7|||
155393510|NCT02308007|560876778|FG001|Overall Study|Positive for STD at Baseline|11|||
155393511|NCT02308007|560876779|FG002|Overall Study|Positive for STD at Baseline|7|||
155735677|NCT05064358|562129431|FG002|Overall Study|Death|25|||
155393512|NCT02308007|560876777|FG000|Overall Study|Lost to Follow-up|3|||
155735678|NCT05064358|562129432|FG003|Overall Study|Death|21|||
155735679|NCT05064358|562129433|FG004|Overall Study|Death|5|||
155735680|NCT05064358|562129429|FG000|Overall Study|Lost to Follow-up|1|||
155735681|NCT05064358|562129430|FG001|Overall Study|Lost to Follow-up|2|||
155735682|NCT05064358|562129431|FG002|Overall Study|Lost to Follow-up|0|||
155735683|NCT05064358|562129432|FG003|Overall Study|Lost to Follow-up|2|||
155735684|NCT05064358|562129433|FG004|Overall Study|Lost to Follow-up|0|||
155735685|NCT05064358|562129429|FG000|Overall Study|Physician Decision|1|||
155735686|NCT05064358|562129430|FG001|Overall Study|Physician Decision|1|||
155735687|NCT05064358|562129431|FG002|Overall Study|Physician Decision|2|||
155735688|NCT05064358|562129432|FG003|Overall Study|Physician Decision|0|||
155735689|NCT05064358|562129433|FG004|Overall Study|Physician Decision|0|||
155735690|NCT05064358|562129429|FG000|Overall Study|Withdrawal by Subject|4|||
155735691|NCT05064358|562129430|FG001|Overall Study|Withdrawal by Subject|5|||
155735692|NCT05064358|562129431|FG002|Overall Study|Withdrawal by Subject|3|||
155735693|NCT05064358|562129432|FG003|Overall Study|Withdrawal by Subject|6|||
155735694|NCT05064358|562129433|FG004|Overall Study|Withdrawal by Subject|3|||
155735695|NCT05064358|562129429|FG000|Overall Study|Ongoing at the time of analysis|1|||
155735696|NCT05064358|562129430|FG001|Overall Study|Ongoing at the time of analysis|2|||
155735697|NCT05064358|562129431|FG002|Overall Study|Ongoing at the time of analysis|2|||
155735698|NCT05064358|562129432|FG003|Overall Study|Ongoing at the time of analysis|2|||
155735699|NCT05064358|562129433|FG004|Overall Study|Ongoing at the time of analysis|2|||
155735700|NCT04421027|562129434|FG000|Treatment Period|Adverse Event|5|||
155735701|NCT04421027|562129435|FG001|Treatment Period|Adverse Event|3|||
155735702|NCT04421027|562129436|FG002|Treatment Period|Adverse Event|0|||
155735703|NCT04421027|562129437|FG003|Treatment Period|Adverse Event|0|||
155735704|NCT04421027|562129434|FG000|Treatment Period|Death|98|||
155735705|NCT04421027|562129435|FG001|Treatment Period|Death|61|||
155735706|NCT04421027|562129436|FG002|Treatment Period|Death|0|||
155735707|NCT04421027|562129437|FG003|Treatment Period|Death|0|||
155735708|NCT04421027|562129434|FG000|Treatment Period|Lost to Follow-up|22|||
155735709|NCT04421027|562129435|FG001|Treatment Period|Lost to Follow-up|20|||
155735710|NCT04421027|562129436|FG002|Treatment Period|Lost to Follow-up|0|||
155735711|NCT04421027|562129437|FG003|Treatment Period|Lost to Follow-up|0|||
155735712|NCT04421027|562129434|FG000|Treatment Period|Other-Unknown|15|||
155735713|NCT04421027|562129435|FG001|Treatment Period|Other-Unknown|9|||
155735714|NCT04421027|562129436|FG002|Treatment Period|Other-Unknown|0|||
155735715|NCT04421027|562129437|FG003|Treatment Period|Other-Unknown|0|||
155735716|NCT04421027|562129434|FG000|Treatment Period|Physician Decision|1|||
155735717|NCT04421027|562129435|FG001|Treatment Period|Physician Decision|1|||
155735718|NCT04421027|562129436|FG002|Treatment Period|Physician Decision|0|||
155735719|NCT04421027|562129437|FG003|Treatment Period|Physician Decision|0|||
155735720|NCT04421027|562129434|FG000|Treatment Period|Withdrawal by Subject|7|||
155735721|NCT04421027|562129435|FG001|Treatment Period|Withdrawal by Subject|12|||
155735722|NCT04421027|562129436|FG002|Treatment Period|Withdrawal by Subject|0|||
155735723|NCT04421027|562129437|FG003|Treatment Period|Withdrawal by Subject|0|||
155735724|NCT04421027|562129434|FG000|Treatment Period|Randomized Not Dosed|9|||
155735725|NCT04421027|562129435|FG001|Treatment Period|Randomized Not Dosed|14|||
155735726|NCT04421027|562129436|FG002|Treatment Period|Randomized Not Dosed|0|||
155735727|NCT04421027|562129437|FG003|Treatment Period|Randomized Not Dosed|0|||
155735728|NCT04421027|562129434|FG000|Follow-Up Period|Adverse Event|0|||
155735729|NCT04421027|562129435|FG001|Follow-Up Period|Adverse Event|0|||
155735730|NCT04421027|562129436|FG002|Follow-Up Period|Adverse Event|0|||
155735731|NCT04421027|562129437|FG003|Follow-Up Period|Adverse Event|3|||
155735732|NCT04421027|562129434|FG000|Follow-Up Period|Death|0|||
155735733|NCT04421027|562129435|FG001|Follow-Up Period|Death|0|||
155735734|NCT04421027|562129436|FG002|Follow-Up Period|Death|16|||
155735735|NCT04421027|562129437|FG003|Follow-Up Period|Death|17|||
155735736|NCT04421027|562129434|FG000|Follow-Up Period|Lost to Follow-up|0|||
155735737|NCT04421027|562129435|FG001|Follow-Up Period|Lost to Follow-up|0|||
155735738|NCT04421027|562129436|FG002|Follow-Up Period|Lost to Follow-up|7|||
155735739|NCT04421027|562129437|FG003|Follow-Up Period|Lost to Follow-up|7|||
155735740|NCT04421027|562129434|FG000|Follow-Up Period|Protocol Deviation|0|||
155735741|NCT04421027|562129435|FG001|Follow-Up Period|Protocol Deviation|0|||
155735742|NCT04421027|562129436|FG002|Follow-Up Period|Protocol Deviation|1|||
155735743|NCT04421027|562129437|FG003|Follow-Up Period|Protocol Deviation|0|||
155735744|NCT04421027|562129434|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155735745|NCT04421027|562129435|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155735746|NCT04421027|562129436|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
155735747|NCT04421027|562129437|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155735748|NCT04421027|562129434|FG000|Follow-Up Period|Left message, participant did not call back|0|||
155735749|NCT04421027|562129435|FG001|Follow-Up Period|Left message, participant did not call back|0|||
155735750|NCT04421027|562129436|FG002|Follow-Up Period|Left message, participant did not call back|0|||
155735751|NCT04421027|562129437|FG003|Follow-Up Period|Left message, participant did not call back|1|||
155735752|NCT04421027|562129434|FG000|Follow-Up Period|Participant died|0|||
155735753|NCT04421027|562129435|FG001|Follow-Up Period|Participant died|0|||
155735754|NCT04421027|562129436|FG002|Follow-Up Period|Participant died|0|||
155735755|NCT04421027|562129437|FG003|Follow-Up Period|Participant died|1|||
155735756|NCT04421027|562129434|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155735757|NCT04421027|562129435|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155735758|NCT04421027|562129436|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155735759|NCT04421027|562129437|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
155735760|NCT04549545|562131017|FG000|Initial Period|Withdrawal by Subject|4|||
155735761|NCT04549545|562131018|FG001|Initial Period|Withdrawal by Subject|0|||
155735762|NCT04549545|562131017|FG000|Initial Period|Additional ENT Procedure|3|||
155735763|NCT04549545|562131018|FG001|Initial Period|Additional ENT Procedure|0|||
155735764|NCT04549545|562131017|FG000|Initial Period|Lost to Follow-up|3|||
155735765|NCT04549545|562131018|FG001|Initial Period|Lost to Follow-up|1|||
155735766|NCT04549545|562131017|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
155735767|NCT04549545|562131018|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
155735768|NCT04549545|562131017|FG000|Crossover Period|Additional ENT Procedure|0|||
155735769|NCT04549545|562131018|FG001|Crossover Period|Additional ENT Procedure|6|||
155735770|NCT04549545|562131017|FG000|Crossover Period|Lost to Follow-up|0|||
155735771|NCT04549545|562131018|FG001|Crossover Period|Lost to Follow-up|1|||
155735772|NCT04549545|562131017|FG000|Crossover Period|Withdrawal by Subject|0|||
155735773|NCT04549545|562131018|FG001|Crossover Period|Withdrawal by Subject|4|||
155735774|NCT01865552|562131021|FG000|Period 1|Adverse Event|1|||
155735775|NCT01865552|562131022|FG001|Period 1|Adverse Event|0|||
155735776|NCT01865552|562131023|FG002|Period 1|Adverse Event|0|||
155735777|NCT01865552|562131024|FG003|Period 1|Adverse Event|1|||
155735778|NCT01865552|562131025|FG004|Period 1|Adverse Event|1|||
155735779|NCT01865552|562131026|FG005|Period 1|Adverse Event|1|||
155735780|NCT01865552|562131021|FG000|Period 1|Pathological lab|0|||
155735781|NCT01865552|562131022|FG001|Period 1|Pathological lab|0|||
155735782|NCT01865552|562131023|FG002|Period 1|Pathological lab|0|||
155735783|NCT01865552|562131024|FG003|Period 1|Pathological lab|0|||
155735784|NCT01865552|562131025|FG004|Period 1|Pathological lab|1|||
155735785|NCT01865552|562131026|FG005|Period 1|Pathological lab|0|||
155735786|NCT01865552|562131021|FG000|Period 1|Other|0|||
155735787|NCT01865552|562131022|FG001|Period 1|Other|0|||
155735788|NCT01865552|562131023|FG002|Period 1|Other|0|||
155735789|NCT01865552|562131024|FG003|Period 1|Other|0|||
155735790|NCT01865552|562131025|FG004|Period 1|Other|1|||
155735791|NCT01865552|562131026|FG005|Period 1|Other|0|||
155735792|NCT03083873|562131027|FG000|Overall Study|Death|6|||
155735793|NCT03083873|562131028|FG001|Overall Study|Death|15|||
155735794|NCT03083873|562131029|FG002|Overall Study|Death|13|||
155735795|NCT03083873|562131030|FG003|Overall Study|Death|9|||
155735796|NCT03083873|562131031|FG004|Overall Study|Death|0|||
155735797|NCT03083873|562131027|FG000|Overall Study|Sponsor Terminated Study|0|||
155735798|NCT03083873|562131028|FG001|Overall Study|Sponsor Terminated Study|1|||
155735799|NCT03083873|562131029|FG002|Overall Study|Sponsor Terminated Study|2|||
155735800|NCT03083873|562131030|FG003|Overall Study|Sponsor Terminated Study|3|||
155735801|NCT03083873|562131031|FG004|Overall Study|Sponsor Terminated Study|0|||
155735802|NCT03083873|562131027|FG000|Overall Study|Lost to Follow-up|0|||
155735803|NCT03083873|562131028|FG001|Overall Study|Lost to Follow-up|1|||
155735804|NCT03083873|562131029|FG002|Overall Study|Lost to Follow-up|1|||
155735805|NCT03083873|562131030|FG003|Overall Study|Lost to Follow-up|0|||
155735806|NCT03083873|562131031|FG004|Overall Study|Lost to Follow-up|0|||
155735807|NCT03083873|562131027|FG000|Overall Study|Withdrawal by Subject|2|||
155735808|NCT03083873|562131028|FG001|Overall Study|Withdrawal by Subject|0|||
155735809|NCT03083873|562131029|FG002|Overall Study|Withdrawal by Subject|0|||
155735810|NCT03083873|562131030|FG003|Overall Study|Withdrawal by Subject|0|||
155735811|NCT03083873|562131031|FG004|Overall Study|Withdrawal by Subject|0|||
155735812|NCT03083873|562131027|FG000|Overall Study|Did Not Receive TIL|2|||
155735813|NCT03083873|562131028|FG001|Overall Study|Did Not Receive TIL|5|||
155735814|NCT03083873|562131029|FG002|Overall Study|Did Not Receive TIL|3|||
155735815|NCT03083873|562131030|FG003|Overall Study|Did Not Receive TIL|1|||
155735816|NCT03083873|562131031|FG004|Overall Study|Did Not Receive TIL|0|||
155735817|NCT00295880|562131032|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
155735818|NCT00295880|562131032|FG000|Overall Study|Unit randomization did not occur|1|||
155735819|NCT03983317|562131035|FG000|Overall Study|Physician Decision|5|||
155735820|NCT00552188|562131040|FG000|Overall Study|Adverse Event|0|||
155735821|NCT00552188|562131041|FG001|Overall Study|Adverse Event|2|||
155735822|NCT00552188|562131040|FG000|Overall Study|Lost to Follow-up|2|||
155735823|NCT00552188|562131041|FG001|Overall Study|Lost to Follow-up|1|||
155735824|NCT00552188|562131040|FG000|Overall Study|Withdrawal of consent|0|||
155735825|NCT00552188|562131041|FG001|Overall Study|Withdrawal of consent|1|||
155735826|NCT00552188|562131040|FG000|Overall Study|Subject returned to home country|0|||
155735827|NCT00552188|562131041|FG001|Overall Study|Subject returned to home country|1|||
155735828|NCT01256294|562131042|FG000|Overall Study|Adverse Event|1|||
155735829|NCT01256294|562131043|FG001|Overall Study|Adverse Event|0|||
155735830|NCT01256294|562131042|FG000|Overall Study|Withdrawal by Subject|1|||
155735831|NCT01256294|562131043|FG001|Overall Study|Withdrawal by Subject|1|||
155735832|NCT01256294|562131042|FG000|Overall Study|Protocol deviation|2|||
155735833|NCT01256294|562131043|FG001|Overall Study|Protocol deviation|1|||
155735834|NCT03887702|562131044|FG000|Overall Study|Study terminated|0|||
155735835|NCT03887702|562131045|FG001|Overall Study|Study terminated|0|||
155735836|NCT03887702|562131046|FG002|Overall Study|Study terminated|2|||
155735837|NCT03887702|562131047|FG003|Overall Study|Study terminated|2|||
155735838|NCT01643772|562131048|FG000|Overall Study|Protocol Violation|0|||
155735839|NCT01643772|562131049|FG001|Overall Study|Protocol Violation|0|||
155735840|NCT01643772|562131050|FG002|Overall Study|Protocol Violation|0|||
155735841|NCT01643772|562131051|FG003|Overall Study|Protocol Violation|1|||
155735842|NCT01643772|562131048|FG000|Overall Study|Adverse Event|0|||
155735843|NCT01643772|562131049|FG001|Overall Study|Adverse Event|0|||
155735844|NCT01643772|562131050|FG002|Overall Study|Adverse Event|0|||
155735845|NCT01643772|562131051|FG003|Overall Study|Adverse Event|1|||
155735846|NCT04329806|562131052|FG000|Overall Study|Physician Decision|3|||
155735847|NCT04329806|562131053|FG001|Overall Study|Physician Decision|4|||
155735848|NCT01349959|562131054|FG000|Overall Study|Adverse Event|7|||
155735849|NCT00811018|562131055|FG000|Overall Study|Additional Chronic Treatment|31|||
155735850|NCT00811018|562131055|FG000|Overall Study|Adverse Event|79|||
155735851|NCT00811018|562131055|FG000|Overall Study|Death|147|||
155735852|NCT00811018|562131055|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
155735853|NCT00811018|562131055|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
155735854|NCT00811018|562131055|FG000|Overall Study|Investigator Decision|57|||
155735855|NCT00811018|562131055|FG000|Overall Study|Lost to Follow-up|19|||
155735856|NCT00811018|562131055|FG000|Overall Study|Pregnancy|6|||
155735857|NCT00811018|562131055|FG000|Overall Study|Sponsor Decision|450|||
155735858|NCT00811018|562131055|FG000|Overall Study|Withdrawal by Subject|70|||
155735859|NCT00811018|562131055|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
155735860|NCT00811018|562131055|FG000|Overall Study|Other|26|||
155735861|NCT01727024|562131056|FG000|Period 1|Lost to Follow-up|1|||
155735862|NCT01727024|562131057|FG001|Period 1|Lost to Follow-up|1|||
155735863|NCT01727024|562131056|FG000|Period 1|Withdrawal by Subject|2|||
155735864|NCT01727024|562131057|FG001|Period 1|Withdrawal by Subject|3|||
155735865|NCT01587014|562131058|FG000|Overall Study|Death|2|||
155735866|NCT03962504|562131061|FG000|Overall Study|Other|11|||
155735867|NCT03962504|562131062|FG001|Overall Study|Other|32|||
155735868|NCT01976741|562131063|FG000|Overall Study|Withdrawal by Subject|1|||
155735869|NCT01976741|562131064|FG001|Overall Study|Withdrawal by Subject|0|||
155735870|NCT01976741|562131065|FG002|Overall Study|Withdrawal by Subject|1|||
155735871|NCT01976741|562131066|FG003|Overall Study|Withdrawal by Subject|1|||
155735872|NCT01976741|562131067|FG004|Overall Study|Withdrawal by Subject|0|||
155735873|NCT01976741|562131068|FG005|Overall Study|Withdrawal by Subject|0|||
155735874|NCT01976741|562131069|FG006|Overall Study|Withdrawal by Subject|1|||
155735875|NCT01976741|562131070|FG007|Overall Study|Withdrawal by Subject|4|||
155735876|NCT01976741|562131071|FG008|Overall Study|Withdrawal by Subject|0|||
155735877|NCT01976741|562131072|FG009|Overall Study|Withdrawal by Subject|0|||
155735878|NCT01976741|562131063|FG000|Overall Study|Adverse Event|0|||
155735879|NCT01976741|562131064|FG001|Overall Study|Adverse Event|0|||
155735880|NCT01976741|562131065|FG002|Overall Study|Adverse Event|2|||
155735881|NCT01976741|562131066|FG003|Overall Study|Adverse Event|0|||
155735882|NCT01976741|562131067|FG004|Overall Study|Adverse Event|0|||
155735883|NCT01976741|562131068|FG005|Overall Study|Adverse Event|0|||
155735884|NCT01976741|562131069|FG006|Overall Study|Adverse Event|3|||
155735885|NCT01976741|562131070|FG007|Overall Study|Adverse Event|8|||
155735886|NCT01976741|562131071|FG008|Overall Study|Adverse Event|1|||
155735887|NCT01976741|562131072|FG009|Overall Study|Adverse Event|4|||
155735888|NCT04999852|562131073|FG000|Overall Study|Withdrawal by Subject|11|||
155735889|NCT04999852|562131074|FG001|Overall Study|Withdrawal by Subject|1|||
155735890|NCT04999852|562131073|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
155735891|NCT04999852|562131074|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
155735892|NCT05626322|562131075|FG000|Overall Study|Death|2|||
155735893|NCT05626322|562131076|FG001|Overall Study|Death|0|||
155735894|NCT05626322|562131077|FG002|Overall Study|Death|0|||
155735895|NCT05626322|562131075|FG000|Overall Study|Physician Decision|1|||
155735896|NCT05626322|562131076|FG001|Overall Study|Physician Decision|0|||
155735897|NCT05626322|562131077|FG002|Overall Study|Physician Decision|0|||
155735898|NCT05626322|562131075|FG000|Overall Study|Progressive Disease|0|||
155735899|NCT05626322|562131076|FG001|Overall Study|Progressive Disease|1|||
155735900|NCT05626322|562131077|FG002|Overall Study|Progressive Disease|1|||
155632826|NCT04460885|561749292|FG000|Overall Study|Withdrawal by Subject|6|||
155632827|NCT04460885|561749293|FG001|Overall Study|Withdrawal by Subject|8|||
155632828|NCT04460885|561749292|FG000|Overall Study|Site closure|1|||
155632829|NCT04460885|561749293|FG001|Overall Study|Site closure|0|||
155632830|NCT04460885|561749292|FG000|Overall Study|Death|5|||
155632831|NCT04460885|561749293|FG001|Overall Study|Death|4|||
155632832|NCT04460885|561749292|FG000|Overall Study|Physician Decision|2|||
155632833|NCT04460885|561749293|FG001|Overall Study|Physician Decision|1|||
155632834|NCT04460885|561749292|FG000|Overall Study|Lost to Follow-up|4|||
155632835|NCT04460885|561749293|FG001|Overall Study|Lost to Follow-up|4|||
155632836|NCT04889040|561749299|FG000|Overall Study|Withdrawal by Subject|3|||
155632837|NCT04889040|561749300|FG001|Overall Study|Withdrawal by Subject|3|||
155632838|NCT04889040|561749299|FG000|Overall Study|Lost to Follow-up|0|||
155632839|NCT04889040|561749300|FG001|Overall Study|Lost to Follow-up|1|||
155632840|NCT04889040|561749299|FG000|Overall Study|Adverse Event|2|||
155632841|NCT04889040|561749300|FG001|Overall Study|Adverse Event|1|||
155632842|NCT03801252|561749303|FG000|Overall Study|Protocol Violation|1|||
155632843|NCT03801252|561749304|FG001|Overall Study|Protocol Violation|2|||
155632844|NCT02690727|561749305|FG000|Overall Study|Adverse Event|2|||
155632845|NCT02690727|561749306|FG001|Overall Study|Adverse Event|2|||
155632846|NCT02030600|561749307|FG000|Treatment Period 1|Adverse Event|5|||
155632847|NCT02030600|561749308|FG001|Treatment Period 1|Adverse Event|7|||
155632848|NCT02030600|561749307|FG000|Treatment Period 1|Lack of Efficacy|0|||
155632849|NCT02030600|561749308|FG001|Treatment Period 1|Lack of Efficacy|1|||
155632850|NCT02030600|561749307|FG000|Treatment Period 1|Lost to Follow-up|11|||
155632851|NCT02030600|561749308|FG001|Treatment Period 1|Lost to Follow-up|3|||
155632852|NCT02030600|561749307|FG000|Treatment Period 1|Protocol Violation|22|||
155632853|NCT02030600|561749308|FG001|Treatment Period 1|Protocol Violation|17|||
155632854|NCT02030600|561749307|FG000|Treatment Period 1|Withdrawal by Subject|13|||
155632855|NCT02030600|561749308|FG001|Treatment Period 1|Withdrawal by Subject|17|||
155632856|NCT02030600|561749307|FG000|Treatment Period 1|Casebook Unsigned|1|||
155632857|NCT02030600|561749308|FG001|Treatment Period 1|Casebook Unsigned|0|||
155632858|NCT02030600|561749307|FG000|Treatment Period 1|Unclassified|1|||
155735901|NCT05626322|562131075|FG000|Overall Study|Study terminated by sponsor|0|||
155735902|NCT05626322|562131076|FG001|Overall Study|Study terminated by sponsor|1|||
155735903|NCT05626322|562131077|FG002|Overall Study|Study terminated by sponsor|0|||
155735904|NCT03776812|562131078|FG000|Overall Study|Death|53|||
155735905|NCT03776812|562131079|FG001|Overall Study|Death|49|||
155735906|NCT03776812|562131080|FG002|Overall Study|Death|56|||
155735907|NCT03776812|562131078|FG000|Overall Study|Withdrawal by Subject|1|||
155735908|NCT03776812|562131079|FG001|Overall Study|Withdrawal by Subject|7|||
155735909|NCT03776812|562131080|FG002|Overall Study|Withdrawal by Subject|2|||
155735910|NCT03776812|562131078|FG000|Overall Study|Lost to Follow-up|1|||
155735911|NCT03776812|562131079|FG001|Overall Study|Lost to Follow-up|1|||
155735912|NCT03776812|562131080|FG002|Overall Study|Lost to Follow-up|0|||
155735913|NCT03776812|562131078|FG000|Overall Study|Did not enter long-term follow-up|3|||
155735914|NCT03776812|562131079|FG001|Overall Study|Did not enter long-term follow-up|3|||
155735915|NCT03776812|562131080|FG002|Overall Study|Did not enter long-term follow-up|2|||
155735916|NCT04758637|562131083|FG000|Overall Study|Lost to Follow-up|0|||
155735917|NCT04758637|562131084|FG001|Overall Study|Lost to Follow-up|1|||
155735918|NCT04758637|562131085|FG002|Overall Study|Lost to Follow-up|0|||
155735919|NCT04758637|562131086|FG003|Overall Study|Lost to Follow-up|0|||
155735920|NCT03350672|562131089|FG000|Overall Study|Withdrawal by Subject|7|||
155735921|NCT03350672|562131090|FG001|Overall Study|Withdrawal by Subject|0|||
155735922|NCT03350672|562131091|FG002|Overall Study|Withdrawal by Subject|0|||
155735923|NCT00048074|562131095|FG000|Overall Study|Adverse Event|46|||
155735924|NCT00048074|562131096|FG001|Overall Study|Adverse Event|41|||
155735925|NCT00048074|562131097|FG002|Overall Study|Adverse Event|53|||
155735926|NCT00048074|562131095|FG000|Overall Study|Death|3|||
155735927|NCT00048074|562131096|FG001|Overall Study|Death|3|||
155735928|NCT00048074|562131097|FG002|Overall Study|Death|2|||
155735929|NCT00048074|562131095|FG000|Overall Study|Lost to Follow-up|2|||
155735930|NCT00048074|562131096|FG001|Overall Study|Lost to Follow-up|6|||
155735931|NCT00048074|562131097|FG002|Overall Study|Lost to Follow-up|6|||
155735932|NCT00048074|562131095|FG000|Overall Study|Withdrawal by Subject|28|||
155735933|NCT00048074|562131096|FG001|Overall Study|Withdrawal by Subject|30|||
155735934|NCT00048074|562131097|FG002|Overall Study|Withdrawal by Subject|35|||
155735935|NCT00048074|562131095|FG000|Overall Study|Protocol Violation|1|||
155735936|NCT00048074|562131096|FG001|Overall Study|Protocol Violation|3|||
155735937|NCT00048074|562131097|FG002|Overall Study|Protocol Violation|0|||
155735938|NCT00048074|562131095|FG000|Overall Study|Study participation was terminated|0|||
155735939|NCT00048074|562131096|FG001|Overall Study|Study participation was terminated|1|||
155735940|NCT00048074|562131097|FG002|Overall Study|Study participation was terminated|0|||
155735941|NCT00048074|562131095|FG000|Overall Study|Husband ill|0|||
155735942|NCT00048074|562131096|FG001|Overall Study|Husband ill|1|||
155735943|NCT00048074|562131097|FG002|Overall Study|Husband ill|0|||
155735944|NCT00048074|562131095|FG000|Overall Study|Poor compliance|0|||
155735945|NCT00048074|562131096|FG001|Overall Study|Poor compliance|1|||
155735946|NCT00048074|562131097|FG002|Overall Study|Poor compliance|0|||
155735947|NCT00048074|562131095|FG000|Overall Study|Out of station|0|||
155735948|NCT00048074|562131096|FG001|Overall Study|Out of station|1|||
155393513|NCT02308007|560876778|FG001|Overall Study|Lost to Follow-up|0|||
155393514|NCT02308007|560876779|FG002|Overall Study|Lost to Follow-up|1|||
155393515|NCT00528567|560876780|FG000|Overall Study|Death|4|||
155735949|NCT00048074|562131097|FG002|Overall Study|Out of station|1|||
155735950|NCT00048074|562131095|FG000|Overall Study|Social reasons|1|||
155735951|NCT00048074|562131096|FG001|Overall Study|Social reasons|0|||
155735952|NCT00048074|562131097|FG002|Overall Study|Social reasons|0|||
155735953|NCT02873377|562131098|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
155735954|NCT02873377|562131099|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
155735955|NCT02873377|562131098|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
155735956|NCT02873377|562131099|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
155735957|NCT03568461|562131120|FG000|Overall Study|Death|7|||
155735958|NCT03568461|562131120|FG000|Overall Study|Physician Decision|5|||
155735959|NCT03568461|562131120|FG000|Overall Study|Subject decision|5|||
155735960|NCT03568461|562131120|FG000|Overall Study|Lost to Follow-up|1|||
155735961|NCT03387085|562131124|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
155735962|NCT04695977|562131125|FG000|Overall Study|Sponsor Decision|9|||
155735963|NCT04695977|562131126|FG001|Overall Study|Sponsor Decision|4|||
155735964|NCT04695977|562131125|FG000|Overall Study|Death|2|||
155735965|NCT04695977|562131126|FG001|Overall Study|Death|5|||
155735966|NCT01243242|562132437|FG000|Overall Study|Adverse Event|1|||
155735967|NCT01243242|562132438|FG001|Overall Study|Adverse Event|1|||
155735968|NCT01243242|562132437|FG000|Overall Study|Withdrawal by Subject|1|||
155735969|NCT01243242|562132438|FG001|Overall Study|Withdrawal by Subject|1|||
155735970|NCT01243242|562132437|FG000|Overall Study|Physician Decision|0|||
155735971|NCT01243242|562132438|FG001|Overall Study|Physician Decision|1|||
155735972|NCT01243242|562132437|FG000|Overall Study|sponsor decision|0|||
155735973|NCT01243242|562132438|FG001|Overall Study|sponsor decision|1|||
155735974|NCT01243242|562132437|FG000|Overall Study|non compliance|1|||
155735975|NCT01243242|562132438|FG001|Overall Study|non compliance|0|||
155735976|NCT04681352|562132443|FG000|Overall Study|Lost to Follow-up|2|||
155735977|NCT04681352|562132443|FG000|Overall Study|Withdrawal by Subject|22|||
155735978|NCT03860818|562132446|FG000|Overall Study|Death|144|||
155393516|NCT00528567|560876781|FG001|Overall Study|Death|5|||
155393517|NCT00528567|560876780|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
155393518|NCT00528567|560876781|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
155735979|NCT03860818|562132447|FG001|Overall Study|Death|195|||
155735980|NCT03860818|562132446|FG000|Overall Study|Graft Loss|32|||
155735981|NCT03860818|562132447|FG001|Overall Study|Graft Loss|45|||
155735982|NCT00792571|562132448|FG000|Overall Study|Death|1|||
155735983|NCT00792571|562132448|FG000|Overall Study|Adverse Event|4|||
155735984|NCT00792571|562132448|FG000|Overall Study|Withdrawal by Subject|1|||
155735985|NCT00792571|562132448|FG000|Overall Study|Other|4|||
155735986|NCT02600819|562132449|FG000|GEN Phase|Adverse Event|2|||
155735987|NCT02600819|562132450|FG001|GEN Phase|Adverse Event|0|||
155735988|NCT02600819|562132449|FG000|GEN Phase|Death|2|||
155735989|NCT02600819|562132450|FG001|GEN Phase|Death|0|||
155735990|NCT02600819|562132449|FG000|GEN Phase|Investigator's Discretion|4|||
155735991|NCT02600819|562132450|FG001|GEN Phase|Investigator's Discretion|0|||
155735992|NCT02600819|562132449|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
155735993|NCT02600819|562132450|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
155735994|NCT02600819|562132449|FG000|GEN Phase|Withdrew Consent|5|||
155735995|NCT02600819|562132450|FG001|GEN Phase|Withdrew Consent|0|||
155393519|NCT00528567|560876780|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
155393520|NCT00528567|560876781|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
155393521|NCT00528567|560876780|FG000|Overall Study|Violation Criteria at Entry|3|||
155393522|NCT00528567|560876781|FG001|Overall Study|Violation Criteria at Entry|17|||
155393523|NCT00528567|560876780|FG000|Overall Study|Withdrew Consent|59|||
155393524|NCT00528567|560876781|FG001|Overall Study|Withdrew Consent|55|||
155393525|NCT00528567|560876780|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
155393526|NCT00528567|560876781|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
155393527|NCT00528567|560876780|FG000|Overall Study|Failure to Return|1|||
155393528|NCT00528567|560876781|FG001|Overall Study|Failure to Return|4|||
155393529|NCT00528567|560876780|FG000|Overall Study|Other Protocol Violation|5|||
155393530|NCT00528567|560876781|FG001|Overall Study|Other Protocol Violation|21|||
155393531|NCT00528567|560876780|FG000|Overall Study|Administrative/Other|22|||
155393532|NCT00528567|560876781|FG001|Overall Study|Administrative/Other|75|||
155393533|NCT03085758|560876782|FG000|Overall Study|Death|26|||
155393534|NCT03085758|560876783|FG001|Overall Study|Death|24|||
155393535|NCT03085758|560876784|FG002|Overall Study|Death|53|||
155393536|NCT03085758|560876782|FG000|Overall Study|Lost to Follow-up|1|||
155393537|NCT03085758|560876783|FG001|Overall Study|Lost to Follow-up|1|||
155393538|NCT03085758|560876784|FG002|Overall Study|Lost to Follow-up|1|||
155393539|NCT03085758|560876782|FG000|Overall Study|Withdrawal by Subject|2|||
155393540|NCT03085758|560876783|FG001|Overall Study|Withdrawal by Subject|2|||
155393541|NCT03085758|560876784|FG002|Overall Study|Withdrawal by Subject|1|||
155393542|NCT03085758|560876782|FG000|Overall Study|Refusal to recall it up to day 90|0|||
155393543|NCT03085758|560876783|FG001|Overall Study|Refusal to recall it up to day 90|0|||
155393544|NCT03085758|560876784|FG002|Overall Study|Refusal to recall it up to day 90|1|||
155393545|NCT03085758|560876782|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
155393546|NCT03085758|560876783|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
155393547|NCT03085758|560876784|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
155393548|NCT01122576|560876785|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
155393549|NCT01122576|560876786|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
155393550|NCT01122576|560876787|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
155632859|NCT02030600|561749308|FG001|Treatment Period 1|Unclassified|0|||
155393551|NCT01122576|560876785|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
155393552|NCT01122576|560876786|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
155393553|NCT01122576|560876787|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
155393554|NCT01122576|560876785|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
155393555|NCT01122576|560876786|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
155393556|NCT01122576|560876787|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
155393557|NCT05696236|560876788|FG000|Overall Study|Lost to Follow-up|1|||
155393558|NCT05696236|560876789|FG001|Overall Study|Lost to Follow-up|0|||
155393559|NCT05696236|560876788|FG000|Overall Study|Later determined to not be eligible for participation|0|||
155393560|NCT05696236|560876789|FG001|Overall Study|Later determined to not be eligible for participation|1|||
155393561|NCT05696236|560876788|FG000|Overall Study|Withdrawal by Subject|2|||
155393562|NCT05696236|560876789|FG001|Overall Study|Withdrawal by Subject|2|||
155393563|NCT01829360|560876790|FG000|Overall Study|Protocol Violation|0|||
155393564|NCT01829360|560876791|FG001|Overall Study|Protocol Violation|0|||
155393565|NCT01829360|560876792|FG002|Overall Study|Protocol Violation|1|||
155632860|NCT02030600|561749307|FG000|Treatment Period 2|Adverse Event|4|||
155632861|NCT02030600|561749308|FG001|Treatment Period 2|Adverse Event|4|||
155632862|NCT02030600|561749307|FG000|Treatment Period 2|Lack of Efficacy|2|||
155632863|NCT02030600|561749308|FG001|Treatment Period 2|Lack of Efficacy|1|||
155632864|NCT02030600|561749307|FG000|Treatment Period 2|Lost to Follow-up|4|||
155632865|NCT02030600|561749308|FG001|Treatment Period 2|Lost to Follow-up|2|||
155632866|NCT02030600|561749307|FG000|Treatment Period 2|Protocol Violation|1|||
155632867|NCT02030600|561749308|FG001|Treatment Period 2|Protocol Violation|2|||
155632868|NCT02030600|561749307|FG000|Treatment Period 2|Withdrawal by Subject|13|||
155632869|NCT02030600|561749308|FG001|Treatment Period 2|Withdrawal by Subject|9|||
155632870|NCT02030600|561749307|FG000|Treatment Period 2|Unclassified|1|||
155632871|NCT02030600|561749308|FG001|Treatment Period 2|Unclassified|0|||
155632872|NCT01240694|561749309|FG000|Overall Study|Adverse Event|9|||
155632873|NCT01240694|561749309|FG000|Overall Study|Lack of Efficacy|6|||
155632874|NCT01240694|561749309|FG000|Overall Study|Withdrawal by Subject|6|||
155632875|NCT01240694|561749309|FG000|Overall Study|Protocol Violation|2|||
155393566|NCT01829360|560876793|FG003|Overall Study|Protocol Violation|0|||
155393567|NCT00024167|560876795|FG000|Overall Study|Death|53|||
155393568|NCT00024167|560876796|FG001|Overall Study|Death|47|||
155393569|NCT01132612|560876797|FG000|Overall Study|Death|0|||
155393570|NCT01132612|560876798|FG001|Overall Study|Death|0|||
155393571|NCT01132612|560876799|FG002|Overall Study|Death|1|||
155632876|NCT01240694|561749309|FG000|Overall Study|Lost to Follow-up|2|||
155632877|NCT01240694|561749309|FG000|Overall Study|Other than specified|3|||
155632878|NCT01240694|561749309|FG000|Overall Study|Withdrawn due to early study termination|107|||
155632879|NCT01881425|561749310|FG000|Overall Study|Death|5|||
155393572|NCT01132612|560876797|FG000|Overall Study|Protocol deviation|0|||
155393573|NCT01132612|560876798|FG001|Overall Study|Protocol deviation|0|||
155632880|NCT01881425|561749311|FG001|Overall Study|Death|1|||
155632881|NCT01881425|561749310|FG000|Overall Study|Withdrawal by Subject|8|||
155632882|NCT01881425|561749311|FG001|Overall Study|Withdrawal by Subject|3|||
155632883|NCT01881425|561749310|FG000|Overall Study|Physician Decision|2|||
155632884|NCT01881425|561749311|FG001|Overall Study|Physician Decision|1|||
155632885|NCT01881425|561749310|FG000|Overall Study|Adverse Event|3|||
155632886|NCT01881425|561749311|FG001|Overall Study|Adverse Event|0|||
155632887|NCT01881425|561749310|FG000|Overall Study|General Anesthesia panic attack|0|||
155632888|NCT01881425|561749311|FG001|Overall Study|General Anesthesia panic attack|1|||
155632889|NCT01881425|561749310|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
155632890|NCT01881425|561749311|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
155632891|NCT01881425|561749310|FG000|Overall Study|Lost to Follow-up|7|||
155632892|NCT01881425|561749311|FG001|Overall Study|Lost to Follow-up|2|||
155632893|NCT00701363|561749312|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
155632894|NCT00701363|561749313|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155632895|NCT00701363|561749314|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155632896|NCT00701363|561749315|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155632897|NCT00701363|561749312|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
155632898|NCT00701363|561749313|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
155632899|NCT00701363|561749314|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
155632900|NCT00701363|561749315|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
155632901|NCT00701363|561749312|FG000|Treatment Phase 1|Adverse Event|7|||
155632902|NCT00701363|561749313|FG001|Treatment Phase 1|Adverse Event|0|||
155632903|NCT00701363|561749314|FG002|Treatment Phase 1|Adverse Event|0|||
155632904|NCT00701363|561749315|FG003|Treatment Phase 1|Adverse Event|0|||
155632905|NCT00701363|561749312|FG000|Treatment Phase 1|Protocol Violation|1|||
155632906|NCT00701363|561749313|FG001|Treatment Phase 1|Protocol Violation|0|||
155632907|NCT00701363|561749314|FG002|Treatment Phase 1|Protocol Violation|0|||
155632908|NCT00701363|561749315|FG003|Treatment Phase 1|Protocol Violation|0|||
155632909|NCT00701363|561749312|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
155632910|NCT00701363|561749313|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
155632911|NCT00701363|561749314|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
155283138|NCT03251378|560468225|FG001|Overall Study|Physician Decision|2|||
155283139|NCT03251378|560468226|FG002|Overall Study|Physician Decision|0|||
155283140|NCT03251378|560468227|FG003|Overall Study|Physician Decision|0|||
155283141|NCT03251378|560468228|FG004|Overall Study|Physician Decision|0|||
155283142|NCT03251378|560468229|FG005|Overall Study|Physician Decision|0|||
155283143|NCT03251378|560468230|FG006|Overall Study|Physician Decision|0|||
155283144|NCT03251378|560468224|FG000|Overall Study|Other|2|||
155283145|NCT03251378|560468225|FG001|Overall Study|Other|3|||
155283146|NCT03251378|560468226|FG002|Overall Study|Other|2|||
155283147|NCT03251378|560468227|FG003|Overall Study|Other|0|||
155283148|NCT03251378|560468228|FG004|Overall Study|Other|1|||
155283149|NCT03251378|560468229|FG005|Overall Study|Other|1|||
155283150|NCT03251378|560468230|FG006|Overall Study|Other|1|||
155283151|NCT03251378|560468224|FG000|Overall Study|Other|0|||
155283152|NCT03251378|560468225|FG001|Overall Study|Other|0|||
155283153|NCT03251378|560468226|FG002|Overall Study|Other|0|||
155283154|NCT03251378|560468227|FG003|Overall Study|Other|4|||
155283155|NCT03251378|560468228|FG004|Overall Study|Other|13|||
155283156|NCT03251378|560468229|FG005|Overall Study|Other|0|||
155283157|NCT03251378|560468230|FG006|Overall Study|Other|0|||
155283158|NCT02956967|560468235|FG000|Overall Study|Adverse Event|3|||
155283159|NCT02956967|560468235|FG000|Overall Study|Reason non-related to neutropenia|10|||
155283160|NCT02956967|560468235|FG000|Overall Study|Lost to Follow-up|5|||
155283161|NCT02956967|560468235|FG000|Overall Study|Missing|1|||
155283162|NCT02956967|560468235|FG000|Overall Study|Termination of Nivestim administration|29|||
155283163|NCT02322775|560468236|FG000|Overall Study|Adverse Event|1|||
155283164|NCT02322775|560468237|FG001|Overall Study|Adverse Event|0|||
155283165|NCT02322775|560468236|FG000|Overall Study|Lost to Follow-up|0|||
155283166|NCT02322775|560468237|FG001|Overall Study|Lost to Follow-up|1|||
155283167|NCT02322775|560468236|FG000|Overall Study|Protocol Violation|1|||
155283168|NCT02322775|560468237|FG001|Overall Study|Protocol Violation|0|||
155283169|NCT02322775|560468236|FG000|Overall Study|Withdrawal by Subject|3|||
155283170|NCT02322775|560468237|FG001|Overall Study|Withdrawal by Subject|4|||
155283171|NCT02322775|560468236|FG000|Overall Study|Not willing to perform all FU visits|0|||
155283172|NCT02322775|560468237|FG001|Overall Study|Not willing to perform all FU visits|1|||
155283173|NCT04739423|560468238|FG000|Overall Study|Protocol Violation|0|||
155283174|NCT04739423|560468239|FG001|Overall Study|Protocol Violation|1|||
155283175|NCT04739423|560468240|FG002|Overall Study|Protocol Violation|0|||
155283176|NCT04739423|560468241|FG003|Overall Study|Protocol Violation|0|||
155283177|NCT04739423|560468242|FG004|Overall Study|Protocol Violation|0|||
155283178|NCT04739423|560468243|FG005|Overall Study|Protocol Violation|0|||
155283179|NCT04739423|560468238|FG000|Overall Study|Adverse Event|0|||
155283180|NCT04739423|560468239|FG001|Overall Study|Adverse Event|0|||
155283181|NCT04739423|560468240|FG002|Overall Study|Adverse Event|1|||
155393574|NCT01132612|560876799|FG002|Overall Study|Protocol deviation|3|||
155632912|NCT00701363|561749315|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
155632913|NCT00701363|561749312|FG000|Treatment Phase 1|Lack of Efficacy|1|||
155632914|NCT00701363|561749313|FG001|Treatment Phase 1|Lack of Efficacy|0|||
155632915|NCT00701363|561749314|FG002|Treatment Phase 1|Lack of Efficacy|0|||
155632916|NCT00701363|561749315|FG003|Treatment Phase 1|Lack of Efficacy|0|||
155632917|NCT00701363|561749312|FG000|Treatment Phase 2|Adverse Event|0|||
155632918|NCT00701363|561749313|FG001|Treatment Phase 2|Adverse Event|0|||
155632919|NCT00701363|561749314|FG002|Treatment Phase 2|Adverse Event|1|||
155632920|NCT00701363|561749315|FG003|Treatment Phase 2|Adverse Event|0|||
155632921|NCT00701363|561749312|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
155632922|NCT00701363|561749313|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
155632923|NCT00701363|561749314|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
155632924|NCT00701363|561749315|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
155632925|NCT04759131|561749316|FG000|Overall Study|Investigator's discretion|1|||
155632926|NCT04759131|561749317|FG001|Overall Study|Investigator's discretion|0|||
155632927|NCT04759131|561749316|FG000|Overall Study|Subject withdrawal|1|||
155632928|NCT04759131|561749317|FG001|Overall Study|Subject withdrawal|0|||
155632929|NCT00284856|561749321|FG000|Overall Study|Adverse Event|3|||
155632930|NCT00284856|561749322|FG001|Overall Study|Adverse Event|3|||
155632931|NCT00284856|561749323|FG002|Overall Study|Adverse Event|3|||
155632932|NCT00284856|561749321|FG000|Overall Study|Lack of Efficacy|2|||
155632933|NCT00284856|561749322|FG001|Overall Study|Lack of Efficacy|1|||
155632934|NCT00284856|561749323|FG002|Overall Study|Lack of Efficacy|8|||
155632935|NCT00284856|561749321|FG000|Overall Study|Lost to Follow-up|25|||
155632936|NCT00284856|561749322|FG001|Overall Study|Lost to Follow-up|21|||
155632937|NCT00284856|561749323|FG002|Overall Study|Lost to Follow-up|22|||
155632938|NCT00284856|561749321|FG000|Overall Study|Protocol Violation|5|||
155632939|NCT00284856|561749322|FG001|Overall Study|Protocol Violation|4|||
155632940|NCT00284856|561749323|FG002|Overall Study|Protocol Violation|5|||
155632941|NCT00284856|561749321|FG000|Overall Study|Withdrawal by Subject|12|||
155632942|NCT00284856|561749322|FG001|Overall Study|Withdrawal by Subject|16|||
155632943|NCT00284856|561749323|FG002|Overall Study|Withdrawal by Subject|18|||
155632944|NCT00284856|561749321|FG000|Overall Study|Other|4|||
155632945|NCT00284856|561749322|FG001|Overall Study|Other|5|||
155632946|NCT00284856|561749323|FG002|Overall Study|Other|4|||
155632947|NCT02592824|561749325|FG000|Overall Study|Protocol Violation|5|||
155632948|NCT02592824|561749326|FG001|Overall Study|Protocol Violation|3|||
155632949|NCT02592824|561749325|FG000|Overall Study|Lost to Follow-up|2|||
155632950|NCT02592824|561749326|FG001|Overall Study|Lost to Follow-up|1|||
155632951|NCT05082025|561749327|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
155632952|NCT00269152|561749330|FG000|Overall Study|Adverse Event|9|||
155632953|NCT00269152|561749331|FG001|Overall Study|Adverse Event|3|||
155632954|NCT00269152|561749330|FG000|Overall Study|Withdrawal by Subject|7|||
155632955|NCT00269152|561749331|FG001|Overall Study|Withdrawal by Subject|3|||
155632956|NCT00269152|561749330|FG000|Overall Study|Physician Decision|2|||
155632957|NCT00269152|561749331|FG001|Overall Study|Physician Decision|3|||
155632958|NCT00269152|561749330|FG000|Overall Study|Protocol Violation|0|||
155632959|NCT00269152|561749331|FG001|Overall Study|Protocol Violation|1|||
155632960|NCT05516758|561749334|FG000|Overall Study|Adverse Event|5|||
155632961|NCT05516758|561749335|FG001|Overall Study|Adverse Event|1|||
155632962|NCT05516758|561749336|FG002|Overall Study|Adverse Event|3|||
155632963|NCT05516758|561749337|FG003|Overall Study|Adverse Event|0|||
155632964|NCT05516758|561749338|FG004|Overall Study|Adverse Event|1|||
155632965|NCT05516758|561749339|FG005|Overall Study|Adverse Event|3|||
155632966|NCT05516758|561749340|FG006|Overall Study|Adverse Event|5|||
155632967|NCT05516758|561749334|FG000|Overall Study|Assigned treatment by mistake|1|||
155632968|NCT05516758|561749335|FG001|Overall Study|Assigned treatment by mistake|0|||
155632969|NCT05516758|561749336|FG002|Overall Study|Assigned treatment by mistake|0|||
155632970|NCT05516758|561749337|FG003|Overall Study|Assigned treatment by mistake|0|||
155632971|NCT05516758|561749338|FG004|Overall Study|Assigned treatment by mistake|1|||
155632972|NCT05516758|561749339|FG005|Overall Study|Assigned treatment by mistake|0|||
155735996|NCT02600819|562132449|FG000|GEN Phase|Lost to Follow-up|2|||
155632973|NCT05516758|561749340|FG006|Overall Study|Assigned treatment by mistake|0|||
155632974|NCT05516758|561749334|FG000|Overall Study|Lack of Efficacy|6|||
155632975|NCT05516758|561749335|FG001|Overall Study|Lack of Efficacy|0|||
155283182|NCT04739423|560468241|FG003|Overall Study|Adverse Event|0|||
155283183|NCT04739423|560468242|FG004|Overall Study|Adverse Event|1|||
155283184|NCT04739423|560468243|FG005|Overall Study|Adverse Event|0|||
155283185|NCT04739423|560468238|FG000|Overall Study|Withdrawal by Subject|0|||
155283186|NCT04739423|560468239|FG001|Overall Study|Withdrawal by Subject|0|||
155283187|NCT04739423|560468240|FG002|Overall Study|Withdrawal by Subject|0|||
155283188|NCT04739423|560468241|FG003|Overall Study|Withdrawal by Subject|0|||
155283189|NCT04739423|560468242|FG004|Overall Study|Withdrawal by Subject|0|||
155283190|NCT04739423|560468243|FG005|Overall Study|Withdrawal by Subject|1|||
155283191|NCT01007552|560468244|FG000|Overall Study|Withdrawal by Subject|1|||
155283192|NCT00764868|560468249|FG000|Overall Study|Adverse Event|18|||
155735997|NCT02600819|562132450|FG001|GEN Phase|Lost to Follow-up|0|||
155735998|NCT01621802|562132452|FG000|Overall Study|Protocol Violation|0|||
155735999|NCT01621802|562132453|FG001|Overall Study|Protocol Violation|0|||
155736000|NCT01621802|562132454|FG002|Overall Study|Protocol Violation|0|||
155736001|NCT01621802|562132455|FG003|Overall Study|Protocol Violation|0|||
155736002|NCT01621802|562132456|FG004|Overall Study|Protocol Violation|0|||
155736003|NCT01621802|562132457|FG005|Overall Study|Protocol Violation|1|||
155736004|NCT01621802|562132452|FG000|Overall Study|Withdrawal by Subject|8|||
155736005|NCT01621802|562132453|FG001|Overall Study|Withdrawal by Subject|4|||
155736006|NCT01621802|562132454|FG002|Overall Study|Withdrawal by Subject|4|||
155736007|NCT01621802|562132455|FG003|Overall Study|Withdrawal by Subject|2|||
155736008|NCT01621802|562132456|FG004|Overall Study|Withdrawal by Subject|2|||
155736009|NCT01621802|562132457|FG005|Overall Study|Withdrawal by Subject|0|||
155736010|NCT01621802|562132452|FG000|Overall Study|Migrated/moved from study area|0|||
155736011|NCT01621802|562132453|FG001|Overall Study|Migrated/moved from study area|0|||
155736012|NCT01621802|562132454|FG002|Overall Study|Migrated/moved from study area|2|||
155736013|NCT01621802|562132455|FG003|Overall Study|Migrated/moved from study area|0|||
155736014|NCT01621802|562132456|FG004|Overall Study|Migrated/moved from study area|1|||
155736015|NCT01621802|562132457|FG005|Overall Study|Migrated/moved from study area|0|||
155736016|NCT01621802|562132452|FG000|Overall Study|Others|3|||
155736017|NCT01621802|562132453|FG001|Overall Study|Others|3|||
155283193|NCT00764868|560468249|FG000|Overall Study|Withdrawal by Subject|31|||
155283194|NCT00764868|560468249|FG000|Overall Study|Non-compliance|16|||
155283195|NCT00764868|560468249|FG000|Overall Study|Lost to Follow-up|25|||
155283196|NCT00764868|560468249|FG000|Overall Study|Lack of Efficacy|5|||
155283197|NCT00764868|560468249|FG000|Overall Study|Subject moved|7|||
155283198|NCT00764868|560468249|FG000|Overall Study|Pregnancy|3|||
155283199|NCT00764868|560468249|FG000|Overall Study|Prohibited medication|1|||
155283200|NCT00764868|560468249|FG000|Overall Study|Out of town|1|||
155283201|NCT00764868|560468249|FG000|Overall Study|Misuse and compliance of study drug|1|||
155283202|NCT00764868|560468249|FG000|Overall Study|Subject sent to boarding school|1|||
155283203|NCT00764868|560468249|FG000|Overall Study|Met an exclusion criteria|1|||
155283204|NCT00764868|560468249|FG000|Overall Study|Positive drug screen|2|||
155283205|NCT00764868|560468249|FG000|Overall Study|Sponsor requested withdrawal|1|||
155283206|NCT00333138|560468259|FG000|Core Study (6 Months)|Adverse Event|4|||
155283207|NCT00333138|560468260|FG001|Core Study (6 Months)|Adverse Event|5|||
155283208|NCT00333138|560468261|FG002|Core Study (6 Months)|Adverse Event|8|||
155283209|NCT00333138|560468259|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
155283210|NCT00333138|560468260|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
155283211|NCT00333138|560468261|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
155283212|NCT00333138|560468259|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
155283213|NCT00333138|560468260|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
155283214|NCT00333138|560468261|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
155283215|NCT00333138|560468259|FG000|Core Study (6 Months)|Protocol Violation|1|||
155283216|NCT00333138|560468260|FG001|Core Study (6 Months)|Protocol Violation|0|||
155283217|NCT00333138|560468261|FG002|Core Study (6 Months)|Protocol Violation|1|||
155283218|NCT00333138|560468259|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
155283219|NCT00333138|560468260|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
155283220|NCT00333138|560468261|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
155283221|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
155283222|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
155283223|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
155283224|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
155283225|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
155283226|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
155283227|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
155283228|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
155283229|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
155283230|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
155283231|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
155283232|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
155283233|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
155283234|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
155283235|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
155283236|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
155283237|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
155283238|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
155283239|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
155736018|NCT01621802|562132454|FG002|Overall Study|Others|3|||
155736019|NCT01621802|562132455|FG003|Overall Study|Others|2|||
155736020|NCT01621802|562132456|FG004|Overall Study|Others|1|||
155736021|NCT01621802|562132457|FG005|Overall Study|Others|0|||
155736022|NCT01621802|562132452|FG000|Overall Study|Lost to Follow-up|36|||
155736023|NCT01621802|562132453|FG001|Overall Study|Lost to Follow-up|16|||
155736024|NCT01621802|562132454|FG002|Overall Study|Lost to Follow-up|24|||
155736025|NCT01621802|562132455|FG003|Overall Study|Lost to Follow-up|7|||
155736026|NCT01621802|562132456|FG004|Overall Study|Lost to Follow-up|31|||
155736027|NCT01621802|562132457|FG005|Overall Study|Lost to Follow-up|11|||
155736028|NCT01149148|562132458|FG000|Overall Study|Lost to Follow-up|1|||
155736029|NCT01149148|562132459|FG001|Overall Study|Lost to Follow-up|2|||
155736030|NCT01149148|562132458|FG000|Overall Study|Death|1|||
155736031|NCT01149148|562132459|FG001|Overall Study|Death|0|||
155736032|NCT03436082|562132460|FG000|Overall Study|Did not undergo procedure|1|||
155736033|NCT03436082|562132461|FG001|Overall Study|Did not undergo procedure|0|||
155736034|NCT04896086|562132462|FG000|Overall Study|Lost to Follow-up|0|||
155736035|NCT04896086|562132463|FG001|Overall Study|Lost to Follow-up|2|||
155736036|NCT04896086|562132464|FG002|Overall Study|Lost to Follow-up|1|||
155736037|NCT04896086|562132465|FG003|Overall Study|Lost to Follow-up|0|||
155736038|NCT04896086|562132466|FG004|Overall Study|Lost to Follow-up|0|||
155736039|NCT04896086|562132462|FG000|Overall Study|Physician Decision|0|||
155736040|NCT04896086|562132463|FG001|Overall Study|Physician Decision|1|||
155736041|NCT04896086|562132464|FG002|Overall Study|Physician Decision|0|||
155736042|NCT04896086|562132465|FG003|Overall Study|Physician Decision|0|||
155736043|NCT04896086|562132466|FG004|Overall Study|Physician Decision|0|||
155736044|NCT04896086|562132462|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155736045|NCT04896086|562132463|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155736046|NCT04896086|562132464|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155736047|NCT04896086|562132465|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
155736048|NCT04896086|562132466|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155736049|NCT04896086|562132462|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
155736050|NCT04896086|562132463|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
155736051|NCT04896086|562132464|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
155736052|NCT04896086|562132465|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
155736053|NCT04896086|562132466|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
155736054|NCT02249832|562132469|FG000|Overall Study|Withdrawal by Subject|3|||
155736055|NCT02249832|562132469|FG000|Overall Study|Lost to Follow-up|10|||
155736056|NCT02078960|562132472|FG000|Treatment Period|Other|0|||
155736057|NCT02078960|562132473|FG001|Treatment Period|Other|0|||
155736058|NCT02078960|562132474|FG002|Treatment Period|Other|1|||
155736059|NCT02078960|562132472|FG000|Treatment Period|Lack of Efficacy|0|||
155736060|NCT02078960|562132473|FG001|Treatment Period|Lack of Efficacy|1|||
155736061|NCT02078960|562132474|FG002|Treatment Period|Lack of Efficacy|0|||
155736062|NCT02078960|562132472|FG000|Treatment Period|Disease progression - accelerated phase|0|||
155736063|NCT02078960|562132473|FG001|Treatment Period|Disease progression - accelerated phase|1|||
155736064|NCT02078960|562132474|FG002|Treatment Period|Disease progression - accelerated phase|0|||
155736065|NCT02078960|562132472|FG000|Treatment Period|Disease progression - blast phase|1|||
155736066|NCT02078960|562132473|FG001|Treatment Period|Disease progression - blast phase|0|||
155736067|NCT02078960|562132474|FG002|Treatment Period|Disease progression - blast phase|0|||
155736068|NCT02078960|562132472|FG000|Treatment Period|Withdrawal by Subject|0|||
155736069|NCT02078960|562132473|FG001|Treatment Period|Withdrawal by Subject|1|||
155736070|NCT02078960|562132474|FG002|Treatment Period|Withdrawal by Subject|1|||
155736071|NCT02078960|562132472|FG000|Treatment Period|Adverse Event|1|||
155736072|NCT02078960|562132473|FG001|Treatment Period|Adverse Event|0|||
155736073|NCT02078960|562132474|FG002|Treatment Period|Adverse Event|0|||
155736074|NCT02078960|562132472|FG000|Treatment Period|Death|0|||
155736075|NCT02078960|562132473|FG001|Treatment Period|Death|0|||
155736076|NCT02078960|562132474|FG002|Treatment Period|Death|1|||
155736077|NCT02078960|562132472|FG000|Follow-up Period|Death|2|||
155736078|NCT02078960|562132473|FG001|Follow-up Period|Death|0|||
155736079|NCT02078960|562132474|FG002|Follow-up Period|Death|0|||
155736080|NCT02078960|562132472|FG000|Follow-up Period|Lost to Follow-up|0|||
155736081|NCT02078960|562132473|FG001|Follow-up Period|Lost to Follow-up|1|||
155736082|NCT02078960|562132474|FG002|Follow-up Period|Lost to Follow-up|0|||
155736083|NCT00859638|562132475|FG000|Overall Study|Lost to Follow-up|6|||
155736084|NCT00859638|562132476|FG001|Overall Study|Lost to Follow-up|1|||
155736085|NCT00859638|562132475|FG000|Overall Study|Withdrawal by Subject|3|||
155736086|NCT00859638|562132476|FG001|Overall Study|Withdrawal by Subject|2|||
155736087|NCT00859638|562132475|FG000|Overall Study|Ill health|1|||
155736088|NCT00859638|562132476|FG001|Overall Study|Ill health|1|||
155736089|NCT04643158|562132480|FG000|Overall Study|Study terminated by sponsor|0|||
155736090|NCT04643158|562132481|FG001|Overall Study|Study terminated by sponsor|0|||
155736091|NCT04643158|562132482|FG002|Overall Study|Study terminated by sponsor|1|||
155736092|NCT04643158|562132483|FG003|Overall Study|Study terminated by sponsor|0|||
155736093|NCT04643158|562132484|FG004|Overall Study|Study terminated by sponsor|0|||
155736094|NCT04643158|562132485|FG005|Overall Study|Study terminated by sponsor|1|||
155736095|NCT04643158|562132486|FG006|Overall Study|Study terminated by sponsor|0|||
155632976|NCT05516758|561749336|FG002|Overall Study|Lack of Efficacy|2|||
155632977|NCT05516758|561749337|FG003|Overall Study|Lack of Efficacy|0|||
155632978|NCT05516758|561749338|FG004|Overall Study|Lack of Efficacy|3|||
155632979|NCT05516758|561749339|FG005|Overall Study|Lack of Efficacy|6|||
155632980|NCT05516758|561749340|FG006|Overall Study|Lack of Efficacy|3|||
155632981|NCT05516758|561749334|FG000|Overall Study|Lost to Follow-up|2|||
155632982|NCT05516758|561749335|FG001|Overall Study|Lost to Follow-up|0|||
155632983|NCT05516758|561749336|FG002|Overall Study|Lost to Follow-up|2|||
155632984|NCT05516758|561749337|FG003|Overall Study|Lost to Follow-up|0|||
155632985|NCT05516758|561749338|FG004|Overall Study|Lost to Follow-up|3|||
155632986|NCT05516758|561749339|FG005|Overall Study|Lost to Follow-up|2|||
155632987|NCT05516758|561749340|FG006|Overall Study|Lost to Follow-up|1|||
155632988|NCT05516758|561749334|FG000|Overall Study|Other- As reported by the site|2|||
155632989|NCT05516758|561749335|FG001|Overall Study|Other- As reported by the site|1|||
155632990|NCT05516758|561749336|FG002|Overall Study|Other- As reported by the site|8|||
155632991|NCT05516758|561749337|FG003|Overall Study|Other- As reported by the site|1|||
155632992|NCT05516758|561749338|FG004|Overall Study|Other- As reported by the site|2|||
155632993|NCT05516758|561749339|FG005|Overall Study|Other- As reported by the site|3|||
155632994|NCT05516758|561749340|FG006|Overall Study|Other- As reported by the site|8|||
155632995|NCT05516758|561749334|FG000|Overall Study|Physician Decision|1|||
155632996|NCT05516758|561749335|FG001|Overall Study|Physician Decision|0|||
155632997|NCT05516758|561749336|FG002|Overall Study|Physician Decision|7|||
155632998|NCT05516758|561749337|FG003|Overall Study|Physician Decision|0|||
155632999|NCT05516758|561749338|FG004|Overall Study|Physician Decision|1|||
155633000|NCT05516758|561749339|FG005|Overall Study|Physician Decision|1|||
155633001|NCT05516758|561749340|FG006|Overall Study|Physician Decision|2|||
155633002|NCT05516758|561749334|FG000|Overall Study|Protocol Deviation|1|||
155633003|NCT05516758|561749335|FG001|Overall Study|Protocol Deviation|0|||
155633004|NCT05516758|561749336|FG002|Overall Study|Protocol Deviation|0|||
155633005|NCT05516758|561749337|FG003|Overall Study|Protocol Deviation|0|||
155633006|NCT05516758|561749338|FG004|Overall Study|Protocol Deviation|0|||
155633007|NCT05516758|561749339|FG005|Overall Study|Protocol Deviation|1|||
155633008|NCT05516758|561749340|FG006|Overall Study|Protocol Deviation|5|||
155633009|NCT05516758|561749334|FG000|Overall Study|Withdrawal by Subject|11|||
155633010|NCT05516758|561749335|FG001|Overall Study|Withdrawal by Subject|1|||
155633011|NCT05516758|561749336|FG002|Overall Study|Withdrawal by Subject|15|||
155633012|NCT05516758|561749337|FG003|Overall Study|Withdrawal by Subject|2|||
155633013|NCT05516758|561749338|FG004|Overall Study|Withdrawal by Subject|7|||
155633014|NCT05516758|561749339|FG005|Overall Study|Withdrawal by Subject|7|||
155633015|NCT05516758|561749340|FG006|Overall Study|Withdrawal by Subject|6|||
155633016|NCT05516758|561749334|FG000|Overall Study|Death|1|||
155633017|NCT05516758|561749335|FG001|Overall Study|Death|0|||
155633018|NCT05516758|561749336|FG002|Overall Study|Death|0|||
155633019|NCT05516758|561749337|FG003|Overall Study|Death|0|||
155633020|NCT05516758|561749338|FG004|Overall Study|Death|0|||
155633021|NCT05516758|561749339|FG005|Overall Study|Death|0|||
155633022|NCT05516758|561749340|FG006|Overall Study|Death|0|||
155633023|NCT05516758|561749334|FG000|Overall Study|Non-compliance With Study Drug|0|||
155633024|NCT05516758|561749335|FG001|Overall Study|Non-compliance With Study Drug|0|||
155633025|NCT05516758|561749336|FG002|Overall Study|Non-compliance With Study Drug|1|||
155633026|NCT05516758|561749337|FG003|Overall Study|Non-compliance With Study Drug|0|||
155633027|NCT05516758|561749338|FG004|Overall Study|Non-compliance With Study Drug|0|||
155633028|NCT05516758|561749339|FG005|Overall Study|Non-compliance With Study Drug|0|||
155633029|NCT05516758|561749340|FG006|Overall Study|Non-compliance With Study Drug|0|||
155633030|NCT05516758|561749334|FG000|Overall Study|Site Terminated by Sponsor|2|||
155633031|NCT05516758|561749335|FG001|Overall Study|Site Terminated by Sponsor|0|||
155633032|NCT05516758|561749336|FG002|Overall Study|Site Terminated by Sponsor|0|||
155633033|NCT05516758|561749337|FG003|Overall Study|Site Terminated by Sponsor|0|||
155633034|NCT05516758|561749338|FG004|Overall Study|Site Terminated by Sponsor|0|||
155633035|NCT05516758|561749339|FG005|Overall Study|Site Terminated by Sponsor|0|||
155633036|NCT05516758|561749340|FG006|Overall Study|Site Terminated by Sponsor|0|||
155633037|NCT05516758|561749334|FG000|Overall Study|Study Terminated by Sponsor|4|||
155633038|NCT05516758|561749335|FG001|Overall Study|Study Terminated by Sponsor|0|||
155633039|NCT05516758|561749336|FG002|Overall Study|Study Terminated by Sponsor|3|||
155633040|NCT05516758|561749337|FG003|Overall Study|Study Terminated by Sponsor|0|||
155633041|NCT05516758|561749338|FG004|Overall Study|Study Terminated by Sponsor|2|||
155633042|NCT05516758|561749339|FG005|Overall Study|Study Terminated by Sponsor|3|||
155633043|NCT05516758|561749340|FG006|Overall Study|Study Terminated by Sponsor|0|||
155633044|NCT05516758|561749334|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
155633045|NCT05516758|561749335|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
155633046|NCT05516758|561749336|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
155633047|NCT05516758|561749337|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
155633048|NCT05516758|561749338|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
155633049|NCT05516758|561749339|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
155633050|NCT05516758|561749340|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
155736096|NCT04643158|562132480|FG000|Overall Study|Global/country situation|0|||
155736097|NCT04643158|562132481|FG001|Overall Study|Global/country situation|0|||
155736098|NCT04643158|562132482|FG002|Overall Study|Global/country situation|1|||
155736099|NCT04643158|562132483|FG003|Overall Study|Global/country situation|0|||
155736100|NCT04643158|562132484|FG004|Overall Study|Global/country situation|0|||
155736101|NCT04643158|562132485|FG005|Overall Study|Global/country situation|0|||
155736102|NCT04643158|562132486|FG006|Overall Study|Global/country situation|0|||
155736103|NCT04643158|562132480|FG000|Overall Study|Withdrawal by Subject|0|||
155736104|NCT04643158|562132481|FG001|Overall Study|Withdrawal by Subject|0|||
155736105|NCT04643158|562132482|FG002|Overall Study|Withdrawal by Subject|0|||
155736106|NCT04643158|562132483|FG003|Overall Study|Withdrawal by Subject|0|||
155736107|NCT04643158|562132484|FG004|Overall Study|Withdrawal by Subject|0|||
155736108|NCT04643158|562132485|FG005|Overall Study|Withdrawal by Subject|1|||
155736109|NCT04643158|562132486|FG006|Overall Study|Withdrawal by Subject|0|||
155736110|NCT00622440|562132499|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
155736111|NCT00622440|562132500|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
155736112|NCT00622440|562132499|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
155736113|NCT00622440|562132500|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
155736114|NCT00622440|562132499|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
155736115|NCT00622440|562132500|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
155736116|NCT00622440|562132499|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
155736117|NCT00622440|562132500|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
155736118|NCT00771953|562132503|FG000|Overall Study|Adverse Event|5|||
155736119|NCT00771953|562132504|FG001|Overall Study|Adverse Event|3|||
155736120|NCT00771953|562132503|FG000|Overall Study|Death|2|||
155736121|NCT00771953|562132504|FG001|Overall Study|Death|2|||
155736122|NCT00771953|562132503|FG000|Overall Study|Progression before active Tx|1|||
155736123|NCT00771953|562132504|FG001|Overall Study|Progression before active Tx|2|||
155736124|NCT00771953|562132503|FG000|Overall Study|Sponsor decision|1|||
155736125|NCT00771953|562132504|FG001|Overall Study|Sponsor decision|0|||
155736126|NCT00771953|562132503|FG000|Overall Study|Other complicating disease|1|||
155736127|NCT00771953|562132504|FG001|Overall Study|Other complicating disease|0|||
155736128|NCT00771953|562132503|FG000|Overall Study|Withdrawal by Subject|0|||
155736129|NCT00771953|562132504|FG001|Overall Study|Withdrawal by Subject|3|||
155736130|NCT00947193|562132507|FG000|Overall Study|Lost to Follow-up|1|||
155736131|NCT00947193|562132508|FG001|Overall Study|Lost to Follow-up|0|||
155736132|NCT00947193|562132507|FG000|Overall Study|Withdrawal by Subject|1|||
155736133|NCT00947193|562132508|FG001|Overall Study|Withdrawal by Subject|0|||
155736134|NCT00947193|562132507|FG000|Overall Study|Factor VIII >1%|1|||
155736135|NCT00947193|562132508|FG001|Overall Study|Factor VIII >1%|0|||
155736136|NCT04364984|562132509|FG000|Overall Study|Death|2|||
155736137|NCT04364984|562132510|FG001|Overall Study|Death|2|||
155736138|NCT04364984|562132511|FG002|Overall Study|Death|0|||
155736139|NCT02867384|562132512|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
155736140|NCT02867384|562132513|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
155736141|NCT02867384|562132514|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
155736142|NCT02867384|562132512|FG000|Overall Study|Progression/ Relapse|15|||
155736143|NCT02867384|562132513|FG001|Overall Study|Progression/ Relapse|19|||
155736144|NCT02867384|562132514|FG002|Overall Study|Progression/ Relapse|0|||
155736145|NCT02867384|562132512|FG000|Overall Study|Adverse Event|13|||
155736146|NCT02867384|562132513|FG001|Overall Study|Adverse Event|1|||
155736147|NCT02867384|562132514|FG002|Overall Study|Adverse Event|0|||
155736148|NCT02867384|562132512|FG000|Overall Study|Withdrawal by Subject|6|||
155736149|NCT02867384|562132513|FG001|Overall Study|Withdrawal by Subject|5|||
155633051|NCT05516758|561749334|FG000|Overall Study|Other|0|||
155633052|NCT05516758|561749335|FG001|Overall Study|Other|0|||
155633053|NCT05516758|561749336|FG002|Overall Study|Other|0|||
155633054|NCT05516758|561749337|FG003|Overall Study|Other|0|||
155633055|NCT05516758|561749338|FG004|Overall Study|Other|0|||
155633056|NCT05516758|561749339|FG005|Overall Study|Other|0|||
155633057|NCT05516758|561749340|FG006|Overall Study|Other|1|||
155633058|NCT00402831|561749341|FG000|Overall Study|Lost to Follow-up|1|||
155633059|NCT00402831|561749342|FG001|Overall Study|Lost to Follow-up|2|||
155633060|NCT00402831|561749341|FG000|Overall Study|Non-compliance with protocol|0|||
155633061|NCT00402831|561749342|FG001|Overall Study|Non-compliance with protocol|1|||
155736150|NCT02867384|562132514|FG002|Overall Study|Withdrawal by Subject|0|||
155736151|NCT02867384|562132512|FG000|Overall Study|Physician Decision|1|||
155736152|NCT02867384|562132513|FG001|Overall Study|Physician Decision|2|||
155736153|NCT02867384|562132514|FG002|Overall Study|Physician Decision|0|||
155736154|NCT02867384|562132512|FG000|Overall Study|Patient compliance|1|||
155736155|NCT02867384|562132513|FG001|Overall Study|Patient compliance|0|||
155736156|NCT02867384|562132514|FG002|Overall Study|Patient compliance|0|||
155736157|NCT02867384|562132512|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
155736158|NCT02867384|562132513|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
155633062|NCT06178991|561749349|FG000|Overall Study|Withdrawal by Subject|2|||
155736159|NCT02867384|562132514|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
155736160|NCT02867384|562132512|FG000|Overall Study|Never start treatment|3|||
155736161|NCT02867384|562132513|FG001|Overall Study|Never start treatment|0|||
155736162|NCT02867384|562132514|FG002|Overall Study|Never start treatment|0|||
155736163|NCT01652534|562132515|FG000|Overall Study|Lack of Efficacy|1|||
155736164|NCT01652534|562132516|FG001|Overall Study|Lack of Efficacy|0|||
155736165|NCT01941186|562132517|FG000|Follow-up|Lost to Follow-up|1|||
155736166|NCT01941186|562132518|FG001|Follow-up|Lost to Follow-up|0|||
155736167|NCT02105961|562132519|FG000|Overall Study|Adverse Event|18|||
155736168|NCT02105961|562132520|FG001|Overall Study|Adverse Event|7|||
155736169|NCT02105961|562132521|FG002|Overall Study|Adverse Event|13|||
155736170|NCT02105961|562132519|FG000|Overall Study|Lack of Efficacy|3|||
155736171|NCT02105961|562132520|FG001|Overall Study|Lack of Efficacy|0|||
155736172|NCT02105961|562132521|FG002|Overall Study|Lack of Efficacy|3|||
155736173|NCT02105961|562132519|FG000|Overall Study|Lost to Follow-up|2|||
155736174|NCT02105961|562132520|FG001|Overall Study|Lost to Follow-up|0|||
155736175|NCT02105961|562132521|FG002|Overall Study|Lost to Follow-up|1|||
155736176|NCT02105961|562132519|FG000|Overall Study|Physician Decision|3|||
155736177|NCT02105961|562132520|FG001|Overall Study|Physician Decision|3|||
155736178|NCT02105961|562132521|FG002|Overall Study|Physician Decision|2|||
155736179|NCT02105961|562132519|FG000|Overall Study|Withdrawal by Subject|15|||
155736180|NCT02105961|562132520|FG001|Overall Study|Withdrawal by Subject|7|||
155736181|NCT02105961|562132521|FG002|Overall Study|Withdrawal by Subject|11|||
155736182|NCT02722304|562132525|FG000|Overall Study|Study Terminated by Sponsor|1|||
155736183|NCT02722304|562132526|FG001|Overall Study|Study Terminated by Sponsor|0|||
155736184|NCT02722304|562132527|FG002|Overall Study|Study Terminated by Sponsor|2|||
155736185|NCT02722304|562132528|FG003|Overall Study|Study Terminated by Sponsor|1|||
155736186|NCT02722304|562132529|FG004|Overall Study|Study Terminated by Sponsor|1|||
155736187|NCT02722304|562132525|FG000|Overall Study|Other|0|||
155736188|NCT02722304|562132526|FG001|Overall Study|Other|0|||
155736189|NCT02722304|562132527|FG002|Overall Study|Other|0|||
155736190|NCT02722304|562132528|FG003|Overall Study|Other|1|||
155736191|NCT02722304|562132529|FG004|Overall Study|Other|1|||
155736192|NCT00934362|562132530|FG000|Overall Study|Adverse Event|1|||
155736193|NCT00934362|562132531|FG001|Overall Study|Adverse Event|0|||
155736194|NCT04154189|562132534|FG000|Overall Study|Withdrawal by Subject|4|||
155736195|NCT04154189|562132535|FG001|Overall Study|Withdrawal by Subject|6|||
155736196|NCT04154189|562132534|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
155736197|NCT04154189|562132535|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
155736198|NCT04154189|562132534|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
155736199|NCT04154189|562132535|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
155736200|NCT04154189|562132534|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
155736201|NCT04154189|562132535|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
155736202|NCT04154189|562132534|FG000|Overall Study|Death|25|||
155736203|NCT04154189|562132535|FG001|Overall Study|Death|25|||
155736204|NCT01092117|562132536|FG000|Index Procedure to 1 Month|Death|1|||
155736205|NCT01092117|562132536|FG000|1 Month|Death|1|||
155736206|NCT01092117|562132536|FG000|1 Month|Withdrawal by Subject|1|||
155736207|NCT01092117|562132536|FG000|1 Month|Lost to Follow-up|1|||
155736208|NCT01092117|562132536|FG000|6 Months|Death|2|||
155736209|NCT01092117|562132536|FG000|6 Months|Withdrawal by Subject|3|||
155736210|NCT01092117|562132536|FG000|12 Month|Death|11|||
155736211|NCT01092117|562132536|FG000|12 Month|Withdrawal by Subject|2|||
155736212|NCT01092117|562132536|FG000|12 Month|Lost to Follow-up|1|||
155633063|NCT06178991|561749350|FG001|Overall Study|Withdrawal by Subject|6|||
155633064|NCT06178991|561749351|FG002|Overall Study|Withdrawal by Subject|44|||
155633065|NCT06178991|561749352|FG003|Overall Study|Withdrawal by Subject|23|||
155633066|NCT06178991|561749353|FG004|Overall Study|Withdrawal by Subject|7|||
155633067|NCT06178991|561749354|FG005|Overall Study|Withdrawal by Subject|7|||
155633068|NCT06178991|561749355|FG006|Overall Study|Withdrawal by Subject|7|||
155633069|NCT06178991|561749356|FG007|Overall Study|Withdrawal by Subject|5|||
155633070|NCT06178991|561749349|FG000|Overall Study|Lost to Follow-up|2|||
155633071|NCT06178991|561749350|FG001|Overall Study|Lost to Follow-up|4|||
155633072|NCT06178991|561749351|FG002|Overall Study|Lost to Follow-up|133|||
155633073|NCT06178991|561749352|FG003|Overall Study|Lost to Follow-up|65|||
155633074|NCT06178991|561749353|FG004|Overall Study|Lost to Follow-up|68|||
155633075|NCT06178991|561749354|FG005|Overall Study|Lost to Follow-up|57|||
155633076|NCT06178991|561749355|FG006|Overall Study|Lost to Follow-up|25|||
155633077|NCT06178991|561749356|FG007|Overall Study|Lost to Follow-up|18|||
155633078|NCT06178991|561749349|FG000|Overall Study|Death|1|||
155633079|NCT06178991|561749350|FG001|Overall Study|Death|0|||
155633080|NCT06178991|561749351|FG002|Overall Study|Death|2|||
155633081|NCT06178991|561749352|FG003|Overall Study|Death|1|||
155633082|NCT06178991|561749353|FG004|Overall Study|Death|1|||
155633083|NCT06178991|561749354|FG005|Overall Study|Death|0|||
155633084|NCT06178991|561749355|FG006|Overall Study|Death|1|||
155633085|NCT06178991|561749356|FG007|Overall Study|Death|1|||
155633086|NCT06178991|561749349|FG000|Overall Study|Randomized but not Vaccinated|4|||
155736213|NCT01092117|562132536|FG000|Year 2|Death|5|||
155736214|NCT01092117|562132536|FG000|Year 2|Withdrawal by Subject|4|||
155736215|NCT01092117|562132536|FG000|Year 2|Lost to Follow-up|1|||
155736216|NCT01092117|562132536|FG000|Year 3|Death|7|||
155736217|NCT01092117|562132536|FG000|Year 3|Withdrawal by Subject|9|||
155736218|NCT01092117|562132536|FG000|Year 3|Lost to Follow-up|3|||
155736219|NCT01092117|562132536|FG000|Year 4|Death|8|||
155736220|NCT01092117|562132536|FG000|Year 4|Withdrawal by Subject|4|||
155736221|NCT01092117|562132536|FG000|Year 4|Lost to Follow-up|4|||
155736222|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
155736223|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
155736224|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
155736225|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
155736226|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
155736227|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
155736228|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
155736229|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
155736230|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
155736231|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
155736232|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
155736233|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
155736234|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
155736235|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
155736236|NCT04173494|562132537|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
155736237|NCT04173494|562132538|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
155736238|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
155736239|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
155736240|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
155736241|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
155736242|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
155736243|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
155736244|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
155736245|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
155736246|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
155736247|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
155736248|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
155633087|NCT06178991|561749350|FG001|Overall Study|Randomized but not Vaccinated|1|||
155633088|NCT06178991|561749351|FG002|Overall Study|Randomized but not Vaccinated|15|||
155633089|NCT06178991|561749352|FG003|Overall Study|Randomized but not Vaccinated|9|||
155633090|NCT06178991|561749353|FG004|Overall Study|Randomized but not Vaccinated|8|||
155633091|NCT06178991|561749354|FG005|Overall Study|Randomized but not Vaccinated|4|||
155633092|NCT06178991|561749355|FG006|Overall Study|Randomized but not Vaccinated|2|||
155633093|NCT06178991|561749356|FG007|Overall Study|Randomized but not Vaccinated|2|||
155633094|NCT06178991|561749349|FG000|Overall Study|Other: Unspecified|0|||
155633095|NCT06178991|561749350|FG001|Overall Study|Other: Unspecified|1|||
155633096|NCT06178991|561749351|FG002|Overall Study|Other: Unspecified|7|||
155633097|NCT06178991|561749352|FG003|Overall Study|Other: Unspecified|6|||
155633098|NCT06178991|561749353|FG004|Overall Study|Other: Unspecified|1|||
155633099|NCT06178991|561749354|FG005|Overall Study|Other: Unspecified|1|||
155633100|NCT06178991|561749355|FG006|Overall Study|Other: Unspecified|1|||
155633101|NCT06178991|561749356|FG007|Overall Study|Other: Unspecified|0|||
155633102|NCT06178991|561749349|FG000|Overall Study|Physician Decision|0|||
155633103|NCT06178991|561749350|FG001|Overall Study|Physician Decision|0|||
155633104|NCT06178991|561749351|FG002|Overall Study|Physician Decision|2|||
155633105|NCT06178991|561749352|FG003|Overall Study|Physician Decision|0|||
155633106|NCT06178991|561749353|FG004|Overall Study|Physician Decision|2|||
155633107|NCT06178991|561749354|FG005|Overall Study|Physician Decision|1|||
155633108|NCT06178991|561749355|FG006|Overall Study|Physician Decision|0|||
155633109|NCT06178991|561749356|FG007|Overall Study|Physician Decision|0|||
155633110|NCT06178991|561749349|FG000|Overall Study|Protocol Violation|0|||
155633111|NCT06178991|561749350|FG001|Overall Study|Protocol Violation|0|||
155633112|NCT06178991|561749351|FG002|Overall Study|Protocol Violation|1|||
155633113|NCT06178991|561749352|FG003|Overall Study|Protocol Violation|0|||
155633114|NCT06178991|561749353|FG004|Overall Study|Protocol Violation|0|||
155633115|NCT06178991|561749354|FG005|Overall Study|Protocol Violation|0|||
155633116|NCT06178991|561749355|FG006|Overall Study|Protocol Violation|0|||
155633117|NCT06178991|561749356|FG007|Overall Study|Protocol Violation|0|||
155633118|NCT01366092|561749359|FG000|Overall Study|Progressive cGVHD|2|||
155633119|NCT01366092|561749359|FG000|Overall Study|Physician Decision|1|||
155633120|NCT01366092|561749359|FG000|Overall Study|Withdrawal by Subject|1|||
155736249|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
155736250|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
155633121|NCT02273167|561749363|FG000|Overall Study|Adverse Event|1|||
155633122|NCT02273167|561749364|FG001|Overall Study|Adverse Event|0|||
155736251|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
155736252|NCT04173494|562132537|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
155736253|NCT04173494|562132538|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
155736254|NCT01623050|562132539|FG000|Overall Study|Lost to Follow-up|9|||
155736255|NCT02147561|562132542|FG000|Overall Study|Lost to Follow-up|3|||
155736256|NCT02147561|562132542|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
155736257|NCT01191762|562132543|FG000|Overall Study|Adverse Event|1|||
155736258|NCT01191762|562132544|FG001|Overall Study|Adverse Event|0|||
155736259|NCT03023813|562132547|FG000|Overall Study|Lost to Follow-up|1|||
155736260|NCT03023813|562132548|FG001|Overall Study|Lost to Follow-up|2|||
155736261|NCT03023813|562132549|FG002|Overall Study|Lost to Follow-up|0|||
155736262|NCT00393861|562132550|FG000|Overall Study|Adverse Event|2|||
155736263|NCT00393861|562132550|FG000|Overall Study|Disease Progression|24|||
155736264|NCT03710083|562132551|FG000|Overall Study|Withdrawal by Subject|2|||
155736265|NCT03710083|562132551|FG000|Overall Study|Unsuccessful Procedure|1|||
155736266|NCT02123472|562132552|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
155736267|NCT02123472|562132553|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
155736268|NCT03801031|562132554|FG000|Overall Study|Lost to Follow-up|1|||
155736269|NCT03801031|562132555|FG001|Overall Study|Lost to Follow-up|0|||
155736270|NCT03801031|562132554|FG000|Overall Study|Unable to comply|1|||
155736271|NCT03801031|562132555|FG001|Overall Study|Unable to comply|0|||
155736272|NCT03801031|562132554|FG000|Overall Study|Withdrawal by Subject|0|||
155736273|NCT03801031|562132555|FG001|Overall Study|Withdrawal by Subject|1|||
155736274|NCT01598506|562132557|FG000|Overall Study|Withdrawal by Subject|2|||
155736275|NCT03865381|562132561|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
155736276|NCT03865381|562132561|FG000|Overall Study|Withdrawal by Subject|2|||
155736277|NCT00104520|562132562|FG000|Overall Study|Unrelated adverse event|34|||
155736278|NCT00104520|562132563|FG001|Overall Study|Unrelated adverse event|47|||
155736279|NCT00104520|562132562|FG000|Overall Study|Study drug intolerance|0|||
155736280|NCT00104520|562132563|FG001|Overall Study|Study drug intolerance|1|||
155736281|NCT00104520|562132562|FG000|Overall Study|Related adverse event|13|||
155736282|NCT00104520|562132563|FG001|Overall Study|Related adverse event|15|||
155736283|NCT00104520|562132562|FG000|Overall Study|Lost to Follow-up|1|||
155736284|NCT00104520|562132563|FG001|Overall Study|Lost to Follow-up|0|||
155736285|NCT00104520|562132562|FG000|Overall Study|Noncompliance|0|||
155736286|NCT00104520|562132563|FG001|Overall Study|Noncompliance|2|||
155736287|NCT00104520|562132562|FG000|Overall Study|Personal/administrative|1|||
155736288|NCT00104520|562132563|FG001|Overall Study|Personal/administrative|1|||
155736289|NCT00104520|562132562|FG000|Overall Study|Other|1|||
155736290|NCT00104520|562132563|FG001|Overall Study|Other|5|||
155736291|NCT04073225|562132564|FG000|Overall Study|Lost to Follow-up|4|||
155736292|NCT04073225|562132565|FG001|Overall Study|Lost to Follow-up|3|||
155736293|NCT00124306|562132567|FG000|Overall Study|Adverse Event|7|||
155736294|NCT00124306|562132568|FG001|Overall Study|Adverse Event|2|||
155736295|NCT00124306|562132567|FG000|Overall Study|Lost to Follow-up|10|||
155736296|NCT00124306|562132568|FG001|Overall Study|Lost to Follow-up|6|||
155736297|NCT00124306|562132567|FG000|Overall Study|Lack of Efficacy|3|||
155736298|NCT00124306|562132568|FG001|Overall Study|Lack of Efficacy|6|||
155736299|NCT00124306|562132567|FG000|Overall Study|Personal constraints|0|||
155736300|NCT00124306|562132568|FG001|Overall Study|Personal constraints|2|||
155736301|NCT00124306|562132567|FG000|Overall Study|Use of unacceptable medication|1|||
155736302|NCT00124306|562132568|FG001|Overall Study|Use of unacceptable medication|0|||
155736303|NCT00124306|562132567|FG000|Overall Study|Abnormal lab result|0|||
155736304|NCT00124306|562132568|FG001|Overall Study|Abnormal lab result|1|||
155736305|NCT00124306|562132567|FG000|Overall Study|Other|2|||
155736306|NCT00124306|562132568|FG001|Overall Study|Other|0|||
155736307|NCT04238819|562132569|FG000|Overall Study|Ongoing Treatment|0|||
155736308|NCT04238819|562132570|FG001|Overall Study|Ongoing Treatment|0|||
155736309|NCT04238819|562132571|FG002|Overall Study|Ongoing Treatment|0|||
155736310|NCT04238819|562132572|FG003|Overall Study|Ongoing Treatment|0|||
155736311|NCT04238819|562132573|FG004|Overall Study|Ongoing Treatment|1|||
155736312|NCT04238819|562132574|FG005|Overall Study|Ongoing Treatment|4|||
155736313|NCT04238819|562132575|FG006|Overall Study|Ongoing Treatment|0|||
155736314|NCT04238819|562132569|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
155736315|NCT04238819|562132570|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
155736316|NCT04238819|562132571|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
155736317|NCT04238819|562132572|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
155736318|NCT04238819|562132573|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
155736319|NCT04238819|562132574|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
155736320|NCT04238819|562132575|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
155736321|NCT05767749|562132576|FG000|Overall Study|Withdrawal by Subject|0|||
155736322|NCT05767749|562132577|FG001|Overall Study|Withdrawal by Subject|0|||
155736323|NCT05767749|562132578|FG002|Overall Study|Withdrawal by Subject|2|||
155736324|NCT05767749|562132579|FG003|Overall Study|Withdrawal by Subject|2|||
155736325|NCT05767749|562132580|FG004|Overall Study|Withdrawal by Subject|2|||
155736326|NCT05767749|562132581|FG005|Overall Study|Withdrawal by Subject|2|||
155736327|NCT00114517|562132582|FG000|Overall Study|Adverse Event|6|||
155736328|NCT00114517|562132583|FG001|Overall Study|Adverse Event|1|||
155736329|NCT00114517|562132584|FG002|Overall Study|Adverse Event|6|||
155736330|NCT00114517|562132585|FG003|Overall Study|Adverse Event|3|||
155736331|NCT00114517|562132582|FG000|Overall Study|Lost to Follow-up|2|||
155736332|NCT00114517|562132583|FG001|Overall Study|Lost to Follow-up|2|||
155736333|NCT00114517|562132584|FG002|Overall Study|Lost to Follow-up|2|||
155736334|NCT00114517|562132585|FG003|Overall Study|Lost to Follow-up|1|||
155736335|NCT00114517|562132582|FG000|Overall Study|Too busy|3|||
155736336|NCT00114517|562132583|FG001|Overall Study|Too busy|1|||
155633123|NCT02273167|561749365|FG002|Overall Study|Adverse Event|0|||
155633124|NCT02273167|561749363|FG000|Overall Study|Protocol Violation|3|||
155633125|NCT02273167|561749364|FG001|Overall Study|Protocol Violation|1|||
155633126|NCT02273167|561749365|FG002|Overall Study|Protocol Violation|1|||
155633127|NCT02273167|561749363|FG000|Overall Study|Lost to Follow-up|0|||
155633128|NCT02273167|561749364|FG001|Overall Study|Lost to Follow-up|1|||
155633129|NCT02273167|561749365|FG002|Overall Study|Lost to Follow-up|1|||
155633130|NCT02273167|561749363|FG000|Overall Study|Withdrawal by Subject|10|||
155633131|NCT02273167|561749364|FG001|Overall Study|Withdrawal by Subject|12|||
155633132|NCT02273167|561749365|FG002|Overall Study|Withdrawal by Subject|11|||
155633133|NCT02273167|561749363|FG000|Overall Study|Various|10|||
155633134|NCT02273167|561749364|FG001|Overall Study|Various|9|||
155633135|NCT02273167|561749365|FG002|Overall Study|Various|8|||
155633136|NCT00834041|561749370|FG000|Overall Study|Withdrawal by Subject|1|||
155633137|NCT00834041|561749371|FG001|Overall Study|Withdrawal by Subject|0|||
155633138|NCT00834041|561749370|FG000|Overall Study|Lost to Follow-up|0|||
155633139|NCT00834041|561749371|FG001|Overall Study|Lost to Follow-up|1|||
155633140|NCT03074500|561749372|FG000|Overall Study|Lost to Follow-up|1|||
155633141|NCT03074500|561749373|FG001|Overall Study|Lost to Follow-up|0|||
155633142|NCT03074500|561749374|FG002|Overall Study|Lost to Follow-up|0|||
155633143|NCT03074500|561749372|FG000|Overall Study|Lack of Efficacy|0|||
155633144|NCT03074500|561749373|FG001|Overall Study|Lack of Efficacy|1|||
155633145|NCT03074500|561749374|FG002|Overall Study|Lack of Efficacy|0|||
155633146|NCT03074500|561749372|FG000|Overall Study|Adverse Event|0|||
155633147|NCT03074500|561749373|FG001|Overall Study|Adverse Event|0|||
155633148|NCT03074500|561749374|FG002|Overall Study|Adverse Event|1|||
155633149|NCT01416571|561749377|FG000|Overall Study|Lost to Follow-up|2|||
155633150|NCT03608163|561749378|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
155633151|NCT03608163|561749379|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
155633152|NCT03353220|561749385|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
155633153|NCT03353220|561749386|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
155633154|NCT03586479|561749387|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
155633155|NCT03586479|561749388|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
155633156|NCT03586479|561749389|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
155633157|NCT03586479|561749387|FG000|Overall Study|Protocol Violation|2|||
155633158|NCT03586479|561749388|FG001|Overall Study|Protocol Violation|0|||
155633159|NCT03586479|561749389|FG002|Overall Study|Protocol Violation|0|||
155633160|NCT03586479|561749387|FG000|Overall Study|Lost to Follow-up|1|||
155633161|NCT03586479|561749388|FG001|Overall Study|Lost to Follow-up|1|||
155633162|NCT03586479|561749389|FG002|Overall Study|Lost to Follow-up|2|||
155633163|NCT03586479|561749387|FG000|Overall Study|Behavioral Issues|1|||
155633164|NCT03586479|561749388|FG001|Overall Study|Behavioral Issues|0|||
155633165|NCT03586479|561749389|FG002|Overall Study|Behavioral Issues|0|||
155633166|NCT03836053|561750755|FG000|Overall Study|Protocol-specified criteria|0|||
155633167|NCT03836053|561750756|FG001|Overall Study|Protocol-specified criteria|2|||
155633168|NCT03836053|561750757|FG002|Overall Study|Protocol-specified criteria|1|||
155633169|NCT03836053|561750755|FG000|Overall Study|Death|1|||
155633170|NCT03836053|561750756|FG001|Overall Study|Death|6|||
155633171|NCT03836053|561750757|FG002|Overall Study|Death|4|||
155633172|NCT03836053|561750755|FG000|Overall Study|Withdrawal of consent from study|0|||
155633173|NCT03836053|561750756|FG001|Overall Study|Withdrawal of consent from study|0|||
155633174|NCT03836053|561750757|FG002|Overall Study|Withdrawal of consent from study|1|||
155633175|NCT03836053|561750755|FG000|Overall Study|Decision by sponsor|0|||
155633176|NCT03836053|561750756|FG001|Overall Study|Decision by sponsor|2|||
155633177|NCT03836053|561750757|FG002|Overall Study|Decision by sponsor|4|||
155633178|NCT00788671|561750758|FG000|Overall Study|Death|2|||
155633179|NCT00788671|561750758|FG000|Overall Study|Unable to biopsy|1|||
155633180|NCT00788671|561750758|FG000|Overall Study|Withdrawal by Subject|4|||
155633181|NCT00788671|561750758|FG000|Overall Study|IUD expulsed|1|||
155633182|NCT00788671|561750758|FG000|Overall Study|Lost to follow up|2|||
155633183|NCT00375752|561750759|FG000|Overall Study|Lack of Efficacy|4|||
155633184|NCT00375752|561750760|FG001|Overall Study|Lack of Efficacy|4|||
155736337|NCT00114517|562132584|FG002|Overall Study|Too busy|1|||
155736338|NCT00114517|562132585|FG003|Overall Study|Too busy|2|||
155633185|NCT00375752|561750759|FG000|Overall Study|Adverse Event|1|||
155633186|NCT00375752|561750760|FG001|Overall Study|Adverse Event|6|||
155633187|NCT00375752|561750759|FG000|Overall Study|Withdrawal by Subject|6|||
155633188|NCT00375752|561750760|FG001|Overall Study|Withdrawal by Subject|1|||
155736339|NCT00114517|562132582|FG000|Overall Study|Moved from area|0|||
155736340|NCT00114517|562132583|FG001|Overall Study|Moved from area|3|||
155736341|NCT00114517|562132584|FG002|Overall Study|Moved from area|2|||
155736342|NCT00114517|562132585|FG003|Overall Study|Moved from area|1|||
155736343|NCT00114517|562132582|FG000|Overall Study|Did not want estradiol|1|||
155736344|NCT00114517|562132583|FG001|Overall Study|Did not want estradiol|1|||
155736345|NCT00114517|562132584|FG002|Overall Study|Did not want estradiol|0|||
155736346|NCT00114517|562132585|FG003|Overall Study|Did not want estradiol|0|||
155736347|NCT00114517|562132582|FG000|Overall Study|Armed-services duty|0|||
155736348|NCT00114517|562132583|FG001|Overall Study|Armed-services duty|1|||
155736349|NCT00114517|562132584|FG002|Overall Study|Armed-services duty|0|||
155736350|NCT00114517|562132585|FG003|Overall Study|Armed-services duty|1|||
155736351|NCT00114517|562132582|FG000|Overall Study|Competing family issue|0|||
155736352|NCT00114517|562132583|FG001|Overall Study|Competing family issue|1|||
155736353|NCT00114517|562132584|FG002|Overall Study|Competing family issue|0|||
155736354|NCT00114517|562132585|FG003|Overall Study|Competing family issue|1|||
155736355|NCT00114517|562132582|FG000|Overall Study|Physician Decision|0|||
155736356|NCT00114517|562132583|FG001|Overall Study|Physician Decision|1|||
155736357|NCT00114517|562132584|FG002|Overall Study|Physician Decision|0|||
155736358|NCT00114517|562132585|FG003|Overall Study|Physician Decision|0|||
155736359|NCT00114517|562132582|FG000|Overall Study|Lost interest|0|||
155736360|NCT00114517|562132583|FG001|Overall Study|Lost interest|0|||
155736361|NCT00114517|562132584|FG002|Overall Study|Lost interest|1|||
155736362|NCT00114517|562132585|FG003|Overall Study|Lost interest|0|||
155736363|NCT00114517|562132582|FG000|Overall Study|Weight increase|0|||
155736364|NCT00114517|562132583|FG001|Overall Study|Weight increase|0|||
155736365|NCT00114517|562132584|FG002|Overall Study|Weight increase|1|||
155736366|NCT00114517|562132585|FG003|Overall Study|Weight increase|0|||
155736367|NCT00114517|562132582|FG000|Overall Study|Concern about blood clots|0|||
155736368|NCT00114517|562132583|FG001|Overall Study|Concern about blood clots|0|||
155736369|NCT00114517|562132584|FG002|Overall Study|Concern about blood clots|1|||
155736370|NCT00114517|562132585|FG003|Overall Study|Concern about blood clots|0|||
155736371|NCT00114517|562132582|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155736372|NCT00114517|562132583|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155736373|NCT00114517|562132584|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155736374|NCT00114517|562132585|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
155736375|NCT04236141|562134139|FG000|Overall Study|Death|18|||
155736376|NCT04236141|562134140|FG001|Overall Study|Death|10|||
155736377|NCT04236141|562134139|FG000|Overall Study|Withdrawal by Participant|1|||
155736378|NCT04236141|562134140|FG001|Overall Study|Withdrawal by Participant|0|||
155736379|NCT04236141|562134139|FG000|Overall Study|Reason not Specified|1|||
155736380|NCT04236141|562134140|FG001|Overall Study|Reason not Specified|0|||
155736381|NCT04236141|562134139|FG000|Overall Study|Study terminated by Sponsor|8|||
155736382|NCT04236141|562134140|FG001|Overall Study|Study terminated by Sponsor|4|||
155736383|NCT01925131|562134141|FG000|Overall Study|Death|0|||
155736384|NCT01925131|562134142|FG001|Overall Study|Death|0|||
155736385|NCT01925131|562134143|FG002|Overall Study|Death|1|||
155736386|NCT01925131|562134144|FG003|Overall Study|Death|0|||
155736387|NCT01925131|562134145|FG004|Overall Study|Death|0|||
155736388|NCT01925131|562134146|FG005|Overall Study|Death|0|||
155736389|NCT01925131|562134141|FG000|Overall Study|Progression/Relapse|1|||
155736390|NCT01925131|562134142|FG001|Overall Study|Progression/Relapse|1|||
155736391|NCT01925131|562134143|FG002|Overall Study|Progression/Relapse|4|||
155736392|NCT01925131|562134144|FG003|Overall Study|Progression/Relapse|0|||
155736393|NCT01925131|562134145|FG004|Overall Study|Progression/Relapse|0|||
155736394|NCT01925131|562134146|FG005|Overall Study|Progression/Relapse|1|||
155736395|NCT01925131|562134141|FG000|Overall Study|Patient Refusal|1|||
155736396|NCT01925131|562134142|FG001|Overall Study|Patient Refusal|0|||
155736397|NCT01925131|562134143|FG002|Overall Study|Patient Refusal|0|||
155736398|NCT01925131|562134144|FG003|Overall Study|Patient Refusal|0|||
155736399|NCT01925131|562134145|FG004|Overall Study|Patient Refusal|0|||
155736400|NCT01925131|562134146|FG005|Overall Study|Patient Refusal|0|||
155736401|NCT01925131|562134141|FG000|Overall Study|Adverse Event|0|||
155736402|NCT01925131|562134142|FG001|Overall Study|Adverse Event|0|||
155736403|NCT01925131|562134143|FG002|Overall Study|Adverse Event|2|||
155736404|NCT01925131|562134144|FG003|Overall Study|Adverse Event|0|||
155736405|NCT01925131|562134145|FG004|Overall Study|Adverse Event|1|||
155736406|NCT01925131|562134146|FG005|Overall Study|Adverse Event|3|||
155736407|NCT01925131|562134141|FG000|Overall Study|Other - Not Protocol Specified|3|||
155736408|NCT01925131|562134142|FG001|Overall Study|Other - Not Protocol Specified|1|||
155736409|NCT01925131|562134143|FG002|Overall Study|Other - Not Protocol Specified|2|||
155736410|NCT01925131|562134144|FG003|Overall Study|Other - Not Protocol Specified|5|||
155736411|NCT01925131|562134145|FG004|Overall Study|Other - Not Protocol Specified|10|||
155736412|NCT01925131|562134146|FG005|Overall Study|Other - Not Protocol Specified|6|||
155736413|NCT01395524|562134151|FG000|Overall Study|Non-compliance with study schedule|1|||
155736414|NCT01395524|562134152|FG001|Overall Study|Non-compliance with study schedule|0|||
155736415|NCT01395524|562134153|FG002|Overall Study|Non-compliance with study schedule|1|||
155736416|NCT01395524|562134151|FG000|Overall Study|Lost to Follow-up|3|||
155736417|NCT01395524|562134152|FG001|Overall Study|Lost to Follow-up|1|||
155283240|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
155283241|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
155283242|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
155283243|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
155283244|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
155283245|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Death|0|||
155633189|NCT00375752|561750759|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155633190|NCT00375752|561750760|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155633191|NCT00375752|561750759|FG000|Overall Study|Protocol Violation|0|||
155633192|NCT00375752|561750760|FG001|Overall Study|Protocol Violation|2|||
155633193|NCT00375752|561750759|FG000|Overall Study|Administrative Problems|0|||
155633194|NCT00375752|561750760|FG001|Overall Study|Administrative Problems|1|||
155633195|NCT02469233|561750762|FG000|Overall Study|Death|1|||
155633196|NCT02469233|561750763|FG001|Overall Study|Death|1|||
155633197|NCT02469233|561750762|FG000|Overall Study|Lost to post or 6 month follow up|7|||
155633198|NCT02469233|561750763|FG001|Overall Study|Lost to post or 6 month follow up|2|||
155633199|NCT00855582|561750766|FG000|Overall Study|Adverse Event|2|||
155633200|NCT00855582|561750767|FG001|Overall Study|Adverse Event|6|||
155633201|NCT00855582|561750768|FG002|Overall Study|Adverse Event|3|||
155633202|NCT00855582|561750766|FG000|Overall Study|Death|1|||
155633203|NCT00855582|561750767|FG001|Overall Study|Death|0|||
155633204|NCT00855582|561750768|FG002|Overall Study|Death|0|||
155633205|NCT00855582|561750766|FG000|Overall Study|Lack of Efficacy|1|||
155633206|NCT00855582|561750767|FG001|Overall Study|Lack of Efficacy|3|||
155633207|NCT00855582|561750768|FG002|Overall Study|Lack of Efficacy|8|||
155633208|NCT00855582|561750766|FG000|Overall Study|Lost to Follow-up|1|||
155633209|NCT00855582|561750767|FG001|Overall Study|Lost to Follow-up|3|||
155633210|NCT00855582|561750768|FG002|Overall Study|Lost to Follow-up|1|||
155633211|NCT00855582|561750766|FG000|Overall Study|Physician Decision|0|||
155633212|NCT00855582|561750767|FG001|Overall Study|Physician Decision|0|||
155633213|NCT00855582|561750768|FG002|Overall Study|Physician Decision|1|||
155633214|NCT00855582|561750766|FG000|Overall Study|Protocol Violation|6|||
155633215|NCT00855582|561750767|FG001|Overall Study|Protocol Violation|2|||
155633216|NCT00855582|561750768|FG002|Overall Study|Protocol Violation|6|||
155633217|NCT00855582|561750766|FG000|Overall Study|Entry Criteria Not Met|8|||
155633218|NCT00855582|561750767|FG001|Overall Study|Entry Criteria Not Met|6|||
155633219|NCT00855582|561750768|FG002|Overall Study|Entry Criteria Not Met|3|||
155633220|NCT00855582|561750766|FG000|Overall Study|Withdrawal by Subject|7|||
155633221|NCT00855582|561750767|FG001|Overall Study|Withdrawal by Subject|4|||
155633222|NCT00855582|561750768|FG002|Overall Study|Withdrawal by Subject|8|||
155633223|NCT04757636|561750772|FG000|Overall Study|Adverse Event|25|||
155633224|NCT04757636|561750773|FG001|Overall Study|Adverse Event|8|||
155633225|NCT04757636|561750774|FG002|Overall Study|Adverse Event|11|||
155633226|NCT04757636|561750772|FG000|Overall Study|Death|9|||
155633227|NCT04757636|561750773|FG001|Overall Study|Death|12|||
155633228|NCT04757636|561750774|FG002|Overall Study|Death|6|||
155633229|NCT04757636|561750772|FG000|Overall Study|Lack of Efficacy|2|||
155633230|NCT04757636|561750773|FG001|Overall Study|Lack of Efficacy|0|||
155633231|NCT04757636|561750774|FG002|Overall Study|Lack of Efficacy|0|||
155633232|NCT04757636|561750772|FG000|Overall Study|Lost to Follow-up|1|||
155633233|NCT04757636|561750773|FG001|Overall Study|Lost to Follow-up|6|||
155633234|NCT04757636|561750774|FG002|Overall Study|Lost to Follow-up|7|||
155633235|NCT04757636|561750772|FG000|Overall Study|Physician Decision|1|||
155633236|NCT04757636|561750773|FG001|Overall Study|Physician Decision|3|||
155633237|NCT04757636|561750774|FG002|Overall Study|Physician Decision|4|||
155633238|NCT04757636|561750772|FG000|Overall Study|Withdrawal by Subject|20|||
155633239|NCT04757636|561750773|FG001|Overall Study|Withdrawal by Subject|23|||
155633240|NCT04757636|561750774|FG002|Overall Study|Withdrawal by Subject|18|||
155633241|NCT04757636|561750772|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
155633242|NCT04757636|561750773|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
155633243|NCT04757636|561750774|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
155633244|NCT04757636|561750772|FG000|Overall Study|Study Terminated by Sponsor|103|||
155633245|NCT04757636|561750773|FG001|Overall Study|Study Terminated by Sponsor|104|||
155633246|NCT04757636|561750774|FG002|Overall Study|Study Terminated by Sponsor|114|||
155633247|NCT04757636|561750772|FG000|Overall Study|Sponsor Decision|0|||
155633248|NCT04757636|561750773|FG001|Overall Study|Sponsor Decision|0|||
155633249|NCT04757636|561750774|FG002|Overall Study|Sponsor Decision|1|||
155633250|NCT04757636|561750772|FG000|Overall Study|Randomized in Error|0|||
155633251|NCT04757636|561750773|FG001|Overall Study|Randomized in Error|0|||
155633252|NCT04757636|561750774|FG002|Overall Study|Randomized in Error|2|||
155633253|NCT01732692|561750778|FG000|Overall Study|Adverse Event|0|||
155633254|NCT01732692|561750779|FG001|Overall Study|Adverse Event|1|||
155633255|NCT00656617|561750780|FG000|Overall Study|Adverse Event|1|||
155633256|NCT00656617|561750780|FG000|Overall Study|Death|2|||
155633257|NCT00656617|561750780|FG000|Overall Study|Insurance Issues|2|||
155633258|NCT00656617|561750780|FG000|Overall Study|Move to different clinical trial|2|||
155633259|NCT01155323|561750787|FG000|First Intervention|exclusion criteria|1|||
155736418|NCT01395524|562134153|FG002|Overall Study|Lost to Follow-up|1|||
155736419|NCT01395524|562134151|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
155736420|NCT01395524|562134152|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
155736421|NCT01395524|562134153|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
155736422|NCT01395524|562134151|FG000|Overall Study|Severe noncompliance with protocol|1|||
155736423|NCT01395524|562134152|FG001|Overall Study|Severe noncompliance with protocol|0|||
155736424|NCT01395524|562134153|FG002|Overall Study|Severe noncompliance with protocol|0|||
155736425|NCT01395524|562134151|FG000|Overall Study|Adverse Event|4|||
155736426|NCT01395524|562134152|FG001|Overall Study|Adverse Event|4|||
155736427|NCT01395524|562134153|FG002|Overall Study|Adverse Event|3|||
155736428|NCT01395524|562134151|FG000|Overall Study|Death|1|||
155736429|NCT01395524|562134152|FG001|Overall Study|Death|0|||
155736430|NCT01395524|562134153|FG002|Overall Study|Death|0|||
155736431|NCT01395524|562134151|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155736432|NCT01395524|562134152|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155736433|NCT01395524|562134153|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155736434|NCT01395524|562134151|FG000|Overall Study|Withdrawal by Subject|4|||
155736435|NCT01395524|562134152|FG001|Overall Study|Withdrawal by Subject|8|||
155736436|NCT01395524|562134153|FG002|Overall Study|Withdrawal by Subject|8|||
155736437|NCT01395524|562134151|FG000|Overall Study|Did not receive treatment|1|||
155736438|NCT01395524|562134152|FG001|Overall Study|Did not receive treatment|1|||
155736439|NCT01395524|562134153|FG002|Overall Study|Did not receive treatment|3|||
155736440|NCT01395524|562134151|FG000|Overall Study|Subject had spinal surgery|0|||
155736441|NCT01395524|562134152|FG001|Overall Study|Subject had spinal surgery|0|||
155736442|NCT01395524|562134153|FG002|Overall Study|Subject had spinal surgery|1|||
155736443|NCT01657461|562134154|FG000|Overall Study|Death|9|||
155736444|NCT01657461|562134155|FG001|Overall Study|Death|12|||
155736445|NCT01657461|562134154|FG000|Overall Study|Lost to Follow-up|0|||
155736446|NCT01657461|562134155|FG001|Overall Study|Lost to Follow-up|3|||
155736447|NCT01657461|562134154|FG000|Overall Study|Physician Decision|0|||
155736448|NCT01657461|562134155|FG001|Overall Study|Physician Decision|2|||
155736449|NCT01657461|562134154|FG000|Overall Study|Withdrawal by Subject|1|||
155736450|NCT01657461|562134155|FG001|Overall Study|Withdrawal by Subject|3|||
155736451|NCT02175199|562134163|FG000|Overall Study|Withdrawal by Subject|1|||
155736452|NCT02175199|562134164|FG001|Overall Study|Withdrawal by Subject|5|||
155736453|NCT02175199|562134163|FG000|Overall Study|Randomized in Error|1|||
155736454|NCT02175199|562134164|FG001|Overall Study|Randomized in Error|0|||
155736455|NCT02175199|562134163|FG000|Overall Study|Sponsor Decision|1|||
155736456|NCT02175199|562134164|FG001|Overall Study|Sponsor Decision|0|||
155633260|NCT01155323|561750788|FG001|First Intervention|exclusion criteria|1|||
155633261|NCT01155323|561750787|FG000|Second Intervention|Lost to Follow-up|1|||
155633262|NCT01155323|561750788|FG001|Second Intervention|Lost to Follow-up|1|||
155633263|NCT01208051|561750789|FG000|Total Enrollment|Withdrawal by Subject|0|||
155633264|NCT01208051|561750790|FG001|Total Enrollment|Withdrawal by Subject|1|||
155633265|NCT01208051|561750791|FG002|Total Enrollment|Withdrawal by Subject|0|||
155633266|NCT01208051|561750792|FG003|Total Enrollment|Withdrawal by Subject|0|||
155633267|NCT01208051|561750793|FG004|Total Enrollment|Withdrawal by Subject|2|||
155633268|NCT01208051|561750789|FG000|Total Enrollment|Brain metastases|0|||
155633269|NCT01208051|561750790|FG001|Total Enrollment|Brain metastases|0|||
155633270|NCT01208051|561750791|FG002|Total Enrollment|Brain metastases|1|||
155633271|NCT01208051|561750792|FG003|Total Enrollment|Brain metastases|0|||
155633272|NCT01208051|561750793|FG004|Total Enrollment|Brain metastases|0|||
155633273|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
155633274|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
155633275|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
155633276|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
155633277|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
155633278|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
155633279|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
155633280|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
155633281|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
155633282|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
155633283|NCT00973973|561750794|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
155736457|NCT00122980|562134165|FG000|Overall Study|Death|0|||
155736458|NCT00122980|562134166|FG001|Overall Study|Death|1|||
155736459|NCT00122980|562134165|FG000|Overall Study|Physician Decision|2|||
155736460|NCT00122980|562134166|FG001|Overall Study|Physician Decision|0|||
155736461|NCT00122980|562134165|FG000|Overall Study|Protocol Violation|5|||
155736462|NCT00122980|562134166|FG001|Overall Study|Protocol Violation|1|||
155736463|NCT00122980|562134165|FG000|Overall Study|Withdrawal by Subject|2|||
155736464|NCT00122980|562134166|FG001|Overall Study|Withdrawal by Subject|3|||
155736465|NCT00122980|562134165|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
155736466|NCT00122980|562134166|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
155736467|NCT00122980|562134165|FG000|Overall Study|Study termination|27|||
155736468|NCT00122980|562134166|FG001|Overall Study|Study termination|35|||
155736469|NCT01124864|562134169|FG000|Overall Study|Follow up phase competed as per protocol|18|||
155736470|NCT01124864|562134170|FG001|Overall Study|Follow up phase competed as per protocol|22|||
155736471|NCT01124864|562134171|FG002|Overall Study|Follow up phase competed as per protocol|24|||
155736472|NCT01124864|562134172|FG003|Overall Study|Follow up phase competed as per protocol|18|||
155736473|NCT01124864|562134173|FG004|Overall Study|Follow up phase competed as per protocol|26|||
155736474|NCT01124864|562134174|FG005|Overall Study|Follow up phase competed as per protocol|2|||
155736475|NCT01124864|562134169|FG000|Overall Study|Death|6|||
155736476|NCT01124864|562134170|FG001|Overall Study|Death|9|||
155736477|NCT01124864|562134171|FG002|Overall Study|Death|6|||
155736478|NCT01124864|562134172|FG003|Overall Study|Death|2|||
155736479|NCT01124864|562134173|FG004|Overall Study|Death|1|||
155736480|NCT01124864|562134174|FG005|Overall Study|Death|0|||
155736481|NCT01124864|562134169|FG000|Overall Study|Withdrawal by Subject|2|||
155736482|NCT01124864|562134170|FG001|Overall Study|Withdrawal by Subject|3|||
155736483|NCT01124864|562134171|FG002|Overall Study|Withdrawal by Subject|4|||
155736484|NCT01124864|562134172|FG003|Overall Study|Withdrawal by Subject|0|||
155736485|NCT01124864|562134173|FG004|Overall Study|Withdrawal by Subject|2|||
155633284|NCT00973973|561750795|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
155633285|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
155633286|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
155633287|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
155633288|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
155633289|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
155633290|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
155633291|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
155633292|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
155633293|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
155633294|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
155633295|NCT00973973|561750794|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
155633296|NCT00973973|561750795|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
155633297|NCT02471339|561750796|FG000|Overall Study|Did not provide follow-up data|2|||
155633298|NCT02471339|561750797|FG001|Overall Study|Did not provide follow-up data|0|||
155633299|NCT06057064|561750798|FG000|Overall Study|Death|2|||
155633300|NCT06057064|561750799|FG001|Overall Study|Death|0|||
155633301|NCT06057064|561750798|FG000|Overall Study|Physician Decision|1|||
155633302|NCT06057064|561750799|FG001|Overall Study|Physician Decision|0|||
155633303|NCT06057064|561750798|FG000|Overall Study|Withdrawal by Subject|1|||
155633304|NCT06057064|561750799|FG001|Overall Study|Withdrawal by Subject|1|||
155633305|NCT00851591|561750801|FG000|Overall Study|Withdrawal by Subject|2|||
155633306|NCT00851591|561750802|FG001|Overall Study|Withdrawal by Subject|0|||
155633307|NCT02736617|561750805|FG000|Treatment|Adverse Event|1|||
155633308|NCT02736617|561750805|FG000|Treatment|Lack of Efficacy|1|||
155633309|NCT02736617|561750805|FG000|Treatment|Withdrawal by Subject|1|||
155633310|NCT02736617|561750805|FG000|Maintenance|Lack of Efficacy|4|||
155633311|NCT02736617|561750805|FG000|Maintenance|Physician Decision|1|||
155633312|NCT02110693|561750808|FG000|Overall Study|Withdrawal by Subject|6|||
155633313|NCT02110693|561750809|FG001|Overall Study|Withdrawal by Subject|7|||
155633314|NCT02110693|561750808|FG000|Overall Study|skipped assessment|15|||
155633315|NCT02110693|561750809|FG001|Overall Study|skipped assessment|18|||
155633316|NCT02110693|561750808|FG000|Overall Study|technical difficulties|6|||
155633317|NCT02110693|561750809|FG001|Overall Study|technical difficulties|4|||
155633318|NCT02110693|561750808|FG000|Overall Study|Other|1|||
155633319|NCT02110693|561750809|FG001|Overall Study|Other|0|||
155633320|NCT00920816|561750810|FG000|Overall Study|Death|116|||
155633321|NCT00920816|561750811|FG001|Overall Study|Death|63|||
155633322|NCT00920816|561750812|FG002|Overall Study|Death|8|||
155633323|NCT00920816|561750813|FG003|Overall Study|Death|3|||
155633324|NCT00920816|561750810|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
155633325|NCT00920816|561750811|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
155633326|NCT00920816|561750812|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
155633327|NCT00920816|561750813|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
155633328|NCT00920816|561750810|FG000|Overall Study|Global deterioration of health status|2|||
155633329|NCT00920816|561750811|FG001|Overall Study|Global deterioration of health status|0|||
155633330|NCT00920816|561750812|FG002|Overall Study|Global deterioration of health status|0|||
155633331|NCT00920816|561750813|FG003|Overall Study|Global deterioration of health status|0|||
155633332|NCT00920816|561750810|FG000|Overall Study|Objective progression or relapse|6|||
155633333|NCT00920816|561750811|FG001|Overall Study|Objective progression or relapse|2|||
155736486|NCT01124864|562134174|FG005|Overall Study|Withdrawal by Subject|1|||
155736487|NCT01124864|562134169|FG000|Overall Study|Lost to Follow-up|1|||
155736488|NCT01124864|562134170|FG001|Overall Study|Lost to Follow-up|1|||
155736489|NCT01124864|562134171|FG002|Overall Study|Lost to Follow-up|0|||
155633334|NCT00920816|561750812|FG002|Overall Study|Objective progression or relapse|0|||
155736490|NCT01124864|562134172|FG003|Overall Study|Lost to Follow-up|1|||
155736491|NCT01124864|562134173|FG004|Overall Study|Lost to Follow-up|0|||
155736492|NCT01124864|562134174|FG005|Overall Study|Lost to Follow-up|0|||
155736493|NCT01124864|562134169|FG000|Overall Study|Protocol Violation|1|||
155736494|NCT01124864|562134170|FG001|Overall Study|Protocol Violation|0|||
155736495|NCT01124864|562134171|FG002|Overall Study|Protocol Violation|0|||
155736496|NCT01124864|562134172|FG003|Overall Study|Protocol Violation|0|||
155736497|NCT01124864|562134173|FG004|Overall Study|Protocol Violation|1|||
155736498|NCT01124864|562134174|FG005|Overall Study|Protocol Violation|0|||
155736499|NCT01761162|562134181|FG000|Overall Study|Withdrawal by Subject|3|||
155736500|NCT00724711|562134186|FG000|Overall Study|Adverse Event|7|||
155736501|NCT00724711|562134187|FG001|Overall Study|Adverse Event|3|||
155736502|NCT00724711|562134186|FG000|Overall Study|Pregnancy|0|||
155736503|NCT00724711|562134187|FG001|Overall Study|Pregnancy|1|||
155736504|NCT00724711|562134186|FG000|Overall Study|Lack of Efficacy|0|||
155736505|NCT00724711|562134187|FG001|Overall Study|Lack of Efficacy|1|||
155736506|NCT00724711|562134186|FG000|Overall Study|Physician Decision|0|||
155736507|NCT00724711|562134187|FG001|Overall Study|Physician Decision|3|||
155736508|NCT00724711|562134186|FG000|Overall Study|Withdrawal by Subject|5|||
155736509|NCT00724711|562134187|FG001|Overall Study|Withdrawal by Subject|4|||
155736510|NCT00724711|562134186|FG000|Overall Study|Lost to Follow-up|4|||
155736511|NCT00724711|562134187|FG001|Overall Study|Lost to Follow-up|5|||
155736512|NCT00724711|562134186|FG000|Overall Study|Protocol Violation|1|||
155736513|NCT00724711|562134187|FG001|Overall Study|Protocol Violation|0|||
155736514|NCT00745849|562134188|FG000|First Intervention|Withdrawal by Subject|0|||
155736515|NCT00745849|562134189|FG001|First Intervention|Withdrawal by Subject|1|||
155736516|NCT00745849|562134188|FG000|First Intervention|Lost to Follow-up|1|||
155736517|NCT00745849|562134189|FG001|First Intervention|Lost to Follow-up|1|||
155736518|NCT00745849|562134188|FG000|Second Intervention|Lost to Follow-up|2|||
155736519|NCT00745849|562134189|FG001|Second Intervention|Lost to Follow-up|1|||
155736520|NCT01139008|562134190|FG000|Overall Study|Withdrawal by Subject|5|||
155736521|NCT01139008|562134190|FG000|Overall Study|Non-compliant, lost product|1|||
155736522|NCT02100696|562134193|FG000|Induction Phase|Adverse Event|0|||
155736523|NCT02100696|562134194|FG001|Induction Phase|Adverse Event|0|||
155736524|NCT02100696|562134195|FG002|Induction Phase|Adverse Event|1|||
155736525|NCT02100696|562134196|FG003|Induction Phase|Adverse Event|0|||
155736526|NCT02100696|562134197|FG004|Induction Phase|Adverse Event|0|||
155736527|NCT02100696|562134198|FG005|Induction Phase|Adverse Event|0|||
155736528|NCT02100696|562134193|FG000|Induction Phase|Lost to Follow-up|1|||
155633335|NCT00920816|561750813|FG003|Overall Study|Objective progression or relapse|0|||
155633336|NCT00920816|561750810|FG000|Overall Study|Other|26|||
155633337|NCT00920816|561750811|FG001|Overall Study|Other|15|||
155633338|NCT00920816|561750812|FG002|Overall Study|Other|1|||
155633339|NCT00920816|561750813|FG003|Overall Study|Other|2|||
155633340|NCT00920816|561750810|FG000|Overall Study|Lost to Follow-up|11|||
155633341|NCT00920816|561750811|FG001|Overall Study|Lost to Follow-up|2|||
155633342|NCT00920816|561750812|FG002|Overall Study|Lost to Follow-up|0|||
155633343|NCT00920816|561750813|FG003|Overall Study|Lost to Follow-up|0|||
155633344|NCT00920816|561750810|FG000|Overall Study|Adverse Event|1|||
155633345|NCT00920816|561750811|FG001|Overall Study|Adverse Event|1|||
155633346|NCT00920816|561750812|FG002|Overall Study|Adverse Event|1|||
155633347|NCT00920816|561750813|FG003|Overall Study|Adverse Event|0|||
155633348|NCT00920816|561750810|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
155633349|NCT00920816|561750811|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
155633350|NCT00920816|561750812|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
155633351|NCT00920816|561750813|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
155633352|NCT00920816|561750810|FG000|Overall Study|Randomized but not treated|3|||
155633353|NCT00920816|561750811|FG001|Overall Study|Randomized but not treated|0|||
155633354|NCT00920816|561750812|FG002|Overall Study|Randomized but not treated|0|||
155633355|NCT00920816|561750813|FG003|Overall Study|Randomized but not treated|0|||
155633356|NCT01180777|561750814|FG000|Overall Study|Protocol Violation|6|||
155633357|NCT01180777|561750814|FG000|Overall Study|Poor lens fit|4|||
155633358|NCT01180777|561750814|FG000|Overall Study|Lost to Follow-up|1|||
155633359|NCT01180777|561750814|FG000|Overall Study|Adverse Event|1|||
155633360|NCT02606253|561750815|FG000|Overall Study|Adverse Event|2|||
155633361|NCT02606253|561750816|FG001|Overall Study|Adverse Event|0|||
155736529|NCT02100696|562134194|FG001|Induction Phase|Lost to Follow-up|0|||
155633362|NCT02606253|561750817|FG002|Overall Study|Adverse Event|0|||
155633363|NCT02606253|561750815|FG000|Overall Study|Protocol Violation|2|||
155736530|NCT02100696|562134195|FG002|Induction Phase|Lost to Follow-up|1|||
155736531|NCT02100696|562134196|FG003|Induction Phase|Lost to Follow-up|0|||
155736532|NCT02100696|562134197|FG004|Induction Phase|Lost to Follow-up|0|||
155633364|NCT02606253|561750816|FG001|Overall Study|Protocol Violation|1|||
155736533|NCT02100696|562134198|FG005|Induction Phase|Lost to Follow-up|0|||
155736534|NCT02100696|562134193|FG000|Induction Phase|Protocol Violation|0|||
155736535|NCT02100696|562134194|FG001|Induction Phase|Protocol Violation|1|||
155736536|NCT02100696|562134195|FG002|Induction Phase|Protocol Violation|1|||
155736537|NCT02100696|562134196|FG003|Induction Phase|Protocol Violation|0|||
155736538|NCT02100696|562134197|FG004|Induction Phase|Protocol Violation|0|||
155736539|NCT02100696|562134198|FG005|Induction Phase|Protocol Violation|0|||
155736540|NCT02100696|562134193|FG000|Induction Phase|Withdrawal by Subject|8|||
155736541|NCT02100696|562134194|FG001|Induction Phase|Withdrawal by Subject|2|||
155736542|NCT02100696|562134195|FG002|Induction Phase|Withdrawal by Subject|13|||
155736543|NCT02100696|562134196|FG003|Induction Phase|Withdrawal by Subject|0|||
155736544|NCT02100696|562134197|FG004|Induction Phase|Withdrawal by Subject|0|||
155736545|NCT02100696|562134198|FG005|Induction Phase|Withdrawal by Subject|0|||
155736546|NCT02100696|562134193|FG000|Induction Phase|Physician Decision|1|||
155736547|NCT02100696|562134194|FG001|Induction Phase|Physician Decision|0|||
155736548|NCT02100696|562134195|FG002|Induction Phase|Physician Decision|2|||
155736549|NCT02100696|562134196|FG003|Induction Phase|Physician Decision|0|||
155736550|NCT02100696|562134197|FG004|Induction Phase|Physician Decision|0|||
155736551|NCT02100696|562134198|FG005|Induction Phase|Physician Decision|0|||
155736552|NCT02100696|562134193|FG000|Induction Phase|Multiple Reasons|5|||
155736553|NCT02100696|562134194|FG001|Induction Phase|Multiple Reasons|2|||
155736554|NCT02100696|562134195|FG002|Induction Phase|Multiple Reasons|8|||
155736555|NCT02100696|562134196|FG003|Induction Phase|Multiple Reasons|0|||
155736556|NCT02100696|562134197|FG004|Induction Phase|Multiple Reasons|0|||
155736557|NCT02100696|562134198|FG005|Induction Phase|Multiple Reasons|0|||
155633365|NCT02606253|561750817|FG002|Overall Study|Protocol Violation|0|||
155633366|NCT02606253|561750815|FG000|Overall Study|Physician Decision|1|||
155633367|NCT02606253|561750816|FG001|Overall Study|Physician Decision|1|||
155633368|NCT02606253|561750817|FG002|Overall Study|Physician Decision|0|||
155633369|NCT01311661|561750822|FG000|Overall Study|Adverse Event|2|||
155633370|NCT01311661|561750822|FG000|Overall Study|Protocol Violation|3|||
155633371|NCT01311661|561750822|FG000|Overall Study|Withdrawal by Subject|2|||
155633372|NCT05853120|561750823|FG000|Overall Study|Lost to Follow-up|4|||
155633373|NCT05853120|561750824|FG001|Overall Study|Lost to Follow-up|4|||
155633374|NCT05853120|561750823|FG000|Overall Study|Physician Decision|3|||
155633375|NCT05853120|561750824|FG001|Overall Study|Physician Decision|0|||
155633376|NCT05853120|561750823|FG000|Overall Study|Withdrawal by Subject|5|||
155633377|NCT05853120|561750824|FG001|Overall Study|Withdrawal by Subject|2|||
155633378|NCT03426878|561750825|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
155633379|NCT03426878|561750825|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
155633380|NCT03426878|561750825|FG000|Overall Study|Declined to receive results|3|||
155633381|NCT03426878|561750825|FG000|Overall Study|Received negative results by mailed letter|65|||
155633382|NCT03426878|561750825|FG000|Overall Study|Lost to Follow-up|177|||
155633383|NCT00869960|561750827|FG000|Overall Study|Lost to Follow-up|2|||
155633384|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Adverse Event|6|||
155633385|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Adverse Event|15|||
155633386|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Adverse Event|0|||
155633387|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Death|0|||
155633388|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Death|2|||
155633389|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Death|0|||
155633390|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
155633391|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
155633392|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
155633393|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
155633394|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
155633395|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
155633396|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Physician Decision|1|||
155633397|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Physician Decision|1|||
155633398|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Physician Decision|0|||
155633399|NCT02921256|561750828|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
155633400|NCT02921256|561750829|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
155736558|NCT02100696|562134193|FG000|Maintenance Phase|Adverse Event|0|||
155736559|NCT02100696|562134194|FG001|Maintenance Phase|Adverse Event|0|||
155736560|NCT02100696|562134195|FG002|Maintenance Phase|Adverse Event|0|||
155736561|NCT02100696|562134196|FG003|Maintenance Phase|Adverse Event|0|||
155736562|NCT02100696|562134197|FG004|Maintenance Phase|Adverse Event|0|||
155736563|NCT02100696|562134198|FG005|Maintenance Phase|Adverse Event|2|||
155633401|NCT02921256|561750830|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
155633402|NCT02921256|561750828|FG000|Arm Ib v Arm III|Adverse Event|9|||
155633403|NCT02921256|561750829|FG001|Arm Ib v Arm III|Adverse Event|0|||
155633404|NCT02921256|561750830|FG002|Arm Ib v Arm III|Adverse Event|4|||
155633405|NCT02921256|561750828|FG000|Arm Ib v Arm III|Death|1|||
155633406|NCT02921256|561750829|FG001|Arm Ib v Arm III|Death|0|||
155633407|NCT02921256|561750830|FG002|Arm Ib v Arm III|Death|1|||
155633408|NCT02921256|561750828|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
155633409|NCT02921256|561750829|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
155736564|NCT02100696|562134193|FG000|Maintenance Phase|Lost to Follow-up|0|||
155736565|NCT02100696|562134194|FG001|Maintenance Phase|Lost to Follow-up|0|||
155736566|NCT02100696|562134195|FG002|Maintenance Phase|Lost to Follow-up|0|||
155736567|NCT02100696|562134196|FG003|Maintenance Phase|Lost to Follow-up|0|||
155736568|NCT02100696|562134197|FG004|Maintenance Phase|Lost to Follow-up|1|||
155736569|NCT02100696|562134198|FG005|Maintenance Phase|Lost to Follow-up|0|||
155736570|NCT02100696|562134193|FG000|Maintenance Phase|Protocol Violation|0|||
155736571|NCT02100696|562134194|FG001|Maintenance Phase|Protocol Violation|0|||
155736572|NCT02100696|562134195|FG002|Maintenance Phase|Protocol Violation|0|||
155736573|NCT02100696|562134196|FG003|Maintenance Phase|Protocol Violation|0|||
155736574|NCT02100696|562134197|FG004|Maintenance Phase|Protocol Violation|1|||
155736575|NCT02100696|562134198|FG005|Maintenance Phase|Protocol Violation|0|||
155736576|NCT02100696|562134193|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155736577|NCT02100696|562134194|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155736578|NCT02100696|562134195|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155736579|NCT02100696|562134196|FG003|Maintenance Phase|Withdrawal by Subject|1|||
155736580|NCT02100696|562134197|FG004|Maintenance Phase|Withdrawal by Subject|4|||
155736581|NCT02100696|562134198|FG005|Maintenance Phase|Withdrawal by Subject|2|||
155736582|NCT02100696|562134193|FG000|Maintenance Phase|Physician Decision|0|||
155736583|NCT02100696|562134194|FG001|Maintenance Phase|Physician Decision|0|||
155736584|NCT02100696|562134195|FG002|Maintenance Phase|Physician Decision|0|||
155736585|NCT02100696|562134196|FG003|Maintenance Phase|Physician Decision|0|||
155736586|NCT02100696|562134197|FG004|Maintenance Phase|Physician Decision|1|||
155736587|NCT02100696|562134198|FG005|Maintenance Phase|Physician Decision|0|||
155736588|NCT02100696|562134193|FG000|Maintenance Phase|Multiple Reasons|0|||
155736589|NCT02100696|562134194|FG001|Maintenance Phase|Multiple Reasons|0|||
155736590|NCT02100696|562134195|FG002|Maintenance Phase|Multiple Reasons|0|||
155736591|NCT02100696|562134196|FG003|Maintenance Phase|Multiple Reasons|0|||
155736592|NCT02100696|562134197|FG004|Maintenance Phase|Multiple Reasons|2|||
155736593|NCT02100696|562134198|FG005|Maintenance Phase|Multiple Reasons|1|||
155736594|NCT01583296|562134203|FG000|Overall Study|Withdrawal by Subject|11|||
155736595|NCT01583296|562134204|FG001|Overall Study|Withdrawal by Subject|10|||
155736596|NCT01063283|562134205|FG000|Cycle 1|Adverse Event|2|||
155736597|NCT01063283|562134206|FG001|Cycle 1|Adverse Event|0|||
155736598|NCT01063283|562134207|FG002|Cycle 1|Adverse Event|0|||
155736599|NCT01063283|562134205|FG000|Cycle 1|Technical failure in data collection|1|||
155736600|NCT01063283|562134206|FG001|Cycle 1|Technical failure in data collection|0|||
155736601|NCT01063283|562134207|FG002|Cycle 1|Technical failure in data collection|0|||
155736602|NCT02504216|562134210|FG000|Overall Study|Lost to Follow-up|3|||
155736603|NCT02504216|562134211|FG001|Overall Study|Lost to Follow-up|3|||
155736604|NCT02504216|562134210|FG000|Overall Study|Withdrawal by Subject|8|||
155736605|NCT02504216|562134211|FG001|Overall Study|Withdrawal by Subject|12|||
155736606|NCT00223080|562134212|FG000|Overall Study|Withdrawal by Subject|253|||
155736607|NCT00223080|562134213|FG001|Overall Study|Withdrawal by Subject|232|||
155736608|NCT00223080|562134212|FG000|Overall Study|Required contraindicated med|0|||
155736609|NCT00223080|562134213|FG001|Overall Study|Required contraindicated med|1|||
155736610|NCT00223080|562134212|FG000|Overall Study|Non-compliant|7|||
155736611|NCT00223080|562134213|FG001|Overall Study|Non-compliant|7|||
155736612|NCT00223080|562134212|FG000|Overall Study|Moved from study area|37|||
155736613|NCT00223080|562134213|FG001|Overall Study|Moved from study area|47|||
155736614|NCT00223080|562134212|FG000|Overall Study|Lost to Follow-up|259|||
155736615|NCT00223080|562134213|FG001|Overall Study|Lost to Follow-up|284|||
155736616|NCT00223080|562134212|FG000|Overall Study|Death|85|||
155736617|NCT00223080|562134213|FG001|Overall Study|Death|74|||
155736618|NCT00223080|562134212|FG000|Overall Study|Other|14|||
155736619|NCT00223080|562134213|FG001|Overall Study|Other|11|||
155736620|NCT00223080|562134212|FG000|Overall Study|Reason not provided|141|||
155736621|NCT00223080|562134213|FG001|Overall Study|Reason not provided|140|||
155736622|NCT00223080|562134212|FG000|Overall Study|Adverse Event|0|||
155283246|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Death|1|||
155283247|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Death|0|||
155283248|NCT03005288|560468262|FG000|Overall Study|Withdrawal by Subject|7|||
155283249|NCT03005288|560468263|FG001|Overall Study|Withdrawal by Subject|5|||
155283250|NCT03005288|560468262|FG000|Overall Study|Lost to Follow-up|0|||
155283251|NCT03005288|560468263|FG001|Overall Study|Lost to Follow-up|1|||
155736623|NCT00223080|562134213|FG001|Overall Study|Adverse Event|1|||
155736624|NCT02598583|562134214|FG000|Extension Period|Withdrawal by Subject|1|||
155736625|NCT02598583|562134215|FG001|Extension Period|Withdrawal by Subject|0|||
155736626|NCT03237286|562134216|FG000|Overall Study|Withdrawal by Subject|1|||
155736627|NCT03237286|562134217|FG001|Overall Study|Withdrawal by Subject|0|||
155736628|NCT03237286|562134218|FG002|Overall Study|Withdrawal by Subject|2|||
155736629|NCT03237286|562134216|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
155283252|NCT03005288|560468262|FG000|Overall Study|Adverse Event|5|||
155736630|NCT03237286|562134217|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
155736631|NCT03237286|562134218|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
155736632|NCT02792829|562134226|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736633|NCT02792829|562134227|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
155736634|NCT02792829|562134228|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736635|NCT02792829|562134229|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736636|NCT02792829|562134230|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736637|NCT02792829|562134231|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736638|NCT02792829|562134232|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736639|NCT02792829|562134233|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155736640|NCT02792829|562134226|FG000|Treatment Period 2|Adverse Event|0|||
155736641|NCT02792829|562134227|FG001|Treatment Period 2|Adverse Event|0|||
155736642|NCT02792829|562134228|FG002|Treatment Period 2|Adverse Event|0|||
155736643|NCT02792829|562134229|FG003|Treatment Period 2|Adverse Event|0|||
155736644|NCT02792829|562134230|FG004|Treatment Period 2|Adverse Event|1|||
155736645|NCT02792829|562134231|FG005|Treatment Period 2|Adverse Event|0|||
155736646|NCT02792829|562134232|FG006|Treatment Period 2|Adverse Event|1|||
155736647|NCT02792829|562134233|FG007|Treatment Period 2|Adverse Event|1|||
155736648|NCT02792829|562134226|FG000|Treatment Period 2|Use of proscribed medications|0|||
155736649|NCT02792829|562134227|FG001|Treatment Period 2|Use of proscribed medications|0|||
155736650|NCT02792829|562134228|FG002|Treatment Period 2|Use of proscribed medications|0|||
155736651|NCT02792829|562134229|FG003|Treatment Period 2|Use of proscribed medications|0|||
155736652|NCT02792829|562134230|FG004|Treatment Period 2|Use of proscribed medications|0|||
155736653|NCT02792829|562134231|FG005|Treatment Period 2|Use of proscribed medications|0|||
155736654|NCT02792829|562134232|FG006|Treatment Period 2|Use of proscribed medications|0|||
155736655|NCT02792829|562134233|FG007|Treatment Period 2|Use of proscribed medications|1|||
155736656|NCT01010867|562134239|FG000|Overall Study|< 50% adherence to probiotic|1|||
155736657|NCT01668589|562134240|FG000|Overall Study|Lost to Follow-up|29|||
155736658|NCT01668589|562134241|FG001|Overall Study|Lost to Follow-up|37|||
155736659|NCT01668589|562134242|FG002|Overall Study|Lost to Follow-up|15|||
155736660|NCT01668589|562134243|FG003|Overall Study|Lost to Follow-up|5|||
155736661|NCT01668589|562134240|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
155736662|NCT01668589|562134241|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
155736663|NCT01668589|562134242|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
155736664|NCT01668589|562134243|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
155736665|NCT01668589|562134240|FG000|Overall Study|Death|12|||
155736666|NCT01668589|562134241|FG001|Overall Study|Death|3|||
155736667|NCT01668589|562134242|FG002|Overall Study|Death|2|||
155736668|NCT01668589|562134243|FG003|Overall Study|Death|11|||
155736669|NCT01668589|562134240|FG000|Overall Study|Other|44|||
155736670|NCT01668589|562134241|FG001|Overall Study|Other|10|||
155736671|NCT01668589|562134242|FG002|Overall Study|Other|7|||
155736672|NCT01668589|562134243|FG003|Overall Study|Other|15|||
155736673|NCT00233064|562134244|FG000|Overall Study|Lost to Follow-up|7|||
155736674|NCT00233064|562134245|FG001|Overall Study|Lost to Follow-up|7|||
155736675|NCT00233064|562134244|FG000|Overall Study|Withdrawal by Subject|5|||
155736676|NCT00233064|562134245|FG001|Overall Study|Withdrawal by Subject|3|||
155736677|NCT00233064|562134244|FG000|Overall Study|Death|0|||
155736678|NCT00233064|562134245|FG001|Overall Study|Death|1|||
155736679|NCT00233064|562134244|FG000|Overall Study|Relocation|0|||
155736680|NCT00233064|562134245|FG001|Overall Study|Relocation|1|||
155736681|NCT00233064|562134244|FG000|Overall Study|Protocol Violation|1|||
155736682|NCT00233064|562134245|FG001|Overall Study|Protocol Violation|0|||
155736683|NCT00233064|562134244|FG000|Overall Study|Moved to Dom. Republic|1|||
155736684|NCT00233064|562134245|FG001|Overall Study|Moved to Dom. Republic|0|||
155736685|NCT02302339|562134246|FG000|Overall Study|Lost to Follow-up|1|||
155283253|NCT03005288|560468263|FG001|Overall Study|Adverse Event|0|||
155283254|NCT03005288|560468262|FG000|Overall Study|Protocol deviation|0|||
155736686|NCT02302339|562134247|FG001|Overall Study|Lost to Follow-up|0|||
155736687|NCT02302339|562134248|FG002|Overall Study|Lost to Follow-up|0|||
155736688|NCT02302339|562134249|FG003|Overall Study|Lost to Follow-up|0|||
155736689|NCT02302339|562134246|FG000|Overall Study|Withdrawal by Subject|0|||
155736690|NCT02302339|562134247|FG001|Overall Study|Withdrawal by Subject|2|||
155736691|NCT02302339|562134248|FG002|Overall Study|Withdrawal by Subject|1|||
155283255|NCT03005288|560468263|FG001|Overall Study|Protocol deviation|1|||
155283256|NCT03005288|560468262|FG000|Overall Study|Physician Decision|0|||
155283257|NCT03005288|560468263|FG001|Overall Study|Physician Decision|1|||
155283258|NCT04438785|560468264|FG000|Overall Study|change of weight, give up intervention|2|||
155283259|NCT04438785|560468265|FG001|Overall Study|change of weight, give up intervention|10|||
155283260|NCT04011033|560468266|FG000|Overall Study|Physician Decision|2|||
155283261|NCT04011033|560468267|FG001|Overall Study|Physician Decision|3|||
155393575|NCT01132612|560876797|FG000|Overall Study|Lost to Follow-up|2|||
155736692|NCT02302339|562134249|FG003|Overall Study|Withdrawal by Subject|0|||
155736693|NCT04393454|562134252|FG000|Overall Study|Death|1|||
155736694|NCT04393454|562134252|FG000|Overall Study|Lost to Follow-up|1|||
155736695|NCT02752165|562134254|FG000|Overall Study|Withdrawal by Subject|6|||
155736696|NCT02752165|562134255|FG001|Overall Study|Withdrawal by Subject|6|||
155736697|NCT02752165|562134254|FG000|Overall Study|Protocol Violation|6|||
155393576|NCT01132612|560876798|FG001|Overall Study|Lost to Follow-up|2|||
155736698|NCT02752165|562134255|FG001|Overall Study|Protocol Violation|5|||
155736699|NCT02752165|562134254|FG000|Overall Study|Lost to Follow-up|33|||
155736700|NCT02752165|562134255|FG001|Overall Study|Lost to Follow-up|38|||
155736701|NCT01120964|562134256|FG000|Overall Study|Did not receive full treatment|1|||
155736702|NCT01120964|562134257|FG001|Overall Study|Did not receive full treatment|0|||
155736703|NCT01704599|562134261|FG000|Overall Study|Adverse Event|1|||
155736704|NCT00912197|562134262|FG000|Overall Study|Withdrawal by Subject|3|||
155736705|NCT00912197|562134263|FG001|Overall Study|Withdrawal by Subject|3|||
155736706|NCT03304249|562134268|FG000|Overall Study|Lost to Follow-up|8|||
155736707|NCT03304249|562134269|FG001|Overall Study|Lost to Follow-up|10|||
155736708|NCT03304249|562134268|FG000|Overall Study|Withdrawal by Subject|12|||
155736709|NCT03304249|562134269|FG001|Overall Study|Withdrawal by Subject|2|||
155736710|NCT03304249|562134268|FG000|Overall Study|Moved Out of District|4|||
155736711|NCT03304249|562134269|FG001|Overall Study|Moved Out of District|2|||
155736712|NCT00494676|562134275|FG000|Allocation|Withdrawal by Subject|2|||
155736713|NCT00494676|562134276|FG001|Allocation|Withdrawal by Subject|4|||
155736714|NCT00494676|562134275|FG000|First Intervention|Withdrawal by Subject|1|||
155736715|NCT00494676|562134276|FG001|First Intervention|Withdrawal by Subject|3|||
155736716|NCT00494676|562134275|FG000|Second Intervention|Withdrawal by Subject|1|||
155736717|NCT00494676|562134276|FG001|Second Intervention|Withdrawal by Subject|1|||
155736718|NCT04976192|562134277|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736719|NCT04976192|562134278|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
155736720|NCT04976192|562134279|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736721|NCT04976192|562134280|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736722|NCT04976192|562134281|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736723|NCT04976192|562134282|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736724|NCT04976192|562134283|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736725|NCT04976192|562134284|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736726|NCT04976192|562134285|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736727|NCT04976192|562134286|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155736728|NCT04976192|562134277|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
155736729|NCT04976192|562134278|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155736730|NCT04976192|562134279|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
155736731|NCT04976192|562134280|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155736732|NCT04976192|562134281|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736733|NCT04976192|562134282|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736734|NCT04976192|562134283|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736735|NCT04976192|562134284|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736736|NCT04976192|562134285|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736737|NCT04976192|562134286|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736738|NCT04976192|562134277|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
155736739|NCT04976192|562134278|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736740|NCT04976192|562134279|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
155736741|NCT04976192|562134280|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736742|NCT04976192|562134281|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736743|NCT04976192|562134282|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736744|NCT04976192|562134283|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736745|NCT04976192|562134284|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736746|NCT04976192|562134285|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736747|NCT04976192|562134286|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155736748|NCT04976192|562134277|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736749|NCT04976192|562134278|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736750|NCT04976192|562134279|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736751|NCT04976192|562134280|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155736752|NCT04976192|562134281|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
155736753|NCT04976192|562134282|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
155736754|NCT04976192|562134283|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155736755|NCT04976192|562134284|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
155736756|NCT04976192|562134285|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
155736757|NCT04976192|562134286|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155736758|NCT04976192|562134277|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736759|NCT04976192|562134278|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736760|NCT04976192|562134279|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736761|NCT04976192|562134280|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736762|NCT04976192|562134281|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
155736763|NCT04976192|562134282|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736764|NCT04976192|562134283|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736765|NCT04976192|562134284|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736766|NCT04976192|562134285|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736767|NCT04976192|562134286|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155736768|NCT04976192|562134277|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736769|NCT04976192|562134278|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736770|NCT04976192|562134279|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736771|NCT04976192|562134280|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736772|NCT04976192|562134281|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736773|NCT04976192|562134282|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155736774|NCT04976192|562134283|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736775|NCT04976192|562134284|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736776|NCT04976192|562134285|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736777|NCT04976192|562134286|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155736778|NCT02621151|562134287|FG000|Overall Study|Not eligible for trial|6|||
155736779|NCT04198714|562134288|FG000|Overall Study|Physician Decision|0|||
155736780|NCT04198714|562134289|FG001|Overall Study|Physician Decision|1|||
155736781|NCT02529553|562134290|FG000|Overall Study|Progressive Disease|1|||
155736782|NCT02529553|562134291|FG001|Overall Study|Progressive Disease|0|||
155736783|NCT02529553|562134292|FG002|Overall Study|Progressive Disease|1|||
155736784|NCT02529553|562134293|FG003|Overall Study|Progressive Disease|3|||
155736785|NCT02529553|562134294|FG004|Overall Study|Progressive Disease|2|||
155736786|NCT02529553|562134295|FG005|Overall Study|Progressive Disease|3|||
155736787|NCT02529553|562134296|FG006|Overall Study|Progressive Disease|3|||
155736788|NCT02529553|562134297|FG007|Overall Study|Progressive Disease|5|||
155736789|NCT02529553|562134298|FG008|Overall Study|Progressive Disease|3|||
155736790|NCT02529553|562134290|FG000|Overall Study|Physician Decision|0|||
155736791|NCT02529553|562134291|FG001|Overall Study|Physician Decision|1|||
155736792|NCT02529553|562134292|FG002|Overall Study|Physician Decision|0|||
155736793|NCT02529553|562134293|FG003|Overall Study|Physician Decision|0|||
155736794|NCT02529553|562134294|FG004|Overall Study|Physician Decision|1|||
155736795|NCT02529553|562134295|FG005|Overall Study|Physician Decision|0|||
155736796|NCT02529553|562134296|FG006|Overall Study|Physician Decision|0|||
155736797|NCT02529553|562134297|FG007|Overall Study|Physician Decision|0|||
155736798|NCT02529553|562134298|FG008|Overall Study|Physician Decision|0|||
155736799|NCT02529553|562134290|FG000|Overall Study|Withdrawal by Subject|0|||
155736800|NCT02529553|562134291|FG001|Overall Study|Withdrawal by Subject|0|||
155736801|NCT02529553|562134292|FG002|Overall Study|Withdrawal by Subject|0|||
155736802|NCT02529553|562134293|FG003|Overall Study|Withdrawal by Subject|0|||
155736803|NCT02529553|562134294|FG004|Overall Study|Withdrawal by Subject|0|||
155736804|NCT02529553|562134295|FG005|Overall Study|Withdrawal by Subject|1|||
155736805|NCT02529553|562134296|FG006|Overall Study|Withdrawal by Subject|0|||
155736806|NCT02529553|562134297|FG007|Overall Study|Withdrawal by Subject|1|||
155736807|NCT02529553|562134298|FG008|Overall Study|Withdrawal by Subject|0|||
155736808|NCT01754727|562136136|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
155736809|NCT02785770|562136137|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
155736810|NCT02785770|562136138|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
155736811|NCT02785770|562136139|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
155736812|NCT02785770|562136140|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
155736813|NCT02785770|562136137|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
155736814|NCT02785770|562136138|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
155736815|NCT02785770|562136139|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
155736816|NCT02785770|562136140|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
155736817|NCT02785770|562136137|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
155736818|NCT02785770|562136138|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
155736819|NCT02785770|562136139|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
155736820|NCT02785770|562136140|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
155736821|NCT04838977|562136144|FG000|Overall Study|Lost to Follow-up|2|||
155736822|NCT04838977|562136145|FG001|Overall Study|Lost to Follow-up|3|||
155283262|NCT04011033|560468266|FG000|Overall Study|Withdrawal by Subject|1|||
155283263|NCT04011033|560468267|FG001|Overall Study|Withdrawal by Subject|0|||
155283264|NCT02027935|560468268|FG000|Overall Study|Death|1|||
155283265|NCT02027935|560468268|FG000|Overall Study|Lack of Efficacy|5|||
155283266|NCT02027935|560468268|FG000|Overall Study|Study Closure|1|||
155283267|NCT04873817|560468269|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
155283268|NCT04873817|560468269|FG000|Overall Study|Lost to Follow-up|4|||
155283269|NCT04873817|560468269|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
155283270|NCT04873817|560468269|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
155736823|NCT04838977|562136144|FG000|Overall Study|Withdrawal by Subject|1|||
155736824|NCT04838977|562136145|FG001|Overall Study|Withdrawal by Subject|1|||
155736825|NCT05367492|562136146|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
155736826|NCT05367492|562136147|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
155736827|NCT05367492|562136148|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
155736828|NCT05367492|562136146|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
155736829|NCT05367492|562136147|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
155283271|NCT04873817|560468269|FG000|Overall Study|Other Reasons|3|||
155736830|NCT05367492|562136148|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
155736831|NCT05367492|562136146|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
155736832|NCT05367492|562136147|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
155736833|NCT05367492|562136148|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
155736834|NCT05367492|562136146|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
155736835|NCT05367492|562136147|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
155736836|NCT05367492|562136148|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
155736837|NCT01088048|562136152|FG000|Overall Study|Adverse Event|7|||
155736838|NCT01088048|562136153|FG001|Overall Study|Adverse Event|9|||
155736839|NCT01088048|562136154|FG002|Overall Study|Adverse Event|7|||
155736840|NCT01088048|562136155|FG003|Overall Study|Adverse Event|5|||
155736841|NCT01088048|562136156|FG004|Overall Study|Adverse Event|6|||
155736842|NCT01088048|562136157|FG005|Overall Study|Adverse Event|3|||
155736843|NCT01088048|562136158|FG006|Overall Study|Adverse Event|3|||
155736844|NCT01088048|562136159|FG007|Overall Study|Adverse Event|0|||
155736845|NCT01088048|562136160|FG008|Overall Study|Adverse Event|2|||
155736846|NCT01088048|562136161|FG009|Overall Study|Adverse Event|2|||
155633410|NCT02921256|561750830|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
155633411|NCT02921256|561750828|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
155633412|NCT02921256|561750829|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
155633413|NCT02921256|561750830|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
155633414|NCT02921256|561750828|FG000|Arm Ib v Arm III|Physician Decision|4|||
155633415|NCT02921256|561750829|FG001|Arm Ib v Arm III|Physician Decision|0|||
155633416|NCT02921256|561750830|FG002|Arm Ib v Arm III|Physician Decision|1|||
155633417|NCT02921256|561750828|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
155633418|NCT02921256|561750829|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
155633419|NCT02921256|561750830|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
155633420|NCT00671788|561750833|FG000|Overall Study|Adverse Event|8|||
155633421|NCT00671788|561750833|FG000|Overall Study|Refused further treatment|3|||
155633422|NCT00671788|561750833|FG000|Overall Study|Ineligible|1|||
155633423|NCT00671788|561750833|FG000|Overall Study|MD Decision|1|||
155633424|NCT00671788|561750833|FG000|Overall Study|Other|1|||
155633425|NCT01035138|561750834|FG000|Overall Study|Adverse Event|4|||
155633426|NCT01035138|561750835|FG001|Overall Study|Adverse Event|0|||
155633427|NCT01035138|561750836|FG002|Overall Study|Adverse Event|2|||
155633428|NCT01035138|561750834|FG000|Overall Study|Caregiver Decision|2|||
155633429|NCT01035138|561750835|FG001|Overall Study|Caregiver Decision|0|||
155633430|NCT01035138|561750836|FG002|Overall Study|Caregiver Decision|1|||
155633431|NCT01035138|561750834|FG000|Overall Study|Withdrawal by Subject|1|||
155633432|NCT01035138|561750835|FG001|Overall Study|Withdrawal by Subject|0|||
155633433|NCT01035138|561750836|FG002|Overall Study|Withdrawal by Subject|0|||
155633434|NCT01035138|561750834|FG000|Overall Study|Physician Decision|0|||
155633435|NCT01035138|561750835|FG001|Overall Study|Physician Decision|0|||
155633436|NCT01035138|561750836|FG002|Overall Study|Physician Decision|1|||
155633437|NCT01035138|561750834|FG000|Overall Study|Sponsor Decision|66|||
155633438|NCT01035138|561750835|FG001|Overall Study|Sponsor Decision|60|||
155633439|NCT01035138|561750836|FG002|Overall Study|Sponsor Decision|42|||
155633440|NCT01035138|561750834|FG000|Overall Study|Lost to Follow-up|0|||
155633441|NCT01035138|561750835|FG001|Overall Study|Lost to Follow-up|0|||
155633442|NCT01035138|561750836|FG002|Overall Study|Lost to Follow-up|1|||
155633443|NCT02966834|561750837|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155633444|NCT02966834|561750838|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155633445|NCT02966834|561750839|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155633446|NCT02966834|561750840|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155633447|NCT02966834|561750841|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
155633448|NCT02966834|561750842|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155633449|NCT02966834|561750837|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
155633450|NCT02966834|561750838|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155633451|NCT02966834|561750839|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155633452|NCT02966834|561750840|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155633453|NCT02966834|561750841|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155633454|NCT02966834|561750842|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155633455|NCT02966834|561750837|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155633456|NCT02966834|561750838|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155633457|NCT02966834|561750839|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
155633458|NCT02966834|561750840|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
155633459|NCT02966834|561750841|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155633460|NCT02966834|561750842|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
155736847|NCT01088048|562136152|FG000|Overall Study|Withdrew Consent|1|||
155633461|NCT02966834|561750837|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155633462|NCT02966834|561750838|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155736848|NCT01088048|562136153|FG001|Overall Study|Withdrew Consent|1|||
155633463|NCT02966834|561750839|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
155283272|NCT00924560|560468273|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
155283273|NCT00924560|560468274|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
155283274|NCT00924560|560468275|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
155283275|NCT00924560|560468273|FG000|Overall Study|Non Compliance with the Protocol|20|||
155283276|NCT00924560|560468274|FG001|Overall Study|Non Compliance with the Protocol|15|||
155283277|NCT00924560|560468275|FG002|Overall Study|Non Compliance with the Protocol|4|||
155633464|NCT02966834|561750840|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
155633465|NCT02966834|561750841|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155633466|NCT02966834|561750842|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
155633467|NCT02966834|561750837|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155633468|NCT02966834|561750838|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155633469|NCT02966834|561750839|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155633470|NCT02966834|561750840|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
155633471|NCT02966834|561750841|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155633472|NCT02966834|561750842|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155633473|NCT02966834|561750837|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155633474|NCT02966834|561750838|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155633475|NCT02966834|561750839|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155633476|NCT02966834|561750840|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
155633477|NCT02966834|561750841|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155633478|NCT02966834|561750842|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155633479|NCT00655889|561750843|FG000|Overall Study|Inadequate cell growth|1|||
155633480|NCT00655889|561750843|FG000|Overall Study|Protocol Violation|1|||
155633481|NCT04739800|561750844|FG000|Overall Study|Adverse Event|2|||
155633482|NCT04739800|561750845|FG001|Overall Study|Adverse Event|1|||
155633483|NCT04739800|561750846|FG002|Overall Study|Adverse Event|4|||
155633484|NCT04739800|561750847|FG003|Overall Study|Adverse Event|5|||
155633485|NCT04739800|561750844|FG000|Overall Study|Never Treated|2|||
155633486|NCT04739800|561750845|FG001|Overall Study|Never Treated|0|||
155633487|NCT04739800|561750846|FG002|Overall Study|Never Treated|1|||
155633488|NCT04739800|561750847|FG003|Overall Study|Never Treated|1|||
155633489|NCT04739800|561750844|FG000|Overall Study|On Treatment|5|||
155633490|NCT04739800|561750845|FG001|Overall Study|On Treatment|9|||
155633491|NCT04739800|561750846|FG002|Overall Study|On Treatment|9|||
155633492|NCT04739800|561750847|FG003|Overall Study|On Treatment|9|||
155633493|NCT04739800|561750844|FG000|Overall Study|Symptomatic Deterioration|1|||
155633494|NCT04739800|561750845|FG001|Overall Study|Symptomatic Deterioration|1|||
155633495|NCT04739800|561750846|FG002|Overall Study|Symptomatic Deterioration|3|||
155633496|NCT04739800|561750847|FG003|Overall Study|Symptomatic Deterioration|0|||
155633497|NCT04739800|561750844|FG000|Overall Study|Withdrawal by Subject|1|||
155633498|NCT04739800|561750845|FG001|Overall Study|Withdrawal by Subject|2|||
155633499|NCT04739800|561750846|FG002|Overall Study|Withdrawal by Subject|1|||
155633500|NCT04739800|561750847|FG003|Overall Study|Withdrawal by Subject|3|||
155633501|NCT04739800|561750844|FG000|Overall Study|Other Reason|1|||
155633502|NCT04739800|561750845|FG001|Overall Study|Other Reason|3|||
155633503|NCT04739800|561750846|FG002|Overall Study|Other Reason|5|||
155633504|NCT04739800|561750847|FG003|Overall Study|Other Reason|4|||
155633505|NCT03415178|561750849|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
155633506|NCT03415178|561750850|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
155736849|NCT01088048|562136154|FG002|Overall Study|Withdrew Consent|1|||
155736850|NCT01088048|562136155|FG003|Overall Study|Withdrew Consent|1|||
155736851|NCT01088048|562136156|FG004|Overall Study|Withdrew Consent|2|||
155736852|NCT01088048|562136157|FG005|Overall Study|Withdrew Consent|1|||
155283278|NCT00924560|560468273|FG000|Overall Study|Physician Decision|2|||
155283279|NCT00924560|560468274|FG001|Overall Study|Physician Decision|3|||
155283280|NCT00924560|560468275|FG002|Overall Study|Physician Decision|4|||
155283281|NCT00924560|560468273|FG000|Overall Study|Withdrawal by Subject|50|||
155283282|NCT00924560|560468274|FG001|Overall Study|Withdrawal by Subject|44|||
155283283|NCT00924560|560468275|FG002|Overall Study|Withdrawal by Subject|18|||
155283284|NCT00924560|560468273|FG000|Overall Study|Adverse Event|39|||
155283285|NCT00924560|560468274|FG001|Overall Study|Adverse Event|33|||
155736853|NCT01088048|562136158|FG006|Overall Study|Withdrew Consent|0|||
155736854|NCT01088048|562136159|FG007|Overall Study|Withdrew Consent|2|||
155736855|NCT01088048|562136160|FG008|Overall Study|Withdrew Consent|2|||
155736856|NCT01088048|562136161|FG009|Overall Study|Withdrew Consent|1|||
155736857|NCT01088048|562136152|FG000|Overall Study|Concomitant Medication Prohibited|1|||
155736858|NCT01088048|562136153|FG001|Overall Study|Concomitant Medication Prohibited|0|||
155736859|NCT01088048|562136154|FG002|Overall Study|Concomitant Medication Prohibited|0|||
155633507|NCT03415178|561750849|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
155633508|NCT03415178|561750850|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
155633509|NCT03321721|561750852|FG000|Overall Study|Lost to Follow-up|4|||
155633510|NCT03321721|561750853|FG001|Overall Study|Lost to Follow-up|8|||
155633511|NCT03321721|561750854|FG002|Overall Study|Lost to Follow-up|11|||
155633512|NCT00661388|561750857|FG000|Overall Study|Adverse Event|14|||
155633513|NCT00661388|561750857|FG000|Overall Study|Protocol Violation|7|||
155633514|NCT00661388|561750857|FG000|Overall Study|Renal transplantation|1|||
155633515|NCT00661388|561750857|FG000|Overall Study|Dialysis initiation|1|||
155633516|NCT00661388|561750857|FG000|Overall Study|Administrative reasons|1|||
155633517|NCT01288430|561752122|FG000|Part 1|Progressive disease|2|||
155633518|NCT01288430|561752123|FG001|Part 1|Progressive disease|1|||
155633519|NCT01288430|561752124|FG002|Part 1|Progressive disease|1|||
155633520|NCT01288430|561752125|FG003|Part 1|Progressive disease|6|||
155283286|NCT00924560|560468275|FG002|Overall Study|Adverse Event|0|||
155633521|NCT01288430|561752126|FG004|Part 1|Progressive disease|2|||
155633522|NCT01288430|561752127|FG005|Part 1|Progressive disease|4|||
155633523|NCT01288430|561752128|FG006|Part 1|Progressive disease|2|||
155633524|NCT01288430|561752129|FG007|Part 1|Progressive disease|0|||
155633525|NCT01288430|561752130|FG008|Part 1|Progressive disease|0|||
155633526|NCT01288430|561752131|FG009|Part 1|Progressive disease|0|||
155633527|NCT01288430|561752122|FG000|Part 1|Clinical disease progression|0|||
155633528|NCT01288430|561752123|FG001|Part 1|Clinical disease progression|0|||
155633529|NCT01288430|561752124|FG002|Part 1|Clinical disease progression|1|||
155633530|NCT01288430|561752125|FG003|Part 1|Clinical disease progression|0|||
155633531|NCT01288430|561752126|FG004|Part 1|Clinical disease progression|0|||
155633532|NCT01288430|561752127|FG005|Part 1|Clinical disease progression|2|||
155633533|NCT01288430|561752128|FG006|Part 1|Clinical disease progression|2|||
155633534|NCT01288430|561752129|FG007|Part 1|Clinical disease progression|0|||
155633535|NCT01288430|561752130|FG008|Part 1|Clinical disease progression|0|||
155633536|NCT01288430|561752131|FG009|Part 1|Clinical disease progression|0|||
155633537|NCT01288430|561752122|FG000|Part 1|Death due to disease progression|0|||
155633538|NCT01288430|561752123|FG001|Part 1|Death due to disease progression|0|||
155633539|NCT01288430|561752124|FG002|Part 1|Death due to disease progression|0|||
155633540|NCT01288430|561752125|FG003|Part 1|Death due to disease progression|0|||
155633541|NCT01288430|561752126|FG004|Part 1|Death due to disease progression|1|||
155633542|NCT01288430|561752127|FG005|Part 1|Death due to disease progression|0|||
155633543|NCT01288430|561752128|FG006|Part 1|Death due to disease progression|0|||
155633544|NCT01288430|561752129|FG007|Part 1|Death due to disease progression|0|||
155633545|NCT01288430|561752130|FG008|Part 1|Death due to disease progression|0|||
155633546|NCT01288430|561752131|FG009|Part 1|Death due to disease progression|0|||
155633547|NCT01288430|561752122|FG000|Part 1|Adverse Event|0|||
155633548|NCT01288430|561752123|FG001|Part 1|Adverse Event|0|||
155633549|NCT01288430|561752124|FG002|Part 1|Adverse Event|3|||
155633550|NCT01288430|561752125|FG003|Part 1|Adverse Event|1|||
155633551|NCT01288430|561752126|FG004|Part 1|Adverse Event|0|||
155633552|NCT01288430|561752127|FG005|Part 1|Adverse Event|0|||
155633553|NCT01288430|561752128|FG006|Part 1|Adverse Event|2|||
155633554|NCT01288430|561752129|FG007|Part 1|Adverse Event|0|||
155633555|NCT01288430|561752130|FG008|Part 1|Adverse Event|0|||
155633556|NCT01288430|561752131|FG009|Part 1|Adverse Event|0|||
155633557|NCT01288430|561752122|FG000|Part 1|Other|0|||
155633558|NCT01288430|561752123|FG001|Part 1|Other|2|||
155633559|NCT01288430|561752124|FG002|Part 1|Other|0|||
155633560|NCT01288430|561752125|FG003|Part 1|Other|0|||
155633561|NCT01288430|561752126|FG004|Part 1|Other|0|||
155633562|NCT01288430|561752127|FG005|Part 1|Other|0|||
155633563|NCT01288430|561752128|FG006|Part 1|Other|1|||
155633564|NCT01288430|561752129|FG007|Part 1|Other|0|||
155633565|NCT01288430|561752130|FG008|Part 1|Other|0|||
155633566|NCT01288430|561752131|FG009|Part 1|Other|0|||
155633567|NCT01288430|561752122|FG000|Part 2|Progressive disease|0|||
155633568|NCT01288430|561752123|FG001|Part 2|Progressive disease|0|||
155633569|NCT01288430|561752124|FG002|Part 2|Progressive disease|0|||
155633570|NCT01288430|561752125|FG003|Part 2|Progressive disease|0|||
155633571|NCT01288430|561752126|FG004|Part 2|Progressive disease|0|||
155633572|NCT01288430|561752127|FG005|Part 2|Progressive disease|0|||
155633573|NCT01288430|561752128|FG006|Part 2|Progressive disease|0|||
155633574|NCT01288430|561752129|FG007|Part 2|Progressive disease|8|||
155633575|NCT01288430|561752130|FG008|Part 2|Progressive disease|7|||
155633576|NCT01288430|561752131|FG009|Part 2|Progressive disease|2|||
155633577|NCT01288430|561752122|FG000|Part 2|Clinical disease progression|0|||
155633578|NCT01288430|561752123|FG001|Part 2|Clinical disease progression|0|||
155633579|NCT01288430|561752124|FG002|Part 2|Clinical disease progression|0|||
155633580|NCT01288430|561752125|FG003|Part 2|Clinical disease progression|0|||
155633581|NCT01288430|561752126|FG004|Part 2|Clinical disease progression|0|||
155633582|NCT01288430|561752127|FG005|Part 2|Clinical disease progression|0|||
155633583|NCT01288430|561752128|FG006|Part 2|Clinical disease progression|0|||
155633584|NCT01288430|561752129|FG007|Part 2|Clinical disease progression|2|||
155633585|NCT01288430|561752130|FG008|Part 2|Clinical disease progression|0|||
155633586|NCT01288430|561752131|FG009|Part 2|Clinical disease progression|0|||
155633587|NCT01288430|561752122|FG000|Part 2|Withdrawal by Subject|0|||
155633588|NCT01288430|561752123|FG001|Part 2|Withdrawal by Subject|0|||
155633589|NCT01288430|561752124|FG002|Part 2|Withdrawal by Subject|0|||
155633590|NCT01288430|561752125|FG003|Part 2|Withdrawal by Subject|0|||
155736860|NCT01088048|562136155|FG003|Overall Study|Concomitant Medication Prohibited|0|||
155736861|NCT01088048|562136156|FG004|Overall Study|Concomitant Medication Prohibited|0|||
155736862|NCT01088048|562136157|FG005|Overall Study|Concomitant Medication Prohibited|0|||
155736863|NCT01088048|562136158|FG006|Overall Study|Concomitant Medication Prohibited|0|||
155736864|NCT01088048|562136159|FG007|Overall Study|Concomitant Medication Prohibited|0|||
155736865|NCT01088048|562136160|FG008|Overall Study|Concomitant Medication Prohibited|0|||
155736866|NCT01088048|562136161|FG009|Overall Study|Concomitant Medication Prohibited|0|||
155736867|NCT01088048|562136152|FG000|Overall Study|Investigator Request|2|||
155736868|NCT01088048|562136153|FG001|Overall Study|Investigator Request|2|||
155736869|NCT01088048|562136154|FG002|Overall Study|Investigator Request|0|||
155736870|NCT01088048|562136155|FG003|Overall Study|Investigator Request|0|||
155736871|NCT01088048|562136156|FG004|Overall Study|Investigator Request|3|||
155736872|NCT01088048|562136157|FG005|Overall Study|Investigator Request|1|||
155736873|NCT01088048|562136158|FG006|Overall Study|Investigator Request|1|||
155736874|NCT01088048|562136159|FG007|Overall Study|Investigator Request|0|||
155736875|NCT01088048|562136160|FG008|Overall Study|Investigator Request|0|||
155736876|NCT01088048|562136161|FG009|Overall Study|Investigator Request|0|||
155736877|NCT01088048|562136152|FG000|Overall Study|Patient Non-compliance|0|||
155736878|NCT01088048|562136153|FG001|Overall Study|Patient Non-compliance|1|||
155736879|NCT01088048|562136154|FG002|Overall Study|Patient Non-compliance|0|||
155736880|NCT01088048|562136155|FG003|Overall Study|Patient Non-compliance|0|||
155736881|NCT01088048|562136156|FG004|Overall Study|Patient Non-compliance|0|||
155736882|NCT01088048|562136157|FG005|Overall Study|Patient Non-compliance|0|||
155736883|NCT01088048|562136158|FG006|Overall Study|Patient Non-compliance|0|||
155736884|NCT01088048|562136159|FG007|Overall Study|Patient Non-compliance|0|||
155736885|NCT01088048|562136160|FG008|Overall Study|Patient Non-compliance|0|||
155736886|NCT01088048|562136161|FG009|Overall Study|Patient Non-compliance|0|||
155736887|NCT01088048|562136152|FG000|Overall Study|Disease Progression|7|||
155736888|NCT01088048|562136153|FG001|Overall Study|Disease Progression|4|||
155736889|NCT01088048|562136154|FG002|Overall Study|Disease Progression|3|||
155736890|NCT01088048|562136155|FG003|Overall Study|Disease Progression|5|||
155736891|NCT01088048|562136156|FG004|Overall Study|Disease Progression|3|||
155736892|NCT01088048|562136157|FG005|Overall Study|Disease Progression|3|||
155736893|NCT01088048|562136158|FG006|Overall Study|Disease Progression|2|||
155736894|NCT01088048|562136159|FG007|Overall Study|Disease Progression|1|||
155736895|NCT01088048|562136160|FG008|Overall Study|Disease Progression|0|||
155736896|NCT01088048|562136161|FG009|Overall Study|Disease Progression|0|||
155736897|NCT01088048|562136152|FG000|Overall Study|Death|1|||
155736898|NCT01088048|562136153|FG001|Overall Study|Death|5|||
155736899|NCT01088048|562136154|FG002|Overall Study|Death|3|||
155736900|NCT01088048|562136155|FG003|Overall Study|Death|3|||
155736901|NCT01088048|562136156|FG004|Overall Study|Death|1|||
155736902|NCT01088048|562136157|FG005|Overall Study|Death|3|||
155736903|NCT01088048|562136158|FG006|Overall Study|Death|0|||
155736904|NCT01088048|562136159|FG007|Overall Study|Death|0|||
155736905|NCT01088048|562136160|FG008|Overall Study|Death|3|||
155736906|NCT01088048|562136161|FG009|Overall Study|Death|1|||
155736907|NCT01088048|562136152|FG000|Overall Study|Other|3|||
155736908|NCT01088048|562136153|FG001|Overall Study|Other|5|||
155736909|NCT01088048|562136154|FG002|Overall Study|Other|0|||
155736910|NCT01088048|562136155|FG003|Overall Study|Other|0|||
155736911|NCT01088048|562136156|FG004|Overall Study|Other|2|||
155736912|NCT01088048|562136157|FG005|Overall Study|Other|0|||
155736913|NCT01088048|562136158|FG006|Overall Study|Other|0|||
155736914|NCT01088048|562136159|FG007|Overall Study|Other|2|||
155736915|NCT01088048|562136160|FG008|Overall Study|Other|0|||
155736916|NCT01088048|562136161|FG009|Overall Study|Other|0|||
155736917|NCT00950859|562136162|FG000|Overall Study|Adverse Event|3|||
155736918|NCT00950859|562136163|FG001|Overall Study|Adverse Event|3|||
155736919|NCT00950859|562136162|FG000|Overall Study|Insufficient Viral Load Response|12|||
155736920|NCT00950859|562136163|FG001|Overall Study|Insufficient Viral Load Response|3|||
155736921|NCT00950859|562136162|FG000|Overall Study|Protocol Violation|1|||
155736922|NCT00950859|562136163|FG001|Overall Study|Protocol Violation|1|||
155736923|NCT00950859|562136162|FG000|Overall Study|Lost to Follow-up|0|||
155736924|NCT00950859|562136163|FG001|Overall Study|Lost to Follow-up|3|||
155736925|NCT01343693|562136165|FG000|Overall Study|Lost to Follow-up|9|||
155736926|NCT00265148|562136166|FG000|Overall Study|Adverse Event|2|||
155736927|NCT00265148|562136167|FG001|Overall Study|Adverse Event|2|||
155736928|NCT00265148|562136166|FG000|Overall Study|Lack of Efficacy|0|||
155736929|NCT00265148|562136167|FG001|Overall Study|Lack of Efficacy|2|||
155736930|NCT00265148|562136166|FG000|Overall Study|Protocol Violation|3|||
155736931|NCT00265148|562136167|FG001|Overall Study|Protocol Violation|2|||
155736932|NCT00265148|562136166|FG000|Overall Study|Lost to Follow-up|0|||
155736933|NCT00265148|562136167|FG001|Overall Study|Lost to Follow-up|1|||
155736934|NCT00265148|562136166|FG000|Overall Study|Withdrawal by Subject|2|||
155736935|NCT00265148|562136167|FG001|Overall Study|Withdrawal by Subject|1|||
155736936|NCT00265148|562136166|FG000|Overall Study|Physician Decision|1|||
155736937|NCT00265148|562136167|FG001|Overall Study|Physician Decision|0|||
155736938|NCT00265148|562136166|FG000|Overall Study|Increasing frailty|0|||
155736939|NCT00265148|562136167|FG001|Overall Study|Increasing frailty|1|||
155736940|NCT00265148|562136166|FG000|Overall Study|Subject chose to change of the dose|1|||
155736941|NCT00265148|562136167|FG001|Overall Study|Subject chose to change of the dose|0|||
155736942|NCT01463007|562136168|FG000|Overall Study|Physician Decision|1|||
155736943|NCT03583385|562136169|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155736944|NCT03583385|562136170|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155736945|NCT03583385|562136169|FG000|Treatment Period 2|Adverse Event|1|||
155736946|NCT03583385|562136170|FG001|Treatment Period 2|Adverse Event|0|||
155736947|NCT00545272|562136176|FG000|Overall Study|Protocol deviation|0|||
155736948|NCT00545272|562136177|FG001|Overall Study|Protocol deviation|1|||
155736949|NCT00545272|562136178|FG002|Overall Study|Protocol deviation|0|||
155736950|NCT00545272|562136179|FG003|Overall Study|Protocol deviation|1|||
155736951|NCT00545272|562136180|FG004|Overall Study|Protocol deviation|0|||
155736952|NCT00545272|562136181|FG005|Overall Study|Protocol deviation|1|||
155736953|NCT00545272|562136176|FG000|Overall Study|Adverse Event|0|||
155736954|NCT00545272|562136177|FG001|Overall Study|Adverse Event|0|||
155736955|NCT00545272|562136178|FG002|Overall Study|Adverse Event|1|||
155736956|NCT00545272|562136179|FG003|Overall Study|Adverse Event|0|||
155736957|NCT00545272|562136180|FG004|Overall Study|Adverse Event|0|||
155736958|NCT00545272|562136181|FG005|Overall Study|Adverse Event|1|||
155736959|NCT00545272|562136176|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155736960|NCT00545272|562136177|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155736961|NCT00545272|562136178|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155736962|NCT00545272|562136179|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155736963|NCT00545272|562136180|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155736964|NCT00545272|562136181|FG005|Overall Study|Abnormal laboratory value(s)|1|||
155736965|NCT00545272|562136176|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155736966|NCT00545272|562136177|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155736967|NCT00545272|562136178|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155736968|NCT00545272|562136179|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155736969|NCT00545272|562136180|FG004|Overall Study|Abnormal test procedure result(s)|1|||
155736970|NCT00545272|562136181|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155736971|NCT00545272|562136176|FG000|Overall Study|Lost to Follow-up|0|||
155736972|NCT00545272|562136177|FG001|Overall Study|Lost to Follow-up|0|||
155736973|NCT00545272|562136178|FG002|Overall Study|Lost to Follow-up|0|||
155736974|NCT00545272|562136179|FG003|Overall Study|Lost to Follow-up|0|||
155736975|NCT00545272|562136180|FG004|Overall Study|Lost to Follow-up|1|||
155736976|NCT00545272|562136181|FG005|Overall Study|Lost to Follow-up|0|||
155736977|NCT02314637|562136182|FG000|Overall Study|Adverse Event|4|||
155736978|NCT02314637|562136183|FG001|Overall Study|Adverse Event|8|||
155736979|NCT02314637|562136182|FG000|Overall Study|Lack of Efficacy|1|||
155736980|NCT02314637|562136183|FG001|Overall Study|Lack of Efficacy|0|||
155736981|NCT02314637|562136182|FG000|Overall Study|Physician Decision|5|||
155736982|NCT02314637|562136183|FG001|Overall Study|Physician Decision|2|||
155736983|NCT02314637|562136182|FG000|Overall Study|Withdrawal by Subject|5|||
155736984|NCT02314637|562136183|FG001|Overall Study|Withdrawal by Subject|4|||
155736985|NCT02314637|562136182|FG000|Overall Study|Other Reason|1|||
155736986|NCT02314637|562136183|FG001|Overall Study|Other Reason|0|||
155736987|NCT02934503|562136184|FG000|Overall Study|progression of disease|3|||
155736988|NCT02934503|562136184|FG000|Overall Study|Withdrawal by Subject|1|||
155736989|NCT00724867|562136187|FG000|Overall Study|Adverse Event|25|||
155736990|NCT00724867|562136187|FG000|Overall Study|Lack of Efficacy|14|||
155736991|NCT00724867|562136187|FG000|Overall Study|Lost to Follow-up|12|||
155736992|NCT00724867|562136187|FG000|Overall Study|Non-compliance with study drug|6|||
155736993|NCT00724867|562136187|FG000|Overall Study|Physician Decision|17|||
155736994|NCT00724867|562136187|FG000|Overall Study|Protocol Violation|1|||
155736995|NCT00724867|562136187|FG000|Overall Study|Withdrawal by Subject|31|||
155736996|NCT00724867|562136187|FG000|Overall Study|Sponsor decision to end study|14|||
155736997|NCT00724867|562136187|FG000|Overall Study|Subject incarcerated|1|||
155736998|NCT00724867|562136187|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
155736999|NCT00724867|562136187|FG000|Overall Study|Subject moved out of state|1|||
155737000|NCT00724867|562136187|FG000|Overall Study|Elected to exit due to site closure|2|||
155737001|NCT00436345|562136192|FG000|Overall Study|ICU resident beyond follow-up period|3|||
155737002|NCT00436345|562136193|FG001|Overall Study|ICU resident beyond follow-up period|0|||
155737003|NCT01296672|562136194|FG000|Overall Study|Lost to Follow-up|73|||
155737004|NCT01296672|562136195|FG001|Overall Study|Lost to Follow-up|18|||
155737005|NCT04027608|562136196|FG000|Overall Study|Withdrawal by Subject|13|||
155737006|NCT04027608|562136197|FG001|Overall Study|Withdrawal by Subject|2|||
155737007|NCT04027608|562136196|FG000|Overall Study|Protocol Violation|2|||
155737008|NCT04027608|562136197|FG001|Overall Study|Protocol Violation|1|||
155737009|NCT04027608|562136196|FG000|Overall Study|Physician Decision|1|||
155737010|NCT04027608|562136197|FG001|Overall Study|Physician Decision|0|||
155737011|NCT04027608|562136196|FG000|Overall Study|Lost to Follow-up|20|||
155737012|NCT04027608|562136197|FG001|Overall Study|Lost to Follow-up|4|||
155737013|NCT04248491|562136201|FG000|Overall Study|Lost to Follow-up|1|||
155737014|NCT04248491|562136202|FG001|Overall Study|Lost to Follow-up|0|||
155737015|NCT04605991|562136203|FG000|Overall Study|Adverse Event|5|||
155737016|NCT04605991|562136203|FG000|Overall Study|Lack of Efficacy|1|||
155737017|NCT04605991|562136203|FG000|Overall Study|Lost to Follow-up|8|||
155633591|NCT01288430|561752126|FG004|Part 2|Withdrawal by Subject|0|||
155633592|NCT01288430|561752127|FG005|Part 2|Withdrawal by Subject|0|||
155633593|NCT01288430|561752128|FG006|Part 2|Withdrawal by Subject|0|||
155633594|NCT01288430|561752129|FG007|Part 2|Withdrawal by Subject|1|||
155633595|NCT01288430|561752130|FG008|Part 2|Withdrawal by Subject|4|||
155633596|NCT01288430|561752131|FG009|Part 2|Withdrawal by Subject|0|||
155633597|NCT01288430|561752122|FG000|Part 2|Adverse Event|0|||
155633598|NCT01288430|561752123|FG001|Part 2|Adverse Event|0|||
155633599|NCT01288430|561752124|FG002|Part 2|Adverse Event|0|||
155633600|NCT01288430|561752125|FG003|Part 2|Adverse Event|0|||
155633601|NCT01288430|561752126|FG004|Part 2|Adverse Event|0|||
155633602|NCT01288430|561752127|FG005|Part 2|Adverse Event|0|||
155633603|NCT01288430|561752128|FG006|Part 2|Adverse Event|0|||
155633604|NCT01288430|561752129|FG007|Part 2|Adverse Event|1|||
155633605|NCT01288430|561752130|FG008|Part 2|Adverse Event|1|||
155633606|NCT01288430|561752131|FG009|Part 2|Adverse Event|0|||
155633607|NCT01288430|561752122|FG000|Part 2|Other|0|||
155633608|NCT01288430|561752123|FG001|Part 2|Other|0|||
155633609|NCT01288430|561752124|FG002|Part 2|Other|0|||
155633610|NCT01288430|561752125|FG003|Part 2|Other|0|||
155633611|NCT01288430|561752126|FG004|Part 2|Other|0|||
155633612|NCT01288430|561752127|FG005|Part 2|Other|0|||
155633613|NCT01288430|561752128|FG006|Part 2|Other|0|||
155633614|NCT01288430|561752129|FG007|Part 2|Other|0|||
155633615|NCT01288430|561752130|FG008|Part 2|Other|0|||
155633616|NCT01288430|561752131|FG009|Part 2|Other|1|||
155633617|NCT05493111|561752132|FG000|Overall Study|Adverse Event|3|||
155633618|NCT05493111|561752133|FG001|Overall Study|Adverse Event|4|||
155633619|NCT05493111|561752132|FG000|Overall Study|Withdrawal of Consent|19|||
155633620|NCT05493111|561752133|FG001|Overall Study|Withdrawal of Consent|10|||
155633621|NCT05493111|561752132|FG000|Overall Study|Non-compliance|1|||
155633622|NCT05493111|561752133|FG001|Overall Study|Non-compliance|1|||
155633623|NCT05493111|561752132|FG000|Overall Study|Lost to Follow-up|8|||
155633624|NCT05493111|561752133|FG001|Overall Study|Lost to Follow-up|1|||
155633625|NCT05493111|561752132|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
155633626|NCT05493111|561752133|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
155633627|NCT05493111|561752132|FG000|Overall Study|Withdrawal by Subject|1|||
155633628|NCT05493111|561752133|FG001|Overall Study|Withdrawal by Subject|1|||
155633629|NCT04486716|561752136|FG000|Core Phase|Subject decision|6|||
155633630|NCT04486716|561752136|FG000|Core Phase|Adverse Event|5|||
155633631|NCT04486716|561752136|FG000|Core Phase|Lost to Follow-up|1|||
155633632|NCT04486716|561752136|FG000|Core Phase|Physician Decision|1|||
155633633|NCT04486716|561752136|FG000|Core Phase|Enrolled subjects not treated|9|||
155633634|NCT02807259|561752137|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
155633635|NCT02807259|561752138|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
155633636|NCT02807259|561752137|FG000|Midline (3 Months)|migration, refusal, not available|30|||
155633637|NCT02807259|561752138|FG001|Midline (3 Months)|migration, refusal, not available|34|||
155633638|NCT02807259|561752137|FG000|Endline (3 Months)|migration, refusal, not available|35|||
155633639|NCT02807259|561752138|FG001|Endline (3 Months)|migration, refusal, not available|87|||
155633640|NCT02332707|561752139|FG000|Overall Study|Adverse Event|0|||
155633641|NCT02332707|561752140|FG001|Overall Study|Adverse Event|0|||
155633642|NCT02332707|561752141|FG002|Overall Study|Adverse Event|0|||
155633643|NCT02332707|561752142|FG003|Overall Study|Adverse Event|0|||
155633644|NCT02332707|561752143|FG004|Overall Study|Adverse Event|0|||
155633645|NCT02332707|561752144|FG005|Overall Study|Adverse Event|0|||
155737018|NCT04605991|562136203|FG000|Overall Study|Physician Decision|4|||
155737019|NCT04605991|562136203|FG000|Overall Study|Withdrawal by Subject|14|||
155737020|NCT04605991|562136203|FG000|Overall Study|Non-compliance with study|1|||
155737021|NCT01311024|562136204|FG000|Overall Study|Protocol Violation|35|||
155737022|NCT01311024|562136205|FG001|Overall Study|Protocol Violation|22|||
155737023|NCT01652469|562136215|FG000|Overall Study|Withdrawal by Subject|1|||
155737024|NCT01652469|562136216|FG001|Overall Study|Withdrawal by Subject|4|||
155737025|NCT01652469|562136215|FG000|Overall Study|Lost to Follow-up|0|||
155737026|NCT01652469|562136216|FG001|Overall Study|Lost to Follow-up|2|||
155737027|NCT01049009|562136217|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155633646|NCT02332707|561752145|FG006|Overall Study|Adverse Event|0|||
155633647|NCT02332707|561752146|FG007|Overall Study|Adverse Event|0|||
155633648|NCT02332707|561752147|FG008|Overall Study|Adverse Event|0|||
155633649|NCT02332707|561752148|FG009|Overall Study|Adverse Event|0|||
155633650|NCT02332707|561752149|FG010|Overall Study|Adverse Event|0|||
155633651|NCT02332707|561752150|FG011|Overall Study|Adverse Event|0|||
155633652|NCT02332707|561752151|FG012|Overall Study|Adverse Event|1|||
155633653|NCT02332707|561752152|FG013|Overall Study|Adverse Event|0|||
155633654|NCT02332707|561752153|FG014|Overall Study|Adverse Event|0|||
155633655|NCT02332707|561752154|FG015|Overall Study|Adverse Event|0|||
155633656|NCT02332707|561752155|FG016|Overall Study|Adverse Event|0|||
155633657|NCT02332707|561752156|FG017|Overall Study|Adverse Event|0|||
155633658|NCT02332707|561752139|FG000|Overall Study|Lost to Follow-up|0|||
155633659|NCT02332707|561752140|FG001|Overall Study|Lost to Follow-up|0|||
155633660|NCT02332707|561752141|FG002|Overall Study|Lost to Follow-up|0|||
155737028|NCT01049009|562136218|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155737029|NCT01049009|562136217|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155737030|NCT01049009|562136218|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155737031|NCT01049009|562136217|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
155737032|NCT01049009|562136218|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
155737033|NCT01049009|562136217|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
155737034|NCT01049009|562136218|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
155737035|NCT01092546|562136220|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
155737036|NCT03860259|562136221|FG000|Overall Study|Lost to Follow-up|5|||
155737037|NCT03860259|562136222|FG001|Overall Study|Lost to Follow-up|5|||
155737038|NCT03860259|562136221|FG000|Overall Study|Protocol Violation|1|||
155737039|NCT03860259|562136222|FG001|Overall Study|Protocol Violation|0|||
155737040|NCT02280408|562136223|FG000|Overall Study|Lost to Follow-up|0|||
155737041|NCT02280408|562136224|FG001|Overall Study|Lost to Follow-up|2|||
155737042|NCT02280408|562136225|FG002|Overall Study|Lost to Follow-up|0|||
155633661|NCT02332707|561752142|FG003|Overall Study|Lost to Follow-up|0|||
155737043|NCT02280408|562136226|FG003|Overall Study|Lost to Follow-up|0|||
155737044|NCT01068600|562136227|FG000|Overall Study|Withdrawal by Subject|5|||
155737045|NCT01068600|562136228|FG001|Overall Study|Withdrawal by Subject|6|||
155737046|NCT01068600|562136227|FG000|Overall Study|Adverse Event|3|||
155633662|NCT02332707|561752143|FG004|Overall Study|Lost to Follow-up|0|||
155633663|NCT02332707|561752144|FG005|Overall Study|Lost to Follow-up|1|||
155633664|NCT02332707|561752145|FG006|Overall Study|Lost to Follow-up|0|||
155633665|NCT02332707|561752146|FG007|Overall Study|Lost to Follow-up|0|||
155633666|NCT02332707|561752147|FG008|Overall Study|Lost to Follow-up|0|||
155633667|NCT02332707|561752148|FG009|Overall Study|Lost to Follow-up|0|||
155633668|NCT02332707|561752149|FG010|Overall Study|Lost to Follow-up|2|||
155633669|NCT02332707|561752150|FG011|Overall Study|Lost to Follow-up|0|||
155633670|NCT02332707|561752151|FG012|Overall Study|Lost to Follow-up|3|||
155633671|NCT02332707|561752152|FG013|Overall Study|Lost to Follow-up|0|||
155633672|NCT02332707|561752153|FG014|Overall Study|Lost to Follow-up|0|||
155633673|NCT02332707|561752154|FG015|Overall Study|Lost to Follow-up|0|||
155633674|NCT02332707|561752155|FG016|Overall Study|Lost to Follow-up|0|||
155633675|NCT02332707|561752156|FG017|Overall Study|Lost to Follow-up|0|||
155633676|NCT02332707|561752139|FG000|Overall Study|Physician Decision|0|||
155633677|NCT02332707|561752140|FG001|Overall Study|Physician Decision|0|||
155633678|NCT02332707|561752141|FG002|Overall Study|Physician Decision|0|||
155633679|NCT02332707|561752142|FG003|Overall Study|Physician Decision|1|||
155633680|NCT02332707|561752143|FG004|Overall Study|Physician Decision|0|||
155633681|NCT02332707|561752144|FG005|Overall Study|Physician Decision|0|||
155633682|NCT02332707|561752145|FG006|Overall Study|Physician Decision|0|||
155633683|NCT02332707|561752146|FG007|Overall Study|Physician Decision|0|||
155633684|NCT02332707|561752147|FG008|Overall Study|Physician Decision|0|||
155633685|NCT02332707|561752148|FG009|Overall Study|Physician Decision|0|||
155633686|NCT02332707|561752149|FG010|Overall Study|Physician Decision|0|||
155633687|NCT02332707|561752150|FG011|Overall Study|Physician Decision|0|||
155633688|NCT02332707|561752151|FG012|Overall Study|Physician Decision|1|||
155633689|NCT02332707|561752152|FG013|Overall Study|Physician Decision|0|||
155633690|NCT02332707|561752153|FG014|Overall Study|Physician Decision|0|||
155633691|NCT02332707|561752154|FG015|Overall Study|Physician Decision|0|||
155633692|NCT02332707|561752155|FG016|Overall Study|Physician Decision|0|||
155633693|NCT02332707|561752156|FG017|Overall Study|Physician Decision|0|||
155633694|NCT02332707|561752139|FG000|Overall Study|Withdrawal by Subject|0|||
155633695|NCT02332707|561752140|FG001|Overall Study|Withdrawal by Subject|0|||
155633696|NCT02332707|561752141|FG002|Overall Study|Withdrawal by Subject|1|||
155633697|NCT02332707|561752142|FG003|Overall Study|Withdrawal by Subject|0|||
155633698|NCT02332707|561752143|FG004|Overall Study|Withdrawal by Subject|0|||
155633699|NCT02332707|561752144|FG005|Overall Study|Withdrawal by Subject|0|||
155633700|NCT02332707|561752145|FG006|Overall Study|Withdrawal by Subject|0|||
155633701|NCT02332707|561752146|FG007|Overall Study|Withdrawal by Subject|0|||
155633702|NCT02332707|561752147|FG008|Overall Study|Withdrawal by Subject|0|||
155633703|NCT02332707|561752148|FG009|Overall Study|Withdrawal by Subject|3|||
155633704|NCT02332707|561752149|FG010|Overall Study|Withdrawal by Subject|0|||
155633705|NCT02332707|561752150|FG011|Overall Study|Withdrawal by Subject|0|||
155633706|NCT02332707|561752151|FG012|Overall Study|Withdrawal by Subject|0|||
155633707|NCT02332707|561752152|FG013|Overall Study|Withdrawal by Subject|0|||
155633708|NCT02332707|561752153|FG014|Overall Study|Withdrawal by Subject|0|||
155633709|NCT02332707|561752154|FG015|Overall Study|Withdrawal by Subject|0|||
155633710|NCT02332707|561752155|FG016|Overall Study|Withdrawal by Subject|0|||
155633711|NCT02332707|561752156|FG017|Overall Study|Withdrawal by Subject|0|||
155633712|NCT01473134|561752157|FG000|Overall Study|Lost to Follow-up|21|||
155633713|NCT01473134|561752158|FG001|Overall Study|Lost to Follow-up|13|||
155737047|NCT01068600|562136228|FG001|Overall Study|Adverse Event|3|||
155633714|NCT01473134|561752157|FG000|Overall Study|Protocol Violation|32|||
155737048|NCT01068600|562136227|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155737049|NCT01068600|562136228|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155633715|NCT01473134|561752158|FG001|Overall Study|Protocol Violation|19|||
155633716|NCT01473134|561752157|FG000|Overall Study|Withdrawal by Subject|1|||
155737050|NCT01068600|562136227|FG000|Overall Study|Lost to Follow-up|1|||
155737051|NCT01068600|562136228|FG001|Overall Study|Lost to Follow-up|2|||
155737052|NCT01068600|562136227|FG000|Overall Study|Protocol deviation|1|||
155737053|NCT01068600|562136228|FG001|Overall Study|Protocol deviation|1|||
155737054|NCT01068600|562136227|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155737055|NCT01068600|562136228|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155737056|NCT01068600|562136227|FG000|Overall Study|Administrative problems|0|||
155737057|NCT01068600|562136228|FG001|Overall Study|Administrative problems|1|||
155737058|NCT01519869|562136231|FG000|Overall Study|Lost to Follow-up|1|||
155737059|NCT02283762|562136232|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
155737060|NCT02283762|562136233|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
155737061|NCT02283762|562136232|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
155737062|NCT02283762|562136233|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
155283287|NCT00924560|560468273|FG000|Overall Study|Pregnancy|5|||
155283288|NCT00924560|560468274|FG001|Overall Study|Pregnancy|7|||
155633717|NCT01473134|561752158|FG001|Overall Study|Withdrawal by Subject|2|||
155633718|NCT01473134|561752157|FG000|Overall Study|Death|0|||
155633719|NCT01473134|561752158|FG001|Overall Study|Death|1|||
155633720|NCT01473134|561752157|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
155633721|NCT01473134|561752158|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
155633722|NCT04761822|561752161|FG000|Overall Study|Adverse Event|3|||
155633723|NCT04761822|561752162|FG001|Overall Study|Adverse Event|1|||
155633724|NCT04761822|561752163|FG002|Overall Study|Adverse Event|1|||
155633725|NCT04761822|561752164|FG003|Overall Study|Adverse Event|3|||
155633726|NCT04761822|561752161|FG000|Overall Study|Lost to Follow-up|1|||
155633727|NCT04761822|561752162|FG001|Overall Study|Lost to Follow-up|0|||
155633728|NCT04761822|561752163|FG002|Overall Study|Lost to Follow-up|2|||
155633729|NCT04761822|561752164|FG003|Overall Study|Lost to Follow-up|3|||
155633730|NCT04761822|561752161|FG000|Overall Study|Physician Decision|0|||
155633731|NCT04761822|561752162|FG001|Overall Study|Physician Decision|1|||
155633732|NCT04761822|561752163|FG002|Overall Study|Physician Decision|0|||
155633733|NCT04761822|561752164|FG003|Overall Study|Physician Decision|0|||
155633734|NCT04761822|561752161|FG000|Overall Study|Withdrawal by Subject|3|||
155633735|NCT04761822|561752162|FG001|Overall Study|Withdrawal by Subject|8|||
155633736|NCT04761822|561752163|FG002|Overall Study|Withdrawal by Subject|1|||
155633737|NCT04761822|561752164|FG003|Overall Study|Withdrawal by Subject|11|||
155633738|NCT04761822|561752161|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
155633739|NCT04761822|561752162|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155633740|NCT04761822|561752163|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155633741|NCT04761822|561752164|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155633742|NCT04761822|561752161|FG000|Overall Study|Participant requested unblinding|0|||
155633743|NCT04761822|561752162|FG001|Overall Study|Participant requested unblinding|0|||
155633744|NCT04761822|561752163|FG002|Overall Study|Participant requested unblinding|0|||
155633745|NCT04761822|561752164|FG003|Overall Study|Participant requested unblinding|1|||
155633746|NCT02233413|561752165|FG000|Overall Study|Lost to Follow-up|7|||
155633747|NCT02233413|561752166|FG001|Overall Study|Lost to Follow-up|9|||
155633748|NCT02233413|561752165|FG000|Overall Study|Withdrawal by Subject|4|||
155633749|NCT02233413|561752166|FG001|Overall Study|Withdrawal by Subject|5|||
155633750|NCT04476043|561752171|FG000|Overall Study|Withdrawal by Subject|1|||
155633751|NCT04476043|561752172|FG001|Overall Study|Withdrawal by Subject|3|||
155633752|NCT04476043|561752173|FG002|Overall Study|Withdrawal by Subject|4|||
155633753|NCT04476043|561752174|FG003|Overall Study|Withdrawal by Subject|1|||
155633754|NCT04476043|561752171|FG000|Overall Study|Lost to Follow-up|1|||
155633755|NCT04476043|561752172|FG001|Overall Study|Lost to Follow-up|1|||
155633756|NCT04476043|561752173|FG002|Overall Study|Lost to Follow-up|2|||
155633757|NCT04476043|561752174|FG003|Overall Study|Lost to Follow-up|1|||
155633758|NCT04476043|561752171|FG000|Overall Study|Adverse Event|2|||
155633759|NCT04476043|561752172|FG001|Overall Study|Adverse Event|0|||
155633760|NCT04476043|561752173|FG002|Overall Study|Adverse Event|1|||
155633761|NCT04476043|561752174|FG003|Overall Study|Adverse Event|0|||
155633762|NCT04476043|561752171|FG000|Overall Study|Protocol Violation|0|||
155633763|NCT04476043|561752172|FG001|Overall Study|Protocol Violation|1|||
155633764|NCT04476043|561752173|FG002|Overall Study|Protocol Violation|0|||
155633765|NCT04476043|561752174|FG003|Overall Study|Protocol Violation|0|||
155737063|NCT02283762|562136232|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
155737064|NCT02283762|562136233|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
155633766|NCT02349386|561752175|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
155633767|NCT02349386|561752176|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
155633768|NCT02349386|561752177|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
155633769|NCT02349386|561752178|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
155633770|NCT02349386|561752175|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
155633771|NCT02349386|561752176|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
155633772|NCT02349386|561752177|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
155633773|NCT02349386|561752178|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
155737065|NCT02283762|562136232|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
155737066|NCT02283762|562136233|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
155737067|NCT02283762|562136232|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
155737068|NCT02283762|562136233|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
155737069|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
155737070|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
155737071|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
155737072|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
155737073|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
155737074|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
155737075|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
155737076|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
155737077|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
155737078|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
155737079|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
155737080|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
155737081|NCT02283762|562136232|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
155737082|NCT02283762|562136233|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
155737083|NCT01474018|562136237|FG000|Overall Study|Lost to Follow-up|0|||
155737084|NCT01474018|562136238|FG001|Overall Study|Lost to Follow-up|1|||
155737085|NCT01474018|562136237|FG000|Overall Study|Withdrawal by Subject|0|||
155737086|NCT01474018|562136238|FG001|Overall Study|Withdrawal by Subject|2|||
155737087|NCT00486291|562136242|FG000|Overall Study|Adverse Event|3|||
155737088|NCT00486291|562136243|FG001|Overall Study|Adverse Event|4|||
155737089|NCT00486291|562136242|FG000|Overall Study|Lost to Follow-up|3|||
155737090|NCT00486291|562136243|FG001|Overall Study|Lost to Follow-up|7|||
155737091|NCT00486291|562136242|FG000|Overall Study|protocol non-compliance|10|||
155737092|NCT00486291|562136243|FG001|Overall Study|protocol non-compliance|15|||
155737093|NCT00486291|562136242|FG000|Overall Study|requirement for restricted medication|0|||
155737094|NCT00486291|562136243|FG001|Overall Study|requirement for restricted medication|3|||
155737095|NCT00126490|562136248|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
155737096|NCT03462511|562136252|FG000|Overall Study|Withdrawal by Subject|2|||
155737097|NCT03462511|562136253|FG001|Overall Study|Withdrawal by Subject|3|||
155737098|NCT00200356|562136254|FG000|Overall Study|Lack of Efficacy|3|||
155737099|NCT00200356|562136255|FG001|Overall Study|Lack of Efficacy|3|||
155737100|NCT00200356|562136254|FG000|Overall Study|Protocol Violation|4|||
155737101|NCT00200356|562136255|FG001|Overall Study|Protocol Violation|4|||
155737102|NCT00200356|562136254|FG000|Overall Study|Nontreatment|1|||
155737103|NCT00200356|562136255|FG001|Overall Study|Nontreatment|0|||
155737104|NCT02367833|562136256|FG000|Overall Study|Withdrawal by Subject|1|||
155737105|NCT02367833|562136257|FG001|Overall Study|Withdrawal by Subject|1|||
155737106|NCT02367833|562136258|FG002|Overall Study|Withdrawal by Subject|0|||
155737107|NCT00035932|562136263|FG000|Overall Study|Adverse Event|10|||
155737108|NCT00035932|562136264|FG001|Overall Study|Adverse Event|9|||
155737109|NCT00035932|562136265|FG002|Overall Study|Adverse Event|9|||
155737110|NCT00035932|562136263|FG000|Overall Study|Death|0|||
155737111|NCT00035932|562136264|FG001|Overall Study|Death|0|||
155737112|NCT00035932|562136265|FG002|Overall Study|Death|1|||
155737113|NCT00035932|562136263|FG000|Overall Study|Disease Progression / Relapse|1|||
155737114|NCT00035932|562136264|FG001|Overall Study|Disease Progression / Relapse|1|||
155737115|NCT00035932|562136265|FG002|Overall Study|Disease Progression / Relapse|0|||
155737116|NCT00035932|562136263|FG000|Overall Study|Lost to Follow-up|4|||
155737117|NCT00035932|562136264|FG001|Overall Study|Lost to Follow-up|4|||
155737118|NCT00035932|562136265|FG002|Overall Study|Lost to Follow-up|3|||
155737119|NCT00035932|562136263|FG000|Overall Study|Noncompliance|6|||
155737120|NCT00035932|562136264|FG001|Overall Study|Noncompliance|7|||
155737121|NCT00035932|562136265|FG002|Overall Study|Noncompliance|6|||
155737122|NCT00035932|562136263|FG000|Overall Study|Protocol Violation While on Study|0|||
155737123|NCT00035932|562136264|FG001|Overall Study|Protocol Violation While on Study|1|||
155737124|NCT00035932|562136265|FG002|Overall Study|Protocol Violation While on Study|2|||
155737125|NCT00035932|562136263|FG000|Overall Study|Withdrawal by Subject|1|||
155737126|NCT00035932|562136264|FG001|Overall Study|Withdrawal by Subject|5|||
155737127|NCT00035932|562136265|FG002|Overall Study|Withdrawal by Subject|0|||
155737128|NCT00035932|562136263|FG000|Overall Study|Study Termination by Sponsor|1|||
155737129|NCT00035932|562136264|FG001|Overall Study|Study Termination by Sponsor|0|||
155737130|NCT00035932|562136265|FG002|Overall Study|Study Termination by Sponsor|0|||
155737131|NCT00035932|562136263|FG000|Overall Study|Lack of Efficacy|33|||
155737132|NCT00035932|562136264|FG001|Overall Study|Lack of Efficacy|33|||
155737133|NCT00035932|562136265|FG002|Overall Study|Lack of Efficacy|28|||
155737134|NCT00889720|562136268|FG000|Overall Study|Withdrawal by Subject|4|||
155737135|NCT00889720|562136268|FG000|Overall Study|Other|4|||
155737136|NCT04080167|562136269|FG000|Overall Study|Lost to Follow-up-Patients|7|||
155737137|NCT04080167|562136270|FG001|Overall Study|Lost to Follow-up-Patients|14|||
155737138|NCT04080167|562136271|FG002|Overall Study|Lost to Follow-up-Patients|0|||
155737139|NCT04080167|562136269|FG000|Overall Study|Lost to Follow-up-Providers|2|||
155737140|NCT04080167|562136270|FG001|Overall Study|Lost to Follow-up-Providers|2|||
155633774|NCT02349386|561752175|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155633775|NCT02349386|561752176|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155633776|NCT02349386|561752177|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
155633777|NCT02349386|561752178|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155633778|NCT02349386|561752175|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155633779|NCT02349386|561752176|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155633780|NCT02349386|561752177|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
155633781|NCT02349386|561752178|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155633782|NCT02349386|561752175|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
155633783|NCT02349386|561752176|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
155633784|NCT02349386|561752177|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
155633785|NCT02349386|561752178|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
155633786|NCT02349386|561752175|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155633787|NCT02349386|561752176|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155633788|NCT02349386|561752177|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
155633789|NCT02349386|561752178|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155633790|NCT04167462|561752179|FG000|Overall Study|Other reasons|3|||
155633791|NCT04167462|561752180|FG001|Overall Study|Other reasons|2|||
155633792|NCT04167462|561752179|FG000|Overall Study|Withdrawal by Subject|6|||
155633793|NCT04167462|561752180|FG001|Overall Study|Withdrawal by Subject|7|||
155633794|NCT04167462|561752179|FG000|Overall Study|Adverse Event|4|||
155633795|NCT04167462|561752180|FG001|Overall Study|Adverse Event|0|||
155633796|NCT04167462|561752179|FG000|Overall Study|Pregnancy|1|||
155633797|NCT04167462|561752180|FG001|Overall Study|Pregnancy|0|||
155633798|NCT04167462|561752179|FG000|Overall Study|Lack of Efficacy|0|||
155633799|NCT04167462|561752180|FG001|Overall Study|Lack of Efficacy|1|||
155633800|NCT02765165|561752181|FG000|Treatment Period|Progressive disease|3|||
155633801|NCT02765165|561752182|FG001|Treatment Period|Progressive disease|2|||
155633802|NCT02765165|561752183|FG002|Treatment Period|Progressive disease|3|||
155633803|NCT02765165|561752184|FG003|Treatment Period|Progressive disease|3|||
155633804|NCT02765165|561752185|FG004|Treatment Period|Progressive disease|4|||
155633805|NCT02765165|561752186|FG005|Treatment Period|Progressive disease|2|||
155633806|NCT02765165|561752187|FG006|Treatment Period|Progressive disease|2|||
155633807|NCT02765165|561752181|FG000|Treatment Period|Physician Decision|0|||
155633808|NCT02765165|561752182|FG001|Treatment Period|Physician Decision|1|||
155633809|NCT02765165|561752183|FG002|Treatment Period|Physician Decision|0|||
155633810|NCT02765165|561752184|FG003|Treatment Period|Physician Decision|0|||
155633811|NCT02765165|561752185|FG004|Treatment Period|Physician Decision|0|||
155633812|NCT02765165|561752186|FG005|Treatment Period|Physician Decision|0|||
155633813|NCT02765165|561752187|FG006|Treatment Period|Physician Decision|0|||
155633814|NCT02765165|561752181|FG000|Treatment Period|Adverse Event|0|||
155633815|NCT02765165|561752182|FG001|Treatment Period|Adverse Event|1|||
155737141|NCT04080167|562136271|FG002|Overall Study|Lost to Follow-up-Providers|0|||
155737142|NCT04080167|562136269|FG000|Overall Study|Withdrawal by Subject|1|||
155737143|NCT04080167|562136270|FG001|Overall Study|Withdrawal by Subject|2|||
155737144|NCT04080167|562136271|FG002|Overall Study|Withdrawal by Subject|0|||
155737145|NCT04080167|562136269|FG000|Overall Study|Withdrawal by Provider|0|||
155737146|NCT04080167|562136270|FG001|Overall Study|Withdrawal by Provider|0|||
155633816|NCT02765165|561752183|FG002|Treatment Period|Adverse Event|0|||
155633817|NCT02765165|561752184|FG003|Treatment Period|Adverse Event|0|||
155633818|NCT02765165|561752185|FG004|Treatment Period|Adverse Event|0|||
155633819|NCT02765165|561752186|FG005|Treatment Period|Adverse Event|0|||
155633820|NCT02765165|561752187|FG006|Treatment Period|Adverse Event|0|||
155633821|NCT02765165|561752181|FG000|Treatment Period|Withdrawal by Subject|0|||
155633822|NCT02765165|561752182|FG001|Treatment Period|Withdrawal by Subject|0|||
155633823|NCT02765165|561752183|FG002|Treatment Period|Withdrawal by Subject|0|||
155633824|NCT02765165|561752184|FG003|Treatment Period|Withdrawal by Subject|0|||
155633825|NCT02765165|561752185|FG004|Treatment Period|Withdrawal by Subject|2|||
155633826|NCT02765165|561752186|FG005|Treatment Period|Withdrawal by Subject|0|||
155633827|NCT02765165|561752187|FG006|Treatment Period|Withdrawal by Subject|0|||
155633828|NCT02765165|561752181|FG000|Treatment Period|Study terminated|0|||
155633829|NCT02765165|561752182|FG001|Treatment Period|Study terminated|0|||
155633830|NCT02765165|561752183|FG002|Treatment Period|Study terminated|0|||
155633831|NCT02765165|561752184|FG003|Treatment Period|Study terminated|0|||
155737147|NCT04080167|562136271|FG002|Overall Study|Withdrawal by Provider|4|||
155633832|NCT02765165|561752185|FG004|Treatment Period|Study terminated|0|||
155737148|NCT04080167|562136269|FG000|Overall Study|Death-Patient|2|||
155633833|NCT02765165|561752186|FG005|Treatment Period|Study terminated|1|||
155633834|NCT02765165|561752187|FG006|Treatment Period|Study terminated|2|||
155633835|NCT02765165|561752181|FG000|Post-treatment Follow-up|Death|1|||
155633836|NCT02765165|561752182|FG001|Post-treatment Follow-up|Death|2|||
155737149|NCT04080167|562136270|FG001|Overall Study|Death-Patient|1|||
155737150|NCT04080167|562136271|FG002|Overall Study|Death-Patient|0|||
155737151|NCT04080167|562136269|FG000|Overall Study|Hydroxyurea New Starts|0|||
155737152|NCT04080167|562136270|FG001|Overall Study|Hydroxyurea New Starts|0|||
155737153|NCT04080167|562136271|FG002|Overall Study|Hydroxyurea New Starts|1|||
155737154|NCT04080167|562136269|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
155737155|NCT04080167|562136270|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
155737156|NCT04080167|562136271|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
155737157|NCT02167139|562136272|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
155737158|NCT02167139|562136273|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
155737159|NCT02167139|562136274|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
155737160|NCT02167139|562136275|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
155737161|NCT02167139|562136272|FG000|Randomised, Double-blind|Adverse Event|2|||
155737162|NCT02167139|562136273|FG001|Randomised, Double-blind|Adverse Event|9|||
155737163|NCT02167139|562136274|FG002|Randomised, Double-blind|Adverse Event|0|||
155737164|NCT02167139|562136275|FG003|Randomised, Double-blind|Adverse Event|0|||
155737165|NCT02167139|562136272|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
155737166|NCT02167139|562136273|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
155737167|NCT02167139|562136274|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
155737168|NCT02167139|562136275|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
155737169|NCT02167139|562136272|FG000|Randomised, Double-blind|Other|3|||
155737170|NCT02167139|562136273|FG001|Randomised, Double-blind|Other|0|||
155737171|NCT02167139|562136274|FG002|Randomised, Double-blind|Other|0|||
155737172|NCT02167139|562136275|FG003|Randomised, Double-blind|Other|0|||
155737173|NCT02167139|562136272|FG000|Transition-extension|Adverse Event|2|||
155737174|NCT02167139|562136273|FG001|Transition-extension|Adverse Event|0|||
155737175|NCT02167139|562136274|FG002|Transition-extension|Adverse Event|2|||
155737176|NCT02167139|562136275|FG003|Transition-extension|Adverse Event|3|||
155737177|NCT02167139|562136272|FG000|Transition-extension|Withdrawal by Subject|2|||
155737178|NCT02167139|562136273|FG001|Transition-extension|Withdrawal by Subject|0|||
155737179|NCT02167139|562136274|FG002|Transition-extension|Withdrawal by Subject|4|||
155737180|NCT02167139|562136275|FG003|Transition-extension|Withdrawal by Subject|1|||
155737181|NCT02167139|562136272|FG000|Transition-extension|Lack of Efficacy|0|||
155737182|NCT02167139|562136273|FG001|Transition-extension|Lack of Efficacy|0|||
155737183|NCT02167139|562136274|FG002|Transition-extension|Lack of Efficacy|1|||
155737184|NCT02167139|562136275|FG003|Transition-extension|Lack of Efficacy|1|||
155737185|NCT02167139|562136272|FG000|Transition-extension|Other|1|||
155737186|NCT02167139|562136273|FG001|Transition-extension|Other|0|||
155737187|NCT02167139|562136274|FG002|Transition-extension|Other|1|||
155737188|NCT02167139|562136275|FG003|Transition-extension|Other|0|||
155737189|NCT02167139|562136272|FG000|Transition-extension|Lost to Follow-up|1|||
155737190|NCT02167139|562136273|FG001|Transition-extension|Lost to Follow-up|0|||
155737191|NCT02167139|562136274|FG002|Transition-extension|Lost to Follow-up|0|||
155737192|NCT02167139|562136275|FG003|Transition-extension|Lost to Follow-up|0|||
155737193|NCT02067676|562136276|FG000|Overall Study|Withdrawal by Subject|1|||
155737194|NCT02067676|562136277|FG001|Overall Study|Withdrawal by Subject|0|||
155737195|NCT02067676|562136278|FG002|Overall Study|Withdrawal by Subject|0|||
155737196|NCT02067676|562136279|FG003|Overall Study|Withdrawal by Subject|0|||
155737197|NCT02067676|562136280|FG004|Overall Study|Withdrawal by Subject|0|||
155737198|NCT02067676|562136281|FG005|Overall Study|Withdrawal by Subject|0|||
155737199|NCT00996333|562136282|FG000|Overall Study|Screen failure|1|||
155737200|NCT00996333|562136282|FG000|Overall Study|Withdrawal by Subject|1|||
155737201|NCT00996333|562136282|FG000|Overall Study|Death|4|||
155737202|NCT00996333|562136282|FG000|Overall Study|Adverse Event|1|||
155737203|NCT00996333|562136282|FG000|Overall Study|Physician Decision|1|||
155737204|NCT00996333|562136282|FG000|Overall Study|Other|5|||
155737205|NCT00476229|562136283|FG000|Overall Study|Progressive shortness of breath|1|||
155737206|NCT02164461|562136284|FG000|Overall Study|Adverse Event|0|||
155737207|NCT02164461|562136285|FG001|Overall Study|Adverse Event|0|||
155737208|NCT02164461|562136286|FG002|Overall Study|Adverse Event|1|||
155737209|NCT02164461|562136284|FG000|Overall Study|Disease Progression|1|||
155737210|NCT02164461|562136285|FG001|Overall Study|Disease Progression|3|||
155737211|NCT02164461|562136286|FG002|Overall Study|Disease Progression|4|||
155737212|NCT02164461|562136284|FG000|Overall Study|Withdrawal by Subject|0|||
155737213|NCT02164461|562136285|FG001|Overall Study|Withdrawal by Subject|3|||
155737214|NCT02164461|562136286|FG002|Overall Study|Withdrawal by Subject|0|||
155737215|NCT01262820|562136288|FG000|Overall Study|Adverse Event|5|||
155737216|NCT01262820|562136288|FG000|Overall Study|Lack of Efficacy|9|||
155737217|NCT01262820|562136288|FG000|Overall Study|Drug held for 21+ days|1|||
155737218|NCT00452361|562136289|FG000|Overall Study|Adverse Event|8|||
155737219|NCT00452361|562136290|FG001|Overall Study|Adverse Event|0|||
155737220|NCT00452361|562136289|FG000|Overall Study|Withdrawal by Subject|0|||
155737221|NCT00452361|562136290|FG001|Overall Study|Withdrawal by Subject|1|||
155737222|NCT00452361|562136289|FG000|Overall Study|Premature termination|13|||
155737223|NCT00452361|562136290|FG001|Overall Study|Premature termination|9|||
155737224|NCT02954172|562136291|FG000|Overall Study|Protocol Violation|3|||
155737225|NCT02954172|562136292|FG001|Overall Study|Protocol Violation|0|||
155737226|NCT02954172|562136291|FG000|Overall Study|allergic reaction|2|||
155633837|NCT02765165|561752183|FG002|Post-treatment Follow-up|Death|1|||
155633838|NCT02765165|561752184|FG003|Post-treatment Follow-up|Death|1|||
155633839|NCT02765165|561752185|FG004|Post-treatment Follow-up|Death|1|||
155633840|NCT02765165|561752186|FG005|Post-treatment Follow-up|Death|1|||
155633841|NCT02765165|561752187|FG006|Post-treatment Follow-up|Death|0|||
155633842|NCT02765165|561752181|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
155633843|NCT02765165|561752182|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
155633844|NCT02765165|561752183|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
155633845|NCT02765165|561752184|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
155633846|NCT02765165|561752185|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
155633847|NCT02765165|561752186|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
155633848|NCT02765165|561752187|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
155633849|NCT02765165|561752181|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633850|NCT02765165|561752182|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633851|NCT02765165|561752183|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
155633852|NCT02765165|561752184|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633853|NCT02765165|561752185|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633854|NCT02765165|561752186|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633855|NCT02765165|561752187|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
155633856|NCT02765165|561752181|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155633857|NCT02765165|561752182|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155633858|NCT02765165|561752183|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
155633859|NCT02765165|561752184|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
155633860|NCT02765165|561752185|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155633861|NCT02765165|561752186|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155633862|NCT02765165|561752187|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155633863|NCT02765165|561752181|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633864|NCT02765165|561752182|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
155633865|NCT02765165|561752183|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633866|NCT02765165|561752184|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633867|NCT02765165|561752185|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633868|NCT02765165|561752186|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633869|NCT02765165|561752187|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
155633870|NCT02765165|561752181|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155633871|NCT02765165|561752182|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155633872|NCT02765165|561752183|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155633873|NCT02765165|561752184|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155633874|NCT02765165|561752185|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
155633875|NCT02765165|561752186|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
155633876|NCT02765165|561752187|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
155633877|NCT01189266|561752188|FG000|Overall Study|Adverse Event|1|||
155633878|NCT01189266|561752189|FG001|Overall Study|Adverse Event|0|||
155633879|NCT01189266|561752190|FG002|Overall Study|Adverse Event|5|||
155633880|NCT01189266|561752188|FG000|Overall Study|Death|0|||
155633881|NCT01189266|561752189|FG001|Overall Study|Death|0|||
155633882|NCT01189266|561752190|FG002|Overall Study|Death|5|||
155633883|NCT01189266|561752188|FG000|Overall Study|Lack of Efficacy|4|||
155633884|NCT01189266|561752189|FG001|Overall Study|Lack of Efficacy|5|||
155633885|NCT01189266|561752190|FG002|Overall Study|Lack of Efficacy|44|||
155633886|NCT01189266|561752188|FG000|Overall Study|Physician Decision|0|||
155633887|NCT01189266|561752189|FG001|Overall Study|Physician Decision|0|||
155633888|NCT01189266|561752190|FG002|Overall Study|Physician Decision|1|||
155633889|NCT01189266|561752188|FG000|Overall Study|Protocol Violation|0|||
155633890|NCT01189266|561752189|FG001|Overall Study|Protocol Violation|1|||
155633891|NCT01189266|561752190|FG002|Overall Study|Protocol Violation|1|||
155633892|NCT01189266|561752188|FG000|Overall Study|Withdrawal by Subject|0|||
155633893|NCT01189266|561752189|FG001|Overall Study|Withdrawal by Subject|0|||
155633894|NCT01189266|561752190|FG002|Overall Study|Withdrawal by Subject|1|||
155633895|NCT01189266|561752188|FG000|Overall Study|Patient refuses further therapy|1|||
155633896|NCT01189266|561752189|FG001|Overall Study|Patient refuses further therapy|0|||
155633897|NCT01189266|561752190|FG002|Overall Study|Patient refuses further therapy|7|||
155633898|NCT01189266|561752188|FG000|Overall Study|No treatment|0|||
155633899|NCT01189266|561752189|FG001|Overall Study|No treatment|0|||
155633900|NCT01189266|561752190|FG002|Overall Study|No treatment|1|||
155633901|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
155633902|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
155633903|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
155737227|NCT02954172|562136292|FG001|Overall Study|allergic reaction|1|||
155737228|NCT02954172|562136291|FG000|Overall Study|non-measurable lesions at baseline|1|||
155737229|NCT02954172|562136292|FG001|Overall Study|non-measurable lesions at baseline|2|||
155737230|NCT00924027|562136293|FG000|Overall Study|Lost to Further Follow-Up|4|||
155737231|NCT00924027|562136294|FG001|Overall Study|Lost to Further Follow-Up|0|||
155737232|NCT00924027|562136295|FG002|Overall Study|Lost to Further Follow-Up|0|||
155737233|NCT00924027|562136296|FG003|Overall Study|Lost to Further Follow-Up|0|||
155737234|NCT00924027|562136293|FG000|Overall Study|Physician Decision|1|||
155737235|NCT00924027|562136294|FG001|Overall Study|Physician Decision|0|||
155737236|NCT00924027|562136295|FG002|Overall Study|Physician Decision|0|||
155737237|NCT00924027|562136296|FG003|Overall Study|Physician Decision|1|||
155737238|NCT00924027|562136293|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
155737239|NCT00924027|562136294|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
155737240|NCT00924027|562136295|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
155737241|NCT00924027|562136296|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
155737242|NCT00924027|562136293|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
155633904|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
155633905|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
155633906|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
155633907|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
155633908|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
155633909|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
155633910|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
155633911|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
155633912|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
155633913|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
155633914|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
155633915|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
155633916|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
155633917|NCT00410163|561752191|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
155633918|NCT00410163|561752192|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
155633919|NCT00410163|561752191|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
155633920|NCT00410163|561752192|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
155633921|NCT00410163|561752191|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
155633922|NCT00410163|561752192|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
155633923|NCT00410163|561752191|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
155633924|NCT00410163|561752192|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
155633925|NCT00410163|561752191|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
155633926|NCT00410163|561752192|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
155633927|NCT00410163|561752191|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
155633928|NCT00410163|561752192|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
155633929|NCT05452239|561752195|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
155633930|NCT05452239|561752196|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
155633931|NCT05452239|561752195|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
155633932|NCT05452239|561752196|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
155633933|NCT05452239|561752195|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
155633934|NCT05452239|561752196|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
155633935|NCT05452239|561752195|FG000|Placebo-controlled Period|Randomized but not treated|2|||
155633936|NCT05452239|561752196|FG001|Placebo-controlled Period|Randomized but not treated|2|||
155633937|NCT05452239|561752195|FG000|Placebo-controlled Period|Other than specified|1|||
155633938|NCT05452239|561752196|FG001|Placebo-controlled Period|Other than specified|1|||
155633939|NCT05452239|561752195|FG000|Open-label Period|Withdrawal by Subject|2|||
155633940|NCT05452239|561752196|FG001|Open-label Period|Withdrawal by Subject|1|||
155633941|NCT05452239|561752195|FG000|Open-label Period|Lost to Follow-up|3|||
155633942|NCT05452239|561752196|FG001|Open-label Period|Lost to Follow-up|0|||
155633943|NCT05452239|561752195|FG000|Open-label Period|Other than specified|1|||
155633944|NCT05452239|561752196|FG001|Open-label Period|Other than specified|2|||
155633945|NCT03692949|561752197|FG000|Overall Study|Lost to Follow-up|0|||
155633946|NCT03692949|561752198|FG001|Overall Study|Lost to Follow-up|0|||
155633947|NCT03692949|561752199|FG002|Overall Study|Lost to Follow-up|0|||
155633948|NCT03692949|561752200|FG003|Overall Study|Lost to Follow-up|0|||
155633949|NCT03692949|561752201|FG004|Overall Study|Lost to Follow-up|0|||
155633950|NCT03692949|561752202|FG005|Overall Study|Lost to Follow-up|0|||
155633951|NCT03692949|561752203|FG006|Overall Study|Lost to Follow-up|0|||
155633952|NCT03692949|561752204|FG007|Overall Study|Lost to Follow-up|1|||
155633953|NCT04428151|561752212|FG000|Overall Study|Death|100|||
155633954|NCT04428151|561752213|FG001|Overall Study|Death|86|||
155633955|NCT04428151|561752214|FG002|Overall Study|Death|57|||
155633956|NCT04428151|561752212|FG000|Overall Study|Lost to Follow-up|1|||
155633957|NCT04428151|561752213|FG001|Overall Study|Lost to Follow-up|1|||
155633958|NCT04428151|561752214|FG002|Overall Study|Lost to Follow-up|0|||
155737243|NCT00924027|562136294|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
155737244|NCT00924027|562136295|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
155737245|NCT00924027|562136296|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
155633959|NCT04428151|561752212|FG000|Overall Study|Withdrawal by Subject|2|||
155633960|NCT04428151|561752213|FG001|Overall Study|Withdrawal by Subject|2|||
155633961|NCT04428151|561752214|FG002|Overall Study|Withdrawal by Subject|3|||
155633962|NCT04428151|561752212|FG000|Overall Study|Participant Ongoing in Study|41|||
155633963|NCT04428151|561752213|FG001|Overall Study|Participant Ongoing in Study|53|||
155633964|NCT04428151|561752214|FG002|Overall Study|Participant Ongoing in Study|28|||
155633965|NCT02783690|561752217|FG000|Overall Study|Withdrawal by Subject|3|||
155633966|NCT02783690|561752218|FG001|Overall Study|Withdrawal by Subject|3|||
155633967|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
155633968|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
155633969|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
155633970|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
155633971|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Death|38|||
155633972|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Death|10|||
155633973|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
155633974|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
155633975|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
155633976|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
155633977|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
155633978|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
155633979|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
155633980|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
155633981|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
155633982|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
155633983|NCT02421939|561752219|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
155633984|NCT02421939|561752220|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
155633985|NCT02421939|561752219|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
155633986|NCT02421939|561752220|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
155633987|NCT02421939|561752219|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
155633988|NCT02421939|561752220|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
155633989|NCT02421939|561752219|FG000|Long Term Follow up: up to 3 Years|Death|118|||
155633990|NCT02421939|561752220|FG001|Long Term Follow up: up to 3 Years|Death|65|||
155633991|NCT02421939|561752219|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
155633992|NCT02421939|561752220|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
155633993|NCT03573297|561752224|FG000|Open Label Treatment Period|Adverse Event|67|||
155633994|NCT03573297|561752225|FG001|Open Label Treatment Period|Adverse Event|0|||
155633995|NCT03573297|561752226|FG002|Open Label Treatment Period|Adverse Event|0|||
155633996|NCT03573297|561752227|FG003|Open Label Treatment Period|Adverse Event|0|||
155633997|NCT03573297|561752224|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
155633998|NCT03573297|561752225|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
155633999|NCT03573297|561752226|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
155634000|NCT03573297|561752227|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
155634001|NCT03573297|561752224|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
155634002|NCT03573297|561752225|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
155634003|NCT03573297|561752226|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
155634004|NCT03573297|561752227|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
155634005|NCT03573297|561752224|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
155634006|NCT03573297|561752225|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
155634007|NCT03573297|561752226|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
155634008|NCT03573297|561752227|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
155634009|NCT03573297|561752224|FG000|Open Label Treatment Period|Pregnancy|1|||
155634010|NCT03573297|561752225|FG001|Open Label Treatment Period|Pregnancy|0|||
155737246|NCT00924027|562136293|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
155737247|NCT00924027|562136294|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
155737248|NCT00924027|562136295|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
155737249|NCT00924027|562136296|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
155737250|NCT01217307|562138163|FG000|Overall Study|Withdrawal by Subject|0|||
155737251|NCT01217307|562138164|FG001|Overall Study|Withdrawal by Subject|1|||
155737252|NCT01868542|562138165|FG000|Overall Study|Protocol Violation|0|||
155737253|NCT01868542|562138166|FG001|Overall Study|Protocol Violation|1|||
155737254|NCT01868542|562138165|FG000|Overall Study|Unclassified|0|||
155737255|NCT01868542|562138166|FG001|Overall Study|Unclassified|1|||
155737256|NCT00130247|562138167|FG000|Overall Study|Pregnancy|1|||
155737257|NCT00130247|562138168|FG001|Overall Study|Pregnancy|0|||
155737258|NCT00130247|562138167|FG000|Overall Study|Post-randomization exclusion|1|||
155737259|NCT00130247|562138168|FG001|Overall Study|Post-randomization exclusion|2|||
155737260|NCT00130247|562138167|FG000|Overall Study|Not compliant with DOT|0|||
155737261|NCT00130247|562138168|FG001|Overall Study|Not compliant with DOT|2|||
155737262|NCT00843284|562138171|FG000|Overall Study|Adverse Event|39|||
155737263|NCT00843284|562138171|FG000|Overall Study|Lack of Efficacy|5|||
155737264|NCT00843284|562138171|FG000|Overall Study|Lost to Follow-up|11|||
155737265|NCT00843284|562138171|FG000|Overall Study|Other|10|||
155737266|NCT00843284|562138171|FG000|Overall Study|Withdrawal by Subject|4|||
155737267|NCT00843284|562138171|FG000|Overall Study|Death|3|||
155737268|NCT02160899|562138174|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155737269|NCT02160899|562138175|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155737270|NCT02160899|562138176|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
155737271|NCT02160899|562138177|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
155737272|NCT02160899|562138178|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
155737273|NCT02160899|562138179|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
155737274|NCT04129151|562138180|FG000|Overall Study|Adverse Event|1|||
155737275|NCT04129151|562138180|FG000|Overall Study|Disease Progression|7|||
155737276|NCT04129151|562138180|FG000|Overall Study|Study closure|1|||
155737277|NCT04473235|562138181|FG000|Overall Study|Lost to Follow-up|6|||
155737278|NCT04473235|562138182|FG001|Overall Study|Lost to Follow-up|5|||
155737279|NCT04473235|562138181|FG000|Overall Study|Declined continuation|2|||
155737280|NCT04473235|562138182|FG001|Overall Study|Declined continuation|0|||
155737281|NCT04473235|562138181|FG000|Overall Study|Physician Decision|1|||
155737282|NCT04473235|562138182|FG001|Overall Study|Physician Decision|1|||
155737283|NCT04473235|562138181|FG000|Overall Study|Protocol Violation|10|||
155737284|NCT04473235|562138182|FG001|Overall Study|Protocol Violation|6|||
155737285|NCT00798759|562138185|FG000|Overall Study|Adverse Event|3|||
155737286|NCT00798759|562138186|FG001|Overall Study|Adverse Event|3|||
155737287|NCT00798759|562138185|FG000|Overall Study|Lost to Follow-up|1|||
155737288|NCT00798759|562138186|FG001|Overall Study|Lost to Follow-up|1|||
155737289|NCT00798759|562138185|FG000|Overall Study|Protocol Violation|4|||
155737290|NCT00798759|562138186|FG001|Overall Study|Protocol Violation|8|||
155737291|NCT00798759|562138185|FG000|Overall Study|Other|0|||
155737292|NCT00798759|562138186|FG001|Overall Study|Other|1|||
155737293|NCT03387111|562138187|FG000|Overall Study|Progressive Disease|3|||
155737294|NCT03387111|562138187|FG000|Overall Study|Other|1|||
155737295|NCT01945710|562138188|FG000|Overall Study|Progressive Disease|5|||
155737296|NCT01945710|562138189|FG001|Overall Study|Progressive Disease|4|||
155737297|NCT01945710|562138190|FG002|Overall Study|Progressive Disease|3|||
155737298|NCT01945710|562138191|FG003|Overall Study|Progressive Disease|2|||
155737299|NCT01945710|562138192|FG004|Overall Study|Progressive Disease|7|||
155737300|NCT01945710|562138193|FG005|Overall Study|Progressive Disease|3|||
155737301|NCT01945710|562138194|FG006|Overall Study|Progressive Disease|19|||
155737302|NCT01945710|562138188|FG000|Overall Study|Adverse Event|0|||
155737303|NCT01945710|562138189|FG001|Overall Study|Adverse Event|1|||
155737304|NCT01945710|562138190|FG002|Overall Study|Adverse Event|0|||
155737305|NCT01945710|562138191|FG003|Overall Study|Adverse Event|0|||
155737306|NCT01945710|562138192|FG004|Overall Study|Adverse Event|0|||
155737307|NCT01945710|562138193|FG005|Overall Study|Adverse Event|0|||
155737308|NCT01945710|562138194|FG006|Overall Study|Adverse Event|0|||
155737309|NCT01945710|562138188|FG000|Overall Study|Other|2|||
155737310|NCT01945710|562138189|FG001|Overall Study|Other|0|||
155737311|NCT01945710|562138190|FG002|Overall Study|Other|3|||
155737312|NCT01945710|562138191|FG003|Overall Study|Other|1|||
155737313|NCT01945710|562138192|FG004|Overall Study|Other|1|||
155737314|NCT01945710|562138193|FG005|Overall Study|Other|0|||
155737315|NCT01945710|562138194|FG006|Overall Study|Other|4|||
155737316|NCT01945710|562138188|FG000|Overall Study|Withdrawal by Subject|0|||
155737317|NCT01945710|562138189|FG001|Overall Study|Withdrawal by Subject|1|||
155737318|NCT01945710|562138190|FG002|Overall Study|Withdrawal by Subject|1|||
155737319|NCT01945710|562138191|FG003|Overall Study|Withdrawal by Subject|0|||
155737320|NCT01945710|562138192|FG004|Overall Study|Withdrawal by Subject|1|||
155737321|NCT01945710|562138193|FG005|Overall Study|Withdrawal by Subject|0|||
155393577|NCT01132612|560876799|FG002|Overall Study|Lost to Follow-up|7|||
155737322|NCT01945710|562138194|FG006|Overall Study|Withdrawal by Subject|0|||
155737323|NCT02730195|562138195|FG000|Overall Study|Withdrawal by Subject|1|||
155737324|NCT01368562|562138198|FG000|Overall Study|Adverse Event|1|||
155737325|NCT01368562|562138198|FG000|Overall Study|Disease progression|1|||
155737326|NCT01368562|562138198|FG000|Overall Study|Lost to Follow-up|1|||
155737327|NCT01368562|562138198|FG000|Overall Study|Death|6|||
155737328|NCT01368562|562138198|FG000|Overall Study|Unresponsive to treatment|5|||
155737329|NCT01368562|562138198|FG000|Overall Study|Other|3|||
155737330|NCT01368562|562138198|FG000|Overall Study|Other than specified|2|||
155737331|NCT00727441|562138200|FG000|Overall Study|Disease Progression|11|||
155737332|NCT00727441|562138201|FG001|Overall Study|Disease Progression|14|||
155737333|NCT00727441|562138202|FG002|Overall Study|Disease Progression|17|||
155737334|NCT00727441|562138200|FG000|Overall Study|Eligibility|7|||
155737335|NCT00727441|562138201|FG001|Overall Study|Eligibility|5|||
155737336|NCT00727441|562138202|FG002|Overall Study|Eligibility|7|||
155737337|NCT00727441|562138200|FG000|Overall Study|Death|0|||
155737338|NCT00727441|562138201|FG001|Overall Study|Death|1|||
155737339|NCT00727441|562138202|FG002|Overall Study|Death|1|||
155737340|NCT00727441|562138200|FG000|Overall Study|Physician Decision|0|||
155737341|NCT00727441|562138201|FG001|Overall Study|Physician Decision|1|||
155737342|NCT00727441|562138202|FG002|Overall Study|Physician Decision|0|||
155737343|NCT00727441|562138200|FG000|Overall Study|Withdrawal by Subject|0|||
155737344|NCT00727441|562138201|FG001|Overall Study|Withdrawal by Subject|1|||
155737345|NCT00727441|562138202|FG002|Overall Study|Withdrawal by Subject|0|||
155737346|NCT01239992|562138203|FG000|Overall Study|Withdrawal by Subject|2|||
155737347|NCT00535288|562138204|FG000|Overall Study|Adverse Event|20|||
155737348|NCT00535288|562138205|FG001|Overall Study|Adverse Event|19|||
155737349|NCT00535288|562138206|FG002|Overall Study|Adverse Event|25|||
155737350|NCT00535288|562138207|FG003|Overall Study|Adverse Event|20|||
155737351|NCT00535288|562138208|FG004|Overall Study|Adverse Event|30|||
155737352|NCT00535288|562138204|FG000|Overall Study|Lost to Follow-up|0|||
155737353|NCT00535288|562138205|FG001|Overall Study|Lost to Follow-up|3|||
155737354|NCT00535288|562138206|FG002|Overall Study|Lost to Follow-up|0|||
155737355|NCT00535288|562138207|FG003|Overall Study|Lost to Follow-up|0|||
155737356|NCT00535288|562138208|FG004|Overall Study|Lost to Follow-up|0|||
155737357|NCT00535288|562138204|FG000|Overall Study|Lack of Efficacy|26|||
155737358|NCT00535288|562138205|FG001|Overall Study|Lack of Efficacy|3|||
155737359|NCT00535288|562138206|FG002|Overall Study|Lack of Efficacy|4|||
155737360|NCT00535288|562138207|FG003|Overall Study|Lack of Efficacy|4|||
155737361|NCT00535288|562138208|FG004|Overall Study|Lack of Efficacy|7|||
155737362|NCT00535288|562138204|FG000|Overall Study|Unwilling to cooperate|6|||
155634011|NCT03573297|561752226|FG002|Open Label Treatment Period|Pregnancy|0|||
155634012|NCT03573297|561752227|FG003|Open Label Treatment Period|Pregnancy|0|||
155634013|NCT03573297|561752224|FG000|Open Label Treatment Period|Protocol Violation|17|||
155634014|NCT03573297|561752225|FG001|Open Label Treatment Period|Protocol Violation|0|||
155634015|NCT03573297|561752226|FG002|Open Label Treatment Period|Protocol Violation|0|||
155634016|NCT03573297|561752227|FG003|Open Label Treatment Period|Protocol Violation|0|||
155634017|NCT03573297|561752224|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
155634018|NCT03573297|561752225|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155634019|NCT03573297|561752226|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155634020|NCT03573297|561752227|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155634021|NCT03573297|561752224|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
155634022|NCT03573297|561752225|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155634023|NCT03573297|561752226|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155634024|NCT03573297|561752227|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155634025|NCT03573297|561752224|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
155634026|NCT03573297|561752225|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155634027|NCT03573297|561752226|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155634028|NCT03573297|561752227|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155634029|NCT03573297|561752224|FG000|Open Label Treatment Period|Other, Not Specified|7|||
155634030|NCT03573297|561752225|FG001|Open Label Treatment Period|Other, Not Specified|0|||
155634031|NCT03573297|561752226|FG002|Open Label Treatment Period|Other, Not Specified|0|||
155634032|NCT03573297|561752227|FG003|Open Label Treatment Period|Other, Not Specified|0|||
155634033|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
155634034|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
155634035|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
155634036|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
155634037|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155634038|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155634039|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Adverse Event|5|||
155634040|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Adverse Event|1|||
155634041|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155634042|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
155634043|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
155634044|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
155634045|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155634046|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
155634047|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
155634048|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
155634049|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155634050|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
155634051|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
155634052|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
155634053|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155634054|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
155737363|NCT00535288|562138205|FG001|Overall Study|Unwilling to cooperate|6|||
155737364|NCT00535288|562138206|FG002|Overall Study|Unwilling to cooperate|3|||
155737365|NCT00535288|562138207|FG003|Overall Study|Unwilling to cooperate|3|||
155737366|NCT00535288|562138208|FG004|Overall Study|Unwilling to cooperate|4|||
155737367|NCT00535288|562138204|FG000|Overall Study|Other|2|||
155737368|NCT00535288|562138205|FG001|Overall Study|Other|1|||
155737369|NCT00535288|562138206|FG002|Overall Study|Other|1|||
155737370|NCT00535288|562138207|FG003|Overall Study|Other|2|||
155737371|NCT00535288|562138208|FG004|Overall Study|Other|1|||
155737372|NCT02810444|562138209|FG000|Overall Study|Screen Failures|14|||
155737373|NCT02810444|562138209|FG000|Overall Study|Withdrawal by Subject|4|||
155737374|NCT02810444|562138209|FG000|Overall Study|Adverse Event|3|||
155737375|NCT02848729|562138212|FG000|Overall Study|Withdrawal by Subject|1|||
155737376|NCT02848729|562138213|FG001|Overall Study|Withdrawal by Subject|0|||
155737377|NCT02848729|562138212|FG000|Overall Study|Emesis|15|||
155737378|NCT02848729|562138213|FG001|Overall Study|Emesis|11|||
155737379|NCT01904773|562138214|FG000|Screen|Screen failure|3|||
155737380|NCT01904773|562138215|FG001|Screen|Screen failure|0|||
155737381|NCT01904773|562138216|FG002|Screen|Screen failure|0|||
155737382|NCT01904773|562138217|FG003|Screen|Screen failure|0|||
155737383|NCT01904773|562138218|FG004|Screen|Screen failure|0|||
155737384|NCT01904773|562138219|FG005|Screen|Screen failure|0|||
155737385|NCT01904773|562138220|FG006|Screen|Screen failure|0|||
155737386|NCT01904773|562138221|FG007|Screen|Screen failure|0|||
155737387|NCT01904773|562138222|FG008|Screen|Screen failure|0|||
155737388|NCT01904773|562138214|FG000|Screen|Withdrawal by Subject|1|||
155737389|NCT01904773|562138215|FG001|Screen|Withdrawal by Subject|0|||
155737390|NCT01904773|562138216|FG002|Screen|Withdrawal by Subject|0|||
155737391|NCT01904773|562138217|FG003|Screen|Withdrawal by Subject|0|||
155737392|NCT01904773|562138218|FG004|Screen|Withdrawal by Subject|0|||
155737393|NCT01904773|562138219|FG005|Screen|Withdrawal by Subject|0|||
155737394|NCT01904773|562138220|FG006|Screen|Withdrawal by Subject|0|||
155737395|NCT01904773|562138221|FG007|Screen|Withdrawal by Subject|0|||
155737396|NCT01904773|562138222|FG008|Screen|Withdrawal by Subject|0|||
155737397|NCT01904773|562138214|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
155737398|NCT01904773|562138215|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737399|NCT01904773|562138216|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737400|NCT01904773|562138217|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737401|NCT01904773|562138218|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737402|NCT01904773|562138219|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737403|NCT01904773|562138220|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737404|NCT01904773|562138221|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737405|NCT01904773|562138222|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155737406|NCT01904773|562138214|FG000|First Intervention|Adverse Event|0|||
155737407|NCT01904773|562138215|FG001|First Intervention|Adverse Event|0|||
155737408|NCT01904773|562138216|FG002|First Intervention|Adverse Event|0|||
155737409|NCT01904773|562138217|FG003|First Intervention|Adverse Event|0|||
155737410|NCT01904773|562138218|FG004|First Intervention|Adverse Event|0|||
155737411|NCT01904773|562138219|FG005|First Intervention|Adverse Event|0|||
155737412|NCT01904773|562138220|FG006|First Intervention|Adverse Event|1|||
155737413|NCT01904773|562138221|FG007|First Intervention|Adverse Event|0|||
155737414|NCT01904773|562138222|FG008|First Intervention|Adverse Event|0|||
155737415|NCT01904773|562138214|FG000|Placebo Washout First Intervention|Condition worsened|0|||
155737416|NCT01904773|562138215|FG001|Placebo Washout First Intervention|Condition worsened|1|||
155737417|NCT01904773|562138216|FG002|Placebo Washout First Intervention|Condition worsened|0|||
155737418|NCT01904773|562138217|FG003|Placebo Washout First Intervention|Condition worsened|0|||
155737419|NCT01904773|562138218|FG004|Placebo Washout First Intervention|Condition worsened|0|||
155737420|NCT01904773|562138219|FG005|Placebo Washout First Intervention|Condition worsened|0|||
155737421|NCT01904773|562138220|FG006|Placebo Washout First Intervention|Condition worsened|0|||
155737422|NCT01904773|562138221|FG007|Placebo Washout First Intervention|Condition worsened|0|||
155737423|NCT01904773|562138222|FG008|Placebo Washout First Intervention|Condition worsened|0|||
155737424|NCT01904773|562138214|FG000|Fifth Intervention|Adverse Event|0|||
155737425|NCT01904773|562138215|FG001|Fifth Intervention|Adverse Event|0|||
155737426|NCT01904773|562138216|FG002|Fifth Intervention|Adverse Event|0|||
155737427|NCT01904773|562138217|FG003|Fifth Intervention|Adverse Event|0|||
155737428|NCT01904773|562138218|FG004|Fifth Intervention|Adverse Event|0|||
155283289|NCT00924560|560468275|FG002|Overall Study|Pregnancy|1|||
155737429|NCT01904773|562138219|FG005|Fifth Intervention|Adverse Event|0|||
155737430|NCT01904773|562138220|FG006|Fifth Intervention|Adverse Event|0|||
155737431|NCT01904773|562138221|FG007|Fifth Intervention|Adverse Event|1|||
155737432|NCT01904773|562138222|FG008|Fifth Intervention|Adverse Event|0|||
155737433|NCT01904773|562138214|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737434|NCT01904773|562138215|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
155737435|NCT01904773|562138216|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737436|NCT01904773|562138217|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737437|NCT01904773|562138218|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155283290|NCT00924560|560468273|FG000|Overall Study|Lost to Follow-up|78|||
155737438|NCT01904773|562138219|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737439|NCT01904773|562138220|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737440|NCT01904773|562138221|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737441|NCT01904773|562138222|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155737442|NCT04518995|562138223|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
155737443|NCT04518995|562138224|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
155737444|NCT04518995|562138225|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
155737445|NCT04518995|562138223|FG000|Overall Study|Lack of Efficacy|2|||
155737446|NCT04518995|562138224|FG001|Overall Study|Lack of Efficacy|1|||
155737447|NCT04518995|562138225|FG002|Overall Study|Lack of Efficacy|0|||
155737448|NCT04518995|562138223|FG000|Overall Study|Non-compliance With Study Drug|0|||
155737449|NCT04518995|562138224|FG001|Overall Study|Non-compliance With Study Drug|3|||
155737450|NCT04518995|562138225|FG002|Overall Study|Non-compliance With Study Drug|2|||
155737451|NCT04518995|562138223|FG000|Overall Study|Pregnancy|0|||
155737452|NCT04518995|562138224|FG001|Overall Study|Pregnancy|0|||
155737453|NCT04518995|562138225|FG002|Overall Study|Pregnancy|1|||
155737454|NCT04518995|562138223|FG000|Overall Study|Protocol Violation|2|||
155737455|NCT04518995|562138224|FG001|Overall Study|Protocol Violation|0|||
155737456|NCT04518995|562138225|FG002|Overall Study|Protocol Violation|1|||
155737457|NCT04518995|562138223|FG000|Overall Study|Reason not Specified|4|||
155737458|NCT04518995|562138224|FG001|Overall Study|Reason not Specified|11|||
155737459|NCT04518995|562138225|FG002|Overall Study|Reason not Specified|2|||
155737460|NCT04518995|562138223|FG000|Overall Study|Lost to Follow-up|1|||
155737461|NCT04518995|562138224|FG001|Overall Study|Lost to Follow-up|10|||
155737462|NCT04518995|562138225|FG002|Overall Study|Lost to Follow-up|6|||
155737463|NCT03390101|562138228|FG000|Weeks 0-12|Withdrawal by Subject|0|||
155737464|NCT03390101|562138229|FG001|Weeks 0-12|Withdrawal by Subject|1|||
155737465|NCT03390101|562138230|FG002|Weeks 0-12|Withdrawal by Subject|1|||
155737466|NCT03390101|562138228|FG000|Weeks 0-12|Lost to Follow-up|0|||
155737467|NCT03390101|562138229|FG001|Weeks 0-12|Lost to Follow-up|1|||
155737468|NCT03390101|562138230|FG002|Weeks 0-12|Lost to Follow-up|0|||
155737469|NCT03390101|562138228|FG000|Weeks 12-54|Withdrawal by Subject|0|||
155737470|NCT03390101|562138229|FG001|Weeks 12-54|Withdrawal by Subject|3|||
155737471|NCT03390101|562138230|FG002|Weeks 12-54|Withdrawal by Subject|1|||
155737472|NCT03390101|562138228|FG000|Weeks 12-54|Pregnancy|1|||
155737473|NCT03390101|562138229|FG001|Weeks 12-54|Pregnancy|0|||
155737474|NCT03390101|562138230|FG002|Weeks 12-54|Pregnancy|0|||
155737475|NCT03390101|562138228|FG000|Weeks 12-54|Adverse Event|2|||
155737476|NCT03390101|562138229|FG001|Weeks 12-54|Adverse Event|1|||
155737477|NCT03390101|562138230|FG002|Weeks 12-54|Adverse Event|1|||
155737478|NCT04590248|562138231|FG000|Overall Study|Lost to Follow-up|1|||
155737479|NCT04590248|562138231|FG000|Overall Study|Withdrawal by Subject|16|||
155737480|NCT04590248|562138231|FG000|Overall Study|Other|2|||
155737481|NCT02052414|562138232|FG000|Overall Study|Adverse Event|12|||
155737482|NCT02052414|562138232|FG000|Overall Study|Lack of Efficacy|2|||
155737483|NCT02052414|562138232|FG000|Overall Study|Withdrawal by Subject|3|||
155737484|NCT02891070|562138238|FG000|Overall Study|Adverse Event|1|||
155737485|NCT02891070|562138239|FG001|Overall Study|Adverse Event|0|||
155737486|NCT02891070|562138238|FG000|Overall Study|Physician Decision|0|||
155737487|NCT02891070|562138239|FG001|Overall Study|Physician Decision|1|||
155737488|NCT02891070|562138238|FG000|Overall Study|Lost to Follow-up|4|||
155737489|NCT02891070|562138239|FG001|Overall Study|Lost to Follow-up|4|||
155737490|NCT02891070|562138238|FG000|Overall Study|Other|1|||
155737491|NCT02891070|562138239|FG001|Overall Study|Other|0|||
155737492|NCT02891070|562138238|FG000|Overall Study|Protocol Violation|0|||
155737493|NCT02891070|562138239|FG001|Overall Study|Protocol Violation|1|||
155737494|NCT02891070|562138238|FG000|Overall Study|Withdrawal by Subject|1|||
155737495|NCT02891070|562138239|FG001|Overall Study|Withdrawal by Subject|2|||
155737496|NCT02891070|562138238|FG000|Overall Study|Death|3|||
155737497|NCT02891070|562138239|FG001|Overall Study|Death|0|||
155737498|NCT01716052|562138244|FG000|Overall Study|Withdrawal of funding|1|||
155737499|NCT01716052|562138245|FG001|Overall Study|Withdrawal of funding|1|||
155737500|NCT02597478|562138252|FG000|Overall Study|Withdrawal by Subject|2|||
155737501|NCT02597478|562138253|FG001|Overall Study|Withdrawal by Subject|0|||
155737502|NCT02597478|562138252|FG000|Overall Study|Change of opioid dose|1|||
155737503|NCT02597478|562138253|FG001|Overall Study|Change of opioid dose|0|||
155737504|NCT02597478|562138252|FG000|Overall Study|Insufficient exertional dyspnea|0|||
155737505|NCT02597478|562138253|FG001|Overall Study|Insufficient exertional dyspnea|1|||
155737506|NCT01305577|562138255|FG000|Overall Study|Adverse Event|2|||
155737507|NCT01305577|562138256|FG001|Overall Study|Adverse Event|2|||
155737508|NCT01305577|562138257|FG002|Overall Study|Adverse Event|1|||
155737509|NCT01305577|562138255|FG000|Overall Study|Withdrawal by Subject|7|||
155737510|NCT01305577|562138256|FG001|Overall Study|Withdrawal by Subject|5|||
155737511|NCT01305577|562138257|FG002|Overall Study|Withdrawal by Subject|6|||
155737512|NCT01305577|562138255|FG000|Overall Study|Lost to Follow-up|4|||
155737513|NCT01305577|562138256|FG001|Overall Study|Lost to Follow-up|3|||
155737514|NCT01305577|562138257|FG002|Overall Study|Lost to Follow-up|2|||
155737515|NCT01305577|562138255|FG000|Overall Study|Protocol Deviation|0|||
155737516|NCT01305577|562138256|FG001|Overall Study|Protocol Deviation|1|||
155737517|NCT01305577|562138257|FG002|Overall Study|Protocol Deviation|1|||
155737518|NCT00796978|562138258|FG000|Overall Study|Cardiac adverse event|5|||
155737519|NCT00796978|562138258|FG000|Overall Study|Adverse Event|4|||
155737520|NCT00796978|562138258|FG000|Overall Study|Withdrawal by Subject|3|||
155634055|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
155634056|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
155634057|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
155634058|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
155634059|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
155634060|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
155634061|NCT03573297|561752224|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
155634062|NCT03573297|561752225|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
155634063|NCT03573297|561752226|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
155634064|NCT03573297|561752227|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
155634065|NCT04880850|561752228|FG000|Overall Study|Death|2|||
155634066|NCT04880850|561752229|FG001|Overall Study|Death|1|||
155634067|NCT04880850|561752228|FG000|Overall Study|Lost to Follow-up|3|||
155634068|NCT04880850|561752229|FG001|Overall Study|Lost to Follow-up|6|||
155634069|NCT04880850|561752228|FG000|Overall Study|Physician Decision|2|||
155634070|NCT04880850|561752229|FG001|Overall Study|Physician Decision|1|||
155634071|NCT04880850|561752228|FG000|Overall Study|Withdrawal by Subject|9|||
155634072|NCT04880850|561752229|FG001|Overall Study|Withdrawal by Subject|10|||
155634073|NCT03907488|561752230|FG000|Overall Study|Adverse Event|20|||
155634074|NCT03907488|561752231|FG001|Overall Study|Adverse Event|20|||
155634075|NCT03907488|561752230|FG000|Overall Study|Withdrawal by Subject|9|||
155634076|NCT03907488|561752231|FG001|Overall Study|Withdrawal by Subject|13|||
155634077|NCT03907488|561752230|FG000|Overall Study|Lack of Efficacy|0|||
155634078|NCT03907488|561752231|FG001|Overall Study|Lack of Efficacy|9|||
155634079|NCT03907488|561752230|FG000|Overall Study|Death|3|||
155634080|NCT03907488|561752231|FG001|Overall Study|Death|8|||
155634081|NCT03907488|561752230|FG000|Overall Study|not protocol specified|5|||
155634082|NCT03907488|561752231|FG001|Overall Study|not protocol specified|8|||
155634083|NCT03907488|561752230|FG000|Overall Study|Ineligible|9|||
155634084|NCT03907488|561752231|FG001|Overall Study|Ineligible|15|||
155634085|NCT01093846|561752232|FG000|Overall Study|Adverse Event|0|||
155634086|NCT01093846|561752233|FG001|Overall Study|Adverse Event|0|||
155634087|NCT01093846|561752234|FG002|Overall Study|Adverse Event|1|||
155634088|NCT01093846|561752232|FG000|Overall Study|Lack of Efficacy|0|||
155634089|NCT01093846|561752233|FG001|Overall Study|Lack of Efficacy|0|||
155634090|NCT01093846|561752234|FG002|Overall Study|Lack of Efficacy|4|||
155634091|NCT01093846|561752232|FG000|Overall Study|Condition no longer required study drug|1|||
155634092|NCT01093846|561752233|FG001|Overall Study|Condition no longer required study drug|1|||
155634093|NCT01093846|561752234|FG002|Overall Study|Condition no longer required study drug|1|||
155634094|NCT01093846|561752232|FG000|Overall Study|Administrative Problems|18|||
155634095|NCT01093846|561752233|FG001|Overall Study|Administrative Problems|17|||
155634096|NCT01093846|561752234|FG002|Overall Study|Administrative Problems|15|||
155634097|NCT03846479|561754089|FG000|Overall Study|Death|8|||
155634098|NCT03846479|561754089|FG000|Overall Study|Lost to Follow-up|1|||
155634099|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
155634100|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
155634101|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Death|1|||
155634102|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Death|3|||
155634103|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
155634104|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
155634105|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
155634106|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
155634107|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
155634108|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
155634109|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
155634110|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
155634111|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
155634112|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
155634113|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
155634114|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
155634115|NCT00362232|561754092|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
155634116|NCT00362232|561754093|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
155737521|NCT01256190|562138259|FG000|Overall Study|Lost to Follow-up|2|||
155634117|NCT00362232|561754092|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
155634118|NCT00362232|561754093|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
155634119|NCT00362232|561754092|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
155737522|NCT01256190|562138260|FG001|Overall Study|Lost to Follow-up|0|||
155737523|NCT02834793|562138261|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
155737524|NCT02834793|562138262|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
155737525|NCT02834793|562138263|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
155737526|NCT02834793|562138264|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
155737527|NCT02834793|562138261|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
155737528|NCT02834793|562138262|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155737529|NCT02834793|562138263|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155737530|NCT02834793|562138264|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155737531|NCT02834793|562138261|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
155634120|NCT00362232|561754093|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
155634121|NCT00362232|561754092|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
155634122|NCT00362232|561754093|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
155634123|NCT00362232|561754092|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
155634124|NCT00362232|561754093|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
155634125|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
155634126|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
155634127|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
155634128|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
155634129|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
155634130|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
155634131|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
155634132|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
155634133|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
155634134|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
155634135|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
155634136|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
155634137|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
155634138|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
155634139|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
155634140|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
155634141|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
155634142|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
155634143|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
155634144|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
155634145|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
155634146|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
155634147|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
155634148|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
155634149|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
155634150|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
155634151|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
155634152|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
155634153|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
155634154|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
155634155|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
155634156|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
155634157|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
155634158|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
155634159|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
155634160|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
155634161|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
155634162|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
155634163|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
155634164|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
155634165|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
155634166|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
155634167|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
155634168|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
155634169|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
155634170|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
155634171|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
155634172|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
155634173|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
155634174|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
155634175|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
155634176|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
155634177|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
155634178|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
155634179|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
155737532|NCT02834793|562138262|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155737533|NCT02834793|562138263|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155737534|NCT02834793|562138264|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155737535|NCT02834793|562138261|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155737536|NCT02834793|562138262|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
155737537|NCT02834793|562138263|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155737538|NCT02834793|562138264|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155737539|NCT02834793|562138261|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155737540|NCT02834793|562138262|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
155737541|NCT02834793|562138263|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155737542|NCT02834793|562138264|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155737543|NCT02834793|562138261|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155737544|NCT02834793|562138262|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155737545|NCT02834793|562138263|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
155737546|NCT02834793|562138264|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155737547|NCT02834793|562138261|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155737548|NCT02834793|562138262|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155737549|NCT02834793|562138263|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
155737550|NCT02834793|562138264|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155737551|NCT02834793|562138261|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155737552|NCT02834793|562138262|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155737553|NCT02834793|562138263|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
155737554|NCT02834793|562138264|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155737555|NCT02834793|562138261|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155737556|NCT02834793|562138262|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155737557|NCT02834793|562138263|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
155737558|NCT02834793|562138264|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155737559|NCT02834793|562138261|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
155737560|NCT02834793|562138262|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
155737561|NCT02834793|562138263|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
155737562|NCT02834793|562138264|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
155737563|NCT02834793|562138261|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155737564|NCT02834793|562138262|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155737565|NCT02834793|562138263|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155737566|NCT02834793|562138264|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
155737567|NCT02834793|562138261|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155737568|NCT02834793|562138262|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155737569|NCT02834793|562138263|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155737570|NCT02834793|562138264|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
155737571|NCT02834793|562138261|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155737572|NCT02834793|562138262|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155737573|NCT02834793|562138263|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155737574|NCT02834793|562138264|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
155737575|NCT02834793|562138261|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
155737576|NCT02834793|562138262|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
155737577|NCT02834793|562138263|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
155737578|NCT02834793|562138264|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
155737579|NCT02834793|562138261|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155737580|NCT02834793|562138262|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155737581|NCT02834793|562138263|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155737582|NCT02834793|562138264|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
155737583|NCT02364336|562138265|FG000|Overall Study|Adverse Event|0|||
155737584|NCT02364336|562138266|FG001|Overall Study|Adverse Event|1|||
155737585|NCT01731938|562138267|FG000|Preliminary Part I|Withdrawal by Subject|2|||
155737586|NCT01731938|562138268|FG001|Preliminary Part I|Withdrawal by Subject|2|||
155737587|NCT01731938|562138267|FG000|Preliminary Part I|Physician Decision|1|||
155737588|NCT01731938|562138268|FG001|Preliminary Part I|Physician Decision|0|||
155737589|NCT01731938|562138267|FG000|Preliminary Part I|Lost to Follow-up|0|||
155737590|NCT01731938|562138268|FG001|Preliminary Part I|Lost to Follow-up|3|||
155737591|NCT01731938|562138267|FG000|Preliminary Part I|Missed Week 6 visit|0|||
155737592|NCT01731938|562138268|FG001|Preliminary Part I|Missed Week 6 visit|3|||
155737593|NCT01731938|562138267|FG000|Primary Part II|Withdrawal by Subject|5|||
155737594|NCT01731938|562138268|FG001|Primary Part II|Withdrawal by Subject|4|||
155737595|NCT01731938|562138267|FG000|Primary Part II|Lost to Follow-up|4|||
155737596|NCT01731938|562138268|FG001|Primary Part II|Lost to Follow-up|5|||
155737597|NCT01731938|562138267|FG000|Primary Part II|Death|2|||
155737598|NCT01731938|562138268|FG001|Primary Part II|Death|1|||
155737599|NCT01731938|562138267|FG000|Primary Part II|Missed Week 6 visit|2|||
155737600|NCT01731938|562138268|FG001|Primary Part II|Missed Week 6 visit|3|||
155737601|NCT04931888|562138269|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
155737602|NCT04931888|562138270|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
155737603|NCT04931888|562138271|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
155737604|NCT04931888|562138272|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
155737605|NCT03179202|562138273|FG000|Overall Study|Screen Failure|67|||
155737606|NCT03179202|562138273|FG000|Overall Study|Subject Lost to Follow Up|12|||
155737607|NCT03179202|562138273|FG000|Overall Study|Withdrawal by Subject|7|||
155737608|NCT03179202|562138273|FG000|Overall Study|Adverse Event|3|||
155737609|NCT03179202|562138273|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
155737610|NCT03179202|562138273|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
155737611|NCT02969408|562138274|FG000|Overall Study|Adverse Event|2|||
155737612|NCT02969408|562138274|FG000|Overall Study|Withdrawal by Subject|8|||
155737613|NCT02969408|562138274|FG000|Overall Study|Lost to Follow-up|4|||
155737614|NCT02969408|562138274|FG000|Overall Study|Protocol Violation|1|||
155737615|NCT02969408|562138274|FG000|Overall Study|Other than specified|1|||
155737616|NCT02350478|562138275|FG000|Overall Study|Lost to Follow-up|5|||
155737617|NCT02350478|562138276|FG001|Overall Study|Lost to Follow-up|1|||
155737618|NCT02779556|562138277|FG000|Baseline|Partial baseline interview completed|1|||
155737619|NCT02779556|562138278|FG001|Baseline|Partial baseline interview completed|0|||
155737620|NCT02779556|562138277|FG000|3 Months|Lost to Follow-up|40|||
155737621|NCT02779556|562138278|FG001|3 Months|Lost to Follow-up|29|||
155737622|NCT02779556|562138277|FG000|3 Months|Missed 3 month clinic visit|27|||
155737623|NCT02779556|562138278|FG001|3 Months|Missed 3 month clinic visit|19|||
155737624|NCT02779556|562138277|FG000|6 Month|Lost to Follow-up|33|||
155737625|NCT02779556|562138278|FG001|6 Month|Lost to Follow-up|39|||
155737626|NCT02779556|562138277|FG000|6 Month HbA1c|No value collected during window|69|||
155737627|NCT02779556|562138278|FG001|6 Month HbA1c|No value collected during window|50|||
155737628|NCT02779556|562138277|FG000|12 Month HbA1c|No value collected during window|138|||
155737629|NCT02779556|562138278|FG001|12 Month HbA1c|No value collected during window|102|||
155737630|NCT01667419|562138282|FG000|Overall Study|Reason Not Specified|1|||
155737631|NCT01667419|562138283|FG001|Overall Study|Reason Not Specified|0|||
155737632|NCT01667419|562138284|FG002|Overall Study|Reason Not Specified|0|||
155737633|NCT01667419|562138285|FG003|Overall Study|Reason Not Specified|0|||
155737634|NCT01667419|562138282|FG000|Overall Study|Withdrawal by Subject|16|||
155737635|NCT01667419|562138283|FG001|Overall Study|Withdrawal by Subject|8|||
155737636|NCT01667419|562138284|FG002|Overall Study|Withdrawal by Subject|9|||
155737637|NCT01667419|562138285|FG003|Overall Study|Withdrawal by Subject|8|||
155737638|NCT01667419|562138282|FG000|Overall Study|Non-compliance|0|||
155737639|NCT01667419|562138283|FG001|Overall Study|Non-compliance|0|||
155737640|NCT01667419|562138284|FG002|Overall Study|Non-compliance|0|||
155737641|NCT01667419|562138285|FG003|Overall Study|Non-compliance|1|||
155737642|NCT01667419|562138282|FG000|Overall Study|Protocol Violation|1|||
155737643|NCT01667419|562138283|FG001|Overall Study|Protocol Violation|0|||
155737644|NCT01667419|562138284|FG002|Overall Study|Protocol Violation|0|||
155737645|NCT01667419|562138285|FG003|Overall Study|Protocol Violation|0|||
155737646|NCT01667419|562138282|FG000|Overall Study|Lost to Follow-up|7|||
155737647|NCT01667419|562138283|FG001|Overall Study|Lost to Follow-up|6|||
155737648|NCT01667419|562138284|FG002|Overall Study|Lost to Follow-up|2|||
155737649|NCT01667419|562138285|FG003|Overall Study|Lost to Follow-up|4|||
155737650|NCT01667419|562138282|FG000|Overall Study|Death|18|||
155737651|NCT01667419|562138283|FG001|Overall Study|Death|33|||
155737652|NCT01667419|562138284|FG002|Overall Study|Death|25|||
155737653|NCT01667419|562138285|FG003|Overall Study|Death|26|||
155737654|NCT00856518|562138286|FG000|Overall Study|Lost to Follow-up|4|||
155737655|NCT00856518|562138287|FG001|Overall Study|Lost to Follow-up|2|||
155737656|NCT02644109|562138297|FG000|Overall Study|Adverse Event|0|||
155737657|NCT02644109|562138298|FG001|Overall Study|Adverse Event|4|||
155737658|NCT02474069|562138299|FG000|Selection Phase (SP)|Adverse Event|8|||
155737659|NCT02474069|562138300|FG001|Selection Phase (SP)|Adverse Event|0|||
155737660|NCT02474069|562138301|FG002|Selection Phase (SP)|Adverse Event|0|||
155737661|NCT02474069|562138299|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
155737662|NCT02474069|562138300|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
155737663|NCT02474069|562138301|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
155737664|NCT02474069|562138299|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
155737665|NCT02474069|562138300|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
155737666|NCT02474069|562138301|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
155737667|NCT02474069|562138299|FG000|Selection Phase (SP)|Physician Decision|1|||
155737668|NCT02474069|562138300|FG001|Selection Phase (SP)|Physician Decision|0|||
155737669|NCT02474069|562138301|FG002|Selection Phase (SP)|Physician Decision|0|||
155737670|NCT02474069|562138299|FG000|Selection Phase (SP)|Protocol Violation|1|||
155737671|NCT02474069|562138300|FG001|Selection Phase (SP)|Protocol Violation|0|||
155737672|NCT02474069|562138301|FG002|Selection Phase (SP)|Protocol Violation|0|||
155737673|NCT02474069|562138299|FG000|Selection Phase (SP)|No longer requires treatment|1|||
155737674|NCT02474069|562138300|FG001|Selection Phase (SP)|No longer requires treatment|0|||
155737675|NCT02474069|562138301|FG002|Selection Phase (SP)|No longer requires treatment|0|||
155737676|NCT02474069|562138299|FG000|Selection Phase (SP)|Technical Problem|1|||
155737677|NCT02474069|562138300|FG001|Selection Phase (SP)|Technical Problem|0|||
155737678|NCT02474069|562138301|FG002|Selection Phase (SP)|Technical Problem|0|||
155737679|NCT02474069|562138299|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
155737680|NCT02474069|562138300|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
155737681|NCT02474069|562138301|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
155737682|NCT02474069|562138299|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
155737683|NCT02474069|562138300|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
155737684|NCT02474069|562138301|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
155737685|NCT02474069|562138299|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
155737686|NCT02474069|562138300|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
155737687|NCT02474069|562138301|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
155737688|NCT02474069|562138299|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
155737689|NCT02474069|562138300|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
155737690|NCT02474069|562138301|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
155737691|NCT02474069|562138299|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
155737692|NCT02474069|562138300|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
155737693|NCT02474069|562138301|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
155737694|NCT02474069|562138299|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
155737695|NCT02474069|562138300|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
155737696|NCT02474069|562138301|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
155737697|NCT00202878|562138304|FG000|Overall Study|Death|964|||
155737698|NCT00202878|562138305|FG001|Overall Study|Death|968|||
155737699|NCT00202878|562138304|FG000|Overall Study|Only Vital Status Known|357|||
155737700|NCT00202878|562138305|FG001|Overall Study|Only Vital Status Known|356|||
155737701|NCT00202878|562138304|FG000|Overall Study|Lost to Follow-up|44|||
155737702|NCT00202878|562138305|FG001|Overall Study|Lost to Follow-up|49|||
155737703|NCT00202878|562138304|FG000|Overall Study|Site Closure|39|||
155737704|NCT00202878|562138305|FG001|Overall Study|Site Closure|36|||
155737705|NCT00202878|562138304|FG000|Overall Study|Withdrawal by Subject|795|||
155737706|NCT00202878|562138305|FG001|Overall Study|Withdrawal by Subject|808|||
155737707|NCT00918736|562138307|FG000|Overall Study|Withdrawal by Subject|4|||
155737708|NCT02433080|562138309|FG000|Overall Study|Lost to Follow-up|1|||
155737709|NCT02433080|562138310|FG001|Overall Study|Lost to Follow-up|2|||
155737710|NCT02433080|562138309|FG000|Overall Study|Withdrawal by Subject|0|||
155737711|NCT02433080|562138310|FG001|Overall Study|Withdrawal by Subject|2|||
155737712|NCT01942733|562138312|FG000|Overall Study|Lost to Follow-up|1|||
155737713|NCT01942733|562138312|FG000|Overall Study|Non-compliance with IMP|1|||
155737714|NCT01942733|562138312|FG000|Overall Study|Administrative|1|||
155737715|NCT02925416|562138314|FG000|Overall Study|Adverse Event|2|||
155737716|NCT02925416|562138315|FG001|Overall Study|Adverse Event|0|||
155737717|NCT02625909|562138316|FG000|Overall Study|Death|2|||
155737718|NCT02625909|562138317|FG001|Overall Study|Death|0|||
155737719|NCT02625909|562138316|FG000|Overall Study|Lost to Follow-up|3|||
155737720|NCT02625909|562138317|FG001|Overall Study|Lost to Follow-up|5|||
155737721|NCT02625909|562138316|FG000|Overall Study|Lack of Efficacy|9|||
155737722|NCT02625909|562138317|FG001|Overall Study|Lack of Efficacy|2|||
155737723|NCT02625909|562138316|FG000|Overall Study|Reinfection|3|||
155737724|NCT02625909|562138317|FG001|Overall Study|Reinfection|2|||
155737725|NCT01297491|562138323|FG000|Overall Study|Adverse Event|11|||
155737726|NCT01297491|562138324|FG001|Overall Study|Adverse Event|6|||
155737727|NCT01297491|562138323|FG000|Overall Study|Physician Decision|3|||
155737728|NCT01297491|562138324|FG001|Overall Study|Physician Decision|2|||
155737729|NCT01297491|562138323|FG000|Overall Study|Progressive disease|11|||
155737730|NCT01297491|562138324|FG001|Overall Study|Progressive disease|20|||
155737731|NCT01297491|562138323|FG000|Overall Study|Patient/Guardian decision|3|||
155737732|NCT01297491|562138324|FG001|Overall Study|Patient/Guardian decision|4|||
155737733|NCT01297491|562138323|FG000|Overall Study|Death|2|||
155737734|NCT01297491|562138324|FG001|Overall Study|Death|1|||
155737735|NCT02355184|562138330|FG000|Overall Study|Lost to Follow-up|2|||
155737736|NCT02355184|562138330|FG000|Overall Study|Study Terminated|10|||
155737737|NCT00813943|562141297|FG000|Overall Study|Ongoing at cut-off date|5|||
155737738|NCT00813943|562141298|FG001|Overall Study|Ongoing at cut-off date|5|||
155737739|NCT00813943|562141299|FG002|Overall Study|Ongoing at cut-off date|3|||
155737740|NCT02704143|562141304|FG000|Overall Study|disease progression|10|||
155737741|NCT01235598|562141305|FG000|Overall Study|Adverse Event|0|||
155737742|NCT01235598|562141306|FG001|Overall Study|Adverse Event|3|||
155737743|NCT01235598|562141305|FG000|Overall Study|Lack of Efficacy|0|||
155737744|NCT01235598|562141306|FG001|Overall Study|Lack of Efficacy|1|||
155737745|NCT01235598|562141305|FG000|Overall Study|Withdrawal by Subject|1|||
155737746|NCT01235598|562141306|FG001|Overall Study|Withdrawal by Subject|0|||
155737747|NCT02551991|562141307|FG000|Overall Study|Death|5|||
155737748|NCT02551991|562141308|FG001|Overall Study|Death|7|||
155737749|NCT02551991|562141309|FG002|Overall Study|Death|8|||
155737750|NCT02551991|562141310|FG003|Overall Study|Death|7|||
155737751|NCT02551991|562141311|FG004|Overall Study|Death|17|||
155737752|NCT02551991|562141307|FG000|Overall Study|Withdrawal by Subject|1|||
155737753|NCT02551991|562141308|FG001|Overall Study|Withdrawal by Subject|0|||
155737754|NCT02551991|562141309|FG002|Overall Study|Withdrawal by Subject|0|||
155737755|NCT02551991|562141310|FG003|Overall Study|Withdrawal by Subject|0|||
155737756|NCT02551991|562141311|FG004|Overall Study|Withdrawal by Subject|2|||
155737757|NCT02551991|562141307|FG000|Overall Study|Lost to Follow-up|0|||
155737758|NCT02551991|562141308|FG001|Overall Study|Lost to Follow-up|0|||
155737759|NCT02551991|562141309|FG002|Overall Study|Lost to Follow-up|1|||
155737760|NCT02551991|562141310|FG003|Overall Study|Lost to Follow-up|0|||
155737761|NCT02551991|562141311|FG004|Overall Study|Lost to Follow-up|0|||
155737762|NCT02551991|562141307|FG000|Overall Study|Sponsor Decision|1|||
155737763|NCT02551991|562141308|FG001|Overall Study|Sponsor Decision|0|||
155737764|NCT02551991|562141309|FG002|Overall Study|Sponsor Decision|1|||
155737765|NCT02551991|562141310|FG003|Overall Study|Sponsor Decision|0|||
155737766|NCT02551991|562141311|FG004|Overall Study|Sponsor Decision|5|||
155737767|NCT02551991|562141307|FG000|Overall Study|Other|0|||
155737768|NCT02551991|562141308|FG001|Overall Study|Other|0|||
155737769|NCT02551991|562141309|FG002|Overall Study|Other|0|||
155737770|NCT02551991|562141310|FG003|Overall Study|Other|0|||
155737771|NCT02551991|562141311|FG004|Overall Study|Other|1|||
155737772|NCT00395343|562141312|FG000|Overall Study|Adverse Event|13|||
155737773|NCT00395343|562141313|FG001|Overall Study|Adverse Event|5|||
155737774|NCT00395343|562141312|FG000|Overall Study|Lack of Efficacy|0|||
155737775|NCT00395343|562141313|FG001|Overall Study|Lack of Efficacy|1|||
155737776|NCT00395343|562141312|FG000|Overall Study|Lost to Follow-up|4|||
155737777|NCT00395343|562141313|FG001|Overall Study|Lost to Follow-up|4|||
155737778|NCT00395343|562141312|FG000|Overall Study|Physician Decision|2|||
155737779|NCT00395343|562141313|FG001|Overall Study|Physician Decision|4|||
155737780|NCT00395343|562141312|FG000|Overall Study|Protocol Violation|6|||
155737781|NCT00395343|562141313|FG001|Overall Study|Protocol Violation|8|||
155737782|NCT00395343|562141312|FG000|Overall Study|Withdrawal by Subject|11|||
155737783|NCT00395343|562141313|FG001|Overall Study|Withdrawal by Subject|12|||
155737784|NCT00395343|562141312|FG000|Overall Study|Other|5|||
155737785|NCT00395343|562141313|FG001|Overall Study|Other|2|||
155737786|NCT00942994|562141317|FG000|Overall Study|Adverse Event|7|||
155737787|NCT00942994|562141318|FG001|Overall Study|Adverse Event|4|||
155737788|NCT00942994|562141317|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155737789|NCT00942994|562141318|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155737790|NCT00942994|562141317|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155737791|NCT00942994|562141318|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155737792|NCT00942994|562141317|FG000|Overall Study|Patient withdrew consent|5|||
155737793|NCT00942994|562141318|FG001|Overall Study|Patient withdrew consent|8|||
155737794|NCT00942994|562141317|FG000|Overall Study|Lost to Follow-up|1|||
155737795|NCT00942994|562141318|FG001|Overall Study|Lost to Follow-up|4|||
155737796|NCT00942994|562141317|FG000|Overall Study|Protocol deviation|1|||
155737797|NCT00942994|562141318|FG001|Overall Study|Protocol deviation|2|||
155737798|NCT00387790|562141319|FG000|Overall Study|Adverse Event|5|||
155737799|NCT00387790|562141319|FG000|Overall Study|Lack of Efficacy|2|||
155737800|NCT00387790|562141319|FG000|Overall Study|Physician Decision|2|||
155737801|NCT00387790|562141319|FG000|Overall Study|Withdrawal by Subject|3|||
155737802|NCT00387790|562141319|FG000|Overall Study|Ineligible for study|2|||
155737803|NCT03539549|562141323|FG000|Overall Study|Adverse Event|12|||
155737804|NCT03539549|562141323|FG000|Overall Study|Lost to Follow-up|1|||
155737805|NCT03539549|562141323|FG000|Overall Study|Death|2|||
155737806|NCT03539549|562141323|FG000|Overall Study|Progressive Disease|1|||
155737807|NCT03539549|562141323|FG000|Overall Study|Reason not Specified|1|||
155737808|NCT03598114|562141327|FG000|Overall Study|Staff turnover/left the program|3|||
155737809|NCT03598114|562141328|FG001|Overall Study|Staff turnover/left the program|39|||
155737810|NCT02527200|562141329|FG000|Overall Study|Withdrawal by Subject|3|||
155737811|NCT02527200|562141330|FG001|Overall Study|Withdrawal by Subject|2|||
155737812|NCT02527200|562141331|FG002|Overall Study|Withdrawal by Subject|1|||
155737813|NCT02527200|562141332|FG003|Overall Study|Withdrawal by Subject|0|||
155737814|NCT02527200|562141329|FG000|Overall Study|Unclassified|0|||
155737815|NCT02527200|562141330|FG001|Overall Study|Unclassified|1|||
155737816|NCT02527200|562141331|FG002|Overall Study|Unclassified|0|||
155737817|NCT02527200|562141332|FG003|Overall Study|Unclassified|0|||
155737818|NCT02527200|562141329|FG000|Overall Study|Lost to Follow-up|0|||
155737819|NCT02527200|562141330|FG001|Overall Study|Lost to Follow-up|0|||
155737820|NCT02527200|562141331|FG002|Overall Study|Lost to Follow-up|1|||
155737821|NCT02527200|562141332|FG003|Overall Study|Lost to Follow-up|0|||
155737822|NCT04540198|562141333|FG000|Overall Study|Lost to Follow-up|25|||
155737823|NCT04540198|562141334|FG001|Overall Study|Lost to Follow-up|23|||
155737824|NCT04540198|562141333|FG000|Overall Study|Withdrawal by Subject|15|||
155737825|NCT04540198|562141334|FG001|Overall Study|Withdrawal by Subject|9|||
155737826|NCT04540198|562141333|FG000|Overall Study|Discontinued|1|||
155737827|NCT04540198|562141334|FG001|Overall Study|Discontinued|0|||
155737828|NCT03110770|562141335|FG000|Overall Study|Death|1|||
155737829|NCT03110770|562141336|FG001|Overall Study|Death|0|||
155737830|NCT03110770|562141337|FG002|Overall Study|Death|0|||
155393578|NCT01132612|560876797|FG000|Overall Study|Adverse Event|5|||
155737831|NCT03110770|562141338|FG003|Overall Study|Death|1|||
155737832|NCT03110770|562141339|FG004|Overall Study|Death|0|||
155737833|NCT03110770|562141335|FG000|Overall Study|Enrolled but did not receive product|0|||
155737834|NCT03110770|562141336|FG001|Overall Study|Enrolled but did not receive product|0|||
155737835|NCT03110770|562141337|FG002|Overall Study|Enrolled but did not receive product|0|||
155737836|NCT03110770|562141338|FG003|Overall Study|Enrolled but did not receive product|8|||
155737837|NCT03110770|562141339|FG004|Overall Study|Enrolled but did not receive product|7|||
155737838|NCT03110770|562141335|FG000|Overall Study|Lost to Follow-up|0|||
155737839|NCT03110770|562141336|FG001|Overall Study|Lost to Follow-up|0|||
155737840|NCT03110770|562141337|FG002|Overall Study|Lost to Follow-up|0|||
155737841|NCT03110770|562141338|FG003|Overall Study|Lost to Follow-up|53|||
155737842|NCT03110770|562141339|FG004|Overall Study|Lost to Follow-up|45|||
155737843|NCT03110770|562141335|FG000|Overall Study|Investigator Decision|0|||
155737844|NCT03110770|562141336|FG001|Overall Study|Investigator Decision|0|||
155737845|NCT03110770|562141337|FG002|Overall Study|Investigator Decision|0|||
155737846|NCT03110770|562141338|FG003|Overall Study|Investigator Decision|5|||
155737847|NCT03110770|562141339|FG004|Overall Study|Investigator Decision|3|||
155737848|NCT03110770|562141335|FG000|Overall Study|Withdrawal by Subject|0|||
155737849|NCT03110770|562141336|FG001|Overall Study|Withdrawal by Subject|0|||
155737850|NCT03110770|562141337|FG002|Overall Study|Withdrawal by Subject|0|||
155737851|NCT03110770|562141338|FG003|Overall Study|Withdrawal by Subject|24|||
155737852|NCT03110770|562141339|FG004|Overall Study|Withdrawal by Subject|24|||
155737853|NCT03110770|562141335|FG000|Overall Study|Moved from area|5|||
155737854|NCT03110770|562141336|FG001|Overall Study|Moved from area|0|||
155737855|NCT03110770|562141337|FG002|Overall Study|Moved from area|2|||
155737856|NCT03110770|562141338|FG003|Overall Study|Moved from area|42|||
155737857|NCT03110770|562141339|FG004|Overall Study|Moved from area|43|||
155737858|NCT03110770|562141335|FG000|Overall Study|Illness/Injury unrelated to product|0|||
155737859|NCT03110770|562141336|FG001|Overall Study|Illness/Injury unrelated to product|0|||
155737860|NCT03110770|562141337|FG002|Overall Study|Illness/Injury unrelated to product|0|||
155737861|NCT03110770|562141338|FG003|Overall Study|Illness/Injury unrelated to product|0|||
155737862|NCT03110770|562141339|FG004|Overall Study|Illness/Injury unrelated to product|1|||
155737863|NCT02082340|562141347|FG000|Overall Study|Lost to Follow-up|1|||
155737864|NCT02082340|562141348|FG001|Overall Study|Lost to Follow-up|1|||
155737865|NCT01625260|562141349|FG000|Overall Study|Adverse Event|3|||
155737866|NCT01625260|562141350|FG001|Overall Study|Adverse Event|0|||
155737867|NCT01625260|562141349|FG000|Overall Study|Study Terminated by Investigator|2|||
155737868|NCT01625260|562141350|FG001|Overall Study|Study Terminated by Investigator|0|||
155737869|NCT01625260|562141349|FG000|Overall Study|Disease Progression|2|||
155737870|NCT01625260|562141350|FG001|Overall Study|Disease Progression|0|||
155737871|NCT01625260|562141349|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
155737872|NCT01625260|562141350|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
155737873|NCT04195893|562141351|FG000|Second Intervention|Withdrawal by Subject|1|||
155737874|NCT04195893|562141352|FG001|Second Intervention|Withdrawal by Subject|0|||
155737875|NCT02745145|562141353|FG000|Overall Study|Adverse Event|1|||
155737876|NCT02745145|562141354|FG001|Overall Study|Adverse Event|0|||
155737877|NCT02745145|562141355|FG002|Overall Study|Adverse Event|0|||
155737878|NCT02745145|562141353|FG000|Overall Study|Death|0|||
155737879|NCT02745145|562141354|FG001|Overall Study|Death|1|||
155737880|NCT02745145|562141355|FG002|Overall Study|Death|0|||
155737881|NCT02745145|562141353|FG000|Overall Study|Progressive disease|0|||
155737882|NCT02745145|562141354|FG001|Overall Study|Progressive disease|0|||
155737883|NCT02745145|562141355|FG002|Overall Study|Progressive disease|1|||
155737884|NCT02745145|562141353|FG000|Overall Study|Withdrew consent|1|||
155737885|NCT02745145|562141354|FG001|Overall Study|Withdrew consent|1|||
155737886|NCT02745145|562141355|FG002|Overall Study|Withdrew consent|1|||
155737887|NCT02745145|562141353|FG000|Overall Study|Study Termination|8|||
155737888|NCT02745145|562141354|FG001|Overall Study|Study Termination|3|||
155737889|NCT02745145|562141355|FG002|Overall Study|Study Termination|7|||
155737890|NCT04413617|562141356|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155737891|NCT04413617|562141357|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155737892|NCT04413617|562141358|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155737893|NCT04413617|562141359|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
155737894|NCT04413617|562141360|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155737895|NCT04413617|562141356|FG000|Overall Study|Protocol Violation|0|||
155737896|NCT04413617|562141357|FG001|Overall Study|Protocol Violation|1|||
155737897|NCT04413617|562141358|FG002|Overall Study|Protocol Violation|0|||
155737898|NCT04413617|562141359|FG003|Overall Study|Protocol Violation|0|||
155737899|NCT04413617|562141360|FG004|Overall Study|Protocol Violation|1|||
155737900|NCT04413617|562141356|FG000|Overall Study|Lack of Efficacy|2|||
155737901|NCT04413617|562141357|FG001|Overall Study|Lack of Efficacy|0|||
155737902|NCT04413617|562141358|FG002|Overall Study|Lack of Efficacy|2|||
155737903|NCT04413617|562141359|FG003|Overall Study|Lack of Efficacy|1|||
155737904|NCT04413617|562141360|FG004|Overall Study|Lack of Efficacy|0|||
155737905|NCT04413617|562141356|FG000|Overall Study|Withdrawal by Subject|3|||
155737906|NCT04413617|562141357|FG001|Overall Study|Withdrawal by Subject|4|||
155737907|NCT04413617|562141358|FG002|Overall Study|Withdrawal by Subject|2|||
155737908|NCT04413617|562141359|FG003|Overall Study|Withdrawal by Subject|5|||
155634180|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
155634181|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
155634182|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
155634183|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
155634184|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
155634185|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
155634186|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
155634187|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
155634188|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
155634189|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
155634190|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
155634191|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
155634192|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
155634193|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
155634194|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
155634195|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
155634196|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
155634197|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
155634198|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
155634199|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
155634200|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
155634201|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
155634202|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
155634203|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
155634204|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
155634205|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
155634206|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
155634207|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
155634208|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
155634209|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
155634210|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
155634211|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
155634212|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
155634213|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
155634214|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
155634215|NCT00090103|561754096|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
155634216|NCT00090103|561754097|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
155634217|NCT00090103|561754098|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
155634218|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
155634219|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
155634220|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
155634221|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
155634222|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
155634223|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
155634224|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
155634225|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
155634226|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
155634227|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
155634228|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
155634229|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
155634230|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
155634231|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
155634232|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
155634233|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
155634234|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
155634235|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
155634236|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
155634237|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
155634238|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
155634239|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
155634240|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
155634241|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
155283291|NCT00924560|560468274|FG001|Overall Study|Lost to Follow-up|94|||
155737909|NCT04413617|562141360|FG004|Overall Study|Withdrawal by Subject|3|||
155737910|NCT04413617|562141356|FG000|Overall Study|Death|1|||
155737911|NCT04413617|562141357|FG001|Overall Study|Death|0|||
155737912|NCT04413617|562141358|FG002|Overall Study|Death|0|||
155737913|NCT04413617|562141359|FG003|Overall Study|Death|0|||
155737914|NCT04413617|562141360|FG004|Overall Study|Death|0|||
155737915|NCT04413617|562141356|FG000|Overall Study|Adverse Event|1|||
155737916|NCT04413617|562141357|FG001|Overall Study|Adverse Event|0|||
155737917|NCT04413617|562141358|FG002|Overall Study|Adverse Event|0|||
155737918|NCT04413617|562141359|FG003|Overall Study|Adverse Event|1|||
155737919|NCT04413617|562141360|FG004|Overall Study|Adverse Event|1|||
155737920|NCT04413617|562141356|FG000|Overall Study|COVID-19|0|||
155737921|NCT04413617|562141357|FG001|Overall Study|COVID-19|1|||
155737922|NCT04413617|562141358|FG002|Overall Study|COVID-19|0|||
155737923|NCT04413617|562141359|FG003|Overall Study|COVID-19|0|||
155737924|NCT04413617|562141360|FG004|Overall Study|COVID-19|0|||
155737925|NCT00775593|562141361|FG000|Overall Study|Unmet eligibility criteria|6|||
155737926|NCT00775593|562141361|FG000|Overall Study|Death|1|||
155737927|NCT02511106|562141364|FG000|Overall Study|Lost to Follow-up|6|||
155737928|NCT02511106|562141365|FG001|Overall Study|Lost to Follow-up|4|||
155737929|NCT02511106|562141364|FG000|Overall Study|Withdrawal by Subject|24|||
155737930|NCT02511106|562141365|FG001|Overall Study|Withdrawal by Subject|21|||
155737931|NCT02511106|562141364|FG000|Overall Study|Death|42|||
155737932|NCT02511106|562141365|FG001|Overall Study|Death|82|||
155737933|NCT02511106|562141364|FG000|Overall Study|Ongoing study at data cut-off|3|||
155737934|NCT02511106|562141365|FG001|Overall Study|Ongoing study at data cut-off|2|||
155737935|NCT02511106|562141364|FG000|Overall Study|Without specified reason|3|||
155737936|NCT02511106|562141365|FG001|Overall Study|Without specified reason|0|||
155737937|NCT01015638|562141366|FG000|Overall Study|Withdrawal by Subject|1|||
155737938|NCT01015638|562141367|FG001|Overall Study|Withdrawal by Subject|0|||
155737939|NCT00984620|562141368|FG000|Overall Study|Adverse Event|5|||
155737940|NCT00984620|562141369|FG001|Overall Study|Adverse Event|5|||
155737941|NCT00984620|562141368|FG000|Overall Study|Lost to Follow-up|1|||
155737942|NCT00984620|562141369|FG001|Overall Study|Lost to Follow-up|1|||
155737943|NCT00984620|562141368|FG000|Overall Study|Withdrawal by Subject|0|||
155737944|NCT00984620|562141369|FG001|Overall Study|Withdrawal by Subject|2|||
155737945|NCT00984620|562141368|FG000|Overall Study|reason other than listed above|0|||
155737946|NCT00984620|562141369|FG001|Overall Study|reason other than listed above|4|||
155737947|NCT00324961|562141373|FG000|Overall Study|Adverse Event|5|||
155737948|NCT00324961|562141373|FG000|Overall Study|Consent Withdrawn|11|||
155737949|NCT00324961|562141373|FG000|Overall Study|Lost to Follow-up|22|||
155737950|NCT00324961|562141373|FG000|Overall Study|Protocol Violation|3|||
155737951|NCT00324961|562141373|FG000|Overall Study|Other|2|||
155737952|NCT00344487|562141374|FG000|Overall Study|immunologic failure|1|||
155737953|NCT01703754|562141377|FG000|Overall Study|Clinically significant disease progression|2|||
155737954|NCT01703754|562141378|FG001|Overall Study|Clinically significant disease progression|2|||
155737955|NCT01703754|562141379|FG002|Overall Study|Clinically significant disease progression|1|||
155737956|NCT01703754|562141377|FG000|Overall Study|Adverse Event|1|||
155737957|NCT01703754|562141378|FG001|Overall Study|Adverse Event|1|||
155737958|NCT01703754|562141379|FG002|Overall Study|Adverse Event|0|||
155737959|NCT01703754|562141377|FG000|Overall Study|Withdrawal by Subject|2|||
155737960|NCT01703754|562141378|FG001|Overall Study|Withdrawal by Subject|0|||
155737961|NCT01703754|562141379|FG002|Overall Study|Withdrawal by Subject|0|||
155737962|NCT01459497|562141383|FG000|Overall Study|Inability to meet trial constraints.|1|||
155737963|NCT01459497|562141384|FG001|Overall Study|Inability to meet trial constraints.|0|||
155737964|NCT01459497|562141383|FG000|Overall Study|Physician Decision|1|||
155737965|NCT01459497|562141384|FG001|Overall Study|Physician Decision|1|||
155737966|NCT01459497|562141383|FG000|Overall Study|Hospitalization.|0|||
155737967|NCT01459497|562141384|FG001|Overall Study|Hospitalization.|3|||
155737968|NCT01459497|562141383|FG000|Overall Study|Disease progression.|0|||
155737969|NCT01459497|562141384|FG001|Overall Study|Disease progression.|1|||
155737970|NCT03530124|562141385|FG000|Overall Study|Withdrawal by Subject|0|||
155737971|NCT03530124|562141386|FG001|Overall Study|Withdrawal by Subject|1|||
155737972|NCT03530124|562141385|FG000|Overall Study|Protocol Violation|1|||
155737973|NCT03530124|562141386|FG001|Overall Study|Protocol Violation|0|||
155737974|NCT03530124|562141385|FG000|Overall Study|Discharged prior to study completion|1|||
155737975|NCT03530124|562141386|FG001|Overall Study|Discharged prior to study completion|0|||
155737976|NCT05188053|562141387|FG000|Overall Study|Lost to Follow-up|23|||
155737977|NCT05188053|562141388|FG001|Overall Study|Lost to Follow-up|30|||
155737978|NCT05188053|562141387|FG000|Overall Study|Protocol Violation|16|||
155737979|NCT05188053|562141388|FG001|Overall Study|Protocol Violation|16|||
155737980|NCT05188053|562141387|FG000|Overall Study|Physician Decision|3|||
155737981|NCT05188053|562141388|FG001|Overall Study|Physician Decision|0|||
155737982|NCT05188053|562141387|FG000|Overall Study|Withdrawal by Subject|0|||
155737983|NCT05188053|562141388|FG001|Overall Study|Withdrawal by Subject|1|||
155737984|NCT02379637|562141392|FG000|Overall Study|Protocol Violation|0|||
155737985|NCT02379637|562141393|FG001|Overall Study|Protocol Violation|1|||
155737986|NCT02379637|562141392|FG000|Overall Study|Adverse Event|1|||
155737987|NCT02379637|562141393|FG001|Overall Study|Adverse Event|0|||
155737988|NCT02379637|562141392|FG000|Overall Study|Withdrawal by Subject|1|||
155737989|NCT02379637|562141393|FG001|Overall Study|Withdrawal by Subject|0|||
155737990|NCT01561313|562141402|FG000|Overall Study|Withdrawal by Subject|1|||
155737991|NCT01561313|562141403|FG001|Overall Study|Withdrawal by Subject|0|||
155737992|NCT01561313|562141402|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
155737993|NCT01561313|562141403|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
155737994|NCT04535453|562141404|FG000|Overall Study|Death|0|||
155737995|NCT04535453|562141405|FG001|Overall Study|Death|1|||
155737996|NCT04535453|562141406|FG002|Overall Study|Death|0|||
155737997|NCT04535453|562141407|FG003|Overall Study|Death|0|||
155737998|NCT04535453|562141408|FG004|Overall Study|Death|0|||
155737999|NCT04535453|562141409|FG005|Overall Study|Death|0|||
155738000|NCT04535453|562141410|FG006|Overall Study|Death|0|||
155738001|NCT04535453|562141411|FG007|Overall Study|Death|0|||
155738002|NCT04535453|562141412|FG008|Overall Study|Death|0|||
155738003|NCT04535453|562141413|FG009|Overall Study|Death|0|||
155738004|NCT04535453|562141414|FG010|Overall Study|Death|0|||
155738005|NCT04535453|562141415|FG011|Overall Study|Death|0|||
155738006|NCT04535453|562141404|FG000|Overall Study|Lost to Follow-up|1|||
155738007|NCT04535453|562141405|FG001|Overall Study|Lost to Follow-up|1|||
155738008|NCT04535453|562141406|FG002|Overall Study|Lost to Follow-up|1|||
155738009|NCT04535453|562141407|FG003|Overall Study|Lost to Follow-up|0|||
155738010|NCT04535453|562141408|FG004|Overall Study|Lost to Follow-up|3|||
155738011|NCT04535453|562141409|FG005|Overall Study|Lost to Follow-up|1|||
155738012|NCT04535453|562141410|FG006|Overall Study|Lost to Follow-up|0|||
155738013|NCT04535453|562141411|FG007|Overall Study|Lost to Follow-up|0|||
155738014|NCT04535453|562141412|FG008|Overall Study|Lost to Follow-up|1|||
155738015|NCT04535453|562141413|FG009|Overall Study|Lost to Follow-up|1|||
155738016|NCT04535453|562141414|FG010|Overall Study|Lost to Follow-up|0|||
155738017|NCT04535453|562141415|FG011|Overall Study|Lost to Follow-up|0|||
155738018|NCT04535453|562141404|FG000|Overall Study|Physician Decision|0|||
155738019|NCT04535453|562141405|FG001|Overall Study|Physician Decision|0|||
155738020|NCT04535453|562141406|FG002|Overall Study|Physician Decision|0|||
155738021|NCT04535453|562141407|FG003|Overall Study|Physician Decision|1|||
155738022|NCT04535453|562141408|FG004|Overall Study|Physician Decision|0|||
155738023|NCT04535453|562141409|FG005|Overall Study|Physician Decision|0|||
155738024|NCT04535453|562141410|FG006|Overall Study|Physician Decision|0|||
155738025|NCT04535453|562141411|FG007|Overall Study|Physician Decision|0|||
155738026|NCT04535453|562141412|FG008|Overall Study|Physician Decision|0|||
155738027|NCT04535453|562141413|FG009|Overall Study|Physician Decision|0|||
155738028|NCT04535453|562141414|FG010|Overall Study|Physician Decision|0|||
155738029|NCT04535453|562141415|FG011|Overall Study|Physician Decision|0|||
155738030|NCT04535453|562141404|FG000|Overall Study|Withdrawal by Subject|3|||
155738031|NCT04535453|562141405|FG001|Overall Study|Withdrawal by Subject|6|||
155738032|NCT04535453|562141406|FG002|Overall Study|Withdrawal by Subject|3|||
155738033|NCT04535453|562141407|FG003|Overall Study|Withdrawal by Subject|3|||
155738034|NCT04535453|562141408|FG004|Overall Study|Withdrawal by Subject|2|||
155738035|NCT04535453|562141409|FG005|Overall Study|Withdrawal by Subject|1|||
155738036|NCT04535453|562141410|FG006|Overall Study|Withdrawal by Subject|1|||
155738037|NCT04535453|562141411|FG007|Overall Study|Withdrawal by Subject|1|||
155738038|NCT04535453|562141412|FG008|Overall Study|Withdrawal by Subject|1|||
155738039|NCT04535453|562141413|FG009|Overall Study|Withdrawal by Subject|1|||
155738040|NCT04535453|562141414|FG010|Overall Study|Withdrawal by Subject|0|||
155738041|NCT04535453|562141415|FG011|Overall Study|Withdrawal by Subject|1|||
155738042|NCT04535453|562141404|FG000|Overall Study|Other|0|||
155738043|NCT04535453|562141405|FG001|Overall Study|Other|0|||
155738044|NCT04535453|562141406|FG002|Overall Study|Other|1|||
155738045|NCT04535453|562141407|FG003|Overall Study|Other|0|||
155738046|NCT04535453|562141408|FG004|Overall Study|Other|1|||
155738047|NCT04535453|562141409|FG005|Overall Study|Other|0|||
155738048|NCT04535453|562141410|FG006|Overall Study|Other|1|||
155738049|NCT04535453|562141411|FG007|Overall Study|Other|1|||
155738050|NCT04535453|562141412|FG008|Overall Study|Other|1|||
155738051|NCT04535453|562141413|FG009|Overall Study|Other|0|||
155738052|NCT04535453|562141414|FG010|Overall Study|Other|0|||
155738053|NCT04535453|562141415|FG011|Overall Study|Other|0|||
155738054|NCT01742286|562141418|FG000|Escalation Phase|Administrative problems|1|||
155738055|NCT01742286|562141419|FG001|Escalation Phase|Administrative problems|1|||
155738056|NCT01742286|562141420|FG002|Escalation Phase|Administrative problems|0|||
155738057|NCT01742286|562141421|FG003|Escalation Phase|Administrative problems|0|||
155738058|NCT01742286|562141422|FG004|Escalation Phase|Administrative problems|0|||
155738059|NCT01742286|562141423|FG005|Escalation Phase|Administrative problems|0|||
155738060|NCT01742286|562141424|FG006|Escalation Phase|Administrative problems|2|||
155738061|NCT01742286|562141418|FG000|Escalation Phase|Adverse Event|0|||
155738062|NCT01742286|562141419|FG001|Escalation Phase|Adverse Event|1|||
155738063|NCT01742286|562141420|FG002|Escalation Phase|Adverse Event|2|||
155738064|NCT01742286|562141421|FG003|Escalation Phase|Adverse Event|0|||
155738065|NCT01742286|562141422|FG004|Escalation Phase|Adverse Event|0|||
155738066|NCT01742286|562141423|FG005|Escalation Phase|Adverse Event|1|||
155738067|NCT01742286|562141424|FG006|Escalation Phase|Adverse Event|0|||
155738068|NCT01742286|562141418|FG000|Escalation Phase|Disease progression|3|||
155738069|NCT01742286|562141419|FG001|Escalation Phase|Disease progression|7|||
155738070|NCT01742286|562141420|FG002|Escalation Phase|Disease progression|4|||
155738071|NCT01742286|562141421|FG003|Escalation Phase|Disease progression|1|||
155738072|NCT01742286|562141422|FG004|Escalation Phase|Disease progression|4|||
155738073|NCT01742286|562141423|FG005|Escalation Phase|Disease progression|3|||
155738074|NCT01742286|562141424|FG006|Escalation Phase|Disease progression|2|||
155738075|NCT01742286|562141418|FG000|Escalation Phase|Death|0|||
155738076|NCT01742286|562141419|FG001|Escalation Phase|Death|0|||
155738077|NCT01742286|562141420|FG002|Escalation Phase|Death|0|||
155738078|NCT01742286|562141421|FG003|Escalation Phase|Death|0|||
155738079|NCT01742286|562141422|FG004|Escalation Phase|Death|0|||
155738080|NCT01742286|562141423|FG005|Escalation Phase|Death|1|||
155738081|NCT01742286|562141424|FG006|Escalation Phase|Death|0|||
155738082|NCT01742286|562141418|FG000|Escalation Phase|Physician Decision|0|||
155738083|NCT01742286|562141419|FG001|Escalation Phase|Physician Decision|3|||
155738084|NCT01742286|562141420|FG002|Escalation Phase|Physician Decision|0|||
155738085|NCT01742286|562141421|FG003|Escalation Phase|Physician Decision|1|||
155738086|NCT01742286|562141422|FG004|Escalation Phase|Physician Decision|0|||
155738087|NCT01742286|562141423|FG005|Escalation Phase|Physician Decision|0|||
155738088|NCT01742286|562141424|FG006|Escalation Phase|Physician Decision|2|||
155738089|NCT01742286|562141418|FG000|Escalation Phase|Subject/guardian decision|1|||
155738090|NCT01742286|562141419|FG001|Escalation Phase|Subject/guardian decision|0|||
155738091|NCT01742286|562141420|FG002|Escalation Phase|Subject/guardian decision|0|||
155738092|NCT01742286|562141421|FG003|Escalation Phase|Subject/guardian decision|0|||
155738093|NCT01742286|562141422|FG004|Escalation Phase|Subject/guardian decision|0|||
155738094|NCT01742286|562141423|FG005|Escalation Phase|Subject/guardian decision|0|||
155738095|NCT01742286|562141424|FG006|Escalation Phase|Subject/guardian decision|0|||
155738096|NCT01742286|562141418|FG000|Expansion Phase|Administrative problems|0|||
155738097|NCT01742286|562141419|FG001|Expansion Phase|Administrative problems|0|||
155738098|NCT01742286|562141420|FG002|Expansion Phase|Administrative problems|0|||
155738099|NCT01742286|562141421|FG003|Expansion Phase|Administrative problems|0|||
155738100|NCT01742286|562141422|FG004|Expansion Phase|Administrative problems|0|||
155738101|NCT01742286|562141423|FG005|Expansion Phase|Administrative problems|0|||
155738102|NCT01742286|562141424|FG006|Expansion Phase|Administrative problems|5|||
155738103|NCT01742286|562141418|FG000|Expansion Phase|Physician Decision|0|||
155738104|NCT01742286|562141419|FG001|Expansion Phase|Physician Decision|0|||
155738105|NCT01742286|562141420|FG002|Expansion Phase|Physician Decision|4|||
155738106|NCT01742286|562141421|FG003|Expansion Phase|Physician Decision|0|||
155738107|NCT01742286|562141422|FG004|Expansion Phase|Physician Decision|0|||
155738108|NCT01742286|562141423|FG005|Expansion Phase|Physician Decision|0|||
155738109|NCT01742286|562141424|FG006|Expansion Phase|Physician Decision|9|||
155738110|NCT01742286|562141418|FG000|Expansion Phase|Adverse Event|0|||
155738111|NCT01742286|562141419|FG001|Expansion Phase|Adverse Event|0|||
155738112|NCT01742286|562141420|FG002|Expansion Phase|Adverse Event|0|||
155738113|NCT01742286|562141421|FG003|Expansion Phase|Adverse Event|0|||
155738114|NCT01742286|562141422|FG004|Expansion Phase|Adverse Event|0|||
155738115|NCT01742286|562141423|FG005|Expansion Phase|Adverse Event|0|||
155738116|NCT01742286|562141424|FG006|Expansion Phase|Adverse Event|6|||
155738117|NCT01742286|562141418|FG000|Expansion Phase|Disease progression|0|||
155738118|NCT01742286|562141419|FG001|Expansion Phase|Disease progression|0|||
155738119|NCT01742286|562141420|FG002|Expansion Phase|Disease progression|3|||
155738120|NCT01742286|562141421|FG003|Expansion Phase|Disease progression|0|||
155738121|NCT01742286|562141422|FG004|Expansion Phase|Disease progression|0|||
155738122|NCT01742286|562141423|FG005|Expansion Phase|Disease progression|0|||
155738123|NCT01742286|562141424|FG006|Expansion Phase|Disease progression|15|||
155738124|NCT01742286|562141418|FG000|Expansion Phase|Withdrawal by Subject|0|||
155738125|NCT01742286|562141419|FG001|Expansion Phase|Withdrawal by Subject|0|||
155738126|NCT01742286|562141420|FG002|Expansion Phase|Withdrawal by Subject|0|||
155738127|NCT01742286|562141421|FG003|Expansion Phase|Withdrawal by Subject|0|||
155738128|NCT01742286|562141422|FG004|Expansion Phase|Withdrawal by Subject|0|||
155738129|NCT01742286|562141423|FG005|Expansion Phase|Withdrawal by Subject|0|||
155738130|NCT01742286|562141424|FG006|Expansion Phase|Withdrawal by Subject|1|||
155738131|NCT02878798|562141425|FG000|Overall Study|Withdrawal by Subject|5|||
155738132|NCT02878798|562141426|FG001|Overall Study|Withdrawal by Subject|4|||
155738133|NCT02878798|562141425|FG000|Overall Study|Lost to Follow-up|2|||
155738134|NCT02878798|562141426|FG001|Overall Study|Lost to Follow-up|2|||
155738135|NCT02878798|562141425|FG000|Overall Study|Protocol Violation|0|||
155738136|NCT02878798|562141426|FG001|Overall Study|Protocol Violation|1|||
155738137|NCT01309282|562141427|FG000|Overall Study|Lost to Follow-up|1|||
155738138|NCT02087423|562141428|FG000|Overall Study|Withdrawal by Subject|20|||
155738139|NCT02087423|562141429|FG001|Overall Study|Withdrawal by Subject|20|||
155738140|NCT02087423|562141430|FG002|Overall Study|Withdrawal by Subject|3|||
155738141|NCT02087423|562141428|FG000|Overall Study|Death|68|||
155738142|NCT02087423|562141429|FG001|Overall Study|Death|207|||
155738143|NCT02087423|562141430|FG002|Overall Study|Death|40|||
155738144|NCT02087423|562141428|FG000|Overall Study|Lost to Follow-up|0|||
155738145|NCT02087423|562141429|FG001|Overall Study|Lost to Follow-up|2|||
155738146|NCT02087423|562141430|FG002|Overall Study|Lost to Follow-up|0|||
155738147|NCT02087423|562141428|FG000|Overall Study|Terminated from study at final DCO|23|||
155738148|NCT02087423|562141429|FG001|Overall Study|Terminated from study at final DCO|36|||
155738149|NCT02087423|562141430|FG002|Overall Study|Terminated from study at final DCO|25|||
155738150|NCT01387542|562141431|FG000|Overall Study|Adverse Event|3|||
155738151|NCT01387542|562141431|FG000|Overall Study|Withdrawal by Subject|1|||
155738152|NCT01387542|562141431|FG000|Overall Study|Changed diagnosis|1|||
155738153|NCT01387542|562141431|FG000|Overall Study|Insufficient response|1|||
155738154|NCT01387542|562141431|FG000|Overall Study|Non-compliant|1|||
155738155|NCT01387542|562141431|FG000|Overall Study|Lost to Follow-up|1|||
155738156|NCT01761240|562141434|FG000|Overall Study|Progressive disease:radiology assessment|3|||
155738157|NCT01761240|562141435|FG001|Overall Study|Progressive disease:radiology assessment|3|||
155738158|NCT01761240|562141436|FG002|Overall Study|Progressive disease:radiology assessment|0|||
155738159|NCT01761240|562141437|FG003|Overall Study|Progressive disease:radiology assessment|0|||
155738160|NCT01761240|562141438|FG004|Overall Study|Progressive disease:radiology assessment|0|||
155738161|NCT01761240|562141434|FG000|Overall Study|Progressive disease:clinical assessment|0|||
155738162|NCT01761240|562141435|FG001|Overall Study|Progressive disease:clinical assessment|0|||
155738163|NCT01761240|562141436|FG002|Overall Study|Progressive disease:clinical assessment|3|||
155738164|NCT01761240|562141437|FG003|Overall Study|Progressive disease:clinical assessment|1|||
155738165|NCT01761240|562141438|FG004|Overall Study|Progressive disease:clinical assessment|0|||
155738166|NCT01761240|562141434|FG000|Overall Study|Withdrawal by Subject|0|||
155738167|NCT01761240|562141435|FG001|Overall Study|Withdrawal by Subject|0|||
155738168|NCT01761240|562141436|FG002|Overall Study|Withdrawal by Subject|0|||
155738169|NCT01761240|562141437|FG003|Overall Study|Withdrawal by Subject|3|||
155738170|NCT01761240|562141438|FG004|Overall Study|Withdrawal by Subject|1|||
155738171|NCT01761240|562141434|FG000|Overall Study|Adverse Event|0|||
155738172|NCT01761240|562141435|FG001|Overall Study|Adverse Event|0|||
155738173|NCT01761240|562141436|FG002|Overall Study|Adverse Event|0|||
155738174|NCT01761240|562141437|FG003|Overall Study|Adverse Event|1|||
155738175|NCT01761240|562141438|FG004|Overall Study|Adverse Event|6|||
155738176|NCT01761240|562141434|FG000|Overall Study|Death|0|||
155738177|NCT01761240|562141435|FG001|Overall Study|Death|1|||
155738178|NCT01761240|562141436|FG002|Overall Study|Death|1|||
155738179|NCT01761240|562141437|FG003|Overall Study|Death|2|||
155738180|NCT01761240|562141438|FG004|Overall Study|Death|1|||
155738181|NCT01761240|562141434|FG000|Overall Study|Non-compliance|0|||
155738182|NCT01761240|562141435|FG001|Overall Study|Non-compliance|0|||
155738183|NCT01761240|562141436|FG002|Overall Study|Non-compliance|1|||
155738184|NCT01761240|562141437|FG003|Overall Study|Non-compliance|0|||
155738185|NCT01761240|562141438|FG004|Overall Study|Non-compliance|0|||
155738186|NCT01233232|562141439|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
155738187|NCT01233232|562141440|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
155738188|NCT01233232|562141441|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
155738189|NCT02762370|562141442|FG000|Overall Study|Protocol Violation|1|||
155738190|NCT02762370|562141443|FG001|Overall Study|Protocol Violation|0|||
155738191|NCT01708902|562141450|FG000|Overall Study|Adverse Event|3|||
155738192|NCT01708902|562141451|FG001|Overall Study|Adverse Event|4|||
155738193|NCT01708902|562141452|FG002|Overall Study|Adverse Event|9|||
155738194|NCT01708902|562141453|FG003|Overall Study|Adverse Event|2|||
155738195|NCT01708902|562141454|FG004|Overall Study|Adverse Event|7|||
155738196|NCT01708902|562141455|FG005|Overall Study|Adverse Event|3|||
155738197|NCT01708902|562141456|FG006|Overall Study|Adverse Event|5|||
155738198|NCT01708902|562141450|FG000|Overall Study|Lack of Efficacy|3|||
155738199|NCT01708902|562141451|FG001|Overall Study|Lack of Efficacy|1|||
155738200|NCT01708902|562141452|FG002|Overall Study|Lack of Efficacy|0|||
155738201|NCT01708902|562141453|FG003|Overall Study|Lack of Efficacy|0|||
155738202|NCT01708902|562141454|FG004|Overall Study|Lack of Efficacy|0|||
155738203|NCT01708902|562141455|FG005|Overall Study|Lack of Efficacy|1|||
155738204|NCT01708902|562141456|FG006|Overall Study|Lack of Efficacy|0|||
155738205|NCT01708902|562141450|FG000|Overall Study|Non compliance with protocol|0|||
155738206|NCT01708902|562141451|FG001|Overall Study|Non compliance with protocol|2|||
155738207|NCT01708902|562141452|FG002|Overall Study|Non compliance with protocol|1|||
155738208|NCT01708902|562141453|FG003|Overall Study|Non compliance with protocol|3|||
155738209|NCT01708902|562141454|FG004|Overall Study|Non compliance with protocol|0|||
155738210|NCT01708902|562141455|FG005|Overall Study|Non compliance with protocol|0|||
155738211|NCT01708902|562141456|FG006|Overall Study|Non compliance with protocol|0|||
155738212|NCT01708902|562141450|FG000|Overall Study|Lost to Follow-up|2|||
155738213|NCT01708902|562141451|FG001|Overall Study|Lost to Follow-up|1|||
155738214|NCT01708902|562141452|FG002|Overall Study|Lost to Follow-up|2|||
155738215|NCT01708902|562141453|FG003|Overall Study|Lost to Follow-up|2|||
155738216|NCT01708902|562141454|FG004|Overall Study|Lost to Follow-up|0|||
155738217|NCT01708902|562141455|FG005|Overall Study|Lost to Follow-up|0|||
155738218|NCT01708902|562141456|FG006|Overall Study|Lost to Follow-up|1|||
155738219|NCT01708902|562141450|FG000|Overall Study|Refused to continue trial medication|8|||
155738220|NCT01708902|562141451|FG001|Overall Study|Refused to continue trial medication|0|||
155738221|NCT01708902|562141452|FG002|Overall Study|Refused to continue trial medication|4|||
155738222|NCT01708902|562141453|FG003|Overall Study|Refused to continue trial medication|2|||
155738223|NCT01708902|562141454|FG004|Overall Study|Refused to continue trial medication|8|||
155738224|NCT01708902|562141455|FG005|Overall Study|Refused to continue trial medication|1|||
155738225|NCT01708902|562141456|FG006|Overall Study|Refused to continue trial medication|1|||
155738226|NCT01708902|562141450|FG000|Overall Study|Other Reason|1|||
155738227|NCT01708902|562141451|FG001|Overall Study|Other Reason|0|||
155738228|NCT01708902|562141452|FG002|Overall Study|Other Reason|1|||
155738229|NCT01708902|562141453|FG003|Overall Study|Other Reason|1|||
155738230|NCT01708902|562141454|FG004|Overall Study|Other Reason|1|||
155738231|NCT01708902|562141455|FG005|Overall Study|Other Reason|2|||
155738232|NCT01708902|562141456|FG006|Overall Study|Other Reason|0|||
155738233|NCT02633020|562141459|FG000|Overall Study|Adverse Event|1|||
155738234|NCT02633020|562141460|FG001|Overall Study|Adverse Event|0|||
155738235|NCT00934440|562141461|FG000|Overall Study|Lost to Follow-up|1|||
155738236|NCT05661851|562141462|FG000|Overall Study|Protocol Violation|1|||
155738237|NCT05661851|562141463|FG001|Overall Study|Protocol Violation|1|||
155738238|NCT05661851|562141462|FG000|Overall Study|Covid-19 Related|3|||
155738239|NCT05661851|562141463|FG001|Overall Study|Covid-19 Related|4|||
155738240|NCT05661851|562141462|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
155738241|NCT05661851|562141463|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
155738242|NCT05661851|562141462|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
155738243|NCT05661851|562141463|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
155738244|NCT02152956|562141464|FG000|Overall Study|Adverse Event|0|||
155738245|NCT02152956|562141465|FG001|Overall Study|Adverse Event|0|||
155738246|NCT02152956|562141466|FG002|Overall Study|Adverse Event|0|||
155738247|NCT02152956|562141467|FG003|Overall Study|Adverse Event|0|||
155738248|NCT02152956|562141468|FG004|Overall Study|Adverse Event|0|||
155738249|NCT02152956|562141469|FG005|Overall Study|Adverse Event|0|||
155738250|NCT02152956|562141470|FG006|Overall Study|Adverse Event|0|||
155738251|NCT02152956|562141471|FG007|Overall Study|Adverse Event|0|||
155738252|NCT02152956|562141472|FG008|Overall Study|Adverse Event|0|||
155738253|NCT02152956|562141473|FG009|Overall Study|Adverse Event|0|||
155738254|NCT02152956|562141474|FG010|Overall Study|Adverse Event|0|||
155738255|NCT02152956|562141475|FG011|Overall Study|Adverse Event|4|||
155738256|NCT02152956|562141476|FG012|Overall Study|Adverse Event|0|||
155738257|NCT02152956|562141464|FG000|Overall Study|Death|0|||
155738258|NCT02152956|562141465|FG001|Overall Study|Death|3|||
155738259|NCT02152956|562141466|FG002|Overall Study|Death|3|||
155738260|NCT02152956|562141467|FG003|Overall Study|Death|4|||
155738261|NCT02152956|562141468|FG004|Overall Study|Death|1|||
155738262|NCT02152956|562141469|FG005|Overall Study|Death|2|||
155738263|NCT02152956|562141470|FG006|Overall Study|Death|6|||
155738264|NCT02152956|562141471|FG007|Overall Study|Death|6|||
155738265|NCT02152956|562141472|FG008|Overall Study|Death|4|||
155738266|NCT02152956|562141473|FG009|Overall Study|Death|5|||
155738267|NCT02152956|562141474|FG010|Overall Study|Death|3|||
155738268|NCT02152956|562141475|FG011|Overall Study|Death|143|||
155738269|NCT02152956|562141476|FG012|Overall Study|Death|12|||
155738270|NCT02152956|562141464|FG000|Overall Study|Lost to Follow-up|0|||
155738271|NCT02152956|562141465|FG001|Overall Study|Lost to Follow-up|1|||
155738272|NCT02152956|562141466|FG002|Overall Study|Lost to Follow-up|0|||
155738273|NCT02152956|562141467|FG003|Overall Study|Lost to Follow-up|0|||
155738274|NCT02152956|562141468|FG004|Overall Study|Lost to Follow-up|0|||
155738275|NCT02152956|562141469|FG005|Overall Study|Lost to Follow-up|0|||
155738276|NCT02152956|562141470|FG006|Overall Study|Lost to Follow-up|0|||
155738277|NCT02152956|562141471|FG007|Overall Study|Lost to Follow-up|0|||
155738278|NCT02152956|562141472|FG008|Overall Study|Lost to Follow-up|0|||
155738279|NCT02152956|562141473|FG009|Overall Study|Lost to Follow-up|0|||
155738280|NCT02152956|562141474|FG010|Overall Study|Lost to Follow-up|0|||
155738281|NCT02152956|562141475|FG011|Overall Study|Lost to Follow-up|3|||
155738282|NCT02152956|562141476|FG012|Overall Study|Lost to Follow-up|0|||
155738283|NCT02152956|562141464|FG000|Overall Study|Withdrawal by Subject|1|||
155738284|NCT02152956|562141465|FG001|Overall Study|Withdrawal by Subject|0|||
155738285|NCT02152956|562141466|FG002|Overall Study|Withdrawal by Subject|1|||
155738286|NCT02152956|562141467|FG003|Overall Study|Withdrawal by Subject|0|||
155738287|NCT02152956|562141468|FG004|Overall Study|Withdrawal by Subject|2|||
155738288|NCT02152956|562141469|FG005|Overall Study|Withdrawal by Subject|2|||
155738289|NCT02152956|562141470|FG006|Overall Study|Withdrawal by Subject|0|||
155738290|NCT02152956|562141471|FG007|Overall Study|Withdrawal by Subject|0|||
155738291|NCT02152956|562141472|FG008|Overall Study|Withdrawal by Subject|1|||
155738292|NCT02152956|562141473|FG009|Overall Study|Withdrawal by Subject|0|||
155738293|NCT02152956|562141474|FG010|Overall Study|Withdrawal by Subject|0|||
155738294|NCT02152956|562141475|FG011|Overall Study|Withdrawal by Subject|4|||
155738295|NCT02152956|562141476|FG012|Overall Study|Withdrawal by Subject|0|||
155738296|NCT02152956|562141464|FG000|Overall Study|Physician Decision|0|||
155738297|NCT02152956|562141465|FG001|Overall Study|Physician Decision|0|||
155738298|NCT02152956|562141466|FG002|Overall Study|Physician Decision|0|||
155393579|NCT01132612|560876798|FG001|Overall Study|Adverse Event|2|||
155393580|NCT01132612|560876799|FG002|Overall Study|Adverse Event|15|||
155634242|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
155634243|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
155634244|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
155634245|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
155634246|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
155634247|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
155634248|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
155634249|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
155634250|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
155634251|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
155634252|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
155634253|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
155634254|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
155634255|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
155634256|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
155634257|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
155634258|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
155634259|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
155634260|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
155634261|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
155634262|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
155634263|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
155634264|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
155634265|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
155634266|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Death|1|||
155634267|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Death|0|||
155634268|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Death|1|||
155634269|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
155634270|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
155634271|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
155634272|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
155634273|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
155634274|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
155634275|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
155634276|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
155634277|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
155634278|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
155634279|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
155634280|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
155634281|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
155634282|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
155634283|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
155634284|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
155634285|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
155634286|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
155634287|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
155634288|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
155634289|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
155634290|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Depression|0|||
155634291|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Depression|1|||
155634292|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Depression|0|||
155634293|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
155634294|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
155634295|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
155634296|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Jailed|0|||
155634297|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Jailed|1|||
155634298|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Jailed|0|||
155634299|NCT00090103|561754096|FG000|16-Week Safety Follow-up Period|Other|0|||
155634300|NCT00090103|561754097|FG001|16-Week Safety Follow-up Period|Other|1|||
155634301|NCT00090103|561754098|FG002|16-Week Safety Follow-up Period|Other|0|||
155634302|NCT01799889|561754101|FG000|Overall Study|Adverse Event|4|||
155634303|NCT01799889|561754102|FG001|Overall Study|Adverse Event|4|||
155634304|NCT01799889|561754103|FG002|Overall Study|Adverse Event|5|||
155634305|NCT01799889|561754104|FG003|Overall Study|Adverse Event|1|||
155634306|NCT01799889|561754105|FG004|Overall Study|Adverse Event|11|||
155634307|NCT01799889|561754106|FG005|Overall Study|Adverse Event|1|||
155634308|NCT01799889|561754107|FG006|Overall Study|Adverse Event|5|||
155634309|NCT01799889|561754108|FG007|Overall Study|Adverse Event|2|||
155634310|NCT01799889|561754109|FG008|Overall Study|Adverse Event|3|||
155634311|NCT01799889|561754110|FG009|Overall Study|Adverse Event|1|||
155634312|NCT01799889|561754111|FG010|Overall Study|Adverse Event|1|||
155634313|NCT01799889|561754112|FG011|Overall Study|Adverse Event|0|||
155634314|NCT01799889|561754101|FG000|Overall Study|Death|1|||
155634315|NCT01799889|561754102|FG001|Overall Study|Death|0|||
155634316|NCT01799889|561754103|FG002|Overall Study|Death|5|||
155634317|NCT01799889|561754104|FG003|Overall Study|Death|3|||
155634318|NCT01799889|561754105|FG004|Overall Study|Death|1|||
155634319|NCT01799889|561754106|FG005|Overall Study|Death|0|||
155634320|NCT01799889|561754107|FG006|Overall Study|Death|0|||
155634321|NCT01799889|561754108|FG007|Overall Study|Death|0|||
155634322|NCT01799889|561754109|FG008|Overall Study|Death|1|||
155634323|NCT01799889|561754110|FG009|Overall Study|Death|0|||
155634324|NCT01799889|561754111|FG010|Overall Study|Death|1|||
155634325|NCT01799889|561754112|FG011|Overall Study|Death|0|||
155634326|NCT01799889|561754101|FG000|Overall Study|Lack of Efficacy|1|||
155634327|NCT01799889|561754102|FG001|Overall Study|Lack of Efficacy|1|||
155634328|NCT01799889|561754103|FG002|Overall Study|Lack of Efficacy|0|||
155634329|NCT01799889|561754104|FG003|Overall Study|Lack of Efficacy|1|||
155634330|NCT01799889|561754105|FG004|Overall Study|Lack of Efficacy|2|||
155634331|NCT01799889|561754106|FG005|Overall Study|Lack of Efficacy|2|||
155634332|NCT01799889|561754107|FG006|Overall Study|Lack of Efficacy|0|||
155634333|NCT01799889|561754108|FG007|Overall Study|Lack of Efficacy|0|||
155634334|NCT01799889|561754109|FG008|Overall Study|Lack of Efficacy|2|||
155634335|NCT01799889|561754110|FG009|Overall Study|Lack of Efficacy|0|||
155634336|NCT01799889|561754111|FG010|Overall Study|Lack of Efficacy|1|||
155634337|NCT01799889|561754112|FG011|Overall Study|Lack of Efficacy|0|||
155634338|NCT01799889|561754101|FG000|Overall Study|Lost to Follow-up|0|||
155634339|NCT01799889|561754102|FG001|Overall Study|Lost to Follow-up|1|||
155634340|NCT01799889|561754103|FG002|Overall Study|Lost to Follow-up|0|||
155634341|NCT01799889|561754104|FG003|Overall Study|Lost to Follow-up|0|||
155634342|NCT01799889|561754105|FG004|Overall Study|Lost to Follow-up|0|||
155634343|NCT01799889|561754106|FG005|Overall Study|Lost to Follow-up|0|||
155634344|NCT01799889|561754107|FG006|Overall Study|Lost to Follow-up|0|||
155634345|NCT01799889|561754108|FG007|Overall Study|Lost to Follow-up|0|||
155634346|NCT01799889|561754109|FG008|Overall Study|Lost to Follow-up|0|||
155634347|NCT01799889|561754110|FG009|Overall Study|Lost to Follow-up|0|||
155634348|NCT01799889|561754111|FG010|Overall Study|Lost to Follow-up|0|||
155634349|NCT01799889|561754112|FG011|Overall Study|Lost to Follow-up|0|||
155634350|NCT01799889|561754101|FG000|Overall Study|Physician Decision|3|||
155634351|NCT01799889|561754102|FG001|Overall Study|Physician Decision|2|||
155634352|NCT01799889|561754103|FG002|Overall Study|Physician Decision|4|||
155634353|NCT01799889|561754104|FG003|Overall Study|Physician Decision|4|||
155634354|NCT01799889|561754105|FG004|Overall Study|Physician Decision|5|||
155634355|NCT01799889|561754106|FG005|Overall Study|Physician Decision|5|||
155634356|NCT01799889|561754107|FG006|Overall Study|Physician Decision|5|||
155634357|NCT01799889|561754108|FG007|Overall Study|Physician Decision|2|||
155634358|NCT01799889|561754109|FG008|Overall Study|Physician Decision|6|||
155634359|NCT01799889|561754110|FG009|Overall Study|Physician Decision|0|||
155634360|NCT01799889|561754111|FG010|Overall Study|Physician Decision|0|||
155634361|NCT01799889|561754112|FG011|Overall Study|Physician Decision|1|||
155634362|NCT01799889|561754101|FG000|Overall Study|Progressive Disease|30|||
155634363|NCT01799889|561754102|FG001|Overall Study|Progressive Disease|26|||
155634364|NCT01799889|561754103|FG002|Overall Study|Progressive Disease|25|||
155738299|NCT02152956|562141467|FG003|Overall Study|Physician Decision|0|||
155738300|NCT02152956|562141468|FG004|Overall Study|Physician Decision|0|||
155738301|NCT02152956|562141469|FG005|Overall Study|Physician Decision|0|||
155738302|NCT02152956|562141470|FG006|Overall Study|Physician Decision|0|||
155738303|NCT02152956|562141471|FG007|Overall Study|Physician Decision|0|||
155738304|NCT02152956|562141472|FG008|Overall Study|Physician Decision|0|||
155738305|NCT02152956|562141473|FG009|Overall Study|Physician Decision|0|||
155738306|NCT02152956|562141474|FG010|Overall Study|Physician Decision|0|||
155738307|NCT02152956|562141475|FG011|Overall Study|Physician Decision|1|||
155738308|NCT02152956|562141476|FG012|Overall Study|Physician Decision|0|||
155738309|NCT02152956|562141464|FG000|Overall Study|Study terminated by sponsor|0|||
155738310|NCT02152956|562141465|FG001|Overall Study|Study terminated by sponsor|0|||
155738311|NCT02152956|562141466|FG002|Overall Study|Study terminated by sponsor|0|||
155634365|NCT01799889|561754104|FG003|Overall Study|Progressive Disease|30|||
155634366|NCT01799889|561754105|FG004|Overall Study|Progressive Disease|23|||
155634367|NCT01799889|561754106|FG005|Overall Study|Progressive Disease|9|||
155738312|NCT02152956|562141467|FG003|Overall Study|Study terminated by sponsor|0|||
155738313|NCT02152956|562141468|FG004|Overall Study|Study terminated by sponsor|0|||
155634368|NCT01799889|561754107|FG006|Overall Study|Progressive Disease|8|||
155634369|NCT01799889|561754108|FG007|Overall Study|Progressive Disease|13|||
155634370|NCT01799889|561754109|FG008|Overall Study|Progressive Disease|18|||
155634371|NCT01799889|561754110|FG009|Overall Study|Progressive Disease|5|||
155634372|NCT01799889|561754111|FG010|Overall Study|Progressive Disease|3|||
155634373|NCT01799889|561754112|FG011|Overall Study|Progressive Disease|1|||
155738314|NCT02152956|562141469|FG005|Overall Study|Study terminated by sponsor|0|||
155634374|NCT01799889|561754101|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
155634375|NCT01799889|561754102|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
155634376|NCT01799889|561754103|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
155634377|NCT01799889|561754104|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
155634378|NCT01799889|561754105|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
155634379|NCT01799889|561754106|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
155634380|NCT01799889|561754107|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
155634381|NCT01799889|561754108|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
155634382|NCT01799889|561754109|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
155634383|NCT01799889|561754110|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
155634384|NCT01799889|561754111|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
155634385|NCT01799889|561754112|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
155634386|NCT01799889|561754101|FG000|Overall Study|Study Terminated By Sponsor|1|||
155634387|NCT01799889|561754102|FG001|Overall Study|Study Terminated By Sponsor|0|||
155634388|NCT01799889|561754103|FG002|Overall Study|Study Terminated By Sponsor|0|||
155634389|NCT01799889|561754104|FG003|Overall Study|Study Terminated By Sponsor|0|||
155634390|NCT01799889|561754105|FG004|Overall Study|Study Terminated By Sponsor|2|||
155634391|NCT01799889|561754106|FG005|Overall Study|Study Terminated By Sponsor|1|||
155634392|NCT01799889|561754107|FG006|Overall Study|Study Terminated By Sponsor|0|||
155634393|NCT01799889|561754108|FG007|Overall Study|Study Terminated By Sponsor|2|||
155634394|NCT01799889|561754109|FG008|Overall Study|Study Terminated By Sponsor|1|||
155634395|NCT01799889|561754110|FG009|Overall Study|Study Terminated By Sponsor|1|||
155634396|NCT01799889|561754111|FG010|Overall Study|Study Terminated By Sponsor|0|||
155634397|NCT01799889|561754112|FG011|Overall Study|Study Terminated By Sponsor|0|||
155634398|NCT01799889|561754101|FG000|Overall Study|Withdrawal by Subject|1|||
155634399|NCT01799889|561754102|FG001|Overall Study|Withdrawal by Subject|6|||
155634400|NCT01799889|561754103|FG002|Overall Study|Withdrawal by Subject|4|||
155634401|NCT01799889|561754104|FG003|Overall Study|Withdrawal by Subject|0|||
155634402|NCT01799889|561754105|FG004|Overall Study|Withdrawal by Subject|5|||
155634403|NCT01799889|561754106|FG005|Overall Study|Withdrawal by Subject|1|||
155634404|NCT01799889|561754107|FG006|Overall Study|Withdrawal by Subject|3|||
155634405|NCT01799889|561754108|FG007|Overall Study|Withdrawal by Subject|1|||
155634406|NCT01799889|561754109|FG008|Overall Study|Withdrawal by Subject|2|||
155634407|NCT01799889|561754110|FG009|Overall Study|Withdrawal by Subject|1|||
155634408|NCT01799889|561754111|FG010|Overall Study|Withdrawal by Subject|1|||
155634409|NCT01799889|561754112|FG011|Overall Study|Withdrawal by Subject|1|||
155634410|NCT01799889|561754101|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155634411|NCT01799889|561754102|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155634412|NCT01799889|561754103|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155634413|NCT01799889|561754104|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155634414|NCT01799889|561754105|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155634415|NCT01799889|561754106|FG005|Overall Study|Non-Compliance With Study Drug|1|||
155634416|NCT01799889|561754107|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155634417|NCT01799889|561754108|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155634418|NCT01799889|561754109|FG008|Overall Study|Non-Compliance With Study Drug|0|||
155634419|NCT01799889|561754110|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155634420|NCT01799889|561754111|FG010|Overall Study|Non-Compliance With Study Drug|0|||
155634421|NCT01799889|561754112|FG011|Overall Study|Non-Compliance With Study Drug|0|||
155634422|NCT06217380|561754113|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
155634423|NCT06217380|561754113|FG000|Overall Study|Physician Decision|1|||
155634424|NCT06217380|561754113|FG000|Overall Study|Withdrawal by Subject|2|||
155634425|NCT03095287|561754117|FG000|Overall Study|Treatment Failure|1|||
155634426|NCT03095287|561754117|FG000|Overall Study|Adverse Event|1|||
155634427|NCT02471183|561754118|FG000|Main Treatment Period|Adverse Event|1|||
155634428|NCT02471183|561754118|FG000|Main Treatment Period|Withdrawal by Subject|1|||
155634429|NCT02471183|561754118|FG000|Extended Treatment Period|Lack of Efficacy|1|||
155634430|NCT03286504|561754126|FG000|Overall Study|Lost to Follow-up|19|||
155634431|NCT03286504|561754127|FG001|Overall Study|Lost to Follow-up|16|||
155634432|NCT05350423|561754128|FG000|Overall Study|Lost to Follow-up|3|||
155634433|NCT05350423|561754129|FG001|Overall Study|Lost to Follow-up|3|||
155634434|NCT05350423|561754128|FG000|Overall Study|screen failure|5|||
155634435|NCT05350423|561754129|FG001|Overall Study|screen failure|6|||
155634436|NCT02097277|561754130|FG000|Overall Study|Subject no longer meets study criteria|0|||
155283292|NCT00924560|560468275|FG002|Overall Study|Lost to Follow-up|45|||
155634437|NCT02097277|561754131|FG001|Overall Study|Subject no longer meets study criteria|1|||
155634438|NCT02097277|561754132|FG002|Overall Study|Subject no longer meets study criteria|0|||
155634439|NCT02097277|561754133|FG003|Overall Study|Subject no longer meets study criteria|1|||
155634440|NCT02097277|561754134|FG004|Overall Study|Subject no longer meets study criteria|0|||
155634441|NCT02097277|561754130|FG000|Overall Study|Subject request to discontinue treatment|0|||
155634442|NCT02097277|561754131|FG001|Overall Study|Subject request to discontinue treatment|0|||
155634443|NCT02097277|561754132|FG002|Overall Study|Subject request to discontinue treatment|0|||
155634444|NCT02097277|561754133|FG003|Overall Study|Subject request to discontinue treatment|0|||
155634445|NCT02097277|561754134|FG004|Overall Study|Subject request to discontinue treatment|1|||
155634446|NCT02097277|561754130|FG000|Overall Study|Lost to Follow-up|0|||
155634447|NCT02097277|561754131|FG001|Overall Study|Lost to Follow-up|1|||
155634448|NCT02097277|561754132|FG002|Overall Study|Lost to Follow-up|1|||
155634449|NCT02097277|561754133|FG003|Overall Study|Lost to Follow-up|0|||
155634450|NCT02097277|561754134|FG004|Overall Study|Lost to Follow-up|0|||
155634451|NCT02097277|561754130|FG000|Overall Study|Withdrawal by Subject|2|||
155634452|NCT02097277|561754131|FG001|Overall Study|Withdrawal by Subject|1|||
155634453|NCT02097277|561754132|FG002|Overall Study|Withdrawal by Subject|0|||
155634454|NCT02097277|561754133|FG003|Overall Study|Withdrawal by Subject|1|||
155634455|NCT02097277|561754134|FG004|Overall Study|Withdrawal by Subject|0|||
155634456|NCT02097277|561754130|FG000|Overall Study|Adverse Event|0|||
155634457|NCT02097277|561754131|FG001|Overall Study|Adverse Event|0|||
155634458|NCT02097277|561754132|FG002|Overall Study|Adverse Event|1|||
155634459|NCT02097277|561754133|FG003|Overall Study|Adverse Event|2|||
155634460|NCT02097277|561754134|FG004|Overall Study|Adverse Event|0|||
155634461|NCT00141921|561754137|FG000|Overall Study|Remain on Study|28|||
155634462|NCT00141921|561754137|FG000|Overall Study|Withdrawal by Subject|42|||
155634463|NCT00141921|561754137|FG000|Overall Study|Lost to Follow-up|19|||
155634464|NCT00141921|561754137|FG000|Overall Study|Noncompliance|17|||
155634465|NCT00141921|561754137|FG000|Overall Study|Disease Progression|7|||
155634466|NCT00141921|561754137|FG000|Overall Study|Protocol Deviation|7|||
155634467|NCT00141921|561754137|FG000|Overall Study|Adverse Event|5|||
155634468|NCT00141921|561754137|FG000|Overall Study|Administrative Decision|2|||
155634469|NCT00141921|561754137|FG000|Overall Study|Pregnancy|4|||
155634470|NCT00141921|561754137|FG000|Overall Study|Ineligibility Determined|2|||
155634471|NCT00141921|561754137|FG000|Overall Study|Other|8|||
155634472|NCT03320369|561754138|FG000|Overall Study|Adverse Event|1|||
155634473|NCT03320369|561754138|FG000|Overall Study|Withdrawal by Subject|2|||
155634474|NCT03473197|561754165|FG000|Overall Study|Adverse Event|4|||
155634475|NCT03473197|561754165|FG000|Overall Study|Lost to Follow-up|1|||
155634476|NCT03473197|561754165|FG000|Overall Study|Withdrawal by Subject|5|||
155634477|NCT02832037|561754166|FG000|Overall Study|Administrative reasons|0|||
155634478|NCT02832037|561754167|FG001|Overall Study|Administrative reasons|0|||
155634479|NCT02832037|561754168|FG002|Overall Study|Administrative reasons|1|||
155634480|NCT02832037|561754169|FG003|Overall Study|Administrative reasons|0|||
155634481|NCT02832037|561754170|FG004|Overall Study|Administrative reasons|0|||
155634482|NCT02832037|561754166|FG000|Overall Study|Protocol Violation|3|||
155634483|NCT02832037|561754167|FG001|Overall Study|Protocol Violation|0|||
155634484|NCT02832037|561754168|FG002|Overall Study|Protocol Violation|4|||
155634485|NCT02832037|561754169|FG003|Overall Study|Protocol Violation|1|||
155634486|NCT02832037|561754170|FG004|Overall Study|Protocol Violation|2|||
155634487|NCT02832037|561754166|FG000|Overall Study|Lost to Follow-up|2|||
155634488|NCT02832037|561754167|FG001|Overall Study|Lost to Follow-up|0|||
155634489|NCT02832037|561754168|FG002|Overall Study|Lost to Follow-up|3|||
155634490|NCT02832037|561754169|FG003|Overall Study|Lost to Follow-up|0|||
155634491|NCT02832037|561754170|FG004|Overall Study|Lost to Follow-up|5|||
155634492|NCT02832037|561754166|FG000|Overall Study|Withdrawal by Subject|9|||
155634493|NCT02832037|561754167|FG001|Overall Study|Withdrawal by Subject|8|||
155634494|NCT02832037|561754168|FG002|Overall Study|Withdrawal by Subject|0|||
155634495|NCT02832037|561754169|FG003|Overall Study|Withdrawal by Subject|4|||
155634496|NCT02832037|561754170|FG004|Overall Study|Withdrawal by Subject|8|||
155634497|NCT02832037|561754166|FG000|Overall Study|Adverse Event|5|||
155634498|NCT02832037|561754167|FG001|Overall Study|Adverse Event|4|||
155634499|NCT02832037|561754168|FG002|Overall Study|Adverse Event|0|||
155634500|NCT02832037|561754169|FG003|Overall Study|Adverse Event|2|||
155634501|NCT02832037|561754170|FG004|Overall Study|Adverse Event|4|||
155634502|NCT02326883|561754171|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
155634503|NCT02326883|561754172|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
155634504|NCT02326883|561754173|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
155634505|NCT00634504|561754175|FG000|Overall Study|Protocol Violation|1|||
155634506|NCT00634504|561754176|FG001|Overall Study|Protocol Violation|0|||
155634507|NCT03329989|561754177|FG000|Overall Study|Withdrawal by Subject|9|||
155634508|NCT03329989|561754177|FG000|Overall Study|Lost to Follow-up|8|||
155634509|NCT03329989|561754177|FG000|Overall Study|Adverse Event|5|||
155634510|NCT03329989|561754177|FG000|Overall Study|Protocol Violation|1|||
155634511|NCT00297167|561754188|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
155634512|NCT00297167|561754189|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
155634513|NCT00297167|561754190|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
155634514|NCT00297167|561754188|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
155634515|NCT00297167|561754189|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
155634516|NCT00297167|561754190|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
155634517|NCT02320396|561754191|FG000|Overall Study|Adverse Event|2|||
155634518|NCT02320396|561754192|FG001|Overall Study|Adverse Event|2|||
155634519|NCT02320396|561754191|FG000|Overall Study|Pregnancy|0|||
155738315|NCT02152956|562141470|FG006|Overall Study|Study terminated by sponsor|0|||
155738316|NCT02152956|562141471|FG007|Overall Study|Study terminated by sponsor|0|||
155738317|NCT02152956|562141472|FG008|Overall Study|Study terminated by sponsor|0|||
155738318|NCT02152956|562141473|FG009|Overall Study|Study terminated by sponsor|0|||
155738319|NCT02152956|562141474|FG010|Overall Study|Study terminated by sponsor|0|||
155738320|NCT02152956|562141475|FG011|Overall Study|Study terminated by sponsor|29|||
155738321|NCT02152956|562141476|FG012|Overall Study|Study terminated by sponsor|0|||
155738322|NCT02152956|562141464|FG000|Overall Study|progressive disease|0|||
155738323|NCT02152956|562141465|FG001|Overall Study|progressive disease|0|||
155738324|NCT02152956|562141466|FG002|Overall Study|progressive disease|0|||
155738325|NCT02152956|562141467|FG003|Overall Study|progressive disease|0|||
155738326|NCT02152956|562141468|FG004|Overall Study|progressive disease|0|||
155738327|NCT02152956|562141469|FG005|Overall Study|progressive disease|0|||
155738328|NCT02152956|562141470|FG006|Overall Study|progressive disease|0|||
155738329|NCT02152956|562141471|FG007|Overall Study|progressive disease|0|||
155738330|NCT02152956|562141472|FG008|Overall Study|progressive disease|1|||
155738331|NCT02152956|562141473|FG009|Overall Study|progressive disease|0|||
155738332|NCT02152956|562141474|FG010|Overall Study|progressive disease|0|||
155738333|NCT02152956|562141475|FG011|Overall Study|progressive disease|1|||
155738334|NCT02152956|562141476|FG012|Overall Study|progressive disease|0|||
155738335|NCT00530816|562141477|FG000|Overall Study|Progressive Disease|16|||
155738336|NCT00530816|562141478|FG001|Overall Study|Progressive Disease|24|||
155738337|NCT00530816|562141479|FG002|Overall Study|Progressive Disease|24|||
155738338|NCT00530816|562141477|FG000|Overall Study|Adverse Event|6|||
155738339|NCT00530816|562141478|FG001|Overall Study|Adverse Event|13|||
155738340|NCT00530816|562141479|FG002|Overall Study|Adverse Event|7|||
155738341|NCT00530816|562141477|FG000|Overall Study|Other|3|||
155738342|NCT00530816|562141478|FG001|Overall Study|Other|3|||
155738343|NCT00530816|562141479|FG002|Overall Study|Other|4|||
155738344|NCT00530816|562141477|FG000|Overall Study|Withdrawal by Subject|1|||
155738345|NCT00530816|562141478|FG001|Overall Study|Withdrawal by Subject|2|||
155738346|NCT00530816|562141479|FG002|Overall Study|Withdrawal by Subject|6|||
155738347|NCT01014910|562141480|FG000|Overall Study|Withdrawal by Subject|0|||
155738348|NCT01014910|562141481|FG001|Overall Study|Withdrawal by Subject|2|||
155738349|NCT02445794|562141482|FG000|Overall Study|Adverse Event|0|||
155738350|NCT02445794|562141483|FG001|Overall Study|Adverse Event|0|||
155738351|NCT02445794|562141484|FG002|Overall Study|Adverse Event|2|||
155738352|NCT02445794|562141485|FG003|Overall Study|Adverse Event|0|||
155738353|NCT01136785|562141486|FG000|Overall Study|Protocol Violation|2|||
155738354|NCT01136785|562141487|FG001|Overall Study|Protocol Violation|1|||
155738355|NCT01388985|562141488|FG000|Overall Study|Death|0|||
155738356|NCT01388985|562141489|FG001|Overall Study|Death|1|||
155738357|NCT01388985|562141488|FG000|Overall Study|Lost to Follow-up|30|||
155738358|NCT01388985|562141489|FG001|Overall Study|Lost to Follow-up|30|||
155738359|NCT01388985|562141488|FG000|Overall Study|Withdrawal by Subject|13|||
155738360|NCT01388985|562141489|FG001|Overall Study|Withdrawal by Subject|4|||
155738361|NCT01388985|562141488|FG000|Overall Study|Subject unavailable|1|||
155738362|NCT01388985|562141489|FG001|Overall Study|Subject unavailable|1|||
155738363|NCT01388985|562141488|FG000|Overall Study|Other (no reason)|0|||
155738364|NCT01388985|562141489|FG001|Overall Study|Other (no reason)|1|||
155738365|NCT01388985|562141488|FG000|Overall Study|Error of nurse|5|||
155738366|NCT01388985|562141489|FG001|Overall Study|Error of nurse|1|||
155738367|NCT01519167|562141492|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
155738368|NCT01519167|562141493|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
155738369|NCT01519167|562141492|FG000|Overall Study|Adverse Event|0|||
155738370|NCT01519167|562141493|FG001|Overall Study|Adverse Event|1|||
155738371|NCT01519167|562141492|FG000|Overall Study|Lack of Efficacy|0|||
155738372|NCT01519167|562141493|FG001|Overall Study|Lack of Efficacy|1|||
155738373|NCT01519167|562141492|FG000|Overall Study|Medical condition changes&deep sedation|0|||
155738374|NCT01519167|562141493|FG001|Overall Study|Medical condition changes&deep sedation|2|||
155738375|NCT01519167|562141492|FG000|Overall Study|Physician Decision|0|||
155738376|NCT01519167|562141493|FG001|Overall Study|Physician Decision|1|||
155738377|NCT01516034|562141496|FG000|Overall Study|Physician Decision|1|||
155738378|NCT01516034|562141496|FG000|Overall Study|Lack of Efficacy|7|||
155738379|NCT00870584|562141502|FG000|Overall Study|Adverse Event|3|||
155738380|NCT00870584|562141503|FG001|Overall Study|Adverse Event|3|||
155738381|NCT00870584|562141502|FG000|Overall Study|Withdrawal by Subject|6|||
155738382|NCT00870584|562141503|FG001|Overall Study|Withdrawal by Subject|7|||
155738383|NCT00870584|562141502|FG000|Overall Study|Lost to Follow-up|5|||
155738384|NCT00870584|562141503|FG001|Overall Study|Lost to Follow-up|1|||
155738385|NCT00870584|562141502|FG000|Overall Study|Protocol Deviation|2|||
155738386|NCT00870584|562141503|FG001|Overall Study|Protocol Deviation|2|||
155738387|NCT01497366|562141504|FG000|Overall Study|Virologic failure|2|||
155738388|NCT01497366|562141505|FG001|Overall Study|Virologic failure|50|||
155738389|NCT01497366|562141504|FG000|Overall Study|Lost to Follow-up|11|||
155738390|NCT01497366|562141505|FG001|Overall Study|Lost to Follow-up|10|||
155738391|NCT01497366|562141504|FG000|Overall Study|Withdrawal by Subject|6|||
155738392|NCT01497366|562141505|FG001|Overall Study|Withdrawal by Subject|6|||
155738393|NCT01497366|562141504|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
155738394|NCT01497366|562141505|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
155738395|NCT01497366|562141504|FG000|Overall Study|Other|5|||
155738396|NCT01497366|562141505|FG001|Overall Study|Other|0|||
155738397|NCT01497366|562141504|FG000|Overall Study|Death|1|||
155738398|NCT01497366|562141505|FG001|Overall Study|Death|1|||
155738399|NCT01497366|562141504|FG000|Overall Study|Randomized but not treated|7|||
155738400|NCT01497366|562141505|FG001|Overall Study|Randomized but not treated|21|||
155738401|NCT02703337|562141506|FG000|Period One (Part A)|Withdrawal by Subject|0|||
155738402|NCT02703337|562141507|FG001|Period One (Part A)|Withdrawal by Subject|0|||
155738403|NCT02703337|562141508|FG002|Period One (Part A)|Withdrawal by Subject|0|||
155738404|NCT02703337|562141509|FG003|Period One (Part A)|Withdrawal by Subject|0|||
155738405|NCT02703337|562141510|FG004|Period One (Part A)|Withdrawal by Subject|1|||
155738406|NCT02703337|562141511|FG005|Period One (Part A)|Withdrawal by Subject|0|||
155738407|NCT02703337|562141512|FG006|Period One (Part A)|Withdrawal by Subject|0|||
155738408|NCT02703337|562141513|FG007|Period One (Part A)|Withdrawal by Subject|0|||
155738409|NCT01888432|562143474|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
155738410|NCT01888432|562143475|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
155738411|NCT01888432|562143474|FG000|12-month Analysis (FAS)|Physician Decision|1|||
155738412|NCT01888432|562143475|FG001|12-month Analysis (FAS)|Physician Decision|1|||
155738413|NCT01888432|562143474|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
155738414|NCT01888432|562143475|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
155738415|NCT01888432|562143474|FG000|12-month Analysis (FAS)|Death|4|||
155738416|NCT01888432|562143475|FG001|12-month Analysis (FAS)|Death|3|||
155738417|NCT01888432|562143474|FG000|24-month Analysis (FAS)|Graft loss|0|||
155738418|NCT01888432|562143475|FG001|24-month Analysis (FAS)|Graft loss|1|||
155738419|NCT01888432|562143474|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
155738420|NCT01888432|562143475|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
155738421|NCT01888432|562143474|FG000|24-month Analysis (FAS)|Physician Decision|2|||
155738422|NCT01888432|562143475|FG001|24-month Analysis (FAS)|Physician Decision|4|||
155738423|NCT01888432|562143474|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
155738424|NCT01888432|562143475|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
155738425|NCT01888432|562143474|FG000|24-month Analysis (FAS)|Death|8|||
155738426|NCT01888432|562143475|FG001|24-month Analysis (FAS)|Death|4|||
155738427|NCT01888432|562143474|FG000|36-month Analysis (Extension)|Death|1|||
155738428|NCT01888432|562143475|FG001|36-month Analysis (Extension)|Death|0|||
155738429|NCT03844945|562143476|FG000|Overall Study|Adverse Event|1|||
155738430|NCT03844945|562143477|FG001|Overall Study|Adverse Event|1|||
155738431|NCT03844945|562143478|FG002|Overall Study|Adverse Event|4|||
155738432|NCT03844945|562143479|FG003|Overall Study|Adverse Event|0|||
155738433|NCT03844945|562143476|FG000|Overall Study|Withdrawal by Subject|0|||
155738434|NCT03844945|562143477|FG001|Overall Study|Withdrawal by Subject|0|||
155738435|NCT03844945|562143478|FG002|Overall Study|Withdrawal by Subject|1|||
155738436|NCT03844945|562143479|FG003|Overall Study|Withdrawal by Subject|0|||
155738437|NCT03844945|562143476|FG000|Overall Study|Lack of Efficacy|0|||
155738438|NCT03844945|562143477|FG001|Overall Study|Lack of Efficacy|0|||
155738439|NCT03844945|562143478|FG002|Overall Study|Lack of Efficacy|0|||
155738440|NCT03844945|562143479|FG003|Overall Study|Lack of Efficacy|1|||
155738441|NCT01794338|562143492|FG000|Overall Study|Death|2|||
155738442|NCT01794338|562143493|FG001|Overall Study|Death|0|||
155738443|NCT01794338|562143492|FG000|Overall Study|Lost to Follow-up|6|||
155738444|NCT01794338|562143493|FG001|Overall Study|Lost to Follow-up|9|||
155738445|NCT01754402|562143494|FG000|Overall Study|Death|0|||
155738446|NCT01754402|562143495|FG001|Overall Study|Death|0|||
155738447|NCT01754402|562143496|FG002|Overall Study|Death|1|||
155738448|NCT01754402|562143494|FG000|Overall Study|Adverse Event|2|||
155738449|NCT01754402|562143495|FG001|Overall Study|Adverse Event|2|||
155738450|NCT01754402|562143496|FG002|Overall Study|Adverse Event|1|||
155738451|NCT01754402|562143494|FG000|Overall Study|Withdrawal by Subject|0|||
155738452|NCT01754402|562143495|FG001|Overall Study|Withdrawal by Subject|0|||
155738453|NCT01754402|562143496|FG002|Overall Study|Withdrawal by Subject|1|||
155738454|NCT01754402|562143494|FG000|Overall Study|Lack of Efficacy|0|||
155738455|NCT01754402|562143495|FG001|Overall Study|Lack of Efficacy|0|||
155738456|NCT01754402|562143496|FG002|Overall Study|Lack of Efficacy|1|||
155738457|NCT01282463|562143497|FG000|Overall Study|Lost to Follow-up|1|||
155738458|NCT01282463|562143498|FG001|Overall Study|Lost to Follow-up|0|||
155738459|NCT01282463|562143499|FG002|Overall Study|Lost to Follow-up|0|||
155738460|NCT01282463|562143497|FG000|Overall Study|Withdrawal by Subject|6|||
155738461|NCT01282463|562143498|FG001|Overall Study|Withdrawal by Subject|2|||
155738462|NCT01282463|562143499|FG002|Overall Study|Withdrawal by Subject|3|||
155738463|NCT01282463|562143497|FG000|Overall Study|"Never Treated Death"|0|||
155738464|NCT01282463|562143498|FG001|Overall Study|"Never Treated Death"|1|||
155738465|NCT01282463|562143499|FG002|Overall Study|"Never Treated Death"|0|||
155738466|NCT01282463|562143497|FG000|Overall Study|"Never Treated PD"|0|||
155738467|NCT01282463|562143498|FG001|Overall Study|"Never Treated PD"|1|||
155738468|NCT01282463|562143499|FG002|Overall Study|"Never Treated PD"|0|||
155738469|NCT01282463|562143497|FG000|Overall Study|Protocol Violation|0|||
155738470|NCT01282463|562143498|FG001|Overall Study|Protocol Violation|0|||
155738471|NCT01282463|562143499|FG002|Overall Study|Protocol Violation|1|||
155738472|NCT01282463|562143497|FG000|Overall Study|Physician Decision|1|||
155738473|NCT01282463|562143498|FG001|Overall Study|Physician Decision|0|||
155738474|NCT01282463|562143499|FG002|Overall Study|Physician Decision|0|||
155738475|NCT01954927|562143500|FG000|Overall Study|Withdrawal by Subject|3|||
155738476|NCT01954927|562143501|FG001|Overall Study|Withdrawal by Subject|1|||
155738477|NCT02156271|562143502|FG000|Overall Study|Physician Decision|4|||
155738478|NCT02156271|562143503|FG001|Overall Study|Physician Decision|3|||
155738479|NCT03320824|562143504|FG000|Overall Study|Withdrawal by Subject|8|||
155738480|NCT03320824|562143505|FG001|Overall Study|Withdrawal by Subject|1|||
155738481|NCT03320824|562143504|FG000|Overall Study|Lost to Follow-up|10|||
155738482|NCT03320824|562143505|FG001|Overall Study|Lost to Follow-up|1|||
155738483|NCT03320824|562143504|FG000|Overall Study|moved out of state|0|||
155738484|NCT03320824|562143505|FG001|Overall Study|moved out of state|1|||
155738485|NCT03320824|562143504|FG000|Overall Study|could not complete final visit|0|||
155738486|NCT03320824|562143505|FG001|Overall Study|could not complete final visit|1|||
155738487|NCT00955305|562143506|FG000|Overall Study|Disease progression|39|||
155738488|NCT00955305|562143507|FG001|Overall Study|Disease progression|41|||
155738489|NCT00955305|562143506|FG000|Overall Study|Adverse Event|22|||
155738490|NCT00955305|562143507|FG001|Overall Study|Adverse Event|22|||
155738491|NCT00955305|562143506|FG000|Overall Study|Death|2|||
155738492|NCT00955305|562143507|FG001|Overall Study|Death|1|||
155738493|NCT00955305|562143506|FG000|Overall Study|Withdrawal by Subject|5|||
155738494|NCT00955305|562143507|FG001|Overall Study|Withdrawal by Subject|4|||
155738495|NCT00955305|562143506|FG000|Overall Study|Alternative therapy|4|||
155738496|NCT00955305|562143507|FG001|Overall Study|Alternative therapy|0|||
155634520|NCT02320396|561754192|FG001|Overall Study|Pregnancy|1|||
155634521|NCT02320396|561754191|FG000|Overall Study|Protocol Violation|0|||
155634522|NCT02320396|561754192|FG001|Overall Study|Protocol Violation|1|||
155634523|NCT02320396|561754191|FG000|Overall Study|Withdrawal by Subject|2|||
155634524|NCT02320396|561754192|FG001|Overall Study|Withdrawal by Subject|0|||
155634525|NCT02441283|561754195|FG000|Overall Study|Withdrew consent|15|||
155634526|NCT02441283|561754195|FG000|Overall Study|Lost to Follow-up|42|||
155634527|NCT02441283|561754195|FG000|Overall Study|Death|1|||
155634528|NCT02441283|561754195|FG000|Overall Study|Other, not specified|32|||
155634529|NCT02382939|561754196|FG000|Overall Study|Adverse Event|1|||
155634530|NCT02382939|561754197|FG001|Overall Study|Adverse Event|1|||
155634531|NCT02382939|561754196|FG000|Overall Study|Withdrawal by Subject|2|||
155634532|NCT02382939|561754197|FG001|Overall Study|Withdrawal by Subject|2|||
155634533|NCT00142415|561754198|FG000|Overall Study|Physician Decision|0|||
155634534|NCT00142415|561754199|FG001|Overall Study|Physician Decision|0|||
155634535|NCT00142415|561754200|FG002|Overall Study|Physician Decision|0|||
155634536|NCT00142415|561754201|FG003|Overall Study|Physician Decision|0|||
155634537|NCT00142415|561754202|FG004|Overall Study|Physician Decision|1|||
155634538|NCT00142415|561754203|FG005|Overall Study|Physician Decision|2|||
155634539|NCT00321763|561754208|FG000|Overall Study|Adverse Event|1|||
155634540|NCT00321763|561754209|FG001|Overall Study|Adverse Event|1|||
155634541|NCT00321763|561754210|FG002|Overall Study|Adverse Event|0|||
155634542|NCT00321763|561754211|FG003|Overall Study|Adverse Event|1|||
155634543|NCT00321763|561754208|FG000|Overall Study|Withdrawal by Subject|2|||
155634544|NCT00321763|561754209|FG001|Overall Study|Withdrawal by Subject|0|||
155634545|NCT00321763|561754210|FG002|Overall Study|Withdrawal by Subject|1|||
155634546|NCT00321763|561754211|FG003|Overall Study|Withdrawal by Subject|0|||
155634547|NCT00321763|561754208|FG000|Overall Study|Lost to Follow-up|3|||
155634548|NCT00321763|561754209|FG001|Overall Study|Lost to Follow-up|1|||
155634549|NCT00321763|561754210|FG002|Overall Study|Lost to Follow-up|5|||
155634550|NCT00321763|561754211|FG003|Overall Study|Lost to Follow-up|4|||
155634551|NCT01572792|561754212|FG000|Lead-in Study|Lost to Follow-up|5|||
155634552|NCT01572792|561754213|FG001|Lead-in Study|Lost to Follow-up|9|||
155634553|NCT01572792|561754214|FG002|Lead-in Study|Lost to Follow-up|4|||
155634554|NCT01572792|561754215|FG003|Lead-in Study|Lost to Follow-up|2|||
155634555|NCT01572792|561754216|FG004|Lead-in Study|Lost to Follow-up|4|||
155634556|NCT01572792|561754212|FG000|Lead-in Study|Withdrawal by Subject|22|||
155738497|NCT00955305|562143506|FG000|Overall Study|Other complicating disease|2|||
155738498|NCT00955305|562143507|FG001|Overall Study|Other complicating disease|4|||
155393581|NCT01132612|560876797|FG000|Overall Study|Withdrawal by Subject|5|||
155738499|NCT00955305|562143506|FG000|Overall Study|Physician Decision|1|||
155634557|NCT01572792|561754213|FG001|Lead-in Study|Withdrawal by Subject|11|||
155634558|NCT01572792|561754214|FG002|Lead-in Study|Withdrawal by Subject|12|||
155634559|NCT01572792|561754215|FG003|Lead-in Study|Withdrawal by Subject|24|||
155634560|NCT01572792|561754216|FG004|Lead-in Study|Withdrawal by Subject|11|||
155634561|NCT01572792|561754212|FG000|Lead-in Study|Protocol Violation|19|||
155634562|NCT01572792|561754213|FG001|Lead-in Study|Protocol Violation|10|||
155634563|NCT01572792|561754214|FG002|Lead-in Study|Protocol Violation|12|||
155738500|NCT00955305|562143507|FG001|Overall Study|Physician Decision|0|||
155738501|NCT00955305|562143506|FG000|Overall Study|Continued presence of residual disease|0|||
155634564|NCT01572792|561754215|FG003|Lead-in Study|Protocol Violation|13|||
155634565|NCT01572792|561754216|FG004|Lead-in Study|Protocol Violation|21|||
155634566|NCT01572792|561754212|FG000|Lead-in Study|Lack of Efficacy|20|||
155738502|NCT00955305|562143507|FG001|Overall Study|Continued presence of residual disease|1|||
155634567|NCT01572792|561754213|FG001|Lead-in Study|Lack of Efficacy|5|||
155634568|NCT01572792|561754214|FG002|Lead-in Study|Lack of Efficacy|4|||
155634569|NCT01572792|561754215|FG003|Lead-in Study|Lack of Efficacy|8|||
155634570|NCT01572792|561754216|FG004|Lead-in Study|Lack of Efficacy|10|||
155634571|NCT01572792|561754212|FG000|Lead-in Study|Adverse Event|21|||
155634572|NCT01572792|561754213|FG001|Lead-in Study|Adverse Event|21|||
155634573|NCT01572792|561754214|FG002|Lead-in Study|Adverse Event|22|||
155634574|NCT01572792|561754215|FG003|Lead-in Study|Adverse Event|16|||
155634575|NCT01572792|561754216|FG004|Lead-in Study|Adverse Event|14|||
155634576|NCT01572792|561754212|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
155634577|NCT01572792|561754213|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
155634578|NCT01572792|561754214|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
155634579|NCT01572792|561754215|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
155634580|NCT01572792|561754216|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
155634581|NCT01572792|561754212|FG000|Extension Study|Lost to Follow-up|6|||
155634582|NCT01572792|561754213|FG001|Extension Study|Lost to Follow-up|2|||
155634583|NCT01572792|561754214|FG002|Extension Study|Lost to Follow-up|0|||
155634584|NCT01572792|561754215|FG003|Extension Study|Lost to Follow-up|3|||
155634585|NCT01572792|561754216|FG004|Extension Study|Lost to Follow-up|3|||
155634586|NCT01572792|561754212|FG000|Extension Study|Withdrawal by Subject|7|||
155634587|NCT01572792|561754213|FG001|Extension Study|Withdrawal by Subject|6|||
155634588|NCT01572792|561754214|FG002|Extension Study|Withdrawal by Subject|11|||
155634589|NCT01572792|561754215|FG003|Extension Study|Withdrawal by Subject|8|||
155634590|NCT01572792|561754216|FG004|Extension Study|Withdrawal by Subject|14|||
155634591|NCT01572792|561754212|FG000|Extension Study|Protocol Violation|0|||
155634592|NCT01572792|561754213|FG001|Extension Study|Protocol Violation|4|||
155634593|NCT01572792|561754214|FG002|Extension Study|Protocol Violation|3|||
155634594|NCT01572792|561754215|FG003|Extension Study|Protocol Violation|4|||
155634595|NCT01572792|561754216|FG004|Extension Study|Protocol Violation|3|||
155634596|NCT01572792|561754212|FG000|Extension Study|Lack of Efficacy|2|||
155634597|NCT01572792|561754213|FG001|Extension Study|Lack of Efficacy|3|||
155634598|NCT01572792|561754214|FG002|Extension Study|Lack of Efficacy|3|||
155634599|NCT01572792|561754215|FG003|Extension Study|Lack of Efficacy|2|||
155634600|NCT01572792|561754216|FG004|Extension Study|Lack of Efficacy|2|||
155634601|NCT01572792|561754212|FG000|Extension Study|Adverse Event|7|||
155634602|NCT01572792|561754213|FG001|Extension Study|Adverse Event|6|||
155634603|NCT01572792|561754214|FG002|Extension Study|Adverse Event|5|||
155634604|NCT01572792|561754215|FG003|Extension Study|Adverse Event|6|||
155634605|NCT01572792|561754216|FG004|Extension Study|Adverse Event|4|||
155634606|NCT01572792|561754212|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
155634607|NCT01572792|561754213|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
155634608|NCT01572792|561754214|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
155634609|NCT01572792|561754215|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
155634610|NCT01572792|561754216|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
155634611|NCT03530696|561754217|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
155634612|NCT03530696|561754218|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
155634613|NCT01129128|561754219|FG000|Overall Study|Lost to Follow-up|2|||
155634614|NCT01129128|561754220|FG001|Overall Study|Lost to Follow-up|2|||
155634615|NCT01129128|561754221|FG002|Overall Study|Lost to Follow-up|1|||
155634616|NCT01129128|561754219|FG000|Overall Study|Protocol Violation|0|||
155634617|NCT01129128|561754220|FG001|Overall Study|Protocol Violation|1|||
155634618|NCT01129128|561754221|FG002|Overall Study|Protocol Violation|0|||
155634619|NCT01129128|561754219|FG000|Overall Study|Withdrawal by Subject|0|||
155634620|NCT01129128|561754220|FG001|Overall Study|Withdrawal by Subject|1|||
155634621|NCT01129128|561754221|FG002|Overall Study|Withdrawal by Subject|3|||
155634622|NCT01129128|561754219|FG000|Overall Study|Physician Decision|1|||
155634623|NCT01129128|561754220|FG001|Overall Study|Physician Decision|0|||
155634624|NCT01129128|561754221|FG002|Overall Study|Physician Decision|0|||
155634625|NCT06438601|561754222|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
155634626|NCT06438601|561754223|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
155634627|NCT06438601|561754222|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
155634628|NCT06438601|561754223|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
155634629|NCT01900314|561754224|FG000|Overall Study|Lost to Follow-up|1|||
155634630|NCT01900314|561754225|FG001|Overall Study|Lost to Follow-up|0|||
155634631|NCT01900314|561754224|FG000|Overall Study|Protocol Violation|0|||
155634632|NCT01900314|561754225|FG001|Overall Study|Protocol Violation|1|||
155634633|NCT01900314|561754224|FG000|Overall Study|Withdrawal by Subject|3|||
155634634|NCT01900314|561754225|FG001|Overall Study|Withdrawal by Subject|3|||
155634635|NCT01385176|561754227|FG000|Randomization Phase|Death|1|||
155634636|NCT01385176|561754228|FG001|Randomization Phase|Death|2|||
155634637|NCT01385176|561754227|FG000|6-18 Month All VNS Active|Death|1|||
155634638|NCT01385176|561754228|FG001|6-18 Month All VNS Active|Death|2|||
155634639|NCT01385176|561754227|FG000|6-18 Month All VNS Active|Physician Decision|0|||
155634640|NCT01385176|561754228|FG001|6-18 Month All VNS Active|Physician Decision|1|||
155738503|NCT00955305|562143506|FG000|Overall Study|Functional decline|2|||
155634641|NCT01385176|561754227|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
155634642|NCT01385176|561754228|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
155738504|NCT00955305|562143507|FG001|Overall Study|Functional decline|0|||
155738505|NCT00955305|562143506|FG000|Overall Study|Maximum response achieved|0|||
155738506|NCT00955305|562143507|FG001|Overall Study|Maximum response achieved|1|||
155738507|NCT00955305|562143506|FG000|Overall Study|Lost to Follow-up|0|||
155738508|NCT00955305|562143507|FG001|Overall Study|Lost to Follow-up|1|||
155738509|NCT00955305|562143506|FG000|Overall Study|No off-treatment reason submitted|1|||
155738510|NCT00955305|562143507|FG001|Overall Study|No off-treatment reason submitted|0|||
155738511|NCT00955305|562143506|FG000|Overall Study|Never started protocol treatment|5|||
155738512|NCT00955305|562143507|FG001|Overall Study|Never started protocol treatment|5|||
155738513|NCT00955305|562143506|FG000|Overall Study|Ineligible|5|||
155738514|NCT00955305|562143507|FG001|Overall Study|Ineligible|7|||
155738515|NCT00109590|562143508|FG000|Overall Study|Lost to Follow-up|1|||
155738516|NCT00109590|562143509|FG001|Overall Study|Lost to Follow-up|0|||
155738517|NCT00109590|562143510|FG002|Overall Study|Lost to Follow-up|1|||
155738518|NCT00109590|562143508|FG000|Overall Study|Never Started Treatment|1|||
155738519|NCT00109590|562143509|FG001|Overall Study|Never Started Treatment|2|||
155738520|NCT00109590|562143510|FG002|Overall Study|Never Started Treatment|3|||
155738521|NCT02123251|562143511|FG000|Overall Study|Death|1|||
155738522|NCT02123251|562143512|FG001|Overall Study|Death|1|||
155738523|NCT02123251|562143511|FG000|Overall Study|Withdrawal by Subject|0|||
155738524|NCT02123251|562143512|FG001|Overall Study|Withdrawal by Subject|3|||
155738525|NCT02123251|562143511|FG000|Overall Study|Lost Medicaid eligibility|29|||
155738526|NCT02123251|562143512|FG001|Overall Study|Lost Medicaid eligibility|22|||
155738527|NCT02123251|562143511|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
155738528|NCT02123251|562143512|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
155738529|NCT01221285|562143513|FG000|Overall Study|Withdrawal by Subject|1|||
155634643|NCT01385176|561754227|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
155634644|NCT01385176|561754228|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
155634645|NCT01056536|561754229|FG000|Overall Study|Lost to Follow-up|202|||
155634646|NCT01056536|561754230|FG001|Overall Study|Lost to Follow-up|116|||
155634647|NCT01056536|561754231|FG002|Overall Study|Lost to Follow-up|248|||
155634648|NCT03034967|561754238|FG000|Overall Study|Withdrawal by Subject|9|||
155634649|NCT03034967|561754239|FG001|Overall Study|Withdrawal by Subject|2|||
155634650|NCT03034967|561754240|FG002|Overall Study|Withdrawal by Subject|6|||
155634651|NCT03034967|561754241|FG003|Overall Study|Withdrawal by Subject|6|||
155634652|NCT03034967|561754242|FG004|Overall Study|Withdrawal by Subject|9|||
155634653|NCT03034967|561754243|FG005|Overall Study|Withdrawal by Subject|2|||
155634654|NCT03034967|561754238|FG000|Overall Study|Physician Decision|1|||
155634655|NCT03034967|561754239|FG001|Overall Study|Physician Decision|0|||
155634656|NCT03034967|561754240|FG002|Overall Study|Physician Decision|1|||
155634657|NCT03034967|561754241|FG003|Overall Study|Physician Decision|1|||
155634658|NCT03034967|561754242|FG004|Overall Study|Physician Decision|1|||
155634659|NCT03034967|561754243|FG005|Overall Study|Physician Decision|0|||
155634660|NCT03034967|561754238|FG000|Overall Study|Lost to Follow-up|0|||
155634661|NCT03034967|561754239|FG001|Overall Study|Lost to Follow-up|0|||
155634662|NCT03034967|561754240|FG002|Overall Study|Lost to Follow-up|0|||
155634663|NCT03034967|561754241|FG003|Overall Study|Lost to Follow-up|1|||
155634664|NCT03034967|561754242|FG004|Overall Study|Lost to Follow-up|0|||
155634665|NCT03034967|561754243|FG005|Overall Study|Lost to Follow-up|2|||
155634666|NCT03034967|561754238|FG000|Overall Study|Liver function test abnormality|0|||
155634667|NCT03034967|561754239|FG001|Overall Study|Liver function test abnormality|0|||
155634668|NCT03034967|561754240|FG002|Overall Study|Liver function test abnormality|1|||
155634669|NCT03034967|561754241|FG003|Overall Study|Liver function test abnormality|0|||
155634670|NCT03034967|561754242|FG004|Overall Study|Liver function test abnormality|0|||
155634671|NCT03034967|561754243|FG005|Overall Study|Liver function test abnormality|0|||
155634672|NCT03034967|561754238|FG000|Overall Study|Protocol Violation|1|||
155634673|NCT03034967|561754239|FG001|Overall Study|Protocol Violation|0|||
155634674|NCT03034967|561754240|FG002|Overall Study|Protocol Violation|0|||
155634675|NCT03034967|561754241|FG003|Overall Study|Protocol Violation|0|||
155634676|NCT03034967|561754242|FG004|Overall Study|Protocol Violation|0|||
155634677|NCT03034967|561754243|FG005|Overall Study|Protocol Violation|2|||
155634678|NCT03034967|561754238|FG000|Overall Study|Lack of Efficacy|0|||
155634679|NCT03034967|561754239|FG001|Overall Study|Lack of Efficacy|1|||
155634680|NCT03034967|561754240|FG002|Overall Study|Lack of Efficacy|2|||
155738530|NCT00375609|562143517|FG000|Overall Study|Did not receive treatment|1|||
155738531|NCT00375609|562143518|FG001|Overall Study|Did not receive treatment|0|||
155738532|NCT00375609|562143519|FG002|Overall Study|Did not receive treatment|0|||
155738533|NCT00375609|562143517|FG000|Overall Study|Adverse Event|0|||
155738534|NCT00375609|562143518|FG001|Overall Study|Adverse Event|3|||
155738535|NCT00375609|562143519|FG002|Overall Study|Adverse Event|0|||
155393582|NCT01132612|560876798|FG001|Overall Study|Withdrawal by Subject|8|||
155393583|NCT01132612|560876799|FG002|Overall Study|Withdrawal by Subject|19|||
155634681|NCT03034967|561754241|FG003|Overall Study|Lack of Efficacy|1|||
155634682|NCT03034967|561754242|FG004|Overall Study|Lack of Efficacy|1|||
155634683|NCT03034967|561754243|FG005|Overall Study|Lack of Efficacy|0|||
155738536|NCT00375609|562143517|FG000|Overall Study|Lost to Follow-up|1|||
155738537|NCT00375609|562143518|FG001|Overall Study|Lost to Follow-up|0|||
155738538|NCT00375609|562143519|FG002|Overall Study|Lost to Follow-up|0|||
155738539|NCT00375609|562143517|FG000|Overall Study|Physician Decision|0|||
155738540|NCT00375609|562143518|FG001|Overall Study|Physician Decision|0|||
155738541|NCT00375609|562143519|FG002|Overall Study|Physician Decision|1|||
155738542|NCT00375609|562143517|FG000|Overall Study|Withdrawal by Subject|1|||
155738543|NCT00375609|562143518|FG001|Overall Study|Withdrawal by Subject|4|||
155738544|NCT00375609|562143519|FG002|Overall Study|Withdrawal by Subject|0|||
155738545|NCT00375609|562143517|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
155738546|NCT00375609|562143518|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
155738547|NCT00375609|562143519|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
155738548|NCT03254459|562143520|FG000|Overall Study|Adverse Event|7|||
155738549|NCT03254459|562143521|FG001|Overall Study|Adverse Event|20|||
155738550|NCT03254459|562143520|FG000|Overall Study|Withdrawal by Subject Consent|3|||
155738551|NCT03254459|562143521|FG001|Overall Study|Withdrawal by Subject Consent|1|||
155738552|NCT03254459|562143520|FG000|Overall Study|Lost to Follow-up|0|||
155738553|NCT03254459|562143521|FG001|Overall Study|Lost to Follow-up|1|||
155738554|NCT03254459|562143520|FG000|Overall Study|Miscellaneous|0|||
155738555|NCT03254459|562143521|FG001|Overall Study|Miscellaneous|1|||
155738556|NCT01511055|562143522|FG000|Overall Study|Withdrawal by Subject|6|||
155738557|NCT00669409|562143528|FG000|Part 2|Withdrawal by Subject|0|||
155738558|NCT00669409|562143529|FG001|Part 2|Withdrawal by Subject|0|||
155738559|NCT00669409|562143530|FG002|Part 2|Withdrawal by Subject|0|||
155738560|NCT00669409|562143531|FG003|Part 2|Withdrawal by Subject|0|||
155738561|NCT00669409|562143532|FG004|Part 2|Withdrawal by Subject|0|||
155738562|NCT00669409|562143533|FG005|Part 2|Withdrawal by Subject|0|||
155738563|NCT00669409|562143534|FG006|Part 2|Withdrawal by Subject|0|||
155738564|NCT00669409|562143535|FG007|Part 2|Withdrawal by Subject|0|||
155738565|NCT00669409|562143536|FG008|Part 2|Withdrawal by Subject|0|||
155738566|NCT00669409|562143537|FG009|Part 2|Withdrawal by Subject|1|||
155738567|NCT00669409|562143538|FG010|Part 2|Withdrawal by Subject|0|||
155738568|NCT04491604|562143539|FG000|Overall Study|Withdrawal by Subject|3|||
155738569|NCT01874340|562143540|FG000|Overall Study|Study terminated by Sponsor|6|||
155738570|NCT01874340|562143541|FG001|Overall Study|Study terminated by Sponsor|8|||
155738571|NCT01874340|562143542|FG002|Overall Study|Study terminated by Sponsor|8|||
155738572|NCT01874340|562143543|FG003|Overall Study|Study terminated by Sponsor|4|||
155738573|NCT01874340|562143540|FG000|Overall Study|Withdrawal by Subject|0|||
155738574|NCT01874340|562143541|FG001|Overall Study|Withdrawal by Subject|0|||
155393584|NCT01132612|560876797|FG000|Overall Study|Administrative problems|5|||
155634684|NCT03034967|561754238|FG000|Overall Study|Adverse Event, non-fatal|3|||
155634685|NCT03034967|561754239|FG001|Overall Study|Adverse Event, non-fatal|1|||
155738575|NCT01874340|562143542|FG002|Overall Study|Withdrawal by Subject|0|||
155738576|NCT01874340|562143543|FG003|Overall Study|Withdrawal by Subject|1|||
155738577|NCT03263702|562143544|FG000|Overall Study|Lost to Follow-up|2|||
155634686|NCT03034967|561754240|FG002|Overall Study|Adverse Event, non-fatal|2|||
155634687|NCT03034967|561754241|FG003|Overall Study|Adverse Event, non-fatal|0|||
155634688|NCT03034967|561754242|FG004|Overall Study|Adverse Event, non-fatal|2|||
155634689|NCT03034967|561754243|FG005|Overall Study|Adverse Event, non-fatal|8|||
155634690|NCT03034967|561754238|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
155634691|NCT03034967|561754239|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
155634692|NCT03034967|561754240|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
155634693|NCT03034967|561754241|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
155634694|NCT03034967|561754242|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
155634695|NCT03034967|561754243|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
155634696|NCT03806296|561754244|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
155634697|NCT03806296|561754245|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
155634698|NCT03806296|561754246|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
155634699|NCT03806296|561754244|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
155634700|NCT03806296|561754245|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
155634701|NCT03806296|561754246|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
155634702|NCT03806296|561754244|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
155634703|NCT03806296|561754245|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
155634704|NCT03806296|561754246|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
155738578|NCT03263702|562143545|FG001|Overall Study|Lost to Follow-up|2|||
155738579|NCT03263702|562143544|FG000|Overall Study|Withdrawal by Subject|1|||
155738580|NCT03263702|562143545|FG001|Overall Study|Withdrawal by Subject|2|||
155738581|NCT02888119|562143547|FG000|Overall Study|Lost to Follow-up|5|||
155738582|NCT02888119|562143548|FG001|Overall Study|Lost to Follow-up|4|||
155738583|NCT02888119|562143549|FG002|Overall Study|Lost to Follow-up|0|||
155738584|NCT03330002|562143550|FG000|Overall Study|Lost to Follow-up|15|||
155738585|NCT03330002|562143550|FG000|Overall Study|Death|7|||
155738586|NCT05573386|562143551|FG000|Overall Study|Withdrawal by Subject|3|||
155738587|NCT05573386|562143552|FG001|Overall Study|Withdrawal by Subject|2|||
155738588|NCT03899805|562143553|FG000|Overall Study|Physician Decision|3|||
155634705|NCT04848480|561754249|FG000|Main Phase (26 Weeks)|Death|1|||
155634706|NCT04848480|561754250|FG001|Main Phase (26 Weeks)|Death|0|||
155634707|NCT04848480|561754249|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
155634708|NCT04848480|561754250|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
155634709|NCT04848480|561754249|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
155634710|NCT04848480|561754250|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
155634711|NCT04848480|561754249|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
155634712|NCT04848480|561754250|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
155634713|NCT04848480|561754249|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
155634714|NCT04848480|561754250|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
155634715|NCT04848480|561754249|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
155634716|NCT04848480|561754250|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
155634717|NCT02781324|561754251|FG000|Overall Study|Withdrawal by Subject|1|||
155634718|NCT02781324|561754252|FG001|Overall Study|Withdrawal by Subject|0|||
155634719|NCT02781324|561754251|FG000|Overall Study|Physician Decision|1|||
155634720|NCT02781324|561754252|FG001|Overall Study|Physician Decision|2|||
155634721|NCT03570892|561754253|FG000|Overall Study|Death|51|||
155634722|NCT03570892|561754254|FG001|Overall Study|Death|45|||
155634723|NCT03570892|561754253|FG000|Overall Study|Subject decision|5|||
155634724|NCT03570892|561754254|FG001|Overall Study|Subject decision|3|||
155634725|NCT03570892|561754253|FG000|Overall Study|Protocol Violation|1|||
155634726|NCT03570892|561754254|FG001|Overall Study|Protocol Violation|4|||
155634727|NCT03570892|561754253|FG000|Overall Study|Physician Decision|0|||
155634728|NCT03570892|561754254|FG001|Overall Study|Physician Decision|2|||
155634729|NCT05020015|561756123|FG000|Overall Study|Ongoing on study|1|||
155634730|NCT05020015|561756124|FG001|Overall Study|Ongoing on study|3|||
155634731|NCT05020015|561756125|FG002|Overall Study|Ongoing on study|4|||
155634732|NCT05020015|561756126|FG003|Overall Study|Ongoing on study|7|||
155634733|NCT05020015|561756123|FG000|Overall Study|Death|2|||
155634734|NCT05020015|561756124|FG001|Overall Study|Death|3|||
155634735|NCT05020015|561756125|FG002|Overall Study|Death|4|||
155634736|NCT05020015|561756126|FG003|Overall Study|Death|0|||
155634737|NCT05020015|561756123|FG000|Overall Study|Withdrawal by Subject|0|||
155634738|NCT05020015|561756124|FG001|Overall Study|Withdrawal by Subject|0|||
155634739|NCT05020015|561756125|FG002|Overall Study|Withdrawal by Subject|1|||
155634740|NCT05020015|561756126|FG003|Overall Study|Withdrawal by Subject|0|||
155634741|NCT05020015|561756123|FG000|Overall Study|Reason Not Specified|0|||
155634742|NCT05020015|561756124|FG001|Overall Study|Reason Not Specified|0|||
155634743|NCT05020015|561756125|FG002|Overall Study|Reason Not Specified|2|||
155634744|NCT05020015|561756126|FG003|Overall Study|Reason Not Specified|0|||
155634745|NCT06633965|561756127|FG000|Overall Study|Withdrawal by Subject|0|||
155634746|NCT06633965|561756128|FG001|Overall Study|Withdrawal by Subject|1|||
155634747|NCT00947544|561756133|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
155634748|NCT00947544|561756134|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
155634749|NCT00300053|561756135|FG000|Overall Study|Patient/Caregiver Preference|2|||
155634750|NCT00300053|561756136|FG001|Overall Study|Patient/Caregiver Preference|2|||
155634751|NCT00300053|561756137|FG002|Overall Study|Patient/Caregiver Preference|3|||
155634752|NCT00300053|561756135|FG000|Overall Study|Death|0|||
155634753|NCT00300053|561756136|FG001|Overall Study|Death|0|||
155634754|NCT00300053|561756137|FG002|Overall Study|Death|3|||
155634755|NCT00300053|561756135|FG000|Overall Study|Lost to Follow-up|0|||
155634756|NCT00300053|561756136|FG001|Overall Study|Lost to Follow-up|1|||
155634757|NCT00300053|561756137|FG002|Overall Study|Lost to Follow-up|0|||
155634758|NCT02566005|561756138|FG000|Overall Study|vaginal bleeding|0|||
155634759|NCT02566005|561756139|FG001|Overall Study|vaginal bleeding|1|||
155634760|NCT02566005|561756138|FG000|Overall Study|received foley|8|||
155634761|NCT02566005|561756139|FG001|Overall Study|received foley|0|||
155634762|NCT02566005|561756138|FG000|Overall Study|did not receive foley|0|||
155634763|NCT02566005|561756139|FG001|Overall Study|did not receive foley|1|||
155634764|NCT02566005|561756138|FG000|Overall Study|labor after randomization|0|||
155634765|NCT02566005|561756139|FG001|Overall Study|labor after randomization|4|||
155634766|NCT01294514|561756142|FG000|Overall Study|Excluded due to Arrhythmia|1|||
155634767|NCT01963611|561756143|FG000|Overall Study|Adverse Event|1|||
155634768|NCT01963611|561756144|FG001|Overall Study|Adverse Event|1|||
155634769|NCT01963611|561756145|FG002|Overall Study|Adverse Event|3|||
155634770|NCT01963611|561756146|FG003|Overall Study|Adverse Event|4|||
155634771|NCT01963611|561756147|FG004|Overall Study|Adverse Event|3|||
155634772|NCT01963611|561756143|FG000|Overall Study|Protocol Violation|0|||
155634773|NCT01963611|561756144|FG001|Overall Study|Protocol Violation|0|||
155634774|NCT01963611|561756145|FG002|Overall Study|Protocol Violation|0|||
155634775|NCT01963611|561756146|FG003|Overall Study|Protocol Violation|1|||
155634776|NCT01963611|561756147|FG004|Overall Study|Protocol Violation|0|||
155634777|NCT01963611|561756143|FG000|Overall Study|Lack of Efficacy|0|||
155634778|NCT01963611|561756144|FG001|Overall Study|Lack of Efficacy|0|||
155634779|NCT01963611|561756145|FG002|Overall Study|Lack of Efficacy|0|||
155634780|NCT01963611|561756146|FG003|Overall Study|Lack of Efficacy|1|||
155634781|NCT01963611|561756147|FG004|Overall Study|Lack of Efficacy|0|||
155634782|NCT01963611|561756143|FG000|Overall Study|Withdrawal by Subject|3|||
155738589|NCT03899805|562143554|FG001|Overall Study|Physician Decision|0|||
155738590|NCT03899805|562143555|FG002|Overall Study|Physician Decision|2|||
155738591|NCT03899805|562143553|FG000|Overall Study|Withdrawal by Subject|1|||
155738592|NCT03899805|562143554|FG001|Overall Study|Withdrawal by Subject|0|||
155738593|NCT03899805|562143555|FG002|Overall Study|Withdrawal by Subject|2|||
155738594|NCT03899805|562143553|FG000|Overall Study|Progressive Disease|10|||
155738595|NCT03899805|562143554|FG001|Overall Study|Progressive Disease|18|||
155738596|NCT03899805|562143555|FG002|Overall Study|Progressive Disease|12|||
155738597|NCT03899805|562143553|FG000|Overall Study|Adverse Event|3|||
155738598|NCT03899805|562143554|FG001|Overall Study|Adverse Event|1|||
155738599|NCT03899805|562143555|FG002|Overall Study|Adverse Event|0|||
155738600|NCT03899805|562143553|FG000|Overall Study|Death|2|||
155738601|NCT03899805|562143554|FG001|Overall Study|Death|0|||
155738602|NCT03899805|562143555|FG002|Overall Study|Death|0|||
155738603|NCT03899805|562143553|FG000|Overall Study|Came off for surgery|0|||
155738604|NCT03899805|562143554|FG001|Overall Study|Came off for surgery|0|||
155738605|NCT03899805|562143555|FG002|Overall Study|Came off for surgery|1|||
155738606|NCT05246514|562143556|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
155738607|NCT05246514|562143556|FG000|Overall Study|Withdrawal by Subject|1|||
155738608|NCT05246514|562143556|FG000|Overall Study|Death|13|||
155738609|NCT03646123|562143557|FG000|Overall Study|Withdrawal by Subject|2|||
155738610|NCT03646123|562143558|FG001|Overall Study|Withdrawal by Subject|2|||
155738611|NCT03646123|562143559|FG002|Overall Study|Withdrawal by Subject|3|||
155738612|NCT03646123|562143557|FG000|Overall Study|Study termination by sponsor|0|||
155738613|NCT03646123|562143558|FG001|Overall Study|Study termination by sponsor|45|||
155738614|NCT03646123|562143559|FG002|Overall Study|Study termination by sponsor|139|||
155738615|NCT03646123|562143557|FG000|Overall Study|Lost to Follow-up|4|||
155738616|NCT03646123|562143558|FG001|Overall Study|Lost to Follow-up|10|||
155738617|NCT03646123|562143559|FG002|Overall Study|Lost to Follow-up|10|||
155738618|NCT03646123|562143557|FG000|Overall Study|Death|2|||
155738619|NCT03646123|562143558|FG001|Overall Study|Death|1|||
155738620|NCT03646123|562143559|FG002|Overall Study|Death|1|||
155738621|NCT03646123|562143557|FG000|Overall Study|Other|2|||
155738622|NCT03646123|562143558|FG001|Overall Study|Other|0|||
155738623|NCT03646123|562143559|FG002|Overall Study|Other|2|||
155738624|NCT04075734|562143562|FG000|Overall Study|Lost to Follow-up|1|||
155738625|NCT04075734|562143563|FG001|Overall Study|Lost to Follow-up|1|||
155738626|NCT04075734|562143564|FG002|Overall Study|Lost to Follow-up|0|||
155738627|NCT04075734|562143562|FG000|Overall Study|Withdrawal by Subject|3|||
155738628|NCT04075734|562143563|FG001|Overall Study|Withdrawal by Subject|0|||
155738629|NCT04075734|562143564|FG002|Overall Study|Withdrawal by Subject|0|||
155738630|NCT01802073|562143565|FG000|Overall Study|Lost to Follow-up|0|||
155738631|NCT01802073|562143566|FG001|Overall Study|Lost to Follow-up|1|||
155738632|NCT01802073|562143565|FG000|Overall Study|Non-compliant|4|||
155738633|NCT01802073|562143566|FG001|Overall Study|Non-compliant|2|||
155738634|NCT01802073|562143565|FG000|Overall Study|Withdrawal by Subject|1|||
155738635|NCT01802073|562143566|FG001|Overall Study|Withdrawal by Subject|1|||
155738636|NCT01802073|562143565|FG000|Overall Study|Physician Decision|0|||
155738637|NCT01802073|562143566|FG001|Overall Study|Physician Decision|7|||
155738638|NCT01776307|562143571|FG000|Overall Study|Not dosed|0|||
155738639|NCT01776307|562143572|FG001|Overall Study|Not dosed|0|||
155738640|NCT01776307|562143573|FG002|Overall Study|Not dosed|1|||
155738641|NCT01327482|562143579|FG000|Overall Study|Adverse Event|1|||
155738642|NCT00312195|562143580|FG000|Overall Study|Adverse Event|4|||
155738643|NCT00312195|562143581|FG001|Overall Study|Adverse Event|6|||
155738644|NCT00312195|562143580|FG000|Overall Study|Lost to Follow-up|1|||
155738645|NCT00312195|562143581|FG001|Overall Study|Lost to Follow-up|0|||
155738646|NCT00312195|562143580|FG000|Overall Study|Protocol Violation|1|||
155738647|NCT00312195|562143581|FG001|Overall Study|Protocol Violation|0|||
155738648|NCT01018810|562143582|FG000|Overall Study|Withdrawal by Subject|0|||
155738649|NCT01018810|562143583|FG001|Overall Study|Withdrawal by Subject|1|||
155738650|NCT01018810|562143584|FG002|Overall Study|Withdrawal by Subject|0|||
155738651|NCT01018810|562143585|FG003|Overall Study|Withdrawal by Subject|0|||
155738652|NCT01018810|562143586|FG004|Overall Study|Withdrawal by Subject|0|||
155738653|NCT01018810|562143582|FG000|Overall Study|Sponsor Decision|2|||
155738654|NCT01018810|562143583|FG001|Overall Study|Sponsor Decision|0|||
155738655|NCT01018810|562143584|FG002|Overall Study|Sponsor Decision|1|||
155738656|NCT01018810|562143585|FG003|Overall Study|Sponsor Decision|1|||
155738657|NCT01018810|562143586|FG004|Overall Study|Sponsor Decision|1|||
155738658|NCT02872935|562143591|FG000|Overall Study|Other|0|||
155738659|NCT02872935|562143592|FG001|Overall Study|Other|1|||
155738660|NCT03179319|562143595|FG000|Overall Study|Lost to Follow-up|6|||
155738661|NCT03179319|562143596|FG001|Overall Study|Lost to Follow-up|0|||
155738662|NCT01120717|562143597|FG000|Overall Study|Withdrawal by Subject|11|||
155738663|NCT01120717|562143598|FG001|Overall Study|Withdrawal by Subject|6|||
155738664|NCT01120717|562143597|FG000|Overall Study|Adverse Event|10|||
155738665|NCT01120717|562143598|FG001|Overall Study|Adverse Event|6|||
155738666|NCT01120717|562143597|FG000|Overall Study|Protocol Deviation|2|||
155738667|NCT01120717|562143598|FG001|Overall Study|Protocol Deviation|5|||
155738668|NCT01120717|562143597|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155738669|NCT01120717|562143598|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155738670|NCT01120717|562143597|FG000|Overall Study|Lost to Follow-up|2|||
155738671|NCT01120717|562143598|FG001|Overall Study|Lost to Follow-up|3|||
155738672|NCT01120717|562143597|FG000|Overall Study|Death|3|||
155738673|NCT01120717|562143598|FG001|Overall Study|Death|1|||
155738674|NCT01120717|562143597|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155738675|NCT01120717|562143598|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155738676|NCT00947882|562143603|FG000|Overall Study|Adverse Event|0|||
155738677|NCT00947882|562143604|FG001|Overall Study|Adverse Event|1|||
155738678|NCT00947882|562143605|FG002|Overall Study|Adverse Event|4|||
155738679|NCT00947882|562143606|FG003|Overall Study|Adverse Event|4|||
155738680|NCT00947882|562143603|FG000|Overall Study|Withdrawal by Subject|2|||
155738681|NCT00947882|562143604|FG001|Overall Study|Withdrawal by Subject|0|||
155738682|NCT00947882|562143605|FG002|Overall Study|Withdrawal by Subject|8|||
155738683|NCT00947882|562143606|FG003|Overall Study|Withdrawal by Subject|2|||
155738684|NCT00947882|562143603|FG000|Overall Study|Protocol Violation|0|||
155738685|NCT00947882|562143604|FG001|Overall Study|Protocol Violation|0|||
155738686|NCT00947882|562143605|FG002|Overall Study|Protocol Violation|1|||
155738687|NCT00947882|562143606|FG003|Overall Study|Protocol Violation|0|||
155738688|NCT00947882|562143603|FG000|Overall Study|Lost to Follow-up|0|||
155738689|NCT00947882|562143604|FG001|Overall Study|Lost to Follow-up|2|||
155738690|NCT00947882|562143605|FG002|Overall Study|Lost to Follow-up|1|||
155738691|NCT00947882|562143606|FG003|Overall Study|Lost to Follow-up|0|||
155738692|NCT00947882|562143603|FG000|Overall Study|Other/Unknown|10|||
155738693|NCT00947882|562143604|FG001|Overall Study|Other/Unknown|13|||
155738694|NCT00947882|562143605|FG002|Overall Study|Other/Unknown|3|||
155738695|NCT00947882|562143606|FG003|Overall Study|Other/Unknown|6|||
155738696|NCT00947882|562143603|FG000|Overall Study|Trial Terminated by Sponsor|62|||
155738697|NCT00947882|562143604|FG001|Overall Study|Trial Terminated by Sponsor|61|||
155738698|NCT00947882|562143605|FG002|Overall Study|Trial Terminated by Sponsor|62|||
155738699|NCT00947882|562143606|FG003|Overall Study|Trial Terminated by Sponsor|70|||
155738700|NCT00329797|562143607|FG000|Overall Study|Protocol Violation|1|||
155738701|NCT00329797|562143608|FG001|Overall Study|Protocol Violation|0|||
155738702|NCT00329797|562143607|FG000|Overall Study|Withdrawal by Subject|6|||
155738703|NCT00329797|562143608|FG001|Overall Study|Withdrawal by Subject|6|||
155738704|NCT02447302|562143618|FG000|Overall Study|Physician Decision|1|||
155738705|NCT02447302|562143619|FG001|Overall Study|Physician Decision|0|||
155738706|NCT02447302|562143620|FG002|Overall Study|Physician Decision|0|||
155738707|NCT02447302|562143618|FG000|Overall Study|Adverse Event|4|||
155738708|NCT02447302|562143619|FG001|Overall Study|Adverse Event|3|||
155738709|NCT02447302|562143620|FG002|Overall Study|Adverse Event|0|||
155738710|NCT02447302|562143618|FG000|Overall Study|Withdrawal by Subject|0|||
155738711|NCT02447302|562143619|FG001|Overall Study|Withdrawal by Subject|1|||
155738712|NCT02447302|562143620|FG002|Overall Study|Withdrawal by Subject|5|||
155738713|NCT02447302|562143618|FG000|Overall Study|Sponsor Decision|0|||
155738714|NCT02447302|562143619|FG001|Overall Study|Sponsor Decision|0|||
155738715|NCT02447302|562143620|FG002|Overall Study|Sponsor Decision|1|||
155738716|NCT02791763|562143621|FG000|Overall Study|Protocol Violation|0|||
155738717|NCT02791763|562143622|FG001|Overall Study|Protocol Violation|0|||
155738718|NCT02791763|562143623|FG002|Overall Study|Protocol Violation|1|||
155738719|NCT02791763|562143621|FG000|Overall Study|Withdrawal by Subject|5|||
155738720|NCT02791763|562143622|FG001|Overall Study|Withdrawal by Subject|1|||
155738721|NCT02791763|562143623|FG002|Overall Study|Withdrawal by Subject|0|||
155738722|NCT02791763|562143621|FG000|Overall Study|Physician Decision|0|||
155738723|NCT02791763|562143622|FG001|Overall Study|Physician Decision|1|||
155738724|NCT02791763|562143623|FG002|Overall Study|Physician Decision|0|||
155738725|NCT02791763|562143621|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
155738726|NCT02791763|562143622|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
155738727|NCT02791763|562143623|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
155738728|NCT02791763|562143621|FG000|Overall Study|Cancer event|1|||
155738729|NCT02791763|562143622|FG001|Overall Study|Cancer event|3|||
155738730|NCT02791763|562143623|FG002|Overall Study|Cancer event|0|||
155738731|NCT02791763|562143621|FG000|Overall Study|Participant had renal transplant|3|||
155738732|NCT02791763|562143622|FG001|Overall Study|Participant had renal transplant|0|||
155738733|NCT02791763|562143623|FG002|Overall Study|Participant had renal transplant|0|||
155738734|NCT02791763|562143621|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
155738735|NCT02791763|562143622|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
155738736|NCT02791763|562143623|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
155738737|NCT02791763|562143621|FG000|Overall Study|Adverse Event|12|||
155738738|NCT02791763|562143622|FG001|Overall Study|Adverse Event|13|||
155738739|NCT02791763|562143623|FG002|Overall Study|Adverse Event|7|||
155738740|NCT05334212|562143624|FG000|Overall Study|Study terminated prematurely|7|||
155738741|NCT00910299|562143625|FG000|Overall Study|Withdrawal by Subject|16|||
155738742|NCT00910299|562143626|FG001|Overall Study|Withdrawal by Subject|13|||
155738743|NCT00910299|562143625|FG000|Overall Study|Sponsor Decision|58|||
155738744|NCT00910299|562143626|FG001|Overall Study|Sponsor Decision|60|||
155738745|NCT00910299|562143625|FG000|Overall Study|Didn't receive any study drug|2|||
155738746|NCT00910299|562143626|FG001|Overall Study|Didn't receive any study drug|1|||
155738747|NCT01456897|562143627|FG000|Overall Study|Adverse Event|19|||
155738748|NCT01456897|562143628|FG001|Overall Study|Adverse Event|22|||
155738749|NCT01456897|562143627|FG000|Overall Study|Protocol Violation|3|||
155738750|NCT01456897|562143628|FG001|Overall Study|Protocol Violation|4|||
155738751|NCT01456897|562143627|FG000|Overall Study|Physician Decision|5|||
155738752|NCT01456897|562143628|FG001|Overall Study|Physician Decision|3|||
155738753|NCT01456897|562143627|FG000|Overall Study|Withdrawal by Subject|44|||
155738754|NCT01456897|562143628|FG001|Overall Study|Withdrawal by Subject|17|||
155738755|NCT01456897|562143627|FG000|Overall Study|Lack of Efficacy|4|||
155738756|NCT01456897|562143628|FG001|Overall Study|Lack of Efficacy|11|||
155738757|NCT02695420|562143629|FG000|Overall Study|Death|0|||
155738758|NCT02695420|562143630|FG001|Overall Study|Death|1|||
155738759|NCT02695420|562143631|FG002|Overall Study|Death|0|||
155738760|NCT02695420|562143632|FG003|Overall Study|Death|0|||
155738761|NCT00916929|562143633|FG000|Overall Study|Lost to Follow-up|1|||
155738762|NCT00916929|562143634|FG001|Overall Study|Lost to Follow-up|3|||
155738763|NCT00916929|562143633|FG000|Overall Study|Death|5|||
155738764|NCT00916929|562143634|FG001|Overall Study|Death|10|||
155738765|NCT00916929|562143633|FG000|Overall Study|Withdrawal by Subject|1|||
155738766|NCT00916929|562143634|FG001|Overall Study|Withdrawal by Subject|5|||
155738767|NCT00916929|562143633|FG000|Overall Study|Left ventricular epicardial lead|1|||
155738768|NCT00916929|562143634|FG001|Overall Study|Left ventricular epicardial lead|2|||
155738769|NCT00916929|562143633|FG000|Overall Study|Transferred to hospice care|1|||
155738770|NCT00916929|562143634|FG001|Overall Study|Transferred to hospice care|1|||
155738771|NCT00916929|562143633|FG000|Overall Study|System explant|1|||
155738772|NCT00916929|562143634|FG001|Overall Study|System explant|0|||
155738773|NCT00916929|562143633|FG000|Overall Study|Moved to another state|0|||
155738774|NCT00916929|562143634|FG001|Overall Study|Moved to another state|1|||
155738775|NCT00916929|562143633|FG000|Overall Study|Device unable to process impedance data|0|||
155738776|NCT00916929|562143634|FG001|Overall Study|Device unable to process impedance data|7|||
155738777|NCT02929407|562143635|FG000|Overall Study|Adverse Event|1|||
155738778|NCT04530136|562143636|FG000|Overall Study|Lost to Follow-up|2|||
155738779|NCT04530136|562143637|FG001|Overall Study|Lost to Follow-up|3|||
155738780|NCT04530136|562143636|FG000|Overall Study|Withdrawal by Subject|1|||
155738781|NCT04530136|562143637|FG001|Overall Study|Withdrawal by Subject|0|||
155738782|NCT04530136|562143636|FG000|Overall Study|Death|0|||
155738783|NCT04530136|562143637|FG001|Overall Study|Death|1|||
155738784|NCT01057589|562143640|FG000|Overall Study|Disease Progression|35|||
155738785|NCT01057589|562143640|FG000|Overall Study|Adverse Event|10|||
155738786|NCT01057589|562143640|FG000|Overall Study|Physician Decision|8|||
155738787|NCT01057589|562143640|FG000|Overall Study|Withdrawal by Subject|3|||
155738788|NCT01057589|562143640|FG000|Overall Study|Sponsor Decision|1|||
155738789|NCT01057589|562143640|FG000|Overall Study|Death|8|||
155738790|NCT01057589|562143640|FG000|Overall Study|Lost to Follow-up|1|||
155738791|NCT02055118|562143641|FG000|Overall Study|Withdrawal by Subject|0|||
155738792|NCT02055118|562143642|FG001|Overall Study|Withdrawal by Subject|2|||
155738793|NCT02055118|562143643|FG002|Overall Study|Withdrawal by Subject|0|||
155738794|NCT02281383|562143645|FG000|Overall Study|Progressive Disease|1|||
155738795|NCT02281383|562143645|FG000|Overall Study|Withdrawal by Subject|6|||
155738796|NCT02281383|562143645|FG000|Overall Study|Protocol Violation|2|||
155738797|NCT02281383|562143645|FG000|Overall Study|Death|1|||
155738798|NCT02281383|562143645|FG000|Overall Study|Adverse Event|2|||
155738799|NCT00472030|562143662|FG000|Overall Study|Physician Decision|1|||
155738800|NCT00472030|562143663|FG001|Overall Study|Physician Decision|0|||
155738801|NCT00829504|562143664|FG000|First Intervention|Adverse Event|1|||
155738802|NCT00829504|562143665|FG001|First Intervention|Adverse Event|0|||
155738803|NCT00829504|562143664|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155738804|NCT00829504|562143665|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155738805|NCT00829504|562143664|FG000|Second Intervention|Physician Decision|1|||
155738806|NCT00829504|562143665|FG001|Second Intervention|Physician Decision|0|||
155738807|NCT01031836|562145428|FG000|Stage I|Adverse Event|1|||
155738808|NCT01031836|562145429|FG001|Stage I|Adverse Event|1|||
155738809|NCT01031836|562145430|FG002|Stage I|Adverse Event|0|||
155738810|NCT01031836|562145431|FG003|Stage I|Adverse Event|0|||
155738811|NCT01031836|562145432|FG004|Stage I|Adverse Event|0|||
155738812|NCT01031836|562145433|FG005|Stage I|Adverse Event|0|||
155738813|NCT01031836|562145428|FG000|Stage I|Other|0|||
155738814|NCT01031836|562145429|FG001|Stage I|Other|1|||
155738815|NCT01031836|562145430|FG002|Stage I|Other|0|||
155738816|NCT01031836|562145431|FG003|Stage I|Other|0|||
155738817|NCT01031836|562145432|FG004|Stage I|Other|0|||
155738818|NCT01031836|562145433|FG005|Stage I|Other|1|||
155738819|NCT01031836|562145428|FG000|Stage II|Adverse Event|0|||
155738820|NCT01031836|562145429|FG001|Stage II|Adverse Event|0|||
155738821|NCT01031836|562145430|FG002|Stage II|Adverse Event|2|||
155738822|NCT01031836|562145431|FG003|Stage II|Adverse Event|2|||
155738823|NCT01031836|562145432|FG004|Stage II|Adverse Event|1|||
155738824|NCT01031836|562145433|FG005|Stage II|Adverse Event|1|||
155738825|NCT01031836|562145428|FG000|Stage II|Other|2|||
155738826|NCT01031836|562145429|FG001|Stage II|Other|0|||
155738827|NCT01031836|562145430|FG002|Stage II|Other|0|||
155634783|NCT01963611|561756144|FG001|Overall Study|Withdrawal by Subject|2|||
155634784|NCT01963611|561756145|FG002|Overall Study|Withdrawal by Subject|1|||
155634785|NCT01963611|561756146|FG003|Overall Study|Withdrawal by Subject|1|||
155634786|NCT01963611|561756147|FG004|Overall Study|Withdrawal by Subject|3|||
155634787|NCT01963611|561756143|FG000|Overall Study|Other|47|||
155634788|NCT01963611|561756144|FG001|Overall Study|Other|46|||
155634789|NCT01963611|561756145|FG002|Overall Study|Other|48|||
155634790|NCT01963611|561756146|FG003|Overall Study|Other|45|||
155634791|NCT01963611|561756147|FG004|Overall Study|Other|45|||
155634792|NCT01126424|561756149|FG000|Overall Study|Adverse Event|0|||
155634793|NCT01126424|561756150|FG001|Overall Study|Adverse Event|0|||
155634794|NCT01126424|561756151|FG002|Overall Study|Adverse Event|0|||
155634795|NCT01126424|561756152|FG003|Overall Study|Adverse Event|0|||
155634796|NCT01126424|561756153|FG004|Overall Study|Adverse Event|1|||
155634797|NCT01126424|561756154|FG005|Overall Study|Adverse Event|0|||
155634798|NCT01126424|561756149|FG000|Overall Study|Withdrawal by Subject|0|||
155634799|NCT01126424|561756150|FG001|Overall Study|Withdrawal by Subject|0|||
155634800|NCT01126424|561756151|FG002|Overall Study|Withdrawal by Subject|1|||
155634801|NCT01126424|561756152|FG003|Overall Study|Withdrawal by Subject|3|||
155634802|NCT01126424|561756153|FG004|Overall Study|Withdrawal by Subject|1|||
155634803|NCT01126424|561756154|FG005|Overall Study|Withdrawal by Subject|0|||
155634804|NCT02127671|561756155|FG000|Overall Study|Death|2|||
155634805|NCT02127671|561756156|FG001|Overall Study|Death|2|||
155634806|NCT02127671|561756155|FG000|Overall Study|Lost to Follow-up|4|||
155634807|NCT02127671|561756156|FG001|Overall Study|Lost to Follow-up|2|||
155634808|NCT02127671|561756155|FG000|Overall Study|Physician Decision|1|||
155634809|NCT02127671|561756156|FG001|Overall Study|Physician Decision|0|||
155634810|NCT02127671|561756155|FG000|Overall Study|incarceration|0|||
155634811|NCT02127671|561756156|FG001|Overall Study|incarceration|1|||
155634812|NCT02127671|561756155|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
155634813|NCT02127671|561756156|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
155634814|NCT02394275|561756157|FG000|Overall Study|Adverse Event|22|||
155634815|NCT02394275|561756157|FG000|Overall Study|Lost to Follow-up|7|||
155634816|NCT00782067|561756159|FG000|Overall Study|Adverse Event|35|||
155634817|NCT00782067|561756159|FG000|Overall Study|Subject withdrew consent|11|||
155634818|NCT00782067|561756159|FG000|Overall Study|Lost to Follow-up|2|||
155634819|NCT00782067|561756159|FG000|Overall Study|Administrative problems|14|||
155634820|NCT00782067|561756159|FG000|Overall Study|Death|9|||
155634821|NCT00782067|561756159|FG000|Overall Study|Disease progression|43|||
155634822|NCT00782067|561756159|FG000|Overall Study|Protocol deviation|2|||
155634823|NCT02328105|561756160|FG000|Overall Study|Death|6|||
155634824|NCT02328105|561756160|FG000|Overall Study|Withdrawal by Subject|1|||
155634825|NCT02328105|561756160|FG000|Overall Study|Still On Study in Follow-Up|4|||
155634826|NCT00614393|561756161|FG000|Overall Study|Adverse Event|20|||
155634827|NCT00614393|561756162|FG001|Overall Study|Adverse Event|2|||
155634828|NCT00614393|561756163|FG002|Overall Study|Adverse Event|3|||
155634829|NCT00614393|561756164|FG003|Overall Study|Adverse Event|13|||
155634830|NCT00614393|561756165|FG004|Overall Study|Adverse Event|21|||
155634831|NCT00614393|561756161|FG000|Overall Study|Lost to Follow-up|0|||
155634832|NCT00614393|561756162|FG001|Overall Study|Lost to Follow-up|0|||
155634833|NCT00614393|561756163|FG002|Overall Study|Lost to Follow-up|0|||
155634834|NCT00614393|561756164|FG003|Overall Study|Lost to Follow-up|1|||
155634835|NCT00614393|561756165|FG004|Overall Study|Lost to Follow-up|2|||
155634836|NCT00614393|561756161|FG000|Overall Study|Physician Decision|17|||
155634837|NCT00614393|561756162|FG001|Overall Study|Physician Decision|0|||
155634838|NCT00614393|561756163|FG002|Overall Study|Physician Decision|1|||
155634839|NCT00614393|561756164|FG003|Overall Study|Physician Decision|8|||
155634840|NCT00614393|561756165|FG004|Overall Study|Physician Decision|9|||
155634841|NCT00614393|561756161|FG000|Overall Study|Progressive Disease|118|||
155634842|NCT00614393|561756162|FG001|Overall Study|Progressive Disease|5|||
155634843|NCT00614393|561756163|FG002|Overall Study|Progressive Disease|5|||
155634844|NCT00614393|561756164|FG003|Overall Study|Progressive Disease|138|||
155634845|NCT00614393|561756165|FG004|Overall Study|Progressive Disease|130|||
155634846|NCT00614393|561756161|FG000|Overall Study|Protocol Violation|1|||
155634847|NCT00614393|561756162|FG001|Overall Study|Protocol Violation|0|||
155634848|NCT00614393|561756163|FG002|Overall Study|Protocol Violation|0|||
155634849|NCT00614393|561756164|FG003|Overall Study|Protocol Violation|0|||
155634850|NCT00614393|561756165|FG004|Overall Study|Protocol Violation|0|||
155634851|NCT00614393|561756161|FG000|Overall Study|Terminated by Sponsor|0|||
155634852|NCT00614393|561756162|FG001|Overall Study|Terminated by Sponsor|0|||
155634853|NCT00614393|561756163|FG002|Overall Study|Terminated by Sponsor|0|||
155634854|NCT00614393|561756164|FG003|Overall Study|Terminated by Sponsor|0|||
155634855|NCT00614393|561756165|FG004|Overall Study|Terminated by Sponsor|1|||
155634856|NCT00614393|561756161|FG000|Overall Study|Withdrawal by Subject|20|||
155634857|NCT00614393|561756162|FG001|Overall Study|Withdrawal by Subject|1|||
155634858|NCT00614393|561756163|FG002|Overall Study|Withdrawal by Subject|1|||
155634859|NCT00614393|561756164|FG003|Overall Study|Withdrawal by Subject|16|||
155634860|NCT00614393|561756165|FG004|Overall Study|Withdrawal by Subject|13|||
155634861|NCT00614393|561756161|FG000|Overall Study|Other|4|||
155634862|NCT00614393|561756162|FG001|Overall Study|Other|0|||
155738828|NCT01031836|562145431|FG003|Stage II|Other|1|||
155738829|NCT01031836|562145432|FG004|Stage II|Other|1|||
155738830|NCT01031836|562145433|FG005|Stage II|Other|0|||
155738831|NCT01696929|562145436|FG000|Overall Study|Physician Decision|1|||
155738832|NCT02051933|562145437|FG000|Overall Study|Physician Decision|0|||
155738833|NCT02051933|562145438|FG001|Overall Study|Physician Decision|1|||
155738834|NCT00588861|562145442|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
155738835|NCT00588861|562145443|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
155738836|NCT00588861|562145442|FG000|6 Months|Patients did not return for follow-up|98|||
155738837|NCT00588861|562145443|FG001|6 Months|Patients did not return for follow-up|73|||
155738838|NCT00588861|562145442|FG000|1 Year|Patients did not return for follow-up|89|||
155738839|NCT00588861|562145443|FG001|1 Year|Patients did not return for follow-up|82|||
155738840|NCT00588861|562145442|FG000|2 Years|Patients did not return for follow-up|92|||
155738841|NCT00588861|562145443|FG001|2 Years|Patients did not return for follow-up|87|||
155738842|NCT00588861|562145442|FG000|4 Years|Patients did not return for follow-up|91|||
155738843|NCT00588861|562145443|FG001|4 Years|Patients did not return for follow-up|103|||
155738844|NCT00588861|562145442|FG000|6 Years|Patients did not return for follow-up|104|||
155738845|NCT00588861|562145443|FG001|6 Years|Patients did not return for follow-up|109|||
155738846|NCT00588861|562145442|FG000|8 Years|Patients did not return for follow-up|105|||
155738847|NCT00588861|562145443|FG001|8 Years|Patients did not return for follow-up|114|||
155738848|NCT00588861|562145442|FG000|10 Years|Incomplete due to study termination|107|||
155738849|NCT00588861|562145443|FG001|10 Years|Incomplete due to study termination|114|||
155738850|NCT01129583|562145449|FG000|Overall Study|Death|1|||
155738851|NCT01129583|562145450|FG001|Overall Study|Death|0|||
155738852|NCT01129583|562145449|FG000|Overall Study|Lost to Follow-up|1|||
155738853|NCT01129583|562145450|FG001|Overall Study|Lost to Follow-up|1|||
155738854|NCT01129583|562145449|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
155738855|NCT01129583|562145450|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
155738856|NCT02338882|562145451|FG000|Overall Study|Death|1|||
155738857|NCT02338882|562145452|FG001|Overall Study|Death|0|||
155738858|NCT02338882|562145451|FG000|Overall Study|Lost to Follow-up|6|||
155738859|NCT02338882|562145452|FG001|Overall Study|Lost to Follow-up|3|||
155738860|NCT02617485|562145462|FG000|Treatment and Observation Period|Adverse Event|9|||
155738861|NCT02617485|562145463|FG001|Treatment and Observation Period|Adverse Event|1|||
155738862|NCT02617485|562145462|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
155738863|NCT02617485|562145463|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
155738864|NCT02617485|562145462|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
155738865|NCT02617485|562145463|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
155738866|NCT02617485|562145462|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
155738867|NCT02617485|562145463|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
155738868|NCT02617485|562145462|FG000|Treatment and Observation Period|Physician Decision|0|||
155738869|NCT02617485|562145463|FG001|Treatment and Observation Period|Physician Decision|1|||
155738870|NCT02617485|562145462|FG000|Follow-up Period|Adverse Event|1|||
155738871|NCT02617485|562145463|FG001|Follow-up Period|Adverse Event|0|||
155738872|NCT02617485|562145462|FG000|Follow-up Period|Withdrawal by Subject|1|||
155738873|NCT02617485|562145463|FG001|Follow-up Period|Withdrawal by Subject|0|||
155738874|NCT02617485|562145462|FG000|Follow-up Period|Disease progression|2|||
155738875|NCT02617485|562145463|FG001|Follow-up Period|Disease progression|1|||
155738876|NCT02617485|562145462|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
155738877|NCT02617485|562145463|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
155738878|NCT02617485|562145462|FG000|Follow-up Period|Patient needed radiotherapy|9|||
155738879|NCT02617485|562145463|FG001|Follow-up Period|Patient needed radiotherapy|5|||
155738880|NCT02617485|562145462|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
155738881|NCT02617485|562145463|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
155738882|NCT00220779|562145467|FG000|Overall Study|Adverse Event|1|||
155738883|NCT00220779|562145468|FG001|Overall Study|Adverse Event|0|||
155738884|NCT00220779|562145469|FG002|Overall Study|Adverse Event|0|||
155738885|NCT00220779|562145467|FG000|Overall Study|Withdrawal by Subject|1|||
155738886|NCT00220779|562145468|FG001|Overall Study|Withdrawal by Subject|4|||
155738887|NCT00220779|562145469|FG002|Overall Study|Withdrawal by Subject|1|||
155738888|NCT00220779|562145467|FG000|Overall Study|Non-compliance|1|||
155738889|NCT00220779|562145468|FG001|Overall Study|Non-compliance|0|||
155738890|NCT00220779|562145469|FG002|Overall Study|Non-compliance|0|||
155738891|NCT00220779|562145467|FG000|Overall Study|Too time consuming|1|||
155738892|NCT00220779|562145468|FG001|Overall Study|Too time consuming|0|||
155738893|NCT00220779|562145469|FG002|Overall Study|Too time consuming|0|||
155738894|NCT00220779|562145467|FG000|Overall Study|Pregnancy|0|||
155738895|NCT00220779|562145468|FG001|Overall Study|Pregnancy|0|||
155738896|NCT00220779|562145469|FG002|Overall Study|Pregnancy|2|||
155738897|NCT00220779|562145467|FG000|Overall Study|Lack of Efficacy|3|||
155738898|NCT00220779|562145468|FG001|Overall Study|Lack of Efficacy|0|||
155738899|NCT00220779|562145469|FG002|Overall Study|Lack of Efficacy|1|||
155738900|NCT00791076|562145470|FG000|Overall Study|Study was terminated,PI left institution|8|||
155738901|NCT02248675|562145478|FG000|Overall Study|Lost to Follow-up|3|||
155738902|NCT02248675|562145479|FG001|Overall Study|Lost to Follow-up|1|||
155738903|NCT00830869|562145480|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
155738904|NCT00830869|562145481|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
155738905|NCT00830869|562145482|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
155738906|NCT00830869|562145483|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
155738907|NCT00830869|562145484|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
155738908|NCT00830869|562145485|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
155738909|NCT00830869|562145486|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
155738910|NCT00830869|562145487|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
155738911|NCT00830869|562145488|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
155738912|NCT00830869|562145489|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
155738913|NCT00830869|562145490|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
155738914|NCT00830869|562145491|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
155738915|NCT00830869|562145480|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
155738916|NCT00830869|562145481|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
155738917|NCT00830869|562145482|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
155738918|NCT00830869|562145483|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
155738919|NCT00830869|562145484|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
155738920|NCT00830869|562145485|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
155738921|NCT00830869|562145486|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
155738922|NCT00830869|562145487|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
155738923|NCT00830869|562145488|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
155738924|NCT00830869|562145489|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
155738925|NCT00830869|562145490|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
155738926|NCT00830869|562145491|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
155738927|NCT00830869|562145480|FG000|Period 1: Part 1|Adverse Event|0|||
155738928|NCT00830869|562145481|FG001|Period 1: Part 1|Adverse Event|0|||
155738929|NCT00830869|562145482|FG002|Period 1: Part 1|Adverse Event|0|||
155738930|NCT00830869|562145483|FG003|Period 1: Part 1|Adverse Event|0|||
155738931|NCT00830869|562145484|FG004|Period 1: Part 1|Adverse Event|0|||
155738932|NCT00830869|562145485|FG005|Period 1: Part 1|Adverse Event|1|||
155738933|NCT00830869|562145486|FG006|Period 1: Part 1|Adverse Event|1|||
155738934|NCT00830869|562145487|FG007|Period 1: Part 1|Adverse Event|0|||
155738935|NCT00830869|562145488|FG008|Period 1: Part 1|Adverse Event|0|||
155738936|NCT00830869|562145489|FG009|Period 1: Part 1|Adverse Event|0|||
155738937|NCT00830869|562145490|FG010|Period 1: Part 1|Adverse Event|0|||
155738938|NCT00830869|562145491|FG011|Period 1: Part 1|Adverse Event|0|||
155738939|NCT00830869|562145480|FG000|Period 1: Part 1|Progressive disease|1|||
155738940|NCT00830869|562145481|FG001|Period 1: Part 1|Progressive disease|0|||
155738941|NCT00830869|562145482|FG002|Period 1: Part 1|Progressive disease|1|||
155738942|NCT00830869|562145483|FG003|Period 1: Part 1|Progressive disease|6|||
155738943|NCT00830869|562145484|FG004|Period 1: Part 1|Progressive disease|4|||
155738944|NCT00830869|562145485|FG005|Period 1: Part 1|Progressive disease|4|||
155738945|NCT00830869|562145486|FG006|Period 1: Part 1|Progressive disease|1|||
155738946|NCT00830869|562145487|FG007|Period 1: Part 1|Progressive disease|0|||
155738947|NCT00830869|562145488|FG008|Period 1: Part 1|Progressive disease|0|||
155738948|NCT00830869|562145489|FG009|Period 1: Part 1|Progressive disease|0|||
155738949|NCT00830869|562145490|FG010|Period 1: Part 1|Progressive disease|0|||
155738950|NCT00830869|562145491|FG011|Period 1: Part 1|Progressive disease|0|||
155738951|NCT00830869|562145480|FG000|Period 2: Part 2|Protocol Violation|0|||
155738952|NCT00830869|562145481|FG001|Period 2: Part 2|Protocol Violation|0|||
155738953|NCT00830869|562145482|FG002|Period 2: Part 2|Protocol Violation|0|||
155738954|NCT00830869|562145483|FG003|Period 2: Part 2|Protocol Violation|0|||
155738955|NCT00830869|562145484|FG004|Period 2: Part 2|Protocol Violation|0|||
155738956|NCT00830869|562145485|FG005|Period 2: Part 2|Protocol Violation|0|||
155738957|NCT00830869|562145486|FG006|Period 2: Part 2|Protocol Violation|0|||
155738958|NCT00830869|562145487|FG007|Period 2: Part 2|Protocol Violation|1|||
155738959|NCT00830869|562145488|FG008|Period 2: Part 2|Protocol Violation|0|||
155738960|NCT00830869|562145489|FG009|Period 2: Part 2|Protocol Violation|1|||
155738961|NCT00830869|562145490|FG010|Period 2: Part 2|Protocol Violation|0|||
155738962|NCT00830869|562145491|FG011|Period 2: Part 2|Protocol Violation|0|||
155738963|NCT00830869|562145480|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
155738964|NCT00830869|562145481|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
155738965|NCT00830869|562145482|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
155738966|NCT00830869|562145483|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
155738967|NCT00830869|562145484|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
155738968|NCT00830869|562145485|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
155738969|NCT00830869|562145486|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
155738970|NCT00830869|562145487|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
155738971|NCT00830869|562145488|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
155738972|NCT00830869|562145489|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
155738973|NCT00830869|562145490|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
155738974|NCT00830869|562145491|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
155738975|NCT00830869|562145480|FG000|Period 2: Part 2|Adverse Event|0|||
155738976|NCT00830869|562145481|FG001|Period 2: Part 2|Adverse Event|0|||
155738977|NCT00830869|562145482|FG002|Period 2: Part 2|Adverse Event|0|||
155738978|NCT00830869|562145483|FG003|Period 2: Part 2|Adverse Event|0|||
155738979|NCT00830869|562145484|FG004|Period 2: Part 2|Adverse Event|0|||
155738980|NCT00830869|562145485|FG005|Period 2: Part 2|Adverse Event|0|||
155738981|NCT00830869|562145486|FG006|Period 2: Part 2|Adverse Event|0|||
155738982|NCT00830869|562145487|FG007|Period 2: Part 2|Adverse Event|4|||
155738983|NCT00830869|562145488|FG008|Period 2: Part 2|Adverse Event|3|||
155738984|NCT00830869|562145489|FG009|Period 2: Part 2|Adverse Event|2|||
155738985|NCT00830869|562145490|FG010|Period 2: Part 2|Adverse Event|2|||
155738986|NCT00830869|562145491|FG011|Period 2: Part 2|Adverse Event|0|||
155738987|NCT00830869|562145480|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
155738988|NCT00830869|562145481|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
155738989|NCT00830869|562145482|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
155738990|NCT00830869|562145483|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
155738991|NCT00830869|562145484|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
155738992|NCT00830869|562145485|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
155738993|NCT00830869|562145486|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
155738994|NCT00830869|562145487|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
155738995|NCT00830869|562145488|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
155738996|NCT00830869|562145489|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
155738997|NCT00830869|562145490|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
155738998|NCT00830869|562145491|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
155738999|NCT00830869|562145480|FG000|Period 2: Part 2|Progressive disease|0|||
155739000|NCT00830869|562145481|FG001|Period 2: Part 2|Progressive disease|0|||
155739001|NCT00830869|562145482|FG002|Period 2: Part 2|Progressive disease|0|||
155739002|NCT00830869|562145483|FG003|Period 2: Part 2|Progressive disease|0|||
155739003|NCT00830869|562145484|FG004|Period 2: Part 2|Progressive disease|0|||
155739004|NCT00830869|562145485|FG005|Period 2: Part 2|Progressive disease|0|||
155739005|NCT00830869|562145486|FG006|Period 2: Part 2|Progressive disease|0|||
155739006|NCT00830869|562145487|FG007|Period 2: Part 2|Progressive disease|14|||
155739007|NCT00830869|562145488|FG008|Period 2: Part 2|Progressive disease|11|||
155739008|NCT00830869|562145489|FG009|Period 2: Part 2|Progressive disease|12|||
155739009|NCT00830869|562145490|FG010|Period 2: Part 2|Progressive disease|8|||
155739010|NCT00830869|562145491|FG011|Period 2: Part 2|Progressive disease|15|||
155739011|NCT00830869|562145480|FG000|Period 2: Part 2|Other|0|||
155739012|NCT00830869|562145481|FG001|Period 2: Part 2|Other|0|||
155739013|NCT00830869|562145482|FG002|Period 2: Part 2|Other|0|||
155739014|NCT00830869|562145483|FG003|Period 2: Part 2|Other|0|||
155739015|NCT00830869|562145484|FG004|Period 2: Part 2|Other|0|||
155739016|NCT00830869|562145485|FG005|Period 2: Part 2|Other|0|||
155739017|NCT00830869|562145486|FG006|Period 2: Part 2|Other|0|||
155739018|NCT00830869|562145487|FG007|Period 2: Part 2|Other|0|||
155739019|NCT00830869|562145488|FG008|Period 2: Part 2|Other|0|||
155739020|NCT00830869|562145489|FG009|Period 2: Part 2|Other|1|||
155739021|NCT00830869|562145490|FG010|Period 2: Part 2|Other|0|||
155739022|NCT00830869|562145491|FG011|Period 2: Part 2|Other|0|||
155739023|NCT00617669|562145492|FG000|Overall Study|Withdrawal by Subject|71|||
155739024|NCT00617669|562145493|FG001|Overall Study|Withdrawal by Subject|77|||
155739025|NCT00617669|562145492|FG000|Overall Study|Lost to Follow-up|3|||
155739026|NCT00617669|562145493|FG001|Overall Study|Lost to Follow-up|2|||
155739027|NCT00617669|562145492|FG000|Overall Study|Adverse Event|87|||
155739028|NCT00617669|562145493|FG001|Overall Study|Adverse Event|76|||
155739029|NCT00617669|562145492|FG000|Overall Study|Protocol Violation|2|||
155739030|NCT00617669|562145493|FG001|Overall Study|Protocol Violation|3|||
155739031|NCT00617669|562145492|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
155739032|NCT00617669|562145493|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
155739033|NCT00617669|562145492|FG000|Overall Study|Patients randomized but not treated|2|||
155739034|NCT00617669|562145493|FG001|Overall Study|Patients randomized but not treated|3|||
155739035|NCT03745820|562145496|FG000|Overall Study|Adverse Event|0|||
155739036|NCT03745820|562145497|FG001|Overall Study|Adverse Event|3|||
155739037|NCT03745820|562145498|FG002|Overall Study|Adverse Event|2|||
155739038|NCT03745820|562145496|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155739039|NCT03745820|562145497|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155739040|NCT03745820|562145498|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155739041|NCT03745820|562145496|FG000|Overall Study|Withdrawal by Subject|4|||
155739042|NCT03745820|562145497|FG001|Overall Study|Withdrawal by Subject|4|||
155739043|NCT03745820|562145498|FG002|Overall Study|Withdrawal by Subject|4|||
155739044|NCT03745820|562145496|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
155739045|NCT03745820|562145497|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
155739046|NCT03745820|562145498|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
155739047|NCT03745820|562145496|FG000|Overall Study|Lost to Follow-up|2|||
155739048|NCT03745820|562145497|FG001|Overall Study|Lost to Follow-up|0|||
155739049|NCT03745820|562145498|FG002|Overall Study|Lost to Follow-up|3|||
155739050|NCT03745820|562145496|FG000|Overall Study|Reason not Specified|2|||
155739051|NCT03745820|562145497|FG001|Overall Study|Reason not Specified|4|||
155739052|NCT03745820|562145498|FG002|Overall Study|Reason not Specified|1|||
155739053|NCT00281658|562145499|FG000|Randomized Phase|Adverse Event|0|||
155739054|NCT00281658|562145500|FG001|Randomized Phase|Adverse Event|2|||
155739055|NCT00281658|562145501|FG002|Randomized Phase|Adverse Event|0|||
155739056|NCT00281658|562145502|FG003|Randomized Phase|Adverse Event|0|||
155739057|NCT00281658|562145499|FG000|Randomized Phase|Lost to Follow-up|34|||
155739058|NCT00281658|562145500|FG001|Randomized Phase|Lost to Follow-up|27|||
155739059|NCT00281658|562145501|FG002|Randomized Phase|Lost to Follow-up|0|||
155739060|NCT00281658|562145502|FG003|Randomized Phase|Lost to Follow-up|0|||
155739061|NCT00281658|562145499|FG000|Randomized Phase|Withdrawal by Subject|8|||
155739062|NCT00281658|562145500|FG001|Randomized Phase|Withdrawal by Subject|7|||
155739063|NCT00281658|562145501|FG002|Randomized Phase|Withdrawal by Subject|0|||
155739064|NCT00281658|562145502|FG003|Randomized Phase|Withdrawal by Subject|0|||
155739065|NCT00281658|562145499|FG000|Randomized Phase|Study closed/terminated|1|||
155739066|NCT00281658|562145500|FG001|Randomized Phase|Study closed/terminated|1|||
155739067|NCT00281658|562145501|FG002|Randomized Phase|Study closed/terminated|0|||
155739068|NCT00281658|562145502|FG003|Randomized Phase|Study closed/terminated|0|||
155739069|NCT00281658|562145499|FG000|Randomized Phase|Disease progression|36|||
155739070|NCT00281658|562145500|FG001|Randomized Phase|Disease progression|27|||
155739071|NCT00281658|562145501|FG002|Randomized Phase|Disease progression|0|||
155739072|NCT00281658|562145502|FG003|Randomized Phase|Disease progression|0|||
155739073|NCT00281658|562145499|FG000|Randomized Phase|Physician Decision|1|||
155739074|NCT00281658|562145500|FG001|Randomized Phase|Physician Decision|1|||
155739075|NCT00281658|562145501|FG002|Randomized Phase|Physician Decision|0|||
155739076|NCT00281658|562145502|FG003|Randomized Phase|Physician Decision|0|||
155739077|NCT00281658|562145499|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
155739078|NCT00281658|562145500|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
155739079|NCT00281658|562145501|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
155739080|NCT00281658|562145502|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
155739081|NCT00281658|562145499|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
155739082|NCT00281658|562145500|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
155739083|NCT00281658|562145501|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
155739084|NCT00281658|562145502|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
155739085|NCT00281658|562145499|FG000|Randomized Phase|Treatment ongoing|1|||
155739086|NCT00281658|562145500|FG001|Randomized Phase|Treatment ongoing|0|||
155739087|NCT00281658|562145501|FG002|Randomized Phase|Treatment ongoing|0|||
155739088|NCT00281658|562145502|FG003|Randomized Phase|Treatment ongoing|0|||
155739089|NCT00281658|562145499|FG000|Open Label Phase|Adverse Event|0|||
155739090|NCT00281658|562145500|FG001|Open Label Phase|Adverse Event|0|||
155739091|NCT00281658|562145501|FG002|Open Label Phase|Adverse Event|1|||
155739092|NCT00281658|562145502|FG003|Open Label Phase|Adverse Event|0|||
155739093|NCT00281658|562145499|FG000|Open Label Phase|Lost to Follow-up|0|||
155739094|NCT00281658|562145500|FG001|Open Label Phase|Lost to Follow-up|0|||
155739095|NCT00281658|562145501|FG002|Open Label Phase|Lost to Follow-up|16|||
155739096|NCT00281658|562145502|FG003|Open Label Phase|Lost to Follow-up|2|||
155739097|NCT00281658|562145499|FG000|Open Label Phase|Withdrawal by Subject|0|||
155739098|NCT00281658|562145500|FG001|Open Label Phase|Withdrawal by Subject|0|||
155739099|NCT00281658|562145501|FG002|Open Label Phase|Withdrawal by Subject|3|||
155739100|NCT00281658|562145502|FG003|Open Label Phase|Withdrawal by Subject|2|||
155739101|NCT00281658|562145499|FG000|Open Label Phase|Disease progression|0|||
155739102|NCT00281658|562145500|FG001|Open Label Phase|Disease progression|0|||
155739103|NCT00281658|562145501|FG002|Open Label Phase|Disease progression|18|||
155739104|NCT00281658|562145502|FG003|Open Label Phase|Disease progression|0|||
155739105|NCT00281658|562145499|FG000|Open Label Phase|Physician Decision|0|||
155739106|NCT00281658|562145500|FG001|Open Label Phase|Physician Decision|0|||
155739107|NCT00281658|562145501|FG002|Open Label Phase|Physician Decision|1|||
155739108|NCT00281658|562145502|FG003|Open Label Phase|Physician Decision|0|||
155739109|NCT00281658|562145499|FG000|Open Label Phase|Relocation of patient|0|||
155739110|NCT00281658|562145500|FG001|Open Label Phase|Relocation of patient|0|||
155739111|NCT00281658|562145501|FG002|Open Label Phase|Relocation of patient|1|||
155739112|NCT00281658|562145502|FG003|Open Label Phase|Relocation of patient|0|||
155739113|NCT00281658|562145499|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
155739114|NCT00281658|562145500|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
155739115|NCT00281658|562145501|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
155739116|NCT00281658|562145502|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
155739117|NCT00507728|562145503|FG000|Randomization to Month 3|Lost to Follow-up|15|||
155739118|NCT00507728|562145504|FG001|Randomization to Month 3|Lost to Follow-up|14|||
155739119|NCT00507728|562145505|FG002|Randomization to Month 3|Lost to Follow-up|20|||
155739120|NCT00507728|562145503|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
155739121|NCT00507728|562145504|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
155739122|NCT00507728|562145505|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
155739123|NCT02151773|562145506|FG000|Overall Study|Protocol Deviation|64|||
155739124|NCT00095940|562145510|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
155739125|NCT00095940|562145511|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
155739126|NCT00095940|562145512|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
155739127|NCT00095940|562145513|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
155739128|NCT00095940|562145514|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
155739129|NCT00095940|562145515|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
155739130|NCT00095940|562145516|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
155739131|NCT00095940|562145517|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
155739132|NCT00095940|562145518|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
155739133|NCT00095940|562145510|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155739134|NCT00095940|562145511|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155739135|NCT00095940|562145512|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155739136|NCT00095940|562145513|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155739137|NCT00095940|562145514|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155739138|NCT00095940|562145515|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155739139|NCT00095940|562145516|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155739140|NCT00095940|562145517|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155739141|NCT00095940|562145518|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155739142|NCT00095940|562145510|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739143|NCT00095940|562145511|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739144|NCT00095940|562145512|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739145|NCT00095940|562145513|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739146|NCT00095940|562145514|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739147|NCT00095940|562145515|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739148|NCT00095940|562145516|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739149|NCT00095940|562145517|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
155739150|NCT00095940|562145518|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
155739151|NCT02864862|562145521|FG000|Overall Study|Lost to Follow-up|1|||
155739152|NCT02864862|562145522|FG001|Overall Study|Lost to Follow-up|0|||
155739153|NCT02864862|562145523|FG002|Overall Study|Lost to Follow-up|1|||
155739154|NCT02864862|562145521|FG000|Overall Study|Protocol Violation|0|||
155739155|NCT02864862|562145522|FG001|Overall Study|Protocol Violation|0|||
155739156|NCT02864862|562145523|FG002|Overall Study|Protocol Violation|1|||
155739157|NCT01523275|562145524|FG000|Overall Study|Lost to Follow-up|1|||
155739158|NCT01523275|562145525|FG001|Overall Study|Lost to Follow-up|2|||
155739159|NCT01523275|562145524|FG000|Overall Study|Withdrawal by Subject|1|||
155739160|NCT01523275|562145525|FG001|Overall Study|Withdrawal by Subject|0|||
155739161|NCT00966875|562145527|FG000|Part A|Adverse Event|2|||
155739162|NCT00966875|562145528|FG001|Part A|Adverse Event|1|||
155739163|NCT00966875|562145529|FG002|Part A|Adverse Event|0|||
155739164|NCT00966875|562145530|FG003|Part A|Adverse Event|1|||
155739165|NCT00966875|562145531|FG004|Part A|Adverse Event|0|||
155739166|NCT00966875|562145532|FG005|Part A|Adverse Event|1|||
155739167|NCT00966875|562145533|FG006|Part A|Adverse Event|0|||
155739168|NCT00966875|562145534|FG007|Part A|Adverse Event|3|||
155739169|NCT00966875|562145535|FG008|Part A|Adverse Event|3|||
155739170|NCT00966875|562145527|FG000|Part A|Entry Criteria|0|||
155739171|NCT00966875|562145528|FG001|Part A|Entry Criteria|0|||
155739172|NCT00966875|562145529|FG002|Part A|Entry Criteria|0|||
155739173|NCT00966875|562145530|FG003|Part A|Entry Criteria|0|||
155739174|NCT00966875|562145531|FG004|Part A|Entry Criteria|0|||
155739175|NCT00966875|562145532|FG005|Part A|Entry Criteria|2|||
155739176|NCT00966875|562145533|FG006|Part A|Entry Criteria|0|||
155739177|NCT00966875|562145534|FG007|Part A|Entry Criteria|0|||
155739178|NCT00966875|562145535|FG008|Part A|Entry Criteria|0|||
155739179|NCT00966875|562145527|FG000|Part A|Lack of Efficacy|0|||
155739180|NCT00966875|562145528|FG001|Part A|Lack of Efficacy|1|||
155739181|NCT00966875|562145529|FG002|Part A|Lack of Efficacy|0|||
155739182|NCT00966875|562145530|FG003|Part A|Lack of Efficacy|0|||
155739183|NCT00966875|562145531|FG004|Part A|Lack of Efficacy|0|||
155739184|NCT00966875|562145532|FG005|Part A|Lack of Efficacy|0|||
155739185|NCT00966875|562145533|FG006|Part A|Lack of Efficacy|4|||
155739186|NCT00966875|562145534|FG007|Part A|Lack of Efficacy|0|||
155739187|NCT00966875|562145535|FG008|Part A|Lack of Efficacy|0|||
155739188|NCT00966875|562145527|FG000|Part A|Lost to Follow-up|2|||
155739189|NCT00966875|562145528|FG001|Part A|Lost to Follow-up|0|||
155739190|NCT00966875|562145529|FG002|Part A|Lost to Follow-up|0|||
155739191|NCT00966875|562145530|FG003|Part A|Lost to Follow-up|0|||
155739192|NCT00966875|562145531|FG004|Part A|Lost to Follow-up|0|||
155739193|NCT00966875|562145532|FG005|Part A|Lost to Follow-up|1|||
155739194|NCT00966875|562145533|FG006|Part A|Lost to Follow-up|0|||
155739195|NCT00966875|562145534|FG007|Part A|Lost to Follow-up|0|||
155739196|NCT00966875|562145535|FG008|Part A|Lost to Follow-up|0|||
155739197|NCT00966875|562145527|FG000|Part A|Parent/Caregiver Decision|0|||
155739198|NCT00966875|562145528|FG001|Part A|Parent/Caregiver Decision|0|||
155739199|NCT00966875|562145529|FG002|Part A|Parent/Caregiver Decision|0|||
155739200|NCT00966875|562145530|FG003|Part A|Parent/Caregiver Decision|1|||
155739201|NCT00966875|562145531|FG004|Part A|Parent/Caregiver Decision|0|||
155739202|NCT00966875|562145532|FG005|Part A|Parent/Caregiver Decision|0|||
155739203|NCT00966875|562145533|FG006|Part A|Parent/Caregiver Decision|0|||
155739204|NCT00966875|562145534|FG007|Part A|Parent/Caregiver Decision|0|||
155739205|NCT00966875|562145535|FG008|Part A|Parent/Caregiver Decision|0|||
155739206|NCT00966875|562145527|FG000|Part A|Physician Decision|0|||
155739207|NCT00966875|562145528|FG001|Part A|Physician Decision|0|||
155739208|NCT00966875|562145529|FG002|Part A|Physician Decision|0|||
155739209|NCT00966875|562145530|FG003|Part A|Physician Decision|0|||
155739210|NCT00966875|562145531|FG004|Part A|Physician Decision|1|||
155739211|NCT00966875|562145532|FG005|Part A|Physician Decision|0|||
155739212|NCT00966875|562145533|FG006|Part A|Physician Decision|1|||
155739213|NCT00966875|562145534|FG007|Part A|Physician Decision|0|||
155739214|NCT00966875|562145535|FG008|Part A|Physician Decision|2|||
155739215|NCT00966875|562145527|FG000|Part A|Sponsor Decision|0|||
155739216|NCT00966875|562145528|FG001|Part A|Sponsor Decision|0|||
155739217|NCT00966875|562145529|FG002|Part A|Sponsor Decision|1|||
155739218|NCT00966875|562145530|FG003|Part A|Sponsor Decision|0|||
155739219|NCT00966875|562145531|FG004|Part A|Sponsor Decision|1|||
155739220|NCT00966875|562145532|FG005|Part A|Sponsor Decision|0|||
155739221|NCT00966875|562145533|FG006|Part A|Sponsor Decision|0|||
155739222|NCT00966875|562145534|FG007|Part A|Sponsor Decision|2|||
155739223|NCT00966875|562145535|FG008|Part A|Sponsor Decision|1|||
155393585|NCT01132612|560876798|FG001|Overall Study|Administrative problems|1|||
155393586|NCT01132612|560876799|FG002|Overall Study|Administrative problems|52|||
155393587|NCT01132612|560876797|FG000|Overall Study|Lack of Efficacy|23|||
155739224|NCT00966875|562145527|FG000|Part A|Withdrawal by Subject|2|||
155739225|NCT00966875|562145528|FG001|Part A|Withdrawal by Subject|2|||
155739226|NCT00966875|562145529|FG002|Part A|Withdrawal by Subject|1|||
155739227|NCT00966875|562145530|FG003|Part A|Withdrawal by Subject|1|||
155739228|NCT00966875|562145531|FG004|Part A|Withdrawal by Subject|3|||
155739229|NCT00966875|562145532|FG005|Part A|Withdrawal by Subject|0|||
155739230|NCT00966875|562145533|FG006|Part A|Withdrawal by Subject|5|||
155739231|NCT00966875|562145534|FG007|Part A|Withdrawal by Subject|1|||
155739232|NCT00966875|562145535|FG008|Part A|Withdrawal by Subject|1|||
155739233|NCT00966875|562145527|FG000|Part A|Protocol Violation|0|||
155739234|NCT00966875|562145528|FG001|Part A|Protocol Violation|0|||
155739235|NCT00966875|562145529|FG002|Part A|Protocol Violation|0|||
155739236|NCT00966875|562145530|FG003|Part A|Protocol Violation|0|||
155739237|NCT00966875|562145531|FG004|Part A|Protocol Violation|0|||
155739238|NCT00966875|562145532|FG005|Part A|Protocol Violation|0|||
155739239|NCT00966875|562145533|FG006|Part A|Protocol Violation|2|||
155739240|NCT00966875|562145534|FG007|Part A|Protocol Violation|1|||
155739241|NCT00966875|562145535|FG008|Part A|Protocol Violation|1|||
155739242|NCT00966875|562145527|FG000|Part B|Adverse Event|0|||
155739243|NCT00966875|562145528|FG001|Part B|Adverse Event|1|||
155739244|NCT00966875|562145529|FG002|Part B|Adverse Event|1|||
155739245|NCT00966875|562145530|FG003|Part B|Adverse Event|0|||
155739246|NCT00966875|562145531|FG004|Part B|Adverse Event|1|||
155739247|NCT00966875|562145532|FG005|Part B|Adverse Event|0|||
155739248|NCT00966875|562145533|FG006|Part B|Adverse Event|5|||
155739249|NCT00966875|562145534|FG007|Part B|Adverse Event|2|||
155739250|NCT00966875|562145535|FG008|Part B|Adverse Event|2|||
155739251|NCT00966875|562145527|FG000|Part B|Death|0|||
155739252|NCT00966875|562145528|FG001|Part B|Death|0|||
155739253|NCT00966875|562145529|FG002|Part B|Death|1|||
155739254|NCT00966875|562145530|FG003|Part B|Death|0|||
155739255|NCT00966875|562145531|FG004|Part B|Death|0|||
155739256|NCT00966875|562145532|FG005|Part B|Death|0|||
155739257|NCT00966875|562145533|FG006|Part B|Death|0|||
155739258|NCT00966875|562145534|FG007|Part B|Death|1|||
155739259|NCT00966875|562145535|FG008|Part B|Death|0|||
155739260|NCT00966875|562145527|FG000|Part B|Lack of Efficacy|2|||
155739261|NCT00966875|562145528|FG001|Part B|Lack of Efficacy|1|||
155739262|NCT00966875|562145529|FG002|Part B|Lack of Efficacy|1|||
155739263|NCT00966875|562145530|FG003|Part B|Lack of Efficacy|1|||
155739264|NCT00966875|562145531|FG004|Part B|Lack of Efficacy|2|||
155739265|NCT00966875|562145532|FG005|Part B|Lack of Efficacy|3|||
155739266|NCT00966875|562145533|FG006|Part B|Lack of Efficacy|12|||
155739267|NCT00966875|562145534|FG007|Part B|Lack of Efficacy|9|||
155739268|NCT00966875|562145535|FG008|Part B|Lack of Efficacy|6|||
155739269|NCT00966875|562145527|FG000|Part B|Lost to Follow-up|0|||
155739270|NCT00966875|562145528|FG001|Part B|Lost to Follow-up|0|||
155739271|NCT00966875|562145529|FG002|Part B|Lost to Follow-up|0|||
155739272|NCT00966875|562145530|FG003|Part B|Lost to Follow-up|1|||
155739273|NCT00966875|562145531|FG004|Part B|Lost to Follow-up|0|||
155739274|NCT00966875|562145532|FG005|Part B|Lost to Follow-up|0|||
155739275|NCT00966875|562145533|FG006|Part B|Lost to Follow-up|0|||
155739276|NCT00966875|562145534|FG007|Part B|Lost to Follow-up|0|||
155393588|NCT01132612|560876798|FG001|Overall Study|Lack of Efficacy|22|||
155739277|NCT00966875|562145535|FG008|Part B|Lost to Follow-up|1|||
155739278|NCT00966875|562145527|FG000|Part B|Physician Decision|0|||
155393589|NCT01132612|560876799|FG002|Overall Study|Lack of Efficacy|73|||
155739279|NCT00966875|562145528|FG001|Part B|Physician Decision|0|||
155739280|NCT00966875|562145529|FG002|Part B|Physician Decision|1|||
155739281|NCT00966875|562145530|FG003|Part B|Physician Decision|0|||
155739282|NCT00966875|562145531|FG004|Part B|Physician Decision|2|||
155739283|NCT00966875|562145532|FG005|Part B|Physician Decision|1|||
155739284|NCT00966875|562145533|FG006|Part B|Physician Decision|0|||
155739285|NCT00966875|562145534|FG007|Part B|Physician Decision|0|||
155739286|NCT00966875|562145535|FG008|Part B|Physician Decision|2|||
155739287|NCT00966875|562145527|FG000|Part B|Sponsor Decision|1|||
155739288|NCT00966875|562145528|FG001|Part B|Sponsor Decision|0|||
155393590|NCT02252536|560876801|FG000|Overall Study|Lost to Follow-up|5|||
155393591|NCT02252536|560876802|FG001|Overall Study|Lost to Follow-up|3|||
155393592|NCT01438151|560876803|FG000|Overall Study|study terminated|8|||
155393593|NCT00006392|560876810|FG000|Overall Study|Ineligible|11|||
155393594|NCT00006392|560876811|FG001|Overall Study|Ineligible|3|||
155393595|NCT00006392|560876812|FG002|Overall Study|Ineligible|5|||
155393596|NCT00006392|560876813|FG003|Overall Study|Ineligible|5|||
155393597|NCT00006392|560876810|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
155393598|NCT00006392|560876811|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155739289|NCT00966875|562145529|FG002|Part B|Sponsor Decision|0|||
155739290|NCT00966875|562145530|FG003|Part B|Sponsor Decision|0|||
155739291|NCT00966875|562145531|FG004|Part B|Sponsor Decision|0|||
155739292|NCT00966875|562145532|FG005|Part B|Sponsor Decision|1|||
155739293|NCT00966875|562145533|FG006|Part B|Sponsor Decision|0|||
155739294|NCT00966875|562145534|FG007|Part B|Sponsor Decision|2|||
155739295|NCT00966875|562145535|FG008|Part B|Sponsor Decision|1|||
155739296|NCT00966875|562145527|FG000|Part B|Withdrawal by Subject|2|||
155739297|NCT00966875|562145528|FG001|Part B|Withdrawal by Subject|1|||
155739298|NCT00966875|562145529|FG002|Part B|Withdrawal by Subject|2|||
155739299|NCT00966875|562145530|FG003|Part B|Withdrawal by Subject|1|||
155739300|NCT00966875|562145531|FG004|Part B|Withdrawal by Subject|2|||
155739301|NCT00966875|562145532|FG005|Part B|Withdrawal by Subject|1|||
155739302|NCT00966875|562145533|FG006|Part B|Withdrawal by Subject|4|||
155739303|NCT00966875|562145534|FG007|Part B|Withdrawal by Subject|5|||
155739304|NCT00966875|562145535|FG008|Part B|Withdrawal by Subject|5|||
155739305|NCT00966875|562145527|FG000|Part B|Entry Criteria|0|||
155739306|NCT00966875|562145528|FG001|Part B|Entry Criteria|0|||
155739307|NCT00966875|562145529|FG002|Part B|Entry Criteria|0|||
155739308|NCT00966875|562145530|FG003|Part B|Entry Criteria|0|||
155739309|NCT00966875|562145531|FG004|Part B|Entry Criteria|0|||
155739310|NCT00966875|562145532|FG005|Part B|Entry Criteria|0|||
155739311|NCT00966875|562145533|FG006|Part B|Entry Criteria|1|||
155739312|NCT00966875|562145534|FG007|Part B|Entry Criteria|0|||
155739313|NCT00966875|562145535|FG008|Part B|Entry Criteria|1|||
155739314|NCT01206322|562145536|FG000|Overall Study|Adverse Event|0|||
155739315|NCT01206322|562145537|FG001|Overall Study|Adverse Event|0|||
155739316|NCT01206322|562145538|FG002|Overall Study|Adverse Event|0|||
155739317|NCT01206322|562145539|FG003|Overall Study|Adverse Event|1|||
155739318|NCT00689117|562145540|FG000|Overall Study|Adverse Event|6|||
155739319|NCT00689117|562145541|FG001|Overall Study|Adverse Event|0|||
155739320|NCT00689117|562145542|FG002|Overall Study|Adverse Event|5|||
155739321|NCT00689117|562145543|FG003|Overall Study|Adverse Event|0|||
155739322|NCT00689117|562145540|FG000|Overall Study|Lost to Follow-up|26|||
155739323|NCT00689117|562145541|FG001|Overall Study|Lost to Follow-up|19|||
155739324|NCT00689117|562145542|FG002|Overall Study|Lost to Follow-up|17|||
155739325|NCT00689117|562145543|FG003|Overall Study|Lost to Follow-up|11|||
155739326|NCT00689117|562145540|FG000|Overall Study|Lack of Efficacy|1|||
155739327|NCT00689117|562145541|FG001|Overall Study|Lack of Efficacy|2|||
155739328|NCT00689117|562145542|FG002|Overall Study|Lack of Efficacy|2|||
155739329|NCT00689117|562145543|FG003|Overall Study|Lack of Efficacy|2|||
155739330|NCT00689117|562145540|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
155739331|NCT00689117|562145541|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
155739332|NCT00689117|562145542|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
155739333|NCT00689117|562145543|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
155739334|NCT00689117|562145540|FG000|Overall Study|Withdrawal by Subject|19|||
155739335|NCT00689117|562145541|FG001|Overall Study|Withdrawal by Subject|18|||
155739336|NCT00689117|562145542|FG002|Overall Study|Withdrawal by Subject|26|||
155739337|NCT00689117|562145543|FG003|Overall Study|Withdrawal by Subject|13|||
155739338|NCT00689117|562145540|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
155739339|NCT00689117|562145541|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
155739340|NCT00689117|562145542|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
155739341|NCT00689117|562145543|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
155739342|NCT00689117|562145540|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155739343|NCT00689117|562145541|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155739344|NCT00689117|562145542|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155739345|NCT00689117|562145543|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155739346|NCT00689117|562145540|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
155739347|NCT00689117|562145541|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
155739348|NCT00689117|562145542|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
155739349|NCT00689117|562145543|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
155739350|NCT00689117|562145540|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
155739351|NCT00689117|562145541|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
155739352|NCT00689117|562145542|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
155739353|NCT00689117|562145543|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
155739354|NCT00689117|562145540|FG000|Overall Study|Use of Prohibitive Medication|2|||
155393599|NCT00006392|560876812|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155393600|NCT00006392|560876813|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155739355|NCT00689117|562145541|FG001|Overall Study|Use of Prohibitive Medication|1|||
155739356|NCT00689117|562145542|FG002|Overall Study|Use of Prohibitive Medication|3|||
155739357|NCT00689117|562145543|FG003|Overall Study|Use of Prohibitive Medication|0|||
155739358|NCT00689117|562145540|FG000|Overall Study|Pregnancy|0|||
155739359|NCT00689117|562145541|FG001|Overall Study|Pregnancy|2|||
155393601|NCT02459769|560876815|FG000|Overall Study|Withdrawal by Subject|7|||
155393602|NCT02459769|560876816|FG001|Overall Study|Withdrawal by Subject|4|||
155739360|NCT00689117|562145542|FG002|Overall Study|Pregnancy|0|||
155739361|NCT00689117|562145543|FG003|Overall Study|Pregnancy|2|||
155739362|NCT00689117|562145540|FG000|Overall Study|Incarceration|2|||
155739363|NCT00689117|562145541|FG001|Overall Study|Incarceration|0|||
155739364|NCT00689117|562145542|FG002|Overall Study|Incarceration|0|||
155739365|NCT00689117|562145543|FG003|Overall Study|Incarceration|0|||
155739366|NCT00689117|562145540|FG000|Overall Study|Fear of Birth Defects|0|||
155739367|NCT00689117|562145541|FG001|Overall Study|Fear of Birth Defects|0|||
155739368|NCT00689117|562145542|FG002|Overall Study|Fear of Birth Defects|1|||
155739369|NCT00689117|562145543|FG003|Overall Study|Fear of Birth Defects|0|||
155739370|NCT00689117|562145540|FG000|Overall Study|Transportation|1|||
155739371|NCT00689117|562145541|FG001|Overall Study|Transportation|0|||
155739372|NCT00689117|562145542|FG002|Overall Study|Transportation|0|||
155739373|NCT00689117|562145543|FG003|Overall Study|Transportation|0|||
155739374|NCT00689117|562145540|FG000|Overall Study|Patient Withdrew from Study|0|||
155739375|NCT00689117|562145541|FG001|Overall Study|Patient Withdrew from Study|0|||
155739376|NCT00689117|562145542|FG002|Overall Study|Patient Withdrew from Study|0|||
155739377|NCT00689117|562145543|FG003|Overall Study|Patient Withdrew from Study|1|||
155739378|NCT00689117|562145540|FG000|Overall Study|Personal Reason|0|||
155739379|NCT00689117|562145541|FG001|Overall Study|Personal Reason|1|||
155739380|NCT00689117|562145542|FG002|Overall Study|Personal Reason|0|||
155739381|NCT00689117|562145543|FG003|Overall Study|Personal Reason|0|||
155739382|NCT00689117|562145540|FG000|Overall Study|Dispensing Error|0|||
155739383|NCT00689117|562145541|FG001|Overall Study|Dispensing Error|1|||
155739384|NCT00689117|562145542|FG002|Overall Study|Dispensing Error|0|||
155739385|NCT00689117|562145543|FG003|Overall Study|Dispensing Error|0|||
155739386|NCT00444678|562145544|FG000|Overall Study|Toxicity|11|||
155739387|NCT00444678|562145544|FG000|Overall Study|Disease Progression|12|||
155739388|NCT00444678|562145544|FG000|Overall Study|Death|3|||
155739389|NCT00444678|562145544|FG000|Overall Study|Physician Decision|3|||
155739390|NCT00444678|562145544|FG000|Overall Study|Withdrawal by Subject|2|||
155739391|NCT04250077|562145548|FG000|Overall Study|Withdrawal by Subject|0|||
155739392|NCT04250077|562145549|FG001|Overall Study|Withdrawal by Subject|1|||
155739393|NCT04250077|562145550|FG002|Overall Study|Withdrawal by Subject|0|||
155739394|NCT04250077|562145548|FG000|Overall Study|Lost to Follow-up|2|||
155739395|NCT04250077|562145549|FG001|Overall Study|Lost to Follow-up|3|||
155739396|NCT04250077|562145550|FG002|Overall Study|Lost to Follow-up|0|||
155739397|NCT03319745|562145552|FG000|Overall Study|Death|1|||
155739398|NCT03319745|562145552|FG000|Overall Study|Toxicity Precluding Surgery|1|||
155739399|NCT00870103|562145553|FG000|Overall Study|Physician Decision|2|||
155739400|NCT00870103|562145553|FG000|Overall Study|Lost to Follow-up|2|||
155739401|NCT01317550|562145554|FG000|Overall Study|Withdrawal by Subject|1|||
155739402|NCT01317550|562145555|FG001|Overall Study|Withdrawal by Subject|0|||
155739403|NCT01317550|562145556|FG002|Overall Study|Withdrawal by Subject|0|||
155739404|NCT01317550|562145557|FG003|Overall Study|Withdrawal by Subject|0|||
155739405|NCT01317550|562145554|FG000|Overall Study|Lack of compliance study med|1|||
155739406|NCT01317550|562145555|FG001|Overall Study|Lack of compliance study med|0|||
155739407|NCT01317550|562145556|FG002|Overall Study|Lack of compliance study med|0|||
155739408|NCT01317550|562145557|FG003|Overall Study|Lack of compliance study med|0|||
155739409|NCT01767142|562145558|FG000|Overall Study|Lost to Follow-up|3|||
155739410|NCT00926029|562145559|FG000|Overall Study|Lost to Follow-up|2|||
155739411|NCT00926029|562145560|FG001|Overall Study|Lost to Follow-up|1|||
155739412|NCT00926029|562145561|FG002|Overall Study|Lost to Follow-up|1|||
155739413|NCT03206788|562145562|FG000|Overall Study|Withdrawal by Subject|0|||
155739414|NCT03206788|562145563|FG001|Overall Study|Withdrawal by Subject|1|||
155739415|NCT03206788|562145562|FG000|Overall Study|Adverse Event|0|||
155739416|NCT03206788|562145563|FG001|Overall Study|Adverse Event|1|||
155739417|NCT03206788|562145562|FG000|Overall Study|Physician Decision|0|||
155739418|NCT03206788|562145563|FG001|Overall Study|Physician Decision|1|||
155739419|NCT02471612|562145564|FG000|Overall Study|Lost to Follow-up|2|||
155739420|NCT00833417|562145565|FG000|Overall Study|Adverse Event|5|||
155739421|NCT00833417|562145566|FG001|Overall Study|Adverse Event|16|||
155739422|NCT00833417|562145565|FG000|Overall Study|Death|1|||
155739423|NCT00833417|562145566|FG001|Overall Study|Death|3|||
155739424|NCT00833417|562145565|FG000|Overall Study|Lost to Follow-up|1|||
155739425|NCT00833417|562145566|FG001|Overall Study|Lost to Follow-up|2|||
155739426|NCT00833417|562145565|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
155739427|NCT00833417|562145566|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
155739428|NCT00833417|562145565|FG000|Overall Study|Patient Decision to Withdraw|4|||
155739429|NCT00833417|562145566|FG001|Overall Study|Patient Decision to Withdraw|23|||
155739430|NCT00833417|562145565|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
155739431|NCT00833417|562145566|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
155739432|NCT00833417|562145565|FG000|Overall Study|Disease Progression|18|||
155739433|NCT00833417|562145566|FG001|Overall Study|Disease Progression|17|||
155739434|NCT00833417|562145565|FG000|Overall Study|Reason Not Specified|0|||
155739435|NCT00833417|562145566|FG001|Overall Study|Reason Not Specified|1|||
155739436|NCT00862082|562145569|FG000|Overall Study|Sponsor decision to terminate the study|5|||
155739437|NCT00862082|562145570|FG001|Overall Study|Sponsor decision to terminate the study|0|||
155739438|NCT00862082|562145569|FG000|Overall Study|Withdrawal by Subject|0|||
155739439|NCT00862082|562145570|FG001|Overall Study|Withdrawal by Subject|1|||
155739440|NCT01396070|562145573|FG000|Overall Study|Withdrawal by Subject|2|||
155739441|NCT01396070|562145573|FG000|Overall Study|Death|2|||
155739442|NCT01396070|562145573|FG000|Overall Study|Adverse Event|8|||
155739443|NCT01396070|562145573|FG000|Overall Study|Physician Decision|3|||
155739444|NCT01396070|562145573|FG000|Overall Study|Lack of Efficacy|4|||
155739445|NCT04254913|562145575|FG000|Overall Study|Adverse Event|1|||
155739446|NCT01396057|562145576|FG000|Overall Study|Adverse Event|2|||
155739447|NCT01396057|562145577|FG001|Overall Study|Adverse Event|6|||
155739448|NCT01396057|562145576|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155739449|NCT01396057|562145577|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155739450|NCT01396057|562145576|FG000|Overall Study|Protocol deviation|4|||
155739451|NCT01396057|562145577|FG001|Overall Study|Protocol deviation|4|||
155739452|NCT01396057|562145576|FG000|Overall Study|Consent withdrawn|3|||
155739453|NCT01396057|562145577|FG001|Overall Study|Consent withdrawn|2|||
155739454|NCT01324401|562145580|FG000|Overall Study|Withdrawn before any treatment|0|||
155393603|NCT02459769|560876817|FG002|Overall Study|Withdrawal by Subject|8|||
155393604|NCT02459769|560876818|FG003|Overall Study|Withdrawal by Subject|5|||
155393605|NCT02459769|560876815|FG000|Overall Study|Lost to Follow-up|1|||
155739455|NCT01324401|562145581|FG001|Overall Study|Withdrawn before any treatment|3|||
155739456|NCT01324401|562145580|FG000|Overall Study|Adverse Event|1|||
155739457|NCT01324401|562145581|FG001|Overall Study|Adverse Event|3|||
155739458|NCT02873429|562145584|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
155739459|NCT02873429|562145585|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
155739460|NCT02873429|562145584|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
155739461|NCT02873429|562145585|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
155739462|NCT02873429|562145584|FG000|16 Weeks|Lost to Follow-up|3|||
155739463|NCT02873429|562145585|FG001|16 Weeks|Lost to Follow-up|0|||
155739464|NCT00744042|562145586|FG000|Overall Study|Withdrawal by Subject|1|||
155739465|NCT00853567|562145587|FG000|Overall Study|Study prematurely terminated|71|||
155739466|NCT02252939|562145591|FG000|Overall Study|Lost to Follow-up|3|||
155739467|NCT01033448|562145592|FG000|Overall Study|Withdrawal by Subject|4|||
155739468|NCT01033448|562145592|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
155739469|NCT01033448|562145592|FG000|Overall Study|Lost to Follow-up|3|||
155739470|NCT01033448|562145592|FG000|Overall Study|Withdrew due to other reasons|3|||
155739471|NCT01033448|562145592|FG000|Overall Study|Unknown disposition|1|||
155739472|NCT02560025|562145593|FG000|Overall Study|Ineligible after consent/ registration|3|||
155739473|NCT02745080|562145598|FG000|Overall Study|Adverse Event|13|||
155739474|NCT02745080|562145599|FG001|Overall Study|Adverse Event|21|||
155739475|NCT02745080|562145598|FG000|Overall Study|Lack of Efficacy|11|||
155739476|NCT02745080|562145599|FG001|Overall Study|Lack of Efficacy|23|||
155739477|NCT02745080|562145598|FG000|Overall Study|Lost to Follow-up|3|||
155739478|NCT02745080|562145599|FG001|Overall Study|Lost to Follow-up|3|||
155739479|NCT02745080|562145598|FG000|Overall Study|Physician Decision|3|||
155739480|NCT02745080|562145599|FG001|Overall Study|Physician Decision|0|||
155739481|NCT02745080|562145598|FG000|Overall Study|Protocol Violation|3|||
155739482|NCT02745080|562145599|FG001|Overall Study|Protocol Violation|1|||
155739483|NCT02745080|562145598|FG000|Overall Study|Withdrawal by Subject|22|||
155739484|NCT02745080|562145599|FG001|Overall Study|Withdrawal by Subject|41|||
155739485|NCT04237116|562145601|FG000|Overall Study|Adverse Event|0|||
155739486|NCT04237116|562145602|FG001|Overall Study|Adverse Event|1|||
155739487|NCT04237116|562145601|FG000|Overall Study|Study terminated by Sponsor|4|||
155393606|NCT02459769|560876816|FG001|Overall Study|Lost to Follow-up|0|||
155393607|NCT02459769|560876817|FG002|Overall Study|Lost to Follow-up|1|||
155393608|NCT02459769|560876818|FG003|Overall Study|Lost to Follow-up|0|||
155739488|NCT04237116|562145602|FG001|Overall Study|Study terminated by Sponsor|1|||
155739489|NCT01821560|562145603|FG000|Overall Study|Lost to Follow-up|5|||
155739490|NCT01821560|562145604|FG001|Overall Study|Lost to Follow-up|5|||
155739491|NCT01821560|562145603|FG000|Overall Study|Withdrawal by Subject|1|||
155739492|NCT01821560|562145604|FG001|Overall Study|Withdrawal by Subject|1|||
155393609|NCT01186796|560876819|FG000|Overall Study|Adverse Event|3|||
155393610|NCT01186796|560876820|FG001|Overall Study|Adverse Event|0|||
155739493|NCT01821560|562145603|FG000|Overall Study|Protocol Violation|0|||
155739494|NCT01821560|562145604|FG001|Overall Study|Protocol Violation|1|||
155739495|NCT04189224|562145606|FG000|Period 2|Adverse Event|0|||
155739496|NCT04189224|562145607|FG001|Period 2|Adverse Event|1|||
155739497|NCT00490529|562146795|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
155739498|NCT00490529|562146795|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
155739499|NCT00490529|562146795|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
155634863|NCT00614393|561756163|FG002|Overall Study|Other|0|||
155634864|NCT00614393|561756164|FG003|Overall Study|Other|4|||
155634865|NCT00614393|561756165|FG004|Overall Study|Other|2|||
155634866|NCT00614393|561756161|FG000|Overall Study|Not Treated|0|||
155634867|NCT00614393|561756162|FG001|Overall Study|Not Treated|0|||
155634868|NCT00614393|561756163|FG002|Overall Study|Not Treated|0|||
155634869|NCT00614393|561756164|FG003|Overall Study|Not Treated|0|||
155634870|NCT00614393|561756165|FG004|Overall Study|Not Treated|2|||
155634871|NCT03813654|561756166|FG000|Overall Study|Protocol Violation|0|||
155634872|NCT03813654|561756167|FG001|Overall Study|Protocol Violation|1|||
155634873|NCT03813654|561756168|FG002|Overall Study|Protocol Violation|2|||
155634874|NCT03813654|561756166|FG000|Overall Study|Withdrawal by Subject|1|||
155634875|NCT03813654|561756167|FG001|Overall Study|Withdrawal by Subject|0|||
155634876|NCT03813654|561756168|FG002|Overall Study|Withdrawal by Subject|0|||
155634877|NCT00984867|561756169|FG000|Overall Study|Adverse Event|3|||
155634878|NCT00984867|561756170|FG001|Overall Study|Adverse Event|7|||
155634879|NCT00984867|561756169|FG000|Overall Study|Death|1|||
155634880|NCT00984867|561756170|FG001|Overall Study|Death|0|||
155634881|NCT00984867|561756169|FG000|Overall Study|Withdrawal by Subject|13|||
155634882|NCT00984867|561756170|FG001|Overall Study|Withdrawal by Subject|4|||
155634883|NCT00984867|561756169|FG000|Overall Study|Lost to Follow-up|3|||
155634884|NCT00984867|561756170|FG001|Overall Study|Lost to Follow-up|4|||
155634885|NCT00984867|561756169|FG000|Overall Study|Poor/non-compliance|0|||
155634886|NCT00984867|561756170|FG001|Overall Study|Poor/non-compliance|1|||
155634887|NCT00984867|561756169|FG000|Overall Study|Subject no longer meets study criteria|1|||
155634888|NCT00984867|561756170|FG001|Overall Study|Subject no longer meets study criteria|1|||
155634889|NCT00984867|561756169|FG000|Overall Study|site closing|1|||
155634890|NCT00984867|561756170|FG001|Overall Study|site closing|0|||
155634891|NCT00984867|561756169|FG000|Overall Study|lack of efficacy and subject compliance|1|||
155634892|NCT00984867|561756170|FG001|Overall Study|lack of efficacy and subject compliance|0|||
155634893|NCT00626639|561756171|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
155634894|NCT00626639|561756172|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
155634895|NCT01461551|561756173|FG000|Overall Study|Physician Decision|2|||
155634896|NCT01461551|561756174|FG001|Overall Study|Physician Decision|1|||
155634897|NCT01461551|561756175|FG002|Overall Study|Physician Decision|2|||
155634898|NCT01155141|561756176|FG000|Overall Study|Withdrawal by Subject|1|||
155634899|NCT01155141|561756176|FG000|Overall Study|Screen Failure|1|||
155634900|NCT00303186|561756177|FG000|Overall Study|Other|52|||
155634901|NCT02020941|561756178|FG000|Overall Study|Adverse Event|1|||
155634902|NCT02020941|561756178|FG000|Overall Study|Physician Decision|2|||
155634903|NCT02020941|561756178|FG000|Overall Study|Withdrawal by Subject|1|||
155634904|NCT02020941|561756178|FG000|Overall Study|Disease Progression|4|||
155634905|NCT02469857|561756180|FG000|Overall Study|Death|24|||
155634906|NCT02469857|561756181|FG001|Overall Study|Death|29|||
155634907|NCT02469857|561756180|FG000|Overall Study|Discontinuation|1|||
155634908|NCT02469857|561756181|FG001|Overall Study|Discontinuation|3|||
155634909|NCT00937950|561756182|FG000|Overall Study|Withdrawal by Subject|23|||
155634910|NCT00937950|561756182|FG000|Overall Study|Migrated/moved from study area|27|||
155634911|NCT00937950|561756182|FG000|Overall Study|Lost to Follow-up|144|||
155634912|NCT00937950|561756182|FG000|Overall Study|Missing confirmed|4|||
155634913|NCT00937950|561756182|FG000|Overall Study|Other|18|||
155634914|NCT01531153|561756185|FG000|Overall Study|Withdrawal by Subject|10|||
155634915|NCT01531153|561756186|FG001|Overall Study|Withdrawal by Subject|9|||
155634916|NCT01531153|561756187|FG002|Overall Study|Withdrawal by Subject|15|||
155634917|NCT03483103|561756188|FG000|Pre-Treatment Phase|Other reasons|1|||
155634918|NCT03483103|561756188|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
155634919|NCT03483103|561756188|FG000|Pre-Treatment Phase|Disease-related complications|1|||
155634920|NCT03483103|561756188|FG000|Pre-Treatment Phase|Death|5|||
155634921|NCT03483103|561756188|FG000|Treatment Phase|Withdrawal by Subject|7|||
155634922|NCT03483103|561756188|FG000|Treatment Phase|Other reasons|1|||
155634923|NCT03483103|561756188|FG000|Treatment Phase|Death|23|||
155634924|NCT03483103|561756188|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
155634925|NCT03483103|561756188|FG000|Treatment Phase|Received nonconforming product|1|||
155634926|NCT00435942|561756189|FG000|Overall Study|Death|17|||
155634927|NCT00435942|561756190|FG001|Overall Study|Death|10|||
155634928|NCT00435942|561756189|FG000|Overall Study|Withdrawal by Subject|2|||
155634929|NCT00435942|561756190|FG001|Overall Study|Withdrawal by Subject|0|||
155634930|NCT00435942|561756189|FG000|Overall Study|Lost to Follow-up|0|||
155634931|NCT00435942|561756190|FG001|Overall Study|Lost to Follow-up|16|||
155634932|NCT00435942|561756189|FG000|Overall Study|Conversion to Open Repair|1|||
155634933|NCT00435942|561756190|FG001|Overall Study|Conversion to Open Repair|0|||
155634934|NCT00435942|561756189|FG000|Overall Study|Technical Failure|3|||
155634935|NCT00435942|561756190|FG001|Overall Study|Technical Failure|0|||
155634936|NCT00435942|561756189|FG000|Overall Study|Other|0|||
155634937|NCT00435942|561756190|FG001|Overall Study|Other|1|||
155634938|NCT02378181|561756191|FG000|Overall Study|Lost to Follow-up|2|||
155634939|NCT02378181|561756192|FG001|Overall Study|Lost to Follow-up|5|||
155634940|NCT02378181|561756191|FG000|Overall Study|Withdrawal by Subject|1|||
155634941|NCT02378181|561756192|FG001|Overall Study|Withdrawal by Subject|1|||
155634942|NCT02378181|561756191|FG000|Overall Study|Incarcerated|0|||
155634943|NCT02378181|561756192|FG001|Overall Study|Incarcerated|1|||
155634944|NCT01898130|561756194|FG000|Treatment|Withdrawal by Subject|2|||
155634945|NCT01898130|561756194|FG000|Treatment|Progressive Disease|4|||
155634946|NCT01898130|561756194|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
155634947|NCT04491994|561756195|FG000|Overall Study|Withdrawal by Subject|10|||
155739500|NCT00490529|562146795|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
155739501|NCT00490529|562146795|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
155739502|NCT00490529|562146795|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
155739503|NCT01589653|562146798|FG000|Overall Study|Protocol Violation|3|||
155739504|NCT01589653|562146799|FG001|Overall Study|Protocol Violation|1|||
155739505|NCT01589653|562146798|FG000|Overall Study|Withdrawal criteria|4|||
155634948|NCT04491994|561756196|FG001|Overall Study|Withdrawal by Subject|5|||
155634949|NCT04491994|561756195|FG000|Overall Study|developed fever > 3 days|4|||
155634950|NCT04491994|561756196|FG001|Overall Study|developed fever > 3 days|1|||
155634951|NCT04491994|561756195|FG000|Overall Study|Protocol Violation|11|||
155634952|NCT04491994|561756196|FG001|Overall Study|Protocol Violation|2|||
155634953|NCT04491994|561756195|FG000|Overall Study|Lost to Follow-up|4|||
155634954|NCT04491994|561756196|FG001|Overall Study|Lost to Follow-up|3|||
155634955|NCT03282097|561756197|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
155634956|NCT03282097|561756198|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
155634957|NCT03282097|561756197|FG000|Intervention Visit Complete|Patient Death|13|||
155634958|NCT03282097|561756198|FG001|Intervention Visit Complete|Patient Death|15|||
155634959|NCT03282097|561756197|FG000|Intervention Visit Complete|Caregiver Death|0|||
155634960|NCT03282097|561756198|FG001|Intervention Visit Complete|Caregiver Death|3|||
155634961|NCT03282097|561756197|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
155634962|NCT03282097|561756198|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
155634963|NCT03282097|561756197|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
155634964|NCT03282097|561756198|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
155634965|NCT03282097|561756197|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
155634966|NCT03282097|561756198|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
155634967|NCT03282097|561756197|FG000|Primary Outcome Data Collection Complete|Missing|2|||
155634968|NCT03282097|561756198|FG001|Primary Outcome Data Collection Complete|Missing|3|||
155634969|NCT03282097|561756197|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
155634970|NCT03282097|561756198|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
155634971|NCT03282097|561756197|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
155634972|NCT03282097|561756198|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
155634973|NCT03282097|561756197|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
155634974|NCT03282097|561756198|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
155634975|NCT03197129|561756199|FG000|Overall Study|did not answer the VPT: shyness|4|||
155634976|NCT03197129|561756200|FG001|Overall Study|did not answer the VPT: shyness|5|||
155634977|NCT05233761|561756201|FG000|Treatment Period A|Withdrawal by Subject|12|||
155634978|NCT05233761|561756202|FG001|Treatment Period A|Withdrawal by Subject|10|||
155634979|NCT05233761|561756201|FG000|Treatment Period A|Lost to Follow-up|6|||
155634980|NCT05233761|561756202|FG001|Treatment Period A|Lost to Follow-up|12|||
155634981|NCT05233761|561756201|FG000|Treatment Period A|Protocol Violation|8|||
155634982|NCT05233761|561756202|FG001|Treatment Period A|Protocol Violation|15|||
155634983|NCT01285518|561756203|FG000|Overall Study|Lost to Follow-up|0|||
155634984|NCT01285518|561756204|FG001|Overall Study|Lost to Follow-up|0|||
155634985|NCT01285518|561756205|FG002|Overall Study|Lost to Follow-up|0|||
155634986|NCT01285518|561756206|FG003|Overall Study|Lost to Follow-up|0|||
155634987|NCT01285518|561756207|FG004|Overall Study|Lost to Follow-up|0|||
155634988|NCT01285518|561756208|FG005|Overall Study|Lost to Follow-up|1|||
155634989|NCT01285518|561756209|FG006|Overall Study|Lost to Follow-up|0|||
155634990|NCT01285518|561756210|FG007|Overall Study|Lost to Follow-up|0|||
155634991|NCT00879658|561756213|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155634992|NCT00879658|561756214|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155634993|NCT00879658|561756215|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155634994|NCT00879658|561756216|FG003|Overall Study|Abnormal laboratory value(s)|1|||
155634995|NCT00879658|561756217|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155634996|NCT00879658|561756218|FG005|Overall Study|Abnormal laboratory value(s)|0|||
155634997|NCT00879658|561756219|FG006|Overall Study|Abnormal laboratory value(s)|0|||
155634998|NCT00879658|561756213|FG000|Overall Study|Administrative problems|2|||
155739506|NCT01589653|562146799|FG001|Overall Study|Withdrawal criteria|7|||
155283293|NCT00924560|560468273|FG000|Overall Study|Miscellaneous Reasons|13|||
155739507|NCT01589653|562146798|FG000|Overall Study|Unclassified|0|||
155283294|NCT00924560|560468274|FG001|Overall Study|Miscellaneous Reasons|10|||
155283295|NCT00924560|560468275|FG002|Overall Study|Miscellaneous Reasons|10|||
155283296|NCT00663962|560468278|FG000|Overall Study|somnolence|1|||
155283297|NCT00663962|560468279|FG001|Overall Study|somnolence|0|||
155283298|NCT04091672|560470701|FG000|Overall Study|Death|6|||
155283299|NCT04091672|560470702|FG001|Overall Study|Death|6|||
155283300|NCT04091672|560470701|FG000|Overall Study|Lost to Follow-up|7|||
155739508|NCT01589653|562146799|FG001|Overall Study|Unclassified|3|||
155739509|NCT01536067|562146800|FG000|Overall Study|Disease Progression|1|||
155739510|NCT02386189|562146803|FG000|Overall Study|Lost to Follow-up|2|||
155739511|NCT02386189|562146804|FG001|Overall Study|Lost to Follow-up|3|||
155739512|NCT02386189|562146803|FG000|Overall Study|Withdrawal by Subject|1|||
155739513|NCT02386189|562146804|FG001|Overall Study|Withdrawal by Subject|0|||
155739514|NCT02386189|562146803|FG000|Overall Study|Death|1|||
155739515|NCT02386189|562146804|FG001|Overall Study|Death|0|||
155739516|NCT00606905|562146805|FG000|Overall Study|No Pregnancy|9|||
155739517|NCT00606905|562146806|FG001|Overall Study|No Pregnancy|6|||
155739518|NCT00606905|562146805|FG000|Overall Study|Non-Index Pregnancy|1|||
155739519|NCT00606905|562146806|FG001|Overall Study|Non-Index Pregnancy|4|||
155739520|NCT00606905|562146805|FG000|Overall Study|Withdrew|5|||
155739521|NCT00606905|562146806|FG001|Overall Study|Withdrew|5|||
155739522|NCT04657666|562146807|FG000|Period 1|Withdrawal of participant consent|2|||
155739523|NCT04657666|562146808|FG001|Period 1|Withdrawal of participant consent|1|||
155739524|NCT04657666|562146807|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
155739525|NCT04657666|562146808|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
155739526|NCT04657666|562146807|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
155739527|NCT04657666|562146808|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
155739528|NCT04657666|562146807|FG000|Period 2|Other|2|||
155739529|NCT04657666|562146808|FG001|Period 2|Other|0|||
155739530|NCT04657666|562146807|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
155739531|NCT04657666|562146808|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
155739532|NCT03120351|562146809|FG000|Overall Study|Physician Decision|1|||
155739533|NCT03120351|562146810|FG001|Overall Study|Physician Decision|1|||
155739534|NCT01022398|562146819|FG000|Overall Study|Study terminated|2|||
155739535|NCT01022398|562146820|FG001|Overall Study|Study terminated|2|||
155739536|NCT03255629|562146821|FG000|Overall Study|Adverse Event|1|||
155739537|NCT03255629|562146822|FG001|Overall Study|Adverse Event|0|||
155739538|NCT03255629|562146821|FG000|Overall Study|did not experience hypoglycemia|2|||
155739539|NCT03255629|562146822|FG001|Overall Study|did not experience hypoglycemia|1|||
155739540|NCT01086358|562146823|FG000|First Intervention|Lost to Follow-up|9|||
155739541|NCT01086358|562146824|FG001|First Intervention|Lost to Follow-up|4|||
155739542|NCT01086358|562146823|FG000|First Intervention|Withdrawal by Subject|0|||
155739543|NCT01086358|562146824|FG001|First Intervention|Withdrawal by Subject|1|||
155739544|NCT01086358|562146823|FG000|Second Intervention|Lost to Follow-up|4|||
155739545|NCT01086358|562146824|FG001|Second Intervention|Lost to Follow-up|4|||
155739546|NCT03317405|562146825|FG000|Overall Study|Withdrawal by Subject|1|||
155739547|NCT03317405|562146826|FG001|Overall Study|Withdrawal by Subject|0|||
155739548|NCT03317405|562146827|FG002|Overall Study|Withdrawal by Subject|0|||
155739549|NCT03317405|562146825|FG000|Overall Study|Physician Decision|0|||
155739550|NCT03317405|562146826|FG001|Overall Study|Physician Decision|0|||
155739551|NCT03317405|562146827|FG002|Overall Study|Physician Decision|1|||
155739552|NCT03317405|562146825|FG000|Overall Study|Surgery Rescheduled|0|||
155739553|NCT03317405|562146826|FG001|Overall Study|Surgery Rescheduled|1|||
155739554|NCT03317405|562146827|FG002|Overall Study|Surgery Rescheduled|0|||
155739555|NCT01137604|562146828|FG000|Overall Study|Adverse Event|3|||
155739556|NCT01137604|562146829|FG001|Overall Study|Adverse Event|6|||
155739557|NCT01137604|562146830|FG002|Overall Study|Adverse Event|9|||
155739558|NCT01137604|562146831|FG003|Overall Study|Adverse Event|9|||
155739559|NCT01137604|562146828|FG000|Overall Study|Participant Choice|0|||
155739560|NCT01137604|562146829|FG001|Overall Study|Participant Choice|2|||
155739561|NCT01137604|562146830|FG002|Overall Study|Participant Choice|2|||
155739562|NCT01137604|562146831|FG003|Overall Study|Participant Choice|0|||
155739563|NCT01137604|562146828|FG000|Overall Study|Withdrawal of consent|0|||
155739564|NCT01137604|562146829|FG001|Overall Study|Withdrawal of consent|0|||
155739565|NCT01137604|562146830|FG002|Overall Study|Withdrawal of consent|0|||
155739566|NCT01137604|562146831|FG003|Overall Study|Withdrawal of consent|2|||
155739567|NCT01137604|562146828|FG000|Overall Study|Clinical progression/deterioration|1|||
155739568|NCT01137604|562146829|FG001|Overall Study|Clinical progression/deterioration|2|||
155739569|NCT01137604|562146830|FG002|Overall Study|Clinical progression/deterioration|2|||
155739570|NCT01137604|562146831|FG003|Overall Study|Clinical progression/deterioration|0|||
155739571|NCT00591318|562146832|FG000|Overall Study|Lack of Efficacy|2|||
155739572|NCT00591318|562146833|FG001|Overall Study|Lack of Efficacy|0|||
155739573|NCT00591318|562146832|FG000|Overall Study|Adverse Event|2|||
155739574|NCT00591318|562146833|FG001|Overall Study|Adverse Event|0|||
155739575|NCT01024309|562146834|FG000|Overall Study|Physician Decision|4|||
155739576|NCT01024309|562146835|FG001|Overall Study|Physician Decision|0|||
155739577|NCT01024309|562146834|FG000|Overall Study|Withdrawal by Subject|4|||
155739578|NCT01024309|562146835|FG001|Overall Study|Withdrawal by Subject|4|||
155739579|NCT00435045|562146836|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
155739580|NCT00435045|562146837|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
155739581|NCT00435045|562146836|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
155739582|NCT00435045|562146837|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
155739583|NCT00435045|562146836|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
155739584|NCT00435045|562146837|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
155739585|NCT00435045|562146836|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
155739586|NCT00435045|562146837|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
155739587|NCT00435045|562146836|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
155739588|NCT00435045|562146837|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
155739589|NCT00435045|562146836|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
155739590|NCT00435045|562146837|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
155393611|NCT01186796|560876819|FG000|Overall Study|Withdrawal by Subject|1|||
155393612|NCT01186796|560876820|FG001|Overall Study|Withdrawal by Subject|1|||
155739591|NCT00435045|562146836|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
155739592|NCT00435045|562146837|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
155739593|NCT00435045|562146836|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
155739594|NCT00435045|562146837|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
155739595|NCT00435045|562146836|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
155739596|NCT00435045|562146837|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
155739597|NCT00435045|562146836|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
155739598|NCT00435045|562146837|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
155739599|NCT00435045|562146836|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
155739600|NCT00435045|562146837|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
155739601|NCT00567255|562146838|FG000|Overall Study|Adverse Event|241|||
155739602|NCT00567255|562146839|FG001|Overall Study|Adverse Event|68|||
155634999|NCT00879658|561756214|FG001|Overall Study|Administrative problems|1|||
155635000|NCT00879658|561756215|FG002|Overall Study|Administrative problems|0|||
155635001|NCT00879658|561756216|FG003|Overall Study|Administrative problems|1|||
155635002|NCT00879658|561756217|FG004|Overall Study|Administrative problems|0|||
155635003|NCT00879658|561756218|FG005|Overall Study|Administrative problems|0|||
155635004|NCT00879658|561756219|FG006|Overall Study|Administrative problems|0|||
155635005|NCT00879658|561756213|FG000|Overall Study|Adverse Event|6|||
155635006|NCT00879658|561756214|FG001|Overall Study|Adverse Event|4|||
155635007|NCT00879658|561756215|FG002|Overall Study|Adverse Event|3|||
155635008|NCT00879658|561756216|FG003|Overall Study|Adverse Event|1|||
155635009|NCT00879658|561756217|FG004|Overall Study|Adverse Event|2|||
155635010|NCT00879658|561756218|FG005|Overall Study|Adverse Event|0|||
155635011|NCT00879658|561756219|FG006|Overall Study|Adverse Event|0|||
155635012|NCT00879658|561756213|FG000|Overall Study|Protocol Violation|1|||
155635013|NCT00879658|561756214|FG001|Overall Study|Protocol Violation|0|||
155635014|NCT00879658|561756215|FG002|Overall Study|Protocol Violation|0|||
155635015|NCT00879658|561756216|FG003|Overall Study|Protocol Violation|0|||
155635016|NCT00879658|561756217|FG004|Overall Study|Protocol Violation|0|||
155635017|NCT00879658|561756218|FG005|Overall Study|Protocol Violation|0|||
155635018|NCT00879658|561756219|FG006|Overall Study|Protocol Violation|0|||
155635019|NCT00879658|561756213|FG000|Overall Study|Withdrawal by Subject|3|||
155635020|NCT00879658|561756214|FG001|Overall Study|Withdrawal by Subject|0|||
155635021|NCT00879658|561756215|FG002|Overall Study|Withdrawal by Subject|2|||
155635022|NCT00879658|561756216|FG003|Overall Study|Withdrawal by Subject|0|||
155635023|NCT00879658|561756217|FG004|Overall Study|Withdrawal by Subject|0|||
155635024|NCT00879658|561756218|FG005|Overall Study|Withdrawal by Subject|1|||
155635025|NCT00879658|561756219|FG006|Overall Study|Withdrawal by Subject|0|||
155635026|NCT00879658|561756213|FG000|Overall Study|Lack of Efficacy|0|||
155635027|NCT00879658|561756214|FG001|Overall Study|Lack of Efficacy|0|||
155635028|NCT00879658|561756215|FG002|Overall Study|Lack of Efficacy|2|||
155635029|NCT00879658|561756216|FG003|Overall Study|Lack of Efficacy|0|||
155635030|NCT00879658|561756217|FG004|Overall Study|Lack of Efficacy|0|||
155635031|NCT00879658|561756218|FG005|Overall Study|Lack of Efficacy|0|||
155635032|NCT00879658|561756219|FG006|Overall Study|Lack of Efficacy|0|||
155635033|NCT00879658|561756213|FG000|Overall Study|misrandomized (never received study med)|0|||
155635034|NCT00879658|561756214|FG001|Overall Study|misrandomized (never received study med)|0|||
155635035|NCT00879658|561756215|FG002|Overall Study|misrandomized (never received study med)|0|||
155635036|NCT00879658|561756216|FG003|Overall Study|misrandomized (never received study med)|1|||
155635037|NCT00879658|561756217|FG004|Overall Study|misrandomized (never received study med)|0|||
155635038|NCT00879658|561756218|FG005|Overall Study|misrandomized (never received study med)|0|||
155635039|NCT00879658|561756219|FG006|Overall Study|misrandomized (never received study med)|0|||
155635040|NCT00639509|561756224|FG000|Overall Study|Death|1|||
155635041|NCT01394276|561756225|FG000|Overall Study|Related Adverse event (AEs)|15|||
155635042|NCT01394276|561756225|FG000|Overall Study|Not related AEs|9|||
155635043|NCT01394276|561756225|FG000|Overall Study|Remission of disease|2|||
155635044|NCT01394276|561756225|FG000|Overall Study|Insufficient therapeutic effect|17|||
155635045|NCT01394276|561756225|FG000|Overall Study|Insufficient compliance|9|||
155635046|NCT01394276|561756225|FG000|Overall Study|Lost to Follow-up|5|||
155635047|NCT01394276|561756225|FG000|Overall Study|Participant moved to another site|1|||
155635048|NCT01394276|561756225|FG000|Overall Study|Pregnancy|1|||
155635049|NCT01394276|561756225|FG000|Overall Study|unavailability of drug at the Hospital|2|||
155635050|NCT01394276|561756225|FG000|Overall Study|Symptoms of concurrent diseases|1|||
155635051|NCT01933594|561756226|FG000|Overall Study|Lost to Follow-up|1|||
155739603|NCT00567255|562146838|FG000|Overall Study|Lost to Follow-up|77|||
155739604|NCT00567255|562146839|FG001|Overall Study|Lost to Follow-up|48|||
155739605|NCT00567255|562146838|FG000|Overall Study|Withdrawal by Subject|75|||
155739606|NCT00567255|562146839|FG001|Overall Study|Withdrawal by Subject|56|||
155739607|NCT00567255|562146838|FG000|Overall Study|Lack of Efficacy|19|||
155739608|NCT00567255|562146839|FG001|Overall Study|Lack of Efficacy|33|||
155739609|NCT00567255|562146838|FG000|Overall Study|Protocol Violation|20|||
155739610|NCT00567255|562146839|FG001|Overall Study|Protocol Violation|8|||
155739611|NCT00567255|562146838|FG000|Overall Study|Pregnancy|6|||
155739612|NCT00567255|562146839|FG001|Overall Study|Pregnancy|0|||
155739613|NCT00567255|562146838|FG000|Overall Study|Drug noncompliance,moved,other|25|||
155739614|NCT00567255|562146839|FG001|Overall Study|Drug noncompliance,moved,other|15|||
155739615|NCT01743001|562146842|FG000|Overall Study|Physician Decision|1|||
155739616|NCT01743001|562146843|FG001|Overall Study|Physician Decision|0|||
155393613|NCT01186796|560876819|FG000|Overall Study|Protocol Violation|0|||
155393614|NCT01186796|560876820|FG001|Overall Study|Protocol Violation|1|||
155393615|NCT03838198|560876821|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393616|NCT03838198|560876822|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393617|NCT03838198|560876823|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
155393618|NCT03838198|560876824|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393619|NCT03838198|560876821|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
155435855|NCT01476787|561022967|FG001|Treatment|Voluntary treatment discontinuation|4|||
155739617|NCT01743001|562146842|FG000|Overall Study|Pregnancy|1|||
155739618|NCT01743001|562146843|FG001|Overall Study|Pregnancy|0|||
155739619|NCT01743001|562146842|FG000|Overall Study|Death|1|||
155739620|NCT01743001|562146843|FG001|Overall Study|Death|0|||
155739621|NCT03052426|562146846|FG000|Overall Study|Withdrawal by Subject|0|||
155739622|NCT03052426|562146847|FG001|Overall Study|Withdrawal by Subject|1|||
155739623|NCT03052426|562146848|FG002|Overall Study|Withdrawal by Subject|0|||
155739624|NCT03052426|562146846|FG000|Overall Study|Lost to Follow-up|2|||
155739625|NCT03052426|562146847|FG001|Overall Study|Lost to Follow-up|0|||
155739626|NCT03052426|562146848|FG002|Overall Study|Lost to Follow-up|1|||
155739627|NCT03083990|562146851|FG000|Overall Study|Adverse Event|1|||
155739628|NCT03083990|562146852|FG001|Overall Study|Adverse Event|0|||
155739629|NCT02657408|562146853|FG000|Overall Study|Adverse Event|3|||
155739630|NCT02657408|562146854|FG001|Overall Study|Adverse Event|7|||
155739631|NCT02160041|562146856|FG000|Overall Study|Adverse Event|11|||
155739632|NCT02160041|562146856|FG000|Overall Study|Death|2|||
155739633|NCT02160041|562146856|FG000|Overall Study|disease progression|57|||
155739634|NCT02160041|562146856|FG000|Overall Study|Protocol Violation|1|||
155739635|NCT02160041|562146856|FG000|Overall Study|non-compliance with study|1|||
155739636|NCT02160041|562146856|FG000|Overall Study|Physician Decision|3|||
155739637|NCT02160041|562146856|FG000|Overall Study|Withdrawal by Subject|8|||
155739638|NCT02160041|562146856|FG000|Overall Study|study terminated by by sponsor|1|||
155739639|NCT01403948|562146857|FG000|Overall Study|Progressive disease|0|||
155739640|NCT01403948|562146858|FG001|Overall Study|Progressive disease|2|||
155739641|NCT01403948|562146859|FG002|Overall Study|Progressive disease|2|||
155739642|NCT01403948|562146860|FG003|Overall Study|Progressive disease|4|||
155739643|NCT01403948|562146861|FG004|Overall Study|Progressive disease|2|||
155739644|NCT01403948|562146862|FG005|Overall Study|Progressive disease|6|||
155739645|NCT01403948|562146863|FG006|Overall Study|Progressive disease|2|||
155739646|NCT01403948|562146864|FG007|Overall Study|Progressive disease|4|||
155739647|NCT01403948|562146865|FG008|Overall Study|Progressive disease|5|||
155739648|NCT01403948|562146866|FG009|Overall Study|Progressive disease|5|||
155739649|NCT01403948|562146857|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739650|NCT01403948|562146858|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739651|NCT01403948|562146859|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739652|NCT01403948|562146860|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739653|NCT01403948|562146861|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
155739654|NCT01403948|562146862|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739655|NCT01403948|562146863|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
155739656|NCT01403948|562146864|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739657|NCT01403948|562146865|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
155739658|NCT01403948|562146866|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
155739659|NCT01403948|562146857|FG000|Overall Study|Lost to Follow-up|0|||
155739660|NCT01403948|562146858|FG001|Overall Study|Lost to Follow-up|0|||
155739661|NCT01403948|562146859|FG002|Overall Study|Lost to Follow-up|0|||
155739662|NCT01403948|562146860|FG003|Overall Study|Lost to Follow-up|0|||
155739663|NCT01403948|562146861|FG004|Overall Study|Lost to Follow-up|0|||
155739664|NCT01403948|562146862|FG005|Overall Study|Lost to Follow-up|0|||
155739665|NCT01403948|562146863|FG006|Overall Study|Lost to Follow-up|0|||
155739666|NCT01403948|562146864|FG007|Overall Study|Lost to Follow-up|0|||
155739667|NCT01403948|562146865|FG008|Overall Study|Lost to Follow-up|0|||
155739668|NCT01403948|562146866|FG009|Overall Study|Lost to Follow-up|1|||
155739669|NCT01403948|562146857|FG000|Overall Study|Refused cont. medication|0|||
155739670|NCT01403948|562146858|FG001|Overall Study|Refused cont. medication|0|||
155739671|NCT01403948|562146859|FG002|Overall Study|Refused cont. medication|0|||
155739672|NCT01403948|562146860|FG003|Overall Study|Refused cont. medication|0|||
155739673|NCT01403948|562146861|FG004|Overall Study|Refused cont. medication|1|||
155739674|NCT01403948|562146862|FG005|Overall Study|Refused cont. medication|0|||
155739675|NCT01403948|562146863|FG006|Overall Study|Refused cont. medication|0|||
155635052|NCT01933594|561756227|FG001|Overall Study|Lost to Follow-up|0|||
155635053|NCT01933594|561756228|FG002|Overall Study|Lost to Follow-up|0|||
155635054|NCT01933594|561756229|FG003|Overall Study|Lost to Follow-up|0|||
155635055|NCT01933594|561756230|FG004|Overall Study|Lost to Follow-up|1|||
155635056|NCT01933594|561756231|FG005|Overall Study|Lost to Follow-up|0|||
155635057|NCT01933594|561756226|FG000|Overall Study|Ineligible for subsequent study step|0|||
155635058|NCT01933594|561756227|FG001|Overall Study|Ineligible for subsequent study step|0|||
155635059|NCT01933594|561756228|FG002|Overall Study|Ineligible for subsequent study step|0|||
155635060|NCT01933594|561756229|FG003|Overall Study|Ineligible for subsequent study step|0|||
155635061|NCT01933594|561756230|FG004|Overall Study|Ineligible for subsequent study step|1|||
155635062|NCT01933594|561756231|FG005|Overall Study|Ineligible for subsequent study step|0|||
155635063|NCT04770779|561756233|FG000|Overall Study|Randomized, never treated|0|||
155635064|NCT04770779|561756234|FG001|Overall Study|Randomized, never treated|1|||
155635065|NCT04770779|561756233|FG000|Overall Study|Adverse Event|9|||
155635066|NCT04770779|561756234|FG001|Overall Study|Adverse Event|1|||
155635067|NCT04770779|561756233|FG000|Overall Study|Withdrawal by Subject|7|||
155635068|NCT04770779|561756234|FG001|Overall Study|Withdrawal by Subject|1|||
155635069|NCT04770779|561756233|FG000|Overall Study|Pregnancy|0|||
155635070|NCT04770779|561756234|FG001|Overall Study|Pregnancy|1|||
155635071|NCT02799602|561756235|FG000|Overall Study|Protocol Violation|1|||
155635072|NCT02799602|561756236|FG001|Overall Study|Protocol Violation|0|||
155635073|NCT02799602|561756235|FG000|Overall Study|Physician Decision|5|||
155635074|NCT02799602|561756236|FG001|Overall Study|Physician Decision|6|||
155635075|NCT02799602|561756235|FG000|Overall Study|Lost to Follow-up|4|||
155635076|NCT02799602|561756236|FG001|Overall Study|Lost to Follow-up|2|||
155635077|NCT02799602|561756235|FG000|Overall Study|Additional primary malignancy|11|||
155635078|NCT02799602|561756236|FG001|Overall Study|Additional primary malignancy|6|||
155635079|NCT02799602|561756235|FG000|Overall Study|Non-compliance with study drug|14|||
155635080|NCT02799602|561756236|FG001|Overall Study|Non-compliance with study drug|12|||
155635081|NCT02799602|561756235|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
155635082|NCT02799602|561756236|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
155635083|NCT02799602|561756235|FG000|Overall Study|Withdrawal by Subject|26|||
155635084|NCT02799602|561756236|FG001|Overall Study|Withdrawal by Subject|40|||
155635085|NCT02799602|561756235|FG000|Overall Study|Progressive disease - clinical progression|131|||
155635086|NCT02799602|561756236|FG001|Overall Study|Progressive disease - clinical progression|276|||
155635087|NCT02799602|561756235|FG000|Overall Study|Progressive disease - radiological progression|90|||
155635088|NCT02799602|561756236|FG001|Overall Study|Progressive disease - radiological progression|133|||
155635089|NCT02799602|561756235|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
155635090|NCT02799602|561756236|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
155635091|NCT02799602|561756235|FG000|Overall Study|Death|9|||
155635092|NCT02799602|561756236|FG001|Overall Study|Death|5|||
155635093|NCT02799602|561756235|FG000|Overall Study|Other|287|||
155635094|NCT02799602|561756236|FG001|Overall Study|Other|118|||
155635095|NCT02799602|561756235|FG000|Overall Study|Study drug never administered|0|||
155635096|NCT02799602|561756236|FG001|Overall Study|Study drug never administered|3|||
155635097|NCT01925417|561756251|FG000|Overall Study|Withdrawal by Subject|2|||
155635098|NCT01925417|561756251|FG000|Overall Study|Death|1|||
155635099|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
155635100|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
155635101|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
155635102|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Death|0|||
155635103|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Death|0|||
155635104|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Death|1|||
155635105|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
155635106|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
155635107|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
155635108|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
155635109|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
155635110|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
155635111|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
155635112|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
155635113|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
155635114|NCT02696798|561756253|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
155635115|NCT02696798|561756254|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
155635116|NCT02696798|561756255|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
155635117|NCT02696798|561756253|FG000|Extended Treatment Period|Adverse Event|1|||
155635118|NCT02696798|561756254|FG001|Extended Treatment Period|Adverse Event|4|||
155635119|NCT02696798|561756255|FG002|Extended Treatment Period|Adverse Event|5|||
155739676|NCT01403948|562146864|FG007|Overall Study|Refused cont. medication|0|||
155739677|NCT01403948|562146865|FG008|Overall Study|Refused cont. medication|0|||
155739678|NCT01403948|562146866|FG009|Overall Study|Refused cont. medication|1|||
155739679|NCT01403948|562146857|FG000|Overall Study|other than above|1|||
155739680|NCT01403948|562146858|FG001|Overall Study|other than above|2|||
155739681|NCT01403948|562146859|FG002|Overall Study|other than above|1|||
155739682|NCT01403948|562146860|FG003|Overall Study|other than above|0|||
155739683|NCT01403948|562146861|FG004|Overall Study|other than above|1|||
155739684|NCT01403948|562146862|FG005|Overall Study|other than above|1|||
155739685|NCT01403948|562146863|FG006|Overall Study|other than above|2|||
155739686|NCT01403948|562146864|FG007|Overall Study|other than above|0|||
155739687|NCT01403948|562146865|FG008|Overall Study|other than above|0|||
155739688|NCT01403948|562146866|FG009|Overall Study|other than above|0|||
155739689|NCT01090323|562146867|FG000|Overall Study|Adverse Event|12|||
155739690|NCT01090323|562146868|FG001|Overall Study|Adverse Event|2|||
155739691|NCT01090323|562146867|FG000|Overall Study|Abnormal Lab Values|3|||
155739692|NCT01090323|562146868|FG001|Overall Study|Abnormal Lab Values|1|||
155739693|NCT01090323|562146867|FG000|Overall Study|Abnormal Test Procedure Results|2|||
155739694|NCT01090323|562146868|FG001|Overall Study|Abnormal Test Procedure Results|0|||
155739695|NCT01090323|562146867|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155739696|NCT01090323|562146868|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155739697|NCT01090323|562146867|FG000|Overall Study|Condition no longer requires drug|5|||
155739698|NCT01090323|562146868|FG001|Overall Study|Condition no longer requires drug|4|||
155739699|NCT01090323|562146867|FG000|Overall Study|Protocol Violation|2|||
155739700|NCT01090323|562146868|FG001|Overall Study|Protocol Violation|1|||
155739701|NCT01090323|562146867|FG000|Overall Study|Withdrew consent|33|||
155739702|NCT01090323|562146868|FG001|Overall Study|Withdrew consent|11|||
155739703|NCT01090323|562146867|FG000|Overall Study|Lost to Follow-up|11|||
155739704|NCT01090323|562146868|FG001|Overall Study|Lost to Follow-up|6|||
155739705|NCT01090323|562146867|FG000|Overall Study|Administrative problems|6|||
155739706|NCT01090323|562146868|FG001|Overall Study|Administrative problems|4|||
155739707|NCT01090323|562146867|FG000|Overall Study|Death|1|||
155739708|NCT01090323|562146868|FG001|Overall Study|Death|2|||
155739709|NCT01090323|562146867|FG000|Overall Study|Stopped end of core|7|||
155739710|NCT01090323|562146868|FG001|Overall Study|Stopped end of core|0|||
155739711|NCT01090323|562146867|FG000|Overall Study|Stopped end of extension 1#|3|||
155739712|NCT01090323|562146868|FG001|Overall Study|Stopped end of extension 1#|1|||
155739713|NCT05498701|562146869|FG000|Period 3|Adverse Event|1|||
155739714|NCT05498701|562146870|FG001|Period 3|Adverse Event|0|||
155739715|NCT02424578|562146871|FG000|Overall Study|Withdrawal by Subject|0|||
155739716|NCT02424578|562146872|FG001|Overall Study|Withdrawal by Subject|1|||
155739717|NCT03179605|562146873|FG000|Overall Study|Withdrawal by Subject|1|||
155739718|NCT00711477|562146874|FG000|Overall Study|Adverse Event|3|||
155739719|NCT00711477|562146875|FG001|Overall Study|Adverse Event|1|||
155739720|NCT00711477|562146874|FG000|Overall Study|Lost to Follow-up|0|||
155739721|NCT00711477|562146875|FG001|Overall Study|Lost to Follow-up|1|||
155739722|NCT00711477|562146874|FG000|Overall Study|Noncompliance|0|||
155739723|NCT00711477|562146875|FG001|Overall Study|Noncompliance|1|||
155739724|NCT00335764|562146879|FG000|Overall Study|wrong histology|1|||
155739725|NCT00335764|562146880|FG001|Overall Study|wrong histology|0|||
155739726|NCT00335764|562146881|FG002|Overall Study|wrong histology|0|||
155739727|NCT00335764|562146882|FG003|Overall Study|wrong histology|0|||
155739728|NCT00335764|562146883|FG004|Overall Study|wrong histology|1|||
155739729|NCT00612807|562146885|FG000|Overall Study|Withdrawal by Subject|2|||
155739730|NCT00612807|562146886|FG001|Overall Study|Withdrawal by Subject|0|||
155739731|NCT00782834|562146895|FG000|Treatment Phase|fibrous tumor not GIST|1|||
155739732|NCT01215097|562146897|FG000|Overall Study|Adverse Event|1|||
155739733|NCT01215097|562146898|FG001|Overall Study|Adverse Event|3|||
155739734|NCT01215097|562146897|FG000|Overall Study|Protocol Violation|0|||
155739735|NCT01215097|562146898|FG001|Overall Study|Protocol Violation|2|||
155739736|NCT01215097|562146897|FG000|Overall Study|Lost to Follow-up|2|||
155739737|NCT01215097|562146898|FG001|Overall Study|Lost to Follow-up|0|||
155739738|NCT01215097|562146897|FG000|Overall Study|Withdrawal by Subject|6|||
155739739|NCT01215097|562146898|FG001|Overall Study|Withdrawal by Subject|3|||
155739740|NCT01215097|562146897|FG000|Overall Study|Lack of Efficacy|0|||
155739741|NCT01215097|562146898|FG001|Overall Study|Lack of Efficacy|3|||
155739742|NCT01215097|562146897|FG000|Overall Study|patient's refusal to come|2|||
155739743|NCT01215097|562146898|FG001|Overall Study|patient's refusal to come|2|||
155739744|NCT01215097|562146897|FG000|Overall Study|patient's private reason|1|||
155739745|NCT01215097|562146898|FG001|Overall Study|patient's private reason|1|||
155739746|NCT02259088|562146899|FG000|Overall Study|Adverse Event|6|||
155739747|NCT02259088|562146900|FG001|Overall Study|Adverse Event|4|||
155739748|NCT02259088|562146899|FG000|Overall Study|Lost to Follow-up|2|||
155739749|NCT02259088|562146900|FG001|Overall Study|Lost to Follow-up|0|||
155739750|NCT02259088|562146899|FG000|Overall Study|Death|2|||
155739751|NCT02259088|562146900|FG001|Overall Study|Death|0|||
155739752|NCT02259088|562146899|FG000|Overall Study|Physician Decision|5|||
155739753|NCT02259088|562146900|FG001|Overall Study|Physician Decision|2|||
155739754|NCT02259088|562146899|FG000|Overall Study|Protocol deviation|5|||
155739755|NCT02259088|562146900|FG001|Overall Study|Protocol deviation|0|||
155739756|NCT02259088|562146899|FG000|Overall Study|Subject/guardian decision|8|||
155739757|NCT02259088|562146900|FG001|Overall Study|Subject/guardian decision|8|||
155739758|NCT04270370|562146902|FG000|Overall Study|Lost to Follow-up|1|||
155739759|NCT04270370|562146903|FG001|Overall Study|Lost to Follow-up|0|||
155739760|NCT04270370|562146904|FG002|Overall Study|Lost to Follow-up|0|||
155739761|NCT04270370|562146905|FG003|Overall Study|Lost to Follow-up|0|||
155739762|NCT04270370|562146906|FG004|Overall Study|Lost to Follow-up|0|||
155739763|NCT04270370|562146907|FG005|Overall Study|Lost to Follow-up|0|||
155739764|NCT04270370|562146908|FG006|Overall Study|Lost to Follow-up|0|||
155739765|NCT04270370|562146909|FG007|Overall Study|Lost to Follow-up|0|||
155739766|NCT04270370|562146910|FG008|Overall Study|Lost to Follow-up|1|||
155739767|NCT04270370|562146911|FG009|Overall Study|Lost to Follow-up|0|||
155739768|NCT04270370|562146912|FG010|Overall Study|Lost to Follow-up|0|||
155739769|NCT04270370|562146913|FG011|Overall Study|Lost to Follow-up|0|||
155739770|NCT00899431|562146914|FG000|Overall Study|Physician Decision|1|||
155739771|NCT00899431|562146915|FG001|Overall Study|Physician Decision|0|||
155739772|NCT00899431|562146916|FG002|Overall Study|Physician Decision|0|||
155739773|NCT03212144|562146917|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
155739774|NCT03212144|562146918|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
155739775|NCT03212144|562146917|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
155739776|NCT03212144|562146918|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
155739777|NCT05688670|562146919|FG000|Overall Study|Change in surgery plan|1|||
155739778|NCT05688670|562146920|FG001|Overall Study|Change in surgery plan|4|||
155739779|NCT05688670|562146919|FG000|Overall Study|Inability to extubate|1|||
155739780|NCT05688670|562146920|FG001|Overall Study|Inability to extubate|2|||
155739781|NCT05688670|562146919|FG000|Overall Study|Day of surgery cancellation|0|||
155739782|NCT05688670|562146920|FG001|Overall Study|Day of surgery cancellation|1|||
155739783|NCT05688670|562146919|FG000|Overall Study|Reintubated on PCICU arrival|0|||
155739784|NCT05688670|562146920|FG001|Overall Study|Reintubated on PCICU arrival|1|||
155739785|NCT00488683|562146921|FG000|Overall Study|Withdrawal by Subject|1|||
155739786|NCT00488683|562146922|FG001|Overall Study|Withdrawal by Subject|2|||
155393620|NCT03838198|560876822|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
155435856|NCT01591330|561022968|FG000|Period 1|Adverse Event|1|||
155739787|NCT00488683|562146923|FG002|Overall Study|Withdrawal by Subject|2|||
155739788|NCT00488683|562146921|FG000|Overall Study|Lost to Follow-up|5|||
155739789|NCT00488683|562146922|FG001|Overall Study|Lost to Follow-up|3|||
155739790|NCT00488683|562146923|FG002|Overall Study|Lost to Follow-up|0|||
155739791|NCT00488683|562146921|FG000|Overall Study|Protocol Violation|5|||
155635120|NCT02696798|561756253|FG000|Extended Treatment Period|Lack of Efficacy|7|||
155635121|NCT02696798|561756254|FG001|Extended Treatment Period|Lack of Efficacy|2|||
155635122|NCT02696798|561756255|FG002|Extended Treatment Period|Lack of Efficacy|2|||
155635123|NCT02696798|561756253|FG000|Extended Treatment Period|Lost to Follow-up|1|||
155635124|NCT02696798|561756254|FG001|Extended Treatment Period|Lost to Follow-up|0|||
155635125|NCT02696798|561756255|FG002|Extended Treatment Period|Lost to Follow-up|0|||
155635126|NCT02696798|561756253|FG000|Extended Treatment Period|Physician Decision|0|||
155635127|NCT02696798|561756254|FG001|Extended Treatment Period|Physician Decision|1|||
155635128|NCT02696798|561756255|FG002|Extended Treatment Period|Physician Decision|0|||
155635129|NCT02696798|561756253|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
155635130|NCT02696798|561756254|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
155635131|NCT02696798|561756255|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
155635132|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
155635133|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
155635134|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
155635135|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
155635136|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
155635137|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
155635138|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
155635139|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
155635140|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
155635141|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
155635142|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
155635143|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
155635144|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
155635145|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
155635146|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
155635147|NCT02696798|561756253|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
155635148|NCT02696798|561756254|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
155635149|NCT02696798|561756255|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
155739792|NCT00488683|562146922|FG001|Overall Study|Protocol Violation|1|||
155739793|NCT00488683|562146923|FG002|Overall Study|Protocol Violation|0|||
155739794|NCT00488683|562146921|FG000|Overall Study|Unable to Classify|1|||
155739795|NCT00488683|562146922|FG001|Overall Study|Unable to Classify|0|||
155739796|NCT00488683|562146923|FG002|Overall Study|Unable to Classify|0|||
155739797|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
155739798|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
155739799|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
155739800|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
155739801|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
155739802|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155739803|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155739804|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155739805|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
155739806|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155739807|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155739808|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155739809|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
155739810|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155739811|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155739812|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155739813|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
155739814|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155739815|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155739816|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155739817|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
155739818|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155739819|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155739820|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155739821|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
155739822|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155739823|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155739824|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155739825|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
155739826|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155739827|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155739828|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155739829|NCT03818035|562146924|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
155739830|NCT03818035|562146925|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
155739831|NCT03818035|562146926|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
155739832|NCT03818035|562146927|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
155739833|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155739834|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155739835|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155739836|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
155739837|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
155739838|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
155739839|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
155739840|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
155739841|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155739842|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155739843|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155739844|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
155739845|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
155739846|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
155739847|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
155739848|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
155739849|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
155739850|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
155739851|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
155739852|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
155739853|NCT03818035|562146924|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
155739854|NCT03818035|562146925|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
155739855|NCT03818035|562146926|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
155739856|NCT03818035|562146927|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
155739857|NCT02894502|562148418|FG000|Baseline|Withdrawal by Subject|24|||
155739858|NCT02894502|562148419|FG001|Baseline|Withdrawal by Subject|31|||
155739859|NCT02894502|562148420|FG002|Baseline|Withdrawal by Subject|36|||
155739860|NCT02894502|562148418|FG000|Baseline|Death|3|||
155739861|NCT02894502|562148419|FG001|Baseline|Death|1|||
155739862|NCT02894502|562148420|FG002|Baseline|Death|9|||
155739863|NCT02894502|562148418|FG000|First Follow up|Withdrawal by Subject|32|||
155739864|NCT02894502|562148419|FG001|First Follow up|Withdrawal by Subject|29|||
155739865|NCT02894502|562148420|FG002|First Follow up|Withdrawal by Subject|37|||
155739866|NCT02894502|562148418|FG000|First Follow up|Death|2|||
155739867|NCT02894502|562148419|FG001|First Follow up|Death|2|||
155739868|NCT02894502|562148420|FG002|First Follow up|Death|3|||
155393621|NCT03838198|560876823|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
155393622|NCT03838198|560876824|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
155393623|NCT02378220|560876829|FG000|Overall Study|Death|6|||
155393624|NCT02378220|560876830|FG001|Overall Study|Death|1|||
155393625|NCT00578786|560876831|FG000|Overall Study|Adverse Event|27|||
155393626|NCT00578786|560876832|FG001|Overall Study|Adverse Event|37|||
155635150|NCT04091451|561756256|FG000|Overall Study|Adverse Event|15|||
155635151|NCT04091451|561756257|FG001|Overall Study|Adverse Event|10|||
155635152|NCT04091451|561756256|FG000|Overall Study|Lost to Follow-up|8|||
155635153|NCT04091451|561756257|FG001|Overall Study|Lost to Follow-up|8|||
155635154|NCT04091451|561756256|FG000|Overall Study|Protocol Violation|5|||
155635155|NCT04091451|561756257|FG001|Overall Study|Protocol Violation|4|||
155635156|NCT04091451|561756256|FG000|Overall Study|Withdrawal by Subject|21|||
155635157|NCT04091451|561756257|FG001|Overall Study|Withdrawal by Subject|27|||
155635158|NCT04091451|561756256|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
155635159|NCT04091451|561756257|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
155635160|NCT04091451|561756256|FG000|Overall Study|Migrated/moved from the study area|3|||
155635161|NCT04091451|561756257|FG001|Overall Study|Migrated/moved from the study area|5|||
155635162|NCT04091451|561756256|FG000|Overall Study|Suspected HZ episode|1|||
155635163|NCT04091451|561756257|FG001|Overall Study|Suspected HZ episode|0|||
155635164|NCT03345004|561757859|FG000|Overall Study|Physician Decision|1|||
155635165|NCT03345004|561757860|FG001|Overall Study|Physician Decision|0|||
155635166|NCT03345004|561757859|FG000|Overall Study|Withdrawal by Subject|0|||
155635167|NCT03345004|561757860|FG001|Overall Study|Withdrawal by Subject|1|||
155635168|NCT01013753|561757863|FG000|Overall Study|Adverse Event|8|||
155635169|NCT01013753|561757863|FG000|Overall Study|Protocol Violation|3|||
155635170|NCT01013753|561757863|FG000|Overall Study|Lost to Follow-up|1|||
155635171|NCT01013753|561757863|FG000|Overall Study|Withdrawal by Subject|2|||
155635172|NCT01013753|561757863|FG000|Overall Study|Other|2|||
155635173|NCT00671060|561757866|FG000|Overall Study|Protocol Violation|1|||
155635174|NCT00671060|561757867|FG001|Overall Study|Protocol Violation|0|||
155635175|NCT00671060|561757866|FG000|Overall Study|Physician Decision|0|||
155635176|NCT00671060|561757867|FG001|Overall Study|Physician Decision|1|||
155635177|NCT01541748|561757868|FG000|Overall Study|Lost to Follow-up|17|||
155635178|NCT01541748|561757868|FG000|Overall Study|Moved out of state|1|||
155635179|NCT01541748|561757868|FG000|Overall Study|Withdrawal by Subject|7|||
155635180|NCT01541748|561757868|FG000|Overall Study|Screen failure|5|||
155635181|NCT01541748|561757868|FG000|Overall Study|Did not receive study device|1|||
155635182|NCT00785629|561757871|FG000|Overall Study|Adverse Event|2|||
155635183|NCT00785629|561757872|FG001|Overall Study|Adverse Event|1|||
155635184|NCT00785629|561757873|FG002|Overall Study|Adverse Event|1|||
155635185|NCT00785629|561757874|FG003|Overall Study|Adverse Event|5|||
155635186|NCT00785629|561757871|FG000|Overall Study|Protocol Violation|1|||
155635187|NCT00785629|561757872|FG001|Overall Study|Protocol Violation|2|||
155635188|NCT00785629|561757873|FG002|Overall Study|Protocol Violation|4|||
155635189|NCT00785629|561757874|FG003|Overall Study|Protocol Violation|5|||
155635190|NCT00785629|561757871|FG000|Overall Study|administrative decision|5|||
155635191|NCT00785629|561757872|FG001|Overall Study|administrative decision|1|||
155635192|NCT00785629|561757873|FG002|Overall Study|administrative decision|3|||
155635193|NCT00785629|561757874|FG003|Overall Study|administrative decision|4|||
155635194|NCT00785629|561757871|FG000|Overall Study|Withdrawal by Subject|0|||
155635195|NCT00785629|561757872|FG001|Overall Study|Withdrawal by Subject|1|||
155635196|NCT00785629|561757873|FG002|Overall Study|Withdrawal by Subject|2|||
155635197|NCT00785629|561757874|FG003|Overall Study|Withdrawal by Subject|2|||
155635198|NCT02107898|561757875|FG000|Overall Study|Adverse Event|4|||
155635199|NCT02107898|561757876|FG001|Overall Study|Adverse Event|7|||
155635200|NCT02107898|561757875|FG000|Overall Study|Poor compliance to protocol|0|||
155635201|NCT02107898|561757876|FG001|Overall Study|Poor compliance to protocol|1|||
155635202|NCT02107898|561757875|FG000|Overall Study|Participant moved|0|||
155635203|NCT02107898|561757876|FG001|Overall Study|Participant moved|2|||
155635204|NCT02107898|561757875|FG000|Overall Study|Consent withdrawn by participant|2|||
155635205|NCT02107898|561757876|FG001|Overall Study|Consent withdrawn by participant|1|||
155635206|NCT02107898|561757875|FG000|Overall Study|Randomized but not treated|0|||
155635207|NCT02107898|561757876|FG001|Overall Study|Randomized but not treated|1|||
155635208|NCT01283386|561757877|FG000|Overall Study|Death|2|||
155635209|NCT01283386|561757878|FG001|Overall Study|Death|0|||
155635210|NCT01283386|561757877|FG000|Overall Study|Withdrawal by Subject|2|||
155635211|NCT01283386|561757878|FG001|Overall Study|Withdrawal by Subject|1|||
155635212|NCT01283386|561757877|FG000|Overall Study|Relapse of underlying disease|1|||
155635213|NCT01283386|561757878|FG001|Overall Study|Relapse of underlying disease|3|||
155635214|NCT01283386|561757877|FG000|Overall Study|Progression of underlying disease|2|||
155635215|NCT01283386|561757878|FG001|Overall Study|Progression of underlying disease|7|||
155635216|NCT01283386|561757877|FG000|Overall Study|Reason not specified|1|||
155393627|NCT00578786|560876833|FG002|Overall Study|Adverse Event|17|||
155393628|NCT00578786|560876831|FG000|Overall Study|Lack of Efficacy|2|||
155393629|NCT00578786|560876832|FG001|Overall Study|Lack of Efficacy|5|||
155393630|NCT00578786|560876833|FG002|Overall Study|Lack of Efficacy|2|||
155393631|NCT00578786|560876831|FG000|Overall Study|Early Escape from Prior Study|2|||
155393632|NCT00578786|560876832|FG001|Overall Study|Early Escape from Prior Study|1|||
155393633|NCT00578786|560876833|FG002|Overall Study|Early Escape from Prior Study|2|||
155393634|NCT00578786|560876831|FG000|Overall Study|Withdrawal by Subject|7|||
155393635|NCT00578786|560876832|FG001|Overall Study|Withdrawal by Subject|8|||
155635217|NCT01283386|561757878|FG001|Overall Study|Reason not specified|0|||
155635218|NCT01283386|561757877|FG000|Overall Study|Protocol Violation|0|||
155635219|NCT01283386|561757878|FG001|Overall Study|Protocol Violation|1|||
155635220|NCT04727749|561757879|FG000|Overall Study|Lost to Follow-up|10|||
155635221|NCT04727749|561757880|FG001|Overall Study|Lost to Follow-up|3|||
155635222|NCT03331562|561757886|FG000|Overall Study|Adverse Event|2|||
155635223|NCT03331562|561757887|FG001|Overall Study|Adverse Event|0|||
155635224|NCT03331562|561757886|FG000|Overall Study|Death|1|||
155635225|NCT03331562|561757887|FG001|Overall Study|Death|0|||
155635226|NCT03718000|561757888|FG000|Overall Study|Relocation|2|||
155635227|NCT03718000|561757889|FG001|Overall Study|Relocation|4|||
155635228|NCT03718000|561757888|FG000|Overall Study|Pregnancy|0|||
155635229|NCT03718000|561757889|FG001|Overall Study|Pregnancy|1|||
155635230|NCT02475213|561757892|FG000|Overall Study|Adverse Event|2|||
155635231|NCT02475213|561757893|FG001|Overall Study|Adverse Event|0|||
155635232|NCT02475213|561757894|FG002|Overall Study|Adverse Event|0|||
155635233|NCT02475213|561757895|FG003|Overall Study|Adverse Event|1|||
155635234|NCT02475213|561757896|FG004|Overall Study|Adverse Event|1|||
155635235|NCT02475213|561757897|FG005|Overall Study|Adverse Event|4|||
155635236|NCT02475213|561757898|FG006|Overall Study|Adverse Event|6|||
155635237|NCT02475213|561757899|FG007|Overall Study|Adverse Event|2|||
155635238|NCT02475213|561757892|FG000|Overall Study|Physician Decision|1|||
155635239|NCT02475213|561757893|FG001|Overall Study|Physician Decision|1|||
155635240|NCT02475213|561757894|FG002|Overall Study|Physician Decision|1|||
155635241|NCT02475213|561757895|FG003|Overall Study|Physician Decision|0|||
155635242|NCT02475213|561757896|FG004|Overall Study|Physician Decision|0|||
155635243|NCT02475213|561757897|FG005|Overall Study|Physician Decision|1|||
155635244|NCT02475213|561757898|FG006|Overall Study|Physician Decision|4|||
155635245|NCT02475213|561757899|FG007|Overall Study|Physician Decision|0|||
155635246|NCT02475213|561757892|FG000|Overall Study|Progressive Disease|3|||
155635247|NCT02475213|561757893|FG001|Overall Study|Progressive Disease|2|||
155635248|NCT02475213|561757894|FG002|Overall Study|Progressive Disease|2|||
155635249|NCT02475213|561757895|FG003|Overall Study|Progressive Disease|13|||
155635250|NCT02475213|561757896|FG004|Overall Study|Progressive Disease|15|||
155635251|NCT02475213|561757897|FG005|Overall Study|Progressive Disease|25|||
155635252|NCT02475213|561757898|FG006|Overall Study|Progressive Disease|30|||
155635253|NCT02475213|561757899|FG007|Overall Study|Progressive Disease|10|||
155635254|NCT02475213|561757892|FG000|Overall Study|Death|0|||
155635255|NCT02475213|561757893|FG001|Overall Study|Death|0|||
155635256|NCT02475213|561757894|FG002|Overall Study|Death|0|||
155635257|NCT02475213|561757895|FG003|Overall Study|Death|0|||
155635258|NCT02475213|561757896|FG004|Overall Study|Death|0|||
155635259|NCT02475213|561757897|FG005|Overall Study|Death|4|||
155635260|NCT02475213|561757898|FG006|Overall Study|Death|1|||
155635261|NCT02475213|561757899|FG007|Overall Study|Death|0|||
155635262|NCT02475213|561757892|FG000|Overall Study|Protocol Violation|0|||
155635263|NCT02475213|561757893|FG001|Overall Study|Protocol Violation|0|||
155635264|NCT02475213|561757894|FG002|Overall Study|Protocol Violation|0|||
155635265|NCT02475213|561757895|FG003|Overall Study|Protocol Violation|0|||
155635266|NCT02475213|561757896|FG004|Overall Study|Protocol Violation|1|||
155635267|NCT02475213|561757897|FG005|Overall Study|Protocol Violation|0|||
155635268|NCT02475213|561757898|FG006|Overall Study|Protocol Violation|0|||
155635269|NCT02475213|561757899|FG007|Overall Study|Protocol Violation|0|||
155635270|NCT02475213|561757892|FG000|Overall Study|Withdrawal by Subject|0|||
155635271|NCT02475213|561757893|FG001|Overall Study|Withdrawal by Subject|0|||
155635272|NCT02475213|561757894|FG002|Overall Study|Withdrawal by Subject|0|||
155635273|NCT02475213|561757895|FG003|Overall Study|Withdrawal by Subject|1|||
155635274|NCT02475213|561757896|FG004|Overall Study|Withdrawal by Subject|0|||
155635275|NCT02475213|561757897|FG005|Overall Study|Withdrawal by Subject|2|||
155635276|NCT02475213|561757898|FG006|Overall Study|Withdrawal by Subject|2|||
155635277|NCT02475213|561757899|FG007|Overall Study|Withdrawal by Subject|0|||
155635278|NCT02475213|561757892|FG000|Overall Study|Other|0|||
155635279|NCT02475213|561757893|FG001|Overall Study|Other|0|||
155635280|NCT02475213|561757894|FG002|Overall Study|Other|0|||
155635281|NCT02475213|561757895|FG003|Overall Study|Other|1|||
155635282|NCT02475213|561757896|FG004|Overall Study|Other|3|||
155635283|NCT02475213|561757897|FG005|Overall Study|Other|1|||
155635284|NCT02475213|561757898|FG006|Overall Study|Other|0|||
155635285|NCT02475213|561757899|FG007|Overall Study|Other|0|||
155635286|NCT01186770|561757900|FG000|Overall Study|Ineligibility|0|||
155635287|NCT01186770|561757901|FG001|Overall Study|Ineligibility|0|||
155635288|NCT01186770|561757902|FG002|Overall Study|Ineligibility|2|||
155635289|NCT01186770|561757903|FG003|Overall Study|Ineligibility|0|||
155393636|NCT00578786|560876833|FG002|Overall Study|Withdrawal by Subject|5|||
155393637|NCT00578786|560876831|FG000|Overall Study|Protocol Violation|0|||
155393638|NCT00578786|560876832|FG001|Overall Study|Protocol Violation|3|||
155393639|NCT00578786|560876833|FG002|Overall Study|Protocol Violation|1|||
155393640|NCT00578786|560876831|FG000|Overall Study|Physician Decision|1|||
155393641|NCT00578786|560876832|FG001|Overall Study|Physician Decision|0|||
155635290|NCT01186770|561757900|FG000|Overall Study|Protocol Violation|7|||
155635291|NCT01186770|561757901|FG001|Overall Study|Protocol Violation|9|||
155635292|NCT01186770|561757902|FG002|Overall Study|Protocol Violation|12|||
155635293|NCT01186770|561757903|FG003|Overall Study|Protocol Violation|14|||
155635294|NCT01186770|561757900|FG000|Overall Study|Adverse Event|2|||
155635295|NCT01186770|561757901|FG001|Overall Study|Adverse Event|9|||
155635296|NCT01186770|561757902|FG002|Overall Study|Adverse Event|7|||
155635297|NCT01186770|561757903|FG003|Overall Study|Adverse Event|9|||
155635298|NCT01186770|561757900|FG000|Overall Study|Withdrawal by Subject|15|||
155635299|NCT01186770|561757901|FG001|Overall Study|Withdrawal by Subject|13|||
155635300|NCT01186770|561757902|FG002|Overall Study|Withdrawal by Subject|11|||
155635301|NCT01186770|561757903|FG003|Overall Study|Withdrawal by Subject|17|||
155635302|NCT01186770|561757900|FG000|Overall Study|Lost to Follow-up|10|||
155635303|NCT01186770|561757901|FG001|Overall Study|Lost to Follow-up|6|||
155635304|NCT01186770|561757902|FG002|Overall Study|Lost to Follow-up|14|||
155635305|NCT01186770|561757903|FG003|Overall Study|Lost to Follow-up|9|||
155635306|NCT01186770|561757900|FG000|Overall Study|Insufficient response to treatment|7|||
155635307|NCT01186770|561757901|FG001|Overall Study|Insufficient response to treatment|8|||
155635308|NCT01186770|561757902|FG002|Overall Study|Insufficient response to treatment|5|||
155635309|NCT01186770|561757903|FG003|Overall Study|Insufficient response to treatment|7|||
155635310|NCT01186770|561757900|FG000|Overall Study|Other than specified|0|||
155635311|NCT01186770|561757901|FG001|Overall Study|Other than specified|1|||
155635312|NCT01186770|561757902|FG002|Overall Study|Other than specified|1|||
155635313|NCT01186770|561757903|FG003|Overall Study|Other than specified|2|||
155635314|NCT00505921|561757904|FG000|Overall Study|Ineligible|1|||
155635315|NCT00505921|561757904|FG000|Overall Study|Failed to Mobilize|8|||
155635316|NCT02567188|561757905|FG000|Overall Study|Death|10|||
155635317|NCT02567188|561757905|FG000|Overall Study|Terminated Mircera Treatment|9|||
155635318|NCT02567188|561757905|FG000|Overall Study|Lost to Follow-up|5|||
155635319|NCT02567188|561757905|FG000|Overall Study|Adverse Event|1|||
155635320|NCT02567188|561757905|FG000|Overall Study|Withdrawal by Subject|1|||
155635321|NCT02567188|561757905|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
155635322|NCT02567188|561757905|FG000|Overall Study|Moved and Changed Clinic|1|||
155635323|NCT02567188|561757905|FG000|Overall Study|Started Hemodialysis|2|||
155635324|NCT02567188|561757905|FG000|Overall Study|Protocol Violation|5|||
155635325|NCT01033136|561757906|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
155635326|NCT01033136|561757907|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
155635327|NCT00630292|561757908|FG000|Overall Study|Withdrawal by Subject|1|||
155635328|NCT05383209|561757909|FG000|Overall Study|Adverse Event: Non-ocular|0|||
155635329|NCT05383209|561757910|FG001|Overall Study|Adverse Event: Non-ocular|1|||
155635330|NCT05383209|561757911|FG002|Overall Study|Adverse Event: Non-ocular|0|||
155635331|NCT05383209|561757909|FG000|Overall Study|Lost to Follow-up|2|||
155635332|NCT05383209|561757910|FG001|Overall Study|Lost to Follow-up|1|||
155635333|NCT05383209|561757911|FG002|Overall Study|Lost to Follow-up|4|||
155635334|NCT05383209|561757909|FG000|Overall Study|Withdrawal by Subject|2|||
155635335|NCT05383209|561757910|FG001|Overall Study|Withdrawal by Subject|0|||
155635336|NCT05383209|561757911|FG002|Overall Study|Withdrawal by Subject|1|||
155635337|NCT05383209|561757909|FG000|Overall Study|Death|1|||
155635338|NCT05383209|561757910|FG001|Overall Study|Death|0|||
155635339|NCT05383209|561757911|FG002|Overall Study|Death|0|||
155635340|NCT05383209|561757909|FG000|Overall Study|Other|0|||
155635341|NCT05383209|561757910|FG001|Overall Study|Other|1|||
155635342|NCT05383209|561757911|FG002|Overall Study|Other|0|||
155635343|NCT00717886|561757913|FG000|Overall Study|Withdrawal by Subject|3|||
155635344|NCT00717886|561757913|FG000|Overall Study|Treatment Failure|1|||
155635345|NCT00716417|561757914|FG000|Overall Study|Adverse Event|0|||
155635346|NCT00716417|561757915|FG001|Overall Study|Adverse Event|0|||
155635347|NCT00716417|561757916|FG002|Overall Study|Adverse Event|2|||
155635348|NCT00716417|561757917|FG003|Overall Study|Adverse Event|1|||
155635349|NCT00716417|561757918|FG004|Overall Study|Adverse Event|0|||
155635350|NCT00716417|561757919|FG005|Overall Study|Adverse Event|0|||
155635351|NCT00716417|561757920|FG006|Overall Study|Adverse Event|3|||
155393642|NCT00578786|560876833|FG002|Overall Study|Physician Decision|1|||
155635352|NCT00716417|561757921|FG007|Overall Study|Adverse Event|1|||
155635353|NCT00716417|561757922|FG008|Overall Study|Adverse Event|0|||
155635354|NCT00716417|561757923|FG009|Overall Study|Adverse Event|3|||
155635355|NCT00716417|561757914|FG000|Overall Study|Withdrawal by Subject|0|||
155635356|NCT00716417|561757915|FG001|Overall Study|Withdrawal by Subject|1|||
155635357|NCT00716417|561757916|FG002|Overall Study|Withdrawal by Subject|0|||
155635358|NCT00716417|561757917|FG003|Overall Study|Withdrawal by Subject|2|||
155635359|NCT00716417|561757918|FG004|Overall Study|Withdrawal by Subject|0|||
155635360|NCT00716417|561757919|FG005|Overall Study|Withdrawal by Subject|0|||
155739869|NCT02894502|562148418|FG000|Second Follow up|Withdrawal by Subject|13|||
155739870|NCT02894502|562148419|FG001|Second Follow up|Withdrawal by Subject|15|||
155739871|NCT02894502|562148420|FG002|Second Follow up|Withdrawal by Subject|13|||
155739872|NCT02894502|562148418|FG000|Second Follow up|Death|2|||
155739873|NCT02894502|562148419|FG001|Second Follow up|Death|3|||
155739874|NCT02894502|562148420|FG002|Second Follow up|Death|1|||
155739875|NCT02894502|562148418|FG000|Third Follow up|Withdrawal by Subject|5|||
155739876|NCT02894502|562148419|FG001|Third Follow up|Withdrawal by Subject|6|||
155739877|NCT02894502|562148420|FG002|Third Follow up|Withdrawal by Subject|3|||
155739878|NCT02894502|562148418|FG000|Third Follow up|Death|1|||
155739879|NCT02894502|562148419|FG001|Third Follow up|Death|1|||
155739880|NCT02894502|562148420|FG002|Third Follow up|Death|0|||
155739881|NCT01410357|562148421|FG000|Overall Study|Death|2|||
155739882|NCT01410357|562148422|FG001|Overall Study|Death|1|||
155739883|NCT01410357|562148421|FG000|Overall Study|Withdrawal by Subject|1|||
155739884|NCT01410357|562148422|FG001|Overall Study|Withdrawal by Subject|2|||
155739885|NCT01410357|562148421|FG000|Overall Study|Lost to Follow-up|23|||
155739886|NCT01410357|562148422|FG001|Overall Study|Lost to Follow-up|21|||
155739887|NCT00615901|562148423|FG000|Overall Study|Withdrawal by Subject|2|||
155739888|NCT00615901|562148423|FG000|Overall Study|Adverse Event|7|||
155739889|NCT00668733|562148430|FG000|Overall Study|Lost to Follow-up|2|||
155739890|NCT00668733|562148431|FG001|Overall Study|Lost to Follow-up|3|||
155739891|NCT00668733|562148430|FG000|Overall Study|Withdrawal by Subject|0|||
155393643|NCT00578786|560876831|FG000|Overall Study|Sponsor Decision|0|||
155393644|NCT00578786|560876832|FG001|Overall Study|Sponsor Decision|0|||
155393645|NCT00578786|560876833|FG002|Overall Study|Sponsor Decision|1|||
155393646|NCT00578786|560876831|FG000|Overall Study|Lost to Follow-up|0|||
155393647|NCT00578786|560876832|FG001|Overall Study|Lost to Follow-up|4|||
155393648|NCT00578786|560876833|FG002|Overall Study|Lost to Follow-up|0|||
155393649|NCT00578786|560876831|FG000|Overall Study|Pregnancy|0|||
155393650|NCT00578786|560876832|FG001|Overall Study|Pregnancy|1|||
155739892|NCT00668733|562148431|FG001|Overall Study|Withdrawal by Subject|4|||
155739893|NCT03467152|562148432|FG000|Overall Study|Adverse Event|4|||
155739894|NCT03467152|562148433|FG001|Overall Study|Adverse Event|5|||
155739895|NCT03467152|562148434|FG002|Overall Study|Adverse Event|0|||
155739896|NCT03467152|562148432|FG000|Overall Study|Subject Choice|1|||
155739897|NCT03467152|562148433|FG001|Overall Study|Subject Choice|3|||
155739898|NCT03467152|562148434|FG002|Overall Study|Subject Choice|0|||
155739899|NCT03467152|562148432|FG000|Overall Study|Lost to Follow-up|1|||
155739900|NCT03467152|562148433|FG001|Overall Study|Lost to Follow-up|0|||
155739901|NCT03467152|562148434|FG002|Overall Study|Lost to Follow-up|0|||
155393651|NCT00578786|560876833|FG002|Overall Study|Pregnancy|0|||
155393652|NCT00578786|560876831|FG000|Overall Study|Not Otherwise Specified|0|||
155393653|NCT00578786|560876832|FG001|Overall Study|Not Otherwise Specified|4|||
155393654|NCT00578786|560876833|FG002|Overall Study|Not Otherwise Specified|1|||
155393655|NCT00578786|560876831|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
155393656|NCT00578786|560876832|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
155393657|NCT00578786|560876833|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
155393658|NCT00312221|560876834|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
155393659|NCT00312221|560876835|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
155739902|NCT03467152|562148432|FG000|Overall Study|Withdrawal by Subject|4|||
155739903|NCT03467152|562148433|FG001|Overall Study|Withdrawal by Subject|2|||
155739904|NCT03467152|562148434|FG002|Overall Study|Withdrawal by Subject|0|||
155739905|NCT03467152|562148432|FG000|Overall Study|Others|3|||
155739906|NCT03467152|562148433|FG001|Overall Study|Others|0|||
155739907|NCT03467152|562148434|FG002|Overall Study|Others|0|||
155739908|NCT03467152|562148432|FG000|Overall Study|Not treated|3|||
155739909|NCT03467152|562148433|FG001|Overall Study|Not treated|1|||
155739910|NCT03467152|562148434|FG002|Overall Study|Not treated|6|||
155739911|NCT00945906|562148436|FG000|Overall Study|Withdrawal by Subject|1|||
155739912|NCT00945906|562148436|FG000|Overall Study|Did not want to return for last visit|2|||
155739913|NCT00945906|562148436|FG000|Overall Study|Unable to return for last visit|2|||
155739914|NCT00945906|562148436|FG000|Overall Study|Moved to another country|2|||
155739915|NCT03700684|562148437|FG000|Overall Study|COVID-19|0|||
155739916|NCT03700684|562148438|FG001|Overall Study|COVID-19|0|||
155739917|NCT03700684|562148439|FG002|Overall Study|COVID-19|2|||
155739918|NCT01120782|562148440|FG000|Overall Study|Test article shipping error|11|||
155739919|NCT04140227|562148441|FG000|Overall Study|Withdrawal by Subject|26|||
155739920|NCT04140227|562148441|FG000|Overall Study|Lost to Follow-up|8|||
155739921|NCT04140227|562148441|FG000|Overall Study|Adverse Event|8|||
155739922|NCT04140227|562148441|FG000|Overall Study|Death|1|||
155739923|NCT04140227|562148441|FG000|Overall Study|Other|3|||
155739924|NCT04140227|562148441|FG000|Overall Study|Protocol Violation|2|||
155739925|NCT00361634|562148446|FG000|Overall Study|Lost to Follow-up|1|||
155393660|NCT00312221|560876836|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
155393661|NCT00312221|560876837|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
155739926|NCT00361634|562148446|FG000|Overall Study|Withdrawal by Subject|1|||
155739927|NCT00635219|562148447|FG000|Overall Study|Adverse Event|12|||
155739928|NCT00635219|562148448|FG001|Overall Study|Adverse Event|10|||
155739929|NCT00635219|562148449|FG002|Overall Study|Adverse Event|18|||
155739930|NCT00635219|562148450|FG003|Overall Study|Adverse Event|15|||
155739931|NCT00635219|562148451|FG004|Overall Study|Adverse Event|19|||
155739932|NCT00635219|562148447|FG000|Overall Study|Lack of Efficacy|5|||
155739933|NCT00635219|562148448|FG001|Overall Study|Lack of Efficacy|6|||
155739934|NCT00635219|562148449|FG002|Overall Study|Lack of Efficacy|3|||
155739935|NCT00635219|562148450|FG003|Overall Study|Lack of Efficacy|4|||
155739936|NCT00635219|562148451|FG004|Overall Study|Lack of Efficacy|6|||
155739937|NCT00635219|562148447|FG000|Overall Study|Non-compliance With Study Product|0|||
155635361|NCT00716417|561757920|FG006|Overall Study|Withdrawal by Subject|1|||
155739938|NCT00635219|562148448|FG001|Overall Study|Non-compliance With Study Product|0|||
155739939|NCT00635219|562148449|FG002|Overall Study|Non-compliance With Study Product|0|||
155739940|NCT00635219|562148450|FG003|Overall Study|Non-compliance With Study Product|2|||
155739941|NCT00635219|562148451|FG004|Overall Study|Non-compliance With Study Product|1|||
155739942|NCT00635219|562148447|FG000|Overall Study|Protocol Violation|0|||
155739943|NCT00635219|562148448|FG001|Overall Study|Protocol Violation|2|||
155739944|NCT00635219|562148449|FG002|Overall Study|Protocol Violation|3|||
155739945|NCT00635219|562148450|FG003|Overall Study|Protocol Violation|2|||
155739946|NCT00635219|562148451|FG004|Overall Study|Protocol Violation|4|||
155739947|NCT00635219|562148447|FG000|Overall Study|Withdrawal of Consent|8|||
155739948|NCT00635219|562148448|FG001|Overall Study|Withdrawal of Consent|6|||
155739949|NCT00635219|562148449|FG002|Overall Study|Withdrawal of Consent|8|||
155739950|NCT00635219|562148450|FG003|Overall Study|Withdrawal of Consent|11|||
155739951|NCT00635219|562148451|FG004|Overall Study|Withdrawal of Consent|8|||
155739952|NCT00635219|562148447|FG000|Overall Study|Lost to Follow-up|0|||
155739953|NCT00635219|562148448|FG001|Overall Study|Lost to Follow-up|0|||
155739954|NCT00635219|562148449|FG002|Overall Study|Lost to Follow-up|2|||
155739955|NCT00635219|562148450|FG003|Overall Study|Lost to Follow-up|0|||
155739956|NCT00635219|562148451|FG004|Overall Study|Lost to Follow-up|3|||
155739957|NCT00635219|562148447|FG000|Overall Study|Administrative or Other Reasons|0|||
155739958|NCT00635219|562148448|FG001|Overall Study|Administrative or Other Reasons|1|||
155739959|NCT00635219|562148449|FG002|Overall Study|Administrative or Other Reasons|1|||
155635362|NCT00716417|561757921|FG007|Overall Study|Withdrawal by Subject|0|||
155635363|NCT00716417|561757922|FG008|Overall Study|Withdrawal by Subject|0|||
155635364|NCT00716417|561757923|FG009|Overall Study|Withdrawal by Subject|0|||
155635365|NCT00716417|561757914|FG000|Overall Study|Progressive disease|3|||
155635366|NCT00716417|561757915|FG001|Overall Study|Progressive disease|5|||
155635367|NCT00716417|561757916|FG002|Overall Study|Progressive disease|3|||
155635368|NCT00716417|561757917|FG003|Overall Study|Progressive disease|8|||
155635369|NCT00716417|561757918|FG004|Overall Study|Progressive disease|0|||
155635370|NCT00716417|561757919|FG005|Overall Study|Progressive disease|3|||
155635371|NCT00716417|561757920|FG006|Overall Study|Progressive disease|3|||
155635372|NCT00716417|561757921|FG007|Overall Study|Progressive disease|1|||
155635373|NCT00716417|561757922|FG008|Overall Study|Progressive disease|5|||
155635374|NCT00716417|561757923|FG009|Overall Study|Progressive disease|0|||
155635375|NCT00716417|561757914|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
155635376|NCT00716417|561757915|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
155635377|NCT00716417|561757916|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155635378|NCT00716417|561757917|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
155635379|NCT00716417|561757918|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
155635380|NCT00716417|561757919|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
155635381|NCT00716417|561757920|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
155635382|NCT00716417|561757921|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
155635383|NCT00716417|561757922|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
155635384|NCT00716417|561757923|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
155635385|NCT00716417|561757914|FG000|Overall Study|On patient request due to toxicities|0|||
155635386|NCT00716417|561757915|FG001|Overall Study|On patient request due to toxicities|0|||
155635387|NCT00716417|561757916|FG002|Overall Study|On patient request due to toxicities|0|||
155635388|NCT00716417|561757917|FG003|Overall Study|On patient request due to toxicities|0|||
155635389|NCT00716417|561757918|FG004|Overall Study|On patient request due to toxicities|0|||
155635390|NCT00716417|561757919|FG005|Overall Study|On patient request due to toxicities|0|||
155635391|NCT00716417|561757920|FG006|Overall Study|On patient request due to toxicities|0|||
155635392|NCT00716417|561757921|FG007|Overall Study|On patient request due to toxicities|1|||
155635393|NCT00716417|561757922|FG008|Overall Study|On patient request due to toxicities|0|||
155635394|NCT00716417|561757923|FG009|Overall Study|On patient request due to toxicities|0|||
155635395|NCT01553851|561757924|FG000|Overall Study|Adverse Event|2|||
155635396|NCT01553851|561757924|FG000|Overall Study|constipation|1|||
155635397|NCT02101294|561757925|FG000|Overall Study|Withdrawal by Subject|5|||
155635398|NCT02101294|561757925|FG000|Overall Study|Lost to Follow-up|6|||
155635399|NCT00797563|561757926|FG000|Overall Study|Adverse Event|1|||
155739960|NCT00635219|562148450|FG003|Overall Study|Administrative or Other Reasons|0|||
155739961|NCT00635219|562148451|FG004|Overall Study|Administrative or Other Reasons|1|||
155739962|NCT04145219|562148456|FG000|Overall Study|Adverse Event|18|||
155635400|NCT03416179|561757927|FG000|Overall Study|Death|90|||
155739963|NCT04145219|562148457|FG001|Overall Study|Adverse Event|6|||
155739964|NCT04145219|562148456|FG000|Overall Study|Lost to Follow-up|2|||
155739965|NCT04145219|562148457|FG001|Overall Study|Lost to Follow-up|3|||
155739966|NCT04145219|562148456|FG000|Overall Study|Physician Decision|0|||
155739967|NCT04145219|562148457|FG001|Overall Study|Physician Decision|2|||
155739968|NCT04145219|562148456|FG000|Overall Study|Withdrawal by Subject|12|||
155739969|NCT04145219|562148457|FG001|Overall Study|Withdrawal by Subject|8|||
155739970|NCT04145219|562148456|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
155739971|NCT04145219|562148457|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
155739972|NCT01640314|562148458|FG000|Overall Study|Protocol Violation|0|||
155739973|NCT01640314|562148459|FG001|Overall Study|Protocol Violation|1|||
155739974|NCT03672097|562148460|FG000|Period 1|Withdrawal by Subject|2|||
155739975|NCT03672097|562148460|FG000|Period 1|Adverse Event|1|||
155739976|NCT03672097|562148460|FG000|Period 1|Did not receive treatment|1|||
155739977|NCT03672097|562148460|FG000|Period 2|Withdrawal by Subject|3|||
155739978|NCT03672097|562148460|FG000|Period 2|Other|1|||
155739979|NCT01290796|562148461|FG000|Overall Study|Lost to Follow-up|21|||
155739980|NCT01290796|562148461|FG000|Overall Study|Withdrawal by Subject|4|||
155739981|NCT01290796|562148461|FG000|Overall Study|Physician Decision|2|||
155739982|NCT01290796|562148461|FG000|Overall Study|Secondary Surgical Intervention|2|||
155393662|NCT00312221|560876834|FG000|Open-label Run-in Period|Adverse Event|74|||
155393663|NCT00312221|560876835|FG001|Open-label Run-in Period|Adverse Event|0|||
155393664|NCT00312221|560876836|FG002|Open-label Run-in Period|Adverse Event|0|||
155393665|NCT00312221|560876837|FG003|Open-label Run-in Period|Adverse Event|0|||
155739983|NCT01290796|562148461|FG000|Overall Study|Withdrawal by Sponsor|1|||
155739984|NCT02709538|562148463|FG000|Overall Study|Adverse Event|13|||
155739985|NCT02709538|562148464|FG001|Overall Study|Adverse Event|2|||
155739986|NCT02709538|562148465|FG002|Overall Study|Adverse Event|3|||
155739987|NCT02709538|562148463|FG000|Overall Study|Lack of Efficacy|1|||
155739988|NCT02709538|562148464|FG001|Overall Study|Lack of Efficacy|0|||
155739989|NCT02709538|562148465|FG002|Overall Study|Lack of Efficacy|0|||
155739990|NCT02709538|562148463|FG000|Overall Study|Lost to Follow-up|24|||
155739991|NCT02709538|562148464|FG001|Overall Study|Lost to Follow-up|8|||
155739992|NCT02709538|562148465|FG002|Overall Study|Lost to Follow-up|4|||
155739993|NCT02709538|562148463|FG000|Overall Study|Physician Decision|1|||
155739994|NCT02709538|562148464|FG001|Overall Study|Physician Decision|0|||
155739995|NCT02709538|562148465|FG002|Overall Study|Physician Decision|0|||
155739996|NCT02709538|562148463|FG000|Overall Study|Withdrawal by Subject|40|||
155739997|NCT02709538|562148464|FG001|Overall Study|Withdrawal by Subject|7|||
155739998|NCT02709538|562148465|FG002|Overall Study|Withdrawal by Subject|4|||
155739999|NCT02709538|562148463|FG000|Overall Study|Non-compliance with study procedures|5|||
155740000|NCT02709538|562148464|FG001|Overall Study|Non-compliance with study procedures|0|||
155740001|NCT02709538|562148465|FG002|Overall Study|Non-compliance with study procedures|0|||
155740002|NCT02709538|562148463|FG000|Overall Study|Non-compliance with study drug|2|||
155740003|NCT02709538|562148464|FG001|Overall Study|Non-compliance with study drug|0|||
155740004|NCT02709538|562148465|FG002|Overall Study|Non-compliance with study drug|0|||
155740005|NCT02709538|562148463|FG000|Overall Study|Protocol deviation|10|||
155740006|NCT02709538|562148464|FG001|Overall Study|Protocol deviation|4|||
155740007|NCT02709538|562148465|FG002|Overall Study|Protocol deviation|4|||
155740008|NCT02709538|562148463|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
155740009|NCT02709538|562148464|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
155740010|NCT02709538|562148465|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
155393666|NCT00312221|560876834|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
155393667|NCT00312221|560876835|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
155393668|NCT00312221|560876836|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
155393669|NCT00312221|560876837|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
155740011|NCT02709538|562148463|FG000|Overall Study|Other|16|||
155740012|NCT02709538|562148464|FG001|Overall Study|Other|7|||
155740013|NCT02709538|562148465|FG002|Overall Study|Other|5|||
155740014|NCT00835211|562148467|FG000|First Intervention|Withdrawal by Subject|0|||
155740015|NCT00835211|562148468|FG001|First Intervention|Withdrawal by Subject|1|||
155740016|NCT00835211|562148467|FG000|Washout: 7 Days|Adverse Event|2|||
155740017|NCT00835211|562148468|FG001|Washout: 7 Days|Adverse Event|1|||
155740018|NCT00835211|562148467|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155740019|NCT00835211|562148468|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155740020|NCT02343549|562148469|FG000|Overall Study|Death|11|||
155740021|NCT02343549|562148469|FG000|Overall Study|Withdrawal by Subject|2|||
155740022|NCT03087617|562148470|FG000|Overall Study|Lost to Follow-up|32|||
155740023|NCT03087617|562148471|FG001|Overall Study|Lost to Follow-up|30|||
155740024|NCT03087617|562148472|FG002|Overall Study|Lost to Follow-up|30|||
155740025|NCT03087617|562148473|FG003|Overall Study|Lost to Follow-up|39|||
155740026|NCT04450381|562148475|FG000|Overall Study|Protocol Violation|4|||
155740027|NCT04450381|562148475|FG000|Overall Study|Wrong device setting|2|||
155740028|NCT01864005|562148476|FG000|Overall Study|Protocol Violation|0|||
155740029|NCT01864005|562148477|FG001|Overall Study|Protocol Violation|1|||
155740030|NCT01864005|562148476|FG000|Overall Study|Withdrawal by Subject|0|||
155740031|NCT01864005|562148477|FG001|Overall Study|Withdrawal by Subject|1|||
155740032|NCT01864005|562148476|FG000|Overall Study|Incorrect enrolment|1|||
155740033|NCT01864005|562148477|FG001|Overall Study|Incorrect enrolment|0|||
155740034|NCT01864005|562148476|FG000|Overall Study|Disease need|1|||
155740035|NCT01864005|562148477|FG001|Overall Study|Disease need|1|||
155740036|NCT01864005|562148476|FG000|Overall Study|Need GP IIb/IIIa|1|||
155740037|NCT01864005|562148477|FG001|Overall Study|Need GP IIb/IIIa|3|||
155740038|NCT02184572|562148485|FG000|Overall Study|Lost to Follow-up|29|||
155740039|NCT02184572|562148486|FG001|Overall Study|Lost to Follow-up|21|||
155740040|NCT02184572|562148485|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
155740041|NCT02184572|562148486|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
155740042|NCT02184572|562148485|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
155740043|NCT02184572|562148486|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
155740044|NCT02184572|562148485|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
155740045|NCT02184572|562148486|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
155740046|NCT02184572|562148485|FG000|Overall Study|Traveling Outside The Country|1|||
155740047|NCT02184572|562148486|FG001|Overall Study|Traveling Outside The Country|0|||
155740048|NCT02184572|562148485|FG000|Overall Study|Withdrawal by Subject|14|||
155740049|NCT02184572|562148486|FG001|Overall Study|Withdrawal by Subject|9|||
155740050|NCT00763698|562148487|FG000|Overall Study|Unsuccessful Implant|5|||
155740051|NCT00763698|562148487|FG000|Overall Study|Death|4|||
155740052|NCT00763698|562148487|FG000|Overall Study|Withdrawal by Subject|1|||
155740053|NCT00006409|562148491|FG000|Baseline|Protocol Violation|48|||
155740054|NCT00006409|562148492|FG001|Baseline|Protocol Violation|70|||
155740055|NCT00006409|562148493|FG002|Baseline|Protocol Violation|0|||
155740056|NCT00006409|562148494|FG003|Baseline|Protocol Violation|0|||
155740057|NCT00006409|562148495|FG004|Baseline|Protocol Violation|0|||
155740058|NCT00006409|562148496|FG005|Baseline|Protocol Violation|0|||
155740059|NCT00006409|562148491|FG000|Post-2 Year Intervention|Protocol Violation|0|||
155740060|NCT00006409|562148492|FG001|Post-2 Year Intervention|Protocol Violation|0|||
155740061|NCT00006409|562148493|FG002|Post-2 Year Intervention|Protocol Violation|251|||
155740062|NCT00006409|562148494|FG003|Post-2 Year Intervention|Protocol Violation|168|||
155740063|NCT00006409|562148495|FG004|Post-2 Year Intervention|Protocol Violation|0|||
155740064|NCT00006409|562148496|FG005|Post-2 Year Intervention|Protocol Violation|0|||
155740065|NCT00006409|562148491|FG000|Post-3 Year Intervention|Protocol Violation|0|||
155740066|NCT00006409|562148492|FG001|Post-3 Year Intervention|Protocol Violation|0|||
155740067|NCT00006409|562148493|FG002|Post-3 Year Intervention|Protocol Violation|0|||
155740068|NCT00006409|562148494|FG003|Post-3 Year Intervention|Protocol Violation|0|||
155740069|NCT00006409|562148495|FG004|Post-3 Year Intervention|Protocol Violation|62|||
155740070|NCT00006409|562148496|FG005|Post-3 Year Intervention|Protocol Violation|62|||
155740071|NCT03679754|562148498|FG000|Overall Study|Investigator request|1|||
155740072|NCT00964171|562148499|FG000|Overall Study|Death|5|||
155740073|NCT00080899|562148500|FG000|Overall Study|Adverse Event|1|||
155740074|NCT05343624|562148502|FG000|Overall Study|Chart review not completed|1|||
155740075|NCT02640508|562148503|FG000|Overall Study|Death|19|||
155740076|NCT02640508|562148503|FG000|Overall Study|Withdrawal by Subject|8|||
155740077|NCT02640508|562148503|FG000|Overall Study|Physician Decision|1|||
155740078|NCT02640508|562148503|FG000|Overall Study|Lost to Follow-up|1|||
155740079|NCT05405257|562148504|FG000|Overall Study|Withdrawal by Subject|1|||
155740080|NCT00776919|562148505|FG000|Overall Study|Withdrawal by Subject|16|||
155740081|NCT00776919|562148506|FG001|Overall Study|Withdrawal by Subject|14|||
155740082|NCT00776919|562148507|FG002|Overall Study|Withdrawal by Subject|15|||
155740083|NCT00776919|562148508|FG003|Overall Study|Withdrawal by Subject|26|||
155740084|NCT00776919|562148505|FG000|Overall Study|Lost to Follow-up|8|||
155740085|NCT00776919|562148506|FG001|Overall Study|Lost to Follow-up|12|||
155740086|NCT00776919|562148507|FG002|Overall Study|Lost to Follow-up|11|||
155740087|NCT00776919|562148508|FG003|Overall Study|Lost to Follow-up|8|||
155740088|NCT00776919|562148505|FG000|Overall Study|Adverse Event|1|||
155740089|NCT00776919|562148506|FG001|Overall Study|Adverse Event|0|||
155740090|NCT00776919|562148507|FG002|Overall Study|Adverse Event|2|||
155740091|NCT00776919|562148508|FG003|Overall Study|Adverse Event|2|||
155393670|NCT00312221|560876834|FG000|Open-label Run-in Period|Administrative|42|||
155393671|NCT00312221|560876835|FG001|Open-label Run-in Period|Administrative|0|||
155393672|NCT00312221|560876836|FG002|Open-label Run-in Period|Administrative|0|||
155740092|NCT00776919|562148505|FG000|Overall Study|Protocol Violation|1|||
155740093|NCT00776919|562148506|FG001|Overall Study|Protocol Violation|2|||
155740094|NCT00776919|562148507|FG002|Overall Study|Protocol Violation|0|||
155740095|NCT00776919|562148508|FG003|Overall Study|Protocol Violation|1|||
155740096|NCT00776919|562148505|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
155740097|NCT00776919|562148506|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
155740098|NCT00776919|562148507|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
155740099|NCT00776919|562148508|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
155740100|NCT03091348|562148517|FG000|Overall Study|Lost to Follow-up|2|||
155740101|NCT03091348|562148518|FG001|Overall Study|Lost to Follow-up|1|||
155740102|NCT04534686|562148519|FG000|Baseline Measurement|Lost to Follow-up|4|||
155740103|NCT04534686|562148520|FG001|Baseline Measurement|Lost to Follow-up|6|||
155393673|NCT00312221|560876837|FG003|Open-label Run-in Period|Administrative|0|||
155740104|NCT04534686|562148519|FG000|Baseline Measurement|Withdrawal by Subject|3|||
155740105|NCT04534686|562148520|FG001|Baseline Measurement|Withdrawal by Subject|1|||
155740106|NCT04534686|562148519|FG000|Intervention|Withdrawal by Subject|2|||
155740107|NCT04534686|562148520|FG001|Intervention|Withdrawal by Subject|2|||
155740108|NCT00635999|562148521|FG000|Overall Study|Withdrawal by Subject|4|||
155740109|NCT00635999|562148522|FG001|Overall Study|Withdrawal by Subject|2|||
155740110|NCT00635999|562148523|FG002|Overall Study|Withdrawal by Subject|1|||
155740111|NCT02636361|562148524|FG000|Period 4|Physician Decision|0|||
155740112|NCT02636361|562148525|FG001|Period 4|Physician Decision|0|||
155740113|NCT02636361|562148526|FG002|Period 4|Physician Decision|0|||
155740114|NCT02636361|562148527|FG003|Period 4|Physician Decision|1|||
155740115|NCT02636361|562148528|FG004|Period 4|Physician Decision|0|||
155740116|NCT03037580|562148532|FG000|Overall Study|Withdrawal by Subject|3|||
155740117|NCT03037580|562148533|FG001|Overall Study|Withdrawal by Subject|0|||
155740118|NCT03037580|562148532|FG000|Overall Study|Adverse Event|1|||
155740119|NCT03037580|562148533|FG001|Overall Study|Adverse Event|0|||
155740120|NCT03037580|562148532|FG000|Overall Study|Study Terminated by Sponsor|12|||
155740121|NCT03037580|562148533|FG001|Overall Study|Study Terminated by Sponsor|15|||
155740122|NCT03037580|562148532|FG000|Overall Study|Death|0|||
155740123|NCT03037580|562148533|FG001|Overall Study|Death|1|||
155740124|NCT02036853|562148534|FG000|Overall Study|Adverse Event|0|||
155740125|NCT02036853|562148535|FG001|Overall Study|Adverse Event|2|||
155740126|NCT02036853|562148534|FG000|Overall Study|Lack of Efficacy|0|||
155740127|NCT02036853|562148535|FG001|Overall Study|Lack of Efficacy|2|||
155740128|NCT02036853|562148534|FG000|Overall Study|Physician Decision|0|||
155740129|NCT02036853|562148535|FG001|Overall Study|Physician Decision|1|||
155740130|NCT02036853|562148534|FG000|Overall Study|Withdrawal by Subject|0|||
155740131|NCT02036853|562148535|FG001|Overall Study|Withdrawal by Subject|1|||
155740132|NCT00228553|562148536|FG000|Overall Study|Adverse Event|112|||
155740133|NCT00228553|562148536|FG000|Overall Study|Lack of Efficacy|34|||
155740134|NCT00228553|562148536|FG000|Overall Study|Lost to Follow-up|67|||
155740135|NCT00228553|562148536|FG000|Overall Study|Physician Decision|48|||
155740136|NCT00228553|562148536|FG000|Overall Study|Protocol Violation|6|||
155740137|NCT00228553|562148536|FG000|Overall Study|Withdrawal by Subject|115|||
155740138|NCT00228553|562148536|FG000|Overall Study|Pregnancy|2|||
155740139|NCT00228553|562148536|FG000|Overall Study|Miscellaneous|46|||
155740140|NCT03500224|562148540|FG000|Overall Study|Withdrawal by Subject|2|||
155740141|NCT00499590|562148541|FG000|Overall Study|Study Terminated|112|||
155740142|NCT00499590|562148542|FG001|Overall Study|Study Terminated|112|||
155740143|NCT00499590|562148543|FG002|Overall Study|Study Terminated|112|||
155740144|NCT00499590|562148541|FG000|Overall Study|Not treated|1|||
155740145|NCT00499590|562148542|FG001|Overall Study|Not treated|0|||
155740146|NCT00499590|562148543|FG002|Overall Study|Not treated|1|||
155740147|NCT01818752|562148544|FG000|Overall Study|Adverse Event|64|||
155740148|NCT01818752|562148545|FG001|Overall Study|Adverse Event|74|||
155740149|NCT01818752|562148544|FG000|Overall Study|Death|14|||
155740150|NCT01818752|562148545|FG001|Overall Study|Death|18|||
155740151|NCT01818752|562148544|FG000|Overall Study|Non-compliance|16|||
155740152|NCT01818752|562148545|FG001|Overall Study|Non-compliance|20|||
155740153|NCT01818752|562148544|FG000|Overall Study|Withdrawal by Subject|15|||
155740154|NCT01818752|562148545|FG001|Overall Study|Withdrawal by Subject|14|||
155740155|NCT01818752|562148544|FG000|Overall Study|Physician Decision|9|||
155740156|NCT01818752|562148545|FG001|Overall Study|Physician Decision|8|||
155740157|NCT01818752|562148544|FG000|Overall Study|Disease Progression|54|||
155740158|NCT01818752|562148545|FG001|Overall Study|Disease Progression|48|||
155740159|NCT01818752|562148544|FG000|Overall Study|Other|7|||
155740160|NCT01818752|562148545|FG001|Overall Study|Other|8|||
155740161|NCT01818752|562148544|FG000|Overall Study|Continuing Treatment|1|||
155740162|NCT01818752|562148545|FG001|Overall Study|Continuing Treatment|4|||
155740163|NCT01818752|562148544|FG000|Overall Study|Randomized but not Dosed|7|||
155740164|NCT01818752|562148545|FG001|Overall Study|Randomized but not Dosed|4|||
155740165|NCT01324141|562148546|FG000|Overall Study|Declined to participate before treatment started|1|||
155740166|NCT01324141|562148546|FG000|Overall Study|Disease progression on study|1|||
155740167|NCT00282308|562148547|FG000|Treatment Period|Lost to Follow-up|1|||
155740168|NCT00282308|562148548|FG001|Treatment Period|Lost to Follow-up|0|||
155740169|NCT00282308|562148549|FG002|Treatment Period|Lost to Follow-up|0|||
155740170|NCT00282308|562148547|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
155740171|NCT00282308|562148548|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
155740172|NCT00282308|562148549|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
155740173|NCT00282308|562148547|FG000|Treatment Period|Adverse Event|0|||
155740174|NCT00282308|562148548|FG001|Treatment Period|Adverse Event|2|||
155740175|NCT00282308|562148549|FG002|Treatment Period|Adverse Event|0|||
155740176|NCT00282308|562148547|FG000|Treatment Period|Not Treated with Study Drug|1|||
155740177|NCT00282308|562148548|FG001|Treatment Period|Not Treated with Study Drug|0|||
155740178|NCT00282308|562148549|FG002|Treatment Period|Not Treated with Study Drug|0|||
155283301|NCT04091672|560470702|FG001|Overall Study|Lost to Follow-up|7|||
155740179|NCT00282308|562148547|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
155740180|NCT00282308|562148548|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
155740181|NCT00282308|562148549|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
155740182|NCT00282308|562148547|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
155740183|NCT00282308|562148548|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
155740184|NCT00282308|562148549|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
155740185|NCT00282308|562148547|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
155740186|NCT00282308|562148548|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
155740187|NCT00282308|562148549|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
155740188|NCT00282308|562148547|FG000|Safety Follow-up Period|Adverse Event|0|||
155740189|NCT00282308|562148548|FG001|Safety Follow-up Period|Adverse Event|0|||
155740190|NCT00282308|562148549|FG002|Safety Follow-up Period|Adverse Event|1|||
155740191|NCT00282308|562148547|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
155740192|NCT00282308|562148548|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
155740193|NCT00282308|562148549|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
155740194|NCT00282308|562148547|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
155740195|NCT00282308|562148548|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
155740196|NCT00282308|562148549|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
155740197|NCT00282308|562148547|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
155740198|NCT00282308|562148548|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
155740199|NCT00282308|562148549|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
155740200|NCT01001325|562148550|FG000|Overall Study|Lost to Follow-up|16|||
155740201|NCT01001325|562148551|FG001|Overall Study|Lost to Follow-up|10|||
155740202|NCT01001325|562148550|FG000|Overall Study|Protocol Violation|2|||
155740203|NCT01001325|562148551|FG001|Overall Study|Protocol Violation|0|||
155740204|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
155740205|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155740206|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155740207|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155740208|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155740209|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
155740210|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
155740211|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
155740212|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
155740213|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
155740214|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
155740215|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155740216|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155740217|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155740218|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155740219|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
155740220|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
155740221|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
155740222|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
155740223|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
155740224|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
155740225|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155740226|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155740227|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155740228|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155740229|NCT01584440|562148554|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155740230|NCT01584440|562148555|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
155740231|NCT01584440|562148556|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155740232|NCT01584440|562148557|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155740233|NCT01584440|562148558|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155740234|NCT01584440|562148554|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155740235|NCT01584440|562148555|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155740236|NCT01584440|562148556|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
155740237|NCT01584440|562148557|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
155740238|NCT01584440|562148558|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155635401|NCT03416179|561757928|FG001|Overall Study|Death|87|||
155635402|NCT03416179|561757929|FG002|Overall Study|Death|117|||
155635403|NCT03416179|561757930|FG003|Overall Study|Death|113|||
155635404|NCT03416179|561757927|FG000|Overall Study|Withdrawal by Subject|15|||
155635405|NCT03416179|561757928|FG001|Overall Study|Withdrawal by Subject|20|||
155635406|NCT03416179|561757929|FG002|Overall Study|Withdrawal by Subject|6|||
155635407|NCT03416179|561757930|FG003|Overall Study|Withdrawal by Subject|9|||
155635408|NCT03416179|561757927|FG000|Overall Study|Lost to Follow-up|1|||
155635409|NCT03416179|561757928|FG001|Overall Study|Lost to Follow-up|1|||
155635410|NCT03416179|561757929|FG002|Overall Study|Lost to Follow-up|0|||
155635411|NCT03416179|561757930|FG003|Overall Study|Lost to Follow-up|3|||
155740239|NCT01584440|562148554|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
155635412|NCT03416179|561757927|FG000|Overall Study|Study participation terminated by Sponsor|93|||
155635413|NCT03416179|561757928|FG001|Overall Study|Study participation terminated by Sponsor|91|||
155635414|NCT03416179|561757929|FG002|Overall Study|Study participation terminated by Sponsor|26|||
155283302|NCT04091672|560470701|FG000|Overall Study|Withdrawal by Subject|3|||
155283303|NCT04091672|560470702|FG001|Overall Study|Withdrawal by Subject|3|||
155283304|NCT04091672|560470701|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
155283305|NCT04091672|560470702|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
155283306|NCT00359619|560470703|FG000|Overall Study|Adverse Event|0|||
155283307|NCT00359619|560470704|FG001|Overall Study|Adverse Event|0|||
155283308|NCT00359619|560470705|FG002|Overall Study|Adverse Event|1|||
155283309|NCT00359619|560470706|FG003|Overall Study|Adverse Event|0|||
155283310|NCT00359619|560470707|FG004|Overall Study|Adverse Event|0|||
155283311|NCT00359619|560470708|FG005|Overall Study|Adverse Event|0|||
155283312|NCT00359619|560470709|FG006|Overall Study|Adverse Event|1|||
155283313|NCT00359619|560470703|FG000|Overall Study|Withdrawal by Subject|3|||
155283314|NCT00359619|560470704|FG001|Overall Study|Withdrawal by Subject|1|||
155283315|NCT00359619|560470705|FG002|Overall Study|Withdrawal by Subject|4|||
155283316|NCT00359619|560470706|FG003|Overall Study|Withdrawal by Subject|2|||
155283317|NCT00359619|560470707|FG004|Overall Study|Withdrawal by Subject|2|||
155283318|NCT00359619|560470708|FG005|Overall Study|Withdrawal by Subject|0|||
155283319|NCT00359619|560470709|FG006|Overall Study|Withdrawal by Subject|3|||
155283320|NCT00359619|560470703|FG000|Overall Study|Other|1|||
155283321|NCT00359619|560470704|FG001|Overall Study|Other|0|||
155283322|NCT00359619|560470705|FG002|Overall Study|Other|0|||
155283323|NCT00359619|560470706|FG003|Overall Study|Other|0|||
155283324|NCT00359619|560470707|FG004|Overall Study|Other|0|||
155283325|NCT00359619|560470708|FG005|Overall Study|Other|0|||
155740240|NCT01584440|562148555|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
155283326|NCT00359619|560470709|FG006|Overall Study|Other|0|||
155283327|NCT00359619|560470703|FG000|Overall Study|Lost to Follow-up|4|||
155283328|NCT00359619|560470704|FG001|Overall Study|Lost to Follow-up|4|||
155283329|NCT00359619|560470705|FG002|Overall Study|Lost to Follow-up|2|||
155283330|NCT00359619|560470706|FG003|Overall Study|Lost to Follow-up|1|||
155283331|NCT00359619|560470707|FG004|Overall Study|Lost to Follow-up|1|||
155283332|NCT00359619|560470708|FG005|Overall Study|Lost to Follow-up|5|||
155283333|NCT00359619|560470709|FG006|Overall Study|Lost to Follow-up|0|||
155283334|NCT01251614|560470715|FG000|Overall Study|Adverse Event|1|||
155283335|NCT01251614|560470716|FG001|Overall Study|Adverse Event|0|||
155283336|NCT01251614|560470717|FG002|Overall Study|Adverse Event|1|||
155283337|NCT01251614|560470715|FG000|Overall Study|Lack of Efficacy|1|||
155283338|NCT01251614|560470716|FG001|Overall Study|Lack of Efficacy|9|||
155283339|NCT01251614|560470717|FG002|Overall Study|Lack of Efficacy|4|||
155283340|NCT01251614|560470715|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
155283341|NCT01251614|560470716|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
155283342|NCT01251614|560470717|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
155283343|NCT01251614|560470715|FG000|Overall Study|Pregnancy|0|||
155283344|NCT01251614|560470716|FG001|Overall Study|Pregnancy|0|||
155283345|NCT01251614|560470717|FG002|Overall Study|Pregnancy|2|||
155283346|NCT01251614|560470715|FG000|Overall Study|Loss of Disease Control|0|||
155283347|NCT01251614|560470716|FG001|Overall Study|Loss of Disease Control|1|||
155283348|NCT01251614|560470717|FG002|Overall Study|Loss of Disease Control|0|||
155283349|NCT01251614|560470715|FG000|Overall Study|Withdrawal by Subject|0|||
155283350|NCT01251614|560470716|FG001|Overall Study|Withdrawal by Subject|2|||
155283351|NCT01251614|560470717|FG002|Overall Study|Withdrawal by Subject|1|||
155740241|NCT01584440|562148556|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
155740242|NCT01584440|562148557|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
155740243|NCT01584440|562148558|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
155740244|NCT01584440|562148554|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155740245|NCT01584440|562148555|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155740246|NCT01584440|562148556|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
155740247|NCT01584440|562148557|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155740248|NCT01584440|562148558|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155740249|NCT00661427|562148559|FG000|Overall Study|Adverse Event|5|||
155740250|NCT00661427|562148560|FG001|Overall Study|Adverse Event|5|||
155740251|NCT00661427|562148559|FG000|Overall Study|Patient not treated|0|||
155740252|NCT00661427|562148560|FG001|Overall Study|Patient not treated|2|||
155740253|NCT00599339|562148561|FG000|Overall Study|Adverse Event|79|||
155740254|NCT00599339|562148561|FG000|Overall Study|Withdrawal by Subject|137|||
155740255|NCT00599339|562148561|FG000|Overall Study|Other Reason|179|||
155740256|NCT00599339|562148561|FG000|Overall Study|Lost to Follow-up|221|||
155740257|NCT00599339|562148561|FG000|Overall Study|No valid data consent|36|||
155740258|NCT00599339|562148561|FG000|Overall Study|Study Termination Status Unknown|12|||
155740259|NCT05564052|562148562|FG000|Overall Study|Withdrawal by Subject|0|||
155740260|NCT05564052|562148563|FG001|Overall Study|Withdrawal by Subject|0|||
155740261|NCT05564052|562148564|FG002|Overall Study|Withdrawal by Subject|0|||
155740262|NCT05564052|562148565|FG003|Overall Study|Withdrawal by Subject|1|||
155740263|NCT01338298|562148566|FG000|Overall Study|Withdrawal by Subject|1|||
155740264|NCT01338298|562148567|FG001|Overall Study|Withdrawal by Subject|1|||
155740265|NCT01338298|562148566|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
155740266|NCT01338298|562148567|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
155740267|NCT01338298|562148566|FG000|Overall Study|Administrative error|0|||
155740268|NCT01338298|562148567|FG001|Overall Study|Administrative error|1|||
155740269|NCT01338298|562148566|FG000|Overall Study|Positive symptom worsening|1|||
155740270|NCT01338298|562148567|FG001|Overall Study|Positive symptom worsening|0|||
155740271|NCT01338298|562148566|FG000|Overall Study|Depressive symptoms and nausea|1|||
155740272|NCT01338298|562148567|FG001|Overall Study|Depressive symptoms and nausea|0|||
155740273|NCT01338298|562148566|FG000|Overall Study|Non-adherence|1|||
155740274|NCT01338298|562148567|FG001|Overall Study|Non-adherence|0|||
155740275|NCT02872285|562148568|FG000|Overall Study|Withdrawal by Subject|2|||
155740276|NCT02872285|562148569|FG001|Overall Study|Withdrawal by Subject|0|||
155740277|NCT02872285|562148568|FG000|Overall Study|Lost to Follow-up|2|||
155740278|NCT02872285|562148569|FG001|Overall Study|Lost to Follow-up|2|||
155740279|NCT02872285|562148568|FG000|Overall Study|Discontinued due to back surgery|1|||
155740280|NCT02872285|562148569|FG001|Overall Study|Discontinued due to back surgery|0|||
155740281|NCT00531427|562148570|FG000|Overall Study|Withdrawal by Subject|7|||
155740282|NCT00531427|562148571|FG001|Overall Study|Withdrawal by Subject|13|||
155740283|NCT00531427|562148570|FG000|Overall Study|Adverse Event|44|||
155740284|NCT00531427|562148571|FG001|Overall Study|Adverse Event|30|||
155740285|NCT00531427|562148570|FG000|Overall Study|Lost to Follow-up|4|||
155740286|NCT00531427|562148571|FG001|Overall Study|Lost to Follow-up|3|||
155740287|NCT00531427|562148570|FG000|Overall Study|Lack of Efficacy|14|||
155740288|NCT00531427|562148571|FG001|Overall Study|Lack of Efficacy|39|||
155740289|NCT00531427|562148570|FG000|Overall Study|Administrative|4|||
155740290|NCT00531427|562148571|FG001|Overall Study|Administrative|9|||
155740291|NCT01253577|562148574|FG000|Overall Study|Lost to Follow-up|3|||
155740292|NCT00721968|562148575|FG000|Overall Study|Lost to Follow-up|2|||
155740293|NCT00721968|562148576|FG001|Overall Study|Lost to Follow-up|0|||
155740294|NCT01948193|562150626|FG000|Overall Study|Serious event|2|||
155740295|NCT01948193|562150626|FG000|Overall Study|Lost to Follow-up|7|||
155740296|NCT00843778|562150627|FG000|Overall Study|Adverse Event|15|||
155740297|NCT00843778|562150627|FG000|Overall Study|Lack of Efficacy|14|||
155740298|NCT00843778|562150627|FG000|Overall Study|Loss of efficacy|2|||
155740299|NCT00843778|562150627|FG000|Overall Study|Withdrawal by Subject|4|||
155740300|NCT03338959|562150628|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
155740301|NCT03338959|562150628|FG000|Overall Study|Physician Decision|1|||
155740302|NCT00409331|562150629|FG000|Overall Study|Physician Decision|1|||
155740303|NCT02184455|562150630|FG000|Overall Study|Lost to Follow-up|1|||
155740304|NCT00730028|562150634|FG000|Overall Study|Adverse Event|23|||
155740305|NCT00730028|562150635|FG001|Overall Study|Adverse Event|26|||
155740306|NCT00730028|562150636|FG002|Overall Study|Adverse Event|16|||
155740307|NCT00730028|562150637|FG003|Overall Study|Adverse Event|20|||
155740308|NCT00730028|562150638|FG004|Overall Study|Adverse Event|43|||
155740309|NCT00730028|562150634|FG000|Overall Study|Lost to Follow-up|13|||
155740310|NCT00730028|562150635|FG001|Overall Study|Lost to Follow-up|26|||
155740311|NCT00730028|562150636|FG002|Overall Study|Lost to Follow-up|22|||
155740312|NCT00730028|562150637|FG003|Overall Study|Lost to Follow-up|26|||
155740313|NCT00730028|562150638|FG004|Overall Study|Lost to Follow-up|25|||
155740314|NCT00730028|562150634|FG000|Overall Study|Protocol Violation|6|||
155740315|NCT00730028|562150635|FG001|Overall Study|Protocol Violation|1|||
155740316|NCT00730028|562150636|FG002|Overall Study|Protocol Violation|1|||
155740317|NCT00730028|562150637|FG003|Overall Study|Protocol Violation|2|||
155740318|NCT00730028|562150638|FG004|Overall Study|Protocol Violation|0|||
155740319|NCT00730028|562150634|FG000|Overall Study|Withdrawal by Subject|9|||
155740320|NCT00730028|562150635|FG001|Overall Study|Withdrawal by Subject|5|||
155740321|NCT00730028|562150636|FG002|Overall Study|Withdrawal by Subject|4|||
155740322|NCT00730028|562150637|FG003|Overall Study|Withdrawal by Subject|5|||
155740323|NCT00730028|562150638|FG004|Overall Study|Withdrawal by Subject|9|||
155740324|NCT00730028|562150634|FG000|Overall Study|Physician Decision|3|||
155740325|NCT00730028|562150635|FG001|Overall Study|Physician Decision|3|||
155740326|NCT00730028|562150636|FG002|Overall Study|Physician Decision|2|||
155740327|NCT00730028|562150637|FG003|Overall Study|Physician Decision|3|||
155740328|NCT00730028|562150638|FG004|Overall Study|Physician Decision|2|||
155740329|NCT00730028|562150634|FG000|Overall Study|Treatment Failure|5|||
155740330|NCT00730028|562150635|FG001|Overall Study|Treatment Failure|5|||
155740331|NCT00730028|562150636|FG002|Overall Study|Treatment Failure|0|||
155740332|NCT00730028|562150637|FG003|Overall Study|Treatment Failure|0|||
155740333|NCT00730028|562150638|FG004|Overall Study|Treatment Failure|1|||
155740334|NCT00730028|562150634|FG000|Overall Study|Randomization Error|1|||
155740335|NCT00730028|562150635|FG001|Overall Study|Randomization Error|0|||
155740336|NCT00730028|562150636|FG002|Overall Study|Randomization Error|0|||
155740337|NCT00730028|562150637|FG003|Overall Study|Randomization Error|0|||
155740338|NCT00730028|562150638|FG004|Overall Study|Randomization Error|2|||
155740339|NCT03680742|562150639|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
155740340|NCT01250496|562150642|FG000|Overall Study|Study terminated|124|||
155740341|NCT01250496|562150643|FG001|Overall Study|Study terminated|124|||
155740342|NCT00003590|562150644|FG000|Overall Study|Ineligible Patient|1|||
155740343|NCT00003590|562150644|FG000|Overall Study|Adverse Event|7|||
155740344|NCT00003590|562150644|FG000|Overall Study|Withdrawal by Subject|1|||
155740345|NCT00003590|562150644|FG000|Overall Study|Lack of Efficacy|11|||
155740346|NCT00003590|562150644|FG000|Overall Study|Death|1|||
155740347|NCT00003590|562150644|FG000|Overall Study|Physician Decision|1|||
155740348|NCT01425463|562150650|FG000|Overall Study|Adverse Event|5|||
155740349|NCT01425463|562150651|FG001|Overall Study|Adverse Event|7|||
155740350|NCT01425463|562150650|FG000|Overall Study|Lack of Efficacy|1|||
155740351|NCT01425463|562150651|FG001|Overall Study|Lack of Efficacy|1|||
155740352|NCT01425463|562150650|FG000|Overall Study|Protocol Violation|2|||
155740353|NCT01425463|562150651|FG001|Overall Study|Protocol Violation|2|||
155740354|NCT01425463|562150650|FG000|Overall Study|Lost to Follow-up|5|||
155740355|NCT01425463|562150651|FG001|Overall Study|Lost to Follow-up|2|||
155740356|NCT01425463|562150650|FG000|Overall Study|Withdrawal by Subject|7|||
155740357|NCT01425463|562150651|FG001|Overall Study|Withdrawal by Subject|5|||
155740358|NCT01425463|562150650|FG000|Overall Study|Unknown Reason|4|||
155740359|NCT01425463|562150651|FG001|Overall Study|Unknown Reason|7|||
155740360|NCT01236547|562150652|FG000|Overall Study|Protocol Violation|0|||
155740361|NCT01236547|562150653|FG001|Overall Study|Protocol Violation|1|||
155740362|NCT01236547|562150654|FG002|Overall Study|Protocol Violation|1|||
155740363|NCT01236547|562150655|FG003|Overall Study|Protocol Violation|6|||
155740364|NCT01236547|562150656|FG004|Overall Study|Protocol Violation|12|||
155740365|NCT01989208|562150658|FG000|200 mg (7 Days)|Protocol Violation|0|||
155740366|NCT01989208|562150659|FG001|200 mg (7 Days)|Protocol Violation|1|||
155740367|NCT04343235|562150663|FG000|Overall Study|Lost to Follow-up|3|||
155740368|NCT04343235|562150664|FG001|Overall Study|Lost to Follow-up|2|||
155740369|NCT00787267|562150665|FG000|Overall Study|Screen failure/Ineligible|10|||
155740370|NCT00787267|562150665|FG000|Overall Study|No Reason Provided|1|||
155740371|NCT00787267|562150665|FG000|Overall Study|Withdrawal by Subject|1|||
155740372|NCT01763996|562150666|FG000|Treatment Period 2|Adverse Event|0|||
155740373|NCT01763996|562150667|FG001|Treatment Period 2|Adverse Event|1|||
155740374|NCT00865280|562150668|FG000|Overall Study|Withdrawal by Subject|4|||
155740375|NCT00865280|562150669|FG001|Overall Study|Withdrawal by Subject|1|||
155740376|NCT00865280|562150668|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
155740377|NCT00865280|562150669|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
155740378|NCT00865280|562150668|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
155740379|NCT00865280|562150669|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
155740380|NCT00865280|562150668|FG000|Overall Study|Exclusion Condition|1|||
155740381|NCT00865280|562150669|FG001|Overall Study|Exclusion Condition|0|||
155740382|NCT00865280|562150668|FG000|Overall Study|Adverse Event|0|||
155740383|NCT00865280|562150669|FG001|Overall Study|Adverse Event|1|||
155740384|NCT01788215|562150672|FG000|Overall Study|Withdrawal by Subject|0|||
155740385|NCT01788215|562150673|FG001|Overall Study|Withdrawal by Subject|1|||
155740386|NCT01788215|562150672|FG000|Overall Study|Lost to Follow-up|2|||
155740387|NCT01788215|562150673|FG001|Overall Study|Lost to Follow-up|0|||
155740388|NCT03116152|562150674|FG000|Overall Study|Disease Progression|49|||
155740389|NCT03116152|562150675|FG001|Overall Study|Disease Progression|47|||
155740390|NCT03116152|562150674|FG000|Overall Study|Death|5|||
155740391|NCT03116152|562150675|FG001|Overall Study|Death|2|||
155740392|NCT03116152|562150674|FG000|Overall Study|Adverse Event|21|||
155740393|NCT03116152|562150675|FG001|Overall Study|Adverse Event|7|||
155740394|NCT03116152|562150674|FG000|Overall Study|Protocol Violation|2|||
155740395|NCT03116152|562150675|FG001|Overall Study|Protocol Violation|2|||
155740396|NCT03116152|562150674|FG000|Overall Study|Withdrawal by Subject|0|||
155740397|NCT03116152|562150675|FG001|Overall Study|Withdrawal by Subject|1|||
155740398|NCT03116152|562150674|FG000|Overall Study|Physician Decision|3|||
155740399|NCT03116152|562150675|FG001|Overall Study|Physician Decision|2|||
155740400|NCT03116152|562150674|FG000|Overall Study|other|11|||
155740401|NCT03116152|562150675|FG001|Overall Study|other|34|||
155740402|NCT00862641|562150678|FG000|Overall Study|Randomized, but drug not received|1|||
155740403|NCT00862641|562150679|FG001|Overall Study|Randomized, but drug not received|4|||
155740404|NCT00862641|562150680|FG002|Overall Study|Randomized, but drug not received|1|||
155740405|NCT00862641|562150681|FG003|Overall Study|Randomized, but drug not received|4|||
155740406|NCT03753789|562150688|FG000|Overall Study|Withdrawal by Subject|2|||
155740407|NCT00145977|562150692|FG000|Overall Study|Lack of Efficacy|0|||
155740408|NCT00145977|562150693|FG001|Overall Study|Lack of Efficacy|4|||
155740409|NCT00145977|562150692|FG000|Overall Study|Lost to Follow-up|1|||
155740410|NCT00145977|562150693|FG001|Overall Study|Lost to Follow-up|0|||
155740411|NCT00145977|562150692|FG000|Overall Study|Withdrawal by Subject|1|||
155740412|NCT00145977|562150693|FG001|Overall Study|Withdrawal by Subject|0|||
155740413|NCT01578850|562150696|FG000|Period 1|Insufficient Clinical Response|1|||
155740414|NCT01578850|562150697|FG001|Period 1|Insufficient Clinical Response|0|||
155740415|NCT01578850|562150698|FG002|Period 1|Insufficient Clinical Response|0|||
155740416|NCT01578850|562150696|FG000|Period 1|Adverse Event|11|||
155740417|NCT01578850|562150697|FG001|Period 1|Adverse Event|0|||
155740418|NCT01578850|562150698|FG002|Period 1|Adverse Event|0|||
155740419|NCT01578850|562150696|FG000|Period 1|Death|1|||
155740420|NCT01578850|562150697|FG001|Period 1|Death|0|||
155740421|NCT01578850|562150698|FG002|Period 1|Death|0|||
155740422|NCT01578850|562150696|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
155740423|NCT01578850|562150697|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
155740424|NCT01578850|562150698|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
155740425|NCT01578850|562150696|FG000|Period 1|Withdrawal by Subject|9|||
155740426|NCT01578850|562150697|FG001|Period 1|Withdrawal by Subject|0|||
155740427|NCT01578850|562150698|FG002|Period 1|Withdrawal by Subject|0|||
155740428|NCT01578850|562150696|FG000|Period 1|Study Terminated by Sponsor|3|||
155740429|NCT01578850|562150697|FG001|Period 1|Study Terminated by Sponsor|0|||
155740430|NCT01578850|562150698|FG002|Period 1|Study Terminated by Sponsor|0|||
155740431|NCT01578850|562150696|FG000|Period 2|Insufficient Clinical Response|0|||
155740432|NCT01578850|562150697|FG001|Period 2|Insufficient Clinical Response|1|||
155740433|NCT01578850|562150698|FG002|Period 2|Insufficient Clinical Response|0|||
155740434|NCT01578850|562150696|FG000|Period 2|Adverse Event|0|||
155740435|NCT01578850|562150697|FG001|Period 2|Adverse Event|3|||
155740436|NCT01578850|562150698|FG002|Period 2|Adverse Event|6|||
155740437|NCT01578850|562150696|FG000|Period 2|Lost to Follow-up|0|||
155740438|NCT01578850|562150697|FG001|Period 2|Lost to Follow-up|1|||
155740439|NCT01578850|562150698|FG002|Period 2|Lost to Follow-up|2|||
155740440|NCT01578850|562150696|FG000|Period 2|Withdrawal by Subject|0|||
155740441|NCT01578850|562150697|FG001|Period 2|Withdrawal by Subject|2|||
155740442|NCT01578850|562150698|FG002|Period 2|Withdrawal by Subject|2|||
155740443|NCT01578850|562150696|FG000|Period 2|Study Terminated by Sponsor|0|||
155740444|NCT01578850|562150697|FG001|Period 2|Study Terminated by Sponsor|5|||
155740445|NCT01578850|562150698|FG002|Period 2|Study Terminated by Sponsor|4|||
155740446|NCT01578850|562150696|FG000|Period 2|Unspecified Reasons|0|||
155740447|NCT01578850|562150697|FG001|Period 2|Unspecified Reasons|1|||
155740448|NCT01578850|562150698|FG002|Period 2|Unspecified Reasons|0|||
155740449|NCT01711216|562150703|FG000|Overall Study|Adverse Event|4|||
155740450|NCT01711216|562150703|FG000|Overall Study|Pregnancy|56|||
155740451|NCT01711216|562150703|FG000|Overall Study|Withdrawal by Subject|6|||
155740452|NCT01711216|562150703|FG000|Overall Study|Lost to Follow-up|46|||
155740453|NCT01711216|562150703|FG000|Overall Study|variety of other minor reasons|83|||
155740454|NCT01711216|562150703|FG000|Overall Study|no reason specified|22|||
155740455|NCT03060551|562150704|FG000|Overall Study|Withdrawal by Subject|1|||
155740456|NCT03060551|562150704|FG000|Overall Study|Adverse Event|1|||
155740457|NCT04629066|562150707|FG000|Overall Study|Lost to Follow-up|3|||
155740458|NCT04629066|562150708|FG001|Overall Study|Lost to Follow-up|2|||
155740459|NCT05477108|562150714|FG000|Overall Study|Participants randomized, not treated|1|||
155740460|NCT05477108|562150715|FG001|Overall Study|Participants randomized, not treated|1|||
155740461|NCT05477108|562150716|FG002|Overall Study|Participants randomized, not treated|1|||
155740462|NCT05477108|562150714|FG000|Overall Study|Physician Decision|0|||
155740463|NCT05477108|562150715|FG001|Overall Study|Physician Decision|0|||
155740464|NCT05477108|562150716|FG002|Overall Study|Physician Decision|1|||
155740465|NCT05477108|562150714|FG000|Overall Study|withdrawn from study|0|||
155740466|NCT05477108|562150715|FG001|Overall Study|withdrawn from study|0|||
155740467|NCT05477108|562150716|FG002|Overall Study|withdrawn from study|1|||
155740468|NCT02660983|562150717|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
155740469|NCT02660983|562150718|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
155740470|NCT02660983|562150717|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
155740471|NCT02660983|562150718|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
155740472|NCT02660983|562150717|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
155740473|NCT02660983|562150718|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
155740474|NCT02660983|562150717|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
155740475|NCT02660983|562150718|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
155740476|NCT02660983|562150717|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
155740477|NCT02660983|562150718|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
155740478|NCT02660983|562150717|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
155740479|NCT02660983|562150718|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
155740480|NCT02660983|562150717|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
155740481|NCT02660983|562150718|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
155740482|NCT00334113|562150720|FG000|Overall Study|Lost to Follow-up|2|||
155740483|NCT00334113|562150721|FG001|Overall Study|Lost to Follow-up|2|||
155740484|NCT00334113|562150720|FG000|Overall Study|Withdrawal by Subject|0|||
155740485|NCT00334113|562150721|FG001|Overall Study|Withdrawal by Subject|1|||
155740486|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
155740487|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
155740488|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
155740489|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
155740490|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Other|2|||
155740491|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
155740492|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
155740493|NCT02509026|562150726|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
155740494|NCT02509026|562150726|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
155740495|NCT02509026|562150726|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
155740496|NCT02509026|562150726|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
155740497|NCT02509026|562150726|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
155740498|NCT02509026|562150726|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
155740499|NCT00243841|562150730|FG000|Overall Study|Physician Decision|0|||
155740500|NCT00243841|562150731|FG001|Overall Study|Physician Decision|0|||
155740501|NCT00243841|562150732|FG002|Overall Study|Physician Decision|1|||
155740502|NCT00243841|562150733|FG003|Overall Study|Physician Decision|0|||
155740503|NCT00243841|562150734|FG004|Overall Study|Physician Decision|0|||
155393674|NCT00312221|560876834|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
155393675|NCT00312221|560876835|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
155393676|NCT00312221|560876836|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
155393677|NCT00312221|560876837|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
155393678|NCT00312221|560876834|FG000|Open-label Run-in Period|Did not qualify|5|||
155393679|NCT00312221|560876835|FG001|Open-label Run-in Period|Did not qualify|0|||
155393680|NCT00312221|560876836|FG002|Open-label Run-in Period|Did not qualify|0|||
155393681|NCT00312221|560876837|FG003|Open-label Run-in Period|Did not qualify|0|||
155393682|NCT00312221|560876834|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155393683|NCT00312221|560876835|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155393684|NCT00312221|560876836|FG002|Double-blind Phase|Withdrawal by Subject|8|||
155740504|NCT00243841|562150735|FG005|Overall Study|Physician Decision|2|||
155740505|NCT05601544|562150736|FG000|Phase 2 Period 1|Adverse Event|0|||
155740506|NCT05601544|562150737|FG001|Phase 2 Period 1|Adverse Event|1|||
155740507|NCT05601544|562150738|FG002|Phase 2 Period 1|Adverse Event|0|||
155740508|NCT05601544|562150739|FG003|Phase 2 Period 1|Adverse Event|0|||
155740509|NCT05601544|562150740|FG004|Phase 2 Period 1|Adverse Event|0|||
155740510|NCT05601544|562150741|FG005|Phase 2 Period 1|Adverse Event|0|||
155740511|NCT04303195|562150742|FG000|Overall Study|Adverse Event|1|||
155740512|NCT04303195|562150743|FG001|Overall Study|Adverse Event|3|||
155740513|NCT04303195|562150744|FG002|Overall Study|Adverse Event|7|||
155740514|NCT04303195|562150745|FG003|Overall Study|Adverse Event|0|||
155740515|NCT04303195|562150742|FG000|Overall Study|Lost to Follow-up|1|||
155740516|NCT04303195|562150743|FG001|Overall Study|Lost to Follow-up|0|||
155740517|NCT04303195|562150744|FG002|Overall Study|Lost to Follow-up|1|||
155740518|NCT04303195|562150745|FG003|Overall Study|Lost to Follow-up|4|||
155740519|NCT04303195|562150742|FG000|Overall Study|Withdrawal by Subject|3|||
155740520|NCT04303195|562150743|FG001|Overall Study|Withdrawal by Subject|1|||
155740521|NCT04303195|562150744|FG002|Overall Study|Withdrawal by Subject|1|||
155740522|NCT04303195|562150745|FG003|Overall Study|Withdrawal by Subject|1|||
155740523|NCT04303195|562150742|FG000|Overall Study|No study drug administered or protocol deviation|0|||
155740524|NCT04303195|562150743|FG001|Overall Study|No study drug administered or protocol deviation|2|||
155740525|NCT04303195|562150744|FG002|Overall Study|No study drug administered or protocol deviation|0|||
155740526|NCT04303195|562150745|FG003|Overall Study|No study drug administered or protocol deviation|2|||
155740527|NCT01064947|562150746|FG000|Overall Study|negative culture|41|||
155740528|NCT02970942|562150747|FG000|Overall Study|Death|0|||
155740529|NCT02970942|562150748|FG001|Overall Study|Death|1|||
155740530|NCT02970942|562150749|FG002|Overall Study|Death|0|||
155740531|NCT02970942|562150750|FG003|Overall Study|Death|0|||
155740532|NCT02970942|562150747|FG000|Overall Study|Lost to Follow-up|1|||
155740533|NCT02970942|562150748|FG001|Overall Study|Lost to Follow-up|0|||
155740534|NCT02970942|562150749|FG002|Overall Study|Lost to Follow-up|2|||
155740535|NCT02970942|562150750|FG003|Overall Study|Lost to Follow-up|1|||
155740536|NCT02970942|562150747|FG000|Overall Study|Withdrawal by Subject|3|||
155740537|NCT02970942|562150748|FG001|Overall Study|Withdrawal by Subject|5|||
155740538|NCT02970942|562150749|FG002|Overall Study|Withdrawal by Subject|3|||
155740539|NCT02970942|562150750|FG003|Overall Study|Withdrawal by Subject|2|||
155740540|NCT06457204|562150751|FG000|Washout|Adverse Event|0|||
155740541|NCT06457204|562150752|FG001|Washout|Adverse Event|2|||
155740542|NCT01065454|562150755|FG000|Treatment|Adverse Event|7|||
155740543|NCT01065454|562150756|FG001|Treatment|Adverse Event|4|||
155740544|NCT01065454|562150757|FG002|Treatment|Adverse Event|3|||
155740545|NCT01065454|562150758|FG003|Treatment|Adverse Event|6|||
155740546|NCT01065454|562150755|FG000|Treatment|Death|1|||
155740547|NCT01065454|562150756|FG001|Treatment|Death|0|||
155740548|NCT01065454|562150757|FG002|Treatment|Death|0|||
155740549|NCT01065454|562150758|FG003|Treatment|Death|0|||
155740550|NCT01065454|562150755|FG000|Treatment|Non-compliance|1|||
155740551|NCT01065454|562150756|FG001|Treatment|Non-compliance|0|||
155740552|NCT01065454|562150757|FG002|Treatment|Non-compliance|0|||
155740553|NCT01065454|562150758|FG003|Treatment|Non-compliance|1|||
155740554|NCT01065454|562150755|FG000|Treatment|Protocol Decision|0|||
155740555|NCT01065454|562150756|FG001|Treatment|Protocol Decision|0|||
155740556|NCT01065454|562150757|FG002|Treatment|Protocol Decision|3|||
155740557|NCT01065454|562150758|FG003|Treatment|Protocol Decision|2|||
155740558|NCT01065454|562150755|FG000|Treatment|Protocol Violation|1|||
155740559|NCT01065454|562150756|FG001|Treatment|Protocol Violation|0|||
155740560|NCT01065454|562150757|FG002|Treatment|Protocol Violation|1|||
155740561|NCT01065454|562150758|FG003|Treatment|Protocol Violation|0|||
155393685|NCT00312221|560876837|FG003|Double-blind Phase|Withdrawal by Subject|7|||
155740562|NCT01065454|562150755|FG000|Treatment|Withdrawal by Subject|3|||
155740563|NCT01065454|562150756|FG001|Treatment|Withdrawal by Subject|1|||
155740564|NCT01065454|562150757|FG002|Treatment|Withdrawal by Subject|2|||
155740565|NCT01065454|562150758|FG003|Treatment|Withdrawal by Subject|3|||
155740566|NCT01065454|562150755|FG000|Follow up|Adverse Event|1|||
155740567|NCT01065454|562150756|FG001|Follow up|Adverse Event|0|||
155740568|NCT01065454|562150757|FG002|Follow up|Adverse Event|0|||
155740569|NCT01065454|562150758|FG003|Follow up|Adverse Event|1|||
155740570|NCT01065454|562150755|FG000|Follow up|Death|0|||
155740571|NCT01065454|562150756|FG001|Follow up|Death|1|||
155740572|NCT01065454|562150757|FG002|Follow up|Death|1|||
155740573|NCT01065454|562150758|FG003|Follow up|Death|0|||
155740574|NCT01065454|562150755|FG000|Follow up|Lost to Follow-up|0|||
155740575|NCT01065454|562150756|FG001|Follow up|Lost to Follow-up|0|||
155740576|NCT01065454|562150757|FG002|Follow up|Lost to Follow-up|0|||
155740577|NCT01065454|562150758|FG003|Follow up|Lost to Follow-up|1|||
155740578|NCT01065454|562150755|FG000|Follow up|Progressive disease|0|||
155740579|NCT01065454|562150756|FG001|Follow up|Progressive disease|0|||
155740580|NCT01065454|562150757|FG002|Follow up|Progressive disease|0|||
155740581|NCT01065454|562150758|FG003|Follow up|Progressive disease|1|||
155740582|NCT01065454|562150755|FG000|Follow up|Withdrawal by Subject|1|||
155740583|NCT01065454|562150756|FG001|Follow up|Withdrawal by Subject|1|||
155740584|NCT01065454|562150757|FG002|Follow up|Withdrawal by Subject|1|||
155740585|NCT01065454|562150758|FG003|Follow up|Withdrawal by Subject|0|||
155740586|NCT01065454|562150755|FG000|Follow up|study ongoing|37|||
155740587|NCT01065454|562150756|FG001|Follow up|study ongoing|22|||
155740588|NCT01065454|562150757|FG002|Follow up|study ongoing|15|||
155740589|NCT01065454|562150758|FG003|Follow up|study ongoing|41|||
155740590|NCT01601652|562150760|FG000|Overall Study|Death|1|||
155740591|NCT03374202|562150776|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
155740592|NCT03374202|562150777|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
155740593|NCT03374202|562150778|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
155740594|NCT03374202|562150776|FG000|Five Year Long Term Follow Up|Death|0|||
155740595|NCT03374202|562150777|FG001|Five Year Long Term Follow Up|Death|1|||
155740596|NCT03374202|562150778|FG002|Five Year Long Term Follow Up|Death|0|||
155740597|NCT00336856|562152608|FG000|Overall Study|Withdrawal by Subject|3|||
155740598|NCT00336856|562152608|FG000|Overall Study|Found ineligible at time of analysis|1|||
155740599|NCT01325337|562152609|FG000|Overall Study|Adverse Event|0|||
155740600|NCT01325337|562152610|FG001|Overall Study|Adverse Event|2|||
155740601|NCT01325337|562152611|FG002|Overall Study|Adverse Event|2|||
155740602|NCT01325337|562152612|FG003|Overall Study|Adverse Event|1|||
155740603|NCT01325337|562152613|FG004|Overall Study|Adverse Event|2|||
155740604|NCT01325337|562152609|FG000|Overall Study|Lost to Follow-up|2|||
155740605|NCT01325337|562152610|FG001|Overall Study|Lost to Follow-up|2|||
155740606|NCT01325337|562152611|FG002|Overall Study|Lost to Follow-up|2|||
155740607|NCT01325337|562152612|FG003|Overall Study|Lost to Follow-up|1|||
155740608|NCT01325337|562152613|FG004|Overall Study|Lost to Follow-up|2|||
155740609|NCT01325337|562152609|FG000|Overall Study|Personal Reasons|2|||
155740610|NCT01325337|562152610|FG001|Overall Study|Personal Reasons|5|||
155740611|NCT01325337|562152611|FG002|Overall Study|Personal Reasons|4|||
155740612|NCT01325337|562152612|FG003|Overall Study|Personal Reasons|8|||
155740613|NCT01325337|562152613|FG004|Overall Study|Personal Reasons|3|||
155740614|NCT01325337|562152609|FG000|Overall Study|Withdrawal by Subject|1|||
155740615|NCT01325337|562152610|FG001|Overall Study|Withdrawal by Subject|0|||
155740616|NCT01325337|562152611|FG002|Overall Study|Withdrawal by Subject|1|||
155740617|NCT01325337|562152612|FG003|Overall Study|Withdrawal by Subject|0|||
155740618|NCT01325337|562152613|FG004|Overall Study|Withdrawal by Subject|1|||
155740619|NCT01332799|562152630|FG000|Overall Study|Insufficient funding|10|||
155740620|NCT01332799|562152631|FG001|Overall Study|Insufficient funding|10|||
155740621|NCT00538785|562152634|FG000|Overall Study|Death|9|||
155740622|NCT00538785|562152635|FG001|Overall Study|Death|10|||
155740623|NCT00538785|562152634|FG000|Overall Study|Withdrawal of consent|9|||
155740624|NCT00538785|562152635|FG001|Overall Study|Withdrawal of consent|7|||
155740625|NCT00538785|562152634|FG000|Overall Study|Lost to Follow-up|1|||
155740626|NCT00538785|562152635|FG001|Overall Study|Lost to Follow-up|0|||
155740627|NCT04022733|562152636|FG000|Overall Study|conversion to open surgery|3|||
155740628|NCT04022733|562152637|FG001|Overall Study|conversion to open surgery|2|||
155740629|NCT04022733|562152636|FG000|Overall Study|bradycardia|0|||
155740630|NCT04022733|562152637|FG001|Overall Study|bradycardia|1|||
155740631|NCT05315908|562152645|FG000|Overall Study|Lost to Follow-up|4477|||
155740632|NCT05315908|562152646|FG001|Overall Study|Lost to Follow-up|4606|||
155740633|NCT01598129|562152655|FG000|Overall Study|Disease progression|6|||
155740634|NCT01598129|562152655|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
155740635|NCT01598129|562152655|FG000|Overall Study|Withdrawal by Subject|1|||
155740636|NCT00505076|562152656|FG000|Overall Study|Adverse Event|1|||
155740637|NCT00505076|562152657|FG001|Overall Study|Adverse Event|0|||
155740638|NCT00505076|562152658|FG002|Overall Study|Adverse Event|1|||
155740639|NCT00505076|562152656|FG000|Overall Study|Protocol Violation|2|||
155740640|NCT00505076|562152657|FG001|Overall Study|Protocol Violation|1|||
155740641|NCT00505076|562152658|FG002|Overall Study|Protocol Violation|2|||
155740642|NCT00505076|562152656|FG000|Overall Study|Withdrawal by Subject|0|||
155283352|NCT01251614|560470715|FG000|Overall Study|Lost to Follow-up|0|||
155740643|NCT00505076|562152657|FG001|Overall Study|Withdrawal by Subject|1|||
155740644|NCT00505076|562152658|FG002|Overall Study|Withdrawal by Subject|2|||
155740645|NCT04093024|562152661|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
155740646|NCT04093024|562152662|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
155740647|NCT04093024|562152661|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
155740648|NCT04093024|562152662|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
155740649|NCT04093024|562152661|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
155740650|NCT04093024|562152662|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
155740651|NCT04093024|562152661|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
155740652|NCT04093024|562152662|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
155740653|NCT00647270|562152667|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
155740654|NCT00647270|562152668|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
155740655|NCT00647270|562152669|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
155393686|NCT00312221|560876834|FG000|Double-blind Phase|Adverse Event|0|||
155393687|NCT00312221|560876835|FG001|Double-blind Phase|Adverse Event|10|||
155393688|NCT00312221|560876836|FG002|Double-blind Phase|Adverse Event|19|||
155393689|NCT00312221|560876837|FG003|Double-blind Phase|Adverse Event|18|||
155393690|NCT00312221|560876834|FG000|Double-blind Phase|Lost to Follow-up|0|||
155393691|NCT00312221|560876835|FG001|Double-blind Phase|Lost to Follow-up|0|||
155393692|NCT00312221|560876836|FG002|Double-blind Phase|Lost to Follow-up|2|||
155393693|NCT00312221|560876837|FG003|Double-blind Phase|Lost to Follow-up|2|||
155393694|NCT00312221|560876834|FG000|Double-blind Phase|Administrative|0|||
155393695|NCT00312221|560876835|FG001|Double-blind Phase|Administrative|26|||
155393696|NCT00312221|560876836|FG002|Double-blind Phase|Administrative|37|||
155393697|NCT00312221|560876837|FG003|Double-blind Phase|Administrative|33|||
155393698|NCT00312221|560876834|FG000|Double-blind Phase|Lack of Efficacy|0|||
155393699|NCT00312221|560876835|FG001|Double-blind Phase|Lack of Efficacy|17|||
155393700|NCT00312221|560876836|FG002|Double-blind Phase|Lack of Efficacy|6|||
155393701|NCT00312221|560876837|FG003|Double-blind Phase|Lack of Efficacy|10|||
155393702|NCT02060721|560876838|FG000|Overall Study|Lost to Follow-up|1|||
155393703|NCT02060721|560876838|FG000|Overall Study|Physician Decision|2|||
155393704|NCT02060721|560876838|FG000|Overall Study|Death|14|||
155393705|NCT02060721|560876838|FG000|Overall Study|Withdrawal by Subject|2|||
155393706|NCT02060721|560876838|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
155393707|NCT05105789|560876839|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
155393708|NCT02558231|560876843|FG000|Overall Study|Death|4|||
155393709|NCT02558231|560876844|FG001|Overall Study|Death|12|||
155393710|NCT02558231|560876843|FG000|Overall Study|Lost to Follow-up|7|||
155393711|NCT02558231|560876844|FG001|Overall Study|Lost to Follow-up|4|||
155393712|NCT02558231|560876843|FG000|Overall Study|Withdrawal by Subject|7|||
155393713|NCT02558231|560876844|FG001|Overall Study|Withdrawal by Subject|4|||
155393714|NCT02558231|560876843|FG000|Overall Study|Physician Decision|7|||
155393715|NCT02558231|560876844|FG001|Overall Study|Physician Decision|5|||
155393716|NCT02558231|560876843|FG000|Overall Study|Sponsor Decision|0|||
155393717|NCT02558231|560876844|FG001|Overall Study|Sponsor Decision|1|||
155393718|NCT02066051|560876847|FG000|Overall Study|Subject developed active GVHD|1|||
155393719|NCT01294150|560876848|FG000|Overall Study|Physician Decision|2|||
155393720|NCT01294150|560876849|FG001|Overall Study|Physician Decision|2|||
155393721|NCT01093625|560876850|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
155393722|NCT01093625|560876851|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
155393723|NCT01093625|560876850|FG000|2-Week Visit|Withdrawal by Subject|1|||
155393724|NCT01093625|560876851|FG001|2-Week Visit|Withdrawal by Subject|0|||
155393725|NCT01093625|560876850|FG000|1-Month Visit|Lost to Follow-up|2|||
155393726|NCT01093625|560876851|FG001|1-Month Visit|Lost to Follow-up|0|||
155393727|NCT01093625|560876850|FG000|3-Month Visit|Lost to Follow-up|2|||
155393728|NCT01093625|560876851|FG001|3-Month Visit|Lost to Follow-up|0|||
155393729|NCT01093625|560876850|FG000|6-Month Visit|Withdrawal by Subject|6|||
155393730|NCT01093625|560876851|FG001|6-Month Visit|Withdrawal by Subject|7|||
155393731|NCT01093625|560876850|FG000|6-Month Visit|Lost to Follow-up|2|||
155393732|NCT01093625|560876851|FG001|6-Month Visit|Lost to Follow-up|2|||
155393733|NCT01093625|560876850|FG000|1-Year Visit|Lost to Follow-up|5|||
155393734|NCT01093625|560876851|FG001|1-Year Visit|Lost to Follow-up|3|||
155393735|NCT02608879|560876852|FG000|Overall Study|Lost to Follow-up|1|||
155393736|NCT02608879|560876853|FG001|Overall Study|Lost to Follow-up|0|||
155393737|NCT02608879|560876854|FG002|Overall Study|Lost to Follow-up|0|||
155393738|NCT02608879|560876852|FG000|Overall Study|Did not meet continuation criteria|0|||
155393739|NCT02608879|560876853|FG001|Overall Study|Did not meet continuation criteria|0|||
155393740|NCT02608879|560876854|FG002|Overall Study|Did not meet continuation criteria|3|||
155393741|NCT01840605|560876855|FG000|Overall Study|Adverse Event|0|||
155393742|NCT01840605|560876856|FG001|Overall Study|Adverse Event|1|||
155393743|NCT01840605|560876855|FG000|Overall Study|Physician Decision|2|||
155393744|NCT01840605|560876856|FG001|Overall Study|Physician Decision|1|||
155393745|NCT03739437|560876857|FG000|Overall Study|Lost to Follow-up|2|||
155393746|NCT03739437|560876858|FG001|Overall Study|Lost to Follow-up|5|||
155393747|NCT03359590|560876859|FG000|First Intervention|Withdrawal by Subject|1|||
155393748|NCT03359590|560876860|FG001|First Intervention|Withdrawal by Subject|1|||
155393749|NCT03359590|560876859|FG000|First Intervention|Protocol Violation|0|||
155393750|NCT03359590|560876860|FG001|First Intervention|Protocol Violation|1|||
155393751|NCT01557348|560876861|FG000|Overall Study|Adverse Event|6|||
155393752|NCT01557348|560876862|FG001|Overall Study|Adverse Event|16|||
155393753|NCT01557348|560876861|FG000|Overall Study|Infusion reaction event|5|||
155393754|NCT01557348|560876862|FG001|Overall Study|Infusion reaction event|5|||
155393755|NCT01557348|560876861|FG000|Overall Study|Death|7|||
155393756|NCT01557348|560876862|FG001|Overall Study|Death|4|||
155393757|NCT01557348|560876861|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155393758|NCT01557348|560876862|FG001|Overall Study|Insufficient Therapeutic Response|28|||
155393759|NCT01557348|560876861|FG000|Overall Study|Withdrawal by Subject|5|||
155393760|NCT01557348|560876862|FG001|Overall Study|Withdrawal by Subject|4|||
155740656|NCT00647270|562152667|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
155740657|NCT00647270|562152668|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
155740658|NCT00647270|562152669|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
155393761|NCT01557348|560876861|FG000|Overall Study|Lost to Follow-up|26|||
155393762|NCT01557348|560876862|FG001|Overall Study|Lost to Follow-up|22|||
155740659|NCT00647270|562152667|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
155740660|NCT00647270|562152668|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
155740661|NCT00647270|562152669|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
155740662|NCT00647270|562152667|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
155740663|NCT00647270|562152668|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
155740664|NCT00647270|562152669|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
155740665|NCT00647270|562152667|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
155740666|NCT00647270|562152668|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
155740667|NCT00647270|562152669|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
155393763|NCT01557348|560876861|FG000|Overall Study|Administrative|18|||
155393764|NCT01557348|560876862|FG001|Overall Study|Administrative|11|||
155393765|NCT06132425|560876863|FG000|Overall Study|Withdrawal by Subject|3|||
155393766|NCT06132425|560876864|FG001|Overall Study|Withdrawal by Subject|0|||
155393767|NCT06132425|560876863|FG000|Overall Study|Did not follow study instructions|0|||
155393768|NCT06132425|560876864|FG001|Overall Study|Did not follow study instructions|2|||
155393769|NCT06132425|560876863|FG000|Overall Study|Lost to Follow-up|3|||
155393770|NCT06132425|560876864|FG001|Overall Study|Lost to Follow-up|5|||
155393771|NCT04014361|560876865|FG000|Period 2|Physician Decision|0|||
155393772|NCT04014361|560876866|FG001|Period 2|Physician Decision|0|||
155393773|NCT04014361|560876867|FG002|Period 2|Physician Decision|0|||
155393774|NCT04014361|560876868|FG003|Period 2|Physician Decision|1|||
155393775|NCT04014361|560876869|FG004|Period 2|Physician Decision|0|||
155393776|NCT04014361|560876870|FG005|Period 2|Physician Decision|0|||
155393777|NCT04014361|560876871|FG006|Period 2|Physician Decision|0|||
155393778|NCT04014361|560876872|FG007|Period 2|Physician Decision|0|||
155740668|NCT00647270|562152667|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
155740669|NCT00647270|562152668|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
155740670|NCT00647270|562152669|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
155740671|NCT00647270|562152667|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
155740672|NCT00647270|562152668|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
155740673|NCT00647270|562152669|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
155740674|NCT03615040|562152670|FG000|Overall Study|Withdrawal by Subject|2|||
155740675|NCT03615040|562152671|FG001|Overall Study|Withdrawal by Subject|1|||
155740676|NCT03615040|562152670|FG000|Overall Study|Physician Decision|2|||
155740677|NCT03615040|562152671|FG001|Overall Study|Physician Decision|2|||
155740678|NCT03615040|562152670|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
155740679|NCT03615040|562152671|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
155740680|NCT03615040|562152670|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
155740681|NCT03615040|562152671|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
155740682|NCT03615040|562152670|FG000|Overall Study|Death|0|||
155740683|NCT03615040|562152671|FG001|Overall Study|Death|2|||
155740684|NCT01541397|562152674|FG000|Overall Study|Study ended prior to data collection|4|||
155740685|NCT01541397|562152675|FG001|Overall Study|Study ended prior to data collection|2|||
155740686|NCT01128621|562152678|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
155740687|NCT01128621|562152679|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
155740688|NCT00233454|562152680|FG000|Overall Study|Death|6|||
155740689|NCT00388583|562152683|FG000|Overall Study|Protocol Violation|1|||
155740690|NCT00388583|562152684|FG001|Overall Study|Protocol Violation|0|||
155740691|NCT00388583|562152683|FG000|Overall Study|Withdrawal by Subject|3|||
155740692|NCT00388583|562152684|FG001|Overall Study|Withdrawal by Subject|3|||
155393779|NCT06308666|560876873|FG000|Overall Study|Withdrawal by Subject|1|||
155393780|NCT06308666|560876873|FG000|Overall Study|Protocol Violation|2|||
155740693|NCT00388583|562152683|FG000|Overall Study|Serious Adverse Event|2|||
155740694|NCT00388583|562152684|FG001|Overall Study|Serious Adverse Event|0|||
155740695|NCT00388583|562152683|FG000|Overall Study|Did not receive vaccine|0|||
155740696|NCT00388583|562152684|FG001|Overall Study|Did not receive vaccine|1|||
155740697|NCT05194579|562152685|FG000|Overall Study|Lost to Follow-up|2|||
155740698|NCT05194579|562152686|FG001|Overall Study|Lost to Follow-up|3|||
155740699|NCT05194579|562152685|FG000|Overall Study|Withdrawal by Subject|3|||
155740700|NCT05194579|562152686|FG001|Overall Study|Withdrawal by Subject|4|||
155740701|NCT05194579|562152685|FG000|Overall Study|Refused further study procedures|0|||
155740702|NCT05194579|562152686|FG001|Overall Study|Refused further study procedures|1|||
155740703|NCT05194579|562152685|FG000|Overall Study|Protocol deviation|1|||
155740704|NCT05194579|562152686|FG001|Overall Study|Protocol deviation|0|||
155740705|NCT03595228|562152691|FG000|Overall Study|Death|2|||
155740706|NCT03595228|562152691|FG000|Overall Study|Lack of Efficacy|13|||
155740707|NCT03595228|562152691|FG000|Overall Study|Withdrawal by Subject|3|||
155740708|NCT03595228|562152691|FG000|Overall Study|Withdrawal by Sponsor|1|||
155740709|NCT01639729|562152692|FG000|Overall Study|Withdrawal by Subject|1|||
155740710|NCT01639729|562152693|FG001|Overall Study|Withdrawal by Subject|0|||
155740711|NCT01639729|562152694|FG002|Overall Study|Withdrawal by Subject|1|||
155740712|NCT01639729|562152695|FG003|Overall Study|Withdrawal by Subject|1|||
155740713|NCT01639729|562152696|FG004|Overall Study|Withdrawal by Subject|0|||
155740714|NCT01639729|562152697|FG005|Overall Study|Withdrawal by Subject|0|||
155740715|NCT03232333|562152698|FG000|Overall Study|Infection or Osteomyelitis|9|||
155740716|NCT03232333|562152698|FG000|Overall Study|Lost to Follow-up|4|||
155740717|NCT03232333|562152698|FG000|Overall Study|Withdrawal by Subject|2|||
155740718|NCT01253811|562152699|FG000|Overall Study|Withdrawal criteria|1|||
155740719|NCT00759564|562152700|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
155740720|NCT00759564|562152701|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
155740721|NCT00759564|562152702|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
155740722|NCT00759564|562152703|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
155393781|NCT01130051|560876875|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
155740723|NCT00759564|562152704|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
155740724|NCT04975438|562152711|FG000|Overall Study|Lost to Follow-up|1|||
155740725|NCT04975438|562152712|FG001|Overall Study|Lost to Follow-up|0|||
155740726|NCT04975438|562152713|FG002|Overall Study|Lost to Follow-up|1|||
155740727|NCT04975438|562152714|FG003|Overall Study|Lost to Follow-up|0|||
155740728|NCT04975438|562152711|FG000|Overall Study|Withdrawal by Subject|1|||
155740729|NCT04975438|562152712|FG001|Overall Study|Withdrawal by Subject|0|||
155740730|NCT04975438|562152713|FG002|Overall Study|Withdrawal by Subject|0|||
155740731|NCT04975438|562152714|FG003|Overall Study|Withdrawal by Subject|0|||
155740732|NCT04973436|562152715|FG000|Overall Study|Lost to Follow-up|3|||
155740733|NCT04973436|562152715|FG000|Overall Study|Withdrawal by Subject|1|||
155740734|NCT04973436|562152715|FG000|Overall Study|Death|2|||
155740735|NCT01276054|562152716|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
155740736|NCT01276054|562152717|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
155740737|NCT01419197|562152721|FG000|Overall Study|Death|247|||
155393782|NCT01130051|560876876|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
155393783|NCT01130051|560876875|FG000|Washout Period of 14 Days|Protocol Violation|1|||
155393784|NCT01130051|560876876|FG001|Washout Period of 14 Days|Protocol Violation|1|||
155393785|NCT04252287|560876878|FG000|Overall Study|Death|5|||
155393786|NCT04252287|560876879|FG001|Overall Study|Death|3|||
155393787|NCT04252287|560876878|FG000|Overall Study|Lost to Follow-up|4|||
155393788|NCT04252287|560876879|FG001|Overall Study|Lost to Follow-up|6|||
155393789|NCT04252287|560876878|FG000|Overall Study|Withdrawal by Subject|19|||
155393790|NCT04252287|560876879|FG001|Overall Study|Withdrawal by Subject|16|||
155393791|NCT04252287|560876878|FG000|Overall Study|Protocol Violation|3|||
155393792|NCT04252287|560876879|FG001|Overall Study|Protocol Violation|4|||
155393793|NCT00835120|560876881|FG000|Overall Study|Lack of Efficacy|1|||
155393794|NCT00835120|560876881|FG000|Overall Study|Lost to Follow-up|3|||
155393795|NCT00835120|560876881|FG000|Overall Study|Adverse Event|2|||
155393796|NCT00835120|560876881|FG000|Overall Study|Withdrawal by Subject|2|||
155393797|NCT02499770|560876882|FG000|Overall Study|Death|17|||
155393798|NCT02499770|560876883|FG001|Overall Study|Death|56|||
155393799|NCT02499770|560876882|FG000|Overall Study|Study completion|1|||
155393800|NCT02499770|560876883|FG001|Overall Study|Study completion|10|||
155393801|NCT02499770|560876882|FG000|Overall Study|Withdrawal by Subject|0|||
155393802|NCT02499770|560876883|FG001|Overall Study|Withdrawal by Subject|7|||
155393803|NCT02499770|560876882|FG000|Overall Study|Lost to Follow-up|0|||
155393804|NCT02499770|560876883|FG001|Overall Study|Lost to Follow-up|2|||
155393805|NCT02499770|560876882|FG000|Overall Study|Subject declined further treatment|1|||
155740738|NCT01419197|562152722|FG001|Overall Study|Death|122|||
155740739|NCT01419197|562152721|FG000|Overall Study|Physician Decision|4|||
155740740|NCT01419197|562152722|FG001|Overall Study|Physician Decision|4|||
155740741|NCT01419197|562152721|FG000|Overall Study|Non-compliance|3|||
155740742|NCT01419197|562152722|FG001|Overall Study|Non-compliance|1|||
155740743|NCT01419197|562152721|FG000|Overall Study|Withdrawal by Subject|33|||
155740744|NCT01419197|562152722|FG001|Overall Study|Withdrawal by Subject|32|||
155740745|NCT01419197|562152721|FG000|Overall Study|Study Completed by Sponsor|103|||
155740746|NCT01419197|562152722|FG001|Overall Study|Study Completed by Sponsor|34|||
155740747|NCT01419197|562152721|FG000|Overall Study|Reason Not Specified|0|||
155393806|NCT02499770|560876883|FG001|Overall Study|Subject declined further treatment|0|||
155393807|NCT02499770|560876882|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
155393808|NCT02499770|560876883|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
155393809|NCT02499770|560876882|FG000|Overall Study|Randomized but not enrolled|0|||
155393810|NCT02499770|560876883|FG001|Overall Study|Randomized but not enrolled|1|||
155393811|NCT01019980|560876886|FG000|Overall Study|Drug not available.|2|||
155393812|NCT01019980|560876887|FG001|Overall Study|Drug not available.|0|||
155393813|NCT03610165|560876888|FG000|Overall Study|Device didn't work|0|||
155393814|NCT03610165|560876889|FG001|Overall Study|Device didn't work|1|||
155393815|NCT04600336|560876896|FG000|Initial Treatment|Withdrawal by Subject|1|||
155393816|NCT04600336|560876897|FG001|Initial Treatment|Withdrawal by Subject|2|||
155393817|NCT04600336|560876898|FG002|Initial Treatment|Withdrawal by Subject|0|||
155393818|NCT04600336|560876899|FG003|Initial Treatment|Withdrawal by Subject|0|||
155393819|NCT04600336|560876896|FG000|Initial Treatment|Adverse Event|0|||
155393820|NCT04600336|560876897|FG001|Initial Treatment|Adverse Event|2|||
155393821|NCT04600336|560876898|FG002|Initial Treatment|Adverse Event|0|||
155393822|NCT04600336|560876899|FG003|Initial Treatment|Adverse Event|0|||
155393823|NCT04600336|560876896|FG000|Initial Treatment|Other complicating disease|0|||
155393824|NCT04600336|560876897|FG001|Initial Treatment|Other complicating disease|0|||
155393825|NCT04600336|560876898|FG002|Initial Treatment|Other complicating disease|1|||
155393826|NCT04600336|560876899|FG003|Initial Treatment|Other complicating disease|0|||
155393827|NCT04600336|560876896|FG000|Crossover Treatment|Withdrawal by Subject|0|||
155393828|NCT04600336|560876897|FG001|Crossover Treatment|Withdrawal by Subject|0|||
155393829|NCT04600336|560876898|FG002|Crossover Treatment|Withdrawal by Subject|2|||
155393830|NCT04600336|560876899|FG003|Crossover Treatment|Withdrawal by Subject|1|||
155393831|NCT04600336|560876896|FG000|Crossover Treatment|Adverse Event|0|||
155393832|NCT04600336|560876897|FG001|Crossover Treatment|Adverse Event|0|||
155393833|NCT04600336|560876898|FG002|Crossover Treatment|Adverse Event|1|||
155393834|NCT04600336|560876899|FG003|Crossover Treatment|Adverse Event|1|||
155393835|NCT01310803|560878179|FG000|Overall Study|Subject terminated by Sponsor|1|||
155393836|NCT01310803|560878180|FG001|Overall Study|Subject terminated by Sponsor|0|||
155393837|NCT03047551|560878183|FG000|Overall Study|Did not receive TAS|1|||
155393838|NCT03047551|560878184|FG001|Overall Study|Did not receive TAS|0|||
155393839|NCT03047551|560878183|FG000|Overall Study|Physician Decision|1|||
155393840|NCT03047551|560878184|FG001|Overall Study|Physician Decision|0|||
155393841|NCT03047551|560878183|FG000|Overall Study|Withdrawal by Subject|0|||
155393842|NCT03047551|560878184|FG001|Overall Study|Withdrawal by Subject|1|||
155393843|NCT03047551|560878183|FG000|Overall Study|Probe malfunction|0|||
155393844|NCT03047551|560878184|FG001|Overall Study|Probe malfunction|1|||
155393845|NCT03047551|560878183|FG000|Overall Study|Ineligible|0|||
155393846|NCT03047551|560878184|FG001|Overall Study|Ineligible|1|||
155393847|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
155393848|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
155393849|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
155393850|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
155393851|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
155393852|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
155393853|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
155393854|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
155393855|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
155393856|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
155393857|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
155393858|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
155393859|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
155393860|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
155393861|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
155393862|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
155393863|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
155393864|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
155393865|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Early termination|0|||
155393866|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Early termination|0|||
155393867|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Early termination|34|||
155393868|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
155393869|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
155393870|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
155393871|NCT01493557|560878186|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
155393872|NCT01493557|560878187|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
155393873|NCT01493557|560878188|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
155393874|NCT01493557|560878186|FG000|Randomized to Management Strategies|Other adverse event|8|||
155393875|NCT01493557|560878187|FG001|Randomized to Management Strategies|Other adverse event|5|||
155393876|NCT01493557|560878188|FG002|Randomized to Management Strategies|Other adverse event|0|||
155393877|NCT01493557|560878186|FG000|Randomized to Management Strategies|Protocol Violation|3|||
155393878|NCT01493557|560878187|FG001|Randomized to Management Strategies|Protocol Violation|0|||
155393879|NCT01493557|560878188|FG002|Randomized to Management Strategies|Protocol Violation|0|||
155393880|NCT01493557|560878186|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
155393881|NCT01493557|560878187|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
155393882|NCT01493557|560878188|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
155393883|NCT01493557|560878186|FG000|Randomized to Management Strategies|Other than stated above|1|||
155393884|NCT01493557|560878187|FG001|Randomized to Management Strategies|Other than stated above|3|||
155393885|NCT01493557|560878188|FG002|Randomized to Management Strategies|Other than stated above|0|||
155393886|NCT01493557|560878186|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
155393887|NCT01493557|560878187|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
155393888|NCT01493557|560878188|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
155393889|NCT01493557|560878186|FG000|Adding the Second Strategy|Other adverse event|1|||
155393890|NCT01493557|560878187|FG001|Adding the Second Strategy|Other adverse event|2|||
155393891|NCT01493557|560878188|FG002|Adding the Second Strategy|Other adverse event|0|||
155393892|NCT01493557|560878186|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
155393893|NCT01493557|560878187|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
155393894|NCT01493557|560878188|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
155393895|NCT02012296|560878191|FG000|Overall Study|Lack of Efficacy|0|||
155393896|NCT02012296|560878192|FG001|Overall Study|Lack of Efficacy|0|||
155393897|NCT02012296|560878193|FG002|Overall Study|Lack of Efficacy|15|||
155393898|NCT02012296|560878191|FG000|Overall Study|Adverse Event|0|||
155393899|NCT02012296|560878192|FG001|Overall Study|Adverse Event|0|||
155393900|NCT02012296|560878193|FG002|Overall Study|Adverse Event|2|||
155393901|NCT02012296|560878191|FG000|Overall Study|Early study closure|0|||
155393902|NCT02012296|560878192|FG001|Overall Study|Early study closure|0|||
155393903|NCT02012296|560878193|FG002|Overall Study|Early study closure|5|||
155393904|NCT02012296|560878191|FG000|Overall Study|Protocol Violation|0|||
155393905|NCT02012296|560878192|FG001|Overall Study|Protocol Violation|1|||
155393906|NCT02012296|560878193|FG002|Overall Study|Protocol Violation|0|||
155393907|NCT00727649|560878196|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
155393908|NCT00727649|560878197|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
155393909|NCT00727649|560878196|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
155393910|NCT00727649|560878197|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
155393911|NCT00727649|560878196|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
155393912|NCT00727649|560878197|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
155393913|NCT00727649|560878196|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
155393914|NCT00727649|560878197|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
155393915|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Death|1|||
155393916|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Death|0|||
155393917|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
155393918|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
155393919|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
155393920|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
155393921|NCT00434421|560878201|FG000|Overall Study|Withdrawal by Subject|1|||
155393922|NCT00434421|560878201|FG000|Overall Study|Non-compliance with study treatment|1|||
155393923|NCT01087957|560878202|FG000|Overall Study|Death|2|||
155393924|NCT01087957|560878203|FG001|Overall Study|Death|2|||
155393925|NCT01087957|560878202|FG000|Overall Study|Lost to Follow-up|3|||
155393926|NCT01087957|560878203|FG001|Overall Study|Lost to Follow-up|4|||
155393927|NCT01087957|560878202|FG000|Overall Study|Protocol Violation|13|||
155393928|NCT01087957|560878203|FG001|Overall Study|Protocol Violation|25|||
155393929|NCT01087957|560878202|FG000|Overall Study|Withdrawal by Subject|18|||
155393930|NCT01087957|560878203|FG001|Overall Study|Withdrawal by Subject|15|||
155393931|NCT01087957|560878202|FG000|Overall Study|Physician Decision|5|||
155393932|NCT01087957|560878203|FG001|Overall Study|Physician Decision|9|||
155393933|NCT03842163|560878204|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
155393934|NCT03842163|560878204|FG000|Overall Study|Scintigraphy was not performed|44|||
155393935|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
155393936|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
155393937|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
155393938|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
155393939|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
155393940|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
155393941|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
155393942|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
155393943|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
155393944|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
155393945|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
155283353|NCT01251614|560470716|FG001|Overall Study|Lost to Follow-up|1|||
155283354|NCT01251614|560470717|FG002|Overall Study|Lost to Follow-up|0|||
155283355|NCT01876043|560470719|FG000|Overall Study|Death|1|||
155283356|NCT01876043|560470719|FG000|Overall Study|Withdrawal by Subject|1|||
155283357|NCT00049517|560470720|FG000|Induction|Disease progression|0|||
155283358|NCT00049517|560470721|FG001|Induction|Disease progression|0|||
155283359|NCT00049517|560470722|FG002|Induction|Disease progression|0|||
155283360|NCT00049517|560470723|FG003|Induction|Disease progression|0|||
155283361|NCT00049517|560470724|FG004|Induction|Disease progression|18|||
155283362|NCT00049517|560470725|FG005|Induction|Disease progression|11|||
155283363|NCT00049517|560470720|FG000|Induction|Adverse Event|0|||
155283364|NCT00049517|560470721|FG001|Induction|Adverse Event|0|||
155283365|NCT00049517|560470722|FG002|Induction|Adverse Event|0|||
155283366|NCT00049517|560470723|FG003|Induction|Adverse Event|0|||
155283367|NCT00049517|560470724|FG004|Induction|Adverse Event|5|||
155283368|NCT00049517|560470725|FG005|Induction|Adverse Event|7|||
155283369|NCT00049517|560470720|FG000|Induction|Death|0|||
155283370|NCT00049517|560470721|FG001|Induction|Death|0|||
155283371|NCT00049517|560470722|FG002|Induction|Death|0|||
155283372|NCT00049517|560470723|FG003|Induction|Death|0|||
155283373|NCT00049517|560470724|FG004|Induction|Death|9|||
155283374|NCT00049517|560470725|FG005|Induction|Death|6|||
155283375|NCT00049517|560470720|FG000|Induction|Withdrawal by Subject|0|||
155283376|NCT00049517|560470721|FG001|Induction|Withdrawal by Subject|0|||
155283377|NCT00049517|560470722|FG002|Induction|Withdrawal by Subject|0|||
155283378|NCT00049517|560470723|FG003|Induction|Withdrawal by Subject|0|||
155283379|NCT00049517|560470724|FG004|Induction|Withdrawal by Subject|1|||
155283380|NCT00049517|560470725|FG005|Induction|Withdrawal by Subject|3|||
155283381|NCT00049517|560470720|FG000|Induction|Alternative therapy|0|||
155283382|NCT00049517|560470721|FG001|Induction|Alternative therapy|0|||
155283383|NCT00049517|560470722|FG002|Induction|Alternative therapy|0|||
155283384|NCT00049517|560470723|FG003|Induction|Alternative therapy|0|||
155283385|NCT00049517|560470724|FG004|Induction|Alternative therapy|2|||
155283386|NCT00049517|560470725|FG005|Induction|Alternative therapy|2|||
155283387|NCT00049517|560470720|FG000|Induction|Other complicating disease|0|||
155283388|NCT00049517|560470721|FG001|Induction|Other complicating disease|0|||
155283389|NCT00049517|560470722|FG002|Induction|Other complicating disease|0|||
155283390|NCT00049517|560470723|FG003|Induction|Other complicating disease|0|||
155283391|NCT00049517|560470724|FG004|Induction|Other complicating disease|3|||
155283392|NCT00049517|560470725|FG005|Induction|Other complicating disease|0|||
155283393|NCT00049517|560470720|FG000|Induction|Reasons not reported|0|||
155283394|NCT00049517|560470721|FG001|Induction|Reasons not reported|0|||
155283395|NCT00049517|560470722|FG002|Induction|Reasons not reported|0|||
155283396|NCT00049517|560470723|FG003|Induction|Reasons not reported|0|||
155283397|NCT00049517|560470724|FG004|Induction|Reasons not reported|22|||
155283398|NCT00049517|560470725|FG005|Induction|Reasons not reported|25|||
155283399|NCT00049517|560470720|FG000|Conditioning/Transplant|Disease progression|14|||
155283400|NCT00049517|560470721|FG001|Conditioning/Transplant|Disease progression|6|||
155283401|NCT00049517|560470722|FG002|Conditioning/Transplant|Disease progression|10|||
155283402|NCT00049517|560470723|FG003|Conditioning/Transplant|Disease progression|6|||
155283403|NCT00049517|560470724|FG004|Conditioning/Transplant|Disease progression|0|||
155283404|NCT00049517|560470725|FG005|Conditioning/Transplant|Disease progression|0|||
155283405|NCT00049517|560470720|FG000|Conditioning/Transplant|Adverse Event|2|||
155283406|NCT00049517|560470721|FG001|Conditioning/Transplant|Adverse Event|1|||
155283407|NCT00049517|560470722|FG002|Conditioning/Transplant|Adverse Event|4|||
155283408|NCT00049517|560470723|FG003|Conditioning/Transplant|Adverse Event|8|||
155283409|NCT00049517|560470724|FG004|Conditioning/Transplant|Adverse Event|0|||
155283410|NCT00049517|560470725|FG005|Conditioning/Transplant|Adverse Event|0|||
155283411|NCT00049517|560470720|FG000|Conditioning/Transplant|Death|1|||
155283412|NCT00049517|560470721|FG001|Conditioning/Transplant|Death|0|||
155283413|NCT00049517|560470722|FG002|Conditioning/Transplant|Death|0|||
155283414|NCT00049517|560470723|FG003|Conditioning/Transplant|Death|2|||
155283415|NCT00049517|560470724|FG004|Conditioning/Transplant|Death|0|||
155283416|NCT00049517|560470725|FG005|Conditioning/Transplant|Death|0|||
155283417|NCT00049517|560470720|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
155283418|NCT00049517|560470721|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
155283419|NCT00049517|560470722|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
155283420|NCT00049517|560470723|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
155283421|NCT00049517|560470724|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
155283422|NCT00049517|560470725|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
155283423|NCT00049517|560470720|FG000|Conditioning/Transplant|Alternative therapy|4|||
155283424|NCT00049517|560470721|FG001|Conditioning/Transplant|Alternative therapy|4|||
155283425|NCT00049517|560470722|FG002|Conditioning/Transplant|Alternative therapy|2|||
155283426|NCT00049517|560470723|FG003|Conditioning/Transplant|Alternative therapy|1|||
155283427|NCT00049517|560470724|FG004|Conditioning/Transplant|Alternative therapy|1|||
155283428|NCT00049517|560470725|FG005|Conditioning/Transplant|Alternative therapy|0|||
155740748|NCT01419197|562152722|FG001|Overall Study|Reason Not Specified|1|||
155740749|NCT01419197|562152721|FG000|Overall Study|Lost to Follow-up|14|||
155740750|NCT01419197|562152722|FG001|Overall Study|Lost to Follow-up|4|||
155740751|NCT00146848|562152723|FG000|Pre-randomization|Death|19|||
155740752|NCT00146848|562152724|FG001|Pre-randomization|Death|0|||
155740753|NCT00146848|562152725|FG002|Pre-randomization|Death|0|||
155740754|NCT00146848|562152723|FG000|Pre-randomization|Lost to Follow-up|70|||
155740755|NCT00146848|562152724|FG001|Pre-randomization|Lost to Follow-up|0|||
155740756|NCT00146848|562152725|FG002|Pre-randomization|Lost to Follow-up|0|||
155740757|NCT00146848|562152723|FG000|Pre-randomization|Physician Decision|8|||
155740758|NCT00146848|562152724|FG001|Pre-randomization|Physician Decision|0|||
155740759|NCT00146848|562152725|FG002|Pre-randomization|Physician Decision|0|||
155740760|NCT00146848|562152723|FG000|Pre-randomization|Protocol Violation|172|||
155740761|NCT00146848|562152724|FG001|Pre-randomization|Protocol Violation|0|||
155740762|NCT00146848|562152725|FG002|Pre-randomization|Protocol Violation|0|||
155740763|NCT00146848|562152723|FG000|Pre-randomization|Withdrawal by Subject|40|||
155740764|NCT00146848|562152724|FG001|Pre-randomization|Withdrawal by Subject|0|||
155740765|NCT00146848|562152725|FG002|Pre-randomization|Withdrawal by Subject|0|||
155740766|NCT00146848|562152723|FG000|Post-randomization|Lost to Follow-up|12|||
155740767|NCT00146848|562152724|FG001|Post-randomization|Lost to Follow-up|15|||
155740768|NCT00146848|562152725|FG002|Post-randomization|Lost to Follow-up|12|||
155740769|NCT00146848|562152723|FG000|Post-randomization|Withdrawn|26|||
155740770|NCT00146848|562152724|FG001|Post-randomization|Withdrawn|32|||
155740771|NCT00146848|562152725|FG002|Post-randomization|Withdrawn|27|||
155740772|NCT01798849|562152726|FG000|Overall Study|Physician Decision|0|||
155740773|NCT01798849|562152727|FG001|Overall Study|Physician Decision|0|||
155740774|NCT01798849|562152728|FG002|Overall Study|Physician Decision|1|||
155740775|NCT00717236|562152729|FG000|Double-Blind Period|Adverse Event|33|||
155740776|NCT00717236|562152730|FG001|Double-Blind Period|Adverse Event|6|||
155740777|NCT00717236|562152729|FG000|Double-Blind Period|Lack of Efficacy|6|||
155740778|NCT00717236|562152730|FG001|Double-Blind Period|Lack of Efficacy|6|||
155740779|NCT00717236|562152729|FG000|Double-Blind Period|Lost to Follow-up|3|||
155740780|NCT00717236|562152730|FG001|Double-Blind Period|Lost to Follow-up|5|||
155740781|NCT00717236|562152729|FG000|Double-Blind Period|Withdrawal by Subject|10|||
155740782|NCT00717236|562152730|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155740783|NCT00717236|562152729|FG000|Double-Blind Period|Loss of efficacy|3|||
155740784|NCT00717236|562152730|FG001|Double-Blind Period|Loss of efficacy|0|||
155740785|NCT00717236|562152729|FG000|Double-Blind Period|Other: Death|1|||
155740786|NCT00717236|562152730|FG001|Double-Blind Period|Other: Death|0|||
155740787|NCT00717236|562152729|FG000|Double-Blind Period|Other: Pregnancy|1|||
155740788|NCT00717236|562152730|FG001|Double-Blind Period|Other: Pregnancy|0|||
155740789|NCT00717236|562152729|FG000|Double-Blind Period|Other: Protocol Violation|2|||
155740790|NCT00717236|562152730|FG001|Double-Blind Period|Other: Protocol Violation|0|||
155740791|NCT00717236|562152729|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
155740792|NCT00717236|562152730|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
155740793|NCT00717236|562152729|FG000|Double-Blind Period|Other: Site withdrew|2|||
155740794|NCT00717236|562152730|FG001|Double-Blind Period|Other: Site withdrew|0|||
155740795|NCT00717236|562152729|FG000|Double-Blind Period|Other: Screening failure|1|||
155740796|NCT00717236|562152730|FG001|Double-Blind Period|Other: Screening failure|0|||
155740797|NCT00717236|562152729|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
155740798|NCT00717236|562152730|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
155740799|NCT00717236|562152729|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
155740800|NCT00717236|562152730|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
155635415|NCT03416179|561757930|FG003|Overall Study|Study participation terminated by Sponsor|31|||
155635416|NCT03416179|561757927|FG000|Overall Study|Other|2|||
155635417|NCT03416179|561757928|FG001|Overall Study|Other|3|||
155635418|NCT03416179|561757929|FG002|Overall Study|Other|1|||
155635419|NCT03416179|561757930|FG003|Overall Study|Other|0|||
155635420|NCT00688597|561757931|FG000|Overall Study|Adverse Event|2|||
155635421|NCT00688597|561757932|FG001|Overall Study|Adverse Event|0|||
155635422|NCT00688597|561757933|FG002|Overall Study|Adverse Event|0|||
155635423|NCT00688597|561757931|FG000|Overall Study|Physician Decision|1|||
155635424|NCT00688597|561757932|FG001|Overall Study|Physician Decision|0|||
155740801|NCT00717236|562152729|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
155740802|NCT00717236|562152730|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
155740803|NCT00717236|562152729|FG000|Double-Blind Period|Other: History of cancer|1|||
155740804|NCT00717236|562152730|FG001|Double-Blind Period|Other: History of cancer|0|||
155740805|NCT00717236|562152729|FG000|Double-Blind Period|Other: Sponsor request|1|||
155740806|NCT00717236|562152730|FG001|Double-Blind Period|Other: Sponsor request|0|||
155740807|NCT00717236|562152729|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
155740808|NCT00717236|562152730|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
155740809|NCT00717236|562152729|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
155283429|NCT00049517|560470720|FG000|Conditioning/Transplant|Other complicating disease|2|||
155635425|NCT00688597|561757933|FG002|Overall Study|Physician Decision|0|||
155635426|NCT02709369|561757934|FG000|Overall Study|Lost to Follow-up|15|||
155740810|NCT00717236|562152730|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
155740811|NCT00717236|562152729|FG000|Double-Blind Period|Other: Subject moved|1|||
155740812|NCT00717236|562152730|FG001|Double-Blind Period|Other: Subject moved|1|||
155740813|NCT00717236|562152729|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
155393946|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
155393947|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
155393948|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
155393949|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
155393950|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
155393951|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
155393952|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
155393953|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
155393954|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
155393955|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
155740814|NCT00717236|562152730|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
155740815|NCT00717236|562152729|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
155740816|NCT00717236|562152730|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
155740817|NCT00717236|562152729|FG000|Double-Blind Period|Other: Transportation problems|0|||
155740818|NCT00717236|562152730|FG001|Double-Blind Period|Other: Transportation problems|1|||
155740819|NCT00717236|562152729|FG000|Double-Blind Period|Other: Investigator Decision|0|||
155740820|NCT00717236|562152730|FG001|Double-Blind Period|Other: Investigator Decision|1|||
155740821|NCT00717236|562152729|FG000|Open-Label Period|Adverse Event|29|||
155740822|NCT00717236|562152730|FG001|Open-Label Period|Adverse Event|4|||
155740823|NCT00717236|562152729|FG000|Open-Label Period|Lack of Efficacy|30|||
155740824|NCT00717236|562152730|FG001|Open-Label Period|Lack of Efficacy|8|||
155740825|NCT00717236|562152729|FG000|Open-Label Period|Lost to Follow-up|28|||
155740826|NCT00717236|562152730|FG001|Open-Label Period|Lost to Follow-up|4|||
155740827|NCT00717236|562152729|FG000|Open-Label Period|Withdrawal by Subject|20|||
155740828|NCT00717236|562152730|FG001|Open-Label Period|Withdrawal by Subject|2|||
155740829|NCT00717236|562152729|FG000|Open-Label Period|Loss of Efficacy|6|||
155740830|NCT00717236|562152730|FG001|Open-Label Period|Loss of Efficacy|1|||
155740831|NCT00717236|562152729|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
155740832|NCT00717236|562152730|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
155740833|NCT00717236|562152729|FG000|Open-Label Period|Other: Lack of Compliance|1|||
155740834|NCT00717236|562152730|FG001|Open-Label Period|Other: Lack of Compliance|1|||
155740835|NCT00717236|562152729|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
155740836|NCT00717236|562152730|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
155740837|NCT00717236|562152729|FG000|Open-Label Period|Other: Moved|1|||
155740838|NCT00717236|562152730|FG001|Open-Label Period|Other: Moved|0|||
155740839|NCT00717236|562152729|FG000|Open-Label Period|Other: Investigator Decision|1|||
155740840|NCT00717236|562152730|FG001|Open-Label Period|Other: Investigator Decision|0|||
155740841|NCT00717236|562152729|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
155740842|NCT00717236|562152730|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
155740843|NCT00717236|562152729|FG000|Open-Label Period|Other: Sponsor Request|3|||
155740844|NCT00717236|562152730|FG001|Open-Label Period|Other: Sponsor Request|0|||
155740845|NCT00717236|562152729|FG000|Open-Label Period|Other: Cataract Surgery|1|||
155740846|NCT00717236|562152730|FG001|Open-Label Period|Other: Cataract Surgery|0|||
155740847|NCT00717236|562152729|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
155740848|NCT00717236|562152730|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
155740849|NCT00717236|562152729|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
155740850|NCT00717236|562152730|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
155740851|NCT00717236|562152729|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
155740852|NCT00717236|562152730|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
155740853|NCT00743106|562152731|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
155740854|NCT00743106|562152732|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
155740855|NCT04556383|562152733|FG000|PCP|Lack of Efficacy|28|||
155740856|NCT04556383|562152734|FG001|PCP|Lack of Efficacy|23|||
155740857|NCT04556383|562152735|FG002|PCP|Lack of Efficacy|23|||
155393956|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
155393957|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
155393958|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
155740858|NCT04556383|562152736|FG003|PCP|Lack of Efficacy|0|||
155740859|NCT04556383|562152733|FG000|PCP|Study terminated by sponsor|15|||
155740860|NCT04556383|562152734|FG001|PCP|Study terminated by sponsor|13|||
155740861|NCT04556383|562152735|FG002|PCP|Study terminated by sponsor|16|||
155740862|NCT04556383|562152736|FG003|PCP|Study terminated by sponsor|0|||
155393959|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
155740863|NCT04556383|562152733|FG000|PCP|Withdrawal by Subject|8|||
155740864|NCT04556383|562152734|FG001|PCP|Withdrawal by Subject|6|||
155740865|NCT04556383|562152735|FG002|PCP|Withdrawal by Subject|6|||
155740866|NCT04556383|562152736|FG003|PCP|Withdrawal by Subject|0|||
155393960|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
155635427|NCT02709369|561757934|FG000|Overall Study|Withdrawal by Subject|10|||
155635428|NCT02709369|561757934|FG000|Overall Study|Did not received intervention|2|||
155635429|NCT02755090|561757936|FG000|Overall Study|equipment malfunction|1|||
155635430|NCT02755090|561757937|FG001|Overall Study|equipment malfunction|0|||
155635431|NCT00207740|561757938|FG000|Overall Study|Adverse Event|4|||
155635432|NCT00207740|561757939|FG001|Overall Study|Adverse Event|14|||
155635433|NCT00207740|561757940|FG002|Overall Study|Adverse Event|14|||
155635434|NCT00207740|561757941|FG003|Overall Study|Adverse Event|11|||
155635435|NCT00207740|561757938|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155635436|NCT00207740|561757939|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155635437|NCT00207740|561757940|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155635438|NCT00207740|561757941|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
155635439|NCT00207740|561757938|FG000|Overall Study|Lost to Follow-up|0|||
155635440|NCT00207740|561757939|FG001|Overall Study|Lost to Follow-up|2|||
155635441|NCT00207740|561757940|FG002|Overall Study|Lost to Follow-up|1|||
155635442|NCT00207740|561757941|FG003|Overall Study|Lost to Follow-up|1|||
155635443|NCT00207740|561757938|FG000|Overall Study|Death|0|||
155635444|NCT00207740|561757939|FG001|Overall Study|Death|0|||
155635445|NCT00207740|561757940|FG002|Overall Study|Death|0|||
155635446|NCT00207740|561757941|FG003|Overall Study|Death|1|||
155635447|NCT00207740|561757938|FG000|Overall Study|Sponsor Directive|22|||
155635448|NCT00207740|561757939|FG001|Overall Study|Sponsor Directive|15|||
155635449|NCT00207740|561757940|FG002|Overall Study|Sponsor Directive|16|||
155635450|NCT00207740|561757941|FG003|Overall Study|Sponsor Directive|21|||
155635451|NCT00207740|561757938|FG000|Overall Study|Other|2|||
155635452|NCT00207740|561757939|FG001|Overall Study|Other|10|||
155635453|NCT00207740|561757940|FG002|Overall Study|Other|7|||
155635454|NCT00207740|561757941|FG003|Overall Study|Other|5|||
155635455|NCT04797169|561757942|FG000|Overall Study|Lost to Follow-up|84|||
155635456|NCT04797169|561757943|FG001|Overall Study|Lost to Follow-up|67|||
155635457|NCT04797169|561757942|FG000|Overall Study|Pregnancy|1|||
155635458|NCT04797169|561757943|FG001|Overall Study|Pregnancy|3|||
155635459|NCT04797169|561757942|FG000|Overall Study|Withdrawal by Subject|27|||
155635460|NCT04797169|561757943|FG001|Overall Study|Withdrawal by Subject|35|||
155635461|NCT03916926|561757944|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
155635462|NCT03916926|561757945|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
155635463|NCT03916926|561757944|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
155635464|NCT03916926|561757945|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
155635465|NCT03916926|561757944|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
155635466|NCT03916926|561757945|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
155635467|NCT03916926|561757944|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
155635468|NCT03916926|561757945|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
155635469|NCT02337829|561757948|FG000|Overall Study|Death|0|||
155635470|NCT02337829|561757949|FG001|Overall Study|Death|1|||
155635471|NCT02337829|561757950|FG002|Overall Study|Death|0|||
155635472|NCT02337829|561757951|FG003|Overall Study|Death|0|||
155635473|NCT02337829|561757948|FG000|Overall Study|Study terminated by sponsor|12|||
155635474|NCT02337829|561757949|FG001|Overall Study|Study terminated by sponsor|10|||
155635475|NCT02337829|561757950|FG002|Overall Study|Study terminated by sponsor|5|||
155635476|NCT02337829|561757951|FG003|Overall Study|Study terminated by sponsor|6|||
155635477|NCT02337829|561757948|FG000|Overall Study|discontinued for other reasons|6|||
155393961|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
155393962|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
155393963|NCT00698451|560878210|FG000|Overall Study|Adverse Event|22|||
155393964|NCT00698451|560878210|FG000|Overall Study|Physician Decision|2|||
155393965|NCT00698451|560878210|FG000|Overall Study|Protocol Violation|6|||
155393966|NCT00698451|560878210|FG000|Overall Study|Withdrawal by Subject|6|||
155393967|NCT00698451|560878210|FG000|Overall Study|Disease progression|3|||
155393968|NCT02224599|560878213|FG000|Overall Study|Physician Decision|1|||
155393969|NCT02224599|560878213|FG000|Overall Study|Progression of Disease|1|||
155393970|NCT00129623|560878215|FG000|Overall Study|Adverse Event|3|||
155393971|NCT00129623|560878216|FG001|Overall Study|Adverse Event|7|||
155393972|NCT00129623|560878215|FG000|Overall Study|Refused Treatment|5|||
155393973|NCT00129623|560878216|FG001|Overall Study|Refused Treatment|3|||
155393974|NCT00129623|560878215|FG000|Overall Study|Failure to Return|1|||
155393975|NCT00129623|560878216|FG001|Overall Study|Failure to Return|1|||
155393976|NCT00129623|560878215|FG000|Overall Study|Relocated job out of state|1|||
155393977|NCT00129623|560878216|FG001|Overall Study|Relocated job out of state|0|||
155635478|NCT02337829|561757949|FG001|Overall Study|discontinued for other reasons|3|||
155635479|NCT02337829|561757950|FG002|Overall Study|discontinued for other reasons|1|||
155635480|NCT02337829|561757951|FG003|Overall Study|discontinued for other reasons|4|||
155635481|NCT02763566|561757961|FG000|Overall Study|Lost to Follow-up|1|||
155635482|NCT02763566|561757962|FG001|Overall Study|Lost to Follow-up|4|||
155635483|NCT02763566|561757963|FG002|Overall Study|Lost to Follow-up|0|||
155635484|NCT02763566|561757964|FG003|Overall Study|Lost to Follow-up|1|||
155635485|NCT02763566|561757961|FG000|Overall Study|On study treatment at study conclusion|114|||
155635486|NCT02763566|561757962|FG001|Overall Study|On study treatment at study conclusion|34|||
155635487|NCT02763566|561757963|FG002|Overall Study|On study treatment at study conclusion|54|||
155635488|NCT02763566|561757964|FG003|Overall Study|On study treatment at study conclusion|13|||
155635489|NCT02763566|561757961|FG000|Overall Study|Withdrawal by Subject|3|||
155635490|NCT02763566|561757962|FG001|Overall Study|Withdrawal by Subject|1|||
155635491|NCT02763566|561757963|FG002|Overall Study|Withdrawal by Subject|0|||
155635492|NCT02763566|561757964|FG003|Overall Study|Withdrawal by Subject|0|||
155635493|NCT00790036|561757965|FG000|Overall Study|Abnormal lab values|3|||
155635494|NCT00790036|561757966|FG001|Overall Study|Abnormal lab values|2|||
155740867|NCT04556383|562152733|FG000|PCP|Adverse Event|1|||
155283430|NCT00049517|560470721|FG001|Conditioning/Transplant|Other complicating disease|0|||
155283431|NCT00049517|560470722|FG002|Conditioning/Transplant|Other complicating disease|0|||
155283432|NCT00049517|560470723|FG003|Conditioning/Transplant|Other complicating disease|4|||
155283433|NCT00049517|560470724|FG004|Conditioning/Transplant|Other complicating disease|0|||
155283434|NCT00049517|560470725|FG005|Conditioning/Transplant|Other complicating disease|1|||
155283435|NCT00049517|560470720|FG000|Conditioning/Transplant|Reasons not reported|25|||
155283436|NCT00049517|560470721|FG001|Conditioning/Transplant|Reasons not reported|31|||
155283437|NCT00049517|560470722|FG002|Conditioning/Transplant|Reasons not reported|18|||
155283438|NCT00049517|560470723|FG003|Conditioning/Transplant|Reasons not reported|15|||
155283439|NCT00049517|560470724|FG004|Conditioning/Transplant|Reasons not reported|5|||
155283440|NCT00049517|560470725|FG005|Conditioning/Transplant|Reasons not reported|5|||
155283441|NCT00079937|560470726|FG000|Overall Study|Adverse Event|2|||
155283442|NCT00079937|560470727|FG001|Overall Study|Adverse Event|1|||
155283443|NCT00079937|560470726|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155283444|NCT00079937|560470727|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155283445|NCT00079937|560470726|FG000|Overall Study|Subject no longer requires study drug|3|||
155283446|NCT00079937|560470727|FG001|Overall Study|Subject no longer requires study drug|0|||
155283447|NCT00079937|560470726|FG000|Overall Study|Protocol Violation|8|||
155283448|NCT00079937|560470727|FG001|Overall Study|Protocol Violation|6|||
155283449|NCT00079937|560470726|FG000|Overall Study|Withdrawal by Subject|21|||
155283450|NCT00079937|560470727|FG001|Overall Study|Withdrawal by Subject|7|||
155283451|NCT00079937|560470726|FG000|Overall Study|Lost to Follow-up|12|||
155283452|NCT00079937|560470727|FG001|Overall Study|Lost to Follow-up|5|||
155283453|NCT00079937|560470726|FG000|Overall Study|Administrative problems|22|||
155283454|NCT00079937|560470727|FG001|Overall Study|Administrative problems|11|||
155283455|NCT02857283|560470728|FG000|First Exposure|Withdrawal by Subject|1|||
155283456|NCT02857283|560470729|FG001|First Exposure|Withdrawal by Subject|0|||
155283457|NCT00093795|560470730|FG000|Overall Study|No follow up data|20|||
155283458|NCT00093795|560470731|FG001|Overall Study|No follow up data|16|||
155283459|NCT00093795|560470732|FG002|Overall Study|No follow up data|17|||
155283460|NCT00940017|560470733|FG000|Overall Study|did not meet entrance criteria|3|||
155283461|NCT00940017|560470733|FG000|Overall Study|Adverse Event|1|||
155283462|NCT00613301|560470734|FG000|Overall Study|Adverse Event|49|||
155283463|NCT00613301|560470734|FG000|Overall Study|Lost to Follow-up|88|||
155283464|NCT00613301|560470734|FG000|Overall Study|Withdrawal by Subject|5|||
155283465|NCT00613301|560470734|FG000|Overall Study|Death|6|||
155283466|NCT00613301|560470734|FG000|Overall Study|Lack of Efficacy|13|||
155283467|NCT00613301|560470734|FG000|Overall Study|Physician Decision|2|||
155283468|NCT00613301|560470734|FG000|Overall Study|No data was collected|53|||
155283469|NCT00613301|560470734|FG000|Overall Study|Irregularly enrolled patients|12|||
155283470|NCT00569946|560470735|FG000|Overall Study|Adverse Event|16|||
155283471|NCT00569946|560470735|FG000|Overall Study|Objective Progression or Relapse|42|||
155283472|NCT00569946|560470735|FG000|Overall Study|Global Deterioration of Health Status|1|||
155283473|NCT01684046|560470738|FG000|Period 1, First 30 Days|Adverse Event|0|||
155283474|NCT01684046|560470739|FG001|Period 1, First 30 Days|Adverse Event|2|||
155283475|NCT01306331|560470740|FG000|Overall Study|Adverse Event|28|||
155283476|NCT01306331|560470741|FG001|Overall Study|Adverse Event|25|||
155283477|NCT01306331|560470740|FG000|Overall Study|Lost to Follow-up|321|||
155283478|NCT01306331|560470741|FG001|Overall Study|Lost to Follow-up|323|||
155283479|NCT01306331|560470740|FG000|Overall Study|Physician Decision|26|||
155283480|NCT01306331|560470741|FG001|Overall Study|Physician Decision|22|||
155283481|NCT01306331|560470740|FG000|Overall Study|Pregnancy|136|||
155283482|NCT01306331|560470741|FG001|Overall Study|Pregnancy|151|||
155283483|NCT01306331|560470740|FG000|Overall Study|Protocol Violation|154|||
155283484|NCT01306331|560470741|FG001|Overall Study|Protocol Violation|124|||
155283485|NCT01306331|560470740|FG000|Overall Study|Withdrawal by Subject|163|||
155283486|NCT01306331|560470741|FG001|Overall Study|Withdrawal by Subject|152|||
155283487|NCT01306331|560470740|FG000|Overall Study|Not sexually active|29|||
155283488|NCT01306331|560470741|FG001|Overall Study|Not sexually active|28|||
155283489|NCT01306331|560470740|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
155283490|NCT01306331|560470741|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
155283491|NCT01306331|560470740|FG000|Overall Study|Other|34|||
155283492|NCT01306331|560470741|FG001|Overall Study|Other|32|||
155740868|NCT04556383|562152734|FG001|PCP|Adverse Event|7|||
155740869|NCT04556383|562152735|FG002|PCP|Adverse Event|7|||
155740870|NCT04556383|562152736|FG003|PCP|Adverse Event|0|||
155740871|NCT04556383|562152733|FG000|PCP|Other, Not Specified|1|||
155740872|NCT04556383|562152734|FG001|PCP|Other, Not Specified|2|||
155740873|NCT04556383|562152735|FG002|PCP|Other, Not Specified|1|||
155740874|NCT04556383|562152736|FG003|PCP|Other, Not Specified|0|||
155740875|NCT04556383|562152733|FG000|PCP|Protocol Violation|1|||
155740876|NCT04556383|562152734|FG001|PCP|Protocol Violation|0|||
155740877|NCT04556383|562152735|FG002|PCP|Protocol Violation|1|||
155740878|NCT04556383|562152736|FG003|PCP|Protocol Violation|0|||
155740879|NCT04556383|562152733|FG000|PCP|Lost to Follow-up|1|||
155740880|NCT04556383|562152734|FG001|PCP|Lost to Follow-up|0|||
155740881|NCT04556383|562152735|FG002|PCP|Lost to Follow-up|0|||
155740882|NCT04556383|562152736|FG003|PCP|Lost to Follow-up|0|||
155740883|NCT04556383|562152733|FG000|PCP|Physician Decision|0|||
155740884|NCT04556383|562152734|FG001|PCP|Physician Decision|1|||
155393978|NCT00129623|560878215|FG000|Overall Study|Uncertainty to return|0|||
155393979|NCT00129623|560878216|FG001|Overall Study|Uncertainty to return|1|||
155393980|NCT00596934|560878217|FG000|Overall Study|Protocol Violation|1|||
155393981|NCT00596934|560878217|FG000|Overall Study|Withdrawal by Subject|1|||
155393982|NCT02315898|560878218|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
155393983|NCT02315898|560878219|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
155393984|NCT02315898|560878220|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
155393985|NCT02315898|560878221|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
155393986|NCT02445755|560878222|FG000|Overall Study|Withdrawal by Subject|2|||
155393987|NCT02445755|560878222|FG000|Overall Study|Protocol Violation|6|||
155393988|NCT02445755|560878222|FG000|Overall Study|Screen Failure|5|||
155393989|NCT01296035|560878224|FG000|Overall Study|Withdrawal by Subject|1|||
155393990|NCT01674712|560878225|FG000|Overall Study|Adverse Event|5|||
155393991|NCT01674712|560878226|FG001|Overall Study|Adverse Event|6|||
155393992|NCT01674712|560878227|FG002|Overall Study|Adverse Event|3|||
155393993|NCT01674712|560878228|FG003|Overall Study|Adverse Event|4|||
155393994|NCT01674712|560878229|FG004|Overall Study|Adverse Event|6|||
155393995|NCT01674712|560878225|FG000|Overall Study|Lost to Follow-up|1|||
155393996|NCT01674712|560878226|FG001|Overall Study|Lost to Follow-up|0|||
155393997|NCT01674712|560878227|FG002|Overall Study|Lost to Follow-up|0|||
155393998|NCT01674712|560878228|FG003|Overall Study|Lost to Follow-up|0|||
155393999|NCT01674712|560878229|FG004|Overall Study|Lost to Follow-up|0|||
155394000|NCT01674712|560878225|FG000|Overall Study|Protocol Violation|2|||
155394001|NCT01674712|560878226|FG001|Overall Study|Protocol Violation|0|||
155394002|NCT01674712|560878227|FG002|Overall Study|Protocol Violation|0|||
155394003|NCT01674712|560878228|FG003|Overall Study|Protocol Violation|0|||
155394004|NCT01674712|560878229|FG004|Overall Study|Protocol Violation|0|||
155394005|NCT01674712|560878225|FG000|Overall Study|Withdrawal by Subject|2|||
155394006|NCT01674712|560878226|FG001|Overall Study|Withdrawal by Subject|2|||
155394007|NCT01674712|560878227|FG002|Overall Study|Withdrawal by Subject|5|||
155394008|NCT01674712|560878228|FG003|Overall Study|Withdrawal by Subject|4|||
155394009|NCT01674712|560878229|FG004|Overall Study|Withdrawal by Subject|3|||
155394010|NCT01674712|560878225|FG000|Overall Study|Administrative|0|||
155394011|NCT01674712|560878226|FG001|Overall Study|Administrative|1|||
155394012|NCT01674712|560878227|FG002|Overall Study|Administrative|0|||
155394013|NCT01674712|560878228|FG003|Overall Study|Administrative|0|||
155394014|NCT01674712|560878229|FG004|Overall Study|Administrative|1|||
155394015|NCT01674712|560878225|FG000|Overall Study|Lack of Efficacy|0|||
155394016|NCT01674712|560878226|FG001|Overall Study|Lack of Efficacy|0|||
155394017|NCT01674712|560878227|FG002|Overall Study|Lack of Efficacy|1|||
155394018|NCT01674712|560878228|FG003|Overall Study|Lack of Efficacy|0|||
155394019|NCT01674712|560878229|FG004|Overall Study|Lack of Efficacy|1|||
155394020|NCT00866723|560878230|FG000|Overall Study|Withdrawal by Subject|1|||
155394021|NCT00866723|560878230|FG000|Overall Study|Disease Progression|4|||
155394022|NCT01271803|560878233|FG000|Overall Study|Progressive disease|0|||
155394023|NCT01271803|560878234|FG001|Overall Study|Progressive disease|0|||
155394024|NCT01271803|560878235|FG002|Overall Study|Progressive disease|2|||
155394025|NCT01271803|560878233|FG000|Overall Study|Death|53|||
155394026|NCT01271803|560878234|FG001|Overall Study|Death|34|||
155394027|NCT01271803|560878235|FG002|Overall Study|Death|0|||
155394028|NCT01271803|560878233|FG000|Overall Study|Withdrawal by Subject|1|||
155394029|NCT01271803|560878234|FG001|Overall Study|Withdrawal by Subject|5|||
155394030|NCT01271803|560878235|FG002|Overall Study|Withdrawal by Subject|0|||
155394031|NCT01271803|560878233|FG000|Overall Study|Lost to Follow-up|1|||
155394032|NCT01271803|560878234|FG001|Overall Study|Lost to Follow-up|0|||
155394033|NCT01271803|560878235|FG002|Overall Study|Lost to Follow-up|0|||
155394034|NCT01975428|560878239|FG000|Overall Study|Lost to Follow-up|17|||
155740885|NCT04556383|562152735|FG002|PCP|Physician Decision|0|||
155740886|NCT04556383|562152736|FG003|PCP|Physician Decision|0|||
155740887|NCT04556383|562152733|FG000|PCP|Site terminated by sponsor|0|||
155740888|NCT04556383|562152734|FG001|PCP|Site terminated by sponsor|1|||
155740889|NCT04556383|562152735|FG002|PCP|Site terminated by sponsor|0|||
155394035|NCT01975428|560878240|FG001|Overall Study|Lost to Follow-up|4|||
155394036|NCT01975428|560878239|FG000|Overall Study|Withdrawal by Subject|3|||
155394037|NCT01975428|560878240|FG001|Overall Study|Withdrawal by Subject|10|||
155394038|NCT00995007|560878241|FG000|Overall Study|Withdrew consent|1|||
155394039|NCT00995007|560878242|FG001|Overall Study|Withdrew consent|0|||
155394040|NCT00995007|560878241|FG000|Overall Study|Refused further treatment|8|||
155394041|NCT00995007|560878242|FG001|Overall Study|Refused further treatment|2|||
155394042|NCT00995007|560878241|FG000|Overall Study|Toxicity|8|||
155394043|NCT00995007|560878242|FG001|Overall Study|Toxicity|0|||
155394044|NCT03933397|560878243|FG000|Overall Study|No emergency department visit|65|||
155394045|NCT03933397|560878244|FG001|Overall Study|No emergency department visit|71|||
155394046|NCT03933397|560878243|FG000|Overall Study|Missed emergency department visit|25|||
155394047|NCT03933397|560878244|FG001|Overall Study|Missed emergency department visit|30|||
155394048|NCT03933397|560878243|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
155394049|NCT03933397|560878244|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
155394050|NCT03933397|560878243|FG000|Overall Study|Withdrawal by Subject|1|||
155394051|NCT03933397|560878244|FG001|Overall Study|Withdrawal by Subject|0|||
155740890|NCT04556383|562152736|FG003|PCP|Site terminated by sponsor|0|||
155740891|NCT04556383|562152733|FG000|OLE|Study terminated by sponsor|0|||
155740892|NCT04556383|562152734|FG001|OLE|Study terminated by sponsor|0|||
155740893|NCT04556383|562152735|FG002|OLE|Study terminated by sponsor|0|||
155740894|NCT04556383|562152736|FG003|OLE|Study terminated by sponsor|68|||
155740895|NCT04556383|562152733|FG000|OLE|Withdrawal by Subject|0|||
155740896|NCT04556383|562152734|FG001|OLE|Withdrawal by Subject|0|||
155740897|NCT04556383|562152735|FG002|OLE|Withdrawal by Subject|0|||
155740898|NCT04556383|562152736|FG003|OLE|Withdrawal by Subject|10|||
155740899|NCT04556383|562152733|FG000|OLE|Lack of Efficacy|0|||
155740900|NCT04556383|562152734|FG001|OLE|Lack of Efficacy|0|||
155740901|NCT04556383|562152735|FG002|OLE|Lack of Efficacy|0|||
155740902|NCT04556383|562152736|FG003|OLE|Lack of Efficacy|7|||
155740903|NCT04556383|562152733|FG000|OLE|Adverse Event|0|||
155740904|NCT04556383|562152734|FG001|OLE|Adverse Event|0|||
155740905|NCT04556383|562152735|FG002|OLE|Adverse Event|0|||
155740906|NCT04556383|562152736|FG003|OLE|Adverse Event|2|||
155740907|NCT04556383|562152733|FG000|OLE|Other, Not Specified|0|||
155394052|NCT03933397|560878243|FG000|Overall Study|Physician Decision|1|||
155394053|NCT03933397|560878244|FG001|Overall Study|Physician Decision|1|||
155394054|NCT03933397|560878243|FG000|Overall Study|missing pain score|1|||
155394055|NCT03933397|560878244|FG001|Overall Study|missing pain score|1|||
155394056|NCT03933397|560878243|FG000|Overall Study|Confirmed COVID-19|1|||
155394057|NCT03933397|560878244|FG001|Overall Study|Confirmed COVID-19|2|||
155394058|NCT01610687|560878246|FG000|Overall Study|Lack of Efficacy|26|||
155394059|NCT01610687|560878246|FG000|Overall Study|Adverse Event|18|||
155394060|NCT01610687|560878246|FG000|Overall Study|Moved out of area|6|||
155394061|NCT01610687|560878246|FG000|Overall Study|Withdrawal by Subject|7|||
155394062|NCT01610687|560878246|FG000|Overall Study|Lost to Follow-up|4|||
155394063|NCT01610687|560878246|FG000|Overall Study|Symptom control without study medication|2|||
155394064|NCT01610687|560878246|FG000|Overall Study|Unable to make journey|1|||
155740908|NCT04556383|562152734|FG001|OLE|Other, Not Specified|0|||
155740909|NCT04556383|562152735|FG002|OLE|Other, Not Specified|0|||
155740910|NCT04556383|562152736|FG003|OLE|Other, Not Specified|2|||
155740911|NCT04556383|562152733|FG000|OLE|Death|0|||
155740912|NCT04556383|562152734|FG001|OLE|Death|0|||
155740913|NCT04556383|562152735|FG002|OLE|Death|0|||
155394065|NCT01610687|560878246|FG000|Overall Study|Death|1|||
155394066|NCT01610687|560878246|FG000|Overall Study|Cannabis affecting job|1|||
155394067|NCT01610687|560878246|FG000|Overall Study|Felt more alter without study medication|1|||
155394068|NCT03675776|560878247|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
155394069|NCT03675776|560878248|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
155394070|NCT03675776|560878249|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
155394071|NCT03675776|560878247|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155394072|NCT03675776|560878248|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155740914|NCT04556383|562152736|FG003|OLE|Death|1|||
155740915|NCT04556383|562152733|FG000|OLE|Lost to Follow-up|0|||
155740916|NCT04556383|562152734|FG001|OLE|Lost to Follow-up|0|||
155740917|NCT04556383|562152735|FG002|OLE|Lost to Follow-up|0|||
155740918|NCT04556383|562152736|FG003|OLE|Lost to Follow-up|1|||
155740919|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
155740920|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155394073|NCT03675776|560878249|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155394074|NCT00999713|560878250|FG000|Overall Study|Physician Decision|2|||
155394075|NCT00999713|560878251|FG001|Overall Study|Physician Decision|0|||
155740921|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155740922|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155394076|NCT01130974|560878252|FG000|Overall Study|Protocol Violation|10|||
155740923|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Death|3|||
155740924|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Death|0|||
155740925|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Death|0|||
155740926|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Death|0|||
155740927|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
155740928|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155394077|NCT01130974|560878253|FG001|Overall Study|Protocol Violation|10|||
155394078|NCT01130974|560878252|FG000|Overall Study|Withdrawal by Subject|0|||
155394079|NCT01130974|560878253|FG001|Overall Study|Withdrawal by Subject|1|||
155394080|NCT01130974|560878252|FG000|Overall Study|Ineligibility criteria|5|||
155394081|NCT01130974|560878253|FG001|Overall Study|Ineligibility criteria|2|||
155394082|NCT02966223|560878254|FG000|Overall Study|Physician Decision|3|||
155394083|NCT02966223|560878254|FG000|Overall Study|Withdrawal by Subject|11|||
155394084|NCT02966223|560878254|FG000|Overall Study|Lost to Follow-up|1|||
155394085|NCT04409353|560878257|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
155394086|NCT04409353|560878258|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
155394087|NCT04409353|560878259|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
155394088|NCT04409353|560878257|FG000|Overall Study|Lost to Follow-up|6|||
155394089|NCT04409353|560878258|FG001|Overall Study|Lost to Follow-up|8|||
155394090|NCT04409353|560878259|FG002|Overall Study|Lost to Follow-up|7|||
155394091|NCT04409353|560878257|FG000|Overall Study|Major surgery during participation window|4|||
155394092|NCT04409353|560878258|FG001|Overall Study|Major surgery during participation window|3|||
155394093|NCT04409353|560878259|FG002|Overall Study|Major surgery during participation window|3|||
155394094|NCT04409353|560878257|FG000|Overall Study|Life event occurred during participation window|3|||
155394095|NCT04409353|560878258|FG001|Overall Study|Life event occurred during participation window|2|||
155394096|NCT04409353|560878259|FG002|Overall Study|Life event occurred during participation window|4|||
155394097|NCT04409353|560878257|FG000|Overall Study|Lack of Efficacy|4|||
155394098|NCT04409353|560878258|FG001|Overall Study|Lack of Efficacy|1|||
155394099|NCT04409353|560878259|FG002|Overall Study|Lack of Efficacy|3|||
155394100|NCT04409353|560878257|FG000|Overall Study|Adverse Event|2|||
155394101|NCT04409353|560878258|FG001|Overall Study|Adverse Event|1|||
155394102|NCT04409353|560878259|FG002|Overall Study|Adverse Event|1|||
155394103|NCT04409353|560878257|FG000|Overall Study|Disease burden - unable to participate|0|||
155394104|NCT04409353|560878258|FG001|Overall Study|Disease burden - unable to participate|1|||
155394105|NCT04409353|560878259|FG002|Overall Study|Disease burden - unable to participate|1|||
155394106|NCT04409353|560878257|FG000|Overall Study|Intervention too complicated|1|||
155394107|NCT04409353|560878258|FG001|Overall Study|Intervention too complicated|0|||
155394108|NCT04409353|560878259|FG002|Overall Study|Intervention too complicated|1|||
155394109|NCT00671554|560878265|FG000|Overall Study|Disease progression|3|||
155394110|NCT04275297|560878269|FG000|Overall Study|Lost to Follow-up|1|||
155394111|NCT04275297|560878270|FG001|Overall Study|Lost to Follow-up|1|||
155740929|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155740930|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155740931|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
155740932|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155740933|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155740934|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155740935|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
155740936|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
155740937|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
155740938|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
155740939|NCT00884741|562152737|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
155740940|NCT00884741|562152738|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155740941|NCT00884741|562152739|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155740942|NCT00884741|562152740|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155740943|NCT00884741|562152737|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155740944|NCT00884741|562152738|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
155740945|NCT00884741|562152739|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155740946|NCT00884741|562152740|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155740947|NCT00884741|562152737|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
155740948|NCT00884741|562152738|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
155740949|NCT00884741|562152739|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
155740950|NCT00884741|562152740|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
155740951|NCT00884741|562152737|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155740952|NCT00884741|562152738|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
155740953|NCT00884741|562152739|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155740954|NCT00884741|562152740|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155394112|NCT01093326|560878273|FG000|Overall Study|Death|0|||
155394113|NCT01093326|560878274|FG001|Overall Study|Death|1|||
155394114|NCT01093326|560878275|FG002|Overall Study|Death|0|||
155394115|NCT01093326|560878273|FG000|Overall Study|Lack of Efficacy|7|||
155394116|NCT01093326|560878274|FG001|Overall Study|Lack of Efficacy|6|||
155394117|NCT01093326|560878275|FG002|Overall Study|Lack of Efficacy|3|||
155394118|NCT01093326|560878273|FG000|Overall Study|Lost to Follow-up|2|||
155394119|NCT01093326|560878274|FG001|Overall Study|Lost to Follow-up|5|||
155394120|NCT01093326|560878275|FG002|Overall Study|Lost to Follow-up|4|||
155394121|NCT01093326|560878273|FG000|Overall Study|Physician Decision|3|||
155394122|NCT01093326|560878274|FG001|Overall Study|Physician Decision|1|||
155394123|NCT01093326|560878275|FG002|Overall Study|Physician Decision|3|||
155394124|NCT01093326|560878273|FG000|Overall Study|Withdrawal by Subject|30|||
155394125|NCT01093326|560878274|FG001|Overall Study|Withdrawal by Subject|27|||
155394126|NCT01093326|560878275|FG002|Overall Study|Withdrawal by Subject|26|||
155394127|NCT01093326|560878273|FG000|Overall Study|Adverse Event|2|||
155394128|NCT01093326|560878274|FG001|Overall Study|Adverse Event|1|||
155394129|NCT01093326|560878275|FG002|Overall Study|Adverse Event|4|||
155635495|NCT00790036|561757965|FG000|Overall Study|Administrative problems|5|||
155635496|NCT00790036|561757966|FG001|Overall Study|Administrative problems|9|||
155635497|NCT00790036|561757965|FG000|Overall Study|Adverse Event|113|||
155635498|NCT00790036|561757966|FG001|Overall Study|Adverse Event|44|||
155635499|NCT00790036|561757965|FG000|Overall Study|Death|1|||
155635500|NCT00790036|561757966|FG001|Overall Study|Death|0|||
155635501|NCT00790036|561757965|FG000|Overall Study|Disease progression|24|||
155635502|NCT00790036|561757966|FG001|Overall Study|Disease progression|48|||
155635503|NCT00790036|561757965|FG000|Overall Study|Lost to Follow-up|1|||
155635504|NCT00790036|561757966|FG001|Overall Study|Lost to Follow-up|2|||
155635505|NCT00790036|561757965|FG000|Overall Study|Protocol Violation|10|||
155635506|NCT00790036|561757966|FG001|Overall Study|Protocol Violation|2|||
155635507|NCT00790036|561757965|FG000|Overall Study|Withdrawal by Subject|18|||
155635508|NCT00790036|561757966|FG001|Overall Study|Withdrawal by Subject|7|||
155635509|NCT00790036|561757965|FG000|Overall Study|Subject/guardian decision|20|||
155635510|NCT00790036|561757966|FG001|Overall Study|Subject/guardian decision|7|||
155635511|NCT02442349|561757967|FG000|Overall Study|Death|95|||
155635512|NCT02442349|561757967|FG000|Overall Study|Withdrawal by Subject|27|||
155635513|NCT02442349|561757967|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
155635514|NCT02442349|561757967|FG000|Overall Study|Lost to Follow-up|1|||
155635515|NCT01551173|561757968|FG000|Overall Study|Withdrawal by Subject|11|||
155635516|NCT01551173|561757969|FG001|Overall Study|Withdrawal by Subject|16|||
155635517|NCT01551173|561757968|FG000|Overall Study|Adverse Event|7|||
155635518|NCT01551173|561757969|FG001|Overall Study|Adverse Event|6|||
155635519|NCT01551173|561757968|FG000|Overall Study|Lost to Follow-up|5|||
155635520|NCT01551173|561757969|FG001|Overall Study|Lost to Follow-up|7|||
155635521|NCT01551173|561757968|FG000|Overall Study|Other|5|||
155635522|NCT01551173|561757969|FG001|Overall Study|Other|3|||
155635523|NCT04530344|561757970|FG000|Overall Study|Lost to Follow-up|3|||
155635524|NCT04530344|561757971|FG001|Overall Study|Lost to Follow-up|3|||
155635525|NCT04530344|561757972|FG002|Overall Study|Lost to Follow-up|3|||
155635526|NCT04530344|561757973|FG003|Overall Study|Lost to Follow-up|10|||
155635527|NCT04530344|561757970|FG000|Overall Study|Withdrawal by Subject|14|||
155635528|NCT04530344|561757971|FG001|Overall Study|Withdrawal by Subject|5|||
155635529|NCT04530344|561757972|FG002|Overall Study|Withdrawal by Subject|18|||
155635530|NCT04530344|561757973|FG003|Overall Study|Withdrawal by Subject|33|||
155635531|NCT04530344|561757970|FG000|Overall Study|Adverse Event|0|||
155635532|NCT04530344|561757971|FG001|Overall Study|Adverse Event|0|||
155635533|NCT04530344|561757972|FG002|Overall Study|Adverse Event|0|||
155635534|NCT04530344|561757973|FG003|Overall Study|Adverse Event|1|||
155635535|NCT04530344|561757970|FG000|Overall Study|Lack of Efficacy|0|||
155635536|NCT04530344|561757971|FG001|Overall Study|Lack of Efficacy|0|||
155635537|NCT04530344|561757972|FG002|Overall Study|Lack of Efficacy|0|||
155635538|NCT04530344|561757973|FG003|Overall Study|Lack of Efficacy|1|||
155635539|NCT04530344|561757970|FG000|Overall Study|Physician Decision|0|||
155635540|NCT04530344|561757971|FG001|Overall Study|Physician Decision|0|||
155635541|NCT04530344|561757972|FG002|Overall Study|Physician Decision|1|||
155635542|NCT04530344|561757973|FG003|Overall Study|Physician Decision|1|||
155635543|NCT04530344|561757970|FG000|Overall Study|Pregnancy|0|||
155635544|NCT04530344|561757971|FG001|Overall Study|Pregnancy|0|||
155635545|NCT04530344|561757972|FG002|Overall Study|Pregnancy|2|||
155635546|NCT04530344|561757973|FG003|Overall Study|Pregnancy|1|||
155635547|NCT04530344|561757970|FG000|Overall Study|Protocol Violation|0|||
155635548|NCT04530344|561757971|FG001|Overall Study|Protocol Violation|0|||
155635549|NCT04530344|561757972|FG002|Overall Study|Protocol Violation|0|||
155635550|NCT04530344|561757973|FG003|Overall Study|Protocol Violation|1|||
155635551|NCT04530344|561757970|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
155635552|NCT04530344|561757971|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
155635553|NCT04530344|561757972|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
155635554|NCT04530344|561757973|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
155635555|NCT04530344|561757970|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155635556|NCT04530344|561757971|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155635557|NCT04530344|561757972|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
155635558|NCT04530344|561757973|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155394130|NCT01093326|560878273|FG000|Overall Study|Other|0|||
155394131|NCT01093326|560878274|FG001|Overall Study|Other|0|||
155635559|NCT04530344|561757970|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
155635560|NCT04530344|561757971|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
155394132|NCT01093326|560878275|FG002|Overall Study|Other|1|||
155394133|NCT04435782|560878276|FG000|Overall Study|Study terminated by sponsor|4|||
155394134|NCT03672461|560878277|FG000|Overall Study|COVID Related|4|||
155394135|NCT03672461|560878278|FG001|Overall Study|COVID Related|2|||
155394136|NCT03672461|560878277|FG000|Overall Study|Adverse Event|2|||
155394137|NCT03672461|560878278|FG001|Overall Study|Adverse Event|0|||
155394138|NCT03672461|560878277|FG000|Overall Study|Serious Adverse Event|0|||
155394139|NCT03672461|560878278|FG001|Overall Study|Serious Adverse Event|1|||
155394140|NCT03672461|560878277|FG000|Overall Study|Too Busy|3|||
155394141|NCT03672461|560878278|FG001|Overall Study|Too Busy|1|||
155394142|NCT03672461|560878277|FG000|Overall Study|Lost to Follow-up|1|||
155394143|NCT03672461|560878278|FG001|Overall Study|Lost to Follow-up|2|||
155394144|NCT03672461|560878277|FG000|Overall Study|Family|2|||
155394145|NCT03672461|560878278|FG001|Overall Study|Family|2|||
155394146|NCT03672461|560878277|FG000|Overall Study|No remote technology access|0|||
155394147|NCT03672461|560878278|FG001|Overall Study|No remote technology access|1|||
155394148|NCT03672461|560878277|FG000|Overall Study|Withdrawal by Subject|1|||
155394149|NCT03672461|560878278|FG001|Overall Study|Withdrawal by Subject|0|||
155394150|NCT03672461|560878277|FG000|Overall Study|Cannot tolerate intervention|1|||
155394151|NCT03672461|560878278|FG001|Overall Study|Cannot tolerate intervention|0|||
155394152|NCT03672461|560878277|FG000|Overall Study|Incomplete outcome data|6|||
155740955|NCT00884741|562152737|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155740956|NCT00884741|562152738|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
155394153|NCT03672461|560878278|FG001|Overall Study|Incomplete outcome data|1|||
155394154|NCT04225806|560878279|FG000|Overall Study|Trial termination|15|||
155394155|NCT00977574|560878282|FG000|Overall Study|Never Treated|4|||
155394156|NCT00977574|560878283|FG001|Overall Study|Never Treated|2|||
155394157|NCT00977574|560878284|FG002|Overall Study|Never Treated|4|||
155394158|NCT04223791|560878285|FG000|Overall Study|Lost to Follow-up|0|||
155394159|NCT04223791|560878286|FG001|Overall Study|Lost to Follow-up|4|||
155394160|NCT04223791|560878285|FG000|Overall Study|Physician Decision|5|||
155394161|NCT04223791|560878286|FG001|Overall Study|Physician Decision|1|||
155394162|NCT04223791|560878285|FG000|Overall Study|Protocol Violation|1|||
155394163|NCT04223791|560878286|FG001|Overall Study|Protocol Violation|1|||
155394164|NCT04223791|560878285|FG000|Overall Study|Withdrawal by Subject|10|||
155394165|NCT04223791|560878286|FG001|Overall Study|Withdrawal by Subject|12|||
155394166|NCT04223791|560878285|FG000|Overall Study|Pregnancy|1|||
155394167|NCT04223791|560878286|FG001|Overall Study|Pregnancy|1|||
155394168|NCT04223791|560878285|FG000|Overall Study|Ongoing in Study|305|||
155394169|NCT04223791|560878286|FG001|Overall Study|Ongoing in Study|302|||
155394170|NCT04667247|560878287|FG000|Overall Study|Withdrawal by Subject|0|||
155394171|NCT04667247|560878288|FG001|Overall Study|Withdrawal by Subject|1|||
155394172|NCT05460273|560878289|FG000|Overall Study|Death|43|||
155394173|NCT05460273|560878290|FG001|Overall Study|Death|9|||
155394174|NCT05460273|560878289|FG000|Overall Study|Lost to Follow-up|7|||
155394175|NCT05460273|560878290|FG001|Overall Study|Lost to Follow-up|0|||
155394176|NCT05460273|560878289|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
155394177|NCT05460273|560878290|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
155394178|NCT04124614|560878291|FG000|Placebo Run-in Period|Not Randomized|34|||
155394179|NCT04124614|560878292|FG001|Placebo Run-in Period|Not Randomized|0|||
155394180|NCT04124614|560878293|FG002|Placebo Run-in Period|Not Randomized|0|||
155394181|NCT04124614|560878291|FG000|Double Blind Treatment Period|Adverse Event|0|||
155394182|NCT04124614|560878292|FG001|Double Blind Treatment Period|Adverse Event|7|||
155394183|NCT04124614|560878293|FG002|Double Blind Treatment Period|Adverse Event|22|||
155740957|NCT00884741|562152739|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155740958|NCT00884741|562152740|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155740959|NCT00884741|562152737|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155283493|NCT00172185|560470749|FG000|Overall Study|Adverse Event|0|||
155283494|NCT00172185|560470750|FG001|Overall Study|Adverse Event|1|||
155283495|NCT00172185|560470751|FG002|Overall Study|Adverse Event|3|||
155283496|NCT00172185|560470752|FG003|Overall Study|Adverse Event|4|||
155283497|NCT00172185|560470749|FG000|Overall Study|Physician Decision|0|||
155283498|NCT00172185|560470750|FG001|Overall Study|Physician Decision|0|||
155283499|NCT00172185|560470751|FG002|Overall Study|Physician Decision|1|||
155283500|NCT00172185|560470752|FG003|Overall Study|Physician Decision|0|||
155283501|NCT00172185|560470749|FG000|Overall Study|SPONSOR Decision|0|||
155283502|NCT00172185|560470750|FG001|Overall Study|SPONSOR Decision|1|||
155394184|NCT04124614|560878291|FG000|Double Blind Treatment Period|Death|0|||
155394185|NCT04124614|560878292|FG001|Double Blind Treatment Period|Death|0|||
155740960|NCT00884741|562152738|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
155283503|NCT00172185|560470751|FG002|Overall Study|SPONSOR Decision|0|||
155283504|NCT00172185|560470752|FG003|Overall Study|SPONSOR Decision|0|||
155394186|NCT04124614|560878293|FG002|Double Blind Treatment Period|Death|1|||
155394187|NCT04124614|560878291|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155394188|NCT04124614|560878292|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
155394189|NCT04124614|560878293|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
155394190|NCT04124614|560878291|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
155740961|NCT00884741|562152739|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155740962|NCT00884741|562152740|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155740963|NCT00884741|562152737|FG000|Randomization|Protocol Violation|0|||
155740964|NCT00884741|562152738|FG001|Randomization|Protocol Violation|0|||
155394191|NCT04124614|560878292|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
155394192|NCT04124614|560878293|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
155283505|NCT00172185|560470749|FG000|Overall Study|Withdrawal by Subject|0|||
155283506|NCT00172185|560470750|FG001|Overall Study|Withdrawal by Subject|0|||
155283507|NCT00172185|560470751|FG002|Overall Study|Withdrawal by Subject|1|||
155283508|NCT00172185|560470752|FG003|Overall Study|Withdrawal by Subject|0|||
155283509|NCT04048135|560470753|FG000|Overall Study|Withdrawal by Subject|1|||
155394193|NCT04124614|560878291|FG000|Double Blind Treatment Period|Physician Decision|0|||
155394194|NCT04124614|560878292|FG001|Double Blind Treatment Period|Physician Decision|0|||
155394195|NCT04124614|560878293|FG002|Double Blind Treatment Period|Physician Decision|3|||
155394196|NCT04124614|560878291|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
155394197|NCT04124614|560878292|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
155394198|NCT04124614|560878293|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
155394199|NCT04124614|560878291|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155394200|NCT04124614|560878292|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
155394201|NCT04124614|560878293|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
155394202|NCT04124614|560878291|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
155394203|NCT04124614|560878292|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
155394204|NCT04124614|560878293|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
155394205|NCT05749952|560878294|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
155394206|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Administrative problems|1|||
155394207|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Administrative problems|1|||
155394208|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
155394209|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
155394210|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
155394211|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
155394212|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Adverse Event|5|||
155394213|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Adverse Event|15|||
155394214|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
155394215|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
155394216|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
155394217|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
155394218|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Death|1|||
155394219|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Death|1|||
155394220|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
155394221|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
155394222|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
155394223|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
155394224|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
155394225|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
155394226|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
155394227|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
155394228|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
155394229|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
155394230|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
155394231|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
155394232|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
155394233|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
155394234|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
155394235|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
155394236|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
155394237|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
155740965|NCT00884741|562152739|FG002|Randomization|Protocol Violation|8|||
155740966|NCT00884741|562152740|FG003|Randomization|Protocol Violation|8|||
155740967|NCT01994889|562152741|FG000|Overall Study|Adverse Event|5|||
155283510|NCT04048135|560470754|FG001|Overall Study|Withdrawal by Subject|1|||
155283511|NCT04048135|560470755|FG002|Overall Study|Withdrawal by Subject|1|||
155283512|NCT04048135|560470756|FG003|Overall Study|Withdrawal by Subject|2|||
155283513|NCT04048135|560470757|FG004|Overall Study|Withdrawal by Subject|0|||
155283514|NCT04048135|560470758|FG005|Overall Study|Withdrawal by Subject|0|||
155283515|NCT04048135|560470759|FG006|Overall Study|Withdrawal by Subject|1|||
155283516|NCT04048135|560470760|FG007|Overall Study|Withdrawal by Subject|1|||
155283517|NCT04048135|560470753|FG000|Overall Study|Adverse Event|0|||
155394238|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
155394239|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
155394240|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
155394241|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
155394242|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
155394243|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
155394244|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
155394245|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
155394246|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
155394247|NCT01876251|560880242|FG000|Overall Study|Clinical progression|1|||
155394248|NCT01876251|560880243|FG001|Overall Study|Clinical progression|0|||
155394249|NCT01876251|560880244|FG002|Overall Study|Clinical progression|0|||
155394250|NCT01876251|560880242|FG000|Overall Study|Death|2|||
155394251|NCT01876251|560880243|FG001|Overall Study|Death|0|||
155394252|NCT01876251|560880244|FG002|Overall Study|Death|1|||
155394253|NCT01876251|560880242|FG000|Overall Study|Participant started new treatment|1|||
155740968|NCT01994889|562152742|FG001|Overall Study|Adverse Event|12|||
155740969|NCT01994889|562152743|FG002|Overall Study|Adverse Event|11|||
155740970|NCT01994889|562152741|FG000|Overall Study|Cardiac Device Implantation|0|||
155740971|NCT01994889|562152742|FG001|Overall Study|Cardiac Device Implantation|2|||
155740972|NCT01994889|562152743|FG002|Overall Study|Cardiac Device Implantation|0|||
155740973|NCT01994889|562152741|FG000|Overall Study|Organ Transplantation|1|||
155740974|NCT01994889|562152742|FG001|Overall Study|Organ Transplantation|5|||
155740975|NCT01994889|562152743|FG002|Overall Study|Organ Transplantation|5|||
155740976|NCT01994889|562152741|FG000|Overall Study|No longer willing to participate|8|||
155740977|NCT01994889|562152742|FG001|Overall Study|No longer willing to participate|17|||
155740978|NCT01994889|562152743|FG002|Overall Study|No longer willing to participate|37|||
155740979|NCT01994889|562152741|FG000|Overall Study|Lost to Follow-up|0|||
155740980|NCT01994889|562152742|FG001|Overall Study|Lost to Follow-up|1|||
155740981|NCT01994889|562152743|FG002|Overall Study|Lost to Follow-up|0|||
155740982|NCT01994889|562152741|FG000|Overall Study|Protocol Violation|0|||
155740983|NCT01994889|562152742|FG001|Overall Study|Protocol Violation|1|||
155740984|NCT01994889|562152743|FG002|Overall Study|Protocol Violation|1|||
155740985|NCT01994889|562152741|FG000|Overall Study|Death|14|||
155740986|NCT01994889|562152742|FG001|Overall Study|Death|25|||
155740987|NCT01994889|562152743|FG002|Overall Study|Death|38|||
155740988|NCT04525885|562152744|FG000|Overall Study|Screen Failure|1|||
155740989|NCT04525885|562152745|FG001|Overall Study|Screen Failure|0|||
155740990|NCT04525885|562152746|FG002|Overall Study|Screen Failure|0|||
155740991|NCT04525885|562152744|FG000|Overall Study|Withdrawal by Subject|14|||
155740992|NCT04525885|562152745|FG001|Overall Study|Withdrawal by Subject|6|||
155740993|NCT04525885|562152746|FG002|Overall Study|Withdrawal by Subject|20|||
155740994|NCT04525885|562152744|FG000|Overall Study|Physician Decision|1|||
155740995|NCT04525885|562152745|FG001|Overall Study|Physician Decision|0|||
155740996|NCT04525885|562152746|FG002|Overall Study|Physician Decision|1|||
155740997|NCT02717832|562152747|FG000|Overall Study|Inability to place IV|3|||
155740998|NCT00750152|562152748|FG000|Overall Study|Adverse Event|2|||
155740999|NCT00750152|562152749|FG001|Overall Study|Adverse Event|1|||
155741000|NCT00750152|562152748|FG000|Overall Study|Lost to Follow-up|8|||
155741001|NCT00750152|562152749|FG001|Overall Study|Lost to Follow-up|13|||
155741002|NCT00750152|562152748|FG000|Overall Study|Withdrawal by Subject|3|||
155741003|NCT00750152|562152749|FG001|Overall Study|Withdrawal by Subject|3|||
155741004|NCT00750152|562152748|FG000|Overall Study|Physician Decision|1|||
155741005|NCT00750152|562152749|FG001|Overall Study|Physician Decision|1|||
155741006|NCT00750152|562152748|FG000|Overall Study|Non-compliance|0|||
155741007|NCT00750152|562152749|FG001|Overall Study|Non-compliance|1|||
155741008|NCT00750152|562152748|FG000|Overall Study|Termination by sponsor|1|||
155741009|NCT00750152|562152749|FG001|Overall Study|Termination by sponsor|0|||
155741010|NCT00750152|562152748|FG000|Overall Study|Other|7|||
155741011|NCT00750152|562152749|FG001|Overall Study|Other|8|||
155741012|NCT02537015|562152750|FG000|Overall Study|Adverse Event|3|||
155741013|NCT02537015|562152750|FG000|Overall Study|Withdrawal by Subject|2|||
155394254|NCT01876251|560880243|FG001|Overall Study|Participant started new treatment|0|||
155394255|NCT01876251|560880244|FG002|Overall Study|Participant started new treatment|1|||
155394256|NCT01876251|560880242|FG000|Overall Study|Participant refused further follow-up|0|||
155741014|NCT02537015|562152750|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155741015|NCT01808092|562152751|FG000|Overall Study|Death|39|||
155394257|NCT01876251|560880243|FG001|Overall Study|Participant refused further follow-up|0|||
155741016|NCT01808092|562152752|FG001|Overall Study|Death|29|||
155741017|NCT01808092|562152751|FG000|Overall Study|Lost to Follow-up|3|||
155741018|NCT01808092|562152752|FG001|Overall Study|Lost to Follow-up|7|||
155741019|NCT01808092|562152751|FG000|Overall Study|Withdrawal by Subject|9|||
155741020|NCT01808092|562152752|FG001|Overall Study|Withdrawal by Subject|4|||
155394258|NCT01876251|560880244|FG002|Overall Study|Participant refused further follow-up|1|||
155394259|NCT01876251|560880242|FG000|Overall Study|Study terminated|1|||
155741021|NCT01808092|562152751|FG000|Overall Study|Other Eligibility criteria|3|||
155741022|NCT01808092|562152752|FG001|Overall Study|Other Eligibility criteria|5|||
155394260|NCT01876251|560880243|FG001|Overall Study|Study terminated|0|||
155394261|NCT01876251|560880244|FG002|Overall Study|Study terminated|0|||
155394262|NCT01876251|560880242|FG000|Overall Study|Objective progression or relapse|10|||
155741023|NCT01097005|562152758|FG000|Overall Study|Case Report Form not collected|18|||
155741024|NCT01097005|562152758|FG000|Overall Study|Subjects cannot visit the hospital|1|||
155741025|NCT01097005|562152758|FG000|Overall Study|Poor medication compliance|1|||
155741026|NCT01097005|562152758|FG000|Overall Study|No examination data available|244|||
155741027|NCT01097005|562152758|FG000|Overall Study|Deviation from exclusion criteria|37|||
155741028|NCT01097005|562152758|FG000|Overall Study|Adverse Event|14|||
155741029|NCT01097005|562152758|FG000|Overall Study|Discontinuance by complication|50|||
155741030|NCT03425253|562152761|FG000|Overall Study|Adverse Event|2|||
155741031|NCT03425253|562152761|FG000|Overall Study|Lost to Follow-up|3|||
155741032|NCT03425253|562152761|FG000|Overall Study|Withdrew Consent|6|||
155741033|NCT03425253|562152761|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
155741034|NCT04614324|562152762|FG000|Overall Study|Lost to Follow-up|3|||
155741035|NCT04614324|562152762|FG000|Overall Study|Physician Decision|1|||
155741036|NCT04614324|562152762|FG000|Overall Study|Withdrawal by Subject|2|||
155741037|NCT04614324|562152762|FG000|Overall Study|Remaining in Follow up|123|||
155741038|NCT04627285|562152763|FG000|Overall Study|Adverse Event|0|||
155741039|NCT04627285|562152764|FG001|Overall Study|Adverse Event|2|||
155741040|NCT04627285|562152763|FG000|Overall Study|Lost to Follow-up|1|||
155741041|NCT04627285|562152764|FG001|Overall Study|Lost to Follow-up|0|||
155741042|NCT04627285|562152763|FG000|Overall Study|Withdrawal by Subject|1|||
155741043|NCT04627285|562152764|FG001|Overall Study|Withdrawal by Subject|1|||
155741044|NCT04627285|562152763|FG000|Overall Study|Sponsor decision|5|||
155741045|NCT04627285|562152764|FG001|Overall Study|Sponsor decision|0|||
155741046|NCT04627285|562152763|FG000|Overall Study|Participant left country; aunt informed the site|0|||
155741047|NCT04627285|562152764|FG001|Overall Study|Participant left country; aunt informed the site|1|||
155741048|NCT00294762|562154772|FG000|Overall Study|Did not receive study treatment|3|||
155741049|NCT00294762|562154773|FG001|Overall Study|Did not receive study treatment|3|||
155741050|NCT02937584|562154774|FG000|Period 1|Adverse Event|1|||
155741051|NCT02937584|562154775|FG001|Period 1|Adverse Event|2|||
155741052|NCT02937584|562154774|FG000|Washout|Adverse Event|0|||
155741053|NCT02937584|562154775|FG001|Washout|Adverse Event|1|||
155741054|NCT02238080|562154776|FG000|Overall Study|Death|13|||
155741055|NCT02238080|562154776|FG000|Overall Study|Treatment interrupted|6|||
155635561|NCT04530344|561757972|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
155635562|NCT04530344|561757973|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
155635563|NCT04530344|561757970|FG000|Overall Study|Personal Reasons|0|||
155635564|NCT04530344|561757971|FG001|Overall Study|Personal Reasons|0|||
155635565|NCT04530344|561757972|FG002|Overall Study|Personal Reasons|0|||
155635566|NCT04530344|561757973|FG003|Overall Study|Personal Reasons|1|||
155635567|NCT04530344|561757970|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155635568|NCT04530344|561757971|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155635569|NCT04530344|561757972|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155635570|NCT04530344|561757973|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
155635571|NCT01402700|561757974|FG000|Overall Study|Death|3|||
155635572|NCT01402700|561757974|FG000|Overall Study|Withdrawal by Subject|3|||
155635573|NCT01402700|561757974|FG000|Overall Study|Missed Visit|1|||
155635574|NCT03507790|561757975|FG000|Overall Study|Adverse Event|0|||
155635575|NCT03507790|561757976|FG001|Overall Study|Adverse Event|11|||
155635576|NCT03507790|561757977|FG002|Overall Study|Adverse Event|3|||
155635577|NCT03507790|561757975|FG000|Overall Study|Withdrawal by Subject|2|||
155635578|NCT03507790|561757976|FG001|Overall Study|Withdrawal by Subject|0|||
155635579|NCT03507790|561757977|FG002|Overall Study|Withdrawal by Subject|0|||
155635580|NCT03507790|561757975|FG000|Overall Study|Subject moved to another location|1|||
155635581|NCT03507790|561757976|FG001|Overall Study|Subject moved to another location|2|||
155635582|NCT03507790|561757977|FG002|Overall Study|Subject moved to another location|0|||
155635583|NCT03507790|561757975|FG000|Overall Study|Non-compliance with study drug|0|||
155635584|NCT03507790|561757976|FG001|Overall Study|Non-compliance with study drug|0|||
155635585|NCT03507790|561757977|FG002|Overall Study|Non-compliance with study drug|1|||
155635586|NCT03507790|561757975|FG000|Overall Study|COVID 19 Pandemic|0|||
155635587|NCT03507790|561757976|FG001|Overall Study|COVID 19 Pandemic|1|||
155635588|NCT03507790|561757977|FG002|Overall Study|COVID 19 Pandemic|0|||
155635589|NCT03507790|561757975|FG000|Overall Study|Lost to Follow-up|0|||
155635590|NCT03507790|561757976|FG001|Overall Study|Lost to Follow-up|1|||
155635591|NCT03507790|561757977|FG002|Overall Study|Lost to Follow-up|0|||
155635592|NCT03507790|561757975|FG000|Overall Study|Discontinuation of the trial at the site|1|||
155635593|NCT03507790|561757976|FG001|Overall Study|Discontinuation of the trial at the site|1|||
155635594|NCT03507790|561757977|FG002|Overall Study|Discontinuation of the trial at the site|0|||
155635595|NCT03507790|561757975|FG000|Overall Study|Randomized in error|0|||
155741056|NCT02238080|562154776|FG000|Overall Study|Withdrawal by Subject|2|||
155635596|NCT03507790|561757976|FG001|Overall Study|Randomized in error|0|||
155635597|NCT03507790|561757977|FG002|Overall Study|Randomized in error|1|||
155635598|NCT00157755|561757979|FG000|Overall Study|Death|2|||
155635599|NCT00157755|561757980|FG001|Overall Study|Death|3|||
155635600|NCT00157755|561757981|FG002|Overall Study|Death|3|||
155635601|NCT00157755|561757982|FG003|Overall Study|Death|2|||
155741057|NCT02238080|562154776|FG000|Overall Study|Other|4|||
155394263|NCT01876251|560880243|FG001|Overall Study|Objective progression or relapse|3|||
155394264|NCT01876251|560880244|FG002|Overall Study|Objective progression or relapse|8|||
155394265|NCT02460497|560880249|FG000|Overall Study|Participant Requested Withdrawal|4|||
155394266|NCT02460497|560880249|FG000|Overall Study|Non-Compliance|1|||
155394267|NCT02460497|560880249|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
155394268|NCT02460497|560880249|FG000|Overall Study|Lost to Follow-up|2|||
155394269|NCT02460497|560880249|FG000|Overall Study|Investigator Decision|1|||
155394270|NCT03876171|560880250|FG000|Overall Study|Withdrawal by Subject|3|||
155394271|NCT03876171|560880251|FG001|Overall Study|Withdrawal by Subject|3|||
155283518|NCT04048135|560470754|FG001|Overall Study|Adverse Event|0|||
155394272|NCT03876171|560880250|FG000|Overall Study|Re-arrest|0|||
155394273|NCT03876171|560880251|FG001|Overall Study|Re-arrest|4|||
155394274|NCT02953639|560880252|FG000|Overall Study|Adverse Event|2|||
155394275|NCT02953639|560880253|FG001|Overall Study|Adverse Event|0|||
155394276|NCT02953639|560880254|FG002|Overall Study|Adverse Event|1|||
155394277|NCT02953639|560880252|FG000|Overall Study|Lost to Follow-up|8|||
155394278|NCT02953639|560880253|FG001|Overall Study|Lost to Follow-up|4|||
155394279|NCT02953639|560880254|FG002|Overall Study|Lost to Follow-up|3|||
155394280|NCT02953639|560880252|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155394281|NCT02953639|560880253|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155741058|NCT04224688|562154780|FG000|Overall Study|Withdrawal by Subject|1|||
155741059|NCT04224688|562154781|FG001|Overall Study|Withdrawal by Subject|3|||
155741060|NCT04224688|562154780|FG000|Overall Study|Lack of Efficacy|1|||
155741061|NCT04224688|562154781|FG001|Overall Study|Lack of Efficacy|1|||
155741062|NCT04224688|562154780|FG000|Overall Study|Adverse event, not fatal|0|||
155741063|NCT04224688|562154781|FG001|Overall Study|Adverse event, not fatal|2|||
155741064|NCT04224688|562154780|FG000|Overall Study|COVID-19|0|||
155741065|NCT04224688|562154781|FG001|Overall Study|COVID-19|1|||
155741066|NCT04074161|562154782|FG000|Overall Study|Withdrawal by Subject|2|||
155741067|NCT04074161|562154783|FG001|Overall Study|Withdrawal by Subject|4|||
155741068|NCT04074161|562154784|FG002|Overall Study|Withdrawal by Subject|1|||
155741069|NCT04074161|562154782|FG000|Overall Study|Lost to Follow-up|4|||
155741070|NCT04074161|562154783|FG001|Overall Study|Lost to Follow-up|5|||
155741071|NCT04074161|562154784|FG002|Overall Study|Lost to Follow-up|3|||
155741072|NCT00796445|562154787|FG000|Overall Study|Protocol Violation|5|||
155741073|NCT00796445|562154788|FG001|Overall Study|Protocol Violation|3|||
155741074|NCT00796445|562154787|FG000|Overall Study|Adverse event, serious fatal|10|||
155741075|NCT00796445|562154788|FG001|Overall Study|Adverse event, serious fatal|5|||
155283519|NCT04048135|560470755|FG002|Overall Study|Adverse Event|0|||
155283520|NCT04048135|560470756|FG003|Overall Study|Adverse Event|1|||
155283521|NCT04048135|560470757|FG004|Overall Study|Adverse Event|1|||
155283522|NCT04048135|560470758|FG005|Overall Study|Adverse Event|0|||
155283523|NCT04048135|560470759|FG006|Overall Study|Adverse Event|0|||
155283524|NCT04048135|560470760|FG007|Overall Study|Adverse Event|0|||
155283525|NCT04048135|560470753|FG000|Overall Study|Protocol Violation|0|||
155283526|NCT04048135|560470754|FG001|Overall Study|Protocol Violation|0|||
155283527|NCT04048135|560470755|FG002|Overall Study|Protocol Violation|0|||
155283528|NCT04048135|560470756|FG003|Overall Study|Protocol Violation|0|||
155283529|NCT04048135|560470757|FG004|Overall Study|Protocol Violation|0|||
155283530|NCT04048135|560470758|FG005|Overall Study|Protocol Violation|1|||
155283531|NCT04048135|560470759|FG006|Overall Study|Protocol Violation|0|||
155283532|NCT04048135|560470760|FG007|Overall Study|Protocol Violation|0|||
155283533|NCT02790606|560470763|FG000|Overall Study|Death|27|||
155283534|NCT02790606|560470763|FG000|Overall Study|Lost to Follow-up|4|||
155283535|NCT02790606|560470763|FG000|Overall Study|Physician Decision|3|||
155283536|NCT02790606|560470763|FG000|Overall Study|Withdrawal by Subject|1|||
155283537|NCT02735915|560470764|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
155283538|NCT02735915|560470764|FG000|Overall Study|Withdrawal following SAE|2|||
155283539|NCT02735915|560470764|FG000|Overall Study|Withdrawal by Subject|1|||
155283540|NCT05328973|560470765|FG000|Overall Study|Withdrawal by Subject|0|||
155283541|NCT05328973|560470766|FG001|Overall Study|Withdrawal by Subject|1|||
155283542|NCT00852475|560470772|FG000|Overall Study|Lost to Follow-up|3|||
155283543|NCT00852475|560470773|FG001|Overall Study|Lost to Follow-up|4|||
155283544|NCT00409708|560470774|FG000|Treatment|Abnormal test procedure result(s)|1|||
155283545|NCT00409708|560470775|FG001|Treatment|Abnormal test procedure result(s)|0|||
155283546|NCT00409708|560470774|FG000|Treatment|Lack of Efficacy|0|||
155283547|NCT00409708|560470775|FG001|Treatment|Lack of Efficacy|1|||
155283548|NCT00409708|560470774|FG000|Treatment|Protocol Violation|6|||
155283549|NCT00409708|560470775|FG001|Treatment|Protocol Violation|2|||
155394282|NCT02953639|560880254|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155741076|NCT00796445|562154787|FG000|Overall Study|Adverse event, non-fatal|4|||
155394283|NCT02953639|560880252|FG000|Overall Study|Multiple Reasons|1|||
155741077|NCT00796445|562154788|FG001|Overall Study|Adverse event, non-fatal|0|||
155741078|NCT00796445|562154787|FG000|Overall Study|Disease progression/recurrence|537|||
155741079|NCT00796445|562154788|FG001|Overall Study|Disease progression/recurrence|268|||
155283550|NCT00409708|560470774|FG000|Treatment|Withdrawal by Subject|3|||
155283551|NCT00409708|560470775|FG001|Treatment|Withdrawal by Subject|8|||
155394284|NCT02953639|560880253|FG001|Overall Study|Multiple Reasons|0|||
155741080|NCT00796445|562154787|FG000|Overall Study|Other|10|||
155741081|NCT00796445|562154788|FG001|Overall Study|Other|7|||
155394285|NCT02953639|560880254|FG002|Overall Study|Multiple Reasons|1|||
155394286|NCT02953639|560880252|FG000|Overall Study|Physician Decision|1|||
155741082|NCT00796445|562154787|FG000|Overall Study|Withdrawal by Subject|18|||
155741083|NCT00796445|562154788|FG001|Overall Study|Withdrawal by Subject|9|||
155741084|NCT00796445|562154787|FG000|Overall Study|Invalid Informed Consent Form|1|||
155394287|NCT02953639|560880253|FG001|Overall Study|Physician Decision|0|||
155394288|NCT02953639|560880254|FG002|Overall Study|Physician Decision|0|||
155394289|NCT02953639|560880252|FG000|Overall Study|Withdrawal by Subject|7|||
155394290|NCT02953639|560880253|FG001|Overall Study|Withdrawal by Subject|8|||
155394291|NCT02953639|560880254|FG002|Overall Study|Withdrawal by Subject|10|||
155394292|NCT02953639|560880252|FG000|Overall Study|Completed or Discontinued information is missing|1|||
155394293|NCT02953639|560880253|FG001|Overall Study|Completed or Discontinued information is missing|0|||
155394294|NCT02953639|560880254|FG002|Overall Study|Completed or Discontinued information is missing|0|||
155394295|NCT01830855|560880255|FG000|Overall Study|Other|7|||
155394296|NCT01830855|560880256|FG001|Overall Study|Other|1|||
155394297|NCT01830855|560880257|FG002|Overall Study|Other|4|||
155394298|NCT01830855|560880258|FG003|Overall Study|Other|4|||
155394299|NCT01830855|560880255|FG000|Overall Study|Medication error without associated AE|1|||
155394300|NCT01830855|560880256|FG001|Overall Study|Medication error without associated AE|0|||
155394301|NCT01830855|560880257|FG002|Overall Study|Medication error without associated AE|0|||
155394302|NCT01830855|560880258|FG003|Overall Study|Medication error without associated AE|1|||
155394303|NCT01830855|560880255|FG000|Overall Study|Pregnancy|3|||
155394304|NCT01830855|560880256|FG001|Overall Study|Pregnancy|1|||
155394305|NCT01830855|560880257|FG002|Overall Study|Pregnancy|2|||
155394306|NCT01830855|560880258|FG003|Overall Study|Pregnancy|1|||
155394307|NCT01830855|560880255|FG000|Overall Study|No longer meets eligibility criteria|11|||
155394308|NCT01830855|560880256|FG001|Overall Study|No longer meets eligibility criteria|2|||
155394309|NCT01830855|560880257|FG002|Overall Study|No longer meets eligibility criteria|3|||
155394310|NCT01830855|560880258|FG003|Overall Study|No longer meets eligibility criteria|5|||
155394311|NCT01830855|560880255|FG000|Overall Study|Adverse Event|11|||
155394312|NCT01830855|560880256|FG001|Overall Study|Adverse Event|5|||
155394313|NCT01830855|560880257|FG002|Overall Study|Adverse Event|6|||
155394314|NCT01830855|560880258|FG003|Overall Study|Adverse Event|3|||
155394315|NCT01830855|560880255|FG000|Overall Study|Protocol deviation|10|||
155394316|NCT01830855|560880256|FG001|Overall Study|Protocol deviation|5|||
155394317|NCT01830855|560880257|FG002|Overall Study|Protocol deviation|6|||
155394318|NCT01830855|560880258|FG003|Overall Study|Protocol deviation|6|||
155394319|NCT01830855|560880255|FG000|Overall Study|Withdrawal by Subject|33|||
155394320|NCT01830855|560880256|FG001|Overall Study|Withdrawal by Subject|14|||
155741085|NCT00796445|562154788|FG001|Overall Study|Invalid Informed Consent Form|0|||
155741086|NCT02500056|562154789|FG000|Overall Study|Lost to Follow-up|3|||
155741087|NCT02500056|562154790|FG001|Overall Study|Lost to Follow-up|7|||
155741088|NCT02500056|562154789|FG000|Overall Study|Recurrence|1|||
155741089|NCT02500056|562154790|FG001|Overall Study|Recurrence|0|||
155741090|NCT02500056|562154789|FG000|Overall Study|Death|3|||
155741091|NCT02500056|562154790|FG001|Overall Study|Death|1|||
155741092|NCT01087736|562154791|FG000|Overall Study|Lost to Follow-up|1|||
155741093|NCT01087736|562154792|FG001|Overall Study|Lost to Follow-up|0|||
155741094|NCT01087736|562154791|FG000|Overall Study|Death|0|||
155741095|NCT01087736|562154792|FG001|Overall Study|Death|1|||
155741096|NCT01087736|562154791|FG000|Overall Study|Withdrawal by Subject|0|||
155741097|NCT01087736|562154792|FG001|Overall Study|Withdrawal by Subject|1|||
155741098|NCT01565343|562154794|FG000|Overall Study|Administrative decision/technical issues|1|||
155741099|NCT01565343|562154795|FG001|Overall Study|Administrative decision/technical issues|0|||
155741100|NCT01565343|562154796|FG002|Overall Study|Administrative decision/technical issues|0|||
155741101|NCT01853839|562154798|FG000|Overall Study|Violated inclusion criteria|2|||
155741102|NCT01853839|562154798|FG000|Overall Study|Not meet ITT population definition|58|||
155741103|NCT01853839|562154798|FG000|Overall Study|End of treatment visit too early|33|||
155741104|NCT01853839|562154798|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
155741105|NCT00638183|562154799|FG000|Overall Study|Adverse Event|23|||
155741106|NCT00638183|562154799|FG000|Overall Study|Lack of Efficacy|14|||
155741107|NCT00638183|562154799|FG000|Overall Study|Physician Decision|9|||
155741108|NCT00638183|562154799|FG000|Overall Study|Lost to Follow-up|46|||
155741109|NCT00638183|562154799|FG000|Overall Study|Other reason not defined above|27|||
155741110|NCT02059291|562154800|FG000|Epoch 2|Lack of Efficacy|0|||
155741111|NCT02059291|562154801|FG001|Epoch 2|Lack of Efficacy|0|||
155741112|NCT02059291|562154802|FG002|Epoch 2|Lack of Efficacy|0|||
155741113|NCT02059291|562154803|FG003|Epoch 2|Lack of Efficacy|1|||
155394321|NCT01830855|560880257|FG002|Overall Study|Withdrawal by Subject|10|||
155394322|NCT01830855|560880258|FG003|Overall Study|Withdrawal by Subject|12|||
155394323|NCT01830855|560880255|FG000|Overall Study|No longer willing to participate|32|||
155394324|NCT01830855|560880256|FG001|Overall Study|No longer willing to participate|13|||
155394325|NCT01830855|560880257|FG002|Overall Study|No longer willing to participate|12|||
155394326|NCT01830855|560880258|FG003|Overall Study|No longer willing to participate|17|||
155394327|NCT01830855|560880255|FG000|Overall Study|Lost to Follow-up|47|||
155394328|NCT01830855|560880256|FG001|Overall Study|Lost to Follow-up|20|||
155741114|NCT02059291|562154804|FG004|Epoch 2|Lack of Efficacy|0|||
155741115|NCT02059291|562154805|FG005|Epoch 2|Lack of Efficacy|1|||
155394329|NCT01830855|560880257|FG002|Overall Study|Lost to Follow-up|23|||
155741116|NCT02059291|562154806|FG006|Epoch 2|Lack of Efficacy|0|||
155741117|NCT02059291|562154807|FG007|Epoch 2|Lack of Efficacy|0|||
155741118|NCT02059291|562154808|FG008|Epoch 2|Lack of Efficacy|0|||
155741119|NCT02059291|562154809|FG009|Epoch 2|Lack of Efficacy|0|||
155741120|NCT02059291|562154810|FG010|Epoch 2|Lack of Efficacy|0|||
155741121|NCT02059291|562154811|FG011|Epoch 2|Lack of Efficacy|0|||
155741122|NCT02059291|562154812|FG012|Epoch 2|Lack of Efficacy|0|||
155741123|NCT02059291|562154813|FG013|Epoch 2|Lack of Efficacy|0|||
155741124|NCT02059291|562154814|FG014|Epoch 2|Lack of Efficacy|0|||
155741125|NCT02059291|562154815|FG015|Epoch 2|Lack of Efficacy|0|||
155741126|NCT02059291|562154816|FG016|Epoch 2|Lack of Efficacy|0|||
155741127|NCT02059291|562154817|FG017|Epoch 2|Lack of Efficacy|0|||
155741128|NCT02059291|562154818|FG018|Epoch 2|Lack of Efficacy|0|||
155741129|NCT02059291|562154819|FG019|Epoch 2|Lack of Efficacy|0|||
155741130|NCT02059291|562154820|FG020|Epoch 2|Lack of Efficacy|0|||
155741131|NCT02059291|562154821|FG021|Epoch 2|Lack of Efficacy|0|||
155741132|NCT02059291|562154822|FG022|Epoch 2|Lack of Efficacy|0|||
155741133|NCT02059291|562154823|FG023|Epoch 2|Lack of Efficacy|0|||
155741134|NCT02059291|562154824|FG024|Epoch 2|Lack of Efficacy|0|||
155741135|NCT02059291|562154800|FG000|Epoch 2|Adverse Event|0|||
155741136|NCT02059291|562154801|FG001|Epoch 2|Adverse Event|0|||
155741137|NCT02059291|562154802|FG002|Epoch 2|Adverse Event|1|||
155741138|NCT02059291|562154803|FG003|Epoch 2|Adverse Event|1|||
155741139|NCT02059291|562154804|FG004|Epoch 2|Adverse Event|0|||
155741140|NCT02059291|562154805|FG005|Epoch 2|Adverse Event|0|||
155741141|NCT02059291|562154806|FG006|Epoch 2|Adverse Event|0|||
155741142|NCT02059291|562154807|FG007|Epoch 2|Adverse Event|1|||
155394330|NCT01830855|560880258|FG003|Overall Study|Lost to Follow-up|33|||
155394331|NCT01667081|560880259|FG000|Overall Study|Death|43|||
155394332|NCT01667081|560880260|FG001|Overall Study|Death|3|||
155394333|NCT01667081|560880259|FG000|Overall Study|Lost to Follow-up|99|||
155394334|NCT01667081|560880260|FG001|Overall Study|Lost to Follow-up|48|||
155394335|NCT01667081|560880259|FG000|Overall Study|Physician Decision|16|||
155394336|NCT01667081|560880260|FG001|Overall Study|Physician Decision|2|||
155741143|NCT02059291|562154808|FG008|Epoch 2|Adverse Event|1|||
155741144|NCT02059291|562154809|FG009|Epoch 2|Adverse Event|0|||
155741145|NCT02059291|562154810|FG010|Epoch 2|Adverse Event|0|||
155741146|NCT02059291|562154811|FG011|Epoch 2|Adverse Event|0|||
155741147|NCT02059291|562154812|FG012|Epoch 2|Adverse Event|0|||
155741148|NCT02059291|562154813|FG013|Epoch 2|Adverse Event|0|||
155741149|NCT02059291|562154814|FG014|Epoch 2|Adverse Event|0|||
155741150|NCT02059291|562154815|FG015|Epoch 2|Adverse Event|0|||
155741151|NCT02059291|562154816|FG016|Epoch 2|Adverse Event|0|||
155741152|NCT02059291|562154817|FG017|Epoch 2|Adverse Event|0|||
155741153|NCT02059291|562154818|FG018|Epoch 2|Adverse Event|0|||
155741154|NCT02059291|562154819|FG019|Epoch 2|Adverse Event|0|||
155741155|NCT02059291|562154820|FG020|Epoch 2|Adverse Event|0|||
155741156|NCT02059291|562154821|FG021|Epoch 2|Adverse Event|0|||
155741157|NCT02059291|562154822|FG022|Epoch 2|Adverse Event|0|||
155741158|NCT02059291|562154823|FG023|Epoch 2|Adverse Event|0|||
155741159|NCT02059291|562154824|FG024|Epoch 2|Adverse Event|0|||
155741160|NCT02059291|562154800|FG000|Epoch 2|Withdrawal by Subject|0|||
155741161|NCT02059291|562154801|FG001|Epoch 2|Withdrawal by Subject|1|||
155741162|NCT02059291|562154802|FG002|Epoch 2|Withdrawal by Subject|0|||
155741163|NCT02059291|562154803|FG003|Epoch 2|Withdrawal by Subject|0|||
155741164|NCT02059291|562154804|FG004|Epoch 2|Withdrawal by Subject|0|||
155741165|NCT02059291|562154805|FG005|Epoch 2|Withdrawal by Subject|1|||
155741166|NCT02059291|562154806|FG006|Epoch 2|Withdrawal by Subject|0|||
155741167|NCT02059291|562154807|FG007|Epoch 2|Withdrawal by Subject|0|||
155741168|NCT02059291|562154808|FG008|Epoch 2|Withdrawal by Subject|1|||
155394337|NCT01667081|560880259|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
155741169|NCT02059291|562154809|FG009|Epoch 2|Withdrawal by Subject|0|||
155741170|NCT02059291|562154810|FG010|Epoch 2|Withdrawal by Subject|0|||
155394338|NCT01667081|560880260|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
155394339|NCT01667081|560880259|FG000|Overall Study|Withdrawal by Subject|90|||
155741171|NCT02059291|562154811|FG011|Epoch 2|Withdrawal by Subject|0|||
155741172|NCT02059291|562154812|FG012|Epoch 2|Withdrawal by Subject|0|||
155741173|NCT02059291|562154813|FG013|Epoch 2|Withdrawal by Subject|0|||
155741174|NCT02059291|562154814|FG014|Epoch 2|Withdrawal by Subject|0|||
155741175|NCT02059291|562154815|FG015|Epoch 2|Withdrawal by Subject|0|||
155741176|NCT02059291|562154816|FG016|Epoch 2|Withdrawal by Subject|0|||
155741177|NCT02059291|562154817|FG017|Epoch 2|Withdrawal by Subject|0|||
155741178|NCT02059291|562154818|FG018|Epoch 2|Withdrawal by Subject|0|||
155741179|NCT02059291|562154819|FG019|Epoch 2|Withdrawal by Subject|0|||
155741180|NCT02059291|562154820|FG020|Epoch 2|Withdrawal by Subject|0|||
155741181|NCT02059291|562154821|FG021|Epoch 2|Withdrawal by Subject|0|||
155741182|NCT02059291|562154822|FG022|Epoch 2|Withdrawal by Subject|0|||
155741183|NCT02059291|562154823|FG023|Epoch 2|Withdrawal by Subject|0|||
155741184|NCT02059291|562154824|FG024|Epoch 2|Withdrawal by Subject|0|||
155635602|NCT00157755|561757983|FG004|Overall Study|Death|0|||
155635603|NCT00157755|561757984|FG005|Overall Study|Death|0|||
155635604|NCT00157755|561757979|FG000|Overall Study|Lost to Follow-up|0|||
155635605|NCT00157755|561757980|FG001|Overall Study|Lost to Follow-up|0|||
155635606|NCT00157755|561757981|FG002|Overall Study|Lost to Follow-up|1|||
155635607|NCT00157755|561757982|FG003|Overall Study|Lost to Follow-up|0|||
155635608|NCT00157755|561757983|FG004|Overall Study|Lost to Follow-up|0|||
155635609|NCT00157755|561757984|FG005|Overall Study|Lost to Follow-up|0|||
155635610|NCT00157755|561757979|FG000|Overall Study|Withdrawal by Subject|0|||
155635611|NCT00157755|561757980|FG001|Overall Study|Withdrawal by Subject|0|||
155635612|NCT00157755|561757981|FG002|Overall Study|Withdrawal by Subject|1|||
155635613|NCT00157755|561757982|FG003|Overall Study|Withdrawal by Subject|1|||
155635614|NCT00157755|561757983|FG004|Overall Study|Withdrawal by Subject|1|||
155635615|NCT00157755|561757984|FG005|Overall Study|Withdrawal by Subject|2|||
155635616|NCT00157755|561757979|FG000|Overall Study|Explant due to infection|0|||
155635617|NCT00157755|561757980|FG001|Overall Study|Explant due to infection|0|||
155635618|NCT00157755|561757981|FG002|Overall Study|Explant due to infection|1|||
155635619|NCT00157755|561757982|FG003|Overall Study|Explant due to infection|0|||
155635620|NCT00157755|561757983|FG004|Overall Study|Explant due to infection|0|||
155635621|NCT00157755|561757984|FG005|Overall Study|Explant due to infection|0|||
155635622|NCT00157755|561757979|FG000|Overall Study|Medical reason|0|||
155635623|NCT00157755|561757980|FG001|Overall Study|Medical reason|0|||
155635624|NCT00157755|561757981|FG002|Overall Study|Medical reason|1|||
155635625|NCT00157755|561757982|FG003|Overall Study|Medical reason|1|||
155635626|NCT00157755|561757983|FG004|Overall Study|Medical reason|0|||
155741185|NCT02059291|562154800|FG000|Epoch 3|Physician Decision|0|||
155283552|NCT00409708|560470774|FG000|Treatment|Lost to Follow-up|0|||
155635627|NCT00157755|561757984|FG005|Overall Study|Medical reason|0|||
155635628|NCT00157755|561757979|FG000|Overall Study|Study site closure|0|||
155635629|NCT00157755|561757980|FG001|Overall Study|Study site closure|1|||
155635630|NCT00157755|561757981|FG002|Overall Study|Study site closure|0|||
155635631|NCT00157755|561757982|FG003|Overall Study|Study site closure|0|||
155635632|NCT00157755|561757983|FG004|Overall Study|Study site closure|0|||
155635633|NCT00157755|561757984|FG005|Overall Study|Study site closure|0|||
155635634|NCT00157755|561757979|FG000|Overall Study|Subject non-compliance|0|||
155635635|NCT00157755|561757980|FG001|Overall Study|Subject non-compliance|0|||
155635636|NCT00157755|561757981|FG002|Overall Study|Subject non-compliance|0|||
155635637|NCT00157755|561757982|FG003|Overall Study|Subject non-compliance|0|||
155635638|NCT00157755|561757983|FG004|Overall Study|Subject non-compliance|0|||
155635639|NCT00157755|561757984|FG005|Overall Study|Subject non-compliance|1|||
155635640|NCT00157755|561757979|FG000|Overall Study|Study completion|0|||
155635641|NCT00157755|561757980|FG001|Overall Study|Study completion|0|||
155635642|NCT00157755|561757981|FG002|Overall Study|Study completion|0|||
155635643|NCT00157755|561757982|FG003|Overall Study|Study completion|0|||
155635644|NCT00157755|561757983|FG004|Overall Study|Study completion|1|||
155635645|NCT00157755|561757984|FG005|Overall Study|Study completion|2|||
155635646|NCT05352399|561758004|FG000|Overall Study|Discontinued intervention|6|||
155635647|NCT02657551|561758005|FG000|Overall Study|Adverse Event|2|||
155635648|NCT02657551|561758005|FG000|Overall Study|Withdrawal by Subject|1|||
155635649|NCT02657551|561758005|FG000|Overall Study|Non-Compliance|1|||
155635650|NCT02657551|561758005|FG000|Overall Study|Progression / Relapse|4|||
155635651|NCT04058717|561758006|FG000|Randomization Period|Lost to Follow-up|2|||
155741186|NCT02059291|562154801|FG001|Epoch 3|Physician Decision|0|||
155283553|NCT00409708|560470775|FG001|Treatment|Lost to Follow-up|6|||
155283554|NCT00409708|560470774|FG000|Treatment|Administrative problems|5|||
155283555|NCT00409708|560470775|FG001|Treatment|Administrative problems|0|||
155283556|NCT00409708|560470774|FG000|Washout|Lack of Efficacy|9|||
155283557|NCT00409708|560470775|FG001|Washout|Lack of Efficacy|1|||
155283558|NCT00409708|560470774|FG000|Washout|Protocol Violation|0|||
155283559|NCT00409708|560470775|FG001|Washout|Protocol Violation|1|||
155283560|NCT00409708|560470774|FG000|Washout|Withdrawal by Subject|11|||
155283561|NCT00409708|560470775|FG001|Washout|Withdrawal by Subject|5|||
155283562|NCT00409708|560470774|FG000|Washout|Lost to Follow-up|1|||
155283563|NCT00409708|560470775|FG001|Washout|Lost to Follow-up|3|||
155283564|NCT00946114|560470776|FG000|Overall Study|Death|5|||
155283565|NCT00946114|560470777|FG001|Overall Study|Death|2|||
155283566|NCT00946114|560470776|FG000|Overall Study|Other|1|||
155283567|NCT00946114|560470777|FG001|Overall Study|Other|0|||
155283568|NCT00946114|560470776|FG000|Overall Study|Withdrawal by Subject|2|||
155283569|NCT00946114|560470777|FG001|Overall Study|Withdrawal by Subject|0|||
155283570|NCT01175707|560470778|FG000|Overall Study|Adverse Event|4|||
155283571|NCT01175707|560470779|FG001|Overall Study|Adverse Event|6|||
155283572|NCT03085017|560470782|FG000|Overall Study|Death|0|||
155283573|NCT03085017|560470783|FG001|Overall Study|Death|3|||
155283574|NCT00058058|560470784|FG000|Overall Study|Withdrawal by Subject|4|||
155283575|NCT00058058|560470784|FG000|Overall Study|Ineligible|20|||
155283576|NCT00058058|560470784|FG000|Overall Study|Claustrophobic|5|||
155283577|NCT00058058|560470784|FG000|Overall Study|technical issues|6|||
155283578|NCT00058058|560470784|FG000|Overall Study|Poor positioning, illness,pain|3|||
155741187|NCT02059291|562154802|FG002|Epoch 3|Physician Decision|0|||
155741188|NCT02059291|562154803|FG003|Epoch 3|Physician Decision|0|||
155741189|NCT02059291|562154804|FG004|Epoch 3|Physician Decision|0|||
155635652|NCT04058717|561758007|FG001|Randomization Period|Lost to Follow-up|3|||
155635653|NCT04058717|561758008|FG002|Randomization Period|Lost to Follow-up|4|||
155635654|NCT04058717|561758009|FG003|Randomization Period|Lost to Follow-up|4|||
155635655|NCT04058717|561758006|FG000|Randomization Period|Withdrawal by Subject|1|||
155635656|NCT04058717|561758007|FG001|Randomization Period|Withdrawal by Subject|3|||
155635657|NCT04058717|561758008|FG002|Randomization Period|Withdrawal by Subject|3|||
155635658|NCT04058717|561758009|FG003|Randomization Period|Withdrawal by Subject|3|||
155635659|NCT04058717|561758006|FG000|Randomization Period|PI decision|0|||
155635660|NCT04058717|561758007|FG001|Randomization Period|PI decision|1|||
155635661|NCT04058717|561758008|FG002|Randomization Period|PI decision|0|||
155635662|NCT04058717|561758009|FG003|Randomization Period|PI decision|0|||
155635663|NCT04817410|561759296|FG000|Overall Study|Withdrawal by Subject|5|||
155635664|NCT04817410|561759296|FG000|Overall Study|Physician Decision|3|||
155635665|NCT03595748|561759297|FG000|Overall Study|Death|11|||
155635666|NCT03595748|561759298|FG001|Overall Study|Death|12|||
155635667|NCT03595748|561759297|FG000|Overall Study|Withdrawal by Subject|28|||
155635668|NCT03595748|561759298|FG001|Overall Study|Withdrawal by Subject|29|||
155635669|NCT03595748|561759297|FG000|Overall Study|Protocol Violation|0|||
155635670|NCT03595748|561759298|FG001|Overall Study|Protocol Violation|1|||
155635671|NCT04809974|561759299|FG000|Lead-in Phase|Withdrawal by Subject|3|||
155635672|NCT04809974|561759300|FG001|Lead-in Phase|Withdrawal by Subject|0|||
155635673|NCT04809974|561759301|FG002|Lead-in Phase|Withdrawal by Subject|0|||
155635674|NCT04809974|561759299|FG000|Lead-in Phase|No longer eligible|11|||
155635675|NCT04809974|561759300|FG001|Lead-in Phase|No longer eligible|0|||
155635676|NCT04809974|561759301|FG002|Lead-in Phase|No longer eligible|0|||
155635677|NCT04809974|561759299|FG000|Randomized Phase|Lost to Follow-up|0|||
155635678|NCT04809974|561759300|FG001|Randomized Phase|Lost to Follow-up|1|||
155635679|NCT04809974|561759301|FG002|Randomized Phase|Lost to Follow-up|5|||
155635680|NCT04809974|561759299|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
155635681|NCT04809974|561759300|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
155741190|NCT02059291|562154805|FG005|Epoch 3|Physician Decision|0|||
155394340|NCT01667081|560880260|FG001|Overall Study|Withdrawal by Subject|35|||
155394341|NCT03034460|560880261|FG000|Overall Study|Adverse Event|0|||
155394342|NCT03034460|560880262|FG001|Overall Study|Adverse Event|1|||
155394343|NCT03034460|560880261|FG000|Overall Study|Withdrawal by Subject|2|||
155394344|NCT03034460|560880262|FG001|Overall Study|Withdrawal by Subject|2|||
155394345|NCT03034460|560880261|FG000|Overall Study|Personal Reasons|1|||
155394346|NCT03034460|560880262|FG001|Overall Study|Personal Reasons|0|||
155394347|NCT00295633|560880265|FG000|Overall Study|Lack of Efficacy|19|||
155394348|NCT00295633|560880266|FG001|Overall Study|Lack of Efficacy|7|||
155394349|NCT00295633|560880267|FG002|Overall Study|Lack of Efficacy|16|||
155394350|NCT00295633|560880265|FG000|Overall Study|Withdrawal of consent by subject|16|||
155394351|NCT00295633|560880266|FG001|Overall Study|Withdrawal of consent by subject|16|||
155394352|NCT00295633|560880267|FG002|Overall Study|Withdrawal of consent by subject|26|||
155394353|NCT00295633|560880265|FG000|Overall Study|Adverse Event|9|||
155394354|NCT00295633|560880266|FG001|Overall Study|Adverse Event|17|||
155394355|NCT00295633|560880267|FG002|Overall Study|Adverse Event|9|||
155394356|NCT00295633|560880265|FG000|Overall Study|Lost to Follow-up|6|||
155394357|NCT00295633|560880266|FG001|Overall Study|Lost to Follow-up|11|||
155394358|NCT00295633|560880267|FG002|Overall Study|Lost to Follow-up|7|||
155394359|NCT00295633|560880265|FG000|Overall Study|Physician Decision|9|||
155394360|NCT00295633|560880266|FG001|Overall Study|Physician Decision|10|||
155394361|NCT00295633|560880267|FG002|Overall Study|Physician Decision|8|||
155394362|NCT00295633|560880265|FG000|Overall Study|Poor/Noncompliance|2|||
155394363|NCT00295633|560880266|FG001|Overall Study|Poor/Noncompliance|2|||
155394364|NCT00295633|560880267|FG002|Overall Study|Poor/Noncompliance|6|||
155394365|NCT00295633|560880265|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155394366|NCT00295633|560880266|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
155394367|NCT00295633|560880267|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
155394368|NCT00295633|560880265|FG000|Overall Study|Death|1|||
155394369|NCT00295633|560880266|FG001|Overall Study|Death|1|||
155394370|NCT00295633|560880267|FG002|Overall Study|Death|0|||
155394371|NCT00295633|560880265|FG000|Overall Study|Administrative reason by sponsor|0|||
155635682|NCT04809974|561759301|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
155741191|NCT02059291|562154806|FG006|Epoch 3|Physician Decision|0|||
155394372|NCT00295633|560880266|FG001|Overall Study|Administrative reason by sponsor|0|||
155394373|NCT00295633|560880267|FG002|Overall Study|Administrative reason by sponsor|1|||
155394374|NCT01798992|560880268|FG000|Overall Study|Administrative withdrawal|0|||
155394375|NCT01798992|560880269|FG001|Overall Study|Administrative withdrawal|1|||
155394376|NCT01798992|560880270|FG002|Overall Study|Administrative withdrawal|0|||
155741192|NCT02059291|562154807|FG007|Epoch 3|Physician Decision|0|||
155435857|NCT01591330|561022969|FG001|Period 1|Adverse Event|0|||
155394377|NCT01798992|560880271|FG003|Overall Study|Administrative withdrawal|1|||
155394378|NCT01798992|560880268|FG000|Overall Study|Lost to Follow-up|0|||
155394379|NCT01798992|560880269|FG001|Overall Study|Lost to Follow-up|1|||
155394380|NCT01798992|560880270|FG002|Overall Study|Lost to Follow-up|1|||
155394381|NCT01798992|560880271|FG003|Overall Study|Lost to Follow-up|0|||
155394382|NCT01798992|560880268|FG000|Overall Study|Insufficient biopsy tissue|0|||
155394383|NCT01798992|560880269|FG001|Overall Study|Insufficient biopsy tissue|0|||
155394384|NCT01798992|560880270|FG002|Overall Study|Insufficient biopsy tissue|1|||
155394385|NCT01798992|560880271|FG003|Overall Study|Insufficient biopsy tissue|0|||
155394386|NCT02294682|560880272|FG000|Overall Study|Could not swallow pills|1|||
155394387|NCT02294682|560880273|FG001|Overall Study|Could not swallow pills|0|||
155394388|NCT01516970|560880274|FG000|Overall Study|Lost to Follow-up|7|||
155394389|NCT01516970|560880275|FG001|Overall Study|Lost to Follow-up|8|||
155394390|NCT01516970|560880274|FG000|Overall Study|Adverse Event|1|||
155394391|NCT01516970|560880275|FG001|Overall Study|Adverse Event|5|||
155394392|NCT01516970|560880274|FG000|Overall Study|Withdrawal by Subject|1|||
155394393|NCT01516970|560880275|FG001|Overall Study|Withdrawal by Subject|1|||
155394394|NCT01516970|560880274|FG000|Overall Study|Other|9|||
155394395|NCT01516970|560880275|FG001|Overall Study|Other|7|||
155394396|NCT01205438|560880276|FG000|Overall Study|Adverse Event|19|||
155394397|NCT01205438|560880277|FG001|Overall Study|Adverse Event|17|||
155394398|NCT01205438|560880278|FG002|Overall Study|Adverse Event|24|||
155394399|NCT01205438|560880276|FG000|Overall Study|Death|1|||
155394400|NCT01205438|560880277|FG001|Overall Study|Death|1|||
155394401|NCT01205438|560880278|FG002|Overall Study|Death|3|||
155394402|NCT01205438|560880276|FG000|Overall Study|Entry Criteria Not Met|16|||
155394403|NCT01205438|560880277|FG001|Overall Study|Entry Criteria Not Met|15|||
155394404|NCT01205438|560880278|FG002|Overall Study|Entry Criteria Not Met|13|||
155394405|NCT01205438|560880276|FG000|Overall Study|Lack of Efficacy|14|||
155394406|NCT01205438|560880277|FG001|Overall Study|Lack of Efficacy|11|||
155394407|NCT01205438|560880278|FG002|Overall Study|Lack of Efficacy|14|||
155394408|NCT01205438|560880276|FG000|Overall Study|Lost to Follow-up|6|||
155394409|NCT01205438|560880277|FG001|Overall Study|Lost to Follow-up|7|||
155394410|NCT01205438|560880278|FG002|Overall Study|Lost to Follow-up|8|||
155394411|NCT01205438|560880276|FG000|Overall Study|Withdrawal by Subject|19|||
155394412|NCT01205438|560880277|FG001|Overall Study|Withdrawal by Subject|25|||
155394413|NCT01205438|560880278|FG002|Overall Study|Withdrawal by Subject|19|||
155394414|NCT01205438|560880276|FG000|Overall Study|Physician Decision|0|||
155394415|NCT01205438|560880277|FG001|Overall Study|Physician Decision|3|||
155394416|NCT01205438|560880278|FG002|Overall Study|Physician Decision|2|||
155394417|NCT01205438|560880276|FG000|Overall Study|Protocol Violation|2|||
155394418|NCT01205438|560880277|FG001|Overall Study|Protocol Violation|7|||
155394419|NCT01205438|560880278|FG002|Overall Study|Protocol Violation|4|||
155394420|NCT01205438|560880276|FG000|Overall Study|Sponsor Decision|0|||
155394421|NCT01205438|560880277|FG001|Overall Study|Sponsor Decision|1|||
155283579|NCT04337489|560470785|FG000|Overall Study|Withdrawal by Subject|1|||
155283580|NCT01579578|560470786|FG000|Overall Study|Death|4|||
155283581|NCT01579578|560470787|FG001|Overall Study|Death|1|||
155283582|NCT01579578|560470786|FG000|Overall Study|Lost to Follow-up|1|||
155283583|NCT01579578|560470787|FG001|Overall Study|Lost to Follow-up|1|||
155283584|NCT01579578|560470786|FG000|Overall Study|Withdrawal by Subject|2|||
155283585|NCT01579578|560470787|FG001|Overall Study|Withdrawal by Subject|1|||
155283586|NCT01579578|560470786|FG000|Overall Study|Eligibility criteria|3|||
155283587|NCT01579578|560470787|FG001|Overall Study|Eligibility criteria|9|||
155283588|NCT01579578|560470786|FG000|Overall Study|Ongoing|3|||
155283589|NCT01579578|560470787|FG001|Overall Study|Ongoing|0|||
155283590|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
155283591|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
155283592|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
155283593|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
155283594|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
155283595|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
155283596|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
155283597|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
155283598|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
155283599|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
155394422|NCT01205438|560880278|FG002|Overall Study|Sponsor Decision|1|||
155635683|NCT04809974|561759299|FG000|Randomized Phase|Adverse Event|0|||
155283600|NCT00530777|560470797|FG000|Overall Study|Lost to Follow-up|0|||
155283601|NCT00530777|560470798|FG001|Overall Study|Lost to Follow-up|1|||
155283602|NCT00530777|560470797|FG000|Overall Study|Death|1|||
155283603|NCT00530777|560470798|FG001|Overall Study|Death|2|||
155394423|NCT03823404|560880279|FG000|Overall Study|Lost to Follow-up|1|||
155394424|NCT03823404|560880280|FG001|Overall Study|Lost to Follow-up|2|||
155394425|NCT03823404|560880281|FG002|Overall Study|Lost to Follow-up|3|||
155394426|NCT03823404|560880279|FG000|Overall Study|Protocol Violation|2|||
155394427|NCT03823404|560880280|FG001|Overall Study|Protocol Violation|0|||
155394428|NCT03823404|560880281|FG002|Overall Study|Protocol Violation|2|||
155741193|NCT02059291|562154808|FG008|Epoch 3|Physician Decision|0|||
155741194|NCT02059291|562154809|FG009|Epoch 3|Physician Decision|0|||
155741195|NCT02059291|562154810|FG010|Epoch 3|Physician Decision|0|||
155741196|NCT02059291|562154811|FG011|Epoch 3|Physician Decision|0|||
155741197|NCT02059291|562154812|FG012|Epoch 3|Physician Decision|0|||
155741198|NCT02059291|562154813|FG013|Epoch 3|Physician Decision|1|||
155741199|NCT02059291|562154814|FG014|Epoch 3|Physician Decision|0|||
155741200|NCT02059291|562154815|FG015|Epoch 3|Physician Decision|1|||
155741201|NCT02059291|562154816|FG016|Epoch 3|Physician Decision|0|||
155741202|NCT02059291|562154817|FG017|Epoch 3|Physician Decision|0|||
155741203|NCT02059291|562154818|FG018|Epoch 3|Physician Decision|0|||
155741204|NCT02059291|562154819|FG019|Epoch 3|Physician Decision|0|||
155741205|NCT02059291|562154820|FG020|Epoch 3|Physician Decision|0|||
155741206|NCT02059291|562154821|FG021|Epoch 3|Physician Decision|0|||
155741207|NCT02059291|562154822|FG022|Epoch 3|Physician Decision|0|||
155741208|NCT02059291|562154823|FG023|Epoch 3|Physician Decision|0|||
155741209|NCT02059291|562154824|FG024|Epoch 3|Physician Decision|0|||
155283604|NCT00530777|560470797|FG000|Overall Study|Physician Decision|1|||
155283605|NCT00530777|560470798|FG001|Overall Study|Physician Decision|0|||
155283606|NCT00530777|560470797|FG000|Overall Study|Withdrawal by Subject|0|||
155283607|NCT00530777|560470798|FG001|Overall Study|Withdrawal by Subject|1|||
155283608|NCT00530777|560470797|FG000|Overall Study|Unable to adhere to visit schedule|5|||
155283609|NCT00530777|560470798|FG001|Overall Study|Unable to adhere to visit schedule|1|||
155283610|NCT01582243|560470802|FG000|Overall Study|Withdrawal by Subject|1|||
155283611|NCT01582243|560470802|FG000|Overall Study|Adverse Event|1|||
155283612|NCT01582243|560470802|FG000|Overall Study|Lost to Follow-up|1|||
155283613|NCT02096003|560470806|FG000|Overall Study|Protocol Violation|0|||
155283614|NCT02096003|560470807|FG001|Overall Study|Protocol Violation|2|||
155283615|NCT02096003|560470806|FG000|Overall Study|additional surgery|2|||
155283616|NCT02096003|560470807|FG001|Overall Study|additional surgery|1|||
155283617|NCT01008748|560470810|FG000|Overall Study|Lost to Follow-up|80|||
155283618|NCT01008748|560470810|FG000|Overall Study|Other|1|||
155283619|NCT04833855|560470811|FG000|Overall Study|Decision by sponsor|0|||
155283620|NCT04833855|560470812|FG001|Overall Study|Decision by sponsor|1|||
155283621|NCT04833855|560470813|FG002|Overall Study|Decision by sponsor|0|||
155283622|NCT04833855|560470814|FG003|Overall Study|Decision by sponsor|0|||
155283623|NCT04833855|560470811|FG000|Overall Study|Withdrawal by Subject|4|||
155283624|NCT04833855|560470812|FG001|Overall Study|Withdrawal by Subject|1|||
155283625|NCT04833855|560470813|FG002|Overall Study|Withdrawal by Subject|3|||
155283626|NCT04833855|560470814|FG003|Overall Study|Withdrawal by Subject|1|||
155283627|NCT04833855|560470811|FG000|Overall Study|Lost to Follow-up|1|||
155283628|NCT04833855|560470812|FG001|Overall Study|Lost to Follow-up|0|||
155283629|NCT04833855|560470813|FG002|Overall Study|Lost to Follow-up|2|||
155394429|NCT03823404|560880279|FG000|Overall Study|Adverse Event|35|||
155394430|NCT03823404|560880280|FG001|Overall Study|Adverse Event|38|||
155394431|NCT03823404|560880281|FG002|Overall Study|Adverse Event|8|||
155394432|NCT03823404|560880279|FG000|Overall Study|Withdrawal by Subject|38|||
155394433|NCT03823404|560880280|FG001|Overall Study|Withdrawal by Subject|40|||
155394434|NCT03823404|560880281|FG002|Overall Study|Withdrawal by Subject|35|||
155394435|NCT03823404|560880279|FG000|Overall Study|Death|4|||
155394436|NCT03823404|560880280|FG001|Overall Study|Death|0|||
155394437|NCT03823404|560880281|FG002|Overall Study|Death|0|||
155394438|NCT03823404|560880279|FG000|Overall Study|Other: Various reasons provided|5|||
155394439|NCT03823404|560880280|FG001|Overall Study|Other: Various reasons provided|5|||
155394440|NCT03823404|560880281|FG002|Overall Study|Other: Various reasons provided|6|||
155394441|NCT01446016|560880282|FG000|Overall Study|Lost to Follow-up|3|||
155394442|NCT01446016|560880282|FG000|Overall Study|Withdrawal by Subject|1|||
155394443|NCT01446016|560880282|FG000|Overall Study|Toxicity|3|||
155394444|NCT00404066|560880289|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
155394445|NCT00404066|560880289|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
155394446|NCT01399190|560880292|FG000|Overall Study|Not Eligible for Final Analysis|5|||
155394447|NCT01399190|560880292|FG000|Overall Study|Adverse Event|8|||
155394448|NCT01399190|560880292|FG000|Overall Study|Participant's Request|5|||
155394449|NCT01399190|560880292|FG000|Overall Study|Physician Decision|2|||
155394450|NCT05395104|560880293|FG000|Overall Study|Met Liver Stopping Criteria|1|||
155635684|NCT04809974|561759300|FG001|Randomized Phase|Adverse Event|1|||
155635685|NCT04809974|561759301|FG002|Randomized Phase|Adverse Event|4|||
155635686|NCT04809974|561759299|FG000|Randomized Phase|Withdrawal by Subject|0|||
155635687|NCT04809974|561759300|FG001|Randomized Phase|Withdrawal by Subject|0|||
155635688|NCT04809974|561759301|FG002|Randomized Phase|Withdrawal by Subject|5|||
155635689|NCT00549055|561759310|FG000|Overall Study|Adverse Event|4|||
155635690|NCT00549055|561759310|FG000|Overall Study|Lack of Efficacy|18|||
155635691|NCT00549055|561759310|FG000|Overall Study|Stabilization|5|||
155635692|NCT00549055|561759310|FG000|Overall Study|Progression to fibrosis|2|||
155635693|NCT00549055|561759310|FG000|Overall Study|Decrease of size|1|||
155635694|NCT00549055|561759310|FG000|Overall Study|Active choroidal neovascula increased|1|||
155635695|NCT00549055|561759310|FG000|Overall Study|Vitreous hemorrhage|1|||
155635696|NCT00549055|561759310|FG000|Overall Study|Growth choroidal neovascularisation|1|||
155635697|NCT00549055|561759310|FG000|Overall Study|Choroidal neovascularization|1|||
155635698|NCT00549055|561759310|FG000|Overall Study|Very low visual acuity (VA)|1|||
155635699|NCT02472405|561759312|FG000|Overall Study|Lost to Follow-up|9|||
155635700|NCT02472405|561759312|FG000|Overall Study|Adverse Event|1|||
155635701|NCT01431976|561759313|FG000|Overall Study|Adverse Event|6|||
155635702|NCT01431976|561759313|FG000|Overall Study|Lack of Efficacy|2|||
155635703|NCT01431976|561759313|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155635704|NCT01431976|561759313|FG000|Overall Study|Physician Decision|1|||
155635705|NCT01431976|561759313|FG000|Overall Study|Withdrawal by Subject|1|||
155635706|NCT01134042|561759316|FG000|Overall Study|Adverse Event|3|||
155635707|NCT01134042|561759317|FG001|Overall Study|Adverse Event|7|||
155635708|NCT01134042|561759318|FG002|Overall Study|Adverse Event|2|||
155635709|NCT01134042|561759316|FG000|Overall Study|Lack of Efficacy|21|||
155635710|NCT01134042|561759317|FG001|Overall Study|Lack of Efficacy|6|||
155635711|NCT01134042|561759318|FG002|Overall Study|Lack of Efficacy|18|||
155635712|NCT01134042|561759316|FG000|Overall Study|Protocol Violation|5|||
155635713|NCT01134042|561759317|FG001|Overall Study|Protocol Violation|3|||
155635714|NCT01134042|561759318|FG002|Overall Study|Protocol Violation|5|||
155635715|NCT01134042|561759316|FG000|Overall Study|Lost to Follow-up|2|||
155635716|NCT01134042|561759317|FG001|Overall Study|Lost to Follow-up|0|||
155635717|NCT01134042|561759318|FG002|Overall Study|Lost to Follow-up|1|||
155635718|NCT01134042|561759316|FG000|Overall Study|Physician Decision|4|||
155635719|NCT01134042|561759317|FG001|Overall Study|Physician Decision|8|||
155635720|NCT01134042|561759318|FG002|Overall Study|Physician Decision|1|||
155635721|NCT01134042|561759316|FG000|Overall Study|Withdrawal by Subject|13|||
155635722|NCT01134042|561759317|FG001|Overall Study|Withdrawal by Subject|4|||
155635723|NCT01134042|561759318|FG002|Overall Study|Withdrawal by Subject|7|||
155635724|NCT00764517|561759319|FG000|Overall Study|Adverse Event|9|||
155635725|NCT00764517|561759320|FG001|Overall Study|Adverse Event|3|||
155635726|NCT00764517|561759319|FG000|Overall Study|Death|3|||
155635727|NCT00764517|561759320|FG001|Overall Study|Death|11|||
155635728|NCT00764517|561759319|FG000|Overall Study|Physician Decision|3|||
155635729|NCT00764517|561759320|FG001|Overall Study|Physician Decision|0|||
155635730|NCT01091259|561759330|FG000|Overall Study|Adverse Event|3|||
155635731|NCT01091259|561759330|FG000|Overall Study|Lack of Efficacy|2|||
155635732|NCT00770367|561759331|FG000|First Intervention|Withdrawal by Subject|0|||
155635733|NCT00770367|561759332|FG001|First Intervention|Withdrawal by Subject|2|||
155635734|NCT00770367|561759331|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
155635735|NCT00770367|561759332|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
155635736|NCT00770367|561759331|FG000|Second Intervention|Lost to Follow-up|2|||
155635737|NCT00770367|561759332|FG001|Second Intervention|Lost to Follow-up|0|||
155635738|NCT04115059|561759333|FG000|Overall Study|Withdrawal by Subject|1|||
155635739|NCT04115059|561759333|FG000|Overall Study|Lack of Efficacy|2|||
155394451|NCT05395104|560880293|FG000|Overall Study|Withdrawal by Subject|1|||
155394452|NCT00381563|560880294|FG000|Overall Study|Withdrawal by Subject|5|||
155394453|NCT00381563|560880295|FG001|Overall Study|Withdrawal by Subject|5|||
155394454|NCT00381563|560880294|FG000|Overall Study|Lost to Follow-up|2|||
155394455|NCT00381563|560880295|FG001|Overall Study|Lost to Follow-up|0|||
155394456|NCT00381563|560880294|FG000|Overall Study|Protocol Violation|0|||
155394457|NCT00381563|560880295|FG001|Overall Study|Protocol Violation|1|||
155394458|NCT01287364|560880296|FG000|Overall Study|Adverse Event|0|||
155394459|NCT01287364|560880297|FG001|Overall Study|Adverse Event|3|||
155394460|NCT01287364|560880296|FG000|Overall Study|Protocol Violation|5|||
155394461|NCT01287364|560880297|FG001|Overall Study|Protocol Violation|5|||
155394462|NCT01287364|560880296|FG000|Overall Study|Other Reason|4|||
155394463|NCT01287364|560880297|FG001|Overall Study|Other Reason|2|||
155394464|NCT05372653|560880304|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
155394465|NCT05372653|560880305|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
155394466|NCT05372653|560880304|FG000|Overall Study|Adverse Event|0|||
155394467|NCT05372653|560880305|FG001|Overall Study|Adverse Event|1|||
155394468|NCT00117507|560880306|FG000|Overall Study|Adverse Event|4|||
155394469|NCT00117507|560880306|FG000|Overall Study|Abnormal laboratory values|3|||
155394470|NCT00117507|560880306|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155394471|NCT00117507|560880306|FG000|Overall Study|Patient withdrew consent|4|||
155394472|NCT00117507|560880306|FG000|Overall Study|Death|3|||
155394473|NCT03740997|560880307|FG000|Overall Study|Withdrawal by Subject|1|||
155394474|NCT03740997|560880308|FG001|Overall Study|Withdrawal by Subject|0|||
155394475|NCT03740997|560880307|FG000|Overall Study|Participant was unable to complete study procedures|1|||
155394476|NCT03740997|560880308|FG001|Overall Study|Participant was unable to complete study procedures|0|||
155394477|NCT01003990|560880309|FG000|Overall Study|Adverse Event|8|||
155394478|NCT01003990|560880310|FG001|Overall Study|Adverse Event|5|||
155394479|NCT01003990|560880311|FG002|Overall Study|Adverse Event|11|||
155394480|NCT01003990|560880309|FG000|Overall Study|Death|0|||
155394481|NCT01003990|560880310|FG001|Overall Study|Death|8|||
155394482|NCT01003990|560880311|FG002|Overall Study|Death|1|||
155394483|NCT01003990|560880309|FG000|Overall Study|Lack of Efficacy|10|||
155394484|NCT01003990|560880310|FG001|Overall Study|Lack of Efficacy|2|||
155394485|NCT01003990|560880311|FG002|Overall Study|Lack of Efficacy|3|||
155394486|NCT01003990|560880309|FG000|Overall Study|Lost to Follow-up|30|||
155394487|NCT01003990|560880310|FG001|Overall Study|Lost to Follow-up|12|||
155394488|NCT01003990|560880311|FG002|Overall Study|Lost to Follow-up|7|||
155394489|NCT01003990|560880309|FG000|Overall Study|Reasons Not Identified|14|||
155394490|NCT01003990|560880310|FG001|Overall Study|Reasons Not Identified|13|||
155394491|NCT01003990|560880311|FG002|Overall Study|Reasons Not Identified|8|||
155394492|NCT01003990|560880309|FG000|Overall Study|Poor/Non-compliance|4|||
155394493|NCT01003990|560880310|FG001|Overall Study|Poor/Non-compliance|3|||
155394494|NCT01003990|560880311|FG002|Overall Study|Poor/Non-compliance|2|||
155394495|NCT01003990|560880309|FG000|Overall Study|Pregnancy|10|||
155394496|NCT01003990|560880310|FG001|Overall Study|Pregnancy|2|||
155394497|NCT01003990|560880311|FG002|Overall Study|Pregnancy|4|||
155394498|NCT01003990|560880309|FG000|Overall Study|No Longer Met Study Criteria|4|||
155394499|NCT01003990|560880310|FG001|Overall Study|No Longer Met Study Criteria|1|||
155394500|NCT01003990|560880311|FG002|Overall Study|No Longer Met Study Criteria|0|||
155394501|NCT01003990|560880309|FG000|Overall Study|Subject Withdrew Consent|12|||
155394502|NCT01003990|560880310|FG001|Overall Study|Subject Withdrew Consent|5|||
155394503|NCT01003990|560880311|FG002|Overall Study|Subject Withdrew Consent|7|||
155394504|NCT01829425|560880317|FG000|Overall Study|Withdrawal by Subject|4|||
155394505|NCT01829425|560880318|FG001|Overall Study|Withdrawal by Subject|3|||
155394506|NCT01829425|560880317|FG000|Overall Study|Lost to Follow-up|2|||
155394507|NCT01829425|560880318|FG001|Overall Study|Lost to Follow-up|1|||
155394508|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
155394509|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394510|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394511|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394512|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394513|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394514|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394515|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394516|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
155394517|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394518|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394519|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394520|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394521|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394522|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394523|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394524|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
155741210|NCT02059291|562154800|FG000|Epoch 3|Adverse Event|0|||
155283630|NCT04833855|560470814|FG003|Overall Study|Lost to Follow-up|2|||
155283631|NCT04833855|560470811|FG000|Overall Study|Protocol specified criteria|0|||
155741211|NCT02059291|562154801|FG001|Epoch 3|Adverse Event|0|||
155741212|NCT02059291|562154802|FG002|Epoch 3|Adverse Event|0|||
155283632|NCT04833855|560470812|FG001|Overall Study|Protocol specified criteria|0|||
155283633|NCT04833855|560470813|FG002|Overall Study|Protocol specified criteria|2|||
155283634|NCT04833855|560470814|FG003|Overall Study|Protocol specified criteria|1|||
155283635|NCT04824131|560470816|FG000|CAB LA Oral Phase|Adverse Event|1|||
155283636|NCT04824131|560470816|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
155283637|NCT04824131|560470816|FG000|Step 3|Withdrawal by Subject|2|||
155283638|NCT03686384|560470817|FG000|Overall Study|Lack of Efficacy|4|||
155283639|NCT03686384|560470818|FG001|Overall Study|Lack of Efficacy|13|||
155283640|NCT03686384|560470817|FG000|Overall Study|Lost to Follow-up|3|||
155283641|NCT03686384|560470818|FG001|Overall Study|Lost to Follow-up|0|||
155283642|NCT03686384|560470817|FG000|Overall Study|Physician Decision|0|||
155283643|NCT03686384|560470818|FG001|Overall Study|Physician Decision|1|||
155283644|NCT03686384|560470817|FG000|Overall Study|Took prohibited medication|0|||
155283645|NCT03686384|560470818|FG001|Overall Study|Took prohibited medication|1|||
155283646|NCT00783692|560470825|FG000|Induction Phase|Adverse Event|7|||
155283647|NCT00783692|560470826|FG001|Induction Phase|Adverse Event|9|||
155283648|NCT00783692|560470827|FG002|Induction Phase|Adverse Event|24|||
155283649|NCT00783692|560470828|FG003|Induction Phase|Adverse Event|0|||
155283650|NCT00783692|560470829|FG004|Induction Phase|Adverse Event|0|||
155283651|NCT00783692|560470830|FG005|Induction Phase|Adverse Event|0|||
155283652|NCT00783692|560470831|FG006|Induction Phase|Adverse Event|0|||
155283653|NCT00783692|560470825|FG000|Induction Phase|Protocol Violation|0|||
155283654|NCT00783692|560470826|FG001|Induction Phase|Protocol Violation|0|||
155283655|NCT00783692|560470827|FG002|Induction Phase|Protocol Violation|1|||
155283656|NCT00783692|560470828|FG003|Induction Phase|Protocol Violation|0|||
155283657|NCT00783692|560470829|FG004|Induction Phase|Protocol Violation|0|||
155283658|NCT00783692|560470830|FG005|Induction Phase|Protocol Violation|0|||
155283659|NCT00783692|560470831|FG006|Induction Phase|Protocol Violation|0|||
155283660|NCT00783692|560470825|FG000|Induction Phase|Lack of Efficacy|1|||
155283661|NCT00783692|560470826|FG001|Induction Phase|Lack of Efficacy|3|||
155283662|NCT00783692|560470827|FG002|Induction Phase|Lack of Efficacy|28|||
155283663|NCT00783692|560470828|FG003|Induction Phase|Lack of Efficacy|0|||
155283664|NCT00783692|560470829|FG004|Induction Phase|Lack of Efficacy|0|||
155283665|NCT00783692|560470830|FG005|Induction Phase|Lack of Efficacy|0|||
155283666|NCT00783692|560470831|FG006|Induction Phase|Lack of Efficacy|0|||
155283667|NCT00783692|560470825|FG000|Induction Phase|Withdrawal by Subject|3|||
155283668|NCT00783692|560470826|FG001|Induction Phase|Withdrawal by Subject|9|||
155283669|NCT00783692|560470827|FG002|Induction Phase|Withdrawal by Subject|16|||
155283670|NCT00783692|560470828|FG003|Induction Phase|Withdrawal by Subject|0|||
155283671|NCT00783692|560470829|FG004|Induction Phase|Withdrawal by Subject|0|||
155283672|NCT00783692|560470830|FG005|Induction Phase|Withdrawal by Subject|0|||
155283673|NCT00783692|560470831|FG006|Induction Phase|Withdrawal by Subject|0|||
155283674|NCT00783692|560470825|FG000|Induction Phase|Lost to Follow-up|0|||
155283675|NCT00783692|560470826|FG001|Induction Phase|Lost to Follow-up|0|||
155283676|NCT00783692|560470827|FG002|Induction Phase|Lost to Follow-up|3|||
155283677|NCT00783692|560470828|FG003|Induction Phase|Lost to Follow-up|0|||
155283678|NCT00783692|560470829|FG004|Induction Phase|Lost to Follow-up|0|||
155283679|NCT00783692|560470830|FG005|Induction Phase|Lost to Follow-up|0|||
155283680|NCT00783692|560470831|FG006|Induction Phase|Lost to Follow-up|0|||
155283681|NCT00783692|560470825|FG000|Induction Phase|Other|0|||
155283682|NCT00783692|560470826|FG001|Induction Phase|Other|0|||
155283683|NCT00783692|560470827|FG002|Induction Phase|Other|2|||
155283684|NCT00783692|560470828|FG003|Induction Phase|Other|0|||
155283685|NCT00783692|560470829|FG004|Induction Phase|Other|0|||
155283686|NCT00783692|560470830|FG005|Induction Phase|Other|0|||
155283687|NCT00783692|560470831|FG006|Induction Phase|Other|0|||
155283688|NCT00783692|560470825|FG000|Maintenance Phase|Adverse Event|7|||
155283689|NCT00783692|560470826|FG001|Maintenance Phase|Adverse Event|0|||
155283690|NCT00783692|560470827|FG002|Maintenance Phase|Adverse Event|0|||
155283691|NCT00783692|560470828|FG003|Maintenance Phase|Adverse Event|15|||
155283692|NCT00783692|560470829|FG004|Maintenance Phase|Adverse Event|12|||
155283693|NCT00783692|560470830|FG005|Maintenance Phase|Adverse Event|9|||
155283694|NCT00783692|560470831|FG006|Maintenance Phase|Adverse Event|38|||
155283695|NCT00783692|560470825|FG000|Maintenance Phase|Protocol Violation|0|||
155283696|NCT00783692|560470826|FG001|Maintenance Phase|Protocol Violation|0|||
155283697|NCT00783692|560470827|FG002|Maintenance Phase|Protocol Violation|0|||
155283698|NCT00783692|560470828|FG003|Maintenance Phase|Protocol Violation|1|||
155283699|NCT00783692|560470829|FG004|Maintenance Phase|Protocol Violation|2|||
155283700|NCT00783692|560470830|FG005|Maintenance Phase|Protocol Violation|3|||
155283701|NCT00783692|560470831|FG006|Maintenance Phase|Protocol Violation|4|||
155283702|NCT00783692|560470825|FG000|Maintenance Phase|Lack of Efficacy|79|||
155283703|NCT00783692|560470826|FG001|Maintenance Phase|Lack of Efficacy|0|||
155394525|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394526|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394527|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394528|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394529|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394530|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394531|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394532|NCT02187809|560880327|FG000|Overall Study|The study was terminated|3|||
155394533|NCT01020448|560880328|FG000|Pre-assignment|Adverse Event|6|||
155394534|NCT01020448|560880328|FG000|Pre-assignment|Withdrawal by Subject|5|||
155394535|NCT01020448|560880328|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
155394536|NCT01020448|560880328|FG000|Treatment|Adverse Event|11|||
155394537|NCT01020448|560880328|FG000|Treatment|Consent Withdrawn|3|||
155394538|NCT01020448|560880328|FG000|Treatment|Disease Progression|2|||
155394539|NCT01020448|560880328|FG000|Treatment|Lack of Efficacy|8|||
155394540|NCT01020448|560880328|FG000|Treatment|Lost to Follow-up|2|||
155394541|NCT01230554|560880329|FG000|Overall Study|Lost to Follow-up|2|||
155394542|NCT01230554|560880329|FG000|Overall Study|Inability to maintain visit schedule|1|||
155394543|NCT01505010|560880330|FG000|Overall Study|Protocol Violation|0|||
155394544|NCT01505010|560880331|FG001|Overall Study|Protocol Violation|1|||
155394545|NCT01505010|560880330|FG000|Overall Study|Lost to Follow-up|0|||
155394546|NCT01505010|560880331|FG001|Overall Study|Lost to Follow-up|1|||
155394547|NCT00698932|560880340|FG000|Overall Study|Adverse Event|0|||
155394548|NCT00698932|560880341|FG001|Overall Study|Adverse Event|2|||
155394549|NCT00698932|560880340|FG000|Overall Study|Incorrect enrollment|0|||
155394550|NCT00698932|560880341|FG001|Overall Study|Incorrect enrollment|2|||
155394551|NCT00698932|560880340|FG000|Overall Study|Study specific discontinuation criteria|3|||
155394552|NCT00698932|560880341|FG001|Overall Study|Study specific discontinuation criteria|4|||
155394553|NCT00698932|560880340|FG000|Overall Study|Withdrawal by Subject|11|||
155394554|NCT00698932|560880341|FG001|Overall Study|Withdrawal by Subject|23|||
155394555|NCT00698932|560880340|FG000|Overall Study|Lost to Follow-up|6|||
155394556|NCT00698932|560880341|FG001|Overall Study|Lost to Follow-up|1|||
155394557|NCT00698932|560880340|FG000|Overall Study|Severe non-compliance to protocol|1|||
155394558|NCT00698932|560880341|FG001|Overall Study|Severe non-compliance to protocol|2|||
155394559|NCT00698932|560880340|FG000|Overall Study|Safety reasons|0|||
155394560|NCT00698932|560880341|FG001|Overall Study|Safety reasons|2|||
155394561|NCT00698932|560880340|FG000|Overall Study|Death|1|||
155394562|NCT00698932|560880341|FG001|Overall Study|Death|0|||
155394563|NCT00601705|560880342|FG000|Overall Study|Withdrawal by Subject|1|||
155394564|NCT04513665|560880343|FG000|Overall Study|Adverse Event|2|||
155394565|NCT04513665|560880344|FG001|Overall Study|Adverse Event|0|||
155394566|NCT04513665|560880343|FG000|Overall Study|Lack of Efficacy|14|||
155394567|NCT04513665|560880344|FG001|Overall Study|Lack of Efficacy|0|||
155394568|NCT02146599|560880348|FG000|Overall Study|Failed to meet inclusion criteria|5|||
155394569|NCT04246801|560880349|FG000|Overall Study|Adverse Event|1|||
155394570|NCT04246801|560880350|FG001|Overall Study|Adverse Event|1|||
155394571|NCT04246801|560880349|FG000|Overall Study|Protocol Violation|1|||
155394572|NCT04246801|560880350|FG001|Overall Study|Protocol Violation|1|||
155394573|NCT04246801|560880349|FG000|Overall Study|Lack of Efficacy|0|||
155394574|NCT04246801|560880350|FG001|Overall Study|Lack of Efficacy|2|||
155394575|NCT04246801|560880349|FG000|Overall Study|Lost to Follow-up|1|||
155394576|NCT04246801|560880350|FG001|Overall Study|Lost to Follow-up|1|||
155394577|NCT04246801|560880349|FG000|Overall Study|Withdrawal by Subject|2|||
155394578|NCT04246801|560880350|FG001|Overall Study|Withdrawal by Subject|1|||
155394579|NCT01368042|560880354|FG000|Overall Study|Death|14|||
155394580|NCT01368042|560880354|FG000|Overall Study|Protocol Violation|11|||
155394581|NCT01368042|560880354|FG000|Overall Study|Lost to Follow-up|4|||
155635740|NCT03517137|561759344|FG000|Overall Study|Lack of Efficacy|1|||
155635741|NCT03517137|561759344|FG000|Overall Study|Adverse Event|2|||
155635742|NCT03517137|561759344|FG000|Overall Study|Withdrawal by Subject|2|||
155635743|NCT03517137|561759344|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
155635744|NCT03575364|561759345|FG000|Overall Study|Death|45|||
155635745|NCT03575364|561759345|FG000|Overall Study|Lost to Follow-up|114|||
155635746|NCT03575364|561759345|FG000|Overall Study|Withdrawal by Subject|21|||
155394582|NCT01368042|560880354|FG000|Overall Study|Transplanted|1|||
155394583|NCT01621542|560880355|FG000|Overall Study|Adverse Event|0|||
155394584|NCT01621542|560880356|FG001|Overall Study|Adverse Event|0|||
155394585|NCT01621542|560880357|FG002|Overall Study|Adverse Event|1|||
155394586|NCT01621542|560880358|FG003|Overall Study|Adverse Event|3|||
155394587|NCT01621542|560880359|FG004|Overall Study|Adverse Event|0|||
155394588|NCT01621542|560880360|FG005|Overall Study|Adverse Event|0|||
155394589|NCT01621542|560880355|FG000|Overall Study|Death|0|||
155394590|NCT01621542|560880356|FG001|Overall Study|Death|1|||
155635747|NCT03575364|561759345|FG000|Overall Study|Physician Decision|11|||
155635748|NCT03575364|561759345|FG000|Overall Study|Subject Refused Follow-up|13|||
155394591|NCT01621542|560880357|FG002|Overall Study|Death|0|||
155394592|NCT01621542|560880358|FG003|Overall Study|Death|0|||
155394593|NCT01621542|560880359|FG004|Overall Study|Death|0|||
155394594|NCT01621542|560880360|FG005|Overall Study|Death|0|||
155394595|NCT01621542|560880355|FG000|Overall Study|Physician Decision|1|||
155394596|NCT01621542|560880356|FG001|Overall Study|Physician Decision|0|||
155394597|NCT01621542|560880357|FG002|Overall Study|Physician Decision|1|||
155394598|NCT01621542|560880358|FG003|Overall Study|Physician Decision|13|||
155394599|NCT01621542|560880359|FG004|Overall Study|Physician Decision|3|||
155394600|NCT01621542|560880360|FG005|Overall Study|Physician Decision|1|||
155394601|NCT01621542|560880355|FG000|Overall Study|Withdrawal by Subject|2|||
155394602|NCT01621542|560880356|FG001|Overall Study|Withdrawal by Subject|0|||
155394603|NCT01621542|560880357|FG002|Overall Study|Withdrawal by Subject|1|||
155394604|NCT01621542|560880358|FG003|Overall Study|Withdrawal by Subject|3|||
155394605|NCT01621542|560880359|FG004|Overall Study|Withdrawal by Subject|3|||
155394606|NCT01621542|560880360|FG005|Overall Study|Withdrawal by Subject|3|||
155394607|NCT01621542|560880355|FG000|Overall Study|progression/treatment failure|2|||
155394608|NCT01621542|560880356|FG001|Overall Study|progression/treatment failure|4|||
155394609|NCT01621542|560880357|FG002|Overall Study|progression/treatment failure|3|||
155394610|NCT01621542|560880358|FG003|Overall Study|progression/treatment failure|7|||
155394611|NCT01621542|560880359|FG004|Overall Study|progression/treatment failure|3|||
155394612|NCT01621542|560880360|FG005|Overall Study|progression/treatment failure|5|||
155394613|NCT01621542|560880355|FG000|Overall Study|Protocol Violation|0|||
155394614|NCT01621542|560880356|FG001|Overall Study|Protocol Violation|0|||
155394615|NCT01621542|560880357|FG002|Overall Study|Protocol Violation|0|||
155394616|NCT01621542|560880358|FG003|Overall Study|Protocol Violation|1|||
155394617|NCT01621542|560880359|FG004|Overall Study|Protocol Violation|0|||
155394618|NCT01621542|560880360|FG005|Overall Study|Protocol Violation|0|||
155394619|NCT01621542|560880355|FG000|Overall Study|study stopped by sponsor|0|||
155394620|NCT01621542|560880356|FG001|Overall Study|study stopped by sponsor|0|||
155394621|NCT01621542|560880357|FG002|Overall Study|study stopped by sponsor|0|||
155394622|NCT01621542|560880358|FG003|Overall Study|study stopped by sponsor|1|||
155394623|NCT01621542|560880359|FG004|Overall Study|study stopped by sponsor|0|||
155394624|NCT01621542|560880360|FG005|Overall Study|study stopped by sponsor|0|||
155394625|NCT00544648|560880365|FG000|Overall Study|Withdrawal by Subject|1|||
155394626|NCT00544648|560880366|FG001|Overall Study|Withdrawal by Subject|0|||
155394627|NCT00544648|560880365|FG000|Overall Study|Adverse Event|1|||
155394628|NCT00544648|560880366|FG001|Overall Study|Adverse Event|1|||
155394629|NCT00544648|560880365|FG000|Overall Study|progression of disease|1|||
155394630|NCT00544648|560880366|FG001|Overall Study|progression of disease|0|||
155394631|NCT02663271|560880367|FG000|Overall Study|Withdrawal by Subject|5|||
155394632|NCT02663271|560880367|FG000|Overall Study|Lack of Efficacy|1|||
155394633|NCT01351623|560880369|FG000|Overall Study|Protocol Violation|2|||
155394634|NCT01351623|560880369|FG000|Overall Study|Adverse Event|4|||
155394635|NCT01351623|560880369|FG000|Overall Study|Withdrawal by Subject|1|||
155394636|NCT01351623|560880369|FG000|Overall Study|Death|2|||
155394637|NCT04399122|560880372|FG000|Overall Study|Lost to Follow-up|2|||
155394638|NCT04399122|560880373|FG001|Overall Study|Lost to Follow-up|0|||
155394639|NCT04399122|560880372|FG000|Overall Study|Withdrawal by Subject|1|||
155394640|NCT04399122|560880373|FG001|Overall Study|Withdrawal by Subject|0|||
155394641|NCT02322229|560880374|FG000|Overall Study|Physician Decision|2|||
155394642|NCT00705432|560880375|FG000|Treatment Period|Adverse Event|45|||
155394643|NCT00705432|560880376|FG001|Treatment Period|Adverse Event|37|||
155394644|NCT00705432|560880377|FG002|Treatment Period|Adverse Event|51|||
155394645|NCT00705432|560880378|FG003|Treatment Period|Adverse Event|12|||
155394646|NCT00705432|560880379|FG004|Treatment Period|Adverse Event|8|||
155394647|NCT00705432|560880380|FG005|Treatment Period|Adverse Event|9|||
155394648|NCT00705432|560880375|FG000|Treatment Period|Treatment failure|92|||
155394649|NCT00705432|560880376|FG001|Treatment Period|Treatment failure|42|||
155394650|NCT00705432|560880377|FG002|Treatment Period|Treatment failure|33|||
155394651|NCT00705432|560880378|FG003|Treatment Period|Treatment failure|25|||
155394652|NCT00705432|560880379|FG004|Treatment Period|Treatment failure|13|||
155394653|NCT00705432|560880380|FG005|Treatment Period|Treatment failure|14|||
155394654|NCT00705432|560880375|FG000|Treatment Period|Non medical reason|26|||
155394655|NCT00705432|560880376|FG001|Treatment Period|Non medical reason|32|||
155394656|NCT00705432|560880377|FG002|Treatment Period|Non medical reason|37|||
155394657|NCT00705432|560880378|FG003|Treatment Period|Non medical reason|4|||
155394658|NCT00705432|560880379|FG004|Treatment Period|Non medical reason|7|||
155394659|NCT00705432|560880380|FG005|Treatment Period|Non medical reason|7|||
155394660|NCT00705432|560880375|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
155394661|NCT00705432|560880376|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
155394662|NCT00705432|560880377|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
155394663|NCT00705432|560880378|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394664|NCT00705432|560880379|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394665|NCT00705432|560880380|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394666|NCT00705432|560880375|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
155394667|NCT00705432|560880376|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
155394668|NCT00705432|560880377|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
155394669|NCT00705432|560880378|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
155394670|NCT00705432|560880379|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
155394671|NCT00705432|560880380|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
155394672|NCT00521053|560880381|FG000|Observation Phase|Disease Progression|55|||
155394673|NCT00521053|560880381|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
155394674|NCT00521053|560880381|FG000|Observation Phase|Death|2|||
155394675|NCT00521053|560880381|FG000|Observation Phase|Adverse Event|1|||
155394676|NCT00521053|560880381|FG000|Observation Phase|Other non-study melanoma treatment|1|||
155394677|NCT00521053|560880381|FG000|Observation Phase|Physician Decision|1|||
155394678|NCT05390580|560880382|FG000|Overall Study|Physician Decision|3|||
155394679|NCT05390580|560880383|FG001|Overall Study|Physician Decision|2|||
155394680|NCT04448756|560880384|FG000|Overall Study|Adverse Event|0|||
155394681|NCT04448756|560880385|FG001|Overall Study|Adverse Event|1|||
155394682|NCT04448756|560880386|FG002|Overall Study|Adverse Event|0|||
155394683|NCT04448756|560880384|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
155394684|NCT04448756|560880385|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
155394685|NCT04448756|560880386|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
155394686|NCT04448756|560880384|FG000|Overall Study|Withdrawal by Subject|0|||
155394687|NCT04448756|560880385|FG001|Overall Study|Withdrawal by Subject|3|||
155394688|NCT04448756|560880386|FG002|Overall Study|Withdrawal by Subject|1|||
155394689|NCT04448756|560880384|FG000|Overall Study|Death|2|||
155394690|NCT04448756|560880385|FG001|Overall Study|Death|1|||
155394691|NCT04448756|560880386|FG002|Overall Study|Death|0|||
155394692|NCT02129205|560880387|FG000|Overall Study|Withdrawal by Subject|0|||
155394693|NCT02129205|560880388|FG001|Overall Study|Withdrawal by Subject|0|||
155394694|NCT02129205|560880389|FG002|Overall Study|Withdrawal by Subject|0|||
155394695|NCT02129205|560880390|FG003|Overall Study|Withdrawal by Subject|0|||
155394696|NCT02129205|560880391|FG004|Overall Study|Withdrawal by Subject|1|||
155394697|NCT02129205|560880392|FG005|Overall Study|Withdrawal by Subject|1|||
155394698|NCT02129205|560880393|FG006|Overall Study|Withdrawal by Subject|1|||
155394699|NCT02129205|560880394|FG007|Overall Study|Withdrawal by Subject|0|||
155394700|NCT02129205|560880395|FG008|Overall Study|Withdrawal by Subject|1|||
155394701|NCT02129205|560880396|FG009|Overall Study|Withdrawal by Subject|0|||
155394702|NCT02129205|560880387|FG000|Overall Study|Other|1|||
155394703|NCT02129205|560880388|FG001|Overall Study|Other|0|||
155394704|NCT02129205|560880389|FG002|Overall Study|Other|0|||
155394705|NCT02129205|560880390|FG003|Overall Study|Other|0|||
155394706|NCT02129205|560880391|FG004|Overall Study|Other|2|||
155394707|NCT02129205|560880392|FG005|Overall Study|Other|3|||
155394708|NCT02129205|560880393|FG006|Overall Study|Other|3|||
155394709|NCT02129205|560880394|FG007|Overall Study|Other|2|||
155394710|NCT02129205|560880395|FG008|Overall Study|Other|1|||
155394711|NCT02129205|560880396|FG009|Overall Study|Other|0|||
155394712|NCT02877927|560880397|FG000|Overall Study|Adverse Event|1|||
155394713|NCT02877927|560880398|FG001|Overall Study|Adverse Event|0|||
155394714|NCT02877927|560880397|FG000|Overall Study|Lost to Follow-up|37|||
155394715|NCT02877927|560880398|FG001|Overall Study|Lost to Follow-up|38|||
155394716|NCT02877927|560880397|FG000|Overall Study|Withdrawal by Subject|11|||
155394717|NCT02877927|560880398|FG001|Overall Study|Withdrawal by Subject|12|||
155394718|NCT02877927|560880397|FG000|Overall Study|Physician Decision|0|||
155394719|NCT02877927|560880398|FG001|Overall Study|Physician Decision|1|||
155394720|NCT02877927|560880397|FG000|Overall Study|Missed EOT/PTE Visit|5|||
155394721|NCT02877927|560880398|FG001|Overall Study|Missed EOT/PTE Visit|6|||
155394722|NCT00601250|560880399|FG000|Overall Study|Adverse Event|3|||
155394723|NCT00601250|560880400|FG001|Overall Study|Adverse Event|9|||
155394724|NCT00601250|560880399|FG000|Overall Study|Protocol Violation|3|||
155394725|NCT00601250|560880400|FG001|Overall Study|Protocol Violation|2|||
155394726|NCT00601250|560880399|FG000|Overall Study|Lost to Follow-up|2|||
155394727|NCT00601250|560880400|FG001|Overall Study|Lost to Follow-up|6|||
155394728|NCT00601250|560880399|FG000|Overall Study|Withdrawal by Subject|4|||
155394729|NCT00601250|560880400|FG001|Overall Study|Withdrawal by Subject|13|||
155394730|NCT00601250|560880399|FG000|Overall Study|Other incl. lack of efficacy|2|||
155394731|NCT00601250|560880400|FG001|Overall Study|Other incl. lack of efficacy|9|||
155394732|NCT04376060|560880401|FG000|Overall Study|Physician Decision|1|||
155394733|NCT01791803|560880402|FG000|Overall Study|Withdrawal by Subject|0|||
155394734|NCT01791803|560880403|FG001|Overall Study|Withdrawal by Subject|0|||
155394735|NCT01791803|560880404|FG002|Overall Study|Withdrawal by Subject|0|||
155394736|NCT01791803|560880405|FG003|Overall Study|Withdrawal by Subject|2|||
155394737|NCT01791803|560880402|FG000|Overall Study|Physician Decision|0|||
155394738|NCT01791803|560880403|FG001|Overall Study|Physician Decision|2|||
155394739|NCT01791803|560880404|FG002|Overall Study|Physician Decision|0|||
155394740|NCT01791803|560880405|FG003|Overall Study|Physician Decision|1|||
155394741|NCT01791803|560880402|FG000|Overall Study|Death|0|||
155394742|NCT01791803|560880403|FG001|Overall Study|Death|0|||
155394743|NCT01791803|560880404|FG002|Overall Study|Death|2|||
155394744|NCT01791803|560880405|FG003|Overall Study|Death|2|||
155394745|NCT00972777|560880406|FG000|Overall Study|Adverse Event|3|||
155394746|NCT00972777|560880407|FG001|Overall Study|Adverse Event|2|||
155394747|NCT00972777|560880406|FG000|Overall Study|Lost to Follow-up|0|||
155394748|NCT00972777|560880407|FG001|Overall Study|Lost to Follow-up|4|||
155394749|NCT00972777|560880406|FG000|Overall Study|Withdrawal by Subject|4|||
155394750|NCT00972777|560880407|FG001|Overall Study|Withdrawal by Subject|5|||
155394751|NCT00972777|560880406|FG000|Overall Study|Physician Decision|4|||
155394752|NCT00972777|560880407|FG001|Overall Study|Physician Decision|0|||
155394753|NCT00972777|560880406|FG000|Overall Study|Protocol Violation|0|||
155394754|NCT00972777|560880407|FG001|Overall Study|Protocol Violation|2|||
155394755|NCT00972777|560880406|FG000|Overall Study|Screening Failure|2|||
155394756|NCT00972777|560880407|FG001|Overall Study|Screening Failure|1|||
155394757|NCT00972777|560880406|FG000|Overall Study|Missed visit|1|||
155394758|NCT00972777|560880407|FG001|Overall Study|Missed visit|0|||
155394759|NCT03426787|560881910|FG000|Overall Study|Withdrawal by Subject|6|||
155394760|NCT03426787|560881910|FG000|Overall Study|Lost to Follow-up|7|||
155394761|NCT03426787|560881910|FG000|Overall Study|Unrelated to intervention death|1|||
155394762|NCT02592551|560881911|FG000|Overall Study|Not evaluable|1|||
155394763|NCT02592551|560881912|FG001|Overall Study|Not evaluable|3|||
155394764|NCT02592551|560881913|FG002|Overall Study|Not evaluable|0|||
155394765|NCT00908583|560881917|FG000|Phase 1|Withdrawal by Subject|1|||
155394766|NCT00908583|560881917|FG000|Phase 1|Adverse Event|4|||
155394767|NCT00908583|560881917|FG000|Phase 2|Physician Decision|1|||
155394768|NCT00908583|560881917|FG000|Phase 2|Adverse Event|1|||
155394769|NCT00908583|560881917|FG000|Phase 3|Adverse Event|2|||
155394770|NCT00908583|560881917|FG000|Phase 4|Adverse Event|1|||
155394771|NCT00908583|560881917|FG000|Phase 4|Physician Decision|1|||
155394772|NCT00908583|560881917|FG000|Phase 5|Adverse Event|3|||
155394773|NCT00993954|560881918|FG000|Overall Study|Protocol Violation|21|||
155394774|NCT00993954|560881919|FG001|Overall Study|Protocol Violation|2|||
155394775|NCT00860951|560881920|FG000|Overall Study|Withdrawal by Subject|2|||
155394776|NCT00860951|560881920|FG000|Overall Study|Lost to Follow-up|5|||
155394777|NCT01950247|560881921|FG000|Overall Study|Withdrawal by Subject|28|||
155394778|NCT01950247|560881922|FG001|Overall Study|Withdrawal by Subject|13|||
155394779|NCT01950247|560881921|FG000|Overall Study|Lost to Follow-up|18|||
155394780|NCT01950247|560881922|FG001|Overall Study|Lost to Follow-up|16|||
155394781|NCT01950247|560881921|FG000|Overall Study|Physician Decision|3|||
155394782|NCT01950247|560881922|FG001|Overall Study|Physician Decision|4|||
155394783|NCT01950247|560881921|FG000|Overall Study|Adverse Event|3|||
155394784|NCT01950247|560881922|FG001|Overall Study|Adverse Event|2|||
155394785|NCT01950247|560881921|FG000|Overall Study|Death|1|||
155394786|NCT01950247|560881922|FG001|Overall Study|Death|1|||
155394787|NCT01950247|560881921|FG000|Overall Study|Not Defined|4|||
155394788|NCT01950247|560881922|FG001|Overall Study|Not Defined|10|||
155394789|NCT01069120|560881925|FG000|Overall Study|Study prematurely terminated|27|||
155394790|NCT00763971|560881926|FG000|Overall Study|Adverse Event|5|||
155394791|NCT00763971|560881927|FG001|Overall Study|Adverse Event|2|||
155394792|NCT00763971|560881928|FG002|Overall Study|Adverse Event|4|||
155394793|NCT00763971|560881926|FG000|Overall Study|Protocol Violation|3|||
155394794|NCT00763971|560881927|FG001|Overall Study|Protocol Violation|3|||
155394795|NCT00763971|560881928|FG002|Overall Study|Protocol Violation|2|||
155394796|NCT00763971|560881926|FG000|Overall Study|Withdrawal by Subject|4|||
155394797|NCT00763971|560881927|FG001|Overall Study|Withdrawal by Subject|5|||
155394798|NCT00763971|560881928|FG002|Overall Study|Withdrawal by Subject|5|||
155394799|NCT00763971|560881926|FG000|Overall Study|Lost to Follow-up|0|||
155394800|NCT00763971|560881927|FG001|Overall Study|Lost to Follow-up|1|||
155394801|NCT00763971|560881928|FG002|Overall Study|Lost to Follow-up|0|||
155394802|NCT00763971|560881926|FG000|Overall Study|Lack of Efficacy|11|||
155394803|NCT00763971|560881927|FG001|Overall Study|Lack of Efficacy|22|||
155394804|NCT00763971|560881928|FG002|Overall Study|Lack of Efficacy|54|||
155394805|NCT00763971|560881926|FG000|Overall Study|Unable to swallow capsule|2|||
155394806|NCT00763971|560881927|FG001|Overall Study|Unable to swallow capsule|1|||
155394807|NCT00763971|560881928|FG002|Overall Study|Unable to swallow capsule|1|||
155394808|NCT00763971|560881926|FG000|Overall Study|Personal reason|3|||
155394809|NCT00763971|560881927|FG001|Overall Study|Personal reason|0|||
155394810|NCT00763971|560881928|FG002|Overall Study|Personal reason|0|||
155394811|NCT00763971|560881926|FG000|Overall Study|Exclusion criteria met|1|||
155394812|NCT00763971|560881927|FG001|Overall Study|Exclusion criteria met|0|||
155394813|NCT00763971|560881928|FG002|Overall Study|Exclusion criteria met|0|||
155394814|NCT00763971|560881926|FG000|Overall Study|Sponsor decision|1|||
155394815|NCT00763971|560881927|FG001|Overall Study|Sponsor decision|0|||
155394816|NCT00763971|560881928|FG002|Overall Study|Sponsor decision|0|||
155394817|NCT00763971|560881926|FG000|Overall Study|Due to holiday season|2|||
155394818|NCT00763971|560881927|FG001|Overall Study|Due to holiday season|0|||
155394819|NCT00763971|560881928|FG002|Overall Study|Due to holiday season|1|||
155394820|NCT00763971|560881926|FG000|Overall Study|Randomization error|0|||
155394821|NCT00763971|560881927|FG001|Overall Study|Randomization error|0|||
155394822|NCT00763971|560881928|FG002|Overall Study|Randomization error|1|||
155394823|NCT00763971|560881926|FG000|Overall Study|Medical monitor decision|0|||
155394824|NCT00763971|560881927|FG001|Overall Study|Medical monitor decision|0|||
155394825|NCT00763971|560881928|FG002|Overall Study|Medical monitor decision|1|||
155394826|NCT00763971|560881926|FG000|Overall Study|Moved to another country|0|||
155283704|NCT00783692|560470827|FG002|Maintenance Phase|Lack of Efficacy|0|||
155283705|NCT00783692|560470828|FG003|Maintenance Phase|Lack of Efficacy|64|||
155283706|NCT00783692|560470829|FG004|Maintenance Phase|Lack of Efficacy|58|||
155283707|NCT00783692|560470830|FG005|Maintenance Phase|Lack of Efficacy|48|||
155283708|NCT00783692|560470831|FG006|Maintenance Phase|Lack of Efficacy|177|||
155283709|NCT00783692|560470825|FG000|Maintenance Phase|Withdrawal by Subject|7|||
155283710|NCT00783692|560470826|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155283711|NCT00783692|560470827|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155283712|NCT00783692|560470828|FG003|Maintenance Phase|Withdrawal by Subject|7|||
155283713|NCT00783692|560470829|FG004|Maintenance Phase|Withdrawal by Subject|6|||
155283714|NCT00783692|560470830|FG005|Maintenance Phase|Withdrawal by Subject|9|||
155283715|NCT00783692|560470831|FG006|Maintenance Phase|Withdrawal by Subject|24|||
155283716|NCT00783692|560470825|FG000|Maintenance Phase|Lost to Follow-up|2|||
155283717|NCT00783692|560470826|FG001|Maintenance Phase|Lost to Follow-up|0|||
155283718|NCT00783692|560470827|FG002|Maintenance Phase|Lost to Follow-up|0|||
155283719|NCT00783692|560470828|FG003|Maintenance Phase|Lost to Follow-up|1|||
155283720|NCT00783692|560470829|FG004|Maintenance Phase|Lost to Follow-up|3|||
155283721|NCT00783692|560470830|FG005|Maintenance Phase|Lost to Follow-up|2|||
155283722|NCT00783692|560470831|FG006|Maintenance Phase|Lost to Follow-up|5|||
155283723|NCT00783692|560470825|FG000|Maintenance Phase|Other|0|||
155283724|NCT00783692|560470826|FG001|Maintenance Phase|Other|0|||
155283725|NCT00783692|560470827|FG002|Maintenance Phase|Other|0|||
155283726|NCT00783692|560470828|FG003|Maintenance Phase|Other|1|||
155283727|NCT00783692|560470829|FG004|Maintenance Phase|Other|0|||
155283728|NCT00783692|560470830|FG005|Maintenance Phase|Other|1|||
155283729|NCT00783692|560470831|FG006|Maintenance Phase|Other|1|||
155283730|NCT00819234|560470838|FG000|Overall Study|Withdrawal by Subject|8|||
155283731|NCT00819234|560470839|FG001|Overall Study|Withdrawal by Subject|13|||
155283732|NCT00819234|560470840|FG002|Overall Study|Withdrawal by Subject|6|||
155283733|NCT00819234|560470841|FG003|Overall Study|Withdrawal by Subject|3|||
155283734|NCT00819234|560470842|FG004|Overall Study|Withdrawal by Subject|0|||
155283735|NCT00819234|560470843|FG005|Overall Study|Withdrawal by Subject|4|||
155283736|NCT00819234|560470844|FG006|Overall Study|Withdrawal by Subject|4|||
155283737|NCT00819234|560470845|FG007|Overall Study|Withdrawal by Subject|8|||
155283738|NCT00819234|560470846|FG008|Overall Study|Withdrawal by Subject|5|||
155283739|NCT00819234|560470847|FG009|Overall Study|Withdrawal by Subject|3|||
155283740|NCT00819234|560470838|FG000|Overall Study|Adverse Event|0|||
155283741|NCT00819234|560470839|FG001|Overall Study|Adverse Event|0|||
155283742|NCT00819234|560470840|FG002|Overall Study|Adverse Event|1|||
155283743|NCT00819234|560470841|FG003|Overall Study|Adverse Event|0|||
155283744|NCT00819234|560470842|FG004|Overall Study|Adverse Event|0|||
155283745|NCT00819234|560470843|FG005|Overall Study|Adverse Event|2|||
155283746|NCT00819234|560470844|FG006|Overall Study|Adverse Event|0|||
155283747|NCT00819234|560470845|FG007|Overall Study|Adverse Event|0|||
155283748|NCT00819234|560470846|FG008|Overall Study|Adverse Event|0|||
155283749|NCT00819234|560470847|FG009|Overall Study|Adverse Event|0|||
155283750|NCT00819234|560470838|FG000|Overall Study|Physician Decision|0|||
155283751|NCT00819234|560470839|FG001|Overall Study|Physician Decision|0|||
155283752|NCT00819234|560470840|FG002|Overall Study|Physician Decision|0|||
155283753|NCT00819234|560470841|FG003|Overall Study|Physician Decision|1|||
155283754|NCT00819234|560470842|FG004|Overall Study|Physician Decision|0|||
155283755|NCT00819234|560470843|FG005|Overall Study|Physician Decision|0|||
155283756|NCT00819234|560470844|FG006|Overall Study|Physician Decision|0|||
155283757|NCT00819234|560470845|FG007|Overall Study|Physician Decision|0|||
155283758|NCT00819234|560470846|FG008|Overall Study|Physician Decision|0|||
155283759|NCT00819234|560470847|FG009|Overall Study|Physician Decision|2|||
155283760|NCT00819234|560470838|FG000|Overall Study|Protocol Violation|0|||
155283761|NCT00819234|560470839|FG001|Overall Study|Protocol Violation|0|||
155283762|NCT00819234|560470840|FG002|Overall Study|Protocol Violation|1|||
155283763|NCT00819234|560470841|FG003|Overall Study|Protocol Violation|0|||
155283764|NCT00819234|560470842|FG004|Overall Study|Protocol Violation|0|||
155283765|NCT00819234|560470843|FG005|Overall Study|Protocol Violation|0|||
155283766|NCT00819234|560470844|FG006|Overall Study|Protocol Violation|0|||
155283767|NCT00819234|560470845|FG007|Overall Study|Protocol Violation|0|||
155283768|NCT00819234|560470846|FG008|Overall Study|Protocol Violation|0|||
155283769|NCT00819234|560470847|FG009|Overall Study|Protocol Violation|0|||
155283770|NCT00819234|560470838|FG000|Overall Study|Lost to Follow-up|2|||
155283771|NCT00819234|560470839|FG001|Overall Study|Lost to Follow-up|2|||
155283772|NCT00819234|560470840|FG002|Overall Study|Lost to Follow-up|0|||
155283773|NCT00819234|560470841|FG003|Overall Study|Lost to Follow-up|2|||
155283774|NCT00819234|560470842|FG004|Overall Study|Lost to Follow-up|1|||
155283775|NCT00819234|560470843|FG005|Overall Study|Lost to Follow-up|1|||
155283776|NCT00819234|560470844|FG006|Overall Study|Lost to Follow-up|1|||
155283777|NCT00819234|560470845|FG007|Overall Study|Lost to Follow-up|1|||
155283778|NCT00819234|560470846|FG008|Overall Study|Lost to Follow-up|1|||
155283779|NCT00819234|560470847|FG009|Overall Study|Lost to Follow-up|2|||
155283780|NCT01823341|560470848|FG000|Overall Study|Failed run-in|7|||
155394827|NCT00763971|560881927|FG001|Overall Study|Moved to another country|1|||
155394828|NCT00763971|560881928|FG002|Overall Study|Moved to another country|0|||
155394829|NCT00763971|560881926|FG000|Overall Study|Subject wanted dose reduction|0|||
155394830|NCT00763971|560881927|FG001|Overall Study|Subject wanted dose reduction|1|||
155394831|NCT00763971|560881928|FG002|Overall Study|Subject wanted dose reduction|0|||
155394832|NCT00763971|560881926|FG000|Overall Study|Lack of availability|0|||
155394833|NCT00763971|560881927|FG001|Overall Study|Lack of availability|1|||
155394834|NCT00763971|560881928|FG002|Overall Study|Lack of availability|0|||
155394835|NCT00763971|560881926|FG000|Overall Study|Performed final visit on phone|0|||
155394836|NCT00763971|560881927|FG001|Overall Study|Performed final visit on phone|1|||
155394837|NCT00763971|560881928|FG002|Overall Study|Performed final visit on phone|0|||
155394838|NCT00763971|560881926|FG000|Overall Study|Participation in 489-326 required|1|||
155394839|NCT00763971|560881927|FG001|Overall Study|Participation in 489-326 required|0|||
155394840|NCT00763971|560881928|FG002|Overall Study|Participation in 489-326 required|0|||
155394841|NCT02713542|560881936|FG000|Overall Study|Use of prohibited medication|14|||
155394842|NCT02713542|560881937|FG001|Overall Study|Use of prohibited medication|5|||
155394843|NCT02713542|560881936|FG000|Overall Study|Withdrawal by Subject|4|||
155394844|NCT02713542|560881937|FG001|Overall Study|Withdrawal by Subject|1|||
155394845|NCT03631667|560881938|FG000|Overall Study|Withdrawal by Subject|3|||
155394846|NCT03383289|560881939|FG000|Overall Study|Death|83|||
155394847|NCT03383289|560881940|FG001|Overall Study|Death|78|||
155394848|NCT03383289|560881939|FG000|Overall Study|discharge from facility|84|||
155394849|NCT03383289|560881940|FG001|Overall Study|discharge from facility|84|||
155394850|NCT03383289|560881939|FG000|Overall Study|Withdrawal by Subject|4|||
155394851|NCT03383289|560881940|FG001|Overall Study|Withdrawal by Subject|1|||
155394852|NCT00884325|560881941|FG000|Overall Study|Lost to Follow-up|1|||
155394853|NCT00884325|560881942|FG001|Overall Study|Lost to Follow-up|2|||
155394854|NCT00884325|560881941|FG000|Overall Study|Lack of Efficacy|0|||
155394855|NCT00884325|560881942|FG001|Overall Study|Lack of Efficacy|1|||
155394856|NCT00884325|560881941|FG000|Overall Study|Withdrawal by Subject|1|||
155394857|NCT00884325|560881942|FG001|Overall Study|Withdrawal by Subject|1|||
155394858|NCT00884325|560881941|FG000|Overall Study|Not provided|1|||
155394859|NCT00884325|560881942|FG001|Overall Study|Not provided|0|||
155394860|NCT01641237|560881943|FG000|Period II|Withdrawal by Subject|1|||
155394861|NCT01641237|560881944|FG001|Period II|Withdrawal by Subject|0|||
155394862|NCT01641237|560881945|FG002|Period II|Withdrawal by Subject|0|||
155394863|NCT01641237|560881946|FG003|Period II|Withdrawal by Subject|0|||
155394864|NCT01641237|560881943|FG000|Period III|Lost to Follow-up|1|||
155394865|NCT01641237|560881944|FG001|Period III|Lost to Follow-up|0|||
155394866|NCT01641237|560881945|FG002|Period III|Lost to Follow-up|0|||
155394867|NCT01641237|560881946|FG003|Period III|Lost to Follow-up|0|||
155394868|NCT00832117|560881958|FG000|Overall Study|Death|1|||
155394869|NCT00832117|560881958|FG000|Overall Study|Disease Progression|11|||
155394870|NCT01301456|560881959|FG000|Stage 1|Withdrawal by Subject|0|||
155394871|NCT01301456|560881960|FG001|Stage 1|Withdrawal by Subject|0|||
155394872|NCT01301456|560881961|FG002|Stage 1|Withdrawal by Subject|1|||
155394873|NCT01301456|560881962|FG003|Stage 1|Withdrawal by Subject|0|||
155394874|NCT01301456|560881963|FG004|Stage 1|Withdrawal by Subject|1|||
155394875|NCT01301456|560881964|FG005|Stage 1|Withdrawal by Subject|0|||
155394876|NCT01301456|560881965|FG006|Stage 1|Withdrawal by Subject|0|||
155394877|NCT01301456|560881966|FG007|Stage 1|Withdrawal by Subject|0|||
155394878|NCT01301456|560881967|FG008|Stage 1|Withdrawal by Subject|0|||
155394879|NCT01301456|560881968|FG009|Stage 1|Withdrawal by Subject|0|||
155394880|NCT01301456|560881969|FG010|Stage 1|Withdrawal by Subject|0|||
155635749|NCT03575364|561759345|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
155635750|NCT03575364|561759345|FG000|Overall Study|Patient moved out of the state|1|||
155635751|NCT03575364|561759345|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
155635752|NCT03575364|561759345|FG000|Overall Study|Patient is lost to follow up|1|||
155635753|NCT03575364|561759345|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
155635754|NCT01369433|561759346|FG000|Overall Study|Adverse Event|31|||
155635755|NCT01369433|561759347|FG001|Overall Study|Adverse Event|1|||
155635756|NCT01369433|561759346|FG000|Overall Study|Required significant surgical procedure|1|||
155635757|NCT01369433|561759347|FG001|Overall Study|Required significant surgical procedure|0|||
155635758|NCT01369433|561759346|FG000|Overall Study|Non-compliance|1|||
155635759|NCT01369433|561759347|FG001|Overall Study|Non-compliance|0|||
155635760|NCT01369433|561759346|FG000|Overall Study|Withdrawal by Subject|5|||
155635761|NCT01369433|561759347|FG001|Overall Study|Withdrawal by Subject|2|||
155635762|NCT01369433|561759346|FG000|Overall Study|Study terminated by Sponsor|67|||
155635763|NCT01369433|561759347|FG001|Overall Study|Study terminated by Sponsor|0|||
155394881|NCT01301456|560881970|FG011|Stage 1|Withdrawal by Subject|0|||
155394882|NCT01301456|560881959|FG000|Stage 1|Randomized but not treated|0|||
155635764|NCT01369433|561759346|FG000|Overall Study|Lost to Follow-up|1|||
155394883|NCT01301456|560881960|FG001|Stage 1|Randomized but not treated|0|||
155394884|NCT01301456|560881961|FG002|Stage 1|Randomized but not treated|0|||
155394885|NCT01301456|560881962|FG003|Stage 1|Randomized but not treated|0|||
155394886|NCT01301456|560881963|FG004|Stage 1|Randomized but not treated|0|||
155394887|NCT01301456|560881964|FG005|Stage 1|Randomized but not treated|0|||
155394888|NCT01301456|560881965|FG006|Stage 1|Randomized but not treated|1|||
155394889|NCT01301456|560881966|FG007|Stage 1|Randomized but not treated|0|||
155394890|NCT01301456|560881967|FG008|Stage 1|Randomized but not treated|0|||
155394891|NCT01301456|560881968|FG009|Stage 1|Randomized but not treated|0|||
155394892|NCT01301456|560881969|FG010|Stage 1|Randomized but not treated|0|||
155394893|NCT01301456|560881970|FG011|Stage 1|Randomized but not treated|0|||
155394894|NCT01301456|560881959|FG000|Stage 2|Adverse Event|0|||
155394895|NCT01301456|560881960|FG001|Stage 2|Adverse Event|0|||
155394896|NCT01301456|560881961|FG002|Stage 2|Adverse Event|0|||
155394897|NCT01301456|560881962|FG003|Stage 2|Adverse Event|0|||
155394898|NCT01301456|560881963|FG004|Stage 2|Adverse Event|0|||
155394899|NCT01301456|560881964|FG005|Stage 2|Adverse Event|0|||
155394900|NCT01301456|560881965|FG006|Stage 2|Adverse Event|0|||
155394901|NCT01301456|560881966|FG007|Stage 2|Adverse Event|0|||
155394902|NCT01301456|560881967|FG008|Stage 2|Adverse Event|0|||
155394903|NCT01301456|560881968|FG009|Stage 2|Adverse Event|0|||
155394904|NCT01301456|560881969|FG010|Stage 2|Adverse Event|1|||
155394905|NCT01301456|560881970|FG011|Stage 2|Adverse Event|0|||
155394906|NCT03239483|560881971|FG000|Overall Study|Lost to Follow-up|1|||
155394907|NCT03239483|560881972|FG001|Overall Study|Lost to Follow-up|0|||
155394908|NCT03239483|560881971|FG000|Overall Study|Withdrawal by Subject|1|||
155394909|NCT03239483|560881972|FG001|Overall Study|Withdrawal by Subject|0|||
155394910|NCT03678103|560881973|FG000|Overall Study|Withdrawn prior to completion|4|||
155394911|NCT04422990|560881976|FG000|Overall Study|Withdrawal by Subject|0|||
155394912|NCT04422990|560881977|FG001|Overall Study|Withdrawal by Subject|1|||
155394913|NCT04422990|560881976|FG000|Overall Study|Travel|3|||
155394914|NCT04422990|560881977|FG001|Overall Study|Travel|0|||
155394915|NCT00770770|560881981|FG000|Overall Study|Lost to Follow-up|1|||
155394916|NCT00770770|560881982|FG001|Overall Study|Lost to Follow-up|0|||
155394917|NCT00770770|560881981|FG000|Overall Study|Withdrawal by Subject|1|||
155394918|NCT00770770|560881982|FG001|Overall Study|Withdrawal by Subject|0|||
155394919|NCT00770770|560881981|FG000|Overall Study|Death|0|||
155394920|NCT00770770|560881982|FG001|Overall Study|Death|1|||
155394921|NCT00770770|560881981|FG000|Overall Study|Study Terminated|8|||
155394922|NCT00770770|560881982|FG001|Overall Study|Study Terminated|0|||
155394923|NCT02486653|560881983|FG000|Overall Study|Withdrawal by Subject|1|||
155394924|NCT02486653|560881984|FG001|Overall Study|Withdrawal by Subject|3|||
155394925|NCT02486653|560881983|FG000|Overall Study|Protocol Violation|1|||
155394926|NCT02486653|560881984|FG001|Overall Study|Protocol Violation|0|||
155394927|NCT02486653|560881983|FG000|Overall Study|surgery cancelled|4|||
155394928|NCT02486653|560881984|FG001|Overall Study|surgery cancelled|1|||
155394929|NCT01006265|560881985|FG000|Overall Study|Lost to Follow-up|1|||
155394930|NCT01006265|560881986|FG001|Overall Study|Lost to Follow-up|0|||
155394931|NCT01006265|560881987|FG002|Overall Study|Lost to Follow-up|1|||
155394932|NCT01006265|560881988|FG003|Overall Study|Lost to Follow-up|0|||
155394933|NCT01006265|560881985|FG000|Overall Study|Withdrawal by Subject|4|||
155394934|NCT01006265|560881986|FG001|Overall Study|Withdrawal by Subject|7|||
155394935|NCT01006265|560881987|FG002|Overall Study|Withdrawal by Subject|5|||
155394936|NCT01006265|560881988|FG003|Overall Study|Withdrawal by Subject|5|||
155394937|NCT01006265|560881985|FG000|Overall Study|Administrative reason|1|||
155394938|NCT01006265|560881986|FG001|Overall Study|Administrative reason|2|||
155394939|NCT01006265|560881987|FG002|Overall Study|Administrative reason|3|||
155394940|NCT01006265|560881988|FG003|Overall Study|Administrative reason|0|||
155394941|NCT01245387|560881989|FG000|Overall Study|Lost to Follow-up|106|||
155394942|NCT01245387|560881989|FG000|Overall Study|Lack of Efficacy|195|||
155394943|NCT01245387|560881989|FG000|Overall Study|Adverse Event|9|||
155394944|NCT01245387|560881989|FG000|Overall Study|Death|3|||
155394945|NCT01245387|560881989|FG000|Overall Study|Other|131|||
155394946|NCT01245387|560881989|FG000|Overall Study|Missing discontinuation status|369|||
155394947|NCT02101021|560881990|FG000|Overall Study|Death|4|||
155394948|NCT02101021|560881991|FG001|Overall Study|Death|3|||
155394949|NCT02101021|560881992|FG002|Overall Study|Death|6|||
155394950|NCT02101021|560881993|FG003|Overall Study|Death|0|||
155394951|NCT02101021|560881994|FG004|Overall Study|Death|3|||
155394952|NCT02101021|560881990|FG000|Overall Study|Withdrew Consent from study|1|||
155394953|NCT02101021|560881991|FG001|Overall Study|Withdrew Consent from study|1|||
155394954|NCT02101021|560881992|FG002|Overall Study|Withdrew Consent from study|0|||
155635765|NCT01369433|561759347|FG001|Overall Study|Lost to Follow-up|0|||
155635766|NCT01369433|561759346|FG000|Overall Study|Death|5|||
155635767|NCT01369433|561759347|FG001|Overall Study|Death|0|||
155635768|NCT01369433|561759346|FG000|Overall Study|Investigator discretion|6|||
155635769|NCT01369433|561759347|FG001|Overall Study|Investigator discretion|1|||
155635770|NCT01369433|561759346|FG000|Overall Study|Progressive Disease|92|||
155635771|NCT01369433|561759347|FG001|Overall Study|Progressive Disease|12|||
155635772|NCT02472353|561759350|FG000|Overall Study|Lost to Follow-up|1|||
155635773|NCT02472353|561759351|FG001|Overall Study|Lost to Follow-up|1|||
155635774|NCT02472353|561759350|FG000|Overall Study|Withdrawal by Subject|2|||
155635775|NCT02472353|561759351|FG001|Overall Study|Withdrawal by Subject|1|||
155741213|NCT02059291|562154803|FG003|Epoch 3|Adverse Event|0|||
155741214|NCT02059291|562154804|FG004|Epoch 3|Adverse Event|0|||
155741215|NCT02059291|562154805|FG005|Epoch 3|Adverse Event|0|||
155741216|NCT02059291|562154806|FG006|Epoch 3|Adverse Event|0|||
155741217|NCT02059291|562154807|FG007|Epoch 3|Adverse Event|0|||
155741218|NCT02059291|562154808|FG008|Epoch 3|Adverse Event|0|||
155741219|NCT02059291|562154809|FG009|Epoch 3|Adverse Event|0|||
155741220|NCT02059291|562154810|FG010|Epoch 3|Adverse Event|0|||
155741221|NCT02059291|562154811|FG011|Epoch 3|Adverse Event|0|||
155394955|NCT02101021|560881993|FG003|Overall Study|Withdrew Consent from study|2|||
155394956|NCT02101021|560881994|FG004|Overall Study|Withdrew Consent from study|0|||
155394957|NCT02101021|560881990|FG000|Overall Study|Lost to Follow-up|1|||
155394958|NCT02101021|560881991|FG001|Overall Study|Lost to Follow-up|0|||
155394959|NCT02101021|560881992|FG002|Overall Study|Lost to Follow-up|0|||
155394960|NCT02101021|560881993|FG003|Overall Study|Lost to Follow-up|0|||
155394961|NCT02101021|560881994|FG004|Overall Study|Lost to Follow-up|0|||
155394962|NCT02101021|560881990|FG000|Overall Study|Study Terminated by Sponsor|1|||
155394963|NCT02101021|560881991|FG001|Overall Study|Study Terminated by Sponsor|0|||
155394964|NCT02101021|560881992|FG002|Overall Study|Study Terminated by Sponsor|1|||
155394965|NCT02101021|560881993|FG003|Overall Study|Study Terminated by Sponsor|1|||
155394966|NCT02101021|560881994|FG004|Overall Study|Study Terminated by Sponsor|1|||
155394967|NCT02632721|560881997|FG000|Overall Study|Adverse Event|0|||
155394968|NCT02632721|560881998|FG001|Overall Study|Adverse Event|0|||
155394969|NCT02632721|560881999|FG002|Overall Study|Adverse Event|2|||
155394970|NCT02632721|560882000|FG003|Overall Study|Adverse Event|5|||
155394971|NCT02632721|560882001|FG004|Overall Study|Adverse Event|3|||
155394972|NCT02632721|560881997|FG000|Overall Study|Dose limiting toxicity|0|||
155394973|NCT02632721|560881998|FG001|Overall Study|Dose limiting toxicity|0|||
155394974|NCT02632721|560881999|FG002|Overall Study|Dose limiting toxicity|0|||
155394975|NCT02632721|560882000|FG003|Overall Study|Dose limiting toxicity|1|||
155394976|NCT02632721|560882001|FG004|Overall Study|Dose limiting toxicity|0|||
155394977|NCT02632721|560881997|FG000|Overall Study|Progressive disease|3|||
155394978|NCT02632721|560881998|FG001|Overall Study|Progressive disease|0|||
155394979|NCT02632721|560881999|FG002|Overall Study|Progressive disease|4|||
155394980|NCT02632721|560882000|FG003|Overall Study|Progressive disease|6|||
155394981|NCT02632721|560882001|FG004|Overall Study|Progressive disease|5|||
155394982|NCT02632721|560881997|FG000|Overall Study|Refused to continue taking trial medication|0|||
155394983|NCT02632721|560881998|FG001|Overall Study|Refused to continue taking trial medication|1|||
155394984|NCT02632721|560881999|FG002|Overall Study|Refused to continue taking trial medication|1|||
155394985|NCT02632721|560882000|FG003|Overall Study|Refused to continue taking trial medication|1|||
155394986|NCT02632721|560882001|FG004|Overall Study|Refused to continue taking trial medication|2|||
155394987|NCT02632721|560881997|FG000|Overall Study|Inadequate clinical condition|0|||
155394988|NCT02632721|560881998|FG001|Overall Study|Inadequate clinical condition|0|||
155394989|NCT02632721|560881999|FG002|Overall Study|Inadequate clinical condition|0|||
155394990|NCT02632721|560882000|FG003|Overall Study|Inadequate clinical condition|0|||
155394991|NCT02632721|560882001|FG004|Overall Study|Inadequate clinical condition|1|||
155394992|NCT02632721|560881997|FG000|Overall Study|No meet eligibility|0|||
155394993|NCT02632721|560881998|FG001|Overall Study|No meet eligibility|0|||
155394994|NCT02632721|560881999|FG002|Overall Study|No meet eligibility|0|||
155394995|NCT02632721|560882000|FG003|Overall Study|No meet eligibility|0|||
155394996|NCT02632721|560882001|FG004|Overall Study|No meet eligibility|1|||
155394997|NCT02632721|560881997|FG000|Overall Study|Allergic reaction|0|||
155394998|NCT02632721|560881998|FG001|Overall Study|Allergic reaction|0|||
155394999|NCT02632721|560881999|FG002|Overall Study|Allergic reaction|0|||
155395000|NCT02632721|560882000|FG003|Overall Study|Allergic reaction|1|||
155395001|NCT02632721|560882001|FG004|Overall Study|Allergic reaction|0|||
155395002|NCT02632721|560881997|FG000|Overall Study|Receiving Decitabine locally|0|||
155395003|NCT02632721|560881998|FG001|Overall Study|Receiving Decitabine locally|0|||
155395004|NCT02632721|560881999|FG002|Overall Study|Receiving Decitabine locally|1|||
155395005|NCT02632721|560882000|FG003|Overall Study|Receiving Decitabine locally|0|||
155395006|NCT02632721|560882001|FG004|Overall Study|Receiving Decitabine locally|0|||
155395007|NCT02632721|560881997|FG000|Overall Study|No benefit from study treatment|1|||
155395008|NCT02632721|560881998|FG001|Overall Study|No benefit from study treatment|1|||
155395009|NCT02632721|560881999|FG002|Overall Study|No benefit from study treatment|0|||
155395010|NCT02632721|560882000|FG003|Overall Study|No benefit from study treatment|0|||
155395011|NCT02632721|560882001|FG004|Overall Study|No benefit from study treatment|1|||
155741222|NCT02059291|562154812|FG012|Epoch 3|Adverse Event|0|||
155741223|NCT02059291|562154813|FG013|Epoch 3|Adverse Event|0|||
155395012|NCT02632721|560881997|FG000|Overall Study|Patient wish for other treatment|0|||
155395013|NCT02632721|560881998|FG001|Overall Study|Patient wish for other treatment|1|||
155395014|NCT02632721|560881999|FG002|Overall Study|Patient wish for other treatment|0|||
155741224|NCT02059291|562154814|FG014|Epoch 3|Adverse Event|0|||
155395015|NCT02632721|560882000|FG003|Overall Study|Patient wish for other treatment|0|||
155395016|NCT02632721|560882001|FG004|Overall Study|Patient wish for other treatment|0|||
155395017|NCT02632721|560881997|FG000|Overall Study|Relapsed Pneumonia|0|||
155741225|NCT02059291|562154815|FG015|Epoch 3|Adverse Event|1|||
155741226|NCT02059291|562154816|FG016|Epoch 3|Adverse Event|0|||
155395018|NCT02632721|560881998|FG001|Overall Study|Relapsed Pneumonia|0|||
155395019|NCT02632721|560881999|FG002|Overall Study|Relapsed Pneumonia|0|||
155395020|NCT02632721|560882000|FG003|Overall Study|Relapsed Pneumonia|0|||
155395021|NCT02632721|560882001|FG004|Overall Study|Relapsed Pneumonia|1|||
155395022|NCT02632721|560881997|FG000|Overall Study|Therapy refractory AML|0|||
155395023|NCT02632721|560881998|FG001|Overall Study|Therapy refractory AML|0|||
155395024|NCT02632721|560881999|FG002|Overall Study|Therapy refractory AML|0|||
155395025|NCT02632721|560882000|FG003|Overall Study|Therapy refractory AML|0|||
155395026|NCT02632721|560882001|FG004|Overall Study|Therapy refractory AML|1|||
155395027|NCT02632721|560881997|FG000|Overall Study|Increase of white blood cell count|0|||
155395028|NCT02632721|560881998|FG001|Overall Study|Increase of white blood cell count|0|||
155395029|NCT02632721|560881999|FG002|Overall Study|Increase of white blood cell count|0|||
155395030|NCT02632721|560882000|FG003|Overall Study|Increase of white blood cell count|0|||
155395031|NCT02632721|560882001|FG004|Overall Study|Increase of white blood cell count|1|||
155395032|NCT02632721|560881997|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395033|NCT02632721|560881998|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395034|NCT02632721|560881999|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
155395035|NCT02632721|560882000|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395036|NCT02632721|560882001|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395037|NCT01572675|560882002|FG000|Overall Study|End of prescribed treatment|140|||
155395038|NCT01572675|560882003|FG001|Overall Study|End of prescribed treatment|118|||
155395039|NCT01572675|560882002|FG000|Overall Study|Recovery|16|||
155395040|NCT01572675|560882003|FG001|Overall Study|Recovery|23|||
155395041|NCT01572675|560882002|FG000|Overall Study|Lack of Efficacy|31|||
155395042|NCT01572675|560882003|FG001|Overall Study|Lack of Efficacy|31|||
155395043|NCT01572675|560882002|FG000|Overall Study|Intolerance|6|||
155395044|NCT01572675|560882003|FG001|Overall Study|Intolerance|5|||
155395045|NCT01572675|560882002|FG000|Overall Study|Improved symptoms|8|||
155395046|NCT01572675|560882003|FG001|Overall Study|Improved symptoms|2|||
155395047|NCT01572675|560882002|FG000|Overall Study|Surgical intervention|3|||
155395048|NCT01572675|560882003|FG001|Overall Study|Surgical intervention|6|||
155395049|NCT01572675|560882002|FG000|Overall Study|Withdrawal by Subject|5|||
155395050|NCT01572675|560882003|FG001|Overall Study|Withdrawal by Subject|1|||
155395051|NCT01572675|560882002|FG000|Overall Study|Physician Decision|2|||
155395052|NCT01572675|560882003|FG001|Overall Study|Physician Decision|2|||
155395053|NCT01572675|560882002|FG000|Overall Study|Death unrelated to coxibs|1|||
155395054|NCT01572675|560882003|FG001|Overall Study|Death unrelated to coxibs|1|||
155395055|NCT01572675|560882002|FG000|Overall Study|Other disease detected|1|||
155395056|NCT01572675|560882003|FG001|Overall Study|Other disease detected|1|||
155395057|NCT01572675|560882002|FG000|Overall Study|Unknown reason|1|||
155395058|NCT01572675|560882003|FG001|Overall Study|Unknown reason|1|||
155395059|NCT01572675|560882002|FG000|Overall Study|Rheumatologist new evaluation|0|||
155395060|NCT01572675|560882003|FG001|Overall Study|Rheumatologist new evaluation|1|||
155395061|NCT01572675|560882002|FG000|Overall Study|Missing data|1|||
155395062|NCT01572675|560882003|FG001|Overall Study|Missing data|4|||
155395063|NCT01572675|560882002|FG000|Overall Study|Lost to Follow-up|22|||
155395064|NCT01572675|560882003|FG001|Overall Study|Lost to Follow-up|27|||
155395065|NCT03346057|560882006|FG000|Overall Study|Death|1|||
155395066|NCT03346057|560882007|FG001|Overall Study|Death|2|||
155395067|NCT03346057|560882008|FG002|Overall Study|Death|0|||
155395068|NCT03346057|560882009|FG003|Overall Study|Death|0|||
155395069|NCT03346057|560882006|FG000|Overall Study|Lost to Follow-up|0|||
155395070|NCT03346057|560882007|FG001|Overall Study|Lost to Follow-up|2|||
155395071|NCT03346057|560882008|FG002|Overall Study|Lost to Follow-up|1|||
155395072|NCT03346057|560882009|FG003|Overall Study|Lost to Follow-up|0|||
155395073|NCT03346057|560882006|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
155395074|NCT03346057|560882007|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
155395075|NCT03346057|560882008|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
155395076|NCT03346057|560882009|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
155395077|NCT03346057|560882006|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
155395078|NCT03346057|560882007|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
155395079|NCT03346057|560882008|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
155395080|NCT03346057|560882009|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
155395081|NCT03346057|560882006|FG000|Overall Study|Physician Decision|3|||
155395082|NCT03346057|560882007|FG001|Overall Study|Physician Decision|2|||
155395083|NCT03346057|560882008|FG002|Overall Study|Physician Decision|0|||
155635776|NCT02472353|561759350|FG000|Overall Study|Study Termination|1|||
155635777|NCT02472353|561759351|FG001|Overall Study|Study Termination|4|||
155635778|NCT02313155|561759356|FG000|Overall Study|Lost to Follow-up|0|||
155635779|NCT02313155|561759357|FG001|Overall Study|Lost to Follow-up|1|||
155635780|NCT03822416|561759362|FG000|Overall Study|Lost to Follow-up|1|||
155635781|NCT03822416|561759363|FG001|Overall Study|Lost to Follow-up|0|||
155635782|NCT03822416|561759362|FG000|Overall Study|Withdrawal by Subject|0|||
155395084|NCT03346057|560882009|FG003|Overall Study|Physician Decision|2|||
155395085|NCT03346057|560882006|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
155635783|NCT03822416|561759363|FG001|Overall Study|Withdrawal by Subject|1|||
155395086|NCT03346057|560882007|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
155395087|NCT03346057|560882008|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
155395088|NCT03346057|560882009|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
155395089|NCT03346057|560882006|FG000|Overall Study|Withdrawal by Subject|1|||
155395090|NCT03346057|560882007|FG001|Overall Study|Withdrawal by Subject|0|||
155395091|NCT03346057|560882008|FG002|Overall Study|Withdrawal by Subject|0|||
155395092|NCT03346057|560882009|FG003|Overall Study|Withdrawal by Subject|0|||
155395093|NCT02921269|560882010|FG000|Overall Study|Did not complete DLT period|1|||
155395094|NCT01326728|560882011|FG000|Overall Study|Death|13|||
155395095|NCT01326728|560882012|FG001|Overall Study|Death|0|||
155395096|NCT01326728|560882011|FG000|Overall Study|Early closure of study|34|||
155395097|NCT01326728|560882012|FG001|Overall Study|Early closure of study|9|||
155395098|NCT01184053|560882013|FG000|Overall Study|progression while on treatment|3|||
155395099|NCT02536755|560882017|FG000|Overall Study|Adverse Event|4|||
155395100|NCT02301936|560882018|FG000|Overall Study|Lost to Follow-up|1|||
155395101|NCT02301936|560882019|FG001|Overall Study|Lost to Follow-up|0|||
155395102|NCT03065023|560882020|FG000|Overall Study|Progressive Disease|0|||
155395103|NCT03065023|560882021|FG001|Overall Study|Progressive Disease|1|||
155395104|NCT03065023|560882022|FG002|Overall Study|Progressive Disease|0|||
155395105|NCT03065023|560882023|FG003|Overall Study|Progressive Disease|0|||
155395106|NCT03065023|560882024|FG004|Overall Study|Progressive Disease|0|||
155395107|NCT03065023|560882020|FG000|Overall Study|Death|2|||
155395108|NCT03065023|560882021|FG001|Overall Study|Death|0|||
155395109|NCT03065023|560882022|FG002|Overall Study|Death|1|||
155395110|NCT03065023|560882023|FG003|Overall Study|Death|1|||
155395111|NCT03065023|560882024|FG004|Overall Study|Death|0|||
155395112|NCT03065023|560882020|FG000|Overall Study|Lost to Follow-up|0|||
155395113|NCT03065023|560882021|FG001|Overall Study|Lost to Follow-up|1|||
155395114|NCT03065023|560882022|FG002|Overall Study|Lost to Follow-up|0|||
155395115|NCT03065023|560882023|FG003|Overall Study|Lost to Follow-up|0|||
155395116|NCT03065023|560882024|FG004|Overall Study|Lost to Follow-up|0|||
155395117|NCT03065023|560882020|FG000|Overall Study|Participant Decision|0|||
155395118|NCT03065023|560882021|FG001|Overall Study|Participant Decision|0|||
155395119|NCT03065023|560882022|FG002|Overall Study|Participant Decision|0|||
155395120|NCT03065023|560882023|FG003|Overall Study|Participant Decision|1|||
155395121|NCT03065023|560882024|FG004|Overall Study|Participant Decision|0|||
155395122|NCT03065023|560882020|FG000|Overall Study|Withdrawal by Subject|0|||
155395123|NCT03065023|560882021|FG001|Overall Study|Withdrawal by Subject|0|||
155395124|NCT03065023|560882022|FG002|Overall Study|Withdrawal by Subject|0|||
155395125|NCT03065023|560882023|FG003|Overall Study|Withdrawal by Subject|1|||
155395126|NCT03065023|560882024|FG004|Overall Study|Withdrawal by Subject|0|||
155395127|NCT01102803|560882025|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
155395128|NCT01102803|560882026|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
155395129|NCT01102803|560882025|FG000|Post to Follow-Up|Lost to Follow-up|1|||
155395130|NCT01102803|560882026|FG001|Post to Follow-Up|Lost to Follow-up|3|||
155395131|NCT01667107|560882027|FG000|Overall Study|Adverse Event|4|||
155395132|NCT01667107|560882028|FG001|Overall Study|Adverse Event|3|||
155395133|NCT01667107|560882027|FG000|Overall Study|Tolerability issues|0|||
155395134|NCT01667107|560882028|FG001|Overall Study|Tolerability issues|2|||
155395135|NCT01667107|560882027|FG000|Overall Study|Protocol Violation|0|||
155395136|NCT01667107|560882028|FG001|Overall Study|Protocol Violation|1|||
155395137|NCT01667107|560882027|FG000|Overall Study|Lack of Efficacy|0|||
155395138|NCT01667107|560882028|FG001|Overall Study|Lack of Efficacy|1|||
155395139|NCT03427125|560882029|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
155395140|NCT03427125|560882030|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
155395141|NCT03427125|560882031|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
155395142|NCT02281357|560882032|FG000|Overall Study|Adverse Event|2|||
155741227|NCT02059291|562154817|FG017|Epoch 3|Adverse Event|0|||
155741228|NCT02059291|562154818|FG018|Epoch 3|Adverse Event|0|||
155741229|NCT02059291|562154819|FG019|Epoch 3|Adverse Event|0|||
155395143|NCT02281357|560882033|FG001|Overall Study|Adverse Event|1|||
155395144|NCT02281357|560882032|FG000|Overall Study|Lost to Follow-up|1|||
155395145|NCT02281357|560882033|FG001|Overall Study|Lost to Follow-up|0|||
155395146|NCT02281357|560882032|FG000|Overall Study|Withdrawal by Subject|4|||
155395147|NCT02281357|560882033|FG001|Overall Study|Withdrawal by Subject|3|||
155395148|NCT01162239|560882034|FG000|Treatment Phase|Withdrawal by Subject|1|||
155395149|NCT01162239|560882035|FG001|Treatment Phase|Withdrawal by Subject|3|||
155395150|NCT01162239|560882036|FG002|Treatment Phase|Withdrawal by Subject|2|||
155395151|NCT01162239|560882037|FG003|Treatment Phase|Withdrawal by Subject|3|||
155395152|NCT01162239|560882034|FG000|Treatment Phase|Death|0|||
155395153|NCT01162239|560882035|FG001|Treatment Phase|Death|0|||
155395154|NCT01162239|560882036|FG002|Treatment Phase|Death|0|||
155395155|NCT01162239|560882037|FG003|Treatment Phase|Death|1|||
155395156|NCT01162239|560882034|FG000|Treatment Phase|Lost to Follow-up|5|||
155395157|NCT01162239|560882035|FG001|Treatment Phase|Lost to Follow-up|4|||
155395158|NCT01162239|560882036|FG002|Treatment Phase|Lost to Follow-up|2|||
155395159|NCT01162239|560882037|FG003|Treatment Phase|Lost to Follow-up|1|||
155741230|NCT02059291|562154820|FG020|Epoch 3|Adverse Event|0|||
155395160|NCT01162239|560882034|FG000|Extended Follow-up|Lost to Follow-up|8|||
155395161|NCT01162239|560882035|FG001|Extended Follow-up|Lost to Follow-up|13|||
155395162|NCT01162239|560882036|FG002|Extended Follow-up|Lost to Follow-up|8|||
155395163|NCT01162239|560882037|FG003|Extended Follow-up|Lost to Follow-up|6|||
155395164|NCT02733185|560882040|FG000|Overall Study|Withdrawal by Subject|12|||
155395165|NCT02733185|560882041|FG001|Overall Study|Withdrawal by Subject|10|||
155395166|NCT02733185|560882042|FG002|Overall Study|Withdrawal by Subject|17|||
155395167|NCT02733185|560882043|FG003|Overall Study|Withdrawal by Subject|21|||
155395168|NCT02733185|560882040|FG000|Overall Study|Death|46|||
155395169|NCT02733185|560882041|FG001|Overall Study|Death|34|||
155395170|NCT02733185|560882042|FG002|Overall Study|Death|35|||
155395171|NCT02733185|560882043|FG003|Overall Study|Death|43|||
155395172|NCT02733185|560882040|FG000|Overall Study|Lost to Follow-up|17|||
155395173|NCT02733185|560882041|FG001|Overall Study|Lost to Follow-up|18|||
155395174|NCT02733185|560882042|FG002|Overall Study|Lost to Follow-up|16|||
155395175|NCT02733185|560882043|FG003|Overall Study|Lost to Follow-up|11|||
155395176|NCT01810016|560882044|FG000|Overall Study|Progressive disease|1|||
155395177|NCT01810016|560882045|FG001|Overall Study|Progressive disease|1|||
155395178|NCT01810016|560882046|FG002|Overall Study|Progressive disease|0|||
155395179|NCT01810016|560882044|FG000|Overall Study|Death|0|||
155395180|NCT01810016|560882045|FG001|Overall Study|Death|0|||
155395181|NCT01810016|560882046|FG002|Overall Study|Death|1|||
155395182|NCT04572854|560882047|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
155395183|NCT04572854|560882048|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
155395184|NCT04572854|560882049|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
155395185|NCT04572854|560882050|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
155395186|NCT04572854|560882047|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395187|NCT04572854|560882048|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395188|NCT04572854|560882049|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
155395189|NCT04572854|560882050|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395190|NCT07052682|560882053|FG000|Overall Study|Withdrawal by Subject|4|||
155395191|NCT06950879|560882054|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
155395192|NCT02246582|560883397|FG000|Overall Study|Withdrawal by Subject|3|||
155395193|NCT02246582|560883398|FG001|Overall Study|Withdrawal by Subject|4|||
155395194|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
155395195|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
155395196|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
155395197|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
155395198|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
155395199|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
155395200|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
155395201|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
155395202|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
155395203|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
155395204|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
155395205|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
155395206|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
155395207|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
155395208|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
155395209|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
155395210|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
155395211|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
155395212|NCT03441334|560883403|FG000|Overall Study|Withdrawal by Subject|1|||
155395213|NCT03441334|560883404|FG001|Overall Study|Withdrawal by Subject|0|||
155395214|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
155395215|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
155395216|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Adverse Event|14|||
155395217|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Adverse Event|19|||
155395218|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Death|11|||
155395219|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Death|12|||
155395220|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
155395221|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
155395222|NCT00088907|560883405|FG000|Randomized Study (Step 1)|complicating disease|3|||
155395223|NCT00088907|560883406|FG001|Randomized Study (Step 1)|complicating disease|1|||
155395224|NCT00088907|560883405|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
155395225|NCT00088907|560883406|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
155395226|NCT00088907|560883405|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
155395227|NCT00088907|560883406|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
155635784|NCT04666298|561759364|FG000|Overall Study|Subject decision|1|||
155635785|NCT04666298|561759365|FG001|Overall Study|Subject decision|0|||
155635786|NCT04666298|561759366|FG002|Overall Study|Subject decision|0|||
155635787|NCT04666298|561759367|FG003|Overall Study|Subject decision|2|||
155395228|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
155395229|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
155395230|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
155395231|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
155395232|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
155395233|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
155395234|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
155395235|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
155395236|NCT00682448|560883413|FG000|Overall Study|Adverse Event|1|||
155395237|NCT00682448|560883414|FG001|Overall Study|Adverse Event|2|||
155395238|NCT00682448|560883413|FG000|Overall Study|Lack of Efficacy|1|||
155395239|NCT00682448|560883414|FG001|Overall Study|Lack of Efficacy|0|||
155395240|NCT00682448|560883413|FG000|Overall Study|Lost to Follow-up|1|||
155395241|NCT00682448|560883414|FG001|Overall Study|Lost to Follow-up|3|||
155395242|NCT00682448|560883413|FG000|Overall Study|Pregnancy|0|||
155395243|NCT00682448|560883414|FG001|Overall Study|Pregnancy|1|||
155395244|NCT00682448|560883413|FG000|Overall Study|Withdrawal by Subject|2|||
155395245|NCT00682448|560883414|FG001|Overall Study|Withdrawal by Subject|0|||
155395246|NCT00257166|560883418|FG000|Overall Study|Adverse Event|18|||
155395247|NCT00257166|560883419|FG001|Overall Study|Adverse Event|13|||
155395248|NCT00257166|560883418|FG000|Overall Study|Laboratory abnormality|1|||
155395249|NCT00257166|560883419|FG001|Overall Study|Laboratory abnormality|0|||
155395250|NCT00257166|560883418|FG000|Overall Study|Lost to Follow-up|8|||
155395251|NCT00257166|560883419|FG001|Overall Study|Lost to Follow-up|1|||
155395252|NCT00257166|560883418|FG000|Overall Study|Withdrawal by Subject|9|||
155395253|NCT00257166|560883419|FG001|Overall Study|Withdrawal by Subject|2|||
155395254|NCT00257166|560883418|FG000|Overall Study|Other|16|||
155395255|NCT00257166|560883419|FG001|Overall Study|Other|21|||
155395256|NCT00257166|560883418|FG000|Overall Study|Randomized, but not treated|1|||
155395257|NCT00257166|560883419|FG001|Overall Study|Randomized, but not treated|0|||
155395258|NCT00525044|560883420|FG000|Overall Study|Lost to Follow-up|0|||
155395259|NCT00525044|560883421|FG001|Overall Study|Lost to Follow-up|1|||
155395260|NCT02553265|560883422|FG000|Enrollment|Death|0|||
155395261|NCT02553265|560883423|FG001|Enrollment|Death|0|||
155395262|NCT02553265|560883424|FG002|Enrollment|Death|1|||
155395263|NCT02553265|560883422|FG000|First Intervention (28 Days)|Adverse Event|1|||
155395264|NCT02553265|560883423|FG001|First Intervention (28 Days)|Adverse Event|0|||
155395265|NCT02553265|560883424|FG002|First Intervention (28 Days)|Adverse Event|0|||
155395266|NCT02553265|560883422|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
155395267|NCT02553265|560883423|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
155395268|NCT02553265|560883424|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
155395269|NCT02553265|560883422|FG000|Second Intervention (28 Days)|Adverse Event|1|||
155395270|NCT02553265|560883423|FG001|Second Intervention (28 Days)|Adverse Event|0|||
155395271|NCT02553265|560883424|FG002|Second Intervention (28 Days)|Adverse Event|0|||
155395272|NCT02553265|560883422|FG000|Third Intervention (28 Days)|Adverse Event|1|||
155395273|NCT02553265|560883423|FG001|Third Intervention (28 Days)|Adverse Event|0|||
155395274|NCT02553265|560883424|FG002|Third Intervention (28 Days)|Adverse Event|0|||
155395275|NCT02553265|560883422|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
155395276|NCT02553265|560883423|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
155395277|NCT02553265|560883424|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
155395278|NCT01650285|560883434|FG000|Overall Study|Adverse Event|1|||
155395279|NCT00659529|560883435|FG000|Overall Study|Withdrawal by Subject|4|||
155395280|NCT00659529|560883435|FG000|Overall Study|Protocol Violation|3|||
155395281|NCT00659529|560883435|FG000|Overall Study|Screen failure|9|||
155395282|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
155395283|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395284|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395285|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395286|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395287|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
155395288|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395289|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395290|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395291|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395292|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
155395293|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395294|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395295|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395296|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395297|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
155395298|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395299|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155435858|NCT01591330|561022970|FG002|Period 1|Adverse Event|0|||
155395300|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395301|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395302|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
155395303|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395304|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395305|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395306|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395307|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
155395308|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395309|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395310|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395311|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395312|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
155395313|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395314|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395315|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395316|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395317|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
155395318|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395319|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395320|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395321|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395322|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
155395323|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395324|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395325|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395326|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395327|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
155395328|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395329|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395330|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395331|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395332|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
155395333|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
155395334|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
155395335|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
155395336|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
155395337|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395338|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395339|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
155395340|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
155395341|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395342|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
155395343|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
155395344|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
155395345|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
155395346|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
155395347|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155395348|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
155395349|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
155395350|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
155395351|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155395352|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155635788|NCT04666298|561759364|FG000|Overall Study|Death|1|||
155635789|NCT04666298|561759365|FG001|Overall Study|Death|0|||
155635790|NCT04666298|561759366|FG002|Overall Study|Death|0|||
155635791|NCT04666298|561759367|FG003|Overall Study|Death|0|||
155635792|NCT04666298|561759364|FG000|Overall Study|Lost to Follow-up|0|||
155635793|NCT04666298|561759365|FG001|Overall Study|Lost to Follow-up|0|||
155635794|NCT04666298|561759366|FG002|Overall Study|Lost to Follow-up|0|||
155635795|NCT04666298|561759367|FG003|Overall Study|Lost to Follow-up|1|||
155635796|NCT04666298|561759364|FG000|Overall Study|Physician Decision|0|||
155741231|NCT02059291|562154821|FG021|Epoch 3|Adverse Event|0|||
155395353|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395354|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
155395355|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395356|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395357|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395358|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395359|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
155395360|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
155395361|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395362|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395363|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395364|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395365|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395366|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
155395367|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395368|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395369|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395370|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395371|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
155395372|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395373|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395374|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395375|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395376|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
155395377|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
155395378|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
155395379|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
155395380|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
155395381|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
155395382|NCT00621751|560883445|FG000|Overall Study|Adverse Event|0|||
155395383|NCT00621751|560883446|FG001|Overall Study|Adverse Event|1|||
155395384|NCT04439071|560883451|FG000|Overall Study|Lost to Follow-up|0|||
155395385|NCT04439071|560883452|FG001|Overall Study|Lost to Follow-up|3|||
155395386|NCT04439071|560883451|FG000|Overall Study|Withdrawal by Subject|3|||
155395387|NCT04439071|560883452|FG001|Overall Study|Withdrawal by Subject|8|||
155395388|NCT04439071|560883451|FG000|Overall Study|Death|6|||
155395389|NCT04439071|560883452|FG001|Overall Study|Death|4|||
155395390|NCT04439071|560883451|FG000|Overall Study|Other than specified|3|||
155395391|NCT04439071|560883452|FG001|Overall Study|Other than specified|3|||
155395392|NCT04439071|560883451|FG000|Overall Study|Randomized but not treated|2|||
155395393|NCT04439071|560883452|FG001|Overall Study|Randomized but not treated|0|||
155395394|NCT00892177|560883453|FG000|Phase II|Ineligible|0|||
155395395|NCT00892177|560883454|FG001|Phase II|Ineligible|0|||
155395396|NCT00892177|560883455|FG002|Phase II|Ineligible|0|||
155395397|NCT00892177|560883456|FG003|Phase II|Ineligible|0|||
155395398|NCT00892177|560883457|FG004|Phase II|Ineligible|1|||
155395399|NCT00892177|560883458|FG005|Phase II|Ineligible|1|||
155395400|NCT00892177|560883453|FG000|Phase II|Withdrawal by Subject|0|||
155395401|NCT00892177|560883454|FG001|Phase II|Withdrawal by Subject|0|||
155395402|NCT00892177|560883455|FG002|Phase II|Withdrawal by Subject|0|||
155395403|NCT00892177|560883456|FG003|Phase II|Withdrawal by Subject|0|||
155395404|NCT00892177|560883457|FG004|Phase II|Withdrawal by Subject|4|||
155395405|NCT00892177|560883458|FG005|Phase II|Withdrawal by Subject|1|||
155395406|NCT05097716|560883459|FG000|Period 1|Adverse Event|1|||
155395407|NCT05097716|560883459|FG000|Period 1|Close contact with highly-transmissible infection|1|||
155395408|NCT01949155|560883460|FG000|Overall Study|Lost to Follow-up|1|||
155395409|NCT01949155|560883461|FG001|Overall Study|Lost to Follow-up|0|||
155635797|NCT04666298|561759365|FG001|Overall Study|Physician Decision|0|||
155635798|NCT04666298|561759366|FG002|Overall Study|Physician Decision|0|||
155635799|NCT04666298|561759367|FG003|Overall Study|Physician Decision|1|||
155635800|NCT04666298|561759364|FG000|Overall Study|Protocol deviation|0|||
155635801|NCT04666298|561759365|FG001|Overall Study|Protocol deviation|0|||
155635802|NCT04666298|561759366|FG002|Overall Study|Protocol deviation|1|||
155635803|NCT04666298|561759367|FG003|Overall Study|Protocol deviation|0|||
155635804|NCT00844519|561759370|FG000|Overall Study|Withdrawal by Subject|1|||
155635805|NCT00844519|561759371|FG001|Overall Study|Withdrawal by Subject|1|||
155635806|NCT00844519|561759370|FG000|Overall Study|Adverse Event|1|||
155635807|NCT00844519|561759371|FG001|Overall Study|Adverse Event|0|||
155635808|NCT01341470|561759372|FG000|Overall Study|Sponsor decision|0|||
155635809|NCT01341470|561759373|FG001|Overall Study|Sponsor decision|0|||
155635810|NCT01341470|561759374|FG002|Overall Study|Sponsor decision|1|||
155635811|NCT01341470|561759375|FG003|Overall Study|Sponsor decision|1|||
155635812|NCT01341470|561759376|FG004|Overall Study|Sponsor decision|0|||
155635813|NCT01341470|561759377|FG005|Overall Study|Sponsor decision|1|||
155650626|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Death|0|||
155395410|NCT01949155|560883460|FG000|Overall Study|Protocol Violation|1|||
155395411|NCT01949155|560883461|FG001|Overall Study|Protocol Violation|0|||
155395412|NCT00800436|560883470|FG000|Overall Study|Withdrawal by Subject|0|||
155395413|NCT00800436|560883471|FG001|Overall Study|Withdrawal by Subject|0|||
155395414|NCT00800436|560883472|FG002|Overall Study|Withdrawal by Subject|1|||
155395415|NCT00800436|560883473|FG003|Overall Study|Withdrawal by Subject|1|||
155395416|NCT00800436|560883474|FG004|Overall Study|Withdrawal by Subject|0|||
155395417|NCT00800436|560883475|FG005|Overall Study|Withdrawal by Subject|0|||
155635814|NCT03188822|561759381|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
155635815|NCT03188822|561759381|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
155635816|NCT02340949|561759382|FG000|Overall Study|Adverse Event|4|||
155635817|NCT02340949|561759383|FG001|Overall Study|Adverse Event|2|||
155635818|NCT02340949|561759382|FG000|Overall Study|Withdrawal by Subject|2|||
155635819|NCT02340949|561759383|FG001|Overall Study|Withdrawal by Subject|0|||
155635820|NCT02340949|561759382|FG000|Overall Study|Progression disease|6|||
155635821|NCT02340949|561759383|FG001|Overall Study|Progression disease|2|||
155635822|NCT02340949|561759382|FG000|Overall Study|Death|3|||
155635823|NCT02340949|561759383|FG001|Overall Study|Death|0|||
155635824|NCT02340949|561759382|FG000|Overall Study|Physician Decision|1|||
155635825|NCT02340949|561759383|FG001|Overall Study|Physician Decision|0|||
155635826|NCT00296517|561759384|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
155635827|NCT00296517|561759385|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
155635828|NCT00296517|561759384|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
155635829|NCT00296517|561759385|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
155635830|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
155635831|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
155635832|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
155635833|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
155635834|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
155635835|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
155635836|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
155635837|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
155635838|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
155635839|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
155635840|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
155635841|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
155635842|NCT00296517|561759384|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
155635843|NCT00296517|561759385|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
155635844|NCT01143324|561759391|FG000|Overall Study|Lost to Follow-up|11|||
155635845|NCT01143324|561759391|FG000|Overall Study|Withdrawal by Subject|4|||
155635846|NCT01143324|561759391|FG000|Overall Study|Explant of the device|4|||
155635847|NCT00596635|561759392|FG000|Overall Study|Lost to Follow-up|0|||
155635848|NCT00596635|561759393|FG001|Overall Study|Lost to Follow-up|2|||
155635849|NCT00596635|561759394|FG002|Overall Study|Lost to Follow-up|0|||
155635850|NCT00596635|561759392|FG000|Overall Study|Treatment for symptomatic UTI|4|||
155635851|NCT00596635|561759393|FG001|Overall Study|Treatment for symptomatic UTI|6|||
155635852|NCT00596635|561759394|FG002|Overall Study|Treatment for symptomatic UTI|3|||
155635853|NCT00596635|561759392|FG000|Overall Study|Hip fracture|2|||
155635854|NCT00596635|561759393|FG001|Overall Study|Hip fracture|3|||
155635855|NCT00596635|561759394|FG002|Overall Study|Hip fracture|3|||
155635856|NCT00596635|561759392|FG000|Overall Study|Could not provide urine specimen|1|||
155635857|NCT00596635|561759393|FG001|Overall Study|Could not provide urine specimen|2|||
155635858|NCT00596635|561759394|FG002|Overall Study|Could not provide urine specimen|2|||
155635859|NCT01850641|561759400|FG000|Overall Study|Physician Decision|1|||
155635860|NCT01850641|561759400|FG000|Overall Study|Decrease in serum phosphorus|1|||
155635861|NCT01850641|561759400|FG000|Overall Study|Decrease in serum calcium|2|||
155635862|NCT01850641|561759400|FG000|Overall Study|Increase in serum ferritin|1|||
155635863|NCT00141817|561759401|FG000|Overall Study|Protocol Violation|0|||
155635864|NCT00141817|561759402|FG001|Overall Study|Protocol Violation|0|||
155635865|NCT00141817|561759403|FG002|Overall Study|Protocol Violation|1|||
155635866|NCT00141817|561759404|FG003|Overall Study|Protocol Violation|0|||
155635867|NCT00141817|561759401|FG000|Overall Study|Parent request|1|||
155635868|NCT00141817|561759402|FG001|Overall Study|Parent request|0|||
155635869|NCT00141817|561759403|FG002|Overall Study|Parent request|0|||
155635870|NCT00141817|561759404|FG003|Overall Study|Parent request|0|||
155635871|NCT00846365|561759405|FG000|Overall Study|Adverse Event|20|||
155635872|NCT00846365|561759406|FG001|Overall Study|Adverse Event|30|||
155635873|NCT00846365|561759407|FG002|Overall Study|Adverse Event|11|||
155635874|NCT00846365|561759405|FG000|Overall Study|Protocol Violation|5|||
155635875|NCT00846365|561759406|FG001|Overall Study|Protocol Violation|4|||
155635876|NCT00846365|561759407|FG002|Overall Study|Protocol Violation|0|||
155635877|NCT00846365|561759405|FG000|Overall Study|Lost to Follow-up|8|||
155635878|NCT00846365|561759406|FG001|Overall Study|Lost to Follow-up|2|||
155395418|NCT00800436|560883476|FG006|Overall Study|Withdrawal by Subject|0|||
155395419|NCT00711529|560883483|FG000|Overall Study|Protocol Violation|2|||
155395420|NCT00711529|560883484|FG001|Overall Study|Protocol Violation|0|||
155635879|NCT00846365|561759407|FG002|Overall Study|Lost to Follow-up|5|||
155635880|NCT00846365|561759405|FG000|Overall Study|Withdrawal by Subject|11|||
155635881|NCT00846365|561759406|FG001|Overall Study|Withdrawal by Subject|11|||
155635882|NCT00846365|561759407|FG002|Overall Study|Withdrawal by Subject|9|||
155635883|NCT00846365|561759405|FG000|Overall Study|Pregnancy|1|||
155635884|NCT00846365|561759406|FG001|Overall Study|Pregnancy|0|||
155635885|NCT00846365|561759407|FG002|Overall Study|Pregnancy|0|||
155635886|NCT00846365|561759405|FG000|Overall Study|Lack of Efficacy|1|||
155635887|NCT00846365|561759406|FG001|Overall Study|Lack of Efficacy|1|||
155635888|NCT00846365|561759407|FG002|Overall Study|Lack of Efficacy|2|||
155635889|NCT00846365|561759405|FG000|Overall Study|Other|9|||
155635890|NCT00846365|561759406|FG001|Overall Study|Other|1|||
155635891|NCT00846365|561759407|FG002|Overall Study|Other|6|||
155635892|NCT01277861|561759417|FG000|Overall Study|Physician Decision|2|||
155635893|NCT01277861|561759418|FG001|Overall Study|Physician Decision|2|||
155635894|NCT05032196|561759419|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155635895|NCT05032196|561759420|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
155635896|NCT05032196|561759421|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155635897|NCT05032196|561759422|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155635898|NCT05032196|561759423|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155635899|NCT05032196|561759424|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155635900|NCT05032196|561759419|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155635901|NCT05032196|561759420|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155635902|NCT05032196|561759421|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155635903|NCT05032196|561759422|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
155635904|NCT05032196|561759423|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155635905|NCT05032196|561759424|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155635906|NCT05032196|561759419|FG000|Period 2 (Multidose)|Physician Decision|0|||
155635907|NCT05032196|561759420|FG001|Period 2 (Multidose)|Physician Decision|0|||
155635908|NCT05032196|561759421|FG002|Period 2 (Multidose)|Physician Decision|0|||
155635909|NCT05032196|561759422|FG003|Period 2 (Multidose)|Physician Decision|0|||
155635910|NCT05032196|561759423|FG004|Period 2 (Multidose)|Physician Decision|1|||
155635911|NCT05032196|561759424|FG005|Period 2 (Multidose)|Physician Decision|0|||
155635912|NCT00857389|561759425|FG000|Overall Study|Did not proceed to transplant|2|||
155635913|NCT05260008|561759426|FG000|Overall Study|Physician Decision|0|||
155635914|NCT05260008|561759427|FG001|Overall Study|Physician Decision|1|||
155635915|NCT05260008|561759428|FG002|Overall Study|Physician Decision|0|||
155635916|NCT05260008|561759429|FG003|Overall Study|Physician Decision|0|||
155635917|NCT04584788|561759433|FG000|Overall Study|Physician Decision|8|||
155635918|NCT04584788|561759433|FG000|Overall Study|Withdrawal by Subject|1|||
155635919|NCT04584788|561759433|FG000|Overall Study|Adverse Event|3|||
155635920|NCT04284774|561759435|FG000|Overall Study|Progressive disease|5|||
155650627|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
155650628|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
155650629|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
155650630|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
155283781|NCT01823341|560470848|FG000|Overall Study|Withdrawal by Subject|7|||
155283782|NCT01823341|560470848|FG000|Overall Study|Adverse Event|1|||
155283783|NCT00689104|560470850|FG000|Overall Study|Eligibility criterion not met|5|||
155283784|NCT00689104|560470851|FG001|Overall Study|Eligibility criterion not met|8|||
155283785|NCT00689104|560470852|FG002|Overall Study|Eligibility criterion not met|0|||
155283786|NCT00689104|560470853|FG003|Overall Study|Eligibility criterion not met|4|||
155283787|NCT00689104|560470850|FG000|Overall Study|Adverse Event|13|||
155283788|NCT00689104|560470851|FG001|Overall Study|Adverse Event|25|||
155283789|NCT00689104|560470852|FG002|Overall Study|Adverse Event|16|||
155283790|NCT00689104|560470853|FG003|Overall Study|Adverse Event|24|||
155283791|NCT00689104|560470850|FG000|Overall Study|Lack of Efficacy|5|||
155283792|NCT00689104|560470851|FG001|Overall Study|Lack of Efficacy|6|||
155283793|NCT00689104|560470852|FG002|Overall Study|Lack of Efficacy|2|||
155283794|NCT00689104|560470853|FG003|Overall Study|Lack of Efficacy|3|||
155283795|NCT00689104|560470850|FG000|Overall Study|Withdrawal by Subject|12|||
155283796|NCT00689104|560470851|FG001|Overall Study|Withdrawal by Subject|11|||
155283797|NCT00689104|560470852|FG002|Overall Study|Withdrawal by Subject|18|||
155283798|NCT00689104|560470853|FG003|Overall Study|Withdrawal by Subject|11|||
155283799|NCT00689104|560470850|FG000|Overall Study|Lost to Follow-up|4|||
155283800|NCT00689104|560470851|FG001|Overall Study|Lost to Follow-up|3|||
155283801|NCT00689104|560470852|FG002|Overall Study|Lost to Follow-up|2|||
155283802|NCT00689104|560470853|FG003|Overall Study|Lost to Follow-up|5|||
155283803|NCT00689104|560470850|FG000|Overall Study|Protocol Violation|2|||
155283804|NCT00689104|560470851|FG001|Overall Study|Protocol Violation|3|||
155283805|NCT00689104|560470852|FG002|Overall Study|Protocol Violation|5|||
155283806|NCT00689104|560470853|FG003|Overall Study|Protocol Violation|3|||
155283807|NCT00689104|560470850|FG000|Overall Study|Randomized but never received study drug|2|||
155283808|NCT00689104|560470851|FG001|Overall Study|Randomized but never received study drug|1|||
155283809|NCT00689104|560470852|FG002|Overall Study|Randomized but never received study drug|1|||
155395421|NCT00711529|560883483|FG000|Overall Study|Withdrawal by Subject|2|||
155395422|NCT00711529|560883484|FG001|Overall Study|Withdrawal by Subject|6|||
155395423|NCT01177384|560883490|FG000|Overall Study|Adverse Event|6|||
155395424|NCT01177384|560883491|FG001|Overall Study|Adverse Event|4|||
155395425|NCT01177384|560883490|FG000|Overall Study|Lack of Efficacy|0|||
155395426|NCT01177384|560883491|FG001|Overall Study|Lack of Efficacy|1|||
155395427|NCT01177384|560883490|FG000|Overall Study|Lost to Follow-up|3|||
155395428|NCT01177384|560883491|FG001|Overall Study|Lost to Follow-up|4|||
155395429|NCT01177384|560883490|FG000|Overall Study|Physician Decision|0|||
155395430|NCT01177384|560883491|FG001|Overall Study|Physician Decision|3|||
155395431|NCT01177384|560883490|FG000|Overall Study|Protocol Violation|0|||
155395432|NCT01177384|560883491|FG001|Overall Study|Protocol Violation|2|||
155395433|NCT01177384|560883490|FG000|Overall Study|Withdrawal by Subject|5|||
155395434|NCT01177384|560883491|FG001|Overall Study|Withdrawal by Subject|12|||
155395435|NCT03606980|560883492|FG000|Overall Study|Lost to Follow-up|3|||
155395436|NCT03606980|560883493|FG001|Overall Study|Lost to Follow-up|2|||
155395437|NCT03606980|560883494|FG002|Overall Study|Lost to Follow-up|3|||
155395438|NCT03606980|560883492|FG000|Overall Study|Withdrawal by Subject|1|||
155395439|NCT03606980|560883493|FG001|Overall Study|Withdrawal by Subject|0|||
155395440|NCT03606980|560883494|FG002|Overall Study|Withdrawal by Subject|4|||
155395441|NCT01849497|560883495|FG000|Overall Study|Withdrawal by Subject|1|||
155395442|NCT01849497|560883496|FG001|Overall Study|Withdrawal by Subject|2|||
155395443|NCT01849497|560883495|FG000|Overall Study|Sponsor Decision|0|||
155395444|NCT01849497|560883496|FG001|Overall Study|Sponsor Decision|1|||
155395445|NCT01849497|560883495|FG000|Overall Study|Lost to Follow-up|0|||
155395446|NCT01849497|560883496|FG001|Overall Study|Lost to Follow-up|1|||
155395447|NCT03044886|560883497|FG000|Overall Study|Lost to Follow-up|15|||
155395448|NCT03044886|560883498|FG001|Overall Study|Lost to Follow-up|10|||
155395449|NCT03044886|560883499|FG002|Overall Study|Lost to Follow-up|12|||
155395450|NCT01174238|560883502|FG000|Overall Study|Lost to Follow-up|2|||
155395451|NCT00732251|560883506|FG000|Overall Study|Lost to Follow-up|3|||
155395452|NCT00732251|560883506|FG000|Overall Study|Withdrawal by Subject|3|||
155395453|NCT00732251|560883506|FG000|Overall Study|Early Term due to Site Closure|1|||
155395454|NCT02684279|560883509|FG000|Overall Study|Adverse Event|87|||
155395455|NCT02684279|560883509|FG000|Overall Study|Lack of Efficacy|4|||
155395456|NCT02684279|560883509|FG000|Overall Study|Lost to Follow-up|61|||
155395457|NCT02684279|560883509|FG000|Overall Study|Protocol Violation|6|||
155395458|NCT02684279|560883509|FG000|Overall Study|Pregnancy|8|||
155395459|NCT02684279|560883509|FG000|Overall Study|Withdrawal by Subject|92|||
155395460|NCT02684279|560883509|FG000|Overall Study|non-compliance with study drug|9|||
155395461|NCT02684279|560883509|FG000|Overall Study|non compliance with study visits|2|||
155395462|NCT02684279|560883509|FG000|Overall Study|subject to have surgery|1|||
155635921|NCT01240746|561760937|FG000|Overall Study|Adverse Event|2|||
155635922|NCT01240746|561760938|FG001|Overall Study|Adverse Event|0|||
155635923|NCT01240746|561760939|FG002|Overall Study|Adverse Event|10|||
155635924|NCT01240746|561760937|FG000|Overall Study|Lost to Follow-up|23|||
155635925|NCT01240746|561760938|FG001|Overall Study|Lost to Follow-up|20|||
155635926|NCT01240746|561760939|FG002|Overall Study|Lost to Follow-up|102|||
155635927|NCT01240746|561760937|FG000|Overall Study|Protocol Violation|24|||
155635928|NCT01240746|561760938|FG001|Overall Study|Protocol Violation|15|||
155635929|NCT01240746|561760939|FG002|Overall Study|Protocol Violation|72|||
155635930|NCT01240746|561760937|FG000|Overall Study|Withdrawal by Subject|10|||
155635931|NCT01240746|561760938|FG001|Overall Study|Withdrawal by Subject|13|||
155635932|NCT01240746|561760939|FG002|Overall Study|Withdrawal by Subject|59|||
155635933|NCT01137786|561760942|FG000|Overall Study|Lost to Follow-up|0|||
155635934|NCT01137786|561760943|FG001|Overall Study|Lost to Follow-up|2|||
155635935|NCT01137786|561760942|FG000|Overall Study|Withdrawal by Subject|1|||
155635936|NCT01137786|561760943|FG001|Overall Study|Withdrawal by Subject|1|||
155635937|NCT01303419|561760946|FG000|Overall Study|Discontinuation of study|60|||
155635938|NCT01303419|561760946|FG000|Overall Study|Did not complete both imaging methods|5|||
155635939|NCT01303419|561760946|FG000|Overall Study|Did not meet all I/E after screening|31|||
155635940|NCT01995201|561760947|FG000|From Baseline Until Week 24|Adverse Event|4|||
155283810|NCT00689104|560470853|FG003|Overall Study|Randomized but never received study drug|0|||
155283811|NCT00689104|560470850|FG000|Overall Study|Physician Decision|1|||
155283812|NCT00689104|560470851|FG001|Overall Study|Physician Decision|0|||
155283813|NCT00689104|560470852|FG002|Overall Study|Physician Decision|0|||
155283814|NCT00689104|560470853|FG003|Overall Study|Physician Decision|0|||
155283815|NCT00689104|560470850|FG000|Overall Study|Non-compliance with study procedures|0|||
155283816|NCT00689104|560470851|FG001|Overall Study|Non-compliance with study procedures|0|||
155283817|NCT00689104|560470852|FG002|Overall Study|Non-compliance with study procedures|1|||
155283818|NCT00689104|560470853|FG003|Overall Study|Non-compliance with study procedures|0|||
155283819|NCT00209274|560470858|FG000|Overall Study|Missed visit|3|||
155283820|NCT00209274|560470859|FG001|Overall Study|Missed visit|2|||
155283821|NCT00209274|560470858|FG000|Overall Study|Death|32|||
155283822|NCT00209274|560470859|FG001|Overall Study|Death|15|||
155283823|NCT00209274|560470858|FG000|Overall Study|Withdrawal by Subject|30|||
155283824|NCT00209274|560470859|FG001|Overall Study|Withdrawal by Subject|15|||
155395463|NCT02684279|560883509|FG000|Overall Study|family emergency|1|||
155395464|NCT02684279|560883509|FG000|Overall Study|Site closures|7|||
155395465|NCT02684279|560883509|FG000|Overall Study|Physician Decision|1|||
155395466|NCT00228566|560883510|FG000|Overall Study|Adverse Event|31|||
155395467|NCT00228566|560883510|FG000|Overall Study|Lack of Efficacy|14|||
155395468|NCT00228566|560883510|FG000|Overall Study|Lost to Follow-up|16|||
155395469|NCT00228566|560883510|FG000|Overall Study|Physician Decision|5|||
155395470|NCT00228566|560883510|FG000|Overall Study|Withdrawal by Subject|4|||
155395471|NCT00228566|560883510|FG000|Overall Study|Miscellaneous|1|||
155395472|NCT05975840|560883511|FG000|Overall Study|Other|1|||
155395473|NCT05975840|560883512|FG001|Overall Study|Other|0|||
155395474|NCT05975840|560883513|FG002|Overall Study|Other|0|||
155395475|NCT05975840|560883514|FG003|Overall Study|Other|0|||
155395476|NCT05975840|560883515|FG004|Overall Study|Other|1|||
155395477|NCT05975840|560883516|FG005|Overall Study|Other|0|||
155395478|NCT05975840|560883517|FG006|Overall Study|Other|0|||
155395479|NCT05975840|560883518|FG007|Overall Study|Other|0|||
155395480|NCT05975840|560883511|FG000|Overall Study|Lost to Follow-up|3|||
155395481|NCT05975840|560883512|FG001|Overall Study|Lost to Follow-up|6|||
155395482|NCT05975840|560883513|FG002|Overall Study|Lost to Follow-up|3|||
155395483|NCT05975840|560883514|FG003|Overall Study|Lost to Follow-up|1|||
155395484|NCT05975840|560883515|FG004|Overall Study|Lost to Follow-up|4|||
155395485|NCT05975840|560883516|FG005|Overall Study|Lost to Follow-up|1|||
155395486|NCT05975840|560883517|FG006|Overall Study|Lost to Follow-up|2|||
155395487|NCT05975840|560883518|FG007|Overall Study|Lost to Follow-up|4|||
155395488|NCT05975840|560883511|FG000|Overall Study|Migrated/moved from the study area|1|||
155395489|NCT05975840|560883512|FG001|Overall Study|Migrated/moved from the study area|0|||
155395490|NCT05975840|560883513|FG002|Overall Study|Migrated/moved from the study area|0|||
155395491|NCT05975840|560883514|FG003|Overall Study|Migrated/moved from the study area|0|||
155395492|NCT05975840|560883515|FG004|Overall Study|Migrated/moved from the study area|0|||
155395493|NCT05975840|560883516|FG005|Overall Study|Migrated/moved from the study area|0|||
155395494|NCT05975840|560883517|FG006|Overall Study|Migrated/moved from the study area|0|||
155395495|NCT05975840|560883518|FG007|Overall Study|Migrated/moved from the study area|0|||
155395496|NCT05975840|560883511|FG000|Overall Study|Withdrawal by Subject|0|||
155395497|NCT05975840|560883512|FG001|Overall Study|Withdrawal by Subject|5|||
155395498|NCT05975840|560883513|FG002|Overall Study|Withdrawal by Subject|2|||
155395499|NCT05975840|560883514|FG003|Overall Study|Withdrawal by Subject|2|||
155395500|NCT05975840|560883515|FG004|Overall Study|Withdrawal by Subject|0|||
155395501|NCT05975840|560883516|FG005|Overall Study|Withdrawal by Subject|2|||
155395502|NCT05975840|560883517|FG006|Overall Study|Withdrawal by Subject|2|||
155395503|NCT05975840|560883518|FG007|Overall Study|Withdrawal by Subject|1|||
155395504|NCT05975840|560883511|FG000|Overall Study|Protocol Violation|0|||
155395505|NCT05975840|560883512|FG001|Overall Study|Protocol Violation|1|||
155395506|NCT05975840|560883513|FG002|Overall Study|Protocol Violation|0|||
155395507|NCT05975840|560883514|FG003|Overall Study|Protocol Violation|0|||
155395508|NCT05975840|560883515|FG004|Overall Study|Protocol Violation|0|||
155395509|NCT05975840|560883516|FG005|Overall Study|Protocol Violation|0|||
155395510|NCT05975840|560883517|FG006|Overall Study|Protocol Violation|0|||
155395511|NCT05975840|560883518|FG007|Overall Study|Protocol Violation|0|||
155395512|NCT05975840|560883511|FG000|Overall Study|Adverse Event|0|||
155395513|NCT05975840|560883512|FG001|Overall Study|Adverse Event|0|||
155395514|NCT05975840|560883513|FG002|Overall Study|Adverse Event|0|||
155395515|NCT05975840|560883514|FG003|Overall Study|Adverse Event|1|||
155395516|NCT05975840|560883515|FG004|Overall Study|Adverse Event|0|||
155395517|NCT05975840|560883516|FG005|Overall Study|Adverse Event|0|||
155395518|NCT05975840|560883517|FG006|Overall Study|Adverse Event|0|||
155395519|NCT05975840|560883518|FG007|Overall Study|Adverse Event|0|||
155395520|NCT05975840|560883511|FG000|Overall Study|Death|0|||
155395521|NCT05975840|560883512|FG001|Overall Study|Death|1|||
155395522|NCT05975840|560883513|FG002|Overall Study|Death|0|||
155395523|NCT05975840|560883514|FG003|Overall Study|Death|0|||
155395524|NCT05975840|560883515|FG004|Overall Study|Death|0|||
155395525|NCT05975840|560883516|FG005|Overall Study|Death|0|||
155395526|NCT05975840|560883517|FG006|Overall Study|Death|0|||
155395527|NCT05975840|560883518|FG007|Overall Study|Death|1|||
155395528|NCT00232141|560883519|FG000|Overall Study|Adverse Event|9|||
155395529|NCT00232141|560883520|FG001|Overall Study|Adverse Event|4|||
155395530|NCT00232141|560883519|FG000|Overall Study|Lack of Efficacy|0|||
155395531|NCT00232141|560883520|FG001|Overall Study|Lack of Efficacy|3|||
155395532|NCT00232141|560883519|FG000|Overall Study|Lost to Follow-up|9|||
155395533|NCT00232141|560883520|FG001|Overall Study|Lost to Follow-up|6|||
155395534|NCT00232141|560883519|FG000|Overall Study|Other|8|||
155395535|NCT00232141|560883520|FG001|Overall Study|Other|10|||
155395536|NCT00232141|560883519|FG000|Overall Study|Withdrawal by Subject|5|||
155395537|NCT00232141|560883520|FG001|Overall Study|Withdrawal by Subject|3|||
155395538|NCT04263896|560883526|FG000|Overall Study|Withdrawal by Subject|2|||
155395539|NCT04263896|560883527|FG001|Overall Study|Withdrawal by Subject|4|||
155395540|NCT04263896|560883526|FG000|Overall Study|converted to open procedure|0|||
155395541|NCT04263896|560883527|FG001|Overall Study|converted to open procedure|1|||
155395542|NCT04263896|560883526|FG000|Overall Study|Lost to Follow-up|9|||
155395543|NCT04263896|560883527|FG001|Overall Study|Lost to Follow-up|11|||
155395544|NCT04263896|560883526|FG000|Overall Study|surveys lost in mail|5|||
155395545|NCT04263896|560883527|FG001|Overall Study|surveys lost in mail|3|||
155395546|NCT04263896|560883526|FG000|Overall Study|excluded from analysis|1|||
155395547|NCT04263896|560883527|FG001|Overall Study|excluded from analysis|0|||
155395548|NCT02060383|560884971|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
155395549|NCT02060383|560884972|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
155395550|NCT02060383|560884973|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
155395551|NCT02060383|560884974|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
155395552|NCT02060383|560884975|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
155741232|NCT02059291|562154822|FG022|Epoch 3|Adverse Event|0|||
155741233|NCT02059291|562154823|FG023|Epoch 3|Adverse Event|0|||
155741234|NCT02059291|562154824|FG024|Epoch 3|Adverse Event|0|||
155741235|NCT02059291|562154800|FG000|Epoch 3|Lack of Efficacy|0|||
155741236|NCT02059291|562154801|FG001|Epoch 3|Lack of Efficacy|0|||
155741237|NCT02059291|562154802|FG002|Epoch 3|Lack of Efficacy|0|||
155741238|NCT02059291|562154803|FG003|Epoch 3|Lack of Efficacy|0|||
155395553|NCT02060383|560884971|FG000|Core Phase|Adverse Event|2|||
155395554|NCT02060383|560884972|FG001|Core Phase|Adverse Event|0|||
155395555|NCT02060383|560884973|FG002|Core Phase|Adverse Event|0|||
155395556|NCT02060383|560884974|FG003|Core Phase|Adverse Event|2|||
155395557|NCT02060383|560884975|FG004|Core Phase|Adverse Event|6|||
155635941|NCT01995201|561760948|FG001|From Baseline Until Week 24|Adverse Event|15|||
155635942|NCT01995201|561760949|FG002|From Baseline Until Week 24|Adverse Event|0|||
155635943|NCT01995201|561760950|FG003|From Baseline Until Week 24|Adverse Event|0|||
155635944|NCT01995201|561760951|FG004|From Baseline Until Week 24|Adverse Event|0|||
155635945|NCT01995201|561760952|FG005|From Baseline Until Week 24|Adverse Event|0|||
155635946|NCT01995201|561760953|FG006|From Baseline Until Week 24|Adverse Event|0|||
155635947|NCT01995201|561760947|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635948|NCT01995201|561760948|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
155635949|NCT01995201|561760949|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635950|NCT01995201|561760950|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635951|NCT01995201|561760951|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635952|NCT01995201|561760952|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635953|NCT01995201|561760953|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155635954|NCT01995201|561760947|FG000|From Baseline Until Week 24|Death|0|||
155635955|NCT01995201|561760948|FG001|From Baseline Until Week 24|Death|1|||
155635956|NCT01995201|561760949|FG002|From Baseline Until Week 24|Death|0|||
155635957|NCT01995201|561760950|FG003|From Baseline Until Week 24|Death|0|||
155635958|NCT01995201|561760951|FG004|From Baseline Until Week 24|Death|0|||
155635959|NCT01995201|561760952|FG005|From Baseline Until Week 24|Death|0|||
155635960|NCT01995201|561760953|FG006|From Baseline Until Week 24|Death|0|||
155635961|NCT01995201|561760947|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
155635962|NCT01995201|561760948|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
155635963|NCT01995201|561760949|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
155635964|NCT01995201|561760950|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
155635965|NCT01995201|561760951|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
155635966|NCT01995201|561760952|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
155635967|NCT01995201|561760953|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
155635968|NCT01995201|561760947|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
155635969|NCT01995201|561760948|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
155635970|NCT01995201|561760949|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
155635971|NCT01995201|561760950|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
155635972|NCT01995201|561760951|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
155635973|NCT01995201|561760952|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
155635974|NCT01995201|561760953|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
155635975|NCT01995201|561760947|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
155635976|NCT01995201|561760948|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
155635977|NCT01995201|561760949|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
155635978|NCT01995201|561760950|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
155635979|NCT01995201|561760951|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
155635980|NCT01995201|561760952|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
155635981|NCT01995201|561760953|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
155395558|NCT02060383|560884971|FG000|Core Phase|Administrative problems|0|||
155395559|NCT02060383|560884972|FG001|Core Phase|Administrative problems|1|||
155395560|NCT02060383|560884973|FG002|Core Phase|Administrative problems|0|||
155395561|NCT02060383|560884974|FG003|Core Phase|Administrative problems|0|||
155635982|NCT01995201|561760947|FG000|From Baseline Until Week 24|Physician Decision|0|||
155635983|NCT01995201|561760948|FG001|From Baseline Until Week 24|Physician Decision|2|||
155635984|NCT01995201|561760949|FG002|From Baseline Until Week 24|Physician Decision|0|||
155741239|NCT02059291|562154804|FG004|Epoch 3|Lack of Efficacy|0|||
155395562|NCT02060383|560884975|FG004|Core Phase|Administrative problems|0|||
155741240|NCT02059291|562154805|FG005|Epoch 3|Lack of Efficacy|0|||
155741241|NCT02059291|562154806|FG006|Epoch 3|Lack of Efficacy|0|||
155395563|NCT02060383|560884971|FG000|Core Phase|Protocol Violation|0|||
155395564|NCT02060383|560884972|FG001|Core Phase|Protocol Violation|0|||
155395565|NCT02060383|560884973|FG002|Core Phase|Protocol Violation|0|||
155395566|NCT02060383|560884974|FG003|Core Phase|Protocol Violation|1|||
155395567|NCT02060383|560884975|FG004|Core Phase|Protocol Violation|0|||
155395568|NCT02060383|560884971|FG000|Core Phase|Withdrawal by Subject|0|||
155395569|NCT02060383|560884972|FG001|Core Phase|Withdrawal by Subject|0|||
155395570|NCT02060383|560884973|FG002|Core Phase|Withdrawal by Subject|0|||
155395571|NCT02060383|560884974|FG003|Core Phase|Withdrawal by Subject|4|||
155395572|NCT02060383|560884975|FG004|Core Phase|Withdrawal by Subject|2|||
155395573|NCT02060383|560884971|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
155395574|NCT02060383|560884972|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
155395575|NCT02060383|560884973|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
155395576|NCT02060383|560884974|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
155635985|NCT01995201|561760950|FG003|From Baseline Until Week 24|Physician Decision|0|||
155635986|NCT01995201|561760951|FG004|From Baseline Until Week 24|Physician Decision|0|||
155395577|NCT02060383|560884975|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
155395578|NCT02060383|560884971|FG000|Extension Phase|Adverse Event|1|||
155395579|NCT02060383|560884972|FG001|Extension Phase|Adverse Event|1|||
155395580|NCT02060383|560884973|FG002|Extension Phase|Adverse Event|2|||
155395581|NCT02060383|560884974|FG003|Extension Phase|Adverse Event|0|||
155395582|NCT02060383|560884975|FG004|Extension Phase|Adverse Event|1|||
155395583|NCT02060383|560884971|FG000|Extension Phase|Withdrawal by Subject|0|||
155395584|NCT02060383|560884972|FG001|Extension Phase|Withdrawal by Subject|1|||
155395585|NCT02060383|560884973|FG002|Extension Phase|Withdrawal by Subject|0|||
155395586|NCT02060383|560884974|FG003|Extension Phase|Withdrawal by Subject|0|||
155395587|NCT02060383|560884975|FG004|Extension Phase|Withdrawal by Subject|2|||
155395588|NCT02060383|560884971|FG000|Extension Phase|Administrative problems|1|||
155395589|NCT02060383|560884972|FG001|Extension Phase|Administrative problems|0|||
155395590|NCT02060383|560884973|FG002|Extension Phase|Administrative problems|0|||
155395591|NCT02060383|560884974|FG003|Extension Phase|Administrative problems|0|||
155395592|NCT02060383|560884975|FG004|Extension Phase|Administrative problems|0|||
155395593|NCT02060383|560884971|FG000|Extension Phase|Death|0|||
155395594|NCT02060383|560884972|FG001|Extension Phase|Death|0|||
155395595|NCT02060383|560884973|FG002|Extension Phase|Death|1|||
155395596|NCT02060383|560884974|FG003|Extension Phase|Death|0|||
155395597|NCT02060383|560884975|FG004|Extension Phase|Death|1|||
155395598|NCT02060383|560884971|FG000|Extension Phase|Protocol Violation|0|||
155395599|NCT02060383|560884972|FG001|Extension Phase|Protocol Violation|0|||
155395600|NCT02060383|560884973|FG002|Extension Phase|Protocol Violation|0|||
155395601|NCT02060383|560884974|FG003|Extension Phase|Protocol Violation|0|||
155395602|NCT02060383|560884975|FG004|Extension Phase|Protocol Violation|1|||
155395603|NCT04050670|560884978|FG000|Period 3|Physician Decision|0|||
155395604|NCT04050670|560884979|FG001|Period 3|Physician Decision|1|||
155395605|NCT04050670|560884980|FG002|Period 3|Physician Decision|0|||
155395606|NCT00761306|560884981|FG000|Overall Study|Adverse Event|5|||
155395607|NCT00761306|560884981|FG000|Overall Study|Lack of Efficacy|4|||
155395608|NCT00761306|560884981|FG000|Overall Study|Protocol Violation|2|||
155395609|NCT00761306|560884981|FG000|Overall Study|Withdrawal of Consent|3|||
155395610|NCT00761306|560884981|FG000|Overall Study|Lost to Follow-up|1|||
155395611|NCT00761306|560884981|FG000|Overall Study|Administrative or Other Reasons|5|||
155635987|NCT01995201|561760952|FG005|From Baseline Until Week 24|Physician Decision|0|||
155395612|NCT00268437|560884982|FG000|Overall Study|Ineligible|1|||
155395613|NCT05162027|560884983|FG000|Overall Study|Adverse Event|1|||
155395614|NCT05162027|560884984|FG001|Overall Study|Adverse Event|0|||
155395615|NCT02982239|560884985|FG000|Overall Study|Lost to Follow-up|3|||
155395616|NCT02982239|560884986|FG001|Overall Study|Lost to Follow-up|2|||
155395617|NCT00907257|560884987|FG000|Overall Study|Adverse Event|0|||
155395618|NCT00907257|560884988|FG001|Overall Study|Adverse Event|4|||
155395619|NCT00907257|560884987|FG000|Overall Study|Protocol Violation|1|||
155395620|NCT00907257|560884988|FG001|Overall Study|Protocol Violation|2|||
155395621|NCT00907257|560884987|FG000|Overall Study|Lost to Follow-up|3|||
155395622|NCT00907257|560884988|FG001|Overall Study|Lost to Follow-up|3|||
155395623|NCT00907257|560884987|FG000|Overall Study|Withdrawal by Subject|1|||
155395624|NCT00907257|560884988|FG001|Overall Study|Withdrawal by Subject|2|||
155395625|NCT00907257|560884987|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
155395626|NCT00907257|560884988|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
155395627|NCT00907257|560884987|FG000|Overall Study|Moved|1|||
155395628|NCT00907257|560884988|FG001|Overall Study|Moved|0|||
155635988|NCT01995201|561760953|FG006|From Baseline Until Week 24|Physician Decision|0|||
155395629|NCT00907257|560884987|FG000|Overall Study|Personal Reasons|6|||
155395630|NCT00907257|560884988|FG001|Overall Study|Personal Reasons|1|||
155395631|NCT00880555|560884989|FG000|Overall Study|Physician Decision|0|||
155395632|NCT00880555|560884990|FG001|Overall Study|Physician Decision|8|||
155395633|NCT00880555|560884991|FG002|Overall Study|Physician Decision|0|||
155395634|NCT00880555|560884992|FG003|Overall Study|Physician Decision|2|||
155395635|NCT00880555|560884993|FG004|Overall Study|Physician Decision|1|||
155395636|NCT00880555|560884994|FG005|Overall Study|Physician Decision|0|||
155395637|NCT00880555|560884989|FG000|Overall Study|Withdrawal by Subject|1|||
155395638|NCT00880555|560884990|FG001|Overall Study|Withdrawal by Subject|1|||
155395639|NCT00880555|560884991|FG002|Overall Study|Withdrawal by Subject|0|||
155395640|NCT00880555|560884992|FG003|Overall Study|Withdrawal by Subject|0|||
155395641|NCT00880555|560884993|FG004|Overall Study|Withdrawal by Subject|0|||
155395642|NCT00880555|560884994|FG005|Overall Study|Withdrawal by Subject|0|||
155395643|NCT00880555|560884989|FG000|Overall Study|Lack of resources (hired rater)|9|||
155395644|NCT00880555|560884990|FG001|Overall Study|Lack of resources (hired rater)|7|||
155395645|NCT00880555|560884991|FG002|Overall Study|Lack of resources (hired rater)|5|||
155395646|NCT00880555|560884992|FG003|Overall Study|Lack of resources (hired rater)|0|||
155395647|NCT00880555|560884993|FG004|Overall Study|Lack of resources (hired rater)|0|||
155395648|NCT00880555|560884994|FG005|Overall Study|Lack of resources (hired rater)|0|||
155395649|NCT00880555|560884989|FG000|Overall Study|Death|0|||
155395650|NCT00880555|560884990|FG001|Overall Study|Death|0|||
155395651|NCT00880555|560884991|FG002|Overall Study|Death|0|||
155395652|NCT00880555|560884992|FG003|Overall Study|Death|0|||
155395653|NCT00880555|560884993|FG004|Overall Study|Death|0|||
155395654|NCT00880555|560884994|FG005|Overall Study|Death|1|||
155395655|NCT00880555|560884989|FG000|Overall Study|Lost to Follow-up|0|||
155283825|NCT00209274|560470858|FG000|Overall Study|Randomized not treated (RNT)|6|||
155283826|NCT00209274|560470859|FG001|Overall Study|Randomized not treated (RNT)|15|||
155283827|NCT00604786|560470867|FG000|Overall Study|Lost to Follow-up|2|||
155283828|NCT00604786|560470868|FG001|Overall Study|Lost to Follow-up|0|||
155283829|NCT00062868|560470878|FG000|Dose Level 1|Death|2|||
155283830|NCT00062868|560470879|FG001|Dose Level 1|Death|0|||
155283831|NCT00062868|560470880|FG002|Dose Level 1|Death|0|||
155283832|NCT00062868|560470881|FG003|Dose Level 1|Death|2|||
155283833|NCT00062868|560470882|FG004|Dose Level 1|Death|0|||
155283834|NCT00062868|560470883|FG005|Dose Level 1|Death|0|||
155283835|NCT00062868|560470884|FG006|Dose Level 1|Death|3|||
155283836|NCT00062868|560470885|FG007|Dose Level 1|Death|0|||
155283837|NCT00062868|560470886|FG008|Dose Level 1|Death|0|||
155283838|NCT00062868|560470887|FG009|Dose Level 1|Death|0|||
155283839|NCT00062868|560470888|FG010|Dose Level 1|Death|0|||
155283840|NCT00062868|560470889|FG011|Dose Level 1|Death|0|||
155283841|NCT00062868|560470890|FG012|Dose Level 1|Death|0|||
155283842|NCT00062868|560470891|FG013|Dose Level 1|Death|0|||
155283843|NCT00062868|560470892|FG014|Dose Level 1|Death|0|||
155283844|NCT00062868|560470893|FG015|Dose Level 1|Death|0|||
155283845|NCT00062868|560470894|FG016|Dose Level 1|Death|0|||
155283846|NCT00062868|560470895|FG017|Dose Level 1|Death|0|||
155283847|NCT00062868|560470896|FG018|Dose Level 1|Death|7|||
155283848|NCT00062868|560470897|FG019|Dose Level 1|Death|0|||
155283849|NCT00062868|560470898|FG020|Dose Level 1|Death|1|||
155283850|NCT00062868|560470878|FG000|Dose Level 1|Lost to Follow-up|0|||
155283851|NCT00062868|560470879|FG001|Dose Level 1|Lost to Follow-up|0|||
155283852|NCT00062868|560470880|FG002|Dose Level 1|Lost to Follow-up|0|||
155283853|NCT00062868|560470881|FG003|Dose Level 1|Lost to Follow-up|0|||
155283854|NCT00062868|560470882|FG004|Dose Level 1|Lost to Follow-up|0|||
155283855|NCT00062868|560470883|FG005|Dose Level 1|Lost to Follow-up|0|||
155283856|NCT00062868|560470884|FG006|Dose Level 1|Lost to Follow-up|0|||
155283857|NCT00062868|560470885|FG007|Dose Level 1|Lost to Follow-up|0|||
155283858|NCT00062868|560470886|FG008|Dose Level 1|Lost to Follow-up|0|||
155283859|NCT00062868|560470887|FG009|Dose Level 1|Lost to Follow-up|0|||
155283860|NCT00062868|560470888|FG010|Dose Level 1|Lost to Follow-up|0|||
155283861|NCT00062868|560470889|FG011|Dose Level 1|Lost to Follow-up|0|||
155283862|NCT00062868|560470890|FG012|Dose Level 1|Lost to Follow-up|1|||
155283863|NCT00062868|560470891|FG013|Dose Level 1|Lost to Follow-up|0|||
155283864|NCT00062868|560470892|FG014|Dose Level 1|Lost to Follow-up|0|||
155283865|NCT00062868|560470893|FG015|Dose Level 1|Lost to Follow-up|0|||
155283866|NCT00062868|560470894|FG016|Dose Level 1|Lost to Follow-up|0|||
155283867|NCT00062868|560470895|FG017|Dose Level 1|Lost to Follow-up|0|||
155283868|NCT00062868|560470896|FG018|Dose Level 1|Lost to Follow-up|2|||
155395656|NCT00880555|560884990|FG001|Overall Study|Lost to Follow-up|1|||
155283869|NCT00062868|560470897|FG019|Dose Level 1|Lost to Follow-up|0|||
155283870|NCT00062868|560470898|FG020|Dose Level 1|Lost to Follow-up|1|||
155283871|NCT00062868|560470878|FG000|Dose Level 2|Death|0|||
155283872|NCT00062868|560470879|FG001|Dose Level 2|Death|3|||
155283873|NCT00062868|560470880|FG002|Dose Level 2|Death|0|||
155395657|NCT00880555|560884991|FG002|Overall Study|Lost to Follow-up|0|||
155395658|NCT00880555|560884992|FG003|Overall Study|Lost to Follow-up|0|||
155283874|NCT00062868|560470881|FG003|Dose Level 2|Death|0|||
155283875|NCT00062868|560470882|FG004|Dose Level 2|Death|2|||
155283876|NCT00062868|560470883|FG005|Dose Level 2|Death|0|||
155283877|NCT00062868|560470884|FG006|Dose Level 2|Death|0|||
155283878|NCT00062868|560470885|FG007|Dose Level 2|Death|0|||
155283879|NCT00062868|560470886|FG008|Dose Level 2|Death|0|||
155283880|NCT00062868|560470887|FG009|Dose Level 2|Death|0|||
155283881|NCT00062868|560470888|FG010|Dose Level 2|Death|1|||
155395659|NCT00880555|560884993|FG004|Overall Study|Lost to Follow-up|0|||
155395660|NCT00880555|560884994|FG005|Overall Study|Lost to Follow-up|0|||
155395661|NCT04163900|560884995|FG000|Overall Study|Radiological disease progression|112|||
155283882|NCT00062868|560470889|FG011|Dose Level 2|Death|0|||
155283883|NCT00062868|560470890|FG012|Dose Level 2|Death|0|||
155283884|NCT00062868|560470891|FG013|Dose Level 2|Death|0|||
155283885|NCT00062868|560470892|FG014|Dose Level 2|Death|0|||
155283886|NCT00062868|560470893|FG015|Dose Level 2|Death|0|||
155283887|NCT00062868|560470894|FG016|Dose Level 2|Death|2|||
155283888|NCT00062868|560470895|FG017|Dose Level 2|Death|0|||
155283889|NCT00062868|560470896|FG018|Dose Level 2|Death|0|||
155283890|NCT00062868|560470897|FG019|Dose Level 2|Death|0|||
155283891|NCT00062868|560470898|FG020|Dose Level 2|Death|0|||
155283892|NCT00062868|560470878|FG000|Dose Level 2|Lost to Follow-up|0|||
155283893|NCT00062868|560470879|FG001|Dose Level 2|Lost to Follow-up|0|||
155283894|NCT00062868|560470880|FG002|Dose Level 2|Lost to Follow-up|0|||
155283895|NCT00062868|560470881|FG003|Dose Level 2|Lost to Follow-up|0|||
155283896|NCT00062868|560470882|FG004|Dose Level 2|Lost to Follow-up|0|||
155283897|NCT00062868|560470883|FG005|Dose Level 2|Lost to Follow-up|0|||
155283898|NCT00062868|560470884|FG006|Dose Level 2|Lost to Follow-up|0|||
155283899|NCT00062868|560470885|FG007|Dose Level 2|Lost to Follow-up|0|||
155283900|NCT00062868|560470886|FG008|Dose Level 2|Lost to Follow-up|0|||
155283901|NCT00062868|560470887|FG009|Dose Level 2|Lost to Follow-up|0|||
155283902|NCT00062868|560470888|FG010|Dose Level 2|Lost to Follow-up|0|||
155283903|NCT00062868|560470889|FG011|Dose Level 2|Lost to Follow-up|0|||
155283904|NCT00062868|560470890|FG012|Dose Level 2|Lost to Follow-up|0|||
155283905|NCT00062868|560470891|FG013|Dose Level 2|Lost to Follow-up|1|||
155283906|NCT00062868|560470892|FG014|Dose Level 2|Lost to Follow-up|0|||
155283907|NCT00062868|560470893|FG015|Dose Level 2|Lost to Follow-up|0|||
155283908|NCT00062868|560470894|FG016|Dose Level 2|Lost to Follow-up|1|||
155283909|NCT00062868|560470895|FG017|Dose Level 2|Lost to Follow-up|0|||
155283910|NCT00062868|560470896|FG018|Dose Level 2|Lost to Follow-up|0|||
155283911|NCT00062868|560470897|FG019|Dose Level 2|Lost to Follow-up|0|||
155283912|NCT00062868|560470898|FG020|Dose Level 2|Lost to Follow-up|0|||
155283913|NCT00062868|560470878|FG000|Dose Level 3|Death|0|||
155283914|NCT00062868|560470879|FG001|Dose Level 3|Death|0|||
155283915|NCT00062868|560470880|FG002|Dose Level 3|Death|0|||
155283916|NCT00062868|560470881|FG003|Dose Level 3|Death|0|||
155283917|NCT00062868|560470882|FG004|Dose Level 3|Death|0|||
155283918|NCT00062868|560470883|FG005|Dose Level 3|Death|0|||
155283919|NCT00062868|560470884|FG006|Dose Level 3|Death|0|||
155283920|NCT00062868|560470885|FG007|Dose Level 3|Death|0|||
155283921|NCT00062868|560470886|FG008|Dose Level 3|Death|0|||
155283922|NCT00062868|560470887|FG009|Dose Level 3|Death|0|||
155283923|NCT00062868|560470888|FG010|Dose Level 3|Death|0|||
155283924|NCT00062868|560470889|FG011|Dose Level 3|Death|1|||
155283925|NCT00062868|560470890|FG012|Dose Level 3|Death|0|||
155283926|NCT00062868|560470891|FG013|Dose Level 3|Death|0|||
155283927|NCT00062868|560470892|FG014|Dose Level 3|Death|0|||
155283928|NCT00062868|560470893|FG015|Dose Level 3|Death|0|||
155283929|NCT00062868|560470894|FG016|Dose Level 3|Death|0|||
155283930|NCT00062868|560470895|FG017|Dose Level 3|Death|1|||
155283931|NCT00062868|560470896|FG018|Dose Level 3|Death|0|||
155283932|NCT00062868|560470897|FG019|Dose Level 3|Death|0|||
155283933|NCT00062868|560470898|FG020|Dose Level 3|Death|0|||
155283934|NCT00062868|560470878|FG000|Dose Level 3|Lost to Follow-up|0|||
155283935|NCT00062868|560470879|FG001|Dose Level 3|Lost to Follow-up|0|||
155283936|NCT00062868|560470880|FG002|Dose Level 3|Lost to Follow-up|0|||
155283937|NCT00062868|560470881|FG003|Dose Level 3|Lost to Follow-up|0|||
155283938|NCT00062868|560470882|FG004|Dose Level 3|Lost to Follow-up|0|||
155283939|NCT00062868|560470883|FG005|Dose Level 3|Lost to Follow-up|0|||
155283940|NCT00062868|560470884|FG006|Dose Level 3|Lost to Follow-up|0|||
155283941|NCT00062868|560470885|FG007|Dose Level 3|Lost to Follow-up|0|||
155283942|NCT00062868|560470886|FG008|Dose Level 3|Lost to Follow-up|0|||
155283943|NCT00062868|560470887|FG009|Dose Level 3|Lost to Follow-up|0|||
155283944|NCT00062868|560470888|FG010|Dose Level 3|Lost to Follow-up|0|||
155283945|NCT00062868|560470889|FG011|Dose Level 3|Lost to Follow-up|0|||
155283946|NCT00062868|560470890|FG012|Dose Level 3|Lost to Follow-up|0|||
155283947|NCT00062868|560470891|FG013|Dose Level 3|Lost to Follow-up|0|||
155283948|NCT00062868|560470892|FG014|Dose Level 3|Lost to Follow-up|1|||
155283949|NCT00062868|560470893|FG015|Dose Level 3|Lost to Follow-up|0|||
155283950|NCT00062868|560470894|FG016|Dose Level 3|Lost to Follow-up|0|||
155283951|NCT00062868|560470895|FG017|Dose Level 3|Lost to Follow-up|0|||
155283952|NCT00062868|560470896|FG018|Dose Level 3|Lost to Follow-up|0|||
155283953|NCT00062868|560470897|FG019|Dose Level 3|Lost to Follow-up|0|||
155283954|NCT00062868|560470898|FG020|Dose Level 3|Lost to Follow-up|0|||
155283955|NCT00062868|560470878|FG000|Dose Level 3|Withdrew|0|||
155283956|NCT00062868|560470879|FG001|Dose Level 3|Withdrew|0|||
155283957|NCT00062868|560470880|FG002|Dose Level 3|Withdrew|2|||
155283958|NCT00062868|560470881|FG003|Dose Level 3|Withdrew|0|||
155283959|NCT00062868|560470882|FG004|Dose Level 3|Withdrew|0|||
155283960|NCT00062868|560470883|FG005|Dose Level 3|Withdrew|0|||
155283961|NCT00062868|560470884|FG006|Dose Level 3|Withdrew|0|||
155283962|NCT00062868|560470885|FG007|Dose Level 3|Withdrew|0|||
155395662|NCT04163900|560884996|FG001|Overall Study|Radiological disease progression|127|||
155395663|NCT04163900|560884995|FG000|Overall Study|Study closure|98|||
155395664|NCT04163900|560884996|FG001|Overall Study|Study closure|133|||
155395665|NCT04163900|560884995|FG000|Overall Study|Adverse Event|78|||
155395666|NCT04163900|560884996|FG001|Overall Study|Adverse Event|32|||
155395667|NCT04163900|560884995|FG000|Overall Study|Withdrawal by Subject|37|||
155395668|NCT04163900|560884996|FG001|Overall Study|Withdrawal by Subject|34|||
155395669|NCT04163900|560884995|FG000|Overall Study|Death|29|||
155395670|NCT04163900|560884996|FG001|Overall Study|Death|16|||
155395671|NCT04163900|560884995|FG000|Overall Study|Physician Decision|17|||
155395672|NCT04163900|560884996|FG001|Overall Study|Physician Decision|25|||
155395673|NCT04163900|560884995|FG000|Overall Study|Clinical disease progression|14|||
155395674|NCT04163900|560884996|FG001|Overall Study|Clinical disease progression|13|||
155395675|NCT04163900|560884995|FG000|Overall Study|Protocol Violation|3|||
155395676|NCT04163900|560884996|FG001|Overall Study|Protocol Violation|4|||
155395677|NCT04163900|560884995|FG000|Overall Study|Lost to Follow-up|0|||
155395678|NCT04163900|560884996|FG001|Overall Study|Lost to Follow-up|1|||
155395679|NCT00283049|560884999|FG000|Overall Study|Adverse Event|6|||
155395680|NCT00283049|560885000|FG001|Overall Study|Adverse Event|1|||
155395681|NCT00283049|560885001|FG002|Overall Study|Adverse Event|4|||
155395682|NCT00283049|560884999|FG000|Overall Study|Protocol Violation|3|||
155395683|NCT00283049|560885000|FG001|Overall Study|Protocol Violation|0|||
155395684|NCT00283049|560885001|FG002|Overall Study|Protocol Violation|3|||
155395685|NCT00283049|560884999|FG000|Overall Study|Death|1|||
155395686|NCT00283049|560885000|FG001|Overall Study|Death|1|||
155395687|NCT00283049|560885001|FG002|Overall Study|Death|1|||
155395688|NCT00283049|560884999|FG000|Overall Study|Lack of Efficacy|0|||
155395689|NCT00283049|560885000|FG001|Overall Study|Lack of Efficacy|1|||
155395690|NCT00283049|560885001|FG002|Overall Study|Lack of Efficacy|1|||
155395691|NCT00283049|560884999|FG000|Overall Study|Lost to Follow-up|4|||
155395692|NCT00283049|560885000|FG001|Overall Study|Lost to Follow-up|2|||
155395693|NCT00283049|560885001|FG002|Overall Study|Lost to Follow-up|5|||
155395694|NCT00283049|560884999|FG000|Overall Study|Withdrawal by Subject|26|||
155395695|NCT00283049|560885000|FG001|Overall Study|Withdrawal by Subject|24|||
155395696|NCT00283049|560885001|FG002|Overall Study|Withdrawal by Subject|19|||
155395697|NCT00283049|560884999|FG000|Overall Study|Discontinuation of Study|18|||
155395698|NCT00283049|560885000|FG001|Overall Study|Discontinuation of Study|16|||
155395699|NCT00283049|560885001|FG002|Overall Study|Discontinuation of Study|20|||
155395700|NCT00283049|560884999|FG000|Overall Study|No longer requires study treatment|0|||
155395701|NCT00283049|560885000|FG001|Overall Study|No longer requires study treatment|0|||
155395702|NCT00283049|560885001|FG002|Overall Study|No longer requires study treatment|1|||
155395703|NCT01873417|560885002|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
155395704|NCT01873417|560885002|FG000|Overall Study|Adverse Event|24|||
155395705|NCT01873417|560885002|FG000|Overall Study|Lost to Follow-up|2|||
155395706|NCT01873417|560885002|FG000|Overall Study|Withdrawal by Subject|2|||
155395707|NCT01873417|560885002|FG000|Overall Study|Physician Decision|3|||
155395708|NCT00785044|560885003|FG000|Overall Study|Dosed at non-participating sites|152|||
155635989|NCT01995201|561760947|FG000|From Baseline Until Week 24|Protocol Violation|0|||
155635990|NCT01995201|561760948|FG001|From Baseline Until Week 24|Protocol Violation|9|||
155635991|NCT01995201|561760949|FG002|From Baseline Until Week 24|Protocol Violation|0|||
155635992|NCT01995201|561760950|FG003|From Baseline Until Week 24|Protocol Violation|0|||
155635993|NCT01995201|561760951|FG004|From Baseline Until Week 24|Protocol Violation|0|||
155635994|NCT01995201|561760952|FG005|From Baseline Until Week 24|Protocol Violation|0|||
155635995|NCT01995201|561760953|FG006|From Baseline Until Week 24|Protocol Violation|0|||
155635996|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Adverse Event|0|||
155635997|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Adverse Event|0|||
155635998|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Adverse Event|2|||
155635999|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Adverse Event|1|||
155636000|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Adverse Event|1|||
155636001|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Adverse Event|3|||
155636002|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Adverse Event|1|||
155636003|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Death|0|||
155395709|NCT00785044|560885003|FG000|Overall Study|Death|77|||
155395710|NCT00785044|560885003|FG000|Overall Study|Lost to Follow-up|266|||
155395711|NCT00785044|560885003|FG000|Overall Study|Withdrawal by Subject|1|||
155636004|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Death|0|||
155636005|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Death|0|||
155395712|NCT01628107|560885004|FG000|Overall Study|Withdrawal by Subject|17|||
155395713|NCT01628107|560885004|FG000|Overall Study|Lost to Follow-up|4|||
155395714|NCT01628107|560885004|FG000|Overall Study|Adverse Event|33|||
155395715|NCT01628107|560885004|FG000|Overall Study|Physician Decision|2|||
155395716|NCT01628107|560885004|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
155395717|NCT01628107|560885004|FG000|Overall Study|Non-compliant with Study Procedures|10|||
155395718|NCT01628107|560885004|FG000|Overall Study|Not Treated|8|||
155395719|NCT01628107|560885004|FG000|Overall Study|Sponsor Decision|11|||
155395720|NCT01628107|560885004|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
155395721|NCT01628107|560885004|FG000|Overall Study|Relocated|8|||
155395722|NCT01628107|560885004|FG000|Overall Study|Kidney Transplant|9|||
155395723|NCT01628107|560885004|FG000|Overall Study|Use of Standard of Care|9|||
155395724|NCT01086410|560885005|FG000|Overall Study|Adverse Event|1|||
155395725|NCT01086410|560885006|FG001|Overall Study|Adverse Event|0|||
155395726|NCT01086410|560885007|FG002|Overall Study|Adverse Event|0|||
155395727|NCT01086410|560885008|FG003|Overall Study|Adverse Event|2|||
155395728|NCT01086410|560885005|FG000|Overall Study|Lack of Efficacy|1|||
155395729|NCT01086410|560885006|FG001|Overall Study|Lack of Efficacy|1|||
155395730|NCT01086410|560885007|FG002|Overall Study|Lack of Efficacy|0|||
155395731|NCT01086410|560885008|FG003|Overall Study|Lack of Efficacy|0|||
155395732|NCT01086410|560885005|FG000|Overall Study|Protocol Violation|1|||
155395733|NCT01086410|560885006|FG001|Overall Study|Protocol Violation|1|||
155395734|NCT01086410|560885007|FG002|Overall Study|Protocol Violation|0|||
155395735|NCT01086410|560885008|FG003|Overall Study|Protocol Violation|0|||
155395736|NCT01086410|560885005|FG000|Overall Study|Lost to Follow-up|0|||
155395737|NCT01086410|560885006|FG001|Overall Study|Lost to Follow-up|0|||
155395738|NCT01086410|560885007|FG002|Overall Study|Lost to Follow-up|1|||
155395739|NCT01086410|560885008|FG003|Overall Study|Lost to Follow-up|0|||
155395740|NCT04196803|560885009|FG000|Overall Study|Withdrawal by Subject|1|||
155395741|NCT04196803|560885010|FG001|Overall Study|Withdrawal by Subject|3|||
155395742|NCT04196803|560885009|FG000|Overall Study|Adverse Event|4|||
155395743|NCT04196803|560885010|FG001|Overall Study|Adverse Event|2|||
155395744|NCT04196803|560885009|FG000|Overall Study|Lost to Follow-up|0|||
155395745|NCT04196803|560885010|FG001|Overall Study|Lost to Follow-up|1|||
155395746|NCT01022996|560885011|FG000|Overall Study|Adverse Event|14|||
155395747|NCT01022996|560885011|FG000|Overall Study|Withdrawal by Subject|3|||
155395748|NCT01022996|560885011|FG000|Overall Study|Lost to Follow-up|1|||
155395749|NCT01022996|560885011|FG000|Overall Study|Administrative problems|6|||
155395750|NCT01022996|560885011|FG000|Overall Study|Disease Progression|32|||
155395751|NCT01022996|560885011|FG000|Overall Study|Protocol Violation|1|||
155395752|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Adverse Event|2|||
155395753|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Adverse Event|2|||
155395754|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Adverse Event|4|||
155395755|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Adverse Event|0|||
155395756|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Adverse Event|0|||
155395757|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Progressive disease|0|||
155395758|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Progressive disease|0|||
155395759|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Progressive disease|1|||
155395760|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Progressive disease|0|||
155395761|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Progressive disease|0|||
155395762|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
155395763|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395764|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395765|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395766|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395767|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
155395768|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155283963|NCT00062868|560470886|FG008|Dose Level 3|Withdrew|0|||
155283964|NCT00062868|560470887|FG009|Dose Level 3|Withdrew|0|||
155283965|NCT00062868|560470888|FG010|Dose Level 3|Withdrew|0|||
155283966|NCT00062868|560470889|FG011|Dose Level 3|Withdrew|0|||
155283967|NCT00062868|560470890|FG012|Dose Level 3|Withdrew|0|||
155283968|NCT00062868|560470891|FG013|Dose Level 3|Withdrew|0|||
155283969|NCT00062868|560470892|FG014|Dose Level 3|Withdrew|0|||
155283970|NCT00062868|560470893|FG015|Dose Level 3|Withdrew|0|||
155283971|NCT00062868|560470894|FG016|Dose Level 3|Withdrew|0|||
155283972|NCT00062868|560470895|FG017|Dose Level 3|Withdrew|0|||
155283973|NCT00062868|560470896|FG018|Dose Level 3|Withdrew|0|||
155283974|NCT00062868|560470897|FG019|Dose Level 3|Withdrew|0|||
155283975|NCT00062868|560470898|FG020|Dose Level 3|Withdrew|0|||
155283976|NCT01641861|560470899|FG000|Overall Study|Lost to Follow-up|21|||
155283977|NCT01641861|560470900|FG001|Overall Study|Lost to Follow-up|16|||
155283978|NCT01641861|560470899|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
155283979|NCT01641861|560470900|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
155395769|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395770|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395771|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395772|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
155395773|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
155395774|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
155395775|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
155395776|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
155283980|NCT01641861|560470899|FG000|Overall Study|Died due to drowning|0|||
155395777|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
155283981|NCT01641861|560470900|FG001|Overall Study|Died due to drowning|1|||
155283982|NCT01712685|560470903|FG000|Overall Study|pt declined to participate before trmt|1|||
155283983|NCT01515319|560470904|FG000|Overall Study|Withdrawal by Subject|0|||
155395778|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
155395779|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
155395780|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
155395781|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
155395782|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
155395783|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
155395784|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
155395785|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
155395786|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
155395787|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Adverse Event|0|||
155395788|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Adverse Event|0|||
155395789|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Adverse Event|0|||
155395790|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Adverse Event|1|||
155395791|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Adverse Event|2|||
155395792|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395793|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395794|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395795|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395796|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
155395797|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395798|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395799|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395800|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
155395801|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
155395802|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
155395803|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
155395804|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
155395805|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
155395806|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
155395807|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
155395808|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
155395809|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
155395810|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
155395811|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
155395812|NCT02230254|560885017|FG000|Overall Study|Lost to Follow-up|3|||
155395813|NCT02023242|560885018|FG000|Overall Study|Lost to Follow-up|3|||
155395814|NCT02023242|560885019|FG001|Overall Study|Lost to Follow-up|1|||
155395815|NCT02023242|560885018|FG000|Overall Study|Death|0|||
155395816|NCT02023242|560885019|FG001|Overall Study|Death|1|||
155395817|NCT00419120|560885021|FG000|Long Term Follow up Period|study ongoing|10|||
155395818|NCT00710879|560885023|FG000|Overall Study|Lost to Follow-up|2|||
155395819|NCT00710879|560885024|FG001|Overall Study|Lost to Follow-up|1|||
155395820|NCT00710879|560885023|FG000|Overall Study|Protocol Violation|0|||
155395821|NCT00710879|560885024|FG001|Overall Study|Protocol Violation|3|||
155395822|NCT01809132|560885025|FG000|Overall Study|Withdrawal by Subject|0|||
155395823|NCT01809132|560885026|FG001|Overall Study|Withdrawal by Subject|0|||
155395824|NCT01809132|560885027|FG002|Overall Study|Withdrawal by Subject|1|||
155395825|NCT04854434|560885028|FG000|Overall Study|Death|1|||
155395826|NCT04854434|560885029|FG001|Overall Study|Death|3|||
155395827|NCT04854434|560885030|FG002|Overall Study|Death|4|||
155395828|NCT04854434|560885028|FG000|Overall Study|Study Terminated by Sponsor|2|||
155395829|NCT04854434|560885029|FG001|Overall Study|Study Terminated by Sponsor|0|||
155395830|NCT04854434|560885030|FG002|Overall Study|Study Terminated by Sponsor|0|||
155395831|NCT04854434|560885028|FG000|Overall Study|Other|1|||
155395832|NCT04854434|560885029|FG001|Overall Study|Other|1|||
155395833|NCT04854434|560885030|FG002|Overall Study|Other|0|||
155395834|NCT03349775|560885031|FG000|Overall Study|Side Effects|1|||
155395835|NCT03349775|560885032|FG001|Overall Study|Side Effects|2|||
155395836|NCT03349775|560885031|FG000|Overall Study|Withdrawal by Subject|1|||
155395837|NCT03349775|560885032|FG001|Overall Study|Withdrawal by Subject|1|||
155395838|NCT03349775|560885031|FG000|Overall Study|No primary outcome measurements|0|||
155395839|NCT03349775|560885032|FG001|Overall Study|No primary outcome measurements|1|||
155395840|NCT01274715|560885037|FG000|Overall Study|Lost to Follow-up|1|||
155395841|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395842|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395843|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395844|NCT03583450|560885038|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
155395845|NCT03583450|560885039|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
155395846|NCT01186939|560885040|FG000|Overall Study|Death|7|||
155395847|NCT01186939|560885040|FG000|Overall Study|Withdrawal by Subject|2|||
155395848|NCT01186939|560885040|FG000|Overall Study|No longer receiving clinical benefit|17|||
155395849|NCT01186939|560885040|FG000|Overall Study|Program closed|5|||
155395850|NCT01186939|560885040|FG000|Overall Study|Sponsor decision|4|||
155395851|NCT01186939|560885040|FG000|Overall Study|Started additional treatment|1|||
155395852|NCT01186939|560885040|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
155395853|NCT01186939|560885040|FG000|Overall Study|Myocardial infarction|1|||
155395854|NCT01186939|560885040|FG000|Overall Study|Bone marrow transplant|1|||
155395855|NCT01186939|560885040|FG000|Overall Study|Transformation to AML|1|||
155395856|NCT03945591|560885045|FG000|Overall Study|Participant not transplanted|1|||
155395857|NCT03945591|560885045|FG000|Overall Study|Change in treatment plan|3|||
155395858|NCT03945591|560885045|FG000|Overall Study|Adverse Event|1|||
155395859|NCT00698204|560885046|FG000|Overall Study|Withdrawal by Subject|1|||
155395860|NCT00698204|560885047|FG001|Overall Study|Withdrawal by Subject|0|||
155395861|NCT01179672|560885048|FG000|Overall Study|Adverse Event|17|||
155395862|NCT01179672|560885049|FG001|Overall Study|Adverse Event|8|||
155395863|NCT01179672|560885048|FG000|Overall Study|Withdrawal by Subject|10|||
155395864|NCT01179672|560885049|FG001|Overall Study|Withdrawal by Subject|12|||
155395865|NCT01179672|560885048|FG000|Overall Study|Entry Criteria Not Met|0|||
155395866|NCT01179672|560885049|FG001|Overall Study|Entry Criteria Not Met|2|||
155395867|NCT01179672|560885048|FG000|Overall Study|Lost to Follow-up|0|||
155395868|NCT01179672|560885049|FG001|Overall Study|Lost to Follow-up|1|||
155395869|NCT01179672|560885048|FG000|Overall Study|Protocol Violation|2|||
155395870|NCT01179672|560885049|FG001|Overall Study|Protocol Violation|2|||
155395871|NCT01179672|560885048|FG000|Overall Study|Physician Decision|1|||
155395872|NCT01179672|560885049|FG001|Overall Study|Physician Decision|1|||
155395873|NCT00210184|560885050|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
155395874|NCT02316340|560885051|FG000|First Progression|Clinical progression|2|||
155395875|NCT02316340|560885052|FG001|First Progression|Clinical progression|1|||
155395876|NCT02316340|560885051|FG000|First Progression|Withdrawal by Subject|1|||
155395877|NCT02316340|560885052|FG001|First Progression|Withdrawal by Subject|0|||
155395878|NCT01835015|560885053|FG000|Overall Study|Adverse Event|0|||
155395879|NCT01835015|560885054|FG001|Overall Study|Adverse Event|0|||
155395880|NCT01835015|560885055|FG002|Overall Study|Adverse Event|1|||
155395881|NCT01835015|560885056|FG003|Overall Study|Adverse Event|0|||
155395882|NCT01835015|560885057|FG004|Overall Study|Adverse Event|0|||
155395883|NCT03781323|560885060|FG000|Overall Study|Withdrawal by Subject|1|||
155395884|NCT00975715|560885064|FG000|Titration Period|Adverse Event|6|||
155395885|NCT00975715|560885065|FG001|Titration Period|Adverse Event|0|||
155395886|NCT00975715|560885064|FG000|Titration Period|Protocol Violation|1|||
155395887|NCT00975715|560885065|FG001|Titration Period|Protocol Violation|0|||
155395888|NCT00975715|560885064|FG000|Maintenance Period|Adverse Event|2|||
155395889|NCT00975715|560885065|FG001|Maintenance Period|Adverse Event|1|||
155395890|NCT01241552|560885066|FG000|Overall Study|Lack of Efficacy|1|||
155395891|NCT01241552|560885067|FG001|Overall Study|Lack of Efficacy|0|||
155395892|NCT01241552|560885068|FG002|Overall Study|Lack of Efficacy|0|||
155395893|NCT01241552|560885069|FG003|Overall Study|Lack of Efficacy|0|||
155395894|NCT01241552|560885066|FG000|Overall Study|Death|26|||
155395895|NCT01241552|560885067|FG001|Overall Study|Death|30|||
155395896|NCT01241552|560885068|FG002|Overall Study|Death|20|||
155395897|NCT01241552|560885069|FG003|Overall Study|Death|25|||
155395898|NCT01241552|560885066|FG000|Overall Study|Adverse Event|1|||
155395899|NCT01241552|560885067|FG001|Overall Study|Adverse Event|1|||
155395900|NCT01241552|560885068|FG002|Overall Study|Adverse Event|0|||
155395901|NCT01241552|560885069|FG003|Overall Study|Adverse Event|0|||
155395902|NCT01241552|560885066|FG000|Overall Study|Technical Problems|2|||
155395903|NCT01241552|560885067|FG001|Overall Study|Technical Problems|0|||
155395904|NCT01241552|560885068|FG002|Overall Study|Technical Problems|2|||
155395905|NCT01241552|560885069|FG003|Overall Study|Technical Problems|2|||
155395906|NCT01241552|560885066|FG000|Overall Study|Progressive Disease|0|||
155636006|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Death|0|||
155636007|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Death|0|||
155636008|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Death|2|||
155636009|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Death|0|||
155636010|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
155636011|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
155636012|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
155636013|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
155636014|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
155636015|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
155636016|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
155636017|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
155636018|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
155636019|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
155636020|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
155395907|NCT01241552|560885067|FG001|Overall Study|Progressive Disease|0|||
155395908|NCT01241552|560885068|FG002|Overall Study|Progressive Disease|1|||
155741242|NCT02059291|562154807|FG007|Epoch 3|Lack of Efficacy|0|||
155395909|NCT01241552|560885069|FG003|Overall Study|Progressive Disease|2|||
155395910|NCT01241552|560885066|FG000|Overall Study|Protocol Violation|0|||
155395911|NCT01241552|560885067|FG001|Overall Study|Protocol Violation|2|||
155395912|NCT01241552|560885068|FG002|Overall Study|Protocol Violation|6|||
155395913|NCT01241552|560885069|FG003|Overall Study|Protocol Violation|1|||
155395914|NCT01241552|560885066|FG000|Overall Study|Withdrawal by Subject|7|||
155636021|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
155741243|NCT02059291|562154808|FG008|Epoch 3|Lack of Efficacy|0|||
155395915|NCT01241552|560885067|FG001|Overall Study|Withdrawal by Subject|15|||
155395916|NCT01241552|560885068|FG002|Overall Study|Withdrawal by Subject|14|||
155395917|NCT01241552|560885069|FG003|Overall Study|Withdrawal by Subject|15|||
155395918|NCT01241552|560885066|FG000|Overall Study|Physician Decision|2|||
155636022|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
155636023|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
155636024|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155636025|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155636026|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
155636027|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155636028|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
155636029|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155636030|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155636031|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Physician Decision|0|||
155636032|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Physician Decision|0|||
155636033|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Physician Decision|0|||
155636034|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Physician Decision|0|||
155636035|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Physician Decision|1|||
155636036|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Physician Decision|0|||
155636037|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Physician Decision|0|||
155636038|NCT01995201|561760947|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
155636039|NCT01995201|561760948|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
155636040|NCT01995201|561760949|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
155636041|NCT01995201|561760950|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
155636042|NCT01995201|561760951|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
155636043|NCT01995201|561760952|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
155636044|NCT01995201|561760953|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
155636045|NCT03329001|561760954|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636046|NCT03329001|561760955|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636047|NCT03329001|561760956|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
155636048|NCT03329001|561760957|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
155636049|NCT03329001|561760958|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636050|NCT03329001|561760959|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636051|NCT03329001|561760960|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636052|NCT03329001|561760961|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155636053|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636054|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636055|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636056|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
155636057|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636058|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636059|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636060|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155636061|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636062|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636063|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636064|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
155636065|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636066|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636067|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636068|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155636069|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636070|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636071|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636072|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
155636073|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636074|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636075|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636076|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155636077|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155636078|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155741244|NCT02059291|562154809|FG009|Epoch 3|Lack of Efficacy|0|||
155741245|NCT02059291|562154810|FG010|Epoch 3|Lack of Efficacy|0|||
155395919|NCT01241552|560885067|FG001|Overall Study|Physician Decision|4|||
155395920|NCT01241552|560885068|FG002|Overall Study|Physician Decision|2|||
155395921|NCT01241552|560885069|FG003|Overall Study|Physician Decision|3|||
155395922|NCT01241552|560885066|FG000|Overall Study|Lost to Follow-up|2|||
155395923|NCT01241552|560885067|FG001|Overall Study|Lost to Follow-up|11|||
155395924|NCT01241552|560885068|FG002|Overall Study|Lost to Follow-up|15|||
155395925|NCT01241552|560885069|FG003|Overall Study|Lost to Follow-up|16|||
155395926|NCT04004429|560885070|FG000|Overall Study|Protocol Violation|1|||
155395927|NCT04004429|560885071|FG001|Overall Study|Protocol Violation|0|||
155395928|NCT04004429|560885072|FG002|Overall Study|Protocol Violation|0|||
155395929|NCT04004429|560885070|FG000|Overall Study|Physician Decision|0|||
155395930|NCT04004429|560885071|FG001|Overall Study|Physician Decision|1|||
155395931|NCT04004429|560885072|FG002|Overall Study|Physician Decision|1|||
155395932|NCT04004429|560885070|FG000|Overall Study|Withdrawal by Subject|1|||
155395933|NCT04004429|560885071|FG001|Overall Study|Withdrawal by Subject|1|||
155395934|NCT04004429|560885072|FG002|Overall Study|Withdrawal by Subject|1|||
155395935|NCT02606461|560885073|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395936|NCT02606461|560885074|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395937|NCT02606461|560885075|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
155395938|NCT02606461|560885076|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395939|NCT02606461|560885077|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395940|NCT02606461|560885078|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395941|NCT00851682|560885080|FG000|Overall Study|screen failure|5|||
155395942|NCT00851682|560885081|FG001|Overall Study|screen failure|0|||
155395943|NCT01379573|560885087|FG000|Overall Study|Lost to Follow-up|1|||
155395944|NCT01379573|560885087|FG000|Overall Study|Screen Failure|10|||
155395945|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Adverse Event|1|||
155395946|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Adverse Event|1|||
155395947|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Adverse Event|1|||
155395948|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Adverse Event|0|||
155395949|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Adverse Event|0|||
155395950|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Adverse Event|0|||
155395951|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Adverse Event|0|||
155395952|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Adverse Event|0|||
155395953|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395954|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395955|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395956|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395957|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395958|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395959|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395960|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395961|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395962|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395963|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
155395964|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395965|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395966|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395967|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395968|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395969|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395970|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395971|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
155395972|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395973|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395974|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395975|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395976|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395977|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395978|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
155395979|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
155636079|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
155395980|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395981|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395982|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395983|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
155636080|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155650631|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
155395984|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395985|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Adverse Event|2|||
155395986|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Adverse Event|2|||
155395987|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Adverse Event|0|||
155395988|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Adverse Event|0|||
155395989|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Adverse Event|0|||
155395990|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Adverse Event|0|||
155395991|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Adverse Event|0|||
155395992|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Adverse Event|0|||
155395993|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395994|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395995|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
155741246|NCT02059291|562154811|FG011|Epoch 3|Lack of Efficacy|0|||
155741247|NCT02059291|562154812|FG012|Epoch 3|Lack of Efficacy|0|||
155741248|NCT02059291|562154813|FG013|Epoch 3|Lack of Efficacy|0|||
155741249|NCT02059291|562154814|FG014|Epoch 3|Lack of Efficacy|0|||
155395996|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
155395997|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395998|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395999|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
155396000|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
155396001|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
155396002|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396003|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
155396004|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396005|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396006|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396007|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396008|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396009|NCT02871778|560885089|FG000|Part B: Treatment Period 3|Adverse Event|0|||
155396010|NCT02871778|560885090|FG001|Part B: Treatment Period 3|Adverse Event|0|||
155396011|NCT02871778|560885091|FG002|Part B: Treatment Period 3|Adverse Event|0|||
155396012|NCT02871778|560885092|FG003|Part B: Treatment Period 3|Adverse Event|0|||
155396013|NCT02871778|560885093|FG004|Part B: Treatment Period 3|Adverse Event|1|||
155396014|NCT02871778|560885094|FG005|Part B: Treatment Period 3|Adverse Event|1|||
155396015|NCT02871778|560885095|FG006|Part B: Treatment Period 3|Adverse Event|1|||
155396016|NCT02871778|560885096|FG007|Part B: Treatment Period 3|Adverse Event|0|||
155396017|NCT02653300|560885097|FG000|Overall Study|Withdrawal by Subject|2|||
155396018|NCT02289352|560885106|FG000|Overall Study|Withdrawal by Subject|1|||
155396019|NCT02289352|560885107|FG001|Overall Study|Withdrawal by Subject|1|||
155396020|NCT02289352|560885108|FG002|Overall Study|Withdrawal by Subject|0|||
155396021|NCT01390272|560885109|FG000|Overall Study|Death|3|||
155396022|NCT01390272|560885110|FG001|Overall Study|Death|2|||
155396023|NCT01390272|560885109|FG000|Overall Study|Withdrawal by Subject|9|||
155396024|NCT01390272|560885110|FG001|Overall Study|Withdrawal by Subject|5|||
155396025|NCT01390272|560885109|FG000|Overall Study|Patient moved, no longer eligible|5|||
155396026|NCT01390272|560885110|FG001|Overall Study|Patient moved, no longer eligible|8|||
155396027|NCT00307333|560885111|FG000|Overall Study|Lost to Follow-up|11|||
155396028|NCT00307333|560885112|FG001|Overall Study|Lost to Follow-up|3|||
155396029|NCT04166383|560885113|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
155396030|NCT04166383|560885113|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
155396031|NCT04166383|560885113|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
155396032|NCT00387764|560885114|FG000|Overall Study|Adverse Event|12|||
155396033|NCT00387764|560885114|FG000|Overall Study|Withdrawal by Subject|8|||
155396034|NCT00387764|560885114|FG000|Overall Study|Sponsor Terminated Study|1|||
155396035|NCT00387764|560885114|FG000|Overall Study|Physician Decision|1|||
155396036|NCT00387764|560885114|FG000|Overall Study|Other|2|||
155396037|NCT00387764|560885114|FG000|Overall Study|Death|7|||
155396038|NCT00375219|560885116|FG000|Overall Study|Failure to achieve a response|16|||
155396039|NCT00375219|560885117|FG001|Overall Study|Failure to achieve a response|2|||
155396040|NCT00375219|560885118|FG002|Overall Study|Failure to achieve a response|0|||
155396041|NCT00375219|560885116|FG000|Overall Study|Adverse Event|8|||
155396042|NCT00375219|560885117|FG001|Overall Study|Adverse Event|2|||
155396043|NCT00375219|560885118|FG002|Overall Study|Adverse Event|1|||
155396044|NCT00375219|560885116|FG000|Overall Study|Protocol Violation|1|||
155396045|NCT00375219|560885117|FG001|Overall Study|Protocol Violation|0|||
155396046|NCT00375219|560885118|FG002|Overall Study|Protocol Violation|1|||
155396047|NCT00375219|560885116|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
155396048|NCT00375219|560885117|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
155396049|NCT00375219|560885118|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
155396050|NCT00375219|560885116|FG000|Overall Study|Lost to Follow-up|1|||
155741250|NCT02059291|562154815|FG015|Epoch 3|Lack of Efficacy|3|||
155741251|NCT02059291|562154816|FG016|Epoch 3|Lack of Efficacy|0|||
155741252|NCT02059291|562154817|FG017|Epoch 3|Lack of Efficacy|0|||
155396051|NCT00375219|560885117|FG001|Overall Study|Lost to Follow-up|1|||
155396052|NCT00375219|560885118|FG002|Overall Study|Lost to Follow-up|0|||
155396053|NCT00375219|560885116|FG000|Overall Study|Disease progression|18|||
155396054|NCT00375219|560885117|FG001|Overall Study|Disease progression|9|||
155396055|NCT00375219|560885118|FG002|Overall Study|Disease progression|12|||
155396056|NCT00375219|560885116|FG000|Overall Study|Death|4|||
155396057|NCT00375219|560885117|FG001|Overall Study|Death|3|||
155396058|NCT00375219|560885118|FG002|Overall Study|Death|7|||
155396059|NCT00375219|560885116|FG000|Overall Study|Hematologic resistance|1|||
155396060|NCT00375219|560885117|FG001|Overall Study|Hematologic resistance|0|||
155396061|NCT00375219|560885118|FG002|Overall Study|Hematologic resistance|0|||
155396062|NCT00375219|560885116|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
155396063|NCT00375219|560885117|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
155396064|NCT00375219|560885118|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
155396065|NCT00375219|560885116|FG000|Overall Study|Allograft|2|||
155396066|NCT00375219|560885117|FG001|Overall Study|Allograft|0|||
155396067|NCT00375219|560885118|FG002|Overall Study|Allograft|0|||
155396068|NCT00375219|560885116|FG000|Overall Study|Cord blood transplantation|1|||
155396069|NCT00375219|560885117|FG001|Overall Study|Cord blood transplantation|0|||
155396070|NCT00375219|560885118|FG002|Overall Study|Cord blood transplantation|0|||
155396071|NCT00375219|560885116|FG000|Overall Study|Withdrawal by Subject|1|||
155396072|NCT00375219|560885117|FG001|Overall Study|Withdrawal by Subject|0|||
155396073|NCT00375219|560885118|FG002|Overall Study|Withdrawal by Subject|0|||
155396074|NCT02767323|560886743|FG000|Overall Study|Withdrawal by Subject|17|||
155396075|NCT02767323|560886744|FG001|Overall Study|Withdrawal by Subject|5|||
155396076|NCT02767323|560886745|FG002|Overall Study|Withdrawal by Subject|13|||
155396077|NCT02767323|560886746|FG003|Overall Study|Withdrawal by Subject|0|||
155396078|NCT02767323|560886743|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
155396079|NCT02767323|560886744|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
155396080|NCT02767323|560886745|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
155396081|NCT02767323|560886746|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
155396082|NCT02667275|560886750|FG000|Overall Study|Protocol Violation|11|||
155396083|NCT02667275|560886751|FG001|Overall Study|Protocol Violation|7|||
155396084|NCT02667275|560886750|FG000|Overall Study|Lost to Follow-up|0|||
155396085|NCT02667275|560886751|FG001|Overall Study|Lost to Follow-up|2|||
155396086|NCT02667275|560886750|FG000|Overall Study|Withdrawal by Subject|0|||
155396087|NCT02667275|560886751|FG001|Overall Study|Withdrawal by Subject|5|||
155396088|NCT02667275|560886750|FG000|Overall Study|Discontinued early without completing|0|||
155396089|NCT02667275|560886751|FG001|Overall Study|Discontinued early without completing|1|||
155396090|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
155396091|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
155396092|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
155396093|NCT04479436|560886753|FG000|Overall Study|Progressive disease|26|||
155396094|NCT04479436|560886754|FG001|Overall Study|Progressive disease|1|||
155396095|NCT04479436|560886753|FG000|Overall Study|Adverse Event|6|||
155396096|NCT04479436|560886754|FG001|Overall Study|Adverse Event|0|||
155396097|NCT04479436|560886753|FG000|Overall Study|Withdrawal by Subject|5|||
155396098|NCT04479436|560886754|FG001|Overall Study|Withdrawal by Subject|0|||
155396099|NCT04479436|560886753|FG000|Overall Study|Clinical progression|1|||
155396100|NCT04479436|560886754|FG001|Overall Study|Clinical progression|0|||
155396101|NCT04479436|560886753|FG000|Overall Study|Physician Decision|1|||
155396102|NCT04479436|560886754|FG001|Overall Study|Physician Decision|0|||
155396103|NCT00791258|560886759|FG000|Overall Study|Adverse Event|87|||
155396104|NCT00791258|560886759|FG000|Overall Study|Lost to Follow-up|18|||
155396105|NCT00791258|560886759|FG000|Overall Study|Protocol Violation|109|||
155396106|NCT00791258|560886759|FG000|Overall Study|Withdrawal by Subject|40|||
155396107|NCT00791258|560886759|FG000|Overall Study|Did not take medication for >3 days|1|||
155396108|NCT00791258|560886759|FG000|Overall Study|subject left area|2|||
155396109|NCT00791258|560886759|FG000|Overall Study|non-compliance|3|||
155396110|NCT00791258|560886759|FG000|Overall Study|Subject incarcerated|1|||
155396111|NCT00791258|560886759|FG000|Overall Study|Subject required restricted medication|1|||
155396112|NCT00791258|560886759|FG000|Overall Study|Lack of Efficacy|1|||
155396113|NCT00436618|560886760|FG000|Overall Study|Withdrawal by Subject|5|||
155396114|NCT00436618|560886761|FG001|Overall Study|Withdrawal by Subject|8|||
155396115|NCT00436618|560886762|FG002|Overall Study|Withdrawal by Subject|11|||
155396116|NCT00436618|560886760|FG000|Overall Study|Adverse Event|8|||
155396117|NCT00436618|560886761|FG001|Overall Study|Adverse Event|8|||
155396118|NCT00436618|560886762|FG002|Overall Study|Adverse Event|9|||
155396119|NCT00436618|560886760|FG000|Overall Study|Alternate Treatment|3|||
155396120|NCT00436618|560886761|FG001|Overall Study|Alternate Treatment|4|||
155396121|NCT00436618|560886762|FG002|Overall Study|Alternate Treatment|12|||
155396122|NCT00436618|560886760|FG000|Overall Study|Other Medical Problems|3|||
155396123|NCT00436618|560886761|FG001|Overall Study|Other Medical Problems|1|||
155396124|NCT00436618|560886762|FG002|Overall Study|Other Medical Problems|7|||
155396125|NCT00436618|560886760|FG000|Overall Study|Death|4|||
155396126|NCT00436618|560886761|FG001|Overall Study|Death|2|||
155396127|NCT00436618|560886762|FG002|Overall Study|Death|3|||
155396128|NCT00436618|560886760|FG000|Overall Study|New Primary or Other Reasons|6|||
155396129|NCT00436618|560886761|FG001|Overall Study|New Primary or Other Reasons|2|||
155396130|NCT00436618|560886762|FG002|Overall Study|New Primary or Other Reasons|12|||
155396131|NCT00436618|560886760|FG000|Overall Study|Still on treatment|1|||
155396132|NCT00436618|560886761|FG001|Overall Study|Still on treatment|2|||
155396133|NCT00436618|560886762|FG002|Overall Study|Still on treatment|7|||
155396134|NCT01994382|560886763|FG000|Overall Study|Informed consent withdrawn|0|||
155396135|NCT01994382|560886764|FG001|Overall Study|Informed consent withdrawn|0|||
155396136|NCT01994382|560886765|FG002|Overall Study|Informed consent withdrawn|0|||
155396137|NCT01994382|560886766|FG003|Overall Study|Informed consent withdrawn|0|||
155396138|NCT01994382|560886767|FG004|Overall Study|Informed consent withdrawn|0|||
155396139|NCT01994382|560886768|FG005|Overall Study|Informed consent withdrawn|0|||
155396140|NCT01994382|560886769|FG006|Overall Study|Informed consent withdrawn|1|||
155396141|NCT01994382|560886770|FG007|Overall Study|Informed consent withdrawn|0|||
155396142|NCT01994382|560886771|FG008|Overall Study|Informed consent withdrawn|0|||
155396143|NCT01994382|560886772|FG009|Overall Study|Informed consent withdrawn|0|||
155396144|NCT01994382|560886773|FG010|Overall Study|Informed consent withdrawn|0|||
155396145|NCT01994382|560886774|FG011|Overall Study|Informed consent withdrawn|0|||
155396146|NCT01994382|560886775|FG012|Overall Study|Informed consent withdrawn|0|||
155396147|NCT01994382|560886776|FG013|Overall Study|Informed consent withdrawn|0|||
155396148|NCT01994382|560886777|FG014|Overall Study|Informed consent withdrawn|0|||
155396149|NCT01994382|560886778|FG015|Overall Study|Informed consent withdrawn|0|||
155396150|NCT01994382|560886779|FG016|Overall Study|Informed consent withdrawn|0|||
155396151|NCT01994382|560886763|FG000|Overall Study|Progressive disease|3|||
155396152|NCT01994382|560886764|FG001|Overall Study|Progressive disease|4|||
155396153|NCT01994382|560886765|FG002|Overall Study|Progressive disease|4|||
155396154|NCT01994382|560886766|FG003|Overall Study|Progressive disease|3|||
155396155|NCT01994382|560886767|FG004|Overall Study|Progressive disease|2|||
155396156|NCT01994382|560886768|FG005|Overall Study|Progressive disease|3|||
155396157|NCT01994382|560886769|FG006|Overall Study|Progressive disease|3|||
155396158|NCT01994382|560886770|FG007|Overall Study|Progressive disease|6|||
155396159|NCT01994382|560886771|FG008|Overall Study|Progressive disease|2|||
155396160|NCT01994382|560886772|FG009|Overall Study|Progressive disease|2|||
155396161|NCT01994382|560886773|FG010|Overall Study|Progressive disease|13|||
155396162|NCT01994382|560886774|FG011|Overall Study|Progressive disease|8|||
155396163|NCT01994382|560886775|FG012|Overall Study|Progressive disease|7|||
155396164|NCT01994382|560886776|FG013|Overall Study|Progressive disease|3|||
155396165|NCT01994382|560886777|FG014|Overall Study|Progressive disease|6|||
155396166|NCT01994382|560886778|FG015|Overall Study|Progressive disease|44|||
155396167|NCT01994382|560886779|FG016|Overall Study|Progressive disease|28|||
155396168|NCT01994382|560886763|FG000|Overall Study|Physician Decision|0|||
155396169|NCT01994382|560886764|FG001|Overall Study|Physician Decision|1|||
155396170|NCT01994382|560886765|FG002|Overall Study|Physician Decision|0|||
155396171|NCT01994382|560886766|FG003|Overall Study|Physician Decision|0|||
155396172|NCT01994382|560886767|FG004|Overall Study|Physician Decision|0|||
155396173|NCT01994382|560886768|FG005|Overall Study|Physician Decision|0|||
155396174|NCT01994382|560886769|FG006|Overall Study|Physician Decision|0|||
155396175|NCT01994382|560886770|FG007|Overall Study|Physician Decision|0|||
155396176|NCT01994382|560886771|FG008|Overall Study|Physician Decision|0|||
155396177|NCT01994382|560886772|FG009|Overall Study|Physician Decision|0|||
155396178|NCT01994382|560886773|FG010|Overall Study|Physician Decision|3|||
155396179|NCT01994382|560886774|FG011|Overall Study|Physician Decision|1|||
155396180|NCT01994382|560886775|FG012|Overall Study|Physician Decision|1|||
155396181|NCT01994382|560886776|FG013|Overall Study|Physician Decision|0|||
155396182|NCT01994382|560886777|FG014|Overall Study|Physician Decision|1|||
155396183|NCT01994382|560886778|FG015|Overall Study|Physician Decision|4|||
155396184|NCT01994382|560886779|FG016|Overall Study|Physician Decision|2|||
155396185|NCT01994382|560886763|FG000|Overall Study|Death|0|||
155396186|NCT01994382|560886764|FG001|Overall Study|Death|0|||
155396187|NCT01994382|560886765|FG002|Overall Study|Death|0|||
155396188|NCT01994382|560886766|FG003|Overall Study|Death|0|||
155396189|NCT01994382|560886767|FG004|Overall Study|Death|1|||
155396190|NCT01994382|560886768|FG005|Overall Study|Death|0|||
155396191|NCT01994382|560886769|FG006|Overall Study|Death|0|||
155396192|NCT01994382|560886770|FG007|Overall Study|Death|0|||
155396193|NCT01994382|560886771|FG008|Overall Study|Death|1|||
155396194|NCT01994382|560886772|FG009|Overall Study|Death|1|||
155396195|NCT01994382|560886773|FG010|Overall Study|Death|0|||
155396196|NCT01994382|560886774|FG011|Overall Study|Death|0|||
155396197|NCT01994382|560886775|FG012|Overall Study|Death|0|||
155396198|NCT01994382|560886776|FG013|Overall Study|Death|0|||
155396199|NCT01994382|560886777|FG014|Overall Study|Death|0|||
155396200|NCT01994382|560886778|FG015|Overall Study|Death|1|||
155396201|NCT01994382|560886779|FG016|Overall Study|Death|0|||
155396202|NCT01994382|560886763|FG000|Overall Study|Adverse Event|0|||
155396203|NCT01994382|560886764|FG001|Overall Study|Adverse Event|1|||
155396204|NCT01994382|560886765|FG002|Overall Study|Adverse Event|2|||
155396205|NCT01994382|560886766|FG003|Overall Study|Adverse Event|0|||
155396206|NCT01994382|560886767|FG004|Overall Study|Adverse Event|0|||
155396207|NCT01994382|560886768|FG005|Overall Study|Adverse Event|0|||
155396208|NCT01994382|560886769|FG006|Overall Study|Adverse Event|0|||
155396209|NCT01994382|560886770|FG007|Overall Study|Adverse Event|0|||
155396210|NCT01994382|560886771|FG008|Overall Study|Adverse Event|0|||
155396211|NCT01994382|560886772|FG009|Overall Study|Adverse Event|0|||
155396212|NCT01994382|560886773|FG010|Overall Study|Adverse Event|15|||
155396213|NCT01994382|560886774|FG011|Overall Study|Adverse Event|2|||
155396214|NCT01994382|560886775|FG012|Overall Study|Adverse Event|7|||
155396215|NCT01994382|560886776|FG013|Overall Study|Adverse Event|3|||
155396216|NCT01994382|560886777|FG014|Overall Study|Adverse Event|17|||
155396217|NCT01994382|560886778|FG015|Overall Study|Adverse Event|6|||
155396218|NCT01994382|560886779|FG016|Overall Study|Adverse Event|3|||
155396219|NCT01994382|560886763|FG000|Overall Study|Other than specified|0|||
155396220|NCT01994382|560886764|FG001|Overall Study|Other than specified|0|||
155396221|NCT01994382|560886765|FG002|Overall Study|Other than specified|0|||
155396222|NCT01994382|560886766|FG003|Overall Study|Other than specified|0|||
155396223|NCT01994382|560886767|FG004|Overall Study|Other than specified|0|||
155396224|NCT01994382|560886768|FG005|Overall Study|Other than specified|0|||
155396225|NCT01994382|560886769|FG006|Overall Study|Other than specified|0|||
155396226|NCT01994382|560886770|FG007|Overall Study|Other than specified|0|||
155396227|NCT01994382|560886771|FG008|Overall Study|Other than specified|0|||
155396228|NCT01994382|560886772|FG009|Overall Study|Other than specified|0|||
155396229|NCT01994382|560886773|FG010|Overall Study|Other than specified|2|||
155396230|NCT01994382|560886774|FG011|Overall Study|Other than specified|0|||
155396231|NCT01994382|560886775|FG012|Overall Study|Other than specified|2|||
155396232|NCT01994382|560886776|FG013|Overall Study|Other than specified|0|||
155396233|NCT01994382|560886777|FG014|Overall Study|Other than specified|0|||
155396234|NCT01994382|560886778|FG015|Overall Study|Other than specified|4|||
155396235|NCT01994382|560886779|FG016|Overall Study|Other than specified|4|||
155396236|NCT01994382|560886763|FG000|Overall Study|Withdrawal by Subject|0|||
155396237|NCT01994382|560886764|FG001|Overall Study|Withdrawal by Subject|0|||
155396238|NCT01994382|560886765|FG002|Overall Study|Withdrawal by Subject|0|||
155396239|NCT01994382|560886766|FG003|Overall Study|Withdrawal by Subject|0|||
155396240|NCT01994382|560886767|FG004|Overall Study|Withdrawal by Subject|0|||
155396241|NCT01994382|560886768|FG005|Overall Study|Withdrawal by Subject|0|||
155396242|NCT01994382|560886769|FG006|Overall Study|Withdrawal by Subject|0|||
155396243|NCT01994382|560886770|FG007|Overall Study|Withdrawal by Subject|0|||
155396244|NCT01994382|560886771|FG008|Overall Study|Withdrawal by Subject|0|||
155396245|NCT01994382|560886772|FG009|Overall Study|Withdrawal by Subject|0|||
155396246|NCT01994382|560886773|FG010|Overall Study|Withdrawal by Subject|6|||
155396247|NCT01994382|560886774|FG011|Overall Study|Withdrawal by Subject|0|||
155396248|NCT01994382|560886775|FG012|Overall Study|Withdrawal by Subject|2|||
155396249|NCT01994382|560886776|FG013|Overall Study|Withdrawal by Subject|0|||
155396250|NCT01994382|560886777|FG014|Overall Study|Withdrawal by Subject|4|||
155396251|NCT01994382|560886778|FG015|Overall Study|Withdrawal by Subject|3|||
155396252|NCT01994382|560886779|FG016|Overall Study|Withdrawal by Subject|0|||
155396253|NCT01994382|560886763|FG000|Overall Study|Lost to Follow-up|0|||
155396254|NCT01994382|560886764|FG001|Overall Study|Lost to Follow-up|0|||
155396255|NCT01994382|560886765|FG002|Overall Study|Lost to Follow-up|0|||
155396256|NCT01994382|560886766|FG003|Overall Study|Lost to Follow-up|0|||
155396257|NCT01994382|560886767|FG004|Overall Study|Lost to Follow-up|0|||
155396258|NCT01994382|560886768|FG005|Overall Study|Lost to Follow-up|0|||
155396259|NCT01994382|560886769|FG006|Overall Study|Lost to Follow-up|0|||
155396260|NCT01994382|560886770|FG007|Overall Study|Lost to Follow-up|0|||
155396261|NCT01994382|560886771|FG008|Overall Study|Lost to Follow-up|0|||
155396262|NCT01994382|560886772|FG009|Overall Study|Lost to Follow-up|0|||
155396263|NCT01994382|560886773|FG010|Overall Study|Lost to Follow-up|1|||
155396264|NCT01994382|560886774|FG011|Overall Study|Lost to Follow-up|0|||
155396265|NCT01994382|560886775|FG012|Overall Study|Lost to Follow-up|0|||
155396266|NCT01994382|560886776|FG013|Overall Study|Lost to Follow-up|0|||
155396267|NCT01994382|560886777|FG014|Overall Study|Lost to Follow-up|0|||
155396268|NCT01994382|560886778|FG015|Overall Study|Lost to Follow-up|0|||
155636081|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155636082|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155636083|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155636084|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155636085|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155636086|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155650632|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
155650633|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
155741253|NCT02059291|562154818|FG018|Epoch 3|Lack of Efficacy|0|||
155396269|NCT01994382|560886779|FG016|Overall Study|Lost to Follow-up|0|||
155396270|NCT01994382|560886763|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396271|NCT01994382|560886764|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396272|NCT01994382|560886765|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396273|NCT01994382|560886766|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396274|NCT01994382|560886767|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396275|NCT01994382|560886768|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396276|NCT01994382|560886769|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396277|NCT01994382|560886770|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396278|NCT01994382|560886771|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396279|NCT01994382|560886772|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396280|NCT01994382|560886773|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
155396281|NCT01994382|560886774|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396282|NCT01994382|560886775|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
155396283|NCT01994382|560886776|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396284|NCT01994382|560886777|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396285|NCT01994382|560886778|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
155396286|NCT01994382|560886779|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
155396287|NCT01994382|560886763|FG000|Overall Study|Protocol violation/noncompliance|0|||
155396288|NCT01994382|560886764|FG001|Overall Study|Protocol violation/noncompliance|0|||
155396289|NCT01994382|560886765|FG002|Overall Study|Protocol violation/noncompliance|0|||
155396290|NCT01994382|560886766|FG003|Overall Study|Protocol violation/noncompliance|0|||
155396291|NCT01994382|560886767|FG004|Overall Study|Protocol violation/noncompliance|0|||
155396292|NCT01994382|560886768|FG005|Overall Study|Protocol violation/noncompliance|0|||
155396293|NCT01994382|560886769|FG006|Overall Study|Protocol violation/noncompliance|0|||
155396294|NCT01994382|560886770|FG007|Overall Study|Protocol violation/noncompliance|0|||
155396295|NCT01994382|560886771|FG008|Overall Study|Protocol violation/noncompliance|0|||
155396296|NCT01994382|560886772|FG009|Overall Study|Protocol violation/noncompliance|0|||
155396297|NCT01994382|560886773|FG010|Overall Study|Protocol violation/noncompliance|0|||
155396298|NCT01994382|560886774|FG011|Overall Study|Protocol violation/noncompliance|1|||
155396299|NCT01994382|560886775|FG012|Overall Study|Protocol violation/noncompliance|0|||
155396300|NCT01994382|560886776|FG013|Overall Study|Protocol violation/noncompliance|0|||
155396301|NCT01994382|560886777|FG014|Overall Study|Protocol violation/noncompliance|0|||
155396302|NCT01994382|560886778|FG015|Overall Study|Protocol violation/noncompliance|0|||
155396303|NCT01994382|560886779|FG016|Overall Study|Protocol violation/noncompliance|2|||
155396304|NCT01994382|560886763|FG000|Overall Study|Rolled over to Phase 2a|0|||
155396305|NCT01994382|560886764|FG001|Overall Study|Rolled over to Phase 2a|0|||
155396306|NCT01994382|560886765|FG002|Overall Study|Rolled over to Phase 2a|1|||
155396307|NCT01994382|560886766|FG003|Overall Study|Rolled over to Phase 2a|0|||
155396308|NCT01994382|560886767|FG004|Overall Study|Rolled over to Phase 2a|0|||
155396309|NCT01994382|560886768|FG005|Overall Study|Rolled over to Phase 2a|0|||
155396310|NCT01994382|560886769|FG006|Overall Study|Rolled over to Phase 2a|0|||
155396311|NCT01994382|560886770|FG007|Overall Study|Rolled over to Phase 2a|0|||
155396312|NCT01994382|560886771|FG008|Overall Study|Rolled over to Phase 2a|0|||
155396313|NCT01994382|560886772|FG009|Overall Study|Rolled over to Phase 2a|2|||
155396314|NCT01994382|560886773|FG010|Overall Study|Rolled over to Phase 2a|0|||
155741254|NCT02059291|562154819|FG019|Epoch 3|Lack of Efficacy|0|||
155741255|NCT02059291|562154820|FG020|Epoch 3|Lack of Efficacy|0|||
155283984|NCT01515319|560470905|FG001|Overall Study|Withdrawal by Subject|0|||
155283985|NCT01515319|560470906|FG002|Overall Study|Withdrawal by Subject|0|||
155396315|NCT01994382|560886774|FG011|Overall Study|Rolled over to Phase 2a|0|||
155396316|NCT01994382|560886775|FG012|Overall Study|Rolled over to Phase 2a|0|||
155396317|NCT01994382|560886776|FG013|Overall Study|Rolled over to Phase 2a|0|||
155396318|NCT01994382|560886777|FG014|Overall Study|Rolled over to Phase 2a|0|||
155396319|NCT01994382|560886778|FG015|Overall Study|Rolled over to Phase 2a|0|||
155396320|NCT01994382|560886779|FG016|Overall Study|Rolled over to Phase 2a|0|||
155396321|NCT00314249|560886780|FG000|Overall Study|Adverse Event|73|||
155396322|NCT00314249|560886781|FG001|Overall Study|Adverse Event|94|||
155396323|NCT00314249|560886780|FG000|Overall Study|Lack of Efficacy|33|||
155396324|NCT00314249|560886781|FG001|Overall Study|Lack of Efficacy|24|||
155396325|NCT00314249|560886780|FG000|Overall Study|Withdrawal by Subject|21|||
155396326|NCT00314249|560886781|FG001|Overall Study|Withdrawal by Subject|28|||
155396327|NCT00314249|560886780|FG000|Overall Study|Lost to Follow-up|15|||
155396328|NCT00314249|560886781|FG001|Overall Study|Lost to Follow-up|9|||
155396329|NCT00314249|560886780|FG000|Overall Study|Physician Decision|1|||
155396330|NCT00314249|560886781|FG001|Overall Study|Physician Decision|1|||
155396331|NCT00314249|560886780|FG000|Overall Study|Withdrawn for other reasons|4|||
155283986|NCT01515319|560470907|FG003|Overall Study|Withdrawal by Subject|0|||
155283987|NCT01515319|560470908|FG004|Overall Study|Withdrawal by Subject|0|||
155283988|NCT01515319|560470909|FG005|Overall Study|Withdrawal by Subject|0|||
155396332|NCT00314249|560886781|FG001|Overall Study|Withdrawn for other reasons|1|||
155396333|NCT00314249|560886780|FG000|Overall Study|Non-Compliant|5|||
155396334|NCT00314249|560886781|FG001|Overall Study|Non-Compliant|6|||
155396335|NCT04667377|560886782|FG000|Dose Escalation Period|Other not specified below|3|||
155396336|NCT04667377|560886783|FG001|Dose Escalation Period|Other not specified below|3|||
155396337|NCT04667377|560886784|FG002|Dose Escalation Period|Other not specified below|2|||
155396338|NCT04667377|560886785|FG003|Dose Escalation Period|Other not specified below|1|||
155396339|NCT04667377|560886786|FG004|Dose Escalation Period|Other not specified below|3|||
155396340|NCT04667377|560886782|FG000|Dose Escalation Period|Protocol Violation|2|||
155396341|NCT04667377|560886783|FG001|Dose Escalation Period|Protocol Violation|2|||
155396342|NCT04667377|560886784|FG002|Dose Escalation Period|Protocol Violation|0|||
155396343|NCT04667377|560886785|FG003|Dose Escalation Period|Protocol Violation|2|||
155396344|NCT04667377|560886786|FG004|Dose Escalation Period|Protocol Violation|1|||
155396345|NCT04667377|560886782|FG000|Dose Escalation Period|Burden of study procedures|2|||
155396346|NCT04667377|560886783|FG001|Dose Escalation Period|Burden of study procedures|1|||
155396347|NCT04667377|560886784|FG002|Dose Escalation Period|Burden of study procedures|1|||
155396348|NCT04667377|560886785|FG003|Dose Escalation Period|Burden of study procedures|1|||
155396349|NCT04667377|560886786|FG004|Dose Escalation Period|Burden of study procedures|5|||
155396350|NCT04667377|560886782|FG000|Dose Escalation Period|Change of residence|0|||
155396351|NCT04667377|560886783|FG001|Dose Escalation Period|Change of residence|0|||
155396352|NCT04667377|560886784|FG002|Dose Escalation Period|Change of residence|1|||
155396353|NCT04667377|560886785|FG003|Dose Escalation Period|Change of residence|0|||
155396354|NCT04667377|560886786|FG004|Dose Escalation Period|Change of residence|0|||
155396355|NCT04667377|560886782|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
155396356|NCT04667377|560886783|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
155396357|NCT04667377|560886784|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
155396358|NCT04667377|560886785|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
155396359|NCT04667377|560886786|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
155396360|NCT04667377|560886782|FG000|Dose Escalation Period|Adverse Event|9|||
155396361|NCT04667377|560886783|FG001|Dose Escalation Period|Adverse Event|10|||
155396362|NCT04667377|560886784|FG002|Dose Escalation Period|Adverse Event|12|||
155396363|NCT04667377|560886785|FG003|Dose Escalation Period|Adverse Event|17|||
155396364|NCT04667377|560886786|FG004|Dose Escalation Period|Adverse Event|3|||
155396365|NCT04667377|560886782|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
155396366|NCT04667377|560886783|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
155396367|NCT04667377|560886784|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
155396368|NCT04667377|560886785|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
155396369|NCT04667377|560886786|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
155396370|NCT04667377|560886782|FG000|Dose Escalation Period|Not treated|1|||
155396371|NCT04667377|560886783|FG001|Dose Escalation Period|Not treated|0|||
155396372|NCT04667377|560886784|FG002|Dose Escalation Period|Not treated|0|||
155396373|NCT04667377|560886785|FG003|Dose Escalation Period|Not treated|0|||
155396374|NCT04667377|560886786|FG004|Dose Escalation Period|Not treated|0|||
155396375|NCT04667377|560886782|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
155396376|NCT04667377|560886783|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
155396377|NCT04667377|560886784|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
155396378|NCT04667377|560886785|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
155396379|NCT04667377|560886786|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
155396380|NCT04667377|560886782|FG000|Dose Escalation Period|Lost to Follow-up|0|||
155396381|NCT04667377|560886783|FG001|Dose Escalation Period|Lost to Follow-up|1|||
155396382|NCT04667377|560886784|FG002|Dose Escalation Period|Lost to Follow-up|0|||
155396383|NCT04667377|560886785|FG003|Dose Escalation Period|Lost to Follow-up|0|||
155396384|NCT04667377|560886786|FG004|Dose Escalation Period|Lost to Follow-up|0|||
155396385|NCT04667377|560886782|FG000|Maintenance Period|Perceived lack of efficacy|0|||
155396386|NCT04667377|560886783|FG001|Maintenance Period|Perceived lack of efficacy|2|||
155396387|NCT04667377|560886784|FG002|Maintenance Period|Perceived lack of efficacy|1|||
155396388|NCT04667377|560886785|FG003|Maintenance Period|Perceived lack of efficacy|0|||
155396389|NCT04667377|560886786|FG004|Maintenance Period|Perceived lack of efficacy|1|||
155396390|NCT04667377|560886782|FG000|Maintenance Period|Adverse Event|2|||
155396391|NCT04667377|560886783|FG001|Maintenance Period|Adverse Event|8|||
155396392|NCT04667377|560886784|FG002|Maintenance Period|Adverse Event|5|||
155396393|NCT04667377|560886785|FG003|Maintenance Period|Adverse Event|4|||
155396394|NCT04667377|560886786|FG004|Maintenance Period|Adverse Event|1|||
155396395|NCT04667377|560886782|FG000|Maintenance Period|Adverse event: COVID infection|0|||
155396396|NCT04667377|560886783|FG001|Maintenance Period|Adverse event: COVID infection|1|||
155396397|NCT04667377|560886784|FG002|Maintenance Period|Adverse event: COVID infection|0|||
155396398|NCT04667377|560886785|FG003|Maintenance Period|Adverse event: COVID infection|0|||
155396399|NCT04667377|560886786|FG004|Maintenance Period|Adverse event: COVID infection|0|||
155396400|NCT04667377|560886782|FG000|Maintenance Period|COVID-related|0|||
155396401|NCT04667377|560886783|FG001|Maintenance Period|COVID-related|0|||
155396402|NCT04667377|560886784|FG002|Maintenance Period|COVID-related|1|||
155396403|NCT04667377|560886785|FG003|Maintenance Period|COVID-related|1|||
155396404|NCT04667377|560886786|FG004|Maintenance Period|COVID-related|0|||
155396405|NCT04667377|560886782|FG000|Maintenance Period|Protocol Violation|1|||
155396406|NCT04667377|560886783|FG001|Maintenance Period|Protocol Violation|0|||
155396407|NCT04667377|560886784|FG002|Maintenance Period|Protocol Violation|0|||
155396408|NCT04667377|560886785|FG003|Maintenance Period|Protocol Violation|0|||
155396409|NCT04667377|560886786|FG004|Maintenance Period|Protocol Violation|1|||
155396410|NCT04667377|560886782|FG000|Maintenance Period|Burden of study procedures|1|||
155396411|NCT04667377|560886783|FG001|Maintenance Period|Burden of study procedures|2|||
155396412|NCT04667377|560886784|FG002|Maintenance Period|Burden of study procedures|0|||
155396413|NCT04667377|560886785|FG003|Maintenance Period|Burden of study procedures|1|||
155396414|NCT04667377|560886786|FG004|Maintenance Period|Burden of study procedures|0|||
155396415|NCT04667377|560886782|FG000|Maintenance Period|Change of residence|0|||
155396416|NCT04667377|560886783|FG001|Maintenance Period|Change of residence|1|||
155396417|NCT04667377|560886784|FG002|Maintenance Period|Change of residence|0|||
155396418|NCT04667377|560886785|FG003|Maintenance Period|Change of residence|0|||
155396419|NCT04667377|560886786|FG004|Maintenance Period|Change of residence|1|||
155396420|NCT04667377|560886782|FG000|Maintenance Period|Missing|1|||
155396421|NCT04667377|560886783|FG001|Maintenance Period|Missing|0|||
155396422|NCT04667377|560886784|FG002|Maintenance Period|Missing|0|||
155396423|NCT04667377|560886785|FG003|Maintenance Period|Missing|0|||
155396424|NCT04667377|560886786|FG004|Maintenance Period|Missing|0|||
155396425|NCT04667377|560886782|FG000|Maintenance Period|Other than listed above|2|||
155396426|NCT04667377|560886783|FG001|Maintenance Period|Other than listed above|0|||
155396427|NCT04667377|560886784|FG002|Maintenance Period|Other than listed above|3|||
155396428|NCT04667377|560886785|FG003|Maintenance Period|Other than listed above|2|||
155396429|NCT04667377|560886786|FG004|Maintenance Period|Other than listed above|6|||
155396430|NCT04667377|560886782|FG000|Maintenance Period|Withdrawal by Subject|0|||
155396431|NCT04667377|560886783|FG001|Maintenance Period|Withdrawal by Subject|1|||
155396432|NCT04667377|560886784|FG002|Maintenance Period|Withdrawal by Subject|0|||
155396433|NCT04667377|560886785|FG003|Maintenance Period|Withdrawal by Subject|0|||
155396434|NCT04667377|560886786|FG004|Maintenance Period|Withdrawal by Subject|0|||
155396435|NCT04667377|560886782|FG000|Maintenance Period|Lost to Follow-up|1|||
155396436|NCT04667377|560886783|FG001|Maintenance Period|Lost to Follow-up|0|||
155396437|NCT04667377|560886784|FG002|Maintenance Period|Lost to Follow-up|1|||
155396438|NCT04667377|560886785|FG003|Maintenance Period|Lost to Follow-up|0|||
155396439|NCT04667377|560886786|FG004|Maintenance Period|Lost to Follow-up|1|||
155396440|NCT02066311|560886787|FG000|Overall Study|Adverse Event|4|||
155396441|NCT02066311|560886787|FG000|Overall Study|Withdrawal by Subject|1|||
155396442|NCT00359021|560886788|FG000|Overall Study|Adverse Event|26|||
155396443|NCT00359021|560886789|FG001|Overall Study|Adverse Event|8|||
155396444|NCT00359021|560886788|FG000|Overall Study|Subject Non-Compliant|1|||
155396445|NCT00359021|560886789|FG001|Overall Study|Subject Non-Compliant|2|||
155396446|NCT00359021|560886788|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
155396447|NCT00359021|560886789|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
155396448|NCT00359021|560886788|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
155396449|NCT00359021|560886789|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
155396450|NCT00359021|560886788|FG000|Overall Study|Withdrawal by Subject|2|||
155396451|NCT00359021|560886789|FG001|Overall Study|Withdrawal by Subject|9|||
155396452|NCT00359021|560886788|FG000|Overall Study|Lost to Follow-up|1|||
155396453|NCT00359021|560886789|FG001|Overall Study|Lost to Follow-up|0|||
155396454|NCT00359021|560886788|FG000|Overall Study|Other|4|||
155396455|NCT00359021|560886789|FG001|Overall Study|Other|1|||
155396456|NCT00359021|560886788|FG000|Overall Study|Pregnancy|1|||
155396457|NCT00359021|560886789|FG001|Overall Study|Pregnancy|0|||
155396458|NCT03861936|560886790|FG000|Overall Study|Withdrawal by Subject|4|||
155396459|NCT03861936|560886791|FG001|Overall Study|Withdrawal by Subject|1|||
155396460|NCT03861936|560886792|FG002|Overall Study|Withdrawal by Subject|3|||
155396461|NCT03861936|560886790|FG000|Overall Study|Lost to Follow-up|5|||
155396462|NCT03861936|560886791|FG001|Overall Study|Lost to Follow-up|3|||
155396463|NCT03861936|560886792|FG002|Overall Study|Lost to Follow-up|3|||
155396464|NCT03861936|560886790|FG000|Overall Study|Physician Decision|0|||
155396465|NCT03861936|560886791|FG001|Overall Study|Physician Decision|1|||
155396466|NCT03861936|560886792|FG002|Overall Study|Physician Decision|0|||
155396467|NCT03861936|560886790|FG000|Overall Study|Protocol Deviation|0|||
155396468|NCT03861936|560886791|FG001|Overall Study|Protocol Deviation|0|||
155396469|NCT03861936|560886792|FG002|Overall Study|Protocol Deviation|1|||
155396470|NCT03861936|560886790|FG000|Overall Study|Reason not Specified|5|||
155396471|NCT03861936|560886791|FG001|Overall Study|Reason not Specified|5|||
155396472|NCT03861936|560886792|FG002|Overall Study|Reason not Specified|3|||
155636087|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
155636088|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155650634|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
155396473|NCT05418673|560886795|FG000|Overall Study|Study Terminated by Sponsor|2|||
155396474|NCT05418673|560886796|FG001|Overall Study|Study Terminated by Sponsor|4|||
155396475|NCT05418673|560886795|FG000|Overall Study|Lost to Follow-up|1|||
155396476|NCT05418673|560886796|FG001|Overall Study|Lost to Follow-up|0|||
155396477|NCT01986920|560886799|FG000|A- 101 25%|Withdrawal by Subject|1|||
155396478|NCT01986920|560886800|FG001|A- 101 25%|Withdrawal by Subject|0|||
155396479|NCT01986920|560886801|FG002|A- 101 25%|Withdrawal by Subject|0|||
155396480|NCT01986920|560886802|FG003|A- 101 25%|Withdrawal by Subject|0|||
155396481|NCT01986920|560886799|FG000|A-101 32.5%|Withdrawal by Subject|0|||
155396482|NCT01986920|560886800|FG001|A-101 32.5%|Withdrawal by Subject|1|||
155396483|NCT01986920|560886801|FG002|A-101 32.5%|Withdrawal by Subject|0|||
155396484|NCT01986920|560886802|FG003|A-101 32.5%|Withdrawal by Subject|0|||
155396485|NCT01986920|560886799|FG000|A-101 40%|Withdrawal by Subject|0|||
155396486|NCT01986920|560886800|FG001|A-101 40%|Withdrawal by Subject|0|||
155396487|NCT01986920|560886801|FG002|A-101 40%|Withdrawal by Subject|1|||
155396488|NCT01986920|560886802|FG003|A-101 40%|Withdrawal by Subject|0|||
155396489|NCT01986920|560886799|FG000|Placebo|Withdrawal by Subject|0|||
155396490|NCT01986920|560886800|FG001|Placebo|Withdrawal by Subject|0|||
155396491|NCT01986920|560886801|FG002|Placebo|Withdrawal by Subject|0|||
155396492|NCT01986920|560886802|FG003|Placebo|Withdrawal by Subject|1|||
155396493|NCT01338415|560886803|FG000|Core + Extension|Adverse Event|8|||
155396494|NCT01338415|560886804|FG001|Core + Extension|Adverse Event|6|||
155396495|NCT01338415|560886805|FG002|Core + Extension|Adverse Event|0|||
155396496|NCT01338415|560886803|FG000|Core + Extension|Withdrawal by Subject|1|||
155396497|NCT01338415|560886804|FG001|Core + Extension|Withdrawal by Subject|1|||
155396498|NCT01338415|560886805|FG002|Core + Extension|Withdrawal by Subject|0|||
155396499|NCT01338415|560886803|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
155396500|NCT01338415|560886804|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
155396501|NCT01338415|560886805|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
155396502|NCT01338415|560886803|FG000|Core + Extension|Other (administrative reason)|1|||
155396503|NCT01338415|560886804|FG001|Core + Extension|Other (administrative reason)|0|||
155396504|NCT01338415|560886805|FG002|Core + Extension|Other (administrative reason)|0|||
155396505|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
155396506|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
155396507|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
155396508|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
155396509|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
155396510|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
155396511|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
155396512|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
155396513|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
155396514|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Death|0|||
155396515|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Death|0|||
155396516|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Death|1|||
155396517|NCT01118325|560886806|FG000|Overall Study|Adverse Event|1|||
155396518|NCT01118325|560886807|FG001|Overall Study|Adverse Event|0|||
155396519|NCT01118325|560886808|FG002|Overall Study|Adverse Event|1|||
155396520|NCT03334409|560886809|FG000|Overall Study|Did not meet inclusion criteria|1|||
155396521|NCT03334409|560886810|FG001|Overall Study|Did not meet inclusion criteria|0|||
155396522|NCT01526551|560886819|FG000|Overall Study|Lack of returned parental consent form|424|||
155396523|NCT00874770|560886820|FG000|Overall Study|Lack of Efficacy|2|||
155396524|NCT00874770|560886821|FG001|Overall Study|Lack of Efficacy|0|||
155396525|NCT00874770|560886822|FG002|Overall Study|Lack of Efficacy|0|||
155396526|NCT00874770|560886823|FG003|Overall Study|Lack of Efficacy|2|||
155396527|NCT00874770|560886820|FG000|Overall Study|Adverse Event|1|||
155396528|NCT00874770|560886821|FG001|Overall Study|Adverse Event|1|||
155396529|NCT00874770|560886822|FG002|Overall Study|Adverse Event|4|||
155396530|NCT00874770|560886823|FG003|Overall Study|Adverse Event|2|||
155396531|NCT00874770|560886820|FG000|Overall Study|Lost to Follow-up|1|||
155396532|NCT00874770|560886821|FG001|Overall Study|Lost to Follow-up|0|||
155396533|NCT00874770|560886822|FG002|Overall Study|Lost to Follow-up|0|||
155396534|NCT00874770|560886823|FG003|Overall Study|Lost to Follow-up|1|||
155396535|NCT00874770|560886820|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
155396536|NCT00874770|560886821|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396537|NCT00874770|560886822|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396538|NCT00874770|560886823|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396539|NCT05215262|560886824|FG000|Overall Study|Lost to Follow-up|12|||
155396540|NCT05215262|560886825|FG001|Overall Study|Lost to Follow-up|0|||
155396541|NCT00718549|560886827|FG000|Induction Phase|Disease Progression|1|||
155396542|NCT00718549|560886828|FG001|Induction Phase|Disease Progression|0|||
155396543|NCT00718549|560886829|FG002|Induction Phase|Disease Progression|0|||
155396544|NCT00718549|560886827|FG000|Induction Phase|Eligibility Criteria Violation|2|||
155396545|NCT00718549|560886828|FG001|Induction Phase|Eligibility Criteria Violation|0|||
155396546|NCT00718549|560886829|FG002|Induction Phase|Eligibility Criteria Violation|0|||
155396547|NCT00718549|560886827|FG000|Induction Phase|Early Termination - No Additional Info|59|||
155396548|NCT00718549|560886828|FG001|Induction Phase|Early Termination - No Additional Info|0|||
155396549|NCT00718549|560886829|FG002|Induction Phase|Early Termination - No Additional Info|0|||
155396550|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
155396551|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
155396552|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
155396553|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Death|0|||
155396554|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Death|1|||
155396555|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Death|2|||
155396556|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
155396557|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
155396558|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
155396559|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Progression|0|||
155396560|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Progression|5|||
155396561|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Progression|14|||
155396562|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Relapse|0|||
155396563|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Relapse|3|||
155396564|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Relapse|2|||
155396565|NCT01576172|560886830|FG000|Overall Study|Ineligible|2|||
155396566|NCT01576172|560886831|FG001|Overall Study|Ineligible|1|||
155396567|NCT01576172|560886830|FG000|Overall Study|Withdrawal by Subject|2|||
155396568|NCT01576172|560886831|FG001|Overall Study|Withdrawal by Subject|0|||
155396569|NCT01576172|560886830|FG000|Overall Study|Insurance issue|1|||
155396570|NCT01576172|560886831|FG001|Overall Study|Insurance issue|0|||
155396571|NCT02092350|560886836|FG000|Overall Study|Adverse Event|0|||
155396572|NCT02092350|560886837|FG001|Overall Study|Adverse Event|3|||
155396573|NCT02092350|560886836|FG000|Overall Study|Death|2|||
155396574|NCT02092350|560886837|FG001|Overall Study|Death|5|||
155396575|NCT02092350|560886836|FG000|Overall Study|Lost to Follow-up|3|||
155396576|NCT02092350|560886837|FG001|Overall Study|Lost to Follow-up|1|||
155396577|NCT02092350|560886836|FG000|Overall Study|Protocol Violation|1|||
155396578|NCT02092350|560886837|FG001|Overall Study|Protocol Violation|0|||
155396579|NCT02092350|560886836|FG000|Overall Study|Physician Decision|1|||
155396580|NCT02092350|560886837|FG001|Overall Study|Physician Decision|1|||
155396581|NCT02092350|560886836|FG000|Overall Study|Screen Failure|1|||
155396582|NCT02092350|560886837|FG001|Overall Study|Screen Failure|0|||
155396583|NCT02092350|560886836|FG000|Overall Study|Withdrawal by Subject|2|||
155396584|NCT02092350|560886837|FG001|Overall Study|Withdrawal by Subject|2|||
155396585|NCT00239226|560886838|FG000|Overall Study|permAF during stabilization period|0|||
155396586|NCT00239226|560886839|FG001|Overall Study|permAF during stabilization period|0|||
155396587|NCT00239226|560886840|FG002|Overall Study|permAF during stabilization period|0|||
155396588|NCT00239226|560886841|FG003|Overall Study|permAF during stabilization period|3|||
155396589|NCT00239226|560886838|FG000|Overall Study|Lost to Follow-up|1|||
155396590|NCT00239226|560886839|FG001|Overall Study|Lost to Follow-up|0|||
155396591|NCT00239226|560886840|FG002|Overall Study|Lost to Follow-up|1|||
155396592|NCT00239226|560886841|FG003|Overall Study|Lost to Follow-up|0|||
155396593|NCT00646906|560886842|FG000|Crossover Period 1|Withdrawal by Subject|1|||
155396594|NCT00646906|560886843|FG001|Crossover Period 1|Withdrawal by Subject|0|||
155396595|NCT00646906|560886844|FG002|Crossover Period 1|Withdrawal by Subject|0|||
155396596|NCT00646906|560886845|FG003|Crossover Period 1|Withdrawal by Subject|0|||
155396597|NCT00646906|560886846|FG004|Crossover Period 1|Withdrawal by Subject|0|||
155396598|NCT00646906|560886847|FG005|Crossover Period 1|Withdrawal by Subject|1|||
155396599|NCT00646906|560886848|FG006|Crossover Period 1|Withdrawal by Subject|0|||
155396600|NCT00646906|560886842|FG000|Crossover Period 2|Withdrawal by Subject|0|||
155396601|NCT00646906|560886843|FG001|Crossover Period 2|Withdrawal by Subject|1|||
155396602|NCT00646906|560886844|FG002|Crossover Period 2|Withdrawal by Subject|2|||
155396603|NCT00646906|560886845|FG003|Crossover Period 2|Withdrawal by Subject|1|||
155396604|NCT00646906|560886846|FG004|Crossover Period 2|Withdrawal by Subject|0|||
155396605|NCT00646906|560886847|FG005|Crossover Period 2|Withdrawal by Subject|0|||
155396606|NCT00646906|560886848|FG006|Crossover Period 2|Withdrawal by Subject|0|||
155396607|NCT00646906|560886842|FG000|Crossover Period 2|Physician Decision|0|||
155396608|NCT00646906|560886843|FG001|Crossover Period 2|Physician Decision|0|||
155396609|NCT00646906|560886844|FG002|Crossover Period 2|Physician Decision|0|||
155396610|NCT00646906|560886845|FG003|Crossover Period 2|Physician Decision|0|||
155396611|NCT00646906|560886846|FG004|Crossover Period 2|Physician Decision|0|||
155636089|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155636090|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155636091|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155636092|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155636093|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155741256|NCT02059291|562154821|FG021|Epoch 3|Lack of Efficacy|0|||
155741257|NCT02059291|562154822|FG022|Epoch 3|Lack of Efficacy|0|||
155396612|NCT00646906|560886847|FG005|Crossover Period 2|Physician Decision|0|||
155396613|NCT00646906|560886848|FG006|Crossover Period 2|Physician Decision|1|||
155396614|NCT01303965|560886849|FG000|Overall Study|Adverse Event|1|||
155396615|NCT01303965|560886850|FG001|Overall Study|Adverse Event|1|||
155396616|NCT01303965|560886849|FG000|Overall Study|Death|0|||
155396617|NCT01303965|560886850|FG001|Overall Study|Death|3|||
155396618|NCT01303965|560886849|FG000|Overall Study|Withdrawal by Subject|1|||
155396619|NCT01303965|560886850|FG001|Overall Study|Withdrawal by Subject|0|||
155396620|NCT01303965|560886849|FG000|Overall Study|Disease Progression|1|||
155396621|NCT01303965|560886850|FG001|Overall Study|Disease Progression|6|||
155396622|NCT02448225|560886854|FG000|Overall Study|Withdrawal by Subject|1|||
155396623|NCT02448225|560886854|FG000|Overall Study|Did not get FSPG scan|18|||
155396624|NCT02448225|560886854|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
155396625|NCT04060563|560886855|FG000|Overall Study|Lost to Follow-up|1|||
155396626|NCT04060563|560886856|FG001|Overall Study|Lost to Follow-up|1|||
155396627|NCT04060563|560886855|FG000|Overall Study|Physician Decision|0|||
155396628|NCT04060563|560886856|FG001|Overall Study|Physician Decision|1|||
155396629|NCT00962390|560886864|FG000|Overall Study|Adverse Event|0|||
155396630|NCT00962390|560886865|FG001|Overall Study|Adverse Event|0|||
155396631|NCT00962390|560886866|FG002|Overall Study|Adverse Event|3|||
155396632|NCT00962390|560886867|FG003|Overall Study|Adverse Event|1|||
155396633|NCT00962390|560886864|FG000|Overall Study|Lost to Follow-up|2|||
155396634|NCT00962390|560886865|FG001|Overall Study|Lost to Follow-up|2|||
155396635|NCT00962390|560886866|FG002|Overall Study|Lost to Follow-up|0|||
155396636|NCT00962390|560886867|FG003|Overall Study|Lost to Follow-up|0|||
155396637|NCT00962390|560886864|FG000|Overall Study|Protocol Violation|1|||
155396638|NCT00962390|560886865|FG001|Overall Study|Protocol Violation|0|||
155396639|NCT00962390|560886866|FG002|Overall Study|Protocol Violation|0|||
155396640|NCT00962390|560886867|FG003|Overall Study|Protocol Violation|0|||
155396641|NCT00962390|560886864|FG000|Overall Study|Withdrawal by Subject|1|||
155396642|NCT00962390|560886865|FG001|Overall Study|Withdrawal by Subject|1|||
155396643|NCT00962390|560886866|FG002|Overall Study|Withdrawal by Subject|1|||
155396644|NCT00962390|560886867|FG003|Overall Study|Withdrawal by Subject|0|||
155396645|NCT02613884|560886868|FG000|Overall Study|Death|1|||
155396646|NCT02613884|560886868|FG000|Overall Study|Lost to Follow-up|1|||
155396647|NCT00131469|560886874|FG000|Overall Study|Withdrawal by Subject|3|||
155396648|NCT00131469|560886875|FG001|Overall Study|Withdrawal by Subject|4|||
155396649|NCT00131469|560886874|FG000|Overall Study|Protocol Violation|3|||
155396650|NCT00131469|560886875|FG001|Overall Study|Protocol Violation|1|||
155396651|NCT00131469|560886874|FG000|Overall Study|Death|0|||
155396652|NCT00131469|560886875|FG001|Overall Study|Death|1|||
155396653|NCT00131469|560886874|FG000|Overall Study|Lost to Follow-up|0|||
155396654|NCT00131469|560886875|FG001|Overall Study|Lost to Follow-up|1|||
155396655|NCT00131469|560886874|FG000|Overall Study|scan not analyzable|3|||
155396656|NCT00131469|560886875|FG001|Overall Study|scan not analyzable|6|||
155396657|NCT01910116|560886877|FG000|Overall Study|Adverse Event|0|||
155396658|NCT01910116|560886878|FG001|Overall Study|Adverse Event|3|||
155396659|NCT01910116|560886877|FG000|Overall Study|Lack of Efficacy|3|||
155396660|NCT01910116|560886878|FG001|Overall Study|Lack of Efficacy|4|||
155396661|NCT01910116|560886877|FG000|Overall Study|Lost to Follow-up|1|||
155396662|NCT01910116|560886878|FG001|Overall Study|Lost to Follow-up|0|||
155396663|NCT01910116|560886877|FG000|Overall Study|Protocol Violation|1|||
155396664|NCT01910116|560886878|FG001|Overall Study|Protocol Violation|2|||
155396665|NCT01910116|560886877|FG000|Overall Study|Withdrawal by Subject|8|||
155396666|NCT01910116|560886878|FG001|Overall Study|Withdrawal by Subject|3|||
155396667|NCT01910116|560886877|FG000|Overall Study|uncertain allocation|1|||
155396668|NCT01910116|560886878|FG001|Overall Study|uncertain allocation|3|||
155396669|NCT01910116|560886877|FG000|Overall Study|incomplete data|0|||
155396670|NCT01910116|560886878|FG001|Overall Study|incomplete data|1|||
155396671|NCT00911625|560886882|FG000|Overall Study|Lost to Follow-up|7|||
155396672|NCT00911625|560886883|FG001|Overall Study|Lost to Follow-up|0|||
155396673|NCT00590044|560886884|FG000|Overall Study|Withdrawal by Subject|2|||
155396674|NCT00590044|560886885|FG001|Overall Study|Withdrawal by Subject|2|||
155396675|NCT00590044|560886884|FG000|Overall Study|wrong insulin arm assigned|1|||
155396676|NCT00590044|560886885|FG001|Overall Study|wrong insulin arm assigned|0|||
155396677|NCT00590044|560886884|FG000|Overall Study|Protocol Violation|1|||
155396678|NCT00590044|560886885|FG001|Overall Study|Protocol Violation|0|||
155396679|NCT00888381|560886886|FG000|Overall Study|Lost to Follow-up|0|||
155396680|NCT00888381|560886887|FG001|Overall Study|Lost to Follow-up|1|||
155396681|NCT02729740|560886888|FG000|Overall Study|Early Termination|130|||
155396682|NCT02729740|560886888|FG000|Overall Study|Other|1|||
155396683|NCT00757003|560886889|FG000|Overall Study|Death|33|||
155396684|NCT00757003|560886889|FG000|Overall Study|Lost to Follow-up|9|||
155396685|NCT00757003|560886889|FG000|Overall Study|Withdrawal by Subject|4|||
155396686|NCT00757003|560886889|FG000|Overall Study|Surgically explanted|2|||
155396687|NCT00757003|560886889|FG000|Overall Study|Not implanted|1|||
155396688|NCT03044249|560886892|FG000|Overall Study|Adverse Event|4|||
155396689|NCT03044249|560886893|FG001|Overall Study|Adverse Event|9|||
155396690|NCT03044249|560886892|FG000|Overall Study|Lost to Follow-up|1|||
155396691|NCT03044249|560886893|FG001|Overall Study|Lost to Follow-up|0|||
155396692|NCT03044249|560886892|FG000|Overall Study|Non-compliance with Study Drug|1|||
155396693|NCT03044249|560886893|FG001|Overall Study|Non-compliance with Study Drug|0|||
155396694|NCT03044249|560886892|FG000|Overall Study|Study Terminated by Sponsor|2|||
155396695|NCT03044249|560886893|FG001|Overall Study|Study Terminated by Sponsor|0|||
155396696|NCT03044249|560886892|FG000|Overall Study|Withdrawal by Subject|2|||
155396697|NCT03044249|560886893|FG001|Overall Study|Withdrawal by Subject|5|||
155396698|NCT03785678|560886906|FG000|Overall Study|Death|44|||
155396699|NCT03785678|560886907|FG001|Overall Study|Death|42|||
155396700|NCT03785678|560886906|FG000|Overall Study|Lost to Follow-up|4|||
155396701|NCT03785678|560886907|FG001|Overall Study|Lost to Follow-up|2|||
155396702|NCT03785678|560886906|FG000|Overall Study|Physician Decision|0|||
155396703|NCT03785678|560886907|FG001|Overall Study|Physician Decision|2|||
155396704|NCT03785678|560886906|FG000|Overall Study|Withdrawal by Subject|5|||
155396705|NCT03785678|560886907|FG001|Overall Study|Withdrawal by Subject|3|||
155396706|NCT02374021|560886908|FG000|Overall Study|Adverse Event|1|||
155396707|NCT02374021|560886909|FG001|Overall Study|Adverse Event|0|||
155396708|NCT02374021|560886908|FG000|Overall Study|Lost to Follow-up|3|||
155396709|NCT02374021|560886909|FG001|Overall Study|Lost to Follow-up|2|||
155396710|NCT02374021|560886908|FG000|Overall Study|Physician Decision|0|||
155396711|NCT02374021|560886909|FG001|Overall Study|Physician Decision|3|||
155396712|NCT02374021|560886908|FG000|Overall Study|Withdrawal by Subject|6|||
155396713|NCT02374021|560886909|FG001|Overall Study|Withdrawal by Subject|5|||
155396714|NCT02374021|560886908|FG000|Overall Study|Poor Adherence|0|||
155396715|NCT02374021|560886909|FG001|Overall Study|Poor Adherence|1|||
155396716|NCT02374021|560886908|FG000|Overall Study|Scan protocol not followed|0|||
155396717|NCT02374021|560886909|FG001|Overall Study|Scan protocol not followed|1|||
155396718|NCT02374021|560886908|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
155396719|NCT02374021|560886909|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
155396720|NCT03007979|560886910|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
155396721|NCT01624259|560886911|FG000|Overall Study|Adverse Event|18|||
155396722|NCT01624259|560886912|FG001|Overall Study|Adverse Event|18|||
155396723|NCT01624259|560886911|FG000|Overall Study|Protocol Violation|1|||
155396724|NCT01624259|560886912|FG001|Overall Study|Protocol Violation|2|||
155396725|NCT01624259|560886911|FG000|Overall Study|Withdrawal by Subject|5|||
155396726|NCT01624259|560886912|FG001|Overall Study|Withdrawal by Subject|7|||
155396727|NCT01624259|560886911|FG000|Overall Study|Physician Decision|1|||
155396728|NCT01624259|560886912|FG001|Overall Study|Physician Decision|1|||
155396729|NCT01624259|560886911|FG000|Overall Study|Lost to Follow-up|2|||
155396730|NCT01624259|560886912|FG001|Overall Study|Lost to Follow-up|3|||
155396731|NCT01624259|560886911|FG000|Overall Study|Abnormal laboratory measure|3|||
155396732|NCT01624259|560886912|FG001|Overall Study|Abnormal laboratory measure|0|||
155396733|NCT01298518|560886913|FG000|Overall Study|Withdrawal by Subject|0|||
155396734|NCT01298518|560886914|FG001|Overall Study|Withdrawal by Subject|0|||
155396735|NCT01298518|560886915|FG002|Overall Study|Withdrawal by Subject|1|||
155396736|NCT02273726|560886916|FG000|Overall Study|Death|70|||
155396737|NCT02273726|560886917|FG001|Overall Study|Death|62|||
155396738|NCT02273726|560886916|FG000|Overall Study|Withdrawal by Subject|41|||
155396739|NCT02273726|560886917|FG001|Overall Study|Withdrawal by Subject|29|||
155396740|NCT02273726|560886916|FG000|Overall Study|Kidney transplant|31|||
155396741|NCT02273726|560886917|FG001|Overall Study|Kidney transplant|39|||
155396742|NCT02273726|560886916|FG000|Overall Study|Physician Decision|30|||
155396743|NCT02273726|560886917|FG001|Overall Study|Physician Decision|15|||
155396744|NCT02273726|560886916|FG000|Overall Study|Adverse Event|27|||
155396745|NCT02273726|560886917|FG001|Overall Study|Adverse Event|9|||
155396746|NCT02273726|560886916|FG000|Overall Study|Lost to Follow-up|6|||
155396747|NCT02273726|560886917|FG001|Overall Study|Lost to Follow-up|3|||
155396748|NCT02273726|560886916|FG000|Overall Study|Lack of Efficacy|6|||
155396749|NCT02273726|560886917|FG001|Overall Study|Lack of Efficacy|1|||
155396750|NCT02273726|560886916|FG000|Overall Study|Protocol Violation|4|||
155396751|NCT02273726|560886917|FG001|Overall Study|Protocol Violation|0|||
155396752|NCT02273726|560886916|FG000|Overall Study|Other than specified|28|||
155396753|NCT02273726|560886917|FG001|Overall Study|Other than specified|30|||
155396754|NCT01979835|560886918|FG000|Primary Outcome SA Measurment|failed insertion|18|||
155396755|NCT01979835|560886918|FG000|Follow-up|Lost to Follow-up|32|||
155396756|NCT01479829|560886919|FG000|Overall Study|Withdrawal by Subject|8|||
155396757|NCT01479829|560886920|FG001|Overall Study|Withdrawal by Subject|10|||
155396758|NCT01444456|560886925|FG000|Overall Study|Withdrawal by Subject|21|||
155396759|NCT01444456|560886925|FG000|Overall Study|Physician Decision|9|||
155396760|NCT01444456|560886925|FG000|Overall Study|Lost to Follow-up|37|||
155396761|NCT01444456|560886925|FG000|Overall Study|Death|73|||
155396762|NCT01444456|560886925|FG000|Overall Study|Ineligibility determined|23|||
155396763|NCT01444456|560886925|FG000|Overall Study|Other|18|||
155396764|NCT01444456|560886925|FG000|Overall Study|Not treated|104|||
155396765|NCT02142738|560888448|FG000|Overall Study|Adverse Event|13|||
155396766|NCT02142738|560888449|FG001|Overall Study|Adverse Event|9|||
155396767|NCT02142738|560888448|FG000|Overall Study|Death|92|||
155396768|NCT02142738|560888449|FG001|Overall Study|Death|112|||
155396769|NCT02142738|560888448|FG000|Overall Study|Lost to Follow-up|0|||
155396770|NCT02142738|560888449|FG001|Overall Study|Lost to Follow-up|3|||
155396771|NCT02142738|560888448|FG000|Overall Study|Withdrawal by Subject|6|||
155396772|NCT02142738|560888449|FG001|Overall Study|Withdrawal by Subject|7|||
155396773|NCT02142738|560888448|FG000|Overall Study|Follow up ended by sponsor|43|||
155396774|NCT02142738|560888449|FG001|Overall Study|Follow up ended by sponsor|20|||
155396775|NCT01168973|560888451|FG000|Overall Study|Progressive Disease|341|||
155396776|NCT01168973|560888452|FG001|Overall Study|Progressive Disease|429|||
155396777|NCT01168973|560888451|FG000|Overall Study|Adverse Event|94|||
155396778|NCT01168973|560888452|FG001|Overall Study|Adverse Event|55|||
155396779|NCT01168973|560888451|FG000|Overall Study|Withdrawal by Subject|90|||
155396780|NCT01168973|560888452|FG001|Overall Study|Withdrawal by Subject|53|||
155396781|NCT01168973|560888451|FG000|Overall Study|Death|42|||
155396782|NCT01168973|560888452|FG001|Overall Study|Death|45|||
155396783|NCT01168973|560888451|FG000|Overall Study|Physician Decision|37|||
155396784|NCT01168973|560888452|FG001|Overall Study|Physician Decision|19|||
155396785|NCT01168973|560888451|FG000|Overall Study|Sponsor Decision|2|||
155396786|NCT01168973|560888452|FG001|Overall Study|Sponsor Decision|1|||
155396787|NCT01168973|560888451|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
155396788|NCT01168973|560888452|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
155396789|NCT00930722|560888453|FG000|Overall Study|Lost to Follow-up|16|||
155396790|NCT00930722|560888453|FG000|Overall Study|No longer willing to participate|9|||
155396791|NCT00930722|560888453|FG000|Overall Study|Study terminated by sponsor|2|||
155396792|NCT00388505|560888456|FG000|Overall Study|Adverse Event or Death|43|||
155396793|NCT00388505|560888457|FG001|Overall Study|Adverse Event or Death|17|||
155396794|NCT00388505|560888456|FG000|Overall Study|Withdrawal by Subject|24|||
155396795|NCT00388505|560888457|FG001|Overall Study|Withdrawal by Subject|9|||
155396796|NCT00388505|560888456|FG000|Overall Study|Lost to Follow-up|5|||
155396797|NCT00388505|560888457|FG001|Overall Study|Lost to Follow-up|3|||
155396798|NCT00388505|560888456|FG000|Overall Study|Inappropriate Enrollment|0|||
155396799|NCT00388505|560888457|FG001|Overall Study|Inappropriate Enrollment|1|||
155396800|NCT00388505|560888456|FG000|Overall Study|Administrative Reason|1|||
155396801|NCT00388505|560888457|FG001|Overall Study|Administrative Reason|0|||
155396802|NCT00388505|560888456|FG000|Overall Study|Protocol Violation|6|||
155396803|NCT00388505|560888457|FG001|Overall Study|Protocol Violation|5|||
155396804|NCT00388505|560888456|FG000|Overall Study|Unable to classify|4|||
155396805|NCT00388505|560888457|FG001|Overall Study|Unable to classify|3|||
155396806|NCT02285920|560888461|FG000|Overall Study|Kidney transplantation|2|||
155396807|NCT02285920|560888462|FG001|Overall Study|Kidney transplantation|2|||
155396808|NCT02285920|560888463|FG002|Overall Study|Kidney transplantation|2|||
155396809|NCT02285920|560888464|FG003|Overall Study|Kidney transplantation|0|||
155396810|NCT02285920|560888461|FG000|Overall Study|Change to peritoneal dialysis|0|||
155396811|NCT02285920|560888462|FG001|Overall Study|Change to peritoneal dialysis|0|||
155396812|NCT02285920|560888463|FG002|Overall Study|Change to peritoneal dialysis|1|||
155396813|NCT02285920|560888464|FG003|Overall Study|Change to peritoneal dialysis|0|||
155396814|NCT02285920|560888461|FG000|Overall Study|Transfer to non-participating unit|0|||
155396815|NCT02285920|560888462|FG001|Overall Study|Transfer to non-participating unit|1|||
155396816|NCT02285920|560888463|FG002|Overall Study|Transfer to non-participating unit|0|||
155396817|NCT02285920|560888464|FG003|Overall Study|Transfer to non-participating unit|0|||
155396818|NCT02285920|560888461|FG000|Overall Study|Dialysis discontinuation|0|||
155396819|NCT02285920|560888462|FG001|Overall Study|Dialysis discontinuation|1|||
155396820|NCT02285920|560888463|FG002|Overall Study|Dialysis discontinuation|0|||
155396821|NCT02285920|560888464|FG003|Overall Study|Dialysis discontinuation|0|||
155396822|NCT02285920|560888461|FG000|Overall Study|Death|2|||
155396823|NCT02285920|560888462|FG001|Overall Study|Death|0|||
155396824|NCT02285920|560888463|FG002|Overall Study|Death|2|||
155396825|NCT02285920|560888464|FG003|Overall Study|Death|1|||
155396826|NCT01383096|560888469|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396827|NCT01383096|560888470|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396828|NCT01383096|560888471|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
155396829|NCT01383096|560888469|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155396830|NCT01383096|560888470|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396831|NCT01383096|560888471|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396832|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Elevated AST|0|||
155396833|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Elevated AST|1|||
155396834|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Elevated AST|0|||
155396835|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
155396836|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
155396837|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396838|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Adverse Event|1|||
155396839|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Adverse Event|0|||
155396840|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Adverse Event|0|||
155396841|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
155396842|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
155396843|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
155396844|NCT01383096|560888469|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
155396845|NCT01383096|560888470|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396846|NCT01383096|560888471|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396847|NCT01383096|560888469|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396848|NCT01383096|560888470|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155435859|NCT01591330|561022971|FG003|Period 1|Adverse Event|0|||
155396849|NCT01383096|560888471|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155396850|NCT01383096|560888469|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
155396851|NCT01383096|560888470|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396852|NCT01383096|560888471|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396853|NCT01383096|560888469|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
155396854|NCT01383096|560888470|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
155396855|NCT01383096|560888471|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
155396856|NCT01383096|560888469|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
155396857|NCT01383096|560888470|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
155396858|NCT01383096|560888471|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
155396859|NCT00616434|560888476|FG000|Overall Study|Adverse Event|5|||
155396860|NCT00616434|560888477|FG001|Overall Study|Adverse Event|2|||
155396861|NCT00616434|560888476|FG000|Overall Study|Physician Decision|0|||
155396862|NCT00616434|560888477|FG001|Overall Study|Physician Decision|4|||
155396863|NCT00616434|560888476|FG000|Overall Study|Withdrawal by Subject|1|||
155396864|NCT00616434|560888477|FG001|Overall Study|Withdrawal by Subject|1|||
155396865|NCT00616434|560888476|FG000|Overall Study|Protocol deviation|0|||
155396866|NCT00616434|560888477|FG001|Overall Study|Protocol deviation|1|||
155396867|NCT00467779|560888478|FG000|Stage 1|Adverse Event|1|||
155396868|NCT00467779|560888479|FG001|Stage 1|Adverse Event|0|||
155396869|NCT00467779|560888480|FG002|Stage 1|Adverse Event|0|||
155396870|NCT00467779|560888481|FG003|Stage 1|Adverse Event|0|||
155396871|NCT00467779|560888482|FG004|Stage 1|Adverse Event|0|||
155396872|NCT00467779|560888483|FG005|Stage 1|Adverse Event|1|||
155396873|NCT00467779|560888484|FG006|Stage 1|Adverse Event|2|||
155396874|NCT00467779|560888485|FG007|Stage 1|Adverse Event|1|||
155396875|NCT00467779|560888486|FG008|Stage 1|Adverse Event|0|||
155396876|NCT00467779|560888487|FG009|Stage 1|Adverse Event|0|||
155396877|NCT00467779|560888488|FG010|Stage 1|Adverse Event|0|||
155396878|NCT00467779|560888489|FG011|Stage 1|Adverse Event|0|||
155396879|NCT00467779|560888490|FG012|Stage 1|Adverse Event|0|||
155396880|NCT00467779|560888491|FG013|Stage 1|Adverse Event|0|||
155396881|NCT00467779|560888492|FG014|Stage 1|Adverse Event|0|||
155396882|NCT00467779|560888478|FG000|Stage 1|Disease Progression|2|||
155396883|NCT00467779|560888479|FG001|Stage 1|Disease Progression|2|||
155396884|NCT00467779|560888480|FG002|Stage 1|Disease Progression|2|||
155396885|NCT00467779|560888481|FG003|Stage 1|Disease Progression|3|||
155396886|NCT00467779|560888482|FG004|Stage 1|Disease Progression|2|||
155396887|NCT00467779|560888483|FG005|Stage 1|Disease Progression|2|||
155396888|NCT00467779|560888484|FG006|Stage 1|Disease Progression|4|||
155396889|NCT00467779|560888485|FG007|Stage 1|Disease Progression|5|||
155396890|NCT00467779|560888486|FG008|Stage 1|Disease Progression|0|||
155396891|NCT00467779|560888487|FG009|Stage 1|Disease Progression|0|||
155396892|NCT00467779|560888488|FG010|Stage 1|Disease Progression|0|||
155396893|NCT00467779|560888489|FG011|Stage 1|Disease Progression|0|||
155396894|NCT00467779|560888490|FG012|Stage 1|Disease Progression|0|||
155396895|NCT00467779|560888491|FG013|Stage 1|Disease Progression|0|||
155396896|NCT00467779|560888492|FG014|Stage 1|Disease Progression|0|||
155396897|NCT00467779|560888478|FG000|Stage 1|Unspecified Reason|1|||
155396898|NCT00467779|560888479|FG001|Stage 1|Unspecified Reason|0|||
155396899|NCT00467779|560888480|FG002|Stage 1|Unspecified Reason|1|||
155396900|NCT00467779|560888481|FG003|Stage 1|Unspecified Reason|0|||
155396901|NCT00467779|560888482|FG004|Stage 1|Unspecified Reason|1|||
155396902|NCT00467779|560888483|FG005|Stage 1|Unspecified Reason|2|||
155396903|NCT00467779|560888484|FG006|Stage 1|Unspecified Reason|0|||
155396904|NCT00467779|560888485|FG007|Stage 1|Unspecified Reason|0|||
155396905|NCT00467779|560888486|FG008|Stage 1|Unspecified Reason|0|||
155396906|NCT00467779|560888487|FG009|Stage 1|Unspecified Reason|0|||
155396907|NCT00467779|560888488|FG010|Stage 1|Unspecified Reason|0|||
155396908|NCT00467779|560888489|FG011|Stage 1|Unspecified Reason|0|||
155396909|NCT00467779|560888490|FG012|Stage 1|Unspecified Reason|0|||
155396910|NCT00467779|560888491|FG013|Stage 1|Unspecified Reason|0|||
155396911|NCT00467779|560888492|FG014|Stage 1|Unspecified Reason|0|||
155396912|NCT00467779|560888478|FG000|Stage 1|Physician Decision|0|||
155396913|NCT00467779|560888479|FG001|Stage 1|Physician Decision|1|||
155396914|NCT00467779|560888480|FG002|Stage 1|Physician Decision|0|||
155396915|NCT00467779|560888481|FG003|Stage 1|Physician Decision|0|||
155396916|NCT00467779|560888482|FG004|Stage 1|Physician Decision|0|||
155396917|NCT00467779|560888483|FG005|Stage 1|Physician Decision|0|||
155396918|NCT00467779|560888484|FG006|Stage 1|Physician Decision|0|||
155741258|NCT02059291|562154823|FG023|Epoch 3|Lack of Efficacy|0|||
155741259|NCT02059291|562154824|FG024|Epoch 3|Lack of Efficacy|0|||
155741260|NCT02059291|562154800|FG000|Epoch 3|Withdrawal by Subject|0|||
155741261|NCT02059291|562154801|FG001|Epoch 3|Withdrawal by Subject|0|||
155741262|NCT02059291|562154802|FG002|Epoch 3|Withdrawal by Subject|0|||
155741263|NCT02059291|562154803|FG003|Epoch 3|Withdrawal by Subject|0|||
155741264|NCT02059291|562154804|FG004|Epoch 3|Withdrawal by Subject|0|||
155741265|NCT02059291|562154805|FG005|Epoch 3|Withdrawal by Subject|0|||
155741266|NCT02059291|562154806|FG006|Epoch 3|Withdrawal by Subject|0|||
155741267|NCT02059291|562154807|FG007|Epoch 3|Withdrawal by Subject|0|||
155741268|NCT02059291|562154808|FG008|Epoch 3|Withdrawal by Subject|0|||
155741269|NCT02059291|562154809|FG009|Epoch 3|Withdrawal by Subject|0|||
155741270|NCT02059291|562154810|FG010|Epoch 3|Withdrawal by Subject|0|||
155741271|NCT02059291|562154811|FG011|Epoch 3|Withdrawal by Subject|0|||
155741272|NCT02059291|562154812|FG012|Epoch 3|Withdrawal by Subject|0|||
155741273|NCT02059291|562154813|FG013|Epoch 3|Withdrawal by Subject|0|||
155396919|NCT00467779|560888485|FG007|Stage 1|Physician Decision|0|||
155396920|NCT00467779|560888486|FG008|Stage 1|Physician Decision|0|||
155396921|NCT00467779|560888487|FG009|Stage 1|Physician Decision|0|||
155396922|NCT00467779|560888488|FG010|Stage 1|Physician Decision|0|||
155396923|NCT00467779|560888489|FG011|Stage 1|Physician Decision|0|||
155396924|NCT00467779|560888490|FG012|Stage 1|Physician Decision|0|||
155396925|NCT00467779|560888491|FG013|Stage 1|Physician Decision|0|||
155396926|NCT00467779|560888492|FG014|Stage 1|Physician Decision|0|||
155396927|NCT00467779|560888478|FG000|Stage 1|Withdrawal by Subject|0|||
155396928|NCT00467779|560888479|FG001|Stage 1|Withdrawal by Subject|0|||
155396929|NCT00467779|560888480|FG002|Stage 1|Withdrawal by Subject|0|||
155396930|NCT00467779|560888481|FG003|Stage 1|Withdrawal by Subject|0|||
155396931|NCT00467779|560888482|FG004|Stage 1|Withdrawal by Subject|0|||
155396932|NCT00467779|560888483|FG005|Stage 1|Withdrawal by Subject|0|||
155396933|NCT00467779|560888484|FG006|Stage 1|Withdrawal by Subject|1|||
155396934|NCT00467779|560888485|FG007|Stage 1|Withdrawal by Subject|1|||
155396935|NCT00467779|560888486|FG008|Stage 1|Withdrawal by Subject|0|||
155396936|NCT00467779|560888487|FG009|Stage 1|Withdrawal by Subject|0|||
155396937|NCT00467779|560888488|FG010|Stage 1|Withdrawal by Subject|0|||
155396938|NCT00467779|560888489|FG011|Stage 1|Withdrawal by Subject|0|||
155396939|NCT00467779|560888490|FG012|Stage 1|Withdrawal by Subject|0|||
155396940|NCT00467779|560888491|FG013|Stage 1|Withdrawal by Subject|0|||
155396941|NCT00467779|560888492|FG014|Stage 1|Withdrawal by Subject|0|||
155396942|NCT00467779|560888478|FG000|Stage 1A|Adverse Event|0|||
155396943|NCT00467779|560888479|FG001|Stage 1A|Adverse Event|0|||
155396944|NCT00467779|560888480|FG002|Stage 1A|Adverse Event|0|||
155396945|NCT00467779|560888481|FG003|Stage 1A|Adverse Event|0|||
155396946|NCT00467779|560888482|FG004|Stage 1A|Adverse Event|0|||
155396947|NCT00467779|560888483|FG005|Stage 1A|Adverse Event|0|||
155396948|NCT00467779|560888484|FG006|Stage 1A|Adverse Event|0|||
155741274|NCT02059291|562154814|FG014|Epoch 3|Withdrawal by Subject|0|||
155741275|NCT02059291|562154815|FG015|Epoch 3|Withdrawal by Subject|1|||
155741276|NCT02059291|562154816|FG016|Epoch 3|Withdrawal by Subject|0|||
155741277|NCT02059291|562154817|FG017|Epoch 3|Withdrawal by Subject|0|||
155741278|NCT02059291|562154818|FG018|Epoch 3|Withdrawal by Subject|0|||
155741279|NCT02059291|562154819|FG019|Epoch 3|Withdrawal by Subject|0|||
155741280|NCT02059291|562154820|FG020|Epoch 3|Withdrawal by Subject|0|||
155741281|NCT02059291|562154821|FG021|Epoch 3|Withdrawal by Subject|0|||
155741282|NCT02059291|562154822|FG022|Epoch 3|Withdrawal by Subject|0|||
155741283|NCT02059291|562154823|FG023|Epoch 3|Withdrawal by Subject|0|||
155741284|NCT02059291|562154824|FG024|Epoch 3|Withdrawal by Subject|0|||
155396949|NCT00467779|560888485|FG007|Stage 1A|Adverse Event|0|||
155396950|NCT00467779|560888486|FG008|Stage 1A|Adverse Event|0|||
155396951|NCT00467779|560888487|FG009|Stage 1A|Adverse Event|0|||
155741285|NCT02059291|562154800|FG000|Epoch 4|Adverse Event|0|||
155741286|NCT02059291|562154801|FG001|Epoch 4|Adverse Event|0|||
155741287|NCT02059291|562154802|FG002|Epoch 4|Adverse Event|0|||
155741288|NCT02059291|562154803|FG003|Epoch 4|Adverse Event|0|||
155396952|NCT00467779|560888488|FG010|Stage 1A|Adverse Event|0|||
155396953|NCT00467779|560888489|FG011|Stage 1A|Adverse Event|0|||
155396954|NCT00467779|560888490|FG012|Stage 1A|Adverse Event|1|||
155396955|NCT00467779|560888491|FG013|Stage 1A|Adverse Event|0|||
155396956|NCT00467779|560888492|FG014|Stage 1A|Adverse Event|0|||
155396957|NCT00467779|560888478|FG000|Stage 1A|Death|0|||
155396958|NCT00467779|560888479|FG001|Stage 1A|Death|0|||
155396959|NCT00467779|560888480|FG002|Stage 1A|Death|0|||
155396960|NCT00467779|560888481|FG003|Stage 1A|Death|0|||
155396961|NCT00467779|560888482|FG004|Stage 1A|Death|0|||
155396962|NCT00467779|560888483|FG005|Stage 1A|Death|0|||
155396963|NCT00467779|560888484|FG006|Stage 1A|Death|0|||
155396964|NCT00467779|560888485|FG007|Stage 1A|Death|0|||
155741289|NCT02059291|562154804|FG004|Epoch 4|Adverse Event|0|||
155741290|NCT02059291|562154805|FG005|Epoch 4|Adverse Event|0|||
155741291|NCT02059291|562154806|FG006|Epoch 4|Adverse Event|0|||
155741292|NCT02059291|562154807|FG007|Epoch 4|Adverse Event|0|||
155741293|NCT02059291|562154808|FG008|Epoch 4|Adverse Event|0|||
155741294|NCT02059291|562154809|FG009|Epoch 4|Adverse Event|0|||
155741295|NCT02059291|562154810|FG010|Epoch 4|Adverse Event|0|||
155741296|NCT02059291|562154811|FG011|Epoch 4|Adverse Event|0|||
155741297|NCT02059291|562154812|FG012|Epoch 4|Adverse Event|0|||
155741298|NCT02059291|562154813|FG013|Epoch 4|Adverse Event|0|||
155741299|NCT02059291|562154814|FG014|Epoch 4|Adverse Event|0|||
155741300|NCT02059291|562154815|FG015|Epoch 4|Adverse Event|0|||
155741301|NCT02059291|562154816|FG016|Epoch 4|Adverse Event|1|||
155741302|NCT02059291|562154817|FG017|Epoch 4|Adverse Event|0|||
155741303|NCT02059291|562154818|FG018|Epoch 4|Adverse Event|0|||
155741304|NCT02059291|562154819|FG019|Epoch 4|Adverse Event|0|||
155741305|NCT02059291|562154820|FG020|Epoch 4|Adverse Event|0|||
155396965|NCT00467779|560888486|FG008|Stage 1A|Death|0|||
155650635|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
155741306|NCT02059291|562154821|FG021|Epoch 4|Adverse Event|0|||
155741307|NCT02059291|562154822|FG022|Epoch 4|Adverse Event|1|||
155396966|NCT00467779|560888487|FG009|Stage 1A|Death|0|||
155396967|NCT00467779|560888488|FG010|Stage 1A|Death|0|||
155396968|NCT00467779|560888489|FG011|Stage 1A|Death|1|||
155396969|NCT00467779|560888490|FG012|Stage 1A|Death|1|||
155396970|NCT00467779|560888491|FG013|Stage 1A|Death|0|||
155396971|NCT00467779|560888492|FG014|Stage 1A|Death|0|||
155396972|NCT00467779|560888478|FG000|Stage 1A|Disease Progression|0|||
155396973|NCT00467779|560888479|FG001|Stage 1A|Disease Progression|0|||
155396974|NCT00467779|560888480|FG002|Stage 1A|Disease Progression|0|||
155396975|NCT00467779|560888481|FG003|Stage 1A|Disease Progression|0|||
155396976|NCT00467779|560888482|FG004|Stage 1A|Disease Progression|0|||
155396977|NCT00467779|560888483|FG005|Stage 1A|Disease Progression|0|||
155396978|NCT00467779|560888484|FG006|Stage 1A|Disease Progression|0|||
155396979|NCT00467779|560888485|FG007|Stage 1A|Disease Progression|0|||
155396980|NCT00467779|560888486|FG008|Stage 1A|Disease Progression|0|||
155396981|NCT00467779|560888487|FG009|Stage 1A|Disease Progression|2|||
155396982|NCT00467779|560888488|FG010|Stage 1A|Disease Progression|2|||
155396983|NCT00467779|560888489|FG011|Stage 1A|Disease Progression|5|||
155396984|NCT00467779|560888490|FG012|Stage 1A|Disease Progression|2|||
155396985|NCT00467779|560888491|FG013|Stage 1A|Disease Progression|0|||
155396986|NCT00467779|560888492|FG014|Stage 1A|Disease Progression|0|||
155396987|NCT00467779|560888478|FG000|Stage 1A|Physician Decision|0|||
155396988|NCT00467779|560888479|FG001|Stage 1A|Physician Decision|0|||
155396989|NCT00467779|560888480|FG002|Stage 1A|Physician Decision|0|||
155396990|NCT00467779|560888481|FG003|Stage 1A|Physician Decision|0|||
155283989|NCT01515319|560470910|FG006|Overall Study|Withdrawal by Subject|1|||
155396991|NCT00467779|560888482|FG004|Stage 1A|Physician Decision|0|||
155396992|NCT00467779|560888483|FG005|Stage 1A|Physician Decision|0|||
155396993|NCT00467779|560888484|FG006|Stage 1A|Physician Decision|0|||
155396994|NCT00467779|560888485|FG007|Stage 1A|Physician Decision|0|||
155396995|NCT00467779|560888486|FG008|Stage 1A|Physician Decision|0|||
155396996|NCT00467779|560888487|FG009|Stage 1A|Physician Decision|1|||
155396997|NCT00467779|560888488|FG010|Stage 1A|Physician Decision|0|||
155396998|NCT00467779|560888489|FG011|Stage 1A|Physician Decision|0|||
155396999|NCT00467779|560888490|FG012|Stage 1A|Physician Decision|0|||
155397000|NCT00467779|560888491|FG013|Stage 1A|Physician Decision|0|||
155397001|NCT00467779|560888492|FG014|Stage 1A|Physician Decision|0|||
155397002|NCT00467779|560888478|FG000|Stage 1A|Withdrawal by Subject|0|||
155397003|NCT00467779|560888479|FG001|Stage 1A|Withdrawal by Subject|0|||
155397004|NCT00467779|560888480|FG002|Stage 1A|Withdrawal by Subject|0|||
155397005|NCT00467779|560888481|FG003|Stage 1A|Withdrawal by Subject|0|||
155397006|NCT00467779|560888482|FG004|Stage 1A|Withdrawal by Subject|0|||
155397007|NCT00467779|560888483|FG005|Stage 1A|Withdrawal by Subject|0|||
155397008|NCT00467779|560888484|FG006|Stage 1A|Withdrawal by Subject|0|||
155397009|NCT00467779|560888485|FG007|Stage 1A|Withdrawal by Subject|0|||
155397010|NCT00467779|560888486|FG008|Stage 1A|Withdrawal by Subject|0|||
155397011|NCT00467779|560888487|FG009|Stage 1A|Withdrawal by Subject|0|||
155397012|NCT00467779|560888488|FG010|Stage 1A|Withdrawal by Subject|1|||
155397013|NCT00467779|560888489|FG011|Stage 1A|Withdrawal by Subject|1|||
155397014|NCT00467779|560888490|FG012|Stage 1A|Withdrawal by Subject|1|||
155397015|NCT00467779|560888491|FG013|Stage 1A|Withdrawal by Subject|0|||
155397016|NCT00467779|560888492|FG014|Stage 1A|Withdrawal by Subject|0|||
155397017|NCT00467779|560888478|FG000|Stage 1A|Unspecified Reason|0|||
155397018|NCT00467779|560888479|FG001|Stage 1A|Unspecified Reason|0|||
155397019|NCT00467779|560888480|FG002|Stage 1A|Unspecified Reason|0|||
155397020|NCT00467779|560888481|FG003|Stage 1A|Unspecified Reason|0|||
155397021|NCT00467779|560888482|FG004|Stage 1A|Unspecified Reason|0|||
155397022|NCT00467779|560888483|FG005|Stage 1A|Unspecified Reason|0|||
155397023|NCT00467779|560888484|FG006|Stage 1A|Unspecified Reason|0|||
155397024|NCT00467779|560888485|FG007|Stage 1A|Unspecified Reason|0|||
155741308|NCT02059291|562154823|FG023|Epoch 4|Adverse Event|0|||
155741309|NCT02059291|562154824|FG024|Epoch 4|Adverse Event|0|||
155741310|NCT02059291|562154800|FG000|Epoch 4|Pregnancy|0|||
155741311|NCT02059291|562154801|FG001|Epoch 4|Pregnancy|0|||
155741312|NCT02059291|562154802|FG002|Epoch 4|Pregnancy|0|||
155741313|NCT02059291|562154803|FG003|Epoch 4|Pregnancy|0|||
155741314|NCT02059291|562154804|FG004|Epoch 4|Pregnancy|0|||
155741315|NCT02059291|562154805|FG005|Epoch 4|Pregnancy|0|||
155741316|NCT02059291|562154806|FG006|Epoch 4|Pregnancy|0|||
155741317|NCT02059291|562154807|FG007|Epoch 4|Pregnancy|0|||
155741318|NCT02059291|562154808|FG008|Epoch 4|Pregnancy|0|||
155741319|NCT02059291|562154809|FG009|Epoch 4|Pregnancy|0|||
155741320|NCT02059291|562154810|FG010|Epoch 4|Pregnancy|0|||
155741321|NCT02059291|562154811|FG011|Epoch 4|Pregnancy|0|||
155741322|NCT02059291|562154812|FG012|Epoch 4|Pregnancy|0|||
155741323|NCT02059291|562154813|FG013|Epoch 4|Pregnancy|0|||
155741324|NCT02059291|562154814|FG014|Epoch 4|Pregnancy|0|||
155397025|NCT00467779|560888486|FG008|Stage 1A|Unspecified Reason|0|||
155397026|NCT00467779|560888487|FG009|Stage 1A|Unspecified Reason|0|||
155397027|NCT00467779|560888488|FG010|Stage 1A|Unspecified Reason|0|||
155397028|NCT00467779|560888489|FG011|Stage 1A|Unspecified Reason|1|||
155397029|NCT00467779|560888490|FG012|Stage 1A|Unspecified Reason|1|||
155397030|NCT00467779|560888491|FG013|Stage 1A|Unspecified Reason|0|||
155741325|NCT02059291|562154815|FG015|Epoch 4|Pregnancy|0|||
155741326|NCT02059291|562154816|FG016|Epoch 4|Pregnancy|1|||
155397031|NCT00467779|560888492|FG014|Stage 1A|Unspecified Reason|0|||
155397032|NCT00467779|560888478|FG000|Stage 2|Adverse Event|0|||
155397033|NCT00467779|560888479|FG001|Stage 2|Adverse Event|0|||
155397034|NCT00467779|560888480|FG002|Stage 2|Adverse Event|0|||
155397035|NCT00467779|560888481|FG003|Stage 2|Adverse Event|0|||
155397036|NCT00467779|560888482|FG004|Stage 2|Adverse Event|0|||
155397037|NCT00467779|560888483|FG005|Stage 2|Adverse Event|0|||
155397038|NCT00467779|560888484|FG006|Stage 2|Adverse Event|0|||
155397039|NCT00467779|560888485|FG007|Stage 2|Adverse Event|0|||
155397040|NCT00467779|560888486|FG008|Stage 2|Adverse Event|1|||
155397041|NCT00467779|560888487|FG009|Stage 2|Adverse Event|0|||
155397042|NCT00467779|560888488|FG010|Stage 2|Adverse Event|0|||
155397043|NCT00467779|560888489|FG011|Stage 2|Adverse Event|0|||
155397044|NCT00467779|560888490|FG012|Stage 2|Adverse Event|0|||
155397045|NCT00467779|560888491|FG013|Stage 2|Adverse Event|0|||
155397046|NCT00467779|560888492|FG014|Stage 2|Adverse Event|0|||
155397047|NCT00467779|560888478|FG000|Stage 2|Death|0|||
155397048|NCT00467779|560888479|FG001|Stage 2|Death|0|||
155397049|NCT00467779|560888480|FG002|Stage 2|Death|0|||
155397050|NCT00467779|560888481|FG003|Stage 2|Death|0|||
155397051|NCT00467779|560888482|FG004|Stage 2|Death|0|||
155397052|NCT00467779|560888483|FG005|Stage 2|Death|0|||
155397053|NCT00467779|560888484|FG006|Stage 2|Death|0|||
155397054|NCT00467779|560888485|FG007|Stage 2|Death|0|||
155397055|NCT00467779|560888486|FG008|Stage 2|Death|1|||
155397056|NCT00467779|560888487|FG009|Stage 2|Death|0|||
155397057|NCT00467779|560888488|FG010|Stage 2|Death|0|||
155397058|NCT00467779|560888489|FG011|Stage 2|Death|0|||
155397059|NCT00467779|560888490|FG012|Stage 2|Death|0|||
155397060|NCT00467779|560888491|FG013|Stage 2|Death|0|||
155397061|NCT00467779|560888492|FG014|Stage 2|Death|0|||
155397062|NCT00467779|560888478|FG000|Stage 2|Disease Progression|0|||
155397063|NCT00467779|560888479|FG001|Stage 2|Disease Progression|0|||
155397064|NCT00467779|560888480|FG002|Stage 2|Disease Progression|0|||
155397065|NCT00467779|560888481|FG003|Stage 2|Disease Progression|0|||
155397066|NCT00467779|560888482|FG004|Stage 2|Disease Progression|0|||
155397067|NCT00467779|560888483|FG005|Stage 2|Disease Progression|0|||
155397068|NCT00467779|560888484|FG006|Stage 2|Disease Progression|0|||
155397069|NCT00467779|560888485|FG007|Stage 2|Disease Progression|0|||
155397070|NCT00467779|560888486|FG008|Stage 2|Disease Progression|16|||
155397071|NCT00467779|560888487|FG009|Stage 2|Disease Progression|0|||
155397072|NCT00467779|560888488|FG010|Stage 2|Disease Progression|0|||
155397073|NCT00467779|560888489|FG011|Stage 2|Disease Progression|0|||
155397074|NCT00467779|560888490|FG012|Stage 2|Disease Progression|0|||
155397075|NCT00467779|560888491|FG013|Stage 2|Disease Progression|0|||
155397076|NCT00467779|560888492|FG014|Stage 2|Disease Progression|0|||
155397077|NCT00467779|560888478|FG000|Stage 2|Unspecified Reason|0|||
155397078|NCT00467779|560888479|FG001|Stage 2|Unspecified Reason|0|||
155397079|NCT00467779|560888480|FG002|Stage 2|Unspecified Reason|0|||
155397080|NCT00467779|560888481|FG003|Stage 2|Unspecified Reason|0|||
155397081|NCT00467779|560888482|FG004|Stage 2|Unspecified Reason|0|||
155397082|NCT00467779|560888483|FG005|Stage 2|Unspecified Reason|0|||
155397083|NCT00467779|560888484|FG006|Stage 2|Unspecified Reason|0|||
155397084|NCT00467779|560888485|FG007|Stage 2|Unspecified Reason|0|||
155397085|NCT00467779|560888486|FG008|Stage 2|Unspecified Reason|3|||
155397086|NCT00467779|560888487|FG009|Stage 2|Unspecified Reason|0|||
155397087|NCT00467779|560888488|FG010|Stage 2|Unspecified Reason|0|||
155397088|NCT00467779|560888489|FG011|Stage 2|Unspecified Reason|0|||
155397089|NCT00467779|560888490|FG012|Stage 2|Unspecified Reason|0|||
155397090|NCT00467779|560888491|FG013|Stage 2|Unspecified Reason|0|||
155397091|NCT00467779|560888492|FG014|Stage 2|Unspecified Reason|0|||
155397092|NCT00467779|560888478|FG000|Stage 2A|Adverse Event|0|||
155397093|NCT00467779|560888479|FG001|Stage 2A|Adverse Event|0|||
155397094|NCT00467779|560888480|FG002|Stage 2A|Adverse Event|0|||
155397095|NCT00467779|560888481|FG003|Stage 2A|Adverse Event|0|||
155397096|NCT00467779|560888482|FG004|Stage 2A|Adverse Event|0|||
155397097|NCT00467779|560888483|FG005|Stage 2A|Adverse Event|0|||
155397098|NCT00467779|560888484|FG006|Stage 2A|Adverse Event|0|||
155397099|NCT00467779|560888485|FG007|Stage 2A|Adverse Event|0|||
155397100|NCT00467779|560888486|FG008|Stage 2A|Adverse Event|0|||
155397101|NCT00467779|560888487|FG009|Stage 2A|Adverse Event|0|||
155397102|NCT00467779|560888488|FG010|Stage 2A|Adverse Event|0|||
155397103|NCT00467779|560888489|FG011|Stage 2A|Adverse Event|0|||
155397104|NCT00467779|560888490|FG012|Stage 2A|Adverse Event|0|||
155397105|NCT00467779|560888491|FG013|Stage 2A|Adverse Event|2|||
155397106|NCT00467779|560888492|FG014|Stage 2A|Adverse Event|0|||
155397107|NCT00467779|560888478|FG000|Stage 2A|Death|0|||
155397108|NCT00467779|560888479|FG001|Stage 2A|Death|0|||
155397109|NCT00467779|560888480|FG002|Stage 2A|Death|0|||
155397110|NCT00467779|560888481|FG003|Stage 2A|Death|0|||
155397111|NCT00467779|560888482|FG004|Stage 2A|Death|0|||
155397112|NCT00467779|560888483|FG005|Stage 2A|Death|0|||
155397113|NCT00467779|560888484|FG006|Stage 2A|Death|0|||
155397114|NCT00467779|560888485|FG007|Stage 2A|Death|0|||
155397115|NCT00467779|560888486|FG008|Stage 2A|Death|0|||
155397116|NCT00467779|560888487|FG009|Stage 2A|Death|0|||
155397117|NCT00467779|560888488|FG010|Stage 2A|Death|0|||
155397118|NCT00467779|560888489|FG011|Stage 2A|Death|0|||
155397119|NCT00467779|560888490|FG012|Stage 2A|Death|0|||
155397120|NCT00467779|560888491|FG013|Stage 2A|Death|1|||
155397121|NCT00467779|560888492|FG014|Stage 2A|Death|0|||
155397122|NCT00467779|560888478|FG000|Stage 2A|Disease Progression|0|||
155397123|NCT00467779|560888479|FG001|Stage 2A|Disease Progression|0|||
155397124|NCT00467779|560888480|FG002|Stage 2A|Disease Progression|0|||
155397125|NCT00467779|560888481|FG003|Stage 2A|Disease Progression|0|||
155397126|NCT00467779|560888482|FG004|Stage 2A|Disease Progression|0|||
155397127|NCT00467779|560888483|FG005|Stage 2A|Disease Progression|0|||
155397128|NCT00467779|560888484|FG006|Stage 2A|Disease Progression|0|||
155397129|NCT00467779|560888485|FG007|Stage 2A|Disease Progression|0|||
155397130|NCT00467779|560888486|FG008|Stage 2A|Disease Progression|0|||
155397131|NCT00467779|560888487|FG009|Stage 2A|Disease Progression|0|||
155397132|NCT00467779|560888488|FG010|Stage 2A|Disease Progression|0|||
155397133|NCT00467779|560888489|FG011|Stage 2A|Disease Progression|0|||
155397134|NCT00467779|560888490|FG012|Stage 2A|Disease Progression|0|||
155397135|NCT00467779|560888491|FG013|Stage 2A|Disease Progression|10|||
155397136|NCT00467779|560888492|FG014|Stage 2A|Disease Progression|0|||
155397137|NCT00467779|560888478|FG000|Stage 2A|Unspecified Reason|0|||
155397138|NCT00467779|560888479|FG001|Stage 2A|Unspecified Reason|0|||
155397139|NCT00467779|560888480|FG002|Stage 2A|Unspecified Reason|0|||
155397140|NCT00467779|560888481|FG003|Stage 2A|Unspecified Reason|0|||
155397141|NCT00467779|560888482|FG004|Stage 2A|Unspecified Reason|0|||
155397142|NCT00467779|560888483|FG005|Stage 2A|Unspecified Reason|0|||
155397143|NCT00467779|560888484|FG006|Stage 2A|Unspecified Reason|0|||
155397144|NCT00467779|560888485|FG007|Stage 2A|Unspecified Reason|0|||
155397145|NCT00467779|560888486|FG008|Stage 2A|Unspecified Reason|0|||
155397146|NCT00467779|560888487|FG009|Stage 2A|Unspecified Reason|0|||
155397147|NCT00467779|560888488|FG010|Stage 2A|Unspecified Reason|0|||
155397148|NCT00467779|560888489|FG011|Stage 2A|Unspecified Reason|0|||
155397149|NCT00467779|560888490|FG012|Stage 2A|Unspecified Reason|0|||
155397150|NCT00467779|560888491|FG013|Stage 2A|Unspecified Reason|7|||
155397151|NCT00467779|560888492|FG014|Stage 2A|Unspecified Reason|0|||
155397152|NCT00467779|560888478|FG000|Stage 2A|Withdrawal by Subject|0|||
155397153|NCT00467779|560888479|FG001|Stage 2A|Withdrawal by Subject|0|||
155397154|NCT00467779|560888480|FG002|Stage 2A|Withdrawal by Subject|0|||
155397155|NCT00467779|560888481|FG003|Stage 2A|Withdrawal by Subject|0|||
155397156|NCT00467779|560888482|FG004|Stage 2A|Withdrawal by Subject|0|||
155397157|NCT00467779|560888483|FG005|Stage 2A|Withdrawal by Subject|0|||
155397158|NCT00467779|560888484|FG006|Stage 2A|Withdrawal by Subject|0|||
155397159|NCT00467779|560888485|FG007|Stage 2A|Withdrawal by Subject|0|||
155397160|NCT00467779|560888486|FG008|Stage 2A|Withdrawal by Subject|0|||
155397161|NCT00467779|560888487|FG009|Stage 2A|Withdrawal by Subject|0|||
155397162|NCT00467779|560888488|FG010|Stage 2A|Withdrawal by Subject|0|||
155397163|NCT00467779|560888489|FG011|Stage 2A|Withdrawal by Subject|0|||
155397164|NCT00467779|560888490|FG012|Stage 2A|Withdrawal by Subject|0|||
155397165|NCT00467779|560888491|FG013|Stage 2A|Withdrawal by Subject|1|||
155397166|NCT00467779|560888492|FG014|Stage 2A|Withdrawal by Subject|0|||
155397167|NCT00467779|560888478|FG000|Stage 3|Adverse Event|0|||
155397168|NCT00467779|560888479|FG001|Stage 3|Adverse Event|0|||
155397169|NCT00467779|560888480|FG002|Stage 3|Adverse Event|0|||
155397170|NCT00467779|560888481|FG003|Stage 3|Adverse Event|0|||
155397171|NCT00467779|560888482|FG004|Stage 3|Adverse Event|0|||
155397172|NCT00467779|560888483|FG005|Stage 3|Adverse Event|0|||
155397173|NCT00467779|560888484|FG006|Stage 3|Adverse Event|0|||
155397174|NCT00467779|560888485|FG007|Stage 3|Adverse Event|0|||
155397175|NCT00467779|560888486|FG008|Stage 3|Adverse Event|0|||
155397176|NCT00467779|560888487|FG009|Stage 3|Adverse Event|0|||
155397177|NCT00467779|560888488|FG010|Stage 3|Adverse Event|0|||
155397178|NCT00467779|560888489|FG011|Stage 3|Adverse Event|0|||
155397179|NCT00467779|560888490|FG012|Stage 3|Adverse Event|0|||
155397180|NCT00467779|560888491|FG013|Stage 3|Adverse Event|0|||
155397181|NCT00467779|560888492|FG014|Stage 3|Adverse Event|2|||
155397182|NCT00467779|560888478|FG000|Stage 3|Death|0|||
155397183|NCT00467779|560888479|FG001|Stage 3|Death|0|||
155397184|NCT00467779|560888480|FG002|Stage 3|Death|0|||
155397185|NCT00467779|560888481|FG003|Stage 3|Death|0|||
155397186|NCT00467779|560888482|FG004|Stage 3|Death|0|||
155397187|NCT00467779|560888483|FG005|Stage 3|Death|0|||
155397188|NCT00467779|560888484|FG006|Stage 3|Death|0|||
155397189|NCT00467779|560888485|FG007|Stage 3|Death|0|||
155397190|NCT00467779|560888486|FG008|Stage 3|Death|0|||
155397191|NCT00467779|560888487|FG009|Stage 3|Death|0|||
155397192|NCT00467779|560888488|FG010|Stage 3|Death|0|||
155397193|NCT00467779|560888489|FG011|Stage 3|Death|0|||
155397194|NCT00467779|560888490|FG012|Stage 3|Death|0|||
155397195|NCT00467779|560888491|FG013|Stage 3|Death|0|||
155397196|NCT00467779|560888492|FG014|Stage 3|Death|1|||
155397197|NCT00467779|560888478|FG000|Stage 3|Disease Progression|0|||
155397198|NCT00467779|560888479|FG001|Stage 3|Disease Progression|0|||
155397199|NCT00467779|560888480|FG002|Stage 3|Disease Progression|0|||
155397200|NCT00467779|560888481|FG003|Stage 3|Disease Progression|0|||
155397201|NCT00467779|560888482|FG004|Stage 3|Disease Progression|0|||
155397202|NCT00467779|560888483|FG005|Stage 3|Disease Progression|0|||
155397203|NCT00467779|560888484|FG006|Stage 3|Disease Progression|0|||
155397204|NCT00467779|560888485|FG007|Stage 3|Disease Progression|0|||
155397205|NCT00467779|560888486|FG008|Stage 3|Disease Progression|0|||
155397206|NCT00467779|560888487|FG009|Stage 3|Disease Progression|0|||
155397207|NCT00467779|560888488|FG010|Stage 3|Disease Progression|0|||
155397208|NCT00467779|560888489|FG011|Stage 3|Disease Progression|0|||
155397209|NCT00467779|560888490|FG012|Stage 3|Disease Progression|0|||
155397210|NCT00467779|560888491|FG013|Stage 3|Disease Progression|0|||
155397211|NCT00467779|560888492|FG014|Stage 3|Disease Progression|9|||
155397212|NCT00467779|560888478|FG000|Stage 3|Unspecified Reason|0|||
155397213|NCT00467779|560888479|FG001|Stage 3|Unspecified Reason|0|||
155397214|NCT00467779|560888480|FG002|Stage 3|Unspecified Reason|0|||
155397215|NCT00467779|560888481|FG003|Stage 3|Unspecified Reason|0|||
155397216|NCT00467779|560888482|FG004|Stage 3|Unspecified Reason|0|||
155397217|NCT00467779|560888483|FG005|Stage 3|Unspecified Reason|0|||
155397218|NCT00467779|560888484|FG006|Stage 3|Unspecified Reason|0|||
155397219|NCT00467779|560888485|FG007|Stage 3|Unspecified Reason|0|||
155397220|NCT00467779|560888486|FG008|Stage 3|Unspecified Reason|0|||
155397221|NCT00467779|560888487|FG009|Stage 3|Unspecified Reason|0|||
155397222|NCT00467779|560888488|FG010|Stage 3|Unspecified Reason|0|||
155397223|NCT00467779|560888489|FG011|Stage 3|Unspecified Reason|0|||
155397224|NCT00467779|560888490|FG012|Stage 3|Unspecified Reason|0|||
155397225|NCT00467779|560888491|FG013|Stage 3|Unspecified Reason|0|||
155397226|NCT00467779|560888492|FG014|Stage 3|Unspecified Reason|5|||
155397227|NCT01509079|560888493|FG000|Overall Study|Lack of Efficacy|0|||
155397228|NCT01509079|560888494|FG001|Overall Study|Lack of Efficacy|2|||
155397229|NCT01509079|560888493|FG000|Overall Study|started an excluded medication|0|||
155397230|NCT01509079|560888494|FG001|Overall Study|started an excluded medication|1|||
155397231|NCT04912245|560888495|FG000|Overall Study|Withdrawal by Subject|21|||
155397232|NCT04912245|560888496|FG001|Overall Study|Withdrawal by Subject|4|||
155397233|NCT04912245|560888495|FG000|Overall Study|Lost to Follow-up|5|||
155397234|NCT04912245|560888496|FG001|Overall Study|Lost to Follow-up|11|||
155397235|NCT01205230|560888497|FG000|Overall Study|Adverse Event|4|||
155397236|NCT01205230|560888498|FG001|Overall Study|Adverse Event|0|||
155397237|NCT01205230|560888497|FG000|Overall Study|Physician Decision|1|||
155397238|NCT01205230|560888498|FG001|Overall Study|Physician Decision|0|||
155397239|NCT00041080|560888499|FG000|Overall Study|Adverse Event|21|||
155397240|NCT00041080|560888500|FG001|Overall Study|Adverse Event|1|||
155397241|NCT00041080|560888499|FG000|Overall Study|Withdrawal by Subject|6|||
155397242|NCT00041080|560888500|FG001|Overall Study|Withdrawal by Subject|6|||
155397243|NCT00041080|560888499|FG000|Overall Study|Concommitant Illness/Other|1|||
155397244|NCT00041080|560888500|FG001|Overall Study|Concommitant Illness/Other|2|||
155397245|NCT00041080|560888499|FG000|Overall Study|Did not start therapy|1|||
155397246|NCT00041080|560888500|FG001|Overall Study|Did not start therapy|1|||
155397247|NCT00041080|560888499|FG000|Overall Study|Ineligible|1|||
155397248|NCT00041080|560888500|FG001|Overall Study|Ineligible|0|||
155397249|NCT00058552|560888501|FG000|Overall Study|Died prior to receiving treatment|4|||
155397250|NCT00058552|560888502|FG001|Overall Study|Died prior to receiving treatment|2|||
155397251|NCT00058552|560888501|FG000|Overall Study|Disease progression|52|||
155397252|NCT00058552|560888502|FG001|Overall Study|Disease progression|44|||
155397253|NCT00058552|560888501|FG000|Overall Study|Adverse Event|4|||
155397254|NCT00058552|560888502|FG001|Overall Study|Adverse Event|2|||
155397255|NCT00058552|560888501|FG000|Overall Study|Withdrawal by Subject|3|||
155397256|NCT00058552|560888502|FG001|Overall Study|Withdrawal by Subject|5|||
155397257|NCT00058552|560888501|FG000|Overall Study|Physician Decision|2|||
155397258|NCT00058552|560888502|FG001|Overall Study|Physician Decision|5|||
155397259|NCT00058552|560888501|FG000|Overall Study|Clinical disease progression|0|||
155397260|NCT00058552|560888502|FG001|Overall Study|Clinical disease progression|4|||
155397261|NCT02428855|560888503|FG000|Overall Study|Withdrawal by Subject|2|||
155397262|NCT01372150|560888506|FG000|Overall Study|Lack of Efficacy|3|||
155397263|NCT01372150|560888507|FG001|Overall Study|Lack of Efficacy|0|||
155397264|NCT01372150|560888508|FG002|Overall Study|Lack of Efficacy|1|||
155397265|NCT01372150|560888506|FG000|Overall Study|Lost to Follow-up|4|||
155397266|NCT01372150|560888507|FG001|Overall Study|Lost to Follow-up|5|||
155397267|NCT01372150|560888508|FG002|Overall Study|Lost to Follow-up|6|||
155397268|NCT01372150|560888506|FG000|Overall Study|Protocol Violation|1|||
155397269|NCT01372150|560888507|FG001|Overall Study|Protocol Violation|0|||
155397270|NCT01372150|560888508|FG002|Overall Study|Protocol Violation|3|||
155397271|NCT01372150|560888506|FG000|Overall Study|Withdrawal by Subject|2|||
155397272|NCT01372150|560888507|FG001|Overall Study|Withdrawal by Subject|7|||
155397273|NCT01372150|560888508|FG002|Overall Study|Withdrawal by Subject|2|||
155397274|NCT01372150|560888506|FG000|Overall Study|Other|1|||
155397275|NCT01372150|560888507|FG001|Overall Study|Other|0|||
155397276|NCT01372150|560888508|FG002|Overall Study|Other|2|||
155397277|NCT01372150|560888506|FG000|Overall Study|Adverse Event|2|||
155397278|NCT01372150|560888507|FG001|Overall Study|Adverse Event|1|||
155397279|NCT01372150|560888508|FG002|Overall Study|Adverse Event|2|||
155397280|NCT01372150|560888506|FG000|Overall Study|Randomized but not treated|0|||
155397281|NCT01372150|560888507|FG001|Overall Study|Randomized but not treated|1|||
155397282|NCT01372150|560888508|FG002|Overall Study|Randomized but not treated|0|||
155397283|NCT03198520|560888509|FG000|Overall Study|Physician Decision|2|||
155397284|NCT03198520|560888509|FG000|Overall Study|Protocol Violation|2|||
155397285|NCT03198520|560888509|FG000|Overall Study|Withdrawal by Subject|1|||
155397286|NCT03198520|560888509|FG000|Overall Study|Study Ended|1|||
155397287|NCT01670539|560888510|FG000|Overall Study|Death|3|||
155397288|NCT01670539|560888511|FG001|Overall Study|Death|5|||
155397289|NCT01670539|560888510|FG000|Overall Study|Withdrawal by Subject|3|||
155397290|NCT01670539|560888511|FG001|Overall Study|Withdrawal by Subject|0|||
155397291|NCT04353596|560888512|FG000|Overall Study|Protocol Violation|4|||
155397292|NCT04353596|560888513|FG001|Overall Study|Protocol Violation|4|||
155397293|NCT04353596|560888512|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
155397294|NCT04353596|560888513|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
155397295|NCT02665052|560888514|FG000|Overall Study|Lost to Follow-up|1|||
155397296|NCT02665052|560888515|FG001|Overall Study|Lost to Follow-up|0|||
155397297|NCT02665052|560888516|FG002|Overall Study|Lost to Follow-up|0|||
155397298|NCT02665052|560888517|FG003|Overall Study|Lost to Follow-up|0|||
155397299|NCT02665052|560888514|FG000|Overall Study|Withdrawal by Subject|1|||
155397300|NCT02665052|560888515|FG001|Overall Study|Withdrawal by Subject|1|||
155397301|NCT02665052|560888516|FG002|Overall Study|Withdrawal by Subject|0|||
155741327|NCT02059291|562154817|FG017|Epoch 4|Pregnancy|0|||
155741328|NCT02059291|562154818|FG018|Epoch 4|Pregnancy|0|||
155741329|NCT02059291|562154819|FG019|Epoch 4|Pregnancy|0|||
155741330|NCT02059291|562154820|FG020|Epoch 4|Pregnancy|0|||
155741331|NCT02059291|562154821|FG021|Epoch 4|Pregnancy|0|||
155741332|NCT02059291|562154822|FG022|Epoch 4|Pregnancy|0|||
155741333|NCT02059291|562154823|FG023|Epoch 4|Pregnancy|0|||
155741334|NCT02059291|562154824|FG024|Epoch 4|Pregnancy|0|||
155741335|NCT02059291|562154800|FG000|Epoch 4|Withdrawal by Subject|0|||
155741336|NCT02059291|562154801|FG001|Epoch 4|Withdrawal by Subject|0|||
155741337|NCT02059291|562154802|FG002|Epoch 4|Withdrawal by Subject|0|||
155741338|NCT02059291|562154803|FG003|Epoch 4|Withdrawal by Subject|0|||
155741339|NCT02059291|562154804|FG004|Epoch 4|Withdrawal by Subject|0|||
155741340|NCT02059291|562154805|FG005|Epoch 4|Withdrawal by Subject|0|||
155741341|NCT02059291|562154806|FG006|Epoch 4|Withdrawal by Subject|0|||
155741342|NCT02059291|562154807|FG007|Epoch 4|Withdrawal by Subject|0|||
155741343|NCT02059291|562154808|FG008|Epoch 4|Withdrawal by Subject|0|||
155741344|NCT02059291|562154809|FG009|Epoch 4|Withdrawal by Subject|0|||
155741345|NCT02059291|562154810|FG010|Epoch 4|Withdrawal by Subject|0|||
155741346|NCT02059291|562154811|FG011|Epoch 4|Withdrawal by Subject|0|||
155741347|NCT02059291|562154812|FG012|Epoch 4|Withdrawal by Subject|0|||
155741348|NCT02059291|562154813|FG013|Epoch 4|Withdrawal by Subject|0|||
155741349|NCT02059291|562154814|FG014|Epoch 4|Withdrawal by Subject|0|||
155741350|NCT02059291|562154815|FG015|Epoch 4|Withdrawal by Subject|0|||
155741351|NCT02059291|562154816|FG016|Epoch 4|Withdrawal by Subject|0|||
155741352|NCT02059291|562154817|FG017|Epoch 4|Withdrawal by Subject|0|||
155741353|NCT02059291|562154818|FG018|Epoch 4|Withdrawal by Subject|0|||
155741354|NCT02059291|562154819|FG019|Epoch 4|Withdrawal by Subject|0|||
155741355|NCT02059291|562154820|FG020|Epoch 4|Withdrawal by Subject|1|||
155741356|NCT02059291|562154821|FG021|Epoch 4|Withdrawal by Subject|0|||
155741357|NCT02059291|562154822|FG022|Epoch 4|Withdrawal by Subject|0|||
155741358|NCT02059291|562154823|FG023|Epoch 4|Withdrawal by Subject|0|||
155741359|NCT02059291|562154824|FG024|Epoch 4|Withdrawal by Subject|0|||
155741360|NCT02059291|562154800|FG000|Epoch 4|Lack of Efficacy|0|||
155741361|NCT02059291|562154801|FG001|Epoch 4|Lack of Efficacy|0|||
155741362|NCT02059291|562154802|FG002|Epoch 4|Lack of Efficacy|0|||
155741363|NCT02059291|562154803|FG003|Epoch 4|Lack of Efficacy|0|||
155741364|NCT02059291|562154804|FG004|Epoch 4|Lack of Efficacy|0|||
155741365|NCT02059291|562154805|FG005|Epoch 4|Lack of Efficacy|0|||
155741366|NCT02059291|562154806|FG006|Epoch 4|Lack of Efficacy|0|||
155741367|NCT02059291|562154807|FG007|Epoch 4|Lack of Efficacy|0|||
155741368|NCT02059291|562154808|FG008|Epoch 4|Lack of Efficacy|0|||
155741369|NCT02059291|562154809|FG009|Epoch 4|Lack of Efficacy|0|||
155741370|NCT02059291|562154810|FG010|Epoch 4|Lack of Efficacy|0|||
155741371|NCT02059291|562154811|FG011|Epoch 4|Lack of Efficacy|0|||
155741372|NCT02059291|562154812|FG012|Epoch 4|Lack of Efficacy|0|||
155741373|NCT02059291|562154813|FG013|Epoch 4|Lack of Efficacy|0|||
155741374|NCT02059291|562154814|FG014|Epoch 4|Lack of Efficacy|0|||
155741375|NCT02059291|562154815|FG015|Epoch 4|Lack of Efficacy|0|||
155741376|NCT02059291|562154816|FG016|Epoch 4|Lack of Efficacy|0|||
155741377|NCT02059291|562154817|FG017|Epoch 4|Lack of Efficacy|0|||
155741378|NCT02059291|562154818|FG018|Epoch 4|Lack of Efficacy|0|||
155741379|NCT02059291|562154819|FG019|Epoch 4|Lack of Efficacy|0|||
155741380|NCT02059291|562154820|FG020|Epoch 4|Lack of Efficacy|0|||
155741381|NCT02059291|562154821|FG021|Epoch 4|Lack of Efficacy|0|||
155741382|NCT02059291|562154822|FG022|Epoch 4|Lack of Efficacy|0|||
155741383|NCT02059291|562154823|FG023|Epoch 4|Lack of Efficacy|1|||
155741384|NCT02059291|562154824|FG024|Epoch 4|Lack of Efficacy|0|||
155741385|NCT03180619|562154825|FG000|Overall Study|Withdrew Consent|5|||
155741386|NCT03180619|562154826|FG001|Overall Study|Withdrew Consent|0|||
155741387|NCT03180619|562154827|FG002|Overall Study|Withdrew Consent|2|||
155741388|NCT03180619|562154825|FG000|Overall Study|Death|2|||
155741389|NCT03180619|562154826|FG001|Overall Study|Death|1|||
155397302|NCT02665052|560888517|FG003|Overall Study|Withdrawal by Subject|5|||
155397303|NCT02665052|560888514|FG000|Overall Study|Adverse Event|1|||
155397304|NCT02665052|560888515|FG001|Overall Study|Adverse Event|1|||
155397305|NCT02665052|560888516|FG002|Overall Study|Adverse Event|0|||
155397306|NCT02665052|560888517|FG003|Overall Study|Adverse Event|0|||
155397307|NCT02234284|560888518|FG000|Overall Study|Death|4|||
155397308|NCT02234284|560888519|FG001|Overall Study|Death|2|||
155397309|NCT02234284|560888518|FG000|Overall Study|Withdrawal by Subject|1|||
155397310|NCT02234284|560888519|FG001|Overall Study|Withdrawal by Subject|0|||
155397311|NCT02234284|560888518|FG000|Overall Study|Lost to Follow-up|20|||
155397312|NCT02234284|560888519|FG001|Overall Study|Lost to Follow-up|7|||
155397313|NCT03023059|560888520|FG000|Overall Study|Withdrawal by Subject|5|||
155397314|NCT00536809|560888521|FG000|Phase II|Adverse Event|1|||
155397315|NCT00536809|560888521|FG000|Phase II|Referred for surgical resection|1|||
155397316|NCT00233363|560888522|FG000|Overall Study|Adverse Event|1|||
155397317|NCT00233363|560888523|FG001|Overall Study|Adverse Event|2|||
155397318|NCT00233363|560888522|FG000|Overall Study|Lack of Efficacy|0|||
155397319|NCT00233363|560888523|FG001|Overall Study|Lack of Efficacy|2|||
155397320|NCT00233363|560888522|FG000|Overall Study|Withdrawal by Subject|1|||
155397321|NCT00233363|560888523|FG001|Overall Study|Withdrawal by Subject|1|||
155397322|NCT00233363|560888522|FG000|Overall Study|Aggravation of complication|1|||
155397323|NCT00233363|560888523|FG001|Overall Study|Aggravation of complication|0|||
155397324|NCT04880447|560888527|FG000|Overall Study|No vaccination information|1|||
155397325|NCT04880447|560888527|FG000|Overall Study|No adverse event information (missing information)|1|||
155397326|NCT04880447|560888527|FG000|Overall Study|Disease not covered in this study|35|||
155397327|NCT01353508|560888532|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397328|NCT01353508|560888533|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397329|NCT01353508|560888534|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397330|NCT01353508|560888535|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
155397331|NCT01353508|560888532|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
155397332|NCT01353508|560888533|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397333|NCT01353508|560888534|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397334|NCT01353508|560888535|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397335|NCT00433914|560888541|FG000|Overall Study|Withdrawal by Subject|0|||
155397336|NCT00433914|560888542|FG001|Overall Study|Withdrawal by Subject|2|||
155397337|NCT00433914|560888541|FG000|Overall Study|Lost to Follow-up|0|||
155397338|NCT00433914|560888542|FG001|Overall Study|Lost to Follow-up|1|||
155397339|NCT02844920|560888543|FG000|Overall Study|Lost to Follow-up|2|||
155397340|NCT04534491|560888544|FG000|Overall Study|Not completed end-of-study interview|24|||
155397341|NCT04534491|560888544|FG000|Overall Study|Non-users|70|||
155397342|NCT04534491|560888544|FG000|Overall Study|Non-verifiable users|58|||
155397343|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397344|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397345|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397346|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397347|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397348|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397349|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397350|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397351|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
155397352|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397353|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397354|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397355|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
155397356|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397357|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397358|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397359|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397360|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397361|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397362|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397363|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397364|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397365|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397366|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397367|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155397368|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397369|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397370|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155397371|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397372|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397373|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397374|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397375|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397376|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397377|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397378|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397379|NCT00766090|560888547|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397380|NCT00766090|560888548|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397381|NCT00766090|560888549|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
155397382|NCT00766090|560888550|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397383|NCT00766090|560888551|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397384|NCT00766090|560888552|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397385|NCT00766090|560888553|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397386|NCT00766090|560888554|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397387|NCT00766090|560888555|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397388|NCT00766090|560888556|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397389|NCT00766090|560888557|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397390|NCT00766090|560888558|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397391|NCT00766090|560888547|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397392|NCT00766090|560888548|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397393|NCT00766090|560888549|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397394|NCT00766090|560888550|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397395|NCT00766090|560888551|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
155397396|NCT00766090|560888552|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397397|NCT00766090|560888553|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397398|NCT00766090|560888554|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397399|NCT00766090|560888555|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397400|NCT00766090|560888556|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397401|NCT00766090|560888557|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397402|NCT00766090|560888558|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397403|NCT00766090|560888547|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397404|NCT00766090|560888548|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397405|NCT00766090|560888549|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
155397406|NCT00766090|560888550|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397407|NCT00766090|560888551|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397408|NCT00766090|560888552|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397409|NCT00766090|560888553|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397410|NCT00766090|560888554|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397411|NCT00766090|560888555|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397412|NCT00766090|560888556|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397413|NCT00766090|560888557|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397414|NCT00766090|560888558|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397415|NCT00766090|560888547|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
155397416|NCT00766090|560888548|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
155397417|NCT00766090|560888549|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
155397418|NCT00766090|560888550|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
155397419|NCT00766090|560888551|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
155397420|NCT00766090|560888552|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
155397421|NCT00766090|560888553|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
155397422|NCT00766090|560888554|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
155397423|NCT00766090|560888555|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
155397424|NCT00766090|560888556|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
155397425|NCT00766090|560888557|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
155397426|NCT00766090|560888558|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
155397427|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397428|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397429|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397430|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397431|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397432|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
155397433|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397434|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397435|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397436|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397437|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155636094|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636095|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
155636096|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636097|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636098|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636099|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636100|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155636101|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636102|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636103|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
155636104|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636105|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636106|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636107|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636108|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155636109|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636110|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636111|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
155636112|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
155636113|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636114|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636115|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636116|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155636117|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636118|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636119|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
155636120|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636121|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636122|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636123|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636124|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155636125|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636126|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636127|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
155636128|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
155636129|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636130|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636131|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636132|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155636133|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636134|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636135|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
155636136|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
155636137|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636138|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636139|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636140|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155636141|NCT03329001|561760954|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636142|NCT03329001|561760955|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636143|NCT03329001|561760956|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
155636144|NCT03329001|561760957|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
155636145|NCT03329001|561760958|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636146|NCT03329001|561760959|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636147|NCT03329001|561760960|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636148|NCT03329001|561760961|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155636149|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636150|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636151|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155741390|NCT03180619|562154827|FG002|Overall Study|Death|2|||
155741391|NCT03180619|562154825|FG000|Overall Study|Adverse Event|2|||
155397438|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397439|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397440|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397441|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397442|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397443|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397444|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397445|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397446|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397447|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397448|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397449|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397450|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397451|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397452|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397453|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397454|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397455|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
155397456|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397457|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397458|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397459|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397460|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397461|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397462|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397463|NCT03024970|560888559|FG000|First Intervention|Adverse Event|1|||
155397464|NCT03024970|560888560|FG001|First Intervention|Adverse Event|0|||
155397465|NCT03024970|560888559|FG000|Second Intervention|Lost to Follow-up|1|||
155397466|NCT03024970|560888560|FG001|Second Intervention|Lost to Follow-up|0|||
155397467|NCT00574288|560888561|FG000|Overall Study|Adverse Event|2|||
155397468|NCT00574288|560888562|FG001|Overall Study|Adverse Event|0|||
155397469|NCT00574288|560888563|FG002|Overall Study|Adverse Event|0|||
155397470|NCT00574288|560888564|FG003|Overall Study|Adverse Event|0|||
155397471|NCT00574288|560888565|FG004|Overall Study|Adverse Event|1|||
155397472|NCT00574288|560888566|FG005|Overall Study|Adverse Event|0|||
155397473|NCT00574288|560888567|FG006|Overall Study|Adverse Event|0|||
155397474|NCT00574288|560888561|FG000|Overall Study|Death|0|||
155397475|NCT00574288|560888562|FG001|Overall Study|Death|0|||
155397476|NCT00574288|560888563|FG002|Overall Study|Death|0|||
155397477|NCT00574288|560888564|FG003|Overall Study|Death|0|||
155397478|NCT00574288|560888565|FG004|Overall Study|Death|0|||
155397479|NCT00574288|560888566|FG005|Overall Study|Death|25|||
155397480|NCT00574288|560888567|FG006|Overall Study|Death|21|||
155397481|NCT00574288|560888561|FG000|Overall Study|Lost to Follow-up|0|||
155397482|NCT00574288|560888562|FG001|Overall Study|Lost to Follow-up|0|||
155397483|NCT00574288|560888563|FG002|Overall Study|Lost to Follow-up|0|||
155397484|NCT00574288|560888564|FG003|Overall Study|Lost to Follow-up|0|||
155397485|NCT00574288|560888565|FG004|Overall Study|Lost to Follow-up|0|||
155397486|NCT00574288|560888566|FG005|Overall Study|Lost to Follow-up|1|||
155397487|NCT00574288|560888567|FG006|Overall Study|Lost to Follow-up|2|||
155397488|NCT00574288|560888561|FG000|Overall Study|Study Terminated By Sponsor|0|||
155397489|NCT00574288|560888562|FG001|Overall Study|Study Terminated By Sponsor|0|||
155397490|NCT00574288|560888563|FG002|Overall Study|Study Terminated By Sponsor|0|||
155397491|NCT00574288|560888564|FG003|Overall Study|Study Terminated By Sponsor|0|||
155397492|NCT00574288|560888565|FG004|Overall Study|Study Terminated By Sponsor|0|||
155397493|NCT00574288|560888566|FG005|Overall Study|Study Terminated By Sponsor|0|||
155397494|NCT00574288|560888567|FG006|Overall Study|Study Terminated By Sponsor|5|||
155397495|NCT00574288|560888561|FG000|Overall Study|Progressive Disease|17|||
155397496|NCT00574288|560888562|FG001|Overall Study|Progressive Disease|2|||
155397497|NCT00574288|560888563|FG002|Overall Study|Progressive Disease|3|||
155397498|NCT00574288|560888564|FG003|Overall Study|Progressive Disease|2|||
155397499|NCT00574288|560888565|FG004|Overall Study|Progressive Disease|1|||
155397500|NCT00574288|560888566|FG005|Overall Study|Progressive Disease|0|||
155397501|NCT00574288|560888567|FG006|Overall Study|Progressive Disease|0|||
155397502|NCT00574288|560888561|FG000|Overall Study|Other|1|||
155397503|NCT00574288|560888562|FG001|Overall Study|Other|1|||
155397504|NCT00574288|560888563|FG002|Overall Study|Other|0|||
155397505|NCT00574288|560888564|FG003|Overall Study|Other|0|||
155397506|NCT00574288|560888565|FG004|Overall Study|Other|0|||
155397507|NCT00574288|560888566|FG005|Overall Study|Other|0|||
155397508|NCT00574288|560888567|FG006|Overall Study|Other|0|||
155397509|NCT01106027|560888568|FG000|Overall Study|Lost graft early, discontinued|1|||
155397510|NCT00356889|560888569|FG000|Overall Study|Protocol Violation|2|||
155397511|NCT00356889|560888569|FG000|Overall Study|Adverse Event|1|||
155397512|NCT02678416|560888570|FG000|Part 1|Withdrawal by Subject|1|||
155397513|NCT02678416|560888570|FG000|Part 2|Adverse Event|2|||
155397514|NCT02678416|560888570|FG000|Part 2|Withdrawal by Subject|1|||
155397515|NCT00736034|560888575|FG000|Overall Study|Adverse Event|2|||
155397516|NCT01514136|560888579|FG000|Test Period 1; Test A|Protocol Violation|1|||
155397517|NCT01514136|560888580|FG001|Test Period 1; Test A|Protocol Violation|0|||
155397518|NCT01514136|560888581|FG002|Test Period 1; Test A|Protocol Violation|0|||
155397519|NCT01514136|560888582|FG003|Test Period 1; Test A|Protocol Violation|0|||
155397520|NCT01514136|560888583|FG004|Test Period 1; Test A|Protocol Violation|0|||
155397521|NCT01514136|560888584|FG005|Test Period 1; Test A|Protocol Violation|0|||
155397522|NCT01514136|560888585|FG006|Test Period 1; Test A|Protocol Violation|0|||
155397523|NCT01514136|560888586|FG007|Test Period 1; Test A|Protocol Violation|0|||
155397524|NCT01514136|560888579|FG000|Test Period 1; Test A|Break from study holiday|2|||
155397525|NCT01514136|560888580|FG001|Test Period 1; Test A|Break from study holiday|0|||
155397526|NCT01514136|560888581|FG002|Test Period 1; Test A|Break from study holiday|0|||
155397527|NCT01514136|560888582|FG003|Test Period 1; Test A|Break from study holiday|0|||
155397528|NCT01514136|560888583|FG004|Test Period 1; Test A|Break from study holiday|0|||
155397529|NCT01514136|560888584|FG005|Test Period 1; Test A|Break from study holiday|0|||
155397530|NCT01514136|560888585|FG006|Test Period 1; Test A|Break from study holiday|0|||
155397531|NCT01514136|560888586|FG007|Test Period 1; Test A|Break from study holiday|0|||
155397532|NCT01514136|560888579|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
155397533|NCT01514136|560888580|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
155397534|NCT01514136|560888581|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
155397535|NCT01514136|560888582|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
155397536|NCT01514136|560888583|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
155397537|NCT01514136|560888584|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
155397538|NCT01514136|560888585|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
155397539|NCT01514136|560888586|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
155397540|NCT01514136|560888579|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397541|NCT01514136|560888580|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397542|NCT01514136|560888581|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397543|NCT01514136|560888582|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
155397544|NCT01514136|560888583|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397545|NCT01514136|560888584|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397546|NCT01514136|560888585|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397547|NCT01514136|560888586|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397548|NCT01514136|560888579|FG000|Test Period 2; Test A*|Adverse Event|0|||
155397549|NCT01514136|560888580|FG001|Test Period 2; Test A*|Adverse Event|0|||
155397550|NCT01514136|560888581|FG002|Test Period 2; Test A*|Adverse Event|0|||
155397551|NCT01514136|560888582|FG003|Test Period 2; Test A*|Adverse Event|0|||
155397552|NCT01514136|560888583|FG004|Test Period 2; Test A*|Adverse Event|1|||
155397553|NCT01514136|560888584|FG005|Test Period 2; Test A*|Adverse Event|0|||
155397554|NCT01514136|560888585|FG006|Test Period 2; Test A*|Adverse Event|0|||
155397555|NCT01514136|560888586|FG007|Test Period 2; Test A*|Adverse Event|0|||
155397556|NCT01514136|560888579|FG000|Test Period 2; Test A*|Holiday|0|||
155397557|NCT01514136|560888580|FG001|Test Period 2; Test A*|Holiday|0|||
155397558|NCT01514136|560888581|FG002|Test Period 2; Test A*|Holiday|0|||
155397559|NCT01514136|560888582|FG003|Test Period 2; Test A*|Holiday|0|||
155397560|NCT01514136|560888583|FG004|Test Period 2; Test A*|Holiday|1|||
155397561|NCT01514136|560888584|FG005|Test Period 2; Test A*|Holiday|0|||
155397562|NCT01514136|560888585|FG006|Test Period 2; Test A*|Holiday|0|||
155397563|NCT01514136|560888586|FG007|Test Period 2; Test A*|Holiday|0|||
155397564|NCT01514136|560888579|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397565|NCT01514136|560888580|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397566|NCT01514136|560888581|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397567|NCT01514136|560888582|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397568|NCT01514136|560888583|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397569|NCT01514136|560888584|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
155397570|NCT01514136|560888585|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397571|NCT01514136|560888586|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397572|NCT01514136|560888579|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397573|NCT01514136|560888580|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397574|NCT01514136|560888581|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397575|NCT01514136|560888582|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397576|NCT01514136|560888583|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397577|NCT01514136|560888584|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397578|NCT01514136|560888585|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
155397579|NCT01514136|560888586|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397580|NCT01514136|560888579|FG000|Test Period 2; Test C*|holiday|0|||
155397581|NCT01514136|560888580|FG001|Test Period 2; Test C*|holiday|0|||
155397582|NCT01514136|560888581|FG002|Test Period 2; Test C*|holiday|0|||
155397583|NCT01514136|560888582|FG003|Test Period 2; Test C*|holiday|0|||
155397584|NCT01514136|560888583|FG004|Test Period 2; Test C*|holiday|0|||
155397585|NCT01514136|560888584|FG005|Test Period 2; Test C*|holiday|0|||
155397586|NCT01514136|560888585|FG006|Test Period 2; Test C*|holiday|1|||
155397587|NCT01514136|560888586|FG007|Test Period 2; Test C*|holiday|0|||
155397588|NCT01514136|560888579|FG000|Test Period 2; Test C*|Protocol Violation|0|||
155397589|NCT01514136|560888580|FG001|Test Period 2; Test C*|Protocol Violation|0|||
155397590|NCT01514136|560888581|FG002|Test Period 2; Test C*|Protocol Violation|0|||
155397591|NCT01514136|560888582|FG003|Test Period 2; Test C*|Protocol Violation|0|||
155397592|NCT01514136|560888583|FG004|Test Period 2; Test C*|Protocol Violation|0|||
155397593|NCT01514136|560888584|FG005|Test Period 2; Test C*|Protocol Violation|0|||
155397594|NCT01514136|560888585|FG006|Test Period 2; Test C*|Protocol Violation|1|||
155397595|NCT01514136|560888586|FG007|Test Period 2; Test C*|Protocol Violation|0|||
155397596|NCT00955279|560888596|FG000|Overall Study|Other|0|||
155397597|NCT00955279|560888597|FG001|Overall Study|Other|0|||
155397598|NCT00955279|560888598|FG002|Overall Study|Other|3|||
155397599|NCT00955279|560888596|FG000|Overall Study|Death|1|||
155397600|NCT00955279|560888597|FG001|Overall Study|Death|1|||
155397601|NCT00955279|560888598|FG002|Overall Study|Death|1|||
155397602|NCT00955279|560888596|FG000|Overall Study|Lost to Follow-up|0|||
155397603|NCT00955279|560888597|FG001|Overall Study|Lost to Follow-up|3|||
155397604|NCT00955279|560888598|FG002|Overall Study|Lost to Follow-up|1|||
155397605|NCT00955279|560888596|FG000|Overall Study|Withdrawal by Subject|2|||
155397606|NCT00955279|560888597|FG001|Overall Study|Withdrawal by Subject|0|||
155397607|NCT00955279|560888598|FG002|Overall Study|Withdrawal by Subject|3|||
155397608|NCT01159912|560888599|FG000|Overall Study|Adverse Event|2|||
155397609|NCT01159912|560888600|FG001|Overall Study|Adverse Event|2|||
155397610|NCT01159912|560888601|FG002|Overall Study|Adverse Event|3|||
155397611|NCT01159912|560888599|FG000|Overall Study|Lack of Efficacy|23|||
155397612|NCT01159912|560888600|FG001|Overall Study|Lack of Efficacy|15|||
155397613|NCT01159912|560888601|FG002|Overall Study|Lack of Efficacy|14|||
155397614|NCT01159912|560888599|FG000|Overall Study|Protocol Violation|1|||
155397615|NCT01159912|560888600|FG001|Overall Study|Protocol Violation|2|||
155397616|NCT01159912|560888601|FG002|Overall Study|Protocol Violation|3|||
155397617|NCT01159912|560888599|FG000|Overall Study|Lost to Follow-up|4|||
155397618|NCT01159912|560888600|FG001|Overall Study|Lost to Follow-up|0|||
155397619|NCT01159912|560888601|FG002|Overall Study|Lost to Follow-up|0|||
155397620|NCT01159912|560888599|FG000|Overall Study|Physician Decision|0|||
155397621|NCT01159912|560888600|FG001|Overall Study|Physician Decision|0|||
155397622|NCT01159912|560888601|FG002|Overall Study|Physician Decision|3|||
155397623|NCT01159912|560888599|FG000|Overall Study|Withdrawal by Subject|10|||
155397624|NCT01159912|560888600|FG001|Overall Study|Withdrawal by Subject|3|||
155397625|NCT01159912|560888601|FG002|Overall Study|Withdrawal by Subject|3|||
155397626|NCT03734016|560888608|FG000|Overall Study|Sponsor Ended Study|225|||
155397627|NCT03734016|560888609|FG001|Overall Study|Sponsor Ended Study|200|||
155397628|NCT03734016|560888608|FG000|Overall Study|Death|69|||
155397629|NCT03734016|560888609|FG001|Overall Study|Death|83|||
155397630|NCT03734016|560888608|FG000|Overall Study|Withdrawal by Subject|21|||
155397631|NCT03734016|560888609|FG001|Overall Study|Withdrawal by Subject|27|||
155397632|NCT03734016|560888608|FG000|Overall Study|Physician Decision|1|||
155397633|NCT03734016|560888609|FG001|Overall Study|Physician Decision|12|||
155397634|NCT03734016|560888608|FG000|Overall Study|Lost to Follow-up|6|||
155397635|NCT03734016|560888609|FG001|Overall Study|Lost to Follow-up|2|||
155397636|NCT03734016|560888608|FG000|Overall Study|Miscellaneous|5|||
155397637|NCT03734016|560888609|FG001|Overall Study|Miscellaneous|1|||
155397638|NCT02737852|560890402|FG000|Overall Study|Withdrawal by Subject|2|||
155397639|NCT03688880|560890403|FG000|Overall Study|Withdrawal by Subject|0|||
155397640|NCT03688880|560890404|FG001|Overall Study|Withdrawal by Subject|2|||
155397641|NCT03688880|560890403|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
155397642|NCT03688880|560890404|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
155397643|NCT03688880|560890403|FG000|Overall Study|Lost to Follow-up|4|||
155397644|NCT03688880|560890404|FG001|Overall Study|Lost to Follow-up|7|||
155397645|NCT03688880|560890403|FG000|Overall Study|Adverse Event|0|||
155397646|NCT03688880|560890404|FG001|Overall Study|Adverse Event|2|||
155397647|NCT03688880|560890403|FG000|Overall Study|Device deficiencies|0|||
155397648|NCT03688880|560890404|FG001|Overall Study|Device deficiencies|2|||
155397649|NCT03688880|560890403|FG000|Overall Study|Other|10|||
155397650|NCT03688880|560890404|FG001|Overall Study|Other|16|||
155397651|NCT01704287|560890406|FG000|Initial Treatment Period|Death|139|||
155397652|NCT01704287|560890407|FG001|Initial Treatment Period|Death|129|||
155397653|NCT01704287|560890408|FG002|Initial Treatment Period|Death|71|||
155397654|NCT01704287|560890409|FG003|Initial Treatment Period|Death|0|||
155397655|NCT01704287|560890410|FG004|Initial Treatment Period|Death|0|||
155397656|NCT01704287|560890406|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
155397657|NCT01704287|560890407|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
155397658|NCT01704287|560890408|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
155397659|NCT01704287|560890409|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
155397660|NCT01704287|560890410|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
155397661|NCT01704287|560890406|FG000|Initial Treatment Period|Lost to Follow-up|5|||
155397662|NCT01704287|560890407|FG001|Initial Treatment Period|Lost to Follow-up|3|||
155397663|NCT01704287|560890408|FG002|Initial Treatment Period|Lost to Follow-up|0|||
155397664|NCT01704287|560890409|FG003|Initial Treatment Period|Lost to Follow-up|0|||
155397665|NCT01704287|560890410|FG004|Initial Treatment Period|Lost to Follow-up|0|||
155397666|NCT01704287|560890406|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397667|NCT01704287|560890407|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397668|NCT01704287|560890408|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
155397669|NCT01704287|560890409|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397670|NCT01704287|560890410|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397671|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397672|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397673|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397674|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
155397675|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
155397676|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
155636152|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
155636153|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636154|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636155|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636156|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155636157|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636158|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636159|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636160|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
155636161|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636162|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636163|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636164|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155636165|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636166|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636167|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
155636168|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636169|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636170|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636171|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636172|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155636173|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155741392|NCT03180619|562154826|FG001|Overall Study|Adverse Event|0|||
155741393|NCT03180619|562154827|FG002|Overall Study|Adverse Event|1|||
155741394|NCT03180619|562154825|FG000|Overall Study|Investigator's discretion|2|||
155741395|NCT03180619|562154826|FG001|Overall Study|Investigator's discretion|0|||
155741396|NCT03180619|562154827|FG002|Overall Study|Investigator's discretion|1|||
155741397|NCT01433289|562154828|FG000|Overall Study|Pregnancy|0|||
155741398|NCT01433289|562154829|FG001|Overall Study|Pregnancy|1|||
155741399|NCT01433289|562154830|FG002|Overall Study|Pregnancy|0|||
155741400|NCT01433289|562154831|FG003|Overall Study|Pregnancy|0|||
155741401|NCT02410343|562154836|FG000|Core Period (24 Weeks)|Adverse Event|1|||
155741402|NCT02410343|562154837|FG001|Core Period (24 Weeks)|Adverse Event|0|||
155741403|NCT02410343|562154836|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
155741404|NCT02410343|562154837|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
155741405|NCT02410343|562154836|FG000|Extension Period (12 Months)|Adverse Event|1|||
155741406|NCT02410343|562154837|FG001|Extension Period (12 Months)|Adverse Event|0|||
155741407|NCT02410343|562154836|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
155741408|NCT02410343|562154837|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
155741409|NCT03704636|562154840|FG000|Overall Study|Inadequate Venous Flow|3|||
155741410|NCT02720042|562154841|FG000|Overall Study|Death|3|||
155741411|NCT02720042|562154841|FG000|Overall Study|Lost to Follow-up|4|||
155741412|NCT02720042|562154841|FG000|Overall Study|Withdrawal by Subject|1|||
155741413|NCT02720042|562154841|FG000|Overall Study|Physician Decision|3|||
155741414|NCT02720042|562154841|FG000|Overall Study|Phasix Mesh explanted|1|||
155741415|NCT02720042|562154841|FG000|Overall Study|unable due to non-study-related illness|3|||
155741416|NCT00539188|562154842|FG000|Overall Study|Withdrawal by Subject|1|||
155741417|NCT00539188|562154843|FG001|Overall Study|Withdrawal by Subject|0|||
155741418|NCT00539188|562154842|FG000|Overall Study|Lost to Follow-up|2|||
155636174|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155636175|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
155636176|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
155636177|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155636178|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155636179|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155636180|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155636181|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636182|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636183|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
155636184|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636185|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636186|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636187|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636188|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155636189|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636190|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636191|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
155636192|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636193|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636194|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636195|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636196|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155636197|NCT03329001|561760954|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636198|NCT03329001|561760955|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636199|NCT03329001|561760956|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636200|NCT03329001|561760957|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
155636201|NCT03329001|561760958|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636202|NCT03329001|561760959|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636203|NCT03329001|561760960|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636204|NCT03329001|561760961|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155636205|NCT03329001|561760954|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636206|NCT03329001|561760955|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636207|NCT03329001|561760956|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636208|NCT03329001|561760957|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636209|NCT03329001|561760958|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636210|NCT03329001|561760959|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
155636211|NCT03329001|561760960|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636212|NCT03329001|561760961|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155636213|NCT03329001|561760954|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636214|NCT03329001|561760955|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636215|NCT03329001|561760956|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636216|NCT03329001|561760957|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636217|NCT03329001|561760958|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
155636218|NCT03329001|561760959|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636219|NCT03329001|561760960|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636220|NCT03329001|561760961|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155636221|NCT03329001|561760954|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636222|NCT03329001|561760955|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636223|NCT03329001|561760956|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636224|NCT03329001|561760957|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636225|NCT03329001|561760958|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
155636226|NCT03329001|561760959|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
155636227|NCT03329001|561760960|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636228|NCT03329001|561760961|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155636229|NCT03329001|561760954|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636230|NCT03329001|561760955|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636231|NCT03329001|561760956|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636232|NCT03329001|561760957|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636233|NCT03329001|561760958|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
155636234|NCT03329001|561760959|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155397677|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
155397678|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
155397679|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
155397680|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
155397681|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397682|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397683|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397684|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
155397685|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397686|NCT04042740|560890411|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
155397687|NCT04042740|560890411|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
155397688|NCT03713034|560890412|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
155397689|NCT03713034|560890413|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
155397690|NCT02615470|560890414|FG000|Overall Study|Lost to Follow-up|21|||
155397691|NCT02615470|560890415|FG001|Overall Study|Lost to Follow-up|32|||
155397692|NCT01717287|560890419|FG000|Overall Study|Lost to Follow-up|0|||
155397693|NCT01717287|560890420|FG001|Overall Study|Lost to Follow-up|2|||
155397694|NCT01717287|560890419|FG000|Overall Study|Protocol Violation|0|||
155397695|NCT01717287|560890420|FG001|Overall Study|Protocol Violation|1|||
155397696|NCT04024228|560890421|FG000|Overall Study|Adverse Event|1|||
155397697|NCT04024228|560890422|FG001|Overall Study|Adverse Event|0|||
155397698|NCT04024228|560890421|FG000|Overall Study|Protocol Deviation|0|||
155397699|NCT04024228|560890422|FG001|Overall Study|Protocol Deviation|2|||
155397700|NCT04024228|560890421|FG000|Overall Study|Withdrawal by Subject|3|||
155397701|NCT04024228|560890422|FG001|Overall Study|Withdrawal by Subject|4|||
155397702|NCT02982590|560890423|FG000|Overall Study|Lost to Follow-up|0|||
155397703|NCT02982590|560890424|FG001|Overall Study|Lost to Follow-up|1|||
155397704|NCT02982590|560890423|FG000|Overall Study|Death|4|||
155397705|NCT02982590|560890424|FG001|Overall Study|Death|0|||
155397706|NCT02163187|560890428|FG000|Overall Study|Device removed|1|||
155397707|NCT02163187|560890429|FG001|Overall Study|Device removed|0|||
155397708|NCT02163187|560890428|FG000|Overall Study|Progressive disease|1|||
155397709|NCT02163187|560890429|FG001|Overall Study|Progressive disease|0|||
155397710|NCT03281668|560890431|FG000|Overall Study|Physician Decision|1|||
155397711|NCT03281668|560890431|FG000|Overall Study|scheduling conflict, family circumstance|2|||
155397712|NCT03281668|560890431|FG000|Overall Study|Withdrawal by Subject|4|||
155397713|NCT03281668|560890431|FG000|Overall Study|Lost to Follow-up|1|||
155397714|NCT02234479|560890433|FG000|Overall Study|Withdrawal by Subject|1|||
155397715|NCT02234479|560890434|FG001|Overall Study|Withdrawal by Subject|3|||
155397716|NCT00677820|560890437|FG000|Overall Study|Lost to Follow-up|1|||
155397717|NCT00677820|560890438|FG001|Overall Study|Lost to Follow-up|0|||
155397718|NCT02357134|560890442|FG000|Overall Study|Lost to Follow-up|1|||
155397719|NCT02357134|560890443|FG001|Overall Study|Lost to Follow-up|0|||
155397720|NCT02357134|560890444|FG002|Overall Study|Lost to Follow-up|0|||
155397721|NCT02357134|560890445|FG003|Overall Study|Lost to Follow-up|0|||
155397722|NCT02716675|560890446|FG000|Overall Study|Death|2|||
155397723|NCT02716675|560890447|FG001|Overall Study|Death|3|||
155397724|NCT02716675|560890448|FG002|Overall Study|Death|0|||
155397725|NCT02716675|560890446|FG000|Overall Study|Physician Decision|2|||
155397726|NCT02716675|560890447|FG001|Overall Study|Physician Decision|1|||
155397727|NCT02716675|560890448|FG002|Overall Study|Physician Decision|1|||
155397728|NCT02716675|560890446|FG000|Overall Study|Lost to Follow-up|100|||
155397729|NCT02716675|560890447|FG001|Overall Study|Lost to Follow-up|87|||
155397730|NCT02716675|560890448|FG002|Overall Study|Lost to Follow-up|99|||
155397731|NCT02716675|560890446|FG000|Overall Study|Withdrawal by Subject|22|||
155397732|NCT02716675|560890447|FG001|Overall Study|Withdrawal by Subject|25|||
155397733|NCT02716675|560890448|FG002|Overall Study|Withdrawal by Subject|20|||
155397734|NCT02716675|560890446|FG000|Overall Study|Protocol Violation|0|||
155397735|NCT02716675|560890447|FG001|Overall Study|Protocol Violation|3|||
155397736|NCT02716675|560890448|FG002|Overall Study|Protocol Violation|1|||
155397737|NCT02716675|560890446|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
155397738|NCT02716675|560890447|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
155397739|NCT02716675|560890448|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
155397740|NCT02716675|560890446|FG000|Overall Study|Other|38|||
155397741|NCT02716675|560890447|FG001|Overall Study|Other|47|||
155397742|NCT02716675|560890448|FG002|Overall Study|Other|48|||
155397743|NCT00290290|560890453|FG000|Overall Study|Death|3|||
155397744|NCT00290290|560890454|FG001|Overall Study|Death|4|||
155397745|NCT00290290|560890453|FG000|Overall Study|Withdrawal by Subject|2|||
155397746|NCT00290290|560890454|FG001|Overall Study|Withdrawal by Subject|2|||
155397747|NCT00290290|560890453|FG000|Overall Study|Underwent clean surgical procedure|13|||
155397748|NCT00290290|560890454|FG001|Overall Study|Underwent clean surgical procedure|12|||
155397749|NCT03374995|560890455|FG000|Overall Study|Withdrawal by Subject|0|||
155397750|NCT03374995|560890456|FG001|Overall Study|Withdrawal by Subject|1|||
155397751|NCT01211535|560890459|FG000|Overall Study|Adverse Event|0|||
155397752|NCT01211535|560890460|FG001|Overall Study|Adverse Event|1|||
155397753|NCT05111041|560890468|FG000|Overall Study|Lost to Follow-up|6|||
155397754|NCT05111041|560890469|FG001|Overall Study|Lost to Follow-up|7|||
155397755|NCT05111041|560890468|FG000|Overall Study|Withdrawal by Subject|1|||
155397756|NCT05111041|560890469|FG001|Overall Study|Withdrawal by Subject|0|||
155397757|NCT01011439|560890470|FG000|Overall Study|Death|37|||
155397758|NCT01011439|560890470|FG000|Overall Study|Lost to Follow-up|4|||
155397759|NCT01011439|560890470|FG000|Overall Study|Withdrawal by Subject|1|||
155397760|NCT01011439|560890470|FG000|Overall Study|Sponsor's decision|15|||
155397761|NCT02361944|560890475|FG000|Overall Study|surgery cancellation|0|||
155397762|NCT02361944|560890476|FG001|Overall Study|surgery cancellation|1|||
155397763|NCT03123250|560890477|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
155397764|NCT00773136|560890504|FG000|Overall Study|Physician Decision|2|||
155397765|NCT02463071|560890511|FG000|Overall Study|Adverse Event|3|||
155397766|NCT02463071|560890512|FG001|Overall Study|Adverse Event|5|||
155397767|NCT02463071|560890513|FG002|Overall Study|Adverse Event|1|||
155397768|NCT02463071|560890511|FG000|Overall Study|Death|1|||
155397769|NCT02463071|560890512|FG001|Overall Study|Death|0|||
155397770|NCT02463071|560890513|FG002|Overall Study|Death|0|||
155397771|NCT02463071|560890511|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
155397772|NCT02463071|560890512|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155397773|NCT02463071|560890513|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155397774|NCT02463071|560890511|FG000|Overall Study|Reason not specified|7|||
155397775|NCT02463071|560890512|FG001|Overall Study|Reason not specified|9|||
155397776|NCT02463071|560890513|FG002|Overall Study|Reason not specified|4|||
155397777|NCT02463071|560890511|FG000|Overall Study|Protocol Violation|0|||
155397778|NCT02463071|560890512|FG001|Overall Study|Protocol Violation|2|||
155397779|NCT02463071|560890513|FG002|Overall Study|Protocol Violation|0|||
155397780|NCT02463071|560890511|FG000|Overall Study|Lost to Follow-up|0|||
155397781|NCT02463071|560890512|FG001|Overall Study|Lost to Follow-up|0|||
155397782|NCT02463071|560890513|FG002|Overall Study|Lost to Follow-up|1|||
155397783|NCT00175877|560890529|FG000|Overall Study|Adverse Event|136|||
155397784|NCT00175877|560890529|FG000|Overall Study|Withdrawal by Subject|141|||
155397785|NCT00175877|560890529|FG000|Overall Study|Lost to Follow-up|9|||
155397786|NCT00175877|560890529|FG000|Overall Study|Lack of Efficacy|26|||
155397787|NCT00175877|560890529|FG000|Overall Study|Protocol Violation|15|||
155397788|NCT00175877|560890529|FG000|Overall Study|Other Reason|20|||
155397789|NCT00175877|560890529|FG000|Overall Study|AE & Other|1|||
155397790|NCT00175877|560890529|FG000|Overall Study|Withdrawal by subject & Other|1|||
155397791|NCT03061175|560890533|FG000|Baseline|Participant was deemed ineligible|1|||
155397792|NCT03061175|560890534|FG001|Baseline|Participant was deemed ineligible|0|||
155397793|NCT03061175|560890533|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
155397794|NCT03061175|560890534|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
155397795|NCT03061175|560890533|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
155397796|NCT03061175|560890534|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
155397797|NCT03061175|560890533|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
155397798|NCT03061175|560890534|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
155397799|NCT00760669|560890535|FG000|Overall Study|Not assessed for overall improvement|18|||
155397800|NCT00760669|560890535|FG000|Overall Study|Participants missing efficacy assessment|6|||
155397801|NCT00760669|560890535|FG000|Overall Study|Participants with overlapping cases|1|||
155397802|NCT00760669|560890535|FG000|Overall Study|Took drug before entering in contract|5|||
155397803|NCT02003014|560890536|FG000|Overall Study|Case report forms uncollected|9|||
155397804|NCT02003014|560890536|FG000|Overall Study|Treatment started after contract period|1|||
155397805|NCT02003014|560890536|FG000|Overall Study|Patient did not visit the study site|5|||
155397806|NCT02003014|560890536|FG000|Overall Study|Investigator's transfer|4|||
155397807|NCT02456662|560890539|FG000|Overall Study|Lost to Follow-up|2|||
155397808|NCT02456662|560890540|FG001|Overall Study|Lost to Follow-up|1|||
155397809|NCT00504153|560890545|FG000|Overall Study|Withdrawal by Subject|1|||
155397810|NCT00504153|560890545|FG000|Overall Study|Adverse Event|4|||
155397811|NCT00504153|560890545|FG000|Overall Study|Death|1|||
155397812|NCT00074581|560890546|FG000|Overall Study|Death|15|||
155397813|NCT00074581|560890547|FG001|Overall Study|Death|16|||
155397814|NCT00074581|560890546|FG000|Overall Study|Withdrawal by Subject|50|||
155397815|NCT00074581|560890547|FG001|Overall Study|Withdrawal by Subject|49|||
155397816|NCT00074581|560890546|FG000|Overall Study|Unable to adhere to visit schedule|13|||
155397817|NCT00074581|560890547|FG001|Overall Study|Unable to adhere to visit schedule|14|||
155397818|NCT00074581|560890546|FG000|Overall Study|Relocated|14|||
155397819|NCT00074581|560890547|FG001|Overall Study|Relocated|9|||
155397820|NCT00074581|560890546|FG000|Overall Study|Were withdrawn by investigator|5|||
155397821|NCT00074581|560890547|FG001|Overall Study|Were withdrawn by investigator|2|||
155397822|NCT00074581|560890546|FG000|Overall Study|Lost to Follow-up|16|||
155397823|NCT00074581|560890547|FG001|Overall Study|Lost to Follow-up|11|||
155397824|NCT00074581|560890546|FG000|Overall Study|Ended relationship w. index participant|117|||
155397825|NCT00074581|560890547|FG001|Overall Study|Ended relationship w. index participant|106|||
155397826|NCT00074581|560890546|FG000|Overall Study|Other|14|||
155397827|NCT00074581|560890547|FG001|Overall Study|Other|19|||
155397828|NCT00617604|560890548|FG000|Overall Study|Death|2|||
155397829|NCT00617604|560890549|FG001|Overall Study|Death|1|||
155397830|NCT00617604|560890548|FG000|Overall Study|Lost to Follow-up|1|||
155397831|NCT00617604|560890549|FG001|Overall Study|Lost to Follow-up|0|||
155397832|NCT00617604|560890548|FG000|Overall Study|Miscellaneous Reasons|8|||
155397833|NCT00617604|560890549|FG001|Overall Study|Miscellaneous Reasons|10|||
155397834|NCT00617604|560890548|FG000|Overall Study|Withdrawal by Subject|4|||
155397835|NCT00617604|560890549|FG001|Overall Study|Withdrawal by Subject|6|||
155397836|NCT00617604|560890548|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
155397837|NCT00617604|560890549|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
155397838|NCT01708291|560890550|FG000|Overall Study|fighting|2|||
155397839|NCT01708291|560890551|FG001|Overall Study|fighting|1|||
155397840|NCT00805025|560890553|FG000|Overall Study|Screened but not enrolled/treated|42|||
155397841|NCT00805025|560890553|FG000|Overall Study|Adverse Event|4|||
155397842|NCT00805025|560890553|FG000|Overall Study|Withdrawal by Subject|2|||
155397843|NCT00805025|560890553|FG000|Overall Study|Physician Decision|1|||
155397844|NCT04029961|560890554|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
155397845|NCT04029961|560890555|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
155397846|NCT04029961|560890554|FG000|Overall Study|Change in Treatment Course|0|||
155397847|NCT04029961|560890555|FG001|Overall Study|Change in Treatment Course|1|||
155397848|NCT00688155|560890556|FG000|Overall Study|Withdrawal by Subject|2|||
155397849|NCT00688155|560890557|FG001|Overall Study|Withdrawal by Subject|2|||
155397850|NCT00688155|560890558|FG002|Overall Study|Withdrawal by Subject|1|||
155397851|NCT00688155|560890559|FG003|Overall Study|Withdrawal by Subject|1|||
155397852|NCT00382720|560892014|FG000|Overall Study|Adverse Event|21|||
155397853|NCT00382720|560892015|FG001|Overall Study|Adverse Event|23|||
155397854|NCT00382720|560892016|FG002|Overall Study|Adverse Event|15|||
155397855|NCT00382720|560892014|FG000|Overall Study|Protocol Violation|2|||
155397856|NCT00382720|560892015|FG001|Overall Study|Protocol Violation|5|||
155397857|NCT00382720|560892016|FG002|Overall Study|Protocol Violation|1|||
155397858|NCT00382720|560892014|FG000|Overall Study|Death|0|||
155397859|NCT00382720|560892015|FG001|Overall Study|Death|1|||
155397860|NCT00382720|560892016|FG002|Overall Study|Death|2|||
155397861|NCT00382720|560892014|FG000|Overall Study|Progressive disease|37|||
155397862|NCT00382720|560892015|FG001|Overall Study|Progressive disease|28|||
155397863|NCT00382720|560892016|FG002|Overall Study|Progressive disease|38|||
155397864|NCT00382720|560892014|FG000|Overall Study|Withdrew consent|1|||
155397865|NCT00382720|560892015|FG001|Overall Study|Withdrew consent|1|||
155397866|NCT00382720|560892016|FG002|Overall Study|Withdrew consent|2|||
155397867|NCT00382720|560892014|FG000|Overall Study|Withdrawal by Subject|11|||
155397868|NCT00382720|560892015|FG001|Overall Study|Withdrawal by Subject|20|||
155397869|NCT00382720|560892016|FG002|Overall Study|Withdrawal by Subject|12|||
155397870|NCT00382720|560892014|FG000|Overall Study|Surgery|1|||
155397871|NCT00382720|560892015|FG001|Overall Study|Surgery|1|||
155397872|NCT00382720|560892016|FG002|Overall Study|Surgery|4|||
155397873|NCT00382720|560892014|FG000|Overall Study|Patient did not receive study medication|1|||
155397874|NCT00382720|560892015|FG001|Overall Study|Patient did not receive study medication|1|||
155397875|NCT00382720|560892016|FG002|Overall Study|Patient did not receive study medication|4|||
155397876|NCT00382720|560892014|FG000|Overall Study|Clinically progressive disease|0|||
155397877|NCT00382720|560892015|FG001|Overall Study|Clinically progressive disease|1|||
155397878|NCT00382720|560892016|FG002|Overall Study|Clinically progressive disease|0|||
155397879|NCT00382720|560892014|FG000|Overall Study|Good prognosis|0|||
155397880|NCT00382720|560892015|FG001|Overall Study|Good prognosis|1|||
155397881|NCT00382720|560892016|FG002|Overall Study|Good prognosis|0|||
155397882|NCT00382720|560892014|FG000|Overall Study|Investigator/Clinical decision|5|||
155397883|NCT00382720|560892015|FG001|Overall Study|Investigator/Clinical decision|6|||
155397884|NCT00382720|560892016|FG002|Overall Study|Investigator/Clinical decision|6|||
155397885|NCT00382720|560892014|FG000|Overall Study|Discontinued at end of study|0|||
155397886|NCT00382720|560892015|FG001|Overall Study|Discontinued at end of study|1|||
155397887|NCT00382720|560892016|FG002|Overall Study|Discontinued at end of study|2|||
155397888|NCT01858532|560892019|FG000|Overall Study|Adverse Event|58|||
155397889|NCT01858532|560892020|FG001|Overall Study|Adverse Event|50|||
155397890|NCT01858532|560892021|FG002|Overall Study|Adverse Event|23|||
155397891|NCT01858532|560892022|FG003|Overall Study|Adverse Event|28|||
155397892|NCT01858532|560892019|FG000|Overall Study|Withdrew consent|71|||
155397893|NCT01858532|560892020|FG001|Overall Study|Withdrew consent|93|||
155397894|NCT01858532|560892021|FG002|Overall Study|Withdrew consent|46|||
155397895|NCT01858532|560892022|FG003|Overall Study|Withdrew consent|27|||
155397896|NCT01858532|560892019|FG000|Overall Study|Lost to Follow-up|17|||
155397897|NCT01858532|560892020|FG001|Overall Study|Lost to Follow-up|26|||
155397898|NCT01858532|560892021|FG002|Overall Study|Lost to Follow-up|11|||
155397899|NCT01858532|560892022|FG003|Overall Study|Lost to Follow-up|14|||
155397900|NCT01858532|560892019|FG000|Overall Study|Deterioration of medical status|3|||
155397901|NCT01858532|560892020|FG001|Overall Study|Deterioration of medical status|4|||
155397902|NCT01858532|560892021|FG002|Overall Study|Deterioration of medical status|3|||
155397903|NCT01858532|560892022|FG003|Overall Study|Deterioration of medical status|7|||
155397904|NCT01858532|560892019|FG000|Overall Study|Investigator request|3|||
155397905|NCT01858532|560892020|FG001|Overall Study|Investigator request|4|||
155397906|NCT01858532|560892021|FG002|Overall Study|Investigator request|2|||
155397907|NCT01858532|560892022|FG003|Overall Study|Investigator request|6|||
155397908|NCT01858532|560892019|FG000|Overall Study|Other, not specified|29|||
155397909|NCT01858532|560892020|FG001|Overall Study|Other, not specified|15|||
155397910|NCT01858532|560892021|FG002|Overall Study|Other, not specified|13|||
155397911|NCT01858532|560892022|FG003|Overall Study|Other, not specified|11|||
155397912|NCT00514514|560892023|FG000|Pre-phase|Death|10|||
155397913|NCT00514514|560892024|FG001|Pre-phase|Death|0|||
155397914|NCT00514514|560892025|FG002|Pre-phase|Death|0|||
155397915|NCT00514514|560892023|FG000|Pre-phase|administrative problems|2|||
155397916|NCT00514514|560892024|FG001|Pre-phase|administrative problems|0|||
155397917|NCT00514514|560892025|FG002|Pre-phase|administrative problems|0|||
155397918|NCT00514514|560892023|FG000|Pre-phase|Protocol Violation|6|||
155397919|NCT00514514|560892024|FG001|Pre-phase|Protocol Violation|0|||
155397920|NCT00514514|560892025|FG002|Pre-phase|Protocol Violation|0|||
155397921|NCT00514514|560892023|FG000|Pre-phase|condition no longer requires study drug|7|||
155397922|NCT00514514|560892024|FG001|Pre-phase|condition no longer requires study drug|0|||
155397923|NCT00514514|560892025|FG002|Pre-phase|condition no longer requires study drug|0|||
155397924|NCT00514514|560892023|FG000|Pre-phase|abnormal test procedure results|15|||
155397925|NCT00514514|560892024|FG001|Pre-phase|abnormal test procedure results|0|||
155636235|NCT03329001|561760960|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636236|NCT03329001|561760961|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155636237|NCT03329001|561760954|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155636238|NCT03329001|561760955|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155636239|NCT03329001|561760956|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155636240|NCT03329001|561760957|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155397926|NCT00514514|560892025|FG002|Pre-phase|abnormal test procedure results|0|||
155397927|NCT00514514|560892023|FG000|Pre-phase|Lost to Follow-up|2|||
155397928|NCT00514514|560892024|FG001|Pre-phase|Lost to Follow-up|0|||
155397929|NCT00514514|560892025|FG002|Pre-phase|Lost to Follow-up|0|||
155397930|NCT00514514|560892023|FG000|Pre-phase|abnormal lab values|23|||
155283990|NCT01515319|560470911|FG007|Overall Study|Withdrawal by Subject|0|||
155397931|NCT00514514|560892024|FG001|Pre-phase|abnormal lab values|0|||
155397932|NCT00514514|560892025|FG002|Pre-phase|abnormal lab values|0|||
155397933|NCT00514514|560892023|FG000|Pre-phase|Lack of Efficacy|35|||
155397934|NCT00514514|560892024|FG001|Pre-phase|Lack of Efficacy|0|||
155397935|NCT00514514|560892025|FG002|Pre-phase|Lack of Efficacy|0|||
155397936|NCT00514514|560892023|FG000|Pre-phase|Adverse Event|137|||
155397937|NCT00514514|560892024|FG001|Pre-phase|Adverse Event|0|||
155397938|NCT00514514|560892025|FG002|Pre-phase|Adverse Event|0|||
155397939|NCT00514514|560892023|FG000|Pre-phase|Withdrawal by Subject|66|||
155397940|NCT00514514|560892024|FG001|Pre-phase|Withdrawal by Subject|0|||
155397941|NCT00514514|560892025|FG002|Pre-phase|Withdrawal by Subject|0|||
155397942|NCT00514514|560892023|FG000|Randomized - 9 Month|Death|3|||
155397943|NCT00514514|560892024|FG001|Randomized - 9 Month|Death|2|||
155397944|NCT00514514|560892025|FG002|Randomized - 9 Month|Death|2|||
155397945|NCT00514514|560892023|FG000|Randomized - 9 Month|Administrative problems|1|||
155397946|NCT00514514|560892024|FG001|Randomized - 9 Month|Administrative problems|1|||
155397947|NCT00514514|560892025|FG002|Randomized - 9 Month|Administrative problems|2|||
155397948|NCT00514514|560892023|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
155397949|NCT00514514|560892024|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
155397950|NCT00514514|560892025|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
155397951|NCT00514514|560892023|FG000|Randomized - 9 Month|Protocol Violation|1|||
155397952|NCT00514514|560892024|FG001|Randomized - 9 Month|Protocol Violation|1|||
155397953|NCT00514514|560892025|FG002|Randomized - 9 Month|Protocol Violation|0|||
155397954|NCT00514514|560892023|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
155397955|NCT00514514|560892024|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
155397956|NCT00514514|560892025|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
155397957|NCT00514514|560892023|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
155397958|NCT00514514|560892024|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
155397959|NCT00514514|560892025|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
155397960|NCT00514514|560892023|FG000|Randomized - 9 Month|Adverse Event|25|||
155397961|NCT00514514|560892024|FG001|Randomized - 9 Month|Adverse Event|44|||
155397962|NCT00514514|560892025|FG002|Randomized - 9 Month|Adverse Event|27|||
155397963|NCT00514514|560892023|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
155397964|NCT00514514|560892024|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
155397965|NCT00514514|560892025|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
155397966|NCT00514514|560892023|FG000|Extension - 4 Years|Lost to Follow-up|12|||
155397967|NCT00514514|560892024|FG001|Extension - 4 Years|Lost to Follow-up|10|||
155397968|NCT00514514|560892025|FG002|Extension - 4 Years|Lost to Follow-up|9|||
155397969|NCT00514514|560892023|FG000|Extension - 4 Years|Administrative problems|3|||
155397970|NCT00514514|560892024|FG001|Extension - 4 Years|Administrative problems|1|||
155397971|NCT00514514|560892025|FG002|Extension - 4 Years|Administrative problems|1|||
155397972|NCT00514514|560892023|FG000|Extension - 4 Years|Death|8|||
155397973|NCT00514514|560892024|FG001|Extension - 4 Years|Death|3|||
155397974|NCT00514514|560892025|FG002|Extension - 4 Years|Death|6|||
155397975|NCT00514514|560892023|FG000|Extension - 4 Years|Adverse Event|9|||
155397976|NCT00514514|560892024|FG001|Extension - 4 Years|Adverse Event|6|||
155397977|NCT00514514|560892025|FG002|Extension - 4 Years|Adverse Event|3|||
155397978|NCT00762892|560892031|FG000|Overall Study|Lost to Follow-up|2|||
155397979|NCT00762892|560892032|FG001|Overall Study|Lost to Follow-up|5|||
155397980|NCT00762892|560892031|FG000|Overall Study|Withdrawal by Subject|0|||
155397981|NCT00762892|560892032|FG001|Overall Study|Withdrawal by Subject|1|||
155397982|NCT00762892|560892031|FG000|Overall Study|Death|1|||
155397983|NCT00762892|560892032|FG001|Overall Study|Death|0|||
155397984|NCT00762892|560892031|FG000|Overall Study|Pregnancy|1|||
155397985|NCT00762892|560892032|FG001|Overall Study|Pregnancy|0|||
155397986|NCT00762892|560892031|FG000|Overall Study|Incarceration|1|||
155397987|NCT00762892|560892032|FG001|Overall Study|Incarceration|0|||
155397988|NCT01848288|560892035|FG000|Overall Study|Death|1|||
155397989|NCT01848288|560892035|FG000|Overall Study|Protocol Violation|1|||
155397990|NCT01848288|560892035|FG000|Overall Study|Withdrawal by Subject|1|||
155283991|NCT01515319|560470912|FG008|Overall Study|Withdrawal by Subject|0|||
155283992|NCT01515319|560470913|FG009|Overall Study|Withdrawal by Subject|0|||
155283993|NCT01515319|560470904|FG000|Overall Study|Adverse Event|0|||
155283994|NCT01515319|560470905|FG001|Overall Study|Adverse Event|0|||
155283995|NCT01515319|560470906|FG002|Overall Study|Adverse Event|0|||
155283996|NCT01515319|560470907|FG003|Overall Study|Adverse Event|0|||
155397991|NCT01841749|560892037|FG000|Overall Study|Protocol Violation|1|||
155397992|NCT01480284|560892045|FG000|Overall Study|Withdrawal by Subject|2|||
155283997|NCT01515319|560470908|FG004|Overall Study|Adverse Event|0|||
155283998|NCT01515319|560470909|FG005|Overall Study|Adverse Event|0|||
155283999|NCT01515319|560470910|FG006|Overall Study|Adverse Event|0|||
155284000|NCT01515319|560470911|FG007|Overall Study|Adverse Event|0|||
155284001|NCT01515319|560470912|FG008|Overall Study|Adverse Event|3|||
155284002|NCT01515319|560470913|FG009|Overall Study|Adverse Event|0|||
155284003|NCT01515319|560470904|FG000|Overall Study|Protocol Violation|0|||
155284004|NCT01515319|560470905|FG001|Overall Study|Protocol Violation|0|||
155284005|NCT01515319|560470906|FG002|Overall Study|Protocol Violation|0|||
155284006|NCT01515319|560470907|FG003|Overall Study|Protocol Violation|0|||
155284007|NCT01515319|560470908|FG004|Overall Study|Protocol Violation|0|||
155284008|NCT01515319|560470909|FG005|Overall Study|Protocol Violation|0|||
155284009|NCT01515319|560470910|FG006|Overall Study|Protocol Violation|0|||
155397993|NCT01480284|560892046|FG001|Overall Study|Withdrawal by Subject|0|||
155397994|NCT01480284|560892045|FG000|Overall Study|Adverse Event|1|||
155397995|NCT01480284|560892046|FG001|Overall Study|Adverse Event|0|||
155284010|NCT01515319|560470911|FG007|Overall Study|Protocol Violation|0|||
155284011|NCT01515319|560470912|FG008|Overall Study|Protocol Violation|2|||
155397996|NCT01480284|560892045|FG000|Overall Study|Study closed/terminated|3|||
155397997|NCT01480284|560892046|FG001|Overall Study|Study closed/terminated|0|||
155397998|NCT01480284|560892045|FG000|Overall Study|Lost to Follow-up|1|||
155397999|NCT01480284|560892046|FG001|Overall Study|Lost to Follow-up|0|||
155398000|NCT01480284|560892045|FG000|Overall Study|Physician Decision|1|||
155284012|NCT01515319|560470913|FG009|Overall Study|Protocol Violation|0|||
155284013|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Adverse Event|5|||
155284014|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Adverse Event|13|||
155398001|NCT01480284|560892046|FG001|Overall Study|Physician Decision|0|||
155398002|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
155398003|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
155398004|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
155398005|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
155398006|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Ineligible|3|||
155398007|NCT00066742|560892047|FG000|Consolidation Chemotherapy|not protocol specified|1|||
155398008|NCT00066742|560892047|FG000|Consolidation Chemotherapy|Ineligible|2|||
155398009|NCT03593850|560892052|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
155398010|NCT03593850|560892053|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
155398011|NCT00003895|560892054|FG000|Overall Study|Adverse Event|4|||
155398012|NCT00003895|560892055|FG001|Overall Study|Adverse Event|0|||
155398013|NCT00003895|560892054|FG000|Overall Study|Lack of Efficacy|1|||
155398014|NCT00003895|560892055|FG001|Overall Study|Lack of Efficacy|1|||
155398015|NCT00003895|560892054|FG000|Overall Study|Patient Vacation|2|||
155398016|NCT00003895|560892055|FG001|Overall Study|Patient Vacation|0|||
155398017|NCT00003895|560892054|FG000|Overall Study|Withdrawal by Subject|0|||
155398018|NCT00003895|560892055|FG001|Overall Study|Withdrawal by Subject|3|||
155398019|NCT01380730|560892056|FG000|Overall Study|Death|0|||
155398020|NCT01380730|560892057|FG001|Overall Study|Death|0|||
155398021|NCT01380730|560892058|FG002|Overall Study|Death|0|||
155398022|NCT01380730|560892059|FG003|Overall Study|Death|0|||
155398023|NCT01380730|560892060|FG004|Overall Study|Death|1|||
155398024|NCT01380730|560892061|FG005|Overall Study|Death|0|||
155398025|NCT01380730|560892062|FG006|Overall Study|Death|0|||
155398026|NCT01380730|560892063|FG007|Overall Study|Death|0|||
155398027|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
155398028|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
155398029|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
155398030|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
155398031|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398032|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
155398033|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398034|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398035|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
155398036|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
155398037|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
155398038|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
155398039|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
155398040|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
155398041|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
155398042|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
155398043|NCT02490475|560892064|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
155398044|NCT02490475|560892065|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
155398045|NCT02490475|560892066|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
155398046|NCT02490475|560892067|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
155398047|NCT02490475|560892064|FG000|Period 2: Extension Phase|Refused Treatment|0|||
155398048|NCT02490475|560892065|FG001|Period 2: Extension Phase|Refused Treatment|0|||
155398049|NCT02490475|560892066|FG002|Period 2: Extension Phase|Refused Treatment|0|||
155398050|NCT02490475|560892067|FG003|Period 2: Extension Phase|Refused Treatment|1|||
155398051|NCT02490475|560892064|FG000|Period 2: Extension Phase|Adverse Event|0|||
155398052|NCT02490475|560892065|FG001|Period 2: Extension Phase|Adverse Event|0|||
155398053|NCT02490475|560892066|FG002|Period 2: Extension Phase|Adverse Event|1|||
155398054|NCT02490475|560892067|FG003|Period 2: Extension Phase|Adverse Event|0|||
155398055|NCT01195090|560892069|FG000|Overall Study|Adverse Event|1|||
155398056|NCT01195090|560892070|FG001|Overall Study|Adverse Event|2|||
155398057|NCT01195090|560892069|FG000|Overall Study|Lost to Follow-up|2|||
155398058|NCT01195090|560892070|FG001|Overall Study|Lost to Follow-up|2|||
155398059|NCT01195090|560892069|FG000|Overall Study|Protocol Violation|3|||
155398060|NCT01195090|560892070|FG001|Overall Study|Protocol Violation|4|||
155398061|NCT04784897|560892071|FG000|Overall Study|Death|4|||
155398062|NCT04784897|560892072|FG001|Overall Study|Death|2|||
155284015|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Adverse Event|0|||
155398063|NCT04784897|560892073|FG002|Overall Study|Death|1|||
155398064|NCT04784897|560892071|FG000|Overall Study|Withdrawal by Subject|0|||
155398065|NCT04784897|560892072|FG001|Overall Study|Withdrawal by Subject|0|||
155398066|NCT04784897|560892073|FG002|Overall Study|Withdrawal by Subject|1|||
155398067|NCT01236573|560892074|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398068|NCT01236573|560892075|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398069|NCT01236573|560892076|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398070|NCT01236573|560892077|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398071|NCT01236573|560892078|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398072|NCT01236573|560892079|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398073|NCT01236573|560892080|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398074|NCT01236573|560892081|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155741419|NCT00539188|562154843|FG001|Overall Study|Lost to Follow-up|1|||
155398075|NCT01236573|560892082|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398076|NCT01236573|560892083|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398077|NCT01236573|560892084|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398078|NCT01236573|560892074|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398079|NCT01236573|560892075|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398080|NCT01236573|560892076|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398081|NCT01236573|560892077|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398082|NCT01236573|560892078|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398083|NCT01236573|560892079|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398084|NCT01236573|560892080|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398085|NCT01236573|560892081|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398086|NCT01236573|560892082|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
155398087|NCT01236573|560892083|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398088|NCT01236573|560892084|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398089|NCT01236573|560892074|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398090|NCT01236573|560892075|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398091|NCT01236573|560892076|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398092|NCT01236573|560892077|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398093|NCT01236573|560892078|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398094|NCT01236573|560892079|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398095|NCT01236573|560892080|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398096|NCT01236573|560892081|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398097|NCT01236573|560892082|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398098|NCT01236573|560892083|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398099|NCT01236573|560892084|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
155398100|NCT00823823|560892087|FG000|Overall Study|Lost to Follow-up|3|||
155398101|NCT00823823|560892088|FG001|Overall Study|Lost to Follow-up|1|||
155398102|NCT00823823|560892087|FG000|Overall Study|Protocol Violation|5|||
155398103|NCT00823823|560892088|FG001|Overall Study|Protocol Violation|5|||
155398104|NCT04754802|560892089|FG000|Overall Study|Lost to Follow-up|0|||
155398105|NCT04754802|560892090|FG001|Overall Study|Lost to Follow-up|2|||
155398106|NCT04754802|560892089|FG000|Overall Study|Withdrawal by Subject|2|||
155398107|NCT04754802|560892090|FG001|Overall Study|Withdrawal by Subject|0|||
155398116|NCT01490814|560892109|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
155398117|NCT01490814|560892110|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
155398118|NCT01490814|560892109|FG000|Overall Study|Physician Decision|1|||
155398119|NCT01490814|560892110|FG001|Overall Study|Physician Decision|0|||
155398120|NCT01490814|560892109|FG000|Overall Study|Withdrawal by Subject|0|||
155398121|NCT01490814|560892110|FG001|Overall Study|Withdrawal by Subject|5|||
155398122|NCT00496730|560892111|FG000|Overall Study|Lost to Follow-up|4|||
155636241|NCT03329001|561760958|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
155636242|NCT03329001|561760959|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
155636243|NCT03329001|561760960|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155636244|NCT03329001|561760961|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155636245|NCT03329001|561760954|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155636246|NCT03329001|561760955|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155636247|NCT03329001|561760956|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155398123|NCT00496730|560892112|FG001|Overall Study|Lost to Follow-up|3|||
155398124|NCT00496730|560892111|FG000|Overall Study|Withdrawal by Subject|2|||
155398125|NCT00496730|560892112|FG001|Overall Study|Withdrawal by Subject|2|||
155398126|NCT02170779|560892116|FG000|Overall Study|Withdrawal by Subject|1|||
155398127|NCT02170779|560892117|FG001|Overall Study|Withdrawal by Subject|0|||
155398128|NCT02170779|560892116|FG000|Overall Study|Lost to Follow-up|0|||
155398129|NCT02170779|560892117|FG001|Overall Study|Lost to Follow-up|1|||
155398130|NCT00369785|560892118|FG000|Overall Study|Physician Decision|3|||
155398131|NCT00369785|560892119|FG001|Overall Study|Physician Decision|2|||
155398132|NCT00369785|560892118|FG000|Overall Study|Death|1|||
155398133|NCT00369785|560892119|FG001|Overall Study|Death|2|||
155398134|NCT00369785|560892118|FG000|Overall Study|Withdrawal by Subject|7|||
155398135|NCT00369785|560892119|FG001|Overall Study|Withdrawal by Subject|6|||
155398136|NCT00369785|560892118|FG000|Overall Study|Toxicity|6|||
155398137|NCT00369785|560892119|FG001|Overall Study|Toxicity|4|||
155398138|NCT00369785|560892118|FG000|Overall Study|Never started|0|||
155398139|NCT00369785|560892119|FG001|Overall Study|Never started|2|||
155398140|NCT00369785|560892118|FG000|Overall Study|Progression|4|||
155398141|NCT00369785|560892119|FG001|Overall Study|Progression|4|||
155398142|NCT00369785|560892118|FG000|Overall Study|Multiple reasons|6|||
155398143|NCT00369785|560892119|FG001|Overall Study|Multiple reasons|5|||
155398144|NCT00800683|560892120|FG000|Overall Study|Adverse Event|11|||
155398145|NCT00800683|560892121|FG001|Overall Study|Adverse Event|8|||
155398146|NCT00800683|560892120|FG000|Overall Study|Lost to Follow-up|3|||
155398147|NCT00800683|560892121|FG001|Overall Study|Lost to Follow-up|1|||
155398148|NCT00800683|560892120|FG000|Overall Study|Withdrawal by Subject|1|||
155398149|NCT00800683|560892121|FG001|Overall Study|Withdrawal by Subject|7|||
155398150|NCT00800683|560892120|FG000|Overall Study|Lack of Efficacy|1|||
155398151|NCT00800683|560892121|FG001|Overall Study|Lack of Efficacy|1|||
155398152|NCT00800683|560892120|FG000|Overall Study|Other|1|||
155398153|NCT00800683|560892121|FG001|Overall Study|Other|2|||
155398154|NCT02247960|560892122|FG000|Patient Consent and Randomization|Physician Decision|2|||
155398155|NCT02247960|560892123|FG001|Patient Consent and Randomization|Physician Decision|2|||
155398156|NCT02247960|560892122|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
155398157|NCT02247960|560892123|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
155398158|NCT02247960|560892122|FG000|Catheter Removed|Lost to Follow-up|7|||
155398159|NCT02247960|560892123|FG001|Catheter Removed|Lost to Follow-up|10|||
155398160|NCT01848353|560892126|FG000|Phase 1|Withdrawal by Subject|3|||
155398161|NCT01848353|560892127|FG001|Phase 1|Withdrawal by Subject|1|||
155398162|NCT01848353|560892128|FG002|Phase 1|Withdrawal by Subject|0|||
155398163|NCT01848353|560892129|FG003|Phase 1|Withdrawal by Subject|0|||
155398164|NCT01848353|560892126|FG000|Phase 2|Withdrawal by Subject|3|||
155398165|NCT01848353|560892127|FG001|Phase 2|Withdrawal by Subject|2|||
155398166|NCT01848353|560892128|FG002|Phase 2|Withdrawal by Subject|0|||
155398167|NCT01848353|560892129|FG003|Phase 2|Withdrawal by Subject|0|||
155398168|NCT01848353|560892126|FG000|Phase 3|Withdrawal by Subject|1|||
155398169|NCT01848353|560892127|FG001|Phase 3|Withdrawal by Subject|1|||
155398170|NCT01848353|560892128|FG002|Phase 3|Withdrawal by Subject|0|||
155398171|NCT01848353|560892129|FG003|Phase 3|Withdrawal by Subject|0|||
155398172|NCT00935272|560892132|FG000|Overall Study|Lost to Follow-up|10|||
155398173|NCT00935272|560892133|FG001|Overall Study|Lost to Follow-up|3|||
155398174|NCT00935272|560892132|FG000|Overall Study|Withdrawal by Subject|8|||
155398175|NCT00935272|560892133|FG001|Overall Study|Withdrawal by Subject|2|||
155398176|NCT00935272|560892132|FG000|Overall Study|Physician Decision|1|||
155398177|NCT00935272|560892133|FG001|Overall Study|Physician Decision|0|||
155398178|NCT00935272|560892132|FG000|Overall Study|Protocol Violation|0|||
155398179|NCT00935272|560892133|FG001|Overall Study|Protocol Violation|1|||
155398180|NCT03492554|560892137|FG000|Overall Study|Protocol Violation|0|||
155398181|NCT03492554|560892138|FG001|Overall Study|Protocol Violation|14|||
155398182|NCT04340557|560892142|FG000|Overall Study|Transferred to ICU and/or death|1|||
155398183|NCT04340557|560892143|FG001|Overall Study|Transferred to ICU and/or death|2|||
155398184|NCT00529451|560892144|FG000|Overall Study|Subject withdrew consent|16|||
155398185|NCT00529451|560892145|FG001|Overall Study|Subject withdrew consent|21|||
155398186|NCT00529451|560892146|FG002|Overall Study|Subject withdrew consent|13|||
155398187|NCT00529451|560892147|FG003|Overall Study|Subject withdrew consent|12|||
155398188|NCT00529451|560892144|FG000|Overall Study|Adverse Event|9|||
155398189|NCT00529451|560892145|FG001|Overall Study|Adverse Event|16|||
155398190|NCT00529451|560892146|FG002|Overall Study|Adverse Event|14|||
155398191|NCT00529451|560892147|FG003|Overall Study|Adverse Event|8|||
155398192|NCT00529451|560892144|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
155398193|NCT00529451|560892145|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
155398194|NCT00529451|560892146|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
155398195|NCT00529451|560892147|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
155398196|NCT00529451|560892144|FG000|Overall Study|Lost to Follow-up|4|||
155398197|NCT00529451|560892145|FG001|Overall Study|Lost to Follow-up|7|||
155398198|NCT00529451|560892146|FG002|Overall Study|Lost to Follow-up|4|||
155398199|NCT00529451|560892147|FG003|Overall Study|Lost to Follow-up|4|||
155398200|NCT00529451|560892144|FG000|Overall Study|Protocol deviation|1|||
155398201|NCT00529451|560892145|FG001|Overall Study|Protocol deviation|1|||
155398202|NCT00529451|560892146|FG002|Overall Study|Protocol deviation|4|||
155398203|NCT00529451|560892147|FG003|Overall Study|Protocol deviation|1|||
155398204|NCT00529451|560892144|FG000|Overall Study|Administrative problems|1|||
155398205|NCT00529451|560892145|FG001|Overall Study|Administrative problems|1|||
155398206|NCT00529451|560892146|FG002|Overall Study|Administrative problems|0|||
155398207|NCT00529451|560892147|FG003|Overall Study|Administrative problems|2|||
155398208|NCT04305275|560892148|FG000|Overall Study|Adverse Event|4|||
155398209|NCT04305275|560892149|FG001|Overall Study|Adverse Event|0|||
155398210|NCT04305275|560892148|FG000|Overall Study|Lost to Follow-up|1|||
155398211|NCT04305275|560892149|FG001|Overall Study|Lost to Follow-up|1|||
155398212|NCT04305275|560892148|FG000|Overall Study|Withdrawal by Participant|8|||
155398213|NCT04305275|560892149|FG001|Overall Study|Withdrawal by Participant|1|||
155398214|NCT00199836|560892150|FG000|Overall Study|Progressive Disease|5|||
155398215|NCT00199836|560892150|FG000|Overall Study|Death|1|||
155398216|NCT01235793|560892151|FG000|Overall Study|Death|6|||
155398217|NCT02303704|560892154|FG000|Overall Study|Protocol Violation|5|||
155398218|NCT02303704|560892155|FG001|Overall Study|Protocol Violation|9|||
155398219|NCT04411628|560892156|FG000|Overall Study|Withdrawal by Subject|1|||
155398220|NCT04411628|560892157|FG001|Overall Study|Withdrawal by Subject|1|||
155398221|NCT04411628|560892158|FG002|Overall Study|Withdrawal by Subject|2|||
155398222|NCT04411628|560892159|FG003|Overall Study|Withdrawal by Subject|0|||
155398223|NCT04411628|560892156|FG000|Overall Study|Lost to Follow-up|0|||
155398224|NCT04411628|560892157|FG001|Overall Study|Lost to Follow-up|1|||
155398225|NCT04411628|560892158|FG002|Overall Study|Lost to Follow-up|0|||
155398226|NCT04411628|560892159|FG003|Overall Study|Lost to Follow-up|0|||
155398227|NCT01034540|560892160|FG000|Overall Study|Adverse Event|0|||
155398228|NCT01034540|560892161|FG001|Overall Study|Adverse Event|1|||
155398229|NCT05293743|560892167|FG000|Overall Study|Withdrawal by Subject|1|||
155398230|NCT05293743|560892168|FG001|Overall Study|Withdrawal by Subject|0|||
155398231|NCT01200238|560892170|FG000|Overall Study|Adverse Event|2|||
155398232|NCT01200238|560892171|FG001|Overall Study|Adverse Event|1|||
155398233|NCT01200238|560892170|FG000|Overall Study|Progressive Disease|5|||
155398234|NCT01200238|560892171|FG001|Overall Study|Progressive Disease|8|||
155398235|NCT01200238|560892170|FG000|Overall Study|Withdrawal by Subject|0|||
155398236|NCT01200238|560892171|FG001|Overall Study|Withdrawal by Subject|1|||
155398237|NCT00482703|560892172|FG000|Overall Study|Poor compliance|1|||
155398238|NCT00482703|560892173|FG001|Overall Study|Poor compliance|0|||
155398239|NCT01428661|560892177|FG000|Double-Masked Phase|Protocol Violation|9|||
155398240|NCT01428661|560892178|FG001|Double-Masked Phase|Protocol Violation|4|||
155398241|NCT01428661|560892179|FG002|Double-Masked Phase|Protocol Violation|0|||
155398242|NCT01428661|560892177|FG000|Double-Masked Phase|Adverse Event|13|||
155398243|NCT01428661|560892178|FG001|Double-Masked Phase|Adverse Event|4|||
155398244|NCT01428661|560892179|FG002|Double-Masked Phase|Adverse Event|0|||
155398245|NCT01428661|560892177|FG000|Double-Masked Phase|Lost to Follow-up|14|||
155398246|NCT01428661|560892178|FG001|Double-Masked Phase|Lost to Follow-up|14|||
155398247|NCT01428661|560892179|FG002|Double-Masked Phase|Lost to Follow-up|0|||
155398248|NCT01428661|560892177|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
155398249|NCT01428661|560892178|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
155398250|NCT01428661|560892179|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
155398251|NCT01428661|560892177|FG000|Double-Masked Phase|Lack of Efficacy|2|||
155398252|NCT01428661|560892178|FG001|Double-Masked Phase|Lack of Efficacy|1|||
155398253|NCT01428661|560892179|FG002|Double-Masked Phase|Lack of Efficacy|0|||
155398254|NCT01428661|560892177|FG000|Double-Masked Phase|*Various|1|||
155398255|NCT01428661|560892178|FG001|Double-Masked Phase|*Various|6|||
155398256|NCT01428661|560892179|FG002|Double-Masked Phase|*Various|0|||
155398257|NCT01428661|560892177|FG000|Open Label Extension|Protocol Violation|0|||
155398258|NCT01428661|560892178|FG001|Open Label Extension|Protocol Violation|0|||
155398259|NCT01428661|560892179|FG002|Open Label Extension|Protocol Violation|9|||
155398260|NCT01428661|560892177|FG000|Open Label Extension|Adverse Event|0|||
155398261|NCT01428661|560892178|FG001|Open Label Extension|Adverse Event|0|||
155398262|NCT01428661|560892179|FG002|Open Label Extension|Adverse Event|15|||
155398263|NCT01428661|560892177|FG000|Open Label Extension|Lost to Follow-up|0|||
155398264|NCT01428661|560892178|FG001|Open Label Extension|Lost to Follow-up|0|||
155398265|NCT01428661|560892179|FG002|Open Label Extension|Lost to Follow-up|38|||
155398266|NCT01428661|560892177|FG000|Open Label Extension|Withdrawal by Subject|0|||
155398267|NCT01428661|560892178|FG001|Open Label Extension|Withdrawal by Subject|0|||
155284016|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
155284017|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
155284018|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
155284019|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
155284020|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
155284021|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
155284022|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
155284023|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
155284024|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
155284025|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
155284026|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
155284027|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
155284028|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155284029|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
155284030|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
155284031|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Physician Decision|2|||
155284032|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Physician Decision|3|||
155284033|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Physician Decision|0|||
155284034|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
155284035|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
155284036|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
155284037|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
155284038|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
155284039|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
155284040|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
155284041|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
155398268|NCT01428661|560892179|FG002|Open Label Extension|Withdrawal by Subject|49|||
155398269|NCT01428661|560892177|FG000|Open Label Extension|Lack of Efficacy|0|||
155398270|NCT01428661|560892178|FG001|Open Label Extension|Lack of Efficacy|0|||
155398271|NCT01428661|560892179|FG002|Open Label Extension|Lack of Efficacy|24|||
155398272|NCT01428661|560892177|FG000|Open Label Extension|**Various|0|||
155398273|NCT01428661|560892178|FG001|Open Label Extension|**Various|0|||
155398274|NCT01428661|560892179|FG002|Open Label Extension|**Various|185|||
155398275|NCT02322125|560893933|FG000|Overall Study|Withdrawal by Subject|2|||
155398276|NCT01183143|560893934|FG000|Overall Study|Protocol Violation|115|||
155398277|NCT01183143|560893934|FG000|Overall Study|Withdrawal by Subject|19|||
155398278|NCT01183143|560893934|FG000|Overall Study|Subject Questionnaires not returned|5|||
155398279|NCT01183143|560893934|FG000|Overall Study|Subjects enrolled, but not treated|11|||
155398280|NCT04096274|560893935|FG000|Phase I|Lost to Follow-up|5|||
155398281|NCT04096274|560893936|FG001|Phase I|Lost to Follow-up|5|||
155398282|NCT04096274|560893935|FG000|Phase II|Lost to Follow-up|11|||
155398283|NCT04096274|560893936|FG001|Phase II|Lost to Follow-up|11|||
155398284|NCT04490395|560893937|FG000|Overall Study|Lost to Follow-up|0|||
155398285|NCT04490395|560893938|FG001|Overall Study|Lost to Follow-up|1|||
155398286|NCT05092919|560893940|FG000|Overall Study|Lost to Follow-up|7|||
155398287|NCT05092919|560893940|FG000|Overall Study|Withdrawal by Subject|2|||
155398288|NCT01942148|560893944|FG000|Overall Study|Adverse Event|4|||
155398289|NCT01942148|560893944|FG000|Overall Study|Lack of Efficacy|2|||
155636248|NCT03329001|561760957|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155636249|NCT03329001|561760958|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155636250|NCT03329001|561760959|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155636251|NCT03329001|561760960|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
155636252|NCT03329001|561760961|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
155636253|NCT03329001|561760954|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636254|NCT03329001|561760955|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155398290|NCT01942148|560893944|FG000|Overall Study|Physician Decision|11|||
155398291|NCT01942148|560893944|FG000|Overall Study|Protocol Violation|1|||
155398292|NCT01942148|560893944|FG000|Overall Study|Withdrawal by Subject|8|||
155398293|NCT01942148|560893944|FG000|Overall Study|Use of the prohibition medicine|1|||
155398294|NCT02248259|560893945|FG000|Treatment Period 1|Adverse Event|0|||
155398295|NCT02248259|560893946|FG001|Treatment Period 1|Adverse Event|0|||
155398296|NCT02248259|560893947|FG002|Treatment Period 1|Adverse Event|1|||
155398297|NCT02248259|560893948|FG003|Treatment Period 1|Adverse Event|0|||
155398298|NCT02807480|560893953|FG000|Overall Study|Withdrawal by Subject|14|||
155398299|NCT02807480|560893954|FG001|Overall Study|Withdrawal by Subject|10|||
155398300|NCT02369848|560893955|FG000|Overall Study|Death|1|||
155398301|NCT02369848|560893955|FG000|Overall Study|Withdrawal by Subject|2|||
155398302|NCT02369848|560893955|FG000|Overall Study|Lost to Follow-up|1|||
155398303|NCT00096785|560893959|FG000|Overall Study|Lost to Follow-up|1|||
155398304|NCT00096785|560893960|FG001|Overall Study|Lost to Follow-up|0|||
155398305|NCT00096785|560893959|FG000|Overall Study|Withdrawal by Subject|0|||
155398306|NCT00096785|560893960|FG001|Overall Study|Withdrawal by Subject|1|||
155398307|NCT00096785|560893959|FG000|Overall Study|Relocated|1|||
155398308|NCT00096785|560893960|FG001|Overall Study|Relocated|0|||
155398309|NCT01838616|560893961|FG000|Titration Period|Adverse Event|18|||
155398310|NCT01838616|560893962|FG001|Titration Period|Adverse Event|48|||
155398311|NCT01838616|560893961|FG000|Titration Period|Lack of Efficacy|5|||
155398312|NCT01838616|560893962|FG001|Titration Period|Lack of Efficacy|12|||
155398313|NCT01838616|560893961|FG000|Titration Period|Withdrawal by Subject|5|||
155398314|NCT01838616|560893962|FG001|Titration Period|Withdrawal by Subject|5|||
155398315|NCT01838616|560893961|FG000|Titration Period|Technical problems|1|||
155398316|NCT01838616|560893962|FG001|Titration Period|Technical problems|0|||
155398317|NCT01838616|560893961|FG000|Titration Period|Other|1|||
155398318|NCT01838616|560893962|FG001|Titration Period|Other|0|||
155398319|NCT01838616|560893961|FG000|Titration Period|Protocol Violation|0|||
155398320|NCT01838616|560893962|FG001|Titration Period|Protocol Violation|1|||
155398321|NCT01838616|560893961|FG000|Continuation Period|Lack of Efficacy|3|||
155398322|NCT01838616|560893962|FG001|Continuation Period|Lack of Efficacy|5|||
155398323|NCT01838616|560893961|FG000|Continuation Period|Adverse Event|8|||
155398324|NCT01838616|560893962|FG001|Continuation Period|Adverse Event|4|||
155398325|NCT01838616|560893961|FG000|Continuation Period|Protocol Violation|2|||
155398326|NCT01838616|560893962|FG001|Continuation Period|Protocol Violation|0|||
155398327|NCT01838616|560893961|FG000|Continuation Period|Lost to Follow-up|1|||
155398328|NCT01838616|560893962|FG001|Continuation Period|Lost to Follow-up|0|||
155398329|NCT01838616|560893961|FG000|Continuation Period|Withdrawal by Subject|0|||
155398330|NCT01838616|560893962|FG001|Continuation Period|Withdrawal by Subject|4|||
155398331|NCT01838616|560893961|FG000|Continuation Period|Technical problems|0|||
155398332|NCT01838616|560893962|FG001|Continuation Period|Technical problems|1|||
155398333|NCT01838616|560893961|FG000|Pick-up Arm|Lack of Efficacy|4|||
155398334|NCT01838616|560893962|FG001|Pick-up Arm|Lack of Efficacy|0|||
155398335|NCT01838616|560893961|FG000|Pick-up Arm|Adverse Event|9|||
155398336|NCT01838616|560893962|FG001|Pick-up Arm|Adverse Event|0|||
155398337|NCT01838616|560893961|FG000|Pick-up Arm|Withdrawal by Subject|1|||
155398338|NCT01838616|560893962|FG001|Pick-up Arm|Withdrawal by Subject|0|||
155398339|NCT01838616|560893961|FG000|Pick-up Arm|Technical problems|1|||
155398340|NCT01838616|560893962|FG001|Pick-up Arm|Technical problems|0|||
155398341|NCT00257725|560893963|FG000|Overall Study|Adverse Event|3|||
155398342|NCT02573870|560893964|FG000|Overall Study|Adverse Event|0|||
155398343|NCT02573870|560893965|FG001|Overall Study|Adverse Event|2|||
155398344|NCT02573870|560893964|FG000|Overall Study|Lack of Efficacy|0|||
155398345|NCT02573870|560893965|FG001|Overall Study|Lack of Efficacy|1|||
155398346|NCT02573870|560893964|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
155398347|NCT02573870|560893965|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
155398348|NCT02573870|560893964|FG000|Overall Study|Lost to Follow-up|0|||
155398349|NCT02573870|560893965|FG001|Overall Study|Lost to Follow-up|1|||
155398350|NCT02573870|560893964|FG000|Overall Study|Other: Fail to Meet Visit|0|||
155398351|NCT02573870|560893965|FG001|Overall Study|Other: Fail to Meet Visit|2|||
155398352|NCT02081534|560893967|FG000|Overall Study|Adverse Event|5|||
155398353|NCT02081534|560893968|FG001|Overall Study|Adverse Event|4|||
155398354|NCT02081534|560893969|FG002|Overall Study|Adverse Event|3|||
155398355|NCT02081534|560893970|FG003|Overall Study|Adverse Event|10|||
155398356|NCT02081534|560893971|FG004|Overall Study|Adverse Event|2|||
155398357|NCT02081534|560893972|FG005|Overall Study|Adverse Event|8|||
155398358|NCT02081534|560893973|FG006|Overall Study|Adverse Event|2|||
155398359|NCT02081534|560893967|FG000|Overall Study|Withdrawal by Subject|0|||
155398360|NCT02081534|560893968|FG001|Overall Study|Withdrawal by Subject|1|||
155398361|NCT02081534|560893969|FG002|Overall Study|Withdrawal by Subject|1|||
155398362|NCT02081534|560893970|FG003|Overall Study|Withdrawal by Subject|1|||
155398363|NCT02081534|560893971|FG004|Overall Study|Withdrawal by Subject|1|||
155398364|NCT02081534|560893972|FG005|Overall Study|Withdrawal by Subject|0|||
155398365|NCT02081534|560893973|FG006|Overall Study|Withdrawal by Subject|1|||
155398366|NCT02081534|560893967|FG000|Overall Study|Protocol Violation|0|||
155398367|NCT02081534|560893968|FG001|Overall Study|Protocol Violation|3|||
155398368|NCT02081534|560893969|FG002|Overall Study|Protocol Violation|0|||
155398369|NCT02081534|560893970|FG003|Overall Study|Protocol Violation|0|||
155398370|NCT02081534|560893971|FG004|Overall Study|Protocol Violation|0|||
155398371|NCT02081534|560893972|FG005|Overall Study|Protocol Violation|0|||
155398372|NCT02081534|560893973|FG006|Overall Study|Protocol Violation|1|||
155398373|NCT02081534|560893967|FG000|Overall Study|Lost to Follow-up|0|||
155398374|NCT02081534|560893968|FG001|Overall Study|Lost to Follow-up|0|||
155398375|NCT02081534|560893969|FG002|Overall Study|Lost to Follow-up|0|||
155398376|NCT02081534|560893970|FG003|Overall Study|Lost to Follow-up|2|||
155398377|NCT02081534|560893971|FG004|Overall Study|Lost to Follow-up|1|||
155398378|NCT02081534|560893972|FG005|Overall Study|Lost to Follow-up|1|||
155398379|NCT02081534|560893973|FG006|Overall Study|Lost to Follow-up|0|||
155398380|NCT01007032|560893974|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
155284042|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
155284043|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
155284044|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
155284045|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
155398381|NCT01007032|560893975|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
155398382|NCT01007032|560893976|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
155398383|NCT01007032|560893977|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
155398384|NCT01007032|560893974|FG000|Overall Study|Withdrawal by Subject|0|||
155398385|NCT01007032|560893975|FG001|Overall Study|Withdrawal by Subject|0|||
155398386|NCT01007032|560893976|FG002|Overall Study|Withdrawal by Subject|0|||
155398387|NCT01007032|560893977|FG003|Overall Study|Withdrawal by Subject|1|||
155398388|NCT00709111|560893978|FG000|Overall Study|Withdrawal by Subject|1|||
155398389|NCT00709111|560893978|FG000|Overall Study|Unable to attend clinic visits|1|||
155398390|NCT00915772|560893979|FG000|Overall Study|Adverse Event|12|||
155398391|NCT00915772|560893980|FG001|Overall Study|Adverse Event|13|||
155398392|NCT00915772|560893981|FG002|Overall Study|Adverse Event|11|||
155398393|NCT00915772|560893979|FG000|Overall Study|Protocol Violation|4|||
155398394|NCT00915772|560893980|FG001|Overall Study|Protocol Violation|1|||
155398395|NCT00915772|560893981|FG002|Overall Study|Protocol Violation|2|||
155284046|NCT01919619|560470917|FG000|Overall Study|Physician Decision|1|||
155284047|NCT01919619|560470918|FG001|Overall Study|Physician Decision|1|||
155284048|NCT02268396|560472656|FG000|Overall Study|Adverse Event|3|||
155398396|NCT00915772|560893979|FG000|Overall Study|Lost to Follow-up|1|||
155398397|NCT00915772|560893980|FG001|Overall Study|Lost to Follow-up|2|||
155398398|NCT00915772|560893981|FG002|Overall Study|Lost to Follow-up|2|||
155398399|NCT00915772|560893979|FG000|Overall Study|Lack of Efficacy|9|||
155398400|NCT00915772|560893980|FG001|Overall Study|Lack of Efficacy|15|||
155398401|NCT00915772|560893981|FG002|Overall Study|Lack of Efficacy|3|||
155398402|NCT00915772|560893979|FG000|Overall Study|Refused to continue trial medication|6|||
155398403|NCT00915772|560893980|FG001|Overall Study|Refused to continue trial medication|8|||
155398404|NCT00915772|560893981|FG002|Overall Study|Refused to continue trial medication|4|||
155398405|NCT00915772|560893979|FG000|Overall Study|Any other reason|4|||
155398406|NCT00915772|560893980|FG001|Overall Study|Any other reason|7|||
155398407|NCT00915772|560893981|FG002|Overall Study|Any other reason|7|||
155398408|NCT00549939|560893985|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
155398409|NCT00549939|560893986|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
155398410|NCT00549939|560893987|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
155398411|NCT00549939|560893985|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
155398412|NCT00549939|560893986|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
155398413|NCT00549939|560893987|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
155398414|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
155398415|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
155398416|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
155398417|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
155398418|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
155398419|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
155398420|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
155398421|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
155398422|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
155398423|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Other|0|||
155398424|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Other|1|||
155398425|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Other|4|||
155398426|NCT01735279|560893988|FG000|Overall Study|Lost to Follow-up|11|||
155398427|NCT01735279|560893989|FG001|Overall Study|Lost to Follow-up|8|||
155398428|NCT00806195|560893990|FG000|Overall Study|Death|6|||
155398429|NCT00806195|560893991|FG001|Overall Study|Death|0|||
155398430|NCT00806195|560893992|FG002|Overall Study|Death|1|||
155398431|NCT00806195|560893993|FG003|Overall Study|Death|0|||
155398432|NCT00806195|560893990|FG000|Overall Study|Adverse Event|25|||
155398433|NCT00806195|560893991|FG001|Overall Study|Adverse Event|5|||
155398434|NCT00806195|560893992|FG002|Overall Study|Adverse Event|11|||
155398435|NCT00806195|560893993|FG003|Overall Study|Adverse Event|2|||
155398436|NCT00806195|560893990|FG000|Overall Study|Withdrawal by Subject|119|||
155398437|NCT00806195|560893991|FG001|Overall Study|Withdrawal by Subject|31|||
155398438|NCT00806195|560893992|FG002|Overall Study|Withdrawal by Subject|76|||
155398439|NCT00806195|560893993|FG003|Overall Study|Withdrawal by Subject|35|||
155398440|NCT00806195|560893990|FG000|Overall Study|Lost to Follow-up|217|||
155398441|NCT00806195|560893991|FG001|Overall Study|Lost to Follow-up|66|||
155398442|NCT00806195|560893992|FG002|Overall Study|Lost to Follow-up|90|||
155398443|NCT00806195|560893993|FG003|Overall Study|Lost to Follow-up|34|||
155398444|NCT00806195|560893990|FG000|Overall Study|Inappropriate Enrollment|0|||
155398445|NCT00806195|560893991|FG001|Overall Study|Inappropriate Enrollment|1|||
155398446|NCT00806195|560893992|FG002|Overall Study|Inappropriate Enrollment|0|||
155398447|NCT00806195|560893993|FG003|Overall Study|Inappropriate Enrollment|0|||
155398448|NCT00806195|560893990|FG000|Overall Study|Administrative Reason|113|||
155398449|NCT00806195|560893991|FG001|Overall Study|Administrative Reason|35|||
155398450|NCT00806195|560893992|FG002|Overall Study|Administrative Reason|66|||
155398451|NCT00806195|560893993|FG003|Overall Study|Administrative Reason|26|||
155398452|NCT00806195|560893990|FG000|Overall Study|Protocol Violation|34|||
155398453|NCT00806195|560893991|FG001|Overall Study|Protocol Violation|24|||
155398454|NCT00806195|560893992|FG002|Overall Study|Protocol Violation|26|||
155398455|NCT00806195|560893993|FG003|Overall Study|Protocol Violation|9|||
155398456|NCT02319668|560893994|FG000|Overall Study|Other (Not specified)|0|||
155398457|NCT02319668|560893995|FG001|Overall Study|Other (Not specified)|2|||
155398458|NCT01161043|560893996|FG000|Overall Study|Withdrawal by Subject|3|||
155398459|NCT02164929|560893997|FG000|Overall Study|Converted to open procedure|1|||
155398460|NCT02164929|560893998|FG001|Overall Study|Converted to open procedure|0|||
155398461|NCT02164929|560893999|FG002|Overall Study|Converted to open procedure|0|||
155398462|NCT02164929|560894000|FG003|Overall Study|Converted to open procedure|2|||
155398463|NCT02164929|560893997|FG000|Overall Study|Failed regional block|0|||
155398464|NCT02164929|560893998|FG001|Overall Study|Failed regional block|0|||
155398465|NCT02164929|560893999|FG002|Overall Study|Failed regional block|1|||
155398466|NCT02164929|560894000|FG003|Overall Study|Failed regional block|0|||
155398467|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Adverse Event|84|||
155398468|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Adverse Event|0|||
155398469|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Non-compliance|3|||
155398470|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Non-compliance|0|||
155398471|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
155398472|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
155398473|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Other|11|||
155398474|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Other|0|||
155398475|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Adverse Event|0|||
155398476|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Adverse Event|6|||
155398477|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Non-compliance|0|||
155398478|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Non-compliance|2|||
155398479|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
155398480|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
155398481|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Other|0|||
155398482|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Other|1|||
155398483|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Adverse Event|13|||
155398484|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Adverse Event|3|||
155398485|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
155398486|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
155398487|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Other|1|||
155398488|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Other|1|||
155398489|NCT00701090|560894008|FG000|Overall Study|Adverse Event|11|||
155398490|NCT00701090|560894009|FG001|Overall Study|Adverse Event|2|||
155398491|NCT00701090|560894008|FG000|Overall Study|Death|0|||
155398492|NCT00701090|560894009|FG001|Overall Study|Death|1|||
155398493|NCT00701090|560894008|FG000|Overall Study|Lack of Efficacy|5|||
155398494|NCT00701090|560894009|FG001|Overall Study|Lack of Efficacy|4|||
155398495|NCT00701090|560894008|FG000|Overall Study|Lost to Follow-up|9|||
155398496|NCT00701090|560894009|FG001|Overall Study|Lost to Follow-up|9|||
155398497|NCT00701090|560894008|FG000|Overall Study|Physician Decision|3|||
155398498|NCT00701090|560894009|FG001|Overall Study|Physician Decision|4|||
155398499|NCT00701090|560894008|FG000|Overall Study|Protocol Violation|2|||
155398500|NCT00701090|560894009|FG001|Overall Study|Protocol Violation|3|||
155398501|NCT00701090|560894008|FG000|Overall Study|Withdrawal by Subject|11|||
155398502|NCT00701090|560894009|FG001|Overall Study|Withdrawal by Subject|16|||
155398503|NCT00701090|560894008|FG000|Overall Study|Other|7|||
155398504|NCT00701090|560894009|FG001|Overall Study|Other|12|||
155398505|NCT00873366|560894010|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
155398506|NCT00873366|560894010|FG000|Overall Study|Off tamoxifen due to side effects|2|||
155398507|NCT00873366|560894010|FG000|Overall Study|Refused to continue DM-BT testing|3|||
155398508|NCT01537198|560894011|FG000|Overall Study|RSV infection|2|||
155398509|NCT01537198|560894011|FG000|Overall Study|Adverse Event|4|||
155398510|NCT01537198|560894011|FG000|Overall Study|No Further Visits to the Clinic|37|||
155398511|NCT01537198|560894011|FG000|Overall Study|Other|111|||
155398512|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
155398513|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
155398514|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
155398515|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
155398516|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
155398517|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
155398518|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
155398519|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
155398520|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
155398521|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
155398522|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
155398523|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
155398524|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
155398525|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
155398526|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
155398527|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
155398528|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
155398529|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
155398530|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
155398531|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
155398532|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
155398533|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
155398534|NCT00113074|560894022|FG000|Overall Study|Lost to Follow-up|10|||
155398535|NCT00113074|560894023|FG001|Overall Study|Lost to Follow-up|10|||
155398536|NCT00113074|560894024|FG002|Overall Study|Lost to Follow-up|14|||
155398537|NCT03680911|560894025|FG000|At Home Treatment|Study Termination|3|||
155398538|NCT03680911|560894026|FG001|At Home Treatment|Study Termination|0|||
155398539|NCT03680911|560894025|FG000|At Home Treatment|Lost to Follow-up|0|||
155398540|NCT03680911|560894026|FG001|At Home Treatment|Lost to Follow-up|1|||
155398541|NCT03680911|560894025|FG000|At Home Treatment|Withdrawal by Subject|0|||
155398542|NCT03680911|560894026|FG001|At Home Treatment|Withdrawal by Subject|2|||
155398543|NCT03680911|560894025|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
155398544|NCT03680911|560894026|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
155398545|NCT03962738|560894027|FG000|Overall Study|Protocol Deviation|3|||
155398546|NCT03962738|560894028|FG001|Overall Study|Protocol Deviation|0|||
155398547|NCT03962738|560894029|FG002|Overall Study|Protocol Deviation|1|||
155398548|NCT03962738|560894030|FG003|Overall Study|Protocol Deviation|1|||
155398549|NCT03962738|560894027|FG000|Overall Study|Withdrawal by Subject|4|||
155398550|NCT03962738|560894028|FG001|Overall Study|Withdrawal by Subject|0|||
155398551|NCT03962738|560894029|FG002|Overall Study|Withdrawal by Subject|0|||
155398552|NCT03962738|560894030|FG003|Overall Study|Withdrawal by Subject|0|||
155398553|NCT03962738|560894027|FG000|Overall Study|Lost to Follow-up|0|||
155398554|NCT03962738|560894028|FG001|Overall Study|Lost to Follow-up|0|||
155398555|NCT03962738|560894029|FG002|Overall Study|Lost to Follow-up|1|||
155398556|NCT03962738|560894030|FG003|Overall Study|Lost to Follow-up|0|||
155398557|NCT01478360|560894031|FG000|Overall Study|Lost to Follow-up|1|||
155398558|NCT01478360|560894032|FG001|Overall Study|Lost to Follow-up|0|||
155398559|NCT01478360|560894031|FG000|Overall Study|Adverse Event|0|||
155398560|NCT01478360|560894032|FG001|Overall Study|Adverse Event|1|||
155398561|NCT01478360|560894031|FG000|Overall Study|Administrative problems|1|||
155398562|NCT01478360|560894032|FG001|Overall Study|Administrative problems|2|||
155398563|NCT01221727|560894033|FG000|Overall Study|Physician Decision|2|||
155398564|NCT01221727|560894034|FG001|Overall Study|Physician Decision|0|||
155398565|NCT01221727|560894033|FG000|Overall Study|Withdrawal by Subject|1|||
155398566|NCT01221727|560894034|FG001|Overall Study|Withdrawal by Subject|1|||
155398567|NCT02566577|560894035|FG000|Overall Study|Withdrawal by Subject|1|||
155398568|NCT02566577|560894036|FG001|Overall Study|Withdrawal by Subject|1|||
155398569|NCT02566577|560894035|FG000|Overall Study|Equipment failure|1|||
155398570|NCT02566577|560894036|FG001|Overall Study|Equipment failure|1|||
155398571|NCT02566577|560894035|FG000|Overall Study|Physical limitation|1|||
155398572|NCT02566577|560894036|FG001|Overall Study|Physical limitation|0|||
155398573|NCT01289821|560894037|FG000|Treatment Period|Withdrawal by Subject|1|||
155398574|NCT01289821|560894037|FG000|Treatment Period|Physician Decision|3|||
155398575|NCT01289821|560894037|FG000|Treatment Period|Adverse Event|4|||
155398576|NCT01289821|560894037|FG000|Treatment Period|Radiological Progression|43|||
155398577|NCT01289821|560894037|FG000|Treatment Period|Clinical Progression|2|||
155398578|NCT01289821|560894037|FG000|Treatment Period|Therapeutic procedure required|1|||
155398579|NCT01289821|560894037|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
155398580|NCT01289821|560894037|FG000|Safety Follow-up Period|Protocol Violation|3|||
155398581|NCT01289821|560894037|FG000|Safety Follow-up Period|Unspecified reason|1|||
155398582|NCT01289821|560894037|FG000|Survival Follow-up Period|Protocol Violation|1|||
155398583|NCT01289821|560894037|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
155398584|NCT01289821|560894037|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
155398585|NCT02941926|560894038|FG000|Core Phase|Progressive disease|1109|||
155398586|NCT02941926|560894038|FG000|Core Phase|Adverse Event|504|||
155398587|NCT02941926|560894038|FG000|Core Phase|Subject/guardian decision|127|||
155398588|NCT02941926|560894038|FG000|Core Phase|Physician Decision|112|||
155398589|NCT02941926|560894038|FG000|Core Phase|Death|46|||
155398590|NCT02941926|560894038|FG000|Core Phase|Protocol deviation|34|||
155398591|NCT02941926|560894038|FG000|Core Phase|Lost to Follow-up|8|||
155398592|NCT02941926|560894038|FG000|Core Phase|Technical problems|5|||
155398593|NCT02941926|560894038|FG000|Extension Phase|Physician Decision|155|||
155398594|NCT02941926|560894038|FG000|Extension Phase|Progressive disease|115|||
155398595|NCT02941926|560894038|FG000|Extension Phase|Adverse Event|13|||
155398596|NCT02941926|560894038|FG000|Extension Phase|Subject/Guardian decision|12|||
155398597|NCT02941926|560894038|FG000|Extension Phase|Death|6|||
155398598|NCT00097773|560894039|FG000|Overall Study|Lost to Follow-up|2|||
155398599|NCT00097773|560894040|FG001|Overall Study|Lost to Follow-up|2|||
155398600|NCT00097773|560894041|FG002|Overall Study|Lost to Follow-up|0|||
155398601|NCT00097773|560894042|FG003|Overall Study|Lost to Follow-up|1|||
155398602|NCT00097773|560894039|FG000|Overall Study|Physician Decision|2|||
155398603|NCT00097773|560894040|FG001|Overall Study|Physician Decision|2|||
155398604|NCT00097773|560894041|FG002|Overall Study|Physician Decision|3|||
155398605|NCT00097773|560894042|FG003|Overall Study|Physician Decision|1|||
155398606|NCT00097773|560894039|FG000|Overall Study|Withdrawal by Subject|3|||
155398607|NCT00097773|560894040|FG001|Overall Study|Withdrawal by Subject|3|||
155398608|NCT00097773|560894041|FG002|Overall Study|Withdrawal by Subject|3|||
155398609|NCT00097773|560894042|FG003|Overall Study|Withdrawal by Subject|1|||
155398610|NCT00097773|560894039|FG000|Overall Study|Adverse Event|0|||
155398611|NCT00097773|560894040|FG001|Overall Study|Adverse Event|1|||
155398612|NCT00097773|560894041|FG002|Overall Study|Adverse Event|0|||
155398613|NCT00097773|560894042|FG003|Overall Study|Adverse Event|0|||
155398614|NCT00097773|560894039|FG000|Overall Study|Other|1|||
155398615|NCT00097773|560894040|FG001|Overall Study|Other|0|||
155398616|NCT00097773|560894041|FG002|Overall Study|Other|2|||
155398617|NCT00097773|560894042|FG003|Overall Study|Other|0|||
155398618|NCT01009034|560894043|FG000|Overall Study|Lost to Follow-up|2|||
155398619|NCT01009034|560894043|FG000|Overall Study|Withdrawal by Subject|2|||
155398620|NCT00474708|560894044|FG000|Overall Study|Lack of Efficacy|11|||
155398621|NCT00474708|560894045|FG001|Overall Study|Lack of Efficacy|5|||
155398622|NCT00474708|560894044|FG000|Overall Study|Suicide ideation/behavior|0|||
155398623|NCT00474708|560894045|FG001|Overall Study|Suicide ideation/behavior|1|||
155398624|NCT00474708|560894044|FG000|Overall Study|Withdrawal by Subject|7|||
155398625|NCT00474708|560894045|FG001|Overall Study|Withdrawal by Subject|0|||
155398626|NCT00474708|560894044|FG000|Overall Study|Lack of compliance|12|||
155398627|NCT00474708|560894045|FG001|Overall Study|Lack of compliance|4|||
155398628|NCT00474708|560894044|FG000|Overall Study|Lost to Follow-up|18|||
155398629|NCT00474708|560894045|FG001|Overall Study|Lost to Follow-up|9|||
155398630|NCT00474708|560894044|FG000|Overall Study|Physician Decision|9|||
155398631|NCT00474708|560894045|FG001|Overall Study|Physician Decision|6|||
155398632|NCT03700320|560894046|FG000|Overall Study|Adverse Event|5|||
155398633|NCT03700320|560894047|FG001|Overall Study|Adverse Event|31|||
155398634|NCT03700320|560894046|FG000|Overall Study|Lack of Efficacy|2|||
155398635|NCT03700320|560894047|FG001|Overall Study|Lack of Efficacy|5|||
155398636|NCT03700320|560894046|FG000|Overall Study|Withdrawal by Subject|29|||
155398637|NCT03700320|560894047|FG001|Overall Study|Withdrawal by Subject|75|||
155398638|NCT03700320|560894046|FG000|Overall Study|Lost to Follow-up|16|||
155398639|NCT03700320|560894047|FG001|Overall Study|Lost to Follow-up|23|||
155398640|NCT03700320|560894046|FG000|Overall Study|Pregnancy|2|||
155398641|NCT03700320|560894047|FG001|Overall Study|Pregnancy|4|||
155398642|NCT03700320|560894046|FG000|Overall Study|Protocol Deviation|7|||
155398643|NCT03700320|560894047|FG001|Overall Study|Protocol Deviation|31|||
155398644|NCT03700320|560894046|FG000|Overall Study|Non-compliance with Study Drug|1|||
155398645|NCT03700320|560894047|FG001|Overall Study|Non-compliance with Study Drug|3|||
155398646|NCT03700320|560894046|FG000|Overall Study|Reason not Specified|0|||
155398647|NCT03700320|560894047|FG001|Overall Study|Reason not Specified|1|||
155398648|NCT02243865|560894051|FG000|Overall Study|Protocol Violation|1|||
155398649|NCT02243865|560894052|FG001|Overall Study|Protocol Violation|3|||
155398650|NCT02243865|560894051|FG000|Overall Study|Lost to Follow-up|1|||
155398651|NCT02243865|560894052|FG001|Overall Study|Lost to Follow-up|1|||
155398652|NCT02243865|560894051|FG000|Overall Study|Withdrawal by Subject|1|||
155398653|NCT02243865|560894052|FG001|Overall Study|Withdrawal by Subject|0|||
155398654|NCT02243865|560894051|FG000|Overall Study|Adverse Event|1|||
155398655|NCT02243865|560894052|FG001|Overall Study|Adverse Event|1|||
155398656|NCT02054325|560894058|FG000|Overall Study|Lost to Follow-up|8|||
155398657|NCT02054325|560894059|FG001|Overall Study|Lost to Follow-up|5|||
155398658|NCT05093322|560894060|FG000|Overall Study|Death|6|||
155398659|NCT05093322|560894061|FG001|Overall Study|Death|2|||
155398660|NCT05093322|560894060|FG000|Overall Study|Other|4|||
155398661|NCT05093322|560894061|FG001|Overall Study|Other|1|||
155398662|NCT00898443|560894062|FG000|Overall Study|Withdrawal by Subject|1|||
155398663|NCT00898443|560894063|FG001|Overall Study|Withdrawal by Subject|0|||
155398664|NCT01843972|560894065|FG000|Overall Study|Withdrawal by Subject|0|||
155398665|NCT01843972|560894066|FG001|Overall Study|Withdrawal by Subject|0|||
155398666|NCT01843972|560894067|FG002|Overall Study|Withdrawal by Subject|0|||
155398667|NCT01843972|560894068|FG003|Overall Study|Withdrawal by Subject|0|||
155398668|NCT01843972|560894069|FG004|Overall Study|Withdrawal by Subject|1|||
155398669|NCT01843972|560894070|FG005|Overall Study|Withdrawal by Subject|0|||
155398670|NCT01843972|560894071|FG006|Overall Study|Withdrawal by Subject|0|||
155398671|NCT01843972|560894072|FG007|Overall Study|Withdrawal by Subject|0|||
155398672|NCT01843972|560894073|FG008|Overall Study|Withdrawal by Subject|0|||
155398673|NCT01843972|560894074|FG009|Overall Study|Withdrawal by Subject|0|||
155398674|NCT00932425|560894077|FG000|Overall Study|Lost to Follow-up|0|||
155398675|NCT00932425|560894078|FG001|Overall Study|Lost to Follow-up|1|||
155398676|NCT00932425|560894077|FG000|Overall Study|Withdrawal by Subject|0|||
155398677|NCT00932425|560894078|FG001|Overall Study|Withdrawal by Subject|1|||
155398678|NCT00916279|560894081|FG000|Overall Study|Death|2|||
155398679|NCT00916279|560894081|FG000|Overall Study|Lost to Follow-up|2|||
155398680|NCT00310804|560894082|FG000|Overall Study|Lost to Follow-up|2|||
155398681|NCT00310804|560894083|FG001|Overall Study|Lost to Follow-up|0|||
155398682|NCT00310804|560894082|FG000|Overall Study|Withdrawal by Subject|3|||
155398683|NCT00310804|560894083|FG001|Overall Study|Withdrawal by Subject|0|||
155398684|NCT02717754|560894086|FG000|Overall Study|Incorrect Infusion Duration|0|||
155398685|NCT02717754|560894087|FG001|Overall Study|Incorrect Infusion Duration|0|||
155398686|NCT02717754|560894088|FG002|Overall Study|Incorrect Infusion Duration|0|||
155398687|NCT02717754|560894089|FG003|Overall Study|Incorrect Infusion Duration|10|||
155398688|NCT02717754|560894090|FG004|Overall Study|Incorrect Infusion Duration|20|||
155284049|NCT02268396|560472656|FG000|Overall Study|Administrative|2|||
155398689|NCT02717754|560894091|FG005|Overall Study|Incorrect Infusion Duration|20|||
155398690|NCT00667823|560894092|FG000|Overall Study|Lost to Follow-up|5|||
155398691|NCT00667823|560894092|FG000|Overall Study|Adverse Event|7|||
155398692|NCT00667823|560894092|FG000|Overall Study|Death|182|||
155398693|NCT00667823|560894092|FG000|Overall Study|Withdrawal by Subject|12|||
155398694|NCT00667823|560894092|FG000|Overall Study|Other|8|||
155398695|NCT00667823|560894092|FG000|Overall Study|Missing (completion page missing)|2|||
155398696|NCT03828292|560894093|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398697|NCT03828292|560894094|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
155398698|NCT03828292|560894095|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398699|NCT03828292|560894096|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398700|NCT03828292|560894097|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398701|NCT03828292|560894098|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398702|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398703|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398704|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
155398705|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398706|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398707|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398708|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398709|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398710|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398711|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
155398712|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398713|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398714|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398715|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398716|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398717|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
155398718|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398719|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398720|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398721|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398722|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
155398723|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
155398724|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398725|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398726|NCT04376827|560894099|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
155284050|NCT02268396|560472656|FG000|Overall Study|Withdrawal by Subject|1|||
155284051|NCT02268396|560472656|FG000|Overall Study|Lost to Follow-up|2|||
155284052|NCT02268396|560472656|FG000|Overall Study|Protocol-Specified Criteria|2|||
155284053|NCT02268396|560472656|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
155284054|NCT01304706|560472659|FG000|Overall Study|Adverse Event|2|||
155284055|NCT01304706|560472659|FG000|Overall Study|Lack of Efficacy|1|||
155284056|NCT01304706|560472659|FG000|Overall Study|Death|3|||
155284057|NCT01304706|560472659|FG000|Overall Study|Withdrawal by Subject|3|||
155284058|NCT01304706|560472659|FG000|Overall Study|Lost to Follow-up|7|||
155284059|NCT01304706|560472659|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
155398727|NCT04376827|560894100|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
155398728|NCT04376827|560894099|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
155398729|NCT04376827|560894100|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
155398730|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
155398731|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
155398732|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
155398733|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
155398734|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
155284060|NCT04978363|560472660|FG000|Overall Study|Other medical issues unrelated to the study|0|||
155284061|NCT04978363|560472661|FG001|Overall Study|Other medical issues unrelated to the study|0|||
155398735|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
155398736|NCT03697720|560895782|FG000|Overall Study|Lost to Follow-up|7|||
155398737|NCT03496012|560895783|FG000|Overall Study|Withdrawal by Subject|2|||
155398738|NCT03496012|560895784|FG001|Overall Study|Withdrawal by Subject|0|||
155398739|NCT03496012|560895785|FG002|Overall Study|Withdrawal by Subject|2|||
155398740|NCT03496012|560895783|FG000|Overall Study|Adverse Event|0|||
155398741|NCT03496012|560895784|FG001|Overall Study|Adverse Event|0|||
155398742|NCT03496012|560895785|FG002|Overall Study|Adverse Event|1|||
155398743|NCT03496012|560895783|FG000|Overall Study|Reason Not Specified|2|||
155398744|NCT03496012|560895784|FG001|Overall Study|Reason Not Specified|0|||
155398745|NCT03496012|560895785|FG002|Overall Study|Reason Not Specified|1|||
155398746|NCT02053168|560895788|FG000|Overall Study|Withdrawal by Subject|1|||
155398747|NCT02053168|560895788|FG000|Overall Study|Physician Decision|1|||
155398748|NCT02053168|560895788|FG000|Overall Study|Lost to Follow-up|1|||
155284062|NCT04978363|560472662|FG002|Overall Study|Other medical issues unrelated to the study|0|||
155284063|NCT04978363|560472663|FG003|Overall Study|Other medical issues unrelated to the study|0|||
155284064|NCT04978363|560472664|FG004|Overall Study|Other medical issues unrelated to the study|1|||
155398749|NCT03785925|560895789|FG000|Overall Study|Withdrawal by Subject|15|||
155398750|NCT03785925|560895789|FG000|Overall Study|Lost to Follow-up|1|||
155398751|NCT00957528|560895793|FG000|Overall Study|Protocol Violation|0|||
155398752|NCT00957528|560895794|FG001|Overall Study|Protocol Violation|1|||
155398753|NCT00957528|560895795|FG002|Overall Study|Protocol Violation|0|||
155398754|NCT00957528|560895793|FG000|Overall Study|Withdrawal by Subject|0|||
155398755|NCT00957528|560895794|FG001|Overall Study|Withdrawal by Subject|0|||
155398756|NCT00957528|560895795|FG002|Overall Study|Withdrawal by Subject|1|||
155398757|NCT01101438|560895797|FG000|Overall Study|Withdrawal by Subject|8|||
155398758|NCT01101438|560895798|FG001|Overall Study|Withdrawal by Subject|9|||
155398759|NCT03677596|560895814|FG000|Overall Study|Adverse Event|0|||
155398760|NCT03677596|560895815|FG001|Overall Study|Adverse Event|1|||
155398761|NCT03677596|560895814|FG000|Overall Study|Death|10|||
155398762|NCT03677596|560895815|FG001|Overall Study|Death|6|||
155398763|NCT03677596|560895814|FG000|Overall Study|Lost to Follow-up|0|||
155398764|NCT03677596|560895815|FG001|Overall Study|Lost to Follow-up|1|||
155398765|NCT03677596|560895814|FG000|Overall Study|Progressive Disease|8|||
155398766|NCT03677596|560895815|FG001|Overall Study|Progressive Disease|8|||
155398767|NCT03677596|560895814|FG000|Overall Study|Withdrawal by Subject|3|||
155398768|NCT03677596|560895815|FG001|Overall Study|Withdrawal by Subject|0|||
155398769|NCT03677596|560895814|FG000|Overall Study|Disease Relapse|2|||
155398770|NCT03677596|560895815|FG001|Overall Study|Disease Relapse|2|||
155398771|NCT03677596|560895814|FG000|Overall Study|Other|0|||
155398772|NCT03677596|560895815|FG001|Overall Study|Other|1|||
155398773|NCT00922480|560895822|FG000|Main Study|Protocol Violation|3|||
155398774|NCT00922480|560895823|FG001|Main Study|Protocol Violation|6|||
155398775|NCT00922480|560895822|FG000|Main Study|Adverse Event|6|||
155398776|NCT00922480|560895823|FG001|Main Study|Adverse Event|7|||
155398777|NCT00922480|560895822|FG000|Main Study|Lack of Efficacy|3|||
155398778|NCT00922480|560895823|FG001|Main Study|Lack of Efficacy|0|||
155398779|NCT00922480|560895822|FG000|Main Study|Withdrawal by Subject|20|||
155398780|NCT00922480|560895823|FG001|Main Study|Withdrawal by Subject|15|||
155398781|NCT00922480|560895822|FG000|Main Study|Lost to Follow-up|5|||
155398782|NCT00922480|560895823|FG001|Main Study|Lost to Follow-up|0|||
155398783|NCT00922480|560895822|FG000|Main Study|Physician Decision|0|||
155398784|NCT00922480|560895823|FG001|Main Study|Physician Decision|1|||
155398785|NCT00922480|560895822|FG000|Extension Study|Protocol Violation|3|||
155398786|NCT00922480|560895823|FG001|Extension Study|Protocol Violation|0|||
155398787|NCT00922480|560895822|FG000|Extension Study|Adverse Event|1|||
155398788|NCT00922480|560895823|FG001|Extension Study|Adverse Event|1|||
155398789|NCT00922480|560895822|FG000|Extension Study|Withdrawal by Subject|1|||
155398790|NCT00922480|560895823|FG001|Extension Study|Withdrawal by Subject|1|||
155398791|NCT00922480|560895822|FG000|Extension Study|Others|0|||
155398792|NCT00922480|560895823|FG001|Extension Study|Others|1|||
155398793|NCT03716050|560895829|FG000|Overall Study|Lost to Follow-up|0|||
155398794|NCT03716050|560895830|FG001|Overall Study|Lost to Follow-up|0|||
155398795|NCT03716050|560895831|FG002|Overall Study|Lost to Follow-up|1|||
155398796|NCT03716050|560895832|FG003|Overall Study|Lost to Follow-up|0|||
155398797|NCT03716050|560895833|FG004|Overall Study|Lost to Follow-up|0|||
155398798|NCT03716050|560895834|FG005|Overall Study|Lost to Follow-up|0|||
155398799|NCT03716050|560895835|FG006|Overall Study|Lost to Follow-up|0|||
155398800|NCT03716050|560895836|FG007|Overall Study|Lost to Follow-up|0|||
155398801|NCT03716050|560895829|FG000|Overall Study|Physician Decision|0|||
155398802|NCT03716050|560895830|FG001|Overall Study|Physician Decision|0|||
155398803|NCT03716050|560895831|FG002|Overall Study|Physician Decision|0|||
155398804|NCT03716050|560895832|FG003|Overall Study|Physician Decision|1|||
155398805|NCT03716050|560895833|FG004|Overall Study|Physician Decision|0|||
155398806|NCT03716050|560895834|FG005|Overall Study|Physician Decision|0|||
155398807|NCT03716050|560895835|FG006|Overall Study|Physician Decision|0|||
155398808|NCT03716050|560895836|FG007|Overall Study|Physician Decision|0|||
155398809|NCT03716050|560895829|FG000|Overall Study|Protocol Violation|0|||
155398810|NCT03716050|560895830|FG001|Overall Study|Protocol Violation|0|||
155398811|NCT03716050|560895831|FG002|Overall Study|Protocol Violation|0|||
155398812|NCT03716050|560895832|FG003|Overall Study|Protocol Violation|1|||
155398813|NCT03716050|560895833|FG004|Overall Study|Protocol Violation|0|||
155398814|NCT03716050|560895834|FG005|Overall Study|Protocol Violation|0|||
155398815|NCT03716050|560895835|FG006|Overall Study|Protocol Violation|0|||
155398816|NCT03716050|560895836|FG007|Overall Study|Protocol Violation|2|||
155398817|NCT01010633|560895839|FG000|Overall Study|Adverse Event|1|||
155398818|NCT01010633|560895840|FG001|Overall Study|Adverse Event|1|||
155398819|NCT01010633|560895839|FG000|Overall Study|Protocol Violation|1|||
155398820|NCT01010633|560895840|FG001|Overall Study|Protocol Violation|2|||
155398821|NCT01010633|560895839|FG000|Overall Study|Withdrawal by Subject|2|||
155398822|NCT01010633|560895840|FG001|Overall Study|Withdrawal by Subject|1|||
155398823|NCT01010633|560895839|FG000|Overall Study|Investigator decision|0|||
155398824|NCT01010633|560895840|FG001|Overall Study|Investigator decision|1|||
155398825|NCT00073528|560895841|FG000|Overall Study|Death|488|||
155398826|NCT00073528|560895842|FG001|Overall Study|Death|473|||
155398827|NCT00073528|560895841|FG000|Overall Study|Lost to Follow-up|52|||
155398828|NCT00073528|560895842|FG001|Overall Study|Lost to Follow-up|45|||
155398829|NCT00073528|560895841|FG000|Overall Study|Withdrawal by Subject|50|||
155398830|NCT00073528|560895842|FG001|Overall Study|Withdrawal by Subject|45|||
155398831|NCT00073528|560895841|FG000|Overall Study|Study terminated by Sponsor|10|||
155398832|NCT00073528|560895842|FG001|Overall Study|Study terminated by Sponsor|29|||
155398833|NCT00073528|560895841|FG000|Overall Study|Other|18|||
155398834|NCT00073528|560895842|FG001|Overall Study|Other|19|||
155398835|NCT00073528|560895841|FG000|Overall Study|Other|9|||
155398836|NCT00073528|560895842|FG001|Overall Study|Other|12|||
155398837|NCT00073528|560895841|FG000|Overall Study|Protocol Violation|3|||
155398838|NCT00073528|560895842|FG001|Overall Study|Protocol Violation|5|||
155398839|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
155398840|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
155398841|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
155398842|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
155398843|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
155398844|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
155398845|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
155398846|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
155398847|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
155398848|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
155398849|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
155398850|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
155398851|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Death|1|||
155398852|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Death|0|||
155398853|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Death|0|||
155398854|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Death|0|||
155398855|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
155398856|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
155398857|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
155398858|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
155398859|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398860|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398861|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
155398862|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398863|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
155398864|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
155398865|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
155398866|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
155398867|NCT01494350|560895851|FG000|Overall Study|Worsening of lesion|1|||
155398868|NCT01786603|560895852|FG000|Overall Study|Death|5|||
155398869|NCT01786603|560895853|FG001|Overall Study|Death|1|||
155398870|NCT01786603|560895852|FG000|Overall Study|Adverse Event|6|||
155398871|NCT01786603|560895853|FG001|Overall Study|Adverse Event|2|||
155398872|NCT01786603|560895852|FG000|Overall Study|Physician decision to withdraw|6|||
155398873|NCT01786603|560895853|FG001|Overall Study|Physician decision to withdraw|7|||
155398874|NCT01786603|560895852|FG000|Overall Study|Lost to Follow-up|1|||
155398875|NCT01786603|560895853|FG001|Overall Study|Lost to Follow-up|2|||
155398876|NCT03654976|560895863|FG000|Overall Study|Withdrawal by Subject|12|||
155398877|NCT03654976|560895864|FG001|Overall Study|Withdrawal by Subject|11|||
155398878|NCT03654976|560895863|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
155398879|NCT03654976|560895864|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
155398880|NCT03654976|560895863|FG000|Overall Study|Adverse Event|5|||
155398881|NCT03654976|560895864|FG001|Overall Study|Adverse Event|0|||
155398882|NCT03654976|560895863|FG000|Overall Study|Lost to Follow-up|2|||
155398883|NCT03654976|560895864|FG001|Overall Study|Lost to Follow-up|0|||
155398884|NCT03654976|560895863|FG000|Overall Study|Lack of Efficacy|0|||
155398885|NCT03654976|560895864|FG001|Overall Study|Lack of Efficacy|1|||
155398886|NCT03098836|560895865|FG000|Overall Study|Adverse Event|1|||
155398887|NCT03098836|560895866|FG001|Overall Study|Adverse Event|3|||
155398888|NCT03098836|560895865|FG000|Overall Study|Lack of Efficacy|30|||
155398889|NCT03098836|560895866|FG001|Overall Study|Lack of Efficacy|15|||
155398890|NCT03098836|560895865|FG000|Overall Study|Physician Decision|2|||
155398891|NCT03098836|560895866|FG001|Overall Study|Physician Decision|1|||
155398892|NCT03098836|560895865|FG000|Overall Study|Withdrawal by Subject|3|||
155398893|NCT03098836|560895866|FG001|Overall Study|Withdrawal by Subject|2|||
155398894|NCT03986866|560895867|FG000|Overall Study|Withdrawal by Subject|0|||
155398895|NCT03986866|560895868|FG001|Overall Study|Withdrawal by Subject|3|||
155435860|NCT01591330|561022968|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
155636255|NCT03329001|561760956|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636256|NCT03329001|561760957|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636257|NCT03329001|561760958|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636258|NCT03329001|561760959|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636259|NCT03329001|561760960|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
155636260|NCT03329001|561760961|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155636261|NCT03329001|561760954|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636262|NCT03329001|561760955|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636263|NCT03329001|561760956|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636264|NCT03329001|561760957|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636265|NCT03329001|561760958|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636266|NCT03329001|561760959|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155636267|NCT03329001|561760960|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
155636268|NCT03329001|561760961|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
155636269|NCT03329001|561760954|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155636270|NCT03329001|561760955|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155636271|NCT03329001|561760956|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155636272|NCT03329001|561760957|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155636273|NCT03329001|561760958|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155636274|NCT03329001|561760959|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155284065|NCT04978363|560472665|FG005|Overall Study|Other medical issues unrelated to the study|0|||
155398896|NCT03986866|560895867|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
155398897|NCT03986866|560895868|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
155398898|NCT00545064|560895871|FG000|Overall Study|Lost to Follow-up|3|||
155398899|NCT00545064|560895871|FG000|Overall Study|Withdrawal by Subject|2|||
155398900|NCT00545064|560895871|FG000|Overall Study|did not complete course of treatment|1|||
155398901|NCT00545064|560895871|FG000|Overall Study|cancel all appointments, no rebooking|1|||
155398902|NCT00545064|560895871|FG000|Overall Study|inclement weather|1|||
155398903|NCT01660451|560895874|FG000|Overall Study|Protocol Violation|0|||
155398904|NCT01660451|560895875|FG001|Overall Study|Protocol Violation|1|||
155398905|NCT01660451|560895876|FG002|Overall Study|Protocol Violation|1|||
155398906|NCT01660451|560895874|FG000|Overall Study|AE not associated with clinical disease progression|13|||
155398907|NCT01660451|560895875|FG001|Overall Study|AE not associated with clinical disease progression|10|||
155398908|NCT01660451|560895876|FG002|Overall Study|AE not associated with clinical disease progression|40|||
155398909|NCT01660451|560895874|FG000|Overall Study|AE associated with clinical disease progression|1|||
155398910|NCT01660451|560895875|FG001|Overall Study|AE associated with clinical disease progression|3|||
155398911|NCT01660451|560895876|FG002|Overall Study|AE associated with clinical disease progression|11|||
155398912|NCT01660451|560895874|FG000|Overall Study|Sponsor Decision|0|||
155398913|NCT01660451|560895875|FG001|Overall Study|Sponsor Decision|0|||
155398914|NCT01660451|560895876|FG002|Overall Study|Sponsor Decision|1|||
155398915|NCT01660451|560895874|FG000|Overall Study|Protocol Deviation|0|||
155398916|NCT01660451|560895875|FG001|Overall Study|Protocol Deviation|0|||
155398917|NCT01660451|560895876|FG002|Overall Study|Protocol Deviation|1|||
155398918|NCT01660451|560895874|FG000|Overall Study|Physician Decision|1|||
155398919|NCT01660451|560895875|FG001|Overall Study|Physician Decision|2|||
155398920|NCT01660451|560895876|FG002|Overall Study|Physician Decision|5|||
155398921|NCT01660451|560895874|FG000|Overall Study|Withdrawal by Subject|1|||
155398922|NCT01660451|560895875|FG001|Overall Study|Withdrawal by Subject|1|||
155398923|NCT01660451|560895876|FG002|Overall Study|Withdrawal by Subject|20|||
155398924|NCT01660451|560895874|FG000|Overall Study|Trial closure.|0|||
155398925|NCT01660451|560895875|FG001|Overall Study|Trial closure.|0|||
155398926|NCT01660451|560895876|FG002|Overall Study|Trial closure.|1|||
155398927|NCT01660451|560895874|FG000|Overall Study|Switching to other therapy|0|||
155398928|NCT01660451|560895875|FG001|Overall Study|Switching to other therapy|1|||
155398929|NCT01660451|560895876|FG002|Overall Study|Switching to other therapy|1|||
155398930|NCT01660451|560895874|FG000|Overall Study|Progressive disease - clinical progression|4|||
155398931|NCT01660451|560895875|FG001|Overall Study|Progressive disease - clinical progression|10|||
155398932|NCT01660451|560895876|FG002|Overall Study|Progressive disease - clinical progression|9|||
155398933|NCT01660451|560895874|FG000|Overall Study|Progressive disease - radiological progression|12|||
155398934|NCT01660451|560895875|FG001|Overall Study|Progressive disease - radiological progression|23|||
155398935|NCT01660451|560895876|FG002|Overall Study|Progressive disease - radiological progression|50|||
155398936|NCT01660451|560895874|FG000|Overall Study|Death|1|||
155398937|NCT01660451|560895875|FG001|Overall Study|Death|0|||
155398938|NCT01660451|560895876|FG002|Overall Study|Death|1|||
155398939|NCT01660451|560895874|FG000|Overall Study|Other|0|||
155398940|NCT01660451|560895875|FG001|Overall Study|Other|0|||
155398941|NCT01660451|560895876|FG002|Overall Study|Other|1|||
155398942|NCT04688775|560895877|FG000|Placebo-controlled Period|Randomized, not treated|1|||
155398943|NCT04688775|560895878|FG001|Placebo-controlled Period|Randomized, not treated|1|||
155398944|NCT04688775|560895879|FG002|Placebo-controlled Period|Randomized, not treated|0|||
155398945|NCT04688775|560895880|FG003|Placebo-controlled Period|Randomized, not treated|0|||
155398946|NCT04688775|560895877|FG000|Placebo-controlled Period|Adverse Event|2|||
155398947|NCT04688775|560895878|FG001|Placebo-controlled Period|Adverse Event|0|||
155398948|NCT04688775|560895879|FG002|Placebo-controlled Period|Adverse Event|0|||
155398949|NCT04688775|560895880|FG003|Placebo-controlled Period|Adverse Event|0|||
155398950|NCT04688775|560895877|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
155398951|NCT04688775|560895878|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
155398952|NCT04688775|560895879|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
155398953|NCT04688775|560895880|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
155398954|NCT04688775|560895877|FG000|Placebo-controlled Period|Protocol Violation|0|||
155398955|NCT04688775|560895878|FG001|Placebo-controlled Period|Protocol Violation|1|||
155398956|NCT04688775|560895879|FG002|Placebo-controlled Period|Protocol Violation|0|||
155398957|NCT04688775|560895880|FG003|Placebo-controlled Period|Protocol Violation|0|||
155398958|NCT04688775|560895877|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155398959|NCT04688775|560895878|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
155398960|NCT04688775|560895879|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
155398961|NCT04688775|560895880|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
155398962|NCT04688775|560895877|FG000|Placebo-controlled Period|Other reasons|0|||
155398963|NCT04688775|560895878|FG001|Placebo-controlled Period|Other reasons|1|||
155398964|NCT04688775|560895879|FG002|Placebo-controlled Period|Other reasons|0|||
155398965|NCT04688775|560895880|FG003|Placebo-controlled Period|Other reasons|0|||
155398966|NCT04688775|560895877|FG000|Delayed Start Period|Adverse Event|0|||
155398967|NCT04688775|560895878|FG001|Delayed Start Period|Adverse Event|0|||
155398968|NCT04688775|560895879|FG002|Delayed Start Period|Adverse Event|1|||
155398969|NCT04688775|560895880|FG003|Delayed Start Period|Adverse Event|0|||
155398970|NCT04688775|560895877|FG000|Delayed Start Period|Lack of Efficacy|0|||
155398971|NCT04688775|560895878|FG001|Delayed Start Period|Lack of Efficacy|0|||
155398972|NCT04688775|560895879|FG002|Delayed Start Period|Lack of Efficacy|0|||
155398973|NCT04688775|560895880|FG003|Delayed Start Period|Lack of Efficacy|3|||
155398974|NCT04688775|560895877|FG000|Delayed Start Period|Withdrawal by Subject|0|||
155398975|NCT04688775|560895878|FG001|Delayed Start Period|Withdrawal by Subject|0|||
155398976|NCT04688775|560895879|FG002|Delayed Start Period|Withdrawal by Subject|2|||
155398977|NCT04688775|560895880|FG003|Delayed Start Period|Withdrawal by Subject|4|||
155398978|NCT04688775|560895877|FG000|Delayed Start Period|Lost to Follow-up|0|||
155398979|NCT04688775|560895878|FG001|Delayed Start Period|Lost to Follow-up|0|||
155398980|NCT04688775|560895879|FG002|Delayed Start Period|Lost to Follow-up|2|||
155398981|NCT04688775|560895880|FG003|Delayed Start Period|Lost to Follow-up|1|||
155398982|NCT04688775|560895877|FG000|Delayed Start Period|other reasons|0|||
155398983|NCT04688775|560895878|FG001|Delayed Start Period|other reasons|0|||
155398984|NCT04688775|560895879|FG002|Delayed Start Period|other reasons|1|||
155398985|NCT04688775|560895880|FG003|Delayed Start Period|other reasons|0|||
155398986|NCT01770912|560895883|FG000|Overall Study|Lost to Follow-up|2|||
155398987|NCT01770912|560895884|FG001|Overall Study|Lost to Follow-up|0|||
155398988|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
155398989|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
155398990|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
155398991|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
155398992|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
155398993|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
155398994|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
155398995|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398996|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398997|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398998|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398999|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
155399000|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
155399001|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
155399002|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
155399003|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
155399004|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
155399005|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
155399006|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
155399007|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399008|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399009|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399010|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399011|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399012|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399013|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399014|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
155399015|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399016|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399017|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399018|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399019|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399020|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399021|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399022|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399023|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399024|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399025|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399026|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
155284066|NCT04978363|560472666|FG006|Overall Study|Other medical issues unrelated to the study|0|||
155284067|NCT04978363|560472667|FG007|Overall Study|Other medical issues unrelated to the study|0|||
155399027|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399028|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399029|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399030|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399031|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
155399032|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399033|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399034|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399035|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399036|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399037|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399038|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399039|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399040|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399041|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399042|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399043|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
155399044|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399045|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399046|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399047|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399048|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399049|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399050|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399051|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399052|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399053|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399054|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399055|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
155399056|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399057|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399058|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399059|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399060|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399061|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399062|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399063|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399064|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399065|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399066|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399067|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
155399068|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399069|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399070|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399071|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399072|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399073|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399074|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399075|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399076|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399077|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399078|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399079|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
155399080|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399081|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399082|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399083|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399084|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399085|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399086|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
155636275|NCT03329001|561760960|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
155399087|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399088|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399089|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399090|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399091|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399092|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
155399093|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
155399094|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399095|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399096|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399097|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399098|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399099|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399100|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399101|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399102|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399103|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399104|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
155399105|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
155399106|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399107|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399108|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399109|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399110|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399111|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399112|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399113|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399114|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399115|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399116|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
155399117|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
155399118|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399119|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399120|NCT03250832|560895885|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399121|NCT03250832|560895886|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399122|NCT03250832|560895887|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399123|NCT03250832|560895888|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399124|NCT03250832|560895889|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399125|NCT03250832|560895890|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399126|NCT03250832|560895891|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399127|NCT03250832|560895892|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399128|NCT03250832|560895893|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399129|NCT03250832|560895894|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399130|NCT03250832|560895895|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399131|NCT03250832|560895896|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
155399132|NCT01536951|560895899|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399133|NCT01536951|560895900|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399134|NCT01536951|560895901|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
155399135|NCT01536951|560895902|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399136|NCT01536951|560895903|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399137|NCT01536951|560895904|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399138|NCT01536951|560895905|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399139|NCT01536951|560895906|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399140|NCT01536951|560895907|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399141|NCT01536951|560895899|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
155399142|NCT01536951|560895900|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
155399143|NCT01536951|560895901|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
155399144|NCT01536951|560895902|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
155399145|NCT01536951|560895903|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
155399146|NCT01536951|560895904|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
155399147|NCT01536951|560895905|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
155399148|NCT01536951|560895906|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
155284068|NCT04978363|560472668|FG008|Overall Study|Other medical issues unrelated to the study|0|||
155284069|NCT04978363|560472669|FG009|Overall Study|Other medical issues unrelated to the study|0|||
155284070|NCT04978363|560472670|FG010|Overall Study|Other medical issues unrelated to the study|0|||
155284071|NCT04978363|560472660|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
155284072|NCT04978363|560472661|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
155284073|NCT04978363|560472662|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
155284074|NCT04978363|560472663|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
155284075|NCT04978363|560472664|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
155284076|NCT04978363|560472665|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
155284077|NCT04978363|560472666|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
155284078|NCT04978363|560472667|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
155284079|NCT04978363|560472668|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
155284080|NCT04978363|560472669|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
155284081|NCT04978363|560472670|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
155284082|NCT04978363|560472660|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284083|NCT04978363|560472661|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
155284084|NCT04978363|560472662|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284085|NCT04978363|560472663|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284086|NCT04978363|560472664|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284087|NCT04978363|560472665|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284088|NCT04978363|560472666|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284089|NCT04978363|560472667|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284090|NCT04978363|560472668|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284091|NCT04978363|560472669|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284092|NCT04978363|560472670|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284093|NCT00723294|560472676|FG000|Overall Study|Lobular histology|2|||
155284094|NCT00723294|560472676|FG000|Overall Study|>25% intraductal component|1|||
155284095|NCT00723294|560472676|FG000|Overall Study|No MRI tumor enhancement|1|||
155284096|NCT00723294|560472676|FG000|Overall Study|1.0-Tesla MRI|1|||
155284097|NCT00723294|560472676|FG000|Overall Study|No cryoabalation|2|||
155284098|NCT00723294|560472676|FG000|Overall Study|Did not undergo surgery|1|||
155284099|NCT00723294|560472676|FG000|Overall Study|Treated prior to registration|1|||
155284100|NCT00723294|560472676|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
155284101|NCT00723294|560472676|FG000|Overall Study|Benign lesion|1|||
155284102|NCT00723294|560472676|FG000|Overall Study|Withdrawal by Subject|1|||
155284103|NCT00723294|560472676|FG000|Overall Study|No treatment due to probe failure|1|||
155284104|NCT01211665|560472677|FG000|Overall Study|Withdrawal by Subject|1|||
155284105|NCT01211665|560472678|FG001|Overall Study|Withdrawal by Subject|0|||
155284106|NCT01211665|560472677|FG000|Overall Study|Death|1|||
155636276|NCT03329001|561760961|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
155636277|NCT01138046|561760964|FG000|Overall Study|Withdrawal due to death|6|||
155636278|NCT02178956|561760965|FG000|Overall Study|Lost to Follow-up|4|||
155636279|NCT02178956|561760966|FG001|Overall Study|Lost to Follow-up|4|||
155636280|NCT02178956|561760965|FG000|Overall Study|Sponsor terminated study|49|||
155636281|NCT02178956|561760966|FG001|Overall Study|Sponsor terminated study|58|||
155636282|NCT02178956|561760965|FG000|Overall Study|Withdrawal by Subject|15|||
155636283|NCT02178956|561760966|FG001|Overall Study|Withdrawal by Subject|11|||
155636284|NCT02178956|561760965|FG000|Overall Study|Various Reasons|3|||
155636285|NCT02178956|561760966|FG001|Overall Study|Various Reasons|5|||
155636286|NCT00963235|561760970|FG000|Overall Study|Withdrawal by Subject|22|||
155636287|NCT00963235|561760970|FG000|Overall Study|Lost to Follow-up|14|||
155636288|NCT00963235|561760970|FG000|Overall Study|Failed to return|9|||
155636289|NCT00963235|561760970|FG000|Overall Study|Protocol Violation|7|||
155636290|NCT00963235|561760970|FG000|Overall Study|Adverse Event|5|||
155636291|NCT00963235|561760970|FG000|Overall Study|Physician Decision|2|||
155636292|NCT00963235|561760970|FG000|Overall Study|Other|1|||
155636293|NCT01136915|561760973|FG000|Overall Study|Lost to Follow-up|2|||
155636294|NCT01136915|561760974|FG001|Overall Study|Lost to Follow-up|0|||
155636295|NCT01136915|561760973|FG000|Overall Study|Exclusion criterion met|0|||
155636296|NCT01136915|561760974|FG001|Overall Study|Exclusion criterion met|1|||
155636297|NCT03965923|561760979|FG000|Overall Study|Withdrawal by Subject|1|||
155636298|NCT03965923|561760980|FG001|Overall Study|Withdrawal by Subject|2|||
155284107|NCT01211665|560472678|FG001|Overall Study|Death|0|||
155284108|NCT00498186|560472681|FG000|Overall Study|Protocol Violation|10|||
155284109|NCT00498186|560472681|FG000|Overall Study|Lack of Efficacy|31|||
155284110|NCT00498186|560472681|FG000|Overall Study|Adverse Event|89|||
155284111|NCT00498186|560472681|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
155284112|NCT00498186|560472681|FG000|Overall Study|Withdrawal by Subject|18|||
155284113|NCT00498186|560472681|FG000|Overall Study|Lost to Follow-up|3|||
155284114|NCT00498186|560472681|FG000|Overall Study|Other|10|||
155284115|NCT04454567|560472682|FG000|Overall Study|Study Terminated by Sponsor|1|||
155284116|NCT04454567|560472683|FG001|Overall Study|Study Terminated by Sponsor|1|||
155284117|NCT02757885|560472684|FG000|Overall Study|Screen Failures|4|||
155284118|NCT01456780|560472685|FG000|Overall Study|Lost to Follow-up|3|||
155284119|NCT01456780|560472686|FG001|Overall Study|Lost to Follow-up|3|||
155284120|NCT01456780|560472687|FG002|Overall Study|Lost to Follow-up|0|||
155284121|NCT02688621|560472692|FG000|Overall Study|Pregnancy|1|||
155284122|NCT02688621|560472693|FG001|Overall Study|Pregnancy|3|||
155284123|NCT02688621|560472692|FG000|Overall Study|Lost to Follow-up|38|||
155284124|NCT02688621|560472693|FG001|Overall Study|Lost to Follow-up|15|||
155284125|NCT02688621|560472692|FG000|Overall Study|Withdrawal by Subject|1|||
155284126|NCT02688621|560472693|FG001|Overall Study|Withdrawal by Subject|0|||
155284127|NCT04565249|560472698|FG000|Overall Study|Death|0|||
155284128|NCT04565249|560472699|FG001|Overall Study|Death|0|||
155284129|NCT04565249|560472700|FG002|Overall Study|Death|0|||
155284130|NCT04565249|560472701|FG003|Overall Study|Death|1|||
155284131|NCT05349864|560472706|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
155284132|NCT05349864|560472707|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
155284133|NCT02333630|560472708|FG000|Overall Study|Lost to Follow-up|5|||
155284134|NCT02333630|560472709|FG001|Overall Study|Lost to Follow-up|2|||
155284135|NCT00984282|560472710|FG000|Double Blind Treatment|Adverse Event|40|||
155284136|NCT00984282|560472711|FG001|Double Blind Treatment|Adverse Event|6|||
155284137|NCT00984282|560472710|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
155284138|NCT00984282|560472711|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
155284139|NCT00984282|560472710|FG000|Double Blind Treatment|Physician Decision|1|||
155284140|NCT00984282|560472711|FG001|Double Blind Treatment|Physician Decision|2|||
155284141|NCT00984282|560472710|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
155284142|NCT00984282|560472711|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
155284143|NCT00984282|560472710|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
155284144|NCT00984282|560472711|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
155284145|NCT00984282|560472710|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
155284146|NCT00984282|560472711|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
155284147|NCT00984282|560472710|FG000|Double Blind Treatment|Lost to Follow-up|3|||
155284148|NCT00984282|560472711|FG001|Double Blind Treatment|Lost to Follow-up|0|||
155284149|NCT00984282|560472710|FG000|Double Blind Treatment|Death|8|||
155284150|NCT00984282|560472711|FG001|Double Blind Treatment|Death|4|||
155284151|NCT00984282|560472710|FG000|Double Blind Treatment|Not treated|0|||
155284152|NCT00984282|560472711|FG001|Double Blind Treatment|Not treated|1|||
155284153|NCT00984282|560472710|FG000|Double Blind Treatment|Switched to commercial drug|6|||
155284154|NCT00984282|560472711|FG001|Double Blind Treatment|Switched to commercial drug|1|||
155284155|NCT00984282|560472710|FG000|Double Blind Treatment|protocol driven decision point|1|||
155284156|NCT00984282|560472711|FG001|Double Blind Treatment|protocol driven decision point|1|||
155284157|NCT00984282|560472710|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
155284158|NCT00984282|560472711|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
155284159|NCT00984282|560472710|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
155284160|NCT00984282|560472711|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
155284161|NCT00984282|560472710|FG000|Open-label Treatment|Adverse Event|20|||
155284162|NCT00984282|560472711|FG001|Open-label Treatment|Adverse Event|30|||
155284163|NCT00984282|560472710|FG000|Open-label Treatment|Withdrawal by Subject|6|||
155284164|NCT00984282|560472711|FG001|Open-label Treatment|Withdrawal by Subject|21|||
155284165|NCT00984282|560472710|FG000|Open-label Treatment|Death|7|||
155284166|NCT00984282|560472711|FG001|Open-label Treatment|Death|15|||
155284167|NCT00984282|560472710|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
155284168|NCT00984282|560472711|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
155284169|NCT00984282|560472710|FG000|Open-label Treatment|Lost to Follow-up|1|||
155284170|NCT00984282|560472711|FG001|Open-label Treatment|Lost to Follow-up|1|||
155399149|NCT01536951|560895907|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
155284171|NCT00984282|560472710|FG000|Open-label Treatment|Patient convenience|1|||
155284172|NCT00984282|560472711|FG001|Open-label Treatment|Patient convenience|0|||
155284173|NCT00984282|560472710|FG000|Open-label Treatment|Non-compliant with study medication|1|||
155284174|NCT00984282|560472711|FG001|Open-label Treatment|Non-compliant with study medication|0|||
155284175|NCT00984282|560472710|FG000|Open-label Treatment|Target lesion removed|0|||
155284176|NCT00984282|560472711|FG001|Open-label Treatment|Target lesion removed|1|||
155284177|NCT00984282|560472710|FG000|Open-label Treatment|Protocol driven decision point|1|||
155399150|NCT00545402|560895910|FG000|Overall Study|Discontinuation of treatment|17|||
155399151|NCT00545402|560895911|FG001|Overall Study|Discontinuation of treatment|9|||
155399152|NCT00545402|560895910|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
155399153|NCT00545402|560895911|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
155399154|NCT00545402|560895910|FG000|Overall Study|Death|5|||
155399155|NCT00545402|560895911|FG001|Overall Study|Death|7|||
155399156|NCT00545402|560895910|FG000|Overall Study|Graft loss|2|||
155399157|NCT00545402|560895911|FG001|Overall Study|Graft loss|4|||
155399158|NCT00545402|560895910|FG000|Overall Study|Withdrawal by Subject|0|||
155399159|NCT00545402|560895911|FG001|Overall Study|Withdrawal by Subject|1|||
155399160|NCT00545402|560895910|FG000|Overall Study|Protocol Violation|1|||
155399161|NCT00545402|560895911|FG001|Overall Study|Protocol Violation|0|||
155399162|NCT00545402|560895910|FG000|Overall Study|Reason not specified|1|||
155399163|NCT00545402|560895911|FG001|Overall Study|Reason not specified|1|||
155399164|NCT01721876|560895912|FG000|Overall Study|Not treated|1|||
155399165|NCT01721876|560895913|FG001|Overall Study|Not treated|4|||
155399166|NCT01721876|560895912|FG000|Overall Study|Disease progression / relapse|123|||
155399167|NCT01721876|560895913|FG001|Overall Study|Disease progression / relapse|156|||
155399168|NCT01721876|560895912|FG000|Overall Study|Death|6|||
155399169|NCT01721876|560895913|FG001|Overall Study|Death|13|||
155399170|NCT01721876|560895912|FG000|Overall Study|Adverse Event|41|||
155399171|NCT01721876|560895913|FG001|Overall Study|Adverse Event|165|||
155399172|NCT01721876|560895912|FG000|Overall Study|Protocol Violation|2|||
155399173|NCT01721876|560895913|FG001|Overall Study|Protocol Violation|1|||
155399174|NCT01721876|560895912|FG000|Overall Study|Withdrawal by Subject|15|||
155399175|NCT01721876|560895913|FG001|Overall Study|Withdrawal by Subject|38|||
155399176|NCT01721876|560895912|FG000|Overall Study|Reason not listed|34|||
155399177|NCT01721876|560895913|FG001|Overall Study|Reason not listed|63|||
155399178|NCT01721876|560895912|FG000|Overall Study|Sponsor terminated trial|0|||
155399179|NCT01721876|560895913|FG001|Overall Study|Sponsor terminated trial|4|||
155399180|NCT01252810|560895914|FG000|Overall Study|Withdrawal by Subject|4|||
155399181|NCT01252810|560895915|FG001|Overall Study|Withdrawal by Subject|1|||
155399182|NCT01252810|560895914|FG000|Overall Study|Lost to Follow-up|0|||
155399183|NCT01252810|560895915|FG001|Overall Study|Lost to Follow-up|1|||
155399184|NCT01252810|560895914|FG000|Overall Study|Physician Decision|2|||
155399185|NCT01252810|560895915|FG001|Overall Study|Physician Decision|1|||
155399186|NCT01252810|560895914|FG000|Overall Study|Various reasons|8|||
155399187|NCT01252810|560895915|FG001|Overall Study|Various reasons|0|||
155399188|NCT03805750|560895916|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
155399189|NCT03805750|560895917|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
155399190|NCT01984164|560895918|FG000|Overall Study|Withdrawal by Subject|4|||
155399191|NCT01984164|560895919|FG001|Overall Study|Withdrawal by Subject|3|||
155399192|NCT01984164|560895918|FG000|Overall Study|Adverse Event|5|||
155399193|NCT01984164|560895919|FG001|Overall Study|Adverse Event|19|||
155399194|NCT01984164|560895918|FG000|Overall Study|Lost to Follow-up|1|||
155399195|NCT01984164|560895919|FG001|Overall Study|Lost to Follow-up|3|||
155399196|NCT02811549|560895920|FG000|Overall Study|Lost to Follow-up|1|||
155399197|NCT02811549|560895920|FG000|Overall Study|Withdrawal by Subject|3|||
155399198|NCT02811549|560895920|FG000|Overall Study|Subject screen failed|4|||
155399199|NCT02811549|560895920|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
155399200|NCT05082376|560895921|FG000|Overall Study|Lost to Follow-up|2|||
155399201|NCT00493220|560895922|FG000|Third Intervention|Withdrawal by Subject|1|||
155399202|NCT00493220|560895923|FG001|Third Intervention|Withdrawal by Subject|0|||
155399203|NCT00493220|560895924|FG002|Third Intervention|Withdrawal by Subject|0|||
155399204|NCT00493220|560895925|FG003|Third Intervention|Withdrawal by Subject|0|||
155399205|NCT00493220|560895926|FG004|Third Intervention|Withdrawal by Subject|0|||
155399206|NCT00493220|560895927|FG005|Third Intervention|Withdrawal by Subject|0|||
155399207|NCT03184077|560895933|FG000|Overall Study|Lost to Follow-up|21|||
155399208|NCT03184077|560895934|FG001|Overall Study|Lost to Follow-up|21|||
155399209|NCT01889238|560895936|FG000|Overall Study|Death|1|||
155399210|NCT01889238|560895936|FG000|Overall Study|Withdrawal by Subject|1|||
155399211|NCT01889238|560895936|FG000|Overall Study|Adverse Event|6|||
155399212|NCT01889238|560895936|FG000|Overall Study|Disease Progression|104|||
155399213|NCT01889238|560895936|FG000|Overall Study|Other|6|||
155399214|NCT04136184|560895937|FG000|Overall Study|Lost to Follow-up|0|||
155399215|NCT04136184|560895938|FG001|Overall Study|Lost to Follow-up|3|||
155399216|NCT04136184|560895937|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
155284178|NCT00984282|560472711|FG001|Open-label Treatment|Protocol driven decision point|1|||
155284179|NCT00984282|560472710|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
155284180|NCT00984282|560472711|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
155284181|NCT00984282|560472710|FG000|Open-label Treatment|Switched to commercial drug|6|||
155284182|NCT00984282|560472711|FG001|Open-label Treatment|Switched to commercial drug|7|||
155399217|NCT04136184|560895938|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
155399218|NCT03318978|560895942|FG000|Overall Study|Withdrawal by Subject|1|||
155399219|NCT02844816|560895943|FG000|Overall Study|No protocol treatment received|5|||
155399220|NCT02844816|560895944|FG001|Overall Study|No protocol treatment received|1|||
155399221|NCT02844816|560895943|FG000|Overall Study|Ineligible|22|||
155399222|NCT02844816|560895944|FG001|Overall Study|Ineligible|15|||
155399223|NCT02844816|560895943|FG000|Overall Study|Participant refusal|5|||
155399224|NCT02844816|560895944|FG001|Overall Study|Participant refusal|5|||
155399225|NCT02844816|560895943|FG000|Overall Study|Adverse Event|5|||
155399226|NCT02844816|560895944|FG001|Overall Study|Adverse Event|4|||
155399227|NCT02844816|560895943|FG000|Overall Study|Death|0|||
155399228|NCT02844816|560895944|FG001|Overall Study|Death|1|||
155399229|NCT02844816|560895943|FG000|Overall Study|Disease progression/recurrence|50|||
155399230|NCT02844816|560895944|FG001|Overall Study|Disease progression/recurrence|24|||
155399231|NCT02844816|560895943|FG000|Overall Study|Physician Decision|1|||
155399232|NCT02844816|560895944|FG001|Overall Study|Physician Decision|1|||
155399233|NCT02592018|560895948|FG000|Overall Study|Adverse Event|1|||
155399234|NCT02592018|560895948|FG000|Overall Study|Lost to Follow-up|1|||
155399235|NCT06156215|560895951|FG000|Overall Study|Withdrawal by Subject|2|||
155399236|NCT06156215|560895952|FG001|Overall Study|Withdrawal by Subject|4|||
155399237|NCT06156215|560895953|FG002|Overall Study|Withdrawal by Subject|4|||
155399238|NCT06156215|560895954|FG003|Overall Study|Withdrawal by Subject|0|||
155399239|NCT06156215|560895955|FG004|Overall Study|Withdrawal by Subject|2|||
155399240|NCT06156215|560895956|FG005|Overall Study|Withdrawal by Subject|2|||
155399241|NCT06156215|560895951|FG000|Overall Study|Left ED without completing study|9|||
155399242|NCT06156215|560895952|FG001|Overall Study|Left ED without completing study|3|||
155399243|NCT06156215|560895953|FG002|Overall Study|Left ED without completing study|9|||
155399244|NCT06156215|560895954|FG003|Overall Study|Left ED without completing study|0|||
155399245|NCT06156215|560895955|FG004|Overall Study|Left ED without completing study|8|||
155399246|NCT06156215|560895956|FG005|Overall Study|Left ED without completing study|16|||
155399247|NCT06156215|560895951|FG000|Overall Study|Physician Decision|1|||
155399248|NCT06156215|560895952|FG001|Overall Study|Physician Decision|0|||
155399249|NCT06156215|560895953|FG002|Overall Study|Physician Decision|0|||
155399250|NCT06156215|560895954|FG003|Overall Study|Physician Decision|0|||
155399251|NCT06156215|560895955|FG004|Overall Study|Physician Decision|0|||
155399252|NCT06156215|560895956|FG005|Overall Study|Physician Decision|0|||
155399253|NCT06156215|560895951|FG000|Overall Study|Became or found ineligible|2|||
155399254|NCT06156215|560895952|FG001|Overall Study|Became or found ineligible|0|||
155399255|NCT06156215|560895953|FG002|Overall Study|Became or found ineligible|2|||
155399256|NCT06156215|560895954|FG003|Overall Study|Became or found ineligible|0|||
155399257|NCT06156215|560895955|FG004|Overall Study|Became or found ineligible|1|||
155399258|NCT06156215|560895956|FG005|Overall Study|Became or found ineligible|2|||
155399259|NCT04360551|560897442|FG000|Overall Study|Withdrawal by Subject|1|||
155399260|NCT04360551|560897443|FG001|Overall Study|Withdrawal by Subject|0|||
155399261|NCT01524198|560897455|FG000|Overall Study|Protocol Violation|8|||
155399262|NCT01524198|560897456|FG001|Overall Study|Protocol Violation|6|||
155399263|NCT01524198|560897455|FG000|Overall Study|Withdrawal by Subject|15|||
155399264|NCT01524198|560897456|FG001|Overall Study|Withdrawal by Subject|10|||
155399265|NCT02232802|560897457|FG000|Period 1|Sponsor request|1|||
155399266|NCT02232802|560897458|FG001|Period 1|Sponsor request|0|||
155399267|NCT02232802|560897457|FG000|Period 1|Adverse Event|1|||
155399268|NCT02232802|560897458|FG001|Period 1|Adverse Event|1|||
155399269|NCT00885703|560897463|FG000|Overall Study|Death|9|||
155399270|NCT00885703|560897464|FG001|Overall Study|Death|7|||
155399271|NCT00885703|560897465|FG002|Overall Study|Death|8|||
155399272|NCT00885703|560897466|FG003|Overall Study|Death|7|||
155399273|NCT00885703|560897467|FG004|Overall Study|Death|7|||
155399274|NCT00885703|560897468|FG005|Overall Study|Death|8|||
155399275|NCT00885703|560897469|FG006|Overall Study|Death|4|||
155399276|NCT00885703|560897463|FG000|Overall Study|Lost to Follow-up|0|||
155399277|NCT00885703|560897464|FG001|Overall Study|Lost to Follow-up|0|||
155399278|NCT00885703|560897465|FG002|Overall Study|Lost to Follow-up|1|||
155399279|NCT00885703|560897466|FG003|Overall Study|Lost to Follow-up|0|||
155399280|NCT00885703|560897467|FG004|Overall Study|Lost to Follow-up|0|||
155399281|NCT00885703|560897468|FG005|Overall Study|Lost to Follow-up|1|||
155399282|NCT00885703|560897469|FG006|Overall Study|Lost to Follow-up|0|||
155399283|NCT00885703|560897463|FG000|Overall Study|Withdrawal by Subject|0|||
155399284|NCT00885703|560897464|FG001|Overall Study|Withdrawal by Subject|0|||
155399285|NCT00885703|560897465|FG002|Overall Study|Withdrawal by Subject|0|||
155399286|NCT00885703|560897466|FG003|Overall Study|Withdrawal by Subject|1|||
155399287|NCT00885703|560897467|FG004|Overall Study|Withdrawal by Subject|3|||
155399288|NCT00885703|560897468|FG005|Overall Study|Withdrawal by Subject|1|||
155399289|NCT00885703|560897469|FG006|Overall Study|Withdrawal by Subject|1|||
155399290|NCT00885703|560897463|FG000|Overall Study|Ineligible (no CM)|1|||
155399291|NCT00885703|560897464|FG001|Overall Study|Ineligible (no CM)|3|||
155399292|NCT00885703|560897465|FG002|Overall Study|Ineligible (no CM)|2|||
155399293|NCT00885703|560897466|FG003|Overall Study|Ineligible (no CM)|1|||
155399294|NCT00885703|560897467|FG004|Overall Study|Ineligible (no CM)|2|||
155399295|NCT00885703|560897468|FG005|Overall Study|Ineligible (no CM)|3|||
155399296|NCT00885703|560897469|FG006|Overall Study|Ineligible (no CM)|1|||
155399297|NCT01490450|560897470|FG000|Period 1|Lack of Efficacy|2|||
155399298|NCT01490450|560897471|FG001|Period 1|Lack of Efficacy|0|||
155399299|NCT01490450|560897472|FG002|Period 1|Lack of Efficacy|3|||
155399300|NCT01490450|560897473|FG003|Period 1|Lack of Efficacy|0|||
155399301|NCT01490450|560897470|FG000|Period 1|Adverse Event|0|||
155399302|NCT01490450|560897471|FG001|Period 1|Adverse Event|0|||
155399303|NCT01490450|560897472|FG002|Period 1|Adverse Event|0|||
155399304|NCT01490450|560897473|FG003|Period 1|Adverse Event|5|||
155399305|NCT01490450|560897470|FG000|Period 1|Request to discontinue treatment|1|||
155399306|NCT01490450|560897471|FG001|Period 1|Request to discontinue treatment|0|||
155399307|NCT01490450|560897472|FG002|Period 1|Request to discontinue treatment|0|||
155399308|NCT01490450|560897473|FG003|Period 1|Request to discontinue treatment|0|||
155399309|NCT01490450|560897470|FG000|Period 1|Withdrawal by Subject|0|||
155399310|NCT01490450|560897471|FG001|Period 1|Withdrawal by Subject|0|||
155399311|NCT01490450|560897472|FG002|Period 1|Withdrawal by Subject|0|||
155399312|NCT01490450|560897473|FG003|Period 1|Withdrawal by Subject|3|||
155399313|NCT01490450|560897470|FG000|Period 1|No longer met study criteria|0|||
155399314|NCT01490450|560897471|FG001|Period 1|No longer met study criteria|1|||
155399315|NCT01490450|560897472|FG002|Period 1|No longer met study criteria|1|||
155399316|NCT01490450|560897473|FG003|Period 1|No longer met study criteria|0|||
155399317|NCT01490450|560897470|FG000|Period 2|Lack of Efficacy|0|||
155399318|NCT01490450|560897471|FG001|Period 2|Lack of Efficacy|0|||
155399319|NCT01490450|560897472|FG002|Period 2|Lack of Efficacy|0|||
155399320|NCT01490450|560897473|FG003|Period 2|Lack of Efficacy|1|||
155399321|NCT01490450|560897470|FG000|Period 2|Adverse Event|1|||
155399322|NCT01490450|560897471|FG001|Period 2|Adverse Event|1|||
155399323|NCT01490450|560897472|FG002|Period 2|Adverse Event|0|||
155399324|NCT01490450|560897473|FG003|Period 2|Adverse Event|1|||
155399325|NCT01490450|560897470|FG000|Period 2|Withdrawal by Subject|1|||
155399326|NCT01490450|560897471|FG001|Period 2|Withdrawal by Subject|0|||
155399327|NCT01490450|560897472|FG002|Period 2|Withdrawal by Subject|0|||
155399328|NCT01490450|560897473|FG003|Period 2|Withdrawal by Subject|0|||
155399329|NCT01490450|560897470|FG000|Period 2|Lost to Follow-up|0|||
155399330|NCT01490450|560897471|FG001|Period 2|Lost to Follow-up|0|||
155399331|NCT01490450|560897472|FG002|Period 2|Lost to Follow-up|0|||
155399332|NCT01490450|560897473|FG003|Period 2|Lost to Follow-up|2|||
155399333|NCT00404820|560897474|FG000|Overall Study|Adverse Event|4|||
155399334|NCT00404820|560897475|FG001|Overall Study|Adverse Event|16|||
155399335|NCT00404820|560897474|FG000|Overall Study|Withdrawal by Subject|5|||
155399336|NCT00404820|560897475|FG001|Overall Study|Withdrawal by Subject|3|||
155636299|NCT03965923|561760981|FG002|Overall Study|Withdrawal by Subject|3|||
155636300|NCT03965923|561760982|FG003|Overall Study|Withdrawal by Subject|1|||
155636301|NCT03965923|561760983|FG004|Overall Study|Withdrawal by Subject|2|||
155636302|NCT03965923|561760984|FG005|Overall Study|Withdrawal by Subject|0|||
155636303|NCT03965923|561760985|FG006|Overall Study|Withdrawal by Subject|4|||
155636304|NCT03965923|561760986|FG007|Overall Study|Withdrawal by Subject|3|||
155636305|NCT03965923|561760987|FG008|Overall Study|Withdrawal by Subject|4|||
155636306|NCT03965923|561760988|FG009|Overall Study|Withdrawal by Subject|0|||
155636307|NCT03965923|561760989|FG010|Overall Study|Withdrawal by Subject|2|||
155636308|NCT03965923|561760990|FG011|Overall Study|Withdrawal by Subject|0|||
155636309|NCT03965923|561760979|FG000|Overall Study|Lost to Follow-up|2|||
155636310|NCT03965923|561760980|FG001|Overall Study|Lost to Follow-up|1|||
155636311|NCT03965923|561760981|FG002|Overall Study|Lost to Follow-up|1|||
155636312|NCT03965923|561760982|FG003|Overall Study|Lost to Follow-up|0|||
155636313|NCT03965923|561760983|FG004|Overall Study|Lost to Follow-up|2|||
155399337|NCT00404820|560897474|FG000|Overall Study|Lost to Follow-up|7|||
155399338|NCT00404820|560897475|FG001|Overall Study|Lost to Follow-up|3|||
155399339|NCT00404820|560897474|FG000|Overall Study|Administrative problems|2|||
155399340|NCT00404820|560897475|FG001|Overall Study|Administrative problems|0|||
155399341|NCT00404820|560897474|FG000|Overall Study|Death|1|||
155399342|NCT00404820|560897475|FG001|Overall Study|Death|0|||
155636314|NCT03965923|561760984|FG005|Overall Study|Lost to Follow-up|1|||
155399343|NCT00404820|560897474|FG000|Overall Study|Other|0|||
155399344|NCT00404820|560897475|FG001|Overall Study|Other|2|||
155399345|NCT00938717|560897476|FG000|Overall Study|Adverse Event|10|||
155399346|NCT00938717|560897477|FG001|Overall Study|Adverse Event|41|||
155399347|NCT00938717|560897476|FG000|Overall Study|Protocol Violation|11|||
155636315|NCT03965923|561760985|FG006|Overall Study|Lost to Follow-up|2|||
155636316|NCT03965923|561760986|FG007|Overall Study|Lost to Follow-up|1|||
155741420|NCT04784442|562154846|FG000|Overall Study|Adverse Event|1|||
155741421|NCT04784442|562154847|FG001|Overall Study|Adverse Event|0|||
155636317|NCT03965923|561760987|FG008|Overall Study|Lost to Follow-up|0|||
155284183|NCT00984282|560472710|FG000|Open-label Treatment|Physician Decision|1|||
155284184|NCT00984282|560472711|FG001|Open-label Treatment|Physician Decision|0|||
155636318|NCT03965923|561760988|FG009|Overall Study|Lost to Follow-up|2|||
155636319|NCT03965923|561760989|FG010|Overall Study|Lost to Follow-up|0|||
155636320|NCT03965923|561760990|FG011|Overall Study|Lost to Follow-up|0|||
155636321|NCT03965923|561760979|FG000|Overall Study|Death|0|||
155636322|NCT03965923|561760980|FG001|Overall Study|Death|0|||
155636323|NCT03965923|561760981|FG002|Overall Study|Death|0|||
155636324|NCT03965923|561760982|FG003|Overall Study|Death|0|||
155636325|NCT03965923|561760983|FG004|Overall Study|Death|0|||
155636326|NCT03965923|561760984|FG005|Overall Study|Death|0|||
155636327|NCT03965923|561760985|FG006|Overall Study|Death|0|||
155636328|NCT03965923|561760986|FG007|Overall Study|Death|1|||
155636329|NCT03965923|561760987|FG008|Overall Study|Death|4|||
155636330|NCT03965923|561760988|FG009|Overall Study|Death|0|||
155636331|NCT03965923|561760989|FG010|Overall Study|Death|4|||
155636332|NCT03965923|561760990|FG011|Overall Study|Death|0|||
155636333|NCT03965923|561760979|FG000|Overall Study|Other reason|0|||
155636334|NCT03965923|561760980|FG001|Overall Study|Other reason|0|||
155636335|NCT03965923|561760981|FG002|Overall Study|Other reason|0|||
155636336|NCT03965923|561760982|FG003|Overall Study|Other reason|1|||
155636337|NCT03965923|561760983|FG004|Overall Study|Other reason|0|||
155636338|NCT03965923|561760984|FG005|Overall Study|Other reason|0|||
155636339|NCT03965923|561760985|FG006|Overall Study|Other reason|0|||
155636340|NCT03965923|561760986|FG007|Overall Study|Other reason|0|||
155636341|NCT03965923|561760987|FG008|Overall Study|Other reason|0|||
155636342|NCT03965923|561760988|FG009|Overall Study|Other reason|0|||
155636343|NCT03965923|561760989|FG010|Overall Study|Other reason|2|||
155636344|NCT03965923|561760990|FG011|Overall Study|Other reason|0|||
155636345|NCT02452190|561760991|FG000|Overall Study|Withdrawal by Sponsor|1|||
155636346|NCT02452190|561760992|FG001|Overall Study|Withdrawal by Sponsor|3|||
155636347|NCT02452190|561760991|FG000|Overall Study|Pregnancy|1|||
155636348|NCT02452190|561760992|FG001|Overall Study|Pregnancy|0|||
155636349|NCT02452190|561760991|FG000|Overall Study|Investigator's Decision|2|||
155636350|NCT02452190|561760992|FG001|Overall Study|Investigator's Decision|0|||
155636351|NCT02452190|561760991|FG000|Overall Study|Lack of Efficacy|3|||
155636352|NCT02452190|561760992|FG001|Overall Study|Lack of Efficacy|1|||
155636353|NCT02452190|561760991|FG000|Overall Study|Lost to Follow-up|4|||
155636354|NCT02452190|561760992|FG001|Overall Study|Lost to Follow-up|3|||
155636355|NCT02452190|561760991|FG000|Overall Study|Adverse Event|2|||
155636356|NCT02452190|561760992|FG001|Overall Study|Adverse Event|5|||
155636357|NCT02452190|561760991|FG000|Overall Study|Withdrawal by Subject|20|||
155636358|NCT02452190|561760992|FG001|Overall Study|Withdrawal by Subject|11|||
155636359|NCT02452190|561760991|FG000|Overall Study|Noncompliance with study drug|1|||
155636360|NCT02452190|561760992|FG001|Overall Study|Noncompliance with study drug|0|||
155636361|NCT02452190|561760991|FG000|Overall Study|Participant traveled abroad|1|||
155636362|NCT02452190|561760992|FG001|Overall Study|Participant traveled abroad|0|||
155636363|NCT02452190|561760991|FG000|Overall Study|Death|0|||
155636364|NCT02452190|561760992|FG001|Overall Study|Death|1|||
155636365|NCT02327078|561760997|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155636366|NCT02327078|561760998|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155636367|NCT02327078|561760999|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
155636368|NCT02327078|561761000|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155636369|NCT02327078|561761001|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155636370|NCT02327078|561761002|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155636371|NCT02327078|561761003|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155636372|NCT02327078|561761004|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
155636373|NCT02327078|561761005|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
155636374|NCT02327078|561760997|FG000|Overall Study|Death|2|||
155636375|NCT02327078|561760998|FG001|Overall Study|Death|4|||
155636376|NCT02327078|561760999|FG002|Overall Study|Death|10|||
155636377|NCT02327078|561761000|FG003|Overall Study|Death|6|||
155636378|NCT02327078|561761001|FG004|Overall Study|Death|4|||
155636379|NCT02327078|561761002|FG005|Overall Study|Death|3|||
155636380|NCT02327078|561761003|FG006|Overall Study|Death|2|||
155636381|NCT02327078|561761004|FG007|Overall Study|Death|51|||
155636382|NCT02327078|561761005|FG008|Overall Study|Death|97|||
155636383|NCT02327078|561760997|FG000|Overall Study|Lost to Follow-up|0|||
155636384|NCT02327078|561760998|FG001|Overall Study|Lost to Follow-up|1|||
155636385|NCT02327078|561760999|FG002|Overall Study|Lost to Follow-up|1|||
155636386|NCT02327078|561761000|FG003|Overall Study|Lost to Follow-up|0|||
155636387|NCT02327078|561761001|FG004|Overall Study|Lost to Follow-up|0|||
155636388|NCT02327078|561761002|FG005|Overall Study|Lost to Follow-up|0|||
155493765|NCT01100073|561232646|FG000|Overall Study|Insufficient Tolerability|21|||
155636389|NCT02327078|561761003|FG006|Overall Study|Lost to Follow-up|0|||
155636390|NCT02327078|561761004|FG007|Overall Study|Lost to Follow-up|2|||
155636391|NCT02327078|561761005|FG008|Overall Study|Lost to Follow-up|5|||
155636392|NCT02327078|561760997|FG000|Overall Study|Site Terminated by Sponsor|1|||
155284185|NCT00984282|560472710|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
155284186|NCT00984282|560472711|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
155284187|NCT00984282|560472710|FG000|Long Term Follow-up|Death|27|||
155284188|NCT00984282|560472711|FG001|Long Term Follow-up|Death|68|||
155284189|NCT00984282|560472710|FG000|Long Term Follow-up|Lost to Follow-up|3|||
155284190|NCT00984282|560472711|FG001|Long Term Follow-up|Lost to Follow-up|6|||
155284191|NCT00984282|560472710|FG000|Long Term Follow-up|Protocol driven decision point|25|||
155284192|NCT00984282|560472711|FG001|Long Term Follow-up|Protocol driven decision point|26|||
155284193|NCT00984282|560472710|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
155284194|NCT00984282|560472711|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
155284195|NCT00984282|560472710|FG000|Long Term Follow-up|Switched to commercial drug|4|||
155284196|NCT00984282|560472711|FG001|Long Term Follow-up|Switched to commercial drug|2|||
155284197|NCT00984282|560472710|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
155284198|NCT00984282|560472711|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
155284199|NCT02223793|560472712|FG000|Overall Study|Lost to Follow-up|10|||
155284200|NCT02223793|560472713|FG001|Overall Study|Lost to Follow-up|1|||
155284201|NCT02223793|560472714|FG002|Overall Study|Lost to Follow-up|2|||
155284202|NCT02223793|560472712|FG000|Overall Study|Withdrawal by Subject|3|||
155284203|NCT02223793|560472713|FG001|Overall Study|Withdrawal by Subject|2|||
155284204|NCT02223793|560472714|FG002|Overall Study|Withdrawal by Subject|3|||
155284205|NCT02223793|560472712|FG000|Overall Study|Moved/studycenter unable to participate|4|||
155284206|NCT02223793|560472713|FG001|Overall Study|Moved/studycenter unable to participate|6|||
155284207|NCT02223793|560472714|FG002|Overall Study|Moved/studycenter unable to participate|8|||
155284208|NCT00315055|560472715|FG000|Overall Study|Protocol Violation|2|||
155284209|NCT00315055|560472716|FG001|Overall Study|Protocol Violation|4|||
155284210|NCT00315055|560472715|FG000|Overall Study|Lost to Follow-up|1|||
155284211|NCT00315055|560472716|FG001|Overall Study|Lost to Follow-up|1|||
155284212|NCT02321540|560472718|FG000|Overall Study|Death|0|||
155284213|NCT02321540|560472719|FG001|Overall Study|Death|1|||
155284214|NCT02321540|560472718|FG000|Overall Study|Progression|3|||
155284215|NCT02321540|560472719|FG001|Overall Study|Progression|9|||
155284216|NCT03606460|560472720|FG000|Overall Study|Lost to Follow-up|1|||
155284217|NCT03606460|560472721|FG001|Overall Study|Lost to Follow-up|8|||
155284218|NCT04541186|560472725|FG000|Main Study|Adverse Event|0|||
155284219|NCT04541186|560472726|FG001|Main Study|Adverse Event|0|||
155284220|NCT04541186|560472727|FG002|Main Study|Adverse Event|4|||
155284221|NCT04541186|560472728|FG003|Main Study|Adverse Event|0|||
155284222|NCT04541186|560472729|FG004|Main Study|Adverse Event|0|||
155284223|NCT04541186|560472725|FG000|Main Study|Investigator Decision|0|||
155284224|NCT04541186|560472726|FG001|Main Study|Investigator Decision|0|||
155284225|NCT04541186|560472727|FG002|Main Study|Investigator Decision|1|||
155284226|NCT04541186|560472728|FG003|Main Study|Investigator Decision|1|||
155284227|NCT04541186|560472729|FG004|Main Study|Investigator Decision|0|||
155284228|NCT04541186|560472725|FG000|Main Study|Withdrawal by Subject|1|||
155284229|NCT04541186|560472726|FG001|Main Study|Withdrawal by Subject|1|||
155284230|NCT04541186|560472727|FG002|Main Study|Withdrawal by Subject|0|||
155284231|NCT04541186|560472728|FG003|Main Study|Withdrawal by Subject|0|||
155284232|NCT04541186|560472729|FG004|Main Study|Withdrawal by Subject|0|||
155284233|NCT04541186|560472725|FG000|Main Study|COVID-19-related Dose Interruption|0|||
155284234|NCT04541186|560472726|FG001|Main Study|COVID-19-related Dose Interruption|0|||
155284235|NCT04541186|560472727|FG002|Main Study|COVID-19-related Dose Interruption|0|||
155636393|NCT02327078|561760998|FG001|Overall Study|Site Terminated by Sponsor|0|||
155636394|NCT02327078|561760999|FG002|Overall Study|Site Terminated by Sponsor|1|||
155636395|NCT02327078|561761000|FG003|Overall Study|Site Terminated by Sponsor|4|||
155636396|NCT02327078|561761001|FG004|Overall Study|Site Terminated by Sponsor|0|||
155636397|NCT02327078|561761002|FG005|Overall Study|Site Terminated by Sponsor|0|||
155636398|NCT02327078|561761003|FG006|Overall Study|Site Terminated by Sponsor|0|||
155636399|NCT02327078|561761004|FG007|Overall Study|Site Terminated by Sponsor|11|||
155636400|NCT02327078|561761005|FG008|Overall Study|Site Terminated by Sponsor|25|||
155636401|NCT02327078|561760997|FG000|Overall Study|Physician Decision|0|||
155636402|NCT02327078|561760998|FG001|Overall Study|Physician Decision|0|||
155284236|NCT04541186|560472728|FG003|Main Study|COVID-19-related Dose Interruption|0|||
155399348|NCT00938717|560897477|FG001|Overall Study|Protocol Violation|8|||
155399349|NCT00938717|560897476|FG000|Overall Study|Withdrawal by Subject|26|||
155284237|NCT04541186|560472729|FG004|Main Study|COVID-19-related Dose Interruption|1|||
155284238|NCT04541186|560472725|FG000|Main Study|Randomized in Error Not Treated|0|||
155284239|NCT04541186|560472726|FG001|Main Study|Randomized in Error Not Treated|0|||
155399350|NCT00938717|560897477|FG001|Overall Study|Withdrawal by Subject|24|||
155399351|NCT00938717|560897476|FG000|Overall Study|Lost to Follow-up|13|||
155399352|NCT00938717|560897477|FG001|Overall Study|Lost to Follow-up|18|||
155399353|NCT00938717|560897476|FG000|Overall Study|Lack of Efficacy|33|||
155284240|NCT04541186|560472727|FG002|Main Study|Randomized in Error Not Treated|1|||
155284241|NCT04541186|560472728|FG003|Main Study|Randomized in Error Not Treated|0|||
155284242|NCT04541186|560472729|FG004|Main Study|Randomized in Error Not Treated|0|||
155399354|NCT00938717|560897477|FG001|Overall Study|Lack of Efficacy|15|||
155399355|NCT00938717|560897476|FG000|Overall Study|Other reason|5|||
155399356|NCT00938717|560897477|FG001|Overall Study|Other reason|2|||
155399357|NCT01462435|560897479|FG000|Overall Study|Lack of Efficacy|1|||
155399358|NCT01462435|560897480|FG001|Overall Study|Lack of Efficacy|0|||
155399359|NCT01462435|560897481|FG002|Overall Study|Lack of Efficacy|0|||
155399360|NCT01462435|560897482|FG003|Overall Study|Lack of Efficacy|3|||
155399361|NCT01462435|560897479|FG000|Overall Study|Physician Decision|0|||
155399362|NCT01462435|560897480|FG001|Overall Study|Physician Decision|0|||
155399363|NCT01462435|560897481|FG002|Overall Study|Physician Decision|1|||
155399364|NCT01462435|560897482|FG003|Overall Study|Physician Decision|0|||
155399365|NCT01462435|560897479|FG000|Overall Study|Withdrawal by Subject|0|||
155399366|NCT01462435|560897480|FG001|Overall Study|Withdrawal by Subject|0|||
155399367|NCT01462435|560897481|FG002|Overall Study|Withdrawal by Subject|0|||
155399368|NCT01462435|560897482|FG003|Overall Study|Withdrawal by Subject|1|||
155399369|NCT01462435|560897479|FG000|Overall Study|Lost to Follow-up|0|||
155399370|NCT01462435|560897480|FG001|Overall Study|Lost to Follow-up|0|||
155399371|NCT01462435|560897481|FG002|Overall Study|Lost to Follow-up|0|||
155399372|NCT01462435|560897482|FG003|Overall Study|Lost to Follow-up|1|||
155399373|NCT01543152|560897485|FG000|Overall Study|Withdrawal by Subject|0|||
155399374|NCT01543152|560897486|FG001|Overall Study|Withdrawal by Subject|2|||
155399375|NCT01543152|560897487|FG002|Overall Study|Withdrawal by Subject|0|||
155399376|NCT01543152|560897488|FG003|Overall Study|Withdrawal by Subject|0|||
155399377|NCT01543152|560897489|FG004|Overall Study|Withdrawal by Subject|0|||
155399378|NCT00636675|560897492|FG000|Overall Study|Lost to Follow-up|121|||
155399379|NCT00636675|560897493|FG001|Overall Study|Lost to Follow-up|31|||
155399380|NCT00636675|560897492|FG000|Overall Study|Withdrawal by Subject|19|||
155399381|NCT00636675|560897493|FG001|Overall Study|Withdrawal by Subject|10|||
155399382|NCT02687542|560897495|FG000|Overall Study|Medication error without associated AEs|0|||
155399383|NCT02687542|560897496|FG001|Overall Study|Medication error without associated AEs|0|||
155399384|NCT02687542|560897497|FG002|Overall Study|Medication error without associated AEs|0|||
155399385|NCT02687542|560897498|FG003|Overall Study|Medication error without associated AEs|0|||
155399386|NCT02687542|560897499|FG004|Overall Study|Medication error without associated AEs|1|||
155399387|NCT02687542|560897495|FG000|Overall Study|Lost to Follow-up|0|||
155399388|NCT02687542|560897496|FG001|Overall Study|Lost to Follow-up|0|||
155399389|NCT02687542|560897497|FG002|Overall Study|Lost to Follow-up|0|||
155399390|NCT02687542|560897498|FG003|Overall Study|Lost to Follow-up|0|||
155399391|NCT02687542|560897499|FG004|Overall Study|Lost to Follow-up|1|||
155399392|NCT02687542|560897495|FG000|Overall Study|Protocol Violation|0|||
155399393|NCT02687542|560897496|FG001|Overall Study|Protocol Violation|1|||
155399394|NCT02687542|560897497|FG002|Overall Study|Protocol Violation|0|||
155399395|NCT02687542|560897498|FG003|Overall Study|Protocol Violation|0|||
155399396|NCT02687542|560897499|FG004|Overall Study|Protocol Violation|0|||
155399397|NCT02687542|560897495|FG000|Overall Study|Other|5|||
155399398|NCT02687542|560897496|FG001|Overall Study|Other|9|||
155399399|NCT02687542|560897497|FG002|Overall Study|Other|10|||
155399400|NCT02687542|560897498|FG003|Overall Study|Other|6|||
155399401|NCT02687542|560897499|FG004|Overall Study|Other|5|||
155399402|NCT02687542|560897495|FG000|Overall Study|Adverse Event|3|||
155399403|NCT02687542|560897496|FG001|Overall Study|Adverse Event|1|||
155399404|NCT02687542|560897497|FG002|Overall Study|Adverse Event|3|||
155399405|NCT02687542|560897498|FG003|Overall Study|Adverse Event|2|||
155399406|NCT02687542|560897499|FG004|Overall Study|Adverse Event|9|||
155399407|NCT02687542|560897495|FG000|Overall Study|Withdrawal by Subject|0|||
155399408|NCT02687542|560897496|FG001|Overall Study|Withdrawal by Subject|1|||
155399409|NCT02687542|560897497|FG002|Overall Study|Withdrawal by Subject|1|||
155399410|NCT02687542|560897498|FG003|Overall Study|Withdrawal by Subject|2|||
155399411|NCT02687542|560897499|FG004|Overall Study|Withdrawal by Subject|4|||
155399412|NCT01227187|560897500|FG000|Overall Study|Physician Decision|0|||
155399413|NCT01227187|560897501|FG001|Overall Study|Physician Decision|0|||
155399414|NCT01227187|560897502|FG002|Overall Study|Physician Decision|0|||
155399415|NCT01227187|560897503|FG003|Overall Study|Physician Decision|1|||
155399416|NCT00914927|560897505|FG000|Overall Study|Adverse Event|0|||
155399417|NCT00914927|560897506|FG001|Overall Study|Adverse Event|0|||
155493766|NCT01100073|561232646|FG000|Overall Study|Withdrawal by Subject|13|||
155493767|NCT01100073|561232646|FG000|Overall Study|Lost to Follow-up|39|||
155399418|NCT00914927|560897507|FG002|Overall Study|Adverse Event|0|||
155399419|NCT00914927|560897508|FG003|Overall Study|Adverse Event|0|||
155399420|NCT00914927|560897509|FG004|Overall Study|Adverse Event|1|||
155399421|NCT00914927|560897510|FG005|Overall Study|Adverse Event|0|||
155399422|NCT00914927|560897511|FG006|Overall Study|Adverse Event|0|||
155399423|NCT00914927|560897505|FG000|Overall Study|Withdrawal by Subject|0|||
155399424|NCT00914927|560897506|FG001|Overall Study|Withdrawal by Subject|1|||
155399425|NCT00914927|560897507|FG002|Overall Study|Withdrawal by Subject|0|||
155399426|NCT00914927|560897508|FG003|Overall Study|Withdrawal by Subject|1|||
155399427|NCT00914927|560897509|FG004|Overall Study|Withdrawal by Subject|0|||
155399428|NCT00914927|560897510|FG005|Overall Study|Withdrawal by Subject|0|||
155399429|NCT00914927|560897511|FG006|Overall Study|Withdrawal by Subject|0|||
155399430|NCT00914927|560897505|FG000|Overall Study|Lost to Follow-up|0|||
155399431|NCT00914927|560897506|FG001|Overall Study|Lost to Follow-up|0|||
155399432|NCT00914927|560897507|FG002|Overall Study|Lost to Follow-up|0|||
155399433|NCT00914927|560897508|FG003|Overall Study|Lost to Follow-up|1|||
155399434|NCT00914927|560897509|FG004|Overall Study|Lost to Follow-up|0|||
155399435|NCT00914927|560897510|FG005|Overall Study|Lost to Follow-up|0|||
155399436|NCT00914927|560897511|FG006|Overall Study|Lost to Follow-up|0|||
155399437|NCT00914927|560897505|FG000|Overall Study|Administrative/Other|2|||
155399438|NCT00914927|560897506|FG001|Overall Study|Administrative/Other|1|||
155399439|NCT00914927|560897507|FG002|Overall Study|Administrative/Other|0|||
155399440|NCT00914927|560897508|FG003|Overall Study|Administrative/Other|0|||
155399441|NCT00914927|560897509|FG004|Overall Study|Administrative/Other|1|||
155399442|NCT00914927|560897510|FG005|Overall Study|Administrative/Other|0|||
155399443|NCT00914927|560897511|FG006|Overall Study|Administrative/Other|0|||
155399444|NCT01519934|560897512|FG000|Overall Study|Lost to Follow-up|3|||
155399445|NCT04109222|560897517|FG000|Overall Study|Adverse Event|1|||
155399446|NCT04109222|560897518|FG001|Overall Study|Adverse Event|0|||
155399447|NCT04109222|560897519|FG002|Overall Study|Adverse Event|0|||
155399448|NCT02577406|560897520|FG000|Randomized Period|Death|1|||
155399449|NCT02577406|560897521|FG001|Randomized Period|Death|0|||
155399450|NCT02577406|560897520|FG000|Randomized Period|Other reasons|0|||
155284243|NCT04541186|560472725|FG000|Fibrate Expansion Study|Other than Specified|0|||
155284244|NCT04541186|560472726|FG001|Fibrate Expansion Study|Other than Specified|0|||
155284245|NCT04541186|560472727|FG002|Fibrate Expansion Study|Other than Specified|0|||
155399451|NCT02577406|560897521|FG001|Randomized Period|Other reasons|20|||
155399452|NCT02577406|560897520|FG000|Treatment Period|Death|38|||
155399453|NCT02577406|560897521|FG001|Treatment Period|Death|23|||
155399454|NCT02577406|560897520|FG000|Treatment Period|Adverse Event|17|||
155399455|NCT02577406|560897521|FG001|Treatment Period|Adverse Event|12|||
155399456|NCT02577406|560897520|FG000|Treatment Period|Progressive Disease|53|||
155399457|NCT02577406|560897521|FG001|Treatment Period|Progressive Disease|37|||
155399458|NCT02577406|560897520|FG000|Treatment Period|Withdrawal by Subject|10|||
155399459|NCT02577406|560897521|FG001|Treatment Period|Withdrawal by Subject|24|||
155399460|NCT02577406|560897520|FG000|Treatment Period|Lost to Follow-up|0|||
155399461|NCT02577406|560897521|FG001|Treatment Period|Lost to Follow-up|1|||
155399462|NCT02577406|560897520|FG000|Treatment Period|Transition to commercially available treatment|1|||
155399463|NCT02577406|560897521|FG001|Treatment Period|Transition to commercially available treatment|1|||
155399464|NCT02577406|560897520|FG000|Treatment Period|Physician Decision|1|||
155399465|NCT02577406|560897521|FG001|Treatment Period|Physician Decision|0|||
155399466|NCT02577406|560897520|FG000|Treatment Period|Disease Relapse|28|||
155399467|NCT02577406|560897521|FG001|Treatment Period|Disease Relapse|1|||
155399468|NCT02577406|560897520|FG000|Treatment Period|Protocol Violation|0|||
155399469|NCT02577406|560897521|FG001|Treatment Period|Protocol Violation|1|||
155399470|NCT02577406|560897520|FG000|Treatment Period|Other Reasons|3|||
155399471|NCT02577406|560897521|FG001|Treatment Period|Other Reasons|39|||
155399472|NCT02577406|560897520|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
155399473|NCT02577406|560897521|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
155399474|NCT02138617|560897522|FG000|Overall Study|Death|1|||
155399475|NCT02138617|560897523|FG001|Overall Study|Death|2|||
155399476|NCT02138617|560897524|FG002|Overall Study|Death|2|||
155399477|NCT02138617|560897522|FG000|Overall Study|Adverse Event|8|||
155399478|NCT02138617|560897523|FG001|Overall Study|Adverse Event|5|||
155399479|NCT02138617|560897524|FG002|Overall Study|Adverse Event|2|||
155399480|NCT02138617|560897522|FG000|Overall Study|Disease Progression|20|||
155399481|NCT02138617|560897523|FG001|Overall Study|Disease Progression|13|||
155284246|NCT04541186|560472728|FG003|Fibrate Expansion Study|Other than Specified|0|||
155284247|NCT04541186|560472729|FG004|Fibrate Expansion Study|Other than Specified|1|||
155284248|NCT02347943|560472730|FG000|Overall Study|Study was cancelled|140|||
155399482|NCT02138617|560897524|FG002|Overall Study|Disease Progression|4|||
155399483|NCT02138617|560897522|FG000|Overall Study|Withdrawal by Subject|7|||
155399484|NCT02138617|560897523|FG001|Overall Study|Withdrawal by Subject|10|||
155399485|NCT02138617|560897524|FG002|Overall Study|Withdrawal by Subject|2|||
155399486|NCT02138617|560897522|FG000|Overall Study|other complicating disease|0|||
155399487|NCT02138617|560897523|FG001|Overall Study|other complicating disease|2|||
155399488|NCT02138617|560897524|FG002|Overall Study|other complicating disease|0|||
155284249|NCT02347943|560472731|FG001|Overall Study|Study was cancelled|67|||
155284250|NCT02347943|560472732|FG002|Overall Study|Study was cancelled|45|||
155284251|NCT00303303|560472734|FG000|Overall Study|Withdrawal by Subject|0|||
155284252|NCT00303303|560472735|FG001|Overall Study|Withdrawal by Subject|0|||
155284253|NCT00303303|560472736|FG002|Overall Study|Withdrawal by Subject|1|||
155284254|NCT00691028|560472737|FG000|Open-label Period|Adverse Event|0|||
155284255|NCT00691028|560472738|FG001|Open-label Period|Adverse Event|0|||
155284256|NCT00691028|560472739|FG002|Open-label Period|Adverse Event|0|||
155284257|NCT00691028|560472740|FG003|Open-label Period|Adverse Event|16|||
155284258|NCT00691028|560472737|FG000|Open-label Period|Withdrawal by Subject|0|||
155284259|NCT00691028|560472738|FG001|Open-label Period|Withdrawal by Subject|0|||
155284260|NCT00691028|560472739|FG002|Open-label Period|Withdrawal by Subject|0|||
155284261|NCT00691028|560472740|FG003|Open-label Period|Withdrawal by Subject|3|||
155284262|NCT00691028|560472737|FG000|Open-label Period|not come to a hospital|0|||
155284263|NCT00691028|560472738|FG001|Open-label Period|not come to a hospital|0|||
155284264|NCT00691028|560472739|FG002|Open-label Period|not come to a hospital|0|||
155284265|NCT00691028|560472740|FG003|Open-label Period|not come to a hospital|1|||
155284266|NCT00691028|560472737|FG000|Double-blind Period|Adverse Event|8|||
155399489|NCT02138617|560897522|FG000|Overall Study|Protocol Violation|1|||
155399490|NCT02138617|560897523|FG001|Overall Study|Protocol Violation|0|||
155399491|NCT02138617|560897524|FG002|Overall Study|Protocol Violation|0|||
155399492|NCT02138617|560897522|FG000|Overall Study|Physician Decision|7|||
155399493|NCT02138617|560897523|FG001|Overall Study|Physician Decision|6|||
155399494|NCT02138617|560897524|FG002|Overall Study|Physician Decision|0|||
155399495|NCT02138617|560897522|FG000|Overall Study|financial reason|0|||
155399496|NCT02138617|560897523|FG001|Overall Study|financial reason|1|||
155399497|NCT02138617|560897524|FG002|Overall Study|financial reason|0|||
155399498|NCT02138617|560897522|FG000|Overall Study|other therapy|3|||
155399499|NCT02138617|560897523|FG001|Overall Study|other therapy|4|||
155399500|NCT02138617|560897524|FG002|Overall Study|other therapy|0|||
155399501|NCT01970488|560897526|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
155399502|NCT01970488|560897527|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
155399503|NCT01970488|560897528|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399504|NCT01970488|560897529|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399505|NCT01970488|560897530|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399506|NCT01970488|560897526|FG000|Part 1: Through Week 16|Protocol Violation|1|||
155399507|NCT01970488|560897527|FG001|Part 1: Through Week 16|Protocol Violation|2|||
155399508|NCT01970488|560897528|FG002|Part 1: Through Week 16|Protocol Violation|0|||
155399509|NCT01970488|560897529|FG003|Part 1: Through Week 16|Protocol Violation|0|||
155399510|NCT01970488|560897530|FG004|Part 1: Through Week 16|Protocol Violation|0|||
155399511|NCT01970488|560897526|FG000|Part 1: Through Week 16|Adverse Event|6|||
155399512|NCT01970488|560897527|FG001|Part 1: Through Week 16|Adverse Event|5|||
155399513|NCT01970488|560897528|FG002|Part 1: Through Week 16|Adverse Event|0|||
155399514|NCT01970488|560897529|FG003|Part 1: Through Week 16|Adverse Event|0|||
155399515|NCT01970488|560897530|FG004|Part 1: Through Week 16|Adverse Event|0|||
155399516|NCT01970488|560897526|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
155399517|NCT01970488|560897527|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
155399518|NCT01970488|560897528|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399519|NCT01970488|560897529|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399520|NCT01970488|560897530|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399521|NCT01970488|560897526|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
155399522|NCT01970488|560897527|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
155399523|NCT01970488|560897528|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
155399524|NCT01970488|560897529|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
155399525|NCT01970488|560897530|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
155399526|NCT01970488|560897526|FG000|Part 2: Post Week 16|Physician Decision|0|||
155399527|NCT01970488|560897527|FG001|Part 2: Post Week 16|Physician Decision|0|||
155399528|NCT01970488|560897528|FG002|Part 2: Post Week 16|Physician Decision|0|||
155399529|NCT01970488|560897529|FG003|Part 2: Post Week 16|Physician Decision|0|||
155399530|NCT01970488|560897530|FG004|Part 2: Post Week 16|Physician Decision|1|||
155399531|NCT01970488|560897526|FG000|Part 2: Post Week 16|Non-compliance|0|||
155284267|NCT00691028|560472738|FG001|Double-blind Period|Adverse Event|9|||
155284268|NCT00691028|560472739|FG002|Double-blind Period|Adverse Event|6|||
155284269|NCT00691028|560472740|FG003|Double-blind Period|Adverse Event|0|||
155284270|NCT00691028|560472737|FG000|Double-blind Period|Lack of Efficacy|4|||
155284271|NCT00691028|560472738|FG001|Double-blind Period|Lack of Efficacy|3|||
155284272|NCT00691028|560472739|FG002|Double-blind Period|Lack of Efficacy|2|||
155284273|NCT00691028|560472740|FG003|Double-blind Period|Lack of Efficacy|0|||
155284274|NCT00691028|560472737|FG000|Double-blind Period|Withdrawal by Subject|1|||
155284275|NCT00691028|560472738|FG001|Double-blind Period|Withdrawal by Subject|0|||
155284276|NCT00691028|560472739|FG002|Double-blind Period|Withdrawal by Subject|1|||
155399532|NCT01970488|560897527|FG001|Part 2: Post Week 16|Non-compliance|0|||
155399533|NCT01970488|560897528|FG002|Part 2: Post Week 16|Non-compliance|1|||
155284277|NCT00691028|560472740|FG003|Double-blind Period|Withdrawal by Subject|0|||
155284278|NCT00691028|560472737|FG000|Double-blind Period|not come to a hospital.|0|||
155284279|NCT00691028|560472738|FG001|Double-blind Period|not come to a hospital.|1|||
155284280|NCT00691028|560472739|FG002|Double-blind Period|not come to a hospital.|0|||
155399534|NCT01970488|560897529|FG003|Part 2: Post Week 16|Non-compliance|0|||
155399535|NCT01970488|560897530|FG004|Part 2: Post Week 16|Non-compliance|0|||
155399536|NCT01970488|560897526|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
155399537|NCT01970488|560897527|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
155399538|NCT01970488|560897528|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
155399539|NCT01970488|560897529|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
155399540|NCT01970488|560897530|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
155399541|NCT01970488|560897526|FG000|Part 2: Post Week 16|Adverse Event|0|||
155284281|NCT00691028|560472740|FG003|Double-blind Period|not come to a hospital.|0|||
155284282|NCT02680756|560472747|FG000|Overall Study|Adverse Event|10|||
155284283|NCT02680756|560472748|FG001|Overall Study|Adverse Event|2|||
155284284|NCT02680756|560472747|FG000|Overall Study|Lost to Follow-up|7|||
155284285|NCT02680756|560472748|FG001|Overall Study|Lost to Follow-up|6|||
155284286|NCT02680756|560472747|FG000|Overall Study|Withdrawal by Subject|5|||
155284287|NCT02680756|560472748|FG001|Overall Study|Withdrawal by Subject|5|||
155284288|NCT02680756|560472747|FG000|Overall Study|Physician Decision|4|||
155284289|NCT02680756|560472748|FG001|Overall Study|Physician Decision|1|||
155284290|NCT02680756|560472747|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
155284291|NCT02680756|560472748|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
155399542|NCT01970488|560897527|FG001|Part 2: Post Week 16|Adverse Event|0|||
155399543|NCT01970488|560897528|FG002|Part 2: Post Week 16|Adverse Event|5|||
155399544|NCT01970488|560897529|FG003|Part 2: Post Week 16|Adverse Event|1|||
155399545|NCT01970488|560897530|FG004|Part 2: Post Week 16|Adverse Event|1|||
155399546|NCT01970488|560897526|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
155399547|NCT01970488|560897527|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
155399548|NCT01970488|560897528|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
155399549|NCT01970488|560897529|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
155399550|NCT01970488|560897530|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
155399551|NCT01970488|560897526|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
155399552|NCT01970488|560897527|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
155399553|NCT01970488|560897528|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
155399554|NCT01970488|560897529|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
155284292|NCT02680756|560472747|FG000|Overall Study|Blood transfusion for any reason|0|||
155284293|NCT02680756|560472748|FG001|Overall Study|Blood transfusion for any reason|1|||
155284294|NCT02680756|560472747|FG000|Overall Study|Death|1|||
155284295|NCT02680756|560472748|FG001|Overall Study|Death|0|||
155284296|NCT02680756|560472747|FG000|Overall Study|Protocol Violation|1|||
155284297|NCT02680756|560472748|FG001|Overall Study|Protocol Violation|0|||
155284298|NCT02680756|560472747|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
155284299|NCT02680756|560472748|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
155284300|NCT02680756|560472747|FG000|Overall Study|None of above or not recorded|3|||
155284301|NCT02680756|560472748|FG001|Overall Study|None of above or not recorded|2|||
155284302|NCT03681691|560472749|FG000|Overall Study|COVID|1|||
155284303|NCT03681691|560472750|FG001|Overall Study|COVID|0|||
155284304|NCT03681691|560472749|FG000|Overall Study|prolonged bleeding|1|||
155284305|NCT03681691|560472750|FG001|Overall Study|prolonged bleeding|0|||
155284306|NCT03681691|560472749|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
155284307|NCT03681691|560472750|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
155284308|NCT02334306|560472751|FG000|Double-blind Period|Adverse Event|0|||
155284309|NCT02334306|560472752|FG001|Double-blind Period|Adverse Event|1|||
155284310|NCT02334306|560472751|FG000|Double-blind Period|Withdrawal by Subject|1|||
155399555|NCT01970488|560897530|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
155399556|NCT01816061|560897531|FG000|Overall Study|Lost to Follow-up|13|||
155399557|NCT01816061|560897532|FG001|Overall Study|Lost to Follow-up|24|||
155399558|NCT01671111|560897533|FG000|Overall Study|Adverse Event|2|||
155399559|NCT01671111|560897533|FG000|Overall Study|Lack of Efficacy|1|||
155399560|NCT01671111|560897533|FG000|Overall Study|Withdrawal by Subject|2|||
155399561|NCT01671111|560897533|FG000|Overall Study|Physician Decision|1|||
155284311|NCT02334306|560472752|FG001|Double-blind Period|Withdrawal by Subject|1|||
155284312|NCT01687270|560472753|FG000|Overall Study|Lack of Efficacy|11|||
155284313|NCT01687270|560472753|FG000|Overall Study|Lost to Follow-up|1|||
155284314|NCT00465985|560472754|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
155284315|NCT00465985|560472755|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
155399562|NCT01671111|560897533|FG000|Overall Study|Other|24|||
155399563|NCT01231659|560897534|FG000|Overall Study|Adverse Event|9|||
155284316|NCT00465985|560472754|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
155284317|NCT00465985|560472755|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
155284318|NCT00465985|560472754|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
155284319|NCT00465985|560472755|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
155284320|NCT00465985|560472754|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
155284321|NCT00465985|560472755|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
155284322|NCT03302156|560472756|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
155284323|NCT03302156|560472757|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
155284324|NCT03302156|560472758|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
155284325|NCT02390557|560472759|FG000|Wave 2|Survey non-respondent|72|||
155284326|NCT02390557|560472760|FG001|Wave 2|Survey non-respondent|41|||
155284327|NCT02390557|560472761|FG002|Wave 2|Survey non-respondent|23|||
155284328|NCT03635112|560472763|FG000|Overall Study|Adverse Event|5|||
155284329|NCT03635112|560472764|FG001|Overall Study|Adverse Event|9|||
155284330|NCT03635112|560472765|FG002|Overall Study|Adverse Event|14|||
155284331|NCT03635112|560472763|FG000|Overall Study|Lost to Follow-up|1|||
155284332|NCT03635112|560472764|FG001|Overall Study|Lost to Follow-up|0|||
155284333|NCT03635112|560472765|FG002|Overall Study|Lost to Follow-up|1|||
155284334|NCT03635112|560472763|FG000|Overall Study|Physician Decision|5|||
155284335|NCT03635112|560472764|FG001|Overall Study|Physician Decision|7|||
155284336|NCT03635112|560472765|FG002|Overall Study|Physician Decision|5|||
155284337|NCT03635112|560472763|FG000|Overall Study|Protocol Violation|0|||
155284338|NCT03635112|560472764|FG001|Overall Study|Protocol Violation|0|||
155284339|NCT03635112|560472765|FG002|Overall Study|Protocol Violation|1|||
155284340|NCT03635112|560472763|FG000|Overall Study|Study Terminated by Sponsor|11|||
155284341|NCT03635112|560472764|FG001|Overall Study|Study Terminated by Sponsor|17|||
155284342|NCT03635112|560472765|FG002|Overall Study|Study Terminated by Sponsor|21|||
155284343|NCT03635112|560472763|FG000|Overall Study|Withdrawal by Subject|4|||
155284344|NCT03635112|560472764|FG001|Overall Study|Withdrawal by Subject|9|||
155284345|NCT03635112|560472765|FG002|Overall Study|Withdrawal by Subject|7|||
155284346|NCT03635112|560472763|FG000|Overall Study|Miscellaneous|0|||
155284347|NCT03635112|560472764|FG001|Overall Study|Miscellaneous|0|||
155284348|NCT03635112|560472765|FG002|Overall Study|Miscellaneous|1|||
155399564|NCT01231659|560897534|FG000|Overall Study|Disease Progression|48|||
155399565|NCT01231659|560897534|FG000|Overall Study|Death|2|||
155399566|NCT01231659|560897534|FG000|Overall Study|Patient refused to complete study visit|1|||
155399567|NCT01231659|560897534|FG000|Overall Study|Other protocol defined criteria|12|||
155399568|NCT00509067|560897535|FG000|Overall Study|Lost to Follow-up|1|||
155399569|NCT00509067|560897536|FG001|Overall Study|Lost to Follow-up|1|||
155399570|NCT00509067|560897535|FG000|Overall Study|Adverse Event|3|||
155399571|NCT00509067|560897536|FG001|Overall Study|Adverse Event|1|||
155399572|NCT00509067|560897535|FG000|Overall Study|Protocol Violation|0|||
155399573|NCT00509067|560897536|FG001|Overall Study|Protocol Violation|3|||
155399574|NCT00702325|560897550|FG000|Overall Study|Adverse Event|1|||
155399575|NCT00702325|560897551|FG001|Overall Study|Adverse Event|0|||
155399576|NCT00702325|560897550|FG000|Overall Study|Withdrawal by Subject|7|||
155399577|NCT00702325|560897551|FG001|Overall Study|Withdrawal by Subject|7|||
155399578|NCT00702325|560897550|FG000|Overall Study|Lost to Follow-up|3|||
155399579|NCT00702325|560897551|FG001|Overall Study|Lost to Follow-up|4|||
155399580|NCT00702325|560897550|FG000|Overall Study|Incorrect enrollment|5|||
155399581|NCT00702325|560897551|FG001|Overall Study|Incorrect enrollment|7|||
155399582|NCT00702325|560897550|FG000|Overall Study|Developed study discontinuation criteria|18|||
155399583|NCT00702325|560897551|FG001|Overall Study|Developed study discontinuation criteria|28|||
155399584|NCT00702325|560897550|FG000|Overall Study|Severe noncompliance to protocol|3|||
155399585|NCT00702325|560897551|FG001|Overall Study|Severe noncompliance to protocol|3|||
155399586|NCT00702325|560897550|FG000|Overall Study|Termination due to lab results|1|||
155399587|NCT00702325|560897551|FG001|Overall Study|Termination due to lab results|0|||
155399588|NCT00702325|560897550|FG000|Overall Study|Didn't follow study medication dosage|0|||
155399589|NCT00702325|560897551|FG001|Overall Study|Didn't follow study medication dosage|2|||
155399590|NCT00702325|560897550|FG000|Overall Study|Withdrew consent|0|||
155399591|NCT00702325|560897551|FG001|Overall Study|Withdrew consent|1|||
155399592|NCT00702325|560897550|FG000|Overall Study|Incorrectly Discontinued|0|||
155399593|NCT00702325|560897551|FG001|Overall Study|Incorrectly Discontinued|1|||
155399594|NCT04556136|560897555|FG000|Overall Study|Lost to Follow-up|6|||
155399595|NCT04556136|560897556|FG001|Overall Study|Lost to Follow-up|6|||
155399596|NCT04556136|560897555|FG000|Overall Study|Physician Decision|2|||
155399597|NCT04556136|560897556|FG001|Overall Study|Physician Decision|1|||
155399598|NCT04556136|560897555|FG000|Overall Study|Withdrawal by Subject|2|||
155399599|NCT04556136|560897556|FG001|Overall Study|Withdrawal by Subject|1|||
155399600|NCT01022502|560897559|FG000|Overall Study|Adverse Event|1|||
155399601|NCT01022502|560897559|FG000|Overall Study|employment related reasons|1|||
155399602|NCT01022502|560897559|FG000|Overall Study|Withdrawal by Subject|1|||
155399603|NCT03199040|560897567|FG000|Overall Study|Lack of Efficacy|2|||
155399604|NCT03199040|560897568|FG001|Overall Study|Lack of Efficacy|0|||
155399605|NCT03199040|560897567|FG000|Overall Study|Withdrawal by Subject|2|||
155399606|NCT03199040|560897568|FG001|Overall Study|Withdrawal by Subject|0|||
155399607|NCT03199040|560897567|FG000|Overall Study|Adverse Event|0|||
155399608|NCT03199040|560897568|FG001|Overall Study|Adverse Event|1|||
155284349|NCT00463151|560472770|FG000|Overall Study|Adverse Event|0|||
155284350|NCT00463151|560472771|FG001|Overall Study|Adverse Event|0|||
155284351|NCT00463151|560472772|FG002|Overall Study|Adverse Event|1|||
155284352|NCT00463151|560472773|FG003|Overall Study|Adverse Event|0|||
155399609|NCT03199040|560897567|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
155399610|NCT03199040|560897568|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
155399611|NCT01226459|560897569|FG000|Overall Study|Adverse Event|2|||
155399612|NCT01226459|560897570|FG001|Overall Study|Adverse Event|8|||
155399613|NCT01226459|560897569|FG000|Overall Study|Protocol Violation|4|||
155399614|NCT01226459|560897570|FG001|Overall Study|Protocol Violation|3|||
155399615|NCT01226459|560897569|FG000|Overall Study|Withdrawal by Subject|10|||
155399616|NCT01226459|560897570|FG001|Overall Study|Withdrawal by Subject|13|||
155399617|NCT01226459|560897569|FG000|Overall Study|Lost to Follow-up|4|||
155399618|NCT01226459|560897570|FG001|Overall Study|Lost to Follow-up|8|||
155399619|NCT01226459|560897569|FG000|Overall Study|Pregnancy|1|||
155399620|NCT01226459|560897570|FG001|Overall Study|Pregnancy|0|||
155399621|NCT01092143|560897571|FG000|Overall Study|Adverse Event|10|||
155399622|NCT01092143|560897572|FG001|Overall Study|Adverse Event|5|||
155399623|NCT01092143|560897573|FG002|Overall Study|Adverse Event|1|||
155399624|NCT01092143|560897574|FG003|Overall Study|Adverse Event|4|||
155399625|NCT01092143|560897575|FG004|Overall Study|Adverse Event|3|||
155399626|NCT01092143|560897571|FG000|Overall Study|Lost to Follow-up|1|||
155399627|NCT01092143|560897572|FG001|Overall Study|Lost to Follow-up|0|||
155399628|NCT01092143|560897573|FG002|Overall Study|Lost to Follow-up|1|||
155399629|NCT01092143|560897574|FG003|Overall Study|Lost to Follow-up|0|||
155399630|NCT01092143|560897575|FG004|Overall Study|Lost to Follow-up|0|||
155399631|NCT01092143|560897571|FG000|Overall Study|Consent withdrawn|2|||
155399632|NCT01092143|560897572|FG001|Overall Study|Consent withdrawn|1|||
155399633|NCT01092143|560897573|FG002|Overall Study|Consent withdrawn|0|||
155399634|NCT01092143|560897574|FG003|Overall Study|Consent withdrawn|1|||
155399635|NCT01092143|560897575|FG004|Overall Study|Consent withdrawn|3|||
155399636|NCT01092143|560897571|FG000|Overall Study|Not treated|0|||
155399637|NCT01092143|560897572|FG001|Overall Study|Not treated|0|||
155399638|NCT01092143|560897573|FG002|Overall Study|Not treated|1|||
155399639|NCT01092143|560897574|FG003|Overall Study|Not treated|0|||
155399640|NCT01092143|560897575|FG004|Overall Study|Not treated|0|||
155399641|NCT01092143|560897571|FG000|Overall Study|did not reversibility criteria|0|||
155399642|NCT01092143|560897572|FG001|Overall Study|did not reversibility criteria|0|||
155399643|NCT01092143|560897573|FG002|Overall Study|did not reversibility criteria|1|||
155399644|NCT01092143|560897574|FG003|Overall Study|did not reversibility criteria|0|||
155399645|NCT01092143|560897575|FG004|Overall Study|did not reversibility criteria|0|||
155399646|NCT01092143|560897571|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
155399647|NCT01092143|560897572|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
155399648|NCT01092143|560897573|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
155399649|NCT01092143|560897574|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
155399650|NCT01092143|560897575|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
155399651|NCT01092143|560897571|FG000|Overall Study|Ineligible patient|1|||
155399652|NCT01092143|560897572|FG001|Overall Study|Ineligible patient|0|||
155399653|NCT01092143|560897573|FG002|Overall Study|Ineligible patient|0|||
155399654|NCT01092143|560897574|FG003|Overall Study|Ineligible patient|0|||
155399655|NCT01092143|560897575|FG004|Overall Study|Ineligible patient|0|||
155399656|NCT01092143|560897571|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
155399657|NCT01092143|560897572|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
155399658|NCT01092143|560897573|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
155399659|NCT01092143|560897574|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
155399660|NCT01092143|560897575|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
155399661|NCT01092143|560897571|FG000|Overall Study|Patient travel|0|||
155399662|NCT01092143|560897572|FG001|Overall Study|Patient travel|0|||
155399663|NCT01092143|560897573|FG002|Overall Study|Patient travel|0|||
155399664|NCT01092143|560897574|FG003|Overall Study|Patient travel|0|||
155399665|NCT01092143|560897575|FG004|Overall Study|Patient travel|1|||
155399666|NCT01092143|560897571|FG000|Overall Study|Non compliance with study medication|0|||
155399667|NCT01092143|560897572|FG001|Overall Study|Non compliance with study medication|0|||
155399668|NCT01092143|560897573|FG002|Overall Study|Non compliance with study medication|0|||
155399669|NCT01092143|560897574|FG003|Overall Study|Non compliance with study medication|0|||
155399670|NCT01092143|560897575|FG004|Overall Study|Non compliance with study medication|1|||
155399671|NCT01092143|560897571|FG000|Overall Study|Randomized by mistake|0|||
155399672|NCT01092143|560897572|FG001|Overall Study|Randomized by mistake|0|||
155399673|NCT01092143|560897573|FG002|Overall Study|Randomized by mistake|0|||
155399674|NCT01092143|560897574|FG003|Overall Study|Randomized by mistake|1|||
155399675|NCT01092143|560897575|FG004|Overall Study|Randomized by mistake|0|||
155399676|NCT01092143|560897571|FG000|Overall Study|Pregnancy|0|||
155399677|NCT01092143|560897572|FG001|Overall Study|Pregnancy|0|||
155399678|NCT01092143|560897573|FG002|Overall Study|Pregnancy|0|||
155399679|NCT01092143|560897574|FG003|Overall Study|Pregnancy|1|||
155399680|NCT01092143|560897575|FG004|Overall Study|Pregnancy|0|||
155399681|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Death|40|||
155399682|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Death|41|||
155399683|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Death|37|||
155399684|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Death|0|||
155399685|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Death|0|||
155399686|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155284353|NCT00463151|560472770|FG000|Overall Study|Lack of Efficacy|2|||
155284354|NCT00463151|560472771|FG001|Overall Study|Lack of Efficacy|5|||
155284355|NCT00463151|560472772|FG002|Overall Study|Lack of Efficacy|2|||
155284356|NCT00463151|560472773|FG003|Overall Study|Lack of Efficacy|5|||
155284357|NCT00463151|560472770|FG000|Overall Study|Protocol Violation|0|||
155284358|NCT00463151|560472771|FG001|Overall Study|Protocol Violation|0|||
155284359|NCT00463151|560472772|FG002|Overall Study|Protocol Violation|0|||
155284360|NCT00463151|560472773|FG003|Overall Study|Protocol Violation|1|||
155284361|NCT00463151|560472770|FG000|Overall Study|Withdrawal by Subject|0|||
155284362|NCT00463151|560472771|FG001|Overall Study|Withdrawal by Subject|0|||
155284363|NCT00463151|560472772|FG002|Overall Study|Withdrawal by Subject|0|||
155284364|NCT00463151|560472773|FG003|Overall Study|Withdrawal by Subject|1|||
155284365|NCT05349084|560472774|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
155284366|NCT00972543|560472775|FG000|Overall Study|Adverse Event|1|||
155284367|NCT00972543|560472776|FG001|Overall Study|Adverse Event|0|||
155284368|NCT00972543|560472775|FG000|Overall Study|Early study termination by sponsor|4|||
155284369|NCT00972543|560472776|FG001|Overall Study|Early study termination by sponsor|1|||
155284370|NCT00688688|560472777|FG000|Overall Study|Eligibility criterion not met|7|||
155284371|NCT00688688|560472778|FG001|Overall Study|Eligibility criterion not met|7|||
155284372|NCT00688688|560472779|FG002|Overall Study|Eligibility criterion not met|10|||
155284373|NCT00688688|560472777|FG000|Overall Study|Adverse Event|52|||
155284374|NCT00688688|560472778|FG001|Overall Study|Adverse Event|51|||
155284375|NCT00688688|560472779|FG002|Overall Study|Adverse Event|50|||
155284376|NCT00688688|560472777|FG000|Overall Study|Lack of Efficacy|34|||
155284377|NCT00688688|560472778|FG001|Overall Study|Lack of Efficacy|25|||
155284378|NCT00688688|560472779|FG002|Overall Study|Lack of Efficacy|45|||
155636403|NCT02327078|561760999|FG002|Overall Study|Physician Decision|0|||
155284379|NCT00688688|560472777|FG000|Overall Study|Withdrawal by Subject|66|||
155284380|NCT00688688|560472778|FG001|Overall Study|Withdrawal by Subject|75|||
155284381|NCT00688688|560472779|FG002|Overall Study|Withdrawal by Subject|65|||
155399687|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
155399688|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
155636404|NCT02327078|561761000|FG003|Overall Study|Physician Decision|1|||
155636405|NCT02327078|561761001|FG004|Overall Study|Physician Decision|0|||
155636406|NCT02327078|561761002|FG005|Overall Study|Physician Decision|0|||
155636407|NCT02327078|561761003|FG006|Overall Study|Physician Decision|0|||
155636408|NCT02327078|561761004|FG007|Overall Study|Physician Decision|0|||
155636409|NCT02327078|561761005|FG008|Overall Study|Physician Decision|1|||
155636410|NCT02327078|561760997|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155636411|NCT02327078|561760998|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155636412|NCT02327078|561760999|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155636413|NCT02327078|561761000|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155636414|NCT02327078|561761001|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155636415|NCT02327078|561761002|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155636416|NCT02327078|561761003|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155636417|NCT02327078|561761004|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
155636418|NCT02327078|561761005|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
155636419|NCT02327078|561760997|FG000|Overall Study|Reason not Specified|0|||
155636420|NCT02327078|561760998|FG001|Overall Study|Reason not Specified|0|||
155636421|NCT02327078|561760999|FG002|Overall Study|Reason not Specified|0|||
155636422|NCT02327078|561761000|FG003|Overall Study|Reason not Specified|0|||
155636423|NCT02327078|561761001|FG004|Overall Study|Reason not Specified|0|||
155636424|NCT02327078|561761002|FG005|Overall Study|Reason not Specified|0|||
155636425|NCT02327078|561761003|FG006|Overall Study|Reason not Specified|0|||
155636426|NCT02327078|561761004|FG007|Overall Study|Reason not Specified|5|||
155636427|NCT02327078|561761005|FG008|Overall Study|Reason not Specified|12|||
155636428|NCT06001866|561761010|FG000|Overall Study|Withdrawal by Subject|0|||
155636429|NCT06001866|561761011|FG001|Overall Study|Withdrawal by Subject|2|||
155636430|NCT06001866|561761010|FG000|Overall Study|Protocol Violation|0|||
155636431|NCT06001866|561761011|FG001|Overall Study|Protocol Violation|2|||
155636432|NCT04725188|561761012|FG000|Overall Study|Death|72|||
155636433|NCT04725188|561761013|FG001|Overall Study|Death|69|||
155636434|NCT04725188|561761014|FG002|Overall Study|Death|76|||
155636435|NCT04725188|561761012|FG000|Overall Study|Lost to Follow-up|1|||
155636436|NCT04725188|561761013|FG001|Overall Study|Lost to Follow-up|0|||
155399689|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155399690|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155399691|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
155399692|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
155636437|NCT04725188|561761014|FG002|Overall Study|Lost to Follow-up|1|||
155636438|NCT04725188|561761012|FG000|Overall Study|Withdrawal by Subject|2|||
155636439|NCT04725188|561761013|FG001|Overall Study|Withdrawal by Subject|2|||
155636440|NCT04725188|561761014|FG002|Overall Study|Withdrawal by Subject|1|||
155636441|NCT04725188|561761012|FG000|Overall Study|Sponsor Decision|12|||
155636442|NCT04725188|561761013|FG001|Overall Study|Sponsor Decision|12|||
155284382|NCT00688688|560472777|FG000|Overall Study|Lost to Follow-up|14|||
155284383|NCT00688688|560472778|FG001|Overall Study|Lost to Follow-up|7|||
155284384|NCT00688688|560472779|FG002|Overall Study|Lost to Follow-up|7|||
155284385|NCT00688688|560472777|FG000|Overall Study|Protocol Violation|6|||
155284386|NCT00688688|560472778|FG001|Overall Study|Protocol Violation|9|||
155284387|NCT00688688|560472779|FG002|Overall Study|Protocol Violation|11|||
155284388|NCT00688688|560472777|FG000|Overall Study|Randomized but never received study drug|1|||
155284389|NCT00688688|560472778|FG001|Overall Study|Randomized but never received study drug|0|||
155284390|NCT00688688|560472779|FG002|Overall Study|Randomized but never received study drug|0|||
155284391|NCT00688688|560472777|FG000|Overall Study|Non-compliance with study procedures|5|||
155284392|NCT00688688|560472778|FG001|Overall Study|Non-compliance with study procedures|3|||
155284393|NCT00688688|560472779|FG002|Overall Study|Non-compliance with study procedures|4|||
155284394|NCT00688688|560472777|FG000|Overall Study|Taking exclusionary medications|1|||
155284395|NCT00688688|560472778|FG001|Overall Study|Taking exclusionary medications|0|||
155284396|NCT00688688|560472779|FG002|Overall Study|Taking exclusionary medications|0|||
155284397|NCT00688688|560472777|FG000|Overall Study|Site closure|0|||
155284398|NCT00688688|560472778|FG001|Overall Study|Site closure|1|||
155284399|NCT00688688|560472779|FG002|Overall Study|Site closure|0|||
155284400|NCT00688688|560472777|FG000|Overall Study|Violation of exclusion criterion|0|||
155284401|NCT00688688|560472778|FG001|Overall Study|Violation of exclusion criterion|1|||
155284402|NCT00688688|560472779|FG002|Overall Study|Violation of exclusion criterion|0|||
155284403|NCT03283553|560472783|FG000|Patient Participant Flow|Death|5|||
155284404|NCT03283553|560472784|FG001|Patient Participant Flow|Death|10|||
155284405|NCT03283553|560472783|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
155284406|NCT03283553|560472784|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
155284407|NCT03283553|560472783|FG000|Patient Participant Flow|Lost to Follow-up|1|||
155284408|NCT03283553|560472784|FG001|Patient Participant Flow|Lost to Follow-up|1|||
155284409|NCT03283553|560472783|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
155284410|NCT03283553|560472784|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
155284411|NCT03283553|560472783|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
155284412|NCT03283553|560472784|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
155284413|NCT03283553|560472783|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
155284414|NCT03283553|560472784|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
155284415|NCT03686683|560472785|FG000|Overall Study|Withdrawal by Subject|52|||
155284416|NCT03686683|560472786|FG001|Overall Study|Withdrawal by Subject|32|||
155284417|NCT03686683|560472785|FG000|Overall Study|Lost to Follow-up|23|||
155284418|NCT03686683|560472786|FG001|Overall Study|Lost to Follow-up|19|||
155284419|NCT03686683|560472785|FG000|Overall Study|Adverse Event|1|||
155284420|NCT03686683|560472786|FG001|Overall Study|Adverse Event|0|||
155284421|NCT03686683|560472785|FG000|Overall Study|Death|10|||
155284422|NCT03686683|560472786|FG001|Overall Study|Death|5|||
155284423|NCT03686683|560472785|FG000|Overall Study|Progressive Disease|1|||
155284424|NCT03686683|560472786|FG001|Overall Study|Progressive Disease|1|||
155284425|NCT03686683|560472785|FG000|Overall Study|Noncompliance|1|||
155284426|NCT03686683|560472786|FG001|Overall Study|Noncompliance|0|||
155284427|NCT03686683|560472785|FG000|Overall Study|Physician Decision|1|||
155284428|NCT03686683|560472786|FG001|Overall Study|Physician Decision|1|||
155284429|NCT03686683|560472785|FG000|Overall Study|Screen fail post-randomization|1|||
155284430|NCT03686683|560472786|FG001|Overall Study|Screen fail post-randomization|0|||
155284431|NCT03686683|560472785|FG000|Overall Study|Protocol Violation|3|||
155284432|NCT03686683|560472786|FG001|Overall Study|Protocol Violation|0|||
155284433|NCT03686683|560472785|FG000|Overall Study|No data available|1|||
155284434|NCT03686683|560472786|FG001|Overall Study|No data available|0|||
155284435|NCT04296942|560472787|FG000|Overall Study|Study closure by sponsor|1|||
155284436|NCT04296942|560472788|FG001|Overall Study|Study closure by sponsor|0|||
155284437|NCT04296942|560472789|FG002|Overall Study|Study closure by sponsor|0|||
155636443|NCT04725188|561761014|FG002|Overall Study|Sponsor Decision|7|||
155284438|NCT03255941|560472790|FG000|Overall Study|Not eligible or refused injection|37|||
155284439|NCT03255941|560472791|FG001|Overall Study|Not eligible or refused injection|44|||
155284440|NCT03255941|560472792|FG002|Overall Study|Not eligible or refused injection|5|||
155284441|NCT03255941|560472793|FG003|Overall Study|Not eligible or refused injection|6|||
155284442|NCT03255941|560472790|FG000|Overall Study|Did not complete exit interview|1|||
155636444|NCT00390013|561761015|FG000|Phase 1|tired|0|||
155636445|NCT00390013|561761016|FG001|Phase 1|tired|0|||
155636446|NCT00390013|561761017|FG002|Phase 1|tired|0|||
155636447|NCT00390013|561761018|FG003|Phase 1|tired|1|||
155636448|NCT00390013|561761015|FG000|Phase 2 First Treatment|tired|1|||
155636449|NCT00390013|561761016|FG001|Phase 2 First Treatment|tired|0|||
155636450|NCT00390013|561761017|FG002|Phase 2 First Treatment|tired|0|||
155636451|NCT00390013|561761018|FG003|Phase 2 First Treatment|tired|0|||
155636452|NCT00390013|561761015|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
155636453|NCT00390013|561761016|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
155284443|NCT03255941|560472791|FG001|Overall Study|Did not complete exit interview|2|||
155284444|NCT03255941|560472792|FG002|Overall Study|Did not complete exit interview|0|||
155636454|NCT00390013|561761017|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
155284445|NCT03255941|560472793|FG003|Overall Study|Did not complete exit interview|0|||
155284446|NCT01770860|560472805|FG000|Overall Study|Withdrawal by Subject|4|||
155399693|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
155399694|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
155399695|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
155399696|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Other|15|||
155399697|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Other|9|||
155399698|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Other|9|||
155399699|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Other|0|||
155399700|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Other|0|||
155399701|NCT00117598|560897576|FG000|After Treament Cross Over|Death|0|||
155399702|NCT00117598|560897577|FG001|After Treament Cross Over|Death|0|||
155399703|NCT00117598|560897578|FG002|After Treament Cross Over|Death|0|||
155399704|NCT00117598|560897579|FG003|After Treament Cross Over|Death|1|||
155399705|NCT00117598|560897580|FG004|After Treament Cross Over|Death|2|||
155399706|NCT00117598|560897576|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
155399707|NCT00117598|560897577|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
155399708|NCT00117598|560897578|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
155399709|NCT00117598|560897579|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
155399710|NCT00117598|560897580|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
155399711|NCT00117598|560897576|FG000|After Treament Cross Over|Other|0|||
155399712|NCT00117598|560897577|FG001|After Treament Cross Over|Other|0|||
155399713|NCT00117598|560897578|FG002|After Treament Cross Over|Other|0|||
155399714|NCT00117598|560897579|FG003|After Treament Cross Over|Other|1|||
155399715|NCT00117598|560897580|FG004|After Treament Cross Over|Other|2|||
155399716|NCT00382018|560897581|FG000|Overall Study|Progression|0|||
155399717|NCT00382018|560897582|FG001|Overall Study|Progression|136|||
155399718|NCT00382018|560897583|FG002|Overall Study|Progression|51|||
155399719|NCT00382018|560897584|FG003|Overall Study|Progression|43|||
155399720|NCT00382018|560897581|FG000|Overall Study|Death|0|||
155399721|NCT00382018|560897582|FG001|Overall Study|Death|9|||
155399722|NCT00382018|560897583|FG002|Overall Study|Death|7|||
155399723|NCT00382018|560897584|FG003|Overall Study|Death|11|||
155399724|NCT00382018|560897581|FG000|Overall Study|Withdrawal by Subject|0|||
155399725|NCT00382018|560897582|FG001|Overall Study|Withdrawal by Subject|4|||
155399726|NCT00382018|560897583|FG002|Overall Study|Withdrawal by Subject|3|||
155399727|NCT00382018|560897584|FG003|Overall Study|Withdrawal by Subject|4|||
155399728|NCT00382018|560897581|FG000|Overall Study|Other, not protocol specified|0|||
155399729|NCT00382018|560897582|FG001|Overall Study|Other, not protocol specified|16|||
155399730|NCT00382018|560897583|FG002|Overall Study|Other, not protocol specified|3|||
155399731|NCT00382018|560897584|FG003|Overall Study|Other, not protocol specified|1|||
155399732|NCT00427349|560897590|FG000|Overall Study|Lack of Efficacy|23|||
155399733|NCT00427349|560897590|FG000|Overall Study|Adverse Event|14|||
155399734|NCT00427349|560897590|FG000|Overall Study|Death|1|||
155399735|NCT00427349|560897590|FG000|Overall Study|Withdrawal by Subject|3|||
155399736|NCT00427349|560897590|FG000|Overall Study|Alternative therapy|1|||
155399737|NCT00427349|560897590|FG000|Overall Study|Other|2|||
155399738|NCT00427349|560897590|FG000|Overall Study|Ineligible|1|||
155399739|NCT00427349|560897590|FG000|Overall Study|Never started therapy|1|||
155399740|NCT02064920|560897595|FG000|Overall Study|Adverse Event|0|||
155399741|NCT02064920|560897596|FG001|Overall Study|Adverse Event|4|||
155399742|NCT02064920|560897595|FG000|Overall Study|Physician Decision|0|||
155399743|NCT02064920|560897596|FG001|Overall Study|Physician Decision|1|||
155399744|NCT02064920|560897595|FG000|Overall Study|Technical Problems|0|||
155399745|NCT02064920|560897596|FG001|Overall Study|Technical Problems|1|||
155399746|NCT02064920|560897595|FG000|Overall Study|Withdrawal by Subject|1|||
155399747|NCT02064920|560897596|FG001|Overall Study|Withdrawal by Subject|3|||
155399748|NCT02109562|560897597|FG000|Overall Study|Insufficient clinical response|2|||
155399749|NCT02109562|560897598|FG001|Overall Study|Insufficient clinical response|0|||
155399750|NCT02109562|560897599|FG002|Overall Study|Insufficient clinical response|4|||
155399751|NCT02109562|560897597|FG000|Overall Study|Adverse Event|0|||
155399752|NCT02109562|560897598|FG001|Overall Study|Adverse Event|2|||
155399753|NCT02109562|560897599|FG002|Overall Study|Adverse Event|3|||
155399754|NCT02109562|560897597|FG000|Overall Study|Lost to Follow-up|1|||
155399755|NCT02109562|560897598|FG001|Overall Study|Lost to Follow-up|0|||
155399756|NCT02109562|560897599|FG002|Overall Study|Lost to Follow-up|1|||
155399757|NCT02109562|560897597|FG000|Overall Study|Protocol Violation|0|||
155399758|NCT02109562|560897598|FG001|Overall Study|Protocol Violation|3|||
155399759|NCT02109562|560897599|FG002|Overall Study|Protocol Violation|1|||
155399760|NCT02109562|560897597|FG000|Overall Study|Withdrawal by Subject|20|||
155399761|NCT02109562|560897598|FG001|Overall Study|Withdrawal by Subject|25|||
155636455|NCT00390013|561761018|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
155636456|NCT04221490|561761020|FG000|At 30 Days Follow-up|Death|7|||
155636457|NCT04221490|561761020|FG000|At 30 Days Follow-up|Missed Visit|4|||
155636458|NCT04221490|561761020|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
155636459|NCT04221490|561761020|FG000|At 6 Months Follow-up|Death|9|||
155636460|NCT04221490|561761020|FG000|At 6 Months Follow-up|Physician Decision|1|||
155636461|NCT04221490|561761020|FG000|At 6 Months Follow-up|Missed Visit|8|||
155636462|NCT04221490|561761020|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
155636463|NCT04537299|561761025|FG000|Overall Study|Withdrawal by Subject|2|||
155636464|NCT04537299|561761026|FG001|Overall Study|Withdrawal by Subject|0|||
155636465|NCT04537299|561761025|FG000|Overall Study|Protocol Violation|1|||
155636466|NCT04537299|561761026|FG001|Overall Study|Protocol Violation|1|||
155636467|NCT00314145|561761029|FG000|Overall Study|Withdrawal by Subject|8|||
155636468|NCT00314145|561761030|FG001|Overall Study|Withdrawal by Subject|10|||
155636469|NCT00314145|561761029|FG000|Overall Study|Lost to Follow-up|5|||
155636470|NCT00314145|561761030|FG001|Overall Study|Lost to Follow-up|12|||
155636471|NCT00314145|561761029|FG000|Overall Study|Physician Decision|3|||
155636472|NCT00314145|561761030|FG001|Overall Study|Physician Decision|4|||
155636473|NCT00314145|561761029|FG000|Overall Study|Adverse Event|0|||
155636474|NCT00314145|561761030|FG001|Overall Study|Adverse Event|3|||
155636475|NCT00314145|561761029|FG000|Overall Study|Protocol Violation|3|||
155636476|NCT00314145|561761030|FG001|Overall Study|Protocol Violation|0|||
155636477|NCT00314145|561761029|FG000|Overall Study|Sponsor Decision|2|||
155636478|NCT00314145|561761030|FG001|Overall Study|Sponsor Decision|0|||
155636479|NCT03314935|561761031|FG000|Phase 1|Death|4|||
155636480|NCT03314935|561761032|FG001|Phase 1|Death|2|||
155636481|NCT03314935|561761033|FG002|Phase 1|Death|5|||
155636482|NCT03314935|561761034|FG003|Phase 1|Death|4|||
155636483|NCT03314935|561761035|FG004|Phase 1|Death|3|||
155636484|NCT03314935|561761036|FG005|Phase 1|Death|4|||
155636485|NCT03314935|561761037|FG006|Phase 1|Death|5|||
155636486|NCT03314935|561761038|FG007|Phase 1|Death|4|||
155636487|NCT03314935|561761039|FG008|Phase 1|Death|3|||
155636488|NCT03314935|561761040|FG009|Phase 1|Death|0|||
155636489|NCT03314935|561761041|FG010|Phase 1|Death|0|||
155636490|NCT03314935|561761042|FG011|Phase 1|Death|0|||
155636491|NCT03314935|561761043|FG012|Phase 1|Death|0|||
155636492|NCT03314935|561761044|FG013|Phase 1|Death|0|||
155636493|NCT03314935|561761045|FG014|Phase 1|Death|0|||
155636494|NCT03314935|561761031|FG000|Phase 1|Withdrawal by Subject|2|||
155636495|NCT03314935|561761032|FG001|Phase 1|Withdrawal by Subject|1|||
155636496|NCT03314935|561761033|FG002|Phase 1|Withdrawal by Subject|1|||
155636497|NCT03314935|561761034|FG003|Phase 1|Withdrawal by Subject|2|||
155636498|NCT03314935|561761035|FG004|Phase 1|Withdrawal by Subject|1|||
155636499|NCT03314935|561761036|FG005|Phase 1|Withdrawal by Subject|0|||
155636500|NCT03314935|561761037|FG006|Phase 1|Withdrawal by Subject|1|||
155636501|NCT03314935|561761038|FG007|Phase 1|Withdrawal by Subject|0|||
155636502|NCT03314935|561761039|FG008|Phase 1|Withdrawal by Subject|1|||
155636503|NCT03314935|561761040|FG009|Phase 1|Withdrawal by Subject|0|||
155636504|NCT03314935|561761041|FG010|Phase 1|Withdrawal by Subject|0|||
155636505|NCT03314935|561761042|FG011|Phase 1|Withdrawal by Subject|0|||
155636506|NCT03314935|561761043|FG012|Phase 1|Withdrawal by Subject|0|||
155636507|NCT03314935|561761044|FG013|Phase 1|Withdrawal by Subject|0|||
155636508|NCT03314935|561761045|FG014|Phase 1|Withdrawal by Subject|0|||
155636509|NCT03314935|561761031|FG000|Phase 1|Progressive Disease|2|||
155636510|NCT03314935|561761032|FG001|Phase 1|Progressive Disease|0|||
155636511|NCT03314935|561761033|FG002|Phase 1|Progressive Disease|0|||
155636512|NCT03314935|561761034|FG003|Phase 1|Progressive Disease|1|||
155399762|NCT02109562|560897599|FG002|Overall Study|Withdrawal by Subject|21|||
155399763|NCT02109562|560897597|FG000|Overall Study|Physician Decision|3|||
155399764|NCT02109562|560897598|FG001|Overall Study|Physician Decision|4|||
155399765|NCT02109562|560897599|FG002|Overall Study|Physician Decision|5|||
155636513|NCT03314935|561761035|FG004|Phase 1|Progressive Disease|0|||
155636514|NCT03314935|561761036|FG005|Phase 1|Progressive Disease|0|||
155636515|NCT03314935|561761037|FG006|Phase 1|Progressive Disease|0|||
155399766|NCT00445224|560897609|FG000|Specific Exercises|Withdrawal by Subject|3|||
155399767|NCT00445224|560897610|FG001|Specific Exercises|Withdrawal by Subject|3|||
155399768|NCT00445224|560897609|FG000|Specific Exercises|Withdrawal by Subject|1|||
155399769|NCT00445224|560897610|FG001|Specific Exercises|Withdrawal by Subject|0|||
155399770|NCT00176605|560899403|FG000|Overall Study|Withdrawal by Subject|2|||
155399771|NCT01566773|560899406|FG000|Overall Study|Protocol specified criteria|4|||
155399772|NCT01566773|560899406|FG000|Overall Study|Protocol Violation|4|||
155399773|NCT01566773|560899406|FG000|Overall Study|Withdrawal by Subject|9|||
155399774|NCT01566773|560899406|FG000|Overall Study|Administrative reason|1|||
155399775|NCT01566773|560899406|FG000|Overall Study|Adverse Event|10|||
155399776|NCT01566773|560899406|FG000|Overall Study|Physician Decision|2|||
155399777|NCT01033734|560899407|FG000|Overall Study|Withdrawal by Subject|1|||
155399778|NCT00139776|560899410|FG000|Period I|Did not enter Period II|575|||
155399779|NCT00139776|560899411|FG001|Period I|Did not enter Period II|0|||
155636516|NCT03314935|561761038|FG007|Phase 1|Progressive Disease|0|||
155636517|NCT03314935|561761039|FG008|Phase 1|Progressive Disease|0|||
155284447|NCT01770860|560472805|FG000|Overall Study|Lost to Follow-up|1|||
155284448|NCT01770860|560472805|FG000|Overall Study|Administrative decision made by the PI|1|||
155284449|NCT05124899|560472806|FG000|Overall Study|Lost to Follow-up|3|||
155284450|NCT03432533|560472813|FG000|Overall Study|Lost to Follow-up|1|||
155284451|NCT03432533|560472814|FG001|Overall Study|Lost to Follow-up|2|||
155284452|NCT03432533|560472813|FG000|Overall Study|Withdrawal by Subject|14|||
155284453|NCT03432533|560472814|FG001|Overall Study|Withdrawal by Subject|9|||
155399780|NCT00139776|560899412|FG002|Period I|Did not enter Period II|0|||
155399781|NCT00139776|560899413|FG003|Period I|Did not enter Period II|0|||
155399782|NCT00139776|560899410|FG000|Period II|Not Randomized into Period III|0|||
155399783|NCT00139776|560899411|FG001|Period II|Not Randomized into Period III|322|||
155399784|NCT00139776|560899412|FG002|Period II|Not Randomized into Period III|0|||
155399785|NCT00139776|560899413|FG003|Period II|Not Randomized into Period III|0|||
155399786|NCT00139776|560899410|FG000|Period III|Adverse Event|0|||
155399787|NCT00139776|560899411|FG001|Period III|Adverse Event|0|||
155399788|NCT00139776|560899412|FG002|Period III|Adverse Event|22|||
155399789|NCT00139776|560899413|FG003|Period III|Adverse Event|23|||
155399790|NCT00139776|560899410|FG000|Period III|Other|0|||
155399791|NCT00139776|560899411|FG001|Period III|Other|0|||
155399792|NCT00139776|560899412|FG002|Period III|Other|23|||
155284454|NCT01648283|560472815|FG000|Overall Study|Withdrawal by Subject|14|||
155284455|NCT00821236|560472816|FG000|Overall Study|Lost to Follow-up|3|||
155284456|NCT03382821|560472821|FG000|Overall Study|Did not receive allocated intervention.|0|||
155284457|NCT03382821|560472822|FG001|Overall Study|Did not receive allocated intervention.|3|||
155284458|NCT00797225|560472823|FG000|Weeks 1 to 12|Adverse Event|0|||
155284459|NCT00797225|560472824|FG001|Weeks 1 to 12|Adverse Event|0|||
155284460|NCT00797225|560472825|FG002|Weeks 1 to 12|Adverse Event|1|||
155284461|NCT00797225|560472826|FG003|Weeks 1 to 12|Adverse Event|0|||
155284462|NCT00797225|560472827|FG004|Weeks 1 to 12|Adverse Event|0|||
155284463|NCT00797225|560472828|FG005|Weeks 1 to 12|Adverse Event|0|||
155284464|NCT00797225|560472829|FG006|Weeks 1 to 12|Adverse Event|0|||
155284465|NCT00797225|560472830|FG007|Weeks 1 to 12|Adverse Event|0|||
155284466|NCT00797225|560472823|FG000|Weeks 1 to 12|Non-compliance|0|||
155284467|NCT00797225|560472824|FG001|Weeks 1 to 12|Non-compliance|1|||
155284468|NCT00797225|560472825|FG002|Weeks 1 to 12|Non-compliance|0|||
155284469|NCT00797225|560472826|FG003|Weeks 1 to 12|Non-compliance|0|||
155284470|NCT00797225|560472827|FG004|Weeks 1 to 12|Non-compliance|0|||
155284471|NCT00797225|560472828|FG005|Weeks 1 to 12|Non-compliance|0|||
155284472|NCT00797225|560472829|FG006|Weeks 1 to 12|Non-compliance|0|||
155284473|NCT00797225|560472830|FG007|Weeks 1 to 12|Non-compliance|0|||
155284474|NCT00797225|560472823|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
155284475|NCT00797225|560472824|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
155284476|NCT00797225|560472825|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
155284477|NCT00797225|560472826|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
155284478|NCT00797225|560472827|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
155636518|NCT03314935|561761040|FG009|Phase 1|Progressive Disease|0|||
155636519|NCT03314935|561761041|FG010|Phase 1|Progressive Disease|0|||
155636520|NCT03314935|561761042|FG011|Phase 1|Progressive Disease|0|||
155636521|NCT03314935|561761043|FG012|Phase 1|Progressive Disease|0|||
155636522|NCT03314935|561761044|FG013|Phase 1|Progressive Disease|0|||
155636523|NCT03314935|561761045|FG014|Phase 1|Progressive Disease|0|||
155636524|NCT03314935|561761031|FG000|Phase 1|Study Terminated by Sponsor|0|||
155636525|NCT03314935|561761032|FG001|Phase 1|Study Terminated by Sponsor|1|||
155636526|NCT03314935|561761033|FG002|Phase 1|Study Terminated by Sponsor|0|||
155636527|NCT03314935|561761034|FG003|Phase 1|Study Terminated by Sponsor|0|||
155636528|NCT03314935|561761035|FG004|Phase 1|Study Terminated by Sponsor|0|||
155636529|NCT03314935|561761036|FG005|Phase 1|Study Terminated by Sponsor|0|||
155636530|NCT03314935|561761037|FG006|Phase 1|Study Terminated by Sponsor|0|||
155636531|NCT03314935|561761038|FG007|Phase 1|Study Terminated by Sponsor|0|||
155636532|NCT03314935|561761039|FG008|Phase 1|Study Terminated by Sponsor|1|||
155636533|NCT03314935|561761040|FG009|Phase 1|Study Terminated by Sponsor|0|||
155636534|NCT03314935|561761041|FG010|Phase 1|Study Terminated by Sponsor|0|||
155636535|NCT03314935|561761042|FG011|Phase 1|Study Terminated by Sponsor|0|||
155636536|NCT03314935|561761043|FG012|Phase 1|Study Terminated by Sponsor|0|||
155636537|NCT03314935|561761044|FG013|Phase 1|Study Terminated by Sponsor|0|||
155636538|NCT03314935|561761045|FG014|Phase 1|Study Terminated by Sponsor|0|||
155636539|NCT03314935|561761031|FG000|Phase 1|"Captured as Other in Database"|0|||
155284479|NCT00797225|560472828|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
155284480|NCT00797225|560472829|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
155399793|NCT00139776|560899413|FG003|Period III|Other|34|||
155399794|NCT00139776|560899410|FG000|Period III|Lack of Efficacy|0|||
155636540|NCT03314935|561761032|FG001|Phase 1|"Captured as Other in Database"|2|||
155636541|NCT03314935|561761033|FG002|Phase 1|"Captured as Other in Database"|0|||
155284481|NCT00797225|560472830|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
155284482|NCT00797225|560472823|FG000|Weeks 1 to 12|Sponsor Decision|1|||
155284483|NCT00797225|560472824|FG001|Weeks 1 to 12|Sponsor Decision|0|||
155399795|NCT00139776|560899411|FG001|Period III|Lack of Efficacy|0|||
155399796|NCT00139776|560899412|FG002|Period III|Lack of Efficacy|10|||
155399797|NCT00139776|560899413|FG003|Period III|Lack of Efficacy|24|||
155399798|NCT00139776|560899410|FG000|Period III|Lost to Follow-up|0|||
155399799|NCT00139776|560899411|FG001|Period III|Lost to Follow-up|0|||
155399800|NCT00139776|560899412|FG002|Period III|Lost to Follow-up|5|||
155399801|NCT00139776|560899413|FG003|Period III|Lost to Follow-up|4|||
155399802|NCT00139776|560899410|FG000|Period III|Withdrawal by Subject|0|||
155399803|NCT00139776|560899411|FG001|Period III|Withdrawal by Subject|0|||
155399804|NCT00139776|560899412|FG002|Period III|Withdrawal by Subject|16|||
155399805|NCT00139776|560899413|FG003|Period III|Withdrawal by Subject|21|||
155399806|NCT00187096|560899414|FG000|Overall Study|unacceptable toxicity|0|||
155399807|NCT00187096|560899415|FG001|Overall Study|unacceptable toxicity|0|||
155399808|NCT00187096|560899416|FG002|Overall Study|unacceptable toxicity|1|||
155399809|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
155399810|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
155399811|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399812|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399813|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
155399814|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399815|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
155399816|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399817|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
155399818|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399819|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399820|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
155399821|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
155399822|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
155399823|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
155399824|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
155399825|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
155399826|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
155399827|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
155399828|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
155399829|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
155399830|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
155399831|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
155399832|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
155636542|NCT03314935|561761034|FG003|Phase 1|"Captured as Other in Database"|0|||
155284484|NCT00797225|560472825|FG002|Weeks 1 to 12|Sponsor Decision|0|||
155399833|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
155399834|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399835|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399836|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
155399837|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399838|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155636543|NCT03314935|561761035|FG004|Phase 1|"Captured as Other in Database"|0|||
155636544|NCT03314935|561761036|FG005|Phase 1|"Captured as Other in Database"|0|||
155636545|NCT03314935|561761037|FG006|Phase 1|"Captured as Other in Database"|1|||
155636546|NCT03314935|561761038|FG007|Phase 1|"Captured as Other in Database"|1|||
155636547|NCT03314935|561761039|FG008|Phase 1|"Captured as Other in Database"|1|||
155636548|NCT03314935|561761040|FG009|Phase 1|"Captured as Other in Database"|0|||
155636549|NCT03314935|561761041|FG010|Phase 1|"Captured as Other in Database"|0|||
155636550|NCT03314935|561761042|FG011|Phase 1|"Captured as Other in Database"|0|||
155636551|NCT03314935|561761043|FG012|Phase 1|"Captured as Other in Database"|0|||
155636552|NCT03314935|561761044|FG013|Phase 1|"Captured as Other in Database"|0|||
155636553|NCT03314935|561761045|FG014|Phase 1|"Captured as Other in Database"|0|||
155284485|NCT00797225|560472826|FG003|Weeks 1 to 12|Sponsor Decision|0|||
155284486|NCT00797225|560472827|FG004|Weeks 1 to 12|Sponsor Decision|0|||
155284487|NCT00797225|560472828|FG005|Weeks 1 to 12|Sponsor Decision|0|||
155284488|NCT00797225|560472829|FG006|Weeks 1 to 12|Sponsor Decision|0|||
155284489|NCT00797225|560472830|FG007|Weeks 1 to 12|Sponsor Decision|0|||
155284490|NCT00797225|560472823|FG000|Weeks 13 to 24|Non-compliance|0|||
155284491|NCT00797225|560472824|FG001|Weeks 13 to 24|Non-compliance|2|||
155284492|NCT00797225|560472825|FG002|Weeks 13 to 24|Non-compliance|0|||
155284493|NCT00797225|560472826|FG003|Weeks 13 to 24|Non-compliance|0|||
155284494|NCT00797225|560472827|FG004|Weeks 13 to 24|Non-compliance|0|||
155284495|NCT00797225|560472828|FG005|Weeks 13 to 24|Non-compliance|0|||
155284496|NCT00797225|560472829|FG006|Weeks 13 to 24|Non-compliance|0|||
155284497|NCT00797225|560472830|FG007|Weeks 13 to 24|Non-compliance|0|||
155284498|NCT00797225|560472823|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
155284499|NCT00797225|560472824|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
155284500|NCT00797225|560472825|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
155284501|NCT00797225|560472826|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
155284502|NCT00797225|560472827|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
155284503|NCT00797225|560472828|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
155284504|NCT00797225|560472829|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
155284505|NCT00797225|560472830|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
155284506|NCT00797225|560472823|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
155399839|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399840|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399841|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399842|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399843|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399844|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399845|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399846|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399847|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399848|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399849|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399850|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399851|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
155399852|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
155284507|NCT00797225|560472824|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
155284508|NCT00797225|560472825|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
155284509|NCT00797225|560472826|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
155284510|NCT00797225|560472827|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
155284511|NCT00797225|560472828|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
155284512|NCT00797225|560472829|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
155284513|NCT00797225|560472830|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
155284514|NCT00797225|560472823|FG000|Weeks 13 to 24|Adverse Event|0|||
155284515|NCT00797225|560472824|FG001|Weeks 13 to 24|Adverse Event|1|||
155284516|NCT00797225|560472825|FG002|Weeks 13 to 24|Adverse Event|0|||
155284517|NCT00797225|560472826|FG003|Weeks 13 to 24|Adverse Event|0|||
155284518|NCT00797225|560472827|FG004|Weeks 13 to 24|Adverse Event|0|||
155284519|NCT00797225|560472828|FG005|Weeks 13 to 24|Adverse Event|0|||
155284520|NCT00797225|560472829|FG006|Weeks 13 to 24|Adverse Event|1|||
155284521|NCT00797225|560472830|FG007|Weeks 13 to 24|Adverse Event|0|||
155284522|NCT00797225|560472823|FG000|Weeks 13 to 24|Sponsor Decision|0|||
155284523|NCT00797225|560472824|FG001|Weeks 13 to 24|Sponsor Decision|0|||
155284524|NCT00797225|560472825|FG002|Weeks 13 to 24|Sponsor Decision|0|||
155284525|NCT00797225|560472826|FG003|Weeks 13 to 24|Sponsor Decision|0|||
155399853|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155399854|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155399855|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155284526|NCT00797225|560472827|FG004|Weeks 13 to 24|Sponsor Decision|0|||
155284527|NCT00797225|560472828|FG005|Weeks 13 to 24|Sponsor Decision|0|||
155284528|NCT00797225|560472829|FG006|Weeks 13 to 24|Sponsor Decision|1|||
155284529|NCT00797225|560472830|FG007|Weeks 13 to 24|Sponsor Decision|0|||
155284530|NCT05174065|560472831|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155284531|NCT05174065|560472832|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
155399856|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155741422|NCT04784442|562154848|FG002|Overall Study|Adverse Event|2|||
155284532|NCT05174065|560472833|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
155284533|NCT05174065|560472831|FG000|Placebo-controlled Period|Other|0|||
155284534|NCT05174065|560472832|FG001|Placebo-controlled Period|Other|1|||
155284535|NCT05174065|560472833|FG002|Placebo-controlled Period|Other|0|||
155284536|NCT05174065|560472831|FG000|Placebo-controlled Period|Adverse Event|1|||
155284537|NCT05174065|560472832|FG001|Placebo-controlled Period|Adverse Event|1|||
155284538|NCT05174065|560472833|FG002|Placebo-controlled Period|Adverse Event|0|||
155284539|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
155399857|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
155399858|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399859|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399860|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399861|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399862|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399863|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155636554|NCT03314935|561761031|FG000|Phase 1|Lost to Follow-up|0|||
155399864|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
155399865|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399866|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399867|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399868|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399869|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399870|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
155399871|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399872|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399873|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399874|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399875|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399876|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
155399877|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399878|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399879|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399880|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399881|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399882|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
155399883|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399884|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399885|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399886|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399887|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399888|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399889|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399890|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
155399891|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399892|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399893|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399894|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399895|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399896|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
155399897|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399898|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399899|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399900|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399901|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399902|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399903|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
155399904|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399905|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399906|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399907|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399908|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399909|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
155399910|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399911|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399912|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399913|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399914|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399915|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399916|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
155399917|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399918|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
155399919|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
155399920|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
155399921|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399922|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399923|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399924|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
155284540|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
155284541|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
155284542|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
155284543|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
155284544|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
155284545|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
155284546|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
155284547|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
155284548|NCT01419717|560474349|FG000|Overall Study|Protocol-specified Criteria|62|||
155284549|NCT01419717|560474349|FG000|Overall Study|Adverse Event|19|||
155284550|NCT01419717|560474349|FG000|Overall Study|Death|17|||
155284551|NCT01419717|560474349|FG000|Overall Study|Withdrawal by Subject|10|||
155284552|NCT01419717|560474349|FG000|Overall Study|Disease Progression|9|||
155284553|NCT01419717|560474349|FG000|Overall Study|Other|4|||
155284554|NCT01419717|560474349|FG000|Overall Study|Lost to Follow-up|2|||
155284555|NCT01419717|560474349|FG000|Overall Study|Administrative Decision|1|||
155284556|NCT01419717|560474349|FG000|Overall Study|Noncompliance|1|||
155284557|NCT00587288|560474350|FG000|Overall Study|Adverse Event|0|||
155636555|NCT03314935|561761032|FG001|Phase 1|Lost to Follow-up|0|||
155636556|NCT03314935|561761033|FG002|Phase 1|Lost to Follow-up|0|||
155636557|NCT03314935|561761034|FG003|Phase 1|Lost to Follow-up|0|||
155636558|NCT03314935|561761035|FG004|Phase 1|Lost to Follow-up|0|||
155636559|NCT03314935|561761036|FG005|Phase 1|Lost to Follow-up|0|||
155636560|NCT03314935|561761037|FG006|Phase 1|Lost to Follow-up|0|||
155636561|NCT03314935|561761038|FG007|Phase 1|Lost to Follow-up|0|||
155636562|NCT03314935|561761039|FG008|Phase 1|Lost to Follow-up|1|||
155636563|NCT03314935|561761040|FG009|Phase 1|Lost to Follow-up|0|||
155636564|NCT03314935|561761041|FG010|Phase 1|Lost to Follow-up|0|||
155636565|NCT03314935|561761042|FG011|Phase 1|Lost to Follow-up|0|||
155399925|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
155399926|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399927|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399928|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155284558|NCT00587288|560474351|FG001|Overall Study|Adverse Event|1|||
155399929|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399930|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
155399931|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
155399932|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399933|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
155399934|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399935|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399936|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
155399937|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399938|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399939|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
155399940|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399941|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399942|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399943|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399944|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155636566|NCT03314935|561761043|FG012|Phase 1|Lost to Follow-up|0|||
155636567|NCT03314935|561761044|FG013|Phase 1|Lost to Follow-up|0|||
155636568|NCT03314935|561761045|FG014|Phase 1|Lost to Follow-up|0|||
155636569|NCT03314935|561761031|FG000|Phase 2|Death|0|||
155284559|NCT00587288|560474350|FG000|Overall Study|Lack of Efficacy|2|||
155399945|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399946|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399947|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399948|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
155399949|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399950|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399951|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399952|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399953|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399954|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155493768|NCT01100073|561232646|FG000|Overall Study|Lack of effect + patient's wish|2|||
155493769|NCT01100073|561232646|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
155493770|NCT01100073|561232646|FG000|Overall Study|Other|8|||
155493771|NCT01100073|561232646|FG000|Overall Study|Missing|5|||
155493772|NCT03099265|561232647|FG000|Overall Study|Adverse Event|1|||
155493773|NCT01656850|561232652|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
155493774|NCT01656850|561232653|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
155493775|NCT02074982|561232654|FG000|Overall Study|Adverse Event|15|||
155493776|NCT02074982|561232655|FG001|Overall Study|Adverse Event|7|||
155493777|NCT02074982|561232654|FG000|Overall Study|Lack of Efficacy|6|||
155493778|NCT02074982|561232655|FG001|Overall Study|Lack of Efficacy|1|||
155493779|NCT02074982|561232654|FG000|Overall Study|Lost to Follow-up|9|||
155493780|NCT02074982|561232655|FG001|Overall Study|Lost to Follow-up|10|||
155493781|NCT02074982|561232654|FG000|Overall Study|Non-compliance with study treatment|0|||
155493782|NCT02074982|561232655|FG001|Overall Study|Non-compliance with study treatment|2|||
155493783|NCT02074982|561232654|FG000|Overall Study|Physician Decision|1|||
155493784|NCT02074982|561232655|FG001|Overall Study|Physician Decision|1|||
155493785|NCT02074982|561232654|FG000|Overall Study|Pregnancy|1|||
155493786|NCT02074982|561232655|FG001|Overall Study|Pregnancy|2|||
155493787|NCT02074982|561232654|FG000|Overall Study|Protocol deviation|4|||
155493788|NCT02074982|561232655|FG001|Overall Study|Protocol deviation|3|||
155493789|NCT02074982|561232654|FG000|Overall Study|Technical problems|0|||
155493790|NCT02074982|561232655|FG001|Overall Study|Technical problems|2|||
155493791|NCT02074982|561232654|FG000|Overall Study|Subject/guardian decision|15|||
155493792|NCT02074982|561232655|FG001|Overall Study|Subject/guardian decision|24|||
155493793|NCT02074982|561232654|FG000|Overall Study|Death|0|||
155493794|NCT02074982|561232655|FG001|Overall Study|Death|2|||
155493795|NCT02094573|561232658|FG000|Overall Study|Adverse Event|4|||
155493796|NCT02094573|561232659|FG001|Overall Study|Adverse Event|14|||
155493797|NCT02094573|561232658|FG000|Overall Study|Clinical Progressive Disease|9|||
155493798|NCT02094573|561232659|FG001|Overall Study|Clinical Progressive Disease|13|||
155493799|NCT02094573|561232658|FG000|Overall Study|Death|11|||
155493800|NCT02094573|561232659|FG001|Overall Study|Death|3|||
155493801|NCT02094573|561232658|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
155493802|NCT02094573|561232659|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
155493803|NCT02094573|561232658|FG000|Overall Study|Non-compliance with Study Drug|1|||
155493804|NCT02094573|561232659|FG001|Overall Study|Non-compliance with Study Drug|1|||
155493805|NCT02094573|561232658|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
155493806|NCT02094573|561232659|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
155493807|NCT02094573|561232658|FG000|Overall Study|Physician Decision|4|||
155284560|NCT00587288|560474351|FG001|Overall Study|Lack of Efficacy|8|||
155284561|NCT00587288|560474350|FG000|Overall Study|Protocol Violation|1|||
155284562|NCT00587288|560474351|FG001|Overall Study|Protocol Violation|0|||
155284563|NCT00797862|560474352|FG000|Overall Study|Adverse Event|86|||
155284564|NCT00797862|560474353|FG001|Overall Study|Adverse Event|44|||
155284565|NCT00797862|560474354|FG002|Overall Study|Adverse Event|58|||
155284566|NCT00797862|560474352|FG000|Overall Study|Abnormal Test Procedure Result|0|||
155493808|NCT02094573|561232659|FG001|Overall Study|Physician Decision|4|||
155493809|NCT02094573|561232658|FG000|Overall Study|Site Terminated by Sponsor|10|||
155493810|NCT02094573|561232659|FG001|Overall Study|Site Terminated by Sponsor|17|||
155493811|NCT02094573|561232658|FG000|Overall Study|Withdrawal by Subject|6|||
155493812|NCT02094573|561232659|FG001|Overall Study|Withdrawal by Subject|8|||
155493813|NCT02094573|561232658|FG000|Overall Study|Randomized but not Treated|3|||
155493814|NCT02094573|561232659|FG001|Overall Study|Randomized but not Treated|0|||
155493815|NCT02875340|561232660|FG000|Overall Study|Death|2|||
155493816|NCT02875340|561232660|FG000|Overall Study|Withdrawal by Subject|2|||
155493817|NCT02875340|561232660|FG000|Overall Study|Physician Decision|3|||
155493818|NCT02875340|561232660|FG000|Overall Study|Adverse Event|1|||
155493819|NCT01160770|561232663|FG000|Overall Study|Adverse Event|10|||
155284567|NCT00797862|560474353|FG001|Overall Study|Abnormal Test Procedure Result|1|||
155493820|NCT01160770|561232663|FG000|Overall Study|Protocol Violation|2|||
155493821|NCT01160770|561232663|FG000|Overall Study|Subject/parent/caregiver request|33|||
155493822|NCT01160770|561232663|FG000|Overall Study|Physician Decision|1|||
155284568|NCT00797862|560474354|FG002|Overall Study|Abnormal Test Procedure Result|1|||
155284569|NCT00797862|560474352|FG000|Overall Study|Lack of Efficacy|1|||
155284570|NCT00797862|560474353|FG001|Overall Study|Lack of Efficacy|7|||
155284571|NCT00797862|560474354|FG002|Overall Study|Lack of Efficacy|6|||
155284572|NCT00797862|560474352|FG000|Overall Study|No longer required study medication|1|||
155284573|NCT00797862|560474353|FG001|Overall Study|No longer required study medication|0|||
155284574|NCT00797862|560474354|FG002|Overall Study|No longer required study medication|0|||
155284575|NCT00797862|560474352|FG000|Overall Study|Withdrawal by Subject|14|||
155284576|NCT00797862|560474353|FG001|Overall Study|Withdrawal by Subject|7|||
155284577|NCT00797862|560474354|FG002|Overall Study|Withdrawal by Subject|7|||
155284578|NCT00797862|560474352|FG000|Overall Study|Lost to Follow-up|11|||
155284579|NCT00797862|560474353|FG001|Overall Study|Lost to Follow-up|0|||
155284580|NCT00797862|560474354|FG002|Overall Study|Lost to Follow-up|5|||
155284581|NCT00797862|560474352|FG000|Overall Study|Administrative Problem|4|||
155284582|NCT00797862|560474353|FG001|Overall Study|Administrative Problem|0|||
155284583|NCT00797862|560474354|FG002|Overall Study|Administrative Problem|0|||
155284584|NCT00797862|560474352|FG000|Overall Study|Protocol Violation|4|||
155284585|NCT00797862|560474353|FG001|Overall Study|Protocol Violation|6|||
155284586|NCT00797862|560474354|FG002|Overall Study|Protocol Violation|8|||
155284587|NCT00797862|560474352|FG000|Overall Study|Mis-randomized|3|||
155284588|NCT00797862|560474353|FG001|Overall Study|Mis-randomized|3|||
155284589|NCT00797862|560474354|FG002|Overall Study|Mis-randomized|1|||
155284590|NCT05074498|560474357|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284591|NCT05074498|560474358|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284592|NCT05074498|560474359|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284593|NCT05074498|560474360|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
155284594|NCT05074498|560474361|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284595|NCT05074498|560474362|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284596|NCT05074498|560474357|FG000|Part 1 (Upto Day 104)|Other|1|||
155284597|NCT05074498|560474358|FG001|Part 1 (Upto Day 104)|Other|0|||
155399955|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
155399956|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399957|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399958|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155284598|NCT05074498|560474359|FG002|Part 1 (Upto Day 104)|Other|0|||
155284599|NCT05074498|560474360|FG003|Part 1 (Upto Day 104)|Other|0|||
155284600|NCT05074498|560474361|FG004|Part 1 (Upto Day 104)|Other|0|||
155284601|NCT05074498|560474362|FG005|Part 1 (Upto Day 104)|Other|0|||
155284602|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284603|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284604|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155399959|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155636570|NCT03314935|561761032|FG001|Phase 2|Death|0|||
155636571|NCT03314935|561761033|FG002|Phase 2|Death|0|||
155493823|NCT01160770|561232663|FG000|Overall Study|Lost to Follow-up|7|||
155636572|NCT03314935|561761034|FG003|Phase 2|Death|0|||
155636573|NCT03314935|561761035|FG004|Phase 2|Death|0|||
155636574|NCT03314935|561761036|FG005|Phase 2|Death|0|||
155636575|NCT03314935|561761037|FG006|Phase 2|Death|0|||
155636576|NCT03314935|561761038|FG007|Phase 2|Death|0|||
155636577|NCT03314935|561761039|FG008|Phase 2|Death|0|||
155636578|NCT03314935|561761040|FG009|Phase 2|Death|5|||
155284605|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284606|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
155399960|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155636579|NCT03314935|561761041|FG010|Phase 2|Death|20|||
155636580|NCT03314935|561761042|FG011|Phase 2|Death|6|||
155636581|NCT03314935|561761043|FG012|Phase 2|Death|7|||
155636582|NCT03314935|561761044|FG013|Phase 2|Death|6|||
155636583|NCT03314935|561761045|FG014|Phase 2|Death|17|||
155636584|NCT03314935|561761031|FG000|Phase 2|Withdrawal by Subject|0|||
155636585|NCT03314935|561761032|FG001|Phase 2|Withdrawal by Subject|0|||
155636586|NCT03314935|561761033|FG002|Phase 2|Withdrawal by Subject|0|||
155636587|NCT03314935|561761034|FG003|Phase 2|Withdrawal by Subject|0|||
155636588|NCT03314935|561761035|FG004|Phase 2|Withdrawal by Subject|0|||
155284607|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155399961|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
155399962|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155284608|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Death|0|||
155284609|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Death|0|||
155284610|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Death|0|||
155399963|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155399964|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155399965|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
155399966|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155399967|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155493824|NCT01160770|561232663|FG000|Overall Study|Study termination or sponsor request|1|||
155493825|NCT01160770|561232663|FG000|Overall Study|Death|9|||
155493826|NCT01160770|561232663|FG000|Overall Study|Lack of Efficacy|15|||
155493827|NCT01160770|561232663|FG000|Overall Study|Other Reasons|1|||
155493828|NCT05279807|561232664|FG000|Overall Study|Withdrawal by Subject|1|||
155493829|NCT05279807|561232665|FG001|Overall Study|Withdrawal by Subject|0|||
155493830|NCT05279807|561232664|FG000|Overall Study|Adverse Event|0|||
155493831|NCT05279807|561232665|FG001|Overall Study|Adverse Event|1|||
155493832|NCT05279807|561232664|FG000|Overall Study|Laboratory Abnormal Results|1|||
155493833|NCT05279807|561232665|FG001|Overall Study|Laboratory Abnormal Results|0|||
155493834|NCT03985982|561232666|FG000|Double-Blind Phase|Lost to Follow-up|4|||
155493835|NCT03985982|561232667|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155493836|NCT03985982|561232668|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155493837|NCT03985982|561232666|FG000|Double-Blind Phase|Physician Decision|1|||
155493838|NCT03985982|561232667|FG001|Double-Blind Phase|Physician Decision|0|||
155493839|NCT03985982|561232668|FG002|Double-Blind Phase|Physician Decision|0|||
155493840|NCT03985982|561232666|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
155493841|NCT03985982|561232667|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
155493842|NCT03985982|561232668|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155493843|NCT03985982|561232666|FG000|Double-Blind Phase|COVID-19|1|||
155493844|NCT03985982|561232667|FG001|Double-Blind Phase|COVID-19|0|||
155493845|NCT03985982|561232668|FG002|Double-Blind Phase|COVID-19|0|||
155493846|NCT03985982|561232666|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
155493847|NCT03985982|561232667|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
155493848|NCT03985982|561232668|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
155493849|NCT03985982|561232666|FG000|Open-Label Phase|Lost to Follow-up|0|||
155493850|NCT03985982|561232667|FG001|Open-Label Phase|Lost to Follow-up|0|||
155493851|NCT03985982|561232668|FG002|Open-Label Phase|Lost to Follow-up|13|||
155493852|NCT03985982|561232666|FG000|Open-Label Phase|Physician Decision|0|||
155493853|NCT03985982|561232667|FG001|Open-Label Phase|Physician Decision|0|||
155493854|NCT03985982|561232668|FG002|Open-Label Phase|Physician Decision|2|||
155493855|NCT03985982|561232666|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155493856|NCT03985982|561232667|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155493857|NCT03985982|561232668|FG002|Open-Label Phase|Withdrawal by Subject|11|||
155493858|NCT05981365|561232669|FG000|Period 1|Adverse Event|1|||
155493859|NCT05981365|561232670|FG001|Period 1|Adverse Event|0|||
155493860|NCT05102162|561232675|FG000|Overall Study|Withdrawal by Subject|3|||
155493861|NCT05102162|561232676|FG001|Overall Study|Withdrawal by Subject|0|||
155493862|NCT05102162|561232675|FG000|Overall Study|Baseline cultures negative|4|||
155493863|NCT05102162|561232676|FG001|Overall Study|Baseline cultures negative|2|||
155493864|NCT05102162|561232675|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
155493865|NCT05102162|561232676|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
155493866|NCT05102162|561232675|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
155493867|NCT05102162|561232676|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
155493868|NCT01353586|561232677|FG000|Overall Study|Procedure terminated prior to ablation|3|||
155493869|NCT01353586|561232678|FG001|Overall Study|Procedure terminated prior to ablation|0|||
155493870|NCT01353586|561232677|FG000|Overall Study|Never had insertion of study catheter|4|||
155493871|NCT01353586|561232678|FG001|Overall Study|Never had insertion of study catheter|1|||
155493872|NCT01353586|561232677|FG000|Overall Study|Neurological exam not done|0|||
155493873|NCT01353586|561232678|FG001|Overall Study|Neurological exam not done|1|||
155493874|NCT05027958|561232679|FG000|Overall Study|Lost to Follow-up|1|||
155493875|NCT05027958|561232680|FG001|Overall Study|Lost to Follow-up|1|||
155493876|NCT05027958|561232679|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
155493877|NCT05027958|561232680|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
155493878|NCT05027958|561232679|FG000|Overall Study|Physician Decision|1|||
155493879|NCT05027958|561232680|FG001|Overall Study|Physician Decision|4|||
155493880|NCT05027958|561232679|FG000|Overall Study|Adverse Event|0|||
155493881|NCT05027958|561232680|FG001|Overall Study|Adverse Event|1|||
155493882|NCT02871921|561232681|FG000|Overall Study|Withdrawal by Subject|34|||
155493883|NCT02871921|561232682|FG001|Overall Study|Withdrawal by Subject|27|||
155493884|NCT02871921|561232683|FG002|Overall Study|Withdrawal by Subject|27|||
155493885|NCT02871921|561232684|FG003|Overall Study|Withdrawal by Subject|30|||
155493886|NCT00890409|561232690|FG000|Overall Study|Lost to Follow-up|20|||
155493887|NCT00890409|561232691|FG001|Overall Study|Lost to Follow-up|21|||
155493888|NCT02353572|561232692|FG000|Overall Study|Withdrawal by Subject|1|||
155493889|NCT02353572|561232692|FG000|Overall Study|Study terminated|2|||
155493890|NCT01870921|561232701|FG000|Overall Study|Subject decision|80|||
155493891|NCT01870921|561232701|FG000|Overall Study|Severe non-compliance to protocol|7|||
155493892|NCT01870921|561232701|FG000|Overall Study|Subject Lost to Follow up|2|||
155493893|NCT01870921|561232701|FG000|Overall Study|Other|1|||
155493894|NCT02060188|561232705|FG000|Overall Study|Disease Progression|36|||
155493895|NCT02060188|561232706|FG001|Overall Study|Disease Progression|42|||
155493896|NCT02060188|561232707|FG002|Overall Study|Disease Progression|8|||
155493897|NCT02060188|561232708|FG003|Overall Study|Disease Progression|5|||
155284611|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Death|0|||
155284612|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Death|1|||
155284613|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Death|0|||
155284614|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284615|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284616|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284617|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284618|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
155284619|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
155636589|NCT03314935|561761036|FG005|Phase 2|Withdrawal by Subject|0|||
155636590|NCT03314935|561761037|FG006|Phase 2|Withdrawal by Subject|0|||
155636591|NCT03314935|561761038|FG007|Phase 2|Withdrawal by Subject|0|||
155636592|NCT03314935|561761039|FG008|Phase 2|Withdrawal by Subject|0|||
155636593|NCT03314935|561761040|FG009|Phase 2|Withdrawal by Subject|1|||
155636594|NCT03314935|561761041|FG010|Phase 2|Withdrawal by Subject|4|||
155636595|NCT03314935|561761042|FG011|Phase 2|Withdrawal by Subject|0|||
155636596|NCT03314935|561761043|FG012|Phase 2|Withdrawal by Subject|1|||
155284620|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Other|0|||
155284621|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Other|0|||
155284622|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Other|0|||
155284623|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Other|0|||
155636597|NCT03314935|561761044|FG013|Phase 2|Withdrawal by Subject|0|||
155636598|NCT03314935|561761045|FG014|Phase 2|Withdrawal by Subject|1|||
155636599|NCT03314935|561761031|FG000|Phase 2|Progressive Disease|0|||
155636600|NCT03314935|561761032|FG001|Phase 2|Progressive Disease|0|||
155636601|NCT03314935|561761033|FG002|Phase 2|Progressive Disease|0|||
155636602|NCT03314935|561761034|FG003|Phase 2|Progressive Disease|0|||
155636603|NCT03314935|561761035|FG004|Phase 2|Progressive Disease|0|||
155636604|NCT03314935|561761036|FG005|Phase 2|Progressive Disease|0|||
155284624|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Other|1|||
155284625|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Other|0|||
155284626|NCT01257503|560474363|FG000|Overall Study|Lost to Follow-up|7|||
155284627|NCT01257503|560474364|FG001|Overall Study|Lost to Follow-up|10|||
155284628|NCT01257503|560474363|FG000|Overall Study|Over 5 years old at enrollment|0|||
155284629|NCT01257503|560474364|FG001|Overall Study|Over 5 years old at enrollment|1|||
155284630|NCT01257503|560474363|FG000|Overall Study|strep culture positive at enrollment|1|||
155284631|NCT01257503|560474364|FG001|Overall Study|strep culture positive at enrollment|0|||
155284632|NCT00367237|560474365|FG000|Overall Study|Adverse Event|7|||
155284633|NCT00367237|560474366|FG001|Overall Study|Adverse Event|2|||
155284634|NCT00367237|560474365|FG000|Overall Study|Lost to Follow-up|1|||
155284635|NCT00367237|560474366|FG001|Overall Study|Lost to Follow-up|0|||
155284636|NCT00367237|560474365|FG000|Overall Study|Withdrawal by Subject|0|||
155284637|NCT00367237|560474366|FG001|Overall Study|Withdrawal by Subject|4|||
155284638|NCT00367237|560474365|FG000|Overall Study|Protocol Violation|2|||
155284639|NCT00367237|560474366|FG001|Overall Study|Protocol Violation|5|||
155284640|NCT02359435|560474367|FG000|Overall Study|Lost to Follow-up|4|||
155284641|NCT02359435|560474368|FG001|Overall Study|Lost to Follow-up|4|||
155284642|NCT01528709|560474374|FG000|Overall Study|Death|2|||
155284643|NCT01528709|560474375|FG001|Overall Study|Death|0|||
155284644|NCT01528709|560474374|FG000|Overall Study|Withdrawal by Subject|10|||
155284645|NCT01528709|560474375|FG001|Overall Study|Withdrawal by Subject|15|||
155284646|NCT01528709|560474374|FG000|Overall Study|allergy|1|||
155284647|NCT01528709|560474375|FG001|Overall Study|allergy|0|||
155284648|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
155284649|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
155284650|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
155284651|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
155284652|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
155284653|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
155284654|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
155284655|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
155284656|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
155284657|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
155284658|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
155284659|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
155284660|NCT01237678|560474376|FG000|Phase II|Adverse Event|0|||
155284661|NCT01237678|560474377|FG001|Phase II|Adverse Event|39|||
155284662|NCT01237678|560474378|FG002|Phase II|Adverse Event|9|||
155284663|NCT01237678|560474376|FG000|Phase II|Death|0|||
155284664|NCT01237678|560474377|FG001|Phase II|Death|0|||
155284665|NCT01237678|560474378|FG002|Phase II|Death|2|||
155284666|NCT01237678|560474376|FG000|Phase II|Lack of Efficacy|0|||
155284667|NCT01237678|560474377|FG001|Phase II|Lack of Efficacy|25|||
155284668|NCT01237678|560474378|FG002|Phase II|Lack of Efficacy|3|||
155284669|NCT01237678|560474376|FG000|Phase II|Withdrawal by Subject|0|||
155284670|NCT01237678|560474377|FG001|Phase II|Withdrawal by Subject|1|||
155284671|NCT01237678|560474378|FG002|Phase II|Withdrawal by Subject|5|||
155399968|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155399969|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
155399970|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399971|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399972|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399973|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
155399974|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399975|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399976|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399977|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
155399978|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399979|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399980|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399981|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
155399982|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
155636605|NCT03314935|561761037|FG006|Phase 2|Progressive Disease|0|||
155636606|NCT03314935|561761038|FG007|Phase 2|Progressive Disease|0|||
155636607|NCT03314935|561761039|FG008|Phase 2|Progressive Disease|0|||
155636608|NCT03314935|561761040|FG009|Phase 2|Progressive Disease|1|||
155636609|NCT03314935|561761041|FG010|Phase 2|Progressive Disease|1|||
155636610|NCT03314935|561761042|FG011|Phase 2|Progressive Disease|1|||
155636611|NCT03314935|561761043|FG012|Phase 2|Progressive Disease|2|||
155636612|NCT03314935|561761044|FG013|Phase 2|Progressive Disease|0|||
155636613|NCT03314935|561761045|FG014|Phase 2|Progressive Disease|1|||
155636614|NCT03314935|561761031|FG000|Phase 2|Study Terminated by Sponsor|0|||
155636615|NCT03314935|561761032|FG001|Phase 2|Study Terminated by Sponsor|0|||
155636616|NCT03314935|561761033|FG002|Phase 2|Study Terminated by Sponsor|0|||
155636617|NCT03314935|561761034|FG003|Phase 2|Study Terminated by Sponsor|0|||
155636618|NCT03314935|561761035|FG004|Phase 2|Study Terminated by Sponsor|0|||
155636619|NCT03314935|561761036|FG005|Phase 2|Study Terminated by Sponsor|0|||
155636620|NCT03314935|561761037|FG006|Phase 2|Study Terminated by Sponsor|0|||
155636621|NCT03314935|561761038|FG007|Phase 2|Study Terminated by Sponsor|0|||
155636622|NCT03314935|561761039|FG008|Phase 2|Study Terminated by Sponsor|0|||
155636623|NCT03314935|561761040|FG009|Phase 2|Study Terminated by Sponsor|0|||
155636624|NCT03314935|561761041|FG010|Phase 2|Study Terminated by Sponsor|7|||
155636625|NCT03314935|561761042|FG011|Phase 2|Study Terminated by Sponsor|2|||
155636626|NCT03314935|561761043|FG012|Phase 2|Study Terminated by Sponsor|1|||
155636627|NCT03314935|561761044|FG013|Phase 2|Study Terminated by Sponsor|4|||
155636628|NCT03314935|561761045|FG014|Phase 2|Study Terminated by Sponsor|4|||
155636629|NCT03314935|561761031|FG000|Phase 2|Lost to Follow-up|0|||
155636630|NCT03314935|561761032|FG001|Phase 2|Lost to Follow-up|0|||
155636631|NCT03314935|561761033|FG002|Phase 2|Lost to Follow-up|0|||
155636632|NCT03314935|561761034|FG003|Phase 2|Lost to Follow-up|0|||
155636633|NCT03314935|561761035|FG004|Phase 2|Lost to Follow-up|0|||
155636634|NCT03314935|561761036|FG005|Phase 2|Lost to Follow-up|0|||
155636635|NCT03314935|561761037|FG006|Phase 2|Lost to Follow-up|0|||
155636636|NCT03314935|561761038|FG007|Phase 2|Lost to Follow-up|0|||
155636637|NCT03314935|561761039|FG008|Phase 2|Lost to Follow-up|0|||
155636638|NCT03314935|561761040|FG009|Phase 2|Lost to Follow-up|1|||
155636639|NCT03314935|561761041|FG010|Phase 2|Lost to Follow-up|0|||
155636640|NCT03314935|561761042|FG011|Phase 2|Lost to Follow-up|0|||
155636641|NCT03314935|561761043|FG012|Phase 2|Lost to Follow-up|0|||
155636642|NCT03314935|561761044|FG013|Phase 2|Lost to Follow-up|0|||
155636643|NCT03314935|561761045|FG014|Phase 2|Lost to Follow-up|1|||
155636644|NCT03314935|561761031|FG000|Phase 2|Physician Decision|0|||
155636645|NCT03314935|561761032|FG001|Phase 2|Physician Decision|0|||
155636646|NCT03314935|561761033|FG002|Phase 2|Physician Decision|0|||
155636647|NCT03314935|561761034|FG003|Phase 2|Physician Decision|0|||
155636648|NCT03314935|561761035|FG004|Phase 2|Physician Decision|0|||
155636649|NCT03314935|561761036|FG005|Phase 2|Physician Decision|0|||
155636650|NCT03314935|561761037|FG006|Phase 2|Physician Decision|0|||
155636651|NCT03314935|561761038|FG007|Phase 2|Physician Decision|0|||
155636652|NCT03314935|561761039|FG008|Phase 2|Physician Decision|0|||
155636653|NCT03314935|561761040|FG009|Phase 2|Physician Decision|0|||
155636654|NCT03314935|561761041|FG010|Phase 2|Physician Decision|1|||
155636655|NCT03314935|561761042|FG011|Phase 2|Physician Decision|0|||
155493898|NCT02060188|561232709|FG004|Overall Study|Disease Progression|6|||
155741423|NCT04784442|562154849|FG003|Overall Study|Adverse Event|1|||
155636656|NCT03314935|561761043|FG012|Phase 2|Physician Decision|0|||
155636657|NCT03314935|561761044|FG013|Phase 2|Physician Decision|0|||
155636658|NCT03314935|561761045|FG014|Phase 2|Physician Decision|0|||
155636659|NCT05252702|561761046|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
155636660|NCT05252702|561761046|FG000|Overall Study|Death|16|||
155636661|NCT05252702|561761046|FG000|Overall Study|System explant|5|||
155636662|NCT05252702|561761046|FG000|Overall Study|Lost to Follow-up|1|||
155636663|NCT05252702|561761046|FG000|Overall Study|Withdrawn by investigator|1|||
155741424|NCT04784442|562154846|FG000|Overall Study|Protocol Violation|1|||
155284672|NCT01237678|560474376|FG000|Phase II|Completed Cycles 4-6|0|||
155284673|NCT01237678|560474377|FG001|Phase II|Completed Cycles 4-6|11|||
155284674|NCT01237678|560474378|FG002|Phase II|Completed Cycles 4-6|21|||
155284675|NCT01237678|560474376|FG000|Phase II|Sponsor Decision/Study Closed|0|||
155284676|NCT01237678|560474377|FG001|Phase II|Sponsor Decision/Study Closed|18|||
155284677|NCT01237678|560474378|FG002|Phase II|Sponsor Decision/Study Closed|7|||
155284678|NCT01237678|560474376|FG000|Phase II|Randomized but were not treated|0|||
155284679|NCT01237678|560474377|FG001|Phase II|Randomized but were not treated|4|||
155284680|NCT01237678|560474378|FG002|Phase II|Randomized but were not treated|3|||
155284681|NCT03398356|560474379|FG000|Before Treatment|Lost to Follow-up|1|||
155284682|NCT03398356|560474380|FG001|Before Treatment|Lost to Follow-up|2|||
155284683|NCT03398356|560474381|FG002|Before Treatment|Lost to Follow-up|0|||
155284684|NCT03398356|560474379|FG000|Before Treatment|drug intolerance|2|||
155399983|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
155399984|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
155399985|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
155399986|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399987|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399988|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399989|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
155399990|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
155399991|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
155399992|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
155399993|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
155399994|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
155399995|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
155399996|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
155399997|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
155399998|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
155399999|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
155400000|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
155400001|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
155400002|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
155400003|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
155400004|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
155284685|NCT03398356|560474380|FG001|Before Treatment|drug intolerance|1|||
155284686|NCT03398356|560474381|FG002|Before Treatment|drug intolerance|0|||
155284687|NCT03398356|560474379|FG000|Before Treatment|Withdrawal by Subject|0|||
155284688|NCT03398356|560474380|FG001|Before Treatment|Withdrawal by Subject|5|||
155284689|NCT03398356|560474381|FG002|Before Treatment|Withdrawal by Subject|0|||
155284690|NCT03398356|560474379|FG000|Before Treatment|Physician Decision|0|||
155284691|NCT03398356|560474380|FG001|Before Treatment|Physician Decision|0|||
155284692|NCT03398356|560474381|FG002|Before Treatment|Physician Decision|11|||
155284693|NCT03398356|560474379|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
155284694|NCT03398356|560474380|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
155284695|NCT03398356|560474381|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
155284696|NCT01982760|560474382|FG000|Overall Study|Physician Decision|1|||
155284697|NCT01982760|560474383|FG001|Overall Study|Physician Decision|0|||
155284698|NCT00282438|560474384|FG000|Overall Study|Lack of Efficacy|1|||
155284699|NCT00282438|560474385|FG001|Overall Study|Lack of Efficacy|0|||
155284700|NCT00282438|560474384|FG000|Overall Study|Death|0|||
155284701|NCT00282438|560474385|FG001|Overall Study|Death|1|||
155284702|NCT02397889|560474386|FG000|Overall Study|Physician Decision|1|||
155284703|NCT02397889|560474387|FG001|Overall Study|Physician Decision|0|||
155284704|NCT02954055|560474392|FG000|Overall Study|Did not initiate therapy|6|||
155284705|NCT02954055|560474393|FG001|Overall Study|Did not initiate therapy|1|||
155284706|NCT01119703|560474398|FG000|Overall Study|Adverse Event|0|||
155284707|NCT01119703|560474399|FG001|Overall Study|Adverse Event|1|||
155284708|NCT01511250|560474400|FG000|Overall Study|Withdrawal of Consent|1|||
155284709|NCT01511250|560474401|FG001|Overall Study|Withdrawal of Consent|0|||
155284710|NCT01511250|560474402|FG002|Overall Study|Withdrawal of Consent|0|||
155284711|NCT01511250|560474403|FG003|Overall Study|Withdrawal of Consent|0|||
155400005|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
155284712|NCT01511250|560474404|FG004|Overall Study|Withdrawal of Consent|0|||
155284713|NCT01511250|560474405|FG005|Overall Study|Withdrawal of Consent|0|||
155284714|NCT01511250|560474406|FG006|Overall Study|Withdrawal of Consent|0|||
155284715|NCT01511250|560474407|FG007|Overall Study|Withdrawal of Consent|1|||
155284716|NCT01511250|560474408|FG008|Overall Study|Withdrawal of Consent|1|||
155284717|NCT01511250|560474409|FG009|Overall Study|Withdrawal of Consent|0|||
155284718|NCT01511250|560474400|FG000|Overall Study|Sponsor/Investigator Decision|1|||
155284719|NCT01511250|560474401|FG001|Overall Study|Sponsor/Investigator Decision|0|||
155284720|NCT01511250|560474402|FG002|Overall Study|Sponsor/Investigator Decision|0|||
155493899|NCT02060188|561232710|FG005|Overall Study|Disease Progression|3|||
155493900|NCT02060188|561232711|FG006|Overall Study|Disease Progression|23|||
155493901|NCT02060188|561232712|FG007|Overall Study|Disease Progression|20|||
155493902|NCT02060188|561232713|FG008|Overall Study|Disease Progression|43|||
155493903|NCT02060188|561232705|FG000|Overall Study|Study Drug Toxicity|10|||
155493904|NCT02060188|561232706|FG001|Overall Study|Study Drug Toxicity|18|||
155493905|NCT02060188|561232707|FG002|Overall Study|Study Drug Toxicity|7|||
155493906|NCT02060188|561232708|FG003|Overall Study|Study Drug Toxicity|4|||
155493907|NCT02060188|561232709|FG004|Overall Study|Study Drug Toxicity|3|||
155493908|NCT02060188|561232710|FG005|Overall Study|Study Drug Toxicity|0|||
155493909|NCT02060188|561232711|FG006|Overall Study|Study Drug Toxicity|2|||
155493910|NCT02060188|561232712|FG007|Overall Study|Study Drug Toxicity|5|||
155493911|NCT02060188|561232713|FG008|Overall Study|Study Drug Toxicity|0|||
155493912|NCT02060188|561232705|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155493913|NCT02060188|561232706|FG001|Overall Study|Adverse event unrelated to study drug|5|||
155493914|NCT02060188|561232707|FG002|Overall Study|Adverse event unrelated to study drug|6|||
155493915|NCT02060188|561232708|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155493916|NCT02060188|561232709|FG004|Overall Study|Adverse event unrelated to study drug|1|||
155493917|NCT02060188|561232710|FG005|Overall Study|Adverse event unrelated to study drug|0|||
155493918|NCT02060188|561232711|FG006|Overall Study|Adverse event unrelated to study drug|4|||
155493919|NCT02060188|561232712|FG007|Overall Study|Adverse event unrelated to study drug|4|||
155493920|NCT02060188|561232713|FG008|Overall Study|Adverse event unrelated to study drug|1|||
155493921|NCT02060188|561232705|FG000|Overall Study|Participant request to discontinue study treatment|7|||
155493922|NCT02060188|561232706|FG001|Overall Study|Participant request to discontinue study treatment|7|||
155493923|NCT02060188|561232707|FG002|Overall Study|Participant request to discontinue study treatment|4|||
155493924|NCT02060188|561232708|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155493925|NCT02060188|561232709|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155493926|NCT02060188|561232710|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155493927|NCT02060188|561232711|FG006|Overall Study|Participant request to discontinue study treatment|1|||
155493928|NCT02060188|561232712|FG007|Overall Study|Participant request to discontinue study treatment|1|||
155493929|NCT02060188|561232713|FG008|Overall Study|Participant request to discontinue study treatment|0|||
155493930|NCT02060188|561232705|FG000|Overall Study|Participant withdrew consent|3|||
155493931|NCT02060188|561232706|FG001|Overall Study|Participant withdrew consent|0|||
155493932|NCT02060188|561232707|FG002|Overall Study|Participant withdrew consent|0|||
155493933|NCT02060188|561232708|FG003|Overall Study|Participant withdrew consent|0|||
155493934|NCT02060188|561232709|FG004|Overall Study|Participant withdrew consent|0|||
155493935|NCT02060188|561232710|FG005|Overall Study|Participant withdrew consent|0|||
155493936|NCT02060188|561232711|FG006|Overall Study|Participant withdrew consent|0|||
155493937|NCT02060188|561232712|FG007|Overall Study|Participant withdrew consent|0|||
155493938|NCT02060188|561232713|FG008|Overall Study|Participant withdrew consent|0|||
155493939|NCT02060188|561232705|FG000|Overall Study|Maximum clinical benefit|13|||
155493940|NCT02060188|561232706|FG001|Overall Study|Maximum clinical benefit|38|||
155493941|NCT02060188|561232707|FG002|Overall Study|Maximum clinical benefit|19|||
155493942|NCT02060188|561232708|FG003|Overall Study|Maximum clinical benefit|0|||
155493943|NCT02060188|561232709|FG004|Overall Study|Maximum clinical benefit|0|||
155493944|NCT02060188|561232710|FG005|Overall Study|Maximum clinical benefit|0|||
155400006|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
155400007|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
155400008|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
155400009|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Death|0|||
155400010|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Death|25|||
155400011|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Death|13|||
155400012|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Death|4|||
155400013|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
155400014|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
155400015|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
155400016|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
155400017|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
155400018|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
155400019|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
155400020|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
155400021|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
155493945|NCT02060188|561232711|FG006|Overall Study|Maximum clinical benefit|0|||
155493946|NCT02060188|561232712|FG007|Overall Study|Maximum clinical benefit|10|||
155493947|NCT02060188|561232713|FG008|Overall Study|Maximum clinical benefit|0|||
155493948|NCT02060188|561232705|FG000|Overall Study|Other reason|3|||
155493949|NCT02060188|561232706|FG001|Overall Study|Other reason|7|||
155493950|NCT02060188|561232707|FG002|Overall Study|Other reason|0|||
155493951|NCT02060188|561232708|FG003|Overall Study|Other reason|1|||
155493952|NCT02060188|561232709|FG004|Overall Study|Other reason|0|||
155493953|NCT02060188|561232710|FG005|Overall Study|Other reason|0|||
155493954|NCT02060188|561232711|FG006|Overall Study|Other reason|0|||
155493955|NCT02060188|561232712|FG007|Overall Study|Other reason|9|||
155493956|NCT02060188|561232713|FG008|Overall Study|Other reason|0|||
155493957|NCT02060188|561232705|FG000|Overall Study|Death|0|||
155493958|NCT02060188|561232706|FG001|Overall Study|Death|1|||
155493959|NCT02060188|561232707|FG002|Overall Study|Death|0|||
155493960|NCT02060188|561232708|FG003|Overall Study|Death|0|||
155493961|NCT02060188|561232709|FG004|Overall Study|Death|0|||
155493962|NCT02060188|561232710|FG005|Overall Study|Death|0|||
155493963|NCT02060188|561232711|FG006|Overall Study|Death|0|||
155493964|NCT02060188|561232712|FG007|Overall Study|Death|1|||
155493965|NCT02060188|561232713|FG008|Overall Study|Death|0|||
155636664|NCT05252702|561761046|FG000|Overall Study|Visit not due|306|||
155636665|NCT05252702|561761046|FG000|Overall Study|Visit within window but not completed|92|||
155636666|NCT05252702|561761046|FG000|Overall Study|Unsuccessful implant|1|||
155636667|NCT01654276|561761048|FG000|Overall Study|Lack of Efficacy|1|||
155636668|NCT01654276|561761048|FG000|Overall Study|Lost to Follow-up|4|||
155636669|NCT01654276|561761048|FG000|Overall Study|Withdrawal by Subject|1|||
155636670|NCT04478266|561761049|FG000|Overall Study|Adverse Event|20|||
155636671|NCT04478266|561761050|FG001|Overall Study|Adverse Event|21|||
155636672|NCT04478266|561761049|FG000|Overall Study|Progressive disease|146|||
155636673|NCT04478266|561761050|FG001|Overall Study|Progressive disease|168|||
155636674|NCT04478266|561761049|FG000|Overall Study|Poor compliance to protocol|1|||
155636675|NCT04478266|561761050|FG001|Overall Study|Poor compliance to protocol|0|||
155636676|NCT04478266|561761049|FG000|Overall Study|Withdrawal by Subject|19|||
155636677|NCT04478266|561761050|FG001|Overall Study|Withdrawal by Subject|16|||
155636678|NCT04478266|561761049|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
155636679|NCT04478266|561761050|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
155636680|NCT04478266|561761049|FG000|Overall Study|Study terminated by sponsor|33|||
155636681|NCT04478266|561761050|FG001|Overall Study|Study terminated by sponsor|35|||
155636682|NCT04478266|561761049|FG000|Overall Study|Other: unspecified|5|||
155636683|NCT04478266|561761050|FG001|Overall Study|Other: unspecified|7|||
155636684|NCT04478266|561761049|FG000|Overall Study|Randomized but not treated|1|||
155636685|NCT04478266|561761050|FG001|Overall Study|Randomized but not treated|1|||
155636686|NCT01192178|561761051|FG000|Overall Study|Withdrawal by Subject|6|||
155636687|NCT01192178|561761052|FG001|Overall Study|Withdrawal by Subject|10|||
155636688|NCT01192178|561761051|FG000|Overall Study|Protocol Violation|10|||
155636689|NCT01192178|561761052|FG001|Overall Study|Protocol Violation|3|||
155636690|NCT01192178|561761051|FG000|Overall Study|Physician Decision|2|||
155636691|NCT01192178|561761052|FG001|Overall Study|Physician Decision|4|||
155636692|NCT01192178|561761051|FG000|Overall Study|Lost to Follow-up|3|||
155636693|NCT01192178|561761052|FG001|Overall Study|Lost to Follow-up|3|||
155636694|NCT01192178|561761051|FG000|Overall Study|Adverse Event|2|||
155636695|NCT01192178|561761052|FG001|Overall Study|Adverse Event|1|||
155636696|NCT01192178|561761051|FG000|Overall Study|Lack of Efficacy|1|||
155636697|NCT01192178|561761052|FG001|Overall Study|Lack of Efficacy|2|||
155636698|NCT02164916|561761055|FG000|Overall Study|Adverse Event|3|||
155636699|NCT02164916|561761056|FG001|Overall Study|Adverse Event|8|||
155636700|NCT02164916|561761055|FG000|Overall Study|Death|1|||
155636701|NCT02164916|561761056|FG001|Overall Study|Death|1|||
155636702|NCT02164916|561761055|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155636703|NCT02164916|561761056|FG001|Overall Study|Refusal unrelated to adverse event|7|||
155636704|NCT02164916|561761055|FG000|Overall Study|Progression|37|||
155636705|NCT02164916|561761056|FG001|Overall Study|Progression|26|||
155636706|NCT02164916|561761055|FG000|Overall Study|Not protocol specified|5|||
155636707|NCT02164916|561761056|FG001|Overall Study|Not protocol specified|1|||
155636708|NCT02164916|561761055|FG000|Overall Study|Reason under review|1|||
155636709|NCT02164916|561761056|FG001|Overall Study|Reason under review|6|||
155636710|NCT02164916|561761055|FG000|Overall Study|Not eligible|2|||
155636711|NCT02164916|561761056|FG001|Overall Study|Not eligible|5|||
155636712|NCT00964782|561761059|FG000|Overall Study|Lost to Follow-up|1|||
155636713|NCT00964782|561761060|FG001|Overall Study|Lost to Follow-up|0|||
155636714|NCT01101178|561761061|FG000|Period 1|Withdrawal by Subject|1|||
155636715|NCT01101178|561761062|FG001|Period 1|Withdrawal by Subject|2|||
155636716|NCT01101178|561761061|FG000|Period 1|Positive drug screen|1|||
155636717|NCT01101178|561761062|FG001|Period 1|Positive drug screen|1|||
155636718|NCT01101178|561761061|FG000|Period 1|Adverse Event|2|||
155636719|NCT01101178|561761062|FG001|Period 1|Adverse Event|1|||
155636720|NCT01101178|561761061|FG000|Period 2|Withdrawal by Subject|0|||
155636721|NCT01101178|561761062|FG001|Period 2|Withdrawal by Subject|1|||
155741425|NCT04784442|562154847|FG001|Overall Study|Protocol Violation|0|||
155493966|NCT02060188|561232705|FG000|Overall Study|Administrative reasons by sponsor|0|||
155493967|NCT02060188|561232706|FG001|Overall Study|Administrative reasons by sponsor|1|||
155493968|NCT02060188|561232707|FG002|Overall Study|Administrative reasons by sponsor|0|||
155636722|NCT00127803|561761063|FG000|Overall Study|Adverse Event|2|||
155636723|NCT00127803|561761064|FG001|Overall Study|Adverse Event|0|||
155636724|NCT00127803|561761065|FG002|Overall Study|Adverse Event|0|||
155493969|NCT02060188|561232708|FG003|Overall Study|Administrative reasons by sponsor|0|||
155493970|NCT02060188|561232709|FG004|Overall Study|Administrative reasons by sponsor|0|||
155493971|NCT02060188|561232710|FG005|Overall Study|Administrative reasons by sponsor|0|||
155493972|NCT02060188|561232711|FG006|Overall Study|Administrative reasons by sponsor|0|||
155493973|NCT02060188|561232712|FG007|Overall Study|Administrative reasons by sponsor|0|||
155493974|NCT02060188|561232713|FG008|Overall Study|Administrative reasons by sponsor|0|||
155493975|NCT02060188|561232705|FG000|Overall Study|Lost to Follow-up|0|||
155493976|NCT02060188|561232706|FG001|Overall Study|Lost to Follow-up|0|||
155493977|NCT02060188|561232707|FG002|Overall Study|Lost to Follow-up|1|||
155493978|NCT02060188|561232708|FG003|Overall Study|Lost to Follow-up|0|||
155493979|NCT02060188|561232709|FG004|Overall Study|Lost to Follow-up|0|||
155493980|NCT02060188|561232710|FG005|Overall Study|Lost to Follow-up|0|||
155493981|NCT02060188|561232711|FG006|Overall Study|Lost to Follow-up|0|||
155493982|NCT02060188|561232712|FG007|Overall Study|Lost to Follow-up|0|||
155493983|NCT02060188|561232713|FG008|Overall Study|Lost to Follow-up|0|||
155493984|NCT02242942|561232716|FG000|Overall Study|Death|17|||
155493985|NCT02242942|561232717|FG001|Overall Study|Death|20|||
155493986|NCT02242942|561232718|FG002|Overall Study|Death|2|||
155493987|NCT02242942|561232716|FG000|Overall Study|Physician Decision|1|||
155493988|NCT02242942|561232717|FG001|Overall Study|Physician Decision|0|||
155493989|NCT02242942|561232718|FG002|Overall Study|Physician Decision|0|||
155493990|NCT02242942|561232716|FG000|Overall Study|Withdrawal by Subject|8|||
155493991|NCT02242942|561232717|FG001|Overall Study|Withdrawal by Subject|10|||
155493992|NCT02242942|561232718|FG002|Overall Study|Withdrawal by Subject|0|||
155493993|NCT02242942|561232716|FG000|Overall Study|On-going in Study|190|||
155493994|NCT02242942|561232717|FG001|Overall Study|On-going in Study|186|||
155493995|NCT02242942|561232718|FG002|Overall Study|On-going in Study|11|||
155493996|NCT04882085|561232719|FG000|Overall Study|Death|6|||
155493997|NCT04882085|561232720|FG001|Overall Study|Death|9|||
155493998|NCT04882085|561232719|FG000|Overall Study|Withdrawal by Subject|0|||
155493999|NCT04882085|561232720|FG001|Overall Study|Withdrawal by Subject|3|||
155494000|NCT04882085|561232719|FG000|Overall Study|Randomized not treated|1|||
155494001|NCT04882085|561232720|FG001|Overall Study|Randomized not treated|0|||
155494002|NCT04455620|561232724|FG000|Overall Study|Withdrawal by Subject|0|||
155494003|NCT04455620|561232725|FG001|Overall Study|Withdrawal by Subject|0|||
155400022|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
155400023|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
155400024|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
155400025|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
155400026|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
155400027|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
155400028|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
155400029|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400030|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
155400031|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400032|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400033|NCT00971178|560899443|FG000|Overall Study|Lost to Follow-up|2|||
155400034|NCT00971178|560899444|FG001|Overall Study|Lost to Follow-up|2|||
155400035|NCT00971178|560899445|FG002|Overall Study|Lost to Follow-up|2|||
155400036|NCT02161575|560899446|FG000|Overall Study|Protocol Violation|8|||
155400037|NCT02161575|560899446|FG000|Overall Study|Lack of Efficacy|1|||
155400038|NCT02161575|560899446|FG000|Overall Study|Adverse Event|2|||
155400039|NCT00326209|560899447|FG000|Overall Study|Adverse Event|28|||
155400040|NCT00326209|560899447|FG000|Overall Study|Withdrawal by Subject|22|||
155400041|NCT00326209|560899447|FG000|Overall Study|Lack of Efficacy|31|||
155400042|NCT00326209|560899447|FG000|Overall Study|Lost to Follow-up|18|||
155400043|NCT00326209|560899447|FG000|Overall Study|Participant non-compliant|6|||
155400044|NCT00326209|560899447|FG000|Overall Study|Sponsor closed study|173|||
155400045|NCT00326209|560899447|FG000|Overall Study|Prohibited medication use|1|||
155400046|NCT00326209|560899447|FG000|Overall Study|Violation of entry criteria|1|||
155400047|NCT00326209|560899447|FG000|Overall Study|Withdrawn in error|1|||
155400048|NCT00326209|560899447|FG000|Overall Study|Pregnancy|1|||
155400049|NCT00714285|560899448|FG000|Overall Study|Lost to Follow-up|0|||
155400050|NCT00714285|560899449|FG001|Overall Study|Lost to Follow-up|2|||
155400051|NCT00714285|560899450|FG002|Overall Study|Lost to Follow-up|0|||
155494004|NCT04455620|561232726|FG002|Overall Study|Withdrawal by Subject|2|||
155494005|NCT04455620|561232727|FG003|Overall Study|Withdrawal by Subject|0|||
155494006|NCT04455620|561232728|FG004|Overall Study|Withdrawal by Subject|1|||
155400052|NCT00714285|560899451|FG003|Overall Study|Lost to Follow-up|1|||
155400053|NCT00714285|560899448|FG000|Overall Study|Migrated/moved from study area|0|||
155494007|NCT04455620|561232724|FG000|Overall Study|Lost to Follow-up|0|||
155400054|NCT00714285|560899449|FG001|Overall Study|Migrated/moved from study area|1|||
155494008|NCT04455620|561232725|FG001|Overall Study|Lost to Follow-up|0|||
155494009|NCT04455620|561232726|FG002|Overall Study|Lost to Follow-up|1|||
155494010|NCT04455620|561232727|FG003|Overall Study|Lost to Follow-up|1|||
155494011|NCT04455620|561232728|FG004|Overall Study|Lost to Follow-up|0|||
155284721|NCT01511250|560474403|FG003|Overall Study|Sponsor/Investigator Decision|0|||
155284722|NCT01511250|560474404|FG004|Overall Study|Sponsor/Investigator Decision|0|||
155284723|NCT01511250|560474405|FG005|Overall Study|Sponsor/Investigator Decision|0|||
155284724|NCT01511250|560474406|FG006|Overall Study|Sponsor/Investigator Decision|0|||
155284725|NCT01511250|560474407|FG007|Overall Study|Sponsor/Investigator Decision|0|||
155284726|NCT01511250|560474408|FG008|Overall Study|Sponsor/Investigator Decision|0|||
155284727|NCT01511250|560474409|FG009|Overall Study|Sponsor/Investigator Decision|0|||
155284728|NCT01511250|560474400|FG000|Overall Study|Lost to Follow-up|7|||
155284729|NCT01511250|560474401|FG001|Overall Study|Lost to Follow-up|3|||
155284730|NCT01511250|560474402|FG002|Overall Study|Lost to Follow-up|3|||
155284731|NCT01511250|560474403|FG003|Overall Study|Lost to Follow-up|3|||
155284732|NCT01511250|560474404|FG004|Overall Study|Lost to Follow-up|0|||
155284733|NCT01511250|560474405|FG005|Overall Study|Lost to Follow-up|0|||
155284734|NCT01511250|560474406|FG006|Overall Study|Lost to Follow-up|2|||
155284735|NCT01511250|560474407|FG007|Overall Study|Lost to Follow-up|3|||
155284736|NCT01511250|560474408|FG008|Overall Study|Lost to Follow-up|13|||
155284737|NCT01511250|560474409|FG009|Overall Study|Lost to Follow-up|5|||
155284738|NCT01511250|560474400|FG000|Overall Study|Protocol Violation|0|||
155284739|NCT01511250|560474401|FG001|Overall Study|Protocol Violation|2|||
155284740|NCT01511250|560474402|FG002|Overall Study|Protocol Violation|1|||
155284741|NCT01511250|560474403|FG003|Overall Study|Protocol Violation|0|||
155284742|NCT01511250|560474404|FG004|Overall Study|Protocol Violation|0|||
155284743|NCT01511250|560474405|FG005|Overall Study|Protocol Violation|0|||
155284744|NCT01511250|560474406|FG006|Overall Study|Protocol Violation|0|||
155284745|NCT01511250|560474407|FG007|Overall Study|Protocol Violation|0|||
155284746|NCT01511250|560474408|FG008|Overall Study|Protocol Violation|0|||
155284747|NCT01511250|560474409|FG009|Overall Study|Protocol Violation|0|||
155284748|NCT01763047|560474410|FG000|Period 1|Test Article Not Available|4|||
155494012|NCT04455620|561232724|FG000|Overall Study|Death|1|||
155636725|NCT00127803|561761066|FG003|Overall Study|Adverse Event|0|||
155636726|NCT00127803|561761063|FG000|Overall Study|Withdrawal by Subject|1|||
155636727|NCT00127803|561761064|FG001|Overall Study|Withdrawal by Subject|0|||
155636728|NCT00127803|561761065|FG002|Overall Study|Withdrawal by Subject|0|||
155636729|NCT00127803|561761066|FG003|Overall Study|Withdrawal by Subject|0|||
155636730|NCT00127803|561761063|FG000|Overall Study|Lost to Follow-up|0|||
155636731|NCT00127803|561761064|FG001|Overall Study|Lost to Follow-up|0|||
155636732|NCT00127803|561761065|FG002|Overall Study|Lost to Follow-up|0|||
155636733|NCT00127803|561761066|FG003|Overall Study|Lost to Follow-up|1|||
155636734|NCT00858988|561761071|FG000|Analysis|Lactulose unable to be detected in urine|2|||
155636735|NCT00858988|561761072|FG001|Analysis|Lactulose unable to be detected in urine|1|||
155636736|NCT01020123|561761075|FG000|Main Period|Withdrawal by Subject|6|||
155636737|NCT01020123|561761076|FG001|Main Period|Withdrawal by Subject|5|||
155636738|NCT01020123|561761077|FG002|Main Period|Withdrawal by Subject|3|||
155636739|NCT01020123|561761078|FG003|Main Period|Withdrawal by Subject|1|||
155636740|NCT01020123|561761079|FG004|Main Period|Withdrawal by Subject|6|||
155636741|NCT01020123|561761080|FG005|Main Period|Withdrawal by Subject|3|||
155636742|NCT01020123|561761081|FG006|Main Period|Withdrawal by Subject|2|||
155636743|NCT01020123|561761075|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
155636744|NCT01020123|561761076|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
155636745|NCT01020123|561761077|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
155636746|NCT01020123|561761078|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
155636747|NCT01020123|561761079|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
155636748|NCT01020123|561761080|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
155636749|NCT01020123|561761081|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
155636750|NCT01020123|561761075|FG000|Main Period|Adverse Event|5|||
155636751|NCT01020123|561761076|FG001|Main Period|Adverse Event|2|||
155636752|NCT01020123|561761077|FG002|Main Period|Adverse Event|2|||
155636753|NCT01020123|561761078|FG003|Main Period|Adverse Event|1|||
155636754|NCT01020123|561761079|FG004|Main Period|Adverse Event|1|||
155636755|NCT01020123|561761080|FG005|Main Period|Adverse Event|2|||
155636756|NCT01020123|561761081|FG006|Main Period|Adverse Event|1|||
155636757|NCT01020123|561761075|FG000|Main Period|Protocol Violation|4|||
155636758|NCT01020123|561761076|FG001|Main Period|Protocol Violation|4|||
155636759|NCT01020123|561761077|FG002|Main Period|Protocol Violation|2|||
155636760|NCT01020123|561761078|FG003|Main Period|Protocol Violation|5|||
155636761|NCT01020123|561761079|FG004|Main Period|Protocol Violation|2|||
155636762|NCT01020123|561761080|FG005|Main Period|Protocol Violation|3|||
155636763|NCT01020123|561761081|FG006|Main Period|Protocol Violation|2|||
155636764|NCT01020123|561761075|FG000|Main Period|Lost to Follow-up|0|||
155636765|NCT01020123|561761076|FG001|Main Period|Lost to Follow-up|2|||
155494013|NCT04455620|561232725|FG001|Overall Study|Death|6|||
155636766|NCT01020123|561761077|FG002|Main Period|Lost to Follow-up|0|||
155636767|NCT01020123|561761078|FG003|Main Period|Lost to Follow-up|0|||
155636768|NCT01020123|561761079|FG004|Main Period|Lost to Follow-up|0|||
155636769|NCT01020123|561761080|FG005|Main Period|Lost to Follow-up|0|||
155636770|NCT01020123|561761081|FG006|Main Period|Lost to Follow-up|0|||
155636771|NCT01020123|561761075|FG000|Main Period|Unclasified|2|||
155636772|NCT01020123|561761076|FG001|Main Period|Unclasified|0|||
155636773|NCT01020123|561761077|FG002|Main Period|Unclasified|1|||
155284749|NCT01763047|560474411|FG001|Period 1|Test Article Not Available|1|||
155284750|NCT01763047|560474410|FG000|Period 1|Protocol Violation|4|||
155284751|NCT01763047|560474411|FG001|Period 1|Protocol Violation|4|||
155284752|NCT01763047|560474410|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
155284753|NCT01763047|560474411|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
155284754|NCT01763047|560474410|FG000|Period 1|Adverse Event|0|||
155284755|NCT01763047|560474411|FG001|Period 1|Adverse Event|1|||
155284756|NCT01763047|560474410|FG000|Period 1|Unsatisfactory Visual Response|0|||
155284757|NCT01763047|560474411|FG001|Period 1|Unsatisfactory Visual Response|3|||
155284758|NCT01763047|560474410|FG000|Period 1|Lens Power Not Available|0|||
155284759|NCT01763047|560474411|FG001|Period 1|Lens Power Not Available|1|||
155284760|NCT01763047|560474410|FG000|Period 1|Study Site office Closed|0|||
155284761|NCT01763047|560474411|FG001|Period 1|Study Site office Closed|1|||
155284762|NCT01763047|560474410|FG000|Period 2|Lens Discomfort|1|||
155284763|NCT01763047|560474411|FG001|Period 2|Lens Discomfort|0|||
155284764|NCT01763047|560474410|FG000|Period 2|No longer meets Eligibility Criteria|1|||
155284765|NCT01763047|560474411|FG001|Period 2|No longer meets Eligibility Criteria|0|||
155284766|NCT01763047|560474410|FG000|Period 2|Study Site office Closed|1|||
155284767|NCT01763047|560474411|FG001|Period 2|Study Site office Closed|1|||
155284768|NCT01763047|560474410|FG000|Period 2|Unsatisfactory Visual Response|1|||
155284769|NCT01763047|560474411|FG001|Period 2|Unsatisfactory Visual Response|1|||
155284770|NCT01763047|560474410|FG000|Period 2|Protocol Violation|0|||
155284771|NCT01763047|560474411|FG001|Period 2|Protocol Violation|2|||
155284772|NCT01763047|560474410|FG000|Period 2|Unsatisfactory lens Fitting|0|||
155284773|NCT01763047|560474411|FG001|Period 2|Unsatisfactory lens Fitting|1|||
155400055|NCT00714285|560899450|FG002|Overall Study|Migrated/moved from study area|0|||
155400056|NCT00714285|560899451|FG003|Overall Study|Migrated/moved from study area|0|||
155400057|NCT01131676|560899456|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
155400058|NCT01131676|560899457|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
155400059|NCT01131676|560899458|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
155400060|NCT01131676|560899456|FG000|Discontinuation From Treatment|Not treated|4|||
155400061|NCT01131676|560899457|FG001|Discontinuation From Treatment|Not treated|2|||
155400062|NCT01131676|560899458|FG002|Discontinuation From Treatment|Not treated|2|||
155636774|NCT01020123|561761078|FG003|Main Period|Unclasified|0|||
155636775|NCT01020123|561761079|FG004|Main Period|Unclasified|1|||
155636776|NCT01020123|561761080|FG005|Main Period|Unclasified|3|||
155636777|NCT01020123|561761081|FG006|Main Period|Unclasified|6|||
155636778|NCT01020123|561761075|FG000|Extention Period|Withdrawal by Subject|2|||
155636779|NCT01020123|561761076|FG001|Extention Period|Withdrawal by Subject|1|||
155636780|NCT01020123|561761077|FG002|Extention Period|Withdrawal by Subject|1|||
155636781|NCT01020123|561761078|FG003|Extention Period|Withdrawal by Subject|0|||
155636782|NCT01020123|561761079|FG004|Extention Period|Withdrawal by Subject|0|||
155636783|NCT01020123|561761080|FG005|Extention Period|Withdrawal by Subject|0|||
155636784|NCT01020123|561761081|FG006|Extention Period|Withdrawal by Subject|0|||
155636785|NCT01020123|561761075|FG000|Extention Period|Adverse Event|0|||
155636786|NCT01020123|561761076|FG001|Extention Period|Adverse Event|0|||
155636787|NCT01020123|561761077|FG002|Extention Period|Adverse Event|0|||
155636788|NCT01020123|561761078|FG003|Extention Period|Adverse Event|1|||
155636789|NCT01020123|561761079|FG004|Extention Period|Adverse Event|0|||
155636790|NCT01020123|561761080|FG005|Extention Period|Adverse Event|0|||
155636791|NCT01020123|561761081|FG006|Extention Period|Adverse Event|0|||
155636792|NCT01020123|561761075|FG000|Extention Period|Protocol Violation|1|||
155636793|NCT01020123|561761076|FG001|Extention Period|Protocol Violation|1|||
155636794|NCT01020123|561761077|FG002|Extention Period|Protocol Violation|1|||
155636795|NCT01020123|561761078|FG003|Extention Period|Protocol Violation|0|||
155636796|NCT01020123|561761079|FG004|Extention Period|Protocol Violation|0|||
155636797|NCT01020123|561761080|FG005|Extention Period|Protocol Violation|0|||
155636798|NCT01020123|561761081|FG006|Extention Period|Protocol Violation|1|||
155636799|NCT01020123|561761075|FG000|Extention Period|Lost to Follow-up|0|||
155636800|NCT01020123|561761076|FG001|Extention Period|Lost to Follow-up|0|||
155636801|NCT01020123|561761077|FG002|Extention Period|Lost to Follow-up|0|||
155636802|NCT01020123|561761078|FG003|Extention Period|Lost to Follow-up|0|||
155636803|NCT01020123|561761079|FG004|Extention Period|Lost to Follow-up|0|||
155636804|NCT01020123|561761080|FG005|Extention Period|Lost to Follow-up|2|||
155636805|NCT01020123|561761081|FG006|Extention Period|Lost to Follow-up|0|||
155636806|NCT01349595|561761082|FG000|Overall Study|Lack of funding|2|||
155636807|NCT01349595|561761083|FG001|Overall Study|Lack of funding|2|||
155636808|NCT03479905|561761086|FG000|Overall Study|Other airway method used|4|||
155284774|NCT01941316|560474417|FG000|Overall Study|Adverse Event|0|||
155284775|NCT01941316|560474418|FG001|Overall Study|Adverse Event|1|||
155284776|NCT01941316|560474419|FG002|Overall Study|Adverse Event|0|||
155284777|NCT01941316|560474420|FG003|Overall Study|Adverse Event|7|||
155636809|NCT03479905|561761087|FG001|Overall Study|Other airway method used|5|||
155636810|NCT03479905|561761088|FG002|Overall Study|Other airway method used|5|||
155636811|NCT00862992|561761089|FG000|Overall Study|Adverse Event|2|||
155636812|NCT00862992|561761090|FG001|Overall Study|Adverse Event|1|||
155636813|NCT00862992|561761091|FG002|Overall Study|Adverse Event|1|||
155400063|NCT01131676|560899456|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
155400064|NCT01131676|560899457|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
155400065|NCT01131676|560899458|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
155400066|NCT01131676|560899456|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
155400067|NCT01131676|560899457|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
155400068|NCT01131676|560899458|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
155400069|NCT01131676|560899456|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
155400070|NCT01131676|560899457|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
155400071|NCT01131676|560899458|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
155400072|NCT01131676|560899456|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
155400073|NCT01131676|560899457|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
155400074|NCT01131676|560899458|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
155400075|NCT01131676|560899456|FG000|Discontinuation From Treatment|Other than those specified|162|||
155400076|NCT01131676|560899457|FG001|Discontinuation From Treatment|Other than those specified|142|||
155400077|NCT01131676|560899458|FG002|Discontinuation From Treatment|Other than those specified|125|||
155400078|NCT01131676|560899456|FG000|Discontinuation From Treatment|Adverse Event|303|||
155400079|NCT01131676|560899457|FG001|Discontinuation From Treatment|Adverse Event|267|||
155400080|NCT01131676|560899458|FG002|Discontinuation From Treatment|Adverse Event|273|||
155400081|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
155400082|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
155400083|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
155400084|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
155400085|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
155400086|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
155400087|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
155400088|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
155400089|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
155400090|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
155400091|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
155400092|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
155400093|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
155400094|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
155400095|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
155400096|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
155400097|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
155400098|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
155400099|NCT01111851|560899459|FG000|Overall Study|All planned PET scans were not obtained.|2|||
155400100|NCT01111851|560899460|FG001|Overall Study|All planned PET scans were not obtained.|0|||
155400101|NCT01961349|560899461|FG000|Overall Study|Withdrawal by Subject|1|||
155400102|NCT01961349|560899462|FG001|Overall Study|Withdrawal by Subject|4|||
155400103|NCT01961349|560899463|FG002|Overall Study|Withdrawal by Subject|0|||
155400104|NCT01961349|560899461|FG000|Overall Study|Adverse Event|0|||
155400105|NCT01961349|560899462|FG001|Overall Study|Adverse Event|0|||
155400106|NCT01961349|560899463|FG002|Overall Study|Adverse Event|1|||
155400107|NCT01961349|560899461|FG000|Overall Study|registration error, personal reason etc|2|||
155400108|NCT01961349|560899462|FG001|Overall Study|registration error, personal reason etc|2|||
155400109|NCT01961349|560899463|FG002|Overall Study|registration error, personal reason etc|1|||
155400110|NCT05525689|560899465|FG000|Overall Study|Lost to Follow-up|1|||
155636814|NCT00862992|561761089|FG000|Overall Study|Physician Decision|1|||
155636815|NCT00862992|561761090|FG001|Overall Study|Physician Decision|0|||
155636816|NCT00862992|561761091|FG002|Overall Study|Physician Decision|0|||
155636817|NCT00862992|561761089|FG000|Overall Study|Withdrawal by Subject|0|||
155636818|NCT00862992|561761090|FG001|Overall Study|Withdrawal by Subject|0|||
155636819|NCT00862992|561761091|FG002|Overall Study|Withdrawal by Subject|2|||
155636820|NCT00720759|561761092|FG000|Overall Study|Lost to Follow-up|0|||
155636821|NCT00720759|561761093|FG001|Overall Study|Lost to Follow-up|1|||
155636822|NCT00720759|561761094|FG002|Overall Study|Lost to Follow-up|1|||
155636823|NCT00720759|561761095|FG003|Overall Study|Lost to Follow-up|0|||
155636824|NCT02318940|561761096|FG000|Overall Study|lost the record|1|||
155636825|NCT02318940|561761097|FG001|Overall Study|lost the record|0|||
155636826|NCT01706328|561761098|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
155636827|NCT01706328|561761099|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155636828|NCT01706328|561761100|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155636829|NCT01706328|561761098|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
155494014|NCT04455620|561232726|FG002|Overall Study|Death|20|||
155494015|NCT04455620|561232727|FG003|Overall Study|Death|1|||
155494016|NCT04455620|561232728|FG004|Overall Study|Death|7|||
155494017|NCT04455620|561232724|FG000|Overall Study|Study Termination|0|||
155494018|NCT04455620|561232725|FG001|Overall Study|Study Termination|2|||
155494019|NCT04455620|561232726|FG002|Overall Study|Study Termination|1|||
155494020|NCT04455620|561232727|FG003|Overall Study|Study Termination|0|||
155494021|NCT04455620|561232728|FG004|Overall Study|Study Termination|6|||
155494022|NCT03792633|561232729|FG000|Overall Study|Alternative Treatment|17|||
155494023|NCT03792633|561232730|FG001|Overall Study|Alternative Treatment|19|||
155494024|NCT03792633|561232729|FG000|Overall Study|Death|2|||
155494025|NCT03792633|561232730|FG001|Overall Study|Death|0|||
155494026|NCT03792633|561232729|FG000|Overall Study|Disease progression|8|||
155494027|NCT03792633|561232730|FG001|Overall Study|Disease progression|9|||
155494028|NCT03792633|561232729|FG000|Overall Study|Lost to Follow-up|1|||
155494029|NCT03792633|561232730|FG001|Overall Study|Lost to Follow-up|1|||
155494030|NCT03792633|561232729|FG000|Overall Study|Screen fail|1|||
155494031|NCT03792633|561232730|FG001|Overall Study|Screen fail|0|||
155494032|NCT03792633|561232729|FG000|Overall Study|Second malignancy|0|||
155494033|NCT03792633|561232730|FG001|Overall Study|Second malignancy|1|||
155494034|NCT00145119|561232731|FG000|Overall Study|Death|45|||
155494035|NCT05681715|561232732|FG000|Training Period (6-weeks)|Adverse Event|3|||
155494036|NCT05681715|561232733|FG001|Training Period (6-weeks)|Adverse Event|0|||
155494037|NCT05681715|561232734|FG002|Training Period (6-weeks)|Adverse Event|0|||
155494038|NCT05681715|561232732|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
155494039|NCT05681715|561232733|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
155494040|NCT05681715|561232734|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
155494041|NCT05681715|561232732|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
155494042|NCT05681715|561232733|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
155494043|NCT05681715|561232734|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
155494044|NCT05681715|561232732|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
155494045|NCT05681715|561232733|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
155494046|NCT05681715|561232734|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
155494047|NCT05681715|561232732|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
155494048|NCT05681715|561232733|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
155494049|NCT05681715|561232734|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
155494050|NCT05681715|561232732|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
155400111|NCT05525689|560899466|FG001|Overall Study|Lost to Follow-up|0|||
155400112|NCT01075412|560899475|FG000|Overall Study|Withdrawal by Subject|0|||
155400113|NCT01075412|560899476|FG001|Overall Study|Withdrawal by Subject|1|||
155400114|NCT01854645|560899483|FG000|Overall Study|Protocol-Specified Criteria|13|||
155400115|NCT01854645|560899484|FG001|Overall Study|Protocol-Specified Criteria|10|||
155400116|NCT01854645|560899485|FG002|Overall Study|Protocol-Specified Criteria|8|||
155400117|NCT01854645|560899486|FG003|Overall Study|Protocol-Specified Criteria|5|||
155400118|NCT01854645|560899487|FG004|Overall Study|Protocol-Specified Criteria|7|||
155400119|NCT01854645|560899483|FG000|Overall Study|Administrative Reasons / Missing|0|||
155400120|NCT01854645|560899484|FG001|Overall Study|Administrative Reasons / Missing|0|||
155400121|NCT01854645|560899485|FG002|Overall Study|Administrative Reasons / Missing|0|||
155400122|NCT01854645|560899486|FG003|Overall Study|Administrative Reasons / Missing|1|||
155400123|NCT01854645|560899487|FG004|Overall Study|Administrative Reasons / Missing|1|||
155400124|NCT01854645|560899483|FG000|Overall Study|Protocol Violation|3|||
155400125|NCT01854645|560899484|FG001|Overall Study|Protocol Violation|0|||
155400126|NCT01854645|560899485|FG002|Overall Study|Protocol Violation|5|||
155400127|NCT01854645|560899486|FG003|Overall Study|Protocol Violation|4|||
155400128|NCT01854645|560899487|FG004|Overall Study|Protocol Violation|1|||
155400129|NCT01854645|560899483|FG000|Overall Study|Lost to Follow-up|10|||
155400130|NCT01854645|560899484|FG001|Overall Study|Lost to Follow-up|7|||
155400131|NCT01854645|560899485|FG002|Overall Study|Lost to Follow-up|8|||
155400132|NCT01854645|560899486|FG003|Overall Study|Lost to Follow-up|5|||
155400133|NCT01854645|560899487|FG004|Overall Study|Lost to Follow-up|0|||
155400134|NCT01854645|560899483|FG000|Overall Study|Physician Decision|1|||
155400135|NCT01854645|560899484|FG001|Overall Study|Physician Decision|5|||
155400136|NCT01854645|560899485|FG002|Overall Study|Physician Decision|3|||
155400137|NCT01854645|560899486|FG003|Overall Study|Physician Decision|3|||
155400138|NCT01854645|560899487|FG004|Overall Study|Physician Decision|7|||
155400139|NCT01854645|560899483|FG000|Overall Study|Withdrawal by Subject|31|||
155400140|NCT01854645|560899484|FG001|Overall Study|Withdrawal by Subject|41|||
155400141|NCT01854645|560899485|FG002|Overall Study|Withdrawal by Subject|30|||
155400142|NCT01854645|560899486|FG003|Overall Study|Withdrawal by Subject|21|||
155400143|NCT01854645|560899487|FG004|Overall Study|Withdrawal by Subject|24|||
155400144|NCT01854645|560899483|FG000|Overall Study|Lack of Efficacy|7|||
155400145|NCT01854645|560899484|FG001|Overall Study|Lack of Efficacy|12|||
155494051|NCT05681715|561232733|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
155494052|NCT05681715|561232734|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
155494053|NCT05681715|561232732|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
155494054|NCT05681715|561232733|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
155494055|NCT05681715|561232734|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
155494056|NCT05681715|561232732|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
155494057|NCT05681715|561232733|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
155494058|NCT05681715|561232734|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
155494059|NCT05455684|561232735|FG000|Overall Study|Withdrawal by Subject|7|||
155494060|NCT05455684|561232736|FG001|Overall Study|Withdrawal by Subject|4|||
155494061|NCT05455684|561232735|FG000|Overall Study|Lost to Follow-up|3|||
155494062|NCT05455684|561232736|FG001|Overall Study|Lost to Follow-up|3|||
155494063|NCT05455684|561232735|FG000|Overall Study|Adverse Event|2|||
155494064|NCT05455684|561232736|FG001|Overall Study|Adverse Event|3|||
155494065|NCT05455684|561232735|FG000|Overall Study|Protocol Violation|1|||
155494066|NCT05455684|561232736|FG001|Overall Study|Protocol Violation|1|||
155494067|NCT05455684|561232735|FG000|Overall Study|Non-Compliant with study drug|0|||
155494068|NCT05455684|561232736|FG001|Overall Study|Non-Compliant with study drug|1|||
155494069|NCT05455684|561232735|FG000|Overall Study|Other|1|||
155494070|NCT05455684|561232736|FG001|Overall Study|Other|2|||
155494071|NCT05455684|561232735|FG000|Overall Study|Randomized but not treated|1|||
155494072|NCT05455684|561232736|FG001|Overall Study|Randomized but not treated|0|||
155494073|NCT05204563|561232737|FG000|Overall Study|Other than Specified|2|||
155494074|NCT05204563|561232738|FG001|Overall Study|Other than Specified|1|||
155494075|NCT05204563|561232737|FG000|Overall Study|Death|18|||
155494076|NCT05204563|561232738|FG001|Overall Study|Death|4|||
155494077|NCT05204563|561232737|FG000|Overall Study|Lost to Follow-up|6|||
155494078|NCT05204563|561232738|FG001|Overall Study|Lost to Follow-up|3|||
155494079|NCT05204563|561232737|FG000|Overall Study|Withdrawal by Subject|12|||
155494080|NCT05204563|561232738|FG001|Overall Study|Withdrawal by Subject|3|||
155494081|NCT05204563|561232737|FG000|Overall Study|Enrolled, Not Treated|1|||
155494082|NCT05204563|561232738|FG001|Overall Study|Enrolled, Not Treated|0|||
155494083|NCT04411641|561232739|FG000|DB Period|Other|7|||
155494084|NCT04411641|561232740|FG001|DB Period|Other|27|||
155494085|NCT04411641|561232741|FG002|DB Period|Other|0|||
155494086|NCT04411641|561232742|FG003|DB Period|Other|0|||
155494087|NCT04411641|561232739|FG000|DB Period|Withdrawal by Subject|67|||
155494088|NCT04411641|561232740|FG001|DB Period|Withdrawal by Subject|122|||
155494089|NCT04411641|561232741|FG002|DB Period|Withdrawal by Subject|0|||
155494090|NCT04411641|561232742|FG003|DB Period|Withdrawal by Subject|0|||
155494091|NCT04411641|561232739|FG000|DB Period|Progressive disease|76|||
155494092|NCT04411641|561232740|FG001|DB Period|Progressive disease|116|||
155494093|NCT04411641|561232741|FG002|DB Period|Progressive disease|0|||
155494094|NCT04411641|561232742|FG003|DB Period|Progressive disease|0|||
155494095|NCT04411641|561232739|FG000|DB Period|Poor compliance to protocol|1|||
155494096|NCT04411641|561232740|FG001|DB Period|Poor compliance to protocol|5|||
155494097|NCT04411641|561232741|FG002|DB Period|Poor compliance to protocol|0|||
155494098|NCT04411641|561232742|FG003|DB Period|Poor compliance to protocol|0|||
155494099|NCT04411641|561232739|FG000|DB Period|Lack of Efficacy|19|||
155494100|NCT04411641|561232740|FG001|DB Period|Lack of Efficacy|19|||
155494101|NCT04411641|561232741|FG002|DB Period|Lack of Efficacy|0|||
155494102|NCT04411641|561232742|FG003|DB Period|Lack of Efficacy|0|||
155494103|NCT04411641|561232739|FG000|DB Period|Adverse Event|13|||
155494104|NCT04411641|561232740|FG001|DB Period|Adverse Event|29|||
155494105|NCT04411641|561232741|FG002|DB Period|Adverse Event|0|||
155494106|NCT04411641|561232742|FG003|DB Period|Adverse Event|0|||
155494107|NCT04411641|561232739|FG000|DB Period|Randomized and not treated|2|||
155494108|NCT04411641|561232740|FG001|DB Period|Randomized and not treated|2|||
155494109|NCT04411641|561232741|FG002|DB Period|Randomized and not treated|0|||
155494110|NCT04411641|561232742|FG003|DB Period|Randomized and not treated|0|||
155494111|NCT04411641|561232739|FG000|OL|Withdrawal by Subject|0|||
155494112|NCT04411641|561232740|FG001|OL|Withdrawal by Subject|0|||
155494113|NCT04411641|561232741|FG002|OL|Withdrawal by Subject|6|||
155494114|NCT04411641|561232742|FG003|OL|Withdrawal by Subject|17|||
155494115|NCT04411641|561232739|FG000|OL|Progressive disease|0|||
155494116|NCT04411641|561232740|FG001|OL|Progressive disease|0|||
155494117|NCT04411641|561232741|FG002|OL|Progressive disease|1|||
155494118|NCT04411641|561232742|FG003|OL|Progressive disease|2|||
155494119|NCT04411641|561232739|FG000|OL|Poor compliance to protocol|0|||
155494120|NCT04411641|561232740|FG001|OL|Poor compliance to protocol|0|||
155741426|NCT04784442|562154848|FG002|Overall Study|Protocol Violation|0|||
155494121|NCT04411641|561232741|FG002|OL|Poor compliance to protocol|1|||
155494122|NCT04411641|561232742|FG003|OL|Poor compliance to protocol|0|||
155494123|NCT04411641|561232739|FG000|OL|Adverse Event|0|||
155494124|NCT04411641|561232740|FG001|OL|Adverse Event|0|||
155494125|NCT04411641|561232741|FG002|OL|Adverse Event|1|||
155494126|NCT04411641|561232742|FG003|OL|Adverse Event|0|||
155494127|NCT04411641|561232739|FG000|OL|Other|0|||
155494128|NCT04411641|561232740|FG001|OL|Other|0|||
155400146|NCT01854645|560899485|FG002|Overall Study|Lack of Efficacy|9|||
155400147|NCT01854645|560899486|FG003|Overall Study|Lack of Efficacy|3|||
155400148|NCT01854645|560899487|FG004|Overall Study|Lack of Efficacy|9|||
155400149|NCT01854645|560899483|FG000|Overall Study|Adverse Event|33|||
155400150|NCT01854645|560899484|FG001|Overall Study|Adverse Event|31|||
155400151|NCT01854645|560899485|FG002|Overall Study|Adverse Event|19|||
155400152|NCT01854645|560899486|FG003|Overall Study|Adverse Event|20|||
155400153|NCT01854645|560899487|FG004|Overall Study|Adverse Event|11|||
155400154|NCT01817751|560899493|FG000|Overall Study|Physician Decision|1|||
155400155|NCT00555477|560899494|FG000|Overall Study|Adverse Event|0|||
155636830|NCT01706328|561761099|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155636831|NCT01706328|561761100|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155636832|NCT01706328|561761098|FG000|2-week Run-in Period|Physician Decision|4|||
155636833|NCT01706328|561761099|FG001|2-week Run-in Period|Physician Decision|0|||
155636834|NCT01706328|561761100|FG002|2-week Run-in Period|Physician Decision|0|||
155636835|NCT01706328|561761098|FG000|2-week Run-in Period|Adverse Event|4|||
155636836|NCT01706328|561761099|FG001|2-week Run-in Period|Adverse Event|0|||
155636837|NCT01706328|561761100|FG002|2-week Run-in Period|Adverse Event|0|||
155636838|NCT01706328|561761098|FG000|2-week Run-in Period|Lost to Follow-up|2|||
155636839|NCT01706328|561761099|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155636840|NCT01706328|561761100|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155636841|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
155636842|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
155636843|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
155636844|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
155636845|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
155636846|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
155636847|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
155636848|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
155636849|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
155636850|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
155636851|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
155636852|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
155636853|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
155636854|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
155636855|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
155636856|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
155636857|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
155636858|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
155636859|NCT01706328|561761098|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155636860|NCT01706328|561761099|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
155636861|NCT01706328|561761100|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
155636862|NCT01157845|561761109|FG000|Overall Study|Lost to Follow-up|5|||
155636863|NCT01157845|561761109|FG000|Overall Study|Withdrawal by Subject|12|||
155636864|NCT01157845|561761109|FG000|Overall Study|Physician Decision|3|||
155636865|NCT01157845|561761109|FG000|Overall Study|Protocol Violation|13|||
155636866|NCT01157845|561761109|FG000|Overall Study|Study was ended|1|||
155636867|NCT01157845|561761109|FG000|Overall Study|Device malfunction|1|||
155636868|NCT03311555|561761110|FG000|Overall Study|Adverse Event|1|||
155636869|NCT04609553|561762823|FG000|Overall Study|Lost to Follow-up|27|||
155636870|NCT04609553|561762824|FG001|Overall Study|Lost to Follow-up|31|||
155636871|NCT04609553|561762825|FG002|Overall Study|Lost to Follow-up|24|||
155636872|NCT04609553|561762823|FG000|Overall Study|Discontinued|12|||
155636873|NCT04609553|561762824|FG001|Overall Study|Discontinued|10|||
155636874|NCT04609553|561762825|FG002|Overall Study|Discontinued|9|||
155636875|NCT02239328|561762829|FG000|Overall Study|Benign disease noted at time of surgery|6|||
155636876|NCT02239328|561762829|FG000|Overall Study|Equipment or website malfunction|2|||
155636877|NCT00460798|561762831|FG000|Overall Study|Death|59|||
155636878|NCT00460798|561762831|FG000|Overall Study|Adverse Event|27|||
155636879|NCT00460798|561762831|FG000|Overall Study|Lost to Follow-up|19|||
155636880|NCT00460798|561762831|FG000|Overall Study|Progressive Disease|99|||
155636881|NCT00460798|561762831|FG000|Overall Study|Other|27|||
155636882|NCT00460798|561762831|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
155636883|NCT00460798|561762831|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
155636884|NCT03881371|561762836|FG000|Overall Study|Adverse Event|8|||
155636885|NCT03881371|561762837|FG001|Overall Study|Adverse Event|9|||
155636886|NCT03881371|561762836|FG000|Overall Study|Death|1|||
155636887|NCT03881371|561762837|FG001|Overall Study|Death|0|||
155636888|NCT03881371|561762836|FG000|Overall Study|Lost to Follow-up|1|||
155636889|NCT03881371|561762837|FG001|Overall Study|Lost to Follow-up|0|||
155400156|NCT00555477|560899495|FG001|Overall Study|Adverse Event|9|||
155400157|NCT00555477|560899494|FG000|Overall Study|Withdrawal by Subject|1|||
155400158|NCT00555477|560899495|FG001|Overall Study|Withdrawal by Subject|2|||
155400159|NCT00555477|560899494|FG000|Overall Study|Physician Decision|1|||
155636890|NCT03881371|561762836|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155636891|NCT03881371|561762837|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155636892|NCT03881371|561762836|FG000|Overall Study|Physician Decision|3|||
155636893|NCT03881371|561762837|FG001|Overall Study|Physician Decision|3|||
155636894|NCT03881371|561762836|FG000|Overall Study|Withdrawal by Subject|2|||
155636895|NCT03881371|561762837|FG001|Overall Study|Withdrawal by Subject|10|||
155636896|NCT03881371|561762836|FG000|Overall Study|Discontinuation from Study|1|||
155636897|NCT03881371|561762837|FG001|Overall Study|Discontinuation from Study|0|||
155636898|NCT01104766|561762841|FG000|Overall Study|Did not meet inc/exc criteria|1|||
155636899|NCT01104766|561762842|FG001|Overall Study|Did not meet inc/exc criteria|0|||
155636900|NCT01104766|561762843|FG002|Overall Study|Did not meet inc/exc criteria|0|||
155636901|NCT01104766|561762844|FG003|Overall Study|Did not meet inc/exc criteria|0|||
155636902|NCT01104766|561762841|FG000|Overall Study|Adverse Event|17|||
155636903|NCT01104766|561762842|FG001|Overall Study|Adverse Event|15|||
155636904|NCT01104766|561762843|FG002|Overall Study|Adverse Event|20|||
155636905|NCT01104766|561762844|FG003|Overall Study|Adverse Event|14|||
155636906|NCT01104766|561762841|FG000|Overall Study|Lack of Efficacy|20|||
155636907|NCT01104766|561762842|FG001|Overall Study|Lack of Efficacy|15|||
155636908|NCT01104766|561762843|FG002|Overall Study|Lack of Efficacy|14|||
155636909|NCT01104766|561762844|FG003|Overall Study|Lack of Efficacy|8|||
155636910|NCT01104766|561762841|FG000|Overall Study|Protocol Violation|2|||
155636911|NCT01104766|561762842|FG001|Overall Study|Protocol Violation|0|||
155636912|NCT01104766|561762843|FG002|Overall Study|Protocol Violation|0|||
155636913|NCT01104766|561762844|FG003|Overall Study|Protocol Violation|0|||
155636914|NCT01104766|561762841|FG000|Overall Study|Withdrawal by Subject|17|||
155636915|NCT01104766|561762842|FG001|Overall Study|Withdrawal by Subject|19|||
155636916|NCT01104766|561762843|FG002|Overall Study|Withdrawal by Subject|25|||
155636917|NCT01104766|561762844|FG003|Overall Study|Withdrawal by Subject|15|||
155636918|NCT01104766|561762841|FG000|Overall Study|Lost to Follow-up|1|||
155636919|NCT01104766|561762842|FG001|Overall Study|Lost to Follow-up|2|||
155636920|NCT01104766|561762843|FG002|Overall Study|Lost to Follow-up|1|||
155636921|NCT01104766|561762844|FG003|Overall Study|Lost to Follow-up|1|||
155636922|NCT01756235|561762845|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
155636923|NCT05376358|561762846|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
155636924|NCT05376358|561762847|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
155636925|NCT05376358|561762846|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
155636926|NCT05376358|561762847|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
155636927|NCT05376358|561762846|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
155636928|NCT05376358|561762847|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
155636929|NCT05376358|561762846|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
155636930|NCT05376358|561762847|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
155636931|NCT05376358|561762846|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
155636932|NCT05376358|561762847|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
155636933|NCT05376358|561762846|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
155636934|NCT05376358|561762847|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
155636935|NCT04225832|561762848|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
155636936|NCT04225832|561762849|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
155636937|NCT04225832|561762848|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
155636938|NCT04225832|561762849|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
155636939|NCT00311168|561762850|FG000|First Intervention|Withdrawal by Subject|2|||
155636940|NCT00311168|561762851|FG001|First Intervention|Withdrawal by Subject|2|||
155636941|NCT00311168|561762850|FG000|First Intervention|Lost to Follow-up|1|||
155636942|NCT00311168|561762851|FG001|First Intervention|Lost to Follow-up|1|||
155636943|NCT00311168|561762850|FG000|First Intervention|Protocol Violation|1|||
155636944|NCT00311168|561762851|FG001|First Intervention|Protocol Violation|1|||
155636945|NCT00311168|561762850|FG000|First Intervention|Adverse Event|1|||
155636946|NCT00311168|561762851|FG001|First Intervention|Adverse Event|0|||
155636947|NCT00311168|561762850|FG000|First Intervention|Other|2|||
155636948|NCT00311168|561762851|FG001|First Intervention|Other|2|||
155636949|NCT00311168|561762850|FG000|Second Intervention|Lost to Follow-up|9|||
155636950|NCT00311168|561762851|FG001|Second Intervention|Lost to Follow-up|2|||
155636951|NCT00311168|561762850|FG000|Second Intervention|Withdrawal by Subject|0|||
155636952|NCT00311168|561762851|FG001|Second Intervention|Withdrawal by Subject|1|||
155636953|NCT00311168|561762850|FG000|Second Intervention|Other|1|||
155636954|NCT00311168|561762851|FG001|Second Intervention|Other|1|||
155636955|NCT06001021|561762854|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
155636956|NCT06001021|561762855|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155636957|NCT06001021|561762856|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155636958|NCT06001021|561762857|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
155400160|NCT00555477|560899495|FG001|Overall Study|Physician Decision|2|||
155400161|NCT00397033|560899496|FG000|Overall Study|Adverse Event|7|||
155400162|NCT00397033|560899497|FG001|Overall Study|Adverse Event|10|||
155400163|NCT00397033|560899498|FG002|Overall Study|Adverse Event|4|||
155400164|NCT00397033|560899496|FG000|Overall Study|Lack of Efficacy|22|||
155400165|NCT00397033|560899497|FG001|Overall Study|Lack of Efficacy|12|||
155400166|NCT00397033|560899498|FG002|Overall Study|Lack of Efficacy|9|||
155400167|NCT00397033|560899496|FG000|Overall Study|Lost to Follow-up|3|||
155400168|NCT00397033|560899497|FG001|Overall Study|Lost to Follow-up|3|||
155400169|NCT00397033|560899498|FG002|Overall Study|Lost to Follow-up|3|||
155400170|NCT00397033|560899496|FG000|Overall Study|Withdrawal by Subject|12|||
155400171|NCT00397033|560899497|FG001|Overall Study|Withdrawal by Subject|7|||
155400172|NCT00397033|560899498|FG002|Overall Study|Withdrawal by Subject|5|||
155400173|NCT00397033|560899496|FG000|Overall Study|Other|0|||
155400174|NCT00397033|560899497|FG001|Overall Study|Other|5|||
155400175|NCT00397033|560899498|FG002|Overall Study|Other|2|||
155400176|NCT03519867|560899499|FG000|Overall Study|Adverse Event|1|||
155400177|NCT03519867|560899500|FG001|Overall Study|Adverse Event|1|||
155400178|NCT03519867|560899501|FG002|Overall Study|Adverse Event|0|||
155400179|NCT03519867|560899502|FG003|Overall Study|Adverse Event|0|||
155400180|NCT03519867|560899503|FG004|Overall Study|Adverse Event|0|||
155400181|NCT03519867|560899504|FG005|Overall Study|Adverse Event|0|||
155400182|NCT03519867|560899505|FG006|Overall Study|Adverse Event|0|||
155400183|NCT03519867|560899506|FG007|Overall Study|Adverse Event|0|||
155400184|NCT03519867|560899507|FG008|Overall Study|Adverse Event|0|||
155400185|NCT03519867|560899508|FG009|Overall Study|Adverse Event|0|||
155400186|NCT03519867|560899499|FG000|Overall Study|Protocol Violation|0|||
155400187|NCT03519867|560899500|FG001|Overall Study|Protocol Violation|0|||
155400188|NCT03519867|560899501|FG002|Overall Study|Protocol Violation|0|||
155400189|NCT03519867|560899502|FG003|Overall Study|Protocol Violation|0|||
155400190|NCT03519867|560899503|FG004|Overall Study|Protocol Violation|0|||
155400191|NCT03519867|560899504|FG005|Overall Study|Protocol Violation|1|||
155400192|NCT03519867|560899505|FG006|Overall Study|Protocol Violation|0|||
155400193|NCT03519867|560899506|FG007|Overall Study|Protocol Violation|0|||
155400194|NCT03519867|560899507|FG008|Overall Study|Protocol Violation|0|||
155400195|NCT03519867|560899508|FG009|Overall Study|Protocol Violation|0|||
155400196|NCT03519867|560899499|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400197|NCT03519867|560899500|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400198|NCT03519867|560899501|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400199|NCT03519867|560899502|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400200|NCT03519867|560899503|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400201|NCT03519867|560899504|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400202|NCT03519867|560899505|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
155400203|NCT03519867|560899506|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400204|NCT03519867|560899507|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400205|NCT03519867|560899508|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400206|NCT03519867|560899499|FG000|Overall Study|Admin. of other reversal agent|1|||
155400207|NCT03519867|560899500|FG001|Overall Study|Admin. of other reversal agent|1|||
155400208|NCT03519867|560899501|FG002|Overall Study|Admin. of other reversal agent|0|||
155400209|NCT03519867|560899502|FG003|Overall Study|Admin. of other reversal agent|0|||
155400210|NCT03519867|560899503|FG004|Overall Study|Admin. of other reversal agent|0|||
155636959|NCT06001021|561762858|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
155636960|NCT06001021|561762859|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
155636961|NCT06001021|561762860|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155636962|NCT06001021|561762854|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
155636963|NCT06001021|561762855|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155636964|NCT06001021|561762856|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155636965|NCT06001021|561762857|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
155636966|NCT06001021|561762858|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
155636967|NCT06001021|561762859|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155636968|NCT06001021|561762860|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155400211|NCT03519867|560899504|FG005|Overall Study|Admin. of other reversal agent|1|||
155400212|NCT03519867|560899505|FG006|Overall Study|Admin. of other reversal agent|0|||
155400213|NCT03519867|560899506|FG007|Overall Study|Admin. of other reversal agent|0|||
155400214|NCT03519867|560899507|FG008|Overall Study|Admin. of other reversal agent|0|||
155400215|NCT03519867|560899508|FG009|Overall Study|Admin. of other reversal agent|0|||
155400216|NCT03519867|560899499|FG000|Overall Study|Reason not provided|1|||
155400217|NCT03519867|560899500|FG001|Overall Study|Reason not provided|1|||
155400218|NCT03519867|560899501|FG002|Overall Study|Reason not provided|1|||
155400219|NCT03519867|560899502|FG003|Overall Study|Reason not provided|1|||
155400220|NCT03519867|560899503|FG004|Overall Study|Reason not provided|0|||
155400221|NCT03519867|560899504|FG005|Overall Study|Reason not provided|1|||
155400222|NCT03519867|560899505|FG006|Overall Study|Reason not provided|0|||
155400223|NCT03519867|560899506|FG007|Overall Study|Reason not provided|1|||
155400224|NCT03519867|560899507|FG008|Overall Study|Reason not provided|1|||
155400225|NCT03519867|560899508|FG009|Overall Study|Reason not provided|0|||
155400226|NCT01846624|560899509|FG000|Overall Study|Died during induction, no midostaurin|1|||
155400227|NCT01721057|560899510|FG000|Treatment Period|Withdrawal by Subject|11|||
155400228|NCT01721057|560899511|FG001|Treatment Period|Withdrawal by Subject|5|||
155400229|NCT01721057|560899512|FG002|Treatment Period|Withdrawal by Subject|8|||
155400230|NCT01721057|560899513|FG003|Treatment Period|Withdrawal by Subject|0|||
155400231|NCT01721057|560899514|FG004|Treatment Period|Withdrawal by Subject|0|||
155400232|NCT01721057|560899515|FG005|Treatment Period|Withdrawal by Subject|0|||
155400233|NCT01721057|560899516|FG006|Treatment Period|Withdrawal by Subject|0|||
155400234|NCT01721057|560899510|FG000|Treatment Period|Adverse Event|7|||
155400235|NCT01721057|560899511|FG001|Treatment Period|Adverse Event|10|||
155400236|NCT01721057|560899512|FG002|Treatment Period|Adverse Event|12|||
155400237|NCT01721057|560899513|FG003|Treatment Period|Adverse Event|0|||
155400238|NCT01721057|560899514|FG004|Treatment Period|Adverse Event|0|||
155400239|NCT01721057|560899515|FG005|Treatment Period|Adverse Event|0|||
155400240|NCT01721057|560899516|FG006|Treatment Period|Adverse Event|0|||
155400241|NCT01721057|560899510|FG000|Treatment Period|Lack of Efficacy|7|||
155400242|NCT01721057|560899511|FG001|Treatment Period|Lack of Efficacy|3|||
155400243|NCT01721057|560899512|FG002|Treatment Period|Lack of Efficacy|0|||
155400244|NCT01721057|560899513|FG003|Treatment Period|Lack of Efficacy|0|||
155400245|NCT01721057|560899514|FG004|Treatment Period|Lack of Efficacy|0|||
155400246|NCT01721057|560899515|FG005|Treatment Period|Lack of Efficacy|0|||
155400247|NCT01721057|560899516|FG006|Treatment Period|Lack of Efficacy|0|||
155400248|NCT01721057|560899510|FG000|Treatment Period|Lost to Follow-up|1|||
155400249|NCT01721057|560899511|FG001|Treatment Period|Lost to Follow-up|0|||
155400250|NCT01721057|560899512|FG002|Treatment Period|Lost to Follow-up|0|||
155400251|NCT01721057|560899513|FG003|Treatment Period|Lost to Follow-up|0|||
155400252|NCT01721057|560899514|FG004|Treatment Period|Lost to Follow-up|0|||
155400253|NCT01721057|560899515|FG005|Treatment Period|Lost to Follow-up|0|||
155400254|NCT01721057|560899516|FG006|Treatment Period|Lost to Follow-up|0|||
155400255|NCT01721057|560899510|FG000|Treatment Period|Physician Decision|0|||
155400256|NCT01721057|560899511|FG001|Treatment Period|Physician Decision|1|||
155400257|NCT01721057|560899512|FG002|Treatment Period|Physician Decision|3|||
155400258|NCT01721057|560899513|FG003|Treatment Period|Physician Decision|0|||
155400259|NCT01721057|560899514|FG004|Treatment Period|Physician Decision|0|||
155400260|NCT01721057|560899515|FG005|Treatment Period|Physician Decision|0|||
155400261|NCT01721057|560899516|FG006|Treatment Period|Physician Decision|0|||
155400262|NCT01721057|560899510|FG000|Treatment Period|Death|2|||
155400263|NCT01721057|560899511|FG001|Treatment Period|Death|0|||
155400264|NCT01721057|560899512|FG002|Treatment Period|Death|0|||
155400265|NCT01721057|560899513|FG003|Treatment Period|Death|0|||
155400266|NCT01721057|560899514|FG004|Treatment Period|Death|0|||
155400267|NCT01721057|560899515|FG005|Treatment Period|Death|0|||
155400268|NCT01721057|560899516|FG006|Treatment Period|Death|0|||
155400269|NCT01721057|560899510|FG000|Rescue Period|Adverse Event|0|||
155400270|NCT01721057|560899511|FG001|Rescue Period|Adverse Event|0|||
155400271|NCT01721057|560899512|FG002|Rescue Period|Adverse Event|0|||
155400272|NCT01721057|560899513|FG003|Rescue Period|Adverse Event|1|||
155400273|NCT01721057|560899514|FG004|Rescue Period|Adverse Event|0|||
155400274|NCT01721057|560899515|FG005|Rescue Period|Adverse Event|0|||
155400275|NCT01721057|560899516|FG006|Rescue Period|Adverse Event|0|||
155400276|NCT01721057|560899510|FG000|Rescue Period|Lack of Efficacy|0|||
155400277|NCT01721057|560899511|FG001|Rescue Period|Lack of Efficacy|0|||
155400278|NCT01721057|560899512|FG002|Rescue Period|Lack of Efficacy|0|||
155400279|NCT01721057|560899513|FG003|Rescue Period|Lack of Efficacy|2|||
155400280|NCT01721057|560899514|FG004|Rescue Period|Lack of Efficacy|0|||
155400281|NCT01721057|560899515|FG005|Rescue Period|Lack of Efficacy|0|||
155494129|NCT04411641|561232741|FG002|OL|Other|0|||
155400282|NCT01721057|560899516|FG006|Rescue Period|Lack of Efficacy|0|||
155400283|NCT01202279|560899517|FG000|Overall Study|Adverse Event|8|||
155400284|NCT01202279|560899518|FG001|Overall Study|Adverse Event|6|||
155400285|NCT01202279|560899517|FG000|Overall Study|Withdrawal by Subject|13|||
155400286|NCT01202279|560899518|FG001|Overall Study|Withdrawal by Subject|10|||
155400287|NCT01202279|560899517|FG000|Overall Study|Physician Decision|0|||
155400288|NCT01202279|560899518|FG001|Overall Study|Physician Decision|1|||
155400289|NCT01202279|560899517|FG000|Overall Study|Lost to Follow-up|10|||
155400290|NCT01202279|560899518|FG001|Overall Study|Lost to Follow-up|7|||
155400291|NCT01202279|560899517|FG000|Overall Study|Protocol Violation|1|||
155400292|NCT01202279|560899518|FG001|Overall Study|Protocol Violation|1|||
155400293|NCT01202279|560899517|FG000|Overall Study|study compliance|5|||
155400294|NCT01202279|560899518|FG001|Overall Study|study compliance|2|||
155400295|NCT03574753|560899519|FG000|Overall Study|Adverse Event|3|||
155494130|NCT04411641|561232742|FG003|OL|Other|6|||
155400296|NCT03574753|560899519|FG000|Overall Study|Progression/relapse|19|||
155400297|NCT03574753|560899519|FG000|Overall Study|Death|1|||
155400298|NCT01177683|560899520|FG000|Study Treatment|Disease Progressions during treatment|2|||
155494131|NCT02268214|561232743|FG000|Overall Study|Subject no longer meets study criteria|0|||
155494132|NCT02268214|561232744|FG001|Overall Study|Subject no longer meets study criteria|2|||
155494133|NCT02268214|561232745|FG002|Overall Study|Subject no longer meets study criteria|0|||
155494134|NCT02268214|561232743|FG000|Overall Study|Pregnancy|2|||
155494135|NCT02268214|561232744|FG001|Overall Study|Pregnancy|2|||
155494136|NCT02268214|561232745|FG002|Overall Study|Pregnancy|1|||
155494137|NCT02268214|561232743|FG000|Overall Study|Lost to Follow-up|3|||
155494138|NCT02268214|561232744|FG001|Overall Study|Lost to Follow-up|3|||
155494139|NCT02268214|561232745|FG002|Overall Study|Lost to Follow-up|4|||
155494140|NCT02268214|561232743|FG000|Overall Study|Lack of Efficacy|1|||
155494141|NCT02268214|561232744|FG001|Overall Study|Lack of Efficacy|0|||
155494142|NCT02268214|561232745|FG002|Overall Study|Lack of Efficacy|2|||
155494143|NCT02268214|561232743|FG000|Overall Study|Adverse Event|11|||
155494144|NCT02268214|561232744|FG001|Overall Study|Adverse Event|14|||
155494145|NCT02268214|561232745|FG002|Overall Study|Adverse Event|9|||
155494146|NCT02268214|561232743|FG000|Overall Study|Withdrawal by Subject|4|||
155494147|NCT02268214|561232744|FG001|Overall Study|Withdrawal by Subject|5|||
155494148|NCT02268214|561232745|FG002|Overall Study|Withdrawal by Subject|10|||
155494149|NCT02268214|561232743|FG000|Overall Study|Subject request to discontinue treatment|10|||
155494150|NCT02268214|561232744|FG001|Overall Study|Subject request to discontinue treatment|8|||
155494151|NCT02268214|561232745|FG002|Overall Study|Subject request to discontinue treatment|6|||
155494152|NCT02268214|561232743|FG000|Overall Study|Poor/non-compliance|2|||
155494153|NCT02268214|561232744|FG001|Overall Study|Poor/non-compliance|1|||
155494154|NCT02268214|561232745|FG002|Overall Study|Poor/non-compliance|2|||
155494155|NCT02268214|561232743|FG000|Overall Study|Other reasons|7|||
155494156|NCT02268214|561232744|FG001|Overall Study|Other reasons|3|||
155494157|NCT02268214|561232745|FG002|Overall Study|Other reasons|3|||
155494158|NCT02268214|561232743|FG000|Overall Study|Not entering long-term period|2|||
155494159|NCT02268214|561232744|FG001|Overall Study|Not entering long-term period|3|||
155494160|NCT02268214|561232745|FG002|Overall Study|Not entering long-term period|5|||
155494161|NCT02951130|561232746|FG000|Overall Study|Protocol Violation|1|||
155494162|NCT02951130|561232747|FG001|Overall Study|Protocol Violation|1|||
155494163|NCT01119118|561232748|FG000|Overall Study|Adverse Event|1|||
155494164|NCT02711306|561232755|FG000|Overall Study|Withdrawal by Subject|2|||
155494165|NCT02711306|561232756|FG001|Overall Study|Withdrawal by Subject|2|||
155494166|NCT01519635|561234217|FG000|Overall Study|Withdrawal by Subject|0|||
155494167|NCT01519635|561234218|FG001|Overall Study|Withdrawal by Subject|1|||
155494168|NCT01519635|561234217|FG000|Overall Study|No possibility to put a catheter|1|||
155494169|NCT01519635|561234218|FG001|Overall Study|No possibility to put a catheter|2|||
155494170|NCT00347776|561234219|FG000|1.5 Month Follow-up|Death|2|||
155494171|NCT00347776|561234220|FG001|1.5 Month Follow-up|Death|0|||
155494172|NCT00347776|561234221|FG002|1.5 Month Follow-up|Death|0|||
155494173|NCT00347776|561234219|FG000|1.5 Month Follow-up|reached the endpoint|12|||
155494174|NCT00347776|561234220|FG001|1.5 Month Follow-up|reached the endpoint|8|||
155494175|NCT00347776|561234221|FG002|1.5 Month Follow-up|reached the endpoint|12|||
155494176|NCT00347776|561234219|FG000|6 Month Follow-up|Death|2|||
155494177|NCT00347776|561234220|FG001|6 Month Follow-up|Death|1|||
155494178|NCT00347776|561234221|FG002|6 Month Follow-up|Death|3|||
155494179|NCT00347776|561234219|FG000|6 Month Follow-up|reached endpont|20|||
155494180|NCT00347776|561234220|FG001|6 Month Follow-up|reached endpont|12|||
155494181|NCT00347776|561234221|FG002|6 Month Follow-up|reached endpont|15|||
155494182|NCT00347776|561234219|FG000|12 Month Follow-up|Lost to Follow-up|7|||
155494183|NCT00347776|561234220|FG001|12 Month Follow-up|Lost to Follow-up|6|||
155494184|NCT00347776|561234221|FG002|12 Month Follow-up|Lost to Follow-up|6|||
155494185|NCT00347776|561234219|FG000|12 Month Follow-up|Death|3|||
155494186|NCT00347776|561234220|FG001|12 Month Follow-up|Death|4|||
155494187|NCT00347776|561234221|FG002|12 Month Follow-up|Death|4|||
155494188|NCT00347776|561234219|FG000|12 Month Follow-up|Reached endpoint|13|||
155494189|NCT00347776|561234220|FG001|12 Month Follow-up|Reached endpoint|6|||
155494190|NCT00347776|561234221|FG002|12 Month Follow-up|Reached endpoint|9|||
155494191|NCT00299546|561234222|FG000|Overall Study|Death|3|||
155494192|NCT00299546|561234223|FG001|Overall Study|Death|2|||
155494193|NCT00299546|561234224|FG002|Overall Study|Death|0|||
155494194|NCT00299546|561234222|FG000|Overall Study|Lost to Follow-up|2|||
155494195|NCT00299546|561234223|FG001|Overall Study|Lost to Follow-up|2|||
155494196|NCT00299546|561234224|FG002|Overall Study|Lost to Follow-up|5|||
155494197|NCT00299546|561234222|FG000|Overall Study|Adverse Event|37|||
155494198|NCT00299546|561234223|FG001|Overall Study|Adverse Event|22|||
155494199|NCT00299546|561234224|FG002|Overall Study|Adverse Event|27|||
155494200|NCT00299546|561234222|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
155494201|NCT00299546|561234223|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
155494202|NCT00299546|561234224|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
155494203|NCT00299546|561234222|FG000|Overall Study|Other|24|||
155494204|NCT00299546|561234223|FG001|Overall Study|Other|26|||
155494205|NCT00299546|561234224|FG002|Overall Study|Other|19|||
155494206|NCT00299546|561234222|FG000|Overall Study|Not treated|0|||
155494207|NCT00299546|561234223|FG001|Overall Study|Not treated|1|||
155636969|NCT03112603|561762864|FG000|End of Randomization Period|Lost to Follow-up|3|||
155494208|NCT00299546|561234224|FG002|Overall Study|Not treated|1|||
155494209|NCT00968539|561234228|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
155400299|NCT01177683|560899521|FG001|Study Treatment|Disease Progressions during treatment|0|||
155400300|NCT01177683|560899522|FG002|Study Treatment|Disease Progressions during treatment|3|||
155400301|NCT01177683|560899520|FG000|Study Treatment|Adverse Event|0|||
155400302|NCT01177683|560899521|FG001|Study Treatment|Adverse Event|1|||
155400303|NCT01177683|560899522|FG002|Study Treatment|Adverse Event|12|||
155400304|NCT01177683|560899520|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155400305|NCT01177683|560899521|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
155400306|NCT01177683|560899522|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
155400307|NCT01177683|560899520|FG000|Study Treatment|Alternative therapy|0|||
155400308|NCT01177683|560899521|FG001|Study Treatment|Alternative therapy|0|||
155400309|NCT01177683|560899522|FG002|Study Treatment|Alternative therapy|4|||
155400310|NCT01177683|560899520|FG000|Study Treatment|Physician Decision|1|||
155400311|NCT01177683|560899521|FG001|Study Treatment|Physician Decision|0|||
155400312|NCT01177683|560899522|FG002|Study Treatment|Physician Decision|1|||
155400313|NCT01177683|560899520|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
155400314|NCT01177683|560899521|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
155400315|NCT01177683|560899522|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
155400316|NCT01177683|560899520|FG000|Study Treatment|Symptomatic Deterioration|0|||
155400317|NCT01177683|560899521|FG001|Study Treatment|Symptomatic Deterioration|0|||
155400318|NCT01177683|560899522|FG002|Study Treatment|Symptomatic Deterioration|1|||
155400319|NCT01177683|560899520|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
155400320|NCT01177683|560899521|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
155400321|NCT01177683|560899522|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
155400322|NCT01177683|560899520|FG000|Follow up|Patient lost to follow up|0|||
155400323|NCT01177683|560899521|FG001|Follow up|Patient lost to follow up|0|||
155400324|NCT01177683|560899522|FG002|Follow up|Patient lost to follow up|2|||
155400325|NCT01177683|560899520|FG000|Follow up|Death|2|||
155400326|NCT01177683|560899521|FG001|Follow up|Death|1|||
155400327|NCT01177683|560899522|FG002|Follow up|Death|7|||
155400328|NCT01177683|560899520|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
155400329|NCT01177683|560899521|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
155400330|NCT01177683|560899522|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
155400331|NCT02546765|560899525|FG000|Overall Study|Withdrawal by Subject|0|||
155400332|NCT02546765|560899526|FG001|Overall Study|Withdrawal by Subject|1|||
155400333|NCT02546765|560899527|FG002|Overall Study|Withdrawal by Subject|0|||
155400334|NCT02546765|560899528|FG003|Overall Study|Withdrawal by Subject|0|||
155400335|NCT01977820|560899529|FG000|Overall Study|Sponsor terminated the study|1|||
155400336|NCT01977820|560899530|FG001|Overall Study|Sponsor terminated the study|1|||
155400337|NCT00698997|560899531|FG000|Overall Study|Lost to Follow-up|3|||
155400338|NCT00698997|560899532|FG001|Overall Study|Lost to Follow-up|0|||
155400339|NCT00698997|560899531|FG000|Overall Study|Withdrawal by Subject|7|||
155400340|NCT00698997|560899532|FG001|Overall Study|Withdrawal by Subject|27|||
155400341|NCT00475722|560899533|FG000|Overall Study|Withdrawal by Subject|12|||
155400342|NCT00475722|560899534|FG001|Overall Study|Withdrawal by Subject|12|||
155400343|NCT00475722|560899533|FG000|Overall Study|Protocol Violation|3|||
155400344|NCT00475722|560899534|FG001|Overall Study|Protocol Violation|0|||
155400345|NCT02568475|560899535|FG000|Overall Study|Lost to Follow-up|40|||
155400346|NCT02568475|560899536|FG001|Overall Study|Lost to Follow-up|39|||
155400347|NCT02568475|560899535|FG000|Overall Study|Withdrawal by Subject|2|||
155400348|NCT02568475|560899536|FG001|Overall Study|Withdrawal by Subject|0|||
155400349|NCT02568475|560899535|FG000|Overall Study|Discharged home|4|||
155400350|NCT02568475|560899536|FG001|Overall Study|Discharged home|4|||
155400351|NCT02568475|560899535|FG000|Overall Study|Short-term: Discharge location unknown|4|||
155400352|NCT02568475|560899536|FG001|Overall Study|Short-term: Discharge location unknown|0|||
155400353|NCT02568475|560899535|FG000|Overall Study|Transferred to another facility|1|||
155400354|NCT02568475|560899536|FG001|Overall Study|Transferred to another facility|0|||
155400355|NCT02625233|560899537|FG000|Overall Study|Adverse Event|2|||
155400356|NCT02625233|560899538|FG001|Overall Study|Adverse Event|0|||
155400357|NCT04425720|560899539|FG000|Overall Study|Withdrawal by Subject|0|||
155400358|NCT04425720|560899540|FG001|Overall Study|Withdrawal by Subject|20|||
155400359|NCT00290186|560899541|FG000|Overall Study|Adverse Event|1|||
155400360|NCT00290186|560899542|FG001|Overall Study|Adverse Event|1|||
155400361|NCT00290186|560899541|FG000|Overall Study|Lost to Follow-up|3|||
155400362|NCT00290186|560899542|FG001|Overall Study|Lost to Follow-up|2|||
155400363|NCT00290186|560899541|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
155400364|NCT00290186|560899542|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
155400365|NCT00290186|560899541|FG000|Overall Study|Withdrawal by Subject|0|||
155400366|NCT00290186|560899542|FG001|Overall Study|Withdrawal by Subject|1|||
155400367|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
155400368|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
155400369|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
155400370|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
155400371|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
155400372|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
155400373|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
155400374|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
155400375|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
155400376|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
155400377|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
155400378|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
155400379|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
155400380|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
155400381|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
155400382|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
155494210|NCT00968539|561234229|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155494211|NCT00396318|561234230|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
155494212|NCT00326118|561234231|FG000|Active Phase|Withdrawal by Subject|4|||
155494213|NCT00326118|561234232|FG001|Active Phase|Withdrawal by Subject|1|||
155494214|NCT00602927|561234233|FG000|Period 1: 13 Days|Protocol Violation|2|||
155494215|NCT00602927|561234234|FG001|Period 1: 13 Days|Protocol Violation|4|||
155494216|NCT00602927|561234233|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
155494217|NCT00602927|561234234|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
155494218|NCT00602927|561234233|FG000|Period 1: 13 Days|Time|1|||
155494219|NCT00602927|561234234|FG001|Period 1: 13 Days|Time|0|||
155494220|NCT00602927|561234233|FG000|Period 1: 13 Days|Claustrophobia|0|||
155494221|NCT00602927|561234234|FG001|Period 1: 13 Days|Claustrophobia|1|||
155494222|NCT00602927|561234233|FG000|Period 2: 14 Days|Protocol Violation|0|||
155494223|NCT00602927|561234234|FG001|Period 2: 14 Days|Protocol Violation|2|||
155494224|NCT00602927|561234233|FG000|Period 3: 13 Days|Protocol Violation|0|||
155494225|NCT00602927|561234234|FG001|Period 3: 13 Days|Protocol Violation|1|||
155741427|NCT04784442|562154849|FG003|Overall Study|Protocol Violation|0|||
155741428|NCT04784442|562154846|FG000|Overall Study|Non-compliance with study drug|1|||
155741429|NCT04784442|562154847|FG001|Overall Study|Non-compliance with study drug|0|||
155741430|NCT04784442|562154848|FG002|Overall Study|Non-compliance with study drug|0|||
155741431|NCT04784442|562154849|FG003|Overall Study|Non-compliance with study drug|0|||
155741432|NCT00509145|562154850|FG000|Overall Study|Death|0|||
155741433|NCT00509145|562154851|FG001|Overall Study|Death|2|||
155741434|NCT00509145|562154850|FG000|Overall Study|Adverse Event|42|||
155400383|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Death|1|||
155400384|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Death|0|||
155400385|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Death|0|||
155400386|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Death|0|||
155400387|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
155400388|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
155400389|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
155400390|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
155400391|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
155400392|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
155400393|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
155400394|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
155400395|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
155400396|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
155400397|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
155400398|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
155400399|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
155400400|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
155400401|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
155400402|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
155400403|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Death|2|||
155400404|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Death|0|||
155400405|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Death|1|||
155400406|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Death|0|||
155400407|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
155400408|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
155400409|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
155400410|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
155741435|NCT00509145|562154851|FG001|Overall Study|Adverse Event|28|||
155741436|NCT00509145|562154850|FG000|Overall Study|Withdrawal by Subject|32|||
155741437|NCT00509145|562154851|FG001|Overall Study|Withdrawal by Subject|38|||
155741438|NCT00509145|562154850|FG000|Overall Study|Physician Decision|11|||
155741439|NCT00509145|562154851|FG001|Overall Study|Physician Decision|14|||
155741440|NCT00509145|562154850|FG000|Overall Study|Protocol Violation|1|||
155741441|NCT00509145|562154851|FG001|Overall Study|Protocol Violation|6|||
155741442|NCT00509145|562154850|FG000|Overall Study|Pregnancy|3|||
155741443|NCT00509145|562154851|FG001|Overall Study|Pregnancy|8|||
155400411|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
155741444|NCT00509145|562154850|FG000|Overall Study|Lost to Follow-up|6|||
155741445|NCT00509145|562154851|FG001|Overall Study|Lost to Follow-up|5|||
155741446|NCT00509145|562154850|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
155741447|NCT00509145|562154851|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
155741448|NCT00509145|562154850|FG000|Overall Study|Other|6|||
155741449|NCT00509145|562154851|FG001|Overall Study|Other|6|||
155741450|NCT00246740|562154852|FG000|Initial Enrollment|Death|1|||
155741451|NCT00246740|562154853|FG001|Initial Enrollment|Death|0|||
155741452|NCT00246740|562154852|FG000|Initial Enrollment|Additional surgery scheduled|0|||
155741453|NCT00246740|562154853|FG001|Initial Enrollment|Additional surgery scheduled|2|||
155741454|NCT00246740|562154852|FG000|Initial Enrollment|Surgery schedule change|4|||
155741455|NCT00246740|562154853|FG001|Initial Enrollment|Surgery schedule change|4|||
155741456|NCT00246740|562154852|FG000|Initial Enrollment|Other|1|||
155741457|NCT00246740|562154853|FG001|Initial Enrollment|Other|2|||
155741458|NCT00101452|562154856|FG000|Overall Study|Adverse Event|2|||
155741459|NCT00101452|562154857|FG001|Overall Study|Adverse Event|0|||
155741460|NCT00101452|562154858|FG002|Overall Study|Adverse Event|1|||
155741461|NCT00101452|562154856|FG000|Overall Study|Lost to Follow-up|13|||
155741462|NCT00101452|562154857|FG001|Overall Study|Lost to Follow-up|8|||
155741463|NCT00101452|562154858|FG002|Overall Study|Lost to Follow-up|14|||
155741464|NCT00101452|562154856|FG000|Overall Study|Withdrawal by Subject|10|||
155741465|NCT00101452|562154857|FG001|Overall Study|Withdrawal by Subject|14|||
155741466|NCT00101452|562154858|FG002|Overall Study|Withdrawal by Subject|9|||
155741467|NCT00101452|562154856|FG000|Overall Study|Baseline Fail|2|||
155741468|NCT00101452|562154857|FG001|Overall Study|Baseline Fail|1|||
155741469|NCT00101452|562154858|FG002|Overall Study|Baseline Fail|2|||
155741470|NCT00101452|562154856|FG000|Overall Study|Physician Decision|0|||
155741471|NCT00101452|562154857|FG001|Overall Study|Physician Decision|3|||
155741472|NCT00101452|562154858|FG002|Overall Study|Physician Decision|2|||
155741473|NCT00101452|562154856|FG000|Overall Study|Protocol Violation|2|||
155741474|NCT00101452|562154857|FG001|Overall Study|Protocol Violation|1|||
155741475|NCT00101452|562154858|FG002|Overall Study|Protocol Violation|3|||
155741476|NCT00101452|562154856|FG000|Overall Study|Other|15|||
155741477|NCT00101452|562154857|FG001|Overall Study|Other|16|||
155741478|NCT00101452|562154858|FG002|Overall Study|Other|12|||
155741479|NCT02969655|562154859|FG000|Overall Study|Withdrawal by Subject|3|||
155741480|NCT02969655|562154860|FG001|Overall Study|Withdrawal by Subject|2|||
155741481|NCT02969655|562154859|FG000|Overall Study|Physician Decision|4|||
155741482|NCT02969655|562154860|FG001|Overall Study|Physician Decision|3|||
155741483|NCT02969655|562154859|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
155741484|NCT02969655|562154860|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
155741485|NCT02969655|562154859|FG000|Overall Study|Adverse Event|10|||
155741486|NCT02969655|562154860|FG001|Overall Study|Adverse Event|8|||
155741487|NCT00929643|562154863|FG000|Overall Study|Protocol Violation|2|||
155741488|NCT01536392|562154864|FG000|Overall Study|Adverse Event|2|||
155741489|NCT01536392|562154865|FG001|Overall Study|Adverse Event|2|||
155741490|NCT01536392|562154864|FG000|Overall Study|Physician Decision|2|||
155741491|NCT01536392|562154865|FG001|Overall Study|Physician Decision|3|||
155741492|NCT01536392|562154864|FG000|Overall Study|Withdrawal by Subject|3|||
155741493|NCT01536392|562154865|FG001|Overall Study|Withdrawal by Subject|6|||
155741494|NCT01536392|562154864|FG000|Overall Study|Non Compliance|3|||
155741495|NCT01536392|562154865|FG001|Overall Study|Non Compliance|4|||
155741496|NCT01536392|562154864|FG000|Overall Study|Completed therapy early|3|||
155741497|NCT01536392|562154865|FG001|Overall Study|Completed therapy early|0|||
155741498|NCT02874144|562154867|FG000|Overall Study|Lost to Follow-up|3|||
155741499|NCT02874144|562154868|FG001|Overall Study|Lost to Follow-up|5|||
155741500|NCT00852371|562154872|FG000|Overall Study|Lost to Follow-up|2|||
155741501|NCT00852371|562154873|FG001|Overall Study|Lost to Follow-up|3|||
155741502|NCT00852371|562154874|FG002|Overall Study|Lost to Follow-up|4|||
155741503|NCT00852371|562154875|FG003|Overall Study|Lost to Follow-up|2|||
155741504|NCT03158285|562154876|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
155741505|NCT03158285|562154877|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
155741506|NCT03158285|562154878|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
155741507|NCT03158285|562154876|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155741508|NCT03158285|562154877|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
155741509|NCT03158285|562154878|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
155741510|NCT03158285|562154876|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
155741511|NCT03158285|562154877|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
155741512|NCT03158285|562154878|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
155741513|NCT03158285|562154876|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155741514|NCT03158285|562154877|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
155741515|NCT03158285|562154878|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155741516|NCT03158285|562154876|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
155741517|NCT03158285|562154877|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
155741518|NCT03158285|562154878|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
155741519|NCT03158285|562154876|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
155400412|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
155400413|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
155400414|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
155400415|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
155400416|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
155400417|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
155400418|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
155400419|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
155400420|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
155400421|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
155400422|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
155400423|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
155400424|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
155400425|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
155400426|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
155400427|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
155400428|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
155400429|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
155400430|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
155400431|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Death|2|||
155400432|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Death|0|||
155400433|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Death|2|||
155400434|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Death|0|||
155400435|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
155400436|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
155400437|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
155400438|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
155400439|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
155400440|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
155400441|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
155400442|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
155400443|NCT05314517|560899560|FG000|Double-blind Period|Adverse Event|4|||
155400444|NCT05314517|560899561|FG001|Double-blind Period|Adverse Event|0|||
155400445|NCT05314517|560899562|FG002|Double-blind Period|Adverse Event|0|||
155400446|NCT05314517|560899563|FG003|Double-blind Period|Adverse Event|0|||
155400447|NCT05314517|560899560|FG000|Double-blind Period|Noncompliance|0|||
155400448|NCT05314517|560899561|FG001|Double-blind Period|Noncompliance|1|||
155400449|NCT05314517|560899562|FG002|Double-blind Period|Noncompliance|0|||
155400450|NCT05314517|560899563|FG003|Double-blind Period|Noncompliance|0|||
155400451|NCT05314517|560899560|FG000|Double-blind Period|Randomized, not treated|1|||
155400452|NCT05314517|560899561|FG001|Double-blind Period|Randomized, not treated|0|||
155400453|NCT05314517|560899562|FG002|Double-blind Period|Randomized, not treated|0|||
155400454|NCT05314517|560899563|FG003|Double-blind Period|Randomized, not treated|0|||
155400455|NCT05314517|560899560|FG000|Open-label Extension|Adverse Event|0|||
155400456|NCT05314517|560899561|FG001|Open-label Extension|Adverse Event|0|||
155400457|NCT05314517|560899562|FG002|Open-label Extension|Adverse Event|1|||
155400458|NCT05314517|560899563|FG003|Open-label Extension|Adverse Event|2|||
155400459|NCT05314517|560899560|FG000|Open-label Extension|Investigator decision|0|||
155400460|NCT05314517|560899561|FG001|Open-label Extension|Investigator decision|0|||
155400461|NCT05314517|560899562|FG002|Open-label Extension|Investigator decision|1|||
155400462|NCT05314517|560899563|FG003|Open-label Extension|Investigator decision|0|||
155400463|NCT05314517|560899560|FG000|Open-label Extension|Lost to Follow-up|0|||
155400464|NCT05314517|560899561|FG001|Open-label Extension|Lost to Follow-up|0|||
155400465|NCT05314517|560899562|FG002|Open-label Extension|Lost to Follow-up|0|||
155400466|NCT05314517|560899563|FG003|Open-label Extension|Lost to Follow-up|1|||
155400467|NCT05314517|560899560|FG000|Open-label Extension|Withdrawal by Subject|0|||
155400468|NCT05314517|560899561|FG001|Open-label Extension|Withdrawal by Subject|0|||
155400469|NCT05314517|560899562|FG002|Open-label Extension|Withdrawal by Subject|1|||
155400470|NCT05314517|560899563|FG003|Open-label Extension|Withdrawal by Subject|2|||
155741520|NCT03158285|562154877|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
155741521|NCT03158285|562154878|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
155741522|NCT03158285|562154876|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
155741523|NCT03158285|562154877|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
155741524|NCT03158285|562154878|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
155741525|NCT03158285|562154876|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
155400471|NCT05314517|560899560|FG000|Open-label Extension|Use of prohibited medication|0|||
155400472|NCT05314517|560899561|FG001|Open-label Extension|Use of prohibited medication|0|||
155741526|NCT03158285|562154877|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
155741527|NCT03158285|562154878|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
155741528|NCT03158285|562154876|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
155741529|NCT03158285|562154877|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
155741530|NCT03158285|562154878|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
155741531|NCT03158285|562154876|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
155741532|NCT03158285|562154877|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
155741533|NCT03158285|562154878|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
155741534|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
155741535|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
155741536|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
155741537|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
155741538|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
155741539|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
155741540|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
155741541|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
155741542|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
155741543|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
155741544|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
155741545|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
155741546|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Death|1|||
155741547|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Death|0|||
155741548|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Death|0|||
155741549|NCT03158285|562154876|FG000|Active Treatment Period: Week 52-100|Other|4|||
155741550|NCT03158285|562154877|FG001|Active Treatment Period: Week 52-100|Other|1|||
155741551|NCT03158285|562154878|FG002|Active Treatment Period: Week 52-100|Other|0|||
155741552|NCT02744040|562154881|FG000|Overall Study|Withdrawal by Subject|3|||
155741553|NCT02744040|562154882|FG001|Overall Study|Withdrawal by Subject|2|||
155741554|NCT02744040|562154883|FG002|Overall Study|Withdrawal by Subject|2|||
155741555|NCT02744040|562154881|FG000|Overall Study|Physician Decision|0|||
155741556|NCT02744040|562154882|FG001|Overall Study|Physician Decision|8|||
155741557|NCT02744040|562154883|FG002|Overall Study|Physician Decision|13|||
155741558|NCT02744040|562154881|FG000|Overall Study|Lost to Follow-up|3|||
155741559|NCT02744040|562154882|FG001|Overall Study|Lost to Follow-up|1|||
155741560|NCT02744040|562154883|FG002|Overall Study|Lost to Follow-up|7|||
155741561|NCT01642615|562154884|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
155741562|NCT01642615|562154885|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155741563|NCT01642615|562154886|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155741564|NCT01642615|562154884|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
155400473|NCT05314517|560899562|FG002|Open-label Extension|Use of prohibited medication|1|||
155400474|NCT05314517|560899563|FG003|Open-label Extension|Use of prohibited medication|0|||
155400475|NCT05314517|560899560|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
155741565|NCT01642615|562154885|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
155741566|NCT01642615|562154886|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
155741567|NCT01642615|562154884|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
155741568|NCT01642615|562154885|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
155741569|NCT01642615|562154886|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
155741570|NCT01642615|562154884|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
155741571|NCT01642615|562154885|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
155741572|NCT01642615|562154886|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
155741573|NCT01642615|562154884|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
155741574|NCT01642615|562154885|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
155741575|NCT01642615|562154886|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
155741576|NCT01642615|562154884|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
155741577|NCT01642615|562154885|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
155741578|NCT01642615|562154886|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
155741579|NCT01642615|562154884|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
155741580|NCT01642615|562154885|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
155741581|NCT01642615|562154886|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
155741582|NCT01642615|562154884|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155741583|NCT01642615|562154885|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
155741584|NCT01642615|562154886|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155741585|NCT01642615|562154884|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
155741586|NCT01642615|562154885|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
155741587|NCT01642615|562154886|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
155741588|NCT00402740|562154889|FG000|Overall Study|Withdrawal by Subject|18|||
155741589|NCT00402740|562154889|FG000|Overall Study|Death|50|||
155741590|NCT00402740|562154889|FG000|Overall Study|Lost to Follow-up|6|||
155741591|NCT00402740|562154889|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
155400476|NCT05314517|560899561|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
155400477|NCT05314517|560899562|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
155400478|NCT05314517|560899563|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
155400479|NCT02710136|560899566|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
155400480|NCT02710136|560899567|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
155400481|NCT02269787|560899568|FG000|Overall Study|Lost to Follow-up|20|||
155400482|NCT02269787|560899569|FG001|Overall Study|Lost to Follow-up|6|||
155400483|NCT02269787|560899568|FG000|Overall Study|Death|2|||
155400484|NCT02269787|560899569|FG001|Overall Study|Death|3|||
155400485|NCT02269787|560899568|FG000|Overall Study|Incapacitated|0|||
155400486|NCT02269787|560899569|FG001|Overall Study|Incapacitated|1|||
155400487|NCT00798135|560899570|FG000|Overall Study|Disease progression, relapse|11|||
155400488|NCT00798135|560899570|FG000|Overall Study|Disease progression, refractory|1|||
155400489|NCT00798135|560899570|FG000|Overall Study|Physician Decision|1|||
155400490|NCT03337542|560899571|FG000|Overall Study|Withdrew Consent|17|||
155400491|NCT03337542|560899571|FG000|Overall Study|Allergic Adverse Event|1|||
155400492|NCT03337542|560899571|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
155400493|NCT03337542|560899571|FG000|Overall Study|Lost to Follow-up|1|||
155400494|NCT03337542|560899571|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
155400495|NCT01401842|560899572|FG000|Overall Study|Withdrawal by Subject|3|||
155400496|NCT01401842|560899573|FG001|Overall Study|Withdrawal by Subject|2|||
155400497|NCT01401842|560899572|FG000|Overall Study|academic reason|4|||
155400498|NCT01401842|560899573|FG001|Overall Study|academic reason|1|||
155400499|NCT01401842|560899572|FG000|Overall Study|changed companies|20|||
155400500|NCT01401842|560899573|FG001|Overall Study|changed companies|34|||
155400501|NCT01401842|560899572|FG000|Overall Study|discharged from US Army|3|||
155400502|NCT01401842|560899573|FG001|Overall Study|discharged from US Army|4|||
155400503|NCT01401842|560899572|FG000|Overall Study|invalid follow-up strength data|1|||
155400504|NCT01401842|560899573|FG001|Overall Study|invalid follow-up strength data|4|||
155400505|NCT01401842|560899572|FG000|Overall Study|on profile|9|||
155400506|NCT01401842|560899573|FG001|Overall Study|on profile|5|||
155400507|NCT01401842|560899572|FG000|Overall Study|other/unknown|28|||
155400508|NCT01401842|560899573|FG001|Overall Study|other/unknown|17|||
155400509|NCT00282295|560899574|FG000|Overall Study|Adverse Event|0|||
155400510|NCT00282295|560899575|FG001|Overall Study|Adverse Event|1|||
155400511|NCT00282295|560899576|FG002|Overall Study|Adverse Event|0|||
155636970|NCT03112603|561762865|FG001|End of Randomization Period|Lost to Follow-up|0|||
155636971|NCT03112603|561762866|FG002|End of Randomization Period|Lost to Follow-up|0|||
155636972|NCT03112603|561762864|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
155636973|NCT03112603|561762865|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
155636974|NCT03112603|561762866|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
155636975|NCT03112603|561762864|FG000|End of Randomization Period|Physician Decision|43|||
155636976|NCT03112603|561762865|FG001|End of Randomization Period|Physician Decision|18|||
155636977|NCT03112603|561762866|FG002|End of Randomization Period|Physician Decision|0|||
155636978|NCT03112603|561762864|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
155636979|NCT03112603|561762865|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
155636980|NCT03112603|561762866|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
155636981|NCT03112603|561762864|FG000|End of Randomization Period|Death|10|||
155636982|NCT03112603|561762865|FG001|End of Randomization Period|Death|7|||
155636983|NCT03112603|561762866|FG002|End of Randomization Period|Death|0|||
155636984|NCT03112603|561762864|FG000|End of Randomization Period|Disease Relapse|12|||
155636985|NCT03112603|561762865|FG001|End of Randomization Period|Disease Relapse|7|||
155636986|NCT03112603|561762866|FG002|End of Randomization Period|Disease Relapse|0|||
155636987|NCT03112603|561762864|FG000|End of Randomization Period|Lack of Efficacy|25|||
155636988|NCT03112603|561762865|FG001|End of Randomization Period|Lack of Efficacy|77|||
155636989|NCT03112603|561762866|FG002|End of Randomization Period|Lack of Efficacy|0|||
155636990|NCT03112603|561762864|FG000|End of Randomization Period|Adverse Event|32|||
155636991|NCT03112603|561762865|FG001|End of Randomization Period|Adverse Event|12|||
155636992|NCT03112603|561762866|FG002|End of Randomization Period|Adverse Event|0|||
155636993|NCT03112603|561762864|FG000|End of Cross Over Period|Death|0|||
155636994|NCT03112603|561762865|FG001|End of Cross Over Period|Death|0|||
155636995|NCT03112603|561762866|FG002|End of Cross Over Period|Death|2|||
155636996|NCT03112603|561762864|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
155636997|NCT03112603|561762865|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
155636998|NCT03112603|561762866|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
155636999|NCT03112603|561762864|FG000|End of Cross Over Period|Physician Decision|0|||
155637000|NCT03112603|561762865|FG001|End of Cross Over Period|Physician Decision|0|||
155637001|NCT03112603|561762866|FG002|End of Cross Over Period|Physician Decision|29|||
155637002|NCT03112603|561762864|FG000|End of Cross Over Period|Lack of Efficacy|0|||
155637003|NCT03112603|561762865|FG001|End of Cross Over Period|Lack of Efficacy|0|||
155637004|NCT03112603|561762866|FG002|End of Cross Over Period|Lack of Efficacy|8|||
155741592|NCT00402740|562154889|FG000|Overall Study|Subject disposition unknown.|1|||
155400512|NCT00282295|560899574|FG000|Overall Study|Serious Adverse Events|0|||
155400513|NCT00282295|560899575|FG001|Overall Study|Serious Adverse Events|0|||
155741593|NCT01214395|562154892|FG000|Overall Study|All patients had infection|5|||
155741594|NCT00946153|562154896|FG000|Phase 2|Adverse Event|0|||
155741595|NCT00946153|562154897|FG001|Phase 2|Adverse Event|0|||
155741596|NCT00946153|562154898|FG002|Phase 2|Adverse Event|0|||
155741597|NCT00946153|562154899|FG003|Phase 2|Adverse Event|0|||
155741598|NCT00946153|562154900|FG004|Phase 2|Adverse Event|6|||
155741599|NCT00946153|562154896|FG000|Phase 2|Need more reduction of dose|0|||
155741600|NCT00946153|562154897|FG001|Phase 2|Need more reduction of dose|0|||
155741601|NCT00946153|562154898|FG002|Phase 2|Need more reduction of dose|0|||
155741602|NCT00946153|562154899|FG003|Phase 2|Need more reduction of dose|0|||
155741603|NCT00946153|562154900|FG004|Phase 2|Need more reduction of dose|2|||
155741604|NCT00946153|562154896|FG000|Phase 2|Physician Decision|0|||
155741605|NCT00946153|562154897|FG001|Phase 2|Physician Decision|0|||
155741606|NCT00946153|562154898|FG002|Phase 2|Physician Decision|0|||
155741607|NCT00946153|562154899|FG003|Phase 2|Physician Decision|0|||
155741608|NCT00946153|562154900|FG004|Phase 2|Physician Decision|1|||
155741609|NCT00946153|562154896|FG000|Phase 2|14 days washout for recovery due to AE|0|||
155741610|NCT00946153|562154897|FG001|Phase 2|14 days washout for recovery due to AE|0|||
155741611|NCT00946153|562154898|FG002|Phase 2|14 days washout for recovery due to AE|0|||
155741612|NCT00946153|562154899|FG003|Phase 2|14 days washout for recovery due to AE|0|||
155741613|NCT00946153|562154900|FG004|Phase 2|14 days washout for recovery due to AE|4|||
155741614|NCT03698591|562154903|FG000|Overall Study|Withdrawal by Subject|2|||
155741615|NCT03698591|562154904|FG001|Overall Study|Withdrawal by Subject|2|||
155741616|NCT03698591|562154903|FG000|Overall Study|Failed drug screen|1|||
155741617|NCT03698591|562154904|FG001|Overall Study|Failed drug screen|1|||
155741618|NCT03698591|562154903|FG000|Overall Study|Failed health screen|0|||
155741619|NCT03698591|562154904|FG001|Overall Study|Failed health screen|1|||
155741620|NCT03698591|562154903|FG000|Overall Study|Ineligible for financial compensation|1|||
155741621|NCT03698591|562154904|FG001|Overall Study|Ineligible for financial compensation|0|||
155741622|NCT03698591|562154903|FG000|Overall Study|Equipment Error|1|||
155741623|NCT03698591|562154904|FG001|Overall Study|Equipment Error|0|||
155741624|NCT03698591|562154903|FG000|Overall Study|Could not establish TMS dosage|0|||
155741625|NCT03698591|562154904|FG001|Overall Study|Could not establish TMS dosage|1|||
155741626|NCT01165216|562154915|FG000|Overall Study|Adverse Event|6|||
155741627|NCT01165216|562154916|FG001|Overall Study|Adverse Event|3|||
155741628|NCT01165216|562154915|FG000|Overall Study|Withdrawal by Subject|1|||
155741629|NCT01165216|562154916|FG001|Overall Study|Withdrawal by Subject|1|||
155741630|NCT01165216|562154915|FG000|Overall Study|Disease progression|1|||
155741631|NCT01165216|562154916|FG001|Overall Study|Disease progression|3|||
155741632|NCT03255083|562154917|FG000|Overall Study|Clinical progression|1|||
155741633|NCT03255083|562154918|FG001|Overall Study|Clinical progression|0|||
155741634|NCT03255083|562154919|FG002|Overall Study|Clinical progression|0|||
155741635|NCT03255083|562154920|FG003|Overall Study|Clinical progression|0|||
155741636|NCT03255083|562154917|FG000|Overall Study|Adverse Event|0|||
155741637|NCT03255083|562154918|FG001|Overall Study|Adverse Event|1|||
155741638|NCT03255083|562154919|FG002|Overall Study|Adverse Event|0|||
155741639|NCT03255083|562154920|FG003|Overall Study|Adverse Event|0|||
155741640|NCT03255083|562154917|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
155741641|NCT03255083|562154918|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
155741642|NCT03255083|562154919|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
155741643|NCT03255083|562154920|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
155741644|NCT03255083|562154917|FG000|Overall Study|Withdrawal by Subject|1|||
155741645|NCT03255083|562154918|FG001|Overall Study|Withdrawal by Subject|1|||
155741646|NCT03255083|562154919|FG002|Overall Study|Withdrawal by Subject|1|||
155741647|NCT03255083|562154920|FG003|Overall Study|Withdrawal by Subject|0|||
155741648|NCT01457352|562154925|FG000|Period 1|Adverse Event|2|||
155741649|NCT01457352|562154926|FG001|Period 1|Adverse Event|0|||
155741650|NCT01457352|562154925|FG000|Period 1|Withdrawal by Subject|2|||
155741651|NCT01457352|562154926|FG001|Period 1|Withdrawal by Subject|0|||
155741652|NCT01457352|562154925|FG000|Period 1|Physician Decision|2|||
155741653|NCT01457352|562154926|FG001|Period 1|Physician Decision|0|||
155400514|NCT00282295|560899576|FG002|Overall Study|Serious Adverse Events|1|||
155400515|NCT00282295|560899574|FG000|Overall Study|Protocol Violation|0|||
155400516|NCT00282295|560899575|FG001|Overall Study|Protocol Violation|2|||
155400517|NCT00282295|560899576|FG002|Overall Study|Protocol Violation|1|||
155741654|NCT01457352|562154925|FG000|Period 1|MS related disease progression|1|||
155741655|NCT01457352|562154926|FG001|Period 1|MS related disease progression|0|||
155741656|NCT01457352|562154925|FG000|Period 1|Withdrawn|1|||
155741657|NCT01457352|562154926|FG001|Period 1|Withdrawn|0|||
155741658|NCT01457352|562154925|FG000|Period 1|withdrew per sponsor|1|||
155741659|NCT01457352|562154926|FG001|Period 1|withdrew per sponsor|0|||
155741660|NCT01457352|562154925|FG000|Period 1|Protocol Violation|4|||
155741661|NCT01457352|562154926|FG001|Period 1|Protocol Violation|0|||
155741662|NCT01457352|562154925|FG000|Period 1|Did not meet eligibility criteria|3|||
155741663|NCT01457352|562154926|FG001|Period 1|Did not meet eligibility criteria|0|||
155741664|NCT01457352|562154925|FG000|Period 2|Withdrawal by Subject|23|||
155400518|NCT00282295|560899574|FG000|Overall Study|Withdrawal by Subject|2|||
155400519|NCT00282295|560899575|FG001|Overall Study|Withdrawal by Subject|6|||
155400520|NCT00282295|560899576|FG002|Overall Study|Withdrawal by Subject|4|||
155400521|NCT00282295|560899574|FG000|Overall Study|Lost to Follow-up|1|||
155400522|NCT00282295|560899575|FG001|Overall Study|Lost to Follow-up|7|||
155400523|NCT00282295|560899576|FG002|Overall Study|Lost to Follow-up|2|||
155400524|NCT00282295|560899574|FG000|Overall Study|Other|0|||
155400525|NCT00282295|560899575|FG001|Overall Study|Other|1|||
155400526|NCT00282295|560899576|FG002|Overall Study|Other|0|||
155400527|NCT00430482|560899577|FG000|Completed Treatment|Insufficient Treatment|7|||
155400528|NCT00430482|560899578|FG001|Completed Treatment|Insufficient Treatment|11|||
155400529|NCT00574145|560901176|FG000|Overall Study|Withdrawal by Subject|2|||
155400530|NCT00574145|560901177|FG001|Overall Study|Withdrawal by Subject|1|||
155400531|NCT03227471|560901178|FG000|Overall Study|Withdrawal by Subject|0|||
155400532|NCT03227471|560901179|FG001|Overall Study|Withdrawal by Subject|0|||
155400533|NCT03227471|560901180|FG002|Overall Study|Withdrawal by Subject|0|||
155400534|NCT03227471|560901181|FG003|Overall Study|Withdrawal by Subject|0|||
155400535|NCT03227471|560901182|FG004|Overall Study|Withdrawal by Subject|1|||
155400536|NCT03227471|560901183|FG005|Overall Study|Withdrawal by Subject|0|||
155400537|NCT03227471|560901184|FG006|Overall Study|Withdrawal by Subject|0|||
155400538|NCT03227471|560901185|FG007|Overall Study|Withdrawal by Subject|0|||
155400539|NCT03227471|560901186|FG008|Overall Study|Withdrawal by Subject|0|||
155400540|NCT03227471|560901187|FG009|Overall Study|Withdrawal by Subject|0|||
155400541|NCT03227471|560901188|FG010|Overall Study|Withdrawal by Subject|0|||
155400542|NCT03227471|560901189|FG011|Overall Study|Withdrawal by Subject|0|||
155400543|NCT03227471|560901190|FG012|Overall Study|Withdrawal by Subject|1|||
155400544|NCT03227471|560901191|FG013|Overall Study|Withdrawal by Subject|0|||
155400545|NCT03227471|560901192|FG014|Overall Study|Withdrawal by Subject|0|||
155400546|NCT03227471|560901178|FG000|Overall Study|Randomized, Never Dosed|0|||
155400547|NCT03227471|560901179|FG001|Overall Study|Randomized, Never Dosed|0|||
155400548|NCT03227471|560901180|FG002|Overall Study|Randomized, Never Dosed|0|||
155400549|NCT03227471|560901181|FG003|Overall Study|Randomized, Never Dosed|0|||
155400550|NCT03227471|560901182|FG004|Overall Study|Randomized, Never Dosed|0|||
155400551|NCT03227471|560901183|FG005|Overall Study|Randomized, Never Dosed|0|||
155400552|NCT03227471|560901184|FG006|Overall Study|Randomized, Never Dosed|0|||
155400553|NCT03227471|560901185|FG007|Overall Study|Randomized, Never Dosed|0|||
155400554|NCT03227471|560901186|FG008|Overall Study|Randomized, Never Dosed|0|||
155400555|NCT03227471|560901187|FG009|Overall Study|Randomized, Never Dosed|0|||
155400556|NCT03227471|560901188|FG010|Overall Study|Randomized, Never Dosed|0|||
155400557|NCT03227471|560901189|FG011|Overall Study|Randomized, Never Dosed|0|||
155400558|NCT03227471|560901190|FG012|Overall Study|Randomized, Never Dosed|0|||
155400559|NCT03227471|560901191|FG013|Overall Study|Randomized, Never Dosed|0|||
155400560|NCT03227471|560901192|FG014|Overall Study|Randomized, Never Dosed|1|||
155400561|NCT00766038|560901195|FG000|Overall Study|Lost to Follow-up|15|||
155637005|NCT03112603|561762864|FG000|End of Cross Over Period|Adverse Event|0|||
155637006|NCT03112603|561762865|FG001|End of Cross Over Period|Adverse Event|0|||
155637007|NCT03112603|561762866|FG002|End of Cross Over Period|Adverse Event|6|||
155400562|NCT00766038|560901196|FG001|Overall Study|Lost to Follow-up|14|||
155400563|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
155400564|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
155637008|NCT03112603|561762864|FG000|End of Cross Over Period|Disease Relapse|0|||
155637009|NCT03112603|561762865|FG001|End of Cross Over Period|Disease Relapse|0|||
155637010|NCT03112603|561762866|FG002|End of Cross Over Period|Disease Relapse|2|||
155637011|NCT03839641|561762868|FG000|Overall Study|Withdrawal by Subject|1|||
155637012|NCT03839641|561762869|FG001|Overall Study|Withdrawal by Subject|1|||
155637013|NCT00876343|561762878|FG000|Overall Study|Adverse Event|7|||
155637014|NCT00876343|561762879|FG001|Overall Study|Adverse Event|8|||
155637015|NCT00876343|561762880|FG002|Overall Study|Adverse Event|2|||
155637016|NCT00876343|561762878|FG000|Overall Study|Withdrawal by Subject|4|||
155637017|NCT00876343|561762879|FG001|Overall Study|Withdrawal by Subject|4|||
155637018|NCT00876343|561762880|FG002|Overall Study|Withdrawal by Subject|3|||
155637019|NCT00876343|561762878|FG000|Overall Study|Lack of Efficacy|0|||
155637020|NCT00876343|561762879|FG001|Overall Study|Lack of Efficacy|0|||
155637021|NCT00876343|561762880|FG002|Overall Study|Lack of Efficacy|1|||
155637022|NCT00876343|561762878|FG000|Overall Study|Protocol Violation|4|||
155637023|NCT00876343|561762879|FG001|Overall Study|Protocol Violation|1|||
155637024|NCT00876343|561762880|FG002|Overall Study|Protocol Violation|1|||
155637025|NCT00876343|561762878|FG000|Overall Study|Physician Decision|0|||
155637026|NCT00876343|561762879|FG001|Overall Study|Physician Decision|1|||
155637027|NCT00876343|561762880|FG002|Overall Study|Physician Decision|1|||
155637028|NCT00876343|561762878|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
155637029|NCT00876343|561762879|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
155637030|NCT00876343|561762880|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
155741665|NCT01457352|562154926|FG001|Period 2|Withdrawal by Subject|0|||
155400565|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
155400566|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
155400567|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
155284778|NCT01941316|560474417|FG000|Overall Study|Progressive Disease|3|||
155400568|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
155400569|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
155400570|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
155400571|NCT00449670|560901197|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
155400572|NCT00449670|560901198|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
155400573|NCT00449670|560901197|FG000|Booster Phase (Study no.109873)|Other|0|||
155400574|NCT00449670|560901198|FG001|Booster Phase (Study no.109873)|Other|2|||
155400575|NCT00847145|560901202|FG000|Overall Study|AE or Death|0|||
155400576|NCT00847145|560901203|FG001|Overall Study|AE or Death|1|||
155400577|NCT00847145|560901204|FG002|Overall Study|AE or Death|1|||
155400578|NCT00847145|560901205|FG003|Overall Study|AE or Death|0|||
155400579|NCT00847145|560901206|FG004|Overall Study|AE or Death|0|||
155400580|NCT00847145|560901207|FG005|Overall Study|AE or Death|0|||
155400581|NCT00847145|560901208|FG006|Overall Study|AE or Death|0|||
155400582|NCT00847145|560901209|FG007|Overall Study|AE or Death|0|||
155400583|NCT00847145|560901202|FG000|Overall Study|Withdrawal by Subject|3|||
155400584|NCT00847145|560901203|FG001|Overall Study|Withdrawal by Subject|4|||
155400585|NCT00847145|560901204|FG002|Overall Study|Withdrawal by Subject|6|||
155637031|NCT00876343|561762878|FG000|Overall Study|Change of residence or other commitments|2|||
155637032|NCT00876343|561762879|FG001|Overall Study|Change of residence or other commitments|2|||
155637033|NCT00876343|561762880|FG002|Overall Study|Change of residence or other commitments|3|||
155637034|NCT02802228|561762884|FG000|Overall Study|Withdrawal by Subject|2|||
155637035|NCT02802228|561762885|FG001|Overall Study|Withdrawal by Subject|0|||
155637036|NCT02802228|561762884|FG000|Overall Study|Lost to Follow-up|1|||
155637037|NCT02802228|561762885|FG001|Overall Study|Lost to Follow-up|0|||
155637038|NCT02802228|561762884|FG000|Overall Study|Adverse Event|1|||
155637039|NCT02802228|561762885|FG001|Overall Study|Adverse Event|0|||
155637040|NCT02802228|561762884|FG000|Overall Study|Physician Decision|1|||
155637041|NCT02802228|561762885|FG001|Overall Study|Physician Decision|0|||
155637042|NCT00695019|561762888|FG000|Overall Study|Withdrawal by Subject|8|||
155637043|NCT00695019|561762889|FG001|Overall Study|Withdrawal by Subject|6|||
155637044|NCT00695019|561762890|FG002|Overall Study|Withdrawal by Subject|4|||
155637045|NCT00695019|561762888|FG000|Overall Study|Protocol Violation|1|||
155637046|NCT00695019|561762889|FG001|Overall Study|Protocol Violation|3|||
155637047|NCT00695019|561762890|FG002|Overall Study|Protocol Violation|1|||
155637048|NCT00695019|561762888|FG000|Overall Study|Lack of Efficacy|0|||
155637049|NCT00695019|561762889|FG001|Overall Study|Lack of Efficacy|0|||
155637050|NCT00695019|561762890|FG002|Overall Study|Lack of Efficacy|1|||
155637051|NCT00695019|561762888|FG000|Overall Study|Various|4|||
155637052|NCT00695019|561762889|FG001|Overall Study|Various|5|||
155637053|NCT00695019|561762890|FG002|Overall Study|Various|4|||
155637054|NCT00924898|561762891|FG000|Overall Study|Withdrawal by Subject|2|||
155637055|NCT04896385|561762894|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
155637056|NCT04896385|561762895|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
155637057|NCT04896385|561762896|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
155637058|NCT04896385|561762897|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155637059|NCT04896385|561762894|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
155637060|NCT04896385|561762895|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
155637061|NCT04896385|561762896|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155637062|NCT04896385|561762897|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155637063|NCT04896385|561762894|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155637064|NCT04896385|561762895|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155637065|NCT04896385|561762896|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
155637066|NCT04896385|561762897|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
155637067|NCT04896385|561762894|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155637068|NCT04896385|561762895|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155637069|NCT04896385|561762896|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
155637070|NCT04896385|561762897|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
155637071|NCT04896385|561762894|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
155637072|NCT04896385|561762895|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
155284779|NCT01941316|560474418|FG001|Overall Study|Progressive Disease|6|||
155400586|NCT00847145|560901205|FG003|Overall Study|Withdrawal by Subject|1|||
155637073|NCT04896385|561762896|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
155637074|NCT04896385|561762897|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
155637075|NCT04896385|561762894|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
155637076|NCT04896385|561762895|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
155637077|NCT04896385|561762896|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
155637078|NCT04896385|561762897|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
155637079|NCT05291689|561762901|FG000|Overall Study|Adverse Event|3|||
155400587|NCT00847145|560901206|FG004|Overall Study|Withdrawal by Subject|0|||
155400588|NCT00847145|560901207|FG005|Overall Study|Withdrawal by Subject|0|||
155400589|NCT00847145|560901208|FG006|Overall Study|Withdrawal by Subject|1|||
155741666|NCT01457352|562154925|FG000|Period 2|Adverse Event|22|||
155741667|NCT01457352|562154926|FG001|Period 2|Adverse Event|0|||
155741668|NCT01457352|562154925|FG000|Period 2|no analysis|10|||
155741669|NCT01457352|562154926|FG001|Period 2|no analysis|0|||
155741670|NCT01457352|562154925|FG000|Period 2|Lack of Efficacy|8|||
155741671|NCT01457352|562154926|FG001|Period 2|Lack of Efficacy|0|||
155741672|NCT01457352|562154925|FG000|Period 2|Protocol Violation|4|||
155741673|NCT01457352|562154926|FG001|Period 2|Protocol Violation|0|||
155741674|NCT01457352|562154925|FG000|Period 2|Sponsor's withdrawal|7|||
155741675|NCT01457352|562154926|FG001|Period 2|Sponsor's withdrawal|0|||
155741676|NCT01457352|562154925|FG000|Period 2|Lost to Follow-up|1|||
155741677|NCT01457352|562154926|FG001|Period 2|Lost to Follow-up|0|||
155741678|NCT01457352|562154925|FG000|Period 2|dose change|1|||
155741679|NCT01457352|562154926|FG001|Period 2|dose change|0|||
155741680|NCT01457352|562154925|FG000|Period 2|Physician Decision|1|||
155741681|NCT01457352|562154926|FG001|Period 2|Physician Decision|0|||
155741682|NCT01457352|562154925|FG000|Period 2|Did not meet eligibility criteria|3|||
155741683|NCT01457352|562154926|FG001|Period 2|Did not meet eligibility criteria|0|||
155741684|NCT01457352|562154925|FG000|Period 3|Adverse Event|1|||
155741685|NCT01457352|562154926|FG001|Period 3|Adverse Event|1|||
155741686|NCT01457352|562154925|FG000|Period 3|Withdrawal by Subject|0|||
155741687|NCT01457352|562154926|FG001|Period 3|Withdrawal by Subject|2|||
155741688|NCT01457352|562154925|FG000|Period 3|incorrect treatment|0|||
155741689|NCT01457352|562154926|FG001|Period 3|incorrect treatment|1|||
155741690|NCT01457352|562154925|FG000|Period 3|Sponsor's withdrawal|0|||
155741691|NCT01457352|562154926|FG001|Period 3|Sponsor's withdrawal|1|||
155741692|NCT02626624|562154927|FG000|Overall Study|Adverse Event|1|||
155741693|NCT02626624|562154927|FG000|Overall Study|Lost to Follow-up|3|||
155741694|NCT02626624|562154927|FG000|Overall Study|Protocol Violation|4|||
155741695|NCT02626624|562154927|FG000|Overall Study|Death|2|||
155741696|NCT04174365|562154930|FG000|Overall Study|Lost to Follow-up|1|||
155741697|NCT04174365|562154931|FG001|Overall Study|Lost to Follow-up|2|||
155741698|NCT04174365|562154930|FG000|Overall Study|Adverse Event|2|||
155284780|NCT01941316|560474419|FG002|Overall Study|Progressive Disease|2|||
155400590|NCT00847145|560901209|FG007|Overall Study|Withdrawal by Subject|1|||
155400591|NCT00847145|560901202|FG000|Overall Study|Lost to Follow-up|3|||
155400592|NCT00847145|560901203|FG001|Overall Study|Lost to Follow-up|1|||
155400593|NCT00847145|560901204|FG002|Overall Study|Lost to Follow-up|1|||
155400594|NCT00847145|560901205|FG003|Overall Study|Lost to Follow-up|0|||
155400595|NCT00847145|560901206|FG004|Overall Study|Lost to Follow-up|4|||
155400596|NCT00847145|560901207|FG005|Overall Study|Lost to Follow-up|4|||
155400597|NCT00847145|560901208|FG006|Overall Study|Lost to Follow-up|8|||
155400598|NCT00847145|560901209|FG007|Overall Study|Lost to Follow-up|2|||
155400599|NCT00847145|560901202|FG000|Overall Study|Inappropriate enrollment|0|||
155400600|NCT00847145|560901203|FG001|Overall Study|Inappropriate enrollment|0|||
155400601|NCT00847145|560901204|FG002|Overall Study|Inappropriate enrollment|0|||
155400602|NCT00847145|560901205|FG003|Overall Study|Inappropriate enrollment|0|||
155400603|NCT00847145|560901206|FG004|Overall Study|Inappropriate enrollment|1|||
155400604|NCT00847145|560901207|FG005|Overall Study|Inappropriate enrollment|0|||
155400605|NCT00847145|560901208|FG006|Overall Study|Inappropriate enrollment|0|||
155400606|NCT00847145|560901209|FG007|Overall Study|Inappropriate enrollment|0|||
155400607|NCT00847145|560901202|FG000|Overall Study|Protocol Violation|0|||
155400608|NCT00847145|560901203|FG001|Overall Study|Protocol Violation|0|||
155400609|NCT00847145|560901204|FG002|Overall Study|Protocol Violation|3|||
155400610|NCT00847145|560901205|FG003|Overall Study|Protocol Violation|0|||
155400611|NCT00847145|560901206|FG004|Overall Study|Protocol Violation|1|||
155400612|NCT00847145|560901207|FG005|Overall Study|Protocol Violation|0|||
155400613|NCT00847145|560901208|FG006|Overall Study|Protocol Violation|0|||
155741699|NCT04174365|562154931|FG001|Overall Study|Adverse Event|1|||
155741700|NCT04174365|562154930|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
155741701|NCT04174365|562154931|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
155741702|NCT04174365|562154930|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
155741703|NCT04174365|562154931|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
155741704|NCT04174365|562154930|FG000|Overall Study|Protocol Deviation|1|||
155400614|NCT00847145|560901209|FG007|Overall Study|Protocol Violation|1|||
155400615|NCT02833974|560901210|FG000|Overall Study|Lost to Follow-up|1|||
155400616|NCT02833974|560901211|FG001|Overall Study|Lost to Follow-up|0|||
155400617|NCT02833974|560901210|FG000|Overall Study|Adverse Event|0|||
155741705|NCT04174365|562154931|FG001|Overall Study|Protocol Deviation|0|||
155400618|NCT02833974|560901211|FG001|Overall Study|Adverse Event|3|||
155400619|NCT00833053|560901215|FG000|Overall Study|Adverse Event|4|||
155741706|NCT04174365|562154930|FG000|Overall Study|Lack of Efficacy|0|||
155400620|NCT00833053|560901216|FG001|Overall Study|Adverse Event|0|||
155400621|NCT00833053|560901215|FG000|Overall Study|Treatment Failure|3|||
155400622|NCT00833053|560901216|FG001|Overall Study|Treatment Failure|1|||
155741707|NCT04174365|562154931|FG001|Overall Study|Lack of Efficacy|2|||
155741708|NCT04174365|562154930|FG000|Overall Study|Disease Relapse|1|||
155741709|NCT04174365|562154931|FG001|Overall Study|Disease Relapse|0|||
155741710|NCT04174365|562154930|FG000|Overall Study|Reason Not Specified|0|||
155741711|NCT04174365|562154931|FG001|Overall Study|Reason Not Specified|1|||
155741712|NCT03472547|562154932|FG000|Overall Study|Withdrawal by Subject|30|||
155741713|NCT05141448|562154933|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155741714|NCT05141448|562154934|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
155741715|NCT05141448|562154935|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155741716|NCT05141448|562154936|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155741717|NCT05141448|562154937|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155741718|NCT05141448|562154938|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155741719|NCT05141448|562154933|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155741720|NCT05141448|562154934|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155741721|NCT05141448|562154935|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155741722|NCT05141448|562154936|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155741723|NCT05141448|562154937|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
155741724|NCT05141448|562154938|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155741725|NCT05141448|562154933|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155741726|NCT05141448|562154934|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
155400623|NCT00833053|560901215|FG000|Overall Study|Withdrawal by Subject|0|||
155400624|NCT00833053|560901216|FG001|Overall Study|Withdrawal by Subject|1|||
155400625|NCT00833053|560901215|FG000|Overall Study|Protocol Violation|2|||
155400626|NCT00833053|560901216|FG001|Overall Study|Protocol Violation|1|||
155400627|NCT02187471|560901217|FG000|Overall Study|Protocol Violation|4|||
155400628|NCT02187471|560901218|FG001|Overall Study|Protocol Violation|5|||
155400629|NCT02187471|560901219|FG002|Overall Study|Protocol Violation|4|||
155400630|NCT02187471|560901220|FG003|Overall Study|Protocol Violation|4|||
155400631|NCT02187471|560901217|FG000|Overall Study|Missing|0|||
155400632|NCT02187471|560901218|FG001|Overall Study|Missing|0|||
155400633|NCT02187471|560901219|FG002|Overall Study|Missing|0|||
155400634|NCT02187471|560901220|FG003|Overall Study|Missing|1|||
155400635|NCT02187471|560901217|FG000|Overall Study|Lack of Efficacy|18|||
155741727|NCT05141448|562154935|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155741728|NCT05141448|562154936|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155741729|NCT05141448|562154937|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155741730|NCT05141448|562154938|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155741731|NCT05141448|562154933|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155741732|NCT05141448|562154934|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155741733|NCT05141448|562154935|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155741734|NCT05141448|562154936|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155741735|NCT05141448|562154937|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155741736|NCT05141448|562154938|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155741737|NCT05141448|562154933|FG000|Period 2|COVID-19 Related|0|||
155741738|NCT05141448|562154934|FG001|Period 2|COVID-19 Related|0|||
155741739|NCT05141448|562154935|FG002|Period 2|COVID-19 Related|0|||
155741740|NCT05141448|562154936|FG003|Period 2|COVID-19 Related|1|||
155741741|NCT05141448|562154937|FG004|Period 2|COVID-19 Related|0|||
155741742|NCT05141448|562154938|FG005|Period 2|COVID-19 Related|1|||
155741743|NCT05141448|562154933|FG000|3|Covid-19 related|2|||
155741744|NCT05141448|562154934|FG001|3|Covid-19 related|0|||
155741745|NCT05141448|562154935|FG002|3|Covid-19 related|0|||
155741746|NCT05141448|562154936|FG003|3|Covid-19 related|0|||
155741747|NCT05141448|562154937|FG004|3|Covid-19 related|0|||
155741748|NCT05141448|562154938|FG005|3|Covid-19 related|1|||
155741749|NCT05141448|562154933|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
155741750|NCT05141448|562154934|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
155741751|NCT05141448|562154935|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
155741752|NCT05141448|562154936|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
155741753|NCT05141448|562154937|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
155741754|NCT05141448|562154938|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
155741755|NCT01106092|562156327|FG000|Overall Study|Withdrawal by Subject|0|||
155741756|NCT01106092|562156328|FG001|Overall Study|Withdrawal by Subject|0|||
155741757|NCT01106092|562156329|FG002|Overall Study|Withdrawal by Subject|0|||
155741758|NCT01106092|562156330|FG003|Overall Study|Withdrawal by Subject|1|||
155741759|NCT02434471|562156333|FG000|Overall Study|Physician Decision|9|||
155400636|NCT02187471|560901218|FG001|Overall Study|Lack of Efficacy|9|||
155400637|NCT02187471|560901219|FG002|Overall Study|Lack of Efficacy|13|||
155400638|NCT02187471|560901220|FG003|Overall Study|Lack of Efficacy|11|||
155400639|NCT02187471|560901217|FG000|Overall Study|Adverse Event|24|||
155400640|NCT02187471|560901218|FG001|Overall Study|Adverse Event|34|||
155400641|NCT02187471|560901219|FG002|Overall Study|Adverse Event|44|||
155400642|NCT02187471|560901220|FG003|Overall Study|Adverse Event|36|||
155400643|NCT02187471|560901217|FG000|Overall Study|Withdrawal by Subject|23|||
155400644|NCT02187471|560901218|FG001|Overall Study|Withdrawal by Subject|29|||
155400645|NCT02187471|560901219|FG002|Overall Study|Withdrawal by Subject|22|||
155400646|NCT02187471|560901220|FG003|Overall Study|Withdrawal by Subject|24|||
155400647|NCT02187471|560901217|FG000|Overall Study|Other|7|||
155400648|NCT02187471|560901218|FG001|Overall Study|Other|5|||
155400649|NCT02187471|560901219|FG002|Overall Study|Other|3|||
155400650|NCT02187471|560901220|FG003|Overall Study|Other|4|||
155400651|NCT02318667|560901221|FG000|Overall Study|Adverse Event|1|||
155400652|NCT02318667|560901221|FG000|Overall Study|Lack of Efficacy|6|||
155400653|NCT02318667|560901221|FG000|Overall Study|Protocol Violation|2|||
155400654|NCT02289742|560901222|FG000|First Wear Period|Adverse event prior to treatment|0|||
155400655|NCT02289742|560901223|FG001|First Wear Period|Adverse event prior to treatment|1|||
155400656|NCT02289742|560901224|FG002|First Wear Period|Adverse event prior to treatment|0|||
155400657|NCT02289742|560901225|FG003|First Wear Period|Adverse event prior to treatment|0|||
155400658|NCT02289742|560901222|FG000|First Wear Period|Adverse Event|0|||
155400659|NCT02289742|560901223|FG001|First Wear Period|Adverse Event|0|||
155400660|NCT02289742|560901224|FG002|First Wear Period|Adverse Event|1|||
155400661|NCT02289742|560901225|FG003|First Wear Period|Adverse Event|0|||
155400662|NCT02289742|560901222|FG000|First Wear Period|Other prior to treatment|0|||
155400663|NCT02289742|560901223|FG001|First Wear Period|Other prior to treatment|0|||
155400664|NCT02289742|560901224|FG002|First Wear Period|Other prior to treatment|0|||
155400665|NCT02289742|560901225|FG003|First Wear Period|Other prior to treatment|1|||
155400666|NCT02289742|560901222|FG000|Third Wear Period|Adverse Event|0|||
155400667|NCT02289742|560901223|FG001|Third Wear Period|Adverse Event|1|||
155400668|NCT02289742|560901224|FG002|Third Wear Period|Adverse Event|0|||
155400669|NCT02289742|560901225|FG003|Third Wear Period|Adverse Event|0|||
155400670|NCT02289742|560901222|FG000|Third Wear Period|Reason not given|0|||
155400671|NCT02289742|560901223|FG001|Third Wear Period|Reason not given|0|||
155400672|NCT02289742|560901224|FG002|Third Wear Period|Reason not given|0|||
155400673|NCT02289742|560901225|FG003|Third Wear Period|Reason not given|1|||
155400674|NCT02865018|560901226|FG000|Overall Study|Withdrawal by Subject|1|||
155400675|NCT01365039|560901227|FG000|Overall Study|Study related symptoms and complaints|1|||
155400676|NCT01365039|560901228|FG001|Overall Study|Study related symptoms and complaints|0|||
155400677|NCT00294060|560901231|FG000|Overall Study|Death|225|||
155400678|NCT00294060|560901231|FG000|Overall Study|Other|59|||
155400679|NCT00294060|560901231|FG000|Overall Study|Lost to Follow-up|55|||
155400680|NCT00294060|560901231|FG000|Overall Study|Withdrawal by Subject|11|||
155400681|NCT00294060|560901231|FG000|Overall Study|Physician Decision|797|||
155400682|NCT00294060|560901231|FG000|Overall Study|Medical condition|3|||
155400683|NCT00294060|560901231|FG000|Overall Study|Device explanted/not replaced|23|||
155400684|NCT01360554|560901232|FG000|Overall Study|Death|359|||
155400685|NCT01360554|560901233|FG001|Overall Study|Death|371|||
155400686|NCT01360554|560901232|FG000|Overall Study|Lost to Follow-up|4|||
155400687|NCT01360554|560901233|FG001|Overall Study|Lost to Follow-up|4|||
155400688|NCT01360554|560901232|FG000|Overall Study|Withdrawal by Subject|23|||
155400689|NCT01360554|560901233|FG001|Overall Study|Withdrawal by Subject|24|||
155400690|NCT01360554|560901232|FG000|Overall Study|Study terminated by sponsor|49|||
155400691|NCT01360554|560901233|FG001|Overall Study|Study terminated by sponsor|37|||
155400692|NCT01360554|560901232|FG000|Overall Study|Other, not specified|1|||
155400693|NCT01360554|560901233|FG001|Overall Study|Other, not specified|0|||
155741760|NCT01604278|562156338|FG000|Overall Study|Lack of Efficacy|0|||
155400694|NCT01360554|560901232|FG000|Overall Study|Randomized but not treated.|3|||
155400695|NCT01360554|560901233|FG001|Overall Study|Randomized but not treated.|3|||
155400696|NCT03668600|560901234|FG000|Overall Study|Study Terminated by the Sponsor|157|||
155400697|NCT03668600|560901234|FG000|Overall Study|Protocol Violation|1|||
155741761|NCT01604278|562156339|FG001|Overall Study|Lack of Efficacy|1|||
155741762|NCT01604278|562156338|FG000|Overall Study|Lost to Follow-up|1|||
155741763|NCT01604278|562156339|FG001|Overall Study|Lost to Follow-up|0|||
155400698|NCT03668600|560901234|FG000|Overall Study|Pregnancy|1|||
155741764|NCT01604278|562156338|FG000|Overall Study|Administrative problems|2|||
155741765|NCT01604278|562156339|FG001|Overall Study|Administrative problems|1|||
155741766|NCT01604278|562156338|FG000|Overall Study|Withdrawal by Subject|3|||
155741767|NCT01604278|562156339|FG001|Overall Study|Withdrawal by Subject|3|||
155741768|NCT01604278|562156338|FG000|Overall Study|Adverse Event|3|||
155400699|NCT03668600|560901234|FG000|Overall Study|Lost to Follow-up|7|||
155400700|NCT03668600|560901234|FG000|Overall Study|Withdrawal by Subject|56|||
155741769|NCT01604278|562156339|FG001|Overall Study|Adverse Event|5|||
155741770|NCT01604278|562156338|FG000|Overall Study|Protocol Deviation|5|||
155741771|NCT01604278|562156339|FG001|Overall Study|Protocol Deviation|3|||
155400701|NCT03668600|560901234|FG000|Overall Study|Lack of Efficacy|7|||
155400702|NCT03668600|560901234|FG000|Overall Study|Adverse Event|1|||
155400703|NCT00424749|560901236|FG000|Overall Study|Withdrawal by Subject|1|||
155400704|NCT01263483|560901237|FG000|Overall Study|Adverse Event|4|||
155400705|NCT01263483|560901238|FG001|Overall Study|Adverse Event|0|||
155400706|NCT01263483|560901239|FG002|Overall Study|Adverse Event|3|||
155400707|NCT01263483|560901237|FG000|Overall Study|Withdrawal by Subject|1|||
155400708|NCT01263483|560901238|FG001|Overall Study|Withdrawal by Subject|0|||
155741772|NCT02870933|562156340|FG000|Overall Study|Death|2|||
155741773|NCT02870933|562156341|FG001|Overall Study|Death|1|||
155400709|NCT01263483|560901239|FG002|Overall Study|Withdrawal by Subject|0|||
155400710|NCT01263483|560901237|FG000|Overall Study|Lack of Efficacy|2|||
155400711|NCT01263483|560901238|FG001|Overall Study|Lack of Efficacy|0|||
155400712|NCT01263483|560901239|FG002|Overall Study|Lack of Efficacy|0|||
155400713|NCT01263483|560901237|FG000|Overall Study|Protocol Violation|0|||
155400714|NCT01263483|560901238|FG001|Overall Study|Protocol Violation|1|||
155400715|NCT01263483|560901239|FG002|Overall Study|Protocol Violation|1|||
155400716|NCT01263483|560901237|FG000|Overall Study|Participant Unavailability|0|||
155400717|NCT01263483|560901238|FG001|Overall Study|Participant Unavailability|1|||
155400718|NCT01263483|560901239|FG002|Overall Study|Participant Unavailability|1|||
155400719|NCT05500274|560901245|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
155400720|NCT05500274|560901246|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
155400721|NCT05500274|560901245|FG000|Overall Study|Lost to Follow-up|76|||
155400722|NCT05500274|560901246|FG001|Overall Study|Lost to Follow-up|51|||
155400723|NCT05807464|560901249|FG000|Overall Study|Adverse Event|1|||
155400724|NCT01555151|560901250|FG000|Overall Study|Withdrawal by Subject|6|||
155400725|NCT01555151|560901251|FG001|Overall Study|Withdrawal by Subject|2|||
155400726|NCT01555151|560901252|FG002|Overall Study|Withdrawal by Subject|0|||
155284781|NCT01941316|560474420|FG003|Overall Study|Progressive Disease|29|||
155637080|NCT05291689|561762901|FG000|Overall Study|Lack of Efficacy|10|||
155637081|NCT05291689|561762901|FG000|Overall Study|Withdrawal by Subject|4|||
155637082|NCT01931098|561762902|FG000|Overall Study|Withdrawal by Subject|0|||
155637083|NCT01931098|561762903|FG001|Overall Study|Withdrawal by Subject|1|||
155637084|NCT01931098|561762902|FG000|Overall Study|Enrolled in different protocol|0|||
155637085|NCT01931098|561762903|FG001|Overall Study|Enrolled in different protocol|1|||
155637086|NCT01931098|561762902|FG000|Overall Study|Unable to begin trmt:active infection|0|||
155637087|NCT01931098|561762903|FG001|Overall Study|Unable to begin trmt:active infection|1|||
155637088|NCT01931098|561762902|FG000|Overall Study|Refused further treatment|0|||
155637089|NCT01931098|561762903|FG001|Overall Study|Refused further treatment|1|||
155637090|NCT02278354|561762907|FG000|Overall Study|Lost to Follow-up|2|||
155637091|NCT02278354|561762908|FG001|Overall Study|Lost to Follow-up|2|||
155637092|NCT02278354|561762907|FG000|Overall Study|Withdrawal by Subject|0|||
155637093|NCT02278354|561762908|FG001|Overall Study|Withdrawal by Subject|1|||
155637094|NCT02278354|561762907|FG000|Overall Study|<10 professional fights|2|||
155637095|NCT02278354|561762908|FG001|Overall Study|<10 professional fights|0|||
155637096|NCT01901562|561762913|FG000|Overall Study|Protocol Violation|5|||
155637097|NCT01901562|561762913|FG000|Overall Study|Excluded intraoperatively|4|||
155637098|NCT01925794|561762914|FG000|180 Days|Death|2|||
155637099|NCT01925794|561762914|FG000|180 Days|Withdrawal by Subject|2|||
155637100|NCT01925794|561762914|FG000|270 Days|Death|2|||
155637101|NCT01925794|561762914|FG000|270 Days|Protocol Violation|3|||
155637102|NCT02612155|561762915|FG000|Overall Study|Death|1|||
155637103|NCT02612155|561762916|FG001|Overall Study|Death|1|||
155637104|NCT02612155|561762915|FG000|Overall Study|Lost to Follow-up|2|||
155637105|NCT02612155|561762916|FG001|Overall Study|Lost to Follow-up|2|||
155637106|NCT01564407|561762925|FG000|Overall Study|Lost to Follow-up|0|||
155637107|NCT01564407|561762926|FG001|Overall Study|Lost to Follow-up|1|||
155637108|NCT01564407|561762927|FG002|Overall Study|Lost to Follow-up|0|||
155637109|NCT01564407|561762928|FG003|Overall Study|Lost to Follow-up|0|||
155637110|NCT01564407|561762929|FG004|Overall Study|Lost to Follow-up|0|||
155637111|NCT01564407|561762925|FG000|Overall Study|Withdrawal by Subject|0|||
155637112|NCT01564407|561762926|FG001|Overall Study|Withdrawal by Subject|1|||
155637113|NCT01564407|561762927|FG002|Overall Study|Withdrawal by Subject|0|||
155637114|NCT01564407|561762928|FG003|Overall Study|Withdrawal by Subject|0|||
155637115|NCT01564407|561762929|FG004|Overall Study|Withdrawal by Subject|0|||
155637116|NCT01564407|561762925|FG000|Overall Study|funding lost, study ended|0|||
155637117|NCT01564407|561762926|FG001|Overall Study|funding lost, study ended|0|||
155637118|NCT01564407|561762927|FG002|Overall Study|funding lost, study ended|0|||
155637119|NCT01564407|561762928|FG003|Overall Study|funding lost, study ended|1|||
155637120|NCT01564407|561762929|FG004|Overall Study|funding lost, study ended|0|||
155637121|NCT04235374|561762932|FG000|Overall Study|Death|91|||
155637122|NCT04235374|561762933|FG001|Overall Study|Death|91|||
155637123|NCT04235374|561762932|FG000|Overall Study|Refused|2|||
155637124|NCT04235374|561762933|FG001|Overall Study|Refused|2|||
155637125|NCT04235374|561762932|FG000|Overall Study|Unavailable|12|||
155637126|NCT04235374|561762933|FG001|Overall Study|Unavailable|3|||
155637127|NCT04235374|561762932|FG000|Overall Study|Withdrawal by Subject|0|||
155637128|NCT04235374|561762933|FG001|Overall Study|Withdrawal by Subject|1|||
155637129|NCT04235374|561762932|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
155637130|NCT04235374|561762933|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
155741774|NCT02870933|562156340|FG000|Overall Study|Withdrawal by Subject|0|||
155637131|NCT00294658|561762934|FG000|Overall Study|Death|0|||
155400727|NCT01555151|560901253|FG003|Overall Study|Withdrawal by Subject|2|||
155400728|NCT01555151|560901250|FG000|Overall Study|Administrative|3|||
155400729|NCT01555151|560901251|FG001|Overall Study|Administrative|1|||
155400730|NCT01555151|560901252|FG002|Overall Study|Administrative|2|||
155637132|NCT00294658|561762935|FG001|Overall Study|Death|1|||
155741775|NCT02870933|562156341|FG001|Overall Study|Withdrawal by Subject|1|||
155400731|NCT01555151|560901253|FG003|Overall Study|Administrative|0|||
155400732|NCT01555151|560901250|FG000|Overall Study|Protocol Violation|3|||
155400733|NCT01555151|560901251|FG001|Overall Study|Protocol Violation|3|||
155400734|NCT01555151|560901252|FG002|Overall Study|Protocol Violation|3|||
155400735|NCT01555151|560901253|FG003|Overall Study|Protocol Violation|5|||
155400736|NCT01555151|560901250|FG000|Overall Study|Adverse Event|1|||
155400737|NCT01555151|560901251|FG001|Overall Study|Adverse Event|2|||
155400738|NCT01555151|560901252|FG002|Overall Study|Adverse Event|1|||
155400739|NCT01555151|560901253|FG003|Overall Study|Adverse Event|2|||
155400740|NCT01555151|560901250|FG000|Overall Study|Lost to Follow-up|0|||
155400741|NCT01555151|560901251|FG001|Overall Study|Lost to Follow-up|0|||
155400742|NCT01555151|560901252|FG002|Overall Study|Lost to Follow-up|0|||
155400743|NCT01555151|560901253|FG003|Overall Study|Lost to Follow-up|1|||
155400744|NCT03596866|560901254|FG000|Overall Study|Site terminated by Sponsor|64|||
155400745|NCT03596866|560901255|FG001|Overall Study|Site terminated by Sponsor|65|||
155400746|NCT03596866|560901254|FG000|Overall Study|Death|37|||
155400747|NCT03596866|560901255|FG001|Overall Study|Death|24|||
155400748|NCT03596866|560901254|FG000|Overall Study|Withdrawal by Subject|4|||
155400749|NCT03596866|560901255|FG001|Overall Study|Withdrawal by Subject|6|||
155400750|NCT03596866|560901254|FG000|Overall Study|Missing|0|||
155400751|NCT03596866|560901255|FG001|Overall Study|Missing|6|||
155400752|NCT03596866|560901254|FG000|Overall Study|Lost to Follow-up|2|||
155400753|NCT03596866|560901255|FG001|Overall Study|Lost to Follow-up|3|||
155400754|NCT03596866|560901254|FG000|Overall Study|Protocol Violation|1|||
155400755|NCT03596866|560901255|FG001|Overall Study|Protocol Violation|0|||
155400756|NCT03596866|560901254|FG000|Overall Study|Reason Not Specified|14|||
155400757|NCT03596866|560901255|FG001|Overall Study|Reason Not Specified|13|||
155400758|NCT02343159|560901257|FG000|Overall Study|Early Study Termination|16|||
155400759|NCT02343159|560901258|FG001|Overall Study|Early Study Termination|19|||
155400760|NCT02343159|560901259|FG002|Overall Study|Early Study Termination|23|||
155400761|NCT02343159|560901257|FG000|Overall Study|Physician Decision|2|||
155400762|NCT02343159|560901258|FG001|Overall Study|Physician Decision|0|||
155400763|NCT02343159|560901259|FG002|Overall Study|Physician Decision|1|||
155400764|NCT02343159|560901257|FG000|Overall Study|Withdrawal by Subject|3|||
155400765|NCT02343159|560901258|FG001|Overall Study|Withdrawal by Subject|0|||
155400766|NCT02343159|560901259|FG002|Overall Study|Withdrawal by Subject|2|||
155400767|NCT02343159|560901257|FG000|Overall Study|Lost to Follow-up|0|||
155400768|NCT02343159|560901258|FG001|Overall Study|Lost to Follow-up|2|||
155400769|NCT02343159|560901259|FG002|Overall Study|Lost to Follow-up|2|||
155400770|NCT02343159|560901257|FG000|Overall Study|Adverse Event|4|||
155400771|NCT02343159|560901258|FG001|Overall Study|Adverse Event|4|||
155400772|NCT02343159|560901259|FG002|Overall Study|Adverse Event|2|||
155400773|NCT02343159|560901257|FG000|Overall Study|Sponsor Decision|0|||
155400774|NCT02343159|560901258|FG001|Overall Study|Sponsor Decision|1|||
155400775|NCT02343159|560901259|FG002|Overall Study|Sponsor Decision|0|||
155400776|NCT02343159|560901257|FG000|Overall Study|Enrollment Error|1|||
155400777|NCT02343159|560901258|FG001|Overall Study|Enrollment Error|0|||
155400778|NCT02343159|560901259|FG002|Overall Study|Enrollment Error|0|||
155400779|NCT02114268|560901262|FG000|Overall Study|Lost to Follow-up|4|||
155400780|NCT02114268|560901263|FG001|Overall Study|Lost to Follow-up|1|||
155400781|NCT02114268|560901264|FG002|Overall Study|Lost to Follow-up|1|||
155400782|NCT02114268|560901265|FG003|Overall Study|Lost to Follow-up|0|||
155400783|NCT02114268|560901266|FG004|Overall Study|Lost to Follow-up|0|||
155400784|NCT02114268|560901267|FG005|Overall Study|Lost to Follow-up|2|||
155400785|NCT02114268|560901262|FG000|Overall Study|Withdrawal by Subject|1|||
155400786|NCT02114268|560901263|FG001|Overall Study|Withdrawal by Subject|0|||
155400787|NCT02114268|560901264|FG002|Overall Study|Withdrawal by Subject|0|||
155400788|NCT02114268|560901265|FG003|Overall Study|Withdrawal by Subject|0|||
155400789|NCT02114268|560901266|FG004|Overall Study|Withdrawal by Subject|0|||
155400790|NCT02114268|560901267|FG005|Overall Study|Withdrawal by Subject|1|||
155400791|NCT02114268|560901262|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
155400792|NCT02114268|560901263|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
155400793|NCT02114268|560901264|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
155400794|NCT02114268|560901265|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
155741776|NCT01252667|562156342|FG000|Overall Study|Transplant aborted post-conditioning|0|||
155741777|NCT01252667|562156343|FG001|Overall Study|Transplant aborted post-conditioning|0|||
155400795|NCT02114268|560901266|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
155741778|NCT01252667|562156344|FG002|Overall Study|Transplant aborted post-conditioning|0|||
155741779|NCT01252667|562156345|FG003|Overall Study|Transplant aborted post-conditioning|0|||
155400796|NCT02114268|560901267|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
155400797|NCT01431274|560901272|FG000|Overall Study|Adverse Event|51|||
155400798|NCT01431274|560901273|FG001|Overall Study|Adverse Event|37|||
155494226|NCT00602927|561234233|FG000|Period 3: 13 Days|MRI data quality|2|||
155400799|NCT01431274|560901274|FG002|Overall Study|Adverse Event|43|||
155400800|NCT01431274|560901275|FG003|Overall Study|Adverse Event|30|||
155400801|NCT01431274|560901276|FG004|Overall Study|Adverse Event|37|||
155400802|NCT01431274|560901272|FG000|Overall Study|Consent withdrawn not due to AE|29|||
155400803|NCT01431274|560901273|FG001|Overall Study|Consent withdrawn not due to AE|20|||
155400804|NCT01431274|560901274|FG002|Overall Study|Consent withdrawn not due to AE|17|||
155400805|NCT01431274|560901275|FG003|Overall Study|Consent withdrawn not due to AE|20|||
155400806|NCT01431274|560901276|FG004|Overall Study|Consent withdrawn not due to AE|11|||
155400807|NCT01431274|560901272|FG000|Overall Study|Non compliant with protocol|5|||
155400808|NCT01431274|560901273|FG001|Overall Study|Non compliant with protocol|8|||
155400809|NCT01431274|560901274|FG002|Overall Study|Non compliant with protocol|4|||
155400810|NCT01431274|560901275|FG003|Overall Study|Non compliant with protocol|4|||
155400811|NCT01431274|560901276|FG004|Overall Study|Non compliant with protocol|4|||
155400812|NCT01431274|560901272|FG000|Overall Study|Lost to Follow-up|6|||
155400813|NCT01431274|560901273|FG001|Overall Study|Lost to Follow-up|7|||
155400814|NCT01431274|560901274|FG002|Overall Study|Lost to Follow-up|1|||
155400815|NCT01431274|560901275|FG003|Overall Study|Lost to Follow-up|4|||
155400816|NCT01431274|560901276|FG004|Overall Study|Lost to Follow-up|0|||
155400817|NCT01431274|560901272|FG000|Overall Study|Other reason not stated above|6|||
155400818|NCT01431274|560901273|FG001|Overall Study|Other reason not stated above|5|||
155400819|NCT01431274|560901274|FG002|Overall Study|Other reason not stated above|7|||
155741780|NCT01252667|562156346|FG004|Overall Study|Transplant aborted post-conditioning|0|||
155741781|NCT01252667|562156347|FG005|Overall Study|Transplant aborted post-conditioning|1|||
155741782|NCT01738646|562156348|FG000|Overall Study|Still Receiving Treatment|2|||
155400820|NCT01431274|560901275|FG003|Overall Study|Other reason not stated above|2|||
155400821|NCT01431274|560901276|FG004|Overall Study|Other reason not stated above|4|||
155400822|NCT00003702|560901277|FG000|Overall Study|Ineligible cell types|2|||
155400823|NCT00003702|560901278|FG001|Overall Study|Ineligible cell types|2|||
155400824|NCT00003702|560901277|FG000|Overall Study|Did not meet criteria for persistence|8|||
155400825|NCT00003702|560901278|FG001|Overall Study|Did not meet criteria for persistence|5|||
155400826|NCT00003702|560901277|FG000|Overall Study|WHO score > 6|2|||
155400827|NCT00003702|560901278|FG001|Overall Study|WHO score > 6|1|||
155400828|NCT00003702|560901277|FG000|Overall Study|Inadequate documentation of disease|1|||
155400829|NCT00003702|560901278|FG001|Overall Study|Inadequate documentation of disease|3|||
155400830|NCT02790138|560901279|FG000|Overall Study|Adverse Event|5|||
155400831|NCT02790138|560901280|FG001|Overall Study|Adverse Event|2|||
155400832|NCT02790138|560901279|FG000|Overall Study|Significant Protocol Deviation|0|||
155400833|NCT02790138|560901280|FG001|Overall Study|Significant Protocol Deviation|1|||
155400834|NCT02790138|560901279|FG000|Overall Study|Lost to Follow-up|1|||
155400835|NCT02790138|560901280|FG001|Overall Study|Lost to Follow-up|0|||
155400836|NCT02790138|560901279|FG000|Overall Study|Voluntary Withdrawal|8|||
155400837|NCT02790138|560901280|FG001|Overall Study|Voluntary Withdrawal|9|||
155400838|NCT02790138|560901279|FG000|Overall Study|Lack of Efficacy|6|||
155400839|NCT02790138|560901280|FG001|Overall Study|Lack of Efficacy|7|||
155400840|NCT02790138|560901279|FG000|Overall Study|Reason not Specified|1|||
155400841|NCT02790138|560901280|FG001|Overall Study|Reason not Specified|0|||
155400842|NCT04037748|560901281|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155400843|NCT04037748|560901282|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155400844|NCT04037748|560901281|FG000|Treatment Period 1|Adverse Event|1|||
155400845|NCT04037748|560901282|FG001|Treatment Period 1|Adverse Event|1|||
155400846|NCT04037748|560901281|FG000|Treatment Period 1|Protocol Violation|4|||
155400847|NCT04037748|560901282|FG001|Treatment Period 1|Protocol Violation|5|||
155400848|NCT04037748|560901281|FG000|Treatment Period 2|Adverse Event|0|||
155400849|NCT04037748|560901282|FG001|Treatment Period 2|Adverse Event|1|||
155400850|NCT04037748|560901281|FG000|Treatment Period 2|Protocol Violation|2|||
155400851|NCT04037748|560901282|FG001|Treatment Period 2|Protocol Violation|0|||
155400852|NCT04702737|560901283|FG000|Overall Study|Decision by Sponsor|1|||
155400853|NCT04702737|560901283|FG000|Overall Study|Withdrawal of Consent from Study|3|||
155400854|NCT04702737|560901283|FG000|Overall Study|Lost to Follow-up|1|||
155400855|NCT04702737|560901283|FG000|Overall Study|Death|35|||
155741783|NCT03642132|562156349|FG000|Chemotherapy Period|Adverse Event|1|||
155741784|NCT03642132|562156350|FG001|Chemotherapy Period|Adverse Event|1|||
155741785|NCT03642132|562156351|FG002|Chemotherapy Period|Adverse Event|0|||
155741786|NCT03642132|562156349|FG000|Chemotherapy Period|Physician's decision|4|||
155400856|NCT02047253|560901284|FG000|Overall Study|Lost to Follow-up|8|||
155400857|NCT03472924|560901286|FG000|Overall Study|Adverse Event|1|||
155400858|NCT03472924|560901287|FG001|Overall Study|Adverse Event|0|||
155400859|NCT05318937|560901294|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155400860|NCT05318937|560901295|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155400861|NCT05318937|560901294|FG000|Overall Study|Lost to Follow-up|0|||
155400862|NCT05318937|560901295|FG001|Overall Study|Lost to Follow-up|1|||
155400863|NCT05318937|560901294|FG000|Overall Study|Withdrawal by Subject|0|||
155400864|NCT05318937|560901295|FG001|Overall Study|Withdrawal by Subject|2|||
155400865|NCT05318937|560901294|FG000|Overall Study|Protocol Violation|0|||
155400866|NCT05318937|560901295|FG001|Overall Study|Protocol Violation|1|||
155400867|NCT01877915|560901296|FG000|Overall Study|Lost to Follow-up|10|||
155400868|NCT01877915|560901297|FG001|Overall Study|Lost to Follow-up|9|||
155400869|NCT01877915|560901296|FG000|Overall Study|Withdrawal by Subject|42|||
155741787|NCT03642132|562156350|FG001|Chemotherapy Period|Physician's decision|1|||
155741788|NCT03642132|562156351|FG002|Chemotherapy Period|Physician's decision|0|||
155400870|NCT01877915|560901297|FG001|Overall Study|Withdrawal by Subject|55|||
155400871|NCT01877915|560901296|FG000|Overall Study|Other|2|||
155400872|NCT01877915|560901297|FG001|Overall Study|Other|4|||
155400873|NCT01045798|560901298|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
155637133|NCT00294658|561762934|FG000|Overall Study|Lost to Follow-up|4|||
155637134|NCT00294658|561762935|FG001|Overall Study|Lost to Follow-up|0|||
155637135|NCT00294658|561762934|FG000|Overall Study|Physician Decision|1|||
155637136|NCT00294658|561762935|FG001|Overall Study|Physician Decision|2|||
155637137|NCT00294658|561762934|FG000|Overall Study|Pregnancy|0|||
155637138|NCT00294658|561762935|FG001|Overall Study|Pregnancy|1|||
155637139|NCT00294658|561762934|FG000|Overall Study|Withdrawal by Subject|0|||
155637140|NCT00294658|561762935|FG001|Overall Study|Withdrawal by Subject|4|||
155637141|NCT00294658|561762934|FG000|Overall Study|Found to have invasive thymoma|1|||
155637142|NCT00294658|561762935|FG001|Overall Study|Found to have invasive thymoma|0|||
155637143|NCT00294658|561762934|FG000|Overall Study|Patient and family were not satisfied|0|||
155637144|NCT00294658|561762935|FG001|Overall Study|Patient and family were not satisfied|1|||
155637145|NCT05049122|561762938|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
155637146|NCT05049122|561762938|FG000|Overall Study|Participant moved|1|||
155637147|NCT05049122|561762938|FG000|Overall Study|At the direction of the doctor|1|||
155637148|NCT01910441|561762939|FG000|Overall Study|Sponsor decision|0|||
155637149|NCT01910441|561762940|FG001|Overall Study|Sponsor decision|2|||
155637150|NCT01910441|561762939|FG000|Overall Study|Lost to Follow-up|6|||
155637151|NCT01910441|561762940|FG001|Overall Study|Lost to Follow-up|5|||
155637152|NCT01910441|561762939|FG000|Overall Study|Withdrawal by Subject|0|||
155637153|NCT01910441|561762940|FG001|Overall Study|Withdrawal by Subject|1|||
155637154|NCT01910441|561762939|FG000|Overall Study|Non-compliance|0|||
155637155|NCT01910441|561762940|FG001|Overall Study|Non-compliance|1|||
155637156|NCT01910441|561762939|FG000|Overall Study|Adverse Event|1|||
155637157|NCT01910441|561762940|FG001|Overall Study|Adverse Event|0|||
155637158|NCT01910441|561762939|FG000|Overall Study|Physician Decision|0|||
155637159|NCT01910441|561762940|FG001|Overall Study|Physician Decision|1|||
155637160|NCT05168800|561762941|FG000|Time 1 Survey|Did not start T1 survey|182|||
155637161|NCT05168800|561762942|FG001|Time 1 Survey|Did not start T1 survey|150|||
155637162|NCT05168800|561762943|FG002|Time 1 Survey|Did not start T1 survey|140|||
155637163|NCT05168800|561762941|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
155637164|NCT05168800|561762942|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
155637165|NCT05168800|561762943|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
155637166|NCT05168800|561762941|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
155637167|NCT05168800|561762942|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
155637168|NCT05168800|561762943|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
155637169|NCT05168800|561762941|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
155637170|NCT05168800|561762942|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
155637171|NCT05168800|561762943|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
155637172|NCT05168800|561762941|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
155637173|NCT05168800|561762942|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
155637174|NCT05168800|561762943|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
155637175|NCT05168800|561762941|FG000|Time 1 Survey|Withdrawal by Subject|6|||
155637176|NCT05168800|561762942|FG001|Time 1 Survey|Withdrawal by Subject|3|||
155637177|NCT05168800|561762943|FG002|Time 1 Survey|Withdrawal by Subject|2|||
155637178|NCT05168800|561762941|FG000|Time 2 Survey|Already excluded at Time 1|228|||
155637179|NCT05168800|561762942|FG001|Time 2 Survey|Already excluded at Time 1|202|||
155637180|NCT05168800|561762943|FG002|Time 2 Survey|Already excluded at Time 1|173|||
155637181|NCT05168800|561762941|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
155637182|NCT05168800|561762942|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
155637183|NCT05168800|561762943|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
155637184|NCT05168800|561762941|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
155637185|NCT05168800|561762942|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
155637186|NCT05168800|561762943|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
155637187|NCT05168800|561762941|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
155637188|NCT05168800|561762942|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
155637189|NCT05168800|561762943|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
155637190|NCT05168800|561762941|FG000|Time 2 Survey|Withdrawal by Subject|1|||
155637191|NCT05168800|561762942|FG001|Time 2 Survey|Withdrawal by Subject|0|||
155637192|NCT05168800|561762943|FG002|Time 2 Survey|Withdrawal by Subject|1|||
155637193|NCT05168800|561762941|FG000|Time 3 Survey|Already excluded at Time 1|228|||
155637194|NCT05168800|561762942|FG001|Time 3 Survey|Already excluded at Time 1|200|||
155741789|NCT03642132|562156349|FG000|Chemotherapy Period|Progressive disease|0|||
155637195|NCT05168800|561762943|FG002|Time 3 Survey|Already excluded at Time 1|173|||
155637196|NCT05168800|561762941|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
155637197|NCT05168800|561762942|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
155637198|NCT05168800|561762943|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
155741790|NCT03642132|562156350|FG001|Chemotherapy Period|Progressive disease|0|||
155400874|NCT01045798|560901299|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
155400875|NCT01045798|560901298|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
155400876|NCT01045798|560901299|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
155400877|NCT01045798|560901298|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
155400878|NCT01045798|560901299|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
155400879|NCT01045798|560901298|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
155400880|NCT01045798|560901299|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
155400881|NCT01449461|560901300|FG000|Overall Study|Adverse Event|0|||
155400882|NCT01449461|560901301|FG001|Overall Study|Adverse Event|3|||
155400883|NCT01449461|560901302|FG002|Overall Study|Adverse Event|2|||
155400884|NCT01449461|560901303|FG003|Overall Study|Adverse Event|3|||
155400885|NCT01449461|560901304|FG004|Overall Study|Adverse Event|4|||
155400886|NCT01449461|560901305|FG005|Overall Study|Adverse Event|4|||
155400887|NCT01449461|560901300|FG000|Overall Study|Death|0|||
155400888|NCT01449461|560901301|FG001|Overall Study|Death|2|||
155400889|NCT01449461|560901302|FG002|Overall Study|Death|0|||
155400890|NCT01449461|560901303|FG003|Overall Study|Death|0|||
155400891|NCT01449461|560901304|FG004|Overall Study|Death|7|||
155400892|NCT01449461|560901305|FG005|Overall Study|Death|1|||
155400893|NCT01449461|560901300|FG000|Overall Study|Physician Decision|0|||
155400894|NCT01449461|560901301|FG001|Overall Study|Physician Decision|1|||
155400895|NCT01449461|560901302|FG002|Overall Study|Physician Decision|0|||
155400896|NCT01449461|560901303|FG003|Overall Study|Physician Decision|4|||
155400897|NCT01449461|560901304|FG004|Overall Study|Physician Decision|1|||
155400898|NCT01449461|560901305|FG005|Overall Study|Physician Decision|0|||
155400899|NCT01449461|560901300|FG000|Overall Study|Documented Progressive Disease|4|||
155400900|NCT01449461|560901301|FG001|Overall Study|Documented Progressive Disease|7|||
155400901|NCT01449461|560901302|FG002|Overall Study|Documented Progressive Disease|14|||
155400902|NCT01449461|560901303|FG003|Overall Study|Documented Progressive Disease|15|||
155400903|NCT01449461|560901304|FG004|Overall Study|Documented Progressive Disease|24|||
155400904|NCT01449461|560901305|FG005|Overall Study|Documented Progressive Disease|5|||
155400905|NCT01449461|560901300|FG000|Overall Study|Clinical Progressive Disease|2|||
155400906|NCT01449461|560901301|FG001|Overall Study|Clinical Progressive Disease|2|||
155400907|NCT01449461|560901302|FG002|Overall Study|Clinical Progressive Disease|0|||
155400908|NCT01449461|560901303|FG003|Overall Study|Clinical Progressive Disease|3|||
155400909|NCT01449461|560901304|FG004|Overall Study|Clinical Progressive Disease|4|||
155400910|NCT01449461|560901305|FG005|Overall Study|Clinical Progressive Disease|2|||
155400911|NCT01449461|560901300|FG000|Overall Study|Protocol Violation|0|||
155400912|NCT01449461|560901301|FG001|Overall Study|Protocol Violation|0|||
155400913|NCT01449461|560901302|FG002|Overall Study|Protocol Violation|0|||
155400914|NCT01449461|560901303|FG003|Overall Study|Protocol Violation|1|||
155400915|NCT01449461|560901304|FG004|Overall Study|Protocol Violation|0|||
155400916|NCT01449461|560901305|FG005|Overall Study|Protocol Violation|0|||
155400917|NCT01449461|560901300|FG000|Overall Study|Site Terminated by Sponsor|0|||
155400918|NCT01449461|560901301|FG001|Overall Study|Site Terminated by Sponsor|1|||
155400919|NCT01449461|560901302|FG002|Overall Study|Site Terminated by Sponsor|2|||
155400920|NCT01449461|560901303|FG003|Overall Study|Site Terminated by Sponsor|3|||
155400921|NCT01449461|560901304|FG004|Overall Study|Site Terminated by Sponsor|4|||
155400922|NCT01449461|560901305|FG005|Overall Study|Site Terminated by Sponsor|1|||
155400923|NCT01449461|560901300|FG000|Overall Study|Withdrawal by Subject|0|||
155400924|NCT01449461|560901301|FG001|Overall Study|Withdrawal by Subject|1|||
155400925|NCT01449461|560901302|FG002|Overall Study|Withdrawal by Subject|0|||
155400926|NCT01449461|560901303|FG003|Overall Study|Withdrawal by Subject|0|||
155400927|NCT01449461|560901304|FG004|Overall Study|Withdrawal by Subject|2|||
155400928|NCT01449461|560901305|FG005|Overall Study|Withdrawal by Subject|1|||
155400929|NCT01449461|560901300|FG000|Overall Study|Reason not Specified|0|||
155400930|NCT01449461|560901301|FG001|Overall Study|Reason not Specified|1|||
155400931|NCT01449461|560901302|FG002|Overall Study|Reason not Specified|0|||
155400932|NCT01449461|560901303|FG003|Overall Study|Reason not Specified|3|||
155400933|NCT01449461|560901304|FG004|Overall Study|Reason not Specified|2|||
155400934|NCT01449461|560901305|FG005|Overall Study|Reason not Specified|1|||
155400935|NCT02228720|560901307|FG000|Open Label - Day 30|Lost to Follow-up|1|||
155400936|NCT00583024|560901314|FG000|Overall Study|Lost to Follow-up|4|||
155741791|NCT03642132|562156351|FG002|Chemotherapy Period|Progressive disease|1|||
155400937|NCT04198623|560902473|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
155400938|NCT05050318|560902481|FG000|Overall Study|Protocol Deviation|1|||
155400939|NCT05050318|560902482|FG001|Overall Study|Protocol Deviation|0|||
155400940|NCT05050318|560902483|FG002|Overall Study|Protocol Deviation|0|||
155400941|NCT04259411|560902484|FG000|Overall Study|Death|1|||
155400942|NCT04259411|560902484|FG000|Overall Study|Missed visit|2|||
155400943|NCT00736255|560902485|FG000|Overall Study|Adverse Event|1|||
155400944|NCT00736255|560902486|FG001|Overall Study|Adverse Event|0|||
155400945|NCT00736255|560902485|FG000|Overall Study|Physician Decision|1|||
155400946|NCT00736255|560902486|FG001|Overall Study|Physician Decision|0|||
155400947|NCT00736255|560902485|FG000|Overall Study|Non-compliance|1|||
155400948|NCT00736255|560902486|FG001|Overall Study|Non-compliance|1|||
155400949|NCT04183790|560902489|FG000|Overall Study|Participants did not rollover to Part B|12|||
155400950|NCT04183790|560902490|FG001|Overall Study|Participants did not rollover to Part B|0|||
155400951|NCT04183790|560902489|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
155400952|NCT04183790|560902490|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155400953|NCT04183790|560902489|FG000|Overall Study|Commercial drug is available for participant|6|||
155741792|NCT03642132|562156349|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
155741793|NCT03642132|562156350|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
155741794|NCT03642132|562156351|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
155741795|NCT03642132|562156349|FG000|Chemotherapy Period|Other|1|||
155741796|NCT03642132|562156350|FG001|Chemotherapy Period|Other|0|||
155741797|NCT03642132|562156351|FG002|Chemotherapy Period|Other|2|||
155741798|NCT03642132|562156349|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
155741799|NCT03642132|562156350|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
155741800|NCT03642132|562156351|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
155741801|NCT03642132|562156349|FG000|Maintenance Period|Adverse Event|1|||
155741802|NCT03642132|562156350|FG001|Maintenance Period|Adverse Event|2|||
155741803|NCT03642132|562156351|FG002|Maintenance Period|Adverse Event|0|||
155741804|NCT03642132|562156349|FG000|Maintenance Period|Non-compliance with study drug|0|||
155741805|NCT03642132|562156350|FG001|Maintenance Period|Non-compliance with study drug|0|||
155741806|NCT03642132|562156351|FG002|Maintenance Period|Non-compliance with study drug|1|||
155741807|NCT03642132|562156349|FG000|Maintenance Period|Physician's decision|2|||
155741808|NCT03642132|562156350|FG001|Maintenance Period|Physician's decision|2|||
155741809|NCT03642132|562156351|FG002|Maintenance Period|Physician's decision|2|||
155741810|NCT03642132|562156349|FG000|Maintenance Period|Progressive disease|9|||
155741811|NCT03642132|562156350|FG001|Maintenance Period|Progressive disease|3|||
155741812|NCT03642132|562156351|FG002|Maintenance Period|Progressive disease|6|||
155741813|NCT03642132|562156349|FG000|Maintenance Period|Other|0|||
155741814|NCT03642132|562156350|FG001|Maintenance Period|Other|0|||
155741815|NCT03642132|562156351|FG002|Maintenance Period|Other|3|||
155741816|NCT03642132|562156349|FG000|Maintenance Period|Withdrawal by Subject|1|||
155741817|NCT03642132|562156350|FG001|Maintenance Period|Withdrawal by Subject|1|||
155741818|NCT03642132|562156351|FG002|Maintenance Period|Withdrawal by Subject|2|||
155741819|NCT03642132|562156349|FG000|Follow-up Period|Other|0|||
155741820|NCT03642132|562156350|FG001|Follow-up Period|Other|0|||
155741821|NCT03642132|562156351|FG002|Follow-up Period|Other|1|||
155741822|NCT03642132|562156349|FG000|Follow-up Period|Withdrawal by Subject|1|||
155741823|NCT03642132|562156350|FG001|Follow-up Period|Withdrawal by Subject|2|||
155741824|NCT03642132|562156351|FG002|Follow-up Period|Withdrawal by Subject|0|||
155741825|NCT03642132|562156349|FG000|Follow-up Period|Study terminated by sponsor|1|||
155741826|NCT03642132|562156350|FG001|Follow-up Period|Study terminated by sponsor|0|||
155741827|NCT03642132|562156351|FG002|Follow-up Period|Study terminated by sponsor|1|||
155741828|NCT03642132|562156349|FG000|Follow-up Period|Lack of Efficacy|1|||
155741829|NCT03642132|562156350|FG001|Follow-up Period|Lack of Efficacy|0|||
155741830|NCT03642132|562156351|FG002|Follow-up Period|Lack of Efficacy|0|||
155741831|NCT03642132|562156349|FG000|Follow-up Period|Death|1|||
155741832|NCT03642132|562156350|FG001|Follow-up Period|Death|0|||
155741833|NCT03642132|562156351|FG002|Follow-up Period|Death|2|||
155741834|NCT03642132|562156349|FG000|Follow-up Period|Adverse Event|1|||
155741835|NCT03642132|562156350|FG001|Follow-up Period|Adverse Event|0|||
155741836|NCT03642132|562156351|FG002|Follow-up Period|Adverse Event|0|||
155741837|NCT02577887|562156353|FG000|Overall Study|Death|93|||
155741838|NCT02577887|562156353|FG000|Overall Study|Protocol Violation|125|||
155741839|NCT02577887|562156353|FG000|Overall Study|Withdrawal by Subject|80|||
155741840|NCT01155011|562156354|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
155741841|NCT01155011|562156355|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
155741842|NCT01155011|562156354|FG000|Baseline to 6 Months|investigator decision, moved|4|||
155741843|NCT01155011|562156355|FG001|Baseline to 6 Months|investigator decision, moved|5|||
155741844|NCT01155011|562156354|FG000|Baseline to 6 Months|Death|0|||
155741845|NCT01155011|562156355|FG001|Baseline to 6 Months|Death|1|||
155741846|NCT01155011|562156354|FG000|6 to 12 Months|Withdrawal by Subject|8|||
155741847|NCT01155011|562156355|FG001|6 to 12 Months|Withdrawal by Subject|5|||
155741848|NCT01155011|562156354|FG000|6 to 12 Months|Death|1|||
155741849|NCT01155011|562156355|FG001|6 to 12 Months|Death|5|||
155741850|NCT01038869|562156358|FG000|Overall Study|Withdrawal by Subject|1|||
155741851|NCT01038869|562156358|FG000|Overall Study|Lost to Follow-up|6|||
155741852|NCT02238067|562156359|FG000|Overall Study|Not completed survey at Month 6|45|||
155741853|NCT02743611|562156362|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
155741854|NCT02743611|562156363|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
155741855|NCT02743611|562156364|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
155741856|NCT02743611|562156365|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
155741857|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
155741858|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
155741859|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
155741860|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
155741861|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
155400954|NCT04183790|560902490|FG001|Overall Study|Commercial drug is available for participant|0|||
155741862|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
155741863|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155741864|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
155400955|NCT04183790|560902489|FG000|Overall Study|Adverse Event|1|||
155400956|NCT04183790|560902490|FG001|Overall Study|Adverse Event|0|||
155400957|NCT04183790|560902489|FG000|Overall Study|Not enrolled in 107 study|0|||
155400958|NCT04183790|560902490|FG001|Overall Study|Not enrolled in 107 study|2|||
155400959|NCT01251653|560902491|FG000|Overall Study|Progressive Disease|1|||
155400960|NCT01251653|560902492|FG001|Overall Study|Progressive Disease|7|||
155400961|NCT01251653|560902493|FG002|Overall Study|Progressive Disease|16|||
155400962|NCT01251653|560902494|FG003|Overall Study|Progressive Disease|4|||
155400963|NCT01251653|560902495|FG004|Overall Study|Progressive Disease|0|||
155400964|NCT01251653|560902496|FG005|Overall Study|Progressive Disease|17|||
155400965|NCT01251653|560902497|FG006|Overall Study|Progressive Disease|14|||
155400966|NCT01251653|560902498|FG007|Overall Study|Progressive Disease|7|||
155400967|NCT01251653|560902499|FG008|Overall Study|Progressive Disease|5|||
155400968|NCT01251653|560902491|FG000|Overall Study|Dose-limiting toxicity|0|||
155400969|NCT01251653|560902492|FG001|Overall Study|Dose-limiting toxicity|1|||
155400970|NCT01251653|560902493|FG002|Overall Study|Dose-limiting toxicity|1|||
155400971|NCT01251653|560902494|FG003|Overall Study|Dose-limiting toxicity|1|||
155400972|NCT01251653|560902495|FG004|Overall Study|Dose-limiting toxicity|0|||
155400973|NCT01251653|560902496|FG005|Overall Study|Dose-limiting toxicity|0|||
155400974|NCT01251653|560902497|FG006|Overall Study|Dose-limiting toxicity|2|||
155400975|NCT01251653|560902498|FG007|Overall Study|Dose-limiting toxicity|0|||
155400976|NCT01251653|560902499|FG008|Overall Study|Dose-limiting toxicity|0|||
155400977|NCT01251653|560902491|FG000|Overall Study|Adverse Event|1|||
155400978|NCT01251653|560902492|FG001|Overall Study|Adverse Event|0|||
155400979|NCT01251653|560902493|FG002|Overall Study|Adverse Event|2|||
155400980|NCT01251653|560902494|FG003|Overall Study|Adverse Event|1|||
155400981|NCT01251653|560902495|FG004|Overall Study|Adverse Event|1|||
155400982|NCT01251653|560902496|FG005|Overall Study|Adverse Event|0|||
155400983|NCT01251653|560902497|FG006|Overall Study|Adverse Event|2|||
155400984|NCT01251653|560902498|FG007|Overall Study|Adverse Event|2|||
155400985|NCT01251653|560902499|FG008|Overall Study|Adverse Event|1|||
155400986|NCT01251653|560902491|FG000|Overall Study|Withdrawal by Subject|1|||
155400987|NCT01251653|560902492|FG001|Overall Study|Withdrawal by Subject|0|||
155400988|NCT01251653|560902493|FG002|Overall Study|Withdrawal by Subject|1|||
155400989|NCT01251653|560902494|FG003|Overall Study|Withdrawal by Subject|0|||
155400990|NCT01251653|560902495|FG004|Overall Study|Withdrawal by Subject|1|||
155400991|NCT01251653|560902496|FG005|Overall Study|Withdrawal by Subject|1|||
155400992|NCT01251653|560902497|FG006|Overall Study|Withdrawal by Subject|0|||
155400993|NCT01251653|560902498|FG007|Overall Study|Withdrawal by Subject|1|||
155400994|NCT01251653|560902499|FG008|Overall Study|Withdrawal by Subject|0|||
155400995|NCT01251653|560902491|FG000|Overall Study|Other reason not mentioned above|0|||
155400996|NCT01251653|560902492|FG001|Overall Study|Other reason not mentioned above|0|||
155400997|NCT01251653|560902493|FG002|Overall Study|Other reason not mentioned above|0|||
155400998|NCT01251653|560902494|FG003|Overall Study|Other reason not mentioned above|0|||
155400999|NCT01251653|560902495|FG004|Overall Study|Other reason not mentioned above|0|||
155401000|NCT01251653|560902496|FG005|Overall Study|Other reason not mentioned above|0|||
155401001|NCT01251653|560902497|FG006|Overall Study|Other reason not mentioned above|0|||
155741865|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
155741866|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155741867|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155741868|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155741869|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155741870|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155741871|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
155401002|NCT01251653|560902498|FG007|Overall Study|Other reason not mentioned above|2|||
155741872|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155284782|NCT01941316|560474417|FG000|Overall Study|Withdrawal by Subject|0|||
155401003|NCT01251653|560902499|FG008|Overall Study|Other reason not mentioned above|0|||
155401004|NCT01502709|560902501|FG000|Overall Study|Lost to Follow-up|4|||
155741873|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
155401005|NCT01502709|560902502|FG001|Overall Study|Lost to Follow-up|0|||
155401006|NCT00346073|560902504|FG000|Overall Study|Serious Adverse Event|2|||
155401007|NCT00346073|560902505|FG001|Overall Study|Serious Adverse Event|0|||
155741874|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155401008|NCT00346073|560902504|FG000|Overall Study|Lost to Follow-up|39|||
155401009|NCT00346073|560902505|FG001|Overall Study|Lost to Follow-up|24|||
155401010|NCT00457015|560902507|FG000|Overall Study|Left study site against medical advice|0|||
155494227|NCT00602927|561234234|FG001|Period 3: 13 Days|MRI data quality|2|||
155401011|NCT00457015|560902508|FG001|Overall Study|Left study site against medical advice|1|||
155741875|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
155741876|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155741877|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155741878|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155741879|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155741880|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155741881|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
155741882|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
155741883|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
155741884|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
155741885|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
155741886|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
155741887|NCT00600119|562156366|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
155741888|NCT00600119|562156367|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
155741889|NCT00600119|562156368|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155741890|NCT00600119|562156369|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155741891|NCT00600119|562156370|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155741892|NCT00600119|562156371|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155741893|NCT00600119|562156366|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
155741894|NCT00600119|562156367|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155741895|NCT00600119|562156368|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155741896|NCT00600119|562156369|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
155741897|NCT00600119|562156370|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155741898|NCT00600119|562156371|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
155741899|NCT00600119|562156366|FG000|Double-blind Treatment Period|Other|0|||
155741900|NCT00600119|562156367|FG001|Double-blind Treatment Period|Other|0|||
155741901|NCT00600119|562156368|FG002|Double-blind Treatment Period|Other|0|||
155741902|NCT00600119|562156369|FG003|Double-blind Treatment Period|Other|0|||
155741903|NCT00600119|562156370|FG004|Double-blind Treatment Period|Other|2|||
155741904|NCT00600119|562156371|FG005|Double-blind Treatment Period|Other|1|||
155741905|NCT00600119|562156366|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155741906|NCT00600119|562156367|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
155741907|NCT00600119|562156368|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155741908|NCT00600119|562156369|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155741909|NCT00600119|562156370|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
155741910|NCT00600119|562156371|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155741911|NCT00600119|562156366|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155741912|NCT00600119|562156367|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
155741913|NCT00600119|562156368|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155741914|NCT00600119|562156369|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155741915|NCT00600119|562156370|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155741916|NCT00600119|562156371|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155741917|NCT00600119|562156366|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
155741918|NCT00600119|562156367|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
155741919|NCT00600119|562156368|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
155741920|NCT00600119|562156369|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
155741921|NCT00600119|562156370|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
155741922|NCT00600119|562156371|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
155741923|NCT00600119|562156366|FG000|Double-blind Treatment Period|Physician Decision|2|||
155741924|NCT00600119|562156367|FG001|Double-blind Treatment Period|Physician Decision|0|||
155741925|NCT00600119|562156368|FG002|Double-blind Treatment Period|Physician Decision|0|||
155741926|NCT00600119|562156369|FG003|Double-blind Treatment Period|Physician Decision|0|||
155741927|NCT00600119|562156370|FG004|Double-blind Treatment Period|Physician Decision|0|||
155741928|NCT00600119|562156371|FG005|Double-blind Treatment Period|Physician Decision|0|||
155741929|NCT00600119|562156366|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155741930|NCT00600119|562156367|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155741931|NCT00600119|562156368|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155741932|NCT00600119|562156369|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155741933|NCT00600119|562156370|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
155741934|NCT00600119|562156371|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
155284783|NCT01941316|560474418|FG001|Overall Study|Withdrawal by Subject|2|||
155284784|NCT01941316|560474419|FG002|Overall Study|Withdrawal by Subject|1|||
155284785|NCT01941316|560474420|FG003|Overall Study|Withdrawal by Subject|8|||
155401012|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
155401013|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155284786|NCT01941316|560474417|FG000|Overall Study|Death|0|||
155284787|NCT01941316|560474418|FG001|Overall Study|Death|0|||
155741935|NCT00600119|562156366|FG000|Double-blind Treatment Period|Adverse Event|1|||
155741936|NCT00600119|562156367|FG001|Double-blind Treatment Period|Adverse Event|1|||
155741937|NCT00600119|562156368|FG002|Double-blind Treatment Period|Adverse Event|0|||
155741938|NCT00600119|562156369|FG003|Double-blind Treatment Period|Adverse Event|1|||
155741939|NCT00600119|562156370|FG004|Double-blind Treatment Period|Adverse Event|2|||
155741940|NCT00600119|562156371|FG005|Double-blind Treatment Period|Adverse Event|10|||
155741941|NCT00600119|562156366|FG000|Follow-up Period|Adverse Event|0|||
155741942|NCT00600119|562156367|FG001|Follow-up Period|Adverse Event|0|||
155741943|NCT00600119|562156368|FG002|Follow-up Period|Adverse Event|0|||
155741944|NCT00600119|562156369|FG003|Follow-up Period|Adverse Event|0|||
155741945|NCT00600119|562156370|FG004|Follow-up Period|Adverse Event|0|||
155741946|NCT00600119|562156371|FG005|Follow-up Period|Adverse Event|1|||
155741947|NCT00600119|562156366|FG000|Follow-up Period|Other|1|||
155741948|NCT00600119|562156367|FG001|Follow-up Period|Other|0|||
155741949|NCT00600119|562156368|FG002|Follow-up Period|Other|0|||
155741950|NCT00600119|562156369|FG003|Follow-up Period|Other|0|||
155741951|NCT00600119|562156370|FG004|Follow-up Period|Other|0|||
155741952|NCT00600119|562156371|FG005|Follow-up Period|Other|0|||
155741953|NCT00729469|562156372|FG000|Overall Study|Adverse Event|14|||
155741954|NCT00729469|562156373|FG001|Overall Study|Adverse Event|25|||
155741955|NCT00729469|562156372|FG000|Overall Study|Lost to Follow-up|9|||
155741956|NCT00729469|562156373|FG001|Overall Study|Lost to Follow-up|9|||
155741957|NCT00729469|562156372|FG000|Overall Study|Protocol Violation|2|||
155741958|NCT00729469|562156373|FG001|Overall Study|Protocol Violation|1|||
155741959|NCT00729469|562156372|FG000|Overall Study|Withdrawal by Subject|19|||
155741960|NCT00729469|562156373|FG001|Overall Study|Withdrawal by Subject|8|||
155741961|NCT00729469|562156372|FG000|Overall Study|Other-Not mentioned|9|||
155741962|NCT00729469|562156373|FG001|Overall Study|Other-Not mentioned|4|||
155741963|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
155741964|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
155741965|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Adverse Event|7|||
155741966|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Adverse Event|6|||
155741967|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
155741968|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
155741969|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Physician Decision|4|||
155741970|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Physician Decision|4|||
155741971|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
155741972|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
155741973|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
155741974|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
155741975|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
155741976|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
155741977|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Non-compliance|1|||
155741978|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Non-compliance|0|||
155741979|NCT00470834|562156374|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
155741980|NCT00470834|562156375|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
155741981|NCT00470834|562156374|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
155741982|NCT00470834|562156375|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
155741983|NCT00470834|562156374|FG000|Extension Period (24 Months)|Adverse Event|3|||
155741984|NCT00470834|562156375|FG001|Extension Period (24 Months)|Adverse Event|4|||
155741985|NCT00470834|562156374|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
155741986|NCT00470834|562156375|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
155741987|NCT00470834|562156374|FG000|Extension Period (24 Months)|Physician Decision|4|||
155741988|NCT00470834|562156375|FG001|Extension Period (24 Months)|Physician Decision|3|||
155741989|NCT00470834|562156374|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
155741990|NCT00470834|562156375|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
155741991|NCT00470834|562156374|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
155741992|NCT00470834|562156375|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
155741993|NCT00470834|562156374|FG000|Extension Period (24 Months)|Non-compliance|0|||
155741994|NCT00470834|562156375|FG001|Extension Period (24 Months)|Non-compliance|1|||
155741995|NCT00470834|562156374|FG000|Extension Period (24 Months)|Disease Progression|0|||
155741996|NCT00470834|562156375|FG001|Extension Period (24 Months)|Disease Progression|1|||
155741997|NCT00561977|562156376|FG000|Overall Study|Withdrawal by Subject|0|||
155741998|NCT00561977|562156377|FG001|Overall Study|Withdrawal by Subject|2|||
155741999|NCT00561977|562156378|FG002|Overall Study|Withdrawal by Subject|1|||
155742000|NCT00561977|562156376|FG000|Overall Study|Pregnancy|0|||
155742001|NCT00561977|562156377|FG001|Overall Study|Pregnancy|1|||
155742002|NCT00561977|562156378|FG002|Overall Study|Pregnancy|1|||
155742003|NCT00566696|562156379|FG000|Overall Study|Met Exclusion Criteria|2|||
155742004|NCT00566696|562156379|FG000|Overall Study|Muromonab not available|1|||
155494228|NCT01741259|561234243|FG000|Overall Study|Protocol Violation|6|||
155742005|NCT00566696|562156379|FG000|Overall Study|Health Status Change|1|||
155742006|NCT00566696|562156379|FG000|Overall Study|Physician Decision|1|||
155742007|NCT00566696|562156379|FG000|Overall Study|Non-Patient Donors|37|||
155284788|NCT01941316|560474419|FG002|Overall Study|Death|0|||
155401014|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155401015|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155401016|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
155401017|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401018|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401019|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401020|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
155401021|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401022|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401023|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401024|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
155401025|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401026|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401027|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401028|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
155401029|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401030|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401031|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401032|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401033|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
155401034|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401035|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401036|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401037|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
155401038|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401039|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401040|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401041|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
155401042|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401043|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401044|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401045|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
155401046|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401047|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401048|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401049|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
155401050|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401051|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401052|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401053|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
155401054|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401055|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401056|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
155401057|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
155401058|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
155401059|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
155637199|NCT05168800|561762941|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
155637200|NCT05168800|561762942|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
155637201|NCT05168800|561762943|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
155637202|NCT05168800|561762941|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
155637203|NCT05168800|561762942|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
155637204|NCT05168800|561762943|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
155637205|NCT04153864|561762944|FG000|Overall Study|Withdrawal by Subject|21|||
155637206|NCT04153864|561762945|FG001|Overall Study|Withdrawal by Subject|7|||
155637207|NCT04153864|561762946|FG002|Overall Study|Withdrawal by Subject|23|||
155637208|NCT04153864|561762947|FG003|Overall Study|Withdrawal by Subject|2|||
155637209|NCT04153864|561762944|FG000|Overall Study|Lost to Follow-up|4|||
155637210|NCT04153864|561762945|FG001|Overall Study|Lost to Follow-up|0|||
155637211|NCT04153864|561762946|FG002|Overall Study|Lost to Follow-up|3|||
155637212|NCT04153864|561762947|FG003|Overall Study|Lost to Follow-up|0|||
155637213|NCT04153864|561762944|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
155637214|NCT04153864|561762945|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
155637215|NCT04153864|561762946|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
155637216|NCT04153864|561762947|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
155637217|NCT04279522|561762949|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
155637218|NCT04279522|561762950|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
155637219|NCT04279522|561762949|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
155284789|NCT01941316|560474420|FG003|Overall Study|Death|3|||
155742008|NCT00275340|562156383|FG000|Overall Study|Lost to Follow-up|2|||
155742009|NCT00275340|562156384|FG001|Overall Study|Lost to Follow-up|4|||
155742010|NCT01950013|562156385|FG000|Overall Study|Withdrawal by Subject|0|||
155401060|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
155401061|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
155401062|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
155401063|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
155401064|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
155401065|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
155401066|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
155401067|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
155401068|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
155401069|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
155401070|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
155401071|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
155401072|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401073|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401074|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
155401075|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401076|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
155401077|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
155401078|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
155401079|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
155401080|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401081|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401082|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
155401083|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401084|NCT04179734|560902513|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
155401085|NCT04179734|560902514|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
155401086|NCT04179734|560902513|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
155401087|NCT04179734|560902514|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
155401088|NCT00937937|560902516|FG000|Overall Study|Adverse Event|6|||
155401089|NCT00937937|560902516|FG000|Overall Study|Withdrawal by Subject|2|||
155401090|NCT00937937|560902516|FG000|Overall Study|Progression/relapse|61|||
155401091|NCT00937937|560902516|FG000|Overall Study|Death|1|||
155401092|NCT00937937|560902516|FG000|Overall Study|Other|2|||
155401093|NCT03197493|560902518|FG000|Overall Study|Withdrawal by Subject|5|||
155401094|NCT00054704|560902519|FG000|Overall Study|Lack of Efficacy|2|||
155401095|NCT00054704|560902520|FG001|Overall Study|Lack of Efficacy|3|||
155401096|NCT00054704|560902519|FG000|Overall Study|Adverse Event|3|||
155401097|NCT00054704|560902520|FG001|Overall Study|Adverse Event|1|||
155401098|NCT00054704|560902519|FG000|Overall Study|Lost to Follow-up|0|||
155401099|NCT00054704|560902520|FG001|Overall Study|Lost to Follow-up|1|||
155401100|NCT00362414|560902523|FG000|Overall Study|Death|2|||
155401101|NCT00362414|560902523|FG000|Overall Study|Adverse Event|1|||
155401102|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
155401103|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
155401104|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
155401105|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155401106|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
155401107|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
155401108|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Death|2|||
155401109|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Death|0|||
155401110|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
155401111|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
155401112|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
155401113|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155401114|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
155401115|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155401116|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
155401117|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
155401118|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
155401119|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
155401120|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
155401121|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
155401122|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
155401123|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
155401124|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
155401125|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
155401126|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
155401127|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
155401128|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
155401129|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
155401130|NCT01469182|560902526|FG000|Overall Study|Adverse Event|21|||
155401131|NCT01469182|560902527|FG001|Overall Study|Adverse Event|3|||
155401132|NCT01469182|560902526|FG000|Overall Study|Lost to Follow-up|3|||
155401133|NCT01469182|560902527|FG001|Overall Study|Lost to Follow-up|0|||
155401134|NCT01469182|560902526|FG000|Overall Study|Withdrawal by Subject|4|||
155401135|NCT01469182|560902527|FG001|Overall Study|Withdrawal by Subject|1|||
155401136|NCT01469182|560902526|FG000|Overall Study|Protocol Violation|4|||
155401137|NCT01469182|560902527|FG001|Overall Study|Protocol Violation|2|||
155401138|NCT01469182|560902526|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
155401139|NCT01469182|560902527|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
155401140|NCT02236520|560902529|FG000|Overall Study|Physician Decision|0|||
155401141|NCT02236520|560902530|FG001|Overall Study|Physician Decision|5|||
155401142|NCT02236520|560902531|FG002|Overall Study|Physician Decision|0|||
155401143|NCT02236520|560902532|FG003|Overall Study|Physician Decision|0|||
155401144|NCT02236520|560902529|FG000|Overall Study|Withdrawal by Subject|1|||
155401145|NCT02236520|560902530|FG001|Overall Study|Withdrawal by Subject|0|||
155401146|NCT02236520|560902531|FG002|Overall Study|Withdrawal by Subject|0|||
155401147|NCT02236520|560902532|FG003|Overall Study|Withdrawal by Subject|1|||
155401148|NCT02236520|560902529|FG000|Overall Study|Pregnancy|1|||
155401149|NCT02236520|560902530|FG001|Overall Study|Pregnancy|0|||
155401150|NCT02236520|560902531|FG002|Overall Study|Pregnancy|0|||
155401151|NCT02236520|560902532|FG003|Overall Study|Pregnancy|0|||
155401152|NCT01785160|560902533|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
155401153|NCT01785160|560902533|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
155401154|NCT03807349|560902534|FG000|Overall Study|Early Study Termination|9|||
155401155|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
155401156|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
155401157|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
155401158|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
155401159|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
155401160|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
155401161|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
155401162|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
155401163|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
155401164|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
155401165|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
155401166|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
155401167|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
155401168|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
155401169|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
155401170|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
155401171|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
155401172|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
155401173|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
155401174|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
155401175|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
155401176|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
155401177|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
155401178|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
155401179|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
155401180|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
155401181|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
155401182|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
155401183|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
155401184|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
155401185|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
155401186|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
155401187|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
155401188|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
155401189|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
155401190|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
155401191|NCT00253643|560902537|FG000|Overall Study|Withdrawal by Subject|0|||
155401192|NCT00253643|560902538|FG001|Overall Study|Withdrawal by Subject|0|||
155401193|NCT00253643|560902539|FG002|Overall Study|Withdrawal by Subject|1|||
155401194|NCT00253643|560902540|FG003|Overall Study|Withdrawal by Subject|1|||
155401195|NCT00253643|560902537|FG000|Overall Study|Non-Compliance|0|||
155401196|NCT00253643|560902538|FG001|Overall Study|Non-Compliance|0|||
155401197|NCT00253643|560902539|FG002|Overall Study|Non-Compliance|0|||
155401198|NCT00253643|560902540|FG003|Overall Study|Non-Compliance|2|||
155401199|NCT01368536|560902544|FG000|Overall Study|Adverse Event|5|||
155401200|NCT01368536|560902545|FG001|Overall Study|Adverse Event|6|||
155401201|NCT01368536|560902546|FG002|Overall Study|Adverse Event|8|||
155401202|NCT01368536|560902544|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155401203|NCT01368536|560902545|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155401204|NCT01368536|560902546|FG002|Overall Study|Abnormal laboratory value(s)|2|||
155401205|NCT01368536|560902544|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155401206|NCT01368536|560902545|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155401207|NCT01368536|560902546|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155401208|NCT01368536|560902544|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
155401209|NCT01368536|560902545|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155401210|NCT01368536|560902546|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155401211|NCT01368536|560902544|FG000|Overall Study|No longer required study medication|0|||
155401212|NCT01368536|560902545|FG001|Overall Study|No longer required study medication|0|||
155401213|NCT01368536|560902546|FG002|Overall Study|No longer required study medication|1|||
155401214|NCT01368536|560902544|FG000|Overall Study|Withdrawal by Subject|2|||
155401215|NCT01368536|560902545|FG001|Overall Study|Withdrawal by Subject|5|||
155401216|NCT01368536|560902546|FG002|Overall Study|Withdrawal by Subject|4|||
155401217|NCT01368536|560902544|FG000|Overall Study|Lost to Follow-up|3|||
155401218|NCT01368536|560902545|FG001|Overall Study|Lost to Follow-up|3|||
155401219|NCT01368536|560902546|FG002|Overall Study|Lost to Follow-up|5|||
155401220|NCT01368536|560902544|FG000|Overall Study|Administrative problems|34|||
155401221|NCT01368536|560902545|FG001|Overall Study|Administrative problems|39|||
155401222|NCT01368536|560902546|FG002|Overall Study|Administrative problems|35|||
155401223|NCT01368536|560902544|FG000|Overall Study|Protocol deviation|0|||
155401224|NCT01368536|560902545|FG001|Overall Study|Protocol deviation|3|||
155401225|NCT01368536|560902546|FG002|Overall Study|Protocol deviation|1|||
155401226|NCT02636582|560902549|FG000|Overall Study|Surgical Pathology|1|||
155401227|NCT02636582|560902550|FG001|Overall Study|Surgical Pathology|0|||
155401228|NCT04451161|560902551|FG000|Overall Study|Lost to Follow-up|28|||
155401229|NCT04451161|560902552|FG001|Overall Study|Lost to Follow-up|37|||
155401230|NCT04451161|560902553|FG002|Overall Study|Lost to Follow-up|22|||
155401231|NCT04451161|560902554|FG003|Overall Study|Lost to Follow-up|13|||
155401232|NCT04451161|560902555|FG004|Overall Study|Lost to Follow-up|11|||
155401233|NCT04451161|560902556|FG005|Overall Study|Lost to Follow-up|14|||
155401234|NCT04451161|560902551|FG000|Overall Study|Withdrawal by Subject|3|||
155401235|NCT04451161|560902552|FG001|Overall Study|Withdrawal by Subject|0|||
155401236|NCT04451161|560902553|FG002|Overall Study|Withdrawal by Subject|0|||
155401237|NCT04451161|560902554|FG003|Overall Study|Withdrawal by Subject|0|||
155401238|NCT04451161|560902555|FG004|Overall Study|Withdrawal by Subject|2|||
155401239|NCT04451161|560902556|FG005|Overall Study|Withdrawal by Subject|4|||
155401240|NCT00454857|560902557|FG000|Overall Study|Withdrawal by Subject|15|||
155401241|NCT00454857|560902557|FG000|Overall Study|Lost to Follow-up|16|||
155401242|NCT00454857|560902557|FG000|Overall Study|Noncompliance|6|||
155401243|NCT00454857|560902557|FG000|Overall Study|Death|5|||
155401244|NCT00454857|560902557|FG000|Overall Study|Other|11|||
155401245|NCT00454857|560902557|FG000|Overall Study|Reason unknown|1|||
155401246|NCT00596947|560902558|FG000|Overall Study|study halted due to low enrollment|5|||
155401247|NCT00596947|560902559|FG001|Overall Study|study halted due to low enrollment|3|||
155401248|NCT00596947|560902558|FG000|Overall Study|Lost to Follow-up|1|||
155401249|NCT00596947|560902559|FG001|Overall Study|Lost to Follow-up|0|||
155401250|NCT00829179|560902560|FG000|Overall Study|Withdrawal by Subject|1|||
155401251|NCT03000179|560902561|FG000|Overall Study|Lost to Follow-up|2|||
155401252|NCT00827606|560902563|FG000|Overall Study|Protocol Violation|4|||
155401253|NCT00827606|560902564|FG001|Overall Study|Protocol Violation|3|||
155401254|NCT00827606|560902563|FG000|Overall Study|Lost to Follow-up|3|||
155401255|NCT00827606|560902564|FG001|Overall Study|Lost to Follow-up|1|||
155401256|NCT00827606|560902563|FG000|Overall Study|Withdrawal by Subject|7|||
155401257|NCT00827606|560902564|FG001|Overall Study|Withdrawal by Subject|6|||
155401258|NCT00827606|560902563|FG000|Overall Study|Pregnancy|0|||
155401259|NCT00827606|560902564|FG001|Overall Study|Pregnancy|1|||
155742011|NCT01950013|562156386|FG001|Overall Study|Withdrawal by Subject|2|||
155401260|NCT00827606|560902563|FG000|Overall Study|Other|5|||
155401261|NCT00827606|560902564|FG001|Overall Study|Other|13|||
155401262|NCT00827606|560902563|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
155401263|NCT00827606|560902564|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
155401264|NCT00827606|560902563|FG000|Overall Study|Adverse Event|4|||
155401265|NCT00827606|560902564|FG001|Overall Study|Adverse Event|2|||
155401266|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
155401267|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
155401268|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
155401269|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
155401270|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
155401271|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
155494229|NCT01741259|561234244|FG001|Overall Study|Protocol Violation|4|||
155401272|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
155401273|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
155401274|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
155401275|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
155401276|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
155401277|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
155401278|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
155401279|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
155401280|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
155401281|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
155401282|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
155401283|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
155401284|NCT00243386|560902569|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
155401285|NCT00243386|560902570|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
155401286|NCT00243386|560902571|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
155401287|NCT00243386|560902569|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
155401288|NCT00243386|560902570|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
155401289|NCT00243386|560902571|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
155401290|NCT04995055|560902572|FG000|Period 1|COVID-19 Related|1|||
155401291|NCT04995055|560902573|FG001|Period 1|COVID-19 Related|0|||
155401292|NCT04995055|560902572|FG000|Period 1|Withdrawal by Subject|0|||
155401293|NCT04995055|560902573|FG001|Period 1|Withdrawal by Subject|1|||
155401294|NCT04995055|560902572|FG000|Period 1|Subject discontinued due to timing|4|||
155401295|NCT04995055|560902573|FG001|Period 1|Subject discontinued due to timing|4|||
155401296|NCT01358760|560902575|FG000|Overall Study|Adverse Event|3|||
155401297|NCT01358760|560902576|FG001|Overall Study|Adverse Event|4|||
155401298|NCT01358760|560902577|FG002|Overall Study|Adverse Event|3|||
155401299|NCT01358760|560902575|FG000|Overall Study|Lost to Follow-up|1|||
155401300|NCT01358760|560902576|FG001|Overall Study|Lost to Follow-up|1|||
155401301|NCT01358760|560902577|FG002|Overall Study|Lost to Follow-up|3|||
155401302|NCT01358760|560902575|FG000|Overall Study|Withdrawal by Subject|5|||
155401303|NCT01358760|560902576|FG001|Overall Study|Withdrawal by Subject|3|||
155401304|NCT01358760|560902577|FG002|Overall Study|Withdrawal by Subject|2|||
155401305|NCT01358760|560902575|FG000|Overall Study|Physician Decision|1|||
155401306|NCT01358760|560902576|FG001|Overall Study|Physician Decision|0|||
155401307|NCT01358760|560902577|FG002|Overall Study|Physician Decision|1|||
155401308|NCT01358760|560902575|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
155401309|NCT01358760|560902576|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
155401310|NCT01358760|560902577|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
155401311|NCT04695392|560902578|FG000|Overall Study|Withdrawn by parent/guardian|0|||
155401312|NCT04695392|560902579|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155401313|NCT04695392|560902578|FG000|Overall Study|Withdrawn by physician|0|||
155401314|NCT04695392|560902579|FG001|Overall Study|Withdrawn by physician|1|||
155401315|NCT01506960|560902580|FG000|Overall Study|Did not meet angiographic criteria|47|||
155401316|NCT01987960|560902582|FG000|Period 1|Adverse Event|24|||
155401317|NCT01987960|560902583|FG001|Period 1|Adverse Event|0|||
155401318|NCT01987960|560902584|FG002|Period 1|Adverse Event|0|||
155401319|NCT01987960|560902585|FG003|Period 1|Adverse Event|0|||
155401320|NCT01987960|560902582|FG000|Period 1|Lack of Efficacy|4|||
155401321|NCT01987960|560902583|FG001|Period 1|Lack of Efficacy|0|||
155401322|NCT01987960|560902584|FG002|Period 1|Lack of Efficacy|0|||
155401323|NCT01987960|560902585|FG003|Period 1|Lack of Efficacy|0|||
155401324|NCT01987960|560902582|FG000|Period 1|Non-compliance with IMP|6|||
155401325|NCT01987960|560902583|FG001|Period 1|Non-compliance with IMP|0|||
155637220|NCT04279522|561762950|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
155637221|NCT04279522|561762949|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
155637222|NCT04279522|561762950|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
155637223|NCT04279522|561762949|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
155637224|NCT04279522|561762950|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
155637225|NCT04279522|561762949|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
155637226|NCT04279522|561762950|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
155637227|NCT04279522|561762949|FG000|Period 2: Open Label Phase|Physician Decision|0|||
155637228|NCT04279522|561762950|FG001|Period 2: Open Label Phase|Physician Decision|3|||
155637229|NCT04279522|561762949|FG000|Period 2: Open Label Phase|Adverse Event|0|||
155401326|NCT01987960|560902584|FG002|Period 1|Non-compliance with IMP|0|||
155401327|NCT01987960|560902585|FG003|Period 1|Non-compliance with IMP|0|||
155401328|NCT01987960|560902582|FG000|Period 1|Protocol Violation|12|||
155401329|NCT01987960|560902583|FG001|Period 1|Protocol Violation|0|||
155401330|NCT01987960|560902584|FG002|Period 1|Protocol Violation|0|||
155401331|NCT01987960|560902585|FG003|Period 1|Protocol Violation|0|||
155401332|NCT01987960|560902582|FG000|Period 1|Withdrawal by Subject|21|||
155401333|NCT01987960|560902583|FG001|Period 1|Withdrawal by Subject|0|||
155401334|NCT01987960|560902584|FG002|Period 1|Withdrawal by Subject|0|||
155401335|NCT01987960|560902585|FG003|Period 1|Withdrawal by Subject|0|||
155401336|NCT01987960|560902582|FG000|Period 1|Lost to Follow-up|40|||
155401337|NCT01987960|560902583|FG001|Period 1|Lost to Follow-up|0|||
155401338|NCT01987960|560902584|FG002|Period 1|Lost to Follow-up|0|||
155401339|NCT01987960|560902585|FG003|Period 1|Lost to Follow-up|0|||
155401340|NCT01987960|560902582|FG000|Period 1|administrative or other reason|75|||
155401341|NCT01987960|560902583|FG001|Period 1|administrative or other reason|0|||
155401342|NCT01987960|560902584|FG002|Period 1|administrative or other reason|0|||
155401343|NCT01987960|560902585|FG003|Period 1|administrative or other reason|0|||
155401344|NCT01987960|560902582|FG000|Period 1|Withdrawal of consent before treatment|4|||
155401345|NCT01987960|560902583|FG001|Period 1|Withdrawal of consent before treatment|0|||
155401346|NCT01987960|560902584|FG002|Period 1|Withdrawal of consent before treatment|0|||
155401347|NCT01987960|560902585|FG003|Period 1|Withdrawal of consent before treatment|0|||
155401348|NCT01987960|560902582|FG000|Period 2|Adverse Event|0|||
155401349|NCT01987960|560902583|FG001|Period 2|Adverse Event|0|||
155401350|NCT01987960|560902584|FG002|Period 2|Adverse Event|1|||
155401351|NCT01987960|560902585|FG003|Period 2|Adverse Event|0|||
155401352|NCT01987960|560902582|FG000|Period 2|Withdrawal by Subject|0|||
155401353|NCT01987960|560902583|FG001|Period 2|Withdrawal by Subject|0|||
155401354|NCT01987960|560902584|FG002|Period 2|Withdrawal by Subject|1|||
155401355|NCT01987960|560902585|FG003|Period 2|Withdrawal by Subject|0|||
155401356|NCT01987960|560902582|FG000|Period 2|Administrative or other reason|0|||
155401357|NCT01987960|560902583|FG001|Period 2|Administrative or other reason|5|||
155401358|NCT01987960|560902584|FG002|Period 2|Administrative or other reason|7|||
155401359|NCT01987960|560902585|FG003|Period 2|Administrative or other reason|0|||
155401360|NCT01987960|560902582|FG000|Period 3|Adverse Event|0|||
155401361|NCT01987960|560902583|FG001|Period 3|Adverse Event|0|||
155401362|NCT01987960|560902584|FG002|Period 3|Adverse Event|0|||
155401363|NCT01987960|560902585|FG003|Period 3|Adverse Event|7|||
155401364|NCT01987960|560902582|FG000|Period 3|Non-compliance with IMP|0|||
155401365|NCT01987960|560902583|FG001|Period 3|Non-compliance with IMP|0|||
155401366|NCT01987960|560902584|FG002|Period 3|Non-compliance with IMP|0|||
155401367|NCT01987960|560902585|FG003|Period 3|Non-compliance with IMP|1|||
155401368|NCT01987960|560902582|FG000|Period 3|Protocol Violation|0|||
155401369|NCT01987960|560902583|FG001|Period 3|Protocol Violation|0|||
155401370|NCT01987960|560902584|FG002|Period 3|Protocol Violation|0|||
155401371|NCT01987960|560902585|FG003|Period 3|Protocol Violation|6|||
155401372|NCT01987960|560902582|FG000|Period 3|Withdrawal by Subject|0|||
155401373|NCT01987960|560902583|FG001|Period 3|Withdrawal by Subject|0|||
155401374|NCT01987960|560902584|FG002|Period 3|Withdrawal by Subject|0|||
155401375|NCT01987960|560902585|FG003|Period 3|Withdrawal by Subject|9|||
155401376|NCT01987960|560902582|FG000|Period 3|Lost to Follow-up|0|||
155401377|NCT01987960|560902583|FG001|Period 3|Lost to Follow-up|0|||
155401378|NCT01987960|560902584|FG002|Period 3|Lost to Follow-up|0|||
155401379|NCT01987960|560902585|FG003|Period 3|Lost to Follow-up|5|||
155401380|NCT01987960|560902582|FG000|Period 3|Administrative or other reason|0|||
155401381|NCT01987960|560902583|FG001|Period 3|Administrative or other reason|0|||
155401382|NCT01987960|560902584|FG002|Period 3|Administrative or other reason|0|||
155401383|NCT01987960|560902585|FG003|Period 3|Administrative or other reason|43|||
155401384|NCT00807742|560902588|FG000|Overall Study|Death|9|||
155401385|NCT00807742|560902589|FG001|Overall Study|Death|2|||
155401386|NCT00807742|560902588|FG000|Overall Study|Withdrawal by Subject|2|||
155637230|NCT04279522|561762950|FG001|Period 2: Open Label Phase|Adverse Event|1|||
155637231|NCT04279522|561762949|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
155637232|NCT04279522|561762950|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
155637233|NCT04717557|561762951|FG000|Overall Study|Withdrawal by Subject|2|||
155637234|NCT04717557|561762952|FG001|Overall Study|Withdrawal by Subject|0|||
155637235|NCT04717557|561762951|FG000|Overall Study|Death|1|||
155637236|NCT04717557|561762952|FG001|Overall Study|Death|0|||
155637237|NCT06354257|561762957|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155637238|NCT06354257|561762957|FG000|Treatment Period 2|Adverse Event|1|||
155637239|NCT02685735|561762958|FG000|Overall Study|Surgery Cancelled|4|||
155401387|NCT00807742|560902589|FG001|Overall Study|Withdrawal by Subject|1|||
155401388|NCT00807742|560902588|FG000|Overall Study|Lost to Follow-up|35|||
155401389|NCT00807742|560902589|FG001|Overall Study|Lost to Follow-up|51|||
155401390|NCT04814823|560902591|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
155401391|NCT05678257|560902596|FG000|Overall Study|Withdrawal by Subject|2|||
155401392|NCT05678257|560902597|FG001|Overall Study|Withdrawal by Subject|0|||
155401393|NCT05678257|560902598|FG002|Overall Study|Withdrawal by Subject|5|||
155401394|NCT05678257|560902596|FG000|Overall Study|Physician Decision|1|||
155401395|NCT05678257|560902597|FG001|Overall Study|Physician Decision|0|||
155401396|NCT05678257|560902598|FG002|Overall Study|Physician Decision|1|||
155401397|NCT05678257|560902596|FG000|Overall Study|Adverse Event|1|||
155401398|NCT05678257|560902597|FG001|Overall Study|Adverse Event|3|||
155401399|NCT05678257|560902598|FG002|Overall Study|Adverse Event|1|||
155401400|NCT05678257|560902596|FG000|Overall Study|Progressive disease|11|||
155401401|NCT05678257|560902597|FG001|Overall Study|Progressive disease|18|||
155401402|NCT05678257|560902598|FG002|Overall Study|Progressive disease|7|||
155401403|NCT05678257|560902596|FG000|Overall Study|No longer clinically benefitting|2|||
155401404|NCT05678257|560902597|FG001|Overall Study|No longer clinically benefitting|1|||
155401405|NCT05678257|560902598|FG002|Overall Study|No longer clinically benefitting|0|||
155401406|NCT05678257|560902596|FG000|Overall Study|Sponsor decision|5|||
155401407|NCT05678257|560902597|FG001|Overall Study|Sponsor decision|9|||
155401408|NCT05678257|560902598|FG002|Overall Study|Sponsor decision|8|||
155401409|NCT05678257|560902596|FG000|Overall Study|Protocol Violation|0|||
155401410|NCT05678257|560902597|FG001|Overall Study|Protocol Violation|0|||
155401411|NCT05678257|560902598|FG002|Overall Study|Protocol Violation|1|||
155401412|NCT05678257|560902596|FG000|Overall Study|Patient non-compliance|0|||
155401413|NCT05678257|560902597|FG001|Overall Study|Patient non-compliance|0|||
155401414|NCT05678257|560902598|FG002|Overall Study|Patient non-compliance|3|||
155401415|NCT03520959|560902599|FG000|Overall Study|Study terminated by Sponsor|0|||
155401416|NCT03520959|560902600|FG001|Overall Study|Study terminated by Sponsor|1|||
155401417|NCT01357577|560902601|FG000|Overall Study|Lost to Follow-up|20|||
155401418|NCT01357577|560902602|FG001|Overall Study|Lost to Follow-up|16|||
155401419|NCT01357577|560902601|FG000|Overall Study|Withdrawal by Subject|16|||
155401420|NCT01357577|560902602|FG001|Overall Study|Withdrawal by Subject|8|||
155401421|NCT01357577|560902601|FG000|Overall Study|look at data in database?|1|||
155401422|NCT01357577|560902602|FG001|Overall Study|look at data in database?|2|||
155401423|NCT04419610|560903712|FG000|Overall Study|Withdrawal by Subject|3|||
155401424|NCT04419610|560903713|FG001|Overall Study|Withdrawal by Subject|1|||
155401425|NCT04419610|560903712|FG000|Overall Study|Adverse Event|1|||
155401426|NCT04419610|560903713|FG001|Overall Study|Adverse Event|0|||
155401427|NCT04419610|560903712|FG000|Overall Study|discharged early|1|||
155401428|NCT04419610|560903713|FG001|Overall Study|discharged early|1|||
155401429|NCT01439282|560903714|FG000|Overall Study|Adverse Event|5|||
155401430|NCT01439282|560903715|FG001|Overall Study|Adverse Event|0|||
155401431|NCT01439282|560903714|FG000|Overall Study|Withdrawal by Subject|2|||
155401432|NCT01439282|560903715|FG001|Overall Study|Withdrawal by Subject|0|||
155401433|NCT01439282|560903714|FG000|Overall Study|Other|1|||
155401434|NCT01439282|560903715|FG001|Overall Study|Other|1|||
155401435|NCT00307151|560903718|FG000|Overall Study|Death|4|||
155401436|NCT00307151|560903719|FG001|Overall Study|Death|3|||
155401437|NCT00307151|560903720|FG002|Overall Study|Death|10|||
155401438|NCT00307151|560903721|FG003|Overall Study|Death|3|||
155401439|NCT00307151|560903718|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155401440|NCT00307151|560903719|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155401441|NCT00307151|560903720|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155401442|NCT00307151|560903721|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155401443|NCT00307151|560903718|FG000|Overall Study|Subject unable to get to clinic|1|||
155401444|NCT00307151|560903719|FG001|Overall Study|Subject unable to get to clinic|0|||
155401445|NCT00307151|560903720|FG002|Overall Study|Subject unable to get to clinic|6|||
155401446|NCT00307151|560903721|FG003|Overall Study|Subject unable to get to clinic|2|||
155401447|NCT00307151|560903718|FG000|Overall Study|Withdrew consent|0|||
155401448|NCT00307151|560903719|FG001|Overall Study|Withdrew consent|1|||
155401449|NCT00307151|560903720|FG002|Overall Study|Withdrew consent|1|||
155401450|NCT00307151|560903721|FG003|Overall Study|Withdrew consent|3|||
155401451|NCT00307151|560903718|FG000|Overall Study|Not willing to adhere to study reqs|2|||
155401452|NCT00307151|560903719|FG001|Overall Study|Not willing to adhere to study reqs|0|||
155401453|NCT00307151|560903720|FG002|Overall Study|Not willing to adhere to study reqs|2|||
155401454|NCT00307151|560903721|FG003|Overall Study|Not willing to adhere to study reqs|2|||
155401455|NCT00307151|560903718|FG000|Overall Study|Clinic unable to contact subject|3|||
155401456|NCT00307151|560903719|FG001|Overall Study|Clinic unable to contact subject|3|||
155401457|NCT00307151|560903720|FG002|Overall Study|Clinic unable to contact subject|1|||
155401458|NCT00307151|560903721|FG003|Overall Study|Clinic unable to contact subject|1|||
155401459|NCT00980200|560903723|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401460|NCT00980200|560903724|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
155401461|NCT00980200|560903725|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401462|NCT00980200|560903726|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401463|NCT00980200|560903727|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
155742012|NCT01950013|562156387|FG002|Overall Study|Withdrawal by Subject|0|||
155742013|NCT02365480|562156388|FG000|Overall Study|Withdrawal by Subject|2|||
155401464|NCT00980200|560903723|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
155401465|NCT00980200|560903724|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
155401466|NCT00980200|560903725|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
155401467|NCT00980200|560903726|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
155401468|NCT00980200|560903727|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
155742014|NCT02365480|562156389|FG001|Overall Study|Withdrawal by Subject|0|||
155742015|NCT00706342|562156390|FG000|Overall Study|Adverse Event|3|||
155401469|NCT01617460|560903728|FG000|Overall Study|Adverse Event|10|||
155401470|NCT01617460|560903728|FG000|Overall Study|Physician Decision|16|||
155401471|NCT01617460|560903728|FG000|Overall Study|Protocol Violation|5|||
155401472|NCT01617460|560903728|FG000|Overall Study|Withdrawal by Subject|9|||
155401473|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
155401474|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
155401475|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Death|0|||
155401476|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Death|1|||
155401477|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
155401478|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
155637240|NCT02685735|561762959|FG001|Overall Study|Surgery Cancelled|9|||
155637241|NCT02685735|561762958|FG000|Overall Study|Adverse Event|10|||
155637242|NCT02685735|561762959|FG001|Overall Study|Adverse Event|3|||
155637243|NCT02685735|561762958|FG000|Overall Study|Preop testing found to be incomplete|2|||
155637244|NCT02685735|561762959|FG001|Overall Study|Preop testing found to be incomplete|2|||
155637245|NCT02685735|561762958|FG000|Overall Study|Withdrawal by Subject|1|||
155637246|NCT02685735|561762959|FG001|Overall Study|Withdrawal by Subject|2|||
155637247|NCT02685735|561762958|FG000|Overall Study|Death|1|||
155637248|NCT02685735|561762959|FG001|Overall Study|Death|0|||
155637249|NCT01977846|561762964|FG000|Total Study - Prospective|Death|0|||
155637250|NCT01977846|561762965|FG001|Total Study - Prospective|Death|1|||
155637251|NCT01977846|561762964|FG000|Total Study - Prospective|Lost to Follow-up|0|||
155637252|NCT01977846|561762965|FG001|Total Study - Prospective|Lost to Follow-up|8|||
155637253|NCT01977846|561762964|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
155637254|NCT01977846|561762965|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
155637255|NCT01977846|561762964|FG000|Total Study - Prospective|Not available at time of visit|0|||
155637256|NCT01977846|561762965|FG001|Total Study - Prospective|Not available at time of visit|5|||
155637257|NCT01977846|561762964|FG000|Total Study - Prospective|No show|0|||
155637258|NCT01977846|561762965|FG001|Total Study - Prospective|No show|1|||
155637259|NCT01977846|561762964|FG000|Total Study - Prospective|Protocol Violation|0|||
155637260|NCT01977846|561762965|FG001|Total Study - Prospective|Protocol Violation|1|||
155637261|NCT01047319|561762966|FG000|Overall Study|Teva requested participant withdrawal|3|||
155637262|NCT01047319|561762967|FG001|Overall Study|Teva requested participant withdrawal|0|||
155637263|NCT01047319|561762968|FG002|Overall Study|Teva requested participant withdrawal|1|||
155637264|NCT01047319|561762966|FG000|Overall Study|Protocol Violation|3|||
155637265|NCT01047319|561762967|FG001|Overall Study|Protocol Violation|2|||
155637266|NCT01047319|561762968|FG002|Overall Study|Protocol Violation|4|||
155637267|NCT01047319|561762966|FG000|Overall Study|Lack of Efficacy|4|||
155637268|NCT01047319|561762967|FG001|Overall Study|Lack of Efficacy|3|||
155637269|NCT01047319|561762968|FG002|Overall Study|Lack of Efficacy|3|||
155637270|NCT01047319|561762966|FG000|Overall Study|Death|5|||
155637271|NCT01047319|561762967|FG001|Overall Study|Death|1|||
155637272|NCT01047319|561762968|FG002|Overall Study|Death|5|||
155637273|NCT01047319|561762966|FG000|Overall Study|Pregnancy|13|||
155637274|NCT01047319|561762967|FG001|Overall Study|Pregnancy|8|||
155637275|NCT01047319|561762968|FG002|Overall Study|Pregnancy|8|||
155637276|NCT01047319|561762966|FG000|Overall Study|Physician Decision|12|||
155637277|NCT01047319|561762967|FG001|Overall Study|Physician Decision|9|||
155637278|NCT01047319|561762968|FG002|Overall Study|Physician Decision|10|||
155637279|NCT01047319|561762966|FG000|Overall Study|Lost to Follow-up|14|||
155637280|NCT01047319|561762967|FG001|Overall Study|Lost to Follow-up|10|||
155637281|NCT01047319|561762968|FG002|Overall Study|Lost to Follow-up|10|||
155637282|NCT01047319|561762966|FG000|Overall Study|Adverse Event|16|||
155637283|NCT01047319|561762967|FG001|Overall Study|Adverse Event|27|||
155637284|NCT01047319|561762968|FG002|Overall Study|Adverse Event|21|||
155637285|NCT01047319|561762966|FG000|Overall Study|Withdrawal by Subject|77|||
155637286|NCT01047319|561762967|FG001|Overall Study|Withdrawal by Subject|75|||
155637287|NCT01047319|561762968|FG002|Overall Study|Withdrawal by Subject|87|||
155637288|NCT01047319|561762966|FG000|Overall Study|Study terminated by Sponsor|198|||
155637289|NCT01047319|561762967|FG001|Overall Study|Study terminated by Sponsor|215|||
155637290|NCT01047319|561762968|FG002|Overall Study|Study terminated by Sponsor|203|||
155637291|NCT06481579|561762969|FG000|Overall Study|Death|1|||
155637292|NCT06481579|561762970|FG001|Overall Study|Death|0|||
155637293|NCT06481579|561762969|FG000|Overall Study|Withdrawal by Subject|3|||
155637294|NCT06481579|561762970|FG001|Overall Study|Withdrawal by Subject|0|||
155637295|NCT06481579|561762969|FG000|Overall Study|Other|1|||
155637296|NCT06481579|561762970|FG001|Overall Study|Other|1|||
155637297|NCT04338581|561764718|FG000|Overall Study|Lack of Efficacy|1|||
155637298|NCT04338581|561764719|FG001|Overall Study|Lack of Efficacy|0|||
155637299|NCT04338581|561764718|FG000|Overall Study|Withdrawal by Subject|4|||
155637300|NCT04338581|561764719|FG001|Overall Study|Withdrawal by Subject|4|||
155637301|NCT04338581|561764718|FG000|Overall Study|Prohibited Medication|1|||
155637302|NCT04338581|561764719|FG001|Overall Study|Prohibited Medication|0|||
155637303|NCT00770809|561764724|FG000|Overall Study|Adverse Event|9|||
155637304|NCT00770809|561764725|FG001|Overall Study|Adverse Event|1|||
155742016|NCT00706342|562156390|FG000|Overall Study|Not responding to treatment|2|||
155742017|NCT00706342|562156390|FG000|Overall Study|Withdrawn due to failure to respond|1|||
155742018|NCT00706342|562156390|FG000|Overall Study|Death|1|||
155742019|NCT00706342|562156390|FG000|Overall Study|Withdrew from the study on his own.|1|||
155401479|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
155401480|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
155401481|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Death|22|||
155401482|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Death|25|||
155401483|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
155401484|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
155401485|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
155401486|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
155401487|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
155401488|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
155401489|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Death|36|||
155401490|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Death|33|||
155401491|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
155401492|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
155401493|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
155401494|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
155401495|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
155401496|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
155401497|NCT02966509|560903734|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
155401498|NCT02966509|560903735|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
155401499|NCT02966509|560903734|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
155401500|NCT02966509|560903735|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
155401501|NCT03332498|560903736|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
155401502|NCT03332498|560903737|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
155401503|NCT03332498|560903738|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
155401504|NCT00916357|560903739|FG000|Period 1|Withdrawal by Subject|1|||
155401505|NCT00916357|560903740|FG001|Period 1|Withdrawal by Subject|0|||
155401506|NCT00916357|560903741|FG002|Period 1|Withdrawal by Subject|0|||
155401507|NCT00916357|560903742|FG003|Period 1|Withdrawal by Subject|0|||
155401508|NCT00916357|560903743|FG004|Period 1|Withdrawal by Subject|0|||
155401509|NCT00916357|560903744|FG005|Period 1|Withdrawal by Subject|0|||
155401510|NCT00916357|560903739|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401511|NCT00916357|560903740|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401512|NCT00916357|560903741|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401513|NCT00916357|560903742|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
155401514|NCT00916357|560903743|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401515|NCT00916357|560903744|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401516|NCT05611671|560903748|FG000|Overall Study|Adverse Event|1|||
155401517|NCT05611671|560903749|FG001|Overall Study|Adverse Event|1|||
155401518|NCT05611671|560903750|FG002|Overall Study|Adverse Event|0|||
155401519|NCT05611671|560903751|FG003|Overall Study|Adverse Event|1|||
155401520|NCT05611671|560903748|FG000|Overall Study|Lack of Efficacy|1|||
155401521|NCT05611671|560903749|FG001|Overall Study|Lack of Efficacy|0|||
155401522|NCT05611671|560903750|FG002|Overall Study|Lack of Efficacy|1|||
155401523|NCT05611671|560903751|FG003|Overall Study|Lack of Efficacy|2|||
155401524|NCT05611671|560903748|FG000|Overall Study|Lost to Follow-up|0|||
155401525|NCT05611671|560903749|FG001|Overall Study|Lost to Follow-up|0|||
155401526|NCT05611671|560903750|FG002|Overall Study|Lost to Follow-up|0|||
155401527|NCT05611671|560903751|FG003|Overall Study|Lost to Follow-up|1|||
155401528|NCT05611671|560903748|FG000|Overall Study|Protocol Violation|0|||
155401529|NCT05611671|560903749|FG001|Overall Study|Protocol Violation|1|||
155401530|NCT05611671|560903750|FG002|Overall Study|Protocol Violation|0|||
155401531|NCT05611671|560903751|FG003|Overall Study|Protocol Violation|0|||
155401532|NCT05611671|560903748|FG000|Overall Study|Withdrawal by Subject|2|||
155401533|NCT05611671|560903749|FG001|Overall Study|Withdrawal by Subject|1|||
155401534|NCT05611671|560903750|FG002|Overall Study|Withdrawal by Subject|2|||
155742020|NCT00706342|562156390|FG000|Overall Study|Investigator discretion|2|||
155742021|NCT00706342|562156390|FG000|Overall Study|Non-responder Week 12|1|||
155742022|NCT00706342|562156390|FG000|Overall Study|Ongoing|6|||
155284790|NCT01941316|560474417|FG000|Overall Study|Physician Decision|0|||
155401535|NCT05611671|560903751|FG003|Overall Study|Withdrawal by Subject|1|||
155401536|NCT01911442|560903752|FG000|Overall Study|Adverse Event|2|||
155401537|NCT01911442|560903753|FG001|Overall Study|Adverse Event|2|||
155401538|NCT01911442|560903754|FG002|Overall Study|Adverse Event|4|||
155401539|NCT01911442|560903752|FG000|Overall Study|Lack of Efficacy|1|||
155401540|NCT01911442|560903753|FG001|Overall Study|Lack of Efficacy|1|||
155401541|NCT01911442|560903754|FG002|Overall Study|Lack of Efficacy|1|||
155401542|NCT01911442|560903752|FG000|Overall Study|Lost to Follow-up|2|||
155401543|NCT01911442|560903753|FG001|Overall Study|Lost to Follow-up|0|||
155401544|NCT01911442|560903754|FG002|Overall Study|Lost to Follow-up|1|||
155742023|NCT00706342|562156390|FG000|Overall Study|WIthdrawal of consent|1|||
155401545|NCT01911442|560903752|FG000|Overall Study|Withdrawal by Subject|1|||
155401546|NCT01911442|560903753|FG001|Overall Study|Withdrawal by Subject|0|||
155401547|NCT01911442|560903754|FG002|Overall Study|Withdrawal by Subject|6|||
155401548|NCT01911442|560903752|FG000|Overall Study|Mother's Work Schedule|0|||
155401549|NCT01911442|560903753|FG001|Overall Study|Mother's Work Schedule|1|||
155401550|NCT01911442|560903754|FG002|Overall Study|Mother's Work Schedule|0|||
155401551|NCT01648790|560903755|FG000|Treatment 3|Withdrawal by Subject|0|||
155401552|NCT01648790|560903756|FG001|Treatment 3|Withdrawal by Subject|0|||
155401553|NCT01648790|560903757|FG002|Treatment 3|Withdrawal by Subject|0|||
155401554|NCT01648790|560903758|FG003|Treatment 3|Withdrawal by Subject|1|||
155401555|NCT01648790|560903759|FG004|Treatment 3|Withdrawal by Subject|0|||
155742024|NCT01781299|562156395|FG000|Overall Study|Withdrawal by Subject|0|||
155742025|NCT01781299|562156396|FG001|Overall Study|Withdrawal by Subject|1|||
155742026|NCT02395172|562156401|FG000|Overall Study|Participants randomized but not treated|3|||
155742027|NCT02395172|562156402|FG001|Overall Study|Participants randomized but not treated|31|||
155401556|NCT01486927|560903760|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
155401557|NCT01486927|560903760|FG000|Overall Study|Physician Decision|1|||
155401558|NCT01486927|560903760|FG000|Overall Study|50 Exposure days not reached|2|||
155401559|NCT01486927|560903760|FG000|Overall Study|Withdrawal by Subject|8|||
155401560|NCT01486927|560903760|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
155401561|NCT02159729|560903761|FG000|Overall Study|Adverse Event|0|||
155401562|NCT02159729|560903762|FG001|Overall Study|Adverse Event|1|||
155401563|NCT02159729|560903761|FG000|Overall Study|Subject's Request|13|||
155401564|NCT02159729|560903762|FG001|Overall Study|Subject's Request|10|||
155401565|NCT02159729|560903761|FG000|Overall Study|Lost to Follow-up|24|||
155401566|NCT02159729|560903762|FG001|Overall Study|Lost to Follow-up|9|||
155401567|NCT02159729|560903761|FG000|Overall Study|Non compliance|2|||
155401568|NCT02159729|560903762|FG001|Overall Study|Non compliance|0|||
155401569|NCT02159729|560903761|FG000|Overall Study|Other Unspecified|3|||
155401570|NCT02159729|560903762|FG001|Overall Study|Other Unspecified|1|||
155401571|NCT00573430|560903763|FG000|Overall Study|Incorrect enrollment of randomization|0|||
155401572|NCT00573430|560903764|FG001|Overall Study|Incorrect enrollment of randomization|4|||
155401573|NCT00573430|560903765|FG002|Overall Study|Incorrect enrollment of randomization|3|||
155401574|NCT00573430|560903763|FG000|Overall Study|Adverse Event|0|||
155401575|NCT00573430|560903764|FG001|Overall Study|Adverse Event|0|||
155401576|NCT00573430|560903765|FG002|Overall Study|Adverse Event|2|||
155401577|NCT00573430|560903763|FG000|Overall Study|Withdrawal by Subject|1|||
155401578|NCT00573430|560903764|FG001|Overall Study|Withdrawal by Subject|0|||
155401579|NCT00573430|560903765|FG002|Overall Study|Withdrawal by Subject|1|||
155401580|NCT00573430|560903763|FG000|Overall Study|Protocol Violation|0|||
155401581|NCT00573430|560903764|FG001|Overall Study|Protocol Violation|1|||
155401582|NCT00573430|560903765|FG002|Overall Study|Protocol Violation|1|||
155401583|NCT00573430|560903763|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155401584|NCT00573430|560903764|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155401585|NCT00573430|560903765|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
155401586|NCT02953340|560903769|FG000|Overall Study|Death|0|||
155401587|NCT02953340|560903770|FG001|Overall Study|Death|1|||
155401588|NCT02953340|560903769|FG000|Overall Study|Investigator Decision|3|||
155401589|NCT02953340|560903770|FG001|Overall Study|Investigator Decision|3|||
155401590|NCT02953340|560903769|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
155401591|NCT02953340|560903770|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
155401592|NCT02953340|560903769|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
155401593|NCT02953340|560903770|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
155401594|NCT02953340|560903769|FG000|Overall Study|Withdrawal by Subject|9|||
155401595|NCT02953340|560903770|FG001|Overall Study|Withdrawal by Subject|9|||
155401596|NCT02953340|560903769|FG000|Overall Study|Sponsor decision|0|||
155401597|NCT02953340|560903770|FG001|Overall Study|Sponsor decision|2|||
155401598|NCT02953340|560903769|FG000|Overall Study|Lost to Follow-up|3|||
155401599|NCT02953340|560903770|FG001|Overall Study|Lost to Follow-up|2|||
155401600|NCT02953340|560903769|FG000|Overall Study|Reason not specified|2|||
155401601|NCT02953340|560903770|FG001|Overall Study|Reason not specified|2|||
155401602|NCT04232553|560903771|FG000|Overall Study|Adverse Event|3|||
155401603|NCT04232553|560903772|FG001|Overall Study|Adverse Event|2|||
155401604|NCT04232553|560903773|FG002|Overall Study|Adverse Event|1|||
155401605|NCT04232553|560903774|FG003|Overall Study|Adverse Event|2|||
155401606|NCT04232553|560903775|FG004|Overall Study|Adverse Event|1|||
155401607|NCT04232553|560903776|FG005|Overall Study|Adverse Event|1|||
155401608|NCT04232553|560903777|FG006|Overall Study|Adverse Event|0|||
155401609|NCT04232553|560903778|FG007|Overall Study|Adverse Event|0|||
155401610|NCT04232553|560903779|FG008|Overall Study|Adverse Event|0|||
155401611|NCT04232553|560903771|FG000|Overall Study|Death|0|||
155742028|NCT00653939|562156403|FG000|Overall Study|Adverse Event|1|||
155742029|NCT00653939|562156404|FG001|Overall Study|Adverse Event|3|||
155742030|NCT00653939|562156403|FG000|Overall Study|Withdrawal by Subject|3|||
155401612|NCT04232553|560903772|FG001|Overall Study|Death|1|||
155401613|NCT04232553|560903773|FG002|Overall Study|Death|0|||
155401614|NCT04232553|560903774|FG003|Overall Study|Death|1|||
155742031|NCT00653939|562156404|FG001|Overall Study|Withdrawal by Subject|3|||
155742032|NCT00653939|562156403|FG000|Overall Study|Physician Decision|4|||
155742033|NCT00653939|562156404|FG001|Overall Study|Physician Decision|0|||
155742034|NCT00653939|562156403|FG000|Overall Study|Disease Progression|2|||
155742035|NCT00653939|562156404|FG001|Overall Study|Disease Progression|3|||
155742036|NCT00653939|562156403|FG000|Overall Study|Other|2|||
155742037|NCT00653939|562156404|FG001|Overall Study|Other|6|||
155742038|NCT02032238|562156405|FG000|Overall Study|Lost to Follow-up|2|||
155742039|NCT02032238|562156406|FG001|Overall Study|Lost to Follow-up|0|||
155742040|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
155742041|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
155742042|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
155742043|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
155742044|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
155742045|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
155742046|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
155742047|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
155742048|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
155742049|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
155742050|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
155742051|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
155742052|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
155742053|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
155742054|NCT00612105|562156407|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
155742055|NCT00612105|562156408|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
155742056|NCT00612105|562156407|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
155742057|NCT00612105|562156408|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
155742058|NCT00612105|562156407|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
155742059|NCT00612105|562156408|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
155742060|NCT00612105|562156407|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
155742061|NCT00612105|562156408|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
155742062|NCT00612105|562156407|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
155742063|NCT00612105|562156408|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
155742064|NCT01105767|562156409|FG000|Overall Study|Lost to Follow-up|1160|||
155742065|NCT01105767|562156410|FG001|Overall Study|Lost to Follow-up|1614|||
155742066|NCT01105767|562156411|FG002|Overall Study|Lost to Follow-up|1184|||
155401615|NCT04232553|560903775|FG004|Overall Study|Death|0|||
155401616|NCT04232553|560903776|FG005|Overall Study|Death|0|||
155401617|NCT04232553|560903777|FG006|Overall Study|Death|0|||
155401618|NCT04232553|560903778|FG007|Overall Study|Death|0|||
155401619|NCT04232553|560903779|FG008|Overall Study|Death|0|||
155401620|NCT04232553|560903771|FG000|Overall Study|Lack of Efficacy|0|||
155401621|NCT04232553|560903772|FG001|Overall Study|Lack of Efficacy|2|||
155401622|NCT04232553|560903773|FG002|Overall Study|Lack of Efficacy|0|||
155401623|NCT04232553|560903774|FG003|Overall Study|Lack of Efficacy|0|||
155401624|NCT04232553|560903775|FG004|Overall Study|Lack of Efficacy|0|||
155401625|NCT04232553|560903776|FG005|Overall Study|Lack of Efficacy|0|||
155401626|NCT04232553|560903777|FG006|Overall Study|Lack of Efficacy|0|||
155401627|NCT04232553|560903778|FG007|Overall Study|Lack of Efficacy|0|||
155401628|NCT04232553|560903779|FG008|Overall Study|Lack of Efficacy|1|||
155401629|NCT04232553|560903771|FG000|Overall Study|Lost to Follow-up|0|||
155401630|NCT04232553|560903772|FG001|Overall Study|Lost to Follow-up|1|||
155401631|NCT04232553|560903773|FG002|Overall Study|Lost to Follow-up|0|||
155401632|NCT04232553|560903774|FG003|Overall Study|Lost to Follow-up|0|||
155401633|NCT04232553|560903775|FG004|Overall Study|Lost to Follow-up|1|||
155401634|NCT04232553|560903776|FG005|Overall Study|Lost to Follow-up|0|||
155401635|NCT04232553|560903777|FG006|Overall Study|Lost to Follow-up|0|||
155401636|NCT04232553|560903778|FG007|Overall Study|Lost to Follow-up|0|||
155401637|NCT04232553|560903779|FG008|Overall Study|Lost to Follow-up|1|||
155742067|NCT00475982|562156412|FG000|Overall Study|surgery rescheduled|7|||
155742068|NCT00475982|562156413|FG001|Overall Study|surgery rescheduled|3|||
155742069|NCT00783198|562156422|FG000|Overall Study|Adverse Event|15|||
155742070|NCT00783198|562156423|FG001|Overall Study|Adverse Event|19|||
155742071|NCT00783198|562156424|FG002|Overall Study|Adverse Event|3|||
155742072|NCT00783198|562156422|FG000|Overall Study|Lost to Follow-up|11|||
155401638|NCT04232553|560903771|FG000|Overall Study|Other - As reported by the investigator|0|||
155401639|NCT04232553|560903772|FG001|Overall Study|Other - As reported by the investigator|1|||
155401640|NCT04232553|560903773|FG002|Overall Study|Other - As reported by the investigator|0|||
155401641|NCT04232553|560903774|FG003|Overall Study|Other - As reported by the investigator|0|||
155401642|NCT04232553|560903775|FG004|Overall Study|Other - As reported by the investigator|0|||
155401643|NCT04232553|560903776|FG005|Overall Study|Other - As reported by the investigator|0|||
155401644|NCT04232553|560903777|FG006|Overall Study|Other - As reported by the investigator|0|||
155742073|NCT00783198|562156423|FG001|Overall Study|Lost to Follow-up|1|||
155284791|NCT01941316|560474418|FG001|Overall Study|Physician Decision|0|||
155401645|NCT04232553|560903778|FG007|Overall Study|Other - As reported by the investigator|0|||
155401646|NCT04232553|560903779|FG008|Overall Study|Other - As reported by the investigator|0|||
155401647|NCT04232553|560903771|FG000|Overall Study|Physician Decision|1|||
155401648|NCT04232553|560903772|FG001|Overall Study|Physician Decision|1|||
155401649|NCT04232553|560903773|FG002|Overall Study|Physician Decision|0|||
155401650|NCT04232553|560903774|FG003|Overall Study|Physician Decision|0|||
155401651|NCT04232553|560903775|FG004|Overall Study|Physician Decision|1|||
155401652|NCT04232553|560903776|FG005|Overall Study|Physician Decision|0|||
155401653|NCT04232553|560903777|FG006|Overall Study|Physician Decision|0|||
155401654|NCT04232553|560903778|FG007|Overall Study|Physician Decision|0|||
155401655|NCT04232553|560903779|FG008|Overall Study|Physician Decision|0|||
155401656|NCT04232553|560903771|FG000|Overall Study|Pregnancy|1|||
155401657|NCT04232553|560903772|FG001|Overall Study|Pregnancy|0|||
155401658|NCT04232553|560903773|FG002|Overall Study|Pregnancy|0|||
155401659|NCT04232553|560903774|FG003|Overall Study|Pregnancy|0|||
155401660|NCT04232553|560903775|FG004|Overall Study|Pregnancy|0|||
155401661|NCT04232553|560903776|FG005|Overall Study|Pregnancy|0|||
155401662|NCT04232553|560903777|FG006|Overall Study|Pregnancy|0|||
155401663|NCT04232553|560903778|FG007|Overall Study|Pregnancy|0|||
155401664|NCT04232553|560903779|FG008|Overall Study|Pregnancy|0|||
155401665|NCT04232553|560903771|FG000|Overall Study|Withdrawal by Subject|7|||
155401666|NCT04232553|560903772|FG001|Overall Study|Withdrawal by Subject|5|||
155401667|NCT04232553|560903773|FG002|Overall Study|Withdrawal by Subject|0|||
155401668|NCT04232553|560903774|FG003|Overall Study|Withdrawal by Subject|0|||
155401669|NCT04232553|560903775|FG004|Overall Study|Withdrawal by Subject|2|||
155401670|NCT04232553|560903776|FG005|Overall Study|Withdrawal by Subject|2|||
155401671|NCT04232553|560903777|FG006|Overall Study|Withdrawal by Subject|0|||
155401672|NCT04232553|560903778|FG007|Overall Study|Withdrawal by Subject|2|||
155401673|NCT04232553|560903779|FG008|Overall Study|Withdrawal by Subject|0|||
155401674|NCT02969915|560903780|FG000|Overall Study|Death|104|||
155401675|NCT02969915|560903781|FG001|Overall Study|Death|125|||
155401676|NCT02969915|560903780|FG000|Overall Study|Lost to Follow-up|108|||
155401677|NCT02969915|560903781|FG001|Overall Study|Lost to Follow-up|112|||
155401678|NCT02969915|560903780|FG000|Overall Study|Censored due to COVID-19|481|||
155401679|NCT02969915|560903781|FG001|Overall Study|Censored due to COVID-19|471|||
155401680|NCT01378858|560903784|FG000|Overall Study|Withdrawal by Subject|4|||
155401681|NCT01378858|560903785|FG001|Overall Study|Withdrawal by Subject|4|||
155401682|NCT02664272|560903786|FG000|Overall Study|Fluoroscopic images not made available|2|||
155401683|NCT03073980|560903787|FG000|Overall Study|Lost to Follow-up|10|||
155401684|NCT03073980|560903788|FG001|Overall Study|Lost to Follow-up|2|||
155401685|NCT03073980|560903789|FG002|Overall Study|Lost to Follow-up|9|||
155401686|NCT03073980|560903787|FG000|Overall Study|No post-procedure data|0|||
155401687|NCT03073980|560903788|FG001|Overall Study|No post-procedure data|0|||
155401688|NCT03073980|560903789|FG002|Overall Study|No post-procedure data|2|||
155401689|NCT04810689|560903790|FG000|Overall Study|Withdrawal by Subject|0|||
155401690|NCT04810689|560903791|FG001|Overall Study|Withdrawal by Subject|1|||
155401691|NCT00450723|560903793|FG000|Overall Study|Physician Decision|5|||
155401692|NCT00789880|560903796|FG000|Overall Study|Adverse Event|0|||
155401693|NCT00789880|560903797|FG001|Overall Study|Adverse Event|0|||
155401694|NCT00789880|560903798|FG002|Overall Study|Adverse Event|0|||
155401695|NCT00789880|560903799|FG003|Overall Study|Adverse Event|0|||
155401696|NCT00789880|560903800|FG004|Overall Study|Adverse Event|1|||
155401697|NCT00789880|560903801|FG005|Overall Study|Adverse Event|0|||
155401698|NCT00789880|560903796|FG000|Overall Study|Protocol Violation|0|||
155401699|NCT00789880|560903797|FG001|Overall Study|Protocol Violation|1|||
155401700|NCT00789880|560903798|FG002|Overall Study|Protocol Violation|0|||
155401701|NCT00789880|560903799|FG003|Overall Study|Protocol Violation|1|||
155401702|NCT00789880|560903800|FG004|Overall Study|Protocol Violation|0|||
155401703|NCT00789880|560903801|FG005|Overall Study|Protocol Violation|0|||
155401704|NCT00789880|560903796|FG000|Overall Study|Withdrawal by Subject|1|||
155401705|NCT00789880|560903797|FG001|Overall Study|Withdrawal by Subject|0|||
155401706|NCT00789880|560903798|FG002|Overall Study|Withdrawal by Subject|0|||
155401707|NCT00789880|560903799|FG003|Overall Study|Withdrawal by Subject|0|||
155401708|NCT00789880|560903800|FG004|Overall Study|Withdrawal by Subject|2|||
155401709|NCT00789880|560903801|FG005|Overall Study|Withdrawal by Subject|0|||
155401710|NCT06347731|560903802|FG000|Overall Study|Death|1|||
155401711|NCT06347731|560903802|FG000|Overall Study|Protocol Violation|1|||
155401712|NCT06347731|560903802|FG000|Overall Study|Withdrawal by Subject|2|||
155401713|NCT00609986|560903803|FG000|Overall Study|Did not receive transplant or treatment|8|||
155401714|NCT00609986|560903804|FG001|Overall Study|Did not receive transplant or treatment|3|||
155401715|NCT03159091|560903805|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
155401716|NCT03159091|560903806|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
155401717|NCT03159091|560903805|FG000|Overall Study|Patient has taken no dose of study drug|0|||
155284792|NCT01941316|560474419|FG002|Overall Study|Physician Decision|0|||
155401718|NCT03159091|560903806|FG001|Overall Study|Patient has taken no dose of study drug|1|||
155401719|NCT02044133|560903810|FG000|Overall Study|Lost to Follow-up|1|||
155401720|NCT02044133|560903811|FG001|Overall Study|Lost to Follow-up|1|||
155401721|NCT02044133|560903810|FG000|Overall Study|Death|1|||
155401722|NCT02044133|560903811|FG001|Overall Study|Death|0|||
155401723|NCT02044133|560903810|FG000|Overall Study|Release|3|||
155401724|NCT02044133|560903811|FG001|Overall Study|Release|4|||
155401725|NCT02044133|560903810|FG000|Overall Study|Transfer|1|||
155401726|NCT02044133|560903811|FG001|Overall Study|Transfer|0|||
155401727|NCT02044133|560903810|FG000|Overall Study|refusal of blood sampling|0|||
155401728|NCT02044133|560903811|FG001|Overall Study|refusal of blood sampling|1|||
155401729|NCT04722042|560903812|FG000|Overall Study|Withdrawal by Subject|2|||
155401730|NCT04722042|560903813|FG001|Overall Study|Withdrawal by Subject|1|||
155401731|NCT04722042|560903814|FG002|Overall Study|Withdrawal by Subject|0|||
155401732|NCT02046096|560903815|FG000|Overall Study|Death|28|||
155401733|NCT02046096|560903816|FG001|Overall Study|Death|45|||
155401734|NCT02046096|560903815|FG000|Overall Study|Lost to Follow-up|9|||
155401735|NCT02046096|560903816|FG001|Overall Study|Lost to Follow-up|20|||
155401736|NCT02046096|560903815|FG000|Overall Study|Withdrawal by Subject|5|||
155401737|NCT02046096|560903816|FG001|Overall Study|Withdrawal by Subject|17|||
155401738|NCT02046096|560903815|FG000|Overall Study|Other endpoint|2|||
155401739|NCT02046096|560903816|FG001|Overall Study|Other endpoint|19|||
155401740|NCT04969276|560903818|FG000|Overall Study|Protocol Deviation|0|||
155401741|NCT04969276|560903819|FG001|Overall Study|Protocol Deviation|1|||
155401742|NCT04969276|560903820|FG002|Overall Study|Protocol Deviation|0|||
155401743|NCT04969276|560903818|FG000|Overall Study|Withdrawal by Subject|1|||
155401744|NCT04969276|560903819|FG001|Overall Study|Withdrawal by Subject|10|||
155401745|NCT04969276|560903820|FG002|Overall Study|Withdrawal by Subject|0|||
155401746|NCT04969276|560903818|FG000|Overall Study|Lost to Follow-up|0|||
155401747|NCT04969276|560903819|FG001|Overall Study|Lost to Follow-up|1|||
155401748|NCT04969276|560903820|FG002|Overall Study|Lost to Follow-up|0|||
155401749|NCT03834519|560903821|FG000|Overall Study|Lost to Follow-up|2|||
155401750|NCT03834519|560903822|FG001|Overall Study|Lost to Follow-up|1|||
155401751|NCT03834519|560903821|FG000|Overall Study|Withdrawal by Subject|5|||
155401752|NCT03834519|560903822|FG001|Overall Study|Withdrawal by Subject|8|||
155401753|NCT03834519|560903821|FG000|Overall Study|Death|368|||
155401754|NCT03834519|560903822|FG001|Overall Study|Death|174|||
155401755|NCT03834519|560903821|FG000|Overall Study|Physician Decision|5|||
155401756|NCT03834519|560903822|FG001|Overall Study|Physician Decision|1|||
155401757|NCT03834519|560903821|FG000|Overall Study|Sponsor decision|149|||
155401758|NCT03834519|560903822|FG001|Overall Study|Sponsor decision|80|||
155401759|NCT04655144|560903826|FG000|Overall Study|Consumed THC|1|||
155401760|NCT04655144|560903827|FG001|Overall Study|Consumed THC|0|||
155401761|NCT04655144|560903826|FG000|Overall Study|Unilateral embolization|0|||
155401762|NCT04655144|560903827|FG001|Overall Study|Unilateral embolization|1|||
155401763|NCT00943579|560903830|FG000|Overall Study|Adverse Event|4|||
155401764|NCT00943579|560903831|FG001|Overall Study|Adverse Event|3|||
155401765|NCT00943579|560903830|FG000|Overall Study|Lack of Efficacy|2|||
155401766|NCT00943579|560903831|FG001|Overall Study|Lack of Efficacy|2|||
155401767|NCT00418665|560903834|FG000|Treatment Period|Ineligibility determined|1|||
155401768|NCT00418665|560903835|FG001|Treatment Period|Ineligibility determined|1|||
155401769|NCT00418665|560903836|FG002|Treatment Period|Ineligibility determined|0|||
155401770|NCT00418665|560903834|FG000|Treatment Period|Adverse Event|2|||
155401771|NCT00418665|560903835|FG001|Treatment Period|Adverse Event|2|||
155401772|NCT00418665|560903836|FG002|Treatment Period|Adverse Event|0|||
155401773|NCT00418665|560903834|FG000|Treatment Period|Withdrawal by Subject|0|||
155401774|NCT00418665|560903835|FG001|Treatment Period|Withdrawal by Subject|3|||
155401775|NCT00418665|560903836|FG002|Treatment Period|Withdrawal by Subject|1|||
155401776|NCT00418665|560903834|FG000|Treatment Period|Requirement for alternative therapy|1|||
155401777|NCT00418665|560903835|FG001|Treatment Period|Requirement for alternative therapy|0|||
155401778|NCT00418665|560903836|FG002|Treatment Period|Requirement for alternative therapy|0|||
155401779|NCT00418665|560903834|FG000|Treatment Period|Physician Decision|1|||
155401780|NCT00418665|560903835|FG001|Treatment Period|Physician Decision|0|||
155401781|NCT00418665|560903836|FG002|Treatment Period|Physician Decision|3|||
155401782|NCT00418665|560903834|FG000|Treatment Extension|Adverse Event|1|||
155401783|NCT00418665|560903835|FG001|Treatment Extension|Adverse Event|0|||
155401784|NCT00418665|560903836|FG002|Treatment Extension|Adverse Event|0|||
155401785|NCT00418665|560903834|FG000|Treatment Extension|Withdrawal by Subject|1|||
155401786|NCT00418665|560903835|FG001|Treatment Extension|Withdrawal by Subject|0|||
155401787|NCT00418665|560903836|FG002|Treatment Extension|Withdrawal by Subject|0|||
155401788|NCT00418665|560903834|FG000|Treatment Extension|Requirement for alternative therapy|2|||
155401789|NCT00418665|560903835|FG001|Treatment Extension|Requirement for alternative therapy|2|||
155401790|NCT00418665|560903836|FG002|Treatment Extension|Requirement for alternative therapy|0|||
155401791|NCT00418665|560903834|FG000|Treatment Extension|Physician Decision|2|||
155401792|NCT00418665|560903835|FG001|Treatment Extension|Physician Decision|2|||
155401793|NCT00418665|560903836|FG002|Treatment Extension|Physician Decision|1|||
155401794|NCT00418665|560903834|FG000|Treatment Extension|Death|0|||
155401795|NCT00418665|560903835|FG001|Treatment Extension|Death|0|||
155401796|NCT00418665|560903836|FG002|Treatment Extension|Death|1|||
155401797|NCT00853749|560903837|FG000|Overall Study|Lost to Follow-up|0|||
155401798|NCT00853749|560903838|FG001|Overall Study|Lost to Follow-up|1|||
155401799|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
155401800|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
155401801|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
155401802|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
155401803|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
155401804|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
155401805|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
155401806|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
155401807|NCT00687440|560903845|FG000|Overall Study|Adverse Event|3|||
155401808|NCT00687440|560903845|FG000|Overall Study|Lost to Follow-up|3|||
155401809|NCT00687440|560903845|FG000|Overall Study|Lack of Efficacy|2|||
155401810|NCT00687440|560903845|FG000|Overall Study|Death|2|||
155401811|NCT00687440|560903845|FG000|Overall Study|Other|1|||
155401812|NCT00687440|560903845|FG000|Overall Study|Missing|1|||
155401813|NCT05937165|560903854|FG000|Overall Study|Withdrawal by Subject|0|||
155401814|NCT05937165|560903855|FG001|Overall Study|Withdrawal by Subject|1|||
155401815|NCT01538628|560903856|FG000|Overall Study|Withdrawal by Subject|1|||
155401816|NCT01538628|560903857|FG001|Overall Study|Withdrawal by Subject|1|||
155401817|NCT01538628|560903856|FG000|Overall Study|Lost to Follow-up|0|||
155401818|NCT01538628|560903857|FG001|Overall Study|Lost to Follow-up|1|||
155401819|NCT03703882|560904646|FG000|Overall Study|Adverse Event|1|||
155401820|NCT03703882|560904647|FG001|Overall Study|Adverse Event|0|||
155401821|NCT03703882|560904646|FG000|Overall Study|Lost to Follow-up|0|||
155401822|NCT03703882|560904647|FG001|Overall Study|Lost to Follow-up|2|||
155401823|NCT03703882|560904646|FG000|Overall Study|Non-compliance with study drug|0|||
155401824|NCT03703882|560904647|FG001|Overall Study|Non-compliance with study drug|1|||
155401825|NCT03703882|560904646|FG000|Overall Study|Physician Decision|0|||
155401826|NCT03703882|560904647|FG001|Overall Study|Physician Decision|1|||
155401827|NCT03703882|560904646|FG000|Overall Study|Progressive disease|1|||
155401828|NCT03703882|560904647|FG001|Overall Study|Progressive disease|0|||
155401829|NCT03703882|560904646|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155401830|NCT03703882|560904647|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155401831|NCT03703882|560904646|FG000|Overall Study|Starting another treatment|0|||
155401832|NCT03703882|560904647|FG001|Overall Study|Starting another treatment|1|||
155401833|NCT03703882|560904646|FG000|Overall Study|noncompliance with study procedures|0|||
155401834|NCT03703882|560904647|FG001|Overall Study|noncompliance with study procedures|1|||
155401835|NCT01321710|560904648|FG000|Overall Study|Lost to Follow-up|4|||
155401836|NCT01321710|560904649|FG001|Overall Study|Lost to Follow-up|5|||
155401837|NCT01321710|560904650|FG002|Overall Study|Lost to Follow-up|0|||
155401838|NCT01761292|560904652|FG000|Part 1|Adverse Event|1|||
155401839|NCT01761292|560904652|FG000|Part 1|not receiving treatment in Part 1|1|||
155401840|NCT01761292|560904652|FG000|Extension 1|Withdrawal by Subject|1|||
155401841|NCT00840086|560904653|FG000|Overall Study|Adverse Event|1|||
155401842|NCT00840086|560904653|FG000|Overall Study|Protocol Violation|2|||
155401843|NCT00840086|560904653|FG000|Overall Study|Lost to Follow-up|1|||
155401844|NCT03577730|560904654|FG000|Overall Study|Physician Decision|3|||
155401845|NCT03577730|560904655|FG001|Overall Study|Physician Decision|1|||
155401846|NCT03577730|560904654|FG000|Overall Study|Did not receive allocated intervention|1|||
155401847|NCT03577730|560904655|FG001|Overall Study|Did not receive allocated intervention|0|||
155401848|NCT03810781|560904656|FG000|Overall Study|COVID shut down|2|||
155401849|NCT02181816|560904657|FG000|Overall Study|Case Report Forms Uncollected|38|||
155401850|NCT02181816|560904657|FG000|Overall Study|Protocol Deviation|21|||
155401851|NCT00909181|560904658|FG000|Overall Study|Lost to Follow-up|39|||
155401852|NCT00909181|560904659|FG001|Overall Study|Lost to Follow-up|18|||
155401853|NCT00909181|560904660|FG002|Overall Study|Lost to Follow-up|33|||
155401854|NCT02349048|560904663|FG000|Overall Study|Withdrawal by Subject|4|||
155401855|NCT02349048|560904664|FG001|Overall Study|Withdrawal by Subject|0|||
155401856|NCT02349048|560904663|FG000|Overall Study|Lost to Follow-up|1|||
155401857|NCT02349048|560904664|FG001|Overall Study|Lost to Follow-up|0|||
155401858|NCT00383084|560904673|FG000|Overall Study|Withdrawal by Subject|12|||
155401859|NCT00383084|560904674|FG001|Overall Study|Withdrawal by Subject|10|||
155401860|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Adverse Event|1|||
155401861|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Adverse Event|0|||
155401862|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Adverse Event|0|||
155401863|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Adverse Event|0|||
155401864|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
155401865|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
155401866|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
155401867|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
155401868|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
155401869|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
155401870|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
155401871|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
155401872|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
155401873|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155284793|NCT01941316|560474420|FG003|Overall Study|Physician Decision|3|||
155401874|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155401875|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155401876|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Adverse Event|0|||
155401877|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Adverse Event|0|||
155401878|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Adverse Event|4|||
155401879|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Adverse Event|5|||
155401880|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
155401881|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
155401882|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
155401883|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
155401884|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Physician Decision|0|||
155401885|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Physician Decision|0|||
155401886|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Physician Decision|2|||
155401887|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Physician Decision|0|||
155401888|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
155401889|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
155401890|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
155401891|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
155401892|NCT05895552|560904682|FG000|Overall Study|Adverse Event|2|||
155401893|NCT05895552|560904683|FG001|Overall Study|Adverse Event|2|||
155401894|NCT05895552|560904684|FG002|Overall Study|Adverse Event|1|||
155401895|NCT05895552|560904682|FG000|Overall Study|Lost to Follow-up|0|||
155401896|NCT05895552|560904683|FG001|Overall Study|Lost to Follow-up|1|||
155401897|NCT05895552|560904684|FG002|Overall Study|Lost to Follow-up|0|||
155401898|NCT05895552|560904682|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155401899|NCT05895552|560904683|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155401900|NCT05895552|560904684|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155401901|NCT05895552|560904682|FG000|Overall Study|Protocol Deviation|0|||
155401902|NCT05895552|560904683|FG001|Overall Study|Protocol Deviation|0|||
155401903|NCT05895552|560904684|FG002|Overall Study|Protocol Deviation|2|||
155401904|NCT05895552|560904682|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155401905|NCT05895552|560904683|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155401906|NCT05895552|560904684|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
155401907|NCT05895552|560904682|FG000|Overall Study|Withdrawal by Subject|2|||
155401908|NCT05895552|560904683|FG001|Overall Study|Withdrawal by Subject|2|||
155401909|NCT05895552|560904684|FG002|Overall Study|Withdrawal by Subject|4|||
155401910|NCT03810911|560904685|FG000|Overall Study|Death|1|||
155401911|NCT03810911|560904686|FG001|Overall Study|Death|1|||
155401912|NCT03810911|560904685|FG000|Overall Study|Withdrawal by Subject|1|||
155401913|NCT03810911|560904686|FG001|Overall Study|Withdrawal by Subject|1|||
155401914|NCT04770532|560904687|FG000|Overall Study|Withdrawal by Subject|0|||
155401915|NCT04770532|560904688|FG001|Overall Study|Withdrawal by Subject|3|||
155401916|NCT04770532|560904687|FG000|Overall Study|Physician Decision|1|||
155401917|NCT04770532|560904688|FG001|Overall Study|Physician Decision|0|||
155401918|NCT04770532|560904687|FG000|Overall Study|Death|2|||
155401919|NCT04770532|560904688|FG001|Overall Study|Death|2|||
155401920|NCT04707157|560904692|FG000|Overall Study|Adverse Event|12|||
155401921|NCT04707157|560904693|FG001|Overall Study|Adverse Event|3|||
155401922|NCT04707157|560904692|FG000|Overall Study|Lost to Follow-up|2|||
155401923|NCT04707157|560904693|FG001|Overall Study|Lost to Follow-up|0|||
155401924|NCT04707157|560904692|FG000|Overall Study|Sponsor's decision|1|||
155401925|NCT04707157|560904693|FG001|Overall Study|Sponsor's decision|0|||
155401926|NCT04707157|560904692|FG000|Overall Study|Physician Decision|8|||
155401927|NCT04707157|560904693|FG001|Overall Study|Physician Decision|5|||
155401928|NCT04707157|560904692|FG000|Overall Study|Protocol Deviation|1|||
155401929|NCT04707157|560904693|FG001|Overall Study|Protocol Deviation|0|||
155401930|NCT04707157|560904692|FG000|Overall Study|Withdrawal by Subject|1|||
155401931|NCT04707157|560904693|FG001|Overall Study|Withdrawal by Subject|1|||
155401932|NCT00133991|560904696|FG000|Overall Study|Death|4|||
155401933|NCT05998148|560904699|FG000|Allocation|Did not attend any appointments|1|||
155401934|NCT05998148|560904700|FG001|Allocation|Did not attend any appointments|4|||
155284794|NCT01941316|560474417|FG000|Overall Study|Protocol Violation|0|||
155284795|NCT01941316|560474418|FG001|Overall Study|Protocol Violation|0|||
155284796|NCT01941316|560474419|FG002|Overall Study|Protocol Violation|0|||
155284797|NCT01941316|560474420|FG003|Overall Study|Protocol Violation|3|||
155401935|NCT05998148|560904699|FG000|Follow-Up|Lost to Follow-up|1|||
155401936|NCT05998148|560904700|FG001|Follow-Up|Lost to Follow-up|2|||
155401937|NCT05998148|560904699|FG000|Follow-Up|Change in insurance|1|||
155401938|NCT05998148|560904700|FG001|Follow-Up|Change in insurance|1|||
155401939|NCT04085523|560904701|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401940|NCT04085523|560904702|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401941|NCT04085523|560904703|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401942|NCT04085523|560904704|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401943|NCT04085523|560904705|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401944|NCT04085523|560904706|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
155401945|NCT03977974|560904716|FG000|Period 2|Adverse Event|0|||
155401946|NCT03977974|560904717|FG001|Period 2|Adverse Event|0|||
155401947|NCT03977974|560904718|FG002|Period 2|Adverse Event|0|||
155401948|NCT03977974|560904719|FG003|Period 2|Adverse Event|0|||
155401949|NCT03977974|560904720|FG004|Period 2|Adverse Event|1|||
155401950|NCT03977974|560904721|FG005|Period 2|Adverse Event|0|||
155401951|NCT03977974|560904722|FG006|Period 2|Adverse Event|0|||
155401952|NCT03977974|560904723|FG007|Period 2|Adverse Event|0|||
155401953|NCT03977974|560904724|FG008|Period 2|Adverse Event|0|||
155401954|NCT03977974|560904725|FG009|Period 2|Adverse Event|0|||
155401955|NCT03977974|560904726|FG010|Period 2|Adverse Event|0|||
155401956|NCT03977974|560904727|FG011|Period 2|Adverse Event|0|||
155401957|NCT03977974|560904728|FG012|Period 2|Adverse Event|0|||
155401958|NCT04526899|560904730|FG000|Overall Study|Withdrawal by Subject|3|||
155401959|NCT04526899|560904731|FG001|Overall Study|Withdrawal by Subject|2|||
155401960|NCT04526899|560904732|FG002|Overall Study|Withdrawal by Subject|2|||
155401961|NCT04526899|560904730|FG000|Overall Study|Lost to Follow-up|3|||
155401962|NCT04526899|560904731|FG001|Overall Study|Lost to Follow-up|3|||
155401963|NCT04526899|560904732|FG002|Overall Study|Lost to Follow-up|1|||
155401964|NCT04526899|560904730|FG000|Overall Study|Investigator's decision|1|||
155401965|NCT04526899|560904731|FG001|Overall Study|Investigator's decision|0|||
155401966|NCT04526899|560904732|FG002|Overall Study|Investigator's decision|0|||
155401967|NCT04526899|560904730|FG000|Overall Study|Death|33|||
155401968|NCT04526899|560904731|FG001|Overall Study|Death|17|||
155401969|NCT04526899|560904732|FG002|Overall Study|Death|13|||
155401970|NCT04526899|560904730|FG000|Overall Study|Other|1|||
155401971|NCT04526899|560904731|FG001|Overall Study|Other|0|||
155401972|NCT04526899|560904732|FG002|Overall Study|Other|0|||
155401973|NCT04526899|560904730|FG000|Overall Study|On-Treatment|19|||
155401974|NCT04526899|560904731|FG001|Overall Study|On-Treatment|10|||
155401975|NCT04526899|560904732|FG002|Overall Study|On-Treatment|12|||
155401976|NCT04526899|560904730|FG000|Overall Study|Survival Follow-up|34|||
155401977|NCT04526899|560904731|FG001|Overall Study|Survival Follow-up|14|||
155401978|NCT04526899|560904732|FG002|Overall Study|Survival Follow-up|16|||
155401979|NCT00516048|560905593|FG000|Overall Study|Death|0|||
155401980|NCT00516048|560905594|FG001|Overall Study|Death|0|||
155401981|NCT00516048|560905595|FG002|Overall Study|Death|1|||
155401982|NCT00516048|560905593|FG000|Overall Study|Subject Decision|0|||
155401983|NCT00516048|560905594|FG001|Overall Study|Subject Decision|2|||
155401984|NCT00516048|560905595|FG002|Overall Study|Subject Decision|0|||
155401985|NCT02263079|560905596|FG000|Overall Study|Physician Decision|1|||
155401986|NCT02263079|560905597|FG001|Overall Study|Physician Decision|0|||
155401987|NCT02263079|560905598|FG002|Overall Study|Physician Decision|0|||
155401988|NCT02263079|560905596|FG000|Overall Study|Withdrawal by Subject|2|||
155401989|NCT02263079|560905597|FG001|Overall Study|Withdrawal by Subject|8|||
155401990|NCT02263079|560905598|FG002|Overall Study|Withdrawal by Subject|0|||
155401991|NCT02554019|560905604|FG000|Overall Study|Withdrawal by Subject|1|||
155401992|NCT02554019|560905605|FG001|Overall Study|Withdrawal by Subject|0|||
155401993|NCT02554019|560905606|FG002|Overall Study|Withdrawal by Subject|2|||
155401994|NCT02554019|560905604|FG000|Overall Study|Adverse Event|1|||
155401995|NCT02554019|560905605|FG001|Overall Study|Adverse Event|0|||
155401996|NCT02554019|560905606|FG002|Overall Study|Adverse Event|0|||
155401997|NCT02463409|560905607|FG000|Overall Study|Withdrawal by Subject|1|||
155401998|NCT02463409|560905607|FG000|Overall Study|Screen failure|1|||
155401999|NCT00003535|560905609|FG000|Overall Study|Not evaluable|5|||
155402000|NCT01278745|560905615|FG000|Overall Study|Death|2|||
155402001|NCT01278745|560905616|FG001|Overall Study|Death|5|||
155402002|NCT01278745|560905617|FG002|Overall Study|Death|7|||
155402003|NCT01278745|560905618|FG003|Overall Study|Death|0|||
155402004|NCT01278745|560905615|FG000|Overall Study|Physician Decision|1|||
155402005|NCT01278745|560905616|FG001|Overall Study|Physician Decision|0|||
155402006|NCT01278745|560905617|FG002|Overall Study|Physician Decision|0|||
155402007|NCT01278745|560905618|FG003|Overall Study|Physician Decision|9|||
155402008|NCT01278745|560905615|FG000|Overall Study|Withdrawal by Subject|1|||
155402009|NCT01278745|560905616|FG001|Overall Study|Withdrawal by Subject|1|||
155402010|NCT01278745|560905617|FG002|Overall Study|Withdrawal by Subject|5|||
155402011|NCT01278745|560905618|FG003|Overall Study|Withdrawal by Subject|1|||
155402012|NCT01278745|560905615|FG000|Overall Study|Sponsor Decision|1|||
155402013|NCT01278745|560905616|FG001|Overall Study|Sponsor Decision|0|||
155402014|NCT01278745|560905617|FG002|Overall Study|Sponsor Decision|62|||
155402015|NCT01278745|560905618|FG003|Overall Study|Sponsor Decision|6|||
155402016|NCT01278745|560905615|FG000|Overall Study|Ineligible|0|||
155402017|NCT01278745|560905616|FG001|Overall Study|Ineligible|0|||
155402018|NCT01278745|560905617|FG002|Overall Study|Ineligible|42|||
155402019|NCT01278745|560905618|FG003|Overall Study|Ineligible|61|||
155402020|NCT01278745|560905615|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
155402021|NCT01278745|560905616|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
155402022|NCT01278745|560905617|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
155402023|NCT01278745|560905618|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
155402024|NCT01148537|560905619|FG000|Overall Study|Withdrawal by Subject|1|||
155402025|NCT01148537|560905620|FG001|Overall Study|Withdrawal by Subject|0|||
155402026|NCT01148537|560905621|FG002|Overall Study|Withdrawal by Subject|2|||
155402027|NCT01148537|560905619|FG000|Overall Study|Adverse Event|2|||
155402028|NCT01148537|560905620|FG001|Overall Study|Adverse Event|0|||
155402029|NCT01148537|560905621|FG002|Overall Study|Adverse Event|1|||
155402030|NCT05630001|560905622|FG000|Overall Study|Adverse Event|1|||
155402031|NCT05374525|560905624|FG000|Overall Study|Adverse Event|5|||
155402032|NCT05374525|560905625|FG001|Overall Study|Adverse Event|6|||
155402033|NCT05374525|560905624|FG000|Overall Study|Lost to Follow-up|3|||
155402034|NCT05374525|560905625|FG001|Overall Study|Lost to Follow-up|3|||
155402035|NCT05374525|560905624|FG000|Overall Study|Physician Decision|2|||
155402036|NCT05374525|560905625|FG001|Overall Study|Physician Decision|2|||
155402037|NCT05374525|560905624|FG000|Overall Study|Withdrawal by Subject|26|||
155402038|NCT05374525|560905625|FG001|Overall Study|Withdrawal by Subject|8|||
155402039|NCT01349101|560905628|FG000|Overall Study|Disease Progression|1|||
155402040|NCT01349101|560905629|FG001|Overall Study|Disease Progression|1|||
155402041|NCT01349101|560905628|FG000|Overall Study|Death|3|||
155402042|NCT01349101|560905629|FG001|Overall Study|Death|8|||
155402043|NCT00632099|560905630|FG000|Overall Study|Lost to Follow-up|3|||
155402044|NCT00632099|560905631|FG001|Overall Study|Lost to Follow-up|3|||
155402045|NCT01517893|560905634|FG000|Overall Study|Withdrawal by Subject|3|||
155402046|NCT01517893|560905635|FG001|Overall Study|Withdrawal by Subject|0|||
155402047|NCT00865904|560905639|FG000|Overall Study|Randomized but not Treated|2|||
155402048|NCT00865904|560905640|FG001|Overall Study|Randomized but not Treated|0|||
155402049|NCT00865904|560905641|FG002|Overall Study|Randomized but not Treated|0|||
155402050|NCT00865904|560905642|FG003|Overall Study|Randomized but not Treated|1|||
155402051|NCT00865904|560905643|FG004|Overall Study|Randomized but not Treated|1|||
155402052|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
155402053|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
155402054|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Death|0|||
155402055|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Death|1|||
155402056|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
155402057|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
155402058|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
155402059|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
155402060|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
155402061|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
155402062|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
155402063|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
155402064|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
155402065|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
155402066|NCT00589420|560905649|FG000|Overall Study|screen failure|1|||
155402067|NCT01131520|560905655|FG000|Overall Study|Computer problem|1|||
155402068|NCT01131520|560905656|FG001|Overall Study|Computer problem|0|||
155402069|NCT01131520|560905655|FG000|Overall Study|Counselor not available|0|||
155402070|NCT01131520|560905656|FG001|Overall Study|Counselor not available|3|||
155402071|NCT01131520|560905655|FG000|Overall Study|Subject changed history after enrollment|0|||
155402072|NCT01131520|560905656|FG001|Overall Study|Subject changed history after enrollment|1|||
155402073|NCT04857996|560905659|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
155402074|NCT04857996|560905660|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
155402075|NCT04857996|560905659|FG000|Overall Study|Lost to Follow-up|1|||
155402076|NCT04857996|560905660|FG001|Overall Study|Lost to Follow-up|3|||
155402077|NCT04857996|560905659|FG000|Overall Study|Site Closure|1|||
155402078|NCT04857996|560905660|FG001|Overall Study|Site Closure|0|||
155402079|NCT04857996|560905659|FG000|Overall Study|Withdrawal by Subject|1|||
155402080|NCT04857996|560905660|FG001|Overall Study|Withdrawal by Subject|0|||
155402081|NCT02988661|560905661|FG000|Overall Study|Death|2|||
155402082|NCT02988661|560905662|FG001|Overall Study|Death|18|||
155402083|NCT02988661|560905661|FG000|Overall Study|Lost to Follow-up|0|||
155402084|NCT02988661|560905662|FG001|Overall Study|Lost to Follow-up|33|||
155402085|NCT02988661|560905661|FG000|Overall Study|Withdrawal by Subject|0|||
155402086|NCT02988661|560905662|FG001|Overall Study|Withdrawal by Subject|6|||
155402087|NCT02988661|560905661|FG000|Overall Study|Unable to complete the 18-month survey|1|||
155402088|NCT02988661|560905662|FG001|Overall Study|Unable to complete the 18-month survey|27|||
155402089|NCT01392677|560905663|FG000|Overall Study|Adverse Event|3|||
155402090|NCT01392677|560905664|FG001|Overall Study|Adverse Event|1|||
155402091|NCT01392677|560905663|FG000|Overall Study|Withdrawal by Subject|0|||
155402092|NCT01392677|560905664|FG001|Overall Study|Withdrawal by Subject|2|||
155402093|NCT01392677|560905663|FG000|Overall Study|Incorrect enrollment|2|||
155402094|NCT01392677|560905664|FG001|Overall Study|Incorrect enrollment|3|||
155402095|NCT01392677|560905663|FG000|Overall Study|Other reason|3|||
155402096|NCT01392677|560905664|FG001|Overall Study|Other reason|2|||
155402097|NCT01380379|560905665|FG000|Overall Study|Pregnancy|1|||
155402098|NCT05493280|560905668|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
155637305|NCT00770809|561764726|FG002|Overall Study|Adverse Event|12|||
155402099|NCT05493280|560905669|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
155402100|NCT06608368|560905670|FG000|Overall Study|Family Emergency|0|||
155402101|NCT06608368|560905671|FG001|Overall Study|Family Emergency|1|||
155402102|NCT06608368|560905672|FG002|Overall Study|Family Emergency|0|||
155402103|NCT06608368|560905670|FG000|Overall Study|Scheduling Issues|0|||
155402104|NCT06608368|560905671|FG001|Overall Study|Scheduling Issues|1|||
155402105|NCT06608368|560905672|FG002|Overall Study|Scheduling Issues|0|||
155402106|NCT02982954|560907142|FG000|Overall Study|Death|55|||
155402107|NCT02982954|560907143|FG001|Overall Study|Death|29|||
155402108|NCT02982954|560907144|FG002|Overall Study|Death|15|||
155402109|NCT02982954|560907145|FG003|Overall Study|Death|20|||
155402110|NCT02982954|560907142|FG000|Overall Study|Lost to Follow-up|2|||
155402111|NCT02982954|560907143|FG001|Overall Study|Lost to Follow-up|1|||
155402112|NCT02982954|560907144|FG002|Overall Study|Lost to Follow-up|0|||
155284798|NCT01941316|560474417|FG000|Overall Study|Intercurrent illness|0|||
155402113|NCT02982954|560907145|FG003|Overall Study|Lost to Follow-up|0|||
155402114|NCT02982954|560907142|FG000|Overall Study|Participant withdrew consent|7|||
155402115|NCT02982954|560907143|FG001|Overall Study|Participant withdrew consent|5|||
155402116|NCT02982954|560907144|FG002|Overall Study|Participant withdrew consent|1|||
155637306|NCT00770809|561764724|FG000|Overall Study|Death|1|||
155284799|NCT01941316|560474418|FG001|Overall Study|Intercurrent illness|0|||
155284800|NCT01941316|560474419|FG002|Overall Study|Intercurrent illness|0|||
155284801|NCT01941316|560474420|FG003|Overall Study|Intercurrent illness|1|||
155284802|NCT01941316|560474417|FG000|Overall Study|Other, not specified|0|||
155284803|NCT01941316|560474418|FG001|Overall Study|Other, not specified|0|||
155284804|NCT01941316|560474419|FG002|Overall Study|Other, not specified|0|||
155284805|NCT01941316|560474420|FG003|Overall Study|Other, not specified|1|||
155284806|NCT02775435|560474421|FG000|Overall Study|Adverse Event|32|||
155284807|NCT02775435|560474422|FG001|Overall Study|Adverse Event|27|||
155284808|NCT02775435|560474421|FG000|Overall Study|Lost to Follow-up|2|||
155284809|NCT02775435|560474422|FG001|Overall Study|Lost to Follow-up|2|||
155284810|NCT02775435|560474421|FG000|Overall Study|Sponsor decision|44|||
155284811|NCT02775435|560474422|FG001|Overall Study|Sponsor decision|19|||
155284812|NCT02775435|560474421|FG000|Overall Study|Withdrawal by Subject|4|||
155284813|NCT02775435|560474422|FG001|Overall Study|Withdrawal by Subject|9|||
155284814|NCT02775435|560474421|FG000|Overall Study|Death|196|||
155284815|NCT02775435|560474422|FG001|Overall Study|Death|224|||
155284816|NCT02282527|560474423|FG000|Overall Study|Lost to Follow-up|0|||
155284817|NCT02282527|560474424|FG001|Overall Study|Lost to Follow-up|1|||
155284818|NCT02282527|560474423|FG000|Overall Study|Lack of home health aid|1|||
155284819|NCT02282527|560474424|FG001|Overall Study|Lack of home health aid|0|||
155284820|NCT00941031|560474425|FG000|Induction Period|Lack of Efficacy|2|||
155284821|NCT00941031|560474426|FG001|Induction Period|Lack of Efficacy|1|||
155284822|NCT00941031|560474427|FG002|Induction Period|Lack of Efficacy|0|||
155284823|NCT00941031|560474428|FG003|Induction Period|Lack of Efficacy|5|||
155284824|NCT00941031|560474429|FG004|Induction Period|Lack of Efficacy|0|||
155284825|NCT00941031|560474430|FG005|Induction Period|Lack of Efficacy|0|||
155284826|NCT00941031|560474431|FG006|Induction Period|Lack of Efficacy|0|||
155284827|NCT00941031|560474425|FG000|Induction Period|Withdrawal by Subject|1|||
155284828|NCT00941031|560474426|FG001|Induction Period|Withdrawal by Subject|2|||
155284829|NCT00941031|560474427|FG002|Induction Period|Withdrawal by Subject|2|||
155284830|NCT00941031|560474428|FG003|Induction Period|Withdrawal by Subject|2|||
155284831|NCT00941031|560474429|FG004|Induction Period|Withdrawal by Subject|0|||
155284832|NCT00941031|560474430|FG005|Induction Period|Withdrawal by Subject|0|||
155284833|NCT00941031|560474431|FG006|Induction Period|Withdrawal by Subject|0|||
155284834|NCT00941031|560474425|FG000|Induction Period|Adminstative Problems|1|||
155284835|NCT00941031|560474426|FG001|Induction Period|Adminstative Problems|1|||
155284836|NCT00941031|560474427|FG002|Induction Period|Adminstative Problems|1|||
155284837|NCT00941031|560474428|FG003|Induction Period|Adminstative Problems|0|||
155284838|NCT00941031|560474429|FG004|Induction Period|Adminstative Problems|0|||
155284839|NCT00941031|560474430|FG005|Induction Period|Adminstative Problems|0|||
155284840|NCT00941031|560474431|FG006|Induction Period|Adminstative Problems|0|||
155284841|NCT00941031|560474425|FG000|Induction Period|Adverse Event|1|||
155402117|NCT02982954|560907145|FG003|Overall Study|Participant withdrew consent|1|||
155637307|NCT00770809|561764725|FG001|Overall Study|Death|0|||
155284842|NCT00941031|560474426|FG001|Induction Period|Adverse Event|0|||
155284843|NCT00941031|560474427|FG002|Induction Period|Adverse Event|3|||
155284844|NCT00941031|560474428|FG003|Induction Period|Adverse Event|2|||
155284845|NCT00941031|560474429|FG004|Induction Period|Adverse Event|0|||
155284846|NCT00941031|560474430|FG005|Induction Period|Adverse Event|0|||
155637308|NCT00770809|561764726|FG002|Overall Study|Death|0|||
155284847|NCT00941031|560474431|FG006|Induction Period|Adverse Event|0|||
155284848|NCT00941031|560474425|FG000|Maintenance Period|Withdrawal by Subject|0|||
155284849|NCT00941031|560474426|FG001|Maintenance Period|Withdrawal by Subject|0|||
155402118|NCT02982954|560907142|FG000|Overall Study|Other reasons|42|||
155402119|NCT02982954|560907143|FG001|Overall Study|Other reasons|17|||
155402120|NCT02982954|560907144|FG002|Overall Study|Other reasons|12|||
155637309|NCT00770809|561764724|FG000|Overall Study|Withdrawal by Subject|3|||
155284850|NCT00941031|560474427|FG002|Maintenance Period|Withdrawal by Subject|0|||
155637310|NCT00770809|561764725|FG001|Overall Study|Withdrawal by Subject|3|||
155402121|NCT02982954|560907145|FG003|Overall Study|Other reasons|3|||
155402122|NCT02982954|560907142|FG000|Overall Study|Premature site closure|0|||
155402123|NCT02982954|560907143|FG001|Overall Study|Premature site closure|0|||
155402124|NCT02982954|560907144|FG002|Overall Study|Premature site closure|0|||
155402125|NCT02982954|560907145|FG003|Overall Study|Premature site closure|1|||
155402126|NCT02634151|560907146|FG000|Overall Study|Withdrawal by Subject|1|||
155402127|NCT02634151|560907147|FG001|Overall Study|Withdrawal by Subject|0|||
155402128|NCT02634151|560907146|FG000|Overall Study|Non-Compliance|0|||
155402129|NCT02634151|560907147|FG001|Overall Study|Non-Compliance|1|||
155402130|NCT02634151|560907146|FG000|Overall Study|Other|0|||
155402131|NCT02634151|560907147|FG001|Overall Study|Other|1|||
155402132|NCT02347098|560907148|FG000|Overall Study|Death|1|||
155402133|NCT02347098|560907149|FG001|Overall Study|Death|0|||
155402134|NCT02347098|560907148|FG000|Overall Study|Withdrawal by Subject|1|||
155402135|NCT02347098|560907149|FG001|Overall Study|Withdrawal by Subject|0|||
155402136|NCT02347098|560907148|FG000|Overall Study|Lost to Follow-up|2|||
155402137|NCT02347098|560907149|FG001|Overall Study|Lost to Follow-up|2|||
155402138|NCT02347098|560907148|FG000|Overall Study|Refuse Follow-up Visit|1|||
155402139|NCT02347098|560907149|FG001|Overall Study|Refuse Follow-up Visit|5|||
155402140|NCT02347098|560907148|FG000|Overall Study|no visit due to illness|2|||
155402141|NCT02347098|560907149|FG001|Overall Study|no visit due to illness|1|||
155402142|NCT01444742|560907150|FG000|Overall Study|Death|1|||
155402143|NCT02830880|560907151|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
155402144|NCT02830880|560907151|FG000|Overall Study|Death|1|||
155402145|NCT02830880|560907151|FG000|Overall Study|Physician Decision|1|||
155402146|NCT01843842|560907156|FG000|Overall Study|Do not meet inclusion criteria|1|||
155402147|NCT01843842|560907157|FG001|Overall Study|Do not meet inclusion criteria|1|||
155402148|NCT01376778|560907158|FG000|Overall Study|Lost to Follow-up|3|||
155402149|NCT01376778|560907159|FG001|Overall Study|Lost to Follow-up|2|||
155402150|NCT03462576|560907160|FG000|Overall Study|Protocol Violation|5|||
155402151|NCT03462576|560907161|FG001|Overall Study|Protocol Violation|11|||
155402152|NCT03462576|560907162|FG002|Overall Study|Protocol Violation|7|||
155402153|NCT03462576|560907160|FG000|Overall Study|Device Malfunction|0|||
155402154|NCT03462576|560907161|FG001|Overall Study|Device Malfunction|0|||
155402155|NCT03462576|560907162|FG002|Overall Study|Device Malfunction|1|||
155402156|NCT00271596|560907163|FG000|Overall Study|Protocol Violation|1|||
155402157|NCT00271596|560907164|FG001|Overall Study|Protocol Violation|0|||
155402158|NCT00271596|560907163|FG000|Overall Study|Withdrawal by Subject|0|||
155402159|NCT00271596|560907164|FG001|Overall Study|Withdrawal by Subject|1|||
155402160|NCT04206605|560907171|FG000|Overall Study|Adverse Event|0|||
155402161|NCT04206605|560907172|FG001|Overall Study|Adverse Event|1|||
155402162|NCT04206605|560907171|FG000|Overall Study|Withdrawal by Subject|1|||
155402163|NCT04206605|560907172|FG001|Overall Study|Withdrawal by Subject|0|||
155402164|NCT05879107|560907173|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
155402165|NCT05879107|560907174|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
155402166|NCT05879107|560907173|FG000|Overall Study|Migrated / moved from the study area|1|||
155402167|NCT05879107|560907174|FG001|Overall Study|Migrated / moved from the study area|1|||
155402168|NCT05879107|560907173|FG000|Overall Study|Lost to Follow-up|8|||
155402169|NCT05879107|560907174|FG001|Overall Study|Lost to Follow-up|13|||
155402170|NCT05879107|560907173|FG000|Overall Study|Death|0|||
155402171|NCT05879107|560907174|FG001|Overall Study|Death|2|||
155402172|NCT05879107|560907173|FG000|Overall Study|Other|0|||
155402173|NCT05879107|560907174|FG001|Overall Study|Other|3|||
155402174|NCT03418129|560907179|FG000|Overall Study|Lost to Follow-up|11|||
155402175|NCT03418129|560907180|FG001|Overall Study|Lost to Follow-up|20|||
155402176|NCT03418129|560907181|FG002|Overall Study|Lost to Follow-up|15|||
155402177|NCT03418129|560907179|FG000|Overall Study|Withdrawal by Subject|3|||
155402178|NCT03418129|560907180|FG001|Overall Study|Withdrawal by Subject|6|||
155402179|NCT03418129|560907181|FG002|Overall Study|Withdrawal by Subject|4|||
155402180|NCT00942175|560907184|FG000|Overall Study|Adverse Event|2|||
155402181|NCT00942175|560907185|FG001|Overall Study|Adverse Event|1|||
155402182|NCT00942175|560907186|FG002|Overall Study|Adverse Event|0|||
155402183|NCT00942175|560907187|FG003|Overall Study|Adverse Event|0|||
155402184|NCT00942175|560907184|FG000|Overall Study|Protocol Violation|0|||
155402185|NCT00942175|560907185|FG001|Overall Study|Protocol Violation|1|||
155402186|NCT00942175|560907186|FG002|Overall Study|Protocol Violation|2|||
155402187|NCT00942175|560907187|FG003|Overall Study|Protocol Violation|0|||
155402188|NCT00942175|560907184|FG000|Overall Study|Pregnancy|0|||
155402189|NCT00942175|560907185|FG001|Overall Study|Pregnancy|0|||
155402190|NCT00942175|560907186|FG002|Overall Study|Pregnancy|0|||
155402191|NCT00942175|560907187|FG003|Overall Study|Pregnancy|1|||
155284851|NCT00941031|560474428|FG003|Maintenance Period|Withdrawal by Subject|0|||
155402192|NCT00942175|560907184|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
155637311|NCT00770809|561764726|FG002|Overall Study|Withdrawal by Subject|7|||
155402193|NCT00942175|560907185|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
155402194|NCT00942175|560907186|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
155402195|NCT00942175|560907187|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
155402196|NCT00942175|560907184|FG000|Overall Study|Low Platelet Count|0|||
155402197|NCT00942175|560907185|FG001|Overall Study|Low Platelet Count|2|||
155402198|NCT00942175|560907186|FG002|Overall Study|Low Platelet Count|0|||
155402199|NCT00942175|560907187|FG003|Overall Study|Low Platelet Count|0|||
155402200|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
155402201|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
155402202|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
155402203|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
155402204|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
155402205|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
155402206|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155402207|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155402208|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
155402209|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
155402210|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155402211|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155402212|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
155402213|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
155402214|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
155402215|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
155402216|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
155402217|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
155402218|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
155402219|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
155402220|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
155402221|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
155402222|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
155402223|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
155402224|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Death|2|||
155402225|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Death|1|||
155402226|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Death|0|||
155402227|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Death|0|||
155402228|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155402229|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155402230|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155402231|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155402232|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
155402233|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
155402234|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
155402235|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
155402236|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
155402237|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
155402238|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155402239|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155402240|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
155402241|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402242|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402243|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402244|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
155402245|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
155402246|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
155402247|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
155402248|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155402249|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155402250|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
155402251|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
155402252|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155402253|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155402254|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
155402255|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
155402256|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155402257|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155402258|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
155402259|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
155402260|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
155402261|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
155402262|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
155402263|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
155402264|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155402265|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155402266|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
155402267|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
155402268|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155402269|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155402270|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
155402271|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
155402272|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402273|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402274|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
155402275|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402276|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402277|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402278|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
155402279|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402280|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402281|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402282|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
155402283|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402284|NCT02973087|560907192|FG000|Overall Study|Withdrawal by Subject|2|||
155402285|NCT02973087|560907193|FG001|Overall Study|Withdrawal by Subject|1|||
155402286|NCT02973087|560907192|FG000|Overall Study|Adverse Event|1|||
155402287|NCT02973087|560907193|FG001|Overall Study|Adverse Event|0|||
155402288|NCT02973087|560907192|FG000|Overall Study|other|1|||
155402289|NCT02973087|560907193|FG001|Overall Study|other|1|||
155402290|NCT03710486|560907194|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
155402291|NCT03710486|560907195|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
155402292|NCT03710486|560907194|FG000|Overall Study|Missing|0|||
155402293|NCT03710486|560907195|FG001|Overall Study|Missing|2|||
155402294|NCT01279850|560907200|FG000|Overall Study|Protocol Violation|50|||
155402295|NCT01279850|560907200|FG000|Overall Study|No Drug Administration Information|7|||
155402296|NCT01279850|560907200|FG000|Overall Study|No Visit After Treatment|34|||
155402297|NCT01147744|560907201|FG000|Overall Study|Protocol Violation|1|||
155402298|NCT01147744|560907202|FG001|Overall Study|Protocol Violation|0|||
155402299|NCT01147744|560907203|FG002|Overall Study|Protocol Violation|1|||
155402300|NCT01147744|560907204|FG003|Overall Study|Protocol Violation|0|||
155402301|NCT01147744|560907205|FG004|Overall Study|Protocol Violation|1|||
155402302|NCT01147744|560907206|FG005|Overall Study|Protocol Violation|3|||
155402303|NCT01147744|560907207|FG006|Overall Study|Protocol Violation|1|||
155402304|NCT01147744|560907201|FG000|Overall Study|Physician Decision|0|||
155402305|NCT01147744|560907202|FG001|Overall Study|Physician Decision|1|||
155402306|NCT01147744|560907203|FG002|Overall Study|Physician Decision|1|||
155402307|NCT01147744|560907204|FG003|Overall Study|Physician Decision|0|||
155402308|NCT01147744|560907205|FG004|Overall Study|Physician Decision|0|||
155402309|NCT01147744|560907206|FG005|Overall Study|Physician Decision|0|||
155402310|NCT01147744|560907207|FG006|Overall Study|Physician Decision|1|||
155402311|NCT01147744|560907201|FG000|Overall Study|Lack of Efficacy|11|||
155402312|NCT01147744|560907202|FG001|Overall Study|Lack of Efficacy|11|||
155402313|NCT01147744|560907203|FG002|Overall Study|Lack of Efficacy|9|||
155402314|NCT01147744|560907204|FG003|Overall Study|Lack of Efficacy|11|||
155402315|NCT01147744|560907205|FG004|Overall Study|Lack of Efficacy|13|||
155402316|NCT01147744|560907206|FG005|Overall Study|Lack of Efficacy|8|||
155402317|NCT01147744|560907207|FG006|Overall Study|Lack of Efficacy|7|||
155402318|NCT01147744|560907201|FG000|Overall Study|Adverse Event|1|||
155402319|NCT01147744|560907202|FG001|Overall Study|Adverse Event|2|||
155402320|NCT01147744|560907203|FG002|Overall Study|Adverse Event|3|||
155402321|NCT01147744|560907204|FG003|Overall Study|Adverse Event|0|||
155402322|NCT01147744|560907205|FG004|Overall Study|Adverse Event|2|||
155402323|NCT01147744|560907206|FG005|Overall Study|Adverse Event|1|||
155402324|NCT01147744|560907207|FG006|Overall Study|Adverse Event|2|||
155402325|NCT01147744|560907201|FG000|Overall Study|Withdrawal by Subject|8|||
155402326|NCT01147744|560907202|FG001|Overall Study|Withdrawal by Subject|4|||
155402327|NCT01147744|560907203|FG002|Overall Study|Withdrawal by Subject|2|||
155402328|NCT01147744|560907204|FG003|Overall Study|Withdrawal by Subject|2|||
155402329|NCT01147744|560907205|FG004|Overall Study|Withdrawal by Subject|2|||
155402330|NCT01147744|560907206|FG005|Overall Study|Withdrawal by Subject|5|||
155402331|NCT01147744|560907207|FG006|Overall Study|Withdrawal by Subject|2|||
155402332|NCT01147744|560907201|FG000|Overall Study|Lost to Follow-up|0|||
155402333|NCT01147744|560907202|FG001|Overall Study|Lost to Follow-up|1|||
155402334|NCT01147744|560907203|FG002|Overall Study|Lost to Follow-up|0|||
155402335|NCT01147744|560907204|FG003|Overall Study|Lost to Follow-up|0|||
155402336|NCT01147744|560907205|FG004|Overall Study|Lost to Follow-up|0|||
155402337|NCT01147744|560907206|FG005|Overall Study|Lost to Follow-up|0|||
155402338|NCT01147744|560907207|FG006|Overall Study|Lost to Follow-up|0|||
155402339|NCT01147744|560907201|FG000|Overall Study|Sponsor decision to amend protocol|7|||
155402340|NCT01147744|560907202|FG001|Overall Study|Sponsor decision to amend protocol|4|||
155402341|NCT01147744|560907203|FG002|Overall Study|Sponsor decision to amend protocol|2|||
155402342|NCT01147744|560907204|FG003|Overall Study|Sponsor decision to amend protocol|5|||
155402343|NCT01147744|560907205|FG004|Overall Study|Sponsor decision to amend protocol|7|||
155402344|NCT01147744|560907206|FG005|Overall Study|Sponsor decision to amend protocol|2|||
155402345|NCT01147744|560907207|FG006|Overall Study|Sponsor decision to amend protocol|6|||
155402346|NCT01147744|560907201|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155402347|NCT01147744|560907202|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402348|NCT01147744|560907203|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402349|NCT01147744|560907204|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402350|NCT01147744|560907205|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402351|NCT01147744|560907206|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155402352|NCT01147744|560907207|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402353|NCT01342484|560907212|FG000|Overall Study|Other Reasons|1|||
155402354|NCT01342484|560907213|FG001|Overall Study|Other Reasons|0|||
155402355|NCT01342484|560907214|FG002|Overall Study|Other Reasons|0|||
155402356|NCT01342484|560907212|FG000|Overall Study|Protocol Violation|0|||
155402357|NCT01342484|560907213|FG001|Overall Study|Protocol Violation|0|||
155402358|NCT01342484|560907214|FG002|Overall Study|Protocol Violation|1|||
155402359|NCT01342484|560907212|FG000|Overall Study|Withdrawal by Subject|1|||
155402360|NCT01342484|560907213|FG001|Overall Study|Withdrawal by Subject|0|||
155402361|NCT01342484|560907214|FG002|Overall Study|Withdrawal by Subject|0|||
155402362|NCT01840579|560907215|FG000|Overall Study|Status not recorded|0|||
155402363|NCT01840579|560907216|FG001|Overall Study|Status not recorded|0|||
155402364|NCT01840579|560907217|FG002|Overall Study|Status not recorded|2|||
155402365|NCT01840579|560907218|FG003|Overall Study|Status not recorded|3|||
155402366|NCT01840579|560907219|FG004|Overall Study|Status not recorded|4|||
155402367|NCT01840579|560907220|FG005|Overall Study|Status not recorded|3|||
155402368|NCT01840579|560907221|FG006|Overall Study|Status not recorded|0|||
155402369|NCT01840579|560907222|FG007|Overall Study|Status not recorded|3|||
155402370|NCT01840579|560907223|FG008|Overall Study|Status not recorded|3|||
155402371|NCT01840579|560907224|FG009|Overall Study|Status not recorded|3|||
155402372|NCT01840579|560907215|FG000|Overall Study|Progressive disease|3|||
155402373|NCT01840579|560907216|FG001|Overall Study|Progressive disease|5|||
155402374|NCT01840579|560907217|FG002|Overall Study|Progressive disease|0|||
155402375|NCT01840579|560907218|FG003|Overall Study|Progressive disease|0|||
155402376|NCT01840579|560907219|FG004|Overall Study|Progressive disease|0|||
155402377|NCT01840579|560907220|FG005|Overall Study|Progressive disease|0|||
155402378|NCT01840579|560907221|FG006|Overall Study|Progressive disease|0|||
155402379|NCT01840579|560907222|FG007|Overall Study|Progressive disease|0|||
155402380|NCT01840579|560907223|FG008|Overall Study|Progressive disease|0|||
155402381|NCT01840579|560907224|FG009|Overall Study|Progressive disease|0|||
155402382|NCT01840579|560907215|FG000|Overall Study|Ongoing in study|0|||
155402383|NCT01840579|560907216|FG001|Overall Study|Ongoing in study|1|||
155402384|NCT01840579|560907217|FG002|Overall Study|Ongoing in study|0|||
155402385|NCT01840579|560907218|FG003|Overall Study|Ongoing in study|0|||
155402386|NCT01840579|560907219|FG004|Overall Study|Ongoing in study|0|||
155402387|NCT01840579|560907220|FG005|Overall Study|Ongoing in study|0|||
155402388|NCT01840579|560907221|FG006|Overall Study|Ongoing in study|0|||
155402389|NCT01840579|560907222|FG007|Overall Study|Ongoing in study|0|||
155402390|NCT01840579|560907223|FG008|Overall Study|Ongoing in study|0|||
155402391|NCT01840579|560907224|FG009|Overall Study|Ongoing in study|0|||
155402392|NCT01840579|560907215|FG000|Overall Study|Death|0|||
155402393|NCT01840579|560907216|FG001|Overall Study|Death|0|||
155402394|NCT01840579|560907217|FG002|Overall Study|Death|0|||
155402395|NCT01840579|560907218|FG003|Overall Study|Death|0|||
155402396|NCT01840579|560907219|FG004|Overall Study|Death|0|||
155402397|NCT01840579|560907220|FG005|Overall Study|Death|1|||
155402398|NCT01840579|560907221|FG006|Overall Study|Death|0|||
155402399|NCT01840579|560907222|FG007|Overall Study|Death|0|||
155402400|NCT01840579|560907223|FG008|Overall Study|Death|0|||
155402401|NCT01840579|560907224|FG009|Overall Study|Death|0|||
155402402|NCT01840579|560907215|FG000|Overall Study|Adverse Event|0|||
155284852|NCT00941031|560474429|FG004|Maintenance Period|Withdrawal by Subject|6|||
155284853|NCT00941031|560474430|FG005|Maintenance Period|Withdrawal by Subject|2|||
155402403|NCT01840579|560907216|FG001|Overall Study|Adverse Event|1|||
155402404|NCT01840579|560907217|FG002|Overall Study|Adverse Event|0|||
155402405|NCT01840579|560907218|FG003|Overall Study|Adverse Event|0|||
155402406|NCT01840579|560907219|FG004|Overall Study|Adverse Event|0|||
155402407|NCT01840579|560907220|FG005|Overall Study|Adverse Event|0|||
155402408|NCT01840579|560907221|FG006|Overall Study|Adverse Event|0|||
155402409|NCT01840579|560907222|FG007|Overall Study|Adverse Event|0|||
155402410|NCT01840579|560907223|FG008|Overall Study|Adverse Event|0|||
155402411|NCT01840579|560907224|FG009|Overall Study|Adverse Event|0|||
155402412|NCT01840579|560907215|FG000|Overall Study|Follow-up ended by Sponsor|0|||
155402413|NCT01840579|560907216|FG001|Overall Study|Follow-up ended by Sponsor|0|||
155402414|NCT01840579|560907217|FG002|Overall Study|Follow-up ended by Sponsor|0|||
155402415|NCT01840579|560907218|FG003|Overall Study|Follow-up ended by Sponsor|0|||
155402416|NCT01840579|560907219|FG004|Overall Study|Follow-up ended by Sponsor|0|||
155402417|NCT01840579|560907220|FG005|Overall Study|Follow-up ended by Sponsor|0|||
155402418|NCT01840579|560907221|FG006|Overall Study|Follow-up ended by Sponsor|2|||
155402419|NCT01840579|560907222|FG007|Overall Study|Follow-up ended by Sponsor|0|||
155402420|NCT01840579|560907223|FG008|Overall Study|Follow-up ended by Sponsor|0|||
155402421|NCT01840579|560907224|FG009|Overall Study|Follow-up ended by Sponsor|0|||
155402422|NCT03302975|560907226|FG000|Overall Study|Lost to Follow-up|4|||
155402423|NCT01436084|560907227|FG000|Overall Study|Disease Progression|2|||
155402424|NCT01436084|560907227|FG000|Overall Study|Withdrawal by Subject|1|||
155402425|NCT01436084|560907227|FG000|Overall Study|Early Closure of Study|1|||
155402426|NCT02090413|560907230|FG000|Overall Study|Adverse Event|11|||
155402427|NCT02090413|560907231|FG001|Overall Study|Adverse Event|15|||
155402428|NCT02090413|560907232|FG002|Overall Study|Adverse Event|20|||
155402429|NCT02090413|560907230|FG000|Overall Study|Flushing event|2|||
155402430|NCT02090413|560907231|FG001|Overall Study|Flushing event|0|||
155402431|NCT02090413|560907232|FG002|Overall Study|Flushing event|1|||
155402432|NCT02090413|560907230|FG000|Overall Study|Withdrawal by Subject|2|||
155402433|NCT02090413|560907231|FG001|Overall Study|Withdrawal by Subject|2|||
155402434|NCT02090413|560907232|FG002|Overall Study|Withdrawal by Subject|2|||
155402435|NCT02090413|560907230|FG000|Overall Study|Investigator Decision|1|||
155402436|NCT02090413|560907231|FG001|Overall Study|Investigator Decision|1|||
155402437|NCT02090413|560907232|FG002|Overall Study|Investigator Decision|0|||
155402438|NCT02090413|560907230|FG000|Overall Study|Other|2|||
155402439|NCT02090413|560907231|FG001|Overall Study|Other|1|||
155402440|NCT02090413|560907232|FG002|Overall Study|Other|0|||
155402441|NCT02090413|560907230|FG000|Overall Study|Lost to Follow-up|1|||
155402442|NCT02090413|560907231|FG001|Overall Study|Lost to Follow-up|1|||
155402443|NCT02090413|560907232|FG002|Overall Study|Lost to Follow-up|0|||
155402444|NCT05419128|560907233|FG000|Overall Study|Withdrawal by Subject|1|||
155402445|NCT05419128|560907234|FG001|Overall Study|Withdrawal by Subject|1|||
155402446|NCT05419128|560907235|FG002|Overall Study|Withdrawal by Subject|0|||
155402447|NCT05419128|560907236|FG003|Overall Study|Withdrawal by Subject|1|||
155402448|NCT05419128|560907237|FG004|Overall Study|Withdrawal by Subject|1|||
155402449|NCT05419128|560907238|FG005|Overall Study|Withdrawal by Subject|0|||
155402450|NCT05419128|560907233|FG000|Overall Study|Lost to Follow-up|0|||
155402451|NCT05419128|560907234|FG001|Overall Study|Lost to Follow-up|0|||
155402452|NCT05419128|560907235|FG002|Overall Study|Lost to Follow-up|1|||
155402453|NCT05419128|560907236|FG003|Overall Study|Lost to Follow-up|0|||
155402454|NCT05419128|560907237|FG004|Overall Study|Lost to Follow-up|0|||
155402455|NCT05419128|560907238|FG005|Overall Study|Lost to Follow-up|1|||
155402456|NCT05248295|560907239|FG000|Overall Study|found ineligible|4|||
155402457|NCT05248295|560907240|FG001|Overall Study|found ineligible|1|||
155742074|NCT00783198|562156424|FG002|Overall Study|Lost to Follow-up|7|||
155402458|NCT05248295|560907239|FG000|Overall Study|Withdrawal by Subject|0|||
155402459|NCT05248295|560907240|FG001|Overall Study|Withdrawal by Subject|1|||
155402460|NCT05248295|560907239|FG000|Overall Study|Data loss: audio recording error|1|||
155402461|NCT05248295|560907240|FG001|Overall Study|Data loss: audio recording error|1|||
155402462|NCT04066491|560907241|FG000|Overall Study|Randomized, not treated|0|||
155402463|NCT04066491|560907242|FG001|Overall Study|Randomized, not treated|0|||
155402464|NCT04066491|560907243|FG002|Overall Study|Randomized, not treated|2|||
155402465|NCT04506086|560907244|FG000|Overall Study|Withdrawal by Subject|2|||
155402466|NCT04490018|560907245|FG000|Overall Study|Protocol Violation|0|||
155402467|NCT04490018|560907246|FG001|Overall Study|Protocol Violation|2|||
155402468|NCT04490018|560907247|FG002|Overall Study|Protocol Violation|1|||
155402469|NCT04490018|560907245|FG000|Overall Study|Lost to Follow-up|2|||
155402470|NCT04490018|560907246|FG001|Overall Study|Lost to Follow-up|2|||
155402471|NCT04490018|560907247|FG002|Overall Study|Lost to Follow-up|0|||
155402472|NCT04490018|560907245|FG000|Overall Study|Withdrawal by Subject|2|||
155402473|NCT04490018|560907246|FG001|Overall Study|Withdrawal by Subject|1|||
155402474|NCT04490018|560907247|FG002|Overall Study|Withdrawal by Subject|0|||
155402475|NCT04490018|560907245|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155402476|NCT04490018|560907246|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155402477|NCT04490018|560907247|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155402478|NCT02321930|560907250|FG000|Overall Study|Lost to Follow-up|1|||
155402479|NCT01484977|560907251|FG000|Overall Study|Adverse Event|8|||
155402480|NCT01484977|560907251|FG000|Overall Study|Lack of Efficacy|4|||
155402481|NCT01484977|560907251|FG000|Overall Study|Protocol Violation|6|||
155402482|NCT01484977|560907251|FG000|Overall Study|Lost to Follow-up|1|||
155402483|NCT01484977|560907251|FG000|Overall Study|Withdrawal by Subject|4|||
155402484|NCT01484977|560907251|FG000|Overall Study|Subject Protocol Non-compliant|1|||
155402485|NCT01484977|560907251|FG000|Overall Study|Moving Overseas|1|||
155402486|NCT01484977|560907251|FG000|Overall Study|Low White Blood Cell Count|1|||
155742075|NCT00783198|562156422|FG000|Overall Study|Withdrawal by Subject|22|||
155402487|NCT01484977|560907251|FG000|Overall Study|Lack of Compliance|1|||
155742076|NCT00783198|562156423|FG001|Overall Study|Withdrawal by Subject|14|||
155742077|NCT00783198|562156424|FG002|Overall Study|Withdrawal by Subject|20|||
155402488|NCT01133379|560907252|FG000|Overall Study|Withdrawal by Subject|0|||
155402489|NCT01133379|560907253|FG001|Overall Study|Withdrawal by Subject|1|||
155402490|NCT01133379|560907254|FG002|Overall Study|Withdrawal by Subject|1|||
155402491|NCT01133379|560907252|FG000|Overall Study|Lost to Follow-up|1|||
155402492|NCT01133379|560907253|FG001|Overall Study|Lost to Follow-up|1|||
155402493|NCT01133379|560907254|FG002|Overall Study|Lost to Follow-up|1|||
155284854|NCT00941031|560474431|FG006|Maintenance Period|Withdrawal by Subject|13|||
155284855|NCT00941031|560474425|FG000|Maintenance Period|Administrative Problems|0|||
155284856|NCT00941031|560474426|FG001|Maintenance Period|Administrative Problems|0|||
155284857|NCT00941031|560474427|FG002|Maintenance Period|Administrative Problems|0|||
155284858|NCT00941031|560474428|FG003|Maintenance Period|Administrative Problems|0|||
155402494|NCT00591214|560907255|FG000|Overall Study|Physician Decision|7|||
155402495|NCT00591214|560907255|FG000|Overall Study|Withdrawal by Subject|1|||
155402496|NCT00597753|560907258|FG000|Overall Study|Adverse Event|6|||
155402497|NCT00597753|560907259|FG001|Overall Study|Adverse Event|2|||
155402498|NCT00597753|560907258|FG000|Overall Study|Death|55|||
155402499|NCT00597753|560907259|FG001|Overall Study|Death|29|||
155402500|NCT00597753|560907258|FG000|Overall Study|Lack of Efficacy|2|||
155402501|NCT00597753|560907259|FG001|Overall Study|Lack of Efficacy|0|||
155402502|NCT00597753|560907258|FG000|Overall Study|Lost to Follow-up|10|||
155402503|NCT00597753|560907259|FG001|Overall Study|Lost to Follow-up|3|||
155402504|NCT00597753|560907258|FG000|Overall Study|Physician Decision|5|||
155402505|NCT00597753|560907259|FG001|Overall Study|Physician Decision|1|||
155402506|NCT00597753|560907258|FG000|Overall Study|Pregnancy|1|||
155402507|NCT00597753|560907259|FG001|Overall Study|Pregnancy|0|||
155402508|NCT00597753|560907258|FG000|Overall Study|Withdrawal by Subject|35|||
155402509|NCT00597753|560907259|FG001|Overall Study|Withdrawal by Subject|12|||
155402510|NCT00597753|560907258|FG000|Overall Study|Discontinued Dialysis|0|||
155402511|NCT00597753|560907259|FG001|Overall Study|Discontinued Dialysis|1|||
155402512|NCT00597753|560907258|FG000|Overall Study|Never dosed|2|||
155402513|NCT00597753|560907259|FG001|Overall Study|Never dosed|0|||
155402514|NCT00597753|560907258|FG000|Overall Study|Noncompliance|2|||
155402515|NCT00597753|560907259|FG001|Overall Study|Noncompliance|1|||
155402516|NCT00597753|560907258|FG000|Overall Study|Relocation|17|||
155402517|NCT00597753|560907259|FG001|Overall Study|Relocation|6|||
155402518|NCT00597753|560907258|FG000|Overall Study|Renal transplant|10|||
155402519|NCT00597753|560907259|FG001|Overall Study|Renal transplant|3|||
155402520|NCT00597753|560907258|FG000|Overall Study|Site closed by sponsor|19|||
155402521|NCT00597753|560907259|FG001|Overall Study|Site closed by sponsor|7|||
155402522|NCT00597753|560907258|FG000|Overall Study|Site elected to close|2|||
155402523|NCT00597753|560907259|FG001|Overall Study|Site elected to close|4|||
155402524|NCT03080883|560907260|FG000|Overall Study|Withdrawal by Subject|11|||
155402525|NCT03080883|560907261|FG001|Overall Study|Withdrawal by Subject|15|||
155402526|NCT03080883|560907260|FG000|Overall Study|Adverse Event|22|||
155402527|NCT03080883|560907261|FG001|Overall Study|Adverse Event|22|||
155402528|NCT03080883|560907260|FG000|Overall Study|Alternative Therapy|0|||
155402529|NCT03080883|560907261|FG001|Overall Study|Alternative Therapy|3|||
155402530|NCT03080883|560907260|FG000|Overall Study|Other Complicating Disease|9|||
155402531|NCT03080883|560907261|FG001|Overall Study|Other Complicating Disease|5|||
155402532|NCT03080883|560907260|FG000|Overall Study|Death|21|||
155402533|NCT03080883|560907261|FG001|Overall Study|Death|16|||
155402534|NCT03080883|560907260|FG000|Overall Study|Physician Decision|2|||
155402535|NCT03080883|560907261|FG001|Overall Study|Physician Decision|2|||
155402536|NCT03080883|560907260|FG000|Overall Study|Disease Progression|2|||
155402537|NCT03080883|560907261|FG001|Overall Study|Disease Progression|8|||
155402538|NCT03080883|560907260|FG000|Overall Study|Lost to Follow-up|1|||
155402539|NCT03080883|560907261|FG001|Overall Study|Lost to Follow-up|1|||
155637312|NCT00770809|561764724|FG000|Overall Study|Progression|2|||
155284859|NCT00941031|560474429|FG004|Maintenance Period|Administrative Problems|1|||
155637313|NCT00770809|561764725|FG001|Overall Study|Progression|2|||
155494230|NCT01741259|561234243|FG000|Overall Study|Withdrawal by Subject|0|||
155637314|NCT00770809|561764726|FG002|Overall Study|Progression|0|||
155637315|NCT00770809|561764724|FG000|Overall Study|Complicating illness|0|||
155637316|NCT00770809|561764725|FG001|Overall Study|Complicating illness|0|||
155742078|NCT00783198|562156422|FG000|Overall Study|Noncompliance with protocol|7|||
155435861|NCT01591330|561022969|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
155435862|NCT01591330|561022970|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
155435863|NCT01591330|561022971|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
155435864|NCT01591330|561022968|FG000|Period 2|Adverse Event|1|||
155435865|NCT01591330|561022969|FG001|Period 2|Adverse Event|0|||
155435866|NCT01591330|561022970|FG002|Period 2|Adverse Event|0|||
155435867|NCT01591330|561022971|FG003|Period 2|Adverse Event|0|||
155402809|NCT00388973|560909793|FG000|Overall Study|Adverse Event|16|||
155402810|NCT00388973|560909794|FG001|Overall Study|Adverse Event|6|||
155284860|NCT00941031|560474430|FG005|Maintenance Period|Administrative Problems|0|||
155284861|NCT00941031|560474431|FG006|Maintenance Period|Administrative Problems|1|||
155284862|NCT00941031|560474425|FG000|Maintenance Period|Protocol Violation|0|||
155284863|NCT00941031|560474426|FG001|Maintenance Period|Protocol Violation|0|||
155284864|NCT00941031|560474427|FG002|Maintenance Period|Protocol Violation|0|||
155284865|NCT00941031|560474428|FG003|Maintenance Period|Protocol Violation|0|||
155284866|NCT00941031|560474429|FG004|Maintenance Period|Protocol Violation|0|||
155284867|NCT00941031|560474430|FG005|Maintenance Period|Protocol Violation|0|||
155284868|NCT00941031|560474431|FG006|Maintenance Period|Protocol Violation|1|||
155284869|NCT00941031|560474425|FG000|Maintenance Period|Adverse Event|0|||
155284870|NCT00941031|560474426|FG001|Maintenance Period|Adverse Event|0|||
155284871|NCT00941031|560474427|FG002|Maintenance Period|Adverse Event|0|||
155284872|NCT00941031|560474428|FG003|Maintenance Period|Adverse Event|0|||
155284873|NCT00941031|560474429|FG004|Maintenance Period|Adverse Event|0|||
155284874|NCT00941031|560474430|FG005|Maintenance Period|Adverse Event|2|||
155284875|NCT00941031|560474431|FG006|Maintenance Period|Adverse Event|8|||
155742079|NCT00783198|562156423|FG001|Overall Study|Noncompliance with protocol|7|||
155742080|NCT00783198|562156424|FG002|Overall Study|Noncompliance with protocol|10|||
155742081|NCT00783198|562156422|FG000|Overall Study|Did not meet protocol eligibility|0|||
155742082|NCT00783198|562156423|FG001|Overall Study|Did not meet protocol eligibility|1|||
155742083|NCT00783198|562156424|FG002|Overall Study|Did not meet protocol eligibility|0|||
155742084|NCT00783198|562156422|FG000|Overall Study|Administrative|2|||
155742085|NCT00783198|562156423|FG001|Overall Study|Administrative|1|||
155284876|NCT00941031|560474425|FG000|Maintenance Period|Lost to Follow-up|0|||
155284877|NCT00941031|560474426|FG001|Maintenance Period|Lost to Follow-up|0|||
155284878|NCT00941031|560474427|FG002|Maintenance Period|Lost to Follow-up|0|||
155284879|NCT00941031|560474428|FG003|Maintenance Period|Lost to Follow-up|0|||
155284880|NCT00941031|560474429|FG004|Maintenance Period|Lost to Follow-up|2|||
155284881|NCT00941031|560474430|FG005|Maintenance Period|Lost to Follow-up|2|||
155742086|NCT00783198|562156424|FG002|Overall Study|Administrative|2|||
155742087|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
155742088|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
155742089|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
155742090|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
155742091|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
155742092|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
155742093|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
155742094|NCT00946985|562156425|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
155742095|NCT00946985|562156425|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
155742096|NCT00271505|562156426|FG000|Overall Study|Screen Failure|3|||
155742097|NCT00271505|562156426|FG000|Overall Study|Adverse Event|1|||
155742098|NCT00271505|562156426|FG000|Overall Study|Death|1|||
155742099|NCT00119678|562156427|FG000|Double-blind Treatment Period|Death|1|||
155742100|NCT00119678|562156428|FG001|Double-blind Treatment Period|Death|0|||
155742101|NCT00119678|562156427|FG000|Double-blind Treatment Period|Adverse Event|7|||
155742102|NCT00119678|562156428|FG001|Double-blind Treatment Period|Adverse Event|1|||
155742103|NCT00119678|562156427|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
155742104|NCT00119678|562156428|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
155742105|NCT00119678|562156427|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155742106|NCT00119678|562156428|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
155742107|NCT00119678|562156427|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
155742108|NCT00119678|562156428|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
155742109|NCT00119678|562156427|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
155742110|NCT00119678|562156428|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
155742111|NCT00119678|562156427|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
155742112|NCT00119678|562156428|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
155742113|NCT00119678|562156427|FG000|Double-blind Treatment Period|Pregnancy|0|||
155742114|NCT00119678|562156428|FG001|Double-blind Treatment Period|Pregnancy|2|||
155742115|NCT00119678|562156427|FG000|Double-blind Treatment Period|Not treated|1|||
155742116|NCT00119678|562156428|FG001|Double-blind Treatment Period|Not treated|2|||
155742117|NCT00119678|562156427|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
155742118|NCT00119678|562156428|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
155742119|NCT00119678|562156427|FG000|Open-label Treatment Period|Death|1|||
155742120|NCT00119678|562156428|FG001|Open-label Treatment Period|Death|0|||
155742121|NCT00119678|562156427|FG000|Open-label Treatment Period|Adverse Event|3|||
155742122|NCT00119678|562156428|FG001|Open-label Treatment Period|Adverse Event|0|||
155742123|NCT00119678|562156427|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
155742124|NCT00119678|562156428|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
155742125|NCT00119678|562156427|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
155742126|NCT00119678|562156428|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155742127|NCT00119678|562156427|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
155742128|NCT00119678|562156428|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
155742129|NCT00119678|562156427|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
155742130|NCT00119678|562156428|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
155742131|NCT00119678|562156427|FG000|Open-label Treatment Period|Pregnancy|1|||
155742132|NCT00119678|562156428|FG001|Open-label Treatment Period|Pregnancy|0|||
155742133|NCT00119678|562156427|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
155742134|NCT00119678|562156428|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
155742135|NCT01134705|562156431|FG000|Overall Study|Adverse Event|1|||
155742136|NCT01134705|562156432|FG001|Overall Study|Adverse Event|7|||
155742137|NCT01134705|562156431|FG000|Overall Study|Withdrawal by Subject|6|||
155742138|NCT01134705|562156432|FG001|Overall Study|Withdrawal by Subject|6|||
155742139|NCT01134705|562156431|FG000|Overall Study|Pregnancy|1|||
155742140|NCT01134705|562156432|FG001|Overall Study|Pregnancy|0|||
155742141|NCT01134705|562156431|FG000|Overall Study|Lost to Follow-up|5|||
155742142|NCT01134705|562156432|FG001|Overall Study|Lost to Follow-up|2|||
155742143|NCT01134705|562156431|FG000|Overall Study|Protocol Violation|1|||
155742144|NCT01134705|562156432|FG001|Overall Study|Protocol Violation|1|||
155742145|NCT01134705|562156431|FG000|Overall Study|Other|1|||
155742146|NCT01134705|562156432|FG001|Overall Study|Other|6|||
155742147|NCT01510769|562156433|FG000|Overall Study|Adverse Event|7|||
155742148|NCT01510769|562156434|FG001|Overall Study|Adverse Event|6|||
155742149|NCT01510769|562156435|FG002|Overall Study|Adverse Event|4|||
155742150|NCT01510769|562156433|FG000|Overall Study|Gout Flare|0|||
155742151|NCT01510769|562156434|FG001|Overall Study|Gout Flare|3|||
155742152|NCT01510769|562156435|FG002|Overall Study|Gout Flare|1|||
155742153|NCT01510769|562156433|FG000|Overall Study|Protocol Violation|11|||
155742154|NCT01510769|562156434|FG001|Overall Study|Protocol Violation|10|||
155742155|NCT01510769|562156435|FG002|Overall Study|Protocol Violation|9|||
155742156|NCT01510769|562156433|FG000|Overall Study|Lost to Follow-up|5|||
155742157|NCT01510769|562156434|FG001|Overall Study|Lost to Follow-up|1|||
155742158|NCT01510769|562156435|FG002|Overall Study|Lost to Follow-up|5|||
155742159|NCT01510769|562156433|FG000|Overall Study|Withdrawal by Subject|3|||
155742160|NCT01510769|562156434|FG001|Overall Study|Withdrawal by Subject|4|||
155742161|NCT01510769|562156435|FG002|Overall Study|Withdrawal by Subject|3|||
155742162|NCT01510769|562156433|FG000|Overall Study|Death|1|||
155742163|NCT01510769|562156434|FG001|Overall Study|Death|1|||
155742164|NCT01510769|562156435|FG002|Overall Study|Death|0|||
155742165|NCT02674204|562156436|FG000|Overall Study|Adverse Event|1|||
155742166|NCT02674204|562156437|FG001|Overall Study|Adverse Event|0|||
155742167|NCT01008423|562156438|FG000|Overall Study|Adverse Event|13|||
155742168|NCT01008423|562156439|FG001|Overall Study|Adverse Event|6|||
155742169|NCT01008423|562156438|FG000|Overall Study|Withdrawal by Subject|4|||
155742170|NCT01008423|562156439|FG001|Overall Study|Withdrawal by Subject|7|||
155742171|NCT01008423|562156438|FG000|Overall Study|Lost to Follow-up|0|||
155742172|NCT01008423|562156439|FG001|Overall Study|Lost to Follow-up|2|||
155742173|NCT01008423|562156438|FG000|Overall Study|Low Cortisol|0|||
155742174|NCT01008423|562156439|FG001|Overall Study|Low Cortisol|1|||
155742175|NCT01008423|562156438|FG000|Overall Study|Lack of Efficacy|0|||
155742176|NCT01008423|562156439|FG001|Overall Study|Lack of Efficacy|5|||
155742177|NCT01008423|562156438|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
155742178|NCT01008423|562156439|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
155742179|NCT01008423|562156438|FG000|Overall Study|Personal Conflict|1|||
155742180|NCT01008423|562156439|FG001|Overall Study|Personal Conflict|0|||
155742181|NCT01008423|562156438|FG000|Overall Study|Other|0|||
155742182|NCT01008423|562156439|FG001|Overall Study|Other|1|||
155742183|NCT00978757|562156445|FG000|Overall Study|Physician Decision|1|||
155742184|NCT00978757|562156446|FG001|Overall Study|Physician Decision|3|||
155742185|NCT01028300|562156447|FG000|Overall Study|Study Terminated|4|||
155742186|NCT00715910|562156448|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
155742187|NCT00715910|562156449|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
155402811|NCT00388973|560909793|FG000|Overall Study|Lack of Efficacy|1|||
155742188|NCT00715910|562156450|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
155742189|NCT00715910|562156451|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
155742190|NCT00715910|562156452|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
155742191|NCT00715910|562156453|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
155742192|NCT00715910|562156448|FG000|Booster and ESFU Phase|Other|0|||
155742193|NCT00715910|562156449|FG001|Booster and ESFU Phase|Other|0|||
155742194|NCT00715910|562156450|FG002|Booster and ESFU Phase|Other|0|||
155742195|NCT00715910|562156451|FG003|Booster and ESFU Phase|Other|5|||
155742196|NCT00715910|562156452|FG004|Booster and ESFU Phase|Other|1|||
155742197|NCT00715910|562156453|FG005|Booster and ESFU Phase|Other|0|||
155742198|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155742199|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155742200|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155742201|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155742202|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
155742203|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155742204|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155742205|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155742206|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155742207|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155742208|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742209|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742210|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742211|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742212|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
155742213|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742214|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742215|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742216|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742217|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155742218|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
155742219|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742220|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742221|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742222|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
155742223|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742224|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742225|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742226|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742227|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155742228|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742229|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742230|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
155742231|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742232|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
155742233|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742234|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742235|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742236|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742237|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155742238|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742239|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742240|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742241|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742242|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
155742243|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742244|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742245|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742246|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742247|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155742248|NCT01185353|562156454|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
155742249|NCT01185353|562156455|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742250|NCT01185353|562156456|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742251|NCT01185353|562156457|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742252|NCT01185353|562156458|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
155742253|NCT01185353|562156459|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742254|NCT01185353|562156460|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742255|NCT01185353|562156461|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742256|NCT01185353|562156462|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742257|NCT01185353|562156463|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155742258|NCT01185353|562156454|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742259|NCT01185353|562156455|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742260|NCT01185353|562156456|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
155742261|NCT01185353|562156457|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155637317|NCT00770809|561764726|FG002|Overall Study|Complicating illness|1|||
155637318|NCT00770809|561764724|FG000|Overall Study|Other Medical Reasons|2|||
155637319|NCT00770809|561764725|FG001|Overall Study|Other Medical Reasons|4|||
155637320|NCT00770809|561764726|FG002|Overall Study|Other Medical Reasons|3|||
155637321|NCT05028569|561764727|FG000|Double-Blind Phase|Death|0|||
155637322|NCT05028569|561764728|FG001|Double-Blind Phase|Death|0|||
155637323|NCT05028569|561764729|FG002|Double-Blind Phase|Death|0|||
155637324|NCT05028569|561764730|FG003|Double-Blind Phase|Death|1|||
155637325|NCT05028569|561764731|FG004|Double-Blind Phase|Death|0|||
155637326|NCT05028569|561764732|FG005|Double-Blind Phase|Death|0|||
155637327|NCT05028569|561764733|FG006|Double-Blind Phase|Death|0|||
155637328|NCT05028569|561764727|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155637329|NCT05028569|561764728|FG001|Double-Blind Phase|Lost to Follow-up|6|||
155637330|NCT05028569|561764729|FG002|Double-Blind Phase|Lost to Follow-up|3|||
155637331|NCT05028569|561764730|FG003|Double-Blind Phase|Lost to Follow-up|9|||
155637332|NCT05028569|561764731|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155637333|NCT05028569|561764732|FG005|Double-Blind Phase|Lost to Follow-up|0|||
155284882|NCT00941031|560474431|FG006|Maintenance Period|Lost to Follow-up|7|||
155284883|NCT00941031|560474425|FG000|Maintenance Period|Lack of Efficacy|0|||
155284884|NCT00941031|560474426|FG001|Maintenance Period|Lack of Efficacy|0|||
155284885|NCT00941031|560474427|FG002|Maintenance Period|Lack of Efficacy|0|||
155284886|NCT00941031|560474428|FG003|Maintenance Period|Lack of Efficacy|0|||
155284887|NCT00941031|560474429|FG004|Maintenance Period|Lack of Efficacy|0|||
155284888|NCT00941031|560474430|FG005|Maintenance Period|Lack of Efficacy|0|||
155284889|NCT00941031|560474431|FG006|Maintenance Period|Lack of Efficacy|13|||
155284890|NCT04555044|560474434|FG000|Overall Study|Adverse Event|0|||
155284891|NCT04555044|560474435|FG001|Overall Study|Adverse Event|1|||
155284892|NCT00631917|560474437|FG000|Overall Study|Adverse Event|34|||
155284893|NCT00631917|560474438|FG001|Overall Study|Adverse Event|45|||
155284894|NCT00631917|560474437|FG000|Overall Study|Abnormal laboratory value(s)|2|||
155284895|NCT00631917|560474438|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155284896|NCT00631917|560474437|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155284897|NCT00631917|560474438|FG001|Overall Study|Abnormal test procedure result(s)|2|||
155284898|NCT00631917|560474437|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
155284899|NCT00631917|560474438|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
155284900|NCT00631917|560474437|FG000|Overall Study|No longer required study drug|0|||
155284901|NCT00631917|560474438|FG001|Overall Study|No longer required study drug|1|||
155284902|NCT00631917|560474437|FG000|Overall Study|Protocol deviation|6|||
155284903|NCT00631917|560474438|FG001|Overall Study|Protocol deviation|5|||
155284904|NCT00631917|560474437|FG000|Overall Study|Subject withdrew consent|25|||
155284905|NCT00631917|560474438|FG001|Overall Study|Subject withdrew consent|33|||
155284906|NCT00631917|560474437|FG000|Overall Study|Lost to Follow-up|7|||
155284907|NCT00631917|560474438|FG001|Overall Study|Lost to Follow-up|7|||
155284908|NCT00631917|560474437|FG000|Overall Study|Administrative problems|2|||
155284909|NCT00631917|560474438|FG001|Overall Study|Administrative problems|0|||
155284910|NCT00631917|560474437|FG000|Overall Study|Death|1|||
155284911|NCT00631917|560474438|FG001|Overall Study|Death|0|||
155284912|NCT01767909|560474441|FG000|Overall Study|Withdrawal by Subject|4|||
155284913|NCT01767909|560474442|FG001|Overall Study|Withdrawal by Subject|7|||
155284914|NCT01767909|560474441|FG000|Overall Study|Adverse Event|3|||
155284915|NCT01767909|560474442|FG001|Overall Study|Adverse Event|1|||
155284916|NCT01767909|560474441|FG000|Overall Study|Withdrawal by Study Partner|3|||
155284917|NCT01767909|560474442|FG001|Overall Study|Withdrawal by Study Partner|1|||
155284918|NCT01767909|560474441|FG000|Overall Study|Non-Compliance|2|||
155284919|NCT01767909|560474442|FG001|Overall Study|Non-Compliance|0|||
155284920|NCT01767909|560474441|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155284921|NCT01767909|560474442|FG001|Overall Study|Perceived Lack of Efficacy|0|||
155284922|NCT01767909|560474441|FG000|Overall Study|Investigator Recommendation|0|||
155284923|NCT01767909|560474442|FG001|Overall Study|Investigator Recommendation|1|||
155284924|NCT01767909|560474441|FG000|Overall Study|Lost to Follow-up|0|||
155284925|NCT01767909|560474442|FG001|Overall Study|Lost to Follow-up|1|||
155284926|NCT01767909|560474441|FG000|Overall Study|LP uncessessful|0|||
155284927|NCT01767909|560474442|FG001|Overall Study|LP uncessessful|1|||
155284928|NCT02696785|560474451|FG000|Blinded Treatment Period|Adverse Event|0|||
155284929|NCT02696785|560474452|FG001|Blinded Treatment Period|Adverse Event|1|||
155402812|NCT00388973|560909794|FG001|Overall Study|Lack of Efficacy|12|||
155402813|NCT00388973|560909793|FG000|Overall Study|Protocol Violation|3|||
155402814|NCT00388973|560909794|FG001|Overall Study|Protocol Violation|0|||
155402815|NCT00388973|560909793|FG000|Overall Study|Withdrawal by Subject|14|||
155402816|NCT00388973|560909794|FG001|Overall Study|Withdrawal by Subject|17|||
155402817|NCT00388973|560909793|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
155402818|NCT00388973|560909794|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
155402819|NCT00388973|560909793|FG000|Overall Study|Did not complete 61 days of treatment|5|||
155402820|NCT00388973|560909794|FG001|Overall Study|Did not complete 61 days of treatment|4|||
155402821|NCT00388973|560909793|FG000|Overall Study|Left region|0|||
155402822|NCT00388973|560909794|FG001|Overall Study|Left region|1|||
155402823|NCT00388973|560909793|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
155402824|NCT00388973|560909794|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
155402825|NCT01652885|560909795|FG000|Overall Study|Adverse Event|1|||
155402826|NCT00075400|560909796|FG000|Overall Study|Ineligible: wrong primary|1|||
155402827|NCT00075400|560909796|FG000|Overall Study|Never treated|2|||
155402828|NCT03723707|560909798|FG000|Overall Study|Death|32|||
155402829|NCT03723707|560909799|FG001|Overall Study|Death|32|||
155402830|NCT03723707|560909798|FG000|Overall Study|Admitted to long term care|12|||
155402831|NCT03723707|560909799|FG001|Overall Study|Admitted to long term care|12|||
155402832|NCT03723707|560909798|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
155402833|NCT03723707|560909799|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
155402834|NCT03723707|560909798|FG000|Overall Study|Lost to Follow-up|40|||
155402835|NCT03723707|560909799|FG001|Overall Study|Lost to Follow-up|22|||
155402836|NCT03723707|560909798|FG000|Overall Study|Discontinued after study closure|24|||
155402837|NCT03723707|560909799|FG001|Overall Study|Discontinued after study closure|12|||
155402838|NCT00075023|560909800|FG000|Pilot Study|Physician Decision|1|||
155402839|NCT00075023|560909801|FG001|Pilot Study|Physician Decision|2|||
155402840|NCT00075023|560909800|FG000|Pilot Study|Withdrawal by Subject|1|||
155637334|NCT05028569|561764733|FG006|Double-Blind Phase|Lost to Follow-up|0|||
155637335|NCT05028569|561764727|FG000|Double-Blind Phase|Protocol Deviation|0|||
155402841|NCT00075023|560909801|FG001|Pilot Study|Withdrawal by Subject|0|||
155402842|NCT04342871|560909802|FG000|Overall Study|Death|4|||
155402843|NCT04342871|560909802|FG000|Overall Study|Clinical deterioration/illness progression|2|||
155402844|NCT04342871|560909802|FG000|Overall Study|Did not complete baseline assessments|5|||
155402845|NCT04342871|560909802|FG000|Overall Study|Lost to Follow-up|13|||
155402846|NCT00666458|560909804|FG000|Overall Study|Adverse Event|8|||
155402847|NCT00666458|560909805|FG001|Overall Study|Adverse Event|7|||
155402848|NCT00666458|560909804|FG000|Overall Study|Withdrawal by Subject|5|||
155402849|NCT00666458|560909805|FG001|Overall Study|Withdrawal by Subject|4|||
155402850|NCT00666458|560909804|FG000|Overall Study|Lost to Follow-up|0|||
155402851|NCT00666458|560909805|FG001|Overall Study|Lost to Follow-up|3|||
155402852|NCT00666458|560909804|FG000|Overall Study|Administrative reason by sponsor|1|||
155402853|NCT00666458|560909805|FG001|Overall Study|Administrative reason by sponsor|1|||
155402854|NCT00666458|560909804|FG000|Overall Study|Incorrect enrollment|7|||
155402855|NCT00666458|560909805|FG001|Overall Study|Incorrect enrollment|1|||
155402856|NCT00666458|560909804|FG000|Overall Study|Study specific discontinuation criteria|14|||
155402857|NCT00666458|560909805|FG001|Overall Study|Study specific discontinuation criteria|7|||
155402858|NCT00666458|560909804|FG000|Overall Study|Severe non-compliance to the protocol|1|||
155402859|NCT00666458|560909805|FG001|Overall Study|Severe non-compliance to the protocol|1|||
155402860|NCT00666458|560909804|FG000|Overall Study|Safety reasons|1|||
155402861|NCT00666458|560909805|FG001|Overall Study|Safety reasons|0|||
155402862|NCT00666458|560909804|FG000|Overall Study|Medical history of anemia|1|||
155402863|NCT00666458|560909805|FG001|Overall Study|Medical history of anemia|0|||
155402864|NCT01429584|560909806|FG000|Overall Study|Withdrawal by Subject|1|||
155402865|NCT01429584|560909807|FG001|Overall Study|Withdrawal by Subject|0|||
155402866|NCT01429584|560909806|FG000|Overall Study|Protocol Violation|0|||
155402867|NCT01429584|560909807|FG001|Overall Study|Protocol Violation|1|||
155402868|NCT00750698|560909811|FG000|Overall Study|Withdrawal by Subject|1|||
155402869|NCT00750698|560909812|FG001|Overall Study|Withdrawal by Subject|0|||
155402870|NCT00750698|560909811|FG000|Overall Study|Progressive disease|5|||
155402871|NCT00750698|560909812|FG001|Overall Study|Progressive disease|2|||
155402872|NCT00402649|560909813|FG000|Overall Study|Lost to Follow-up|1|||
155402873|NCT00402649|560909813|FG000|Overall Study|Withdrawal by Subject|1|||
155402874|NCT01999465|560909814|FG000|Overall Study|Lost to Follow-up|0|||
155284930|NCT02696785|560474453|FG002|Blinded Treatment Period|Adverse Event|3|||
155402875|NCT01999465|560909815|FG001|Overall Study|Lost to Follow-up|2|||
155402876|NCT01999465|560909814|FG000|Overall Study|Protocol Violation|0|||
155402877|NCT01999465|560909815|FG001|Overall Study|Protocol Violation|1|||
155402878|NCT02325219|560909816|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
155402879|NCT02325219|560909817|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
155402880|NCT02325219|560909818|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
155402881|NCT02325219|560909819|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
155402882|NCT02325219|560909820|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
155402883|NCT02325219|560909816|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
155402884|NCT02325219|560909817|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
155402885|NCT02325219|560909818|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155402886|NCT02325219|560909819|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155402887|NCT02325219|560909820|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155402888|NCT02325219|560909816|FG000|Controlled Period (Week 0 - 16)|Other|0|||
155402889|NCT02325219|560909817|FG001|Controlled Period (Week 0 - 16)|Other|0|||
155402890|NCT02325219|560909818|FG002|Controlled Period (Week 0 - 16)|Other|1|||
155402891|NCT02325219|560909819|FG003|Controlled Period (Week 0 - 16)|Other|0|||
155402892|NCT02325219|560909820|FG004|Controlled Period (Week 0 - 16)|Other|0|||
155402893|NCT02325219|560909816|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155402894|NCT02325219|560909817|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155402895|NCT02325219|560909818|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155402896|NCT02325219|560909819|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155402897|NCT02325219|560909820|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155402898|NCT02325219|560909816|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
155402899|NCT02325219|560909817|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
155402900|NCT02325219|560909818|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
155402901|NCT02325219|560909819|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
155402902|NCT02325219|560909820|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
155402903|NCT02325219|560909816|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155402904|NCT02325219|560909817|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
155637336|NCT05028569|561764728|FG001|Double-Blind Phase|Protocol Deviation|2|||
155637337|NCT05028569|561764729|FG002|Double-Blind Phase|Protocol Deviation|0|||
155637338|NCT05028569|561764730|FG003|Double-Blind Phase|Protocol Deviation|0|||
155402905|NCT02325219|560909818|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155402906|NCT02325219|560909819|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155402907|NCT02325219|560909820|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155402908|NCT02187172|560909821|FG000|Overall Study|Lost to Follow-up|1|||
155402909|NCT02187172|560909822|FG001|Overall Study|Lost to Follow-up|2|||
155402910|NCT02187172|560909821|FG000|Overall Study|Lack of Efficacy|1|||
155402911|NCT02187172|560909822|FG001|Overall Study|Lack of Efficacy|2|||
155402912|NCT02187172|560909821|FG000|Overall Study|Adverse Event|0|||
155402913|NCT02187172|560909822|FG001|Overall Study|Adverse Event|1|||
155402914|NCT02187172|560909821|FG000|Overall Study|Physician Decision|1|||
155402915|NCT02187172|560909822|FG001|Overall Study|Physician Decision|1|||
155402916|NCT01549275|560909828|FG000|Overall Study|Lost to Follow-up|1|||
155402917|NCT01549275|560909829|FG001|Overall Study|Lost to Follow-up|0|||
155402918|NCT03179891|560909833|FG000|First Intervention|Withdrawal by Subject|1|||
155402919|NCT03179891|560909834|FG001|First Intervention|Withdrawal by Subject|1|||
155402920|NCT03179891|560909833|FG000|First Intervention|Unspecified reason|1|||
155402921|NCT03179891|560909834|FG001|First Intervention|Unspecified reason|0|||
155402922|NCT03179891|560909833|FG000|First Intervention|Protocol Violation|0|||
155402923|NCT03179891|560909834|FG001|First Intervention|Protocol Violation|1|||
155402924|NCT02969187|560909839|FG000|Overall Study|Physician Decision|12|||
155402925|NCT02969187|560909840|FG001|Overall Study|Physician Decision|13|||
155402926|NCT03719690|560909845|FG000|Overall Study|Withdrawal by Subject|5|||
155402927|NCT03719690|560909846|FG001|Overall Study|Withdrawal by Subject|10|||
155402928|NCT03719690|560909845|FG000|Overall Study|Death|40|||
155402929|NCT03719690|560909846|FG001|Overall Study|Death|149|||
155402930|NCT03719690|560909845|FG000|Overall Study|Miscellaneous|12|||
155402931|NCT03719690|560909846|FG001|Overall Study|Miscellaneous|56|||
155402932|NCT03719690|560909845|FG000|Overall Study|Lost to Follow-up|2|||
155402933|NCT03719690|560909846|FG001|Overall Study|Lost to Follow-up|18|||
155402934|NCT03719690|560909845|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
155402935|NCT03719690|560909846|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
155402936|NCT00530270|560909849|FG000|Overall Study|Protocol Violation|1|||
155402937|NCT00530270|560909850|FG001|Overall Study|Protocol Violation|0|||
155402938|NCT03374189|560909852|FG000|Overall Study|Lost to Follow-up|1|||
155402939|NCT03374189|560909853|FG001|Overall Study|Lost to Follow-up|0|||
155402940|NCT02375724|560909854|FG000|Overall Study|Lack of Efficacy|1|||
155402941|NCT02375724|560909855|FG001|Overall Study|Lack of Efficacy|1|||
155402942|NCT02375724|560909854|FG000|Overall Study|Withdrawal by Subject|1|||
155402943|NCT02375724|560909855|FG001|Overall Study|Withdrawal by Subject|1|||
155402944|NCT02375724|560909854|FG000|Overall Study|Lost to Follow-up|1|||
155402945|NCT02375724|560909855|FG001|Overall Study|Lost to Follow-up|0|||
155402946|NCT02375724|560909854|FG000|Overall Study|Protocol Violation|1|||
155402947|NCT02375724|560909855|FG001|Overall Study|Protocol Violation|0|||
155402948|NCT02375724|560909854|FG000|Overall Study|Adverse Event|2|||
155402949|NCT02375724|560909855|FG001|Overall Study|Adverse Event|4|||
155402950|NCT04712110|560909858|FG000|Overall Study|Lost to Follow-up|0|||
155402951|NCT04712110|560909859|FG001|Overall Study|Lost to Follow-up|1|||
155402952|NCT04712110|560909858|FG000|Overall Study|Withdrawal by Subject|0|||
155402953|NCT04712110|560909859|FG001|Overall Study|Withdrawal by Subject|4|||
155402954|NCT04712110|560909858|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
155402955|NCT04712110|560909859|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
155402956|NCT01197521|560909860|FG000|Overall Study|Not reported|24|||
155402957|NCT01197521|560909861|FG001|Overall Study|Not reported|25|||
155402958|NCT01197521|560909862|FG002|Overall Study|Not reported|21|||
155402959|NCT01197521|560909860|FG000|Overall Study|Enrolment in long term extension|42|||
155402960|NCT01197521|560909861|FG001|Overall Study|Enrolment in long term extension|36|||
155402961|NCT01197521|560909862|FG002|Overall Study|Enrolment in long term extension|87|||
155402962|NCT01197521|560909860|FG000|Overall Study|Severe non-compliance to protocol|1|||
155402963|NCT01197521|560909861|FG001|Overall Study|Severe non-compliance to protocol|3|||
155402964|NCT01197521|560909862|FG002|Overall Study|Severe non-compliance to protocol|3|||
155402965|NCT01197521|560909860|FG000|Overall Study|Lack of therapeutic response|2|||
155402966|NCT01197521|560909861|FG001|Overall Study|Lack of therapeutic response|3|||
155402967|NCT01197521|560909862|FG002|Overall Study|Lack of therapeutic response|4|||
155402968|NCT01197521|560909860|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
155402969|NCT01197521|560909861|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
155402970|NCT01197521|560909862|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
155402971|NCT01197521|560909860|FG000|Overall Study|Lost to Follow-up|3|||
155402972|NCT01197521|560909861|FG001|Overall Study|Lost to Follow-up|2|||
155402973|NCT01197521|560909862|FG002|Overall Study|Lost to Follow-up|2|||
155402974|NCT01197521|560909860|FG000|Overall Study|Adverse Event|25|||
155402975|NCT01197521|560909861|FG001|Overall Study|Adverse Event|28|||
155402976|NCT01197521|560909862|FG002|Overall Study|Adverse Event|24|||
155402977|NCT02018822|560909863|FG000|Overall Study|filling replaced by crown|0|||
155402978|NCT02018822|560909864|FG001|Overall Study|filling replaced by crown|1|||
155402979|NCT02018822|560909865|FG002|Overall Study|filling replaced by crown|0|||
155402980|NCT02018822|560909863|FG000|Overall Study|Physician Decision|0|||
155402981|NCT02018822|560909864|FG001|Overall Study|Physician Decision|1|||
155402982|NCT02018822|560909865|FG002|Overall Study|Physician Decision|1|||
155402983|NCT02018822|560909863|FG000|Overall Study|Lost to Follow-up|6|||
155402984|NCT02018822|560909864|FG001|Overall Study|Lost to Follow-up|6|||
155402985|NCT02018822|560909865|FG002|Overall Study|Lost to Follow-up|5|||
155402986|NCT02285777|560909866|FG000|Overall Study|Withdrawal by Subject|1|||
155402987|NCT02285777|560909867|FG001|Overall Study|Withdrawal by Subject|1|||
155402988|NCT02285777|560909866|FG000|Overall Study|Lost to Follow-up|4|||
155402989|NCT02285777|560909867|FG001|Overall Study|Lost to Follow-up|2|||
155402990|NCT03201458|560909868|FG000|Overall Study|No longer eligible|2|||
155402991|NCT03201458|560909869|FG001|Overall Study|No longer eligible|5|||
155402992|NCT03201458|560909868|FG000|Overall Study|Health event before starting|1|||
155402993|NCT03201458|560909869|FG001|Overall Study|Health event before starting|0|||
155402994|NCT03201458|560909868|FG000|Overall Study|Physician Decision|1|||
155402995|NCT03201458|560909869|FG001|Overall Study|Physician Decision|0|||
155402996|NCT00715026|560909872|FG000|Overall Study|Withdrawal by Subject|5|||
155402997|NCT00715026|560909872|FG000|Overall Study|Lost to Follow-up|3|||
155402998|NCT00715026|560909872|FG000|Overall Study|Protocol Violation|1|||
155402999|NCT00715026|560909872|FG000|Overall Study|Surgery done on non-study consented hip|1|||
155403000|NCT00750737|560909880|FG000|Overall Study|Withdrawal by Subject|3|||
155403001|NCT00750737|560909881|FG001|Overall Study|Withdrawal by Subject|3|||
155403002|NCT03625687|560909882|FG000|Overall Study|Death|1|||
155403003|NCT01543828|560909883|FG000|Treatment 2|Lost to Follow-up|1|||
155403004|NCT01543828|560909884|FG001|Treatment 2|Lost to Follow-up|0|||
155403005|NCT01069172|560909887|FG000|Overall Study|Withdrawal by Subject|1|||
155403006|NCT01069172|560909888|FG001|Overall Study|Withdrawal by Subject|0|||
155403007|NCT00711425|560909891|FG000|Overall Study|Protocol Violation|1|||
155403008|NCT00711425|560909891|FG000|Overall Study|Death|2|||
155403009|NCT00711425|560909891|FG000|Overall Study|Lost to Follow-up|1|||
155403010|NCT03901079|560909892|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
155403011|NCT00916149|560909893|FG000|Overall Study|Lost to Follow-up|3|||
155403012|NCT00916149|560909894|FG001|Overall Study|Lost to Follow-up|2|||
155403013|NCT00916149|560909895|FG002|Overall Study|Lost to Follow-up|0|||
155403014|NCT00916149|560909893|FG000|Overall Study|Unable to place scalp EEG leads|1|||
155403015|NCT00916149|560909894|FG001|Overall Study|Unable to place scalp EEG leads|0|||
155403016|NCT00916149|560909895|FG002|Overall Study|Unable to place scalp EEG leads|0|||
155403017|NCT00912028|560909898|FG000|Overall Study|Lost to Follow-up|2|||
155403018|NCT00912028|560909899|FG001|Overall Study|Lost to Follow-up|3|||
155403019|NCT00912028|560909900|FG002|Overall Study|Lost to Follow-up|0|||
155403020|NCT00912028|560909901|FG003|Overall Study|Lost to Follow-up|1|||
155403021|NCT00912028|560909902|FG004|Overall Study|Lost to Follow-up|3|||
155403022|NCT00912028|560909898|FG000|Overall Study|Withdrawal by Subject|3|||
155403023|NCT00912028|560909899|FG001|Overall Study|Withdrawal by Subject|0|||
155403024|NCT00912028|560909900|FG002|Overall Study|Withdrawal by Subject|0|||
155284931|NCT02696785|560474454|FG003|Blinded Treatment Period|Adverse Event|0|||
155403025|NCT00912028|560909901|FG003|Overall Study|Withdrawal by Subject|0|||
155403026|NCT00912028|560909902|FG004|Overall Study|Withdrawal by Subject|0|||
155403027|NCT00841568|560909903|FG000|Overall Study|Adverse Event|1|||
155284932|NCT02696785|560474451|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
155284933|NCT02696785|560474452|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
155284934|NCT02696785|560474453|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
155284935|NCT02696785|560474454|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
155284936|NCT02696785|560474451|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
155284937|NCT02696785|560474452|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
155284938|NCT02696785|560474453|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
155284939|NCT02696785|560474454|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
155284940|NCT02696785|560474451|FG000|Blinded Treatment Period|Screen Failure|1|||
155284941|NCT02696785|560474452|FG001|Blinded Treatment Period|Screen Failure|0|||
155284942|NCT02696785|560474453|FG002|Blinded Treatment Period|Screen Failure|0|||
155284943|NCT02696785|560474454|FG003|Blinded Treatment Period|Screen Failure|0|||
155284944|NCT02696785|560474451|FG000|Washout Period|Withdrawal by Subject|0|||
155284945|NCT02696785|560474452|FG001|Washout Period|Withdrawal by Subject|1|||
155284946|NCT02696785|560474453|FG002|Washout Period|Withdrawal by Subject|0|||
155284947|NCT02696785|560474454|FG003|Washout Period|Withdrawal by Subject|0|||
155284948|NCT02696785|560474451|FG000|Washout Period|Lack of Efficacy|0|||
155284949|NCT02696785|560474452|FG001|Washout Period|Lack of Efficacy|1|||
155284950|NCT02696785|560474453|FG002|Washout Period|Lack of Efficacy|0|||
155284951|NCT02696785|560474454|FG003|Washout Period|Lack of Efficacy|0|||
155403028|NCT00841568|560909903|FG000|Overall Study|Death|1|||
155403029|NCT00841568|560909903|FG000|Overall Study|Withdrawal by Subject|2|||
155284952|NCT02696785|560474451|FG000|Extended Treatment Period|Adverse Event|2|||
155403030|NCT00841568|560909903|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
155403031|NCT03002155|560909904|FG000|Overall Study|Lost to Follow-up|1|||
155403032|NCT03002155|560909905|FG001|Overall Study|Lost to Follow-up|2|||
155403033|NCT03002155|560909904|FG000|Overall Study|Withdrawal by Subject|1|||
155637339|NCT05028569|561764731|FG004|Double-Blind Phase|Protocol Deviation|0|||
155284953|NCT02696785|560474452|FG001|Extended Treatment Period|Adverse Event|3|||
155284954|NCT02696785|560474453|FG002|Extended Treatment Period|Adverse Event|2|||
155284955|NCT02696785|560474454|FG003|Extended Treatment Period|Adverse Event|1|||
155284956|NCT02696785|560474451|FG000|Extended Treatment Period|Lack of Efficacy|0|||
155403034|NCT03002155|560909905|FG001|Overall Study|Withdrawal by Subject|0|||
155403035|NCT03002155|560909904|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
155403036|NCT03002155|560909905|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
155403037|NCT00978029|560909906|FG000|Overall Study|Adverse Event|1|||
155403038|NCT00978029|560909907|FG001|Overall Study|Adverse Event|2|||
155403039|NCT00978029|560909908|FG002|Overall Study|Adverse Event|5|||
155403040|NCT00978029|560909906|FG000|Overall Study|Withdrawal by Subject|0|||
155403041|NCT00978029|560909907|FG001|Overall Study|Withdrawal by Subject|0|||
155403042|NCT00978029|560909908|FG002|Overall Study|Withdrawal by Subject|1|||
155403043|NCT00978029|560909906|FG000|Overall Study|Protocol Violation|0|||
155403044|NCT00978029|560909907|FG001|Overall Study|Protocol Violation|1|||
155403045|NCT00978029|560909908|FG002|Overall Study|Protocol Violation|0|||
155403046|NCT00545298|560909909|FG000|Overall Study|Issues with Standard of Care|2|||
155403047|NCT00545298|560909910|FG001|Overall Study|Issues with Standard of Care|0|||
155403048|NCT00545298|560909911|FG002|Overall Study|Issues with Standard of Care|1|||
155403049|NCT01793142|560909912|FG000|Overall Study|Randomized not treated|7|||
155403050|NCT01820364|560909913|FG000|Part I: LGX818|Death|1|||
155403051|NCT01820364|560909914|FG001|Part I: LGX818|Death|0|||
155403052|NCT01820364|560909913|FG000|Part I: LGX818|Administrative Problems|3|||
155403053|NCT01820364|560909914|FG001|Part I: LGX818|Administrative Problems|0|||
155403054|NCT01820364|560909913|FG000|Part I: LGX818|Adverse Event|6|||
155637340|NCT05028569|561764732|FG005|Double-Blind Phase|Protocol Deviation|0|||
155637341|NCT05028569|561764733|FG006|Double-Blind Phase|Protocol Deviation|0|||
155637342|NCT05028569|561764727|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155284957|NCT02696785|560474452|FG001|Extended Treatment Period|Lack of Efficacy|1|||
155284958|NCT02696785|560474453|FG002|Extended Treatment Period|Lack of Efficacy|0|||
155284959|NCT02696785|560474454|FG003|Extended Treatment Period|Lack of Efficacy|0|||
155284960|NCT02696785|560474451|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
155284961|NCT02696785|560474452|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
155284962|NCT02696785|560474453|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
155284963|NCT02696785|560474454|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
155284964|NCT02696785|560474451|FG000|Follow-up Period|Adverse Event|0|||
155284965|NCT02696785|560474452|FG001|Follow-up Period|Adverse Event|0|||
155284966|NCT02696785|560474453|FG002|Follow-up Period|Adverse Event|8|||
155284967|NCT02696785|560474454|FG003|Follow-up Period|Adverse Event|2|||
155284968|NCT02696785|560474451|FG000|Follow-up Period|Lost to Follow-up|0|||
155284969|NCT02696785|560474452|FG001|Follow-up Period|Lost to Follow-up|0|||
155284970|NCT02696785|560474453|FG002|Follow-up Period|Lost to Follow-up|0|||
155284971|NCT02696785|560474454|FG003|Follow-up Period|Lost to Follow-up|1|||
155284972|NCT02696785|560474451|FG000|Follow-up Period|Lack of Efficacy|0|||
155284973|NCT02696785|560474452|FG001|Follow-up Period|Lack of Efficacy|0|||
155284974|NCT02696785|560474453|FG002|Follow-up Period|Lack of Efficacy|0|||
155284975|NCT02696785|560474454|FG003|Follow-up Period|Lack of Efficacy|1|||
155284976|NCT02696785|560474451|FG000|Follow-up Period|Withdrawal by Subject|1|||
155284977|NCT02696785|560474452|FG001|Follow-up Period|Withdrawal by Subject|0|||
155284978|NCT02696785|560474453|FG002|Follow-up Period|Withdrawal by Subject|5|||
155284979|NCT02696785|560474454|FG003|Follow-up Period|Withdrawal by Subject|4|||
155284980|NCT04863898|560474458|FG000|Overall Study|Away from study clinic during intervention training period|2|||
155284981|NCT04863898|560474458|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
155284982|NCT04863898|560474458|FG000|Overall Study|Lost to Follow-up|3|||
155284983|NCT04863898|560474458|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
155284984|NCT04863898|560474458|FG000|Overall Study|No longer employed at clinic|3|||
155284985|NCT00614744|560474459|FG000|Overall Study|Lost to Follow-up|5|||
155284986|NCT00614744|560474460|FG001|Overall Study|Lost to Follow-up|4|||
155284987|NCT00614744|560474459|FG000|Overall Study|Incomplete for Behavior Issues|0|||
155284988|NCT00614744|560474460|FG001|Overall Study|Incomplete for Behavior Issues|2|||
155284989|NCT02431533|560474461|FG000|Overall Study|Withdrawal by Subject|1|||
155284990|NCT02431533|560474462|FG001|Overall Study|Withdrawal by Subject|3|||
155284991|NCT02431533|560474461|FG000|Overall Study|Developed Exclusionary criteria|1|||
155637343|NCT05028569|561764728|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
155637344|NCT05028569|561764729|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
155403055|NCT01820364|560909914|FG001|Part I: LGX818|Adverse Event|0|||
155403056|NCT01820364|560909913|FG000|Part I: LGX818|Disease Progression|4|||
155403057|NCT01820364|560909914|FG001|Part I: LGX818|Disease Progression|0|||
155403058|NCT01820364|560909913|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
155403059|NCT01820364|560909914|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
155403060|NCT01087775|560909915|FG000|Overall Study|failed inclusion criteria|2|||
155403061|NCT00974675|560909916|FG000|Overall Study|Adverse Event|2|||
155403062|NCT00974675|560909917|FG001|Overall Study|Adverse Event|1|||
155403063|NCT00974675|560909918|FG002|Overall Study|Adverse Event|1|||
155403064|NCT00974675|560909919|FG003|Overall Study|Adverse Event|1|||
155403065|NCT00974675|560909916|FG000|Overall Study|Physician Decision|0|||
155403066|NCT00974675|560909917|FG001|Overall Study|Physician Decision|0|||
155403067|NCT00974675|560909918|FG002|Overall Study|Physician Decision|1|||
155403068|NCT00974675|560909919|FG003|Overall Study|Physician Decision|0|||
155403069|NCT00974675|560909916|FG000|Overall Study|Participant on holiday; unable to attend|0|||
155403070|NCT00974675|560909917|FG001|Overall Study|Participant on holiday; unable to attend|0|||
155403071|NCT00974675|560909918|FG002|Overall Study|Participant on holiday; unable to attend|0|||
155403072|NCT00974675|560909919|FG003|Overall Study|Participant on holiday; unable to attend|1|||
155403073|NCT00825162|560909920|FG000|Overall Study|Withdrawal by Subject|11|||
155403074|NCT00825162|560909921|FG001|Overall Study|Withdrawal by Subject|13|||
155403075|NCT00825162|560909922|FG002|Overall Study|Withdrawal by Subject|3|||
155403076|NCT00825162|560909920|FG000|Overall Study|Lost to Follow-up|9|||
155403077|NCT00825162|560909921|FG001|Overall Study|Lost to Follow-up|6|||
155403078|NCT00825162|560909922|FG002|Overall Study|Lost to Follow-up|3|||
155403079|NCT00825162|560909920|FG000|Overall Study|Physician Decision|2|||
155403080|NCT00825162|560909921|FG001|Overall Study|Physician Decision|0|||
155403081|NCT00825162|560909922|FG002|Overall Study|Physician Decision|0|||
155403082|NCT00825162|560909920|FG000|Overall Study|Move away from the study area|1|||
155403083|NCT00825162|560909921|FG001|Overall Study|Move away from the study area|0|||
155403084|NCT00825162|560909922|FG002|Overall Study|Move away from the study area|0|||
155403085|NCT00825162|560909920|FG000|Overall Study|Unable to attend the study visit|5|||
155403086|NCT00825162|560909921|FG001|Overall Study|Unable to attend the study visit|2|||
155403087|NCT00825162|560909922|FG002|Overall Study|Unable to attend the study visit|0|||
155403088|NCT03803059|560909923|FG000|Overall Study|Protocol Violation|2|||
155403089|NCT03803059|560909923|FG000|Overall Study|Lost to Follow-up|1|||
155403090|NCT01293968|560909926|FG000|Overall Study|non-cooperation|3|||
155403091|NCT01293968|560909927|FG001|Overall Study|non-cooperation|3|||
155403092|NCT03996876|560909930|FG000|Overall Study|Incomplete Data|2|||
155403093|NCT03996876|560909931|FG001|Overall Study|Incomplete Data|4|||
155403094|NCT00121108|560909932|FG000|Overall Study|Lost to Follow-up|10|||
155403095|NCT00121108|560909933|FG001|Overall Study|Lost to Follow-up|22|||
155403096|NCT00121108|560909932|FG000|Overall Study|Withdrawal by Subject|106|||
155403097|NCT00121108|560909933|FG001|Overall Study|Withdrawal by Subject|195|||
155403098|NCT00121108|560909932|FG000|Overall Study|Death|5|||
155403099|NCT00121108|560909933|FG001|Overall Study|Death|8|||
155637345|NCT05028569|561764730|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
155403100|NCT00747643|560911463|FG000|Overall Study|Withdrawal by Subject|36|||
155403101|NCT00747643|560911464|FG001|Overall Study|Withdrawal by Subject|27|||
155403102|NCT00390546|560911467|FG000|Overall Study|Renal impairment|1|||
155403103|NCT00390546|560911468|FG001|Overall Study|Renal impairment|0|||
155403104|NCT00390546|560911467|FG000|Overall Study|Physician Decision|5|||
155403105|NCT00390546|560911468|FG001|Overall Study|Physician Decision|5|||
155403106|NCT01308008|560911469|FG000|4 Weeks|Illness, disinterest, time|9|||
155403107|NCT01308008|560911470|FG001|4 Weeks|Illness, disinterest, time|2|||
155403108|NCT01417195|560911471|FG000|Overall Study|Stimulation failure|1|||
155403109|NCT01417195|560911472|FG001|Overall Study|Stimulation failure|0|||
155403110|NCT01417195|560911471|FG000|Overall Study|No embryos for transfer|0|||
155403111|NCT01417195|560911472|FG001|Overall Study|No embryos for transfer|1|||
155403112|NCT01417195|560911471|FG000|Overall Study|No transfer due to risk of OHSS|1|||
155403113|NCT01417195|560911472|FG001|Overall Study|No transfer due to risk of OHSS|0|||
155403114|NCT01417195|560911471|FG000|Overall Study|No transfer due to elevated progesterone|1|||
155403115|NCT01417195|560911472|FG001|Overall Study|No transfer due to elevated progesterone|0|||
155403116|NCT01239342|560911473|FG000|Overall Study|Adverse Event|1|||
155403117|NCT01239342|560911474|FG001|Overall Study|Adverse Event|0|||
155403118|NCT01239342|560911473|FG000|Overall Study|Withdrawal by Subject|1|||
155403119|NCT01239342|560911474|FG001|Overall Study|Withdrawal by Subject|5|||
155403120|NCT01239342|560911473|FG000|Overall Study|Reason Unknown|1|||
155403121|NCT01239342|560911474|FG001|Overall Study|Reason Unknown|1|||
155403122|NCT02918864|560911475|FG000|Overall Study|Withdrawal by Subject|1|||
155403123|NCT02918864|560911476|FG001|Overall Study|Withdrawal by Subject|1|||
155403124|NCT02918864|560911475|FG000|Overall Study|Lost to Follow-up|3|||
155403125|NCT02918864|560911476|FG001|Overall Study|Lost to Follow-up|2|||
155403126|NCT02257372|560911482|FG000|Overall Study|Adverse Event|3|||
155403127|NCT02257372|560911483|FG001|Overall Study|Adverse Event|7|||
155403128|NCT02257372|560911482|FG000|Overall Study|Lack of Efficacy|2|||
155403129|NCT02257372|560911483|FG001|Overall Study|Lack of Efficacy|1|||
155403130|NCT02257372|560911482|FG000|Overall Study|Protocol Violation|1|||
155403131|NCT02257372|560911483|FG001|Overall Study|Protocol Violation|1|||
155403132|NCT02257372|560911482|FG000|Overall Study|Lost to Follow-up|0|||
155403133|NCT02257372|560911483|FG001|Overall Study|Lost to Follow-up|1|||
155403134|NCT02257372|560911482|FG000|Overall Study|Withdrew consent|1|||
155403135|NCT02257372|560911483|FG001|Overall Study|Withdrew consent|0|||
155403136|NCT00880399|560911486|FG000|Overall Study|Adverse Event|4|||
155403137|NCT00880399|560911487|FG001|Overall Study|Adverse Event|6|||
155403138|NCT00880399|560911488|FG002|Overall Study|Adverse Event|5|||
155403139|NCT00880399|560911486|FG000|Overall Study|Lack of Efficacy|1|||
155403140|NCT00880399|560911487|FG001|Overall Study|Lack of Efficacy|4|||
155403141|NCT00880399|560911488|FG002|Overall Study|Lack of Efficacy|2|||
155403142|NCT00880399|560911486|FG000|Overall Study|Protocol Violation|4|||
155403143|NCT00880399|560911487|FG001|Overall Study|Protocol Violation|4|||
155403144|NCT00880399|560911488|FG002|Overall Study|Protocol Violation|6|||
155403145|NCT00880399|560911486|FG000|Overall Study|Study closed/terminated|3|||
155403146|NCT00880399|560911487|FG001|Overall Study|Study closed/terminated|7|||
155403147|NCT00880399|560911488|FG002|Overall Study|Study closed/terminated|4|||
155403148|NCT00880399|560911486|FG000|Overall Study|Lost to Follow-up|8|||
155403149|NCT00880399|560911487|FG001|Overall Study|Lost to Follow-up|5|||
155403150|NCT00880399|560911488|FG002|Overall Study|Lost to Follow-up|3|||
155403151|NCT00880399|560911486|FG000|Overall Study|Physician Decision|5|||
155403152|NCT00880399|560911487|FG001|Overall Study|Physician Decision|0|||
155403153|NCT00880399|560911488|FG002|Overall Study|Physician Decision|3|||
155403154|NCT00880399|560911486|FG000|Overall Study|Withdrawal by Subject|6|||
155403155|NCT00880399|560911487|FG001|Overall Study|Withdrawal by Subject|3|||
155403156|NCT00880399|560911488|FG002|Overall Study|Withdrawal by Subject|3|||
155403157|NCT04353284|560911489|FG000|Overall Study|Adverse Event|1|||
155403158|NCT04353284|560911490|FG001|Overall Study|Adverse Event|1|||
155403159|NCT04353284|560911489|FG000|Overall Study|Lost to Follow-up|1|||
155403160|NCT04353284|560911490|FG001|Overall Study|Lost to Follow-up|0|||
155403161|NCT04773106|560911497|FG000|Overall Study|Withdrawal by Subject|3|||
155403162|NCT04773106|560911497|FG000|Overall Study|Death|1|||
155403163|NCT00530894|560911500|FG000|Overall Study|Death|84|||
155403164|NCT00530894|560911501|FG001|Overall Study|Death|89|||
155403165|NCT00530894|560911502|FG002|Overall Study|Death|55|||
155637346|NCT05028569|561764731|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155637347|NCT05028569|561764732|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
155637348|NCT05028569|561764733|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
155403166|NCT00530894|560911503|FG003|Overall Study|Death|89|||
155403167|NCT00530894|560911500|FG000|Overall Study|Lost to Follow-up|1|||
155403168|NCT00530894|560911501|FG001|Overall Study|Lost to Follow-up|3|||
155403169|NCT00530894|560911502|FG002|Overall Study|Lost to Follow-up|0|||
155403170|NCT00530894|560911503|FG003|Overall Study|Lost to Follow-up|0|||
155403171|NCT00530894|560911500|FG000|Overall Study|Withdrawal by Subject|1|||
155403172|NCT00530894|560911501|FG001|Overall Study|Withdrawal by Subject|23|||
155403173|NCT00530894|560911502|FG002|Overall Study|Withdrawal by Subject|0|||
155403174|NCT00530894|560911503|FG003|Overall Study|Withdrawal by Subject|5|||
155403175|NCT00530894|560911500|FG000|Overall Study|Alive and censored prior to 1 year|2|||
155403176|NCT00530894|560911501|FG001|Overall Study|Alive and censored prior to 1 year|0|||
155403177|NCT00530894|560911502|FG002|Overall Study|Alive and censored prior to 1 year|0|||
155403178|NCT00530894|560911503|FG003|Overall Study|Alive and censored prior to 1 year|0|||
155403179|NCT01349465|560911504|FG000|Overall Study|Adverse Event|1|||
155403180|NCT01349465|560911505|FG001|Overall Study|Adverse Event|0|||
155403181|NCT01349465|560911504|FG000|Overall Study|Death|3|||
155403182|NCT01349465|560911505|FG001|Overall Study|Death|0|||
155403183|NCT01349465|560911504|FG000|Overall Study|Lost to Follow-up|10|||
155403184|NCT01349465|560911505|FG001|Overall Study|Lost to Follow-up|1|||
155403185|NCT01349465|560911504|FG000|Overall Study|Withdrawal by Subject|4|||
155403186|NCT01349465|560911505|FG001|Overall Study|Withdrawal by Subject|2|||
155403187|NCT01349465|560911504|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
155403188|NCT01349465|560911505|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
155403189|NCT01230242|560911506|FG000|Overall Study|Physician Decision|2|||
155403190|NCT01230242|560911506|FG000|Overall Study|Withdrawal by Subject|1|||
155403191|NCT04329702|560911509|FG000|Overall Study|illness|3|||
155403192|NCT04329702|560911510|FG001|Overall Study|illness|4|||
155403193|NCT04329702|560911511|FG002|Overall Study|illness|0|||
155403194|NCT04329702|560911509|FG000|Overall Study|Lost to Follow-up|0|||
155403195|NCT04329702|560911510|FG001|Overall Study|Lost to Follow-up|0|||
155403196|NCT04329702|560911511|FG002|Overall Study|Lost to Follow-up|2|||
155403197|NCT04329702|560911509|FG000|Overall Study|Death|0|||
155403198|NCT04329702|560911510|FG001|Overall Study|Death|2|||
155403199|NCT04329702|560911511|FG002|Overall Study|Death|0|||
155403200|NCT00766532|560911512|FG000|Overall Study|Protocol Violation|2|||
155403201|NCT01438489|560911513|FG000|Overall Study|Lost to Follow-up|4|||
155403202|NCT01438489|560911514|FG001|Overall Study|Lost to Follow-up|2|||
155403203|NCT01438489|560911515|FG002|Overall Study|Lost to Follow-up|2|||
155403204|NCT01438489|560911513|FG000|Overall Study|Withdrawal by Subject|11|||
155403205|NCT01438489|560911514|FG001|Overall Study|Withdrawal by Subject|3|||
155403206|NCT01438489|560911515|FG002|Overall Study|Withdrawal by Subject|8|||
155403207|NCT01438489|560911513|FG000|Overall Study|Death|0|||
155403208|NCT01438489|560911514|FG001|Overall Study|Death|0|||
155403209|NCT01438489|560911515|FG002|Overall Study|Death|1|||
155403210|NCT01438489|560911513|FG000|Overall Study|Sponsor decision|4|||
155403211|NCT01438489|560911514|FG001|Overall Study|Sponsor decision|1|||
155403212|NCT01438489|560911515|FG002|Overall Study|Sponsor decision|4|||
155403213|NCT01438489|560911513|FG000|Overall Study|Subject choice/Subject moved|2|||
155403214|NCT01438489|560911514|FG001|Overall Study|Subject choice/Subject moved|1|||
155403215|NCT01438489|560911515|FG002|Overall Study|Subject choice/Subject moved|1|||
155403216|NCT01438489|560911513|FG000|Overall Study|Investigator decision|0|||
155403217|NCT01438489|560911514|FG001|Overall Study|Investigator decision|1|||
155403218|NCT01438489|560911515|FG002|Overall Study|Investigator decision|0|||
155403219|NCT01438489|560911513|FG000|Overall Study|AE/SAEs|2|||
155403220|NCT01438489|560911514|FG001|Overall Study|AE/SAEs|1|||
155403221|NCT01438489|560911515|FG002|Overall Study|AE/SAEs|1|||
155403222|NCT01438489|560911513|FG000|Overall Study|Received prohibited medication|1|||
155403223|NCT01438489|560911514|FG001|Overall Study|Received prohibited medication|0|||
155403224|NCT01438489|560911515|FG002|Overall Study|Received prohibited medication|0|||
155403225|NCT01438489|560911513|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
155403226|NCT01438489|560911514|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
155403227|NCT01438489|560911515|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
155403228|NCT01438489|560911513|FG000|Overall Study|Inadequate venous access|0|||
155403229|NCT01438489|560911514|FG001|Overall Study|Inadequate venous access|2|||
155403230|NCT01438489|560911515|FG002|Overall Study|Inadequate venous access|0|||
155403231|NCT01372384|560911517|FG000|Overall Study|Progression of disease|3|||
155403232|NCT02576444|560911524|FG000|Overall Study|Death|1|||
155403233|NCT02576444|560911525|FG001|Overall Study|Death|1|||
155403234|NCT02576444|560911526|FG002|Overall Study|Death|0|||
155403235|NCT02576444|560911527|FG003|Overall Study|Death|0|||
155403236|NCT02576444|560911524|FG000|Overall Study|Withdrawal by Subject|0|||
155403237|NCT02576444|560911525|FG001|Overall Study|Withdrawal by Subject|0|||
155403238|NCT02576444|560911526|FG002|Overall Study|Withdrawal by Subject|2|||
155403239|NCT02576444|560911527|FG003|Overall Study|Withdrawal by Subject|0|||
155403240|NCT02576444|560911524|FG000|Overall Study|Adverse Event|0|||
155403241|NCT02576444|560911525|FG001|Overall Study|Adverse Event|0|||
155403242|NCT02576444|560911526|FG002|Overall Study|Adverse Event|1|||
155403243|NCT02576444|560911527|FG003|Overall Study|Adverse Event|0|||
155403244|NCT02576444|560911524|FG000|Overall Study|Physician Decision|0|||
155637349|NCT05028569|561764727|FG000|Double-Blind Phase|Other, not specified|0|||
155637350|NCT05028569|561764728|FG001|Double-Blind Phase|Other, not specified|5|||
155637351|NCT05028569|561764729|FG002|Double-Blind Phase|Other, not specified|4|||
155403245|NCT02576444|560911525|FG001|Overall Study|Physician Decision|0|||
155403246|NCT02576444|560911526|FG002|Overall Study|Physician Decision|1|||
155403247|NCT02576444|560911527|FG003|Overall Study|Physician Decision|0|||
155403248|NCT03370120|560911534|FG000|Overall Study|Adverse event, non-fatal|24|||
155403249|NCT03370120|560911534|FG000|Overall Study|Withdrawal by Subject|6|||
155403250|NCT03370120|560911534|FG000|Overall Study|Lost to Follow-up|1|||
155403251|NCT03370120|560911534|FG000|Overall Study|Lack of Efficacy|37|||
155403252|NCT03370120|560911534|FG000|Overall Study|Per sponsor's instructions|1|||
155403253|NCT03370120|560911534|FG000|Overall Study|Study was terminated by parent company UCB|2|||
155403254|NCT03370120|560911534|FG000|Overall Study|The study was ended by the promoter|3|||
155403255|NCT03370120|560911534|FG000|Overall Study|Discontinuation of drug development|3|||
155403256|NCT03370120|560911534|FG000|Overall Study|End of project|2|||
155403257|NCT03370120|560911534|FG000|Overall Study|Premature study closure|2|||
155403258|NCT03370120|560911534|FG000|Overall Study|Premature program termination|1|||
155403259|NCT03370120|560911534|FG000|Overall Study|Premature study termination|7|||
155403260|NCT03370120|560911534|FG000|Overall Study|Trial terminated by sponsor|2|||
155403261|NCT03370120|560911534|FG000|Overall Study|Trial discontinued by sponsor|2|||
155403262|NCT03370120|560911534|FG000|Overall Study|Study ended|15|||
155403263|NCT03370120|560911534|FG000|Overall Study|Clinical trial has been cancelled|1|||
155403264|NCT03370120|560911534|FG000|Overall Study|End of study per sponsor decision|2|||
155403265|NCT03370120|560911534|FG000|Overall Study|Promoter's decision|2|||
155403266|NCT03370120|560911534|FG000|Overall Study|The trial has been suspended|3|||
155403267|NCT03370120|560911534|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
155403268|NCT03370120|560911534|FG000|Overall Study|Early termination by order of sponsor|2|||
155403269|NCT03370120|560911534|FG000|Overall Study|Discontinuation of the study|5|||
155403270|NCT03370120|560911534|FG000|Overall Study|End of clinical trial discontinuation|1|||
155403271|NCT03370120|560911534|FG000|Overall Study|Because the clinical trial ended halfway|4|||
155403272|NCT03370120|560911534|FG000|Overall Study|Development discontinued|5|||
155403273|NCT03370120|560911534|FG000|Overall Study|Padsenovil program closed|3|||
155403274|NCT03370120|560911534|FG000|Overall Study|End of project|2|||
155403275|NCT03370120|560911534|FG000|Overall Study|Termination of project|1|||
155403276|NCT03370120|560911534|FG000|Overall Study|The study was interrupted by sponsor|4|||
155403277|NCT03370120|560911534|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
155403278|NCT03370120|560911534|FG000|Overall Study|End of sponsor decision|1|||
155403279|NCT03370120|560911534|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
155403280|NCT03370120|560911534|FG000|Overall Study|Early termination of studies|5|||
155403281|NCT03370120|560911534|FG000|Overall Study|This study is ended early|1|||
155403282|NCT03370120|560911534|FG000|Overall Study|End of padsevonil program|2|||
155403283|NCT03370120|560911534|FG000|Overall Study|Decision of sponsor|6|||
155403284|NCT03370120|560911534|FG000|Overall Study|Asked by the sponsor|3|||
155403285|NCT03370120|560911534|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
155403286|NCT03370120|560911534|FG000|Overall Study|PI decision poor compliance from participant|1|||
155403287|NCT03370120|560911534|FG000|Overall Study|Promoter ended the study|3|||
155403288|NCT03370120|560911534|FG000|Overall Study|Premature study close by sponsor's decision|4|||
155403289|NCT03370120|560911534|FG000|Overall Study|Study terminated by sponsor|33|||
155435868|NCT01919411|561022980|FG000|Overall Study|Lost to Follow-up|2|||
155403290|NCT03370120|560911534|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
155403291|NCT03370120|560911534|FG000|Overall Study|Sponsor decision to terminate study|63|||
155403292|NCT03370120|560911534|FG000|Overall Study|Program closure|3|||
155403293|NCT03370120|560911534|FG000|Overall Study|Study ended prematurely|1|||
155403294|NCT03370120|560911534|FG000|Overall Study|Study stopped by sponsor|2|||
155403295|NCT03370120|560911534|FG000|Overall Study|Program termination|55|||
155403296|NCT03370120|560911534|FG000|Overall Study|Sponsor decision|62|||
155403297|NCT03370120|560911534|FG000|Overall Study|Sponsor study closure|10|||
155403298|NCT02700412|560911538|FG000|Overall Study|Adverse Event|6|||
155403299|NCT02700412|560911538|FG000|Overall Study|Death|1|||
155403300|NCT02700412|560911538|FG000|Overall Study|Lack of Efficacy|19|||
155403301|NCT02700412|560911538|FG000|Overall Study|Protocol Violation|5|||
155403302|NCT02700412|560911538|FG000|Overall Study|Withdrawal by Subject|2|||
155403303|NCT00928889|560911539|FG000|Overall Study|Lost to Follow-up|3|||
155403304|NCT00928889|560911540|FG001|Overall Study|Lost to Follow-up|1|||
155403305|NCT00928889|560911539|FG000|Overall Study|Protocol Violation|0|||
155403306|NCT00928889|560911540|FG001|Overall Study|Protocol Violation|1|||
155403307|NCT00928889|560911539|FG000|Overall Study|Adverse Event|1|||
155403308|NCT00928889|560911540|FG001|Overall Study|Adverse Event|0|||
155637352|NCT05028569|561764730|FG003|Double-Blind Phase|Other, not specified|6|||
155403309|NCT00928889|560911539|FG000|Overall Study|Other|1|||
155403310|NCT00928889|560911540|FG001|Overall Study|Other|0|||
155403311|NCT04416555|560911544|FG000|Overall Study|Withdrawal by Subject|0|||
155403312|NCT04416555|560911545|FG001|Overall Study|Withdrawal by Subject|3|||
155403313|NCT01923285|560911554|FG000|Overall Study|Withdrawal by Subject|7|||
155403314|NCT01923285|560911555|FG001|Overall Study|Withdrawal by Subject|6|||
155403315|NCT01356407|560911556|FG000|Overall Study|Lost to Follow-up|2|||
155403316|NCT01356407|560911557|FG001|Overall Study|Lost to Follow-up|0|||
155403317|NCT01356407|560911556|FG000|Overall Study|Patient Withdrew Consent|2|||
155403318|NCT01356407|560911557|FG001|Overall Study|Patient Withdrew Consent|1|||
155403319|NCT01356407|560911556|FG000|Overall Study|Could not afford IMP administration|0|||
155403320|NCT01356407|560911557|FG001|Overall Study|Could not afford IMP administration|1|||
155403321|NCT01356407|560911556|FG000|Overall Study|Not complete Endoscopy|2|||
155403322|NCT01356407|560911557|FG001|Overall Study|Not complete Endoscopy|2|||
155403323|NCT01309659|560911558|FG000|Overall Study|Protocol Violation|0|||
155403324|NCT01309659|560911559|FG001|Overall Study|Protocol Violation|1|||
155403325|NCT02184195|560911561|FG000|Overall Study|Patient decision|5|||
155403326|NCT02184195|560911562|FG001|Overall Study|Patient decision|2|||
155403327|NCT02184195|560911561|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155403328|NCT02184195|560911562|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155403329|NCT02184195|560911561|FG000|Overall Study|Death|67|||
155403330|NCT02184195|560911562|FG001|Overall Study|Death|44|||
155403331|NCT02184195|560911561|FG000|Overall Study|Lost to Follow-up|1|||
155403332|NCT02184195|560911562|FG001|Overall Study|Lost to Follow-up|5|||
155403333|NCT02184195|560911561|FG000|Overall Study|Other|0|||
155403334|NCT02184195|560911562|FG001|Overall Study|Other|3|||
155403335|NCT02716987|560911565|FG000|Overall Study|Ligand synthesis failure|0|||
155403336|NCT02716987|560911566|FG001|Overall Study|Ligand synthesis failure|0|||
155403337|NCT02716987|560911567|FG002|Overall Study|Ligand synthesis failure|1|||
155403338|NCT02716987|560911568|FG003|Overall Study|Ligand synthesis failure|0|||
155403339|NCT02716987|560911569|FG004|Overall Study|Ligand synthesis failure|0|||
155403340|NCT02716987|560911570|FG005|Overall Study|Ligand synthesis failure|0|||
155403341|NCT02716987|560911565|FG000|Overall Study|Withdrawal by Subject|0|||
155403342|NCT02716987|560911566|FG001|Overall Study|Withdrawal by Subject|0|||
155403343|NCT02716987|560911567|FG002|Overall Study|Withdrawal by Subject|0|||
155403344|NCT02716987|560911568|FG003|Overall Study|Withdrawal by Subject|0|||
155403345|NCT02716987|560911569|FG004|Overall Study|Withdrawal by Subject|1|||
155403346|NCT02716987|560911570|FG005|Overall Study|Withdrawal by Subject|1|||
155403347|NCT02829138|560911571|FG000|Overall Study|Withdrawal by Subject|1|||
155403348|NCT02829138|560911572|FG001|Overall Study|Withdrawal by Subject|0|||
155403349|NCT04744207|560911574|FG000|Treatment|Withdrawal by Subject|2|||
155403350|NCT04744207|560911575|FG001|Treatment|Withdrawal by Subject|0|||
155403351|NCT04744207|560911574|FG000|Treatment|Adverse Event|1|||
155403352|NCT04744207|560911575|FG001|Treatment|Adverse Event|2|||
155403353|NCT00808236|560911582|FG000|Overall Study|Was not resuscitated|50|||
155403354|NCT00808236|560911583|FG001|Overall Study|Was not resuscitated|56|||
155403355|NCT00808236|560911582|FG000|Overall Study|Pre-defined exclusion|13|||
155403356|NCT00808236|560911583|FG001|Overall Study|Pre-defined exclusion|3|||
155403357|NCT00808236|560911582|FG000|Overall Study|Lost to Follow-up|1|||
155637353|NCT05028569|561764731|FG004|Double-Blind Phase|Other, not specified|0|||
155637354|NCT05028569|561764732|FG005|Double-Blind Phase|Other, not specified|0|||
155403358|NCT00808236|560911583|FG001|Overall Study|Lost to Follow-up|1|||
155403359|NCT00808236|560911582|FG000|Overall Study|Physician Decision|0|||
155403360|NCT00808236|560911583|FG001|Overall Study|Physician Decision|1|||
155403361|NCT00808236|560911582|FG000|Overall Study|Death|18|||
155403362|NCT00808236|560911583|FG001|Overall Study|Death|30|||
155637355|NCT05028569|561764733|FG006|Double-Blind Phase|Other, not specified|0|||
155403363|NCT00961220|560911584|FG000|Overall Study|Adverse Event|3|||
155403364|NCT00961220|560911584|FG000|Overall Study|Lack of Efficacy|1|||
155403365|NCT00961220|560911584|FG000|Overall Study|No IV access for O6BG|1|||
155403366|NCT00961220|560911584|FG000|Overall Study|O6BG no longer supplied|1|||
155403367|NCT00961220|560911584|FG000|Overall Study|Complete Response prior to 12 courses|1|||
155403368|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
155403369|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
155403370|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
155403371|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
155403372|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
155403373|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
155403374|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
155403375|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
155403376|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
155403377|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
155403378|NCT04041284|560911587|FG000|DB Phase (12 Weeks)|Other than specified|1|||
155403379|NCT04041284|560911588|FG001|DB Phase (12 Weeks)|Other than specified|0|||
155403380|NCT04041284|560911587|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
155403381|NCT04041284|560911588|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
155403382|NCT04041284|560911587|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
155403383|NCT04041284|560911588|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
155403384|NCT04041284|560911587|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
155403385|NCT04041284|560911588|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
155403386|NCT04041284|560911587|FG000|OL Phase (12 Weeks)|Other than specified|6|||
155403387|NCT04041284|560911588|FG001|OL Phase (12 Weeks)|Other than specified|2|||
155403388|NCT00258674|560911595|FG000|Overall Study|Death|32|||
155403389|NCT00258674|560911596|FG001|Overall Study|Death|53|||
155403390|NCT00258674|560911597|FG002|Overall Study|Death|34|||
155403391|NCT00432042|560911602|FG000|Overall Study|Protocol Violation|2|||
155403392|NCT00432042|560911603|FG001|Overall Study|Protocol Violation|0|||
155403393|NCT00432042|560911604|FG002|Overall Study|Protocol Violation|0|||
155403394|NCT00432042|560911602|FG000|Overall Study|Withdrawal by Subject|0|||
155403395|NCT00432042|560911603|FG001|Overall Study|Withdrawal by Subject|0|||
155403396|NCT00432042|560911604|FG002|Overall Study|Withdrawal by Subject|2|||
155403397|NCT00432042|560911602|FG000|Overall Study|Lost to Follow-up|5|||
155403398|NCT00432042|560911603|FG001|Overall Study|Lost to Follow-up|1|||
155403399|NCT00432042|560911604|FG002|Overall Study|Lost to Follow-up|0|||
155403400|NCT01744665|560911606|FG000|Monitoring Phase|Adverse Event|4|||
155403401|NCT01744665|560911606|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
155403402|NCT01744665|560911606|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
155403403|NCT01744665|560911606|FG000|Monitoring Phase|Withdrawal by Subject|5|||
155403404|NCT01744665|560911606|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
155403405|NCT01744665|560911606|FG000|Consolidation Phase|Adverse Event|2|||
155403406|NCT01744665|560911606|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
155403407|NCT01744665|560911606|FG000|Consolidation Phase|Withdrawal by Subject|4|||
155403408|NCT01744665|560911606|FG000|Consolidation Phase|Administrative problems|9|||
155403409|NCT01744665|560911606|FG000|Re-initiation Phase|Administrative problems|10|||
155403410|NCT01744665|560911606|FG000|Re-initiation Phase|Adverse Event|1|||
155403411|NCT01744665|560911606|FG000|Re-initiation Phase|No longer required treatment|1|||
155403412|NCT01744665|560911606|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
155403413|NCT00492752|560911607|FG000|Double Blind Treatment|Death|13|||
155403414|NCT00492752|560911608|FG001|Double Blind Treatment|Death|0|||
155403415|NCT00492752|560911609|FG002|Double Blind Treatment|Death|2|||
155403416|NCT00492752|560911610|FG003|Double Blind Treatment|Death|0|||
155403417|NCT00492752|560911607|FG000|Double Blind Treatment|Adverse Event|1|||
155403418|NCT00492752|560911608|FG001|Double Blind Treatment|Adverse Event|0|||
155403419|NCT00492752|560911609|FG002|Double Blind Treatment|Adverse Event|0|||
155403420|NCT00492752|560911610|FG003|Double Blind Treatment|Adverse Event|0|||
155403421|NCT00492752|560911607|FG000|Double Blind Treatment|Protocol Violation|0|||
155403422|NCT00492752|560911608|FG001|Double Blind Treatment|Protocol Violation|0|||
155403423|NCT00492752|560911609|FG002|Double Blind Treatment|Protocol Violation|1|||
155403424|NCT00492752|560911610|FG003|Double Blind Treatment|Protocol Violation|0|||
155403425|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
155403426|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
155403427|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
155403428|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
155403429|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
155403430|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
155403431|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
155403432|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
155403433|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
155403434|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
155403435|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
155284992|NCT02431533|560474462|FG001|Overall Study|Developed Exclusionary criteria|0|||
155403436|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
155435869|NCT01919411|561022981|FG001|Overall Study|Lost to Follow-up|4|||
155403437|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
155403438|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
155403439|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
155284993|NCT00235495|560474465|FG000|Overall Study|Death|52|||
155403440|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
155403441|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
155403442|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
155403443|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
155403444|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
155403445|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
155403446|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
155403447|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
155403448|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
155403449|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
155403450|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
155403451|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
155637356|NCT05028569|561764727|FG000|Open-Label Phase|Death|0|||
155637357|NCT05028569|561764728|FG001|Open-Label Phase|Death|0|||
155637358|NCT05028569|561764729|FG002|Open-Label Phase|Death|0|||
155637359|NCT05028569|561764730|FG003|Open-Label Phase|Death|0|||
155637360|NCT05028569|561764731|FG004|Open-Label Phase|Death|0|||
155637361|NCT05028569|561764732|FG005|Open-Label Phase|Death|0|||
155637362|NCT05028569|561764733|FG006|Open-Label Phase|Death|1|||
155637363|NCT05028569|561764727|FG000|Open-Label Phase|Lost to Follow-up|0|||
155637364|NCT05028569|561764728|FG001|Open-Label Phase|Lost to Follow-up|0|||
155637365|NCT05028569|561764729|FG002|Open-Label Phase|Lost to Follow-up|0|||
155637366|NCT05028569|561764730|FG003|Open-Label Phase|Lost to Follow-up|0|||
155637367|NCT05028569|561764731|FG004|Open-Label Phase|Lost to Follow-up|5|||
155637368|NCT05028569|561764732|FG005|Open-Label Phase|Lost to Follow-up|5|||
155637369|NCT05028569|561764733|FG006|Open-Label Phase|Lost to Follow-up|4|||
155637370|NCT05028569|561764727|FG000|Open-Label Phase|Protocol Deviation|0|||
155637371|NCT05028569|561764728|FG001|Open-Label Phase|Protocol Deviation|0|||
155637372|NCT05028569|561764729|FG002|Open-Label Phase|Protocol Deviation|0|||
155637373|NCT05028569|561764730|FG003|Open-Label Phase|Protocol Deviation|0|||
155637374|NCT05028569|561764731|FG004|Open-Label Phase|Protocol Deviation|1|||
155637375|NCT05028569|561764732|FG005|Open-Label Phase|Protocol Deviation|0|||
155637376|NCT05028569|561764733|FG006|Open-Label Phase|Protocol Deviation|0|||
155637377|NCT05028569|561764727|FG000|Open-Label Phase|Pregnancy|0|||
155637378|NCT05028569|561764728|FG001|Open-Label Phase|Pregnancy|0|||
155637379|NCT05028569|561764729|FG002|Open-Label Phase|Pregnancy|0|||
155637380|NCT05028569|561764730|FG003|Open-Label Phase|Pregnancy|0|||
155637381|NCT05028569|561764731|FG004|Open-Label Phase|Pregnancy|0|||
155637382|NCT05028569|561764732|FG005|Open-Label Phase|Pregnancy|1|||
155637383|NCT05028569|561764733|FG006|Open-Label Phase|Pregnancy|0|||
155637384|NCT05028569|561764727|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155637385|NCT05028569|561764728|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155637386|NCT05028569|561764729|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155637387|NCT05028569|561764730|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155637388|NCT05028569|561764731|FG004|Open-Label Phase|Withdrawal by Subject|15|||
155637389|NCT05028569|561764732|FG005|Open-Label Phase|Withdrawal by Subject|8|||
155637390|NCT05028569|561764733|FG006|Open-Label Phase|Withdrawal by Subject|13|||
155637391|NCT05028569|561764727|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
155637392|NCT05028569|561764728|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
155637393|NCT05028569|561764729|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
155637394|NCT05028569|561764730|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
155637395|NCT05028569|561764731|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
155637396|NCT05028569|561764732|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
155637397|NCT05028569|561764733|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
155637398|NCT05028569|561764727|FG000|Open-Label Phase|Other, not specified|0|||
155637399|NCT05028569|561764728|FG001|Open-Label Phase|Other, not specified|0|||
155637400|NCT05028569|561764729|FG002|Open-Label Phase|Other, not specified|0|||
155637401|NCT05028569|561764730|FG003|Open-Label Phase|Other, not specified|0|||
155637402|NCT05028569|561764731|FG004|Open-Label Phase|Other, not specified|6|||
155284994|NCT00235495|560474466|FG001|Overall Study|Death|42|||
155284995|NCT00235495|560474465|FG000|Overall Study|Withdrawal by Subject|5|||
155403452|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
155403453|NCT00492752|560911607|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
155403454|NCT00492752|560911608|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
155403455|NCT00492752|560911609|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
155403456|NCT00492752|560911610|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
155403457|NCT02222207|560913039|FG000|Overall Study|Death|1|||
155403458|NCT02222207|560913039|FG000|Overall Study|Other reasons|2|||
155403459|NCT02222207|560913039|FG000|Overall Study|Adverse Event|1|||
155403460|NCT04682405|560913040|FG000|Overall Study|Adverse Event|0|||
155403461|NCT04682405|560913041|FG001|Overall Study|Adverse Event|1|||
155403462|NCT03557281|560913042|FG000|Overall Study|Investigator discretion|0|||
155403463|NCT03557281|560913043|FG001|Overall Study|Investigator discretion|0|||
155403464|NCT03557281|560913044|FG002|Overall Study|Investigator discretion|1|||
155403465|NCT03557281|560913045|FG003|Overall Study|Investigator discretion|0|||
155403466|NCT03557281|560913046|FG004|Overall Study|Investigator discretion|0|||
155403467|NCT03557281|560913042|FG000|Overall Study|Withdrawal by Subject|0|||
155403468|NCT03557281|560913043|FG001|Overall Study|Withdrawal by Subject|1|||
155403469|NCT03557281|560913044|FG002|Overall Study|Withdrawal by Subject|1|||
155403470|NCT03557281|560913045|FG003|Overall Study|Withdrawal by Subject|1|||
155403471|NCT03557281|560913046|FG004|Overall Study|Withdrawal by Subject|2|||
155403472|NCT03557281|560913042|FG000|Overall Study|Randomized, but did not receive treatment|0|||
155403473|NCT03557281|560913043|FG001|Overall Study|Randomized, but did not receive treatment|0|||
155403474|NCT03557281|560913044|FG002|Overall Study|Randomized, but did not receive treatment|0|||
155403475|NCT03557281|560913045|FG003|Overall Study|Randomized, but did not receive treatment|0|||
155403476|NCT03557281|560913046|FG004|Overall Study|Randomized, but did not receive treatment|1|||
155403477|NCT01199042|560913047|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
155403478|NCT01199042|560913047|FG000|At Home (3 Months)|Lost to Follow-up|1|||
155403479|NCT03357731|560913050|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
155403480|NCT03357731|560913051|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
155403481|NCT03357731|560913052|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
155403482|NCT03357731|560913053|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
155403483|NCT03357731|560913054|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
155403484|NCT03357731|560913055|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
155403485|NCT03357731|560913050|FG000|Overall Study|Acute bradycardia and hypotension|0|||
155403486|NCT03357731|560913051|FG001|Overall Study|Acute bradycardia and hypotension|0|||
155403487|NCT03357731|560913052|FG002|Overall Study|Acute bradycardia and hypotension|0|||
155403488|NCT03357731|560913053|FG003|Overall Study|Acute bradycardia and hypotension|1|||
155403489|NCT03357731|560913054|FG004|Overall Study|Acute bradycardia and hypotension|0|||
155403490|NCT03357731|560913055|FG005|Overall Study|Acute bradycardia and hypotension|0|||
155403491|NCT03357731|560913050|FG000|Overall Study|Adverse Event|0|||
155403492|NCT03357731|560913051|FG001|Overall Study|Adverse Event|0|||
155403493|NCT03357731|560913052|FG002|Overall Study|Adverse Event|0|||
155403494|NCT03357731|560913053|FG003|Overall Study|Adverse Event|0|||
155403495|NCT03357731|560913054|FG004|Overall Study|Adverse Event|0|||
155403496|NCT03357731|560913055|FG005|Overall Study|Adverse Event|1|||
155403497|NCT03357731|560913050|FG000|Overall Study|Hypotension|0|||
155403498|NCT03357731|560913051|FG001|Overall Study|Hypotension|0|||
155403499|NCT03357731|560913052|FG002|Overall Study|Hypotension|1|||
155403500|NCT03357731|560913053|FG003|Overall Study|Hypotension|1|||
155403501|NCT03357731|560913054|FG004|Overall Study|Hypotension|0|||
155403502|NCT03357731|560913055|FG005|Overall Study|Hypotension|0|||
155403503|NCT03357731|560913050|FG000|Overall Study|Lost to Follow-up|0|||
155403504|NCT03357731|560913051|FG001|Overall Study|Lost to Follow-up|0|||
155403505|NCT03357731|560913052|FG002|Overall Study|Lost to Follow-up|0|||
155403506|NCT03357731|560913053|FG003|Overall Study|Lost to Follow-up|1|||
155403507|NCT03357731|560913054|FG004|Overall Study|Lost to Follow-up|0|||
155403508|NCT03357731|560913055|FG005|Overall Study|Lost to Follow-up|0|||
155403509|NCT01773109|560913056|FG000|Overall Study|Symptomatic Progression|2|||
155403510|NCT01773109|560913056|FG000|Overall Study|Death|1|||
155403511|NCT04036708|560913059|FG000|Overall Study|Lost to Follow-up|14|||
155403512|NCT04036708|560913060|FG001|Overall Study|Lost to Follow-up|4|||
155403513|NCT04036708|560913061|FG002|Overall Study|Lost to Follow-up|14|||
155403514|NCT04036708|560913062|FG003|Overall Study|Lost to Follow-up|4|||
155403515|NCT04766021|560913063|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
155403516|NCT04766021|560913063|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
155403517|NCT01849874|560913065|FG000|Overall Study|Death|89|||
155403518|NCT01849874|560913066|FG001|Overall Study|Death|42|||
155403519|NCT01849874|560913065|FG000|Overall Study|Withdrawal by Subject|17|||
155403520|NCT01849874|560913066|FG001|Overall Study|Withdrawal by Subject|16|||
155403521|NCT01849874|560913065|FG000|Overall Study|Lost to Follow-up|3|||
155403522|NCT01849874|560913066|FG001|Overall Study|Lost to Follow-up|2|||
155403523|NCT01849874|560913065|FG000|Overall Study|Study Termination By Sponsor|93|||
155403524|NCT01849874|560913066|FG001|Overall Study|Study Termination By Sponsor|48|||
155403525|NCT01849874|560913065|FG000|Overall Study|Completed as per protocol amendment 6|3|||
155403526|NCT01849874|560913066|FG001|Overall Study|Completed as per protocol amendment 6|0|||
155403527|NCT01849874|560913065|FG000|Overall Study|Physician Decision|7|||
155403528|NCT01849874|560913066|FG001|Overall Study|Physician Decision|1|||
155403529|NCT01849874|560913065|FG000|Overall Study|Other|16|||
155403530|NCT01849874|560913066|FG001|Overall Study|Other|4|||
155403531|NCT02104583|560913067|FG000|Overall Study|New ICD or CRT-D implanted|2|||
155403532|NCT02104583|560913068|FG001|Overall Study|New ICD or CRT-D implanted|0|||
155403533|NCT02104583|560913069|FG002|Overall Study|New ICD or CRT-D implanted|1|||
155403534|NCT02104583|560913070|FG003|Overall Study|New ICD or CRT-D implanted|0|||
155403535|NCT02104583|560913071|FG004|Overall Study|New ICD or CRT-D implanted|0|||
155403536|NCT02104583|560913067|FG000|Overall Study|Death|2|||
155403537|NCT02104583|560913068|FG001|Overall Study|Death|1|||
155403538|NCT02104583|560913069|FG002|Overall Study|Death|3|||
155403539|NCT02104583|560913070|FG003|Overall Study|Death|3|||
155403540|NCT02104583|560913071|FG004|Overall Study|Death|5|||
155403541|NCT02104583|560913067|FG000|Overall Study|Subject required cardiac ablation|6|||
155403542|NCT02104583|560913068|FG001|Overall Study|Subject required cardiac ablation|4|||
155403543|NCT02104583|560913069|FG002|Overall Study|Subject required cardiac ablation|4|||
155403544|NCT02104583|560913070|FG003|Overall Study|Subject required cardiac ablation|5|||
155403545|NCT02104583|560913071|FG004|Overall Study|Subject required cardiac ablation|4|||
155403546|NCT02104583|560913067|FG000|Overall Study|Subject required prohibited medication|0|||
155403547|NCT02104583|560913068|FG001|Overall Study|Subject required prohibited medication|1|||
155403548|NCT02104583|560913069|FG002|Overall Study|Subject required prohibited medication|1|||
155403549|NCT02104583|560913070|FG003|Overall Study|Subject required prohibited medication|0|||
155403550|NCT02104583|560913071|FG004|Overall Study|Subject required prohibited medication|1|||
155403551|NCT02104583|560913067|FG000|Overall Study|Withdrew Consent|3|||
155403552|NCT02104583|560913068|FG001|Overall Study|Withdrew Consent|2|||
155403553|NCT02104583|560913069|FG002|Overall Study|Withdrew Consent|0|||
155403554|NCT02104583|560913070|FG003|Overall Study|Withdrew Consent|2|||
155403555|NCT02104583|560913071|FG004|Overall Study|Withdrew Consent|1|||
155403556|NCT02104583|560913067|FG000|Overall Study|Investigator's Discretion|1|||
155403557|NCT02104583|560913068|FG001|Overall Study|Investigator's Discretion|0|||
155403558|NCT02104583|560913069|FG002|Overall Study|Investigator's Discretion|0|||
155403559|NCT02104583|560913070|FG003|Overall Study|Investigator's Discretion|0|||
155403560|NCT02104583|560913071|FG004|Overall Study|Investigator's Discretion|0|||
155403561|NCT02104583|560913067|FG000|Overall Study|Protocol Violation|0|||
155403562|NCT02104583|560913068|FG001|Overall Study|Protocol Violation|0|||
155403563|NCT02104583|560913069|FG002|Overall Study|Protocol Violation|1|||
155403564|NCT02104583|560913070|FG003|Overall Study|Protocol Violation|0|||
155403565|NCT02104583|560913071|FG004|Overall Study|Protocol Violation|0|||
155403566|NCT02104583|560913067|FG000|Overall Study|Adverse Event|3|||
155403567|NCT02104583|560913068|FG001|Overall Study|Adverse Event|3|||
155403568|NCT02104583|560913069|FG002|Overall Study|Adverse Event|6|||
155403569|NCT02104583|560913070|FG003|Overall Study|Adverse Event|6|||
155403570|NCT02104583|560913071|FG004|Overall Study|Adverse Event|1|||
155403571|NCT02104583|560913067|FG000|Overall Study|Lost to Follow-up|1|||
155403572|NCT02104583|560913068|FG001|Overall Study|Lost to Follow-up|0|||
155403573|NCT02104583|560913069|FG002|Overall Study|Lost to Follow-up|0|||
155403574|NCT02104583|560913070|FG003|Overall Study|Lost to Follow-up|0|||
155403575|NCT02104583|560913071|FG004|Overall Study|Lost to Follow-up|0|||
155403576|NCT02104583|560913067|FG000|Overall Study|Randomized but Never Treated|0|||
155403577|NCT02104583|560913068|FG001|Overall Study|Randomized but Never Treated|0|||
155403578|NCT02104583|560913069|FG002|Overall Study|Randomized but Never Treated|0|||
155403579|NCT02104583|560913070|FG003|Overall Study|Randomized but Never Treated|1|||
155403580|NCT02104583|560913071|FG004|Overall Study|Randomized but Never Treated|0|||
155403581|NCT04640272|560913072|FG000|Overall Study|Subject moved out of area|1|||
155403582|NCT02535715|560913076|FG000|Overall Study|Withdrawal by Subject|0|||
155403583|NCT02535715|560913077|FG001|Overall Study|Withdrawal by Subject|0|||
155403584|NCT02535715|560913078|FG002|Overall Study|Withdrawal by Subject|1|||
155403585|NCT03709654|560913079|FG000|Overall Study|Lost to Follow-up|1|||
155403586|NCT03709654|560913080|FG001|Overall Study|Lost to Follow-up|1|||
155403587|NCT03709654|560913079|FG000|Overall Study|Withdrawal by Subject|1|||
155403588|NCT03709654|560913080|FG001|Overall Study|Withdrawal by Subject|1|||
155403589|NCT03709654|560913079|FG000|Overall Study|Adverse Event|1|||
155403590|NCT03709654|560913080|FG001|Overall Study|Adverse Event|0|||
155403591|NCT01902966|560913081|FG000|Overall Study|Death|1|||
155403592|NCT01902966|560913081|FG000|Overall Study|Physician Decision|1|||
155403593|NCT01902966|560913081|FG000|Overall Study|Withdrawal by Subject|1|||
155403594|NCT01040351|560913082|FG000|Overall Study|poor ovarian response|1|||
155403595|NCT01040351|560913083|FG001|Overall Study|poor ovarian response|2|||
155403596|NCT01230307|560913084|FG000|Overall Study|LVAD Placement|0|||
155403597|NCT01230307|560913085|FG001|Overall Study|LVAD Placement|2|||
155403598|NCT02256540|560913087|FG000|Overall Study|Withdrawal by Subject|0|||
155403599|NCT02256540|560913088|FG001|Overall Study|Withdrawal by Subject|1|||
155284996|NCT00235495|560474466|FG001|Overall Study|Withdrawal by Subject|3|||
155403600|NCT02256540|560913089|FG002|Overall Study|Withdrawal by Subject|1|||
155403601|NCT02256540|560913087|FG000|Overall Study|Back pain preventing exercise|0|||
155403602|NCT02256540|560913088|FG001|Overall Study|Back pain preventing exercise|0|||
155403603|NCT02256540|560913089|FG002|Overall Study|Back pain preventing exercise|1|||
155284997|NCT00235495|560474465|FG000|Overall Study|Lost to Follow-up|11|||
155284998|NCT00235495|560474466|FG001|Overall Study|Lost to Follow-up|13|||
155403604|NCT03923426|560913090|FG000|Overall Study|Other|19|||
155403605|NCT03923426|560913090|FG000|Overall Study|Lost to Follow-up|16|||
155403606|NCT03923426|560913090|FG000|Overall Study|Death|107|||
155403607|NCT03923426|560913090|FG000|Overall Study|Incomplete response to question|13|||
155403608|NCT00751400|560913093|FG000|Overall Study|Lost to Follow-up|10|||
155403609|NCT01918007|560913095|FG000|Overall Study|Baseline oximetry not acceptable|11|||
155403610|NCT01918007|560913096|FG001|Overall Study|Baseline oximetry not acceptable|7|||
155403611|NCT01918007|560913095|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
155403612|NCT01918007|560913096|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
155403613|NCT01918007|560913095|FG000|Overall Study|Lost to Follow-up|4|||
155403614|NCT01918007|560913096|FG001|Overall Study|Lost to Follow-up|7|||
155403615|NCT01471015|560913098|FG000|Overall Study|Death|0|||
155403616|NCT01471015|560913099|FG001|Overall Study|Death|1|||
155403617|NCT01471015|560913100|FG002|Overall Study|Death|1|||
155403618|NCT04206020|560913101|FG000|Overall Study|Adverse Event|1|||
155403619|NCT04206020|560913102|FG001|Overall Study|Adverse Event|4|||
155403620|NCT04206020|560913101|FG000|Overall Study|Protocol Violation|2|||
155403621|NCT04206020|560913102|FG001|Overall Study|Protocol Violation|0|||
155403622|NCT04206020|560913101|FG000|Overall Study|Withdrawal by Subject|2|||
155403623|NCT04206020|560913102|FG001|Overall Study|Withdrawal by Subject|0|||
155403624|NCT04206020|560913101|FG000|Overall Study|Lost to Follow-up|2|||
155403625|NCT04206020|560913102|FG001|Overall Study|Lost to Follow-up|0|||
155403626|NCT04206020|560913101|FG000|Overall Study|Pregnancy|0|||
155403627|NCT04206020|560913102|FG001|Overall Study|Pregnancy|1|||
155403628|NCT04206020|560913101|FG000|Overall Study|Unable to attend visits|1|||
155403629|NCT04206020|560913102|FG001|Overall Study|Unable to attend visits|2|||
155403630|NCT04962022|560913103|FG000|Period 1|Withdrawal by Subject|1|||
155403631|NCT04962022|560913104|FG001|Period 1|Withdrawal by Subject|0|||
155403632|NCT03962101|560913107|FG000|Overall Study|Adverse Event|1|||
155403633|NCT03962101|560913107|FG000|Overall Study|Physician Decision|2|||
155403634|NCT03962101|560913107|FG000|Overall Study|Not related to medical events|1|||
155403635|NCT00552175|560913108|FG000|Overall Study|Lack of Efficacy|2|||
155403636|NCT00552175|560913109|FG001|Overall Study|Lack of Efficacy|0|||
155403637|NCT00552175|560913110|FG002|Overall Study|Lack of Efficacy|1|||
155403638|NCT00552175|560913108|FG000|Overall Study|Adverse Event|9|||
155403639|NCT00552175|560913109|FG001|Overall Study|Adverse Event|9|||
155403640|NCT00552175|560913110|FG002|Overall Study|Adverse Event|10|||
155403641|NCT00552175|560913108|FG000|Overall Study|Withdrawal by Subject|2|||
155403642|NCT00552175|560913109|FG001|Overall Study|Withdrawal by Subject|2|||
155403643|NCT00552175|560913110|FG002|Overall Study|Withdrawal by Subject|1|||
155403644|NCT00552175|560913108|FG000|Overall Study|Lost to Follow-up|0|||
155403645|NCT00552175|560913109|FG001|Overall Study|Lost to Follow-up|0|||
155403646|NCT00552175|560913110|FG002|Overall Study|Lost to Follow-up|1|||
155403647|NCT00552175|560913108|FG000|Overall Study|Entry Criteria Not Met|1|||
155403648|NCT00552175|560913109|FG001|Overall Study|Entry Criteria Not Met|1|||
155403649|NCT00552175|560913110|FG002|Overall Study|Entry Criteria Not Met|0|||
155403650|NCT00552175|560913108|FG000|Overall Study|Reason Not Specified|3|||
155403651|NCT00552175|560913109|FG001|Overall Study|Reason Not Specified|1|||
155403652|NCT00552175|560913110|FG002|Overall Study|Reason Not Specified|1|||
155403653|NCT03972969|560913112|FG000|3-month Follow-up|Death|1|||
155403654|NCT03972969|560913113|FG001|3-month Follow-up|Death|1|||
155403655|NCT03972969|560913114|FG002|3-month Follow-up|Death|0|||
155403656|NCT03972969|560913112|FG000|6-month Follow-up|Death|1|||
155403657|NCT03972969|560913113|FG001|6-month Follow-up|Death|1|||
155403658|NCT03972969|560913114|FG002|6-month Follow-up|Death|1|||
155403659|NCT03972969|560913112|FG000|6-month Follow-up|Lost to Follow-up|2|||
155403660|NCT03972969|560913113|FG001|6-month Follow-up|Lost to Follow-up|2|||
155403661|NCT03972969|560913114|FG002|6-month Follow-up|Lost to Follow-up|2|||
155403662|NCT02919436|560913115|FG000|Overall Study|Did not undergo surgery|16|||
155403663|NCT02919436|560913116|FG001|Overall Study|Did not undergo surgery|20|||
155403664|NCT02919436|560913115|FG000|Overall Study|Enrolled before trial registration|44|||
155403665|NCT02919436|560913116|FG001|Overall Study|Enrolled before trial registration|33|||
155403666|NCT00283595|560913117|FG000|Overall Study|Withdrawal by Subject|1|||
155403667|NCT00283595|560913118|FG001|Overall Study|Withdrawal by Subject|2|||
155403668|NCT02409290|560913119|FG000|Overall Study|Protocol Violation|3|||
155403669|NCT02409290|560913120|FG001|Overall Study|Protocol Violation|6|||
155403670|NCT02409290|560913121|FG002|Overall Study|Protocol Violation|9|||
155403671|NCT02409290|560913122|FG003|Overall Study|Protocol Violation|4|||
155403672|NCT02409290|560913119|FG000|Overall Study|No positive culture/no baseline sample|3|||
155403673|NCT02409290|560913120|FG001|Overall Study|No positive culture/no baseline sample|9|||
155403674|NCT02409290|560913121|FG002|Overall Study|No positive culture/no baseline sample|6|||
155403675|NCT02409290|560913122|FG003|Overall Study|No positive culture/no baseline sample|5|||
155403676|NCT02409290|560913119|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
155403677|NCT02409290|560913120|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
155403678|NCT02409290|560913121|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
155403679|NCT02409290|560913122|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
155403680|NCT04607148|560913123|FG000|Overall Study|Withdrawal by Subject|0|||
155435870|NCT01919411|561022980|FG000|Overall Study|Physician Decision|1|||
155403681|NCT04607148|560913124|FG001|Overall Study|Withdrawal by Subject|4|||
155403682|NCT04607148|560913125|FG002|Overall Study|Withdrawal by Subject|2|||
155403683|NCT04607148|560913126|FG003|Overall Study|Withdrawal by Subject|8|||
155403684|NCT04607148|560913123|FG000|Overall Study|Study Terminated by Sponsor|14|||
155403685|NCT04607148|560913124|FG001|Overall Study|Study Terminated by Sponsor|59|||
155403686|NCT04607148|560913125|FG002|Overall Study|Study Terminated by Sponsor|9|||
155403687|NCT04607148|560913126|FG003|Overall Study|Study Terminated by Sponsor|39|||
155403688|NCT04607148|560913123|FG000|Overall Study|Sponsor Decision|0|||
155742262|NCT01185353|562156458|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742263|NCT01185353|562156459|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
155742264|NCT01185353|562156460|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742265|NCT01185353|562156461|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155403689|NCT04607148|560913124|FG001|Overall Study|Sponsor Decision|0|||
155403690|NCT04607148|560913125|FG002|Overall Study|Sponsor Decision|1|||
155403691|NCT04607148|560913126|FG003|Overall Study|Sponsor Decision|0|||
155403692|NCT04607148|560913123|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155742266|NCT01185353|562156462|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742267|NCT01185353|562156463|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155742268|NCT01185353|562156454|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742269|NCT01185353|562156455|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
155742270|NCT01185353|562156456|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742271|NCT01185353|562156457|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
155742272|NCT01185353|562156458|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742273|NCT01185353|562156459|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742274|NCT01185353|562156460|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742275|NCT01185353|562156461|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742276|NCT01185353|562156462|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742277|NCT01185353|562156463|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155742278|NCT01185353|562156454|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742279|NCT01185353|562156455|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742280|NCT01185353|562156456|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742281|NCT01185353|562156457|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
155742282|NCT01185353|562156458|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742283|NCT01185353|562156459|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742284|NCT01185353|562156460|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
155742285|NCT01185353|562156461|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742286|NCT01185353|562156462|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742287|NCT01185353|562156463|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155742288|NCT01185353|562156454|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742289|NCT01185353|562156455|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742290|NCT01185353|562156456|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
155742291|NCT01185353|562156457|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
155742292|NCT01185353|562156458|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742293|NCT01185353|562156459|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
155742294|NCT01185353|562156460|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
155742295|NCT01185353|562156461|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742296|NCT01185353|562156462|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742297|NCT01185353|562156463|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155742298|NCT01185353|562156454|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742299|NCT01185353|562156455|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742300|NCT01185353|562156456|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742301|NCT01185353|562156457|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742302|NCT01185353|562156458|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742303|NCT01185353|562156459|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742304|NCT01185353|562156460|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
155742305|NCT01185353|562156461|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742306|NCT01185353|562156462|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742307|NCT01185353|562156463|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155742308|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742309|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742310|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742311|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742312|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742313|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742314|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155742315|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
155742316|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
155742317|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
155403693|NCT04607148|560913124|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155403694|NCT04607148|560913125|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155403695|NCT04607148|560913126|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155403696|NCT04607148|560913123|FG000|Overall Study|Lost to Follow-up|0|||
155403697|NCT04607148|560913124|FG001|Overall Study|Lost to Follow-up|2|||
155403698|NCT04607148|560913125|FG002|Overall Study|Lost to Follow-up|0|||
155403699|NCT04607148|560913126|FG003|Overall Study|Lost to Follow-up|0|||
155403700|NCT04607148|560913123|FG000|Overall Study|Death|0|||
155403701|NCT04607148|560913124|FG001|Overall Study|Death|3|||
155403702|NCT04607148|560913125|FG002|Overall Study|Death|0|||
155403703|NCT04607148|560913126|FG003|Overall Study|Death|1|||
155403704|NCT04607148|560913123|FG000|Overall Study|Adverse Event|0|||
155403705|NCT04607148|560913124|FG001|Overall Study|Adverse Event|1|||
155403706|NCT04607148|560913125|FG002|Overall Study|Adverse Event|0|||
155403707|NCT04607148|560913126|FG003|Overall Study|Adverse Event|0|||
155403708|NCT00804570|560913127|FG000|Overall Study|Adverse Event|14|||
155403709|NCT00804570|560913128|FG001|Overall Study|Adverse Event|7|||
155403710|NCT00804570|560913127|FG000|Overall Study|Lack of Efficacy|0|||
155403711|NCT00804570|560913128|FG001|Overall Study|Lack of Efficacy|1|||
155403712|NCT00804570|560913127|FG000|Overall Study|Lost to Follow-up|18|||
155403713|NCT00804570|560913128|FG001|Overall Study|Lost to Follow-up|21|||
155403714|NCT00804570|560913127|FG000|Overall Study|Entry criteria not met|5|||
155403715|NCT00804570|560913128|FG001|Overall Study|Entry criteria not met|5|||
155403716|NCT00804570|560913127|FG000|Overall Study|Protocol Violation|12|||
155403717|NCT00804570|560913128|FG001|Overall Study|Protocol Violation|16|||
155403718|NCT00804570|560913127|FG000|Overall Study|Physician Decision|1|||
155403719|NCT00804570|560913128|FG001|Overall Study|Physician Decision|2|||
155403720|NCT00804570|560913127|FG000|Overall Study|Sponsor decision|1|||
155403721|NCT00804570|560913128|FG001|Overall Study|Sponsor decision|4|||
155403722|NCT00804570|560913127|FG000|Overall Study|Withdrawal by Subject|21|||
155403723|NCT00804570|560913128|FG001|Overall Study|Withdrawal by Subject|38|||
155403724|NCT00290342|560913129|FG000|Overall Study|Other|0|||
155403725|NCT00290342|560913130|FG001|Overall Study|Other|1|||
155403726|NCT00290342|560913129|FG000|Overall Study|Withdrawal by Subject|6|||
155403727|NCT00290342|560913130|FG001|Overall Study|Withdrawal by Subject|4|||
155403728|NCT00290342|560913129|FG000|Overall Study|Lost to Follow-up|1|||
155403729|NCT00290342|560913130|FG001|Overall Study|Lost to Follow-up|0|||
155403730|NCT01056510|560913133|FG000|Overall Study|Dropout Before Start of Treatment|1|||
155403731|NCT01056510|560913134|FG001|Overall Study|Dropout Before Start of Treatment|1|||
155403732|NCT01056510|560913133|FG000|Overall Study|Withdrawal by Subject|4|||
155403733|NCT01056510|560913134|FG001|Overall Study|Withdrawal by Subject|2|||
155403734|NCT01056510|560913133|FG000|Overall Study|Death|29|||
155403735|NCT01056510|560913134|FG001|Overall Study|Death|34|||
155403736|NCT01056510|560913133|FG000|Overall Study|Noncompliance|1|||
155403737|NCT01056510|560913134|FG001|Overall Study|Noncompliance|3|||
155403738|NCT01056510|560913133|FG000|Overall Study|Physician Decision|4|||
155403739|NCT01056510|560913134|FG001|Overall Study|Physician Decision|5|||
155403740|NCT01056510|560913133|FG000|Overall Study|Lost to Follow-up|5|||
155403741|NCT01056510|560913134|FG001|Overall Study|Lost to Follow-up|6|||
155403742|NCT01056510|560913133|FG000|Overall Study|Other|10|||
155403743|NCT01056510|560913134|FG001|Overall Study|Other|12|||
155403744|NCT01056510|560913133|FG000|Overall Study|Missing|0|||
155403745|NCT01056510|560913134|FG001|Overall Study|Missing|1|||
155403746|NCT02285998|560913135|FG000|Overall Study|Adverse Event|9|||
155403747|NCT02285998|560913136|FG001|Overall Study|Adverse Event|8|||
155403748|NCT02285998|560913135|FG000|Overall Study|Physician Decision|1|||
155403749|NCT02285998|560913136|FG001|Overall Study|Physician Decision|2|||
155403750|NCT02285998|560913135|FG000|Overall Study|Lost to Follow-up|176|||
155403751|NCT02285998|560913136|FG001|Overall Study|Lost to Follow-up|172|||
155403752|NCT02285998|560913135|FG000|Overall Study|Withdrawal by Subject|53|||
155403753|NCT02285998|560913136|FG001|Overall Study|Withdrawal by Subject|61|||
155403754|NCT02285998|560913135|FG000|Overall Study|Other Reasons|7|||
155403755|NCT02285998|560913136|FG001|Overall Study|Other Reasons|10|||
155403756|NCT02830776|560913137|FG000|Overall Study|Lost to Follow-up|1|||
155403757|NCT03029143|560913138|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
155403758|NCT03029143|560913139|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
155403759|NCT03029143|560913140|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
155403760|NCT03029143|560913138|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
155403761|NCT03029143|560913139|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
155403762|NCT03029143|560913140|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
155403763|NCT03029143|560913138|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
155403764|NCT03029143|560913139|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
155403765|NCT03029143|560913140|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
155403766|NCT03029143|560913138|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
155403767|NCT03029143|560913139|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
155403768|NCT03029143|560913140|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
155403769|NCT03029143|560913138|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
155403770|NCT03029143|560913139|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
155403771|NCT03029143|560913140|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
155403772|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
155403773|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
155403774|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
155403775|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
155403776|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
155403777|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
155403778|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155403779|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155403780|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
155403781|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
155403782|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
155403783|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
155403784|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155403785|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
155403786|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
155403787|NCT03029143|560913138|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
155403788|NCT03029143|560913139|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
155403789|NCT03029143|560913140|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
155403790|NCT01394627|560913142|FG000|First Intervention (1 Day)|poor intravenous access|0|||
155403791|NCT01394627|560913143|FG001|First Intervention (1 Day)|poor intravenous access|1|||
155403792|NCT01394627|560913142|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
155403793|NCT01394627|560913143|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
155403794|NCT01617070|560913144|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
155403795|NCT03223428|560913149|FG000|Overall Study|No longer taking Xermelo|27|||
155403796|NCT03223428|560913149|FG000|Overall Study|Declined Consent|1|||
155403797|NCT03223428|560913149|FG000|Overall Study|Non-responders|56|||
155403798|NCT03223428|560913149|FG000|Overall Study|Withdrawal by Subject|14|||
155403799|NCT02230384|560913151|FG000|Phase 1|Lost to Follow-up|1|||
155403800|NCT02230384|560913152|FG001|Phase 1|Lost to Follow-up|0|||
155403801|NCT02230384|560913151|FG000|Phase 1|Physician Decision|0|||
155403802|NCT02230384|560913152|FG001|Phase 1|Physician Decision|1|||
155403803|NCT02230384|560913151|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
155403804|NCT02230384|560913152|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
155403805|NCT02230384|560913151|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
155403806|NCT02230384|560913152|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
155637403|NCT05028569|561764732|FG005|Open-Label Phase|Other, not specified|5|||
155637404|NCT05028569|561764733|FG006|Open-Label Phase|Other, not specified|7|||
155403807|NCT02230384|560913151|FG000|Phase 2 - Switch|Adverse Event|2|||
155403808|NCT02230384|560913152|FG001|Phase 2 - Switch|Adverse Event|0|||
155403809|NCT00777101|560913153|FG000|Overall Study|Death|48|||
155403810|NCT00777101|560913154|FG001|Overall Study|Death|43|||
155403811|NCT00777101|560913153|FG000|Overall Study|Withdrawal by Subject|11|||
155403812|NCT00777101|560913154|FG001|Overall Study|Withdrawal by Subject|6|||
155403813|NCT00777101|560913153|FG000|Overall Study|Lost to Follow-up|2|||
155403814|NCT00777101|560913154|FG001|Overall Study|Lost to Follow-up|1|||
155403815|NCT00777101|560913153|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
155403816|NCT00777101|560913154|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155403817|NCT00777101|560913153|FG000|Overall Study|Failed to Return|0|||
155403818|NCT00777101|560913154|FG001|Overall Study|Failed to Return|1|||
155403819|NCT05376215|560913155|FG000|Overall Study|Withdrawal by Subject|2|||
155403820|NCT05376215|560913156|FG001|Overall Study|Withdrawal by Subject|1|||
155403821|NCT05376215|560913155|FG000|Overall Study|Lost to Follow-up|0|||
155403822|NCT05376215|560913156|FG001|Overall Study|Lost to Follow-up|1|||
155403823|NCT00282334|560913159|FG000|Overall Study|Withdrawal by Subject|8|||
155403824|NCT00282334|560913160|FG001|Overall Study|Withdrawal by Subject|5|||
155403825|NCT01301950|560913164|FG000|Overall Study|Surgery was cancelled by patient|0|||
155403826|NCT01301950|560913165|FG001|Overall Study|Surgery was cancelled by patient|1|||
155403827|NCT01066585|560913166|FG000|Overall Study|Protocol Violation|1|||
155403828|NCT01066585|560913167|FG001|Overall Study|Protocol Violation|0|||
155403829|NCT01066585|560913166|FG000|Overall Study|Withdrawal by Subject|0|||
155403830|NCT01066585|560913167|FG001|Overall Study|Withdrawal by Subject|3|||
155403831|NCT02424253|560913171|FG000|Overall Study|Other, unspecified|1|||
155403832|NCT02424253|560913172|FG001|Overall Study|Other, unspecified|0|||
155403833|NCT02424253|560913171|FG000|Overall Study|Compliance problems|1|||
155403834|NCT02424253|560913172|FG001|Overall Study|Compliance problems|0|||
155403835|NCT02424253|560913171|FG000|Overall Study|Physician Decision|2|||
155403836|NCT02424253|560913172|FG001|Overall Study|Physician Decision|0|||
155403837|NCT02424253|560913171|FG000|Overall Study|Lack of Efficacy|0|||
155403838|NCT02424253|560913172|FG001|Overall Study|Lack of Efficacy|7|||
155403839|NCT02424253|560913171|FG000|Overall Study|Adverse Event|2|||
155403840|NCT02424253|560913172|FG001|Overall Study|Adverse Event|0|||
155403841|NCT02424253|560913171|FG000|Overall Study|Consent withdrawn by subject|4|||
155403842|NCT02424253|560913172|FG001|Overall Study|Consent withdrawn by subject|1|||
155403843|NCT02424253|560913171|FG000|Overall Study|Lost to Follow-up|1|||
155403844|NCT02424253|560913172|FG001|Overall Study|Lost to Follow-up|1|||
155403845|NCT00884273|560913173|FG000|Overall Study|Adverse Event|0|||
155403846|NCT00884273|560913174|FG001|Overall Study|Adverse Event|2|||
155403847|NCT00884273|560913173|FG000|Overall Study|Protocol Violation|1|||
155403848|NCT00884273|560913174|FG001|Overall Study|Protocol Violation|3|||
155403849|NCT00884273|560913173|FG000|Overall Study|Practical reasons|1|||
155403850|NCT00884273|560913174|FG001|Overall Study|Practical reasons|0|||
155403851|NCT03021499|560913182|FG000|Overall Study|Adverse Event|1|||
155403852|NCT03021499|560913183|FG001|Overall Study|Adverse Event|0|||
155403853|NCT03021499|560913182|FG000|Overall Study|Death|1|||
155403854|NCT03021499|560913183|FG001|Overall Study|Death|5|||
155403855|NCT03021499|560913182|FG000|Overall Study|Lack of Efficacy|0|||
155403856|NCT03021499|560913183|FG001|Overall Study|Lack of Efficacy|1|||
155403857|NCT03021499|560913182|FG000|Overall Study|Lost to Follow-up|1|||
155403858|NCT03021499|560913183|FG001|Overall Study|Lost to Follow-up|3|||
155403859|NCT03021499|560913182|FG000|Overall Study|Physician Decision|2|||
155403860|NCT03021499|560913183|FG001|Overall Study|Physician Decision|3|||
155403861|NCT03021499|560913182|FG000|Overall Study|Pregnancy|1|||
155403862|NCT03021499|560913183|FG001|Overall Study|Pregnancy|0|||
155403863|NCT03021499|560913182|FG000|Overall Study|Withdrawal by Subject|7|||
155403864|NCT03021499|560913183|FG001|Overall Study|Withdrawal by Subject|14|||
155403865|NCT03021499|560913182|FG000|Overall Study|Prohibited medication required|1|||
155403866|NCT03021499|560913183|FG001|Overall Study|Prohibited medication required|0|||
155403867|NCT03021499|560913182|FG000|Overall Study|Protocol non-compliance|1|||
155403868|NCT03021499|560913183|FG001|Overall Study|Protocol non-compliance|1|||
155403869|NCT03021499|560913182|FG000|Overall Study|None of the above|0|||
155403870|NCT03021499|560913183|FG001|Overall Study|None of the above|4|||
155403871|NCT03021499|560913182|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
155403872|NCT03021499|560913183|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
155403873|NCT02581202|560913187|FG000|Overall Study|Lack of Efficacy|2|||
155403874|NCT02581202|560913187|FG000|Overall Study|Withdrawal by Subject|4|||
155403875|NCT02581202|560913187|FG000|Overall Study|Lost to Follow-up|5|||
155403876|NCT02581202|560913187|FG000|Overall Study|Pregnancy|3|||
155403877|NCT04050982|560913188|FG000|Overall Study|Did not meet eligibility criteria|0|||
155403878|NCT04050982|560913189|FG001|Overall Study|Did not meet eligibility criteria|1|||
155403879|NCT04050982|560913190|FG002|Overall Study|Did not meet eligibility criteria|0|||
155403880|NCT04050982|560913188|FG000|Overall Study|Withdrawal by Subject|1|||
155403881|NCT04050982|560913189|FG001|Overall Study|Withdrawal by Subject|0|||
155403882|NCT04050982|560913190|FG002|Overall Study|Withdrawal by Subject|0|||
155403883|NCT04050982|560913188|FG000|Overall Study|Unable to enroll on platform|1|||
155403884|NCT04050982|560913189|FG001|Overall Study|Unable to enroll on platform|0|||
155403885|NCT04050982|560913190|FG002|Overall Study|Unable to enroll on platform|0|||
155403886|NCT00609791|560914973|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
155403887|NCT04218201|560914974|FG000|Overall Study|Death|0|||
155403888|NCT04218201|560914975|FG001|Overall Study|Death|0|||
155403889|NCT04218201|560914976|FG002|Overall Study|Death|2|||
155403890|NCT04218201|560914977|FG003|Overall Study|Death|0|||
155403891|NCT04218201|560914974|FG000|Overall Study|Unable to contact participant|4|||
155403892|NCT04218201|560914975|FG001|Overall Study|Unable to contact participant|0|||
155403893|NCT04218201|560914976|FG002|Overall Study|Unable to contact participant|3|||
155403894|NCT04218201|560914977|FG003|Overall Study|Unable to contact participant|0|||
155403895|NCT04218201|560914974|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
155403896|NCT04218201|560914975|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
155403897|NCT04218201|560914976|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
155403898|NCT04218201|560914977|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
155403899|NCT04218201|560914974|FG000|Overall Study|Withdrawal by Subject|2|||
155403900|NCT04218201|560914975|FG001|Overall Study|Withdrawal by Subject|0|||
155403901|NCT04218201|560914976|FG002|Overall Study|Withdrawal by Subject|0|||
155403902|NCT04218201|560914977|FG003|Overall Study|Withdrawal by Subject|0|||
155403903|NCT04218201|560914974|FG000|Overall Study|PCP plans to leave practice|0|||
155403904|NCT04218201|560914975|FG001|Overall Study|PCP plans to leave practice|8|||
155403905|NCT04218201|560914976|FG002|Overall Study|PCP plans to leave practice|0|||
155403906|NCT04218201|560914977|FG003|Overall Study|PCP plans to leave practice|5|||
155403907|NCT04218201|560914974|FG000|Overall Study|Reduced panel|0|||
155403908|NCT04218201|560914975|FG001|Overall Study|Reduced panel|0|||
155403909|NCT04218201|560914976|FG002|Overall Study|Reduced panel|0|||
155403910|NCT04218201|560914977|FG003|Overall Study|Reduced panel|1|||
155403911|NCT04218201|560914974|FG000|Overall Study|No longer interested in participating|0|||
155403912|NCT04218201|560914975|FG001|Overall Study|No longer interested in participating|1|||
155403913|NCT04218201|560914976|FG002|Overall Study|No longer interested in participating|0|||
155403914|NCT04218201|560914977|FG003|Overall Study|No longer interested in participating|0|||
155403915|NCT04649255|560914978|FG000|Overall Study|Death|9|||
155403916|NCT04649255|560914978|FG000|Overall Study|Withdrawal by Subject|1|||
155403917|NCT00122681|560914986|FG000|Overall Study|Adverse Event|20|||
155403918|NCT00122681|560914987|FG001|Overall Study|Adverse Event|16|||
155403919|NCT00122681|560914986|FG000|Overall Study|Lost to Follow-up|1080|||
155403920|NCT00122681|560914987|FG001|Overall Study|Lost to Follow-up|1097|||
155403921|NCT00122681|560914986|FG000|Overall Study|Protocol Violation|7|||
155403922|NCT00122681|560914987|FG001|Overall Study|Protocol Violation|10|||
155403923|NCT00122681|560914986|FG000|Overall Study|Withdrawal by Subject|257|||
155403924|NCT00122681|560914987|FG001|Overall Study|Withdrawal by Subject|251|||
155403925|NCT00122681|560914986|FG000|Overall Study|Personal reasons|150|||
155403926|NCT00122681|560914987|FG001|Overall Study|Personal reasons|147|||
155403927|NCT02819635|560914988|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
155403928|NCT02819635|560914989|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
155403929|NCT02819635|560914990|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
155403930|NCT02819635|560914991|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
155403931|NCT02819635|560914992|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
155403932|NCT02819635|560914993|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
155403933|NCT02819635|560914994|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
155403934|NCT02819635|560914995|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
155403935|NCT02819635|560914996|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
155403936|NCT02819635|560914997|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
155403937|NCT02819635|560914998|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
155403938|NCT02819635|560914999|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
155403939|NCT02819635|560914988|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403940|NCT02819635|560914989|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403941|NCT02819635|560914990|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403942|NCT02819635|560914991|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403943|NCT02819635|560914992|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
155403944|NCT02819635|560914993|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
155403945|NCT02819635|560914994|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
155403946|NCT02819635|560914995|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403947|NCT02819635|560914996|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403948|NCT02819635|560914997|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403949|NCT02819635|560914998|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403950|NCT02819635|560914999|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
155403951|NCT02819635|560914988|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403952|NCT02819635|560914989|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403953|NCT02819635|560914990|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403954|NCT02819635|560914991|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403955|NCT02819635|560914992|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403956|NCT02819635|560914993|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
155403957|NCT02819635|560914994|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
155403958|NCT02819635|560914995|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403959|NCT02819635|560914996|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403960|NCT02819635|560914997|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403961|NCT02819635|560914998|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403962|NCT02819635|560914999|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
155403963|NCT02819635|560914988|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403964|NCT02819635|560914989|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403965|NCT02819635|560914990|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403966|NCT02819635|560914991|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403967|NCT02819635|560914992|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403968|NCT02819635|560914993|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403969|NCT02819635|560914994|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
155403970|NCT02819635|560914995|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403971|NCT02819635|560914996|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403972|NCT02819635|560914997|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403973|NCT02819635|560914998|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403974|NCT02819635|560914999|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
155403975|NCT02819635|560914988|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
155403976|NCT02819635|560914989|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
155403977|NCT02819635|560914990|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
155403978|NCT02819635|560914991|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
155403979|NCT02819635|560914992|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
155403980|NCT02819635|560914993|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
155403981|NCT02819635|560914994|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
155403982|NCT02819635|560914995|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155403983|NCT02819635|560914996|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155403984|NCT02819635|560914997|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155403985|NCT02819635|560914998|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155403986|NCT02819635|560914999|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155403987|NCT02819635|560914988|FG000|Substudy 2, Part 2|Adverse Event|0|||
155403988|NCT02819635|560914989|FG001|Substudy 2, Part 2|Adverse Event|0|||
155403989|NCT02819635|560914990|FG002|Substudy 2, Part 2|Adverse Event|0|||
155403990|NCT02819635|560914991|FG003|Substudy 2, Part 2|Adverse Event|0|||
155403991|NCT02819635|560914992|FG004|Substudy 2, Part 2|Adverse Event|0|||
155403992|NCT02819635|560914993|FG005|Substudy 2, Part 2|Adverse Event|4|||
155403993|NCT02819635|560914994|FG006|Substudy 2, Part 2|Adverse Event|0|||
155403994|NCT02819635|560914995|FG007|Substudy 2, Part 2|Adverse Event|0|||
155403995|NCT02819635|560914996|FG008|Substudy 2, Part 2|Adverse Event|0|||
155403996|NCT02819635|560914997|FG009|Substudy 2, Part 2|Adverse Event|0|||
155403997|NCT02819635|560914998|FG010|Substudy 2, Part 2|Adverse Event|0|||
155403998|NCT02819635|560914999|FG011|Substudy 2, Part 2|Adverse Event|0|||
155403999|NCT02819635|560914988|FG000|Substudy 2, Part 2|Withdrew consent|0|||
155404000|NCT02819635|560914989|FG001|Substudy 2, Part 2|Withdrew consent|0|||
155404001|NCT02819635|560914990|FG002|Substudy 2, Part 2|Withdrew consent|0|||
155404002|NCT02819635|560914991|FG003|Substudy 2, Part 2|Withdrew consent|0|||
155404003|NCT02819635|560914992|FG004|Substudy 2, Part 2|Withdrew consent|0|||
155404004|NCT02819635|560914993|FG005|Substudy 2, Part 2|Withdrew consent|3|||
155404005|NCT02819635|560914994|FG006|Substudy 2, Part 2|Withdrew consent|1|||
155404006|NCT02819635|560914995|FG007|Substudy 2, Part 2|Withdrew consent|0|||
155404007|NCT02819635|560914996|FG008|Substudy 2, Part 2|Withdrew consent|0|||
155404008|NCT02819635|560914997|FG009|Substudy 2, Part 2|Withdrew consent|0|||
155404009|NCT02819635|560914998|FG010|Substudy 2, Part 2|Withdrew consent|0|||
155404010|NCT02819635|560914999|FG011|Substudy 2, Part 2|Withdrew consent|0|||
155404011|NCT02819635|560914988|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
155404012|NCT02819635|560914989|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
155404013|NCT02819635|560914990|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
155404014|NCT02819635|560914991|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
155404015|NCT02819635|560914992|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
155404016|NCT02819635|560914993|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
155404017|NCT02819635|560914994|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
155404018|NCT02819635|560914995|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
155404019|NCT02819635|560914996|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
155404020|NCT02819635|560914997|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
155404021|NCT02819635|560914998|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
155404022|NCT02819635|560914999|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
155404023|NCT02819635|560914988|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404024|NCT02819635|560914989|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404025|NCT02819635|560914990|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404026|NCT02819635|560914991|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404027|NCT02819635|560914992|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404028|NCT02819635|560914993|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404029|NCT02819635|560914994|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
155404030|NCT02819635|560914995|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404031|NCT02819635|560914996|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404032|NCT02819635|560914997|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404033|NCT02819635|560914998|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404034|NCT02819635|560914999|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155404035|NCT02819635|560914988|FG000|Substudy 2, Part 2|Other, not specified|0|||
155404036|NCT02819635|560914989|FG001|Substudy 2, Part 2|Other, not specified|0|||
155404037|NCT02819635|560914990|FG002|Substudy 2, Part 2|Other, not specified|0|||
155404038|NCT02819635|560914991|FG003|Substudy 2, Part 2|Other, not specified|0|||
155404039|NCT02819635|560914992|FG004|Substudy 2, Part 2|Other, not specified|0|||
155404040|NCT02819635|560914993|FG005|Substudy 2, Part 2|Other, not specified|4|||
155404041|NCT02819635|560914994|FG006|Substudy 2, Part 2|Other, not specified|8|||
155404042|NCT02819635|560914995|FG007|Substudy 2, Part 2|Other, not specified|0|||
155404043|NCT02819635|560914996|FG008|Substudy 2, Part 2|Other, not specified|0|||
155404044|NCT02819635|560914997|FG009|Substudy 2, Part 2|Other, not specified|0|||
155404045|NCT02819635|560914998|FG010|Substudy 2, Part 2|Other, not specified|0|||
155404046|NCT02819635|560914999|FG011|Substudy 2, Part 2|Other, not specified|0|||
155404047|NCT02819635|560914988|FG000|Substudy 3|Adverse Event|0|||
155404048|NCT02819635|560914989|FG001|Substudy 3|Adverse Event|0|||
155404049|NCT02819635|560914990|FG002|Substudy 3|Adverse Event|0|||
155404050|NCT02819635|560914991|FG003|Substudy 3|Adverse Event|0|||
155404051|NCT02819635|560914992|FG004|Substudy 3|Adverse Event|0|||
155404052|NCT02819635|560914993|FG005|Substudy 3|Adverse Event|0|||
155404053|NCT02819635|560914994|FG006|Substudy 3|Adverse Event|0|||
155404054|NCT02819635|560914995|FG007|Substudy 3|Adverse Event|0|||
155404055|NCT02819635|560914996|FG008|Substudy 3|Adverse Event|32|||
155404056|NCT02819635|560914997|FG009|Substudy 3|Adverse Event|3|||
155404057|NCT02819635|560914998|FG010|Substudy 3|Adverse Event|12|||
155404058|NCT02819635|560914999|FG011|Substudy 3|Adverse Event|18|||
155404059|NCT02819635|560914988|FG000|Substudy 3|Withdrew consent|0|||
155404060|NCT02819635|560914989|FG001|Substudy 3|Withdrew consent|0|||
155404061|NCT02819635|560914990|FG002|Substudy 3|Withdrew consent|0|||
155404062|NCT02819635|560914991|FG003|Substudy 3|Withdrew consent|0|||
155404063|NCT02819635|560914992|FG004|Substudy 3|Withdrew consent|0|||
155404064|NCT02819635|560914993|FG005|Substudy 3|Withdrew consent|0|||
155404065|NCT02819635|560914994|FG006|Substudy 3|Withdrew consent|0|||
155404066|NCT02819635|560914995|FG007|Substudy 3|Withdrew consent|0|||
155404067|NCT02819635|560914996|FG008|Substudy 3|Withdrew consent|11|||
155404068|NCT02819635|560914997|FG009|Substudy 3|Withdrew consent|1|||
155404069|NCT02819635|560914998|FG010|Substudy 3|Withdrew consent|4|||
155404070|NCT02819635|560914999|FG011|Substudy 3|Withdrew consent|9|||
155404071|NCT02819635|560914988|FG000|Substudy 3|Lost to Follow-up|0|||
155404072|NCT02819635|560914989|FG001|Substudy 3|Lost to Follow-up|0|||
155404073|NCT02819635|560914990|FG002|Substudy 3|Lost to Follow-up|0|||
155404074|NCT02819635|560914991|FG003|Substudy 3|Lost to Follow-up|0|||
155404075|NCT02819635|560914992|FG004|Substudy 3|Lost to Follow-up|0|||
155404076|NCT02819635|560914993|FG005|Substudy 3|Lost to Follow-up|0|||
155404077|NCT02819635|560914994|FG006|Substudy 3|Lost to Follow-up|0|||
155404078|NCT02819635|560914995|FG007|Substudy 3|Lost to Follow-up|0|||
155404079|NCT02819635|560914996|FG008|Substudy 3|Lost to Follow-up|1|||
155404080|NCT02819635|560914997|FG009|Substudy 3|Lost to Follow-up|0|||
155404081|NCT02819635|560914998|FG010|Substudy 3|Lost to Follow-up|1|||
155404082|NCT02819635|560914999|FG011|Substudy 3|Lost to Follow-up|1|||
155404083|NCT02819635|560914988|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404084|NCT02819635|560914989|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404085|NCT02819635|560914990|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404086|NCT02819635|560914991|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404087|NCT02819635|560914992|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404088|NCT02819635|560914993|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404089|NCT02819635|560914994|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404090|NCT02819635|560914995|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404091|NCT02819635|560914996|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404092|NCT02819635|560914997|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404093|NCT02819635|560914998|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
155404094|NCT02819635|560914999|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
155404095|NCT02819635|560914988|FG000|Substudy 3|Other, not specified|0|||
155404096|NCT02819635|560914989|FG001|Substudy 3|Other, not specified|0|||
155404097|NCT02819635|560914990|FG002|Substudy 3|Other, not specified|0|||
155404098|NCT02819635|560914991|FG003|Substudy 3|Other, not specified|0|||
155404099|NCT02819635|560914992|FG004|Substudy 3|Other, not specified|0|||
155404100|NCT02819635|560914993|FG005|Substudy 3|Other, not specified|0|||
155404101|NCT02819635|560914994|FG006|Substudy 3|Other, not specified|0|||
155404102|NCT02819635|560914995|FG007|Substudy 3|Other, not specified|0|||
155404103|NCT02819635|560914996|FG008|Substudy 3|Other, not specified|202|||
155404104|NCT02819635|560914997|FG009|Substudy 3|Other, not specified|5|||
155404105|NCT02819635|560914998|FG010|Substudy 3|Other, not specified|89|||
155404106|NCT02819635|560914999|FG011|Substudy 3|Other, not specified|39|||
155404107|NCT01476475|560915000|FG000|Overall Study|Adverse Event|6|||
155404108|NCT01476475|560915001|FG001|Overall Study|Adverse Event|0|||
155404109|NCT01476475|560915000|FG000|Overall Study|Poor compliance to protocol|1|||
155404110|NCT01476475|560915001|FG001|Overall Study|Poor compliance to protocol|1|||
155404111|NCT01476475|560915000|FG000|Overall Study|Other reasons|4|||
155404112|NCT01476475|560915001|FG001|Overall Study|Other reasons|2|||
155404113|NCT00441974|560915002|FG000|Overall Study|Adverse Event|6|||
155404114|NCT00441974|560915002|FG000|Overall Study|Consent Withdrawn|35|||
155404115|NCT00441974|560915002|FG000|Overall Study|Lost to Follow-up|80|||
155404116|NCT00441974|560915002|FG000|Overall Study|Protocol Violation|7|||
155404117|NCT01146873|560915010|FG000|Overall Study|Transfer out|0|||
155404118|NCT01146873|560915011|FG001|Overall Study|Transfer out|6|||
155404119|NCT02055820|560915014|FG000|Phase I: Dose-Finding|Death|1|||
155404120|NCT02055820|560915015|FG001|Phase I: Dose-Finding|Death|0|||
155404121|NCT02055820|560915016|FG002|Phase I: Dose-Finding|Death|1|||
155404122|NCT02055820|560915017|FG003|Phase I: Dose-Finding|Death|2|||
155404123|NCT02055820|560915018|FG004|Phase I: Dose-Finding|Death|0|||
155404124|NCT02055820|560915019|FG005|Phase I: Dose-Finding|Death|1|||
155404125|NCT02055820|560915020|FG006|Phase I: Dose-Finding|Death|1|||
155404126|NCT02055820|560915021|FG007|Phase I: Dose-Finding|Death|0|||
155404127|NCT02055820|560915022|FG008|Phase I: Dose-Finding|Death|0|||
155404128|NCT02055820|560915023|FG009|Phase I: Dose-Finding|Death|0|||
155404129|NCT02055820|560915014|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404130|NCT02055820|560915015|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404131|NCT02055820|560915016|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404132|NCT02055820|560915017|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404133|NCT02055820|560915018|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404134|NCT02055820|560915019|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
155404135|NCT02055820|560915020|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404136|NCT02055820|560915021|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404137|NCT02055820|560915022|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404138|NCT02055820|560915023|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
155404139|NCT02055820|560915014|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404140|NCT02055820|560915015|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404141|NCT02055820|560915016|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404142|NCT02055820|560915017|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
155404143|NCT02055820|560915018|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404144|NCT02055820|560915019|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404145|NCT02055820|560915020|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
155404146|NCT02055820|560915021|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404147|NCT02055820|560915022|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404148|NCT02055820|560915023|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
155404149|NCT02055820|560915014|FG000|Phase II: Expansion|Death|0|||
155404150|NCT02055820|560915015|FG001|Phase II: Expansion|Death|0|||
155404151|NCT02055820|560915016|FG002|Phase II: Expansion|Death|0|||
155404152|NCT02055820|560915017|FG003|Phase II: Expansion|Death|0|||
155404153|NCT02055820|560915018|FG004|Phase II: Expansion|Death|33|||
155404154|NCT02055820|560915019|FG005|Phase II: Expansion|Death|0|||
155404155|NCT02055820|560915020|FG006|Phase II: Expansion|Death|0|||
155404156|NCT02055820|560915021|FG007|Phase II: Expansion|Death|0|||
155404157|NCT02055820|560915022|FG008|Phase II: Expansion|Death|0|||
155404158|NCT02055820|560915023|FG009|Phase II: Expansion|Death|0|||
155404159|NCT02055820|560915014|FG000|Phase II: Expansion|Lost to Follow-up|0|||
155404160|NCT02055820|560915015|FG001|Phase II: Expansion|Lost to Follow-up|0|||
155404161|NCT02055820|560915016|FG002|Phase II: Expansion|Lost to Follow-up|0|||
155404162|NCT02055820|560915017|FG003|Phase II: Expansion|Lost to Follow-up|0|||
155404163|NCT02055820|560915018|FG004|Phase II: Expansion|Lost to Follow-up|4|||
155404164|NCT02055820|560915019|FG005|Phase II: Expansion|Lost to Follow-up|0|||
155404165|NCT02055820|560915020|FG006|Phase II: Expansion|Lost to Follow-up|0|||
155404166|NCT02055820|560915021|FG007|Phase II: Expansion|Lost to Follow-up|0|||
155404167|NCT02055820|560915022|FG008|Phase II: Expansion|Lost to Follow-up|0|||
155404168|NCT02055820|560915023|FG009|Phase II: Expansion|Lost to Follow-up|0|||
155404169|NCT02055820|560915014|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
155404170|NCT02055820|560915015|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
155404171|NCT02055820|560915016|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
155404172|NCT02055820|560915017|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
155404173|NCT02055820|560915018|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
155404174|NCT02055820|560915019|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
155404175|NCT02055820|560915020|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
155404176|NCT02055820|560915021|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
155404177|NCT02055820|560915022|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
155404178|NCT02055820|560915023|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
155404179|NCT00631020|560915026|FG000|Overall Study|Lost to Follow-up|7|||
155404180|NCT00631020|560915026|FG000|Overall Study|Incarcerated|1|||
155404181|NCT02614859|560915028|FG000|Overall Study|Physician Decision|0|||
155404182|NCT02614859|560915029|FG001|Overall Study|Physician Decision|1|||
155404183|NCT03548935|560915030|FG000|Overall Study|Withdrawal by Subject|26|||
155404184|NCT03548935|560915031|FG001|Overall Study|Withdrawal by Subject|17|||
155404185|NCT03548935|560915030|FG000|Overall Study|Lost to Follow-up|39|||
155404186|NCT03548935|560915031|FG001|Overall Study|Lost to Follow-up|28|||
155404187|NCT03548935|560915030|FG000|Overall Study|Death|1|||
155404188|NCT03548935|560915031|FG001|Overall Study|Death|1|||
155404189|NCT04677959|560915032|FG000|Overall Study|Adverse Event|1|||
155404190|NCT04677959|560915033|FG001|Overall Study|Adverse Event|9|||
155404191|NCT04677959|560915032|FG000|Overall Study|Withdrawal by Subject|2|||
155404192|NCT04677959|560915033|FG001|Overall Study|Withdrawal by Subject|15|||
155404193|NCT04677959|560915032|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155404194|NCT04677959|560915033|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155404195|NCT04677959|560915032|FG000|Overall Study|Non-compliance with study drug|0|||
155404196|NCT04677959|560915033|FG001|Overall Study|Non-compliance with study drug|2|||
155404197|NCT04677959|560915032|FG000|Overall Study|Protocol deviation|0|||
155404198|NCT04677959|560915033|FG001|Overall Study|Protocol deviation|11|||
155404199|NCT04677959|560915032|FG000|Overall Study|Lost to Follow-up|9|||
155404200|NCT04677959|560915033|FG001|Overall Study|Lost to Follow-up|13|||
155404201|NCT04677959|560915032|FG000|Overall Study|Other than specified|0|||
155404202|NCT04677959|560915033|FG001|Overall Study|Other than specified|8|||
155404203|NCT01074190|560915034|FG000|Overall Study|Emergency Cesarean Delivery|1|||
155404204|NCT01074190|560915035|FG001|Overall Study|Emergency Cesarean Delivery|2|||
155404205|NCT01074190|560915036|FG002|Overall Study|Emergency Cesarean Delivery|1|||
155404206|NCT01074190|560915034|FG000|Overall Study|Protocol Violation|2|||
155404207|NCT01074190|560915035|FG001|Overall Study|Protocol Violation|1|||
155404208|NCT01074190|560915036|FG002|Overall Study|Protocol Violation|0|||
155404209|NCT01074190|560915034|FG000|Overall Study|Delivered in under 90 minutes|0|||
155404210|NCT01074190|560915035|FG001|Overall Study|Delivered in under 90 minutes|2|||
155404211|NCT01074190|560915036|FG002|Overall Study|Delivered in under 90 minutes|1|||
155404212|NCT01074190|560915034|FG000|Overall Study|Subject withdrew consent|1|||
155404213|NCT01074190|560915035|FG001|Overall Study|Subject withdrew consent|1|||
155404214|NCT01074190|560915036|FG002|Overall Study|Subject withdrew consent|1|||
155404215|NCT00732303|560915043|FG000|Overall Study|Study Terminated|2|||
155404216|NCT01399788|560915044|FG000|First Intervention Period|Adverse Event|1|||
155404217|NCT01399788|560915045|FG001|First Intervention Period|Adverse Event|0|||
155404218|NCT03699007|560915049|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
155404219|NCT03699007|560915050|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
155404220|NCT03699007|560915049|FG000|6-month Follow Up|Lost to Follow-up|2|||
155404221|NCT03699007|560915050|FG001|6-month Follow Up|Lost to Follow-up|3|||
155404222|NCT04718974|560915051|FG000|Overall Study|Death|0|||
155404223|NCT04718974|560915052|FG001|Overall Study|Death|2|||
155404224|NCT04718974|560915051|FG000|Overall Study|Lost to Follow-up|10|||
155404225|NCT04718974|560915052|FG001|Overall Study|Lost to Follow-up|20|||
155404226|NCT04718974|560915051|FG000|Overall Study|Transferred out|2|||
155404227|NCT04718974|560915052|FG001|Overall Study|Transferred out|4|||
155404228|NCT00845728|560915053|FG000|Overall Study|Abnormal laboratory value (s)|2|||
155404229|NCT00845728|560915054|FG001|Overall Study|Abnormal laboratory value (s)|2|||
155404230|NCT00845728|560915053|FG000|Overall Study|Patient's inability to use the device|4|||
155404231|NCT00845728|560915054|FG001|Overall Study|Patient's inability to use the device|6|||
155404232|NCT00845728|560915053|FG000|Overall Study|Abnormal test procedure result (s)|7|||
155404233|NCT00845728|560915054|FG001|Overall Study|Abnormal test procedure result (s)|2|||
155404234|NCT00845728|560915053|FG000|Overall Study|Lost to Follow-up|22|||
155404235|NCT00845728|560915054|FG001|Overall Study|Lost to Follow-up|13|||
155404236|NCT00845728|560915053|FG000|Overall Study|Death|24|||
155404237|NCT00845728|560915054|FG001|Overall Study|Death|26|||
155404238|NCT00845728|560915053|FG000|Overall Study|Administrative Problems|34|||
155404239|NCT00845728|560915054|FG001|Overall Study|Administrative Problems|26|||
155404240|NCT00845728|560915053|FG000|Overall Study|Protocol Violation|36|||
155404241|NCT00845728|560915054|FG001|Overall Study|Protocol Violation|24|||
155404242|NCT00845728|560915053|FG000|Overall Study|Lack of Efficacy|51|||
155404243|NCT00845728|560915054|FG001|Overall Study|Lack of Efficacy|39|||
155404244|NCT00845728|560915053|FG000|Overall Study|Adverse Event|101|||
155404245|NCT00845728|560915054|FG001|Overall Study|Adverse Event|96|||
155404246|NCT00845728|560915053|FG000|Overall Study|Withdrawal by Subject|105|||
155404247|NCT00845728|560915054|FG001|Overall Study|Withdrawal by Subject|108|||
155404248|NCT01389752|560915055|FG000|Study Period 1|Sponsor decision|0|||
155404249|NCT01389752|560915056|FG001|Study Period 1|Sponsor decision|2|||
155404250|NCT01389752|560915055|FG000|Study Period 2|Sponsor decision|1|||
155404251|NCT01389752|560915056|FG001|Study Period 2|Sponsor decision|0|||
155404252|NCT03259074|560915057|FG000|Overall Study|Adverse Event|9|||
155404253|NCT03259074|560915058|FG001|Overall Study|Adverse Event|12|||
155404254|NCT03259074|560915059|FG002|Overall Study|Adverse Event|8|||
155404255|NCT03259074|560915057|FG000|Overall Study|Death|1|||
155404256|NCT03259074|560915058|FG001|Overall Study|Death|1|||
155404257|NCT03259074|560915059|FG002|Overall Study|Death|3|||
155404258|NCT03259074|560915057|FG000|Overall Study|Lost to Follow-up|2|||
155404259|NCT03259074|560915058|FG001|Overall Study|Lost to Follow-up|4|||
155404260|NCT03259074|560915059|FG002|Overall Study|Lost to Follow-up|3|||
155404261|NCT03259074|560915057|FG000|Overall Study|New Therapy For Study Indication|1|||
155404262|NCT03259074|560915058|FG001|Overall Study|New Therapy For Study Indication|2|||
155404263|NCT03259074|560915059|FG002|Overall Study|New Therapy For Study Indication|2|||
155404264|NCT03259074|560915057|FG000|Overall Study|Physician Decision|4|||
155404265|NCT03259074|560915058|FG001|Overall Study|Physician Decision|12|||
155404266|NCT03259074|560915059|FG002|Overall Study|Physician Decision|10|||
155404267|NCT03259074|560915057|FG000|Overall Study|Pregnancy|1|||
155404268|NCT03259074|560915058|FG001|Overall Study|Pregnancy|1|||
155404269|NCT03259074|560915059|FG002|Overall Study|Pregnancy|0|||
155404270|NCT03259074|560915057|FG000|Overall Study|Progressive Disease|1|||
155404271|NCT03259074|560915058|FG001|Overall Study|Progressive Disease|0|||
155404272|NCT03259074|560915059|FG002|Overall Study|Progressive Disease|0|||
155404273|NCT03259074|560915057|FG000|Overall Study|Protocol Deviation|1|||
155404274|NCT03259074|560915058|FG001|Overall Study|Protocol Deviation|1|||
155404275|NCT03259074|560915059|FG002|Overall Study|Protocol Deviation|3|||
155404276|NCT03259074|560915057|FG000|Overall Study|Subject/Guardian Decision|13|||
155404277|NCT03259074|560915058|FG001|Overall Study|Subject/Guardian Decision|16|||
155404278|NCT03259074|560915059|FG002|Overall Study|Subject/Guardian Decision|14|||
155404279|NCT00053417|560915070|FG000|Overall Study|Adverse Event|1|||
155404280|NCT00053417|560915071|FG001|Overall Study|Adverse Event|0|||
155404281|NCT00053417|560915072|FG002|Overall Study|Adverse Event|1|||
155404282|NCT00053417|560915073|FG003|Overall Study|Adverse Event|5|||
155404283|NCT00053417|560915070|FG000|Overall Study|Non-Compliance|0|||
155404284|NCT00053417|560915071|FG001|Overall Study|Non-Compliance|0|||
155404285|NCT00053417|560915072|FG002|Overall Study|Non-Compliance|0|||
155404286|NCT00053417|560915073|FG003|Overall Study|Non-Compliance|1|||
155404287|NCT00053417|560915070|FG000|Overall Study|Withdrawal by Subject|0|||
155404288|NCT00053417|560915071|FG001|Overall Study|Withdrawal by Subject|1|||
155404289|NCT00053417|560915072|FG002|Overall Study|Withdrawal by Subject|0|||
155404290|NCT00053417|560915073|FG003|Overall Study|Withdrawal by Subject|0|||
155404291|NCT00053417|560915070|FG000|Overall Study|Lost to Follow-up|1|||
155404292|NCT00053417|560915071|FG001|Overall Study|Lost to Follow-up|1|||
155404293|NCT00053417|560915072|FG002|Overall Study|Lost to Follow-up|0|||
155404294|NCT00053417|560915073|FG003|Overall Study|Lost to Follow-up|0|||
155404295|NCT04251910|560915079|FG000|Overall Study|Covid 19 lockdown|0|||
155404296|NCT04251910|560915080|FG001|Overall Study|Covid 19 lockdown|5|||
155404297|NCT04251910|560915081|FG002|Overall Study|Covid 19 lockdown|0|||
155404298|NCT04251910|560915082|FG003|Overall Study|Covid 19 lockdown|4|||
155404299|NCT04251910|560915083|FG004|Overall Study|Covid 19 lockdown|0|||
155404300|NCT04251910|560915084|FG005|Overall Study|Covid 19 lockdown|0|||
155404301|NCT04251910|560915079|FG000|Overall Study|Assisted living facility was closed|0|||
155404302|NCT04251910|560915080|FG001|Overall Study|Assisted living facility was closed|0|||
155404303|NCT04251910|560915081|FG002|Overall Study|Assisted living facility was closed|0|||
155404304|NCT04251910|560915082|FG003|Overall Study|Assisted living facility was closed|0|||
155404305|NCT04251910|560915083|FG004|Overall Study|Assisted living facility was closed|1|||
155404306|NCT04251910|560915084|FG005|Overall Study|Assisted living facility was closed|0|||
155404307|NCT03451084|560915087|FG000|Overall Study|Withdrawal by Subject|2|||
155404308|NCT03451084|560915088|FG001|Overall Study|Withdrawal by Subject|1|||
155404309|NCT03451084|560915089|FG002|Overall Study|Withdrawal by Subject|2|||
155404310|NCT03451084|560915090|FG003|Overall Study|Withdrawal by Subject|1|||
155404311|NCT03451084|560915087|FG000|Overall Study|Disease recurrence|0|||
155404312|NCT03451084|560915088|FG001|Overall Study|Disease recurrence|2|||
155404313|NCT03451084|560915089|FG002|Overall Study|Disease recurrence|0|||
155404314|NCT03451084|560915090|FG003|Overall Study|Disease recurrence|0|||
155404315|NCT03451084|560915087|FG000|Overall Study|Lack of Efficacy|0|||
155404316|NCT03451084|560915088|FG001|Overall Study|Lack of Efficacy|3|||
155404317|NCT03451084|560915089|FG002|Overall Study|Lack of Efficacy|0|||
155404318|NCT03451084|560915090|FG003|Overall Study|Lack of Efficacy|1|||
155404319|NCT03451084|560915087|FG000|Overall Study|Death|1|||
155404320|NCT03451084|560915088|FG001|Overall Study|Death|0|||
155404321|NCT03451084|560915089|FG002|Overall Study|Death|2|||
155404322|NCT03451084|560915090|FG003|Overall Study|Death|0|||
155404323|NCT03451084|560915087|FG000|Overall Study|Physician Decision|0|||
155404324|NCT03451084|560915088|FG001|Overall Study|Physician Decision|0|||
155404325|NCT03451084|560915089|FG002|Overall Study|Physician Decision|2|||
155404326|NCT03451084|560915090|FG003|Overall Study|Physician Decision|2|||
155404327|NCT03451084|560915087|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
155404328|NCT03451084|560915088|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
155404329|NCT03451084|560915089|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
155404330|NCT03451084|560915090|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
155404331|NCT02121262|560915098|FG000|Overall Study|Adverse Event|6|||
155404332|NCT02121262|560915099|FG001|Overall Study|Adverse Event|3|||
155404333|NCT02121262|560915098|FG000|Overall Study|Lack of Efficacy|3|||
155404334|NCT02121262|560915099|FG001|Overall Study|Lack of Efficacy|0|||
155404335|NCT02121262|560915098|FG000|Overall Study|Personal Reasons|19|||
155404336|NCT02121262|560915099|FG001|Overall Study|Personal Reasons|5|||
155404337|NCT02121262|560915098|FG000|Overall Study|Protocol Violation|1|||
155404338|NCT02121262|560915099|FG001|Overall Study|Protocol Violation|1|||
155404339|NCT02121262|560915098|FG000|Overall Study|Participant Dropped-out|0|||
155404340|NCT02121262|560915099|FG001|Overall Study|Participant Dropped-out|1|||
155404341|NCT02121262|560915098|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
155404342|NCT02121262|560915099|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
155404343|NCT02121262|560915098|FG000|Overall Study|Consent Withdrawn|1|||
155404344|NCT02121262|560915099|FG001|Overall Study|Consent Withdrawn|0|||
155404345|NCT01553188|560915102|FG000|Overall Study|Patient choice|1|||
155404346|NCT01553188|560915103|FG001|Overall Study|Patient choice|0|||
155404347|NCT01553188|560915104|FG002|Overall Study|Patient choice|0|||
155404348|NCT01553188|560915105|FG003|Overall Study|Patient choice|0|||
155404349|NCT01553188|560915102|FG000|Overall Study|Intercurrent illness and adverse event|0|||
155404350|NCT01553188|560915103|FG001|Overall Study|Intercurrent illness and adverse event|1|||
155404351|NCT01553188|560915104|FG002|Overall Study|Intercurrent illness and adverse event|2|||
155404352|NCT01553188|560915105|FG003|Overall Study|Intercurrent illness and adverse event|0|||
155404353|NCT05289570|560915106|FG000|Overall Study|Physician Decision|1|||
155404354|NCT04544475|560915107|FG000|Overall Study|Withdrawal by Subject|1|||
155404355|NCT04544475|560915108|FG001|Overall Study|Withdrawal by Subject|3|||
155404356|NCT00964743|560915114|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
155404357|NCT03317795|560915115|FG000|Overall Study|IUD Expulsion|1|||
155404358|NCT03317795|560915116|FG001|Overall Study|IUD Expulsion|0|||
155404359|NCT03317795|560915115|FG000|Overall Study|Lost to Follow-up|1|||
155404360|NCT03317795|560915116|FG001|Overall Study|Lost to Follow-up|3|||
155404361|NCT03317795|560915115|FG000|Overall Study|Treatment change|0|||
155404362|NCT03317795|560915116|FG001|Overall Study|Treatment change|3|||
155404363|NCT03317795|560915115|FG000|Overall Study|Intolerance of medication|0|||
155404364|NCT03317795|560915116|FG001|Overall Study|Intolerance of medication|1|||
155404365|NCT00886600|560915117|FG000|Double-blind Monotherapy|Adverse Event|1|||
155404366|NCT00886600|560915118|FG001|Double-blind Monotherapy|Adverse Event|1|||
155404367|NCT00886600|560915119|FG002|Double-blind Monotherapy|Adverse Event|1|||
155404368|NCT00886600|560915120|FG003|Double-blind Monotherapy|Adverse Event|1|||
155404369|NCT00886600|560915117|FG000|Double-blind Monotherapy|Protocol Violation|0|||
155404370|NCT00886600|560915118|FG001|Double-blind Monotherapy|Protocol Violation|0|||
155404371|NCT00886600|560915119|FG002|Double-blind Monotherapy|Protocol Violation|0|||
155404372|NCT00886600|560915120|FG003|Double-blind Monotherapy|Protocol Violation|1|||
155404373|NCT00886600|560915117|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
155404374|NCT00886600|560915118|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
155404375|NCT00886600|560915119|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
155404376|NCT00886600|560915120|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
155404377|NCT00886600|560915117|FG000|Combination Therapy Period|Adverse Event|0|||
155404378|NCT00886600|560915118|FG001|Combination Therapy Period|Adverse Event|0|||
155404379|NCT00886600|560915119|FG002|Combination Therapy Period|Adverse Event|1|||
155404380|NCT00886600|560915120|FG003|Combination Therapy Period|Adverse Event|0|||
155404381|NCT00886600|560915117|FG000|Combination Therapy Period|Protocol Violation|0|||
155404382|NCT00886600|560915118|FG001|Combination Therapy Period|Protocol Violation|0|||
155404383|NCT00886600|560915119|FG002|Combination Therapy Period|Protocol Violation|1|||
155404384|NCT00886600|560915120|FG003|Combination Therapy Period|Protocol Violation|0|||
155404385|NCT00501007|560915121|FG000|Overall Study|Inclusion criteria not met.|29|||
155404386|NCT00501007|560915122|FG001|Overall Study|Inclusion criteria not met.|25|||
155404387|NCT03917823|560915124|FG000|Overall Study|Lost to Follow-up|1|||
155637405|NCT05028569|561764727|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155637406|NCT05028569|561764728|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155637407|NCT05028569|561764729|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155650636|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
155404388|NCT03917823|560915125|FG001|Overall Study|Lost to Follow-up|1|||
155404389|NCT03917823|560915124|FG000|Overall Study|Withdrawal by Subject|0|||
155404390|NCT03917823|560915125|FG001|Overall Study|Withdrawal by Subject|1|||
155404391|NCT00135668|560915126|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
155404392|NCT00135668|560915127|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
155404393|NCT00135668|560915128|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
155404394|NCT00135668|560915129|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
155404395|NCT02016820|560915130|FG000|Overall Study|Lost to Follow-up|2|||
155404396|NCT02016820|560915131|FG001|Overall Study|Lost to Follow-up|4|||
155404397|NCT00473343|560915134|FG000|Overall Study|Adverse Event|9|||
155404398|NCT00473343|560915134|FG000|Overall Study|Lost to Follow-up|8|||
155404399|NCT00473343|560915134|FG000|Overall Study|Treatment failure|27|||
155404400|NCT00473343|560915134|FG000|Overall Study|Withdrew consent|3|||
155404401|NCT00473343|560915134|FG000|Overall Study|Other un-specified reason|3|||
155404402|NCT02290873|560915135|FG000|Overall Study|Withdrawal by Subject|0|||
155404403|NCT02290873|560915136|FG001|Overall Study|Withdrawal by Subject|1|||
155404404|NCT02290873|560915137|FG002|Overall Study|Withdrawal by Subject|1|||
155404405|NCT02290873|560915135|FG000|Overall Study|Nellcor device error|1|||
155404406|NCT02290873|560915136|FG001|Overall Study|Nellcor device error|0|||
155404407|NCT02290873|560915137|FG002|Overall Study|Nellcor device error|0|||
155404408|NCT02290873|560915135|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
155404409|NCT02290873|560915136|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
155404410|NCT02290873|560915137|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
155404411|NCT02290873|560915135|FG000|Overall Study|Protocol Violation|0|||
155404412|NCT02290873|560915136|FG001|Overall Study|Protocol Violation|0|||
155404413|NCT02290873|560915137|FG002|Overall Study|Protocol Violation|1|||
155404414|NCT03715153|560915138|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
155404415|NCT03715153|560915139|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
155404416|NCT03715153|560915138|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
155404417|NCT03715153|560915139|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
155404418|NCT03715153|560915138|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
155404419|NCT03715153|560915139|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
155404420|NCT03715153|560915138|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
155404421|NCT03715153|560915139|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
155404422|NCT03715153|560915138|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
155404423|NCT03715153|560915139|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
155404424|NCT03715153|560915138|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
155404425|NCT03715153|560915139|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
155404426|NCT01519765|560915142|FG000|Overall Study|Adverse Event|0|||
155404427|NCT01519765|560915143|FG001|Overall Study|Adverse Event|1|||
155404428|NCT01519765|560915142|FG000|Overall Study|Lack of Efficacy|2|||
155637408|NCT05028569|561764730|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155637409|NCT05028569|561764731|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155637410|NCT05028569|561764732|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
155637411|NCT05028569|561764733|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155637412|NCT05028569|561764727|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637413|NCT05028569|561764728|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637414|NCT05028569|561764729|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637415|NCT05028569|561764730|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637416|NCT05028569|561764731|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637417|NCT05028569|561764732|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155637418|NCT05028569|561764733|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
155637419|NCT01136954|561764734|FG000|Overall Study|Adverse Event|3|||
155637420|NCT01136954|561764735|FG001|Overall Study|Adverse Event|2|||
155637421|NCT01136954|561764734|FG000|Overall Study|Withdrawal by Subject|6|||
155637422|NCT01136954|561764735|FG001|Overall Study|Withdrawal by Subject|2|||
155637423|NCT01136954|561764734|FG000|Overall Study|Lack of Efficacy|14|||
155637424|NCT01136954|561764735|FG001|Overall Study|Lack of Efficacy|13|||
155637425|NCT01136954|561764734|FG000|Overall Study|Physician Decision|0|||
155637426|NCT01136954|561764735|FG001|Overall Study|Physician Decision|1|||
155637427|NCT01136954|561764734|FG000|Overall Study|Other|1|||
155404429|NCT01519765|560915143|FG001|Overall Study|Lack of Efficacy|0|||
155404430|NCT01519765|560915142|FG000|Overall Study|Protocol Violation|1|||
155404431|NCT01519765|560915143|FG001|Overall Study|Protocol Violation|0|||
155404432|NCT01519765|560915142|FG000|Overall Study|Withdrawal by Subject|0|||
155404433|NCT01519765|560915143|FG001|Overall Study|Withdrawal by Subject|1|||
155404434|NCT04126083|560915144|FG000|Overall Study|Withdrawal by Subject|1|||
155404435|NCT02437864|560915151|FG000|Overall Study|Protocol Violation|4|||
155404436|NCT02437864|560915152|FG001|Overall Study|Protocol Violation|0|||
155435871|NCT01919411|561022981|FG001|Overall Study|Physician Decision|0|||
155404437|NCT00645593|560915154|FG000|Overall Study|Later found to be ineligible|1|||
155404438|NCT00645593|560915155|FG001|Overall Study|Later found to be ineligible|0|||
155404439|NCT01585272|560915156|FG000|Overall Study|Adverse Event|22|||
155404440|NCT01585272|560915156|FG000|Overall Study|Protocol Violation|7|||
155404441|NCT01585272|560915156|FG000|Overall Study|Withdrawal by Subject|10|||
155404442|NCT02577146|560915157|FG000|Overall Study|Lost to Follow-up|8|||
155404443|NCT02577146|560915157|FG000|Overall Study|Physician Decision|3|||
155404444|NCT02577146|560915157|FG000|Overall Study|Screen Failure|17|||
155404445|NCT00781911|560915160|FG000|Overall Study|Adverse Event|4|||
155404446|NCT00781911|560915161|FG001|Overall Study|Adverse Event|4|||
155404447|NCT00781911|560915160|FG000|Overall Study|Withdrawal by Subject|1|||
155404448|NCT00781911|560915161|FG001|Overall Study|Withdrawal by Subject|2|||
155404449|NCT00781911|560915160|FG000|Overall Study|Physician Decision|0|||
155404450|NCT00781911|560915161|FG001|Overall Study|Physician Decision|2|||
155404451|NCT00781911|560915160|FG000|Overall Study|Sponsor Decision|1|||
155404452|NCT00781911|560915161|FG001|Overall Study|Sponsor Decision|0|||
155404453|NCT01357655|560915162|FG000|Overall Study|Administrative Reason by Sponsor|45|||
155404454|NCT01357655|560915163|FG001|Overall Study|Administrative Reason by Sponsor|0|||
155404455|NCT01357655|560915162|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155404456|NCT01357655|560915163|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155404457|NCT01357655|560915162|FG000|Overall Study|Disease Progression|1|||
155404458|NCT01357655|560915163|FG001|Overall Study|Disease Progression|0|||
155404459|NCT01357655|560915162|FG000|Overall Study|Lost to Follow-up|2|||
155404460|NCT01357655|560915163|FG001|Overall Study|Lost to Follow-up|0|||
155404461|NCT01357655|560915162|FG000|Overall Study|Maximum Clinical Benefit|2|||
155404462|NCT01357655|560915163|FG001|Overall Study|Maximum Clinical Benefit|0|||
155404463|NCT01357655|560915162|FG000|Overall Study|Reason Unspecified|1|||
155404464|NCT01357655|560915163|FG001|Overall Study|Reason Unspecified|0|||
155404465|NCT01357655|560915162|FG000|Overall Study|Study Drug Toxicity|11|||
155404466|NCT01357655|560915163|FG001|Overall Study|Study Drug Toxicity|0|||
155404467|NCT01357655|560915162|FG000|Overall Study|Subject Withdrew Consent|1|||
155404468|NCT01357655|560915163|FG001|Overall Study|Subject Withdrew Consent|0|||
155404469|NCT05003622|560915164|FG000|Overall Study|Progressive disease|2|||
155404470|NCT05003622|560915164|FG000|Overall Study|Withdrawal by Subject|1|||
155404471|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
155404472|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
155404473|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
155404474|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
155404475|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
155404476|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
155404477|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
155404478|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
155404479|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to death|4|||
155404480|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to death|3|||
155404481|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
155404482|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
155404483|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
155404484|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
155742318|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155404485|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
155404486|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
155404487|NCT02258451|560915166|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
155404488|NCT02258451|560915167|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
155404489|NCT02258451|560915166|FG000|Overall Study|Other reason|1|||
155404490|NCT02258451|560915167|FG001|Overall Study|Other reason|1|||
155404491|NCT02258451|560915166|FG000|Overall Study|Never treated|2|||
155404492|NCT02258451|560915167|FG001|Overall Study|Never treated|3|||
155404493|NCT00129766|560916387|FG000|Overall Study|Death|3|||
155404494|NCT00129766|560916388|FG001|Overall Study|Death|8|||
155404495|NCT00129766|560916387|FG000|Overall Study|Withdrawal of consent|31|||
155404496|NCT00129766|560916388|FG001|Overall Study|Withdrawal of consent|30|||
155404497|NCT00129766|560916387|FG000|Overall Study|Lost to Follow-up|26|||
155404498|NCT00129766|560916388|FG001|Overall Study|Lost to Follow-up|21|||
155404499|NCT01081912|560916389|FG000|Conversion/Titration|Adverse Event|47|||
155742319|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155404500|NCT01081912|560916390|FG001|Conversion/Titration|Adverse Event|0|||
155404501|NCT01081912|560916391|FG002|Conversion/Titration|Adverse Event|0|||
155284999|NCT00235495|560474465|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
155404502|NCT01081912|560916389|FG000|Conversion/Titration|Lack of Efficacy|17|||
155404503|NCT01081912|560916390|FG001|Conversion/Titration|Lack of Efficacy|0|||
155404504|NCT01081912|560916391|FG002|Conversion/Titration|Lack of Efficacy|0|||
155404505|NCT01081912|560916389|FG000|Conversion/Titration|Lost to Follow-up|5|||
155404506|NCT01081912|560916390|FG001|Conversion/Titration|Lost to Follow-up|0|||
155404507|NCT01081912|560916391|FG002|Conversion/Titration|Lost to Follow-up|0|||
155404508|NCT01081912|560916389|FG000|Conversion/Titration|Physician Decision|2|||
155404509|NCT01081912|560916390|FG001|Conversion/Titration|Physician Decision|0|||
155404510|NCT01081912|560916391|FG002|Conversion/Titration|Physician Decision|0|||
155404511|NCT01081912|560916389|FG000|Conversion/Titration|Protocol Violation|67|||
155404512|NCT01081912|560916390|FG001|Conversion/Titration|Protocol Violation|0|||
155404513|NCT01081912|560916391|FG002|Conversion/Titration|Protocol Violation|0|||
155404514|NCT01081912|560916389|FG000|Conversion/Titration|Withdrawal by Subject|23|||
155404515|NCT01081912|560916390|FG001|Conversion/Titration|Withdrawal by Subject|0|||
155404516|NCT01081912|560916391|FG002|Conversion/Titration|Withdrawal by Subject|0|||
155404517|NCT01081912|560916389|FG000|Conversion/Titration|Non-Compliance|47|||
155404518|NCT01081912|560916390|FG001|Conversion/Titration|Non-Compliance|0|||
155404519|NCT01081912|560916391|FG002|Conversion/Titration|Non-Compliance|0|||
155404520|NCT01081912|560916389|FG000|Maintenance Treatment|Adverse Event|0|||
155404521|NCT01081912|560916390|FG001|Maintenance Treatment|Adverse Event|2|||
155404522|NCT01081912|560916391|FG002|Maintenance Treatment|Adverse Event|12|||
155404523|NCT01081912|560916389|FG000|Maintenance Treatment|Lack of Efficacy|0|||
155404524|NCT01081912|560916390|FG001|Maintenance Treatment|Lack of Efficacy|14|||
155404525|NCT01081912|560916391|FG002|Maintenance Treatment|Lack of Efficacy|64|||
155404526|NCT01081912|560916389|FG000|Maintenance Treatment|Lost to Follow-up|0|||
155404527|NCT01081912|560916390|FG001|Maintenance Treatment|Lost to Follow-up|1|||
155404528|NCT01081912|560916391|FG002|Maintenance Treatment|Lost to Follow-up|0|||
155404529|NCT01081912|560916389|FG000|Maintenance Treatment|Physician Decision|0|||
155404530|NCT01081912|560916390|FG001|Maintenance Treatment|Physician Decision|0|||
155404531|NCT01081912|560916391|FG002|Maintenance Treatment|Physician Decision|1|||
155404532|NCT01081912|560916389|FG000|Maintenance Treatment|Protocol Violation|0|||
155404533|NCT01081912|560916390|FG001|Maintenance Treatment|Protocol Violation|1|||
155404534|NCT01081912|560916391|FG002|Maintenance Treatment|Protocol Violation|2|||
155404535|NCT01081912|560916389|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
155404536|NCT01081912|560916390|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
155404537|NCT01081912|560916391|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
155404538|NCT01081912|560916389|FG000|Maintenance Treatment|Non-Compliance|0|||
155404539|NCT01081912|560916390|FG001|Maintenance Treatment|Non-Compliance|4|||
155404540|NCT01081912|560916391|FG002|Maintenance Treatment|Non-Compliance|7|||
155404541|NCT01081912|560916389|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
155404542|NCT01081912|560916390|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
155404543|NCT01081912|560916391|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
155404544|NCT02037295|560916392|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
155404545|NCT02037295|560916393|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
155404546|NCT02037295|560916394|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
155404547|NCT02037295|560916395|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
155404548|NCT01140451|560916396|FG000|Overall Study|Withdrawal by Subject|26|||
155404549|NCT01140451|560916397|FG001|Overall Study|Withdrawal by Subject|33|||
155404550|NCT01140451|560916396|FG000|Overall Study|Adverse Event|2|||
155404551|NCT01140451|560916397|FG001|Overall Study|Adverse Event|6|||
155404552|NCT01140451|560916396|FG000|Overall Study|Physician Decision|5|||
155404553|NCT01140451|560916397|FG001|Overall Study|Physician Decision|3|||
155404554|NCT01140451|560916396|FG000|Overall Study|Lost to Follow-up|2|||
155404555|NCT01140451|560916397|FG001|Overall Study|Lost to Follow-up|0|||
155404556|NCT01140451|560916396|FG000|Overall Study|Participants Planning Pregnancy|3|||
155404557|NCT01140451|560916397|FG001|Overall Study|Participants Planning Pregnancy|0|||
155404558|NCT00661531|560916403|FG000|Overall Study|Withdrawal by Subject|3|||
155404559|NCT03134599|560916404|FG000|Week 1|Lost to Follow-up|0|||
155404560|NCT03134599|560916405|FG001|Week 1|Lost to Follow-up|0|||
155404561|NCT03134599|560916406|FG002|Week 1|Lost to Follow-up|0|||
155404562|NCT03134599|560916407|FG003|Week 1|Lost to Follow-up|0|||
155404563|NCT03134599|560916408|FG004|Week 1|Lost to Follow-up|1|||
155404564|NCT03134599|560916409|FG005|Week 1|Lost to Follow-up|0|||
155404565|NCT03134599|560916404|FG000|Week 2|Lost to Follow-up|1|||
155404566|NCT03134599|560916405|FG001|Week 2|Lost to Follow-up|0|||
155404567|NCT03134599|560916406|FG002|Week 2|Lost to Follow-up|0|||
155404568|NCT03134599|560916407|FG003|Week 2|Lost to Follow-up|1|||
155404569|NCT03134599|560916408|FG004|Week 2|Lost to Follow-up|1|||
155404570|NCT03134599|560916409|FG005|Week 2|Lost to Follow-up|0|||
155404571|NCT03134599|560916404|FG000|Week 3|Lost to Follow-up|0|||
155404572|NCT03134599|560916405|FG001|Week 3|Lost to Follow-up|0|||
155404573|NCT03134599|560916406|FG002|Week 3|Lost to Follow-up|0|||
155404574|NCT03134599|560916407|FG003|Week 3|Lost to Follow-up|1|||
155404575|NCT03134599|560916408|FG004|Week 3|Lost to Follow-up|0|||
155404576|NCT03134599|560916409|FG005|Week 3|Lost to Follow-up|1|||
155404577|NCT00705783|560916421|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
155404578|NCT00705783|560916422|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
155435872|NCT01919411|561022980|FG000|Overall Study|Protocol Violation|2|||
155404579|NCT00705783|560916423|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
155404580|NCT00705783|560916421|FG000|Conversion Phase|Lost to Follow-up|13|||
155404581|NCT00705783|560916422|FG001|Conversion Phase|Lost to Follow-up|0|||
155404582|NCT00705783|560916423|FG002|Conversion Phase|Lost to Follow-up|0|||
155404583|NCT00705783|560916421|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
155404584|NCT00705783|560916422|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
155404585|NCT00705783|560916423|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
155404586|NCT00705783|560916421|FG000|Conversion Phase|Withdrawn by Investigator|4|||
155404587|NCT00705783|560916422|FG001|Conversion Phase|Withdrawn by Investigator|0|||
155404588|NCT00705783|560916423|FG002|Conversion Phase|Withdrawn by Investigator|0|||
155404589|NCT00705783|560916421|FG000|Conversion Phase|Withdrew Consent|24|||
155404590|NCT00705783|560916422|FG001|Conversion Phase|Withdrew Consent|0|||
155404591|NCT00705783|560916423|FG002|Conversion Phase|Withdrew Consent|0|||
155404592|NCT00705783|560916421|FG000|Conversion Phase|Protocol Deviation|2|||
155404593|NCT00705783|560916422|FG001|Conversion Phase|Protocol Deviation|0|||
155404594|NCT00705783|560916423|FG002|Conversion Phase|Protocol Deviation|0|||
155404595|NCT00705783|560916421|FG000|Conversion Phase|Adverse Event|11|||
155404596|NCT00705783|560916422|FG001|Conversion Phase|Adverse Event|0|||
155404597|NCT00705783|560916423|FG002|Conversion Phase|Adverse Event|0|||
155404598|NCT00705783|560916421|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
155404599|NCT00705783|560916422|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155404600|NCT00705783|560916423|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155404601|NCT00705783|560916421|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
155404602|NCT00705783|560916422|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155404603|NCT00705783|560916423|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155404604|NCT00705783|560916421|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
155404605|NCT00705783|560916422|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
155404606|NCT00705783|560916423|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
155404607|NCT00705783|560916421|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
155404608|NCT00705783|560916422|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
155404609|NCT00705783|560916423|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
155404610|NCT00705783|560916421|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
155404611|NCT00705783|560916422|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155404612|NCT00705783|560916423|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155404613|NCT00705783|560916421|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
155404614|NCT00705783|560916422|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155404615|NCT00705783|560916423|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155404616|NCT00705783|560916421|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
155404617|NCT00705783|560916422|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
155404618|NCT00705783|560916423|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
155404619|NCT00705783|560916421|FG000|Oral Stabilization Phase|Adverse Event|14|||
155404620|NCT00705783|560916422|FG001|Oral Stabilization Phase|Adverse Event|0|||
155404621|NCT00705783|560916423|FG002|Oral Stabilization Phase|Adverse Event|0|||
155404622|NCT00705783|560916421|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
155404623|NCT00705783|560916422|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155404624|NCT00705783|560916423|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155404625|NCT00705783|560916421|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
155404626|NCT00705783|560916422|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155404627|NCT00705783|560916423|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155404628|NCT00705783|560916421|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
155404629|NCT00705783|560916422|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
155404630|NCT00705783|560916423|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
155404631|NCT00705783|560916421|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
155404632|NCT00705783|560916422|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
155404633|NCT00705783|560916423|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
155404634|NCT00705783|560916421|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
155404635|NCT00705783|560916422|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
155404636|NCT00705783|560916423|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
155404637|NCT00705783|560916421|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
155404638|NCT00705783|560916422|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
155404639|NCT00705783|560916423|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
155404640|NCT00705783|560916421|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
155637428|NCT01136954|561764735|FG001|Overall Study|Other|3|||
155637429|NCT01838876|561764744|FG000|Overall Study|Adverse Event|49|||
155404641|NCT00705783|560916422|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
155404642|NCT00705783|560916423|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
155404643|NCT00705783|560916421|FG000|Depot Stabilization Phase|Adverse Event|17|||
155637430|NCT01838876|561764744|FG000|Overall Study|Insufficient Therapeutic Response|10|||
155404644|NCT00705783|560916422|FG001|Depot Stabilization Phase|Adverse Event|0|||
155404645|NCT00705783|560916423|FG002|Depot Stabilization Phase|Adverse Event|0|||
155404646|NCT00705783|560916421|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
155404647|NCT00705783|560916422|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155404648|NCT00705783|560916423|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155404649|NCT00705783|560916421|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
155404650|NCT00705783|560916422|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155404651|NCT00705783|560916423|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155404652|NCT00705783|560916421|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
155404653|NCT00705783|560916422|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
155404654|NCT00705783|560916423|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
155404655|NCT00705783|560916421|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
155404656|NCT00705783|560916422|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
155404657|NCT00705783|560916423|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
155404658|NCT00705783|560916421|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
155404659|NCT00705783|560916422|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
155404660|NCT00705783|560916423|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
155404661|NCT00705783|560916421|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
155404662|NCT00705783|560916422|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
155404663|NCT00705783|560916423|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
155404664|NCT00705783|560916421|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
155404665|NCT00705783|560916422|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
155404666|NCT00705783|560916423|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
155404667|NCT00705783|560916421|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
155404668|NCT00705783|560916422|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
155404669|NCT00705783|560916423|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
155404670|NCT00705783|560916421|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
155404671|NCT00705783|560916422|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
155404672|NCT00705783|560916423|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
155404673|NCT00705783|560916421|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
155404674|NCT00705783|560916422|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
155404675|NCT00705783|560916423|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
155404676|NCT00705783|560916421|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
155404677|NCT00705783|560916422|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
155404678|NCT00705783|560916423|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
155404679|NCT01549002|560916433|FG000|Overall Study|Excessive pain|0|||
155404680|NCT01549002|560916434|FG001|Overall Study|Excessive pain|2|||
155404681|NCT01549002|560916433|FG000|Overall Study|Moderate sedation required|0|||
155404682|NCT01549002|560916434|FG001|Overall Study|Moderate sedation required|2|||
155404683|NCT01251367|560916435|FG000|Overall Study|Protocol Violation|1|||
155404684|NCT01251367|560916435|FG000|Overall Study|Lack of Efficacy|2|||
155404685|NCT01251367|560916435|FG000|Overall Study|Adverse Event|19|||
155404686|NCT01251367|560916435|FG000|Overall Study|Withdrawal by Subject|36|||
155404687|NCT01251367|560916435|FG000|Overall Study|Lost to Follow-up|5|||
155404688|NCT01251367|560916435|FG000|Overall Study|Subject Required Alternative Treatment|7|||
155404689|NCT01251367|560916435|FG000|Overall Study|No Study Drug Available|1|||
155404690|NCT01251367|560916435|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
155404691|NCT01251367|560916435|FG000|Overall Study|End of Study Visit Performed in Error|1|||
155404692|NCT02370615|560916440|FG000|Overall Study|Adverse Event|1|||
155404693|NCT02370615|560916441|FG001|Overall Study|Adverse Event|0|||
155404694|NCT00506883|560916444|FG000|Overall Study|Lost to Follow-up|1|||
155404695|NCT00506883|560916445|FG001|Overall Study|Lost to Follow-up|1|||
155404696|NCT00506883|560916446|FG002|Overall Study|Lost to Follow-up|1|||
155404697|NCT00506883|560916444|FG000|Overall Study|Withdrawal by Subject|1|||
155404698|NCT00506883|560916445|FG001|Overall Study|Withdrawal by Subject|0|||
155404699|NCT00506883|560916446|FG002|Overall Study|Withdrawal by Subject|1|||
155404700|NCT00506883|560916444|FG000|Overall Study|Lack of Efficacy|0|||
155404701|NCT00506883|560916445|FG001|Overall Study|Lack of Efficacy|1|||
155404702|NCT00506883|560916446|FG002|Overall Study|Lack of Efficacy|1|||
155404703|NCT00506883|560916444|FG000|Overall Study|Other|5|||
155404704|NCT00506883|560916445|FG001|Overall Study|Other|1|||
155404705|NCT00506883|560916446|FG002|Overall Study|Other|1|||
155404706|NCT00078325|560916447|FG000|Overall Study|Adverse Event|15|||
155404707|NCT00078325|560916448|FG001|Overall Study|Adverse Event|10|||
155404708|NCT00078325|560916449|FG002|Overall Study|Adverse Event|5|||
155404709|NCT00078325|560916447|FG000|Overall Study|Protocol Violation|2|||
155742320|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155404710|NCT00078325|560916448|FG001|Overall Study|Protocol Violation|2|||
155404711|NCT00078325|560916449|FG002|Overall Study|Protocol Violation|0|||
155404712|NCT00078325|560916447|FG000|Overall Study|Withdrawal by Subject|1|||
155404713|NCT00078325|560916448|FG001|Overall Study|Withdrawal by Subject|5|||
155404714|NCT00078325|560916449|FG002|Overall Study|Withdrawal by Subject|3|||
155404715|NCT00078325|560916447|FG000|Overall Study|Lost to Follow-up|0|||
155404716|NCT00078325|560916448|FG001|Overall Study|Lost to Follow-up|1|||
155404717|NCT00078325|560916449|FG002|Overall Study|Lost to Follow-up|1|||
155404718|NCT00078325|560916447|FG000|Overall Study|Physician Decision|2|||
155404719|NCT00078325|560916448|FG001|Overall Study|Physician Decision|0|||
155404720|NCT00078325|560916449|FG002|Overall Study|Physician Decision|1|||
155404721|NCT00078325|560916447|FG000|Overall Study|Miscellaneous|1|||
155404722|NCT00078325|560916448|FG001|Overall Study|Miscellaneous|1|||
155404723|NCT00078325|560916449|FG002|Overall Study|Miscellaneous|1|||
155404724|NCT00578136|560916450|FG000|Overall Study|Not given intervention|1|||
155404725|NCT00578136|560916451|FG001|Overall Study|Not given intervention|1|||
155404726|NCT00754793|560916455|FG000|Overall Study|voluntary withdrawn from study|0|||
155404727|NCT00754793|560916456|FG001|Overall Study|voluntary withdrawn from study|1|||
155404728|NCT00932360|560916457|FG000|Washout (One Week)|Withdrawal by Subject|0|||
155404729|NCT00932360|560916458|FG001|Washout (One Week)|Withdrawal by Subject|0|||
155404730|NCT00932360|560916459|FG002|Washout (One Week)|Withdrawal by Subject|0|||
155404731|NCT00932360|560916460|FG003|Washout (One Week)|Withdrawal by Subject|0|||
155404732|NCT00932360|560916461|FG004|Washout (One Week)|Withdrawal by Subject|2|||
155404733|NCT00932360|560916462|FG005|Washout (One Week)|Withdrawal by Subject|0|||
155404734|NCT01892163|560916465|FG000|Overall Study|Death|1|||
155404735|NCT01892163|560916466|FG001|Overall Study|Death|1|||
155404736|NCT01892163|560916465|FG000|Overall Study|Lost to Follow-up|1|||
155404737|NCT01892163|560916466|FG001|Overall Study|Lost to Follow-up|0|||
155404738|NCT01624662|560916470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
155404739|NCT01624662|560916471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
155404740|NCT01624662|560916472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
155404741|NCT01624662|560916473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
155404742|NCT01624662|560916470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
155404743|NCT01624662|560916471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
155404744|NCT01624662|560916472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
155404745|NCT01624662|560916473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
155404746|NCT01624662|560916470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
155404747|NCT01624662|560916471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
155404748|NCT01624662|560916472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
155404749|NCT01624662|560916473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
155404750|NCT01624662|560916470|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
155404751|NCT01624662|560916471|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
155404752|NCT01624662|560916472|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
155404753|NCT01624662|560916473|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
155404754|NCT01624662|560916470|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
155404755|NCT01624662|560916471|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
155404756|NCT01624662|560916472|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
155404757|NCT01624662|560916473|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
155404758|NCT01624662|560916470|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155404759|NCT01624662|560916471|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
155404760|NCT01624662|560916472|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155404761|NCT01624662|560916473|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155404762|NCT01624662|560916470|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
155404763|NCT01624662|560916471|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
155404764|NCT01624662|560916472|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
155404765|NCT01624662|560916473|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
155404766|NCT00361270|560916474|FG000|Overall Study|Death|0|||
155404767|NCT00361270|560916475|FG001|Overall Study|Death|0|||
155404768|NCT00361270|560916476|FG002|Overall Study|Death|0|||
155404769|NCT00361270|560916477|FG003|Overall Study|Death|2|||
155404770|NCT00361270|560916474|FG000|Overall Study|Lost to Follow-up|4|||
155404771|NCT00361270|560916475|FG001|Overall Study|Lost to Follow-up|1|||
155404772|NCT00361270|560916476|FG002|Overall Study|Lost to Follow-up|0|||
155404773|NCT00361270|560916477|FG003|Overall Study|Lost to Follow-up|0|||
155404774|NCT00361270|560916474|FG000|Overall Study|Physician Decision|0|||
155404775|NCT00361270|560916475|FG001|Overall Study|Physician Decision|0|||
155404776|NCT00361270|560916476|FG002|Overall Study|Physician Decision|1|||
155404777|NCT00361270|560916477|FG003|Overall Study|Physician Decision|0|||
155404778|NCT00361270|560916474|FG000|Overall Study|Protocol Violation|9|||
155404779|NCT00361270|560916475|FG001|Overall Study|Protocol Violation|4|||
155404780|NCT00361270|560916476|FG002|Overall Study|Protocol Violation|5|||
155404781|NCT00361270|560916477|FG003|Overall Study|Protocol Violation|4|||
155404782|NCT00361270|560916474|FG000|Overall Study|Withdrawal by Subject|6|||
155404783|NCT00361270|560916475|FG001|Overall Study|Withdrawal by Subject|6|||
155404784|NCT00361270|560916476|FG002|Overall Study|Withdrawal by Subject|3|||
155404785|NCT00361270|560916477|FG003|Overall Study|Withdrawal by Subject|7|||
155404786|NCT00361270|560916474|FG000|Overall Study|Afraid of Hypnosis|1|||
155404787|NCT00361270|560916475|FG001|Overall Study|Afraid of Hypnosis|2|||
155404788|NCT00361270|560916476|FG002|Overall Study|Afraid of Hypnosis|0|||
155404789|NCT00361270|560916477|FG003|Overall Study|Afraid of Hypnosis|0|||
155404790|NCT00361270|560916474|FG000|Overall Study|Problems with Transportation|4|||
155404791|NCT00361270|560916475|FG001|Overall Study|Problems with Transportation|0|||
155404792|NCT00361270|560916476|FG002|Overall Study|Problems with Transportation|0|||
155404793|NCT00361270|560916477|FG003|Overall Study|Problems with Transportation|0|||
155404794|NCT00361270|560916474|FG000|Overall Study|Adverse Event|0|||
155404795|NCT00361270|560916475|FG001|Overall Study|Adverse Event|1|||
155404796|NCT00361270|560916476|FG002|Overall Study|Adverse Event|1|||
155404797|NCT00361270|560916477|FG003|Overall Study|Adverse Event|0|||
155404798|NCT04013529|560916481|FG000|Overall Study|Withdrawal by Subject|1|||
155404799|NCT04013529|560916482|FG001|Overall Study|Withdrawal by Subject|1|||
155404800|NCT00517751|560916488|FG000|Overall Study|Death|3|||
155404801|NCT00517751|560916488|FG000|Overall Study|Withdrawal by Subject|37|||
155404802|NCT00517751|560916488|FG000|Overall Study|Lost to Follow-up|4|||
155404803|NCT00517751|560916488|FG000|Overall Study|patient not over due|6|||
155404804|NCT00517751|560916488|FG000|Overall Study|Patient not due for visit|76|||
155404805|NCT00517751|560916488|FG000|Overall Study|Missing|3|||
155404806|NCT00495820|560916491|FG000|Overall Study|Adverse Event|1|||
155404807|NCT00495820|560916492|FG001|Overall Study|Adverse Event|1|||
155404808|NCT00820950|560916493|FG000|Overall Study|Scheduling Conflict|0|||
155404809|NCT00820950|560916494|FG001|Overall Study|Scheduling Conflict|0|||
155404810|NCT00820950|560916495|FG002|Overall Study|Scheduling Conflict|0|||
155404811|NCT00820950|560916496|FG003|Overall Study|Scheduling Conflict|0|||
155404812|NCT00820950|560916497|FG004|Overall Study|Scheduling Conflict|0|||
155404813|NCT00820950|560916498|FG005|Overall Study|Scheduling Conflict|0|||
155404814|NCT00820950|560916499|FG006|Overall Study|Scheduling Conflict|1|||
155404815|NCT00820950|560916500|FG007|Overall Study|Scheduling Conflict|1|||
155404816|NCT00820950|560916501|FG008|Overall Study|Scheduling Conflict|0|||
155404817|NCT00820950|560916502|FG009|Overall Study|Scheduling Conflict|0|||
155404818|NCT00820950|560916493|FG000|Overall Study|Protocol Violation|1|||
155404819|NCT00820950|560916494|FG001|Overall Study|Protocol Violation|1|||
155742321|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155742322|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155742323|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155742324|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155742325|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
155742326|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
155742327|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
155742328|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742329|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742330|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742331|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742332|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742333|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742334|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155742335|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
155742336|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
155742337|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
155742338|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155742339|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155742340|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155742341|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155404820|NCT00820950|560916495|FG002|Overall Study|Protocol Violation|0|||
155404821|NCT00820950|560916496|FG003|Overall Study|Protocol Violation|0|||
155404822|NCT00820950|560916497|FG004|Overall Study|Protocol Violation|0|||
155404823|NCT00820950|560916498|FG005|Overall Study|Protocol Violation|0|||
155404824|NCT00820950|560916499|FG006|Overall Study|Protocol Violation|0|||
155404825|NCT00820950|560916500|FG007|Overall Study|Protocol Violation|0|||
155404826|NCT00820950|560916501|FG008|Overall Study|Protocol Violation|0|||
155404827|NCT00820950|560916502|FG009|Overall Study|Protocol Violation|0|||
155404828|NCT01246583|560916505|FG000|Overall Study|Lost to Follow-up|0|||
155404829|NCT01246583|560916506|FG001|Overall Study|Lost to Follow-up|0|||
155404830|NCT01246583|560916507|FG002|Overall Study|Lost to Follow-up|0|||
155404831|NCT01246583|560916508|FG003|Overall Study|Lost to Follow-up|1|||
155404832|NCT01246583|560916505|FG000|Overall Study|Protocol Violation|0|||
155404833|NCT01246583|560916506|FG001|Overall Study|Protocol Violation|0|||
155404834|NCT01246583|560916507|FG002|Overall Study|Protocol Violation|1|||
155404835|NCT01246583|560916508|FG003|Overall Study|Protocol Violation|0|||
155404836|NCT01246583|560916505|FG000|Overall Study|Withdrawal by Subject|1|||
155404837|NCT01246583|560916506|FG001|Overall Study|Withdrawal by Subject|0|||
155404838|NCT01246583|560916507|FG002|Overall Study|Withdrawal by Subject|0|||
155404839|NCT01246583|560916508|FG003|Overall Study|Withdrawal by Subject|0|||
155404840|NCT05264740|560916509|FG000|Baseline|Withdrawal by Subject|0|||
155404841|NCT05264740|560916510|FG001|Baseline|Withdrawal by Subject|1|||
155404842|NCT05264740|560916509|FG000|Follow Up 1|Lost to Follow-up|1|||
155404843|NCT05264740|560916510|FG001|Follow Up 1|Lost to Follow-up|1|||
155404844|NCT05264740|560916509|FG000|Follow Up 1|Withdrawal by Subject|0|||
155404845|NCT05264740|560916510|FG001|Follow Up 1|Withdrawal by Subject|1|||
155404846|NCT05264740|560916509|FG000|Follow Up 2|Lost to Follow-up|1|||
155404847|NCT05264740|560916510|FG001|Follow Up 2|Lost to Follow-up|4|||
155404848|NCT05264740|560916509|FG000|Follow Up 3|Lost to Follow-up|7|||
155404849|NCT05264740|560916510|FG001|Follow Up 3|Lost to Follow-up|4|||
155404850|NCT05885737|560916514|FG000|DB Period|Adverse Event|4|||
155404851|NCT05885737|560916515|FG001|DB Period|Adverse Event|4|||
155404852|NCT05885737|560916514|FG000|DB Period|Lost to Follow-up|0|||
155404853|NCT05885737|560916515|FG001|DB Period|Lost to Follow-up|1|||
155404854|NCT05885737|560916514|FG000|DB Period|Physician Decision|2|||
155404855|NCT05885737|560916515|FG001|DB Period|Physician Decision|0|||
155404856|NCT05885737|560916514|FG000|DB Period|Withdrawal by Subject|12|||
155404857|NCT05885737|560916515|FG001|DB Period|Withdrawal by Subject|6|||
155404858|NCT05885737|560916514|FG000|DB Period|Other: Unspecified|2|||
155404859|NCT05885737|560916515|FG001|DB Period|Other: Unspecified|2|||
155404860|NCT05885737|560916514|FG000|OLE Period|Adverse Event|3|||
155404861|NCT05885737|560916515|FG001|OLE Period|Adverse Event|2|||
155404862|NCT05885737|560916514|FG000|OLE Period|Physician Decision|1|||
155404863|NCT05885737|560916515|FG001|OLE Period|Physician Decision|0|||
155404864|NCT05885737|560916514|FG000|OLE Period|Withdrawal by Subject|5|||
155404865|NCT05885737|560916515|FG001|OLE Period|Withdrawal by Subject|5|||
155404866|NCT05885737|560916514|FG000|OLE Period|Other: Unspecified|2|||
155404867|NCT05885737|560916515|FG001|OLE Period|Other: Unspecified|1|||
155404868|NCT02484911|560918137|FG000|Overall Study|Withdrawal by Subject|2|||
155404869|NCT02484911|560918138|FG001|Overall Study|Withdrawal by Subject|1|||
155404870|NCT02484911|560918137|FG000|Overall Study|Protocol Violation|2|||
155404871|NCT02484911|560918138|FG001|Overall Study|Protocol Violation|1|||
155404872|NCT04129528|560918139|FG000|Overall Study|Adverse Event|1|||
155404873|NCT04129528|560918140|FG001|Overall Study|Adverse Event|0|||
155404874|NCT04129528|560918139|FG000|Overall Study|Physician Decision|1|||
155404875|NCT04129528|560918140|FG001|Overall Study|Physician Decision|1|||
155404876|NCT04129528|560918139|FG000|Overall Study|Withdrawal by Subject|1|||
155404877|NCT04129528|560918140|FG001|Overall Study|Withdrawal by Subject|1|||
155404878|NCT00490568|560918146|FG000|Overall Study|Adverse Event|116|||
155404879|NCT00490568|560918146|FG000|Overall Study|Lost to Follow-up|13|||
155404880|NCT00490568|560918146|FG000|Overall Study|Protocol Violation|45|||
155404881|NCT00490568|560918146|FG000|Overall Study|Withdrawal by Subject|135|||
155404882|NCT00490568|560918146|FG000|Overall Study|Still in the study at termination|974|||
155404883|NCT00490568|560918146|FG000|Overall Study|Other|1|||
155404884|NCT00490568|560918146|FG000|Overall Study|Exclusion criteria met|1|||
155404885|NCT00490568|560918146|FG000|Overall Study|Caregiver related|20|||
155404886|NCT00490568|560918146|FG000|Overall Study|Abnormal ECG|25|||
155404887|NCT00490568|560918146|FG000|Overall Study|Participant refused follow-up|9|||
155404888|NCT00490568|560918146|FG000|Overall Study|Legal representative withdrew consent|1|||
155404889|NCT00490568|560918146|FG000|Overall Study|Disease progression|4|||
155404890|NCT00490568|560918146|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
155404891|NCT00490568|560918146|FG000|Overall Study|Investigator decision|3|||
155404892|NCT00490568|560918146|FG000|Overall Study|Non-Compliance|7|||
155404893|NCT00490568|560918146|FG000|Overall Study|Efficacy related|3|||
155404894|NCT00490568|560918146|FG000|Overall Study|Participant died|1|||
155404895|NCT00490568|560918146|FG000|Overall Study|Participant withdrawal due to surgery|1|||
155404896|NCT01351389|560918150|FG000|Overall Study|Withdrawal by Subject|7|||
155404897|NCT01351389|560918151|FG001|Overall Study|Withdrawal by Subject|0|||
155404898|NCT01351389|560918150|FG000|Overall Study|did not complete intervention|23|||
155404899|NCT01351389|560918151|FG001|Overall Study|did not complete intervention|15|||
155404900|NCT03776175|560918153|FG000|Treatment Period (42 Days)|Adverse Event|0|||
155404901|NCT03776175|560918154|FG001|Treatment Period (42 Days)|Adverse Event|1|||
155404902|NCT03776175|560918155|FG002|Treatment Period (42 Days)|Adverse Event|1|||
155404903|NCT03776175|560918156|FG003|Treatment Period (42 Days)|Adverse Event|0|||
155404904|NCT03776175|560918153|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
155637431|NCT01838876|561764744|FG000|Overall Study|Protocol Violation|34|||
155404905|NCT03776175|560918154|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
155637432|NCT01838876|561764744|FG000|Overall Study|Withdrawal of Consent|33|||
155404906|NCT03776175|560918155|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
155637433|NCT01838876|561764744|FG000|Overall Study|Lost to Follow-up|21|||
155637434|NCT01838876|561764744|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
155404907|NCT03776175|560918156|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
155404908|NCT03776175|560918153|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
155404909|NCT03776175|560918154|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
155404910|NCT03776175|560918155|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
155404911|NCT03776175|560918156|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
155637435|NCT01838876|561764744|FG000|Overall Study|Reason not Specified|7|||
155404912|NCT03776175|560918153|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
155404913|NCT03776175|560918154|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
155404914|NCT03776175|560918155|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
155404915|NCT03776175|560918156|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
155404916|NCT03776175|560918153|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
155404917|NCT03776175|560918154|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
155404918|NCT03776175|560918155|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
155404919|NCT03776175|560918156|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
155404920|NCT03776175|560918153|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
155404921|NCT03776175|560918154|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
155404922|NCT03776175|560918155|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
155404923|NCT03776175|560918156|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
155404924|NCT02770547|560918160|FG000|Overall Study|Patient non-compliant|1|||
155404925|NCT02770547|560918161|FG001|Overall Study|Patient non-compliant|0|||
155404926|NCT02770547|560918160|FG000|Overall Study|Adverse Event|0|||
155404927|NCT02770547|560918161|FG001|Overall Study|Adverse Event|1|||
155404928|NCT01324232|560918162|FG000|Overall Study|Protocol Violation|0|||
155404929|NCT01324232|560918163|FG001|Overall Study|Protocol Violation|0|||
155404930|NCT01324232|560918164|FG002|Overall Study|Protocol Violation|0|||
155404931|NCT01324232|560918165|FG003|Overall Study|Protocol Violation|2|||
155404932|NCT01324232|560918162|FG000|Overall Study|Missing|0|||
155404933|NCT01324232|560918163|FG001|Overall Study|Missing|0|||
155404934|NCT01324232|560918164|FG002|Overall Study|Missing|1|||
155404935|NCT01324232|560918165|FG003|Overall Study|Missing|0|||
155404936|NCT01324232|560918162|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
155404937|NCT01324232|560918163|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
155404938|NCT01324232|560918164|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
155404939|NCT01324232|560918165|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
155404940|NCT01324232|560918162|FG000|Overall Study|Lack of Efficacy|2|||
155404941|NCT01324232|560918163|FG001|Overall Study|Lack of Efficacy|1|||
155404942|NCT01324232|560918164|FG002|Overall Study|Lack of Efficacy|2|||
155404943|NCT01324232|560918165|FG003|Overall Study|Lack of Efficacy|2|||
155404944|NCT01324232|560918162|FG000|Overall Study|Participant Refused Medication|0|||
155404945|NCT01324232|560918163|FG001|Overall Study|Participant Refused Medication|1|||
155404946|NCT01324232|560918164|FG002|Overall Study|Participant Refused Medication|0|||
155404947|NCT01324232|560918165|FG003|Overall Study|Participant Refused Medication|0|||
155404948|NCT01324232|560918162|FG000|Overall Study|Intercurrent illness|0|||
155404949|NCT01324232|560918163|FG001|Overall Study|Intercurrent illness|0|||
155404950|NCT01324232|560918164|FG002|Overall Study|Intercurrent illness|0|||
155404951|NCT01324232|560918165|FG003|Overall Study|Intercurrent illness|1|||
155404952|NCT01324232|560918162|FG000|Overall Study|Adverse Event|2|||
155404953|NCT01324232|560918163|FG001|Overall Study|Adverse Event|5|||
155404954|NCT01324232|560918164|FG002|Overall Study|Adverse Event|6|||
155404955|NCT01324232|560918165|FG003|Overall Study|Adverse Event|6|||
155404956|NCT01324232|560918162|FG000|Overall Study|Withdrawal by Subject|0|||
155404957|NCT01324232|560918163|FG001|Overall Study|Withdrawal by Subject|3|||
155404958|NCT01324232|560918164|FG002|Overall Study|Withdrawal by Subject|4|||
155404959|NCT01324232|560918165|FG003|Overall Study|Withdrawal by Subject|0|||
155404960|NCT01324232|560918162|FG000|Overall Study|Lost to Follow-up|1|||
155404961|NCT01324232|560918163|FG001|Overall Study|Lost to Follow-up|0|||
155404962|NCT01324232|560918164|FG002|Overall Study|Lost to Follow-up|0|||
155404963|NCT01324232|560918165|FG003|Overall Study|Lost to Follow-up|0|||
155404964|NCT00393887|560918166|FG000|Overall Study|Physician Decision|5|||
155404965|NCT00393887|560918167|FG001|Overall Study|Physician Decision|0|||
155404966|NCT00393887|560918166|FG000|Overall Study|Lost to Follow-up|11|||
155404967|NCT00393887|560918167|FG001|Overall Study|Lost to Follow-up|9|||
155404968|NCT01265615|560918168|FG000|Overall Study|Protocol Violation|2|||
155404969|NCT01265615|560918169|FG001|Overall Study|Protocol Violation|2|||
155404970|NCT01265615|560918170|FG002|Overall Study|Protocol Violation|4|||
155404971|NCT01265615|560918171|FG003|Overall Study|Protocol Violation|3|||
155404972|NCT01732796|560918172|FG000|Overall Study|Adverse Event|16|||
155404973|NCT01732796|560918173|FG001|Overall Study|Adverse Event|16|||
155404974|NCT01732796|560918174|FG002|Overall Study|Adverse Event|4|||
155404975|NCT01732796|560918172|FG000|Overall Study|Lack of Efficacy|21|||
155404976|NCT01732796|560918173|FG001|Overall Study|Lack of Efficacy|18|||
155404977|NCT01732796|560918174|FG002|Overall Study|Lack of Efficacy|5|||
155404978|NCT01732796|560918172|FG000|Overall Study|Lost to Follow-up|2|||
155404979|NCT01732796|560918173|FG001|Overall Study|Lost to Follow-up|0|||
155404980|NCT01732796|560918174|FG002|Overall Study|Lost to Follow-up|0|||
155404981|NCT01732796|560918172|FG000|Overall Study|Withdrawal by Subject|6|||
155404982|NCT01732796|560918173|FG001|Overall Study|Withdrawal by Subject|8|||
155404983|NCT01732796|560918174|FG002|Overall Study|Withdrawal by Subject|2|||
155404984|NCT01732796|560918172|FG000|Overall Study|Other reason not defined above|1|||
155404985|NCT01732796|560918173|FG001|Overall Study|Other reason not defined above|0|||
155404986|NCT01732796|560918174|FG002|Overall Study|Other reason not defined above|2|||
155404987|NCT00876187|560918176|FG000|Overall Study|Adverse Event|14|||
155404988|NCT00876187|560918177|FG001|Overall Study|Adverse Event|12|||
155404989|NCT00876187|560918178|FG002|Overall Study|Adverse Event|19|||
155404990|NCT00876187|560918179|FG003|Overall Study|Adverse Event|29|||
155404991|NCT00876187|560918180|FG004|Overall Study|Adverse Event|10|||
155404992|NCT00876187|560918176|FG000|Overall Study|Lack of Efficacy|59|||
155404993|NCT00876187|560918177|FG001|Overall Study|Lack of Efficacy|34|||
155404994|NCT00876187|560918178|FG002|Overall Study|Lack of Efficacy|45|||
155404995|NCT00876187|560918179|FG003|Overall Study|Lack of Efficacy|34|||
155404996|NCT00876187|560918180|FG004|Overall Study|Lack of Efficacy|59|||
155404997|NCT00876187|560918176|FG000|Overall Study|Lost to Follow-up|9|||
155404998|NCT00876187|560918177|FG001|Overall Study|Lost to Follow-up|10|||
155404999|NCT00876187|560918178|FG002|Overall Study|Lost to Follow-up|8|||
155405000|NCT00876187|560918179|FG003|Overall Study|Lost to Follow-up|8|||
155405001|NCT00876187|560918180|FG004|Overall Study|Lost to Follow-up|11|||
155405002|NCT00876187|560918176|FG000|Overall Study|Protocol Violation|6|||
155405003|NCT00876187|560918177|FG001|Overall Study|Protocol Violation|7|||
155405004|NCT00876187|560918178|FG002|Overall Study|Protocol Violation|7|||
155405005|NCT00876187|560918179|FG003|Overall Study|Protocol Violation|6|||
155405006|NCT00876187|560918180|FG004|Overall Study|Protocol Violation|3|||
155405007|NCT00876187|560918176|FG000|Overall Study|Withdrawal by Subject|16|||
155405008|NCT00876187|560918177|FG001|Overall Study|Withdrawal by Subject|26|||
155405009|NCT00876187|560918178|FG002|Overall Study|Withdrawal by Subject|32|||
155405010|NCT00876187|560918179|FG003|Overall Study|Withdrawal by Subject|38|||
155405011|NCT00876187|560918180|FG004|Overall Study|Withdrawal by Subject|37|||
155405012|NCT00876187|560918176|FG000|Overall Study|Entered extension study|101|||
155405013|NCT00876187|560918177|FG001|Overall Study|Entered extension study|120|||
155405014|NCT00876187|560918178|FG002|Overall Study|Entered extension study|156|||
155405015|NCT00876187|560918179|FG003|Overall Study|Entered extension study|151|||
155405016|NCT00876187|560918180|FG004|Overall Study|Entered extension study|144|||
155405017|NCT00876187|560918176|FG000|Overall Study|Randomized but not treated|3|||
155405018|NCT00876187|560918177|FG001|Overall Study|Randomized but not treated|1|||
155405019|NCT00876187|560918178|FG002|Overall Study|Randomized but not treated|3|||
155405020|NCT00876187|560918179|FG003|Overall Study|Randomized but not treated|2|||
155405021|NCT00876187|560918180|FG004|Overall Study|Randomized but not treated|3|||
155405022|NCT00876187|560918176|FG000|Overall Study|Other|2|||
155405023|NCT00876187|560918177|FG001|Overall Study|Other|5|||
155405024|NCT00876187|560918178|FG002|Overall Study|Other|9|||
155405025|NCT00876187|560918179|FG003|Overall Study|Other|7|||
155405026|NCT00876187|560918180|FG004|Overall Study|Other|4|||
155405027|NCT00838331|560918181|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
155405028|NCT01379274|560918182|FG000|Overall Study|funding withdrawn|1|||
155405029|NCT03200366|560918183|FG000|Patient Navigation Intervention Given|Death|0|||
155405030|NCT03200366|560918184|FG001|Patient Navigation Intervention Given|Death|2|||
155405031|NCT03200366|560918185|FG002|Patient Navigation Intervention Given|Death|0|||
155405032|NCT03200366|560918183|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
155405033|NCT03200366|560918184|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
155405034|NCT03200366|560918185|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
155405035|NCT03200366|560918183|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
155405036|NCT03200366|560918184|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
155405037|NCT03200366|560918185|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
155405038|NCT03200366|560918183|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
155405039|NCT03200366|560918184|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
155405040|NCT03200366|560918185|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
155405041|NCT03200366|560918183|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
155405042|NCT03200366|560918184|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
155405043|NCT03200366|560918185|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
155405044|NCT03200366|560918183|FG000|6 Month Post-Baseline Interview|Death|1|||
155405045|NCT03200366|560918184|FG001|6 Month Post-Baseline Interview|Death|1|||
155405046|NCT03200366|560918185|FG002|6 Month Post-Baseline Interview|Death|1|||
155405047|NCT03200366|560918183|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
155405048|NCT03200366|560918184|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
155405049|NCT03200366|560918185|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
155405050|NCT03200366|560918183|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
155405051|NCT03200366|560918184|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
155405052|NCT03200366|560918185|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
155405053|NCT03200366|560918183|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
155405054|NCT03200366|560918184|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
155405055|NCT03200366|560918185|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
155405056|NCT03200366|560918183|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
155435873|NCT01919411|561022981|FG001|Overall Study|Protocol Violation|1|||
155637436|NCT01838876|561764744|FG000|Overall Study|Did not meet eligibility criteria|78|||
155405057|NCT03200366|560918184|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
155405058|NCT03200366|560918185|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
155405059|NCT03200366|560918183|FG000|9 Month Post-Baseline Interview|Death|1|||
155405060|NCT03200366|560918184|FG001|9 Month Post-Baseline Interview|Death|1|||
155405061|NCT03200366|560918185|FG002|9 Month Post-Baseline Interview|Death|1|||
155405062|NCT03200366|560918183|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
155405063|NCT03200366|560918184|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
155405064|NCT03200366|560918185|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
155405065|NCT03200366|560918183|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
155405066|NCT03200366|560918184|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
155405067|NCT03200366|560918185|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
155405068|NCT03200366|560918183|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
155405069|NCT03200366|560918184|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
155405070|NCT03200366|560918185|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
155405071|NCT00405067|560918186|FG000|Overall Study|Adverse Event|4|||
155405072|NCT00405067|560918187|FG001|Overall Study|Adverse Event|9|||
155405073|NCT00405067|560918188|FG002|Overall Study|Adverse Event|4|||
155405074|NCT00405067|560918186|FG000|Overall Study|Lost to Follow-up|0|||
155405075|NCT00405067|560918187|FG001|Overall Study|Lost to Follow-up|0|||
155405076|NCT00405067|560918188|FG002|Overall Study|Lost to Follow-up|1|||
155405077|NCT03287219|560918189|FG000|Overall Study|Protocol Violation|0|||
155405078|NCT03287219|560918190|FG001|Overall Study|Protocol Violation|2|||
155405079|NCT00930761|560918191|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
155405080|NCT00930761|560918192|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
155405081|NCT00930761|560918191|FG000|Overall Study|less than 3 music therapy sessions|0|||
155405082|NCT00930761|560918192|FG001|Overall Study|less than 3 music therapy sessions|3|||
155405083|NCT03571646|560918193|FG000|Overall Study|Adverse Event|1|||
155405084|NCT03571646|560918194|FG001|Overall Study|Adverse Event|0|||
155405085|NCT03571646|560918193|FG000|Overall Study|Withdrawal by Subject|1|||
155405086|NCT03571646|560918194|FG001|Overall Study|Withdrawal by Subject|1|||
155405087|NCT01576549|560918195|FG000|Overall Study|Sponsor Decision|2|||
155405088|NCT04081363|560918196|FG000|Overall Study|Withdrawal by Subject|1|||
155405089|NCT04081363|560918197|FG001|Overall Study|Withdrawal by Subject|0|||
155405090|NCT01765920|560918199|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
155405091|NCT01765920|560918200|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
155405092|NCT01765920|560918199|FG000|Overall Study|Patient code disclosure|0|||
155405093|NCT01765920|560918200|FG001|Overall Study|Patient code disclosure|1|||
155405094|NCT02025907|560918201|FG000|Overall Study|Lack of Efficacy|1|||
155405095|NCT02025907|560918202|FG001|Overall Study|Lack of Efficacy|0|||
155405096|NCT02025907|560918201|FG000|Overall Study|Withdrawal by Subject|15|||
155405097|NCT02025907|560918202|FG001|Overall Study|Withdrawal by Subject|8|||
155405098|NCT02025907|560918201|FG000|Overall Study|Protocol Violation|2|||
155405099|NCT02025907|560918202|FG001|Overall Study|Protocol Violation|0|||
155405100|NCT02025907|560918201|FG000|Overall Study|Physician Decision|2|||
155405101|NCT02025907|560918202|FG001|Overall Study|Physician Decision|0|||
155405102|NCT02025907|560918201|FG000|Overall Study|Lost to Follow-up|2|||
155405103|NCT02025907|560918202|FG001|Overall Study|Lost to Follow-up|2|||
155405104|NCT02025907|560918201|FG000|Overall Study|Adverse Event|3|||
155405105|NCT02025907|560918202|FG001|Overall Study|Adverse Event|1|||
155405106|NCT02025907|560918201|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
155405107|NCT02025907|560918202|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
155405108|NCT02411539|560918208|FG000|Overall Study|Lost to Follow-up|2|||
155405109|NCT02411539|560918209|FG001|Overall Study|Lost to Follow-up|0|||
155405110|NCT02411539|560918208|FG000|Overall Study|Confounding medical condition|0|||
155405111|NCT02411539|560918209|FG001|Overall Study|Confounding medical condition|1|||
155405112|NCT00939783|560918210|FG000|Overall Study|Death|6|||
155405113|NCT00939783|560918210|FG000|Overall Study|Adverse Event|39|||
155405114|NCT00939783|560918210|FG000|Overall Study|Study Terminated by Sponsor|498|||
155405115|NCT00939783|560918210|FG000|Overall Study|Withdrawal by Subject|78|||
155405116|NCT00939783|560918210|FG000|Overall Study|Other|16|||
155405117|NCT00939783|560918210|FG000|Overall Study|Lost to Follow-up|8|||
155405118|NCT00939783|560918210|FG000|Overall Study|Protocol Violation|3|||
155405119|NCT00939783|560918210|FG000|Overall Study|Enrolled but not treated|1|||
155405120|NCT01439204|560918216|FG000|Overall Study|Withdrawal by Subject|0|||
155405121|NCT01439204|560918217|FG001|Overall Study|Withdrawal by Subject|1|||
155405122|NCT01439204|560918216|FG000|Overall Study|Lost to Follow-up|0|||
155405123|NCT01439204|560918217|FG001|Overall Study|Lost to Follow-up|2|||
155405124|NCT01439204|560918216|FG000|Overall Study|No longer meets study criteria|1|||
155405125|NCT01439204|560918217|FG001|Overall Study|No longer meets study criteria|0|||
155405126|NCT01439204|560918216|FG000|Overall Study|poor/non-compliance|3|||
155405127|NCT01439204|560918217|FG001|Overall Study|poor/non-compliance|0|||
155405128|NCT02255409|560918218|FG000|Overall Study|Administrative Reason|3|||
155405129|NCT02255409|560918219|FG001|Overall Study|Administrative Reason|7|||
155405130|NCT02255409|560918218|FG000|Overall Study|Withdrawal by Subject|1|||
155405131|NCT02255409|560918219|FG001|Overall Study|Withdrawal by Subject|5|||
155405132|NCT02255409|560918218|FG000|Overall Study|Lost to Follow-up|10|||
155405133|NCT02255409|560918219|FG001|Overall Study|Lost to Follow-up|19|||
155405134|NCT03775421|560918221|FG000|Overall Study|Lost to Follow-up|2|||
155405135|NCT03775421|560918221|FG000|Overall Study|Withdrawal by Subject|10|||
155405136|NCT03775421|560918221|FG000|Overall Study|Physician Decision|3|||
155405137|NCT03775421|560918221|FG000|Overall Study|Death|1|||
155405138|NCT03775421|560918221|FG000|Overall Study|Study Terminated by Sponsor|94|||
155405139|NCT02287623|560918229|FG000|Overall Study|Protocol Violation|0|||
155405140|NCT02287623|560918230|FG001|Overall Study|Protocol Violation|1|||
155405141|NCT02700997|560918231|FG000|Overall Study|Did not undergo CT imaging|1|||
155405142|NCT02700997|560918231|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
155405143|NCT00455013|560918235|FG000|Short Term Period|Adverse Event|2|||
155405144|NCT00455013|560918236|FG001|Short Term Period|Adverse Event|5|||
155405145|NCT00455013|560918237|FG002|Short Term Period|Adverse Event|0|||
155405146|NCT00455013|560918235|FG000|Short Term Period|Withdrawal by Subject|0|||
155405147|NCT00455013|560918236|FG001|Short Term Period|Withdrawal by Subject|0|||
155405148|NCT00455013|560918237|FG002|Short Term Period|Withdrawal by Subject|1|||
155405149|NCT00455013|560918235|FG000|Short Term Period|Lack of Efficacy|4|||
155405150|NCT00455013|560918236|FG001|Short Term Period|Lack of Efficacy|0|||
155405151|NCT00455013|560918237|FG002|Short Term Period|Lack of Efficacy|0|||
155405152|NCT00455013|560918235|FG000|Short Term Period|Other|0|||
155405153|NCT00455013|560918236|FG001|Short Term Period|Other|0|||
155405154|NCT00455013|560918237|FG002|Short Term Period|Other|1|||
155405155|NCT00455013|560918235|FG000|Long Term Extension (LTE)|Adverse Event|0|||
155405156|NCT00455013|560918236|FG001|Long Term Extension (LTE)|Adverse Event|1|||
155405157|NCT00455013|560918237|FG002|Long Term Extension (LTE)|Adverse Event|1|||
155405158|NCT00455013|560918235|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
155405159|NCT00455013|560918236|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
155405160|NCT00455013|560918237|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
155405161|NCT00455013|560918235|FG000|Long Term Extension (LTE)|Death|1|||
155405162|NCT00455013|560918236|FG001|Long Term Extension (LTE)|Death|1|||
155405163|NCT00455013|560918237|FG002|Long Term Extension (LTE)|Death|0|||
155405164|NCT00455013|560918235|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
155405165|NCT00455013|560918236|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
155405166|NCT00455013|560918237|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
155405167|NCT00455013|560918235|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
155405168|NCT00455013|560918236|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
155405169|NCT00455013|560918237|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
155405170|NCT00455013|560918235|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
155405171|NCT00455013|560918236|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
155405172|NCT00455013|560918237|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
155405173|NCT00455013|560918235|FG000|Long Term Extension (LTE)|non-specified|0|||
155405174|NCT00455013|560918236|FG001|Long Term Extension (LTE)|non-specified|0|||
155405175|NCT00455013|560918237|FG002|Long Term Extension (LTE)|non-specified|1|||
155405176|NCT01445951|560918238|FG000|Overall Study|Adverse Event|16|||
155405177|NCT01445951|560918239|FG001|Overall Study|Adverse Event|9|||
155405178|NCT01445951|560918240|FG002|Overall Study|Adverse Event|0|||
155405179|NCT01445951|560918238|FG000|Overall Study|Protocol Violation|2|||
155405180|NCT01445951|560918239|FG001|Overall Study|Protocol Violation|2|||
155405181|NCT01445951|560918240|FG002|Overall Study|Protocol Violation|2|||
155405182|NCT01445951|560918238|FG000|Overall Study|Withdrawal by Subject|21|||
155405183|NCT01445951|560918239|FG001|Overall Study|Withdrawal by Subject|16|||
155405184|NCT01445951|560918240|FG002|Overall Study|Withdrawal by Subject|8|||
155405185|NCT01445951|560918238|FG000|Overall Study|Physician Decision|3|||
155405186|NCT01445951|560918239|FG001|Overall Study|Physician Decision|1|||
155405187|NCT01445951|560918240|FG002|Overall Study|Physician Decision|0|||
155405188|NCT01445951|560918238|FG000|Overall Study|Lost to Follow-up|1|||
155405189|NCT01445951|560918239|FG001|Overall Study|Lost to Follow-up|2|||
155405190|NCT01445951|560918240|FG002|Overall Study|Lost to Follow-up|4|||
155405191|NCT01445951|560918238|FG000|Overall Study|Pregnancy|0|||
155405192|NCT01445951|560918239|FG001|Overall Study|Pregnancy|1|||
155405193|NCT01445951|560918240|FG002|Overall Study|Pregnancy|4|||
155405194|NCT01445951|560918238|FG000|Overall Study|Death|0|||
155405195|NCT01445951|560918239|FG001|Overall Study|Death|0|||
155637437|NCT00689936|561764745|FG000|Active Treatment Phase|Adverse Event|68|||
155405196|NCT01445951|560918240|FG002|Overall Study|Death|1|||
155405197|NCT01445951|560918238|FG000|Overall Study|Non-compliance with study drug|1|||
155405198|NCT01445951|560918239|FG001|Overall Study|Non-compliance with study drug|2|||
155405199|NCT01445951|560918240|FG002|Overall Study|Non-compliance with study drug|0|||
155405200|NCT01445951|560918238|FG000|Overall Study|Non-compliance with protocol|0|||
155405201|NCT01445951|560918239|FG001|Overall Study|Non-compliance with protocol|1|||
155405202|NCT01445951|560918240|FG002|Overall Study|Non-compliance with protocol|0|||
155405203|NCT01445951|560918238|FG000|Overall Study|Sponsor decision - subject travel|0|||
155405204|NCT01445951|560918239|FG001|Overall Study|Sponsor decision - subject travel|1|||
155405205|NCT01445951|560918240|FG002|Overall Study|Sponsor decision - subject travel|0|||
155405206|NCT01445951|560918238|FG000|Overall Study|Cough|0|||
155405207|NCT01445951|560918239|FG001|Overall Study|Cough|1|||
155285000|NCT00235495|560474466|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
155285001|NCT02320253|560474467|FG000|Overall Study|Withdrawal by Subject|3|||
155285002|NCT02320253|560474468|FG001|Overall Study|Withdrawal by Subject|0|||
155285003|NCT02320253|560474469|FG002|Overall Study|Withdrawal by Subject|0|||
155285004|NCT02320253|560474467|FG000|Overall Study|Lost to Follow-up|2|||
155405208|NCT01445951|560918240|FG002|Overall Study|Cough|0|||
155405209|NCT03610724|560918241|FG000|Overall Study|Death|17|||
155405210|NCT03610724|560918241|FG000|Overall Study|Lost to Follow-up|1|||
155405211|NCT03610724|560918241|FG000|Overall Study|Physician Decision|1|||
155405212|NCT03610724|560918241|FG000|Overall Study|Died prior to infusion|1|||
155405213|NCT01473563|560918242|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
155405214|NCT00786565|560918246|FG000|Enrollment Prior to Surgery|Site Closed|3|||
155405215|NCT00786565|560918246|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
155405216|NCT00786565|560918246|FG000|Post Surgery|Abnormal macular pucker|1|||
155405217|NCT00786565|560918246|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
155405218|NCT05513625|560918247|FG000|Overall Study|Withdrawal by Subject|1|||
155405219|NCT02943564|560918249|FG000|Overall Study|Miscellaneous Reasons|0|||
155405220|NCT02943564|560918250|FG001|Overall Study|Miscellaneous Reasons|0|||
155405221|NCT02943564|560918251|FG002|Overall Study|Miscellaneous Reasons|3|||
155405222|NCT02943564|560918249|FG000|Overall Study|Site terminated by sponsor|0|||
155405223|NCT02943564|560918250|FG001|Overall Study|Site terminated by sponsor|1|||
155405224|NCT02943564|560918251|FG002|Overall Study|Site terminated by sponsor|0|||
155405225|NCT02943564|560918249|FG000|Overall Study|Non-compliance with study drug|0|||
155405226|NCT02943564|560918250|FG001|Overall Study|Non-compliance with study drug|1|||
155405227|NCT02943564|560918251|FG002|Overall Study|Non-compliance with study drug|0|||
155405228|NCT02943564|560918249|FG000|Overall Study|Pregnancy|0|||
155405229|NCT02943564|560918250|FG001|Overall Study|Pregnancy|1|||
155405230|NCT02943564|560918251|FG002|Overall Study|Pregnancy|1|||
155405231|NCT02943564|560918249|FG000|Overall Study|Protocol Violation|2|||
155405232|NCT02943564|560918250|FG001|Overall Study|Protocol Violation|2|||
155405233|NCT02943564|560918251|FG002|Overall Study|Protocol Violation|2|||
155405234|NCT02943564|560918249|FG000|Overall Study|Lost to Follow-up|1|||
155405235|NCT02943564|560918250|FG001|Overall Study|Lost to Follow-up|0|||
155405236|NCT02943564|560918251|FG002|Overall Study|Lost to Follow-up|0|||
155405237|NCT02943564|560918249|FG000|Overall Study|Withdrawal by Subject|6|||
155405238|NCT02943564|560918250|FG001|Overall Study|Withdrawal by Subject|5|||
155405239|NCT02943564|560918251|FG002|Overall Study|Withdrawal by Subject|2|||
155405240|NCT02943564|560918249|FG000|Overall Study|Adverse Event|1|||
155405241|NCT02943564|560918250|FG001|Overall Study|Adverse Event|2|||
155405242|NCT02943564|560918251|FG002|Overall Study|Adverse Event|1|||
155405243|NCT02943564|560918249|FG000|Overall Study|Lack of Efficacy|0|||
155405244|NCT02943564|560918250|FG001|Overall Study|Lack of Efficacy|1|||
155405245|NCT02943564|560918251|FG002|Overall Study|Lack of Efficacy|0|||
155405246|NCT04143009|560918252|FG000|Pilot Trial|Lost to Follow-up|0|||
155405247|NCT04143009|560918253|FG001|Pilot Trial|Lost to Follow-up|1|||
155405248|NCT04143009|560918254|FG002|Pilot Trial|Lost to Follow-up|1|||
155405249|NCT03116698|560918261|FG000|Overall Study|Adverse Event|1|||
155405250|NCT03116698|560918262|FG001|Overall Study|Adverse Event|1|||
155405251|NCT03116698|560918263|FG002|Overall Study|Adverse Event|1|||
155405252|NCT03116698|560918264|FG003|Overall Study|Adverse Event|0|||
155405253|NCT03116698|560918261|FG000|Overall Study|Withdrawal by Subject|1|||
155405254|NCT03116698|560918262|FG001|Overall Study|Withdrawal by Subject|4|||
155405255|NCT03116698|560918263|FG002|Overall Study|Withdrawal by Subject|5|||
155405256|NCT03116698|560918264|FG003|Overall Study|Withdrawal by Subject|2|||
155405257|NCT03116698|560918261|FG000|Overall Study|Lost to Follow-up|2|||
155405258|NCT03116698|560918262|FG001|Overall Study|Lost to Follow-up|0|||
155405259|NCT03116698|560918263|FG002|Overall Study|Lost to Follow-up|0|||
155405260|NCT03116698|560918264|FG003|Overall Study|Lost to Follow-up|0|||
155405261|NCT03116698|560918261|FG000|Overall Study|Physician Decision|1|||
155405262|NCT03116698|560918262|FG001|Overall Study|Physician Decision|1|||
155405263|NCT03116698|560918263|FG002|Overall Study|Physician Decision|0|||
155405264|NCT03116698|560918264|FG003|Overall Study|Physician Decision|0|||
155405265|NCT03116698|560918261|FG000|Overall Study|Protocol Violation|1|||
155405266|NCT03116698|560918262|FG001|Overall Study|Protocol Violation|0|||
155405267|NCT03116698|560918263|FG002|Overall Study|Protocol Violation|0|||
155405268|NCT03116698|560918264|FG003|Overall Study|Protocol Violation|0|||
155405269|NCT03116698|560918261|FG000|Overall Study|Death|0|||
155405270|NCT03116698|560918262|FG001|Overall Study|Death|0|||
155405271|NCT03116698|560918263|FG002|Overall Study|Death|2|||
155405272|NCT03116698|560918264|FG003|Overall Study|Death|0|||
155405273|NCT00788372|560918265|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
155405274|NCT00788372|560918265|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
155405275|NCT00788372|560918265|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
155405276|NCT00788372|560918265|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
155405277|NCT00788372|560918265|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
155405278|NCT00788372|560918265|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
155405279|NCT00788372|560918265|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
155405280|NCT03099187|560918274|FG000|Double-blind Treatment|Adverse Event|19|||
155405281|NCT03099187|560918275|FG001|Double-blind Treatment|Adverse Event|1|||
155405282|NCT03099187|560918276|FG002|Double-blind Treatment|Adverse Event|0|||
155405283|NCT03099187|560918277|FG003|Double-blind Treatment|Adverse Event|0|||
155405284|NCT03099187|560918274|FG000|Double-blind Treatment|Death|1|||
155405285|NCT03099187|560918275|FG001|Double-blind Treatment|Death|3|||
155405286|NCT03099187|560918276|FG002|Double-blind Treatment|Death|0|||
155405287|NCT03099187|560918277|FG003|Double-blind Treatment|Death|0|||
155405288|NCT03099187|560918274|FG000|Double-blind Treatment|Lack of Efficacy|1|||
155405289|NCT03099187|560918275|FG001|Double-blind Treatment|Lack of Efficacy|0|||
155405290|NCT03099187|560918276|FG002|Double-blind Treatment|Lack of Efficacy|0|||
155405291|NCT03099187|560918277|FG003|Double-blind Treatment|Lack of Efficacy|0|||
155405292|NCT03099187|560918274|FG000|Double-blind Treatment|Physician Decision|2|||
155405293|NCT03099187|560918275|FG001|Double-blind Treatment|Physician Decision|1|||
155405294|NCT03099187|560918276|FG002|Double-blind Treatment|Physician Decision|0|||
155405295|NCT03099187|560918277|FG003|Double-blind Treatment|Physician Decision|0|||
155405296|NCT03099187|560918274|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
155405297|NCT03099187|560918275|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
155405298|NCT03099187|560918276|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
155405299|NCT03099187|560918277|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
155405300|NCT03099187|560918274|FG000|Double-blind Treatment|Lung transplantation|0|||
155405301|NCT03099187|560918275|FG001|Double-blind Treatment|Lung transplantation|1|||
155405302|NCT03099187|560918276|FG002|Double-blind Treatment|Lung transplantation|0|||
155405303|NCT03099187|560918277|FG003|Double-blind Treatment|Lung transplantation|0|||
155405304|NCT03099187|560918274|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
155405305|NCT03099187|560918275|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
155405306|NCT03099187|560918276|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
155405307|NCT03099187|560918277|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
155405308|NCT03099187|560918274|FG000|Double-blind Treatment|Disease progression|0|||
155405309|NCT03099187|560918275|FG001|Double-blind Treatment|Disease progression|1|||
155405310|NCT03099187|560918276|FG002|Double-blind Treatment|Disease progression|0|||
155405311|NCT03099187|560918277|FG003|Double-blind Treatment|Disease progression|0|||
155405312|NCT03099187|560918274|FG000|Double-blind Treatment|Randomization error|0|||
155405313|NCT03099187|560918275|FG001|Double-blind Treatment|Randomization error|2|||
155405314|NCT03099187|560918276|FG002|Double-blind Treatment|Randomization error|0|||
155405315|NCT03099187|560918277|FG003|Double-blind Treatment|Randomization error|0|||
155405316|NCT03099187|560918274|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
155405317|NCT03099187|560918275|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
155405318|NCT03099187|560918276|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
155405319|NCT03099187|560918277|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
155405320|NCT03099187|560918274|FG000|12-month Safety Follow-up|Adverse Event|0|||
155405321|NCT03099187|560918275|FG001|12-month Safety Follow-up|Adverse Event|0|||
155405322|NCT03099187|560918276|FG002|12-month Safety Follow-up|Adverse Event|5|||
155405323|NCT03099187|560918277|FG003|12-month Safety Follow-up|Adverse Event|12|||
155405324|NCT03099187|560918274|FG000|12-month Safety Follow-up|Death|0|||
155405325|NCT03099187|560918275|FG001|12-month Safety Follow-up|Death|0|||
155405326|NCT03099187|560918276|FG002|12-month Safety Follow-up|Death|7|||
155405327|NCT03099187|560918277|FG003|12-month Safety Follow-up|Death|9|||
155405328|NCT03099187|560918274|FG000|12-month Safety Follow-up|Lung transplantation|0|||
155405329|NCT03099187|560918275|FG001|12-month Safety Follow-up|Lung transplantation|0|||
155405330|NCT03099187|560918276|FG002|12-month Safety Follow-up|Lung transplantation|2|||
155405331|NCT03099187|560918277|FG003|12-month Safety Follow-up|Lung transplantation|1|||
155405332|NCT03099187|560918274|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
155405333|NCT03099187|560918275|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
155405334|NCT03099187|560918276|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
155405335|NCT03099187|560918277|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
155405336|NCT03099187|560918274|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
155405337|NCT03099187|560918275|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
155405338|NCT03099187|560918276|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
155405339|NCT03099187|560918277|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
155405340|NCT03099187|560918274|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
155405341|NCT03099187|560918275|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
155405342|NCT03099187|560918276|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
155405343|NCT03099187|560918277|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
155285005|NCT02320253|560474468|FG001|Overall Study|Lost to Follow-up|2|||
155405344|NCT03099187|560918274|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
155405345|NCT03099187|560918275|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
155405346|NCT03099187|560918276|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
155405347|NCT03099187|560918277|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
155405348|NCT01210690|560918280|FG000|Overall Study|Adverse Event|7|||
155405349|NCT01210690|560918280|FG000|Overall Study|Lack of Efficacy|12|||
155405350|NCT01210690|560918280|FG000|Overall Study|Lost to Follow-up|3|||
155405351|NCT01210690|560918280|FG000|Overall Study|Disease Remission|1|||
155405352|NCT01210690|560918280|FG000|Overall Study|Withdrawal by Subject|1|||
155405353|NCT01210690|560918280|FG000|Overall Study|Patient refused to swallow|1|||
155405354|NCT01210690|560918280|FG000|Overall Study|Patient could not take glucose|1|||
155405355|NCT00470054|560918281|FG000|Overall Study|Ineligible|1|||
155405356|NCT00528021|560918285|FG000|Overall Study|Lack of Efficacy|17|||
155405357|NCT00528021|560918286|FG001|Overall Study|Lack of Efficacy|13|||
155405358|NCT00528021|560918287|FG002|Overall Study|Lack of Efficacy|7|||
155405359|NCT00528021|560918288|FG003|Overall Study|Lack of Efficacy|9|||
155405360|NCT01423851|560918289|FG000|Whole Study|Disease progression|2|||
155405361|NCT01423851|560918290|FG001|Whole Study|Disease progression|1|||
155405362|NCT01423851|560918291|FG002|Whole Study|Disease progression|1|||
155405363|NCT01423851|560918292|FG003|Whole Study|Disease progression|4|||
155405364|NCT01423851|560918293|FG004|Whole Study|Disease progression|1|||
155405365|NCT01423851|560918294|FG005|Whole Study|Disease progression|3|||
155405366|NCT01423851|560918295|FG006|Whole Study|Disease progression|1|||
155405367|NCT01423851|560918296|FG007|Whole Study|Disease progression|4|||
155405368|NCT01423851|560918297|FG008|Whole Study|Disease progression|0|||
155405369|NCT01423851|560918298|FG009|Whole Study|Disease progression|2|||
155405370|NCT01423851|560918299|FG010|Whole Study|Disease progression|10|||
155405371|NCT01423851|560918289|FG000|Whole Study|Physician Decision|0|||
155405372|NCT01423851|560918290|FG001|Whole Study|Physician Decision|1|||
155405373|NCT01423851|560918291|FG002|Whole Study|Physician Decision|2|||
155405374|NCT01423851|560918292|FG003|Whole Study|Physician Decision|0|||
155405375|NCT01423851|560918293|FG004|Whole Study|Physician Decision|2|||
155405376|NCT01423851|560918294|FG005|Whole Study|Physician Decision|0|||
155405377|NCT01423851|560918295|FG006|Whole Study|Physician Decision|2|||
155405378|NCT01423851|560918296|FG007|Whole Study|Physician Decision|1|||
155405379|NCT01423851|560918297|FG008|Whole Study|Physician Decision|3|||
155405380|NCT01423851|560918298|FG009|Whole Study|Physician Decision|4|||
155405381|NCT01423851|560918299|FG010|Whole Study|Physician Decision|12|||
155405382|NCT01423851|560918289|FG000|Whole Study|Withdrawal by Subject|1|||
155405383|NCT01423851|560918290|FG001|Whole Study|Withdrawal by Subject|1|||
155405384|NCT01423851|560918291|FG002|Whole Study|Withdrawal by Subject|0|||
155405385|NCT01423851|560918292|FG003|Whole Study|Withdrawal by Subject|0|||
155405386|NCT01423851|560918293|FG004|Whole Study|Withdrawal by Subject|0|||
155405387|NCT01423851|560918294|FG005|Whole Study|Withdrawal by Subject|0|||
155405388|NCT01423851|560918295|FG006|Whole Study|Withdrawal by Subject|0|||
155405389|NCT01423851|560918296|FG007|Whole Study|Withdrawal by Subject|0|||
155405390|NCT01423851|560918297|FG008|Whole Study|Withdrawal by Subject|2|||
155405391|NCT01423851|560918298|FG009|Whole Study|Withdrawal by Subject|0|||
155405392|NCT01423851|560918299|FG010|Whole Study|Withdrawal by Subject|4|||
155405393|NCT01423851|560918289|FG000|Whole Study|Adverse Event|0|||
155405394|NCT01423851|560918290|FG001|Whole Study|Adverse Event|0|||
155405395|NCT01423851|560918291|FG002|Whole Study|Adverse Event|0|||
155405396|NCT01423851|560918292|FG003|Whole Study|Adverse Event|2|||
155405397|NCT01423851|560918293|FG004|Whole Study|Adverse Event|0|||
155405398|NCT01423851|560918294|FG005|Whole Study|Adverse Event|0|||
155405399|NCT01423851|560918295|FG006|Whole Study|Adverse Event|0|||
155405400|NCT01423851|560918296|FG007|Whole Study|Adverse Event|3|||
155405401|NCT01423851|560918297|FG008|Whole Study|Adverse Event|3|||
155405402|NCT01423851|560918298|FG009|Whole Study|Adverse Event|2|||
155405403|NCT01423851|560918299|FG010|Whole Study|Adverse Event|3|||
155405404|NCT01395394|560919926|FG000|Baseline Study Visit|Protocol Violation|1|||
155405405|NCT01395394|560919927|FG001|Baseline Study Visit|Protocol Violation|0|||
155405406|NCT01395394|560919928|FG002|Baseline Study Visit|Protocol Violation|0|||
155405407|NCT05121480|560919929|FG000|Overall Study|Lack of Efficacy|2|||
155405408|NCT05121480|560919930|FG001|Overall Study|Lack of Efficacy|2|||
155405409|NCT05121480|560919931|FG002|Overall Study|Lack of Efficacy|1|||
155405410|NCT05121480|560919932|FG003|Overall Study|Lack of Efficacy|4|||
155742342|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155405411|NCT05121480|560919933|FG004|Overall Study|Lack of Efficacy|0|||
155405412|NCT05121480|560919934|FG005|Overall Study|Lack of Efficacy|1|||
155405413|NCT05121480|560919935|FG006|Overall Study|Lack of Efficacy|0|||
155405414|NCT05121480|560919936|FG007|Overall Study|Lack of Efficacy|2|||
155405415|NCT05121480|560919929|FG000|Overall Study|Treatment Failure|0|||
155405416|NCT05121480|560919930|FG001|Overall Study|Treatment Failure|2|||
155405417|NCT05121480|560919931|FG002|Overall Study|Treatment Failure|0|||
155405418|NCT05121480|560919932|FG003|Overall Study|Treatment Failure|1|||
155405419|NCT05121480|560919933|FG004|Overall Study|Treatment Failure|0|||
155405420|NCT05121480|560919934|FG005|Overall Study|Treatment Failure|0|||
155405421|NCT05121480|560919935|FG006|Overall Study|Treatment Failure|0|||
155405422|NCT05121480|560919936|FG007|Overall Study|Treatment Failure|0|||
155742343|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155742344|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155405423|NCT05121480|560919929|FG000|Overall Study|Adverse Event|0|||
155405424|NCT05121480|560919930|FG001|Overall Study|Adverse Event|1|||
155405425|NCT05121480|560919931|FG002|Overall Study|Adverse Event|0|||
155405426|NCT05121480|560919932|FG003|Overall Study|Adverse Event|5|||
155405427|NCT05121480|560919933|FG004|Overall Study|Adverse Event|3|||
155405428|NCT05121480|560919934|FG005|Overall Study|Adverse Event|2|||
155405429|NCT05121480|560919935|FG006|Overall Study|Adverse Event|0|||
155405430|NCT05121480|560919936|FG007|Overall Study|Adverse Event|4|||
155405431|NCT05121480|560919929|FG000|Overall Study|Withdrawal by Subject|4|||
155405432|NCT05121480|560919930|FG001|Overall Study|Withdrawal by Subject|9|||
155405433|NCT05121480|560919931|FG002|Overall Study|Withdrawal by Subject|1|||
155405434|NCT05121480|560919932|FG003|Overall Study|Withdrawal by Subject|8|||
155405435|NCT05121480|560919933|FG004|Overall Study|Withdrawal by Subject|0|||
155405436|NCT05121480|560919934|FG005|Overall Study|Withdrawal by Subject|9|||
155405437|NCT05121480|560919935|FG006|Overall Study|Withdrawal by Subject|0|||
155405438|NCT05121480|560919936|FG007|Overall Study|Withdrawal by Subject|4|||
155405439|NCT05121480|560919929|FG000|Overall Study|Non-compliance with the protocol|0|||
155405440|NCT05121480|560919930|FG001|Overall Study|Non-compliance with the protocol|0|||
155405441|NCT05121480|560919931|FG002|Overall Study|Non-compliance with the protocol|0|||
155405442|NCT05121480|560919932|FG003|Overall Study|Non-compliance with the protocol|0|||
155405443|NCT05121480|560919933|FG004|Overall Study|Non-compliance with the protocol|1|||
155405444|NCT05121480|560919934|FG005|Overall Study|Non-compliance with the protocol|6|||
155637438|NCT00689936|561764746|FG001|Active Treatment Phase|Adverse Event|71|||
155405445|NCT05121480|560919935|FG006|Overall Study|Non-compliance with the protocol|0|||
155405446|NCT05121480|560919936|FG007|Overall Study|Non-compliance with the protocol|1|||
155405447|NCT05121480|560919929|FG000|Overall Study|Lost to Follow-up|0|||
155405448|NCT05121480|560919930|FG001|Overall Study|Lost to Follow-up|4|||
155405449|NCT05121480|560919931|FG002|Overall Study|Lost to Follow-up|1|||
155405450|NCT05121480|560919932|FG003|Overall Study|Lost to Follow-up|3|||
155405451|NCT05121480|560919933|FG004|Overall Study|Lost to Follow-up|1|||
155405452|NCT05121480|560919934|FG005|Overall Study|Lost to Follow-up|1|||
155405453|NCT05121480|560919935|FG006|Overall Study|Lost to Follow-up|1|||
155405454|NCT05121480|560919936|FG007|Overall Study|Lost to Follow-up|4|||
155405455|NCT05121480|560919929|FG000|Overall Study|Physician Decision|0|||
155405456|NCT05121480|560919930|FG001|Overall Study|Physician Decision|0|||
155405457|NCT05121480|560919931|FG002|Overall Study|Physician Decision|0|||
155405458|NCT05121480|560919932|FG003|Overall Study|Physician Decision|0|||
155405459|NCT05121480|560919933|FG004|Overall Study|Physician Decision|0|||
155405460|NCT05121480|560919934|FG005|Overall Study|Physician Decision|1|||
155405461|NCT05121480|560919935|FG006|Overall Study|Physician Decision|0|||
155405462|NCT05121480|560919936|FG007|Overall Study|Physician Decision|1|||
155405463|NCT05121480|560919929|FG000|Overall Study|Other Reason|0|||
155405464|NCT05121480|560919930|FG001|Overall Study|Other Reason|0|||
155405465|NCT05121480|560919931|FG002|Overall Study|Other Reason|0|||
155405466|NCT05121480|560919932|FG003|Overall Study|Other Reason|0|||
155405467|NCT05121480|560919933|FG004|Overall Study|Other Reason|0|||
155405468|NCT05121480|560919934|FG005|Overall Study|Other Reason|1|||
155405469|NCT05121480|560919935|FG006|Overall Study|Other Reason|1|||
155405470|NCT05121480|560919936|FG007|Overall Study|Other Reason|1|||
155405471|NCT02356562|560919937|FG000|Overall Study|Withdrawal by Subject|0|||
155405472|NCT02356562|560919938|FG001|Overall Study|Withdrawal by Subject|1|||
155405473|NCT02356562|560919937|FG000|Overall Study|Re-entered treatment in a previous study|1|||
155405474|NCT02356562|560919938|FG001|Overall Study|Re-entered treatment in a previous study|0|||
155405475|NCT02356562|560919937|FG000|Overall Study|site closure|1|||
155405476|NCT02356562|560919938|FG001|Overall Study|site closure|0|||
155405477|NCT00412750|560919939|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155405478|NCT00412750|560919940|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155405479|NCT00412750|560919941|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155405480|NCT00412750|560919939|FG000|Overall Study|Administrative problems|21|||
155405481|NCT00412750|560919940|FG001|Overall Study|Administrative problems|17|||
155405482|NCT00412750|560919941|FG002|Overall Study|Administrative problems|14|||
155405483|NCT00412750|560919939|FG000|Overall Study|Adverse Event|8|||
155405484|NCT00412750|560919940|FG001|Overall Study|Adverse Event|3|||
155405485|NCT00412750|560919941|FG002|Overall Study|Adverse Event|3|||
155405486|NCT00412750|560919939|FG000|Overall Study|Lost to Follow-up|1|||
155405487|NCT00412750|560919940|FG001|Overall Study|Lost to Follow-up|0|||
155405488|NCT00412750|560919941|FG002|Overall Study|Lost to Follow-up|1|||
155405489|NCT00412750|560919939|FG000|Overall Study|Withdrawal by Subject|0|||
155405490|NCT00412750|560919940|FG001|Overall Study|Withdrawal by Subject|1|||
155405491|NCT00412750|560919941|FG002|Overall Study|Withdrawal by Subject|2|||
155405492|NCT00412750|560919939|FG000|Overall Study|Lack of Efficacy|0|||
155405493|NCT00412750|560919940|FG001|Overall Study|Lack of Efficacy|0|||
155405494|NCT00412750|560919941|FG002|Overall Study|Lack of Efficacy|3|||
155637439|NCT00689936|561764747|FG002|Active Treatment Phase|Adverse Event|76|||
155405495|NCT01157078|560919942|FG000|Overall Study|Withdrawal by Subject|12|||
155405496|NCT01157078|560919943|FG001|Overall Study|Withdrawal by Subject|14|||
155405497|NCT01157078|560919942|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155405498|NCT01157078|560919943|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155405499|NCT01157078|560919942|FG000|Overall Study|Adverse Event|6|||
155637440|NCT00689936|561764745|FG000|Active Treatment Phase|Disease Progression|273|||
155405500|NCT01157078|560919943|FG001|Overall Study|Adverse Event|6|||
155405501|NCT01157078|560919942|FG000|Overall Study|Severe non-compliance to protocol|2|||
155405502|NCT01157078|560919943|FG001|Overall Study|Severe non-compliance to protocol|4|||
155405503|NCT01157078|560919942|FG000|Overall Study|Condition under investigation worsened|0|||
155405504|NCT01157078|560919943|FG001|Overall Study|Condition under investigation worsened|1|||
155405505|NCT01157078|560919942|FG000|Overall Study|Lack of Efficacy|2|||
155405506|NCT01157078|560919943|FG001|Overall Study|Lack of Efficacy|0|||
155405507|NCT01157078|560919942|FG000|Overall Study|Study-specific withdrawal criteria|2|||
155405508|NCT01157078|560919943|FG001|Overall Study|Study-specific withdrawal criteria|2|||
155405509|NCT01157078|560919942|FG000|Overall Study|Lost to Follow-up|7|||
155405510|NCT01157078|560919943|FG001|Overall Study|Lost to Follow-up|5|||
155405511|NCT01157078|560919942|FG000|Overall Study|Other|2|||
155405512|NCT01157078|560919943|FG001|Overall Study|Other|4|||
155405513|NCT01623271|560919946|FG000|Overall Study|Withdrawal by Subject|2|||
155405514|NCT01611974|560919947|FG000|Overall Study|Death|10|||
155405515|NCT01611974|560919948|FG001|Overall Study|Death|12|||
155405516|NCT01611974|560919949|FG002|Overall Study|Death|10|||
155405517|NCT01611974|560919947|FG000|Overall Study|Lost to Follow-up|0|||
155405518|NCT01611974|560919948|FG001|Overall Study|Lost to Follow-up|1|||
155405519|NCT01611974|560919949|FG002|Overall Study|Lost to Follow-up|0|||
155405520|NCT01611974|560919947|FG000|Overall Study|Physician Decision|5|||
155405521|NCT01611974|560919948|FG001|Overall Study|Physician Decision|1|||
155405522|NCT01611974|560919949|FG002|Overall Study|Physician Decision|2|||
155405523|NCT01611974|560919947|FG000|Overall Study|Withdrawal by Subject|0|||
155405524|NCT01611974|560919948|FG001|Overall Study|Withdrawal by Subject|1|||
155405525|NCT01611974|560919949|FG002|Overall Study|Withdrawal by Subject|4|||
155405526|NCT00522431|560919950|FG000|Overall Study|Adverse Event|5|||
155405527|NCT00522431|560919950|FG000|Overall Study|Protocol Violation|2|||
155405528|NCT00522431|560919950|FG000|Overall Study|Withdrawal by Subject|2|||
155405529|NCT00522431|560919950|FG000|Overall Study|Subject non-compliance|1|||
155405530|NCT00522431|560919950|FG000|Overall Study|Other/unknown|1|||
155405531|NCT03927105|560919951|FG000|Overall Study|Death|1|||
155405532|NCT03927105|560919951|FG000|Overall Study|In observation for potential re-treatment|2|||
155405533|NCT03927105|560919951|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
155405534|NCT00789529|560919952|FG000|Overall Study|Withdrawal by Subject|0|||
155405535|NCT00789529|560919953|FG001|Overall Study|Withdrawal by Subject|1|||
155405536|NCT00789529|560919952|FG000|Overall Study|Other Reason|1|||
155405537|NCT00789529|560919953|FG001|Overall Study|Other Reason|0|||
155405538|NCT01870401|560919954|FG000|Overall Study|Death|48|||
155405539|NCT01870401|560919955|FG001|Overall Study|Death|24|||
155405540|NCT01870401|560919954|FG000|Overall Study|Withdrawal by Subject|39|||
155405541|NCT01870401|560919955|FG001|Overall Study|Withdrawal by Subject|26|||
155405542|NCT01870401|560919954|FG000|Overall Study|Lost to Follow-up|19|||
155405543|NCT01870401|560919955|FG001|Overall Study|Lost to Follow-up|14|||
155405544|NCT01870401|560919954|FG000|Overall Study|Other|9|||
155405545|NCT01870401|560919955|FG001|Overall Study|Other|7|||
155405546|NCT01870401|560919954|FG000|Overall Study|On-going in the Study|35|||
155405547|NCT01870401|560919955|FG001|Overall Study|On-going in the Study|25|||
155405548|NCT01135498|560919956|FG000|Overall Study|Adverse Event|20|||
155405549|NCT01135498|560919956|FG000|Overall Study|Progressive disease|38|||
155405550|NCT01135498|560919956|FG000|Overall Study|Investigator judgement|25|||
155405551|NCT01135498|560919956|FG000|Overall Study|Withdrawal by Subject|4|||
155405552|NCT01135498|560919956|FG000|Overall Study|Death|1|||
155405553|NCT01135498|560919956|FG000|Overall Study|Ongoing at time of analysis|2|||
155405554|NCT01192022|560919957|FG000|Overall Study|Withdrawal of Consent|3|||
155405555|NCT01192022|560919958|FG001|Overall Study|Withdrawal of Consent|1|||
155405556|NCT01192022|560919959|FG002|Overall Study|Withdrawal of Consent|0|||
155405557|NCT01192022|560919960|FG003|Overall Study|Withdrawal of Consent|0|||
155405558|NCT01192022|560919961|FG004|Overall Study|Withdrawal of Consent|0|||
155405559|NCT01192022|560919957|FG000|Overall Study|Lost to Follow-up|4|||
155405560|NCT01192022|560919958|FG001|Overall Study|Lost to Follow-up|2|||
155405561|NCT01192022|560919959|FG002|Overall Study|Lost to Follow-up|1|||
155405562|NCT01192022|560919960|FG003|Overall Study|Lost to Follow-up|1|||
155405563|NCT01192022|560919961|FG004|Overall Study|Lost to Follow-up|0|||
155405564|NCT01192022|560919957|FG000|Overall Study|Adverse Event|1|||
155405565|NCT01192022|560919958|FG001|Overall Study|Adverse Event|0|||
155405566|NCT01192022|560919959|FG002|Overall Study|Adverse Event|0|||
155405567|NCT01192022|560919960|FG003|Overall Study|Adverse Event|0|||
155405568|NCT01192022|560919961|FG004|Overall Study|Adverse Event|0|||
155405569|NCT01192022|560919957|FG000|Overall Study|Fatal Adverse Event|4|||
155405570|NCT01192022|560919958|FG001|Overall Study|Fatal Adverse Event|6|||
155405571|NCT01192022|560919959|FG002|Overall Study|Fatal Adverse Event|0|||
155405572|NCT01192022|560919960|FG003|Overall Study|Fatal Adverse Event|0|||
155405573|NCT01192022|560919961|FG004|Overall Study|Fatal Adverse Event|1|||
155405574|NCT01192022|560919957|FG000|Overall Study|Physician withdrew-patient hardship|1|||
155405575|NCT01192022|560919958|FG001|Overall Study|Physician withdrew-patient hardship|0|||
155405576|NCT01192022|560919959|FG002|Overall Study|Physician withdrew-patient hardship|0|||
155405577|NCT01192022|560919960|FG003|Overall Study|Physician withdrew-patient hardship|0|||
155405578|NCT01192022|560919961|FG004|Overall Study|Physician withdrew-patient hardship|0|||
155405579|NCT01192022|560919957|FG000|Overall Study|Patient too sick from chemotherapy|0|||
155405580|NCT01192022|560919958|FG001|Overall Study|Patient too sick from chemotherapy|1|||
155285006|NCT02320253|560474469|FG002|Overall Study|Lost to Follow-up|1|||
155285007|NCT02320253|560474467|FG000|Overall Study|Death|1|||
155285008|NCT02320253|560474468|FG001|Overall Study|Death|0|||
155285009|NCT02320253|560474469|FG002|Overall Study|Death|1|||
155285010|NCT05780047|560474471|FG000|Overall Study|Did not submit baseline urine test kit|226|||
155285011|NCT05780047|560474471|FG000|Overall Study|Lost to Follow-up|34|||
155285012|NCT05780047|560474471|FG000|Overall Study|Did not submit second urine test kit|124|||
155285013|NCT03115346|560474480|FG000|Overall Study|Did not have AAA surgery|28|||
155285014|NCT03115346|560474481|FG001|Overall Study|Did not have AAA surgery|15|||
155285015|NCT03115346|560474480|FG000|Overall Study|Death|3|||
155285016|NCT03115346|560474481|FG001|Overall Study|Death|1|||
155285017|NCT03115346|560474480|FG000|Overall Study|Withdrawal by Subject|0|||
155285018|NCT03115346|560474481|FG001|Overall Study|Withdrawal by Subject|3|||
155285019|NCT03115346|560474480|FG000|Overall Study|Lost to Follow-up|0|||
155285020|NCT03115346|560474481|FG001|Overall Study|Lost to Follow-up|3|||
155285021|NCT01737268|560474483|FG000|Overall Study|Adverse Event|6|||
155285022|NCT01737268|560474483|FG000|Overall Study|Worsening of Target Disease|2|||
155285023|NCT01737268|560474483|FG000|Overall Study|In consideration of the patient's safety|1|||
155285024|NCT02753530|560474484|FG000|Overall Study|Adverse Event|7|||
155285025|NCT02753530|560474485|FG001|Overall Study|Adverse Event|1|||
155285026|NCT02753530|560474484|FG000|Overall Study|Death|0|||
155285027|NCT02753530|560474485|FG001|Overall Study|Death|1|||
155285028|NCT02753530|560474484|FG000|Overall Study|Physician Decision|0|||
155285029|NCT02753530|560474485|FG001|Overall Study|Physician Decision|1|||
155285030|NCT02753530|560474484|FG000|Overall Study|Protocol Violation|1|||
155285031|NCT02753530|560474485|FG001|Overall Study|Protocol Violation|0|||
155285032|NCT02753530|560474484|FG000|Overall Study|Withdrawal by Subject|4|||
155285033|NCT02753530|560474485|FG001|Overall Study|Withdrawal by Subject|3|||
155285034|NCT01221181|560474486|FG000|Overall Study|Lost to Follow-up|1|||
155285035|NCT03369951|560474487|FG000|Overall Study|Withdrawal by Subject|3|||
155285036|NCT03369951|560474487|FG000|Overall Study|Death|1|||
155285037|NCT03369951|560474487|FG000|Overall Study|Lost to Follow-up|1|||
155285038|NCT03369951|560474487|FG000|Overall Study|Protocol Violation|1|||
155285039|NCT04580407|560474493|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
155285040|NCT04949399|560474494|FG000|Overall Study|Lost to Follow-up|11|||
155285041|NCT04949399|560474495|FG001|Overall Study|Lost to Follow-up|6|||
155285042|NCT04949399|560474494|FG000|Overall Study|Withdrawal by Subject|2|||
155285043|NCT04949399|560474495|FG001|Overall Study|Withdrawal by Subject|3|||
155285044|NCT00670540|560474496|FG000|Overall Study|ineligible|17|||
155285045|NCT00670540|560474496|FG000|Overall Study|not living in France|348|||
155285046|NCT00670540|560474496|FG000|Overall Study|refused to participate|189|||
155285047|NCT00670540|560474496|FG000|Overall Study|controls randomised for no follow up|2770|||
155285048|NCT00670540|560474496|FG000|Overall Study|missing information inclusion criteria|1|||
155285049|NCT01866917|560474497|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
155285050|NCT01866917|560474498|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
155285051|NCT01311648|560476235|FG000|Main Study|Protocol Violation|0|||
155285052|NCT01311648|560476236|FG001|Main Study|Protocol Violation|1|||
155285053|NCT01311648|560476235|FG000|Main Study|Adverse Event|0|||
155285054|NCT01311648|560476236|FG001|Main Study|Adverse Event|1|||
155285055|NCT01311648|560476235|FG000|Main Study|Inhibitor management|0|||
155285056|NCT01311648|560476236|FG001|Main Study|Inhibitor management|17|||
155285057|NCT01311648|560476235|FG000|Main Study|Withdrawal by Subject|0|||
155285058|NCT01311648|560476236|FG001|Main Study|Withdrawal by Subject|2|||
155285059|NCT01311648|560476235|FG000|Extension Study|Physician Decision|0|||
155285060|NCT01311648|560476236|FG001|Extension Study|Physician Decision|1|||
155285061|NCT01311648|560476235|FG000|Extension Study|ITI therapy with marketed product|0|||
155285062|NCT01311648|560476236|FG001|Extension Study|ITI therapy with marketed product|1|||
155285063|NCT01311648|560476235|FG000|Extension Study|Incorrect visit planning|0|||
155285064|NCT01311648|560476236|FG001|Extension Study|Incorrect visit planning|1|||
155285065|NCT01311648|560476235|FG000|Extension Study|Family's decision|0|||
155285066|NCT01311648|560476236|FG001|Extension Study|Family's decision|1|||
155285067|NCT01311648|560476235|FG000|Extension Study|Failure of ITI therapy|0|||
155285068|NCT01311648|560476236|FG001|Extension Study|Failure of ITI therapy|3|||
155285069|NCT01311648|560476235|FG000|Extension Study|Long travel|0|||
155285070|NCT01311648|560476236|FG001|Extension Study|Long travel|1|||
155285071|NCT01311648|560476235|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
155285072|NCT01311648|560476236|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
155285073|NCT01311648|560476235|FG000|Extension Study|Withdrawal by Subject|0|||
155285074|NCT01311648|560476236|FG001|Extension Study|Withdrawal by Subject|1|||
155285075|NCT01311648|560476235|FG000|Extension Study|Inhibitor management|0|||
155285076|NCT01311648|560476236|FG001|Extension Study|Inhibitor management|2|||
155285077|NCT01645111|560476237|FG000|Overall Study|Did not require Clevidipine|15|||
155285078|NCT05526911|560476238|FG000|Overall Study|Adverse Event|2|||
155285079|NCT05025449|560476239|FG000|Overall Study|Withdrawal by Subject|1|||
155285080|NCT05025449|560476239|FG000|Overall Study|Patient emergently taken to operating room|1|||
155285081|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
155405581|NCT01192022|560919959|FG002|Overall Study|Patient too sick from chemotherapy|0|||
155405582|NCT01192022|560919960|FG003|Overall Study|Patient too sick from chemotherapy|0|||
155405583|NCT01192022|560919961|FG004|Overall Study|Patient too sick from chemotherapy|0|||
155405584|NCT01192022|560919957|FG000|Overall Study|Patient needed surgery|0|||
155405585|NCT01192022|560919958|FG001|Overall Study|Patient needed surgery|1|||
155405586|NCT01192022|560919959|FG002|Overall Study|Patient needed surgery|0|||
155405587|NCT01192022|560919960|FG003|Overall Study|Patient needed surgery|0|||
155405588|NCT01192022|560919961|FG004|Overall Study|Patient needed surgery|0|||
155405589|NCT01192022|560919957|FG000|Overall Study|Parents did not allow all follow up|0|||
155405590|NCT01192022|560919958|FG001|Overall Study|Parents did not allow all follow up|0|||
155405591|NCT01192022|560919959|FG002|Overall Study|Parents did not allow all follow up|0|||
155405592|NCT01192022|560919960|FG003|Overall Study|Parents did not allow all follow up|1|||
155405593|NCT01192022|560919961|FG004|Overall Study|Parents did not allow all follow up|0|||
155405594|NCT04839978|560919962|FG000|Overall Study|Lost to Follow-up|135|||
155405595|NCT04839978|560919963|FG001|Overall Study|Lost to Follow-up|147|||
155405596|NCT03551509|560919964|FG000|Overall Study|Lost to Follow-up|0|||
155405597|NCT03551509|560919965|FG001|Overall Study|Lost to Follow-up|1|||
155405598|NCT03551509|560919966|FG002|Overall Study|Lost to Follow-up|0|||
155405599|NCT05440539|560919973|FG000|Overall Study|Lost to Follow-up|4|||
155405600|NCT05440539|560919974|FG001|Overall Study|Lost to Follow-up|4|||
155405601|NCT05440539|560919973|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
155405602|NCT05440539|560919974|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
155405603|NCT02004262|560919977|FG000|Overall Study|Death|67|||
155405604|NCT02004262|560919978|FG001|Overall Study|Death|64|||
155405605|NCT02004262|560919979|FG002|Overall Study|Death|66|||
155405606|NCT02004262|560919980|FG003|Overall Study|Death|28|||
155405607|NCT02004262|560919981|FG004|Overall Study|Death|29|||
155405608|NCT02004262|560919982|FG005|Overall Study|Death|22|||
155405609|NCT02004262|560919977|FG000|Overall Study|Withdrawal by Subject|1|||
155405610|NCT02004262|560919978|FG001|Overall Study|Withdrawal by Subject|0|||
155405611|NCT02004262|560919979|FG002|Overall Study|Withdrawal by Subject|4|||
155405612|NCT02004262|560919980|FG003|Overall Study|Withdrawal by Subject|0|||
155405613|NCT02004262|560919981|FG004|Overall Study|Withdrawal by Subject|1|||
155405614|NCT02004262|560919982|FG005|Overall Study|Withdrawal by Subject|3|||
155405615|NCT02004262|560919977|FG000|Overall Study|Lost to Follow-up|1|||
155405616|NCT02004262|560919978|FG001|Overall Study|Lost to Follow-up|1|||
155405617|NCT02004262|560919979|FG002|Overall Study|Lost to Follow-up|0|||
155405618|NCT02004262|560919980|FG003|Overall Study|Lost to Follow-up|0|||
155405619|NCT02004262|560919981|FG004|Overall Study|Lost to Follow-up|0|||
155405620|NCT02004262|560919982|FG005|Overall Study|Lost to Follow-up|0|||
155405621|NCT02004262|560919977|FG000|Overall Study|Study Terminated by Sponsor|4|||
155405622|NCT02004262|560919978|FG001|Overall Study|Study Terminated by Sponsor|3|||
155405623|NCT02004262|560919979|FG002|Overall Study|Study Terminated by Sponsor|2|||
155405624|NCT02004262|560919980|FG003|Overall Study|Study Terminated by Sponsor|1|||
155405625|NCT02004262|560919981|FG004|Overall Study|Study Terminated by Sponsor|1|||
155405626|NCT02004262|560919982|FG005|Overall Study|Study Terminated by Sponsor|5|||
155405627|NCT00957008|560919983|FG000|Overall Study|Withdrawal by Subject|13|||
155405628|NCT00957008|560919984|FG001|Overall Study|Withdrawal by Subject|10|||
155405629|NCT00957008|560919985|FG002|Overall Study|Withdrawal by Subject|12|||
155405630|NCT00957008|560919986|FG003|Overall Study|Withdrawal by Subject|16|||
155405631|NCT00957008|560919983|FG000|Overall Study|Lost to Follow-up|3|||
155405632|NCT00957008|560919984|FG001|Overall Study|Lost to Follow-up|1|||
155405633|NCT00957008|560919985|FG002|Overall Study|Lost to Follow-up|3|||
155405634|NCT00957008|560919986|FG003|Overall Study|Lost to Follow-up|4|||
155405635|NCT00957008|560919983|FG000|Overall Study|Physician Decision|1|||
155405636|NCT00957008|560919984|FG001|Overall Study|Physician Decision|0|||
155405637|NCT00957008|560919985|FG002|Overall Study|Physician Decision|1|||
155405638|NCT00957008|560919986|FG003|Overall Study|Physician Decision|1|||
155405639|NCT00957008|560919983|FG000|Overall Study|Relocated; Family conflict|4|||
155405640|NCT00957008|560919984|FG001|Overall Study|Relocated; Family conflict|1|||
155405641|NCT00957008|560919985|FG002|Overall Study|Relocated; Family conflict|1|||
155405642|NCT00957008|560919986|FG003|Overall Study|Relocated; Family conflict|3|||
155405643|NCT01709435|560919993|FG000|Overall Study|Adverse Event|1|||
155405644|NCT01709435|560919994|FG001|Overall Study|Adverse Event|1|||
155405645|NCT01709435|560919995|FG002|Overall Study|Adverse Event|1|||
155405646|NCT01709435|560919996|FG003|Overall Study|Adverse Event|0|||
155405647|NCT01709435|560919997|FG004|Overall Study|Adverse Event|0|||
155405648|NCT01709435|560919998|FG005|Overall Study|Adverse Event|1|||
155405649|NCT01709435|560919993|FG000|Overall Study|Lack of Efficacy|5|||
155405650|NCT01709435|560919994|FG001|Overall Study|Lack of Efficacy|7|||
155405651|NCT01709435|560919995|FG002|Overall Study|Lack of Efficacy|2|||
155405652|NCT01709435|560919996|FG003|Overall Study|Lack of Efficacy|2|||
155405653|NCT01709435|560919997|FG004|Overall Study|Lack of Efficacy|6|||
155405654|NCT01709435|560919998|FG005|Overall Study|Lack of Efficacy|3|||
155405655|NCT01709435|560919993|FG000|Overall Study|Physician Decision|0|||
155405656|NCT01709435|560919994|FG001|Overall Study|Physician Decision|1|||
155405657|NCT01709435|560919995|FG002|Overall Study|Physician Decision|0|||
155405658|NCT01709435|560919996|FG003|Overall Study|Physician Decision|1|||
155405659|NCT01709435|560919997|FG004|Overall Study|Physician Decision|2|||
155405660|NCT01709435|560919998|FG005|Overall Study|Physician Decision|0|||
155405661|NCT01709435|560919993|FG000|Overall Study|Withdrawal by Subject|0|||
155405662|NCT01709435|560919994|FG001|Overall Study|Withdrawal by Subject|0|||
155405663|NCT01709435|560919995|FG002|Overall Study|Withdrawal by Subject|3|||
155405664|NCT01709435|560919996|FG003|Overall Study|Withdrawal by Subject|0|||
155405665|NCT01709435|560919997|FG004|Overall Study|Withdrawal by Subject|2|||
155405666|NCT01709435|560919998|FG005|Overall Study|Withdrawal by Subject|2|||
155405667|NCT01157364|560919999|FG000|Overall Study|Other Reasons|1|||
155405668|NCT01157364|560920000|FG001|Overall Study|Other Reasons|1|||
155405669|NCT01157364|560920001|FG002|Overall Study|Other Reasons|2|||
155405670|NCT01157364|560920002|FG003|Overall Study|Other Reasons|1|||
155405671|NCT01157364|560920003|FG004|Overall Study|Other Reasons|0|||
155405672|NCT01157364|560920004|FG005|Overall Study|Other Reasons|0|||
155405673|NCT01157364|560919999|FG000|Overall Study|Personal Reasons|0|||
155405674|NCT01157364|560920000|FG001|Overall Study|Personal Reasons|2|||
155405675|NCT01157364|560920001|FG002|Overall Study|Personal Reasons|0|||
155405676|NCT01157364|560920002|FG003|Overall Study|Personal Reasons|0|||
155405677|NCT01157364|560920003|FG004|Overall Study|Personal Reasons|1|||
155405678|NCT01157364|560920004|FG005|Overall Study|Personal Reasons|1|||
155405679|NCT01157364|560919999|FG000|Overall Study|Lost to Follow-up|1|||
155405680|NCT01157364|560920000|FG001|Overall Study|Lost to Follow-up|0|||
155405681|NCT01157364|560920001|FG002|Overall Study|Lost to Follow-up|1|||
155405682|NCT01157364|560920002|FG003|Overall Study|Lost to Follow-up|0|||
155405683|NCT01157364|560920003|FG004|Overall Study|Lost to Follow-up|0|||
155405684|NCT01157364|560920004|FG005|Overall Study|Lost to Follow-up|0|||
155405685|NCT01157364|560919999|FG000|Overall Study|Lack of Efficacy|0|||
155405686|NCT01157364|560920000|FG001|Overall Study|Lack of Efficacy|0|||
155405687|NCT01157364|560920001|FG002|Overall Study|Lack of Efficacy|0|||
155405688|NCT01157364|560920002|FG003|Overall Study|Lack of Efficacy|1|||
155405689|NCT01157364|560920003|FG004|Overall Study|Lack of Efficacy|0|||
155405690|NCT01157364|560920004|FG005|Overall Study|Lack of Efficacy|0|||
155405691|NCT01157364|560919999|FG000|Overall Study|Adverse Event|0|||
155405692|NCT01157364|560920000|FG001|Overall Study|Adverse Event|1|||
155405693|NCT01157364|560920001|FG002|Overall Study|Adverse Event|1|||
155405694|NCT01157364|560920002|FG003|Overall Study|Adverse Event|0|||
155405695|NCT01157364|560920003|FG004|Overall Study|Adverse Event|1|||
155405696|NCT01157364|560920004|FG005|Overall Study|Adverse Event|0|||
155405697|NCT01780662|560920005|FG000|Overall Study|Adverse Event|1|||
155405698|NCT01780662|560920006|FG001|Overall Study|Adverse Event|0|||
155405699|NCT01780662|560920007|FG002|Overall Study|Adverse Event|2|||
155405700|NCT01780662|560920005|FG000|Overall Study|Physician Decision|0|||
155405701|NCT01780662|560920006|FG001|Overall Study|Physician Decision|5|||
155405702|NCT01780662|560920007|FG002|Overall Study|Physician Decision|7|||
155405703|NCT01780662|560920005|FG000|Overall Study|Protocol Violation|0|||
155405704|NCT01780662|560920006|FG001|Overall Study|Protocol Violation|1|||
155405705|NCT01780662|560920007|FG002|Overall Study|Protocol Violation|0|||
155405706|NCT01780662|560920005|FG000|Overall Study|Ineligible|0|||
155405707|NCT01780662|560920006|FG001|Overall Study|Ineligible|0|||
155405708|NCT01780662|560920007|FG002|Overall Study|Ineligible|1|||
155405709|NCT02182687|560920009|FG000|Overall Study|Withdrawal by Subject|4|||
155405710|NCT02182687|560920010|FG001|Overall Study|Withdrawal by Subject|0|||
155405711|NCT02182687|560920009|FG000|Overall Study|Adverse Event|1|||
155405712|NCT02182687|560920010|FG001|Overall Study|Adverse Event|0|||
155405713|NCT02182687|560920009|FG000|Overall Study|Lost to Follow-up|0|||
155405714|NCT02182687|560920010|FG001|Overall Study|Lost to Follow-up|1|||
155405715|NCT01422915|560920013|FG000|Overall Study|Adverse Event|1|||
155405716|NCT01265797|560920014|FG000|Run-in Month|Withdrawal by Subject|0|||
155405717|NCT01265797|560920015|FG001|Run-in Month|Withdrawal by Subject|4|||
155405718|NCT01265797|560920014|FG000|Run-in Month|1st seizure during run-in month|0|||
155405719|NCT01265797|560920015|FG001|Run-in Month|1st seizure during run-in month|1|||
155405720|NCT01265797|560920014|FG000|Blinded Month|Lack of Efficacy|5|||
155405721|NCT01265797|560920015|FG001|Blinded Month|Lack of Efficacy|0|||
155405722|NCT01265797|560920014|FG000|Blinded Month|Lost to Follow-up|1|||
155405723|NCT01265797|560920015|FG001|Blinded Month|Lost to Follow-up|0|||
155405724|NCT01265797|560920014|FG000|Blinded Month|Protocol Violation|2|||
155405725|NCT01265797|560920015|FG001|Blinded Month|Protocol Violation|1|||
155405726|NCT01265797|560920014|FG000|Blinded Month|Adverse Event|2|||
155405727|NCT01265797|560920015|FG001|Blinded Month|Adverse Event|0|||
155405728|NCT01265797|560920014|FG000|Blinded Month|Diary data incomplete|0|||
155405729|NCT01265797|560920015|FG001|Blinded Month|Diary data incomplete|1|||
155405730|NCT01265797|560920014|FG000|Open Label Month|Lost to Follow-up|0|||
155405731|NCT01265797|560920015|FG001|Open Label Month|Lost to Follow-up|1|||
155405732|NCT03631732|560920016|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
155405733|NCT03631732|560920017|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
155405734|NCT03631732|560920016|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
155405735|NCT03631732|560920017|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
155405736|NCT03631732|560920016|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
155405737|NCT03631732|560920017|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
155405738|NCT03631732|560920016|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
155405739|NCT03631732|560920017|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
155405740|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
155405741|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
155405742|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
155405743|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
155405744|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
155405745|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
155405746|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
155405747|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
155405748|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
155405749|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
155405750|NCT03631732|560920016|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
155405751|NCT03631732|560920017|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
155405752|NCT01378104|560920018|FG000|Overall Study|Adverse Event|8|||
155405753|NCT01378104|560920019|FG001|Overall Study|Adverse Event|8|||
155405754|NCT01378104|560920018|FG000|Overall Study|Lack of Efficacy|7|||
155405755|NCT01378104|560920019|FG001|Overall Study|Lack of Efficacy|5|||
155405756|NCT01378104|560920018|FG000|Overall Study|Withdrawal by Subject|12|||
155405757|NCT01378104|560920019|FG001|Overall Study|Withdrawal by Subject|13|||
155405758|NCT02739620|560920030|FG000|Overall Study|Lost to Follow-up|3|||
155405759|NCT02739620|560920031|FG001|Overall Study|Lost to Follow-up|1|||
155405760|NCT02739620|560920030|FG000|Overall Study|Adverse Event|0|||
155405761|NCT02739620|560920031|FG001|Overall Study|Adverse Event|1|||
155405762|NCT02354222|560920032|FG000|Overall Study|Adverse Event|0|||
155405763|NCT02354222|560920033|FG001|Overall Study|Adverse Event|3|||
155405764|NCT02354222|560920032|FG000|Overall Study|Physician Decision|1|||
155405765|NCT02354222|560920033|FG001|Overall Study|Physician Decision|1|||
155405766|NCT02354222|560920032|FG000|Overall Study|Pregnancy|1|||
155405767|NCT02354222|560920033|FG001|Overall Study|Pregnancy|0|||
155405768|NCT02354222|560920032|FG000|Overall Study|Withdrawal by Subject|2|||
155405769|NCT02354222|560920033|FG001|Overall Study|Withdrawal by Subject|3|||
155405770|NCT02354222|560920032|FG000|Overall Study|Conflict with the stopping criteria|0|||
155405771|NCT02354222|560920033|FG001|Overall Study|Conflict with the stopping criteria|4|||
155405772|NCT02536313|560920034|FG000|Overall Study|Lack of Efficacy|0|||
155405773|NCT02536313|560920035|FG001|Overall Study|Lack of Efficacy|1|||
155405774|NCT01924182|560920036|FG000|Overall Study|Withdrawal by Subject|1|||
155405775|NCT01924182|560920037|FG001|Overall Study|Withdrawal by Subject|0|||
155405776|NCT00993265|560920039|FG000|Overall Study|Adverse Event|1|||
155405777|NCT00993265|560920040|FG001|Overall Study|Adverse Event|0|||
155405778|NCT00993265|560920039|FG000|Overall Study|Changed dose of concomitant drug|2|||
155405779|NCT00993265|560920040|FG001|Overall Study|Changed dose of concomitant drug|0|||
155405780|NCT00993265|560920039|FG000|Overall Study|Non-compliant with study medication|1|||
155405781|NCT00993265|560920040|FG001|Overall Study|Non-compliant with study medication|0|||
155405782|NCT03885089|560920041|FG000|Overall Study|No informed consent for publication of study results|2|||
155405783|NCT03349099|560920042|FG000|Overall Study|Physician Decision|3|||
155405784|NCT03349099|560920043|FG001|Overall Study|Physician Decision|4|||
155405785|NCT03349099|560920042|FG000|Overall Study|Stone migrated from the kidney|1|||
155405786|NCT03349099|560920043|FG001|Overall Study|Stone migrated from the kidney|0|||
155405787|NCT04869345|560920044|FG000|Overall Study|Lost to Follow-up|8|||
155405788|NCT04869345|560920045|FG001|Overall Study|Lost to Follow-up|3|||
155405789|NCT04194528|560920054|FG000|Overall Study|Adverse Event|1|||
155405790|NCT03077685|560920065|FG000|Overall Study|Lost to Follow-up|0|||
155405791|NCT03077685|560920066|FG001|Overall Study|Lost to Follow-up|0|||
155405792|NCT03077685|560920067|FG002|Overall Study|Lost to Follow-up|0|||
155405793|NCT03077685|560920068|FG003|Overall Study|Lost to Follow-up|0|||
155405794|NCT03077685|560920069|FG004|Overall Study|Lost to Follow-up|1|||
155405795|NCT03077685|560920065|FG000|Overall Study|Death|0|||
155405796|NCT03077685|560920066|FG001|Overall Study|Death|0|||
155405797|NCT03077685|560920067|FG002|Overall Study|Death|1|||
155405798|NCT03077685|560920068|FG003|Overall Study|Death|1|||
155405799|NCT03077685|560920069|FG004|Overall Study|Death|3|||
155405800|NCT03077685|560920065|FG000|Overall Study|Withdrawal by Subject|0|||
155405801|NCT03077685|560920066|FG001|Overall Study|Withdrawal by Subject|0|||
155405802|NCT03077685|560920067|FG002|Overall Study|Withdrawal by Subject|0|||
155405803|NCT03077685|560920068|FG003|Overall Study|Withdrawal by Subject|2|||
155405804|NCT03077685|560920069|FG004|Overall Study|Withdrawal by Subject|1|||
155405805|NCT03077685|560920065|FG000|Overall Study|Physician Decision|0|||
155405806|NCT03077685|560920066|FG001|Overall Study|Physician Decision|0|||
155405807|NCT03077685|560920067|FG002|Overall Study|Physician Decision|1|||
155405808|NCT03077685|560920068|FG003|Overall Study|Physician Decision|0|||
155405809|NCT03077685|560920069|FG004|Overall Study|Physician Decision|3|||
155405810|NCT03077685|560920065|FG000|Overall Study|Disease Progression|1|||
155405811|NCT03077685|560920066|FG001|Overall Study|Disease Progression|0|||
155405812|NCT03077685|560920067|FG002|Overall Study|Disease Progression|0|||
155405813|NCT03077685|560920068|FG003|Overall Study|Disease Progression|2|||
155405814|NCT03077685|560920069|FG004|Overall Study|Disease Progression|1|||
155405815|NCT03077685|560920065|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
155405816|NCT03077685|560920066|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
155405817|NCT03077685|560920067|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
155405818|NCT03077685|560920068|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
155405819|NCT03077685|560920069|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
155405820|NCT03077685|560920065|FG000|Overall Study|Subject entered hospice care|0|||
155405821|NCT03077685|560920066|FG001|Overall Study|Subject entered hospice care|0|||
155405822|NCT03077685|560920067|FG002|Overall Study|Subject entered hospice care|0|||
155405823|NCT03077685|560920068|FG003|Overall Study|Subject entered hospice care|0|||
155405824|NCT03077685|560920069|FG004|Overall Study|Subject entered hospice care|1|||
155405825|NCT02116777|560920070|FG000|Overall Study|Adverse Event|0|||
155405826|NCT02116777|560920071|FG001|Overall Study|Adverse Event|0|||
155405827|NCT02116777|560920072|FG002|Overall Study|Adverse Event|0|||
155405828|NCT02116777|560920073|FG003|Overall Study|Adverse Event|0|||
155405829|NCT02116777|560920074|FG004|Overall Study|Adverse Event|2|||
155405830|NCT02116777|560920075|FG005|Overall Study|Adverse Event|2|||
155405831|NCT02116777|560920076|FG006|Overall Study|Adverse Event|0|||
155405832|NCT02116777|560920070|FG000|Overall Study|Death|0|||
155405833|NCT02116777|560920071|FG001|Overall Study|Death|0|||
155405834|NCT02116777|560920072|FG002|Overall Study|Death|0|||
155405835|NCT02116777|560920073|FG003|Overall Study|Death|1|||
155405836|NCT02116777|560920074|FG004|Overall Study|Death|0|||
155405837|NCT02116777|560920075|FG005|Overall Study|Death|0|||
155405838|NCT02116777|560920076|FG006|Overall Study|Death|0|||
155405839|NCT02116777|560920070|FG000|Overall Study|Lack of Efficacy|3|||
155405840|NCT02116777|560920071|FG001|Overall Study|Lack of Efficacy|3|||
155405841|NCT02116777|560920072|FG002|Overall Study|Lack of Efficacy|3|||
155405842|NCT02116777|560920073|FG003|Overall Study|Lack of Efficacy|8|||
155405843|NCT02116777|560920074|FG004|Overall Study|Lack of Efficacy|4|||
155405844|NCT02116777|560920075|FG005|Overall Study|Lack of Efficacy|1|||
155405845|NCT02116777|560920076|FG006|Overall Study|Lack of Efficacy|9|||
155405846|NCT02116777|560920070|FG000|Overall Study|Physician Decision|0|||
155405847|NCT02116777|560920071|FG001|Overall Study|Physician Decision|0|||
155405848|NCT02116777|560920072|FG002|Overall Study|Physician Decision|0|||
155405849|NCT02116777|560920073|FG003|Overall Study|Physician Decision|2|||
155405850|NCT02116777|560920074|FG004|Overall Study|Physician Decision|0|||
155405851|NCT02116777|560920075|FG005|Overall Study|Physician Decision|0|||
155405852|NCT02116777|560920076|FG006|Overall Study|Physician Decision|0|||
155405853|NCT02116777|560920070|FG000|Overall Study|Protocol Violation|0|||
155405854|NCT02116777|560920071|FG001|Overall Study|Protocol Violation|0|||
155405855|NCT02116777|560920072|FG002|Overall Study|Protocol Violation|0|||
155405856|NCT02116777|560920073|FG003|Overall Study|Protocol Violation|1|||
155405857|NCT02116777|560920074|FG004|Overall Study|Protocol Violation|0|||
155405858|NCT02116777|560920075|FG005|Overall Study|Protocol Violation|0|||
155405859|NCT02116777|560920076|FG006|Overall Study|Protocol Violation|0|||
155405860|NCT02116777|560920070|FG000|Overall Study|Withdrawal by Subject|0|||
155405861|NCT02116777|560920071|FG001|Overall Study|Withdrawal by Subject|0|||
155405862|NCT02116777|560920072|FG002|Overall Study|Withdrawal by Subject|0|||
155405863|NCT02116777|560920073|FG003|Overall Study|Withdrawal by Subject|1|||
155405864|NCT02116777|560920074|FG004|Overall Study|Withdrawal by Subject|0|||
155405865|NCT02116777|560920075|FG005|Overall Study|Withdrawal by Subject|0|||
155405866|NCT02116777|560920076|FG006|Overall Study|Withdrawal by Subject|0|||
155405867|NCT00102960|560920079|FG000|Overall Study|Death|23|||
155405868|NCT00102960|560920080|FG001|Overall Study|Death|11|||
155405869|NCT00102960|560920081|FG002|Overall Study|Death|11|||
155405870|NCT00102960|560920079|FG000|Overall Study|Lost to Follow-up|6|||
155405871|NCT00102960|560920080|FG001|Overall Study|Lost to Follow-up|12|||
155405872|NCT00102960|560920081|FG002|Overall Study|Lost to Follow-up|16|||
155405873|NCT00102960|560920079|FG000|Overall Study|Withdrawal by Subject|1|||
155405874|NCT00102960|560920080|FG001|Overall Study|Withdrawal by Subject|0|||
155405875|NCT00102960|560920081|FG002|Overall Study|Withdrawal by Subject|1|||
155405876|NCT00733954|560920082|FG000|Overall Study|Lost to Follow-up|5|||
155405877|NCT00733954|560920083|FG001|Overall Study|Lost to Follow-up|2|||
155285082|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
155405878|NCT00733954|560920082|FG000|Overall Study|Protocol Violation|1|||
155405879|NCT00733954|560920083|FG001|Overall Study|Protocol Violation|0|||
155405880|NCT00733954|560920082|FG000|Overall Study|Withdrawal by Subject|2|||
155405881|NCT00733954|560920083|FG001|Overall Study|Withdrawal by Subject|0|||
155405882|NCT02663453|560920084|FG000|Overall Study|Death|4|||
155405883|NCT02663453|560920085|FG001|Overall Study|Death|4|||
155405884|NCT02663453|560920084|FG000|Overall Study|Withdrawal by Subject|1|||
155405885|NCT02663453|560920085|FG001|Overall Study|Withdrawal by Subject|0|||
155405886|NCT01964352|560921669|FG000|Overall Study|Adverse Event|13|||
155405887|NCT01964352|560921670|FG001|Overall Study|Adverse Event|3|||
155405888|NCT01964352|560921671|FG002|Overall Study|Adverse Event|4|||
155405889|NCT01964352|560921672|FG003|Overall Study|Adverse Event|3|||
155405890|NCT01964352|560921669|FG000|Overall Study|Lack of Efficacy|6|||
155405891|NCT01964352|560921670|FG001|Overall Study|Lack of Efficacy|0|||
155405892|NCT01964352|560921671|FG002|Overall Study|Lack of Efficacy|0|||
155405893|NCT01964352|560921672|FG003|Overall Study|Lack of Efficacy|0|||
155405894|NCT01964352|560921669|FG000|Overall Study|Protocol Violation|2|||
155405895|NCT01964352|560921670|FG001|Overall Study|Protocol Violation|4|||
155405896|NCT01964352|560921671|FG002|Overall Study|Protocol Violation|0|||
155405897|NCT01964352|560921672|FG003|Overall Study|Protocol Violation|2|||
155405898|NCT01964352|560921669|FG000|Overall Study|Lost to Follow-up|1|||
155405899|NCT01964352|560921670|FG001|Overall Study|Lost to Follow-up|0|||
155405900|NCT01964352|560921671|FG002|Overall Study|Lost to Follow-up|0|||
155405901|NCT01964352|560921672|FG003|Overall Study|Lost to Follow-up|1|||
155405902|NCT01964352|560921669|FG000|Overall Study|Withdrawal by Subject|4|||
155405903|NCT01964352|560921670|FG001|Overall Study|Withdrawal by Subject|2|||
155405904|NCT01964352|560921671|FG002|Overall Study|Withdrawal by Subject|1|||
155405905|NCT01964352|560921672|FG003|Overall Study|Withdrawal by Subject|0|||
155405906|NCT01964352|560921669|FG000|Overall Study|Other than stated above|0|||
155405907|NCT01964352|560921670|FG001|Overall Study|Other than stated above|2|||
155405908|NCT01964352|560921671|FG002|Overall Study|Other than stated above|1|||
155405909|NCT01964352|560921672|FG003|Overall Study|Other than stated above|2|||
155405910|NCT00874120|560921678|FG000|First Intervention|Adverse Event|0|||
155405911|NCT00874120|560921679|FG001|First Intervention|Adverse Event|1|||
155405912|NCT00874120|560921678|FG000|First Intervention|Withdrawal by Subject|2|||
155405913|NCT00874120|560921679|FG001|First Intervention|Withdrawal by Subject|0|||
155405914|NCT00874120|560921678|FG000|First Intervention|Lost to Follow-up|0|||
155405915|NCT00874120|560921679|FG001|First Intervention|Lost to Follow-up|1|||
155405916|NCT00874120|560921678|FG000|First Intervention|Protocol Violation|3|||
155405917|NCT00874120|560921679|FG001|First Intervention|Protocol Violation|0|||
155405918|NCT00874120|560921678|FG000|First Intervention|positive drug test|1|||
155405919|NCT00874120|560921679|FG001|First Intervention|positive drug test|0|||
155405920|NCT00874120|560921678|FG000|Second Intervention|Withdrawal by Subject|1|||
155405921|NCT00874120|560921679|FG001|Second Intervention|Withdrawal by Subject|0|||
155405922|NCT00874120|560921678|FG000|Second Intervention|Protocol Violation|1|||
155405923|NCT00874120|560921679|FG001|Second Intervention|Protocol Violation|0|||
155405924|NCT00477165|560921680|FG000|Overall Study|Adverse Event|7|||
155405925|NCT00477165|560921681|FG001|Overall Study|Adverse Event|2|||
155405926|NCT01823679|560921682|FG000|Overall Study|Death|1|||
155405927|NCT00105443|560921686|FG000|Double-Blind Treatment|Adverse Event|1|||
155405928|NCT00105443|560921687|FG001|Double-Blind Treatment|Adverse Event|0|||
155405929|NCT00105443|560921688|FG002|Double-Blind Treatment|Adverse Event|0|||
155405930|NCT00105443|560921689|FG003|Double-Blind Treatment|Adverse Event|0|||
155405931|NCT00105443|560921686|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
155405932|NCT00105443|560921687|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
155405933|NCT00105443|560921688|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
155405934|NCT00105443|560921689|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
155405935|NCT00105443|560921686|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
155405936|NCT00105443|560921687|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
155405937|NCT00105443|560921688|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
155405938|NCT00105443|560921689|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
155405939|NCT00105443|560921686|FG000|Double-Blind Treatment|Physician Decision|1|||
155405940|NCT00105443|560921687|FG001|Double-Blind Treatment|Physician Decision|0|||
155405941|NCT00105443|560921688|FG002|Double-Blind Treatment|Physician Decision|2|||
155405942|NCT00105443|560921689|FG003|Double-Blind Treatment|Physician Decision|0|||
155405943|NCT00105443|560921686|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
155405944|NCT00105443|560921687|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
155405945|NCT00105443|560921688|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
155405946|NCT00105443|560921689|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
155405947|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
155405948|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
155405949|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
155405950|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
155405951|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
155405952|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
155405953|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
155405954|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
155405955|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
155405956|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
155405957|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
155405958|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
155405959|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
155405960|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
155405961|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
155405962|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
155405963|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
155435874|NCT00144300|561022982|FG000|Overall Study|Adverse Event|18|||
155405964|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
155405965|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
155405966|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
155405967|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
155405968|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
155405969|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
155405970|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
155405971|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
155405972|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
155405973|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
155405974|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
155405975|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
155405976|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
155405977|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
155405978|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
155405979|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
155405980|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
155742345|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155405981|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
155405982|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
155405983|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
155405984|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
155405985|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
155405986|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
155405987|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
155405988|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
155405989|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
155405990|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
155405991|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
155405992|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
155405993|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
155405994|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
155405995|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
155405996|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
155405997|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
155405998|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
155405999|NCT00105443|560921686|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
155406000|NCT00105443|560921687|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
155406001|NCT00105443|560921688|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
155406002|NCT00105443|560921689|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
155406003|NCT02135692|560921690|FG000|Overall Study|Adverse Event|3|||
155406004|NCT02135692|560921690|FG000|Overall Study|Lack of Efficacy|2|||
155406005|NCT02135692|560921690|FG000|Overall Study|Protocol Violation|2|||
155406006|NCT02135692|560921690|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
155406007|NCT02135692|560921690|FG000|Overall Study|Product commercially available|159|||
155406008|NCT02135692|560921690|FG000|Overall Study|Study closed/terminated|153|||
155406009|NCT02135692|560921690|FG000|Overall Study|Lost to Follow-up|4|||
155406010|NCT02135692|560921690|FG000|Overall Study|Withdrawal by Subject|15|||
155406011|NCT02495844|560921693|FG000|Overall Study|Lack of Efficacy|1|||
155406012|NCT02495844|560921694|FG001|Overall Study|Lack of Efficacy|2|||
155406013|NCT02495844|560921693|FG000|Overall Study|AE, non-fatal|0|||
155406014|NCT02495844|560921694|FG001|Overall Study|AE, non-fatal|1|||
155406015|NCT02495844|560921693|FG000|Overall Study|Hepatitis Positivity|0|||
155406016|NCT02495844|560921694|FG001|Overall Study|Hepatitis Positivity|1|||
155406017|NCT00623480|560921697|FG000|Overall Study|Lost to Follow-up|0|||
155406018|NCT00623480|560921698|FG001|Overall Study|Lost to Follow-up|1|||
155406019|NCT00623480|560921697|FG000|Overall Study|Withdrawal by Subject|2|||
155406020|NCT00623480|560921698|FG001|Overall Study|Withdrawal by Subject|4|||
155406021|NCT00623480|560921697|FG000|Overall Study|Lack of Efficacy|1|||
155742346|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
155742347|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155406022|NCT00623480|560921698|FG001|Overall Study|Lack of Efficacy|0|||
155406023|NCT00623480|560921697|FG000|Overall Study|Non-compliant with study medication|4|||
155406024|NCT00623480|560921698|FG001|Overall Study|Non-compliant with study medication|0|||
155742348|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Death|0|||
155742349|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Death|0|||
155406025|NCT00623480|560921697|FG000|Overall Study|Protocol Violation|0|||
155406026|NCT00623480|560921698|FG001|Overall Study|Protocol Violation|1|||
155406027|NCT00623480|560921697|FG000|Overall Study|Site closed by sponsor|0|||
155406028|NCT00623480|560921698|FG001|Overall Study|Site closed by sponsor|1|||
155406029|NCT01594853|560921699|FG000|Overall Study|Withdrawal by Subject|1|||
155406030|NCT01594853|560921700|FG001|Overall Study|Withdrawal by Subject|1|||
155406031|NCT01594853|560921699|FG000|Overall Study|Lost to Follow-up|1|||
155406032|NCT01594853|560921700|FG001|Overall Study|Lost to Follow-up|1|||
155406033|NCT01594853|560921699|FG000|Overall Study|noncompliance with exercise|0|||
155406034|NCT01594853|560921700|FG001|Overall Study|noncompliance with exercise|1|||
155406035|NCT00711100|560921701|FG000|Overall Study|Lack of Efficacy|5|||
155406036|NCT00711100|560921701|FG000|Overall Study|Withdrawal by Subject|8|||
155406037|NCT00783094|560921702|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
155406038|NCT00783094|560921703|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
155406039|NCT00783094|560921704|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
155406040|NCT00783094|560921702|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
155406041|NCT00783094|560921703|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
155406042|NCT00783094|560921704|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
155406043|NCT00783094|560921702|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
155406044|NCT00783094|560921703|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
155406045|NCT00783094|560921704|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
155406046|NCT00783094|560921702|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
155406047|NCT00783094|560921703|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
155406048|NCT00783094|560921704|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
155406049|NCT00783094|560921702|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
155406050|NCT00783094|560921703|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
155406051|NCT00783094|560921704|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
155406052|NCT00783094|560921702|FG000|Open-Label Extension Period|Adverse Event|12|||
155406053|NCT00783094|560921703|FG001|Open-Label Extension Period|Adverse Event|7|||
155406054|NCT00783094|560921704|FG002|Open-Label Extension Period|Adverse Event|16|||
155406055|NCT00783094|560921702|FG000|Open-Label Extension Period|Death|0|||
155406056|NCT00783094|560921703|FG001|Open-Label Extension Period|Death|0|||
155406057|NCT00783094|560921704|FG002|Open-Label Extension Period|Death|1|||
155406058|NCT00783094|560921702|FG000|Open-Label Extension Period|Protocol Violation|4|||
155406059|NCT00783094|560921703|FG001|Open-Label Extension Period|Protocol Violation|5|||
155406060|NCT00783094|560921704|FG002|Open-Label Extension Period|Protocol Violation|7|||
155406061|NCT00783094|560921702|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
155406062|NCT00783094|560921703|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
155406063|NCT00783094|560921704|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
155406064|NCT00783094|560921702|FG000|Open-Label Extension Period|Physician Decision|4|||
155406065|NCT00783094|560921703|FG001|Open-Label Extension Period|Physician Decision|2|||
155406066|NCT00783094|560921704|FG002|Open-Label Extension Period|Physician Decision|3|||
155406067|NCT00783094|560921702|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
155406068|NCT00783094|560921703|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
155406069|NCT00783094|560921704|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
155406070|NCT02513329|560921705|FG000|Overall Study|Lost to Follow-up|5|||
155406071|NCT02513329|560921706|FG001|Overall Study|Lost to Follow-up|2|||
155406072|NCT03808077|560921707|FG000|Overall Study|Physician Decision|2|||
155406073|NCT03808077|560921708|FG001|Overall Study|Physician Decision|3|||
155406074|NCT03808077|560921707|FG000|Overall Study|Withdrawal by Subject|1|||
155406075|NCT03808077|560921708|FG001|Overall Study|Withdrawal by Subject|0|||
155406076|NCT03808077|560921707|FG000|Overall Study|Equipment Issues|2|||
155406077|NCT03808077|560921708|FG001|Overall Study|Equipment Issues|1|||
155406078|NCT03703102|560921711|FG000|Overall Study|Adverse Event|4|||
155406079|NCT03703102|560921712|FG001|Overall Study|Adverse Event|3|||
155406080|NCT03703102|560921713|FG002|Overall Study|Adverse Event|7|||
155406081|NCT03703102|560921714|FG003|Overall Study|Adverse Event|3|||
155406082|NCT03703102|560921715|FG004|Overall Study|Adverse Event|13|||
155406083|NCT03703102|560921711|FG000|Overall Study|Lack of Efficacy|4|||
155406084|NCT03703102|560921712|FG001|Overall Study|Lack of Efficacy|0|||
155406085|NCT03703102|560921713|FG002|Overall Study|Lack of Efficacy|1|||
155406086|NCT03703102|560921714|FG003|Overall Study|Lack of Efficacy|4|||
155406087|NCT03703102|560921715|FG004|Overall Study|Lack of Efficacy|1|||
155406088|NCT03703102|560921711|FG000|Overall Study|Lost to Follow-up|0|||
155406089|NCT03703102|560921712|FG001|Overall Study|Lost to Follow-up|0|||
155406090|NCT03703102|560921713|FG002|Overall Study|Lost to Follow-up|1|||
155406091|NCT03703102|560921714|FG003|Overall Study|Lost to Follow-up|2|||
155406092|NCT03703102|560921715|FG004|Overall Study|Lost to Follow-up|2|||
155742350|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Death|0|||
155406093|NCT03703102|560921711|FG000|Overall Study|Physician Decision|2|||
155406094|NCT03703102|560921712|FG001|Overall Study|Physician Decision|2|||
155406095|NCT03703102|560921713|FG002|Overall Study|Physician Decision|2|||
155406096|NCT03703102|560921714|FG003|Overall Study|Physician Decision|2|||
155406097|NCT03703102|560921715|FG004|Overall Study|Physician Decision|4|||
155406098|NCT03703102|560921711|FG000|Overall Study|Withdrawal by Subject|7|||
155406099|NCT03703102|560921712|FG001|Overall Study|Withdrawal by Subject|5|||
155406100|NCT03703102|560921713|FG002|Overall Study|Withdrawal by Subject|5|||
155406101|NCT03703102|560921714|FG003|Overall Study|Withdrawal by Subject|5|||
155406102|NCT03703102|560921715|FG004|Overall Study|Withdrawal by Subject|9|||
155406103|NCT03703102|560921711|FG000|Overall Study|Ineligibility|0|||
155406104|NCT03703102|560921712|FG001|Overall Study|Ineligibility|0|||
155406105|NCT03703102|560921713|FG002|Overall Study|Ineligibility|1|||
155406106|NCT03703102|560921714|FG003|Overall Study|Ineligibility|0|||
155406107|NCT03703102|560921715|FG004|Overall Study|Ineligibility|0|||
155406108|NCT03703102|560921711|FG000|Overall Study|Protocol Deviation|4|||
155406109|NCT03703102|560921712|FG001|Overall Study|Protocol Deviation|4|||
155406110|NCT03703102|560921713|FG002|Overall Study|Protocol Deviation|3|||
155406111|NCT03703102|560921714|FG003|Overall Study|Protocol Deviation|0|||
155406112|NCT03703102|560921715|FG004|Overall Study|Protocol Deviation|0|||
155406113|NCT03703102|560921711|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155406114|NCT03703102|560921712|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155406115|NCT03703102|560921713|FG002|Overall Study|Non-Compliance with Study Drug|2|||
155406116|NCT03703102|560921714|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155406117|NCT03703102|560921715|FG004|Overall Study|Non-Compliance with Study Drug|4|||
155406118|NCT02311153|560921716|FG000|Overall Study|Lost to Follow-up|5|||
155406119|NCT02311153|560921717|FG001|Overall Study|Lost to Follow-up|7|||
155406120|NCT01967628|560921718|FG000|Overall Study|Withdrawal by Subject|2|||
155406121|NCT01967628|560921719|FG001|Overall Study|Withdrawal by Subject|0|||
155406122|NCT01967628|560921718|FG000|Overall Study|Unable to complete bronchoscopy|4|||
155406123|NCT01967628|560921719|FG001|Overall Study|Unable to complete bronchoscopy|6|||
155406124|NCT01967628|560921718|FG000|Overall Study|Lost to Follow-up|1|||
155406125|NCT01967628|560921719|FG001|Overall Study|Lost to Follow-up|0|||
155406126|NCT01967628|560921718|FG000|Overall Study|Low protein concentration in sample|20|||
155406127|NCT01967628|560921719|FG001|Overall Study|Low protein concentration in sample|25|||
155406128|NCT01650636|560921724|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
155406129|NCT01650636|560921725|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
155406130|NCT01650636|560921724|FG000|Washout up to 5 Months|Physician Decision|2|||
155406131|NCT01650636|560921725|FG001|Washout up to 5 Months|Physician Decision|2|||
155406132|NCT01650636|560921724|FG000|Washout up to 5 Months|Death|1|||
155406133|NCT01650636|560921725|FG001|Washout up to 5 Months|Death|0|||
155406134|NCT01650636|560921724|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
155406135|NCT01650636|560921725|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
155406136|NCT01650636|560921724|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
155406137|NCT01650636|560921725|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
155406138|NCT01650636|560921724|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
155406139|NCT01650636|560921725|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
155406140|NCT01560780|560921726|FG000|Overall Study|Death|2|||
155406141|NCT01560780|560921727|FG001|Overall Study|Death|1|||
155406142|NCT01560780|560921726|FG000|Overall Study|Patient Preference|11|||
155406143|NCT01560780|560921727|FG001|Overall Study|Patient Preference|11|||
155406144|NCT02797808|560921728|FG000|Overall Study|Withdrawal by Subject|1|||
155406145|NCT02797808|560921729|FG001|Overall Study|Withdrawal by Subject|1|||
155406146|NCT02797808|560921728|FG000|Overall Study|Physician Decision|6|||
155406147|NCT02797808|560921729|FG001|Overall Study|Physician Decision|2|||
155406148|NCT02192827|560921730|FG000|Overall Study|Lost to Follow-up|25|||
155406149|NCT02192827|560921731|FG001|Overall Study|Lost to Follow-up|27|||
155406150|NCT02192827|560921730|FG000|Overall Study|Given additional steroids with admission|13|||
155406151|NCT02192827|560921731|FG001|Overall Study|Given additional steroids with admission|11|||
155406152|NCT00264875|560921736|FG000|Overall Study|Adverse Event|6|||
155406153|NCT00264875|560921736|FG000|Overall Study|Lost to Follow-up|6|||
155406154|NCT00264875|560921736|FG000|Overall Study|Protocol Violation|11|||
155406155|NCT00264875|560921736|FG000|Overall Study|Withdrawal by Subject|7|||
155406156|NCT01500278|560921738|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
155406157|NCT01500278|560921739|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
155406158|NCT01500278|560921738|FG000|Week 0 - Week 12|Protocol Violation|10|||
155406159|NCT01500278|560921739|FG001|Week 0 - Week 12|Protocol Violation|16|||
155406160|NCT01500278|560921738|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
155406161|NCT01500278|560921739|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
155406162|NCT01500278|560921738|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
155406163|NCT01500278|560921739|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
155406164|NCT01500278|560921738|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
155406165|NCT01500278|560921739|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
155406166|NCT01500278|560921738|FG000|Week 0 - Week 12|Patient decision|1|||
155406167|NCT01500278|560921739|FG001|Week 0 - Week 12|Patient decision|0|||
155406168|NCT01500278|560921738|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
155406169|NCT01500278|560921739|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
155406170|NCT01500278|560921738|FG000|Week 0 - Week 12|Investigator decision|1|||
155406171|NCT01500278|560921739|FG001|Week 0 - Week 12|Investigator decision|0|||
155406172|NCT01500278|560921738|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
155406173|NCT01500278|560921739|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
155742351|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Death|0|||
155742352|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Death|0|||
155742353|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Death|0|||
155742354|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Death|0|||
155742355|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Death|0|||
155742356|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Death|0|||
155742357|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Death|1|||
155742358|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742359|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742360|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742361|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742362|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742363|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742364|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742365|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742366|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155742367|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
155742368|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742369|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742370|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742371|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742372|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742373|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742374|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742375|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742376|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155742377|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
155742378|NCT01185353|562156454|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742379|NCT01185353|562156455|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742380|NCT01185353|562156456|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742381|NCT01185353|562156457|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742382|NCT01185353|562156458|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742383|NCT01185353|562156459|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742384|NCT01185353|562156460|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742385|NCT01185353|562156461|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742386|NCT01185353|562156462|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
155742387|NCT01185353|562156463|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
155742388|NCT01185353|562156454|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742389|NCT01185353|562156455|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742390|NCT01185353|562156456|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742391|NCT01185353|562156457|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742392|NCT01185353|562156458|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742393|NCT01185353|562156459|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742394|NCT01185353|562156460|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742395|NCT01185353|562156461|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
155742396|NCT01185353|562156462|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
155406174|NCT01500278|560921738|FG000|Week 0 - Week 12|Sponsor decision|1|||
155406175|NCT01500278|560921739|FG001|Week 0 - Week 12|Sponsor decision|0|||
155406176|NCT01500278|560921738|FG000|Week 0 - Week 12|Personal reason|0|||
155742397|NCT01185353|562156463|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155742398|NCT01185353|562156454|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742399|NCT01185353|562156455|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742400|NCT01185353|562156456|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742401|NCT01185353|562156457|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742402|NCT01185353|562156458|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742403|NCT01185353|562156459|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742404|NCT01185353|562156460|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155742405|NCT01185353|562156461|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
155742406|NCT01185353|562156462|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
155742407|NCT01185353|562156463|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
155742408|NCT01185353|562156454|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742409|NCT01185353|562156455|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742410|NCT01185353|562156456|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155406177|NCT01500278|560921739|FG001|Week 0 - Week 12|Personal reason|1|||
155406178|NCT01500278|560921738|FG000|Week 0 - Week 12|Other serious disease|0|||
155742411|NCT01185353|562156457|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742412|NCT01185353|562156458|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155406179|NCT01500278|560921739|FG001|Week 0 - Week 12|Other serious disease|1|||
155406180|NCT01500278|560921738|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
155435875|NCT00144300|561022983|FG001|Overall Study|Adverse Event|16|||
155742413|NCT01185353|562156459|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742414|NCT01185353|562156460|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742415|NCT01185353|562156461|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
155742416|NCT01185353|562156462|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
155742417|NCT01185353|562156463|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155742418|NCT01030666|562156464|FG000|Overall Study|Lost to Follow-up|3|||
155742419|NCT01030666|562156465|FG001|Overall Study|Lost to Follow-up|2|||
155742420|NCT03952039|562156468|FG000|Overall Study|Adverse Event|22|||
155742421|NCT03952039|562156469|FG001|Overall Study|Adverse Event|8|||
155406181|NCT01500278|560921739|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
155406182|NCT01500278|560921738|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
155742422|NCT03952039|562156468|FG000|Overall Study|Withdrawal by Participant|17|||
155742423|NCT03952039|562156469|FG001|Overall Study|Withdrawal by Participant|12|||
155742424|NCT03952039|562156468|FG000|Overall Study|Death|13|||
155742425|NCT03952039|562156469|FG001|Overall Study|Death|6|||
155742426|NCT03952039|562156468|FG000|Overall Study|Lack of Efficacy|12|||
155742427|NCT03952039|562156469|FG001|Overall Study|Lack of Efficacy|2|||
155742428|NCT03952039|562156468|FG000|Overall Study|Physician Decision|9|||
155742429|NCT03952039|562156469|FG001|Overall Study|Physician Decision|3|||
155742430|NCT03952039|562156468|FG000|Overall Study|Progressive Disease|6|||
155742431|NCT03952039|562156469|FG001|Overall Study|Progressive Disease|4|||
155742432|NCT03952039|562156468|FG000|Overall Study|Other Reasons|12|||
155742433|NCT03952039|562156469|FG001|Overall Study|Other Reasons|4|||
155742434|NCT03865316|562158115|FG000|Overall Study|Procedure Cancelled|4|||
155742435|NCT03865316|562158115|FG000|Overall Study|Equipment failure|4|||
155742436|NCT03137069|562158120|FG000|Overall Study|Withdrawal by Subject|1|||
155742437|NCT03137069|562158121|FG001|Overall Study|Withdrawal by Subject|2|||
155406183|NCT01500278|560921739|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
155406184|NCT01500278|560921738|FG000|Week 13 - Week 104|Protocol Violation|6|||
155406185|NCT01500278|560921739|FG001|Week 13 - Week 104|Protocol Violation|6|||
155406186|NCT01500278|560921738|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
155406187|NCT01500278|560921739|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
155406188|NCT01500278|560921738|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
155406189|NCT01500278|560921739|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
155406190|NCT01500278|560921738|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
155406191|NCT01500278|560921739|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
155406192|NCT01500278|560921738|FG000|Week 13 - Week 104|Non/bad compliance|7|||
155742438|NCT03137069|562158122|FG002|Overall Study|Withdrawal by Subject|2|||
155742439|NCT03137069|562158123|FG003|Overall Study|Withdrawal by Subject|2|||
155742440|NCT03137069|562158124|FG004|Overall Study|Withdrawal by Subject|0|||
155406193|NCT01500278|560921739|FG001|Week 13 - Week 104|Non/bad compliance|5|||
155435876|NCT00144300|561022982|FG000|Overall Study|Protocol Violation|1|||
155637441|NCT00689936|561764746|FG001|Active Treatment Phase|Disease Progression|362|||
155637442|NCT00689936|561764747|FG002|Active Treatment Phase|Disease Progression|339|||
155637443|NCT00689936|561764745|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
155637444|NCT00689936|561764746|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
155637445|NCT00689936|561764747|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
155637446|NCT00689936|561764745|FG000|Active Treatment Phase|Death|60|||
155637447|NCT00689936|561764746|FG001|Active Treatment Phase|Death|28|||
155637448|NCT00689936|561764747|FG002|Active Treatment Phase|Death|37|||
155637449|NCT00689936|561764745|FG000|Active Treatment Phase|Lost to Follow-up|0|||
155637450|NCT00689936|561764746|FG001|Active Treatment Phase|Lost to Follow-up|2|||
155637451|NCT00689936|561764747|FG002|Active Treatment Phase|Lost to Follow-up|2|||
155637452|NCT00689936|561764745|FG000|Active Treatment Phase|Protocol Violation|2|||
155637453|NCT00689936|561764746|FG001|Active Treatment Phase|Protocol Violation|2|||
155637454|NCT00689936|561764747|FG002|Active Treatment Phase|Protocol Violation|4|||
155637455|NCT00689936|561764745|FG000|Active Treatment Phase|Study Close Out|64|||
155637456|NCT00689936|561764746|FG001|Active Treatment Phase|Study Close Out|26|||
155637457|NCT00689936|561764747|FG002|Active Treatment Phase|Study Close Out|21|||
155637458|NCT00689936|561764745|FG000|Active Treatment Phase|Miscellaneous|52|||
155637459|NCT00689936|561764746|FG001|Active Treatment Phase|Miscellaneous|34|||
155637460|NCT00689936|561764747|FG002|Active Treatment Phase|Miscellaneous|47|||
155637461|NCT00689936|561764745|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
155637462|NCT00689936|561764746|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
155637463|NCT00689936|561764747|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
155637464|NCT01682031|561764748|FG000|Overall Study|Withdrawal by Subject|0|||
155637465|NCT01682031|561764749|FG001|Overall Study|Withdrawal by Subject|1|||
155637466|NCT01682031|561764748|FG000|Overall Study|Adverse Event|0|||
155637467|NCT01682031|561764749|FG001|Overall Study|Adverse Event|2|||
155637468|NCT01682031|561764748|FG000|Overall Study|MRI results indicate increased nodul|0|||
155637469|NCT01682031|561764749|FG001|Overall Study|MRI results indicate increased nodul|1|||
155742441|NCT03137069|562158125|FG005|Overall Study|Withdrawal by Subject|0|||
155637470|NCT01682031|561764748|FG000|Overall Study|Patient could not swallow tablets|1|||
155637471|NCT01682031|561764749|FG001|Overall Study|Patient could not swallow tablets|0|||
155406194|NCT01500278|560921738|FG000|Week 13 - Week 104|Recurrent infections|1|||
155742442|NCT03137069|562158120|FG000|Overall Study|Adverse Event|0|||
155742443|NCT03137069|562158121|FG001|Overall Study|Adverse Event|3|||
155742444|NCT03137069|562158122|FG002|Overall Study|Adverse Event|1|||
155742445|NCT03137069|562158123|FG003|Overall Study|Adverse Event|1|||
155742446|NCT03137069|562158124|FG004|Overall Study|Adverse Event|0|||
155742447|NCT03137069|562158125|FG005|Overall Study|Adverse Event|1|||
155742448|NCT03137069|562158120|FG000|Overall Study|Protocol Violation|0|||
155742449|NCT03137069|562158121|FG001|Overall Study|Protocol Violation|1|||
155742450|NCT03137069|562158122|FG002|Overall Study|Protocol Violation|0|||
155742451|NCT03137069|562158123|FG003|Overall Study|Protocol Violation|1|||
155742452|NCT03137069|562158124|FG004|Overall Study|Protocol Violation|1|||
155742453|NCT03137069|562158125|FG005|Overall Study|Protocol Violation|1|||
155742454|NCT03137069|562158120|FG000|Overall Study|Physician Decision|0|||
155742455|NCT03137069|562158121|FG001|Overall Study|Physician Decision|0|||
155742456|NCT03137069|562158122|FG002|Overall Study|Physician Decision|0|||
155742457|NCT03137069|562158123|FG003|Overall Study|Physician Decision|1|||
155742458|NCT03137069|562158124|FG004|Overall Study|Physician Decision|0|||
155742459|NCT03137069|562158125|FG005|Overall Study|Physician Decision|0|||
155742460|NCT03137069|562158120|FG000|Overall Study|Study Terminated by Sponsor|0|||
155742461|NCT03137069|562158121|FG001|Overall Study|Study Terminated by Sponsor|0|||
155742462|NCT03137069|562158122|FG002|Overall Study|Study Terminated by Sponsor|0|||
155742463|NCT03137069|562158123|FG003|Overall Study|Study Terminated by Sponsor|0|||
155742464|NCT03137069|562158124|FG004|Overall Study|Study Terminated by Sponsor|1|||
155742465|NCT03137069|562158125|FG005|Overall Study|Study Terminated by Sponsor|0|||
155742466|NCT03137069|562158120|FG000|Overall Study|Data Entry Error|0|||
155742467|NCT03137069|562158121|FG001|Overall Study|Data Entry Error|0|||
155742468|NCT03137069|562158122|FG002|Overall Study|Data Entry Error|0|||
155742469|NCT03137069|562158123|FG003|Overall Study|Data Entry Error|1|||
155742470|NCT03137069|562158124|FG004|Overall Study|Data Entry Error|0|||
155742471|NCT03137069|562158125|FG005|Overall Study|Data Entry Error|0|||
155742472|NCT02043899|562158127|FG000|Overall Study|Adverse Event|3|||
155742473|NCT02043899|562158127|FG000|Overall Study|Physician Decision|1|||
155742474|NCT02043899|562158127|FG000|Overall Study|Withdrawal by Subject|2|||
155742475|NCT02043899|562158127|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
155742476|NCT02043899|562158127|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
155742477|NCT02043899|562158127|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
155742478|NCT02043899|562158127|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
155742479|NCT02043899|562158127|FG000|Overall Study|Treatment delayed|1|||
155742480|NCT02522624|562158129|FG000|Overall Study|Technical failure|1|||
155742481|NCT02522624|562158130|FG001|Overall Study|Technical failure|0|||
155742482|NCT00369629|562158131|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
155742483|NCT00369629|562158132|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
155742484|NCT00369629|562158133|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
155742485|NCT00369629|562158134|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
155742486|NCT00369629|562158131|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155742487|NCT00369629|562158132|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155742488|NCT00369629|562158133|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
155742489|NCT00369629|562158134|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155742490|NCT00369629|562158131|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
155742491|NCT00369629|562158132|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155742492|NCT00369629|562158133|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155742493|NCT00369629|562158134|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155742494|NCT00369629|562158131|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
155742495|NCT00369629|562158132|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
155742496|NCT00369629|562158133|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
155742497|NCT00369629|562158134|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
155742498|NCT00369629|562158131|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
155742499|NCT00369629|562158132|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
155742500|NCT00369629|562158133|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
155742501|NCT00369629|562158134|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
155742502|NCT00369629|562158131|FG000|Completed 4 More Cycles|Progressive disease|2|||
155742503|NCT00369629|562158132|FG001|Completed 4 More Cycles|Progressive disease|1|||
155742504|NCT00369629|562158133|FG002|Completed 4 More Cycles|Progressive disease|2|||
155742505|NCT00369629|562158134|FG003|Completed 4 More Cycles|Progressive disease|0|||
155742506|NCT00369629|562158131|FG000|Follow up for 1 Year|Death|2|||
155742507|NCT00369629|562158132|FG001|Follow up for 1 Year|Death|1|||
155742508|NCT00369629|562158133|FG002|Follow up for 1 Year|Death|1|||
155742509|NCT00369629|562158134|FG003|Follow up for 1 Year|Death|0|||
155742510|NCT00369629|562158131|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
155742511|NCT00369629|562158132|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
155742512|NCT00369629|562158133|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
155435877|NCT00144300|561022983|FG001|Overall Study|Protocol Violation|3|||
155285083|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
155285084|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
155285085|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
155285086|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
155285087|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
155285088|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
155285089|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
155285090|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
155285091|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
155285092|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
155285093|NCT00762463|560476241|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
155285094|NCT00762463|560476242|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
155285095|NCT00762463|560476243|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
155285096|NCT00762463|560476244|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
155285097|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
155406195|NCT01500278|560921739|FG001|Week 13 - Week 104|Recurrent infections|0|||
155406196|NCT01500278|560921738|FG000|Week 13 - Week 104|False positive test|1|||
155406197|NCT01500278|560921739|FG001|Week 13 - Week 104|False positive test|2|||
155406198|NCT01500278|560921738|FG000|Week 13 - Week 104|Sponsor request|4|||
155406199|NCT01500278|560921739|FG001|Week 13 - Week 104|Sponsor request|0|||
155742513|NCT00369629|562158134|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
155742514|NCT00369629|562158131|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
155742515|NCT00369629|562158132|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
155406200|NCT01500278|560921738|FG000|Week 13 - Week 104|Withdrawn in error|1|||
155406201|NCT01500278|560921739|FG001|Week 13 - Week 104|Withdrawn in error|0|||
155406202|NCT01500278|560921738|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
155406203|NCT01500278|560921739|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
155406204|NCT01500278|560921738|FG000|Week 13 - Week 104|Protocol deviation|1|||
155406205|NCT01500278|560921739|FG001|Week 13 - Week 104|Protocol deviation|0|||
155406206|NCT01500278|560921738|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
155406207|NCT01500278|560921739|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
155406208|NCT01500278|560921738|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
155406209|NCT01500278|560921739|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
155406210|NCT01500278|560921738|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
155406211|NCT01500278|560921739|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
155406212|NCT01500278|560921738|FG000|Week 13 - Week 104|Relocation|0|||
155406213|NCT01500278|560921739|FG001|Week 13 - Week 104|Relocation|1|||
155406214|NCT01500278|560921738|FG000|Week 13 - Week 104|Sponsor decision|0|||
155406215|NCT01500278|560921739|FG001|Week 13 - Week 104|Sponsor decision|2|||
155406216|NCT01500278|560921738|FG000|Week 13 - Week 104|Medical monitor decision|0|||
155406217|NCT01500278|560921739|FG001|Week 13 - Week 104|Medical monitor decision|2|||
155406218|NCT01500278|560921738|FG000|Week 13 - Week 104|Personal reason|0|||
155406219|NCT01500278|560921739|FG001|Week 13 - Week 104|Personal reason|1|||
155406220|NCT01500278|560921738|FG000|Week 13 - Week 104|Not completed|0|||
155406221|NCT01500278|560921739|FG001|Week 13 - Week 104|Not completed|1|||
155406222|NCT01500278|560921738|FG000|Week 13 - Week 104|Death|2|||
155406223|NCT01500278|560921739|FG001|Week 13 - Week 104|Death|4|||
155406224|NCT01500278|560921738|FG000|Week 13 - Week 104|Adverse Event|54|||
155406225|NCT01500278|560921739|FG001|Week 13 - Week 104|Adverse Event|54|||
155406226|NCT01970995|560921740|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155406227|NCT01970995|560921741|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155406228|NCT01970995|560921742|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155406229|NCT01970995|560921740|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
155406230|NCT01970995|560921741|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
155406231|NCT01970995|560921742|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
155406232|NCT00414453|560921745|FG000|Overall Study|Abnormal lab work|16|||
155406233|NCT01263639|560921746|FG000|Overall Study|Lost to Follow-up|66|||
155406234|NCT01263639|560921747|FG001|Overall Study|Lost to Follow-up|70|||
155406235|NCT01263639|560921746|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
155406236|NCT01263639|560921747|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
155406237|NCT03975920|560921750|FG000|Overall Study|Lost to Follow-up|1|||
155406238|NCT03975920|560921751|FG001|Overall Study|Lost to Follow-up|2|||
155406239|NCT03975920|560921750|FG000|Overall Study|Protocol Violation|1|||
155406240|NCT03975920|560921751|FG001|Overall Study|Protocol Violation|1|||
155406241|NCT03975920|560921750|FG000|Overall Study|Did not complete survey|2|||
155406242|NCT03975920|560921751|FG001|Overall Study|Did not complete survey|1|||
155406243|NCT00586495|560921752|FG000|Treatment Period|Adverse Event|11|||
155406244|NCT00586495|560921752|FG000|Treatment Period|Death|1|||
155406245|NCT00586495|560921752|FG000|Treatment Period|Protocol Violation|1|||
155285098|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
155285099|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
155285100|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
155406246|NCT00586495|560921752|FG000|Treatment Period|Withdrawal by Subject|1|||
155406247|NCT00586495|560921752|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
155406248|NCT00586495|560921752|FG000|Treatment Period|Switch to commercial drug|10|||
155406249|NCT00586495|560921752|FG000|Follow-up|Death|40|||
155406250|NCT00586495|560921752|FG000|Follow-up|Lost to Follow-up|1|||
155406251|NCT00586495|560921752|FG000|Follow-up|Withdrawal by Subject|4|||
155406252|NCT00586495|560921752|FG000|Follow-up|Protocol driven decision point|37|||
155406253|NCT00586495|560921752|FG000|Follow-up|Switch to commercial drug|10|||
155406254|NCT01081249|560921753|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
155406255|NCT01081249|560921754|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
155406256|NCT00205855|560921757|FG000|Overall Study|Only received temporary implants|16|||
155406257|NCT00205855|560921757|FG000|Overall Study|Withdrawal by Subject|5|||
155406258|NCT02039375|560921758|FG000|Overall Study|Lost to Follow-up|2|||
155406259|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
155406260|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
155406261|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
155406262|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
155406263|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
155406264|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
155406265|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
155406266|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
155406267|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
155406268|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
155406269|NCT00219284|560921760|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
155406270|NCT00219284|560921761|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
155406271|NCT00219284|560921760|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
155406272|NCT00219284|560921761|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
155406273|NCT00219284|560921760|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
155406274|NCT00219284|560921761|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
155406275|NCT00219284|560921760|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
155406276|NCT00219284|560921761|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
155406277|NCT01692275|560921762|FG000|Overall Study|Lost to Follow-up|57|||
155406278|NCT01692275|560921763|FG001|Overall Study|Lost to Follow-up|48|||
155406279|NCT01692275|560921762|FG000|Overall Study|Withdrawal by Subject|9|||
155406280|NCT01692275|560921763|FG001|Overall Study|Withdrawal by Subject|11|||
155406281|NCT00640328|560921769|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
155406282|NCT00640328|560921770|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
155406283|NCT00640328|560921771|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
155406284|NCT00640328|560921772|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
155406285|NCT00640328|560921773|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
155406286|NCT00640328|560921774|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
155406287|NCT00640328|560921769|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
155406288|NCT00640328|560921770|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
155406289|NCT00640328|560921771|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
155406290|NCT00640328|560921772|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
155406291|NCT00640328|560921773|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
155406292|NCT00640328|560921774|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
155406293|NCT00640328|560921769|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155406294|NCT00640328|560921770|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155406295|NCT00640328|560921771|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
155406296|NCT00640328|560921772|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155406297|NCT00640328|560921773|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155406298|NCT00640328|560921774|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155406299|NCT00640328|560921769|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
155285101|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155285102|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155406300|NCT00640328|560921770|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
155406301|NCT00640328|560921771|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
155406302|NCT00640328|560921772|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
155435878|NCT00144300|561022982|FG000|Overall Study|Lost to Follow-up|3|||
155406303|NCT00640328|560921773|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
155406304|NCT00640328|560921774|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
155406305|NCT02374099|560921775|FG000|Overall Study|Adverse Event|1|||
155406306|NCT02374099|560921776|FG001|Overall Study|Adverse Event|0|||
155406307|NCT02374099|560921775|FG000|Overall Study|Progressive Disease|35|||
155406308|NCT02374099|560921776|FG001|Overall Study|Progressive Disease|40|||
155406309|NCT02374099|560921775|FG000|Overall Study|Withdrawal by Subject|5|||
155406310|NCT02374099|560921776|FG001|Overall Study|Withdrawal by Subject|1|||
155406311|NCT02374099|560921775|FG000|Overall Study|Miscellaneous|2|||
155406312|NCT02374099|560921776|FG001|Overall Study|Miscellaneous|3|||
155637472|NCT01682031|561764748|FG000|Overall Study|Patient stopped selenium on his own|0|||
155637473|NCT01682031|561764749|FG001|Overall Study|Patient stopped selenium on his own|1|||
155637474|NCT00933933|561764752|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
155637475|NCT00933933|561764753|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
155637476|NCT00933933|561764754|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
155637477|NCT00933933|561764752|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
155637478|NCT00933933|561764753|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
155637479|NCT00933933|561764754|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
155637480|NCT04703192|561764755|FG000|Overall Study|Withdrawal by Subject|2|||
155637481|NCT04703192|561764756|FG001|Overall Study|Withdrawal by Subject|0|||
155637482|NCT04703192|561764755|FG000|Overall Study|Death|3|||
155637483|NCT04703192|561764756|FG001|Overall Study|Death|1|||
155637484|NCT04703192|561764755|FG000|Overall Study|Adverse Event|13|||
155637485|NCT04703192|561764756|FG001|Overall Study|Adverse Event|2|||
155637486|NCT04703192|561764755|FG000|Overall Study|Progressive or Relapsed Disease|46|||
155637487|NCT04703192|561764756|FG001|Overall Study|Progressive or Relapsed Disease|7|||
155637488|NCT04703192|561764755|FG000|Overall Study|Clinical Progression|19|||
155637489|NCT04703192|561764756|FG001|Overall Study|Clinical Progression|8|||
155637490|NCT04703192|561764755|FG000|Overall Study|Lost to Follow-up|1|||
155637491|NCT04703192|561764756|FG001|Overall Study|Lost to Follow-up|0|||
155637492|NCT04703192|561764755|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
155637493|NCT04703192|561764756|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
155637494|NCT04703192|561764755|FG000|Overall Study|Other|5|||
155637495|NCT04703192|561764756|FG001|Overall Study|Other|1|||
155637496|NCT03330197|561764759|FG000|Overall Study|Adverse Event|0|||
155637497|NCT03330197|561764760|FG001|Overall Study|Adverse Event|1|||
155637498|NCT03330197|561764759|FG000|Overall Study|Withdrawal by Subject|0|||
155637499|NCT03330197|561764760|FG001|Overall Study|Withdrawal by Subject|1|||
155637500|NCT02879695|561764765|FG000|Overall Study|Did not start study treatment|2|||
155637501|NCT02879695|561764766|FG001|Overall Study|Did not start study treatment|0|||
155637502|NCT02879695|561764767|FG002|Overall Study|Did not start study treatment|3|||
155637503|NCT02879695|561764768|FG003|Overall Study|Did not start study treatment|0|||
155637504|NCT03126110|561764770|FG000|Phase 1|Death|2|||
155637505|NCT03126110|561764771|FG001|Phase 1|Death|2|||
155637506|NCT03126110|561764772|FG002|Phase 1|Death|4|||
155637507|NCT03126110|561764773|FG003|Phase 1|Death|3|||
155637508|NCT03126110|561764774|FG004|Phase 1|Death|4|||
155637509|NCT03126110|561764775|FG005|Phase 1|Death|4|||
155435879|NCT00144300|561022983|FG001|Overall Study|Lost to Follow-up|0|||
155637510|NCT03126110|561764776|FG006|Phase 1|Death|3|||
155637511|NCT03126110|561764777|FG007|Phase 1|Death|4|||
155637512|NCT03126110|561764778|FG008|Phase 1|Death|5|||
155637513|NCT03126110|561764779|FG009|Phase 1|Death|2|||
155637514|NCT03126110|561764780|FG010|Phase 1|Death|6|||
155637515|NCT03126110|561764781|FG011|Phase 1|Death|0|||
155637516|NCT03126110|561764782|FG012|Phase 1|Death|0|||
155637517|NCT03126110|561764783|FG013|Phase 1|Death|0|||
155637518|NCT03126110|561764784|FG014|Phase 1|Death|0|||
155637519|NCT03126110|561764785|FG015|Phase 1|Death|0|||
155637520|NCT03126110|561764786|FG016|Phase 1|Death|0|||
155637521|NCT03126110|561764770|FG000|Phase 1|Lost to Follow-up|0|||
155637522|NCT03126110|561764771|FG001|Phase 1|Lost to Follow-up|1|||
155637523|NCT03126110|561764772|FG002|Phase 1|Lost to Follow-up|0|||
155637524|NCT03126110|561764773|FG003|Phase 1|Lost to Follow-up|0|||
155637525|NCT03126110|561764774|FG004|Phase 1|Lost to Follow-up|0|||
155406313|NCT02374099|560921775|FG000|Overall Study|Randomized, but not treated|2|||
155406314|NCT02374099|560921776|FG001|Overall Study|Randomized, but not treated|1|||
155406315|NCT02374099|560921775|FG000|Overall Study|Study Terminated by Sponsor|3|||
155406316|NCT02374099|560921776|FG001|Overall Study|Study Terminated by Sponsor|4|||
155406317|NCT01033825|560921777|FG000|Overall Study|Withdrawal by Subject|2|||
155406318|NCT01033825|560921778|FG001|Overall Study|Withdrawal by Subject|3|||
155406319|NCT01033825|560921779|FG002|Overall Study|Withdrawal by Subject|2|||
155406320|NCT01033825|560921780|FG003|Overall Study|Withdrawal by Subject|1|||
155406321|NCT01033825|560921781|FG004|Overall Study|Withdrawal by Subject|1|||
155406322|NCT01033825|560921782|FG005|Overall Study|Withdrawal by Subject|0|||
155406323|NCT01033825|560921783|FG006|Overall Study|Withdrawal by Subject|0|||
155406324|NCT01033825|560921777|FG000|Overall Study|Adverse Event|0|||
155406325|NCT01033825|560921778|FG001|Overall Study|Adverse Event|0|||
155406326|NCT01033825|560921779|FG002|Overall Study|Adverse Event|0|||
155406327|NCT01033825|560921780|FG003|Overall Study|Adverse Event|1|||
155406328|NCT01033825|560921781|FG004|Overall Study|Adverse Event|0|||
155406329|NCT01033825|560921782|FG005|Overall Study|Adverse Event|0|||
155406330|NCT01033825|560921783|FG006|Overall Study|Adverse Event|0|||
155406331|NCT01033825|560921777|FG000|Overall Study|Protocol Violation|1|||
155406332|NCT01033825|560921778|FG001|Overall Study|Protocol Violation|0|||
155406333|NCT01033825|560921779|FG002|Overall Study|Protocol Violation|0|||
155406334|NCT01033825|560921780|FG003|Overall Study|Protocol Violation|0|||
155406335|NCT01033825|560921781|FG004|Overall Study|Protocol Violation|0|||
155406336|NCT01033825|560921782|FG005|Overall Study|Protocol Violation|0|||
155406337|NCT01033825|560921783|FG006|Overall Study|Protocol Violation|0|||
155406338|NCT01033825|560921777|FG000|Overall Study|Other|0|||
155406339|NCT01033825|560921778|FG001|Overall Study|Other|0|||
155406340|NCT01033825|560921779|FG002|Overall Study|Other|0|||
155406341|NCT01033825|560921780|FG003|Overall Study|Other|0|||
155406342|NCT01033825|560921781|FG004|Overall Study|Other|1|||
155406343|NCT01033825|560921782|FG005|Overall Study|Other|0|||
155406344|NCT01033825|560921783|FG006|Overall Study|Other|0|||
155406345|NCT04294719|560921784|FG000|Overall Study|Withdrawal by Subject|1|||
155406346|NCT01714687|560921785|FG000|Overall Study|Withdrawal by Subject|1|||
155406347|NCT01714687|560921786|FG001|Overall Study|Withdrawal by Subject|0|||
155406348|NCT01714687|560921785|FG000|Overall Study|Lost to Follow-up|2|||
155406349|NCT01714687|560921786|FG001|Overall Study|Lost to Follow-up|4|||
155406350|NCT00278993|560921787|FG000|Overall Study|Adverse Event|24|||
155406351|NCT00278993|560921787|FG000|Overall Study|Withdrawal by Subject|5|||
155406352|NCT00278993|560921787|FG000|Overall Study|Progressive Disease|65|||
155406353|NCT00278993|560921787|FG000|Overall Study|Physician Decision|9|||
155406354|NCT00278993|560921787|FG000|Overall Study|Not Otherwise Specified|4|||
155406355|NCT01439555|560921789|FG000|Overall Study|Protocol Violation|1|||
155406356|NCT03921424|560921792|FG000|Overall Study|Lost to Follow-up|0|||
155406357|NCT03921424|560921793|FG001|Overall Study|Lost to Follow-up|1|||
155406358|NCT03921424|560921792|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155406359|NCT03921424|560921793|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
155637526|NCT03126110|561764775|FG005|Phase 1|Lost to Follow-up|0|||
155637527|NCT03126110|561764776|FG006|Phase 1|Lost to Follow-up|0|||
155637528|NCT03126110|561764777|FG007|Phase 1|Lost to Follow-up|0|||
155637529|NCT03126110|561764778|FG008|Phase 1|Lost to Follow-up|1|||
155637530|NCT03126110|561764779|FG009|Phase 1|Lost to Follow-up|0|||
155637531|NCT03126110|561764780|FG010|Phase 1|Lost to Follow-up|0|||
155637532|NCT03126110|561764781|FG011|Phase 1|Lost to Follow-up|0|||
155637533|NCT03126110|561764782|FG012|Phase 1|Lost to Follow-up|0|||
155637534|NCT03126110|561764783|FG013|Phase 1|Lost to Follow-up|0|||
155637535|NCT03126110|561764784|FG014|Phase 1|Lost to Follow-up|0|||
155637536|NCT03126110|561764785|FG015|Phase 1|Lost to Follow-up|0|||
155637537|NCT03126110|561764786|FG016|Phase 1|Lost to Follow-up|0|||
155637538|NCT03126110|561764770|FG000|Phase 1|Withdrawal by Subject|1|||
155637539|NCT03126110|561764771|FG001|Phase 1|Withdrawal by Subject|0|||
155637540|NCT03126110|561764772|FG002|Phase 1|Withdrawal by Subject|0|||
155637541|NCT03126110|561764773|FG003|Phase 1|Withdrawal by Subject|1|||
155406360|NCT01934556|560921803|FG000|Overall Study|Withdrawal by Subject|0|||
155406361|NCT01934556|560921804|FG001|Overall Study|Withdrawal by Subject|1|||
155406362|NCT01934556|560921805|FG002|Overall Study|Withdrawal by Subject|1|||
155406363|NCT01934556|560921803|FG000|Overall Study|Lost to Follow-up|4|||
155406364|NCT01934556|560921804|FG001|Overall Study|Lost to Follow-up|10|||
155406365|NCT01934556|560921805|FG002|Overall Study|Lost to Follow-up|7|||
155406366|NCT01934556|560921803|FG000|Overall Study|Death|1|||
155637542|NCT03126110|561764774|FG004|Phase 1|Withdrawal by Subject|1|||
155637543|NCT03126110|561764775|FG005|Phase 1|Withdrawal by Subject|0|||
155637544|NCT03126110|561764776|FG006|Phase 1|Withdrawal by Subject|0|||
155637545|NCT03126110|561764777|FG007|Phase 1|Withdrawal by Subject|0|||
155637546|NCT03126110|561764778|FG008|Phase 1|Withdrawal by Subject|2|||
155637547|NCT03126110|561764779|FG009|Phase 1|Withdrawal by Subject|1|||
155637548|NCT03126110|561764780|FG010|Phase 1|Withdrawal by Subject|0|||
155637549|NCT03126110|561764781|FG011|Phase 1|Withdrawal by Subject|0|||
155637550|NCT03126110|561764782|FG012|Phase 1|Withdrawal by Subject|0|||
155637551|NCT03126110|561764783|FG013|Phase 1|Withdrawal by Subject|0|||
155637552|NCT03126110|561764784|FG014|Phase 1|Withdrawal by Subject|0|||
155285103|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
155285104|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155285105|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
155285106|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
155285107|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
155285108|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
155285109|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
155285110|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
155285111|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
155285112|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
155285113|NCT00531479|560476245|FG000|Overall Study|Death|68|||
155285114|NCT00531479|560476246|FG001|Overall Study|Death|71|||
155285115|NCT00531479|560476245|FG000|Overall Study|Lost to Follow-up|0|||
155285116|NCT00531479|560476246|FG001|Overall Study|Lost to Follow-up|2|||
155285117|NCT00531479|560476245|FG000|Overall Study|Other|0|||
155285118|NCT00531479|560476246|FG001|Overall Study|Other|1|||
155285119|NCT00531479|560476245|FG000|Overall Study|Withdrawal by Subject|6|||
155285120|NCT00531479|560476246|FG001|Overall Study|Withdrawal by Subject|6|||
155285121|NCT00531479|560476245|FG000|Overall Study|Did not receive treatment|2|||
155285122|NCT00531479|560476246|FG001|Overall Study|Did not receive treatment|3|||
155285123|NCT01240356|560476247|FG000|Overall Study|Withdrawal by Subject|2|||
155285124|NCT01240356|560476248|FG001|Overall Study|Withdrawal by Subject|0|||
155285125|NCT01240356|560476247|FG000|Overall Study|MRI contraindication|1|||
155285126|NCT01240356|560476248|FG001|Overall Study|MRI contraindication|0|||
155285127|NCT01677936|560476249|FG000|Overall Study|Lost to Follow-up|4|||
155285128|NCT01677936|560476250|FG001|Overall Study|Lost to Follow-up|1|||
155285129|NCT01677936|560476249|FG000|Overall Study|Protocol Violation|3|||
155285130|NCT01677936|560476250|FG001|Overall Study|Protocol Violation|0|||
155285131|NCT01677936|560476249|FG000|Overall Study|Adverse Event|1|||
155285132|NCT01677936|560476250|FG001|Overall Study|Adverse Event|0|||
155285133|NCT01677936|560476249|FG000|Overall Study|Lost to Follow-up|1|||
155285134|NCT01677936|560476250|FG001|Overall Study|Lost to Follow-up|0|||
155285135|NCT01677936|560476249|FG000|Overall Study|Protocol Violation|0|||
155285136|NCT01677936|560476250|FG001|Overall Study|Protocol Violation|4|||
155285137|NCT03837028|560476254|FG000|Overall Study|Lost to Follow-up|4|||
155285138|NCT03837028|560476255|FG001|Overall Study|Lost to Follow-up|0|||
155285139|NCT03837028|560476256|FG002|Overall Study|Lost to Follow-up|2|||
155285140|NCT03837028|560476257|FG003|Overall Study|Lost to Follow-up|0|||
155285141|NCT03837028|560476254|FG000|Overall Study|Withdrawal by Subject|12|||
155285142|NCT03837028|560476255|FG001|Overall Study|Withdrawal by Subject|11|||
155285143|NCT03837028|560476256|FG002|Overall Study|Withdrawal by Subject|11|||
155285144|NCT03837028|560476257|FG003|Overall Study|Withdrawal by Subject|7|||
155285145|NCT00157014|560476258|FG000|Overall Study|Death|4|||
155285146|NCT00157014|560476259|FG001|Overall Study|Death|2|||
155285147|NCT00157014|560476260|FG002|Overall Study|Death|1|||
155742516|NCT00369629|562158133|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
155742517|NCT00369629|562158134|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
155742518|NCT04839562|562158135|FG000|Overall Study|Withdrawal by Subject|0|||
155742519|NCT04839562|562158136|FG001|Overall Study|Withdrawal by Subject|1|||
155742520|NCT04839562|562158135|FG000|Overall Study|Physician Decision|0|||
155742521|NCT04839562|562158136|FG001|Overall Study|Physician Decision|1|||
155742522|NCT00877773|562158137|FG000|Overall Study|Disease Progression|44|||
155742523|NCT01347580|562158138|FG000|Overall Study|Withdrawal by Subject|13|||
155742524|NCT01347580|562158139|FG001|Overall Study|Withdrawal by Subject|23|||
155742525|NCT01347580|562158138|FG000|Overall Study|Death|30|||
155742526|NCT01347580|562158139|FG001|Overall Study|Death|19|||
155742527|NCT01347580|562158138|FG000|Overall Study|Protocol Violation|10|||
155742528|NCT01347580|562158139|FG001|Overall Study|Protocol Violation|7|||
155742529|NCT01347580|562158138|FG000|Overall Study|Lost to Follow-up|3|||
155742530|NCT01347580|562158139|FG001|Overall Study|Lost to Follow-up|1|||
155406367|NCT01934556|560921804|FG001|Overall Study|Death|5|||
155406368|NCT01934556|560921805|FG002|Overall Study|Death|2|||
155742531|NCT01347580|562158138|FG000|Overall Study|Had other reason|9|||
155742532|NCT01347580|562158139|FG001|Overall Study|Had other reason|6|||
155742533|NCT01964755|562158140|FG000|Overall Study|Death|2|||
155742534|NCT01659554|562158142|FG000|Overall Study|Study Termination|4|||
155742535|NCT00097981|562158154|FG000|Overall Study|Adverse Event|31|||
155742536|NCT00097981|562158155|FG001|Overall Study|Adverse Event|44|||
155742537|NCT00097981|562158154|FG000|Overall Study|Withdrawal by Subject|10|||
155285148|NCT00157014|560476261|FG003|Overall Study|Death|1|||
155285149|NCT00157014|560476258|FG000|Overall Study|Physician Decision|0|||
155742538|NCT00097981|562158155|FG001|Overall Study|Withdrawal by Subject|8|||
155285150|NCT00157014|560476259|FG001|Overall Study|Physician Decision|1|||
155285151|NCT00157014|560476260|FG002|Overall Study|Physician Decision|0|||
155285152|NCT00157014|560476261|FG003|Overall Study|Physician Decision|0|||
155285153|NCT00157014|560476258|FG000|Overall Study|Medications withdrawn on family request|0|||
155406369|NCT05038020|560921807|FG000|Overall Study|Early Termination|3|||
155285154|NCT00157014|560476259|FG001|Overall Study|Medications withdrawn on family request|1|||
155285155|NCT00157014|560476260|FG002|Overall Study|Medications withdrawn on family request|0|||
155285156|NCT00157014|560476261|FG003|Overall Study|Medications withdrawn on family request|0|||
155285157|NCT00157014|560476258|FG000|Overall Study|Patient withdrawn by investigator|1|||
155285158|NCT00157014|560476259|FG001|Overall Study|Patient withdrawn by investigator|0|||
155285159|NCT00157014|560476260|FG002|Overall Study|Patient withdrawn by investigator|0|||
155285160|NCT00157014|560476261|FG003|Overall Study|Patient withdrawn by investigator|0|||
155285161|NCT00157014|560476258|FG000|Overall Study|Patient unable to return in nursing home|1|||
155285162|NCT00157014|560476259|FG001|Overall Study|Patient unable to return in nursing home|0|||
155285163|NCT00157014|560476260|FG002|Overall Study|Patient unable to return in nursing home|0|||
155285164|NCT00157014|560476261|FG003|Overall Study|Patient unable to return in nursing home|0|||
155285165|NCT00157014|560476258|FG000|Overall Study|Patient would not receive transplant|0|||
155285166|NCT00157014|560476259|FG001|Overall Study|Patient would not receive transplant|1|||
155285167|NCT00157014|560476260|FG002|Overall Study|Patient would not receive transplant|0|||
155285168|NCT00157014|560476261|FG003|Overall Study|Patient would not receive transplant|0|||
155285169|NCT00157014|560476258|FG000|Overall Study|Withdrawal by Subject|1|||
155285170|NCT00157014|560476259|FG001|Overall Study|Withdrawal by Subject|0|||
155285171|NCT00157014|560476260|FG002|Overall Study|Withdrawal by Subject|0|||
155285172|NCT00157014|560476261|FG003|Overall Study|Withdrawal by Subject|0|||
155285173|NCT01362491|560476262|FG000|Overall Study|Ineligible|1|||
155285174|NCT01362491|560476263|FG001|Overall Study|Ineligible|0|||
155285175|NCT01362491|560476264|FG002|Overall Study|Ineligible|0|||
155285176|NCT04867902|560476265|FG000|Overall Study|Lost to Follow-up|1|||
155285177|NCT04867902|560476265|FG000|Overall Study|Withdrawal by Subject|2|||
155285178|NCT04867902|560476265|FG000|Overall Study|Protocol Violation|1|||
155285179|NCT00088465|560476268|FG000|Overall Study|Withdrawal by Subject|290|||
155285180|NCT00088465|560476268|FG000|Overall Study|Adverse Event|77|||
155285181|NCT00088465|560476268|FG000|Overall Study|Lost to Follow-up|57|||
155285182|NCT00088465|560476268|FG000|Overall Study|Physician Decision|45|||
155285183|NCT00088465|560476268|FG000|Overall Study|Sponsor Decision|37|||
155285184|NCT00088465|560476268|FG000|Overall Study|Lack of Efficacy|27|||
155285185|NCT00088465|560476268|FG000|Overall Study|Protocol Violation|17|||
155285186|NCT00088465|560476268|FG000|Overall Study|Death|11|||
155285187|NCT00448864|560476269|FG000|Overall Study|Death|1|||
155285188|NCT00448864|560476270|FG001|Overall Study|Death|0|||
155742539|NCT00097981|562158154|FG000|Overall Study|Protocol Violation|1|||
155742540|NCT00097981|562158155|FG001|Overall Study|Protocol Violation|1|||
155742541|NCT00097981|562158154|FG000|Overall Study|Death|2|||
155742542|NCT00097981|562158155|FG001|Overall Study|Death|4|||
155742543|NCT00097981|562158154|FG000|Overall Study|Physician Decision|7|||
155742544|NCT00097981|562158155|FG001|Overall Study|Physician Decision|1|||
155742545|NCT00097981|562158154|FG000|Overall Study|Disease Progression|8|||
155742546|NCT00097981|562158155|FG001|Overall Study|Disease Progression|2|||
155742547|NCT00097981|562158154|FG000|Overall Study|Transplant planned|28|||
155742548|NCT00097981|562158155|FG001|Overall Study|Transplant planned|27|||
155742549|NCT00097981|562158154|FG000|Overall Study|Other|19|||
155742550|NCT00097981|562158155|FG001|Overall Study|Other|13|||
155742551|NCT00412373|562158156|FG000|Overall Study|Adverse Event|8|||
155742552|NCT00412373|562158157|FG001|Overall Study|Adverse Event|13|||
155742553|NCT00412373|562158156|FG000|Overall Study|Lack of Efficacy|16|||
155742554|NCT00412373|562158157|FG001|Overall Study|Lack of Efficacy|22|||
155742555|NCT00412373|562158156|FG000|Overall Study|Lost to Follow-up|7|||
155742556|NCT00412373|562158157|FG001|Overall Study|Lost to Follow-up|13|||
155742557|NCT00412373|562158156|FG000|Overall Study|Withdrawal by Subject|8|||
155742558|NCT00412373|562158157|FG001|Overall Study|Withdrawal by Subject|27|||
155742559|NCT00412373|562158156|FG000|Overall Study|Other|2|||
155742560|NCT00412373|562158157|FG001|Overall Study|Other|2|||
155742561|NCT03032380|562158164|FG000|Overall Study|Adverse Event|0|||
155742562|NCT03032380|562158165|FG001|Overall Study|Adverse Event|1|||
155742563|NCT03032380|562158164|FG000|Overall Study|Lack of Efficacy|1|||
155742564|NCT03032380|562158165|FG001|Overall Study|Lack of Efficacy|0|||
155742565|NCT03032380|562158164|FG000|Overall Study|Withdrawal by Subject|2|||
155742566|NCT03032380|562158165|FG001|Overall Study|Withdrawal by Subject|3|||
155742567|NCT03032380|562158164|FG000|Overall Study|Recovery|0|||
155742568|NCT03032380|562158165|FG001|Overall Study|Recovery|1|||
155285189|NCT00448864|560476271|FG002|Overall Study|Death|0|||
155285190|NCT00448864|560476269|FG000|Overall Study|Lost to Follow-up|3|||
155285191|NCT00448864|560476270|FG001|Overall Study|Lost to Follow-up|1|||
155285192|NCT00448864|560476271|FG002|Overall Study|Lost to Follow-up|0|||
155285193|NCT00448864|560476269|FG000|Overall Study|Physician Decision|1|||
155285194|NCT00448864|560476270|FG001|Overall Study|Physician Decision|0|||
155494231|NCT01741259|561234244|FG001|Overall Study|Withdrawal by Subject|2|||
155742569|NCT03032380|562158164|FG000|Overall Study|Death|39|||
155742570|NCT03032380|562158165|FG001|Overall Study|Death|34|||
155742571|NCT03032380|562158164|FG000|Overall Study|Other - Miscellaneous|0|||
155742572|NCT03032380|562158165|FG001|Overall Study|Other - Miscellaneous|1|||
155742573|NCT00864916|562158166|FG000|Overall Study|Lost to Follow-up|4|||
155285195|NCT00448864|560476271|FG002|Overall Study|Physician Decision|1|||
155406370|NCT05038020|560921808|FG001|Overall Study|Early Termination|0|||
155406371|NCT03416153|560921810|FG000|Overall Study|Physician Decision|1|||
155406372|NCT03416153|560921811|FG001|Overall Study|Physician Decision|1|||
155406373|NCT03416153|560921810|FG000|Overall Study|Withdrawal by Subject|1|||
155742574|NCT00864916|562158167|FG001|Overall Study|Lost to Follow-up|4|||
155742575|NCT00864916|562158166|FG000|Overall Study|Protocol Violation|1|||
155742576|NCT00864916|562158167|FG001|Overall Study|Protocol Violation|0|||
155742577|NCT00864916|562158166|FG000|Overall Study|Withdrawal by Subject|1|||
155742578|NCT00864916|562158167|FG001|Overall Study|Withdrawal by Subject|0|||
155742579|NCT03890666|562158169|FG000|Overall Study|Withdrawal by Subject|0|||
155742580|NCT03890666|562158170|FG001|Overall Study|Withdrawal by Subject|1|||
155742581|NCT03890666|562158169|FG000|Overall Study|Protocol deviation|1|||
155742582|NCT03890666|562158170|FG001|Overall Study|Protocol deviation|4|||
155742583|NCT03890666|562158169|FG000|Overall Study|Lost to Follow-up|2|||
155742584|NCT03890666|562158170|FG001|Overall Study|Lost to Follow-up|5|||
155742585|NCT03890666|562158169|FG000|Overall Study|Other than specified|1|||
155742586|NCT03890666|562158170|FG001|Overall Study|Other than specified|8|||
155742587|NCT02122783|562158175|FG000|Overall Study|Adverse Event|0|||
155742588|NCT02122783|562158176|FG001|Overall Study|Adverse Event|1|||
155742589|NCT00322621|562158179|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
155742590|NCT00322621|562158180|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
155742591|NCT00322621|562158181|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
155742592|NCT00322621|562158179|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
155742593|NCT00322621|562158180|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
155742594|NCT00322621|562158181|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
155742595|NCT00322621|562158179|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
155742596|NCT00322621|562158180|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
155742597|NCT00322621|562158181|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
155742598|NCT00322621|562158179|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
155742599|NCT00322621|562158180|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
155742600|NCT00322621|562158181|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
155742601|NCT00322621|562158179|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
155742602|NCT00322621|562158180|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
155742603|NCT00322621|562158181|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
155742604|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
155742605|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
155742606|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
155742607|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
155742608|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
155742609|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
155742610|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
155742611|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
155742612|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
155742613|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
155742614|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
155285196|NCT00448864|560476269|FG000|Overall Study|Withdrawal by Subject|0|||
155406374|NCT03416153|560921811|FG001|Overall Study|Withdrawal by Subject|0|||
155742615|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
155742616|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
155742617|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
155742618|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
155742619|NCT00322621|562158179|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
155742620|NCT00322621|562158180|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
155742621|NCT00322621|562158181|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
155742622|NCT02213133|562158183|FG000|Overall Study|Participant discontinued study therapy|2|||
155742623|NCT02213133|562158184|FG001|Overall Study|Participant discontinued study therapy|0|||
155742624|NCT02213133|562158185|FG002|Overall Study|Participant discontinued study therapy|0|||
155742625|NCT02213133|562158183|FG000|Overall Study|Participant withdrew informed consent|2|||
155285197|NCT00448864|560476270|FG001|Overall Study|Withdrawal by Subject|2|||
155285198|NCT00448864|560476271|FG002|Overall Study|Withdrawal by Subject|0|||
155285199|NCT00448864|560476269|FG000|Overall Study|Protocol Violation|0|||
155285200|NCT00448864|560476270|FG001|Overall Study|Protocol Violation|2|||
155285201|NCT00448864|560476271|FG002|Overall Study|Protocol Violation|0|||
155285202|NCT01390857|560476272|FG000|Overall Study|Protocol Violation|2|||
155285203|NCT01390857|560476272|FG000|Overall Study|Lost to Follow-up|1|||
155285204|NCT01390857|560476272|FG000|Overall Study|No Visit after the First Visit|7|||
155285205|NCT01474538|560476274|FG000|Treatment Period 1|Death|1|||
155285206|NCT01474538|560476275|FG001|Treatment Period 1|Death|0|||
155285207|NCT01474538|560476274|FG000|Treatment Period 1|Physician Decision|1|||
155285208|NCT01474538|560476275|FG001|Treatment Period 1|Physician Decision|0|||
155285209|NCT01474538|560476274|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155285210|NCT01474538|560476275|FG001|Treatment Period 1|Withdrawal by Subject|3|||
155285211|NCT01474538|560476274|FG000|Treatment Period 1|Protocol Violation|0|||
155285212|NCT01474538|560476275|FG001|Treatment Period 1|Protocol Violation|1|||
155285213|NCT01474538|560476274|FG000|Treatment Period 2|Death|1|||
155285214|NCT01474538|560476275|FG001|Treatment Period 2|Death|0|||
155285215|NCT01474538|560476274|FG000|Treatment Period 2|Adverse Event|1|||
155285216|NCT01474538|560476275|FG001|Treatment Period 2|Adverse Event|1|||
155285217|NCT01474538|560476274|FG000|Treatment Period 2|Withdrawal by Subject|2|||
155285218|NCT01474538|560476275|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155285219|NCT01474538|560476274|FG000|Treatment Period 2|Sponsor decision|1|||
155285220|NCT01474538|560476275|FG001|Treatment Period 2|Sponsor decision|0|||
155285221|NCT01474538|560476274|FG000|Treatment Period 2|Physician Decision|0|||
155285222|NCT01474538|560476275|FG001|Treatment Period 2|Physician Decision|1|||
155285223|NCT01474538|560476274|FG000|Treatment Period 2|Protocol Violation|1|||
155285224|NCT01474538|560476275|FG001|Treatment Period 2|Protocol Violation|0|||
155285225|NCT02501629|560476276|FG000|Overall Study|Death|0|||
155285226|NCT02501629|560476277|FG001|Overall Study|Death|1|||
155285227|NCT02501629|560476276|FG000|Overall Study|Withdrawn from study by sponsor|1|||
155285228|NCT02501629|560476277|FG001|Overall Study|Withdrawn from study by sponsor|0|||
155285229|NCT02501629|560476276|FG000|Overall Study|Early termination by sponsor|1|||
155285230|NCT02501629|560476277|FG001|Overall Study|Early termination by sponsor|0|||
155285231|NCT02501629|560476276|FG000|Overall Study|Withdrawal by Subject|3|||
155285232|NCT02501629|560476277|FG001|Overall Study|Withdrawal by Subject|5|||
155285233|NCT02501629|560476276|FG000|Overall Study|Subject did not return to site|0|||
155285234|NCT02501629|560476277|FG001|Overall Study|Subject did not return to site|1|||
155285235|NCT03120676|560476280|FG000|Overall Study|Not treated|1|||
155285236|NCT00886613|560476285|FG000|Overall Study|Protocol deviation (Part B)|1|||
155285237|NCT00886613|560476286|FG001|Overall Study|Protocol deviation (Part B)|0|||
155285238|NCT00886613|560476287|FG002|Overall Study|Protocol deviation (Part B)|0|||
155285239|NCT00886613|560476285|FG000|Overall Study|Lost to follow-up (Part B)|1|||
155285240|NCT00886613|560476286|FG001|Overall Study|Lost to follow-up (Part B)|0|||
155285241|NCT00886613|560476287|FG002|Overall Study|Lost to follow-up (Part B)|1|||
155285242|NCT00886613|560476285|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
155285243|NCT00886613|560476286|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
155285244|NCT00886613|560476287|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
155285245|NCT01289119|560476291|FG000|Overall Study|Adverse Event|2|||
155285246|NCT01289119|560476292|FG001|Overall Study|Adverse Event|1|||
155285247|NCT01289119|560476293|FG002|Overall Study|Adverse Event|0|||
155285248|NCT01289119|560476294|FG003|Overall Study|Adverse Event|2|||
155285249|NCT01289119|560476295|FG004|Overall Study|Adverse Event|1|||
155285250|NCT01289119|560476296|FG005|Overall Study|Adverse Event|0|||
155285251|NCT01289119|560476291|FG000|Overall Study|Major Protocol Deviation|2|||
155285252|NCT01289119|560476292|FG001|Overall Study|Major Protocol Deviation|1|||
155285253|NCT01289119|560476293|FG002|Overall Study|Major Protocol Deviation|3|||
155285254|NCT01289119|560476294|FG003|Overall Study|Major Protocol Deviation|0|||
155285255|NCT01289119|560476295|FG004|Overall Study|Major Protocol Deviation|2|||
155285256|NCT01289119|560476296|FG005|Overall Study|Major Protocol Deviation|1|||
155285257|NCT01289119|560476291|FG000|Overall Study|Lost to Follow-up|0|||
155285258|NCT01289119|560476292|FG001|Overall Study|Lost to Follow-up|3|||
155285259|NCT01289119|560476293|FG002|Overall Study|Lost to Follow-up|0|||
155285260|NCT01289119|560476294|FG003|Overall Study|Lost to Follow-up|0|||
155285261|NCT01289119|560476295|FG004|Overall Study|Lost to Follow-up|0|||
155285262|NCT01289119|560476296|FG005|Overall Study|Lost to Follow-up|1|||
155285263|NCT01289119|560476291|FG000|Overall Study|Withdrawal by Subject|4|||
155285264|NCT01289119|560476292|FG001|Overall Study|Withdrawal by Subject|2|||
155285265|NCT01289119|560476293|FG002|Overall Study|Withdrawal by Subject|4|||
155285266|NCT01289119|560476294|FG003|Overall Study|Withdrawal by Subject|3|||
155285267|NCT01289119|560476295|FG004|Overall Study|Withdrawal by Subject|1|||
155285268|NCT01289119|560476296|FG005|Overall Study|Withdrawal by Subject|1|||
155406375|NCT03770260|560923404|FG000|Overall Study|Disease progression|0|||
155406376|NCT03770260|560923405|FG001|Overall Study|Disease progression|1|||
155406377|NCT03770260|560923406|FG002|Overall Study|Disease progression|0|||
155406378|NCT03770260|560923407|FG003|Overall Study|Disease progression|0|||
155406379|NCT01908101|560923414|FG000|Overall Study|Physician Decision|1|||
155406380|NCT01908101|560923414|FG000|Overall Study|Withdrawal by Subject|1|||
155637553|NCT03126110|561764785|FG015|Phase 1|Withdrawal by Subject|0|||
155637554|NCT03126110|561764786|FG016|Phase 1|Withdrawal by Subject|0|||
155637555|NCT03126110|561764770|FG000|Phase 1|Safety follow-up no longer necessary|1|||
155637556|NCT03126110|561764771|FG001|Phase 1|Safety follow-up no longer necessary|0|||
155285269|NCT01289119|560476291|FG000|Overall Study|Pregnancy|0|||
155637557|NCT03126110|561764772|FG002|Phase 1|Safety follow-up no longer necessary|0|||
155637558|NCT03126110|561764773|FG003|Phase 1|Safety follow-up no longer necessary|0|||
155637559|NCT03126110|561764774|FG004|Phase 1|Safety follow-up no longer necessary|0|||
155637560|NCT03126110|561764775|FG005|Phase 1|Safety follow-up no longer necessary|0|||
155637561|NCT03126110|561764776|FG006|Phase 1|Safety follow-up no longer necessary|0|||
155637562|NCT03126110|561764777|FG007|Phase 1|Safety follow-up no longer necessary|0|||
155637563|NCT03126110|561764778|FG008|Phase 1|Safety follow-up no longer necessary|0|||
155637564|NCT03126110|561764779|FG009|Phase 1|Safety follow-up no longer necessary|0|||
155637565|NCT03126110|561764780|FG010|Phase 1|Safety follow-up no longer necessary|0|||
155637566|NCT03126110|561764781|FG011|Phase 1|Safety follow-up no longer necessary|0|||
155637567|NCT03126110|561764782|FG012|Phase 1|Safety follow-up no longer necessary|0|||
155637568|NCT03126110|561764783|FG013|Phase 1|Safety follow-up no longer necessary|0|||
155637569|NCT03126110|561764784|FG014|Phase 1|Safety follow-up no longer necessary|0|||
155637570|NCT03126110|561764785|FG015|Phase 1|Safety follow-up no longer necessary|0|||
155637571|NCT03126110|561764786|FG016|Phase 1|Safety follow-up no longer necessary|0|||
155637572|NCT03126110|561764770|FG000|Phase 1|Survival follow-up no longer necessary|0|||
155637573|NCT03126110|561764771|FG001|Phase 1|Survival follow-up no longer necessary|0|||
155637574|NCT03126110|561764772|FG002|Phase 1|Survival follow-up no longer necessary|1|||
155637575|NCT03126110|561764773|FG003|Phase 1|Survival follow-up no longer necessary|0|||
155637576|NCT03126110|561764774|FG004|Phase 1|Survival follow-up no longer necessary|0|||
155637577|NCT03126110|561764775|FG005|Phase 1|Survival follow-up no longer necessary|0|||
155637578|NCT03126110|561764776|FG006|Phase 1|Survival follow-up no longer necessary|0|||
155637579|NCT03126110|561764777|FG007|Phase 1|Survival follow-up no longer necessary|0|||
155637580|NCT03126110|561764778|FG008|Phase 1|Survival follow-up no longer necessary|0|||
155637581|NCT03126110|561764779|FG009|Phase 1|Survival follow-up no longer necessary|0|||
155637582|NCT03126110|561764780|FG010|Phase 1|Survival follow-up no longer necessary|0|||
155637583|NCT03126110|561764781|FG011|Phase 1|Survival follow-up no longer necessary|0|||
155637584|NCT03126110|561764782|FG012|Phase 1|Survival follow-up no longer necessary|0|||
155637585|NCT03126110|561764783|FG013|Phase 1|Survival follow-up no longer necessary|0|||
155637586|NCT03126110|561764784|FG014|Phase 1|Survival follow-up no longer necessary|0|||
155637587|NCT03126110|561764785|FG015|Phase 1|Survival follow-up no longer necessary|0|||
155637588|NCT03126110|561764786|FG016|Phase 1|Survival follow-up no longer necessary|0|||
155637589|NCT03126110|561764770|FG000|Phase 2|Study terminated by the sponsor|0|||
155637590|NCT03126110|561764771|FG001|Phase 2|Study terminated by the sponsor|0|||
155637591|NCT03126110|561764772|FG002|Phase 2|Study terminated by the sponsor|0|||
155637592|NCT03126110|561764773|FG003|Phase 2|Study terminated by the sponsor|0|||
155637593|NCT03126110|561764774|FG004|Phase 2|Study terminated by the sponsor|0|||
155637594|NCT03126110|561764775|FG005|Phase 2|Study terminated by the sponsor|0|||
155637595|NCT03126110|561764776|FG006|Phase 2|Study terminated by the sponsor|0|||
155637596|NCT03126110|561764777|FG007|Phase 2|Study terminated by the sponsor|0|||
155637597|NCT03126110|561764778|FG008|Phase 2|Study terminated by the sponsor|0|||
155637598|NCT03126110|561764779|FG009|Phase 2|Study terminated by the sponsor|0|||
155637599|NCT03126110|561764780|FG010|Phase 2|Study terminated by the sponsor|0|||
155637600|NCT03126110|561764781|FG011|Phase 2|Study terminated by the sponsor|0|||
155637601|NCT03126110|561764782|FG012|Phase 2|Study terminated by the sponsor|0|||
155637602|NCT03126110|561764783|FG013|Phase 2|Study terminated by the sponsor|4|||
155637603|NCT03126110|561764784|FG014|Phase 2|Study terminated by the sponsor|0|||
155637604|NCT03126110|561764785|FG015|Phase 2|Study terminated by the sponsor|0|||
155637605|NCT03126110|561764786|FG016|Phase 2|Study terminated by the sponsor|0|||
155637606|NCT03126110|561764770|FG000|Phase 2|Withdrawal by Subject|0|||
155637607|NCT03126110|561764771|FG001|Phase 2|Withdrawal by Subject|0|||
155637608|NCT03126110|561764772|FG002|Phase 2|Withdrawal by Subject|0|||
155637609|NCT03126110|561764773|FG003|Phase 2|Withdrawal by Subject|0|||
155637610|NCT03126110|561764774|FG004|Phase 2|Withdrawal by Subject|0|||
155637611|NCT03126110|561764775|FG005|Phase 2|Withdrawal by Subject|0|||
155637612|NCT03126110|561764776|FG006|Phase 2|Withdrawal by Subject|0|||
155637613|NCT03126110|561764777|FG007|Phase 2|Withdrawal by Subject|0|||
155406381|NCT01908101|560923414|FG000|Overall Study|Incorrect Diagnosis|2|||
155637614|NCT03126110|561764778|FG008|Phase 2|Withdrawal by Subject|0|||
155285270|NCT01289119|560476292|FG001|Overall Study|Pregnancy|1|||
155285271|NCT01289119|560476293|FG002|Overall Study|Pregnancy|0|||
155285272|NCT01289119|560476294|FG003|Overall Study|Pregnancy|0|||
155285273|NCT01289119|560476295|FG004|Overall Study|Pregnancy|0|||
155285274|NCT01289119|560476296|FG005|Overall Study|Pregnancy|0|||
155285275|NCT01289119|560476291|FG000|Overall Study|Lack of Efficacy|0|||
155285276|NCT01289119|560476292|FG001|Overall Study|Lack of Efficacy|1|||
155285277|NCT01289119|560476293|FG002|Overall Study|Lack of Efficacy|1|||
155285278|NCT01289119|560476294|FG003|Overall Study|Lack of Efficacy|1|||
155285279|NCT01289119|560476295|FG004|Overall Study|Lack of Efficacy|1|||
155285280|NCT01289119|560476296|FG005|Overall Study|Lack of Efficacy|1|||
155285281|NCT01289119|560476291|FG000|Overall Study|Other|1|||
155285282|NCT01289119|560476292|FG001|Overall Study|Other|0|||
155285283|NCT01289119|560476293|FG002|Overall Study|Other|1|||
155285284|NCT01289119|560476294|FG003|Overall Study|Other|0|||
155285285|NCT01289119|560476295|FG004|Overall Study|Other|0|||
155285286|NCT01289119|560476296|FG005|Overall Study|Other|0|||
155285287|NCT01704846|560476297|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155285288|NCT01704846|560476298|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155285289|NCT00530335|560476301|FG000|Overall Study|Adverse Event|3|||
155285290|NCT00530335|560476301|FG000|Overall Study|Protocol Violation|1|||
155285291|NCT00530335|560476301|FG000|Overall Study|Withdrawal by Subject|1|||
155285292|NCT00530335|560476301|FG000|Overall Study|Physician Decision|1|||
155285293|NCT01244984|560476302|FG000|Overall Study|Adverse Event|2|||
155285294|NCT01244984|560476303|FG001|Overall Study|Adverse Event|11|||
155285295|NCT01244984|560476304|FG002|Overall Study|Adverse Event|2|||
155285296|NCT01244984|560476302|FG000|Overall Study|Protocol Violation|1|||
155285297|NCT01244984|560476303|FG001|Overall Study|Protocol Violation|0|||
155285298|NCT01244984|560476304|FG002|Overall Study|Protocol Violation|0|||
155285299|NCT01244984|560476302|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
155285300|NCT01244984|560476303|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
155285301|NCT01244984|560476304|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
155285302|NCT01244984|560476302|FG000|Overall Study|Withdrawal by Subject|1|||
155285303|NCT01244984|560476303|FG001|Overall Study|Withdrawal by Subject|2|||
155285304|NCT01244984|560476304|FG002|Overall Study|Withdrawal by Subject|2|||
155285305|NCT04577183|560476306|FG000|Overall Study|Death|1|||
155285306|NCT04577183|560476306|FG000|Overall Study|Withdrawal by Subject|3|||
155285307|NCT04577183|560476306|FG000|Overall Study|Early termination|2|||
155285308|NCT00672256|560476307|FG000|Overall Study|PI dropped, bad data|44|||
155285309|NCT01360840|560476310|FG000|Overall Study|Ongoing at data cut-off|10|||
155285310|NCT01360840|560476311|FG001|Overall Study|Ongoing at data cut-off|10|||
155285311|NCT01360840|560476312|FG002|Overall Study|Ongoing at data cut-off|9|||
155285312|NCT00920686|560476314|FG000|Overall Study|Lost to Follow-up|2|||
155285313|NCT00920686|560476315|FG001|Overall Study|Lost to Follow-up|3|||
155285314|NCT00920686|560476316|FG002|Overall Study|Lost to Follow-up|1|||
155285315|NCT00920686|560476314|FG000|Overall Study|Study drug dosing criteria not met|17|||
155637615|NCT03126110|561764779|FG009|Phase 2|Withdrawal by Subject|0|||
155637616|NCT03126110|561764780|FG010|Phase 2|Withdrawal by Subject|0|||
155637617|NCT03126110|561764781|FG011|Phase 2|Withdrawal by Subject|1|||
155637618|NCT03126110|561764782|FG012|Phase 2|Withdrawal by Subject|3|||
155637619|NCT03126110|561764783|FG013|Phase 2|Withdrawal by Subject|3|||
155637620|NCT03126110|561764784|FG014|Phase 2|Withdrawal by Subject|2|||
155637621|NCT03126110|561764785|FG015|Phase 2|Withdrawal by Subject|1|||
155637622|NCT03126110|561764786|FG016|Phase 2|Withdrawal by Subject|0|||
155637623|NCT03126110|561764770|FG000|Phase 2|Lost to Follow-up|0|||
155637624|NCT03126110|561764771|FG001|Phase 2|Lost to Follow-up|0|||
155637625|NCT03126110|561764772|FG002|Phase 2|Lost to Follow-up|0|||
155637626|NCT03126110|561764773|FG003|Phase 2|Lost to Follow-up|0|||
155637627|NCT03126110|561764774|FG004|Phase 2|Lost to Follow-up|0|||
155637628|NCT03126110|561764775|FG005|Phase 2|Lost to Follow-up|0|||
155637629|NCT03126110|561764776|FG006|Phase 2|Lost to Follow-up|0|||
155637630|NCT03126110|561764777|FG007|Phase 2|Lost to Follow-up|0|||
155637631|NCT03126110|561764778|FG008|Phase 2|Lost to Follow-up|0|||
155637632|NCT03126110|561764779|FG009|Phase 2|Lost to Follow-up|0|||
155637633|NCT03126110|561764780|FG010|Phase 2|Lost to Follow-up|0|||
155637634|NCT03126110|561764781|FG011|Phase 2|Lost to Follow-up|1|||
155637635|NCT03126110|561764782|FG012|Phase 2|Lost to Follow-up|1|||
155637636|NCT03126110|561764783|FG013|Phase 2|Lost to Follow-up|1|||
155637637|NCT03126110|561764784|FG014|Phase 2|Lost to Follow-up|2|||
155637638|NCT03126110|561764785|FG015|Phase 2|Lost to Follow-up|0|||
155637639|NCT03126110|561764786|FG016|Phase 2|Lost to Follow-up|0|||
155637640|NCT03126110|561764770|FG000|Phase 2|Death|0|||
155637641|NCT03126110|561764771|FG001|Phase 2|Death|0|||
155637642|NCT03126110|561764772|FG002|Phase 2|Death|0|||
155742626|NCT02213133|562158184|FG001|Overall Study|Participant withdrew informed consent|1|||
155742627|NCT02213133|562158185|FG002|Overall Study|Participant withdrew informed consent|2|||
155742628|NCT02213133|562158183|FG000|Overall Study|Disease progression|11|||
155742629|NCT02213133|562158184|FG001|Overall Study|Disease progression|2|||
155742630|NCT02213133|562158185|FG002|Overall Study|Disease progression|0|||
155742631|NCT02213133|562158183|FG000|Overall Study|Adverse Event (AE)|1|||
155742632|NCT02213133|562158184|FG001|Overall Study|Adverse Event (AE)|0|||
155742633|NCT02213133|562158185|FG002|Overall Study|Adverse Event (AE)|0|||
155742634|NCT02213133|562158183|FG000|Overall Study|Death|16|||
155742635|NCT02213133|562158184|FG001|Overall Study|Death|2|||
155742636|NCT02213133|562158185|FG002|Overall Study|Death|1|||
155742637|NCT02213133|562158183|FG000|Overall Study|Other|5|||
155742638|NCT02213133|562158184|FG001|Overall Study|Other|0|||
155742639|NCT02213133|562158185|FG002|Overall Study|Other|0|||
155742640|NCT02350764|562158186|FG000|Overall Study|Adverse Event|4|||
155742641|NCT02350764|562158186|FG000|Overall Study|Death|3|||
155742642|NCT02350764|562158186|FG000|Overall Study|Physician Decision|2|||
155742643|NCT02350764|562158186|FG000|Overall Study|Withdrawal by Subject|2|||
155742644|NCT00977080|562158187|FG000|Overall Study|Adverse Event|2|||
155742645|NCT00977080|562158188|FG001|Overall Study|Adverse Event|7|||
155742646|NCT00977080|562158189|FG002|Overall Study|Adverse Event|7|||
155742647|NCT00977080|562158190|FG003|Overall Study|Adverse Event|7|||
155742648|NCT00977080|562158187|FG000|Overall Study|Withdrawal by Subject|1|||
155742649|NCT00977080|562158188|FG001|Overall Study|Withdrawal by Subject|5|||
155742650|NCT00977080|562158189|FG002|Overall Study|Withdrawal by Subject|1|||
155742651|NCT00977080|562158190|FG003|Overall Study|Withdrawal by Subject|5|||
155742652|NCT00977080|562158187|FG000|Overall Study|Protocol Violation|7|||
155742653|NCT00977080|562158188|FG001|Overall Study|Protocol Violation|3|||
155742654|NCT00977080|562158189|FG002|Overall Study|Protocol Violation|4|||
155742655|NCT00977080|562158190|FG003|Overall Study|Protocol Violation|3|||
155742656|NCT00977080|562158187|FG000|Overall Study|Noncompliance|0|||
155742657|NCT00977080|562158188|FG001|Overall Study|Noncompliance|2|||
155406382|NCT01908101|560923414|FG000|Overall Study|Incorrect Starting Dose|1|||
155637643|NCT03126110|561764773|FG003|Phase 2|Death|0|||
155637644|NCT03126110|561764774|FG004|Phase 2|Death|0|||
155637645|NCT03126110|561764775|FG005|Phase 2|Death|0|||
155637646|NCT03126110|561764776|FG006|Phase 2|Death|0|||
155637647|NCT03126110|561764777|FG007|Phase 2|Death|0|||
155637648|NCT03126110|561764778|FG008|Phase 2|Death|0|||
155637649|NCT03126110|561764779|FG009|Phase 2|Death|0|||
155637650|NCT03126110|561764780|FG010|Phase 2|Death|0|||
155637651|NCT03126110|561764781|FG011|Phase 2|Death|6|||
155637652|NCT03126110|561764782|FG012|Phase 2|Death|12|||
155637653|NCT03126110|561764783|FG013|Phase 2|Death|25|||
155637654|NCT03126110|561764784|FG014|Phase 2|Death|11|||
155637655|NCT03126110|561764785|FG015|Phase 2|Death|3|||
155637656|NCT03126110|561764786|FG016|Phase 2|Death|2|||
155637657|NCT03126110|561764770|FG000|Phase 2|Progressive Disease|0|||
155637658|NCT03126110|561764771|FG001|Phase 2|Progressive Disease|0|||
155637659|NCT03126110|561764772|FG002|Phase 2|Progressive Disease|0|||
155637660|NCT03126110|561764773|FG003|Phase 2|Progressive Disease|0|||
155637661|NCT03126110|561764774|FG004|Phase 2|Progressive Disease|0|||
155637662|NCT03126110|561764775|FG005|Phase 2|Progressive Disease|0|||
155637663|NCT03126110|561764776|FG006|Phase 2|Progressive Disease|0|||
155637664|NCT03126110|561764777|FG007|Phase 2|Progressive Disease|0|||
155637665|NCT03126110|561764778|FG008|Phase 2|Progressive Disease|0|||
155637666|NCT03126110|561764779|FG009|Phase 2|Progressive Disease|0|||
155637667|NCT03126110|561764780|FG010|Phase 2|Progressive Disease|0|||
155637668|NCT03126110|561764781|FG011|Phase 2|Progressive Disease|0|||
155637669|NCT03126110|561764782|FG012|Phase 2|Progressive Disease|0|||
155637670|NCT03126110|561764783|FG013|Phase 2|Progressive Disease|1|||
155637671|NCT03126110|561764784|FG014|Phase 2|Progressive Disease|0|||
155637672|NCT03126110|561764785|FG015|Phase 2|Progressive Disease|0|||
155637673|NCT03126110|561764786|FG016|Phase 2|Progressive Disease|0|||
155637674|NCT03126110|561764770|FG000|Phase 2|Started new treatment|0|||
155637675|NCT03126110|561764771|FG001|Phase 2|Started new treatment|0|||
155637676|NCT03126110|561764772|FG002|Phase 2|Started new treatment|0|||
155637677|NCT03126110|561764773|FG003|Phase 2|Started new treatment|0|||
155637678|NCT03126110|561764774|FG004|Phase 2|Started new treatment|0|||
155637679|NCT03126110|561764775|FG005|Phase 2|Started new treatment|0|||
155637680|NCT03126110|561764776|FG006|Phase 2|Started new treatment|0|||
155637681|NCT03126110|561764777|FG007|Phase 2|Started new treatment|0|||
155637682|NCT03126110|561764778|FG008|Phase 2|Started new treatment|0|||
155742658|NCT00977080|562158189|FG002|Overall Study|Noncompliance|1|||
155742659|NCT00977080|562158190|FG003|Overall Study|Noncompliance|0|||
155742660|NCT00977080|562158187|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
155406383|NCT01908101|560923414|FG000|Overall Study|Did not complete the first cycle|4|||
155406384|NCT01394939|560923415|FG000|Overall Study|Adverse Event|1|||
155406385|NCT01394939|560923416|FG001|Overall Study|Adverse Event|3|||
155637683|NCT03126110|561764779|FG009|Phase 2|Started new treatment|0|||
155637684|NCT03126110|561764780|FG010|Phase 2|Started new treatment|0|||
155637685|NCT03126110|561764781|FG011|Phase 2|Started new treatment|0|||
155637686|NCT03126110|561764782|FG012|Phase 2|Started new treatment|0|||
155406386|NCT01394939|560923417|FG002|Overall Study|Adverse Event|0|||
155406387|NCT01394939|560923418|FG003|Overall Study|Adverse Event|2|||
155406388|NCT01394939|560923415|FG000|Overall Study|Death|0|||
155406389|NCT01394939|560923416|FG001|Overall Study|Death|2|||
155406390|NCT01394939|560923417|FG002|Overall Study|Death|0|||
155285316|NCT00920686|560476315|FG001|Overall Study|Study drug dosing criteria not met|19|||
155406391|NCT01394939|560923418|FG003|Overall Study|Death|0|||
155406392|NCT01394939|560923415|FG000|Overall Study|Physician Decision|0|||
155406393|NCT01394939|560923416|FG001|Overall Study|Physician Decision|1|||
155406394|NCT01394939|560923417|FG002|Overall Study|Physician Decision|0|||
155406395|NCT01394939|560923418|FG003|Overall Study|Physician Decision|0|||
155406396|NCT01394939|560923415|FG000|Overall Study|Withdrawal by Subject|0|||
155406397|NCT01394939|560923416|FG001|Overall Study|Withdrawal by Subject|2|||
155406398|NCT01394939|560923417|FG002|Overall Study|Withdrawal by Subject|0|||
155406399|NCT01394939|560923418|FG003|Overall Study|Withdrawal by Subject|2|||
155406400|NCT01394939|560923415|FG000|Overall Study|Others|0|||
155637687|NCT03126110|561764783|FG013|Phase 2|Started new treatment|0|||
155285317|NCT00920686|560476316|FG002|Overall Study|Study drug dosing criteria not met|12|||
155406401|NCT01394939|560923416|FG001|Overall Study|Others|2|||
155637688|NCT03126110|561764784|FG014|Phase 2|Started new treatment|1|||
155637689|NCT03126110|561764785|FG015|Phase 2|Started new treatment|0|||
155637690|NCT03126110|561764786|FG016|Phase 2|Started new treatment|0|||
155637691|NCT04435626|561764790|FG000|Overall Study|Lost to Follow-up|1|||
155637692|NCT04435626|561764791|FG001|Overall Study|Lost to Follow-up|5|||
155637693|NCT04435626|561764790|FG000|Overall Study|Withdrawal by Subject|6|||
155637694|NCT04435626|561764791|FG001|Overall Study|Withdrawal by Subject|7|||
155637695|NCT04435626|561764790|FG000|Overall Study|major GCP violations|8|||
155637696|NCT04435626|561764791|FG001|Overall Study|major GCP violations|7|||
155637697|NCT05845619|561764795|FG000|Overall Study|duplicate enrollment|2|||
155637698|NCT05845619|561764796|FG001|Overall Study|duplicate enrollment|2|||
155637699|NCT05845619|561764797|FG002|Overall Study|duplicate enrollment|1|||
155637700|NCT03621592|561764798|FG000|Overall Study|Lost to Follow-up|1|||
155637701|NCT03621592|561764799|FG001|Overall Study|Lost to Follow-up|0|||
155637702|NCT03621592|561764798|FG000|Overall Study|Lack of Improvement|1|||
155637703|NCT03621592|561764799|FG001|Overall Study|Lack of Improvement|0|||
155637704|NCT03621592|561764798|FG000|Overall Study|Preference to receive wound care closer to home|1|||
155637705|NCT03621592|561764799|FG001|Overall Study|Preference to receive wound care closer to home|0|||
155637706|NCT03621592|561764798|FG000|Overall Study|Lack of healing|0|||
155637707|NCT03621592|561764799|FG001|Overall Study|Lack of healing|2|||
155637708|NCT04967222|561764800|FG000|Randomized|Lost to Follow-up|0|||
155637709|NCT04967222|561764801|FG001|Randomized|Lost to Follow-up|1|||
155637710|NCT04967222|561764802|FG002|Randomized|Lost to Follow-up|1|||
155637711|NCT04967222|561764800|FG000|Randomized|Physician Decision|0|||
155637712|NCT04967222|561764801|FG001|Randomized|Physician Decision|0|||
155637713|NCT04967222|561764802|FG002|Randomized|Physician Decision|1|||
155637714|NCT04967222|561764800|FG000|Randomized|Withdrawal by Subject|0|||
155637715|NCT04967222|561764801|FG001|Randomized|Withdrawal by Subject|0|||
155637716|NCT04967222|561764802|FG002|Randomized|Withdrawal by Subject|2|||
155637717|NCT04967222|561764800|FG000|Randomized|abnormal finding in MRI|0|||
155637718|NCT04967222|561764801|FG001|Randomized|abnormal finding in MRI|2|||
155637719|NCT04967222|561764802|FG002|Randomized|abnormal finding in MRI|0|||
155637720|NCT04958707|561764810|FG000|Post Intervention|Withdrawal by Subject|1|||
155637721|NCT04958707|561764811|FG001|Post Intervention|Withdrawal by Subject|0|||
155637722|NCT04958707|561764812|FG002|Post Intervention|Withdrawal by Subject|0|||
155637723|NCT04958707|561764810|FG000|3 Months Follow- up|Lost to Follow-up|0|||
155637724|NCT04958707|561764811|FG001|3 Months Follow- up|Lost to Follow-up|3|||
155637725|NCT04958707|561764812|FG002|3 Months Follow- up|Lost to Follow-up|0|||
155637726|NCT04958707|561764810|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
155637727|NCT04958707|561764811|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
155637728|NCT04958707|561764812|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
155637729|NCT02629159|561764815|FG000|Overall Study|Adverse Event|17|||
155637730|NCT02629159|561764816|FG001|Overall Study|Adverse Event|20|||
155637731|NCT02629159|561764817|FG002|Overall Study|Adverse Event|22|||
155637732|NCT02629159|561764815|FG000|Overall Study|Withdrawal by Subject|22|||
155637733|NCT02629159|561764816|FG001|Overall Study|Withdrawal by Subject|11|||
155637734|NCT02629159|561764817|FG002|Overall Study|Withdrawal by Subject|15|||
155637735|NCT02629159|561764815|FG000|Overall Study|Lost to Follow-up|7|||
155637736|NCT02629159|561764816|FG001|Overall Study|Lost to Follow-up|4|||
155406402|NCT01394939|560923417|FG002|Overall Study|Others|0|||
155406403|NCT01394939|560923418|FG003|Overall Study|Others|3|||
155637737|NCT02629159|561764817|FG002|Overall Study|Lost to Follow-up|5|||
155406404|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
155406405|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
155637738|NCT02629159|561764815|FG000|Overall Study|Lack of Efficacy|4|||
155406406|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
155406407|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
155637739|NCT02629159|561764816|FG001|Overall Study|Lack of Efficacy|0|||
155637740|NCT02629159|561764817|FG002|Overall Study|Lack of Efficacy|1|||
155285318|NCT03006341|560476317|FG000|Overall Study|Not linked in the EMR|25069|||
155285319|NCT03006341|560476318|FG001|Overall Study|Not linked in the EMR|67505|||
155285320|NCT03006341|560476319|FG002|Overall Study|Not linked in the EMR|30993|||
155285321|NCT03006341|560476320|FG003|Overall Study|Not linked in the EMR|10685|||
155285322|NCT00293462|560476321|FG000|Overall Study|Withdrawal by Subject|4|||
155285323|NCT00293462|560476322|FG001|Overall Study|Withdrawal by Subject|3|||
155285324|NCT00293462|560476323|FG002|Overall Study|Withdrawal by Subject|8|||
155285325|NCT00293462|560476321|FG000|Overall Study|Death|1|||
155285326|NCT00293462|560476322|FG001|Overall Study|Death|0|||
155285327|NCT00293462|560476323|FG002|Overall Study|Death|0|||
155285328|NCT00293462|560476321|FG000|Overall Study|Lost to Follow-up|0|||
155285329|NCT00293462|560476322|FG001|Overall Study|Lost to Follow-up|1|||
155285330|NCT00293462|560476323|FG002|Overall Study|Lost to Follow-up|0|||
155285331|NCT00293462|560476321|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
155285332|NCT00293462|560476322|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
155285333|NCT00293462|560476323|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
155285334|NCT00293462|560476321|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
155285335|NCT00293462|560476322|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
155285336|NCT00293462|560476323|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
155285337|NCT00293462|560476321|FG000|Overall Study|Refuse Radiation Treatment|1|||
155285338|NCT00293462|560476322|FG001|Overall Study|Refuse Radiation Treatment|0|||
155285339|NCT00293462|560476323|FG002|Overall Study|Refuse Radiation Treatment|0|||
155285340|NCT00293462|560476321|FG000|Overall Study|No Show|0|||
155285341|NCT00293462|560476322|FG001|Overall Study|No Show|0|||
155285342|NCT00293462|560476323|FG002|Overall Study|No Show|1|||
155285343|NCT00293462|560476321|FG000|Overall Study|Went back to his home country|0|||
155285344|NCT00293462|560476322|FG001|Overall Study|Went back to his home country|0|||
155285345|NCT00293462|560476323|FG002|Overall Study|Went back to his home country|1|||
155285346|NCT00293462|560476321|FG000|Overall Study|Blood clot after chemotherapy|0|||
155285347|NCT00293462|560476322|FG001|Overall Study|Blood clot after chemotherapy|0|||
155285348|NCT00293462|560476323|FG002|Overall Study|Blood clot after chemotherapy|1|||
155285349|NCT00293462|560476321|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
155285350|NCT00293462|560476322|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
155285351|NCT00293462|560476323|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
155285352|NCT00293462|560476321|FG000|Overall Study|Possible Tracheostomy leakage|0|||
155285353|NCT00293462|560476322|FG001|Overall Study|Possible Tracheostomy leakage|1|||
155285354|NCT00293462|560476323|FG002|Overall Study|Possible Tracheostomy leakage|0|||
155285355|NCT00293462|560476321|FG000|Overall Study|Low radiation dose in oral cavity|0|||
155285356|NCT00293462|560476322|FG001|Overall Study|Low radiation dose in oral cavity|1|||
155285357|NCT00293462|560476323|FG002|Overall Study|Low radiation dose in oral cavity|0|||
155285358|NCT00293462|560476321|FG000|Overall Study|Physician Decision|0|||
155285359|NCT00293462|560476322|FG001|Overall Study|Physician Decision|1|||
155285360|NCT00293462|560476323|FG002|Overall Study|Physician Decision|0|||
155285361|NCT02950545|560476324|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285362|NCT02950545|560476325|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285363|NCT02950545|560476326|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285364|NCT02950545|560476327|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285365|NCT02950545|560476328|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285366|NCT02950545|560476329|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
155285367|NCT02950545|560476324|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285368|NCT02950545|560476325|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
155406408|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
155406409|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
155637741|NCT02629159|561764815|FG000|Overall Study|Other|6|||
155637742|NCT02629159|561764816|FG001|Overall Study|Other|4|||
155637743|NCT02629159|561764817|FG002|Overall Study|Other|8|||
155637744|NCT05523297|561764826|FG000|Overall Study|Death|7|||
155637745|NCT05523297|561764827|FG001|Overall Study|Death|8|||
155637746|NCT05523297|561764826|FG000|Overall Study|Lost to Follow-up|2|||
155637747|NCT05523297|561764827|FG001|Overall Study|Lost to Follow-up|1|||
155285369|NCT02950545|560476326|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
155285370|NCT02950545|560476327|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285371|NCT02950545|560476328|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
155285372|NCT02950545|560476329|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285373|NCT02950545|560476324|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285374|NCT02950545|560476325|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285375|NCT02950545|560476326|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285376|NCT02950545|560476327|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285377|NCT02950545|560476328|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
155285378|NCT02950545|560476329|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285379|NCT02950545|560476324|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
155285380|NCT02950545|560476325|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285381|NCT02950545|560476326|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155637748|NCT02401230|561764828|FG000|Overall Study|Adverse Event|3|||
155285382|NCT02950545|560476327|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285383|NCT02950545|560476328|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285384|NCT02950545|560476329|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285385|NCT02950545|560476324|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285386|NCT02950545|560476325|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285387|NCT02950545|560476326|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285388|NCT02950545|560476327|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285389|NCT02950545|560476328|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285390|NCT02950545|560476329|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
155285391|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
155285392|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
155285393|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
155285394|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
155285395|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
155285396|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
155285397|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
155285398|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
155285399|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
155285400|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
155285401|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
155285402|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
155285403|NCT01004263|560476332|FG000|Overall Study|Adverse Event|15|||
155285404|NCT01004263|560476332|FG000|Overall Study|Withdrawal by Subject|58|||
155285405|NCT01004263|560476332|FG000|Overall Study|Protocol Violation|10|||
155285406|NCT01004263|560476332|FG000|Overall Study|Lost to Follow-up|64|||
155285407|NCT01004263|560476332|FG000|Overall Study|Lack of Efficacy|13|||
155285408|NCT01004263|560476332|FG000|Overall Study|Pregnancy|2|||
155285409|NCT01004263|560476332|FG000|Overall Study|Physician Decision|15|||
155285410|NCT01004263|560476332|FG000|Overall Study|Lack of Qualifying Event|2|||
155285411|NCT01516892|560476343|FG000|Overall Study|Adverse Event|25|||
155285412|NCT01516892|560476343|FG000|Overall Study|Lack of Efficacy|35|||
155285413|NCT01516892|560476343|FG000|Overall Study|Pregnancy|5|||
155285414|NCT01516892|560476343|FG000|Overall Study|Lost to Follow-up|82|||
155285415|NCT01516892|560476343|FG000|Overall Study|Subject Withdrew Consent|92|||
155285416|NCT01516892|560476343|FG000|Overall Study|Protocol Violation|60|||
155285417|NCT01516892|560476343|FG000|Overall Study|Other Miscellaneous Reasons|43|||
155285418|NCT01516892|560476343|FG000|Overall Study|Missing|1|||
155285419|NCT04794179|560476344|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
155285420|NCT04794179|560476345|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
155285421|NCT01096056|560476346|FG000|Overall Study|Lost to Follow-up|0|||
155285422|NCT01096056|560476347|FG001|Overall Study|Lost to Follow-up|1|||
155285423|NCT03568162|560476348|FG000|Overall Study|Adverse Event|0|||
155285424|NCT03568162|560476349|FG001|Overall Study|Adverse Event|1|||
155285425|NCT03568162|560476350|FG002|Overall Study|Adverse Event|2|||
155285426|NCT03568162|560476351|FG003|Overall Study|Adverse Event|0|||
155285427|NCT03568162|560476352|FG004|Overall Study|Adverse Event|0|||
155285428|NCT03568162|560476353|FG005|Overall Study|Adverse Event|1|||
155285429|NCT03568162|560476348|FG000|Overall Study|Death|0|||
155285430|NCT03568162|560476349|FG001|Overall Study|Death|0|||
155285431|NCT03568162|560476350|FG002|Overall Study|Death|0|||
155285432|NCT03568162|560476351|FG003|Overall Study|Death|0|||
155285433|NCT03568162|560476352|FG004|Overall Study|Death|1|||
155285434|NCT03568162|560476353|FG005|Overall Study|Death|0|||
155285435|NCT03568162|560476348|FG000|Overall Study|Lost to Follow-up|3|||
155285436|NCT03568162|560476349|FG001|Overall Study|Lost to Follow-up|2|||
155285437|NCT03568162|560476350|FG002|Overall Study|Lost to Follow-up|4|||
155285438|NCT03568162|560476351|FG003|Overall Study|Lost to Follow-up|2|||
155285439|NCT03568162|560476352|FG004|Overall Study|Lost to Follow-up|3|||
155285440|NCT03568162|560476353|FG005|Overall Study|Lost to Follow-up|2|||
155285441|NCT03568162|560476348|FG000|Overall Study|Physician Decision|0|||
155285442|NCT03568162|560476349|FG001|Overall Study|Physician Decision|1|||
155285443|NCT03568162|560476350|FG002|Overall Study|Physician Decision|1|||
155406410|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
155406411|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
155406412|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
155406413|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
155406414|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
155406415|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
155406416|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
155285444|NCT03568162|560476351|FG003|Overall Study|Physician Decision|0|||
155285445|NCT03568162|560476352|FG004|Overall Study|Physician Decision|1|||
155285446|NCT03568162|560476353|FG005|Overall Study|Physician Decision|0|||
155285447|NCT03568162|560476348|FG000|Overall Study|Pregnancy|0|||
155285448|NCT03568162|560476349|FG001|Overall Study|Pregnancy|0|||
155406417|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
155285449|NCT03568162|560476350|FG002|Overall Study|Pregnancy|0|||
155285450|NCT03568162|560476351|FG003|Overall Study|Pregnancy|1|||
155285451|NCT03568162|560476352|FG004|Overall Study|Pregnancy|0|||
155285452|NCT03568162|560476353|FG005|Overall Study|Pregnancy|0|||
155285453|NCT03568162|560476348|FG000|Overall Study|Protocol Violation|1|||
155285454|NCT03568162|560476349|FG001|Overall Study|Protocol Violation|0|||
155285455|NCT03568162|560476350|FG002|Overall Study|Protocol Violation|1|||
155285456|NCT03568162|560476351|FG003|Overall Study|Protocol Violation|1|||
155285457|NCT03568162|560476352|FG004|Overall Study|Protocol Violation|1|||
155285458|NCT03568162|560476353|FG005|Overall Study|Protocol Violation|1|||
155285459|NCT03568162|560476348|FG000|Overall Study|Withdrawal by Subject|15|||
155285460|NCT03568162|560476349|FG001|Overall Study|Withdrawal by Subject|15|||
155285461|NCT03568162|560476350|FG002|Overall Study|Withdrawal by Subject|26|||
155285462|NCT03568162|560476351|FG003|Overall Study|Withdrawal by Subject|22|||
155285463|NCT03568162|560476352|FG004|Overall Study|Withdrawal by Subject|6|||
155285464|NCT03568162|560476353|FG005|Overall Study|Withdrawal by Subject|9|||
155285465|NCT03568162|560476348|FG000|Overall Study|Others|3|||
155285466|NCT03568162|560476349|FG001|Overall Study|Others|4|||
155285467|NCT03568162|560476350|FG002|Overall Study|Others|1|||
155285468|NCT03568162|560476351|FG003|Overall Study|Others|4|||
155285469|NCT03568162|560476352|FG004|Overall Study|Others|2|||
155285470|NCT03568162|560476353|FG005|Overall Study|Others|1|||
155285471|NCT00768066|560476355|FG000|Overall Study|Did not receive study product injection.|3|||
155285472|NCT00768066|560476356|FG001|Overall Study|Did not receive study product injection.|3|||
155285473|NCT00768066|560476357|FG002|Overall Study|Did not receive study product injection.|0|||
155285474|NCT04831775|560476358|FG000|Overall Study|Lost to Follow-up|11|||
155285475|NCT04831775|560476359|FG001|Overall Study|Lost to Follow-up|13|||
155285476|NCT00337818|560476360|FG000|Overall Study|Lost to Follow-up|289|||
155285477|NCT00337818|560476361|FG001|Overall Study|Lost to Follow-up|91|||
155285478|NCT00337818|560476362|FG002|Overall Study|Lost to Follow-up|107|||
155285479|NCT03590743|560476363|FG000|Overall Study|Withdrawal by Subject|0|||
155285480|NCT03590743|560476364|FG001|Overall Study|Withdrawal by Subject|1|||
155285481|NCT02696226|560476365|FG000|Overall Study|Study terminated - lack of enrollment|1|||
155285482|NCT02696226|560476366|FG001|Overall Study|Study terminated - lack of enrollment|0|||
155285483|NCT02696226|560476367|FG002|Overall Study|Study terminated - lack of enrollment|2|||
155285484|NCT02696226|560476368|FG003|Overall Study|Study terminated - lack of enrollment|0|||
155285485|NCT01190176|560476369|FG000|Overall Study|Withdrawal by Subject|1|||
155285486|NCT01190176|560476369|FG000|Overall Study|Lost to Follow-up|1|||
155285487|NCT02909101|560476370|FG000|Overall Study|Lost to Follow-up|1|||
155285488|NCT02909101|560476371|FG001|Overall Study|Lost to Follow-up|1|||
155285489|NCT02189863|560476372|FG000|First 2 Weeks|Motion Sickness|4|||
155285490|NCT02189863|560476373|FG001|First 2 Weeks|Motion Sickness|2|||
155285491|NCT03697460|560476374|FG000|Overall Study|Withdrawal by Subject|3|||
155285492|NCT00429793|560476375|FG000|Overall Study|Improper pre-protocol treatment|3|||
155285493|NCT00429793|560476375|FG000|Overall Study|Required test not done|1|||
155285494|NCT00429793|560476375|FG000|Overall Study|Never treated|1|||
155285495|NCT00429793|560476375|FG000|Overall Study|Non-measurable|1|||
155285496|NCT02414828|560476379|FG000|Overall Study|Lost to Follow-up|0|||
155285497|NCT02414828|560476380|FG001|Overall Study|Lost to Follow-up|1|||
155285498|NCT02414828|560476381|FG002|Overall Study|Lost to Follow-up|1|||
155285499|NCT02414828|560476382|FG003|Overall Study|Lost to Follow-up|2|||
155285500|NCT00389519|560476386|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
155285501|NCT00389519|560476387|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285502|NCT00389519|560476388|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285503|NCT00389519|560476389|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285504|NCT00389519|560476386|FG000|Placebo Run-In|Withdrawal by Subject|19|||
155742661|NCT00977080|562158188|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
155742662|NCT00977080|562158189|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
155742663|NCT00977080|562158190|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
155742664|NCT00977080|562158187|FG000|Overall Study|Required kidney transplantation|1|||
155742665|NCT00977080|562158188|FG001|Overall Study|Required kidney transplantation|3|||
155742666|NCT00977080|562158189|FG002|Overall Study|Required kidney transplantation|3|||
155742667|NCT00977080|562158190|FG003|Overall Study|Required kidney transplantation|1|||
155742668|NCT00977080|562158187|FG000|Overall Study|Travel for family reasons|1|||
155742669|NCT00977080|562158188|FG001|Overall Study|Travel for family reasons|0|||
155742670|NCT00977080|562158189|FG002|Overall Study|Travel for family reasons|0|||
155285505|NCT00389519|560476387|FG001|Placebo Run-In|Withdrawal by Subject|0|||
155285506|NCT00389519|560476388|FG002|Placebo Run-In|Withdrawal by Subject|0|||
155285507|NCT00389519|560476389|FG003|Placebo Run-In|Withdrawal by Subject|0|||
155285508|NCT00389519|560476386|FG000|Placebo Run-In|Reason not specified|40|||
155285509|NCT00389519|560476387|FG001|Placebo Run-In|Reason not specified|0|||
155285510|NCT00389519|560476388|FG002|Placebo Run-In|Reason not specified|0|||
155285511|NCT00389519|560476389|FG003|Placebo Run-In|Reason not specified|0|||
155285512|NCT00389519|560476386|FG000|Randomized|Did not receive study drug|2|||
155285513|NCT00389519|560476387|FG001|Randomized|Did not receive study drug|0|||
155285514|NCT00389519|560476388|FG002|Randomized|Did not receive study drug|0|||
155285515|NCT00389519|560476389|FG003|Randomized|Did not receive study drug|0|||
155285516|NCT00389519|560476386|FG000|Treated|Adverse Event|1|||
155285517|NCT00389519|560476387|FG001|Treated|Adverse Event|0|||
155285518|NCT00389519|560476388|FG002|Treated|Adverse Event|0|||
155285519|NCT00389519|560476389|FG003|Treated|Adverse Event|2|||
155285520|NCT00389519|560476386|FG000|Treated|Reason not specified|1|||
155285521|NCT00389519|560476387|FG001|Treated|Reason not specified|1|||
155285522|NCT00389519|560476388|FG002|Treated|Reason not specified|0|||
155285523|NCT00389519|560476389|FG003|Treated|Reason not specified|2|||
155285524|NCT01140347|560476390|FG000|Overall Study|Lost to Follow-up|5|||
155285525|NCT01140347|560476391|FG001|Overall Study|Lost to Follow-up|6|||
155285526|NCT01140347|560476390|FG000|Overall Study|Withdrawal by Subject|13|||
155285527|NCT01140347|560476391|FG001|Overall Study|Withdrawal by Subject|8|||
155285528|NCT01959880|560476392|FG000|Overall Study|Withdrawal by Subject|11|||
155285529|NCT01959880|560476393|FG001|Overall Study|Withdrawal by Subject|13|||
155285530|NCT01959880|560476394|FG002|Overall Study|Withdrawal by Subject|8|||
155285531|NCT01959880|560476395|FG003|Overall Study|Withdrawal by Subject|7|||
155285532|NCT01959880|560476392|FG000|Overall Study|Death|1|||
155285533|NCT01959880|560476393|FG001|Overall Study|Death|10|||
155285534|NCT01959880|560476394|FG002|Overall Study|Death|1|||
155285535|NCT01959880|560476395|FG003|Overall Study|Death|2|||
155285536|NCT01959880|560476392|FG000|Overall Study|Lost to Follow-up|95|||
155285537|NCT01959880|560476393|FG001|Overall Study|Lost to Follow-up|18|||
155285538|NCT01959880|560476394|FG002|Overall Study|Lost to Follow-up|15|||
155285539|NCT01959880|560476395|FG003|Overall Study|Lost to Follow-up|8|||
155285540|NCT01959880|560476392|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
155285541|NCT01959880|560476393|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
155285542|NCT01959880|560476394|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
155285543|NCT01959880|560476395|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
155285544|NCT01959880|560476392|FG000|Overall Study|Study completed early-FDA approved|1003|||
155285545|NCT01959880|560476393|FG001|Overall Study|Study completed early-FDA approved|311|||
155285546|NCT01959880|560476394|FG002|Overall Study|Study completed early-FDA approved|179|||
155285547|NCT01959880|560476395|FG003|Overall Study|Study completed early-FDA approved|152|||
155285548|NCT04155424|560476396|FG000|Overall Study|Other than specified|3|||
155285549|NCT04155424|560476396|FG000|Overall Study|Withdrawal by Subject|1|||
155285550|NCT04155424|560476396|FG000|Overall Study|Adverse Event|1|||
155285551|NCT01801930|560478285|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
155285552|NCT01801930|560478286|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
155285553|NCT01801930|560478287|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
155285554|NCT01801930|560478288|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
155285555|NCT01801930|560478285|FG000|Overall Study|DLT occurs|0|||
155285556|NCT01801930|560478286|FG001|Overall Study|DLT occurs|1|||
155285557|NCT01801930|560478287|FG002|Overall Study|DLT occurs|0|||
155285558|NCT01801930|560478288|FG003|Overall Study|DLT occurs|0|||
155285559|NCT02072226|560478289|FG000|Overall Study|Lost to Follow-up|11|||
155285560|NCT02072226|560478290|FG001|Overall Study|Lost to Follow-up|7|||
155285561|NCT02072226|560478289|FG000|Overall Study|Patient Non-compliance|2|||
155285562|NCT02072226|560478290|FG001|Overall Study|Patient Non-compliance|3|||
155285563|NCT02072226|560478289|FG000|Overall Study|Death|1|||
155637749|NCT02401230|561764829|FG001|Overall Study|Adverse Event|2|||
155637750|NCT02401230|561764830|FG002|Overall Study|Adverse Event|0|||
155637751|NCT02401230|561764828|FG000|Overall Study|Withdrawal by Subject|2|||
155637752|NCT02401230|561764829|FG001|Overall Study|Withdrawal by Subject|1|||
155637753|NCT02401230|561764830|FG002|Overall Study|Withdrawal by Subject|1|||
155637754|NCT02401230|561764828|FG000|Overall Study|Lost to Follow-up|1|||
155637755|NCT02401230|561764829|FG001|Overall Study|Lost to Follow-up|3|||
155637756|NCT02401230|561764830|FG002|Overall Study|Lost to Follow-up|3|||
155637757|NCT00831844|561764836|FG000|Overall Study|Adverse Event|2|||
155637758|NCT00831844|561764837|FG001|Overall Study|Adverse Event|0|||
155637759|NCT00831844|561764838|FG002|Overall Study|Adverse Event|0|||
155637760|NCT00831844|561764839|FG003|Overall Study|Adverse Event|0|||
155637761|NCT00831844|561764840|FG004|Overall Study|Adverse Event|1|||
155637762|NCT00831844|561764841|FG005|Overall Study|Adverse Event|1|||
155637763|NCT00831844|561764842|FG006|Overall Study|Adverse Event|2|||
155637764|NCT00831844|561764843|FG007|Overall Study|Adverse Event|0|||
155637765|NCT00831844|561764844|FG008|Overall Study|Adverse Event|0|||
155285564|NCT02072226|560478290|FG001|Overall Study|Death|0|||
155285565|NCT02072226|560478289|FG000|Overall Study|Patient Withdrawal of Consent|1|||
155285566|NCT02072226|560478290|FG001|Overall Study|Patient Withdrawal of Consent|0|||
155285567|NCT03255018|560478292|FG000|Overall Study|Death on study|0|||
155285568|NCT03255018|560478293|FG001|Overall Study|Death on study|5|||
155285569|NCT03255018|560478292|FG000|Overall Study|Withdrawal by Subject|0|||
155285570|NCT03255018|560478293|FG001|Overall Study|Withdrawal by Subject|2|||
155285571|NCT01720043|560478295|FG000|Overall Study|Withdrawal by Subject|1|||
155285572|NCT01688973|560478296|FG000|Overall Study|Ineligible|2|||
155285573|NCT01688973|560478297|FG001|Overall Study|Ineligible|3|||
155285574|NCT01124162|560478298|FG000|First Intervention|Adverse Event|2|||
155285575|NCT01124162|560478299|FG001|First Intervention|Adverse Event|0|||
155285576|NCT01124162|560478298|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155285577|NCT01124162|560478299|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155285578|NCT03613129|560478305|FG000|Pre-treatment Assessment|Protocol Violation|2|||
155285579|NCT03613129|560478306|FG001|Pre-treatment Assessment|Protocol Violation|0|||
155285580|NCT03613129|560478307|FG002|Pre-treatment Assessment|Protocol Violation|0|||
155285581|NCT03613129|560478308|FG003|Pre-treatment Assessment|Protocol Violation|0|||
155285582|NCT03613129|560478309|FG004|Pre-treatment Assessment|Protocol Violation|0|||
155285583|NCT03613129|560478305|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
155285584|NCT03613129|560478306|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285585|NCT03613129|560478307|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285586|NCT03613129|560478308|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285587|NCT03613129|560478309|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285588|NCT02534896|560478310|FG000|Overall Study|Adverse Event|2|||
155285589|NCT02534896|560478311|FG001|Overall Study|Adverse Event|1|||
155285590|NCT02534896|560478312|FG002|Overall Study|Adverse Event|1|||
155285591|NCT02534896|560478310|FG000|Overall Study|Insufficient therapeutic response|2|||
155285592|NCT02534896|560478311|FG001|Overall Study|Insufficient therapeutic response|0|||
155285593|NCT02534896|560478312|FG002|Overall Study|Insufficient therapeutic response|0|||
155285594|NCT00711646|560478315|FG000|Overall Study|Adverse Event|6|||
155285595|NCT00711646|560478316|FG001|Overall Study|Adverse Event|1|||
155285596|NCT00711646|560478315|FG000|Overall Study|Withdrawal by Subject|4|||
155285597|NCT00711646|560478316|FG001|Overall Study|Withdrawal by Subject|0|||
155285598|NCT00711646|560478315|FG000|Overall Study|Protocol Violation|0|||
155285599|NCT00711646|560478316|FG001|Overall Study|Protocol Violation|1|||
155285600|NCT00711646|560478315|FG000|Overall Study|Lost to Follow-up|1|||
155285601|NCT00711646|560478316|FG001|Overall Study|Lost to Follow-up|0|||
155285602|NCT00711646|560478315|FG000|Overall Study|administrative decision|0|||
155285603|NCT00711646|560478316|FG001|Overall Study|administrative decision|1|||
155285604|NCT00711646|560478315|FG000|Overall Study|patient non-compliance|1|||
155285605|NCT00711646|560478316|FG001|Overall Study|patient non-compliance|0|||
155285606|NCT03441360|560478317|FG000|Overall Study|Radiological disease progression|5|||
155285607|NCT03441360|560478318|FG001|Overall Study|Radiological disease progression|6|||
155285608|NCT03441360|560478319|FG002|Overall Study|Radiological disease progression|4|||
155285609|NCT03441360|560478317|FG000|Overall Study|Clinical disease progression|2|||
155285610|NCT03441360|560478318|FG001|Overall Study|Clinical disease progression|2|||
155285611|NCT03441360|560478319|FG002|Overall Study|Clinical disease progression|0|||
155285612|NCT03441360|560478317|FG000|Overall Study|Adverse Event|1|||
155285613|NCT03441360|560478318|FG001|Overall Study|Adverse Event|0|||
155285614|NCT03441360|560478319|FG002|Overall Study|Adverse Event|1|||
155285615|NCT00269399|560478320|FG000|Overall Study|Lack of Efficacy|27|||
155285616|NCT00269399|560478321|FG001|Overall Study|Lack of Efficacy|10|||
155285617|NCT00269399|560478320|FG000|Overall Study|Adverse Event|10|||
155285618|NCT00269399|560478321|FG001|Overall Study|Adverse Event|4|||
155285619|NCT00269399|560478320|FG000|Overall Study|Withdrawal by Subject|2|||
155285620|NCT00269399|560478321|FG001|Overall Study|Withdrawal by Subject|5|||
155285621|NCT00269399|560478320|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
155285622|NCT00269399|560478321|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
155285623|NCT00269399|560478320|FG000|Overall Study|Other|0|||
155285624|NCT00269399|560478321|FG001|Overall Study|Other|4|||
155285625|NCT00269399|560478320|FG000|Overall Study|Development of exclusion criteria|0|||
155285626|NCT00269399|560478321|FG001|Overall Study|Development of exclusion criteria|1|||
155285627|NCT03439124|560478322|FG000|Overall Study|Adverse Event|2|||
155285628|NCT03439124|560478323|FG001|Overall Study|Adverse Event|0|||
155285629|NCT03439124|560478322|FG000|Overall Study|Lost to Follow-up|1|||
155285630|NCT03439124|560478323|FG001|Overall Study|Lost to Follow-up|0|||
155285631|NCT03439124|560478322|FG000|Overall Study|Other reasons|1|||
155285632|NCT03439124|560478323|FG001|Overall Study|Other reasons|0|||
155285633|NCT04353037|560478324|FG000|Overall Study|Lost to Follow-up|0|||
155285634|NCT04353037|560478325|FG001|Overall Study|Lost to Follow-up|1|||
155285635|NCT04353037|560478326|FG002|Overall Study|Lost to Follow-up|2|||
155285636|NCT04353037|560478327|FG003|Overall Study|Lost to Follow-up|3|||
155285637|NCT04353037|560478324|FG000|Overall Study|Withdrawal by Subject|0|||
155285638|NCT04353037|560478325|FG001|Overall Study|Withdrawal by Subject|2|||
155285639|NCT04353037|560478326|FG002|Overall Study|Withdrawal by Subject|3|||
155285640|NCT04353037|560478327|FG003|Overall Study|Withdrawal by Subject|5|||
155285641|NCT04353037|560478324|FG000|Overall Study|Adverse Event|0|||
155637766|NCT00831844|561764845|FG009|Overall Study|Adverse Event|0|||
155285642|NCT04353037|560478325|FG001|Overall Study|Adverse Event|0|||
155285643|NCT04353037|560478326|FG002|Overall Study|Adverse Event|2|||
155285644|NCT04353037|560478327|FG003|Overall Study|Adverse Event|0|||
155285645|NCT04353037|560478324|FG000|Overall Study|Exposure Change|0|||
155285646|NCT04353037|560478325|FG001|Overall Study|Exposure Change|0|||
155285647|NCT04353037|560478326|FG002|Overall Study|Exposure Change|0|||
155285648|NCT04353037|560478327|FG003|Overall Study|Exposure Change|2|||
155285649|NCT03101592|560478329|FG000|Overall Study|participant files could not be located|111|||
155285650|NCT03101592|560478330|FG001|Overall Study|participant files could not be located|170|||
155285651|NCT03101592|560478331|FG002|Overall Study|participant files could not be located|118|||
155285652|NCT00647348|560478332|FG000|Overall Study|Lost to Follow-up|3|||
155285653|NCT00647348|560478333|FG001|Overall Study|Lost to Follow-up|6|||
155285654|NCT02219490|560478339|FG000|Overall Study|Adverse Event|24|||
155285655|NCT02219490|560478339|FG000|Overall Study|Withdrew consent|96|||
155285656|NCT02219490|560478339|FG000|Overall Study|Lost to Follow-up|126|||
155285657|NCT02219490|560478339|FG000|Overall Study|COVID-19 infection|2|||
155285658|NCT02219490|560478339|FG000|Overall Study|COVID-19 logistical restrictions|33|||
155285659|NCT02219490|560478339|FG000|Overall Study|Other, not specified|57|||
155285660|NCT01928940|560478343|FG000|Overall Study|Adverse Event|0|||
155285661|NCT01928940|560478344|FG001|Overall Study|Adverse Event|1|||
155285662|NCT01352507|560478347|FG000|Treatment Period 1|Adverse Event|3|||
155285663|NCT01352507|560478348|FG001|Treatment Period 1|Adverse Event|0|||
155285664|NCT01352507|560478347|FG000|Treatment Period 1|Lost to Follow-up|3|||
155285665|NCT01352507|560478348|FG001|Treatment Period 1|Lost to Follow-up|4|||
155285666|NCT01352507|560478347|FG000|Treatment Period 1|Withdrawal by Subject|7|||
155285667|NCT01352507|560478348|FG001|Treatment Period 1|Withdrawal by Subject|5|||
155285668|NCT01352507|560478347|FG000|Treatment Period 1|Physician Decision|1|||
155285669|NCT01352507|560478348|FG001|Treatment Period 1|Physician Decision|0|||
155285670|NCT01352507|560478347|FG000|Washout Period|Withdrawal by Subject|0|||
155285671|NCT01352507|560478348|FG001|Washout Period|Withdrawal by Subject|1|||
155285672|NCT01352507|560478347|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
155285673|NCT01352507|560478348|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
155285674|NCT01352507|560478347|FG000|Treatment Period 2|Withdrawal by Subject|4|||
155285675|NCT01352507|560478348|FG001|Treatment Period 2|Withdrawal by Subject|3|||
155285676|NCT01352507|560478347|FG000|Treatment Period 2|Lack of Efficacy|1|||
155285677|NCT01352507|560478348|FG001|Treatment Period 2|Lack of Efficacy|0|||
155285678|NCT03178201|560478349|FG000|Overall Study|Off study|5|||
155285679|NCT04668144|560478350|FG000|Overall Study|Protocol Violation|0|||
155285680|NCT04668144|560478351|FG001|Overall Study|Protocol Violation|1|||
155285681|NCT04668144|560478352|FG002|Overall Study|Protocol Violation|2|||
155285682|NCT02095158|560478356|FG000|Overall Study|Adverse Event|14|||
155285683|NCT02095158|560478356|FG000|Overall Study|Lack of Efficacy|3|||
155285684|NCT02095158|560478356|FG000|Overall Study|Pregnancy|1|||
155285685|NCT02095158|560478356|FG000|Overall Study|Lost to Follow-up|20|||
155285686|NCT02095158|560478356|FG000|Overall Study|Personal Reasons|35|||
155285687|NCT02095158|560478356|FG000|Overall Study|Protocol Violation|1|||
155285688|NCT02095158|560478356|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155285689|NCT00320489|560478357|FG000|Overall Study|Adverse Event|26|||
155285690|NCT00320489|560478358|FG001|Overall Study|Adverse Event|25|||
155285691|NCT00320489|560478357|FG000|Overall Study|Clinical Relapse|26|||
155285692|NCT00320489|560478358|FG001|Overall Study|Clinical Relapse|20|||
155285693|NCT00320489|560478357|FG000|Overall Study|Death|0|||
155285694|NCT00320489|560478358|FG001|Overall Study|Death|2|||
155285695|NCT00320489|560478357|FG000|Overall Study|Entry Criteria Exclusion|2|||
155285696|NCT00320489|560478358|FG001|Overall Study|Entry Criteria Exclusion|4|||
155285697|NCT00320489|560478357|FG000|Overall Study|Lack of Efficacy|16|||
155285698|NCT00320489|560478358|FG001|Overall Study|Lack of Efficacy|7|||
155285699|NCT00320489|560478357|FG000|Overall Study|Lost to Follow-up|21|||
155285700|NCT00320489|560478358|FG001|Overall Study|Lost to Follow-up|22|||
155285701|NCT00320489|560478357|FG000|Overall Study|Physician Decision|8|||
155285702|NCT00320489|560478358|FG001|Overall Study|Physician Decision|8|||
155285703|NCT00320489|560478357|FG000|Overall Study|Protocol Violation|4|||
155285704|NCT00320489|560478358|FG001|Overall Study|Protocol Violation|4|||
155285705|NCT00320489|560478357|FG000|Overall Study|Sponsor Decision|3|||
155285706|NCT00320489|560478358|FG001|Overall Study|Sponsor Decision|3|||
155285707|NCT00320489|560478357|FG000|Overall Study|Withdrawal by Subject|39|||
155285708|NCT00320489|560478358|FG001|Overall Study|Withdrawal by Subject|41|||
155285709|NCT01872611|560478360|FG000|Overall Study|Adverse Event|3|||
155406418|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
155406419|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
155637767|NCT00831844|561764836|FG000|Overall Study|Death|0|||
155285710|NCT01872611|560478361|FG001|Overall Study|Adverse Event|1|||
155285711|NCT01872611|560478360|FG000|Overall Study|Adverse Event, prior to treatment|0|||
155285712|NCT01872611|560478361|FG001|Overall Study|Adverse Event, prior to treatment|1|||
155285713|NCT01872611|560478360|FG000|Overall Study|Death|0|||
155285714|NCT01872611|560478361|FG001|Overall Study|Death|1|||
155285715|NCT01872611|560478360|FG000|Overall Study|Death, prior to treatment|0|||
155285716|NCT01872611|560478361|FG001|Overall Study|Death, prior to treatment|1|||
155285717|NCT01872611|560478360|FG000|Overall Study|Lost to Follow-up|8|||
155285718|NCT01872611|560478361|FG001|Overall Study|Lost to Follow-up|1|||
155285719|NCT01872611|560478360|FG000|Overall Study|Physician Decision|1|||
155285720|NCT01872611|560478361|FG001|Overall Study|Physician Decision|0|||
155637768|NCT00831844|561764837|FG001|Overall Study|Death|0|||
155285721|NCT01872611|560478360|FG000|Overall Study|Withdrawal by Subject|6|||
155285722|NCT01872611|560478361|FG001|Overall Study|Withdrawal by Subject|1|||
155285723|NCT01872611|560478360|FG000|Overall Study|Reason not provided|6|||
155285724|NCT01872611|560478361|FG001|Overall Study|Reason not provided|6|||
155285725|NCT03441984|560478362|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285726|NCT03441984|560478363|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285727|NCT03441984|560478364|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
155285728|NCT03441984|560478365|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285729|NCT03441984|560478366|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285730|NCT03441984|560478367|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285731|NCT03441984|560478368|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285732|NCT03441984|560478369|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285733|NCT03441984|560478370|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285734|NCT03441984|560478371|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285735|NCT03441984|560478372|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285736|NCT03441984|560478373|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285737|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
155285738|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
155285739|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
155285740|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Other|1|||
155285741|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
155285742|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155285743|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
155285744|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Other|1|||
155285745|NCT01835899|560478379|FG000|Overall Study|Adverse Event|0|||
155285746|NCT01835899|560478380|FG001|Overall Study|Adverse Event|0|||
155285747|NCT01835899|560478381|FG002|Overall Study|Adverse Event|1|||
155285748|NCT01835899|560478379|FG000|Overall Study|Other than stated above|0|||
155285749|NCT01835899|560478380|FG001|Overall Study|Other than stated above|1|||
155285750|NCT01835899|560478381|FG002|Overall Study|Other than stated above|0|||
155285751|NCT04939428|560478384|FG000|Overall Study|Death|0|||
155285752|NCT04939428|560478385|FG001|Overall Study|Death|1|||
155285753|NCT04939428|560478386|FG002|Overall Study|Death|0|||
155285754|NCT04939428|560478384|FG000|Overall Study|Lost to Follow-up|0|||
155285755|NCT04939428|560478385|FG001|Overall Study|Lost to Follow-up|5|||
155285756|NCT04939428|560478386|FG002|Overall Study|Lost to Follow-up|0|||
155285757|NCT04939428|560478384|FG000|Overall Study|Physician Decision|1|||
155285758|NCT04939428|560478385|FG001|Overall Study|Physician Decision|0|||
155285759|NCT04939428|560478386|FG002|Overall Study|Physician Decision|0|||
155285760|NCT04939428|560478384|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155285761|NCT04939428|560478385|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155285762|NCT04939428|560478386|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155285763|NCT04939428|560478384|FG000|Overall Study|Withdrawal by Subject|10|||
155285764|NCT04939428|560478385|FG001|Overall Study|Withdrawal by Subject|11|||
155285765|NCT04939428|560478386|FG002|Overall Study|Withdrawal by Subject|0|||
155285766|NCT04939428|560478384|FG000|Overall Study|Unkown|6|||
155285767|NCT04939428|560478385|FG001|Overall Study|Unkown|3|||
155285768|NCT04939428|560478386|FG002|Overall Study|Unkown|0|||
155285769|NCT04939428|560478384|FG000|Overall Study|Discotinued per protocol|0|||
155285770|NCT04939428|560478385|FG001|Overall Study|Discotinued per protocol|0|||
155285771|NCT04939428|560478386|FG002|Overall Study|Discotinued per protocol|902|||
155285772|NCT04319094|560478387|FG000|Baseline|Lost to Follow-up|4|||
155285773|NCT04319094|560478388|FG001|Baseline|Lost to Follow-up|5|||
155285774|NCT04319094|560478387|FG000|Baseline|Protocol Violation|0|||
155285775|NCT04319094|560478388|FG001|Baseline|Protocol Violation|3|||
155285776|NCT04319094|560478387|FG000|Baseline|Withdrawal by Subject|2|||
155285777|NCT04319094|560478388|FG001|Baseline|Withdrawal by Subject|1|||
155285778|NCT04319094|560478387|FG000|Post-Intervention|Death|0|||
155285779|NCT04319094|560478388|FG001|Post-Intervention|Death|1|||
155285780|NCT04319094|560478387|FG000|Post-Intervention|Lost to Follow-up|4|||
155637769|NCT00831844|561764838|FG002|Overall Study|Death|0|||
155285781|NCT04319094|560478388|FG001|Post-Intervention|Lost to Follow-up|4|||
155637770|NCT00831844|561764839|FG003|Overall Study|Death|1|||
155637771|NCT00831844|561764840|FG004|Overall Study|Death|0|||
155637772|NCT00831844|561764841|FG005|Overall Study|Death|0|||
155637773|NCT00831844|561764842|FG006|Overall Study|Death|0|||
155637774|NCT00831844|561764843|FG007|Overall Study|Death|0|||
155637775|NCT00831844|561764844|FG008|Overall Study|Death|0|||
155637776|NCT00831844|561764845|FG009|Overall Study|Death|0|||
155637777|NCT00831844|561764836|FG000|Overall Study|Lack of Efficacy|8|||
155637778|NCT00831844|561764837|FG001|Overall Study|Lack of Efficacy|10|||
155637779|NCT00831844|561764838|FG002|Overall Study|Lack of Efficacy|15|||
155637780|NCT00831844|561764839|FG003|Overall Study|Lack of Efficacy|8|||
155637781|NCT00831844|561764840|FG004|Overall Study|Lack of Efficacy|11|||
155637782|NCT00831844|561764841|FG005|Overall Study|Lack of Efficacy|17|||
155637783|NCT00831844|561764842|FG006|Overall Study|Lack of Efficacy|8|||
155637784|NCT00831844|561764843|FG007|Overall Study|Lack of Efficacy|9|||
155285782|NCT04319094|560478387|FG000|Post-Intervention|Withdrawal by Subject|8|||
155285783|NCT04319094|560478388|FG001|Post-Intervention|Withdrawal by Subject|5|||
155285784|NCT04319094|560478387|FG000|Post-Intervention|Incomplete Data Collection|1|||
155285785|NCT04319094|560478388|FG001|Post-Intervention|Incomplete Data Collection|3|||
155285786|NCT04319094|560478387|FG000|3-month|Death|1|||
155285787|NCT04319094|560478388|FG001|3-month|Death|0|||
155285788|NCT04319094|560478387|FG000|3-month|Lost to Follow-up|2|||
155285789|NCT04319094|560478388|FG001|3-month|Lost to Follow-up|2|||
155285790|NCT04319094|560478387|FG000|3-month|Withdrawal by Subject|0|||
155285791|NCT04319094|560478388|FG001|3-month|Withdrawal by Subject|3|||
155285792|NCT04319094|560478387|FG000|3-month|Incomplete data collection|9|||
155285793|NCT04319094|560478388|FG001|3-month|Incomplete data collection|7|||
155285794|NCT04319094|560478387|FG000|6-month|Lost to Follow-up|1|||
155285795|NCT04319094|560478388|FG001|6-month|Lost to Follow-up|1|||
155285796|NCT04319094|560478387|FG000|6-month|Withdrawal by Subject|0|||
155285797|NCT04319094|560478388|FG001|6-month|Withdrawal by Subject|3|||
155285798|NCT04319094|560478387|FG000|6-month|Incomplete data collection|14|||
155285799|NCT04319094|560478388|FG001|6-month|Incomplete data collection|9|||
155285800|NCT04319094|560478387|FG000|9-month|Lost to Follow-up|8|||
155285801|NCT04319094|560478388|FG001|9-month|Lost to Follow-up|4|||
155285802|NCT04319094|560478387|FG000|9-month|Withdrawal by Subject|0|||
155285803|NCT04319094|560478388|FG001|9-month|Withdrawal by Subject|1|||
155285804|NCT04319094|560478387|FG000|9-month|Incomplete data collection|8|||
155285805|NCT04319094|560478388|FG001|9-month|Incomplete data collection|5|||
155285806|NCT04319094|560478387|FG000|12-month|Lost to Follow-up|11|||
155285807|NCT04319094|560478388|FG001|12-month|Lost to Follow-up|8|||
155285808|NCT00877851|560478389|FG000|Overall Study|Lost to Follow-up|5|||
155285809|NCT00877851|560478390|FG001|Overall Study|Lost to Follow-up|5|||
155285810|NCT00877851|560478389|FG000|Overall Study|computer problem|3|||
155285811|NCT00877851|560478390|FG001|Overall Study|computer problem|0|||
155285812|NCT00877851|560478389|FG000|Overall Study|no longer interested in participating|1|||
155285813|NCT00877851|560478390|FG001|Overall Study|no longer interested in participating|0|||
155285814|NCT03285711|560478391|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
155285815|NCT03285711|560478392|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
155285816|NCT03285711|560478393|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
155285817|NCT03285711|560478394|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
155285818|NCT03285711|560478391|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
155285819|NCT03285711|560478392|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285820|NCT03285711|560478393|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285821|NCT03285711|560478394|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285822|NCT03285711|560478391|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285823|NCT03285711|560478392|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285824|NCT03285711|560478393|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
155285825|NCT03285711|560478394|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285826|NCT03285711|560478391|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285827|NCT03285711|560478392|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
155285828|NCT03285711|560478393|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285829|NCT03285711|560478394|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285830|NCT03424239|560478395|FG000|Overall Study|Withdrawal by Subject|2|||
155285831|NCT00770211|560478396|FG000|Overall Study|Lost to Follow-up|1|||
155285832|NCT00770211|560478397|FG001|Overall Study|Lost to Follow-up|0|||
155285833|NCT00770211|560478396|FG000|Overall Study|Withdrawal by Subject|0|||
155285834|NCT00770211|560478397|FG001|Overall Study|Withdrawal by Subject|2|||
155285835|NCT00318656|560478399|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
155742671|NCT00977080|562158190|FG003|Overall Study|Travel for family reasons|0|||
155742672|NCT00313781|562158191|FG000|Before Crossover|Death|22|||
155742673|NCT00313781|562158192|FG001|Before Crossover|Death|8|||
155742674|NCT00313781|562158193|FG002|Before Crossover|Death|0|||
155742675|NCT00313781|562158191|FG000|Before Crossover|Lost to Follow-up|0|||
155285836|NCT00318656|560478400|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
155285837|NCT00318656|560478399|FG000|Overall Study|Did not receive any treatment|0|||
155285838|NCT00318656|560478400|FG001|Overall Study|Did not receive any treatment|1|||
155285839|NCT01446003|560478401|FG000|Period 1|Protocol Violation|2|||
155285840|NCT01446003|560478402|FG001|Period 1|Protocol Violation|0|||
155285841|NCT01446003|560478401|FG000|Period 2|Adverse Event|1|||
155285842|NCT01446003|560478402|FG001|Period 2|Adverse Event|0|||
155285843|NCT03905135|560478403|FG000|Dose Escalation|Adverse Event|1|||
155285844|NCT03905135|560478404|FG001|Dose Escalation|Adverse Event|1|||
155285845|NCT03905135|560478403|FG000|Dose Escalation|Progressive disease|3|||
155285846|NCT03905135|560478404|FG001|Dose Escalation|Progressive disease|1|||
155285847|NCT03905135|560478403|FG000|Dose Escalation|Intercurrent illness|1|||
155285848|NCT03905135|560478404|FG001|Dose Escalation|Intercurrent illness|0|||
155285849|NCT01740557|560478405|FG000|Overall Study|Ineligible|1|||
155285850|NCT01740557|560478405|FG000|Overall Study|Screen failure|1|||
155285851|NCT00490555|560478406|FG000|Overall Study|noncompliant with drug administration|0|||
155285852|NCT00490555|560478407|FG001|Overall Study|noncompliant with drug administration|0|||
155285853|NCT00490555|560478408|FG002|Overall Study|noncompliant with drug administration|2|||
155285854|NCT00490555|560478409|FG003|Overall Study|noncompliant with drug administration|0|||
155285855|NCT02042443|560478410|FG000|Overall Study|Adverse Event|2|||
155285856|NCT02042443|560478411|FG001|Overall Study|Adverse Event|1|||
155285857|NCT02042443|560478410|FG000|Overall Study|Withdrawal by Subject|0|||
155285858|NCT02042443|560478411|FG001|Overall Study|Withdrawal by Subject|1|||
155285859|NCT02042443|560478410|FG000|Overall Study|Progression|21|||
155285860|NCT02042443|560478411|FG001|Overall Study|Progression|17|||
155285861|NCT02042443|560478410|FG000|Overall Study|not protocol specified|1|||
155285862|NCT02042443|560478411|FG001|Overall Study|not protocol specified|1|||
155285863|NCT02042443|560478410|FG000|Overall Study|Not eligible/not analyzable|3|||
155406420|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
155637785|NCT00831844|561764844|FG008|Overall Study|Lack of Efficacy|7|||
155285864|NCT02042443|560478411|FG001|Overall Study|Not eligible/not analyzable|6|||
155285865|NCT01007149|560478414|FG000|Overall Study|Administrative problems|0|||
155406421|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
155406422|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
155406423|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
155406424|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
155406425|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
155406426|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
155406427|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
155406428|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
155406429|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
155406430|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
155406431|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
155406432|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
155406433|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
155406434|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
155406435|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
155406436|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
155406437|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
155406438|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
155406439|NCT02831673|560923420|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
155406440|NCT02831673|560923421|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
155406441|NCT02831673|560923422|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
155406442|NCT02831673|560923423|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
155406443|NCT02831673|560923424|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
155406444|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155406445|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155406446|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
155406447|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
155406448|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155406449|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155406450|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155406451|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
155406452|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
155406453|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155406454|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155406455|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155406456|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155406457|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
155406458|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155406459|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
155406460|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
155406461|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
155406462|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
155406463|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
155406464|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155406465|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155406466|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
155406467|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
155406468|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155406469|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155406470|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155406471|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
155406472|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
155406473|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155406474|NCT02831673|560923420|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155637786|NCT00831844|561764845|FG009|Overall Study|Lack of Efficacy|0|||
155637787|NCT00831844|561764836|FG000|Overall Study|Physician Decision|0|||
155637788|NCT00831844|561764837|FG001|Overall Study|Physician Decision|1|||
155637789|NCT00831844|561764838|FG002|Overall Study|Physician Decision|3|||
155637790|NCT00831844|561764839|FG003|Overall Study|Physician Decision|1|||
155637791|NCT00831844|561764840|FG004|Overall Study|Physician Decision|1|||
155637792|NCT00831844|561764841|FG005|Overall Study|Physician Decision|1|||
155637793|NCT00831844|561764842|FG006|Overall Study|Physician Decision|0|||
155637794|NCT00831844|561764843|FG007|Overall Study|Physician Decision|0|||
155637795|NCT00831844|561764844|FG008|Overall Study|Physician Decision|1|||
155637796|NCT00831844|561764845|FG009|Overall Study|Physician Decision|0|||
155742676|NCT00313781|562158192|FG001|Before Crossover|Lost to Follow-up|3|||
155406475|NCT02831673|560923421|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155406476|NCT02831673|560923422|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
155406477|NCT02831673|560923423|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
155406478|NCT02831673|560923424|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155406479|NCT02831673|560923420|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
155406480|NCT02831673|560923421|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
155406481|NCT02831673|560923422|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
155742677|NCT00313781|562158193|FG002|Before Crossover|Lost to Follow-up|0|||
155742678|NCT00313781|562158191|FG000|Before Crossover|Withdrawal by Subject|3|||
155742679|NCT00313781|562158192|FG001|Before Crossover|Withdrawal by Subject|1|||
155742680|NCT00313781|562158193|FG002|Before Crossover|Withdrawal by Subject|0|||
155742681|NCT00313781|562158191|FG000|Before Crossover|Other|45|||
155742682|NCT00313781|562158192|FG001|Before Crossover|Other|30|||
155742683|NCT00313781|562158193|FG002|Before Crossover|Other|0|||
155742684|NCT00313781|562158191|FG000|Before Crossover|Crossover|0|||
155742685|NCT00313781|562158192|FG001|Before Crossover|Crossover|37|||
155742686|NCT00313781|562158193|FG002|Before Crossover|Crossover|0|||
155742687|NCT00313781|562158191|FG000|Before Crossover|Randomized, not treated|5|||
155742688|NCT00313781|562158192|FG001|Before Crossover|Randomized, not treated|0|||
155742689|NCT00313781|562158193|FG002|Before Crossover|Randomized, not treated|0|||
155742690|NCT00313781|562158191|FG000|After Crossover|Death|0|||
155742691|NCT00313781|562158192|FG001|After Crossover|Death|0|||
155742692|NCT00313781|562158193|FG002|After Crossover|Death|6|||
155742693|NCT00313781|562158191|FG000|After Crossover|Withdrawal by Subject|0|||
155742694|NCT00313781|562158192|FG001|After Crossover|Withdrawal by Subject|0|||
155742695|NCT00313781|562158193|FG002|After Crossover|Withdrawal by Subject|3|||
155742696|NCT00313781|562158191|FG000|After Crossover|Other|0|||
155742697|NCT00313781|562158192|FG001|After Crossover|Other|0|||
155742698|NCT00313781|562158193|FG002|After Crossover|Other|18|||
155742699|NCT01546623|562158194|FG000|Overall Study|Adverse Event|2|||
155742700|NCT01546623|562158195|FG001|Overall Study|Adverse Event|3|||
155742701|NCT01546623|562158194|FG000|Overall Study|Major Protocol Deviation|1|||
155742702|NCT01546623|562158195|FG001|Overall Study|Major Protocol Deviation|1|||
155742703|NCT01546623|562158194|FG000|Overall Study|High Prostate specific antigen|2|||
155742704|NCT01546623|562158195|FG001|Overall Study|High Prostate specific antigen|1|||
155742705|NCT01546623|562158194|FG000|Overall Study|Did Not Receive Study Drug|1|||
155742706|NCT01546623|562158195|FG001|Overall Study|Did Not Receive Study Drug|1|||
155742707|NCT03567343|562158196|FG000|Overall Study|Lost to Follow-up|2|||
155742708|NCT03567343|562158197|FG001|Overall Study|Lost to Follow-up|1|||
155406482|NCT02831673|560923423|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
155406483|NCT02831673|560923424|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
155406484|NCT02831673|560923420|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155406485|NCT02831673|560923421|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155406486|NCT02831673|560923422|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155406487|NCT02831673|560923423|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155406488|NCT02831673|560923424|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
155406489|NCT02831673|560923420|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155406490|NCT02831673|560923421|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155406491|NCT02831673|560923422|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155406492|NCT02831673|560923423|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155406493|NCT02831673|560923424|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
155406494|NCT02831673|560923420|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155406495|NCT02831673|560923421|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155742709|NCT03567343|562158196|FG000|Overall Study|No longer eligible|2|||
155742710|NCT03567343|562158197|FG001|Overall Study|No longer eligible|1|||
155742711|NCT03567343|562158196|FG000|Overall Study|Adverse Event|1|||
155406496|NCT02831673|560923422|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155742712|NCT03567343|562158197|FG001|Overall Study|Adverse Event|0|||
155742713|NCT03567343|562158196|FG000|Overall Study|Protocol Violation|1|||
155742714|NCT03567343|562158197|FG001|Overall Study|Protocol Violation|1|||
155742715|NCT02466659|562158198|FG000|Overall Study|Lost to Follow-up|5|||
155742716|NCT02466659|562158199|FG001|Overall Study|Lost to Follow-up|2|||
155742717|NCT00486811|562158200|FG000|Overall Study|Adverse Event|28|||
155742718|NCT00486811|562158201|FG001|Overall Study|Adverse Event|60|||
155742719|NCT00486811|562158202|FG002|Overall Study|Adverse Event|135|||
155742720|NCT00486811|562158200|FG000|Overall Study|Lack of Efficacy|34|||
155742721|NCT00486811|562158201|FG001|Overall Study|Lack of Efficacy|14|||
155742722|NCT00486811|562158202|FG002|Overall Study|Lack of Efficacy|7|||
155742723|NCT00486811|562158200|FG000|Overall Study|Lost to Follow-up|4|||
155742724|NCT00486811|562158201|FG001|Overall Study|Lost to Follow-up|6|||
155742725|NCT00486811|562158202|FG002|Overall Study|Lost to Follow-up|4|||
155742726|NCT00486811|562158200|FG000|Overall Study|Withdrawal by Subject|33|||
155742727|NCT00486811|562158201|FG001|Overall Study|Withdrawal by Subject|44|||
155742728|NCT00486811|562158202|FG002|Overall Study|Withdrawal by Subject|58|||
155285866|NCT01007149|560478415|FG001|Overall Study|Administrative problems|1|||
155285867|NCT02784704|560478416|FG000|Overall Study|Adverse Event|4|||
155285868|NCT02784704|560478417|FG001|Overall Study|Adverse Event|2|||
155285869|NCT02784704|560478416|FG000|Overall Study|Lost to Follow-up|6|||
155285870|NCT02784704|560478417|FG001|Overall Study|Lost to Follow-up|4|||
155285871|NCT02784704|560478416|FG000|Overall Study|Withdrawal by Subject|1|||
155285872|NCT02784704|560478417|FG001|Overall Study|Withdrawal by Subject|3|||
155285873|NCT02784704|560478416|FG000|Overall Study|Subject Non Compliance|2|||
155285874|NCT02784704|560478417|FG001|Overall Study|Subject Non Compliance|0|||
155285875|NCT01913340|560478418|FG000|Overall Study|Death|2|||
155285876|NCT01913340|560478419|FG001|Overall Study|Death|5|||
155406497|NCT02831673|560923423|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155285877|NCT01913340|560478418|FG000|Overall Study|Lost to Follow-up|1|||
155285878|NCT01913340|560478419|FG001|Overall Study|Lost to Follow-up|1|||
155285879|NCT00603538|560478420|FG000|Overall Study|Adverse Event|0|||
155285880|NCT00603538|560478421|FG001|Overall Study|Adverse Event|4|||
155285881|NCT00603538|560478422|FG002|Overall Study|Adverse Event|2|||
155285882|NCT00603538|560478420|FG000|Overall Study|Objective progression or relapse|3|||
155285883|NCT00603538|560478421|FG001|Overall Study|Objective progression or relapse|0|||
155285884|NCT00603538|560478422|FG002|Overall Study|Objective progression or relapse|0|||
155285885|NCT05750745|560478424|FG000|Overall Study|Adverse Event|1|||
155285886|NCT05750745|560478425|FG001|Overall Study|Adverse Event|0|||
155285887|NCT05750745|560478426|FG002|Overall Study|Adverse Event|0|||
155285888|NCT05750745|560478424|FG000|Overall Study|Protocol Violation|1|||
155285889|NCT05750745|560478425|FG001|Overall Study|Protocol Violation|0|||
155285890|NCT05750745|560478426|FG002|Overall Study|Protocol Violation|0|||
155285891|NCT05750745|560478424|FG000|Overall Study|Withdrawal by Subject|0|||
155285892|NCT05750745|560478425|FG001|Overall Study|Withdrawal by Subject|1|||
155285893|NCT05750745|560478426|FG002|Overall Study|Withdrawal by Subject|0|||
155285894|NCT00938340|560478427|FG000|Overall Study|Withdrawal by Subject|3|||
155285895|NCT00938340|560478427|FG000|Overall Study|Protocol Violation|1|||
155285896|NCT00938340|560478427|FG000|Overall Study|Adverse Event|1|||
155285897|NCT03677375|560478431|FG000|Overall Study|Incomplete procedure|8|||
155285898|NCT03677375|560478431|FG000|Overall Study|Adverse Event|3|||
155285899|NCT03677375|560478431|FG000|Overall Study|Physician Decision|1|||
155285900|NCT00725010|560478432|FG000|Overall Study|Toxicity|9|||
155285901|NCT00725010|560478432|FG000|Overall Study|Tumor Progression|7|||
155285902|NCT00725010|560478432|FG000|Overall Study|Withdrawal by Subject|2|||
155285903|NCT00725010|560478432|FG000|Overall Study|Death|1|||
155285904|NCT00725010|560478432|FG000|Overall Study|Lost to Follow-up|1|||
155285905|NCT00725010|560478432|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
155285906|NCT00725010|560478432|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
155285907|NCT00725010|560478432|FG000|Overall Study|No further documentation|1|||
155285908|NCT00725010|560478432|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
155285909|NCT03425539|560478433|FG000|Overall Study|Randomized but not treated|0|||
155285910|NCT03425539|560478434|FG001|Overall Study|Randomized but not treated|1|||
155285911|NCT03425539|560478433|FG000|Overall Study|Adverse Event|2|||
155285912|NCT03425539|560478434|FG001|Overall Study|Adverse Event|2|||
155285913|NCT03425539|560478433|FG000|Overall Study|Withdrawal by Subject|3|||
155285914|NCT03425539|560478434|FG001|Overall Study|Withdrawal by Subject|0|||
155285915|NCT03425539|560478433|FG000|Overall Study|Lost to Follow-up|0|||
155285916|NCT03425539|560478434|FG001|Overall Study|Lost to Follow-up|1|||
155285917|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
155285918|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
155285919|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
155285920|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
155285921|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
155285922|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
155285923|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
155285924|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
155285925|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Death|1|||
155285926|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Death|0|||
155285927|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
155285928|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
155285929|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
155285930|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
155285931|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
155406498|NCT02831673|560923424|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
155285932|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
155285933|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
155285934|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
155285935|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
155285936|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
155285937|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
155285938|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
155285939|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
155285940|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
155285941|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
155285942|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
155285943|NCT00299702|560478437|FG000|Overall Study|Death|1|||
155285944|NCT00299702|560478438|FG001|Overall Study|Death|0|||
155285945|NCT00299702|560478437|FG000|Overall Study|Adverse Event|0|||
155285946|NCT00299702|560478438|FG001|Overall Study|Adverse Event|4|||
155285947|NCT00299702|560478437|FG000|Overall Study|Lost to Follow-up|18|||
155285948|NCT00299702|560478438|FG001|Overall Study|Lost to Follow-up|10|||
155285949|NCT00299702|560478437|FG000|Overall Study|Withdrawal by Subject|25|||
155285950|NCT00299702|560478438|FG001|Overall Study|Withdrawal by Subject|23|||
155285951|NCT00299702|560478437|FG000|Overall Study|Pregnancy|0|||
155285952|NCT00299702|560478438|FG001|Overall Study|Pregnancy|1|||
155285953|NCT00299702|560478437|FG000|Overall Study|Insufficient Response|4|||
155285954|NCT00299702|560478438|FG001|Overall Study|Insufficient Response|3|||
155285955|NCT00299702|560478437|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
155285956|NCT00299702|560478438|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
155285957|NCT01560949|560478439|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
155285958|NCT01560949|560478439|FG000|Surgery Phase|Physician Decision|3|||
155285959|NCT00751036|560478440|FG000|Overall Study|Disease Progression|28|||
155285960|NCT00751036|560478441|FG001|Overall Study|Disease Progression|29|||
155285961|NCT00751036|560478440|FG000|Overall Study|Adverse Event|6|||
155285962|NCT00751036|560478441|FG001|Overall Study|Adverse Event|4|||
155285963|NCT00751036|560478440|FG000|Overall Study|Administrative Problems|3|||
155285964|NCT00751036|560478441|FG001|Overall Study|Administrative Problems|4|||
155285965|NCT00751036|560478440|FG000|Overall Study|Withdrawal by Subject|5|||
155285966|NCT00751036|560478441|FG001|Overall Study|Withdrawal by Subject|2|||
155285967|NCT00751036|560478440|FG000|Overall Study|Death|3|||
155406499|NCT02831673|560923420|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155406500|NCT02831673|560923421|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155406501|NCT02831673|560923422|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155406502|NCT02831673|560923423|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155406503|NCT02831673|560923424|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
155406504|NCT00150592|560923425|FG000|Overall Study|Adverse Event|4|||
155406505|NCT00150592|560923426|FG001|Overall Study|Adverse Event|1|||
155406506|NCT00150592|560923425|FG000|Overall Study|Protocol Violation|1|||
155406507|NCT00150592|560923426|FG001|Overall Study|Protocol Violation|0|||
155406508|NCT00150592|560923425|FG000|Overall Study|Withdrawal by Subject|1|||
155406509|NCT00150592|560923426|FG001|Overall Study|Withdrawal by Subject|2|||
155406510|NCT00150592|560923425|FG000|Overall Study|Non-compliance|1|||
155406511|NCT00150592|560923426|FG001|Overall Study|Non-compliance|0|||
155406512|NCT01097746|560923437|FG000|Overall Study|Adverse Event|4|||
155406513|NCT01097746|560923437|FG000|Overall Study|taken off study before any treatment given|1|||
155406514|NCT00772954|560923440|FG000|Overall Study|Adverse Event|0|||
155406515|NCT00772954|560923441|FG001|Overall Study|Adverse Event|0|||
155406516|NCT00772954|560923442|FG002|Overall Study|Adverse Event|1|||
155406517|NCT01659320|560923447|FG000|Overall Study|Withdrawal by Subject|2|||
155406518|NCT01659320|560923447|FG000|Overall Study|Physician Decision|1|||
155406519|NCT01514682|560923448|FG000|Overall Study|Withdrawal by Subject|2|||
155406520|NCT01514682|560923449|FG001|Overall Study|Withdrawal by Subject|3|||
155406521|NCT01514682|560923448|FG000|Overall Study|Physician Decision|4|||
155406522|NCT01514682|560923449|FG001|Overall Study|Physician Decision|3|||
155406523|NCT00590590|560923450|FG000|Overall Study|Lack of Efficacy|1|||
155406524|NCT00590590|560923451|FG001|Overall Study|Lack of Efficacy|2|||
155406525|NCT00590590|560923452|FG002|Overall Study|Lack of Efficacy|0|||
155285968|NCT00751036|560478441|FG001|Overall Study|Death|3|||
155285969|NCT00751036|560478440|FG000|Overall Study|Lost to Follow-up|0|||
155285970|NCT00751036|560478441|FG001|Overall Study|Lost to Follow-up|1|||
155285971|NCT00751036|560478440|FG000|Overall Study|Protocol Violation|1|||
155285972|NCT00751036|560478441|FG001|Overall Study|Protocol Violation|0|||
155285973|NCT00751036|560478440|FG000|Overall Study|Missing end of Treatment Page|2|||
155406526|NCT00590590|560923450|FG000|Overall Study|Adverse Event|1|||
155406527|NCT00590590|560923451|FG001|Overall Study|Adverse Event|0|||
155406528|NCT00590590|560923452|FG002|Overall Study|Adverse Event|0|||
155406529|NCT00590590|560923450|FG000|Overall Study|Protocol Violation|0|||
155406530|NCT00590590|560923451|FG001|Overall Study|Protocol Violation|0|||
155285974|NCT00751036|560478441|FG001|Overall Study|Missing end of Treatment Page|3|||
155285975|NCT02738840|560480390|FG000|Overall Study|MRI Scan not Performed|5|||
155406531|NCT00590590|560923452|FG002|Overall Study|Protocol Violation|2|||
155406532|NCT00590590|560923450|FG000|Overall Study|Lost to Follow-up|4|||
155406533|NCT00590590|560923451|FG001|Overall Study|Lost to Follow-up|1|||
155406534|NCT00590590|560923452|FG002|Overall Study|Lost to Follow-up|2|||
155406535|NCT00590590|560923450|FG000|Overall Study|Withdrawal by Subject|0|||
155406536|NCT00590590|560923451|FG001|Overall Study|Withdrawal by Subject|1|||
155406537|NCT00590590|560923452|FG002|Overall Study|Withdrawal by Subject|1|||
155285976|NCT02738840|560480390|FG000|Overall Study|Lost to Follow-up|1|||
155285977|NCT02738840|560480390|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
155285978|NCT02738840|560480390|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
155285979|NCT00256308|560480396|FG000|Overall Study|Death|2|||
155285980|NCT01537133|560480397|FG000|Overall Study|Withdrawal by Subject|2|||
155285981|NCT01537133|560480398|FG001|Overall Study|Withdrawal by Subject|0|||
155285982|NCT01537133|560480399|FG002|Overall Study|Withdrawal by Subject|0|||
155285983|NCT01537133|560480400|FG003|Overall Study|Withdrawal by Subject|0|||
155285984|NCT01537133|560480397|FG000|Overall Study|Lost to Follow-up|1|||
155285985|NCT01537133|560480398|FG001|Overall Study|Lost to Follow-up|0|||
155285986|NCT01537133|560480399|FG002|Overall Study|Lost to Follow-up|0|||
155285987|NCT01537133|560480400|FG003|Overall Study|Lost to Follow-up|0|||
155285988|NCT02466516|560480403|FG000|Overall Study|Adverse Event|1|||
155285989|NCT02466516|560480404|FG001|Overall Study|Adverse Event|1|||
155285990|NCT02466516|560480405|FG002|Overall Study|Adverse Event|0|||
155285991|NCT02466516|560480406|FG003|Overall Study|Adverse Event|0|||
155285992|NCT02466516|560480407|FG004|Overall Study|Adverse Event|0|||
155285993|NCT02466516|560480403|FG000|Overall Study|Withdrew Consent|1|||
155285994|NCT02466516|560480404|FG001|Overall Study|Withdrew Consent|0|||
155285995|NCT02466516|560480405|FG002|Overall Study|Withdrew Consent|0|||
155285996|NCT02466516|560480406|FG003|Overall Study|Withdrew Consent|0|||
155285997|NCT02466516|560480407|FG004|Overall Study|Withdrew Consent|0|||
155285998|NCT02466516|560480403|FG000|Overall Study|Lost to Follow-up|2|||
155285999|NCT02466516|560480404|FG001|Overall Study|Lost to Follow-up|0|||
155286000|NCT02466516|560480405|FG002|Overall Study|Lost to Follow-up|1|||
155286001|NCT02466516|560480406|FG003|Overall Study|Lost to Follow-up|0|||
155286002|NCT02466516|560480407|FG004|Overall Study|Lost to Follow-up|0|||
155286003|NCT04358549|560480408|FG000|Overall Study|Adverse Event|0|||
155286004|NCT04358549|560480409|FG001|Overall Study|Adverse Event|1|||
155286005|NCT04358549|560480408|FG000|Overall Study|Death|1|||
155286006|NCT04358549|560480409|FG001|Overall Study|Death|0|||
155286007|NCT04358549|560480408|FG000|Overall Study|Lost to Follow-up|2|||
155286008|NCT04358549|560480409|FG001|Overall Study|Lost to Follow-up|1|||
155286009|NCT04358549|560480408|FG000|Overall Study|Withdrawal by Subject|6|||
155286010|NCT04358549|560480409|FG001|Overall Study|Withdrawal by Subject|6|||
155286011|NCT04358549|560480408|FG000|Overall Study|Start remdesivir|1|||
155286012|NCT04358549|560480409|FG001|Overall Study|Start remdesivir|0|||
155286013|NCT03712930|560480410|FG000|Overall Study|Death|7|||
155286014|NCT03712930|560480410|FG000|Overall Study|Physician Decision|1|||
155286015|NCT03712930|560480410|FG000|Overall Study|Study Terminated by Sponsor|3|||
155286016|NCT03712930|560480410|FG000|Overall Study|Progressive Disease|2|||
155286017|NCT01062126|560480414|FG000|Overall Study|Death|209|||
155286018|NCT01062126|560480414|FG000|Overall Study|All Withdrawals|324|||
155286019|NCT00646451|560480415|FG000|Overall Study|Adverse Event|3|||
155286020|NCT00646451|560480416|FG001|Overall Study|Adverse Event|0|||
155406538|NCT00590590|560923450|FG000|Overall Study|Did not complete due to study closure|1|||
155406539|NCT00590590|560923451|FG001|Overall Study|Did not complete due to study closure|1|||
155637797|NCT00831844|561764836|FG000|Overall Study|Withdrawal by Subject|0|||
155637798|NCT00831844|561764837|FG001|Overall Study|Withdrawal by Subject|0|||
155637799|NCT00831844|561764838|FG002|Overall Study|Withdrawal by Subject|1|||
155637800|NCT00831844|561764839|FG003|Overall Study|Withdrawal by Subject|0|||
155637801|NCT00831844|561764840|FG004|Overall Study|Withdrawal by Subject|0|||
155637802|NCT00831844|561764841|FG005|Overall Study|Withdrawal by Subject|0|||
155637803|NCT00831844|561764842|FG006|Overall Study|Withdrawal by Subject|0|||
155637804|NCT00831844|561764843|FG007|Overall Study|Withdrawal by Subject|1|||
155637805|NCT00831844|561764844|FG008|Overall Study|Withdrawal by Subject|1|||
155637806|NCT00831844|561764845|FG009|Overall Study|Withdrawal by Subject|0|||
155637807|NCT00831844|561764836|FG000|Overall Study|Ineligible|0|||
155637808|NCT00831844|561764837|FG001|Overall Study|Ineligible|1|||
155637809|NCT00831844|561764838|FG002|Overall Study|Ineligible|1|||
155637810|NCT00831844|561764839|FG003|Overall Study|Ineligible|0|||
155637811|NCT00831844|561764840|FG004|Overall Study|Ineligible|1|||
155637812|NCT00831844|561764841|FG005|Overall Study|Ineligible|0|||
155637813|NCT00831844|561764842|FG006|Overall Study|Ineligible|0|||
155637814|NCT00831844|561764843|FG007|Overall Study|Ineligible|0|||
155637815|NCT00831844|561764844|FG008|Overall Study|Ineligible|0|||
155637816|NCT00831844|561764845|FG009|Overall Study|Ineligible|0|||
155637817|NCT04133909|561764848|FG000|Overall Study|Death|11|||
155637818|NCT04133909|561764849|FG001|Overall Study|Death|11|||
155637819|NCT04133909|561764848|FG000|Overall Study|Adverse Event|4|||
155286021|NCT00646451|560480415|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
155286022|NCT00646451|560480416|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
155286023|NCT03784963|560480417|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
155406540|NCT00590590|560923452|FG002|Overall Study|Did not complete due to study closure|1|||
155406541|NCT00590590|560923450|FG000|Overall Study|Did not complete study|0|||
155637820|NCT04133909|561764849|FG001|Overall Study|Adverse Event|5|||
155637821|NCT04133909|561764848|FG000|Overall Study|Lost to Follow-up|3|||
155637822|NCT04133909|561764849|FG001|Overall Study|Lost to Follow-up|5|||
155286024|NCT03784963|560480418|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
155286025|NCT03784963|560480419|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
155286026|NCT03784963|560480420|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
155286027|NCT05355116|560480421|FG000|Overall Study|Withdrawal by Subject|2|||
155286028|NCT00868231|560480422|FG000|Treatment Period 1|Adverse Event|0|||
155286029|NCT00868231|560480423|FG001|Treatment Period 1|Adverse Event|0|||
155286030|NCT00868231|560480424|FG002|Treatment Period 1|Adverse Event|0|||
155286031|NCT00868231|560480425|FG003|Treatment Period 1|Adverse Event|0|||
155286032|NCT00868231|560480426|FG004|Treatment Period 1|Adverse Event|1|||
155286033|NCT00868231|560480427|FG005|Treatment Period 1|Adverse Event|0|||
155286034|NCT00868231|560480422|FG000|Treatment Period 2|Adverse Event|1|||
155286035|NCT00868231|560480423|FG001|Treatment Period 2|Adverse Event|0|||
155286036|NCT00868231|560480424|FG002|Treatment Period 2|Adverse Event|0|||
155286037|NCT00868231|560480425|FG003|Treatment Period 2|Adverse Event|0|||
155286038|NCT00868231|560480426|FG004|Treatment Period 2|Adverse Event|0|||
155286039|NCT00868231|560480427|FG005|Treatment Period 2|Adverse Event|0|||
155286040|NCT00868231|560480422|FG000|Treatment Period 3|Adverse Event|0|||
155286041|NCT00868231|560480423|FG001|Treatment Period 3|Adverse Event|0|||
155286042|NCT00868231|560480424|FG002|Treatment Period 3|Adverse Event|1|||
155286043|NCT00868231|560480425|FG003|Treatment Period 3|Adverse Event|0|||
155286044|NCT00868231|560480426|FG004|Treatment Period 3|Adverse Event|0|||
155286045|NCT00868231|560480427|FG005|Treatment Period 3|Adverse Event|0|||
155286046|NCT01168401|560480431|FG000|Overall Study|Lost to Follow-up|1|||
155286047|NCT01168401|560480432|FG001|Overall Study|Lost to Follow-up|1|||
155286048|NCT01168401|560480433|FG002|Overall Study|Lost to Follow-up|2|||
155286049|NCT01168401|560480434|FG003|Overall Study|Lost to Follow-up|1|||
155286050|NCT01168401|560480435|FG004|Overall Study|Lost to Follow-up|0|||
155286051|NCT01168401|560480436|FG005|Overall Study|Lost to Follow-up|0|||
155286052|NCT01168401|560480437|FG006|Overall Study|Lost to Follow-up|0|||
155286053|NCT01168401|560480438|FG007|Overall Study|Lost to Follow-up|0|||
155286054|NCT01168401|560480439|FG008|Overall Study|Lost to Follow-up|0|||
155286055|NCT01168401|560480440|FG009|Overall Study|Lost to Follow-up|0|||
155286056|NCT01168401|560480441|FG010|Overall Study|Lost to Follow-up|0|||
155286057|NCT01168401|560480431|FG000|Overall Study|Withdrawal by Subject|0|||
155286058|NCT01168401|560480432|FG001|Overall Study|Withdrawal by Subject|0|||
155286059|NCT01168401|560480433|FG002|Overall Study|Withdrawal by Subject|0|||
155286060|NCT01168401|560480434|FG003|Overall Study|Withdrawal by Subject|1|||
155286061|NCT01168401|560480435|FG004|Overall Study|Withdrawal by Subject|0|||
155286062|NCT01168401|560480436|FG005|Overall Study|Withdrawal by Subject|0|||
155286063|NCT01168401|560480437|FG006|Overall Study|Withdrawal by Subject|0|||
155286064|NCT01168401|560480438|FG007|Overall Study|Withdrawal by Subject|0|||
155286065|NCT01168401|560480439|FG008|Overall Study|Withdrawal by Subject|0|||
155286066|NCT01168401|560480440|FG009|Overall Study|Withdrawal by Subject|0|||
155286067|NCT01168401|560480441|FG010|Overall Study|Withdrawal by Subject|0|||
155286068|NCT03396835|560480446|FG000|Overall Study|Withdrawn prior to completion|1|||
155286069|NCT03396835|560480446|FG000|Overall Study|Did not meet criteria for data analysis|1|||
155286070|NCT01451814|560480447|FG000|Overall Study|Withdrawal by Subject|1|||
155286071|NCT01451814|560480448|FG001|Overall Study|Withdrawal by Subject|1|||
155286072|NCT01451814|560480447|FG000|Overall Study|Lost to Follow-up|5|||
155286073|NCT01451814|560480448|FG001|Overall Study|Lost to Follow-up|4|||
155286074|NCT02049866|560480449|FG000|Overall Study|Withdrawal by Subject|1|||
155286075|NCT03710564|560480451|FG000|Overall Study|Study Terminated by Sponsor|104|||
155286076|NCT03710564|560480452|FG001|Overall Study|Study Terminated by Sponsor|55|||
155286077|NCT03710564|560480451|FG000|Overall Study|Withdrawal by Subject|57|||
155286078|NCT03710564|560480452|FG001|Overall Study|Withdrawal by Subject|25|||
155286079|NCT03710564|560480451|FG000|Overall Study|Death|10|||
155286080|NCT03710564|560480452|FG001|Overall Study|Death|4|||
155286081|NCT03710564|560480451|FG000|Overall Study|Lost to Follow-up|5|||
155286082|NCT03710564|560480452|FG001|Overall Study|Lost to Follow-up|4|||
155286083|NCT03710564|560480451|FG000|Overall Study|Protocol Violation|3|||
155286084|NCT03710564|560480452|FG001|Overall Study|Protocol Violation|2|||
155286085|NCT03710564|560480451|FG000|Overall Study|Adverse Event|3|||
155286086|NCT03710564|560480452|FG001|Overall Study|Adverse Event|0|||
155286087|NCT03710564|560480451|FG000|Overall Study|Physician Decision|2|||
155286088|NCT03710564|560480452|FG001|Overall Study|Physician Decision|3|||
155286089|NCT02993471|560480453|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
155286090|NCT02993471|560480453|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
155286091|NCT00619151|560480454|FG000|Overall Study|Study terminated prior to followup|1|||
155286092|NCT00619151|560480455|FG001|Overall Study|Study terminated prior to followup|0|||
155286093|NCT04088188|560480456|FG000|Overall Study|Withdrawal by Subject|2|||
155286094|NCT04088188|560480457|FG001|Overall Study|Withdrawal by Subject|0|||
155286095|NCT04088188|560480456|FG000|Overall Study|Adverse Event|2|||
155286096|NCT04088188|560480457|FG001|Overall Study|Adverse Event|0|||
155286097|NCT02524288|560480458|FG000|Overall Study|Adverse Event|115|||
155286098|NCT02524288|560480458|FG000|Overall Study|Lost to Follow-up|216|||
155286099|NCT02524288|560480458|FG000|Overall Study|Non-Compliance With Protocol|32|||
155286100|NCT02524288|560480458|FG000|Overall Study|Non-Compliance With Study Drug|14|||
155286101|NCT02524288|560480458|FG000|Overall Study|Pregnancy Wish|6|||
155286102|NCT02524288|560480458|FG000|Overall Study|Protocol Violation|6|||
155286103|NCT02524288|560480458|FG000|Overall Study|Screen Failure|2|||
155286104|NCT02524288|560480458|FG000|Overall Study|Site Discontinued Study Participation|1|||
155286105|NCT02524288|560480458|FG000|Overall Study|Study Terminated By Sponsor|1417|||
155286106|NCT02524288|560480458|FG000|Overall Study|Subject Moved|32|||
155286107|NCT02524288|560480458|FG000|Overall Study|Withdrawal by Subject|76|||
155286108|NCT02524288|560480458|FG000|Overall Study|Pregnancy|22|||
155286109|NCT02524288|560480458|FG000|Overall Study|Physician Decision|2|||
155286110|NCT02616263|560480460|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
155286111|NCT02616263|560480461|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
155286112|NCT02616263|560480460|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
155286113|NCT02616263|560480461|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
155286114|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Death|1|||
155286115|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Death|0|||
155286116|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
155286117|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
155286118|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
155286119|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
155286120|NCT02616263|560480460|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
155286121|NCT02616263|560480461|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
155286122|NCT02939183|560480465|FG000|Overall Study|Death|0|||
155286123|NCT02939183|560480466|FG001|Overall Study|Death|0|||
155286124|NCT02939183|560480467|FG002|Overall Study|Death|1|||
155286125|NCT02939183|560480468|FG003|Overall Study|Death|0|||
155286126|NCT02939183|560480469|FG004|Overall Study|Death|0|||
155286127|NCT02939183|560480470|FG005|Overall Study|Death|2|||
155286128|NCT02939183|560480471|FG006|Overall Study|Death|1|||
155286129|NCT02939183|560480472|FG007|Overall Study|Death|0|||
155286130|NCT02939183|560480473|FG008|Overall Study|Death|0|||
155286131|NCT02939183|560480465|FG000|Overall Study|Sponsor decision|0|||
155286132|NCT02939183|560480466|FG001|Overall Study|Sponsor decision|1|||
155286133|NCT02939183|560480467|FG002|Overall Study|Sponsor decision|0|||
155286134|NCT02939183|560480468|FG003|Overall Study|Sponsor decision|1|||
155406542|NCT00590590|560923451|FG001|Overall Study|Did not complete study|1|||
155286135|NCT02939183|560480469|FG004|Overall Study|Sponsor decision|2|||
155286136|NCT02939183|560480470|FG005|Overall Study|Sponsor decision|0|||
155286137|NCT02939183|560480471|FG006|Overall Study|Sponsor decision|3|||
155286138|NCT02939183|560480472|FG007|Overall Study|Sponsor decision|1|||
155286139|NCT02939183|560480473|FG008|Overall Study|Sponsor decision|4|||
155286140|NCT02939183|560480465|FG000|Overall Study|Withdrawal by Subject|0|||
155286141|NCT02939183|560480466|FG001|Overall Study|Withdrawal by Subject|2|||
155286142|NCT02939183|560480467|FG002|Overall Study|Withdrawal by Subject|0|||
155286143|NCT02939183|560480468|FG003|Overall Study|Withdrawal by Subject|1|||
155286144|NCT02939183|560480469|FG004|Overall Study|Withdrawal by Subject|0|||
155286145|NCT02939183|560480470|FG005|Overall Study|Withdrawal by Subject|0|||
155286146|NCT02939183|560480471|FG006|Overall Study|Withdrawal by Subject|2|||
155286147|NCT02939183|560480472|FG007|Overall Study|Withdrawal by Subject|2|||
155286148|NCT02939183|560480473|FG008|Overall Study|Withdrawal by Subject|2|||
155286149|NCT02939183|560480465|FG000|Overall Study|Not treated due to adverse event|0|||
155286150|NCT02939183|560480466|FG001|Overall Study|Not treated due to adverse event|0|||
155286151|NCT02939183|560480467|FG002|Overall Study|Not treated due to adverse event|0|||
155286152|NCT02939183|560480468|FG003|Overall Study|Not treated due to adverse event|1|||
155286153|NCT02939183|560480469|FG004|Overall Study|Not treated due to adverse event|0|||
155286154|NCT02939183|560480470|FG005|Overall Study|Not treated due to adverse event|0|||
155286155|NCT02939183|560480471|FG006|Overall Study|Not treated due to adverse event|1|||
155286156|NCT02939183|560480472|FG007|Overall Study|Not treated due to adverse event|0|||
155286157|NCT02939183|560480473|FG008|Overall Study|Not treated due to adverse event|0|||
155286158|NCT05015478|560480474|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
155286159|NCT05015478|560480475|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
155286160|NCT05015478|560480476|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
155286161|NCT05015478|560480477|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
155286162|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
155286163|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
155286164|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
155286165|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
155286166|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
155286167|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
155286168|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286169|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286170|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286171|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
155286172|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
155286173|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286174|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Death|0|||
155286175|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Death|0|||
155286176|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Death|0|||
155286177|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Death|0|||
155286178|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Death|0|||
155286179|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Death|1|||
155286180|NCT04927975|560480480|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
155286181|NCT04927975|560480481|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
155286182|NCT04927975|560480482|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
155286183|NCT04927975|560480483|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
155286184|NCT04927975|560480484|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
155286185|NCT04927975|560480485|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
155286186|NCT04927975|560480480|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
155286187|NCT04927975|560480481|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286188|NCT04927975|560480482|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286189|NCT04927975|560480483|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
155286190|NCT04927975|560480484|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286191|NCT04927975|560480485|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155637823|NCT04133909|561764848|FG000|Overall Study|Physician Decision|4|||
155637824|NCT04133909|561764849|FG001|Overall Study|Physician Decision|7|||
155637825|NCT04133909|561764848|FG000|Overall Study|Withdrawal by Subject|40|||
155637826|NCT04133909|561764849|FG001|Overall Study|Withdrawal by Subject|35|||
155637827|NCT04133909|561764848|FG000|Overall Study|Lack of Efficacy|2|||
155637828|NCT04133909|561764849|FG001|Overall Study|Lack of Efficacy|7|||
155637829|NCT04133909|561764848|FG000|Overall Study|Randomized in error|1|||
155637830|NCT04133909|561764849|FG001|Overall Study|Randomized in error|1|||
155637831|NCT00315445|561764850|FG000|Overall Study|Adverse Event|7|||
155637832|NCT00315445|561764851|FG001|Overall Study|Adverse Event|12|||
155637833|NCT00315445|561764852|FG002|Overall Study|Adverse Event|15|||
155637834|NCT00315445|561764850|FG000|Overall Study|Lack of Efficacy|16|||
155637835|NCT00315445|561764851|FG001|Overall Study|Lack of Efficacy|1|||
155637836|NCT00315445|561764852|FG002|Overall Study|Lack of Efficacy|7|||
155637837|NCT00315445|561764850|FG000|Overall Study|Lost to Follow-up|1|||
155637838|NCT00315445|561764851|FG001|Overall Study|Lost to Follow-up|0|||
155286192|NCT03781804|560480486|FG000|Overall Study|Adverse Event|2|||
155286193|NCT03781804|560480487|FG001|Overall Study|Adverse Event|2|||
155286194|NCT03781804|560480488|FG002|Overall Study|Adverse Event|3|||
155637839|NCT00315445|561764852|FG002|Overall Study|Lost to Follow-up|1|||
155637840|NCT00315445|561764850|FG000|Overall Study|Protocol Violation|2|||
155286195|NCT03781804|560480486|FG000|Overall Study|Lost to Follow-up|1|||
155286196|NCT03781804|560480487|FG001|Overall Study|Lost to Follow-up|1|||
155286197|NCT03781804|560480488|FG002|Overall Study|Lost to Follow-up|2|||
155406543|NCT00590590|560923452|FG002|Overall Study|Did not complete study|0|||
155742729|NCT00486811|562158200|FG000|Overall Study|Study drug non-compliant|5|||
155742730|NCT00486811|562158201|FG001|Overall Study|Study drug non-compliant|6|||
155742731|NCT00486811|562158202|FG002|Overall Study|Study drug non-compliant|3|||
155742732|NCT00486811|562158200|FG000|Overall Study|All other|18|||
155742733|NCT00486811|562158201|FG001|Overall Study|All other|11|||
155742734|NCT00486811|562158202|FG002|Overall Study|All other|7|||
155742735|NCT01590758|562158205|FG000|Overall Study|Withdrawal by Subject|0|||
155742736|NCT01590758|562158206|FG001|Overall Study|Withdrawal by Subject|3|||
155742737|NCT01590758|562158205|FG000|Overall Study|Physician Decision|1|||
155742738|NCT01590758|562158206|FG001|Overall Study|Physician Decision|2|||
155742739|NCT01590758|562158205|FG000|Overall Study|Lost to Follow-up|4|||
155742740|NCT01590758|562158206|FG001|Overall Study|Lost to Follow-up|2|||
155742741|NCT02756806|562158207|FG000|Overall Study|Study terminated early|5|||
155742742|NCT02228980|562158208|FG000|Overall Study|Adverse Event|14|||
155742743|NCT02228980|562158209|FG001|Overall Study|Adverse Event|0|||
155742744|NCT02228980|562158210|FG002|Overall Study|Adverse Event|0|||
155742745|NCT02228980|562158211|FG003|Overall Study|Adverse Event|0|||
155742746|NCT02228980|562158208|FG000|Overall Study|Protocol Violation|7|||
155742747|NCT02228980|562158209|FG001|Overall Study|Protocol Violation|0|||
155742748|NCT02228980|562158210|FG002|Overall Study|Protocol Violation|0|||
155742749|NCT02228980|562158211|FG003|Overall Study|Protocol Violation|0|||
155742750|NCT02228980|562158208|FG000|Overall Study|Withdrawal by Subject|3|||
155742751|NCT02228980|562158209|FG001|Overall Study|Withdrawal by Subject|3|||
155286198|NCT03781804|560480486|FG000|Overall Study|Lack of Efficacy|4|||
155406544|NCT00132132|560923453|FG000|Overall Study|Lost to Follow-up|7|||
155742752|NCT02228980|562158210|FG002|Overall Study|Withdrawal by Subject|2|||
155742753|NCT02228980|562158211|FG003|Overall Study|Withdrawal by Subject|3|||
155742754|NCT02929498|562158212|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
155742755|NCT02929498|562158213|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
155742756|NCT02929498|562158214|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
155406545|NCT00132132|560923454|FG001|Overall Study|Lost to Follow-up|2|||
155406546|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
155406547|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
155406548|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
155406549|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
155406550|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
155406551|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
155406552|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
155286199|NCT03781804|560480487|FG001|Overall Study|Lack of Efficacy|2|||
155286200|NCT03781804|560480488|FG002|Overall Study|Lack of Efficacy|9|||
155286201|NCT03781804|560480486|FG000|Overall Study|Protocol Violation|0|||
155286202|NCT03781804|560480487|FG001|Overall Study|Protocol Violation|0|||
155286203|NCT03781804|560480488|FG002|Overall Study|Protocol Violation|1|||
155286204|NCT03781804|560480486|FG000|Overall Study|Withdrawal by Subject|0|||
155286205|NCT03781804|560480487|FG001|Overall Study|Withdrawal by Subject|1|||
155286206|NCT03781804|560480488|FG002|Overall Study|Withdrawal by Subject|1|||
155286207|NCT03781804|560480486|FG000|Overall Study|Reason not provided|2|||
155286208|NCT03781804|560480487|FG001|Overall Study|Reason not provided|2|||
155286209|NCT03781804|560480488|FG002|Overall Study|Reason not provided|0|||
155286210|NCT03717194|560480489|FG000|Overall Study|Withdrawal by Subject|2|||
155286211|NCT03717194|560480490|FG001|Overall Study|Withdrawal by Subject|4|||
155286212|NCT03717194|560480489|FG000|Overall Study|Adverse Event|1|||
155286213|NCT03717194|560480490|FG001|Overall Study|Adverse Event|1|||
155286214|NCT03499600|560480493|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
155286215|NCT03499600|560480494|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
155286216|NCT00561574|560480495|FG000|Overall Study|Adverse Event|21|||
155286217|NCT00561574|560480496|FG001|Overall Study|Adverse Event|24|||
155286218|NCT00561574|560480495|FG000|Overall Study|Lack of Efficacy|11|||
155286219|NCT00561574|560480496|FG001|Overall Study|Lack of Efficacy|21|||
155286220|NCT00561574|560480495|FG000|Overall Study|Withdrawal by Subject|4|||
155286221|NCT00561574|560480496|FG001|Overall Study|Withdrawal by Subject|4|||
155286222|NCT00561574|560480495|FG000|Overall Study|Reason Unrelated to Trial|6|||
155286223|NCT00561574|560480496|FG001|Overall Study|Reason Unrelated to Trial|2|||
155286224|NCT00561574|560480495|FG000|Overall Study|Lost to Follow-up|1|||
155286225|NCT00561574|560480496|FG001|Overall Study|Lost to Follow-up|0|||
155286226|NCT00561574|560480495|FG000|Overall Study|Other|5|||
155286227|NCT00561574|560480496|FG001|Overall Study|Other|7|||
155286228|NCT03971357|560480497|FG000|Overall Study|Lack of Efficacy|0|||
155286229|NCT03971357|560480498|FG001|Overall Study|Lack of Efficacy|1|||
155286230|NCT00445692|560480499|FG000|Overall Study|Adverse Event|11|||
155286231|NCT00445692|560480499|FG000|Overall Study|Lack of Efficacy|5|||
155286232|NCT00630864|560480506|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
155286233|NCT00630864|560480506|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
155286234|NCT00430677|560480507|FG000|Short-term Period|Death|1|||
155286235|NCT00430677|560480508|FG001|Short-term Period|Death|1|||
155286236|NCT00430677|560480509|FG002|Short-term Period|Death|5|||
155286237|NCT00430677|560480507|FG000|Short-term Period|Adverse Event|15|||
155286238|NCT00430677|560480508|FG001|Short-term Period|Adverse Event|13|||
155286239|NCT00430677|560480509|FG002|Short-term Period|Adverse Event|9|||
155286240|NCT00430677|560480507|FG000|Short-term Period|Lack of Efficacy|5|||
155286241|NCT00430677|560480508|FG001|Short-term Period|Lack of Efficacy|6|||
155286242|NCT00430677|560480509|FG002|Short-term Period|Lack of Efficacy|4|||
155286243|NCT00430677|560480507|FG000|Short-term Period|Withdrawal by Subject|1|||
155286244|NCT00430677|560480508|FG001|Short-term Period|Withdrawal by Subject|1|||
155286245|NCT00430677|560480509|FG002|Short-term Period|Withdrawal by Subject|2|||
155286246|NCT00430677|560480507|FG000|Short-term Period|Participant no longer met study criteria|1|||
155286247|NCT00430677|560480508|FG001|Short-term Period|Participant no longer met study criteria|1|||
155286248|NCT00430677|560480509|FG002|Short-term Period|Participant no longer met study criteria|2|||
155286249|NCT00430677|560480507|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
155286250|NCT00430677|560480508|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
155286251|NCT00430677|560480509|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
155286252|NCT00430677|560480507|FG000|Short-term Period|Pregnancy|0|||
155286253|NCT00430677|560480508|FG001|Short-term Period|Pregnancy|2|||
155286254|NCT00430677|560480509|FG002|Short-term Period|Pregnancy|0|||
155406553|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
155637841|NCT00315445|561764851|FG001|Overall Study|Protocol Violation|0|||
155637842|NCT00315445|561764852|FG002|Overall Study|Protocol Violation|1|||
155637843|NCT00315445|561764850|FG000|Overall Study|Other|1|||
155637844|NCT00315445|561764851|FG001|Overall Study|Other|3|||
155637845|NCT00315445|561764852|FG002|Overall Study|Other|0|||
155637846|NCT03980223|561764853|FG000|Overall Study|Lost to Follow-up|3|||
155637847|NCT03980223|561764854|FG001|Overall Study|Lost to Follow-up|7|||
155637848|NCT03980223|561764855|FG002|Overall Study|Lost to Follow-up|10|||
155637849|NCT03980223|561764856|FG003|Overall Study|Lost to Follow-up|8|||
155637850|NCT03980223|561764853|FG000|Overall Study|Withdrawal by Subject|0|||
155637851|NCT03980223|561764854|FG001|Overall Study|Withdrawal by Subject|0|||
155286255|NCT00430677|560480507|FG000|Long-term Extension Period|Death|1|||
155286256|NCT00430677|560480508|FG001|Long-term Extension Period|Death|0|||
155286257|NCT00430677|560480509|FG002|Long-term Extension Period|Death|0|||
155286258|NCT00430677|560480507|FG000|Long-term Extension Period|Adverse Event|3|||
155286259|NCT00430677|560480508|FG001|Long-term Extension Period|Adverse Event|2|||
155286260|NCT00430677|560480509|FG002|Long-term Extension Period|Adverse Event|5|||
155286261|NCT00430677|560480507|FG000|Long-term Extension Period|Lack of Efficacy|5|||
155286262|NCT00430677|560480508|FG001|Long-term Extension Period|Lack of Efficacy|3|||
155286263|NCT00430677|560480509|FG002|Long-term Extension Period|Lack of Efficacy|8|||
155286264|NCT00430677|560480507|FG000|Long-term Extension Period|Lost to Follow-up|1|||
155286265|NCT00430677|560480508|FG001|Long-term Extension Period|Lost to Follow-up|1|||
155286266|NCT00430677|560480509|FG002|Long-term Extension Period|Lost to Follow-up|1|||
155286267|NCT00430677|560480507|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
155286268|NCT00430677|560480508|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
155286269|NCT00430677|560480509|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
155286270|NCT00430677|560480507|FG000|Long-term Extension Period|Pregnancy|1|||
155286271|NCT00430677|560480508|FG001|Long-term Extension Period|Pregnancy|1|||
155286272|NCT00430677|560480509|FG002|Long-term Extension Period|Pregnancy|0|||
155286273|NCT00430677|560480507|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
155286274|NCT00430677|560480508|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
155286275|NCT00430677|560480509|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
155286276|NCT00430677|560480507|FG000|Long-term Extension Period|Other|2|||
155286277|NCT00430677|560480508|FG001|Long-term Extension Period|Other|1|||
155286278|NCT00430677|560480509|FG002|Long-term Extension Period|Other|1|||
155286279|NCT00430677|560480507|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
155286280|NCT00430677|560480508|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
155286281|NCT00430677|560480509|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
155286282|NCT01555762|560480510|FG000|Overall Study|No information on Bevacizumab intake|11|||
155286283|NCT01555762|560480510|FG000|Overall Study|Missing start date of infusion|8|||
155286284|NCT01555762|560480510|FG000|Overall Study|75 years old or more ticked No|1|||
155286285|NCT01555762|560480510|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
155286286|NCT01555762|560480510|FG000|Overall Study|Death linked to progression of disease|165|||
155286287|NCT01555762|560480510|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
155286288|NCT01555762|560480510|FG000|Overall Study|Investigator's decision|10|||
155286289|NCT01555762|560480510|FG000|Overall Study|Participant not wishing to continue|5|||
155286290|NCT01555762|560480510|FG000|Overall Study|Missing data|1|||
155286291|NCT01555762|560480510|FG000|Overall Study|Death linked to an adverse event|14|||
155286292|NCT00819910|560480511|FG000|Overall Study|Adverse Event|0|||
155286293|NCT00819910|560480512|FG001|Overall Study|Adverse Event|0|||
155286294|NCT00819910|560480513|FG002|Overall Study|Adverse Event|2|||
155286295|NCT00819910|560480514|FG003|Overall Study|Adverse Event|1|||
155286296|NCT00819910|560480511|FG000|Overall Study|Withdrawal by Subject|1|||
155286297|NCT00819910|560480512|FG001|Overall Study|Withdrawal by Subject|1|||
155286298|NCT00819910|560480513|FG002|Overall Study|Withdrawal by Subject|1|||
155286299|NCT00819910|560480514|FG003|Overall Study|Withdrawal by Subject|0|||
155286300|NCT00819910|560480511|FG000|Overall Study|Lost to Follow-up|1|||
155286301|NCT00819910|560480512|FG001|Overall Study|Lost to Follow-up|0|||
155286302|NCT00819910|560480513|FG002|Overall Study|Lost to Follow-up|0|||
155286303|NCT00819910|560480514|FG003|Overall Study|Lost to Follow-up|0|||
155286304|NCT02040844|560480519|FG000|Overall Study|Adverse Event|0|||
155286305|NCT02040844|560480520|FG001|Overall Study|Adverse Event|0|||
155286306|NCT02040844|560480521|FG002|Overall Study|Adverse Event|1|||
155286307|NCT02040844|560480519|FG000|Overall Study|Withdrawal by Subject|16|||
155286308|NCT02040844|560480520|FG001|Overall Study|Withdrawal by Subject|22|||
155286309|NCT02040844|560480521|FG002|Overall Study|Withdrawal by Subject|25|||
155286310|NCT02040844|560480519|FG000|Overall Study|Lost to Follow-up|12|||
155286311|NCT02040844|560480520|FG001|Overall Study|Lost to Follow-up|9|||
155286312|NCT02040844|560480521|FG002|Overall Study|Lost to Follow-up|13|||
155286313|NCT02040844|560480519|FG000|Overall Study|Missing|13|||
155286314|NCT02040844|560480520|FG001|Overall Study|Missing|3|||
155286315|NCT02040844|560480521|FG002|Overall Study|Missing|2|||
155286316|NCT02040844|560480519|FG000|Overall Study|Non-specified|8|||
155286317|NCT02040844|560480520|FG001|Overall Study|Non-specified|2|||
155286318|NCT02040844|560480521|FG002|Overall Study|Non-specified|5|||
155286319|NCT02040844|560480519|FG000|Overall Study|Concomitant medication|1|||
155286320|NCT02040844|560480520|FG001|Overall Study|Concomitant medication|3|||
155286321|NCT02040844|560480521|FG002|Overall Study|Concomitant medication|1|||
155286322|NCT00946192|560480522|FG000|Overall Study|Lost to Follow-up|6|||
155286323|NCT00946192|560480523|FG001|Overall Study|Lost to Follow-up|11|||
155286324|NCT00946192|560480524|FG002|Overall Study|Lost to Follow-up|9|||
155286325|NCT00946192|560480522|FG000|Overall Study|Withdrawal by Subject|10|||
155286326|NCT00946192|560480523|FG001|Overall Study|Withdrawal by Subject|7|||
155286327|NCT00946192|560480524|FG002|Overall Study|Withdrawal by Subject|3|||
155286328|NCT00946192|560480522|FG000|Overall Study|Did not start medication|2|||
155286329|NCT00946192|560480523|FG001|Overall Study|Did not start medication|0|||
155286330|NCT00946192|560480524|FG002|Overall Study|Did not start medication|0|||
155286331|NCT05460663|560480527|FG000|Overall Study|Withdrawal by Subject|2|||
155286332|NCT05460663|560480528|FG001|Overall Study|Withdrawal by Subject|5|||
155286333|NCT02068885|560480529|FG000|Overall Study|Withdrew|3|||
155286334|NCT02068885|560480530|FG001|Overall Study|Withdrew|5|||
155286335|NCT02068885|560480531|FG002|Overall Study|Withdrew|8|||
155286336|NCT00681811|560480532|FG000|Overall Study|Adverse Event|1|||
155286337|NCT00681811|560480533|FG001|Overall Study|Adverse Event|1|||
155286338|NCT00681811|560480532|FG000|Overall Study|Withdrawal by Subject|2|||
155637852|NCT03980223|561764855|FG002|Overall Study|Withdrawal by Subject|1|||
155637853|NCT03980223|561764856|FG003|Overall Study|Withdrawal by Subject|2|||
155637854|NCT03980223|561764853|FG000|Overall Study|Physician Decision|0|||
155637855|NCT03980223|561764854|FG001|Overall Study|Physician Decision|0|||
155637856|NCT03980223|561764855|FG002|Overall Study|Physician Decision|1|||
155637857|NCT03980223|561764856|FG003|Overall Study|Physician Decision|0|||
155637858|NCT03980223|561764853|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
155637859|NCT03980223|561764854|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
155637860|NCT03980223|561764855|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
155637861|NCT03980223|561764856|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
155637862|NCT02460289|561764860|FG000|Overall Study|Adverse Event|1|||
155637863|NCT02460289|561764860|FG000|Overall Study|Withdrawal by Subject|8|||
155637864|NCT02460289|561764860|FG000|Overall Study|Lost to Follow-up|1|||
155637865|NCT01155570|561764861|FG000|Overall Study|Adverse Event|39|||
155637866|NCT01155570|561764861|FG000|Overall Study|Lack of Efficacy|46|||
155286339|NCT00681811|560480533|FG001|Overall Study|Withdrawal by Subject|2|||
155637867|NCT01155570|561764861|FG000|Overall Study|Participant's Economic Reasons|17|||
155637868|NCT01155570|561764861|FG000|Overall Study|No Hospital Visits|7|||
155637869|NCT01155570|561764861|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
155637870|NCT01155570|561764861|FG000|Overall Study|Adverse Event + Other Reasons|7|||
155637871|NCT01155570|561764861|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
155637872|NCT01155570|561764861|FG000|Overall Study|Other Reasons|23|||
155637873|NCT02916927|561764862|FG000|Overall Study|Discharged prior to study drug receipt|0|||
155286340|NCT00681811|560480532|FG000|Overall Study|Non-compliance|0|||
155286341|NCT00681811|560480533|FG001|Overall Study|Non-compliance|1|||
155286342|NCT00828919|560480534|FG000|Overall Study|Death|0|||
155286343|NCT00828919|560480535|FG001|Overall Study|Death|1|||
155286344|NCT00828919|560480536|FG002|Overall Study|Death|2|||
155406554|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
155406555|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
155406556|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
155406557|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
155406558|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
155406559|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
155406560|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
155406561|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
155286345|NCT00828919|560480537|FG003|Overall Study|Death|0|||
155286346|NCT00828919|560480538|FG004|Overall Study|Death|0|||
155286347|NCT00828919|560480534|FG000|Overall Study|Adverse Event|2|||
155286348|NCT00828919|560480535|FG001|Overall Study|Adverse Event|2|||
155286349|NCT00828919|560480536|FG002|Overall Study|Adverse Event|2|||
155286350|NCT00828919|560480537|FG003|Overall Study|Adverse Event|1|||
155286351|NCT00828919|560480538|FG004|Overall Study|Adverse Event|3|||
155286352|NCT00828919|560480534|FG000|Overall Study|Objective progression or relapse|4|||
155286353|NCT00828919|560480535|FG001|Overall Study|Objective progression or relapse|4|||
155286354|NCT00828919|560480536|FG002|Overall Study|Objective progression or relapse|11|||
155286355|NCT00828919|560480537|FG003|Overall Study|Objective progression or relapse|0|||
155286356|NCT00828919|560480538|FG004|Overall Study|Objective progression or relapse|5|||
155742757|NCT02929498|562158212|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
155742758|NCT02929498|562158213|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
155742759|NCT02929498|562158214|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
155742760|NCT00096356|562158217|FG000|Overall Study|Adverse Event|11|||
155742761|NCT00096356|562158218|FG001|Overall Study|Adverse Event|9|||
155742762|NCT00096356|562158217|FG000|Overall Study|Physician Decision|5|||
155742763|NCT00096356|562158218|FG001|Overall Study|Physician Decision|3|||
155742764|NCT00096356|562158217|FG000|Overall Study|Withdrawal by Subject|17|||
155742765|NCT00096356|562158218|FG001|Overall Study|Withdrawal by Subject|23|||
155742766|NCT00096356|562158217|FG000|Overall Study|Lack of Efficacy|1|||
155742767|NCT00096356|562158218|FG001|Overall Study|Lack of Efficacy|0|||
155742768|NCT00096356|562158217|FG000|Overall Study|multiple reasons|10|||
155742769|NCT00096356|562158218|FG001|Overall Study|multiple reasons|18|||
155742770|NCT03288142|562158220|FG000|Overall Study|Lost to Follow-up|22|||
155742771|NCT03288142|562158221|FG001|Overall Study|Lost to Follow-up|15|||
155742772|NCT02034409|562158222|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
155742773|NCT02034409|562158223|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
155742774|NCT02034409|562158222|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
155742775|NCT02034409|562158223|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
155742776|NCT02034409|562158222|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
155742777|NCT02034409|562158223|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
155742778|NCT02034409|562158222|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
155742779|NCT02034409|562158223|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
155742780|NCT02034409|562158222|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
155742781|NCT02034409|562158223|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
155742782|NCT02034409|562158222|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
155742783|NCT02034409|562158223|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
155742784|NCT02270944|562158227|FG000|Overall Study|Lost to Follow-up|9|||
155742785|NCT02270944|562158228|FG001|Overall Study|Lost to Follow-up|4|||
155742786|NCT02270944|562158227|FG000|Overall Study|Withdrawal by Subject|2|||
155742787|NCT02270944|562158228|FG001|Overall Study|Withdrawal by Subject|1|||
155742788|NCT01699867|562158229|FG000|Overall Study|Screening Failure|3|||
155742789|NCT04002908|562158242|FG000|Overall Study|Death|41|||
155742790|NCT04002908|562158243|FG001|Overall Study|Death|0|||
155742791|NCT04002908|562158244|FG002|Overall Study|Death|0|||
155742792|NCT04002908|562158245|FG003|Overall Study|Death|0|||
155742793|NCT04002908|562158242|FG000|Overall Study|Withdrawal by Subject|112|||
155742794|NCT04002908|562158243|FG001|Overall Study|Withdrawal by Subject|0|||
155742795|NCT04002908|562158244|FG002|Overall Study|Withdrawal by Subject|0|||
155742796|NCT04002908|562158245|FG003|Overall Study|Withdrawal by Subject|0|||
155742797|NCT04002908|562158242|FG000|Overall Study|Lost to Follow-up|72|||
155742798|NCT04002908|562158243|FG001|Overall Study|Lost to Follow-up|0|||
155742799|NCT04002908|562158244|FG002|Overall Study|Lost to Follow-up|0|||
155286357|NCT00828919|560480534|FG000|Overall Study|No longer willing to participate in study|0|||
155286358|NCT00828919|560480535|FG001|Overall Study|No longer willing to participate in study|0|||
155286359|NCT00828919|560480536|FG002|Overall Study|No longer willing to participate in study|2|||
155286360|NCT00828919|560480537|FG003|Overall Study|No longer willing to participate in study|0|||
155742800|NCT04002908|562158245|FG003|Overall Study|Lost to Follow-up|0|||
155742801|NCT04002908|562158242|FG000|Overall Study|Infant died, so mother withdrawn|34|||
155742802|NCT04002908|562158243|FG001|Overall Study|Infant died, so mother withdrawn|0|||
155742803|NCT04002908|562158244|FG002|Overall Study|Infant died, so mother withdrawn|0|||
155742804|NCT04002908|562158245|FG003|Overall Study|Infant died, so mother withdrawn|0|||
155742805|NCT00530504|562158246|FG000|Overall Study|Death|54|||
155742806|NCT00530504|562158246|FG000|Overall Study|Lost to Follow-up|26|||
155742807|NCT00530504|562158246|FG000|Overall Study|Withdrawal by Subject|39|||
155742808|NCT00530504|562158246|FG000|Overall Study|Exited study due to other reasons|33|||
155742809|NCT00006289|562158247|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
155742810|NCT00006289|562158248|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
155742811|NCT00006289|562158247|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
155742812|NCT00006289|562158248|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
155742813|NCT04359901|562158257|FG000|Overall Study|Withdrawal by Subject|0|||
155742814|NCT04359901|562158258|FG001|Overall Study|Withdrawal by Subject|1|||
155286361|NCT00828919|560480538|FG004|Overall Study|No longer willing to participate in study|0|||
155286362|NCT00828919|560480534|FG000|Overall Study|Insufficient Clinical Response|0|||
155286363|NCT00828919|560480535|FG001|Overall Study|Insufficient Clinical Response|1|||
155286364|NCT00828919|560480536|FG002|Overall Study|Insufficient Clinical Response|2|||
155286365|NCT00828919|560480537|FG003|Overall Study|Insufficient Clinical Response|0|||
155286366|NCT00828919|560480538|FG004|Overall Study|Insufficient Clinical Response|0|||
155286367|NCT00828919|560480534|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286368|NCT00828919|560480535|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286369|NCT00828919|560480536|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286370|NCT00828919|560480537|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286371|NCT00828919|560480538|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
155286372|NCT00828919|560480534|FG000|Overall Study|Other|1|||
155286373|NCT00828919|560480535|FG001|Overall Study|Other|0|||
155286374|NCT00828919|560480536|FG002|Overall Study|Other|1|||
155286375|NCT00828919|560480537|FG003|Overall Study|Other|1|||
155286376|NCT00828919|560480538|FG004|Overall Study|Other|0|||
155286377|NCT00828919|560480534|FG000|Overall Study|Lost to Follow-up|0|||
155286378|NCT00828919|560480535|FG001|Overall Study|Lost to Follow-up|1|||
155286379|NCT00828919|560480536|FG002|Overall Study|Lost to Follow-up|0|||
155286380|NCT00828919|560480537|FG003|Overall Study|Lost to Follow-up|0|||
155286381|NCT00828919|560480538|FG004|Overall Study|Lost to Follow-up|0|||
155286382|NCT01562743|560480539|FG000|Overall Study|Adverse Event|29|||
155286383|NCT01562743|560480539|FG000|Overall Study|Lack of Efficacy|3|||
155286384|NCT01562743|560480539|FG000|Overall Study|Withdrawal by Subject|13|||
155286385|NCT01562743|560480539|FG000|Overall Study|Protocol Violation|1|||
155286386|NCT01562743|560480539|FG000|Overall Study|Discontinuation criteria|2|||
155286387|NCT01562743|560480539|FG000|Overall Study|Lost to Follow-up|2|||
155286388|NCT01562743|560480539|FG000|Overall Study|Physician Decision|2|||
155286389|NCT05567159|560480540|FG000|Overall Study|Adverse Event|4|||
155286390|NCT05567159|560480540|FG000|Overall Study|Physician Decision|3|||
155286391|NCT05567159|560480540|FG000|Overall Study|Protocol deviation|1|||
155286392|NCT02449044|560480543|FG000|Overall Study|Lost to Follow-up|2|||
155286393|NCT02449044|560480543|FG000|Overall Study|Withdrawal by Subject|13|||
155286394|NCT02449044|560480543|FG000|Overall Study|Adverse Event|30|||
155286395|NCT02449044|560480543|FG000|Overall Study|Met Withdrawal Criteria|7|||
155286396|NCT02449044|560480543|FG000|Overall Study|Physician Decision|9|||
155286397|NCT02449044|560480543|FG000|Overall Study|Sponsor Discontinued Trial|3|||
155286398|NCT00349908|560482249|FG000|Overall Study|Withdrawal by Subject|0|||
155286399|NCT00349908|560482250|FG001|Overall Study|Withdrawal by Subject|4|||
155286400|NCT04381494|560482257|FG000|Overall Study|Early termination of trial|19|||
155286401|NCT04381494|560482257|FG000|Overall Study|Investigator's discretion|1|||
155286402|NCT04381494|560482257|FG000|Overall Study|Withdrawal by Subject|9|||
155286403|NCT04381494|560482257|FG000|Overall Study|NSCLC disease progression|4|||
155286404|NCT04381494|560482257|FG000|Overall Study|Device-Related Adverse Event|2|||
155286405|NCT04310579|560482258|FG000|Overall Study|Adverse Event|0|||
155286406|NCT04310579|560482259|FG001|Overall Study|Adverse Event|0|||
155286407|NCT04310579|560482260|FG002|Overall Study|Adverse Event|0|||
155286408|NCT04310579|560482261|FG003|Overall Study|Adverse Event|0|||
155286409|NCT04310579|560482262|FG004|Overall Study|Adverse Event|0|||
155286410|NCT04310579|560482263|FG005|Overall Study|Adverse Event|0|||
155286411|NCT04310579|560482264|FG006|Overall Study|Adverse Event|2|||
155286412|NCT04310579|560482265|FG007|Overall Study|Adverse Event|0|||
155286413|NCT04310579|560482266|FG008|Overall Study|Adverse Event|1|||
155286414|NCT04310579|560482267|FG009|Overall Study|Adverse Event|1|||
155286415|NCT04310579|560482268|FG010|Overall Study|Adverse Event|0|||
155286416|NCT04310579|560482258|FG000|Overall Study|Withdrawal by Subject|0|||
155286417|NCT04310579|560482259|FG001|Overall Study|Withdrawal by Subject|0|||
155286418|NCT04310579|560482260|FG002|Overall Study|Withdrawal by Subject|0|||
155637874|NCT02916927|561764863|FG001|Overall Study|Discharged prior to study drug receipt|2|||
155286419|NCT04310579|560482261|FG003|Overall Study|Withdrawal by Subject|0|||
155286420|NCT04310579|560482262|FG004|Overall Study|Withdrawal by Subject|0|||
155637875|NCT02916927|561764862|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
155637876|NCT02916927|561764863|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
155637877|NCT02916927|561764862|FG000|Overall Study|Withdrawal before first time point|1|||
155286421|NCT04310579|560482263|FG005|Overall Study|Withdrawal by Subject|1|||
155286422|NCT04310579|560482264|FG006|Overall Study|Withdrawal by Subject|0|||
155286423|NCT04310579|560482265|FG007|Overall Study|Withdrawal by Subject|0|||
155286424|NCT04310579|560482266|FG008|Overall Study|Withdrawal by Subject|0|||
155286425|NCT04310579|560482267|FG009|Overall Study|Withdrawal by Subject|0|||
155286426|NCT04310579|560482268|FG010|Overall Study|Withdrawal by Subject|0|||
155286427|NCT04310579|560482258|FG000|Overall Study|Positive COVID-19 test|0|||
155286428|NCT04310579|560482259|FG001|Overall Study|Positive COVID-19 test|0|||
155286429|NCT04310579|560482260|FG002|Overall Study|Positive COVID-19 test|0|||
155637878|NCT02916927|561764863|FG001|Overall Study|Withdrawal before first time point|0|||
155637879|NCT02774889|561764864|FG000|Overall Study|Lost to Follow-up|2|||
155286430|NCT04310579|560482261|FG003|Overall Study|Positive COVID-19 test|0|||
155286431|NCT04310579|560482262|FG004|Overall Study|Positive COVID-19 test|0|||
155286432|NCT04310579|560482263|FG005|Overall Study|Positive COVID-19 test|0|||
155286433|NCT04310579|560482264|FG006|Overall Study|Positive COVID-19 test|0|||
155286434|NCT04310579|560482265|FG007|Overall Study|Positive COVID-19 test|0|||
155286435|NCT04310579|560482266|FG008|Overall Study|Positive COVID-19 test|0|||
155286436|NCT04310579|560482267|FG009|Overall Study|Positive COVID-19 test|0|||
155286437|NCT04310579|560482268|FG010|Overall Study|Positive COVID-19 test|1|||
155286438|NCT03467724|560482269|FG000|Overall Study|Lost to Follow-up|5|||
155286439|NCT03467724|560482269|FG000|Overall Study|Withdrawal by Subject|1|||
155286440|NCT03467724|560482269|FG000|Overall Study|Protocol Violation|1|||
155286441|NCT03467724|560482269|FG000|Overall Study|Adverse Event|1|||
155286442|NCT02236559|560482273|FG000|Overall Study|Met Exclusion|3|||
155286443|NCT02236559|560482274|FG001|Overall Study|Met Exclusion|6|||
155286444|NCT02236559|560482273|FG000|Overall Study|Did not Meet Inclusion|3|||
155286445|NCT02236559|560482274|FG001|Overall Study|Did not Meet Inclusion|3|||
155286446|NCT02236559|560482273|FG000|Overall Study|Subject Did Not Consent|4|||
155286447|NCT02236559|560482274|FG001|Overall Study|Subject Did Not Consent|2|||
155286448|NCT02236559|560482273|FG000|Overall Study|Physician Decision|1|||
155286449|NCT02236559|560482274|FG001|Overall Study|Physician Decision|1|||
155286450|NCT02236559|560482273|FG000|Overall Study|Withdrawal by Subject|1|||
155286451|NCT02236559|560482274|FG001|Overall Study|Withdrawal by Subject|0|||
155286452|NCT03721016|560482275|FG000|Overall Study|Adverse Event|0|||
155286453|NCT03721016|560482276|FG001|Overall Study|Adverse Event|1|||
155286454|NCT03721016|560482277|FG002|Overall Study|Adverse Event|1|||
155286455|NCT03721016|560482275|FG000|Overall Study|Withdrawal by Subject|8|||
155286456|NCT03721016|560482276|FG001|Overall Study|Withdrawal by Subject|16|||
155286457|NCT03721016|560482277|FG002|Overall Study|Withdrawal by Subject|13|||
155286458|NCT03721016|560482275|FG000|Overall Study|Lost to Follow-up|4|||
155286459|NCT03721016|560482276|FG001|Overall Study|Lost to Follow-up|6|||
155406562|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
155406563|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
155286460|NCT03721016|560482277|FG002|Overall Study|Lost to Follow-up|5|||
155406564|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
155406565|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
155406566|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
155406567|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
155406568|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
155406569|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
155406570|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
155406571|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
155406572|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
155406573|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
155406574|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
155406575|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
155406576|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
155406577|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
155406578|NCT03605680|560923457|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
155406579|NCT03605680|560923458|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
155406580|NCT03605680|560923459|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
155406581|NCT03605680|560923460|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
155406582|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
155406583|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
155406584|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
155406585|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
155406586|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
155406587|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
155406588|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
155406589|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
155406590|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155406591|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155406592|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155406593|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155406594|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
155406595|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155406596|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
155406597|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155406598|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
155406599|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
155406600|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
155406601|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
155406602|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
155406603|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
155406604|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
155406605|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
155406606|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
155406607|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155406608|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155637880|NCT02774889|561764865|FG001|Overall Study|Lost to Follow-up|1|||
155637881|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
155637882|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
155637883|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
155637884|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
155637885|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
155637886|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
155286461|NCT03721016|560482275|FG000|Overall Study|Physician Decision|0|||
155286462|NCT03721016|560482276|FG001|Overall Study|Physician Decision|1|||
155286463|NCT03721016|560482277|FG002|Overall Study|Physician Decision|2|||
155286464|NCT03721016|560482275|FG000|Overall Study|Protocol Violation|0|||
155286465|NCT03721016|560482276|FG001|Overall Study|Protocol Violation|1|||
155286466|NCT03721016|560482277|FG002|Overall Study|Protocol Violation|0|||
155637887|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
155742815|NCT04359901|562158257|FG000|Overall Study|Death|6|||
155286467|NCT03721016|560482275|FG000|Overall Study|Site terminated by sponsor|3|||
155286468|NCT03721016|560482276|FG001|Overall Study|Site terminated by sponsor|7|||
155286469|NCT03721016|560482277|FG002|Overall Study|Site terminated by sponsor|6|||
155286470|NCT03721016|560482275|FG000|Overall Study|Subject exited early due to COVID-19|1|||
155286471|NCT03721016|560482276|FG001|Overall Study|Subject exited early due to COVID-19|0|||
155286472|NCT03721016|560482277|FG002|Overall Study|Subject exited early due to COVID-19|0|||
155286473|NCT01149681|560482279|FG000|Overall Study|Withdrawal by Subject|7|||
155286474|NCT01149681|560482279|FG000|Overall Study|Progressive disease|1|||
155286475|NCT01149681|560482279|FG000|Overall Study|Physician Decision|2|||
155286476|NCT01149681|560482279|FG000|Overall Study|adverse events nonrelated study drug|2|||
155286477|NCT03107611|560482280|FG000|Overall Study|Adverse Event|1|||
155286478|NCT03107611|560482281|FG001|Overall Study|Adverse Event|0|||
155286479|NCT03107611|560482282|FG002|Overall Study|Adverse Event|2|||
155286480|NCT03107611|560482280|FG000|Overall Study|Lost to Follow-up|3|||
155286481|NCT03107611|560482281|FG001|Overall Study|Lost to Follow-up|3|||
155286482|NCT03107611|560482282|FG002|Overall Study|Lost to Follow-up|3|||
155286483|NCT03107611|560482280|FG000|Overall Study|Protocol Violation|0|||
155286484|NCT03107611|560482281|FG001|Overall Study|Protocol Violation|0|||
155286485|NCT03107611|560482282|FG002|Overall Study|Protocol Violation|1|||
155286486|NCT03107611|560482280|FG000|Overall Study|Withdrawal by Subject|1|||
155286487|NCT03107611|560482281|FG001|Overall Study|Withdrawal by Subject|0|||
155286488|NCT03107611|560482282|FG002|Overall Study|Withdrawal by Subject|1|||
155286489|NCT03107611|560482280|FG000|Overall Study|Worsening signs/symptoms|2|||
155286490|NCT03107611|560482281|FG001|Overall Study|Worsening signs/symptoms|1|||
155286491|NCT03107611|560482282|FG002|Overall Study|Worsening signs/symptoms|2|||
155286492|NCT01020838|560482283|FG000|Overall Study|Death|90|||
155286493|NCT01020838|560482283|FG000|Overall Study|Adverse Event|1|||
155286494|NCT01020838|560482283|FG000|Overall Study|Withdrawal by Subject|9|||
155286495|NCT01020838|560482283|FG000|Overall Study|Lost to Follow-up|6|||
155406609|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
155406610|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
155286496|NCT01020838|560482283|FG000|Overall Study|Most common: Study ended by sponsor|77|||
155286497|NCT00763282|560482288|FG000|Overall Study|Withdrawal by Subject|6|||
155286498|NCT00763282|560482289|FG001|Overall Study|Withdrawal by Subject|5|||
155286499|NCT00763282|560482288|FG000|Overall Study|Death|4|||
155286500|NCT00763282|560482289|FG001|Overall Study|Death|3|||
155286501|NCT00763282|560482288|FG000|Overall Study|Lost to Follow-up|22|||
155286502|NCT00763282|560482289|FG001|Overall Study|Lost to Follow-up|26|||
155286503|NCT00742274|560482290|FG000|Overall Study|Death|1|||
155286504|NCT00742274|560482291|FG001|Overall Study|Death|0|||
155286505|NCT00742274|560482290|FG000|Overall Study|Withdrawal by Subject|1|||
155286506|NCT00742274|560482291|FG001|Overall Study|Withdrawal by Subject|2|||
155286507|NCT00742274|560482290|FG000|Overall Study|Removed for medical reasons|1|||
155286508|NCT00742274|560482291|FG001|Overall Study|Removed for medical reasons|1|||
155286509|NCT00335556|560482296|FG000|Overall Study|Death|0|||
155286510|NCT00335556|560482297|FG001|Overall Study|Death|5|||
155286511|NCT00335556|560482298|FG002|Overall Study|Death|0|||
155286512|NCT00335556|560482299|FG003|Overall Study|Death|0|||
155286513|NCT00335556|560482300|FG004|Overall Study|Death|1|||
155286514|NCT00335556|560482301|FG005|Overall Study|Death|0|||
155286515|NCT00335556|560482296|FG000|Overall Study|Lack of Efficacy|0|||
155286516|NCT00335556|560482297|FG001|Overall Study|Lack of Efficacy|19|||
155286517|NCT00335556|560482298|FG002|Overall Study|Lack of Efficacy|3|||
155286518|NCT00335556|560482299|FG003|Overall Study|Lack of Efficacy|3|||
155286519|NCT00335556|560482300|FG004|Overall Study|Lack of Efficacy|0|||
155286520|NCT00335556|560482301|FG005|Overall Study|Lack of Efficacy|1|||
155286521|NCT00335556|560482296|FG000|Overall Study|Physician Decision|0|||
155286522|NCT00335556|560482297|FG001|Overall Study|Physician Decision|6|||
155286523|NCT00335556|560482298|FG002|Overall Study|Physician Decision|2|||
155286524|NCT00335556|560482299|FG003|Overall Study|Physician Decision|1|||
155286525|NCT00335556|560482300|FG004|Overall Study|Physician Decision|0|||
155286526|NCT00335556|560482301|FG005|Overall Study|Physician Decision|0|||
155286527|NCT00335556|560482296|FG000|Overall Study|Ineligible|2|||
155286528|NCT00335556|560482297|FG001|Overall Study|Ineligible|0|||
155286529|NCT00335556|560482298|FG002|Overall Study|Ineligible|0|||
155286530|NCT00335556|560482299|FG003|Overall Study|Ineligible|0|||
155286531|NCT00335556|560482300|FG004|Overall Study|Ineligible|0|||
155286532|NCT00335556|560482301|FG005|Overall Study|Ineligible|0|||
155286533|NCT00335556|560482296|FG000|Overall Study|Refusal of further protocol therapy|0|||
155286534|NCT00335556|560482297|FG001|Overall Study|Refusal of further protocol therapy|4|||
155286535|NCT00335556|560482298|FG002|Overall Study|Refusal of further protocol therapy|0|||
155286536|NCT00335556|560482299|FG003|Overall Study|Refusal of further protocol therapy|1|||
155742816|NCT04359901|562158258|FG001|Overall Study|Death|2|||
155286537|NCT00335556|560482300|FG004|Overall Study|Refusal of further protocol therapy|0|||
155286538|NCT00335556|560482301|FG005|Overall Study|Refusal of further protocol therapy|0|||
155742817|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155742818|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
155742819|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155286539|NCT02365298|560482302|FG000|Period 2|incorrect Rx dispensed|1|||
155286540|NCT02365298|560482303|FG001|Period 2|incorrect Rx dispensed|0|||
155286541|NCT02365298|560482302|FG000|Period 2|Discontinued at request of Sponsor|1|||
155286542|NCT02365298|560482303|FG001|Period 2|Discontinued at request of Sponsor|0|||
155286543|NCT02365298|560482302|FG000|Period 2|Test Article longer available|0|||
155286544|NCT02365298|560482303|FG001|Period 2|Test Article longer available|1|||
155286545|NCT02365298|560482302|FG000|Period 2|Protocol Violation|0|||
155286546|NCT02365298|560482303|FG001|Period 2|Protocol Violation|1|||
155286547|NCT03124108|560482306|FG000|Overall Study|Adverse Event|0|||
155286548|NCT03124108|560482307|FG001|Overall Study|Adverse Event|1|||
155286549|NCT03124108|560482308|FG002|Overall Study|Adverse Event|0|||
155286550|NCT01670019|560482313|FG000|Overall Study|Adverse Event|3|||
155286551|NCT01670019|560482314|FG001|Overall Study|Adverse Event|0|||
155286552|NCT01670019|560482313|FG000|Overall Study|Withdrawal by Subject|6|||
155286553|NCT01670019|560482314|FG001|Overall Study|Withdrawal by Subject|0|||
155286554|NCT05487703|560482315|FG000|Overall Study|Other|19|||
155286555|NCT05487703|560482315|FG000|Overall Study|Participant not well|5|||
155286556|NCT05487703|560482315|FG000|Overall Study|Insurance Reasons|6|||
155286557|NCT05487703|560482315|FG000|Overall Study|Physician Decision|19|||
155286558|NCT05487703|560482315|FG000|Overall Study|Lack of Efficacy|60|||
155286559|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
155286560|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
155286561|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
155286562|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Death|3|||
155286563|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Death|0|||
155286564|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Death|0|||
155286565|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
155286566|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155286567|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155286568|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
155286569|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
155286570|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
155286571|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
155286572|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
155286573|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
155286574|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
155286575|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
155286576|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
155286577|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
155286578|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
155286579|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
155286580|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Other|1|||
155286581|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Other|0|||
155286582|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Other|0|||
155286583|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
155286584|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155286585|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155286586|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155286587|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
155286588|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155286589|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
155286590|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
155286591|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
155286592|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
155286593|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
155286594|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
155286595|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155286596|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
155286597|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155286598|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155742820|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
155742821|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155742822|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
155742823|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
155286599|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
155286600|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
155286601|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
155286602|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
155286603|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
155406611|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
155406612|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
155406613|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
155637888|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
155637889|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
155637890|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
155637891|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
155637892|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
155637893|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
155637894|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
155637895|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
155637896|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
155637897|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
155286604|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
155286605|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
155286606|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
155286607|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
155286608|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
155286609|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
155286610|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
155286611|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
155286612|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
155286613|NCT00197236|560482322|FG000|Overall Study|Adverse Event|1|||
155286614|NCT00197236|560482323|FG001|Overall Study|Adverse Event|0|||
155286615|NCT00197236|560482324|FG002|Overall Study|Adverse Event|1|||
155286616|NCT00197236|560482322|FG000|Overall Study|Lost to Follow-up|5|||
155286617|NCT00197236|560482323|FG001|Overall Study|Lost to Follow-up|14|||
155286618|NCT00197236|560482324|FG002|Overall Study|Lost to Follow-up|6|||
155286619|NCT00197236|560482322|FG000|Overall Study|Protocol Violation|0|||
155286620|NCT00197236|560482323|FG001|Overall Study|Protocol Violation|0|||
155286621|NCT00197236|560482324|FG002|Overall Study|Protocol Violation|1|||
155286622|NCT00197236|560482322|FG000|Overall Study|Withdrawal by Subject|7|||
155286623|NCT00197236|560482323|FG001|Overall Study|Withdrawal by Subject|3|||
155286624|NCT00197236|560482324|FG002|Overall Study|Withdrawal by Subject|11|||
155286625|NCT00197236|560482322|FG000|Overall Study|Study drug/medication expiration|1|||
155286626|NCT00197236|560482323|FG001|Overall Study|Study drug/medication expiration|0|||
155286627|NCT00197236|560482324|FG002|Overall Study|Study drug/medication expiration|3|||
155286628|NCT00197236|560482322|FG000|Overall Study|Returned out of specified time window|0|||
155286629|NCT00197236|560482323|FG001|Overall Study|Returned out of specified time window|0|||
155286630|NCT00197236|560482324|FG002|Overall Study|Returned out of specified time window|1|||
155286631|NCT03885596|560482325|FG000|Overall Study|Withdrawal by Subject|2|||
155286632|NCT03885596|560482326|FG001|Overall Study|Withdrawal by Subject|1|||
155286633|NCT03885596|560482327|FG002|Overall Study|Withdrawal by Subject|0|||
155286634|NCT03885596|560482328|FG003|Overall Study|Withdrawal by Subject|0|||
155286635|NCT00746330|560482329|FG000|Period 1|Abnormal test procedure result|0|||
155286636|NCT00746330|560482330|FG001|Period 1|Abnormal test procedure result|0|||
155286637|NCT00746330|560482331|FG002|Period 1|Abnormal test procedure result|1|||
155286638|NCT00746330|560482332|FG003|Period 1|Abnormal test procedure result|0|||
155286639|NCT01076335|560482333|FG000|Overall Study|Withdrawal by Subject|3|||
155286640|NCT01076335|560482333|FG000|Overall Study|Withdrawal without treatment|1|||
155286641|NCT00517933|560482335|FG000|Period 1|Death|2|||
155286642|NCT00517933|560482336|FG001|Period 1|Death|1|||
155286643|NCT00517933|560482335|FG000|Period 1|Adverse Event|4|||
155286644|NCT00517933|560482336|FG001|Period 1|Adverse Event|4|||
155286645|NCT00517933|560482335|FG000|Period 1|Lost to Follow-up|2|||
155286646|NCT00517933|560482336|FG001|Period 1|Lost to Follow-up|0|||
155286647|NCT00517933|560482335|FG000|Period 1|Underwent lung transplant|0|||
155286648|NCT00517933|560482336|FG001|Period 1|Underwent lung transplant|1|||
155286649|NCT00517933|560482335|FG000|Period 2|Death|2|||
155286650|NCT00517933|560482336|FG001|Period 2|Death|4|||
155286651|NCT00517933|560482335|FG000|Period 2|Adverse Event|2|||
155286652|NCT00517933|560482336|FG001|Period 2|Adverse Event|4|||
155286653|NCT00517933|560482335|FG000|Period 2|Physician Decision|1|||
155286654|NCT00517933|560482336|FG001|Period 2|Physician Decision|0|||
155286655|NCT00517933|560482335|FG000|Period 2|Withdrawal by Subject|1|||
155286656|NCT00517933|560482336|FG001|Period 2|Withdrawal by Subject|3|||
155286657|NCT00517933|560482335|FG000|Period 2|Underwent lung transplant|0|||
155286658|NCT00517933|560482336|FG001|Period 2|Underwent lung transplant|2|||
155286659|NCT04639947|560482339|FG000|Overall Study|Screen fail|1|||
155286660|NCT01018511|560482340|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
155286661|NCT01018511|560482341|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
155286662|NCT01018511|560482342|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
155286663|NCT01018511|560482343|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
155286664|NCT01018511|560482340|FG000|Overall Study|Adverse Event|5|||
155286665|NCT01018511|560482341|FG001|Overall Study|Adverse Event|9|||
155286666|NCT01018511|560482342|FG002|Overall Study|Adverse Event|13|||
155286667|NCT01018511|560482343|FG003|Overall Study|Adverse Event|10|||
155286668|NCT01018511|560482340|FG000|Overall Study|Lack of Efficacy|4|||
155286669|NCT01018511|560482341|FG001|Overall Study|Lack of Efficacy|1|||
155286670|NCT01018511|560482342|FG002|Overall Study|Lack of Efficacy|1|||
155286671|NCT01018511|560482343|FG003|Overall Study|Lack of Efficacy|2|||
155286672|NCT01018511|560482340|FG000|Overall Study|Withdrawal by Subject|6|||
155286673|NCT01018511|560482341|FG001|Overall Study|Withdrawal by Subject|5|||
155286674|NCT01018511|560482342|FG002|Overall Study|Withdrawal by Subject|11|||
155286675|NCT01018511|560482343|FG003|Overall Study|Withdrawal by Subject|9|||
155286676|NCT01018511|560482340|FG000|Overall Study|Lost to Follow-up|0|||
155286677|NCT01018511|560482341|FG001|Overall Study|Lost to Follow-up|0|||
155286678|NCT01018511|560482342|FG002|Overall Study|Lost to Follow-up|1|||
155286679|NCT01018511|560482343|FG003|Overall Study|Lost to Follow-up|0|||
155742824|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155406614|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
155406615|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
155742825|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
155742826|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
155742827|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742828|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
155742829|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742830|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742831|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742832|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742833|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155406616|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
155406617|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
155406618|NCT03605680|560923457|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
155406619|NCT03605680|560923458|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
155406620|NCT03605680|560923459|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
155406621|NCT03605680|560923460|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
155406622|NCT00647556|560923461|FG000|Overall Study|Adverse Event|0|||
155406623|NCT00647556|560923462|FG001|Overall Study|Adverse Event|1|||
155406624|NCT00647556|560923461|FG000|Overall Study|Lost to Follow-up|1|||
155406625|NCT00647556|560923462|FG001|Overall Study|Lost to Follow-up|0|||
155406626|NCT00647556|560923461|FG000|Overall Study|Protocol Violation|0|||
155406627|NCT00647556|560923462|FG001|Overall Study|Protocol Violation|1|||
155406628|NCT00647556|560923461|FG000|Overall Study|Withdrawal by Subject|1|||
155406629|NCT00647556|560923462|FG001|Overall Study|Withdrawal by Subject|0|||
155406630|NCT00647556|560923461|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
155406631|NCT00647556|560923462|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
155406632|NCT02145741|560923463|FG000|Overall Study|Progressive disease|3|||
155406633|NCT02145741|560923464|FG001|Overall Study|Progressive disease|6|||
155406634|NCT02145741|560923465|FG002|Overall Study|Progressive disease|6|||
155406635|NCT02145741|560923463|FG000|Overall Study|quality issue with the administered drug|3|||
155406636|NCT02145741|560923464|FG001|Overall Study|quality issue with the administered drug|0|||
155406637|NCT02145741|560923465|FG002|Overall Study|quality issue with the administered drug|0|||
155406638|NCT03865706|560923469|FG000|Overall Study|Death|0|||
155406639|NCT03865706|560923470|FG001|Overall Study|Death|3|||
155406640|NCT03865706|560923471|FG002|Overall Study|Death|1|||
155406641|NCT02646982|560923472|FG000|Overall Study|Adverse Event|1|||
155406642|NCT02646982|560923473|FG001|Overall Study|Adverse Event|1|||
155406643|NCT02646982|560923472|FG000|Overall Study|Withdrawal by Subject|2|||
155406644|NCT02646982|560923473|FG001|Overall Study|Withdrawal by Subject|1|||
155406645|NCT02095535|560923474|FG000|Recruitment|Protocol Violation|2|||
155406646|NCT00769002|560923475|FG000|Overall Study|Study was not completed, no data|9|||
155406647|NCT00769002|560923476|FG001|Overall Study|Study was not completed, no data|9|||
155406648|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
155406649|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
155406650|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
155406651|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
155406652|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
155406653|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
155406654|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
155406655|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
155406656|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
155406657|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
155406658|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
155406659|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
155406660|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
155406661|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
155406662|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
155406663|NCT00960661|560923477|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
155406664|NCT00960661|560923478|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
155742834|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155742835|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
155742836|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
155742837|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
155742838|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
155742839|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
155742840|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
155742841|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
155742842|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
155742843|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
155742844|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|Other|0|||
155742845|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|Other|0|||
155742846|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|Other|1|||
155742847|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|Other|1|||
155742848|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|Other|0|||
155742849|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|Other|0|||
155742850|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|Other|0|||
155742851|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|Other|1|||
155742852|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|Other|0|||
155742853|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|Death|0|||
155742854|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|Death|0|||
155742855|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|Death|0|||
155742856|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|Death|0|||
155742857|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|Death|0|||
155742858|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|Death|1|||
155742859|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|Death|0|||
155286680|NCT01018511|560482340|FG000|Overall Study|Protocol Violation|5|||
155637898|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
155637899|NCT01069939|561764866|FG000|Randomised and Included in the Analyses|Removal|1|||
155637900|NCT01069939|561764867|FG001|Randomised and Included in the Analyses|Removal|0|||
155637901|NCT00724945|561764868|FG000|Period 1|non-compliance|1|||
155637902|NCT00724945|561764869|FG001|Period 1|non-compliance|0|||
155637903|NCT00724945|561764868|FG000|Period 1|Adverse Event|1|||
155637904|NCT00724945|561764869|FG001|Period 1|Adverse Event|1|||
155637905|NCT00724945|561764868|FG000|Period 1|Lost to Follow-up|1|||
155637906|NCT00724945|561764869|FG001|Period 1|Lost to Follow-up|0|||
155637907|NCT00724945|561764868|FG000|Period 2|lens comfort issue|3|||
155637908|NCT00724945|561764869|FG001|Period 2|lens comfort issue|0|||
155637909|NCT00724945|561764868|FG000|Period 2|lens physiology issue|1|||
155637910|NCT00724945|561764869|FG001|Period 2|lens physiology issue|0|||
155637911|NCT05166876|561764870|FG000|Overall Study|Withdrawal by Subject|1|||
155637912|NCT05166876|561764871|FG001|Overall Study|Withdrawal by Subject|0|||
155637913|NCT05166876|561764872|FG002|Overall Study|Withdrawal by Subject|0|||
155637914|NCT00658528|561764873|FG000|Overall Study|Adverse Event|5|||
155637915|NCT00658528|561764874|FG001|Overall Study|Adverse Event|7|||
155637916|NCT00658528|561764873|FG000|Overall Study|Lost to Follow-up|14|||
155637917|NCT00658528|561764874|FG001|Overall Study|Lost to Follow-up|22|||
155637918|NCT00658528|561764873|FG000|Overall Study|Withdrawal by Subject|8|||
155637919|NCT00658528|561764874|FG001|Overall Study|Withdrawal by Subject|6|||
155637920|NCT00658528|561764873|FG000|Overall Study|Withdrawal of consent|5|||
155637921|NCT00658528|561764874|FG001|Overall Study|Withdrawal of consent|6|||
155637922|NCT00658528|561764873|FG000|Overall Study|Other|8|||
155637923|NCT00658528|561764874|FG001|Overall Study|Other|4|||
155637924|NCT01147458|561764881|FG000|First Intervention|Study terminated by sponsor|8|||
155637925|NCT01147458|561764882|FG001|First Intervention|Study terminated by sponsor|8|||
155637926|NCT01147458|561764883|FG002|First Intervention|Study terminated by sponsor|7|||
155637927|NCT01147458|561764884|FG003|First Intervention|Study terminated by sponsor|8|||
155637928|NCT01147458|561764881|FG000|First Intervention|Protocol Violation|2|||
155637929|NCT01147458|561764882|FG001|First Intervention|Protocol Violation|3|||
155637930|NCT01147458|561764883|FG002|First Intervention|Protocol Violation|2|||
155637931|NCT01147458|561764884|FG003|First Intervention|Protocol Violation|3|||
155637932|NCT01147458|561764881|FG000|First Intervention|Withdrawal by Subject|3|||
155637933|NCT01147458|561764882|FG001|First Intervention|Withdrawal by Subject|0|||
155637934|NCT01147458|561764883|FG002|First Intervention|Withdrawal by Subject|1|||
155637935|NCT01147458|561764884|FG003|First Intervention|Withdrawal by Subject|0|||
155637936|NCT01147458|561764881|FG000|First Intervention|Adverse Event|0|||
155637937|NCT01147458|561764882|FG001|First Intervention|Adverse Event|3|||
155637938|NCT01147458|561764883|FG002|First Intervention|Adverse Event|2|||
155637939|NCT01147458|561764884|FG003|First Intervention|Adverse Event|3|||
155637940|NCT01147458|561764881|FG000|First Intervention|Other|1|||
155742860|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|Death|0|||
155286681|NCT01018511|560482341|FG001|Overall Study|Protocol Violation|8|||
155286682|NCT01018511|560482342|FG002|Overall Study|Protocol Violation|7|||
155286683|NCT01018511|560482343|FG003|Overall Study|Protocol Violation|9|||
155286684|NCT01018511|560482340|FG000|Overall Study|Miscellaneous|0|||
155286685|NCT01018511|560482341|FG001|Overall Study|Miscellaneous|2|||
155286686|NCT01018511|560482342|FG002|Overall Study|Miscellaneous|0|||
155286687|NCT01018511|560482343|FG003|Overall Study|Miscellaneous|0|||
155286688|NCT00654238|560482344|FG000|Overall Study|Screen Failures|4|||
155286689|NCT04523181|560482346|FG000|Overall Study|Withdrawal by Subject|4|||
155286690|NCT04523181|560482347|FG001|Overall Study|Withdrawal by Subject|5|||
155286691|NCT04523181|560482346|FG000|Overall Study|Lost to Follow-up|2|||
155286692|NCT04523181|560482347|FG001|Overall Study|Lost to Follow-up|3|||
155286693|NCT04523181|560482346|FG000|Overall Study|Physician Decision|1|||
155286694|NCT04523181|560482347|FG001|Overall Study|Physician Decision|0|||
155286695|NCT04523181|560482346|FG000|Overall Study|Transferred to external facility.|1|||
155286696|NCT04523181|560482347|FG001|Overall Study|Transferred to external facility.|1|||
155286697|NCT01559090|560482352|FG000|Stage I|Withdrawal by Subject|2|||
155286698|NCT01559090|560482353|FG001|Stage I|Withdrawal by Subject|2|||
155286699|NCT01559090|560482354|FG002|Stage I|Withdrawal by Subject|3|||
155286700|NCT01559090|560482352|FG000|Stage II|Withdrawal by Subject|1|||
155286701|NCT01559090|560482353|FG001|Stage II|Withdrawal by Subject|0|||
155286702|NCT01559090|560482354|FG002|Stage II|Withdrawal by Subject|0|||
155286703|NCT01729871|560482357|FG000|Overall Study|Adverse Event|7|||
155286704|NCT01729871|560482358|FG001|Overall Study|Adverse Event|7|||
155286705|NCT01729871|560482357|FG000|Overall Study|Death|0|||
155286706|NCT01729871|560482358|FG001|Overall Study|Death|1|||
155286707|NCT01729871|560482357|FG000|Overall Study|Lack of Efficacy|0|||
155286708|NCT01729871|560482358|FG001|Overall Study|Lack of Efficacy|1|||
155286709|NCT01729871|560482357|FG000|Overall Study|Physician Decision|0|||
155286710|NCT01729871|560482358|FG001|Overall Study|Physician Decision|2|||
155286711|NCT01729871|560482357|FG000|Overall Study|Protocol Violation|1|||
155286712|NCT01729871|560482358|FG001|Overall Study|Protocol Violation|0|||
155286713|NCT01729871|560482357|FG000|Overall Study|Withdrawal by Subject|0|||
155286714|NCT01729871|560482358|FG001|Overall Study|Withdrawal by Subject|3|||
155286715|NCT01729871|560482357|FG000|Overall Study|Other|4|||
155286716|NCT01729871|560482358|FG001|Overall Study|Other|9|||
155286717|NCT01143077|560482359|FG000|Overall Study|Lack of Efficacy|0|||
155286718|NCT01143077|560482360|FG001|Overall Study|Lack of Efficacy|2|||
155286719|NCT01143077|560482361|FG002|Overall Study|Lack of Efficacy|1|||
155286720|NCT01143077|560482359|FG000|Overall Study|Adverse Event|5|||
155286721|NCT01143077|560482360|FG001|Overall Study|Adverse Event|6|||
155286722|NCT01143077|560482361|FG002|Overall Study|Adverse Event|5|||
155286723|NCT01143077|560482359|FG000|Overall Study|Lost to Follow-up|2|||
155286724|NCT01143077|560482360|FG001|Overall Study|Lost to Follow-up|3|||
155286725|NCT01143077|560482361|FG002|Overall Study|Lost to Follow-up|4|||
155286726|NCT01143077|560482359|FG000|Overall Study|Protocol Violation|2|||
155286727|NCT01143077|560482360|FG001|Overall Study|Protocol Violation|0|||
155286728|NCT01143077|560482361|FG002|Overall Study|Protocol Violation|0|||
155286729|NCT01143077|560482359|FG000|Overall Study|Withdrawal by Subject|4|||
155286730|NCT01143077|560482360|FG001|Overall Study|Withdrawal by Subject|3|||
155286731|NCT01143077|560482361|FG002|Overall Study|Withdrawal by Subject|3|||
155286732|NCT01143077|560482359|FG000|Overall Study|Non-compliance with study drug|0|||
155286733|NCT01143077|560482360|FG001|Overall Study|Non-compliance with study drug|1|||
155286734|NCT01143077|560482361|FG002|Overall Study|Non-compliance with study drug|1|||
155286735|NCT01143077|560482359|FG000|Overall Study|Administrative|1|||
155286736|NCT01143077|560482360|FG001|Overall Study|Administrative|0|||
155286737|NCT01143077|560482361|FG002|Overall Study|Administrative|0|||
155286738|NCT01143077|560482359|FG000|Overall Study|Principal Investigator Decision|2|||
155286739|NCT01143077|560482360|FG001|Overall Study|Principal Investigator Decision|0|||
155286740|NCT01143077|560482361|FG002|Overall Study|Principal Investigator Decision|1|||
155286741|NCT00836810|560482362|FG000|Overall Study|New diagnosis|1|||
155286742|NCT00836810|560482363|FG001|Overall Study|New diagnosis|0|||
155286743|NCT01772719|560482365|FG000|Overall Study|Withdrawal by Subject|3|||
155286744|NCT01772719|560482365|FG000|Overall Study|Adverse Event|2|||
155286745|NCT01772719|560482365|FG000|Overall Study|Protocol Violation|1|||
155286746|NCT01772719|560482365|FG000|Overall Study|Lost to Follow-up|1|||
155286747|NCT02014558|560482370|FG000|Overall Study|Never Received Study Drug|0|||
155286748|NCT02014558|560482371|FG001|Overall Study|Never Received Study Drug|0|||
155286749|NCT02014558|560482372|FG002|Overall Study|Never Received Study Drug|0|||
155286750|NCT02014558|560482373|FG003|Overall Study|Never Received Study Drug|0|||
155637941|NCT01147458|561764882|FG001|First Intervention|Other|2|||
155286751|NCT02014558|560482374|FG004|Overall Study|Never Received Study Drug|1|||
155286752|NCT02014558|560482375|FG005|Overall Study|Never Received Study Drug|0|||
155637942|NCT01147458|561764883|FG002|First Intervention|Other|0|||
155637943|NCT01147458|561764884|FG003|First Intervention|Other|0|||
155637944|NCT01147458|561764881|FG000|Second Intervention|Study terminated by sponsor|7|||
155637945|NCT01147458|561764882|FG001|Second Intervention|Study terminated by sponsor|5|||
155637946|NCT01147458|561764883|FG002|Second Intervention|Study terminated by sponsor|5|||
155637947|NCT01147458|561764884|FG003|Second Intervention|Study terminated by sponsor|3|||
155286753|NCT02014558|560482376|FG006|Overall Study|Never Received Study Drug|1|||
155286754|NCT02014558|560482377|FG007|Overall Study|Never Received Study Drug|0|||
155286755|NCT02014558|560482378|FG008|Overall Study|Never Received Study Drug|2|||
155286756|NCT02014558|560482379|FG009|Overall Study|Never Received Study Drug|0|||
155286757|NCT02014558|560482380|FG010|Overall Study|Never Received Study Drug|2|||
155286758|NCT02014558|560482381|FG011|Overall Study|Never Received Study Drug|2|||
155286759|NCT02014558|560482382|FG012|Overall Study|Never Received Study Drug|0|||
155286760|NCT02014558|560482370|FG000|Overall Study|Adverse Event|0|||
155286761|NCT02014558|560482371|FG001|Overall Study|Adverse Event|0|||
155286762|NCT02014558|560482372|FG002|Overall Study|Adverse Event|0|||
155286763|NCT02014558|560482373|FG003|Overall Study|Adverse Event|0|||
155286764|NCT02014558|560482374|FG004|Overall Study|Adverse Event|1|||
155286765|NCT02014558|560482375|FG005|Overall Study|Adverse Event|0|||
155286766|NCT02014558|560482376|FG006|Overall Study|Adverse Event|0|||
155286767|NCT02014558|560482377|FG007|Overall Study|Adverse Event|0|||
155286768|NCT02014558|560482378|FG008|Overall Study|Adverse Event|2|||
155286769|NCT02014558|560482379|FG009|Overall Study|Adverse Event|2|||
155286770|NCT02014558|560482380|FG010|Overall Study|Adverse Event|5|||
155286771|NCT02014558|560482381|FG011|Overall Study|Adverse Event|21|||
155286772|NCT02014558|560482382|FG012|Overall Study|Adverse Event|3|||
155286773|NCT02014558|560482370|FG000|Overall Study|Death|1|||
155286774|NCT02014558|560482371|FG001|Overall Study|Death|0|||
155286775|NCT02014558|560482372|FG002|Overall Study|Death|0|||
155286776|NCT02014558|560482373|FG003|Overall Study|Death|0|||
155286777|NCT02014558|560482374|FG004|Overall Study|Death|0|||
155286778|NCT02014558|560482375|FG005|Overall Study|Death|0|||
155286779|NCT02014558|560482376|FG006|Overall Study|Death|1|||
155286780|NCT02014558|560482377|FG007|Overall Study|Death|1|||
155286781|NCT02014558|560482378|FG008|Overall Study|Death|2|||
155286782|NCT02014558|560482379|FG009|Overall Study|Death|5|||
155286783|NCT02014558|560482380|FG010|Overall Study|Death|5|||
155286784|NCT02014558|560482381|FG011|Overall Study|Death|19|||
155286785|NCT02014558|560482382|FG012|Overall Study|Death|2|||
155286786|NCT02014558|560482370|FG000|Overall Study|Lack of Efficacy|1|||
155286787|NCT02014558|560482371|FG001|Overall Study|Lack of Efficacy|2|||
155286788|NCT02014558|560482372|FG002|Overall Study|Lack of Efficacy|1|||
155286789|NCT02014558|560482373|FG003|Overall Study|Lack of Efficacy|1|||
155286790|NCT02014558|560482374|FG004|Overall Study|Lack of Efficacy|0|||
155286791|NCT02014558|560482375|FG005|Overall Study|Lack of Efficacy|0|||
155286792|NCT02014558|560482376|FG006|Overall Study|Lack of Efficacy|1|||
155286793|NCT02014558|560482377|FG007|Overall Study|Lack of Efficacy|3|||
155286794|NCT02014558|560482378|FG008|Overall Study|Lack of Efficacy|3|||
155286795|NCT02014558|560482379|FG009|Overall Study|Lack of Efficacy|3|||
155286796|NCT02014558|560482380|FG010|Overall Study|Lack of Efficacy|16|||
155286797|NCT02014558|560482381|FG011|Overall Study|Lack of Efficacy|8|||
155286798|NCT02014558|560482382|FG012|Overall Study|Lack of Efficacy|5|||
155286799|NCT02014558|560482370|FG000|Overall Study|Lost to Follow-up|0|||
155286800|NCT02014558|560482371|FG001|Overall Study|Lost to Follow-up|0|||
155286801|NCT02014558|560482372|FG002|Overall Study|Lost to Follow-up|0|||
155286802|NCT02014558|560482373|FG003|Overall Study|Lost to Follow-up|0|||
155286803|NCT02014558|560482374|FG004|Overall Study|Lost to Follow-up|0|||
155286804|NCT02014558|560482375|FG005|Overall Study|Lost to Follow-up|0|||
155286805|NCT02014558|560482376|FG006|Overall Study|Lost to Follow-up|0|||
155286806|NCT02014558|560482377|FG007|Overall Study|Lost to Follow-up|0|||
155286807|NCT02014558|560482378|FG008|Overall Study|Lost to Follow-up|0|||
155286808|NCT02014558|560482379|FG009|Overall Study|Lost to Follow-up|0|||
155286809|NCT02014558|560482380|FG010|Overall Study|Lost to Follow-up|1|||
155286810|NCT02014558|560482381|FG011|Overall Study|Lost to Follow-up|0|||
155286811|NCT02014558|560482382|FG012|Overall Study|Lost to Follow-up|0|||
155286812|NCT02014558|560482370|FG000|Overall Study|Progressive Disease|1|||
155286813|NCT02014558|560482371|FG001|Overall Study|Progressive Disease|0|||
155637948|NCT01147458|561764881|FG000|Second Intervention|Protocol Violation|0|||
155637949|NCT01147458|561764882|FG001|Second Intervention|Protocol Violation|1|||
155286814|NCT02014558|560482372|FG002|Overall Study|Progressive Disease|1|||
155286815|NCT02014558|560482373|FG003|Overall Study|Progressive Disease|1|||
155286816|NCT02014558|560482374|FG004|Overall Study|Progressive Disease|1|||
155637950|NCT01147458|561764883|FG002|Second Intervention|Protocol Violation|1|||
155286817|NCT02014558|560482375|FG005|Overall Study|Progressive Disease|2|||
155286818|NCT02014558|560482376|FG006|Overall Study|Progressive Disease|1|||
155286819|NCT02014558|560482377|FG007|Overall Study|Progressive Disease|6|||
155286820|NCT02014558|560482378|FG008|Overall Study|Progressive Disease|5|||
155286821|NCT02014558|560482379|FG009|Overall Study|Progressive Disease|6|||
155286822|NCT02014558|560482380|FG010|Overall Study|Progressive Disease|22|||
155286823|NCT02014558|560482381|FG011|Overall Study|Progressive Disease|31|||
155286824|NCT02014558|560482382|FG012|Overall Study|Progressive Disease|6|||
155286825|NCT02014558|560482370|FG000|Overall Study|Withdrawal by Subject|0|||
155286826|NCT02014558|560482371|FG001|Overall Study|Withdrawal by Subject|0|||
155286827|NCT02014558|560482372|FG002|Overall Study|Withdrawal by Subject|0|||
155286828|NCT02014558|560482373|FG003|Overall Study|Withdrawal by Subject|0|||
155286829|NCT02014558|560482374|FG004|Overall Study|Withdrawal by Subject|1|||
155286830|NCT02014558|560482375|FG005|Overall Study|Withdrawal by Subject|0|||
155286831|NCT02014558|560482376|FG006|Overall Study|Withdrawal by Subject|0|||
155286832|NCT02014558|560482377|FG007|Overall Study|Withdrawal by Subject|0|||
155286833|NCT02014558|560482378|FG008|Overall Study|Withdrawal by Subject|0|||
155286834|NCT02014558|560482379|FG009|Overall Study|Withdrawal by Subject|2|||
155286835|NCT02014558|560482380|FG010|Overall Study|Withdrawal by Subject|6|||
155286836|NCT02014558|560482381|FG011|Overall Study|Withdrawal by Subject|10|||
155286837|NCT02014558|560482382|FG012|Overall Study|Withdrawal by Subject|0|||
155286838|NCT02014558|560482370|FG000|Overall Study|Miscellaneous|2|||
155286839|NCT02014558|560482371|FG001|Overall Study|Miscellaneous|1|||
155286840|NCT02014558|560482372|FG002|Overall Study|Miscellaneous|1|||
155286841|NCT02014558|560482373|FG003|Overall Study|Miscellaneous|1|||
155286842|NCT02014558|560482374|FG004|Overall Study|Miscellaneous|0|||
155286843|NCT02014558|560482375|FG005|Overall Study|Miscellaneous|1|||
155286844|NCT02014558|560482376|FG006|Overall Study|Miscellaneous|0|||
155286845|NCT02014558|560482377|FG007|Overall Study|Miscellaneous|1|||
155286846|NCT02014558|560482378|FG008|Overall Study|Miscellaneous|1|||
155286847|NCT02014558|560482379|FG009|Overall Study|Miscellaneous|3|||
155286848|NCT02014558|560482380|FG010|Overall Study|Miscellaneous|12|||
155286849|NCT02014558|560482381|FG011|Overall Study|Miscellaneous|11|||
155286850|NCT02014558|560482382|FG012|Overall Study|Miscellaneous|1|||
155286851|NCT02931396|560482385|FG000|Overall Study|Lost to Follow-up|3|||
155286852|NCT02931396|560482386|FG001|Overall Study|Lost to Follow-up|0|||
155286853|NCT02931396|560482385|FG000|Overall Study|Withdrawal by Subject|2|||
155286854|NCT02931396|560482386|FG001|Overall Study|Withdrawal by Subject|0|||
155286855|NCT05273801|560482387|FG000|Overall Study|Physician Decision|1|||
155286856|NCT04159506|560482388|FG000|Overall Study|Lost to Follow-up|2|||
155286857|NCT04159506|560482389|FG001|Overall Study|Lost to Follow-up|5|||
155286858|NCT03227757|560484190|FG000|Overall Study|Death|25|||
155286859|NCT03227757|560484190|FG000|Overall Study|Withdrawal|10|||
155286860|NCT03227757|560484190|FG000|Overall Study|Missed visits|1|||
155286861|NCT03227757|560484190|FG000|Overall Study|Lost to Follow-up|2|||
155286862|NCT01144468|560484191|FG000|Overall Study|Lost to Follow-up|4|||
155286863|NCT01144468|560484192|FG001|Overall Study|Lost to Follow-up|7|||
155286864|NCT01144468|560484191|FG000|Overall Study|Adverse Event|3|||
155286865|NCT01144468|560484192|FG001|Overall Study|Adverse Event|2|||
155286866|NCT01144468|560484191|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
155286867|NCT01144468|560484192|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
155286868|NCT02960659|560484193|FG000|Overall Study|Withdrawal by Subject|1|||
155286869|NCT02960659|560484194|FG001|Overall Study|Withdrawal by Subject|0|||
155286870|NCT02960659|560484193|FG000|Overall Study|Poor compliance|0|||
155286871|NCT02960659|560484194|FG001|Overall Study|Poor compliance|1|||
155286872|NCT04199728|560484198|FG000|Overall Study|Adverse Event|1|||
155286873|NCT04199728|560484199|FG001|Overall Study|Adverse Event|0|||
155286874|NCT04199728|560484198|FG000|Overall Study|Withdrawal by Subject|8|||
155286875|NCT04199728|560484199|FG001|Overall Study|Withdrawal by Subject|3|||
155286876|NCT04199728|560484198|FG000|Overall Study|Screen fail after consent|0|||
155286877|NCT04199728|560484199|FG001|Overall Study|Screen fail after consent|1|||
155286878|NCT04199728|560484198|FG000|Overall Study|Early withdraw criteria met|0|||
155286879|NCT04199728|560484199|FG001|Overall Study|Early withdraw criteria met|1|||
155286880|NCT04199728|560484198|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
155286881|NCT04199728|560484199|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
155286882|NCT03068468|560484200|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
155286883|NCT03068468|560484201|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
155286884|NCT03068468|560484202|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
155286885|NCT03068468|560484203|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
155406665|NCT00960661|560923479|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
155406666|NCT00960661|560923477|FG000|Interventional Phase|Adverse Event|0|||
155406667|NCT00960661|560923478|FG001|Interventional Phase|Adverse Event|17|||
155286886|NCT03068468|560484200|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
155286887|NCT03068468|560484201|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
155286888|NCT03068468|560484202|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
155286889|NCT03068468|560484203|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
155286890|NCT03068468|560484200|FG000|Placebo-Controlled Period|Adverse Event|16|||
155286891|NCT03068468|560484201|FG001|Placebo-Controlled Period|Adverse Event|21|||
155286892|NCT03068468|560484202|FG002|Placebo-Controlled Period|Adverse Event|0|||
155286893|NCT03068468|560484203|FG003|Placebo-Controlled Period|Adverse Event|0|||
155286894|NCT03068468|560484200|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
155286895|NCT03068468|560484201|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
155286896|NCT03068468|560484202|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
155286897|NCT03068468|560484203|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
155286898|NCT03068468|560484200|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155286899|NCT03068468|560484201|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
155286900|NCT03068468|560484202|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155637951|NCT01147458|561764884|FG003|Second Intervention|Protocol Violation|0|||
155637952|NCT01147458|561764881|FG000|Second Intervention|Withdrawal by Subject|0|||
155286901|NCT03068468|560484203|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155286902|NCT03068468|560484200|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
155286903|NCT03068468|560484201|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
155286904|NCT03068468|560484202|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
155286905|NCT03068468|560484203|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
155286906|NCT03068468|560484200|FG000|Placebo-Controlled Period|Death|0|||
155286907|NCT03068468|560484201|FG001|Placebo-Controlled Period|Death|1|||
155286908|NCT03068468|560484202|FG002|Placebo-Controlled Period|Death|0|||
155286909|NCT03068468|560484203|FG003|Placebo-Controlled Period|Death|0|||
155286910|NCT03068468|560484200|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
155286911|NCT03068468|560484201|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
155286912|NCT03068468|560484202|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
155286913|NCT03068468|560484203|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
155286914|NCT03068468|560484200|FG000|Open-Label Extension Period|Adverse Event|0|||
155286915|NCT03068468|560484201|FG001|Open-Label Extension Period|Adverse Event|0|||
155286916|NCT03068468|560484202|FG002|Open-Label Extension Period|Adverse Event|13|||
155286917|NCT03068468|560484203|FG003|Open-Label Extension Period|Adverse Event|17|||
155286918|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
155286919|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
155286920|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
155286921|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
155286922|NCT03068468|560484200|FG000|Open-Label Extension Period|Death|0|||
155286923|NCT03068468|560484201|FG001|Open-Label Extension Period|Death|0|||
155286924|NCT03068468|560484202|FG002|Open-Label Extension Period|Death|0|||
155286925|NCT03068468|560484203|FG003|Open-Label Extension Period|Death|1|||
155286926|NCT03068468|560484200|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
155286927|NCT03068468|560484201|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
155286928|NCT03068468|560484202|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
155286929|NCT03068468|560484203|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
155286930|NCT03068468|560484200|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286931|NCT03068468|560484201|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286932|NCT03068468|560484202|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
155286933|NCT03068468|560484203|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286934|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
155286935|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
155286936|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
155286937|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
155286938|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286939|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286940|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286941|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
155286942|NCT03068468|560484200|FG000|Open-Label Extension Period|Reason not Specified|0|||
155286943|NCT03068468|560484201|FG001|Open-Label Extension Period|Reason not Specified|0|||
155286944|NCT03068468|560484202|FG002|Open-Label Extension Period|Reason not Specified|1|||
155286945|NCT03068468|560484203|FG003|Open-Label Extension Period|Reason not Specified|4|||
155286946|NCT03181958|560484205|FG000|Overall Study|Lost to Follow-up|17|||
155286947|NCT03181958|560484206|FG001|Overall Study|Lost to Follow-up|21|||
155286948|NCT03181958|560484207|FG002|Overall Study|Lost to Follow-up|15|||
155286949|NCT01268891|560484213|FG000|Overall Study|Adverse Event|3|||
155286950|NCT01268891|560484214|FG001|Overall Study|Adverse Event|7|||
155286951|NCT01268891|560484213|FG000|Overall Study|Lack of Efficacy|1|||
155286952|NCT01268891|560484214|FG001|Overall Study|Lack of Efficacy|0|||
155286953|NCT01268891|560484213|FG000|Overall Study|Withdrawal of Consent|3|||
155406668|NCT00960661|560923479|FG002|Interventional Phase|Adverse Event|8|||
155406669|NCT00960661|560923477|FG000|Interventional Phase|Death|0|||
155286954|NCT01268891|560484214|FG001|Overall Study|Withdrawal of Consent|1|||
155286955|NCT01268891|560484213|FG000|Overall Study|Administrative or other reason(s)|1|||
155286956|NCT01268891|560484214|FG001|Overall Study|Administrative or other reason(s)|0|||
155286957|NCT00991276|560484216|FG000|First Intervention Period|Adverse Event|0|||
155286958|NCT00991276|560484217|FG001|First Intervention Period|Adverse Event|1|||
155286959|NCT00991276|560484218|FG002|First Intervention Period|Adverse Event|0|||
155286960|NCT00991276|560484219|FG003|First Intervention Period|Adverse Event|1|||
155286961|NCT00991276|560484220|FG004|First Intervention Period|Adverse Event|0|||
155286962|NCT00991276|560484221|FG005|First Intervention Period|Adverse Event|0|||
155286963|NCT00991276|560484216|FG000|First Intervention Period|Protocol Violation|0|||
155286964|NCT00991276|560484217|FG001|First Intervention Period|Protocol Violation|0|||
155286965|NCT00991276|560484218|FG002|First Intervention Period|Protocol Violation|0|||
155286966|NCT00991276|560484219|FG003|First Intervention Period|Protocol Violation|0|||
155286967|NCT00991276|560484220|FG004|First Intervention Period|Protocol Violation|2|||
155286968|NCT00991276|560484221|FG005|First Intervention Period|Protocol Violation|0|||
155286969|NCT00991276|560484216|FG000|First Intervention Period|Insufficient clinical response|0|||
155286970|NCT00991276|560484217|FG001|First Intervention Period|Insufficient clinical response|0|||
155286971|NCT00991276|560484218|FG002|First Intervention Period|Insufficient clinical response|0|||
155286972|NCT00991276|560484219|FG003|First Intervention Period|Insufficient clinical response|0|||
155286973|NCT00991276|560484220|FG004|First Intervention Period|Insufficient clinical response|1|||
155286974|NCT00991276|560484221|FG005|First Intervention Period|Insufficient clinical response|0|||
155286975|NCT00991276|560484216|FG000|First Intervention Period|Other|0|||
155286976|NCT00991276|560484217|FG001|First Intervention Period|Other|0|||
155286977|NCT00991276|560484218|FG002|First Intervention Period|Other|0|||
155286978|NCT00991276|560484219|FG003|First Intervention Period|Other|1|||
155286979|NCT00991276|560484220|FG004|First Intervention Period|Other|1|||
155286980|NCT00991276|560484221|FG005|First Intervention Period|Other|0|||
155286981|NCT00991276|560484216|FG000|First Intervention Period|Withdrawal by Subject|0|||
155286982|NCT00991276|560484217|FG001|First Intervention Period|Withdrawal by Subject|1|||
155286983|NCT00991276|560484218|FG002|First Intervention Period|Withdrawal by Subject|0|||
155286984|NCT00991276|560484219|FG003|First Intervention Period|Withdrawal by Subject|1|||
155286985|NCT00991276|560484220|FG004|First Intervention Period|Withdrawal by Subject|0|||
155286986|NCT00991276|560484221|FG005|First Intervention Period|Withdrawal by Subject|1|||
155286987|NCT00991276|560484216|FG000|First Intervention Period|Lost to Follow-up|0|||
155286988|NCT00991276|560484217|FG001|First Intervention Period|Lost to Follow-up|1|||
155286989|NCT00991276|560484218|FG002|First Intervention Period|Lost to Follow-up|0|||
155286990|NCT00991276|560484219|FG003|First Intervention Period|Lost to Follow-up|1|||
155286991|NCT00991276|560484220|FG004|First Intervention Period|Lost to Follow-up|0|||
155286992|NCT00991276|560484221|FG005|First Intervention Period|Lost to Follow-up|0|||
155286993|NCT00991276|560484216|FG000|Second Intervention Period|Adverse Event|0|||
155286994|NCT00991276|560484217|FG001|Second Intervention Period|Adverse Event|2|||
155286995|NCT00991276|560484218|FG002|Second Intervention Period|Adverse Event|0|||
155286996|NCT00991276|560484219|FG003|Second Intervention Period|Adverse Event|1|||
155286997|NCT00991276|560484220|FG004|Second Intervention Period|Adverse Event|1|||
155286998|NCT00991276|560484221|FG005|Second Intervention Period|Adverse Event|0|||
155286999|NCT00991276|560484216|FG000|Second Intervention Period|Protocol Violation|1|||
155287000|NCT00991276|560484217|FG001|Second Intervention Period|Protocol Violation|0|||
155287001|NCT00991276|560484218|FG002|Second Intervention Period|Protocol Violation|0|||
155287002|NCT00991276|560484219|FG003|Second Intervention Period|Protocol Violation|0|||
155287003|NCT00991276|560484220|FG004|Second Intervention Period|Protocol Violation|0|||
155287004|NCT00991276|560484221|FG005|Second Intervention Period|Protocol Violation|0|||
155287005|NCT00991276|560484216|FG000|Second Intervention Period|Other|0|||
155287006|NCT00991276|560484217|FG001|Second Intervention Period|Other|0|||
155287007|NCT00991276|560484218|FG002|Second Intervention Period|Other|0|||
155287008|NCT00991276|560484219|FG003|Second Intervention Period|Other|1|||
155287009|NCT00991276|560484220|FG004|Second Intervention Period|Other|0|||
155287010|NCT00991276|560484221|FG005|Second Intervention Period|Other|1|||
155406670|NCT00960661|560923478|FG001|Interventional Phase|Death|1|||
155406671|NCT00960661|560923479|FG002|Interventional Phase|Death|0|||
155406672|NCT00960661|560923477|FG000|Interventional Phase|Lost to Follow-up|0|||
155406673|NCT00960661|560923478|FG001|Interventional Phase|Lost to Follow-up|0|||
155406674|NCT00960661|560923479|FG002|Interventional Phase|Lost to Follow-up|2|||
155406675|NCT00960661|560923477|FG000|Interventional Phase|entry criteria not met|0|||
155406676|NCT00960661|560923478|FG001|Interventional Phase|entry criteria not met|3|||
155406677|NCT00960661|560923479|FG002|Interventional Phase|entry criteria not met|0|||
155406678|NCT00960661|560923477|FG000|Interventional Phase|Protocol Violation|0|||
155406679|NCT00960661|560923478|FG001|Interventional Phase|Protocol Violation|7|||
155406680|NCT00960661|560923479|FG002|Interventional Phase|Protocol Violation|2|||
155406681|NCT00960661|560923477|FG000|Interventional Phase|Withdrawal by Subject|0|||
155406682|NCT00960661|560923478|FG001|Interventional Phase|Withdrawal by Subject|18|||
155406683|NCT00960661|560923479|FG002|Interventional Phase|Withdrawal by Subject|29|||
155406684|NCT00960661|560923477|FG000|Interventional Phase|Physician Decision|0|||
155287011|NCT00991276|560484216|FG000|Third Intervention Period|Protocol Violation|1|||
155287012|NCT00991276|560484217|FG001|Third Intervention Period|Protocol Violation|0|||
155287013|NCT00991276|560484218|FG002|Third Intervention Period|Protocol Violation|0|||
155287014|NCT00991276|560484219|FG003|Third Intervention Period|Protocol Violation|0|||
155287015|NCT00991276|560484220|FG004|Third Intervention Period|Protocol Violation|0|||
155287016|NCT00991276|560484221|FG005|Third Intervention Period|Protocol Violation|0|||
155287017|NCT00991276|560484216|FG000|Third Intervention Period|Other|0|||
155287018|NCT00991276|560484217|FG001|Third Intervention Period|Other|0|||
155287019|NCT00991276|560484218|FG002|Third Intervention Period|Other|0|||
155287020|NCT00991276|560484219|FG003|Third Intervention Period|Other|0|||
155287021|NCT00991276|560484220|FG004|Third Intervention Period|Other|0|||
155406685|NCT00960661|560923478|FG001|Interventional Phase|Physician Decision|3|||
155287022|NCT00991276|560484221|FG005|Third Intervention Period|Other|1|||
155287023|NCT00991276|560484216|FG000|Third Intervention Period|Adverse Event|0|||
155287024|NCT00991276|560484217|FG001|Third Intervention Period|Adverse Event|0|||
155287025|NCT00991276|560484218|FG002|Third Intervention Period|Adverse Event|1|||
155287026|NCT00991276|560484219|FG003|Third Intervention Period|Adverse Event|0|||
155287027|NCT00991276|560484220|FG004|Third Intervention Period|Adverse Event|0|||
155287028|NCT00991276|560484221|FG005|Third Intervention Period|Adverse Event|0|||
155287029|NCT00991276|560484216|FG000|Third Intervention Period|Withdrawal by Subject|0|||
155287030|NCT00991276|560484217|FG001|Third Intervention Period|Withdrawal by Subject|0|||
155287031|NCT00991276|560484218|FG002|Third Intervention Period|Withdrawal by Subject|0|||
155287032|NCT00991276|560484219|FG003|Third Intervention Period|Withdrawal by Subject|1|||
155287033|NCT00991276|560484220|FG004|Third Intervention Period|Withdrawal by Subject|0|||
155287034|NCT00991276|560484221|FG005|Third Intervention Period|Withdrawal by Subject|0|||
155287035|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
155287036|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287037|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287038|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287039|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Adverse Event|198|||
155287040|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Adverse Event|0|||
155287041|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Adverse Event|0|||
155287042|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Adverse Event|0|||
155287043|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Death|62|||
155287044|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Death|0|||
155287045|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Death|0|||
155287046|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Death|0|||
155287047|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
155287048|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287049|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287050|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287051|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Complicating disease|13|||
155287052|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Complicating disease|0|||
155287053|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Complicating disease|0|||
155287054|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Complicating disease|0|||
155287055|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
155287056|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
155287057|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
155287058|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
155287059|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
155287060|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287061|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287062|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287063|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Non-compliance|4|||
155287064|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Non-compliance|0|||
155287065|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Non-compliance|0|||
155287066|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Non-compliance|0|||
155287067|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Pain|4|||
155287068|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Pain|0|||
155287069|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Pain|0|||
155287070|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Pain|0|||
155287071|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
155287072|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
155287073|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
155287074|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
155287075|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Hospice care|1|||
155287076|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Hospice care|0|||
155287077|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Hospice care|0|||
155406686|NCT00960661|560923479|FG002|Interventional Phase|Physician Decision|5|||
155406687|NCT00960661|560923477|FG000|Interventional Phase|sponsor decision|0|||
155742861|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|Death|0|||
155742862|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742863|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155287078|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Hospice care|0|||
155287079|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Physician Decision|1|||
155287080|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Physician Decision|0|||
155287081|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Physician Decision|0|||
155287082|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Physician Decision|0|||
155287083|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
155287084|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155287085|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155287086|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155406688|NCT00960661|560923478|FG001|Interventional Phase|sponsor decision|1|||
155287087|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
155287088|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
155287089|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
155287090|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
155287091|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
155287092|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
155287093|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
155287094|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
155287095|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Death|0|||
155287096|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Death|8|||
155287097|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Death|2|||
155287098|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Death|13|||
155287099|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
155287100|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
155287101|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
155287102|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
155287103|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
155287104|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
155287105|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
155287106|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
155287107|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
155287108|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
155287109|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
155287110|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
155287111|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
155287112|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
155287113|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
155287114|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
155287115|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
155287116|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
155287117|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
155287118|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
155287119|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
155287120|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
155287121|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
155406689|NCT00960661|560923479|FG002|Interventional Phase|sponsor decision|0|||
155406690|NCT00960661|560923477|FG000|Interventional Phase|Lack of Efficacy|0|||
155406691|NCT00960661|560923478|FG001|Interventional Phase|Lack of Efficacy|2|||
155406692|NCT00960661|560923479|FG002|Interventional Phase|Lack of Efficacy|0|||
155406693|NCT02699892|560923480|FG000|Overall Study|Other|36|||
155406694|NCT04677712|560923481|FG000|Overall Study|Lost to Follow-up|0|||
155406695|NCT04677712|560923482|FG001|Overall Study|Lost to Follow-up|1|||
155406696|NCT04677712|560923483|FG002|Overall Study|Lost to Follow-up|0|||
155406697|NCT04677712|560923484|FG003|Overall Study|Lost to Follow-up|0|||
155406698|NCT04677712|560923485|FG004|Overall Study|Lost to Follow-up|0|||
155406699|NCT04677712|560923486|FG005|Overall Study|Lost to Follow-up|0|||
155406700|NCT00847912|560923487|FG000|Overall Study|Protocol Violation|6|||
155406701|NCT00847912|560923488|FG001|Overall Study|Protocol Violation|7|||
155406702|NCT00847912|560923487|FG000|Overall Study|Withdrawal by Subject|3|||
155406703|NCT00847912|560923488|FG001|Overall Study|Withdrawal by Subject|6|||
155406704|NCT02083380|560923490|FG000|Overall Study|Lack of Efficacy|68|||
155406705|NCT02083380|560923491|FG001|Overall Study|Lack of Efficacy|79|||
155406706|NCT02083380|560923492|FG002|Overall Study|Lack of Efficacy|64|||
155406707|NCT02083380|560923490|FG000|Overall Study|Withdrawal by Subject|9|||
155406708|NCT02083380|560923491|FG001|Overall Study|Withdrawal by Subject|3|||
155406709|NCT02083380|560923492|FG002|Overall Study|Withdrawal by Subject|7|||
155406710|NCT02083380|560923490|FG000|Overall Study|Physician Decision|1|||
155406711|NCT02083380|560923491|FG001|Overall Study|Physician Decision|6|||
155406712|NCT02083380|560923492|FG002|Overall Study|Physician Decision|3|||
155637953|NCT01147458|561764882|FG001|Second Intervention|Withdrawal by Subject|1|||
155637954|NCT01147458|561764883|FG002|Second Intervention|Withdrawal by Subject|0|||
155406713|NCT02083380|560923490|FG000|Overall Study|Adverse Event|0|||
155637955|NCT01147458|561764884|FG003|Second Intervention|Withdrawal by Subject|0|||
155637956|NCT01147458|561764881|FG000|Second Intervention|Adverse Event|2|||
155637957|NCT01147458|561764882|FG001|Second Intervention|Adverse Event|0|||
155637958|NCT01147458|561764883|FG002|Second Intervention|Adverse Event|1|||
155637959|NCT01147458|561764884|FG003|Second Intervention|Adverse Event|1|||
155637960|NCT01147458|561764881|FG000|Second Intervention|Other|0|||
155637961|NCT01147458|561764882|FG001|Second Intervention|Other|0|||
155287122|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
155287123|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
155287124|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
155406714|NCT02083380|560923491|FG001|Overall Study|Adverse Event|0|||
155287125|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
155287126|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
155287127|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
155287128|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
155287129|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
155287130|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
155287131|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
155287132|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
155287133|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
155287134|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
155287135|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
155287136|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
155287137|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
155287138|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
155287139|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Pain|0|||
155287140|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Pain|0|||
155287141|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Pain|0|||
155287142|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Pain|1|||
155287143|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
155287144|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
155287145|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
155287146|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
155287147|NCT00817635|560484229|FG000|Overall Study|Adverse Event|1|||
155287148|NCT00817635|560484230|FG001|Overall Study|Adverse Event|0|||
155287149|NCT00817635|560484231|FG002|Overall Study|Adverse Event|0|||
155287150|NCT00817635|560484232|FG003|Overall Study|Adverse Event|1|||
155287151|NCT00817635|560484233|FG004|Overall Study|Adverse Event|1|||
155287152|NCT00817635|560484229|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155287153|NCT00817635|560484230|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155287154|NCT00817635|560484231|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155287155|NCT00817635|560484232|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155287156|NCT00817635|560484233|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
155287157|NCT00817635|560484229|FG000|Overall Study|Withdrawal by Subject|2|||
155287158|NCT00817635|560484230|FG001|Overall Study|Withdrawal by Subject|1|||
155287159|NCT00817635|560484231|FG002|Overall Study|Withdrawal by Subject|0|||
155287160|NCT00817635|560484232|FG003|Overall Study|Withdrawal by Subject|1|||
155287161|NCT00817635|560484233|FG004|Overall Study|Withdrawal by Subject|2|||
155287162|NCT00817635|560484229|FG000|Overall Study|Lost to Follow-up|0|||
155287163|NCT00817635|560484230|FG001|Overall Study|Lost to Follow-up|1|||
155287164|NCT00817635|560484231|FG002|Overall Study|Lost to Follow-up|0|||
155287165|NCT00817635|560484232|FG003|Overall Study|Lost to Follow-up|1|||
155287166|NCT00817635|560484233|FG004|Overall Study|Lost to Follow-up|0|||
155287167|NCT00817635|560484229|FG000|Overall Study|Administrative Problems|0|||
155287168|NCT00817635|560484230|FG001|Overall Study|Administrative Problems|0|||
155287169|NCT00817635|560484231|FG002|Overall Study|Administrative Problems|0|||
155287170|NCT00817635|560484232|FG003|Overall Study|Administrative Problems|0|||
155287171|NCT00817635|560484233|FG004|Overall Study|Administrative Problems|1|||
155287172|NCT00817635|560484229|FG000|Overall Study|Protocol Violation|5|||
155287173|NCT00817635|560484230|FG001|Overall Study|Protocol Violation|1|||
155287174|NCT00817635|560484231|FG002|Overall Study|Protocol Violation|3|||
155287175|NCT00817635|560484232|FG003|Overall Study|Protocol Violation|2|||
155287176|NCT00817635|560484233|FG004|Overall Study|Protocol Violation|3|||
155287177|NCT00918957|560484234|FG000|Overall Study|Adverse Event|2|||
155287178|NCT00918957|560484235|FG001|Overall Study|Adverse Event|0|||
155287179|NCT00918957|560484234|FG000|Overall Study|Withdrawal by Subject|1|||
155287180|NCT00918957|560484235|FG001|Overall Study|Withdrawal by Subject|0|||
155287181|NCT01720446|560484238|FG000|Overall Study|Lost to Follow-up|12|||
155287182|NCT01720446|560484239|FG001|Overall Study|Lost to Follow-up|6|||
155287183|NCT01720446|560484240|FG002|Overall Study|Lost to Follow-up|16|||
155287184|NCT01720446|560484241|FG003|Overall Study|Lost to Follow-up|16|||
155406715|NCT02083380|560923492|FG002|Overall Study|Adverse Event|1|||
155406716|NCT02083380|560923490|FG000|Overall Study|Lost to Follow-up|5|||
155637962|NCT01147458|561764883|FG002|Second Intervention|Other|1|||
155287185|NCT01720446|560484238|FG000|Overall Study|Withdrawal by Subject|2|||
155287186|NCT01720446|560484239|FG001|Overall Study|Withdrawal by Subject|5|||
155287187|NCT01720446|560484240|FG002|Overall Study|Withdrawal by Subject|4|||
155637963|NCT01147458|561764884|FG003|Second Intervention|Other|0|||
155287188|NCT01720446|560484241|FG003|Overall Study|Withdrawal by Subject|4|||
155287189|NCT01167426|560484242|FG000|Overall Study|Lost to Follow-up|6|||
155287190|NCT01167426|560484242|FG000|Overall Study|Protocol Violation|1|||
155287191|NCT01167426|560484242|FG000|Overall Study|Withdrawal by Subject|2|||
155287192|NCT01167426|560484242|FG000|Overall Study|Sponsor Decision|1|||
155287193|NCT01908634|560484243|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
155287194|NCT01908634|560484243|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
155287195|NCT04176458|560484245|FG000|Overall Study|Covid 19|4|||
155287196|NCT02131324|560484246|FG000|Overall Study|Withdrawal by Subject|1|||
155287197|NCT02131324|560484247|FG001|Overall Study|Withdrawal by Subject|2|||
155287198|NCT02131324|560484246|FG000|Overall Study|Lost to Follow-up|1|||
155287199|NCT02131324|560484247|FG001|Overall Study|Lost to Follow-up|1|||
155287200|NCT00891618|560484248|FG000|Overall Study|Withdrawal by Subject|1|||
155287201|NCT04582877|560484251|FG000|Overall Study|Did not use device measurement|5|||
155287202|NCT04582877|560484251|FG000|Overall Study|No fractional flow reserve test results|2|||
155287203|NCT04582877|560484251|FG000|Overall Study|Protocol Violation|1|||
155287204|NCT00003656|560484252|FG000|Overall Study|Adverse Event|0|||
155287205|NCT00003656|560484253|FG001|Overall Study|Adverse Event|1|||
155287206|NCT01268566|560484257|FG000|Overall Study|Lost to Follow-up|1|||
155287207|NCT01268566|560484257|FG000|Overall Study|Withdrawal by Subject|12|||
155287208|NCT01268566|560484257|FG000|Overall Study|Death|30|||
155287209|NCT01649427|560484262|FG000|Overall Study|Adverse Event|1|||
155287210|NCT01649427|560484263|FG001|Overall Study|Adverse Event|1|||
155287211|NCT01649427|560484262|FG000|Overall Study|Withdrawal by Subject|8|||
155287212|NCT01649427|560484263|FG001|Overall Study|Withdrawal by Subject|7|||
155406717|NCT02083380|560923491|FG001|Overall Study|Lost to Follow-up|3|||
155406718|NCT02083380|560923492|FG002|Overall Study|Lost to Follow-up|3|||
155406719|NCT02083380|560923490|FG000|Overall Study|Other|8|||
155406720|NCT02083380|560923491|FG001|Overall Study|Other|4|||
155406721|NCT02083380|560923492|FG002|Overall Study|Other|6|||
155406722|NCT02412787|560923493|FG000|Overall Study|Withdrawal by Subject|9|||
155406723|NCT02412787|560923493|FG000|Overall Study|Participation Terminated by Investigator|1|||
155406724|NCT02412787|560923493|FG000|Overall Study|Site Terminated by Sponsor|21|||
155406725|NCT02412787|560923493|FG000|Overall Study|Technical Problems|1|||
155406726|NCT02412787|560923493|FG000|Overall Study|Reason Not Specified|1|||
155406727|NCT00001379|560923494|FG000|Initial Treatment|Disease progression|21|||
155406728|NCT00001379|560923495|FG001|Initial Treatment|Disease progression|3|||
155406729|NCT00001379|560923496|FG002|Initial Treatment|Disease progression|0|||
155406730|NCT00001379|560923497|FG003|Initial Treatment|Disease progression|0|||
155406731|NCT00001379|560923494|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
155406732|NCT00001379|560923495|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
155406733|NCT00001379|560923496|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
155406734|NCT00001379|560923497|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
155406735|NCT00001379|560923494|FG000|Initial Treatment|Received alternative treatment|2|||
155406736|NCT00001379|560923495|FG001|Initial Treatment|Received alternative treatment|1|||
155406737|NCT00001379|560923496|FG002|Initial Treatment|Received alternative treatment|0|||
155406738|NCT00001379|560923497|FG003|Initial Treatment|Received alternative treatment|0|||
155406739|NCT00001379|560923494|FG000|Initial Treatment|Refused further treatment|2|||
155406740|NCT00001379|560923495|FG001|Initial Treatment|Refused further treatment|0|||
155406741|NCT00001379|560923496|FG002|Initial Treatment|Refused further treatment|0|||
155406742|NCT00001379|560923497|FG003|Initial Treatment|Refused further treatment|0|||
155406743|NCT00001379|560923494|FG000|Initial Treatment|Did not receive protocol treatment|0|||
155406744|NCT00001379|560923495|FG001|Initial Treatment|Did not receive protocol treatment|0|||
155406745|NCT00001379|560923496|FG002|Initial Treatment|Did not receive protocol treatment|5|||
155406746|NCT00001379|560923497|FG003|Initial Treatment|Did not receive protocol treatment|0|||
155406747|NCT00001379|560923494|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
155406748|NCT00001379|560923495|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
155406749|NCT00001379|560923496|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
155406750|NCT00001379|560923497|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
155406751|NCT00001379|560923494|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
155637964|NCT02811159|561764885|FG000|Treatment Course 1|Lost to Follow-up|1|||
155287213|NCT01649427|560484262|FG000|Overall Study|Lost to Follow-up|0|||
155287214|NCT01649427|560484263|FG001|Overall Study|Lost to Follow-up|1|||
155406752|NCT00001379|560923495|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
155406753|NCT00001379|560923496|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
155406754|NCT00001379|560923497|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
155406755|NCT00001379|560923494|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
155406756|NCT00001379|560923495|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
155637965|NCT05759338|561764887|FG000|Overall Study|Withdrawal by Subject|3|||
155637966|NCT04409002|561764888|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
155637967|NCT04611126|561764890|FG000|Overall Study|TIL expansion unsuccessful|1|||
155637968|NCT04611126|561764891|FG001|Overall Study|TIL expansion unsuccessful|0|||
155637969|NCT04190225|561766340|FG000|Overall Study|Lost to Follow-up|2|||
155637970|NCT04190225|561766341|FG001|Overall Study|Lost to Follow-up|3|||
155287215|NCT01649427|560484262|FG000|Overall Study|Graft loss|0|||
155287216|NCT01649427|560484263|FG001|Overall Study|Graft loss|1|||
155287217|NCT01649427|560484262|FG000|Overall Study|Surgical problems during nephrectomy|2|||
155287218|NCT01649427|560484263|FG001|Overall Study|Surgical problems during nephrectomy|2|||
155287219|NCT02138916|560484264|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
155287220|NCT02138916|560484265|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
155287221|NCT02138916|560484266|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
155287222|NCT02138916|560484264|FG000|Overall Study|Death|14|||
155287223|NCT02138916|560484265|FG001|Overall Study|Death|11|||
155287224|NCT02138916|560484266|FG002|Overall Study|Death|12|||
155287225|NCT02138916|560484264|FG000|Overall Study|Withdrawal by Subject|27|||
155287226|NCT02138916|560484265|FG001|Overall Study|Withdrawal by Subject|31|||
155287227|NCT02138916|560484266|FG002|Overall Study|Withdrawal by Subject|32|||
155287228|NCT02138916|560484264|FG000|Overall Study|Study specific withdrawal criteria|0|||
155287229|NCT02138916|560484265|FG001|Overall Study|Study specific withdrawal criteria|0|||
155287230|NCT02138916|560484266|FG002|Overall Study|Study specific withdrawal criteria|1|||
155287231|NCT02138916|560484264|FG000|Overall Study|incorrect enrolment|1|||
155287232|NCT02138916|560484265|FG001|Overall Study|incorrect enrolment|1|||
155287233|NCT02138916|560484266|FG002|Overall Study|incorrect enrolment|0|||
155287234|NCT02138916|560484264|FG000|Overall Study|Severe non-compliance|1|||
155287235|NCT02138916|560484265|FG001|Overall Study|Severe non-compliance|2|||
155287236|NCT02138916|560484266|FG002|Overall Study|Severe non-compliance|1|||
155287237|NCT02138916|560484264|FG000|Overall Study|Lost to Follow-up|4|||
155287238|NCT02138916|560484265|FG001|Overall Study|Lost to Follow-up|2|||
155287239|NCT02138916|560484266|FG002|Overall Study|Lost to Follow-up|3|||
155287240|NCT02138916|560484264|FG000|Overall Study|Adverse Event|4|||
155287241|NCT02138916|560484265|FG001|Overall Study|Adverse Event|4|||
155287242|NCT02138916|560484266|FG002|Overall Study|Adverse Event|3|||
155287243|NCT05096884|560484268|FG000|Overall Study|Excluded based on negative tilt table test|4|||
155287244|NCT02482233|560484273|FG000|Overall Study|Lost to Follow-up|1|||
155287245|NCT02482233|560484274|FG001|Overall Study|Lost to Follow-up|1|||
155287246|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287247|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287248|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287249|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
155287250|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
155287251|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287252|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287253|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287254|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287255|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287256|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287257|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287258|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
155287259|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
155406757|NCT00001379|560923496|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
155406758|NCT00001379|560923497|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
155406759|NCT00001379|560923494|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
155406760|NCT00001379|560923495|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
155406761|NCT00001379|560923496|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
155406762|NCT00001379|560923497|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
155406763|NCT00001379|560923494|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
155406764|NCT00001379|560923495|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
155406765|NCT00001379|560923496|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
155406766|NCT00001379|560923497|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
155406767|NCT03246958|560923498|FG000|Overall Study|Withdrawal by Subject|0|||
155406768|NCT03246958|560923499|FG001|Overall Study|Withdrawal by Subject|1|||
155406769|NCT03246958|560923500|FG002|Overall Study|Withdrawal by Subject|0|||
155406770|NCT03246958|560923501|FG003|Overall Study|Withdrawal by Subject|0|||
155406771|NCT03246958|560923502|FG004|Overall Study|Withdrawal by Subject|0|||
155406772|NCT03246958|560923503|FG005|Overall Study|Withdrawal by Subject|1|||
155406773|NCT03246958|560923504|FG006|Overall Study|Withdrawal by Subject|0|||
155406774|NCT03246958|560923498|FG000|Overall Study|Progression|13|||
155406775|NCT03246958|560923499|FG001|Overall Study|Progression|9|||
155406776|NCT03246958|560923500|FG002|Overall Study|Progression|3|||
155406777|NCT03246958|560923501|FG003|Overall Study|Progression|2|||
155637971|NCT04190225|561766340|FG000|Overall Study|Withdrawal by Subject|3|||
155637972|NCT04190225|561766341|FG001|Overall Study|Withdrawal by Subject|2|||
155287260|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
155287261|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
155406778|NCT03246958|560923502|FG004|Overall Study|Progression|1|||
155406779|NCT03246958|560923503|FG005|Overall Study|Progression|2|||
155406780|NCT03246958|560923504|FG006|Overall Study|Progression|1|||
155637973|NCT04190225|561766340|FG000|Overall Study|Unrelated health condition|2|||
155637974|NCT04190225|561766341|FG001|Overall Study|Unrelated health condition|0|||
155637975|NCT02362451|561766342|FG000|Overall Study|Withdrawal by Subject|0|||
155287262|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287263|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287264|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287265|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287266|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287267|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287268|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287269|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287270|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
155287271|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287272|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
155287273|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287274|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287275|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287276|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287277|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287278|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287279|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287280|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287281|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287282|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287283|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287284|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287285|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287286|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
155287287|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287288|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287289|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
155287290|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287291|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287292|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287293|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287294|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287295|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
155287296|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
155287297|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287298|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287299|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287300|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
155287301|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155287302|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155406781|NCT03246958|560923498|FG000|Overall Study|Adverse Event|2|||
155406782|NCT03246958|560923499|FG001|Overall Study|Adverse Event|2|||
155742864|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742865|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742866|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742867|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
155742868|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
155742869|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742870|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155742871|NCT00557856|562158261|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
155742872|NCT00557856|562158262|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155406783|NCT03246958|560923500|FG002|Overall Study|Adverse Event|0|||
155406784|NCT03246958|560923501|FG003|Overall Study|Adverse Event|1|||
155406785|NCT03246958|560923502|FG004|Overall Study|Adverse Event|1|||
155742873|NCT00557856|562158263|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742874|NCT00557856|562158264|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742875|NCT00557856|562158265|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742876|NCT00557856|562158266|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742877|NCT00557856|562158267|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742878|NCT00557856|562158268|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155742879|NCT00557856|562158269|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155287303|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155406786|NCT03246958|560923503|FG005|Overall Study|Adverse Event|0|||
155406787|NCT03246958|560923504|FG006|Overall Study|Adverse Event|2|||
155406788|NCT03246958|560923498|FG000|Overall Study|Death|0|||
155406789|NCT03246958|560923499|FG001|Overall Study|Death|1|||
155406790|NCT03246958|560923500|FG002|Overall Study|Death|0|||
155406791|NCT03246958|560923501|FG003|Overall Study|Death|0|||
155406792|NCT03246958|560923502|FG004|Overall Study|Death|0|||
155406793|NCT03246958|560923503|FG005|Overall Study|Death|0|||
155406794|NCT03246958|560923504|FG006|Overall Study|Death|0|||
155406795|NCT03246958|560923498|FG000|Overall Study|Physician Decision|0|||
155406796|NCT03246958|560923499|FG001|Overall Study|Physician Decision|0|||
155406797|NCT03246958|560923500|FG002|Overall Study|Physician Decision|0|||
155406798|NCT03246958|560923501|FG003|Overall Study|Physician Decision|1|||
155406799|NCT03246958|560923502|FG004|Overall Study|Physician Decision|0|||
155406800|NCT03246958|560923503|FG005|Overall Study|Physician Decision|0|||
155406801|NCT03246958|560923504|FG006|Overall Study|Physician Decision|0|||
155406802|NCT03246958|560923498|FG000|Overall Study|Never start treatment|1|||
155406803|NCT03246958|560923499|FG001|Overall Study|Never start treatment|0|||
155406804|NCT03246958|560923500|FG002|Overall Study|Never start treatment|0|||
155406805|NCT03246958|560923501|FG003|Overall Study|Never start treatment|0|||
155406806|NCT03246958|560923502|FG004|Overall Study|Never start treatment|0|||
155406807|NCT03246958|560923503|FG005|Overall Study|Never start treatment|0|||
155406808|NCT03246958|560923504|FG006|Overall Study|Never start treatment|0|||
155406809|NCT03246958|560923498|FG000|Overall Study|Over enrollment|0|||
155406810|NCT03246958|560923499|FG001|Overall Study|Over enrollment|2|||
155406811|NCT03246958|560923500|FG002|Overall Study|Over enrollment|0|||
155406812|NCT03246958|560923501|FG003|Overall Study|Over enrollment|0|||
155406813|NCT03246958|560923502|FG004|Overall Study|Over enrollment|0|||
155406814|NCT03246958|560923503|FG005|Overall Study|Over enrollment|0|||
155406815|NCT03246958|560923504|FG006|Overall Study|Over enrollment|0|||
155406816|NCT01577186|560923510|FG000|Overall Study|Adverse Event|23|||
155406817|NCT01577186|560923510|FG000|Overall Study|Death|1|||
155406818|NCT01577186|560923510|FG000|Overall Study|Lost to Follow-up|28|||
155406819|NCT01577186|560923510|FG000|Overall Study|Withdrawal by Subject|35|||
155406820|NCT01577186|560923510|FG000|Overall Study|Insufficient Response|18|||
155406821|NCT01577186|560923510|FG000|Overall Study|Ineligible to Continue|15|||
155406822|NCT01577186|560923510|FG000|Overall Study|Non-Compliant|8|||
155406823|NCT01577186|560923510|FG000|Overall Study|Other|2|||
155406824|NCT01032915|560923511|FG000|Overall Study|Adverse Event|2|||
155406825|NCT01032915|560923512|FG001|Overall Study|Adverse Event|2|||
155406826|NCT01032915|560923513|FG002|Overall Study|Adverse Event|1|||
155406827|NCT01032915|560923514|FG003|Overall Study|Adverse Event|1|||
155406828|NCT01032915|560923511|FG000|Overall Study|Abnormal test procedure result|0|||
155406829|NCT01032915|560923512|FG001|Overall Study|Abnormal test procedure result|0|||
155406830|NCT01032915|560923513|FG002|Overall Study|Abnormal test procedure result|1|||
155406831|NCT01032915|560923514|FG003|Overall Study|Abnormal test procedure result|0|||
155406832|NCT01032915|560923511|FG000|Overall Study|Withdrawal by Subject|0|||
155406833|NCT01032915|560923512|FG001|Overall Study|Withdrawal by Subject|3|||
155406834|NCT01032915|560923513|FG002|Overall Study|Withdrawal by Subject|1|||
155406835|NCT01032915|560923514|FG003|Overall Study|Withdrawal by Subject|1|||
155406836|NCT01032915|560923511|FG000|Overall Study|Administrative reasons|5|||
155406837|NCT01032915|560923512|FG001|Overall Study|Administrative reasons|6|||
155406838|NCT01032915|560923513|FG002|Overall Study|Administrative reasons|4|||
155406839|NCT01032915|560923514|FG003|Overall Study|Administrative reasons|4|||
155406840|NCT01032915|560923511|FG000|Overall Study|Protocol Violation|1|||
155406841|NCT01032915|560923512|FG001|Overall Study|Protocol Violation|0|||
155406842|NCT01032915|560923513|FG002|Overall Study|Protocol Violation|0|||
155406843|NCT01032915|560923514|FG003|Overall Study|Protocol Violation|1|||
155406844|NCT00811135|560923515|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
155406845|NCT00811135|560923515|FG000|Overall Study|Death|3|||
155406846|NCT00811135|560923515|FG000|Overall Study|Protocol Violation|2|||
155406847|NCT00811135|560923515|FG000|Overall Study|Violation of Selection Criteria|1|||
155742880|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742881|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742882|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742883|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
155406848|NCT00811135|560923515|FG000|Overall Study|Refused Treatment|1|||
155406849|NCT00811135|560923515|FG000|Overall Study|Withdrawal by Subject|3|||
155406850|NCT00811135|560923515|FG000|Overall Study|Administrative/Other Unspecified|11|||
155406851|NCT00811135|560923515|FG000|Overall Study|Ongoing|59|||
155406852|NCT01118351|560923516|FG000|Overall Study|Adverse Event|3|||
155406853|NCT01118351|560923516|FG000|Overall Study|Withdrawal by Subject|1|||
155406854|NCT00535132|560923520|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
155406855|NCT00535132|560923521|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
155406856|NCT00535132|560923520|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
155406857|NCT00535132|560923521|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
155406858|NCT00183274|560923524|FG000|Phase 1: Open-Label|Adverse Event|31|||
155406859|NCT00183274|560923525|FG001|Phase 1: Open-Label|Adverse Event|0|||
155406860|NCT00183274|560923526|FG002|Phase 1: Open-Label|Adverse Event|0|||
155406861|NCT00183274|560923527|FG003|Phase 1: Open-Label|Adverse Event|0|||
155406862|NCT00183274|560923528|FG004|Phase 1: Open-Label|Adverse Event|0|||
155406863|NCT00183274|560923529|FG005|Phase 1: Open-Label|Adverse Event|0|||
155406864|NCT00183274|560923524|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
155406865|NCT00183274|560923525|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
155406866|NCT00183274|560923526|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
155406867|NCT00183274|560923527|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
155406868|NCT00183274|560923528|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
155406869|NCT00183274|560923529|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
155406870|NCT00183274|560923524|FG000|Phase 1: Open-Label|Protocol Violation|11|||
155406871|NCT00183274|560923525|FG001|Phase 1: Open-Label|Protocol Violation|0|||
155406872|NCT00183274|560923526|FG002|Phase 1: Open-Label|Protocol Violation|0|||
155406873|NCT00183274|560923527|FG003|Phase 1: Open-Label|Protocol Violation|0|||
155406874|NCT00183274|560923528|FG004|Phase 1: Open-Label|Protocol Violation|0|||
155406875|NCT00183274|560923529|FG005|Phase 1: Open-Label|Protocol Violation|0|||
155406876|NCT00183274|560923524|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
155406877|NCT00183274|560923525|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
155406878|NCT00183274|560923526|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
155406879|NCT00183274|560923527|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
155406880|NCT00183274|560923528|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
155406881|NCT00183274|560923529|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
155406882|NCT00183274|560923524|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
155406883|NCT00183274|560923525|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
155406884|NCT00183274|560923526|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
155406885|NCT00183274|560923527|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
155406886|NCT00183274|560923528|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
155406887|NCT00183274|560923529|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
155406888|NCT00183274|560923524|FG000|Phase 1: Open-Label|Other|9|||
155406889|NCT00183274|560923525|FG001|Phase 1: Open-Label|Other|0|||
155406890|NCT00183274|560923526|FG002|Phase 1: Open-Label|Other|0|||
155406891|NCT00183274|560923527|FG003|Phase 1: Open-Label|Other|0|||
155406892|NCT00183274|560923528|FG004|Phase 1: Open-Label|Other|0|||
155406893|NCT00183274|560923529|FG005|Phase 1: Open-Label|Other|0|||
155406894|NCT00183274|560923524|FG000|Phase 2: Double-Blind|Relapsed|0|||
155406895|NCT00183274|560923525|FG001|Phase 2: Double-Blind|Relapsed|8|||
155406896|NCT00183274|560923526|FG002|Phase 2: Double-Blind|Relapsed|29|||
155406897|NCT00183274|560923527|FG003|Phase 2: Double-Blind|Relapsed|0|||
155406898|NCT00183274|560923528|FG004|Phase 2: Double-Blind|Relapsed|0|||
155406899|NCT00183274|560923529|FG005|Phase 2: Double-Blind|Relapsed|0|||
155406900|NCT00183274|560923524|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
155406901|NCT00183274|560923525|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
155406902|NCT00183274|560923526|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
155406903|NCT00183274|560923527|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
155406904|NCT00183274|560923528|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
155406905|NCT00183274|560923529|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
155406906|NCT00183274|560923524|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
155406907|NCT00183274|560923525|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
155406908|NCT00183274|560923526|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
155406909|NCT00183274|560923527|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
155406910|NCT00183274|560923528|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
155406911|NCT00183274|560923529|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
155406912|NCT00183274|560923524|FG000|Phase 3: Double-Blind|Relapsed|0|||
155406913|NCT00183274|560923525|FG001|Phase 3: Double-Blind|Relapsed|0|||
155406914|NCT00183274|560923526|FG002|Phase 3: Double-Blind|Relapsed|0|||
155406915|NCT00183274|560923527|FG003|Phase 3: Double-Blind|Relapsed|1|||
155406916|NCT00183274|560923528|FG004|Phase 3: Double-Blind|Relapsed|11|||
155406917|NCT00183274|560923529|FG005|Phase 3: Double-Blind|Relapsed|2|||
155406918|NCT00708500|560923530|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
155406919|NCT00708500|560923531|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
155406920|NCT00708500|560923532|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
155406921|NCT00708500|560923530|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
155406922|NCT00708500|560923531|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
155406923|NCT00708500|560923532|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
155406924|NCT00708500|560923530|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
155406925|NCT00708500|560923531|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
155406926|NCT00708500|560923532|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
155406927|NCT00708500|560923530|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
155406928|NCT00708500|560923531|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
155406929|NCT00708500|560923532|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
155406930|NCT00708500|560923530|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
155406931|NCT00708500|560923531|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
155406932|NCT00708500|560923532|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
155406933|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
155406934|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
155406935|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
155406936|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
155406937|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
155406938|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
155406939|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
155406940|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
155406941|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
155406942|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
155406943|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
155406944|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
155406945|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
155406946|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
155406947|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
155406948|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
155406949|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
155406950|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
155406951|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
155406952|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
155406953|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
155406954|NCT00708500|560923530|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
155406955|NCT00708500|560923531|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
155406956|NCT00708500|560923532|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
155406957|NCT00708500|560923530|FG000|FOLLOWUP|Adverse Event|0|||
155406958|NCT00708500|560923531|FG001|FOLLOWUP|Adverse Event|1|||
155406959|NCT00708500|560923532|FG002|FOLLOWUP|Adverse Event|0|||
155406960|NCT00708500|560923530|FG000|FOLLOWUP|Lost to Follow-up|1|||
155406961|NCT00708500|560923531|FG001|FOLLOWUP|Lost to Follow-up|6|||
155406962|NCT00708500|560923532|FG002|FOLLOWUP|Lost to Follow-up|4|||
155406963|NCT00708500|560923530|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
155406964|NCT00708500|560923531|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
155406965|NCT00708500|560923532|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
155406966|NCT00708500|560923530|FG000|FOLLOWUP|Subject withdrew consent|31|||
155406967|NCT00708500|560923531|FG001|FOLLOWUP|Subject withdrew consent|4|||
155406968|NCT00708500|560923532|FG002|FOLLOWUP|Subject withdrew consent|5|||
155406969|NCT00708500|560923530|FG000|FOLLOWUP|Non-compliance with protocol|5|||
155406970|NCT00708500|560923531|FG001|FOLLOWUP|Non-compliance with protocol|0|||
155406971|NCT00708500|560923532|FG002|FOLLOWUP|Non-compliance with protocol|1|||
155406972|NCT00794677|560923544|FG000|First Intervention|Withdrawal by Subject|2|||
155406973|NCT00794677|560923545|FG001|First Intervention|Withdrawal by Subject|0|||
155406974|NCT03882970|560923546|FG000|Overall Study|Adverse Event|5|||
155406975|NCT03882970|560923547|FG001|Overall Study|Adverse Event|7|||
155742884|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
155406976|NCT03882970|560923548|FG002|Overall Study|Adverse Event|3|||
155406977|NCT03882970|560923549|FG003|Overall Study|Adverse Event|1|||
155406978|NCT03882970|560923546|FG000|Overall Study|Death|1|||
155742885|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742886|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742887|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
155742888|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
155742889|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742890|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742891|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742892|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742893|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742894|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742895|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742896|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155742897|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
155742898|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
155742899|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
155742900|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
155742901|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
155742902|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
155742903|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
155742904|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
155742905|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
155742906|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
155742907|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|Other|0|||
155742908|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|Other|0|||
155406979|NCT03882970|560923547|FG001|Overall Study|Death|2|||
155406980|NCT03882970|560923548|FG002|Overall Study|Death|1|||
155406981|NCT03882970|560923549|FG003|Overall Study|Death|1|||
155406982|NCT03882970|560923546|FG000|Overall Study|Lost to Follow-up|8|||
155406983|NCT03882970|560923547|FG001|Overall Study|Lost to Follow-up|9|||
155406984|NCT03882970|560923548|FG002|Overall Study|Lost to Follow-up|5|||
155406985|NCT03882970|560923549|FG003|Overall Study|Lost to Follow-up|5|||
155406986|NCT03882970|560923546|FG000|Overall Study|Physician Decision|0|||
155406987|NCT03882970|560923547|FG001|Overall Study|Physician Decision|2|||
155406988|NCT03882970|560923548|FG002|Overall Study|Physician Decision|2|||
155406989|NCT03882970|560923549|FG003|Overall Study|Physician Decision|2|||
155406990|NCT03882970|560923546|FG000|Overall Study|Protocol Violation|2|||
155406991|NCT03882970|560923547|FG001|Overall Study|Protocol Violation|0|||
155406992|NCT03882970|560923548|FG002|Overall Study|Protocol Violation|0|||
155406993|NCT03882970|560923549|FG003|Overall Study|Protocol Violation|0|||
155406994|NCT03882970|560923546|FG000|Overall Study|Withdrawal by Subject|8|||
155406995|NCT03882970|560923547|FG001|Overall Study|Withdrawal by Subject|17|||
155406996|NCT03882970|560923548|FG002|Overall Study|Withdrawal by Subject|7|||
155406997|NCT03882970|560923549|FG003|Overall Study|Withdrawal by Subject|22|||
155406998|NCT03882970|560923546|FG000|Overall Study|Personal Reason|2|||
155406999|NCT03882970|560923547|FG001|Overall Study|Personal Reason|3|||
155407000|NCT03882970|560923548|FG002|Overall Study|Personal Reason|1|||
155407001|NCT03882970|560923549|FG003|Overall Study|Personal Reason|3|||
155407002|NCT02863809|560923562|FG000|Overall Study|Adverse Event|8|||
155407003|NCT02863809|560923563|FG001|Overall Study|Adverse Event|8|||
155407004|NCT02863809|560923562|FG000|Overall Study|Withdrawal by Subject|0|||
155407005|NCT02863809|560923563|FG001|Overall Study|Withdrawal by Subject|1|||
155407006|NCT02863809|560923562|FG000|Overall Study|Lost to Follow-up|1|||
155407007|NCT02863809|560923563|FG001|Overall Study|Lost to Follow-up|1|||
155407008|NCT02863809|560923562|FG000|Overall Study|Death|1|||
155407009|NCT02863809|560923563|FG001|Overall Study|Death|0|||
155407010|NCT00607386|560923564|FG000|Overall Study|Physician Decision|1|||
155407011|NCT02980224|560923574|FG000|Overall Study|Adverse Event|4|||
155407012|NCT02980224|560923575|FG001|Overall Study|Adverse Event|1|||
155407013|NCT02980224|560923574|FG000|Overall Study|Withdrawal by Subject|0|||
155407014|NCT02980224|560923575|FG001|Overall Study|Withdrawal by Subject|2|||
155407015|NCT00606320|560923576|FG000|Overall Study|Adverse Event|3|||
155407016|NCT00606320|560923576|FG000|Overall Study|Lack of Efficacy|5|||
155407017|NCT00606320|560923576|FG000|Overall Study|Physician Decision|7|||
155407018|NCT00606320|560923576|FG000|Overall Study|Protocol Violation|8|||
155407019|NCT00606320|560923576|FG000|Overall Study|Withdrawal by Subject|10|||
155407020|NCT00606320|560923576|FG000|Overall Study|Progression to depressive phase|4|||
155407021|NCT04839380|560923577|FG000|Overall Study|Withdrawal by Subject|2|||
155407022|NCT04839380|560923577|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
155407023|NCT00879645|560923578|FG000|Overall Study|Adverse Event|1|||
155407024|NCT00879645|560923579|FG001|Overall Study|Adverse Event|0|||
155407025|NCT00879645|560923580|FG002|Overall Study|Adverse Event|0|||
155407026|NCT00879645|560923581|FG003|Overall Study|Adverse Event|0|||
155407027|NCT00513500|560923582|FG000|Overall Study|Lost to Follow-up|35|||
155407028|NCT00513500|560923583|FG001|Overall Study|Lost to Follow-up|39|||
155407029|NCT00513500|560923582|FG000|Overall Study|Death|2|||
155407030|NCT00513500|560923583|FG001|Overall Study|Death|1|||
155407031|NCT00513500|560923582|FG000|Overall Study|Hospitalized|4|||
155407032|NCT00513500|560923583|FG001|Overall Study|Hospitalized|14|||
155407033|NCT00749996|560923584|FG000|Overall Study|Lost to Follow-up|7|||
155407034|NCT00749996|560923585|FG001|Overall Study|Lost to Follow-up|4|||
155407035|NCT00749996|560923584|FG000|Overall Study|Withdrawal by Subject|5|||
155407036|NCT00749996|560923585|FG001|Overall Study|Withdrawal by Subject|4|||
155407037|NCT00749996|560923584|FG000|Overall Study|Protocol Violation|2|||
155407038|NCT00749996|560923585|FG001|Overall Study|Protocol Violation|3|||
155407039|NCT00749996|560923584|FG000|Overall Study|Physician Decision|2|||
155407040|NCT00749996|560923585|FG001|Overall Study|Physician Decision|0|||
155407041|NCT00749996|560923584|FG000|Overall Study|Pregnancy|0|||
155407042|NCT00749996|560923585|FG001|Overall Study|Pregnancy|2|||
155407043|NCT00749996|560923584|FG000|Overall Study|Adverse Event|1|||
155407044|NCT00749996|560923585|FG001|Overall Study|Adverse Event|0|||
155407045|NCT00749996|560923584|FG000|Overall Study|Death|1|||
155407046|NCT00749996|560923585|FG001|Overall Study|Death|0|||
155407047|NCT01227044|560923586|FG000|Overall Study|Lost to Follow-up|5|||
155407048|NCT01227044|560923587|FG001|Overall Study|Lost to Follow-up|7|||
155407049|NCT01227044|560923586|FG000|Overall Study|Discontinued Intervention|1|||
155407050|NCT01227044|560923587|FG001|Overall Study|Discontinued Intervention|2|||
155407051|NCT04247061|560923588|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
155407052|NCT04247061|560923588|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
155407053|NCT04247061|560923588|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
155407054|NCT00917150|560923589|FG000|Overall Study|Adverse Event|12|||
155407055|NCT00917150|560923590|FG001|Overall Study|Adverse Event|7|||
155407056|NCT00917150|560923591|FG002|Overall Study|Adverse Event|12|||
155407057|NCT00917150|560923592|FG003|Overall Study|Adverse Event|11|||
155407058|NCT00917150|560923589|FG000|Overall Study|Death|1|||
155407059|NCT00917150|560923590|FG001|Overall Study|Death|4|||
155407060|NCT00917150|560923591|FG002|Overall Study|Death|3|||
155407061|NCT00917150|560923592|FG003|Overall Study|Death|2|||
155407062|NCT00917150|560923589|FG000|Overall Study|Lost to Follow-up|1|||
155407063|NCT00917150|560923590|FG001|Overall Study|Lost to Follow-up|0|||
155407064|NCT00917150|560923591|FG002|Overall Study|Lost to Follow-up|4|||
155407065|NCT00917150|560923592|FG003|Overall Study|Lost to Follow-up|2|||
155407066|NCT00917150|560923589|FG000|Overall Study|Physician Decision|0|||
155407067|NCT00917150|560923590|FG001|Overall Study|Physician Decision|2|||
155407068|NCT00917150|560923591|FG002|Overall Study|Physician Decision|0|||
155407069|NCT00917150|560923592|FG003|Overall Study|Physician Decision|1|||
155407070|NCT00917150|560923589|FG000|Overall Study|Protocol Violation|5|||
155407071|NCT00917150|560923590|FG001|Overall Study|Protocol Violation|5|||
155407072|NCT00917150|560923591|FG002|Overall Study|Protocol Violation|3|||
155407073|NCT00917150|560923592|FG003|Overall Study|Protocol Violation|5|||
155407074|NCT00917150|560923589|FG000|Overall Study|Withdrawal by Subject|15|||
155407075|NCT00917150|560923590|FG001|Overall Study|Withdrawal by Subject|16|||
155407076|NCT00917150|560923591|FG002|Overall Study|Withdrawal by Subject|18|||
155407077|NCT00917150|560923592|FG003|Overall Study|Withdrawal by Subject|11|||
155407078|NCT00917150|560923589|FG000|Overall Study|Other than specified|3|||
155407079|NCT00917150|560923590|FG001|Overall Study|Other than specified|3|||
155407080|NCT00917150|560923591|FG002|Overall Study|Other than specified|2|||
155407081|NCT00917150|560923592|FG003|Overall Study|Other than specified|2|||
155407082|NCT03891264|560923593|FG000|Overall Study|Adverse Event|1|||
155407083|NCT03891264|560923593|FG000|Overall Study|Withdrawal by Subject|2|||
155407084|NCT03891264|560923593|FG000|Overall Study|Physician Decision|2|||
155407085|NCT01979536|560923594|FG000|Overall Study|Physician Decision|2|||
155407086|NCT01979536|560923595|FG001|Overall Study|Physician Decision|3|||
155407087|NCT01979536|560923594|FG000|Overall Study|Withdrawal by Subject|0|||
155407088|NCT01979536|560923595|FG001|Overall Study|Withdrawal by Subject|1|||
155407089|NCT01979536|560923594|FG000|Overall Study|Refusal|0|||
155407090|NCT01979536|560923595|FG001|Overall Study|Refusal|1|||
155407091|NCT01979536|560923594|FG000|Overall Study|Relapse|0|||
155407092|NCT01979536|560923595|FG001|Overall Study|Relapse|1|||
155407093|NCT01979536|560923594|FG000|Overall Study|Study terminated by Sponsor|0|||
155407094|NCT01979536|560923595|FG001|Overall Study|Study terminated by Sponsor|1|||
155407095|NCT01979536|560923594|FG000|Overall Study|Did not start treatment|0|||
155407096|NCT01979536|560923595|FG001|Overall Study|Did not start treatment|1|||
155407097|NCT05054114|560923600|FG000|Overall Study|Protocol Violation|13|||
155407098|NCT05054114|560923601|FG001|Overall Study|Protocol Violation|1|||
155407099|NCT05054114|560923600|FG000|Overall Study|Pregnancy|0|||
155407100|NCT05054114|560923601|FG001|Overall Study|Pregnancy|1|||
155407101|NCT01806779|560923602|FG000|Overall Study|Physician Decision|2|||
155407102|NCT01806779|560923603|FG001|Overall Study|Physician Decision|0|||
155407103|NCT01806779|560923604|FG002|Overall Study|Physician Decision|1|||
155407104|NCT01806779|560923602|FG000|Overall Study|Lack of Efficacy|1|||
155407105|NCT01806779|560923603|FG001|Overall Study|Lack of Efficacy|1|||
155407106|NCT01806779|560923604|FG002|Overall Study|Lack of Efficacy|0|||
155407107|NCT01806779|560923602|FG000|Overall Study|Lost to Follow-up|19|||
155407108|NCT01806779|560923603|FG001|Overall Study|Lost to Follow-up|20|||
155407109|NCT01806779|560923604|FG002|Overall Study|Lost to Follow-up|0|||
155407110|NCT01806779|560923602|FG000|Overall Study|Withdrawal by Subject|20|||
155407111|NCT01806779|560923603|FG001|Overall Study|Withdrawal by Subject|23|||
155407112|NCT01806779|560923604|FG002|Overall Study|Withdrawal by Subject|22|||
155407113|NCT00805480|560923605|FG000|Overall Study|Withdrawal by Subject|13|||
155407114|NCT00805480|560923606|FG001|Overall Study|Withdrawal by Subject|5|||
155407115|NCT00805480|560923607|FG002|Overall Study|Withdrawal by Subject|11|||
155407116|NCT00805480|560923608|FG003|Overall Study|Withdrawal by Subject|5|||
155407117|NCT00805480|560923605|FG000|Overall Study|Lost to Follow-up|1|||
155407118|NCT00805480|560923606|FG001|Overall Study|Lost to Follow-up|2|||
155407119|NCT00805480|560923607|FG002|Overall Study|Lost to Follow-up|0|||
155407120|NCT00805480|560923608|FG003|Overall Study|Lost to Follow-up|0|||
155407121|NCT00805480|560923605|FG000|Overall Study|Adverse Event|0|||
155407122|NCT00805480|560923606|FG001|Overall Study|Adverse Event|0|||
155407123|NCT00805480|560923607|FG002|Overall Study|Adverse Event|1|||
155407124|NCT00805480|560923608|FG003|Overall Study|Adverse Event|0|||
155407125|NCT02595450|560923611|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
155407126|NCT02595450|560923611|FG000|Overall Study|Enrolled, but not treated|8|||
155407127|NCT04294901|560923612|FG000|Overall Study|Death|86|||
155407128|NCT04294901|560923613|FG001|Overall Study|Death|110|||
155407129|NCT04294901|560923612|FG000|Overall Study|Provider did not have historical control patients|581|||
155407130|NCT04294901|560923613|FG001|Overall Study|Provider did not have historical control patients|0|||
155407131|NCT04294901|560923612|FG000|Overall Study|Provider did not have intervention patients|0|||
155407132|NCT04294901|560923613|FG001|Overall Study|Provider did not have intervention patients|98|||
155407133|NCT02239939|560925393|FG000|Overall Study|Adverse Event|1|||
155407134|NCT02239939|560925394|FG001|Overall Study|Adverse Event|0|||
155407135|NCT02239939|560925393|FG000|Overall Study|Withdrawal by Subject|1|||
155407136|NCT02239939|560925394|FG001|Overall Study|Withdrawal by Subject|1|||
155407137|NCT02239939|560925393|FG000|Overall Study|Lost to Follow-up|0|||
155407138|NCT02239939|560925394|FG001|Overall Study|Lost to Follow-up|1|||
155407139|NCT05634577|560925395|FG000|Overall Study|Lost to Follow-up|1|||
155407140|NCT05634577|560925395|FG000|Overall Study|Withdrawal by Subject|1|||
155407141|NCT02631200|560925398|FG000|First Period|Death|1|||
155407142|NCT02631200|560925399|FG001|First Period|Death|2|||
155407143|NCT02631200|560925398|FG000|First Period|Patient ill-health|2|||
155407144|NCT02631200|560925399|FG001|First Period|Patient ill-health|4|||
155407145|NCT02631200|560925398|FG000|First Period|Withdrawal by Subject|4|||
155407146|NCT02631200|560925399|FG001|First Period|Withdrawal by Subject|1|||
155407147|NCT02631200|560925398|FG000|Deferred Period|Death|0|||
155407148|NCT02631200|560925399|FG001|Deferred Period|Death|1|||
155742909|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|Other|0|||
155407149|NCT02631200|560925398|FG000|Deferred Period|Received kidney transplant|0|||
155742910|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|Other|0|||
155742911|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|Other|0|||
155742912|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|Other|0|||
155742913|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|Other|0|||
155742914|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|Other|0|||
155742915|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|Other|1|||
155742916|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|Death|0|||
155742917|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|Death|0|||
155742918|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|Death|0|||
155742919|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|Death|0|||
155742920|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|Death|0|||
155742921|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|Death|0|||
155742922|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|Death|0|||
155742923|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|Death|0|||
155742924|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|Death|2|||
155742925|NCT00557856|562158261|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742926|NCT00557856|562158262|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742927|NCT00557856|562158263|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742928|NCT00557856|562158264|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742929|NCT00557856|562158265|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742930|NCT00557856|562158266|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742931|NCT00557856|562158267|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742932|NCT00557856|562158268|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
155742933|NCT00557856|562158269|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
155742934|NCT05092360|562158270|FG000|Overall Study|Withdrawal by Subject|21|||
155742935|NCT05092360|562158271|FG001|Overall Study|Withdrawal by Subject|4|||
155742936|NCT05092360|562158272|FG002|Overall Study|Withdrawal by Subject|9|||
155742937|NCT05092360|562158273|FG003|Overall Study|Withdrawal by Subject|26|||
155742938|NCT05092360|562158270|FG000|Overall Study|Death|97|||
155742939|NCT05092360|562158271|FG001|Overall Study|Death|14|||
155742940|NCT05092360|562158272|FG002|Overall Study|Death|31|||
155742941|NCT05092360|562158273|FG003|Overall Study|Death|101|||
155742942|NCT05092360|562158270|FG000|Overall Study|Lost to Follow-up|1|||
155742943|NCT05092360|562158271|FG001|Overall Study|Lost to Follow-up|2|||
155742944|NCT05092360|562158272|FG002|Overall Study|Lost to Follow-up|2|||
155742945|NCT05092360|562158273|FG003|Overall Study|Lost to Follow-up|2|||
155742946|NCT05092360|562158270|FG000|Overall Study|Study terminated by sponsor|65|||
155742947|NCT05092360|562158271|FG001|Overall Study|Study terminated by sponsor|7|||
155742948|NCT05092360|562158272|FG002|Overall Study|Study terminated by sponsor|13|||
155742949|NCT05092360|562158273|FG003|Overall Study|Study terminated by sponsor|61|||
155742950|NCT01675167|562158274|FG000|Open-label Titration Phase|Adverse Event|81|||
155742951|NCT01675167|562158275|FG001|Open-label Titration Phase|Adverse Event|0|||
155742952|NCT01675167|562158276|FG002|Open-label Titration Phase|Adverse Event|0|||
155742953|NCT01675167|562158274|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
155742954|NCT01675167|562158275|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
155742955|NCT01675167|562158276|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
155742956|NCT01675167|562158274|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
155742957|NCT01675167|562158275|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
155742958|NCT01675167|562158276|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
155742959|NCT01675167|562158274|FG000|Open-label Titration Phase|Protocol Violation|43|||
155742960|NCT01675167|562158275|FG001|Open-label Titration Phase|Protocol Violation|0|||
155742961|NCT01675167|562158276|FG002|Open-label Titration Phase|Protocol Violation|0|||
155742962|NCT01675167|562158274|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
155742963|NCT01675167|562158275|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
155742964|NCT01675167|562158276|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
155742965|NCT01675167|562158274|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
155742966|NCT01675167|562158275|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
155742967|NCT01675167|562158276|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
155742968|NCT01675167|562158274|FG000|Open-label Titration Phase|Other|55|||
155742969|NCT01675167|562158275|FG001|Open-label Titration Phase|Other|0|||
155742970|NCT01675167|562158276|FG002|Open-label Titration Phase|Other|0|||
155742971|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155742972|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
155742973|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
155742974|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155742975|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155742976|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155742977|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155742978|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Adverse Event|5|||
155742979|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Adverse Event|13|||
155742980|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155742981|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
155742982|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
155742983|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155742984|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
155742985|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
155742986|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
155742987|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
155742988|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
155742989|NCT01675167|562158274|FG000|Double-blind Treatment Phase|Other|0|||
155742990|NCT01675167|562158275|FG001|Double-blind Treatment Phase|Other|7|||
155742991|NCT01675167|562158276|FG002|Double-blind Treatment Phase|Other|5|||
155742992|NCT01379508|562158277|FG000|Treatment to Week 104|Adverse Event|2|||
155742993|NCT01379508|562158278|FG001|Treatment to Week 104|Adverse Event|0|||
155742994|NCT01379508|562158279|FG002|Treatment to Week 104|Adverse Event|5|||
155742995|NCT01379508|562158280|FG003|Treatment to Week 104|Adverse Event|0|||
155742996|NCT01379508|562158277|FG000|Treatment to Week 104|Abnormal lab value|1|||
155407150|NCT02631200|560925399|FG001|Deferred Period|Received kidney transplant|1|||
155407151|NCT02631200|560925398|FG000|Deferred Period|Withdrawal by Subject|0|||
155407152|NCT02631200|560925399|FG001|Deferred Period|Withdrawal by Subject|2|||
155407153|NCT02631200|560925398|FG000|Deferred Period|Lost to Follow-up|0|||
155407154|NCT02631200|560925399|FG001|Deferred Period|Lost to Follow-up|1|||
155407155|NCT01496885|560925401|FG000|Overall Study|Lost to Follow-up|13|||
155407156|NCT01496885|560925401|FG000|Overall Study|Withdrawal by Subject|7|||
155407157|NCT01496885|560925401|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
155407158|NCT01496885|560925401|FG000|Overall Study|Death|1|||
155407159|NCT03273166|560925402|FG000|Overall Study|Withdrawn prior to Completion|31|||
155407160|NCT01294670|560925403|FG000|Overall Study|Not treated|1|||
155407161|NCT01294670|560925404|FG001|Overall Study|Not treated|0|||
155407162|NCT01294670|560925405|FG002|Overall Study|Not treated|0|||
155407163|NCT01294670|560925406|FG003|Overall Study|Not treated|0|||
155407164|NCT01294670|560925407|FG004|Overall Study|Not treated|0|||
155407165|NCT04091087|560925408|FG000|Overall Study|Not treated|1|||
155407166|NCT04091087|560925409|FG001|Overall Study|Not treated|0|||
155407167|NCT04091087|560925408|FG000|Overall Study|Adverse Event|4|||
155407168|NCT04091087|560925409|FG001|Overall Study|Adverse Event|4|||
155407169|NCT04091087|560925408|FG000|Overall Study|Protocol Violation|0|||
155407170|NCT04091087|560925409|FG001|Overall Study|Protocol Violation|1|||
155407171|NCT04091087|560925408|FG000|Overall Study|Withdrawal by Subject|5|||
155407172|NCT04091087|560925409|FG001|Overall Study|Withdrawal by Subject|2|||
155407173|NCT04152161|560925410|FG000|Overall Study|Death|0|||
155407174|NCT04152161|560925411|FG001|Overall Study|Death|1|||
155407175|NCT04152161|560925410|FG000|Overall Study|Physician Decision|0|||
155407176|NCT04152161|560925411|FG001|Overall Study|Physician Decision|1|||
155407177|NCT04152161|560925410|FG000|Overall Study|Lost to Follow-up|9|||
155407178|NCT04152161|560925411|FG001|Overall Study|Lost to Follow-up|3|||
155407179|NCT04152161|560925410|FG000|Overall Study|Protocol Violation|1|||
155407180|NCT04152161|560925411|FG001|Overall Study|Protocol Violation|0|||
155407181|NCT04152161|560925410|FG000|Overall Study|Withdrawal by Subject|29|||
155407182|NCT04152161|560925411|FG001|Overall Study|Withdrawal by Subject|28|||
155407183|NCT04152161|560925410|FG000|Overall Study|Sponsor termination of study|750|||
155407184|NCT04152161|560925411|FG001|Overall Study|Sponsor termination of study|755|||
155407185|NCT04152161|560925410|FG000|Overall Study|Other|20|||
155407186|NCT04152161|560925411|FG001|Overall Study|Other|18|||
155407187|NCT03363321|560925412|FG000|Overall Study|Withdrawal by Subject|0|||
155407188|NCT03363321|560925413|FG001|Overall Study|Withdrawal by Subject|1|||
155407189|NCT03363321|560925414|FG002|Overall Study|Withdrawal by Subject|0|||
155407190|NCT03363321|560925415|FG003|Overall Study|Withdrawal by Subject|1|||
155407191|NCT03363321|560925416|FG004|Overall Study|Withdrawal by Subject|0|||
155407192|NCT02915523|560925418|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
155407193|NCT02915523|560925419|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
155407194|NCT02915523|560925420|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
155407195|NCT02915523|560925421|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
155407196|NCT02915523|560925418|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
155407197|NCT02915523|560925419|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
155407198|NCT02915523|560925420|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
155407199|NCT02915523|560925421|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
155407200|NCT02915523|560925418|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
155407201|NCT02915523|560925419|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
155407202|NCT02915523|560925420|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
155407203|NCT02915523|560925421|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
155407204|NCT02915523|560925418|FG000|Expansion Phase (Phase 2)|Death|0|||
155407205|NCT02915523|560925419|FG001|Expansion Phase (Phase 2)|Death|0|||
155407206|NCT02915523|560925420|FG002|Expansion Phase (Phase 2)|Death|26|||
155407207|NCT02915523|560925421|FG003|Expansion Phase (Phase 2)|Death|53|||
155407208|NCT02915523|560925418|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
155407209|NCT02915523|560925419|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
155407210|NCT02915523|560925420|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
155637976|NCT02362451|561766343|FG001|Overall Study|Withdrawal by Subject|1|||
155407211|NCT02915523|560925421|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
155637977|NCT02362451|561766342|FG000|Overall Study|Lack of Efficacy|2|||
155637978|NCT02362451|561766343|FG001|Overall Study|Lack of Efficacy|0|||
155637979|NCT02362451|561766342|FG000|Overall Study|Progression|1|||
155407212|NCT02915523|560925418|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
155407213|NCT02915523|560925419|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
155407214|NCT02915523|560925420|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
155407215|NCT02915523|560925421|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
155407216|NCT02915523|560925418|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
155407217|NCT02915523|560925419|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
155407218|NCT02915523|560925420|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
155407219|NCT02915523|560925421|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
155407220|NCT02590588|560925424|FG000|Overall Study|Adverse Event|1|||
155637980|NCT02362451|561766343|FG001|Overall Study|Progression|0|||
155742997|NCT01379508|562158278|FG001|Treatment to Week 104|Abnormal lab value|0|||
155742998|NCT01379508|562158279|FG002|Treatment to Week 104|Abnormal lab value|0|||
155742999|NCT01379508|562158280|FG003|Treatment to Week 104|Abnormal lab value|0|||
155743000|NCT01379508|562158277|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
155743001|NCT01379508|562158278|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155743002|NCT01379508|562158279|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155743003|NCT01379508|562158280|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155743004|NCT01379508|562158277|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
155743005|NCT01379508|562158278|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
155743006|NCT01379508|562158279|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
155743007|NCT01379508|562158280|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
155743008|NCT01379508|562158277|FG000|Treatment to Week 104|Lost to Follow-up|5|||
155743009|NCT01379508|562158278|FG001|Treatment to Week 104|Lost to Follow-up|0|||
155743010|NCT01379508|562158279|FG002|Treatment to Week 104|Lost to Follow-up|3|||
155743011|NCT01379508|562158280|FG003|Treatment to Week 104|Lost to Follow-up|0|||
155743012|NCT01379508|562158277|FG000|Treatment to Week 104|Administrative problems|3|||
155743013|NCT01379508|562158278|FG001|Treatment to Week 104|Administrative problems|1|||
155743014|NCT01379508|562158279|FG002|Treatment to Week 104|Administrative problems|0|||
155743015|NCT01379508|562158280|FG003|Treatment to Week 104|Administrative problems|0|||
155743016|NCT01379508|562158277|FG000|Treatment to Week 104|Protocol Violation|1|||
155743017|NCT01379508|562158278|FG001|Treatment to Week 104|Protocol Violation|1|||
155743018|NCT01379508|562158279|FG002|Treatment to Week 104|Protocol Violation|1|||
155743019|NCT01379508|562158280|FG003|Treatment to Week 104|Protocol Violation|0|||
155743020|NCT01379508|562158277|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
155743021|NCT01379508|562158278|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
155743022|NCT01379508|562158279|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
155743023|NCT01379508|562158280|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
155743024|NCT01379508|562158277|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
155743025|NCT01379508|562158278|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
155743026|NCT01379508|562158279|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
155743027|NCT01379508|562158280|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
155743028|NCT01379508|562158277|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
155743029|NCT01379508|562158278|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
155743030|NCT01379508|562158279|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
155743031|NCT01379508|562158280|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
155743032|NCT01379508|562158277|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
155743033|NCT01379508|562158278|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
155743034|NCT01379508|562158279|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
155743035|NCT01379508|562158280|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
155743036|NCT01330017|562159780|FG000|Overall Study|Adverse Event|0|||
155743037|NCT01330017|562159781|FG001|Overall Study|Adverse Event|1|||
155743038|NCT01330017|562159782|FG002|Overall Study|Adverse Event|1|||
155743039|NCT01330017|562159783|FG003|Overall Study|Adverse Event|4|||
155743040|NCT01330017|562159784|FG004|Overall Study|Adverse Event|0|||
155743041|NCT01330017|562159780|FG000|Overall Study|Withdrawal by Subject|0|||
155743042|NCT01330017|562159781|FG001|Overall Study|Withdrawal by Subject|0|||
155743043|NCT01330017|562159782|FG002|Overall Study|Withdrawal by Subject|1|||
155743044|NCT01330017|562159783|FG003|Overall Study|Withdrawal by Subject|0|||
155743045|NCT01330017|562159784|FG004|Overall Study|Withdrawal by Subject|1|||
155743046|NCT01330017|562159780|FG000|Overall Study|Lost to Follow-up|0|||
155743047|NCT01330017|562159781|FG001|Overall Study|Lost to Follow-up|0|||
155743048|NCT01330017|562159782|FG002|Overall Study|Lost to Follow-up|1|||
155743049|NCT01330017|562159783|FG003|Overall Study|Lost to Follow-up|0|||
155743050|NCT01330017|562159784|FG004|Overall Study|Lost to Follow-up|0|||
155743051|NCT01330017|562159780|FG000|Overall Study|Protocol Violation|0|||
155743052|NCT01330017|562159781|FG001|Overall Study|Protocol Violation|0|||
155743053|NCT01330017|562159782|FG002|Overall Study|Protocol Violation|0|||
155743054|NCT01330017|562159783|FG003|Overall Study|Protocol Violation|1|||
155743055|NCT01330017|562159784|FG004|Overall Study|Protocol Violation|0|||
155743056|NCT01330017|562159780|FG000|Overall Study|Unknown Reason|5|||
155743057|NCT01330017|562159781|FG001|Overall Study|Unknown Reason|3|||
155743058|NCT01330017|562159782|FG002|Overall Study|Unknown Reason|5|||
155743059|NCT01330017|562159783|FG003|Overall Study|Unknown Reason|7|||
155743060|NCT01330017|562159784|FG004|Overall Study|Unknown Reason|2|||
155743061|NCT01122264|562159786|FG000|Overall Study|Adverse Event|6|||
155743062|NCT01122264|562159787|FG001|Overall Study|Adverse Event|5|||
155743063|NCT01122264|562159788|FG002|Overall Study|Adverse Event|7|||
155743064|NCT01122264|562159786|FG000|Overall Study|Death|1|||
155743065|NCT01122264|562159787|FG001|Overall Study|Death|0|||
155743066|NCT01122264|562159788|FG002|Overall Study|Death|0|||
155407221|NCT01780831|560925432|FG000|Overall Study|Withdrawal by Subject|0|||
155407222|NCT01780831|560925433|FG001|Overall Study|Withdrawal by Subject|0|||
155407223|NCT01780831|560925434|FG002|Overall Study|Withdrawal by Subject|4|||
155407224|NCT01780831|560925435|FG003|Overall Study|Withdrawal by Subject|0|||
155407225|NCT01780831|560925432|FG000|Overall Study|Lost to Follow-up|0|||
155407226|NCT01780831|560925433|FG001|Overall Study|Lost to Follow-up|0|||
155407227|NCT01780831|560925434|FG002|Overall Study|Lost to Follow-up|0|||
155407228|NCT01780831|560925435|FG003|Overall Study|Lost to Follow-up|1|||
155407229|NCT01784861|560925439|FG000|Overall Study|Adverse Event|0|||
155407230|NCT01784861|560925440|FG001|Overall Study|Adverse Event|0|||
155407231|NCT01784861|560925441|FG002|Overall Study|Adverse Event|1|||
155743067|NCT01122264|562159786|FG000|Overall Study|Lost to Follow-up|5|||
155743068|NCT01122264|562159787|FG001|Overall Study|Lost to Follow-up|9|||
155743069|NCT01122264|562159788|FG002|Overall Study|Lost to Follow-up|13|||
155743070|NCT01122264|562159786|FG000|Overall Study|Entry Criteria Not Met|1|||
155743071|NCT01122264|562159787|FG001|Overall Study|Entry Criteria Not Met|0|||
155743072|NCT01122264|562159788|FG002|Overall Study|Entry Criteria Not Met|0|||
155407232|NCT01784861|560925442|FG003|Overall Study|Adverse Event|2|||
155407233|NCT01784861|560925443|FG004|Overall Study|Adverse Event|1|||
155407234|NCT01784861|560925444|FG005|Overall Study|Adverse Event|0|||
155407235|NCT01784861|560925439|FG000|Overall Study|Withdrawal by Subject|0|||
155407236|NCT01784861|560925440|FG001|Overall Study|Withdrawal by Subject|0|||
155407237|NCT01784861|560925441|FG002|Overall Study|Withdrawal by Subject|0|||
155407238|NCT01784861|560925442|FG003|Overall Study|Withdrawal by Subject|1|||
155407239|NCT01784861|560925443|FG004|Overall Study|Withdrawal by Subject|0|||
155407240|NCT01784861|560925444|FG005|Overall Study|Withdrawal by Subject|0|||
155407241|NCT01784861|560925439|FG000|Overall Study|Physician Decision|0|||
155407242|NCT01784861|560925440|FG001|Overall Study|Physician Decision|0|||
155407243|NCT01784861|560925441|FG002|Overall Study|Physician Decision|0|||
155407244|NCT01784861|560925442|FG003|Overall Study|Physician Decision|2|||
155407245|NCT01784861|560925443|FG004|Overall Study|Physician Decision|0|||
155407246|NCT01784861|560925444|FG005|Overall Study|Physician Decision|1|||
155407247|NCT01965262|560925453|FG000|Second Intervention (7 Days)|Discontinued|0|||
155407248|NCT01965262|560925454|FG001|Second Intervention (7 Days)|Discontinued|1|||
155407249|NCT01965262|560925453|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
155407250|NCT01965262|560925454|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
155407251|NCT01965262|560925453|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
155407252|NCT01965262|560925454|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
155407253|NCT01029366|560925455|FG000|Overall Study|Withdrawal by Subject|1|||
155407254|NCT01029366|560925456|FG001|Overall Study|Withdrawal by Subject|0|||
155407255|NCT01029366|560925455|FG000|Overall Study|Death|1|||
155407256|NCT01029366|560925456|FG001|Overall Study|Death|1|||
155407257|NCT01029366|560925455|FG000|Overall Study|disease progression|2|||
155407258|NCT01029366|560925456|FG001|Overall Study|disease progression|0|||
155407259|NCT01029366|560925455|FG000|Overall Study|manufacturing failure|0|||
155407260|NCT01029366|560925456|FG001|Overall Study|manufacturing failure|1|||
155407261|NCT00440947|560925457|FG000|36-Week Induction Phase|Adverse Event|16|||
155407262|NCT00440947|560925458|FG001|36-Week Induction Phase|Adverse Event|0|||
155407263|NCT00440947|560925459|FG002|36-Week Induction Phase|Adverse Event|0|||
155743073|NCT01122264|562159786|FG000|Overall Study|Protocol Violation|7|||
155743074|NCT01122264|562159787|FG001|Overall Study|Protocol Violation|7|||
155743075|NCT01122264|562159788|FG002|Overall Study|Protocol Violation|9|||
155743076|NCT01122264|562159786|FG000|Overall Study|Withdrawal by Subject|6|||
155743077|NCT01122264|562159787|FG001|Overall Study|Withdrawal by Subject|6|||
155407264|NCT00440947|560925460|FG003|36-Week Induction Phase|Adverse Event|0|||
155407265|NCT00440947|560925461|FG004|36-Week Induction Phase|Adverse Event|0|||
155407266|NCT00440947|560925457|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
155407267|NCT00440947|560925458|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
155407268|NCT00440947|560925459|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
155407269|NCT00440947|560925460|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
155407270|NCT00440947|560925461|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
155407271|NCT00440947|560925457|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
155407272|NCT00440947|560925458|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
155407273|NCT00440947|560925459|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
155407274|NCT00440947|560925460|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
155407275|NCT00440947|560925461|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
155407276|NCT00440947|560925457|FG000|36-Week Induction Phase|Non-compliance|10|||
155407277|NCT00440947|560925458|FG001|36-Week Induction Phase|Non-compliance|0|||
155407278|NCT00440947|560925459|FG002|36-Week Induction Phase|Non-compliance|0|||
155407279|NCT00440947|560925460|FG003|36-Week Induction Phase|Non-compliance|0|||
155407280|NCT00440947|560925461|FG004|36-Week Induction Phase|Non-compliance|0|||
155407281|NCT00440947|560925457|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
155743078|NCT01122264|562159788|FG002|Overall Study|Withdrawal by Subject|16|||
155743079|NCT01122264|562159786|FG000|Overall Study|Physician Decision|3|||
155743080|NCT01122264|562159787|FG001|Overall Study|Physician Decision|1|||
155407282|NCT00440947|560925458|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
155407283|NCT00440947|560925459|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
155407284|NCT00440947|560925460|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
155407285|NCT00440947|560925461|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
155407286|NCT00440947|560925457|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
155407287|NCT00440947|560925458|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
155407288|NCT00440947|560925459|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
155407289|NCT00440947|560925460|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
155407290|NCT00440947|560925461|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
155407291|NCT00440947|560925457|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
155407292|NCT00440947|560925458|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
155407293|NCT00440947|560925459|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
155407294|NCT00440947|560925460|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
155407295|NCT00440947|560925461|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
155407296|NCT00440947|560925457|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
155407297|NCT00440947|560925458|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
155407298|NCT00440947|560925459|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
155407299|NCT00440947|560925460|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
155407300|NCT00440947|560925461|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
155407301|NCT00440947|560925457|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
155407302|NCT00440947|560925458|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
155407303|NCT00440947|560925459|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
155407304|NCT00440947|560925460|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
155407305|NCT00440947|560925461|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
155407306|NCT00440947|560925457|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
155407307|NCT00440947|560925458|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
155407308|NCT00440947|560925459|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
155407309|NCT00440947|560925460|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
155407310|NCT00440947|560925461|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
155407311|NCT00440947|560925457|FG000|36-Week Induction Phase|Incarceration|3|||
155407312|NCT00440947|560925458|FG001|36-Week Induction Phase|Incarceration|0|||
155407313|NCT00440947|560925459|FG002|36-Week Induction Phase|Incarceration|0|||
155407314|NCT00440947|560925460|FG003|36-Week Induction Phase|Incarceration|0|||
155407315|NCT00440947|560925461|FG004|36-Week Induction Phase|Incarceration|0|||
155407316|NCT00440947|560925457|FG000|36-Week Induction Phase|Pregnancy|1|||
155407317|NCT00440947|560925458|FG001|36-Week Induction Phase|Pregnancy|0|||
155407318|NCT00440947|560925459|FG002|36-Week Induction Phase|Pregnancy|0|||
155407319|NCT00440947|560925460|FG003|36-Week Induction Phase|Pregnancy|0|||
155407320|NCT00440947|560925461|FG004|36-Week Induction Phase|Pregnancy|0|||
155407321|NCT00440947|560925457|FG000|48-Week Randomization Phase|Adverse Event|0|||
155407322|NCT00440947|560925458|FG001|48-Week Randomization Phase|Adverse Event|2|||
155407323|NCT00440947|560925459|FG002|48-Week Randomization Phase|Adverse Event|5|||
155407324|NCT00440947|560925460|FG003|48-Week Randomization Phase|Adverse Event|0|||
155407325|NCT00440947|560925461|FG004|48-Week Randomization Phase|Adverse Event|0|||
155407326|NCT00440947|560925457|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
155407327|NCT00440947|560925458|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
155407328|NCT00440947|560925459|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
155407329|NCT00440947|560925460|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
155407330|NCT00440947|560925461|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
155407331|NCT00440947|560925457|FG000|48-Week Randomization Phase|Non-compliance|0|||
155407332|NCT00440947|560925458|FG001|48-Week Randomization Phase|Non-compliance|3|||
155407333|NCT00440947|560925459|FG002|48-Week Randomization Phase|Non-compliance|4|||
155407334|NCT00440947|560925460|FG003|48-Week Randomization Phase|Non-compliance|0|||
155407335|NCT00440947|560925461|FG004|48-Week Randomization Phase|Non-compliance|0|||
155407336|NCT00440947|560925457|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
155407337|NCT00440947|560925458|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
155407338|NCT00440947|560925459|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
155637981|NCT02362451|561766342|FG000|Overall Study|Participant chose other therapy.|1|||
155637982|NCT02362451|561766343|FG001|Overall Study|Participant chose other therapy.|0|||
155637983|NCT01732783|561766346|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
155637984|NCT01732783|561766347|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
155637985|NCT01732783|561766348|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
155407339|NCT00440947|560925460|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
155407340|NCT00440947|560925461|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
155407341|NCT00440947|560925457|FG000|48-Week Randomization Phase|Protocol Violation|0|||
155407342|NCT00440947|560925458|FG001|48-Week Randomization Phase|Protocol Violation|0|||
155407343|NCT00440947|560925459|FG002|48-Week Randomization Phase|Protocol Violation|1|||
155407344|NCT00440947|560925460|FG003|48-Week Randomization Phase|Protocol Violation|0|||
155637986|NCT01732783|561766346|FG000|Overall Study|Death|13|||
155407345|NCT00440947|560925461|FG004|48-Week Randomization Phase|Protocol Violation|0|||
155407346|NCT00440947|560925457|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
155407347|NCT00440947|560925458|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
155407348|NCT00440947|560925459|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
155407349|NCT00440947|560925460|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
155407350|NCT00440947|560925461|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
155407351|NCT00440947|560925457|FG000|48-Week Randomization Phase|Pregnancy|0|||
155743081|NCT01122264|562159788|FG002|Overall Study|Physician Decision|1|||
155287304|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155743082|NCT01122264|562159786|FG000|Overall Study|Lack of Efficacy|3|||
155743083|NCT01122264|562159787|FG001|Overall Study|Lack of Efficacy|1|||
155743084|NCT01122264|562159788|FG002|Overall Study|Lack of Efficacy|1|||
155743085|NCT00640224|562159789|FG000|Overall Study|Lost to Follow-up|5|||
155743086|NCT00640224|562159790|FG001|Overall Study|Lost to Follow-up|2|||
155743087|NCT00640224|562159791|FG002|Overall Study|Lost to Follow-up|0|||
155743088|NCT00640224|562159792|FG003|Overall Study|Lost to Follow-up|0|||
155743089|NCT00640224|562159789|FG000|Overall Study|Withdrawal by Subject|1|||
155743090|NCT00640224|562159790|FG001|Overall Study|Withdrawal by Subject|0|||
155743091|NCT00640224|562159791|FG002|Overall Study|Withdrawal by Subject|0|||
155743092|NCT00640224|562159792|FG003|Overall Study|Withdrawal by Subject|0|||
155743093|NCT00640224|562159789|FG000|Overall Study|Headaches|0|||
155743094|NCT00640224|562159790|FG001|Overall Study|Headaches|1|||
155743095|NCT00640224|562159791|FG002|Overall Study|Headaches|0|||
155743096|NCT00640224|562159792|FG003|Overall Study|Headaches|0|||
155743097|NCT00422513|562159793|FG000|Overall Study|Lack of Efficacy|4|||
155743098|NCT00422513|562159794|FG001|Overall Study|Lack of Efficacy|5|||
155743099|NCT00422513|562159793|FG000|Overall Study|Protocol Violation|23|||
155287305|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155287306|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
155287307|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
155287308|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
155287309|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
155287310|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
155287311|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
155287312|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287313|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287314|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287315|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287316|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287317|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
155287318|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
155287319|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
155287320|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
155287321|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
155287322|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
155287323|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287324|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287325|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287326|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287327|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287328|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287329|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
155287330|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
155287331|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
155287332|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
155287333|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287334|NCT04678830|560484292|FG000|Overall Study|Lack of Efficacy|2|||
155287335|NCT04678830|560484293|FG001|Overall Study|Lack of Efficacy|0|||
155287336|NCT04678830|560484292|FG000|Overall Study|Withdrawal by Subject|0|||
155287337|NCT04678830|560484293|FG001|Overall Study|Withdrawal by Subject|1|||
155287338|NCT05550337|560484294|FG000|Overall Study|Lack of Efficacy|0|||
155287339|NCT05550337|560484295|FG001|Overall Study|Lack of Efficacy|0|||
155287340|NCT05550337|560484296|FG002|Overall Study|Lack of Efficacy|1|||
155287341|NCT05550337|560484294|FG000|Overall Study|Adverse Event|1|||
155287342|NCT05550337|560484295|FG001|Overall Study|Adverse Event|5|||
155287343|NCT05550337|560484296|FG002|Overall Study|Adverse Event|0|||
155287344|NCT05550337|560484294|FG000|Overall Study|Withdrawal by Subject|8|||
155287345|NCT05550337|560484295|FG001|Overall Study|Withdrawal by Subject|14|||
155743100|NCT00422513|562159794|FG001|Overall Study|Protocol Violation|7|||
155743101|NCT00422513|562159793|FG000|Overall Study|Refused Treatment|4|||
155743102|NCT00422513|562159794|FG001|Overall Study|Refused Treatment|2|||
155743103|NCT00422513|562159793|FG000|Overall Study|Withdrawal by Subject|2|||
155743104|NCT00422513|562159794|FG001|Overall Study|Withdrawal by Subject|1|||
155743105|NCT00422513|562159793|FG000|Overall Study|early termination of the study|67|||
155743106|NCT00422513|562159794|FG001|Overall Study|early termination of the study|80|||
155743107|NCT00422513|562159793|FG000|Overall Study|Adverse Event|4|||
155743108|NCT00422513|562159794|FG001|Overall Study|Adverse Event|4|||
155743109|NCT00422513|562159793|FG000|Overall Study|Death|3|||
155743110|NCT00422513|562159794|FG001|Overall Study|Death|7|||
155287346|NCT05550337|560484296|FG002|Overall Study|Withdrawal by Subject|10|||
155287347|NCT05550337|560484294|FG000|Overall Study|Pregnancy|0|||
155287348|NCT05550337|560484295|FG001|Overall Study|Pregnancy|0|||
155287349|NCT05550337|560484296|FG002|Overall Study|Pregnancy|1|||
155287350|NCT05550337|560484294|FG000|Overall Study|Protocol Violation|1|||
155287351|NCT05550337|560484295|FG001|Overall Study|Protocol Violation|3|||
155287352|NCT05550337|560484296|FG002|Overall Study|Protocol Violation|4|||
155407352|NCT00440947|560925458|FG001|48-Week Randomization Phase|Pregnancy|0|||
155407353|NCT00440947|560925459|FG002|48-Week Randomization Phase|Pregnancy|1|||
155407354|NCT00440947|560925460|FG003|48-Week Randomization Phase|Pregnancy|0|||
155407355|NCT00440947|560925461|FG004|48-Week Randomization Phase|Pregnancy|0|||
155407356|NCT00440947|560925457|FG000|48-Week Randomization Phase|Incarceration|0|||
155407357|NCT00440947|560925458|FG001|48-Week Randomization Phase|Incarceration|3|||
155407358|NCT00440947|560925459|FG002|48-Week Randomization Phase|Incarceration|0|||
155407359|NCT00440947|560925460|FG003|48-Week Randomization Phase|Incarceration|0|||
155407360|NCT00440947|560925461|FG004|48-Week Randomization Phase|Incarceration|0|||
155407361|NCT00440947|560925457|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
155407362|NCT00440947|560925458|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
155407363|NCT00440947|560925459|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
155407364|NCT00440947|560925460|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
155287353|NCT05550337|560484294|FG000|Overall Study|Physician Decision|2|||
155287354|NCT05550337|560484295|FG001|Overall Study|Physician Decision|1|||
155407365|NCT00440947|560925461|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
155407366|NCT00440947|560925457|FG000|48-Week Randomization Phase|Physician Decision|0|||
155407367|NCT00440947|560925458|FG001|48-Week Randomization Phase|Physician Decision|2|||
155637987|NCT01732783|561766347|FG001|Overall Study|Death|4|||
155637988|NCT01732783|561766348|FG002|Overall Study|Death|1|||
155637989|NCT01732783|561766346|FG000|Overall Study|Lost to Follow-up|7|||
155637990|NCT01732783|561766347|FG001|Overall Study|Lost to Follow-up|1|||
155637991|NCT01732783|561766348|FG002|Overall Study|Lost to Follow-up|1|||
155637992|NCT01732783|561766346|FG000|Overall Study|Administrative Decision|8|||
155637993|NCT01732783|561766347|FG001|Overall Study|Administrative Decision|2|||
155637994|NCT01732783|561766348|FG002|Overall Study|Administrative Decision|1|||
155637995|NCT01732783|561766346|FG000|Overall Study|Withdrawal by Subject|1|||
155637996|NCT01732783|561766347|FG001|Overall Study|Withdrawal by Subject|0|||
155637997|NCT01732783|561766348|FG002|Overall Study|Withdrawal by Subject|0|||
155637998|NCT04429971|561766349|FG000|Overall Study|Lost to Follow-up|7|||
155637999|NCT04429971|561766350|FG001|Overall Study|Lost to Follow-up|8|||
155638000|NCT05522751|561766356|FG000|Overall Study|Adverse Event|1|||
155638001|NCT04044690|561766358|FG000|Period 1|Lack of Efficacy|1|||
155638002|NCT04044690|561766359|FG001|Period 1|Lack of Efficacy|1|||
155638003|NCT04044690|561766358|FG000|Period 1|Adverse Event|4|||
155638004|NCT04044690|561766359|FG001|Period 1|Adverse Event|2|||
155638005|NCT04044690|561766358|FG000|Period 1|Physician Decision|0|||
155638006|NCT04044690|561766359|FG001|Period 1|Physician Decision|1|||
155638007|NCT04044690|561766358|FG000|Period 1|Withdrawal by Subject|2|||
155638008|NCT04044690|561766359|FG001|Period 1|Withdrawal by Subject|5|||
155638009|NCT04044690|561766358|FG000|Period 1|Protocol Deviation|2|||
155638010|NCT04044690|561766359|FG001|Period 1|Protocol Deviation|0|||
155638011|NCT04044690|561766358|FG000|Period 1|Site Terminated by Sponsor|0|||
155638012|NCT04044690|561766359|FG001|Period 1|Site Terminated by Sponsor|1|||
155638013|NCT04044690|561766358|FG000|Period 1|Study Terminated by Sponsor|0|||
155638014|NCT04044690|561766359|FG001|Period 1|Study Terminated by Sponsor|1|||
155638015|NCT04044690|561766358|FG000|Period 1|Death|1|||
155638016|NCT04044690|561766359|FG001|Period 1|Death|1|||
155638017|NCT04044690|561766358|FG000|Period 1|Other: Unspecified|1|||
155638018|NCT04044690|561766359|FG001|Period 1|Other: Unspecified|0|||
155638019|NCT04044690|561766358|FG000|Period 2|Lack of Efficacy|0|||
155638020|NCT04044690|561766359|FG001|Period 2|Lack of Efficacy|1|||
155638021|NCT04044690|561766358|FG000|Period 2|Adverse Event|0|||
155638022|NCT04044690|561766359|FG001|Period 2|Adverse Event|1|||
155638023|NCT04044690|561766358|FG000|Period 2|Physician Decision|0|||
155638024|NCT04044690|561766359|FG001|Period 2|Physician Decision|2|||
155638025|NCT04044690|561766358|FG000|Period 2|Withdrawal by Subject|5|||
155638026|NCT04044690|561766359|FG001|Period 2|Withdrawal by Subject|5|||
155638027|NCT04044690|561766358|FG000|Period 2|Lost to Follow-up|0|||
155638028|NCT04044690|561766359|FG001|Period 2|Lost to Follow-up|1|||
155638029|NCT04044690|561766358|FG000|Period 2|Site Terminated by Sponsor|1|||
155638030|NCT04044690|561766359|FG001|Period 2|Site Terminated by Sponsor|3|||
155638031|NCT04044690|561766358|FG000|Period 2|Study Terminated by Sponsor|8|||
155638032|NCT04044690|561766359|FG001|Period 2|Study Terminated by Sponsor|3|||
155638033|NCT04044690|561766358|FG000|Period 2|Death|1|||
155638034|NCT04044690|561766359|FG001|Period 2|Death|0|||
155638035|NCT04044690|561766358|FG000|Period 2|Other: Unspecified|1|||
155638036|NCT04044690|561766359|FG001|Period 2|Other: Unspecified|1|||
155638037|NCT04044690|561766358|FG000|Period 3|Site Terminated by Sponsor|1|||
155638038|NCT04044690|561766359|FG001|Period 3|Site Terminated by Sponsor|2|||
155287355|NCT05550337|560484296|FG002|Overall Study|Physician Decision|1|||
155407368|NCT00440947|560925459|FG002|48-Week Randomization Phase|Physician Decision|0|||
155407369|NCT00440947|560925460|FG003|48-Week Randomization Phase|Physician Decision|0|||
155407370|NCT00440947|560925461|FG004|48-Week Randomization Phase|Physician Decision|0|||
155407371|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
155407372|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
155407373|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
155407374|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
155407375|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
155407376|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
155407377|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
155407378|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
155407379|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
155407380|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
155407381|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
155407382|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
155407383|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
155407384|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
155407385|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
155407386|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
155407387|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
155407388|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
155407389|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
155407390|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
155407391|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
155407392|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
155407393|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
155407394|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
155407395|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
155407396|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
155407397|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
155407398|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
155407399|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
155407400|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
155407401|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
155407402|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
155407403|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
155407404|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
155407405|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
155407406|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
155407407|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
155407408|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
155407409|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
155407410|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
155407411|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
155407412|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
155407413|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
155407414|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
155407415|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
155407416|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
155407417|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
155743111|NCT03135119|562159795|FG000|Overall Study|Lost to Follow-up|2|||
155743112|NCT03135119|562159796|FG001|Overall Study|Lost to Follow-up|0|||
155743113|NCT03135119|562159795|FG000|Overall Study|Physician Decision|1|||
155743114|NCT03135119|562159796|FG001|Overall Study|Physician Decision|1|||
155743115|NCT03135119|562159795|FG000|Overall Study|COVID-19 Shutdown|2|||
155743116|NCT03135119|562159796|FG001|Overall Study|COVID-19 Shutdown|2|||
155743117|NCT01478048|562159797|FG000|Overall Study|Disease Progression|52|||
155743118|NCT01478048|562159798|FG001|Overall Study|Disease Progression|35|||
155743119|NCT01478048|562159797|FG000|Overall Study|study drug toxicity|11|||
155743120|NCT01478048|562159798|FG001|Overall Study|study drug toxicity|14|||
155287356|NCT05550337|560484294|FG000|Overall Study|Lost to Follow-up|16|||
155407418|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
155407419|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
155407420|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
155743121|NCT01478048|562159797|FG000|Overall Study|Adverse Event|2|||
155743122|NCT01478048|562159798|FG001|Overall Study|Adverse Event|11|||
155743123|NCT01478048|562159797|FG000|Overall Study|subject request to discontinue treatment|3|||
155743124|NCT01478048|562159798|FG001|Overall Study|subject request to discontinue treatment|5|||
155407421|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
155407422|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
155407423|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
155287357|NCT05550337|560484295|FG001|Overall Study|Lost to Follow-up|11|||
155407424|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
155407425|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
155407426|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Other|0|||
155407427|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Other|0|||
155407428|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Other|0|||
155407429|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Other|1|||
155407430|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Other|0|||
155407431|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
155407432|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
155407433|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
155407434|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
155407435|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
155407436|NCT00440947|560925457|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
155407437|NCT00440947|560925458|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
155407438|NCT00440947|560925459|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
155407439|NCT00440947|560925460|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
155407440|NCT00440947|560925461|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
155407441|NCT01827670|560925472|FG000|Overall Study|Withdrawal of Consent|3|||
155407442|NCT01827670|560925473|FG001|Overall Study|Withdrawal of Consent|2|||
155407443|NCT01827670|560925472|FG000|Overall Study|Lost to Follow-up|0|||
155743125|NCT01478048|562159797|FG000|Overall Study|Withdrawal by Subject|2|||
155743126|NCT01478048|562159798|FG001|Overall Study|Withdrawal by Subject|5|||
155743127|NCT01478048|562159797|FG000|Overall Study|non-specified|6|||
155743128|NCT01478048|562159798|FG001|Overall Study|non-specified|4|||
155743129|NCT01478048|562159797|FG000|Overall Study|poor/non-compliance|0|||
155743130|NCT01478048|562159798|FG001|Overall Study|poor/non-compliance|1|||
155743131|NCT01478048|562159797|FG000|Overall Study|no longer meets study criteria|1|||
155743132|NCT01478048|562159798|FG001|Overall Study|no longer meets study criteria|0|||
155743133|NCT01369329|562159800|FG000|Overall Study|Withdrawal by Subject|8|||
155743134|NCT01369329|562159801|FG001|Overall Study|Withdrawal by Subject|6|||
155743135|NCT01369329|562159802|FG002|Overall Study|Withdrawal by Subject|10|||
155743136|NCT01369329|562159800|FG000|Overall Study|Lost to Follow-up|2|||
155743137|NCT01369329|562159801|FG001|Overall Study|Lost to Follow-up|2|||
155743138|NCT01369329|562159802|FG002|Overall Study|Lost to Follow-up|2|||
155743139|NCT01369329|562159800|FG000|Overall Study|Other|2|||
155743140|NCT01369329|562159801|FG001|Overall Study|Other|3|||
155743141|NCT01369329|562159802|FG002|Overall Study|Other|2|||
155743142|NCT04644315|562159803|FG000|Overall Study|Subject withdrawal of consent|1|||
155743143|NCT01836276|562159804|FG000|Overall Study|Lost to Follow-up|28|||
155743144|NCT01836276|562159805|FG001|Overall Study|Lost to Follow-up|51|||
155743145|NCT01561898|562159808|FG000|Overall Study|Withdrawal by Subject|0|||
155743146|NCT01561898|562159809|FG001|Overall Study|Withdrawal by Subject|8|||
155743147|NCT01561898|562159810|FG002|Overall Study|Withdrawal by Subject|12|||
155743148|NCT01561898|562159811|FG003|Overall Study|Withdrawal by Subject|5|||
155743149|NCT01561898|562159808|FG000|Overall Study|Lack of Efficacy|0|||
155743150|NCT01561898|562159809|FG001|Overall Study|Lack of Efficacy|8|||
155743151|NCT01561898|562159810|FG002|Overall Study|Lack of Efficacy|10|||
155743152|NCT01561898|562159811|FG003|Overall Study|Lack of Efficacy|5|||
155743153|NCT01561898|562159808|FG000|Overall Study|Worsening of complications|0|||
155743154|NCT01561898|562159809|FG001|Overall Study|Worsening of complications|1|||
155743155|NCT01561898|562159810|FG002|Overall Study|Worsening of complications|0|||
155743156|NCT01561898|562159811|FG003|Overall Study|Worsening of complications|0|||
155743157|NCT01561898|562159808|FG000|Overall Study|Lost to Follow-up|0|||
155743158|NCT01561898|562159809|FG001|Overall Study|Lost to Follow-up|0|||
155743159|NCT01561898|562159810|FG002|Overall Study|Lost to Follow-up|1|||
155743160|NCT01561898|562159811|FG003|Overall Study|Lost to Follow-up|0|||
155743161|NCT01561898|562159808|FG000|Overall Study|Adverse Event|1|||
155743162|NCT01561898|562159809|FG001|Overall Study|Adverse Event|19|||
155743163|NCT01561898|562159810|FG002|Overall Study|Adverse Event|14|||
155743164|NCT01561898|562159811|FG003|Overall Study|Adverse Event|9|||
155743165|NCT01561898|562159808|FG000|Overall Study|Physician Decision|1|||
155743166|NCT01561898|562159809|FG001|Overall Study|Physician Decision|5|||
155743167|NCT01561898|562159810|FG002|Overall Study|Physician Decision|7|||
155743168|NCT01561898|562159811|FG003|Overall Study|Physician Decision|1|||
155743169|NCT00331552|562159812|FG000|Period 3: Phase II|Neurological Symptoms|1|||
155743170|NCT00331552|562159813|FG001|Period 3: Phase II|Neurological Symptoms|0|||
155743171|NCT00331552|562159812|FG000|Period 3: Phase II|Severe Nausea|1|||
155743172|NCT00331552|562159813|FG001|Period 3: Phase II|Severe Nausea|0|||
155743173|NCT01883453|562159814|FG000|Overall Study|No episode of common cold|25|||
155743174|NCT01883453|562159815|FG001|Overall Study|No episode of common cold|23|||
155743175|NCT04493892|562159824|FG000|Overall Study|Withdrawal by Subject|15|||
155638039|NCT04044690|561766358|FG000|Period 3|Study Terminated by Sponsor|24|||
155638040|NCT04044690|561766359|FG001|Period 3|Study Terminated by Sponsor|18|||
155407444|NCT01827670|560925473|FG001|Overall Study|Lost to Follow-up|1|||
155407445|NCT02813694|560925484|FG000|Overall Study|Physician Decision|0|||
155407446|NCT02813694|560925485|FG001|Overall Study|Physician Decision|1|||
155407447|NCT02813694|560925484|FG000|Overall Study|Withdrawal by Subject|10|||
155407448|NCT02813694|560925485|FG001|Overall Study|Withdrawal by Subject|9|||
155407449|NCT02813694|560925484|FG000|Overall Study|Lost to Follow-up|1|||
155407450|NCT02813694|560925485|FG001|Overall Study|Lost to Follow-up|1|||
155407451|NCT02813694|560925484|FG000|Overall Study|Death|3|||
155407452|NCT02813694|560925485|FG001|Overall Study|Death|3|||
155407453|NCT02813694|560925484|FG000|Overall Study|Randomized- did not receive study drug|2|||
155407454|NCT02813694|560925485|FG001|Overall Study|Randomized- did not receive study drug|0|||
155407455|NCT02813694|560925484|FG000|Overall Study|Patient hospitalized|1|||
155407456|NCT02813694|560925485|FG001|Overall Study|Patient hospitalized|0|||
155407457|NCT00563186|560925489|FG000|Overall Study|LOS<48 hours|97|||
155407458|NCT00563186|560925490|FG001|Overall Study|LOS<48 hours|74|||
155407459|NCT00563186|560925489|FG000|Overall Study|Incomplete data|1|||
155407460|NCT00563186|560925490|FG001|Overall Study|Incomplete data|1|||
155407461|NCT01152021|560925491|FG000|Overall Study|Adverse Event|4|||
155407462|NCT01152021|560925492|FG001|Overall Study|Adverse Event|4|||
155407463|NCT01152021|560925491|FG000|Overall Study|Study drug had expired|1|||
155407464|NCT01152021|560925492|FG001|Overall Study|Study drug had expired|0|||
155407465|NCT01152021|560925491|FG000|Overall Study|Physician Decision|1|||
155407466|NCT01152021|560925492|FG001|Overall Study|Physician Decision|1|||
155407467|NCT01152021|560925491|FG000|Overall Study|No access to study drug in Pharmacy|0|||
155407468|NCT01152021|560925492|FG001|Overall Study|No access to study drug in Pharmacy|1|||
155407469|NCT00996944|560925493|FG000|Double-blind Treatment Period|Adverse Event|2|||
155407470|NCT00996944|560925494|FG001|Double-blind Treatment Period|Adverse Event|1|||
155407471|NCT00996944|560925493|FG000|Double-blind Treatment Period|Protocol Violation|1|||
155407472|NCT00996944|560925494|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155407473|NCT00996944|560925493|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
155407474|NCT00996944|560925494|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
155407475|NCT00996944|560925493|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155407476|NCT00996944|560925494|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155407477|NCT00996944|560925493|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
155743176|NCT02267317|562159827|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
155743177|NCT02267317|562159828|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155743178|NCT02267317|562159829|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155743179|NCT02267317|562159830|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155743180|NCT02267317|562159831|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155743181|NCT02267317|562159832|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155743182|NCT02267317|562159827|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
155743183|NCT02267317|562159828|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155743184|NCT02267317|562159829|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155743185|NCT02267317|562159830|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155743186|NCT02267317|562159831|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155743187|NCT02267317|562159832|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155743188|NCT02208063|562159835|FG000|Overall Study|Death|3|||
155743189|NCT02208063|562159836|FG001|Overall Study|Death|5|||
155743190|NCT02208063|562159835|FG000|Overall Study|Not Specified in report|3|||
155743191|NCT02208063|562159836|FG001|Overall Study|Not Specified in report|4|||
155743192|NCT02208063|562159835|FG000|Overall Study|Withdrawal by Subject|5|||
155743193|NCT02208063|562159836|FG001|Overall Study|Withdrawal by Subject|2|||
155743194|NCT02208063|562159835|FG000|Overall Study|Lost to Follow-up|1|||
155743195|NCT02208063|562159836|FG001|Overall Study|Lost to Follow-up|0|||
155743196|NCT00913458|562159837|FG000|Phase 1|Non-Responder|54|||
155743197|NCT00913458|562159838|FG001|Phase 1|Non-Responder|0|||
155743198|NCT00913458|562159839|FG002|Phase 1|Non-Responder|0|||
155743199|NCT00913458|562159840|FG003|Phase 1|Non-Responder|0|||
155743200|NCT00913458|562159841|FG004|Phase 1|Non-Responder|0|||
155287358|NCT05550337|560484296|FG002|Overall Study|Lost to Follow-up|11|||
155407478|NCT00996944|560925494|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
155407479|NCT00769184|560925495|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
155407480|NCT00769184|560925496|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
155407481|NCT00769184|560925495|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
155743201|NCT00913458|562159842|FG005|Phase 1|Non-Responder|0|||
155743202|NCT00913458|562159843|FG006|Phase 1|Non-Responder|0|||
155743203|NCT00913458|562159837|FG000|Phase 1|Subject Request|17|||
155743204|NCT00913458|562159838|FG001|Phase 1|Subject Request|0|||
155743205|NCT00913458|562159839|FG002|Phase 1|Subject Request|0|||
155743206|NCT00913458|562159840|FG003|Phase 1|Subject Request|0|||
155743207|NCT00913458|562159841|FG004|Phase 1|Subject Request|0|||
155743208|NCT00913458|562159842|FG005|Phase 1|Subject Request|0|||
155743209|NCT00913458|562159843|FG006|Phase 1|Subject Request|0|||
155743210|NCT00913458|562159837|FG000|Phase 1|Adverse Event|20|||
155743211|NCT00913458|562159838|FG001|Phase 1|Adverse Event|0|||
155407482|NCT00769184|560925496|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
155407483|NCT00769184|560925495|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
155407484|NCT00769184|560925496|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
155407485|NCT00517829|560925497|FG000|Overall Study|Adverse Event|22|||
155407486|NCT00517829|560925498|FG001|Overall Study|Adverse Event|34|||
155407487|NCT00517829|560925497|FG000|Overall Study|Disease Progression|39|||
155407488|NCT00517829|560925498|FG001|Overall Study|Disease Progression|32|||
155407489|NCT00517829|560925497|FG000|Overall Study|Patient Request|6|||
155407490|NCT00517829|560925498|FG001|Overall Study|Patient Request|5|||
155407491|NCT00517829|560925497|FG000|Overall Study|Investigator Request|5|||
155407492|NCT00517829|560925498|FG001|Overall Study|Investigator Request|3|||
155407493|NCT00517829|560925497|FG000|Overall Study|Other|3|||
155407494|NCT00517829|560925498|FG001|Overall Study|Other|1|||
155407495|NCT02250274|560925500|FG000|Overall Study|Insufficient blood draw amount|7|||
155407496|NCT02250274|560925501|FG001|Overall Study|Insufficient blood draw amount|6|||
155407497|NCT00583362|560925502|FG000|Overall Study|Adverse Event|44|||
155407498|NCT00583362|560925502|FG000|Overall Study|Lack of Efficacy|22|||
155407499|NCT00583362|560925502|FG000|Overall Study|Lost to Follow-up|4|||
155407500|NCT00583362|560925502|FG000|Overall Study|Non-compliance with study drug|28|||
155407501|NCT00583362|560925502|FG000|Overall Study|Pregnancy|7|||
155407502|NCT00583362|560925502|FG000|Overall Study|Miscommunication of visit window|5|||
155407503|NCT00583362|560925502|FG000|Overall Study|Current site closed|7|||
155407504|NCT00583362|560925502|FG000|Overall Study|Subject not dosed in LBSL99|1|||
155407505|NCT00583362|560925502|FG000|Overall Study|Subject moved out of the country/state|2|||
155407506|NCT00583362|560925502|FG000|Overall Study|Missed visits due to staff changes|1|||
155407507|NCT00583362|560925502|FG000|Overall Study|Misunderstanding of protocol|1|||
155407508|NCT00583362|560925502|FG000|Overall Study|Behavioral problems and non-compliance|1|||
155407509|NCT00583362|560925502|FG000|Overall Study|Sponsor request due to missed doses|1|||
155407510|NCT00583362|560925502|FG000|Overall Study|Physician Decision|19|||
155407511|NCT00583362|560925502|FG000|Overall Study|Protocol Violation|2|||
155407512|NCT00583362|560925502|FG000|Overall Study|Withdrawal by Subject|57|||
155407513|NCT00446511|560925503|FG000|Overall Study|Adverse Event|7|||
155407514|NCT00446511|560925504|FG001|Overall Study|Adverse Event|2|||
155407515|NCT00446511|560925505|FG002|Overall Study|Adverse Event|3|||
155407516|NCT00446511|560925506|FG003|Overall Study|Adverse Event|1|||
155407517|NCT00446511|560925503|FG000|Overall Study|Protocol Violation|0|||
155407518|NCT00446511|560925504|FG001|Overall Study|Protocol Violation|0|||
155407519|NCT00446511|560925505|FG002|Overall Study|Protocol Violation|0|||
155407520|NCT00446511|560925506|FG003|Overall Study|Protocol Violation|1|||
155407521|NCT00446511|560925503|FG000|Overall Study|Withdrawal by Subject|0|||
155407522|NCT00446511|560925504|FG001|Overall Study|Withdrawal by Subject|0|||
155407523|NCT00446511|560925505|FG002|Overall Study|Withdrawal by Subject|0|||
155407524|NCT00446511|560925506|FG003|Overall Study|Withdrawal by Subject|3|||
155407525|NCT00446511|560925503|FG000|Overall Study|Administrative Problems|3|||
155407526|NCT00446511|560925504|FG001|Overall Study|Administrative Problems|0|||
155407527|NCT00446511|560925505|FG002|Overall Study|Administrative Problems|4|||
155407528|NCT00446511|560925506|FG003|Overall Study|Administrative Problems|1|||
155407529|NCT01136655|560925511|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
155407530|NCT01136655|560925511|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
155407531|NCT01136655|560925511|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
155407532|NCT01136655|560925511|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
155407533|NCT04770389|560925519|FG000|Overall Study|Adverse Event|1|||
155407534|NCT04770389|560925520|FG001|Overall Study|Adverse Event|2|||
155407535|NCT04770389|560925521|FG002|Overall Study|Adverse Event|0|||
155407536|NCT04770389|560925522|FG003|Overall Study|Adverse Event|1|||
155407537|NCT04770389|560925519|FG000|Overall Study|Withdrawal by Subject|0|||
155407538|NCT04770389|560925520|FG001|Overall Study|Withdrawal by Subject|2|||
155407539|NCT04770389|560925521|FG002|Overall Study|Withdrawal by Subject|1|||
155407540|NCT04770389|560925522|FG003|Overall Study|Withdrawal by Subject|0|||
155407541|NCT04770389|560925519|FG000|Overall Study|Failed attempt to draw blood|1|||
155407542|NCT04770389|560925520|FG001|Overall Study|Failed attempt to draw blood|0|||
155407543|NCT04770389|560925521|FG002|Overall Study|Failed attempt to draw blood|0|||
155638041|NCT04044690|561766358|FG000|Period 3|Missing|0|||
155638042|NCT04044690|561766359|FG001|Period 3|Missing|2|||
155407544|NCT04770389|560925522|FG003|Overall Study|Failed attempt to draw blood|0|||
155407545|NCT04770389|560925519|FG000|Overall Study|Left the country|0|||
155407546|NCT04770389|560925520|FG001|Overall Study|Left the country|0|||
155407547|NCT04770389|560925521|FG002|Overall Study|Left the country|1|||
155407548|NCT04770389|560925522|FG003|Overall Study|Left the country|2|||
155407549|NCT04770389|560925519|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
155407550|NCT04770389|560925520|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
155407551|NCT04770389|560925521|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
155407552|NCT04770389|560925522|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
155407553|NCT04770389|560925519|FG000|Overall Study|Lost to Follow-up|0|||
155407554|NCT04770389|560925520|FG001|Overall Study|Lost to Follow-up|0|||
155287359|NCT01836458|560484299|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155287360|NCT01836458|560484300|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155287361|NCT01836458|560484301|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
155287362|NCT01836458|560484302|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
155287363|NCT02081391|560484303|FG000|12-hour Treatment|Withdrawal by Subject|3|||
155287364|NCT02081391|560484304|FG001|12-hour Treatment|Withdrawal by Subject|2|||
155287365|NCT02081391|560484305|FG002|12-hour Treatment|Withdrawal by Subject|0|||
155287366|NCT02081391|560484306|FG003|12-hour Treatment|Withdrawal by Subject|0|||
155287367|NCT02081391|560484303|FG000|12-hour Treatment|Physician Decision|4|||
155287368|NCT02081391|560484304|FG001|12-hour Treatment|Physician Decision|1|||
155287369|NCT02081391|560484305|FG002|12-hour Treatment|Physician Decision|0|||
155287370|NCT02081391|560484306|FG003|12-hour Treatment|Physician Decision|0|||
155287371|NCT02081391|560484303|FG000|12-hour Treatment|Lack of Efficacy|3|||
155287372|NCT02081391|560484304|FG001|12-hour Treatment|Lack of Efficacy|0|||
155287373|NCT02081391|560484305|FG002|12-hour Treatment|Lack of Efficacy|0|||
155287374|NCT02081391|560484306|FG003|12-hour Treatment|Lack of Efficacy|0|||
155287375|NCT02081391|560484303|FG000|12-hour Treatment|Adverse Event|4|||
155287376|NCT02081391|560484304|FG001|12-hour Treatment|Adverse Event|2|||
155287377|NCT02081391|560484305|FG002|12-hour Treatment|Adverse Event|0|||
155287378|NCT02081391|560484306|FG003|12-hour Treatment|Adverse Event|0|||
155287379|NCT02081391|560484303|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
155287380|NCT02081391|560484304|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
155287381|NCT02081391|560484305|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
155287382|NCT02081391|560484306|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
155287383|NCT02081391|560484303|FG000|12-hour Treatment|Further reasons|2|||
155287384|NCT02081391|560484304|FG001|12-hour Treatment|Further reasons|1|||
155287385|NCT02081391|560484305|FG002|12-hour Treatment|Further reasons|0|||
155287386|NCT02081391|560484306|FG003|12-hour Treatment|Further reasons|0|||
155287387|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
155287388|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
155287389|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
155287390|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
155287391|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
155287392|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
155287393|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
155287394|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
155287395|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
155287396|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287397|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287398|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287399|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
155287400|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
155287401|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
155287402|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
155287403|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
155287404|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
155287405|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
155287406|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
155287407|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
155287408|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
155287409|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
155287410|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
155287411|NCT00813488|560484308|FG000|Titration Period 1|Adverse Event|6|||
155287412|NCT00813488|560484309|FG001|Titration Period 1|Adverse Event|1|||
155287413|NCT00813488|560484308|FG000|Titration Period 1|Lack of Efficacy|9|||
155287414|NCT00813488|560484309|FG001|Titration Period 1|Lack of Efficacy|7|||
155287415|NCT00813488|560484308|FG000|Titration Period 1|Withdrawal by Subject|2|||
155287416|NCT00813488|560484309|FG001|Titration Period 1|Withdrawal by Subject|2|||
155287417|NCT00813488|560484308|FG000|Titration Period 1|Protocol Violation|4|||
155287418|NCT00813488|560484309|FG001|Titration Period 1|Protocol Violation|3|||
155287419|NCT00813488|560484308|FG000|Titration Period 1|Non-compliance to study medication|4|||
155287420|NCT00813488|560484309|FG001|Titration Period 1|Non-compliance to study medication|1|||
155287421|NCT00813488|560484308|FG000|Titration Period 1|Non-compliance to study procedures|2|||
155407555|NCT04770389|560925521|FG002|Overall Study|Lost to Follow-up|0|||
155407556|NCT04770389|560925522|FG003|Overall Study|Lost to Follow-up|1|||
155407557|NCT04770389|560925519|FG000|Overall Study|Moved away from study site|0|||
155407558|NCT04770389|560925520|FG001|Overall Study|Moved away from study site|1|||
155407559|NCT04770389|560925521|FG002|Overall Study|Moved away from study site|0|||
155407560|NCT04770389|560925522|FG003|Overall Study|Moved away from study site|0|||
155407561|NCT03765138|560925523|FG000|Overall Study|Lost to Follow-up|1|||
155407562|NCT00794157|560925524|FG000|Overall Study|Adverse Event|4|||
155287422|NCT00813488|560484309|FG001|Titration Period 1|Non-compliance to study procedures|2|||
155287423|NCT00813488|560484308|FG000|Titration Period 1|Technical Difficulties|0|||
155287424|NCT00813488|560484309|FG001|Titration Period 1|Technical Difficulties|1|||
155287425|NCT00813488|560484308|FG000|Titration Period 2|Adverse Event|2|||
155287426|NCT00813488|560484309|FG001|Titration Period 2|Adverse Event|3|||
155287427|NCT00813488|560484308|FG000|Titration Period 2|Lack of Efficacy|8|||
155287428|NCT00813488|560484309|FG001|Titration Period 2|Lack of Efficacy|4|||
155287429|NCT00813488|560484308|FG000|Titration Period 2|Protocol Violation|3|||
155287430|NCT00813488|560484309|FG001|Titration Period 2|Protocol Violation|2|||
155287431|NCT00813488|560484308|FG000|Titration Period 2|Lost to Follow-up|1|||
155287432|NCT00813488|560484309|FG001|Titration Period 2|Lost to Follow-up|0|||
155287433|NCT00813488|560484308|FG000|Titration Period 2|Non-compliance with study procedures|2|||
155287434|NCT00813488|560484309|FG001|Titration Period 2|Non-compliance with study procedures|1|||
155287435|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
155287436|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
155287437|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
155287438|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
155287439|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
155287440|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
155287441|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
155287442|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
155287443|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
155287444|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
155287445|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155287446|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155287447|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
155287448|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
155287449|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Other|1|||
155287450|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Other|0|||
155287451|NCT00813488|560484308|FG000|Open-label Extension|Adverse Event|1|||
155287452|NCT00813488|560484309|FG001|Open-label Extension|Adverse Event|2|||
155287453|NCT00813488|560484308|FG000|Open-label Extension|Lack of Efficacy|3|||
155287454|NCT00813488|560484309|FG001|Open-label Extension|Lack of Efficacy|0|||
155287455|NCT00813488|560484308|FG000|Open-label Extension|Withdrawal by Subject|0|||
155287456|NCT00813488|560484309|FG001|Open-label Extension|Withdrawal by Subject|2|||
155287457|NCT00813488|560484308|FG000|Open-label Extension|Protocol Violation|1|||
155287458|NCT00813488|560484309|FG001|Open-label Extension|Protocol Violation|2|||
155287459|NCT00813488|560484308|FG000|Open-label Extension|Non-compliance study medication|4|||
155287460|NCT00813488|560484309|FG001|Open-label Extension|Non-compliance study medication|0|||
155287461|NCT00813488|560484308|FG000|Open-label Extension|Non-compliance study procedures|2|||
155287462|NCT00813488|560484309|FG001|Open-label Extension|Non-compliance study procedures|1|||
155287463|NCT00813488|560484308|FG000|Open-label Extension|Other|1|||
155287464|NCT00813488|560484309|FG001|Open-label Extension|Other|0|||
155287465|NCT02926937|560484310|FG000|Overall Study|Adverse Event|0|||
155287466|NCT02926937|560484311|FG001|Overall Study|Adverse Event|1|||
155287467|NCT02926937|560484312|FG002|Overall Study|Adverse Event|1|||
155287468|NCT02926937|560484310|FG000|Overall Study|Poor Compliance to Protocol|1|||
155287469|NCT02926937|560484311|FG001|Overall Study|Poor Compliance to Protocol|0|||
155287470|NCT02926937|560484312|FG002|Overall Study|Poor Compliance to Protocol|0|||
155287471|NCT02926937|560484310|FG000|Overall Study|Lost to Follow-up|4|||
155287472|NCT02926937|560484311|FG001|Overall Study|Lost to Follow-up|5|||
155287473|NCT02926937|560484312|FG002|Overall Study|Lost to Follow-up|0|||
155287474|NCT02926937|560484310|FG000|Overall Study|At the Participant's own Request|11|||
155287475|NCT02926937|560484311|FG001|Overall Study|At the Participant's own Request|5|||
155287476|NCT02926937|560484312|FG002|Overall Study|At the Participant's own Request|8|||
155287477|NCT02926937|560484310|FG000|Overall Study|Reason not Specified|3|||
155287478|NCT02926937|560484311|FG001|Overall Study|Reason not Specified|4|||
155287479|NCT02926937|560484312|FG002|Overall Study|Reason not Specified|2|||
155287480|NCT01333514|560484314|FG000|Overall Study|Withdrawal by Subject|1|||
155287481|NCT01333514|560484315|FG001|Overall Study|Withdrawal by Subject|0|||
155287482|NCT00477412|560484316|FG000|Overall Study|Death|0|||
155287483|NCT00477412|560484317|FG001|Overall Study|Death|0|||
155287484|NCT00477412|560484318|FG002|Overall Study|Death|0|||
155287485|NCT00477412|560484319|FG003|Overall Study|Death|4|||
155287486|NCT00477412|560484316|FG000|Overall Study|Lost to Follow-up|0|||
155407563|NCT00794157|560925525|FG001|Overall Study|Adverse Event|1|||
155407564|NCT00794157|560925526|FG002|Overall Study|Adverse Event|8|||
155287487|NCT00477412|560484317|FG001|Overall Study|Lost to Follow-up|0|||
155287488|NCT00477412|560484318|FG002|Overall Study|Lost to Follow-up|0|||
155287489|NCT00477412|560484319|FG003|Overall Study|Lost to Follow-up|1|||
155287490|NCT00477412|560484316|FG000|Overall Study|Withdrawal by Subject|0|||
155287491|NCT00477412|560484317|FG001|Overall Study|Withdrawal by Subject|0|||
155287492|NCT00477412|560484318|FG002|Overall Study|Withdrawal by Subject|0|||
155407565|NCT00794157|560925524|FG000|Overall Study|Subject withdrew consent|2|||
155287493|NCT00477412|560484319|FG003|Overall Study|Withdrawal by Subject|2|||
155287494|NCT00477412|560484316|FG000|Overall Study|Second Malignancy|0|||
155287495|NCT00477412|560484317|FG001|Overall Study|Second Malignancy|0|||
155287496|NCT00477412|560484318|FG002|Overall Study|Second Malignancy|0|||
155287497|NCT00477412|560484319|FG003|Overall Study|Second Malignancy|1|||
155287498|NCT00477412|560484316|FG000|Overall Study|Adverse Event|1|||
155287499|NCT00477412|560484317|FG001|Overall Study|Adverse Event|0|||
155287500|NCT00477412|560484318|FG002|Overall Study|Adverse Event|1|||
155287501|NCT00477412|560484319|FG003|Overall Study|Adverse Event|0|||
155287502|NCT02501811|560484321|FG000|Overall Study|Death|1|||
155287503|NCT02501811|560484322|FG001|Overall Study|Death|3|||
155287504|NCT02501811|560484323|FG002|Overall Study|Death|2|||
155287505|NCT02501811|560484324|FG003|Overall Study|Death|3|||
155287506|NCT02501811|560484321|FG000|Overall Study|Withdrawal by Subject|3|||
155287507|NCT02501811|560484322|FG001|Overall Study|Withdrawal by Subject|3|||
155287508|NCT02501811|560484323|FG002|Overall Study|Withdrawal by Subject|2|||
155287509|NCT02501811|560484324|FG003|Overall Study|Withdrawal by Subject|3|||
155287510|NCT02501811|560484321|FG000|Overall Study|Lost to Follow-up|0|||
155287511|NCT02501811|560484322|FG001|Overall Study|Lost to Follow-up|0|||
155287512|NCT02501811|560484323|FG002|Overall Study|Lost to Follow-up|2|||
155287513|NCT02501811|560484324|FG003|Overall Study|Lost to Follow-up|1|||
155287514|NCT00662909|560484325|FG000|Overall Study|Adverse Event|17|||
155287515|NCT00662909|560484326|FG001|Overall Study|Adverse Event|18|||
155287516|NCT00662909|560484327|FG002|Overall Study|Adverse Event|19|||
155287517|NCT00662909|560484325|FG000|Overall Study|Lack of Efficacy|9|||
155287518|NCT00662909|560484326|FG001|Overall Study|Lack of Efficacy|1|||
155407566|NCT00794157|560925525|FG001|Overall Study|Subject withdrew consent|0|||
155407567|NCT00794157|560925526|FG002|Overall Study|Subject withdrew consent|3|||
155407568|NCT00794157|560925524|FG000|Overall Study|Lost to Follow-up|2|||
155407569|NCT00794157|560925525|FG001|Overall Study|Lost to Follow-up|0|||
155407570|NCT00794157|560925526|FG002|Overall Study|Lost to Follow-up|1|||
155407571|NCT00794157|560925524|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155407572|NCT00794157|560925525|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155407573|NCT00794157|560925526|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155407574|NCT00794157|560925524|FG000|Overall Study|Administrative problems|1|||
155407575|NCT00794157|560925525|FG001|Overall Study|Administrative problems|7|||
155407576|NCT00794157|560925526|FG002|Overall Study|Administrative problems|4|||
155407577|NCT00794157|560925524|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155407578|NCT00794157|560925525|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155407579|NCT00794157|560925526|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155407580|NCT00794157|560925524|FG000|Overall Study|Protocol deviation|0|||
155407581|NCT00794157|560925525|FG001|Overall Study|Protocol deviation|1|||
155407582|NCT00794157|560925526|FG002|Overall Study|Protocol deviation|1|||
155407583|NCT01970501|560925527|FG000|Overall Study|Discontinuation of study by sponsor|16|||
155407584|NCT01970501|560925528|FG001|Overall Study|Discontinuation of study by sponsor|14|||
155407585|NCT01970501|560925527|FG000|Overall Study|Withdrawal by Subject|6|||
155407586|NCT01970501|560925528|FG001|Overall Study|Withdrawal by Subject|7|||
155407587|NCT01970501|560925527|FG000|Overall Study|Adverse Event|2|||
155407588|NCT01970501|560925528|FG001|Overall Study|Adverse Event|4|||
155407589|NCT01970501|560925527|FG000|Overall Study|Death|1|||
155407590|NCT01970501|560925528|FG001|Overall Study|Death|3|||
155743212|NCT00913458|562159839|FG002|Phase 1|Adverse Event|0|||
155743213|NCT00913458|562159840|FG003|Phase 1|Adverse Event|0|||
155743214|NCT00913458|562159841|FG004|Phase 1|Adverse Event|0|||
155287519|NCT00662909|560484327|FG002|Overall Study|Lack of Efficacy|5|||
155287520|NCT00662909|560484325|FG000|Overall Study|Withdrawal by Subject|29|||
155407591|NCT01970501|560925527|FG000|Overall Study|Physician Decision|2|||
155287521|NCT00662909|560484326|FG001|Overall Study|Withdrawal by Subject|22|||
155287522|NCT00662909|560484327|FG002|Overall Study|Withdrawal by Subject|16|||
155287523|NCT00662909|560484325|FG000|Overall Study|Lost to Follow-up|2|||
155407592|NCT01970501|560925528|FG001|Overall Study|Physician Decision|0|||
155407593|NCT00708123|560925529|FG000|Period 1|Protocol Violation|0|||
155407594|NCT00708123|560925530|FG001|Period 1|Protocol Violation|1|||
155407595|NCT00708123|560925531|FG002|Period 1|Protocol Violation|0|||
155407596|NCT00708123|560925532|FG003|Period 1|Protocol Violation|1|||
155743215|NCT00913458|562159842|FG005|Phase 1|Adverse Event|0|||
155287524|NCT00662909|560484326|FG001|Overall Study|Lost to Follow-up|9|||
155287525|NCT00662909|560484327|FG002|Overall Study|Lost to Follow-up|3|||
155287526|NCT00662909|560484325|FG000|Overall Study|Protocol Violation|7|||
155287527|NCT00662909|560484326|FG001|Overall Study|Protocol Violation|4|||
155287528|NCT00662909|560484327|FG002|Overall Study|Protocol Violation|5|||
155287529|NCT00662909|560484325|FG000|Overall Study|Randomized- never received study drug|1|||
155407597|NCT00708123|560925533|FG004|Period 1|Protocol Violation|0|||
155407598|NCT00708123|560925529|FG000|Period 1|Adverse Event|0|||
155407599|NCT00708123|560925530|FG001|Period 1|Adverse Event|0|||
155407600|NCT00708123|560925531|FG002|Period 1|Adverse Event|1|||
155407601|NCT00708123|560925532|FG003|Period 1|Adverse Event|0|||
155407602|NCT00708123|560925533|FG004|Period 1|Adverse Event|0|||
155407603|NCT00708123|560925529|FG000|Period 2|Protocol Violation|0|||
155743216|NCT00913458|562159843|FG006|Phase 1|Adverse Event|0|||
155287530|NCT00662909|560484326|FG001|Overall Study|Randomized- never received study drug|0|||
155287531|NCT00662909|560484327|FG002|Overall Study|Randomized- never received study drug|0|||
155287532|NCT00662909|560484325|FG000|Overall Study|Non-compliance with study procedures|3|||
155287533|NCT00662909|560484326|FG001|Overall Study|Non-compliance with study procedures|3|||
155287534|NCT00662909|560484327|FG002|Overall Study|Non-compliance with study procedures|2|||
155287535|NCT00662909|560484325|FG000|Overall Study|Physician Decision|1|||
155287536|NCT00662909|560484326|FG001|Overall Study|Physician Decision|1|||
155287537|NCT00662909|560484327|FG002|Overall Study|Physician Decision|2|||
155287538|NCT00662909|560484325|FG000|Overall Study|Eligibility criterion not met|0|||
155287539|NCT00662909|560484326|FG001|Overall Study|Eligibility criterion not met|1|||
155287540|NCT00662909|560484327|FG002|Overall Study|Eligibility criterion not met|1|||
155287541|NCT04257058|560486069|FG000|Overall Study|Lost to Follow-up|31|||
155287542|NCT04057196|560486072|FG000|Overall Study|Withdrawal by Subject|3|||
155287543|NCT04057196|560486072|FG000|Overall Study|Death|3|||
155287544|NCT03895034|560486073|FG000|Overall Study|Lost to Follow-up|2|||
155287545|NCT01118377|560486078|FG000|Overall Study|Did Not Receive Study Medication|1|||
155287546|NCT01118377|560486078|FG000|Overall Study|Death|38|||
155287547|NCT01118377|560486078|FG000|Overall Study|Failure to Return|3|||
155287548|NCT00739102|560486079|FG000|Overall Study|Death|5|||
155287549|NCT00739102|560486079|FG000|Overall Study|Withdrawal by Subject|10|||
155287550|NCT01331824|560486081|FG000|Overall Study|Adverse Event|2|||
155287551|NCT01331824|560486081|FG000|Overall Study|Death|1|||
155287552|NCT01331824|560486081|FG000|Overall Study|Disease Progression|9|||
155287553|NCT01331824|560486081|FG000|Overall Study|Withdrawal by Subject|1|||
155287554|NCT01091454|560486084|FG000|Overall Study|Ineligible|1|||
155287555|NCT01510912|560486085|FG000|Overall Study|Adverse Event|99|||
155287556|NCT01510912|560486085|FG000|Overall Study|Lack of Efficacy|12|||
155287557|NCT01510912|560486085|FG000|Overall Study|Non-compliance with trial drug|23|||
155287558|NCT01510912|560486085|FG000|Overall Study|Withdrawal by Subject|49|||
155287559|NCT01510912|560486085|FG000|Overall Study|Physician Decision|1|||
155287560|NCT01510912|560486085|FG000|Overall Study|Protocol Violation|27|||
155287561|NCT01510912|560486085|FG000|Overall Study|Lost to Follow-up|26|||
155287562|NCT01510912|560486085|FG000|Overall Study|Other, including joint replacement|5|||
155287563|NCT02001623|560486097|FG000|Overall Study|Disease Progression|2|||
155287564|NCT02001623|560486098|FG001|Overall Study|Disease Progression|2|||
155287565|NCT02001623|560486099|FG002|Overall Study|Disease Progression|3|||
155287566|NCT02001623|560486100|FG003|Overall Study|Disease Progression|2|||
155287567|NCT02001623|560486101|FG004|Overall Study|Disease Progression|3|||
155287568|NCT02001623|560486102|FG005|Overall Study|Disease Progression|2|||
155287569|NCT02001623|560486103|FG006|Overall Study|Disease Progression|3|||
155287570|NCT02001623|560486104|FG007|Overall Study|Disease Progression|3|||
155287571|NCT02001623|560486105|FG008|Overall Study|Disease Progression|7|||
155287572|NCT02001623|560486106|FG009|Overall Study|Disease Progression|40|||
155287573|NCT02001623|560486107|FG010|Overall Study|Disease Progression|5|||
155287574|NCT02001623|560486108|FG011|Overall Study|Disease Progression|9|||
155287575|NCT02001623|560486109|FG012|Overall Study|Disease Progression|9|||
155287576|NCT02001623|560486110|FG013|Overall Study|Disease Progression|20|||
155287577|NCT02001623|560486111|FG014|Overall Study|Disease Progression|9|||
155287578|NCT02001623|560486097|FG000|Overall Study|Physician Decision|0|||
155287579|NCT02001623|560486098|FG001|Overall Study|Physician Decision|0|||
155287580|NCT02001623|560486099|FG002|Overall Study|Physician Decision|0|||
155287581|NCT02001623|560486100|FG003|Overall Study|Physician Decision|0|||
155287582|NCT02001623|560486101|FG004|Overall Study|Physician Decision|0|||
155287583|NCT02001623|560486102|FG005|Overall Study|Physician Decision|0|||
155287584|NCT02001623|560486103|FG006|Overall Study|Physician Decision|0|||
155287585|NCT02001623|560486104|FG007|Overall Study|Physician Decision|0|||
155287586|NCT02001623|560486105|FG008|Overall Study|Physician Decision|3|||
155287587|NCT02001623|560486106|FG009|Overall Study|Physician Decision|2|||
155287588|NCT02001623|560486107|FG010|Overall Study|Physician Decision|3|||
155287589|NCT02001623|560486108|FG011|Overall Study|Physician Decision|3|||
155287590|NCT02001623|560486109|FG012|Overall Study|Physician Decision|1|||
155287591|NCT02001623|560486110|FG013|Overall Study|Physician Decision|2|||
155287592|NCT02001623|560486111|FG014|Overall Study|Physician Decision|1|||
155287593|NCT02001623|560486097|FG000|Overall Study|Death|0|||
155287594|NCT02001623|560486098|FG001|Overall Study|Death|1|||
155287595|NCT02001623|560486099|FG002|Overall Study|Death|0|||
155287596|NCT02001623|560486100|FG003|Overall Study|Death|0|||
155287597|NCT02001623|560486101|FG004|Overall Study|Death|0|||
155287598|NCT02001623|560486102|FG005|Overall Study|Death|0|||
155287599|NCT02001623|560486103|FG006|Overall Study|Death|0|||
155287600|NCT02001623|560486104|FG007|Overall Study|Death|0|||
155287601|NCT02001623|560486105|FG008|Overall Study|Death|0|||
155287602|NCT02001623|560486106|FG009|Overall Study|Death|0|||
155287603|NCT02001623|560486107|FG010|Overall Study|Death|0|||
155287604|NCT02001623|560486108|FG011|Overall Study|Death|0|||
155287605|NCT02001623|560486109|FG012|Overall Study|Death|0|||
155287606|NCT02001623|560486110|FG013|Overall Study|Death|0|||
155287607|NCT02001623|560486111|FG014|Overall Study|Death|0|||
155287608|NCT02001623|560486097|FG000|Overall Study|Adverse Event|0|||
155287609|NCT02001623|560486098|FG001|Overall Study|Adverse Event|0|||
155407604|NCT00708123|560925530|FG001|Period 2|Protocol Violation|0|||
155407605|NCT00708123|560925531|FG002|Period 2|Protocol Violation|0|||
155407606|NCT00708123|560925532|FG003|Period 2|Protocol Violation|1|||
155407607|NCT00708123|560925533|FG004|Period 2|Protocol Violation|0|||
155407608|NCT00708123|560925529|FG000|Period 2|Other Reason|1|||
155407609|NCT00708123|560925530|FG001|Period 2|Other Reason|0|||
155407610|NCT00708123|560925531|FG002|Period 2|Other Reason|0|||
155407611|NCT00708123|560925532|FG003|Period 2|Other Reason|0|||
155407612|NCT00708123|560925533|FG004|Period 2|Other Reason|0|||
155407613|NCT00708123|560925529|FG000|Period 3|Lost to Follow-up|0|||
155407614|NCT00708123|560925530|FG001|Period 3|Lost to Follow-up|0|||
155407615|NCT00708123|560925531|FG002|Period 3|Lost to Follow-up|1|||
155407616|NCT00708123|560925532|FG003|Period 3|Lost to Follow-up|1|||
155407617|NCT00708123|560925533|FG004|Period 3|Lost to Follow-up|0|||
155407618|NCT00708123|560925529|FG000|Period 4|Protocol Violation|0|||
155407619|NCT00708123|560925530|FG001|Period 4|Protocol Violation|1|||
155407620|NCT00708123|560925531|FG002|Period 4|Protocol Violation|0|||
155407621|NCT00708123|560925532|FG003|Period 4|Protocol Violation|0|||
155407622|NCT00708123|560925533|FG004|Period 4|Protocol Violation|0|||
155407623|NCT02970292|560925534|FG000|Overall Study|Physician Decision|1|||
155407624|NCT02970292|560925535|FG001|Overall Study|Physician Decision|1|||
155407625|NCT02970292|560925534|FG000|Overall Study|Withdrawal by Subject|11|||
155407626|NCT02970292|560925535|FG001|Overall Study|Withdrawal by Subject|5|||
155407627|NCT02970292|560925534|FG000|Overall Study|Noncompliance with study drug|2|||
155407628|NCT02970292|560925535|FG001|Overall Study|Noncompliance with study drug|2|||
155407629|NCT02970292|560925534|FG000|Overall Study|Adverse Event|5|||
155407630|NCT02970292|560925535|FG001|Overall Study|Adverse Event|0|||
155407631|NCT02970292|560925534|FG000|Overall Study|Lack of Efficacy|1|||
155407632|NCT02970292|560925535|FG001|Overall Study|Lack of Efficacy|0|||
155407633|NCT02970292|560925534|FG000|Overall Study|Lost to Follow-up|1|||
155407634|NCT02970292|560925535|FG001|Overall Study|Lost to Follow-up|0|||
155407635|NCT02970292|560925534|FG000|Overall Study|Protocol Violation|2|||
155407636|NCT02970292|560925535|FG001|Overall Study|Protocol Violation|0|||
155407637|NCT02970292|560925534|FG000|Overall Study|Other|1|||
155407638|NCT02970292|560925535|FG001|Overall Study|Other|0|||
155407639|NCT04486950|560925537|FG000|Overall Study|Lost to Follow-up|0|||
155407640|NCT04486950|560925538|FG001|Overall Study|Lost to Follow-up|0|||
155407641|NCT04486950|560925539|FG002|Overall Study|Lost to Follow-up|0|||
155407642|NCT04486950|560925540|FG003|Overall Study|Lost to Follow-up|0|||
155407643|NCT04486950|560925541|FG004|Overall Study|Lost to Follow-up|0|||
155407644|NCT04486950|560925542|FG005|Overall Study|Lost to Follow-up|1|||
155407645|NCT04486950|560925543|FG006|Overall Study|Lost to Follow-up|0|||
155407646|NCT00401375|560925544|FG000|Overall Study|Protocol Violation|2|||
155407647|NCT00401375|560925545|FG001|Overall Study|Protocol Violation|2|||
155407648|NCT00401375|560925546|FG002|Overall Study|Protocol Violation|1|||
155407649|NCT00401375|560925544|FG000|Overall Study|Adverse Event|6|||
155407650|NCT00401375|560925545|FG001|Overall Study|Adverse Event|11|||
155407651|NCT00401375|560925546|FG002|Overall Study|Adverse Event|10|||
155407652|NCT00401375|560925544|FG000|Overall Study|Withdrawal by Subject|9|||
155407653|NCT00401375|560925545|FG001|Overall Study|Withdrawal by Subject|7|||
155407654|NCT00401375|560925546|FG002|Overall Study|Withdrawal by Subject|7|||
155407655|NCT00401375|560925544|FG000|Overall Study|Lost to Follow-up|0|||
155407656|NCT00401375|560925545|FG001|Overall Study|Lost to Follow-up|1|||
155407657|NCT00401375|560925546|FG002|Overall Study|Lost to Follow-up|1|||
155407658|NCT00401375|560925544|FG000|Overall Study|Other than specified|2|||
155407659|NCT00401375|560925545|FG001|Overall Study|Other than specified|1|||
155287610|NCT02001623|560486099|FG002|Overall Study|Adverse Event|0|||
155287611|NCT02001623|560486100|FG003|Overall Study|Adverse Event|0|||
155287612|NCT02001623|560486101|FG004|Overall Study|Adverse Event|0|||
155407660|NCT00401375|560925546|FG002|Overall Study|Other than specified|3|||
155407661|NCT00401375|560925544|FG000|Overall Study|Randomized but not treated|3|||
155407662|NCT00401375|560925545|FG001|Overall Study|Randomized but not treated|3|||
155638043|NCT01582451|561766360|FG000|Overall Study|Adverse Event|1|||
155638044|NCT01582451|561766361|FG001|Overall Study|Adverse Event|3|||
155287613|NCT02001623|560486102|FG005|Overall Study|Adverse Event|1|||
155287614|NCT02001623|560486103|FG006|Overall Study|Adverse Event|0|||
155407663|NCT00401375|560925546|FG002|Overall Study|Randomized but not treated|3|||
155407664|NCT02821715|560925547|FG000|Overall Study|Protocol Violation|1|||
155407665|NCT02821715|560925548|FG001|Overall Study|Protocol Violation|0|||
155407666|NCT02821715|560925549|FG002|Overall Study|Protocol Violation|0|||
155407667|NCT02821715|560925550|FG003|Overall Study|Protocol Violation|0|||
155407668|NCT02821715|560925551|FG004|Overall Study|Protocol Violation|0|||
155407669|NCT02821715|560925552|FG005|Overall Study|Protocol Violation|0|||
155407670|NCT00923130|560925558|FG000|Overall Study|Stopped treatment due to progression|17|||
155407671|NCT00923130|560925558|FG000|Overall Study|Death|1|||
155407672|NCT00923130|560925558|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
155407673|NCT00923130|560925558|FG000|Overall Study|Switched to alternative treatment|2|||
155407674|NCT00923130|560925558|FG000|Overall Study|Refused further treatment|2|||
155407675|NCT01187953|560925559|FG000|Overall Study|Death|11|||
155407676|NCT01187953|560925560|FG001|Overall Study|Death|13|||
155287615|NCT02001623|560486104|FG007|Overall Study|Adverse Event|3|||
155287616|NCT02001623|560486105|FG008|Overall Study|Adverse Event|4|||
155287617|NCT02001623|560486106|FG009|Overall Study|Adverse Event|6|||
155287618|NCT02001623|560486107|FG010|Overall Study|Adverse Event|4|||
155287619|NCT02001623|560486108|FG011|Overall Study|Adverse Event|0|||
155287620|NCT02001623|560486109|FG012|Overall Study|Adverse Event|3|||
155287621|NCT02001623|560486110|FG013|Overall Study|Adverse Event|5|||
155287622|NCT02001623|560486111|FG014|Overall Study|Adverse Event|6|||
155287623|NCT02001623|560486097|FG000|Overall Study|Other - Miscellaneous|0|||
155287624|NCT02001623|560486098|FG001|Overall Study|Other - Miscellaneous|0|||
155287625|NCT02001623|560486099|FG002|Overall Study|Other - Miscellaneous|0|||
155287626|NCT02001623|560486100|FG003|Overall Study|Other - Miscellaneous|0|||
155287627|NCT02001623|560486101|FG004|Overall Study|Other - Miscellaneous|0|||
155287628|NCT02001623|560486102|FG005|Overall Study|Other - Miscellaneous|0|||
155287629|NCT02001623|560486103|FG006|Overall Study|Other - Miscellaneous|0|||
155287630|NCT02001623|560486104|FG007|Overall Study|Other - Miscellaneous|0|||
155287631|NCT02001623|560486105|FG008|Overall Study|Other - Miscellaneous|0|||
155287632|NCT02001623|560486106|FG009|Overall Study|Other - Miscellaneous|1|||
155287633|NCT02001623|560486107|FG010|Overall Study|Other - Miscellaneous|0|||
155287634|NCT02001623|560486108|FG011|Overall Study|Other - Miscellaneous|0|||
155287635|NCT02001623|560486109|FG012|Overall Study|Other - Miscellaneous|0|||
155287636|NCT02001623|560486110|FG013|Overall Study|Other - Miscellaneous|1|||
155287637|NCT02001623|560486111|FG014|Overall Study|Other - Miscellaneous|0|||
155287638|NCT02001623|560486097|FG000|Overall Study|Withdrawal by Subject|1|||
155287639|NCT02001623|560486098|FG001|Overall Study|Withdrawal by Subject|0|||
155287640|NCT02001623|560486099|FG002|Overall Study|Withdrawal by Subject|0|||
155287641|NCT02001623|560486100|FG003|Overall Study|Withdrawal by Subject|0|||
155287642|NCT02001623|560486101|FG004|Overall Study|Withdrawal by Subject|0|||
155287643|NCT02001623|560486102|FG005|Overall Study|Withdrawal by Subject|0|||
155287644|NCT02001623|560486103|FG006|Overall Study|Withdrawal by Subject|0|||
155287645|NCT02001623|560486104|FG007|Overall Study|Withdrawal by Subject|0|||
155287646|NCT02001623|560486105|FG008|Overall Study|Withdrawal by Subject|1|||
155287647|NCT02001623|560486106|FG009|Overall Study|Withdrawal by Subject|3|||
155287648|NCT02001623|560486107|FG010|Overall Study|Withdrawal by Subject|2|||
155287649|NCT02001623|560486108|FG011|Overall Study|Withdrawal by Subject|2|||
155287650|NCT02001623|560486109|FG012|Overall Study|Withdrawal by Subject|1|||
155287651|NCT02001623|560486110|FG013|Overall Study|Withdrawal by Subject|5|||
155287652|NCT02001623|560486111|FG014|Overall Study|Withdrawal by Subject|2|||
155287653|NCT02001623|560486097|FG000|Overall Study|Lost to Follow-up|0|||
155287654|NCT02001623|560486098|FG001|Overall Study|Lost to Follow-up|0|||
155287655|NCT02001623|560486099|FG002|Overall Study|Lost to Follow-up|0|||
155287656|NCT02001623|560486100|FG003|Overall Study|Lost to Follow-up|0|||
155287657|NCT02001623|560486101|FG004|Overall Study|Lost to Follow-up|0|||
155287658|NCT02001623|560486102|FG005|Overall Study|Lost to Follow-up|0|||
155287659|NCT02001623|560486103|FG006|Overall Study|Lost to Follow-up|0|||
155287660|NCT02001623|560486104|FG007|Overall Study|Lost to Follow-up|0|||
155287661|NCT02001623|560486105|FG008|Overall Study|Lost to Follow-up|0|||
155287662|NCT02001623|560486106|FG009|Overall Study|Lost to Follow-up|1|||
155287663|NCT02001623|560486107|FG010|Overall Study|Lost to Follow-up|0|||
155287664|NCT02001623|560486108|FG011|Overall Study|Lost to Follow-up|0|||
155287665|NCT02001623|560486109|FG012|Overall Study|Lost to Follow-up|0|||
155287666|NCT02001623|560486110|FG013|Overall Study|Lost to Follow-up|0|||
155287667|NCT02001623|560486111|FG014|Overall Study|Lost to Follow-up|0|||
155287668|NCT02001623|560486097|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
155287669|NCT02001623|560486098|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
155287670|NCT02001623|560486099|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
155287671|NCT02001623|560486100|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
155287672|NCT02001623|560486101|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
155287673|NCT02001623|560486102|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
155287674|NCT02001623|560486103|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
155287675|NCT02001623|560486104|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
155287676|NCT02001623|560486105|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
155287677|NCT02001623|560486106|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
155287678|NCT02001623|560486107|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
155287679|NCT02001623|560486108|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
155287680|NCT02001623|560486109|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
155287681|NCT02001623|560486110|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
155287682|NCT02001623|560486111|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
155287683|NCT02001623|560486097|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
155287684|NCT02001623|560486098|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
155287685|NCT02001623|560486099|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
155287686|NCT02001623|560486100|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
155287687|NCT02001623|560486101|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
155287688|NCT02001623|560486102|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
155287689|NCT02001623|560486103|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
155638045|NCT01582451|561766360|FG000|Overall Study|Death|3|||
155287690|NCT02001623|560486104|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
155287691|NCT02001623|560486105|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
155287692|NCT02001623|560486106|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
155287693|NCT02001623|560486107|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
155287694|NCT02001623|560486108|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
155287695|NCT02001623|560486109|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
155287696|NCT02001623|560486110|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
155287697|NCT02001623|560486111|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
155287698|NCT00109967|560486118|FG000|Overall Study|Cancel Prior to Treatment|2|||
155287699|NCT00109967|560486119|FG001|Overall Study|Cancel Prior to Treatment|0|||
155287700|NCT00109967|560486118|FG000|Overall Study|Adverse Event|12|||
155287701|NCT00109967|560486119|FG001|Overall Study|Adverse Event|1|||
155287702|NCT00109967|560486118|FG000|Overall Study|Withdrawal by Subject|5|||
155287703|NCT00109967|560486119|FG001|Overall Study|Withdrawal by Subject|0|||
155287704|NCT00109967|560486118|FG000|Overall Study|Physician Decision|1|||
155287705|NCT00109967|560486119|FG001|Overall Study|Physician Decision|3|||
155287706|NCT00109967|560486118|FG000|Overall Study|Death|0|||
155287707|NCT00109967|560486119|FG001|Overall Study|Death|2|||
155287708|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Adverse Event|1|||
155287709|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
155287710|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
155287711|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
155287712|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Pregnancy|1|||
155287713|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
155287714|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
155287715|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
155287716|NCT01977612|560486127|FG000|Overall Study|Lost to Follow-up|1|||
155287717|NCT01977612|560486128|FG001|Overall Study|Lost to Follow-up|1|||
155287718|NCT02715258|560486130|FG000|Overall Study|Withdrawal by Subject|6|||
155287719|NCT02715258|560486131|FG001|Overall Study|Withdrawal by Subject|1|||
155287720|NCT02715258|560486130|FG000|Overall Study|Lost to Follow-up|7|||
155287721|NCT02715258|560486131|FG001|Overall Study|Lost to Follow-up|1|||
155287722|NCT02715258|560486130|FG000|Overall Study|Terminated by Sponsor|0|||
155287723|NCT02715258|560486131|FG001|Overall Study|Terminated by Sponsor|1|||
155287724|NCT02715258|560486130|FG000|Overall Study|Death|0|||
155287725|NCT02715258|560486131|FG001|Overall Study|Death|1|||
155287726|NCT02715258|560486130|FG000|Overall Study|Subject non-compliant|1|||
155287727|NCT02715258|560486131|FG001|Overall Study|Subject non-compliant|1|||
155287728|NCT02715258|560486130|FG000|Overall Study|GCP violation|2|||
155287729|NCT02715258|560486131|FG001|Overall Study|GCP violation|1|||
155287730|NCT02263508|560486139|FG000|Overall Study|Withdrawal by Subject|1|||
155287731|NCT02263508|560486140|FG001|Overall Study|Withdrawal by Subject|23|||
155287732|NCT02263508|560486141|FG002|Overall Study|Withdrawal by Subject|17|||
155287733|NCT02263508|560486139|FG000|Overall Study|Sponsor Decision|12|||
155287734|NCT02263508|560486140|FG001|Overall Study|Sponsor Decision|165|||
155287735|NCT02263508|560486141|FG002|Overall Study|Sponsor Decision|182|||
155287736|NCT02263508|560486139|FG000|Overall Study|Lost to Follow-up|2|||
155287737|NCT02263508|560486140|FG001|Overall Study|Lost to Follow-up|7|||
155287738|NCT02263508|560486141|FG002|Overall Study|Lost to Follow-up|7|||
155287739|NCT02263508|560486139|FG000|Overall Study|Death|6|||
155287740|NCT02263508|560486140|FG001|Overall Study|Death|151|||
155287741|NCT02263508|560486141|FG002|Overall Study|Death|140|||
155287742|NCT01117480|560486142|FG000|Overall Study|Protocol Violation|8|||
155287743|NCT01117480|560486142|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
155287744|NCT01280591|560486143|FG000|Overall Study|Withdrawal by Subject|0|||
155287745|NCT01280591|560486144|FG001|Overall Study|Withdrawal by Subject|0|||
155287746|NCT01280591|560486145|FG002|Overall Study|Withdrawal by Subject|0|||
155287747|NCT01280591|560486146|FG003|Overall Study|Withdrawal by Subject|2|||
155287748|NCT01280591|560486143|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
155287749|NCT01280591|560486144|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
155287750|NCT01280591|560486145|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
155287751|NCT01280591|560486146|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
155287752|NCT02955069|560486147|FG000|Overall Study|Adverse Event|7|||
155287753|NCT02955069|560486148|FG001|Overall Study|Adverse Event|2|||
155287754|NCT02955069|560486147|FG000|Overall Study|Death|7|||
155287755|NCT02955069|560486148|FG001|Overall Study|Death|3|||
155287756|NCT02955069|560486147|FG000|Overall Study|Physician Decision|10|||
155287757|NCT02955069|560486148|FG001|Overall Study|Physician Decision|2|||
155287758|NCT02955069|560486147|FG000|Overall Study|Progressive disease|64|||
155287759|NCT02955069|560486148|FG001|Overall Study|Progressive disease|13|||
155287760|NCT02955069|560486147|FG000|Overall Study|Study terminated by sponsor|4|||
155287761|NCT02955069|560486148|FG001|Overall Study|Study terminated by sponsor|0|||
155287762|NCT02955069|560486147|FG000|Overall Study|Subject/Guardian decision|3|||
155287763|NCT02955069|560486148|FG001|Overall Study|Subject/Guardian decision|1|||
155287764|NCT00943605|560486149|FG000|Overall Study|Study termination|30|||
155287765|NCT00943605|560486150|FG001|Overall Study|Study termination|30|||
155287766|NCT04148937|560486151|FG000|Overall Study|Withdrawal by Subject|0|||
155287767|NCT04148937|560486152|FG001|Overall Study|Withdrawal by Subject|0|||
155287768|NCT04148937|560486153|FG002|Overall Study|Withdrawal by Subject|0|||
155287769|NCT04148937|560486154|FG003|Overall Study|Withdrawal by Subject|1|||
155287770|NCT04148937|560486155|FG004|Overall Study|Withdrawal by Subject|0|||
155287771|NCT04148937|560486156|FG005|Overall Study|Withdrawal by Subject|1|||
155287772|NCT04148937|560486157|FG006|Overall Study|Withdrawal by Subject|1|||
155287773|NCT04148937|560486158|FG007|Overall Study|Withdrawal by Subject|0|||
155287774|NCT04148937|560486151|FG000|Overall Study|Lost to Follow-up|0|||
155287775|NCT04148937|560486152|FG001|Overall Study|Lost to Follow-up|0|||
155287776|NCT04148937|560486153|FG002|Overall Study|Lost to Follow-up|1|||
155287777|NCT04148937|560486154|FG003|Overall Study|Lost to Follow-up|0|||
155287778|NCT04148937|560486155|FG004|Overall Study|Lost to Follow-up|0|||
155287779|NCT04148937|560486156|FG005|Overall Study|Lost to Follow-up|2|||
155287780|NCT04148937|560486157|FG006|Overall Study|Lost to Follow-up|0|||
155287781|NCT04148937|560486158|FG007|Overall Study|Lost to Follow-up|0|||
155287782|NCT03999554|560486159|FG000|Overall Study|Lost to Follow-up|4|||
155287783|NCT03999554|560486160|FG001|Overall Study|Lost to Follow-up|5|||
155287784|NCT03999554|560486161|FG002|Overall Study|Lost to Follow-up|4|||
155287785|NCT03999554|560486162|FG003|Overall Study|Lost to Follow-up|5|||
155287786|NCT03999554|560486163|FG004|Overall Study|Lost to Follow-up|8|||
155287787|NCT03999554|560486159|FG000|Overall Study|Protocol Violation|0|||
155287788|NCT03999554|560486160|FG001|Overall Study|Protocol Violation|0|||
155287789|NCT03999554|560486161|FG002|Overall Study|Protocol Violation|5|||
155287790|NCT03999554|560486162|FG003|Overall Study|Protocol Violation|0|||
155287791|NCT03999554|560486163|FG004|Overall Study|Protocol Violation|0|||
155287792|NCT03999554|560486159|FG000|Overall Study|Pregnancy|0|||
155287793|NCT03999554|560486160|FG001|Overall Study|Pregnancy|0|||
155287794|NCT03999554|560486161|FG002|Overall Study|Pregnancy|1|||
155287795|NCT03999554|560486162|FG003|Overall Study|Pregnancy|0|||
155287796|NCT03999554|560486163|FG004|Overall Study|Pregnancy|0|||
155287797|NCT03999554|560486159|FG000|Overall Study|Withdrawal by Subject|2|||
155287798|NCT03999554|560486160|FG001|Overall Study|Withdrawal by Subject|2|||
155287799|NCT03999554|560486161|FG002|Overall Study|Withdrawal by Subject|2|||
155287800|NCT03999554|560486162|FG003|Overall Study|Withdrawal by Subject|1|||
155287801|NCT03999554|560486163|FG004|Overall Study|Withdrawal by Subject|1|||
155287802|NCT03999554|560486159|FG000|Overall Study|failure to comply with protocol requirements|0|||
155287803|NCT03999554|560486160|FG001|Overall Study|failure to comply with protocol requirements|0|||
155287804|NCT03999554|560486161|FG002|Overall Study|failure to comply with protocol requirements|0|||
155287805|NCT03999554|560486162|FG003|Overall Study|failure to comply with protocol requirements|1|||
155287806|NCT03999554|560486163|FG004|Overall Study|failure to comply with protocol requirements|0|||
155287807|NCT02082158|560486164|FG000|Overall Study|Withdrawal by Subject|0|||
155287808|NCT02082158|560486165|FG001|Overall Study|Withdrawal by Subject|0|||
155287809|NCT02082158|560486166|FG002|Overall Study|Withdrawal by Subject|0|||
155287810|NCT02082158|560486167|FG003|Overall Study|Withdrawal by Subject|0|||
155287811|NCT02082158|560486168|FG004|Overall Study|Withdrawal by Subject|1|||
155287812|NCT02082158|560486169|FG005|Overall Study|Withdrawal by Subject|0|||
155287813|NCT02082158|560486164|FG000|Overall Study|Failed Fit-testing|8|||
155287814|NCT02082158|560486165|FG001|Overall Study|Failed Fit-testing|8|||
155287815|NCT02082158|560486166|FG002|Overall Study|Failed Fit-testing|14|||
155287816|NCT02082158|560486167|FG003|Overall Study|Failed Fit-testing|4|||
155287817|NCT02082158|560486168|FG004|Overall Study|Failed Fit-testing|3|||
155287818|NCT02082158|560486169|FG005|Overall Study|Failed Fit-testing|7|||
155287819|NCT04012853|560486170|FG000|Overall Study|Withdrawal by Subject|1|||
155287820|NCT04012853|560486171|FG001|Overall Study|Withdrawal by Subject|1|||
155287821|NCT04012853|560486170|FG000|Overall Study|Protocol Violation|1|||
155287822|NCT04012853|560486171|FG001|Overall Study|Protocol Violation|0|||
155287823|NCT04012853|560486170|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
155287824|NCT04012853|560486171|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
155287825|NCT04304534|560486172|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
155287826|NCT04304534|560486173|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
155287827|NCT04304534|560486174|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
155287828|NCT04304534|560486175|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
155287829|NCT04304534|560486172|FG000|Overall Study|Non-Compliance with study drug|0|||
155287830|NCT04304534|560486173|FG001|Overall Study|Non-Compliance with study drug|1|||
155287831|NCT04304534|560486174|FG002|Overall Study|Non-Compliance with study drug|1|||
155287832|NCT04304534|560486175|FG003|Overall Study|Non-Compliance with study drug|1|||
155407677|NCT01187953|560925559|FG000|Overall Study|Adverse Event|1|||
155287833|NCT04304534|560486172|FG000|Overall Study|Lost to Follow-up|0|||
155287834|NCT04304534|560486173|FG001|Overall Study|Lost to Follow-up|1|||
155287835|NCT04304534|560486174|FG002|Overall Study|Lost to Follow-up|2|||
155287836|NCT04304534|560486175|FG003|Overall Study|Lost to Follow-up|3|||
155287837|NCT04304534|560486172|FG000|Overall Study|Unspecific|4|||
155287838|NCT04304534|560486173|FG001|Overall Study|Unspecific|2|||
155287839|NCT04304534|560486174|FG002|Overall Study|Unspecific|2|||
155287840|NCT04304534|560486175|FG003|Overall Study|Unspecific|2|||
155407678|NCT01187953|560925560|FG001|Overall Study|Adverse Event|2|||
155287841|NCT04304534|560486172|FG000|Overall Study|Technical Problems|2|||
155287842|NCT04304534|560486173|FG001|Overall Study|Technical Problems|2|||
155287843|NCT04304534|560486174|FG002|Overall Study|Technical Problems|3|||
155287844|NCT04304534|560486175|FG003|Overall Study|Technical Problems|4|||
155287845|NCT04304534|560486172|FG000|Overall Study|Death|7|||
155287846|NCT04304534|560486173|FG001|Overall Study|Death|2|||
155287847|NCT04304534|560486174|FG002|Overall Study|Death|4|||
155287848|NCT04304534|560486175|FG003|Overall Study|Death|3|||
155287849|NCT04304534|560486172|FG000|Overall Study|Withdrawal by Subject|7|||
155287850|NCT04304534|560486173|FG001|Overall Study|Withdrawal by Subject|2|||
155287851|NCT04304534|560486174|FG002|Overall Study|Withdrawal by Subject|7|||
155287852|NCT04304534|560486175|FG003|Overall Study|Withdrawal by Subject|4|||
155287853|NCT04304534|560486172|FG000|Overall Study|Physician Decision|4|||
155287854|NCT04304534|560486173|FG001|Overall Study|Physician Decision|9|||
155287855|NCT04304534|560486174|FG002|Overall Study|Physician Decision|9|||
155287856|NCT04304534|560486175|FG003|Overall Study|Physician Decision|5|||
155287857|NCT04304534|560486172|FG000|Overall Study|Subject Decision|34|||
155287858|NCT04304534|560486173|FG001|Overall Study|Subject Decision|25|||
155287859|NCT04304534|560486174|FG002|Overall Study|Subject Decision|25|||
155287860|NCT04304534|560486175|FG003|Overall Study|Subject Decision|26|||
155287861|NCT04304534|560486172|FG000|Overall Study|Adverse Event|35|||
155287862|NCT04304534|560486173|FG001|Overall Study|Adverse Event|40|||
155287863|NCT04304534|560486174|FG002|Overall Study|Adverse Event|39|||
155287864|NCT04304534|560486175|FG003|Overall Study|Adverse Event|44|||
155287865|NCT01695317|560486176|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
155287866|NCT01695317|560486177|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
155287867|NCT01695317|560486176|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
155287868|NCT01695317|560486177|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
155287869|NCT00464672|560486178|FG000|Overall Study|withdrawal of consent|0|||
155287870|NCT00464672|560486179|FG001|Overall Study|withdrawal of consent|0|||
155287871|NCT00464672|560486180|FG002|Overall Study|withdrawal of consent|0|||
155287872|NCT00464672|560486181|FG003|Overall Study|withdrawal of consent|1|||
155287873|NCT00464672|560486182|FG004|Overall Study|withdrawal of consent|9|||
155287874|NCT00464672|560486183|FG005|Overall Study|withdrawal of consent|4|||
155287875|NCT00464672|560486178|FG000|Overall Study|Lost to Follow-up|25|||
155287876|NCT00464672|560486179|FG001|Overall Study|Lost to Follow-up|10|||
155287877|NCT00464672|560486180|FG002|Overall Study|Lost to Follow-up|0|||
155287878|NCT00464672|560486181|FG003|Overall Study|Lost to Follow-up|0|||
155287879|NCT00464672|560486182|FG004|Overall Study|Lost to Follow-up|1|||
155287880|NCT00464672|560486183|FG005|Overall Study|Lost to Follow-up|0|||
155287881|NCT03055767|560486184|FG000|Open-Label Period|Lost to Follow-up|0|||
155287882|NCT03055767|560486185|FG001|Open-Label Period|Lost to Follow-up|0|||
155287883|NCT03055767|560486186|FG002|Open-Label Period|Lost to Follow-up|2|||
155287884|NCT03055767|560486187|FG003|Open-Label Period|Lost to Follow-up|0|||
155287885|NCT03055767|560486184|FG000|Open-Label Period|Withdrawal by Subject|0|||
155287886|NCT03055767|560486185|FG001|Open-Label Period|Withdrawal by Subject|0|||
155287887|NCT03055767|560486186|FG002|Open-Label Period|Withdrawal by Subject|0|||
155287888|NCT03055767|560486187|FG003|Open-Label Period|Withdrawal by Subject|1|||
155287889|NCT02759731|560486188|FG000|Overall Study|Did not complete treatment.|8|||
155287890|NCT01101165|560486189|FG000|Period 1|Adverse Event|1|||
155287891|NCT01101165|560486190|FG001|Period 1|Adverse Event|2|||
155287892|NCT01101165|560486189|FG000|Period 1|Withdrawal by Subject|0|||
155287893|NCT01101165|560486190|FG001|Period 1|Withdrawal by Subject|2|||
155287894|NCT01101165|560486189|FG000|Period 1|Positive Drug Screen|0|||
155287895|NCT01101165|560486190|FG001|Period 1|Positive Drug Screen|1|||
155287896|NCT01101165|560486189|FG000|Period 1|Lost to Follow-up|1|||
155287897|NCT01101165|560486190|FG001|Period 1|Lost to Follow-up|0|||
155287898|NCT01101165|560486189|FG000|Period 2|Withdrawal by Subject|3|||
155287899|NCT01101165|560486190|FG001|Period 2|Withdrawal by Subject|1|||
155287900|NCT01101165|560486189|FG000|Period 2|Adverse Event|1|||
155287901|NCT01101165|560486190|FG001|Period 2|Adverse Event|0|||
155287902|NCT00015457|560486193|FG000|First Intervention|Adverse Event|0|||
155287903|NCT00015457|560486194|FG001|First Intervention|Adverse Event|2|||
155287904|NCT00015457|560486193|FG000|First Intervention|Lack of Efficacy|0|||
155287905|NCT00015457|560486194|FG001|First Intervention|Lack of Efficacy|1|||
155287906|NCT00015457|560486193|FG000|Second Intervention|Withdrawal by Subject|1|||
155638046|NCT01582451|561766361|FG001|Overall Study|Death|3|||
155287907|NCT00015457|560486194|FG001|Second Intervention|Withdrawal by Subject|0|||
155287908|NCT01456936|560486199|FG000|Overall Study|Other reason|41|||
155287909|NCT01456936|560486200|FG001|Overall Study|Other reason|30|||
155287910|NCT01456936|560486201|FG002|Overall Study|Other reason|36|||
155287911|NCT01456936|560486202|FG003|Overall Study|Other reason|33|||
155287912|NCT01456936|560486199|FG000|Overall Study|No longer meets eligibility criteria|4|||
155638047|NCT01582451|561766360|FG000|Overall Study|Lost to Follow-up|0|||
155287913|NCT01456936|560486200|FG001|Overall Study|No longer meets eligibility criteria|8|||
155287914|NCT01456936|560486201|FG002|Overall Study|No longer meets eligibility criteria|6|||
155287915|NCT01456936|560486202|FG003|Overall Study|No longer meets eligibility criteria|5|||
155287916|NCT01456936|560486199|FG000|Overall Study|Protocol Violation|4|||
155287917|NCT01456936|560486200|FG001|Overall Study|Protocol Violation|2|||
155287918|NCT01456936|560486201|FG002|Overall Study|Protocol Violation|5|||
155287919|NCT01456936|560486202|FG003|Overall Study|Protocol Violation|5|||
155287920|NCT01456936|560486199|FG000|Overall Study|Pregnancy|1|||
155287921|NCT01456936|560486200|FG001|Overall Study|Pregnancy|0|||
155287922|NCT01456936|560486201|FG002|Overall Study|Pregnancy|0|||
155287923|NCT01456936|560486202|FG003|Overall Study|Pregnancy|1|||
155287924|NCT01456936|560486199|FG000|Overall Study|Insufficient clinical response|4|||
155287925|NCT01456936|560486200|FG001|Overall Study|Insufficient clinical response|4|||
155287926|NCT01456936|560486201|FG002|Overall Study|Insufficient clinical response|14|||
155287927|NCT01456936|560486202|FG003|Overall Study|Insufficient clinical response|13|||
155287928|NCT01456936|560486199|FG000|Overall Study|No longer willing to participate|195|||
155287929|NCT01456936|560486200|FG001|Overall Study|No longer willing to participate|218|||
155287930|NCT01456936|560486201|FG002|Overall Study|No longer willing to participate|224|||
155287931|NCT01456936|560486202|FG003|Overall Study|No longer willing to participate|248|||
155287932|NCT01456936|560486199|FG000|Overall Study|Lost to Follow-up|135|||
155287933|NCT01456936|560486200|FG001|Overall Study|Lost to Follow-up|126|||
155287934|NCT01456936|560486201|FG002|Overall Study|Lost to Follow-up|144|||
155287935|NCT01456936|560486202|FG003|Overall Study|Lost to Follow-up|127|||
155287936|NCT01456936|560486199|FG000|Overall Study|Medication error|0|||
155287937|NCT01456936|560486200|FG001|Overall Study|Medication error|1|||
155287938|NCT01456936|560486201|FG002|Overall Study|Medication error|0|||
155287939|NCT01456936|560486202|FG003|Overall Study|Medication error|1|||
155287940|NCT01456936|560486199|FG000|Overall Study|Adverse event (study drug)|25|||
155287941|NCT01456936|560486200|FG001|Overall Study|Adverse event (study drug)|21|||
155287942|NCT01456936|560486201|FG002|Overall Study|Adverse event (study drug)|26|||
155287943|NCT01456936|560486202|FG003|Overall Study|Adverse event (study drug)|17|||
155287944|NCT01456936|560486199|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
155287945|NCT01456936|560486200|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
155287946|NCT01456936|560486201|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
155287947|NCT01456936|560486202|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
155287948|NCT01456936|560486199|FG000|Overall Study|Death|0|||
155287949|NCT01456936|560486200|FG001|Overall Study|Death|3|||
155287950|NCT01456936|560486201|FG002|Overall Study|Death|1|||
155287951|NCT01456936|560486202|FG003|Overall Study|Death|3|||
155287952|NCT01456936|560486199|FG000|Overall Study|Randomized but not treated|21|||
155287953|NCT01456936|560486200|FG001|Overall Study|Randomized but not treated|28|||
155287954|NCT01456936|560486201|FG002|Overall Study|Randomized but not treated|16|||
155287955|NCT01456936|560486202|FG003|Overall Study|Randomized but not treated|21|||
155287956|NCT02317705|560486203|FG000|Overall Study|Withdrawal by Subject|3|||
155287957|NCT02317705|560486203|FG000|Overall Study|Physician Decision|1|||
155287958|NCT02317705|560486203|FG000|Overall Study|Drug not usable|1|||
155287959|NCT03095508|560486204|FG000|Overall Study|Adverse Event|0|||
155287960|NCT03095508|560486205|FG001|Overall Study|Adverse Event|1|||
155287961|NCT01674569|560486206|FG000|Overall Study|Adverse Event|0|||
155287962|NCT01674569|560486207|FG001|Overall Study|Adverse Event|2|||
155287963|NCT01674569|560486208|FG002|Overall Study|Adverse Event|0|||
155287964|NCT01674569|560486209|FG003|Overall Study|Adverse Event|1|||
155287965|NCT01674569|560486210|FG004|Overall Study|Adverse Event|2|||
155287966|NCT01674569|560486211|FG005|Overall Study|Adverse Event|2|||
155287967|NCT01674569|560486206|FG000|Overall Study|Protocol Violation|0|||
155287968|NCT01674569|560486207|FG001|Overall Study|Protocol Violation|1|||
155287969|NCT01674569|560486208|FG002|Overall Study|Protocol Violation|1|||
155287970|NCT01674569|560486209|FG003|Overall Study|Protocol Violation|0|||
155287971|NCT01674569|560486210|FG004|Overall Study|Protocol Violation|0|||
155287972|NCT01674569|560486211|FG005|Overall Study|Protocol Violation|0|||
155287973|NCT01674569|560486206|FG000|Overall Study|Withdrawal by Subject|0|||
155287974|NCT01674569|560486207|FG001|Overall Study|Withdrawal by Subject|0|||
155287975|NCT01674569|560486208|FG002|Overall Study|Withdrawal by Subject|1|||
155287976|NCT01674569|560486209|FG003|Overall Study|Withdrawal by Subject|0|||
155287977|NCT01674569|560486210|FG004|Overall Study|Withdrawal by Subject|0|||
155287978|NCT01674569|560486211|FG005|Overall Study|Withdrawal by Subject|0|||
155287979|NCT01599325|560486212|FG000|Primary Parent Phase|Adverse Event|5|||
155287980|NCT01599325|560486212|FG000|Primary Parent Phase|Disease Progression|7|||
155287981|NCT01599325|560486212|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
155287982|NCT01599325|560486212|FG000|Primary Parent Phase|Death|13|||
155287983|NCT01599325|560486212|FG000|Primary Parent Phase|Protocol Violation|1|||
155287984|NCT01599325|560486212|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
155287985|NCT01599325|560486212|FG000|Primary Parent Phase|Other|2|||
155287986|NCT01599325|560486212|FG000|Extension Phase|Study Closure|1|||
155287987|NCT01599325|560486212|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
155287988|NCT01599325|560486212|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
155287989|NCT01599325|560486212|FG000|Extension Phase|Disease Progression|1|||
155407679|NCT01187953|560925559|FG000|Overall Study|Lost to Follow-up|0|||
155287990|NCT01599325|560486212|FG000|Extension Phase|Withdrawal by Subject|8|||
155287991|NCT01710514|560486214|FG000|Overall Study|Adverse Event|6|||
155287992|NCT01710514|560486215|FG001|Overall Study|Adverse Event|7|||
155287993|NCT01710514|560486214|FG000|Overall Study|Withdrawal by Subject|1|||
155287994|NCT01710514|560486215|FG001|Overall Study|Withdrawal by Subject|0|||
155287995|NCT03404843|560486218|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
155287996|NCT03404843|560486219|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
155287997|NCT04044664|560486220|FG000|Stage 1|Adverse Event|3|||
155287998|NCT04044664|560486221|FG001|Stage 1|Adverse Event|3|||
155287999|NCT04044664|560486222|FG002|Stage 1|Adverse Event|1|||
155288000|NCT04044664|560486220|FG000|Stage 1|Lost to Follow-up|3|||
155288001|NCT04044664|560486221|FG001|Stage 1|Lost to Follow-up|2|||
155288002|NCT04044664|560486222|FG002|Stage 1|Lost to Follow-up|2|||
155288003|NCT04044664|560486220|FG000|Stage 1|Withdrawal by Subject|9|||
155288004|NCT04044664|560486221|FG001|Stage 1|Withdrawal by Subject|1|||
155288005|NCT04044664|560486222|FG002|Stage 1|Withdrawal by Subject|0|||
155288006|NCT04044664|560486220|FG000|Stage 1|noncompliance, personal reason|2|||
155288007|NCT04044664|560486221|FG001|Stage 1|noncompliance, personal reason|0|||
155288008|NCT04044664|560486222|FG002|Stage 1|noncompliance, personal reason|0|||
155288009|NCT04044664|560486220|FG000|Stage 1|randomization error|0|||
155288010|NCT04044664|560486221|FG001|Stage 1|randomization error|1|||
155288011|NCT04044664|560486222|FG002|Stage 1|randomization error|0|||
155288012|NCT04044664|560486220|FG000|Stage 2|Adverse Event|2|||
155288013|NCT04044664|560486221|FG001|Stage 2|Adverse Event|0|||
155288014|NCT04044664|560486222|FG002|Stage 2|Adverse Event|0|||
155288015|NCT04044664|560486220|FG000|Stage 2|Lost to Follow-up|3|||
155288016|NCT04044664|560486221|FG001|Stage 2|Lost to Follow-up|2|||
155288017|NCT04044664|560486222|FG002|Stage 2|Lost to Follow-up|1|||
155288018|NCT04044664|560486220|FG000|Stage 2|Withdrawal by Subject|3|||
155288019|NCT04044664|560486221|FG001|Stage 2|Withdrawal by Subject|0|||
155288020|NCT04044664|560486222|FG002|Stage 2|Withdrawal by Subject|0|||
155288021|NCT04044664|560486220|FG000|Stage 2|protocol deviation|1|||
155288022|NCT04044664|560486221|FG001|Stage 2|protocol deviation|0|||
155288023|NCT04044664|560486222|FG002|Stage 2|protocol deviation|0|||
155288024|NCT03822351|560486234|FG000|Overall Study|Death|27|||
155288025|NCT03822351|560486235|FG001|Overall Study|Death|23|||
155288026|NCT03822351|560486236|FG002|Overall Study|Death|24|||
155288027|NCT03822351|560486234|FG000|Overall Study|Lost to Follow-up|6|||
155288028|NCT03822351|560486235|FG001|Overall Study|Lost to Follow-up|2|||
155288029|NCT03822351|560486236|FG002|Overall Study|Lost to Follow-up|1|||
155288030|NCT03822351|560486234|FG000|Overall Study|Withdrawal by Subject|10|||
155288031|NCT03822351|560486235|FG001|Overall Study|Withdrawal by Subject|4|||
155288032|NCT03822351|560486236|FG002|Overall Study|Withdrawal by Subject|6|||
155288033|NCT03822351|560486234|FG000|Overall Study|Progressive Disease|2|||
155288034|NCT03822351|560486235|FG001|Overall Study|Progressive Disease|1|||
155288035|NCT03822351|560486236|FG002|Overall Study|Progressive Disease|0|||
155288036|NCT03822351|560486234|FG000|Overall Study|Not Treated|1|||
155288037|NCT03822351|560486235|FG001|Overall Study|Not Treated|1|||
155288038|NCT03822351|560486236|FG002|Overall Study|Not Treated|1|||
155288039|NCT01458275|560486237|FG000|Overall Study|Adverse Event|3|||
155288040|NCT01458275|560486238|FG001|Overall Study|Adverse Event|4|||
155288041|NCT01458275|560486239|FG002|Overall Study|Adverse Event|1|||
155288042|NCT01458275|560486237|FG000|Overall Study|Lost to Follow-up|3|||
155288043|NCT01458275|560486238|FG001|Overall Study|Lost to Follow-up|2|||
155288044|NCT01458275|560486239|FG002|Overall Study|Lost to Follow-up|5|||
155288045|NCT01458275|560486237|FG000|Overall Study|Protocol Violation|5|||
155288046|NCT01458275|560486238|FG001|Overall Study|Protocol Violation|5|||
155288047|NCT01458275|560486239|FG002|Overall Study|Protocol Violation|2|||
155288048|NCT01458275|560486237|FG000|Overall Study|Withdrawal by Subject|3|||
155288049|NCT01458275|560486238|FG001|Overall Study|Withdrawal by Subject|2|||
155288050|NCT01458275|560486239|FG002|Overall Study|Withdrawal by Subject|1|||
155288051|NCT00871429|560486240|FG000|Overall Study|Lost to Follow-up|6|||
155288052|NCT00871429|560486240|FG000|Overall Study|Withdrawal by Subject|17|||
155288053|NCT00871429|560486240|FG000|Overall Study|Questionnaire not completed|1|||
155288054|NCT03102242|560486241|FG000|Overall Study|Adverse Event|2|||
155288055|NCT01875250|560488425|FG000|Overall Study|Adverse Event|2|||
155288056|NCT01875250|560488426|FG001|Overall Study|Adverse Event|0|||
155288057|NCT00661778|560488429|FG000|Overall Study|Disease Progression|23|||
155288058|NCT00661778|560488429|FG000|Overall Study|Adverse Event|18|||
155288059|NCT00661778|560488429|FG000|Overall Study|Reason not Specified|6|||
155288060|NCT00661778|560488429|FG000|Overall Study|Protocol Violation|2|||
155288061|NCT00661778|560488429|FG000|Overall Study|Withdrawal of Consent|1|||
155288062|NCT05298111|560488430|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
155288063|NCT05298111|560488431|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
155288064|NCT02232178|560488432|FG000|Overall Study|Lost to Follow-up|0|||
155288065|NCT02232178|560488433|FG001|Overall Study|Lost to Follow-up|1|||
155288066|NCT02232178|560488434|FG002|Overall Study|Lost to Follow-up|0|||
155288067|NCT02232178|560488432|FG000|Overall Study|ineligibility|0|||
155288068|NCT02232178|560488433|FG001|Overall Study|ineligibility|0|||
155288069|NCT02232178|560488434|FG002|Overall Study|ineligibility|1|||
155288070|NCT02232178|560488432|FG000|Overall Study|surgical complication|1|||
155288071|NCT02232178|560488433|FG001|Overall Study|surgical complication|0|||
155288072|NCT02232178|560488434|FG002|Overall Study|surgical complication|0|||
155288073|NCT01259102|560488435|FG000|Overall Study|Adverse Event|1|||
155407680|NCT01187953|560925560|FG001|Overall Study|Lost to Follow-up|3|||
155407681|NCT01187953|560925559|FG000|Overall Study|Withdrawal by Subject|3|||
155407682|NCT01187953|560925560|FG001|Overall Study|Withdrawal by Subject|3|||
155407683|NCT02457637|560925565|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
155407684|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Death|3|||
155407685|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Death|0|||
155407686|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Adverse Event|12|||
155407687|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Adverse Event|6|||
155407688|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
155407689|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
155407690|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
155407691|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
155407692|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
155407693|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
155407694|NCT00159861|560925566|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
155407695|NCT00159861|560925567|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
155407696|NCT00159861|560925566|FG000|Extension Study - up to 3 Years|Death|24|||
155407697|NCT00159861|560925567|FG001|Extension Study - up to 3 Years|Death|28|||
155407698|NCT00159861|560925566|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
155407699|NCT00159861|560925567|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
155407700|NCT00159861|560925566|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
155407701|NCT00159861|560925567|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
155407702|NCT00159861|560925566|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
155407703|NCT00159861|560925567|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
155407704|NCT00159861|560925566|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
155407705|NCT00159861|560925567|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
155407706|NCT01553136|560925569|FG000|Overall Study|Adverse Event|3|||
155407707|NCT01553136|560925570|FG001|Overall Study|Adverse Event|2|||
155407708|NCT01553136|560925569|FG000|Overall Study|Withdrawal by Subject|2|||
155407709|NCT01553136|560925570|FG001|Overall Study|Withdrawal by Subject|3|||
155407710|NCT01553136|560925569|FG000|Overall Study|Lost to Follow-up|4|||
155407711|NCT01553136|560925570|FG001|Overall Study|Lost to Follow-up|10|||
155407712|NCT01553136|560925569|FG000|Overall Study|Physician Decision|2|||
155407713|NCT01553136|560925570|FG001|Overall Study|Physician Decision|3|||
155407714|NCT01553136|560925569|FG000|Overall Study|Scheduling Difficulties|5|||
155407715|NCT01553136|560925570|FG001|Overall Study|Scheduling Difficulties|4|||
155407716|NCT03451773|560927230|FG000|Overall Study|Death on study|1|||
155407717|NCT03451773|560927231|FG001|Overall Study|Death on study|5|||
155407718|NCT03451773|560927230|FG000|Overall Study|Death during follow-up period|0|||
155407719|NCT03451773|560927231|FG001|Overall Study|Death during follow-up period|1|||
155407720|NCT02068547|560927232|FG000|Overall Study|Lost to Follow-up|3|||
155407721|NCT02068547|560927233|FG001|Overall Study|Lost to Follow-up|3|||
155407722|NCT02068547|560927232|FG000|Overall Study|Physician Decision|1|||
155407723|NCT02068547|560927233|FG001|Overall Study|Physician Decision|0|||
155407724|NCT03657043|560927234|FG000|Overall Study|Withdrawal by Subject|1|||
155407725|NCT03657043|560927235|FG001|Overall Study|Withdrawal by Subject|1|||
155407726|NCT03657043|560927236|FG002|Overall Study|Withdrawal by Subject|0|||
155407727|NCT03657043|560927237|FG003|Overall Study|Withdrawal by Subject|0|||
155407728|NCT03657043|560927238|FG004|Overall Study|Withdrawal by Subject|4|||
155407729|NCT03657043|560927234|FG000|Overall Study|Study closure by Sponsor|0|||
155407730|NCT03657043|560927235|FG001|Overall Study|Study closure by Sponsor|2|||
155407731|NCT03657043|560927236|FG002|Overall Study|Study closure by Sponsor|0|||
155407732|NCT03657043|560927237|FG003|Overall Study|Study closure by Sponsor|0|||
155407733|NCT03657043|560927238|FG004|Overall Study|Study closure by Sponsor|17|||
155407734|NCT03657043|560927234|FG000|Overall Study|Lost to Follow-up|0|||
155407735|NCT03657043|560927235|FG001|Overall Study|Lost to Follow-up|0|||
155407736|NCT03657043|560927236|FG002|Overall Study|Lost to Follow-up|0|||
155407737|NCT03657043|560927237|FG003|Overall Study|Lost to Follow-up|0|||
155407738|NCT03657043|560927238|FG004|Overall Study|Lost to Follow-up|4|||
155407739|NCT03657043|560927234|FG000|Overall Study|Death|6|||
155407740|NCT03657043|560927235|FG001|Overall Study|Death|5|||
155407741|NCT03657043|560927236|FG002|Overall Study|Death|0|||
155407742|NCT03657043|560927237|FG003|Overall Study|Death|0|||
155407743|NCT03657043|560927238|FG004|Overall Study|Death|53|||
155407744|NCT03657043|560927234|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
155407745|NCT03657043|560927235|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
155407746|NCT03657043|560927236|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
155407747|NCT03657043|560927237|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
155407748|NCT03657043|560927238|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
155407749|NCT03657043|560927234|FG000|Overall Study|Adverse Event|0|||
155407750|NCT03657043|560927235|FG001|Overall Study|Adverse Event|0|||
155407751|NCT03657043|560927236|FG002|Overall Study|Adverse Event|0|||
155407752|NCT03657043|560927237|FG003|Overall Study|Adverse Event|0|||
155407753|NCT03657043|560927238|FG004|Overall Study|Adverse Event|2|||
155407754|NCT03657043|560927234|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
155407755|NCT03657043|560927235|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
155288074|NCT01259102|560488436|FG001|Overall Study|Adverse Event|0|||
155288075|NCT01259102|560488437|FG002|Overall Study|Adverse Event|1|||
155288076|NCT01259102|560488438|FG003|Overall Study|Adverse Event|1|||
155288077|NCT01259102|560488439|FG004|Overall Study|Adverse Event|0|||
155288078|NCT01259102|560488435|FG000|Overall Study|Other|0|||
155288079|NCT01259102|560488436|FG001|Overall Study|Other|0|||
155288080|NCT01259102|560488437|FG002|Overall Study|Other|1|||
155288081|NCT01259102|560488438|FG003|Overall Study|Other|1|||
155288082|NCT01259102|560488439|FG004|Overall Study|Other|1|||
155288083|NCT00686517|560488441|FG000|Treatment|Serious Adverse Event|1|||
155288084|NCT00686517|560488442|FG001|Treatment|Serious Adverse Event|2|||
155288085|NCT00686517|560488443|FG002|Treatment|Serious Adverse Event|1|||
155288086|NCT00686517|560488441|FG000|Treatment|Adverse Event|2|||
155288087|NCT00686517|560488442|FG001|Treatment|Adverse Event|0|||
155288088|NCT00686517|560488443|FG002|Treatment|Adverse Event|0|||
155288089|NCT00686517|560488441|FG000|Treatment|Poor Protocol Compliance|1|||
155288090|NCT00686517|560488442|FG001|Treatment|Poor Protocol Compliance|0|||
155288091|NCT00686517|560488443|FG002|Treatment|Poor Protocol Compliance|0|||
155288092|NCT00686517|560488441|FG000|Treatment|Protocol Violation|2|||
155288093|NCT00686517|560488442|FG001|Treatment|Protocol Violation|1|||
155288094|NCT00686517|560488443|FG002|Treatment|Protocol Violation|0|||
155288095|NCT01803646|560488444|FG000|Overall Study|Protocol Violation|1|||
155288096|NCT01803646|560488445|FG001|Overall Study|Protocol Violation|0|||
155288097|NCT01803646|560488444|FG000|Overall Study|Adverse Event|1|||
155288098|NCT01803646|560488445|FG001|Overall Study|Adverse Event|1|||
155288099|NCT01803646|560488444|FG000|Overall Study|Withdrawal by Subject|9|||
155288100|NCT01803646|560488445|FG001|Overall Study|Withdrawal by Subject|6|||
155288101|NCT01803646|560488444|FG000|Overall Study|Randomization error|1|||
155288102|NCT01803646|560488445|FG001|Overall Study|Randomization error|2|||
155288103|NCT01803646|560488444|FG000|Overall Study|Lost to Follow-up|5|||
155288104|NCT01803646|560488445|FG001|Overall Study|Lost to Follow-up|1|||
155288105|NCT01072357|560488448|FG000|Overall Study|Lost to Follow-up|0|||
155288106|NCT01072357|560488449|FG001|Overall Study|Lost to Follow-up|1|||
155288107|NCT01876511|560488450|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
155288108|NCT01876511|560488451|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
155288109|NCT01876511|560488452|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
155288110|NCT01876511|560488450|FG000|Overall Study|Death (unrelated)|3|||
155288111|NCT01876511|560488451|FG001|Overall Study|Death (unrelated)|0|||
155288112|NCT01876511|560488452|FG002|Overall Study|Death (unrelated)|2|||
155288113|NCT01876511|560488450|FG000|Overall Study|Drug-related Toxicity|5|||
155288114|NCT01876511|560488451|FG001|Overall Study|Drug-related Toxicity|1|||
155288115|NCT01876511|560488452|FG002|Overall Study|Drug-related Toxicity|6|||
155288116|NCT01876511|560488450|FG000|Overall Study|Patient Decision|3|||
155288117|NCT01876511|560488451|FG001|Overall Study|Patient Decision|0|||
155288118|NCT01876511|560488452|FG002|Overall Study|Patient Decision|6|||
155288119|NCT01876511|560488450|FG000|Overall Study|Physician Decision|1|||
155288120|NCT01876511|560488451|FG001|Overall Study|Physician Decision|0|||
155288121|NCT01876511|560488452|FG002|Overall Study|Physician Decision|1|||
155288122|NCT01048788|560488453|FG000|Overall Study|Adverse Event|5|||
155288123|NCT01048788|560488454|FG001|Overall Study|Adverse Event|1|||
155288124|NCT01048788|560488455|FG002|Overall Study|Adverse Event|1|||
155288125|NCT01048788|560488453|FG000|Overall Study|Lack of Efficacy|0|||
155288126|NCT01048788|560488454|FG001|Overall Study|Lack of Efficacy|0|||
155288127|NCT01048788|560488455|FG002|Overall Study|Lack of Efficacy|1|||
155288128|NCT01048788|560488453|FG000|Overall Study|Withdrawal by Subject|0|||
155288129|NCT01048788|560488454|FG001|Overall Study|Withdrawal by Subject|1|||
155288130|NCT01048788|560488455|FG002|Overall Study|Withdrawal by Subject|0|||
155288131|NCT02145182|560488456|FG000|Overall Study|Adverse Event|4|||
155288132|NCT02145182|560488457|FG001|Overall Study|Adverse Event|1|||
155288133|NCT02145182|560488456|FG000|Overall Study|Death|7|||
155288134|NCT02145182|560488457|FG001|Overall Study|Death|7|||
155288135|NCT02145182|560488456|FG000|Overall Study|Lost to Follow-up|2|||
155288136|NCT02145182|560488457|FG001|Overall Study|Lost to Follow-up|2|||
155288137|NCT02145182|560488456|FG000|Overall Study|Pre-transplant Withdrawal|0|||
155288138|NCT02145182|560488457|FG001|Overall Study|Pre-transplant Withdrawal|2|||
155288139|NCT02145182|560488456|FG000|Overall Study|Withdrawal by Subject|5|||
155407756|NCT03657043|560927236|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
155407757|NCT03657043|560927237|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
155407758|NCT03657043|560927238|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
155407759|NCT03657043|560927234|FG000|Overall Study|Withdrawal - declined follow-up|0|||
155288140|NCT02145182|560488457|FG001|Overall Study|Withdrawal by Subject|4|||
155288141|NCT01196988|560488458|FG000|Overall Study|Adverse Event|1|||
155288142|NCT01196988|560488459|FG001|Overall Study|Adverse Event|2|||
155288143|NCT01196988|560488460|FG002|Overall Study|Adverse Event|0|||
155288144|NCT01196988|560488461|FG003|Overall Study|Adverse Event|0|||
155288145|NCT01196988|560488458|FG000|Overall Study|Withdrawal by Subject|5|||
155288146|NCT01196988|560488459|FG001|Overall Study|Withdrawal by Subject|1|||
155288147|NCT01196988|560488460|FG002|Overall Study|Withdrawal by Subject|4|||
155288148|NCT01196988|560488461|FG003|Overall Study|Withdrawal by Subject|0|||
155407760|NCT03657043|560927235|FG001|Overall Study|Withdrawal - declined follow-up|0|||
155407761|NCT03657043|560927236|FG002|Overall Study|Withdrawal - declined follow-up|0|||
155407762|NCT03657043|560927237|FG003|Overall Study|Withdrawal - declined follow-up|0|||
155407763|NCT03657043|560927238|FG004|Overall Study|Withdrawal - declined follow-up|1|||
155407764|NCT00631371|560927246|FG000|Overall Study|Lost to Follow-up|24|||
155407765|NCT00631371|560927247|FG001|Overall Study|Lost to Follow-up|19|||
155407766|NCT00631371|560927246|FG000|Overall Study|Other reason|5|||
155407767|NCT00631371|560927247|FG001|Overall Study|Other reason|12|||
155407768|NCT00631371|560927246|FG000|Overall Study|subject request|38|||
155407769|NCT00631371|560927247|FG001|Overall Study|subject request|45|||
155407770|NCT00631371|560927246|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
155407771|NCT00631371|560927247|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
155407772|NCT00631371|560927246|FG000|Overall Study|Death|263|||
155407773|NCT00631371|560927247|FG001|Overall Study|Death|239|||
155407774|NCT01661140|560927248|FG000|Open-Label Period|Adverse Event|44|||
155407775|NCT01661140|560927249|FG001|Open-Label Period|Adverse Event|0|||
155407776|NCT01661140|560927250|FG002|Open-Label Period|Adverse Event|0|||
155407777|NCT01661140|560927248|FG000|Open-Label Period|Protocol Violation|3|||
155407778|NCT01661140|560927249|FG001|Open-Label Period|Protocol Violation|0|||
155407779|NCT01661140|560927250|FG002|Open-Label Period|Protocol Violation|0|||
155407780|NCT01661140|560927248|FG000|Open-Label Period|Withdrawal by Subject|5|||
155407781|NCT01661140|560927249|FG001|Open-Label Period|Withdrawal by Subject|0|||
155407782|NCT01661140|560927250|FG002|Open-Label Period|Withdrawal by Subject|0|||
155407783|NCT01661140|560927248|FG000|Open-Label Period|Investigator Decision|3|||
155407784|NCT01661140|560927249|FG001|Open-Label Period|Investigator Decision|0|||
155407785|NCT01661140|560927250|FG002|Open-Label Period|Investigator Decision|0|||
155407786|NCT01661140|560927248|FG000|Open-Label Period|Death|1|||
155407787|NCT01661140|560927249|FG001|Open-Label Period|Death|0|||
155407788|NCT01661140|560927250|FG002|Open-Label Period|Death|0|||
155407789|NCT01661140|560927248|FG000|Open-Label Period|Administrative/Other|1|||
155407790|NCT01661140|560927249|FG001|Open-Label Period|Administrative/Other|0|||
155407791|NCT01661140|560927250|FG002|Open-Label Period|Administrative/Other|0|||
155407792|NCT01661140|560927248|FG000|Open-Label Period|Sponsor termination|16|||
155407793|NCT01661140|560927249|FG001|Open-Label Period|Sponsor termination|0|||
155407794|NCT01661140|560927250|FG002|Open-Label Period|Sponsor termination|0|||
155407795|NCT01661140|560927248|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
155407796|NCT01661140|560927249|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
155407797|NCT01661140|560927250|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
155407798|NCT01661140|560927248|FG000|Open-Label Period|Lost to Follow-up|2|||
155407799|NCT01661140|560927249|FG001|Open-Label Period|Lost to Follow-up|0|||
155407800|NCT01661140|560927250|FG002|Open-Label Period|Lost to Follow-up|0|||
155407801|NCT01661140|560927248|FG000|Double-Blind Period|Refused Treatment|0|||
155407802|NCT01661140|560927249|FG001|Double-Blind Period|Refused Treatment|0|||
155407803|NCT01661140|560927250|FG002|Double-Blind Period|Refused Treatment|1|||
155407804|NCT01661140|560927248|FG000|Double-Blind Period|Adverse Event|0|||
155407805|NCT01661140|560927249|FG001|Double-Blind Period|Adverse Event|16|||
155407806|NCT01661140|560927250|FG002|Double-Blind Period|Adverse Event|18|||
155407807|NCT01661140|560927248|FG000|Double-Blind Period|Protocol Violation|0|||
155407808|NCT01661140|560927249|FG001|Double-Blind Period|Protocol Violation|2|||
155407809|NCT01661140|560927250|FG002|Double-Blind Period|Protocol Violation|3|||
155407810|NCT01661140|560927248|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155407811|NCT01661140|560927249|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155407812|NCT01661140|560927250|FG002|Double-Blind Period|Withdrawal by Subject|3|||
155407813|NCT01661140|560927248|FG000|Double-Blind Period|Investigator's Decision|0|||
155407814|NCT01661140|560927249|FG001|Double-Blind Period|Investigator's Decision|1|||
155407815|NCT01661140|560927250|FG002|Double-Blind Period|Investigator's Decision|2|||
155407816|NCT01661140|560927248|FG000|Double-Blind Period|Sponsor Termination|0|||
155407817|NCT01661140|560927249|FG001|Double-Blind Period|Sponsor Termination|14|||
155407818|NCT01661140|560927250|FG002|Double-Blind Period|Sponsor Termination|17|||
155407819|NCT01661140|560927248|FG000|Double-Blind Period|Administrative/Other|0|||
155407820|NCT01661140|560927249|FG001|Double-Blind Period|Administrative/Other|7|||
155743217|NCT00913458|562159837|FG000|Phase 1|Lost to Follow-up|2|||
155407821|NCT01661140|560927250|FG002|Double-Blind Period|Administrative/Other|6|||
155407822|NCT00781456|560927251|FG000|Overall Study|Adverse Event|3|||
155407823|NCT00781456|560927252|FG001|Overall Study|Adverse Event|3|||
155407824|NCT00781456|560927251|FG000|Overall Study|Withdrawal by Subject|3|||
155407825|NCT00781456|560927252|FG001|Overall Study|Withdrawal by Subject|5|||
155407826|NCT00781456|560927251|FG000|Overall Study|Protocol Violation|4|||
155407827|NCT00781456|560927252|FG001|Overall Study|Protocol Violation|1|||
155407828|NCT00781456|560927251|FG000|Overall Study|Noncompliance With Protocol|1|||
155407829|NCT00781456|560927252|FG001|Overall Study|Noncompliance With Protocol|1|||
155407830|NCT00781456|560927251|FG000|Overall Study|Lost to Follow-up|10|||
155407831|NCT00781456|560927252|FG001|Overall Study|Lost to Follow-up|5|||
155407832|NCT00781456|560927251|FG000|Overall Study|Other Reason, Unknown|0|||
155638048|NCT01582451|561766361|FG001|Overall Study|Lost to Follow-up|2|||
155638049|NCT01582451|561766360|FG000|Overall Study|Protocol Violation|11|||
155638050|NCT01582451|561766361|FG001|Overall Study|Protocol Violation|3|||
155288149|NCT01196988|560488458|FG000|Overall Study|Lost to Follow-up|16|||
155288150|NCT01196988|560488459|FG001|Overall Study|Lost to Follow-up|29|||
155288151|NCT01196988|560488460|FG002|Overall Study|Lost to Follow-up|21|||
155288152|NCT01196988|560488461|FG003|Overall Study|Lost to Follow-up|1|||
155288153|NCT01196988|560488458|FG000|Overall Study|Other|2|||
155288154|NCT01196988|560488459|FG001|Overall Study|Other|0|||
155288155|NCT01196988|560488460|FG002|Overall Study|Other|0|||
155288156|NCT01196988|560488461|FG003|Overall Study|Other|0|||
155288157|NCT01233050|560488462|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
155407833|NCT00781456|560927252|FG001|Overall Study|Other Reason, Unknown|1|||
155407834|NCT01877187|560927254|FG000|Overall Study|Death|2|||
155407835|NCT01877187|560927254|FG000|Overall Study|Withdrawal by Subject|4|||
155407836|NCT01877187|560927254|FG000|Overall Study|Lost to Follow-up|3|||
155407837|NCT01877187|560927254|FG000|Overall Study|Declining clinical status|11|||
155407838|NCT01877187|560927254|FG000|Overall Study|Liver transplant|2|||
155407839|NCT05098041|560927258|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
155407840|NCT00618410|560927259|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
155407841|NCT00618410|560927260|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
155407842|NCT01297270|560927266|FG000|Overall Study|Adverse Event|19|||
155407843|NCT01297270|560927267|FG001|Overall Study|Adverse Event|32|||
155407844|NCT01297270|560927268|FG002|Overall Study|Adverse Event|5|||
155407845|NCT01297270|560927266|FG000|Overall Study|Lack of Efficacy|15|||
155407846|NCT01297270|560927267|FG001|Overall Study|Lack of Efficacy|17|||
155407847|NCT01297270|560927268|FG002|Overall Study|Lack of Efficacy|15|||
155407848|NCT01297270|560927266|FG000|Overall Study|Lost to Follow-up|1|||
155407849|NCT01297270|560927267|FG001|Overall Study|Lost to Follow-up|2|||
155407850|NCT01297270|560927268|FG002|Overall Study|Lost to Follow-up|1|||
155407851|NCT01297270|560927266|FG000|Overall Study|Protocol Violation|0|||
155407852|NCT01297270|560927267|FG001|Overall Study|Protocol Violation|2|||
155407853|NCT01297270|560927268|FG002|Overall Study|Protocol Violation|0|||
155407854|NCT01297270|560927266|FG000|Overall Study|Withdrawal by Subject|7|||
155407855|NCT01297270|560927267|FG001|Overall Study|Withdrawal by Subject|15|||
155407856|NCT01297270|560927268|FG002|Overall Study|Withdrawal by Subject|7|||
155407857|NCT01297270|560927266|FG000|Overall Study|Other reason not defined above|3|||
155407858|NCT01297270|560927267|FG001|Overall Study|Other reason not defined above|3|||
155407859|NCT01297270|560927268|FG002|Overall Study|Other reason not defined above|1|||
155407860|NCT01297270|560927266|FG000|Overall Study|Not treated|0|||
155407861|NCT01297270|560927267|FG001|Overall Study|Not treated|1|||
155407862|NCT01297270|560927268|FG002|Overall Study|Not treated|0|||
155407863|NCT00382993|560927271|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
155407864|NCT00382993|560927272|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
155407865|NCT00382993|560927271|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
155407866|NCT00382993|560927272|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
155407867|NCT00382993|560927271|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
155407868|NCT00382993|560927272|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
155407869|NCT00382993|560927271|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
155407870|NCT00382993|560927272|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
155407871|NCT00382993|560927271|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
155407872|NCT00382993|560927272|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
155407873|NCT00382993|560927271|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
155407874|NCT00382993|560927272|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
155407875|NCT00382993|560927271|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
155407876|NCT00382993|560927272|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
155407877|NCT00382993|560927271|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
155407878|NCT00382993|560927272|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
155407879|NCT00382993|560927271|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
155407880|NCT00382993|560927272|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
155407881|NCT00382993|560927271|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
155407882|NCT00382993|560927272|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
155407883|NCT00906087|560927282|FG000|Initial Washout|Withdrawal by Subject|1|||
155407884|NCT00906087|560927282|FG000|Initial Washout|Physician Decision|1|||
155288158|NCT01233050|560488463|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
155407885|NCT02898259|560927283|FG000|Overall Study|Adverse Event|0|||
155407886|NCT02898259|560927284|FG001|Overall Study|Adverse Event|0|||
155407887|NCT02898259|560927285|FG002|Overall Study|Adverse Event|1|||
155407888|NCT02898259|560927286|FG003|Overall Study|Adverse Event|0|||
155407889|NCT02898259|560927287|FG004|Overall Study|Adverse Event|0|||
155407890|NCT02898259|560927283|FG000|Overall Study|Lack of Efficacy|1|||
155407891|NCT02898259|560927284|FG001|Overall Study|Lack of Efficacy|1|||
155288159|NCT01466881|560488466|FG000|Overall Study|Ineligible|5|||
155288160|NCT01466881|560488466|FG000|Overall Study|Adverse Event|6|||
155407892|NCT02898259|560927285|FG002|Overall Study|Lack of Efficacy|3|||
155407893|NCT02898259|560927286|FG003|Overall Study|Lack of Efficacy|0|||
155407894|NCT02898259|560927287|FG004|Overall Study|Lack of Efficacy|0|||
155288161|NCT01466881|560488466|FG000|Overall Study|Progression/relapse|20|||
155288162|NCT01466881|560488466|FG000|Overall Study|Death|4|||
155288163|NCT01466881|560488466|FG000|Overall Study|Other reason not protocol specified|5|||
155288164|NCT00957229|560488467|FG000|Study Start|Adverse Event|0|||
155288165|NCT00957229|560488468|FG001|Study Start|Adverse Event|3|||
155288166|NCT00957229|560488467|FG000|Study Start|Disease Progression|1|||
155288167|NCT00957229|560488468|FG001|Study Start|Disease Progression|0|||
155288168|NCT00957229|560488467|FG000|Reallocated to or Continued Vismodegib|Death|1|||
155288169|NCT00957229|560488468|FG001|Reallocated to or Continued Vismodegib|Death|1|||
155288170|NCT00957229|560488467|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
155288171|NCT00957229|560488468|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
155288172|NCT00606580|560488469|FG000|Overall Study|Lost to Follow-up|1|||
155288173|NCT00606580|560488470|FG001|Overall Study|Lost to Follow-up|1|||
155288174|NCT00606580|560488471|FG002|Overall Study|Lost to Follow-up|4|||
155288175|NCT00606580|560488469|FG000|Overall Study|Clinical failures|1|||
155288176|NCT00606580|560488470|FG001|Overall Study|Clinical failures|0|||
155288177|NCT00606580|560488471|FG002|Overall Study|Clinical failures|12|||
155288178|NCT00606580|560488469|FG000|Overall Study|Withdrawal by investigator|0|||
155288179|NCT00606580|560488470|FG001|Overall Study|Withdrawal by investigator|1|||
155288180|NCT00606580|560488471|FG002|Overall Study|Withdrawal by investigator|6|||
155288181|NCT00606580|560488469|FG000|Overall Study|Withdrawal by Subject|0|||
155288182|NCT00606580|560488470|FG001|Overall Study|Withdrawal by Subject|1|||
155288183|NCT00606580|560488471|FG002|Overall Study|Withdrawal by Subject|0|||
155288184|NCT04580303|560488472|FG000|Overall Study|Adverse Event|0|||
155288185|NCT04580303|560488473|FG001|Overall Study|Adverse Event|1|||
155288186|NCT04580303|560488474|FG002|Overall Study|Adverse Event|0|||
155288187|NCT04580303|560488475|FG003|Overall Study|Adverse Event|0|||
155288188|NCT04580303|560488472|FG000|Overall Study|Withdrawal by Subject|0|||
155288189|NCT04580303|560488473|FG001|Overall Study|Withdrawal by Subject|0|||
155288190|NCT04580303|560488474|FG002|Overall Study|Withdrawal by Subject|1|||
155288191|NCT04580303|560488475|FG003|Overall Study|Withdrawal by Subject|0|||
155288192|NCT01833065|560488477|FG000|Overall Study|Adverse Event|6|||
155288193|NCT01833065|560488478|FG001|Overall Study|Adverse Event|1|||
155288194|NCT01833065|560488479|FG002|Overall Study|Adverse Event|0|||
155288195|NCT01833065|560488480|FG003|Overall Study|Adverse Event|2|||
155288196|NCT01833065|560488481|FG004|Overall Study|Adverse Event|3|||
155288197|NCT01833065|560488477|FG000|Overall Study|Protocol Violation|1|||
155288198|NCT01833065|560488478|FG001|Overall Study|Protocol Violation|0|||
155288199|NCT01833065|560488479|FG002|Overall Study|Protocol Violation|0|||
155288200|NCT01833065|560488480|FG003|Overall Study|Protocol Violation|0|||
155288201|NCT01833065|560488481|FG004|Overall Study|Protocol Violation|2|||
155288202|NCT01833065|560488477|FG000|Overall Study|Lost to Follow-up|1|||
155288203|NCT01833065|560488478|FG001|Overall Study|Lost to Follow-up|0|||
155288204|NCT01833065|560488479|FG002|Overall Study|Lost to Follow-up|0|||
155288205|NCT01833065|560488480|FG003|Overall Study|Lost to Follow-up|0|||
155288206|NCT01833065|560488481|FG004|Overall Study|Lost to Follow-up|3|||
155288207|NCT01833065|560488477|FG000|Overall Study|Withdrawal by Subject|6|||
155288208|NCT01833065|560488478|FG001|Overall Study|Withdrawal by Subject|2|||
155288209|NCT01833065|560488479|FG002|Overall Study|Withdrawal by Subject|4|||
155288210|NCT01833065|560488480|FG003|Overall Study|Withdrawal by Subject|3|||
155288211|NCT01833065|560488481|FG004|Overall Study|Withdrawal by Subject|11|||
155288212|NCT01833065|560488477|FG000|Overall Study|Subject's substantial non-compliance|0|||
155288213|NCT01833065|560488478|FG001|Overall Study|Subject's substantial non-compliance|1|||
155288214|NCT01833065|560488479|FG002|Overall Study|Subject's substantial non-compliance|0|||
155288215|NCT01833065|560488480|FG003|Overall Study|Subject's substantial non-compliance|0|||
155288216|NCT01833065|560488481|FG004|Overall Study|Subject's substantial non-compliance|0|||
155288217|NCT01833065|560488477|FG000|Overall Study|Trial terminated by sponsor|8|||
155288218|NCT01833065|560488478|FG001|Overall Study|Trial terminated by sponsor|8|||
155288219|NCT01833065|560488479|FG002|Overall Study|Trial terminated by sponsor|7|||
155288220|NCT01833065|560488480|FG003|Overall Study|Trial terminated by sponsor|3|||
155288221|NCT01833065|560488481|FG004|Overall Study|Trial terminated by sponsor|13|||
155288222|NCT01833065|560488477|FG000|Overall Study|Others|2|||
155288223|NCT01833065|560488478|FG001|Overall Study|Others|1|||
155288224|NCT01833065|560488479|FG002|Overall Study|Others|1|||
155288225|NCT01833065|560488480|FG003|Overall Study|Others|1|||
155288226|NCT01833065|560488481|FG004|Overall Study|Others|4|||
155288227|NCT00927823|560488484|FG000|Continuous Dosing Period|Death|0|||
155288228|NCT00927823|560488485|FG001|Continuous Dosing Period|Death|0|||
155288229|NCT00927823|560488486|FG002|Continuous Dosing Period|Death|6|||
155288230|NCT00927823|560488487|FG003|Continuous Dosing Period|Death|0|||
155288231|NCT00927823|560488484|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
155288232|NCT00927823|560488485|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
155288233|NCT00927823|560488486|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
155288234|NCT00927823|560488487|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
155288235|NCT00927823|560488484|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
155288236|NCT00927823|560488485|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
155288237|NCT00927823|560488486|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
155407895|NCT02898259|560927283|FG000|Overall Study|Lost to Follow-up|0|||
155407896|NCT02898259|560927284|FG001|Overall Study|Lost to Follow-up|0|||
155407897|NCT02898259|560927285|FG002|Overall Study|Lost to Follow-up|1|||
155407898|NCT02898259|560927286|FG003|Overall Study|Lost to Follow-up|0|||
155407899|NCT02898259|560927287|FG004|Overall Study|Lost to Follow-up|0|||
155407900|NCT02898259|560927283|FG000|Overall Study|Transformation before study began|0|||
155407901|NCT02898259|560927284|FG001|Overall Study|Transformation before study began|0|||
155407902|NCT02898259|560927285|FG002|Overall Study|Transformation before study began|0|||
155638051|NCT01582451|561766360|FG000|Overall Study|Withdrawal by Subject|13|||
155638052|NCT01582451|561766361|FG001|Overall Study|Withdrawal by Subject|9|||
155288238|NCT00927823|560488487|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
155288239|NCT00927823|560488484|FG000|Continuous Dosing Period|Other|1|||
155288240|NCT00927823|560488485|FG001|Continuous Dosing Period|Other|2|||
155288241|NCT00927823|560488486|FG002|Continuous Dosing Period|Other|9|||
155288242|NCT00927823|560488487|FG003|Continuous Dosing Period|Other|3|||
155288243|NCT00828672|560488488|FG000|Study Treatment|Lost to Follow-up|1|||
155288244|NCT00828672|560488489|FG001|Study Treatment|Lost to Follow-up|0|||
155288245|NCT00828672|560488488|FG000|Study Treatment|Adverse Event|0|||
155288246|NCT00828672|560488489|FG001|Study Treatment|Adverse Event|1|||
155288247|NCT00828672|560488488|FG000|Study Treatment|Complete response, no surgery|1|||
155288248|NCT00828672|560488489|FG001|Study Treatment|Complete response, no surgery|1|||
155288249|NCT00828672|560488488|FG000|Post-surgery (<30 Days)|No central review materials|0|||
155288250|NCT00828672|560488489|FG001|Post-surgery (<30 Days)|No central review materials|1|||
155288251|NCT00601640|560488490|FG000|Overall Study|Withdrawal by Subject|3|||
155288252|NCT00601640|560488491|FG001|Overall Study|Withdrawal by Subject|0|||
155288253|NCT00601640|560488492|FG002|Overall Study|Withdrawal by Subject|7|||
155288254|NCT00601640|560488490|FG000|Overall Study|Death|1|||
155288255|NCT00601640|560488491|FG001|Overall Study|Death|0|||
155288256|NCT00601640|560488492|FG002|Overall Study|Death|0|||
155288257|NCT00601640|560488490|FG000|Overall Study|Adverse Event|0|||
155288258|NCT00601640|560488491|FG001|Overall Study|Adverse Event|4|||
155288259|NCT00601640|560488492|FG002|Overall Study|Adverse Event|2|||
155288260|NCT00601640|560488490|FG000|Overall Study|intercurrent illness|1|||
155288261|NCT00601640|560488491|FG001|Overall Study|intercurrent illness|0|||
155288262|NCT00601640|560488492|FG002|Overall Study|intercurrent illness|0|||
155288263|NCT00601640|560488490|FG000|Overall Study|change in eligibility status|0|||
155288264|NCT00601640|560488491|FG001|Overall Study|change in eligibility status|1|||
155288265|NCT00601640|560488492|FG002|Overall Study|change in eligibility status|1|||
155288266|NCT01878890|560488498|FG000|Overall Study|Protocol Violation|0|||
155288267|NCT01878890|560488499|FG001|Overall Study|Protocol Violation|1|||
155288268|NCT01878890|560488500|FG002|Overall Study|Protocol Violation|0|||
155288269|NCT01878890|560488501|FG003|Overall Study|Protocol Violation|0|||
155288270|NCT00831792|560488507|FG000|Overall Study|Not Eligible|3|||
155288271|NCT00831792|560488507|FG000|Overall Study|Adverse Event|1|||
155288272|NCT00831792|560488507|FG000|Overall Study|Death|1|||
155288273|NCT00831792|560488507|FG000|Overall Study|Lack of Efficacy|1|||
155288274|NCT03736785|560488508|FG000|Overall Study|Adverse Event|1|||
155638053|NCT01582451|561766360|FG000|Overall Study|Physician Decision|3|||
155638054|NCT01582451|561766361|FG001|Overall Study|Physician Decision|0|||
155638055|NCT01582451|561766360|FG000|Overall Study|Sponsor Decision|1|||
155638056|NCT01582451|561766361|FG001|Overall Study|Sponsor Decision|0|||
155288275|NCT03736785|560488509|FG001|Overall Study|Adverse Event|1|||
155288276|NCT03736785|560488510|FG002|Overall Study|Adverse Event|1|||
155288277|NCT03736785|560488508|FG000|Overall Study|Death|1|||
155288278|NCT03736785|560488509|FG001|Overall Study|Death|0|||
155288279|NCT03736785|560488510|FG002|Overall Study|Death|1|||
155288280|NCT03736785|560488508|FG000|Overall Study|Lost to Follow-up|0|||
155288281|NCT03736785|560488509|FG001|Overall Study|Lost to Follow-up|2|||
155288282|NCT03736785|560488510|FG002|Overall Study|Lost to Follow-up|3|||
155288283|NCT03736785|560488508|FG000|Overall Study|Non compliance with study drug|1|||
155288284|NCT03736785|560488509|FG001|Overall Study|Non compliance with study drug|1|||
155288285|NCT03736785|560488510|FG002|Overall Study|Non compliance with study drug|0|||
155288286|NCT03736785|560488508|FG000|Overall Study|Physician Decision|0|||
155288287|NCT03736785|560488509|FG001|Overall Study|Physician Decision|1|||
155288288|NCT03736785|560488510|FG002|Overall Study|Physician Decision|1|||
155288289|NCT03736785|560488508|FG000|Overall Study|Protocol Violation|1|||
155288290|NCT03736785|560488509|FG001|Overall Study|Protocol Violation|4|||
155288291|NCT03736785|560488510|FG002|Overall Study|Protocol Violation|3|||
155288292|NCT03736785|560488508|FG000|Overall Study|Sponsor Decision|1|||
155288293|NCT03736785|560488509|FG001|Overall Study|Sponsor Decision|0|||
155288294|NCT03736785|560488510|FG002|Overall Study|Sponsor Decision|0|||
155288295|NCT03736785|560488508|FG000|Overall Study|Unknown/Missing data|3|||
155288296|NCT03736785|560488509|FG001|Overall Study|Unknown/Missing data|2|||
155288297|NCT03736785|560488510|FG002|Overall Study|Unknown/Missing data|1|||
155288298|NCT03736785|560488508|FG000|Overall Study|Withdrawal by Subject|9|||
155288299|NCT03736785|560488509|FG001|Overall Study|Withdrawal by Subject|6|||
155407903|NCT02898259|560927286|FG003|Overall Study|Transformation before study began|1|||
155638057|NCT05472142|561766364|FG000|Total Participants|Lost to Follow-up|312|||
155407904|NCT02898259|560927287|FG004|Overall Study|Transformation before study began|0|||
155407905|NCT03016325|560927290|FG000|Treatment Period|Participant withdrew consent|0|||
155407906|NCT03016325|560927291|FG001|Treatment Period|Participant withdrew consent|1|||
155407907|NCT03016325|560927292|FG002|Treatment Period|Participant withdrew consent|0|||
155407908|NCT03016325|560927293|FG003|Treatment Period|Participant withdrew consent|0|||
155407909|NCT03016325|560927294|FG004|Treatment Period|Participant withdrew consent|0|||
155407910|NCT03016325|560927295|FG005|Treatment Period|Participant withdrew consent|0|||
155407911|NCT03016325|560927296|FG006|Treatment Period|Participant withdrew consent|0|||
155407912|NCT03016325|560927297|FG007|Treatment Period|Participant withdrew consent|0|||
155407913|NCT03016325|560927290|FG000|Treatment Period|Death|0|||
155407914|NCT03016325|560927291|FG001|Treatment Period|Death|0|||
155407915|NCT03016325|560927292|FG002|Treatment Period|Death|0|||
155407916|NCT03016325|560927293|FG003|Treatment Period|Death|0|||
155407917|NCT03016325|560927294|FG004|Treatment Period|Death|2|||
155407918|NCT03016325|560927295|FG005|Treatment Period|Death|0|||
155407919|NCT03016325|560927296|FG006|Treatment Period|Death|0|||
155407920|NCT03016325|560927297|FG007|Treatment Period|Death|0|||
155407921|NCT03016325|560927290|FG000|Treatment Period|Participant refuses assessments|0|||
155407922|NCT03016325|560927291|FG001|Treatment Period|Participant refuses assessments|0|||
155407923|NCT03016325|560927292|FG002|Treatment Period|Participant refuses assessments|1|||
155407924|NCT03016325|560927293|FG003|Treatment Period|Participant refuses assessments|0|||
155407925|NCT03016325|560927294|FG004|Treatment Period|Participant refuses assessments|0|||
155407926|NCT03016325|560927295|FG005|Treatment Period|Participant refuses assessments|0|||
155407927|NCT03016325|560927296|FG006|Treatment Period|Participant refuses assessments|0|||
155407928|NCT03016325|560927297|FG007|Treatment Period|Participant refuses assessments|0|||
155407929|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Death|2|||
155407930|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Death|0|||
155407931|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Death|5|||
155407932|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Death|6|||
155407933|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Death|3|||
155407934|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Death|0|||
155407935|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Death|0|||
155407936|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Death|0|||
155407937|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
155407938|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
155407939|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
155407940|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
155407941|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
155407942|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
155407943|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
155407944|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
155407945|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
155407946|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
155407947|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
155407948|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
155407949|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
155407950|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
155407951|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
155407952|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
155407953|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
155407954|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
155407955|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
155407956|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
155407957|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
155407958|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
155407959|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
155638058|NCT05472142|561766365|FG001|Total Participants|Lost to Follow-up|0|||
155638059|NCT05472142|561766364|FG000|Clinic Patients|Lost to Follow-up|312|||
155638060|NCT05472142|561766365|FG001|Clinic Patients|Lost to Follow-up|0|||
155638061|NCT04092777|561766366|FG000|Overall Study|Lost to Follow-up|28|||
155638062|NCT04092777|561766367|FG001|Overall Study|Lost to Follow-up|46|||
155638063|NCT04092777|561766366|FG000|Overall Study|Withdrawal by Subject|8|||
155638064|NCT04092777|561766367|FG001|Overall Study|Withdrawal by Subject|5|||
155638065|NCT02550795|561766368|FG000|Overall Study|Physician Decision|0|||
155638066|NCT02550795|561766369|FG001|Overall Study|Physician Decision|1|||
155638067|NCT02550795|561766370|FG002|Overall Study|Physician Decision|0|||
155288300|NCT03736785|560488510|FG002|Overall Study|Withdrawal by Subject|4|||
155288301|NCT02974010|560488512|FG000|Overall Study|Lost to Follow-up|3|||
155288302|NCT02974010|560488513|FG001|Overall Study|Lost to Follow-up|1|||
155288303|NCT02974010|560488514|FG002|Overall Study|Lost to Follow-up|0|||
155288304|NCT02974010|560488515|FG003|Overall Study|Lost to Follow-up|0|||
155288305|NCT02974010|560488512|FG000|Overall Study|Withdrawal by Subject|2|||
155288306|NCT02974010|560488513|FG001|Overall Study|Withdrawal by Subject|1|||
155288307|NCT02974010|560488514|FG002|Overall Study|Withdrawal by Subject|0|||
155288308|NCT02974010|560488515|FG003|Overall Study|Withdrawal by Subject|0|||
155288309|NCT02974010|560488512|FG000|Overall Study|Adverse Event|0|||
155288310|NCT02974010|560488513|FG001|Overall Study|Adverse Event|1|||
155288311|NCT02974010|560488514|FG002|Overall Study|Adverse Event|0|||
155288312|NCT02974010|560488515|FG003|Overall Study|Adverse Event|0|||
155288313|NCT02974010|560488512|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
155288314|NCT02974010|560488513|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
155288315|NCT02974010|560488514|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
155288316|NCT02974010|560488515|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
155288317|NCT02974010|560488512|FG000|Overall Study|Lack of Efficacy|0|||
155288318|NCT02974010|560488513|FG001|Overall Study|Lack of Efficacy|0|||
155288319|NCT02974010|560488514|FG002|Overall Study|Lack of Efficacy|1|||
155288320|NCT02974010|560488515|FG003|Overall Study|Lack of Efficacy|0|||
155288321|NCT02595398|560488526|FG000|Overall Study|Non-compliance|1|||
155288322|NCT02595398|560488527|FG001|Overall Study|Non-compliance|0|||
155288323|NCT02595398|560488526|FG000|Overall Study|Withdrawal by Subject|2|||
155288324|NCT02595398|560488527|FG001|Overall Study|Withdrawal by Subject|1|||
155288325|NCT02595398|560488526|FG000|Overall Study|Lost to Follow-up|1|||
155288326|NCT02595398|560488527|FG001|Overall Study|Lost to Follow-up|0|||
155288327|NCT00502593|560488528|FG000|Overall Study|Withdrawn unspecified reason|1|||
155288328|NCT00502593|560488529|FG001|Overall Study|Withdrawn unspecified reason|1|||
155288329|NCT00502593|560488530|FG002|Overall Study|Withdrawn unspecified reason|3|||
155288330|NCT00502593|560488531|FG003|Overall Study|Withdrawn unspecified reason|1|||
155288331|NCT00502593|560488532|FG004|Overall Study|Withdrawn unspecified reason|2|||
155288332|NCT00502593|560488533|FG005|Overall Study|Withdrawn unspecified reason|0|||
155288333|NCT00502593|560488534|FG006|Overall Study|Withdrawn unspecified reason|2|||
155288334|NCT00502593|560488535|FG007|Overall Study|Withdrawn unspecified reason|0|||
155288335|NCT00502593|560488536|FG008|Overall Study|Withdrawn unspecified reason|0|||
155288336|NCT00502593|560488537|FG009|Overall Study|Withdrawn unspecified reason|0|||
155288337|NCT00502593|560488538|FG010|Overall Study|Withdrawn unspecified reason|0|||
155288338|NCT00502593|560488539|FG011|Overall Study|Withdrawn unspecified reason|0|||
155288339|NCT00502593|560488528|FG000|Overall Study|Withdrawal by Subject|0|||
155288340|NCT00502593|560488529|FG001|Overall Study|Withdrawal by Subject|0|||
155288341|NCT00502593|560488530|FG002|Overall Study|Withdrawal by Subject|6|||
155288342|NCT00502593|560488531|FG003|Overall Study|Withdrawal by Subject|2|||
155288343|NCT00502593|560488532|FG004|Overall Study|Withdrawal by Subject|2|||
155288344|NCT00502593|560488533|FG005|Overall Study|Withdrawal by Subject|0|||
155288345|NCT00502593|560488534|FG006|Overall Study|Withdrawal by Subject|3|||
155288346|NCT00502593|560488535|FG007|Overall Study|Withdrawal by Subject|0|||
155288347|NCT00502593|560488536|FG008|Overall Study|Withdrawal by Subject|3|||
155288348|NCT00502593|560488537|FG009|Overall Study|Withdrawal by Subject|0|||
155288349|NCT00502593|560488538|FG010|Overall Study|Withdrawal by Subject|1|||
155288350|NCT00502593|560488539|FG011|Overall Study|Withdrawal by Subject|0|||
155288351|NCT00502593|560488528|FG000|Overall Study|Lost to Follow-up|2|||
155288352|NCT00502593|560488529|FG001|Overall Study|Lost to Follow-up|1|||
155288353|NCT00502593|560488530|FG002|Overall Study|Lost to Follow-up|1|||
155288354|NCT00502593|560488531|FG003|Overall Study|Lost to Follow-up|1|||
155288355|NCT00502593|560488532|FG004|Overall Study|Lost to Follow-up|0|||
155288356|NCT00502593|560488533|FG005|Overall Study|Lost to Follow-up|0|||
155288357|NCT00502593|560488534|FG006|Overall Study|Lost to Follow-up|0|||
155288358|NCT00502593|560488535|FG007|Overall Study|Lost to Follow-up|0|||
155638068|NCT02225587|561766371|FG000|Overall Study|Adverse Event|5|||
155288359|NCT00502593|560488536|FG008|Overall Study|Lost to Follow-up|3|||
155288360|NCT00502593|560488537|FG009|Overall Study|Lost to Follow-up|0|||
155288361|NCT00502593|560488538|FG010|Overall Study|Lost to Follow-up|1|||
155288362|NCT00502593|560488539|FG011|Overall Study|Lost to Follow-up|0|||
155288363|NCT00880906|560488540|FG000|Overall Study|Lost to Follow-up|0|||
155288364|NCT00880906|560488541|FG001|Overall Study|Lost to Follow-up|1|||
155638069|NCT02225587|561766372|FG001|Overall Study|Adverse Event|5|||
155288365|NCT00880906|560488540|FG000|Overall Study|Did not meet criteria following patholog|12|||
155288366|NCT00880906|560488541|FG001|Overall Study|Did not meet criteria following patholog|6|||
155288367|NCT00544440|560488542|FG000|Overall Study|Other|1|||
155288368|NCT00544440|560488542|FG000|Overall Study|Adverse Event|1|||
155288369|NCT00544440|560488542|FG000|Overall Study|Withdrawal by Subject|2|||
155288370|NCT00544440|560488542|FG000|Overall Study|Subject Non-compliance|1|||
155288371|NCT00544440|560488542|FG000|Overall Study|Progressive Disease|47|||
155288372|NCT00544440|560488542|FG000|Overall Study|Other|5|||
155288373|NCT03601507|560488543|FG000|Overall Study|Adverse Event|1|||
155288374|NCT05650333|560488544|FG000|Treatment Period (7 Days)|Adverse Event|1|||
155288375|NCT01460342|560488547|FG000|Overall Study|Adverse Event|5|||
155288376|NCT01460342|560488548|FG001|Overall Study|Adverse Event|4|||
155288377|NCT01460342|560488547|FG000|Overall Study|Lost to Follow-up|1|||
155288378|NCT01460342|560488548|FG001|Overall Study|Lost to Follow-up|2|||
155288379|NCT01460342|560488547|FG000|Overall Study|Protocol Violation|0|||
155288380|NCT01460342|560488548|FG001|Overall Study|Protocol Violation|1|||
155288381|NCT01460342|560488547|FG000|Overall Study|Withdrawal by Subject|3|||
155288382|NCT01460342|560488548|FG001|Overall Study|Withdrawal by Subject|4|||
155288383|NCT01460342|560488547|FG000|Overall Study|Physician Decision|1|||
155288384|NCT01460342|560488548|FG001|Overall Study|Physician Decision|3|||
155288385|NCT01460342|560488547|FG000|Overall Study|Lack of Efficacy|1|||
155288386|NCT01460342|560488548|FG001|Overall Study|Lack of Efficacy|0|||
155288387|NCT02107014|560488550|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
155288388|NCT00591838|560488551|FG000|Overall Study|Withdrawal by Subject|0|||
155288389|NCT00591838|560488552|FG001|Overall Study|Withdrawal by Subject|0|||
155288390|NCT00591838|560488553|FG002|Overall Study|Withdrawal by Subject|0|||
155288391|NCT00591838|560488554|FG003|Overall Study|Withdrawal by Subject|1|||
155288392|NCT00591838|560488555|FG004|Overall Study|Withdrawal by Subject|0|||
155288393|NCT03586167|560488556|FG000|Overall Study|Other|1|||
155288394|NCT03586167|560488557|FG001|Overall Study|Other|0|||
155288395|NCT03761784|560488558|FG000|Overall Study|Adverse Event|4|||
155407960|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
155407961|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407962|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407963|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407964|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407965|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
155407966|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407967|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
155407968|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
155407969|NCT03016325|560927290|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407970|NCT03016325|560927291|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407971|NCT03016325|560927292|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
155407972|NCT03016325|560927293|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407973|NCT03016325|560927294|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407974|NCT03016325|560927295|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407975|NCT03016325|560927296|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407976|NCT03016325|560927297|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
155407977|NCT03016325|560927290|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407978|NCT03016325|560927291|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
155407979|NCT03016325|560927292|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407980|NCT03016325|560927293|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407981|NCT03016325|560927294|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407982|NCT03016325|560927295|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407983|NCT03016325|560927296|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407984|NCT03016325|560927297|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
155407985|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Death|3|||
155407986|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Death|3|||
155407987|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Death|11|||
155638070|NCT02225587|561766371|FG000|Overall Study|Lost to Follow-up|5|||
155638071|NCT02225587|561766372|FG001|Overall Study|Lost to Follow-up|5|||
155288396|NCT03761784|560488559|FG001|Overall Study|Adverse Event|0|||
155288397|NCT03761784|560488558|FG000|Overall Study|Lost to Follow-up|10|||
155288398|NCT03761784|560488559|FG001|Overall Study|Lost to Follow-up|7|||
155288399|NCT03761784|560488558|FG000|Overall Study|Pregnancy|1|||
155288400|NCT03761784|560488559|FG001|Overall Study|Pregnancy|0|||
155288401|NCT03761784|560488558|FG000|Overall Study|Protocol Violation|2|||
155288402|NCT03761784|560488559|FG001|Overall Study|Protocol Violation|0|||
155288403|NCT03761784|560488558|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
155288404|NCT03761784|560488559|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
155288405|NCT03761784|560488558|FG000|Overall Study|Withdrawal by Subject|9|||
155288406|NCT03761784|560488559|FG001|Overall Study|Withdrawal by Subject|4|||
155288407|NCT03761784|560488558|FG000|Overall Study|Physician Decision|1|||
155288408|NCT03761784|560488559|FG001|Overall Study|Physician Decision|0|||
155288409|NCT03761784|560488558|FG000|Overall Study|Other Than Specified|1|||
155288410|NCT03761784|560488559|FG001|Overall Study|Other Than Specified|0|||
155288411|NCT00586339|560488562|FG000|Overall Study|Withdrawal by Subject|1|||
155288412|NCT00586339|560488563|FG001|Overall Study|Withdrawal by Subject|3|||
155288413|NCT00586339|560488564|FG002|Overall Study|Withdrawal by Subject|1|||
155288414|NCT00586339|560488562|FG000|Overall Study|Migrated/moved from study area|3|||
155288415|NCT00586339|560488563|FG001|Overall Study|Migrated/moved from study area|2|||
155288416|NCT00586339|560488564|FG002|Overall Study|Migrated/moved from study area|4|||
155288417|NCT00586339|560488562|FG000|Overall Study|Lost to Follow-up|3|||
155288418|NCT00586339|560488563|FG001|Overall Study|Lost to Follow-up|2|||
155288419|NCT00586339|560488564|FG002|Overall Study|Lost to Follow-up|1|||
155288420|NCT04163458|560488567|FG000|Overall Study|Protocol Deviation|7|||
155288421|NCT04163458|560488568|FG001|Overall Study|Protocol Deviation|13|||
155288422|NCT04163458|560488567|FG000|Overall Study|Adverse Event|5|||
155288423|NCT04163458|560488568|FG001|Overall Study|Adverse Event|8|||
155288424|NCT04163458|560488567|FG000|Overall Study|Due to COVID-19 pandemic|4|||
155288425|NCT04163458|560488568|FG001|Overall Study|Due to COVID-19 pandemic|2|||
155288426|NCT04163458|560488567|FG000|Overall Study|Participant withdrew consent|2|||
155288427|NCT04163458|560488568|FG001|Overall Study|Participant withdrew consent|3|||
155407988|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Death|12|||
155288428|NCT04163458|560488567|FG000|Overall Study|Randomization failure|2|||
155407989|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Death|9|||
155638072|NCT02225587|561766371|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155288429|NCT04163458|560488568|FG001|Overall Study|Randomization failure|2|||
155288430|NCT04163458|560488567|FG000|Overall Study|Other|4|||
155288431|NCT04163458|560488568|FG001|Overall Study|Other|2|||
155288432|NCT03852433|560488570|FG000|Overall Study|Withdrawal of consent|5|||
155288433|NCT03852433|560488571|FG001|Overall Study|Withdrawal of consent|8|||
155288434|NCT03852433|560488572|FG002|Overall Study|Withdrawal of consent|1|||
155288435|NCT03852433|560488573|FG003|Overall Study|Withdrawal of consent|1|||
155288436|NCT03852433|560488570|FG000|Overall Study|Adverse Event|1|||
155288437|NCT03852433|560488571|FG001|Overall Study|Adverse Event|1|||
155288438|NCT03852433|560488572|FG002|Overall Study|Adverse Event|1|||
155288439|NCT03852433|560488573|FG003|Overall Study|Adverse Event|1|||
155288440|NCT03852433|560488570|FG000|Overall Study|Lost to Follow-up|0|||
155288441|NCT03852433|560488571|FG001|Overall Study|Lost to Follow-up|1|||
155288442|NCT03852433|560488572|FG002|Overall Study|Lost to Follow-up|0|||
155288443|NCT03852433|560488573|FG003|Overall Study|Lost to Follow-up|1|||
155288444|NCT03852433|560488570|FG000|Overall Study|Pregnancy|0|||
155288445|NCT03852433|560488571|FG001|Overall Study|Pregnancy|1|||
155288446|NCT03852433|560488572|FG002|Overall Study|Pregnancy|1|||
155288447|NCT03852433|560488573|FG003|Overall Study|Pregnancy|0|||
155288448|NCT03852433|560488570|FG000|Overall Study|Protocol Violation|0|||
155288449|NCT03852433|560488571|FG001|Overall Study|Protocol Violation|0|||
155288450|NCT03852433|560488572|FG002|Overall Study|Protocol Violation|1|||
155288451|NCT03852433|560488573|FG003|Overall Study|Protocol Violation|1|||
155288452|NCT03852433|560488570|FG000|Overall Study|Death|0|||
155407990|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Death|0|||
155407991|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Death|0|||
155407992|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Death|1|||
155407993|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
155407994|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155407995|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155407996|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155407997|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155407998|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155407999|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155408000|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155408001|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
155408002|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
155408003|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
155408004|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
155408005|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
155408006|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
155743218|NCT00913458|562159838|FG001|Phase 1|Lost to Follow-up|0|||
155288453|NCT03852433|560488571|FG001|Overall Study|Death|0|||
155288454|NCT03852433|560488572|FG002|Overall Study|Death|1|||
155288455|NCT03852433|560488573|FG003|Overall Study|Death|0|||
155288456|NCT03852433|560488570|FG000|Overall Study|Lack of Efficacy|0|||
155288457|NCT03852433|560488571|FG001|Overall Study|Lack of Efficacy|1|||
155288458|NCT03852433|560488572|FG002|Overall Study|Lack of Efficacy|0|||
155288459|NCT03852433|560488573|FG003|Overall Study|Lack of Efficacy|0|||
155288460|NCT03852433|560488570|FG000|Overall Study|Non-compliance with study drug|0|||
155288461|NCT03852433|560488571|FG001|Overall Study|Non-compliance with study drug|0|||
155288462|NCT03852433|560488572|FG002|Overall Study|Non-compliance with study drug|0|||
155288463|NCT03852433|560488573|FG003|Overall Study|Non-compliance with study drug|1|||
155288464|NCT03852433|560488570|FG000|Overall Study|Physician Decision|1|||
155288465|NCT03852433|560488571|FG001|Overall Study|Physician Decision|0|||
155288466|NCT03852433|560488572|FG002|Overall Study|Physician Decision|0|||
155288467|NCT03852433|560488573|FG003|Overall Study|Physician Decision|0|||
155288468|NCT03852433|560488570|FG000|Overall Study|Randomized but never treated|1|||
155288469|NCT03852433|560488571|FG001|Overall Study|Randomized but never treated|0|||
155288470|NCT03852433|560488572|FG002|Overall Study|Randomized but never treated|0|||
155288471|NCT03852433|560488573|FG003|Overall Study|Randomized but never treated|0|||
155288472|NCT01981850|560488574|FG000|Main Phase Stage 1|Death|2|||
155288473|NCT01981850|560488575|FG001|Main Phase Stage 1|Death|0|||
155288474|NCT01981850|560488576|FG002|Main Phase Stage 1|Death|0|||
155288475|NCT01981850|560488577|FG003|Main Phase Stage 1|Death|0|||
155288476|NCT01981850|560488578|FG004|Main Phase Stage 1|Death|0|||
155288477|NCT01981850|560488579|FG005|Main Phase Stage 1|Death|0|||
155288478|NCT01981850|560488580|FG006|Main Phase Stage 1|Death|0|||
155288479|NCT01981850|560488581|FG007|Main Phase Stage 1|Death|0|||
155288480|NCT01981850|560488582|FG008|Main Phase Stage 1|Death|0|||
155288481|NCT01981850|560488583|FG009|Main Phase Stage 1|Death|0|||
155288482|NCT01981850|560488574|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
155288483|NCT01981850|560488575|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288484|NCT01981850|560488576|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288485|NCT01981850|560488577|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288486|NCT01981850|560488578|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288487|NCT01981850|560488579|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288488|NCT01981850|560488580|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288489|NCT01981850|560488581|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288490|NCT01981850|560488582|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288491|NCT01981850|560488583|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288492|NCT01981850|560488574|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
155288493|NCT01981850|560488575|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
155288494|NCT01981850|560488576|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
155288495|NCT01981850|560488577|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
155288496|NCT01981850|560488578|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
155288497|NCT01981850|560488579|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
155288498|NCT01981850|560488580|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
155288499|NCT01981850|560488581|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
155288500|NCT01981850|560488582|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
155288501|NCT01981850|560488583|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
155288502|NCT01981850|560488574|FG000|Main Phase Stage 1|Various reasons|0|||
155288503|NCT01981850|560488575|FG001|Main Phase Stage 1|Various reasons|0|||
155288504|NCT01981850|560488576|FG002|Main Phase Stage 1|Various reasons|2|||
155288505|NCT01981850|560488577|FG003|Main Phase Stage 1|Various reasons|0|||
155288506|NCT01981850|560488578|FG004|Main Phase Stage 1|Various reasons|0|||
155288507|NCT01981850|560488579|FG005|Main Phase Stage 1|Various reasons|0|||
155288508|NCT01981850|560488580|FG006|Main Phase Stage 1|Various reasons|0|||
155288509|NCT01981850|560488581|FG007|Main Phase Stage 1|Various reasons|0|||
155288510|NCT01981850|560488582|FG008|Main Phase Stage 1|Various reasons|0|||
155288511|NCT01981850|560488583|FG009|Main Phase Stage 1|Various reasons|0|||
155288512|NCT01981850|560488574|FG000|Main Phase Stage 2|Adverse Event|0|||
155288513|NCT01981850|560488575|FG001|Main Phase Stage 2|Adverse Event|0|||
155288514|NCT01981850|560488576|FG002|Main Phase Stage 2|Adverse Event|0|||
155288515|NCT01981850|560488577|FG003|Main Phase Stage 2|Adverse Event|0|||
155288516|NCT01981850|560488578|FG004|Main Phase Stage 2|Adverse Event|6|||
155288517|NCT01981850|560488579|FG005|Main Phase Stage 2|Adverse Event|5|||
155288518|NCT01981850|560488580|FG006|Main Phase Stage 2|Adverse Event|7|||
155288519|NCT01981850|560488581|FG007|Main Phase Stage 2|Adverse Event|0|||
155288520|NCT01981850|560488582|FG008|Main Phase Stage 2|Adverse Event|0|||
155288521|NCT01981850|560488583|FG009|Main Phase Stage 2|Adverse Event|0|||
155288522|NCT01981850|560488574|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288523|NCT01981850|560488575|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288524|NCT01981850|560488576|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288525|NCT01981850|560488577|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288526|NCT01981850|560488578|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
155288527|NCT01981850|560488579|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
155288528|NCT01981850|560488580|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
155288529|NCT01981850|560488581|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288530|NCT01981850|560488582|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288531|NCT01981850|560488583|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288532|NCT01981850|560488574|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
155288533|NCT01981850|560488575|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
155288534|NCT01981850|560488576|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
155288535|NCT01981850|560488577|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
155288536|NCT01981850|560488578|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
155288537|NCT01981850|560488579|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
155288538|NCT01981850|560488580|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
155288539|NCT01981850|560488581|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
155288540|NCT01981850|560488582|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
155288541|NCT01981850|560488583|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
155288542|NCT01981850|560488574|FG000|Main Phase Stage 2|Various reasons|0|||
155288543|NCT01981850|560488575|FG001|Main Phase Stage 2|Various reasons|0|||
155288544|NCT01981850|560488576|FG002|Main Phase Stage 2|Various reasons|0|||
155288545|NCT01981850|560488577|FG003|Main Phase Stage 2|Various reasons|0|||
155288546|NCT01981850|560488578|FG004|Main Phase Stage 2|Various reasons|2|||
155288547|NCT01981850|560488579|FG005|Main Phase Stage 2|Various reasons|0|||
155288548|NCT01981850|560488580|FG006|Main Phase Stage 2|Various reasons|1|||
155288549|NCT01981850|560488581|FG007|Main Phase Stage 2|Various reasons|0|||
155288550|NCT01981850|560488582|FG008|Main Phase Stage 2|Various reasons|0|||
155288551|NCT01981850|560488583|FG009|Main Phase Stage 2|Various reasons|0|||
155288552|NCT01981850|560488574|FG000|Main Phase Stage 2|Progressive Disease|0|||
155288553|NCT01981850|560488575|FG001|Main Phase Stage 2|Progressive Disease|0|||
155288554|NCT01981850|560488576|FG002|Main Phase Stage 2|Progressive Disease|0|||
155288555|NCT01981850|560488577|FG003|Main Phase Stage 2|Progressive Disease|0|||
155288556|NCT01981850|560488578|FG004|Main Phase Stage 2|Progressive Disease|0|||
155743219|NCT00913458|562159839|FG002|Phase 1|Lost to Follow-up|0|||
155288557|NCT01981850|560488579|FG005|Main Phase Stage 2|Progressive Disease|6|||
155288558|NCT01981850|560488580|FG006|Main Phase Stage 2|Progressive Disease|6|||
155288559|NCT01981850|560488581|FG007|Main Phase Stage 2|Progressive Disease|0|||
155288560|NCT01981850|560488582|FG008|Main Phase Stage 2|Progressive Disease|0|||
155288561|NCT01981850|560488583|FG009|Main Phase Stage 2|Progressive Disease|0|||
155288562|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Adverse Event|0|||
155288563|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Adverse Event|0|||
155288564|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Adverse Event|0|||
155288565|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Adverse Event|0|||
155288566|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Adverse Event|0|||
155288567|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Adverse Event|0|||
155288568|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Adverse Event|0|||
155288569|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Adverse Event|2|||
155288570|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Adverse Event|1|||
155288571|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Adverse Event|8|||
155288572|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288573|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288574|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288575|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288576|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288577|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288578|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288579|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
155288580|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
155288581|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
155288582|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Various reasons|0|||
155288583|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Various reasons|0|||
155288584|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Various reasons|0|||
155288585|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Various reasons|0|||
155288586|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Various reasons|0|||
155288587|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Various reasons|0|||
155288588|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Various reasons|0|||
155288589|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Various reasons|3|||
155288590|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Various reasons|1|||
155288591|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Various reasons|3|||
155288592|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
155288593|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
155288594|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
155288595|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
155288596|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
155288597|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
155288598|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
155288599|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
155288600|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
155288601|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
155288602|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288603|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288604|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288605|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288606|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288607|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288608|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288609|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288610|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288611|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
155288612|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288613|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288614|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288615|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288616|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288617|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288618|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288619|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288620|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
155408007|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
155638073|NCT02225587|561766372|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155638074|NCT02225587|561766371|FG000|Overall Study|Physician Decision|2|||
155638075|NCT02225587|561766372|FG001|Overall Study|Physician Decision|0|||
155638076|NCT02225587|561766371|FG000|Overall Study|Protocol Violation|1|||
155288621|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
155288622|NCT01467700|560488584|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
155288623|NCT01467700|560488585|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
155288624|NCT01467700|560488586|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
155288625|NCT01467700|560488587|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
155288626|NCT01467700|560488584|FG000|Overall Study|Major Protocol Deviation|3|||
155288627|NCT01467700|560488585|FG001|Overall Study|Major Protocol Deviation|3|||
155408008|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
155408009|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408010|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408011|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408012|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408013|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
155408014|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408015|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408016|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
155408017|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408018|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408019|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408020|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408021|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
155408022|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408023|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408024|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
155408025|NCT03016325|560927290|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408026|NCT03016325|560927291|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408027|NCT03016325|560927292|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408028|NCT03016325|560927293|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
155408029|NCT03016325|560927294|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408030|NCT03016325|560927295|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408031|NCT03016325|560927296|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408032|NCT03016325|560927297|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
155408033|NCT03016325|560927290|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408034|NCT03016325|560927291|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
155408035|NCT03016325|560927292|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408036|NCT03016325|560927293|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408037|NCT03016325|560927294|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408038|NCT03016325|560927295|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408039|NCT03016325|560927296|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408040|NCT03016325|560927297|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155408041|NCT03016325|560927290|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
155408042|NCT03016325|560927291|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
155408043|NCT03016325|560927292|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
155408044|NCT03016325|560927293|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
155408045|NCT03016325|560927294|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
155408046|NCT03016325|560927295|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
155408047|NCT03016325|560927296|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
155408048|NCT03016325|560927297|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
155408049|NCT02941627|560927298|FG000|Overall Study|Death|1|||
155408050|NCT02941627|560927298|FG000|Overall Study|Surgical failure|1|||
155408051|NCT02941627|560927298|FG000|Overall Study|cholesteatoma prevented implantation|1|||
155408052|NCT02595723|560927299|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
155408053|NCT02595723|560927300|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
155408054|NCT02595723|560927301|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
155408055|NCT02595723|560927299|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
155408056|NCT02595723|560927300|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
155408057|NCT02595723|560927301|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
155408058|NCT01087905|560927302|FG000|Overall Study|Lost to Follow-up|24|||
155408059|NCT01087905|560927303|FG001|Overall Study|Lost to Follow-up|28|||
155408060|NCT01087905|560927304|FG002|Overall Study|Lost to Follow-up|18|||
155408061|NCT01087905|560927305|FG003|Overall Study|Lost to Follow-up|31|||
155408062|NCT01087905|560927306|FG004|Overall Study|Lost to Follow-up|27|||
155408063|NCT01087905|560927307|FG005|Overall Study|Lost to Follow-up|25|||
155408064|NCT01087905|560927308|FG006|Overall Study|Lost to Follow-up|20|||
155408065|NCT01087905|560927309|FG007|Overall Study|Lost to Follow-up|24|||
155408066|NCT01087905|560927302|FG000|Overall Study|Withdrawal by Subject|5|||
155408067|NCT01087905|560927303|FG001|Overall Study|Withdrawal by Subject|4|||
155408068|NCT01087905|560927304|FG002|Overall Study|Withdrawal by Subject|4|||
155408069|NCT01087905|560927305|FG003|Overall Study|Withdrawal by Subject|5|||
155408070|NCT01087905|560927306|FG004|Overall Study|Withdrawal by Subject|4|||
155408071|NCT01087905|560927307|FG005|Overall Study|Withdrawal by Subject|3|||
155408072|NCT01087905|560927308|FG006|Overall Study|Withdrawal by Subject|3|||
155408073|NCT01087905|560927309|FG007|Overall Study|Withdrawal by Subject|5|||
155408074|NCT01902290|560927315|FG000|Overall Study|Withdrawal by Subject|19|||
155408075|NCT01902290|560927316|FG001|Overall Study|Withdrawal by Subject|27|||
155408076|NCT01902290|560927315|FG000|Overall Study|Lost to Follow-up|2|||
155408077|NCT01902290|560927316|FG001|Overall Study|Lost to Follow-up|2|||
155288628|NCT01467700|560488586|FG002|Overall Study|Major Protocol Deviation|2|||
155288629|NCT01467700|560488587|FG003|Overall Study|Major Protocol Deviation|3|||
155288630|NCT01467700|560488584|FG000|Overall Study|Lost to Follow-up|6|||
155288631|NCT01467700|560488585|FG001|Overall Study|Lost to Follow-up|5|||
155288632|NCT01467700|560488586|FG002|Overall Study|Lost to Follow-up|2|||
155288633|NCT01467700|560488587|FG003|Overall Study|Lost to Follow-up|3|||
155288634|NCT01467700|560488584|FG000|Overall Study|Voluntary Withdrawal|5|||
155288635|NCT01467700|560488585|FG001|Overall Study|Voluntary Withdrawal|7|||
155288636|NCT01467700|560488586|FG002|Overall Study|Voluntary Withdrawal|6|||
155288637|NCT01467700|560488587|FG003|Overall Study|Voluntary Withdrawal|2|||
155288638|NCT01467700|560488584|FG000|Overall Study|Study Termination|6|||
155288639|NCT01467700|560488585|FG001|Overall Study|Study Termination|5|||
155288640|NCT01467700|560488586|FG002|Overall Study|Study Termination|10|||
155288641|NCT01467700|560488587|FG003|Overall Study|Study Termination|7|||
155288642|NCT01467700|560488584|FG000|Overall Study|Pregnancy|0|||
155288643|NCT01467700|560488585|FG001|Overall Study|Pregnancy|1|||
155288644|NCT01467700|560488586|FG002|Overall Study|Pregnancy|1|||
155288645|NCT01467700|560488587|FG003|Overall Study|Pregnancy|0|||
155288646|NCT01467700|560488584|FG000|Overall Study|Lack of Efficacy|2|||
155288647|NCT01467700|560488585|FG001|Overall Study|Lack of Efficacy|0|||
155288648|NCT01467700|560488586|FG002|Overall Study|Lack of Efficacy|2|||
155288649|NCT01467700|560488587|FG003|Overall Study|Lack of Efficacy|1|||
155288650|NCT01467700|560488584|FG000|Overall Study|Reason not Specified|1|||
155288651|NCT01467700|560488585|FG001|Overall Study|Reason not Specified|3|||
155288652|NCT01467700|560488586|FG002|Overall Study|Reason not Specified|2|||
155288653|NCT01467700|560488587|FG003|Overall Study|Reason not Specified|8|||
155288654|NCT03168438|560488588|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
155288655|NCT03168438|560488589|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
155288656|NCT04109118|560488592|FG000|Overall Study|Lost to Follow-up|3|||
155288657|NCT03235349|560488593|FG000|Overall Study|Adverse Event|1|||
155288658|NCT03235349|560488593|FG000|Overall Study|Other|1|||
155288659|NCT03394027|560488594|FG000|Overall Study|Ineligible|3|||
155288660|NCT03394027|560488595|FG001|Overall Study|Ineligible|1|||
155288661|NCT03394027|560488596|FG002|Overall Study|Ineligible|3|||
155288662|NCT03394027|560488594|FG000|Overall Study|Participant declined to participate before treatment started|0|||
155288663|NCT03394027|560488595|FG001|Overall Study|Participant declined to participate before treatment started|0|||
155288664|NCT03394027|560488596|FG002|Overall Study|Participant declined to participate before treatment started|1|||
155288665|NCT04305912|560488600|FG000|First Intervention|COVID-19 Suspension|2|||
155288666|NCT04305912|560488601|FG001|First Intervention|COVID-19 Suspension|0|||
155288667|NCT04305912|560488600|FG000|First Intervention|Withdrawal by Subject|0|||
155288668|NCT04305912|560488601|FG001|First Intervention|Withdrawal by Subject|1|||
155288669|NCT04305912|560488600|FG000|Second Intervention|Adverse Event|0|||
155288670|NCT04305912|560488601|FG001|Second Intervention|Adverse Event|1|||
155288671|NCT01348087|560488603|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
155288672|NCT01348087|560488603|FG000|Overall Study|Administrative problems|79|||
155288673|NCT01348087|560488603|FG000|Overall Study|protocol deviation|1|||
155288674|NCT01348087|560488603|FG000|Overall Study|Lost to Follow-up|1|||
155288675|NCT01348087|560488603|FG000|Overall Study|Subject withdrew consent|7|||
155288676|NCT01348087|560488603|FG000|Overall Study|Adverse Event|25|||
155288677|NCT03140176|560490285|FG000|Overall Study|Reason missing|23|||
155288678|NCT03140176|560490285|FG000|Overall Study|Death|33|||
155288679|NCT03140176|560490285|FG000|Overall Study|Disease progression|1|||
155408078|NCT01902290|560927315|FG000|Overall Study|Death|1|||
155638077|NCT02225587|561766372|FG001|Overall Study|Protocol Violation|0|||
155638078|NCT02225587|561766371|FG000|Overall Study|Participant Moved|1|||
155288680|NCT03140176|560490285|FG000|Overall Study|Physician Decision|1|||
155288681|NCT03140176|560490285|FG000|Overall Study|Withdrawal by Subject|1|||
155288682|NCT03140176|560490285|FG000|Overall Study|Lost to Follow-up|15|||
155288683|NCT03179787|560490291|FG000|Overall Study|Lost to Follow-up|15|||
155288684|NCT03179787|560490291|FG000|Overall Study|Case report failures|2|||
155638079|NCT02225587|561766372|FG001|Overall Study|Participant Moved|0|||
155638080|NCT02225587|561766371|FG000|Overall Study|Withdrawal by Subject|13|||
155288685|NCT03179787|560490291|FG000|Overall Study|Treatment not administered|1|||
155288686|NCT02030028|560490292|FG000|Overall Study|Withdrawal by Subject|4|||
155288687|NCT02030028|560490292|FG000|Overall Study|lack of transportation|1|||
155288688|NCT00149630|560490293|FG000|Overall Study|Incarceration|2|||
155288689|NCT00149630|560490294|FG001|Overall Study|Incarceration|0|||
155288690|NCT00149630|560490293|FG000|Overall Study|Treatment Programs|4|||
155288691|NCT00149630|560490294|FG001|Overall Study|Treatment Programs|5|||
155288692|NCT00149630|560490293|FG000|Overall Study|Adverse Event|2|||
155288693|NCT00149630|560490294|FG001|Overall Study|Adverse Event|0|||
155288694|NCT03357341|560490303|FG000|Overall Study|Withdrawal by Subject|3|||
155408079|NCT01902290|560927316|FG001|Overall Study|Death|0|||
155288695|NCT03357341|560490304|FG001|Overall Study|Withdrawal by Subject|6|||
155288696|NCT03357341|560490303|FG000|Overall Study|Lost to Follow-up|4|||
155288697|NCT03357341|560490304|FG001|Overall Study|Lost to Follow-up|5|||
155288698|NCT03357341|560490303|FG000|Overall Study|Death|0|||
155288699|NCT03357341|560490304|FG001|Overall Study|Death|1|||
155288700|NCT01956669|560490307|FG000|Overall Study|Disease Progression|12|||
155288701|NCT01956669|560490308|FG001|Overall Study|Disease Progression|7|||
155288702|NCT01956669|560490309|FG002|Overall Study|Disease Progression|7|||
155288703|NCT01956669|560490310|FG003|Overall Study|Disease Progression|8|||
155288704|NCT01956669|560490311|FG004|Overall Study|Disease Progression|4|||
155288705|NCT01956669|560490312|FG005|Overall Study|Disease Progression|3|||
155288706|NCT01956669|560490313|FG006|Overall Study|Disease Progression|5|||
155288707|NCT01956669|560490307|FG000|Overall Study|Adverse Event|0|||
155288708|NCT01956669|560490308|FG001|Overall Study|Adverse Event|2|||
155288709|NCT01956669|560490309|FG002|Overall Study|Adverse Event|2|||
155288710|NCT01956669|560490310|FG003|Overall Study|Adverse Event|1|||
155288711|NCT01956669|560490311|FG004|Overall Study|Adverse Event|0|||
155288712|NCT01956669|560490312|FG005|Overall Study|Adverse Event|0|||
155288713|NCT01956669|560490313|FG006|Overall Study|Adverse Event|0|||
155288714|NCT01956669|560490307|FG000|Overall Study|Physician Decision|0|||
155288715|NCT01956669|560490308|FG001|Overall Study|Physician Decision|2|||
155288716|NCT01956669|560490309|FG002|Overall Study|Physician Decision|0|||
155288717|NCT01956669|560490310|FG003|Overall Study|Physician Decision|0|||
155288718|NCT01956669|560490311|FG004|Overall Study|Physician Decision|0|||
155288719|NCT01956669|560490312|FG005|Overall Study|Physician Decision|1|||
155288720|NCT01956669|560490313|FG006|Overall Study|Physician Decision|0|||
155288721|NCT01956669|560490307|FG000|Overall Study|Withdrawal by Subject|0|||
155288722|NCT01956669|560490308|FG001|Overall Study|Withdrawal by Subject|0|||
155288723|NCT01956669|560490309|FG002|Overall Study|Withdrawal by Subject|1|||
155288724|NCT01956669|560490310|FG003|Overall Study|Withdrawal by Subject|1|||
155288725|NCT01956669|560490311|FG004|Overall Study|Withdrawal by Subject|0|||
155288726|NCT01956669|560490312|FG005|Overall Study|Withdrawal by Subject|0|||
155288727|NCT01956669|560490313|FG006|Overall Study|Withdrawal by Subject|1|||
155288728|NCT01570751|560490314|FG000|Period A (16 Weeks)|Protocol Violation|1|||
155288729|NCT01570751|560490315|FG001|Period A (16 Weeks)|Protocol Violation|1|||
155288730|NCT01570751|560490314|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
155288731|NCT01570751|560490315|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
155288732|NCT01570751|560490314|FG000|Period A (16 Weeks)|Unclassified|2|||
155288733|NCT01570751|560490315|FG001|Period A (16 Weeks)|Unclassified|3|||
155288734|NCT01570751|560490314|FG000|Period B (16 Weeks)|Adverse Event|1|||
155288735|NCT01570751|560490315|FG001|Period B (16 Weeks)|Adverse Event|0|||
155288736|NCT01570751|560490314|FG000|Period B (16 Weeks)|Protocol Violation|0|||
155288737|NCT01570751|560490315|FG001|Period B (16 Weeks)|Protocol Violation|1|||
155288738|NCT00930813|560490316|FG000|Overall Study|Death|4|||
155288739|NCT00930813|560490317|FG001|Overall Study|Death|5|||
155288740|NCT00930813|560490316|FG000|Overall Study|Withdrawal by Subject|2|||
155288741|NCT00930813|560490317|FG001|Overall Study|Withdrawal by Subject|5|||
155288742|NCT00930813|560490316|FG000|Overall Study|Lost to Follow-up|2|||
155288743|NCT00930813|560490317|FG001|Overall Study|Lost to Follow-up|4|||
155288744|NCT05790408|560490322|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
155288745|NCT01693614|560490323|FG000|Overall Study|Adverse Event|7|||
155288746|NCT01693614|560490324|FG001|Overall Study|Adverse Event|11|||
155288747|NCT01693614|560490325|FG002|Overall Study|Adverse Event|5|||
155288748|NCT01693614|560490323|FG000|Overall Study|Disease progression|11|||
155288749|NCT01693614|560490324|FG001|Overall Study|Disease progression|8|||
155288750|NCT01693614|560490325|FG002|Overall Study|Disease progression|7|||
155288751|NCT01693614|560490323|FG000|Overall Study|Protocol Violation|5|||
155288752|NCT01693614|560490324|FG001|Overall Study|Protocol Violation|2|||
155288753|NCT01693614|560490325|FG002|Overall Study|Protocol Violation|1|||
155288754|NCT01693614|560490323|FG000|Overall Study|Death|1|||
155288755|NCT01693614|560490324|FG001|Overall Study|Death|0|||
155288756|NCT01693614|560490325|FG002|Overall Study|Death|0|||
155288757|NCT01693614|560490323|FG000|Overall Study|Physician Decision|1|||
155288758|NCT01693614|560490324|FG001|Overall Study|Physician Decision|1|||
155288759|NCT01693614|560490325|FG002|Overall Study|Physician Decision|4|||
155288760|NCT01693614|560490323|FG000|Overall Study|Withdrawal by subject/guardian|0|||
155288761|NCT01693614|560490324|FG001|Overall Study|Withdrawal by subject/guardian|0|||
155288762|NCT01693614|560490325|FG002|Overall Study|Withdrawal by subject/guardian|2|||
155288763|NCT01693614|560490323|FG000|Overall Study|Withdrawal by Subject|1|||
155288764|NCT01693614|560490324|FG001|Overall Study|Withdrawal by Subject|0|||
155288765|NCT01693614|560490325|FG002|Overall Study|Withdrawal by Subject|5|||
155288766|NCT01131494|560490326|FG000|Overall Study|Withdrawal by Subject|2|||
155288767|NCT05419557|560490327|FG000|Overall Study|Lost to Follow-up|11|||
155288768|NCT05419557|560490328|FG001|Overall Study|Lost to Follow-up|4|||
155288769|NCT00588666|560490330|FG000|Overall Study|Adverse Event|4|||
155288770|NCT02281318|560490331|FG000|Overall Study|Adverse Event|2|||
155408080|NCT01902290|560927315|FG000|Overall Study|Sponsor Decision|26|||
155288771|NCT02281318|560490332|FG001|Overall Study|Adverse Event|2|||
155288772|NCT02281318|560490331|FG000|Overall Study|Lack of Efficacy|2|||
155288773|NCT02281318|560490332|FG001|Overall Study|Lack of Efficacy|0|||
155288774|NCT02281318|560490331|FG000|Overall Study|Lost to Follow-up|2|||
155288775|NCT02281318|560490332|FG001|Overall Study|Lost to Follow-up|1|||
155288776|NCT02281318|560490331|FG000|Overall Study|Physician Decision|2|||
155288777|NCT02281318|560490332|FG001|Overall Study|Physician Decision|0|||
155743220|NCT00913458|562159840|FG003|Phase 1|Lost to Follow-up|0|||
155743221|NCT00913458|562159841|FG004|Phase 1|Lost to Follow-up|0|||
155743222|NCT00913458|562159842|FG005|Phase 1|Lost to Follow-up|0|||
155743223|NCT00913458|562159843|FG006|Phase 1|Lost to Follow-up|0|||
155743224|NCT00913458|562159837|FG000|Phase 1|Protocol Violation|10|||
155743225|NCT00913458|562159838|FG001|Phase 1|Protocol Violation|0|||
155743226|NCT00913458|562159839|FG002|Phase 1|Protocol Violation|0|||
155743227|NCT00913458|562159840|FG003|Phase 1|Protocol Violation|0|||
155743228|NCT00913458|562159841|FG004|Phase 1|Protocol Violation|0|||
155743229|NCT00913458|562159842|FG005|Phase 1|Protocol Violation|0|||
155743230|NCT00913458|562159843|FG006|Phase 1|Protocol Violation|0|||
155743231|NCT00913458|562159837|FG000|Phase 1|Sponsor|2|||
155743232|NCT00913458|562159838|FG001|Phase 1|Sponsor|0|||
155743233|NCT00913458|562159839|FG002|Phase 1|Sponsor|0|||
155743234|NCT00913458|562159840|FG003|Phase 1|Sponsor|0|||
155743235|NCT00913458|562159841|FG004|Phase 1|Sponsor|0|||
155743236|NCT00913458|562159842|FG005|Phase 1|Sponsor|0|||
155743237|NCT00913458|562159843|FG006|Phase 1|Sponsor|0|||
155743238|NCT00913458|562159837|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
155743239|NCT00913458|562159838|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
155743240|NCT00913458|562159839|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
155743241|NCT00913458|562159840|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
155743242|NCT00913458|562159841|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
155743243|NCT00913458|562159842|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
155743244|NCT00913458|562159843|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
155743245|NCT00913458|562159837|FG000|Phase 2|Non-Responder|0|||
155743246|NCT00913458|562159838|FG001|Phase 2|Non-Responder|5|||
155743247|NCT00913458|562159839|FG002|Phase 2|Non-Responder|7|||
155743248|NCT00913458|562159840|FG003|Phase 2|Non-Responder|12|||
155743249|NCT00913458|562159841|FG004|Phase 2|Non-Responder|0|||
155743250|NCT00913458|562159842|FG005|Phase 2|Non-Responder|0|||
155743251|NCT00913458|562159843|FG006|Phase 2|Non-Responder|0|||
155743252|NCT00913458|562159837|FG000|Phase 2|Subject Request|0|||
155743253|NCT00913458|562159838|FG001|Phase 2|Subject Request|0|||
155743254|NCT00913458|562159839|FG002|Phase 2|Subject Request|1|||
155743255|NCT00913458|562159840|FG003|Phase 2|Subject Request|2|||
155743256|NCT00913458|562159841|FG004|Phase 2|Subject Request|0|||
155743257|NCT00913458|562159842|FG005|Phase 2|Subject Request|0|||
155743258|NCT00913458|562159843|FG006|Phase 2|Subject Request|0|||
155743259|NCT00913458|562159837|FG000|Phase 2|Adverse Event|0|||
155743260|NCT00913458|562159838|FG001|Phase 2|Adverse Event|3|||
155743261|NCT00913458|562159839|FG002|Phase 2|Adverse Event|0|||
155743262|NCT00913458|562159840|FG003|Phase 2|Adverse Event|1|||
155743263|NCT00913458|562159841|FG004|Phase 2|Adverse Event|0|||
155743264|NCT00913458|562159842|FG005|Phase 2|Adverse Event|0|||
155743265|NCT00913458|562159843|FG006|Phase 2|Adverse Event|0|||
155743266|NCT00913458|562159837|FG000|Phase 2|Lost to Follow-up|0|||
155743267|NCT00913458|562159838|FG001|Phase 2|Lost to Follow-up|0|||
155743268|NCT00913458|562159839|FG002|Phase 2|Lost to Follow-up|0|||
155743269|NCT00913458|562159840|FG003|Phase 2|Lost to Follow-up|1|||
155743270|NCT00913458|562159841|FG004|Phase 2|Lost to Follow-up|0|||
155743271|NCT00913458|562159842|FG005|Phase 2|Lost to Follow-up|0|||
155743272|NCT00913458|562159843|FG006|Phase 2|Lost to Follow-up|0|||
155743273|NCT00913458|562159837|FG000|Phase 2|Protocol Violation|0|||
155743274|NCT00913458|562159838|FG001|Phase 2|Protocol Violation|2|||
155743275|NCT00913458|562159839|FG002|Phase 2|Protocol Violation|0|||
155743276|NCT00913458|562159840|FG003|Phase 2|Protocol Violation|0|||
155743277|NCT00913458|562159841|FG004|Phase 2|Protocol Violation|0|||
155743278|NCT00913458|562159842|FG005|Phase 2|Protocol Violation|0|||
155743279|NCT00913458|562159843|FG006|Phase 2|Protocol Violation|0|||
155743280|NCT00913458|562159837|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
155743281|NCT00913458|562159838|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
155743282|NCT00913458|562159839|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
155743283|NCT00913458|562159840|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
155743284|NCT00913458|562159841|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
155743285|NCT00913458|562159842|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
155743286|NCT00913458|562159843|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
155743287|NCT00913458|562159837|FG000|Phase 3|Adverse Event|0|||
155743288|NCT00913458|562159838|FG001|Phase 3|Adverse Event|0|||
155743289|NCT00913458|562159839|FG002|Phase 3|Adverse Event|0|||
155743290|NCT00913458|562159840|FG003|Phase 3|Adverse Event|0|||
155743291|NCT00913458|562159841|FG004|Phase 3|Adverse Event|5|||
155743292|NCT00913458|562159842|FG005|Phase 3|Adverse Event|4|||
155743293|NCT00913458|562159843|FG006|Phase 3|Adverse Event|1|||
155743294|NCT00913458|562159837|FG000|Phase 3|Lost to Follow-up|0|||
155743295|NCT00913458|562159838|FG001|Phase 3|Lost to Follow-up|0|||
155743296|NCT00913458|562159839|FG002|Phase 3|Lost to Follow-up|0|||
155743297|NCT00913458|562159840|FG003|Phase 3|Lost to Follow-up|0|||
155743298|NCT00913458|562159841|FG004|Phase 3|Lost to Follow-up|2|||
155743299|NCT00913458|562159842|FG005|Phase 3|Lost to Follow-up|0|||
155743300|NCT00913458|562159843|FG006|Phase 3|Lost to Follow-up|0|||
155743301|NCT00913458|562159837|FG000|Phase 3|Non-Responder|0|||
155743302|NCT00913458|562159838|FG001|Phase 3|Non-Responder|0|||
155743303|NCT00913458|562159839|FG002|Phase 3|Non-Responder|0|||
155288778|NCT02281318|560490331|FG000|Overall Study|Withdrawal by Subject|6|||
155288779|NCT02281318|560490332|FG001|Overall Study|Withdrawal by Subject|2|||
155288780|NCT05257798|560490333|FG000|Follow-up Phase|Lost to Follow-up|1|||
155288781|NCT05257798|560490334|FG001|Follow-up Phase|Lost to Follow-up|0|||
155288782|NCT00703911|560490337|FG000|Overall Study|Death|1|||
155288783|NCT00703911|560490337|FG000|Overall Study|Physician Decision|6|||
155288784|NCT00703911|560490337|FG000|Overall Study|Lost to Follow-up|1|||
155288785|NCT00703911|560490337|FG000|Overall Study|Withdrawal by Subject|2|||
155288786|NCT01064817|560490338|FG000|Study Completion|Physician Decision|1|||
155288787|NCT01064817|560490339|FG001|Study Completion|Physician Decision|0|||
155288788|NCT01064817|560490338|FG000|Study Completion|Withdrawal by Subject|1|||
155288789|NCT01064817|560490339|FG001|Study Completion|Withdrawal by Subject|0|||
155288790|NCT03102710|560490340|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
155288791|NCT03102710|560490341|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
155288792|NCT03102710|560490342|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
155288793|NCT03102710|560490340|FG000|Overall Study|Technical issues during final MRI scan|0|||
155288794|NCT03102710|560490341|FG001|Overall Study|Technical issues during final MRI scan|1|||
155288795|NCT03102710|560490342|FG002|Overall Study|Technical issues during final MRI scan|0|||
155288796|NCT03102710|560490340|FG000|Overall Study|Nausea during MRI scan|0|||
155288797|NCT03102710|560490341|FG001|Overall Study|Nausea during MRI scan|1|||
155288798|NCT03102710|560490342|FG002|Overall Study|Nausea during MRI scan|0|||
155288799|NCT03102710|560490340|FG000|Overall Study|Subject unable to attend final session|0|||
155288800|NCT03102710|560490341|FG001|Overall Study|Subject unable to attend final session|1|||
155288801|NCT03102710|560490342|FG002|Overall Study|Subject unable to attend final session|0|||
155288802|NCT01368406|560490343|FG000|Overall Study|Lost to Follow-up|8|||
155288803|NCT01368406|560490344|FG001|Overall Study|Lost to Follow-up|4|||
155288804|NCT01368406|560490343|FG000|Overall Study|Withdrawal by Subject|8|||
155288805|NCT01368406|560490344|FG001|Overall Study|Withdrawal by Subject|4|||
155288806|NCT01368406|560490343|FG000|Overall Study|relapse of the disease|3|||
155288807|NCT01368406|560490344|FG001|Overall Study|relapse of the disease|2|||
155288808|NCT01368406|560490343|FG000|Overall Study|started working|2|||
155288809|NCT01368406|560490344|FG001|Overall Study|started working|3|||
155288810|NCT02299635|560490350|FG000|Overall Study|Adverse Event|2|||
155288811|NCT02299635|560490350|FG000|Overall Study|Death|1|||
155288812|NCT02299635|560490350|FG000|Overall Study|Global deterioration of health status|1|||
155288813|NCT02299635|560490350|FG000|Overall Study|Objective progression or relapse|10|||
155288814|NCT02299635|560490350|FG000|Overall Study|Withdrawal by Subject|2|||
155288815|NCT02299635|560490350|FG000|Overall Study|Other|3|||
155288816|NCT00543725|560490351|FG000|Overall Study|Adverse Event|18|||
155288817|NCT00543725|560490352|FG001|Overall Study|Adverse Event|27|||
155288818|NCT00543725|560490351|FG000|Overall Study|Sponsor's Decision|0|||
155288819|NCT00543725|560490352|FG001|Overall Study|Sponsor's Decision|1|||
155288820|NCT00543725|560490351|FG000|Overall Study|Subject Non-Compliant|4|||
155288821|NCT00543725|560490352|FG001|Overall Study|Subject Non-Compliant|4|||
155288822|NCT00543725|560490351|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
155288823|NCT00543725|560490352|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
155288824|NCT00543725|560490351|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
155288825|NCT00543725|560490352|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
155288826|NCT00543725|560490351|FG000|Overall Study|Protocol Violation|0|||
155288827|NCT00543725|560490352|FG001|Overall Study|Protocol Violation|1|||
155288828|NCT00543725|560490351|FG000|Overall Study|Withdrawal by Subject|4|||
155288829|NCT00543725|560490352|FG001|Overall Study|Withdrawal by Subject|13|||
155288830|NCT00543725|560490351|FG000|Overall Study|Lost to Follow-up|15|||
155408081|NCT01902290|560927316|FG001|Overall Study|Sponsor Decision|24|||
155408082|NCT00385255|560927317|FG000|Overall Study|Serious Adverse Event|1|||
155408083|NCT00385255|560927318|FG001|Overall Study|Serious Adverse Event|2|||
155408084|NCT00385255|560927317|FG000|Overall Study|Protocol Violation|0|||
155408085|NCT00385255|560927318|FG001|Overall Study|Protocol Violation|4|||
155408086|NCT00385255|560927317|FG000|Overall Study|Withdrawal by Subject|0|||
155288831|NCT00543725|560490352|FG001|Overall Study|Lost to Follow-up|11|||
155288832|NCT00543725|560490351|FG000|Overall Study|Other|3|||
155288833|NCT00543725|560490352|FG001|Overall Study|Other|3|||
155288834|NCT00906698|560490353|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288835|NCT00906698|560490354|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
155408087|NCT00385255|560927318|FG001|Overall Study|Withdrawal by Subject|8|||
155408088|NCT00385255|560927317|FG000|Overall Study|Migrated/moved from study area|0|||
155288836|NCT00906698|560490355|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288837|NCT00906698|560490356|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288838|NCT00906698|560490357|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
155288839|NCT00906698|560490358|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288840|NCT00906698|560490353|FG000|Overall Study|Adverse Event|0|||
155288841|NCT00906698|560490354|FG001|Overall Study|Adverse Event|0|||
155288842|NCT00906698|560490355|FG002|Overall Study|Adverse Event|2|||
155288843|NCT00906698|560490356|FG003|Overall Study|Adverse Event|0|||
155408089|NCT00385255|560927318|FG001|Overall Study|Migrated/moved from study area|1|||
155408090|NCT00385255|560927317|FG000|Overall Study|Lost to Follow-up|20|||
155408091|NCT00385255|560927318|FG001|Overall Study|Lost to Follow-up|58|||
155408092|NCT01265550|560927319|FG000|Pre Randomization|Withdrawal by Subject|0|||
155408093|NCT01265550|560927320|FG001|Pre Randomization|Withdrawal by Subject|0|||
155408094|NCT01265550|560927321|FG002|Pre Randomization|Withdrawal by Subject|0|||
155408095|NCT01265550|560927322|FG003|Pre Randomization|Withdrawal by Subject|70|||
155408096|NCT01265550|560927319|FG000|Pre Randomization|Technical Exclusions|0|||
155408097|NCT01265550|560927320|FG001|Pre Randomization|Technical Exclusions|0|||
155408098|NCT01265550|560927321|FG002|Pre Randomization|Technical Exclusions|0|||
155408099|NCT01265550|560927322|FG003|Pre Randomization|Technical Exclusions|54|||
155408100|NCT01265550|560927319|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
155408101|NCT01265550|560927320|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
155408102|NCT01265550|560927321|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
155408103|NCT01265550|560927322|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
155408104|NCT01265550|560927319|FG000|Pre Randomization|Non-GERD organic disorders|0|||
155408105|NCT01265550|560927320|FG001|Pre Randomization|Non-GERD organic disorders|0|||
155408106|NCT01265550|560927321|FG002|Pre Randomization|Non-GERD organic disorders|0|||
155408107|NCT01265550|560927322|FG003|Pre Randomization|Non-GERD organic disorders|23|||
155408108|NCT01265550|560927319|FG000|Pre Randomization|Functional heartburn|0|||
155408109|NCT01265550|560927320|FG001|Pre Randomization|Functional heartburn|0|||
155408110|NCT01265550|560927321|FG002|Pre Randomization|Functional heartburn|0|||
155408111|NCT01265550|560927322|FG003|Pre Randomization|Functional heartburn|99|||
155408112|NCT01929408|560927324|FG000|Overall Study|received HCT as initial treatment|8|||
155408113|NCT01015768|560927329|FG000|Overall Study|Some subject data unuseable|4|||
155408114|NCT01015768|560927330|FG001|Overall Study|Some subject data unuseable|4|||
155408115|NCT01073267|560927331|FG000|Overall Study|Disease Progression|3|||
155408116|NCT01225731|560927332|FG000|Part 1|Did not meet eligibility criteria|1|||
155408117|NCT01225731|560927333|FG001|Part 1|Did not meet eligibility criteria|0|||
155408118|NCT01225731|560927334|FG002|Part 1|Did not meet eligibility criteria|0|||
155408119|NCT01225731|560927335|FG003|Part 1|Did not meet eligibility criteria|0|||
155408120|NCT01225731|560927336|FG004|Part 1|Did not meet eligibility criteria|1|||
155408121|NCT01225731|560927337|FG005|Part 1|Did not meet eligibility criteria|0|||
155408122|NCT01225731|560927338|FG006|Part 1|Did not meet eligibility criteria|0|||
155408123|NCT01225731|560927339|FG007|Part 1|Did not meet eligibility criteria|0|||
155408124|NCT01225731|560927340|FG008|Part 1|Did not meet eligibility criteria|0|||
155408125|NCT01225731|560927341|FG009|Part 1|Did not meet eligibility criteria|0|||
155408126|NCT01225731|560927342|FG010|Part 1|Did not meet eligibility criteria|0|||
155408127|NCT01225731|560927343|FG011|Part 1|Did not meet eligibility criteria|0|||
155408128|NCT01225731|560927344|FG012|Part 1|Did not meet eligibility criteria|0|||
155408129|NCT01225731|560927332|FG000|Part 1|Adverse Event|1|||
155408130|NCT01225731|560927333|FG001|Part 1|Adverse Event|2|||
155408131|NCT01225731|560927334|FG002|Part 1|Adverse Event|1|||
155408132|NCT01225731|560927335|FG003|Part 1|Adverse Event|1|||
155408133|NCT01225731|560927336|FG004|Part 1|Adverse Event|1|||
155408134|NCT01225731|560927337|FG005|Part 1|Adverse Event|0|||
155408135|NCT01225731|560927338|FG006|Part 1|Adverse Event|0|||
155408136|NCT01225731|560927339|FG007|Part 1|Adverse Event|0|||
155408137|NCT01225731|560927340|FG008|Part 1|Adverse Event|0|||
155408138|NCT01225731|560927341|FG009|Part 1|Adverse Event|0|||
155408139|NCT01225731|560927342|FG010|Part 1|Adverse Event|0|||
155408140|NCT01225731|560927343|FG011|Part 1|Adverse Event|0|||
155408141|NCT01225731|560927344|FG012|Part 1|Adverse Event|0|||
155408142|NCT01225731|560927332|FG000|Part 1|Withdrawal by Subject|0|||
155408143|NCT01225731|560927333|FG001|Part 1|Withdrawal by Subject|3|||
155408144|NCT01225731|560927334|FG002|Part 1|Withdrawal by Subject|0|||
155408145|NCT01225731|560927335|FG003|Part 1|Withdrawal by Subject|0|||
155408146|NCT01225731|560927336|FG004|Part 1|Withdrawal by Subject|4|||
155408147|NCT01225731|560927337|FG005|Part 1|Withdrawal by Subject|0|||
155408148|NCT01225731|560927338|FG006|Part 1|Withdrawal by Subject|0|||
155408149|NCT01225731|560927339|FG007|Part 1|Withdrawal by Subject|0|||
155408150|NCT01225731|560927340|FG008|Part 1|Withdrawal by Subject|0|||
155408151|NCT01225731|560927341|FG009|Part 1|Withdrawal by Subject|0|||
155408152|NCT01225731|560927342|FG010|Part 1|Withdrawal by Subject|0|||
155408153|NCT01225731|560927343|FG011|Part 1|Withdrawal by Subject|0|||
155408154|NCT01225731|560927344|FG012|Part 1|Withdrawal by Subject|0|||
155408155|NCT01225731|560927332|FG000|Part 1|Protocol Violation|0|||
155408156|NCT01225731|560927333|FG001|Part 1|Protocol Violation|0|||
155408157|NCT01225731|560927334|FG002|Part 1|Protocol Violation|0|||
155408158|NCT01225731|560927335|FG003|Part 1|Protocol Violation|1|||
155408159|NCT01225731|560927336|FG004|Part 1|Protocol Violation|0|||
155408160|NCT01225731|560927337|FG005|Part 1|Protocol Violation|0|||
155408161|NCT01225731|560927338|FG006|Part 1|Protocol Violation|0|||
155408162|NCT01225731|560927339|FG007|Part 1|Protocol Violation|0|||
155408163|NCT01225731|560927340|FG008|Part 1|Protocol Violation|0|||
155408164|NCT01225731|560927341|FG009|Part 1|Protocol Violation|0|||
155408165|NCT01225731|560927342|FG010|Part 1|Protocol Violation|0|||
155408166|NCT01225731|560927343|FG011|Part 1|Protocol Violation|0|||
155408167|NCT01225731|560927344|FG012|Part 1|Protocol Violation|0|||
155408168|NCT01225731|560927332|FG000|Part 2|Protocol Violation|0|||
155408169|NCT01225731|560927333|FG001|Part 2|Protocol Violation|0|||
155288844|NCT00906698|560490357|FG004|Overall Study|Adverse Event|4|||
155288845|NCT00906698|560490358|FG005|Overall Study|Adverse Event|1|||
155288846|NCT00906698|560490353|FG000|Overall Study|Disease progression|3|||
155288847|NCT00906698|560490354|FG001|Overall Study|Disease progression|12|||
155288848|NCT00906698|560490355|FG002|Overall Study|Disease progression|4|||
155288849|NCT00906698|560490356|FG003|Overall Study|Disease progression|4|||
155288850|NCT00906698|560490357|FG004|Overall Study|Disease progression|12|||
155288851|NCT00906698|560490358|FG005|Overall Study|Disease progression|4|||
155288852|NCT00906698|560490353|FG000|Overall Study|Withdrawal by Subject|0|||
155638081|NCT02225587|561766372|FG001|Overall Study|Withdrawal by Subject|28|||
155638082|NCT04063163|561766373|FG000|Overall Study|Death|281|||
155638083|NCT04063163|561766374|FG001|Overall Study|Death|166|||
155638084|NCT04063163|561766373|FG000|Overall Study|Lost to Follow-up|12|||
155638085|NCT04063163|561766374|FG001|Overall Study|Lost to Follow-up|8|||
155288853|NCT00906698|560490354|FG001|Overall Study|Withdrawal by Subject|0|||
155288854|NCT00906698|560490355|FG002|Overall Study|Withdrawal by Subject|0|||
155288855|NCT00906698|560490356|FG003|Overall Study|Withdrawal by Subject|0|||
155288856|NCT00906698|560490357|FG004|Overall Study|Withdrawal by Subject|1|||
155288857|NCT00906698|560490358|FG005|Overall Study|Withdrawal by Subject|0|||
155288858|NCT00906698|560490353|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
155288859|NCT00906698|560490354|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
155288860|NCT00906698|560490355|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
155288861|NCT00906698|560490356|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
155288862|NCT00906698|560490357|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
155288863|NCT00906698|560490358|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
155288864|NCT01250002|560490359|FG000|Overall Study|Change to open surgical procedure|4|||
155288865|NCT01250002|560490360|FG001|Overall Study|Change to open surgical procedure|3|||
155288866|NCT00567164|560490374|FG000|Overall Study|Withdrawal by Subject|171|||
155288867|NCT00567164|560490375|FG001|Overall Study|Withdrawal by Subject|21|||
155288868|NCT00567164|560490376|FG002|Overall Study|Withdrawal by Subject|17|||
155288869|NCT00567164|560490374|FG000|Overall Study|Protocol Violation|23|||
155288870|NCT00567164|560490375|FG001|Overall Study|Protocol Violation|4|||
155288871|NCT00567164|560490376|FG002|Overall Study|Protocol Violation|2|||
155288872|NCT00567164|560490374|FG000|Overall Study|Adverse Event|92|||
155288873|NCT00567164|560490375|FG001|Overall Study|Adverse Event|13|||
155288874|NCT00567164|560490376|FG002|Overall Study|Adverse Event|9|||
155288875|NCT00567164|560490374|FG000|Overall Study|Death|0|||
155288876|NCT00567164|560490375|FG001|Overall Study|Death|0|||
155288877|NCT00567164|560490376|FG002|Overall Study|Death|1|||
155288878|NCT00567164|560490374|FG000|Overall Study|Lost to Follow-up|202|||
155288879|NCT00567164|560490375|FG001|Overall Study|Lost to Follow-up|23|||
155288880|NCT00567164|560490376|FG002|Overall Study|Lost to Follow-up|21|||
155288881|NCT00567164|560490374|FG000|Overall Study|Pregnancy|20|||
155288882|NCT00567164|560490375|FG001|Overall Study|Pregnancy|4|||
155288883|NCT00567164|560490376|FG002|Overall Study|Pregnancy|6|||
155288884|NCT00567164|560490374|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
155288885|NCT00567164|560490375|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
155288886|NCT00567164|560490376|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
155288887|NCT00567164|560490374|FG000|Overall Study|Missing|1|||
155288888|NCT00567164|560490375|FG001|Overall Study|Missing|0|||
155288889|NCT00567164|560490376|FG002|Overall Study|Missing|0|||
155288890|NCT00001575|560490377|FG000|Overall Study|Screening failures-Ph I portion|22|||
155288891|NCT00001575|560490377|FG000|Overall Study|Withdrawn/deaths|23|||
155288892|NCT03256344|560490378|FG000|Overall Study|Death|6|||
155288893|NCT03256344|560490379|FG001|Overall Study|Death|22|||
155288894|NCT03256344|560490378|FG000|Overall Study|Withdrawal by Subject|3|||
155288895|NCT03256344|560490379|FG001|Overall Study|Withdrawal by Subject|3|||
155288896|NCT03256344|560490378|FG000|Overall Study|Sponsor Decision|1|||
155288897|NCT03256344|560490379|FG001|Overall Study|Sponsor Decision|0|||
155288898|NCT00404079|560490380|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
155288899|NCT00404079|560490381|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
155288900|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Other|4|||
155288901|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Other|0|||
155288902|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
155288903|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
155288904|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
155288905|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
155288906|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
155288907|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
155288908|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
155288909|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
155288910|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
155288911|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
155288912|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
155638086|NCT04063163|561766373|FG000|Overall Study|Withdrawal by Subject|19|||
155408170|NCT01225731|560927334|FG002|Part 2|Protocol Violation|0|||
155408171|NCT01225731|560927335|FG003|Part 2|Protocol Violation|0|||
155408172|NCT01225731|560927336|FG004|Part 2|Protocol Violation|0|||
155408173|NCT01225731|560927337|FG005|Part 2|Protocol Violation|1|||
155408174|NCT01225731|560927338|FG006|Part 2|Protocol Violation|0|||
155408175|NCT01225731|560927339|FG007|Part 2|Protocol Violation|0|||
155408176|NCT01225731|560927340|FG008|Part 2|Protocol Violation|1|||
155408177|NCT01225731|560927341|FG009|Part 2|Protocol Violation|0|||
155408178|NCT01225731|560927342|FG010|Part 2|Protocol Violation|0|||
155408179|NCT01225731|560927343|FG011|Part 2|Protocol Violation|0|||
155408180|NCT01225731|560927344|FG012|Part 2|Protocol Violation|0|||
155408181|NCT01225731|560927332|FG000|Part 2|Adverse Event|0|||
155408182|NCT01225731|560927333|FG001|Part 2|Adverse Event|0|||
155408183|NCT01225731|560927334|FG002|Part 2|Adverse Event|0|||
155408184|NCT01225731|560927335|FG003|Part 2|Adverse Event|0|||
155408185|NCT01225731|560927336|FG004|Part 2|Adverse Event|0|||
155408186|NCT01225731|560927337|FG005|Part 2|Adverse Event|0|||
155408187|NCT01225731|560927338|FG006|Part 2|Adverse Event|4|||
155408188|NCT01225731|560927339|FG007|Part 2|Adverse Event|4|||
155408189|NCT01225731|560927340|FG008|Part 2|Adverse Event|2|||
155408190|NCT01225731|560927341|FG009|Part 2|Adverse Event|0|||
155408191|NCT01225731|560927342|FG010|Part 2|Adverse Event|0|||
155408192|NCT01225731|560927343|FG011|Part 2|Adverse Event|0|||
155408193|NCT01225731|560927344|FG012|Part 2|Adverse Event|0|||
155408194|NCT01225731|560927332|FG000|Part 2|Lack of Efficacy|0|||
155408195|NCT01225731|560927333|FG001|Part 2|Lack of Efficacy|0|||
155408196|NCT01225731|560927334|FG002|Part 2|Lack of Efficacy|0|||
155408197|NCT01225731|560927335|FG003|Part 2|Lack of Efficacy|0|||
155408198|NCT01225731|560927336|FG004|Part 2|Lack of Efficacy|0|||
155408199|NCT01225731|560927337|FG005|Part 2|Lack of Efficacy|1|||
155408200|NCT01225731|560927338|FG006|Part 2|Lack of Efficacy|0|||
155408201|NCT01225731|560927339|FG007|Part 2|Lack of Efficacy|12|||
155408202|NCT01225731|560927340|FG008|Part 2|Lack of Efficacy|3|||
155408203|NCT01225731|560927341|FG009|Part 2|Lack of Efficacy|0|||
155408204|NCT01225731|560927342|FG010|Part 2|Lack of Efficacy|0|||
155408205|NCT01225731|560927343|FG011|Part 2|Lack of Efficacy|0|||
155408206|NCT01225731|560927344|FG012|Part 2|Lack of Efficacy|0|||
155408207|NCT01225731|560927332|FG000|Part 2|Pregnancy|0|||
155408208|NCT01225731|560927333|FG001|Part 2|Pregnancy|0|||
155408209|NCT01225731|560927334|FG002|Part 2|Pregnancy|0|||
155408210|NCT01225731|560927335|FG003|Part 2|Pregnancy|0|||
155408211|NCT01225731|560927336|FG004|Part 2|Pregnancy|0|||
155408212|NCT01225731|560927337|FG005|Part 2|Pregnancy|0|||
155408213|NCT01225731|560927338|FG006|Part 2|Pregnancy|1|||
155408214|NCT01225731|560927339|FG007|Part 2|Pregnancy|0|||
155408215|NCT01225731|560927340|FG008|Part 2|Pregnancy|1|||
155408216|NCT01225731|560927341|FG009|Part 2|Pregnancy|0|||
155408217|NCT01225731|560927342|FG010|Part 2|Pregnancy|0|||
155408218|NCT01225731|560927343|FG011|Part 2|Pregnancy|0|||
155408219|NCT01225731|560927344|FG012|Part 2|Pregnancy|0|||
155408220|NCT01225731|560927332|FG000|Part 2|Lost to Follow-up|0|||
155408221|NCT01225731|560927333|FG001|Part 2|Lost to Follow-up|0|||
155408222|NCT01225731|560927334|FG002|Part 2|Lost to Follow-up|0|||
155408223|NCT01225731|560927335|FG003|Part 2|Lost to Follow-up|0|||
155408224|NCT01225731|560927336|FG004|Part 2|Lost to Follow-up|0|||
155408225|NCT01225731|560927337|FG005|Part 2|Lost to Follow-up|0|||
155408226|NCT01225731|560927338|FG006|Part 2|Lost to Follow-up|0|||
155408227|NCT01225731|560927339|FG007|Part 2|Lost to Follow-up|3|||
155638087|NCT04063163|561766374|FG001|Overall Study|Withdrawal by Subject|10|||
155638088|NCT02572167|561766377|FG000|Overall Study|Withdrawal by Subject|0|||
155638089|NCT02572167|561766378|FG001|Overall Study|Withdrawal by Subject|3|||
155638090|NCT02572167|561766379|FG002|Overall Study|Withdrawal by Subject|0|||
155638091|NCT02572167|561766377|FG000|Overall Study|Lost to Follow-up|2|||
155638092|NCT02572167|561766378|FG001|Overall Study|Lost to Follow-up|5|||
155638093|NCT02572167|561766379|FG002|Overall Study|Lost to Follow-up|3|||
155638094|NCT02572167|561766377|FG000|Overall Study|Death|0|||
155638095|NCT02572167|561766378|FG001|Overall Study|Death|8|||
155638096|NCT02572167|561766379|FG002|Overall Study|Death|3|||
155638097|NCT02572167|561766377|FG000|Overall Study|Did not meet inclusion criteria|0|||
155638098|NCT02572167|561766378|FG001|Overall Study|Did not meet inclusion criteria|0|||
155638099|NCT02572167|561766379|FG002|Overall Study|Did not meet inclusion criteria|1|||
155638100|NCT02572167|561766377|FG000|Overall Study|Study closure by Sponsor|4|||
155638101|NCT02572167|561766378|FG001|Overall Study|Study closure by Sponsor|40|||
155638102|NCT02572167|561766379|FG002|Overall Study|Study closure by Sponsor|24|||
155408228|NCT01225731|560927340|FG008|Part 2|Lost to Follow-up|1|||
155408229|NCT01225731|560927341|FG009|Part 2|Lost to Follow-up|0|||
155408230|NCT01225731|560927342|FG010|Part 2|Lost to Follow-up|0|||
155408231|NCT01225731|560927343|FG011|Part 2|Lost to Follow-up|0|||
155408232|NCT01225731|560927344|FG012|Part 2|Lost to Follow-up|0|||
155408233|NCT01225731|560927332|FG000|Part 2|Physician Decision|0|||
155408234|NCT01225731|560927333|FG001|Part 2|Physician Decision|0|||
155408235|NCT01225731|560927334|FG002|Part 2|Physician Decision|0|||
155408236|NCT01225731|560927335|FG003|Part 2|Physician Decision|0|||
155408237|NCT01225731|560927336|FG004|Part 2|Physician Decision|0|||
155408238|NCT01225731|560927337|FG005|Part 2|Physician Decision|0|||
155408239|NCT01225731|560927338|FG006|Part 2|Physician Decision|0|||
155288913|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
155288914|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
155288915|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
155288916|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
155288917|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
155288918|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
155288919|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
155288920|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
155288921|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
155288922|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
155288923|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
155288924|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
155288925|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
155288926|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
155288927|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
155288928|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
155288929|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
155288930|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Death|1|||
155288931|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Death|6|||
155288932|NCT00580801|560490394|FG000|Overall Study|Physician Decision|1|||
155288933|NCT00580801|560490395|FG001|Overall Study|Physician Decision|0|||
155288934|NCT00580801|560490396|FG002|Overall Study|Physician Decision|0|||
155288935|NCT00580801|560490394|FG000|Overall Study|Adverse Event|2|||
155288936|NCT00580801|560490395|FG001|Overall Study|Adverse Event|0|||
155288937|NCT00580801|560490396|FG002|Overall Study|Adverse Event|0|||
155288938|NCT00580801|560490394|FG000|Overall Study|Lost to Follow-up|2|||
155288939|NCT00580801|560490395|FG001|Overall Study|Lost to Follow-up|0|||
155288940|NCT00580801|560490396|FG002|Overall Study|Lost to Follow-up|0|||
155288941|NCT00580801|560490394|FG000|Overall Study|Reached a virologic endpoint|0|||
155408240|NCT01225731|560927339|FG007|Part 2|Physician Decision|2|||
155408241|NCT01225731|560927340|FG008|Part 2|Physician Decision|2|||
155408242|NCT01225731|560927341|FG009|Part 2|Physician Decision|0|||
155408243|NCT01225731|560927342|FG010|Part 2|Physician Decision|0|||
155408244|NCT01225731|560927343|FG011|Part 2|Physician Decision|0|||
155408245|NCT01225731|560927344|FG012|Part 2|Physician Decision|0|||
155408246|NCT01225731|560927332|FG000|Part 2|Withdrawal by Subject|0|||
155408247|NCT01225731|560927333|FG001|Part 2|Withdrawal by Subject|0|||
155408248|NCT01225731|560927334|FG002|Part 2|Withdrawal by Subject|0|||
155408249|NCT01225731|560927335|FG003|Part 2|Withdrawal by Subject|0|||
155408250|NCT01225731|560927336|FG004|Part 2|Withdrawal by Subject|0|||
155408251|NCT01225731|560927337|FG005|Part 2|Withdrawal by Subject|1|||
155408252|NCT01225731|560927338|FG006|Part 2|Withdrawal by Subject|3|||
155288942|NCT00580801|560490395|FG001|Overall Study|Reached a virologic endpoint|1|||
155288943|NCT00580801|560490396|FG002|Overall Study|Reached a virologic endpoint|2|||
155288944|NCT00580801|560490394|FG000|Overall Study|Participant non-compliant|0|||
155288945|NCT00580801|560490395|FG001|Overall Study|Participant non-compliant|0|||
155288946|NCT00580801|560490396|FG002|Overall Study|Participant non-compliant|1|||
155288947|NCT00580801|560490394|FG000|Overall Study|Travel|1|||
155288948|NCT00580801|560490395|FG001|Overall Study|Travel|0|||
155288949|NCT00580801|560490396|FG002|Overall Study|Travel|0|||
155288950|NCT01664104|560490397|FG000|Overall Study|Adverse Event|6|||
155288951|NCT01664104|560490397|FG000|Overall Study|Lack of Efficacy|2|||
155288952|NCT01664104|560490397|FG000|Overall Study|Withdrawal by Subject|1|||
155288953|NCT01664104|560490397|FG000|Overall Study|Lost to Follow-up|4|||
155288954|NCT01664104|560490397|FG000|Overall Study|Other|1|||
155288955|NCT01664104|560490397|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
155288956|NCT00559949|560490398|FG000|Overall Study|Progressive Disease during cycle 1|1|||
155288957|NCT00559949|560490398|FG000|Overall Study|Adverse Event|1|||
155288958|NCT00559949|560490398|FG000|Overall Study|Withdrawal by Subject|4|||
155288959|NCT00559949|560490398|FG000|Overall Study|No disease evaluation per protocol|1|||
155408253|NCT01225731|560927339|FG007|Part 2|Withdrawal by Subject|4|||
155408254|NCT01225731|560927340|FG008|Part 2|Withdrawal by Subject|1|||
155288960|NCT02512042|560490399|FG000|Overall Study|Adverse Event|0|||
155408255|NCT01225731|560927341|FG009|Part 2|Withdrawal by Subject|0|||
155408256|NCT01225731|560927342|FG010|Part 2|Withdrawal by Subject|0|||
155288961|NCT02512042|560490400|FG001|Overall Study|Adverse Event|4|||
155288962|NCT02512042|560490399|FG000|Overall Study|Withdrawal by Subject|6|||
155288963|NCT02512042|560490400|FG001|Overall Study|Withdrawal by Subject|6|||
155288964|NCT02512042|560490399|FG000|Overall Study|Non-compliance with study drug|1|||
155408257|NCT01225731|560927343|FG011|Part 2|Withdrawal by Subject|0|||
155408258|NCT01225731|560927344|FG012|Part 2|Withdrawal by Subject|0|||
155408259|NCT01225731|560927332|FG000|Part 3|Adverse Event|0|||
155288965|NCT02512042|560490400|FG001|Overall Study|Non-compliance with study drug|2|||
155288966|NCT02512042|560490399|FG000|Overall Study|Lost to Follow-up|5|||
155408260|NCT01225731|560927333|FG001|Part 3|Adverse Event|0|||
155743304|NCT00913458|562159840|FG003|Phase 3|Non-Responder|0|||
155743305|NCT00913458|562159841|FG004|Phase 3|Non-Responder|0|||
155288967|NCT02512042|560490400|FG001|Overall Study|Lost to Follow-up|2|||
155288968|NCT02512042|560490399|FG000|Overall Study|Other|11|||
155288969|NCT02512042|560490400|FG001|Overall Study|Other|11|||
155288970|NCT01194258|560490406|FG000|Titration Period|Withdrawal by Subject|6|||
155288971|NCT01194258|560490407|FG001|Titration Period|Withdrawal by Subject|0|||
155288972|NCT01194258|560490408|FG002|Titration Period|Withdrawal by Subject|0|||
155288973|NCT01194258|560490409|FG003|Titration Period|Withdrawal by Subject|0|||
155288974|NCT01194258|560490410|FG004|Titration Period|Withdrawal by Subject|0|||
155743306|NCT00913458|562159842|FG005|Phase 3|Non-Responder|1|||
155743307|NCT00913458|562159843|FG006|Phase 3|Non-Responder|3|||
155743308|NCT00913458|562159837|FG000|Phase 3|Withdrawal by Subject|0|||
155743309|NCT00913458|562159838|FG001|Phase 3|Withdrawal by Subject|0|||
155743310|NCT00913458|562159839|FG002|Phase 3|Withdrawal by Subject|0|||
155743311|NCT00913458|562159840|FG003|Phase 3|Withdrawal by Subject|0|||
155288975|NCT01194258|560490406|FG000|Titration Period|Lost to Follow-up|2|||
155288976|NCT01194258|560490407|FG001|Titration Period|Lost to Follow-up|0|||
155288977|NCT01194258|560490408|FG002|Titration Period|Lost to Follow-up|0|||
155288978|NCT01194258|560490409|FG003|Titration Period|Lost to Follow-up|0|||
155288979|NCT01194258|560490410|FG004|Titration Period|Lost to Follow-up|0|||
155288980|NCT01194258|560490406|FG000|Titration Period|Titration failure|3|||
155288981|NCT01194258|560490407|FG001|Titration Period|Titration failure|0|||
155288982|NCT01194258|560490408|FG002|Titration Period|Titration failure|0|||
155288983|NCT01194258|560490409|FG003|Titration Period|Titration failure|0|||
155288984|NCT01194258|560490410|FG004|Titration Period|Titration failure|0|||
155288985|NCT01194258|560490406|FG000|Period 1 (12 Weeks)|Death|0|||
155288986|NCT01194258|560490407|FG001|Period 1 (12 Weeks)|Death|0|||
155408261|NCT01225731|560927334|FG002|Part 3|Adverse Event|0|||
155408262|NCT01225731|560927335|FG003|Part 3|Adverse Event|0|||
155408263|NCT01225731|560927336|FG004|Part 3|Adverse Event|0|||
155408264|NCT01225731|560927337|FG005|Part 3|Adverse Event|0|||
155408265|NCT01225731|560927338|FG006|Part 3|Adverse Event|0|||
155408266|NCT01225731|560927339|FG007|Part 3|Adverse Event|0|||
155408267|NCT01225731|560927340|FG008|Part 3|Adverse Event|0|||
155408268|NCT01225731|560927341|FG009|Part 3|Adverse Event|0|||
155408269|NCT01225731|560927342|FG010|Part 3|Adverse Event|1|||
155408270|NCT01225731|560927343|FG011|Part 3|Adverse Event|1|||
155408271|NCT01225731|560927344|FG012|Part 3|Adverse Event|0|||
155408272|NCT01225731|560927332|FG000|Part 3|Lost to Follow-up|0|||
155408273|NCT01225731|560927333|FG001|Part 3|Lost to Follow-up|0|||
155408274|NCT01225731|560927334|FG002|Part 3|Lost to Follow-up|0|||
155408275|NCT01225731|560927335|FG003|Part 3|Lost to Follow-up|0|||
155408276|NCT01225731|560927336|FG004|Part 3|Lost to Follow-up|0|||
155408277|NCT01225731|560927337|FG005|Part 3|Lost to Follow-up|0|||
155408278|NCT01225731|560927338|FG006|Part 3|Lost to Follow-up|0|||
155408279|NCT01225731|560927339|FG007|Part 3|Lost to Follow-up|0|||
155408280|NCT01225731|560927340|FG008|Part 3|Lost to Follow-up|0|||
155408281|NCT01225731|560927341|FG009|Part 3|Lost to Follow-up|0|||
155408282|NCT01225731|560927342|FG010|Part 3|Lost to Follow-up|1|||
155408283|NCT01225731|560927343|FG011|Part 3|Lost to Follow-up|2|||
155408284|NCT01225731|560927344|FG012|Part 3|Lost to Follow-up|1|||
155408285|NCT01225731|560927332|FG000|Part 3|Physician Decision|0|||
155408286|NCT01225731|560927333|FG001|Part 3|Physician Decision|0|||
155408287|NCT01225731|560927334|FG002|Part 3|Physician Decision|0|||
155408288|NCT01225731|560927335|FG003|Part 3|Physician Decision|0|||
155408289|NCT01225731|560927336|FG004|Part 3|Physician Decision|0|||
155408290|NCT01225731|560927337|FG005|Part 3|Physician Decision|0|||
155408291|NCT01225731|560927338|FG006|Part 3|Physician Decision|0|||
155408292|NCT01225731|560927339|FG007|Part 3|Physician Decision|0|||
155408293|NCT01225731|560927340|FG008|Part 3|Physician Decision|0|||
155408294|NCT01225731|560927341|FG009|Part 3|Physician Decision|0|||
155408295|NCT01225731|560927342|FG010|Part 3|Physician Decision|0|||
155408296|NCT01225731|560927343|FG011|Part 3|Physician Decision|1|||
155408297|NCT01225731|560927344|FG012|Part 3|Physician Decision|2|||
155408298|NCT01225731|560927332|FG000|Part 3|Withdrawal by Subject|0|||
155408299|NCT01225731|560927333|FG001|Part 3|Withdrawal by Subject|0|||
155288987|NCT01194258|560490408|FG002|Period 1 (12 Weeks)|Death|0|||
155288988|NCT01194258|560490409|FG003|Period 1 (12 Weeks)|Death|0|||
155288989|NCT01194258|560490410|FG004|Period 1 (12 Weeks)|Death|1|||
155288990|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288991|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155408300|NCT01225731|560927334|FG002|Part 3|Withdrawal by Subject|0|||
155408301|NCT01225731|560927335|FG003|Part 3|Withdrawal by Subject|0|||
155408302|NCT01225731|560927336|FG004|Part 3|Withdrawal by Subject|0|||
155408303|NCT01225731|560927337|FG005|Part 3|Withdrawal by Subject|0|||
155288992|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288993|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155408304|NCT01225731|560927338|FG006|Part 3|Withdrawal by Subject|0|||
155408305|NCT01225731|560927339|FG007|Part 3|Withdrawal by Subject|0|||
155408306|NCT01225731|560927340|FG008|Part 3|Withdrawal by Subject|0|||
155408307|NCT01225731|560927341|FG009|Part 3|Withdrawal by Subject|0|||
155743312|NCT00913458|562159841|FG004|Phase 3|Withdrawal by Subject|1|||
155743313|NCT00913458|562159842|FG005|Phase 3|Withdrawal by Subject|2|||
155408308|NCT01225731|560927342|FG010|Part 3|Withdrawal by Subject|4|||
155408309|NCT01225731|560927343|FG011|Part 3|Withdrawal by Subject|6|||
155408310|NCT01225731|560927344|FG012|Part 3|Withdrawal by Subject|4|||
155408311|NCT00577642|560927345|FG000|Overall Study|Clinical Disease Progression|1|||
155408312|NCT01505634|560927351|FG000|Overall Study|Withdrawal by Subject|2|||
155408313|NCT01505634|560927352|FG001|Overall Study|Withdrawal by Subject|5|||
155408314|NCT01505634|560927353|FG002|Overall Study|Withdrawal by Subject|1|||
155408315|NCT01505634|560927351|FG000|Overall Study|Physician Decision|1|||
155408316|NCT01505634|560927352|FG001|Overall Study|Physician Decision|1|||
155408317|NCT01505634|560927353|FG002|Overall Study|Physician Decision|0|||
155408318|NCT01505634|560927351|FG000|Overall Study|Adverse Event|1|||
155408319|NCT01505634|560927352|FG001|Overall Study|Adverse Event|0|||
155408320|NCT01505634|560927353|FG002|Overall Study|Adverse Event|0|||
155408321|NCT01505634|560927351|FG000|Overall Study|Insufficient supply of drug at site|1|||
155408322|NCT01505634|560927352|FG001|Overall Study|Insufficient supply of drug at site|0|||
155408323|NCT01505634|560927353|FG002|Overall Study|Insufficient supply of drug at site|0|||
155408324|NCT01505634|560927351|FG000|Overall Study|Protocol Violation|2|||
155408325|NCT01505634|560927352|FG001|Overall Study|Protocol Violation|0|||
155408326|NCT01505634|560927353|FG002|Overall Study|Protocol Violation|0|||
155408327|NCT01505634|560927351|FG000|Overall Study|Lost to Follow-up|1|||
155408328|NCT01505634|560927352|FG001|Overall Study|Lost to Follow-up|4|||
155408329|NCT01505634|560927353|FG002|Overall Study|Lost to Follow-up|4|||
155408330|NCT01505634|560927351|FG000|Overall Study|Death|1|||
155408331|NCT01505634|560927352|FG001|Overall Study|Death|0|||
155408332|NCT01505634|560927353|FG002|Overall Study|Death|0|||
155408333|NCT01505634|560927351|FG000|Overall Study|In a conflict zone|0|||
155408334|NCT01505634|560927352|FG001|Overall Study|In a conflict zone|0|||
155408335|NCT01505634|560927353|FG002|Overall Study|In a conflict zone|1|||
155408336|NCT00542269|560927357|FG000|Overall Study|Adverse Event|10|||
155408337|NCT00542269|560927358|FG001|Overall Study|Adverse Event|4|||
155408338|NCT00542269|560927359|FG002|Overall Study|Adverse Event|5|||
155408339|NCT00542269|560927357|FG000|Overall Study|Protocol Violation|1|||
155408340|NCT00542269|560927358|FG001|Overall Study|Protocol Violation|1|||
155408341|NCT00542269|560927359|FG002|Overall Study|Protocol Violation|0|||
155408342|NCT00542269|560927357|FG000|Overall Study|Withdrawal by Subject|1|||
155408343|NCT00542269|560927358|FG001|Overall Study|Withdrawal by Subject|0|||
155408344|NCT00542269|560927359|FG002|Overall Study|Withdrawal by Subject|0|||
155408345|NCT00542269|560927357|FG000|Overall Study|Administrative problems|1|||
155408346|NCT00542269|560927358|FG001|Overall Study|Administrative problems|1|||
155408347|NCT00542269|560927359|FG002|Overall Study|Administrative problems|1|||
155408348|NCT03873714|560927360|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
155408349|NCT00814892|560927361|FG000|Overall Study|Disease Progression|1|||
155408350|NCT00814892|560927361|FG000|Overall Study|Study Termination|1|||
155408351|NCT00845650|560927362|FG000|Overall Study|Withdrawal by Subject|0|||
155408352|NCT00845650|560927363|FG001|Overall Study|Withdrawal by Subject|0|||
155408353|NCT00845650|560927364|FG002|Overall Study|Withdrawal by Subject|0|||
155408354|NCT00845650|560927365|FG003|Overall Study|Withdrawal by Subject|0|||
155408355|NCT00845650|560927366|FG004|Overall Study|Withdrawal by Subject|2|||
155408356|NCT00845650|560927367|FG005|Overall Study|Withdrawal by Subject|0|||
155408357|NCT00845650|560927362|FG000|Overall Study|Lost to Follow-up|0|||
155408358|NCT00845650|560927363|FG001|Overall Study|Lost to Follow-up|0|||
155408359|NCT00845650|560927364|FG002|Overall Study|Lost to Follow-up|3|||
155408360|NCT00845650|560927365|FG003|Overall Study|Lost to Follow-up|1|||
155408361|NCT00845650|560927366|FG004|Overall Study|Lost to Follow-up|0|||
155408362|NCT00845650|560927367|FG005|Overall Study|Lost to Follow-up|1|||
155408363|NCT00845650|560927362|FG000|Overall Study|Sponsor hold on dosing|0|||
155408364|NCT00845650|560927363|FG001|Overall Study|Sponsor hold on dosing|0|||
155408365|NCT00845650|560927364|FG002|Overall Study|Sponsor hold on dosing|0|||
155408366|NCT00845650|560927365|FG003|Overall Study|Sponsor hold on dosing|0|||
155408367|NCT00845650|560927366|FG004|Overall Study|Sponsor hold on dosing|1|||
155408368|NCT00845650|560927367|FG005|Overall Study|Sponsor hold on dosing|1|||
155288994|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
155288995|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
155288996|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
155408369|NCT00845650|560927362|FG000|Overall Study|Unable to access IV line|1|||
155408370|NCT00845650|560927363|FG001|Overall Study|Unable to access IV line|0|||
155408371|NCT00845650|560927364|FG002|Overall Study|Unable to access IV line|0|||
155408372|NCT00845650|560927365|FG003|Overall Study|Unable to access IV line|0|||
155408373|NCT00845650|560927366|FG004|Overall Study|Unable to access IV line|0|||
155408374|NCT00845650|560927367|FG005|Overall Study|Unable to access IV line|0|||
155408375|NCT00531752|560927371|FG000|First Double-blind Intervention Period|Adverse Event|2|||
155408376|NCT00531752|560927372|FG001|First Double-blind Intervention Period|Adverse Event|0|||
155408377|NCT00531752|560927373|FG002|First Double-blind Intervention Period|Adverse Event|1|||
155408378|NCT00531752|560927374|FG003|First Double-blind Intervention Period|Adverse Event|1|||
155408379|NCT00531752|560927371|FG000|First Double-blind Intervention Period|Other|1|||
155288997|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
155408380|NCT00531752|560927372|FG001|First Double-blind Intervention Period|Other|4|||
155288998|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
155288999|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
155289000|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289001|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155289002|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155289003|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289004|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289005|NCT00121199|560490418|FG000|Overall Study|Adverse Event|11|||
155289006|NCT00121199|560490418|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155289007|NCT00121199|560490418|FG000|Overall Study|Progression/Relapse|1|||
155289008|NCT00121199|560490418|FG000|Overall Study|Death|3|||
155289009|NCT00121199|560490418|FG000|Overall Study|Other - Not Protocol Specified|3|||
155289010|NCT00121199|560490418|FG000|Overall Study|Ineligible|9|||
155289011|NCT02824432|560490422|FG000|Overall Study|Major Protocol Deviation|1|||
155289012|NCT02824432|560490423|FG001|Overall Study|Major Protocol Deviation|0|||
155289013|NCT00117988|560490427|FG000|Overall Study|Death|3|||
155289014|NCT00117988|560490427|FG000|Overall Study|Adverse Event|1|||
155289015|NCT03563053|560490428|FG000|Overall Study|Withdrawal by Subject|17|||
155289016|NCT03563053|560490428|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
155289017|NCT03563053|560490428|FG000|Overall Study|Adverse Event|3|||
155289018|NCT03563053|560490428|FG000|Overall Study|Physician Decision|1|||
155289019|NCT03563053|560490428|FG000|Overall Study|study terminated by sponsor|71|||
155289020|NCT00124982|560490429|FG000|Short-term Period|Death|1|||
155289021|NCT00124982|560490430|FG001|Short-term Period|Death|1|||
155289022|NCT00124982|560490431|FG002|Short-term Period|Death|0|||
155289023|NCT00124982|560490429|FG000|Short-term Period|Adverse Event|17|||
155289024|NCT00124982|560490430|FG001|Short-term Period|Adverse Event|22|||
155289025|NCT00124982|560490431|FG002|Short-term Period|Adverse Event|0|||
155289026|NCT00124982|560490429|FG000|Short-term Period|Lack of Efficacy|32|||
155289027|NCT00124982|560490430|FG001|Short-term Period|Lack of Efficacy|73|||
155289028|NCT00124982|560490431|FG002|Short-term Period|Lack of Efficacy|0|||
155289029|NCT00124982|560490429|FG000|Short-term Period|Lost to Follow-up|8|||
155289030|NCT00124982|560490430|FG001|Short-term Period|Lost to Follow-up|5|||
155289031|NCT00124982|560490431|FG002|Short-term Period|Lost to Follow-up|0|||
155289032|NCT00124982|560490429|FG000|Short-term Period|Withdrawal of Consent|7|||
155289033|NCT00124982|560490430|FG001|Short-term Period|Withdrawal of Consent|9|||
155289034|NCT00124982|560490431|FG002|Short-term Period|Withdrawal of Consent|0|||
155289035|NCT00124982|560490429|FG000|Short-term Period|Poor/Non-compliance|3|||
155289036|NCT00124982|560490430|FG001|Short-term Period|Poor/Non-compliance|1|||
155289037|NCT00124982|560490431|FG002|Short-term Period|Poor/Non-compliance|0|||
155289038|NCT00124982|560490429|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
155289039|NCT00124982|560490430|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
155289040|NCT00124982|560490431|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
155289041|NCT00124982|560490429|FG000|Short-term Period|Participant Decision|1|||
155289042|NCT00124982|560490430|FG001|Short-term Period|Participant Decision|0|||
155289043|NCT00124982|560490431|FG002|Short-term Period|Participant Decision|0|||
155289044|NCT00124982|560490429|FG000|Short-term Period|Participant Chose Own Doctor|0|||
155289045|NCT00124982|560490430|FG001|Short-term Period|Participant Chose Own Doctor|1|||
155289046|NCT00124982|560490431|FG002|Short-term Period|Participant Chose Own Doctor|0|||
155289047|NCT00124982|560490429|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
155289048|NCT00124982|560490430|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
155289049|NCT00124982|560490431|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
155289050|NCT00124982|560490429|FG000|Short-term Period|Participant Had Lymphopenia|1|||
155289051|NCT00124982|560490430|FG001|Short-term Period|Participant Had Lymphopenia|0|||
155289052|NCT00124982|560490431|FG002|Short-term Period|Participant Had Lymphopenia|0|||
155289053|NCT00124982|560490429|FG000|Long-term Period|Death|0|||
155289054|NCT00124982|560490430|FG001|Long-term Period|Death|0|||
155289055|NCT00124982|560490431|FG002|Long-term Period|Death|1|||
155289056|NCT00124982|560490429|FG000|Long-term Period|Adverse Event|0|||
155289057|NCT00124982|560490430|FG001|Long-term Period|Adverse Event|0|||
155289058|NCT00124982|560490431|FG002|Long-term Period|Adverse Event|17|||
155289059|NCT00124982|560490429|FG000|Long-term Period|Lack of Efficacy|0|||
155289060|NCT00124982|560490430|FG001|Long-term Period|Lack of Efficacy|0|||
155289061|NCT00124982|560490431|FG002|Long-term Period|Lack of Efficacy|46|||
155289062|NCT00124982|560490429|FG000|Long-term Period|Lost to Follow-up|0|||
155289063|NCT00124982|560490430|FG001|Long-term Period|Lost to Follow-up|0|||
155289064|NCT00124982|560490431|FG002|Long-term Period|Lost to Follow-up|4|||
155289065|NCT00124982|560490429|FG000|Long-term Period|Withdrawal by Subject|0|||
155289066|NCT00124982|560490430|FG001|Long-term Period|Withdrawal by Subject|0|||
155289067|NCT00124982|560490431|FG002|Long-term Period|Withdrawal by Subject|16|||
155289068|NCT00124982|560490429|FG000|Long-term Period|Pregnancy|0|||
155289069|NCT00124982|560490430|FG001|Long-term Period|Pregnancy|0|||
155289070|NCT00124982|560490431|FG002|Long-term Period|Pregnancy|1|||
155289071|NCT00124982|560490429|FG000|Long-term Period|Poor/Non-compliance|0|||
155289072|NCT00124982|560490430|FG001|Long-term Period|Poor/Non-compliance|0|||
155289073|NCT00124982|560490431|FG002|Long-term Period|Poor/Non-compliance|2|||
155638103|NCT00580840|561766380|FG000|Run-in|Adverse Event|17|||
155408381|NCT00531752|560927373|FG002|First Double-blind Intervention Period|Other|4|||
155408382|NCT00531752|560927374|FG003|First Double-blind Intervention Period|Other|0|||
155408383|NCT00531752|560927371|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
155408384|NCT00531752|560927372|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
155408385|NCT00531752|560927373|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
155408386|NCT00531752|560927374|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
155408387|NCT00531752|560927371|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
155408388|NCT00531752|560927372|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
155408389|NCT00531752|560927373|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
155408390|NCT00531752|560927374|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
155408391|NCT00531752|560927371|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
155408392|NCT00531752|560927372|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
155408393|NCT00531752|560927373|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
155408394|NCT00531752|560927374|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
155408395|NCT00531752|560927371|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
155408396|NCT00531752|560927372|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
155408397|NCT00531752|560927373|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
155408398|NCT00531752|560927374|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
155408399|NCT00531752|560927371|FG000|Second Double-blind Intervention Period|Other|1|||
155408400|NCT00531752|560927372|FG001|Second Double-blind Intervention Period|Other|1|||
155408401|NCT00531752|560927373|FG002|Second Double-blind Intervention Period|Other|0|||
155408402|NCT00531752|560927374|FG003|Second Double-blind Intervention Period|Other|0|||
155408403|NCT00531752|560927371|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155408404|NCT00531752|560927372|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155408405|NCT00531752|560927373|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155408406|NCT00531752|560927374|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
155408407|NCT00531752|560927371|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
155408408|NCT00531752|560927372|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
155408409|NCT00531752|560927373|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
155408410|NCT00531752|560927374|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
155408411|NCT01181011|560927375|FG000|Overall Study|Adverse Event|2|||
155408412|NCT01181011|560927375|FG000|Overall Study|Lost to Follow-up|1|||
155408413|NCT00950664|560927376|FG000|First Intervention|Lost to Follow-up|1|||
155408414|NCT00950664|560927377|FG001|First Intervention|Lost to Follow-up|3|||
155408415|NCT00950664|560927376|FG000|First Intervention|Withdrawal by Subject|2|||
155408416|NCT00950664|560927377|FG001|First Intervention|Withdrawal by Subject|2|||
155408417|NCT00677014|560927378|FG000|Overall Study|Lost to Follow-up|20|||
155408418|NCT00677014|560927379|FG001|Overall Study|Lost to Follow-up|12|||
155408419|NCT00677014|560927380|FG002|Overall Study|Lost to Follow-up|24|||
155408420|NCT00677014|560927378|FG000|Overall Study|Death|6|||
155408421|NCT00677014|560927379|FG001|Overall Study|Death|15|||
155408422|NCT00677014|560927380|FG002|Overall Study|Death|7|||
155408423|NCT00677014|560927378|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
155408424|NCT00677014|560927379|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
155408425|NCT00677014|560927380|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
155408426|NCT01326546|560927381|FG000|Overall Study|Lost to Follow-up|8|||
155408427|NCT01326546|560927382|FG001|Overall Study|Lost to Follow-up|7|||
155408428|NCT01326546|560927381|FG000|Overall Study|Protocol Violation|3|||
155408429|NCT01326546|560927382|FG001|Overall Study|Protocol Violation|4|||
155408430|NCT01326546|560927381|FG000|Overall Study|Pregnancy|0|||
155408431|NCT01326546|560927382|FG001|Overall Study|Pregnancy|1|||
155408432|NCT01326546|560927381|FG000|Overall Study|Adverse Event|1|||
155408433|NCT01326546|560927382|FG001|Overall Study|Adverse Event|0|||
155408434|NCT01326546|560927381|FG000|Overall Study|Withdrawal by Subject|5|||
155408435|NCT01326546|560927382|FG001|Overall Study|Withdrawal by Subject|1|||
155408436|NCT03152019|560927383|FG000|Overall Study|Adverse Event|0|||
155408437|NCT03152019|560927384|FG001|Overall Study|Adverse Event|1|||
155408438|NCT00081159|560927387|FG000|Overall Study|Withdrawal by Subject|0|||
155408439|NCT00081159|560927388|FG001|Overall Study|Withdrawal by Subject|3|||
155408440|NCT00081159|560927387|FG000|Overall Study|Myelosuppression prior to treatment|0|||
155408441|NCT00081159|560927388|FG001|Overall Study|Myelosuppression prior to treatment|1|||
155408442|NCT00081159|560927387|FG000|Overall Study|Lost to Follow-up|2|||
155408443|NCT00081159|560927388|FG001|Overall Study|Lost to Follow-up|1|||
155408444|NCT03693625|560927389|FG000|Overall Study|Adverse Event|2|||
155408445|NCT03693625|560927390|FG001|Overall Study|Adverse Event|0|||
155408446|NCT03693625|560927389|FG000|Overall Study|Study Terminated By Sponsor|20|||
155408447|NCT03693625|560927390|FG001|Overall Study|Study Terminated By Sponsor|7|||
155743314|NCT00913458|562159843|FG006|Phase 3|Withdrawal by Subject|0|||
155408448|NCT03693625|560927389|FG000|Overall Study|Withdrawal by Subject|1|||
155408449|NCT03693625|560927390|FG001|Overall Study|Withdrawal by Subject|1|||
155408450|NCT01883635|560927392|FG000|Overall Study|Withdrawal by Subject|4|||
155408451|NCT01883635|560927393|FG001|Overall Study|Withdrawal by Subject|0|||
155289074|NCT00124982|560490429|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
155289075|NCT00124982|560490430|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
155289076|NCT00124982|560490431|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
155289077|NCT00124982|560490429|FG000|Long-term Period|Neurologist Recommendation|0|||
155289078|NCT00124982|560490430|FG001|Long-term Period|Neurologist Recommendation|0|||
155289079|NCT00124982|560490431|FG002|Long-term Period|Neurologist Recommendation|1|||
155289080|NCT01137292|560490432|FG000|Overall Study|Death|30|||
155289081|NCT01137292|560490432|FG000|Overall Study|Adverse Event|3|||
155289082|NCT01137292|560490432|FG000|Overall Study|Lack of Efficacy|13|||
155289083|NCT01137292|560490432|FG000|Overall Study|Lost to Follow-up|1|||
155289084|NCT01137292|560490432|FG000|Overall Study|Other|7|||
155289085|NCT01311713|560490435|FG000|Overall Study|Death|0|||
155289086|NCT01311713|560490436|FG001|Overall Study|Death|0|||
155289087|NCT01311713|560490437|FG002|Overall Study|Death|1|||
155289088|NCT01311713|560490438|FG003|Overall Study|Death|1|||
155289089|NCT01311713|560490439|FG004|Overall Study|Death|0|||
155289090|NCT01311713|560490440|FG005|Overall Study|Death|1|||
155289091|NCT01311713|560490441|FG006|Overall Study|Death|0|||
155289092|NCT01311713|560490435|FG000|Overall Study|Adverse Event|0|||
155289093|NCT01311713|560490436|FG001|Overall Study|Adverse Event|1|||
155289094|NCT01311713|560490437|FG002|Overall Study|Adverse Event|0|||
155289095|NCT01311713|560490438|FG003|Overall Study|Adverse Event|2|||
155289096|NCT01311713|560490439|FG004|Overall Study|Adverse Event|0|||
155289097|NCT01311713|560490440|FG005|Overall Study|Adverse Event|0|||
155289098|NCT01311713|560490441|FG006|Overall Study|Adverse Event|2|||
155289099|NCT01311713|560490435|FG000|Overall Study|Withdrawal by Subject|0|||
155289100|NCT01311713|560490436|FG001|Overall Study|Withdrawal by Subject|1|||
155289101|NCT01311713|560490437|FG002|Overall Study|Withdrawal by Subject|1|||
155289102|NCT01311713|560490438|FG003|Overall Study|Withdrawal by Subject|0|||
155289103|NCT01311713|560490439|FG004|Overall Study|Withdrawal by Subject|0|||
155289104|NCT01311713|560490440|FG005|Overall Study|Withdrawal by Subject|1|||
155289105|NCT01311713|560490441|FG006|Overall Study|Withdrawal by Subject|2|||
155289106|NCT01311713|560490435|FG000|Overall Study|Disease progression|3|||
155289107|NCT01311713|560490436|FG001|Overall Study|Disease progression|4|||
155289108|NCT01311713|560490437|FG002|Overall Study|Disease progression|3|||
155289109|NCT01311713|560490438|FG003|Overall Study|Disease progression|2|||
155289110|NCT01311713|560490439|FG004|Overall Study|Disease progression|4|||
155289111|NCT01311713|560490440|FG005|Overall Study|Disease progression|4|||
155289112|NCT01311713|560490441|FG006|Overall Study|Disease progression|5|||
155289113|NCT01311713|560490435|FG000|Overall Study|Lost to Follow-up|0|||
155289114|NCT01311713|560490436|FG001|Overall Study|Lost to Follow-up|0|||
155289115|NCT01311713|560490437|FG002|Overall Study|Lost to Follow-up|1|||
155289116|NCT01311713|560490438|FG003|Overall Study|Lost to Follow-up|0|||
155289117|NCT01311713|560490439|FG004|Overall Study|Lost to Follow-up|0|||
155289118|NCT01311713|560490440|FG005|Overall Study|Lost to Follow-up|0|||
155289119|NCT01311713|560490441|FG006|Overall Study|Lost to Follow-up|0|||
155289120|NCT01311713|560490435|FG000|Overall Study|Stopped taking study medication|0|||
155289121|NCT01311713|560490436|FG001|Overall Study|Stopped taking study medication|0|||
155289122|NCT01311713|560490437|FG002|Overall Study|Stopped taking study medication|0|||
155289123|NCT01311713|560490438|FG003|Overall Study|Stopped taking study medication|1|||
155289124|NCT01311713|560490439|FG004|Overall Study|Stopped taking study medication|1|||
155289125|NCT01311713|560490440|FG005|Overall Study|Stopped taking study medication|0|||
155289126|NCT01311713|560490441|FG006|Overall Study|Stopped taking study medication|0|||
155289127|NCT01311713|560490435|FG000|Overall Study|Enrolled but not treated|0|||
155289128|NCT01311713|560490436|FG001|Overall Study|Enrolled but not treated|0|||
155289129|NCT01311713|560490437|FG002|Overall Study|Enrolled but not treated|1|||
155289130|NCT01311713|560490438|FG003|Overall Study|Enrolled but not treated|0|||
155289131|NCT01311713|560490439|FG004|Overall Study|Enrolled but not treated|0|||
155289132|NCT01311713|560490440|FG005|Overall Study|Enrolled but not treated|0|||
155289133|NCT01311713|560490441|FG006|Overall Study|Enrolled but not treated|0|||
155289134|NCT01311713|560490435|FG000|Overall Study|Other than specified|0|||
155289135|NCT01311713|560490436|FG001|Overall Study|Other than specified|1|||
155289136|NCT01311713|560490437|FG002|Overall Study|Other than specified|2|||
155289137|NCT01311713|560490438|FG003|Overall Study|Other than specified|0|||
155289138|NCT01311713|560490439|FG004|Overall Study|Other than specified|0|||
155289139|NCT01311713|560490440|FG005|Overall Study|Other than specified|0|||
155289140|NCT01311713|560490441|FG006|Overall Study|Other than specified|0|||
155289141|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
155289142|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
155289143|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
155743315|NCT00913458|562159837|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
155289144|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289145|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289146|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289147|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
155289148|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
155408452|NCT01464307|560927394|FG000|Main Period|Death|0|||
155289149|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
155289150|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
155289151|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
155289152|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
155289153|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289154|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289155|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289156|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
155289157|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289158|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289159|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
155289160|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
155289161|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
155289162|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289163|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289164|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289165|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289166|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289167|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289168|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
155289169|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
155289170|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
155289171|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289172|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289173|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289174|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289175|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289176|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289177|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
155289178|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
155289179|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
155289180|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289181|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289182|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289183|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
155289184|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289185|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289186|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
155408453|NCT01464307|560927395|FG001|Main Period|Death|1|||
155408454|NCT01464307|560927394|FG000|Main Period|Adverse Event|6|||
155408455|NCT01464307|560927395|FG001|Main Period|Adverse Event|1|||
155408456|NCT01464307|560927394|FG000|Main Period|Lack of Efficacy|2|||
155408457|NCT01464307|560927395|FG001|Main Period|Lack of Efficacy|0|||
155408458|NCT01464307|560927394|FG000|Main Period|Withdrawal by Subject|5|||
155408459|NCT01464307|560927395|FG001|Main Period|Withdrawal by Subject|2|||
155408460|NCT01464307|560927394|FG000|Main Period|Predefined discontinuation criteria|2|||
155408461|NCT01464307|560927395|FG001|Main Period|Predefined discontinuation criteria|1|||
155408462|NCT01464307|560927394|FG000|Open-Label Extension Period|Adverse Event|15|||
155408463|NCT01464307|560927395|FG001|Open-Label Extension Period|Adverse Event|0|||
155408464|NCT01464307|560927394|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
155408465|NCT01464307|560927395|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
155408466|NCT01464307|560927394|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
155408467|NCT01464307|560927395|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
155408468|NCT01464307|560927394|FG000|Open-Label Extension Period|Death|1|||
155408469|NCT01464307|560927395|FG001|Open-Label Extension Period|Death|0|||
155408470|NCT01464307|560927394|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
155408471|NCT01464307|560927395|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
155408472|NCT01464307|560927394|FG000|Open-Label Extension Period|Non-compliance|9|||
155408473|NCT01464307|560927395|FG001|Open-Label Extension Period|Non-compliance|0|||
155408474|NCT01464307|560927394|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
155408475|NCT01464307|560927395|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
155408476|NCT00761514|560927396|FG000|Overall Study|Adverse Event|1|||
155408477|NCT00761514|560927396|FG000|Overall Study|Withdrawal by Subject|2|||
155408478|NCT00761514|560927396|FG000|Overall Study|Lost to Follow-up|1|||
155408479|NCT00761514|560927396|FG000|Overall Study|Health insurance didn't cover study drug|1|||
155408480|NCT00761514|560927396|FG000|Overall Study|Problem complying with study visit|1|||
155408481|NCT00761514|560927396|FG000|Overall Study|Unable to pay for medications|1|||
155408482|NCT01035905|560927398|FG000|Overall Study|Lack of Efficacy|1|||
155743316|NCT00913458|562159838|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
155289187|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289188|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289189|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289190|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289191|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289192|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289193|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289194|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289195|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289196|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
155289197|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289198|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289199|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289200|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289201|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289202|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289203|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289204|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289205|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289206|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
155289207|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289208|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289209|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289210|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289211|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289212|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289213|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
155289214|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289215|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289216|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289217|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289218|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289219|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289220|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289221|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289222|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
155289223|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289224|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289225|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289226|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289227|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289228|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289229|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289230|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289231|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
155289232|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289233|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289234|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289235|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289236|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289237|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289238|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289239|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289240|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289241|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
155289242|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
155289243|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155408483|NCT01035905|560927399|FG001|Overall Study|Lack of Efficacy|1|||
155408484|NCT01273883|560927400|FG000|First Intervention|Adverse Event|2|||
155743317|NCT00913458|562159839|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
155743318|NCT00913458|562159840|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
155743319|NCT00913458|562159841|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
155289244|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289245|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289246|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289247|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289248|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289249|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
155289250|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
155289251|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289252|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289253|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289254|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289255|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289256|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289257|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289258|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289259|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
155289260|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289261|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289262|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289263|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289264|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289265|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289266|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289267|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289268|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
155289269|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289270|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289271|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289272|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289273|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289274|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289275|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289276|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289277|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289278|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
155289279|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289280|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289281|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289282|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289283|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289284|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289285|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289286|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289287|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
155289288|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289289|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289290|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289291|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289292|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289293|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289294|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289295|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289296|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
155289297|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289298|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289299|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289300|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155408485|NCT01273883|560927401|FG001|First Intervention|Adverse Event|1|||
155743320|NCT00913458|562159842|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
155743321|NCT00913458|562159843|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
155743322|NCT02366091|562159844|FG000|Overall Study|Withdrawal by Subject|3|||
155289301|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289302|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289303|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289304|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289305|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289306|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289307|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289308|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289309|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
155289310|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289311|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289312|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
155289313|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
155289314|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289315|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289316|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289317|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289318|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289319|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289320|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289321|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155743323|NCT02366091|562159845|FG001|Overall Study|Withdrawal by Subject|7|||
155743324|NCT02366091|562159846|FG002|Overall Study|Withdrawal by Subject|3|||
155743325|NCT02366091|562159847|FG003|Overall Study|Withdrawal by Subject|1|||
155743326|NCT03595618|562159848|FG000|Overall Study|Adverse Event|16|||
155743327|NCT03595618|562159849|FG001|Overall Study|Adverse Event|17|||
155743328|NCT03595618|562159850|FG002|Overall Study|Adverse Event|20|||
155743329|NCT03595618|562159851|FG003|Overall Study|Adverse Event|8|||
155743330|NCT03595618|562159848|FG000|Overall Study|Withdrawal by Subject|12|||
155743331|NCT03595618|562159849|FG001|Overall Study|Withdrawal by Subject|14|||
155743332|NCT03595618|562159850|FG002|Overall Study|Withdrawal by Subject|14|||
155743333|NCT03595618|562159851|FG003|Overall Study|Withdrawal by Subject|10|||
155289322|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289323|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
155289324|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289325|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289326|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289327|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155408486|NCT01273883|560927400|FG000|Second Intervention|Lost to Follow-up|1|||
155408487|NCT01273883|560927401|FG001|Second Intervention|Lost to Follow-up|1|||
155408488|NCT01273883|560927400|FG000|Second Intervention|Lack of Efficacy|1|||
155408489|NCT01273883|560927401|FG001|Second Intervention|Lack of Efficacy|0|||
155408490|NCT00894556|560927402|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
155743334|NCT03595618|562159848|FG000|Overall Study|Lost to Follow-up|6|||
155743335|NCT03595618|562159849|FG001|Overall Study|Lost to Follow-up|4|||
155743336|NCT03595618|562159850|FG002|Overall Study|Lost to Follow-up|5|||
155743337|NCT03595618|562159851|FG003|Overall Study|Lost to Follow-up|6|||
155743338|NCT03595618|562159848|FG000|Overall Study|Protocol Violation|2|||
155743339|NCT03595618|562159849|FG001|Overall Study|Protocol Violation|0|||
155743340|NCT03595618|562159850|FG002|Overall Study|Protocol Violation|6|||
155743341|NCT03595618|562159851|FG003|Overall Study|Protocol Violation|2|||
155743342|NCT03595618|562159848|FG000|Overall Study|Physician Decision|0|||
155743343|NCT03595618|562159849|FG001|Overall Study|Physician Decision|0|||
155743344|NCT03595618|562159850|FG002|Overall Study|Physician Decision|1|||
155743345|NCT03595618|562159851|FG003|Overall Study|Physician Decision|2|||
155743346|NCT03595618|562159848|FG000|Overall Study|Miscellaneous|7|||
155743347|NCT03595618|562159849|FG001|Overall Study|Miscellaneous|5|||
155743348|NCT03595618|562159850|FG002|Overall Study|Miscellaneous|10|||
155743349|NCT03595618|562159851|FG003|Overall Study|Miscellaneous|6|||
155743350|NCT02338232|562159852|FG000|Overall Study|Screen Failure|3|||
155743351|NCT02338232|562159852|FG000|Overall Study|Withdrawal by Subject|6|||
155743352|NCT02338232|562159852|FG000|Overall Study|Adverse Event|2|||
155743353|NCT02279407|562159853|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
155743354|NCT02279407|562159854|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
155743355|NCT02279407|562159855|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
155743356|NCT02279407|562159856|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
155289328|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289329|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289330|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289331|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289332|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289333|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155289334|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155289335|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155289336|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289337|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289338|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289339|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289340|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289341|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289342|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
155289343|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289344|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289345|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289346|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289347|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289348|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289349|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289350|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289351|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
155289352|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289353|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289354|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289355|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289356|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289357|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289358|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289359|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289360|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
155289361|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
155289362|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289363|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289364|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289365|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289366|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289367|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289368|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289369|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
155289370|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289371|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289372|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289373|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289374|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289375|NCT05570006|560492269|FG000|Overall Study|Lost to Follow-up|2|||
155289376|NCT05570006|560492269|FG000|Overall Study|Withdrawal by Subject|5|||
155289377|NCT05570006|560492269|FG000|Overall Study|Other than Specified|5|||
155289378|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289379|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
155289380|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289381|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289382|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289383|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289384|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289385|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289386|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289387|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289388|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289389|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
155289390|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
155289391|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289392|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289393|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289394|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289395|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289396|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289397|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289398|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289399|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289400|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
155289401|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
155289402|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289403|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289404|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289405|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289406|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289407|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289408|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289409|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289410|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289411|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
155289412|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289413|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289414|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289415|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289416|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289417|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289418|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289419|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289420|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289421|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289422|NCT03410992|560492277|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
155289423|NCT03410992|560492278|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
155289424|NCT03410992|560492279|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289425|NCT03410992|560492280|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289426|NCT03410992|560492281|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289427|NCT03410992|560492282|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289428|NCT03410992|560492283|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289429|NCT03410992|560492284|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289430|NCT03410992|560492285|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289431|NCT03410992|560492286|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289432|NCT03410992|560492287|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289433|NCT03410992|560492277|FG000|Week 16 Assessment|Incorrect escapers|0|||
155289434|NCT03410992|560492278|FG001|Week 16 Assessment|Incorrect escapers|6|||
155289435|NCT03410992|560492279|FG002|Week 16 Assessment|Incorrect escapers|0|||
155289436|NCT03410992|560492280|FG003|Week 16 Assessment|Incorrect escapers|0|||
155289437|NCT03410992|560492281|FG004|Week 16 Assessment|Incorrect escapers|0|||
155289438|NCT03410992|560492282|FG005|Week 16 Assessment|Incorrect escapers|0|||
155289439|NCT03410992|560492283|FG006|Week 16 Assessment|Incorrect escapers|0|||
155289440|NCT03410992|560492284|FG007|Week 16 Assessment|Incorrect escapers|0|||
155289441|NCT03410992|560492285|FG008|Week 16 Assessment|Incorrect escapers|0|||
155289442|NCT03410992|560492286|FG009|Week 16 Assessment|Incorrect escapers|0|||
155289443|NCT03410992|560492287|FG010|Week 16 Assessment|Incorrect escapers|0|||
155289444|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289445|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289446|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289447|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
155289448|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
155289449|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289450|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289451|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289452|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289453|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289454|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289455|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289456|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289457|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289458|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
155289459|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
155289460|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
155289461|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289462|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289463|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289464|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289465|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289466|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289467|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289468|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289469|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289470|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289471|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
155289472|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289473|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155743357|NCT02279407|562159853|FG000|Overall Study|Withdrawal by Subject|1|||
155743358|NCT02279407|562159854|FG001|Overall Study|Withdrawal by Subject|0|||
155743359|NCT02279407|562159855|FG002|Overall Study|Withdrawal by Subject|1|||
155743360|NCT02279407|562159856|FG003|Overall Study|Withdrawal by Subject|1|||
155743361|NCT02279407|562159853|FG000|Overall Study|Adverse Event|1|||
155743362|NCT02279407|562159854|FG001|Overall Study|Adverse Event|1|||
155289474|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289475|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289476|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289477|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289478|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289479|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289480|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
155289481|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
155289482|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
155289483|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289484|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289485|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289486|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289487|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289488|NCT03410992|560492277|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289489|NCT03410992|560492278|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289490|NCT03410992|560492279|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289491|NCT03410992|560492280|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289492|NCT03410992|560492281|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289493|NCT03410992|560492282|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289494|NCT03410992|560492283|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289495|NCT03410992|560492284|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
155289496|NCT03410992|560492285|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289497|NCT03410992|560492286|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289498|NCT03410992|560492287|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289499|NCT03410992|560492277|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289500|NCT03410992|560492278|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155408491|NCT00894556|560927403|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
155408492|NCT00894556|560927404|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
155408493|NCT00894556|560927405|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
155408494|NCT00894556|560927402|FG000|Treatment Phase|Lost to Follow-up|2|||
155408495|NCT00894556|560927403|FG001|Treatment Phase|Lost to Follow-up|3|||
155408496|NCT00894556|560927404|FG002|Treatment Phase|Lost to Follow-up|1|||
155408497|NCT00894556|560927405|FG003|Treatment Phase|Lost to Follow-up|0|||
155408498|NCT00894556|560927402|FG000|Treatment Phase|Lack of Qualifying Event|2|||
155408499|NCT00894556|560927403|FG001|Treatment Phase|Lack of Qualifying Event|1|||
155408500|NCT00894556|560927404|FG002|Treatment Phase|Lack of Qualifying Event|0|||
155408501|NCT00894556|560927405|FG003|Treatment Phase|Lack of Qualifying Event|0|||
155435880|NCT00144300|561022982|FG000|Overall Study|Withdrawal by Subject|6|||
155435881|NCT00144300|561022983|FG001|Overall Study|Withdrawal by Subject|6|||
155435882|NCT00144300|561022982|FG000|Overall Study|Other reason (not specified)|1|||
155435883|NCT00144300|561022983|FG001|Overall Study|Other reason (not specified)|3|||
155435884|NCT02403206|561022985|FG000|Overall Study|Lost to Follow-up|4|||
155435885|NCT02403206|561022986|FG001|Overall Study|Lost to Follow-up|3|||
155435886|NCT02403206|561022985|FG000|Overall Study|Physician Decision|2|||
155743363|NCT02279407|562159855|FG002|Overall Study|Adverse Event|2|||
155743364|NCT02279407|562159856|FG003|Overall Study|Adverse Event|0|||
155289501|NCT03410992|560492279|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289502|NCT03410992|560492280|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289503|NCT03410992|560492281|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289504|NCT03410992|560492282|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289505|NCT03410992|560492283|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289506|NCT03410992|560492284|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289507|NCT03410992|560492285|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
155289508|NCT03410992|560492286|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289509|NCT03410992|560492287|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289510|NCT04804605|560492288|FG000|Overall Study|Withdrawal by Subject|46|||
155289511|NCT04804605|560492289|FG001|Overall Study|Withdrawal by Subject|26|||
155289512|NCT04804605|560492290|FG002|Overall Study|Withdrawal by Subject|37|||
155289513|NCT04804605|560492291|FG003|Overall Study|Withdrawal by Subject|21|||
155289514|NCT04804605|560492288|FG000|Overall Study|Lost to Follow-up|47|||
155743365|NCT01105065|562159859|FG000|Overall Study|Adverse Event|5|||
155743366|NCT01105065|562159859|FG000|Overall Study|Technical Problems|1|||
155743367|NCT00422084|562159860|FG000|Overall Study|Adverse Event|21|||
155743368|NCT00422084|562159861|FG001|Overall Study|Adverse Event|7|||
155743369|NCT00422084|562159860|FG000|Overall Study|Withdrawal by Subject|12|||
155743370|NCT00422084|562159861|FG001|Overall Study|Withdrawal by Subject|9|||
155743371|NCT00422084|562159860|FG000|Overall Study|Lost to Follow-up|14|||
155743372|NCT00422084|562159861|FG001|Overall Study|Lost to Follow-up|9|||
155743373|NCT00422084|562159860|FG000|Overall Study|Protocol Violation|4|||
155743374|NCT00422084|562159861|FG001|Overall Study|Protocol Violation|1|||
155743375|NCT00422084|562159860|FG000|Overall Study|Lack of Efficacy|40|||
155743376|NCT00422084|562159861|FG001|Overall Study|Lack of Efficacy|42|||
155743377|NCT00422084|562159860|FG000|Overall Study|P. vivax infection|3|||
155743378|NCT00422084|562159861|FG001|Overall Study|P. vivax infection|6|||
155743379|NCT00422084|562159860|FG000|Overall Study|Cyesis|1|||
155743380|NCT00422084|562159861|FG001|Overall Study|Cyesis|0|||
155743381|NCT00422084|562159860|FG000|Overall Study|Withdrawn from study accidentally|1|||
155743382|NCT00422084|562159861|FG001|Overall Study|Withdrawn from study accidentally|0|||
155743383|NCT00422084|562159860|FG000|Overall Study|Non-compliance|1|||
155743384|NCT00422084|562159861|FG001|Overall Study|Non-compliance|0|||
155743385|NCT00422084|562159860|FG000|Overall Study|Re-location|0|||
155743386|NCT00422084|562159861|FG001|Overall Study|Re-location|1|||
155743387|NCT00422084|562159860|FG000|Overall Study|Not defined|1|||
155743388|NCT00422084|562159861|FG001|Overall Study|Not defined|1|||
155743389|NCT03774823|562159862|FG000|Overall Study|Withdrawal by Subject|1|||
155743390|NCT03774823|562159863|FG001|Overall Study|Withdrawal by Subject|1|||
155743391|NCT00329849|562159869|FG000|Overall Study|Withdrawal by Subject|6|||
155743392|NCT00329849|562159870|FG001|Overall Study|Withdrawal by Subject|4|||
155743393|NCT03996369|562159871|FG000|Overall Study|Protocol deviation|1|||
155743394|NCT03996369|562159872|FG001|Overall Study|Protocol deviation|1|||
155743395|NCT03996369|562159871|FG000|Overall Study|Physician Decision|4|||
155743396|NCT03996369|562159872|FG001|Overall Study|Physician Decision|2|||
155743397|NCT03996369|562159871|FG000|Overall Study|Participant decision|0|||
155743398|NCT03996369|562159872|FG001|Overall Study|Participant decision|1|||
155289515|NCT04804605|560492289|FG001|Overall Study|Lost to Follow-up|21|||
155289516|NCT04804605|560492290|FG002|Overall Study|Lost to Follow-up|30|||
155289517|NCT04804605|560492291|FG003|Overall Study|Lost to Follow-up|17|||
155289518|NCT04804605|560492288|FG000|Overall Study|Lack of Efficacy|28|||
155289519|NCT04804605|560492289|FG001|Overall Study|Lack of Efficacy|11|||
155289520|NCT04804605|560492290|FG002|Overall Study|Lack of Efficacy|37|||
155289521|NCT04804605|560492291|FG003|Overall Study|Lack of Efficacy|8|||
155289522|NCT04804605|560492288|FG000|Overall Study|Adverse Event|10|||
155743399|NCT03996369|562159871|FG000|Overall Study|Lack of Efficacy|4|||
155743400|NCT03996369|562159872|FG001|Overall Study|Lack of Efficacy|0|||
155743401|NCT03996369|562159871|FG000|Overall Study|Adverse Event|9|||
155743402|NCT03996369|562159872|FG001|Overall Study|Adverse Event|0|||
155289523|NCT04804605|560492289|FG001|Overall Study|Adverse Event|10|||
155289524|NCT04804605|560492290|FG002|Overall Study|Adverse Event|10|||
155289525|NCT04804605|560492291|FG003|Overall Study|Adverse Event|7|||
155289526|NCT04804605|560492288|FG000|Overall Study|Non-compliance|8|||
155289527|NCT04804605|560492289|FG001|Overall Study|Non-compliance|3|||
155289528|NCT04804605|560492290|FG002|Overall Study|Non-compliance|5|||
155743403|NCT03996369|562159871|FG000|Overall Study|Withdrawal by Subject|6|||
155743404|NCT03996369|562159872|FG001|Overall Study|Withdrawal by Subject|8|||
155289529|NCT04804605|560492291|FG003|Overall Study|Non-compliance|1|||
155289530|NCT04804605|560492288|FG000|Overall Study|Physician Decision|3|||
155743405|NCT03996369|562159871|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
155743406|NCT03996369|562159872|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
155743407|NCT03996369|562159871|FG000|Overall Study|Lost to Follow-up|0|||
155289531|NCT04804605|560492289|FG001|Overall Study|Physician Decision|0|||
155289532|NCT04804605|560492290|FG002|Overall Study|Physician Decision|5|||
155289533|NCT04804605|560492291|FG003|Overall Study|Physician Decision|0|||
155289534|NCT04804605|560492288|FG000|Overall Study|Protocol Violation|1|||
155289535|NCT04804605|560492289|FG001|Overall Study|Protocol Violation|0|||
155289536|NCT04804605|560492290|FG002|Overall Study|Protocol Violation|0|||
155289537|NCT04804605|560492291|FG003|Overall Study|Protocol Violation|1|||
155289538|NCT04804605|560492288|FG000|Overall Study|Miscellaneous|7|||
155289539|NCT04804605|560492289|FG001|Overall Study|Miscellaneous|3|||
155289540|NCT04804605|560492290|FG002|Overall Study|Miscellaneous|4|||
155289541|NCT04804605|560492291|FG003|Overall Study|Miscellaneous|2|||
155289542|NCT04018066|560492294|FG000|Overall Study|participants started taking medications during the study period|3|||
155289543|NCT04018066|560492294|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
155289544|NCT03568318|560492295|FG000|Overall Study|Adverse Event|3|||
155289545|NCT03568318|560492296|FG001|Overall Study|Adverse Event|1|||
155289546|NCT03568318|560492297|FG002|Overall Study|Adverse Event|1|||
155289547|NCT03568318|560492298|FG003|Overall Study|Adverse Event|0|||
155289548|NCT03568318|560492299|FG004|Overall Study|Adverse Event|1|||
155289549|NCT03568318|560492300|FG005|Overall Study|Adverse Event|0|||
155289550|NCT03568318|560492295|FG000|Overall Study|Withdrawal by Subject|6|||
155289551|NCT03568318|560492296|FG001|Overall Study|Withdrawal by Subject|5|||
155289552|NCT03568318|560492297|FG002|Overall Study|Withdrawal by Subject|2|||
155289553|NCT03568318|560492298|FG003|Overall Study|Withdrawal by Subject|1|||
155408502|NCT04311502|560928725|FG000|Overall Study|Death|1|||
155408503|NCT04311502|560928726|FG001|Overall Study|Death|1|||
155289554|NCT03568318|560492299|FG004|Overall Study|Withdrawal by Subject|0|||
155289555|NCT03568318|560492300|FG005|Overall Study|Withdrawal by Subject|0|||
155289556|NCT03568318|560492295|FG000|Overall Study|Lost to Follow-up|3|||
155289557|NCT03568318|560492296|FG001|Overall Study|Lost to Follow-up|2|||
155289558|NCT03568318|560492297|FG002|Overall Study|Lost to Follow-up|2|||
155289559|NCT03568318|560492298|FG003|Overall Study|Lost to Follow-up|2|||
155289560|NCT03568318|560492299|FG004|Overall Study|Lost to Follow-up|1|||
155289561|NCT03568318|560492300|FG005|Overall Study|Lost to Follow-up|0|||
155289562|NCT03568318|560492295|FG000|Overall Study|Other|3|||
155289563|NCT03568318|560492296|FG001|Overall Study|Other|1|||
155289564|NCT03568318|560492297|FG002|Overall Study|Other|3|||
155289565|NCT03568318|560492298|FG003|Overall Study|Other|0|||
155289566|NCT03568318|560492299|FG004|Overall Study|Other|0|||
155289567|NCT03568318|560492300|FG005|Overall Study|Other|0|||
155289568|NCT03568318|560492295|FG000|Overall Study|Ongoing at Time of Analysis|5|||
155289569|NCT03568318|560492296|FG001|Overall Study|Ongoing at Time of Analysis|3|||
155289570|NCT03568318|560492297|FG002|Overall Study|Ongoing at Time of Analysis|2|||
155289571|NCT03568318|560492298|FG003|Overall Study|Ongoing at Time of Analysis|1|||
155289572|NCT03568318|560492299|FG004|Overall Study|Ongoing at Time of Analysis|0|||
155289573|NCT03568318|560492300|FG005|Overall Study|Ongoing at Time of Analysis|0|||
155289574|NCT04988295|560492304|FG000|Overall Study|Withdrawal by Subject|9|||
155289575|NCT04988295|560492305|FG001|Overall Study|Withdrawal by Subject|29|||
155289576|NCT04988295|560492306|FG002|Overall Study|Withdrawal by Subject|6|||
155289577|NCT04988295|560492307|FG003|Overall Study|Withdrawal by Subject|0|||
155289578|NCT04988295|560492304|FG000|Overall Study|Lost to Follow-up|1|||
155289579|NCT04988295|560492305|FG001|Overall Study|Lost to Follow-up|0|||
155289580|NCT04988295|560492306|FG002|Overall Study|Lost to Follow-up|0|||
155289581|NCT04988295|560492307|FG003|Overall Study|Lost to Follow-up|0|||
155289582|NCT04988295|560492304|FG000|Overall Study|Study participation ongoing|186|||
155289583|NCT04988295|560492305|FG001|Overall Study|Study participation ongoing|169|||
155289584|NCT04988295|560492306|FG002|Overall Study|Study participation ongoing|99|||
155289585|NCT04988295|560492307|FG003|Overall Study|Study participation ongoing|119|||
155408504|NCT04311502|560928727|FG002|Overall Study|Death|1|||
155408505|NCT04311502|560928725|FG000|Overall Study|Lost to Follow-up|2|||
155408506|NCT04311502|560928726|FG001|Overall Study|Lost to Follow-up|3|||
155408507|NCT04311502|560928727|FG002|Overall Study|Lost to Follow-up|0|||
155408508|NCT04311502|560928725|FG000|Overall Study|Participant is in prison|1|||
155289586|NCT04083976|560492310|FG000|Overall Study|Lost to Follow-up|3|||
155289587|NCT04083976|560492311|FG001|Overall Study|Lost to Follow-up|0|||
155289588|NCT04083976|560492312|FG002|Overall Study|Lost to Follow-up|0|||
155289589|NCT04083976|560492313|FG003|Overall Study|Lost to Follow-up|1|||
155289590|NCT04083976|560492310|FG000|Overall Study|Withdrawal by Subject|16|||
155408509|NCT04311502|560928726|FG001|Overall Study|Participant is in prison|0|||
155408510|NCT04311502|560928727|FG002|Overall Study|Participant is in prison|0|||
155408511|NCT04311502|560928725|FG000|Overall Study|Participant moved out of country|1|||
155408512|NCT04311502|560928726|FG001|Overall Study|Participant moved out of country|0|||
155408513|NCT04311502|560928727|FG002|Overall Study|Participant moved out of country|0|||
155289591|NCT04083976|560492311|FG001|Overall Study|Withdrawal by Subject|1|||
155289592|NCT04083976|560492312|FG002|Overall Study|Withdrawal by Subject|9|||
155289593|NCT04083976|560492313|FG003|Overall Study|Withdrawal by Subject|0|||
155289594|NCT04083976|560492310|FG000|Overall Study|Sponsor Decision|14|||
155289595|NCT04083976|560492311|FG001|Overall Study|Sponsor Decision|0|||
155289596|NCT04083976|560492312|FG002|Overall Study|Sponsor Decision|0|||
155289597|NCT04083976|560492313|FG003|Overall Study|Sponsor Decision|7|||
155289598|NCT04083976|560492310|FG000|Overall Study|Other|1|||
155289599|NCT04083976|560492311|FG001|Overall Study|Other|0|||
155289600|NCT04083976|560492312|FG002|Overall Study|Other|1|||
155289601|NCT04083976|560492313|FG003|Overall Study|Other|0|||
155408514|NCT04311502|560928725|FG000|Overall Study|Withdrawal by Subject|2|||
155289602|NCT04618471|560492314|FG000|Overall Study|Screen Failure|62|||
155289603|NCT04618471|560492314|FG000|Overall Study|Withdrawal by Subject|6|||
155289604|NCT04618471|560492314|FG000|Overall Study|Physician Decision|2|||
155289605|NCT04618471|560492314|FG000|Overall Study|Lost to Follow-up|1|||
155289606|NCT04618471|560492314|FG000|Overall Study|Various other reasons|2|||
155289607|NCT04618471|560492314|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
155289608|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289609|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
155289610|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289611|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289612|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289613|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289614|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289615|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289616|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289617|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289618|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289619|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289620|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289621|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Death|0|||
155289622|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Death|0|||
155289623|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Death|0|||
155289624|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Death|1|||
155289625|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Death|0|||
155289626|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Death|0|||
155289627|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Death|0|||
155289628|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Death|0|||
155289629|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Death|0|||
155289630|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Death|0|||
155289631|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Death|0|||
155289632|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Death|0|||
155289633|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Death|0|||
155289634|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289635|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289636|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289637|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
155289638|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289639|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289640|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289641|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289642|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289643|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289644|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289645|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289646|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289647|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289648|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
155289649|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289650|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289651|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289652|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289653|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289654|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289655|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289656|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289657|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289658|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155408515|NCT04311502|560928726|FG001|Overall Study|Withdrawal by Subject|0|||
155408516|NCT04311502|560928727|FG002|Overall Study|Withdrawal by Subject|0|||
155408517|NCT04311502|560928725|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
155408518|NCT04311502|560928726|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
155638104|NCT00580840|561766381|FG001|Run-in|Adverse Event|0|||
155638105|NCT00580840|561766382|FG002|Run-in|Adverse Event|0|||
155638106|NCT00580840|561766383|FG003|Run-in|Adverse Event|0|||
155638107|NCT00580840|561766380|FG000|Run-in|Lack of Efficacy|93|||
155638108|NCT00580840|561766381|FG001|Run-in|Lack of Efficacy|0|||
155638109|NCT00580840|561766382|FG002|Run-in|Lack of Efficacy|0|||
155638110|NCT00580840|561766383|FG003|Run-in|Lack of Efficacy|0|||
155638111|NCT00580840|561766380|FG000|Run-in|Loss of Efficacy|1|||
155289659|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289660|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289661|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289662|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
155289663|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289664|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289665|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289666|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289667|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289668|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289669|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289670|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289671|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289672|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289673|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
155289674|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
155289675|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
155289676|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
155289677|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
155289678|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289679|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289680|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289681|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289682|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289683|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289684|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155408519|NCT04311502|560928727|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
155408520|NCT03040999|560928728|FG000|Overall Study|Lost to Follow-up|2|||
155408521|NCT03040999|560928729|FG001|Overall Study|Lost to Follow-up|2|||
155408522|NCT03040999|560928728|FG000|Overall Study|Withdrawal by Subject|12|||
155408523|NCT03040999|560928729|FG001|Overall Study|Withdrawal by Subject|13|||
155408524|NCT03040999|560928728|FG000|Overall Study|Death|155|||
155408525|NCT03040999|560928729|FG001|Overall Study|Death|171|||
155408526|NCT03040999|560928728|FG000|Overall Study|Physician Decision|0|||
155408527|NCT03040999|560928729|FG001|Overall Study|Physician Decision|3|||
155408528|NCT03468855|560928730|FG000|Overall Study|Adverse Event|2|||
155408529|NCT03468855|560928730|FG000|Overall Study|Lost to Follow-up|5|||
155408530|NCT03468855|560928730|FG000|Overall Study|Withdrawal by Subject|3|||
155408531|NCT03468855|560928730|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
155408532|NCT02404103|560928736|FG000|Overall Study|Adverse Event|1|||
155408533|NCT02404103|560928737|FG001|Overall Study|Adverse Event|0|||
155408534|NCT02404103|560928736|FG000|Overall Study|Lost to Follow-up|3|||
155408535|NCT02404103|560928737|FG001|Overall Study|Lost to Follow-up|3|||
155408536|NCT01995071|560928738|FG000|Overall Study|Adverse Event|0|||
155408537|NCT01995071|560928739|FG001|Overall Study|Adverse Event|0|||
155408538|NCT01995071|560928740|FG002|Overall Study|Adverse Event|0|||
155408539|NCT01995071|560928741|FG003|Overall Study|Adverse Event|0|||
155408540|NCT01995071|560928742|FG004|Overall Study|Adverse Event|0|||
155408541|NCT01995071|560928743|FG005|Overall Study|Adverse Event|0|||
155408542|NCT01995071|560928744|FG006|Overall Study|Adverse Event|1|||
155408543|NCT01995071|560928745|FG007|Overall Study|Adverse Event|0|||
155408544|NCT01995071|560928746|FG008|Overall Study|Adverse Event|0|||
155408545|NCT01995071|560928747|FG009|Overall Study|Adverse Event|0|||
155408546|NCT01995071|560928748|FG010|Overall Study|Adverse Event|0|||
155408547|NCT01995071|560928749|FG011|Overall Study|Adverse Event|0|||
155408548|NCT01995071|560928738|FG000|Overall Study|Moved|0|||
155408549|NCT01995071|560928739|FG001|Overall Study|Moved|0|||
155408550|NCT01995071|560928740|FG002|Overall Study|Moved|1|||
155408551|NCT01995071|560928741|FG003|Overall Study|Moved|0|||
155408552|NCT01995071|560928742|FG004|Overall Study|Moved|1|||
155408553|NCT01995071|560928743|FG005|Overall Study|Moved|0|||
155408554|NCT01995071|560928744|FG006|Overall Study|Moved|0|||
155408555|NCT01995071|560928745|FG007|Overall Study|Moved|0|||
155408556|NCT01995071|560928746|FG008|Overall Study|Moved|0|||
155408557|NCT01995071|560928747|FG009|Overall Study|Moved|0|||
155408558|NCT01995071|560928748|FG010|Overall Study|Moved|1|||
155408559|NCT01995071|560928749|FG011|Overall Study|Moved|0|||
155408560|NCT01995071|560928738|FG000|Overall Study|Lost to Follow-up|1|||
155408561|NCT01995071|560928739|FG001|Overall Study|Lost to Follow-up|0|||
155408562|NCT01995071|560928740|FG002|Overall Study|Lost to Follow-up|0|||
155638112|NCT00580840|561766381|FG001|Run-in|Loss of Efficacy|0|||
155638113|NCT00580840|561766382|FG002|Run-in|Loss of Efficacy|0|||
155638114|NCT00580840|561766383|FG003|Run-in|Loss of Efficacy|0|||
155289685|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289686|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289687|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289688|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289689|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289690|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
155289691|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289692|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289693|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289694|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289695|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289696|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289697|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289698|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289699|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
155289700|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289701|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289702|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289703|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289704|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289705|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289706|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289707|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289708|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289709|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289710|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289711|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289712|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289713|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289714|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289715|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289716|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289717|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
155289718|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
155289719|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289720|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289721|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
155289722|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
155289723|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
155289724|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
155289725|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289726|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289727|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289728|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289729|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289730|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289731|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289732|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289733|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289734|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
155289735|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289736|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289737|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
155289738|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289739|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289740|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289741|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289742|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289743|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289744|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289745|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289746|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289747|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
155289748|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289749|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
155289750|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289751|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289752|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289753|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289754|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289755|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289756|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
155289757|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289758|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
155289759|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289760|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289761|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289762|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289763|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289764|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Death|0|||
155289765|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Death|0|||
155289766|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Death|0|||
155289767|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Death|0|||
155289768|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Death|0|||
155289769|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Death|0|||
155289770|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Death|0|||
155289771|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Death|0|||
155289772|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Death|0|||
155289773|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Death|1|||
155289774|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Death|0|||
155289775|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Death|0|||
155408563|NCT01995071|560928741|FG003|Overall Study|Lost to Follow-up|0|||
155408564|NCT01995071|560928742|FG004|Overall Study|Lost to Follow-up|0|||
155408565|NCT01995071|560928743|FG005|Overall Study|Lost to Follow-up|0|||
155408566|NCT01995071|560928744|FG006|Overall Study|Lost to Follow-up|0|||
155289776|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Death|0|||
155289777|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289778|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155408567|NCT01995071|560928745|FG007|Overall Study|Lost to Follow-up|1|||
155408568|NCT01995071|560928746|FG008|Overall Study|Lost to Follow-up|1|||
155408569|NCT01995071|560928747|FG009|Overall Study|Lost to Follow-up|0|||
155408570|NCT01995071|560928748|FG010|Overall Study|Lost to Follow-up|0|||
155408571|NCT01995071|560928749|FG011|Overall Study|Lost to Follow-up|0|||
155408572|NCT01995071|560928738|FG000|Overall Study|Incarcerated|0|||
155408573|NCT01995071|560928739|FG001|Overall Study|Incarcerated|0|||
155408574|NCT01995071|560928740|FG002|Overall Study|Incarcerated|0|||
155408575|NCT01995071|560928741|FG003|Overall Study|Incarcerated|0|||
155408576|NCT01995071|560928742|FG004|Overall Study|Incarcerated|0|||
155408577|NCT01995071|560928743|FG005|Overall Study|Incarcerated|0|||
155408578|NCT01995071|560928744|FG006|Overall Study|Incarcerated|0|||
155408579|NCT01995071|560928745|FG007|Overall Study|Incarcerated|1|||
155408580|NCT01995071|560928746|FG008|Overall Study|Incarcerated|0|||
155408581|NCT01995071|560928747|FG009|Overall Study|Incarcerated|0|||
155408582|NCT01995071|560928748|FG010|Overall Study|Incarcerated|0|||
155408583|NCT01995071|560928749|FG011|Overall Study|Incarcerated|0|||
155408584|NCT01979523|560928753|FG000|Overall Study|Withdrawal by Subject|1|||
155408585|NCT01979523|560928754|FG001|Overall Study|Withdrawal by Subject|0|||
155408586|NCT01339559|560928761|FG000|Overall Study|Adverse Event|92|||
155408587|NCT01339559|560928761|FG000|Overall Study|Death|5|||
155408588|NCT01339559|560928761|FG000|Overall Study|Lack of Efficacy|164|||
155408589|NCT01339559|560928761|FG000|Overall Study|Lost to Follow-up|22|||
155638115|NCT00580840|561766380|FG000|Run-in|Lost to Follow-up|4|||
155638116|NCT00580840|561766381|FG001|Run-in|Lost to Follow-up|0|||
155289779|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289780|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155638117|NCT00580840|561766382|FG002|Run-in|Lost to Follow-up|0|||
155289781|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289782|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
155408590|NCT01339559|560928761|FG000|Overall Study|Subject choice|89|||
155408591|NCT01339559|560928761|FG000|Overall Study|Protocol Violation|15|||
155408592|NCT01339559|560928761|FG000|Overall Study|Study closure at site|1|||
155408593|NCT01339559|560928761|FG000|Overall Study|Incarcerated|2|||
155408594|NCT01339559|560928761|FG000|Overall Study|Epilepsy surgery|1|||
155408595|NCT01339559|560928761|FG000|Overall Study|Pregnancy planned|2|||
155408596|NCT01339559|560928761|FG000|Overall Study|Left the country|1|||
155408597|NCT01339559|560928761|FG000|Overall Study|Investigator decision|2|||
155408598|NCT01339559|560928761|FG000|Overall Study|Patient didn't wish to continue|1|||
155638118|NCT00580840|561766383|FG003|Run-in|Lost to Follow-up|0|||
155408599|NCT01339559|560928761|FG000|Overall Study|PI decision|1|||
155408600|NCT00971945|560928762|FG000|Overall Study|Progressive Disease|3|||
155408601|NCT00971945|560928762|FG000|Overall Study|Change in treatment policy|1|||
155408602|NCT00971945|560928762|FG000|Overall Study|Other reasons|2|||
155408603|NCT03354663|560928763|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
155408604|NCT03354663|560928763|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
155408605|NCT03354663|560928763|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
155408606|NCT03354663|560928763|FG000|Completed 30-day Visit|Missed Visit|1|||
155408607|NCT00513409|560928769|FG000|Overall Study|Adverse Event|0|||
155408608|NCT00513409|560928770|FG001|Overall Study|Adverse Event|1|||
155408609|NCT00513409|560928769|FG000|Overall Study|Withdrawal by Subject|0|||
155408610|NCT00513409|560928770|FG001|Overall Study|Withdrawal by Subject|2|||
155408611|NCT00513409|560928769|FG000|Overall Study|Lost to Follow-up|0|||
155408612|NCT00513409|560928770|FG001|Overall Study|Lost to Follow-up|1|||
155408613|NCT00513409|560928769|FG000|Overall Study|Physician Decision|1|||
155408614|NCT00513409|560928770|FG001|Overall Study|Physician Decision|0|||
155408615|NCT00513409|560928769|FG000|Overall Study|Visit 3 not done|1|||
155408616|NCT00513409|560928770|FG001|Overall Study|Visit 3 not done|2|||
155408617|NCT03548051|560928771|FG000|Overall Study|Death|1|||
155408618|NCT03548051|560928772|FG001|Overall Study|Death|1|||
155408619|NCT03548051|560928771|FG000|Overall Study|Withdrawal by Subject|1|||
155408620|NCT03548051|560928772|FG001|Overall Study|Withdrawal by Subject|0|||
155408621|NCT00817531|560928774|FG000|Overall Study|Adverse Event|1|||
155408622|NCT00817531|560928774|FG000|Overall Study|Lack of Efficacy|1|||
155408623|NCT00812214|560928775|FG000|Overall Study|Lost to Follow-up|3|||
155408624|NCT00812214|560928776|FG001|Overall Study|Lost to Follow-up|1|||
155408625|NCT03325673|560928777|FG000|Overall Study|Adverse Event|4|||
155408626|NCT03325673|560928778|FG001|Overall Study|Adverse Event|0|||
155408627|NCT00883337|560928779|FG000|Core Treatment Period|Adverse Event|9|||
155408628|NCT00883337|560928780|FG001|Core Treatment Period|Adverse Event|12|||
155408629|NCT00883337|560928781|FG002|Core Treatment Period|Adverse Event|22|||
155408630|NCT00883337|560928779|FG000|Core Treatment Period|Lack of Efficacy|7|||
155408631|NCT00883337|560928780|FG001|Core Treatment Period|Lack of Efficacy|4|||
155408632|NCT00883337|560928781|FG002|Core Treatment Period|Lack of Efficacy|2|||
155408633|NCT00883337|560928779|FG000|Core Treatment Period|Lost to Follow-up|1|||
155408634|NCT00883337|560928780|FG001|Core Treatment Period|Lost to Follow-up|1|||
155408635|NCT00883337|560928781|FG002|Core Treatment Period|Lost to Follow-up|0|||
155408636|NCT00883337|560928779|FG000|Core Treatment Period|Withdrawal by Subject|2|||
155408637|NCT00883337|560928780|FG001|Core Treatment Period|Withdrawal by Subject|2|||
155408638|NCT00883337|560928781|FG002|Core Treatment Period|Withdrawal by Subject|6|||
155408639|NCT00883337|560928779|FG000|Core Treatment Period|Wish to be pregnant|1|||
155408640|NCT00883337|560928780|FG001|Core Treatment Period|Wish to be pregnant|2|||
155408641|NCT00883337|560928781|FG002|Core Treatment Period|Wish to be pregnant|1|||
155408642|NCT00883337|560928779|FG000|Core Treatment Period|Poor compliance to protocol|0|||
155408643|NCT00883337|560928780|FG001|Core Treatment Period|Poor compliance to protocol|0|||
155408644|NCT00883337|560928781|FG002|Core Treatment Period|Poor compliance to protocol|1|||
155408645|NCT00883337|560928779|FG000|Core Treatment Period|Other than above|0|||
155408646|NCT00883337|560928780|FG001|Core Treatment Period|Other than above|1|||
155408647|NCT00883337|560928781|FG002|Core Treatment Period|Other than above|1|||
155408648|NCT00883337|560928779|FG000|Extension Treatment Period|Adverse Event|8|||
155408649|NCT00883337|560928780|FG001|Extension Treatment Period|Adverse Event|5|||
155408650|NCT00883337|560928781|FG002|Extension Treatment Period|Adverse Event|5|||
155408651|NCT00883337|560928779|FG000|Extension Treatment Period|Lack of Efficacy|8|||
155408652|NCT00883337|560928780|FG001|Extension Treatment Period|Lack of Efficacy|8|||
155408653|NCT00883337|560928781|FG002|Extension Treatment Period|Lack of Efficacy|8|||
155408654|NCT00883337|560928779|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
155408655|NCT00883337|560928780|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
155408656|NCT00883337|560928781|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
155408657|NCT00883337|560928779|FG000|Extension Treatment Period|Lost to Follow-up|1|||
155408658|NCT00883337|560928780|FG001|Extension Treatment Period|Lost to Follow-up|0|||
155408659|NCT00883337|560928781|FG002|Extension Treatment Period|Lost to Follow-up|0|||
155408660|NCT00883337|560928779|FG000|Extension Treatment Period|Other than above|10|||
155408661|NCT00883337|560928780|FG001|Extension Treatment Period|Other than above|9|||
155408662|NCT00883337|560928781|FG002|Extension Treatment Period|Other than above|5|||
155408663|NCT00763139|560928782|FG000|Overall Study|Adverse Event|4|||
155408664|NCT00763139|560928783|FG001|Overall Study|Adverse Event|2|||
155408665|NCT00763139|560928782|FG000|Overall Study|Withdrawal by Subject|0|||
155408666|NCT00763139|560928783|FG001|Overall Study|Withdrawal by Subject|1|||
155408667|NCT00763139|560928782|FG000|Overall Study|med change not allowed by protocol|1|||
155408668|NCT00763139|560928783|FG001|Overall Study|med change not allowed by protocol|0|||
155408669|NCT00713700|560928784|FG000|Overall Study|Lost to Follow-up|3|||
155408670|NCT00713700|560928784|FG000|Overall Study|Withdrawal by Subject|1|||
155408671|NCT02669017|560928785|FG000|Overall Study|Death|1|||
155408672|NCT02669017|560928786|FG001|Overall Study|Death|2|||
155408673|NCT02669017|560928787|FG002|Overall Study|Death|2|||
155408674|NCT02669017|560928788|FG003|Overall Study|Death|3|||
155289783|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289784|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289785|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289786|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
155289787|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
155289788|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289789|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289790|NCT01313182|560492328|FG000|Overall Study|Protocol Violation|66|||
155289791|NCT01313182|560492329|FG001|Overall Study|Protocol Violation|92|||
155289792|NCT03673124|560492330|FG000|Overall Study|Eligible with no protocol therapy|2|||
155289793|NCT05827926|560492333|FG000|Overall Study|Lost to Follow-up|1|||
155289794|NCT05827926|560492334|FG001|Overall Study|Lost to Follow-up|0|||
155289795|NCT05827926|560492335|FG002|Overall Study|Lost to Follow-up|0|||
155289796|NCT05827926|560492336|FG003|Overall Study|Lost to Follow-up|0|||
155289797|NCT05827926|560492337|FG004|Overall Study|Lost to Follow-up|0|||
155289798|NCT05827926|560492338|FG005|Overall Study|Lost to Follow-up|1|||
155289799|NCT05827926|560492339|FG006|Overall Study|Lost to Follow-up|0|||
155289800|NCT05827926|560492340|FG007|Overall Study|Lost to Follow-up|0|||
155289801|NCT05827926|560492341|FG008|Overall Study|Lost to Follow-up|0|||
155289802|NCT05827926|560492342|FG009|Overall Study|Lost to Follow-up|0|||
155289803|NCT05827926|560492343|FG010|Overall Study|Lost to Follow-up|0|||
155289804|NCT05827926|560492344|FG011|Overall Study|Lost to Follow-up|0|||
155289805|NCT05827926|560492345|FG012|Overall Study|Lost to Follow-up|1|||
155289806|NCT05827926|560492346|FG013|Overall Study|Lost to Follow-up|1|||
155289807|NCT05827926|560492347|FG014|Overall Study|Lost to Follow-up|0|||
155289808|NCT05827926|560492348|FG015|Overall Study|Lost to Follow-up|1|||
155289809|NCT05827926|560492349|FG016|Overall Study|Lost to Follow-up|2|||
155289810|NCT05827926|560492350|FG017|Overall Study|Lost to Follow-up|0|||
155289811|NCT05827926|560492351|FG018|Overall Study|Lost to Follow-up|0|||
155289812|NCT05827926|560492352|FG019|Overall Study|Lost to Follow-up|0|||
155289813|NCT05827926|560492353|FG020|Overall Study|Lost to Follow-up|1|||
155289814|NCT05827926|560492354|FG021|Overall Study|Lost to Follow-up|2|||
155289815|NCT05827926|560492355|FG022|Overall Study|Lost to Follow-up|1|||
155289816|NCT05827926|560492356|FG023|Overall Study|Lost to Follow-up|1|||
155289817|NCT05827926|560492357|FG024|Overall Study|Lost to Follow-up|2|||
155289818|NCT05827926|560492358|FG025|Overall Study|Lost to Follow-up|1|||
155408675|NCT02669017|560928789|FG004|Overall Study|Death|8|||
155408676|NCT02669017|560928790|FG005|Overall Study|Death|18|||
155408677|NCT02669017|560928791|FG006|Overall Study|Death|10|||
155408678|NCT02669017|560928792|FG007|Overall Study|Death|47|||
155408679|NCT02669017|560928793|FG008|Overall Study|Death|20|||
155408680|NCT02669017|560928785|FG000|Overall Study|Withdrawal by Subject|0|||
155638119|NCT00580840|561766380|FG000|Run-in|Withdrawal by Subject|5|||
155638120|NCT00580840|561766381|FG001|Run-in|Withdrawal by Subject|0|||
155638121|NCT00580840|561766382|FG002|Run-in|Withdrawal by Subject|0|||
155638122|NCT00580840|561766383|FG003|Run-in|Withdrawal by Subject|0|||
155638123|NCT00580840|561766380|FG000|Run-in|Other: Per Sponsor Request|2|||
155638124|NCT00580840|561766381|FG001|Run-in|Other: Per Sponsor Request|0|||
155638125|NCT00580840|561766382|FG002|Run-in|Other: Per Sponsor Request|0|||
155638126|NCT00580840|561766383|FG003|Run-in|Other: Per Sponsor Request|0|||
155638127|NCT00580840|561766380|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
155638128|NCT00580840|561766381|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155638129|NCT00580840|561766382|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155638130|NCT00580840|561766383|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155638131|NCT00580840|561766380|FG000|Run-in|Other: Exclusionary Lab Value|1|||
155638132|NCT00580840|561766381|FG001|Run-in|Other: Exclusionary Lab Value|0|||
155638133|NCT00580840|561766382|FG002|Run-in|Other: Exclusionary Lab Value|0|||
155638134|NCT00580840|561766383|FG003|Run-in|Other: Exclusionary Lab Value|0|||
155638135|NCT00580840|561766380|FG000|Double-Blind|Adverse Event|0|||
155638136|NCT00580840|561766381|FG001|Double-Blind|Adverse Event|3|||
155638137|NCT00580840|561766382|FG002|Double-Blind|Adverse Event|4|||
155638138|NCT00580840|561766383|FG003|Double-Blind|Adverse Event|1|||
155638139|NCT00580840|561766380|FG000|Double-Blind|Loss of Efficacy|0|||
155638140|NCT00580840|561766381|FG001|Double-Blind|Loss of Efficacy|1|||
155638141|NCT00580840|561766382|FG002|Double-Blind|Loss of Efficacy|2|||
155638142|NCT00580840|561766383|FG003|Double-Blind|Loss of Efficacy|10|||
155638143|NCT00580840|561766380|FG000|Double-Blind|Lost to Follow-up|0|||
155638144|NCT00580840|561766381|FG001|Double-Blind|Lost to Follow-up|1|||
155638145|NCT00580840|561766382|FG002|Double-Blind|Lost to Follow-up|0|||
155638146|NCT00580840|561766383|FG003|Double-Blind|Lost to Follow-up|2|||
155638147|NCT00580840|561766380|FG000|Double-Blind|Withdrawal by Subject|0|||
155638148|NCT00580840|561766381|FG001|Double-Blind|Withdrawal by Subject|1|||
155638149|NCT00580840|561766382|FG002|Double-Blind|Withdrawal by Subject|2|||
155638150|NCT00580840|561766383|FG003|Double-Blind|Withdrawal by Subject|2|||
155638151|NCT00580840|561766380|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
155638152|NCT00580840|561766381|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
155638153|NCT00580840|561766382|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
155638154|NCT00580840|561766383|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
155289819|NCT05827926|560492359|FG026|Overall Study|Lost to Follow-up|4|||
155289820|NCT05827926|560492360|FG027|Overall Study|Lost to Follow-up|1|||
155289821|NCT05827926|560492361|FG028|Overall Study|Lost to Follow-up|2|||
155289822|NCT05827926|560492362|FG029|Overall Study|Lost to Follow-up|1|||
155289823|NCT05827926|560492363|FG030|Overall Study|Lost to Follow-up|5|||
155289824|NCT05827926|560492364|FG031|Overall Study|Lost to Follow-up|0|||
155289825|NCT05827926|560492365|FG032|Overall Study|Lost to Follow-up|3|||
155289826|NCT05827926|560492366|FG033|Overall Study|Lost to Follow-up|2|||
155289827|NCT05827926|560492367|FG034|Overall Study|Lost to Follow-up|1|||
155289828|NCT05827926|560492368|FG035|Overall Study|Lost to Follow-up|3|||
155289829|NCT05827926|560492369|FG036|Overall Study|Lost to Follow-up|4|||
155289830|NCT05827926|560492333|FG000|Overall Study|Withdrawal by Subject|1|||
155289831|NCT05827926|560492334|FG001|Overall Study|Withdrawal by Subject|0|||
155289832|NCT05827926|560492335|FG002|Overall Study|Withdrawal by Subject|1|||
155289833|NCT05827926|560492336|FG003|Overall Study|Withdrawal by Subject|1|||
155289834|NCT05827926|560492337|FG004|Overall Study|Withdrawal by Subject|0|||
155289835|NCT05827926|560492338|FG005|Overall Study|Withdrawal by Subject|0|||
155289836|NCT05827926|560492339|FG006|Overall Study|Withdrawal by Subject|0|||
155289837|NCT05827926|560492340|FG007|Overall Study|Withdrawal by Subject|0|||
155289838|NCT05827926|560492341|FG008|Overall Study|Withdrawal by Subject|0|||
155289839|NCT05827926|560492342|FG009|Overall Study|Withdrawal by Subject|0|||
155289840|NCT05827926|560492343|FG010|Overall Study|Withdrawal by Subject|0|||
155289841|NCT05827926|560492344|FG011|Overall Study|Withdrawal by Subject|0|||
155289842|NCT05827926|560492345|FG012|Overall Study|Withdrawal by Subject|1|||
155289843|NCT05827926|560492346|FG013|Overall Study|Withdrawal by Subject|1|||
155289844|NCT05827926|560492347|FG014|Overall Study|Withdrawal by Subject|1|||
155289845|NCT05827926|560492348|FG015|Overall Study|Withdrawal by Subject|2|||
155289846|NCT05827926|560492349|FG016|Overall Study|Withdrawal by Subject|1|||
155289847|NCT05827926|560492350|FG017|Overall Study|Withdrawal by Subject|1|||
155289848|NCT05827926|560492351|FG018|Overall Study|Withdrawal by Subject|0|||
155289849|NCT05827926|560492352|FG019|Overall Study|Withdrawal by Subject|0|||
155289850|NCT05827926|560492353|FG020|Overall Study|Withdrawal by Subject|1|||
155289851|NCT05827926|560492354|FG021|Overall Study|Withdrawal by Subject|0|||
155289852|NCT05827926|560492355|FG022|Overall Study|Withdrawal by Subject|0|||
155289853|NCT05827926|560492356|FG023|Overall Study|Withdrawal by Subject|2|||
155289854|NCT05827926|560492357|FG024|Overall Study|Withdrawal by Subject|1|||
155289855|NCT05827926|560492358|FG025|Overall Study|Withdrawal by Subject|0|||
155289856|NCT05827926|560492359|FG026|Overall Study|Withdrawal by Subject|0|||
155289857|NCT05827926|560492360|FG027|Overall Study|Withdrawal by Subject|1|||
155289858|NCT05827926|560492361|FG028|Overall Study|Withdrawal by Subject|0|||
155289859|NCT05827926|560492362|FG029|Overall Study|Withdrawal by Subject|0|||
155289860|NCT05827926|560492363|FG030|Overall Study|Withdrawal by Subject|0|||
155289861|NCT05827926|560492364|FG031|Overall Study|Withdrawal by Subject|2|||
155289862|NCT05827926|560492365|FG032|Overall Study|Withdrawal by Subject|0|||
155289863|NCT05827926|560492366|FG033|Overall Study|Withdrawal by Subject|0|||
155289864|NCT05827926|560492367|FG034|Overall Study|Withdrawal by Subject|0|||
155289865|NCT05827926|560492368|FG035|Overall Study|Withdrawal by Subject|0|||
155289866|NCT05827926|560492369|FG036|Overall Study|Withdrawal by Subject|1|||
155289867|NCT05827926|560492333|FG000|Overall Study|Other Than Specified|0|||
155289868|NCT05827926|560492334|FG001|Overall Study|Other Than Specified|0|||
155289869|NCT05827926|560492335|FG002|Overall Study|Other Than Specified|0|||
155289870|NCT05827926|560492336|FG003|Overall Study|Other Than Specified|1|||
155289871|NCT05827926|560492337|FG004|Overall Study|Other Than Specified|0|||
155289872|NCT05827926|560492338|FG005|Overall Study|Other Than Specified|0|||
155289873|NCT05827926|560492339|FG006|Overall Study|Other Than Specified|1|||
155289874|NCT05827926|560492340|FG007|Overall Study|Other Than Specified|0|||
155289875|NCT05827926|560492341|FG008|Overall Study|Other Than Specified|0|||
155289876|NCT05827926|560492342|FG009|Overall Study|Other Than Specified|0|||
155289877|NCT05827926|560492343|FG010|Overall Study|Other Than Specified|0|||
155289878|NCT05827926|560492344|FG011|Overall Study|Other Than Specified|0|||
155289879|NCT05827926|560492345|FG012|Overall Study|Other Than Specified|0|||
155289880|NCT05827926|560492346|FG013|Overall Study|Other Than Specified|1|||
155289881|NCT05827926|560492347|FG014|Overall Study|Other Than Specified|0|||
155289882|NCT05827926|560492348|FG015|Overall Study|Other Than Specified|1|||
155289883|NCT05827926|560492349|FG016|Overall Study|Other Than Specified|0|||
155289884|NCT05827926|560492350|FG017|Overall Study|Other Than Specified|0|||
155289885|NCT05827926|560492351|FG018|Overall Study|Other Than Specified|0|||
155289886|NCT05827926|560492352|FG019|Overall Study|Other Than Specified|0|||
155289887|NCT05827926|560492353|FG020|Overall Study|Other Than Specified|0|||
155289888|NCT05827926|560492354|FG021|Overall Study|Other Than Specified|1|||
155289889|NCT05827926|560492355|FG022|Overall Study|Other Than Specified|1|||
155289890|NCT05827926|560492356|FG023|Overall Study|Other Than Specified|0|||
155289891|NCT05827926|560492357|FG024|Overall Study|Other Than Specified|0|||
155408681|NCT02669017|560928786|FG001|Overall Study|Withdrawal by Subject|0|||
155289892|NCT05827926|560492358|FG025|Overall Study|Other Than Specified|1|||
155289893|NCT05827926|560492359|FG026|Overall Study|Other Than Specified|0|||
155289894|NCT05827926|560492360|FG027|Overall Study|Other Than Specified|0|||
155289895|NCT05827926|560492361|FG028|Overall Study|Other Than Specified|0|||
155289896|NCT05827926|560492362|FG029|Overall Study|Other Than Specified|0|||
155289897|NCT05827926|560492363|FG030|Overall Study|Other Than Specified|0|||
155289898|NCT05827926|560492364|FG031|Overall Study|Other Than Specified|1|||
155289899|NCT05827926|560492365|FG032|Overall Study|Other Than Specified|0|||
155289900|NCT05827926|560492366|FG033|Overall Study|Other Than Specified|0|||
155289901|NCT05827926|560492367|FG034|Overall Study|Other Than Specified|0|||
155289902|NCT05827926|560492368|FG035|Overall Study|Other Than Specified|0|||
155289903|NCT05827926|560492369|FG036|Overall Study|Other Than Specified|0|||
155289904|NCT05827926|560492333|FG000|Overall Study|Physician Decision|0|||
155289905|NCT05827926|560492334|FG001|Overall Study|Physician Decision|0|||
155289906|NCT05827926|560492335|FG002|Overall Study|Physician Decision|0|||
155289907|NCT05827926|560492336|FG003|Overall Study|Physician Decision|0|||
155289908|NCT05827926|560492337|FG004|Overall Study|Physician Decision|0|||
155289909|NCT05827926|560492338|FG005|Overall Study|Physician Decision|0|||
155289910|NCT05827926|560492339|FG006|Overall Study|Physician Decision|0|||
155289911|NCT05827926|560492340|FG007|Overall Study|Physician Decision|0|||
155289912|NCT05827926|560492341|FG008|Overall Study|Physician Decision|0|||
155289913|NCT05827926|560492342|FG009|Overall Study|Physician Decision|0|||
155289914|NCT05827926|560492343|FG010|Overall Study|Physician Decision|0|||
155289915|NCT05827926|560492344|FG011|Overall Study|Physician Decision|0|||
155289916|NCT05827926|560492345|FG012|Overall Study|Physician Decision|0|||
155289917|NCT05827926|560492346|FG013|Overall Study|Physician Decision|0|||
155289918|NCT05827926|560492347|FG014|Overall Study|Physician Decision|0|||
155289919|NCT05827926|560492348|FG015|Overall Study|Physician Decision|0|||
155289920|NCT05827926|560492349|FG016|Overall Study|Physician Decision|0|||
155289921|NCT05827926|560492350|FG017|Overall Study|Physician Decision|0|||
155289922|NCT05827926|560492351|FG018|Overall Study|Physician Decision|1|||
155289923|NCT05827926|560492352|FG019|Overall Study|Physician Decision|0|||
155289924|NCT05827926|560492353|FG020|Overall Study|Physician Decision|0|||
155289925|NCT05827926|560492354|FG021|Overall Study|Physician Decision|0|||
155289926|NCT05827926|560492355|FG022|Overall Study|Physician Decision|0|||
155289927|NCT05827926|560492356|FG023|Overall Study|Physician Decision|0|||
155289928|NCT05827926|560492357|FG024|Overall Study|Physician Decision|0|||
155289929|NCT05827926|560492358|FG025|Overall Study|Physician Decision|0|||
155289930|NCT05827926|560492359|FG026|Overall Study|Physician Decision|0|||
155289931|NCT05827926|560492360|FG027|Overall Study|Physician Decision|0|||
155289932|NCT05827926|560492361|FG028|Overall Study|Physician Decision|0|||
155289933|NCT05827926|560492362|FG029|Overall Study|Physician Decision|0|||
155289934|NCT05827926|560492363|FG030|Overall Study|Physician Decision|0|||
155289935|NCT05827926|560492364|FG031|Overall Study|Physician Decision|0|||
155289936|NCT05827926|560492365|FG032|Overall Study|Physician Decision|0|||
155289937|NCT05827926|560492366|FG033|Overall Study|Physician Decision|0|||
155289938|NCT05827926|560492367|FG034|Overall Study|Physician Decision|0|||
155289939|NCT05827926|560492368|FG035|Overall Study|Physician Decision|0|||
155289940|NCT05827926|560492369|FG036|Overall Study|Physician Decision|0|||
155289941|NCT05197049|560492370|FG000|Overall Study|Death|0|||
155289942|NCT05197049|560492371|FG001|Overall Study|Death|1|||
155289943|NCT05197049|560492372|FG002|Overall Study|Death|0|||
155289944|NCT05197049|560492370|FG000|Overall Study|Lost to Follow-up|3|||
155289945|NCT05197049|560492371|FG001|Overall Study|Lost to Follow-up|1|||
155289946|NCT05197049|560492372|FG002|Overall Study|Lost to Follow-up|0|||
155289947|NCT05197049|560492370|FG000|Overall Study|Withdrawal by Subject|15|||
155289948|NCT05197049|560492371|FG001|Overall Study|Withdrawal by Subject|3|||
155289949|NCT05197049|560492372|FG002|Overall Study|Withdrawal by Subject|1|||
155289950|NCT05197049|560492370|FG000|Overall Study|GCP non-compliance|1|||
155289951|NCT05197049|560492371|FG001|Overall Study|GCP non-compliance|2|||
155289952|NCT05197049|560492372|FG002|Overall Study|GCP non-compliance|0|||
155289953|NCT04889118|560492373|FG000|Overall Study|Death|49|||
155289954|NCT04889118|560492374|FG001|Overall Study|Death|47|||
155408682|NCT02669017|560928787|FG002|Overall Study|Withdrawal by Subject|0|||
155408683|NCT02669017|560928788|FG003|Overall Study|Withdrawal by Subject|1|||
155408684|NCT02669017|560928789|FG004|Overall Study|Withdrawal by Subject|2|||
155289955|NCT04889118|560492373|FG000|Overall Study|Sponsor Decision|15|||
155289956|NCT04889118|560492374|FG001|Overall Study|Sponsor Decision|20|||
155289957|NCT02846415|560492379|FG000|Overall Study|Lost to Follow-up|2|||
155289958|NCT02846415|560492380|FG001|Overall Study|Lost to Follow-up|0|||
155289959|NCT02846415|560492379|FG000|Overall Study|Withdrawal by Subject|1|||
155289960|NCT02846415|560492380|FG001|Overall Study|Withdrawal by Subject|1|||
155289961|NCT05576051|560492381|FG000|Overall Study|Lack of Efficacy|543|||
155289962|NCT05576051|560492382|FG001|Overall Study|Lack of Efficacy|343|||
155289963|NCT05576051|560492383|FG002|Overall Study|Lack of Efficacy|108|||
155289964|NCT05576051|560492384|FG003|Overall Study|Lack of Efficacy|72|||
155289965|NCT05576051|560492385|FG004|Overall Study|Lack of Efficacy|28|||
155289966|NCT05576051|560492386|FG005|Overall Study|Lack of Efficacy|50|||
155289967|NCT05576051|560492381|FG000|Overall Study|Safety|78|||
155289968|NCT05576051|560492382|FG001|Overall Study|Safety|74|||
155289969|NCT05576051|560492383|FG002|Overall Study|Safety|16|||
155289970|NCT05576051|560492384|FG003|Overall Study|Safety|14|||
155289971|NCT05576051|560492385|FG004|Overall Study|Safety|4|||
155289972|NCT05576051|560492386|FG005|Overall Study|Safety|5|||
155289973|NCT05576051|560492381|FG000|Overall Study|Efficacy + Safety|10|||
155289974|NCT05576051|560492382|FG001|Overall Study|Efficacy + Safety|7|||
155289975|NCT05576051|560492383|FG002|Overall Study|Efficacy + Safety|3|||
155289976|NCT05576051|560492384|FG003|Overall Study|Efficacy + Safety|0|||
155289977|NCT05576051|560492385|FG004|Overall Study|Efficacy + Safety|0|||
155289978|NCT05576051|560492386|FG005|Overall Study|Efficacy + Safety|0|||
155289979|NCT05576051|560492381|FG000|Overall Study|Other|231|||
155289980|NCT05576051|560492382|FG001|Overall Study|Other|127|||
155289981|NCT05576051|560492383|FG002|Overall Study|Other|35|||
155289982|NCT05576051|560492384|FG003|Overall Study|Other|14|||
155289983|NCT05576051|560492385|FG004|Overall Study|Other|6|||
155289984|NCT05576051|560492386|FG005|Overall Study|Other|0|||
155289985|NCT04154943|560492387|FG000|Overall Study|Study Ongoing|68|||
155289986|NCT04154943|560492387|FG000|Overall Study|Lost to Follow-up|1|||
155289987|NCT04154943|560492387|FG000|Overall Study|Decision by the Investigator|1|||
155289988|NCT04154943|560492387|FG000|Overall Study|Death|5|||
155289989|NCT04154943|560492387|FG000|Overall Study|Withdrawal by Subject|4|||
155289990|NCT03381274|560492390|FG000|Overall Study|Death|2|||
155289991|NCT03381274|560492391|FG001|Overall Study|Death|9|||
155289992|NCT03381274|560492392|FG002|Overall Study|Death|3|||
155289993|NCT03381274|560492393|FG003|Overall Study|Death|2|||
155289994|NCT03381274|560492394|FG004|Overall Study|Death|3|||
155289995|NCT03381274|560492390|FG000|Overall Study|Lost to Follow-up|0|||
155289996|NCT03381274|560492391|FG001|Overall Study|Lost to Follow-up|0|||
155289997|NCT03381274|560492392|FG002|Overall Study|Lost to Follow-up|0|||
155289998|NCT03381274|560492393|FG003|Overall Study|Lost to Follow-up|1|||
155289999|NCT03381274|560492394|FG004|Overall Study|Lost to Follow-up|0|||
155290000|NCT03381274|560492390|FG000|Overall Study|Withdrawal by Subject|2|||
155290001|NCT03381274|560492391|FG001|Overall Study|Withdrawal by Subject|1|||
155290002|NCT03381274|560492392|FG002|Overall Study|Withdrawal by Subject|3|||
155290003|NCT03381274|560492393|FG003|Overall Study|Withdrawal by Subject|1|||
155290004|NCT03381274|560492394|FG004|Overall Study|Withdrawal by Subject|0|||
155290005|NCT03381274|560492390|FG000|Overall Study|Other|1|||
155290006|NCT03381274|560492391|FG001|Overall Study|Other|11|||
155290007|NCT03381274|560492392|FG002|Overall Study|Other|0|||
155290008|NCT03381274|560492393|FG003|Overall Study|Other|2|||
155290009|NCT03381274|560492394|FG004|Overall Study|Other|2|||
155290010|NCT05916170|560492395|FG000|No Warning Control|Lost to Follow-up|12|||
155290011|NCT05916170|560492395|FG000|No Warning Control|Withdrawal by Subject|15|||
155290012|NCT05916170|560492395|FG000|No Warning Control|Noncompliance with protocol|1|||
155290013|NCT05916170|560492395|FG000|Health Warning Intervention|Lost to Follow-up|15|||
155290014|NCT05916170|560492395|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
155290015|NCT05916170|560492395|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
155290016|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
155290017|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
155290018|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
155290019|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
155290020|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
155290021|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
155290022|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
155290023|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
155290024|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
155290025|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
155290026|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
155290027|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
155290028|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
155290029|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
155290030|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
155290031|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
155290032|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
155290033|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
155290034|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
155290035|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
155290036|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
155290037|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
155290038|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
155290039|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
155290040|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
155290041|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
155290042|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
155290043|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
155290044|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
155435887|NCT02403206|561022986|FG001|Overall Study|Physician Decision|0|||
155290045|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
155290046|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
155290047|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
155290048|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
155290049|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
155290050|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
155290051|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
155290052|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
155290053|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
155290054|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
155290055|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
155290056|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
155290057|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
155290058|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
155290059|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
155290060|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
155290061|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
155290062|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
155290063|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
155290064|NCT04075266|560492399|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
155290065|NCT04075266|560492400|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
155290066|NCT04075266|560492399|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
155290067|NCT04075266|560492400|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
155290068|NCT03473743|560492403|FG000|Overall Study|Withdrawal by Subject|0|||
155290069|NCT03473743|560492404|FG001|Overall Study|Withdrawal by Subject|0|||
155290070|NCT03473743|560492405|FG002|Overall Study|Withdrawal by Subject|0|||
155290071|NCT03473743|560492406|FG003|Overall Study|Withdrawal by Subject|0|||
155290072|NCT03473743|560492407|FG004|Overall Study|Withdrawal by Subject|0|||
155290073|NCT03473743|560492408|FG005|Overall Study|Withdrawal by Subject|0|||
155290074|NCT03473743|560492409|FG006|Overall Study|Withdrawal by Subject|0|||
155290075|NCT03473743|560492410|FG007|Overall Study|Withdrawal by Subject|3|||
155290076|NCT03473743|560492403|FG000|Overall Study|Other|0|||
155290077|NCT03473743|560492404|FG001|Overall Study|Other|0|||
155290078|NCT03473743|560492405|FG002|Overall Study|Other|0|||
155290079|NCT03473743|560492406|FG003|Overall Study|Other|1|||
155290080|NCT03473743|560492407|FG004|Overall Study|Other|0|||
155290081|NCT03473743|560492408|FG005|Overall Study|Other|0|||
155290082|NCT03473743|560492409|FG006|Overall Study|Other|0|||
155290083|NCT03473743|560492410|FG007|Overall Study|Other|0|||
155290084|NCT03473743|560492403|FG000|Overall Study|Ongoing|0|||
155290085|NCT03473743|560492404|FG001|Overall Study|Ongoing|0|||
155290086|NCT03473743|560492405|FG002|Overall Study|Ongoing|6|||
155290087|NCT03473743|560492406|FG003|Overall Study|Ongoing|8|||
155290088|NCT03473743|560492407|FG004|Overall Study|Ongoing|1|||
155290089|NCT03473743|560492408|FG005|Overall Study|Ongoing|1|||
155290090|NCT03473743|560492409|FG006|Overall Study|Ongoing|22|||
155290091|NCT03473743|560492410|FG007|Overall Study|Ongoing|24|||
155290092|NCT03473743|560492403|FG000|Overall Study|Randomized but not treated|0|||
155290093|NCT03473743|560492404|FG001|Overall Study|Randomized but not treated|0|||
155290094|NCT03473743|560492405|FG002|Overall Study|Randomized but not treated|0|||
155290095|NCT03473743|560492406|FG003|Overall Study|Randomized but not treated|0|||
155290096|NCT03473743|560492407|FG004|Overall Study|Randomized but not treated|0|||
155290097|NCT03473743|560492408|FG005|Overall Study|Randomized but not treated|0|||
155290098|NCT03473743|560492409|FG006|Overall Study|Randomized but not treated|1|||
155290099|NCT03473743|560492410|FG007|Overall Study|Randomized but not treated|1|||
155290100|NCT02864992|560492415|FG000|Overall Study|still on treatment|15|||
155290101|NCT02864992|560492416|FG001|Overall Study|still on treatment|1|||
155408685|NCT02669017|560928790|FG005|Overall Study|Withdrawal by Subject|0|||
155408686|NCT02669017|560928791|FG006|Overall Study|Withdrawal by Subject|0|||
155408687|NCT02669017|560928792|FG007|Overall Study|Withdrawal by Subject|2|||
155408688|NCT02669017|560928793|FG008|Overall Study|Withdrawal by Subject|2|||
155408689|NCT02669017|560928785|FG000|Overall Study|Lost to Follow-up|0|||
155290102|NCT02864992|560492417|FG002|Overall Study|still on treatment|33|||
155290103|NCT04982575|560492418|FG000|Overall Study|Withdrawal by Subject|2|||
155290104|NCT04982575|560492419|FG001|Overall Study|Withdrawal by Subject|0|||
155290105|NCT04982575|560492420|FG002|Overall Study|Withdrawal by Subject|2|||
155290106|NCT04948333|560492423|FG000|Overall Study|Adverse Event|6|||
155290107|NCT04948333|560492424|FG001|Overall Study|Adverse Event|4|||
155290108|NCT04948333|560492425|FG002|Overall Study|Adverse Event|0|||
155290109|NCT04948333|560492426|FG003|Overall Study|Adverse Event|2|||
155290110|NCT04948333|560492423|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155290111|NCT04948333|560492424|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155290112|NCT04948333|560492425|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155290113|NCT04948333|560492426|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155290114|NCT04948333|560492423|FG000|Overall Study|Progressive Disease|1|||
155290115|NCT04948333|560492424|FG001|Overall Study|Progressive Disease|5|||
155290116|NCT04948333|560492425|FG002|Overall Study|Progressive Disease|0|||
155290117|NCT04948333|560492426|FG003|Overall Study|Progressive Disease|0|||
155290118|NCT04948333|560492423|FG000|Overall Study|Physician Decision|2|||
155290119|NCT04948333|560492424|FG001|Overall Study|Physician Decision|2|||
155290120|NCT04948333|560492425|FG002|Overall Study|Physician Decision|0|||
155290121|NCT04948333|560492426|FG003|Overall Study|Physician Decision|0|||
155290122|NCT04948333|560492423|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
155290123|NCT04948333|560492424|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
155290124|NCT04948333|560492425|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
155290125|NCT04948333|560492426|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
155290126|NCT04948333|560492423|FG000|Overall Study|Withdrawal by Subject|2|||
155290127|NCT04948333|560492424|FG001|Overall Study|Withdrawal by Subject|0|||
155290128|NCT04948333|560492425|FG002|Overall Study|Withdrawal by Subject|0|||
155290129|NCT04948333|560492426|FG003|Overall Study|Withdrawal by Subject|1|||
155290130|NCT04948333|560492423|FG000|Overall Study|Protocol Violation|0|||
155290131|NCT04948333|560492424|FG001|Overall Study|Protocol Violation|1|||
155290132|NCT04948333|560492425|FG002|Overall Study|Protocol Violation|0|||
155290133|NCT04948333|560492426|FG003|Overall Study|Protocol Violation|0|||
155290134|NCT04948333|560492423|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
155290135|NCT04948333|560492424|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
155290136|NCT04948333|560492425|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
155290137|NCT04948333|560492426|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
155290138|NCT03038022|560492427|FG000|Overall Study|Withdrawal by Subject|2|||
155290139|NCT03038022|560492428|FG001|Overall Study|Withdrawal by Subject|0|||
155290140|NCT03038022|560492427|FG000|Overall Study|Adverse Event|4|||
155290141|NCT03038022|560492428|FG001|Overall Study|Adverse Event|2|||
155290142|NCT03887936|560492429|FG000|Overall Study|Relocation|2|||
155290143|NCT03887936|560492430|FG001|Overall Study|Relocation|2|||
155290144|NCT03887936|560492429|FG000|Overall Study|Physician Decision|0|||
155290145|NCT03887936|560492430|FG001|Overall Study|Physician Decision|1|||
155290146|NCT03887936|560492429|FG000|Overall Study|Withdrawal by Subject|0|||
155290147|NCT03887936|560492430|FG001|Overall Study|Withdrawal by Subject|1|||
155290148|NCT00539591|560492431|FG000|Overall Study|Toxicity|3|||
155290149|NCT00539591|560492432|FG001|Overall Study|Toxicity|0|||
155290150|NCT00539591|560492433|FG002|Overall Study|Toxicity|0|||
155290151|NCT00539591|560492431|FG000|Overall Study|Disease progression|2|||
155290152|NCT00539591|560492432|FG001|Overall Study|Disease progression|2|||
155290153|NCT00539591|560492433|FG002|Overall Study|Disease progression|3|||
155290154|NCT06269367|560492434|FG000|Phase I|Unable to perform study procedures|0|||
155290155|NCT06269367|560492435|FG001|Phase I|Unable to perform study procedures|1|||
155290156|NCT06269367|560492434|FG000|Phase I|Could not continue study for personal reasons.|1|||
155290157|NCT06269367|560492435|FG001|Phase I|Could not continue study for personal reasons.|0|||
155290158|NCT03331250|560492436|FG000|Overall Study|Withdrawal by Subject|1|||
155290159|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
155290160|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
155290161|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
155290162|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
155290163|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
155290164|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
155290165|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
155290166|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
155290167|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
155290168|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
155290169|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
155290170|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
155290171|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
155290172|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
155290173|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
155290174|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
155290175|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
155290176|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
155290177|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290178|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
155290179|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290180|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
155290181|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
155290182|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
155290183|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
155290184|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
155290185|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
155290186|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
155290187|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
155290188|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
155290189|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Other|0|||
155290190|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Other|1|||
155290191|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Other|0|||
155290192|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
155290193|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
155290194|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
155290195|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Early site closure|0|||
155290196|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Early site closure|2|||
155290197|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Early site closure|0|||
155290198|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
155290199|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
155290200|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
155290201|NCT02137850|560492440|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
155290202|NCT02137850|560492441|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
155290203|NCT02137850|560492442|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
155290204|NCT02137850|560492440|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
155290205|NCT02137850|560492441|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
155290206|NCT02137850|560492442|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
155290207|NCT02137850|560492440|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
155290208|NCT02137850|560492441|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
155290209|NCT02137850|560492442|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
155290210|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
155290211|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
155290212|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
155290213|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
155290214|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
155290215|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
155290216|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290217|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
155290218|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290219|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Other|0|||
155290220|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Other|1|||
155290221|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Other|0|||
155290222|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
155290223|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
155290224|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
155290225|NCT02912260|560492443|FG000|Main Study|Lost to Follow-up|5|||
155290226|NCT02912260|560492444|FG001|Main Study|Lost to Follow-up|4|||
155408690|NCT02669017|560928786|FG001|Overall Study|Lost to Follow-up|0|||
155408691|NCT02669017|560928787|FG002|Overall Study|Lost to Follow-up|0|||
155408692|NCT02669017|560928788|FG003|Overall Study|Lost to Follow-up|0|||
155290227|NCT02912260|560492443|FG000|Main Study|Withdrawal by Subject|2|||
155290228|NCT02912260|560492444|FG001|Main Study|Withdrawal by Subject|2|||
155290229|NCT02912260|560492443|FG000|Main Study|Adverse Event|3|||
155408693|NCT02669017|560928789|FG004|Overall Study|Lost to Follow-up|0|||
155408694|NCT02669017|560928790|FG005|Overall Study|Lost to Follow-up|0|||
155408695|NCT02669017|560928791|FG006|Overall Study|Lost to Follow-up|0|||
155408696|NCT02669017|560928792|FG007|Overall Study|Lost to Follow-up|0|||
155408697|NCT02669017|560928793|FG008|Overall Study|Lost to Follow-up|1|||
155408698|NCT02669017|560928785|FG000|Overall Study|Miscellaneous|0|||
155408699|NCT02669017|560928786|FG001|Overall Study|Miscellaneous|0|||
155408700|NCT02669017|560928787|FG002|Overall Study|Miscellaneous|0|||
155408701|NCT02669017|560928788|FG003|Overall Study|Miscellaneous|0|||
155408702|NCT02669017|560928789|FG004|Overall Study|Miscellaneous|2|||
155408703|NCT02669017|560928790|FG005|Overall Study|Miscellaneous|1|||
155408704|NCT02669017|560928791|FG006|Overall Study|Miscellaneous|1|||
155408705|NCT02669017|560928792|FG007|Overall Study|Miscellaneous|13|||
155408706|NCT02669017|560928793|FG008|Overall Study|Miscellaneous|2|||
155408707|NCT00915681|560928798|FG000|Overall Study|Screening failures|46|||
155408708|NCT03221751|560928801|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
155408709|NCT03221751|560928802|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
155408710|NCT02559687|560928803|FG000|Overall Study|Death|112|||
155408711|NCT02559687|560928803|FG000|Overall Study|Sponsor Decision|5|||
155290230|NCT02912260|560492444|FG001|Main Study|Adverse Event|0|||
155290231|NCT02912260|560492443|FG000|Main Study|Physician Decision|0|||
155408712|NCT02559687|560928803|FG000|Overall Study|Withdrawal by Subject|4|||
155408713|NCT03245450|560928805|FG000|Overall Study|Radiological disease progression|3|||
155290232|NCT02912260|560492444|FG001|Main Study|Physician Decision|1|||
155290233|NCT02912260|560492443|FG000|Extension Study|Withdrawal by Subject|1|||
155290234|NCT02912260|560492444|FG001|Extension Study|Withdrawal by Subject|1|||
155408714|NCT03245450|560928806|FG001|Overall Study|Radiological disease progression|3|||
155743408|NCT03996369|562159872|FG001|Overall Study|Lost to Follow-up|1|||
155290235|NCT00980538|560492446|FG000|Overall Study|Lost to Follow-up|20|||
155290236|NCT00980538|560492446|FG000|Overall Study|Sponsor's Decision|4|||
155290237|NCT00980538|560492446|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
155290238|NCT00980538|560492446|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
155408715|NCT03245450|560928807|FG002|Overall Study|Radiological disease progression|2|||
155408716|NCT03245450|560928808|FG003|Overall Study|Radiological disease progression|2|||
155408717|NCT03245450|560928809|FG004|Overall Study|Radiological disease progression|7|||
155408718|NCT03245450|560928810|FG005|Overall Study|Radiological disease progression|6|||
155408719|NCT03245450|560928811|FG006|Overall Study|Radiological disease progression|6|||
155290239|NCT00980538|560492446|FG000|Overall Study|Switch to Commercially Available Medication|25|||
155290240|NCT00980538|560492446|FG000|Overall Study|Participant Non-Compliant|9|||
155408720|NCT03245450|560928805|FG000|Overall Study|Clinical disease progression|0|||
155408721|NCT03245450|560928806|FG001|Overall Study|Clinical disease progression|0|||
155408722|NCT03245450|560928807|FG002|Overall Study|Clinical disease progression|1|||
155408723|NCT03245450|560928808|FG003|Overall Study|Clinical disease progression|0|||
155408724|NCT03245450|560928809|FG004|Overall Study|Clinical disease progression|0|||
155408725|NCT03245450|560928810|FG005|Overall Study|Clinical disease progression|2|||
155408726|NCT03245450|560928811|FG006|Overall Study|Clinical disease progression|0|||
155408727|NCT03245450|560928805|FG000|Overall Study|Other|0|||
155408728|NCT03245450|560928806|FG001|Overall Study|Other|0|||
155408729|NCT03245450|560928807|FG002|Overall Study|Other|0|||
155408730|NCT03245450|560928808|FG003|Overall Study|Other|1|||
155408731|NCT03245450|560928809|FG004|Overall Study|Other|1|||
155408732|NCT03245450|560928810|FG005|Overall Study|Other|1|||
155408733|NCT03245450|560928811|FG006|Overall Study|Other|1|||
155408734|NCT03245450|560928805|FG000|Overall Study|Withdrawal by Subject|0|||
155408735|NCT03245450|560928806|FG001|Overall Study|Withdrawal by Subject|1|||
155408736|NCT03245450|560928807|FG002|Overall Study|Withdrawal by Subject|0|||
155408737|NCT03245450|560928808|FG003|Overall Study|Withdrawal by Subject|0|||
155408738|NCT03245450|560928809|FG004|Overall Study|Withdrawal by Subject|0|||
155408739|NCT03245450|560928810|FG005|Overall Study|Withdrawal by Subject|0|||
155408740|NCT03245450|560928811|FG006|Overall Study|Withdrawal by Subject|0|||
155408741|NCT03245450|560928805|FG000|Overall Study|Adverse Event|0|||
155408742|NCT03245450|560928806|FG001|Overall Study|Adverse Event|0|||
155408743|NCT03245450|560928807|FG002|Overall Study|Adverse Event|0|||
155408744|NCT03245450|560928808|FG003|Overall Study|Adverse Event|0|||
155408745|NCT03245450|560928809|FG004|Overall Study|Adverse Event|1|||
155408746|NCT03245450|560928810|FG005|Overall Study|Adverse Event|0|||
155408747|NCT03245450|560928811|FG006|Overall Study|Adverse Event|2|||
155638155|NCT00580840|561766380|FG000|Double-Blind|Other: Forbidden Medication|0|||
155638156|NCT00580840|561766381|FG001|Double-Blind|Other: Forbidden Medication|0|||
155638157|NCT00580840|561766382|FG002|Double-Blind|Other: Forbidden Medication|1|||
155638158|NCT00580840|561766383|FG003|Double-Blind|Other: Forbidden Medication|0|||
155638159|NCT00976027|561766384|FG000|Overall Study|Serious Adverse Event|36|||
155638160|NCT00976027|561766385|FG001|Overall Study|Serious Adverse Event|17|||
155638161|NCT00976027|561766384|FG000|Overall Study|Adverse Event|0|||
155638162|NCT00976027|561766385|FG001|Overall Study|Adverse Event|2|||
155638163|NCT00976027|561766384|FG000|Overall Study|Protocol Violation|60|||
155638164|NCT00976027|561766385|FG001|Overall Study|Protocol Violation|27|||
155638165|NCT00976027|561766384|FG000|Overall Study|Lost to Follow-up|208|||
155638166|NCT00976027|561766385|FG001|Overall Study|Lost to Follow-up|103|||
155638167|NCT00976027|561766384|FG000|Overall Study|Withdrawal by Subject|107|||
155638168|NCT00976027|561766385|FG001|Overall Study|Withdrawal by Subject|66|||
155638169|NCT01771107|561766391|FG000|Overall Study|Adverse Event|1|||
155638170|NCT01771107|561766392|FG001|Overall Study|Adverse Event|3|||
155638171|NCT01771107|561766391|FG000|Overall Study|Withdrawal by Subject|0|||
155638172|NCT01771107|561766392|FG001|Overall Study|Withdrawal by Subject|2|||
155638173|NCT01771107|561766391|FG000|Overall Study|Lost to Follow-up|0|||
155638174|NCT01771107|561766392|FG001|Overall Study|Lost to Follow-up|1|||
155638175|NCT01771107|561766391|FG000|Overall Study|participant moved|0|||
155638176|NCT01771107|561766392|FG001|Overall Study|participant moved|1|||
155638177|NCT01771107|561766391|FG000|Overall Study|Other|0|||
155638178|NCT01771107|561766392|FG001|Overall Study|Other|1|||
155638179|NCT01160614|561766393|FG000|Overall Study|Withdrawal by Subject|0|||
155638180|NCT01160614|561766394|FG001|Overall Study|Withdrawal by Subject|2|||
155638181|NCT03805841|561766395|FG000|Overall Study|Clinical Progression|2|||
155638182|NCT03805841|561766396|FG001|Overall Study|Clinical Progression|0|||
155638183|NCT03805841|561766397|FG002|Overall Study|Clinical Progression|0|||
155638184|NCT03805841|561766395|FG000|Overall Study|Death|0|||
155638185|NCT03805841|561766396|FG001|Overall Study|Death|3|||
155638186|NCT03805841|561766397|FG002|Overall Study|Death|1|||
155638187|NCT03805841|561766395|FG000|Overall Study|Lost to Follow-up|0|||
155638188|NCT03805841|561766396|FG001|Overall Study|Lost to Follow-up|0|||
155638189|NCT03805841|561766397|FG002|Overall Study|Lost to Follow-up|1|||
155638190|NCT03805841|561766395|FG000|Overall Study|Withdrawal by Subject|2|||
155638191|NCT03805841|561766396|FG001|Overall Study|Withdrawal by Subject|3|||
155638192|NCT03805841|561766397|FG002|Overall Study|Withdrawal by Subject|0|||
155290241|NCT00980538|560492446|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
155290242|NCT00980538|560492446|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
155290243|NCT00980538|560492446|FG000|Overall Study|Other|60|||
155290244|NCT00980538|560492446|FG000|Overall Study|Other|1|||
155290245|NCT03878446|560492447|FG000|Overall Study|Withdrawn by parent or guardian|1|||
155290246|NCT03878446|560492448|FG001|Overall Study|Withdrawn by parent or guardian|0|||
155290247|NCT03878446|560492449|FG002|Overall Study|Withdrawn by parent or guardian|0|||
155290248|NCT03878446|560492450|FG003|Overall Study|Withdrawn by parent or guardian|0|||
155290249|NCT03878446|560492451|FG004|Overall Study|Withdrawn by parent or guardian|0|||
155290250|NCT05663866|560492452|FG000|Overall Study|Adverse Event|0|||
155290251|NCT05663866|560492453|FG001|Overall Study|Adverse Event|0|||
155290252|NCT05663866|560492454|FG002|Overall Study|Adverse Event|1|||
155290253|NCT05663866|560492455|FG003|Overall Study|Adverse Event|0|||
155290254|NCT05663866|560492452|FG000|Overall Study|Physician Decision|0|||
155290255|NCT05663866|560492453|FG001|Overall Study|Physician Decision|0|||
155290256|NCT05663866|560492454|FG002|Overall Study|Physician Decision|0|||
155290257|NCT05663866|560492455|FG003|Overall Study|Physician Decision|1|||
155290258|NCT05663866|560492452|FG000|Overall Study|Withdrawal by Subject|0|||
155290259|NCT05663866|560492453|FG001|Overall Study|Withdrawal by Subject|2|||
155290260|NCT05663866|560492454|FG002|Overall Study|Withdrawal by Subject|1|||
155743409|NCT01579812|562159878|FG000|Overall Study|Ineligible after treatment start|40|||
155743410|NCT01579812|562159878|FG000|Overall Study|Patient choice|3|||
155743411|NCT01579812|562159878|FG000|Overall Study|Noncompliance|3|||
155743412|NCT01579812|562159878|FG000|Overall Study|Withdrawal by Subject|6|||
155743413|NCT00653432|562159880|FG000|Overall Study|Adverse Event|4|||
155743414|NCT00653432|562159881|FG001|Overall Study|Adverse Event|1|||
155743415|NCT00653432|562159880|FG000|Overall Study|Withdrawal by Subject|4|||
155743416|NCT00653432|562159881|FG001|Overall Study|Withdrawal by Subject|5|||
155743417|NCT00653432|562159880|FG000|Overall Study|Lost to Follow-up|7|||
155743418|NCT00653432|562159881|FG001|Overall Study|Lost to Follow-up|6|||
155743419|NCT00653432|562159880|FG000|Overall Study|Use/Need of Con Therapy|2|||
155743420|NCT00653432|562159881|FG001|Overall Study|Use/Need of Con Therapy|1|||
155743421|NCT00653432|562159880|FG000|Overall Study|Other - Reason Not Provided|5|||
155743422|NCT00653432|562159881|FG001|Overall Study|Other - Reason Not Provided|3|||
155743423|NCT05277337|562159882|FG000|Overall Study|Lost to Follow-up|2|||
155743424|NCT05277337|562159883|FG001|Overall Study|Lost to Follow-up|0|||
155743425|NCT05277337|562159882|FG000|Overall Study|Withdrawal by Subject|1|||
155743426|NCT05277337|562159883|FG001|Overall Study|Withdrawal by Subject|0|||
155743427|NCT03726996|562159884|FG000|Overall Study|Parent's decision|2|||
155743428|NCT03726996|562159884|FG000|Overall Study|Study early termination|2|||
155743429|NCT03531632|562159889|FG000|Overall Study|Adverse Event|0|||
155743430|NCT03531632|562159890|FG001|Overall Study|Adverse Event|0|||
155743431|NCT03531632|562159891|FG002|Overall Study|Adverse Event|1|||
155743432|NCT03531632|562159889|FG000|Overall Study|Death|4|||
155743433|NCT03531632|562159890|FG001|Overall Study|Death|0|||
155743434|NCT03531632|562159891|FG002|Overall Study|Death|14|||
155743435|NCT03531632|562159889|FG000|Overall Study|Study Terminated|1|||
155743436|NCT03531632|562159890|FG001|Overall Study|Study Terminated|3|||
155743437|NCT03531632|562159891|FG002|Overall Study|Study Terminated|11|||
155743438|NCT01224782|562159894|FG000|Overall Study|Lost to Follow-up|177|||
155743439|NCT01224782|562159894|FG000|Overall Study|Withdrawal by Subject|16|||
155743440|NCT01224782|562159894|FG000|Overall Study|Death|14|||
155743441|NCT01224782|562159894|FG000|Overall Study|Improvement|13|||
155743442|NCT01224782|562159894|FG000|Overall Study|Adverse Event|12|||
155290261|NCT05663866|560492455|FG003|Overall Study|Withdrawal by Subject|2|||
155290262|NCT05663866|560492452|FG000|Overall Study|Progressive disease|4|||
155290263|NCT05663866|560492453|FG001|Overall Study|Progressive disease|8|||
155290264|NCT05663866|560492454|FG002|Overall Study|Progressive disease|5|||
155743443|NCT01224782|562159894|FG000|Overall Study|Adverse Reaction|11|||
155743444|NCT01224782|562159894|FG000|Overall Study|Noncompliance|10|||
155743445|NCT01224782|562159894|FG000|Overall Study|Other|4|||
155743446|NCT01224782|562159894|FG000|Overall Study|Start of Dialysis|3|||
155743447|NCT01224782|562159894|FG000|Overall Study|Change of Treatment|1|||
155290265|NCT05663866|560492455|FG003|Overall Study|Progressive disease|2|||
155290266|NCT05663866|560492452|FG000|Overall Study|Other|1|||
155408748|NCT02599961|560928815|FG000|Overall Study|Withdrawal by Subject|1|||
155743448|NCT01224782|562159894|FG000|Overall Study|Financial Reasons|1|||
155743449|NCT01224782|562159894|FG000|Overall Study|Deterioration|1|||
155743450|NCT01224782|562159894|FG000|Overall Study|Transplantation|1|||
155290267|NCT05663866|560492453|FG001|Overall Study|Other|0|||
155290268|NCT05663866|560492454|FG002|Overall Study|Other|0|||
155743451|NCT03554486|562159895|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
155743452|NCT03554486|562159896|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
155743453|NCT03554486|562159897|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
155290269|NCT05663866|560492455|FG003|Overall Study|Other|0|||
155743454|NCT03554486|562159895|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
155743455|NCT03554486|562159896|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
155743456|NCT03554486|562159897|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
155290270|NCT05663866|560492452|FG000|Overall Study|Ongoing|1|||
155290271|NCT05663866|560492453|FG001|Overall Study|Ongoing|27|||
155290272|NCT05663866|560492454|FG002|Overall Study|Ongoing|6|||
155290273|NCT05663866|560492455|FG003|Overall Study|Ongoing|1|||
155290274|NCT01467427|560493310|FG000|Overall Study|Withdrawal by Subject|1|||
155290275|NCT01467427|560493311|FG001|Overall Study|Withdrawal by Subject|0|||
155290276|NCT01467427|560493310|FG000|Overall Study|Not continuing in extension phase|0|||
155290277|NCT01467427|560493311|FG001|Overall Study|Not continuing in extension phase|2|||
155290278|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
155290279|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
155290280|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
155290281|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
155290282|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
155290283|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
155290284|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
155290285|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
155290286|NCT03805295|560493312|FG000|Overall Study|Lost to Follow-up|17|||
155290287|NCT03805295|560493313|FG001|Overall Study|Lost to Follow-up|43|||
155290288|NCT04925752|560493314|FG000|Overall Study|Still on Study|1826|||
155638193|NCT03805841|561766395|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
155290289|NCT04925752|560493315|FG001|Overall Study|Still on Study|926|||
155290290|NCT04925752|560493314|FG000|Overall Study|Withdrew Consent|128|||
155638194|NCT03805841|561766396|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
155638195|NCT03805841|561766397|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
155638196|NCT05248386|561766398|FG000|Overall Study|Technical problems|0|||
155638197|NCT05248386|561766399|FG001|Overall Study|Technical problems|1|||
155638198|NCT05248386|561766398|FG000|Overall Study|Withdrawal by Subject|15|||
155638199|NCT05248386|561766399|FG001|Overall Study|Withdrawal by Subject|10|||
155638200|NCT05248386|561766398|FG000|Overall Study|Physician Decision|0|||
155638201|NCT05248386|561766399|FG001|Overall Study|Physician Decision|1|||
155638202|NCT05248386|561766398|FG000|Overall Study|Adverse Event|2|||
155638203|NCT05248386|561766399|FG001|Overall Study|Adverse Event|4|||
155638204|NCT05248386|561766398|FG000|Overall Study|Other|1|||
155638205|NCT05248386|561766399|FG001|Overall Study|Other|0|||
155638206|NCT05248386|561766398|FG000|Overall Study|Lack of Efficacy|14|||
155638207|NCT05248386|561766399|FG001|Overall Study|Lack of Efficacy|12|||
155638208|NCT01723774|561766400|FG000|Neoadjuvant|Ki67 > 10%|4|||
155638209|NCT01723774|561766401|FG001|Neoadjuvant|Ki67 > 10%|0|||
155638210|NCT01723774|561766402|FG002|Neoadjuvant|Ki67 > 10%|10|||
155638211|NCT01723774|561766403|FG003|Neoadjuvant|Ki67 > 10%|0|||
155638212|NCT01723774|561766400|FG000|Neoadjuvant|Withdrawal by Subject|3|||
155638213|NCT01723774|561766401|FG001|Neoadjuvant|Withdrawal by Subject|1|||
155638214|NCT01723774|561766402|FG002|Neoadjuvant|Withdrawal by Subject|0|||
155638215|NCT01723774|561766403|FG003|Neoadjuvant|Withdrawal by Subject|0|||
155638216|NCT01723774|561766400|FG000|Neoadjuvant|Disease progression|0|||
155638217|NCT01723774|561766401|FG001|Neoadjuvant|Disease progression|1|||
155638218|NCT01723774|561766402|FG002|Neoadjuvant|Disease progression|1|||
155290291|NCT04925752|560493315|FG001|Overall Study|Withdrew Consent|59|||
155290292|NCT04925752|560493314|FG000|Overall Study|Lost to Follow-up|73|||
155290293|NCT04925752|560493315|FG001|Overall Study|Lost to Follow-up|47|||
155290294|NCT04925752|560493314|FG000|Overall Study|Randomized but Never Treated|12|||
155290295|NCT04925752|560493315|FG001|Overall Study|Randomized but Never Treated|9|||
155290296|NCT04925752|560493314|FG000|Overall Study|Hiv-1 Infection|6|||
155290297|NCT04925752|560493315|FG001|Overall Study|Hiv-1 Infection|7|||
155290298|NCT04925752|560493314|FG000|Overall Study|Investigator's discretion|8|||
155290299|NCT04925752|560493315|FG001|Overall Study|Investigator's discretion|5|||
155290300|NCT04925752|560493314|FG000|Overall Study|Non-compliance with Study Drug|8|||
155290301|NCT04925752|560493315|FG001|Overall Study|Non-compliance with Study Drug|5|||
155290302|NCT04925752|560493314|FG000|Overall Study|Adverse Event|5|||
155290303|NCT04925752|560493315|FG001|Overall Study|Adverse Event|2|||
155290304|NCT04925752|560493314|FG000|Overall Study|Death|4|||
155290305|NCT04925752|560493315|FG001|Overall Study|Death|2|||
155290306|NCT04925752|560493314|FG000|Overall Study|Protocol Violation|1|||
155290307|NCT04925752|560493315|FG001|Overall Study|Protocol Violation|3|||
155290308|NCT04925752|560493314|FG000|Overall Study|Withdrew Assent|1|||
155290309|NCT04925752|560493315|FG001|Overall Study|Withdrew Assent|0|||
155290310|NCT04269200|560493316|FG000|Global Cohort|Death|72|||
155290311|NCT04269200|560493317|FG001|Global Cohort|Death|54|||
155290312|NCT04269200|560493318|FG002|Global Cohort|Death|49|||
155290313|NCT04269200|560493316|FG000|Global Cohort|Lost to Follow-up|0|||
155290314|NCT04269200|560493317|FG001|Global Cohort|Lost to Follow-up|0|||
155290315|NCT04269200|560493318|FG002|Global Cohort|Lost to Follow-up|2|||
155290316|NCT04269200|560493316|FG000|Global Cohort|Withdrawal by Subject|22|||
155290317|NCT04269200|560493317|FG001|Global Cohort|Withdrawal by Subject|25|||
155290318|NCT04269200|560493318|FG002|Global Cohort|Withdrawal by Subject|18|||
155290319|NCT04269200|560493316|FG000|China Cohort|Death|12|||
155290320|NCT04269200|560493317|FG001|China Cohort|Death|11|||
155290321|NCT04269200|560493318|FG002|China Cohort|Death|13|||
155290322|NCT04269200|560493316|FG000|China Cohort|Lost to Follow-up|0|||
155290323|NCT04269200|560493317|FG001|China Cohort|Lost to Follow-up|1|||
155290324|NCT04269200|560493318|FG002|China Cohort|Lost to Follow-up|1|||
155290325|NCT04269200|560493316|FG000|China Cohort|Withdrawal by Subject|2|||
155290326|NCT04269200|560493317|FG001|China Cohort|Withdrawal by Subject|2|||
155290327|NCT04269200|560493318|FG002|China Cohort|Withdrawal by Subject|4|||
155290328|NCT04181827|560493319|FG000|Overall Study|Ongoing|124|||
155290329|NCT04181827|560493320|FG001|Overall Study|Ongoing|157|||
155290330|NCT04181827|560493319|FG000|Overall Study|Death|82|||
155290331|NCT04181827|560493320|FG001|Overall Study|Death|50|||
155290332|NCT04181827|560493319|FG000|Overall Study|Lost to Follow-up|0|||
155290333|NCT04181827|560493320|FG001|Overall Study|Lost to Follow-up|1|||
155290334|NCT04181827|560493319|FG000|Overall Study|Withdrawal by Subject|5|||
155743457|NCT03554486|562159895|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155743458|NCT03554486|562159896|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155743459|NCT03554486|562159897|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155743460|NCT01616693|562159899|FG000|Evaluated for Safety|Physician Decision|1|||
155743461|NCT01616693|562159900|FG001|Evaluated for Safety|Physician Decision|0|||
155743462|NCT01616693|562159901|FG002|Evaluated for Safety|Physician Decision|1|||
155743463|NCT01616693|562159902|FG003|Evaluated for Safety|Physician Decision|0|||
155743464|NCT01616693|562159899|FG000|Received Both Vaccines|Adverse Event|2|||
155743465|NCT01616693|562159900|FG001|Received Both Vaccines|Adverse Event|0|||
155743466|NCT01616693|562159901|FG002|Received Both Vaccines|Adverse Event|0|||
155743467|NCT01616693|562159902|FG003|Received Both Vaccines|Adverse Event|0|||
155743468|NCT01616693|562159899|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
155743469|NCT01616693|562159900|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
155743470|NCT01616693|562159901|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
155743471|NCT01616693|562159902|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
155743472|NCT01616693|562159899|FG000|Received Both Vaccines|Lost to Follow-up|4|||
155743473|NCT01616693|562159900|FG001|Received Both Vaccines|Lost to Follow-up|3|||
155743474|NCT01616693|562159901|FG002|Received Both Vaccines|Lost to Follow-up|4|||
155743475|NCT01616693|562159902|FG003|Received Both Vaccines|Lost to Follow-up|4|||
155743476|NCT01616693|562159899|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
155743477|NCT01616693|562159900|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
155743478|NCT01616693|562159901|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
155743479|NCT01616693|562159902|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
155743480|NCT02925338|562159906|FG000|Overall Study|Death|0|||
155743481|NCT02925338|562159907|FG001|Overall Study|Death|2|||
155743482|NCT02925338|562159908|FG002|Overall Study|Death|1|||
155743483|NCT02925338|562159909|FG003|Overall Study|Death|0|||
155743484|NCT02925338|562159910|FG004|Overall Study|Death|0|||
155743485|NCT02925338|562159906|FG000|Overall Study|Lost to Follow-up|30|||
155743486|NCT02925338|562159907|FG001|Overall Study|Lost to Follow-up|10|||
155743487|NCT02925338|562159908|FG002|Overall Study|Lost to Follow-up|1|||
155743488|NCT02925338|562159909|FG003|Overall Study|Lost to Follow-up|16|||
155743489|NCT02925338|562159910|FG004|Overall Study|Lost to Follow-up|3|||
155743490|NCT02925338|562159906|FG000|Overall Study|Withdrawal by Subject|3|||
155743491|NCT02925338|562159907|FG001|Overall Study|Withdrawal by Subject|0|||
155743492|NCT02925338|562159908|FG002|Overall Study|Withdrawal by Subject|3|||
155743493|NCT02925338|562159909|FG003|Overall Study|Withdrawal by Subject|2|||
155743494|NCT02925338|562159910|FG004|Overall Study|Withdrawal by Subject|2|||
155743495|NCT02925338|562159906|FG000|Overall Study|Missing|38|||
155743496|NCT02925338|562159907|FG001|Overall Study|Missing|27|||
155290335|NCT04181827|560493320|FG001|Overall Study|Withdrawal by Subject|0|||
155743497|NCT02925338|562159908|FG002|Overall Study|Missing|0|||
155743498|NCT02925338|562159909|FG003|Overall Study|Missing|3|||
155743499|NCT02925338|562159910|FG004|Overall Study|Missing|2|||
155743500|NCT02925338|562159906|FG000|Overall Study|Participant's Decision|11|||
155743501|NCT02925338|562159907|FG001|Overall Study|Participant's Decision|7|||
155743502|NCT02925338|562159908|FG002|Overall Study|Participant's Decision|3|||
155743503|NCT02925338|562159909|FG003|Overall Study|Participant's Decision|8|||
155743504|NCT02925338|562159910|FG004|Overall Study|Participant's Decision|1|||
155743505|NCT02925338|562159906|FG000|Overall Study|Treatment Discontinuation|144|||
155743506|NCT02925338|562159907|FG001|Overall Study|Treatment Discontinuation|65|||
155743507|NCT02925338|562159908|FG002|Overall Study|Treatment Discontinuation|56|||
155743508|NCT02925338|562159909|FG003|Overall Study|Treatment Discontinuation|131|||
155290336|NCT04538664|560493321|FG000|Overall Study|Withdrawal by Subject|5|||
155743509|NCT02925338|562159910|FG004|Overall Study|Treatment Discontinuation|22|||
155743510|NCT00029146|562159915|FG000|Overall Study|Lost to Follow-up|2|||
155743511|NCT00029146|562159916|FG001|Overall Study|Lost to Follow-up|1|||
155743512|NCT01765218|562159917|FG000|Overall Study|Protocol Violation|1|||
155290337|NCT04538664|560493322|FG001|Overall Study|Withdrawal by Subject|9|||
155290338|NCT04538664|560493321|FG000|Overall Study|Lost to Follow-up|2|||
155290339|NCT04538664|560493322|FG001|Overall Study|Lost to Follow-up|1|||
155290340|NCT04538664|560493321|FG000|Overall Study|Ongoing|106|||
155290341|NCT04538664|560493322|FG001|Overall Study|Ongoing|115|||
155290342|NCT03681678|560493323|FG000|Overall Study|Lost to Follow-up|20|||
155290343|NCT03431350|560493324|FG000|Overall Study|ONGOING|0|||
155290344|NCT03431350|560493325|FG001|Overall Study|ONGOING|0|||
155290345|NCT03431350|560493326|FG002|Overall Study|ONGOING|2|||
155290346|NCT03431350|560493327|FG003|Overall Study|ONGOING|0|||
155290347|NCT03431350|560493328|FG004|Overall Study|ONGOING|1|||
155290348|NCT03431350|560493329|FG005|Overall Study|ONGOING|3|||
155290349|NCT03431350|560493330|FG006|Overall Study|ONGOING|0|||
155290350|NCT03431350|560493331|FG007|Overall Study|ONGOING|1|||
155290351|NCT03431350|560493332|FG008|Overall Study|ONGOING|3|||
155290352|NCT03431350|560493333|FG009|Overall Study|ONGOING|4|||
155290353|NCT03431350|560493334|FG010|Overall Study|ONGOING|2|||
155290354|NCT03431350|560493335|FG011|Overall Study|ONGOING|1|||
155290355|NCT03431350|560493324|FG000|Overall Study|Death|6|||
155290356|NCT03431350|560493325|FG001|Overall Study|Death|5|||
155290357|NCT03431350|560493326|FG002|Overall Study|Death|18|||
155290358|NCT03431350|560493327|FG003|Overall Study|Death|7|||
155290359|NCT03431350|560493328|FG004|Overall Study|Death|4|||
155290360|NCT03431350|560493329|FG005|Overall Study|Death|3|||
155290361|NCT03431350|560493330|FG006|Overall Study|Death|2|||
155290362|NCT03431350|560493331|FG007|Overall Study|Death|0|||
155290363|NCT03431350|560493332|FG008|Overall Study|Death|0|||
155290364|NCT03431350|560493333|FG009|Overall Study|Death|0|||
155290365|NCT03431350|560493334|FG010|Overall Study|Death|4|||
155290366|NCT03431350|560493335|FG011|Overall Study|Death|0|||
155290367|NCT03431350|560493324|FG000|Overall Study|Lost to Follow-up|0|||
155290368|NCT03431350|560493325|FG001|Overall Study|Lost to Follow-up|1|||
155290369|NCT03431350|560493326|FG002|Overall Study|Lost to Follow-up|0|||
155290370|NCT03431350|560493327|FG003|Overall Study|Lost to Follow-up|0|||
155290371|NCT03431350|560493328|FG004|Overall Study|Lost to Follow-up|0|||
155290372|NCT03431350|560493329|FG005|Overall Study|Lost to Follow-up|0|||
155290373|NCT03431350|560493330|FG006|Overall Study|Lost to Follow-up|0|||
155290374|NCT03431350|560493331|FG007|Overall Study|Lost to Follow-up|0|||
155743513|NCT01765218|562159918|FG001|Overall Study|Protocol Violation|2|||
155743514|NCT01011309|562159919|FG000|Overall Study|Adverse Event|2|||
155743515|NCT01011309|562159920|FG001|Overall Study|Adverse Event|1|||
155743516|NCT01011309|562159921|FG002|Overall Study|Adverse Event|2|||
155743517|NCT01011309|562159919|FG000|Overall Study|Lack of Efficacy|0|||
155743518|NCT01011309|562159920|FG001|Overall Study|Lack of Efficacy|1|||
155743519|NCT01011309|562159921|FG002|Overall Study|Lack of Efficacy|0|||
155743520|NCT01011309|562159919|FG000|Overall Study|Protocol Violation|0|||
155743521|NCT01011309|562159920|FG001|Overall Study|Protocol Violation|1|||
155743522|NCT01011309|562159921|FG002|Overall Study|Protocol Violation|3|||
155743523|NCT01525225|562159929|FG000|Enrollment|No longer met study criteria|1|||
155743524|NCT01525225|562159929|FG000|Enrollment|Other|1|||
155743525|NCT00363545|562159930|FG000|Overall Study|Serious Adverse Event|0|||
155743526|NCT00363545|562159931|FG001|Overall Study|Serious Adverse Event|1|||
155743527|NCT00363545|562159930|FG000|Overall Study|Withdrawal by Subject|12|||
155743528|NCT00363545|562159931|FG001|Overall Study|Withdrawal by Subject|15|||
155743529|NCT00363545|562159930|FG000|Overall Study|Migrated/moved from study area|3|||
155290375|NCT03431350|560493332|FG008|Overall Study|Lost to Follow-up|0|||
155290376|NCT03431350|560493333|FG009|Overall Study|Lost to Follow-up|0|||
155290377|NCT03431350|560493334|FG010|Overall Study|Lost to Follow-up|0|||
155290378|NCT03431350|560493335|FG011|Overall Study|Lost to Follow-up|0|||
155290379|NCT03431350|560493324|FG000|Overall Study|Withdrawal by Subject|0|||
155290380|NCT03431350|560493325|FG001|Overall Study|Withdrawal by Subject|0|||
155290381|NCT03431350|560493326|FG002|Overall Study|Withdrawal by Subject|0|||
155408749|NCT02599961|560928815|FG000|Overall Study|Subject Non-Compliance|2|||
155408750|NCT02599961|560928815|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
155408751|NCT02599961|560928815|FG000|Overall Study|Other, Not Specified|3|||
155408752|NCT00401752|560928816|FG000|Overall Study|Adverse Event|2|||
155290382|NCT03431350|560493327|FG003|Overall Study|Withdrawal by Subject|1|||
155408753|NCT00401752|560928817|FG001|Overall Study|Adverse Event|5|||
155408754|NCT00401752|560928816|FG000|Overall Study|Withdrawal by Subject|2|||
155743530|NCT00363545|562159931|FG001|Overall Study|Migrated/moved from study area|6|||
155743531|NCT00363545|562159930|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
155290383|NCT03431350|560493328|FG004|Overall Study|Withdrawal by Subject|1|||
155743532|NCT00363545|562159931|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
155290384|NCT03431350|560493329|FG005|Overall Study|Withdrawal by Subject|1|||
155290385|NCT03431350|560493330|FG006|Overall Study|Withdrawal by Subject|0|||
155743533|NCT00363545|562159930|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
155743534|NCT00363545|562159931|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
155743535|NCT00363545|562159930|FG000|Overall Study|Others|1|||
155743536|NCT00363545|562159931|FG001|Overall Study|Others|0|||
155290386|NCT03431350|560493331|FG007|Overall Study|Withdrawal by Subject|0|||
155290387|NCT03431350|560493332|FG008|Overall Study|Withdrawal by Subject|0|||
155290388|NCT03431350|560493333|FG009|Overall Study|Withdrawal by Subject|2|||
155290389|NCT03431350|560493334|FG010|Overall Study|Withdrawal by Subject|0|||
155408755|NCT00401752|560928817|FG001|Overall Study|Withdrawal by Subject|6|||
155290390|NCT03431350|560493335|FG011|Overall Study|Withdrawal by Subject|1|||
155290391|NCT03431350|560493324|FG000|Overall Study|Other|0|||
155290392|NCT03431350|560493325|FG001|Overall Study|Other|0|||
155290393|NCT03431350|560493326|FG002|Overall Study|Other|1|||
155290394|NCT03431350|560493327|FG003|Overall Study|Other|3|||
155290395|NCT03431350|560493328|FG004|Overall Study|Other|2|||
155290396|NCT03431350|560493329|FG005|Overall Study|Other|2|||
155290397|NCT03431350|560493330|FG006|Overall Study|Other|4|||
155290398|NCT03431350|560493331|FG007|Overall Study|Other|0|||
155290399|NCT03431350|560493332|FG008|Overall Study|Other|14|||
155290400|NCT03431350|560493333|FG009|Overall Study|Other|11|||
155290401|NCT03431350|560493334|FG010|Overall Study|Other|11|||
155290402|NCT03431350|560493335|FG011|Overall Study|Other|15|||
155290403|NCT02141074|560493338|FG000|Pre-prophylaxis|Adverse Event|3|||
155290404|NCT02141074|560493339|FG001|Pre-prophylaxis|Adverse Event|0|||
155290405|NCT02141074|560493338|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
155290406|NCT02141074|560493339|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
155290407|NCT02141074|560493338|FG000|Prophylaxis|Adverse Event|0|||
155290408|NCT02141074|560493339|FG001|Prophylaxis|Adverse Event|4|||
155290409|NCT02141074|560493338|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
155290410|NCT02141074|560493339|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
155290411|NCT02141074|560493338|FG000|Prophylaxis|Withdrawal by Subject|0|||
155290412|NCT02141074|560493339|FG001|Prophylaxis|Withdrawal by Subject|1|||
155290413|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
155290414|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
155290415|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290416|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290417|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290418|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290419|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290420|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290421|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290422|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290423|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290424|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290425|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290426|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
155290427|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290428|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290429|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290430|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290431|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290432|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290433|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155743537|NCT01182844|562159932|FG000|Overall Study|Withdrawal by Subject|0|||
155290434|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290435|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290436|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290437|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
155290438|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
155290439|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290440|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290441|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290442|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290443|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290444|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290445|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290446|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290447|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290448|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290449|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290450|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
155290451|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290452|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290453|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290454|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290455|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290456|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155743538|NCT01182844|562159933|FG001|Overall Study|Withdrawal by Subject|2|||
155290457|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290458|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290459|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290460|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290461|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290462|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
155290463|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290464|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290465|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290466|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290467|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290468|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290469|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290470|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290471|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290472|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290473|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290474|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
155290475|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290476|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290477|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290478|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290479|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290480|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290481|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290482|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290483|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290484|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290485|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290486|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290487|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
155290488|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290489|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
155290490|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290491|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290492|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290493|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290494|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290495|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290496|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290497|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290498|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290499|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
155290500|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
155290501|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
155290502|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290503|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290504|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290505|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290506|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290507|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290508|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290509|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290510|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290511|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290512|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
155290513|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
155290514|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290515|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290516|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290517|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155408756|NCT00401752|560928816|FG000|Overall Study|Lost to Follow-up|1|||
155408757|NCT00401752|560928817|FG001|Overall Study|Lost to Follow-up|4|||
155408758|NCT00401752|560928816|FG000|Overall Study|Development of any exclusion criteria|4|||
155638219|NCT01723774|561766403|FG003|Neoadjuvant|Disease progression|0|||
155638220|NCT01723774|561766400|FG000|Neoadjuvant|Adverse Event|0|||
155638221|NCT01723774|561766401|FG001|Neoadjuvant|Adverse Event|1|||
155638222|NCT01723774|561766402|FG002|Neoadjuvant|Adverse Event|2|||
155638223|NCT01723774|561766403|FG003|Neoadjuvant|Adverse Event|0|||
155743539|NCT05009979|562159937|FG000|Overall Study|Withdrawal by Subject|1|||
155743540|NCT01350544|562161510|FG000|Overall Study|Administrative Withdrawal|0|||
155743541|NCT01350544|562161511|FG001|Overall Study|Administrative Withdrawal|1|||
155743542|NCT01350544|562161510|FG000|Overall Study|Death|1|||
155743543|NCT01350544|562161511|FG001|Overall Study|Death|2|||
155743544|NCT01350544|562161510|FG000|Overall Study|Moved out of LA County|2|||
155743545|NCT01350544|562161511|FG001|Overall Study|Moved out of LA County|2|||
155743546|NCT01350544|562161510|FG000|Overall Study|Medical Issues|1|||
155743547|NCT01350544|562161511|FG001|Overall Study|Medical Issues|1|||
155743548|NCT01350544|562161510|FG000|Overall Study|Withdrawal by Subject|0|||
155743549|NCT01350544|562161511|FG001|Overall Study|Withdrawal by Subject|1|||
155743550|NCT01350544|562161510|FG000|Overall Study|Incarceration|1|||
155743551|NCT01350544|562161511|FG001|Overall Study|Incarceration|0|||
155743552|NCT01350544|562161510|FG000|Overall Study|Lost to Follow-up|18|||
155743553|NCT01350544|562161511|FG001|Overall Study|Lost to Follow-up|15|||
155743554|NCT00910624|562161512|FG000|Treatment Phase|Adverse Event|2|||
155743555|NCT00910624|562161513|FG001|Treatment Phase|Adverse Event|6|||
155743556|NCT00910624|562161514|FG002|Treatment Phase|Adverse Event|6|||
155743557|NCT00910624|562161515|FG003|Treatment Phase|Adverse Event|0|||
155743558|NCT00910624|562161512|FG000|Treatment Phase|Treatment Failure|23|||
155743559|NCT00910624|562161513|FG001|Treatment Phase|Treatment Failure|10|||
155743560|NCT00910624|562161514|FG002|Treatment Phase|Treatment Failure|0|||
155743561|NCT00910624|562161515|FG003|Treatment Phase|Treatment Failure|0|||
155743562|NCT00910624|562161512|FG000|Treatment Phase|Lost to Follow-up|0|||
155743563|NCT00910624|562161513|FG001|Treatment Phase|Lost to Follow-up|0|||
155743564|NCT00910624|562161514|FG002|Treatment Phase|Lost to Follow-up|1|||
155743565|NCT00910624|562161515|FG003|Treatment Phase|Lost to Follow-up|0|||
155743566|NCT00910624|562161512|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
155743567|NCT00910624|562161513|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
155743568|NCT00910624|562161514|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
155743569|NCT00910624|562161515|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
155743570|NCT00910624|562161512|FG000|Treatment Phase|Withdrawal by Subject|2|||
155743571|NCT00910624|562161513|FG001|Treatment Phase|Withdrawal by Subject|1|||
155743572|NCT00910624|562161514|FG002|Treatment Phase|Withdrawal by Subject|0|||
155743573|NCT00910624|562161515|FG003|Treatment Phase|Withdrawal by Subject|0|||
155743574|NCT00910624|562161512|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
155743575|NCT00910624|562161513|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
155743576|NCT00910624|562161514|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
155743577|NCT00910624|562161515|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
155743578|NCT00910624|562161512|FG000|Follow-Up Phase|Adverse Event|0|||
155743579|NCT00910624|562161513|FG001|Follow-Up Phase|Adverse Event|0|||
155743580|NCT00910624|562161514|FG002|Follow-Up Phase|Adverse Event|1|||
155743581|NCT00910624|562161515|FG003|Follow-Up Phase|Adverse Event|0|||
155743582|NCT00910624|562161512|FG000|Follow-Up Phase|Lost to Follow-up|3|||
155638224|NCT01723774|561766400|FG000|Neoadjuvant|High estradiol|0|||
155638225|NCT01723774|561766401|FG001|Neoadjuvant|High estradiol|1|||
155638226|NCT01723774|561766402|FG002|Neoadjuvant|High estradiol|0|||
155743583|NCT00910624|562161513|FG001|Follow-Up Phase|Lost to Follow-up|1|||
155743584|NCT00910624|562161514|FG002|Follow-Up Phase|Lost to Follow-up|2|||
155743585|NCT00910624|562161515|FG003|Follow-Up Phase|Lost to Follow-up|0|||
155743586|NCT00910624|562161512|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
155743587|NCT00910624|562161513|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
155743588|NCT00910624|562161514|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
155743589|NCT00910624|562161515|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
155743590|NCT00910624|562161512|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
155743591|NCT00910624|562161513|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
155743592|NCT00910624|562161514|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
155743593|NCT00910624|562161515|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
155743594|NCT00910624|562161512|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
155743595|NCT00910624|562161513|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
155743596|NCT00910624|562161514|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
155743597|NCT00910624|562161515|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
155638227|NCT01723774|561766403|FG003|Neoadjuvant|High estradiol|0|||
155638228|NCT02964182|561766404|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155638229|NCT02964182|561766405|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
155743598|NCT00910624|562161512|FG000|Follow-Up Phase|Administrative|0|||
155743599|NCT00910624|562161513|FG001|Follow-Up Phase|Administrative|1|||
155743600|NCT00910624|562161514|FG002|Follow-Up Phase|Administrative|1|||
155743601|NCT00910624|562161515|FG003|Follow-Up Phase|Administrative|0|||
155743602|NCT04585009|562161519|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
155743603|NCT04585009|562161520|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743604|NCT04585009|562161521|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743605|NCT04585009|562161522|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743606|NCT04585009|562161523|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743607|NCT04585009|562161524|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743608|NCT04585009|562161525|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743609|NCT04585009|562161526|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743610|NCT04585009|562161527|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743611|NCT04585009|562161528|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743612|NCT04585009|562161529|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155743613|NCT04585009|562161530|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155290518|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290519|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290520|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290521|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290522|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290523|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
155290524|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
155290525|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
155290526|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290527|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290528|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290529|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290530|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290531|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290532|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290533|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290534|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290535|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
155290536|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
155290537|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
155290538|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290539|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290540|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290541|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290542|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290543|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290544|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290545|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290546|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290547|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290548|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290549|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290550|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
155290551|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
155290552|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
155290553|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
155290554|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290555|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290556|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290557|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290558|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290559|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290560|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290561|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290562|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290563|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290564|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290565|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
155290566|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155408759|NCT00401752|560928817|FG001|Overall Study|Development of any exclusion criteria|2|||
155743614|NCT04585009|562161519|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
155743615|NCT04585009|562161520|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155408760|NCT00401752|560928816|FG000|Overall Study|Physician Decision|1|||
155743616|NCT04585009|562161521|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743617|NCT04585009|562161522|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155638230|NCT02964182|561766406|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155638231|NCT02964182|561766407|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155638232|NCT02964182|561766408|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155638233|NCT02964182|561766409|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
155638234|NCT02964182|561766410|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155638235|NCT02964182|561766411|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155290567|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290568|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290569|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290570|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290571|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290572|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290573|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290574|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
155290575|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290576|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
155290577|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290578|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290579|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290580|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290581|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290582|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155408761|NCT00401752|560928817|FG001|Overall Study|Physician Decision|1|||
155408762|NCT00143312|560928820|FG000|Overall Study|Death|11|||
155408763|NCT00143312|560928820|FG000|Overall Study|Adverse Event|2|||
155408764|NCT00143312|560928820|FG000|Overall Study|Lost to Follow-up|1|||
155408765|NCT00143312|560928820|FG000|Overall Study|Other|1|||
155408766|NCT00143312|560928820|FG000|Overall Study|Withdrawal by Subject|1|||
155408767|NCT01046877|560928824|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
155408768|NCT01046877|560928824|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
155408769|NCT01834274|560928825|FG000|Overall Study|Study Termination|41|||
155408770|NCT01834274|560928826|FG001|Overall Study|Study Termination|38|||
155408771|NCT01834274|560928825|FG000|Overall Study|Withdrawal by Subject|1|||
155408772|NCT01834274|560928826|FG001|Overall Study|Withdrawal by Subject|1|||
155408773|NCT01834274|560928825|FG000|Overall Study|Lost to Follow-up|3|||
155408774|NCT01834274|560928826|FG001|Overall Study|Lost to Follow-up|1|||
155408775|NCT01834274|560928825|FG000|Overall Study|Other|2|||
155408776|NCT01834274|560928826|FG001|Overall Study|Other|1|||
155408777|NCT03681119|560928831|FG000|Overall Study|No specific reason|4|||
155408778|NCT03681119|560928832|FG001|Overall Study|No specific reason|0|||
155408779|NCT03681119|560928831|FG000|Overall Study|Sickness|2|||
155408780|NCT03681119|560928832|FG001|Overall Study|Sickness|0|||
155408781|NCT04288154|560928836|FG000|Overall Study|Withdrawal by Subject|9|||
155408782|NCT04288154|560928837|FG001|Overall Study|Withdrawal by Subject|9|||
155408783|NCT00835237|560928838|FG000|Overall Study|Lost to Follow-up|4|||
155408784|NCT00835237|560928839|FG001|Overall Study|Lost to Follow-up|0|||
155408785|NCT00835237|560928838|FG000|Overall Study|Withdrawal by Subject|2|||
155638236|NCT02964182|561766404|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638237|NCT02964182|561766405|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638238|NCT02964182|561766406|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638239|NCT02964182|561766407|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638240|NCT02964182|561766408|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638241|NCT02964182|561766409|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
155638242|NCT02964182|561766410|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638243|NCT02964182|561766411|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155638244|NCT02964182|561766404|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638245|NCT02964182|561766405|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
155638246|NCT02964182|561766406|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638247|NCT02964182|561766407|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638248|NCT02964182|561766408|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638249|NCT02964182|561766409|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
155638250|NCT02964182|561766410|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638251|NCT02964182|561766411|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155638252|NCT02964182|561766404|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155638253|NCT02964182|561766405|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155638254|NCT02964182|561766406|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
155638255|NCT02964182|561766407|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
155638256|NCT02964182|561766408|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155638257|NCT02964182|561766409|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155638258|NCT02964182|561766410|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
155638259|NCT02964182|561766411|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155638260|NCT02964182|561766404|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155638261|NCT02964182|561766405|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155638262|NCT02964182|561766406|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
155638263|NCT02964182|561766407|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
155638264|NCT02964182|561766408|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155638265|NCT02964182|561766409|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155290583|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290584|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290585|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290586|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
155290587|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290588|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
155290589|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
155290590|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290591|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290592|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290593|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290594|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290595|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290596|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290597|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290598|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
155290599|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
155290600|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
155290601|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
155290602|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290603|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290604|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290605|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290606|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290607|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290608|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290609|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290610|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
155290611|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290612|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290613|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290614|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290615|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290616|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290617|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290618|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290619|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290620|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290621|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290622|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290623|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
155290624|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290625|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290626|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290627|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155408786|NCT00835237|560928839|FG001|Overall Study|Withdrawal by Subject|0|||
155408787|NCT00606086|560928842|FG000|Overall Study|Adverse Event|1|||
155408788|NCT00606086|560928843|FG001|Overall Study|Adverse Event|1|||
155408789|NCT00606086|560928842|FG000|Overall Study|Lost to Follow-up|4|||
155408790|NCT00606086|560928843|FG001|Overall Study|Lost to Follow-up|8|||
155408791|NCT00606086|560928842|FG000|Overall Study|Protocol Violation|1|||
155408792|NCT00606086|560928843|FG001|Overall Study|Protocol Violation|0|||
155408793|NCT00606086|560928842|FG000|Overall Study|Withdrawal by Subject|5|||
155408794|NCT00606086|560928843|FG001|Overall Study|Withdrawal by Subject|3|||
155408795|NCT00606086|560928842|FG000|Overall Study|Non-compliance|0|||
155408796|NCT00606086|560928843|FG001|Overall Study|Non-compliance|1|||
155408797|NCT00606086|560928842|FG000|Overall Study|Randomized, not treated|1|||
155408798|NCT00606086|560928843|FG001|Overall Study|Randomized, not treated|2|||
155408799|NCT00391222|560928849|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
155290628|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290629|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290630|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290631|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155408800|NCT00391222|560928850|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
155408801|NCT00391222|560928851|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
155743618|NCT04585009|562161523|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155290632|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290633|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290634|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290635|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
155290636|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290637|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290638|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290639|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290640|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290641|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290642|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290643|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290644|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290645|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290646|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
155290647|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290648|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290649|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290650|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290651|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290652|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290653|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290654|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290655|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290656|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290657|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290658|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290659|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290660|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290661|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
155290662|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290663|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290664|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290665|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290666|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290667|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290668|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290669|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290670|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290671|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290672|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290673|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290674|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155290675|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155290676|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155290677|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290678|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290679|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290680|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290681|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290682|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290683|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290684|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290685|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290686|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290687|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290688|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290689|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155408802|NCT00391222|560928852|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
155408803|NCT00391222|560928849|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
155408804|NCT00391222|560928850|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
155408805|NCT00391222|560928851|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
155408806|NCT00391222|560928852|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
155408807|NCT00391222|560928849|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
155408808|NCT00391222|560928850|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
155743619|NCT04585009|562161524|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155290690|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290691|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290692|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290693|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290694|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290695|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290696|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290697|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290698|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290699|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
155290700|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290701|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290702|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290703|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290704|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290705|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290706|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290707|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290708|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290709|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290710|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290711|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290712|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
155290713|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155743620|NCT04585009|562161525|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743621|NCT04585009|562161526|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743622|NCT04585009|562161527|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743623|NCT04585009|562161528|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743624|NCT04585009|562161529|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743625|NCT04585009|562161530|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155743626|NCT04585009|562161519|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743627|NCT04585009|562161520|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743628|NCT04585009|562161521|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743629|NCT04585009|562161522|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743630|NCT04585009|562161523|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743631|NCT04585009|562161524|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743632|NCT04585009|562161525|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743633|NCT04585009|562161526|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
155743634|NCT04585009|562161527|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743635|NCT04585009|562161528|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155290714|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290715|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290716|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290717|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290718|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290719|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290720|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290721|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290722|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290723|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290724|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
155290725|NCT03301220|560493352|FG000|Overall Study|Death|26|||
155290726|NCT03301220|560493353|FG001|Overall Study|Death|15|||
155290727|NCT03301220|560493352|FG000|Overall Study|Withdrawal by Subject|23|||
155408809|NCT00391222|560928851|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
155743636|NCT04585009|562161529|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743637|NCT04585009|562161530|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155743638|NCT04585009|562161519|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743639|NCT04585009|562161520|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743640|NCT04585009|562161521|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743641|NCT04585009|562161522|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155290728|NCT03301220|560493353|FG001|Overall Study|Withdrawal by Subject|12|||
155290729|NCT03301220|560493352|FG000|Overall Study|Lost to Follow-up|1|||
155290730|NCT03301220|560493353|FG001|Overall Study|Lost to Follow-up|1|||
155290731|NCT03301220|560493352|FG000|Overall Study|Randomized in error|1|||
155290732|NCT03301220|560493353|FG001|Overall Study|Randomized in error|1|||
155290733|NCT03301220|560493352|FG000|Overall Study|Randomized but not treated|0|||
155290734|NCT03301220|560493353|FG001|Overall Study|Randomized but not treated|1|||
155290735|NCT03301220|560493352|FG000|Overall Study|Ongoing followup|145|||
155290736|NCT03301220|560493353|FG001|Overall Study|Ongoing followup|163|||
155290737|NCT03301220|560493352|FG000|Overall Study|Principal Investigator and participant decision|0|||
155290738|NCT03301220|560493353|FG001|Overall Study|Principal Investigator and participant decision|1|||
155290739|NCT04845620|560493354|FG000|Overall Study|Withdrawal by Subject|11|||
155290740|NCT04845620|560493355|FG001|Overall Study|Withdrawal by Subject|10|||
155290741|NCT04845620|560493354|FG000|Overall Study|Adverse Event|5|||
155290742|NCT04845620|560493355|FG001|Overall Study|Adverse Event|4|||
155290743|NCT04845620|560493354|FG000|Overall Study|Lost to Follow-up|5|||
155290744|NCT04845620|560493355|FG001|Overall Study|Lost to Follow-up|4|||
155290745|NCT04845620|560493354|FG000|Overall Study|Lack of Efficacy|4|||
155290746|NCT04845620|560493355|FG001|Overall Study|Lack of Efficacy|4|||
155743642|NCT04585009|562161523|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
155743643|NCT04585009|562161524|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743644|NCT04585009|562161525|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743645|NCT04585009|562161526|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743646|NCT04585009|562161527|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743647|NCT04585009|562161528|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743648|NCT04585009|562161529|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743649|NCT04585009|562161530|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155743650|NCT04585009|562161519|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743651|NCT04585009|562161520|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743652|NCT04585009|562161521|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743653|NCT04585009|562161522|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743654|NCT04585009|562161523|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743655|NCT04585009|562161524|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743656|NCT04585009|562161525|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743657|NCT04585009|562161526|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743658|NCT04585009|562161527|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743659|NCT04585009|562161528|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
155743660|NCT04585009|562161529|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743661|NCT04585009|562161530|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155743662|NCT04585009|562161519|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743663|NCT04585009|562161520|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743664|NCT04585009|562161521|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743665|NCT04585009|562161522|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743666|NCT04585009|562161523|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743667|NCT04585009|562161524|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743668|NCT04585009|562161525|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743669|NCT04585009|562161526|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743670|NCT04585009|562161527|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743671|NCT04585009|562161528|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743672|NCT04585009|562161529|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155743673|NCT04585009|562161530|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
155743674|NCT01104376|562161531|FG000|Overall Study|Withdrawal by Subject|15|||
155743675|NCT01104376|562161531|FG000|Overall Study|Consented but excluded after labs|13|||
155290747|NCT04845620|560493354|FG000|Overall Study|Physician Decision|2|||
155290748|NCT04845620|560493355|FG001|Overall Study|Physician Decision|1|||
155743676|NCT01673347|562161532|FG000|Overall Study|failure of allograft|7|||
155743677|NCT00895011|562161537|FG000|Overall Study|Withdrawal by Subject|14|||
155743678|NCT00895011|562161538|FG001|Overall Study|Withdrawal by Subject|7|||
155743679|NCT00895011|562161539|FG002|Overall Study|Withdrawal by Subject|2|||
155743680|NCT00895011|562161537|FG000|Overall Study|Lost to Follow-up|5|||
155743681|NCT00895011|562161538|FG001|Overall Study|Lost to Follow-up|4|||
155743682|NCT00895011|562161539|FG002|Overall Study|Lost to Follow-up|1|||
155743683|NCT00895011|562161537|FG000|Overall Study|Protocol Violation|3|||
155290749|NCT05803720|560493356|FG000|Overall Study|Lost to Follow-up|3|||
155290750|NCT05803720|560493357|FG001|Overall Study|Lost to Follow-up|4|||
155290751|NCT05803720|560493356|FG000|Overall Study|Family leave/emergency|1|||
155290752|NCT05803720|560493357|FG001|Overall Study|Family leave/emergency|1|||
155290753|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
155743684|NCT00895011|562161538|FG001|Overall Study|Protocol Violation|1|||
155743685|NCT00895011|562161539|FG002|Overall Study|Protocol Violation|3|||
155743686|NCT00895011|562161537|FG000|Overall Study|Adverse Event|1|||
155743687|NCT00895011|562161538|FG001|Overall Study|Adverse Event|2|||
155743688|NCT00895011|562161539|FG002|Overall Study|Adverse Event|2|||
155743689|NCT00895011|562161537|FG000|Overall Study|schedule conflict|1|||
155290754|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
155290755|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
155290756|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290757|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290758|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290759|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Death|1|||
155290760|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Death|1|||
155290761|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Death|1|||
155290762|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Death|0|||
155290763|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Death|0|||
155290764|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Death|0|||
155290765|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
155290766|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
155290767|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290768|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290769|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290770|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290771|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290772|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290773|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
155290774|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290775|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290776|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290777|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290778|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
155290779|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290780|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290781|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290782|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290783|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
155290784|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
155290785|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
155290786|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290787|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290788|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290789|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290790|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
155290791|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290792|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290793|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290794|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290795|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
155290796|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
155290797|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
155290798|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
155290799|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
155290800|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
155290801|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290802|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290803|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290804|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
155290805|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
155290806|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
155290807|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290808|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290809|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290810|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290811|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
155408810|NCT00391222|560928852|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
155408811|NCT00391222|560928849|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
155290812|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
155743690|NCT00895011|562161538|FG001|Overall Study|schedule conflict|0|||
155743691|NCT00895011|562161539|FG002|Overall Study|schedule conflict|0|||
155290813|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290814|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290815|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290816|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
155290817|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
155290818|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290819|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290820|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290821|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290822|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290823|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
155290824|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
155290825|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290826|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290827|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290828|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
155290829|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
155290830|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
155290831|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290832|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290833|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290834|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290835|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
155290836|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290837|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290838|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290839|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290840|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290841|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290842|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
155290843|NCT06688370|560493364|FG000|Overall Study|Discontinued the treatment|1|||
155290844|NCT06688370|560493364|FG000|Overall Study|Prohibited treatment taken|4|||
155290845|NCT04540835|560493365|FG000|Week 1|Lost to Follow-up|1|||
155290846|NCT04540835|560493365|FG000|Week 6|Pregnancy|1|||
155290847|NCT04540835|560493365|FG000|Week 6|Lack of Efficacy|1|||
155290848|NCT04487080|560493366|FG000|Overall Study|Withdrawal by Subject|19|||
155290849|NCT04487080|560493367|FG001|Overall Study|Withdrawal by Subject|18|||
155290850|NCT04487080|560493368|FG002|Overall Study|Withdrawal by Subject|13|||
155290851|NCT04487080|560493366|FG000|Overall Study|Lost to Follow-up|3|||
155290852|NCT04487080|560493367|FG001|Overall Study|Lost to Follow-up|1|||
155290853|NCT04487080|560493368|FG002|Overall Study|Lost to Follow-up|0|||
155290854|NCT04487080|560493366|FG000|Overall Study|Ongoing|313|||
155290855|NCT04487080|560493367|FG001|Overall Study|Ongoing|297|||
155290856|NCT04487080|560493368|FG002|Overall Study|Ongoing|149|||
155290857|NCT03105336|560493369|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
155290858|NCT03105336|560493370|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
155290859|NCT03105336|560493369|FG000|Overall Study|Death|40|||
155290860|NCT03105336|560493370|FG001|Overall Study|Death|8|||
155290861|NCT03105336|560493369|FG000|Overall Study|Lost to Follow-up|13|||
155290862|NCT03105336|560493370|FG001|Overall Study|Lost to Follow-up|2|||
155290863|NCT03105336|560493369|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
155290864|NCT03105336|560493370|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
155290865|NCT03105336|560493369|FG000|Overall Study|Reason Not Specified|3|||
155290866|NCT03105336|560493370|FG001|Overall Study|Reason Not Specified|3|||
155290867|NCT03105336|560493369|FG000|Overall Study|Investigator Decision|3|||
155408812|NCT00391222|560928850|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
155408813|NCT00391222|560928851|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
155408814|NCT00391222|560928852|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
155408815|NCT00391222|560928849|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
155408816|NCT00391222|560928850|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
155408817|NCT00391222|560928851|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
155408818|NCT00391222|560928852|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
155408819|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
155408820|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
155408821|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
155408822|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
155290868|NCT03105336|560493370|FG001|Overall Study|Investigator Decision|0|||
155290869|NCT03451851|560493371|FG000|PCP: Week 0 -16|Adverse Event|1|||
155290870|NCT03451851|560493372|FG001|PCP: Week 0 -16|Adverse Event|0|||
155290871|NCT03451851|560493373|FG002|PCP: Week 0 -16|Adverse Event|0|||
155290872|NCT03451851|560493374|FG003|PCP: Week 0 -16|Adverse Event|0|||
155290873|NCT03451851|560493375|FG004|PCP: Week 0 -16|Adverse Event|0|||
155290874|NCT03451851|560493376|FG005|PCP: Week 0 -16|Adverse Event|0|||
155290875|NCT03451851|560493377|FG006|PCP: Week 0 -16|Adverse Event|1|||
155290876|NCT03451851|560493378|FG007|PCP: Week 0 -16|Adverse Event|0|||
155290877|NCT03451851|560493371|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290878|NCT03451851|560493372|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290879|NCT03451851|560493373|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
155290880|NCT03451851|560493374|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290881|NCT03451851|560493375|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290882|NCT03451851|560493376|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290883|NCT03451851|560493377|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290884|NCT03451851|560493378|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290885|NCT03451851|560493371|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290886|NCT03451851|560493372|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290887|NCT03451851|560493373|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
155290888|NCT03451851|560493374|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290889|NCT03451851|560493375|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290890|NCT03451851|560493376|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290891|NCT03451851|560493377|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290892|NCT03451851|560493378|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290893|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290894|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290895|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290896|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290897|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
155290898|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
155290899|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290900|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290901|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290902|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290903|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290904|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290905|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
155290906|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290907|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290908|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290909|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290910|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290911|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290912|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290913|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
155290914|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290915|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290916|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290917|NCT07214922|560493381|FG000|Overall Study|Adverse Event|0|||
155290918|NCT07214922|560493382|FG001|Overall Study|Adverse Event|0|||
155290919|NCT07214922|560493383|FG002|Overall Study|Adverse Event|1|||
155290920|NCT07214922|560493384|FG003|Overall Study|Adverse Event|0|||
155290921|NCT07214922|560493381|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290922|NCT07214922|560493382|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
155290923|NCT07214922|560493383|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290924|NCT07214922|560493384|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290925|NCT03944512|560493385|FG000|Overall Study|Death|0|||
155290926|NCT03944512|560493386|FG001|Overall Study|Death|0|||
155290927|NCT03944512|560493387|FG002|Overall Study|Death|1|||
155290928|NCT03944512|560493388|FG003|Overall Study|Death|2|||
155290929|NCT03944512|560493385|FG000|Overall Study|Lost to Follow-up|0|||
155408823|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
155408824|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
155290930|NCT03944512|560493386|FG001|Overall Study|Lost to Follow-up|0|||
155290931|NCT03944512|560493387|FG002|Overall Study|Lost to Follow-up|4|||
155290932|NCT03944512|560493388|FG003|Overall Study|Lost to Follow-up|4|||
155290933|NCT03944512|560493385|FG000|Overall Study|refused follow-up|0|||
155290934|NCT03944512|560493386|FG001|Overall Study|refused follow-up|0|||
155290935|NCT03944512|560493387|FG002|Overall Study|refused follow-up|2|||
155290936|NCT03944512|560493388|FG003|Overall Study|refused follow-up|2|||
155290937|NCT00567879|560494154|FG000|Overall Study|Adverse Event|2|||
155290938|NCT00567879|560494155|FG001|Overall Study|Adverse Event|0|||
155290939|NCT00567879|560494156|FG002|Overall Study|Adverse Event|1|||
155290940|NCT00567879|560494157|FG003|Overall Study|Adverse Event|0|||
155290941|NCT00567879|560494158|FG004|Overall Study|Adverse Event|1|||
155290942|NCT00567879|560494159|FG005|Overall Study|Adverse Event|0|||
155290943|NCT00567879|560494154|FG000|Overall Study|Abnormal test procedure(s)|0|||
155290944|NCT00567879|560494155|FG001|Overall Study|Abnormal test procedure(s)|0|||
155290945|NCT00567879|560494156|FG002|Overall Study|Abnormal test procedure(s)|1|||
155290946|NCT00567879|560494157|FG003|Overall Study|Abnormal test procedure(s)|0|||
155290947|NCT00567879|560494158|FG004|Overall Study|Abnormal test procedure(s)|0|||
155290948|NCT00567879|560494159|FG005|Overall Study|Abnormal test procedure(s)|0|||
155290949|NCT00567879|560494154|FG000|Overall Study|Withdrawal by Subject|0|||
155290950|NCT00567879|560494155|FG001|Overall Study|Withdrawal by Subject|0|||
155290951|NCT00567879|560494156|FG002|Overall Study|Withdrawal by Subject|3|||
155290952|NCT00567879|560494157|FG003|Overall Study|Withdrawal by Subject|1|||
155290953|NCT00567879|560494158|FG004|Overall Study|Withdrawal by Subject|0|||
155290954|NCT00567879|560494159|FG005|Overall Study|Withdrawal by Subject|0|||
155290955|NCT00567879|560494154|FG000|Overall Study|New cancer therapy|0|||
155290956|NCT00567879|560494155|FG001|Overall Study|New cancer therapy|0|||
155290957|NCT00567879|560494156|FG002|Overall Study|New cancer therapy|1|||
155290958|NCT00567879|560494157|FG003|Overall Study|New cancer therapy|0|||
155290959|NCT00567879|560494158|FG004|Overall Study|New cancer therapy|0|||
155290960|NCT00567879|560494159|FG005|Overall Study|New cancer therapy|0|||
155290961|NCT00567879|560494154|FG000|Overall Study|Disease progression|5|||
155290962|NCT00567879|560494155|FG001|Overall Study|Disease progression|7|||
155290963|NCT00567879|560494156|FG002|Overall Study|Disease progression|15|||
155290964|NCT00567879|560494157|FG003|Overall Study|Disease progression|5|||
155290965|NCT00567879|560494158|FG004|Overall Study|Disease progression|11|||
155290966|NCT00567879|560494159|FG005|Overall Study|Disease progression|3|||
155290967|NCT00151996|560494160|FG000|Overall Study|Adverse Event|3|||
155290968|NCT00151996|560494161|FG001|Overall Study|Adverse Event|2|||
155290969|NCT00151996|560494160|FG000|Overall Study|Withdrawal by Subject|1|||
155290970|NCT00151996|560494161|FG001|Overall Study|Withdrawal by Subject|1|||
155290971|NCT00151996|560494160|FG000|Overall Study|Protocol Violation|1|||
155290972|NCT00151996|560494161|FG001|Overall Study|Protocol Violation|2|||
155290973|NCT00151996|560494160|FG000|Overall Study|Sponsor's decision|0|||
155290974|NCT00151996|560494161|FG001|Overall Study|Sponsor's decision|2|||
155290975|NCT01281813|560494164|FG000|Overall Study|Adverse Event|0|||
155290976|NCT01281813|560494165|FG001|Overall Study|Adverse Event|0|||
155290977|NCT01281813|560494166|FG002|Overall Study|Adverse Event|10|||
155290978|NCT01281813|560494164|FG000|Overall Study|Lost to Follow-up|0|||
155290979|NCT01281813|560494165|FG001|Overall Study|Lost to Follow-up|0|||
155290980|NCT01281813|560494166|FG002|Overall Study|Lost to Follow-up|31|||
155290981|NCT01281813|560494164|FG000|Overall Study|Withdrawal by Subject|0|||
155290982|NCT01281813|560494165|FG001|Overall Study|Withdrawal by Subject|0|||
155290983|NCT01281813|560494166|FG002|Overall Study|Withdrawal by Subject|13|||
155290984|NCT01281813|560494164|FG000|Overall Study|Subject Non-Compliant|0|||
155290985|NCT01281813|560494165|FG001|Overall Study|Subject Non-Compliant|0|||
155290986|NCT01281813|560494166|FG002|Overall Study|Subject Non-Compliant|6|||
155290987|NCT01281813|560494164|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
155290988|NCT01281813|560494165|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
155290989|NCT01281813|560494166|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
155290990|NCT01281813|560494164|FG000|Overall Study|Sponsor's Decision|4|||
155290991|NCT01281813|560494165|FG001|Overall Study|Sponsor's Decision|3|||
155290992|NCT01281813|560494166|FG002|Overall Study|Sponsor's Decision|7|||
155290993|NCT01281813|560494164|FG000|Overall Study|Switched to Commercially Available Medication|0|||
155290994|NCT01281813|560494165|FG001|Overall Study|Switched to Commercially Available Medication|0|||
155290995|NCT01281813|560494166|FG002|Overall Study|Switched to Commercially Available Medication|26|||
155290996|NCT01281813|560494164|FG000|Overall Study|Other|0|||
155290997|NCT01281813|560494165|FG001|Overall Study|Other|1|||
155290998|NCT01281813|560494166|FG002|Overall Study|Other|39|||
155290999|NCT02274493|560494167|FG000|Overall Study|Withdrawal by Subject|1|||
155291000|NCT01744691|560494176|FG000|Overall Study|Progressive Disease|18|||
155291001|NCT01744691|560494176|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
155291002|NCT01744691|560494176|FG000|Overall Study|Withdrawal of consent for treatment|3|||
155291003|NCT01744691|560494176|FG000|Overall Study|Physician Decision|4|||
155291004|NCT02701361|560494178|FG000|Overall Study|Lost to Follow-up|5|||
155291005|NCT02701361|560494179|FG001|Overall Study|Lost to Follow-up|2|||
155291006|NCT02701361|560494180|FG002|Overall Study|Lost to Follow-up|1|||
155291007|NCT02701361|560494178|FG000|Overall Study|Withdrawal by Subject|4|||
155291008|NCT02701361|560494179|FG001|Overall Study|Withdrawal by Subject|0|||
155291009|NCT02701361|560494180|FG002|Overall Study|Withdrawal by Subject|0|||
155291010|NCT02701361|560494178|FG000|Overall Study|timed out in rehab center|0|||
155291011|NCT02701361|560494179|FG001|Overall Study|timed out in rehab center|1|||
155291012|NCT02701361|560494180|FG002|Overall Study|timed out in rehab center|0|||
155291013|NCT02701361|560494178|FG000|Overall Study|incarceration|0|||
155291014|NCT02701361|560494179|FG001|Overall Study|incarceration|0|||
155291015|NCT02701361|560494180|FG002|Overall Study|incarceration|1|||
155291016|NCT04588480|560494181|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
155291017|NCT04588480|560494182|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
155291018|NCT04588480|560494183|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
155291019|NCT04588480|560494181|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
155291020|NCT04588480|560494182|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
155291021|NCT04588480|560494183|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
155291022|NCT01242085|560494184|FG000|Overall Study|Withdrawal by Subject|4|||
155291023|NCT01242085|560494185|FG001|Overall Study|Withdrawal by Subject|2|||
155291024|NCT01242085|560494186|FG002|Overall Study|Withdrawal by Subject|0|||
155291025|NCT01242085|560494184|FG000|Overall Study|medically unable to have surgery|4|||
155291026|NCT01242085|560494185|FG001|Overall Study|medically unable to have surgery|5|||
155291027|NCT01242085|560494186|FG002|Overall Study|medically unable to have surgery|0|||
155291028|NCT01178762|560494187|FG000|Overall Study|Lost to Follow-up|15|||
155291029|NCT02322216|560494190|FG000|Overall Study|Adverse Event|1|||
155291030|NCT02322216|560494191|FG001|Overall Study|Adverse Event|0|||
155291031|NCT02322216|560494190|FG000|Overall Study|Withdrawal by Subject|1|||
155291032|NCT02322216|560494191|FG001|Overall Study|Withdrawal by Subject|4|||
155291033|NCT02430532|560494193|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
155291034|NCT02430532|560494194|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
155291035|NCT02430532|560494193|FG000|Overall Study|Consent Withdrawn|0|||
155291036|NCT02430532|560494194|FG001|Overall Study|Consent Withdrawn|2|||
155291037|NCT02430532|560494193|FG000|Overall Study|Adverse Event|0|||
155291038|NCT02430532|560494194|FG001|Overall Study|Adverse Event|1|||
155291039|NCT01190150|560494195|FG000|First Treatment|Withdrawal by Subject|1|||
155291040|NCT01190150|560494196|FG001|First Treatment|Withdrawal by Subject|0|||
155291041|NCT01190150|560494195|FG000|Washout|Withdrawal by Subject|0|||
155291042|NCT01190150|560494196|FG001|Washout|Withdrawal by Subject|1|||
155291043|NCT01190150|560494195|FG000|Washout|Difficulty in adherence|0|||
155291044|NCT01190150|560494196|FG001|Washout|Difficulty in adherence|1|||
155291045|NCT01549652|560494204|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
155291046|NCT01549652|560494205|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
155291047|NCT01549652|560494206|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
155291048|NCT01549652|560494207|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
155291049|NCT01549652|560494204|FG000|Overall Study|Study Drug Titration Failure|5|||
155743692|NCT03859973|562161540|FG000|Overall Study|Other reason than listed|3|||
155743693|NCT03859973|562161541|FG001|Overall Study|Other reason than listed|2|||
155743694|NCT03859973|562161540|FG000|Overall Study|COVID-19 related, not due to AE|3|||
155743695|NCT03859973|562161541|FG001|Overall Study|COVID-19 related, not due to AE|4|||
155743696|NCT03859973|562161540|FG000|Overall Study|Withdrawal by Subject|8|||
155291050|NCT01549652|560494205|FG001|Overall Study|Study Drug Titration Failure|6|||
155291051|NCT01549652|560494206|FG002|Overall Study|Study Drug Titration Failure|0|||
155291052|NCT01549652|560494207|FG003|Overall Study|Study Drug Titration Failure|0|||
155291053|NCT01549652|560494204|FG000|Overall Study|Withdrawal Effect|0|||
155291054|NCT01549652|560494205|FG001|Overall Study|Withdrawal Effect|2|||
155291055|NCT01549652|560494206|FG002|Overall Study|Withdrawal Effect|0|||
155291056|NCT01549652|560494207|FG003|Overall Study|Withdrawal Effect|0|||
155291057|NCT01549652|560494204|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
155291058|NCT01549652|560494205|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
155291059|NCT01549652|560494206|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
155291060|NCT01549652|560494207|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
155408825|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
155291061|NCT01549652|560494204|FG000|Overall Study|Problem with Infusion|1|||
155291062|NCT01549652|560494205|FG001|Overall Study|Problem with Infusion|0|||
155291063|NCT01549652|560494206|FG002|Overall Study|Problem with Infusion|0|||
155291064|NCT01549652|560494207|FG003|Overall Study|Problem with Infusion|0|||
155408826|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
155408827|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
155408828|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
155408829|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
155408830|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
155408831|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
155408832|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
155408833|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
155408834|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
155408835|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
155408836|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
155408837|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
155408838|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
155408839|NCT00391222|560928849|FG000|Period III (Double-Blind Treatment)|Other|6|||
155408840|NCT00391222|560928850|FG001|Period III (Double-Blind Treatment)|Other|1|||
155408841|NCT00391222|560928851|FG002|Period III (Double-Blind Treatment)|Other|6|||
155408842|NCT00391222|560928852|FG003|Period III (Double-Blind Treatment)|Other|0|||
155408843|NCT01627860|560928853|FG000|Overall Study|Adverse Event|9|||
155408844|NCT01627860|560928854|FG001|Overall Study|Adverse Event|4|||
155408845|NCT01627860|560928853|FG000|Overall Study|Withdrawal by Subject|2|||
155408846|NCT01627860|560928854|FG001|Overall Study|Withdrawal by Subject|1|||
155408847|NCT01627860|560928853|FG000|Overall Study|Seizure frequency doubled|0|||
155408848|NCT01627860|560928854|FG001|Overall Study|Seizure frequency doubled|1|||
155408849|NCT01627860|560928853|FG000|Overall Study|Protocol Violation|1|||
155408850|NCT01627860|560928854|FG001|Overall Study|Protocol Violation|0|||
155408851|NCT01014689|560928857|FG000|Overall Study|Lack of Efficacy|0|||
155408852|NCT01014689|560928858|FG001|Overall Study|Lack of Efficacy|1|||
155408853|NCT01014689|560928857|FG000|Overall Study|Adverse Event|3|||
155408854|NCT01014689|560928858|FG001|Overall Study|Adverse Event|0|||
155408855|NCT01014689|560928857|FG000|Overall Study|Withdrawal by Subject|5|||
155408856|NCT01014689|560928858|FG001|Overall Study|Withdrawal by Subject|4|||
155408857|NCT01014689|560928857|FG000|Overall Study|Protocol Violation|1|||
155408858|NCT01014689|560928858|FG001|Overall Study|Protocol Violation|1|||
155408859|NCT01014689|560928857|FG000|Overall Study|Lost to Follow-up|3|||
155408860|NCT01014689|560928858|FG001|Overall Study|Lost to Follow-up|7|||
155408861|NCT01014689|560928857|FG000|Overall Study|Pregnancy|1|||
155408862|NCT01014689|560928858|FG001|Overall Study|Pregnancy|0|||
155408863|NCT00333359|560928864|FG000|Overall Study|Adverse Event|29|||
155408864|NCT00333359|560928865|FG001|Overall Study|Adverse Event|35|||
155408865|NCT00333359|560928864|FG000|Overall Study|Withdrawal by Subject|19|||
155408866|NCT00333359|560928865|FG001|Overall Study|Withdrawal by Subject|37|||
155408867|NCT00333359|560928864|FG000|Overall Study|Physician Decision|2|||
155408868|NCT00333359|560928865|FG001|Overall Study|Physician Decision|2|||
155408869|NCT00333359|560928864|FG000|Overall Study|Protocol Non-compliance|2|||
155408870|NCT00333359|560928865|FG001|Overall Study|Protocol Non-compliance|8|||
155408871|NCT00333359|560928864|FG000|Overall Study|Lost to Follow-up|15|||
155408872|NCT00333359|560928865|FG001|Overall Study|Lost to Follow-up|25|||
155408873|NCT00333359|560928864|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
155408874|NCT00333359|560928865|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
155408875|NCT00333359|560928864|FG000|Overall Study|Treatment Failure|3|||
155408876|NCT00333359|560928865|FG001|Overall Study|Treatment Failure|8|||
155408877|NCT00333359|560928864|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
155408878|NCT00333359|560928865|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
155408879|NCT01534533|560928869|FG000|Overall Study|Lost to Follow-up|3|||
155408880|NCT01534533|560928870|FG001|Overall Study|Lost to Follow-up|0|||
155408881|NCT01534533|560928871|FG002|Overall Study|Lost to Follow-up|4|||
155638266|NCT02964182|561766410|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155638267|NCT02964182|561766411|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
155638268|NCT02964182|561766404|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638269|NCT02964182|561766405|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638270|NCT02964182|561766406|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
155638271|NCT02964182|561766407|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
155638272|NCT02964182|561766408|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638273|NCT02964182|561766409|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638274|NCT02964182|561766410|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638275|NCT02964182|561766411|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155638276|NCT02964182|561766404|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155638277|NCT02964182|561766405|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155638278|NCT02964182|561766406|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
155638279|NCT02964182|561766407|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
155638280|NCT02964182|561766408|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155638281|NCT02964182|561766409|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155638282|NCT02964182|561766410|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
155638283|NCT02964182|561766411|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155291065|NCT01549652|560494204|FG000|Overall Study|Titration Non-Compliance|1|||
155291066|NCT01549652|560494205|FG001|Overall Study|Titration Non-Compliance|3|||
155291067|NCT01549652|560494206|FG002|Overall Study|Titration Non-Compliance|4|||
155291068|NCT01549652|560494207|FG003|Overall Study|Titration Non-Compliance|5|||
155291069|NCT01549652|560494204|FG000|Overall Study|Titration Side Effects|0|||
155291070|NCT01549652|560494205|FG001|Overall Study|Titration Side Effects|0|||
155291071|NCT01549652|560494206|FG002|Overall Study|Titration Side Effects|6|||
155291072|NCT01549652|560494207|FG003|Overall Study|Titration Side Effects|3|||
155291073|NCT01549652|560494204|FG000|Overall Study|Withdrawal by Subject|0|||
155291074|NCT01549652|560494205|FG001|Overall Study|Withdrawal by Subject|0|||
155291075|NCT01549652|560494206|FG002|Overall Study|Withdrawal by Subject|5|||
155291076|NCT01549652|560494207|FG003|Overall Study|Withdrawal by Subject|3|||
155291077|NCT02873754|560494213|FG000|Overall Study|Lost to Follow-up|5|||
155291078|NCT02873754|560494213|FG000|Overall Study|Couldn't complete study procedures|1|||
155291079|NCT03523962|560494214|FG000|Closed Fractures|Death|86|||
155291080|NCT03523962|560494215|FG001|Closed Fractures|Death|71|||
155291081|NCT03523962|560494216|FG002|Closed Fractures|Death|0|||
155291082|NCT03523962|560494217|FG003|Closed Fractures|Death|0|||
155291083|NCT03523962|560494214|FG000|Closed Fractures|Lost to Follow-up|62|||
155291084|NCT03523962|560494215|FG001|Closed Fractures|Lost to Follow-up|36|||
155291085|NCT03523962|560494216|FG002|Closed Fractures|Lost to Follow-up|0|||
155291086|NCT03523962|560494217|FG003|Closed Fractures|Lost to Follow-up|0|||
155291087|NCT03523962|560494214|FG000|Closed Fractures|Withdrawal by Subject|19|||
155291088|NCT03523962|560494215|FG001|Closed Fractures|Withdrawal by Subject|29|||
155291089|NCT03523962|560494216|FG002|Closed Fractures|Withdrawal by Subject|0|||
155291090|NCT03523962|560494217|FG003|Closed Fractures|Withdrawal by Subject|0|||
155291091|NCT03523962|560494214|FG000|Closed Fractures|Incarceration|1|||
155291092|NCT03523962|560494215|FG001|Closed Fractures|Incarceration|4|||
155291093|NCT03523962|560494216|FG002|Closed Fractures|Incarceration|0|||
155291094|NCT03523962|560494217|FG003|Closed Fractures|Incarceration|0|||
155291095|NCT03523962|560494214|FG000|Open Fractures|Death|0|||
155291096|NCT03523962|560494215|FG001|Open Fractures|Death|0|||
155291097|NCT03523962|560494216|FG002|Open Fractures|Death|11|||
155291098|NCT03523962|560494217|FG003|Open Fractures|Death|6|||
155291099|NCT03523962|560494214|FG000|Open Fractures|Lost to Follow-up|0|||
155291100|NCT03523962|560494215|FG001|Open Fractures|Lost to Follow-up|0|||
155291101|NCT03523962|560494216|FG002|Open Fractures|Lost to Follow-up|15|||
155291102|NCT03523962|560494217|FG003|Open Fractures|Lost to Follow-up|8|||
155291103|NCT03523962|560494214|FG000|Open Fractures|Withdrawal by Subject|0|||
155291104|NCT03523962|560494215|FG001|Open Fractures|Withdrawal by Subject|0|||
155291105|NCT03523962|560494216|FG002|Open Fractures|Withdrawal by Subject|6|||
155291106|NCT03523962|560494217|FG003|Open Fractures|Withdrawal by Subject|2|||
155291107|NCT03523962|560494214|FG000|Open Fractures|Incarceration|0|||
155291108|NCT03523962|560494215|FG001|Open Fractures|Incarceration|0|||
155291109|NCT03523962|560494216|FG002|Open Fractures|Incarceration|1|||
155291110|NCT03523962|560494217|FG003|Open Fractures|Incarceration|0|||
155291111|NCT01081145|560494221|FG000|Open-Label Phase|Lack of Efficacy|56|||
155291112|NCT01081145|560494222|FG001|Open-Label Phase|Lack of Efficacy|0|||
155291113|NCT01081145|560494221|FG000|Open-Label Phase|Response criteria not met|46|||
155291114|NCT01081145|560494222|FG001|Open-Label Phase|Response criteria not met|0|||
155291115|NCT01081145|560494221|FG000|Open-Label Phase|Adverse Event|42|||
155291116|NCT01081145|560494222|FG001|Open-Label Phase|Adverse Event|0|||
155291117|NCT01081145|560494221|FG000|Open-Label Phase|Withdrawal by Subject|41|||
155291118|NCT01081145|560494222|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155291119|NCT01081145|560494221|FG000|Open-Label Phase|Other|12|||
155291120|NCT01081145|560494222|FG001|Open-Label Phase|Other|0|||
155291121|NCT01081145|560494221|FG000|Open-Label Phase|Lost to Follow-up|11|||
155291122|NCT01081145|560494222|FG001|Open-Label Phase|Lost to Follow-up|0|||
155291123|NCT01081145|560494221|FG000|Open-Label Phase|Protocol Violation|4|||
155291124|NCT01081145|560494222|FG001|Open-Label Phase|Protocol Violation|0|||
155291125|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
155291126|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
155291127|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
155291128|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
155291129|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
155291130|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
155291131|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
155291132|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
155291133|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
155291134|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
155291135|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
155291136|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
155291137|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
155291138|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
155291139|NCT01582945|560494224|FG000|Overall Study|Intolerable side-effects|1|||
155291140|NCT01582945|560494224|FG000|Overall Study|Scheduling conflicts|1|||
155291141|NCT01726023|560494225|FG000|Overall Study|Death|1|||
155291142|NCT01726023|560494226|FG001|Overall Study|Death|1|||
155291143|NCT01726023|560494225|FG000|Overall Study|Lost to Follow-up|5|||
155291144|NCT01726023|560494226|FG001|Overall Study|Lost to Follow-up|10|||
155291145|NCT01726023|560494225|FG000|Overall Study|Other Eligibility criteria|7|||
155291146|NCT01726023|560494226|FG001|Overall Study|Other Eligibility criteria|7|||
155291147|NCT01726023|560494225|FG000|Overall Study|Withdrawal by Subject|16|||
155291148|NCT01726023|560494226|FG001|Overall Study|Withdrawal by Subject|8|||
155291149|NCT03643211|560494229|FG000|Overall Study|Contract violation/deficiency|12|||
155291150|NCT03643211|560494229|FG000|Overall Study|Invalid registration|3|||
155291151|NCT03643211|560494229|FG000|Overall Study|No treatment information|2|||
155291152|NCT03643211|560494229|FG000|Overall Study|No adverse event information - No revisit|4|||
155291153|NCT04858425|560494230|FG000|Overall Study|Adverse Event|2|||
155291154|NCT04858425|560494231|FG001|Overall Study|Adverse Event|2|||
155291155|NCT04858425|560494230|FG000|Overall Study|Withdrawal by Subject|3|||
155291156|NCT04858425|560494231|FG001|Overall Study|Withdrawal by Subject|1|||
155291157|NCT04858425|560494230|FG000|Overall Study|Lost to Follow-up|4|||
155291158|NCT04858425|560494231|FG001|Overall Study|Lost to Follow-up|2|||
155291159|NCT04858425|560494230|FG000|Overall Study|Lost to Follow-up|1|||
155291160|NCT04858425|560494231|FG001|Overall Study|Lost to Follow-up|0|||
155291161|NCT04536077|560494233|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
155291162|NCT04536077|560494234|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
155291163|NCT04536077|560494233|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
155291164|NCT04536077|560494234|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
155291165|NCT01155869|560494244|FG000|Overall Study|Lost to Follow-up|3|||
155291166|NCT01155869|560494245|FG001|Overall Study|Lost to Follow-up|1|||
155291167|NCT00881335|560494247|FG000|Overall Study|Lost to Follow-up|3|||
155291168|NCT00881335|560494248|FG001|Overall Study|Lost to Follow-up|2|||
155291169|NCT05824351|560494249|FG000|Overall Study|Adverse Event|6|||
155291170|NCT03722446|560494250|FG000|Overall Study|Protocol Violation|15|||
155291171|NCT03722446|560494251|FG001|Overall Study|Protocol Violation|2|||
155291172|NCT00470626|560495457|FG000|Overall Study|Lost to Follow-up|10|||
155291173|NCT00470626|560495457|FG000|Overall Study|Withdrawal by Subject|7|||
155291174|NCT01249092|560495459|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
155291175|NCT01249092|560495459|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
155291176|NCT02380742|560495460|FG000|Overall Study|Withdrawal by Subject|1|||
155291177|NCT02380742|560495461|FG001|Overall Study|Withdrawal by Subject|0|||
155291178|NCT03518112|560495464|FG000|Overall Study|Withdrawal by Subject|1|||
155291179|NCT01546155|560495465|FG000|Overall Study|could not tolerate long scan duration|3|||
155291180|NCT02930343|560495466|FG000|Overall Study|Lost to Follow-up|9|||
155291181|NCT02930343|560495467|FG001|Overall Study|Lost to Follow-up|7|||
155291182|NCT01729819|560495471|FG000|Overall Study|Adverse Event|2|||
155291183|NCT01729819|560495472|FG001|Overall Study|Adverse Event|4|||
155291184|NCT01729819|560495471|FG000|Overall Study|Lack of Efficacy|1|||
155291185|NCT01729819|560495472|FG001|Overall Study|Lack of Efficacy|0|||
155291186|NCT01729819|560495471|FG000|Overall Study|Lost to Follow-up|2|||
155291187|NCT01729819|560495472|FG001|Overall Study|Lost to Follow-up|0|||
155291188|NCT01729819|560495471|FG000|Overall Study|Other reason|1|||
155291189|NCT01729819|560495472|FG001|Overall Study|Other reason|0|||
155291190|NCT01729819|560495471|FG000|Overall Study|Protocol Violation|0|||
155291191|NCT01729819|560495472|FG001|Overall Study|Protocol Violation|1|||
155291192|NCT01729819|560495471|FG000|Overall Study|Withdrawal by Subject|0|||
155291193|NCT01729819|560495472|FG001|Overall Study|Withdrawal by Subject|2|||
155291194|NCT01025843|560495473|FG000|Washout 4|Withdrawal by Subject|0|||
155291195|NCT01025843|560495474|FG001|Washout 4|Withdrawal by Subject|0|||
155291196|NCT01025843|560495475|FG002|Washout 4|Withdrawal by Subject|1|||
155291197|NCT01025843|560495476|FG003|Washout 4|Withdrawal by Subject|1|||
155291198|NCT01025843|560495477|FG004|Washout 4|Withdrawal by Subject|0|||
155408882|NCT01534533|560928872|FG003|Overall Study|Lost to Follow-up|3|||
155408883|NCT01534533|560928869|FG000|Overall Study|Withdrawal by Subject|5|||
155291199|NCT01025843|560495478|FG005|Washout 4|Withdrawal by Subject|0|||
155291200|NCT01025843|560495479|FG006|Washout 4|Withdrawal by Subject|0|||
155291201|NCT01025843|560495480|FG007|Washout 4|Withdrawal by Subject|0|||
155291202|NCT01025843|560495481|FG008|Washout 4|Withdrawal by Subject|0|||
155291203|NCT01025843|560495482|FG009|Washout 4|Withdrawal by Subject|0|||
155291204|NCT01649791|560495483|FG000|Overall Study|Disease Progression|2|||
155291205|NCT01649791|560495483|FG000|Overall Study|Adverse Event|1|||
155291206|NCT00364286|560495484|FG000|Overall Study|Withdrawal by Subject|1|||
155291207|NCT00364286|560495484|FG000|Overall Study|Adverse Event|2|||
155291208|NCT02814643|560495485|FG000|Overall Study|Lost to Follow-up|0|||
155291209|NCT02814643|560495486|FG001|Overall Study|Lost to Follow-up|1|||
155291210|NCT02814643|560495485|FG000|Overall Study|Withdrawal by Subject|1|||
155408884|NCT01534533|560928870|FG001|Overall Study|Withdrawal by Subject|3|||
155291211|NCT02814643|560495486|FG001|Overall Study|Withdrawal by Subject|2|||
155408885|NCT01534533|560928871|FG002|Overall Study|Withdrawal by Subject|4|||
155291212|NCT01227278|560495489|FG000|Overall Study|Withdrawal by Subject|4|||
155291213|NCT01227278|560495490|FG001|Overall Study|Withdrawal by Subject|4|||
155291214|NCT01227278|560495489|FG000|Overall Study|Death|0|||
155291215|NCT01227278|560495490|FG001|Overall Study|Death|2|||
155291216|NCT01227278|560495489|FG000|Overall Study|Other|1|||
155291217|NCT01227278|560495490|FG001|Overall Study|Other|2|||
155291218|NCT00420316|560495491|FG000|Overall Study|Withdrawal by Subject|0|||
155291219|NCT00420316|560495492|FG001|Overall Study|Withdrawal by Subject|1|||
155291220|NCT00420316|560495491|FG000|Overall Study|Lost to Follow-up|12|||
155291221|NCT00420316|560495492|FG001|Overall Study|Lost to Follow-up|8|||
155291222|NCT03546907|560495501|FG000|Overall Study|Lack of Efficacy|1|||
155291223|NCT03546907|560495502|FG001|Overall Study|Lack of Efficacy|1|||
155291224|NCT03546907|560495501|FG000|Overall Study|Withdrawal by Subject|8|||
155291225|NCT03546907|560495502|FG001|Overall Study|Withdrawal by Subject|9|||
155291226|NCT03546907|560495501|FG000|Overall Study|Adverse events (AEs)|7|||
155291227|NCT03546907|560495502|FG001|Overall Study|Adverse events (AEs)|10|||
155291228|NCT03546907|560495501|FG000|Overall Study|Other-unspecified|1|||
155291229|NCT03546907|560495502|FG001|Overall Study|Other-unspecified|1|||
155291230|NCT03720210|560495509|FG000|Overall Study|Lost to Follow-up|1|||
155291231|NCT04033432|560495510|FG000|Overall Study|Progressive Disease|8|||
155291232|NCT04033432|560495510|FG000|Overall Study|Adverse Event|4|||
155291233|NCT04033432|560495510|FG000|Overall Study|Death|1|||
155291234|NCT00558363|560495516|FG000|Overall Study|Physician Decision|18|||
155291235|NCT00558363|560495517|FG001|Overall Study|Physician Decision|4|||
155291236|NCT00558363|560495516|FG000|Overall Study|Withdrawal by Subject|11|||
155291237|NCT00558363|560495517|FG001|Overall Study|Withdrawal by Subject|4|||
155291238|NCT00558363|560495516|FG000|Overall Study|Adverse Event|5|||
155291239|NCT00558363|560495517|FG001|Overall Study|Adverse Event|5|||
155291240|NCT00558363|560495516|FG000|Overall Study|Lack of Efficacy|2|||
155291241|NCT00558363|560495517|FG001|Overall Study|Lack of Efficacy|2|||
155291242|NCT00558363|560495516|FG000|Overall Study|Protocol Violation|2|||
155291243|NCT00558363|560495517|FG001|Overall Study|Protocol Violation|1|||
155291244|NCT00558363|560495516|FG000|Overall Study|Lost to Follow-up|0|||
155291245|NCT00558363|560495517|FG001|Overall Study|Lost to Follow-up|1|||
155291246|NCT00558363|560495516|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
155291247|NCT00558363|560495517|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
155291248|NCT00558363|560495516|FG000|Overall Study|Randomized in Error|1|||
155291249|NCT00558363|560495517|FG001|Overall Study|Randomized in Error|2|||
155291250|NCT00558363|560495516|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
155291251|NCT00558363|560495517|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
155291252|NCT02174562|560495518|FG000|Overall Study|Withdrawal by Subject|7|||
155291253|NCT02174562|560495519|FG001|Overall Study|Withdrawal by Subject|2|||
155291254|NCT02174562|560495518|FG000|Overall Study|Death|2|||
155291255|NCT02174562|560495519|FG001|Overall Study|Death|0|||
155291256|NCT02174562|560495518|FG000|Overall Study|Lost to Follow-up|0|||
155291257|NCT02174562|560495519|FG001|Overall Study|Lost to Follow-up|3|||
155291258|NCT03201809|560495520|FG000|Overall Study|Lost to Follow-up|2|||
155291259|NCT03201809|560495521|FG001|Overall Study|Lost to Follow-up|0|||
155291260|NCT01651949|560495525|FG000|Overall Study|Unknown status|4|||
155291261|NCT01651949|560495526|FG001|Overall Study|Unknown status|4|||
155291262|NCT01651949|560495527|FG002|Overall Study|Unknown status|0|||
155291263|NCT01651949|560495525|FG000|Overall Study|Lost to Follow-up|30|||
155291264|NCT01651949|560495526|FG001|Overall Study|Lost to Follow-up|56|||
155291265|NCT01651949|560495527|FG002|Overall Study|Lost to Follow-up|20|||
155291266|NCT01651949|560495525|FG000|Overall Study|Protocol Violation|0|||
155291267|NCT01651949|560495526|FG001|Overall Study|Protocol Violation|2|||
155291268|NCT01651949|560495527|FG002|Overall Study|Protocol Violation|1|||
155291269|NCT01651949|560495525|FG000|Overall Study|Physician Decision|0|||
155291270|NCT01651949|560495526|FG001|Overall Study|Physician Decision|2|||
155291271|NCT01651949|560495527|FG002|Overall Study|Physician Decision|0|||
155291272|NCT01651949|560495525|FG000|Overall Study|Adverse Event|0|||
155638284|NCT03636477|561766415|FG000|Overall Study|Adverse Event|0|||
155638285|NCT03636477|561766416|FG001|Overall Study|Adverse Event|0|||
155638286|NCT03636477|561766417|FG002|Overall Study|Adverse Event|1|||
155638287|NCT02382380|561766419|FG000|Overall Study|Withdrawal by Subject|2|||
155638288|NCT02382380|561766420|FG001|Overall Study|Withdrawal by Subject|2|||
155638289|NCT02382380|561766419|FG000|Overall Study|Lost to Follow-up|0|||
155638290|NCT02382380|561766420|FG001|Overall Study|Lost to Follow-up|1|||
155638291|NCT01295944|561766421|FG000|Overall Study|Switched to alternative treatment|1|||
155291273|NCT01651949|560495526|FG001|Overall Study|Adverse Event|2|||
155291274|NCT01651949|560495527|FG002|Overall Study|Adverse Event|1|||
155291275|NCT01651949|560495525|FG000|Overall Study|Screen failure|2|||
155291276|NCT01651949|560495526|FG001|Overall Study|Screen failure|2|||
155291277|NCT01651949|560495527|FG002|Overall Study|Screen failure|0|||
155291278|NCT01651949|560495525|FG000|Overall Study|Withdrawal by Subject|17|||
155291279|NCT01651949|560495526|FG001|Overall Study|Withdrawal by Subject|18|||
155291280|NCT01651949|560495527|FG002|Overall Study|Withdrawal by Subject|9|||
155291281|NCT02155829|560495528|FG000|Overall Study|Adverse Event|1|||
155638292|NCT01295944|561766421|FG000|Overall Study|Ineligible|9|||
155408886|NCT01534533|560928872|FG003|Overall Study|Withdrawal by Subject|1|||
155408887|NCT05032157|560930800|FG000|Overall Study|Adverse Event|12|||
155408888|NCT05032157|560930801|FG001|Overall Study|Adverse Event|7|||
155408889|NCT05032157|560930800|FG000|Overall Study|Pregnancy|0|||
155408890|NCT05032157|560930801|FG001|Overall Study|Pregnancy|2|||
155408891|NCT05032157|560930800|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155408892|NCT05032157|560930801|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
155408893|NCT05032157|560930800|FG000|Overall Study|Protocol Deviation|8|||
155408894|NCT05032157|560930801|FG001|Overall Study|Protocol Deviation|4|||
155408895|NCT05032157|560930800|FG000|Overall Study|Lost to Follow-up|1|||
155408896|NCT05032157|560930801|FG001|Overall Study|Lost to Follow-up|3|||
155408897|NCT05032157|560930800|FG000|Overall Study|Physician Decision|7|||
155408898|NCT05032157|560930801|FG001|Overall Study|Physician Decision|2|||
155408899|NCT05032157|560930800|FG000|Overall Study|Patient Decision|38|||
155408900|NCT05032157|560930801|FG001|Overall Study|Patient Decision|19|||
155408901|NCT02627495|560930804|FG000|Overall Study|Withdrawal by Subject|4|||
155408902|NCT00880893|560930805|FG000|Overall Study|Protocol Violation|13|||
155408903|NCT00880893|560930806|FG001|Overall Study|Protocol Violation|1|||
155408904|NCT00880893|560930805|FG000|Overall Study|Withdrawal by Subject|15|||
155408905|NCT00880893|560930806|FG001|Overall Study|Withdrawal by Subject|11|||
155408906|NCT00880893|560930805|FG000|Overall Study|Lost to Follow-up|76|||
155408907|NCT00880893|560930806|FG001|Overall Study|Lost to Follow-up|33|||
155408908|NCT00880893|560930805|FG000|Overall Study|Serious adverse event|3|||
155408909|NCT00880893|560930806|FG001|Overall Study|Serious adverse event|0|||
155408910|NCT01736579|560930807|FG000|Overall Study|Termination of Study by Sponsor|2|||
155408911|NCT01736579|560930808|FG001|Overall Study|Termination of Study by Sponsor|2|||
155408912|NCT01783678|560930813|FG000|Overall Study|Randomized but Not Treated|0|||
155408913|NCT01783678|560930814|FG001|Overall Study|Randomized but Not Treated|0|||
155408914|NCT01783678|560930815|FG002|Overall Study|Randomized but Not Treated|0|||
155408915|NCT01783678|560930816|FG003|Overall Study|Randomized but Not Treated|1|||
155408916|NCT01783678|560930817|FG004|Overall Study|Randomized but Not Treated|0|||
155408917|NCT01783678|560930818|FG005|Overall Study|Randomized but Not Treated|0|||
155408918|NCT01783678|560930813|FG000|Overall Study|Lack of Efficacy|1|||
155408919|NCT01783678|560930814|FG001|Overall Study|Lack of Efficacy|13|||
155408920|NCT01783678|560930815|FG002|Overall Study|Lack of Efficacy|1|||
155408921|NCT01783678|560930816|FG003|Overall Study|Lack of Efficacy|3|||
155408922|NCT01783678|560930817|FG004|Overall Study|Lack of Efficacy|6|||
155408923|NCT01783678|560930818|FG005|Overall Study|Lack of Efficacy|5|||
155408924|NCT01783678|560930813|FG000|Overall Study|Lost to Follow-up|0|||
155408925|NCT01783678|560930814|FG001|Overall Study|Lost to Follow-up|4|||
155408926|NCT01783678|560930815|FG002|Overall Study|Lost to Follow-up|0|||
155408927|NCT01783678|560930816|FG003|Overall Study|Lost to Follow-up|2|||
155408928|NCT01783678|560930817|FG004|Overall Study|Lost to Follow-up|1|||
155408929|NCT01783678|560930818|FG005|Overall Study|Lost to Follow-up|0|||
155408930|NCT01783678|560930813|FG000|Overall Study|Withdrew Consent|1|||
155408931|NCT01783678|560930814|FG001|Overall Study|Withdrew Consent|1|||
155408932|NCT01783678|560930815|FG002|Overall Study|Withdrew Consent|0|||
155408933|NCT01783678|560930816|FG003|Overall Study|Withdrew Consent|2|||
155408934|NCT01783678|560930817|FG004|Overall Study|Withdrew Consent|0|||
155408935|NCT01783678|560930818|FG005|Overall Study|Withdrew Consent|0|||
155408936|NCT02543528|560930819|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
155408937|NCT02543528|560930820|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
155408938|NCT02543528|560930821|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
155408939|NCT02543528|560930822|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
155408940|NCT02543528|560930823|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
155408941|NCT02543528|560930819|FG000|Adaptation Period|Lens Handling Difficultes|0|||
155408942|NCT02543528|560930820|FG001|Adaptation Period|Lens Handling Difficultes|0|||
155408943|NCT02543528|560930821|FG002|Adaptation Period|Lens Handling Difficultes|0|||
155408944|NCT02543528|560930822|FG003|Adaptation Period|Lens Handling Difficultes|0|||
155408945|NCT02543528|560930823|FG004|Adaptation Period|Lens Handling Difficultes|8|||
155408946|NCT02543528|560930819|FG000|Adaptation Period|Lost to Follow-up|0|||
155408947|NCT02543528|560930820|FG001|Adaptation Period|Lost to Follow-up|0|||
155408948|NCT02543528|560930821|FG002|Adaptation Period|Lost to Follow-up|0|||
155408949|NCT02543528|560930822|FG003|Adaptation Period|Lost to Follow-up|0|||
155408950|NCT02543528|560930823|FG004|Adaptation Period|Lost to Follow-up|14|||
155408951|NCT02543528|560930819|FG000|Adaptation Period|Adverse Event|0|||
155408952|NCT02543528|560930820|FG001|Adaptation Period|Adverse Event|0|||
155408953|NCT02543528|560930821|FG002|Adaptation Period|Adverse Event|0|||
155408954|NCT02543528|560930822|FG003|Adaptation Period|Adverse Event|0|||
155408955|NCT02543528|560930823|FG004|Adaptation Period|Adverse Event|2|||
155291282|NCT02155829|560495529|FG001|Overall Study|Adverse Event|0|||
155291283|NCT02155829|560495528|FG000|Overall Study|Withdrawal by Subject|3|||
155408956|NCT02543528|560930819|FG000|Extended Wear Period|Adverse Event|17|||
155408957|NCT02543528|560930820|FG001|Extended Wear Period|Adverse Event|11|||
155408958|NCT02543528|560930821|FG002|Extended Wear Period|Adverse Event|16|||
155291284|NCT02155829|560495529|FG001|Overall Study|Withdrawal by Subject|3|||
155291285|NCT02155829|560495528|FG000|Overall Study|Protocol Violation|2|||
155291286|NCT02155829|560495529|FG001|Overall Study|Protocol Violation|0|||
155291287|NCT00771849|560495530|FG000|Overall Study|Lost to Follow-up|1|||
155291288|NCT00771849|560495531|FG001|Overall Study|Lost to Follow-up|2|||
155291289|NCT00771849|560495530|FG000|Overall Study|Withdrawal by Subject|1|||
155291290|NCT00771849|560495531|FG001|Overall Study|Withdrawal by Subject|1|||
155291291|NCT00771849|560495530|FG000|Overall Study|Not vaccinated|0|||
155291292|NCT00771849|560495531|FG001|Overall Study|Not vaccinated|1|||
155291293|NCT03058991|560495532|FG000|Overall Study|Lost to Follow-up|17|||
155291294|NCT03058991|560495533|FG001|Overall Study|Lost to Follow-up|12|||
155291295|NCT03058991|560495534|FG002|Overall Study|Lost to Follow-up|12|||
155291296|NCT03058991|560495532|FG000|Overall Study|Withdrawal by Subject|1|||
155291297|NCT03058991|560495533|FG001|Overall Study|Withdrawal by Subject|0|||
155291298|NCT03058991|560495534|FG002|Overall Study|Withdrawal by Subject|0|||
155291299|NCT01689519|560495535|FG000|Intent to Treat|Death|157|||
155291300|NCT01689519|560495536|FG001|Intent to Treat|Death|167|||
155291301|NCT01689519|560495535|FG000|Intent to Treat|Lost to Follow-up|4|||
155291302|NCT01689519|560495536|FG001|Intent to Treat|Lost to Follow-up|8|||
155291303|NCT01689519|560495535|FG000|Intent to Treat|Other|2|||
155291304|NCT01689519|560495536|FG001|Intent to Treat|Other|4|||
155291305|NCT01689519|560495535|FG000|Intent to Treat|Physician Decision|4|||
155291306|NCT01689519|560495536|FG001|Intent to Treat|Physician Decision|1|||
155291307|NCT01689519|560495535|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
155291308|NCT01689519|560495536|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
155291309|NCT01689519|560495535|FG000|Intent to Treat|Withdrawal by Subject|21|||
155291310|NCT01689519|560495536|FG001|Intent to Treat|Withdrawal by Subject|20|||
155291311|NCT01689519|560495535|FG000|Safety Population|Death|158|||
155291312|NCT01689519|560495536|FG001|Safety Population|Death|165|||
155291313|NCT01689519|560495535|FG000|Safety Population|Lost to Follow-up|4|||
155291314|NCT01689519|560495536|FG001|Safety Population|Lost to Follow-up|8|||
155291315|NCT01689519|560495535|FG000|Safety Population|Other|2|||
155291316|NCT01689519|560495536|FG001|Safety Population|Other|4|||
155291317|NCT01689519|560495535|FG000|Safety Population|Physician Decision|4|||
155291318|NCT01689519|560495536|FG001|Safety Population|Physician Decision|1|||
155291319|NCT01689519|560495535|FG000|Safety Population|Study Terminated By Sponsor|60|||
155291320|NCT01689519|560495536|FG001|Safety Population|Study Terminated By Sponsor|47|||
155291321|NCT01689519|560495535|FG000|Safety Population|Withdrawal by Subject|20|||
155291322|NCT01689519|560495536|FG001|Safety Population|Withdrawal by Subject|20|||
155291323|NCT02982213|560495541|FG000|Overall Study|Did not complete follow up questionnaire|5|||
155291324|NCT02982213|560495542|FG001|Overall Study|Did not complete follow up questionnaire|1|||
155291325|NCT02596035|560495545|FG000|Overall Study|Disease Progression|64|||
155291326|NCT02596035|560495546|FG001|Overall Study|Disease Progression|32|||
155291327|NCT02596035|560495547|FG002|Overall Study|Disease Progression|1|||
155291328|NCT02596035|560495545|FG000|Overall Study|study drug toxicity|12|||
155291329|NCT02596035|560495546|FG001|Overall Study|study drug toxicity|3|||
155291330|NCT02596035|560495547|FG002|Overall Study|study drug toxicity|0|||
155291331|NCT02596035|560495545|FG000|Overall Study|AE unrelated to study drug|5|||
155291332|NCT02596035|560495546|FG001|Overall Study|AE unrelated to study drug|2|||
155291333|NCT02596035|560495547|FG002|Overall Study|AE unrelated to study drug|0|||
155291334|NCT02596035|560495545|FG000|Overall Study|participant request to discontinue study treatment|2|||
155291335|NCT02596035|560495546|FG001|Overall Study|participant request to discontinue study treatment|0|||
155291336|NCT02596035|560495547|FG002|Overall Study|participant request to discontinue study treatment|0|||
155291337|NCT02596035|560495545|FG000|Overall Study|participant withdrew consent|2|||
155291338|NCT02596035|560495546|FG001|Overall Study|participant withdrew consent|2|||
155291339|NCT02596035|560495547|FG002|Overall Study|participant withdrew consent|0|||
155291340|NCT02596035|560495545|FG000|Overall Study|Poor/Non Comlpiance|0|||
155291341|NCT02596035|560495546|FG001|Overall Study|Poor/Non Comlpiance|1|||
155743697|NCT03859973|562161541|FG001|Overall Study|Withdrawal by Subject|9|||
155291342|NCT02596035|560495547|FG002|Overall Study|Poor/Non Comlpiance|0|||
155291343|NCT02596035|560495545|FG000|Overall Study|participant no longer meets study criteria|1|||
155291344|NCT02596035|560495546|FG001|Overall Study|participant no longer meets study criteria|0|||
155291345|NCT02596035|560495547|FG002|Overall Study|participant no longer meets study criteria|0|||
155743698|NCT03859973|562161540|FG000|Overall Study|Lost to Follow-up|2|||
155291346|NCT02596035|560495545|FG000|Overall Study|other reasons|11|||
155291347|NCT02596035|560495546|FG001|Overall Study|other reasons|4|||
155291348|NCT02596035|560495547|FG002|Overall Study|other reasons|0|||
155291349|NCT00835380|560495550|FG000|Overall Study|Withdrawal by Subject|2|||
155291350|NCT03247543|560495551|FG000|Overall Study|Adverse Event|3|||
155291351|NCT03247543|560495552|FG001|Overall Study|Adverse Event|6|||
155291352|NCT03247543|560495553|FG002|Overall Study|Adverse Event|4|||
155291353|NCT03247543|560495551|FG000|Overall Study|Lost to Follow-up|10|||
155408959|NCT02543528|560930822|FG003|Extended Wear Period|Adverse Event|3|||
155291354|NCT03247543|560495552|FG001|Overall Study|Lost to Follow-up|7|||
155291355|NCT03247543|560495553|FG002|Overall Study|Lost to Follow-up|8|||
155291356|NCT03247543|560495551|FG000|Overall Study|Consent withdrawn by caregiver|2|||
155743699|NCT03859973|562161541|FG001|Overall Study|Lost to Follow-up|3|||
155408960|NCT02543528|560930823|FG004|Extended Wear Period|Adverse Event|0|||
155408961|NCT02543528|560930819|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
155408962|NCT02543528|560930820|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
155408963|NCT02543528|560930821|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
155408964|NCT02543528|560930822|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
155408965|NCT02543528|560930823|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
155408966|NCT02543528|560930819|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
155408967|NCT02543528|560930820|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
155408968|NCT02543528|560930821|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
155408969|NCT02543528|560930822|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
155408970|NCT02543528|560930823|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
155408971|NCT02543528|560930819|FG000|Extended Wear Period|Lost to Follow-up|0|||
155408972|NCT02543528|560930820|FG001|Extended Wear Period|Lost to Follow-up|1|||
155408973|NCT02543528|560930821|FG002|Extended Wear Period|Lost to Follow-up|2|||
155408974|NCT02543528|560930822|FG003|Extended Wear Period|Lost to Follow-up|1|||
155408975|NCT02543528|560930823|FG004|Extended Wear Period|Lost to Follow-up|0|||
155408976|NCT02543528|560930819|FG000|Extended Wear Period|Withdrawal by Subject|10|||
155408977|NCT02543528|560930820|FG001|Extended Wear Period|Withdrawal by Subject|9|||
155408978|NCT02543528|560930821|FG002|Extended Wear Period|Withdrawal by Subject|4|||
155408979|NCT02543528|560930822|FG003|Extended Wear Period|Withdrawal by Subject|5|||
155408980|NCT02543528|560930823|FG004|Extended Wear Period|Withdrawal by Subject|0|||
155408981|NCT01042600|560930824|FG000|Overall Study|Ineligible|1|||
155408982|NCT01042600|560930825|FG001|Overall Study|Ineligible|0|||
155408983|NCT03311711|560930826|FG000|Overall Study|Death|1|||
155408984|NCT03311711|560930827|FG001|Overall Study|Death|0|||
155408985|NCT03311711|560930828|FG002|Overall Study|Death|0|||
155408986|NCT03311711|560930829|FG003|Overall Study|Death|0|||
155408987|NCT03311711|560930830|FG004|Overall Study|Death|0|||
155408988|NCT03311711|560930831|FG005|Overall Study|Death|0|||
155408989|NCT03311711|560930832|FG006|Overall Study|Death|1|||
155408990|NCT03311711|560930833|FG007|Overall Study|Death|0|||
155408991|NCT03311711|560930834|FG008|Overall Study|Death|1|||
155408992|NCT03311711|560930835|FG009|Overall Study|Death|0|||
155408993|NCT03311711|560930826|FG000|Overall Study|Death of dyad partner|0|||
155408994|NCT03311711|560930827|FG001|Overall Study|Death of dyad partner|1|||
155638293|NCT01295944|561766421|FG000|Overall Study|Withdrawal by Subject|1|||
155638294|NCT01295944|561766421|FG000|Overall Study|Participant chose to be treated in Peru|1|||
155638295|NCT01295944|561766421|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
155638296|NCT01295944|561766421|FG000|Overall Study|Physician Decision|1|||
155638297|NCT01295944|561766421|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
155638298|NCT01295944|561766421|FG000|Overall Study|Disease progression|4|||
155638299|NCT01295944|561766421|FG000|Overall Study|Transferred care before starting new treatment|1|||
155638300|NCT03036254|561766428|FG000|Overall Study|Adverse Event|6|||
155638301|NCT03036254|561766429|FG001|Overall Study|Adverse Event|4|||
155638302|NCT03036254|561766428|FG000|Overall Study|Death|3|||
155638303|NCT03036254|561766429|FG001|Overall Study|Death|1|||
155638304|NCT03036254|561766428|FG000|Overall Study|Lack of Efficacy|5|||
155638305|NCT03036254|561766429|FG001|Overall Study|Lack of Efficacy|1|||
155638306|NCT03036254|561766428|FG000|Overall Study|Withdrawal by Subject|3|||
155638307|NCT03036254|561766429|FG001|Overall Study|Withdrawal by Subject|5|||
155638308|NCT02783274|561766430|FG000|Overall Study|Withdrawal by Subject|16|||
155638309|NCT02783274|561766430|FG000|Overall Study|Physician Decision|6|||
155638310|NCT02783274|561766430|FG000|Overall Study|Death|9|||
155638311|NCT02783274|561766430|FG000|Overall Study|Lost to Follow-up|22|||
155638312|NCT02783274|561766430|FG000|Overall Study|Other|22|||
155638313|NCT05722015|561766435|FG000|Overall Study|Death|57|||
155638314|NCT05722015|561766436|FG001|Overall Study|Death|37|||
155638315|NCT05722015|561766435|FG000|Overall Study|Lost to Follow-up|1|||
155638316|NCT05722015|561766436|FG001|Overall Study|Lost to Follow-up|0|||
155638317|NCT05722015|561766435|FG000|Overall Study|Withdrawal by Subject|5|||
155638318|NCT05722015|561766436|FG001|Overall Study|Withdrawal by Subject|1|||
155638319|NCT05722015|561766435|FG000|Overall Study|Participants Ongoing|188|||
155638320|NCT05722015|561766436|FG001|Overall Study|Participants Ongoing|88|||
155638321|NCT01802281|561766437|FG000|Overall Study|Death|1|||
155638322|NCT01802281|561766438|FG001|Overall Study|Death|2|||
155638323|NCT01802281|561766437|FG000|Overall Study|Withdrawal by Subject|2|||
155638324|NCT01802281|561766438|FG001|Overall Study|Withdrawal by Subject|1|||
155638325|NCT01802281|561766437|FG000|Overall Study|Ineligible|5|||
155638326|NCT01802281|561766438|FG001|Overall Study|Ineligible|3|||
155638327|NCT05020743|561766440|FG000|Overall Study|Enrollment in Interventional Study|2|||
155638328|NCT05020743|561766441|FG001|Overall Study|Enrollment in Interventional Study|9|||
155638329|NCT05020743|561766442|FG002|Overall Study|Enrollment in Interventional Study|0|||
155638330|NCT05020743|561766440|FG000|Overall Study|Withdrawal by Subject|0|||
155638331|NCT05020743|561766441|FG001|Overall Study|Withdrawal by Subject|3|||
155638332|NCT05020743|561766442|FG002|Overall Study|Withdrawal by Subject|1|||
155638333|NCT05020743|561766440|FG000|Overall Study|Lost to Follow-up|1|||
155638334|NCT05020743|561766441|FG001|Overall Study|Lost to Follow-up|0|||
155291357|NCT03247543|560495552|FG001|Overall Study|Consent withdrawn by caregiver|2|||
155291358|NCT03247543|560495553|FG002|Overall Study|Consent withdrawn by caregiver|9|||
155291359|NCT03247543|560495551|FG000|Overall Study|Withdrawal by Subject|0|||
155291360|NCT03247543|560495552|FG001|Overall Study|Withdrawal by Subject|0|||
155291361|NCT03247543|560495553|FG002|Overall Study|Withdrawal by Subject|1|||
155291362|NCT03247543|560495551|FG000|Overall Study|Failure to Follow study procedures|1|||
155291363|NCT03247543|560495552|FG001|Overall Study|Failure to Follow study procedures|3|||
155291364|NCT03247543|560495553|FG002|Overall Study|Failure to Follow study procedures|1|||
155291365|NCT03247543|560495551|FG000|Overall Study|Lack of Efficacy|1|||
155291366|NCT03247543|560495552|FG001|Overall Study|Lack of Efficacy|0|||
155291367|NCT03247543|560495553|FG002|Overall Study|Lack of Efficacy|0|||
155291368|NCT03247543|560495551|FG000|Overall Study|Non-compliance with study visits|0|||
155291369|NCT03247543|560495552|FG001|Overall Study|Non-compliance with study visits|1|||
155291370|NCT03247543|560495553|FG002|Overall Study|Non-compliance with study visits|0|||
155291371|NCT02059980|560495560|FG000|Overall Study|Lost to Follow-up|2|||
155291372|NCT02059980|560495561|FG001|Overall Study|Lost to Follow-up|1|||
155291373|NCT01321606|560495562|FG000|Overall Study|Lost to Follow-up|0|||
155291374|NCT01321606|560495563|FG001|Overall Study|Lost to Follow-up|0|||
155291375|NCT01321606|560495564|FG002|Overall Study|Lost to Follow-up|0|||
155291376|NCT01321606|560495565|FG003|Overall Study|Lost to Follow-up|1|||
155291377|NCT01253226|560495566|FG000|Overall Study|Adverse Event|0|||
155291378|NCT01253226|560495567|FG001|Overall Study|Adverse Event|0|||
155291379|NCT01253226|560495568|FG002|Overall Study|Adverse Event|1|||
155291380|NCT01253226|560495569|FG003|Overall Study|Adverse Event|0|||
155291381|NCT01253226|560495570|FG004|Overall Study|Adverse Event|0|||
155291382|NCT01253226|560495566|FG000|Overall Study|Death|0|||
155291383|NCT01253226|560495567|FG001|Overall Study|Death|1|||
155291384|NCT01253226|560495568|FG002|Overall Study|Death|0|||
155291385|NCT01253226|560495569|FG003|Overall Study|Death|0|||
155291386|NCT01253226|560495570|FG004|Overall Study|Death|0|||
155291387|NCT01253226|560495566|FG000|Overall Study|Physician Decision|0|||
155291388|NCT01253226|560495567|FG001|Overall Study|Physician Decision|0|||
155291389|NCT01253226|560495568|FG002|Overall Study|Physician Decision|0|||
155408995|NCT03311711|560930828|FG002|Overall Study|Death of dyad partner|0|||
155408996|NCT03311711|560930829|FG003|Overall Study|Death of dyad partner|0|||
155408997|NCT03311711|560930830|FG004|Overall Study|Death of dyad partner|0|||
155408998|NCT03311711|560930831|FG005|Overall Study|Death of dyad partner|0|||
155408999|NCT03311711|560930832|FG006|Overall Study|Death of dyad partner|0|||
155409000|NCT03311711|560930833|FG007|Overall Study|Death of dyad partner|1|||
155409001|NCT03311711|560930834|FG008|Overall Study|Death of dyad partner|0|||
155409002|NCT03311711|560930835|FG009|Overall Study|Death of dyad partner|1|||
155409003|NCT03311711|560930826|FG000|Overall Study|Lost to Follow-up|2|||
155409004|NCT03311711|560930827|FG001|Overall Study|Lost to Follow-up|2|||
155409005|NCT03311711|560930828|FG002|Overall Study|Lost to Follow-up|0|||
155409006|NCT03311711|560930829|FG003|Overall Study|Lost to Follow-up|0|||
155409007|NCT03311711|560930830|FG004|Overall Study|Lost to Follow-up|0|||
155409008|NCT03311711|560930831|FG005|Overall Study|Lost to Follow-up|0|||
155409009|NCT03311711|560930832|FG006|Overall Study|Lost to Follow-up|1|||
155409010|NCT03311711|560930833|FG007|Overall Study|Lost to Follow-up|1|||
155409011|NCT03311711|560930834|FG008|Overall Study|Lost to Follow-up|0|||
155409012|NCT03311711|560930835|FG009|Overall Study|Lost to Follow-up|0|||
155409013|NCT03311711|560930826|FG000|Overall Study|Withdrawal by Subject|1|||
155409014|NCT03311711|560930827|FG001|Overall Study|Withdrawal by Subject|1|||
155409015|NCT03311711|560930828|FG002|Overall Study|Withdrawal by Subject|0|||
155409016|NCT03311711|560930829|FG003|Overall Study|Withdrawal by Subject|0|||
155409017|NCT03311711|560930830|FG004|Overall Study|Withdrawal by Subject|0|||
155409018|NCT03311711|560930831|FG005|Overall Study|Withdrawal by Subject|0|||
155409019|NCT03311711|560930832|FG006|Overall Study|Withdrawal by Subject|3|||
155409020|NCT03311711|560930833|FG007|Overall Study|Withdrawal by Subject|3|||
155409021|NCT03311711|560930834|FG008|Overall Study|Withdrawal by Subject|0|||
155409022|NCT03311711|560930835|FG009|Overall Study|Withdrawal by Subject|0|||
155409023|NCT01049035|560930836|FG000|Overall Study|Serious adverse event|0|||
155291390|NCT01253226|560495569|FG003|Overall Study|Physician Decision|0|||
155291391|NCT01253226|560495570|FG004|Overall Study|Physician Decision|2|||
155291392|NCT01253226|560495566|FG000|Overall Study|Withdrawal by Subject|0|||
155291393|NCT01253226|560495567|FG001|Overall Study|Withdrawal by Subject|0|||
155409024|NCT01049035|560930837|FG001|Overall Study|Serious adverse event|1|||
155409025|NCT01049035|560930838|FG002|Overall Study|Serious adverse event|1|||
155638335|NCT05020743|561766442|FG002|Overall Study|Lost to Follow-up|0|||
155638336|NCT05020743|561766440|FG000|Overall Study|Study Termination by Sponsor|10|||
155638337|NCT05020743|561766441|FG001|Overall Study|Study Termination by Sponsor|11|||
155638338|NCT05020743|561766442|FG002|Overall Study|Study Termination by Sponsor|10|||
155291394|NCT01253226|560495568|FG002|Overall Study|Withdrawal by Subject|0|||
155291395|NCT01253226|560495569|FG003|Overall Study|Withdrawal by Subject|1|||
155409026|NCT01049035|560930839|FG003|Overall Study|Serious adverse event|2|||
155409027|NCT01049035|560930840|FG004|Overall Study|Serious adverse event|0|||
155409028|NCT01049035|560930841|FG005|Overall Study|Serious adverse event|0|||
155291396|NCT01253226|560495570|FG004|Overall Study|Withdrawal by Subject|0|||
155291397|NCT04550039|560495576|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
155291398|NCT04550039|560495577|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
155291399|NCT04550039|560495576|FG000|Overall Study|patient self-withdrew from study|0|||
155291400|NCT04550039|560495577|FG001|Overall Study|patient self-withdrew from study|1|||
155291401|NCT00554801|560495580|FG000|Overall Study|left area before completion|5|||
155291402|NCT00554801|560495581|FG001|Overall Study|left area before completion|0|||
155291403|NCT00554801|560495580|FG000|Overall Study|Withdrawal by Subject|14|||
155291404|NCT00554801|560495581|FG001|Overall Study|Withdrawal by Subject|0|||
155291405|NCT05196737|560495582|FG000|Non-intervention Week|Lost to Follow-up|2|||
155291406|NCT05196737|560495582|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
155291407|NCT00828945|560495585|FG000|Overall Study|Death|4|||
155291408|NCT00828945|560495585|FG000|Overall Study|Participant was missing|1|||
155291409|NCT00828945|560495585|FG000|Overall Study|Other|36|||
155291410|NCT04222959|560495586|FG000|Overall Study|Lost to Follow-up|76|||
155291411|NCT04222959|560495587|FG001|Overall Study|Lost to Follow-up|28|||
155291412|NCT00603447|560495598|FG000|Overall Study|Adverse Event|0|||
155291413|NCT00603447|560495599|FG001|Overall Study|Adverse Event|1|||
155291414|NCT00603447|560495600|FG002|Overall Study|Adverse Event|1|||
155291415|NCT00603447|560495601|FG003|Overall Study|Adverse Event|2|||
155291416|NCT00603447|560495602|FG004|Overall Study|Adverse Event|1|||
155291417|NCT00603447|560495603|FG005|Overall Study|Adverse Event|2|||
155291418|NCT00603447|560495604|FG006|Overall Study|Adverse Event|10|||
155291419|NCT00603447|560495598|FG000|Overall Study|Other|0|||
155291420|NCT00603447|560495599|FG001|Overall Study|Other|0|||
155743700|NCT03859973|562161540|FG000|Overall Study|Protocol Violation|1|||
155743701|NCT03859973|562161541|FG001|Overall Study|Protocol Violation|3|||
155291421|NCT00603447|560495600|FG002|Overall Study|Other|1|||
155291422|NCT00603447|560495601|FG003|Overall Study|Other|0|||
155291423|NCT00603447|560495602|FG004|Overall Study|Other|3|||
155291424|NCT00603447|560495603|FG005|Overall Study|Other|0|||
155291425|NCT00603447|560495604|FG006|Overall Study|Other|13|||
155291426|NCT00603447|560495598|FG000|Overall Study|Withdrew Consent|0|||
155291427|NCT00603447|560495599|FG001|Overall Study|Withdrew Consent|2|||
155291428|NCT00603447|560495600|FG002|Overall Study|Withdrew Consent|0|||
155291429|NCT00603447|560495601|FG003|Overall Study|Withdrew Consent|0|||
155291430|NCT00603447|560495602|FG004|Overall Study|Withdrew Consent|1|||
155291431|NCT00603447|560495603|FG005|Overall Study|Withdrew Consent|0|||
155291432|NCT00603447|560495604|FG006|Overall Study|Withdrew Consent|1|||
155291433|NCT04133363|560495607|FG000|Overall Study|Lost to Follow-up|2|||
155291434|NCT04133363|560495608|FG001|Overall Study|Lost to Follow-up|1|||
155291435|NCT04133363|560495609|FG002|Overall Study|Lost to Follow-up|4|||
155291436|NCT00482729|560497498|FG000|Overall Study|Adverse Event|29|||
155291437|NCT00482729|560497499|FG001|Overall Study|Adverse Event|33|||
155291438|NCT00482729|560497498|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
155291439|NCT00482729|560497499|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
155291440|NCT00482729|560497498|FG000|Overall Study|Hyperglycemia Criteria|7|||
155291441|NCT00482729|560497499|FG001|Overall Study|Hyperglycemia Criteria|5|||
155291442|NCT00482729|560497498|FG000|Overall Study|Lack of Efficacy|4|||
155291443|NCT00482729|560497499|FG001|Overall Study|Lack of Efficacy|16|||
155291444|NCT00482729|560497498|FG000|Overall Study|Lost to Follow-up|86|||
155291445|NCT00482729|560497499|FG001|Overall Study|Lost to Follow-up|66|||
155291446|NCT00482729|560497498|FG000|Overall Study|Physician Decision|10|||
155291447|NCT00482729|560497499|FG001|Overall Study|Physician Decision|7|||
155291448|NCT00482729|560497498|FG000|Overall Study|Pregnancy|4|||
155291449|NCT00482729|560497499|FG001|Overall Study|Pregnancy|2|||
155291450|NCT00482729|560497498|FG000|Overall Study|Protocol Violation|10|||
155291451|NCT00482729|560497499|FG001|Overall Study|Protocol Violation|18|||
155291452|NCT00482729|560497498|FG000|Overall Study|Withdrawal by Subject|67|||
155291453|NCT00482729|560497499|FG001|Overall Study|Withdrawal by Subject|69|||
155494232|NCT05604521|561234249|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
155743702|NCT03859973|562161540|FG000|Overall Study|Adverse Event|3|||
155291456|NCT01090024|560497505|FG000|Period 1|Met exclusion criteria|0|||
155291457|NCT01090024|560497506|FG001|Period 1|Met exclusion criteria|0|||
155291458|NCT01090024|560497507|FG002|Period 1|Met exclusion criteria|0|||
155291459|NCT01090024|560497508|FG003|Period 1|Met exclusion criteria|0|||
155291460|NCT01090024|560497509|FG004|Period 1|Met exclusion criteria|0|||
155291461|NCT01090024|560497510|FG005|Period 1|Met exclusion criteria|0|||
155291462|NCT01090024|560497511|FG006|Period 1|Met exclusion criteria|0|||
155743703|NCT03859973|562161541|FG001|Overall Study|Adverse Event|5|||
155291463|NCT01090024|560497512|FG007|Period 1|Met exclusion criteria|0|||
155291464|NCT01090024|560497513|FG008|Period 1|Met exclusion criteria|0|||
155743704|NCT03085914|562161542|FG000|Overall Study|Death|6|||
155743705|NCT03085914|562161543|FG001|Overall Study|Death|6|||
155291465|NCT01090024|560497514|FG009|Period 1|Met exclusion criteria|0|||
155743706|NCT03085914|562161544|FG002|Overall Study|Death|4|||
155291466|NCT01090024|560497515|FG010|Period 1|Met exclusion criteria|0|||
155291467|NCT01090024|560497516|FG011|Period 1|Met exclusion criteria|0|||
155291468|NCT01090024|560497517|FG012|Period 1|Met exclusion criteria|0|||
155291469|NCT01090024|560497518|FG013|Period 1|Met exclusion criteria|0|||
155291470|NCT01090024|560497519|FG014|Period 1|Met exclusion criteria|1|||
155291471|NCT01090024|560497520|FG015|Period 1|Met exclusion criteria|0|||
155291472|NCT01090024|560497521|FG016|Period 1|Met exclusion criteria|0|||
155291473|NCT01090024|560497522|FG017|Period 1|Met exclusion criteria|0|||
155291474|NCT01090024|560497505|FG000|Period 1|Adverse Event|0|||
155291475|NCT01090024|560497506|FG001|Period 1|Adverse Event|0|||
155291476|NCT01090024|560497507|FG002|Period 1|Adverse Event|0|||
155291477|NCT01090024|560497508|FG003|Period 1|Adverse Event|0|||
155291478|NCT01090024|560497509|FG004|Period 1|Adverse Event|0|||
155291479|NCT01090024|560497510|FG005|Period 1|Adverse Event|0|||
155291480|NCT01090024|560497511|FG006|Period 1|Adverse Event|0|||
155291481|NCT01090024|560497512|FG007|Period 1|Adverse Event|0|||
155291482|NCT01090024|560497513|FG008|Period 1|Adverse Event|0|||
155291483|NCT01090024|560497514|FG009|Period 1|Adverse Event|1|||
155291484|NCT01090024|560497515|FG010|Period 1|Adverse Event|0|||
155291485|NCT01090024|560497516|FG011|Period 1|Adverse Event|1|||
155291486|NCT01090024|560497517|FG012|Period 1|Adverse Event|0|||
155291487|NCT01090024|560497518|FG013|Period 1|Adverse Event|0|||
155291488|NCT01090024|560497519|FG014|Period 1|Adverse Event|0|||
155291489|NCT01090024|560497520|FG015|Period 1|Adverse Event|0|||
155291490|NCT01090024|560497521|FG016|Period 1|Adverse Event|0|||
155291491|NCT01090024|560497522|FG017|Period 1|Adverse Event|1|||
155291492|NCT01090024|560497505|FG000|Period 1|Withdrawal by Subject|0|||
155291493|NCT01090024|560497506|FG001|Period 1|Withdrawal by Subject|0|||
155291494|NCT01090024|560497507|FG002|Period 1|Withdrawal by Subject|0|||
155291495|NCT01090024|560497508|FG003|Period 1|Withdrawal by Subject|1|||
155291496|NCT01090024|560497509|FG004|Period 1|Withdrawal by Subject|0|||
155743707|NCT03085914|562161545|FG003|Overall Study|Death|1|||
155743708|NCT03085914|562161546|FG004|Overall Study|Death|5|||
155743709|NCT03085914|562161547|FG005|Overall Study|Death|2|||
155743710|NCT03085914|562161548|FG006|Overall Study|Death|2|||
155743711|NCT03085914|562161542|FG000|Overall Study|Withdrawal by Subject|1|||
155743712|NCT03085914|562161543|FG001|Overall Study|Withdrawal by Subject|1|||
155743713|NCT03085914|562161544|FG002|Overall Study|Withdrawal by Subject|2|||
155743714|NCT03085914|562161545|FG003|Overall Study|Withdrawal by Subject|2|||
155743715|NCT03085914|562161546|FG004|Overall Study|Withdrawal by Subject|2|||
155743716|NCT03085914|562161547|FG005|Overall Study|Withdrawal by Subject|0|||
155743717|NCT03085914|562161548|FG006|Overall Study|Withdrawal by Subject|1|||
155743718|NCT03085914|562161542|FG000|Overall Study|Lost to Follow-up|0|||
155743719|NCT03085914|562161543|FG001|Overall Study|Lost to Follow-up|0|||
155743720|NCT03085914|562161544|FG002|Overall Study|Lost to Follow-up|1|||
155743721|NCT03085914|562161545|FG003|Overall Study|Lost to Follow-up|0|||
155743722|NCT03085914|562161546|FG004|Overall Study|Lost to Follow-up|0|||
155743723|NCT03085914|562161547|FG005|Overall Study|Lost to Follow-up|1|||
155743724|NCT03085914|562161548|FG006|Overall Study|Lost to Follow-up|1|||
155743725|NCT03085914|562161542|FG000|Overall Study|Reason was not specified,|2|||
155743726|NCT03085914|562161543|FG001|Overall Study|Reason was not specified,|2|||
155743727|NCT03085914|562161544|FG002|Overall Study|Reason was not specified,|2|||
155291497|NCT01090024|560497510|FG005|Period 1|Withdrawal by Subject|0|||
155291498|NCT01090024|560497511|FG006|Period 1|Withdrawal by Subject|0|||
155291499|NCT01090024|560497512|FG007|Period 1|Withdrawal by Subject|0|||
155743728|NCT03085914|562161545|FG003|Overall Study|Reason was not specified,|3|||
155743729|NCT03085914|562161546|FG004|Overall Study|Reason was not specified,|3|||
155743730|NCT03085914|562161547|FG005|Overall Study|Reason was not specified,|3|||
155743731|NCT03085914|562161548|FG006|Overall Study|Reason was not specified,|6|||
155743732|NCT03085914|562161542|FG000|Overall Study|Progressive Disease|0|||
155743733|NCT03085914|562161543|FG001|Overall Study|Progressive Disease|0|||
155291500|NCT01090024|560497513|FG008|Period 1|Withdrawal by Subject|0|||
155291501|NCT01090024|560497514|FG009|Period 1|Withdrawal by Subject|0|||
155291502|NCT01090024|560497515|FG010|Period 1|Withdrawal by Subject|0|||
155291503|NCT01090024|560497516|FG011|Period 1|Withdrawal by Subject|0|||
155291504|NCT01090024|560497517|FG012|Period 1|Withdrawal by Subject|0|||
155743734|NCT03085914|562161544|FG002|Overall Study|Progressive Disease|2|||
155291505|NCT01090024|560497518|FG013|Period 1|Withdrawal by Subject|0|||
155291506|NCT01090024|560497519|FG014|Period 1|Withdrawal by Subject|0|||
155291507|NCT01090024|560497520|FG015|Period 1|Withdrawal by Subject|0|||
155291508|NCT01090024|560497521|FG016|Period 1|Withdrawal by Subject|0|||
155291509|NCT01090024|560497522|FG017|Period 1|Withdrawal by Subject|0|||
155291510|NCT01090024|560497505|FG000|Period 1|Lost to Follow-up|0|||
155291511|NCT01090024|560497506|FG001|Period 1|Lost to Follow-up|1|||
155291512|NCT01090024|560497507|FG002|Period 1|Lost to Follow-up|0|||
155743735|NCT03085914|562161545|FG003|Overall Study|Progressive Disease|2|||
155291513|NCT01090024|560497508|FG003|Period 1|Lost to Follow-up|0|||
155291514|NCT01090024|560497509|FG004|Period 1|Lost to Follow-up|0|||
155291515|NCT01090024|560497510|FG005|Period 1|Lost to Follow-up|0|||
155743736|NCT03085914|562161546|FG004|Overall Study|Progressive Disease|1|||
155743737|NCT03085914|562161547|FG005|Overall Study|Progressive Disease|1|||
155743738|NCT03085914|562161548|FG006|Overall Study|Progressive Disease|1|||
155291516|NCT01090024|560497511|FG006|Period 1|Lost to Follow-up|0|||
155291517|NCT01090024|560497512|FG007|Period 1|Lost to Follow-up|0|||
155743739|NCT03085914|562161542|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155291518|NCT01090024|560497513|FG008|Period 1|Lost to Follow-up|0|||
155291519|NCT01090024|560497514|FG009|Period 1|Lost to Follow-up|0|||
155291520|NCT01090024|560497515|FG010|Period 1|Lost to Follow-up|0|||
155291521|NCT01090024|560497516|FG011|Period 1|Lost to Follow-up|0|||
155291522|NCT01090024|560497517|FG012|Period 1|Lost to Follow-up|0|||
155291523|NCT01090024|560497518|FG013|Period 1|Lost to Follow-up|0|||
155291524|NCT01090024|560497519|FG014|Period 1|Lost to Follow-up|0|||
155291525|NCT01090024|560497520|FG015|Period 1|Lost to Follow-up|0|||
155291526|NCT01090024|560497521|FG016|Period 1|Lost to Follow-up|0|||
155291527|NCT01090024|560497522|FG017|Period 1|Lost to Follow-up|0|||
155291528|NCT01090024|560497505|FG000|Period 2|Lost to Follow-up|0|||
155291529|NCT01090024|560497506|FG001|Period 2|Lost to Follow-up|0|||
155291530|NCT01090024|560497507|FG002|Period 2|Lost to Follow-up|0|||
155291531|NCT01090024|560497508|FG003|Period 2|Lost to Follow-up|1|||
155291532|NCT01090024|560497509|FG004|Period 2|Lost to Follow-up|0|||
155291533|NCT01090024|560497510|FG005|Period 2|Lost to Follow-up|0|||
155291534|NCT01090024|560497511|FG006|Period 2|Lost to Follow-up|0|||
155291535|NCT01090024|560497512|FG007|Period 2|Lost to Follow-up|0|||
155291536|NCT01090024|560497513|FG008|Period 2|Lost to Follow-up|0|||
155291537|NCT01090024|560497514|FG009|Period 2|Lost to Follow-up|0|||
155291538|NCT01090024|560497515|FG010|Period 2|Lost to Follow-up|0|||
155743740|NCT03085914|562161543|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155743741|NCT03085914|562161544|FG002|Overall Study|Study Terminated by the Sponsor|0|||
155743742|NCT03085914|562161545|FG003|Overall Study|Study Terminated by the Sponsor|1|||
155743743|NCT03085914|562161546|FG004|Overall Study|Study Terminated by the Sponsor|2|||
155743744|NCT03085914|562161547|FG005|Overall Study|Study Terminated by the Sponsor|1|||
155743745|NCT03085914|562161548|FG006|Overall Study|Study Terminated by the Sponsor|0|||
155743746|NCT01445548|562161550|FG000|Overall Study|Adverse Event|1|||
155743747|NCT03560518|562161552|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
155743748|NCT03560518|562161553|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
155743749|NCT03560518|562161554|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
155743750|NCT03560518|562161552|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
155743751|NCT03560518|562161553|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
155743752|NCT03560518|562161554|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
155743753|NCT03560518|562161552|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155743754|NCT03560518|562161553|FG001|Double Blind Treatment Period|Protocol Violation|2|||
155743755|NCT03560518|562161554|FG002|Double Blind Treatment Period|Protocol Violation|0|||
155743756|NCT03560518|562161552|FG000|Double Blind Treatment Period|Pregnancy|0|||
155743757|NCT03560518|562161553|FG001|Double Blind Treatment Period|Pregnancy|2|||
155743758|NCT03560518|562161554|FG002|Double Blind Treatment Period|Pregnancy|0|||
155743759|NCT03560518|562161552|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
155743760|NCT03560518|562161553|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
155743761|NCT03560518|562161554|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
155743762|NCT03560518|562161552|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
155743763|NCT03560518|562161553|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
155743764|NCT03560518|562161554|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
155743765|NCT03560518|562161552|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
155743766|NCT03560518|562161553|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
155743767|NCT03560518|562161554|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
155743768|NCT03560518|562161552|FG000|Double Blind Treatment Period|Adverse Event|0|||
155743769|NCT03560518|562161553|FG001|Double Blind Treatment Period|Adverse Event|3|||
155743770|NCT03560518|562161554|FG002|Double Blind Treatment Period|Adverse Event|1|||
155743771|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
155743772|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Adverse Event|9|||
155743773|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Death|4|||
155743774|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
155291539|NCT01090024|560497516|FG011|Period 2|Lost to Follow-up|0|||
155291540|NCT01090024|560497517|FG012|Period 2|Lost to Follow-up|0|||
155291541|NCT01090024|560497518|FG013|Period 2|Lost to Follow-up|0|||
155291542|NCT01090024|560497519|FG014|Period 2|Lost to Follow-up|0|||
155291543|NCT01090024|560497520|FG015|Period 2|Lost to Follow-up|0|||
155291544|NCT01090024|560497521|FG016|Period 2|Lost to Follow-up|0|||
155291545|NCT01090024|560497522|FG017|Period 2|Lost to Follow-up|0|||
155291546|NCT01090024|560497505|FG000|Period 2|Adverse Event|1|||
155291547|NCT01090024|560497506|FG001|Period 2|Adverse Event|0|||
155291548|NCT01090024|560497507|FG002|Period 2|Adverse Event|0|||
155291549|NCT01090024|560497508|FG003|Period 2|Adverse Event|0|||
155291550|NCT01090024|560497509|FG004|Period 2|Adverse Event|0|||
155291551|NCT01090024|560497510|FG005|Period 2|Adverse Event|0|||
155291552|NCT01090024|560497511|FG006|Period 2|Adverse Event|0|||
155291553|NCT01090024|560497512|FG007|Period 2|Adverse Event|0|||
155291554|NCT01090024|560497513|FG008|Period 2|Adverse Event|0|||
155291555|NCT01090024|560497514|FG009|Period 2|Adverse Event|0|||
155291556|NCT01090024|560497515|FG010|Period 2|Adverse Event|0|||
155291557|NCT01090024|560497516|FG011|Period 2|Adverse Event|0|||
155291558|NCT01090024|560497517|FG012|Period 2|Adverse Event|0|||
155743775|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
155743776|NCT00159822|562161555|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
155743777|NCT00159822|562161555|FG000|Post-treatment Follow-up Period|Death|1|||
155743778|NCT00159822|562161555|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
155743779|NCT00159822|562161555|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
155743780|NCT00275821|562161556|FG000|Overall Study|Adverse Event|4|||
155743781|NCT00275821|562161557|FG001|Overall Study|Adverse Event|12|||
155743782|NCT00275821|562161558|FG002|Overall Study|Adverse Event|5|||
155743783|NCT00275821|562161556|FG000|Overall Study|Administrative problems|3|||
155743784|NCT00275821|562161557|FG001|Overall Study|Administrative problems|4|||
155743785|NCT00275821|562161558|FG002|Overall Study|Administrative problems|4|||
155743786|NCT00275821|562161556|FG000|Overall Study|Withdrawal by Subject|0|||
155743787|NCT00275821|562161557|FG001|Overall Study|Withdrawal by Subject|2|||
155743788|NCT00275821|562161558|FG002|Overall Study|Withdrawal by Subject|1|||
155743789|NCT00275821|562161556|FG000|Overall Study|Lost to Follow-up|0|||
155743790|NCT00275821|562161557|FG001|Overall Study|Lost to Follow-up|1|||
155743791|NCT00275821|562161558|FG002|Overall Study|Lost to Follow-up|1|||
155743792|NCT00275821|562161556|FG000|Overall Study|Death|0|||
155743793|NCT00275821|562161557|FG001|Overall Study|Death|2|||
155743794|NCT00275821|562161558|FG002|Overall Study|Death|1|||
155743795|NCT00275821|562161556|FG000|Overall Study|Lack of Efficacy|2|||
155743796|NCT00275821|562161557|FG001|Overall Study|Lack of Efficacy|1|||
155743797|NCT00275821|562161558|FG002|Overall Study|Lack of Efficacy|0|||
155743798|NCT00275821|562161556|FG000|Overall Study|Protocol Violation|5|||
155743799|NCT00275821|562161557|FG001|Overall Study|Protocol Violation|1|||
155743800|NCT00275821|562161558|FG002|Overall Study|Protocol Violation|0|||
155743801|NCT01215916|562161559|FG000|Overall Study|Progressive Disease|0|||
155743802|NCT01215916|562161560|FG001|Overall Study|Progressive Disease|2|||
155743803|NCT01215916|562161561|FG002|Overall Study|Progressive Disease|1|||
155743804|NCT01215916|562161562|FG003|Overall Study|Progressive Disease|2|||
155743805|NCT01215916|562161563|FG004|Overall Study|Progressive Disease|5|||
155743806|NCT01215916|562161564|FG005|Overall Study|Progressive Disease|4|||
155743807|NCT01215916|562161565|FG006|Overall Study|Progressive Disease|5|||
155743808|NCT01215916|562161566|FG007|Overall Study|Progressive Disease|3|||
155743809|NCT01215916|562161567|FG008|Overall Study|Progressive Disease|1|||
155743810|NCT01215916|562161559|FG000|Overall Study|Adverse Event|1|||
155743811|NCT01215916|562161560|FG001|Overall Study|Adverse Event|1|||
155743812|NCT01215916|562161561|FG002|Overall Study|Adverse Event|0|||
155743813|NCT01215916|562161562|FG003|Overall Study|Adverse Event|1|||
155743814|NCT01215916|562161563|FG004|Overall Study|Adverse Event|0|||
155743815|NCT01215916|562161564|FG005|Overall Study|Adverse Event|0|||
155743816|NCT01215916|562161565|FG006|Overall Study|Adverse Event|3|||
155743817|NCT01215916|562161566|FG007|Overall Study|Adverse Event|0|||
155743818|NCT01215916|562161567|FG008|Overall Study|Adverse Event|0|||
155743819|NCT01215916|562161559|FG000|Overall Study|Withdrawal by Subject|0|||
155743820|NCT01215916|562161560|FG001|Overall Study|Withdrawal by Subject|1|||
155743821|NCT01215916|562161561|FG002|Overall Study|Withdrawal by Subject|1|||
155743822|NCT01215916|562161562|FG003|Overall Study|Withdrawal by Subject|2|||
155743823|NCT01215916|562161563|FG004|Overall Study|Withdrawal by Subject|0|||
155743824|NCT01215916|562161564|FG005|Overall Study|Withdrawal by Subject|0|||
155743825|NCT01215916|562161565|FG006|Overall Study|Withdrawal by Subject|1|||
155743826|NCT01215916|562161566|FG007|Overall Study|Withdrawal by Subject|0|||
155743827|NCT01215916|562161567|FG008|Overall Study|Withdrawal by Subject|0|||
155743828|NCT01215916|562161559|FG000|Overall Study|Death|0|||
155743829|NCT01215916|562161560|FG001|Overall Study|Death|1|||
155743830|NCT01215916|562161561|FG002|Overall Study|Death|0|||
155743831|NCT01215916|562161562|FG003|Overall Study|Death|0|||
155743832|NCT01215916|562161563|FG004|Overall Study|Death|1|||
155743833|NCT01215916|562161564|FG005|Overall Study|Death|0|||
155743834|NCT01215916|562161565|FG006|Overall Study|Death|0|||
155743835|NCT01215916|562161566|FG007|Overall Study|Death|0|||
155743836|NCT01215916|562161567|FG008|Overall Study|Death|1|||
155743837|NCT01215916|562161559|FG000|Overall Study|Physician Decision|0|||
155743838|NCT01215916|562161560|FG001|Overall Study|Physician Decision|0|||
155743839|NCT01215916|562161561|FG002|Overall Study|Physician Decision|1|||
155743840|NCT01215916|562161562|FG003|Overall Study|Physician Decision|1|||
155743841|NCT01215916|562161563|FG004|Overall Study|Physician Decision|0|||
155743842|NCT01215916|562161564|FG005|Overall Study|Physician Decision|0|||
155743843|NCT01215916|562161565|FG006|Overall Study|Physician Decision|0|||
155743844|NCT01215916|562161566|FG007|Overall Study|Physician Decision|0|||
155743845|NCT01215916|562161567|FG008|Overall Study|Physician Decision|0|||
155743846|NCT00958438|562161573|FG000|Overall Study|Protocol Violation|3|||
155743847|NCT00958438|562161574|FG001|Overall Study|Protocol Violation|2|||
155743848|NCT00958438|562161575|FG002|Overall Study|Protocol Violation|2|||
155743849|NCT00958438|562161573|FG000|Overall Study|Withdrawal by Subject|4|||
155743850|NCT00958438|562161574|FG001|Overall Study|Withdrawal by Subject|2|||
155743851|NCT00958438|562161575|FG002|Overall Study|Withdrawal by Subject|1|||
155743852|NCT00958438|562161573|FG000|Overall Study|Adverse Event|0|||
155743853|NCT00958438|562161574|FG001|Overall Study|Adverse Event|3|||
155743854|NCT00958438|562161575|FG002|Overall Study|Adverse Event|0|||
155743855|NCT00958438|562161573|FG000|Overall Study|Physician Decision|1|||
155743856|NCT00958438|562161574|FG001|Overall Study|Physician Decision|0|||
155743857|NCT00958438|562161575|FG002|Overall Study|Physician Decision|1|||
155291559|NCT01090024|560497518|FG013|Period 2|Adverse Event|0|||
155291560|NCT01090024|560497519|FG014|Period 2|Adverse Event|0|||
155291561|NCT01090024|560497520|FG015|Period 2|Adverse Event|0|||
155291562|NCT01090024|560497521|FG016|Period 2|Adverse Event|0|||
155291563|NCT01090024|560497522|FG017|Period 2|Adverse Event|0|||
155291564|NCT01090024|560497505|FG000|Period 3|Withdrawal by Subject|0|||
155291565|NCT01090024|560497506|FG001|Period 3|Withdrawal by Subject|0|||
155291566|NCT01090024|560497507|FG002|Period 3|Withdrawal by Subject|0|||
155291567|NCT01090024|560497508|FG003|Period 3|Withdrawal by Subject|0|||
155291568|NCT01090024|560497509|FG004|Period 3|Withdrawal by Subject|0|||
155291569|NCT01090024|560497510|FG005|Period 3|Withdrawal by Subject|0|||
155291570|NCT01090024|560497511|FG006|Period 3|Withdrawal by Subject|0|||
155291571|NCT01090024|560497512|FG007|Period 3|Withdrawal by Subject|0|||
155291572|NCT01090024|560497513|FG008|Period 3|Withdrawal by Subject|0|||
155291573|NCT01090024|560497514|FG009|Period 3|Withdrawal by Subject|0|||
155291574|NCT01090024|560497515|FG010|Period 3|Withdrawal by Subject|0|||
155291575|NCT01090024|560497516|FG011|Period 3|Withdrawal by Subject|0|||
155291576|NCT01090024|560497517|FG012|Period 3|Withdrawal by Subject|0|||
155291577|NCT01090024|560497518|FG013|Period 3|Withdrawal by Subject|0|||
155291578|NCT01090024|560497519|FG014|Period 3|Withdrawal by Subject|0|||
155291579|NCT01090024|560497520|FG015|Period 3|Withdrawal by Subject|1|||
155291580|NCT01090024|560497521|FG016|Period 3|Withdrawal by Subject|0|||
155291581|NCT01090024|560497522|FG017|Period 3|Withdrawal by Subject|0|||
155291582|NCT01090024|560497505|FG000|Period 3|Protocol Violation|0|||
155291583|NCT01090024|560497506|FG001|Period 3|Protocol Violation|0|||
155291584|NCT01090024|560497507|FG002|Period 3|Protocol Violation|0|||
155291585|NCT01090024|560497508|FG003|Period 3|Protocol Violation|0|||
155291586|NCT01090024|560497509|FG004|Period 3|Protocol Violation|0|||
155291587|NCT01090024|560497510|FG005|Period 3|Protocol Violation|0|||
155291588|NCT01090024|560497511|FG006|Period 3|Protocol Violation|0|||
155743858|NCT00958438|562161573|FG000|Overall Study|Other than specified above|2|||
155291589|NCT01090024|560497512|FG007|Period 3|Protocol Violation|0|||
155291590|NCT01090024|560497513|FG008|Period 3|Protocol Violation|1|||
155291591|NCT01090024|560497514|FG009|Period 3|Protocol Violation|0|||
155409029|NCT01049035|560930842|FG006|Overall Study|Serious adverse event|0|||
155409030|NCT01049035|560930836|FG000|Overall Study|Other adverse event (AE)|0|||
155409031|NCT01049035|560930837|FG001|Overall Study|Other adverse event (AE)|0|||
155409032|NCT01049035|560930838|FG002|Overall Study|Other adverse event (AE)|0|||
155409033|NCT01049035|560930839|FG003|Overall Study|Other adverse event (AE)|1|||
155409034|NCT01049035|560930840|FG004|Overall Study|Other adverse event (AE)|0|||
155409035|NCT01049035|560930841|FG005|Overall Study|Other adverse event (AE)|0|||
155409036|NCT01049035|560930842|FG006|Overall Study|Other adverse event (AE)|0|||
155409037|NCT01049035|560930836|FG000|Overall Study|Non-compliance with the protocol|12|||
155409038|NCT01049035|560930837|FG001|Overall Study|Non-compliance with the protocol|6|||
155409039|NCT01049035|560930838|FG002|Overall Study|Non-compliance with the protocol|14|||
155409040|NCT01049035|560930839|FG003|Overall Study|Non-compliance with the protocol|5|||
155409041|NCT01049035|560930840|FG004|Overall Study|Non-compliance with the protocol|3|||
155409042|NCT01049035|560930841|FG005|Overall Study|Non-compliance with the protocol|4|||
155409043|NCT01049035|560930842|FG006|Overall Study|Non-compliance with the protocol|10|||
155409044|NCT01049035|560930836|FG000|Overall Study|Lost to Follow-up|5|||
155409045|NCT01049035|560930837|FG001|Overall Study|Lost to Follow-up|4|||
155409046|NCT01049035|560930838|FG002|Overall Study|Lost to Follow-up|4|||
155409047|NCT01049035|560930839|FG003|Overall Study|Lost to Follow-up|1|||
155409048|NCT01049035|560930840|FG004|Overall Study|Lost to Follow-up|0|||
155409049|NCT01049035|560930841|FG005|Overall Study|Lost to Follow-up|3|||
155409050|NCT01049035|560930842|FG006|Overall Study|Lost to Follow-up|3|||
155409051|NCT01049035|560930836|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
155409052|NCT01049035|560930837|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
155409053|NCT01049035|560930838|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
155743859|NCT00958438|562161574|FG001|Overall Study|Other than specified above|3|||
155743860|NCT00958438|562161575|FG002|Overall Study|Other than specified above|2|||
155291592|NCT01090024|560497515|FG010|Period 3|Protocol Violation|0|||
155291593|NCT01090024|560497516|FG011|Period 3|Protocol Violation|0|||
155291594|NCT01090024|560497517|FG012|Period 3|Protocol Violation|0|||
155409054|NCT01049035|560930839|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
155743861|NCT02788279|562161577|FG000|Overall Study|Death|62|||
155743862|NCT02788279|562161578|FG001|Overall Study|Death|136|||
155291595|NCT01090024|560497518|FG013|Period 3|Protocol Violation|0|||
155291596|NCT01090024|560497519|FG014|Period 3|Protocol Violation|0|||
155291597|NCT01090024|560497520|FG015|Period 3|Protocol Violation|0|||
155291598|NCT01090024|560497521|FG016|Period 3|Protocol Violation|0|||
155291599|NCT01090024|560497522|FG017|Period 3|Protocol Violation|0|||
155291600|NCT01090024|560497505|FG000|Period 3|Adverse Event|0|||
155291601|NCT01090024|560497506|FG001|Period 3|Adverse Event|0|||
155291602|NCT01090024|560497507|FG002|Period 3|Adverse Event|0|||
155291603|NCT01090024|560497508|FG003|Period 3|Adverse Event|0|||
155409055|NCT01049035|560930840|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
155291604|NCT01090024|560497509|FG004|Period 3|Adverse Event|0|||
155743863|NCT02788279|562161579|FG002|Overall Study|Death|72|||
155743864|NCT02788279|562161577|FG000|Overall Study|Withdrawal by Subject|10|||
155743865|NCT02788279|562161578|FG001|Overall Study|Withdrawal by Subject|15|||
155291605|NCT01090024|560497510|FG005|Period 3|Adverse Event|1|||
155291606|NCT01090024|560497511|FG006|Period 3|Adverse Event|0|||
155291607|NCT01090024|560497512|FG007|Period 3|Adverse Event|0|||
155291608|NCT01090024|560497513|FG008|Period 3|Adverse Event|0|||
155291609|NCT01090024|560497514|FG009|Period 3|Adverse Event|0|||
155291610|NCT01090024|560497515|FG010|Period 3|Adverse Event|0|||
155291611|NCT01090024|560497516|FG011|Period 3|Adverse Event|0|||
155291612|NCT01090024|560497517|FG012|Period 3|Adverse Event|0|||
155291613|NCT01090024|560497518|FG013|Period 3|Adverse Event|0|||
155291614|NCT01090024|560497519|FG014|Period 3|Adverse Event|0|||
155291615|NCT01090024|560497520|FG015|Period 3|Adverse Event|0|||
155291616|NCT01090024|560497521|FG016|Period 3|Adverse Event|0|||
155291617|NCT01090024|560497522|FG017|Period 3|Adverse Event|0|||
155291618|NCT00771667|560497523|FG000|Induction Phase|Adverse Event|5|||
155291619|NCT00771667|560497524|FG001|Induction Phase|Adverse Event|2|||
155291620|NCT00771667|560497525|FG002|Induction Phase|Adverse Event|4|||
155291621|NCT00771667|560497526|FG003|Induction Phase|Adverse Event|1|||
155291622|NCT00771667|560497527|FG004|Induction Phase|Adverse Event|0|||
155291623|NCT00771667|560497528|FG005|Induction Phase|Adverse Event|0|||
155291624|NCT00771667|560497529|FG006|Induction Phase|Adverse Event|0|||
155291625|NCT00771667|560497530|FG007|Induction Phase|Adverse Event|0|||
155291626|NCT00771667|560497531|FG008|Induction Phase|Adverse Event|0|||
155291627|NCT00771667|560497532|FG009|Induction Phase|Adverse Event|0|||
155291628|NCT00771667|560497523|FG000|Induction Phase|Lack of Efficacy|9|||
155291629|NCT00771667|560497524|FG001|Induction Phase|Lack of Efficacy|2|||
155291630|NCT00771667|560497525|FG002|Induction Phase|Lack of Efficacy|4|||
155291631|NCT00771667|560497526|FG003|Induction Phase|Lack of Efficacy|3|||
155291632|NCT00771667|560497527|FG004|Induction Phase|Lack of Efficacy|0|||
155291633|NCT00771667|560497528|FG005|Induction Phase|Lack of Efficacy|0|||
155291634|NCT00771667|560497529|FG006|Induction Phase|Lack of Efficacy|0|||
155291635|NCT00771667|560497530|FG007|Induction Phase|Lack of Efficacy|0|||
155291636|NCT00771667|560497531|FG008|Induction Phase|Lack of Efficacy|0|||
155291637|NCT00771667|560497532|FG009|Induction Phase|Lack of Efficacy|0|||
155291638|NCT00771667|560497523|FG000|Induction Phase|Lost to Follow-up|1|||
155291639|NCT00771667|560497524|FG001|Induction Phase|Lost to Follow-up|0|||
155291640|NCT00771667|560497525|FG002|Induction Phase|Lost to Follow-up|1|||
155291641|NCT00771667|560497526|FG003|Induction Phase|Lost to Follow-up|0|||
155291642|NCT00771667|560497527|FG004|Induction Phase|Lost to Follow-up|0|||
155291643|NCT00771667|560497528|FG005|Induction Phase|Lost to Follow-up|0|||
155291644|NCT00771667|560497529|FG006|Induction Phase|Lost to Follow-up|0|||
155291645|NCT00771667|560497530|FG007|Induction Phase|Lost to Follow-up|0|||
155291646|NCT00771667|560497531|FG008|Induction Phase|Lost to Follow-up|0|||
155291647|NCT00771667|560497532|FG009|Induction Phase|Lost to Follow-up|0|||
155291648|NCT00771667|560497523|FG000|Induction Phase|Other|4|||
155291649|NCT00771667|560497524|FG001|Induction Phase|Other|6|||
155291650|NCT00771667|560497525|FG002|Induction Phase|Other|3|||
155291651|NCT00771667|560497526|FG003|Induction Phase|Other|4|||
155291652|NCT00771667|560497527|FG004|Induction Phase|Other|0|||
155291653|NCT00771667|560497528|FG005|Induction Phase|Other|0|||
155291654|NCT00771667|560497529|FG006|Induction Phase|Other|0|||
155291655|NCT00771667|560497530|FG007|Induction Phase|Other|0|||
155291656|NCT00771667|560497531|FG008|Induction Phase|Other|0|||
155291657|NCT00771667|560497532|FG009|Induction Phase|Other|0|||
155291658|NCT00771667|560497523|FG000|Maintenance Phase|Adverse Event|0|||
155291659|NCT00771667|560497524|FG001|Maintenance Phase|Adverse Event|0|||
155291660|NCT00771667|560497525|FG002|Maintenance Phase|Adverse Event|0|||
155291661|NCT00771667|560497526|FG003|Maintenance Phase|Adverse Event|0|||
155291662|NCT00771667|560497527|FG004|Maintenance Phase|Adverse Event|1|||
155291663|NCT00771667|560497528|FG005|Maintenance Phase|Adverse Event|3|||
155291664|NCT00771667|560497529|FG006|Maintenance Phase|Adverse Event|5|||
155291665|NCT00771667|560497530|FG007|Maintenance Phase|Adverse Event|1|||
155291666|NCT00771667|560497531|FG008|Maintenance Phase|Adverse Event|8|||
155409056|NCT01049035|560930841|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
155743866|NCT02788279|562161579|FG002|Overall Study|Withdrawal by Subject|5|||
155291667|NCT00771667|560497532|FG009|Maintenance Phase|Adverse Event|7|||
155291668|NCT00771667|560497523|FG000|Maintenance Phase|Lack of Efficacy|0|||
155291669|NCT00771667|560497524|FG001|Maintenance Phase|Lack of Efficacy|0|||
155291670|NCT00771667|560497525|FG002|Maintenance Phase|Lack of Efficacy|0|||
155291671|NCT00771667|560497526|FG003|Maintenance Phase|Lack of Efficacy|0|||
155743867|NCT02788279|562161577|FG000|Overall Study|Lost to Follow-up|0|||
155743868|NCT02788279|562161578|FG001|Overall Study|Lost to Follow-up|3|||
155291672|NCT00771667|560497527|FG004|Maintenance Phase|Lack of Efficacy|1|||
155291673|NCT00771667|560497528|FG005|Maintenance Phase|Lack of Efficacy|3|||
155291674|NCT00771667|560497529|FG006|Maintenance Phase|Lack of Efficacy|3|||
155291675|NCT00771667|560497530|FG007|Maintenance Phase|Lack of Efficacy|2|||
155291676|NCT00771667|560497531|FG008|Maintenance Phase|Lack of Efficacy|11|||
155291677|NCT00771667|560497532|FG009|Maintenance Phase|Lack of Efficacy|7|||
155291678|NCT00771667|560497523|FG000|Maintenance Phase|Other|0|||
155291679|NCT00771667|560497524|FG001|Maintenance Phase|Other|0|||
155291680|NCT00771667|560497525|FG002|Maintenance Phase|Other|0|||
155291681|NCT00771667|560497526|FG003|Maintenance Phase|Other|0|||
155291682|NCT00771667|560497527|FG004|Maintenance Phase|Other|0|||
155291683|NCT00771667|560497528|FG005|Maintenance Phase|Other|1|||
155291684|NCT00771667|560497529|FG006|Maintenance Phase|Other|2|||
155291685|NCT00771667|560497530|FG007|Maintenance Phase|Other|2|||
155291686|NCT00771667|560497531|FG008|Maintenance Phase|Other|3|||
155291687|NCT00771667|560497532|FG009|Maintenance Phase|Other|3|||
155291688|NCT01897233|560497533|FG000|Part B (24 Weeks)|Adverse Event|1|||
155291689|NCT01897233|560497533|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
155291690|NCT01897233|560497533|FG000|Part B (24 Weeks)|Physician Decision|1|||
155291691|NCT00628862|560497538|FG000|Overall Study|Adverse Event|6|||
155291692|NCT00628862|560497539|FG001|Overall Study|Adverse Event|8|||
155291693|NCT00628862|560497540|FG002|Overall Study|Adverse Event|10|||
155291694|NCT00628862|560497538|FG000|Overall Study|Withdrawal by Subject|4|||
155291695|NCT00628862|560497539|FG001|Overall Study|Withdrawal by Subject|6|||
155291696|NCT00628862|560497540|FG002|Overall Study|Withdrawal by Subject|11|||
155291697|NCT00628862|560497538|FG000|Overall Study|Lost to Follow-up|0|||
155291698|NCT00628862|560497539|FG001|Overall Study|Lost to Follow-up|2|||
155291699|NCT00628862|560497540|FG002|Overall Study|Lost to Follow-up|1|||
155291700|NCT00628862|560497538|FG000|Overall Study|Protocol Violation|1|||
155291701|NCT00628862|560497539|FG001|Overall Study|Protocol Violation|0|||
155291702|NCT00628862|560497540|FG002|Overall Study|Protocol Violation|0|||
155291703|NCT00628862|560497538|FG000|Overall Study|COPD Exacerbation|0|||
155291704|NCT00628862|560497539|FG001|Overall Study|COPD Exacerbation|1|||
155291705|NCT00628862|560497540|FG002|Overall Study|COPD Exacerbation|0|||
155291706|NCT01883492|560497541|FG000|Overall Study|Lost to Follow-up|3|||
155291707|NCT01883492|560497542|FG001|Overall Study|Lost to Follow-up|4|||
155291708|NCT01883492|560497541|FG000|Overall Study|Surgery on contra-lateral hip|0|||
155291709|NCT01883492|560497542|FG001|Overall Study|Surgery on contra-lateral hip|1|||
155291710|NCT01883492|560497541|FG000|Overall Study|Poor X-ray quality|7|||
155291711|NCT01883492|560497542|FG001|Overall Study|Poor X-ray quality|4|||
155291712|NCT01883492|560497541|FG000|Overall Study|Withdrawal by Subject|1|||
155291713|NCT01883492|560497542|FG001|Overall Study|Withdrawal by Subject|0|||
155291714|NCT01883492|560497541|FG000|Overall Study|inappropriate implant used|1|||
155291715|NCT01883492|560497542|FG001|Overall Study|inappropriate implant used|1|||
155291716|NCT01883492|560497541|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
155291717|NCT01883492|560497542|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
155291718|NCT03265210|560497543|FG000|Overall Study|Withdrawal by Subject|7|||
155291719|NCT03265210|560497544|FG001|Overall Study|Withdrawal by Subject|9|||
155291720|NCT03265210|560497543|FG000|Overall Study|Lost to Follow-up|2|||
155291721|NCT03265210|560497544|FG001|Overall Study|Lost to Follow-up|0|||
155291722|NCT03265210|560497543|FG000|Overall Study|Physician Decision|2|||
155291723|NCT03265210|560497544|FG001|Overall Study|Physician Decision|0|||
155291724|NCT03265210|560497543|FG000|Overall Study|Adverse Event|1|||
155291725|NCT03265210|560497544|FG001|Overall Study|Adverse Event|0|||
155291726|NCT00549848|560497548|FG000|Overall Study|Death|1|||
155291727|NCT00549848|560497549|FG001|Overall Study|Death|4|||
155409057|NCT01049035|560930842|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
155409058|NCT01137773|560930843|FG000|Overall Study|Death|3|||
155409059|NCT01137773|560930844|FG001|Overall Study|Death|3|||
155409060|NCT01137773|560930843|FG000|Overall Study|Lost to Follow-up|6|||
155743869|NCT02788279|562161579|FG002|Overall Study|Lost to Follow-up|2|||
155409061|NCT01137773|560930844|FG001|Overall Study|Lost to Follow-up|0|||
155409062|NCT00493870|560930848|FG000|Overall Study|Lost to Follow-up|12|||
155409063|NCT00493870|560930849|FG001|Overall Study|Lost to Follow-up|15|||
155409064|NCT05594173|560930852|FG000|Overall Study|Adverse Event|1|||
155409065|NCT05594173|560930852|FG000|Overall Study|COVID-19 Pandemic|2|||
155409066|NCT01485627|560930855|FG000|Overall Study|Patient withdrew|6|||
155409067|NCT01485627|560930856|FG001|Overall Study|Patient withdrew|5|||
155409068|NCT01485627|560930855|FG000|Overall Study|Patient died|3|||
155743870|NCT02788279|562161577|FG000|Overall Study|Sponsor decision|18|||
155409069|NCT01485627|560930856|FG001|Overall Study|Patient died|1|||
155291728|NCT00549848|560497550|FG002|Overall Study|Death|13|||
155291729|NCT00549848|560497548|FG000|Overall Study|Physician Decision|0|||
155291730|NCT00549848|560497549|FG001|Overall Study|Physician Decision|0|||
155291731|NCT00549848|560497550|FG002|Overall Study|Physician Decision|4|||
155291732|NCT00549848|560497548|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
155291733|NCT00549848|560497549|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
155409070|NCT01485627|560930855|FG000|Overall Study|Patient lost to followup|0|||
155409071|NCT01485627|560930856|FG001|Overall Study|Patient lost to followup|1|||
155409072|NCT01485627|560930855|FG000|Overall Study|Caregiver withdrew|3|||
155409073|NCT01485627|560930856|FG001|Overall Study|Caregiver withdrew|3|||
155409074|NCT01485627|560930855|FG000|Overall Study|Caregiver lost to follow up|11|||
155409075|NCT01485627|560930856|FG001|Overall Study|Caregiver lost to follow up|12|||
155291734|NCT00549848|560497550|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
155743871|NCT02788279|562161578|FG001|Overall Study|Sponsor decision|29|||
155291735|NCT00549848|560497548|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
155409076|NCT01485627|560930855|FG000|Overall Study|Caregiver died|1|||
155291736|NCT00549848|560497549|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
155291737|NCT00549848|560497550|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
155291738|NCT00549848|560497548|FG000|Overall Study|Participant/Family Withdraw|2|||
155291739|NCT00549848|560497549|FG001|Overall Study|Participant/Family Withdraw|3|||
155291740|NCT00549848|560497550|FG002|Overall Study|Participant/Family Withdraw|5|||
155291741|NCT00549848|560497548|FG000|Overall Study|Second Malignancy|1|||
155291742|NCT00549848|560497549|FG001|Overall Study|Second Malignancy|0|||
155291743|NCT00549848|560497550|FG002|Overall Study|Second Malignancy|0|||
155291744|NCT00549848|560497548|FG000|Overall Study|Transplant|3|||
155291745|NCT00549848|560497549|FG001|Overall Study|Transplant|3|||
155291746|NCT00549848|560497550|FG002|Overall Study|Transplant|18|||
155291747|NCT00549848|560497548|FG000|Overall Study|Unacceptable Toxicity|1|||
155291748|NCT00549848|560497549|FG001|Overall Study|Unacceptable Toxicity|6|||
155291749|NCT00549848|560497550|FG002|Overall Study|Unacceptable Toxicity|6|||
155291750|NCT00868192|560497551|FG000|Overall Study|Ineligible|4|||
155291751|NCT00798096|560497554|FG000|Overall Study|Ongoing|2|||
155291752|NCT03670602|560497555|FG000|Overall Study|Lost to Follow-up|1|||
155291753|NCT03670602|560497556|FG001|Overall Study|Lost to Follow-up|0|||
155291754|NCT03670602|560497555|FG000|Overall Study|Withdrawal by Subject|0|||
155291755|NCT03670602|560497556|FG001|Overall Study|Withdrawal by Subject|3|||
155291756|NCT03383887|560497557|FG000|Overall Study|Lost to Follow-up|0|||
155291757|NCT03383887|560497558|FG001|Overall Study|Lost to Follow-up|1|||
155291758|NCT00975806|560497565|FG000|Overall Study|Adverse Event|2|||
155291759|NCT00975806|560497566|FG001|Overall Study|Adverse Event|1|||
155291760|NCT00975806|560497567|FG002|Overall Study|Adverse Event|2|||
155291761|NCT00975806|560497565|FG000|Overall Study|Disease Progression|1|||
155291762|NCT00975806|560497566|FG001|Overall Study|Disease Progression|5|||
155291763|NCT00975806|560497567|FG002|Overall Study|Disease Progression|1|||
155291764|NCT00975806|560497565|FG000|Overall Study|Withdrawal by Subject|1|||
155291765|NCT00975806|560497566|FG001|Overall Study|Withdrawal by Subject|0|||
155291766|NCT00975806|560497567|FG002|Overall Study|Withdrawal by Subject|0|||
155291767|NCT00975806|560497565|FG000|Overall Study|Death|0|||
155291768|NCT00975806|560497566|FG001|Overall Study|Death|1|||
155291769|NCT00975806|560497567|FG002|Overall Study|Death|0|||
155291770|NCT00975806|560497565|FG000|Overall Study|Physician decision and disease related|1|||
155291771|NCT00975806|560497566|FG001|Overall Study|Physician decision and disease related|0|||
155409077|NCT01485627|560930856|FG001|Overall Study|Caregiver died|0|||
155743872|NCT02788279|562161579|FG002|Overall Study|Sponsor decision|11|||
155743873|NCT01133990|562161581|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
155291772|NCT00975806|560497567|FG002|Overall Study|Physician decision and disease related|1|||
155409078|NCT01485627|560930855|FG000|Overall Study|caregiver was not bereaved|42|||
155409079|NCT01485627|560930856|FG001|Overall Study|caregiver was not bereaved|35|||
155409080|NCT01709149|560930857|FG000|Open-label Lead-in Phase|Adverse Event|109|||
155743874|NCT01133990|562161582|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155743875|NCT01133990|562161583|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155743876|NCT01133990|562161584|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155743877|NCT01133990|562161585|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155743878|NCT01133990|562161586|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155743879|NCT01133990|562161581|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
155743880|NCT01133990|562161582|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155743881|NCT01133990|562161583|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155743882|NCT01133990|562161584|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155743883|NCT01133990|562161585|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155743884|NCT01133990|562161586|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155743885|NCT01133990|562161581|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155743886|NCT01133990|562161582|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155743887|NCT01133990|562161583|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155743888|NCT01133990|562161584|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155743889|NCT01133990|562161585|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155743890|NCT01133990|562161586|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155743891|NCT01133990|562161581|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
155743892|NCT01133990|562161582|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155743893|NCT01133990|562161583|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155743894|NCT01133990|562161584|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155291773|NCT00246012|560497568|FG000|Overall Study|Adverse Event|0|||
155743895|NCT01133990|562161585|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155291774|NCT00246012|560497569|FG001|Overall Study|Adverse Event|0|||
155291775|NCT00246012|560497570|FG002|Overall Study|Adverse Event|0|||
155291776|NCT00246012|560497571|FG003|Overall Study|Adverse Event|0|||
155291777|NCT00246012|560497572|FG004|Overall Study|Adverse Event|0|||
155291778|NCT00246012|560497573|FG005|Overall Study|Adverse Event|1|||
155409081|NCT01709149|560930858|FG001|Open-label Lead-in Phase|Adverse Event|0|||
155291779|NCT00246012|560497574|FG006|Overall Study|Adverse Event|0|||
155291780|NCT00246012|560497575|FG007|Overall Study|Adverse Event|0|||
155291781|NCT00246012|560497576|FG008|Overall Study|Adverse Event|2|||
155291782|NCT00246012|560497568|FG000|Overall Study|Withdrawal by Subject|0|||
155291783|NCT00246012|560497569|FG001|Overall Study|Withdrawal by Subject|0|||
155291784|NCT00246012|560497570|FG002|Overall Study|Withdrawal by Subject|0|||
155291785|NCT00246012|560497571|FG003|Overall Study|Withdrawal by Subject|0|||
155291786|NCT00246012|560497572|FG004|Overall Study|Withdrawal by Subject|0|||
155291787|NCT00246012|560497573|FG005|Overall Study|Withdrawal by Subject|1|||
155291788|NCT00246012|560497574|FG006|Overall Study|Withdrawal by Subject|0|||
155291789|NCT00246012|560497575|FG007|Overall Study|Withdrawal by Subject|0|||
155291790|NCT00246012|560497576|FG008|Overall Study|Withdrawal by Subject|0|||
155291791|NCT00246012|560497568|FG000|Overall Study|Disease progression|3|||
155291792|NCT00246012|560497569|FG001|Overall Study|Disease progression|1|||
155291793|NCT00246012|560497570|FG002|Overall Study|Disease progression|2|||
155291794|NCT00246012|560497571|FG003|Overall Study|Disease progression|3|||
155291795|NCT00246012|560497572|FG004|Overall Study|Disease progression|3|||
155291796|NCT00246012|560497573|FG005|Overall Study|Disease progression|25|||
155291797|NCT00246012|560497574|FG006|Overall Study|Disease progression|30|||
155291798|NCT00246012|560497575|FG007|Overall Study|Disease progression|27|||
155291799|NCT00246012|560497576|FG008|Overall Study|Disease progression|26|||
155291800|NCT00246012|560497568|FG000|Overall Study|Other|0|||
155291801|NCT00246012|560497569|FG001|Overall Study|Other|0|||
155291802|NCT00246012|560497570|FG002|Overall Study|Other|0|||
155291803|NCT00246012|560497571|FG003|Overall Study|Other|0|||
155291804|NCT00246012|560497572|FG004|Overall Study|Other|0|||
155291805|NCT00246012|560497573|FG005|Overall Study|Other|0|||
155291806|NCT00246012|560497574|FG006|Overall Study|Other|0|||
155291807|NCT00246012|560497575|FG007|Overall Study|Other|1|||
155291808|NCT00246012|560497576|FG008|Overall Study|Other|0|||
155291809|NCT00246012|560497568|FG000|Overall Study|Randomly assigned but not treated|0|||
155291810|NCT00246012|560497569|FG001|Overall Study|Randomly assigned but not treated|0|||
155291811|NCT00246012|560497570|FG002|Overall Study|Randomly assigned but not treated|0|||
155291812|NCT00246012|560497571|FG003|Overall Study|Randomly assigned but not treated|0|||
155291813|NCT00246012|560497572|FG004|Overall Study|Randomly assigned but not treated|0|||
155291814|NCT00246012|560497573|FG005|Overall Study|Randomly assigned but not treated|1|||
155291815|NCT00246012|560497574|FG006|Overall Study|Randomly assigned but not treated|1|||
155291816|NCT00246012|560497575|FG007|Overall Study|Randomly assigned but not treated|0|||
155291817|NCT00246012|560497576|FG008|Overall Study|Randomly assigned but not treated|0|||
155291818|NCT02377362|560497577|FG000|Part A Second Treatment|Protocol Violation|0|||
155291819|NCT02377362|560497578|FG001|Part A Second Treatment|Protocol Violation|0|||
155291820|NCT02377362|560497579|FG002|Part A Second Treatment|Protocol Violation|0|||
155291821|NCT02377362|560497580|FG003|Part A Second Treatment|Protocol Violation|0|||
155291822|NCT02377362|560497581|FG004|Part A Second Treatment|Protocol Violation|1|||
155291823|NCT02377362|560497582|FG005|Part A Second Treatment|Protocol Violation|0|||
155291824|NCT02377362|560497583|FG006|Part A Second Treatment|Protocol Violation|0|||
155291825|NCT02377362|560497584|FG007|Part A Second Treatment|Protocol Violation|0|||
155291826|NCT02377362|560497585|FG008|Part A Second Treatment|Protocol Violation|0|||
155291827|NCT02377362|560497586|FG009|Part A Second Treatment|Protocol Violation|0|||
155291828|NCT02377362|560497587|FG010|Part A Second Treatment|Protocol Violation|0|||
155291829|NCT02377362|560497588|FG011|Part A Second Treatment|Protocol Violation|0|||
155291830|NCT02377362|560497589|FG012|Part A Second Treatment|Protocol Violation|0|||
155291831|NCT02377362|560497577|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291832|NCT02377362|560497578|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291833|NCT02377362|560497579|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291834|NCT02377362|560497580|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
155409082|NCT01709149|560930859|FG002|Open-label Lead-in Phase|Adverse Event|0|||
155409083|NCT01709149|560930857|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
155409084|NCT01709149|560930858|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
155409085|NCT01709149|560930859|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
155409086|NCT01709149|560930857|FG000|Open-label Lead-in Phase|Death|1|||
155409087|NCT01709149|560930858|FG001|Open-label Lead-in Phase|Death|0|||
155409088|NCT01709149|560930859|FG002|Open-label Lead-in Phase|Death|0|||
155409089|NCT01709149|560930857|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
155409090|NCT01709149|560930858|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
155409091|NCT01709149|560930859|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
155409092|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155638339|NCT03488524|561766443|FG000|Overall Study|Withdrawal by Subject|51|||
155291835|NCT02377362|560497581|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
155291836|NCT02377362|560497582|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
155291837|NCT02377362|560497583|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
155409093|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
155638340|NCT03488524|561766443|FG000|Overall Study|Death|19|||
155291838|NCT02377362|560497584|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291839|NCT02377362|560497585|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291840|NCT02377362|560497586|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291841|NCT02377362|560497587|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291842|NCT02377362|560497588|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291843|NCT02377362|560497589|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291844|NCT02377362|560497577|FG000|Part B Overall|Protocol Violation|0|||
155291845|NCT02377362|560497578|FG001|Part B Overall|Protocol Violation|0|||
155291846|NCT02377362|560497579|FG002|Part B Overall|Protocol Violation|0|||
155291847|NCT02377362|560497580|FG003|Part B Overall|Protocol Violation|0|||
155291848|NCT02377362|560497581|FG004|Part B Overall|Protocol Violation|0|||
155291849|NCT02377362|560497582|FG005|Part B Overall|Protocol Violation|0|||
155291850|NCT02377362|560497583|FG006|Part B Overall|Protocol Violation|0|||
155291851|NCT02377362|560497584|FG007|Part B Overall|Protocol Violation|0|||
155291852|NCT02377362|560497585|FG008|Part B Overall|Protocol Violation|0|||
155291853|NCT02377362|560497586|FG009|Part B Overall|Protocol Violation|1|||
155291854|NCT02377362|560497587|FG010|Part B Overall|Protocol Violation|0|||
155291855|NCT02377362|560497588|FG011|Part B Overall|Protocol Violation|0|||
155291856|NCT02377362|560497589|FG012|Part B Overall|Protocol Violation|0|||
155291857|NCT02377362|560497577|FG000|Part B Overall|Adverse Event|0|||
155291858|NCT02377362|560497578|FG001|Part B Overall|Adverse Event|0|||
155291859|NCT02377362|560497579|FG002|Part B Overall|Adverse Event|0|||
155291860|NCT02377362|560497580|FG003|Part B Overall|Adverse Event|0|||
155291861|NCT02377362|560497581|FG004|Part B Overall|Adverse Event|0|||
155291862|NCT02377362|560497582|FG005|Part B Overall|Adverse Event|0|||
155291863|NCT02377362|560497583|FG006|Part B Overall|Adverse Event|1|||
155291864|NCT02377362|560497584|FG007|Part B Overall|Adverse Event|1|||
155291865|NCT02377362|560497585|FG008|Part B Overall|Adverse Event|0|||
155291866|NCT02377362|560497586|FG009|Part B Overall|Adverse Event|0|||
155291867|NCT02377362|560497587|FG010|Part B Overall|Adverse Event|0|||
155291868|NCT02377362|560497588|FG011|Part B Overall|Adverse Event|0|||
155291869|NCT02377362|560497589|FG012|Part B Overall|Adverse Event|0|||
155291870|NCT02377362|560497577|FG000|Part B Overall|Withdrawal by Subject|0|||
155291871|NCT02377362|560497578|FG001|Part B Overall|Withdrawal by Subject|0|||
155291872|NCT02377362|560497579|FG002|Part B Overall|Withdrawal by Subject|0|||
155291873|NCT02377362|560497580|FG003|Part B Overall|Withdrawal by Subject|0|||
155291874|NCT02377362|560497581|FG004|Part B Overall|Withdrawal by Subject|0|||
155291875|NCT02377362|560497582|FG005|Part B Overall|Withdrawal by Subject|0|||
155291876|NCT02377362|560497583|FG006|Part B Overall|Withdrawal by Subject|1|||
155291877|NCT02377362|560497584|FG007|Part B Overall|Withdrawal by Subject|0|||
155291878|NCT02377362|560497585|FG008|Part B Overall|Withdrawal by Subject|0|||
155291879|NCT02377362|560497586|FG009|Part B Overall|Withdrawal by Subject|0|||
155291880|NCT02377362|560497587|FG010|Part B Overall|Withdrawal by Subject|0|||
155291881|NCT02377362|560497588|FG011|Part B Overall|Withdrawal by Subject|1|||
155291882|NCT02377362|560497589|FG012|Part B Overall|Withdrawal by Subject|0|||
155291883|NCT01806714|560497592|FG000|Overall Study|No functioning phone number|200|||
155291884|NCT01806714|560497593|FG001|Overall Study|No functioning phone number|170|||
155291885|NCT01585038|560497594|FG000|Overall Study|Adverse Event|2|||
155291886|NCT01585038|560497595|FG001|Overall Study|Adverse Event|2|||
155291887|NCT00678795|560497596|FG000|Overall Study|Adverse Event|7|||
155291888|NCT00678795|560497597|FG001|Overall Study|Adverse Event|3|||
155291889|NCT00678795|560497596|FG000|Overall Study|Withdrawal by Subject|3|||
155638341|NCT03488524|561766443|FG000|Overall Study|Study Sponsor|11|||
155638342|NCT03488524|561766443|FG000|Overall Study|Physician Decision|4|||
155291890|NCT00678795|560497597|FG001|Overall Study|Withdrawal by Subject|0|||
155291891|NCT00678795|560497596|FG000|Overall Study|Protocol Violation|0|||
155291892|NCT00678795|560497597|FG001|Overall Study|Protocol Violation|1|||
155291893|NCT00678795|560497596|FG000|Overall Study|Lost to Follow-up|0|||
155291894|NCT00678795|560497597|FG001|Overall Study|Lost to Follow-up|1|||
155291895|NCT00678795|560497596|FG000|Overall Study|Lack of Efficacy|1|||
155638343|NCT03488524|561766443|FG000|Overall Study|Lost to Follow-up|3|||
155638344|NCT00830765|561766444|FG000|Overall Study|Protocol Violation|3|||
155638345|NCT00830765|561766445|FG001|Overall Study|Protocol Violation|2|||
155638346|NCT02390284|561766446|FG000|Overall Study|Physician Decision|0|||
155638347|NCT02390284|561766447|FG001|Overall Study|Physician Decision|0|||
155638348|NCT02390284|561766448|FG002|Overall Study|Physician Decision|9|||
155638349|NCT01299909|561766449|FG000|Overall Study|Lost to Follow-up|22|||
155638350|NCT01299909|561766450|FG001|Overall Study|Lost to Follow-up|18|||
155291896|NCT00678795|560497597|FG001|Overall Study|Lack of Efficacy|1|||
155291897|NCT04107805|560497600|FG000|Overall Study|Adverse Event|0|||
155291898|NCT04107805|560497601|FG001|Overall Study|Adverse Event|0|||
155291899|NCT04107805|560497602|FG002|Overall Study|Adverse Event|0|||
155291900|NCT04107805|560497603|FG003|Overall Study|Adverse Event|1|||
155291901|NCT04107805|560497604|FG004|Overall Study|Adverse Event|0|||
155291902|NCT04107805|560497605|FG005|Overall Study|Adverse Event|1|||
155291903|NCT04107805|560497606|FG006|Overall Study|Adverse Event|0|||
155291904|NCT04107805|560497607|FG007|Overall Study|Adverse Event|0|||
155291905|NCT04107805|560497608|FG008|Overall Study|Adverse Event|1|||
155291906|NCT02750709|560497609|FG000|Treatment Period 1|Adverse Event|0|||
155291907|NCT02750709|560497610|FG001|Treatment Period 1|Adverse Event|0|||
155291908|NCT02750709|560497611|FG002|Treatment Period 1|Adverse Event|0|||
155291909|NCT02750709|560497612|FG003|Treatment Period 1|Adverse Event|0|||
155291910|NCT02750709|560497613|FG004|Treatment Period 1|Adverse Event|0|||
155291911|NCT02750709|560497614|FG005|Treatment Period 1|Adverse Event|1|||
155291912|NCT01120275|560497617|FG000|Overall Study|Adverse Event|3|||
155291913|NCT01120275|560497617|FG000|Overall Study|Progression|27|||
155291914|NCT01120275|560497617|FG000|Overall Study|Ineligible|3|||
155291915|NCT01120275|560497617|FG000|Overall Study|Withdrawal by Subject|1|||
155291916|NCT01120275|560497617|FG000|Overall Study|Refusal|1|||
155291917|NCT01120275|560497617|FG000|Overall Study|Not specific|1|||
155291918|NCT01191086|560497619|FG000|Overall Study|Adverse Event|20|||
155291919|NCT01191086|560497619|FG000|Overall Study|Lack of Efficacy|10|||
155291920|NCT01191086|560497619|FG000|Overall Study|Lost to Follow-up|4|||
155291921|NCT01191086|560497619|FG000|Overall Study|Physician Decision|2|||
155291922|NCT01191086|560497619|FG000|Overall Study|Withdrawal by Subject|24|||
155409094|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
155638351|NCT01299909|561766451|FG002|Overall Study|Lost to Follow-up|17|||
155638352|NCT01811238|561766452|FG000|Overall Study|Withdrawal by Subject|42|||
155638353|NCT01811238|561766452|FG000|Overall Study|Adverse Event|25|||
155638354|NCT01811238|561766452|FG000|Overall Study|Protocol Violation|4|||
155638355|NCT01811238|561766452|FG000|Overall Study|Lack of Efficacy|4|||
155638356|NCT01811238|561766452|FG000|Overall Study|subject refused study medication|6|||
155638357|NCT01922934|561766456|FG000|Eligible Patients|Death|0|||
155638358|NCT01922934|561766457|FG001|Eligible Patients|Death|7|||
155638359|NCT01922934|561766456|FG000|Eligible Patients|Physician Decision|17|||
155638360|NCT01922934|561766457|FG001|Eligible Patients|Physician Decision|0|||
155638361|NCT01922934|561766456|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
155638362|NCT01922934|561766457|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
155638363|NCT01922934|561766456|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
155638364|NCT01922934|561766457|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
155638365|NCT01922934|561766456|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
155638366|NCT01922934|561766457|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
155638367|NCT01922934|561766456|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
155638368|NCT01922934|561766457|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
155638369|NCT04603066|561766481|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
155638370|NCT04603066|561766482|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
155638371|NCT02328014|561767636|FG000|Overall Study|Adverse Event|1|||
155638372|NCT02328014|561767637|FG001|Overall Study|Adverse Event|0|||
155638373|NCT02328014|561767638|FG002|Overall Study|Adverse Event|0|||
155638374|NCT02328014|561767639|FG003|Overall Study|Adverse Event|1|||
155638375|NCT02328014|561767636|FG000|Overall Study|Death|0|||
155638376|NCT02328014|561767637|FG001|Overall Study|Death|0|||
155638377|NCT02328014|561767638|FG002|Overall Study|Death|0|||
155638378|NCT02328014|561767639|FG003|Overall Study|Death|4|||
155638379|NCT02328014|561767636|FG000|Overall Study|Physician Decision|0|||
155638380|NCT02328014|561767637|FG001|Overall Study|Physician Decision|0|||
155638381|NCT02328014|561767638|FG002|Overall Study|Physician Decision|0|||
155638382|NCT02328014|561767639|FG003|Overall Study|Physician Decision|1|||
155638383|NCT02328014|561767636|FG000|Overall Study|Disease Progression|1|||
155638384|NCT02328014|561767637|FG001|Overall Study|Disease Progression|0|||
155638385|NCT02328014|561767638|FG002|Overall Study|Disease Progression|1|||
155638386|NCT02328014|561767639|FG003|Overall Study|Disease Progression|3|||
155638387|NCT02328014|561767636|FG000|Overall Study|Study Terminated by Sponsor|4|||
155638388|NCT02328014|561767637|FG001|Overall Study|Study Terminated by Sponsor|1|||
155638389|NCT02328014|561767638|FG002|Overall Study|Study Terminated by Sponsor|1|||
155638390|NCT02328014|561767639|FG003|Overall Study|Study Terminated by Sponsor|0|||
155638391|NCT02328014|561767636|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
155638392|NCT02328014|561767637|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
155638393|NCT02328014|561767638|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
155638394|NCT02328014|561767639|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
155638395|NCT02328014|561767636|FG000|Overall Study|Withdrawal by Subject|0|||
155638396|NCT02328014|561767637|FG001|Overall Study|Withdrawal by Subject|0|||
155638397|NCT02328014|561767638|FG002|Overall Study|Withdrawal by Subject|0|||
155638398|NCT02328014|561767639|FG003|Overall Study|Withdrawal by Subject|1|||
155638399|NCT00177671|561767642|FG000|Overall Study|Withdrawal by Subject|5|||
155638400|NCT00177671|561767643|FG001|Overall Study|Withdrawal by Subject|6|||
155638401|NCT00177671|561767642|FG000|Overall Study|medical complications|2|||
155638402|NCT00177671|561767643|FG001|Overall Study|medical complications|0|||
155638403|NCT00177671|561767642|FG000|Overall Study|Adverse Event|6|||
155638404|NCT00177671|561767643|FG001|Overall Study|Adverse Event|0|||
155638405|NCT00177671|561767642|FG000|Overall Study|Physician Decision|12|||
155638406|NCT00177671|561767643|FG001|Overall Study|Physician Decision|8|||
155638407|NCT03765073|561767653|FG000|Stage 1|Lost to Follow-up|1|||
155638408|NCT03765073|561767654|FG001|Stage 1|Lost to Follow-up|0|||
155743896|NCT01133990|562161586|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155291923|NCT01191086|560497619|FG000|Overall Study|Discontinuation criterion met|1|||
155291924|NCT01191086|560497619|FG000|Overall Study|Other|1|||
155291925|NCT00290732|560497621|FG000|Overall Study|Inability to instill drug intraductally.|0|||
155291926|NCT00290732|560497622|FG001|Overall Study|Inability to instill drug intraductally.|1|||
155291927|NCT00290732|560497623|FG002|Overall Study|Inability to instill drug intraductally.|1|||
155291928|NCT00290732|560497624|FG003|Overall Study|Inability to instill drug intraductally.|0|||
155291929|NCT00290732|560497625|FG004|Overall Study|Inability to instill drug intraductally.|0|||
155291930|NCT02736799|560497626|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291931|NCT02736799|560497627|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291932|NCT02736799|560497628|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291933|NCT02736799|560497629|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
155291934|NCT01833832|560497630|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
155291935|NCT01156116|560497631|FG000|Overall Study|Withdrawal by Subject|3|||
155291936|NCT01156116|560497632|FG001|Overall Study|Withdrawal by Subject|1|||
155291937|NCT01156116|560497631|FG000|Overall Study|CPAP intolerance|2|||
155291938|NCT01156116|560497632|FG001|Overall Study|CPAP intolerance|0|||
155291939|NCT00843193|560497633|FG000|Overall Study|Adverse Event|2|||
155291940|NCT00843193|560497634|FG001|Overall Study|Adverse Event|4|||
155291941|NCT00843193|560497633|FG000|Overall Study|Lack of Efficacy|1|||
155291942|NCT00843193|560497634|FG001|Overall Study|Lack of Efficacy|1|||
155291943|NCT00843193|560497633|FG000|Overall Study|Protocol Violation|1|||
155291944|NCT00843193|560497634|FG001|Overall Study|Protocol Violation|2|||
155291945|NCT00843193|560497633|FG000|Overall Study|Lost to Follow-up|1|||
155291946|NCT00843193|560497634|FG001|Overall Study|Lost to Follow-up|0|||
155291947|NCT00843193|560497633|FG000|Overall Study|Physician Decision|0|||
155291948|NCT00843193|560497634|FG001|Overall Study|Physician Decision|1|||
155291949|NCT00843193|560497633|FG000|Overall Study|Withdrawal by Subject|3|||
155291950|NCT00843193|560497634|FG001|Overall Study|Withdrawal by Subject|3|||
155291951|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
155291952|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
155291953|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
155291954|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
155291955|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
155291956|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
155291957|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
155291958|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
155291959|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
155291960|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
155291961|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
155291962|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
155291963|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
155291964|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
155291965|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
155291966|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
155291967|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
155291968|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
155291969|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
155291970|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
155291971|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
155291972|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
155291973|NCT00542386|560497637|FG000|Overall Study|Adverse Event|1|||
155291974|NCT00542386|560497638|FG001|Overall Study|Adverse Event|7|||
155291975|NCT00542386|560497639|FG002|Overall Study|Adverse Event|7|||
155291976|NCT00542386|560497640|FG003|Overall Study|Adverse Event|8|||
155409095|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155409096|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
155409097|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
155409098|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155409099|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
155409100|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
155409101|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
155409102|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
155409103|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
155409104|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
155409105|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
155409106|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
155409107|NCT01709149|560930857|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155409108|NCT01709149|560930858|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
155638409|NCT03765073|561767655|FG002|Stage 1|Lost to Follow-up|0|||
155638410|NCT03765073|561767656|FG003|Stage 1|Lost to Follow-up|0|||
155291977|NCT00542386|560497641|FG004|Overall Study|Adverse Event|13|||
155743897|NCT01782469|562161587|FG000|Overall Study|Lost to Follow-up|1|||
155743898|NCT01185301|562161588|FG000|Overall Study|Adverse Event|3|||
155743899|NCT01185301|562161589|FG001|Overall Study|Adverse Event|0|||
155743900|NCT01185301|562161590|FG002|Overall Study|Adverse Event|2|||
155743901|NCT01185301|562161591|FG003|Overall Study|Adverse Event|3|||
155743902|NCT01185301|562161588|FG000|Overall Study|Withdrawal by Subject|7|||
155743903|NCT01185301|562161589|FG001|Overall Study|Withdrawal by Subject|5|||
155743904|NCT01185301|562161590|FG002|Overall Study|Withdrawal by Subject|2|||
155743905|NCT01185301|562161591|FG003|Overall Study|Withdrawal by Subject|3|||
155743906|NCT01185301|562161588|FG000|Overall Study|Lost to Follow-up|2|||
155743907|NCT01185301|562161589|FG001|Overall Study|Lost to Follow-up|0|||
155743908|NCT01185301|562161590|FG002|Overall Study|Lost to Follow-up|0|||
155743909|NCT01185301|562161591|FG003|Overall Study|Lost to Follow-up|1|||
155743910|NCT01185301|562161588|FG000|Overall Study|Other Reason|3|||
155743911|NCT01185301|562161589|FG001|Overall Study|Other Reason|2|||
155743912|NCT01185301|562161590|FG002|Overall Study|Other Reason|2|||
155743913|NCT01185301|562161591|FG003|Overall Study|Other Reason|2|||
155743914|NCT04987944|562161592|FG000|Overall Study|Adverse Event|0|||
155743915|NCT04987944|562161593|FG001|Overall Study|Adverse Event|1|||
155743916|NCT04987944|562161592|FG000|Overall Study|Withdrawal by Subject|0|||
155743917|NCT04987944|562161593|FG001|Overall Study|Withdrawal by Subject|1|||
155743918|NCT00357760|562161598|FG000|Overall Study|Disease progression|44|||
155743919|NCT00357760|562161599|FG001|Overall Study|Disease progression|17|||
155743920|NCT00357760|562161598|FG000|Overall Study|Adverse Event|10|||
155743921|NCT00357760|562161599|FG001|Overall Study|Adverse Event|7|||
155743922|NCT00357760|562161598|FG000|Overall Study|Death|0|||
155743923|NCT00357760|562161599|FG001|Overall Study|Death|3|||
155409109|NCT01709149|560930859|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155409110|NCT00763815|560930860|FG000|Overall Study|Adverse Event|14|||
155743924|NCT00357760|562161598|FG000|Overall Study|Alternative therapy|1|||
155743925|NCT00357760|562161599|FG001|Overall Study|Alternative therapy|0|||
155743926|NCT00357760|562161598|FG000|Overall Study|Withdrawal by Subject|0|||
155743927|NCT00357760|562161599|FG001|Overall Study|Withdrawal by Subject|2|||
155743928|NCT00357760|562161598|FG000|Overall Study|Never started treatment|2|||
155743929|NCT00357760|562161599|FG001|Overall Study|Never started treatment|1|||
155743930|NCT00357760|562161598|FG000|Overall Study|Ineligible|0|||
155743931|NCT00357760|562161599|FG001|Overall Study|Ineligible|2|||
155743932|NCT00357760|562161598|FG000|Overall Study|Physician Decision|2|||
155743933|NCT00357760|562161599|FG001|Overall Study|Physician Decision|1|||
155743934|NCT00357760|562161598|FG000|Overall Study|Protocol Violation|0|||
155743935|NCT00357760|562161599|FG001|Overall Study|Protocol Violation|1|||
155743936|NCT00357760|562161598|FG000|Overall Study|To receive hospice care|0|||
155743937|NCT00357760|562161599|FG001|Overall Study|To receive hospice care|1|||
155743938|NCT04136444|562161600|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
155743939|NCT04136444|562161601|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
155743940|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155743941|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155743942|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155743943|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155743944|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
155743945|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
155743946|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155743947|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155743948|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155743949|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155409111|NCT00763815|560930861|FG001|Overall Study|Adverse Event|29|||
155409112|NCT00763815|560930860|FG000|Overall Study|Lack of Efficacy|10|||
155409113|NCT00763815|560930861|FG001|Overall Study|Lack of Efficacy|11|||
155409114|NCT00763815|560930860|FG000|Overall Study|Poor Compliance to Protocol|6|||
155409115|NCT00763815|560930861|FG001|Overall Study|Poor Compliance to Protocol|6|||
155409116|NCT00763815|560930860|FG000|Overall Study|Lost to Follow-up|2|||
155409117|NCT00763815|560930861|FG001|Overall Study|Lost to Follow-up|4|||
155409118|NCT00763815|560930860|FG000|Overall Study|Early Termination|1|||
155409119|NCT00763815|560930861|FG001|Overall Study|Early Termination|0|||
155743950|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155743951|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
155743952|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155743953|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155743954|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155743955|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155743956|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155743957|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155743958|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155743959|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
155743960|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155291978|NCT00542386|560497642|FG005|Overall Study|Adverse Event|4|||
155291979|NCT00542386|560497637|FG000|Overall Study|Death|0|||
155291980|NCT00542386|560497638|FG001|Overall Study|Death|0|||
155291981|NCT00542386|560497639|FG002|Overall Study|Death|1|||
155291982|NCT00542386|560497640|FG003|Overall Study|Death|2|||
155291983|NCT00542386|560497641|FG004|Overall Study|Death|1|||
155291984|NCT00542386|560497642|FG005|Overall Study|Death|2|||
155291985|NCT00542386|560497637|FG000|Overall Study|Lack of Efficacy|32|||
155291986|NCT00542386|560497638|FG001|Overall Study|Lack of Efficacy|12|||
155291987|NCT00542386|560497639|FG002|Overall Study|Lack of Efficacy|10|||
155291988|NCT00542386|560497640|FG003|Overall Study|Lack of Efficacy|13|||
155291989|NCT00542386|560497641|FG004|Overall Study|Lack of Efficacy|7|||
155291990|NCT00542386|560497642|FG005|Overall Study|Lack of Efficacy|31|||
155291991|NCT00542386|560497637|FG000|Overall Study|Physician Decision|1|||
155291992|NCT00542386|560497638|FG001|Overall Study|Physician Decision|0|||
155291993|NCT00542386|560497639|FG002|Overall Study|Physician Decision|0|||
155291994|NCT00542386|560497640|FG003|Overall Study|Physician Decision|1|||
155291995|NCT00542386|560497641|FG004|Overall Study|Physician Decision|0|||
155291996|NCT00542386|560497642|FG005|Overall Study|Physician Decision|0|||
155291997|NCT00542386|560497637|FG000|Overall Study|Protocol Violation|0|||
155291998|NCT00542386|560497638|FG001|Overall Study|Protocol Violation|0|||
155291999|NCT00542386|560497639|FG002|Overall Study|Protocol Violation|1|||
155292000|NCT00542386|560497640|FG003|Overall Study|Protocol Violation|0|||
155292001|NCT00542386|560497641|FG004|Overall Study|Protocol Violation|0|||
155292002|NCT00542386|560497642|FG005|Overall Study|Protocol Violation|4|||
155292003|NCT00542386|560497637|FG000|Overall Study|Withdrawal by Subject|5|||
155292004|NCT00542386|560497638|FG001|Overall Study|Withdrawal by Subject|8|||
155292005|NCT00542386|560497639|FG002|Overall Study|Withdrawal by Subject|10|||
155292006|NCT00542386|560497640|FG003|Overall Study|Withdrawal by Subject|11|||
155292007|NCT00542386|560497641|FG004|Overall Study|Withdrawal by Subject|15|||
155292008|NCT00542386|560497642|FG005|Overall Study|Withdrawal by Subject|7|||
155292009|NCT00542386|560497637|FG000|Overall Study|Other Reasons|4|||
155292010|NCT00542386|560497638|FG001|Overall Study|Other Reasons|1|||
155292011|NCT00542386|560497639|FG002|Overall Study|Other Reasons|4|||
155292012|NCT00542386|560497640|FG003|Overall Study|Other Reasons|3|||
155292013|NCT00542386|560497641|FG004|Overall Study|Other Reasons|4|||
155292014|NCT00542386|560497642|FG005|Overall Study|Other Reasons|2|||
155292015|NCT00197015|560497643|FG000|Overall Study|Adverse Event|3|||
155292016|NCT00197015|560497644|FG001|Overall Study|Adverse Event|0|||
155292017|NCT00197015|560497645|FG002|Overall Study|Adverse Event|1|||
155292018|NCT00197015|560497643|FG000|Overall Study|Protocol Violation|0|||
155292019|NCT00197015|560497644|FG001|Overall Study|Protocol Violation|3|||
155292020|NCT00197015|560497645|FG002|Overall Study|Protocol Violation|3|||
155292021|NCT00197015|560497643|FG000|Overall Study|Withdrawal by Subject|17|||
155292022|NCT00197015|560497644|FG001|Overall Study|Withdrawal by Subject|37|||
155292023|NCT00197015|560497645|FG002|Overall Study|Withdrawal by Subject|34|||
155292024|NCT00197015|560497643|FG000|Overall Study|Lost to Follow-up|28|||
155292025|NCT00197015|560497644|FG001|Overall Study|Lost to Follow-up|46|||
155292026|NCT00197015|560497645|FG002|Overall Study|Lost to Follow-up|37|||
155292027|NCT00197015|560497643|FG000|Overall Study|Other|2|||
155292028|NCT00197015|560497644|FG001|Overall Study|Other|3|||
155292029|NCT00197015|560497645|FG002|Overall Study|Other|2|||
155292030|NCT04511650|560497648|FG000|Overall Study|Lost to Follow-up|1|||
155292031|NCT04511650|560497649|FG001|Overall Study|Lost to Follow-up|0|||
155292032|NCT04511650|560497650|FG002|Overall Study|Lost to Follow-up|0|||
155292033|NCT04511650|560497648|FG000|Overall Study|Withdrawal by Subject|1|||
155292034|NCT04511650|560497649|FG001|Overall Study|Withdrawal by Subject|0|||
155292035|NCT04511650|560497650|FG002|Overall Study|Withdrawal by Subject|0|||
155292036|NCT04511650|560497648|FG000|Overall Study|reason not provided|0|||
155292037|NCT04511650|560497649|FG001|Overall Study|reason not provided|0|||
155292038|NCT04511650|560497650|FG002|Overall Study|reason not provided|1|||
155292039|NCT04511650|560497648|FG000|Overall Study|Death|1|||
155292040|NCT04511650|560497649|FG001|Overall Study|Death|1|||
155292041|NCT04511650|560497650|FG002|Overall Study|Death|1|||
155292042|NCT00608907|560497654|FG000|Overall Study|Adverse Event|6|||
155292043|NCT00608907|560497655|FG001|Overall Study|Adverse Event|0|||
155292044|NCT00608907|560497656|FG002|Overall Study|Adverse Event|1|||
155292045|NCT00608907|560497654|FG000|Overall Study|Death|1|||
155292046|NCT00608907|560497655|FG001|Overall Study|Death|0|||
155292047|NCT00608907|560497656|FG002|Overall Study|Death|0|||
155292048|NCT00608907|560497654|FG000|Overall Study|Withdrawal by Subject|4|||
155292049|NCT00608907|560497655|FG001|Overall Study|Withdrawal by Subject|0|||
155292050|NCT00608907|560497656|FG002|Overall Study|Withdrawal by Subject|0|||
155292051|NCT00608907|560497654|FG000|Overall Study|Progressive Disease|1|||
155292052|NCT00608907|560497655|FG001|Overall Study|Progressive Disease|0|||
155292053|NCT00608907|560497656|FG002|Overall Study|Progressive Disease|0|||
155292054|NCT01186848|560497659|FG000|Overall Study|Lost to Follow-up|4|||
155292055|NCT01186848|560497659|FG000|Overall Study|Withdrawal by Subject|2|||
155292056|NCT01186848|560497659|FG000|Overall Study|Adverse Event|2|||
155292057|NCT01104415|560497660|FG000|Core Phase|Consent withdrawn by subjects|1|||
155292058|NCT01104415|560497661|FG001|Core Phase|Consent withdrawn by subjects|0|||
155292059|NCT01104415|560497660|FG000|Extension Period|Progressive disease|0|||
155292060|NCT01104415|560497661|FG001|Extension Period|Progressive disease|4|||
155292061|NCT01104415|560497660|FG000|Extension Period|Death|0|||
155292062|NCT01104415|560497661|FG001|Extension Period|Death|1|||
155292063|NCT01104415|560497660|FG000|Extension Period|Physician Decision|0|||
155292064|NCT01104415|560497661|FG001|Extension Period|Physician Decision|1|||
155292065|NCT01104415|560497660|FG000|Extension Period|Transition to Study LX1606.302|0|||
155292066|NCT01104415|560497661|FG001|Extension Period|Transition to Study LX1606.302|4|||
155292067|NCT01104415|560497660|FG000|Extension Period|Heart surgery/feeling miserable|0|||
155292068|NCT01104415|560497661|FG001|Extension Period|Heart surgery/feeling miserable|1|||
155292069|NCT03593070|560497663|FG000|Overall Study|administrative withdrawal|1|||
155292070|NCT03593070|560497664|FG001|Overall Study|administrative withdrawal|1|||
155292071|NCT03612804|560497665|FG000|Overall Study|Death|0|||
155292072|NCT03612804|560497666|FG001|Overall Study|Death|7|||
155292073|NCT03612804|560497667|FG002|Overall Study|Death|0|||
155292074|NCT03612804|560497668|FG003|Overall Study|Death|8|||
155292075|NCT03612804|560497665|FG000|Overall Study|Medication copay coverage issues|0|||
155292076|NCT03612804|560497666|FG001|Overall Study|Medication copay coverage issues|0|||
155292077|NCT03612804|560497667|FG002|Overall Study|Medication copay coverage issues|0|||
155292078|NCT03612804|560497668|FG003|Overall Study|Medication copay coverage issues|17|||
155292079|NCT03612804|560497665|FG000|Overall Study|Not current smoker at time of screening|0|||
155292080|NCT03612804|560497666|FG001|Overall Study|Not current smoker at time of screening|1|||
155292081|NCT03612804|560497667|FG002|Overall Study|Not current smoker at time of screening|0|||
155292082|NCT03612804|560497668|FG003|Overall Study|Not current smoker at time of screening|3|||
155292083|NCT03612804|560497665|FG000|Overall Study|Non-veteran status|0|||
155292084|NCT03612804|560497666|FG001|Overall Study|Non-veteran status|1|||
155292085|NCT03612804|560497667|FG002|Overall Study|Non-veteran status|0|||
155292086|NCT03612804|560497668|FG003|Overall Study|Non-veteran status|0|||
155292087|NCT03612804|560497665|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
155292088|NCT03612804|560497666|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
155292089|NCT03612804|560497667|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
155292090|NCT03612804|560497668|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
155292091|NCT03612804|560497665|FG000|Overall Study|Provider retired from VA|0|||
155292092|NCT03612804|560497666|FG001|Overall Study|Provider retired from VA|0|||
155292093|NCT03612804|560497667|FG002|Overall Study|Provider retired from VA|2|||
155292094|NCT03612804|560497668|FG003|Overall Study|Provider retired from VA|0|||
155292095|NCT03612804|560497665|FG000|Overall Study|Withdrawal by Subject|0|||
155292096|NCT03612804|560497666|FG001|Overall Study|Withdrawal by Subject|0|||
155292097|NCT03612804|560497667|FG002|Overall Study|Withdrawal by Subject|7|||
155292098|NCT03612804|560497668|FG003|Overall Study|Withdrawal by Subject|0|||
155292099|NCT03612804|560497665|FG000|Overall Study|Provider involved with study activities|1|||
155292100|NCT03612804|560497666|FG001|Overall Study|Provider involved with study activities|0|||
155292101|NCT03612804|560497667|FG002|Overall Study|Provider involved with study activities|0|||
155292102|NCT03612804|560497668|FG003|Overall Study|Provider involved with study activities|0|||
155292103|NCT02104765|560497669|FG000|Overall Study|Lost to Follow-up|0|||
155292104|NCT02104765|560497670|FG001|Overall Study|Lost to Follow-up|0|||
155292105|NCT02104765|560497671|FG002|Overall Study|Lost to Follow-up|1|||
155292106|NCT02104765|560497672|FG003|Overall Study|Lost to Follow-up|0|||
155292107|NCT02104765|560497673|FG004|Overall Study|Lost to Follow-up|0|||
155292108|NCT02104765|560497674|FG005|Overall Study|Lost to Follow-up|0|||
155292109|NCT02104765|560497675|FG006|Overall Study|Lost to Follow-up|0|||
155292110|NCT02104765|560497669|FG000|Overall Study|Withdrawal by Subject|0|||
155292111|NCT02104765|560497670|FG001|Overall Study|Withdrawal by Subject|0|||
155292112|NCT02104765|560497671|FG002|Overall Study|Withdrawal by Subject|0|||
155292113|NCT02104765|560497672|FG003|Overall Study|Withdrawal by Subject|1|||
155292114|NCT02104765|560497673|FG004|Overall Study|Withdrawal by Subject|1|||
155292115|NCT02104765|560497674|FG005|Overall Study|Withdrawal by Subject|0|||
155292116|NCT02104765|560497675|FG006|Overall Study|Withdrawal by Subject|1|||
155292117|NCT04771273|560497676|FG000|Dose Escalation Period|Not treated with trial medication|0|||
155292118|NCT04771273|560497677|FG001|Dose Escalation Period|Not treated with trial medication|1|||
155292119|NCT04771273|560497678|FG002|Dose Escalation Period|Not treated with trial medication|1|||
155292120|NCT04771273|560497679|FG003|Dose Escalation Period|Not treated with trial medication|0|||
155292121|NCT04771273|560497676|FG000|Dose Escalation Period|Other reasons than listed|2|||
155292122|NCT04771273|560497677|FG001|Dose Escalation Period|Other reasons than listed|0|||
155292123|NCT04771273|560497678|FG002|Dose Escalation Period|Other reasons than listed|2|||
155292124|NCT04771273|560497679|FG003|Dose Escalation Period|Other reasons than listed|1|||
155292125|NCT04771273|560497676|FG000|Dose Escalation Period|Protocol Violation|0|||
155292126|NCT04771273|560497677|FG001|Dose Escalation Period|Protocol Violation|0|||
155292127|NCT04771273|560497678|FG002|Dose Escalation Period|Protocol Violation|3|||
155292128|NCT04771273|560497679|FG003|Dose Escalation Period|Protocol Violation|1|||
155292129|NCT04771273|560497676|FG000|Dose Escalation Period|Burden of study procedures|1|||
155292130|NCT04771273|560497677|FG001|Dose Escalation Period|Burden of study procedures|0|||
155292131|NCT04771273|560497678|FG002|Dose Escalation Period|Burden of study procedures|0|||
155292132|NCT04771273|560497679|FG003|Dose Escalation Period|Burden of study procedures|0|||
155292133|NCT04771273|560497676|FG000|Dose Escalation Period|Change of residence|0|||
155292134|NCT04771273|560497677|FG001|Dose Escalation Period|Change of residence|0|||
155292135|NCT04771273|560497678|FG002|Dose Escalation Period|Change of residence|0|||
155292136|NCT04771273|560497679|FG003|Dose Escalation Period|Change of residence|1|||
155292137|NCT04771273|560497676|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
155292138|NCT04771273|560497677|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
155292139|NCT04771273|560497678|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
155292140|NCT04771273|560497679|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
155292141|NCT04771273|560497676|FG000|Dose Escalation Period|Adverse Event|8|||
155292142|NCT04771273|560497677|FG001|Dose Escalation Period|Adverse Event|9|||
155292143|NCT04771273|560497678|FG002|Dose Escalation Period|Adverse Event|12|||
155292144|NCT04771273|560497679|FG003|Dose Escalation Period|Adverse Event|2|||
155292145|NCT04771273|560497676|FG000|Maintenance Period|Other than listed|4|||
155292146|NCT04771273|560497677|FG001|Maintenance Period|Other than listed|2|||
155292147|NCT04771273|560497678|FG002|Maintenance Period|Other than listed|0|||
155292148|NCT04771273|560497679|FG003|Maintenance Period|Other than listed|3|||
155292149|NCT04771273|560497676|FG000|Maintenance Period|Burden of study procedures|1|||
155292150|NCT04771273|560497677|FG001|Maintenance Period|Burden of study procedures|0|||
155292151|NCT04771273|560497678|FG002|Maintenance Period|Burden of study procedures|0|||
155292152|NCT04771273|560497679|FG003|Maintenance Period|Burden of study procedures|0|||
155292153|NCT04771273|560497676|FG000|Maintenance Period|Change of residence|0|||
155292154|NCT04771273|560497677|FG001|Maintenance Period|Change of residence|1|||
155292155|NCT04771273|560497678|FG002|Maintenance Period|Change of residence|3|||
155292156|NCT04771273|560497679|FG003|Maintenance Period|Change of residence|0|||
155292157|NCT04771273|560497676|FG000|Maintenance Period|Perceived lack of efficacy|0|||
155292158|NCT04771273|560497677|FG001|Maintenance Period|Perceived lack of efficacy|0|||
155292159|NCT04771273|560497678|FG002|Maintenance Period|Perceived lack of efficacy|0|||
155292160|NCT04771273|560497679|FG003|Maintenance Period|Perceived lack of efficacy|1|||
155292161|NCT04771273|560497676|FG000|Maintenance Period|Adverse Event|4|||
155292162|NCT04771273|560497677|FG001|Maintenance Period|Adverse Event|5|||
155292163|NCT04771273|560497678|FG002|Maintenance Period|Adverse Event|5|||
155292164|NCT04771273|560497679|FG003|Maintenance Period|Adverse Event|0|||
155292165|NCT02357784|560497680|FG000|Overall Study|Withdrawal by Subject|1|||
155409120|NCT00763815|560930860|FG000|Overall Study|Familial and Personal Reasons|9|||
155409121|NCT00763815|560930861|FG001|Overall Study|Familial and Personal Reasons|16|||
155409122|NCT00763815|560930860|FG000|Overall Study|Physician Decision|1|||
155409123|NCT00763815|560930861|FG001|Overall Study|Physician Decision|0|||
155409124|NCT00763815|560930860|FG000|Overall Study|Withdrawal by Subject|7|||
155409125|NCT00763815|560930861|FG001|Overall Study|Withdrawal by Subject|12|||
155409126|NCT00763815|560930860|FG000|Overall Study|Protocol Violation|2|||
155409127|NCT00763815|560930861|FG001|Overall Study|Protocol Violation|5|||
155409128|NCT00763815|560930860|FG000|Overall Study|Sponsor's Decision|0|||
155409129|NCT00763815|560930861|FG001|Overall Study|Sponsor's Decision|1|||
155409130|NCT04951037|560930862|FG000|Overall Study|Lost to Follow-up|16|||
155409131|NCT04951037|560930862|FG000|Overall Study|Withdrawal by Subject|5|||
155409132|NCT04951037|560930862|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
155409133|NCT05630937|560930863|FG000|Overall Study|Study terminated by sponsor|1|||
155409134|NCT05630937|560930864|FG001|Overall Study|Study terminated by sponsor|1|||
155409135|NCT05630937|560930865|FG002|Overall Study|Study terminated by sponsor|8|||
155409136|NCT05630937|560930866|FG003|Overall Study|Study terminated by sponsor|0|||
155409137|NCT05630937|560930863|FG000|Overall Study|Lost to Follow-up|0|||
155409138|NCT05630937|560930864|FG001|Overall Study|Lost to Follow-up|0|||
155409139|NCT05630937|560930865|FG002|Overall Study|Lost to Follow-up|1|||
155743961|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155743962|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
155409140|NCT05630937|560930866|FG003|Overall Study|Lost to Follow-up|0|||
155409141|NCT05630937|560930863|FG000|Overall Study|Enrolled but not treated|0|||
155409142|NCT05630937|560930864|FG001|Overall Study|Enrolled but not treated|0|||
155409143|NCT05630937|560930865|FG002|Overall Study|Enrolled but not treated|0|||
155409144|NCT05630937|560930866|FG003|Overall Study|Enrolled but not treated|1|||
155292166|NCT00995709|560497681|FG000|Overall Study|Adverse Event|4|||
155292167|NCT00995709|560497682|FG001|Overall Study|Adverse Event|2|||
155292168|NCT00995709|560497683|FG002|Overall Study|Adverse Event|0|||
155292169|NCT00995709|560497681|FG000|Overall Study|Lack of Efficacy|0|||
155292170|NCT00995709|560497682|FG001|Overall Study|Lack of Efficacy|1|||
155292171|NCT00995709|560497683|FG002|Overall Study|Lack of Efficacy|4|||
155292172|NCT00995709|560497681|FG000|Overall Study|Withdrawal by Subject|0|||
155292173|NCT00995709|560497682|FG001|Overall Study|Withdrawal by Subject|4|||
155292174|NCT00995709|560497683|FG002|Overall Study|Withdrawal by Subject|1|||
155292175|NCT00995709|560497681|FG000|Overall Study|Lost to Follow-up|1|||
155292176|NCT00995709|560497682|FG001|Overall Study|Lost to Follow-up|0|||
155292177|NCT00995709|560497683|FG002|Overall Study|Lost to Follow-up|0|||
155409145|NCT00267748|560930868|FG000|Non-randomized Period|Progressive disease|10|||
155409146|NCT00267748|560930869|FG001|Non-randomized Period|Progressive disease|0|||
155292178|NCT00995709|560497681|FG000|Overall Study|Death|0|||
155292179|NCT00995709|560497682|FG001|Overall Study|Death|1|||
155292180|NCT00995709|560497683|FG002|Overall Study|Death|0|||
155292181|NCT00995709|560497681|FG000|Overall Study|Protocol Violation|2|||
155292182|NCT00995709|560497682|FG001|Overall Study|Protocol Violation|1|||
155292183|NCT00995709|560497683|FG002|Overall Study|Protocol Violation|0|||
155292184|NCT03395353|560497691|FG000|Overall Study|Adverse Event|20|||
155292185|NCT03395353|560497691|FG000|Overall Study|Protocol Violation|1|||
155292186|NCT03395353|560497691|FG000|Overall Study|Lack of Efficacy|3|||
155292187|NCT03395353|560497691|FG000|Overall Study|Withdrawal by Subject|24|||
155292188|NCT03395353|560497691|FG000|Overall Study|Discontinued visit|1|||
155292189|NCT03395353|560497691|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
155292190|NCT03395353|560497691|FG000|Overall Study|Physician Decision|4|||
155292191|NCT03395353|560497691|FG000|Overall Study|Early termination of overall study|33|||
155292192|NCT02685033|560497692|FG000|Overall Study|Withdrawal of Consent|0|||
155292193|NCT02685033|560497693|FG001|Overall Study|Withdrawal of Consent|1|||
155292194|NCT02685033|560497692|FG000|Overall Study|Lost to Follow-up|2|||
155292195|NCT02685033|560497693|FG001|Overall Study|Lost to Follow-up|1|||
155292196|NCT02685033|560497692|FG000|Overall Study|Adverse Event|1|||
155292197|NCT02685033|560497693|FG001|Overall Study|Adverse Event|0|||
155292198|NCT00708097|560497694|FG000|Period 1|Protocol Violation|0|||
155292199|NCT00708097|560497695|FG001|Period 1|Protocol Violation|1|||
155292200|NCT00708097|560497696|FG002|Period 1|Protocol Violation|0|||
155292201|NCT00708097|560497697|FG003|Period 1|Protocol Violation|2|||
155292202|NCT00708097|560497698|FG004|Period 1|Protocol Violation|0|||
155292203|NCT00708097|560497694|FG000|Period 1|Other Reason|0|||
155292204|NCT00708097|560497695|FG001|Period 1|Other Reason|0|||
155292205|NCT00708097|560497696|FG002|Period 1|Other Reason|0|||
155292206|NCT00708097|560497697|FG003|Period 1|Other Reason|0|||
155292207|NCT00708097|560497698|FG004|Period 1|Other Reason|1|||
155292208|NCT00708097|560497694|FG000|Period 2|Protocol Violation|0|||
155292209|NCT00708097|560497695|FG001|Period 2|Protocol Violation|1|||
155292210|NCT00708097|560497696|FG002|Period 2|Protocol Violation|1|||
155292211|NCT00708097|560497697|FG003|Period 2|Protocol Violation|1|||
155292212|NCT00708097|560497698|FG004|Period 2|Protocol Violation|0|||
155292213|NCT03425643|560497699|FG000|Overall Study|Withdrawal by Subject|10|||
155409147|NCT00267748|560930870|FG002|Non-randomized Period|Progressive disease|0|||
155409148|NCT00267748|560930868|FG000|Non-randomized Period|Adverse Event|8|||
155409149|NCT00267748|560930869|FG001|Non-randomized Period|Adverse Event|0|||
155409150|NCT00267748|560930870|FG002|Non-randomized Period|Adverse Event|0|||
155409151|NCT00267748|560930868|FG000|Non-randomized Period|Death|1|||
155409152|NCT00267748|560930869|FG001|Non-randomized Period|Death|0|||
155409153|NCT00267748|560930870|FG002|Non-randomized Period|Death|0|||
155409154|NCT00267748|560930868|FG000|Non-randomized Period|Participant not willing to participate|1|||
155409155|NCT00267748|560930869|FG001|Non-randomized Period|Participant not willing to participate|0|||
155409156|NCT00267748|560930870|FG002|Non-randomized Period|Participant not willing to participate|0|||
155409157|NCT00267748|560930868|FG000|Non-randomized Period|Other|3|||
155409158|NCT00267748|560930869|FG001|Non-randomized Period|Other|0|||
155409159|NCT00267748|560930870|FG002|Non-randomized Period|Other|0|||
155409160|NCT00267748|560930868|FG000|Randomized Period|Death|0|||
155409161|NCT00267748|560930869|FG001|Randomized Period|Death|2|||
155409162|NCT00267748|560930870|FG002|Randomized Period|Death|3|||
155409163|NCT00267748|560930868|FG000|Randomized Period|Adverse Event|0|||
155409164|NCT00267748|560930869|FG001|Randomized Period|Adverse Event|23|||
155409165|NCT00267748|560930870|FG002|Randomized Period|Adverse Event|25|||
155409166|NCT00267748|560930868|FG000|Randomized Period|Global deterioration of health status|0|||
155409167|NCT00267748|560930869|FG001|Randomized Period|Global deterioration of health status|6|||
155409168|NCT00267748|560930870|FG002|Randomized Period|Global deterioration of health status|7|||
155409169|NCT00267748|560930868|FG000|Randomized Period|Lost to Follow-up|0|||
155409170|NCT00267748|560930869|FG001|Randomized Period|Lost to Follow-up|1|||
155292214|NCT03425643|560497700|FG001|Overall Study|Withdrawal by Subject|12|||
155409171|NCT00267748|560930870|FG002|Randomized Period|Lost to Follow-up|0|||
155409172|NCT00267748|560930868|FG000|Randomized Period|Objective progression or relapse|0|||
155292215|NCT03425643|560497699|FG000|Overall Study|Lost to Follow-up|2|||
155292216|NCT03425643|560497700|FG001|Overall Study|Lost to Follow-up|0|||
155292217|NCT03425643|560497699|FG000|Overall Study|Death|109|||
155292218|NCT03425643|560497700|FG001|Overall Study|Death|141|||
155292219|NCT03425643|560497699|FG000|Overall Study|Ongoing in study|276|||
155292220|NCT03425643|560497700|FG001|Overall Study|Ongoing in study|247|||
155292221|NCT01838200|560497701|FG000|Overall Study|Adverse Event|0|||
155292222|NCT01838200|560497702|FG001|Overall Study|Adverse Event|2|||
155292223|NCT01838200|560497701|FG000|Overall Study|Progressive disease|3|||
155409173|NCT00267748|560930869|FG001|Randomized Period|Objective progression or relapse|77|||
155409174|NCT00267748|560930870|FG002|Randomized Period|Objective progression or relapse|86|||
155409175|NCT00267748|560930868|FG000|Randomized Period|Withdrawal by Subject|0|||
155292224|NCT01838200|560497702|FG001|Overall Study|Progressive disease|0|||
155292225|NCT03354390|560497706|FG000|Level 1|Death|2|||
155292226|NCT03354390|560497707|FG001|Level 1|Death|0|||
155409176|NCT00267748|560930869|FG001|Randomized Period|Withdrawal by Subject|9|||
155743963|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155743964|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
155743965|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155743966|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155743967|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155743968|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155743969|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155743970|NCT01328444|562161602|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155743971|NCT01328444|562161603|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
155743972|NCT01328444|562161604|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155743973|NCT01328444|562161605|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
155743974|NCT01328444|562161606|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155743975|NCT01328444|562161607|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155743976|NCT01328444|562161602|FG000|Washout Period (14 Days)|Adverse Event|1|||
155743977|NCT01328444|562161603|FG001|Washout Period (14 Days)|Adverse Event|1|||
155743978|NCT01328444|562161604|FG002|Washout Period (14 Days)|Adverse Event|0|||
155292227|NCT03354390|560497708|FG002|Level 1|Death|0|||
155292228|NCT03354390|560497709|FG003|Level 1|Death|0|||
155292229|NCT03354390|560497706|FG000|Level 1|Physician Decision|1|||
155292230|NCT03354390|560497707|FG001|Level 1|Physician Decision|0|||
155292231|NCT03354390|560497708|FG002|Level 1|Physician Decision|0|||
155292232|NCT03354390|560497709|FG003|Level 1|Physician Decision|0|||
155409177|NCT00267748|560930870|FG002|Randomized Period|Withdrawal by Subject|2|||
155409178|NCT00267748|560930868|FG000|Randomized Period|Other|0|||
155409179|NCT00267748|560930869|FG001|Randomized Period|Other|9|||
155409180|NCT00267748|560930870|FG002|Randomized Period|Other|6|||
155292233|NCT03354390|560497706|FG000|Level 2|Physician Decision|0|||
155292234|NCT03354390|560497707|FG001|Level 2|Physician Decision|2|||
155292235|NCT03354390|560497708|FG002|Level 2|Physician Decision|0|||
155292236|NCT03354390|560497709|FG003|Level 2|Physician Decision|0|||
155292237|NCT03354390|560497706|FG000|Level 2|Lack of Efficacy|0|||
155292238|NCT03354390|560497707|FG001|Level 2|Lack of Efficacy|1|||
155292239|NCT03354390|560497708|FG002|Level 2|Lack of Efficacy|0|||
155292240|NCT03354390|560497709|FG003|Level 2|Lack of Efficacy|0|||
155292241|NCT03354390|560497706|FG000|Level 2|Lost to Follow-up|0|||
155292242|NCT03354390|560497707|FG001|Level 2|Lost to Follow-up|1|||
155292243|NCT03354390|560497708|FG002|Level 2|Lost to Follow-up|0|||
155292244|NCT03354390|560497709|FG003|Level 2|Lost to Follow-up|0|||
155292245|NCT03354390|560497706|FG000|Level 3|Death|0|||
155292246|NCT03354390|560497707|FG001|Level 3|Death|0|||
155292247|NCT03354390|560497708|FG002|Level 3|Death|1|||
155292248|NCT03354390|560497709|FG003|Level 3|Death|0|||
155292249|NCT03354390|560497706|FG000|Level 3|Physician Decision|0|||
155292250|NCT03354390|560497707|FG001|Level 3|Physician Decision|0|||
155292251|NCT03354390|560497708|FG002|Level 3|Physician Decision|2|||
155292252|NCT03354390|560497709|FG003|Level 3|Physician Decision|0|||
155292253|NCT03354390|560497706|FG000|Level 4|Death|0|||
155292254|NCT03354390|560497707|FG001|Level 4|Death|0|||
155292255|NCT03354390|560497708|FG002|Level 4|Death|0|||
155292256|NCT03354390|560497709|FG003|Level 4|Death|3|||
155292257|NCT00777556|560499016|FG000|Overall Study|Inappropriate self-selection|34|||
155292258|NCT00777556|560499016|FG000|Overall Study|Dispensed but did not use product|12|||
155292259|NCT00777556|560499016|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
155292260|NCT02689349|560499017|FG000|Overall Study|Not implanted|4|||
155292261|NCT02689349|560499018|FG001|Overall Study|Not implanted|0|||
155292262|NCT02689349|560499017|FG000|Overall Study|Withdrawal by Subject|9|||
155292263|NCT02689349|560499018|FG001|Overall Study|Withdrawal by Subject|0|||
155292264|NCT00486759|560499027|FG000|Treatment|Adverse event/intercurrent illness|86|||
155292265|NCT00486759|560499028|FG001|Treatment|Adverse event/intercurrent illness|39|||
155292266|NCT00486759|560499027|FG000|Treatment|Insufficient therapeutic response|37|||
155292267|NCT00486759|560499028|FG001|Treatment|Insufficient therapeutic response|39|||
155409181|NCT00267748|560930868|FG000|Randomized Period|randomized but not treated|0|||
155409182|NCT00267748|560930869|FG001|Randomized Period|randomized but not treated|0|||
155409183|NCT00267748|560930870|FG002|Randomized Period|randomized but not treated|3|||
155292268|NCT00486759|560499027|FG000|Treatment|Death|17|||
155292269|NCT00486759|560499028|FG001|Treatment|Death|10|||
155292270|NCT00486759|560499027|FG000|Treatment|Withdrew consent|15|||
155292271|NCT00486759|560499028|FG001|Treatment|Withdrew consent|12|||
155292272|NCT00486759|560499027|FG000|Treatment|Administrative/reason not specified|17|||
155409184|NCT02429414|560930871|FG000|Overall Study|Physician Decision|0|||
155292273|NCT00486759|560499028|FG001|Treatment|Administrative/reason not specified|21|||
155292274|NCT00486759|560499027|FG000|Treatment|Refused treatment|10|||
155292275|NCT00486759|560499028|FG001|Treatment|Refused treatment|7|||
155292276|NCT00486759|560499027|FG000|Treatment|Violation of selection criteria at entry|3|||
155292277|NCT00486759|560499028|FG001|Treatment|Violation of selection criteria at entry|3|||
155409185|NCT02429414|560930872|FG001|Overall Study|Physician Decision|1|||
155743979|NCT01328444|562161605|FG003|Washout Period (14 Days)|Adverse Event|1|||
155743980|NCT01328444|562161606|FG004|Washout Period (14 Days)|Adverse Event|1|||
155292278|NCT00486759|560499027|FG000|Treatment|Other protocol violation|1|||
155292279|NCT00486759|560499028|FG001|Treatment|Other protocol violation|5|||
155292280|NCT00486759|560499027|FG000|Treatment|Failure to return|1|||
155292281|NCT00486759|560499028|FG001|Treatment|Failure to return|1|||
155292282|NCT00486759|560499027|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
155292283|NCT00486759|560499028|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
155292284|NCT00486759|560499027|FG000|Safety Follow-up|Death|40|||
155292285|NCT00486759|560499028|FG001|Safety Follow-up|Death|29|||
155292286|NCT00486759|560499027|FG000|Safety Follow-up|Withdrew consent|32|||
155292287|NCT00486759|560499028|FG001|Safety Follow-up|Withdrew consent|23|||
155409186|NCT01098071|560930885|FG000|Overall Study|Surgery (adenoidectomy)|2|||
155743981|NCT01328444|562161607|FG005|Washout Period (14 Days)|Adverse Event|2|||
155743982|NCT01328444|562161602|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
155743983|NCT01328444|562161603|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
155743984|NCT01328444|562161604|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
155743985|NCT01328444|562161605|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
155743986|NCT01328444|562161606|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
155743987|NCT01328444|562161607|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
155743988|NCT01328444|562161602|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
155743989|NCT01328444|562161603|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
155409187|NCT01098071|560930885|FG000|Overall Study|Lost to Follow-up|13|||
155409188|NCT01604265|560930886|FG000|Overall Study|Adverse Event|1|||
155409189|NCT01604265|560930887|FG001|Overall Study|Adverse Event|0|||
155409190|NCT01604265|560930886|FG000|Overall Study|Withdrawal by Subject|1|||
155409191|NCT01604265|560930887|FG001|Overall Study|Withdrawal by Subject|0|||
155409192|NCT01903837|560930888|FG000|Part A|Withdrawal by Subject|4|||
155409193|NCT01903837|560930889|FG001|Part A|Withdrawal by Subject|9|||
155409194|NCT01903837|560930890|FG002|Part A|Withdrawal by Subject|8|||
155409195|NCT01903837|560930891|FG003|Part A|Withdrawal by Subject|5|||
155409196|NCT01903837|560930888|FG000|Part A|Adverse Event|3|||
155409197|NCT01903837|560930889|FG001|Part A|Adverse Event|6|||
155409198|NCT01903837|560930890|FG002|Part A|Adverse Event|9|||
155409199|NCT01903837|560930891|FG003|Part A|Adverse Event|6|||
155409200|NCT01903837|560930888|FG000|Part A|Lost to Follow-up|9|||
155409201|NCT01903837|560930889|FG001|Part A|Lost to Follow-up|7|||
155409202|NCT01903837|560930890|FG002|Part A|Lost to Follow-up|7|||
155409203|NCT01903837|560930891|FG003|Part A|Lost to Follow-up|2|||
155409204|NCT01903837|560930888|FG000|Part A|Non-compliance with study drug|1|||
155409205|NCT01903837|560930889|FG001|Part A|Non-compliance with study drug|4|||
155409206|NCT01903837|560930890|FG002|Part A|Non-compliance with study drug|4|||
155409207|NCT01903837|560930891|FG003|Part A|Non-compliance with study drug|0|||
155409208|NCT01903837|560930888|FG000|Part A|Physician Decision|1|||
155409209|NCT01903837|560930889|FG001|Part A|Physician Decision|1|||
155409210|NCT01903837|560930890|FG002|Part A|Physician Decision|0|||
155409211|NCT01903837|560930891|FG003|Part A|Physician Decision|0|||
155409212|NCT01903837|560930888|FG000|Part A|Protocol Violation|1|||
155409213|NCT01903837|560930889|FG001|Part A|Protocol Violation|1|||
155409214|NCT01903837|560930890|FG002|Part A|Protocol Violation|0|||
155409215|NCT01903837|560930891|FG003|Part A|Protocol Violation|0|||
155409216|NCT01903837|560930888|FG000|Part B|Lost to Follow-up|0|||
155409217|NCT01903837|560930889|FG001|Part B|Lost to Follow-up|3|||
155409218|NCT01903837|560930890|FG002|Part B|Lost to Follow-up|3|||
155409219|NCT01903837|560930891|FG003|Part B|Lost to Follow-up|4|||
155409220|NCT01903837|560930888|FG000|Part B|Withdrawal by Subject|1|||
155409221|NCT01903837|560930889|FG001|Part B|Withdrawal by Subject|2|||
155409222|NCT01903837|560930890|FG002|Part B|Withdrawal by Subject|0|||
155409223|NCT01903837|560930891|FG003|Part B|Withdrawal by Subject|3|||
155409224|NCT01903837|560930888|FG000|Part B|Adverse Event|3|||
155409225|NCT01903837|560930889|FG001|Part B|Adverse Event|0|||
155743990|NCT01328444|562161604|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
155743991|NCT01328444|562161605|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
155743992|NCT01328444|562161606|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
155743993|NCT01328444|562161607|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
155409226|NCT01903837|560930890|FG002|Part B|Adverse Event|2|||
155409227|NCT01903837|560930891|FG003|Part B|Adverse Event|0|||
155409228|NCT01903837|560930888|FG000|Part B|Non-compliance with study drug|2|||
155409229|NCT01903837|560930889|FG001|Part B|Non-compliance with study drug|0|||
155409230|NCT01903837|560930890|FG002|Part B|Non-compliance with study drug|0|||
155292288|NCT00486759|560499027|FG000|Safety Follow-up|Failure to return|9|||
155292289|NCT00486759|560499028|FG001|Safety Follow-up|Failure to return|6|||
155292290|NCT00486759|560499027|FG000|Safety Follow-up|Administrative/not specified|8|||
155409231|NCT01903837|560930891|FG003|Part B|Non-compliance with study drug|1|||
155409232|NCT01903837|560930888|FG000|Part B|Incarceration|2|||
155409233|NCT01903837|560930889|FG001|Part B|Incarceration|0|||
155409234|NCT01903837|560930890|FG002|Part B|Incarceration|0|||
155409235|NCT01903837|560930891|FG003|Part B|Incarceration|1|||
155409236|NCT01903837|560930888|FG000|Part B|Physician Decision|1|||
155743994|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
155743995|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155743996|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155292291|NCT00486759|560499028|FG001|Safety Follow-up|Administrative/not specified|6|||
155292292|NCT00486759|560499027|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
155292293|NCT00486759|560499028|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
155292294|NCT00486759|560499027|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
155292295|NCT00486759|560499028|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
155292296|NCT01185522|560499029|FG000|Overall Study|Lack of Efficacy|28|||
155292297|NCT01185522|560499029|FG000|Overall Study|Lost to Follow-up|19|||
155292298|NCT01185522|560499029|FG000|Overall Study|Withdrawal by Subject|10|||
155292299|NCT01185522|560499029|FG000|Overall Study|Poor tolerance|39|||
155292300|NCT01185522|560499029|FG000|Overall Study|Other reasons|12|||
155292301|NCT02987543|560499030|FG000|Overall Study|Ongoing study at data cut off|49|||
155292302|NCT02987543|560499031|FG001|Overall Study|Ongoing study at data cut off|21|||
155292303|NCT02987543|560499032|FG002|Overall Study|Ongoing study at data cut off|19|||
155292304|NCT02987543|560499033|FG003|Overall Study|Ongoing study at data cut off|12|||
155292305|NCT02987543|560499030|FG000|Overall Study|Death|88|||
155292306|NCT02987543|560499031|FG001|Overall Study|Death|54|||
155292307|NCT02987543|560499032|FG002|Overall Study|Death|67|||
155292308|NCT02987543|560499033|FG003|Overall Study|Death|28|||
155292309|NCT02987543|560499030|FG000|Overall Study|Lost to Follow-up|3|||
155292310|NCT02987543|560499031|FG001|Overall Study|Lost to Follow-up|0|||
155292311|NCT02987543|560499032|FG002|Overall Study|Lost to Follow-up|1|||
155292312|NCT02987543|560499033|FG003|Overall Study|Lost to Follow-up|0|||
155292313|NCT02987543|560499030|FG000|Overall Study|Screen failure|0|||
155292314|NCT02987543|560499031|FG001|Overall Study|Screen failure|0|||
155292315|NCT02987543|560499032|FG002|Overall Study|Screen failure|0|||
155292316|NCT02987543|560499033|FG003|Overall Study|Screen failure|1|||
155292317|NCT02987543|560499030|FG000|Overall Study|Withdrawal by Subject|21|||
155292318|NCT02987543|560499031|FG001|Overall Study|Withdrawal by Subject|7|||
155292319|NCT02987543|560499032|FG002|Overall Study|Withdrawal by Subject|7|||
155292320|NCT02987543|560499033|FG003|Overall Study|Withdrawal by Subject|6|||
155292321|NCT02987543|560499030|FG000|Overall Study|Study terminated by sponsor|1|||
155292322|NCT02987543|560499031|FG001|Overall Study|Study terminated by sponsor|0|||
155292323|NCT02987543|560499032|FG002|Overall Study|Study terminated by sponsor|0|||
155292324|NCT02987543|560499033|FG003|Overall Study|Study terminated by sponsor|0|||
155292325|NCT02987543|560499030|FG000|Overall Study|Investigator decision|0|||
155292326|NCT02987543|560499031|FG001|Overall Study|Investigator decision|1|||
155292327|NCT02987543|560499032|FG002|Overall Study|Investigator decision|0|||
155292328|NCT02987543|560499033|FG003|Overall Study|Investigator decision|0|||
155292329|NCT02987543|560499030|FG000|Overall Study|Disease progression|0|||
155292330|NCT02987543|560499031|FG001|Overall Study|Disease progression|0|||
155292331|NCT02987543|560499032|FG002|Overall Study|Disease progression|0|||
155292332|NCT02987543|560499033|FG003|Overall Study|Disease progression|1|||
155292333|NCT03646669|560499036|FG000|Overall Study|Withdrawal by Subject|5|||
155292334|NCT03646669|560499037|FG001|Overall Study|Withdrawal by Subject|0|||
155292335|NCT00377455|560499038|FG000|Overall Study|Withdrawal by Subject|1|||
155292336|NCT00309452|560499039|FG000|Overall Study|Withdrawal by Subject|3|||
155292337|NCT00309452|560499040|FG001|Overall Study|Withdrawal by Subject|0|||
155292338|NCT02962674|560499041|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
155292339|NCT05193318|560499044|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
155292340|NCT05193318|560499044|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
155292341|NCT02046616|560499045|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
155292342|NCT02046616|560499045|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
155292343|NCT02046616|560499045|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
155292344|NCT02046616|560499045|FG000|24-Week Treatment Period|Physician Decision|3|||
155292345|NCT02046616|560499045|FG000|24-Week Treatment Period|Other|1|||
155292346|NCT02046616|560499045|FG000|8-Week FU Period|Lost to Follow-up|1|||
155292347|NCT00344019|560499049|FG000|Overall Study|did not meet final inclusion criteria|0|||
155292348|NCT00344019|560499050|FG001|Overall Study|did not meet final inclusion criteria|0|||
155292349|NCT00344019|560499051|FG002|Overall Study|did not meet final inclusion criteria|74|||
155292350|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Death|1|||
155292351|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Death|1|||
155292352|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Death|0|||
155292353|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Death|0|||
155292354|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Death|0|||
155292355|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
155292356|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
155292357|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
155292358|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
155292359|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
155292360|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Physician Decision|0|||
155292361|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Physician Decision|0|||
155292362|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Physician Decision|0|||
155409237|NCT01903837|560930889|FG001|Part B|Physician Decision|0|||
155409238|NCT01903837|560930890|FG002|Part B|Physician Decision|0|||
155292363|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Physician Decision|0|||
155292364|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Physician Decision|1|||
155292365|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
155292366|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
155292367|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
155292368|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
155292369|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
155292370|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292371|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292372|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
155292373|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
155292374|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292375|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
155292376|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
155292377|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
155292378|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
155292379|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
155292380|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Death|1|||
155292381|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Death|0|||
155292382|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Death|0|||
155292383|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Death|0|||
155292384|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Death|0|||
155292385|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
155292386|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
155292387|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
155292388|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
155292389|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
155292390|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Physician Decision|1|||
155292391|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Physician Decision|0|||
155292392|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Physician Decision|1|||
155292393|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Physician Decision|3|||
155292394|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Physician Decision|0|||
155292395|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
155292396|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
155743997|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155292397|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
155292398|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
155292399|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
155292400|NCT00906035|560499057|FG000|Overall Study|Withdrawal by Subject|2|||
155292401|NCT00906035|560499058|FG001|Overall Study|Withdrawal by Subject|3|||
155292402|NCT00906035|560499059|FG002|Overall Study|Withdrawal by Subject|0|||
155292403|NCT00139737|560499060|FG000|Overall Study|Withdrawal by Subject|190|||
155292404|NCT00139737|560499060|FG000|Overall Study|Adverse Event|58|||
155292405|NCT00139737|560499060|FG000|Overall Study|Lack of Efficacy|40|||
155292406|NCT00139737|560499060|FG000|Overall Study|Lost to Follow-up|8|||
155292407|NCT00139737|560499060|FG000|Overall Study|Death|3|||
155292408|NCT00139737|560499060|FG000|Overall Study|Laboratory Abnormality|2|||
155292409|NCT00139737|560499060|FG000|Overall Study|Protocol Violation|18|||
155292410|NCT00139737|560499060|FG000|Overall Study|Withdrew During Screening Phase|8|||
155292411|NCT00139737|560499060|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155292412|NCT00139737|560499060|FG000|Overall Study|Screened, Not Treated|13|||
155292413|NCT00217672|560499067|FG000|Allocation|Ineligible|2|||
155292414|NCT00217672|560499068|FG001|Allocation|Ineligible|0|||
155292415|NCT00217672|560499067|FG000|Treatment|disease progression|33|||
155292416|NCT00217672|560499068|FG001|Treatment|disease progression|4|||
155292417|NCT00217672|560499067|FG000|Treatment|Adverse Event|18|||
155292418|NCT00217672|560499068|FG001|Treatment|Adverse Event|2|||
155292419|NCT00217672|560499067|FG000|Treatment|reqd treatment not permitted by protocol|6|||
155292420|NCT00217672|560499068|FG001|Treatment|reqd treatment not permitted by protocol|0|||
155292421|NCT00217672|560499067|FG000|Treatment|Physician Decision|6|||
155292422|NCT00217672|560499068|FG001|Treatment|Physician Decision|0|||
155409239|NCT01903837|560930891|FG003|Part B|Physician Decision|2|||
155292423|NCT00217672|560499067|FG000|Treatment|insurance issues|1|||
155409240|NCT01903837|560930888|FG000|Part B|Lack of Efficacy|0|||
155409241|NCT01903837|560930889|FG001|Part B|Lack of Efficacy|1|||
155409242|NCT01903837|560930890|FG002|Part B|Lack of Efficacy|0|||
155409243|NCT01903837|560930891|FG003|Part B|Lack of Efficacy|0|||
155292424|NCT00217672|560499068|FG001|Treatment|insurance issues|1|||
155292425|NCT00217672|560499067|FG000|Treatment|Death|2|||
155292426|NCT00217672|560499068|FG001|Treatment|Death|0|||
155292427|NCT00217672|560499067|FG000|Treatment|secondary malignancy|1|||
155292428|NCT00217672|560499068|FG001|Treatment|secondary malignancy|0|||
155292429|NCT00217672|560499067|FG000|Follow-up|Withdrawal by Subject|4|||
155409244|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
155409245|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
155409246|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
155409247|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
155409248|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
155409249|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
155409250|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
155409251|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
155409252|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
155409253|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
155409254|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
155409255|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
155409256|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
155409257|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
155409258|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
155409259|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
155409260|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
155409261|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
155409262|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
155409263|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
155409264|NCT02706873|560930892|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
155409265|NCT02706873|560930893|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
155409266|NCT02706873|560930894|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
155409267|NCT02706873|560930895|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
155292430|NCT00217672|560499068|FG001|Follow-up|Withdrawal by Subject|0|||
155292431|NCT00217672|560499067|FG000|Follow-up|Lost to Follow-up|1|||
155292432|NCT00217672|560499068|FG001|Follow-up|Lost to Follow-up|0|||
155292433|NCT01591616|560499069|FG000|Overall Study|Withdrawal by Subject|1|||
155292434|NCT03525119|560499070|FG000|Overall Study|Adverse Event|0|||
155292435|NCT03525119|560499071|FG001|Overall Study|Adverse Event|1|||
155292436|NCT03525119|560499072|FG002|Overall Study|Adverse Event|0|||
155292437|NCT03525119|560499070|FG000|Overall Study|Lost to Follow-up|32|||
155292438|NCT03525119|560499071|FG001|Overall Study|Lost to Follow-up|33|||
155292439|NCT03525119|560499072|FG002|Overall Study|Lost to Follow-up|37|||
155292440|NCT03525119|560499070|FG000|Overall Study|Withdrawal by Subject|5|||
155292441|NCT03525119|560499071|FG001|Overall Study|Withdrawal by Subject|4|||
155292442|NCT03525119|560499072|FG002|Overall Study|Withdrawal by Subject|2|||
155292443|NCT03525119|560499070|FG000|Overall Study|Reason not Specified|2|||
155292444|NCT03525119|560499071|FG001|Overall Study|Reason not Specified|1|||
155292445|NCT03525119|560499072|FG002|Overall Study|Reason not Specified|2|||
155292446|NCT03525119|560499070|FG000|Overall Study|Randomized but not Vaccinated|1|||
155292447|NCT03525119|560499071|FG001|Overall Study|Randomized but not Vaccinated|0|||
155292448|NCT03525119|560499072|FG002|Overall Study|Randomized but not Vaccinated|2|||
155292449|NCT03781336|560499073|FG000|Overall Study|Withdrawal by Subject|2|||
155292450|NCT03781336|560499074|FG001|Overall Study|Withdrawal by Subject|2|||
155292451|NCT00158054|560499079|FG000|Overall Study|Refused to continue|3|||
155292452|NCT00158054|560499080|FG001|Overall Study|Refused to continue|0|||
155292453|NCT00158054|560499079|FG000|Overall Study|Unavailable for follow up|7|||
155292454|NCT00158054|560499080|FG001|Overall Study|Unavailable for follow up|3|||
155292455|NCT00414648|560499081|FG000|Overall Study|Adverse Event|5|||
155292456|NCT00414648|560499082|FG001|Overall Study|Adverse Event|5|||
155292457|NCT00414648|560499081|FG000|Overall Study|Death|0|||
155292458|NCT00414648|560499082|FG001|Overall Study|Death|1|||
155292459|NCT00414648|560499081|FG000|Overall Study|Lack of Efficacy|0|||
155292460|NCT00414648|560499082|FG001|Overall Study|Lack of Efficacy|2|||
155292461|NCT00414648|560499081|FG000|Overall Study|Withdrawal by Subject|0|||
155292462|NCT00414648|560499082|FG001|Overall Study|Withdrawal by Subject|1|||
155292463|NCT00988637|560499083|FG000|Overall Study|Lost to Follow-up|2|||
155292464|NCT00988637|560499084|FG001|Overall Study|Lost to Follow-up|1|||
155292465|NCT00988637|560499083|FG000|Overall Study|Withdrawal by Subject|1|||
155292466|NCT00988637|560499084|FG001|Overall Study|Withdrawal by Subject|1|||
155292467|NCT00988637|560499083|FG000|Overall Study|non-compliance with study drug|0|||
155292468|NCT00988637|560499084|FG001|Overall Study|non-compliance with study drug|1|||
155292469|NCT03098030|560499087|FG000|Overall Study|Death|10|||
155292470|NCT03098030|560499088|FG001|Overall Study|Death|156|||
155292471|NCT03098030|560499089|FG002|Overall Study|Death|156|||
155292472|NCT03098030|560499090|FG003|Overall Study|Death|82|||
155292473|NCT03098030|560499087|FG000|Overall Study|Withdrawal by Subject|0|||
155292474|NCT03098030|560499088|FG001|Overall Study|Withdrawal by Subject|7|||
155292475|NCT03098030|560499089|FG002|Overall Study|Withdrawal by Subject|8|||
155292476|NCT03098030|560499090|FG003|Overall Study|Withdrawal by Subject|2|||
155292477|NCT03098030|560499087|FG000|Overall Study|Lost to Follow-up|0|||
155292478|NCT03098030|560499088|FG001|Overall Study|Lost to Follow-up|0|||
155292479|NCT03098030|560499089|FG002|Overall Study|Lost to Follow-up|2|||
155292480|NCT03098030|560499090|FG003|Overall Study|Lost to Follow-up|1|||
155292481|NCT05484726|560499091|FG000|Overall Study|Protocol Violation|3|||
155409268|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
155409269|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
155409270|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
155292482|NCT05484726|560499092|FG001|Overall Study|Protocol Violation|3|||
155409271|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
155409272|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
155409273|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
155409274|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
155409275|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
155409276|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
155409277|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
155409278|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
155409279|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
155409280|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
155409281|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
155409282|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
155409283|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
155409284|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
155409285|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
155409286|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
155409287|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
155409288|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
155409289|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
155409290|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
155409291|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
155409292|NCT02706873|560930892|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
155409293|NCT02706873|560930893|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
155409294|NCT02706873|560930894|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
155409295|NCT02706873|560930895|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
155409296|NCT00705939|560930898|FG000|Overall Study|Protocol Violation|0|||
155409297|NCT00705939|560930899|FG001|Overall Study|Protocol Violation|0|||
155409298|NCT00705939|560930900|FG002|Overall Study|Protocol Violation|1|||
155409299|NCT00705939|560930898|FG000|Overall Study|Withdrawal by Subject|0|||
155409300|NCT00705939|560930899|FG001|Overall Study|Withdrawal by Subject|1|||
155409301|NCT00705939|560930900|FG002|Overall Study|Withdrawal by Subject|3|||
155409302|NCT00705939|560930898|FG000|Overall Study|Physician Decision|0|||
155409303|NCT00705939|560930899|FG001|Overall Study|Physician Decision|1|||
155409304|NCT00705939|560930900|FG002|Overall Study|Physician Decision|0|||
155409305|NCT00464334|560930906|FG000|Overall Study|Adverse Event|0|||
155409306|NCT00464334|560930907|FG001|Overall Study|Adverse Event|0|||
155409307|NCT00464334|560930908|FG002|Overall Study|Adverse Event|0|||
155409308|NCT00464334|560930909|FG003|Overall Study|Adverse Event|1|||
155409309|NCT00464334|560930910|FG004|Overall Study|Adverse Event|1|||
155409310|NCT00464334|560930911|FG005|Overall Study|Adverse Event|1|||
155409311|NCT00464334|560930912|FG006|Overall Study|Adverse Event|0|||
155409312|NCT00464334|560930913|FG007|Overall Study|Adverse Event|0|||
155409313|NCT00464334|560930914|FG008|Overall Study|Adverse Event|2|||
155409314|NCT00464334|560930915|FG009|Overall Study|Adverse Event|1|||
155409315|NCT00464334|560930916|FG010|Overall Study|Adverse Event|2|||
155409316|NCT00464334|560930906|FG000|Overall Study|Lack of Efficacy|0|||
155409317|NCT00464334|560930907|FG001|Overall Study|Lack of Efficacy|1|||
155409318|NCT00464334|560930908|FG002|Overall Study|Lack of Efficacy|0|||
155409319|NCT00464334|560930909|FG003|Overall Study|Lack of Efficacy|0|||
155409320|NCT00464334|560930910|FG004|Overall Study|Lack of Efficacy|0|||
155409321|NCT00464334|560930911|FG005|Overall Study|Lack of Efficacy|0|||
155409322|NCT00464334|560930912|FG006|Overall Study|Lack of Efficacy|0|||
155409323|NCT00464334|560930913|FG007|Overall Study|Lack of Efficacy|0|||
155409324|NCT00464334|560930914|FG008|Overall Study|Lack of Efficacy|0|||
155409325|NCT00464334|560930915|FG009|Overall Study|Lack of Efficacy|0|||
155409326|NCT00464334|560930916|FG010|Overall Study|Lack of Efficacy|0|||
155409327|NCT00464334|560930906|FG000|Overall Study|Lost to Follow-up|0|||
155409328|NCT00464334|560930907|FG001|Overall Study|Lost to Follow-up|0|||
155409329|NCT00464334|560930908|FG002|Overall Study|Lost to Follow-up|1|||
155409330|NCT00464334|560930909|FG003|Overall Study|Lost to Follow-up|0|||
155409331|NCT00464334|560930910|FG004|Overall Study|Lost to Follow-up|1|||
155292483|NCT05484726|560499091|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
155409332|NCT00464334|560930911|FG005|Overall Study|Lost to Follow-up|0|||
155409333|NCT00464334|560930912|FG006|Overall Study|Lost to Follow-up|1|||
155409334|NCT00464334|560930913|FG007|Overall Study|Lost to Follow-up|0|||
155292484|NCT05484726|560499092|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
155409335|NCT00464334|560930914|FG008|Overall Study|Lost to Follow-up|0|||
155409336|NCT00464334|560930915|FG009|Overall Study|Lost to Follow-up|0|||
155292485|NCT05484726|560499091|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
155292486|NCT05484726|560499092|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
155409337|NCT00464334|560930916|FG010|Overall Study|Lost to Follow-up|2|||
155409338|NCT00464334|560930906|FG000|Overall Study|Progressive Disease|0|||
155409339|NCT00464334|560930907|FG001|Overall Study|Progressive Disease|0|||
155409340|NCT00464334|560930908|FG002|Overall Study|Progressive Disease|0|||
155292487|NCT05484726|560499091|FG000|Overall Study|continued need of mechanical ventilation|2|||
155292488|NCT05484726|560499092|FG001|Overall Study|continued need of mechanical ventilation|3|||
155292489|NCT05484726|560499091|FG000|Overall Study|Withdrawal by Subject|2|||
155292490|NCT05484726|560499092|FG001|Overall Study|Withdrawal by Subject|3|||
155292491|NCT05484726|560499091|FG000|Overall Study|IVH (G III & IV)|2|||
155292492|NCT05484726|560499092|FG001|Overall Study|IVH (G III & IV)|1|||
155292493|NCT05484726|560499091|FG000|Overall Study|NEC (stage II & III)|2|||
155292494|NCT05484726|560499092|FG001|Overall Study|NEC (stage II & III)|3|||
155292495|NCT04391309|560499093|FG000|Overall Study|Death|1|||
155292496|NCT04391309|560499094|FG001|Overall Study|Death|1|||
155292497|NCT04391309|560499093|FG000|Overall Study|Lost to Follow-up|3|||
155292498|NCT04391309|560499094|FG001|Overall Study|Lost to Follow-up|2|||
155292499|NCT04391309|560499093|FG000|Overall Study|Withdrawal by Subject|2|||
155292500|NCT04391309|560499094|FG001|Overall Study|Withdrawal by Subject|2|||
155292501|NCT00768651|560499097|FG000|Overall Study|Withdrawal by Subject|1|||
155292502|NCT00462943|560499098|FG000|Overall Study|Failure to achieve a response|5|||
155292503|NCT00462943|560499099|FG001|Overall Study|Failure to achieve a response|5|||
155292504|NCT00462943|560499100|FG002|Overall Study|Failure to achieve a response|1|||
155292505|NCT00462943|560499098|FG000|Overall Study|Adverse Event|6|||
155292506|NCT00462943|560499099|FG001|Overall Study|Adverse Event|4|||
155292507|NCT00462943|560499100|FG002|Overall Study|Adverse Event|1|||
155292508|NCT00462943|560499098|FG000|Overall Study|Protocol Violation|1|||
155292509|NCT00462943|560499099|FG001|Overall Study|Protocol Violation|0|||
155292510|NCT00462943|560499100|FG002|Overall Study|Protocol Violation|0|||
155292511|NCT00462943|560499098|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
155292512|NCT00462943|560499099|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
155292513|NCT00462943|560499100|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
155292514|NCT00462943|560499098|FG000|Overall Study|Disease Progression|15|||
155292515|NCT00462943|560499099|FG001|Overall Study|Disease Progression|15|||
155292516|NCT00462943|560499100|FG002|Overall Study|Disease Progression|9|||
155292517|NCT00462943|560499098|FG000|Overall Study|Death|5|||
155292518|NCT00462943|560499099|FG001|Overall Study|Death|2|||
155292519|NCT00462943|560499100|FG002|Overall Study|Death|7|||
155409341|NCT00464334|560930909|FG003|Overall Study|Progressive Disease|0|||
155409342|NCT00464334|560930910|FG004|Overall Study|Progressive Disease|0|||
155409343|NCT00464334|560930911|FG005|Overall Study|Progressive Disease|1|||
155409344|NCT00464334|560930912|FG006|Overall Study|Progressive Disease|0|||
155409345|NCT00464334|560930913|FG007|Overall Study|Progressive Disease|0|||
155409346|NCT00464334|560930914|FG008|Overall Study|Progressive Disease|1|||
155409347|NCT00464334|560930915|FG009|Overall Study|Progressive Disease|0|||
155409348|NCT00464334|560930916|FG010|Overall Study|Progressive Disease|0|||
155409349|NCT00464334|560930906|FG000|Overall Study|Study Terminated by Sponsor|0|||
155409350|NCT00464334|560930907|FG001|Overall Study|Study Terminated by Sponsor|0|||
155409351|NCT00464334|560930908|FG002|Overall Study|Study Terminated by Sponsor|0|||
155409352|NCT00464334|560930909|FG003|Overall Study|Study Terminated by Sponsor|1|||
155409353|NCT00464334|560930910|FG004|Overall Study|Study Terminated by Sponsor|0|||
155409354|NCT00464334|560930911|FG005|Overall Study|Study Terminated by Sponsor|0|||
155409355|NCT00464334|560930912|FG006|Overall Study|Study Terminated by Sponsor|0|||
155409356|NCT00464334|560930913|FG007|Overall Study|Study Terminated by Sponsor|0|||
155409357|NCT00464334|560930914|FG008|Overall Study|Study Terminated by Sponsor|0|||
155409358|NCT00464334|560930915|FG009|Overall Study|Study Terminated by Sponsor|0|||
155409359|NCT00464334|560930916|FG010|Overall Study|Study Terminated by Sponsor|0|||
155409360|NCT00464334|560930906|FG000|Overall Study|Withdrawal by Subject|1|||
155409361|NCT00464334|560930907|FG001|Overall Study|Withdrawal by Subject|7|||
155409362|NCT00464334|560930908|FG002|Overall Study|Withdrawal by Subject|4|||
155409363|NCT00464334|560930909|FG003|Overall Study|Withdrawal by Subject|2|||
155409364|NCT00464334|560930910|FG004|Overall Study|Withdrawal by Subject|2|||
155409365|NCT00464334|560930911|FG005|Overall Study|Withdrawal by Subject|2|||
155409366|NCT00464334|560930912|FG006|Overall Study|Withdrawal by Subject|2|||
155409367|NCT00464334|560930913|FG007|Overall Study|Withdrawal by Subject|1|||
155409368|NCT00464334|560930914|FG008|Overall Study|Withdrawal by Subject|3|||
155409369|NCT00464334|560930915|FG009|Overall Study|Withdrawal by Subject|0|||
155409370|NCT00464334|560930916|FG010|Overall Study|Withdrawal by Subject|0|||
155409371|NCT03948178|560930917|FG000|Overall Study|Protocol Violation|1|||
155292520|NCT00462943|560499098|FG000|Overall Study|Stem Cell Transplant|1|||
155409372|NCT03948178|560930917|FG000|Overall Study|Lost to Follow-up|2|||
155409373|NCT03948178|560930917|FG000|Overall Study|Withdrawal by Subject|2|||
155409374|NCT03948178|560930917|FG000|Overall Study|Reason not known|2|||
155409375|NCT03948178|560930917|FG000|Overall Study|Personal reason|14|||
155292521|NCT00462943|560499099|FG001|Overall Study|Stem Cell Transplant|1|||
155292522|NCT00462943|560499100|FG002|Overall Study|Stem Cell Transplant|0|||
155292523|NCT00462943|560499098|FG000|Overall Study|Bone Marrow Transplant|1|||
155409376|NCT03948178|560930917|FG000|Overall Study|Disease progression|30|||
155409377|NCT03948178|560930917|FG000|Overall Study|Adverse Event|12|||
155409378|NCT03948178|560930917|FG000|Overall Study|Sponsor terminated study|164|||
155292524|NCT00462943|560499099|FG001|Overall Study|Bone Marrow Transplant|0|||
155292525|NCT00462943|560499100|FG002|Overall Study|Bone Marrow Transplant|0|||
155638411|NCT03765073|561767657|FG004|Stage 1|Lost to Follow-up|0|||
155638412|NCT03765073|561767658|FG005|Stage 1|Lost to Follow-up|0|||
155638413|NCT03765073|561767659|FG006|Stage 1|Lost to Follow-up|0|||
155638414|NCT03765073|561767660|FG007|Stage 1|Lost to Follow-up|0|||
155638415|NCT03765073|561767661|FG008|Stage 1|Lost to Follow-up|0|||
155638416|NCT03765073|561767662|FG009|Stage 1|Lost to Follow-up|0|||
155638417|NCT03765073|561767663|FG010|Stage 1|Lost to Follow-up|0|||
155638418|NCT03765073|561767664|FG011|Stage 1|Lost to Follow-up|0|||
155638419|NCT03765073|561767665|FG012|Stage 1|Lost to Follow-up|0|||
155638420|NCT03765073|561767666|FG013|Stage 1|Lost to Follow-up|0|||
155638421|NCT03765073|561767667|FG014|Stage 1|Lost to Follow-up|0|||
155638422|NCT03765073|561767668|FG015|Stage 1|Lost to Follow-up|0|||
155638423|NCT03765073|561767669|FG016|Stage 1|Lost to Follow-up|0|||
155743998|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155743999|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155744000|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
155744001|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155744002|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155744003|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155744004|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
155744005|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
155744006|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
155744007|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155744008|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155744009|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155744010|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
155744011|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155744012|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155744013|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155744014|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155744015|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155744016|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155744017|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155744018|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155744019|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155744020|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155744021|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155744022|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155744023|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
155744024|NCT01328444|562161602|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155744025|NCT01328444|562161603|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155744026|NCT01328444|562161604|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155744027|NCT01328444|562161605|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155744028|NCT01328444|562161606|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155744029|NCT01328444|562161607|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155744030|NCT03241368|562161612|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
155744031|NCT03241368|562161612|FG000|Overall Study|Lost to Follow-up|1|||
155744032|NCT03241368|562161612|FG000|Overall Study|Physician Decision|6|||
155744033|NCT03241368|562161612|FG000|Overall Study|Withdrawal by Subject|6|||
155744034|NCT03241368|562161612|FG000|Overall Study|Protocol Violation|1|||
155744035|NCT04740905|562161613|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
155744036|NCT04740905|562161614|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
155744037|NCT04740905|562161613|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
155744038|NCT04740905|562161614|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
155744039|NCT04740905|562161613|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
155744040|NCT04740905|562161614|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
155744041|NCT04740905|562161613|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
155744042|NCT04740905|562161614|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
155744043|NCT04740905|562161613|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
155744044|NCT04740905|562161614|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
155744045|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
155744046|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
155638424|NCT03765073|561767670|FG017|Stage 1|Lost to Follow-up|0|||
155638425|NCT03765073|561767671|FG018|Stage 1|Lost to Follow-up|0|||
155638426|NCT03765073|561767672|FG019|Stage 1|Lost to Follow-up|0|||
155638427|NCT03765073|561767673|FG020|Stage 1|Lost to Follow-up|0|||
155638428|NCT03765073|561767653|FG000|Stage 1|Withdrawal by participant|0|||
155638429|NCT03765073|561767654|FG001|Stage 1|Withdrawal by participant|1|||
155638430|NCT03765073|561767655|FG002|Stage 1|Withdrawal by participant|0|||
155638431|NCT03765073|561767656|FG003|Stage 1|Withdrawal by participant|0|||
155744047|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
155744048|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
155744049|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
155292526|NCT00462943|560499098|FG000|Overall Study|Required Lymphocyte Infusion|1|||
155292527|NCT00462943|560499099|FG001|Overall Study|Required Lymphocyte Infusion|0|||
155292528|NCT00462943|560499100|FG002|Overall Study|Required Lymphocyte Infusion|0|||
155292529|NCT00462943|560499098|FG000|Overall Study|Transplant - not specified|1|||
155292530|NCT00462943|560499099|FG001|Overall Study|Transplant - not specified|0|||
155292531|NCT00462943|560499100|FG002|Overall Study|Transplant - not specified|1|||
155292532|NCT00462943|560499098|FG000|Overall Study|Physician Decision|1|||
155292533|NCT00462943|560499099|FG001|Overall Study|Physician Decision|0|||
155292534|NCT00462943|560499100|FG002|Overall Study|Physician Decision|0|||
155292535|NCT00462943|560499098|FG000|Overall Study|Withdrawal by Subject|0|||
155292536|NCT00462943|560499099|FG001|Overall Study|Withdrawal by Subject|1|||
155292537|NCT00462943|560499100|FG002|Overall Study|Withdrawal by Subject|0|||
155292538|NCT01697319|560499101|FG000|Primary Phase|Withdrawal by Subject|1|||
155292539|NCT01697319|560499101|FG000|Extension Phase|Terminated by Sponsor|15|||
155292540|NCT02698241|560499104|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
155292541|NCT02698241|560499104|FG000|Overall Study|Screening not met|7|||
155292542|NCT02698241|560499104|FG000|Overall Study|Withdrawal by Subject|7|||
155292543|NCT02698241|560499104|FG000|Overall Study|Physician Decision|2|||
155292544|NCT02698241|560499104|FG000|Overall Study|Subject underwent system modification|2|||
155292545|NCT02698241|560499104|FG000|Overall Study|Lost to Follow-up|3|||
155292546|NCT02698241|560499104|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
155292547|NCT02698241|560499104|FG000|Overall Study|geographic and licensing issue|1|||
155292548|NCT02698241|560499104|FG000|Overall Study|Death|2|||
155292549|NCT01543685|560499109|FG000|Overall Study|Lack of Efficacy|1|||
155292550|NCT01543685|560499110|FG001|Overall Study|Lack of Efficacy|2|||
155292551|NCT01543685|560499111|FG002|Overall Study|Lack of Efficacy|2|||
155292552|NCT01543685|560499112|FG003|Overall Study|Lack of Efficacy|0|||
155292553|NCT01543685|560499113|FG004|Overall Study|Lack of Efficacy|2|||
155292554|NCT01543685|560499109|FG000|Overall Study|Adverse Event|2|||
155292555|NCT01543685|560499110|FG001|Overall Study|Adverse Event|1|||
155292556|NCT01543685|560499111|FG002|Overall Study|Adverse Event|0|||
155292557|NCT01543685|560499112|FG003|Overall Study|Adverse Event|0|||
155292558|NCT01543685|560499113|FG004|Overall Study|Adverse Event|2|||
155292559|NCT00604721|560499114|FG000|Overall Study|Physician Decision|1|||
155292560|NCT00604721|560499114|FG000|Overall Study|Withdrawal by Subject|1|||
155292561|NCT04776213|560499115|FG000|Overall Study|Other|1|||
155292562|NCT04776213|560499115|FG000|Overall Study|Withdrawal by Subject|7|||
155292563|NCT04776213|560499115|FG000|Overall Study|Protocol Violation|1|||
155292564|NCT04776213|560499115|FG000|Overall Study|Lost to Follow-up|2|||
155292565|NCT01838551|560499119|FG000|Overall Study|Adverse Event|16|||
155292566|NCT01838551|560499119|FG000|Overall Study|Death|1|||
155292567|NCT01838551|560499119|FG000|Overall Study|Lack of Efficacy|10|||
155292568|NCT01838551|560499119|FG000|Overall Study|Physician Decision|4|||
155292569|NCT01838551|560499119|FG000|Overall Study|Withdrawal by Subject|10|||
155292570|NCT01838551|560499119|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
155292571|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155292572|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
155292573|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Progressive disease|6|||
155292574|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Toxicity|1|||
155292575|NCT02908464|560499121|FG000|Overall Study|Withdrawal by Subject|2|||
155292576|NCT02908464|560499122|FG001|Overall Study|Withdrawal by Subject|1|||
155292577|NCT02908464|560499121|FG000|Overall Study|Found ineligible after randomization|0|||
155292578|NCT02908464|560499122|FG001|Overall Study|Found ineligible after randomization|2|||
155292579|NCT02163915|560499127|FG000|Overall Study|Withdrawal by Subject|2|||
155292580|NCT02163915|560499128|FG001|Overall Study|Withdrawal by Subject|0|||
155292581|NCT02163915|560499129|FG002|Overall Study|Withdrawal by Subject|2|||
155292582|NCT02163915|560499130|FG003|Overall Study|Withdrawal by Subject|2|||
155292583|NCT02163915|560499131|FG004|Overall Study|Withdrawal by Subject|2|||
155292584|NCT02163915|560499127|FG000|Overall Study|Study termination|1|||
155292585|NCT02163915|560499128|FG001|Overall Study|Study termination|0|||
155292586|NCT02163915|560499129|FG002|Overall Study|Study termination|0|||
155292587|NCT02163915|560499130|FG003|Overall Study|Study termination|0|||
155292588|NCT02163915|560499131|FG004|Overall Study|Study termination|2|||
155292589|NCT02163915|560499127|FG000|Overall Study|Physician Decision|0|||
155292590|NCT02163915|560499128|FG001|Overall Study|Physician Decision|0|||
155638432|NCT03765073|561767657|FG004|Stage 1|Withdrawal by participant|0|||
155292591|NCT02163915|560499129|FG002|Overall Study|Physician Decision|0|||
155292592|NCT02163915|560499130|FG003|Overall Study|Physician Decision|1|||
155292593|NCT02163915|560499131|FG004|Overall Study|Physician Decision|0|||
155292594|NCT01751724|560499132|FG000|Overall Study|extubated bef.start assigned treatment|1|||
155292595|NCT01751724|560499133|FG001|Overall Study|extubated bef.start assigned treatment|0|||
155292596|NCT01751724|560499132|FG000|Overall Study|withdrawn by parent|0|||
155638433|NCT03765073|561767658|FG005|Stage 1|Withdrawal by participant|0|||
155292597|NCT01751724|560499133|FG001|Overall Study|withdrawn by parent|2|||
155292598|NCT02013037|560499134|FG000|Overall Study|Death|6|||
155292599|NCT02013037|560499134|FG000|Overall Study|Withdrawal by Subject|1|||
155292600|NCT02013037|560499134|FG000|Overall Study|Awaiting Transplantation|7|||
155292601|NCT02013037|560499134|FG000|Overall Study|Transplanted without DSA|2|||
155292602|NCT01278862|560499135|FG000|Overall Study|Lost to Follow-up|1|||
155292603|NCT01278862|560499136|FG001|Overall Study|Lost to Follow-up|1|||
155292604|NCT00589667|560500600|FG000|Overall Study|Adverse Event|2|||
155292605|NCT00589667|560500600|FG000|Overall Study|Withdrawal by Subject|1|||
155292606|NCT03538041|560500603|FG000|12-Week Treatment Period|Adverse Event|1|||
155292607|NCT03538041|560500604|FG001|12-Week Treatment Period|Adverse Event|1|||
155292608|NCT03538041|560500603|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
155409379|NCT02432235|560930920|FG000|Overall Study|Death|1|||
155409380|NCT02432235|560930921|FG001|Overall Study|Death|1|||
155409381|NCT02432235|560930922|FG002|Overall Study|Death|2|||
155409382|NCT02432235|560930923|FG003|Overall Study|Death|2|||
155409383|NCT02432235|560930924|FG004|Overall Study|Death|1|||
155409384|NCT02432235|560930925|FG005|Overall Study|Death|3|||
155409385|NCT02432235|560930926|FG006|Overall Study|Death|11|||
155409386|NCT02432235|560930927|FG007|Overall Study|Death|15|||
155409387|NCT02432235|560930928|FG008|Overall Study|Death|15|||
155409388|NCT02432235|560930929|FG009|Overall Study|Death|3|||
155409389|NCT02432235|560930930|FG010|Overall Study|Death|1|||
155409390|NCT02432235|560930931|FG011|Overall Study|Death|0|||
155409391|NCT02432235|560930920|FG000|Overall Study|Withdrawal by Subject|0|||
155409392|NCT02432235|560930921|FG001|Overall Study|Withdrawal by Subject|1|||
155409393|NCT02432235|560930922|FG002|Overall Study|Withdrawal by Subject|0|||
155409394|NCT02432235|560930923|FG003|Overall Study|Withdrawal by Subject|0|||
155409395|NCT02432235|560930924|FG004|Overall Study|Withdrawal by Subject|0|||
155409396|NCT02432235|560930925|FG005|Overall Study|Withdrawal by Subject|2|||
155409397|NCT02432235|560930926|FG006|Overall Study|Withdrawal by Subject|5|||
155409398|NCT02432235|560930927|FG007|Overall Study|Withdrawal by Subject|3|||
155409399|NCT02432235|560930928|FG008|Overall Study|Withdrawal by Subject|1|||
155409400|NCT02432235|560930929|FG009|Overall Study|Withdrawal by Subject|0|||
155409401|NCT02432235|560930930|FG010|Overall Study|Withdrawal by Subject|0|||
155409402|NCT02432235|560930931|FG011|Overall Study|Withdrawal by Subject|0|||
155409403|NCT02432235|560930920|FG000|Overall Study|Lost to Follow-up|0|||
155409404|NCT02432235|560930921|FG001|Overall Study|Lost to Follow-up|0|||
155409405|NCT02432235|560930922|FG002|Overall Study|Lost to Follow-up|0|||
155409406|NCT02432235|560930923|FG003|Overall Study|Lost to Follow-up|0|||
155409407|NCT02432235|560930924|FG004|Overall Study|Lost to Follow-up|0|||
155409408|NCT02432235|560930925|FG005|Overall Study|Lost to Follow-up|1|||
155409409|NCT02432235|560930926|FG006|Overall Study|Lost to Follow-up|0|||
155409410|NCT02432235|560930927|FG007|Overall Study|Lost to Follow-up|0|||
155409411|NCT02432235|560930928|FG008|Overall Study|Lost to Follow-up|1|||
155409412|NCT02432235|560930929|FG009|Overall Study|Lost to Follow-up|0|||
155409413|NCT02432235|560930930|FG010|Overall Study|Lost to Follow-up|0|||
155409414|NCT02432235|560930931|FG011|Overall Study|Lost to Follow-up|0|||
155409415|NCT02432235|560930920|FG000|Overall Study|Miscellaneous|0|||
155409416|NCT02432235|560930921|FG001|Overall Study|Miscellaneous|0|||
155409417|NCT02432235|560930922|FG002|Overall Study|Miscellaneous|0|||
155409418|NCT02432235|560930923|FG003|Overall Study|Miscellaneous|0|||
155409419|NCT02432235|560930924|FG004|Overall Study|Miscellaneous|1|||
155409420|NCT02432235|560930925|FG005|Overall Study|Miscellaneous|6|||
155409421|NCT02432235|560930926|FG006|Overall Study|Miscellaneous|2|||
155409422|NCT02432235|560930927|FG007|Overall Study|Miscellaneous|2|||
155409423|NCT02432235|560930928|FG008|Overall Study|Miscellaneous|4|||
155409424|NCT02432235|560930929|FG009|Overall Study|Miscellaneous|0|||
155409425|NCT02432235|560930930|FG010|Overall Study|Miscellaneous|0|||
155409426|NCT02432235|560930931|FG011|Overall Study|Miscellaneous|1|||
155409427|NCT01895322|560930932|FG000|Overall Study|Adverse Event|1|||
155409428|NCT01895322|560930932|FG000|Overall Study|Withdrawal by Subject|2|||
155409429|NCT01895322|560930932|FG000|Overall Study|Protocol Violation|10|||
155409430|NCT02728830|560930943|FG000|Overall Study|Exclusionary Surgery|9|||
155409431|NCT02728830|560930943|FG000|Overall Study|Exclusionary Pathology|6|||
155409432|NCT02728830|560930943|FG000|Overall Study|Physician Decision|3|||
155409433|NCT02728830|560930943|FG000|Overall Study|Withdrawal by Subject|2|||
155409434|NCT02728830|560930943|FG000|Overall Study|Lost to Follow-up|1|||
155409435|NCT02728830|560930943|FG000|Overall Study|Exclusionary Lab Values|1|||
155409436|NCT02728830|560930943|FG000|Overall Study|Contraindicated Illness|1|||
155409437|NCT02728830|560930943|FG000|Overall Study|Language Barrier|1|||
155409438|NCT01347554|560930944|FG000|Overall Study|Lack of Efficacy|7|||
155638434|NCT03765073|561767659|FG006|Stage 1|Withdrawal by participant|0|||
155638435|NCT03765073|561767660|FG007|Stage 1|Withdrawal by participant|0|||
155638436|NCT03765073|561767661|FG008|Stage 1|Withdrawal by participant|0|||
155638437|NCT03765073|561767662|FG009|Stage 1|Withdrawal by participant|0|||
155638438|NCT03765073|561767663|FG010|Stage 1|Withdrawal by participant|0|||
155638439|NCT03765073|561767664|FG011|Stage 1|Withdrawal by participant|0|||
155409439|NCT01347554|560930945|FG001|Overall Study|Lack of Efficacy|11|||
155409440|NCT03603496|560930946|FG000|Overall Study|Death|19|||
155409441|NCT03603496|560930947|FG001|Overall Study|Death|24|||
155409442|NCT03603496|560930946|FG000|Overall Study|Lost to Follow-up|141|||
155409443|NCT03603496|560930947|FG001|Overall Study|Lost to Follow-up|141|||
155409444|NCT03603496|560930946|FG000|Overall Study|Withdrawal by Subject|26|||
155409445|NCT03603496|560930947|FG001|Overall Study|Withdrawal by Subject|20|||
155409446|NCT00004259|560930949|FG000|Overall Study|Protocol Violation|1|||
155409447|NCT00004259|560930950|FG001|Overall Study|Protocol Violation|2|||
155409448|NCT00004259|560930951|FG002|Overall Study|Protocol Violation|0|||
155409449|NCT00004259|560930952|FG003|Overall Study|Protocol Violation|0|||
155409450|NCT00004259|560930949|FG000|Overall Study|Withdrawal by Subject|0|||
155409451|NCT00004259|560930950|FG001|Overall Study|Withdrawal by Subject|2|||
155409452|NCT00004259|560930951|FG002|Overall Study|Withdrawal by Subject|0|||
155409453|NCT00004259|560930952|FG003|Overall Study|Withdrawal by Subject|0|||
155409454|NCT03594227|560930953|FG000|Overall Study|Adverse Event|2|||
155409455|NCT03594227|560930954|FG001|Overall Study|Adverse Event|1|||
155409456|NCT03594227|560930955|FG002|Overall Study|Adverse Event|0|||
155409457|NCT03594227|560930956|FG003|Overall Study|Adverse Event|2|||
155409458|NCT03594227|560930953|FG000|Overall Study|Lost to Follow-up|1|||
155409459|NCT03594227|560930954|FG001|Overall Study|Lost to Follow-up|1|||
155409460|NCT03594227|560930955|FG002|Overall Study|Lost to Follow-up|1|||
155409461|NCT03594227|560930956|FG003|Overall Study|Lost to Follow-up|0|||
155409462|NCT03594227|560930953|FG000|Overall Study|Withdrawal by Subject|1|||
155409463|NCT03594227|560930954|FG001|Overall Study|Withdrawal by Subject|1|||
155409464|NCT03594227|560930955|FG002|Overall Study|Withdrawal by Subject|1|||
155409465|NCT03594227|560930956|FG003|Overall Study|Withdrawal by Subject|1|||
155409466|NCT03594227|560930953|FG000|Overall Study|Pregnancy|0|||
155409467|NCT03594227|560930954|FG001|Overall Study|Pregnancy|1|||
155409468|NCT03594227|560930955|FG002|Overall Study|Pregnancy|0|||
155409469|NCT03594227|560930956|FG003|Overall Study|Pregnancy|0|||
155409470|NCT03594227|560930953|FG000|Overall Study|Sponsor Decision|0|||
155409471|NCT03594227|560930954|FG001|Overall Study|Sponsor Decision|0|||
155409472|NCT03594227|560930955|FG002|Overall Study|Sponsor Decision|0|||
155409473|NCT03594227|560930956|FG003|Overall Study|Sponsor Decision|1|||
155409474|NCT03594227|560930953|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
155409475|NCT03594227|560930954|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
155409476|NCT03594227|560930955|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
155409477|NCT03594227|560930956|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
155409478|NCT00790907|560930957|FG000|Overall Study|Adverse Event|9|||
155409479|NCT00790907|560930958|FG001|Overall Study|Adverse Event|7|||
155409480|NCT00790907|560930959|FG002|Overall Study|Adverse Event|6|||
155409481|NCT00790907|560930957|FG000|Overall Study|Physician Decision|304|||
155409482|NCT00790907|560930958|FG001|Overall Study|Physician Decision|271|||
155409483|NCT00790907|560930959|FG002|Overall Study|Physician Decision|255|||
155409484|NCT00790907|560930957|FG000|Overall Study|Withdrawal by Subject|1|||
155409485|NCT00790907|560930958|FG001|Overall Study|Withdrawal by Subject|7|||
155409486|NCT00790907|560930959|FG002|Overall Study|Withdrawal by Subject|5|||
155409487|NCT00790907|560930957|FG000|Overall Study|Bleeding Event|11|||
155409488|NCT00790907|560930958|FG001|Overall Study|Bleeding Event|16|||
155409489|NCT00790907|560930959|FG002|Overall Study|Bleeding Event|21|||
155409490|NCT00790907|560930957|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
155409491|NCT00790907|560930958|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
155409492|NCT00790907|560930959|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
155409493|NCT00790907|560930957|FG000|Overall Study|Qualifying Condition Not Present|29|||
155409494|NCT00790907|560930958|FG001|Overall Study|Qualifying Condition Not Present|14|||
155409495|NCT00790907|560930959|FG002|Overall Study|Qualifying Condition Not Present|16|||
155409496|NCT00790907|560930957|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
155409497|NCT00790907|560930958|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
155409498|NCT00790907|560930959|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
155409499|NCT00790907|560930957|FG000|Overall Study|Did Not Receive Study Drug|10|||
155409500|NCT00790907|560930958|FG001|Overall Study|Did Not Receive Study Drug|0|||
155409501|NCT00790907|560930959|FG002|Overall Study|Did Not Receive Study Drug|0|||
155409502|NCT00774345|560930960|FG000|Pre-treatment|Other reasons|2|||
155409503|NCT00774345|560930961|FG001|Pre-treatment|Other reasons|0|||
155409504|NCT00774345|560930960|FG000|Treatment|Adverse Event|61|||
155409505|NCT00774345|560930961|FG001|Treatment|Adverse Event|15|||
155409506|NCT00774345|560930960|FG000|Treatment|Progressive Disease without histologic transformation|51|||
155409507|NCT00774345|560930961|FG001|Treatment|Progressive Disease without histologic transformation|111|||
155409508|NCT00774345|560930960|FG000|Treatment|Progressive Disease with histologic transformation|4|||
155409509|NCT00774345|560930961|FG001|Treatment|Progressive Disease with histologic transformation|2|||
155409510|NCT00774345|560930960|FG000|Treatment|Withdrawal by Subject|5|||
155409511|NCT00774345|560930961|FG001|Treatment|Withdrawal by Subject|2|||
155409512|NCT00774345|560930960|FG000|Treatment|Lost to Follow-up|1|||
155409513|NCT00774345|560930961|FG001|Treatment|Lost to Follow-up|1|||
155409514|NCT00774345|560930960|FG000|Treatment|Death|4|||
155409515|NCT00774345|560930961|FG001|Treatment|Death|0|||
155409516|NCT00774345|560930960|FG000|Treatment|Other Reasons|32|||
155409517|NCT00774345|560930961|FG001|Treatment|Other Reasons|26|||
155409518|NCT03436862|560930967|FG000|Overall Study|Adverse Event|4|||
155409519|NCT03436862|560930967|FG000|Overall Study|Progressive Disease|2|||
155409520|NCT02054897|560930969|FG000|Overall Study|Withdrawal by Subject|2|||
155744050|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
155409521|NCT02054897|560930970|FG001|Overall Study|Withdrawal by Subject|0|||
155409522|NCT02054897|560930971|FG002|Overall Study|Withdrawal by Subject|2|||
155409523|NCT02054897|560930969|FG000|Overall Study|Missing follow-up information|3|||
155744051|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
155744052|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
155744053|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
155744054|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
155744055|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
155744056|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
155409524|NCT02054897|560930970|FG001|Overall Study|Missing follow-up information|5|||
155409525|NCT02054897|560930971|FG002|Overall Study|Missing follow-up information|3|||
155409526|NCT02054897|560930969|FG000|Overall Study|Lost to Follow-up|4|||
155409527|NCT02054897|560930970|FG001|Overall Study|Lost to Follow-up|2|||
155409528|NCT02054897|560930971|FG002|Overall Study|Lost to Follow-up|7|||
155409529|NCT02054897|560930969|FG000|Overall Study|Randomized but not exposed|1|||
155409530|NCT02054897|560930970|FG001|Overall Study|Randomized but not exposed|0|||
155409531|NCT02054897|560930971|FG002|Overall Study|Randomized but not exposed|0|||
155409532|NCT00960843|560930972|FG000|Overall Study|Lost to Follow-up|2|||
155409533|NCT00960843|560930973|FG001|Overall Study|Lost to Follow-up|0|||
155409534|NCT00960843|560930972|FG000|Overall Study|Protocol Violation|0|||
155409535|NCT00960843|560930973|FG001|Overall Study|Protocol Violation|4|||
155409536|NCT00960843|560930972|FG000|Overall Study|Repeated needle dislodgment|0|||
155409537|NCT00960843|560930973|FG001|Overall Study|Repeated needle dislodgment|1|||
155409538|NCT00652366|560930974|FG000|Overall Study|Adverse Event|8|||
155409539|NCT00652366|560930975|FG001|Overall Study|Adverse Event|4|||
155409540|NCT00652366|560930976|FG002|Overall Study|Adverse Event|7|||
155409541|NCT00652366|560930977|FG003|Overall Study|Adverse Event|17|||
155409542|NCT00652366|560930978|FG004|Overall Study|Adverse Event|13|||
155409543|NCT00652366|560930974|FG000|Overall Study|Death|5|||
155409544|NCT00652366|560930975|FG001|Overall Study|Death|4|||
155409545|NCT00652366|560930976|FG002|Overall Study|Death|1|||
155409546|NCT00652366|560930977|FG003|Overall Study|Death|8|||
155409547|NCT00652366|560930978|FG004|Overall Study|Death|5|||
155409548|NCT00652366|560930974|FG000|Overall Study|Lack of Efficacy|84|||
155409549|NCT00652366|560930975|FG001|Overall Study|Lack of Efficacy|58|||
155409550|NCT00652366|560930976|FG002|Overall Study|Lack of Efficacy|53|||
155409551|NCT00652366|560930977|FG003|Overall Study|Lack of Efficacy|133|||
155409552|NCT00652366|560930978|FG004|Overall Study|Lack of Efficacy|13|||
155409553|NCT00652366|560930974|FG000|Overall Study|Violation of Selection Criteria|0|||
155409554|NCT00652366|560930975|FG001|Overall Study|Violation of Selection Criteria|0|||
155409555|NCT00652366|560930976|FG002|Overall Study|Violation of Selection Criteria|1|||
155409556|NCT00652366|560930977|FG003|Overall Study|Violation of Selection Criteria|0|||
155409557|NCT00652366|560930978|FG004|Overall Study|Violation of Selection Criteria|0|||
155409558|NCT00652366|560930974|FG000|Overall Study|Protocol Violation|1|||
155409559|NCT00652366|560930975|FG001|Overall Study|Protocol Violation|0|||
155409560|NCT00652366|560930976|FG002|Overall Study|Protocol Violation|0|||
155409561|NCT00652366|560930977|FG003|Overall Study|Protocol Violation|0|||
155409562|NCT00652366|560930978|FG004|Overall Study|Protocol Violation|0|||
155409563|NCT00652366|560930974|FG000|Overall Study|Refused treatment|3|||
155409564|NCT00652366|560930975|FG001|Overall Study|Refused treatment|7|||
155409565|NCT00652366|560930976|FG002|Overall Study|Refused treatment|6|||
155409566|NCT00652366|560930977|FG003|Overall Study|Refused treatment|17|||
155409567|NCT00652366|560930978|FG004|Overall Study|Refused treatment|5|||
155409568|NCT00652366|560930974|FG000|Overall Study|Other|5|||
155409569|NCT00652366|560930975|FG001|Overall Study|Other|2|||
155409570|NCT00652366|560930976|FG002|Overall Study|Other|3|||
155409571|NCT00652366|560930977|FG003|Overall Study|Other|4|||
155409572|NCT00652366|560930978|FG004|Overall Study|Other|0|||
155409573|NCT02069899|560930979|FG000|Overall Study|Adverse Event|6|||
155409574|NCT02069899|560930980|FG001|Overall Study|Adverse Event|0|||
155409575|NCT02069899|560930981|FG002|Overall Study|Adverse Event|1|||
155409576|NCT02069899|560930979|FG000|Overall Study|Withdrawal by Participant|2|||
155409577|NCT02069899|560930980|FG001|Overall Study|Withdrawal by Participant|0|||
155409578|NCT02069899|560930981|FG002|Overall Study|Withdrawal by Participant|0|||
155409579|NCT02069899|560930979|FG000|Overall Study|Lost to Follow-up|1|||
155409580|NCT02069899|560930980|FG001|Overall Study|Lost to Follow-up|0|||
155409581|NCT02069899|560930981|FG002|Overall Study|Lost to Follow-up|1|||
155409582|NCT02069899|560930979|FG000|Overall Study|Other|4|||
155409583|NCT02069899|560930980|FG001|Overall Study|Other|0|||
155409584|NCT02069899|560930981|FG002|Overall Study|Other|0|||
155409585|NCT02069899|560930979|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
155409586|NCT02069899|560930980|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
155409587|NCT02069899|560930981|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
155409588|NCT02069899|560930979|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
155435888|NCT02403206|561022985|FG000|Overall Study|Withdrawal by Subject|3|||
155409589|NCT02069899|560930980|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
155409590|NCT02069899|560930981|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
155409591|NCT01967537|560930982|FG000|Overall Study|Withdrawal by Subject|52|||
155409592|NCT01967537|560930982|FG000|Overall Study|Refuse treatment|2|||
155409593|NCT01967537|560930982|FG000|Overall Study|Lost to Follow-up|6|||
155409594|NCT04703075|560930983|FG000|Overall Study|Adverse Event|11|||
155409595|NCT04703075|560930984|FG001|Overall Study|Adverse Event|7|||
155409596|NCT04703075|560930983|FG000|Overall Study|Lost to Follow-up|6|||
155409597|NCT04703075|560930984|FG001|Overall Study|Lost to Follow-up|12|||
155409598|NCT04703075|560930983|FG000|Overall Study|Physician Decision|3|||
155409599|NCT04703075|560930984|FG001|Overall Study|Physician Decision|0|||
155409600|NCT04703075|560930983|FG000|Overall Study|Moved|0|||
155409601|NCT04703075|560930984|FG001|Overall Study|Moved|2|||
155409602|NCT04703075|560930983|FG000|Overall Study|Index INH Resistant|0|||
155409603|NCT04703075|560930984|FG001|Overall Study|Index INH Resistant|1|||
155409604|NCT04703075|560930983|FG000|Overall Study|Lack of Efficacy|6|||
155409605|NCT04703075|560930984|FG001|Overall Study|Lack of Efficacy|18|||
155409606|NCT00550680|560930987|FG000|Overall Study|Administrative Reasons|1|||
155409607|NCT00550680|560930987|FG000|Overall Study|Adverse Event|5|||
155409608|NCT00550680|560930987|FG000|Overall Study|Death|3|||
155409609|NCT00550680|560930987|FG000|Overall Study|Early Improvement|1|||
155409610|NCT00550680|560930987|FG000|Overall Study|Lost to Follow-up|3|||
155409611|NCT00550680|560930987|FG000|Overall Study|Lack of Efficacy|1|||
155409612|NCT00550680|560930987|FG000|Overall Study|Other|10|||
155409613|NCT00550680|560930987|FG000|Overall Study|Protocol Violation|7|||
155409614|NCT00550680|560930987|FG000|Overall Study|Refused Treatment|19|||
155409615|NCT00550680|560930987|FG000|Overall Study|Screen Failure|6|||
155409616|NCT01119248|560930988|FG000|Overall Study|Physician Decision|5|||
155409617|NCT01967550|560930989|FG000|Overall Study|Withdrawal by Subject|1|||
155409618|NCT01967550|560930990|FG001|Overall Study|Withdrawal by Subject|0|||
155409619|NCT01967550|560930989|FG000|Overall Study|Adverse Event|2|||
155409620|NCT01967550|560930990|FG001|Overall Study|Adverse Event|0|||
155409621|NCT01967550|560930989|FG000|Overall Study|Protocol Violation|2|||
155409622|NCT01967550|560930990|FG001|Overall Study|Protocol Violation|1|||
155409623|NCT01967550|560930989|FG000|Overall Study|Non Compliance|0|||
155409624|NCT01967550|560930990|FG001|Overall Study|Non Compliance|1|||
155409625|NCT00250835|560930991|FG000|Overall Study|Withdrawal by Subject|1|||
155409626|NCT01836783|560930995|FG000|Overall Study|Withdrawal by Subject|0|||
155409627|NCT01836783|560930996|FG001|Overall Study|Withdrawal by Subject|2|||
155409628|NCT01100437|560930997|FG000|Titration/Stabilization|Adverse Event|0|||
155409629|NCT01100437|560930998|FG001|Titration/Stabilization|Adverse Event|0|||
155409630|NCT01100437|560930999|FG002|Titration/Stabilization|Adverse Event|4|||
155409631|NCT01100437|560930997|FG000|Titration/Stabilization|Non-compliance|0|||
155409632|NCT01100437|560930998|FG001|Titration/Stabilization|Non-compliance|0|||
155409633|NCT01100437|560930999|FG002|Titration/Stabilization|Non-compliance|1|||
155409634|NCT01100437|560930997|FG000|Titration/Stabilization|Sponsor canceled study|0|||
155409635|NCT01100437|560930998|FG001|Titration/Stabilization|Sponsor canceled study|0|||
155409636|NCT01100437|560930999|FG002|Titration/Stabilization|Sponsor canceled study|1|||
155409637|NCT01100437|560930997|FG000|Maintenance|Withdrawal by Subject|0|||
155409638|NCT01100437|560930998|FG001|Maintenance|Withdrawal by Subject|0|||
155409639|NCT01100437|560930999|FG002|Maintenance|Withdrawal by Subject|1|||
155409640|NCT01100437|560930997|FG000|Maintenance|Sponsor termination of study|0|||
155409641|NCT01100437|560930998|FG001|Maintenance|Sponsor termination of study|0|||
155409642|NCT01100437|560930999|FG002|Maintenance|Sponsor termination of study|1|||
155409643|NCT04099251|560932319|FG000|Pre-Treatment|Other reasons|1|||
155409644|NCT04099251|560932320|FG001|Pre-Treatment|Other reasons|0|||
155409645|NCT04099251|560932319|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
155409646|NCT04099251|560932320|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
155409647|NCT04099251|560932319|FG000|Blinded Treatment Phase|Other reasons|16|||
155409648|NCT04099251|560932320|FG001|Blinded Treatment Phase|Other reasons|7|||
155409649|NCT04099251|560932319|FG000|Blinded Treatment Phase|Disease recurrence|26|||
155409650|NCT04099251|560932320|FG001|Blinded Treatment Phase|Disease recurrence|41|||
155409651|NCT04099251|560932319|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
155409652|NCT04099251|560932320|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
155409653|NCT04099251|560932319|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
155409654|NCT04099251|560932320|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
155638440|NCT03765073|561767665|FG012|Stage 1|Withdrawal by participant|0|||
155409655|NCT04099251|560932319|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
155409656|NCT04099251|560932320|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
155409657|NCT04099251|560932319|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
155409658|NCT04099251|560932320|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
155638441|NCT03765073|561767666|FG013|Stage 1|Withdrawal by participant|0|||
155409659|NCT04099251|560932319|FG000|Blinded Treatment Phase|Death|6|||
155409660|NCT04099251|560932320|FG001|Blinded Treatment Phase|Death|2|||
155409661|NCT04099251|560932319|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
155292609|NCT03538041|560500604|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
155292610|NCT03538041|560500603|FG000|Treatment Extension Period|Adverse Event|4|||
155292611|NCT03538041|560500604|FG001|Treatment Extension Period|Adverse Event|1|||
155292612|NCT03538041|560500603|FG000|Treatment Extension Period|Physician Decision|1|||
155292613|NCT03538041|560500604|FG001|Treatment Extension Period|Physician Decision|1|||
155292614|NCT03538041|560500603|FG000|Treatment Extension Period|Lack of Efficacy|1|||
155292615|NCT03538041|560500604|FG001|Treatment Extension Period|Lack of Efficacy|4|||
155292616|NCT03538041|560500603|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
155292617|NCT03538041|560500604|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
155292618|NCT03538041|560500603|FG000|Treatment Extension Period|Death|0|||
155292619|NCT03538041|560500604|FG001|Treatment Extension Period|Death|1|||
155292620|NCT01049503|560500605|FG000|Overall Study|Lost to Follow-up|11|||
155292621|NCT01049503|560500606|FG001|Overall Study|Lost to Follow-up|12|||
155292622|NCT01049503|560500607|FG002|Overall Study|Lost to Follow-up|24|||
155292623|NCT01049503|560500608|FG003|Overall Study|Lost to Follow-up|26|||
155292624|NCT01049503|560500609|FG004|Overall Study|Lost to Follow-up|27|||
155292625|NCT01049503|560500610|FG005|Overall Study|Lost to Follow-up|8|||
155292626|NCT00726596|560500611|FG000|Overall Study|Adverse Event|2|||
155292627|NCT00726596|560500612|FG001|Overall Study|Adverse Event|1|||
155292628|NCT00726596|560500611|FG000|Overall Study|Withdrawal by Subject|3|||
155292629|NCT00726596|560500612|FG001|Overall Study|Withdrawal by Subject|3|||
155292630|NCT00954707|560500614|FG000|Overall Study|Death|34|||
155292631|NCT00954707|560500614|FG000|Overall Study|Withdrawal by Subject|100|||
155292632|NCT00954707|560500614|FG000|Overall Study|Lost to Follow-up|33|||
155292633|NCT00357396|560500621|FG000|Overall Study|Adverse Event|1|||
155292634|NCT00357396|560500622|FG001|Overall Study|Adverse Event|0|||
155292635|NCT00487578|560500624|FG000|Overall Study|Adverse Event|1|||
155292636|NCT00487578|560500625|FG001|Overall Study|Adverse Event|2|||
155292637|NCT00487578|560500624|FG000|Overall Study|Lack of Efficacy|0|||
155292638|NCT00487578|560500625|FG001|Overall Study|Lack of Efficacy|1|||
155292639|NCT00487578|560500624|FG000|Overall Study|Lost to Follow-up|0|||
155292640|NCT00487578|560500625|FG001|Overall Study|Lost to Follow-up|1|||
155292641|NCT00726999|560500630|FG000|Overall Study|Physician Decision|0|||
155292642|NCT00726999|560500631|FG001|Overall Study|Physician Decision|1|||
155292643|NCT00726999|560500630|FG000|Overall Study|Withdrawal by Subject|2|||
155292644|NCT00726999|560500631|FG001|Overall Study|Withdrawal by Subject|0|||
155292645|NCT00726999|560500630|FG000|Overall Study|Protocol Violation|1|||
155292646|NCT00726999|560500631|FG001|Overall Study|Protocol Violation|0|||
155292647|NCT02488980|560500632|FG000|Overall Study|Protocol Violation|2|||
155292648|NCT02488980|560500633|FG001|Overall Study|Protocol Violation|2|||
155292649|NCT02488980|560500634|FG002|Overall Study|Protocol Violation|2|||
155292650|NCT02614560|560500639|FG000|Overall Study|Death|6|||
155292651|NCT02614560|560500640|FG001|Overall Study|Death|2|||
155292652|NCT02192606|560500641|FG000|Overall Study|surgery type was changed|1|||
155292653|NCT02192606|560500642|FG001|Overall Study|surgery type was changed|1|||
155292654|NCT02192606|560500641|FG000|Overall Study|Physician Decision|1|||
155292655|NCT02192606|560500642|FG001|Overall Study|Physician Decision|2|||
155292656|NCT02192606|560500641|FG000|Overall Study|3D equipment rep unable to join|0|||
155292657|NCT02192606|560500642|FG001|Overall Study|3D equipment rep unable to join|1|||
155292658|NCT00738699|560500643|FG000|Overall Study|Withdrawal by Subject|5|||
155292659|NCT00738699|560500644|FG001|Overall Study|Withdrawal by Subject|0|||
155292660|NCT00738699|560500643|FG000|Overall Study|Lost to Follow-up|1|||
155292661|NCT00738699|560500644|FG001|Overall Study|Lost to Follow-up|0|||
155292662|NCT00738699|560500643|FG000|Overall Study|Death|144|||
155292663|NCT00738699|560500644|FG001|Overall Study|Death|68|||
155292664|NCT00738699|560500643|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
155292665|NCT00738699|560500644|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
155292666|NCT00738699|560500643|FG000|Overall Study|Other|2|||
155292667|NCT00738699|560500644|FG001|Overall Study|Other|0|||
155292668|NCT05174013|560500646|FG000|Overall Study|Lost to Follow-up|0|||
155292669|NCT05174013|560500647|FG001|Overall Study|Lost to Follow-up|0|||
155292670|NCT05174013|560500648|FG002|Overall Study|Lost to Follow-up|0|||
155292671|NCT05174013|560500649|FG003|Overall Study|Lost to Follow-up|1|||
155292672|NCT05174013|560500650|FG004|Overall Study|Lost to Follow-up|0|||
155292673|NCT05174013|560500651|FG005|Overall Study|Lost to Follow-up|0|||
155292674|NCT05174013|560500646|FG000|Overall Study|Withdrawal by Subject|0|||
155292675|NCT05174013|560500647|FG001|Overall Study|Withdrawal by Subject|0|||
155292676|NCT05174013|560500648|FG002|Overall Study|Withdrawal by Subject|1|||
155292677|NCT05174013|560500649|FG003|Overall Study|Withdrawal by Subject|0|||
155292678|NCT05174013|560500650|FG004|Overall Study|Withdrawal by Subject|0|||
155292679|NCT05174013|560500651|FG005|Overall Study|Withdrawal by Subject|0|||
155292680|NCT02034916|560500652|FG000|Overall Study|Death|39|||
155292681|NCT02034916|560500653|FG001|Overall Study|Death|28|||
155292682|NCT02034916|560500652|FG000|Overall Study|Withdrawal by Subject|2|||
155292683|NCT02034916|560500653|FG001|Overall Study|Withdrawal by Subject|1|||
155292684|NCT02034916|560500652|FG000|Overall Study|Lost to Follow-up|4|||
155292685|NCT02034916|560500653|FG001|Overall Study|Lost to Follow-up|1|||
155292686|NCT02034916|560500652|FG000|Overall Study|Study terminated by sponsor|4|||
155409662|NCT04099251|560932320|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
155409663|NCT04099251|560932319|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
155409664|NCT04099251|560932320|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
155409665|NCT04099251|560932319|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
155409666|NCT04099251|560932320|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
155409667|NCT04099251|560932319|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
155409668|NCT04099251|560932320|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
155409669|NCT04099251|560932319|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
155409670|NCT04099251|560932320|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
155409671|NCT04099251|560932319|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
155409672|NCT04099251|560932320|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
155409673|NCT04099251|560932319|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
155409674|NCT04099251|560932320|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
155409675|NCT04099251|560932319|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
155409676|NCT04099251|560932320|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
155409677|NCT04099251|560932319|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
155409678|NCT04099251|560932320|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
155409679|NCT01408147|560932327|FG000|Overall Study|Withdrawal by Subject|0|||
155409680|NCT01408147|560932328|FG001|Overall Study|Withdrawal by Subject|1|||
155409681|NCT00621504|560932329|FG000|Overall Study|Adverse Event|1|||
155409682|NCT00621504|560932330|FG001|Overall Study|Adverse Event|3|||
155409683|NCT00621504|560932329|FG000|Overall Study|At the request of sponsor/investigator|1|||
155409684|NCT00621504|560932330|FG001|Overall Study|At the request of sponsor/investigator|0|||
155409685|NCT00621504|560932329|FG000|Overall Study|Withdrew consent|9|||
155409686|NCT00621504|560932330|FG001|Overall Study|Withdrew consent|6|||
155409687|NCT00621504|560932329|FG000|Overall Study|Lost to Follow-up|8|||
155409688|NCT00621504|560932330|FG001|Overall Study|Lost to Follow-up|10|||
155409689|NCT00621504|560932329|FG000|Overall Study|Other|1|||
155409690|NCT00621504|560932330|FG001|Overall Study|Other|0|||
155409691|NCT00621504|560932329|FG000|Overall Study|Death|6|||
155409692|NCT00621504|560932330|FG001|Overall Study|Death|6|||
155409693|NCT03445000|560932332|FG000|Overall Study|Disease progression|8|||
155409694|NCT03445000|560932332|FG000|Overall Study|Adverse Event|3|||
155409695|NCT03445000|560932332|FG000|Overall Study|Death|2|||
155409696|NCT03445000|560932332|FG000|Overall Study|Physician Decision|1|||
155409697|NCT00706134|560932333|FG000|Overall Study|Adverse Event|8|||
155409698|NCT00706134|560932334|FG001|Overall Study|Adverse Event|7|||
155409699|NCT00706134|560932335|FG002|Overall Study|Adverse Event|2|||
155409700|NCT00706134|560932336|FG003|Overall Study|Adverse Event|3|||
155409701|NCT00706134|560932333|FG000|Overall Study|Lost to Follow-up|0|||
155409702|NCT00706134|560932334|FG001|Overall Study|Lost to Follow-up|1|||
155409703|NCT00706134|560932335|FG002|Overall Study|Lost to Follow-up|0|||
155409704|NCT00706134|560932336|FG003|Overall Study|Lost to Follow-up|0|||
155409705|NCT00706134|560932333|FG000|Overall Study|Protocol Violation|0|||
155409706|NCT00706134|560932334|FG001|Overall Study|Protocol Violation|6|||
155409707|NCT00706134|560932335|FG002|Overall Study|Protocol Violation|0|||
155409708|NCT00706134|560932336|FG003|Overall Study|Protocol Violation|3|||
155409709|NCT00706134|560932333|FG000|Overall Study|Withdrawal by Subject|1|||
155409710|NCT00706134|560932334|FG001|Overall Study|Withdrawal by Subject|2|||
155409711|NCT00706134|560932335|FG002|Overall Study|Withdrawal by Subject|1|||
155409712|NCT00706134|560932336|FG003|Overall Study|Withdrawal by Subject|0|||
155409713|NCT00706134|560932333|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
155409714|NCT00706134|560932334|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155409715|NCT00706134|560932335|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
155638442|NCT03765073|561767667|FG014|Stage 1|Withdrawal by participant|0|||
155638443|NCT03765073|561767668|FG015|Stage 1|Withdrawal by participant|0|||
155638444|NCT03765073|561767669|FG016|Stage 1|Withdrawal by participant|0|||
155638445|NCT03765073|561767670|FG017|Stage 1|Withdrawal by participant|0|||
155638446|NCT03765073|561767671|FG018|Stage 1|Withdrawal by participant|0|||
155638447|NCT03765073|561767672|FG019|Stage 1|Withdrawal by participant|0|||
155638448|NCT03765073|561767673|FG020|Stage 1|Withdrawal by participant|0|||
155638449|NCT03765073|561767653|FG000|Stage 2|Death|0|||
155638450|NCT03765073|561767654|FG001|Stage 2|Death|0|||
155638451|NCT03765073|561767655|FG002|Stage 2|Death|0|||
155638452|NCT03765073|561767656|FG003|Stage 2|Death|0|||
155638453|NCT03765073|561767657|FG004|Stage 2|Death|0|||
155638454|NCT03765073|561767658|FG005|Stage 2|Death|0|||
155638455|NCT03765073|561767659|FG006|Stage 2|Death|0|||
155638456|NCT03765073|561767660|FG007|Stage 2|Death|0|||
155638457|NCT03765073|561767661|FG008|Stage 2|Death|0|||
155638458|NCT03765073|561767662|FG009|Stage 2|Death|1|||
155638459|NCT03765073|561767663|FG010|Stage 2|Death|0|||
155638460|NCT03765073|561767664|FG011|Stage 2|Death|1|||
155638461|NCT03765073|561767665|FG012|Stage 2|Death|0|||
155638462|NCT03765073|561767666|FG013|Stage 2|Death|0|||
155292687|NCT02034916|560500653|FG001|Overall Study|Study terminated by sponsor|5|||
155292688|NCT00753012|560500654|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
155292689|NCT00753012|560500655|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
155292690|NCT00753012|560500654|FG000|Overall Study|Adverse Event|2|||
155292691|NCT00753012|560500655|FG001|Overall Study|Adverse Event|0|||
155292692|NCT00753012|560500654|FG000|Overall Study|Withdrawal by Subject|0|||
155292693|NCT00753012|560500655|FG001|Overall Study|Withdrawal by Subject|1|||
155292694|NCT00753012|560500654|FG000|Overall Study|Lost to Follow-up|4|||
155292695|NCT00753012|560500655|FG001|Overall Study|Lost to Follow-up|0|||
155292696|NCT00753012|560500654|FG000|Overall Study|Confounded endpoint data|1|||
155292697|NCT00753012|560500655|FG001|Overall Study|Confounded endpoint data|0|||
155292698|NCT00864682|560500656|FG000|Overall Study|Protocol Violation|2|||
155292699|NCT00864682|560500657|FG001|Overall Study|Protocol Violation|1|||
155292700|NCT00864682|560500658|FG002|Overall Study|Protocol Violation|2|||
155292701|NCT00957658|560500659|FG000|Overall Study|Death|1|||
155292702|NCT00957658|560500659|FG000|Overall Study|Lost to Follow-up|4|||
155292703|NCT00957658|560500659|FG000|Overall Study|Withdrawal by Subject|12|||
155292704|NCT00957658|560500659|FG000|Overall Study|Revision|1|||
155292705|NCT00957658|560500659|FG000|Overall Study|Incomplete 2 yr data|28|||
155292706|NCT00957658|560500659|FG000|Overall Study|Site termination|10|||
155292707|NCT00957658|560500659|FG000|Overall Study|unwilling/unable to return|2|||
155292708|NCT00957658|560500659|FG000|Overall Study|surgery cancelled|2|||
155292709|NCT00957658|560500659|FG000|Overall Study|Protocol Violation|5|||
155292710|NCT04889664|560500660|FG000|Screen|Lost to Follow-up|1|||
155292711|NCT04889664|560500660|FG000|Screen|Failed to meet screening criteria|1|||
155292712|NCT04889664|560500660|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
155292713|NCT00130637|560500666|FG000|Overall Study|Adverse Event|2|||
155292714|NCT00130637|560500666|FG000|Overall Study|Withdrawal by Subject|1|||
155292715|NCT01972152|560500667|FG000|First Treatment Visit|Lost to Follow-up|0|||
155292716|NCT01972152|560500668|FG001|First Treatment Visit|Lost to Follow-up|1|||
155292717|NCT01972152|560500669|FG002|First Treatment Visit|Lost to Follow-up|0|||
155292718|NCT01972152|560500670|FG003|First Treatment Visit|Lost to Follow-up|0|||
155292719|NCT01972152|560500671|FG004|First Treatment Visit|Lost to Follow-up|0|||
155292720|NCT01972152|560500672|FG005|First Treatment Visit|Lost to Follow-up|0|||
155292721|NCT01972152|560500667|FG000|Second Treatment Visit|Protocol Violation|0|||
155292722|NCT01972152|560500668|FG001|Second Treatment Visit|Protocol Violation|1|||
155292723|NCT01972152|560500669|FG002|Second Treatment Visit|Protocol Violation|0|||
155292724|NCT01972152|560500670|FG003|Second Treatment Visit|Protocol Violation|0|||
155292725|NCT01972152|560500671|FG004|Second Treatment Visit|Protocol Violation|0|||
155292726|NCT01972152|560500672|FG005|Second Treatment Visit|Protocol Violation|0|||
155292727|NCT01959412|560500673|FG000|Overall Study|Protocol deviation|1|||
155292728|NCT01959412|560500674|FG001|Overall Study|Protocol deviation|1|||
155292729|NCT01959412|560500675|FG002|Overall Study|Protocol deviation|0|||
155292730|NCT01959412|560500676|FG003|Overall Study|Protocol deviation|1|||
155292731|NCT01959412|560500677|FG004|Overall Study|Protocol deviation|3|||
155292732|NCT01959412|560500678|FG005|Overall Study|Protocol deviation|0|||
155292733|NCT01959412|560500673|FG000|Overall Study|Adverse Event|0|||
155292734|NCT01959412|560500674|FG001|Overall Study|Adverse Event|0|||
155292735|NCT01959412|560500675|FG002|Overall Study|Adverse Event|0|||
155292736|NCT01959412|560500676|FG003|Overall Study|Adverse Event|1|||
155292737|NCT01959412|560500677|FG004|Overall Study|Adverse Event|0|||
155292738|NCT01959412|560500678|FG005|Overall Study|Adverse Event|0|||
155292739|NCT04379713|560500679|FG000|Overall Study|Adverse Event|2|||
155292740|NCT04379713|560500680|FG001|Overall Study|Adverse Event|0|||
155292741|NCT04379713|560500679|FG000|Overall Study|Physician Decision|2|||
155292742|NCT04379713|560500680|FG001|Overall Study|Physician Decision|1|||
155292743|NCT04379713|560500679|FG000|Overall Study|Protocol Violation|11|||
155292744|NCT04379713|560500680|FG001|Overall Study|Protocol Violation|6|||
155292745|NCT04379713|560500679|FG000|Overall Study|No longer met eligibility criteria|14|||
155292746|NCT04379713|560500680|FG001|Overall Study|No longer met eligibility criteria|11|||
155292747|NCT04379713|560500679|FG000|Overall Study|Withdrawal by parent/guardian|36|||
155292748|NCT04379713|560500680|FG001|Overall Study|Withdrawal by parent/guardian|15|||
155292749|NCT04379713|560500679|FG000|Overall Study|Lost to Follow-up|31|||
155409716|NCT00706134|560932336|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
155292750|NCT04379713|560500680|FG001|Overall Study|Lost to Follow-up|21|||
155292751|NCT04567888|560500681|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
155292752|NCT04567888|560500682|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
155292753|NCT04567888|560500681|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
155292754|NCT04567888|560500682|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
155292755|NCT04567888|560500681|FG000|Overall Study|Reported Unusual Birth Year|2|||
155292756|NCT04567888|560500682|FG001|Overall Study|Reported Unusual Birth Year|3|||
155292757|NCT04567888|560500681|FG000|Overall Study|Duplicate Responses|0|||
155292758|NCT04567888|560500682|FG001|Overall Study|Duplicate Responses|1|||
155409717|NCT00706134|560932333|FG000|Overall Study|Did not meet study criteria|2|||
155409718|NCT00706134|560932334|FG001|Overall Study|Did not meet study criteria|0|||
155409719|NCT00706134|560932335|FG002|Overall Study|Did not meet study criteria|0|||
155292759|NCT00509769|560500683|FG000|Overall Study|Progressive disease|77|||
155409720|NCT00706134|560932336|FG003|Overall Study|Did not meet study criteria|0|||
155409721|NCT01982292|560932337|FG000|Overall Study|Adverse Event|2|||
155409722|NCT01982292|560932338|FG001|Overall Study|Adverse Event|0|||
155409723|NCT01982292|560932337|FG000|Overall Study|Death|1|||
155409724|NCT01982292|560932338|FG001|Overall Study|Death|0|||
155409725|NCT01982292|560932337|FG000|Overall Study|Lost to Follow-up|2|||
155409726|NCT01982292|560932338|FG001|Overall Study|Lost to Follow-up|0|||
155409727|NCT01982292|560932337|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
155409728|NCT01982292|560932338|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
155409729|NCT01982292|560932337|FG000|Overall Study|Protocol Deviation|1|||
155409730|NCT01982292|560932338|FG001|Overall Study|Protocol Deviation|0|||
155409731|NCT01982292|560932337|FG000|Overall Study|Patient/Guardian Decision|3|||
155409732|NCT01982292|560932338|FG001|Overall Study|Patient/Guardian Decision|1|||
155409733|NCT01982292|560932337|FG000|Overall Study|Technical Problems|2|||
155409734|NCT01982292|560932338|FG001|Overall Study|Technical Problems|0|||
155409735|NCT00264004|560932340|FG000|Overall Study|Adverse Event|2|||
155409736|NCT00264004|560932341|FG001|Overall Study|Adverse Event|3|||
155409737|NCT00264004|560932342|FG002|Overall Study|Adverse Event|6|||
155409738|NCT00264004|560932343|FG003|Overall Study|Adverse Event|4|||
155409739|NCT00264004|560932340|FG000|Overall Study|Withdrawal by Subject|0|||
155409740|NCT00264004|560932341|FG001|Overall Study|Withdrawal by Subject|1|||
155638463|NCT03765073|561767667|FG014|Stage 2|Death|0|||
155638464|NCT03765073|561767668|FG015|Stage 2|Death|0|||
155638465|NCT03765073|561767669|FG016|Stage 2|Death|2|||
155638466|NCT03765073|561767670|FG017|Stage 2|Death|0|||
155638467|NCT03765073|561767671|FG018|Stage 2|Death|0|||
155638468|NCT03765073|561767672|FG019|Stage 2|Death|0|||
155638469|NCT03765073|561767673|FG020|Stage 2|Death|0|||
155638470|NCT03765073|561767653|FG000|Stage 2|Lost to Follow-up|0|||
155638471|NCT03765073|561767654|FG001|Stage 2|Lost to Follow-up|0|||
155638472|NCT03765073|561767655|FG002|Stage 2|Lost to Follow-up|0|||
155638473|NCT03765073|561767656|FG003|Stage 2|Lost to Follow-up|5|||
155638474|NCT03765073|561767657|FG004|Stage 2|Lost to Follow-up|1|||
155638475|NCT03765073|561767658|FG005|Stage 2|Lost to Follow-up|0|||
155638476|NCT03765073|561767659|FG006|Stage 2|Lost to Follow-up|3|||
155638477|NCT03765073|561767660|FG007|Stage 2|Lost to Follow-up|3|||
155638478|NCT03765073|561767661|FG008|Stage 2|Lost to Follow-up|1|||
155638479|NCT03765073|561767662|FG009|Stage 2|Lost to Follow-up|6|||
155638480|NCT03765073|561767663|FG010|Stage 2|Lost to Follow-up|5|||
155638481|NCT03765073|561767664|FG011|Stage 2|Lost to Follow-up|1|||
155638482|NCT03765073|561767665|FG012|Stage 2|Lost to Follow-up|1|||
155638483|NCT03765073|561767666|FG013|Stage 2|Lost to Follow-up|3|||
155638484|NCT03765073|561767667|FG014|Stage 2|Lost to Follow-up|3|||
155638485|NCT03765073|561767668|FG015|Stage 2|Lost to Follow-up|1|||
155638486|NCT03765073|561767669|FG016|Stage 2|Lost to Follow-up|6|||
155638487|NCT03765073|561767670|FG017|Stage 2|Lost to Follow-up|0|||
155638488|NCT03765073|561767671|FG018|Stage 2|Lost to Follow-up|0|||
155638489|NCT03765073|561767672|FG019|Stage 2|Lost to Follow-up|0|||
155638490|NCT03765073|561767673|FG020|Stage 2|Lost to Follow-up|0|||
155638491|NCT03765073|561767653|FG000|Stage 2|Other|0|||
155638492|NCT03765073|561767654|FG001|Stage 2|Other|0|||
155638493|NCT03765073|561767655|FG002|Stage 2|Other|0|||
155638494|NCT03765073|561767656|FG003|Stage 2|Other|0|||
155638495|NCT03765073|561767657|FG004|Stage 2|Other|0|||
155638496|NCT03765073|561767658|FG005|Stage 2|Other|0|||
155638497|NCT03765073|561767659|FG006|Stage 2|Other|0|||
155638498|NCT03765073|561767660|FG007|Stage 2|Other|1|||
155638499|NCT03765073|561767661|FG008|Stage 2|Other|1|||
155638500|NCT03765073|561767662|FG009|Stage 2|Other|3|||
155638501|NCT03765073|561767663|FG010|Stage 2|Other|0|||
155638502|NCT03765073|561767664|FG011|Stage 2|Other|0|||
155638503|NCT03765073|561767665|FG012|Stage 2|Other|0|||
155638504|NCT03765073|561767666|FG013|Stage 2|Other|0|||
155638505|NCT03765073|561767667|FG014|Stage 2|Other|0|||
155638506|NCT03765073|561767668|FG015|Stage 2|Other|1|||
155409741|NCT00264004|560932342|FG002|Overall Study|Withdrawal by Subject|2|||
155409742|NCT00264004|560932343|FG003|Overall Study|Withdrawal by Subject|2|||
155409743|NCT00264004|560932340|FG000|Overall Study|Other|2|||
155409744|NCT00264004|560932341|FG001|Overall Study|Other|2|||
155409745|NCT00264004|560932342|FG002|Overall Study|Other|0|||
155638507|NCT03765073|561767669|FG016|Stage 2|Other|2|||
155638508|NCT03765073|561767670|FG017|Stage 2|Other|0|||
155638509|NCT03765073|561767671|FG018|Stage 2|Other|0|||
155638510|NCT03765073|561767672|FG019|Stage 2|Other|0|||
155638511|NCT03765073|561767673|FG020|Stage 2|Other|0|||
155638512|NCT03765073|561767653|FG000|Stage 2|Withdrawal by parent/guardian|0|||
155638513|NCT03765073|561767654|FG001|Stage 2|Withdrawal by parent/guardian|0|||
155638514|NCT03765073|561767655|FG002|Stage 2|Withdrawal by parent/guardian|0|||
155638515|NCT03765073|561767656|FG003|Stage 2|Withdrawal by parent/guardian|0|||
155638516|NCT03765073|561767657|FG004|Stage 2|Withdrawal by parent/guardian|0|||
155638517|NCT03765073|561767658|FG005|Stage 2|Withdrawal by parent/guardian|0|||
155638518|NCT03765073|561767659|FG006|Stage 2|Withdrawal by parent/guardian|0|||
155638519|NCT03765073|561767660|FG007|Stage 2|Withdrawal by parent/guardian|0|||
155638520|NCT03765073|561767661|FG008|Stage 2|Withdrawal by parent/guardian|0|||
155638521|NCT03765073|561767662|FG009|Stage 2|Withdrawal by parent/guardian|0|||
155638522|NCT03765073|561767663|FG010|Stage 2|Withdrawal by parent/guardian|3|||
155292760|NCT00509769|560500683|FG000|Overall Study|Adverse Event|4|||
155292761|NCT00509769|560500683|FG000|Overall Study|Patient's decision|1|||
155292762|NCT00509769|560500683|FG000|Overall Study|Physician Decision|8|||
155292763|NCT00509769|560500683|FG000|Overall Study|Use of prohibited therapies during study|1|||
155292764|NCT02371746|560500684|FG000|Overall Study|Consent withdrawn|0|||
155292765|NCT02371746|560500685|FG001|Overall Study|Consent withdrawn|0|||
155292766|NCT02371746|560500686|FG002|Overall Study|Consent withdrawn|0|||
155292767|NCT02371746|560500687|FG003|Overall Study|Consent withdrawn|0|||
155292768|NCT02371746|560500688|FG004|Overall Study|Consent withdrawn|0|||
155292769|NCT02371746|560500689|FG005|Overall Study|Consent withdrawn|0|||
155292770|NCT02371746|560500690|FG006|Overall Study|Consent withdrawn|1|||
155292771|NCT00754936|560500691|FG000|Overall Study|Lost to Follow-up|3|||
155292772|NCT00754936|560500691|FG000|Overall Study|Physician Decision|1|||
155292773|NCT00754936|560500691|FG000|Overall Study|Withdrawal by Subject|2|||
155292774|NCT00754936|560500691|FG000|Overall Study|Side Effects|3|||
155292775|NCT00754936|560500691|FG000|Overall Study|Inter-current medical events|3|||
155292776|NCT00619645|560500692|FG000|Overall Study|Adverse Event|1|||
155292777|NCT01157182|560500693|FG000|Washout of 28 Days|Adverse Event|2|||
155292778|NCT01157182|560500694|FG001|Washout of 28 Days|Adverse Event|0|||
155292779|NCT01490580|560500695|FG000|Overall Study|Parents withdrew consent|0|||
155292780|NCT01490580|560500696|FG001|Overall Study|Parents withdrew consent|2|||
155292781|NCT00878722|560500697|FG000|Overall Study|Progressive disease|3|||
155292782|NCT00878722|560500698|FG001|Overall Study|Progressive disease|3|||
155292783|NCT00878722|560500699|FG002|Overall Study|Progressive disease|3|||
155292784|NCT00878722|560500700|FG003|Overall Study|Progressive disease|7|||
155292785|NCT00878722|560500701|FG004|Overall Study|Progressive disease|7|||
155292786|NCT00878722|560500702|FG005|Overall Study|Progressive disease|1|||
155292787|NCT00878722|560500703|FG006|Overall Study|Progressive disease|4|||
155292788|NCT00878722|560500704|FG007|Overall Study|Progressive disease|3|||
155292789|NCT00878722|560500697|FG000|Overall Study|Death|0|||
155292790|NCT00878722|560500698|FG001|Overall Study|Death|0|||
155292791|NCT00878722|560500699|FG002|Overall Study|Death|0|||
155292792|NCT00878722|560500700|FG003|Overall Study|Death|1|||
155292793|NCT00878722|560500701|FG004|Overall Study|Death|0|||
155292794|NCT00878722|560500702|FG005|Overall Study|Death|1|||
155292795|NCT00878722|560500703|FG006|Overall Study|Death|0|||
155292796|NCT00878722|560500704|FG007|Overall Study|Death|2|||
155292797|NCT00878722|560500697|FG000|Overall Study|Adverse Event|0|||
155292798|NCT00878722|560500698|FG001|Overall Study|Adverse Event|0|||
155292799|NCT00878722|560500699|FG002|Overall Study|Adverse Event|0|||
155292800|NCT00878722|560500700|FG003|Overall Study|Adverse Event|0|||
155292801|NCT00878722|560500701|FG004|Overall Study|Adverse Event|0|||
155292802|NCT00878722|560500702|FG005|Overall Study|Adverse Event|0|||
155292803|NCT00878722|560500703|FG006|Overall Study|Adverse Event|2|||
155292804|NCT00878722|560500704|FG007|Overall Study|Adverse Event|0|||
155292805|NCT00878722|560500697|FG000|Overall Study|Withdrawal by Subject|0|||
155292806|NCT00878722|560500698|FG001|Overall Study|Withdrawal by Subject|0|||
155292807|NCT00878722|560500699|FG002|Overall Study|Withdrawal by Subject|0|||
155292808|NCT00878722|560500700|FG003|Overall Study|Withdrawal by Subject|0|||
155292809|NCT00878722|560500701|FG004|Overall Study|Withdrawal by Subject|0|||
155409746|NCT00264004|560932343|FG003|Overall Study|Other|3|||
155292810|NCT00878722|560500702|FG005|Overall Study|Withdrawal by Subject|0|||
155292811|NCT00878722|560500703|FG006|Overall Study|Withdrawal by Subject|0|||
155292812|NCT00878722|560500704|FG007|Overall Study|Withdrawal by Subject|2|||
155292813|NCT00878722|560500697|FG000|Overall Study|Relapse|0|||
155292814|NCT00878722|560500698|FG001|Overall Study|Relapse|0|||
155292815|NCT00878722|560500699|FG002|Overall Study|Relapse|0|||
155292816|NCT00878722|560500700|FG003|Overall Study|Relapse|1|||
155292817|NCT00878722|560500701|FG004|Overall Study|Relapse|0|||
155292818|NCT00878722|560500702|FG005|Overall Study|Relapse|0|||
155292819|NCT00878722|560500703|FG006|Overall Study|Relapse|0|||
155292820|NCT00878722|560500704|FG007|Overall Study|Relapse|0|||
155292821|NCT00383188|560500705|FG000|Overall Study|Adverse Event|4|||
155292822|NCT00383188|560500706|FG001|Overall Study|Adverse Event|7|||
155292823|NCT00383188|560500707|FG002|Overall Study|Adverse Event|9|||
155292824|NCT00383188|560500708|FG003|Overall Study|Adverse Event|8|||
155292825|NCT00383188|560500709|FG004|Overall Study|Adverse Event|8|||
155292826|NCT00383188|560500705|FG000|Overall Study|Lack of Efficacy|9|||
155409747|NCT00264004|560932340|FG000|Overall Study|Development study specific disc. crit.|1|||
155292827|NCT00383188|560500706|FG001|Overall Study|Lack of Efficacy|3|||
155292828|NCT00383188|560500707|FG002|Overall Study|Lack of Efficacy|3|||
155292829|NCT00383188|560500708|FG003|Overall Study|Lack of Efficacy|2|||
155292830|NCT00383188|560500709|FG004|Overall Study|Lack of Efficacy|6|||
155292831|NCT00383188|560500705|FG000|Overall Study|Other|3|||
155292832|NCT00383188|560500706|FG001|Overall Study|Other|1|||
155292833|NCT00383188|560500707|FG002|Overall Study|Other|0|||
155292834|NCT00383188|560500708|FG003|Overall Study|Other|2|||
155292835|NCT00383188|560500709|FG004|Overall Study|Other|6|||
155292836|NCT00383188|560500705|FG000|Overall Study|No longer willing to participate|1|||
155292837|NCT00383188|560500706|FG001|Overall Study|No longer willing to participate|0|||
155292838|NCT00383188|560500707|FG002|Overall Study|No longer willing to participate|1|||
155292839|NCT00383188|560500708|FG003|Overall Study|No longer willing to participate|0|||
155292840|NCT00383188|560500709|FG004|Overall Study|No longer willing to participate|2|||
155292841|NCT00383188|560500705|FG000|Overall Study|Lost to Follow-up|0|||
155292842|NCT00383188|560500706|FG001|Overall Study|Lost to Follow-up|0|||
155292843|NCT00383188|560500707|FG002|Overall Study|Lost to Follow-up|0|||
155292844|NCT00383188|560500708|FG003|Overall Study|Lost to Follow-up|0|||
155292845|NCT00383188|560500709|FG004|Overall Study|Lost to Follow-up|1|||
155292846|NCT01839877|560500715|FG000|Overall Study|Protocol Violation|1|||
155292847|NCT00597519|560500716|FG000|Overall Study|Death|1|||
155292848|NCT02781584|560500717|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
155292849|NCT02781584|560500718|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
155292850|NCT02781584|560500719|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
155292851|NCT02781584|560500720|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
155292852|NCT02781584|560500721|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
155292853|NCT02781584|560500722|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
155292854|NCT02781584|560500723|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
155292855|NCT02781584|560500724|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
155292856|NCT02781584|560500725|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
155292857|NCT02781584|560500726|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
155292858|NCT02781584|560500727|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
155292859|NCT02781584|560500728|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
155292860|NCT02781584|560500729|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
155292861|NCT02781584|560500717|FG000|Pre-treatment Phase|Adverse Event|0|||
155292862|NCT02781584|560500718|FG001|Pre-treatment Phase|Adverse Event|0|||
155292863|NCT02781584|560500719|FG002|Pre-treatment Phase|Adverse Event|0|||
155292864|NCT02781584|560500720|FG003|Pre-treatment Phase|Adverse Event|0|||
155292865|NCT02781584|560500721|FG004|Pre-treatment Phase|Adverse Event|0|||
155292866|NCT02781584|560500722|FG005|Pre-treatment Phase|Adverse Event|0|||
155292867|NCT02781584|560500723|FG006|Pre-treatment Phase|Adverse Event|0|||
155292868|NCT02781584|560500724|FG007|Pre-treatment Phase|Adverse Event|0|||
155292869|NCT02781584|560500725|FG008|Pre-treatment Phase|Adverse Event|0|||
155292870|NCT02781584|560500726|FG009|Pre-treatment Phase|Adverse Event|0|||
155292871|NCT02781584|560500727|FG010|Pre-treatment Phase|Adverse Event|0|||
155292872|NCT02781584|560500728|FG011|Pre-treatment Phase|Adverse Event|1|||
155292873|NCT02781584|560500729|FG012|Pre-treatment Phase|Adverse Event|0|||
155292874|NCT02781584|560500717|FG000|Treatment Phase|Withdrew Consent|0|||
155292875|NCT02781584|560500718|FG001|Treatment Phase|Withdrew Consent|0|||
155292876|NCT02781584|560500719|FG002|Treatment Phase|Withdrew Consent|0|||
155292877|NCT02781584|560500720|FG003|Treatment Phase|Withdrew Consent|0|||
155292878|NCT02781584|560500721|FG004|Treatment Phase|Withdrew Consent|0|||
155292879|NCT02781584|560500722|FG005|Treatment Phase|Withdrew Consent|1|||
155292880|NCT02781584|560500723|FG006|Treatment Phase|Withdrew Consent|0|||
155292881|NCT02781584|560500724|FG007|Treatment Phase|Withdrew Consent|0|||
155292882|NCT02781584|560500725|FG008|Treatment Phase|Withdrew Consent|0|||
155292883|NCT02781584|560500726|FG009|Treatment Phase|Withdrew Consent|0|||
155292884|NCT02781584|560500727|FG010|Treatment Phase|Withdrew Consent|1|||
155292885|NCT02781584|560500728|FG011|Treatment Phase|Withdrew Consent|2|||
155292886|NCT02781584|560500729|FG012|Treatment Phase|Withdrew Consent|0|||
155292887|NCT02781584|560500717|FG000|Treatment Phase|Adverse Event|0|||
155292888|NCT02781584|560500718|FG001|Treatment Phase|Adverse Event|0|||
155409748|NCT00264004|560932341|FG001|Overall Study|Development study specific disc. crit.|0|||
155409749|NCT00264004|560932342|FG002|Overall Study|Development study specific disc. crit.|1|||
155409750|NCT00264004|560932343|FG003|Overall Study|Development study specific disc. crit.|0|||
155409751|NCT00264004|560932340|FG000|Overall Study|Cond. under inv. worsened|9|||
155409752|NCT00264004|560932341|FG001|Overall Study|Cond. under inv. worsened|5|||
155409753|NCT00264004|560932342|FG002|Overall Study|Cond. under inv. worsened|3|||
155409754|NCT00264004|560932343|FG003|Overall Study|Cond. under inv. worsened|4|||
155409755|NCT00264004|560932340|FG000|Overall Study|Not treated|3|||
155409756|NCT00264004|560932341|FG001|Overall Study|Not treated|0|||
155409757|NCT00264004|560932342|FG002|Overall Study|Not treated|2|||
155409758|NCT00264004|560932343|FG003|Overall Study|Not treated|2|||
155409759|NCT03691974|560932344|FG000|Overall Study|Physician Decision|1|||
155409760|NCT03691974|560932345|FG001|Overall Study|Physician Decision|0|||
155409761|NCT03691974|560932344|FG000|Overall Study|Adverse Event|1|||
155638523|NCT03765073|561767664|FG011|Stage 2|Withdrawal by parent/guardian|3|||
155638524|NCT03765073|561767665|FG012|Stage 2|Withdrawal by parent/guardian|3|||
155409762|NCT03691974|560932345|FG001|Overall Study|Adverse Event|0|||
155409763|NCT03691974|560932344|FG000|Overall Study|Withdrawal by Subject|11|||
155292889|NCT02781584|560500719|FG002|Treatment Phase|Adverse Event|0|||
155292890|NCT02781584|560500720|FG003|Treatment Phase|Adverse Event|0|||
155292891|NCT02781584|560500721|FG004|Treatment Phase|Adverse Event|0|||
155292892|NCT02781584|560500722|FG005|Treatment Phase|Adverse Event|0|||
155292893|NCT02781584|560500723|FG006|Treatment Phase|Adverse Event|0|||
155292894|NCT02781584|560500724|FG007|Treatment Phase|Adverse Event|1|||
155292895|NCT02781584|560500725|FG008|Treatment Phase|Adverse Event|0|||
155292896|NCT02781584|560500726|FG009|Treatment Phase|Adverse Event|0|||
155292897|NCT02781584|560500727|FG010|Treatment Phase|Adverse Event|0|||
155409764|NCT03691974|560932345|FG001|Overall Study|Withdrawal by Subject|9|||
155409765|NCT03691974|560932344|FG000|Overall Study|Protocol Violation|1|||
155409766|NCT03691974|560932345|FG001|Overall Study|Protocol Violation|0|||
155292898|NCT02781584|560500728|FG011|Treatment Phase|Adverse Event|0|||
155292899|NCT02781584|560500729|FG012|Treatment Phase|Adverse Event|0|||
155292900|NCT03396913|560500730|FG000|Overall Study|Lost to Follow-up|0|||
155292901|NCT03396913|560500731|FG001|Overall Study|Lost to Follow-up|6|||
155292902|NCT05826431|560500732|FG000|Overall Study|Withdrawal by Subject|1|||
155292903|NCT01981356|560500743|FG000|Overall Study|Lost to Follow-up|4|||
155292904|NCT01981356|560500744|FG001|Overall Study|Lost to Follow-up|1|||
155292905|NCT01981356|560500743|FG000|Overall Study|Withdrawal by Subject|1|||
155292906|NCT01981356|560500744|FG001|Overall Study|Withdrawal by Subject|1|||
155292907|NCT01981356|560500743|FG000|Overall Study|Protocol Violation|2|||
155292908|NCT01981356|560500744|FG001|Overall Study|Protocol Violation|0|||
155292909|NCT02317016|560500745|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
155292910|NCT02317016|560500745|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
155292911|NCT02317016|560500745|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
155292912|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
155292913|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
155292914|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
155292915|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
155292916|NCT02465359|560500748|FG000|Overall Study|Lack of Efficacy|1|||
155292917|NCT02465359|560500748|FG000|Overall Study|Withdrawal by Subject|1|||
155292918|NCT02465359|560500748|FG000|Overall Study|Adverse Event|1|||
155292919|NCT02952261|560500749|FG000|Overall Study|Withdrawal by Subject|4|||
155292920|NCT02952261|560500750|FG001|Overall Study|Withdrawal by Subject|5|||
155292921|NCT02952261|560500749|FG000|Overall Study|Protocol Violation|1|||
155292922|NCT02952261|560500750|FG001|Overall Study|Protocol Violation|0|||
155292923|NCT00798265|560500751|FG000|Overall Study|Lost to Follow-up|1|||
155292924|NCT00798265|560500752|FG001|Overall Study|Lost to Follow-up|10|||
155292925|NCT00798265|560500751|FG000|Overall Study|Study closing|7|||
155292926|NCT00798265|560500752|FG001|Overall Study|Study closing|6|||
155292927|NCT00798265|560500751|FG000|Overall Study|Withdrawal by Subject|0|||
155292928|NCT00798265|560500752|FG001|Overall Study|Withdrawal by Subject|1|||
155292929|NCT00798265|560500751|FG000|Overall Study|Screen failure|0|||
155292930|NCT00798265|560500752|FG001|Overall Study|Screen failure|1|||
155292931|NCT03141788|560500753|FG000|Overall Study|Lost to Follow-up|1|||
155292932|NCT03141788|560500753|FG000|Overall Study|Protocol Violation|3|||
155292933|NCT03141788|560500753|FG000|Overall Study|Withdrawal by Subject|4|||
155292934|NCT02810080|560502676|FG000|Overall Study|Adverse Event|3|||
155292935|NCT02810080|560502677|FG001|Overall Study|Adverse Event|0|||
155292936|NCT02810080|560502676|FG000|Overall Study|Death|0|||
155292937|NCT02810080|560502677|FG001|Overall Study|Death|2|||
155292938|NCT02810080|560502676|FG000|Overall Study|Physician Decision|4|||
155292939|NCT02810080|560502677|FG001|Overall Study|Physician Decision|0|||
155292940|NCT02810080|560502676|FG000|Overall Study|Withdrawal by Subject|0|||
155292941|NCT02810080|560502677|FG001|Overall Study|Withdrawal by Subject|2|||
155409767|NCT03691974|560932344|FG000|Overall Study|Lost to Follow-up|8|||
155409768|NCT03691974|560932345|FG001|Overall Study|Lost to Follow-up|7|||
155409769|NCT00691483|560932346|FG000|Overall Study|Adverse Event|14|||
155409770|NCT00691483|560932347|FG001|Overall Study|Adverse Event|6|||
155292942|NCT00094809|560502689|FG000|Overall Study|Protocol deviation|2|||
155409771|NCT00691483|560932346|FG000|Overall Study|Lost to Follow-up|17|||
155409772|NCT00691483|560932347|FG001|Overall Study|Lost to Follow-up|10|||
155409773|NCT00691483|560932346|FG000|Overall Study|Withdrawal by Subject|24|||
155409774|NCT00691483|560932347|FG001|Overall Study|Withdrawal by Subject|7|||
155409775|NCT00691483|560932346|FG000|Overall Study|Other known cause|6|||
155409776|NCT00691483|560932347|FG001|Overall Study|Other known cause|1|||
155409777|NCT00691483|560932346|FG000|Overall Study|Randomized by not treated|7|||
155409778|NCT00691483|560932347|FG001|Overall Study|Randomized by not treated|1|||
155292943|NCT00094809|560502690|FG001|Overall Study|Protocol deviation|2|||
155292944|NCT00094809|560502689|FG000|Overall Study|Noncompliance|1|||
155292945|NCT00094809|560502690|FG001|Overall Study|Noncompliance|0|||
155409779|NCT00746252|560932348|FG000|Overall Study|weight gain >7.5 %|1|||
155409780|NCT00746252|560932349|FG001|Overall Study|weight gain >7.5 %|2|||
155409781|NCT01391000|560932351|FG000|Overall Study|Lost to Follow-up|2|||
155409782|NCT01391000|560932352|FG001|Overall Study|Lost to Follow-up|0|||
155292946|NCT00094809|560502689|FG000|Overall Study|Adverse Event|3|||
155292947|NCT00094809|560502690|FG001|Overall Study|Adverse Event|1|||
155292948|NCT00094809|560502689|FG000|Overall Study|Withdrawal by Subject|8|||
155409783|NCT00082888|560932353|FG000|Overall Study|Ineligible|1|||
155409784|NCT00082888|560932354|FG001|Overall Study|Ineligible|0|||
155409785|NCT00082888|560932355|FG002|Overall Study|Ineligible|0|||
155409786|NCT03860961|560932356|FG000|Overall Study|Withdrawal by Subject|6|||
155292949|NCT00094809|560502690|FG001|Overall Study|Withdrawal by Subject|9|||
155292950|NCT00094809|560502689|FG000|Overall Study|Disease progression|3|||
155292951|NCT00094809|560502690|FG001|Overall Study|Disease progression|3|||
155292952|NCT00094809|560502689|FG000|Overall Study|Physician Decision|3|||
155409787|NCT03860961|560932357|FG001|Overall Study|Withdrawal by Subject|11|||
155292953|NCT00094809|560502690|FG001|Overall Study|Physician Decision|5|||
155292954|NCT00094809|560502689|FG000|Overall Study|Lost to Follow-up|6|||
155292955|NCT00094809|560502690|FG001|Overall Study|Lost to Follow-up|6|||
155292956|NCT00094809|560502689|FG000|Overall Study|Death|19|||
155292957|NCT00094809|560502690|FG001|Overall Study|Death|25|||
155292958|NCT00094809|560502689|FG000|Overall Study|Protocol-specified criteria|1|||
155292959|NCT00094809|560502690|FG001|Overall Study|Protocol-specified criteria|1|||
155292960|NCT00094809|560502689|FG000|Overall Study|Other|2|||
155292961|NCT00094809|560502690|FG001|Overall Study|Other|4|||
155292962|NCT00094809|560502689|FG000|Overall Study|Informed consent signed after treatment|1|||
155292963|NCT00094809|560502690|FG001|Overall Study|Informed consent signed after treatment|0|||
155292964|NCT00094809|560502689|FG000|Overall Study|Study drug not received|2|||
155292965|NCT00094809|560502690|FG001|Overall Study|Study drug not received|8|||
155292966|NCT00094809|560502689|FG000|Overall Study|Other|1|||
155292967|NCT00094809|560502690|FG001|Overall Study|Other|1|||
155292968|NCT02469064|560502696|FG000|Overall Study|Request not to receive intervention.|1|||
155292969|NCT02469064|560502697|FG001|Overall Study|Request not to receive intervention.|3|||
155292970|NCT02506257|560502698|FG000|Overall Study|Adverse Event|0|||
155292971|NCT02506257|560502699|FG001|Overall Study|Adverse Event|2|||
155292972|NCT02506257|560502700|FG002|Overall Study|Adverse Event|3|||
155292973|NCT02506257|560502701|FG003|Overall Study|Adverse Event|0|||
155292974|NCT02506257|560502698|FG000|Overall Study|Protocol Violation|0|||
155292975|NCT02506257|560502699|FG001|Overall Study|Protocol Violation|0|||
155292976|NCT02506257|560502700|FG002|Overall Study|Protocol Violation|1|||
155292977|NCT02506257|560502701|FG003|Overall Study|Protocol Violation|0|||
155292978|NCT00964366|560502702|FG000|Overall Study|Did not qualify at Day 1|1|||
155292979|NCT00964366|560502703|FG001|Overall Study|Did not qualify at Day 1|0|||
155292980|NCT00964366|560502702|FG000|Overall Study|Withdrawal by Subject|0|||
155292981|NCT00964366|560502703|FG001|Overall Study|Withdrawal by Subject|1|||
155292982|NCT02957539|560502707|FG000|Baseline to Week 16|Lost to Follow-up|8|||
155292983|NCT02957539|560502708|FG001|Baseline to Week 16|Lost to Follow-up|10|||
155292984|NCT02957539|560502709|FG002|Baseline to Week 16|Lost to Follow-up|16|||
155292985|NCT02957539|560502707|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
155292986|NCT02957539|560502708|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
155292987|NCT02957539|560502709|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
155292988|NCT02957539|560502707|FG000|Week 16 to 32|Withdrawal by Subject|3|||
155292989|NCT02957539|560502708|FG001|Week 16 to 32|Withdrawal by Subject|3|||
155292990|NCT02957539|560502709|FG002|Week 16 to 32|Withdrawal by Subject|1|||
155292991|NCT02957539|560502707|FG000|Week 16 to 32|Lost to Follow-up|8|||
155409788|NCT03860961|560932356|FG000|Overall Study|Death|10|||
155409789|NCT03860961|560932357|FG001|Overall Study|Death|6|||
155409790|NCT03860961|560932356|FG000|Overall Study|Incomplete two-year data|4|||
155409791|NCT03860961|560932357|FG001|Overall Study|Incomplete two-year data|0|||
155409792|NCT00272038|560932358|FG000|Overall Study|withdrew before they received 2 cycles|7|||
155409793|NCT03189446|560932359|FG000|Overall Study|Adverse Event|2|||
155409794|NCT03189446|560932359|FG000|Overall Study|Withdrawal by Subject|2|||
155409795|NCT03189446|560932359|FG000|Overall Study|Physician Decision|1|||
155409796|NCT00527605|560932360|FG000|Overall Study|Adverse Event|3|||
155409797|NCT00527605|560932361|FG001|Overall Study|Adverse Event|0|||
155409798|NCT00527605|560932360|FG000|Overall Study|Withdrawal by Subject|3|||
155409799|NCT00527605|560932361|FG001|Overall Study|Withdrawal by Subject|7|||
155409800|NCT00527605|560932360|FG000|Overall Study|Lost to Follow-up|6|||
155409801|NCT00527605|560932361|FG001|Overall Study|Lost to Follow-up|2|||
155409802|NCT00527605|560932360|FG000|Overall Study|Protocol Violation|1|||
155409803|NCT00527605|560932361|FG001|Overall Study|Protocol Violation|2|||
155409804|NCT04312009|560932365|FG000|Overall Study|Withdrawal by Subject|2|||
155409805|NCT04312009|560932366|FG001|Overall Study|Withdrawal by Subject|1|||
155409806|NCT01268293|560932368|FG000|Overall Study|Disease progression|7|||
155409807|NCT01268293|560932368|FG000|Overall Study|Adverse Event|1|||
155409808|NCT01268293|560932368|FG000|Overall Study|Subject choice|1|||
155409809|NCT03468309|560932369|FG000|Overall Study|Lost to Follow-up|4|||
155409810|NCT03468309|560932369|FG000|Overall Study|Withdrawal by Subject|2|||
155409811|NCT03548558|560932371|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
155409812|NCT03548558|560932372|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
155409813|NCT03548558|560932373|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
155409814|NCT03548558|560932374|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
155409815|NCT03548558|560932375|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
155409816|NCT03548558|560932376|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
155409817|NCT03548558|560932377|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
155292992|NCT02957539|560502708|FG001|Week 16 to 32|Lost to Follow-up|7|||
155292993|NCT02957539|560502709|FG002|Week 16 to 32|Lost to Follow-up|5|||
155292994|NCT02957539|560502707|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
155292995|NCT02957539|560502708|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
155292996|NCT02957539|560502709|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
155292997|NCT02957539|560502707|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
155292998|NCT02957539|560502708|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
155292999|NCT02957539|560502709|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
155293000|NCT04842604|560502711|FG000|Overall Study|Death|1|||
155293001|NCT04842604|560502712|FG001|Overall Study|Death|0|||
155293002|NCT04842604|560502711|FG000|Overall Study|Other|4|||
155293003|NCT04842604|560502712|FG001|Overall Study|Other|4|||
155293004|NCT04842604|560502711|FG000|Overall Study|Randomized but not treated|1|||
155293005|NCT04842604|560502712|FG001|Overall Study|Randomized but not treated|0|||
155293006|NCT01193153|560502714|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
155293007|NCT01193153|560502715|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
155293008|NCT01193153|560502714|FG000|Open-label Lead in Period|Pregnancy|1|||
155293009|NCT01193153|560502715|FG001|Open-label Lead in Period|Pregnancy|0|||
155293010|NCT01193153|560502714|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
155293011|NCT01193153|560502715|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
155293012|NCT01193153|560502714|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
155293013|NCT01193153|560502715|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
155293014|NCT01193153|560502714|FG000|Open-label Lead in Period|Other|14|||
155293015|NCT01193153|560502715|FG001|Open-label Lead in Period|Other|0|||
155293016|NCT01193153|560502714|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
155293017|NCT01193153|560502715|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
155293018|NCT01193153|560502714|FG000|Open-label Lead in Period|Adverse Event|41|||
155293019|NCT01193153|560502715|FG001|Open-label Lead in Period|Adverse Event|0|||
155293020|NCT01193153|560502714|FG000|Open-label Lead in Period|Death|1|||
155293021|NCT01193153|560502715|FG001|Open-label Lead in Period|Death|0|||
155293022|NCT01193153|560502714|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
155293023|NCT01193153|560502715|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
155293024|NCT01193153|560502714|FG000|Open-label Stabilization Period|Adverse Event|9|||
155293025|NCT01193153|560502715|FG001|Open-label Stabilization Period|Adverse Event|0|||
155293026|NCT01193153|560502714|FG000|Open-label Stabilization Period|Death|2|||
155293027|NCT01193153|560502715|FG001|Open-label Stabilization Period|Death|0|||
155293028|NCT01193153|560502714|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
155293029|NCT01193153|560502715|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
155293030|NCT01193153|560502714|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
155293031|NCT01193153|560502715|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
155293032|NCT01193153|560502714|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
155293033|NCT01193153|560502715|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
155293034|NCT01193153|560502714|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
155293035|NCT01193153|560502715|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
155293036|NCT01193153|560502714|FG000|Open-label Stabilization Period|Other|8|||
155293037|NCT01193153|560502715|FG001|Open-label Stabilization Period|Other|0|||
155293038|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Other|2|||
155293039|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Other|3|||
155293040|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
155293041|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
155293042|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Death|2|||
155293043|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Death|0|||
155293044|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
155293045|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
155293046|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
155293047|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
155293048|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
155409818|NCT03548558|560932371|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
155409819|NCT03548558|560932372|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
155409820|NCT03548558|560932373|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
155409821|NCT03548558|560932374|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
155409822|NCT03548558|560932375|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
155638525|NCT03765073|561767666|FG013|Stage 2|Withdrawal by parent/guardian|1|||
155638526|NCT03765073|561767667|FG014|Stage 2|Withdrawal by parent/guardian|1|||
155638527|NCT03765073|561767668|FG015|Stage 2|Withdrawal by parent/guardian|0|||
155638528|NCT03765073|561767669|FG016|Stage 2|Withdrawal by parent/guardian|3|||
155638529|NCT03765073|561767670|FG017|Stage 2|Withdrawal by parent/guardian|0|||
155638530|NCT03765073|561767671|FG018|Stage 2|Withdrawal by parent/guardian|0|||
155638531|NCT03765073|561767672|FG019|Stage 2|Withdrawal by parent/guardian|0|||
155638532|NCT03765073|561767673|FG020|Stage 2|Withdrawal by parent/guardian|0|||
155638533|NCT03765073|561767653|FG000|Stage 2|Withdrawal by Subject|0|||
155293049|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
155293050|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
155293051|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
155638534|NCT03765073|561767654|FG001|Stage 2|Withdrawal by Subject|0|||
155638535|NCT03765073|561767655|FG002|Stage 2|Withdrawal by Subject|0|||
155638536|NCT03765073|561767656|FG003|Stage 2|Withdrawal by Subject|3|||
155638537|NCT03765073|561767657|FG004|Stage 2|Withdrawal by Subject|3|||
155638538|NCT03765073|561767658|FG005|Stage 2|Withdrawal by Subject|3|||
155293052|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
155293053|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
155293054|NCT01563354|560502718|FG000|Core Phase|Adverse Event|5|||
155293055|NCT01563354|560502719|FG001|Core Phase|Adverse Event|15|||
155293056|NCT01563354|560502720|FG002|Core Phase|Adverse Event|13|||
155293057|NCT01563354|560502718|FG000|Core Phase|Withdrawal by Subject|1|||
155293058|NCT01563354|560502719|FG001|Core Phase|Withdrawal by Subject|0|||
155293059|NCT01563354|560502720|FG002|Core Phase|Withdrawal by Subject|3|||
155293060|NCT01563354|560502718|FG000|Core Phase|Lost to Follow-up|1|||
155293061|NCT01563354|560502719|FG001|Core Phase|Lost to Follow-up|0|||
155293062|NCT01563354|560502720|FG002|Core Phase|Lost to Follow-up|0|||
155293063|NCT01563354|560502718|FG000|Core Phase|Death|1|||
155293064|NCT01563354|560502719|FG001|Core Phase|Death|5|||
155293065|NCT01563354|560502720|FG002|Core Phase|Death|2|||
155293066|NCT01563354|560502718|FG000|Core Phase|Diseasse progression|18|||
155293067|NCT01563354|560502719|FG001|Core Phase|Diseasse progression|7|||
155293068|NCT01563354|560502720|FG002|Core Phase|Diseasse progression|8|||
155293069|NCT01563354|560502718|FG000|Core Phase|Protocol deviation|2|||
155293070|NCT01563354|560502719|FG001|Core Phase|Protocol deviation|0|||
155293071|NCT01563354|560502720|FG002|Core Phase|Protocol deviation|0|||
155293072|NCT01563354|560502718|FG000|Core Phase|PI decision - did not enter extension|0|||
155293073|NCT01563354|560502719|FG001|Core Phase|PI decision - did not enter extension|1|||
155293074|NCT01563354|560502720|FG002|Core Phase|PI decision - did not enter extension|0|||
155293075|NCT01563354|560502718|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
155293076|NCT01563354|560502719|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
155293077|NCT01563354|560502720|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
155293078|NCT01563354|560502718|FG000|Extension Phase|Adverse Event|0|||
155293079|NCT01563354|560502719|FG001|Extension Phase|Adverse Event|3|||
155293080|NCT01563354|560502720|FG002|Extension Phase|Adverse Event|2|||
155293081|NCT01563354|560502718|FG000|Extension Phase|Withdrawal by Subject|0|||
155293082|NCT01563354|560502719|FG001|Extension Phase|Withdrawal by Subject|1|||
155293083|NCT01563354|560502720|FG002|Extension Phase|Withdrawal by Subject|0|||
155293084|NCT01563354|560502718|FG000|Extension Phase|Administration problems|3|||
155293085|NCT01563354|560502719|FG001|Extension Phase|Administration problems|2|||
155293086|NCT01563354|560502720|FG002|Extension Phase|Administration problems|3|||
155293087|NCT01563354|560502718|FG000|Extension Phase|Disease progression|9|||
155293088|NCT01563354|560502719|FG001|Extension Phase|Disease progression|8|||
155293089|NCT01563354|560502720|FG002|Extension Phase|Disease progression|10|||
155293090|NCT00079183|560502754|FG000|Overall Study|Withdrawal by Subject|4|||
155293091|NCT00079183|560502754|FG000|Overall Study|Study medication non-compliance|2|||
155293092|NCT00079183|560502754|FG000|Overall Study|Specimen collection non-compliance|1|||
155293093|NCT00770965|560502755|FG000|Safety Set|Withdrawal by Subject|0|||
155293094|NCT00770965|560502756|FG001|Safety Set|Withdrawal by Subject|0|||
155409823|NCT03548558|560932376|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
155638539|NCT03765073|561767659|FG006|Stage 2|Withdrawal by Subject|0|||
155638540|NCT03765073|561767660|FG007|Stage 2|Withdrawal by Subject|1|||
155638541|NCT03765073|561767661|FG008|Stage 2|Withdrawal by Subject|0|||
155638542|NCT03765073|561767662|FG009|Stage 2|Withdrawal by Subject|5|||
155638543|NCT03765073|561767663|FG010|Stage 2|Withdrawal by Subject|0|||
155638544|NCT03765073|561767664|FG011|Stage 2|Withdrawal by Subject|0|||
155638545|NCT03765073|561767665|FG012|Stage 2|Withdrawal by Subject|0|||
155638546|NCT03765073|561767666|FG013|Stage 2|Withdrawal by Subject|0|||
155638547|NCT03765073|561767667|FG014|Stage 2|Withdrawal by Subject|0|||
155638548|NCT03765073|561767668|FG015|Stage 2|Withdrawal by Subject|0|||
155638549|NCT03765073|561767669|FG016|Stage 2|Withdrawal by Subject|0|||
155638550|NCT03765073|561767670|FG017|Stage 2|Withdrawal by Subject|0|||
155638551|NCT03765073|561767671|FG018|Stage 2|Withdrawal by Subject|0|||
155638552|NCT03765073|561767672|FG019|Stage 2|Withdrawal by Subject|0|||
155638553|NCT03765073|561767673|FG020|Stage 2|Withdrawal by Subject|0|||
155638554|NCT03765073|561767653|FG000|Stage 3|Adverse Event|0|||
155638555|NCT03765073|561767654|FG001|Stage 3|Adverse Event|0|||
155638556|NCT03765073|561767655|FG002|Stage 3|Adverse Event|0|||
155293095|NCT00770965|560502757|FG002|Safety Set|Withdrawal by Subject|0|||
155293096|NCT00770965|560502758|FG003|Safety Set|Withdrawal by Subject|1|||
155293097|NCT00770965|560502755|FG000|Safety Set|Protocol deviation|0|||
155293098|NCT00770965|560502756|FG001|Safety Set|Protocol deviation|0|||
155293099|NCT00770965|560502757|FG002|Safety Set|Protocol deviation|1|||
155293100|NCT00770965|560502758|FG003|Safety Set|Protocol deviation|0|||
155638557|NCT03765073|561767656|FG003|Stage 3|Adverse Event|0|||
155638558|NCT03765073|561767657|FG004|Stage 3|Adverse Event|0|||
155638559|NCT03765073|561767658|FG005|Stage 3|Adverse Event|0|||
155293101|NCT00770965|560502755|FG000|Excluded Set|Administrative problems|14|||
155293102|NCT00770965|560502756|FG001|Excluded Set|Administrative problems|12|||
155293103|NCT00770965|560502757|FG002|Excluded Set|Administrative problems|12|||
155293104|NCT00770965|560502758|FG003|Excluded Set|Administrative problems|10|||
155638560|NCT03765073|561767659|FG006|Stage 3|Adverse Event|0|||
155638561|NCT03765073|561767660|FG007|Stage 3|Adverse Event|0|||
155638562|NCT03765073|561767661|FG008|Stage 3|Adverse Event|0|||
155638563|NCT03765073|561767662|FG009|Stage 3|Adverse Event|0|||
155638564|NCT03765073|561767663|FG010|Stage 3|Adverse Event|0|||
155638565|NCT03765073|561767664|FG011|Stage 3|Adverse Event|0|||
155638566|NCT03765073|561767665|FG012|Stage 3|Adverse Event|0|||
155638567|NCT03765073|561767666|FG013|Stage 3|Adverse Event|0|||
155638568|NCT03765073|561767667|FG014|Stage 3|Adverse Event|0|||
155638569|NCT03765073|561767668|FG015|Stage 3|Adverse Event|0|||
155638570|NCT03765073|561767669|FG016|Stage 3|Adverse Event|0|||
155638571|NCT03765073|561767670|FG017|Stage 3|Adverse Event|0|||
155638572|NCT03765073|561767671|FG018|Stage 3|Adverse Event|1|||
155638573|NCT03765073|561767672|FG019|Stage 3|Adverse Event|0|||
155638574|NCT03765073|561767673|FG020|Stage 3|Adverse Event|0|||
155638575|NCT03765073|561767653|FG000|Stage 3|Death|0|||
155638576|NCT03765073|561767654|FG001|Stage 3|Death|0|||
155638577|NCT03765073|561767655|FG002|Stage 3|Death|0|||
155638578|NCT03765073|561767656|FG003|Stage 3|Death|0|||
155638579|NCT03765073|561767657|FG004|Stage 3|Death|0|||
155638580|NCT03765073|561767658|FG005|Stage 3|Death|0|||
155638581|NCT03765073|561767659|FG006|Stage 3|Death|0|||
155638582|NCT03765073|561767660|FG007|Stage 3|Death|0|||
155638583|NCT03765073|561767661|FG008|Stage 3|Death|0|||
155638584|NCT03765073|561767662|FG009|Stage 3|Death|0|||
155638585|NCT03765073|561767663|FG010|Stage 3|Death|0|||
155638586|NCT03765073|561767664|FG011|Stage 3|Death|0|||
155638587|NCT03765073|561767665|FG012|Stage 3|Death|0|||
155638588|NCT03765073|561767666|FG013|Stage 3|Death|0|||
155638589|NCT03765073|561767667|FG014|Stage 3|Death|0|||
155638590|NCT03765073|561767668|FG015|Stage 3|Death|0|||
155638591|NCT03765073|561767669|FG016|Stage 3|Death|0|||
155638592|NCT03765073|561767670|FG017|Stage 3|Death|0|||
155638593|NCT03765073|561767671|FG018|Stage 3|Death|0|||
155638594|NCT03765073|561767672|FG019|Stage 3|Death|3|||
155638595|NCT03765073|561767673|FG020|Stage 3|Death|2|||
155638596|NCT03765073|561767653|FG000|Stage 3|Lost to Follow-up|0|||
155638597|NCT03765073|561767654|FG001|Stage 3|Lost to Follow-up|0|||
155638598|NCT03765073|561767655|FG002|Stage 3|Lost to Follow-up|0|||
155293105|NCT00770965|560502755|FG000|Excluded Set|Withdrawal by Subject|1|||
155293106|NCT00770965|560502756|FG001|Excluded Set|Withdrawal by Subject|1|||
155293107|NCT00770965|560502757|FG002|Excluded Set|Withdrawal by Subject|2|||
155293108|NCT00770965|560502758|FG003|Excluded Set|Withdrawal by Subject|3|||
155293109|NCT02613364|560502759|FG000|Overall Study|Other|19|||
155293110|NCT02613364|560502760|FG001|Overall Study|Other|29|||
155293111|NCT02613364|560502761|FG002|Overall Study|Other|17|||
155293112|NCT02613364|560502759|FG000|Overall Study|Too time consuming|21|||
155293113|NCT02613364|560502760|FG001|Overall Study|Too time consuming|26|||
155293114|NCT02613364|560502761|FG002|Overall Study|Too time consuming|26|||
155293115|NCT02613364|560502759|FG000|Overall Study|Withdrawal by Subject|13|||
155293116|NCT02613364|560502760|FG001|Overall Study|Withdrawal by Subject|18|||
155293117|NCT02613364|560502761|FG002|Overall Study|Withdrawal by Subject|17|||
155293118|NCT02613364|560502759|FG000|Overall Study|Medical|12|||
155293119|NCT02613364|560502760|FG001|Overall Study|Medical|13|||
155293120|NCT02613364|560502761|FG002|Overall Study|Medical|9|||
155293121|NCT02613364|560502759|FG000|Overall Study|Disliked Study Procedure|1|||
155293122|NCT02613364|560502760|FG001|Overall Study|Disliked Study Procedure|1|||
155293123|NCT02613364|560502761|FG002|Overall Study|Disliked Study Procedure|4|||
155293124|NCT02613364|560502759|FG000|Overall Study|Disliked Intervention|0|||
155293125|NCT02613364|560502760|FG001|Overall Study|Disliked Intervention|3|||
155293126|NCT02613364|560502761|FG002|Overall Study|Disliked Intervention|3|||
155293127|NCT01235949|560502762|FG000|Primary Phase|Migrated/moved from study area|1|||
155293128|NCT01235949|560502763|FG001|Primary Phase|Migrated/moved from study area|1|||
155293129|NCT01235949|560502764|FG002|Primary Phase|Migrated/moved from study area|0|||
155293130|NCT01235949|560502765|FG003|Primary Phase|Migrated/moved from study area|0|||
155293131|NCT01235949|560502766|FG004|Primary Phase|Migrated/moved from study area|1|||
155293132|NCT01235949|560502767|FG005|Primary Phase|Migrated/moved from study area|2|||
155293133|NCT01235949|560502768|FG006|Primary Phase|Migrated/moved from study area|0|||
155293134|NCT01235949|560502769|FG007|Primary Phase|Migrated/moved from study area|0|||
155293135|NCT01235949|560502770|FG008|Primary Phase|Migrated/moved from study area|0|||
155293136|NCT01235949|560502771|FG009|Primary Phase|Migrated/moved from study area|0|||
155293137|NCT01235949|560502772|FG010|Primary Phase|Migrated/moved from study area|0|||
155293138|NCT01235949|560502773|FG011|Primary Phase|Migrated/moved from study area|0|||
155293139|NCT01235949|560502774|FG012|Primary Phase|Migrated/moved from study area|0|||
155293140|NCT01235949|560502775|FG013|Primary Phase|Migrated/moved from study area|0|||
155293141|NCT01235949|560502776|FG014|Primary Phase|Migrated/moved from study area|0|||
155293142|NCT01235949|560502777|FG015|Primary Phase|Migrated/moved from study area|0|||
155293143|NCT01235949|560502778|FG016|Primary Phase|Migrated/moved from study area|0|||
155293144|NCT01235949|560502779|FG017|Primary Phase|Migrated/moved from study area|0|||
155293145|NCT01235949|560502762|FG000|Primary Phase|Adverse Event|0|||
155293146|NCT01235949|560502763|FG001|Primary Phase|Adverse Event|0|||
155293147|NCT01235949|560502764|FG002|Primary Phase|Adverse Event|0|||
155293148|NCT01235949|560502765|FG003|Primary Phase|Adverse Event|1|||
155293149|NCT01235949|560502766|FG004|Primary Phase|Adverse Event|0|||
155293150|NCT01235949|560502767|FG005|Primary Phase|Adverse Event|0|||
155293151|NCT01235949|560502768|FG006|Primary Phase|Adverse Event|0|||
155293152|NCT01235949|560502769|FG007|Primary Phase|Adverse Event|0|||
155293153|NCT01235949|560502770|FG008|Primary Phase|Adverse Event|0|||
155293154|NCT01235949|560502771|FG009|Primary Phase|Adverse Event|0|||
155293155|NCT01235949|560502772|FG010|Primary Phase|Adverse Event|0|||
155293156|NCT01235949|560502773|FG011|Primary Phase|Adverse Event|0|||
155293157|NCT01235949|560502774|FG012|Primary Phase|Adverse Event|0|||
155293158|NCT01235949|560502775|FG013|Primary Phase|Adverse Event|0|||
155293159|NCT01235949|560502776|FG014|Primary Phase|Adverse Event|0|||
155293160|NCT01235949|560502777|FG015|Primary Phase|Adverse Event|0|||
155293161|NCT01235949|560502778|FG016|Primary Phase|Adverse Event|0|||
155293162|NCT01235949|560502779|FG017|Primary Phase|Adverse Event|0|||
155293163|NCT01235949|560502762|FG000|Primary Phase|Withdrawal by Subject|3|||
155638599|NCT03765073|561767656|FG003|Stage 3|Lost to Follow-up|0|||
155638600|NCT03765073|561767657|FG004|Stage 3|Lost to Follow-up|0|||
155638601|NCT03765073|561767658|FG005|Stage 3|Lost to Follow-up|0|||
155638602|NCT03765073|561767659|FG006|Stage 3|Lost to Follow-up|0|||
155638603|NCT03765073|561767660|FG007|Stage 3|Lost to Follow-up|0|||
155293164|NCT01235949|560502763|FG001|Primary Phase|Withdrawal by Subject|2|||
155293165|NCT01235949|560502764|FG002|Primary Phase|Withdrawal by Subject|2|||
155293166|NCT01235949|560502765|FG003|Primary Phase|Withdrawal by Subject|0|||
155293167|NCT01235949|560502766|FG004|Primary Phase|Withdrawal by Subject|0|||
155293168|NCT01235949|560502767|FG005|Primary Phase|Withdrawal by Subject|3|||
155293169|NCT01235949|560502768|FG006|Primary Phase|Withdrawal by Subject|0|||
155293170|NCT01235949|560502769|FG007|Primary Phase|Withdrawal by Subject|0|||
155638604|NCT03765073|561767661|FG008|Stage 3|Lost to Follow-up|0|||
155293171|NCT01235949|560502770|FG008|Primary Phase|Withdrawal by Subject|0|||
155293172|NCT01235949|560502771|FG009|Primary Phase|Withdrawal by Subject|0|||
155293173|NCT01235949|560502772|FG010|Primary Phase|Withdrawal by Subject|0|||
155293174|NCT01235949|560502773|FG011|Primary Phase|Withdrawal by Subject|0|||
155638605|NCT03765073|561767662|FG009|Stage 3|Lost to Follow-up|0|||
155293175|NCT01235949|560502774|FG012|Primary Phase|Withdrawal by Subject|0|||
155293176|NCT01235949|560502775|FG013|Primary Phase|Withdrawal by Subject|0|||
155293177|NCT01235949|560502776|FG014|Primary Phase|Withdrawal by Subject|0|||
155293178|NCT01235949|560502777|FG015|Primary Phase|Withdrawal by Subject|0|||
155293179|NCT01235949|560502778|FG016|Primary Phase|Withdrawal by Subject|0|||
155293180|NCT01235949|560502779|FG017|Primary Phase|Withdrawal by Subject|0|||
155293181|NCT01235949|560502762|FG000|Primary Phase|Lost to Follow-up|0|||
155293182|NCT01235949|560502763|FG001|Primary Phase|Lost to Follow-up|0|||
155293183|NCT01235949|560502764|FG002|Primary Phase|Lost to Follow-up|1|||
155293184|NCT01235949|560502765|FG003|Primary Phase|Lost to Follow-up|1|||
155293185|NCT01235949|560502766|FG004|Primary Phase|Lost to Follow-up|0|||
155293186|NCT01235949|560502767|FG005|Primary Phase|Lost to Follow-up|2|||
155293187|NCT01235949|560502768|FG006|Primary Phase|Lost to Follow-up|0|||
155293188|NCT01235949|560502769|FG007|Primary Phase|Lost to Follow-up|0|||
155293189|NCT01235949|560502770|FG008|Primary Phase|Lost to Follow-up|0|||
155293190|NCT01235949|560502771|FG009|Primary Phase|Lost to Follow-up|0|||
155293191|NCT01235949|560502772|FG010|Primary Phase|Lost to Follow-up|0|||
155293192|NCT01235949|560502773|FG011|Primary Phase|Lost to Follow-up|0|||
155293193|NCT01235949|560502774|FG012|Primary Phase|Lost to Follow-up|0|||
155293194|NCT01235949|560502775|FG013|Primary Phase|Lost to Follow-up|0|||
155293195|NCT01235949|560502776|FG014|Primary Phase|Lost to Follow-up|0|||
155293196|NCT01235949|560502777|FG015|Primary Phase|Lost to Follow-up|0|||
155293197|NCT01235949|560502778|FG016|Primary Phase|Lost to Follow-up|0|||
155293198|NCT01235949|560502779|FG017|Primary Phase|Lost to Follow-up|0|||
155293199|NCT01235949|560502762|FG000|Booster Phase|Migrated/moved from study area|0|||
155293200|NCT01235949|560502763|FG001|Booster Phase|Migrated/moved from study area|0|||
155293201|NCT01235949|560502764|FG002|Booster Phase|Migrated/moved from study area|0|||
155293202|NCT01235949|560502765|FG003|Booster Phase|Migrated/moved from study area|0|||
155293203|NCT01235949|560502766|FG004|Booster Phase|Migrated/moved from study area|0|||
155293204|NCT01235949|560502767|FG005|Booster Phase|Migrated/moved from study area|0|||
155293205|NCT01235949|560502768|FG006|Booster Phase|Migrated/moved from study area|0|||
155293206|NCT01235949|560502769|FG007|Booster Phase|Migrated/moved from study area|0|||
155293207|NCT01235949|560502770|FG008|Booster Phase|Migrated/moved from study area|0|||
155293208|NCT01235949|560502771|FG009|Booster Phase|Migrated/moved from study area|0|||
155293209|NCT01235949|560502772|FG010|Booster Phase|Migrated/moved from study area|0|||
155293210|NCT01235949|560502773|FG011|Booster Phase|Migrated/moved from study area|1|||
155293211|NCT01235949|560502774|FG012|Booster Phase|Migrated/moved from study area|1|||
155293212|NCT01235949|560502775|FG013|Booster Phase|Migrated/moved from study area|0|||
155293213|NCT01235949|560502776|FG014|Booster Phase|Migrated/moved from study area|0|||
155293214|NCT01235949|560502777|FG015|Booster Phase|Migrated/moved from study area|0|||
155293215|NCT01235949|560502778|FG016|Booster Phase|Migrated/moved from study area|0|||
155293216|NCT01235949|560502779|FG017|Booster Phase|Migrated/moved from study area|1|||
155293217|NCT01235949|560502762|FG000|Booster Phase|Adverse Event|0|||
155293218|NCT01235949|560502763|FG001|Booster Phase|Adverse Event|0|||
155293219|NCT01235949|560502764|FG002|Booster Phase|Adverse Event|0|||
155293220|NCT01235949|560502765|FG003|Booster Phase|Adverse Event|0|||
155293221|NCT01235949|560502766|FG004|Booster Phase|Adverse Event|0|||
155293222|NCT01235949|560502767|FG005|Booster Phase|Adverse Event|0|||
155293223|NCT01235949|560502768|FG006|Booster Phase|Adverse Event|0|||
155293224|NCT01235949|560502769|FG007|Booster Phase|Adverse Event|0|||
155293225|NCT01235949|560502770|FG008|Booster Phase|Adverse Event|0|||
155293226|NCT01235949|560502771|FG009|Booster Phase|Adverse Event|0|||
155293227|NCT01235949|560502772|FG010|Booster Phase|Adverse Event|0|||
155293228|NCT01235949|560502773|FG011|Booster Phase|Adverse Event|0|||
155293229|NCT01235949|560502774|FG012|Booster Phase|Adverse Event|0|||
155293230|NCT01235949|560502775|FG013|Booster Phase|Adverse Event|0|||
155293231|NCT01235949|560502776|FG014|Booster Phase|Adverse Event|0|||
155293232|NCT01235949|560502777|FG015|Booster Phase|Adverse Event|1|||
155293233|NCT01235949|560502778|FG016|Booster Phase|Adverse Event|0|||
155293234|NCT01235949|560502779|FG017|Booster Phase|Adverse Event|0|||
155293235|NCT01235949|560502762|FG000|Booster Phase|Withdrawal by Subject|0|||
155293236|NCT01235949|560502763|FG001|Booster Phase|Withdrawal by Subject|0|||
155293237|NCT01235949|560502764|FG002|Booster Phase|Withdrawal by Subject|0|||
155293238|NCT01235949|560502765|FG003|Booster Phase|Withdrawal by Subject|0|||
155293239|NCT01235949|560502766|FG004|Booster Phase|Withdrawal by Subject|0|||
155293240|NCT01235949|560502767|FG005|Booster Phase|Withdrawal by Subject|0|||
155293241|NCT01235949|560502768|FG006|Booster Phase|Withdrawal by Subject|0|||
155293242|NCT01235949|560502769|FG007|Booster Phase|Withdrawal by Subject|1|||
155293243|NCT01235949|560502770|FG008|Booster Phase|Withdrawal by Subject|1|||
155293244|NCT01235949|560502771|FG009|Booster Phase|Withdrawal by Subject|0|||
155293245|NCT01235949|560502772|FG010|Booster Phase|Withdrawal by Subject|1|||
155293246|NCT01235949|560502773|FG011|Booster Phase|Withdrawal by Subject|1|||
155293247|NCT01235949|560502774|FG012|Booster Phase|Withdrawal by Subject|2|||
155293248|NCT01235949|560502775|FG013|Booster Phase|Withdrawal by Subject|0|||
155293249|NCT01235949|560502776|FG014|Booster Phase|Withdrawal by Subject|2|||
155409824|NCT03548558|560932377|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
155293250|NCT01235949|560502777|FG015|Booster Phase|Withdrawal by Subject|0|||
155293251|NCT01235949|560502778|FG016|Booster Phase|Withdrawal by Subject|0|||
155293252|NCT01235949|560502779|FG017|Booster Phase|Withdrawal by Subject|0|||
155293253|NCT01235949|560502762|FG000|Booster Phase|Lost to Follow-up|0|||
155293254|NCT01235949|560502763|FG001|Booster Phase|Lost to Follow-up|0|||
155293255|NCT01235949|560502764|FG002|Booster Phase|Lost to Follow-up|0|||
155293256|NCT01235949|560502765|FG003|Booster Phase|Lost to Follow-up|0|||
155293257|NCT01235949|560502766|FG004|Booster Phase|Lost to Follow-up|0|||
155293258|NCT01235949|560502767|FG005|Booster Phase|Lost to Follow-up|0|||
155293259|NCT01235949|560502768|FG006|Booster Phase|Lost to Follow-up|0|||
155293260|NCT01235949|560502769|FG007|Booster Phase|Lost to Follow-up|0|||
155293261|NCT01235949|560502770|FG008|Booster Phase|Lost to Follow-up|1|||
155293262|NCT01235949|560502771|FG009|Booster Phase|Lost to Follow-up|1|||
155293263|NCT01235949|560502772|FG010|Booster Phase|Lost to Follow-up|1|||
155293264|NCT01235949|560502773|FG011|Booster Phase|Lost to Follow-up|1|||
155293265|NCT01235949|560502774|FG012|Booster Phase|Lost to Follow-up|0|||
155293266|NCT01235949|560502775|FG013|Booster Phase|Lost to Follow-up|0|||
155638606|NCT03765073|561767663|FG010|Stage 3|Lost to Follow-up|0|||
155638607|NCT03765073|561767664|FG011|Stage 3|Lost to Follow-up|0|||
155638608|NCT03765073|561767665|FG012|Stage 3|Lost to Follow-up|0|||
155638609|NCT03765073|561767666|FG013|Stage 3|Lost to Follow-up|0|||
155638610|NCT03765073|561767667|FG014|Stage 3|Lost to Follow-up|0|||
155293267|NCT01235949|560502776|FG014|Booster Phase|Lost to Follow-up|0|||
155293268|NCT01235949|560502777|FG015|Booster Phase|Lost to Follow-up|0|||
155293269|NCT01235949|560502778|FG016|Booster Phase|Lost to Follow-up|0|||
155293270|NCT01235949|560502779|FG017|Booster Phase|Lost to Follow-up|1|||
155293271|NCT00371566|560502780|FG000|Treatment Phase|Withdrawal by Subject|0|||
155293272|NCT00371566|560502781|FG001|Treatment Phase|Withdrawal by Subject|1|||
155293273|NCT00371566|560502780|FG000|Treatment Phase|Adverse Event|0|||
155293274|NCT00371566|560502781|FG001|Treatment Phase|Adverse Event|1|||
155293275|NCT00371566|560502780|FG000|Treatment Phase|Protocol Violation|0|||
155293276|NCT00371566|560502781|FG001|Treatment Phase|Protocol Violation|1|||
155293277|NCT00371566|560502780|FG000|Chemoradiation Phase|Physician Decision|2|||
155293278|NCT00371566|560502781|FG001|Chemoradiation Phase|Physician Decision|0|||
155293279|NCT00371566|560502780|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
155293280|NCT00371566|560502781|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
155293281|NCT00371566|560502780|FG000|Chemoradiation Phase|Non compliant|0|||
155293282|NCT00371566|560502781|FG001|Chemoradiation Phase|Non compliant|1|||
155293283|NCT00371566|560502780|FG000|Chemoradiation Phase|Progressive Disease|1|||
155293284|NCT00371566|560502781|FG001|Chemoradiation Phase|Progressive Disease|1|||
155293285|NCT00371566|560502780|FG000|Chemoradiation Phase|Death|2|||
155293286|NCT00371566|560502781|FG001|Chemoradiation Phase|Death|0|||
155293287|NCT00371566|560502780|FG000|Follow Up Phase|Death|0|||
155293288|NCT00371566|560502781|FG001|Follow Up Phase|Death|5|||
155293289|NCT00371566|560502780|FG000|Follow Up Phase|Disease progression|1|||
155293290|NCT00371566|560502781|FG001|Follow Up Phase|Disease progression|0|||
155293291|NCT00371566|560502780|FG000|Follow Up Phase|Withdrawal by Subject|0|||
155293292|NCT00371566|560502781|FG001|Follow Up Phase|Withdrawal by Subject|1|||
155293293|NCT00371566|560502780|FG000|Follow Up Phase|Physician Decision|1|||
155293294|NCT00371566|560502781|FG001|Follow Up Phase|Physician Decision|1|||
155293295|NCT00371566|560502780|FG000|Follow Up Phase|Lost to Follow-up|1|||
155293296|NCT00371566|560502781|FG001|Follow Up Phase|Lost to Follow-up|0|||
155293297|NCT02534350|560502782|FG000|Overall Study|Randomized But Not Treated|1|||
155293298|NCT02534350|560502783|FG001|Overall Study|Randomized But Not Treated|0|||
155293299|NCT02534350|560502782|FG000|Overall Study|Protocol Violation|1|||
155293300|NCT02534350|560502783|FG001|Overall Study|Protocol Violation|0|||
155293301|NCT02534350|560502782|FG000|Overall Study|Withdrew Consent|2|||
155293302|NCT02534350|560502783|FG001|Overall Study|Withdrew Consent|0|||
155293303|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
155293304|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
155293305|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
155293306|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
155293307|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
155293308|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
155293309|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
155293310|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
155293311|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
155293312|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
155293313|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
155293314|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
155293315|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Death|7|||
155293316|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Death|4|||
155293317|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
155293318|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
155293319|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
155638611|NCT03765073|561767668|FG015|Stage 3|Lost to Follow-up|0|||
155409825|NCT03548558|560932371|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
155409826|NCT03548558|560932372|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
155409827|NCT03548558|560932373|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
155409828|NCT03548558|560932374|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
155409829|NCT03548558|560932375|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
155409830|NCT03548558|560932376|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
155409831|NCT03548558|560932377|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
155409832|NCT03548558|560932371|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
155744057|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
155744058|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
155409833|NCT03548558|560932372|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
155409834|NCT03548558|560932373|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
155409835|NCT03548558|560932374|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
155409836|NCT03548558|560932375|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
155409837|NCT03548558|560932376|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
155409838|NCT03548558|560932377|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
155409839|NCT03548558|560932371|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
155409840|NCT03548558|560932372|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
155409841|NCT03548558|560932373|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
155409842|NCT03548558|560932374|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
155409843|NCT03548558|560932375|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
155409844|NCT03548558|560932376|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
155409845|NCT03548558|560932377|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
155409846|NCT03548558|560932371|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
155409847|NCT03548558|560932372|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
155409848|NCT03548558|560932373|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
155409849|NCT03548558|560932374|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
155409850|NCT03548558|560932375|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
155409851|NCT03548558|560932376|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
155409852|NCT03548558|560932377|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
155409853|NCT03509350|560932379|FG000|Overall Study|Withdrawal by Subject|0|||
155409854|NCT03509350|560932380|FG001|Overall Study|Withdrawal by Subject|2|||
155409855|NCT00797732|560932383|FG000|Overall Study|Withdrawal by Subject|3|||
155409856|NCT00797732|560932384|FG001|Overall Study|Withdrawal by Subject|3|||
155409857|NCT00797732|560932385|FG002|Overall Study|Withdrawal by Subject|0|||
155409858|NCT00797732|560932383|FG000|Overall Study|Lost to Follow-up|1|||
155409859|NCT00797732|560932384|FG001|Overall Study|Lost to Follow-up|0|||
155409860|NCT00797732|560932385|FG002|Overall Study|Lost to Follow-up|0|||
155409861|NCT00797732|560932383|FG000|Overall Study|Death|1|||
155409862|NCT00797732|560932384|FG001|Overall Study|Death|0|||
155409863|NCT00797732|560932385|FG002|Overall Study|Death|0|||
155409864|NCT00797732|560932383|FG000|Overall Study|Not meet inclusion criteria|0|||
155409865|NCT00797732|560932384|FG001|Overall Study|Not meet inclusion criteria|0|||
155409866|NCT00797732|560932385|FG002|Overall Study|Not meet inclusion criteria|7|||
155409867|NCT00797732|560932383|FG000|Overall Study|Excluded due to time constraints|0|||
155409868|NCT00797732|560932384|FG001|Overall Study|Excluded due to time constraints|0|||
155409869|NCT00797732|560932385|FG002|Overall Study|Excluded due to time constraints|24|||
155409870|NCT00797732|560932383|FG000|Overall Study|Refused to Participate|0|||
155409871|NCT00797732|560932384|FG001|Overall Study|Refused to Participate|0|||
155409872|NCT00797732|560932385|FG002|Overall Study|Refused to Participate|123|||
155409873|NCT01857869|560932386|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
155409874|NCT01857869|560932387|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
155409875|NCT01857869|560932388|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
155409876|NCT01857869|560932389|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
155409877|NCT01857869|560932390|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
155409878|NCT01857869|560932391|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
155409879|NCT01857869|560932392|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
155409880|NCT01857869|560932393|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
155409881|NCT01857869|560932394|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
155409882|NCT01857869|560932395|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
155409883|NCT01857869|560932386|FG000|Primary/Challenge Phase|Pregnancy|1|||
155409884|NCT01857869|560932387|FG001|Primary/Challenge Phase|Pregnancy|0|||
155409885|NCT01857869|560932388|FG002|Primary/Challenge Phase|Pregnancy|0|||
155409886|NCT01857869|560932389|FG003|Primary/Challenge Phase|Pregnancy|0|||
155744059|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
155409887|NCT01857869|560932390|FG004|Primary/Challenge Phase|Pregnancy|0|||
155409888|NCT01857869|560932391|FG005|Primary/Challenge Phase|Pregnancy|0|||
155409889|NCT01857869|560932392|FG006|Primary/Challenge Phase|Pregnancy|0|||
155409890|NCT01857869|560932393|FG007|Primary/Challenge Phase|Pregnancy|0|||
155409891|NCT01857869|560932394|FG008|Primary/Challenge Phase|Pregnancy|0|||
155409892|NCT01857869|560932395|FG009|Primary/Challenge Phase|Pregnancy|0|||
155293320|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
155293321|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
155293322|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
155293323|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
155293324|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
155293325|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
155293326|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
155293327|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
155293328|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
155293329|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
155293330|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
155293331|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
155293332|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
155293333|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
155293334|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
155293335|NCT00319436|560502786|FG000|Overall Study|Withdrawal by Subject|6|||
155293336|NCT00319436|560502787|FG001|Overall Study|Withdrawal by Subject|7|||
155293337|NCT02341625|560502794|FG000|Overall Study|Disease Progression|2|||
155293338|NCT02341625|560502795|FG001|Overall Study|Disease Progression|2|||
155293339|NCT02341625|560502796|FG002|Overall Study|Disease Progression|3|||
155293340|NCT02341625|560502797|FG003|Overall Study|Disease Progression|6|||
155293341|NCT02341625|560502798|FG004|Overall Study|Disease Progression|7|||
155293342|NCT02341625|560502799|FG005|Overall Study|Disease Progression|7|||
155293343|NCT02341625|560502800|FG006|Overall Study|Disease Progression|28|||
155293344|NCT02341625|560502801|FG007|Overall Study|Disease Progression|5|||
155293345|NCT02341625|560502802|FG008|Overall Study|Disease Progression|4|||
155293346|NCT02341625|560502803|FG009|Overall Study|Disease Progression|19|||
155293347|NCT02341625|560502794|FG000|Overall Study|Study Drug Toxicity|0|||
155293348|NCT02341625|560502795|FG001|Overall Study|Study Drug Toxicity|0|||
155293349|NCT02341625|560502796|FG002|Overall Study|Study Drug Toxicity|0|||
155293350|NCT02341625|560502797|FG003|Overall Study|Study Drug Toxicity|1|||
155293351|NCT02341625|560502798|FG004|Overall Study|Study Drug Toxicity|0|||
155293352|NCT02341625|560502799|FG005|Overall Study|Study Drug Toxicity|3|||
155293353|NCT02341625|560502800|FG006|Overall Study|Study Drug Toxicity|10|||
155293354|NCT02341625|560502801|FG007|Overall Study|Study Drug Toxicity|0|||
155293355|NCT02341625|560502802|FG008|Overall Study|Study Drug Toxicity|0|||
155293356|NCT02341625|560502803|FG009|Overall Study|Study Drug Toxicity|3|||
155293357|NCT02341625|560502794|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293358|NCT02341625|560502795|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293359|NCT02341625|560502796|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293360|NCT02341625|560502797|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293361|NCT02341625|560502798|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293362|NCT02341625|560502799|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293363|NCT02341625|560502800|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155293364|NCT02341625|560502801|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155293365|NCT02341625|560502802|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293366|NCT02341625|560502803|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155293367|NCT02341625|560502794|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293368|NCT02341625|560502795|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293369|NCT02341625|560502796|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293370|NCT02341625|560502797|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293371|NCT02341625|560502798|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293372|NCT02341625|560502799|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293373|NCT02341625|560502800|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
155293374|NCT02341625|560502801|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
155293375|NCT02341625|560502802|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293376|NCT02341625|560502803|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293377|NCT02341625|560502794|FG000|Overall Study|Participant Withdrew Consent|0|||
155293378|NCT02341625|560502795|FG001|Overall Study|Participant Withdrew Consent|0|||
155293379|NCT02341625|560502796|FG002|Overall Study|Participant Withdrew Consent|0|||
155293380|NCT02341625|560502797|FG003|Overall Study|Participant Withdrew Consent|1|||
155293381|NCT02341625|560502798|FG004|Overall Study|Participant Withdrew Consent|0|||
155293382|NCT02341625|560502799|FG005|Overall Study|Participant Withdrew Consent|0|||
155293383|NCT02341625|560502800|FG006|Overall Study|Participant Withdrew Consent|0|||
155293384|NCT02341625|560502801|FG007|Overall Study|Participant Withdrew Consent|0|||
155293385|NCT02341625|560502802|FG008|Overall Study|Participant Withdrew Consent|0|||
155409893|NCT01857869|560932386|FG000|Primary/Challenge Phase|Protocol Violation|1|||
155409894|NCT01857869|560932387|FG001|Primary/Challenge Phase|Protocol Violation|0|||
155409895|NCT01857869|560932388|FG002|Primary/Challenge Phase|Protocol Violation|0|||
155293386|NCT02341625|560502803|FG009|Overall Study|Participant Withdrew Consent|0|||
155293387|NCT02341625|560502794|FG000|Overall Study|Completed Treatment as per Protocol|0|||
155293388|NCT02341625|560502795|FG001|Overall Study|Completed Treatment as per Protocol|0|||
155293389|NCT02341625|560502796|FG002|Overall Study|Completed Treatment as per Protocol|0|||
155293390|NCT02341625|560502797|FG003|Overall Study|Completed Treatment as per Protocol|0|||
155293391|NCT02341625|560502798|FG004|Overall Study|Completed Treatment as per Protocol|0|||
155293392|NCT02341625|560502799|FG005|Overall Study|Completed Treatment as per Protocol|0|||
155293393|NCT02341625|560502800|FG006|Overall Study|Completed Treatment as per Protocol|0|||
155293394|NCT02341625|560502801|FG007|Overall Study|Completed Treatment as per Protocol|0|||
155293395|NCT02341625|560502802|FG008|Overall Study|Completed Treatment as per Protocol|0|||
155293396|NCT02341625|560502803|FG009|Overall Study|Completed Treatment as per Protocol|1|||
155293397|NCT02341625|560502794|FG000|Overall Study|Other Reasons|0|||
155293398|NCT02341625|560502795|FG001|Overall Study|Other Reasons|0|||
155293399|NCT02341625|560502796|FG002|Overall Study|Other Reasons|0|||
155293400|NCT02341625|560502797|FG003|Overall Study|Other Reasons|0|||
155293401|NCT02341625|560502798|FG004|Overall Study|Other Reasons|1|||
155293402|NCT02341625|560502799|FG005|Overall Study|Other Reasons|0|||
155293403|NCT02341625|560502800|FG006|Overall Study|Other Reasons|5|||
155293404|NCT02341625|560502801|FG007|Overall Study|Other Reasons|0|||
155293405|NCT02341625|560502802|FG008|Overall Study|Other Reasons|0|||
155293406|NCT02341625|560502803|FG009|Overall Study|Other Reasons|2|||
155293407|NCT02341625|560502794|FG000|Overall Study|Not Reported|0|||
155293408|NCT02341625|560502795|FG001|Overall Study|Not Reported|0|||
155293409|NCT02341625|560502796|FG002|Overall Study|Not Reported|0|||
155293410|NCT02341625|560502797|FG003|Overall Study|Not Reported|0|||
155293411|NCT02341625|560502798|FG004|Overall Study|Not Reported|0|||
155293412|NCT02341625|560502799|FG005|Overall Study|Not Reported|0|||
155293413|NCT02341625|560502800|FG006|Overall Study|Not Reported|0|||
155293414|NCT02341625|560502801|FG007|Overall Study|Not Reported|0|||
155293415|NCT02341625|560502802|FG008|Overall Study|Not Reported|0|||
155293416|NCT02341625|560502803|FG009|Overall Study|Not Reported|3|||
155293417|NCT01161498|560502804|FG000|Overall Study|Disease Progression|0|||
155293418|NCT01161498|560502805|FG001|Overall Study|Disease Progression|1|||
155293419|NCT03310983|560502809|FG000|Overall Study|Lost to Follow-up|15|||
155293420|NCT03310983|560502810|FG001|Overall Study|Lost to Follow-up|17|||
155293421|NCT03368001|560502811|FG000|Allocation|Lost to Pretest|16|||
155293422|NCT03368001|560502812|FG001|Allocation|Lost to Pretest|25|||
155293423|NCT03368001|560502811|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
155293424|NCT03368001|560502812|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
155293425|NCT03368001|560502811|FG000|Posttest|Lost to Posttest|7|||
155293426|NCT03368001|560502812|FG001|Posttest|Lost to Posttest|11|||
155293427|NCT03368001|560502811|FG000|Posttest|Discontinued Intervention|6|||
155293428|NCT03368001|560502812|FG001|Posttest|Discontinued Intervention|19|||
155293429|NCT03368001|560502811|FG000|Follow-up|Lost to Follow-up|6|||
155293430|NCT03368001|560502812|FG001|Follow-up|Lost to Follow-up|3|||
155293431|NCT01656304|560502813|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
155293432|NCT01093534|560502814|FG000|Overall Study|Adverse Event|2|||
155293433|NCT01093534|560502815|FG001|Overall Study|Adverse Event|5|||
155293434|NCT01093534|560502816|FG002|Overall Study|Adverse Event|2|||
155293435|NCT01093534|560502814|FG000|Overall Study|Lack of Efficacy|2|||
155293436|NCT01093534|560502815|FG001|Overall Study|Lack of Efficacy|1|||
155293437|NCT01093534|560502816|FG002|Overall Study|Lack of Efficacy|1|||
155293438|NCT01093534|560502814|FG000|Overall Study|Withdrawal by Subject|5|||
155293439|NCT01093534|560502815|FG001|Overall Study|Withdrawal by Subject|7|||
155293440|NCT01093534|560502816|FG002|Overall Study|Withdrawal by Subject|2|||
155293441|NCT01093534|560502814|FG000|Overall Study|Other|1|||
155293442|NCT01093534|560502815|FG001|Overall Study|Other|3|||
155293443|NCT01093534|560502816|FG002|Overall Study|Other|4|||
155293444|NCT04436120|560502817|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293445|NCT04436120|560502818|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293446|NCT04436120|560502819|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293447|NCT04436120|560502820|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
155293448|NCT04436120|560502821|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293449|NCT04436120|560502822|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
155293450|NCT04436120|560502823|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293451|NCT01769391|560502830|FG000|Overall Study|Death|10|||
155293452|NCT01769391|560502831|FG001|Overall Study|Death|1|||
155293453|NCT01769391|560502830|FG000|Overall Study|Adverse Event|0|||
155293454|NCT01769391|560502831|FG001|Overall Study|Adverse Event|3|||
155293455|NCT01769391|560502830|FG000|Overall Study|Progressive Disease|1|||
155293456|NCT01769391|560502831|FG001|Overall Study|Progressive Disease|2|||
155293457|NCT01769391|560502830|FG000|Overall Study|Withdrawal by Subject|4|||
155293458|NCT01769391|560502831|FG001|Overall Study|Withdrawal by Subject|3|||
155293459|NCT01769391|560502830|FG000|Overall Study|Investigator Decision|2|||
155293460|NCT01769391|560502831|FG001|Overall Study|Investigator Decision|0|||
155293461|NCT00038103|560502835|FG000|Overall Study|Adverse Event|5|||
155293462|NCT00038103|560502836|FG001|Overall Study|Adverse Event|6|||
155293463|NCT00038103|560502835|FG000|Overall Study|Lack of Efficacy|48|||
155293464|NCT00038103|560502836|FG001|Overall Study|Lack of Efficacy|41|||
155293465|NCT00038103|560502835|FG000|Overall Study|Withdrawal by Subject|0|||
155293466|NCT00038103|560502836|FG001|Overall Study|Withdrawal by Subject|3|||
155293467|NCT00038103|560502835|FG000|Overall Study|Lost to Follow-up|0|||
155293468|NCT00038103|560502836|FG001|Overall Study|Lost to Follow-up|3|||
155293469|NCT00038103|560502835|FG000|Overall Study|Protocol Violation|0|||
155293470|NCT00038103|560502836|FG001|Overall Study|Protocol Violation|2|||
155293471|NCT00038103|560502835|FG000|Overall Study|Sponsor Decision|0|||
155293472|NCT00038103|560502836|FG001|Overall Study|Sponsor Decision|1|||
155293473|NCT00038103|560502835|FG000|Overall Study|Randomized/never treated|2|||
155293474|NCT00038103|560502836|FG001|Overall Study|Randomized/never treated|0|||
155293475|NCT01144182|560502837|FG000|Overall Study|Death|5|||
155293476|NCT01144182|560502838|FG001|Overall Study|Death|6|||
155293477|NCT01144182|560502837|FG000|Overall Study|Withdrawal by Subject|3|||
155293478|NCT01144182|560502838|FG001|Overall Study|Withdrawal by Subject|6|||
155293479|NCT01144182|560502837|FG000|Overall Study|Lost to Follow-up|9|||
155638612|NCT03765073|561767669|FG016|Stage 3|Lost to Follow-up|0|||
155638613|NCT03765073|561767670|FG017|Stage 3|Lost to Follow-up|8|||
155293480|NCT01144182|560502838|FG001|Overall Study|Lost to Follow-up|9|||
155293481|NCT03254394|560502843|FG000|Overall Study|Withdrawal by Subject|0|||
155293482|NCT03254394|560502844|FG001|Overall Study|Withdrawal by Subject|2|||
155293483|NCT03545984|560502845|FG000|Overall Study|CSF cases not present during rotation|11|||
155293484|NCT03545984|560502846|FG001|Overall Study|CSF cases not present during rotation|9|||
155293485|NCT00387465|560502847|FG000|Overall Study|Withdrawal by Subject|0|||
155293486|NCT00387465|560502848|FG001|Overall Study|Withdrawal by Subject|1|||
155293487|NCT00387465|560502849|FG002|Overall Study|Withdrawal by Subject|0|||
155293488|NCT01768676|560502851|FG000|Overall Study|Adverse Event|3|||
155293489|NCT01768676|560502852|FG001|Overall Study|Adverse Event|3|||
155293490|NCT01768676|560502851|FG000|Overall Study|Lost to Follow-up|13|||
155293491|NCT01768676|560502852|FG001|Overall Study|Lost to Follow-up|16|||
155293492|NCT01768676|560502851|FG000|Overall Study|Protocol Violation|1|||
155293493|NCT01768676|560502852|FG001|Overall Study|Protocol Violation|1|||
155293494|NCT01768676|560502851|FG000|Overall Study|Physician Decision|4|||
155293495|NCT01768676|560502852|FG001|Overall Study|Physician Decision|1|||
155293496|NCT01768676|560502851|FG000|Overall Study|Withdrawal by Subject|3|||
155293497|NCT01768676|560502852|FG001|Overall Study|Withdrawal by Subject|10|||
155293498|NCT01867580|560502858|FG000|Overall Study|Withdrawal by Subject|2|||
155293499|NCT01867580|560502859|FG001|Overall Study|Withdrawal by Subject|3|||
155293500|NCT01867580|560502858|FG000|Overall Study|Physician Decision|17|||
155409896|NCT01857869|560932389|FG003|Primary/Challenge Phase|Protocol Violation|0|||
155409897|NCT01857869|560932390|FG004|Primary/Challenge Phase|Protocol Violation|0|||
155409898|NCT01857869|560932391|FG005|Primary/Challenge Phase|Protocol Violation|0|||
155409899|NCT01857869|560932392|FG006|Primary/Challenge Phase|Protocol Violation|0|||
155409900|NCT01857869|560932393|FG007|Primary/Challenge Phase|Protocol Violation|0|||
155409901|NCT01857869|560932394|FG008|Primary/Challenge Phase|Protocol Violation|0|||
155409902|NCT01857869|560932395|FG009|Primary/Challenge Phase|Protocol Violation|0|||
155409903|NCT01857869|560932386|FG000|Primary/Challenge Phase|Other|1|||
155409904|NCT01857869|560932387|FG001|Primary/Challenge Phase|Other|1|||
155409905|NCT01857869|560932388|FG002|Primary/Challenge Phase|Other|0|||
155409906|NCT01857869|560932389|FG003|Primary/Challenge Phase|Other|0|||
155409907|NCT01857869|560932390|FG004|Primary/Challenge Phase|Other|0|||
155409908|NCT01857869|560932391|FG005|Primary/Challenge Phase|Other|0|||
155409909|NCT01857869|560932392|FG006|Primary/Challenge Phase|Other|0|||
155409910|NCT01857869|560932393|FG007|Primary/Challenge Phase|Other|0|||
155409911|NCT01857869|560932394|FG008|Primary/Challenge Phase|Other|0|||
155409912|NCT01857869|560932395|FG009|Primary/Challenge Phase|Other|0|||
155409913|NCT01857869|560932386|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409914|NCT01857869|560932387|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409915|NCT01857869|560932388|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155638614|NCT03765073|561767671|FG018|Stage 3|Lost to Follow-up|5|||
155638615|NCT03765073|561767672|FG019|Stage 3|Lost to Follow-up|7|||
155638616|NCT03765073|561767673|FG020|Stage 3|Lost to Follow-up|4|||
155638617|NCT03765073|561767653|FG000|Stage 3|No longer meets eligibility criteria|0|||
155638618|NCT03765073|561767654|FG001|Stage 3|No longer meets eligibility criteria|0|||
155293501|NCT01867580|560502859|FG001|Overall Study|Physician Decision|12|||
155293502|NCT01867580|560502858|FG000|Overall Study|Lost to Follow-up|3|||
155293503|NCT01867580|560502859|FG001|Overall Study|Lost to Follow-up|5|||
155293504|NCT01867580|560502858|FG000|Overall Study|Sponsor terminated study|1|||
155293505|NCT01867580|560502859|FG001|Overall Study|Sponsor terminated study|0|||
155293506|NCT01867580|560502858|FG000|Overall Study|Missed follow-up assessment|2|||
155293507|NCT01867580|560502859|FG001|Overall Study|Missed follow-up assessment|1|||
155293508|NCT01867580|560502858|FG000|Overall Study|Interruption to therapy|3|||
155293509|NCT01867580|560502859|FG001|Overall Study|Interruption to therapy|0|||
155409916|NCT01857869|560932389|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
155409917|NCT01857869|560932390|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409918|NCT01857869|560932391|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409919|NCT01857869|560932392|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409920|NCT01857869|560932393|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409921|NCT01857869|560932394|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409922|NCT01857869|560932395|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
155409923|NCT01857869|560932386|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409924|NCT01857869|560932387|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409925|NCT01857869|560932388|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409926|NCT01857869|560932389|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
155409927|NCT01857869|560932390|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409928|NCT01857869|560932391|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409929|NCT01857869|560932392|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409930|NCT01857869|560932393|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409931|NCT01857869|560932394|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409932|NCT01857869|560932395|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155409933|NCT02199080|560932399|FG000|Overall Study|Protocol Violation|12|||
155409934|NCT02443883|560932400|FG000|Overall Study|Adverse Event|0|||
155409935|NCT02443883|560932401|FG001|Overall Study|Adverse Event|1|||
155409936|NCT02443883|560932402|FG002|Overall Study|Adverse Event|0|||
155293510|NCT01867580|560502858|FG000|Overall Study|Osteomyelitis|0|||
155293511|NCT01867580|560502859|FG001|Overall Study|Osteomyelitis|1|||
155293512|NCT01867580|560502858|FG000|Overall Study|Continuation of therapy|0|||
155293513|NCT01867580|560502859|FG001|Overall Study|Continuation of therapy|1|||
155293514|NCT01867580|560502858|FG000|Overall Study|Wound recurrence|0|||
155293515|NCT01867580|560502859|FG001|Overall Study|Wound recurrence|1|||
155293516|NCT01304147|560502860|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
155293517|NCT01304147|560502861|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
155293518|NCT01244828|560502862|FG000|Overall Study|Adverse Event|37|||
155293519|NCT01244828|560502862|FG000|Overall Study|Withdrawal by Subject|31|||
155409937|NCT02443883|560932403|FG003|Overall Study|Adverse Event|0|||
155409938|NCT02443883|560932400|FG000|Overall Study|Lost to Follow-up|3|||
155409939|NCT02443883|560932401|FG001|Overall Study|Lost to Follow-up|2|||
155409940|NCT02443883|560932402|FG002|Overall Study|Lost to Follow-up|1|||
155409941|NCT02443883|560932403|FG003|Overall Study|Lost to Follow-up|0|||
155409942|NCT02443883|560932400|FG000|Overall Study|Physician Decision|1|||
155409943|NCT02443883|560932401|FG001|Overall Study|Physician Decision|1|||
155409944|NCT02443883|560932402|FG002|Overall Study|Physician Decision|0|||
155409945|NCT02443883|560932403|FG003|Overall Study|Physician Decision|3|||
155409946|NCT02443883|560932400|FG000|Overall Study|Withdrawal by Subject|1|||
155409947|NCT02443883|560932401|FG001|Overall Study|Withdrawal by Subject|0|||
155409948|NCT02443883|560932402|FG002|Overall Study|Withdrawal by Subject|0|||
155409949|NCT02443883|560932403|FG003|Overall Study|Withdrawal by Subject|2|||
155409950|NCT02443883|560932400|FG000|Overall Study|Randomized, but never treated|1|||
155409951|NCT02443883|560932401|FG001|Overall Study|Randomized, but never treated|0|||
155409952|NCT02443883|560932402|FG002|Overall Study|Randomized, but never treated|0|||
155409953|NCT02443883|560932403|FG003|Overall Study|Randomized, but never treated|0|||
155409954|NCT02937818|560932408|FG000|Overall Study|Participants decision|2|||
155409955|NCT02937818|560932409|FG001|Overall Study|Participants decision|1|||
155409956|NCT02937818|560932410|FG002|Overall Study|Participants decision|1|||
155409957|NCT02937818|560932411|FG003|Overall Study|Participants decision|1|||
155409958|NCT02937818|560932408|FG000|Overall Study|Adverse Event|2|||
155409959|NCT02937818|560932409|FG001|Overall Study|Adverse Event|4|||
155409960|NCT02937818|560932410|FG002|Overall Study|Adverse Event|1|||
155409961|NCT02937818|560932411|FG003|Overall Study|Adverse Event|1|||
155409962|NCT02937818|560932408|FG000|Overall Study|Disease progression|17|||
155409963|NCT02937818|560932409|FG001|Overall Study|Disease progression|15|||
155409964|NCT02937818|560932410|FG002|Overall Study|Disease progression|7|||
155409965|NCT02937818|560932411|FG003|Overall Study|Disease progression|19|||
155409966|NCT02937818|560932408|FG000|Overall Study|Condition under investigation worsened|0|||
155409967|NCT02937818|560932409|FG001|Overall Study|Condition under investigation worsened|0|||
155409968|NCT02937818|560932410|FG002|Overall Study|Condition under investigation worsened|1|||
155409969|NCT02937818|560932411|FG003|Overall Study|Condition under investigation worsened|0|||
155409970|NCT02873936|560932414|FG000|Overall Study|Withdrew Consent|4|||
155409971|NCT02873936|560932415|FG001|Overall Study|Withdrew Consent|11|||
155409972|NCT02873936|560932416|FG002|Overall Study|Withdrew Consent|20|||
155409973|NCT02873936|560932414|FG000|Overall Study|Investigator's Discretion|3|||
155409974|NCT02873936|560932415|FG001|Overall Study|Investigator's Discretion|5|||
155293520|NCT01244828|560502862|FG000|Overall Study|Lack of Efficacy|7|||
155293521|NCT01244828|560502862|FG000|Overall Study|Lost to Follow-up|2|||
155409975|NCT02873936|560932416|FG002|Overall Study|Investigator's Discretion|4|||
155409976|NCT02873936|560932414|FG000|Overall Study|Adverse Event|3|||
155409977|NCT02873936|560932415|FG001|Overall Study|Adverse Event|5|||
155409978|NCT02873936|560932416|FG002|Overall Study|Adverse Event|3|||
155293522|NCT01244828|560502862|FG000|Overall Study|Other reason (not specified)|1|||
155293523|NCT05233085|560502864|FG000|Overall Study|Adverse Event|1|||
155293524|NCT05233085|560502865|FG001|Overall Study|Adverse Event|0|||
155293525|NCT05233085|560502866|FG002|Overall Study|Adverse Event|0|||
155293526|NCT05233085|560502867|FG003|Overall Study|Adverse Event|0|||
155293527|NCT02812966|560502870|FG000|Overall Study|Death|1|||
155293528|NCT02812966|560502871|FG001|Overall Study|Death|0|||
155293529|NCT01066923|560502872|FG000|Overall Study|Withdrawal by Subject|3|||
155293530|NCT01066923|560502873|FG001|Overall Study|Withdrawal by Subject|3|||
155409979|NCT02873936|560932414|FG000|Overall Study|Protocol Violation|0|||
155409980|NCT02873936|560932415|FG001|Overall Study|Protocol Violation|1|||
155409981|NCT02873936|560932416|FG002|Overall Study|Protocol Violation|3|||
155409982|NCT02873936|560932414|FG000|Overall Study|Lost to Follow-up|1|||
155409983|NCT02873936|560932415|FG001|Overall Study|Lost to Follow-up|1|||
155409984|NCT02873936|560932416|FG002|Overall Study|Lost to Follow-up|1|||
155409985|NCT02873936|560932414|FG000|Overall Study|Non-compliance With Study Drug|1|||
155409986|NCT02873936|560932415|FG001|Overall Study|Non-compliance With Study Drug|0|||
155409987|NCT02873936|560932416|FG002|Overall Study|Non-compliance With Study Drug|1|||
155409988|NCT02873936|560932414|FG000|Overall Study|Randomized but not Dosed|1|||
155409989|NCT02873936|560932415|FG001|Overall Study|Randomized but not Dosed|0|||
155409990|NCT02873936|560932416|FG002|Overall Study|Randomized but not Dosed|0|||
155409991|NCT00490451|560932417|FG000|Overall Study|Adverse Event|3|||
155409992|NCT00490451|560932418|FG001|Overall Study|Adverse Event|3|||
155409993|NCT00490451|560932417|FG000|Overall Study|Death|3|||
155409994|NCT00490451|560932418|FG001|Overall Study|Death|1|||
155409995|NCT00490451|560932417|FG000|Overall Study|Withdrawal by Subject|2|||
155409996|NCT00490451|560932418|FG001|Overall Study|Withdrawal by Subject|0|||
155409997|NCT00490451|560932417|FG000|Overall Study|Investigator Decision|1|||
155409998|NCT00490451|560932418|FG001|Overall Study|Investigator Decision|0|||
155409999|NCT00490451|560932417|FG000|Overall Study|Protocol Violation|1|||
155410000|NCT00490451|560932418|FG001|Overall Study|Protocol Violation|0|||
155410001|NCT00490451|560932417|FG000|Overall Study|Progressive Disease|53|||
155410002|NCT00490451|560932418|FG001|Overall Study|Progressive Disease|34|||
155410003|NCT00254501|560932421|FG000|Overall Study|Lost to Follow-up|1|||
155410004|NCT00254501|560932422|FG001|Overall Study|Lost to Follow-up|1|||
155410005|NCT01508702|560932427|FG000|Overall Study|Adverse Event|7|||
155410006|NCT01508702|560932428|FG001|Overall Study|Adverse Event|3|||
155410007|NCT01508702|560932427|FG000|Overall Study|Gout flare|2|||
155410008|NCT01508702|560932428|FG001|Overall Study|Gout flare|0|||
155410009|NCT01508702|560932427|FG000|Overall Study|Protocol Violation|2|||
155410010|NCT01508702|560932428|FG001|Overall Study|Protocol Violation|1|||
155410011|NCT01508702|560932427|FG000|Overall Study|Lost to Follow-up|1|||
155410012|NCT01508702|560932428|FG001|Overall Study|Lost to Follow-up|2|||
155410013|NCT01508702|560932427|FG000|Overall Study|Withdrawal by Subject|11|||
155410014|NCT01508702|560932428|FG001|Overall Study|Withdrawal by Subject|7|||
155410015|NCT03861559|560932429|FG000|Overall Study|Adverse Event|0|||
155410016|NCT03861559|560932430|FG001|Overall Study|Adverse Event|2|||
155410017|NCT03861559|560932429|FG000|Overall Study|Treatment failure|0|||
155410018|NCT03861559|560932430|FG001|Overall Study|Treatment failure|2|||
155410019|NCT03861559|560932429|FG000|Overall Study|Noncompliance|1|||
155410020|NCT03861559|560932430|FG001|Overall Study|Noncompliance|1|||
155410021|NCT03861559|560932429|FG000|Overall Study|Did not meet eligibility requirements|1|||
155410022|NCT03861559|560932430|FG001|Overall Study|Did not meet eligibility requirements|0|||
155410023|NCT00879697|560932433|FG000|Overall Study|Physician Decision|2|||
155410024|NCT00879697|560932434|FG001|Overall Study|Physician Decision|2|||
155410025|NCT02500121|560932435|FG000|Overall Study|Lost to Follow-up|0|||
155410026|NCT02500121|560932436|FG001|Overall Study|Lost to Follow-up|1|||
155410027|NCT02500121|560932435|FG000|Overall Study|Withdrawal by Subject|1|||
155410028|NCT02500121|560932436|FG001|Overall Study|Withdrawal by Subject|1|||
155410029|NCT02500121|560932435|FG000|Overall Study|Death|26|||
155410030|NCT02500121|560932436|FG001|Overall Study|Death|24|||
155410031|NCT02124564|560932440|FG000|Treatment Period|Adverse Event|2|||
155410032|NCT02124564|560932440|FG000|Treatment Period|Lack of Efficacy|3|||
155293531|NCT01066923|560502874|FG002|Overall Study|Withdrawal by Subject|8|||
155638619|NCT03765073|561767655|FG002|Stage 3|No longer meets eligibility criteria|0|||
155293532|NCT01066923|560502875|FG003|Overall Study|Withdrawal by Subject|8|||
155293533|NCT02577523|560504898|FG000|Overall Study|Adverse Event|1|||
155410033|NCT02124564|560932440|FG000|Treatment Period|Withdrawal by Subject|2|||
155410034|NCT04489888|560932441|FG000|Overall Study|Death|75|||
155410035|NCT04489888|560932441|FG000|Overall Study|Sponsor Decision|26|||
155410036|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
155410037|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
155410038|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
155410039|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
155410040|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
155410041|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
155410042|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155293534|NCT02577523|560504899|FG001|Overall Study|Adverse Event|1|||
155293535|NCT02577523|560504898|FG000|Overall Study|Lack of Efficacy|1|||
155293536|NCT02577523|560504899|FG001|Overall Study|Lack of Efficacy|1|||
155293537|NCT02577523|560504898|FG000|Overall Study|Withdrawal by Subject|1|||
155293538|NCT02577523|560504899|FG001|Overall Study|Withdrawal by Subject|0|||
155410043|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155410044|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155410045|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155410046|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
155410047|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
155410048|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
155410049|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
155410050|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
155410051|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
155410052|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
155410053|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
155410054|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155410055|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155410056|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
155410057|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
155410058|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
155410059|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
155410060|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
155410061|NCT03829657|560932449|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
155410062|NCT03829657|560932450|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
155410063|NCT03829657|560932451|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
155410064|NCT03829657|560932452|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
155410065|NCT03829657|560932453|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
155410066|NCT03829657|560932449|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
155410067|NCT03829657|560932450|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
155410068|NCT03829657|560932451|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
155410069|NCT03829657|560932452|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
155410070|NCT03829657|560932453|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
155410071|NCT03829657|560932449|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
155410072|NCT03829657|560932450|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
155410073|NCT03829657|560932451|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
155410074|NCT03829657|560932452|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
155410075|NCT03829657|560932453|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
155410076|NCT03829657|560932449|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
155410077|NCT03829657|560932450|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
155410078|NCT03829657|560932451|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
155410079|NCT03829657|560932452|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
155410080|NCT03829657|560932453|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
155410081|NCT03829657|560932449|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
155410082|NCT03829657|560932450|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
155410083|NCT03829657|560932451|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
155410084|NCT03829657|560932452|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
155410085|NCT03829657|560932453|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
155410086|NCT04418076|560932454|FG000|Overall Study|Death|1|||
155410087|NCT04418076|560932455|FG001|Overall Study|Death|0|||
155410088|NCT04418076|560932456|FG002|Overall Study|Death|0|||
155410089|NCT04418076|560932457|FG003|Overall Study|Death|0|||
155410090|NCT04418076|560932454|FG000|Overall Study|Lost to Follow-up|2|||
155410091|NCT04418076|560932455|FG001|Overall Study|Lost to Follow-up|5|||
155410092|NCT04418076|560932456|FG002|Overall Study|Lost to Follow-up|1|||
155410093|NCT04418076|560932457|FG003|Overall Study|Lost to Follow-up|2|||
155410094|NCT04418076|560932454|FG000|Overall Study|Withdrawal by Subject|1|||
155410095|NCT04418076|560932455|FG001|Overall Study|Withdrawal by Subject|0|||
155410096|NCT04418076|560932456|FG002|Overall Study|Withdrawal by Subject|1|||
155410097|NCT04418076|560932457|FG003|Overall Study|Withdrawal by Subject|1|||
155410098|NCT04418076|560932454|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
155410099|NCT04418076|560932455|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
155410100|NCT04418076|560932456|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
155293539|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155293540|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155744060|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
155744061|NCT04740905|562161613|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
155744062|NCT04740905|562161614|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
155744063|NCT01534182|562161617|FG000|Overall Study|Administrative problems|1|||
155744064|NCT01534182|562161618|FG001|Overall Study|Administrative problems|0|||
155744065|NCT01534182|562161617|FG000|Overall Study|Withdrawal by Subject|4|||
155744066|NCT01534182|562161618|FG001|Overall Study|Withdrawal by Subject|7|||
155744067|NCT01534182|562161617|FG000|Overall Study|Adverse Event|7|||
155744068|NCT01534182|562161618|FG001|Overall Study|Adverse Event|3|||
155744069|NCT03077087|562161619|FG000|Overall Study|Physician Decision|2|||
155744070|NCT02412488|562161620|FG000|Overall Study|Lost to Follow-up|10|||
155744071|NCT02412488|562161620|FG000|Overall Study|Withdrawal by Subject|5|||
155744072|NCT02412488|562161620|FG000|Overall Study|Physician Decision|1|||
155744073|NCT02412488|562161620|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
155744074|NCT02412488|562161620|FG000|Overall Study|Reveal LINQ explant|1|||
155744075|NCT01989468|562161621|FG000|Overall Study|Adverse Event|10|||
155744076|NCT01989468|562161622|FG001|Overall Study|Adverse Event|15|||
155744077|NCT01989468|562161623|FG002|Overall Study|Adverse Event|4|||
155744078|NCT01989468|562161624|FG003|Overall Study|Adverse Event|5|||
155744079|NCT01989468|562161625|FG004|Overall Study|Adverse Event|4|||
155744080|NCT01989468|562161621|FG000|Overall Study|Lack of Efficacy|11|||
155744081|NCT01989468|562161622|FG001|Overall Study|Lack of Efficacy|11|||
155744082|NCT01989468|562161623|FG002|Overall Study|Lack of Efficacy|7|||
155744083|NCT01989468|562161624|FG003|Overall Study|Lack of Efficacy|4|||
155744084|NCT01989468|562161625|FG004|Overall Study|Lack of Efficacy|2|||
155744085|NCT01989468|562161621|FG000|Overall Study|Lost to Follow-up|5|||
155744086|NCT01989468|562161622|FG001|Overall Study|Lost to Follow-up|2|||
155744087|NCT01989468|562161623|FG002|Overall Study|Lost to Follow-up|0|||
155744088|NCT01989468|562161624|FG003|Overall Study|Lost to Follow-up|1|||
155744089|NCT01989468|562161625|FG004|Overall Study|Lost to Follow-up|1|||
155744090|NCT01989468|562161621|FG000|Overall Study|Physician Decision|4|||
155744091|NCT01989468|562161622|FG001|Overall Study|Physician Decision|1|||
155744092|NCT01989468|562161623|FG002|Overall Study|Physician Decision|0|||
155410101|NCT04418076|560932457|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
155410102|NCT01452152|560932461|FG000|Overall Study|Study termination by sponsor|5|||
155410103|NCT01452152|560932462|FG001|Overall Study|Study termination by sponsor|0|||
155410104|NCT01452152|560932463|FG002|Overall Study|Study termination by sponsor|4|||
155410105|NCT02867995|560932465|FG000|Overall Study|Withdrawal by Subject|0|||
155410106|NCT02867995|560932466|FG001|Overall Study|Withdrawal by Subject|1|||
155410107|NCT02867995|560932465|FG000|Overall Study|Lost to Follow-up|0|||
155410108|NCT02867995|560932466|FG001|Overall Study|Lost to Follow-up|2|||
155410109|NCT03368170|560933919|FG000|Overall Study|Adverse Event|2|||
155410110|NCT03368170|560933920|FG001|Overall Study|Adverse Event|1|||
155410111|NCT03047980|560933921|FG000|Overall Study|Adverse Event|1|||
155410112|NCT02164981|560933922|FG000|Started|Withdrawal by Subject|2|||
155410113|NCT02164981|560933923|FG001|Started|Withdrawal by Subject|1|||
155410114|NCT02164981|560933924|FG002|Started|Withdrawal by Subject|0|||
155410115|NCT02164981|560933922|FG000|Started|Protocol Violation|2|||
155410116|NCT02164981|560933923|FG001|Started|Protocol Violation|0|||
155410117|NCT02164981|560933924|FG002|Started|Protocol Violation|0|||
155410118|NCT02164981|560933922|FG000|Started|Adverse Event|1|||
155410119|NCT02164981|560933923|FG001|Started|Adverse Event|2|||
155410120|NCT02164981|560933924|FG002|Started|Adverse Event|0|||
155410121|NCT02164981|560933922|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
155410122|NCT02164981|560933923|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
155744093|NCT01989468|562161624|FG003|Overall Study|Physician Decision|1|||
155744094|NCT01989468|562161625|FG004|Overall Study|Physician Decision|0|||
155744095|NCT01989468|562161621|FG000|Overall Study|Pregnancy|0|||
155744096|NCT01989468|562161622|FG001|Overall Study|Pregnancy|1|||
155410123|NCT02164981|560933924|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
155410124|NCT02164981|560933922|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
155410125|NCT02164981|560933923|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
155410126|NCT02164981|560933924|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
155410127|NCT02164981|560933922|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
155410128|NCT02164981|560933923|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
155410129|NCT02164981|560933924|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
155410130|NCT01765673|560933930|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
155410131|NCT02600507|560933931|FG000|Overall Study|Adverse Event|3|||
155410132|NCT02600507|560933932|FG001|Overall Study|Adverse Event|15|||
155410133|NCT02600507|560933933|FG002|Overall Study|Adverse Event|5|||
155410134|NCT02600507|560933931|FG000|Overall Study|Lack of Efficacy|3|||
155744097|NCT01989468|562161623|FG002|Overall Study|Pregnancy|0|||
155744098|NCT01989468|562161624|FG003|Overall Study|Pregnancy|0|||
155744099|NCT01989468|562161625|FG004|Overall Study|Pregnancy|0|||
155744100|NCT01989468|562161621|FG000|Overall Study|Technical Problems|3|||
155744101|NCT01989468|562161622|FG001|Overall Study|Technical Problems|1|||
155744102|NCT01989468|562161623|FG002|Overall Study|Technical Problems|3|||
155744103|NCT01989468|562161624|FG003|Overall Study|Technical Problems|1|||
155293541|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155293542|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
155293543|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
155293544|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
155293545|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
155293546|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
155293547|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
155293548|NCT02525796|560504900|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
155293549|NCT02525796|560504901|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
155293550|NCT02525796|560504902|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
155293551|NCT02525796|560504900|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
155293552|NCT02525796|560504901|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
155293553|NCT02525796|560504902|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
155410135|NCT02600507|560933932|FG001|Overall Study|Lack of Efficacy|8|||
155410136|NCT02600507|560933933|FG002|Overall Study|Lack of Efficacy|5|||
155410137|NCT02600507|560933931|FG000|Overall Study|Lost to Follow-up|3|||
155410138|NCT02600507|560933932|FG001|Overall Study|Lost to Follow-up|5|||
155410139|NCT02600507|560933933|FG002|Overall Study|Lost to Follow-up|2|||
155410140|NCT02600507|560933931|FG000|Overall Study|Protocol Violation|12|||
155410141|NCT02600507|560933932|FG001|Overall Study|Protocol Violation|4|||
155410142|NCT02600507|560933933|FG002|Overall Study|Protocol Violation|4|||
155410143|NCT02600507|560933931|FG000|Overall Study|Physician Decision|1|||
155410144|NCT02600507|560933932|FG001|Overall Study|Physician Decision|0|||
155410145|NCT02600507|560933933|FG002|Overall Study|Physician Decision|1|||
155410146|NCT02600507|560933931|FG000|Overall Study|Withdrawal by Subject|7|||
155410147|NCT02600507|560933932|FG001|Overall Study|Withdrawal by Subject|11|||
155410148|NCT02600507|560933933|FG002|Overall Study|Withdrawal by Subject|7|||
155410149|NCT02600507|560933931|FG000|Overall Study|Other|0|||
155410150|NCT02600507|560933932|FG001|Overall Study|Other|1|||
155410151|NCT02600507|560933933|FG002|Overall Study|Other|1|||
155410152|NCT02684981|560933936|FG000|Overall Study|Permanently discontinued the treatment|157|||
155410153|NCT02684981|560933937|FG001|Overall Study|Permanently discontinued the treatment|161|||
155410154|NCT02684981|560933938|FG002|Overall Study|Permanently discontinued the treatment|110|||
155410155|NCT02684981|560933936|FG000|Overall Study|Other|83|||
155410156|NCT02684981|560933937|FG001|Overall Study|Other|49|||
155410157|NCT02684981|560933938|FG002|Overall Study|Other|17|||
155410158|NCT04623242|560933939|FG000|Overall Study|Withdrawal by Subject|7|||
155410159|NCT04623242|560933940|FG001|Overall Study|Withdrawal by Subject|12|||
155410160|NCT04623242|560933941|FG002|Overall Study|Withdrawal by Subject|5|||
155410161|NCT04623242|560933942|FG003|Overall Study|Withdrawal by Subject|7|||
155410162|NCT04623242|560933943|FG004|Overall Study|Withdrawal by Subject|0|||
155410163|NCT04623242|560933939|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
155410164|NCT04623242|560933940|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
155410165|NCT04623242|560933941|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
155410166|NCT04623242|560933942|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
155410167|NCT04623242|560933943|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
155410168|NCT04623242|560933939|FG000|Overall Study|Subject unblinded to mutation status|0|||
155410169|NCT04623242|560933940|FG001|Overall Study|Subject unblinded to mutation status|0|||
155410170|NCT04623242|560933941|FG002|Overall Study|Subject unblinded to mutation status|0|||
155410171|NCT04623242|560933942|FG003|Overall Study|Subject unblinded to mutation status|13|||
155410172|NCT04623242|560933943|FG004|Overall Study|Subject unblinded to mutation status|0|||
155410173|NCT00820898|560933948|FG000|Overall Study|Inelgible - wrong primary site|1|||
155410174|NCT00452699|560933951|FG000|Overall Study|Adverse Event|10|||
155410175|NCT00452699|560933952|FG001|Overall Study|Adverse Event|3|||
155410176|NCT00452699|560933951|FG000|Overall Study|Lack of Efficacy|6|||
155410177|NCT00452699|560933952|FG001|Overall Study|Lack of Efficacy|4|||
155410178|NCT00452699|560933951|FG000|Overall Study|Lost to Follow-up|6|||
155410179|NCT00452699|560933952|FG001|Overall Study|Lost to Follow-up|9|||
155410180|NCT00452699|560933951|FG000|Overall Study|Protocol Violation|21|||
155638620|NCT03765073|561767656|FG003|Stage 3|No longer meets eligibility criteria|0|||
155638621|NCT03765073|561767657|FG004|Stage 3|No longer meets eligibility criteria|0|||
155638622|NCT03765073|561767658|FG005|Stage 3|No longer meets eligibility criteria|0|||
155638623|NCT03765073|561767659|FG006|Stage 3|No longer meets eligibility criteria|0|||
155293554|NCT00955825|560504905|FG000|Overall Study|Adverse Event|15|||
155410181|NCT00452699|560933952|FG001|Overall Study|Protocol Violation|25|||
155410182|NCT00452699|560933951|FG000|Overall Study|Withdrawal by Subject|26|||
155410183|NCT00452699|560933952|FG001|Overall Study|Withdrawal by Subject|25|||
155410184|NCT00452699|560933951|FG000|Overall Study|Other|12|||
155410185|NCT00452699|560933952|FG001|Overall Study|Other|7|||
155410186|NCT02921971|560933953|FG000|Overall Study|Adverse Event|1|||
155410187|NCT02921971|560933954|FG001|Overall Study|Adverse Event|2|||
155410188|NCT02921971|560933953|FG000|Overall Study|Lack of Efficacy|3|||
155410189|NCT02921971|560933954|FG001|Overall Study|Lack of Efficacy|1|||
155410190|NCT02921971|560933953|FG000|Overall Study|Other than specified above|2|||
155410191|NCT02921971|560933954|FG001|Overall Study|Other than specified above|1|||
155410192|NCT02105454|560933957|FG000|Overall Study|Withdrawal by Subject|1|||
155410193|NCT00326898|560933958|FG000|Overall Study|Disease progression|52|||
155410194|NCT00326898|560933959|FG001|Overall Study|Disease progression|54|||
155410195|NCT00326898|560933960|FG002|Overall Study|Disease progression|102|||
155410196|NCT00326898|560933958|FG000|Overall Study|Adverse Event|124|||
155410197|NCT00326898|560933959|FG001|Overall Study|Adverse Event|128|||
155410198|NCT00326898|560933960|FG002|Overall Study|Adverse Event|33|||
155410199|NCT00326898|560933958|FG000|Overall Study|Death|2|||
155410200|NCT00326898|560933959|FG001|Overall Study|Death|0|||
155410201|NCT00326898|560933960|FG002|Overall Study|Death|0|||
155410202|NCT00326898|560933958|FG000|Overall Study|Withdrawal by Subject|134|||
155410203|NCT00326898|560933959|FG001|Overall Study|Withdrawal by Subject|128|||
155410204|NCT00326898|560933960|FG002|Overall Study|Withdrawal by Subject|32|||
155410205|NCT00326898|560933958|FG000|Overall Study|Alternative therapy|1|||
155410206|NCT00326898|560933959|FG001|Overall Study|Alternative therapy|0|||
155410207|NCT00326898|560933960|FG002|Overall Study|Alternative therapy|0|||
155410208|NCT00326898|560933958|FG000|Overall Study|Other complicating disease|5|||
155410209|NCT00326898|560933959|FG001|Overall Study|Other complicating disease|5|||
155410210|NCT00326898|560933960|FG002|Overall Study|Other complicating disease|4|||
155410211|NCT00326898|560933958|FG000|Overall Study|Other/Missing/Unknown|33|||
155410212|NCT00326898|560933959|FG001|Overall Study|Other/Missing/Unknown|28|||
155410213|NCT00326898|560933960|FG002|Overall Study|Other/Missing/Unknown|32|||
155410214|NCT03847987|560933961|FG000|Overall Study|Lost to Follow-up|1|||
155410215|NCT03847987|560933962|FG001|Overall Study|Lost to Follow-up|0|||
155410216|NCT03847987|560933961|FG000|Overall Study|Adverse Event|2|||
155410217|NCT03847987|560933962|FG001|Overall Study|Adverse Event|0|||
155410218|NCT02721355|560933963|FG000|Overall Study|Lost to Follow-up|6|||
155410219|NCT02721355|560933964|FG001|Overall Study|Lost to Follow-up|1|||
155410220|NCT00356278|560933965|FG000|Overall Study|Withdrawal by Subject|25|||
155410221|NCT00356278|560933966|FG001|Overall Study|Withdrawal by Subject|15|||
155410222|NCT00356278|560933967|FG002|Overall Study|Withdrawal by Subject|19|||
155410223|NCT01592760|560933974|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
155410224|NCT01592760|560933975|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
155410225|NCT01592760|560933976|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
155410226|NCT01363986|560933979|FG000|Overall Study|Disease progression|1|||
155410227|NCT01637142|560933980|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
155410228|NCT02111564|560933981|FG000|Overall Study|Death|109|||
155410229|NCT02111564|560933982|FG001|Overall Study|Death|120|||
155410230|NCT02111564|560933981|FG000|Overall Study|Lost to Follow-up|2|||
155410231|NCT02111564|560933982|FG001|Overall Study|Lost to Follow-up|3|||
155410232|NCT02111564|560933981|FG000|Overall Study|Withdrawal by Subject|20|||
155410233|NCT02111564|560933982|FG001|Overall Study|Withdrawal by Subject|20|||
155744104|NCT01989468|562161625|FG004|Overall Study|Technical Problems|0|||
155744105|NCT01989468|562161621|FG000|Overall Study|Subject Guardian Decision|11|||
155744106|NCT01989468|562161622|FG001|Overall Study|Subject Guardian Decision|6|||
155744107|NCT01989468|562161623|FG002|Overall Study|Subject Guardian Decision|4|||
155744108|NCT01989468|562161624|FG003|Overall Study|Subject Guardian Decision|4|||
155744109|NCT01989468|562161625|FG004|Overall Study|Subject Guardian Decision|1|||
155744110|NCT01989468|562161621|FG000|Overall Study|Death|3|||
155744111|NCT01989468|562161622|FG001|Overall Study|Death|0|||
155744112|NCT01989468|562161623|FG002|Overall Study|Death|1|||
155744113|NCT01989468|562161624|FG003|Overall Study|Death|0|||
155744114|NCT01989468|562161625|FG004|Overall Study|Death|0|||
155744115|NCT01960907|562161630|FG000|Overall Study|Death|4|||
155744116|NCT01960907|562161631|FG001|Overall Study|Death|3|||
155744117|NCT01960907|562161630|FG000|Overall Study|Withdrawal by Subject|32|||
155744118|NCT01960907|562161631|FG001|Overall Study|Withdrawal by Subject|42|||
155293555|NCT00955825|560504906|FG001|Overall Study|Adverse Event|2|||
155293556|NCT00955825|560504905|FG000|Overall Study|Withdrawal by Subject|4|||
155293557|NCT00955825|560504906|FG001|Overall Study|Withdrawal by Subject|6|||
155744119|NCT00065429|562161634|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155744120|NCT00065429|562161635|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155293558|NCT00955825|560504905|FG000|Overall Study|Any other reason not above-mentioned|7|||
155744121|NCT00065429|562161636|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155293559|NCT00955825|560504906|FG001|Overall Study|Any other reason not above-mentioned|9|||
155410234|NCT00687362|560933983|FG000|Overall Study|Protocol Violation|2|||
155410235|NCT00687362|560933983|FG000|Overall Study|Withdrawal by Subject|1|||
155410236|NCT00925015|560933984|FG000|Overall Study|Adverse Event|1|||
155410237|NCT00925015|560933985|FG001|Overall Study|Adverse Event|2|||
155410238|NCT00925015|560933986|FG002|Overall Study|Adverse Event|1|||
155293560|NCT01198275|560504907|FG000|Overall Study|Adverse Event|2|||
155293561|NCT01198275|560504908|FG001|Overall Study|Adverse Event|3|||
155410239|NCT00925015|560933984|FG000|Overall Study|Physician Decision|0|||
155410240|NCT00925015|560933985|FG001|Overall Study|Physician Decision|1|||
155410241|NCT00925015|560933986|FG002|Overall Study|Physician Decision|0|||
155744122|NCT00065429|562161637|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155293562|NCT01198275|560504907|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
155293563|NCT01198275|560504908|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
155410242|NCT00925015|560933984|FG000|Overall Study|Progressive Disease|7|||
155410243|NCT00925015|560933985|FG001|Overall Study|Progressive Disease|3|||
155410244|NCT00925015|560933986|FG002|Overall Study|Progressive Disease|4|||
155410245|NCT00925015|560933984|FG000|Overall Study|Withdrawal by Subject|0|||
155410246|NCT00925015|560933985|FG001|Overall Study|Withdrawal by Subject|0|||
155410247|NCT00925015|560933986|FG002|Overall Study|Withdrawal by Subject|1|||
155410248|NCT04986202|560933987|FG000|Overall Study|Death|10|||
155410249|NCT04986202|560933988|FG001|Overall Study|Death|3|||
155410250|NCT04986202|560933989|FG002|Overall Study|Death|10|||
155410251|NCT04986202|560933987|FG000|Overall Study|Physician Decision|3|||
155410252|NCT04986202|560933988|FG001|Overall Study|Physician Decision|1|||
155410253|NCT04986202|560933989|FG002|Overall Study|Physician Decision|2|||
155410254|NCT04986202|560933987|FG000|Overall Study|Withdrawal by Subject|4|||
155410255|NCT04986202|560933988|FG001|Overall Study|Withdrawal by Subject|2|||
155410256|NCT04986202|560933989|FG002|Overall Study|Withdrawal by Subject|4|||
155410257|NCT01289015|560933992|FG000|Overall Study|Protocol Violation|12|||
155410258|NCT01289015|560933993|FG001|Overall Study|Protocol Violation|9|||
155410259|NCT01289015|560933992|FG000|Overall Study|Adverse Event|3|||
155410260|NCT01289015|560933993|FG001|Overall Study|Adverse Event|0|||
155410261|NCT01289015|560933992|FG000|Overall Study|Lost to Follow-up|33|||
155410262|NCT01289015|560933993|FG001|Overall Study|Lost to Follow-up|17|||
155410263|NCT01289015|560933992|FG000|Overall Study|Withdrawal by Subject|17|||
155410264|NCT01289015|560933993|FG001|Overall Study|Withdrawal by Subject|8|||
155410265|NCT01289015|560933992|FG000|Overall Study|Disease progression|1|||
155410266|NCT01289015|560933993|FG001|Overall Study|Disease progression|0|||
155410267|NCT01289015|560933992|FG000|Overall Study|Negative baseline culture and others|33|||
155293564|NCT00391846|560504909|FG000|Overall Study|Adverse Event|4|||
155293565|NCT00391846|560504910|FG001|Overall Study|Adverse Event|1|||
155293566|NCT00391846|560504909|FG000|Overall Study|Did not meet the required elig. crit|2|||
155293567|NCT00391846|560504910|FG001|Overall Study|Did not meet the required elig. crit|2|||
155410268|NCT01289015|560933993|FG001|Overall Study|Negative baseline culture and others|20|||
155410269|NCT01425203|560933996|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
155410270|NCT01425203|560933997|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
155410271|NCT01425203|560933998|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
155410272|NCT01425203|560933996|FG000|Treatment Phase|Failure at futility timepoint|8|||
155410273|NCT01425203|560933997|FG001|Treatment Phase|Failure at futility timepoint|27|||
155410274|NCT01425203|560933998|FG002|Treatment Phase|Failure at futility timepoint|0|||
155410275|NCT01425203|560933996|FG000|Treatment Phase|Other virologic failure criteria|5|||
155410276|NCT01425203|560933997|FG001|Treatment Phase|Other virologic failure criteria|3|||
155410277|NCT01425203|560933998|FG002|Treatment Phase|Other virologic failure criteria|0|||
155410278|NCT01425203|560933996|FG000|Treatment Phase|Unidentified reasons|11|||
155410279|NCT01425203|560933997|FG001|Treatment Phase|Unidentified reasons|5|||
155410280|NCT01425203|560933998|FG002|Treatment Phase|Unidentified reasons|0|||
155410281|NCT01425203|560933996|FG000|Treatment Phase|Did not receive treatment|0|||
155410282|NCT01425203|560933997|FG001|Treatment Phase|Did not receive treatment|1|||
155410283|NCT01425203|560933998|FG002|Treatment Phase|Did not receive treatment|0|||
155410284|NCT01425203|560933996|FG000|Crossover Phase|Failure at futility timepoint|0|||
155410285|NCT01425203|560933997|FG001|Crossover Phase|Failure at futility timepoint|0|||
155410286|NCT01425203|560933998|FG002|Crossover Phase|Failure at futility timepoint|3|||
155410287|NCT01425203|560933996|FG000|Crossover Phase|Other virologic failure criteria|0|||
155410288|NCT01425203|560933997|FG001|Crossover Phase|Other virologic failure criteria|0|||
155410289|NCT01425203|560933998|FG002|Crossover Phase|Other virologic failure criteria|3|||
155410290|NCT00290433|560934005|FG000|Overall Study|Disease Progression|13|||
155410291|NCT00290433|560934005|FG000|Overall Study|Adverse Event|14|||
155410292|NCT00290433|560934005|FG000|Overall Study|Withdrawal by Subject|1|||
155410293|NCT00290433|560934005|FG000|Overall Study|Non-Compliance|1|||
155744123|NCT00065429|562161638|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155744124|NCT00065429|562161639|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
155744125|NCT00065429|562161640|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155744126|NCT00065429|562161634|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155293568|NCT00391846|560504909|FG000|Overall Study|Withdrawal by Subject|2|||
155410294|NCT00290433|560934005|FG000|Overall Study|Congestive Heart Failure|1|||
155410295|NCT00290433|560934005|FG000|Overall Study|Transplant in CR|5|||
155410296|NCT00290433|560934005|FG000|Overall Study|Unrelated Infection/Death|1|||
155410297|NCT01888640|560934014|FG000|Overall Study|Lost to Follow-up|1|||
155410298|NCT01888640|560934015|FG001|Overall Study|Lost to Follow-up|2|||
155410299|NCT01888640|560934016|FG002|Overall Study|Lost to Follow-up|0|||
155410300|NCT01888640|560934014|FG000|Overall Study|Withdrawal by Subject|15|||
155410301|NCT01888640|560934015|FG001|Overall Study|Withdrawal by Subject|11|||
155410302|NCT01888640|560934016|FG002|Overall Study|Withdrawal by Subject|4|||
155410303|NCT01888640|560934014|FG000|Overall Study|Minimum dose not met|10|||
155410304|NCT01888640|560934015|FG001|Overall Study|Minimum dose not met|16|||
155410305|NCT01888640|560934016|FG002|Overall Study|Minimum dose not met|0|||
155293569|NCT00391846|560504910|FG001|Overall Study|Withdrawal by Subject|3|||
155293570|NCT00391846|560504909|FG000|Overall Study|Developed study specific DC criteria|0|||
155293571|NCT00391846|560504910|FG001|Overall Study|Developed study specific DC criteria|1|||
155293572|NCT02385669|560504913|FG000|Overall Study|Adverse Event|2|||
155293573|NCT02477670|560504914|FG000|Stage 1|Adverse Event|2|||
155293574|NCT02477670|560504915|FG001|Stage 1|Adverse Event|7|||
155293575|NCT02477670|560504916|FG002|Stage 1|Adverse Event|0|||
155293576|NCT02477670|560504917|FG003|Stage 1|Adverse Event|0|||
155293577|NCT02477670|560504918|FG004|Stage 1|Adverse Event|0|||
155293578|NCT02477670|560504919|FG005|Stage 1|Adverse Event|0|||
155293579|NCT02477670|560504920|FG006|Stage 1|Adverse Event|0|||
155293580|NCT02477670|560504914|FG000|Stage 1|Lost to Follow-up|0|||
155293581|NCT02477670|560504915|FG001|Stage 1|Lost to Follow-up|2|||
155293582|NCT02477670|560504916|FG002|Stage 1|Lost to Follow-up|0|||
155293583|NCT02477670|560504917|FG003|Stage 1|Lost to Follow-up|0|||
155293584|NCT02477670|560504918|FG004|Stage 1|Lost to Follow-up|0|||
155293585|NCT02477670|560504919|FG005|Stage 1|Lost to Follow-up|0|||
155293586|NCT02477670|560504920|FG006|Stage 1|Lost to Follow-up|0|||
155293587|NCT02477670|560504914|FG000|Stage 1|Withdrawal by Subject|1|||
155293588|NCT02477670|560504915|FG001|Stage 1|Withdrawal by Subject|2|||
155293589|NCT02477670|560504916|FG002|Stage 1|Withdrawal by Subject|0|||
155293590|NCT02477670|560504917|FG003|Stage 1|Withdrawal by Subject|0|||
155293591|NCT02477670|560504918|FG004|Stage 1|Withdrawal by Subject|0|||
155293592|NCT02477670|560504919|FG005|Stage 1|Withdrawal by Subject|0|||
155293593|NCT02477670|560504920|FG006|Stage 1|Withdrawal by Subject|0|||
155293594|NCT02477670|560504914|FG000|Stage 1|Non-compliance with Study Drug|1|||
155410306|NCT01888640|560934014|FG000|Overall Study|Given wrong unit (placebo)|1|||
155293595|NCT02477670|560504915|FG001|Stage 1|Non-compliance with Study Drug|2|||
155410307|NCT01888640|560934015|FG001|Overall Study|Given wrong unit (placebo)|0|||
155410308|NCT01888640|560934016|FG002|Overall Study|Given wrong unit (placebo)|0|||
155410309|NCT01888640|560934014|FG000|Overall Study|Excluded for prior TENS|0|||
155410310|NCT01888640|560934015|FG001|Overall Study|Excluded for prior TENS|1|||
155410311|NCT01888640|560934016|FG002|Overall Study|Excluded for prior TENS|0|||
155410312|NCT01888640|560934014|FG000|Overall Study|Researcher Termination of Participant|0|||
155410313|NCT01888640|560934015|FG001|Overall Study|Researcher Termination of Participant|1|||
155410314|NCT01888640|560934016|FG002|Overall Study|Researcher Termination of Participant|1|||
155410315|NCT00109707|560934017|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
155410316|NCT00109707|560934018|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
155410317|NCT00109707|560934019|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
155410318|NCT00109707|560934017|FG000|Overall Study|Abnormal laboratory values|1|||
155410319|NCT00109707|560934018|FG001|Overall Study|Abnormal laboratory values|0|||
155410320|NCT00109707|560934019|FG002|Overall Study|Abnormal laboratory values|0|||
155410321|NCT00109707|560934017|FG000|Overall Study|Administrative problems|2|||
155410322|NCT00109707|560934018|FG001|Overall Study|Administrative problems|0|||
155410323|NCT00109707|560934019|FG002|Overall Study|Administrative problems|1|||
155410324|NCT00109707|560934017|FG000|Overall Study|Adverse Event|10|||
155410325|NCT00109707|560934018|FG001|Overall Study|Adverse Event|2|||
155410326|NCT00109707|560934019|FG002|Overall Study|Adverse Event|3|||
155410327|NCT00109707|560934017|FG000|Overall Study|Death|4|||
155410328|NCT00109707|560934018|FG001|Overall Study|Death|0|||
155410329|NCT00109707|560934019|FG002|Overall Study|Death|0|||
155410330|NCT00109707|560934017|FG000|Overall Study|Disease progression|12|||
155410331|NCT00109707|560934018|FG001|Overall Study|Disease progression|4|||
155410332|NCT00109707|560934019|FG002|Overall Study|Disease progression|3|||
155410333|NCT00109707|560934017|FG000|Overall Study|Lost to Follow-up|3|||
155410334|NCT00109707|560934018|FG001|Overall Study|Lost to Follow-up|0|||
155410335|NCT00109707|560934019|FG002|Overall Study|Lost to Follow-up|0|||
155410336|NCT00109707|560934017|FG000|Overall Study|Protocol Violation|1|||
155410337|NCT00109707|560934018|FG001|Overall Study|Protocol Violation|0|||
155410338|NCT00109707|560934019|FG002|Overall Study|Protocol Violation|0|||
155410339|NCT00109707|560934017|FG000|Overall Study|Patient withdrew consent|6|||
155638624|NCT03765073|561767660|FG007|Stage 3|No longer meets eligibility criteria|0|||
155638625|NCT03765073|561767661|FG008|Stage 3|No longer meets eligibility criteria|0|||
155638626|NCT03765073|561767662|FG009|Stage 3|No longer meets eligibility criteria|0|||
155293596|NCT02477670|560504916|FG002|Stage 1|Non-compliance with Study Drug|0|||
155293597|NCT02477670|560504917|FG003|Stage 1|Non-compliance with Study Drug|0|||
155293598|NCT02477670|560504918|FG004|Stage 1|Non-compliance with Study Drug|0|||
155293599|NCT02477670|560504919|FG005|Stage 1|Non-compliance with Study Drug|0|||
155293600|NCT02477670|560504920|FG006|Stage 1|Non-compliance with Study Drug|0|||
155410340|NCT00109707|560934018|FG001|Overall Study|Patient withdrew consent|1|||
155410341|NCT00109707|560934019|FG002|Overall Study|Patient withdrew consent|0|||
155410342|NCT01277549|560934020|FG000|Overall Study|Failed to meet eligibility criteria|13|||
155410343|NCT01277549|560934021|FG001|Overall Study|Failed to meet eligibility criteria|9|||
155410344|NCT01277549|560934020|FG000|Overall Study|Withdrawal by Subject|1|||
155638627|NCT03765073|561767663|FG010|Stage 3|No longer meets eligibility criteria|0|||
155293601|NCT02477670|560504914|FG000|Stage 2|Adverse Event|0|||
155293602|NCT02477670|560504915|FG001|Stage 2|Adverse Event|0|||
155744127|NCT00065429|562161635|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155744128|NCT00065429|562161636|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
155744129|NCT00065429|562161637|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155744130|NCT00065429|562161638|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155744131|NCT00065429|562161639|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155293603|NCT02477670|560504916|FG002|Stage 2|Adverse Event|1|||
155293604|NCT02477670|560504917|FG003|Stage 2|Adverse Event|0|||
155293605|NCT02477670|560504918|FG004|Stage 2|Adverse Event|0|||
155293606|NCT02477670|560504919|FG005|Stage 2|Adverse Event|0|||
155293607|NCT02477670|560504920|FG006|Stage 2|Adverse Event|0|||
155293608|NCT02477670|560504914|FG000|Stage 2|Antipsychotic Medication Changed|0|||
155293609|NCT02477670|560504915|FG001|Stage 2|Antipsychotic Medication Changed|0|||
155293610|NCT02477670|560504916|FG002|Stage 2|Antipsychotic Medication Changed|1|||
155293611|NCT02477670|560504917|FG003|Stage 2|Antipsychotic Medication Changed|0|||
155293612|NCT02477670|560504918|FG004|Stage 2|Antipsychotic Medication Changed|0|||
155293613|NCT02477670|560504919|FG005|Stage 2|Antipsychotic Medication Changed|0|||
155293614|NCT02477670|560504920|FG006|Stage 2|Antipsychotic Medication Changed|0|||
155293615|NCT02477670|560504914|FG000|Stage 2|Withdrawal by Subject|0|||
155293616|NCT02477670|560504915|FG001|Stage 2|Withdrawal by Subject|0|||
155293617|NCT02477670|560504916|FG002|Stage 2|Withdrawal by Subject|0|||
155293618|NCT02477670|560504917|FG003|Stage 2|Withdrawal by Subject|1|||
155293619|NCT02477670|560504918|FG004|Stage 2|Withdrawal by Subject|0|||
155293620|NCT02477670|560504919|FG005|Stage 2|Withdrawal by Subject|0|||
155293621|NCT02477670|560504920|FG006|Stage 2|Withdrawal by Subject|0|||
155293622|NCT00970307|560504921|FG000|Overall Study|Serious Adverse Event|1|||
155293623|NCT00970307|560504922|FG001|Overall Study|Serious Adverse Event|0|||
155293624|NCT00970307|560504923|FG002|Overall Study|Serious Adverse Event|0|||
155293625|NCT00970307|560504921|FG000|Overall Study|Withdrawal by Subject|2|||
155293626|NCT00970307|560504922|FG001|Overall Study|Withdrawal by Subject|3|||
155293627|NCT00970307|560504923|FG002|Overall Study|Withdrawal by Subject|2|||
155293628|NCT02937831|560504924|FG000|Overall Study|Protocol Violation|4|||
155293629|NCT01370694|560504940|FG000|Overall Study|Switched to rituximab|4|||
155293630|NCT01370694|560504940|FG000|Overall Study|Progressive disease|2|||
155293631|NCT01119950|560504941|FG000|Overall Study|Adverse Event|25|||
155293632|NCT01119950|560504941|FG000|Overall Study|Withdrawal by Subject|9|||
155293633|NCT01119950|560504941|FG000|Overall Study|Protocol Violation|5|||
155293634|NCT01119950|560504941|FG000|Overall Study|Lost to Follow-up|4|||
155293635|NCT01119950|560504941|FG000|Overall Study|Administrative|2|||
155293636|NCT01119950|560504941|FG000|Overall Study|Abnormal lab value|1|||
155293637|NCT01119950|560504941|FG000|Overall Study|Death|1|||
155293638|NCT01988233|560504942|FG000|Overall Study|Lost to Follow-up|64|||
155293639|NCT01988233|560504943|FG001|Overall Study|Lost to Follow-up|51|||
155293640|NCT03621761|560504945|FG000|Overall Study|Lost to Follow-up|1|||
155293641|NCT03621761|560504946|FG001|Overall Study|Lost to Follow-up|1|||
155293642|NCT03621761|560504947|FG002|Overall Study|Lost to Follow-up|2|||
155293643|NCT03621761|560504945|FG000|Overall Study|Withdrawal by Subject|2|||
155293644|NCT03621761|560504946|FG001|Overall Study|Withdrawal by Subject|1|||
155293645|NCT03621761|560504947|FG002|Overall Study|Withdrawal by Subject|1|||
155293646|NCT03621761|560504945|FG000|Overall Study|Became Ineligible|0|||
155293647|NCT03621761|560504946|FG001|Overall Study|Became Ineligible|2|||
155293648|NCT03621761|560504947|FG002|Overall Study|Became Ineligible|0|||
155293649|NCT01191788|560504952|FG000|Overall Study|Lost to Follow-up|21|||
155293650|NCT01191788|560504953|FG001|Overall Study|Lost to Follow-up|22|||
155293651|NCT01050569|560504955|FG000|Overall Study|Lost to Follow-up|20|||
155293652|NCT01050569|560504956|FG001|Overall Study|Lost to Follow-up|14|||
155293653|NCT01050569|560504957|FG002|Overall Study|Lost to Follow-up|16|||
155293654|NCT01050569|560504955|FG000|Overall Study|Withdrawal by Subject|9|||
155293655|NCT01050569|560504956|FG001|Overall Study|Withdrawal by Subject|3|||
155293656|NCT01050569|560504957|FG002|Overall Study|Withdrawal by Subject|11|||
155293657|NCT01050569|560504955|FG000|Overall Study|Lack of Efficacy|5|||
155293658|NCT01050569|560504956|FG001|Overall Study|Lack of Efficacy|4|||
155293659|NCT01050569|560504957|FG002|Overall Study|Lack of Efficacy|3|||
155293660|NCT01050569|560504955|FG000|Overall Study|Adverse Event|1|||
155293661|NCT01050569|560504956|FG001|Overall Study|Adverse Event|0|||
155293662|NCT01050569|560504957|FG002|Overall Study|Adverse Event|0|||
155293663|NCT01050569|560504955|FG000|Overall Study|Physician Decision|3|||
155293664|NCT01050569|560504956|FG001|Overall Study|Physician Decision|3|||
155293665|NCT01050569|560504957|FG002|Overall Study|Physician Decision|3|||
155293666|NCT03939819|560504959|FG000|Overall Study|Death|2|||
155293667|NCT03939819|560504960|FG001|Overall Study|Death|0|||
155293668|NCT02148133|560504964|FG000|Overall Study|Investigator discretion|1|||
155293669|NCT02148133|560504964|FG000|Overall Study|Lack of Efficacy|1|||
155293670|NCT02148133|560504964|FG000|Overall Study|Protocol deviation|1|||
155293671|NCT02148133|560504964|FG000|Overall Study|Protocol-defined stopping criteria|2|||
155293672|NCT03808883|560504965|FG000|Overall Study|Withdrawal by Subject|2|||
155293673|NCT03808883|560504966|FG001|Overall Study|Withdrawal by Subject|0|||
155293674|NCT03808883|560504965|FG000|Overall Study|Did not complete pre test or post test survey|4|||
155293675|NCT03808883|560504966|FG001|Overall Study|Did not complete pre test or post test survey|3|||
155410345|NCT01277549|560934021|FG001|Overall Study|Withdrawal by Subject|3|||
155410346|NCT01277549|560934020|FG000|Overall Study|Protocol Violation|10|||
155410347|NCT01277549|560934021|FG001|Overall Study|Protocol Violation|1|||
155410348|NCT01277549|560934020|FG000|Overall Study|Physician Decision|2|||
155410349|NCT01277549|560934021|FG001|Overall Study|Physician Decision|1|||
155410350|NCT01618214|560934022|FG000|Overall Study|Adverse Event|3|||
155410351|NCT01618214|560934023|FG001|Overall Study|Adverse Event|1|||
155410352|NCT01618214|560934022|FG000|Overall Study|Lack of Efficacy|1|||
155410353|NCT01618214|560934023|FG001|Overall Study|Lack of Efficacy|1|||
155410354|NCT01618214|560934022|FG000|Overall Study|Protocol Violation|1|||
155410355|NCT01618214|560934023|FG001|Overall Study|Protocol Violation|4|||
155410356|NCT01618214|560934022|FG000|Overall Study|Withdrawal Criteria|1|||
155410357|NCT01618214|560934023|FG001|Overall Study|Withdrawal Criteria|2|||
155410358|NCT01618214|560934022|FG000|Overall Study|Unclassified|4|||
155410359|NCT01618214|560934023|FG001|Overall Study|Unclassified|5|||
155410360|NCT02228590|560934024|FG000|Overall Study|Withdrawal by Subject|1|||
155410361|NCT02109484|560934025|FG000|Overall Study|Lost to Follow-up|0|||
155410362|NCT02109484|560934026|FG001|Overall Study|Lost to Follow-up|0|||
155410363|NCT02109484|560934027|FG002|Overall Study|Lost to Follow-up|0|||
155410364|NCT02109484|560934028|FG003|Overall Study|Lost to Follow-up|1|||
155410365|NCT02109484|560934029|FG004|Overall Study|Lost to Follow-up|1|||
155410366|NCT02109484|560934030|FG005|Overall Study|Lost to Follow-up|0|||
155410367|NCT02109484|560934031|FG006|Overall Study|Lost to Follow-up|1|||
155410368|NCT02109484|560934032|FG007|Overall Study|Lost to Follow-up|0|||
155410369|NCT02109484|560934025|FG000|Overall Study|Withdrawal by Subject|0|||
155410370|NCT02109484|560934026|FG001|Overall Study|Withdrawal by Subject|0|||
155410371|NCT02109484|560934027|FG002|Overall Study|Withdrawal by Subject|0|||
155410372|NCT02109484|560934028|FG003|Overall Study|Withdrawal by Subject|0|||
155410373|NCT02109484|560934029|FG004|Overall Study|Withdrawal by Subject|1|||
155410374|NCT02109484|560934030|FG005|Overall Study|Withdrawal by Subject|1|||
155410375|NCT02109484|560934031|FG006|Overall Study|Withdrawal by Subject|1|||
155410376|NCT02109484|560934032|FG007|Overall Study|Withdrawal by Subject|0|||
155410377|NCT02109484|560934025|FG000|Overall Study|Physician Decision|0|||
155410378|NCT02109484|560934026|FG001|Overall Study|Physician Decision|0|||
155410379|NCT02109484|560934027|FG002|Overall Study|Physician Decision|0|||
155410380|NCT02109484|560934028|FG003|Overall Study|Physician Decision|0|||
155410381|NCT02109484|560934029|FG004|Overall Study|Physician Decision|2|||
155410382|NCT02109484|560934030|FG005|Overall Study|Physician Decision|0|||
155410383|NCT02109484|560934031|FG006|Overall Study|Physician Decision|0|||
155410384|NCT02109484|560934032|FG007|Overall Study|Physician Decision|0|||
155410385|NCT02109484|560934025|FG000|Overall Study|Death|0|||
155410386|NCT02109484|560934026|FG001|Overall Study|Death|0|||
155410387|NCT02109484|560934027|FG002|Overall Study|Death|0|||
155410388|NCT02109484|560934028|FG003|Overall Study|Death|0|||
155410389|NCT02109484|560934029|FG004|Overall Study|Death|0|||
155293676|NCT01909336|560504967|FG000|Overall Study|Lost to Follow-up|4|||
155293677|NCT01909336|560504968|FG001|Overall Study|Lost to Follow-up|2|||
155293678|NCT01909336|560504969|FG002|Overall Study|Lost to Follow-up|2|||
155293679|NCT01909336|560504967|FG000|Overall Study|Physician Decision|0|||
155293680|NCT01909336|560504968|FG001|Overall Study|Physician Decision|1|||
155293681|NCT01909336|560504969|FG002|Overall Study|Physician Decision|1|||
155293682|NCT00436644|560504970|FG000|Overall Study|Adverse Event|2|||
155410390|NCT02109484|560934030|FG005|Overall Study|Death|0|||
155410391|NCT02109484|560934031|FG006|Overall Study|Death|0|||
155410392|NCT02109484|560934032|FG007|Overall Study|Death|2|||
155410393|NCT02109484|560934025|FG000|Overall Study|Moved away from study area|0|||
155744132|NCT00065429|562161640|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155293683|NCT00436644|560504970|FG000|Overall Study|Death|1|||
155293684|NCT04364269|560504975|FG000|Overall Study|Adverse Event|1|||
155293685|NCT04364269|560504976|FG001|Overall Study|Adverse Event|0|||
155293686|NCT04364269|560504977|FG002|Overall Study|Adverse Event|0|||
155293687|NCT04364269|560504975|FG000|Overall Study|Withdrawal by Subject|0|||
155293688|NCT04364269|560504976|FG001|Overall Study|Withdrawal by Subject|1|||
155293689|NCT04364269|560504977|FG002|Overall Study|Withdrawal by Subject|0|||
155410394|NCT02109484|560934026|FG001|Overall Study|Moved away from study area|0|||
155410395|NCT02109484|560934027|FG002|Overall Study|Moved away from study area|0|||
155410396|NCT02109484|560934028|FG003|Overall Study|Moved away from study area|0|||
155410397|NCT02109484|560934029|FG004|Overall Study|Moved away from study area|0|||
155410398|NCT02109484|560934030|FG005|Overall Study|Moved away from study area|0|||
155410399|NCT02109484|560934031|FG006|Overall Study|Moved away from study area|1|||
155410400|NCT02109484|560934032|FG007|Overall Study|Moved away from study area|1|||
155410401|NCT02111993|560934033|FG000|Overall Study|Physician Decision|5|||
155410402|NCT02111993|560934034|FG001|Overall Study|Physician Decision|4|||
155410403|NCT00419380|560934035|FG000|Overall Study|Lack of Efficacy|1|||
155410404|NCT00419380|560934036|FG001|Overall Study|Lack of Efficacy|7|||
155410405|NCT00419380|560934035|FG000|Overall Study|Physician Decision|0|||
155410406|NCT00419380|560934036|FG001|Overall Study|Physician Decision|1|||
155293690|NCT04173572|560504978|FG000|Overall Study|Withdrawal by Subject|1|||
155410407|NCT00419380|560934035|FG000|Overall Study|Lost to Follow-up|0|||
155293691|NCT04173572|560504979|FG001|Overall Study|Withdrawal by Subject|5|||
155293692|NCT04173572|560504978|FG000|Overall Study|Lost to Follow-up|3|||
155293693|NCT04173572|560504979|FG001|Overall Study|Lost to Follow-up|1|||
155293694|NCT02026258|560504982|FG000|Randomized|Did not start treatment|2|||
155293695|NCT02026258|560504983|FG001|Randomized|Did not start treatment|1|||
155293696|NCT02026258|560504982|FG000|Randomized|Change in treatment plan|1|||
155293697|NCT02026258|560504983|FG001|Randomized|Change in treatment plan|0|||
155293698|NCT02026258|560504982|FG000|Randomized|Presence of periodontal disease|1|||
155293699|NCT02026258|560504983|FG001|Randomized|Presence of periodontal disease|1|||
155293700|NCT02026258|560504982|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
155293701|NCT02026258|560504983|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
155293702|NCT02026258|560504982|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
155293703|NCT02026258|560504983|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
155293704|NCT04246762|560504984|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
155293705|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
155293706|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
155293707|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
155410408|NCT00419380|560934036|FG001|Overall Study|Lost to Follow-up|1|||
155410409|NCT00419380|560934035|FG000|Overall Study|Withdrawal by Subject|0|||
155410410|NCT00419380|560934036|FG001|Overall Study|Withdrawal by Subject|1|||
155410411|NCT00796315|560934037|FG000|Overall Study|Protocol Violation|0|||
155293708|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
155293709|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
155293710|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
155410412|NCT00796315|560934038|FG001|Overall Study|Protocol Violation|1|||
155410413|NCT00796315|560934039|FG002|Overall Study|Protocol Violation|0|||
155410414|NCT01400451|560934048|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
155410415|NCT01400451|560934049|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
155410416|NCT01400451|560934050|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
155410417|NCT01400451|560934048|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
155410418|NCT01400451|560934049|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
155410419|NCT01400451|560934050|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
155410420|NCT01400451|560934048|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
155410421|NCT01400451|560934049|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
155410422|NCT01400451|560934050|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
155410423|NCT01400451|560934048|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
155410424|NCT01400451|560934049|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
155410425|NCT01400451|560934050|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
155410426|NCT01400451|560934048|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
155410427|NCT01400451|560934049|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
155410428|NCT01400451|560934050|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
155410429|NCT00574275|560934051|FG000|Overall Study|Randomized but not treated|2|||
155410430|NCT00574275|560934052|FG001|Overall Study|Randomized but not treated|3|||
155410431|NCT00574275|560934051|FG000|Overall Study|Adverse Event|32|||
155410432|NCT00574275|560934052|FG001|Overall Study|Adverse Event|76|||
155410433|NCT00574275|560934051|FG000|Overall Study|Disease progression|160|||
155410434|NCT00574275|560934052|FG001|Overall Study|Disease progression|146|||
155410435|NCT00574275|560934051|FG000|Overall Study|Lost to Follow-up|2|||
155410436|NCT00574275|560934052|FG001|Overall Study|Lost to Follow-up|1|||
155410437|NCT00574275|560934051|FG000|Overall Study|Study stopped based on DMC decision|62|||
155410438|NCT00574275|560934052|FG001|Overall Study|Study stopped based on DMC decision|23|||
155410439|NCT00574275|560934051|FG000|Overall Study|Withdrawal by Subject|15|||
155410440|NCT00574275|560934052|FG001|Overall Study|Withdrawal by Subject|17|||
155410441|NCT00574275|560934051|FG000|Overall Study|Error calculating tumor measurement|1|||
155410442|NCT00574275|560934052|FG001|Overall Study|Error calculating tumor measurement|0|||
155410443|NCT00574275|560934051|FG000|Overall Study|Physician Decision|1|||
155410444|NCT00574275|560934052|FG001|Overall Study|Physician Decision|1|||
155410445|NCT00574275|560934051|FG000|Overall Study|Protocol Violation|0|||
155410446|NCT00574275|560934052|FG001|Overall Study|Protocol Violation|1|||
155410447|NCT00574275|560934051|FG000|Overall Study|Patient and Investigator decision|0|||
155410448|NCT00574275|560934052|FG001|Overall Study|Patient and Investigator decision|1|||
155410449|NCT00574275|560934051|FG000|Overall Study|Insurance change|0|||
155410450|NCT00574275|560934052|FG001|Overall Study|Insurance change|1|||
155410451|NCT00574275|560934051|FG000|Overall Study|Operation for curative intent|0|||
155410452|NCT00574275|560934052|FG001|Overall Study|Operation for curative intent|1|||
155410453|NCT00889265|560934060|FG000|Overall Study|Adverse Event|1|||
155410454|NCT00889265|560934060|FG000|Overall Study|Lost to Follow-up|5|||
155410455|NCT00889265|560934060|FG000|Overall Study|Protocol Violation|1|||
155410456|NCT03028870|560934061|FG000|Overall Study|Adverse Event|7|||
155410457|NCT03028870|560934062|FG001|Overall Study|Adverse Event|4|||
155410458|NCT03028870|560934063|FG002|Overall Study|Adverse Event|3|||
155410459|NCT03028870|560934064|FG003|Overall Study|Adverse Event|3|||
155293711|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
155293712|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
155410460|NCT03028870|560934061|FG000|Overall Study|Withdrawal by Subject|1|||
155410461|NCT03028870|560934062|FG001|Overall Study|Withdrawal by Subject|1|||
155410462|NCT03028870|560934063|FG002|Overall Study|Withdrawal by Subject|1|||
155410463|NCT03028870|560934064|FG003|Overall Study|Withdrawal by Subject|2|||
155410464|NCT03028870|560934061|FG000|Overall Study|Lost to Follow-up|1|||
155410465|NCT03028870|560934062|FG001|Overall Study|Lost to Follow-up|0|||
155410466|NCT03028870|560934063|FG002|Overall Study|Lost to Follow-up|0|||
155410467|NCT03028870|560934064|FG003|Overall Study|Lost to Follow-up|0|||
155410468|NCT03028870|560934061|FG000|Overall Study|Lack of Efficacy|3|||
155410469|NCT03028870|560934062|FG001|Overall Study|Lack of Efficacy|0|||
155410470|NCT03028870|560934063|FG002|Overall Study|Lack of Efficacy|0|||
155410471|NCT03028870|560934064|FG003|Overall Study|Lack of Efficacy|0|||
155410472|NCT03028870|560934061|FG000|Overall Study|Administrative|5|||
155410473|NCT03028870|560934062|FG001|Overall Study|Administrative|5|||
155410474|NCT03028870|560934063|FG002|Overall Study|Administrative|12|||
155410475|NCT03028870|560934064|FG003|Overall Study|Administrative|4|||
155410476|NCT00317109|560934067|FG000|Overall Study|Withdrawal by Subject|2|||
155410477|NCT00317109|560934068|FG001|Overall Study|Withdrawal by Subject|0|||
155410478|NCT00317109|560934067|FG000|Overall Study|Migated/moved from study area|1|||
155410479|NCT00317109|560934068|FG001|Overall Study|Migated/moved from study area|0|||
155410480|NCT03461757|560934070|FG000|Overall Study|Adverse Event|1|||
155410481|NCT03461757|560934071|FG001|Overall Study|Adverse Event|0|||
155410482|NCT03461757|560934070|FG000|Overall Study|Lost to Follow-up|13|||
155410483|NCT03461757|560934071|FG001|Overall Study|Lost to Follow-up|7|||
155410484|NCT03461757|560934070|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
155410485|NCT03461757|560934071|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
155410486|NCT03461757|560934070|FG000|Overall Study|Non-compliance with study treatment|0|||
155410487|NCT03461757|560934071|FG001|Overall Study|Non-compliance with study treatment|1|||
155410488|NCT03461757|560934070|FG000|Overall Study|Pregnancy|2|||
155410489|NCT03461757|560934071|FG001|Overall Study|Pregnancy|0|||
155410490|NCT03461757|560934070|FG000|Overall Study|Protocol Violation|1|||
155410491|NCT03461757|560934071|FG001|Overall Study|Protocol Violation|1|||
155410492|NCT03461757|560934070|FG000|Overall Study|Withdrawal by Subject|7|||
155410493|NCT03461757|560934071|FG001|Overall Study|Withdrawal by Subject|7|||
155410494|NCT03461757|560934070|FG000|Overall Study|Other Reasons|1|||
155410495|NCT03461757|560934071|FG001|Overall Study|Other Reasons|4|||
155410496|NCT03315871|560934075|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
155410497|NCT03315871|560934076|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
155410498|NCT03315871|560934077|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
155410499|NCT03315871|560934075|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
155410500|NCT03315871|560934076|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
155410501|NCT03315871|560934077|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
155410502|NCT03315871|560934075|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
155410503|NCT03315871|560934076|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
155410504|NCT03315871|560934077|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
155410505|NCT03315871|560934075|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
155410506|NCT03315871|560934076|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
155410507|NCT03315871|560934077|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
155410508|NCT03315871|560934075|FG000|PROSTVAC + CV301|Progressive disease|0|||
155410509|NCT03315871|560934076|FG001|PROSTVAC + CV301|Progressive disease|0|||
155410510|NCT03315871|560934077|FG002|PROSTVAC + CV301|Progressive disease|1|||
155410511|NCT03315871|560934075|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
155410512|NCT03315871|560934076|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
155410513|NCT03315871|560934077|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
155410514|NCT00328627|560937437|FG000|Overall Study|Hyperglycemic Rescue|41|||
155410515|NCT00328627|560937438|FG001|Overall Study|Hyperglycemic Rescue|18|||
155410516|NCT00328627|560937439|FG002|Overall Study|Hyperglycemic Rescue|16|||
155410517|NCT00328627|560937440|FG003|Overall Study|Hyperglycemic Rescue|13|||
155410518|NCT00328627|560937441|FG004|Overall Study|Hyperglycemic Rescue|6|||
155410519|NCT00328627|560937442|FG005|Overall Study|Hyperglycemic Rescue|5|||
155410520|NCT00328627|560937443|FG006|Overall Study|Hyperglycemic Rescue|19|||
155410521|NCT00328627|560937444|FG007|Overall Study|Hyperglycemic Rescue|6|||
155410522|NCT00328627|560937445|FG008|Overall Study|Hyperglycemic Rescue|6|||
155410523|NCT00328627|560937446|FG009|Overall Study|Hyperglycemic Rescue|11|||
155410524|NCT00328627|560937447|FG010|Overall Study|Hyperglycemic Rescue|3|||
155410525|NCT00328627|560937448|FG011|Overall Study|Hyperglycemic Rescue|2|||
155744133|NCT00065429|562161634|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
155410526|NCT00328627|560937437|FG000|Overall Study|Adverse Event|3|||
155410527|NCT00328627|560937438|FG001|Overall Study|Adverse Event|1|||
155410528|NCT00328627|560937439|FG002|Overall Study|Adverse Event|2|||
155410529|NCT00328627|560937440|FG003|Overall Study|Adverse Event|3|||
155410530|NCT00328627|560937441|FG004|Overall Study|Adverse Event|1|||
155410531|NCT00328627|560937442|FG005|Overall Study|Adverse Event|2|||
155410532|NCT00328627|560937443|FG006|Overall Study|Adverse Event|1|||
155638628|NCT03765073|561767664|FG011|Stage 3|No longer meets eligibility criteria|0|||
155638629|NCT03765073|561767665|FG012|Stage 3|No longer meets eligibility criteria|0|||
155638630|NCT03765073|561767666|FG013|Stage 3|No longer meets eligibility criteria|0|||
155638631|NCT03765073|561767667|FG014|Stage 3|No longer meets eligibility criteria|0|||
155638632|NCT03765073|561767668|FG015|Stage 3|No longer meets eligibility criteria|0|||
155638633|NCT03765073|561767669|FG016|Stage 3|No longer meets eligibility criteria|0|||
155638634|NCT03765073|561767670|FG017|Stage 3|No longer meets eligibility criteria|0|||
155638635|NCT03765073|561767671|FG018|Stage 3|No longer meets eligibility criteria|1|||
155638636|NCT03765073|561767672|FG019|Stage 3|No longer meets eligibility criteria|0|||
155638637|NCT03765073|561767673|FG020|Stage 3|No longer meets eligibility criteria|1|||
155638638|NCT03765073|561767653|FG000|Stage 3|Other|0|||
155638639|NCT03765073|561767654|FG001|Stage 3|Other|0|||
155638640|NCT03765073|561767655|FG002|Stage 3|Other|0|||
155638641|NCT03765073|561767656|FG003|Stage 3|Other|0|||
155638642|NCT03765073|561767657|FG004|Stage 3|Other|0|||
155638643|NCT03765073|561767658|FG005|Stage 3|Other|0|||
155638644|NCT03765073|561767659|FG006|Stage 3|Other|0|||
155638645|NCT03765073|561767660|FG007|Stage 3|Other|0|||
155638646|NCT03765073|561767661|FG008|Stage 3|Other|0|||
155638647|NCT03765073|561767662|FG009|Stage 3|Other|0|||
155293713|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
155293714|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
155293715|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
155293716|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
155293717|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
155293718|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
155293719|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
155293720|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
155293721|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
155293722|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
155410533|NCT00328627|560937444|FG007|Overall Study|Adverse Event|2|||
155410534|NCT00328627|560937445|FG008|Overall Study|Adverse Event|0|||
155410535|NCT00328627|560937446|FG009|Overall Study|Adverse Event|7|||
155410536|NCT00328627|560937447|FG010|Overall Study|Adverse Event|5|||
155410537|NCT00328627|560937448|FG011|Overall Study|Adverse Event|4|||
155410538|NCT00328627|560937437|FG000|Overall Study|Protocol Violation|2|||
155410539|NCT00328627|560937438|FG001|Overall Study|Protocol Violation|2|||
155410540|NCT00328627|560937439|FG002|Overall Study|Protocol Violation|2|||
155410541|NCT00328627|560937440|FG003|Overall Study|Protocol Violation|8|||
155410542|NCT00328627|560937441|FG004|Overall Study|Protocol Violation|5|||
155410543|NCT00328627|560937442|FG005|Overall Study|Protocol Violation|5|||
155410544|NCT00328627|560937443|FG006|Overall Study|Protocol Violation|6|||
155410545|NCT00328627|560937444|FG007|Overall Study|Protocol Violation|2|||
155410546|NCT00328627|560937445|FG008|Overall Study|Protocol Violation|1|||
155410547|NCT00328627|560937446|FG009|Overall Study|Protocol Violation|4|||
155410548|NCT00328627|560937447|FG010|Overall Study|Protocol Violation|6|||
155410549|NCT00328627|560937448|FG011|Overall Study|Protocol Violation|2|||
155410550|NCT00328627|560937437|FG000|Overall Study|Lost to Follow-up|4|||
155410551|NCT00328627|560937438|FG001|Overall Study|Lost to Follow-up|2|||
155410552|NCT00328627|560937439|FG002|Overall Study|Lost to Follow-up|2|||
155410553|NCT00328627|560937440|FG003|Overall Study|Lost to Follow-up|4|||
155410554|NCT00328627|560937441|FG004|Overall Study|Lost to Follow-up|0|||
155410555|NCT00328627|560937442|FG005|Overall Study|Lost to Follow-up|2|||
155410556|NCT00328627|560937443|FG006|Overall Study|Lost to Follow-up|3|||
155410557|NCT00328627|560937444|FG007|Overall Study|Lost to Follow-up|0|||
155410558|NCT00328627|560937445|FG008|Overall Study|Lost to Follow-up|3|||
155410559|NCT00328627|560937446|FG009|Overall Study|Lost to Follow-up|2|||
155410560|NCT00328627|560937447|FG010|Overall Study|Lost to Follow-up|0|||
155410561|NCT00328627|560937448|FG011|Overall Study|Lost to Follow-up|1|||
155410562|NCT00328627|560937437|FG000|Overall Study|Withdrawal by Subject|5|||
155410563|NCT00328627|560937438|FG001|Overall Study|Withdrawal by Subject|4|||
155410564|NCT00328627|560937439|FG002|Overall Study|Withdrawal by Subject|5|||
155410565|NCT00328627|560937440|FG003|Overall Study|Withdrawal by Subject|6|||
155410566|NCT00328627|560937441|FG004|Overall Study|Withdrawal by Subject|2|||
155410567|NCT00328627|560937442|FG005|Overall Study|Withdrawal by Subject|5|||
155410568|NCT00328627|560937443|FG006|Overall Study|Withdrawal by Subject|4|||
155410569|NCT00328627|560937444|FG007|Overall Study|Withdrawal by Subject|4|||
155410570|NCT00328627|560937445|FG008|Overall Study|Withdrawal by Subject|4|||
155638648|NCT03765073|561767663|FG010|Stage 3|Other|0|||
155638649|NCT03765073|561767664|FG011|Stage 3|Other|0|||
155410571|NCT00328627|560937446|FG009|Overall Study|Withdrawal by Subject|5|||
155410572|NCT00328627|560937447|FG010|Overall Study|Withdrawal by Subject|2|||
155410573|NCT00328627|560937448|FG011|Overall Study|Withdrawal by Subject|7|||
155410574|NCT00328627|560937437|FG000|Overall Study|Pregnancy|0|||
155410575|NCT00328627|560937438|FG001|Overall Study|Pregnancy|1|||
155638650|NCT03765073|561767665|FG012|Stage 3|Other|0|||
155638651|NCT03765073|561767666|FG013|Stage 3|Other|0|||
155638652|NCT03765073|561767667|FG014|Stage 3|Other|0|||
155638653|NCT03765073|561767668|FG015|Stage 3|Other|0|||
155410576|NCT00328627|560937439|FG002|Overall Study|Pregnancy|0|||
155410577|NCT00328627|560937440|FG003|Overall Study|Pregnancy|0|||
155410578|NCT00328627|560937441|FG004|Overall Study|Pregnancy|0|||
155410579|NCT00328627|560937442|FG005|Overall Study|Pregnancy|0|||
155410580|NCT00328627|560937443|FG006|Overall Study|Pregnancy|0|||
155410581|NCT00328627|560937444|FG007|Overall Study|Pregnancy|0|||
155410582|NCT00328627|560937445|FG008|Overall Study|Pregnancy|0|||
155410583|NCT00328627|560937446|FG009|Overall Study|Pregnancy|0|||
155410584|NCT00328627|560937447|FG010|Overall Study|Pregnancy|0|||
155410585|NCT00328627|560937448|FG011|Overall Study|Pregnancy|0|||
155410586|NCT00328627|560937437|FG000|Overall Study|Physician Decision|4|||
155410587|NCT00328627|560937438|FG001|Overall Study|Physician Decision|3|||
155410588|NCT00328627|560937439|FG002|Overall Study|Physician Decision|1|||
155410589|NCT00328627|560937440|FG003|Overall Study|Physician Decision|2|||
155410590|NCT00328627|560937441|FG004|Overall Study|Physician Decision|1|||
155410591|NCT00328627|560937442|FG005|Overall Study|Physician Decision|1|||
155410592|NCT00328627|560937443|FG006|Overall Study|Physician Decision|1|||
155410593|NCT00328627|560937444|FG007|Overall Study|Physician Decision|0|||
155410594|NCT00328627|560937445|FG008|Overall Study|Physician Decision|3|||
155410595|NCT00328627|560937446|FG009|Overall Study|Physician Decision|2|||
155410596|NCT00328627|560937447|FG010|Overall Study|Physician Decision|1|||
155410597|NCT00328627|560937448|FG011|Overall Study|Physician Decision|0|||
155410598|NCT00328627|560937437|FG000|Overall Study|Other|0|||
155410599|NCT00328627|560937438|FG001|Overall Study|Other|0|||
155410600|NCT00328627|560937439|FG002|Overall Study|Other|0|||
155410601|NCT00328627|560937440|FG003|Overall Study|Other|1|||
155410602|NCT00328627|560937441|FG004|Overall Study|Other|0|||
155410603|NCT00328627|560937442|FG005|Overall Study|Other|0|||
155410604|NCT00328627|560937443|FG006|Overall Study|Other|1|||
155410605|NCT00328627|560937444|FG007|Overall Study|Other|0|||
155410606|NCT00328627|560937445|FG008|Overall Study|Other|0|||
155410607|NCT00328627|560937446|FG009|Overall Study|Other|1|||
155410608|NCT00328627|560937447|FG010|Overall Study|Other|1|||
155410609|NCT00328627|560937448|FG011|Overall Study|Other|0|||
155410610|NCT02049944|560937449|FG000|Overall Study|Protocol Violation|2|||
155410611|NCT01761266|560937450|FG000|Overall Study|Death|415|||
155410612|NCT01761266|560937451|FG001|Overall Study|Death|402|||
155410613|NCT01761266|560937450|FG000|Overall Study|Lost to Follow-up|8|||
155410614|NCT01761266|560937451|FG001|Overall Study|Lost to Follow-up|12|||
155410615|NCT01761266|560937450|FG000|Overall Study|Withdrawal by Subject|14|||
155410616|NCT01761266|560937451|FG001|Overall Study|Withdrawal by Subject|10|||
155410617|NCT01761266|560937450|FG000|Overall Study|Sponsor Decision|41|||
155410618|NCT01761266|560937451|FG001|Overall Study|Sponsor Decision|52|||
155410619|NCT01662440|560937452|FG000|Overall Study|Adverse Event|1|||
155410620|NCT01662440|560937453|FG001|Overall Study|Adverse Event|0|||
155410621|NCT01662440|560937454|FG002|Overall Study|Adverse Event|0|||
155410622|NCT01662440|560937455|FG003|Overall Study|Adverse Event|1|||
155410623|NCT01662440|560937452|FG000|Overall Study|Death|0|||
155410624|NCT01662440|560937453|FG001|Overall Study|Death|1|||
155410625|NCT01662440|560937454|FG002|Overall Study|Death|0|||
155410626|NCT01662440|560937455|FG003|Overall Study|Death|0|||
155410627|NCT01662440|560937452|FG000|Overall Study|Lost to Follow-up|2|||
155410628|NCT01662440|560937453|FG001|Overall Study|Lost to Follow-up|2|||
155410629|NCT01662440|560937454|FG002|Overall Study|Lost to Follow-up|4|||
155410630|NCT01662440|560937455|FG003|Overall Study|Lost to Follow-up|1|||
155410631|NCT01662440|560937452|FG000|Overall Study|Subject moved to another country.|0|||
155410632|NCT01662440|560937453|FG001|Overall Study|Subject moved to another country.|1|||
155744134|NCT00065429|562161635|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155744135|NCT00065429|562161636|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155744136|NCT00065429|562161637|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155744137|NCT00065429|562161638|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155410633|NCT01662440|560937454|FG002|Overall Study|Subject moved to another country.|0|||
155410634|NCT01662440|560937455|FG003|Overall Study|Subject moved to another country.|0|||
155410635|NCT01662440|560937452|FG000|Overall Study|Protocol Violation|1|||
155410636|NCT01662440|560937453|FG001|Overall Study|Protocol Violation|0|||
155410637|NCT01662440|560937454|FG002|Overall Study|Protocol Violation|0|||
155410638|NCT01662440|560937455|FG003|Overall Study|Protocol Violation|0|||
155410639|NCT01662440|560937452|FG000|Overall Study|Withdrawal by Subject|5|||
155410640|NCT01662440|560937453|FG001|Overall Study|Withdrawal by Subject|2|||
155410641|NCT01662440|560937454|FG002|Overall Study|Withdrawal by Subject|2|||
155410642|NCT01662440|560937455|FG003|Overall Study|Withdrawal by Subject|2|||
155410643|NCT00112905|560937456|FG000|Overall Study|Adverse Event|4|||
155410644|NCT00112905|560937456|FG000|Overall Study|Death|1|||
155410645|NCT00112905|560937456|FG000|Overall Study|Ineligibility|5|||
155410646|NCT00112905|560937456|FG000|Overall Study|Alternative treatment|1|||
155410647|NCT00112905|560937456|FG000|Overall Study|performance status was deteiorating|1|||
155410648|NCT05048719|560937461|FG000|Overall Study|Withdrawal by Subject|2|||
155410649|NCT05048719|560937462|FG001|Overall Study|Withdrawal by Subject|1|||
155410650|NCT05048719|560937463|FG002|Overall Study|Withdrawal by Subject|3|||
155410651|NCT05048719|560937464|FG003|Overall Study|Withdrawal by Subject|1|||
155410652|NCT05048719|560937465|FG004|Overall Study|Withdrawal by Subject|0|||
155744138|NCT00065429|562161639|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155744139|NCT00065429|562161640|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155744140|NCT00065429|562161634|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
155744141|NCT00065429|562161635|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
155744142|NCT00065429|562161636|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
155744143|NCT00065429|562161637|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
155744144|NCT00065429|562161638|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
155744145|NCT00065429|562161639|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
155744146|NCT00065429|562161640|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
155744147|NCT00065429|562161634|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155494233|NCT05604521|561234250|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
155494234|NCT05604521|561234249|FG000|Overall Study|Adverse Event|1|||
155494235|NCT05604521|561234250|FG001|Overall Study|Adverse Event|0|||
155494236|NCT02525627|561234253|FG000|Overall Study|Revision|1|||
155494237|NCT02525627|561234254|FG001|Overall Study|Revision|1|||
155494238|NCT02525627|561234253|FG000|Overall Study|Withdrawal by Subject|1|||
155494239|NCT02525627|561234254|FG001|Overall Study|Withdrawal by Subject|2|||
155494240|NCT02525627|561234253|FG000|Overall Study|Death|1|||
155494241|NCT02525627|561234254|FG001|Overall Study|Death|0|||
155494242|NCT02525627|561234253|FG000|Overall Study|Site terminated|11|||
155494243|NCT02525627|561234254|FG001|Overall Study|Site terminated|10|||
155494244|NCT00242567|561234255|FG000|Overall Study|Adverse Event|70|||
155494245|NCT00242567|561234256|FG001|Overall Study|Adverse Event|43|||
155494246|NCT00242567|561234255|FG000|Overall Study|Disease Progression|17|||
155494247|NCT00242567|561234256|FG001|Overall Study|Disease Progression|22|||
155494248|NCT00242567|561234255|FG000|Overall Study|Symptomatic deterioration|9|||
155494249|NCT00242567|561234256|FG001|Overall Study|Symptomatic deterioration|3|||
155494250|NCT00242567|561234255|FG000|Overall Study|Lack of Efficacy|2|||
155494251|NCT00242567|561234256|FG001|Overall Study|Lack of Efficacy|2|||
155494252|NCT00242567|561234255|FG000|Overall Study|Lost to Follow-up|9|||
155494253|NCT00242567|561234256|FG001|Overall Study|Lost to Follow-up|19|||
155494254|NCT00242567|561234255|FG000|Overall Study|Withdrawal by Subject|33|||
155494255|NCT00242567|561234256|FG001|Overall Study|Withdrawal by Subject|28|||
155494256|NCT00242567|561234255|FG000|Overall Study|Protocol Violation|12|||
155494257|NCT00242567|561234256|FG001|Overall Study|Protocol Violation|12|||
155410653|NCT05048719|560937466|FG005|Overall Study|Withdrawal by Subject|2|||
155410654|NCT05048719|560937467|FG006|Overall Study|Withdrawal by Subject|1|||
155410655|NCT05048719|560937468|FG007|Overall Study|Withdrawal by Subject|1|||
155410656|NCT05048719|560937469|FG008|Overall Study|Withdrawal by Subject|0|||
155410657|NCT05048719|560937461|FG000|Overall Study|Death|1|||
155410658|NCT05048719|560937462|FG001|Overall Study|Death|0|||
155410659|NCT05048719|560937463|FG002|Overall Study|Death|0|||
155410660|NCT05048719|560937464|FG003|Overall Study|Death|0|||
155410661|NCT05048719|560937465|FG004|Overall Study|Death|0|||
155410662|NCT05048719|560937466|FG005|Overall Study|Death|0|||
155410663|NCT05048719|560937467|FG006|Overall Study|Death|0|||
155410664|NCT05048719|560937468|FG007|Overall Study|Death|0|||
155410665|NCT05048719|560937469|FG008|Overall Study|Death|0|||
155410666|NCT05048719|560937461|FG000|Overall Study|Adverse Event|0|||
155410667|NCT05048719|560937462|FG001|Overall Study|Adverse Event|1|||
155410668|NCT05048719|560937463|FG002|Overall Study|Adverse Event|2|||
155410669|NCT05048719|560937464|FG003|Overall Study|Adverse Event|0|||
155410670|NCT05048719|560937465|FG004|Overall Study|Adverse Event|1|||
155410671|NCT05048719|560937466|FG005|Overall Study|Adverse Event|0|||
155410672|NCT05048719|560937467|FG006|Overall Study|Adverse Event|0|||
155410673|NCT05048719|560937468|FG007|Overall Study|Adverse Event|0|||
155410674|NCT05048719|560937469|FG008|Overall Study|Adverse Event|0|||
155494258|NCT00242567|561234255|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
155494259|NCT00242567|561234256|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
155494260|NCT00242567|561234255|FG000|Overall Study|Other|14|||
155494261|NCT00242567|561234256|FG001|Overall Study|Other|9|||
155494262|NCT00630994|561234257|FG000|Overall Study|Adverse Event|1|||
155494263|NCT00630994|561234257|FG000|Overall Study|Disease Progression|1|||
155494264|NCT00630994|561234257|FG000|Overall Study|Lack of Efficacy|1|||
155494265|NCT00630994|561234257|FG000|Overall Study|Other|1|||
155494266|NCT05553600|561234258|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
155494267|NCT05553600|561234259|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
155410675|NCT05048719|560937461|FG000|Overall Study|Lost to Follow-up|0|||
155410676|NCT05048719|560937462|FG001|Overall Study|Lost to Follow-up|0|||
155494268|NCT05553600|561234260|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
155494269|NCT05553600|561234261|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
155494270|NCT05553600|561234258|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
155494271|NCT05553600|561234259|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
155410677|NCT05048719|560937463|FG002|Overall Study|Lost to Follow-up|1|||
155410678|NCT05048719|560937464|FG003|Overall Study|Lost to Follow-up|3|||
155410679|NCT05048719|560937465|FG004|Overall Study|Lost to Follow-up|1|||
155410680|NCT05048719|560937466|FG005|Overall Study|Lost to Follow-up|1|||
155293723|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293724|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293725|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293726|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293727|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
155293728|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
155293729|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
155293730|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
155293731|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
155293732|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
155293733|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
155293734|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
155293735|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
155293736|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
155293737|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
155293738|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293739|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
155293740|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
155293741|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
155293742|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293743|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293744|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293745|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293746|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155410681|NCT05048719|560937467|FG006|Overall Study|Lost to Follow-up|1|||
155410682|NCT05048719|560937468|FG007|Overall Study|Lost to Follow-up|1|||
155410683|NCT05048719|560937469|FG008|Overall Study|Lost to Follow-up|0|||
155410684|NCT05048719|560937461|FG000|Overall Study|Physician Decision|0|||
155410685|NCT05048719|560937462|FG001|Overall Study|Physician Decision|0|||
155410686|NCT05048719|560937463|FG002|Overall Study|Physician Decision|0|||
155410687|NCT05048719|560937464|FG003|Overall Study|Physician Decision|0|||
155410688|NCT05048719|560937465|FG004|Overall Study|Physician Decision|0|||
155410689|NCT05048719|560937466|FG005|Overall Study|Physician Decision|0|||
155410690|NCT05048719|560937467|FG006|Overall Study|Physician Decision|0|||
155410691|NCT05048719|560937468|FG007|Overall Study|Physician Decision|1|||
155410692|NCT05048719|560937469|FG008|Overall Study|Physician Decision|1|||
155410693|NCT05048719|560937461|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
155410694|NCT05048719|560937462|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410695|NCT05048719|560937463|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410696|NCT05048719|560937464|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410697|NCT05048719|560937465|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410698|NCT05048719|560937466|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410699|NCT05048719|560937467|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410700|NCT05048719|560937468|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410701|NCT05048719|560937469|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
155410702|NCT05048719|560937461|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410703|NCT05048719|560937462|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
155410704|NCT05048719|560937463|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410705|NCT05048719|560937464|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410706|NCT05048719|560937465|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410707|NCT05048719|560937466|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410708|NCT05048719|560937467|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155494272|NCT05553600|561234260|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
155293747|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293748|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293749|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293750|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293751|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293752|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293753|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
155293754|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293755|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293756|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293757|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293758|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293759|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293760|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
155293761|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293762|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293763|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293764|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293765|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293766|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155494273|NCT05553600|561234261|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
155494274|NCT05553600|561234258|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
155494275|NCT05553600|561234259|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
155494276|NCT05553600|561234260|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
155494277|NCT05553600|561234261|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
155494278|NCT05553600|561234258|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
155494279|NCT05553600|561234259|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
155494280|NCT05553600|561234260|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
155494281|NCT05553600|561234261|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
155494282|NCT05553600|561234258|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
155494283|NCT05553600|561234259|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
155494284|NCT05553600|561234260|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
155293767|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293768|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293769|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293770|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293771|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
155293772|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
155293773|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
155293774|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
155293775|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
155494285|NCT05553600|561234261|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
155494286|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
155494287|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
155494288|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
155494289|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
155494290|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
155494291|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
155494292|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
155494293|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
155494294|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
155494295|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
155494296|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
155494297|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
155494298|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
155494299|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
155494300|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
155494301|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
155494302|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
155494303|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
155494304|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
155494305|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
155494306|NCT05553600|561234258|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
155494307|NCT05553600|561234259|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
155494308|NCT05553600|561234260|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
155494309|NCT05553600|561234261|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
155494310|NCT05553600|561234258|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
155494311|NCT05553600|561234259|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
155494312|NCT05553600|561234260|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
155494313|NCT05553600|561234261|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
155494314|NCT03710824|561234266|FG000|Overall Study|Withdrawal by Subject|1|||
155494315|NCT03710824|561234266|FG000|Overall Study|Lost to Follow-up|3|||
155494316|NCT03710824|561234266|FG000|Overall Study|Adverse Event|25|||
155494317|NCT03710824|561234266|FG000|Overall Study|Treatment discontinuation|2|||
155494318|NCT01605370|561234267|FG000|Overall Study|Adverse Event|1|||
155494319|NCT01605370|561234268|FG001|Overall Study|Adverse Event|0|||
155494320|NCT01317199|561234269|FG000|Dose-escalation Phase 1|Physician Decision|5|||
155494321|NCT01317199|561234270|FG001|Dose-escalation Phase 1|Physician Decision|0|||
155494322|NCT01317199|561234271|FG002|Dose-escalation Phase 1|Physician Decision|0|||
155494323|NCT01317199|561234272|FG003|Dose-escalation Phase 1|Physician Decision|0|||
155494324|NCT01317199|561234269|FG000|Dose-escalation Phase 1|Disease progression|1|||
155494325|NCT01317199|561234270|FG001|Dose-escalation Phase 1|Disease progression|0|||
155494326|NCT01317199|561234271|FG002|Dose-escalation Phase 1|Disease progression|0|||
155494327|NCT01317199|561234272|FG003|Dose-escalation Phase 1|Disease progression|0|||
155494328|NCT01317199|561234269|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
155494329|NCT01317199|561234270|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
155494330|NCT01317199|561234271|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
155494331|NCT01317199|561234272|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
155494332|NCT01317199|561234269|FG000|Randomized Phase 2|Disease progression|0|||
155494333|NCT01317199|561234270|FG001|Randomized Phase 2|Disease progression|3|||
155293776|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
155293777|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
155293778|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
155293779|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
155293780|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
155293781|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
155293782|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293783|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293784|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293785|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293786|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293787|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293788|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293789|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293790|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293791|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293792|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293793|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293794|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293795|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293796|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293797|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293798|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293799|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
155293800|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
155293801|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
155293802|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
155293803|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
155293804|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293805|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293806|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293807|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293808|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293809|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293810|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
155293811|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
155293812|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
155293813|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
155293814|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
155293815|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293816|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293817|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293818|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293819|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293820|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293821|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
155494334|NCT01317199|561234271|FG002|Randomized Phase 2|Disease progression|7|||
155293822|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
155494335|NCT01317199|561234272|FG003|Randomized Phase 2|Disease progression|5|||
155494336|NCT01317199|561234269|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
155494337|NCT01317199|561234270|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
155293823|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
155293824|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293825|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
155293826|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293827|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293828|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293829|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293830|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293831|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293832|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
155293833|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
155293834|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
155293835|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
155293836|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
155293837|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
155293838|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
155293839|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
155293840|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
155293841|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
155293842|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
155293843|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
155293844|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
155293845|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
155293846|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
155293847|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
155293848|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293849|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293850|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293851|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293852|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293853|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293854|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293855|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
155293856|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
155293857|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293858|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293859|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293860|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293861|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293862|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293863|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293864|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293865|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293866|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293867|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
155293868|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
155293869|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293870|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293871|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293872|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293873|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293874|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293875|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293876|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293877|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293878|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293879|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
155494338|NCT01317199|561234271|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
155494339|NCT01317199|561234272|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
155494340|NCT01317199|561234269|FG000|Randomized Phase 2|Adverse Event|0|||
155494341|NCT01317199|561234270|FG001|Randomized Phase 2|Adverse Event|0|||
155293880|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293881|NCT00177216|560504996|FG000|Overall Study|Withdrawal by Subject|6|||
155293882|NCT00177216|560504997|FG001|Overall Study|Withdrawal by Subject|3|||
155494342|NCT01317199|561234271|FG002|Randomized Phase 2|Adverse Event|0|||
155494343|NCT01317199|561234272|FG003|Randomized Phase 2|Adverse Event|1|||
155293883|NCT00177216|560504998|FG002|Overall Study|Withdrawal by Subject|1|||
155293884|NCT00639002|560505001|FG000|Overall Study|Death|1|||
155293885|NCT00639002|560505001|FG000|Overall Study|Adverse Event|1|||
155293886|NCT00639002|560505001|FG000|Overall Study|Protocol Violation|1|||
155293887|NCT00639002|560505001|FG000|Overall Study|Disease progression|3|||
155293888|NCT00639002|560505001|FG000|Overall Study|Physician Decision|6|||
155293889|NCT00639002|560505001|FG000|Overall Study|Lack of Efficacy|1|||
155293890|NCT02807493|560505006|FG000|Overall Study|Adverse Event|5|||
155293891|NCT02807493|560505007|FG001|Overall Study|Adverse Event|2|||
155293892|NCT02807493|560505006|FG000|Overall Study|Lost to Follow-up|6|||
155293893|NCT02807493|560505007|FG001|Overall Study|Lost to Follow-up|0|||
155293894|NCT02807493|560505006|FG000|Overall Study|Physician Decision|4|||
155293895|NCT02807493|560505007|FG001|Overall Study|Physician Decision|1|||
155293896|NCT02807493|560505006|FG000|Overall Study|Protocol Violation|7|||
155293897|NCT02807493|560505007|FG001|Overall Study|Protocol Violation|0|||
155293898|NCT02807493|560505006|FG000|Overall Study|Withdrawal by Subject|17|||
155293899|NCT02807493|560505007|FG001|Overall Study|Withdrawal by Subject|10|||
155293900|NCT02807493|560505006|FG000|Overall Study|Other withdrawal|17|||
155293901|NCT02807493|560505007|FG001|Overall Study|Other withdrawal|0|||
155293902|NCT02807493|560505006|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
155293903|NCT02807493|560505007|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
155293904|NCT01227707|560505008|FG000|Overall Study|Adverse Event|10|||
155293905|NCT01227707|560505008|FG000|Overall Study|Progression of disease|3|||
155293906|NCT01227707|560505008|FG000|Overall Study|Withdrawal by Subject|1|||
155293907|NCT01227707|560505008|FG000|Overall Study|Patient non-compliance|3|||
155293908|NCT01227707|560505008|FG000|Overall Study|Medical decision|6|||
155293909|NCT01227707|560505008|FG000|Overall Study|Death|1|||
155293910|NCT00823979|560505021|FG000|Overall Study|Lack of Efficacy|13|||
155293911|NCT00823979|560505022|FG001|Overall Study|Lack of Efficacy|16|||
155293912|NCT00823979|560505023|FG002|Overall Study|Lack of Efficacy|9|||
155293913|NCT00823979|560505021|FG000|Overall Study|Lost to Follow-up|2|||
155293914|NCT00823979|560505022|FG001|Overall Study|Lost to Follow-up|1|||
155293915|NCT00823979|560505023|FG002|Overall Study|Lost to Follow-up|0|||
155293916|NCT00823979|560505021|FG000|Overall Study|Withdrawal by Subject|2|||
155293917|NCT00823979|560505022|FG001|Overall Study|Withdrawal by Subject|3|||
155293918|NCT00823979|560505023|FG002|Overall Study|Withdrawal by Subject|2|||
155293919|NCT00823979|560505021|FG000|Overall Study|Protocol Violation|1|||
155293920|NCT00823979|560505022|FG001|Overall Study|Protocol Violation|1|||
155293921|NCT00823979|560505023|FG002|Overall Study|Protocol Violation|0|||
155293922|NCT00823979|560505021|FG000|Overall Study|Pregnancy|0|||
155293923|NCT00823979|560505022|FG001|Overall Study|Pregnancy|1|||
155293924|NCT00823979|560505023|FG002|Overall Study|Pregnancy|0|||
155293925|NCT00823979|560505021|FG000|Overall Study|Adverse Event|0|||
155293926|NCT00823979|560505022|FG001|Overall Study|Adverse Event|2|||
155293927|NCT00823979|560505023|FG002|Overall Study|Adverse Event|4|||
155293928|NCT00823979|560505021|FG000|Overall Study|Other|2|||
155293929|NCT00823979|560505022|FG001|Overall Study|Other|0|||
155293930|NCT00823979|560505023|FG002|Overall Study|Other|1|||
155293931|NCT00823979|560505021|FG000|Overall Study|Randomized but not Treated|4|||
155293932|NCT00823979|560505022|FG001|Overall Study|Randomized but not Treated|3|||
155293933|NCT00823979|560505023|FG002|Overall Study|Randomized but not Treated|1|||
155293934|NCT00823979|560505021|FG000|Overall Study|Study Terminated by Sponsor|5|||
155293935|NCT00823979|560505022|FG001|Overall Study|Study Terminated by Sponsor|5|||
155293936|NCT00823979|560505023|FG002|Overall Study|Study Terminated by Sponsor|7|||
155293937|NCT03523091|560505024|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
155293938|NCT03523091|560505025|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
155293939|NCT03523091|560505024|FG000|Overall Study|Withdrawal by Subject|0|||
155293940|NCT03523091|560505025|FG001|Overall Study|Withdrawal by Subject|3|||
155293941|NCT03523091|560505024|FG000|Overall Study|Increase Botox dose|0|||
155293942|NCT03523091|560505025|FG001|Overall Study|Increase Botox dose|1|||
155293943|NCT00741988|560505026|FG000|Overall Study|Adverse Event|2|||
155293944|NCT00741988|560505027|FG001|Overall Study|Adverse Event|4|||
155293945|NCT00741988|560505026|FG000|Overall Study|Lack of Efficacy|2|||
155293946|NCT00741988|560505027|FG001|Overall Study|Lack of Efficacy|0|||
155293947|NCT00811057|560505028|FG000|Overall Study|Protocol Violation|5|||
155293948|NCT00811057|560505029|FG001|Overall Study|Protocol Violation|10|||
155293949|NCT00811057|560505030|FG002|Overall Study|Protocol Violation|10|||
155293950|NCT03008915|560505033|FG000|Treatment 1|Withdrawal by Subject|0|||
155293951|NCT03008915|560505034|FG001|Treatment 1|Withdrawal by Subject|1|||
155293952|NCT00712166|560505037|FG000|Overall Study|Noncompliance|0|||
155293953|NCT00712166|560505038|FG001|Overall Study|Noncompliance|1|||
155293954|NCT01773122|560505039|FG000|Overall Study|Due to amended age eligibility criteria|3|||
155293955|NCT01773122|560505040|FG001|Overall Study|Due to amended age eligibility criteria|1|||
155293956|NCT01773122|560505041|FG002|Overall Study|Due to amended age eligibility criteria|0|||
155293957|NCT01773122|560505042|FG003|Overall Study|Due to amended age eligibility criteria|1|||
155293958|NCT02289560|560505045|FG000|Overall Study|Lost to Follow-up|6|||
155293959|NCT02289560|560505045|FG000|Overall Study|Alternative Treatment|4|||
155293960|NCT02289560|560505045|FG000|Overall Study|Inadequate Treatment|2|||
155293961|NCT02289560|560505045|FG000|Overall Study|Withdrawal by Subject|23|||
155293962|NCT02540213|560505046|FG000|Overall Study|Death/adverse event|18|||
155293963|NCT02540213|560505046|FG000|Overall Study|Administrative reasons|3|||
155293964|NCT02540213|560505046|FG000|Overall Study|Kidney transplant|3|||
155293965|NCT02540213|560505046|FG000|Overall Study|Lack of Efficacy|6|||
155293966|NCT02540213|560505046|FG000|Overall Study|Consent withdrawn|7|||
155293967|NCT02540213|560505046|FG000|Overall Study|Enrolled but not treated|2|||
155293968|NCT01264718|560505047|FG000|Overall Study|Lost to Follow-up|3|||
155293969|NCT01264718|560505048|FG001|Overall Study|Lost to Follow-up|2|||
155293970|NCT01264718|560505047|FG000|Overall Study|Withdrawal by Subject|9|||
155293971|NCT01264718|560505048|FG001|Overall Study|Withdrawal by Subject|15|||
155293972|NCT01264718|560505047|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
155293973|NCT01264718|560505048|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
155293974|NCT03386929|560505049|FG000|Overall Study|Death|0|||
155293975|NCT03386929|560505050|FG001|Overall Study|Death|0|||
155293976|NCT03386929|560505051|FG002|Overall Study|Death|1|||
155293977|NCT03386929|560505049|FG000|Overall Study|Withdrawal by Subject|0|||
155293978|NCT03386929|560505050|FG001|Overall Study|Withdrawal by Subject|1|||
155293979|NCT03386929|560505051|FG002|Overall Study|Withdrawal by Subject|0|||
155293980|NCT03386929|560505049|FG000|Overall Study|Physician Decision|0|||
155293981|NCT03386929|560505050|FG001|Overall Study|Physician Decision|0|||
155293982|NCT03386929|560505051|FG002|Overall Study|Physician Decision|1|||
155293983|NCT03386929|560505049|FG000|Overall Study|Progression|4|||
155293984|NCT03386929|560505050|FG001|Overall Study|Progression|4|||
155293985|NCT03386929|560505051|FG002|Overall Study|Progression|0|||
155293986|NCT03386929|560505049|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293987|NCT03386929|560505050|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293988|NCT03386929|560505051|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293989|NCT03386929|560505049|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
155293990|NCT03386929|560505050|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
155293991|NCT03386929|560505051|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
155293992|NCT00536380|560505052|FG000|Overall Study|Adverse Event|0|||
155293993|NCT00536380|560505053|FG001|Overall Study|Adverse Event|2|||
155293994|NCT00536380|560505054|FG002|Overall Study|Adverse Event|2|||
155293995|NCT00536380|560505052|FG000|Overall Study|Lost to Follow-up|0|||
155293996|NCT00536380|560505053|FG001|Overall Study|Lost to Follow-up|0|||
155293997|NCT00536380|560505054|FG002|Overall Study|Lost to Follow-up|1|||
155293998|NCT00536380|560505052|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
155293999|NCT00536380|560505053|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
155294000|NCT00536380|560505054|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
155294001|NCT00536380|560505052|FG000|Overall Study|Withdrawal related to study drug|7|||
155294002|NCT00536380|560505053|FG001|Overall Study|Withdrawal related to study drug|5|||
155294003|NCT00536380|560505054|FG002|Overall Study|Withdrawal related to study drug|2|||
155294004|NCT00536380|560505052|FG000|Overall Study|Noncompliance with protocol|3|||
155294005|NCT00536380|560505053|FG001|Overall Study|Noncompliance with protocol|2|||
155294006|NCT00536380|560505054|FG002|Overall Study|Noncompliance with protocol|2|||
155294007|NCT00536380|560505052|FG000|Overall Study|Did not meet protocol eligibility|0|||
155294008|NCT00536380|560505053|FG001|Overall Study|Did not meet protocol eligibility|0|||
155294009|NCT00536380|560505054|FG002|Overall Study|Did not meet protocol eligibility|1|||
155294010|NCT00536380|560505052|FG000|Overall Study|Administrative|0|||
155294011|NCT00536380|560505053|FG001|Overall Study|Administrative|0|||
155294012|NCT00536380|560505054|FG002|Overall Study|Administrative|1|||
155294013|NCT03418324|560505055|FG000|Overall Study|Death|0|||
155294014|NCT03418324|560505056|FG001|Overall Study|Death|1|||
155294015|NCT03418324|560505055|FG000|Overall Study|Physician Decision|1|||
155294016|NCT03418324|560505056|FG001|Overall Study|Physician Decision|1|||
155294017|NCT03121950|560505058|FG000|Overall Study|Withdrawal by Subject|11|||
155294018|NCT03121950|560505059|FG001|Overall Study|Withdrawal by Subject|2|||
155294019|NCT04248829|560505062|FG000|Overall Study|Disease progression|44|||
155294020|NCT04248829|560505063|FG001|Overall Study|Disease progression|109|||
155294021|NCT04248829|560505062|FG000|Overall Study|Adverse Event|19|||
155294022|NCT04248829|560505063|FG001|Overall Study|Adverse Event|18|||
155294023|NCT04248829|560505062|FG000|Overall Study|Withdrawal by Subject|11|||
155294024|NCT04248829|560505063|FG001|Overall Study|Withdrawal by Subject|2|||
155294025|NCT04248829|560505062|FG000|Overall Study|Lost to Follow-up|0|||
155294026|NCT04248829|560505063|FG001|Overall Study|Lost to Follow-up|1|||
155294027|NCT04248829|560505062|FG000|Overall Study|Death|12|||
155294028|NCT04248829|560505063|FG001|Overall Study|Death|14|||
155294029|NCT04248829|560505062|FG000|Overall Study|Physician Decision|2|||
155294030|NCT04248829|560505063|FG001|Overall Study|Physician Decision|4|||
155294031|NCT04248829|560505062|FG000|Overall Study|Any reason not specifically recorded|0|||
155294032|NCT04248829|560505063|FG001|Overall Study|Any reason not specifically recorded|2|||
155294033|NCT02132702|560505064|FG000|Overall Study|Protocol Violation|2|||
155294034|NCT02132702|560505064|FG000|Overall Study|Adverse Event|3|||
155294035|NCT02132702|560505064|FG000|Overall Study|Withdrawal by Subject|3|||
155294036|NCT02299336|560505065|FG000|Overall Study|Withdrawal by Subject|11|||
155294037|NCT02299336|560505065|FG000|Overall Study|Adverse Event|1|||
155294038|NCT02299336|560505065|FG000|Overall Study|Death|1|||
155294039|NCT02299336|560505065|FG000|Overall Study|Lost to Follow-up|1|||
155294040|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
155294041|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
155294042|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
155294043|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294044|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294045|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294046|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294047|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294048|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294049|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
155294050|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
155294051|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
155294052|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294053|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294054|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294055|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294056|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294057|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294058|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
155294059|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
155294060|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
155294061|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294062|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294063|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294064|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294065|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294066|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294067|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
155294068|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294069|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
155294070|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294071|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294072|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294073|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294074|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294075|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294076|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155294077|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155294078|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
155294079|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294080|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294081|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294082|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294083|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294084|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294085|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294086|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155294087|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155294088|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294089|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155494344|NCT01317199|561234269|FG000|Randomized Phase 2|Comorbidities|0|||
155294090|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294091|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294092|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294093|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294094|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
155294095|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
155294096|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294097|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294098|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294099|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294100|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294101|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294102|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294103|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294104|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
155294105|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
155294106|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
155294107|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294108|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
155294109|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294110|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294111|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294112|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294113|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
155294114|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
155294115|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
155294116|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294117|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
155294118|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294119|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294120|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294121|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294122|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294123|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
155294124|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294125|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294126|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294127|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294128|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294129|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294130|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294131|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294132|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
155294133|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294134|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
155294135|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294136|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294137|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294138|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294139|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155494345|NCT01317199|561234270|FG001|Randomized Phase 2|Comorbidities|2|||
155494346|NCT01317199|561234271|FG002|Randomized Phase 2|Comorbidities|2|||
155494347|NCT01317199|561234272|FG003|Randomized Phase 2|Comorbidities|2|||
155494348|NCT01317199|561234269|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
155494349|NCT01317199|561234270|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
155494350|NCT01317199|561234271|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
155494351|NCT01317199|561234272|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
155494352|NCT01317199|561234269|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
155494353|NCT01317199|561234270|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
155494354|NCT01317199|561234271|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
155494355|NCT01317199|561234272|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
155494356|NCT01317199|561234269|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
155494357|NCT01317199|561234270|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
155494358|NCT01317199|561234271|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
155494359|NCT01317199|561234272|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
155494360|NCT01317199|561234269|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
155494361|NCT01317199|561234270|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
155494362|NCT01317199|561234271|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
155494363|NCT01317199|561234272|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
155494364|NCT01353209|561234273|FG000|Overall Study|Adverse Event|1|||
155494365|NCT01353209|561234274|FG001|Overall Study|Adverse Event|1|||
155494366|NCT01301625|561234281|FG000|Overall Study|Death|5|||
155494367|NCT01301625|561234281|FG000|Overall Study|Not Due|21|||
155494368|NCT01301625|561234281|FG000|Overall Study|Expected|8|||
155494369|NCT01301625|561234281|FG000|Overall Study|Lost to Follow-up|1|||
155494370|NCT02684370|561234282|FG000|Part A|Adverse Event|2|||
155494371|NCT02684370|561234283|FG001|Part A|Adverse Event|0|||
155494372|NCT02684370|561234284|FG002|Part A|Adverse Event|1|||
155494373|NCT02684370|561234285|FG003|Part A|Adverse Event|0|||
155494374|NCT02684370|561234286|FG004|Part A|Adverse Event|0|||
155494375|NCT02684370|561234287|FG005|Part A|Adverse Event|0|||
155494376|NCT02684370|561234282|FG000|Part A|Lost to Follow-up|1|||
155494377|NCT02684370|561234283|FG001|Part A|Lost to Follow-up|1|||
155494378|NCT02684370|561234284|FG002|Part A|Lost to Follow-up|0|||
155494379|NCT02684370|561234285|FG003|Part A|Lost to Follow-up|0|||
155494380|NCT02684370|561234286|FG004|Part A|Lost to Follow-up|0|||
155494381|NCT02684370|561234287|FG005|Part A|Lost to Follow-up|0|||
155494382|NCT02684370|561234282|FG000|Part A|Subject Withdrawal|1|||
155494383|NCT02684370|561234283|FG001|Part A|Subject Withdrawal|0|||
155494384|NCT02684370|561234284|FG002|Part A|Subject Withdrawal|3|||
155494385|NCT02684370|561234285|FG003|Part A|Subject Withdrawal|0|||
155494386|NCT02684370|561234286|FG004|Part A|Subject Withdrawal|0|||
155494387|NCT02684370|561234287|FG005|Part A|Subject Withdrawal|0|||
155494388|NCT02684370|561234282|FG000|Part A|Other|0|||
155494389|NCT02684370|561234283|FG001|Part A|Other|0|||
155494390|NCT02684370|561234284|FG002|Part A|Other|1|||
155494391|NCT02684370|561234285|FG003|Part A|Other|0|||
155494392|NCT02684370|561234286|FG004|Part A|Other|0|||
155494393|NCT02684370|561234287|FG005|Part A|Other|0|||
155494394|NCT02684370|561234282|FG000|Part B|Adverse Event|0|||
155494395|NCT02684370|561234283|FG001|Part B|Adverse Event|0|||
155494396|NCT02684370|561234284|FG002|Part B|Adverse Event|0|||
155494397|NCT02684370|561234285|FG003|Part B|Adverse Event|0|||
155494398|NCT02684370|561234286|FG004|Part B|Adverse Event|2|||
155494399|NCT02684370|561234287|FG005|Part B|Adverse Event|1|||
155494400|NCT02684370|561234282|FG000|Part B|Lost to Follow-up|0|||
155494401|NCT02684370|561234283|FG001|Part B|Lost to Follow-up|0|||
155494402|NCT02684370|561234284|FG002|Part B|Lost to Follow-up|0|||
155494403|NCT02684370|561234285|FG003|Part B|Lost to Follow-up|1|||
155494404|NCT02684370|561234286|FG004|Part B|Lost to Follow-up|2|||
155494405|NCT02684370|561234287|FG005|Part B|Lost to Follow-up|5|||
155494406|NCT02684370|561234282|FG000|Part B|Subject Withdrawal|0|||
155494407|NCT02684370|561234283|FG001|Part B|Subject Withdrawal|0|||
155494408|NCT02684370|561234284|FG002|Part B|Subject Withdrawal|0|||
155494409|NCT02684370|561234285|FG003|Part B|Subject Withdrawal|1|||
155494410|NCT02684370|561234286|FG004|Part B|Subject Withdrawal|1|||
155494411|NCT02684370|561234287|FG005|Part B|Subject Withdrawal|2|||
155494412|NCT00326625|561234290|FG000|Overall Study|Adverse Event|20|||
155494413|NCT00326625|561234291|FG001|Overall Study|Adverse Event|9|||
155494414|NCT00326625|561234290|FG000|Overall Study|Withdrawal by Subject|15|||
155494415|NCT00326625|561234291|FG001|Overall Study|Withdrawal by Subject|12|||
155494416|NCT00326625|561234290|FG000|Overall Study|Death|18|||
155494417|NCT00326625|561234291|FG001|Overall Study|Death|16|||
155494418|NCT00326625|561234290|FG000|Overall Study|Lost to Follow-up|1|||
155494419|NCT00326625|561234291|FG001|Overall Study|Lost to Follow-up|0|||
155494420|NCT00326625|561234290|FG000|Overall Study|prescheduled medical intervention|0|||
155494421|NCT00326625|561234291|FG001|Overall Study|prescheduled medical intervention|1|||
155494422|NCT00625846|561234297|FG000|Overall Study|Withdrawal by Subject|2|||
155494423|NCT00625846|561234298|FG001|Overall Study|Withdrawal by Subject|0|||
155494424|NCT00625846|561234299|FG002|Overall Study|Withdrawal by Subject|1|||
155494425|NCT00625846|561234300|FG003|Overall Study|Withdrawal by Subject|2|||
155294140|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155294141|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294142|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294143|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155294144|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294145|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294146|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294147|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294148|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294149|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
155294150|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
155294151|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294152|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294153|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294154|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294155|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294156|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294157|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294158|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294159|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294160|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294161|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294162|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294163|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294164|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294165|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
155294166|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294167|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
155294168|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
155294169|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294170|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294171|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294172|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294173|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
155294174|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
155294175|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294176|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
155294177|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
155294178|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294179|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294180|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294181|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294182|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
155294183|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294184|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294185|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
155294186|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
155294187|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294188|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294189|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294190|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294191|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155294192|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
155294193|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294194|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294195|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
155294196|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294197|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294198|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294199|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294200|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294201|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294202|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294203|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
155294204|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
155294205|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294206|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294207|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294208|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294209|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
155294210|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294211|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294212|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
155294213|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
155294214|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294215|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294216|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294217|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294218|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
155294219|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
155294220|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294221|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294222|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
155294223|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294224|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294225|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294226|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294227|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294228|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294229|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294230|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
155294231|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294232|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294233|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294234|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294235|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294236|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294237|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294238|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294239|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294240|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294241|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294242|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294243|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294244|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294245|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294246|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
155294247|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294248|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
155294249|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294250|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294251|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155638654|NCT03765073|561767669|FG016|Stage 3|Other|0|||
155638655|NCT03765073|561767670|FG017|Stage 3|Other|1|||
155638656|NCT03765073|561767671|FG018|Stage 3|Other|2|||
155638657|NCT03765073|561767672|FG019|Stage 3|Other|2|||
155638658|NCT03765073|561767673|FG020|Stage 3|Other|2|||
155638659|NCT03765073|561767653|FG000|Stage 3|Withdrawal by parent/guardian|0|||
155638660|NCT03765073|561767654|FG001|Stage 3|Withdrawal by parent/guardian|0|||
155638661|NCT03765073|561767655|FG002|Stage 3|Withdrawal by parent/guardian|0|||
155435889|NCT02403206|561022986|FG001|Overall Study|Withdrawal by Subject|3|||
155294252|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155638662|NCT03765073|561767656|FG003|Stage 3|Withdrawal by parent/guardian|0|||
155638663|NCT03765073|561767657|FG004|Stage 3|Withdrawal by parent/guardian|0|||
155638664|NCT03765073|561767658|FG005|Stage 3|Withdrawal by parent/guardian|0|||
155638665|NCT03765073|561767659|FG006|Stage 3|Withdrawal by parent/guardian|0|||
155294253|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294254|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294255|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294256|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294257|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294258|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
155294259|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294260|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294261|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294262|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294263|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294264|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
155294265|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294266|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
155294267|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294268|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294269|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294270|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294271|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294272|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294273|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
155294274|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294275|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294276|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
155294277|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294278|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294279|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294280|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294281|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294282|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294283|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294284|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
155294285|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
155294286|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294287|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294288|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294289|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294290|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
155294291|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
155294292|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294293|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
155294294|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
155294295|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294296|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294297|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294298|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294299|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
155294300|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
155294301|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
155294302|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
155294303|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
155294304|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
155294305|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
155294306|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
155294307|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
155294308|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
155494426|NCT00807040|561234301|FG000|Overall Study|Death|24|||
155494427|NCT00807040|561234302|FG001|Overall Study|Death|29|||
155294309|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
155294310|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155494428|NCT00807040|561234301|FG000|Overall Study|Withdrawal by Subject|8|||
155294311|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155494429|NCT00807040|561234302|FG001|Overall Study|Withdrawal by Subject|6|||
155494430|NCT00807040|561234301|FG000|Overall Study|Lost to Follow-up|4|||
155494431|NCT00807040|561234302|FG001|Overall Study|Lost to Follow-up|6|||
155494432|NCT03075826|561234306|FG000|Overall Study|Withdrawal by Subject|1|||
155494433|NCT03075826|561234306|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
155494434|NCT04456998|561234309|FG000|Overall Study|Adverse Event|0|||
155494435|NCT04456998|561234310|FG001|Overall Study|Adverse Event|4|||
155494436|NCT04456998|561234309|FG000|Overall Study|Protocol Deviation|0|||
155494437|NCT04456998|561234310|FG001|Overall Study|Protocol Deviation|1|||
155494438|NCT04456998|561234309|FG000|Overall Study|Withdrawal by Subject|0|||
155494439|NCT04456998|561234310|FG001|Overall Study|Withdrawal by Subject|1|||
155494440|NCT04228107|561234314|FG000|Overall Study|Protocol Violation|1|||
155494441|NCT04228107|561234315|FG001|Overall Study|Protocol Violation|0|||
155494442|NCT04228107|561234314|FG000|Overall Study|Withdrawal by Subject|6|||
155494443|NCT04228107|561234315|FG001|Overall Study|Withdrawal by Subject|0|||
155494444|NCT04228107|561234314|FG000|Overall Study|Lost to Follow-up|18|||
155494445|NCT04228107|561234315|FG001|Overall Study|Lost to Follow-up|0|||
155494446|NCT04228107|561234314|FG000|Overall Study|No controller use data|1|||
155494447|NCT04228107|561234315|FG001|Overall Study|No controller use data|0|||
155494448|NCT04228107|561234314|FG000|Overall Study|No medication data collected|1|||
155494449|NCT04228107|561234315|FG001|Overall Study|No medication data collected|0|||
155494450|NCT00965562|561234316|FG000|Overall Study|Lost to Follow-up|1|||
155494451|NCT00965562|561234317|FG001|Overall Study|Lost to Follow-up|2|||
155494452|NCT00965562|561234318|FG002|Overall Study|Lost to Follow-up|3|||
155494453|NCT00965562|561234316|FG000|Overall Study|Withdrawal by Subject|2|||
155494454|NCT00965562|561234317|FG001|Overall Study|Withdrawal by Subject|2|||
155494455|NCT00965562|561234318|FG002|Overall Study|Withdrawal by Subject|0|||
155494456|NCT04755283|561234319|FG000|Overall Study|Withdrawal by Subject|14|||
155494457|NCT04755283|561234320|FG001|Overall Study|Withdrawal by Subject|3|||
155494458|NCT04755283|561234321|FG002|Overall Study|Withdrawal by Subject|6|||
155494459|NCT04755283|561234319|FG000|Overall Study|Lost to Follow-up|0|||
155494460|NCT04755283|561234320|FG001|Overall Study|Lost to Follow-up|0|||
155494461|NCT04755283|561234321|FG002|Overall Study|Lost to Follow-up|1|||
155494462|NCT04755283|561234319|FG000|Overall Study|Death|31|||
155494463|NCT04755283|561234320|FG001|Overall Study|Death|36|||
155494464|NCT04755283|561234321|FG002|Overall Study|Death|34|||
155494465|NCT04342390|561234325|FG000|Overall Study|Lost to Follow-up|3|||
155494466|NCT04342390|561234326|FG001|Overall Study|Lost to Follow-up|0|||
155494467|NCT04584294|561234327|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
155494468|NCT04584294|561234328|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
155494469|NCT04584294|561234327|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
155494470|NCT04584294|561234328|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
155494471|NCT04584294|561234327|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
155494472|NCT04584294|561234328|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
155494473|NCT04584294|561234327|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
155494474|NCT04584294|561234328|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
155494475|NCT04584294|561234327|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
155494476|NCT04584294|561234328|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
155494477|NCT04584294|561234327|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
155494478|NCT04584294|561234328|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
155494479|NCT05153629|561234339|FG000|Overall Study|Withdrawal by Subject|0|||
155494480|NCT05153629|561234340|FG001|Overall Study|Withdrawal by Subject|2|||
155494481|NCT05403502|561234341|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
155494482|NCT05403502|561234341|FG000|Humalog Lead-In Period|Physician Decision|2|||
155494483|NCT05403502|561234341|FG000|Humalog Lead-In Period|Protocol Violation|1|||
155494484|NCT05403502|561234341|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
155494485|NCT05403502|561234341|FG000|Lyumjev Treatment Period|Physician Decision|2|||
155494486|NCT01058707|561234342|FG000|Overall Study|Disease Progression|15|||
155494487|NCT01058707|561234343|FG001|Overall Study|Disease Progression|20|||
155494488|NCT01058707|561234344|FG002|Overall Study|Disease Progression|20|||
155494489|NCT01058707|561234345|FG003|Overall Study|Disease Progression|15|||
155494490|NCT01058707|561234346|FG004|Overall Study|Disease Progression|23|||
155494491|NCT01058707|561234347|FG005|Overall Study|Disease Progression|10|||
155494492|NCT01058707|561234348|FG006|Overall Study|Disease Progression|12|||
155494493|NCT01058707|561234342|FG000|Overall Study|Adverse Event|11|||
155494494|NCT01058707|561234343|FG001|Overall Study|Adverse Event|4|||
155494495|NCT01058707|561234344|FG002|Overall Study|Adverse Event|7|||
155494496|NCT01058707|561234345|FG003|Overall Study|Adverse Event|6|||
155494497|NCT01058707|561234346|FG004|Overall Study|Adverse Event|7|||
155494498|NCT01058707|561234347|FG005|Overall Study|Adverse Event|3|||
155494499|NCT01058707|561234348|FG006|Overall Study|Adverse Event|1|||
155494500|NCT01058707|561234342|FG000|Overall Study|Subject Decision|5|||
155494501|NCT01058707|561234343|FG001|Overall Study|Subject Decision|3|||
155494502|NCT01058707|561234344|FG002|Overall Study|Subject Decision|3|||
155494503|NCT01058707|561234345|FG003|Overall Study|Subject Decision|1|||
155494504|NCT01058707|561234346|FG004|Overall Study|Subject Decision|2|||
155494505|NCT01058707|561234347|FG005|Overall Study|Subject Decision|3|||
155494506|NCT01058707|561234348|FG006|Overall Study|Subject Decision|6|||
155494507|NCT01058707|561234342|FG000|Overall Study|Lost to Follow-up|0|||
155494508|NCT01058707|561234343|FG001|Overall Study|Lost to Follow-up|0|||
155494509|NCT01058707|561234344|FG002|Overall Study|Lost to Follow-up|1|||
155494510|NCT01058707|561234345|FG003|Overall Study|Lost to Follow-up|0|||
155494511|NCT01058707|561234346|FG004|Overall Study|Lost to Follow-up|0|||
155494512|NCT01058707|561234347|FG005|Overall Study|Lost to Follow-up|0|||
155494513|NCT01058707|561234348|FG006|Overall Study|Lost to Follow-up|0|||
155494514|NCT01058707|561234342|FG000|Overall Study|Reason Not Specified|0|||
155744148|NCT00065429|562161635|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155744149|NCT00065429|562161636|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155744150|NCT00065429|562161637|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
155744151|NCT00065429|562161638|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155744152|NCT00065429|562161639|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
155744153|NCT00065429|562161640|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
155744154|NCT00065429|562161634|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744155|NCT00065429|562161635|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744156|NCT00065429|562161636|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744157|NCT00065429|562161637|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744158|NCT00065429|562161638|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
155744159|NCT00065429|562161639|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744160|NCT00065429|562161640|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155744161|NCT00065429|562161634|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744162|NCT00065429|562161635|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744163|NCT00065429|562161636|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744164|NCT00065429|562161637|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744165|NCT00065429|562161638|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
155744166|NCT00065429|562161639|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744167|NCT00065429|562161640|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155744168|NCT00441116|562161643|FG000|Overall Study|Adverse Event|1|||
155744169|NCT00441116|562161644|FG001|Overall Study|Adverse Event|1|||
155744170|NCT00441116|562161643|FG000|Overall Study|Withdrawal by Subject|1|||
155744171|NCT00441116|562161644|FG001|Overall Study|Withdrawal by Subject|0|||
155744172|NCT00441116|562161643|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
155494515|NCT01058707|561234343|FG001|Overall Study|Reason Not Specified|3|||
155494516|NCT01058707|561234344|FG002|Overall Study|Reason Not Specified|2|||
155494517|NCT01058707|561234345|FG003|Overall Study|Reason Not Specified|0|||
155494518|NCT01058707|561234346|FG004|Overall Study|Reason Not Specified|7|||
155494519|NCT01058707|561234347|FG005|Overall Study|Reason Not Specified|1|||
155494520|NCT01058707|561234348|FG006|Overall Study|Reason Not Specified|7|||
155494521|NCT00157820|561234360|FG000|Randomized|Physician Decision|4|||
155494522|NCT00157820|561234361|FG001|Randomized|Physician Decision|2|||
155494523|NCT00157820|561234362|FG002|Randomized|Physician Decision|3|||
155494524|NCT00157820|561234360|FG000|Randomized|Withdrawal by Subject|1|||
155494525|NCT00157820|561234361|FG001|Randomized|Withdrawal by Subject|2|||
155494526|NCT00157820|561234362|FG002|Randomized|Withdrawal by Subject|3|||
155494527|NCT00157820|561234360|FG000|Randomized|Protocol Violation|2|||
155494528|NCT00157820|561234361|FG001|Randomized|Protocol Violation|1|||
155494529|NCT00157820|561234362|FG002|Randomized|Protocol Violation|2|||
155494530|NCT00157820|561234360|FG000|1st 8 Month|Death|7|||
155494531|NCT00157820|561234361|FG001|1st 8 Month|Death|8|||
155494532|NCT00157820|561234362|FG002|1st 8 Month|Death|3|||
155494533|NCT00157820|561234360|FG000|1st 8 Month|Lost to Follow-up|1|||
155494534|NCT00157820|561234361|FG001|1st 8 Month|Lost to Follow-up|2|||
155494535|NCT00157820|561234362|FG002|1st 8 Month|Lost to Follow-up|1|||
155494536|NCT00157820|561234360|FG000|1st 8 Month|Premature cross-over|0|||
155494537|NCT00157820|561234361|FG001|1st 8 Month|Premature cross-over|2|||
155494538|NCT00157820|561234362|FG002|1st 8 Month|Premature cross-over|2|||
155494539|NCT00157820|561234360|FG000|2nd 8 Months|Death|3|||
155494540|NCT00157820|561234361|FG001|2nd 8 Months|Death|1|||
155494541|NCT00157820|561234362|FG002|2nd 8 Months|Death|3|||
155494542|NCT00157820|561234360|FG000|2nd 8 Months|Lost to Follow-up|1|||
155494543|NCT00157820|561234361|FG001|2nd 8 Months|Lost to Follow-up|5|||
155494544|NCT00157820|561234362|FG002|2nd 8 Months|Lost to Follow-up|2|||
155494545|NCT00157820|561234360|FG000|2nd 8 Months|Premature cross-over|1|||
155494546|NCT00157820|561234361|FG001|2nd 8 Months|Premature cross-over|7|||
155494547|NCT00157820|561234362|FG002|2nd 8 Months|Premature cross-over|9|||
155494548|NCT02207413|561234363|FG000|Overall Study|Withdrawal by Subject|1|||
155494549|NCT02207413|561234364|FG001|Overall Study|Withdrawal by Subject|0|||
155494550|NCT02207413|561234365|FG002|Overall Study|Withdrawal by Subject|0|||
155494551|NCT02207413|561234366|FG003|Overall Study|Withdrawal by Subject|0|||
155494552|NCT02207413|561234367|FG004|Overall Study|Withdrawal by Subject|3|||
155494553|NCT02207413|561234368|FG005|Overall Study|Withdrawal by Subject|7|||
155494554|NCT02207413|561234363|FG000|Overall Study|Lost to Follow-up|0|||
155494555|NCT02207413|561234364|FG001|Overall Study|Lost to Follow-up|0|||
155494556|NCT02207413|561234365|FG002|Overall Study|Lost to Follow-up|0|||
155494557|NCT02207413|561234366|FG003|Overall Study|Lost to Follow-up|1|||
155494558|NCT02207413|561234367|FG004|Overall Study|Lost to Follow-up|1|||
155494559|NCT02207413|561234368|FG005|Overall Study|Lost to Follow-up|5|||
155494560|NCT02207413|561234363|FG000|Overall Study|Adverse Event|0|||
155494561|NCT02207413|561234364|FG001|Overall Study|Adverse Event|0|||
155494562|NCT02207413|561234365|FG002|Overall Study|Adverse Event|0|||
155494563|NCT02207413|561234366|FG003|Overall Study|Adverse Event|0|||
155494564|NCT02207413|561234367|FG004|Overall Study|Adverse Event|2|||
155494565|NCT02207413|561234368|FG005|Overall Study|Adverse Event|1|||
155494566|NCT02207413|561234363|FG000|Overall Study|Migrated/moved from study area|0|||
155494567|NCT02207413|561234364|FG001|Overall Study|Migrated/moved from study area|0|||
155494568|NCT02207413|561234365|FG002|Overall Study|Migrated/moved from study area|0|||
155494569|NCT02207413|561234366|FG003|Overall Study|Migrated/moved from study area|0|||
155494570|NCT02207413|561234367|FG004|Overall Study|Migrated/moved from study area|1|||
155494571|NCT02207413|561234368|FG005|Overall Study|Migrated/moved from study area|0|||
155494572|NCT04075656|561234369|FG000|Overall Study|Withdrawal by Subject|5|||
155494573|NCT04075656|561234370|FG001|Overall Study|Withdrawal by Subject|5|||
155494574|NCT02181673|561236182|FG000|Up to Week 24|Adverse Event|2|||
155494575|NCT02181673|561236183|FG001|Up to Week 24|Adverse Event|0|||
155494576|NCT02181673|561236184|FG002|Up to Week 24|Adverse Event|3|||
155494577|NCT02181673|561236182|FG000|Up to Week 24|Death|1|||
155494578|NCT02181673|561236183|FG001|Up to Week 24|Death|0|||
155494579|NCT02181673|561236184|FG002|Up to Week 24|Death|0|||
155494580|NCT02181673|561236182|FG000|Up to Week 24|Lack of Efficacy|1|||
155494581|NCT02181673|561236183|FG001|Up to Week 24|Lack of Efficacy|0|||
155494582|NCT02181673|561236184|FG002|Up to Week 24|Lack of Efficacy|0|||
155494583|NCT02181673|561236182|FG000|Up to Week 24|Lost to Follow-up|1|||
155494584|NCT02181673|561236183|FG001|Up to Week 24|Lost to Follow-up|0|||
155494585|NCT02181673|561236184|FG002|Up to Week 24|Lost to Follow-up|0|||
155494586|NCT02181673|561236182|FG000|Up to Week 24|Physician Decision|0|||
155494587|NCT02181673|561236183|FG001|Up to Week 24|Physician Decision|0|||
155494588|NCT02181673|561236184|FG002|Up to Week 24|Physician Decision|3|||
155494589|NCT02181673|561236182|FG000|Up to Week 24|Withdrawal by Subject|10|||
155494590|NCT02181673|561236183|FG001|Up to Week 24|Withdrawal by Subject|0|||
155494591|NCT02181673|561236184|FG002|Up to Week 24|Withdrawal by Subject|1|||
155494592|NCT02181673|561236182|FG000|Up to Week 24|Other|2|||
155494593|NCT02181673|561236183|FG001|Up to Week 24|Other|0|||
155494594|NCT02181673|561236184|FG002|Up to Week 24|Other|3|||
155494595|NCT02181673|561236182|FG000|Up to Week 24|Randomized not Treated|0|||
155494596|NCT02181673|561236183|FG001|Up to Week 24|Randomized not Treated|0|||
155494597|NCT02181673|561236184|FG002|Up to Week 24|Randomized not Treated|1|||
155494598|NCT02181673|561236182|FG000|Week 24-Week 60|Adverse Event|0|||
155494599|NCT02181673|561236183|FG001|Week 24-Week 60|Adverse Event|4|||
155294312|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294313|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294314|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294315|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155638666|NCT03765073|561767660|FG007|Stage 3|Withdrawal by parent/guardian|0|||
155638667|NCT03765073|561767661|FG008|Stage 3|Withdrawal by parent/guardian|0|||
155638668|NCT03765073|561767662|FG009|Stage 3|Withdrawal by parent/guardian|0|||
155638669|NCT03765073|561767663|FG010|Stage 3|Withdrawal by parent/guardian|0|||
155638670|NCT03765073|561767664|FG011|Stage 3|Withdrawal by parent/guardian|0|||
155638671|NCT03765073|561767665|FG012|Stage 3|Withdrawal by parent/guardian|0|||
155638672|NCT03765073|561767666|FG013|Stage 3|Withdrawal by parent/guardian|0|||
155638673|NCT03765073|561767667|FG014|Stage 3|Withdrawal by parent/guardian|0|||
155638674|NCT03765073|561767668|FG015|Stage 3|Withdrawal by parent/guardian|0|||
155638675|NCT03765073|561767669|FG016|Stage 3|Withdrawal by parent/guardian|0|||
155638676|NCT03765073|561767670|FG017|Stage 3|Withdrawal by parent/guardian|0|||
155638677|NCT03765073|561767671|FG018|Stage 3|Withdrawal by parent/guardian|0|||
155638678|NCT03765073|561767672|FG019|Stage 3|Withdrawal by parent/guardian|6|||
155638679|NCT03765073|561767673|FG020|Stage 3|Withdrawal by parent/guardian|9|||
155638680|NCT03765073|561767653|FG000|Stage 3|Withdrawal by Subject|0|||
155638681|NCT03765073|561767654|FG001|Stage 3|Withdrawal by Subject|0|||
155638682|NCT03765073|561767655|FG002|Stage 3|Withdrawal by Subject|0|||
155638683|NCT03765073|561767656|FG003|Stage 3|Withdrawal by Subject|0|||
155638684|NCT03765073|561767657|FG004|Stage 3|Withdrawal by Subject|0|||
155638685|NCT03765073|561767658|FG005|Stage 3|Withdrawal by Subject|0|||
155638686|NCT03765073|561767659|FG006|Stage 3|Withdrawal by Subject|0|||
155638687|NCT03765073|561767660|FG007|Stage 3|Withdrawal by Subject|0|||
155638688|NCT03765073|561767661|FG008|Stage 3|Withdrawal by Subject|0|||
155638689|NCT03765073|561767662|FG009|Stage 3|Withdrawal by Subject|0|||
155638690|NCT03765073|561767663|FG010|Stage 3|Withdrawal by Subject|0|||
155638691|NCT03765073|561767664|FG011|Stage 3|Withdrawal by Subject|0|||
155638692|NCT03765073|561767665|FG012|Stage 3|Withdrawal by Subject|0|||
155638693|NCT03765073|561767666|FG013|Stage 3|Withdrawal by Subject|0|||
155638694|NCT03765073|561767667|FG014|Stage 3|Withdrawal by Subject|0|||
155638695|NCT03765073|561767668|FG015|Stage 3|Withdrawal by Subject|0|||
155638696|NCT03765073|561767669|FG016|Stage 3|Withdrawal by Subject|0|||
155638697|NCT03765073|561767670|FG017|Stage 3|Withdrawal by Subject|8|||
155638698|NCT03765073|561767671|FG018|Stage 3|Withdrawal by Subject|11|||
155638699|NCT03765073|561767672|FG019|Stage 3|Withdrawal by Subject|0|||
155638700|NCT03765073|561767673|FG020|Stage 3|Withdrawal by Subject|0|||
155638701|NCT02296125|561767680|FG000|Overall Study|Withdrawal by Subject|18|||
155638702|NCT02296125|561767681|FG001|Overall Study|Withdrawal by Subject|8|||
155638703|NCT02296125|561767682|FG002|Overall Study|Withdrawal by Subject|6|||
155638704|NCT02296125|561767683|FG003|Overall Study|Withdrawal by Subject|2|||
155638705|NCT02296125|561767680|FG000|Overall Study|Adverse Event|41|||
155638706|NCT02296125|561767681|FG001|Overall Study|Adverse Event|52|||
155638707|NCT02296125|561767682|FG002|Overall Study|Adverse Event|9|||
155638708|NCT02296125|561767683|FG003|Overall Study|Adverse Event|4|||
155638709|NCT02296125|561767680|FG000|Overall Study|Severe non-compliance to protocol|0|||
155638710|NCT02296125|561767681|FG001|Overall Study|Severe non-compliance to protocol|1|||
155638711|NCT02296125|561767682|FG002|Overall Study|Severe non-compliance to protocol|0|||
155638712|NCT02296125|561767683|FG003|Overall Study|Severe non-compliance to protocol|0|||
155638713|NCT02296125|561767680|FG000|Overall Study|Condition under investigation worsened|153|||
155638714|NCT02296125|561767681|FG001|Overall Study|Condition under investigation worsened|199|||
155638715|NCT02296125|561767682|FG002|Overall Study|Condition under investigation worsened|39|||
155638716|NCT02296125|561767683|FG003|Overall Study|Condition under investigation worsened|56|||
155638717|NCT02296125|561767680|FG000|Overall Study|Any reason not specifically recorded|6|||
155638718|NCT02296125|561767681|FG001|Overall Study|Any reason not specifically recorded|4|||
155638719|NCT02296125|561767682|FG002|Overall Study|Any reason not specifically recorded|2|||
155638720|NCT02296125|561767683|FG003|Overall Study|Any reason not specifically recorded|0|||
155638721|NCT00984399|561767684|FG000|Overall Study|Adverse Event|0|||
155638722|NCT00984399|561767685|FG001|Overall Study|Adverse Event|1|||
155638723|NCT00984399|561767684|FG000|Overall Study|Physician Decision|1|||
155638724|NCT00984399|561767685|FG001|Overall Study|Physician Decision|0|||
155638725|NCT00984399|561767684|FG000|Overall Study|Withdrawal by Subject|1|||
155638726|NCT00984399|561767685|FG001|Overall Study|Withdrawal by Subject|1|||
155638727|NCT00984399|561767684|FG000|Overall Study|Protocol Violation|0|||
155294316|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294317|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
155638728|NCT00984399|561767685|FG001|Overall Study|Protocol Violation|1|||
155638729|NCT00984399|561767684|FG000|Overall Study|Pts did not start treatment|2|||
155638730|NCT00984399|561767685|FG001|Overall Study|Pts did not start treatment|2|||
155638731|NCT03785366|561767687|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
155638732|NCT03785366|561767688|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
155638733|NCT03785366|561767687|FG000|Overall Study|Lost to Follow-up|1|||
155638734|NCT03785366|561767688|FG001|Overall Study|Lost to Follow-up|0|||
155638735|NCT03785366|561767687|FG000|Overall Study|Partial IUD Expulsion|0|||
155638736|NCT03785366|561767688|FG001|Overall Study|Partial IUD Expulsion|2|||
155638737|NCT03785366|561767687|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
155638738|NCT03785366|561767688|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
155638739|NCT03240874|561767689|FG000|Overall Study|Lost to Follow-up|0|||
155638740|NCT03240874|561767690|FG001|Overall Study|Lost to Follow-up|2|||
155638741|NCT03240874|561767691|FG002|Overall Study|Lost to Follow-up|4|||
155638742|NCT03240874|561767692|FG003|Overall Study|Lost to Follow-up|1|||
155638743|NCT01964404|561767693|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
155638744|NCT01964404|561767694|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
155638745|NCT01964404|561767695|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
155638746|NCT01964404|561767696|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
155638747|NCT01964404|561767697|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
155638748|NCT01964404|561767698|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
155638749|NCT01964404|561767699|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
155638750|NCT01964404|561767700|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
155638751|NCT01964404|561767701|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
155638752|NCT01964404|561767702|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
155638753|NCT01964404|561767693|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
155638754|NCT01964404|561767694|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
155638755|NCT01964404|561767695|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155638756|NCT01964404|561767696|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155638757|NCT01964404|561767697|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638758|NCT01964404|561767698|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638759|NCT01964404|561767699|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638760|NCT01964404|561767700|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638761|NCT01964404|561767701|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638762|NCT01964404|561767702|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638763|NCT01964404|561767693|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155638764|NCT01964404|561767694|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
155638765|NCT01964404|561767695|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638766|NCT01964404|561767696|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
155638767|NCT01964404|561767697|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638768|NCT01964404|561767698|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638769|NCT01964404|561767699|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638770|NCT01964404|561767700|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638771|NCT01964404|561767701|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638772|NCT01964404|561767702|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155638773|NCT05528510|561767703|FG000|Overall Study|Death|1|||
155638774|NCT05528510|561767704|FG001|Overall Study|Death|0|||
155638775|NCT05528510|561767705|FG002|Overall Study|Death|0|||
155638776|NCT05528510|561767703|FG000|Overall Study|Lost to Follow-up|1|||
155638777|NCT05528510|561767704|FG001|Overall Study|Lost to Follow-up|0|||
155638778|NCT05528510|561767705|FG002|Overall Study|Lost to Follow-up|0|||
155638779|NCT05528510|561767703|FG000|Overall Study|Withdrawal by Subject|4|||
155638780|NCT05528510|561767704|FG001|Overall Study|Withdrawal by Subject|1|||
155638781|NCT05528510|561767705|FG002|Overall Study|Withdrawal by Subject|3|||
155638782|NCT05528510|561767703|FG000|Overall Study|Other|2|||
155638783|NCT05528510|561767704|FG001|Overall Study|Other|2|||
155638784|NCT05528510|561767705|FG002|Overall Study|Other|1|||
155638785|NCT00927472|561767706|FG000|Overall Study|Withdrawal by Subject|10|||
155638786|NCT00927472|561767707|FG001|Overall Study|Withdrawal by Subject|11|||
155638787|NCT00927472|561767706|FG000|Overall Study|Lost to Follow-up|1|||
155638788|NCT00927472|561767707|FG001|Overall Study|Lost to Follow-up|6|||
155638789|NCT00927472|561767706|FG000|Overall Study|Protocol Violation|0|||
155638790|NCT00927472|561767707|FG001|Overall Study|Protocol Violation|1|||
155638791|NCT00927472|561767706|FG000|Overall Study|Post treatment Assessment out of window|0|||
155638792|NCT00927472|561767707|FG001|Overall Study|Post treatment Assessment out of window|4|||
155638793|NCT05317546|561767710|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
155494600|NCT02181673|561236184|FG002|Week 24-Week 60|Adverse Event|10|||
155494601|NCT02181673|561236182|FG000|Week 24-Week 60|Other|0|||
155494602|NCT02181673|561236183|FG001|Week 24-Week 60|Other|2|||
155638794|NCT05317546|561767711|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
155638795|NCT05350202|561767712|FG000|Visit 1 - Baseline|Not-treated|18|||
155638796|NCT05350202|561767713|FG001|Visit 1 - Baseline|Not-treated|0|||
155638797|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
155638798|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
155638799|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
155638800|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
155638801|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
155638802|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
155650637|NCT00468546|561812519|FG000|Week 24 to Week 104 Analysis|Other|17|||
155494603|NCT02181673|561236184|FG002|Week 24-Week 60|Other|1|||
155494604|NCT02181673|561236182|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
155494605|NCT02181673|561236183|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
155494606|NCT02181673|561236184|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
155494607|NCT02181673|561236182|FG000|Week 24-Week 60|Pregnancy|0|||
155494608|NCT02181673|561236183|FG001|Week 24-Week 60|Pregnancy|0|||
155494609|NCT02181673|561236184|FG002|Week 24-Week 60|Pregnancy|1|||
155494610|NCT02181673|561236182|FG000|Week 24-Week 60|Lack of Efficacy|0|||
155494611|NCT02181673|561236183|FG001|Week 24-Week 60|Lack of Efficacy|0|||
155494612|NCT02181673|561236184|FG002|Week 24-Week 60|Lack of Efficacy|1|||
155494613|NCT02181673|561236182|FG000|Week 24-Week 60|Lost to Follow-up|0|||
155494614|NCT02181673|561236183|FG001|Week 24-Week 60|Lost to Follow-up|0|||
155494615|NCT02181673|561236184|FG002|Week 24-Week 60|Lost to Follow-up|1|||
155494616|NCT02181673|561236182|FG000|Week 24-Week 60|Physician Decision|0|||
155494617|NCT02181673|561236183|FG001|Week 24-Week 60|Physician Decision|0|||
155494618|NCT02181673|561236184|FG002|Week 24-Week 60|Physician Decision|1|||
155494619|NCT00337727|561236187|FG000|Overall Study|Adverse Event|5|||
155494620|NCT00337727|561236188|FG001|Overall Study|Adverse Event|3|||
155494621|NCT00337727|561236187|FG000|Overall Study|Lost to Follow-up|5|||
155494622|NCT00337727|561236188|FG001|Overall Study|Lost to Follow-up|4|||
155494623|NCT00337727|561236187|FG000|Overall Study|Physician Decision|1|||
155494624|NCT00337727|561236188|FG001|Overall Study|Physician Decision|0|||
155494625|NCT00337727|561236187|FG000|Overall Study|Protocol Violation|4|||
155494626|NCT00337727|561236188|FG001|Overall Study|Protocol Violation|0|||
155494627|NCT00337727|561236187|FG000|Overall Study|Withdrawal by Subject|3|||
155494628|NCT00337727|561236188|FG001|Overall Study|Withdrawal by Subject|5|||
155494629|NCT00320801|561236189|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
155494630|NCT00320801|561236190|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
155494631|NCT00320801|561236191|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
155494632|NCT00320801|561236192|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
155494633|NCT00320801|561236189|FG000|Open-label Run-in Period|Adverse Event|33|||
155494634|NCT00320801|561236190|FG001|Open-label Run-in Period|Adverse Event|0|||
155494635|NCT00320801|561236191|FG002|Open-label Run-in Period|Adverse Event|0|||
155494636|NCT00320801|561236192|FG003|Open-label Run-in Period|Adverse Event|0|||
155494637|NCT00320801|561236189|FG000|Open-label Run-in Period|Administrative|10|||
155494638|NCT00320801|561236190|FG001|Open-label Run-in Period|Administrative|0|||
155494639|NCT00320801|561236191|FG002|Open-label Run-in Period|Administrative|0|||
155494640|NCT00320801|561236192|FG003|Open-label Run-in Period|Administrative|0|||
155494641|NCT00320801|561236189|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
155494642|NCT00320801|561236190|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
155494643|NCT00320801|561236191|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
155494644|NCT00320801|561236192|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
155494645|NCT00320801|561236189|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
155494646|NCT00320801|561236190|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
155494647|NCT00320801|561236191|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
155494648|NCT00320801|561236192|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
155494649|NCT00320801|561236189|FG000|Open-label Run-in Period|Did not qualify|1|||
155494650|NCT00320801|561236190|FG001|Open-label Run-in Period|Did not qualify|0|||
155494651|NCT00320801|561236191|FG002|Open-label Run-in Period|Did not qualify|0|||
155494652|NCT00320801|561236192|FG003|Open-label Run-in Period|Did not qualify|0|||
155494653|NCT00320801|561236189|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155494654|NCT00320801|561236190|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155494655|NCT00320801|561236191|FG002|Double-blind Phase|Withdrawal by Subject|1|||
155494656|NCT00320801|561236192|FG003|Double-blind Phase|Withdrawal by Subject|0|||
155494657|NCT00320801|561236189|FG000|Double-blind Phase|Adverse Event|0|||
155494658|NCT00320801|561236190|FG001|Double-blind Phase|Adverse Event|2|||
155494659|NCT00320801|561236191|FG002|Double-blind Phase|Adverse Event|8|||
155494660|NCT00320801|561236192|FG003|Double-blind Phase|Adverse Event|0|||
155494661|NCT00320801|561236189|FG000|Double-blind Phase|Administrative|0|||
155494662|NCT00320801|561236190|FG001|Double-blind Phase|Administrative|0|||
155494663|NCT00320801|561236191|FG002|Double-blind Phase|Administrative|4|||
155494664|NCT00320801|561236192|FG003|Double-blind Phase|Administrative|0|||
155494665|NCT00320801|561236189|FG000|Double-blind Phase|Lack of Efficacy|0|||
155494666|NCT00320801|561236190|FG001|Double-blind Phase|Lack of Efficacy|9|||
155494667|NCT00320801|561236191|FG002|Double-blind Phase|Lack of Efficacy|1|||
155494668|NCT00320801|561236192|FG003|Double-blind Phase|Lack of Efficacy|0|||
155638803|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
155638804|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
155638805|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
155638806|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
155638807|NCT05350202|561767712|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
155638808|NCT05350202|561767713|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
155638809|NCT04707469|561767714|FG000|Overall Study|Site closure|0|||
155638810|NCT04707469|561767715|FG001|Overall Study|Site closure|2|||
155638811|NCT04707469|561767716|FG002|Overall Study|Site closure|0|||
155638812|NCT04707469|561767714|FG000|Overall Study|Physician Decision|2|||
155638813|NCT04707469|561767715|FG001|Overall Study|Physician Decision|2|||
155638814|NCT04707469|561767716|FG002|Overall Study|Physician Decision|2|||
155638815|NCT04707469|561767714|FG000|Overall Study|Death|1|||
155638816|NCT04707469|561767715|FG001|Overall Study|Death|6|||
155638817|NCT04707469|561767716|FG002|Overall Study|Death|2|||
155638818|NCT04707469|561767714|FG000|Overall Study|Lost to Follow-up|9|||
155638819|NCT04707469|561767715|FG001|Overall Study|Lost to Follow-up|19|||
155638820|NCT04707469|561767716|FG002|Overall Study|Lost to Follow-up|14|||
155638821|NCT04707469|561767714|FG000|Overall Study|Withdrawal by Subject|17|||
155294318|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294319|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294320|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
155294321|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
155435890|NCT02403206|561022985|FG000|Overall Study|Reason not given|2|||
155435891|NCT02403206|561022986|FG001|Overall Study|Reason not given|4|||
155435892|NCT01676116|561022987|FG000|Overall Study|Withdrawal criteria|2|||
155435893|NCT01676116|561022988|FG001|Overall Study|Withdrawal criteria|14|||
155435894|NCT01676116|561022987|FG000|Overall Study|Adverse Event|1|||
155435895|NCT01676116|561022988|FG001|Overall Study|Adverse Event|2|||
155435896|NCT01676116|561022987|FG000|Overall Study|Unclassified|4|||
155435897|NCT01676116|561022988|FG001|Overall Study|Unclassified|10|||
155435898|NCT01676116|561022987|FG000|Overall Study|Protocol Violation|9|||
155435899|NCT01676116|561022988|FG001|Overall Study|Protocol Violation|3|||
155435900|NCT01877655|561022989|FG000|Overall Study|Death|57|||
155435901|NCT01877655|561022990|FG001|Overall Study|Death|52|||
155435902|NCT01877655|561022989|FG000|Overall Study|Withdrawal by Subject|18|||
155435903|NCT01877655|561022990|FG001|Overall Study|Withdrawal by Subject|26|||
155435904|NCT01877655|561022989|FG000|Overall Study|Physician Decision|11|||
155435905|NCT01877655|561022990|FG001|Overall Study|Physician Decision|10|||
155435906|NCT01877655|561022989|FG000|Overall Study|Miscellaneous|4|||
155435907|NCT01877655|561022990|FG001|Overall Study|Miscellaneous|4|||
155435908|NCT01877655|561022989|FG000|Overall Study|Randomized but Never Received Drug|8|||
155435909|NCT01877655|561022990|FG001|Overall Study|Randomized but Never Received Drug|5|||
155435910|NCT01821677|561022993|FG000|Overall Study|Adverse Event|4|||
155435911|NCT01821677|561022994|FG001|Overall Study|Adverse Event|6|||
155435912|NCT01821677|561022995|FG002|Overall Study|Adverse Event|5|||
155435913|NCT01821677|561022993|FG000|Overall Study|Physician Decision|1|||
155435914|NCT01821677|561022994|FG001|Overall Study|Physician Decision|4|||
155435915|NCT01821677|561022995|FG002|Overall Study|Physician Decision|1|||
155435916|NCT01821677|561022993|FG000|Overall Study|Non-compliance|0|||
155435917|NCT01821677|561022994|FG001|Overall Study|Non-compliance|1|||
155435918|NCT01821677|561022995|FG002|Overall Study|Non-compliance|2|||
155435919|NCT01821677|561022993|FG000|Overall Study|Lost to Follow-up|2|||
155435920|NCT01821677|561022994|FG001|Overall Study|Lost to Follow-up|1|||
155435921|NCT01821677|561022995|FG002|Overall Study|Lost to Follow-up|3|||
155435922|NCT01821677|561022993|FG000|Overall Study|Protocol Violation|0|||
155435923|NCT01821677|561022994|FG001|Overall Study|Protocol Violation|0|||
155435924|NCT01821677|561022995|FG002|Overall Study|Protocol Violation|2|||
155435925|NCT01821677|561022993|FG000|Overall Study|Withdrawal by Subject|7|||
155435926|NCT01821677|561022994|FG001|Overall Study|Withdrawal by Subject|3|||
155435927|NCT01821677|561022995|FG002|Overall Study|Withdrawal by Subject|2|||
155435928|NCT01821677|561022993|FG000|Overall Study|Other|9|||
155435929|NCT01821677|561022994|FG001|Overall Study|Other|0|||
155435930|NCT01821677|561022995|FG002|Overall Study|Other|0|||
155435931|NCT00538733|561022996|FG000|Overall Study|Adverse Event|8|||
155435932|NCT00538733|561022996|FG000|Overall Study|Death|1|||
155435933|NCT00538733|561022996|FG000|Overall Study|declined to participate|2|||
155435934|NCT00538733|561022996|FG000|Overall Study|still on therapy|1|||
155435935|NCT03497689|561022999|FG000|Overall Study|Adverse Event|2|||
155435936|NCT03497689|561022999|FG000|Overall Study|Death|1|||
155435937|NCT03497689|561022999|FG000|Overall Study|Physician Decision|1|||
155435938|NCT03497689|561022999|FG000|Overall Study|Withdrawal by Subject|1|||
155435939|NCT03497689|561022999|FG000|Overall Study|Protocol Violation|2|||
155435940|NCT03567187|561023000|FG000|Overall Study|Lost to Follow-up|18|||
155435941|NCT03596645|561023003|FG000|Overall Study|Adverse Event|17|||
155435942|NCT03596645|561023004|FG001|Overall Study|Adverse Event|0|||
155494669|NCT00320801|561236189|FG000|Extension Phase|Withdrawal by Subject|0|||
155494670|NCT00320801|561236190|FG001|Extension Phase|Withdrawal by Subject|0|||
155494671|NCT00320801|561236191|FG002|Extension Phase|Withdrawal by Subject|0|||
155494672|NCT00320801|561236192|FG003|Extension Phase|Withdrawal by Subject|6|||
155494673|NCT00320801|561236189|FG000|Extension Phase|Adverse Event|0|||
155494674|NCT00320801|561236190|FG001|Extension Phase|Adverse Event|0|||
155494675|NCT00320801|561236191|FG002|Extension Phase|Adverse Event|0|||
155494676|NCT00320801|561236192|FG003|Extension Phase|Adverse Event|8|||
155494677|NCT00320801|561236189|FG000|Extension Phase|Administrative|0|||
155494678|NCT00320801|561236190|FG001|Extension Phase|Administrative|0|||
155494679|NCT00320801|561236191|FG002|Extension Phase|Administrative|0|||
155494680|NCT00320801|561236192|FG003|Extension Phase|Administrative|29|||
155494681|NCT00320801|561236189|FG000|Extension Phase|Lack of Efficacy|0|||
155494682|NCT00320801|561236190|FG001|Extension Phase|Lack of Efficacy|0|||
155494683|NCT00320801|561236191|FG002|Extension Phase|Lack of Efficacy|0|||
155494684|NCT00320801|561236192|FG003|Extension Phase|Lack of Efficacy|2|||
155494685|NCT00320801|561236189|FG000|Extension Phase|Lost to Follow-up|0|||
155494686|NCT00320801|561236190|FG001|Extension Phase|Lost to Follow-up|0|||
155494687|NCT00320801|561236191|FG002|Extension Phase|Lost to Follow-up|0|||
155494688|NCT00320801|561236192|FG003|Extension Phase|Lost to Follow-up|3|||
155494689|NCT00491322|561236194|FG000|Overall Study|Protocol Violation|1|||
155494690|NCT00491322|561236195|FG001|Overall Study|Protocol Violation|0|||
155494691|NCT00491322|561236194|FG000|Overall Study|Pregnancy|0|||
155494692|NCT00491322|561236195|FG001|Overall Study|Pregnancy|1|||
155494693|NCT06067191|561236196|FG000|Overall Study|Withdrawal by Subject|0|||
155494694|NCT06067191|561236197|FG001|Overall Study|Withdrawal by Subject|1|||
155494695|NCT03664024|561236199|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
155494696|NCT03664024|561236199|FG000|Overall Study|Lost to Follow-up|2|||
155494697|NCT03664024|561236199|FG000|Overall Study|Withdrawal by Subject|2|||
155494698|NCT03664024|561236199|FG000|Overall Study|Death|80|||
155494699|NCT01157065|561236200|FG000|Overall Study|Death|0|||
155494700|NCT01157065|561236201|FG001|Overall Study|Death|1|||
155494701|NCT05275673|561236204|FG000|Overall Study|Study Termination by Sponsor|2|||
155494702|NCT05275673|561236205|FG001|Overall Study|Study Termination by Sponsor|3|||
155494703|NCT05275673|561236204|FG000|Overall Study|Death|1|||
155494704|NCT05275673|561236205|FG001|Overall Study|Death|0|||
155494705|NCT05275673|561236204|FG000|Overall Study|Withdrawal by Subject|1|||
155494706|NCT05275673|561236205|FG001|Overall Study|Withdrawal by Subject|0|||
155494707|NCT02325739|561236206|FG000|Phase I Part|Adverse Event|1|||
155494708|NCT02325739|561236207|FG001|Phase I Part|Adverse Event|0|||
155494709|NCT02325739|561236208|FG002|Phase I Part|Adverse Event|1|||
155494710|NCT02325739|561236209|FG003|Phase I Part|Adverse Event|2|||
155494711|NCT02325739|561236210|FG004|Phase I Part|Adverse Event|3|||
155494712|NCT02325739|561236211|FG005|Phase I Part|Adverse Event|1|||
155494713|NCT02325739|561236212|FG006|Phase I Part|Adverse Event|0|||
155494714|NCT02325739|561236213|FG007|Phase I Part|Adverse Event|2|||
155294322|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294323|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294324|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294325|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294326|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155494715|NCT02325739|561236214|FG008|Phase I Part|Adverse Event|0|||
155638822|NCT04707469|561767715|FG001|Overall Study|Withdrawal by Subject|16|||
155638823|NCT04707469|561767716|FG002|Overall Study|Withdrawal by Subject|12|||
155638824|NCT01525589|561767722|FG000|Overall Study|Non-treatment-related AE|1|||
155638825|NCT01525589|561767723|FG001|Overall Study|Non-treatment-related AE|0|||
155638826|NCT01525589|561767724|FG002|Overall Study|Non-treatment-related AE|0|||
155638827|NCT01525589|561767722|FG000|Overall Study|Progressive disease|48|||
155638828|NCT01525589|561767723|FG001|Overall Study|Progressive disease|15|||
155638829|NCT01525589|561767724|FG002|Overall Study|Progressive disease|29|||
155638830|NCT01525589|561767722|FG000|Overall Study|Never treated|2|||
155638831|NCT01525589|561767723|FG001|Overall Study|Never treated|0|||
155638832|NCT01525589|561767724|FG002|Overall Study|Never treated|0|||
155638833|NCT01525589|561767722|FG000|Overall Study|Physician Decision|4|||
155638834|NCT01525589|561767723|FG001|Overall Study|Physician Decision|2|||
155638835|NCT01525589|561767724|FG002|Overall Study|Physician Decision|2|||
155638836|NCT01525589|561767722|FG000|Overall Study|Death|0|||
155494716|NCT02325739|561236215|FG009|Phase I Part|Adverse Event|0|||
155494717|NCT02325739|561236216|FG010|Phase I Part|Adverse Event|0|||
155494718|NCT02325739|561236206|FG000|Phase I Part|Progressive disease|9|||
155494719|NCT02325739|561236207|FG001|Phase I Part|Progressive disease|6|||
155494720|NCT02325739|561236208|FG002|Phase I Part|Progressive disease|3|||
155494721|NCT02325739|561236209|FG003|Phase I Part|Progressive disease|23|||
155494722|NCT02325739|561236210|FG004|Phase I Part|Progressive disease|14|||
155494723|NCT02325739|561236211|FG005|Phase I Part|Progressive disease|6|||
155638837|NCT01525589|561767723|FG001|Overall Study|Death|0|||
155494724|NCT02325739|561236212|FG006|Phase I Part|Progressive disease|6|||
155638838|NCT01525589|561767724|FG002|Overall Study|Death|2|||
155294327|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155294328|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294329|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294330|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294331|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294332|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294333|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155638839|NCT01525589|561767722|FG000|Overall Study|Treatment-related AE|1|||
155638840|NCT01525589|561767723|FG001|Overall Study|Treatment-related AE|1|||
155638841|NCT01525589|561767724|FG002|Overall Study|Treatment-related AE|2|||
155638842|NCT01525589|561767722|FG000|Overall Study|Other reasons|0|||
155638843|NCT01525589|561767723|FG001|Overall Study|Other reasons|1|||
155638844|NCT01525589|561767724|FG002|Overall Study|Other reasons|0|||
155638845|NCT01525589|561767722|FG000|Overall Study|Withdrawal by Subject|0|||
155638846|NCT01525589|561767723|FG001|Overall Study|Withdrawal by Subject|1|||
155638847|NCT01525589|561767724|FG002|Overall Study|Withdrawal by Subject|0|||
155638848|NCT02924376|561767725|FG000|Overall Study|Progressive Disease|4|||
155638849|NCT02924376|561767726|FG001|Overall Study|Progressive Disease|0|||
155638850|NCT02924376|561767727|FG002|Overall Study|Progressive Disease|1|||
155638851|NCT02924376|561767728|FG003|Overall Study|Progressive Disease|0|||
155638852|NCT02924376|561767725|FG000|Overall Study|Death|73|||
155638853|NCT02924376|561767726|FG001|Overall Study|Death|18|||
155638854|NCT02924376|561767727|FG002|Overall Study|Death|15|||
155638855|NCT02924376|561767728|FG003|Overall Study|Death|2|||
155638856|NCT02924376|561767725|FG000|Overall Study|Lost to Follow-up|3|||
155638857|NCT02924376|561767726|FG001|Overall Study|Lost to Follow-up|0|||
155638858|NCT02924376|561767727|FG002|Overall Study|Lost to Follow-up|0|||
155638859|NCT02924376|561767728|FG003|Overall Study|Lost to Follow-up|0|||
155638860|NCT02924376|561767725|FG000|Overall Study|Study Terminated by Sponsor|19|||
155638861|NCT02924376|561767726|FG001|Overall Study|Study Terminated by Sponsor|0|||
155638862|NCT02924376|561767727|FG002|Overall Study|Study Terminated by Sponsor|0|||
155638863|NCT02924376|561767728|FG003|Overall Study|Study Terminated by Sponsor|0|||
155638864|NCT02924376|561767725|FG000|Overall Study|Physician Decision|1|||
155638865|NCT02924376|561767726|FG001|Overall Study|Physician Decision|0|||
155638866|NCT02924376|561767727|FG002|Overall Study|Physician Decision|0|||
155638867|NCT02924376|561767728|FG003|Overall Study|Physician Decision|0|||
155638868|NCT02924376|561767725|FG000|Overall Study|Withdrawal by Subject|7|||
155638869|NCT02924376|561767726|FG001|Overall Study|Withdrawal by Subject|2|||
155638870|NCT02924376|561767727|FG002|Overall Study|Withdrawal by Subject|1|||
155638871|NCT02924376|561767728|FG003|Overall Study|Withdrawal by Subject|0|||
155638872|NCT02924376|561767725|FG000|Overall Study|Rolled Over to Another Study|1|||
155638873|NCT02924376|561767726|FG001|Overall Study|Rolled Over to Another Study|0|||
155638874|NCT02924376|561767727|FG002|Overall Study|Rolled Over to Another Study|0|||
155638875|NCT02924376|561767728|FG003|Overall Study|Rolled Over to Another Study|0|||
155638876|NCT04835441|561767729|FG000|Overall Study|Physician Decision|4|||
155638877|NCT04835441|561767730|FG001|Overall Study|Physician Decision|4|||
155638878|NCT04835441|561767729|FG000|Overall Study|Other|1|||
155638879|NCT04835441|561767730|FG001|Overall Study|Other|1|||
155638880|NCT04835441|561767729|FG000|Overall Study|Lost to Follow-up|0|||
155638881|NCT04835441|561767730|FG001|Overall Study|Lost to Follow-up|1|||
155638882|NCT03069989|561767733|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
155638883|NCT03069989|561767734|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
155638884|NCT02145390|561767738|FG000|Overall Study|Withdrawal by Subject|1|||
155638885|NCT02293499|561768772|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
155638886|NCT02293499|561768773|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
155638887|NCT02293499|561768774|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
155638888|NCT02293499|561768772|FG000|Intervention - Camp|Withdrawal by Subject|3|||
155638889|NCT02293499|561768773|FG001|Intervention - Camp|Withdrawal by Subject|6|||
155638890|NCT02293499|561768774|FG002|Intervention - Camp|Withdrawal by Subject|2|||
155638891|NCT02293499|561768772|FG000|Intervention - Camp|these are those not showing up at camp|24|||
155638892|NCT02293499|561768773|FG001|Intervention - Camp|these are those not showing up at camp|28|||
155638893|NCT02293499|561768774|FG002|Intervention - Camp|these are those not showing up at camp|4|||
155494725|NCT02325739|561236213|FG007|Phase I Part|Progressive disease|3|||
155294334|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155638894|NCT02293499|561768772|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
155638895|NCT02293499|561768773|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
155638896|NCT02293499|561768774|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
155638897|NCT02293499|561768772|FG000|3 Month Follow Up|Lost to Follow-up|14|||
155638898|NCT02293499|561768773|FG001|3 Month Follow Up|Lost to Follow-up|15|||
155638899|NCT02293499|561768774|FG002|3 Month Follow Up|Lost to Follow-up|6|||
155638900|NCT02293499|561768772|FG000|6 Month Follow Up|Lost to Follow-up|17|||
155494726|NCT02325739|561236214|FG008|Phase I Part|Progressive disease|0|||
155638901|NCT02293499|561768773|FG001|6 Month Follow Up|Lost to Follow-up|27|||
155638902|NCT02293499|561768774|FG002|6 Month Follow Up|Lost to Follow-up|6|||
155638903|NCT02293499|561768772|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
155638904|NCT02293499|561768773|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
155638905|NCT02293499|561768774|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
155638906|NCT02293499|561768772|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
155638907|NCT02293499|561768773|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
155494727|NCT02325739|561236215|FG009|Phase I Part|Progressive disease|0|||
155294335|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294336|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155638908|NCT02293499|561768774|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
155494728|NCT02325739|561236216|FG010|Phase I Part|Progressive disease|0|||
155494729|NCT02325739|561236206|FG000|Phase I Part|Subject/guardian decision|1|||
155494730|NCT02325739|561236207|FG001|Phase I Part|Subject/guardian decision|0|||
155494731|NCT02325739|561236208|FG002|Phase I Part|Subject/guardian decision|1|||
155494732|NCT02325739|561236209|FG003|Phase I Part|Subject/guardian decision|1|||
155494733|NCT02325739|561236210|FG004|Phase I Part|Subject/guardian decision|0|||
155494734|NCT02325739|561236211|FG005|Phase I Part|Subject/guardian decision|0|||
155494735|NCT02325739|561236212|FG006|Phase I Part|Subject/guardian decision|0|||
155494736|NCT02325739|561236213|FG007|Phase I Part|Subject/guardian decision|1|||
155494737|NCT02325739|561236214|FG008|Phase I Part|Subject/guardian decision|0|||
155494738|NCT02325739|561236215|FG009|Phase I Part|Subject/guardian decision|0|||
155638909|NCT02293499|561768772|FG000|9 Month Follow Up|Lost to Follow-up|24|||
155638910|NCT02293499|561768773|FG001|9 Month Follow Up|Lost to Follow-up|28|||
155638911|NCT02293499|561768774|FG002|9 Month Follow Up|Lost to Follow-up|4|||
155638912|NCT02293499|561768772|FG000|12 Month Follow Up|Lost to Follow-up|26|||
155638913|NCT02293499|561768773|FG001|12 Month Follow Up|Lost to Follow-up|25|||
155638914|NCT02293499|561768774|FG002|12 Month Follow Up|Lost to Follow-up|6|||
155638915|NCT02293499|561768772|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
155638916|NCT02293499|561768773|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
155638917|NCT02293499|561768774|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
155638918|NCT02293499|561768772|FG000|15 Month Follow Up|Lost to Follow-up|22|||
155494739|NCT02325739|561236216|FG010|Phase I Part|Subject/guardian decision|0|||
155494740|NCT02325739|561236206|FG000|Phase I Part|Death|0|||
155494741|NCT02325739|561236207|FG001|Phase I Part|Death|0|||
155494742|NCT02325739|561236208|FG002|Phase I Part|Death|0|||
155494743|NCT02325739|561236209|FG003|Phase I Part|Death|0|||
155494744|NCT02325739|561236210|FG004|Phase I Part|Death|2|||
155494745|NCT02325739|561236211|FG005|Phase I Part|Death|0|||
155494746|NCT02325739|561236212|FG006|Phase I Part|Death|0|||
155494747|NCT02325739|561236213|FG007|Phase I Part|Death|0|||
155494748|NCT02325739|561236214|FG008|Phase I Part|Death|0|||
155494749|NCT02325739|561236215|FG009|Phase I Part|Death|0|||
155494750|NCT02325739|561236216|FG010|Phase I Part|Death|0|||
155494751|NCT02325739|561236206|FG000|Phase II Part|Adverse Event|0|||
155494752|NCT02325739|561236207|FG001|Phase II Part|Adverse Event|0|||
155494753|NCT02325739|561236208|FG002|Phase II Part|Adverse Event|0|||
155494754|NCT02325739|561236209|FG003|Phase II Part|Adverse Event|0|||
155494755|NCT02325739|561236210|FG004|Phase II Part|Adverse Event|0|||
155494756|NCT02325739|561236211|FG005|Phase II Part|Adverse Event|0|||
155494757|NCT02325739|561236212|FG006|Phase II Part|Adverse Event|0|||
155494758|NCT02325739|561236213|FG007|Phase II Part|Adverse Event|0|||
155494759|NCT02325739|561236214|FG008|Phase II Part|Adverse Event|4|||
155494760|NCT02325739|561236215|FG009|Phase II Part|Adverse Event|5|||
155494761|NCT02325739|561236216|FG010|Phase II Part|Adverse Event|1|||
155494762|NCT02325739|561236206|FG000|Phase II Part|Physician Decision|0|||
155494763|NCT02325739|561236207|FG001|Phase II Part|Physician Decision|0|||
155494764|NCT02325739|561236208|FG002|Phase II Part|Physician Decision|0|||
155494765|NCT02325739|561236209|FG003|Phase II Part|Physician Decision|0|||
155494766|NCT02325739|561236210|FG004|Phase II Part|Physician Decision|0|||
155494767|NCT02325739|561236211|FG005|Phase II Part|Physician Decision|0|||
155494768|NCT02325739|561236212|FG006|Phase II Part|Physician Decision|0|||
155494769|NCT02325739|561236213|FG007|Phase II Part|Physician Decision|0|||
155494770|NCT02325739|561236214|FG008|Phase II Part|Physician Decision|0|||
155494771|NCT02325739|561236215|FG009|Phase II Part|Physician Decision|1|||
155494772|NCT02325739|561236216|FG010|Phase II Part|Physician Decision|0|||
155494773|NCT02325739|561236206|FG000|Phase II Part|Progressive disease|0|||
155494774|NCT02325739|561236207|FG001|Phase II Part|Progressive disease|0|||
155494775|NCT02325739|561236208|FG002|Phase II Part|Progressive disease|0|||
155494776|NCT02325739|561236209|FG003|Phase II Part|Progressive disease|0|||
155494777|NCT02325739|561236210|FG004|Phase II Part|Progressive disease|0|||
155494778|NCT02325739|561236211|FG005|Phase II Part|Progressive disease|0|||
155494779|NCT02325739|561236212|FG006|Phase II Part|Progressive disease|0|||
155494780|NCT02325739|561236213|FG007|Phase II Part|Progressive disease|0|||
155494781|NCT02325739|561236214|FG008|Phase II Part|Progressive disease|22|||
155294337|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294338|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
155494782|NCT02325739|561236215|FG009|Phase II Part|Progressive disease|29|||
155494783|NCT02325739|561236216|FG010|Phase II Part|Progressive disease|18|||
155638919|NCT02293499|561768773|FG001|15 Month Follow Up|Lost to Follow-up|22|||
155638920|NCT02293499|561768774|FG002|15 Month Follow Up|Lost to Follow-up|7|||
155638921|NCT01787838|561768775|FG000|Overall Study|refused|1413|||
155638922|NCT00356590|561768782|FG000|Overall Study|Adverse Event|54|||
155494784|NCT02325739|561236206|FG000|Phase II Part|Subject/guardian decision|0|||
155494785|NCT02325739|561236207|FG001|Phase II Part|Subject/guardian decision|0|||
155494786|NCT02325739|561236208|FG002|Phase II Part|Subject/guardian decision|0|||
155494787|NCT02325739|561236209|FG003|Phase II Part|Subject/guardian decision|0|||
155494788|NCT02325739|561236210|FG004|Phase II Part|Subject/guardian decision|0|||
155494789|NCT02325739|561236211|FG005|Phase II Part|Subject/guardian decision|0|||
155638923|NCT00356590|561768782|FG000|Overall Study|Death|10|||
155638924|NCT00356590|561768782|FG000|Overall Study|Lost to Follow-up|35|||
155638925|NCT00356590|561768782|FG000|Overall Study|Physician Decision|46|||
155638926|NCT00356590|561768782|FG000|Overall Study|Withdrawal by Subject|41|||
155638927|NCT00356590|561768782|FG000|Overall Study|Completed month 12 only|2|||
155638928|NCT00356590|561768782|FG000|Overall Study|Protocol issues|6|||
155494790|NCT02325739|561236212|FG006|Phase II Part|Subject/guardian decision|0|||
155494791|NCT02325739|561236213|FG007|Phase II Part|Subject/guardian decision|0|||
155494792|NCT02325739|561236214|FG008|Phase II Part|Subject/guardian decision|4|||
155494793|NCT02325739|561236215|FG009|Phase II Part|Subject/guardian decision|1|||
155494794|NCT02325739|561236216|FG010|Phase II Part|Subject/guardian decision|1|||
155494795|NCT03426995|561236217|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155638929|NCT00356590|561768782|FG000|Overall Study|Response status|28|||
155638930|NCT00356590|561768782|FG000|Overall Study|Other|52|||
155638931|NCT02696616|561768783|FG000|Overall Study|Adverse Event|0|||
155638932|NCT02696616|561768784|FG001|Overall Study|Adverse Event|1|||
155638933|NCT02696616|561768785|FG002|Overall Study|Adverse Event|0|||
155638934|NCT02696616|561768786|FG003|Overall Study|Adverse Event|0|||
155638935|NCT02696616|561768787|FG004|Overall Study|Adverse Event|0|||
155638936|NCT02696616|561768788|FG005|Overall Study|Adverse Event|0|||
155638937|NCT02696616|561768789|FG006|Overall Study|Adverse Event|0|||
155638938|NCT01970371|561768790|FG000|Overall Study|Death|8|||
155638939|NCT01970371|561768791|FG001|Overall Study|Death|13|||
155638940|NCT01970371|561768792|FG002|Overall Study|Death|12|||
155294339|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
155294340|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294341|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294342|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294343|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155435943|NCT03596645|561023003|FG000|Overall Study|Lack of Efficacy|8|||
155435944|NCT03596645|561023004|FG001|Overall Study|Lack of Efficacy|0|||
155435945|NCT03596645|561023003|FG000|Overall Study|Lost to Follow-up|1|||
155435946|NCT03596645|561023004|FG001|Overall Study|Lost to Follow-up|1|||
155435947|NCT03596645|561023003|FG000|Overall Study|Physician Decision|1|||
155435948|NCT03596645|561023004|FG001|Overall Study|Physician Decision|1|||
155435949|NCT03596645|561023003|FG000|Overall Study|Protocol Violation|1|||
155435950|NCT03596645|561023004|FG001|Overall Study|Protocol Violation|0|||
155435951|NCT03596645|561023003|FG000|Overall Study|Initiated Prohibited Medication|1|||
155435952|NCT03596645|561023004|FG001|Overall Study|Initiated Prohibited Medication|0|||
155435953|NCT03596645|561023003|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155435954|NCT03596645|561023004|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155435955|NCT03596645|561023003|FG000|Overall Study|No mucosal healing achieved|1|||
155435956|NCT03596645|561023004|FG001|Overall Study|No mucosal healing achieved|0|||
155435957|NCT03596645|561023003|FG000|Overall Study|Disease progression|1|||
155435958|NCT03596645|561023004|FG001|Overall Study|Disease progression|0|||
155435959|NCT03596645|561023003|FG000|Overall Study|Ongoing|37|||
155435960|NCT03596645|561023004|FG001|Overall Study|Ongoing|12|||
155435961|NCT03596645|561023003|FG000|Overall Study|Randomized but not treated|0|||
155435962|NCT03596645|561023004|FG001|Overall Study|Randomized but not treated|1|||
155435963|NCT01123889|561024452|FG000|Overall Study|Lost to Follow-up|3|||
155435964|NCT01123889|561024453|FG001|Overall Study|Lost to Follow-up|1|||
155435965|NCT00443560|561024454|FG000|Overall Study|No intrathecal dose|58|||
155435966|NCT00443560|561024455|FG001|Overall Study|No intrathecal dose|26|||
155435967|NCT00443560|561024454|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
155435968|NCT00443560|561024455|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
155435969|NCT02333331|561024456|FG000|Overall Study|Adverse Event|1|||
155494796|NCT03426995|561236218|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494797|NCT03426995|561236219|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
155494798|NCT03426995|561236220|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494799|NCT03426995|561236221|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494800|NCT03426995|561236222|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494801|NCT03426995|561236223|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494802|NCT03426995|561236224|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494803|NCT03426995|561236225|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494804|NCT03426995|561236226|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494805|NCT03426995|561236227|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494806|NCT03426995|561236228|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494807|NCT03426995|561236229|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494808|NCT03426995|561236230|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494809|NCT03426995|561236231|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494810|NCT03426995|561236232|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494811|NCT03426995|561236233|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494812|NCT03426995|561236234|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494813|NCT03426995|561236235|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
155494814|NCT03426995|561236217|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494815|NCT03426995|561236218|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494816|NCT03426995|561236219|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494817|NCT03426995|561236220|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494818|NCT03426995|561236221|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494819|NCT03426995|561236222|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
155494820|NCT03426995|561236223|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494821|NCT03426995|561236224|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494822|NCT03426995|561236225|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494823|NCT03426995|561236226|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494824|NCT03426995|561236227|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494825|NCT03426995|561236228|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494826|NCT03426995|561236229|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494827|NCT03426995|561236230|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494828|NCT03426995|561236231|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494829|NCT03426995|561236232|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494830|NCT03426995|561236233|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494831|NCT03426995|561236234|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494832|NCT03426995|561236235|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
155494833|NCT03426995|561236217|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494834|NCT03426995|561236218|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494835|NCT03426995|561236219|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494836|NCT03426995|561236220|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494837|NCT03426995|561236221|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
155494838|NCT03426995|561236222|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
155494839|NCT03426995|561236223|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155744173|NCT00441116|562161644|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
155744174|NCT00636363|562161645|FG000|Overall Study|Conjunctivitis|0|||
155744175|NCT00636363|562161646|FG001|Overall Study|Conjunctivitis|0|||
155744176|NCT00636363|562161647|FG002|Overall Study|Conjunctivitis|1|||
155744177|NCT00636363|562161645|FG000|Overall Study|Adverse Event|0|||
155744178|NCT00636363|562161646|FG001|Overall Study|Adverse Event|0|||
155744179|NCT00636363|562161647|FG002|Overall Study|Adverse Event|1|||
155744180|NCT00636363|562161645|FG000|Overall Study|Positive slit lamp finding|0|||
155744181|NCT00636363|562161646|FG001|Overall Study|Positive slit lamp finding|2|||
155744182|NCT00636363|562161647|FG002|Overall Study|Positive slit lamp finding|1|||
155744183|NCT00636363|562161645|FG000|Overall Study|Study related symptoms/complaints|8|||
155744184|NCT00636363|562161646|FG001|Overall Study|Study related symptoms/complaints|7|||
155744185|NCT00636363|562161647|FG002|Overall Study|Study related symptoms/complaints|4|||
155744186|NCT00636363|562161645|FG000|Overall Study|Met ineligibility criteria|0|||
155744187|NCT00636363|562161646|FG001|Overall Study|Met ineligibility criteria|0|||
155744188|NCT00636363|562161647|FG002|Overall Study|Met ineligibility criteria|3|||
155744189|NCT00636363|562161645|FG000|Overall Study|Missed > 1 visit|0|||
155744190|NCT00636363|562161646|FG001|Overall Study|Missed > 1 visit|1|||
155744191|NCT00636363|562161647|FG002|Overall Study|Missed > 1 visit|3|||
155744192|NCT00636363|562161645|FG000|Overall Study|Lack of motivation|1|||
155744193|NCT00636363|562161646|FG001|Overall Study|Lack of motivation|0|||
155744194|NCT00636363|562161647|FG002|Overall Study|Lack of motivation|1|||
155744195|NCT00636363|562161645|FG000|Overall Study|Protocol Violation|0|||
155410709|NCT05048719|560937468|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155638941|NCT01970371|561768790|FG000|Overall Study|Lost to Follow-up|0|||
155638942|NCT01970371|561768791|FG001|Overall Study|Lost to Follow-up|0|||
155638943|NCT01970371|561768792|FG002|Overall Study|Lost to Follow-up|1|||
155638944|NCT01481779|561768793|FG000|Overall Study|Adverse Event|23|||
155638945|NCT01481779|561768794|FG001|Overall Study|Adverse Event|5|||
155638946|NCT01481779|561768793|FG000|Overall Study|Lost to Follow-up|3|||
155638947|NCT01481779|561768794|FG001|Overall Study|Lost to Follow-up|2|||
155638948|NCT01481779|561768793|FG000|Overall Study|Protocol Violation|2|||
155638949|NCT01481779|561768794|FG001|Overall Study|Protocol Violation|3|||
155638950|NCT01481779|561768793|FG000|Overall Study|Withdrawal by Subject|26|||
155638951|NCT01481779|561768794|FG001|Overall Study|Withdrawal by Subject|13|||
155638952|NCT01481779|561768793|FG000|Overall Study|Physician Decision|13|||
155638953|NCT01481779|561768794|FG001|Overall Study|Physician Decision|4|||
155638954|NCT01481779|561768793|FG000|Overall Study|Sponsor Decision|3|||
155638955|NCT01481779|561768794|FG001|Overall Study|Sponsor Decision|1|||
155638956|NCT06420232|561768802|FG000|Overall Study|Withdrawal by Subject|3|||
155638957|NCT00487188|561768803|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
155638958|NCT00487188|561768804|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
155638959|NCT00487188|561768805|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
155638960|NCT00487188|561768803|FG000|Induction Phase|Adverse Event|5|||
155638961|NCT00487188|561768804|FG001|Induction Phase|Adverse Event|0|||
155638962|NCT00487188|561768805|FG002|Induction Phase|Adverse Event|0|||
155638963|NCT00487188|561768803|FG000|Induction Phase|Lack of Efficacy|0|||
155638964|NCT00487188|561768804|FG001|Induction Phase|Lack of Efficacy|1|||
155638965|NCT00487188|561768805|FG002|Induction Phase|Lack of Efficacy|0|||
155638966|NCT00487188|561768803|FG000|Induction Phase|Protocol Violation|1|||
155638967|NCT00487188|561768804|FG001|Induction Phase|Protocol Violation|0|||
155638968|NCT00487188|561768805|FG002|Induction Phase|Protocol Violation|0|||
155638969|NCT00487188|561768803|FG000|Induction Phase|Refused Treatment|1|||
155638970|NCT00487188|561768804|FG001|Induction Phase|Refused Treatment|2|||
155638971|NCT00487188|561768805|FG002|Induction Phase|Refused Treatment|0|||
155638972|NCT00487188|561768803|FG000|Induction Phase|Lost to Follow-up|2|||
155638973|NCT00487188|561768804|FG001|Induction Phase|Lost to Follow-up|2|||
155638974|NCT00487188|561768805|FG002|Induction Phase|Lost to Follow-up|0|||
155638975|NCT00487188|561768803|FG000|Induction Phase|Administrative|0|||
155638976|NCT00487188|561768804|FG001|Induction Phase|Administrative|1|||
155638977|NCT00487188|561768805|FG002|Induction Phase|Administrative|0|||
155638978|NCT00487188|561768803|FG000|Maintenance Phase|Adverse Event|1|||
155638979|NCT00487188|561768804|FG001|Maintenance Phase|Adverse Event|0|||
155638980|NCT00487188|561768805|FG002|Maintenance Phase|Adverse Event|0|||
155638981|NCT00487188|561768803|FG000|Maintenance Phase|Death|1|||
155638982|NCT00487188|561768804|FG001|Maintenance Phase|Death|0|||
155638983|NCT00487188|561768805|FG002|Maintenance Phase|Death|0|||
155638984|NCT00487188|561768803|FG000|Maintenance Phase|Lost to Follow-up|1|||
155638985|NCT00487188|561768804|FG001|Maintenance Phase|Lost to Follow-up|0|||
155638986|NCT00487188|561768805|FG002|Maintenance Phase|Lost to Follow-up|0|||
155638987|NCT00487188|561768803|FG000|Maintenance Phase|Administrative|0|||
155638988|NCT00487188|561768804|FG001|Maintenance Phase|Administrative|0|||
155638989|NCT00487188|561768805|FG002|Maintenance Phase|Administrative|1|||
155638990|NCT04225039|561768808|FG000|Overall Study|Withdrawal by Subject|1|||
155638991|NCT04225039|561768809|FG001|Overall Study|Withdrawal by Subject|0|||
155638992|NCT04225039|561768810|FG002|Overall Study|Withdrawal by Subject|0|||
155638993|NCT04225039|561768811|FG003|Overall Study|Withdrawal by Subject|1|||
155638994|NCT04225039|561768808|FG000|Overall Study|Currently active on study treatment|0|||
155638995|NCT04225039|561768809|FG001|Overall Study|Currently active on study treatment|1|||
155638996|NCT04225039|561768810|FG002|Overall Study|Currently active on study treatment|0|||
155638997|NCT04225039|561768811|FG003|Overall Study|Currently active on study treatment|0|||
155638998|NCT04225039|561768808|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
155638999|NCT04225039|561768809|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155639000|NCT04225039|561768810|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155494840|NCT03426995|561236224|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494841|NCT03426995|561236225|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494842|NCT03426995|561236226|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494843|NCT03426995|561236227|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494844|NCT03426995|561236228|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494845|NCT03426995|561236229|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494846|NCT03426995|561236230|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494847|NCT03426995|561236231|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494848|NCT03426995|561236232|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494849|NCT03426995|561236233|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494850|NCT03426995|561236234|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494851|NCT03426995|561236235|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
155494852|NCT03426995|561236217|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494853|NCT03426995|561236218|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494854|NCT03426995|561236219|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494855|NCT03426995|561236220|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494856|NCT03426995|561236221|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494857|NCT03426995|561236222|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494858|NCT03426995|561236223|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494859|NCT03426995|561236224|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494860|NCT03426995|561236225|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155639001|NCT04225039|561768811|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155639002|NCT04225039|561768808|FG000|Overall Study|Ineligible for treatment|0|||
155639003|NCT04225039|561768809|FG001|Overall Study|Ineligible for treatment|0|||
155639004|NCT04225039|561768810|FG002|Overall Study|Ineligible for treatment|0|||
155639005|NCT04225039|561768811|FG003|Overall Study|Ineligible for treatment|4|||
155639006|NCT00975923|561768816|FG000|Overall Study|Withdrawal by Subject|0|||
155639007|NCT00975923|561768817|FG001|Overall Study|Withdrawal by Subject|1|||
155639008|NCT03483584|561768818|FG000|Overall Study|Lost to Follow-up|40|||
155639009|NCT03483584|561768819|FG001|Overall Study|Lost to Follow-up|7|||
155639010|NCT03483584|561768818|FG000|Overall Study|Withdrawal by Subject|4|||
155639011|NCT03483584|561768819|FG001|Overall Study|Withdrawal by Subject|1|||
155639012|NCT00005047|561768820|FG000|Overall Study|Withdrawal by Subject|12|||
155639013|NCT00005047|561768821|FG001|Overall Study|Withdrawal by Subject|0|||
155639014|NCT00005047|561768822|FG002|Overall Study|Withdrawal by Subject|0|||
155639015|NCT00005047|561768823|FG003|Overall Study|Withdrawal by Subject|0|||
155639016|NCT00005047|561768820|FG000|Overall Study|Adverse Event|5|||
155639017|NCT00005047|561768821|FG001|Overall Study|Adverse Event|0|||
155639018|NCT00005047|561768822|FG002|Overall Study|Adverse Event|0|||
155639019|NCT00005047|561768823|FG003|Overall Study|Adverse Event|0|||
155639020|NCT00005047|561768820|FG000|Overall Study|Lost to Follow-up|1|||
155639021|NCT00005047|561768821|FG001|Overall Study|Lost to Follow-up|0|||
155639022|NCT00005047|561768822|FG002|Overall Study|Lost to Follow-up|0|||
155639023|NCT00005047|561768823|FG003|Overall Study|Lost to Follow-up|0|||
155639024|NCT00005047|561768820|FG000|Overall Study|Lack of Efficacy|1|||
155639025|NCT00005047|561768821|FG001|Overall Study|Lack of Efficacy|0|||
155639026|NCT00005047|561768822|FG002|Overall Study|Lack of Efficacy|0|||
155639027|NCT00005047|561768823|FG003|Overall Study|Lack of Efficacy|0|||
155639028|NCT05567172|561768824|FG000|Overall Study|Death|3|||
155639029|NCT03168672|561768827|FG000|Overall Study|Withdrawal by Subject|13|||
155639030|NCT03168672|561768827|FG000|Overall Study|Death|3|||
155639031|NCT03168672|561768827|FG000|Overall Study|Investigator's Decision|137|||
155639032|NCT03168672|561768827|FG000|Overall Study|Adverse Event|1|||
155639033|NCT03168672|561768827|FG000|Overall Study|Other|2|||
155639034|NCT03168672|561768827|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
155639035|NCT00433537|561768828|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
155639036|NCT00433537|561768829|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
155639037|NCT00433537|561768830|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
155639038|NCT00433537|561768828|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
155639039|NCT00433537|561768829|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
155639040|NCT00433537|561768830|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
155639041|NCT00433537|561768828|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
155639042|NCT00433537|561768829|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
155639043|NCT00433537|561768830|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
155639044|NCT00433537|561768828|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
155639045|NCT00433537|561768829|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
155639046|NCT00433537|561768830|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
155639047|NCT00433537|561768828|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
155639048|NCT00433537|561768829|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
155639049|NCT00433537|561768830|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
155639050|NCT00433537|561768828|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
155639051|NCT00433537|561768829|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
155639052|NCT00433537|561768830|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
155639053|NCT00433537|561768828|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
155639054|NCT00433537|561768829|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
155639055|NCT00433537|561768830|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
155639056|NCT00433537|561768828|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
155639057|NCT00433537|561768829|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
155639058|NCT00433537|561768830|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
155639059|NCT00433537|561768828|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
155494861|NCT03426995|561236226|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155639060|NCT00433537|561768829|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
155639061|NCT00433537|561768830|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
155639062|NCT04635423|561768843|FG000|Overall Study|Ongoing|493|||
155639063|NCT04635423|561768844|FG001|Overall Study|Ongoing|501|||
155639064|NCT04635423|561768843|FG000|Overall Study|Withdrawal by Subject|36|||
155639065|NCT04635423|561768844|FG001|Overall Study|Withdrawal by Subject|29|||
155639066|NCT05556057|561768845|FG000|Overall Study|Lost to Follow-up|5|||
155639067|NCT05556057|561768846|FG001|Overall Study|Lost to Follow-up|4|||
155639068|NCT05556057|561768845|FG000|Overall Study|Withdrawal by Subject|0|||
155639069|NCT05556057|561768846|FG001|Overall Study|Withdrawal by Subject|2|||
155639070|NCT04364646|561768853|FG000|Overall Study|Lost to Follow-up|1|||
155639071|NCT04364646|561768854|FG001|Overall Study|Lost to Follow-up|0|||
155639072|NCT04364646|561768853|FG000|Overall Study|Withdrawal by Subject|7|||
155494862|NCT03426995|561236227|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
155494863|NCT03426995|561236228|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494864|NCT03426995|561236229|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494865|NCT03426995|561236230|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494866|NCT03426995|561236231|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494867|NCT03426995|561236232|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494868|NCT03426995|561236233|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494869|NCT03426995|561236234|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494870|NCT03426995|561236235|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
155494871|NCT03426995|561236217|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494872|NCT03426995|561236218|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494873|NCT03426995|561236219|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494874|NCT03426995|561236220|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494875|NCT03426995|561236221|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494876|NCT03426995|561236222|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494877|NCT03426995|561236223|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494878|NCT03426995|561236224|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
155494879|NCT03426995|561236225|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494880|NCT03426995|561236226|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494881|NCT03426995|561236227|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494882|NCT03426995|561236228|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494883|NCT03426995|561236229|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494884|NCT03426995|561236230|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494885|NCT03426995|561236231|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494886|NCT03426995|561236232|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494887|NCT03426995|561236233|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494888|NCT03426995|561236234|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494889|NCT03426995|561236235|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
155494890|NCT03426995|561236217|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494891|NCT03426995|561236218|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494892|NCT03426995|561236219|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494893|NCT03426995|561236220|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155744196|NCT00636363|562161646|FG001|Overall Study|Protocol Violation|3|||
155744197|NCT00636363|562161647|FG002|Overall Study|Protocol Violation|0|||
155744198|NCT00636363|562161645|FG000|Overall Study|Lost to Follow-up|3|||
155744199|NCT00636363|562161646|FG001|Overall Study|Lost to Follow-up|4|||
155744200|NCT00636363|562161647|FG002|Overall Study|Lost to Follow-up|2|||
155744201|NCT00636363|562161645|FG000|Overall Study|Withdrawal by Subject|1|||
155744202|NCT00636363|562161646|FG001|Overall Study|Withdrawal by Subject|3|||
155744203|NCT00636363|562161647|FG002|Overall Study|Withdrawal by Subject|2|||
155744204|NCT01144299|562161648|FG000|Overall Study|Lost to Follow-up|1|||
155744205|NCT01144299|562161649|FG001|Overall Study|Lost to Follow-up|0|||
155744206|NCT01144299|562161648|FG000|Overall Study|Withdrawal by Subject|1|||
155744207|NCT01144299|562161649|FG001|Overall Study|Withdrawal by Subject|0|||
155744208|NCT02342418|562161652|FG000|Overall Study|Adverse Event|0|||
155494894|NCT03426995|561236221|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494895|NCT03426995|561236222|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494896|NCT03426995|561236223|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494897|NCT03426995|561236224|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494898|NCT03426995|561236225|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494899|NCT03426995|561236226|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494900|NCT03426995|561236227|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494901|NCT03426995|561236228|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494902|NCT03426995|561236229|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494903|NCT03426995|561236230|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494904|NCT03426995|561236231|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
155494905|NCT03426995|561236232|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
155494906|NCT03426995|561236233|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494907|NCT03426995|561236234|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494908|NCT03426995|561236235|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
155494909|NCT03426995|561236217|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155744209|NCT02342418|562161653|FG001|Overall Study|Adverse Event|1|||
155744210|NCT04255394|562161654|FG000|Overall Study|Death|35|||
155744211|NCT04255394|562161655|FG001|Overall Study|Death|25|||
155639073|NCT04364646|561768854|FG001|Overall Study|Withdrawal by Subject|14|||
155639074|NCT04364646|561768853|FG000|Overall Study|Protocol Violation|4|||
155639075|NCT04364646|561768854|FG001|Overall Study|Protocol Violation|5|||
155639076|NCT02003924|561768855|FG000|Double-blind Phase|Lost to Follow-up|2|||
155639077|NCT02003924|561768856|FG001|Double-blind Phase|Lost to Follow-up|1|||
155639078|NCT02003924|561768857|FG002|Double-blind Phase|Lost to Follow-up|0|||
155639079|NCT02003924|561768855|FG000|Double-blind Phase|Protocol Violation|1|||
155639080|NCT02003924|561768856|FG001|Double-blind Phase|Protocol Violation|2|||
155639081|NCT02003924|561768857|FG002|Double-blind Phase|Protocol Violation|0|||
155639082|NCT02003924|561768855|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
155639083|NCT02003924|561768856|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
155639084|NCT02003924|561768857|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
155639085|NCT02003924|561768855|FG000|Double-blind Phase|Disease Progression|229|||
155639086|NCT02003924|561768856|FG001|Double-blind Phase|Disease Progression|247|||
155639087|NCT02003924|561768857|FG002|Double-blind Phase|Disease Progression|0|||
155639088|NCT02003924|561768855|FG000|Double-blind Phase|Adverse Event|120|||
155639089|NCT02003924|561768856|FG001|Double-blind Phase|Adverse Event|31|||
155639090|NCT02003924|561768857|FG002|Double-blind Phase|Adverse Event|0|||
155639091|NCT02003924|561768855|FG000|Double-blind Phase|Randomized But not Treated|3|||
155639092|NCT02003924|561768856|FG001|Double-blind Phase|Randomized But not Treated|3|||
155639093|NCT02003924|561768857|FG002|Double-blind Phase|Randomized But not Treated|0|||
155639094|NCT02003924|561768855|FG000|Double-blind Phase|Other|29|||
155639095|NCT02003924|561768856|FG001|Double-blind Phase|Other|50|||
155639096|NCT02003924|561768857|FG002|Double-blind Phase|Other|0|||
155639097|NCT02003924|561768855|FG000|Open-label Phase|Lost to Follow-up|0|||
155639098|NCT02003924|561768856|FG001|Open-label Phase|Lost to Follow-up|0|||
155639099|NCT02003924|561768857|FG002|Open-label Phase|Lost to Follow-up|1|||
155639100|NCT02003924|561768855|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
155639101|NCT02003924|561768856|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
155639102|NCT02003924|561768857|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
155639103|NCT02003924|561768855|FG000|Open-label Phase|Disease Progression|59|||
155639104|NCT02003924|561768856|FG001|Open-label Phase|Disease Progression|0|||
155639105|NCT02003924|561768857|FG002|Open-label Phase|Disease Progression|5|||
155639106|NCT02003924|561768855|FG000|Open-label Phase|Adverse Event|25|||
155639107|NCT02003924|561768856|FG001|Open-label Phase|Adverse Event|0|||
155639108|NCT02003924|561768857|FG002|Open-label Phase|Adverse Event|10|||
155639109|NCT02003924|561768855|FG000|Open-label Phase|Other|7|||
155639110|NCT02003924|561768856|FG001|Open-label Phase|Other|0|||
155639111|NCT02003924|561768857|FG002|Open-label Phase|Other|0|||
155639112|NCT02003924|561768855|FG000|Long-term Follow-up Phase|Death|288|||
155639113|NCT02003924|561768856|FG001|Long-term Follow-up Phase|Death|174|||
155639114|NCT02003924|561768857|FG002|Long-term Follow-up Phase|Death|4|||
155639115|NCT02003924|561768855|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
155639116|NCT02003924|561768856|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
155639117|NCT02003924|561768857|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
155639118|NCT02003924|561768855|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
155639119|NCT02003924|561768856|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
155639120|NCT02003924|561768857|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
155639121|NCT02003924|561768855|FG000|Long-term Follow-up Phase|Other|5|||
155639122|NCT02003924|561768856|FG001|Long-term Follow-up Phase|Other|2|||
155639123|NCT02003924|561768857|FG002|Long-term Follow-up Phase|Other|1|||
155639124|NCT00832975|561768859|FG000|Overall Study|Lost to Follow-up|7|||
155639125|NCT00832975|561768859|FG000|Overall Study|Protocol Violation|6|||
155639126|NCT00832975|561768859|FG000|Overall Study|Death|5|||
155639127|NCT00832975|561768859|FG000|Overall Study|Physician Decision|4|||
155639128|NCT00832975|561768859|FG000|Overall Study|Withdrawal by Subject|3|||
155639129|NCT00832975|561768859|FG000|Overall Study|Other reasons|14|||
155639130|NCT06081829|561768862|FG000|Overall Study|Participants still on-study|8|||
155639131|NCT06081829|561768862|FG000|Overall Study|Death|4|||
155639132|NCT03608033|561768863|FG000|Treatment Period|Death|0|||
155639133|NCT03608033|561768864|FG001|Treatment Period|Death|1|||
155639134|NCT03608033|561768863|FG000|Treatment Period|Adverse Event|1|||
155639135|NCT03608033|561768864|FG001|Treatment Period|Adverse Event|5|||
155639136|NCT03608033|561768863|FG000|Treatment Period|Lack of Efficacy|4|||
155639137|NCT03608033|561768864|FG001|Treatment Period|Lack of Efficacy|3|||
155639138|NCT03608033|561768863|FG000|Treatment Period|Lost to Follow-up|2|||
155639139|NCT03608033|561768864|FG001|Treatment Period|Lost to Follow-up|6|||
155639140|NCT03608033|561768863|FG000|Treatment Period|Physician Decision|6|||
155639141|NCT03608033|561768864|FG001|Treatment Period|Physician Decision|10|||
155639142|NCT03608033|561768863|FG000|Treatment Period|Pregnancy|1|||
155639143|NCT03608033|561768864|FG001|Treatment Period|Pregnancy|0|||
155639144|NCT03608033|561768863|FG000|Treatment Period|Protocol Violation|1|||
155639145|NCT03608033|561768864|FG001|Treatment Period|Protocol Violation|2|||
155639146|NCT03608033|561768863|FG000|Treatment Period|Withdrawal by Subject|46|||
155435970|NCT02333331|561024457|FG001|Overall Study|Adverse Event|0|||
155435971|NCT02333331|561024458|FG002|Overall Study|Adverse Event|4|||
155435972|NCT02333331|561024459|FG003|Overall Study|Adverse Event|1|||
155435973|NCT02333331|561024456|FG000|Overall Study|Death|0|||
155435974|NCT02333331|561024457|FG001|Overall Study|Death|0|||
155435975|NCT02333331|561024458|FG002|Overall Study|Death|2|||
155435976|NCT02333331|561024459|FG003|Overall Study|Death|0|||
155435977|NCT02333331|561024456|FG000|Overall Study|Lost to Follow-up|0|||
155435978|NCT02333331|561024457|FG001|Overall Study|Lost to Follow-up|0|||
155435979|NCT02333331|561024458|FG002|Overall Study|Lost to Follow-up|1|||
155435980|NCT02333331|561024459|FG003|Overall Study|Lost to Follow-up|0|||
155435981|NCT02333331|561024456|FG000|Overall Study|Physician Decision|0|||
155435982|NCT02333331|561024457|FG001|Overall Study|Physician Decision|1|||
155435983|NCT02333331|561024458|FG002|Overall Study|Physician Decision|0|||
155435984|NCT02333331|561024459|FG003|Overall Study|Physician Decision|0|||
155435985|NCT02333331|561024456|FG000|Overall Study|Protocol Deviation|0|||
155435986|NCT02333331|561024457|FG001|Overall Study|Protocol Deviation|3|||
155435987|NCT02333331|561024458|FG002|Overall Study|Protocol Deviation|2|||
155435988|NCT02333331|561024459|FG003|Overall Study|Protocol Deviation|1|||
155435989|NCT02333331|561024456|FG000|Overall Study|Patient/Guardian Decision|1|||
155435990|NCT02333331|561024457|FG001|Overall Study|Patient/Guardian Decision|2|||
155435991|NCT02333331|561024458|FG002|Overall Study|Patient/Guardian Decision|9|||
155435992|NCT02333331|561024459|FG003|Overall Study|Patient/Guardian Decision|1|||
155435993|NCT01494038|561024460|FG000|Overall Study|Protocol Violation|1|||
155435994|NCT01494038|561024461|FG001|Overall Study|Protocol Violation|1|||
155435995|NCT01494038|561024460|FG000|Overall Study|Lost to Follow-up|18|||
155435996|NCT01494038|561024461|FG001|Overall Study|Lost to Follow-up|20|||
155435997|NCT01494038|561024460|FG000|Overall Study|Withdrawal by Subject|44|||
155435998|NCT01494038|561024461|FG001|Overall Study|Withdrawal by Subject|34|||
155435999|NCT01494038|561024460|FG000|Overall Study|Not able to get to clinic|21|||
155436000|NCT01494038|561024461|FG001|Overall Study|Not able to get to clinic|15|||
155436001|NCT01494038|561024460|FG000|Overall Study|Not willing to adhere to reqs|2|||
155436002|NCT01494038|561024461|FG001|Overall Study|Not willing to adhere to reqs|9|||
155436003|NCT01494038|561024460|FG000|Overall Study|Death|2|||
155436004|NCT01494038|561024461|FG001|Overall Study|Death|4|||
155436005|NCT00685178|561024468|FG000|Overall Study|Adverse Event|1|||
155436006|NCT00685178|561024469|FG001|Overall Study|Adverse Event|5|||
155436007|NCT00685178|561024470|FG002|Overall Study|Adverse Event|2|||
155436008|NCT00685178|561024471|FG003|Overall Study|Adverse Event|4|||
155436009|NCT00685178|561024468|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
155436010|NCT00685178|561024469|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
155436011|NCT00685178|561024470|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
155436012|NCT00685178|561024471|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
155436013|NCT00685178|561024468|FG000|Overall Study|voluntary study discharge|4|||
155436014|NCT00685178|561024469|FG001|Overall Study|voluntary study discharge|5|||
155436015|NCT00685178|561024470|FG002|Overall Study|voluntary study discharge|1|||
155436016|NCT00685178|561024471|FG003|Overall Study|voluntary study discharge|1|||
155436017|NCT00685178|561024468|FG000|Overall Study|incarcerated|1|||
155436018|NCT00685178|561024469|FG001|Overall Study|incarcerated|3|||
155436019|NCT00685178|561024470|FG002|Overall Study|incarcerated|7|||
155436020|NCT00685178|561024471|FG003|Overall Study|incarcerated|0|||
155436021|NCT00685178|561024468|FG000|Overall Study|administrative (disciplinary) discharge|0|||
155436022|NCT00685178|561024469|FG001|Overall Study|administrative (disciplinary) discharge|1|||
155436023|NCT00685178|561024470|FG002|Overall Study|administrative (disciplinary) discharge|0|||
155436024|NCT00685178|561024471|FG003|Overall Study|administrative (disciplinary) discharge|2|||
155436025|NCT00685178|561024468|FG000|Overall Study|Pregnancy|0|||
155436026|NCT00685178|561024469|FG001|Overall Study|Pregnancy|0|||
155436027|NCT00685178|561024470|FG002|Overall Study|Pregnancy|0|||
155436028|NCT00685178|561024471|FG003|Overall Study|Pregnancy|1|||
155436029|NCT00077623|561024477|FG000|Overall Study|Adverse Event|1|||
155436030|NCT00077623|561024478|FG001|Overall Study|Adverse Event|0|||
155436031|NCT00077623|561024479|FG002|Overall Study|Adverse Event|1|||
155436032|NCT00077623|561024477|FG000|Overall Study|Withdrawal by Subject|2|||
155436033|NCT00077623|561024478|FG001|Overall Study|Withdrawal by Subject|10|||
155436034|NCT00077623|561024479|FG002|Overall Study|Withdrawal by Subject|1|||
155436035|NCT00077623|561024477|FG000|Overall Study|Other-Non safety reason|18|||
155436036|NCT00077623|561024478|FG001|Overall Study|Other-Non safety reason|15|||
155436037|NCT00077623|561024479|FG002|Overall Study|Other-Non safety reason|19|||
155436038|NCT00077623|561024477|FG000|Overall Study|Insufficient therapeutic response|2|||
155436039|NCT00077623|561024478|FG001|Overall Study|Insufficient therapeutic response|0|||
155436040|NCT00077623|561024479|FG002|Overall Study|Insufficient therapeutic response|0|||
155436041|NCT00077623|561024477|FG000|Overall Study|Death|12|||
155436042|NCT00077623|561024478|FG001|Overall Study|Death|18|||
155436043|NCT00077623|561024479|FG002|Overall Study|Death|11|||
155436044|NCT00077623|561024477|FG000|Overall Study|Failure to return|1|||
155494910|NCT03426995|561236218|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494911|NCT03426995|561236219|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494912|NCT03426995|561236220|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494913|NCT03426995|561236221|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494914|NCT03426995|561236222|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494915|NCT03426995|561236223|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494916|NCT03426995|561236224|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494917|NCT03426995|561236225|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494918|NCT03426995|561236226|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494919|NCT03426995|561236227|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494920|NCT03426995|561236228|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494921|NCT03426995|561236229|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494922|NCT03426995|561236230|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494923|NCT03426995|561236231|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
155494924|NCT03426995|561236232|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
155494925|NCT03426995|561236233|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494926|NCT03426995|561236234|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494927|NCT03426995|561236235|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
155494928|NCT00227591|561236236|FG000|Overall Study|Withdrawal by Subject|1|||
155494929|NCT02335411|561236237|FG000|Overall Study|Death|223|||
155494930|NCT02335411|561236238|FG001|Overall Study|Death|22|||
155494931|NCT02335411|561236239|FG002|Overall Study|Death|26|||
155494932|NCT02335411|561236237|FG000|Overall Study|Physician Decision|3|||
155494933|NCT02335411|561236238|FG001|Overall Study|Physician Decision|0|||
155494934|NCT02335411|561236239|FG002|Overall Study|Physician Decision|0|||
155494935|NCT02335411|561236237|FG000|Overall Study|Protocol Violation|1|||
155494936|NCT02335411|561236238|FG001|Overall Study|Protocol Violation|0|||
155494937|NCT02335411|561236239|FG002|Overall Study|Protocol Violation|0|||
155494938|NCT02335411|561236237|FG000|Overall Study|Withdrawal by Subject|11|||
155494939|NCT02335411|561236238|FG001|Overall Study|Withdrawal by Subject|0|||
155494940|NCT02335411|561236239|FG002|Overall Study|Withdrawal by Subject|3|||
155494941|NCT02335411|561236237|FG000|Overall Study|Sponsor Decision|12|||
155494942|NCT02335411|561236238|FG001|Overall Study|Sponsor Decision|3|||
155494943|NCT02335411|561236239|FG002|Overall Study|Sponsor Decision|2|||
155494944|NCT02335411|561236237|FG000|Overall Study|Adverse Event|9|||
155494945|NCT02335411|561236238|FG001|Overall Study|Adverse Event|0|||
155494946|NCT02335411|561236239|FG002|Overall Study|Adverse Event|0|||
155494947|NCT03917654|561236245|FG000|Year 1|Withdrawal by Subject|1|||
155494948|NCT03917654|561236246|FG001|Year 1|Withdrawal by Subject|0|||
155494949|NCT03917654|561236247|FG002|Year 1|Withdrawal by Subject|0|||
155494950|NCT03917654|561236248|FG003|Year 1|Withdrawal by Subject|0|||
155494951|NCT03917654|561236249|FG004|Year 1|Withdrawal by Subject|0|||
155494952|NCT03917654|561236250|FG005|Year 1|Withdrawal by Subject|1|||
155494953|NCT03917654|561236251|FG006|Year 1|Withdrawal by Subject|6|||
155494954|NCT03917654|561236252|FG007|Year 1|Withdrawal by Subject|2|||
155494955|NCT03917654|561236253|FG008|Year 1|Withdrawal by Subject|5|||
155494956|NCT03917654|561236254|FG009|Year 1|Withdrawal by Subject|3|||
155494957|NCT03917654|561236255|FG010|Year 1|Withdrawal by Subject|1|||
155494958|NCT03917654|561236256|FG011|Year 1|Withdrawal by Subject|0|||
155494959|NCT03917654|561236245|FG000|Year 1|Travel|0|||
155494960|NCT03917654|561236246|FG001|Year 1|Travel|1|||
155494961|NCT03917654|561236247|FG002|Year 1|Travel|1|||
155494962|NCT03917654|561236248|FG003|Year 1|Travel|0|||
155494963|NCT03917654|561236249|FG004|Year 1|Travel|4|||
155494964|NCT03917654|561236250|FG005|Year 1|Travel|4|||
155494965|NCT03917654|561236251|FG006|Year 1|Travel|10|||
155494966|NCT03917654|561236252|FG007|Year 1|Travel|8|||
155494967|NCT03917654|561236253|FG008|Year 1|Travel|2|||
155494968|NCT03917654|561236254|FG009|Year 1|Travel|5|||
155494969|NCT03917654|561236255|FG010|Year 1|Travel|3|||
155494970|NCT03917654|561236256|FG011|Year 1|Travel|3|||
155494971|NCT03917654|561236245|FG000|Year 1|Subject moved away from site|0|||
155494972|NCT03917654|561236246|FG001|Year 1|Subject moved away from site|1|||
155494973|NCT03917654|561236247|FG002|Year 1|Subject moved away from site|0|||
155494974|NCT03917654|561236248|FG003|Year 1|Subject moved away from site|0|||
155494975|NCT03917654|561236249|FG004|Year 1|Subject moved away from site|0|||
155494976|NCT03917654|561236250|FG005|Year 1|Subject moved away from site|0|||
155494977|NCT03917654|561236251|FG006|Year 1|Subject moved away from site|1|||
155494978|NCT03917654|561236252|FG007|Year 1|Subject moved away from site|2|||
155494979|NCT03917654|561236253|FG008|Year 1|Subject moved away from site|1|||
155494980|NCT03917654|561236254|FG009|Year 1|Subject moved away from site|0|||
155494981|NCT03917654|561236255|FG010|Year 1|Subject moved away from site|0|||
155494982|NCT03917654|561236256|FG011|Year 1|Subject moved away from site|3|||
155494983|NCT03917654|561236245|FG000|Year 1|Spouse/Family member request|0|||
155494984|NCT03917654|561236246|FG001|Year 1|Spouse/Family member request|0|||
155494985|NCT03917654|561236247|FG002|Year 1|Spouse/Family member request|1|||
155494986|NCT03917654|561236248|FG003|Year 1|Spouse/Family member request|0|||
155494987|NCT03917654|561236249|FG004|Year 1|Spouse/Family member request|1|||
155494988|NCT03917654|561236250|FG005|Year 1|Spouse/Family member request|0|||
155494989|NCT03917654|561236251|FG006|Year 1|Spouse/Family member request|0|||
155494990|NCT03917654|561236252|FG007|Year 1|Spouse/Family member request|2|||
155494991|NCT03917654|561236253|FG008|Year 1|Spouse/Family member request|0|||
155494992|NCT03917654|561236254|FG009|Year 1|Spouse/Family member request|0|||
155494993|NCT03917654|561236255|FG010|Year 1|Spouse/Family member request|0|||
155494994|NCT03917654|561236256|FG011|Year 1|Spouse/Family member request|1|||
155494995|NCT03917654|561236245|FG000|Year 1|Death|0|||
155494996|NCT03917654|561236246|FG001|Year 1|Death|0|||
155494997|NCT03917654|561236247|FG002|Year 1|Death|0|||
155494998|NCT03917654|561236248|FG003|Year 1|Death|0|||
155494999|NCT03917654|561236249|FG004|Year 1|Death|0|||
155495000|NCT03917654|561236250|FG005|Year 1|Death|0|||
155495001|NCT03917654|561236251|FG006|Year 1|Death|0|||
155495002|NCT03917654|561236252|FG007|Year 1|Death|0|||
155495003|NCT03917654|561236253|FG008|Year 1|Death|1|||
155495004|NCT03917654|561236254|FG009|Year 1|Death|1|||
155744212|NCT04255394|562161654|FG000|Overall Study|Device removed|2|||
155744213|NCT04255394|562161655|FG001|Overall Study|Device removed|10|||
155744214|NCT04255394|562161654|FG000|Overall Study|Withdrawal by Subject|9|||
155744215|NCT04255394|562161655|FG001|Overall Study|Withdrawal by Subject|8|||
155744216|NCT04255394|562161654|FG000|Overall Study|Screen Failure/Not treated|12|||
155744217|NCT04255394|562161655|FG001|Overall Study|Screen Failure/Not treated|8|||
155495005|NCT03917654|561236255|FG010|Year 1|Death|0|||
155495006|NCT03917654|561236256|FG011|Year 1|Death|0|||
155495007|NCT03917654|561236245|FG000|Year 1|Lost to Follow-up|0|||
155495008|NCT03917654|561236246|FG001|Year 1|Lost to Follow-up|0|||
155495009|NCT03917654|561236247|FG002|Year 1|Lost to Follow-up|0|||
155495010|NCT03917654|561236248|FG003|Year 1|Lost to Follow-up|0|||
155495011|NCT03917654|561236249|FG004|Year 1|Lost to Follow-up|0|||
155495012|NCT03917654|561236250|FG005|Year 1|Lost to Follow-up|0|||
155495013|NCT03917654|561236251|FG006|Year 1|Lost to Follow-up|2|||
155495014|NCT03917654|561236252|FG007|Year 1|Lost to Follow-up|0|||
155495015|NCT03917654|561236253|FG008|Year 1|Lost to Follow-up|0|||
155495016|NCT03917654|561236254|FG009|Year 1|Lost to Follow-up|0|||
155495017|NCT03917654|561236255|FG010|Year 1|Lost to Follow-up|0|||
155495018|NCT03917654|561236256|FG011|Year 1|Lost to Follow-up|0|||
155495019|NCT03917654|561236245|FG000|Year 1|Missed visits|0|||
155495020|NCT03917654|561236246|FG001|Year 1|Missed visits|0|||
155495021|NCT03917654|561236247|FG002|Year 1|Missed visits|0|||
155495022|NCT03917654|561236248|FG003|Year 1|Missed visits|0|||
155495023|NCT03917654|561236249|FG004|Year 1|Missed visits|0|||
155495024|NCT03917654|561236250|FG005|Year 1|Missed visits|0|||
155495025|NCT03917654|561236251|FG006|Year 1|Missed visits|0|||
155495026|NCT03917654|561236252|FG007|Year 1|Missed visits|0|||
155495027|NCT03917654|561236253|FG008|Year 1|Missed visits|0|||
155495028|NCT03917654|561236254|FG009|Year 1|Missed visits|0|||
155495029|NCT03917654|561236255|FG010|Year 1|Missed visits|1|||
155495030|NCT03917654|561236256|FG011|Year 1|Missed visits|1|||
155495031|NCT03917654|561236245|FG000|Year 1|Pregnancy|0|||
155495032|NCT03917654|561236246|FG001|Year 1|Pregnancy|0|||
155495033|NCT03917654|561236247|FG002|Year 1|Pregnancy|0|||
155495034|NCT03917654|561236248|FG003|Year 1|Pregnancy|0|||
155495035|NCT03917654|561236249|FG004|Year 1|Pregnancy|0|||
155495036|NCT03917654|561236250|FG005|Year 1|Pregnancy|0|||
155294344|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
155294345|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
155294346|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155495037|NCT03917654|561236251|FG006|Year 1|Pregnancy|0|||
155495038|NCT03917654|561236252|FG007|Year 1|Pregnancy|1|||
155495039|NCT03917654|561236253|FG008|Year 1|Pregnancy|0|||
155495040|NCT03917654|561236254|FG009|Year 1|Pregnancy|1|||
155495041|NCT03917654|561236255|FG010|Year 1|Pregnancy|0|||
155495042|NCT03917654|561236256|FG011|Year 1|Pregnancy|0|||
155495043|NCT03917654|561236245|FG000|Year 2|Travel|1|||
155495044|NCT03917654|561236246|FG001|Year 2|Travel|0|||
155495045|NCT03917654|561236247|FG002|Year 2|Travel|0|||
155495046|NCT03917654|561236248|FG003|Year 2|Travel|0|||
155744218|NCT04255394|562161654|FG000|Overall Study|Lost to Follow-up|123|||
155744219|NCT04255394|562161655|FG001|Overall Study|Lost to Follow-up|265|||
155744220|NCT04255394|562161654|FG000|Overall Study|Adverse Event|1|||
155744221|NCT04255394|562161655|FG001|Overall Study|Adverse Event|3|||
155495047|NCT03917654|561236249|FG004|Year 2|Travel|1|||
155744222|NCT03612856|562161658|FG000|Pre-dose Period|Physician Decision|0|||
155495048|NCT03917654|561236250|FG005|Year 2|Travel|1|||
155495049|NCT03917654|561236251|FG006|Year 2|Travel|2|||
155495050|NCT03917654|561236252|FG007|Year 2|Travel|1|||
155495051|NCT03917654|561236253|FG008|Year 2|Travel|0|||
155495052|NCT03917654|561236254|FG009|Year 2|Travel|1|||
155495053|NCT03917654|561236255|FG010|Year 2|Travel|0|||
155495054|NCT03917654|561236256|FG011|Year 2|Travel|1|||
155495055|NCT03917654|561236245|FG000|Year 2|Married|1|||
155495056|NCT03917654|561236246|FG001|Year 2|Married|0|||
155495057|NCT03917654|561236247|FG002|Year 2|Married|0|||
155495058|NCT03917654|561236248|FG003|Year 2|Married|0|||
155744223|NCT03612856|562161659|FG001|Pre-dose Period|Physician Decision|1|||
155744224|NCT03612856|562161660|FG002|Pre-dose Period|Physician Decision|1|||
155495059|NCT03917654|561236249|FG004|Year 2|Married|0|||
155495060|NCT03917654|561236250|FG005|Year 2|Married|0|||
155495061|NCT03917654|561236251|FG006|Year 2|Married|1|||
155495062|NCT03917654|561236252|FG007|Year 2|Married|1|||
155495063|NCT03917654|561236253|FG008|Year 2|Married|0|||
155495064|NCT03917654|561236254|FG009|Year 2|Married|0|||
155495065|NCT03917654|561236255|FG010|Year 2|Married|0|||
155495066|NCT03917654|561236256|FG011|Year 2|Married|0|||
155495067|NCT03917654|561236245|FG000|Year 2|Subject moved away from site|1|||
155495068|NCT03917654|561236246|FG001|Year 2|Subject moved away from site|0|||
155495069|NCT03917654|561236247|FG002|Year 2|Subject moved away from site|0|||
155495070|NCT03917654|561236248|FG003|Year 2|Subject moved away from site|0|||
155495071|NCT03917654|561236249|FG004|Year 2|Subject moved away from site|1|||
155495072|NCT03917654|561236250|FG005|Year 2|Subject moved away from site|0|||
155495073|NCT03917654|561236251|FG006|Year 2|Subject moved away from site|2|||
155495074|NCT03917654|561236252|FG007|Year 2|Subject moved away from site|3|||
155495075|NCT03917654|561236253|FG008|Year 2|Subject moved away from site|0|||
155495076|NCT03917654|561236254|FG009|Year 2|Subject moved away from site|2|||
155495077|NCT03917654|561236255|FG010|Year 2|Subject moved away from site|0|||
155495078|NCT03917654|561236256|FG011|Year 2|Subject moved away from site|1|||
155495079|NCT03917654|561236245|FG000|Year 2|Year 2 Screening failure|0|||
155495080|NCT03917654|561236246|FG001|Year 2|Year 2 Screening failure|1|||
155495081|NCT03917654|561236247|FG002|Year 2|Year 2 Screening failure|0|||
155495082|NCT03917654|561236248|FG003|Year 2|Year 2 Screening failure|0|||
155495083|NCT03917654|561236249|FG004|Year 2|Year 2 Screening failure|2|||
155495084|NCT03917654|561236250|FG005|Year 2|Year 2 Screening failure|0|||
155495085|NCT03917654|561236251|FG006|Year 2|Year 2 Screening failure|4|||
155495086|NCT03917654|561236252|FG007|Year 2|Year 2 Screening failure|3|||
155495087|NCT03917654|561236253|FG008|Year 2|Year 2 Screening failure|10|||
155495088|NCT03917654|561236254|FG009|Year 2|Year 2 Screening failure|2|||
155495089|NCT03917654|561236255|FG010|Year 2|Year 2 Screening failure|1|||
155495090|NCT03917654|561236256|FG011|Year 2|Year 2 Screening failure|1|||
155495091|NCT03917654|561236245|FG000|Year 2|Death|0|||
155495092|NCT03917654|561236246|FG001|Year 2|Death|0|||
155495093|NCT03917654|561236247|FG002|Year 2|Death|0|||
155495094|NCT03917654|561236248|FG003|Year 2|Death|0|||
155495095|NCT03917654|561236249|FG004|Year 2|Death|0|||
155495096|NCT03917654|561236250|FG005|Year 2|Death|1|||
155495097|NCT03917654|561236251|FG006|Year 2|Death|0|||
155495098|NCT03917654|561236252|FG007|Year 2|Death|0|||
155495099|NCT03917654|561236253|FG008|Year 2|Death|1|||
155495100|NCT03917654|561236254|FG009|Year 2|Death|1|||
155294347|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
155294348|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294349|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155436045|NCT00077623|561024478|FG001|Overall Study|Failure to return|0|||
155436046|NCT00077623|561024479|FG002|Overall Study|Failure to return|0|||
155436047|NCT01334125|561024480|FG000|Overall Study|Lost to Follow-up|3|||
155436048|NCT01334125|561024481|FG001|Overall Study|Lost to Follow-up|3|||
155436049|NCT02138110|561024485|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
155436050|NCT02138110|561024485|FG000|Overall Scaffold Implantation|Death|3|||
155436051|NCT00882713|561024487|FG000|Overall Study|Adverse Event|2|||
155436052|NCT00882713|561024487|FG000|Overall Study|Death|3|||
155436053|NCT00882713|561024487|FG000|Overall Study|Administrative reasons|4|||
155436054|NCT00882713|561024487|FG000|Overall Study|refused treatment/withdrew consent|4|||
155495101|NCT03917654|561236255|FG010|Year 2|Death|0|||
155495102|NCT03917654|561236256|FG011|Year 2|Death|0|||
155495103|NCT03917654|561236245|FG000|Year 2|Withdrawal by Subject|0|||
155495104|NCT03917654|561236246|FG001|Year 2|Withdrawal by Subject|0|||
155495105|NCT03917654|561236247|FG002|Year 2|Withdrawal by Subject|0|||
155495106|NCT03917654|561236248|FG003|Year 2|Withdrawal by Subject|0|||
155495107|NCT03917654|561236249|FG004|Year 2|Withdrawal by Subject|0|||
155495108|NCT03917654|561236250|FG005|Year 2|Withdrawal by Subject|0|||
155495109|NCT03917654|561236251|FG006|Year 2|Withdrawal by Subject|3|||
155495110|NCT03917654|561236252|FG007|Year 2|Withdrawal by Subject|0|||
155495111|NCT03917654|561236253|FG008|Year 2|Withdrawal by Subject|2|||
155495112|NCT03917654|561236254|FG009|Year 2|Withdrawal by Subject|5|||
155495113|NCT03917654|561236255|FG010|Year 2|Withdrawal by Subject|0|||
155495114|NCT03917654|561236256|FG011|Year 2|Withdrawal by Subject|0|||
155495115|NCT03917654|561236245|FG000|Year 2|Spouse/family member request|0|||
155495116|NCT03917654|561236246|FG001|Year 2|Spouse/family member request|0|||
155495117|NCT03917654|561236247|FG002|Year 2|Spouse/family member request|0|||
155495118|NCT03917654|561236248|FG003|Year 2|Spouse/family member request|0|||
155495119|NCT03917654|561236249|FG004|Year 2|Spouse/family member request|0|||
155495120|NCT03917654|561236250|FG005|Year 2|Spouse/family member request|0|||
155495121|NCT03917654|561236251|FG006|Year 2|Spouse/family member request|1|||
155495122|NCT03917654|561236252|FG007|Year 2|Spouse/family member request|0|||
155495123|NCT03917654|561236253|FG008|Year 2|Spouse/family member request|0|||
155495124|NCT03917654|561236254|FG009|Year 2|Spouse/family member request|0|||
155495125|NCT03917654|561236255|FG010|Year 2|Spouse/family member request|0|||
155495126|NCT03917654|561236256|FG011|Year 2|Spouse/family member request|0|||
155495127|NCT03917654|561236245|FG000|Year 2|Lost to Follow-up|0|||
155495128|NCT03917654|561236246|FG001|Year 2|Lost to Follow-up|0|||
155495129|NCT03917654|561236247|FG002|Year 2|Lost to Follow-up|0|||
155495130|NCT03917654|561236248|FG003|Year 2|Lost to Follow-up|0|||
155495131|NCT03917654|561236249|FG004|Year 2|Lost to Follow-up|0|||
155495132|NCT03917654|561236250|FG005|Year 2|Lost to Follow-up|0|||
155495133|NCT03917654|561236251|FG006|Year 2|Lost to Follow-up|1|||
155495134|NCT03917654|561236252|FG007|Year 2|Lost to Follow-up|0|||
155495135|NCT03917654|561236253|FG008|Year 2|Lost to Follow-up|1|||
155495136|NCT03917654|561236254|FG009|Year 2|Lost to Follow-up|0|||
155495137|NCT03917654|561236255|FG010|Year 2|Lost to Follow-up|0|||
155495138|NCT03917654|561236256|FG011|Year 2|Lost to Follow-up|1|||
155495139|NCT03917654|561236245|FG000|Year 2|Adverse Event|0|||
155495140|NCT03917654|561236246|FG001|Year 2|Adverse Event|0|||
155495141|NCT03917654|561236247|FG002|Year 2|Adverse Event|0|||
155495142|NCT03917654|561236248|FG003|Year 2|Adverse Event|0|||
155495143|NCT03917654|561236249|FG004|Year 2|Adverse Event|0|||
155495144|NCT03917654|561236250|FG005|Year 2|Adverse Event|0|||
155495145|NCT03917654|561236251|FG006|Year 2|Adverse Event|0|||
155495146|NCT03917654|561236252|FG007|Year 2|Adverse Event|0|||
155495147|NCT03917654|561236253|FG008|Year 2|Adverse Event|0|||
155495148|NCT03917654|561236254|FG009|Year 2|Adverse Event|1|||
155495149|NCT03917654|561236255|FG010|Year 2|Adverse Event|0|||
155495150|NCT03917654|561236256|FG011|Year 2|Adverse Event|0|||
155495151|NCT05012943|561236257|FG000|Overall Study|Adverse Event|2|||
155495152|NCT05012943|561236258|FG001|Overall Study|Adverse Event|1|||
155495153|NCT05012943|561236259|FG002|Overall Study|Adverse Event|0|||
155495154|NCT05012943|561236257|FG000|Overall Study|Withdrawal by Subject|1052|||
155495155|NCT05012943|561236258|FG001|Overall Study|Withdrawal by Subject|1006|||
155495156|NCT05012943|561236259|FG002|Overall Study|Withdrawal by Subject|20|||
155495157|NCT05012943|561236257|FG000|Overall Study|Death|25|||
155495158|NCT05012943|561236258|FG001|Overall Study|Death|17|||
155495159|NCT05012943|561236259|FG002|Overall Study|Death|4|||
155294350|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155495160|NCT05012943|561236257|FG000|Overall Study|Lost to Follow-up|11|||
155495161|NCT05012943|561236258|FG001|Overall Study|Lost to Follow-up|24|||
155495162|NCT05012943|561236259|FG002|Overall Study|Lost to Follow-up|3|||
155495163|NCT05012943|561236257|FG000|Overall Study|Physician Decision|1|||
155495164|NCT05012943|561236258|FG001|Overall Study|Physician Decision|1|||
155495165|NCT05012943|561236259|FG002|Overall Study|Physician Decision|0|||
155495166|NCT05012943|561236257|FG000|Overall Study|Other than Specified|2|||
155495167|NCT05012943|561236258|FG001|Overall Study|Other than Specified|1|||
155495168|NCT05012943|561236259|FG002|Overall Study|Other than Specified|0|||
155495169|NCT00400985|561236261|FG000|Overall Study|Withdrawal by Subject|5|||
155495170|NCT00400985|561236261|FG000|Overall Study|system modification|8|||
155495171|NCT00400985|561236261|FG000|Overall Study|Death|30|||
155495172|NCT00400985|561236261|FG000|Overall Study|Lost to Follow-up|9|||
155495173|NCT05048875|561236263|FG000|Overall Study|Withdrawal by Subject|1|||
155495174|NCT05048875|561236264|FG001|Overall Study|Withdrawal by Subject|0|||
155495175|NCT05048875|561236265|FG002|Overall Study|Withdrawal by Subject|0|||
155495176|NCT05048875|561236266|FG003|Overall Study|Withdrawal by Subject|0|||
155495177|NCT05048875|561236267|FG004|Overall Study|Withdrawal by Subject|0|||
155495178|NCT05048875|561236268|FG005|Overall Study|Withdrawal by Subject|0|||
155495179|NCT05048875|561236269|FG006|Overall Study|Withdrawal by Subject|0|||
155495180|NCT05048875|561236270|FG007|Overall Study|Withdrawal by Subject|0|||
155495181|NCT05048875|561236263|FG000|Overall Study|Adverse Event|0|||
155495182|NCT05048875|561236264|FG001|Overall Study|Adverse Event|0|||
155495183|NCT05048875|561236265|FG002|Overall Study|Adverse Event|0|||
155495184|NCT05048875|561236266|FG003|Overall Study|Adverse Event|1|||
155495185|NCT05048875|561236267|FG004|Overall Study|Adverse Event|0|||
155495186|NCT05048875|561236268|FG005|Overall Study|Adverse Event|0|||
155495187|NCT05048875|561236269|FG006|Overall Study|Adverse Event|0|||
155495188|NCT05048875|561236270|FG007|Overall Study|Adverse Event|0|||
155495189|NCT03179462|561236274|FG000|Overall Study|screening failure|1|||
155495190|NCT03179462|561236275|FG001|Overall Study|screening failure|2|||
155495191|NCT03179462|561236276|FG002|Overall Study|screening failure|0|||
155495192|NCT04410978|561236286|FG000|Overall Study|Poor compliance to protocol|2|||
155495193|NCT04410978|561236287|FG001|Overall Study|Poor compliance to protocol|4|||
155495194|NCT04410978|561236286|FG000|Overall Study|Withdrawal by Subject|64|||
155495195|NCT04410978|561236287|FG001|Overall Study|Withdrawal by Subject|66|||
155495196|NCT04410978|561236286|FG000|Overall Study|Other|6|||
155495197|NCT04410978|561236287|FG001|Overall Study|Other|7|||
155495198|NCT04410978|561236286|FG000|Overall Study|Missing study status|1|||
155495199|NCT04410978|561236287|FG001|Overall Study|Missing study status|0|||
155495200|NCT02684162|561236288|FG000|Overall Study|Physician Decision|0|||
155495201|NCT02684162|561236289|FG001|Overall Study|Physician Decision|1|||
155495202|NCT02684162|561236290|FG002|Overall Study|Physician Decision|0|||
155495203|NCT04089566|561236295|FG000|Overall Study|Death|0|||
155495204|NCT04089566|561236296|FG001|Overall Study|Death|6|||
155495205|NCT04089566|561236297|FG002|Overall Study|Death|10|||
155495206|NCT04089566|561236298|FG003|Overall Study|Death|0|||
155495207|NCT04089566|561236299|FG004|Overall Study|Death|0|||
155495208|NCT04089566|561236300|FG005|Overall Study|Death|0|||
155495209|NCT04089566|561236295|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
155495210|NCT04089566|561236296|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
155495211|NCT04089566|561236297|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
155495212|NCT04089566|561236298|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
155495213|NCT04089566|561236299|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
155495214|NCT04089566|561236300|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
155495215|NCT04089566|561236295|FG000|Overall Study|Reason not Specified|0|||
155495216|NCT04089566|561236296|FG001|Overall Study|Reason not Specified|4|||
155495217|NCT04089566|561236297|FG002|Overall Study|Reason not Specified|4|||
155495218|NCT04089566|561236298|FG003|Overall Study|Reason not Specified|1|||
155495219|NCT04089566|561236299|FG004|Overall Study|Reason not Specified|0|||
155495220|NCT04089566|561236300|FG005|Overall Study|Reason not Specified|0|||
155495221|NCT01083121|561236301|FG000|Overall Study|Use of Humira outside the approved label|81|||
155495222|NCT03743571|561236307|FG000|Overall Study|Withdrawal by Subject|1|||
155495223|NCT03743571|561236308|FG001|Overall Study|Withdrawal by Subject|1|||
155495224|NCT03743571|561236307|FG000|Overall Study|Lost to Follow-up|1|||
155495225|NCT03743571|561236308|FG001|Overall Study|Lost to Follow-up|2|||
155495226|NCT04115488|561236309|FG000|Overall Study|Adverse Event|8|||
155495227|NCT04115488|561236310|FG001|Overall Study|Adverse Event|4|||
155495228|NCT04115488|561236309|FG000|Overall Study|Withdrawal by Subject|3|||
155495229|NCT04115488|561236310|FG001|Overall Study|Withdrawal by Subject|6|||
155495230|NCT04115488|561236309|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
155495231|NCT04115488|561236310|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
155495232|NCT04115488|561236309|FG000|Overall Study|Patient 's location change|1|||
155495233|NCT04115488|561236310|FG001|Overall Study|Patient 's location change|0|||
155495234|NCT04115488|561236309|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
155495235|NCT04115488|561236310|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
155495236|NCT00885677|561236311|FG000|Overall Study|Death|40|||
155495237|NCT00885677|561236312|FG001|Overall Study|Death|34|||
155495238|NCT00885677|561236311|FG000|Overall Study|Lost to Follow-up|15|||
155495239|NCT00885677|561236312|FG001|Overall Study|Lost to Follow-up|13|||
155495240|NCT00885677|561236311|FG000|Overall Study|Protocol Violation|54|||
155495241|NCT00885677|561236312|FG001|Overall Study|Protocol Violation|54|||
155495242|NCT00885677|561236311|FG000|Overall Study|premature study closure|41|||
155495243|NCT00885677|561236312|FG001|Overall Study|premature study closure|44|||
155495244|NCT00885677|561236311|FG000|Overall Study|device/lead revision or replacement|7|||
155495245|NCT00885677|561236312|FG001|Overall Study|device/lead revision or replacement|6|||
155495246|NCT00885677|561236311|FG000|Overall Study|Heart transplantation|1|||
155495247|NCT00885677|561236312|FG001|Overall Study|Heart transplantation|0|||
155639147|NCT03608033|561768864|FG001|Treatment Period|Withdrawal by Subject|45|||
155639148|NCT03608033|561768863|FG000|Treatment Period|Study terminated by sponsor|82|||
155639149|NCT03608033|561768864|FG001|Treatment Period|Study terminated by sponsor|68|||
155639150|NCT03608033|561768863|FG000|Treatment Period|Site Terminated by Sponsor|1|||
155639151|NCT03608033|561768864|FG001|Treatment Period|Site Terminated by Sponsor|0|||
155639152|NCT03608033|561768863|FG000|Open-Label Period: OMS721|Adverse Event|1|||
155639153|NCT03608033|561768864|FG001|Open-Label Period: OMS721|Adverse Event|0|||
155639154|NCT03608033|561768863|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
155639155|NCT03608033|561768864|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
155639156|NCT03608033|561768863|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
155639157|NCT03608033|561768864|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
155639158|NCT03608033|561768863|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
155639159|NCT03608033|561768864|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
155639160|NCT03608033|561768863|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
155639161|NCT03608033|561768864|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
155639162|NCT03483012|561768865|FG000|Overall Study|Lack of Efficacy|6|||
155639163|NCT05253807|561768866|FG000|Overall Study|Death|1|||
155639164|NCT05253807|561768867|FG001|Overall Study|Death|4|||
155639165|NCT05253807|561768866|FG000|Overall Study|Withdrawal by Subject|1|||
155639166|NCT05253807|561768867|FG001|Overall Study|Withdrawal by Subject|0|||
155639167|NCT05253807|561768866|FG000|Overall Study|Study Terminated by Sponsor|1|||
155639168|NCT05253807|561768867|FG001|Overall Study|Study Terminated by Sponsor|1|||
155639169|NCT02900976|561768868|FG000|Overall Study|Adverse Event|0|||
155639170|NCT02900976|561768869|FG001|Overall Study|Adverse Event|1|||
155639171|NCT02900976|561768868|FG000|Overall Study|Physician Decision|0|||
155639172|NCT02900976|561768869|FG001|Overall Study|Physician Decision|2|||
155639173|NCT02900976|561768868|FG000|Overall Study|Progressive disease|0|||
155639174|NCT02900976|561768869|FG001|Overall Study|Progressive disease|6|||
155639175|NCT02360579|561768871|FG000|Initial|Death|16|||
155639176|NCT02360579|561768872|FG001|Initial|Death|49|||
155639177|NCT02360579|561768873|FG002|Initial|Death|0|||
155639178|NCT02360579|561768874|FG003|Initial|Death|71|||
155639179|NCT02360579|561768871|FG000|Initial|Lost to Follow-up|0|||
155639180|NCT02360579|561768872|FG001|Initial|Lost to Follow-up|4|||
155639181|NCT02360579|561768873|FG002|Initial|Lost to Follow-up|0|||
155639182|NCT02360579|561768874|FG003|Initial|Lost to Follow-up|1|||
155639183|NCT02360579|561768871|FG000|Initial|Withdrawal by Subject|0|||
155639184|NCT02360579|561768872|FG001|Initial|Withdrawal by Subject|0|||
155639185|NCT02360579|561768873|FG002|Initial|Withdrawal by Subject|0|||
155639186|NCT02360579|561768874|FG003|Initial|Withdrawal by Subject|3|||
155639187|NCT02360579|561768871|FG000|Initial|Other|7|||
155639188|NCT02360579|561768872|FG001|Initial|Other|0|||
155639189|NCT02360579|561768873|FG002|Initial|Other|0|||
155639190|NCT02360579|561768874|FG003|Initial|Other|0|||
155639191|NCT02360579|561768871|FG000|Initial|Did not receive TIL|8|||
155639192|NCT02360579|561768872|FG001|Initial|Did not receive TIL|11|||
155294351|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294352|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155495248|NCT00885677|561236311|FG000|Overall Study|Inclusion/exclusion not met|25|||
155495249|NCT00885677|561236312|FG001|Overall Study|Inclusion/exclusion not met|27|||
155495250|NCT01233284|561236327|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
155495251|NCT01233284|561236328|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155495252|NCT01233284|561236329|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155495253|NCT01233284|561236330|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155495254|NCT01233284|561236331|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155495255|NCT01233284|561236327|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155495256|NCT01233284|561236328|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
155495257|NCT01233284|561236329|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155495258|NCT01233284|561236330|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155495259|NCT01233284|561236331|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155495260|NCT01233284|561236327|FG000|Period 1 (4 Weeks)|Other|0|||
155495261|NCT01233284|561236328|FG001|Period 1 (4 Weeks)|Other|0|||
155495262|NCT01233284|561236329|FG002|Period 1 (4 Weeks)|Other|1|||
155495263|NCT01233284|561236330|FG003|Period 1 (4 Weeks)|Other|0|||
155495264|NCT01233284|561236331|FG004|Period 1 (4 Weeks)|Other|0|||
155495265|NCT01233284|561236327|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155495266|NCT01233284|561236328|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155495267|NCT01233284|561236329|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
155495268|NCT01233284|561236330|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155495269|NCT01233284|561236331|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155495270|NCT01233284|561236327|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155495271|NCT01233284|561236328|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155495272|NCT01233284|561236329|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
155495273|NCT01233284|561236330|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155495274|NCT01233284|561236331|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155495275|NCT01233284|561236327|FG000|Period 3 (4 Weeks)|Other|0|||
155495276|NCT01233284|561236328|FG001|Period 3 (4 Weeks)|Other|0|||
155495277|NCT01233284|561236329|FG002|Period 3 (4 Weeks)|Other|0|||
155495278|NCT01233284|561236330|FG003|Period 3 (4 Weeks)|Other|1|||
155495279|NCT01233284|561236331|FG004|Period 3 (4 Weeks)|Other|0|||
155495280|NCT01233284|561236327|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
155495281|NCT01233284|561236328|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
155495282|NCT01233284|561236329|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
155495283|NCT01233284|561236330|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
155495284|NCT01233284|561236331|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
155495285|NCT01233284|561236327|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
155495286|NCT01233284|561236328|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
155495287|NCT01233284|561236329|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
155495288|NCT01233284|561236330|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
155495289|NCT01233284|561236331|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
155495290|NCT00167414|561236335|FG000|Overall Study|Death|10|||
155495291|NCT01593761|561236336|FG000|Overall Study|Lost to Follow-up|1|||
155495292|NCT01593761|561236336|FG000|Overall Study|culture negative for MRSA at baseline|5|||
155495293|NCT01593761|561236336|FG000|Overall Study|positive for hepatitis C virus|1|||
155495294|NCT01593761|561236336|FG000|Overall Study|secondary cellulitis|1|||
155495295|NCT00795886|561236337|FG000|Overall Study|Death|10|||
155495296|NCT05554471|561236338|FG000|Overall Study|Physician Decision|2|||
155495297|NCT05554471|561236339|FG001|Overall Study|Physician Decision|1|||
155495298|NCT05554471|561236338|FG000|Overall Study|Lost to Follow-up|2|||
155495299|NCT05554471|561236339|FG001|Overall Study|Lost to Follow-up|1|||
155495300|NCT05554471|561236338|FG000|Overall Study|Death|0|||
155495301|NCT05554471|561236339|FG001|Overall Study|Death|1|||
155495302|NCT04814654|561236340|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
155495303|NCT04814654|561236341|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
155495304|NCT04814654|561236342|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
155495305|NCT03505606|561237771|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
155495306|NCT03505606|561237772|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
155495307|NCT03505606|561237773|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
155495308|NCT03505606|561237771|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
155495309|NCT03505606|561237772|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
155495310|NCT03505606|561237773|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
155639193|NCT02360579|561768873|FG002|Initial|Did not receive TIL|0|||
155639194|NCT02360579|561768874|FG003|Initial|Did not receive TIL|22|||
155639195|NCT02360579|561768871|FG000|Retreatment|Death|0|||
155639196|NCT02360579|561768872|FG001|Retreatment|Death|0|||
155639197|NCT02360579|561768873|FG002|Retreatment|Death|11|||
155639198|NCT02360579|561768874|FG003|Retreatment|Death|0|||
155639199|NCT03682848|561768881|FG000|Overall Study|Withdrawal by Subject|3|||
155639200|NCT03682848|561768881|FG000|Overall Study|Site closed|5|||
155639201|NCT03682848|561768881|FG000|Overall Study|Protocol Deviation|1|||
155639202|NCT03682848|561768881|FG000|Overall Study|Adverse Event|2|||
155639203|NCT03682848|561768881|FG000|Overall Study|Lack of Efficacy|1|||
155639204|NCT00143507|561770396|FG000|Overall Study|Death|572|||
155639205|NCT00143507|561770397|FG001|Overall Study|Death|547|||
155639206|NCT00143507|561770396|FG000|Overall Study|Withdrawal by Subject|114|||
155639207|NCT00143507|561770397|FG001|Overall Study|Withdrawal by Subject|102|||
155639208|NCT00143507|561770396|FG000|Overall Study|Lost to Follow-up|1|||
155639209|NCT00143507|561770397|FG001|Overall Study|Lost to Follow-up|0|||
155639210|NCT00143507|561770396|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
155639211|NCT00143507|561770397|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
155639212|NCT00690898|561770398|FG000|SCREENING|Screen failure|18|||
155639213|NCT00690898|561770398|FG000|TREATMENT|Adverse Event|3|||
155639214|NCT00690898|561770398|FG000|TREATMENT|Lack of Efficacy|18|||
155639215|NCT00690898|561770398|FG000|TREATMENT|Withdrawal by Subject|4|||
155639216|NCT00690898|561770398|FG000|TREATMENT|Other (not otherwise specified)|1|||
155639217|NCT05977868|561770399|FG000|Overall Study|Withdrawal by Subject|1|||
155639218|NCT05977868|561770400|FG001|Overall Study|Withdrawal by Subject|2|||
155639219|NCT05977868|561770399|FG000|Overall Study|Transitioned to comfort care|1|||
155639220|NCT05977868|561770400|FG001|Overall Study|Transitioned to comfort care|0|||
155639221|NCT01991314|561770425|FG000|Overall Study|Adverse Event|5|||
155639222|NCT01991314|561770426|FG001|Overall Study|Adverse Event|1|||
155639223|NCT01991314|561770425|FG000|Overall Study|Lost to Follow-up|6|||
155639224|NCT01991314|561770426|FG001|Overall Study|Lost to Follow-up|10|||
155639225|NCT00970944|561770428|FG000|Overall Study|Death|1|||
155639226|NCT00970944|561770429|FG001|Overall Study|Death|0|||
155639227|NCT00970944|561770428|FG000|Overall Study|Physician Decision|0|||
155639228|NCT00970944|561770429|FG001|Overall Study|Physician Decision|2|||
155639229|NCT02008370|561770430|FG000|Overall Study|Lost to Follow-up|7|||
155639230|NCT00972738|561770431|FG000|Overall Study|Adverse Event|7|||
155639231|NCT00972738|561770432|FG001|Overall Study|Adverse Event|1|||
155639232|NCT00972738|561770433|FG002|Overall Study|Adverse Event|8|||
155639233|NCT00972738|561770431|FG000|Overall Study|Protocol Violation|2|||
155639234|NCT00972738|561770432|FG001|Overall Study|Protocol Violation|1|||
155639235|NCT00972738|561770433|FG002|Overall Study|Protocol Violation|3|||
155639236|NCT00972738|561770431|FG000|Overall Study|Lost to Follow-up|1|||
155294353|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294354|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294355|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294356|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
155639237|NCT00972738|561770432|FG001|Overall Study|Lost to Follow-up|0|||
155639238|NCT00972738|561770433|FG002|Overall Study|Lost to Follow-up|1|||
155639239|NCT00972738|561770431|FG000|Overall Study|Lack of Efficacy|5|||
155639240|NCT00972738|561770432|FG001|Overall Study|Lack of Efficacy|1|||
155639241|NCT00972738|561770433|FG002|Overall Study|Lack of Efficacy|11|||
155639242|NCT00972738|561770431|FG000|Overall Study|Withdrawal by Subject|5|||
155639243|NCT00972738|561770432|FG001|Overall Study|Withdrawal by Subject|1|||
155639244|NCT00972738|561770433|FG002|Overall Study|Withdrawal by Subject|4|||
155639245|NCT00972738|561770431|FG000|Overall Study|Moved|0|||
155639246|NCT00972738|561770432|FG001|Overall Study|Moved|0|||
155639247|NCT00972738|561770433|FG002|Overall Study|Moved|1|||
155639248|NCT00972738|561770431|FG000|Overall Study|Other|1|||
155639249|NCT00972738|561770432|FG001|Overall Study|Other|2|||
155639250|NCT00972738|561770433|FG002|Overall Study|Other|1|||
155639251|NCT03915067|561770434|FG000|Overall Study|Adverse Event|0|||
155639252|NCT03915067|561770435|FG001|Overall Study|Adverse Event|0|||
155639253|NCT03915067|561770436|FG002|Overall Study|Adverse Event|1|||
155639254|NCT03915067|561770434|FG000|Overall Study|Withdrawal by Subject|4|||
155639255|NCT03915067|561770435|FG001|Overall Study|Withdrawal by Subject|3|||
155639256|NCT03915067|561770436|FG002|Overall Study|Withdrawal by Subject|0|||
155639257|NCT03915067|561770434|FG000|Overall Study|Lost to Follow-up|3|||
155639258|NCT03915067|561770435|FG001|Overall Study|Lost to Follow-up|2|||
155639259|NCT03915067|561770436|FG002|Overall Study|Lost to Follow-up|0|||
155639260|NCT03915067|561770434|FG000|Overall Study|Protocol Deviation|0|||
155639261|NCT03915067|561770435|FG001|Overall Study|Protocol Deviation|0|||
155639262|NCT03915067|561770436|FG002|Overall Study|Protocol Deviation|1|||
155639263|NCT03915067|561770434|FG000|Overall Study|Covid-19 Related Issues|2|||
155639264|NCT03915067|561770435|FG001|Overall Study|Covid-19 Related Issues|4|||
155639265|NCT03915067|561770436|FG002|Overall Study|Covid-19 Related Issues|4|||
155639266|NCT03915067|561770434|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
155639267|NCT03915067|561770435|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
155639268|NCT03915067|561770436|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
155639269|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
155639270|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
155639271|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
155639272|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
155639273|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
155639274|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155639275|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
155639276|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155639277|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155639278|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155639279|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Death|0|||
155639280|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Death|0|||
155639281|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Death|1|||
155639282|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Death|0|||
155639283|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Death|0|||
155639284|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
155639285|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
155639286|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
155639287|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
155639288|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
155639289|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Other|2|||
155639290|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Other|1|||
155639291|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Other|0|||
155495311|NCT03505606|561237771|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
155495312|NCT03505606|561237772|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
155495313|NCT03505606|561237773|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
155495314|NCT03505606|561237771|FG000|Overall Study|Poor compliance with refractive correction|0|||
155495315|NCT03505606|561237772|FG001|Overall Study|Poor compliance with refractive correction|0|||
155495316|NCT03505606|561237773|FG002|Overall Study|Poor compliance with refractive correction|1|||
155495317|NCT03505606|561237771|FG000|Overall Study|Insufficient anisometropia|0|||
155495318|NCT03505606|561237772|FG001|Overall Study|Insufficient anisometropia|0|||
155495319|NCT03505606|561237773|FG002|Overall Study|Insufficient anisometropia|2|||
155294357|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
155294358|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294359|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294360|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294361|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294362|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294363|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294364|NCT00573833|560505077|FG000|Overall Study|Not Treated|2|||
155495320|NCT03505606|561237771|FG000|Overall Study|Ectopia Lentis|0|||
155495321|NCT03505606|561237772|FG001|Overall Study|Ectopia Lentis|0|||
155495322|NCT03505606|561237773|FG002|Overall Study|Ectopia Lentis|1|||
155495323|NCT03505606|561237771|FG000|Overall Study|alternation of amblyopic eye|0|||
155495324|NCT03505606|561237772|FG001|Overall Study|alternation of amblyopic eye|1|||
155495325|NCT03505606|561237773|FG002|Overall Study|alternation of amblyopic eye|0|||
155495326|NCT02087865|561237776|FG000|Overall Study|Withdrawal by Subject|6|||
155495327|NCT02087865|561237777|FG001|Overall Study|Withdrawal by Subject|0|||
155495328|NCT02087865|561237778|FG002|Overall Study|Withdrawal by Subject|1|||
155495329|NCT02087865|561237776|FG000|Overall Study|Lost to Follow-up|0|||
155495330|NCT02087865|561237777|FG001|Overall Study|Lost to Follow-up|0|||
155495331|NCT02087865|561237778|FG002|Overall Study|Lost to Follow-up|1|||
155495332|NCT02087865|561237776|FG000|Overall Study|Drug Non-compliance|0|||
155495333|NCT02087865|561237777|FG001|Overall Study|Drug Non-compliance|2|||
155495334|NCT02087865|561237778|FG002|Overall Study|Drug Non-compliance|0|||
155495335|NCT02087865|561237776|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
155495336|NCT02087865|561237777|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
155495337|NCT02087865|561237778|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
155495338|NCT01319994|561237779|FG000|Overall Study|Protocol Violation|7|||
155495339|NCT01319994|561237780|FG001|Overall Study|Protocol Violation|6|||
155495340|NCT01340794|561237781|FG000|Overall Study|Withdrawal by Subject|0|||
155495341|NCT01340794|561237782|FG001|Overall Study|Withdrawal by Subject|1|||
155495342|NCT02674568|561237791|FG000|Overall Study|Withdrawal by Subject|5|||
155495343|NCT02674568|561237791|FG000|Overall Study|Death|303|||
155495344|NCT02674568|561237791|FG000|Overall Study|Physician Decision|2|||
155495345|NCT02674568|561237791|FG000|Overall Study|Lost to Follow-up|9|||
155495346|NCT02674568|561237791|FG000|Overall Study|Other, Not Specified|20|||
155495347|NCT01808508|561237794|FG000|Overall Study|Lost to Follow-up|1|||
155495348|NCT01808508|561237795|FG001|Overall Study|Lost to Follow-up|0|||
155495349|NCT01808508|561237796|FG002|Overall Study|Lost to Follow-up|0|||
155495350|NCT01118949|561237797|FG000|Overall Study|Adverse Event|5|||
155495351|NCT01118949|561237797|FG000|Overall Study|Withdrawal by Subject|4|||
155495352|NCT01017731|561237798|FG000|Overall Study|Lost to Follow-up|2|||
155495353|NCT01017731|561237798|FG000|Overall Study|Withdrawal by Subject|3|||
155495354|NCT01017731|561237798|FG000|Overall Study|Physician Decision|2|||
155495355|NCT01017731|561237798|FG000|Overall Study|Adverse Event|1|||
155495356|NCT00685763|561237799|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
155495357|NCT00685763|561237799|FG000|Overall Study|Protocol Violation|1|||
155495358|NCT00929201|561237806|FG000|Period 1|Withdrawal by Subject|0|||
155495359|NCT00929201|561237807|FG001|Period 1|Withdrawal by Subject|1|||
155294365|NCT05052983|560505078|FG000|Overall Study|Lack of Efficacy|3|||
155294366|NCT05052983|560505079|FG001|Overall Study|Lack of Efficacy|12|||
155294367|NCT05052983|560505078|FG000|Overall Study|Adverse Event|1|||
155294368|NCT05052983|560505079|FG001|Overall Study|Adverse Event|0|||
155495360|NCT03606109|561237811|FG000|Overall Study|Lost to Follow-up|2|||
155294369|NCT01070888|560507320|FG000|First Intervention (14 Days)|Adverse Event|0|||
155294370|NCT01070888|560507321|FG001|First Intervention (14 Days)|Adverse Event|1|||
155495361|NCT03606109|561237812|FG001|Overall Study|Lost to Follow-up|1|||
155495362|NCT03286426|561237817|FG000|Overall Study|Physician Decision|3|||
155495363|NCT01817764|561237818|FG000|Overall Study|Adverse Event|7|||
155495364|NCT01817764|561237819|FG001|Overall Study|Adverse Event|10|||
155495365|NCT01817764|561237818|FG000|Overall Study|Lack of Efficacy|9|||
155495366|NCT01817764|561237819|FG001|Overall Study|Lack of Efficacy|7|||
155495367|NCT01817764|561237818|FG000|Overall Study|Protocol Violation|7|||
155495368|NCT01817764|561237819|FG001|Overall Study|Protocol Violation|5|||
155639292|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Other|0|||
155639293|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Other|0|||
155639294|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155639295|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155639296|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
155639297|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155639298|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155639299|NCT03317496|561770437|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155639300|NCT03317496|561770438|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
155639301|NCT03317496|561770439|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155639302|NCT03317496|561770440|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
155495369|NCT01817764|561237818|FG000|Overall Study|Lost to Follow-up|1|||
155495370|NCT01817764|561237819|FG001|Overall Study|Lost to Follow-up|4|||
155495371|NCT01817764|561237818|FG000|Overall Study|Withdrawal by Subject|10|||
155495372|NCT01817764|561237819|FG001|Overall Study|Withdrawal by Subject|12|||
155495373|NCT04292171|561237820|FG000|Overall Study|Pharmacy error|2|||
155495374|NCT04292171|561237821|FG001|Overall Study|Pharmacy error|0|||
155495375|NCT04292171|561237820|FG000|Overall Study|Delivered prior to procedure|0|||
155495376|NCT04292171|561237821|FG001|Overall Study|Delivered prior to procedure|1|||
155495377|NCT04633434|561237822|FG000|Overall Study|Lost to Follow-up|32|||
155495378|NCT04633434|561237823|FG001|Overall Study|Lost to Follow-up|32|||
155495379|NCT00471237|561237825|FG000|Overall Study|Adverse Event|6|||
155495380|NCT00471237|561237826|FG001|Overall Study|Adverse Event|5|||
155495381|NCT00471237|561237827|FG002|Overall Study|Adverse Event|4|||
155495382|NCT00471237|561237828|FG003|Overall Study|Adverse Event|8|||
155495383|NCT00471237|561237829|FG004|Overall Study|Adverse Event|7|||
155495384|NCT00471237|561237830|FG005|Overall Study|Adverse Event|5|||
155495385|NCT00471237|561237831|FG006|Overall Study|Adverse Event|0|||
155495386|NCT00471237|561237825|FG000|Overall Study|Lost to Follow-up|1|||
155495387|NCT00471237|561237826|FG001|Overall Study|Lost to Follow-up|1|||
155495388|NCT00471237|561237827|FG002|Overall Study|Lost to Follow-up|0|||
155495389|NCT00471237|561237828|FG003|Overall Study|Lost to Follow-up|2|||
155495390|NCT00471237|561237829|FG004|Overall Study|Lost to Follow-up|3|||
155495391|NCT00471237|561237830|FG005|Overall Study|Lost to Follow-up|0|||
155495392|NCT00471237|561237831|FG006|Overall Study|Lost to Follow-up|0|||
155495393|NCT00471237|561237825|FG000|Overall Study|Protocol Violation|3|||
155495394|NCT00471237|561237826|FG001|Overall Study|Protocol Violation|6|||
155495395|NCT00471237|561237827|FG002|Overall Study|Protocol Violation|3|||
155495396|NCT00471237|561237828|FG003|Overall Study|Protocol Violation|2|||
155495397|NCT00471237|561237829|FG004|Overall Study|Protocol Violation|2|||
155495398|NCT00471237|561237830|FG005|Overall Study|Protocol Violation|4|||
155495399|NCT00471237|561237831|FG006|Overall Study|Protocol Violation|1|||
155495400|NCT00471237|561237825|FG000|Overall Study|Withdrawal by Subject|8|||
155495401|NCT00471237|561237826|FG001|Overall Study|Withdrawal by Subject|6|||
155495402|NCT00471237|561237827|FG002|Overall Study|Withdrawal by Subject|5|||
155294371|NCT01070888|560507320|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
155294372|NCT01070888|560507321|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
155294373|NCT01070888|560507320|FG000|Washout (14 Days)|Physician Decision|1|||
155495403|NCT00471237|561237828|FG003|Overall Study|Withdrawal by Subject|8|||
155495404|NCT00471237|561237829|FG004|Overall Study|Withdrawal by Subject|7|||
155495405|NCT00471237|561237830|FG005|Overall Study|Withdrawal by Subject|4|||
155495406|NCT00471237|561237831|FG006|Overall Study|Withdrawal by Subject|2|||
155495407|NCT00471237|561237825|FG000|Overall Study|Sponsor terminated study|20|||
155495408|NCT00471237|561237826|FG001|Overall Study|Sponsor terminated study|23|||
155495409|NCT00471237|561237827|FG002|Overall Study|Sponsor terminated study|19|||
155495410|NCT00471237|561237828|FG003|Overall Study|Sponsor terminated study|22|||
155495411|NCT00471237|561237829|FG004|Overall Study|Sponsor terminated study|18|||
155436055|NCT00882713|561024487|FG000|Overall Study|Blood transfusion|2|||
155436056|NCT00882713|561024487|FG000|Overall Study|Insufficient therapeutic response|3|||
155436057|NCT00882713|561024487|FG000|Overall Study|Failure to return|2|||
155436058|NCT00882713|561024487|FG000|Overall Study|Other - Reasons|2|||
155436059|NCT00401973|561024490|FG000|Overall Study|Adverse Event|2|||
155436060|NCT00401973|561024491|FG001|Overall Study|Adverse Event|8|||
155436061|NCT00401973|561024492|FG002|Overall Study|Adverse Event|4|||
155436062|NCT00401973|561024490|FG000|Overall Study|Clinical Relapse|0|||
155436063|NCT00401973|561024491|FG001|Overall Study|Clinical Relapse|1|||
155436064|NCT00401973|561024492|FG002|Overall Study|Clinical Relapse|1|||
155436065|NCT00401973|561024490|FG000|Overall Study|Lack of Efficacy|0|||
155436066|NCT00401973|561024491|FG001|Overall Study|Lack of Efficacy|0|||
155436067|NCT00401973|561024492|FG002|Overall Study|Lack of Efficacy|3|||
155436068|NCT00401973|561024490|FG000|Overall Study|Lost to Follow-up|2|||
155436069|NCT00401973|561024491|FG001|Overall Study|Lost to Follow-up|2|||
155436070|NCT00401973|561024492|FG002|Overall Study|Lost to Follow-up|2|||
155436071|NCT00401973|561024490|FG000|Overall Study|Physician Decision|2|||
155436072|NCT00401973|561024491|FG001|Overall Study|Physician Decision|0|||
155436073|NCT00401973|561024492|FG002|Overall Study|Physician Decision|1|||
155436074|NCT00401973|561024490|FG000|Overall Study|Protocol Violation|1|||
155436075|NCT00401973|561024491|FG001|Overall Study|Protocol Violation|2|||
155436076|NCT00401973|561024492|FG002|Overall Study|Protocol Violation|3|||
155436077|NCT00401973|561024490|FG000|Overall Study|Sponsor Decision|0|||
155436078|NCT00401973|561024491|FG001|Overall Study|Sponsor Decision|1|||
155436079|NCT00401973|561024492|FG002|Overall Study|Sponsor Decision|0|||
155436080|NCT00401973|561024490|FG000|Overall Study|Withdrawal by Subject|4|||
155436081|NCT00401973|561024491|FG001|Overall Study|Withdrawal by Subject|12|||
155436082|NCT00401973|561024492|FG002|Overall Study|Withdrawal by Subject|9|||
155436083|NCT01335971|561024505|FG000|Overall Study|Withdrawal by Subject|1|||
155436084|NCT01335971|561024506|FG001|Overall Study|Withdrawal by Subject|0|||
155436085|NCT01335971|561024507|FG002|Overall Study|Withdrawal by Subject|0|||
155436086|NCT01335971|561024505|FG000|Overall Study|Did not complete bronchoscopy|1|||
155436087|NCT01335971|561024506|FG001|Overall Study|Did not complete bronchoscopy|1|||
155436088|NCT01335971|561024507|FG002|Overall Study|Did not complete bronchoscopy|1|||
155436089|NCT05299892|561024508|FG000|Overall Study|Withdrawal by Subject|2|||
155436090|NCT01059812|561024509|FG000|Overall Study|Adverse Event|9|||
155436091|NCT01059812|561024510|FG001|Overall Study|Adverse Event|5|||
155436092|NCT01059812|561024509|FG000|Overall Study|Lack of Efficacy|2|||
155436093|NCT01059812|561024510|FG001|Overall Study|Lack of Efficacy|2|||
155436094|NCT01059812|561024509|FG000|Overall Study|Protocol Violation|3|||
155294374|NCT01070888|560507321|FG001|Washout (14 Days)|Physician Decision|0|||
155495412|NCT00471237|561237830|FG005|Overall Study|Sponsor terminated study|24|||
155495413|NCT00471237|561237831|FG006|Overall Study|Sponsor terminated study|0|||
155495414|NCT00471237|561237825|FG000|Overall Study|Non-compliance|0|||
155495415|NCT00471237|561237826|FG001|Overall Study|Non-compliance|1|||
155495416|NCT00471237|561237827|FG002|Overall Study|Non-compliance|0|||
155495417|NCT00471237|561237828|FG003|Overall Study|Non-compliance|1|||
155495418|NCT00471237|561237829|FG004|Overall Study|Non-compliance|0|||
155495419|NCT00471237|561237830|FG005|Overall Study|Non-compliance|0|||
155495420|NCT00471237|561237831|FG006|Overall Study|Non-compliance|0|||
155495421|NCT00471237|561237825|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
155495422|NCT00471237|561237826|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
155495423|NCT00471237|561237827|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
155495424|NCT00471237|561237828|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
155495425|NCT00471237|561237829|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
155495426|NCT00471237|561237830|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
155495427|NCT00471237|561237831|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
155495428|NCT00471237|561237825|FG000|Overall Study|Early stopping due to non-efficacy|1|||
155495429|NCT00471237|561237826|FG001|Overall Study|Early stopping due to non-efficacy|0|||
155495430|NCT00471237|561237827|FG002|Overall Study|Early stopping due to non-efficacy|0|||
155495431|NCT00471237|561237828|FG003|Overall Study|Early stopping due to non-efficacy|0|||
155495432|NCT00471237|561237829|FG004|Overall Study|Early stopping due to non-efficacy|1|||
155495433|NCT00471237|561237830|FG005|Overall Study|Early stopping due to non-efficacy|0|||
155495434|NCT00471237|561237831|FG006|Overall Study|Early stopping due to non-efficacy|0|||
155495435|NCT00471237|561237825|FG000|Overall Study|Participant planned to travel to abraod|1|||
155495436|NCT00471237|561237826|FG001|Overall Study|Participant planned to travel to abraod|0|||
155495437|NCT00471237|561237827|FG002|Overall Study|Participant planned to travel to abraod|0|||
155495438|NCT00471237|561237828|FG003|Overall Study|Participant planned to travel to abraod|0|||
155495439|NCT00471237|561237829|FG004|Overall Study|Participant planned to travel to abraod|0|||
155495440|NCT00471237|561237830|FG005|Overall Study|Participant planned to travel to abraod|1|||
155495441|NCT00471237|561237831|FG006|Overall Study|Participant planned to travel to abraod|0|||
155495442|NCT00471237|561237825|FG000|Overall Study|High parathyroid hormone|0|||
155495443|NCT00471237|561237826|FG001|Overall Study|High parathyroid hormone|0|||
155495444|NCT00471237|561237827|FG002|Overall Study|High parathyroid hormone|1|||
155495445|NCT00471237|561237828|FG003|Overall Study|High parathyroid hormone|0|||
155495446|NCT00471237|561237829|FG004|Overall Study|High parathyroid hormone|0|||
155495447|NCT00471237|561237830|FG005|Overall Study|High parathyroid hormone|0|||
155495448|NCT00471237|561237831|FG006|Overall Study|High parathyroid hormone|0|||
155495449|NCT00471237|561237825|FG000|Overall Study|Participant lost medication|0|||
155495450|NCT00471237|561237826|FG001|Overall Study|Participant lost medication|0|||
155495451|NCT00471237|561237827|FG002|Overall Study|Participant lost medication|0|||
155495452|NCT00471237|561237828|FG003|Overall Study|Participant lost medication|0|||
155495453|NCT00471237|561237829|FG004|Overall Study|Participant lost medication|1|||
155495454|NCT00471237|561237830|FG005|Overall Study|Participant lost medication|0|||
155495455|NCT00471237|561237831|FG006|Overall Study|Participant lost medication|0|||
155495456|NCT00471237|561237825|FG000|Overall Study|Administration of prohibited medicine|0|||
155495457|NCT00471237|561237826|FG001|Overall Study|Administration of prohibited medicine|0|||
155495458|NCT00471237|561237827|FG002|Overall Study|Administration of prohibited medicine|0|||
155495459|NCT00471237|561237828|FG003|Overall Study|Administration of prohibited medicine|0|||
155495460|NCT00471237|561237829|FG004|Overall Study|Administration of prohibited medicine|1|||
155495461|NCT00471237|561237830|FG005|Overall Study|Administration of prohibited medicine|0|||
155495462|NCT00471237|561237831|FG006|Overall Study|Administration of prohibited medicine|0|||
155495463|NCT00471237|561237825|FG000|Overall Study|Participant shifted residence|0|||
155495464|NCT00471237|561237826|FG001|Overall Study|Participant shifted residence|0|||
155495465|NCT00471237|561237827|FG002|Overall Study|Participant shifted residence|0|||
155495466|NCT00471237|561237828|FG003|Overall Study|Participant shifted residence|0|||
155495467|NCT00471237|561237829|FG004|Overall Study|Participant shifted residence|1|||
155495468|NCT00471237|561237830|FG005|Overall Study|Participant shifted residence|0|||
155495469|NCT00471237|561237831|FG006|Overall Study|Participant shifted residence|0|||
155744225|NCT03612856|562161658|FG000|Pre-dose Period|Withdrawal by Subject|0|||
155744226|NCT03612856|562161659|FG001|Pre-dose Period|Withdrawal by Subject|1|||
155744227|NCT03612856|562161660|FG002|Pre-dose Period|Withdrawal by Subject|0|||
155744228|NCT01181986|562161661|FG000|Phase 1|Lost to Follow-up|0|||
155744229|NCT01181986|562161662|FG001|Phase 1|Lost to Follow-up|1|||
155744230|NCT01181986|562161663|FG002|Phase 1|Lost to Follow-up|1|||
155744231|NCT01181986|562161661|FG000|Phase 1|Adverse Event|0|||
155744232|NCT01181986|562161662|FG001|Phase 1|Adverse Event|0|||
155744233|NCT01181986|562161663|FG002|Phase 1|Adverse Event|1|||
155294375|NCT02631148|560507322|FG000|Overall Study|8 were ineligible|8|||
155744234|NCT01181986|562161661|FG000|Phase 1|Protocol Violation|1|||
155744235|NCT01181986|562161662|FG001|Phase 1|Protocol Violation|0|||
155744236|NCT01181986|562161663|FG002|Phase 1|Protocol Violation|0|||
155744237|NCT01181986|562161661|FG000|Phase 2|Adverse Event|0|||
155495470|NCT00471237|561237825|FG000|Overall Study|Participant's decision|0|||
155495471|NCT00471237|561237826|FG001|Overall Study|Participant's decision|0|||
155495472|NCT00471237|561237827|FG002|Overall Study|Participant's decision|0|||
155495473|NCT00471237|561237828|FG003|Overall Study|Participant's decision|0|||
155495474|NCT00471237|561237829|FG004|Overall Study|Participant's decision|0|||
155495475|NCT00471237|561237830|FG005|Overall Study|Participant's decision|1|||
155495476|NCT00471237|561237831|FG006|Overall Study|Participant's decision|0|||
155495477|NCT00848965|561237832|FG000|Overall Study|Adverse Event|1|||
155495478|NCT00848965|561237832|FG000|Overall Study|Withdrawal by Subject|1|||
155495479|NCT02329834|561237833|FG000|Overall Study|Physician Decision|1|||
155495480|NCT02329834|561237834|FG001|Overall Study|Physician Decision|0|||
155744238|NCT01181986|562161662|FG001|Phase 2|Adverse Event|3|||
155744239|NCT01181986|562161663|FG002|Phase 2|Adverse Event|0|||
155744240|NCT01181986|562161661|FG000|Phase 2|Medical condition|0|||
155744241|NCT01181986|562161662|FG001|Phase 2|Medical condition|1|||
155744242|NCT01181986|562161663|FG002|Phase 2|Medical condition|0|||
155744243|NCT00831493|562161665|FG000|Overall Study|Intractable nausea and vomiting|1|||
155495481|NCT00578448|561237835|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
155495482|NCT00578448|561237835|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
155495483|NCT00578448|561237835|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
155495484|NCT00578448|561237835|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
155744244|NCT03658876|562163599|FG000|Overall Study|Protocol Violation|3|||
155744245|NCT03658876|562163600|FG001|Overall Study|Protocol Violation|2|||
155744246|NCT03658876|562163599|FG000|Overall Study|Withdrawal by Subject|2|||
155744247|NCT03658876|562163600|FG001|Overall Study|Withdrawal by Subject|0|||
155744248|NCT03658876|562163599|FG000|Overall Study|Death|0|||
155744249|NCT03658876|562163600|FG001|Overall Study|Death|1|||
155744250|NCT03658876|562163599|FG000|Overall Study|Intercurrent illness|6|||
155744251|NCT03658876|562163600|FG001|Overall Study|Intercurrent illness|4|||
155495485|NCT01976104|561237836|FG000|Overall Study|Adverse Event|0|||
155495486|NCT01976104|561237837|FG001|Overall Study|Adverse Event|0|||
155495487|NCT01976104|561237838|FG002|Overall Study|Adverse Event|1|||
155495488|NCT01976104|561237839|FG003|Overall Study|Adverse Event|0|||
155495489|NCT01976104|561237836|FG000|Overall Study|Lost to Follow-up|3|||
155495490|NCT01976104|561237837|FG001|Overall Study|Lost to Follow-up|0|||
155495491|NCT01976104|561237838|FG002|Overall Study|Lost to Follow-up|1|||
155495492|NCT01976104|561237839|FG003|Overall Study|Lost to Follow-up|1|||
155495493|NCT01976104|561237836|FG000|Overall Study|Subject Choice|0|||
155495494|NCT01976104|561237837|FG001|Overall Study|Subject Choice|1|||
155495495|NCT01976104|561237838|FG002|Overall Study|Subject Choice|0|||
155495496|NCT01976104|561237839|FG003|Overall Study|Subject Choice|1|||
155495497|NCT01976104|561237836|FG000|Overall Study|Withdrawal by Subject|3|||
155495498|NCT01976104|561237837|FG001|Overall Study|Withdrawal by Subject|0|||
155495499|NCT01976104|561237838|FG002|Overall Study|Withdrawal by Subject|0|||
155495500|NCT01976104|561237839|FG003|Overall Study|Withdrawal by Subject|1|||
155495501|NCT01976104|561237836|FG000|Overall Study|Other|0|||
155495502|NCT01976104|561237837|FG001|Overall Study|Other|1|||
155495503|NCT01976104|561237838|FG002|Overall Study|Other|0|||
155495504|NCT01976104|561237839|FG003|Overall Study|Other|0|||
155495505|NCT03237325|561237848|FG000|Overall Study|Lost to Follow-up|3|||
155495506|NCT03237325|561237849|FG001|Overall Study|Lost to Follow-up|5|||
155495507|NCT03237325|561237848|FG000|Overall Study|Physician Decision|2|||
155495508|NCT03237325|561237849|FG001|Overall Study|Physician Decision|4|||
155495509|NCT03237325|561237848|FG000|Overall Study|Withdrawal by Subject|9|||
155744252|NCT03658876|562163599|FG000|Overall Study|Transplantation/other operation|1|||
155744253|NCT03658876|562163600|FG001|Overall Study|Transplantation/other operation|5|||
155744254|NCT00576420|562163601|FG000|Overall Study|Death|0|||
155744255|NCT00576420|562163602|FG001|Overall Study|Death|0|||
155744256|NCT00576420|562163603|FG002|Overall Study|Death|1|||
155744257|NCT02616146|562163604|FG000|Overall Study|Adverse Event|64|||
155744258|NCT02616146|562163605|FG001|Overall Study|Adverse Event|24|||
155495510|NCT03237325|561237849|FG001|Overall Study|Withdrawal by Subject|12|||
155744259|NCT02616146|562163604|FG000|Overall Study|Lost to Follow-up|23|||
155744260|NCT02616146|562163605|FG001|Overall Study|Lost to Follow-up|13|||
155744261|NCT02616146|562163604|FG000|Overall Study|Non-compliance with study protocol|2|||
155744262|NCT02616146|562163605|FG001|Overall Study|Non-compliance with study protocol|0|||
155744263|NCT02616146|562163604|FG000|Overall Study|Non-compliance with study drug|4|||
155744264|NCT02616146|562163605|FG001|Overall Study|Non-compliance with study drug|2|||
155744265|NCT02616146|562163604|FG000|Overall Study|Pregnancy|2|||
155744266|NCT02616146|562163605|FG001|Overall Study|Pregnancy|2|||
155744267|NCT02616146|562163604|FG000|Overall Study|Pregnancy wish|3|||
155744268|NCT02616146|562163605|FG001|Overall Study|Pregnancy wish|0|||
155744269|NCT02616146|562163604|FG000|Overall Study|Protocol Violation|6|||
155744270|NCT02616146|562163605|FG001|Overall Study|Protocol Violation|3|||
155744271|NCT02616146|562163604|FG000|Overall Study|Study terminated by sponsor|1372|||
155744272|NCT02616146|562163605|FG001|Overall Study|Study terminated by sponsor|432|||
155744273|NCT02616146|562163604|FG000|Overall Study|Participant moved|4|||
155744274|NCT02616146|562163605|FG001|Overall Study|Participant moved|3|||
155744275|NCT02616146|562163604|FG000|Overall Study|Withdrawal by Subject|30|||
155744276|NCT02616146|562163605|FG001|Overall Study|Withdrawal by Subject|24|||
155744277|NCT02616146|562163604|FG000|Overall Study|Physician Decision|2|||
155744278|NCT02616146|562163605|FG001|Overall Study|Physician Decision|1|||
155744279|NCT01221272|562163607|FG000|Period 1|Adverse Event|2|||
155744280|NCT01221272|562163608|FG001|Period 1|Adverse Event|0|||
155744281|NCT01221272|562163607|FG000|Period 1|Consent Withdrawal|0|||
155744282|NCT01221272|562163608|FG001|Period 1|Consent Withdrawal|1|||
155744283|NCT01221272|562163607|FG000|Period 1|Significant Dosing Noncompliance|0|||
155744284|NCT01221272|562163608|FG001|Period 1|Significant Dosing Noncompliance|1|||
155744285|NCT01221272|562163607|FG000|Period 2|Adverse Event|0|||
155744286|NCT01221272|562163608|FG001|Period 2|Adverse Event|2|||
155744287|NCT01340872|562163609|FG000|Double-blind Phase|Adverse Event|6|||
155744288|NCT01340872|562163610|FG001|Double-blind Phase|Adverse Event|4|||
155744289|NCT01340872|562163611|FG002|Double-blind Phase|Adverse Event|0|||
155744290|NCT01340872|562163612|FG003|Double-blind Phase|Adverse Event|0|||
155744291|NCT01340872|562163609|FG000|Double-blind Phase|Withdrawal by Subject|3|||
155744292|NCT01340872|562163610|FG001|Double-blind Phase|Withdrawal by Subject|5|||
155744293|NCT01340872|562163611|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155744294|NCT01340872|562163612|FG003|Double-blind Phase|Withdrawal by Subject|0|||
155744295|NCT01340872|562163609|FG000|Double-blind Phase|Lost to Follow-up|0|||
155744296|NCT01340872|562163610|FG001|Double-blind Phase|Lost to Follow-up|1|||
155744297|NCT01340872|562163611|FG002|Double-blind Phase|Lost to Follow-up|0|||
155744298|NCT01340872|562163612|FG003|Double-blind Phase|Lost to Follow-up|0|||
155744299|NCT01340872|562163609|FG000|Double-blind Phase|Protocol Violation|0|||
155744300|NCT01340872|562163610|FG001|Double-blind Phase|Protocol Violation|1|||
155744301|NCT01340872|562163611|FG002|Double-blind Phase|Protocol Violation|0|||
155744302|NCT01340872|562163612|FG003|Double-blind Phase|Protocol Violation|0|||
155744303|NCT01340872|562163609|FG000|Open-label Phase|Physician Decision|0|||
155744304|NCT01340872|562163610|FG001|Open-label Phase|Physician Decision|0|||
155744305|NCT01340872|562163611|FG002|Open-label Phase|Physician Decision|2|||
155744306|NCT01340872|562163612|FG003|Open-label Phase|Physician Decision|1|||
155744307|NCT01340872|562163609|FG000|Open-label Phase|Pregnancy|0|||
155744308|NCT01340872|562163610|FG001|Open-label Phase|Pregnancy|0|||
155744309|NCT01340872|562163611|FG002|Open-label Phase|Pregnancy|1|||
155744310|NCT01340872|562163612|FG003|Open-label Phase|Pregnancy|0|||
155744311|NCT01340872|562163609|FG000|Open-label Phase|Adverse Event|0|||
155744312|NCT01340872|562163610|FG001|Open-label Phase|Adverse Event|0|||
155744313|NCT01340872|562163611|FG002|Open-label Phase|Adverse Event|8|||
155744314|NCT01340872|562163612|FG003|Open-label Phase|Adverse Event|4|||
155744315|NCT01340872|562163609|FG000|Open-label Phase|Withdrawal by Subject|0|||
155744316|NCT01340872|562163610|FG001|Open-label Phase|Withdrawal by Subject|0|||
155744317|NCT01340872|562163611|FG002|Open-label Phase|Withdrawal by Subject|1|||
155744318|NCT01340872|562163612|FG003|Open-label Phase|Withdrawal by Subject|6|||
155744319|NCT01340872|562163609|FG000|Open-label Phase|Worsening of IBD|0|||
155744320|NCT01340872|562163610|FG001|Open-label Phase|Worsening of IBD|0|||
155744321|NCT01340872|562163611|FG002|Open-label Phase|Worsening of IBD|1|||
155744322|NCT01340872|562163612|FG003|Open-label Phase|Worsening of IBD|0|||
155744323|NCT03039621|562163617|FG000|Overall Study|Violation of inclusion criteria|3|||
155294376|NCT02631148|560507323|FG001|Overall Study|8 were ineligible|0|||
155294377|NCT02631148|560507322|FG000|Overall Study|Withdrawal by Subject|1|||
155744324|NCT03039621|562163618|FG001|Overall Study|Violation of inclusion criteria|2|||
155744325|NCT03039621|562163617|FG000|Overall Study|Non-compliance with protocol requirement|4|||
155744326|NCT03039621|562163618|FG001|Overall Study|Non-compliance with protocol requirement|5|||
155744327|NCT03039621|562163617|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
155744328|NCT03039621|562163618|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
155744329|NCT03039621|562163617|FG000|Overall Study|Violation of non-inclusion criteria|1|||
155744330|NCT03039621|562163618|FG001|Overall Study|Violation of non-inclusion criteria|2|||
155744331|NCT03254108|562163619|FG000|Overall Study|Adverse Event|0|||
155744332|NCT03254108|562163620|FG001|Overall Study|Adverse Event|2|||
155744333|NCT03254108|562163621|FG002|Overall Study|Adverse Event|0|||
155744334|NCT03254108|562163622|FG003|Overall Study|Adverse Event|1|||
155744335|NCT03254108|562163623|FG004|Overall Study|Adverse Event|1|||
155744336|NCT03254108|562163619|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155744337|NCT03254108|562163620|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155744338|NCT03254108|562163621|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155744339|NCT03254108|562163622|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155744340|NCT03254108|562163623|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
155744341|NCT01771809|562163624|FG000|Overall Study|Adverse Event|4|||
155744342|NCT01771809|562163625|FG001|Overall Study|Adverse Event|12|||
155744343|NCT01771809|562163624|FG000|Overall Study|Protocol Violation|0|||
155744344|NCT01771809|562163625|FG001|Overall Study|Protocol Violation|1|||
155744345|NCT01771809|562163624|FG000|Overall Study|Withdrawal by Subject|34|||
155744346|NCT01771809|562163625|FG001|Overall Study|Withdrawal by Subject|42|||
155744347|NCT01771809|562163624|FG000|Overall Study|Lost to Follow-up|1|||
155744348|NCT01771809|562163625|FG001|Overall Study|Lost to Follow-up|3|||
155744349|NCT01771809|562163624|FG000|Overall Study|Other (Insufficient clinical response)|22|||
155744350|NCT01771809|562163625|FG001|Overall Study|Other (Insufficient clinical response)|20|||
155744351|NCT01771809|562163624|FG000|Overall Study|Death|1|||
155744352|NCT01771809|562163625|FG001|Overall Study|Death|0|||
155744353|NCT01771809|562163624|FG000|Overall Study|Other (other)|9|||
155744354|NCT01771809|562163625|FG001|Overall Study|Other (other)|5|||
155744355|NCT00362180|562163626|FG000|Treated Period|Withdrawal by Subject|1|||
155744356|NCT00362180|562163627|FG001|Treated Period|Withdrawal by Subject|0|||
155744357|NCT00362180|562163628|FG002|Treated Period|Withdrawal by Subject|0|||
155744358|NCT00362180|562163629|FG003|Treated Period|Withdrawal by Subject|0|||
155744359|NCT00362180|562163630|FG004|Treated Period|Withdrawal by Subject|0|||
155744360|NCT00362180|562163631|FG005|Treated Period|Withdrawal by Subject|0|||
155744361|NCT00362180|562163632|FG006|Treated Period|Withdrawal by Subject|0|||
155744362|NCT00362180|562163633|FG007|Treated Period|Withdrawal by Subject|0|||
155744363|NCT00362180|562163634|FG008|Treated Period|Withdrawal by Subject|0|||
155744364|NCT00362180|562163626|FG000|Treated Period|Adverse Event|0|||
155744365|NCT00362180|562163627|FG001|Treated Period|Adverse Event|0|||
155744366|NCT00362180|562163628|FG002|Treated Period|Adverse Event|0|||
155744367|NCT00362180|562163629|FG003|Treated Period|Adverse Event|0|||
155744368|NCT00362180|562163630|FG004|Treated Period|Adverse Event|0|||
155744369|NCT00362180|562163631|FG005|Treated Period|Adverse Event|1|||
155744370|NCT00362180|562163632|FG006|Treated Period|Adverse Event|0|||
155744371|NCT00362180|562163633|FG007|Treated Period|Adverse Event|1|||
155744372|NCT00362180|562163634|FG008|Treated Period|Adverse Event|0|||
155744373|NCT02656680|562163637|FG000|Overall Study|Lost to Follow-up|0|||
155744374|NCT02656680|562163638|FG001|Overall Study|Lost to Follow-up|1|||
155744375|NCT02656680|562163639|FG002|Overall Study|Lost to Follow-up|7|||
155744376|NCT02600871|562163642|FG000|Overall Study|Lost to Follow-up|13|||
155744377|NCT02600871|562163643|FG001|Overall Study|Lost to Follow-up|10|||
155744378|NCT00002931|562163644|FG000|Overall Study|rapidly progressing disease during|2|||
155744379|NCT01246466|562163647|FG000|Overall Study|Death|1|||
155744380|NCT01246466|562163647|FG000|Overall Study|Withdrawal by Subject|1|||
155744381|NCT01142089|562163653|FG000|Overall Study|Physician Decision|1|||
155744382|NCT01142089|562163654|FG001|Overall Study|Physician Decision|0|||
155744383|NCT01142089|562163653|FG000|Overall Study|Withdrawal by Subject|1|||
155744384|NCT01142089|562163654|FG001|Overall Study|Withdrawal by Subject|2|||
155744385|NCT01142089|562163653|FG000|Overall Study|Use of prohibited medications|0|||
155744386|NCT01142089|562163654|FG001|Overall Study|Use of prohibited medications|1|||
155744387|NCT01142089|562163653|FG000|Overall Study|Noncompliance with study procedures|2|||
155744388|NCT01142089|562163654|FG001|Overall Study|Noncompliance with study procedures|1|||
155744389|NCT01142089|562163653|FG000|Overall Study|Patient required rescue medication|8|||
155744390|NCT01142089|562163654|FG001|Overall Study|Patient required rescue medication|17|||
155744391|NCT01974765|562163657|FG000|Overall Study|Withdrawal by Subject|1|||
155744392|NCT01974765|562163657|FG000|Overall Study|Death|1|||
155744393|NCT01974765|562163657|FG000|Overall Study|Adverse Event|2|||
155744394|NCT00003472|562163662|FG000|Overall Study|Not evaluable|3|||
155744395|NCT01012219|562163663|FG000|Period 1|Withdrawal by Subject|1|||
155744396|NCT01012219|562163663|FG000|Period 2|Withdrawal by Subject|1|||
155744397|NCT00874939|562163664|FG000|Overall Study|Study terminated|4|||
155744398|NCT01909791|562163665|FG000|Overall Study|Death|9|||
155744399|NCT01909791|562163666|FG001|Overall Study|Death|8|||
155744400|NCT01909791|562163667|FG002|Overall Study|Death|4|||
155744401|NCT01909791|562163665|FG000|Overall Study|Withdrawal by Subject|5|||
155744402|NCT01909791|562163666|FG001|Overall Study|Withdrawal by Subject|9|||
155744403|NCT01909791|562163667|FG002|Overall Study|Withdrawal by Subject|13|||
155744404|NCT01909791|562163665|FG000|Overall Study|Lost to Follow-up|5|||
155744405|NCT01909791|562163666|FG001|Overall Study|Lost to Follow-up|11|||
155744406|NCT01909791|562163667|FG002|Overall Study|Lost to Follow-up|10|||
155744407|NCT01909791|562163665|FG000|Overall Study|Missed Visit|2|||
155744408|NCT01909791|562163666|FG001|Overall Study|Missed Visit|0|||
155744409|NCT01909791|562163667|FG002|Overall Study|Missed Visit|1|||
155744410|NCT02168387|562163668|FG000|Overall Study|Planned exubation|6|||
155744411|NCT02168387|562163669|FG001|Overall Study|Planned exubation|3|||
155744412|NCT02168387|562163668|FG000|Overall Study|Death|1|||
155744413|NCT02168387|562163669|FG001|Overall Study|Death|0|||
155744414|NCT01444092|562163672|FG000|Overall Study|Adverse Event|8|||
155744415|NCT01444092|562163672|FG000|Overall Study|Protocol Violation|1|||
155744416|NCT01444092|562163672|FG000|Overall Study|Withdrawal by Subject|1|||
155744417|NCT01444092|562163672|FG000|Overall Study|Other Eligibility criteria|7|||
155744418|NCT01328366|562163673|FG000|Overall Study|Death|1|||
155744419|NCT01328366|562163673|FG000|Overall Study|Withdrawal by Subject|2|||
155744420|NCT01328366|562163673|FG000|Overall Study|Lost to Follow-up|7|||
155744421|NCT00603590|562163674|FG000|Overall Study|Did not attend study clinic|39|||
155744422|NCT00603590|562163675|FG001|Overall Study|Did not attend study clinic|30|||
155744423|NCT00603590|562163674|FG000|Overall Study|Refused blood test|5|||
155744424|NCT00603590|562163675|FG001|Overall Study|Refused blood test|1|||
155744425|NCT00603590|562163674|FG000|Overall Study|Patient discontinued study drug|22|||
155744426|NCT00603590|562163675|FG001|Overall Study|Patient discontinued study drug|15|||
155744427|NCT00603590|562163674|FG000|Overall Study|Adverse Event|2|||
155744428|NCT00603590|562163675|FG001|Overall Study|Adverse Event|0|||
155744429|NCT00603590|562163674|FG000|Overall Study|Lost to Follow-up|8|||
155744430|NCT00603590|562163675|FG001|Overall Study|Lost to Follow-up|4|||
155744431|NCT00603590|562163674|FG000|Overall Study|Cardiovascular event|0|||
155744432|NCT00603590|562163675|FG001|Overall Study|Cardiovascular event|1|||
155744433|NCT03005873|562163676|FG000|Overall Study|Prohibited medication use post radnomization|1|||
155744434|NCT03005873|562163677|FG001|Overall Study|Prohibited medication use post radnomization|1|||
155744435|NCT03005873|562163678|FG002|Overall Study|Prohibited medication use post radnomization|1|||
155744436|NCT03005873|562163676|FG000|Overall Study|Withdrew consent|0|||
155744437|NCT03005873|562163677|FG001|Overall Study|Withdrew consent|1|||
155744438|NCT03005873|562163678|FG002|Overall Study|Withdrew consent|2|||
155744439|NCT03005873|562163676|FG000|Overall Study|Lost to Follow-up|0|||
155744440|NCT03005873|562163677|FG001|Overall Study|Lost to Follow-up|1|||
155744441|NCT03005873|562163678|FG002|Overall Study|Lost to Follow-up|0|||
155744442|NCT03005873|562163676|FG000|Overall Study|Ineligible post randomization|0|||
155744443|NCT03005873|562163677|FG001|Overall Study|Ineligible post randomization|0|||
155744444|NCT03005873|562163678|FG002|Overall Study|Ineligible post randomization|1|||
155744445|NCT02882152|562163679|FG000|Overall Study|Lost to Follow-up|1|||
155744446|NCT02882152|562163680|FG001|Overall Study|Lost to Follow-up|0|||
155744447|NCT00797966|562163685|FG000|Phase A|Lost to Follow-up|0|||
155744448|NCT00797966|562163686|FG001|Phase A|Lost to Follow-up|0|||
155744449|NCT00797966|562163687|FG002|Phase A|Lost to Follow-up|0|||
155744450|NCT00797966|562163688|FG003|Phase A|Lost to Follow-up|0|||
155744451|NCT00797966|562163689|FG004|Phase A|Lost to Follow-up|33|||
155744452|NCT00797966|562163690|FG005|Phase A|Lost to Follow-up|0|||
155744453|NCT00797966|562163685|FG000|Phase A|Adverse Event|0|||
155744454|NCT00797966|562163686|FG001|Phase A|Adverse Event|0|||
155744455|NCT00797966|562163687|FG002|Phase A|Adverse Event|0|||
155744456|NCT00797966|562163688|FG003|Phase A|Adverse Event|0|||
155744457|NCT00797966|562163689|FG004|Phase A|Adverse Event|46|||
155744458|NCT00797966|562163690|FG005|Phase A|Adverse Event|0|||
155744459|NCT00797966|562163685|FG000|Phase A|Met withdrawal criteria|0|||
155744460|NCT00797966|562163686|FG001|Phase A|Met withdrawal criteria|0|||
155744461|NCT00797966|562163687|FG002|Phase A|Met withdrawal criteria|0|||
155744462|NCT00797966|562163688|FG003|Phase A|Met withdrawal criteria|0|||
155744463|NCT00797966|562163689|FG004|Phase A|Met withdrawal criteria|4|||
155744464|NCT00797966|562163690|FG005|Phase A|Met withdrawal criteria|0|||
155744465|NCT00797966|562163685|FG000|Phase A|Physician Decision|0|||
155744466|NCT00797966|562163686|FG001|Phase A|Physician Decision|0|||
155744467|NCT00797966|562163687|FG002|Phase A|Physician Decision|0|||
155744468|NCT00797966|562163688|FG003|Phase A|Physician Decision|0|||
155744469|NCT00797966|562163689|FG004|Phase A|Physician Decision|13|||
155744470|NCT00797966|562163690|FG005|Phase A|Physician Decision|0|||
155744471|NCT00797966|562163685|FG000|Phase A|Withdrawal by Subject|0|||
155744472|NCT00797966|562163686|FG001|Phase A|Withdrawal by Subject|0|||
155744473|NCT00797966|562163687|FG002|Phase A|Withdrawal by Subject|0|||
155744474|NCT00797966|562163688|FG003|Phase A|Withdrawal by Subject|0|||
155744475|NCT00797966|562163689|FG004|Phase A|Withdrawal by Subject|33|||
155744476|NCT00797966|562163690|FG005|Phase A|Withdrawal by Subject|0|||
155744477|NCT00797966|562163685|FG000|Phase A|Protocol deviation|0|||
155744478|NCT00797966|562163686|FG001|Phase A|Protocol deviation|0|||
155744479|NCT00797966|562163687|FG002|Phase A|Protocol deviation|0|||
155744480|NCT00797966|562163688|FG003|Phase A|Protocol deviation|0|||
155744481|NCT00797966|562163689|FG004|Phase A|Protocol deviation|56|||
155744482|NCT00797966|562163690|FG005|Phase A|Protocol deviation|0|||
155744483|NCT00797966|562163685|FG000|Phase B|Lost to Follow-up|0|||
155639303|NCT03317496|561770441|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155639304|NCT03317496|561770437|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
155639305|NCT03317496|561770438|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
155639306|NCT03317496|561770439|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
155639307|NCT03317496|561770440|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
155639308|NCT03317496|561770441|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
155639309|NCT03317496|561770437|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
155639310|NCT03317496|561770438|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155639311|NCT03317496|561770439|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155639312|NCT03317496|561770440|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155744484|NCT00797966|562163686|FG001|Phase B|Lost to Follow-up|1|||
155744485|NCT00797966|562163687|FG002|Phase B|Lost to Follow-up|3|||
155744486|NCT00797966|562163688|FG003|Phase B|Lost to Follow-up|0|||
155744487|NCT00797966|562163689|FG004|Phase B|Lost to Follow-up|0|||
155744488|NCT00797966|562163690|FG005|Phase B|Lost to Follow-up|0|||
155744489|NCT00797966|562163685|FG000|Phase B|Adverse Event|2|||
155744490|NCT00797966|562163686|FG001|Phase B|Adverse Event|1|||
155744491|NCT00797966|562163687|FG002|Phase B|Adverse Event|3|||
155744492|NCT00797966|562163688|FG003|Phase B|Adverse Event|1|||
155744493|NCT00797966|562163689|FG004|Phase B|Adverse Event|0|||
155744494|NCT00797966|562163690|FG005|Phase B|Adverse Event|0|||
155744495|NCT00797966|562163685|FG000|Phase B|Met Withdrawal Criteria|3|||
155744496|NCT00797966|562163686|FG001|Phase B|Met Withdrawal Criteria|3|||
155744497|NCT00797966|562163687|FG002|Phase B|Met Withdrawal Criteria|6|||
155744498|NCT00797966|562163688|FG003|Phase B|Met Withdrawal Criteria|1|||
155744499|NCT00797966|562163689|FG004|Phase B|Met Withdrawal Criteria|0|||
155744500|NCT00797966|562163690|FG005|Phase B|Met Withdrawal Criteria|0|||
155744501|NCT00797966|562163685|FG000|Phase B|Physician Decision|1|||
155744502|NCT00797966|562163686|FG001|Phase B|Physician Decision|0|||
155744503|NCT00797966|562163687|FG002|Phase B|Physician Decision|3|||
155744504|NCT00797966|562163688|FG003|Phase B|Physician Decision|1|||
155744505|NCT00797966|562163689|FG004|Phase B|Physician Decision|0|||
155744506|NCT00797966|562163690|FG005|Phase B|Physician Decision|0|||
155744507|NCT00797966|562163685|FG000|Phase B|Withdrawal by Subject|1|||
155639313|NCT03317496|561770441|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155639314|NCT03317496|561770437|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155639315|NCT03317496|561770438|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155639316|NCT03317496|561770439|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
155639317|NCT03317496|561770440|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155639318|NCT03317496|561770441|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155639319|NCT03317496|561770437|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
155639320|NCT03317496|561770438|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
155639321|NCT03317496|561770439|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
155639322|NCT03317496|561770440|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
155639323|NCT03317496|561770441|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
155639324|NCT03317496|561770437|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
155639325|NCT03317496|561770438|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
155639326|NCT03317496|561770439|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
155639327|NCT03317496|561770440|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
155639328|NCT03317496|561770441|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
155639329|NCT03317496|561770437|FG000|Phase 2: Treatment|Adverse Event|0|||
155639330|NCT03317496|561770438|FG001|Phase 2: Treatment|Adverse Event|0|||
155639331|NCT03317496|561770439|FG002|Phase 2: Treatment|Adverse Event|0|||
155639332|NCT03317496|561770440|FG003|Phase 2: Treatment|Adverse Event|0|||
155639333|NCT03317496|561770441|FG004|Phase 2: Treatment|Adverse Event|6|||
155639334|NCT03317496|561770437|FG000|Phase 2: Treatment|Progressive disease|0|||
155639335|NCT03317496|561770438|FG001|Phase 2: Treatment|Progressive disease|0|||
155639336|NCT03317496|561770439|FG002|Phase 2: Treatment|Progressive disease|0|||
155639337|NCT03317496|561770440|FG003|Phase 2: Treatment|Progressive disease|0|||
155639338|NCT03317496|561770441|FG004|Phase 2: Treatment|Progressive disease|22|||
155639339|NCT03317496|561770437|FG000|Phase 2: Treatment|Other|0|||
155639340|NCT03317496|561770438|FG001|Phase 2: Treatment|Other|0|||
155639341|NCT03317496|561770439|FG002|Phase 2: Treatment|Other|0|||
155639342|NCT03317496|561770440|FG003|Phase 2: Treatment|Other|0|||
155744508|NCT00797966|562163686|FG001|Phase B|Withdrawal by Subject|4|||
155744509|NCT00797966|562163687|FG002|Phase B|Withdrawal by Subject|3|||
155744510|NCT00797966|562163688|FG003|Phase B|Withdrawal by Subject|3|||
155744511|NCT00797966|562163689|FG004|Phase B|Withdrawal by Subject|0|||
155744512|NCT00797966|562163690|FG005|Phase B|Withdrawal by Subject|0|||
155744513|NCT00797966|562163685|FG000|Phase B|Protocol Deviation|4|||
155744514|NCT00797966|562163686|FG001|Phase B|Protocol Deviation|8|||
155744515|NCT00797966|562163687|FG002|Phase B|Protocol Deviation|2|||
155744516|NCT00797966|562163688|FG003|Phase B|Protocol Deviation|6|||
155744517|NCT00797966|562163689|FG004|Phase B|Protocol Deviation|0|||
155744518|NCT00797966|562163690|FG005|Phase B|Protocol Deviation|0|||
155744519|NCT00797966|562163685|FG000|Phase B|Lack of Efficacy|0|||
155744520|NCT00797966|562163686|FG001|Phase B|Lack of Efficacy|1|||
155744521|NCT00797966|562163687|FG002|Phase B|Lack of Efficacy|1|||
155744522|NCT00797966|562163688|FG003|Phase B|Lack of Efficacy|4|||
155744523|NCT00797966|562163689|FG004|Phase B|Lack of Efficacy|0|||
155744524|NCT00797966|562163690|FG005|Phase B|Lack of Efficacy|0|||
155744525|NCT00797966|562163685|FG000|Phase A+|Lost to Follow-up|0|||
155744526|NCT00797966|562163686|FG001|Phase A+|Lost to Follow-up|0|||
155744527|NCT00797966|562163687|FG002|Phase A+|Lost to Follow-up|0|||
155744528|NCT00797966|562163688|FG003|Phase A+|Lost to Follow-up|0|||
155744529|NCT00797966|562163689|FG004|Phase A+|Lost to Follow-up|0|||
155744530|NCT00797966|562163690|FG005|Phase A+|Lost to Follow-up|9|||
155639343|NCT03317496|561770441|FG004|Phase 2: Treatment|Other|4|||
155639344|NCT03317496|561770437|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
155639345|NCT03317496|561770438|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
155639346|NCT03317496|561770439|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
155639347|NCT03317496|561770440|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
155639348|NCT03317496|561770441|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
155639349|NCT03317496|561770437|FG000|Phase 2: Treatment|Physician Decision|0|||
155639350|NCT03317496|561770438|FG001|Phase 2: Treatment|Physician Decision|0|||
155639351|NCT03317496|561770439|FG002|Phase 2: Treatment|Physician Decision|0|||
155639352|NCT03317496|561770440|FG003|Phase 2: Treatment|Physician Decision|0|||
155639353|NCT03317496|561770441|FG004|Phase 2: Treatment|Physician Decision|1|||
155639354|NCT03317496|561770437|FG000|Phase 2: Treatment|Death|0|||
155639355|NCT03317496|561770438|FG001|Phase 2: Treatment|Death|0|||
155639356|NCT03317496|561770439|FG002|Phase 2: Treatment|Death|0|||
155639357|NCT03317496|561770440|FG003|Phase 2: Treatment|Death|0|||
155639358|NCT03317496|561770441|FG004|Phase 2: Treatment|Death|1|||
155639359|NCT03317496|561770437|FG000|Phase 2: Follow-up|Death|0|||
155639360|NCT03317496|561770438|FG001|Phase 2: Follow-up|Death|0|||
155639361|NCT03317496|561770439|FG002|Phase 2: Follow-up|Death|0|||
155639362|NCT03317496|561770440|FG003|Phase 2: Follow-up|Death|0|||
155639363|NCT03317496|561770441|FG004|Phase 2: Follow-up|Death|24|||
155639364|NCT03317496|561770437|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
155639365|NCT03317496|561770438|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
155639366|NCT03317496|561770439|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
155639367|NCT03317496|561770440|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
155639368|NCT03317496|561770441|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
155639369|NCT03317496|561770437|FG000|Phase 2: Follow-up|Other|0|||
155639370|NCT03317496|561770438|FG001|Phase 2: Follow-up|Other|0|||
155639371|NCT03317496|561770439|FG002|Phase 2: Follow-up|Other|0|||
155639372|NCT03317496|561770440|FG003|Phase 2: Follow-up|Other|0|||
155639373|NCT03317496|561770441|FG004|Phase 2: Follow-up|Other|1|||
155639374|NCT03317496|561770437|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
155639375|NCT03317496|561770438|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
155639376|NCT03317496|561770439|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
155639377|NCT03317496|561770440|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
155639378|NCT03317496|561770441|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
155639379|NCT02693418|561770442|FG000|Overall Study|Lost to Follow-up|1|||
155639380|NCT02693418|561770443|FG001|Overall Study|Lost to Follow-up|2|||
155639381|NCT02693418|561770444|FG002|Overall Study|Lost to Follow-up|0|||
155639382|NCT02693418|561770445|FG003|Overall Study|Lost to Follow-up|0|||
155639383|NCT02693418|561770446|FG004|Overall Study|Lost to Follow-up|0|||
155639384|NCT02693418|561770442|FG000|Overall Study|Menses during study period|0|||
155639385|NCT02693418|561770443|FG001|Overall Study|Menses during study period|0|||
155639386|NCT02693418|561770444|FG002|Overall Study|Menses during study period|2|||
155639387|NCT02693418|561770445|FG003|Overall Study|Menses during study period|0|||
155639388|NCT02693418|561770446|FG004|Overall Study|Menses during study period|0|||
155639389|NCT01750346|561770449|FG000|Overall Study|Adverse Event|1|||
155639390|NCT01750346|561770450|FG001|Overall Study|Adverse Event|0|||
155639391|NCT01750346|561770451|FG002|Overall Study|Adverse Event|0|||
155639392|NCT01001104|561770454|FG000|Overall Study|Adverse Event|2|||
155639393|NCT01001104|561770455|FG001|Overall Study|Adverse Event|1|||
155639394|NCT01001104|561770456|FG002|Overall Study|Adverse Event|0|||
155639395|NCT01001104|561770457|FG003|Overall Study|Adverse Event|0|||
155639396|NCT01001104|561770454|FG000|Overall Study|Lost to Follow-up|0|||
155639397|NCT01001104|561770455|FG001|Overall Study|Lost to Follow-up|0|||
155639398|NCT01001104|561770456|FG002|Overall Study|Lost to Follow-up|1|||
155744531|NCT00797966|562163685|FG000|Phase A+|Met withdrawal criteria|0|||
155639399|NCT01001104|561770457|FG003|Overall Study|Lost to Follow-up|0|||
155639400|NCT01001104|561770454|FG000|Overall Study|Entry Criteria Not Met|0|||
155639401|NCT01001104|561770455|FG001|Overall Study|Entry Criteria Not Met|0|||
155639402|NCT01001104|561770456|FG002|Overall Study|Entry Criteria Not Met|0|||
155639403|NCT01001104|561770457|FG003|Overall Study|Entry Criteria Not Met|1|||
155639404|NCT01001104|561770454|FG000|Overall Study|Withdrawal by Subject|0|||
155744532|NCT00797966|562163686|FG001|Phase A+|Met withdrawal criteria|0|||
155744533|NCT00797966|562163687|FG002|Phase A+|Met withdrawal criteria|0|||
155744534|NCT00797966|562163688|FG003|Phase A+|Met withdrawal criteria|0|||
155639405|NCT01001104|561770455|FG001|Overall Study|Withdrawal by Subject|0|||
155639406|NCT01001104|561770456|FG002|Overall Study|Withdrawal by Subject|0|||
155639407|NCT01001104|561770457|FG003|Overall Study|Withdrawal by Subject|2|||
155639408|NCT02034591|561770458|FG000|Overall Study|Withdrawal by Subject|0|||
155639409|NCT02034591|561770459|FG001|Overall Study|Withdrawal by Subject|0|||
155639410|NCT02034591|561770460|FG002|Overall Study|Withdrawal by Subject|0|||
155639411|NCT02034591|561770461|FG003|Overall Study|Withdrawal by Subject|0|||
155639412|NCT02034591|561770462|FG004|Overall Study|Withdrawal by Subject|1|||
155639413|NCT02034591|561770463|FG005|Overall Study|Withdrawal by Subject|0|||
155639414|NCT00599313|561770464|FG000|Overall Study|Adverse Event|19|||
155639415|NCT00599313|561770464|FG000|Overall Study|Disease Progression|12|||
155639416|NCT00599313|561770464|FG000|Overall Study|Patient Request|4|||
155639417|NCT00599313|561770464|FG000|Overall Study|Ineligible|1|||
155639418|NCT01793935|561770465|FG000|Overall Study|Pregnancy|1|||
155639419|NCT01793935|561770466|FG001|Overall Study|Pregnancy|0|||
155639420|NCT01793935|561770465|FG000|Overall Study|Protocol Violation|2|||
155639421|NCT01793935|561770466|FG001|Overall Study|Protocol Violation|1|||
155639422|NCT01793935|561770465|FG000|Overall Study|Adverse Event|2|||
155639423|NCT01793935|561770466|FG001|Overall Study|Adverse Event|0|||
155639424|NCT01793935|561770465|FG000|Overall Study|Patient did not take study medication|1|||
155639425|NCT01793935|561770466|FG001|Overall Study|Patient did not take study medication|1|||
155639426|NCT01793935|561770465|FG000|Overall Study|Lost to Follow-up|0|||
155639427|NCT01793935|561770466|FG001|Overall Study|Lost to Follow-up|1|||
155639428|NCT01121926|561770467|FG000|First Intervention Period|Adverse Event|1|||
155639429|NCT01121926|561770468|FG001|First Intervention Period|Adverse Event|0|||
155639430|NCT01121926|561770467|FG000|Washout Period|Adverse Event|0|||
155639431|NCT01121926|561770468|FG001|Washout Period|Adverse Event|1|||
155639432|NCT01121926|561770467|FG000|Washout Period|Positive pregnancy test|0|||
155639433|NCT01121926|561770468|FG001|Washout Period|Positive pregnancy test|1|||
155639434|NCT02782468|561770469|FG000|Overall Study|Progressive Disease|2|||
155639435|NCT02782468|561770470|FG001|Overall Study|Progressive Disease|5|||
155639436|NCT02782468|561770471|FG002|Overall Study|Progressive Disease|0|||
155639437|NCT02782468|561770472|FG003|Overall Study|Progressive Disease|4|||
155639438|NCT02782468|561770469|FG000|Overall Study|Adverse Event|0|||
155639439|NCT02782468|561770470|FG001|Overall Study|Adverse Event|2|||
155639440|NCT02782468|561770471|FG002|Overall Study|Adverse Event|2|||
155639441|NCT02782468|561770472|FG003|Overall Study|Adverse Event|3|||
155639442|NCT02782468|561770469|FG000|Overall Study|Other|0|||
155639443|NCT02782468|561770470|FG001|Overall Study|Other|0|||
155639444|NCT02782468|561770471|FG002|Overall Study|Other|1|||
155639445|NCT02782468|561770472|FG003|Overall Study|Other|1|||
155639446|NCT02782468|561770469|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155639447|NCT02782468|561770470|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155639448|NCT02782468|561770471|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155639449|NCT02782468|561770472|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
155639450|NCT02782468|561770469|FG000|Overall Study|Symptomatic Deterioration|0|||
155639451|NCT02782468|561770470|FG001|Overall Study|Symptomatic Deterioration|0|||
155639452|NCT02782468|561770471|FG002|Overall Study|Symptomatic Deterioration|0|||
155639453|NCT02782468|561770472|FG003|Overall Study|Symptomatic Deterioration|1|||
155639454|NCT02782468|561770469|FG000|Overall Study|Withdrawal by Subject|1|||
155639455|NCT02782468|561770470|FG001|Overall Study|Withdrawal by Subject|0|||
155639456|NCT02782468|561770471|FG002|Overall Study|Withdrawal by Subject|0|||
155639457|NCT02782468|561770472|FG003|Overall Study|Withdrawal by Subject|0|||
155639458|NCT00817063|561770475|FG000|Overall Study|Adverse Event|32|||
155639459|NCT00817063|561770476|FG001|Overall Study|Adverse Event|13|||
155639460|NCT00817063|561770475|FG000|Overall Study|Death|1|||
155639461|NCT00817063|561770476|FG001|Overall Study|Death|1|||
155639462|NCT00817063|561770475|FG000|Overall Study|Lack of Efficacy|33|||
155639463|NCT00817063|561770476|FG001|Overall Study|Lack of Efficacy|86|||
155639464|NCT00817063|561770475|FG000|Overall Study|Failure to Return|13|||
155639465|NCT00817063|561770476|FG001|Overall Study|Failure to Return|12|||
155639466|NCT00817063|561770475|FG000|Overall Study|Violation of Selection at Entry|7|||
155639467|NCT00817063|561770476|FG001|Overall Study|Violation of Selection at Entry|4|||
155639468|NCT00817063|561770475|FG000|Overall Study|Protocol Violation|3|||
155639469|NCT00817063|561770476|FG001|Overall Study|Protocol Violation|8|||
155639470|NCT00817063|561770475|FG000|Overall Study|Withdrawal by Subject|17|||
155744535|NCT00797966|562163689|FG004|Phase A+|Met withdrawal criteria|0|||
155744536|NCT00797966|562163690|FG005|Phase A+|Met withdrawal criteria|5|||
155639471|NCT00817063|561770476|FG001|Overall Study|Withdrawal by Subject|37|||
155639472|NCT00817063|561770475|FG000|Overall Study|Early Improvement|19|||
155639473|NCT00817063|561770476|FG001|Overall Study|Early Improvement|4|||
155639474|NCT00817063|561770475|FG000|Overall Study|Administrative|10|||
155639475|NCT00817063|561770476|FG001|Overall Study|Administrative|4|||
155639476|NCT00817063|561770475|FG000|Overall Study|Abnormality of Laboratory Test|2|||
155639477|NCT00817063|561770476|FG001|Overall Study|Abnormality of Laboratory Test|1|||
155744537|NCT00797966|562163685|FG000|Phase A+|Withdrawal by Subject|0|||
155744538|NCT00797966|562163686|FG001|Phase A+|Withdrawal by Subject|0|||
155744539|NCT00797966|562163687|FG002|Phase A+|Withdrawal by Subject|0|||
155744540|NCT00797966|562163688|FG003|Phase A+|Withdrawal by Subject|0|||
155744541|NCT00797966|562163689|FG004|Phase A+|Withdrawal by Subject|0|||
155744542|NCT00797966|562163690|FG005|Phase A+|Withdrawal by Subject|6|||
155744543|NCT00797966|562163685|FG000|Phase A+|Adverse Event|0|||
155744544|NCT00797966|562163686|FG001|Phase A+|Adverse Event|0|||
155294378|NCT02631148|560507323|FG001|Overall Study|Withdrawal by Subject|0|||
155294379|NCT02631148|560507322|FG000|Overall Study|PAH not available to study participant|1|||
155744545|NCT00797966|562163687|FG002|Phase A+|Adverse Event|0|||
155744546|NCT00797966|562163688|FG003|Phase A+|Adverse Event|0|||
155744547|NCT00797966|562163689|FG004|Phase A+|Adverse Event|0|||
155744548|NCT00797966|562163690|FG005|Phase A+|Adverse Event|4|||
155744549|NCT00797966|562163685|FG000|Phase A+|Protocol deviation|0|||
155744550|NCT00797966|562163686|FG001|Phase A+|Protocol deviation|0|||
155744551|NCT00797966|562163687|FG002|Phase A+|Protocol deviation|0|||
155744552|NCT00797966|562163688|FG003|Phase A+|Protocol deviation|0|||
155744553|NCT00797966|562163689|FG004|Phase A+|Protocol deviation|0|||
155744554|NCT00797966|562163690|FG005|Phase A+|Protocol deviation|4|||
155744555|NCT01002820|562163693|FG000|Overall Study|Adverse Event|1|||
155744556|NCT01002820|562163693|FG000|Overall Study|Withdrawal by Subject|2|||
155744557|NCT01002820|562163693|FG000|Overall Study|Lack of Efficacy|1|||
155744558|NCT01430754|562163695|FG000|Run-In Phase|Circadian Period Ineligible|24|||
155744559|NCT01430754|562163696|FG001|Run-In Phase|Circadian Period Ineligible|0|||
155744560|NCT01430754|562163695|FG000|Run-In Phase|Protocol Violation|6|||
155744561|NCT01430754|562163696|FG001|Run-In Phase|Protocol Violation|0|||
155744562|NCT01430754|562163695|FG000|Run-In Phase|Adverse Event|2|||
155744563|NCT01430754|562163696|FG001|Run-In Phase|Adverse Event|0|||
155744564|NCT01430754|562163695|FG000|Run-In Phase|Other|2|||
155744565|NCT01430754|562163696|FG001|Run-In Phase|Other|0|||
155744566|NCT01430754|562163695|FG000|Run-In Phase|Withdrawal by Subject|2|||
155744567|NCT01430754|562163696|FG001|Run-In Phase|Withdrawal by Subject|0|||
155744568|NCT01430754|562163695|FG000|Run-In Phase|Lost to Follow-up|1|||
155744569|NCT01430754|562163696|FG001|Run-In Phase|Lost to Follow-up|0|||
155744570|NCT02661178|562163704|FG000|Part 1|Protocol Violation|1|||
155744571|NCT02661178|562163705|FG001|Part 1|Protocol Violation|0|||
155744572|NCT02661178|562163706|FG002|Part 1|Protocol Violation|0|||
155744573|NCT02661178|562163707|FG003|Part 1|Protocol Violation|0|||
155744574|NCT02661178|562163708|FG004|Part 1|Protocol Violation|0|||
155744575|NCT02661178|562163709|FG005|Part 1|Protocol Violation|0|||
155744576|NCT02661178|562163710|FG006|Part 1|Protocol Violation|0|||
155744577|NCT02661178|562163711|FG007|Part 1|Protocol Violation|0|||
155744578|NCT02661178|562163712|FG008|Part 1|Protocol Violation|0|||
155744579|NCT02661178|562163713|FG009|Part 1|Protocol Violation|0|||
155744580|NCT02661178|562163714|FG010|Part 1|Protocol Violation|0|||
155744581|NCT02661178|562163715|FG011|Part 1|Protocol Violation|0|||
155744582|NCT02661178|562163716|FG012|Part 1|Protocol Violation|0|||
155744583|NCT02661178|562163717|FG013|Part 1|Protocol Violation|0|||
155744584|NCT02661178|562163718|FG014|Part 1|Protocol Violation|0|||
155744585|NCT05338671|562163719|FG000|Overall Study|Lost to Follow-up|2|||
155744586|NCT05338671|562163720|FG001|Overall Study|Lost to Follow-up|2|||
155744587|NCT05338671|562163719|FG000|Overall Study|Root canal completed in a single visit|1|||
155744588|NCT05338671|562163720|FG001|Overall Study|Root canal completed in a single visit|0|||
155744589|NCT02855541|562163723|FG000|Overall Study|Change in health status|2|||
155744590|NCT02855541|562163723|FG000|Overall Study|Withdrawal by Subject|2|||
155744591|NCT01242813|562163724|FG000|Overall Study|Lost to Follow-up|2|||
155744592|NCT00701662|562163725|FG000|Overall Study|Lack of Efficacy|1|||
155744593|NCT02683746|562163727|FG000|Overall Study|Adverse Event|3|||
155744594|NCT02683746|562163728|FG001|Overall Study|Adverse Event|2|||
155744595|NCT02683746|562163727|FG000|Overall Study|Lost to Follow-up|5|||
155744596|NCT02683746|562163728|FG001|Overall Study|Lost to Follow-up|6|||
155294380|NCT02631148|560507323|FG001|Overall Study|PAH not available to study participant|0|||
155744597|NCT02683746|562163727|FG000|Overall Study|Withdrawal by Subject|6|||
155294381|NCT00150176|560507325|FG000|Overall Study|Adverse Event|16|||
155744598|NCT02683746|562163728|FG001|Overall Study|Withdrawal by Subject|5|||
155744599|NCT02683746|562163727|FG000|Overall Study|Physician Decision|2|||
155744600|NCT02683746|562163728|FG001|Overall Study|Physician Decision|1|||
155744601|NCT02353143|562163736|FG000|Overall Study|Withdrawal by Subject|1|||
155744602|NCT02353143|562163737|FG001|Overall Study|Withdrawal by Subject|0|||
155744603|NCT02353143|562163738|FG002|Overall Study|Withdrawal by Subject|0|||
155744604|NCT02353143|562163739|FG003|Overall Study|Withdrawal by Subject|0|||
155744605|NCT02353143|562163740|FG004|Overall Study|Withdrawal by Subject|1|||
155744606|NCT02353143|562163741|FG005|Overall Study|Withdrawal by Subject|0|||
155744607|NCT02353143|562163742|FG006|Overall Study|Withdrawal by Subject|0|||
155744608|NCT02353143|562163743|FG007|Overall Study|Withdrawal by Subject|1|||
155744609|NCT02353143|562163744|FG008|Overall Study|Withdrawal by Subject|1|||
155744610|NCT02353143|562163736|FG000|Overall Study|Lack of Efficacy|2|||
155744611|NCT02353143|562163737|FG001|Overall Study|Lack of Efficacy|1|||
155744612|NCT02353143|562163738|FG002|Overall Study|Lack of Efficacy|2|||
155744613|NCT02353143|562163739|FG003|Overall Study|Lack of Efficacy|4|||
155744614|NCT02353143|562163740|FG004|Overall Study|Lack of Efficacy|13|||
155744615|NCT02353143|562163741|FG005|Overall Study|Lack of Efficacy|2|||
155744616|NCT02353143|562163742|FG006|Overall Study|Lack of Efficacy|2|||
155744617|NCT02353143|562163743|FG007|Overall Study|Lack of Efficacy|2|||
155744618|NCT02353143|562163744|FG008|Overall Study|Lack of Efficacy|1|||
155744619|NCT02353143|562163736|FG000|Overall Study|reason not specified|1|||
155744620|NCT02353143|562163737|FG001|Overall Study|reason not specified|2|||
155744621|NCT02353143|562163738|FG002|Overall Study|reason not specified|0|||
155744622|NCT02353143|562163739|FG003|Overall Study|reason not specified|0|||
155744623|NCT02353143|562163740|FG004|Overall Study|reason not specified|6|||
155744624|NCT02353143|562163741|FG005|Overall Study|reason not specified|1|||
155744625|NCT02353143|562163742|FG006|Overall Study|reason not specified|0|||
155744626|NCT02353143|562163743|FG007|Overall Study|reason not specified|3|||
155294382|NCT00150176|560507326|FG001|Overall Study|Adverse Event|53|||
155294383|NCT00150176|560507325|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
155744627|NCT02353143|562163744|FG008|Overall Study|reason not specified|1|||
155744628|NCT02353143|562163736|FG000|Overall Study|Physician Decision|0|||
155744629|NCT02353143|562163737|FG001|Overall Study|Physician Decision|4|||
155744630|NCT02353143|562163738|FG002|Overall Study|Physician Decision|2|||
155744631|NCT02353143|562163739|FG003|Overall Study|Physician Decision|3|||
155744632|NCT02353143|562163740|FG004|Overall Study|Physician Decision|4|||
155744633|NCT02353143|562163741|FG005|Overall Study|Physician Decision|0|||
155744634|NCT02353143|562163742|FG006|Overall Study|Physician Decision|1|||
155744635|NCT02353143|562163743|FG007|Overall Study|Physician Decision|2|||
155744636|NCT02353143|562163744|FG008|Overall Study|Physician Decision|0|||
155744637|NCT02353143|562163736|FG000|Overall Study|Adverse Event|0|||
155744638|NCT02353143|562163737|FG001|Overall Study|Adverse Event|0|||
155744639|NCT02353143|562163738|FG002|Overall Study|Adverse Event|1|||
155744640|NCT02353143|562163739|FG003|Overall Study|Adverse Event|0|||
155744641|NCT02353143|562163740|FG004|Overall Study|Adverse Event|1|||
155744642|NCT02353143|562163741|FG005|Overall Study|Adverse Event|1|||
155744643|NCT02353143|562163742|FG006|Overall Study|Adverse Event|0|||
155744644|NCT02353143|562163743|FG007|Overall Study|Adverse Event|0|||
155495511|NCT03237325|561237848|FG000|Overall Study|Noncompliance with Study Procedures|1|||
155495512|NCT03237325|561237849|FG001|Overall Study|Noncompliance with Study Procedures|1|||
155495513|NCT03237325|561237848|FG000|Overall Study|Termination by Sponsor|0|||
155495514|NCT03237325|561237849|FG001|Overall Study|Termination by Sponsor|1|||
155495515|NCT03237325|561237848|FG000|Overall Study|Reason other than described|0|||
155495516|NCT03237325|561237849|FG001|Overall Study|Reason other than described|2|||
155495517|NCT00627094|561237851|FG000|Overall Study|Adverse Event|8|||
155495518|NCT00627094|561237852|FG001|Overall Study|Adverse Event|7|||
155495519|NCT00627094|561237851|FG000|Overall Study|Lost to Follow-up|1|||
155495520|NCT00627094|561237852|FG001|Overall Study|Lost to Follow-up|0|||
155744645|NCT02353143|562163744|FG008|Overall Study|Adverse Event|0|||
155744646|NCT02353143|562163736|FG000|Overall Study|patient receiving other treatment for AML|0|||
155744647|NCT02353143|562163737|FG001|Overall Study|patient receiving other treatment for AML|0|||
155744648|NCT02353143|562163738|FG002|Overall Study|patient receiving other treatment for AML|1|||
155744649|NCT02353143|562163739|FG003|Overall Study|patient receiving other treatment for AML|0|||
155744650|NCT02353143|562163740|FG004|Overall Study|patient receiving other treatment for AML|0|||
155744651|NCT02353143|562163741|FG005|Overall Study|patient receiving other treatment for AML|0|||
155744652|NCT02353143|562163742|FG006|Overall Study|patient receiving other treatment for AML|0|||
155744653|NCT02353143|562163743|FG007|Overall Study|patient receiving other treatment for AML|0|||
155744654|NCT02353143|562163744|FG008|Overall Study|patient receiving other treatment for AML|0|||
155744655|NCT02353143|562163736|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
155744656|NCT02353143|562163737|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
155744657|NCT02353143|562163738|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155744658|NCT02353143|562163739|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
155744659|NCT02353143|562163740|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
155744660|NCT02353143|562163741|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
155744661|NCT02353143|562163742|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
155744662|NCT02353143|562163743|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
155744663|NCT02353143|562163744|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
155744664|NCT02946931|562163747|FG000|Overall Study|Did not require collection of CRFs|588|||
155744665|NCT02946931|562163747|FG000|Overall Study|Other than listed|37|||
155744666|NCT02946931|562163747|FG000|Overall Study|Discharge from hospital|118|||
155744667|NCT02946931|562163747|FG000|Overall Study|Adverse Event|81|||
155744668|NCT02946931|562163747|FG000|Overall Study|CRFs not valid|1|||
155744669|NCT02946931|562163747|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
155744670|NCT00869778|562163751|FG000|Overall Study|Adverse Event|2|||
155744671|NCT00869778|562163752|FG001|Overall Study|Adverse Event|0|||
155744672|NCT00869778|562163753|FG002|Overall Study|Adverse Event|0|||
155744673|NCT00869778|562163751|FG000|Overall Study|Withdrawal by Subject|3|||
155744674|NCT00869778|562163752|FG001|Overall Study|Withdrawal by Subject|4|||
155744675|NCT00869778|562163753|FG002|Overall Study|Withdrawal by Subject|5|||
155744676|NCT00869778|562163751|FG000|Overall Study|Pregnancy|1|||
155744677|NCT00869778|562163752|FG001|Overall Study|Pregnancy|0|||
155744678|NCT00869778|562163753|FG002|Overall Study|Pregnancy|0|||
155744679|NCT00869778|562163751|FG000|Overall Study|Protocol Violation|5|||
155744680|NCT00869778|562163752|FG001|Overall Study|Protocol Violation|3|||
155744681|NCT00869778|562163753|FG002|Overall Study|Protocol Violation|5|||
155744682|NCT00869778|562163751|FG000|Overall Study|Unblinding|1|||
155744683|NCT00869778|562163752|FG001|Overall Study|Unblinding|0|||
155744684|NCT00869778|562163753|FG002|Overall Study|Unblinding|0|||
155744685|NCT03339297|562163754|FG000|Overall Study|Relapse of Hematologic Disease|1|||
155744686|NCT03339297|562163755|FG001|Overall Study|Relapse of Hematologic Disease|0|||
155744687|NCT03339297|562163754|FG000|Overall Study|Death|10|||
155744688|NCT03339297|562163755|FG001|Overall Study|Death|7|||
155744689|NCT03339297|562163754|FG000|Overall Study|Hepatic Candidosis|1|||
155744690|NCT03339297|562163755|FG001|Overall Study|Hepatic Candidosis|0|||
155744691|NCT03339297|562163754|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
155744692|NCT03339297|562163755|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
155639478|NCT01496456|561770477|FG000|Overall Study|Protocol Violation|1|||
155639479|NCT01496456|561770477|FG000|Overall Study|Lost to Follow-up|7|||
155639480|NCT04919161|561770478|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
155639481|NCT04919161|561770479|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
155639482|NCT04919161|561770478|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
155639483|NCT04919161|561770479|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
155639484|NCT04919161|561770478|FG000|Overall Study|Acute ankle sprain after session 1|0|||
155639485|NCT04919161|561770479|FG001|Overall Study|Acute ankle sprain after session 1|1|||
155639486|NCT02489773|561770480|FG000|Overall Study|Lost to Follow-up|4|||
155639487|NCT02489773|561770481|FG001|Overall Study|Lost to Follow-up|1|||
155639488|NCT02489773|561770480|FG000|Overall Study|Physician Decision|1|||
155639489|NCT02489773|561770481|FG001|Overall Study|Physician Decision|0|||
155639490|NCT02489773|561770480|FG000|Overall Study|Withdrawal by Subject|1|||
155639491|NCT02489773|561770481|FG001|Overall Study|Withdrawal by Subject|0|||
155639492|NCT02489773|561770480|FG000|Overall Study|Leave the country or the state|1|||
155639493|NCT02489773|561770481|FG001|Overall Study|Leave the country or the state|1|||
155639494|NCT00712920|561770482|FG000|Overall Study|Adverse Event|3|||
155639495|NCT00712920|561770483|FG001|Overall Study|Adverse Event|4|||
155639496|NCT00712920|561770484|FG002|Overall Study|Adverse Event|7|||
155639497|NCT00712920|561770482|FG000|Overall Study|Withdrawal by Subject|4|||
155639498|NCT00712920|561770483|FG001|Overall Study|Withdrawal by Subject|2|||
155639499|NCT00712920|561770484|FG002|Overall Study|Withdrawal by Subject|1|||
155639500|NCT00712920|561770482|FG000|Overall Study|Lost to Follow-up|1|||
155639501|NCT00712920|561770483|FG001|Overall Study|Lost to Follow-up|4|||
155639502|NCT00712920|561770484|FG002|Overall Study|Lost to Follow-up|0|||
155639503|NCT00712920|561770482|FG000|Overall Study|Lack of Efficacy|1|||
155639504|NCT00712920|561770483|FG001|Overall Study|Lack of Efficacy|0|||
155639505|NCT00712920|561770484|FG002|Overall Study|Lack of Efficacy|1|||
155639506|NCT00712920|561770482|FG000|Overall Study|Other|5|||
155639507|NCT00712920|561770483|FG001|Overall Study|Other|7|||
155639508|NCT00712920|561770484|FG002|Overall Study|Other|3|||
155639509|NCT00712920|561770482|FG000|Overall Study|Non-compliance|3|||
155639510|NCT00712920|561770483|FG001|Overall Study|Non-compliance|0|||
155639511|NCT00712920|561770484|FG002|Overall Study|Non-compliance|0|||
155639512|NCT01555931|561770488|FG000|Overall Study|Lost to Follow-up|2|||
155639513|NCT01555931|561770489|FG001|Overall Study|Lost to Follow-up|5|||
155639514|NCT05696847|561770490|FG000|Overall Study|Withdrawal by Subject|1|||
155639515|NCT05696847|561770491|FG001|Overall Study|Withdrawal by Subject|0|||
155639516|NCT05696847|561770492|FG002|Overall Study|Withdrawal by Subject|0|||
155639517|NCT05696847|561770493|FG003|Overall Study|Withdrawal by Subject|0|||
155639518|NCT05696847|561770494|FG004|Overall Study|Withdrawal by Subject|0|||
155639519|NCT05696847|561770495|FG005|Overall Study|Withdrawal by Subject|0|||
155639520|NCT05696847|561770490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155639521|NCT05696847|561770491|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155639522|NCT05696847|561770492|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155639523|NCT05696847|561770493|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155639524|NCT05696847|561770494|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155639525|NCT05696847|561770495|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155639526|NCT05696847|561770490|FG000|Overall Study|Adverse Event|0|||
155639527|NCT05696847|561770491|FG001|Overall Study|Adverse Event|0|||
155639528|NCT05696847|561770492|FG002|Overall Study|Adverse Event|0|||
155639529|NCT05696847|561770493|FG003|Overall Study|Adverse Event|0|||
155639530|NCT05696847|561770494|FG004|Overall Study|Adverse Event|0|||
155639531|NCT05696847|561770495|FG005|Overall Study|Adverse Event|1|||
155639532|NCT05696847|561770490|FG000|Overall Study|Sponsor Decision|0|||
155639533|NCT05696847|561770491|FG001|Overall Study|Sponsor Decision|0|||
155639534|NCT05696847|561770492|FG002|Overall Study|Sponsor Decision|0|||
155639535|NCT05696847|561770493|FG003|Overall Study|Sponsor Decision|1|||
155639536|NCT05696847|561770494|FG004|Overall Study|Sponsor Decision|0|||
155639537|NCT05696847|561770495|FG005|Overall Study|Sponsor Decision|0|||
155639538|NCT01697579|561770496|FG000|Base Study-Cycle 1|Adverse Event|1|||
155639539|NCT01697579|561770497|FG001|Base Study-Cycle 1|Adverse Event|0|||
155639540|NCT01697579|561770498|FG002|Base Study-Cycle 1|Adverse Event|0|||
155639541|NCT01697579|561770499|FG003|Base Study-Cycle 1|Adverse Event|0|||
155639542|NCT01697579|561770500|FG004|Base Study-Cycle 1|Adverse Event|0|||
155639543|NCT01697579|561770501|FG005|Base Study-Cycle 1|Adverse Event|0|||
155639544|NCT01697579|561770502|FG006|Base Study-Cycle 1|Adverse Event|0|||
155639545|NCT01697579|561770496|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
155639546|NCT01697579|561770497|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639547|NCT01697579|561770498|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639548|NCT01697579|561770499|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639549|NCT01697579|561770500|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639550|NCT01697579|561770501|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639551|NCT01697579|561770502|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155639552|NCT01697579|561770496|FG000|Base Study-Cycle 1|Protocol Violation|0|||
155744693|NCT03339297|562163754|FG000|Overall Study|Consent Withdrawn by Participant|3|||
155744694|NCT03339297|562163755|FG001|Overall Study|Consent Withdrawn by Participant|3|||
155744695|NCT03339297|562163754|FG000|Overall Study|Disease Relapse|2|||
155744696|NCT03339297|562163755|FG001|Overall Study|Disease Relapse|0|||
155744697|NCT03339297|562163754|FG000|Overall Study|Physician Decision|1|||
155744698|NCT03339297|562163755|FG001|Overall Study|Physician Decision|1|||
155744699|NCT03339297|562163754|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
155744700|NCT03339297|562163755|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
155744701|NCT03339297|562163754|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
155744702|NCT03339297|562163755|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
155744703|NCT03339297|562163754|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
155744704|NCT03339297|562163755|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
155744705|NCT03339297|562163754|FG000|Overall Study|Adverse Event, Non-fatal|1|||
155744706|NCT03339297|562163755|FG001|Overall Study|Adverse Event, Non-fatal|0|||
155744707|NCT03339297|562163754|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
155744708|NCT03339297|562163755|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
155744709|NCT03339297|562163754|FG000|Overall Study|Patient Was Not Eligible|1|||
155744710|NCT03339297|562163755|FG001|Overall Study|Patient Was Not Eligible|0|||
155744711|NCT01566214|562163762|FG000|Overall Study|Lost to Follow-up|3|||
155744712|NCT01566214|562163763|FG001|Overall Study|Lost to Follow-up|0|||
155744713|NCT03051620|562163764|FG000|Overall Study|Lost to Follow-up|6|||
155744714|NCT03051620|562163764|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
155744715|NCT00393510|562163766|FG000|Overall Study|Physician Decision|3|||
155744716|NCT00393510|562163767|FG001|Overall Study|Physician Decision|9|||
155744717|NCT00770146|562163770|FG000|Treatment Period|Withdrawal by Subject|6|||
155744718|NCT00770146|562163771|FG001|Treatment Period|Withdrawal by Subject|13|||
155744719|NCT00770146|562163770|FG000|Treatment Period|Adverse Event|2|||
155744720|NCT00770146|562163771|FG001|Treatment Period|Adverse Event|26|||
155744721|NCT00770146|562163770|FG000|Treatment Period|Other|1|||
155744722|NCT00770146|562163771|FG001|Treatment Period|Other|5|||
155744723|NCT00770146|562163770|FG000|Treatment Period|Protocol non-compliance|0|||
155744724|NCT00770146|562163771|FG001|Treatment Period|Protocol non-compliance|1|||
155744725|NCT00770146|562163770|FG000|Follow-up Period|Withdrawal by Subject|7|||
155744726|NCT00770146|562163771|FG001|Follow-up Period|Withdrawal by Subject|13|||
155744727|NCT00770146|562163770|FG000|Follow-up Period|Adverse Event|0|||
155744728|NCT00770146|562163771|FG001|Follow-up Period|Adverse Event|2|||
155744729|NCT00770146|562163770|FG000|Follow-up Period|Other|4|||
155744730|NCT00770146|562163771|FG001|Follow-up Period|Other|5|||
155744731|NCT04620798|562163774|FG000|Overall Study|Lost to Follow-up|126|||
155744732|NCT04620798|562163775|FG001|Overall Study|Lost to Follow-up|138|||
155744733|NCT00674154|562163780|FG000|Overall Study|Withdrawal by Subject|3|||
155744734|NCT00674154|562163781|FG001|Overall Study|Withdrawal by Subject|1|||
155744735|NCT00674154|562163780|FG000|Overall Study|Did not want parathyroidectomy|0|||
155744736|NCT00674154|562163781|FG001|Overall Study|Did not want parathyroidectomy|2|||
155744737|NCT03222492|562163782|FG000|Overall Study|Withdrawal by Subject|0|||
155744738|NCT03222492|562163783|FG001|Overall Study|Withdrawal by Subject|0|||
155744739|NCT03222492|562163784|FG002|Overall Study|Withdrawal by Subject|1|||
155744740|NCT03222492|562163785|FG003|Overall Study|Withdrawal by Subject|0|||
155744741|NCT03222492|562163782|FG000|Overall Study|COVID-19 related|0|||
155744742|NCT03222492|562163783|FG001|Overall Study|COVID-19 related|0|||
155744743|NCT03222492|562163784|FG002|Overall Study|COVID-19 related|1|||
155744744|NCT03222492|562163785|FG003|Overall Study|COVID-19 related|0|||
155744745|NCT00816023|562163786|FG000|Overall Study|Lost to Follow-up|1|||
155744746|NCT00816023|562163787|FG001|Overall Study|Lost to Follow-up|1|||
155744747|NCT00816023|562163788|FG002|Overall Study|Lost to Follow-up|0|||
155744748|NCT00816023|562163789|FG003|Overall Study|Lost to Follow-up|0|||
155744749|NCT00816023|562163786|FG000|Overall Study|Withdrawal by Subject|1|||
155744750|NCT00816023|562163787|FG001|Overall Study|Withdrawal by Subject|0|||
155744751|NCT00816023|562163788|FG002|Overall Study|Withdrawal by Subject|0|||
155744752|NCT00816023|562163789|FG003|Overall Study|Withdrawal by Subject|0|||
155744753|NCT00816023|562163786|FG000|Overall Study|Physician Decision|0|||
155744754|NCT00816023|562163787|FG001|Overall Study|Physician Decision|0|||
155744755|NCT00816023|562163788|FG002|Overall Study|Physician Decision|1|||
155744756|NCT00816023|562163789|FG003|Overall Study|Physician Decision|0|||
155744757|NCT00816023|562163786|FG000|Overall Study|assessments complete prior to window|1|||
155744758|NCT00816023|562163787|FG001|Overall Study|assessments complete prior to window|1|||
155744759|NCT00816023|562163788|FG002|Overall Study|assessments complete prior to window|2|||
155744760|NCT00816023|562163789|FG003|Overall Study|assessments complete prior to window|1|||
155744761|NCT00816023|562163786|FG000|Overall Study|Randomized Not Treated|6|||
155744762|NCT00816023|562163787|FG001|Overall Study|Randomized Not Treated|4|||
155744763|NCT00816023|562163788|FG002|Overall Study|Randomized Not Treated|6|||
155744764|NCT00816023|562163789|FG003|Overall Study|Randomized Not Treated|11|||
155744765|NCT02907892|562165186|FG000|Overall Study|Lost to Follow-up|27|||
155744766|NCT02907892|562165187|FG001|Overall Study|Lost to Follow-up|40|||
155744767|NCT04531462|562165188|FG000|Overall Study|Withdrawal by Subject|3|||
155744768|NCT04531462|562165189|FG001|Overall Study|Withdrawal by Subject|1|||
155744769|NCT04531462|562165188|FG000|Overall Study|Adverse Event|3|||
155744770|NCT04531462|562165189|FG001|Overall Study|Adverse Event|3|||
155744771|NCT00348933|562165192|FG000|Overall Study|Withdrawal by Subject|10|||
155744772|NCT00348933|562165192|FG000|Overall Study|Lost to Follow-up|6|||
155744773|NCT00348933|562165192|FG000|Overall Study|Protocol Violation|2|||
155744774|NCT00348933|562165192|FG000|Overall Study|Adverse Event|7|||
155744775|NCT01489111|562165193|FG000|Overall Study|Withdrawal criterion|1|||
155744776|NCT01727700|562165194|FG000|Overall Study|Adverse Event|0|||
155744777|NCT01727700|562165195|FG001|Overall Study|Adverse Event|7|||
155744778|NCT01727700|562165196|FG002|Overall Study|Adverse Event|1|||
155744779|NCT01727700|562165194|FG000|Overall Study|Particpant withdrew consent|0|||
155744780|NCT01727700|562165195|FG001|Overall Study|Particpant withdrew consent|3|||
155495521|NCT00627094|561237851|FG000|Overall Study|Withdrawal by Subject|1|||
155495522|NCT00627094|561237852|FG001|Overall Study|Withdrawal by Subject|1|||
155495523|NCT00627094|561237851|FG000|Overall Study|ulcer healed|1|||
155495524|NCT00627094|561237852|FG001|Overall Study|ulcer healed|7|||
155495525|NCT00627094|561237851|FG000|Overall Study|Other reason|1|||
155495526|NCT00627094|561237852|FG001|Overall Study|Other reason|0|||
155495527|NCT00433771|561237857|FG000|Overall Study|screen fail|14|||
155495528|NCT00433771|561237857|FG000|Overall Study|Treated and later found to be ineligible|2|||
155495529|NCT00433771|561237857|FG000|Overall Study|Death|2|||
155495530|NCT00433771|561237857|FG000|Overall Study|Failure to deploy stent|1|||
155495531|NCT00138658|561237858|FG000|Overall Study|Adverse Event|23|||
155495532|NCT00138658|561237858|FG000|Overall Study|Death|1|||
155495533|NCT00138658|561237858|FG000|Overall Study|Disease Progression|21|||
155495534|NCT00138658|561237858|FG000|Overall Study|Physician Decision|11|||
155495535|NCT00138658|561237858|FG000|Overall Study|Withdrawal by Subject|5|||
155495536|NCT01965431|561237859|FG000|Overall Study|Adverse Event|0|||
155495537|NCT01965431|561237860|FG001|Overall Study|Adverse Event|1|||
155495538|NCT01965431|561237861|FG002|Overall Study|Adverse Event|0|||
155495539|NCT01965431|561237862|FG003|Overall Study|Adverse Event|0|||
155495540|NCT01965431|561237863|FG004|Overall Study|Adverse Event|0|||
155744781|NCT01727700|562165196|FG002|Overall Study|Particpant withdrew consent|1|||
155744782|NCT01727700|562165194|FG000|Overall Study|Protocol Violation|2|||
155744783|NCT01727700|562165195|FG001|Overall Study|Protocol Violation|0|||
155744784|NCT01727700|562165196|FG002|Overall Study|Protocol Violation|0|||
155744785|NCT01757691|562165199|FG000|Overall Study|Administrative problems|2|||
155744786|NCT01757691|562165200|FG001|Overall Study|Administrative problems|0|||
155744787|NCT03699475|562165201|FG000|Overall Study|Death|1|||
155744788|NCT01713933|562165202|FG000|Overall Study|Lost to Follow-up|2|||
155744789|NCT01713933|562165202|FG000|Overall Study|Withdrawal by Subject|3|||
155744790|NCT01713933|562165202|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
155744791|NCT00528970|562165205|FG000|Overall Study|Adverse Event|6|||
155744792|NCT00528970|562165206|FG001|Overall Study|Adverse Event|8|||
155744793|NCT00528970|562165207|FG002|Overall Study|Adverse Event|5|||
155744794|NCT00528970|562165205|FG000|Overall Study|Lost to Follow-up|0|||
155744795|NCT00528970|562165206|FG001|Overall Study|Lost to Follow-up|0|||
155744796|NCT00528970|562165207|FG002|Overall Study|Lost to Follow-up|1|||
155744797|NCT00528970|562165205|FG000|Overall Study|Other than specified|2|||
155744798|NCT00528970|562165206|FG001|Overall Study|Other than specified|3|||
155744799|NCT00528970|562165207|FG002|Overall Study|Other than specified|3|||
155744800|NCT00528970|562165205|FG000|Overall Study|Protocol Violation|2|||
155744801|NCT00528970|562165206|FG001|Overall Study|Protocol Violation|1|||
155744802|NCT00528970|562165207|FG002|Overall Study|Protocol Violation|4|||
155744803|NCT00528970|562165205|FG000|Overall Study|Lack of Efficacy|0|||
155744804|NCT00528970|562165206|FG001|Overall Study|Lack of Efficacy|0|||
155744805|NCT00528970|562165207|FG002|Overall Study|Lack of Efficacy|1|||
155744806|NCT00528970|562165205|FG000|Overall Study|Withdrawal by Subject|4|||
155744807|NCT00528970|562165206|FG001|Overall Study|Withdrawal by Subject|3|||
155744808|NCT00528970|562165207|FG002|Overall Study|Withdrawal by Subject|5|||
155744809|NCT00528970|562165205|FG000|Overall Study|Randomized but not treated|0|||
155744810|NCT00528970|562165206|FG001|Overall Study|Randomized but not treated|0|||
155744811|NCT00528970|562165207|FG002|Overall Study|Randomized but not treated|1|||
155495541|NCT01965431|561237864|FG005|Overall Study|Adverse Event|0|||
155495542|NCT01965431|561237859|FG000|Overall Study|Other than stated above|6|||
155495543|NCT01965431|561237860|FG001|Overall Study|Other than stated above|5|||
155495544|NCT01965431|561237861|FG002|Overall Study|Other than stated above|6|||
155495545|NCT01965431|561237862|FG003|Overall Study|Other than stated above|6|||
155495546|NCT01965431|561237863|FG004|Overall Study|Other than stated above|6|||
155495547|NCT01965431|561237864|FG005|Overall Study|Other than stated above|6|||
155495548|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
155495549|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
155495550|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
155495551|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
155495552|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
155495553|NCT01179191|561237867|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
155495554|NCT01179191|561237867|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
155495555|NCT01179191|561237867|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
155495556|NCT01179191|561237867|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
155495557|NCT01179191|561237867|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
155495558|NCT01179191|561237867|FG000|Maintenance Phase (8 Weeks)|Other|66|||
155495559|NCT01833897|561237877|FG000|Overall Study|Lack of Efficacy|1|||
155495560|NCT00669110|561237878|FG000|Overall Study|Adverse Event|4|||
155495561|NCT00669110|561237879|FG001|Overall Study|Adverse Event|3|||
155495562|NCT00669110|561237878|FG000|Overall Study|Caregiver request|3|||
155495563|NCT00669110|561237879|FG001|Overall Study|Caregiver request|2|||
155495564|NCT00669110|561237878|FG000|Overall Study|Physician Decision|0|||
155495565|NCT00669110|561237879|FG001|Overall Study|Physician Decision|1|||
155495566|NCT00669110|561237878|FG000|Overall Study|Lost to Follow-up|1|||
155495567|NCT00669110|561237879|FG001|Overall Study|Lost to Follow-up|0|||
155495568|NCT00669110|561237878|FG000|Overall Study|Protocol Violation|0|||
155495569|NCT00669110|561237879|FG001|Overall Study|Protocol Violation|5|||
155495570|NCT00669110|561237878|FG000|Overall Study|Withdrawal by Subject|0|||
155495571|NCT00669110|561237879|FG001|Overall Study|Withdrawal by Subject|2|||
155495572|NCT00806416|561237882|FG000|Period 1 - Part I|Adverse Event|0|||
155495573|NCT00806416|561237883|FG001|Period 1 - Part I|Adverse Event|1|||
155495574|NCT00806416|561237884|FG002|Period 1 - Part I|Adverse Event|0|||
155495575|NCT00806416|561237885|FG003|Period 1 - Part I|Adverse Event|0|||
155495576|NCT00806416|561237882|FG000|Period 1 - Part I|Lost to Follow-up|0|||
155495577|NCT00806416|561237883|FG001|Period 1 - Part I|Lost to Follow-up|2|||
155495578|NCT00806416|561237884|FG002|Period 1 - Part I|Lost to Follow-up|0|||
155495579|NCT00806416|561237885|FG003|Period 1 - Part I|Lost to Follow-up|0|||
155495580|NCT00806416|561237882|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
155495581|NCT00806416|561237883|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
155495582|NCT00806416|561237884|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
155495583|NCT00806416|561237885|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
155495584|NCT00806416|561237882|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
155495585|NCT00806416|561237883|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
155495586|NCT00806416|561237884|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
155495587|NCT00806416|561237885|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
155495588|NCT01244516|561237889|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
155495589|NCT01244516|561237890|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
155495590|NCT01244516|561237891|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
155495591|NCT01244516|561237889|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
155495592|NCT01244516|561237890|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
155495593|NCT01244516|561237891|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
155495594|NCT01244516|561237889|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
155495595|NCT01244516|561237890|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
155495596|NCT01244516|561237891|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
155495597|NCT01244516|561237889|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
155495598|NCT01244516|561237890|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
155495599|NCT01244516|561237891|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
155495600|NCT01244516|561237889|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
155495601|NCT01244516|561237890|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
155744812|NCT01009840|562165208|FG000|Overall Study|Lost to Follow-up|1|||
155744813|NCT01009840|562165208|FG000|Overall Study|Adverse Event|4|||
155744814|NCT01009840|562165208|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
155744815|NCT01009840|562165208|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
155744816|NCT01009840|562165208|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
155744817|NCT01011478|562165216|FG000|Overall Study|No follow up data|12|||
155744818|NCT01011478|562165217|FG001|Overall Study|No follow up data|7|||
155744819|NCT04461600|562165218|FG000|Overall Study|Death|6|||
155744820|NCT04461600|562165219|FG001|Overall Study|Death|5|||
155744821|NCT04461600|562165218|FG000|Overall Study|Withdrawal by Subject|0|||
155744822|NCT04461600|562165219|FG001|Overall Study|Withdrawal by Subject|1|||
155744823|NCT04905498|562165228|FG000|Overall Study|Lost to Follow-up|0|||
155744824|NCT04905498|562165229|FG001|Overall Study|Lost to Follow-up|2|||
155744825|NCT04905498|562165228|FG000|Overall Study|COVID lockdown|1|||
155744826|NCT04905498|562165229|FG001|Overall Study|COVID lockdown|0|||
155744827|NCT01525901|562165233|FG000|Period 2: 12 Weeks|Adverse Event|0|||
155744828|NCT01525901|562165234|FG001|Period 2: 12 Weeks|Adverse Event|1|||
155744829|NCT01525901|562165235|FG002|Period 2: 12 Weeks|Adverse Event|0|||
155744830|NCT01525901|562165236|FG003|Period 2: 12 Weeks|Adverse Event|0|||
155744831|NCT04449029|562165237|FG000|Overall Study|Adverse Event|0|||
155744832|NCT04449029|562165238|FG001|Overall Study|Adverse Event|1|||
155495602|NCT01244516|561237891|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
155495603|NCT01244516|561237889|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
155495604|NCT01244516|561237890|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
155495605|NCT01244516|561237891|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
155495606|NCT01244516|561237889|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
155744833|NCT04449029|562165239|FG002|Overall Study|Adverse Event|1|||
155744834|NCT04449029|562165240|FG003|Overall Study|Adverse Event|0|||
155744835|NCT04449029|562165241|FG004|Overall Study|Adverse Event|1|||
155744836|NCT04449029|562165242|FG005|Overall Study|Adverse Event|0|||
155744837|NCT04449029|562165243|FG006|Overall Study|Adverse Event|1|||
155744838|NCT04449029|562165244|FG007|Overall Study|Adverse Event|0|||
155744839|NCT04449029|562165237|FG000|Overall Study|Lost to Follow-up|0|||
155744840|NCT04449029|562165238|FG001|Overall Study|Lost to Follow-up|1|||
155744841|NCT04449029|562165239|FG002|Overall Study|Lost to Follow-up|0|||
155744842|NCT04449029|562165240|FG003|Overall Study|Lost to Follow-up|0|||
155744843|NCT04449029|562165241|FG004|Overall Study|Lost to Follow-up|0|||
155744844|NCT04449029|562165242|FG005|Overall Study|Lost to Follow-up|0|||
155744845|NCT04449029|562165243|FG006|Overall Study|Lost to Follow-up|0|||
155744846|NCT04449029|562165244|FG007|Overall Study|Lost to Follow-up|0|||
155744847|NCT04449029|562165237|FG000|Overall Study|Protocol Violation|0|||
155744848|NCT04449029|562165238|FG001|Overall Study|Protocol Violation|1|||
155744849|NCT04449029|562165239|FG002|Overall Study|Protocol Violation|0|||
155495607|NCT01244516|561237890|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
155495608|NCT01244516|561237891|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
155495609|NCT01102972|561237894|FG000|Overall Study|Adverse Event|8|||
155495610|NCT01102972|561237895|FG001|Overall Study|Adverse Event|2|||
155495611|NCT01102972|561237894|FG000|Overall Study|Lack of Efficacy|2|||
155495612|NCT01102972|561237895|FG001|Overall Study|Lack of Efficacy|1|||
155495613|NCT01102972|561237894|FG000|Overall Study|Protocol Violation|1|||
155495614|NCT01102972|561237895|FG001|Overall Study|Protocol Violation|0|||
155495615|NCT01102972|561237894|FG000|Overall Study|Lost to Follow-up|10|||
155495616|NCT01102972|561237895|FG001|Overall Study|Lost to Follow-up|5|||
155495617|NCT01102972|561237894|FG000|Overall Study|Investigator Discretion|2|||
155495618|NCT01102972|561237895|FG001|Overall Study|Investigator Discretion|0|||
155495619|NCT01102972|561237894|FG000|Overall Study|Withdrawal by Subject|6|||
155495620|NCT01102972|561237895|FG001|Overall Study|Withdrawal by Subject|6|||
155495621|NCT01886105|561237899|FG000|Overall Study|Lack of Efficacy|3|||
155495622|NCT01360021|561237902|FG000|Overall Study|Eligibility criteria + other|2|||
155495623|NCT01360021|561237903|FG001|Overall Study|Eligibility criteria + other|1|||
155495624|NCT01360021|561237904|FG002|Overall Study|Eligibility criteria + other|1|||
155495625|NCT01360021|561237902|FG000|Overall Study|Protocol Violation|0|||
155495626|NCT01360021|561237903|FG001|Overall Study|Protocol Violation|0|||
155495627|NCT01360021|561237904|FG002|Overall Study|Protocol Violation|1|||
155495628|NCT01360021|561237902|FG000|Overall Study|Withdrawal by Subject|4|||
155495629|NCT01360021|561237903|FG001|Overall Study|Withdrawal by Subject|0|||
155495630|NCT01360021|561237904|FG002|Overall Study|Withdrawal by Subject|2|||
155744850|NCT04449029|562165240|FG003|Overall Study|Protocol Violation|0|||
155744851|NCT04449029|562165241|FG004|Overall Study|Protocol Violation|0|||
155744852|NCT04449029|562165242|FG005|Overall Study|Protocol Violation|0|||
155744853|NCT04449029|562165243|FG006|Overall Study|Protocol Violation|0|||
155744854|NCT04449029|562165244|FG007|Overall Study|Protocol Violation|0|||
155744855|NCT04449029|562165237|FG000|Overall Study|Physician Decision|0|||
155744856|NCT04449029|562165238|FG001|Overall Study|Physician Decision|0|||
155744857|NCT04449029|562165239|FG002|Overall Study|Physician Decision|0|||
155744858|NCT04449029|562165240|FG003|Overall Study|Physician Decision|0|||
155744859|NCT04449029|562165241|FG004|Overall Study|Physician Decision|0|||
155744860|NCT04449029|562165242|FG005|Overall Study|Physician Decision|1|||
155744861|NCT04449029|562165243|FG006|Overall Study|Physician Decision|0|||
155744862|NCT04449029|562165244|FG007|Overall Study|Physician Decision|0|||
155744863|NCT04449029|562165237|FG000|Overall Study|Withdrawal by Subject|3|||
155744864|NCT04449029|562165238|FG001|Overall Study|Withdrawal by Subject|0|||
155744865|NCT04449029|562165239|FG002|Overall Study|Withdrawal by Subject|1|||
155744866|NCT04449029|562165240|FG003|Overall Study|Withdrawal by Subject|1|||
155744867|NCT04449029|562165241|FG004|Overall Study|Withdrawal by Subject|5|||
155294384|NCT00150176|560507326|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
155744868|NCT04449029|562165242|FG005|Overall Study|Withdrawal by Subject|1|||
155744869|NCT04449029|562165243|FG006|Overall Study|Withdrawal by Subject|4|||
155744870|NCT04449029|562165244|FG007|Overall Study|Withdrawal by Subject|0|||
155744871|NCT02486627|562165245|FG000|Overall Study|Death|1|||
155744872|NCT02486627|562165246|FG001|Overall Study|Death|0|||
155744873|NCT02486627|562165245|FG000|Overall Study|Other Unspecified|0|||
155495631|NCT01360021|561237902|FG000|Overall Study|Adverse Event|2|||
155495632|NCT01360021|561237903|FG001|Overall Study|Adverse Event|3|||
155495633|NCT01360021|561237904|FG002|Overall Study|Adverse Event|3|||
155495634|NCT00530621|561237905|FG000|Overall Study|Adverse Event|11|||
155294385|NCT00150176|560507325|FG000|Overall Study|Withdrawal by Subject|19|||
155294386|NCT00150176|560507326|FG001|Overall Study|Withdrawal by Subject|12|||
155495635|NCT00530621|561237906|FG001|Overall Study|Adverse Event|8|||
155495636|NCT00530621|561237905|FG000|Overall Study|Physician Decision|2|||
155744874|NCT02486627|562165246|FG001|Overall Study|Other Unspecified|2|||
155495637|NCT00530621|561237906|FG001|Overall Study|Physician Decision|4|||
155744875|NCT02486627|562165245|FG000|Overall Study|Consent Withdrawn by Participant|4|||
155639553|NCT01697579|561770497|FG001|Base Study-Cycle 1|Protocol Violation|0|||
155639554|NCT01697579|561770498|FG002|Base Study-Cycle 1|Protocol Violation|0|||
155639555|NCT01697579|561770499|FG003|Base Study-Cycle 1|Protocol Violation|0|||
155639556|NCT01697579|561770500|FG004|Base Study-Cycle 1|Protocol Violation|3|||
155639557|NCT01697579|561770501|FG005|Base Study-Cycle 1|Protocol Violation|0|||
155639558|NCT01697579|561770502|FG006|Base Study-Cycle 1|Protocol Violation|0|||
155639559|NCT01697579|561770496|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639560|NCT01697579|561770497|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
155639561|NCT01697579|561770498|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639562|NCT01697579|561770499|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639563|NCT01697579|561770500|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639564|NCT01697579|561770501|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639565|NCT01697579|561770502|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155639566|NCT01697579|561770496|FG000|Base Study-Cycle 1|Technical Problems|0|||
155639567|NCT01697579|561770497|FG001|Base Study-Cycle 1|Technical Problems|0|||
155639568|NCT01697579|561770498|FG002|Base Study-Cycle 1|Technical Problems|1|||
155639569|NCT01697579|561770499|FG003|Base Study-Cycle 1|Technical Problems|1|||
155639570|NCT01697579|561770500|FG004|Base Study-Cycle 1|Technical Problems|0|||
155639571|NCT01697579|561770501|FG005|Base Study-Cycle 1|Technical Problems|0|||
155639572|NCT01697579|561770502|FG006|Base Study-Cycle 1|Technical Problems|0|||
155639573|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Death|0|||
155639574|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Death|0|||
155639575|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Death|0|||
155639576|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Death|0|||
155639577|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Death|0|||
155639578|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Death|0|||
155639579|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Death|2|||
155639580|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155639581|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155639582|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155639583|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155639584|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155639585|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
155639586|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
155639587|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
155639588|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
155639589|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
155639590|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
155639591|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
155639592|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
155639593|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
155639594|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155639595|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155639596|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155639597|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155639598|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155639599|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155744876|NCT02486627|562165246|FG001|Overall Study|Consent Withdrawn by Participant|3|||
155744877|NCT02486627|562165245|FG000|Overall Study|Significant Participant Noncompliance|1|||
155744878|NCT02486627|562165246|FG001|Overall Study|Significant Participant Noncompliance|1|||
155744879|NCT02486627|562165245|FG000|Overall Study|Lost to Follow-up|1|||
155744880|NCT02486627|562165246|FG001|Overall Study|Lost to Follow-up|3|||
155744881|NCT02112045|562165249|FG000|Overall Study|Withdrawal by Subject|1|||
155744882|NCT02112045|562165250|FG001|Overall Study|Withdrawal by Subject|0|||
155744883|NCT01073462|562165251|FG000|Overall Study|Death|14|||
155744884|NCT01073462|562165251|FG000|Overall Study|Kidney transplant|10|||
155744885|NCT01073462|562165251|FG000|Overall Study|Low parathyroid hormone levels|8|||
155744886|NCT01073462|562165251|FG000|Overall Study|Serious adverse event|2|||
155744887|NCT01073462|562165251|FG000|Overall Study|Lost to Follow-up|7|||
155744888|NCT00247611|562165256|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
155744889|NCT00247611|562165257|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
155744890|NCT00247611|562165256|FG000|Baselined|Completed baseline only|9|||
155744891|NCT00247611|562165257|FG001|Baselined|Completed baseline only|8|||
155744892|NCT05395091|562165258|FG000|Baseline to Month 12|Adverse Event|7|||
155744893|NCT05395091|562165259|FG001|Baseline to Month 12|Adverse Event|2|||
155744894|NCT05395091|562165260|FG002|Baseline to Month 12|Adverse Event|0|||
155744895|NCT05395091|562165258|FG000|Baseline to Month 12|Death|3|||
155744896|NCT05395091|562165259|FG001|Baseline to Month 12|Death|1|||
155744897|NCT05395091|562165260|FG002|Baseline to Month 12|Death|0|||
155744898|NCT05395091|562165258|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
155744899|NCT05395091|562165259|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
155495638|NCT00530621|561237905|FG000|Overall Study|Progressive Disease (PD)|47|||
155495639|NCT00530621|561237906|FG001|Overall Study|Progressive Disease (PD)|40|||
155495640|NCT00530621|561237905|FG000|Overall Study|Sponsor Decision|12|||
155495641|NCT00530621|561237906|FG001|Overall Study|Sponsor Decision|15|||
155495642|NCT00530621|561237905|FG000|Overall Study|Subject Decision|4|||
155495643|NCT00530621|561237906|FG001|Overall Study|Subject Decision|7|||
155495644|NCT00530621|561237905|FG000|Overall Study|Death|3|||
155495645|NCT00530621|561237906|FG001|Overall Study|Death|6|||
155495646|NCT00530621|561237905|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
155495647|NCT00530621|561237906|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
155495648|NCT01875731|561237912|FG000|Overall Study|Fail to obtain lab sample|1|||
155495649|NCT01875731|561237913|FG001|Overall Study|Fail to obtain lab sample|0|||
155495650|NCT02576951|561237914|FG000|Overall Study|Lost to Follow-up|0|||
155495651|NCT02576951|561237915|FG001|Overall Study|Lost to Follow-up|0|||
155495652|NCT02576951|561237916|FG002|Overall Study|Lost to Follow-up|2|||
155495653|NCT02576951|561237917|FG003|Overall Study|Lost to Follow-up|2|||
155495654|NCT02576951|561237914|FG000|Overall Study|Withdrawal by Subject|1|||
155495655|NCT02576951|561237915|FG001|Overall Study|Withdrawal by Subject|0|||
155495656|NCT02576951|561237916|FG002|Overall Study|Withdrawal by Subject|0|||
155495657|NCT02576951|561237917|FG003|Overall Study|Withdrawal by Subject|2|||
155495658|NCT02576951|561237914|FG000|Overall Study|Protocol Violation|0|||
155495659|NCT02576951|561237915|FG001|Overall Study|Protocol Violation|0|||
155495660|NCT02576951|561237916|FG002|Overall Study|Protocol Violation|0|||
155495661|NCT02576951|561237917|FG003|Overall Study|Protocol Violation|1|||
155495662|NCT03417102|561237918|FG000|Overall Study|Adverse Event|0|||
155495663|NCT03417102|561237919|FG001|Overall Study|Adverse Event|1|||
155495664|NCT03417102|561237918|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
155495665|NCT03417102|561237919|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
155495666|NCT03417102|561237918|FG000|Overall Study|Other|0|||
155495667|NCT03417102|561237919|FG001|Overall Study|Other|1|||
155495668|NCT02062385|561237923|FG000|Overall Study|Adverse Event|19|||
155495669|NCT02062385|561237924|FG001|Overall Study|Adverse Event|13|||
155495670|NCT02062385|561237925|FG002|Overall Study|Adverse Event|1|||
155495671|NCT02062385|561237926|FG003|Overall Study|Adverse Event|0|||
155495672|NCT02062385|561237923|FG000|Overall Study|Protocol Violation|1|||
155495673|NCT02062385|561237924|FG001|Overall Study|Protocol Violation|0|||
155495674|NCT02062385|561237925|FG002|Overall Study|Protocol Violation|0|||
155495675|NCT02062385|561237926|FG003|Overall Study|Protocol Violation|0|||
155495676|NCT02062385|561237923|FG000|Overall Study|Incomplete EPI by database lock|2|||
155495677|NCT02062385|561237924|FG001|Overall Study|Incomplete EPI by database lock|0|||
155495678|NCT02062385|561237925|FG002|Overall Study|Incomplete EPI by database lock|0|||
155495679|NCT02062385|561237926|FG003|Overall Study|Incomplete EPI by database lock|0|||
155495680|NCT02062385|561237923|FG000|Overall Study|Moved|10|||
155495681|NCT02062385|561237924|FG001|Overall Study|Moved|11|||
155495682|NCT02062385|561237925|FG002|Overall Study|Moved|1|||
155495683|NCT02062385|561237926|FG003|Overall Study|Moved|0|||
155495684|NCT02062385|561237923|FG000|Overall Study|Withdrawn by parent/guardian|46|||
155495685|NCT02062385|561237924|FG001|Overall Study|Withdrawn by parent/guardian|41|||
155495686|NCT02062385|561237925|FG002|Overall Study|Withdrawn by parent/guardian|9|||
155495687|NCT02062385|561237926|FG003|Overall Study|Withdrawn by parent/guardian|8|||
155495688|NCT02062385|561237923|FG000|Overall Study|Death|0|||
155495689|NCT02062385|561237924|FG001|Overall Study|Death|0|||
155495690|NCT02062385|561237925|FG002|Overall Study|Death|0|||
155495691|NCT02062385|561237926|FG003|Overall Study|Death|1|||
155495692|NCT02062385|561237923|FG000|Overall Study|Lost to Follow-up|0|||
155495693|NCT02062385|561237924|FG001|Overall Study|Lost to Follow-up|0|||
155495694|NCT02062385|561237925|FG002|Overall Study|Lost to Follow-up|1|||
155495695|NCT02062385|561237926|FG003|Overall Study|Lost to Follow-up|0|||
155495696|NCT03188991|561237927|FG000|Overall Study|Withdrawal by Subject|0|||
155495697|NCT03188991|561237928|FG001|Overall Study|Withdrawal by Subject|0|||
155495698|NCT03188991|561237929|FG002|Overall Study|Withdrawal by Subject|0|||
155495699|NCT03188991|561237930|FG003|Overall Study|Withdrawal by Subject|1|||
155495700|NCT00223990|561237931|FG000|Overall Study|Moved from area|2|||
155495701|NCT00223990|561237932|FG001|Overall Study|Moved from area|1|||
155294387|NCT00150176|560507325|FG000|Overall Study|Lost to Follow-up|3|||
155495702|NCT00223990|561237931|FG000|Overall Study|Withdrawal by Subject|4|||
155495703|NCT00223990|561237932|FG001|Overall Study|Withdrawal by Subject|8|||
155495704|NCT00223990|561237931|FG000|Overall Study|Lost to Follow-up|1|||
155495705|NCT00223990|561237932|FG001|Overall Study|Lost to Follow-up|0|||
155495706|NCT01392469|561240296|FG000|Overall Study|Adverse Event|2|||
155495707|NCT01392469|561240296|FG000|Overall Study|Withdrawal by Subject|1|||
155294388|NCT00150176|560507326|FG001|Overall Study|Lost to Follow-up|3|||
155495708|NCT01392469|561240296|FG000|Overall Study|Protocol Violation|1|||
155495709|NCT03255226|561240302|FG000|Overall Study|Adverse Event|2|||
155495710|NCT03255226|561240302|FG000|Overall Study|Physician Decision|3|||
155495711|NCT03255226|561240302|FG000|Overall Study|Withdrawal by Subject|1|||
155294389|NCT00150176|560507325|FG000|Overall Study|OTHER|11|||
155294390|NCT00150176|560507326|FG001|Overall Study|OTHER|13|||
155495712|NCT03255226|561240302|FG000|Overall Study|Serum or blood sodium increased|4|||
155495713|NCT03255226|561240302|FG000|Overall Study|Serum or blood potassium increased|4|||
155495714|NCT01035229|561240303|FG000|Overall Study|Adverse Event|61|||
155495715|NCT01035229|561240304|FG001|Overall Study|Adverse Event|14|||
155495716|NCT01035229|561240303|FG000|Overall Study|Withdrawal by Subject|20|||
155495717|NCT01035229|561240304|FG001|Overall Study|Withdrawal by Subject|7|||
155495718|NCT01035229|561240303|FG000|Overall Study|Lost to Follow-up|1|||
155495719|NCT01035229|561240304|FG001|Overall Study|Lost to Follow-up|0|||
155495720|NCT01035229|561240303|FG000|Overall Study|Administrative problems|1|||
155495721|NCT01035229|561240304|FG001|Overall Study|Administrative problems|1|||
155495722|NCT01035229|561240303|FG000|Overall Study|Death|13|||
155495723|NCT01035229|561240304|FG001|Overall Study|Death|5|||
155495724|NCT01035229|561240303|FG000|Overall Study|New cancer therapy|2|||
155495725|NCT01035229|561240304|FG001|Overall Study|New cancer therapy|0|||
155495726|NCT01035229|561240303|FG000|Overall Study|Protocol Violation|0|||
155495727|NCT01035229|561240304|FG001|Overall Study|Protocol Violation|2|||
155495728|NCT01035229|561240303|FG000|Overall Study|Sponsor's decision to end study|3|||
155495729|NCT01035229|561240304|FG001|Overall Study|Sponsor's decision to end study|3|||
155495730|NCT01035229|561240303|FG000|Overall Study|Disease Progression|261|||
155495731|NCT01035229|561240304|FG001|Overall Study|Disease Progression|152|||
155495732|NCT00648739|561240306|FG000|Overall Study|Adverse Event|1|||
155495733|NCT00648739|561240307|FG001|Overall Study|Adverse Event|0|||
155495734|NCT00648739|561240308|FG002|Overall Study|Adverse Event|1|||
155495735|NCT00648739|561240309|FG003|Overall Study|Adverse Event|2|||
155495736|NCT00648739|561240310|FG004|Overall Study|Adverse Event|1|||
155495737|NCT00648739|561240311|FG005|Overall Study|Adverse Event|0|||
155495738|NCT00648739|561240312|FG006|Overall Study|Adverse Event|0|||
155495739|NCT00648739|561240306|FG000|Overall Study|Withdrawal by Subject|1|||
155495740|NCT00648739|561240307|FG001|Overall Study|Withdrawal by Subject|0|||
155495741|NCT00648739|561240308|FG002|Overall Study|Withdrawal by Subject|1|||
155495742|NCT00648739|561240309|FG003|Overall Study|Withdrawal by Subject|0|||
155495743|NCT00648739|561240310|FG004|Overall Study|Withdrawal by Subject|0|||
155495744|NCT00648739|561240311|FG005|Overall Study|Withdrawal by Subject|2|||
155495745|NCT00648739|561240312|FG006|Overall Study|Withdrawal by Subject|0|||
155495746|NCT00648739|561240306|FG000|Overall Study|Lack of Efficacy|0|||
155495747|NCT00648739|561240307|FG001|Overall Study|Lack of Efficacy|0|||
155495748|NCT00648739|561240308|FG002|Overall Study|Lack of Efficacy|0|||
155495749|NCT00648739|561240309|FG003|Overall Study|Lack of Efficacy|0|||
155495750|NCT00648739|561240310|FG004|Overall Study|Lack of Efficacy|1|||
155495751|NCT00648739|561240311|FG005|Overall Study|Lack of Efficacy|2|||
155495752|NCT00648739|561240312|FG006|Overall Study|Lack of Efficacy|0|||
155495753|NCT00648739|561240306|FG000|Overall Study|Investigator Considered it Advisable|0|||
155495754|NCT00648739|561240307|FG001|Overall Study|Investigator Considered it Advisable|0|||
155495755|NCT00648739|561240308|FG002|Overall Study|Investigator Considered it Advisable|0|||
155495756|NCT00648739|561240309|FG003|Overall Study|Investigator Considered it Advisable|0|||
155495757|NCT00648739|561240310|FG004|Overall Study|Investigator Considered it Advisable|0|||
155495758|NCT00648739|561240311|FG005|Overall Study|Investigator Considered it Advisable|1|||
155495759|NCT00648739|561240312|FG006|Overall Study|Investigator Considered it Advisable|1|||
155495760|NCT00648739|561240306|FG000|Overall Study|Death|0|||
155495761|NCT00648739|561240307|FG001|Overall Study|Death|1|||
155495762|NCT00648739|561240308|FG002|Overall Study|Death|0|||
155495763|NCT00648739|561240309|FG003|Overall Study|Death|0|||
155495764|NCT00648739|561240310|FG004|Overall Study|Death|0|||
155495765|NCT00648739|561240311|FG005|Overall Study|Death|0|||
155495766|NCT00648739|561240312|FG006|Overall Study|Death|0|||
155495767|NCT00648739|561240306|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
155495768|NCT00648739|561240307|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
155495769|NCT00648739|561240308|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
155495770|NCT00648739|561240309|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
155495771|NCT00648739|561240310|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
155495772|NCT00648739|561240311|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
155495773|NCT00648739|561240312|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
155495774|NCT00648739|561240306|FG000|Overall Study|Follow-up Visits Not Completed|0|||
155495775|NCT00648739|561240307|FG001|Overall Study|Follow-up Visits Not Completed|1|||
155495776|NCT00648739|561240308|FG002|Overall Study|Follow-up Visits Not Completed|0|||
155495777|NCT00648739|561240309|FG003|Overall Study|Follow-up Visits Not Completed|0|||
155495778|NCT00648739|561240310|FG004|Overall Study|Follow-up Visits Not Completed|0|||
155495779|NCT00648739|561240311|FG005|Overall Study|Follow-up Visits Not Completed|0|||
155495780|NCT00648739|561240312|FG006|Overall Study|Follow-up Visits Not Completed|0|||
155495781|NCT00698009|561240315|FG000|Overall Study|Withdrawal by Subject|1|||
155495782|NCT00564486|561240319|FG000|Overall Study|Adverse Event|0|||
155495783|NCT00564486|561240320|FG001|Overall Study|Adverse Event|1|||
155495784|NCT00564486|561240321|FG002|Overall Study|Adverse Event|0|||
155495785|NCT00564486|561240322|FG003|Overall Study|Adverse Event|0|||
155495786|NCT00564486|561240319|FG000|Overall Study|Withdrawal by Subject|4|||
155495787|NCT00564486|561240320|FG001|Overall Study|Withdrawal by Subject|0|||
155495788|NCT00564486|561240321|FG002|Overall Study|Withdrawal by Subject|0|||
155495789|NCT00564486|561240322|FG003|Overall Study|Withdrawal by Subject|5|||
155495790|NCT00564486|561240319|FG000|Overall Study|Subject refused to have blood drawn|0|||
155495791|NCT00564486|561240320|FG001|Overall Study|Subject refused to have blood drawn|0|||
155495792|NCT00564486|561240321|FG002|Overall Study|Subject refused to have blood drawn|1|||
155495793|NCT00564486|561240322|FG003|Overall Study|Subject refused to have blood drawn|0|||
155639600|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
155639601|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155495794|NCT00564486|561240319|FG000|Overall Study|Lost to Follow-up|3|||
155495795|NCT00564486|561240320|FG001|Overall Study|Lost to Follow-up|0|||
155495796|NCT00564486|561240321|FG002|Overall Study|Lost to Follow-up|2|||
155495797|NCT00564486|561240322|FG003|Overall Study|Lost to Follow-up|2|||
155495798|NCT03387423|561240323|FG000|Overall Study|Lost to Follow-up|16|||
155495799|NCT03387423|561240324|FG001|Overall Study|Lost to Follow-up|12|||
155495800|NCT03387423|561240325|FG002|Overall Study|Lost to Follow-up|1|||
155495801|NCT03387423|561240326|FG003|Overall Study|Lost to Follow-up|0|||
155495802|NCT03387423|561240323|FG000|Overall Study|Other|0|||
155495803|NCT03387423|561240324|FG001|Overall Study|Other|3|||
155495804|NCT03387423|561240325|FG002|Overall Study|Other|0|||
155495805|NCT03387423|561240326|FG003|Overall Study|Other|0|||
155495806|NCT03387423|561240323|FG000|Overall Study|Administrative Reason|166|||
155495807|NCT03387423|561240324|FG001|Overall Study|Administrative Reason|89|||
155495808|NCT03387423|561240325|FG002|Overall Study|Administrative Reason|17|||
155495809|NCT03387423|561240326|FG003|Overall Study|Administrative Reason|19|||
155495810|NCT03387423|561240323|FG000|Overall Study|Revocation Consent|76|||
155495811|NCT03387423|561240324|FG001|Overall Study|Revocation Consent|32|||
155495812|NCT03387423|561240325|FG002|Overall Study|Revocation Consent|3|||
155495813|NCT03387423|561240326|FG003|Overall Study|Revocation Consent|5|||
155495814|NCT04362761|561240333|FG000|Part A (48 Weeks)|Adverse Event|2|||
155495815|NCT04362761|561240333|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
155495816|NCT04362761|561240333|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
155495817|NCT04362761|561240333|FG000|Part A (48 Weeks)|Other|5|||
155495818|NCT04362761|561240333|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
155495819|NCT04362761|561240333|FG000|Part B (86 Weeks)|Other|4|||
155495820|NCT00798707|561240336|FG000|Overall Study|Adverse Event|6|||
155495821|NCT00798707|561240337|FG001|Overall Study|Adverse Event|8|||
155495822|NCT00798707|561240338|FG002|Overall Study|Adverse Event|8|||
155495823|NCT00798707|561240336|FG000|Overall Study|Failed to return|2|||
155495824|NCT00798707|561240337|FG001|Overall Study|Failed to return|2|||
155495825|NCT00798707|561240338|FG002|Overall Study|Failed to return|0|||
155495826|NCT00798707|561240336|FG000|Overall Study|Investigator|0|||
155495827|NCT00798707|561240337|FG001|Overall Study|Investigator|1|||
155495828|NCT00798707|561240338|FG002|Overall Study|Investigator|2|||
155744900|NCT05395091|562165260|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
155744901|NCT05395091|562165258|FG000|Baseline to Month 12|Protocol Violation|2|||
155744902|NCT05395091|562165259|FG001|Baseline to Month 12|Protocol Violation|3|||
155744903|NCT05395091|562165260|FG002|Baseline to Month 12|Protocol Violation|0|||
155744904|NCT05395091|562165258|FG000|Baseline to Month 12|Physician Decision|1|||
155744905|NCT05395091|562165259|FG001|Baseline to Month 12|Physician Decision|0|||
155744906|NCT05395091|562165260|FG002|Baseline to Month 12|Physician Decision|0|||
155744907|NCT05395091|562165258|FG000|Month 12 to Month 18|Death|1|||
155744908|NCT05395091|562165259|FG001|Month 12 to Month 18|Death|0|||
155744909|NCT05395091|562165260|FG002|Month 12 to Month 18|Death|0|||
155744910|NCT05395091|562165258|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
155744911|NCT05395091|562165259|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
155744912|NCT05395091|562165260|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
155744913|NCT05395091|562165258|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
155744914|NCT05395091|562165259|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
155744915|NCT05395091|562165260|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
155744916|NCT05395091|562165258|FG000|Month 12 to Month 18|Other reasons|0|||
155744917|NCT05395091|562165259|FG001|Month 12 to Month 18|Other reasons|0|||
155744918|NCT05395091|562165260|FG002|Month 12 to Month 18|Other reasons|1|||
155744919|NCT01509053|562165262|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
155639602|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155639603|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155639604|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155639605|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155639606|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
155639607|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
155639608|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155744920|NCT01509053|562165262|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
155744921|NCT01509053|562165262|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
155744922|NCT01509053|562165262|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
155744923|NCT01509053|562165262|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
155744924|NCT01509053|562165262|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
155744925|NCT01915303|562165267|FG000|Core Phase|Adverse Event|7|||
155495829|NCT00798707|561240336|FG000|Overall Study|Lack of Efficacy|2|||
155495830|NCT00798707|561240337|FG001|Overall Study|Lack of Efficacy|2|||
155495831|NCT00798707|561240338|FG002|Overall Study|Lack of Efficacy|1|||
155294391|NCT04035668|560507327|FG000|Overall Study|Adverse Event|3|||
155294392|NCT04035668|560507328|FG001|Overall Study|Adverse Event|4|||
155294393|NCT04035668|560507329|FG002|Overall Study|Adverse Event|2|||
155294394|NCT04035668|560507327|FG000|Overall Study|Lost to Follow-up|0|||
155294395|NCT04035668|560507328|FG001|Overall Study|Lost to Follow-up|1|||
155294396|NCT04035668|560507329|FG002|Overall Study|Lost to Follow-up|0|||
155294397|NCT04035668|560507327|FG000|Overall Study|Physician Decision|2|||
155294398|NCT04035668|560507328|FG001|Overall Study|Physician Decision|1|||
155294399|NCT04035668|560507329|FG002|Overall Study|Physician Decision|1|||
155294400|NCT04035668|560507327|FG000|Overall Study|Subject Decision|2|||
155294401|NCT04035668|560507328|FG001|Overall Study|Subject Decision|2|||
155294402|NCT04035668|560507329|FG002|Overall Study|Subject Decision|0|||
155294403|NCT00004124|560507330|FG000|Overall Study|Received no protocol therapy|12|||
155294404|NCT00004124|560507331|FG001|Overall Study|Received no protocol therapy|20|||
155294405|NCT02224924|560507336|FG000|Overall Study|Withdrawal by Subject|7|||
155294406|NCT02224924|560507337|FG001|Overall Study|Withdrawal by Subject|6|||
155294407|NCT02224924|560507336|FG000|Overall Study|Biopsy cancelled|20|||
155294408|NCT02224924|560507337|FG001|Overall Study|Biopsy cancelled|14|||
155294409|NCT02224924|560507336|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
155294410|NCT02224924|560507337|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
155294411|NCT02224924|560507336|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
155294412|NCT02224924|560507337|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
155294413|NCT01458210|560507338|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
155294414|NCT01458210|560507338|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
155294415|NCT01458210|560507338|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
155294416|NCT01458210|560507338|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
155294417|NCT03923491|560507339|FG000|Overall Study|Lost to Follow-up|5|||
155294418|NCT03923491|560507340|FG001|Overall Study|Lost to Follow-up|8|||
155294419|NCT03923491|560507339|FG000|Overall Study|Withdrawal by Subject|4|||
155294420|NCT03923491|560507340|FG001|Overall Study|Withdrawal by Subject|6|||
155294421|NCT03823300|560507345|FG000|Overall Study|Withdrawal by Subject|16|||
155294422|NCT03823300|560507346|FG001|Overall Study|Withdrawal by Subject|22|||
155294423|NCT03823300|560507345|FG000|Overall Study|Death|10|||
155294424|NCT03823300|560507346|FG001|Overall Study|Death|14|||
155294425|NCT03823300|560507345|FG000|Overall Study|Adverse Event|3|||
155294426|NCT03823300|560507346|FG001|Overall Study|Adverse Event|5|||
155294427|NCT03823300|560507345|FG000|Overall Study|Physician Decision|1|||
155294428|NCT03823300|560507346|FG001|Overall Study|Physician Decision|7|||
155294429|NCT03823300|560507345|FG000|Overall Study|Lost to Follow-up|1|||
155294430|NCT03823300|560507346|FG001|Overall Study|Lost to Follow-up|3|||
155294431|NCT03823300|560507345|FG000|Overall Study|Protocol Violation|1|||
155294432|NCT03823300|560507346|FG001|Overall Study|Protocol Violation|1|||
155294433|NCT03823300|560507345|FG000|Overall Study|Lack of Efficacy|1|||
155294434|NCT03823300|560507346|FG001|Overall Study|Lack of Efficacy|1|||
155294435|NCT03823300|560507345|FG000|Overall Study|Not Eligible|0|||
155294436|NCT03823300|560507346|FG001|Overall Study|Not Eligible|1|||
155495832|NCT00798707|561240336|FG000|Overall Study|Lost to Follow-up|5|||
155495833|NCT00798707|561240337|FG001|Overall Study|Lost to Follow-up|6|||
155495834|NCT00798707|561240338|FG002|Overall Study|Lost to Follow-up|6|||
155495835|NCT00798707|561240336|FG000|Overall Study|Other|0|||
155495836|NCT00798707|561240337|FG001|Overall Study|Other|1|||
155639609|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155639610|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155639611|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155639612|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155639613|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
155639614|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155639615|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155639616|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155639617|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155639618|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155639619|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155639620|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
155639621|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
155639622|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155639623|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155639624|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155639625|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155639626|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155639627|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
155639628|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
155495837|NCT00798707|561240338|FG002|Overall Study|Other|0|||
155495838|NCT00798707|561240336|FG000|Overall Study|Protocol Violation|4|||
155495839|NCT00798707|561240337|FG001|Overall Study|Protocol Violation|0|||
155495840|NCT00798707|561240338|FG002|Overall Study|Protocol Violation|2|||
155495841|NCT00798707|561240336|FG000|Overall Study|Withdrawal by Subject|3|||
155495842|NCT00798707|561240337|FG001|Overall Study|Withdrawal by Subject|8|||
155495843|NCT00798707|561240338|FG002|Overall Study|Withdrawal by Subject|2|||
155495844|NCT00798707|561240336|FG000|Overall Study|Randomized not treated|4|||
155495845|NCT00798707|561240337|FG001|Overall Study|Randomized not treated|5|||
155495846|NCT00798707|561240338|FG002|Overall Study|Randomized not treated|1|||
155495847|NCT01473589|561240339|FG000|Overall Study|Adverse Event|1|||
155495848|NCT01473589|561240340|FG001|Overall Study|Adverse Event|1|||
155495849|NCT01473589|561240339|FG000|Overall Study|Death|2|||
155495850|NCT01473589|561240340|FG001|Overall Study|Death|0|||
155495851|NCT01473589|561240339|FG000|Overall Study|Lost to Follow-up|2|||
155495852|NCT01473589|561240340|FG001|Overall Study|Lost to Follow-up|2|||
155495853|NCT01473589|561240339|FG000|Overall Study|Protocol Violation|1|||
155495854|NCT01473589|561240340|FG001|Overall Study|Protocol Violation|0|||
155495855|NCT01473589|561240339|FG000|Overall Study|Withdrawal by Subject|5|||
155495856|NCT01473589|561240340|FG001|Overall Study|Withdrawal by Subject|11|||
155495857|NCT01473589|561240339|FG000|Overall Study|Physician Decision|0|||
155495858|NCT01473589|561240340|FG001|Overall Study|Physician Decision|1|||
155495859|NCT01473589|561240339|FG000|Overall Study|Entry criteria not met|0|||
155294437|NCT03823300|560507345|FG000|Overall Study|Other|1|||
155495860|NCT01473589|561240340|FG001|Overall Study|Entry criteria not met|1|||
155495861|NCT03457727|561240344|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
155495862|NCT03457727|561240345|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
155294438|NCT03823300|560507346|FG001|Overall Study|Other|0|||
155294439|NCT03622580|560507347|FG000|Overall Study|Death|16|||
155294440|NCT03622580|560507348|FG001|Overall Study|Death|21|||
155294441|NCT03622580|560507349|FG002|Overall Study|Death|13|||
155294442|NCT03622580|560507347|FG000|Overall Study|Adverse Event|6|||
155294443|NCT03622580|560507348|FG001|Overall Study|Adverse Event|6|||
155294444|NCT03622580|560507349|FG002|Overall Study|Adverse Event|5|||
155294445|NCT03622580|560507347|FG000|Overall Study|Withdrawal by Subject|12|||
155294446|NCT03622580|560507348|FG001|Overall Study|Withdrawal by Subject|7|||
155294447|NCT03622580|560507349|FG002|Overall Study|Withdrawal by Subject|19|||
155294448|NCT03622580|560507347|FG000|Overall Study|Lost to Follow-up|12|||
155294449|NCT03622580|560507348|FG001|Overall Study|Lost to Follow-up|9|||
155294450|NCT03622580|560507349|FG002|Overall Study|Lost to Follow-up|9|||
155294451|NCT03622580|560507347|FG000|Overall Study|Protocol Violation|1|||
155294452|NCT03622580|560507348|FG001|Overall Study|Protocol Violation|0|||
155294453|NCT03622580|560507349|FG002|Overall Study|Protocol Violation|1|||
155294454|NCT03622580|560507347|FG000|Overall Study|Physician Decision|3|||
155294455|NCT03622580|560507348|FG001|Overall Study|Physician Decision|0|||
155294456|NCT03622580|560507349|FG002|Overall Study|Physician Decision|1|||
155294457|NCT03622580|560507347|FG000|Overall Study|Pregnancy|0|||
155294458|NCT03622580|560507348|FG001|Overall Study|Pregnancy|1|||
155294459|NCT03622580|560507349|FG002|Overall Study|Pregnancy|0|||
155294460|NCT03622580|560507347|FG000|Overall Study|Lack of Efficacy|0|||
155294461|NCT03622580|560507348|FG001|Overall Study|Lack of Efficacy|0|||
155294462|NCT03622580|560507349|FG002|Overall Study|Lack of Efficacy|1|||
155294463|NCT03622580|560507347|FG000|Overall Study|Other|2|||
155294464|NCT03622580|560507348|FG001|Overall Study|Other|0|||
155294465|NCT03622580|560507349|FG002|Overall Study|Other|3|||
155294466|NCT01930045|560507354|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294467|NCT01930045|560507355|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294468|NCT01930045|560507356|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294469|NCT01930045|560507357|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294470|NCT01930045|560507358|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294471|NCT01930045|560507359|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
155294472|NCT01930045|560507354|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
155639629|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155639630|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155639631|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155639632|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155294473|NCT01930045|560507355|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
155639633|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155639634|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155639635|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
155639636|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
155639637|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
155639638|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
155639639|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
155294474|NCT01930045|560507356|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
155294475|NCT01930045|560507357|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
155294476|NCT01930045|560507358|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
155294477|NCT01930045|560507359|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
155294478|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
155294479|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
155294480|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
155294481|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
155294482|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
155294483|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
155294484|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
155294485|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
155294486|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
155294487|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
155294488|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
155294489|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
155294490|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
155294491|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
155294492|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
155294493|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
155294494|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
155294495|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
155294496|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
155294497|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
155294498|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
155294499|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
155294500|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
155294501|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
155294502|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294503|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294504|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
155294505|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294506|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
155294507|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
155294508|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
155294509|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
155294510|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
155294511|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
155294512|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
155294513|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
155294514|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
155294515|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
155495863|NCT03457727|561240346|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
155495864|NCT03457727|561240347|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
155495865|NCT01721200|561240350|FG000|Overall Study|Lost to Follow-up|3|||
155495866|NCT01721200|561240351|FG001|Overall Study|Lost to Follow-up|5|||
155495867|NCT03722849|561240354|FG000|Overall Study|Withdrawal by Subject|1|||
155495868|NCT03722849|561240355|FG001|Overall Study|Withdrawal by Subject|1|||
155495869|NCT03514121|561240356|FG000|Overall Study|Withdrawal by Subject|0|||
155495870|NCT03514121|561240357|FG001|Overall Study|Withdrawal by Subject|0|||
155495871|NCT03514121|561240358|FG002|Overall Study|Withdrawal by Subject|0|||
155495872|NCT03514121|561240359|FG003|Overall Study|Withdrawal by Subject|0|||
155495873|NCT03514121|561240360|FG004|Overall Study|Withdrawal by Subject|1|||
155495874|NCT03514121|561240361|FG005|Overall Study|Withdrawal by Subject|2|||
155495875|NCT03514121|561240362|FG006|Overall Study|Withdrawal by Subject|1|||
155495876|NCT03514121|561240363|FG007|Overall Study|Withdrawal by Subject|1|||
155495877|NCT03514121|561240364|FG008|Overall Study|Withdrawal by Subject|7|||
155495878|NCT03514121|561240365|FG009|Overall Study|Withdrawal by Subject|2|||
155495879|NCT03514121|561240356|FG000|Overall Study|Death|0|||
155495880|NCT03514121|561240357|FG001|Overall Study|Death|0|||
155495881|NCT03514121|561240358|FG002|Overall Study|Death|0|||
155495882|NCT03514121|561240359|FG003|Overall Study|Death|0|||
155495883|NCT03514121|561240360|FG004|Overall Study|Death|0|||
155495884|NCT03514121|561240361|FG005|Overall Study|Death|3|||
155495885|NCT03514121|561240362|FG006|Overall Study|Death|2|||
155495886|NCT03514121|561240363|FG007|Overall Study|Death|1|||
155294516|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
155294517|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
155294518|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
155495887|NCT03514121|561240364|FG008|Overall Study|Death|26|||
155495888|NCT03514121|561240365|FG009|Overall Study|Death|3|||
155294519|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
155294520|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
155495889|NCT03514121|561240356|FG000|Overall Study|Lost to Follow-up|0|||
155495890|NCT03514121|561240357|FG001|Overall Study|Lost to Follow-up|0|||
155495891|NCT03514121|561240358|FG002|Overall Study|Lost to Follow-up|1|||
155495892|NCT03514121|561240359|FG003|Overall Study|Lost to Follow-up|0|||
155495893|NCT03514121|561240360|FG004|Overall Study|Lost to Follow-up|0|||
155495894|NCT03514121|561240361|FG005|Overall Study|Lost to Follow-up|0|||
155495895|NCT03514121|561240362|FG006|Overall Study|Lost to Follow-up|0|||
155495896|NCT03514121|561240363|FG007|Overall Study|Lost to Follow-up|0|||
155495897|NCT03514121|561240364|FG008|Overall Study|Lost to Follow-up|1|||
155495898|NCT03514121|561240365|FG009|Overall Study|Lost to Follow-up|0|||
155495899|NCT03514121|561240356|FG000|Overall Study|Adverse Event|0|||
155495900|NCT03514121|561240357|FG001|Overall Study|Adverse Event|0|||
155495901|NCT03514121|561240358|FG002|Overall Study|Adverse Event|0|||
155495902|NCT03514121|561240359|FG003|Overall Study|Adverse Event|0|||
155495903|NCT03514121|561240360|FG004|Overall Study|Adverse Event|0|||
155495904|NCT03514121|561240361|FG005|Overall Study|Adverse Event|0|||
155495905|NCT03514121|561240362|FG006|Overall Study|Adverse Event|1|||
155495906|NCT03514121|561240363|FG007|Overall Study|Adverse Event|0|||
155495907|NCT03514121|561240364|FG008|Overall Study|Adverse Event|0|||
155495908|NCT03514121|561240365|FG009|Overall Study|Adverse Event|0|||
155495909|NCT03514121|561240356|FG000|Overall Study|Other|0|||
155495910|NCT03514121|561240357|FG001|Overall Study|Other|1|||
155495911|NCT03514121|561240358|FG002|Overall Study|Other|1|||
155495912|NCT03514121|561240359|FG003|Overall Study|Other|0|||
155495913|NCT03514121|561240360|FG004|Overall Study|Other|1|||
155495914|NCT03514121|561240361|FG005|Overall Study|Other|2|||
155495915|NCT03514121|561240362|FG006|Overall Study|Other|3|||
155495916|NCT03514121|561240363|FG007|Overall Study|Other|2|||
155495917|NCT03514121|561240364|FG008|Overall Study|Other|7|||
155495918|NCT03514121|561240365|FG009|Overall Study|Other|3|||
155495919|NCT03514121|561240356|FG000|Overall Study|Study termination by Sponsor|0|||
155495920|NCT03514121|561240357|FG001|Overall Study|Study termination by Sponsor|0|||
155495921|NCT03514121|561240358|FG002|Overall Study|Study termination by Sponsor|0|||
155495922|NCT03514121|561240359|FG003|Overall Study|Study termination by Sponsor|0|||
155495923|NCT03514121|561240360|FG004|Overall Study|Study termination by Sponsor|0|||
155495924|NCT03514121|561240361|FG005|Overall Study|Study termination by Sponsor|0|||
155495925|NCT03514121|561240362|FG006|Overall Study|Study termination by Sponsor|0|||
155495926|NCT03514121|561240363|FG007|Overall Study|Study termination by Sponsor|0|||
155495927|NCT03514121|561240364|FG008|Overall Study|Study termination by Sponsor|11|||
155495928|NCT03514121|561240365|FG009|Overall Study|Study termination by Sponsor|3|||
155495929|NCT03514121|561240356|FG000|Overall Study|Investigator decision|0|||
155495930|NCT03514121|561240357|FG001|Overall Study|Investigator decision|0|||
155495931|NCT03514121|561240358|FG002|Overall Study|Investigator decision|0|||
155495932|NCT03514121|561240359|FG003|Overall Study|Investigator decision|0|||
155495933|NCT03514121|561240360|FG004|Overall Study|Investigator decision|0|||
155495934|NCT03514121|561240361|FG005|Overall Study|Investigator decision|0|||
155495935|NCT03514121|561240362|FG006|Overall Study|Investigator decision|0|||
155495936|NCT03514121|561240363|FG007|Overall Study|Investigator decision|0|||
155495937|NCT03514121|561240364|FG008|Overall Study|Investigator decision|1|||
155495938|NCT03514121|561240365|FG009|Overall Study|Investigator decision|0|||
155495939|NCT04930536|561240366|FG000|Overall Study|Adverse Event|1|||
155495940|NCT04930536|561240367|FG001|Overall Study|Adverse Event|0|||
155495941|NCT04930536|561240366|FG000|Overall Study|Disease Progression|2|||
155495942|NCT04930536|561240367|FG001|Overall Study|Disease Progression|0|||
155495943|NCT04930536|561240366|FG000|Overall Study|Patient Decision|4|||
155495944|NCT04930536|561240367|FG001|Overall Study|Patient Decision|2|||
155495945|NCT04930536|561240366|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
155495946|NCT04930536|561240367|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
155495947|NCT01432600|561240368|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
155495948|NCT01432600|561240369|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
155495949|NCT01432600|561240370|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
155495950|NCT00740480|561240378|FG000|Overall Study|Adverse Event|1|||
155495951|NCT00740480|561240378|FG000|Overall Study|Physician Decision|1|||
155495952|NCT01005680|561240386|FG000|Overall Study|Lost to Follow-up|4|||
155495953|NCT01005680|561240387|FG001|Overall Study|Lost to Follow-up|6|||
155495954|NCT01005680|561240386|FG000|Overall Study|Withdrawal by Subject|1|||
155495955|NCT01005680|561240387|FG001|Overall Study|Withdrawal by Subject|4|||
155495956|NCT01005680|561240386|FG000|Overall Study|Physician Decision|1|||
155495957|NCT01005680|561240387|FG001|Overall Study|Physician Decision|1|||
155495958|NCT00297882|561240400|FG000|Day 14|Lack of Efficacy|12|||
155744926|NCT01915303|562165267|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
155744927|NCT01915303|562165267|FG000|Core Phase|Death|2|||
155744928|NCT01915303|562165267|FG000|Core Phase|Protocol Violation|2|||
155744929|NCT01915303|562165267|FG000|Core Phase|Abnormal lab value|1|||
155495959|NCT00297882|561240401|FG001|Day 14|Lack of Efficacy|49|||
155495960|NCT00297882|561240400|FG000|Day 28|Lost to Follow-up|13|||
155495961|NCT00297882|561240401|FG001|Day 28|Lost to Follow-up|23|||
155495962|NCT00297882|561240400|FG000|Day 28|Lack of Efficacy|3|||
155744930|NCT01915303|562165267|FG000|Core Phase|Withdrawal by Subject|1|||
155744931|NCT01915303|562165267|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
155744932|NCT01915303|562165267|FG000|Extension Phase|Withdrawal by Subject|4|||
155744933|NCT01915303|562165267|FG000|Extension Phase|Adverse Event|3|||
155744934|NCT01915303|562165267|FG000|Extension Phase|Death|1|||
155294521|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
155294522|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
155294523|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
155294524|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
155294525|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
155294526|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
155294527|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
155294528|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
155294529|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
155294530|NCT03959241|560507364|FG000|Overall Study|Withdrawal by Subject|7|||
155294531|NCT03959241|560507365|FG001|Overall Study|Withdrawal by Subject|8|||
155294532|NCT03959241|560507364|FG000|Overall Study|Lost to Follow-up|1|||
155294533|NCT03959241|560507365|FG001|Overall Study|Lost to Follow-up|0|||
155294534|NCT03959241|560507364|FG000|Overall Study|Move to Hospice Care|1|||
155495963|NCT00297882|561240401|FG001|Day 28|Lack of Efficacy|0|||
155495964|NCT04242264|561240402|FG000|Overall Study|Lost to Follow-up|2|||
155495965|NCT04242264|561240403|FG001|Overall Study|Lost to Follow-up|2|||
155495966|NCT04242264|561240404|FG002|Overall Study|Lost to Follow-up|1|||
155495967|NCT04242264|561240405|FG003|Overall Study|Lost to Follow-up|1|||
155495968|NCT04242264|561240402|FG000|Overall Study|Withdrawal by Subject|1|||
155495969|NCT04242264|561240403|FG001|Overall Study|Withdrawal by Subject|0|||
155495970|NCT04242264|561240404|FG002|Overall Study|Withdrawal by Subject|0|||
155495971|NCT04242264|561240405|FG003|Overall Study|Withdrawal by Subject|0|||
155495972|NCT02116309|561240408|FG000|Overall Study|Lost to Follow-up|0|||
155495973|NCT02116309|561240409|FG001|Overall Study|Lost to Follow-up|1|||
155495974|NCT03292731|561240410|FG000|Overall Study|Protocol Violation|4|||
155495975|NCT03292731|561240411|FG001|Overall Study|Protocol Violation|11|||
155495976|NCT03292731|561240412|FG002|Overall Study|Protocol Violation|1|||
155495977|NCT00348348|561240413|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
155495978|NCT00348348|561240414|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
155495979|NCT00348348|561240413|FG000|Overall Study|Lack of Efficacy|1|||
155495980|NCT00348348|561240414|FG001|Overall Study|Lack of Efficacy|1|||
155495981|NCT00348348|561240413|FG000|Overall Study|Lost to Follow-up|8|||
155495982|NCT00348348|561240414|FG001|Overall Study|Lost to Follow-up|10|||
155495983|NCT00348348|561240413|FG000|Overall Study|Withdrawal by Subject|4|||
155495984|NCT00348348|561240414|FG001|Overall Study|Withdrawal by Subject|1|||
155495985|NCT00348348|561240413|FG000|Overall Study|Other|7|||
155495986|NCT00348348|561240414|FG001|Overall Study|Other|4|||
155495987|NCT00348348|561240413|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
155495988|NCT00348348|561240414|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
155495989|NCT00348348|561240413|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
155495990|NCT00348348|561240414|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
155495991|NCT00348348|561240413|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
155495992|NCT00348348|561240414|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
155495993|NCT00348348|561240413|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
155495994|NCT00348348|561240414|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
155495995|NCT00348348|561240413|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
155495996|NCT00348348|561240414|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
155495997|NCT00348348|561240413|FG000|Overall Study|Adverse event probably related to study|1|||
155495998|NCT00348348|561240414|FG001|Overall Study|Adverse event probably related to study|0|||
155495999|NCT04221373|561240418|FG000|Overall Study|Physician Decision|4|||
155496000|NCT04221373|561240419|FG001|Overall Study|Physician Decision|0|||
155496001|NCT01165424|561240427|FG000|Overall Study|Clinical adverse experiences|1|||
155496002|NCT01165424|561240427|FG000|Overall Study|Laboratory adverse experiences|1|||
155496003|NCT01165424|561240427|FG000|Overall Study|Did not meet entry criteria|1|||
155496004|NCT01165424|561240427|FG000|Overall Study|Participant moved (relocated)|1|||
155496005|NCT04139642|561240428|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
155496006|NCT04139642|561240429|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
155496007|NCT03733301|561240442|FG000|Overall Study|Screen Fail|1|||
155496008|NCT03733301|561240443|FG001|Overall Study|Screen Fail|0|||
155496009|NCT03733301|561240444|FG002|Overall Study|Screen Fail|0|||
155496010|NCT03733301|561240442|FG000|Overall Study|Non-compliance|1|||
155496011|NCT03733301|561240443|FG001|Overall Study|Non-compliance|0|||
155294535|NCT03959241|560507365|FG001|Overall Study|Move to Hospice Care|0|||
155294536|NCT03959241|560507364|FG000|Overall Study|Screen Failure|1|||
155496012|NCT03733301|561240444|FG002|Overall Study|Non-compliance|0|||
155294537|NCT03959241|560507365|FG001|Overall Study|Screen Failure|0|||
155294538|NCT03959241|560507364|FG000|Overall Study|Disease Relapse|0|||
155294539|NCT03959241|560507365|FG001|Overall Study|Disease Relapse|1|||
155294540|NCT03959241|560507364|FG000|Overall Study|Off Study|1|||
155496013|NCT03733301|561240442|FG000|Overall Study|Lack of Efficacy|2|||
155496014|NCT03733301|561240443|FG001|Overall Study|Lack of Efficacy|3|||
155496015|NCT03733301|561240444|FG002|Overall Study|Lack of Efficacy|0|||
155496016|NCT03733301|561240442|FG000|Overall Study|Adverse Event|0|||
155294541|NCT03959241|560507365|FG001|Overall Study|Off Study|0|||
155294542|NCT01713530|560507370|FG000|Overall Study|Adverse Event|0|||
155294543|NCT01713530|560507371|FG001|Overall Study|Adverse Event|5|||
155294544|NCT01713530|560507370|FG000|Overall Study|Withdrawal criteria|21|||
155294545|NCT01713530|560507371|FG001|Overall Study|Withdrawal criteria|12|||
155294546|NCT01713530|560507370|FG000|Overall Study|Unclassified|4|||
155294547|NCT01713530|560507371|FG001|Overall Study|Unclassified|2|||
155294548|NCT00758602|560507372|FG000|Overall Study|Adverse Event|11|||
155294549|NCT00758602|560507373|FG001|Overall Study|Adverse Event|10|||
155294550|NCT00758602|560507372|FG000|Overall Study|Lost to Follow-up|4|||
155294551|NCT00758602|560507373|FG001|Overall Study|Lost to Follow-up|3|||
155294552|NCT00758602|560507372|FG000|Overall Study|Withdrawal by Subject|1|||
155294553|NCT00758602|560507373|FG001|Overall Study|Withdrawal by Subject|3|||
155294554|NCT00758602|560507372|FG000|Overall Study|Protocol Violation|0|||
155294555|NCT00758602|560507373|FG001|Overall Study|Protocol Violation|2|||
155294556|NCT00758602|560507372|FG000|Overall Study|Death|0|||
155294557|NCT00758602|560507373|FG001|Overall Study|Death|1|||
155294558|NCT00758602|560507372|FG000|Overall Study|Reason not specified|3|||
155294559|NCT00758602|560507373|FG001|Overall Study|Reason not specified|3|||
155294560|NCT05046132|560507374|FG000|Overall Study|Adverse Event|4|||
155294561|NCT05046132|560507375|FG001|Overall Study|Adverse Event|0|||
155294562|NCT05046132|560507376|FG002|Overall Study|Adverse Event|0|||
155294563|NCT05046132|560507374|FG000|Overall Study|Withdrawal by Subject|3|||
155294564|NCT05046132|560507375|FG001|Overall Study|Withdrawal by Subject|0|||
155294565|NCT05046132|560507376|FG002|Overall Study|Withdrawal by Subject|0|||
155294566|NCT05046132|560507374|FG000|Overall Study|Positive Covid19 Result.|0|||
155294567|NCT05046132|560507375|FG001|Overall Study|Positive Covid19 Result.|1|||
155294568|NCT05046132|560507376|FG002|Overall Study|Positive Covid19 Result.|0|||
155294569|NCT02441036|560507377|FG000|Overall Study|No tissue resected|0|||
155294570|NCT02441036|560507378|FG001|Overall Study|No tissue resected|1|||
155294571|NCT02441036|560507379|FG002|Overall Study|No tissue resected|0|||
155294572|NCT02441036|560507380|FG003|Overall Study|No tissue resected|1|||
155294573|NCT02441036|560507381|FG004|Overall Study|No tissue resected|0|||
155294574|NCT01183780|560507385|FG000|Overall Study|Withdrawal by Subject|25|||
155294575|NCT01183780|560507386|FG001|Overall Study|Withdrawal by Subject|14|||
155294576|NCT01183780|560507385|FG000|Overall Study|Lost to Follow-up|6|||
155294577|NCT01183780|560507386|FG001|Overall Study|Lost to Follow-up|11|||
155294578|NCT00855465|560507388|FG000|Treatment Period|Adverse Event|4|||
155294579|NCT00855465|560507389|FG001|Treatment Period|Adverse Event|2|||
155294580|NCT00855465|560507388|FG000|Treatment Period|Death|2|||
155294581|NCT00855465|560507389|FG001|Treatment Period|Death|2|||
155294582|NCT00855465|560507388|FG000|Treatment Period|Lack of Efficacy|2|||
155294583|NCT00855465|560507389|FG001|Treatment Period|Lack of Efficacy|1|||
155294584|NCT00855465|560507388|FG000|Treatment Period|Non-compliance|1|||
155294585|NCT00855465|560507389|FG001|Treatment Period|Non-compliance|0|||
155294586|NCT00855465|560507388|FG000|Treatment Period|Protocol Violation|2|||
155294587|NCT00855465|560507389|FG001|Treatment Period|Protocol Violation|0|||
155294588|NCT00855465|560507388|FG000|Treatment Period|Withdrawal by Subject|2|||
155294589|NCT00855465|560507389|FG001|Treatment Period|Withdrawal by Subject|0|||
155294590|NCT00855465|560507388|FG000|Treatment Period|Not treated|1|||
155294591|NCT00855465|560507389|FG001|Treatment Period|Not treated|0|||
155294592|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Adverse Event|0|||
155294593|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Adverse Event|1|||
155294594|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Death|0|||
155294595|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Death|1|||
155294596|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
155294597|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
155294598|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
155294599|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
155294600|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Missing|1|||
155294601|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Missing|0|||
155294602|NCT03743246|560507392|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294603|NCT03743246|560507393|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294604|NCT03743246|560507394|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
155294605|NCT03743246|560507395|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294606|NCT03743246|560507392|FG000|Pre-Treatment Period|Death|0|||
155294607|NCT03743246|560507393|FG001|Pre-Treatment Period|Death|1|||
155294608|NCT03743246|560507394|FG002|Pre-Treatment Period|Death|0|||
155294609|NCT03743246|560507395|FG003|Pre-Treatment Period|Death|1|||
155294610|NCT03743246|560507392|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
155294611|NCT03743246|560507393|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294612|NCT03743246|560507394|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294613|NCT03743246|560507395|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294614|NCT03743246|560507392|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
155294615|NCT03743246|560507393|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
155294616|NCT03743246|560507394|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
155496017|NCT03733301|561240443|FG001|Overall Study|Adverse Event|1|||
155496018|NCT03733301|561240444|FG002|Overall Study|Adverse Event|3|||
155639640|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
155639641|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
155639642|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
155639643|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639644|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639645|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639646|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639647|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639648|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
155639649|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
155639650|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155639651|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155639652|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155639653|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155639654|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155639655|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
155639656|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
155639657|NCT01697579|561770496|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639658|NCT01697579|561770497|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639659|NCT01697579|561770498|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639660|NCT01697579|561770499|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639661|NCT01697579|561770500|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639662|NCT01697579|561770501|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155639663|NCT01697579|561770502|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
155639664|NCT01044498|561770503|FG000|Overall Study|Withdrew consent|1|||
155639665|NCT01044498|561770504|FG001|Overall Study|Withdrew consent|1|||
155639666|NCT01044498|561770503|FG000|Overall Study|Adverse Event|1|||
155639667|NCT01044498|561770504|FG001|Overall Study|Adverse Event|1|||
155639668|NCT01044498|561770503|FG000|Overall Study|Other|1|||
155639669|NCT01044498|561770504|FG001|Overall Study|Other|0|||
155639670|NCT03487445|561770509|FG000|Randomization|Not treated for administrative reasons|1|||
155639671|NCT03487445|561770510|FG001|Randomization|Not treated for administrative reasons|0|||
155639672|NCT04132050|561770513|FG000|Period I (Double-blind Period)|Adverse Event|3|||
155639673|NCT04132050|561770514|FG001|Period I (Double-blind Period)|Adverse Event|0|||
155639674|NCT04132050|561770513|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
155294617|NCT03743246|560507395|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
155294618|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
155496019|NCT03733301|561240442|FG000|Overall Study|Withdrawal by Subject|3|||
155496020|NCT03733301|561240443|FG001|Overall Study|Withdrawal by Subject|5|||
155496021|NCT03733301|561240444|FG002|Overall Study|Withdrawal by Subject|1|||
155496022|NCT00577031|561240447|FG000|Overall Study|Adverse Event|52|||
155496023|NCT00577031|561240447|FG000|Overall Study|Progression of disease|93|||
155496024|NCT00577031|561240447|FG000|Overall Study|Protocol Violation|5|||
155496025|NCT00577031|561240447|FG000|Overall Study|Participant withdrew consent|13|||
155496026|NCT00577031|561240447|FG000|Overall Study|Participant non-compliance|5|||
155496027|NCT00577031|561240447|FG000|Overall Study|Need for surgery|17|||
155496028|NCT00577031|561240447|FG000|Overall Study|Medical decision|14|||
155496029|NCT00577031|561240447|FG000|Overall Study|Death|6|||
155496030|NCT04635631|561240448|FG000|Overall Study|Adverse Event|1|||
155496031|NCT04635631|561240448|FG000|Overall Study|Progressive disease|13|||
155496032|NCT04635631|561240448|FG000|Overall Study|Withdrawal by Subject|1|||
155496033|NCT00943826|561240449|FG000|Concurrent Phase|Adverse Event|50|||
155496034|NCT00943826|561240450|FG001|Concurrent Phase|Adverse Event|27|||
155496035|NCT00943826|561240449|FG000|Concurrent Phase|Withdrew consent|3|||
155496036|NCT00943826|561240450|FG001|Concurrent Phase|Withdrew consent|7|||
155496037|NCT00943826|561240449|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
155496038|NCT00943826|561240450|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
155496039|NCT00943826|561240449|FG000|Concurrent Phase|Administrative reasons|2|||
155496040|NCT00943826|561240450|FG001|Concurrent Phase|Administrative reasons|1|||
155496041|NCT00943826|561240449|FG000|Concurrent Phase|Protocol Violation|1|||
155496042|NCT00943826|561240450|FG001|Concurrent Phase|Protocol Violation|0|||
155496043|NCT00943826|561240449|FG000|Maintenance Phase|Adverse Event|31|||
155496044|NCT00943826|561240450|FG001|Maintenance Phase|Adverse Event|30|||
155496045|NCT00943826|561240449|FG000|Maintenance Phase|Withdrew consent|2|||
155496046|NCT00943826|561240450|FG001|Maintenance Phase|Withdrew consent|4|||
155496047|NCT00943826|561240449|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
155496048|NCT00943826|561240450|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
155496049|NCT00943826|561240449|FG000|Maintenance Phase|Administrative reasons|4|||
155496050|NCT00943826|561240450|FG001|Maintenance Phase|Administrative reasons|1|||
155744935|NCT01915303|562165267|FG000|Extension Phase|Protocol Violation|1|||
155744936|NCT02509117|562165269|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744937|NCT02509117|562165270|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
155744938|NCT02509117|562165271|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744939|NCT02509117|562165272|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744940|NCT02509117|562165273|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744941|NCT02509117|562165274|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744942|NCT02509117|562165275|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744943|NCT02509117|562165276|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744944|NCT02509117|562165277|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744945|NCT02509117|562165278|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155744946|NCT02509117|562165269|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744947|NCT02509117|562165270|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744948|NCT02509117|562165271|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155496051|NCT00943826|561240449|FG000|Maintenance Phase|Failure to return|0|||
155496052|NCT00943826|561240450|FG001|Maintenance Phase|Failure to return|1|||
155496053|NCT00943826|561240449|FG000|Monotherapy Phase|Adverse Event|42|||
155496054|NCT00943826|561240450|FG001|Monotherapy Phase|Adverse Event|5|||
155496055|NCT00943826|561240449|FG000|Monotherapy Phase|Administrative reasons|11|||
155496056|NCT00943826|561240450|FG001|Monotherapy Phase|Administrative reasons|5|||
155496057|NCT00943826|561240449|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
155496058|NCT00943826|561240450|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
155496059|NCT00943826|561240449|FG000|Monotherapy Phase|Withdrew Consent|2|||
155496060|NCT00943826|561240450|FG001|Monotherapy Phase|Withdrew Consent|3|||
155496061|NCT00943826|561240449|FG000|Monotherapy Phase|Failure to return|2|||
155496062|NCT00943826|561240450|FG001|Monotherapy Phase|Failure to return|1|||
155496063|NCT00943826|561240449|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
155496064|NCT00943826|561240450|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
155496065|NCT00943826|561240449|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
155496066|NCT00943826|561240450|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
155496067|NCT00943826|561240449|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
155496068|NCT00943826|561240450|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
155496069|NCT00943826|561240449|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
155496070|NCT00943826|561240450|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
155496071|NCT01067339|561240451|FG000|Overall Study|Withdrawal by Subject|6|||
155496072|NCT01067339|561240452|FG001|Overall Study|Withdrawal by Subject|5|||
155496073|NCT01803464|561240455|FG000|Overall Study|Incomplete data|0|||
155294619|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294620|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294621|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294622|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294623|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
155294624|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294625|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294626|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
155294627|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294628|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294629|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294630|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
155294631|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
155294632|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
155294633|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
155294634|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
155294635|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294636|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294637|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294638|NCT01596504|560507396|FG000|Overall Study|Participant's Private Reason|0|||
155294639|NCT01596504|560507397|FG001|Overall Study|Participant's Private Reason|1|||
155639675|NCT04132050|561770514|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
155639676|NCT04132050|561770513|FG000|R788 Treatment Period|Adverse Event|5|||
155639677|NCT04132050|561770514|FG001|R788 Treatment Period|Adverse Event|0|||
155639678|NCT04132050|561770513|FG000|R788 Treatment Period|Lack of Efficacy|5|||
155639679|NCT04132050|561770514|FG001|R788 Treatment Period|Lack of Efficacy|0|||
155639680|NCT04132050|561770513|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
155639681|NCT04132050|561770514|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
155639682|NCT04556097|561770515|FG000|Overall Study|Death|0|||
155639683|NCT04556097|561770516|FG001|Overall Study|Death|5|||
155639684|NCT04556097|561770517|FG002|Overall Study|Death|0|||
155639685|NCT04556097|561770518|FG003|Overall Study|Death|0|||
155294640|NCT01596504|560507398|FG002|Overall Study|Participant's Private Reason|0|||
155639686|NCT04556097|561770515|FG000|Overall Study|No caregiver|43|||
155639687|NCT04556097|561770516|FG001|Overall Study|No caregiver|53|||
155496074|NCT01803464|561240456|FG001|Overall Study|Incomplete data|0|||
155496075|NCT01803464|561240457|FG002|Overall Study|Incomplete data|4|||
155496076|NCT01803464|561240458|FG003|Overall Study|Incomplete data|0|||
155496077|NCT01803464|561240455|FG000|Overall Study|Withdrawal by Subject|1|||
155496078|NCT01803464|561240456|FG001|Overall Study|Withdrawal by Subject|0|||
155496079|NCT01803464|561240457|FG002|Overall Study|Withdrawal by Subject|0|||
155496080|NCT01803464|561240458|FG003|Overall Study|Withdrawal by Subject|0|||
155496081|NCT03843775|561240459|FG000|Overall Study|Adverse Event|1|||
155496082|NCT03843775|561240460|FG001|Overall Study|Adverse Event|1|||
155496083|NCT03843775|561240459|FG000|Overall Study|Lack of Efficacy|2|||
155496084|NCT03843775|561240460|FG001|Overall Study|Lack of Efficacy|6|||
155496085|NCT03843775|561240459|FG000|Overall Study|Withdrawal by Subject|0|||
155496086|NCT03843775|561240460|FG001|Overall Study|Withdrawal by Subject|1|||
155496087|NCT00650806|561240462|FG000|Overall Study|Adverse Event|0|||
155496088|NCT00650806|561240463|FG001|Overall Study|Adverse Event|5|||
155496089|NCT00650806|561240464|FG002|Overall Study|Adverse Event|3|||
155496090|NCT00650806|561240465|FG003|Overall Study|Adverse Event|4|||
155496091|NCT00650806|561240462|FG000|Overall Study|Lost to Follow-up|7|||
155496092|NCT00650806|561240463|FG001|Overall Study|Lost to Follow-up|6|||
155496093|NCT00650806|561240464|FG002|Overall Study|Lost to Follow-up|11|||
155496094|NCT00650806|561240465|FG003|Overall Study|Lost to Follow-up|10|||
155496095|NCT00650806|561240462|FG000|Overall Study|Protocol Violation|0|||
155496096|NCT00650806|561240463|FG001|Overall Study|Protocol Violation|0|||
155496097|NCT00650806|561240464|FG002|Overall Study|Protocol Violation|0|||
155496098|NCT00650806|561240465|FG003|Overall Study|Protocol Violation|1|||
155496099|NCT00650806|561240462|FG000|Overall Study|Pregnancy|0|||
155496100|NCT00650806|561240463|FG001|Overall Study|Pregnancy|0|||
155496101|NCT00650806|561240464|FG002|Overall Study|Pregnancy|0|||
155496102|NCT00650806|561240465|FG003|Overall Study|Pregnancy|1|||
155496103|NCT00650806|561240462|FG000|Overall Study|Withdrawal by Subject|7|||
155496104|NCT00650806|561240463|FG001|Overall Study|Withdrawal by Subject|5|||
155496105|NCT00650806|561240464|FG002|Overall Study|Withdrawal by Subject|8|||
155496106|NCT00650806|561240465|FG003|Overall Study|Withdrawal by Subject|6|||
155496107|NCT00650806|561240462|FG000|Overall Study|Noncompliance with study drug regimen|1|||
155496108|NCT00650806|561240463|FG001|Overall Study|Noncompliance with study drug regimen|1|||
155496109|NCT00650806|561240464|FG002|Overall Study|Noncompliance with study drug regimen|0|||
155496110|NCT00650806|561240465|FG003|Overall Study|Noncompliance with study drug regimen|0|||
155496111|NCT00650806|561240462|FG000|Overall Study|Study terminated by sponsor|2|||
155496112|NCT00650806|561240463|FG001|Overall Study|Study terminated by sponsor|3|||
155496113|NCT00650806|561240464|FG002|Overall Study|Study terminated by sponsor|5|||
155496114|NCT00650806|561240465|FG003|Overall Study|Study terminated by sponsor|4|||
155496115|NCT00650806|561240462|FG000|Overall Study|Other|1|||
155496116|NCT00650806|561240463|FG001|Overall Study|Other|1|||
155496117|NCT00650806|561240464|FG002|Overall Study|Other|2|||
155496118|NCT00650806|561240465|FG003|Overall Study|Other|0|||
155496119|NCT02596009|561240470|FG000|Overall Study|Administrative problems|0|||
155496120|NCT02596009|561240471|FG001|Overall Study|Administrative problems|1|||
155496121|NCT02596009|561240472|FG002|Overall Study|Administrative problems|0|||
155496122|NCT02596009|561240473|FG003|Overall Study|Administrative problems|0|||
155496123|NCT02596009|561240474|FG004|Overall Study|Administrative problems|0|||
155496124|NCT02596009|561240475|FG005|Overall Study|Administrative problems|0|||
155496125|NCT04611152|561240478|FG000|Overall Study|Adverse Event|9|||
155496126|NCT04611152|561240479|FG001|Overall Study|Adverse Event|8|||
155744949|NCT02509117|562165272|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744950|NCT02509117|562165273|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744951|NCT02509117|562165274|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155294641|NCT01596504|560507396|FG000|Overall Study|Adverse Event|1|||
155744952|NCT02509117|562165275|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744953|NCT02509117|562165276|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155744954|NCT02509117|562165277|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155496127|NCT04611152|561240478|FG000|Overall Study|Non-compliance with study schedule|1|||
155496128|NCT04611152|561240479|FG001|Overall Study|Non-compliance with study schedule|3|||
155294642|NCT01596504|560507397|FG001|Overall Study|Adverse Event|2|||
155294643|NCT01596504|560507398|FG002|Overall Study|Adverse Event|1|||
155294644|NCT01596504|560507396|FG000|Overall Study|Withdrawal by Subject|1|||
155294645|NCT01596504|560507397|FG001|Overall Study|Withdrawal by Subject|0|||
155294646|NCT01596504|560507398|FG002|Overall Study|Withdrawal by Subject|0|||
155294647|NCT00395018|560507399|FG000|On-Treatment|Death|4|||
155294648|NCT00395018|560507399|FG000|On-Treatment|Other Reason|2|||
155294649|NCT00395018|560507399|FG000|On-Treatment|Poor/non-compliance|2|||
155294650|NCT00395018|560507399|FG000|On-Treatment|Subject no longer meets study criteria|2|||
155294651|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
155294652|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
155294653|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
155294654|NCT04439799|560507400|FG000|Overall Study|Lost to Follow-up|6|||
155294655|NCT04439799|560507401|FG001|Overall Study|Lost to Follow-up|6|||
155294656|NCT04439799|560507400|FG000|Overall Study|Withdrawal by Subject|2|||
155294657|NCT04439799|560507401|FG001|Overall Study|Withdrawal by Subject|6|||
155294658|NCT04439799|560507400|FG000|Overall Study|Adverse Event|2|||
155294659|NCT04439799|560507401|FG001|Overall Study|Adverse Event|5|||
155294660|NCT00530842|560507405|FG000|Overall Study|Adverse Event|10|||
155294661|NCT00530842|560507406|FG001|Overall Study|Adverse Event|6|||
155294662|NCT00530842|560507405|FG000|Overall Study|Lack of Efficacy|2|||
155294663|NCT00530842|560507406|FG001|Overall Study|Lack of Efficacy|1|||
155294664|NCT00530842|560507405|FG000|Overall Study|Lost to Follow-up|0|||
155294665|NCT00530842|560507406|FG001|Overall Study|Lost to Follow-up|4|||
155294666|NCT00530842|560507405|FG000|Overall Study|Protocol Violation|3|||
155294667|NCT00530842|560507406|FG001|Overall Study|Protocol Violation|2|||
155294668|NCT00530842|560507405|FG000|Overall Study|Withdrawal by Subject|4|||
155294669|NCT00530842|560507406|FG001|Overall Study|Withdrawal by Subject|5|||
155294670|NCT00530842|560507405|FG000|Overall Study|Individual different reasons|4|||
155294671|NCT00530842|560507406|FG001|Overall Study|Individual different reasons|3|||
155294672|NCT00530842|560507405|FG000|Period 1|Adverse Event|7|||
155294673|NCT00530842|560507406|FG001|Period 1|Adverse Event|3|||
155294674|NCT00530842|560507405|FG000|Period 1|Lack of Efficacy|1|||
155294675|NCT00530842|560507406|FG001|Period 1|Lack of Efficacy|1|||
155294676|NCT00530842|560507405|FG000|Period 1|Protocol Violation|2|||
155294677|NCT00530842|560507406|FG001|Period 1|Protocol Violation|1|||
155294678|NCT00530842|560507405|FG000|Period 1|Withdrawal by Subject|2|||
155294679|NCT00530842|560507406|FG001|Period 1|Withdrawal by Subject|3|||
155294680|NCT00530842|560507405|FG000|Period 1|Individual different reasons|2|||
155294681|NCT00530842|560507406|FG001|Period 1|Individual different reasons|3|||
155294682|NCT00530842|560507405|FG000|Period 2|Adverse Event|3|||
155294683|NCT00530842|560507406|FG001|Period 2|Adverse Event|3|||
155294684|NCT00530842|560507405|FG000|Period 2|Lack of Efficacy|1|||
155294685|NCT00530842|560507406|FG001|Period 2|Lack of Efficacy|0|||
155294686|NCT00530842|560507405|FG000|Period 2|Lost to Follow-up|0|||
155294687|NCT00530842|560507406|FG001|Period 2|Lost to Follow-up|4|||
155294688|NCT00530842|560507405|FG000|Period 2|Protocol Violation|1|||
155294689|NCT00530842|560507406|FG001|Period 2|Protocol Violation|0|||
155294690|NCT00530842|560507405|FG000|Period 2|Withdrawal by Subject|1|||
155294691|NCT00530842|560507406|FG001|Period 2|Withdrawal by Subject|2|||
155294692|NCT00530842|560507405|FG000|Period 2|Individual different reasons|2|||
155294693|NCT00530842|560507406|FG001|Period 2|Individual different reasons|0|||
155294694|NCT00972504|560507419|FG000|Overall Study|Adverse Event|2|||
155294695|NCT00972504|560507419|FG000|Overall Study|Investigator discretion|1|||
155294696|NCT03478696|560507423|FG000|Overall Study|Adverse Event|1|||
155294697|NCT03478696|560507424|FG001|Overall Study|Adverse Event|5|||
155294698|NCT03478696|560507423|FG000|Overall Study|Lost to Follow-up|1|||
155294699|NCT03478696|560507424|FG001|Overall Study|Lost to Follow-up|0|||
155294700|NCT03478696|560507423|FG000|Overall Study|Physician Decision|6|||
155294701|NCT03478696|560507424|FG001|Overall Study|Physician Decision|3|||
155294702|NCT03478696|560507423|FG000|Overall Study|Withdrawal by Subject|9|||
155294703|NCT03478696|560507424|FG001|Overall Study|Withdrawal by Subject|4|||
155294704|NCT03257813|560507425|FG000|Overall Study|Protocol Violation|6|||
155639688|NCT04556097|561770517|FG002|Overall Study|No caregiver|0|||
155294705|NCT03257813|560507426|FG001|Overall Study|Protocol Violation|3|||
155294706|NCT02878330|560507427|FG000|Overall Study|Death|3|||
155294707|NCT02878330|560507428|FG001|Overall Study|Death|2|||
155639689|NCT04556097|561770518|FG003|Overall Study|No caregiver|0|||
155294708|NCT02878330|560507427|FG000|Overall Study|Lost to Follow-up|11|||
155294709|NCT02878330|560507428|FG001|Overall Study|Lost to Follow-up|26|||
155294710|NCT02878330|560507427|FG000|Overall Study|Withdrawal by Subject|11|||
155294711|NCT02878330|560507428|FG001|Overall Study|Withdrawal by Subject|21|||
155294712|NCT02878330|560507427|FG000|Overall Study|Other|4|||
155294713|NCT02878330|560507428|FG001|Overall Study|Other|7|||
155294714|NCT03615924|560507433|FG000|Overall Study|Withdrawal by Subject|2|||
155294715|NCT03615924|560507434|FG001|Overall Study|Withdrawal by Subject|5|||
155294716|NCT03615924|560507433|FG000|Overall Study|Death|3|||
155294717|NCT03615924|560507434|FG001|Overall Study|Death|1|||
155294718|NCT03615924|560507433|FG000|Overall Study|Lost to Follow-up|1|||
155294719|NCT03615924|560507434|FG001|Overall Study|Lost to Follow-up|0|||
155639690|NCT04556097|561770515|FG000|Overall Study|Ineligible, SNF|2|||
155639691|NCT04556097|561770516|FG001|Overall Study|Ineligible, SNF|2|||
155639692|NCT04556097|561770517|FG002|Overall Study|Ineligible, SNF|0|||
155639693|NCT04556097|561770518|FG003|Overall Study|Ineligible, SNF|0|||
155639694|NCT04556097|561770515|FG000|Overall Study|Ineligible, health|3|||
155639695|NCT04556097|561770516|FG001|Overall Study|Ineligible, health|4|||
155639696|NCT04556097|561770517|FG002|Overall Study|Ineligible, health|0|||
155639697|NCT04556097|561770518|FG003|Overall Study|Ineligible, health|0|||
155639698|NCT04556097|561770515|FG000|Overall Study|Ineligible, language|0|||
155639699|NCT04556097|561770516|FG001|Overall Study|Ineligible, language|1|||
155639700|NCT04556097|561770517|FG002|Overall Study|Ineligible, language|0|||
155639701|NCT04556097|561770518|FG003|Overall Study|Ineligible, language|0|||
155639702|NCT04556097|561770515|FG000|Overall Study|Ineligible, no longer in care management|0|||
155639703|NCT04556097|561770516|FG001|Overall Study|Ineligible, no longer in care management|2|||
155639704|NCT04556097|561770517|FG002|Overall Study|Ineligible, no longer in care management|1|||
155639705|NCT04556097|561770518|FG003|Overall Study|Ineligible, no longer in care management|0|||
155639706|NCT04556097|561770515|FG000|Overall Study|No dementia|13|||
155639707|NCT04556097|561770516|FG001|Overall Study|No dementia|3|||
155639708|NCT04556097|561770517|FG002|Overall Study|No dementia|0|||
155639709|NCT04556097|561770518|FG003|Overall Study|No dementia|0|||
155639710|NCT04556097|561770515|FG000|Overall Study|Missing identifier|2|||
155639711|NCT04556097|561770516|FG001|Overall Study|Missing identifier|4|||
155639712|NCT04556097|561770517|FG002|Overall Study|Missing identifier|0|||
155639713|NCT04556097|561770518|FG003|Overall Study|Missing identifier|0|||
155639714|NCT04556097|561770515|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
155639715|NCT04556097|561770516|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
155639716|NCT04556097|561770517|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
155639717|NCT04556097|561770518|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
155639718|NCT05436613|561770519|FG000|Overall Study|Lost to Follow-up|9|||
155639719|NCT05436613|561770519|FG000|Overall Study|Withdrawal by Subject|3|||
155639720|NCT02555878|561770523|FG000|Overall Study|Lost to Follow-up|2|||
155639721|NCT02555878|561770524|FG001|Overall Study|Lost to Follow-up|3|||
155639722|NCT02555878|561770523|FG000|Overall Study|Withdrawal by Subject|48|||
155639723|NCT02555878|561770524|FG001|Overall Study|Withdrawal by Subject|48|||
155639724|NCT02555878|561770523|FG000|Overall Study|Adverse Event|12|||
155639725|NCT02555878|561770524|FG001|Overall Study|Adverse Event|8|||
155639726|NCT02555878|561770523|FG000|Overall Study|Death|74|||
155639727|NCT02555878|561770524|FG001|Overall Study|Death|59|||
155639728|NCT02555878|561770523|FG000|Overall Study|Protocol Violation|1|||
155639729|NCT02555878|561770524|FG001|Overall Study|Protocol Violation|2|||
155639730|NCT02555878|561770523|FG000|Overall Study|Physician Decision|12|||
155639731|NCT02555878|561770524|FG001|Overall Study|Physician Decision|13|||
155639732|NCT02555878|561770523|FG000|Overall Study|Other|17|||
155639733|NCT02555878|561770524|FG001|Overall Study|Other|17|||
155639734|NCT00765076|561770525|FG000|Overall Study|Adverse Event|1|||
155639735|NCT00765076|561770526|FG001|Overall Study|Adverse Event|0|||
155639736|NCT00765076|561770527|FG002|Overall Study|Adverse Event|0|||
155639737|NCT00765076|561770525|FG000|Overall Study|Withdrawal by Subject|0|||
155639738|NCT00765076|561770526|FG001|Overall Study|Withdrawal by Subject|0|||
155639739|NCT00765076|561770527|FG002|Overall Study|Withdrawal by Subject|1|||
155639740|NCT00876395|561771787|FG000|Overall Study|Untreated|8|||
155639741|NCT00876395|561771788|FG001|Overall Study|Untreated|1|||
155639742|NCT00876395|561771787|FG000|Overall Study|Adverse Event|63|||
155639743|NCT00876395|561771788|FG001|Overall Study|Adverse Event|11|||
155639744|NCT00876395|561771787|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155639745|NCT00876395|561771788|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155639746|NCT00876395|561771787|FG000|Overall Study|Disease progression|259|||
155639747|NCT00876395|561771788|FG001|Overall Study|Disease progression|162|||
155639748|NCT00876395|561771787|FG000|Overall Study|New cancer therapy|25|||
155639749|NCT00876395|561771788|FG001|Overall Study|New cancer therapy|7|||
155639750|NCT00876395|561771787|FG000|Overall Study|Protocol Violation|5|||
155639751|NCT00876395|561771788|FG001|Overall Study|Protocol Violation|2|||
155639752|NCT00876395|561771787|FG000|Overall Study|Withdrawal by Subject|66|||
155639753|NCT00876395|561771788|FG001|Overall Study|Withdrawal by Subject|33|||
155639754|NCT00876395|561771787|FG000|Overall Study|Lost to Follow-up|2|||
155639755|NCT00876395|561771788|FG001|Overall Study|Lost to Follow-up|0|||
155639756|NCT00876395|561771787|FG000|Overall Study|Administrative problems|39|||
155639757|NCT00876395|561771788|FG001|Overall Study|Administrative problems|23|||
155639758|NCT00876395|561771787|FG000|Overall Study|Death|12|||
155639759|NCT00876395|561771788|FG001|Overall Study|Death|0|||
155639760|NCT00662259|561771791|FG000|Overall Study|Adverse Event|2|||
155639761|NCT00662259|561771792|FG001|Overall Study|Adverse Event|0|||
155639762|NCT03439514|561771800|FG000|Double-Blind Treatment Period|Other|4|||
155639763|NCT03439514|561771801|FG001|Double-Blind Treatment Period|Other|1|||
155639764|NCT03439514|561771800|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
155294720|NCT03615924|560507433|FG000|Overall Study|Randomized in error|1|||
155294721|NCT03615924|560507434|FG001|Overall Study|Randomized in error|0|||
155294722|NCT03615924|560507433|FG000|Overall Study|Study termination by Sponsor|94|||
155294723|NCT03615924|560507434|FG001|Overall Study|Study termination by Sponsor|86|||
155294724|NCT00716144|560507435|FG000|Overall Study|Withdrawal by Subject|4|||
155294725|NCT00716144|560507436|FG001|Overall Study|Withdrawal by Subject|2|||
155294726|NCT00716144|560507437|FG002|Overall Study|Withdrawal by Subject|6|||
155294727|NCT00716144|560507438|FG003|Overall Study|Withdrawal by Subject|6|||
155294728|NCT00716144|560507435|FG000|Overall Study|Lost to Follow-up|2|||
155294729|NCT00716144|560507436|FG001|Overall Study|Lost to Follow-up|2|||
155294730|NCT00716144|560507437|FG002|Overall Study|Lost to Follow-up|1|||
155294731|NCT00716144|560507438|FG003|Overall Study|Lost to Follow-up|2|||
155294732|NCT00716144|560507435|FG000|Overall Study|Adverse Event|0|||
155294733|NCT00716144|560507436|FG001|Overall Study|Adverse Event|0|||
155294734|NCT00716144|560507437|FG002|Overall Study|Adverse Event|0|||
155294735|NCT00716144|560507438|FG003|Overall Study|Adverse Event|2|||
155294736|NCT00716144|560507435|FG000|Overall Study|Non-compliance|1|||
155294737|NCT00716144|560507436|FG001|Overall Study|Non-compliance|0|||
155294738|NCT00716144|560507437|FG002|Overall Study|Non-compliance|0|||
155294739|NCT00716144|560507438|FG003|Overall Study|Non-compliance|0|||
155294740|NCT00716144|560507435|FG000|Overall Study|Protocol Violation|2|||
155294741|NCT00716144|560507436|FG001|Overall Study|Protocol Violation|0|||
155294742|NCT00716144|560507437|FG002|Overall Study|Protocol Violation|1|||
155294743|NCT00716144|560507438|FG003|Overall Study|Protocol Violation|0|||
155294744|NCT00716144|560507435|FG000|Overall Study|Physician Decision|0|||
155294745|NCT00716144|560507436|FG001|Overall Study|Physician Decision|1|||
155294746|NCT00716144|560507437|FG002|Overall Study|Physician Decision|2|||
155294747|NCT00716144|560507438|FG003|Overall Study|Physician Decision|2|||
155294748|NCT00716144|560507435|FG000|Overall Study|Intercurrent illness|0|||
155294749|NCT00716144|560507436|FG001|Overall Study|Intercurrent illness|0|||
155294750|NCT00716144|560507437|FG002|Overall Study|Intercurrent illness|1|||
155294751|NCT00716144|560507438|FG003|Overall Study|Intercurrent illness|0|||
155294752|NCT00716144|560507435|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
155294753|NCT00716144|560507436|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
155294754|NCT00716144|560507437|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
155294755|NCT00716144|560507438|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
155294756|NCT00716144|560507435|FG000|Overall Study|Adverse event: left foot pain|0|||
155294757|NCT00716144|560507436|FG001|Overall Study|Adverse event: left foot pain|1|||
155294758|NCT00716144|560507437|FG002|Overall Study|Adverse event: left foot pain|0|||
155294759|NCT00716144|560507438|FG003|Overall Study|Adverse event: left foot pain|0|||
155294760|NCT00716144|560507435|FG000|Overall Study|Clinical Depression|0|||
155294761|NCT00716144|560507436|FG001|Overall Study|Clinical Depression|1|||
155294762|NCT00716144|560507437|FG002|Overall Study|Clinical Depression|0|||
155294763|NCT00716144|560507438|FG003|Overall Study|Clinical Depression|0|||
155294764|NCT00880048|560507442|FG000|Overall Study|Adverse Event|2|||
155294765|NCT00880048|560507443|FG001|Overall Study|Adverse Event|3|||
155294766|NCT00880048|560507444|FG002|Overall Study|Adverse Event|5|||
155294767|NCT00880048|560507442|FG000|Overall Study|Lack of Efficacy|1|||
155294768|NCT00880048|560507443|FG001|Overall Study|Lack of Efficacy|2|||
155294769|NCT00880048|560507444|FG002|Overall Study|Lack of Efficacy|2|||
155294770|NCT00880048|560507442|FG000|Overall Study|Protocol Violation|4|||
155294771|NCT00880048|560507443|FG001|Overall Study|Protocol Violation|6|||
155294772|NCT00880048|560507444|FG002|Overall Study|Protocol Violation|5|||
155294773|NCT00880048|560507442|FG000|Overall Study|Lost to Follow-up|6|||
155294774|NCT00880048|560507443|FG001|Overall Study|Lost to Follow-up|6|||
155294775|NCT00880048|560507444|FG002|Overall Study|Lost to Follow-up|5|||
155294776|NCT00880048|560507442|FG000|Overall Study|Physician Decision|1|||
155294777|NCT00880048|560507443|FG001|Overall Study|Physician Decision|1|||
155744955|NCT02509117|562165278|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
155744956|NCT02509117|562165269|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744957|NCT02509117|562165270|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744958|NCT02509117|562165271|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155496129|NCT04611152|561240478|FG000|Overall Study|Withdrawal by Subject|5|||
155496130|NCT04611152|561240479|FG001|Overall Study|Withdrawal by Subject|6|||
155496131|NCT04611152|561240478|FG000|Overall Study|Lost to Follow-up|11|||
155496132|NCT04611152|561240479|FG001|Overall Study|Lost to Follow-up|2|||
155294778|NCT00880048|560507444|FG002|Overall Study|Physician Decision|7|||
155294779|NCT00880048|560507442|FG000|Overall Study|Withdrawal by Subject|5|||
155294780|NCT00880048|560507443|FG001|Overall Study|Withdrawal by Subject|8|||
155294781|NCT00880048|560507444|FG002|Overall Study|Withdrawal by Subject|5|||
155294782|NCT00880048|560507442|FG000|Overall Study|Study closed/terminated|9|||
155294783|NCT00880048|560507443|FG001|Overall Study|Study closed/terminated|7|||
155496133|NCT00605839|561240480|FG000|Overall Study|Protocol Violation|1|||
155496134|NCT00605839|561240481|FG001|Overall Study|Protocol Violation|0|||
155294784|NCT00880048|560507444|FG002|Overall Study|Study closed/terminated|6|||
155294785|NCT01069341|560507445|FG000|Overall Study|Lost to Follow-up|1|||
155294786|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
155294787|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
155294788|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
155294789|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
155294790|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
155294791|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
155294792|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
155294793|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
155294794|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
155294795|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
155294796|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155294797|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
155294798|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
155294799|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
155294800|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
155294801|NCT02808338|560507457|FG000|Screening|Screen Failure|10|||
155294802|NCT02808338|560507457|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
155294803|NCT02808338|560507457|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
155294804|NCT00756730|560507460|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
155294805|NCT00756730|560507461|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
155294806|NCT00756730|560507460|FG000|Overall Study|persistent low-level viremmia|0|||
155294807|NCT00756730|560507461|FG001|Overall Study|persistent low-level viremmia|1|||
155294808|NCT05382104|560507465|FG000|Period 2 (2 Days)|Adverse Event|0|||
155294809|NCT05382104|560507466|FG001|Period 2 (2 Days)|Adverse Event|1|||
155294810|NCT05382104|560507467|FG002|Period 2 (2 Days)|Adverse Event|0|||
155496135|NCT00605839|561240482|FG002|Overall Study|Protocol Violation|0|||
155496136|NCT02255422|561240483|FG000|Overall Study|Withdrawal by Subject|0|||
155496137|NCT02255422|561240484|FG001|Overall Study|Withdrawal by Subject|0|||
155496138|NCT02255422|561240485|FG002|Overall Study|Withdrawal by Subject|0|||
155496139|NCT02255422|561240486|FG003|Overall Study|Withdrawal by Subject|0|||
155496140|NCT02255422|561240487|FG004|Overall Study|Withdrawal by Subject|0|||
155496141|NCT02255422|561240488|FG005|Overall Study|Withdrawal by Subject|0|||
155496142|NCT02255422|561240489|FG006|Overall Study|Withdrawal by Subject|2|||
155496143|NCT02255422|561240483|FG000|Overall Study|Lost to Follow-up|0|||
155496144|NCT02255422|561240484|FG001|Overall Study|Lost to Follow-up|0|||
155496145|NCT02255422|561240485|FG002|Overall Study|Lost to Follow-up|1|||
155496146|NCT02255422|561240486|FG003|Overall Study|Lost to Follow-up|0|||
155496147|NCT02255422|561240487|FG004|Overall Study|Lost to Follow-up|0|||
155496148|NCT02255422|561240488|FG005|Overall Study|Lost to Follow-up|0|||
155496149|NCT02255422|561240489|FG006|Overall Study|Lost to Follow-up|0|||
155496150|NCT00602667|561240490|FG000|Overall Study|Still on Therapy|0|||
155496151|NCT00602667|561240491|FG001|Overall Study|Still on Therapy|2|||
155496152|NCT00602667|561240492|FG002|Overall Study|Still on Therapy|2|||
155496153|NCT00602667|561240490|FG000|Overall Study|Death|0|||
155496154|NCT00602667|561240491|FG001|Overall Study|Death|1|||
155496155|NCT00602667|561240492|FG002|Overall Study|Death|1|||
155496156|NCT00602667|561240490|FG000|Overall Study|Family request|3|||
155496157|NCT00602667|561240491|FG001|Overall Study|Family request|25|||
155496158|NCT00602667|561240492|FG002|Overall Study|Family request|6|||
155496159|NCT00602667|561240490|FG000|Overall Study|Excessive toxicity|1|||
155496160|NCT00602667|561240491|FG001|Overall Study|Excessive toxicity|1|||
155496161|NCT00602667|561240492|FG002|Overall Study|Excessive toxicity|0|||
155496162|NCT00602667|561240490|FG000|Overall Study|Second malignancy|0|||
155496163|NCT00602667|561240491|FG001|Overall Study|Second malignancy|1|||
155294811|NCT05382104|560507468|FG003|Period 2 (2 Days)|Adverse Event|0|||
155294812|NCT05382104|560507469|FG004|Period 2 (2 Days)|Adverse Event|0|||
155294813|NCT05382104|560507470|FG005|Period 2 (2 Days)|Adverse Event|0|||
155294814|NCT01493778|560507472|FG000|Overall Study|Withdrawal by Subject|8|||
155294815|NCT04210180|560507473|FG000|Overall Study|Withdrawal by Subject|2|||
155294816|NCT05190419|560507474|FG000|Overall Study|Lack of Efficacy|8|||
155496164|NCT00602667|561240492|FG002|Overall Study|Second malignancy|0|||
155496165|NCT00602667|561240490|FG000|Overall Study|Physician Decision|2|||
155496166|NCT00602667|561240491|FG001|Overall Study|Physician Decision|3|||
155496167|NCT00602667|561240492|FG002|Overall Study|Physician Decision|8|||
155496168|NCT00602667|561240490|FG000|Overall Study|Progressive disease|13|||
155496169|NCT00602667|561240491|FG001|Overall Study|Progressive disease|48|||
155294817|NCT05190419|560507475|FG001|Overall Study|Lack of Efficacy|0|||
155294818|NCT05190419|560507476|FG002|Overall Study|Lack of Efficacy|1|||
155294819|NCT05190419|560507477|FG003|Overall Study|Lack of Efficacy|0|||
155496170|NCT00602667|561240492|FG002|Overall Study|Progressive disease|45|||
155496171|NCT00602667|561240490|FG000|Overall Study|Progressive disease prior to therapy|0|||
155496172|NCT00602667|561240491|FG001|Overall Study|Progressive disease prior to therapy|0|||
155496173|NCT00602667|561240492|FG002|Overall Study|Progressive disease prior to therapy|1|||
155496174|NCT01489865|561240500|FG000|Overall Study|Progression of Disease|4|||
155496175|NCT01489865|561240501|FG001|Overall Study|Progression of Disease|2|||
155496176|NCT01489865|561240502|FG002|Overall Study|Progression of Disease|2|||
155294820|NCT05190419|560507474|FG000|Overall Study|Withdrawal by Subject|7|||
155294821|NCT05190419|560507475|FG001|Overall Study|Withdrawal by Subject|1|||
155294822|NCT05190419|560507476|FG002|Overall Study|Withdrawal by Subject|2|||
155294823|NCT05190419|560507477|FG003|Overall Study|Withdrawal by Subject|2|||
155294824|NCT05190419|560507474|FG000|Overall Study|Adverse Event|2|||
155294825|NCT05190419|560507475|FG001|Overall Study|Adverse Event|10|||
155294826|NCT05190419|560507476|FG002|Overall Study|Adverse Event|11|||
155294827|NCT05190419|560507477|FG003|Overall Study|Adverse Event|21|||
155294828|NCT05190419|560507474|FG000|Overall Study|Lost to Follow-up|1|||
155294829|NCT05190419|560507475|FG001|Overall Study|Lost to Follow-up|2|||
155294830|NCT05190419|560507476|FG002|Overall Study|Lost to Follow-up|3|||
155294831|NCT05190419|560507477|FG003|Overall Study|Lost to Follow-up|1|||
155294832|NCT05190419|560507474|FG000|Overall Study|Other|1|||
155496177|NCT01489865|561240503|FG003|Overall Study|Progression of Disease|3|||
155496178|NCT01489865|561240504|FG004|Overall Study|Progression of Disease|1|||
155496179|NCT01489865|561240505|FG005|Overall Study|Progression of Disease|6|||
155496180|NCT01489865|561240506|FG006|Overall Study|Progression of Disease|3|||
155496181|NCT01489865|561240507|FG007|Overall Study|Progression of Disease|0|||
155496182|NCT01489865|561240508|FG008|Overall Study|Progression of Disease|23|||
155496183|NCT01489865|561240500|FG000|Overall Study|Adverse Event|2|||
155496184|NCT01489865|561240501|FG001|Overall Study|Adverse Event|0|||
155496185|NCT01489865|561240502|FG002|Overall Study|Adverse Event|0|||
155496186|NCT01489865|561240503|FG003|Overall Study|Adverse Event|0|||
155496187|NCT01489865|561240504|FG004|Overall Study|Adverse Event|1|||
155496188|NCT01489865|561240505|FG005|Overall Study|Adverse Event|0|||
155496189|NCT01489865|561240506|FG006|Overall Study|Adverse Event|2|||
155496190|NCT01489865|561240507|FG007|Overall Study|Adverse Event|0|||
155496191|NCT01489865|561240508|FG008|Overall Study|Adverse Event|5|||
155496192|NCT01489865|561240500|FG000|Overall Study|Death|0|||
155496193|NCT01489865|561240501|FG001|Overall Study|Death|1|||
155496194|NCT01489865|561240502|FG002|Overall Study|Death|0|||
155496195|NCT01489865|561240503|FG003|Overall Study|Death|0|||
155496196|NCT01489865|561240504|FG004|Overall Study|Death|1|||
155496197|NCT01489865|561240505|FG005|Overall Study|Death|0|||
155496198|NCT01489865|561240506|FG006|Overall Study|Death|0|||
155496199|NCT01489865|561240507|FG007|Overall Study|Death|0|||
155496200|NCT01489865|561240508|FG008|Overall Study|Death|2|||
155496201|NCT01489865|561240500|FG000|Overall Study|Withdrawal by Subject|0|||
155496202|NCT01489865|561240501|FG001|Overall Study|Withdrawal by Subject|0|||
155496203|NCT01489865|561240502|FG002|Overall Study|Withdrawal by Subject|0|||
155496204|NCT01489865|561240503|FG003|Overall Study|Withdrawal by Subject|0|||
155496205|NCT01489865|561240504|FG004|Overall Study|Withdrawal by Subject|0|||
155496206|NCT01489865|561240505|FG005|Overall Study|Withdrawal by Subject|1|||
155496207|NCT01489865|561240506|FG006|Overall Study|Withdrawal by Subject|1|||
155496208|NCT01489865|561240507|FG007|Overall Study|Withdrawal by Subject|0|||
155496209|NCT01489865|561240508|FG008|Overall Study|Withdrawal by Subject|2|||
155496210|NCT01489865|561240500|FG000|Overall Study|Shifted|0|||
155496211|NCT01489865|561240501|FG001|Overall Study|Shifted|0|||
155496212|NCT01489865|561240502|FG002|Overall Study|Shifted|1|||
155496213|NCT01489865|561240503|FG003|Overall Study|Shifted|0|||
155496214|NCT01489865|561240504|FG004|Overall Study|Shifted|0|||
155496215|NCT01489865|561240505|FG005|Overall Study|Shifted|0|||
155496216|NCT01489865|561240506|FG006|Overall Study|Shifted|0|||
155496217|NCT01489865|561240507|FG007|Overall Study|Shifted|0|||
155496218|NCT01489865|561240508|FG008|Overall Study|Shifted|0|||
155496219|NCT00972309|561240509|FG000|Overall Study|Switched to alternative treatment|0|||
155496220|NCT00972309|561240510|FG001|Overall Study|Switched to alternative treatment|2|||
155496221|NCT00972309|561240509|FG000|Overall Study|Refused further treatment|0|||
155496222|NCT00972309|561240510|FG001|Overall Study|Refused further treatment|1|||
155294833|NCT05190419|560507475|FG001|Overall Study|Other|1|||
155294834|NCT05190419|560507476|FG002|Overall Study|Other|0|||
155294835|NCT05190419|560507477|FG003|Overall Study|Other|3|||
155294836|NCT03538054|560507478|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
155496223|NCT00972309|561240509|FG000|Overall Study|Late determination of ineligibility|0|||
155496224|NCT00972309|561240510|FG001|Overall Study|Late determination of ineligibility|1|||
155496225|NCT00972309|561240509|FG000|Overall Study|Second malignancy|1|||
155496226|NCT00972309|561240510|FG001|Overall Study|Second malignancy|1|||
155496227|NCT00972309|561240509|FG000|Overall Study|Visa issues|0|||
155496228|NCT00972309|561240510|FG001|Overall Study|Visa issues|1|||
155496229|NCT00972309|561240509|FG000|Overall Study|Secondary cancer (SCC)|0|||
155496230|NCT00972309|561240510|FG001|Overall Study|Secondary cancer (SCC)|1|||
155496231|NCT00972309|561240509|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
155294837|NCT03538054|560507478|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
155496232|NCT00972309|561240510|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
155496233|NCT00972309|561240509|FG000|Overall Study|Lost to Follow-up|1|||
155496234|NCT00972309|561240510|FG001|Overall Study|Lost to Follow-up|1|||
155496235|NCT00972309|561240509|FG000|Overall Study|Disease progression on study|10|||
155496236|NCT00972309|561240510|FG001|Overall Study|Disease progression on study|4|||
155496237|NCT03862807|561242263|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
155294838|NCT03538054|560507478|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
155294839|NCT00208767|560507479|FG000|Overall Study|Adverse Event|9|||
155294840|NCT00208767|560507480|FG001|Overall Study|Adverse Event|1|||
155294841|NCT00208767|560507479|FG000|Overall Study|Withdrawal by Subject|14|||
155294842|NCT00208767|560507480|FG001|Overall Study|Withdrawal by Subject|3|||
155294843|NCT00208767|560507479|FG000|Overall Study|Death|1|||
155294844|NCT00208767|560507480|FG001|Overall Study|Death|0|||
155294845|NCT00208767|560507479|FG000|Overall Study|Lost to Follow-up|3|||
155294846|NCT00208767|560507480|FG001|Overall Study|Lost to Follow-up|3|||
155294847|NCT02754479|560507481|FG000|Overall Study|Lost to Follow-up|1|||
155294848|NCT03183518|560507482|FG000|Overall Study|Other (Not specified)|2|||
155294849|NCT03183518|560507482|FG000|Overall Study|Other (Withdrawal of consent)|1|||
155294850|NCT04493242|560507485|FG000|Overall Study|Death|10|||
155294851|NCT04493242|560507486|FG001|Overall Study|Death|14|||
155294852|NCT04493242|560507487|FG002|Overall Study|Death|16|||
155294853|NCT04493242|560507485|FG000|Overall Study|Lost to Follow-up|1|||
155294854|NCT04493242|560507486|FG001|Overall Study|Lost to Follow-up|1|||
155294855|NCT04493242|560507487|FG002|Overall Study|Lost to Follow-up|0|||
155294856|NCT04493242|560507485|FG000|Overall Study|Withdrawal by Subject|1|||
155294857|NCT04493242|560507486|FG001|Overall Study|Withdrawal by Subject|0|||
155294858|NCT04493242|560507487|FG002|Overall Study|Withdrawal by Subject|0|||
155294859|NCT04493242|560507485|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
155294860|NCT04493242|560507486|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
155294861|NCT04493242|560507487|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
155294862|NCT04493242|560507485|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
155294863|NCT04493242|560507486|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
155294864|NCT04493242|560507487|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
155294865|NCT00849147|560507488|FG000|Overall Study|Withdrawal by Subject|1|||
155294866|NCT00849147|560507488|FG000|Overall Study|Protocol Violation|2|||
155294867|NCT00849147|560507488|FG000|Overall Study|Disease Relapse/Progression|2|||
155294868|NCT03544515|560509061|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
155294869|NCT03544515|560509062|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
155294870|NCT03544515|560509061|FG000|Overall Study|Lost to Follow-up|2|||
155294871|NCT03544515|560509062|FG001|Overall Study|Lost to Follow-up|0|||
155294872|NCT03169244|560509063|FG000|Overall Study|Lost to Follow-up|1|||
155294873|NCT03169244|560509064|FG001|Overall Study|Lost to Follow-up|2|||
155294874|NCT03169244|560509063|FG000|Overall Study|Adverse Event|1|||
155294875|NCT03169244|560509064|FG001|Overall Study|Adverse Event|0|||
155294876|NCT03169244|560509063|FG000|Overall Study|Withdrawal by Subject|2|||
155294877|NCT03169244|560509064|FG001|Overall Study|Withdrawal by Subject|2|||
155294878|NCT03169244|560509063|FG000|Overall Study|Physician Decision|1|||
155496238|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
155496239|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
155496240|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
155496241|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
155496242|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
155496243|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
155496244|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
155496245|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
155496246|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
155294879|NCT03169244|560509064|FG001|Overall Study|Physician Decision|0|||
155294880|NCT00178399|560509065|FG000|Overall Study|Physician Decision|4|||
155294881|NCT00178399|560509065|FG000|Overall Study|Withdrawal by Subject|8|||
155294882|NCT00178399|560509065|FG000|Overall Study|Lost to Follow-up|1|||
155294883|NCT02027558|560509066|FG000|Overall Study|Death|0|||
155294884|NCT02027558|560509067|FG001|Overall Study|Death|1|||
155294885|NCT02027558|560509066|FG000|Overall Study|Withdrawal by Subject|2|||
155294886|NCT02027558|560509067|FG001|Overall Study|Withdrawal by Subject|0|||
155496247|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
155496248|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
155496249|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
155496250|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
155496251|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
155496252|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
155496253|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
155496254|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
155496255|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
155496256|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
155496257|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
155639765|NCT03439514|561771801|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155639766|NCT03439514|561771800|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
155639767|NCT03439514|561771801|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
155639768|NCT03439514|561771800|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
155639769|NCT03439514|561771801|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155639770|NCT03439514|561771800|FG000|Double-Blind Treatment Period|Death|1|||
155639771|NCT03439514|561771801|FG001|Double-Blind Treatment Period|Death|2|||
155639772|NCT02175758|561771802|FG000|Treatment Phase|Lost to Follow-up|0|||
155639773|NCT02175758|561771803|FG001|Treatment Phase|Lost to Follow-up|1|||
155639774|NCT02175758|561771804|FG002|Treatment Phase|Lost to Follow-up|0|||
155639775|NCT02175758|561771805|FG003|Treatment Phase|Lost to Follow-up|0|||
155639776|NCT02175758|561771806|FG004|Treatment Phase|Lost to Follow-up|0|||
155639777|NCT02175758|561771807|FG005|Treatment Phase|Lost to Follow-up|0|||
155639778|NCT02175758|561771802|FG000|Treatment Phase|Adverse Event|0|||
155639779|NCT02175758|561771803|FG001|Treatment Phase|Adverse Event|0|||
155639780|NCT02175758|561771804|FG002|Treatment Phase|Adverse Event|0|||
155639781|NCT02175758|561771805|FG003|Treatment Phase|Adverse Event|0|||
155639782|NCT02175758|561771806|FG004|Treatment Phase|Adverse Event|1|||
155639783|NCT02175758|561771807|FG005|Treatment Phase|Adverse Event|0|||
155639784|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
155639785|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
155639786|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
155639787|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
155639788|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
155639789|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
155639790|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155639791|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155639792|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
155639793|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
155639794|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
155639795|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
155639796|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
155639797|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
155639798|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
155639799|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
155639800|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155639801|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
155639802|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155639803|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155639804|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155639805|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
155639806|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155639807|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155639808|NCT00620542|561771808|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
155639809|NCT00620542|561771809|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
155639810|NCT00620542|561771810|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
155639811|NCT00620542|561771811|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
155639812|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
155639813|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
155639814|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
155639815|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
155639816|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
155639817|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
155639818|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
155639819|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
155639820|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
155639821|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
155639822|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
155639823|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
155496258|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
155496259|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
155496260|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
155294887|NCT02027558|560509066|FG000|Overall Study|Lost to Follow-up|4|||
155294888|NCT02027558|560509067|FG001|Overall Study|Lost to Follow-up|1|||
155294889|NCT02027558|560509066|FG000|Overall Study|Refused assessment|3|||
155294890|NCT02027558|560509067|FG001|Overall Study|Refused assessment|0|||
155294891|NCT00114244|560509068|FG000|Overall Study|Adverse Event|2|||
155294892|NCT00114244|560509069|FG001|Overall Study|Adverse Event|5|||
155294893|NCT00114244|560509068|FG000|Overall Study|Withdrawal by Subject|0|||
155294894|NCT00114244|560509069|FG001|Overall Study|Withdrawal by Subject|2|||
155294895|NCT00393848|560509070|FG000|Overall Study|Surgical schedule|0|||
155294896|NCT00393848|560509071|FG001|Overall Study|Surgical schedule|0|||
155294897|NCT00393848|560509072|FG002|Overall Study|Surgical schedule|0|||
155294898|NCT00393848|560509073|FG003|Overall Study|Surgical schedule|1|||
155294899|NCT00393848|560509070|FG000|Overall Study|Personal reasons|0|||
155294900|NCT00393848|560509071|FG001|Overall Study|Personal reasons|0|||
155294901|NCT00393848|560509072|FG002|Overall Study|Personal reasons|2|||
155294902|NCT00393848|560509073|FG003|Overall Study|Personal reasons|0|||
155294903|NCT02694978|560509080|FG000|Overall Study|Adverse Event|10|||
155294904|NCT02694978|560509081|FG001|Overall Study|Adverse Event|9|||
155294905|NCT02694978|560509080|FG000|Overall Study|Withdrawal by Subject|22|||
155294906|NCT02694978|560509081|FG001|Overall Study|Withdrawal by Subject|19|||
155294907|NCT02694978|560509080|FG000|Overall Study|Lost to Follow-up|14|||
155294908|NCT02694978|560509081|FG001|Overall Study|Lost to Follow-up|17|||
155294909|NCT02694978|560509080|FG000|Overall Study|Death|4|||
155294910|NCT02694978|560509081|FG001|Overall Study|Death|1|||
155294911|NCT02694978|560509080|FG000|Overall Study|Other-Decision of Participant|6|||
155294912|NCT02694978|560509081|FG001|Overall Study|Other-Decision of Participant|1|||
155294913|NCT02694978|560509080|FG000|Overall Study|Other-Investigator's decision|1|||
155294914|NCT02694978|560509081|FG001|Overall Study|Other-Investigator's decision|0|||
155294915|NCT02694978|560509080|FG000|Overall Study|Other-Unable to be reached|0|||
155294916|NCT02694978|560509081|FG001|Overall Study|Other-Unable to be reached|1|||
155294917|NCT02694978|560509080|FG000|Overall Study|Other-Protocol noncompliant|2|||
155294918|NCT02694978|560509081|FG001|Overall Study|Other-Protocol noncompliant|1|||
155294919|NCT02694978|560509080|FG000|Overall Study|Other-Personal reasons|3|||
155294920|NCT02694978|560509081|FG001|Overall Study|Other-Personal reasons|3|||
155294921|NCT02694978|560509080|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
155294922|NCT02694978|560509081|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
155294923|NCT01613716|560509082|FG000|Overall Study|screen failures|3|||
155294924|NCT01613716|560509082|FG000|Overall Study|Lost to Follow-up|4|||
155294925|NCT01376089|560509090|FG000|Overall Study|Patient received no contrast media|3|||
155294926|NCT01376089|560509091|FG001|Overall Study|Patient received no contrast media|4|||
155294927|NCT00419094|560509094|FG000|Overall Study|Adverse Event|3|||
155294928|NCT00419094|560509095|FG001|Overall Study|Adverse Event|7|||
155294929|NCT00419094|560509094|FG000|Overall Study|Lack of Efficacy|1|||
155294930|NCT00419094|560509095|FG001|Overall Study|Lack of Efficacy|0|||
155294931|NCT00419094|560509094|FG000|Overall Study|Lost to Follow-up|0|||
155294932|NCT00419094|560509095|FG001|Overall Study|Lost to Follow-up|2|||
155294933|NCT00419094|560509094|FG000|Overall Study|Protocol Violation|1|||
155294934|NCT00419094|560509095|FG001|Overall Study|Protocol Violation|14|||
155294935|NCT00419094|560509094|FG000|Overall Study|Withdrawal of consent|1|||
155294936|NCT00419094|560509095|FG001|Overall Study|Withdrawal of consent|5|||
155294937|NCT00419094|560509094|FG000|Overall Study|Other: Error determining exit criteria|1|||
155294938|NCT00419094|560509095|FG001|Overall Study|Other: Error determining exit criteria|0|||
155294939|NCT00419094|560509094|FG000|Overall Study|Other: Patient non-compliant|0|||
155294940|NCT00419094|560509095|FG001|Overall Study|Other: Patient non-compliant|1|||
155294941|NCT00419094|560509094|FG000|Overall Study|Other: No contact for extended period|0|||
155294942|NCT00419094|560509095|FG001|Overall Study|Other: No contact for extended period|1|||
155294943|NCT01811706|560509096|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
155294944|NCT01811706|560509097|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
155496261|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
155496262|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
155294945|NCT02567656|560509101|FG000|Overall Study|Premature discontinuation due to PD|1|||
155294946|NCT02567656|560509102|FG001|Overall Study|Premature discontinuation due to PD|1|||
155496263|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
155496264|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
155496265|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
155496266|NCT01299272|561242269|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
155496267|NCT01299272|561242270|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
155294947|NCT02567656|560509103|FG002|Overall Study|Premature discontinuation due to PD|2|||
155294948|NCT02567656|560509104|FG003|Overall Study|Premature discontinuation due to PD|0|||
155294949|NCT02567656|560509105|FG004|Overall Study|Premature discontinuation due to PD|0|||
155294950|NCT02567656|560509106|FG005|Overall Study|Premature discontinuation due to PD|0|||
155294951|NCT03287622|560509108|FG000|Overall Study|Withdrawal by Subject|1|||
155294952|NCT03287622|560509109|FG001|Overall Study|Withdrawal by Subject|0|||
155294953|NCT03287622|560509108|FG000|Overall Study|Lost to Follow-up|27|||
155294954|NCT03287622|560509109|FG001|Overall Study|Lost to Follow-up|15|||
155294955|NCT03287622|560509108|FG000|Overall Study|No prescripion after surgery|28|||
155294956|NCT03287622|560509109|FG001|Overall Study|No prescripion after surgery|31|||
155294957|NCT03287622|560509108|FG000|Overall Study|prolonged Length of stay|2|||
155294958|NCT03287622|560509109|FG001|Overall Study|prolonged Length of stay|0|||
155294959|NCT03287622|560509108|FG000|Overall Study|surgery related|0|||
155294960|NCT03287622|560509109|FG001|Overall Study|surgery related|2|||
155294961|NCT01616654|560509113|FG000|Overall Study|Lack of Efficacy|1|||
155294962|NCT01616654|560509114|FG001|Overall Study|Lack of Efficacy|0|||
155294963|NCT01616654|560509115|FG002|Overall Study|Lack of Efficacy|0|||
155294964|NCT01616654|560509116|FG003|Overall Study|Lack of Efficacy|0|||
155294965|NCT01616654|560509117|FG004|Overall Study|Lack of Efficacy|1|||
155294966|NCT01616654|560509113|FG000|Overall Study|Adverse Event|0|||
155294967|NCT01616654|560509114|FG001|Overall Study|Adverse Event|1|||
155294968|NCT01616654|560509115|FG002|Overall Study|Adverse Event|2|||
155294969|NCT01616654|560509116|FG003|Overall Study|Adverse Event|1|||
155294970|NCT01616654|560509117|FG004|Overall Study|Adverse Event|0|||
155294971|NCT01616654|560509113|FG000|Overall Study|Withdrawal by Subject|2|||
155294972|NCT01616654|560509114|FG001|Overall Study|Withdrawal by Subject|2|||
155294973|NCT01616654|560509115|FG002|Overall Study|Withdrawal by Subject|3|||
155294974|NCT01616654|560509116|FG003|Overall Study|Withdrawal by Subject|1|||
155294975|NCT01616654|560509117|FG004|Overall Study|Withdrawal by Subject|5|||
155294976|NCT01616654|560509113|FG000|Overall Study|Protocol Violation|0|||
155294977|NCT01616654|560509114|FG001|Overall Study|Protocol Violation|5|||
155294978|NCT01616654|560509115|FG002|Overall Study|Protocol Violation|2|||
155294979|NCT01616654|560509116|FG003|Overall Study|Protocol Violation|4|||
155294980|NCT01616654|560509117|FG004|Overall Study|Protocol Violation|4|||
155294981|NCT01616654|560509113|FG000|Overall Study|Lost to Follow-up|1|||
155294982|NCT01616654|560509114|FG001|Overall Study|Lost to Follow-up|0|||
155294983|NCT01616654|560509115|FG002|Overall Study|Lost to Follow-up|3|||
155294984|NCT01616654|560509116|FG003|Overall Study|Lost to Follow-up|2|||
155294985|NCT01616654|560509117|FG004|Overall Study|Lost to Follow-up|1|||
155294986|NCT01616654|560509113|FG000|Overall Study|Pregnancy|1|||
155294987|NCT01616654|560509114|FG001|Overall Study|Pregnancy|0|||
155294988|NCT01616654|560509115|FG002|Overall Study|Pregnancy|0|||
155294989|NCT01616654|560509116|FG003|Overall Study|Pregnancy|0|||
155294990|NCT01616654|560509117|FG004|Overall Study|Pregnancy|1|||
155294991|NCT02057692|560509121|FG000|Overall Study|Adverse Event|1|||
155294992|NCT02057692|560509122|FG001|Overall Study|Adverse Event|0|||
155294993|NCT02057692|560509123|FG002|Overall Study|Adverse Event|0|||
155294994|NCT02057692|560509124|FG003|Overall Study|Adverse Event|0|||
155294995|NCT02057692|560509121|FG000|Overall Study|Lost to Follow-up|0|||
155294996|NCT02057692|560509122|FG001|Overall Study|Lost to Follow-up|0|||
155294997|NCT02057692|560509123|FG002|Overall Study|Lost to Follow-up|0|||
155294998|NCT02057692|560509124|FG003|Overall Study|Lost to Follow-up|1|||
155294999|NCT00943735|560509125|FG000|Overall Study|Adverse Event|12|||
155295000|NCT00943735|560509125|FG000|Overall Study|Withdrawal by Subject|8|||
155295001|NCT00943735|560509125|FG000|Overall Study|Death|1|||
155295002|NCT00943735|560509125|FG000|Overall Study|Other|8|||
155295003|NCT00943735|560509125|FG000|Overall Study|Other|3|||
155295004|NCT00486330|560509126|FG000|Overall Study|Adverse Event|2|||
155496268|NCT01299272|561242271|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
155496269|NCT01299272|561242272|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
155496270|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
155496271|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
155496272|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
155496273|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
155496274|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
155295005|NCT01027286|560509127|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
155295006|NCT01027286|560509128|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
155295007|NCT01027286|560509127|FG000|Overall Study|Lost to Follow-up|0|||
155295008|NCT01027286|560509128|FG001|Overall Study|Lost to Follow-up|1|||
155295009|NCT03804918|560509129|FG000|Overall Study|Participant did not use the app|1|||
155295010|NCT00545844|560509130|FG000|Overall Study|Lost to Follow-up|9|||
155295011|NCT00545844|560509130|FG000|Overall Study|Protocol Violation|1|||
155295012|NCT00545844|560509130|FG000|Overall Study|Withdrawal by Subject|2|||
155295013|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
155295014|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155295015|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
155295016|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155496275|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
155744959|NCT02509117|562165272|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155295017|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155295018|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
155295019|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295020|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
155295021|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295022|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295023|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
155295024|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
155295025|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
155295026|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
155295027|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
155295028|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
155295029|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
155295030|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
155295031|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
155295032|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
155295033|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
155295034|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
155295035|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
155295036|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
155295037|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
155295038|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295039|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295040|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295041|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
155295042|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
155295043|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155295044|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155496276|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
155496277|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
155496278|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
155496279|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
155496280|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
155496281|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
155496282|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
155496283|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
155496284|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
155496285|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
155496286|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
155496287|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
155496288|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
155496289|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
155496290|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
155496291|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
155496292|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
155496293|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
155496294|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
155496295|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
155496296|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
155496297|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
155496298|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
155496299|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
155496300|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
155295045|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155295046|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
155496301|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
155496302|NCT01299272|561242269|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
155496303|NCT01299272|561242270|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
155496304|NCT01299272|561242271|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
155496305|NCT01299272|561242272|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
155496306|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
155496307|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
155295047|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
155295048|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155295049|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155295050|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155496308|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
155295051|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
155295052|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
155295053|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295054|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295055|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295056|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
155295057|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
155295058|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
155295059|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
155295060|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
155295061|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
155295062|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
155295063|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295064|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295065|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295066|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
155295067|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
155295068|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295069|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295070|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295071|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
155295072|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
155295073|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295074|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295075|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295076|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
155295077|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
155295078|NCT01329328|560509136|FG000|Overall Study|Withdrawal by Subject|2|||
155295079|NCT01329328|560509137|FG001|Overall Study|Withdrawal by Subject|4|||
155295080|NCT01329328|560509138|FG002|Overall Study|Withdrawal by Subject|3|||
155295081|NCT01565928|560509139|FG000|Overall Study|Adverse Event|3|||
155295082|NCT01565928|560509139|FG000|Overall Study|Other|3|||
155295083|NCT01565928|560509139|FG000|Overall Study|Progressive Disease|13|||
155295084|NCT01565928|560509139|FG000|Overall Study|Withdrawal by Subject|1|||
155295085|NCT01565928|560509139|FG000|Overall Study|Death|2|||
155295086|NCT00612586|560509141|FG000|Overall Study|Adverse Event|6|||
155295087|NCT00612586|560509142|FG001|Overall Study|Adverse Event|2|||
155295088|NCT00612586|560509141|FG000|Overall Study|Death|1|||
155295089|NCT00612586|560509142|FG001|Overall Study|Death|0|||
155295090|NCT00612586|560509141|FG000|Overall Study|Entry Criteria Not Met|0|||
155295091|NCT00612586|560509142|FG001|Overall Study|Entry Criteria Not Met|2|||
155295092|NCT00612586|560509141|FG000|Overall Study|Withdrawal by Subject|7|||
155295093|NCT00612586|560509142|FG001|Overall Study|Withdrawal by Subject|9|||
155295094|NCT00612586|560509141|FG000|Overall Study|Physician Decision|1|||
155295095|NCT00612586|560509142|FG001|Overall Study|Physician Decision|2|||
155295096|NCT00612586|560509141|FG000|Overall Study|Sponsor Decision|1|||
155295097|NCT00612586|560509142|FG001|Overall Study|Sponsor Decision|1|||
155295098|NCT00612586|560509141|FG000|Overall Study|Progressive Disease|26|||
155295099|NCT00612586|560509142|FG001|Overall Study|Progressive Disease|24|||
155295100|NCT00612586|560509141|FG000|Overall Study|Randomized and Not Treated|1|||
155295101|NCT00612586|560509142|FG001|Overall Study|Randomized and Not Treated|1|||
155295102|NCT00762606|560509143|FG000|Overall Study|Lost to Follow-up|18|||
155295103|NCT00762606|560509144|FG001|Overall Study|Lost to Follow-up|13|||
155295104|NCT00949975|560509146|FG000|Overall Study|Voluntary discontinuation|6|||
155295105|NCT00949975|560509147|FG001|Overall Study|Voluntary discontinuation|5|||
155295106|NCT00949975|560509148|FG002|Overall Study|Voluntary discontinuation|3|||
155295107|NCT00949975|560509149|FG003|Overall Study|Voluntary discontinuation|6|||
155295108|NCT00949975|560509146|FG000|Overall Study|Adverse Event|11|||
155295109|NCT00949975|560509147|FG001|Overall Study|Adverse Event|11|||
155295110|NCT00949975|560509148|FG002|Overall Study|Adverse Event|10|||
155295111|NCT00949975|560509149|FG003|Overall Study|Adverse Event|10|||
155295112|NCT00949975|560509146|FG000|Overall Study|Safety reason|0|||
155295113|NCT00949975|560509147|FG001|Overall Study|Safety reason|1|||
155295114|NCT00949975|560509148|FG002|Overall Study|Safety reason|0|||
155295115|NCT00949975|560509149|FG003|Overall Study|Safety reason|0|||
155496309|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
155496310|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
155496311|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
155496312|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
155496313|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
155496314|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
155496315|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
155496316|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
155496317|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
155496318|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
155496319|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
155496320|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
155496321|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
155496322|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
155496323|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
155496324|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
155496325|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
155496326|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
155496327|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
155496328|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
155496329|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
155496330|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
155496331|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
155496332|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
155496333|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
155496334|NCT01299272|561242269|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
155496335|NCT01299272|561242270|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
155496336|NCT01299272|561242271|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
155496337|NCT01299272|561242272|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
155496338|NCT00464308|561242273|FG000|Overall Study|Adverse Event|22|||
155496339|NCT00464308|561242274|FG001|Overall Study|Adverse Event|27|||
155496340|NCT00464308|561242275|FG002|Overall Study|Adverse Event|16|||
155496341|NCT00464308|561242273|FG000|Overall Study|Lost to Follow-up|29|||
155496342|NCT00464308|561242274|FG001|Overall Study|Lost to Follow-up|19|||
155496343|NCT00464308|561242275|FG002|Overall Study|Lost to Follow-up|20|||
155496344|NCT00464308|561242273|FG000|Overall Study|Patient discontinued and other reasons|17|||
155496345|NCT00464308|561242274|FG001|Overall Study|Patient discontinued and other reasons|17|||
155496346|NCT00464308|561242275|FG002|Overall Study|Patient discontinued and other reasons|23|||
155496347|NCT00464308|561242273|FG000|Overall Study|Physician Decision|1|||
155496348|NCT00464308|561242274|FG001|Overall Study|Physician Decision|0|||
155496349|NCT00464308|561242275|FG002|Overall Study|Physician Decision|0|||
155496350|NCT01513759|561242276|FG000|Overall Study|Protocol Violation|4|||
155496351|NCT01513759|561242276|FG000|Overall Study|Death during catheter placement|1|||
155496352|NCT03926728|561242277|FG000|Overall Study|Withdrawal by Subject|0|||
155496353|NCT03926728|561242278|FG001|Overall Study|Withdrawal by Subject|1|||
155496354|NCT03926728|561242279|FG002|Overall Study|Withdrawal by Subject|1|||
155496355|NCT03926728|561242280|FG003|Overall Study|Withdrawal by Subject|0|||
155496356|NCT03926728|561242281|FG004|Overall Study|Withdrawal by Subject|0|||
155496357|NCT03926728|561242282|FG005|Overall Study|Withdrawal by Subject|1|||
155496358|NCT03926728|561242283|FG006|Overall Study|Withdrawal by Subject|1|||
155496359|NCT03926728|561242284|FG007|Overall Study|Withdrawal by Subject|0|||
155496360|NCT03926728|561242285|FG008|Overall Study|Withdrawal by Subject|0|||
155496361|NCT03926728|561242286|FG009|Overall Study|Withdrawal by Subject|1|||
155496362|NCT03926728|561242287|FG010|Overall Study|Withdrawal by Subject|0|||
155496363|NCT03926728|561242288|FG011|Overall Study|Withdrawal by Subject|0|||
155496364|NCT03669640|561242289|FG000|Overall Study|Study Terminated by Sponsor|0|||
155496365|NCT03669640|561242290|FG001|Overall Study|Study Terminated by Sponsor|0|||
155496366|NCT03669640|561242291|FG002|Overall Study|Study Terminated by Sponsor|0|||
155496367|NCT03669640|561242292|FG003|Overall Study|Study Terminated by Sponsor|0|||
155496368|NCT03669640|561242293|FG004|Overall Study|Study Terminated by Sponsor|1|||
155496369|NCT03669640|561242294|FG005|Overall Study|Study Terminated by Sponsor|0|||
155496370|NCT03669640|561242289|FG000|Overall Study|Lost to Follow-up|0|||
155295116|NCT00949975|560509146|FG000|Overall Study|Study-specific criteria|0|||
155295117|NCT00949975|560509147|FG001|Overall Study|Study-specific criteria|1|||
155295118|NCT00949975|560509148|FG002|Overall Study|Study-specific criteria|1|||
155295119|NCT00949975|560509149|FG003|Overall Study|Study-specific criteria|0|||
155295120|NCT00949975|560509146|FG000|Overall Study|Incorrect enrolment|5|||
155295121|NCT00949975|560509147|FG001|Overall Study|Incorrect enrolment|10|||
155295122|NCT00949975|560509148|FG002|Overall Study|Incorrect enrolment|4|||
155295123|NCT00949975|560509149|FG003|Overall Study|Incorrect enrolment|7|||
155295124|NCT00949975|560509146|FG000|Overall Study|Severe non-compliance|3|||
155295125|NCT00949975|560509147|FG001|Overall Study|Severe non-compliance|1|||
155295126|NCT00949975|560509148|FG002|Overall Study|Severe non-compliance|0|||
155295127|NCT00949975|560509149|FG003|Overall Study|Severe non-compliance|2|||
155295128|NCT00949975|560509146|FG000|Overall Study|Lost to Follow-up|1|||
155295129|NCT00949975|560509147|FG001|Overall Study|Lost to Follow-up|0|||
155295130|NCT00949975|560509148|FG002|Overall Study|Lost to Follow-up|1|||
155295131|NCT00949975|560509149|FG003|Overall Study|Lost to Follow-up|3|||
155295132|NCT00949975|560509146|FG000|Overall Study|Other|1|||
155295133|NCT00949975|560509147|FG001|Overall Study|Other|0|||
155295134|NCT00949975|560509148|FG002|Overall Study|Other|0|||
155295135|NCT00949975|560509149|FG003|Overall Study|Other|0|||
155295136|NCT02954848|560509160|FG000|Overall Study|Randomized but Not Treated|0|||
155295137|NCT02954848|560509161|FG001|Overall Study|Randomized but Not Treated|1|||
155295138|NCT02954848|560509160|FG000|Overall Study|Adverse Event|2|||
155295139|NCT02954848|560509161|FG001|Overall Study|Adverse Event|3|||
155295140|NCT02954848|560509160|FG000|Overall Study|Withdrawal by Participant|0|||
155295141|NCT02954848|560509161|FG001|Overall Study|Withdrawal by Participant|1|||
155295142|NCT01802632|560509162|FG000|Overall Study|Death|28|||
155295143|NCT01802632|560509163|FG001|Overall Study|Death|1|||
155295144|NCT01802632|560509164|FG002|Overall Study|Death|38|||
155295145|NCT01802632|560509165|FG003|Overall Study|Death|0|||
155295146|NCT01802632|560509166|FG004|Overall Study|Death|2|||
155295147|NCT01802632|560509167|FG005|Overall Study|Death|0|||
155295148|NCT01802632|560509162|FG000|Overall Study|Withdrawal by Subject|4|||
155295149|NCT01802632|560509163|FG001|Overall Study|Withdrawal by Subject|2|||
155295150|NCT01802632|560509164|FG002|Overall Study|Withdrawal by Subject|7|||
155295151|NCT01802632|560509165|FG003|Overall Study|Withdrawal by Subject|3|||
155295152|NCT01802632|560509166|FG004|Overall Study|Withdrawal by Subject|0|||
155295153|NCT01802632|560509167|FG005|Overall Study|Withdrawal by Subject|1|||
155295154|NCT01802632|560509162|FG000|Overall Study|Objective Disease Progression|1|||
155295155|NCT01802632|560509163|FG001|Overall Study|Objective Disease Progression|12|||
155295156|NCT01802632|560509164|FG002|Overall Study|Objective Disease Progression|104|||
155295157|NCT01802632|560509165|FG003|Overall Study|Objective Disease Progression|6|||
155295158|NCT01802632|560509166|FG004|Overall Study|Objective Disease Progression|4|||
155295159|NCT01802632|560509167|FG005|Overall Study|Objective Disease Progression|4|||
155295160|NCT01802632|560509162|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
155295161|NCT01802632|560509163|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
155295162|NCT01802632|560509164|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
155295163|NCT01802632|560509165|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
155639824|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
155639825|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
155639826|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
155639827|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
155639828|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
155295164|NCT01802632|560509166|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
155295165|NCT01802632|560509167|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
155295166|NCT01802632|560509162|FG000|Overall Study|Other (not specified)|0|||
155295167|NCT01802632|560509163|FG001|Overall Study|Other (not specified)|0|||
155295168|NCT01802632|560509164|FG002|Overall Study|Other (not specified)|7|||
155295169|NCT01802632|560509165|FG003|Overall Study|Other (not specified)|1|||
155295170|NCT01802632|560509166|FG004|Overall Study|Other (not specified)|0|||
155295171|NCT01802632|560509167|FG005|Overall Study|Other (not specified)|1|||
155295172|NCT03299816|560509168|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
155295173|NCT03299816|560509169|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
155295174|NCT03299816|560509168|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
155295175|NCT03299816|560509169|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
155639829|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
155295176|NCT03299816|560509168|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
155295177|NCT03299816|560509169|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
155295178|NCT00082810|560509170|FG000|Overall Study|Adverse Event|3|||
155295179|NCT00082810|560509170|FG000|Overall Study|Progressive disease|24|||
155295180|NCT00082810|560509170|FG000|Overall Study|Withdrawal by Subject|4|||
155295181|NCT01184508|560509173|FG000|Overall Study|Adverse Event|4|||
155295182|NCT01184508|560509174|FG001|Overall Study|Adverse Event|6|||
155295183|NCT01184508|560509173|FG000|Overall Study|Lack of Efficacy|1|||
155295184|NCT01184508|560509174|FG001|Overall Study|Lack of Efficacy|1|||
155295185|NCT01184508|560509173|FG000|Overall Study|Lost to Follow-up|1|||
155295186|NCT01184508|560509174|FG001|Overall Study|Lost to Follow-up|1|||
155295187|NCT01184508|560509173|FG000|Overall Study|Physician Decision|1|||
155295188|NCT01184508|560509174|FG001|Overall Study|Physician Decision|0|||
155295189|NCT01184508|560509173|FG000|Overall Study|Protocol Violation|3|||
155295190|NCT01184508|560509174|FG001|Overall Study|Protocol Violation|1|||
155295191|NCT01184508|560509173|FG000|Overall Study|Sponsor Decision|5|||
155295192|NCT01184508|560509174|FG001|Overall Study|Sponsor Decision|2|||
155295193|NCT01184508|560509173|FG000|Overall Study|Withdrawal by Subject|1|||
155295194|NCT01184508|560509174|FG001|Overall Study|Withdrawal by Subject|3|||
155295195|NCT01184508|560509173|FG000|Overall Study|Randomized, Not Treated|0|||
155295196|NCT01184508|560509174|FG001|Overall Study|Randomized, Not Treated|1|||
155295197|NCT02194933|560509177|FG000|Overall Study|Lost to Follow-up|1|||
155295198|NCT02194933|560509178|FG001|Overall Study|Lost to Follow-up|2|||
155295199|NCT02194933|560509177|FG000|Overall Study|Participant met withdrawal criteria|1|||
155295200|NCT02194933|560509178|FG001|Overall Study|Participant met withdrawal criteria|3|||
155295201|NCT02194933|560509177|FG000|Overall Study|Withdrawal by Subject|0|||
155295202|NCT02194933|560509178|FG001|Overall Study|Withdrawal by Subject|2|||
155295203|NCT02194933|560509177|FG000|Overall Study|Lack of Efficacy|1|||
155295204|NCT02194933|560509178|FG001|Overall Study|Lack of Efficacy|2|||
155295205|NCT03210402|560509179|FG000|Overall Study|Withdrawal by Subject|0|||
155295206|NCT03210402|560509180|FG001|Overall Study|Withdrawal by Subject|1|||
155295207|NCT02517307|560509195|FG000|Overall Study|Withdrawal by Subject|1|||
155295208|NCT02517307|560509196|FG001|Overall Study|Withdrawal by Subject|0|||
155295209|NCT02517307|560509197|FG002|Overall Study|Withdrawal by Subject|1|||
155295210|NCT02517307|560509198|FG003|Overall Study|Withdrawal by Subject|0|||
155295211|NCT02517307|560509195|FG000|Overall Study|Protocol Violation|0|||
155295212|NCT02517307|560509196|FG001|Overall Study|Protocol Violation|0|||
155295213|NCT02517307|560509197|FG002|Overall Study|Protocol Violation|1|||
155295214|NCT02517307|560509198|FG003|Overall Study|Protocol Violation|1|||
155295215|NCT03863834|560509205|FG000|Overall Study|Lost to Follow-up|3|||
155295216|NCT02685488|560509206|FG000|Overall Study|Withdrawal by Subject|0|||
155295217|NCT02685488|560509207|FG001|Overall Study|Withdrawal by Subject|1|||
155295218|NCT02351180|560509210|FG000|Overall Study|Withdrawal by Subject|1|||
155295219|NCT02351180|560509211|FG001|Overall Study|Withdrawal by Subject|0|||
155295220|NCT00605033|560509218|FG000|Overall Study|Adverse Event|2|||
155295221|NCT00605033|560509219|FG001|Overall Study|Adverse Event|2|||
155295222|NCT00605033|560509218|FG000|Overall Study|Lost to Follow-up|1|||
155295223|NCT00605033|560509219|FG001|Overall Study|Lost to Follow-up|1|||
155295224|NCT00605033|560509218|FG000|Overall Study|Withdrawal by Subject|3|||
155295225|NCT00605033|560509219|FG001|Overall Study|Withdrawal by Subject|4|||
155295226|NCT00605033|560509218|FG000|Overall Study|Protocol Violation|1|||
155295227|NCT00605033|560509219|FG001|Overall Study|Protocol Violation|1|||
155295228|NCT03768206|560509222|FG000|Overall Study|Lost to Follow-up|2|||
155295229|NCT03768206|560509223|FG001|Overall Study|Lost to Follow-up|1|||
155295230|NCT03768206|560509222|FG000|Overall Study|Withdrawal by Subject|0|||
155295231|NCT03768206|560509223|FG001|Overall Study|Withdrawal by Subject|1|||
155295232|NCT05328297|560511463|FG000|Overall Study|Adverse Event|5|||
155295233|NCT05328297|560511464|FG001|Overall Study|Adverse Event|7|||
155295234|NCT05328297|560511463|FG000|Overall Study|Withdrawal by Subject|4|||
155295235|NCT05328297|560511464|FG001|Overall Study|Withdrawal by Subject|3|||
155295236|NCT05328297|560511463|FG000|Overall Study|Lack of Efficacy|1|||
155295237|NCT05328297|560511464|FG001|Overall Study|Lack of Efficacy|0|||
155295238|NCT05328297|560511463|FG000|Overall Study|Lost to Follow-up|1|||
155295239|NCT05328297|560511464|FG001|Overall Study|Lost to Follow-up|0|||
155295240|NCT05328297|560511463|FG000|Overall Study|Protocol Violation|1|||
155295241|NCT05328297|560511464|FG001|Overall Study|Protocol Violation|0|||
155295242|NCT05328297|560511463|FG000|Overall Study|Randomized but not treated|1|||
155295243|NCT05328297|560511464|FG001|Overall Study|Randomized but not treated|1|||
155295244|NCT05147233|560511465|FG000|Overall Study|Adverse Event|0|||
155295245|NCT05147233|560511466|FG001|Overall Study|Adverse Event|1|||
155295246|NCT05147233|560511465|FG000|Overall Study|Lost to Follow-up|1|||
155295247|NCT05147233|560511466|FG001|Overall Study|Lost to Follow-up|1|||
155295248|NCT05147233|560511465|FG000|Overall Study|Protocol Violation|0|||
155295249|NCT05147233|560511466|FG001|Overall Study|Protocol Violation|1|||
155295250|NCT05147233|560511465|FG000|Overall Study|Withdrawal by Subject|2|||
155295251|NCT05147233|560511466|FG001|Overall Study|Withdrawal by Subject|1|||
155295252|NCT04513522|560511467|FG000|Overall Study|Other reasons|1|||
155295253|NCT04513522|560511467|FG000|Overall Study|Adverse event unrelated to study drug|9|||
155295254|NCT04513522|560511467|FG000|Overall Study|Study drug toxicity|14|||
155295255|NCT04513522|560511467|FG000|Overall Study|Disease progression|39|||
155295256|NCT04513522|560511467|FG000|Overall Study|Participants withdrew consent|2|||
155295257|NCT03284957|560511468|FG000|Overall Study|Adverse Event|0|||
155295258|NCT03284957|560511469|FG001|Overall Study|Adverse Event|0|||
155295259|NCT03284957|560511470|FG002|Overall Study|Adverse Event|0|||
155496371|NCT03669640|561242290|FG001|Overall Study|Lost to Follow-up|0|||
155496372|NCT03669640|561242291|FG002|Overall Study|Lost to Follow-up|2|||
155496373|NCT03669640|561242292|FG003|Overall Study|Lost to Follow-up|0|||
155496374|NCT03669640|561242293|FG004|Overall Study|Lost to Follow-up|0|||
155496375|NCT03669640|561242294|FG005|Overall Study|Lost to Follow-up|0|||
155496376|NCT03669640|561242289|FG000|Overall Study|Death|0|||
155496377|NCT03669640|561242290|FG001|Overall Study|Death|0|||
155496378|NCT03669640|561242291|FG002|Overall Study|Death|1|||
155496379|NCT03669640|561242292|FG003|Overall Study|Death|0|||
155496380|NCT03669640|561242293|FG004|Overall Study|Death|0|||
155496381|NCT03669640|561242294|FG005|Overall Study|Death|0|||
155496382|NCT03669640|561242289|FG000|Overall Study|Withdrawal by Subject|1|||
155295260|NCT03284957|560511471|FG003|Overall Study|Adverse Event|0|||
155295261|NCT03284957|560511472|FG004|Overall Study|Adverse Event|0|||
155295262|NCT03284957|560511473|FG005|Overall Study|Adverse Event|1|||
155295263|NCT03284957|560511474|FG006|Overall Study|Adverse Event|1|||
155295264|NCT03284957|560511475|FG007|Overall Study|Adverse Event|1|||
155295265|NCT03284957|560511476|FG008|Overall Study|Adverse Event|0|||
155295266|NCT03284957|560511477|FG009|Overall Study|Adverse Event|4|||
155295267|NCT03284957|560511478|FG010|Overall Study|Adverse Event|1|||
155295268|NCT03284957|560511479|FG011|Overall Study|Adverse Event|1|||
155295269|NCT03284957|560511480|FG012|Overall Study|Adverse Event|0|||
155295270|NCT03284957|560511481|FG013|Overall Study|Adverse Event|0|||
155295271|NCT03284957|560511482|FG014|Overall Study|Adverse Event|0|||
155295272|NCT03284957|560511483|FG015|Overall Study|Adverse Event|0|||
155295273|NCT03284957|560511468|FG000|Overall Study|Progressive Disease|3|||
155295274|NCT03284957|560511469|FG001|Overall Study|Progressive Disease|3|||
155295275|NCT03284957|560511470|FG002|Overall Study|Progressive Disease|4|||
155295276|NCT03284957|560511471|FG003|Overall Study|Progressive Disease|3|||
155295277|NCT03284957|560511472|FG004|Overall Study|Progressive Disease|3|||
155295278|NCT03284957|560511473|FG005|Overall Study|Progressive Disease|5|||
155295279|NCT03284957|560511474|FG006|Overall Study|Progressive Disease|45|||
155295280|NCT03284957|560511475|FG007|Overall Study|Progressive Disease|8|||
155295281|NCT03284957|560511476|FG008|Overall Study|Progressive Disease|5|||
155295282|NCT03284957|560511477|FG009|Overall Study|Progressive Disease|18|||
155295283|NCT03284957|560511478|FG010|Overall Study|Progressive Disease|7|||
155295284|NCT03284957|560511479|FG011|Overall Study|Progressive Disease|2|||
155295285|NCT03284957|560511480|FG012|Overall Study|Progressive Disease|3|||
155295286|NCT03284957|560511481|FG013|Overall Study|Progressive Disease|1|||
155295287|NCT03284957|560511482|FG014|Overall Study|Progressive Disease|1|||
155295288|NCT03284957|560511483|FG015|Overall Study|Progressive Disease|2|||
155295289|NCT03284957|560511468|FG000|Overall Study|Withdrawal by Subject|0|||
155295290|NCT03284957|560511469|FG001|Overall Study|Withdrawal by Subject|0|||
155295291|NCT03284957|560511470|FG002|Overall Study|Withdrawal by Subject|0|||
155295292|NCT03284957|560511471|FG003|Overall Study|Withdrawal by Subject|0|||
155295293|NCT03284957|560511472|FG004|Overall Study|Withdrawal by Subject|0|||
155295294|NCT03284957|560511473|FG005|Overall Study|Withdrawal by Subject|0|||
155295295|NCT03284957|560511474|FG006|Overall Study|Withdrawal by Subject|0|||
155295296|NCT03284957|560511475|FG007|Overall Study|Withdrawal by Subject|0|||
155295297|NCT03284957|560511476|FG008|Overall Study|Withdrawal by Subject|0|||
155295298|NCT03284957|560511477|FG009|Overall Study|Withdrawal by Subject|2|||
155295299|NCT03284957|560511478|FG010|Overall Study|Withdrawal by Subject|0|||
155295300|NCT03284957|560511479|FG011|Overall Study|Withdrawal by Subject|0|||
155295301|NCT03284957|560511480|FG012|Overall Study|Withdrawal by Subject|0|||
155295302|NCT03284957|560511481|FG013|Overall Study|Withdrawal by Subject|0|||
155295303|NCT03284957|560511482|FG014|Overall Study|Withdrawal by Subject|0|||
155295304|NCT03284957|560511483|FG015|Overall Study|Withdrawal by Subject|0|||
155295305|NCT03284957|560511468|FG000|Overall Study|Other|0|||
155295306|NCT03284957|560511469|FG001|Overall Study|Other|0|||
155295307|NCT03284957|560511470|FG002|Overall Study|Other|0|||
155295308|NCT03284957|560511471|FG003|Overall Study|Other|0|||
155295309|NCT03284957|560511472|FG004|Overall Study|Other|0|||
155496383|NCT03669640|561242290|FG001|Overall Study|Withdrawal by Subject|2|||
155496384|NCT03669640|561242291|FG002|Overall Study|Withdrawal by Subject|1|||
155496385|NCT03669640|561242292|FG003|Overall Study|Withdrawal by Subject|0|||
155496386|NCT03669640|561242293|FG004|Overall Study|Withdrawal by Subject|1|||
155295310|NCT03284957|560511473|FG005|Overall Study|Other|0|||
155295311|NCT03284957|560511474|FG006|Overall Study|Other|3|||
155295312|NCT03284957|560511475|FG007|Overall Study|Other|0|||
155295313|NCT03284957|560511476|FG008|Overall Study|Other|1|||
155295314|NCT03284957|560511477|FG009|Overall Study|Other|6|||
155295315|NCT03284957|560511478|FG010|Overall Study|Other|0|||
155295316|NCT03284957|560511479|FG011|Overall Study|Other|0|||
155295317|NCT03284957|560511480|FG012|Overall Study|Other|0|||
155496387|NCT03669640|561242294|FG005|Overall Study|Withdrawal by Subject|3|||
155496388|NCT03669640|561242289|FG000|Overall Study|Protocol Violation|1|||
155295318|NCT03284957|560511481|FG013|Overall Study|Other|0|||
155295319|NCT03284957|560511482|FG014|Overall Study|Other|2|||
155295320|NCT03284957|560511483|FG015|Overall Study|Other|0|||
155295321|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Adverse Event|1|||
155295322|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Adverse Event|0|||
155496389|NCT03669640|561242290|FG001|Overall Study|Protocol Violation|0|||
155496390|NCT03669640|561242291|FG002|Overall Study|Protocol Violation|0|||
155295323|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Adverse Event|0|||
155295324|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
155295325|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
155295326|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
155295327|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
155295328|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
155295329|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
155295330|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
155295331|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
155295332|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
155295333|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Adverse Event|1|||
155295334|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Adverse Event|0|||
155295335|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Adverse Event|0|||
155496391|NCT03669640|561242292|FG003|Overall Study|Protocol Violation|0|||
155496392|NCT03669640|561242293|FG004|Overall Study|Protocol Violation|0|||
155496393|NCT03669640|561242294|FG005|Overall Study|Protocol Violation|0|||
155496394|NCT03669640|561242289|FG000|Overall Study|Physician Decision|0|||
155496395|NCT03669640|561242290|FG001|Overall Study|Physician Decision|2|||
155496396|NCT03669640|561242291|FG002|Overall Study|Physician Decision|0|||
155496397|NCT03669640|561242292|FG003|Overall Study|Physician Decision|0|||
155496398|NCT03669640|561242293|FG004|Overall Study|Physician Decision|0|||
155496399|NCT03669640|561242294|FG005|Overall Study|Physician Decision|0|||
155496400|NCT03669640|561242289|FG000|Overall Study|Disease Relapse|1|||
155496401|NCT03669640|561242290|FG001|Overall Study|Disease Relapse|0|||
155295336|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
155295337|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
155295338|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
155295339|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
155295340|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
155295341|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
155295342|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Physician Decision|1|||
155295343|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Physician Decision|0|||
155295344|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Physician Decision|0|||
155295345|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
155295346|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
155295347|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
155295348|NCT04517864|560511484|FG000|Extension Phase|Adverse Event|0|||
155295349|NCT04517864|560511485|FG001|Extension Phase|Adverse Event|0|||
155295350|NCT04517864|560511486|FG002|Extension Phase|Adverse Event|1|||
155295351|NCT04517864|560511484|FG000|Extension Phase|Lack of Efficacy|0|||
155295352|NCT04517864|560511485|FG001|Extension Phase|Lack of Efficacy|0|||
155295353|NCT04517864|560511486|FG002|Extension Phase|Lack of Efficacy|2|||
155295354|NCT04517864|560511484|FG000|Extension Phase|Study Terminated By Sponsor|0|||
155295355|NCT04517864|560511485|FG001|Extension Phase|Study Terminated By Sponsor|0|||
155295356|NCT04517864|560511486|FG002|Extension Phase|Study Terminated By Sponsor|32|||
155295357|NCT04517864|560511484|FG000|Extension Phase|Withdrawal by Subject|0|||
155295358|NCT04517864|560511485|FG001|Extension Phase|Withdrawal by Subject|0|||
155295359|NCT04517864|560511486|FG002|Extension Phase|Withdrawal by Subject|3|||
155295360|NCT04517864|560511484|FG000|Extension Phase|Approved Drug Available for Indication|0|||
155295361|NCT04517864|560511485|FG001|Extension Phase|Approved Drug Available for Indication|0|||
155295362|NCT04517864|560511486|FG002|Extension Phase|Approved Drug Available for Indication|7|||
155295363|NCT04722003|560511489|FG000|Overall Study|Lost to Follow-up|2|||
155295364|NCT04722003|560511490|FG001|Overall Study|Lost to Follow-up|0|||
155295365|NCT04722003|560511489|FG000|Overall Study|Physician Decision|1|||
155295366|NCT04722003|560511490|FG001|Overall Study|Physician Decision|0|||
155496402|NCT03669640|561242291|FG002|Overall Study|Disease Relapse|0|||
155496403|NCT03669640|561242292|FG003|Overall Study|Disease Relapse|0|||
155496404|NCT03669640|561242293|FG004|Overall Study|Disease Relapse|0|||
155295367|NCT04860258|560511491|FG000|Overall Study|Withdrawal by Subject|0|||
155295368|NCT04860258|560511492|FG001|Overall Study|Withdrawal by Subject|0|||
155295369|NCT04860258|560511493|FG002|Overall Study|Withdrawal by Subject|4|||
155295370|NCT04860258|560511494|FG003|Overall Study|Withdrawal by Subject|1|||
155295371|NCT04860258|560511495|FG004|Overall Study|Withdrawal by Subject|4|||
155295372|NCT04860258|560511496|FG005|Overall Study|Withdrawal by Subject|1|||
155295373|NCT04860258|560511497|FG006|Overall Study|Withdrawal by Subject|0|||
155295374|NCT00028769|560511500|FG000|Overall Study|Adverse Event|2|||
155295375|NCT00028769|560511500|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
155295376|NCT00028769|560511500|FG000|Overall Study|Progression or Death|31|||
155295377|NCT00028769|560511500|FG000|Overall Study|Other - Not Protocol Specified|1|||
155295378|NCT00028769|560511500|FG000|Overall Study|Ineligible|5|||
155295379|NCT00028769|560511500|FG000|Overall Study|Not Analyzable|1|||
155295380|NCT02496702|560511503|FG000|Overall Study|Lost to Follow-up|8|||
155295381|NCT02496702|560511504|FG001|Overall Study|Lost to Follow-up|6|||
155295382|NCT02496702|560511503|FG000|Overall Study|Only partially tested|0|||
155496405|NCT03669640|561242294|FG005|Overall Study|Disease Relapse|0|||
155496406|NCT03669640|561242289|FG000|Overall Study|Adverse Event|2|||
155496407|NCT03669640|561242290|FG001|Overall Study|Adverse Event|1|||
155295383|NCT02496702|560511504|FG001|Overall Study|Only partially tested|2|||
155295384|NCT01499134|560511507|FG000|Overall Study|Withdrawal by Subject|0|||
155295385|NCT01499134|560511508|FG001|Overall Study|Withdrawal by Subject|1|||
155295386|NCT00708032|560511509|FG000|Overall Study|Adverse Event|0|||
155295387|NCT00708032|560511510|FG001|Overall Study|Adverse Event|2|||
155295388|NCT00708032|560511509|FG000|Overall Study|Lost to Follow-up|1|||
155295389|NCT00708032|560511510|FG001|Overall Study|Lost to Follow-up|2|||
155295390|NCT00708032|560511509|FG000|Overall Study|Pregnancy|0|||
155295391|NCT00708032|560511510|FG001|Overall Study|Pregnancy|1|||
155295392|NCT00708032|560511509|FG000|Overall Study|Poor vision|0|||
155295393|NCT00708032|560511510|FG001|Overall Study|Poor vision|6|||
155295394|NCT00708032|560511509|FG000|Overall Study|Visit out of range at month 12|4|||
155295395|NCT00708032|560511510|FG001|Overall Study|Visit out of range at month 12|1|||
155295396|NCT00708032|560511509|FG000|Overall Study|Did not meet protocol criteria|1|||
155295397|NCT00708032|560511510|FG001|Overall Study|Did not meet protocol criteria|2|||
155295398|NCT00708032|560511509|FG000|Overall Study|Protocol Violation|4|||
155295399|NCT00708032|560511510|FG001|Overall Study|Protocol Violation|1|||
155295400|NCT00708032|560511509|FG000|Overall Study|Withdrawal by Subject|0|||
155295401|NCT00708032|560511510|FG001|Overall Study|Withdrawal by Subject|1|||
155295402|NCT00446550|560511515|FG000|Overall Study|Adverse Event|1|||
155295403|NCT00446550|560511516|FG001|Overall Study|Adverse Event|0|||
155295404|NCT01759264|560511517|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
155295405|NCT01759264|560511517|FG000|Overall Study|Adverse Event|1|||
155295406|NCT01759264|560511517|FG000|Overall Study|Other|2|||
155295407|NCT01759264|560511517|FG000|Overall Study|Lost to Follow-up|2|||
155295408|NCT01759264|560511517|FG000|Overall Study|Withdrawal by Subject|3|||
155295409|NCT01759264|560511517|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
155295410|NCT03557008|560511518|FG000|Overall Study|Withdrawal by Subject|2|||
155295411|NCT03557008|560511519|FG001|Overall Study|Withdrawal by Subject|2|||
155295412|NCT03557008|560511518|FG000|Overall Study|Early termination from study|3|||
155295413|NCT03557008|560511519|FG001|Overall Study|Early termination from study|1|||
155295414|NCT03020745|560511522|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295415|NCT03020745|560511523|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295416|NCT03020745|560511524|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295417|NCT03020745|560511525|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295418|NCT03020745|560511526|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295419|NCT03020745|560511527|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295420|NCT03020745|560511528|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295421|NCT03020745|560511529|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295422|NCT03020745|560511530|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
155295423|NCT03020745|560511531|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295424|NCT03020745|560511522|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295425|NCT03020745|560511523|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295426|NCT03020745|560511524|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295427|NCT03020745|560511525|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295428|NCT03020745|560511526|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295429|NCT03020745|560511527|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295430|NCT03020745|560511528|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295431|NCT03020745|560511529|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
155295432|NCT03020745|560511530|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295433|NCT03020745|560511531|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295434|NCT03020745|560511522|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295435|NCT03020745|560511523|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295436|NCT03020745|560511524|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295437|NCT03020745|560511525|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155496408|NCT03669640|561242291|FG002|Overall Study|Adverse Event|0|||
155496409|NCT03669640|561242292|FG003|Overall Study|Adverse Event|0|||
155496410|NCT03669640|561242293|FG004|Overall Study|Adverse Event|1|||
155496411|NCT03669640|561242294|FG005|Overall Study|Adverse Event|0|||
155496412|NCT03993288|561242295|FG000|Overall Study|Lost to Follow-up|2|||
155496413|NCT03993288|561242296|FG001|Overall Study|Lost to Follow-up|1|||
155496414|NCT03993288|561242295|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
155496415|NCT03993288|561242296|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
155496416|NCT03993288|561242295|FG000|Overall Study|wrong randomization|0|||
155295438|NCT03020745|560511526|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295439|NCT03020745|560511527|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
155295440|NCT03020745|560511528|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295441|NCT03020745|560511529|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295442|NCT03020745|560511530|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
155295443|NCT03020745|560511531|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295444|NCT03020745|560511522|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295445|NCT03020745|560511523|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295446|NCT03020745|560511524|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155496417|NCT03993288|561242296|FG001|Overall Study|wrong randomization|1|||
155295447|NCT03020745|560511525|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295448|NCT03020745|560511526|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295449|NCT03020745|560511527|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295450|NCT03020745|560511528|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295451|NCT03020745|560511529|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295452|NCT03020745|560511530|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
155295453|NCT03020745|560511531|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295454|NCT00743444|560511532|FG000|First Intervention|Catheter placement problems|0|||
155295455|NCT00743444|560511533|FG001|First Intervention|Catheter placement problems|1|||
155295456|NCT00743444|560511532|FG000|Washout Period|Adverse Event|0|||
155295457|NCT00743444|560511533|FG001|Washout Period|Adverse Event|1|||
155295458|NCT00186186|560511534|FG000|Overall Study|Lack of Efficacy|3|||
155295459|NCT00186186|560511534|FG000|Overall Study|Withdrawal by Subject|3|||
155295460|NCT00186186|560511534|FG000|Overall Study|Not reported as to reason|2|||
155295461|NCT00807144|560511535|FG000|Overall Study|Lost to Follow-up|0|||
155295462|NCT00807144|560511536|FG001|Overall Study|Lost to Follow-up|1|||
155295463|NCT00813904|560511543|FG000|Overall Study|Death|1|||
155295464|NCT01405924|560511544|FG000|Overall Study|Protocol Violation|8|||
155295465|NCT01405924|560511544|FG000|Overall Study|Missing/Incomplete Data|2|||
155295466|NCT02393716|560511545|FG000|Overall Study|Death|29|||
155295467|NCT02393716|560511545|FG000|Overall Study|Withdrawal by Subject|8|||
155295468|NCT02393716|560511545|FG000|Overall Study|Device Explanted|8|||
155295469|NCT02393716|560511545|FG000|Overall Study|Missed visit|16|||
155295470|NCT01924767|560511546|FG000|Overall Study|Adverse Event|1|||
155295471|NCT01924767|560511547|FG001|Overall Study|Adverse Event|0|||
155295472|NCT01924767|560511548|FG002|Overall Study|Adverse Event|1|||
155295473|NCT01924767|560511549|FG003|Overall Study|Adverse Event|0|||
155295474|NCT01924767|560511550|FG004|Overall Study|Adverse Event|0|||
155295475|NCT01648140|560511551|FG000|Overall Study|Physician Decision|1|||
155295476|NCT01648140|560511552|FG001|Overall Study|Physician Decision|0|||
155295477|NCT01648140|560511553|FG002|Overall Study|Physician Decision|0|||
155295478|NCT01648140|560511554|FG003|Overall Study|Physician Decision|0|||
155295479|NCT01648140|560511551|FG000|Overall Study|Lack of Efficacy|4|||
155295480|NCT01648140|560511552|FG001|Overall Study|Lack of Efficacy|7|||
155295481|NCT01648140|560511553|FG002|Overall Study|Lack of Efficacy|1|||
155295482|NCT01648140|560511554|FG003|Overall Study|Lack of Efficacy|0|||
155295483|NCT01648140|560511551|FG000|Overall Study|Adverse Event|3|||
155295484|NCT01648140|560511552|FG001|Overall Study|Adverse Event|1|||
155295485|NCT01648140|560511553|FG002|Overall Study|Adverse Event|2|||
155295486|NCT01648140|560511554|FG003|Overall Study|Adverse Event|0|||
155295487|NCT01648140|560511551|FG000|Overall Study|Withdrawal by Subject|2|||
155295488|NCT01648140|560511552|FG001|Overall Study|Withdrawal by Subject|3|||
155295489|NCT01648140|560511553|FG002|Overall Study|Withdrawal by Subject|3|||
155295490|NCT01648140|560511554|FG003|Overall Study|Withdrawal by Subject|2|||
155295491|NCT01648140|560511551|FG000|Overall Study|Lost to Follow-up|2|||
155295492|NCT01648140|560511552|FG001|Overall Study|Lost to Follow-up|1|||
155295493|NCT01648140|560511553|FG002|Overall Study|Lost to Follow-up|2|||
155295494|NCT01648140|560511554|FG003|Overall Study|Lost to Follow-up|0|||
155295495|NCT03987451|560511555|FG000|Overall Study|Lost to Follow-up|1|||
155295496|NCT03987451|560511556|FG001|Overall Study|Lost to Follow-up|0|||
155295497|NCT03987451|560511555|FG000|Overall Study|Withdrawal by Subject|1|||
155295498|NCT03987451|560511556|FG001|Overall Study|Withdrawal by Subject|1|||
155295499|NCT03192046|560511557|FG000|Overall Study|Withdrawal by Subject|1|||
155295500|NCT03192046|560511558|FG001|Overall Study|Withdrawal by Subject|1|||
155295501|NCT01194154|560511559|FG000|Overall Study|Adverse Event|12|||
155295502|NCT01194154|560511560|FG001|Overall Study|Adverse Event|7|||
155295503|NCT01194154|560511559|FG000|Overall Study|Lost to Follow-up|2|||
155295504|NCT01194154|560511560|FG001|Overall Study|Lost to Follow-up|3|||
155295505|NCT01194154|560511559|FG000|Overall Study|Protocol Violation|0|||
155295506|NCT01194154|560511560|FG001|Overall Study|Protocol Violation|1|||
155295507|NCT01194154|560511559|FG000|Overall Study|Withdrawal by Subject|5|||
155295508|NCT01194154|560511560|FG001|Overall Study|Withdrawal by Subject|6|||
155295509|NCT01194154|560511559|FG000|Overall Study|Blood pressure increase|5|||
155295510|NCT01194154|560511560|FG001|Overall Study|Blood pressure increase|3|||
155295511|NCT01194154|560511559|FG000|Overall Study|Hemoglobin decrease|0|||
155295512|NCT01194154|560511560|FG001|Overall Study|Hemoglobin decrease|1|||
155295513|NCT01194154|560511559|FG000|Overall Study|Hemoglobin increase|12|||
155295514|NCT01194154|560511560|FG001|Overall Study|Hemoglobin increase|3|||
155295515|NCT01194154|560511559|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
155295516|NCT01194154|560511560|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
155295517|NCT01194154|560511559|FG000|Overall Study|Treatment with prohibited medication|4|||
155295518|NCT01194154|560511560|FG001|Overall Study|Treatment with prohibited medication|5|||
155295519|NCT01194154|560511559|FG000|Overall Study|Other|4|||
155295520|NCT01194154|560511560|FG001|Overall Study|Other|0|||
155295521|NCT01194154|560511559|FG000|Overall Study|Did not receive study medication|2|||
155295522|NCT01194154|560511560|FG001|Overall Study|Did not receive study medication|4|||
155295523|NCT01505881|560511561|FG000|Overall Study|Adverse Event|0|||
155295524|NCT01505881|560511562|FG001|Overall Study|Adverse Event|1|||
155295525|NCT01505881|560511561|FG000|Overall Study|Lost to Follow-up|2|||
155295526|NCT01505881|560511562|FG001|Overall Study|Lost to Follow-up|0|||
155295527|NCT01505881|560511561|FG000|Overall Study|Withdrawal by Subject|2|||
155295528|NCT01505881|560511562|FG001|Overall Study|Withdrawal by Subject|0|||
155295529|NCT01147341|560511563|FG000|Double Blind Period|Lack of Efficacy|1|||
155295530|NCT01147341|560511564|FG001|Double Blind Period|Lack of Efficacy|1|||
155295531|NCT01147341|560511563|FG000|Double Blind Period|Withdrawal by Subject|0|||
155295532|NCT01147341|560511564|FG001|Double Blind Period|Withdrawal by Subject|1|||
155295533|NCT01147341|560511563|FG000|Open Label Period|Lack of Efficacy|3|||
155295534|NCT01147341|560511564|FG001|Open Label Period|Lack of Efficacy|0|||
155295535|NCT01147341|560511563|FG000|Open Label Period|Subject moved|1|||
155295536|NCT01147341|560511564|FG001|Open Label Period|Subject moved|0|||
155295537|NCT01901276|560511565|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
155295538|NCT01901276|560511566|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
155295539|NCT02314117|560511567|FG000|Overall Study|Lost to Follow-up|9|||
155295540|NCT02314117|560511568|FG001|Overall Study|Lost to Follow-up|14|||
155295541|NCT02314117|560511567|FG000|Overall Study|Withdrawal by Subject|3|||
155295542|NCT02314117|560511568|FG001|Overall Study|Withdrawal by Subject|2|||
155295543|NCT02950558|560511572|FG000|Overall Study|Lost to Follow-up|2|||
155295544|NCT02950558|560511573|FG001|Overall Study|Lost to Follow-up|0|||
155295545|NCT03383146|560511574|FG000|Overall Study|Screen Failure|1|||
155295546|NCT03383146|560511575|FG001|Overall Study|Screen Failure|0|||
155295547|NCT03383146|560511574|FG000|Overall Study|Adverse Event|6|||
155295548|NCT03383146|560511575|FG001|Overall Study|Adverse Event|18|||
155295549|NCT03383146|560511574|FG000|Overall Study|Lack of Efficacy|0|||
155295550|NCT03383146|560511575|FG001|Overall Study|Lack of Efficacy|3|||
155295551|NCT03383146|560511574|FG000|Overall Study|Withdrawal by Subject|20|||
155295552|NCT03383146|560511575|FG001|Overall Study|Withdrawal by Subject|36|||
155295553|NCT03383146|560511574|FG000|Overall Study|Lost to Follow-up|5|||
155295554|NCT03383146|560511575|FG001|Overall Study|Lost to Follow-up|15|||
155295555|NCT03383146|560511574|FG000|Overall Study|Death|0|||
155295556|NCT03383146|560511575|FG001|Overall Study|Death|2|||
155295557|NCT03383146|560511574|FG000|Overall Study|Physician Decision|0|||
155295558|NCT03383146|560511575|FG001|Overall Study|Physician Decision|1|||
155295559|NCT03383146|560511574|FG000|Overall Study|Protocol Deviation|1|||
155295560|NCT03383146|560511575|FG001|Overall Study|Protocol Deviation|8|||
155295561|NCT03383146|560511574|FG000|Overall Study|Study Terminated by the Sponsor|48|||
155639830|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
155639831|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
155639832|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
155639833|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
155639834|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
155639835|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
155639836|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
155639837|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
155639838|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
155639839|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
155639840|NCT00620542|561771808|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
155639841|NCT00620542|561771809|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
155639842|NCT00620542|561771810|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
155639843|NCT00620542|561771811|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
155639844|NCT01500083|561771812|FG000|Overall Study|Adverse Event|4|||
155639845|NCT01500083|561771813|FG001|Overall Study|Adverse Event|17|||
155639846|NCT01500083|561771812|FG000|Overall Study|Death|0|||
155639847|NCT01500083|561771813|FG001|Overall Study|Death|2|||
155639848|NCT01500083|561771812|FG000|Overall Study|Lost to Follow-up|1|||
155639849|NCT01500083|561771813|FG001|Overall Study|Lost to Follow-up|0|||
155496418|NCT03993288|561242295|FG000|Overall Study|improper enrollment|0|||
155295562|NCT03383146|560511575|FG001|Overall Study|Study Terminated by the Sponsor|95|||
155295563|NCT03383146|560511574|FG000|Overall Study|Reason not Specified|4|||
155295564|NCT03383146|560511575|FG001|Overall Study|Reason not Specified|6|||
155295565|NCT01317420|560511576|FG000|Overall Study|Progressive disease according to RECIST|2|||
155295566|NCT01317420|560511577|FG001|Overall Study|Progressive disease according to RECIST|3|||
155295567|NCT01317420|560511578|FG002|Overall Study|Progressive disease according to RECIST|3|||
155295568|NCT01317420|560511579|FG003|Overall Study|Progressive disease according to RECIST|3|||
155295569|NCT01317420|560511580|FG004|Overall Study|Progressive disease according to RECIST|3|||
155295570|NCT01317420|560511581|FG005|Overall Study|Progressive disease according to RECIST|3|||
155295571|NCT01317420|560511582|FG006|Overall Study|Progressive disease according to RECIST|3|||
155295572|NCT01317420|560511583|FG007|Overall Study|Progressive disease according to RECIST|3|||
155295573|NCT01317420|560511584|FG008|Overall Study|Progressive disease according to RECIST|3|||
155295574|NCT01317420|560511585|FG009|Overall Study|Progressive disease according to RECIST|2|||
155295575|NCT01317420|560511586|FG010|Overall Study|Progressive disease according to RECIST|3|||
155295576|NCT01317420|560511587|FG011|Overall Study|Progressive disease according to RECIST|11|||
155295577|NCT01317420|560511588|FG012|Overall Study|Progressive disease according to RECIST|16|||
155295578|NCT01317420|560511576|FG000|Overall Study|Other adverse event|1|||
155295579|NCT01317420|560511577|FG001|Overall Study|Other adverse event|0|||
155295580|NCT01317420|560511578|FG002|Overall Study|Other adverse event|0|||
155295581|NCT01317420|560511579|FG003|Overall Study|Other adverse event|0|||
155295582|NCT01317420|560511580|FG004|Overall Study|Other adverse event|0|||
155295583|NCT01317420|560511581|FG005|Overall Study|Other adverse event|0|||
155295584|NCT01317420|560511582|FG006|Overall Study|Other adverse event|0|||
155295585|NCT01317420|560511583|FG007|Overall Study|Other adverse event|0|||
155295586|NCT01317420|560511584|FG008|Overall Study|Other adverse event|0|||
155295587|NCT01317420|560511585|FG009|Overall Study|Other adverse event|0|||
155295588|NCT01317420|560511586|FG010|Overall Study|Other adverse event|0|||
155295589|NCT01317420|560511587|FG011|Overall Study|Other adverse event|0|||
155295590|NCT01317420|560511588|FG012|Overall Study|Other adverse event|2|||
155295591|NCT01317420|560511576|FG000|Overall Study|Non-compliant with protocol|0|||
155295592|NCT01317420|560511577|FG001|Overall Study|Non-compliant with protocol|0|||
155295593|NCT01317420|560511578|FG002|Overall Study|Non-compliant with protocol|0|||
155295594|NCT01317420|560511579|FG003|Overall Study|Non-compliant with protocol|0|||
155295595|NCT01317420|560511580|FG004|Overall Study|Non-compliant with protocol|0|||
155295596|NCT01317420|560511581|FG005|Overall Study|Non-compliant with protocol|0|||
155295597|NCT01317420|560511582|FG006|Overall Study|Non-compliant with protocol|0|||
155295598|NCT01317420|560511583|FG007|Overall Study|Non-compliant with protocol|0|||
155295599|NCT01317420|560511584|FG008|Overall Study|Non-compliant with protocol|0|||
155295600|NCT01317420|560511585|FG009|Overall Study|Non-compliant with protocol|0|||
155295601|NCT01317420|560511586|FG010|Overall Study|Non-compliant with protocol|0|||
155295602|NCT01317420|560511587|FG011|Overall Study|Non-compliant with protocol|0|||
155295603|NCT01317420|560511588|FG012|Overall Study|Non-compliant with protocol|1|||
155295604|NCT01317420|560511576|FG000|Overall Study|Refused to cont. taking trial medication|0|||
155295605|NCT01317420|560511577|FG001|Overall Study|Refused to cont. taking trial medication|0|||
155295606|NCT01317420|560511578|FG002|Overall Study|Refused to cont. taking trial medication|0|||
155295607|NCT01317420|560511579|FG003|Overall Study|Refused to cont. taking trial medication|0|||
155295608|NCT01317420|560511580|FG004|Overall Study|Refused to cont. taking trial medication|0|||
155295609|NCT01317420|560511581|FG005|Overall Study|Refused to cont. taking trial medication|0|||
155295610|NCT01317420|560511582|FG006|Overall Study|Refused to cont. taking trial medication|0|||
155295611|NCT01317420|560511583|FG007|Overall Study|Refused to cont. taking trial medication|0|||
155295612|NCT01317420|560511584|FG008|Overall Study|Refused to cont. taking trial medication|0|||
155295613|NCT01317420|560511585|FG009|Overall Study|Refused to cont. taking trial medication|0|||
155295614|NCT01317420|560511586|FG010|Overall Study|Refused to cont. taking trial medication|0|||
155295615|NCT01317420|560511587|FG011|Overall Study|Refused to cont. taking trial medication|0|||
155295616|NCT01317420|560511588|FG012|Overall Study|Refused to cont. taking trial medication|1|||
155295617|NCT01317420|560511576|FG000|Overall Study|Reason other than those specified|0|||
155295618|NCT01317420|560511577|FG001|Overall Study|Reason other than those specified|0|||
155295619|NCT01317420|560511578|FG002|Overall Study|Reason other than those specified|0|||
155295620|NCT01317420|560511579|FG003|Overall Study|Reason other than those specified|0|||
155295621|NCT01317420|560511580|FG004|Overall Study|Reason other than those specified|0|||
155295622|NCT01317420|560511581|FG005|Overall Study|Reason other than those specified|0|||
155295623|NCT01317420|560511582|FG006|Overall Study|Reason other than those specified|0|||
155295624|NCT01317420|560511583|FG007|Overall Study|Reason other than those specified|0|||
155295625|NCT01317420|560511584|FG008|Overall Study|Reason other than those specified|0|||
155295626|NCT01317420|560511585|FG009|Overall Study|Reason other than those specified|1|||
155295627|NCT01317420|560511586|FG010|Overall Study|Reason other than those specified|0|||
155295628|NCT01317420|560511587|FG011|Overall Study|Reason other than those specified|0|||
155295629|NCT01317420|560511588|FG012|Overall Study|Reason other than those specified|0|||
155295630|NCT03586544|560511590|FG000|First Intervention|Adverse Event|0|||
155295631|NCT03586544|560511591|FG001|First Intervention|Adverse Event|1|||
155295632|NCT03586544|560511590|FG000|Second Intervention|Withdrawal by Subject|0|||
155295633|NCT03586544|560511591|FG001|Second Intervention|Withdrawal by Subject|1|||
155295634|NCT02020616|560511595|FG000|Overall Study|Adverse Event|0|||
155295635|NCT02020616|560511596|FG001|Overall Study|Adverse Event|0|||
155295636|NCT02020616|560511597|FG002|Overall Study|Adverse Event|0|||
155295637|NCT02020616|560511598|FG003|Overall Study|Adverse Event|0|||
155295638|NCT02020616|560511599|FG004|Overall Study|Adverse Event|0|||
155295639|NCT02020616|560511600|FG005|Overall Study|Adverse Event|1|||
155295640|NCT02020616|560511601|FG006|Overall Study|Adverse Event|1|||
155295641|NCT02020616|560511595|FG000|Overall Study|Physician Decision|0|||
155295642|NCT02020616|560511596|FG001|Overall Study|Physician Decision|0|||
155295643|NCT02020616|560511597|FG002|Overall Study|Physician Decision|0|||
155295644|NCT02020616|560511598|FG003|Overall Study|Physician Decision|0|||
155295645|NCT02020616|560511599|FG004|Overall Study|Physician Decision|0|||
155496419|NCT03993288|561242296|FG001|Overall Study|improper enrollment|1|||
155496420|NCT03993288|561242295|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
155496421|NCT03993288|561242296|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
155496422|NCT03993288|561242295|FG000|Overall Study|developed SAE|2|||
155496423|NCT03993288|561242296|FG001|Overall Study|developed SAE|0|||
155496424|NCT03993288|561242295|FG000|Overall Study|consent withdrawal|1|||
155496425|NCT03993288|561242296|FG001|Overall Study|consent withdrawal|0|||
155496426|NCT03993288|561242295|FG000|Overall Study|did not follow the treatment schedule|1|||
155496427|NCT03993288|561242296|FG001|Overall Study|did not follow the treatment schedule|0|||
155496428|NCT03993288|561242295|FG000|Overall Study|did not follow the treatment regimen|1|||
155496429|NCT03993288|561242296|FG001|Overall Study|did not follow the treatment regimen|0|||
155496430|NCT03993288|561242295|FG000|Overall Study|Adverse Event|1|||
155496431|NCT03993288|561242296|FG001|Overall Study|Adverse Event|0|||
155496432|NCT03993288|561242295|FG000|Overall Study|Withdrawal by Subject|1|||
155496433|NCT03993288|561242296|FG001|Overall Study|Withdrawal by Subject|1|||
155496434|NCT02729545|561242297|FG000|Overall Study|Pregnancy|1|||
155496435|NCT02729545|561242298|FG001|Overall Study|Pregnancy|1|||
155496436|NCT02729545|561242297|FG000|Overall Study|Lost to Follow-up|0|||
155496437|NCT02729545|561242298|FG001|Overall Study|Lost to Follow-up|1|||
155496438|NCT02729545|561242297|FG000|Overall Study|Withdrawal by Subject|2|||
155496439|NCT02729545|561242298|FG001|Overall Study|Withdrawal by Subject|3|||
155496440|NCT03533608|561242299|FG000|Overall Study|Withdrawal by Subject|3|||
155496441|NCT03533608|561242299|FG000|Overall Study|Physician Decision|2|||
155496442|NCT00915473|561242300|FG000|Screening|Withdrawal by Subject|1|||
155496443|NCT00915473|561242301|FG001|Screening|Withdrawal by Subject|0|||
155496444|NCT00915473|561242300|FG000|4-week Follow Up|Lost to Follow-up|1|||
155496445|NCT00915473|561242301|FG001|4-week Follow Up|Lost to Follow-up|5|||
155496446|NCT01389024|561242302|FG000|Overall Study|Withdrawal by Subject|0|||
155496447|NCT01389024|561242303|FG001|Overall Study|Withdrawal by Subject|1|||
155496448|NCT01389024|561242302|FG000|Overall Study|Lost to Follow-up|1|||
155496449|NCT01389024|561242303|FG001|Overall Study|Lost to Follow-up|0|||
155496450|NCT03443973|561242307|FG000|Double-blind Treatment Period|Adverse Event|5|||
155496451|NCT03443973|561242308|FG001|Double-blind Treatment Period|Adverse Event|19|||
155496452|NCT03443973|561242309|FG002|Double-blind Treatment Period|Adverse Event|0|||
155496453|NCT03443973|561242310|FG003|Double-blind Treatment Period|Adverse Event|0|||
155496454|NCT03443973|561242307|FG000|Double-blind Treatment Period|Death|5|||
155496455|NCT03443973|561242308|FG001|Double-blind Treatment Period|Death|7|||
155496456|NCT03443973|561242309|FG002|Double-blind Treatment Period|Death|0|||
155496457|NCT03443973|561242310|FG003|Double-blind Treatment Period|Death|0|||
155496458|NCT03443973|561242307|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
155496459|NCT03443973|561242308|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
155295646|NCT02020616|560511600|FG005|Overall Study|Physician Decision|1|||
155295647|NCT02020616|560511601|FG006|Overall Study|Physician Decision|2|||
155295648|NCT02020616|560511595|FG000|Overall Study|Withdrawal by Subject|0|||
155295649|NCT02020616|560511596|FG001|Overall Study|Withdrawal by Subject|0|||
155295650|NCT02020616|560511597|FG002|Overall Study|Withdrawal by Subject|1|||
155295651|NCT02020616|560511598|FG003|Overall Study|Withdrawal by Subject|0|||
155295652|NCT02020616|560511599|FG004|Overall Study|Withdrawal by Subject|0|||
155295653|NCT02020616|560511600|FG005|Overall Study|Withdrawal by Subject|1|||
155295654|NCT02020616|560511601|FG006|Overall Study|Withdrawal by Subject|1|||
155496460|NCT03443973|561242309|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155496461|NCT03443973|561242310|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
155496462|NCT03443973|561242307|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155496463|NCT03443973|561242308|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155496464|NCT03443973|561242309|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155496465|NCT03443973|561242310|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155496466|NCT03443973|561242307|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
155496467|NCT03443973|561242308|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
155295655|NCT02020616|560511595|FG000|Overall Study|Lost to Follow-up|0|||
155496468|NCT03443973|561242309|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
155496469|NCT03443973|561242310|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
155496470|NCT03443973|561242307|FG000|Double-blind Treatment Period|Physician Decision|5|||
155496471|NCT03443973|561242308|FG001|Double-blind Treatment Period|Physician Decision|6|||
155496472|NCT03443973|561242309|FG002|Double-blind Treatment Period|Physician Decision|0|||
155496473|NCT03443973|561242310|FG003|Double-blind Treatment Period|Physician Decision|0|||
155496474|NCT03443973|561242307|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
155496475|NCT03443973|561242308|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
155496476|NCT03443973|561242309|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
155496477|NCT03443973|561242310|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
155496478|NCT03443973|561242307|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
155496479|NCT03443973|561242308|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
155496480|NCT03443973|561242309|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155496481|NCT03443973|561242310|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
155496482|NCT03443973|561242307|FG000|Open-label Extension Period|Reason Not Specified|0|||
155496483|NCT03443973|561242308|FG001|Open-label Extension Period|Reason Not Specified|0|||
155496484|NCT03443973|561242309|FG002|Open-label Extension Period|Reason Not Specified|3|||
155496485|NCT03443973|561242310|FG003|Open-label Extension Period|Reason Not Specified|0|||
155496486|NCT03443973|561242307|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155496487|NCT03443973|561242308|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155496488|NCT03443973|561242309|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
155496489|NCT03443973|561242310|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
155496490|NCT01956123|561242311|FG000|COS Cycle 2|Protocol Violation|8|||
155744960|NCT02509117|562165273|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744961|NCT02509117|562165274|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744962|NCT02509117|562165275|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744963|NCT02509117|562165276|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744964|NCT02509117|562165277|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155744965|NCT02509117|562165278|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
155744966|NCT00832624|562165279|FG000|Overall Study|Study Terminated|10|||
155744967|NCT00548184|562165282|FG000|Overall Study|Adverse Event|3|||
155744968|NCT00548184|562165282|FG000|Overall Study|took other drug|1|||
155744969|NCT00548184|562165282|FG000|Overall Study|Found Her2 negative|1|||
155744970|NCT00280748|562165286|FG000|Overall Study|Decline in performance|3|||
155496491|NCT01956123|561242312|FG001|COS Cycle 2|Protocol Violation|3|||
155496492|NCT01956123|561242313|FG002|COS Cycle 2|Protocol Violation|0|||
155496493|NCT01956123|561242314|FG003|COS Cycle 2|Protocol Violation|0|||
155496494|NCT01956123|561242311|FG000|COS Cycle 2|Adverse Event|3|||
155496495|NCT01956123|561242312|FG001|COS Cycle 2|Adverse Event|4|||
155496496|NCT01956123|561242313|FG002|COS Cycle 2|Adverse Event|0|||
155496497|NCT01956123|561242314|FG003|COS Cycle 2|Adverse Event|0|||
155496498|NCT01956123|561242311|FG000|COS Cycle 2|Personal Reasons|2|||
155496499|NCT01956123|561242312|FG001|COS Cycle 2|Personal Reasons|0|||
155496500|NCT01956123|561242313|FG002|COS Cycle 2|Personal Reasons|0|||
155496501|NCT01956123|561242314|FG003|COS Cycle 2|Personal Reasons|0|||
155496502|NCT01956123|561242311|FG000|COS Cycle 2|Withdrawal by Subject|1|||
155496503|NCT01956123|561242312|FG001|COS Cycle 2|Withdrawal by Subject|0|||
155496504|NCT01956123|561242313|FG002|COS Cycle 2|Withdrawal by Subject|0|||
155496505|NCT01956123|561242314|FG003|COS Cycle 2|Withdrawal by Subject|0|||
155496506|NCT01956123|561242311|FG000|COS Cycle 3|Protocol Violation|0|||
155496507|NCT01956123|561242312|FG001|COS Cycle 3|Protocol Violation|0|||
155496508|NCT01956123|561242313|FG002|COS Cycle 3|Protocol Violation|2|||
155496509|NCT01956123|561242314|FG003|COS Cycle 3|Protocol Violation|1|||
155496510|NCT01956123|561242311|FG000|COS Cycle 3|Adverse Event|0|||
155496511|NCT01956123|561242312|FG001|COS Cycle 3|Adverse Event|0|||
155496512|NCT01956123|561242313|FG002|COS Cycle 3|Adverse Event|3|||
155496513|NCT01956123|561242314|FG003|COS Cycle 3|Adverse Event|0|||
155496514|NCT01956123|561242311|FG000|COS Cycle 3|Personal Reasons|0|||
155496515|NCT01956123|561242312|FG001|COS Cycle 3|Personal Reasons|0|||
155496516|NCT01956123|561242313|FG002|COS Cycle 3|Personal Reasons|1|||
155496517|NCT01956123|561242314|FG003|COS Cycle 3|Personal Reasons|0|||
155496518|NCT01956123|561242311|FG000|COS Cycle 3|Withdrawal by Subject|0|||
155496519|NCT01956123|561242312|FG001|COS Cycle 3|Withdrawal by Subject|0|||
155496520|NCT01956123|561242313|FG002|COS Cycle 3|Withdrawal by Subject|0|||
155496521|NCT01956123|561242314|FG003|COS Cycle 3|Withdrawal by Subject|1|||
155496522|NCT00398632|561242315|FG000|Overall Study|Withdrawal by Subject|1|||
155496523|NCT00398632|561242315|FG000|Overall Study|Lack of Efficacy|1|||
155496524|NCT00267020|561242316|FG000|Overall Study|Adverse Event|22|||
155496525|NCT00267020|561242317|FG001|Overall Study|Adverse Event|5|||
155496526|NCT00267020|561242316|FG000|Overall Study|Death|2|||
155496527|NCT00267020|561242317|FG001|Overall Study|Death|1|||
155496528|NCT00267020|561242316|FG000|Overall Study|Withdrawal by Subject|17|||
155496529|NCT00267020|561242317|FG001|Overall Study|Withdrawal by Subject|7|||
155496530|NCT00267020|561242316|FG000|Overall Study|Physician Decision|3|||
155496531|NCT00267020|561242317|FG001|Overall Study|Physician Decision|2|||
155496532|NCT00267020|561242316|FG000|Overall Study|Disease Progression|39|||
155639850|NCT01500083|561771812|FG000|Overall Study|Withdrawal of Consent|0|||
155639851|NCT01500083|561771813|FG001|Overall Study|Withdrawal of Consent|1|||
155639852|NCT01500083|561771812|FG000|Overall Study|Disease Progression|2|||
155639853|NCT01500083|561771813|FG001|Overall Study|Disease Progression|10|||
155639854|NCT01500083|561771812|FG000|Overall Study|Investigator Discretion|3|||
155639855|NCT01500083|561771813|FG001|Overall Study|Investigator Discretion|8|||
155639856|NCT01500083|561771812|FG000|Overall Study|Other Reasons|2|||
155639857|NCT01500083|561771813|FG001|Overall Study|Other Reasons|5|||
155639858|NCT00741611|561771814|FG000|Overall Study|Death|0|||
155639859|NCT00741611|561771815|FG001|Overall Study|Death|0|||
155639860|NCT00741611|561771816|FG002|Overall Study|Death|1|||
155639861|NCT00741611|561771814|FG000|Overall Study|Withdrawal by Subject|0|||
155639862|NCT00741611|561771815|FG001|Overall Study|Withdrawal by Subject|2|||
155639863|NCT00741611|561771816|FG002|Overall Study|Withdrawal by Subject|2|||
155639864|NCT01510756|561771819|FG000|Overall Study|Death|1|||
155639865|NCT01510756|561771819|FG000|Overall Study|Lack of Efficacy|2|||
155639866|NCT01510756|561771819|FG000|Overall Study|Physician Decision|1|||
155639867|NCT01922011|561771820|FG000|Overall Study|Protocol Violation|0|||
155639868|NCT01922011|561771821|FG001|Overall Study|Protocol Violation|1|||
155639869|NCT01922011|561771820|FG000|Overall Study|Physician Decision|0|||
155639870|NCT01922011|561771821|FG001|Overall Study|Physician Decision|1|||
155639871|NCT01922011|561771820|FG000|Overall Study|Parent/Guardian Decision|3|||
155639872|NCT01922011|561771821|FG001|Overall Study|Parent/Guardian Decision|0|||
155639873|NCT01922011|561771820|FG000|Overall Study|Lost to Follow-up|0|||
155639874|NCT01922011|561771821|FG001|Overall Study|Lost to Follow-up|1|||
155639875|NCT01922011|561771820|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
155639876|NCT01922011|561771821|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
155639877|NCT01922011|561771820|FG000|Overall Study|Not Treated|1|||
155639878|NCT01922011|561771821|FG001|Overall Study|Not Treated|0|||
155639879|NCT01922011|561771820|FG000|Overall Study|Lack of willing home health agency|1|||
155639880|NCT01922011|561771821|FG001|Overall Study|Lack of willing home health agency|0|||
155639881|NCT01922011|561771820|FG000|Overall Study|Randomized in error|1|||
155639882|NCT01922011|561771821|FG001|Overall Study|Randomized in error|0|||
155639883|NCT02299167|561771824|FG000|Overall Study|patients were excluded from the study|11|||
155639884|NCT05513950|561771831|FG000|Overall Study|Not treated due to technical reasons|0|||
155639885|NCT05513950|561771832|FG001|Overall Study|Not treated due to technical reasons|0|||
155639886|NCT05513950|561771833|FG002|Overall Study|Not treated due to technical reasons|1|||
155639887|NCT05513950|561771834|FG003|Overall Study|Not treated due to technical reasons|0|||
155639888|NCT02903914|561771835|FG000|Overall Study|Adverse Event|0|||
155639889|NCT02903914|561771836|FG001|Overall Study|Adverse Event|0|||
155639890|NCT02903914|561771837|FG002|Overall Study|Adverse Event|1|||
155639891|NCT02903914|561771838|FG003|Overall Study|Adverse Event|0|||
155639892|NCT02903914|561771839|FG004|Overall Study|Adverse Event|0|||
155639893|NCT02903914|561771840|FG005|Overall Study|Adverse Event|0|||
155639894|NCT02903914|561771841|FG006|Overall Study|Adverse Event|2|||
155639895|NCT02903914|561771842|FG007|Overall Study|Adverse Event|0|||
155639896|NCT02903914|561771835|FG000|Overall Study|Withdrawal by Subject|3|||
155639897|NCT02903914|561771836|FG001|Overall Study|Withdrawal by Subject|1|||
155639898|NCT02903914|561771837|FG002|Overall Study|Withdrawal by Subject|28|||
155639899|NCT02903914|561771838|FG003|Overall Study|Withdrawal by Subject|0|||
155639900|NCT02903914|561771839|FG004|Overall Study|Withdrawal by Subject|1|||
155639901|NCT02903914|561771840|FG005|Overall Study|Withdrawal by Subject|2|||
155639902|NCT02903914|561771841|FG006|Overall Study|Withdrawal by Subject|12|||
155639903|NCT02903914|561771842|FG007|Overall Study|Withdrawal by Subject|0|||
155639904|NCT02903914|561771835|FG000|Overall Study|Progressive Disease|1|||
155639905|NCT02903914|561771836|FG001|Overall Study|Progressive Disease|0|||
155639906|NCT02903914|561771837|FG002|Overall Study|Progressive Disease|4|||
155639907|NCT02903914|561771838|FG003|Overall Study|Progressive Disease|0|||
155639908|NCT02903914|561771839|FG004|Overall Study|Progressive Disease|0|||
155639909|NCT02903914|561771840|FG005|Overall Study|Progressive Disease|0|||
155639910|NCT02903914|561771841|FG006|Overall Study|Progressive Disease|2|||
155639911|NCT02903914|561771842|FG007|Overall Study|Progressive Disease|0|||
155639912|NCT02903914|561771835|FG000|Overall Study|Death|0|||
155639913|NCT02903914|561771836|FG001|Overall Study|Death|0|||
155639914|NCT02903914|561771837|FG002|Overall Study|Death|9|||
155639915|NCT02903914|561771838|FG003|Overall Study|Death|0|||
155639916|NCT02903914|561771839|FG004|Overall Study|Death|1|||
155639917|NCT02903914|561771840|FG005|Overall Study|Death|3|||
155639918|NCT02903914|561771841|FG006|Overall Study|Death|24|||
155639919|NCT02903914|561771842|FG007|Overall Study|Death|2|||
155496533|NCT00267020|561242317|FG001|Overall Study|Disease Progression|25|||
155496534|NCT00267020|561242316|FG000|Overall Study|Unrelated Complication|1|||
155639920|NCT02903914|561771835|FG000|Overall Study|Lost to Follow-up|0|||
155639921|NCT02903914|561771836|FG001|Overall Study|Lost to Follow-up|1|||
155639922|NCT02903914|561771837|FG002|Overall Study|Lost to Follow-up|0|||
155639923|NCT02903914|561771838|FG003|Overall Study|Lost to Follow-up|0|||
155639924|NCT02903914|561771839|FG004|Overall Study|Lost to Follow-up|2|||
155639925|NCT02903914|561771840|FG005|Overall Study|Lost to Follow-up|0|||
155639926|NCT02903914|561771841|FG006|Overall Study|Lost to Follow-up|1|||
155496535|NCT00267020|561242317|FG001|Overall Study|Unrelated Complication|1|||
155496536|NCT00267020|561242316|FG000|Overall Study|Sponsor Request|1|||
155496537|NCT00267020|561242317|FG001|Overall Study|Sponsor Request|0|||
155496538|NCT00267020|561242316|FG000|Overall Study|Other|1|||
155496539|NCT00267020|561242317|FG001|Overall Study|Other|2|||
155496540|NCT00640614|561242321|FG000|Overall Study|Lost to Follow-up|1|||
155496541|NCT00640614|561242322|FG001|Overall Study|Lost to Follow-up|0|||
155496542|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
155496543|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
155496544|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
155496545|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Death|1|||
155496546|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
155496547|NCT00529802|561242323|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
155496548|NCT00529802|561242323|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
155496549|NCT02209454|561242327|FG000|Second Period|Adverse Event|1|||
155496550|NCT02209454|561242328|FG001|Second Period|Adverse Event|0|||
155496551|NCT00366678|561242331|FG000|Infant Series|Withdrawal by Subject|8|||
155496552|NCT00366678|561242332|FG001|Infant Series|Withdrawal by Subject|6|||
155496553|NCT00366678|561242333|FG002|Infant Series|Withdrawal by Subject|0|||
155744971|NCT00280748|562165286|FG000|Overall Study|Extra-cranial disease progression|1|||
155744972|NCT01433250|562165287|FG000|Overall Study|Protocol Violation|0|||
155496554|NCT00366678|561242331|FG000|Infant Series|Protocol Violation|4|||
155496555|NCT00366678|561242332|FG001|Infant Series|Protocol Violation|3|||
155496556|NCT00366678|561242333|FG002|Infant Series|Protocol Violation|0|||
155496557|NCT00366678|561242331|FG000|Infant Series|Failed to return|1|||
155496558|NCT00366678|561242332|FG001|Infant Series|Failed to return|1|||
155496559|NCT00366678|561242333|FG002|Infant Series|Failed to return|0|||
155496560|NCT00366678|561242331|FG000|Infant Series|Adverse Event|1|||
155496561|NCT00366678|561242332|FG001|Infant Series|Adverse Event|0|||
155496562|NCT00366678|561242333|FG002|Infant Series|Adverse Event|0|||
155496563|NCT00366678|561242331|FG000|After Infant|Withdrawal by Subject|8|||
155744973|NCT01433250|562165288|FG001|Overall Study|Protocol Violation|1|||
155295656|NCT02020616|560511596|FG001|Overall Study|Lost to Follow-up|1|||
155295657|NCT02020616|560511597|FG002|Overall Study|Lost to Follow-up|0|||
155295658|NCT02020616|560511598|FG003|Overall Study|Lost to Follow-up|1|||
155295659|NCT02020616|560511599|FG004|Overall Study|Lost to Follow-up|1|||
155295660|NCT02020616|560511600|FG005|Overall Study|Lost to Follow-up|1|||
155295661|NCT02020616|560511601|FG006|Overall Study|Lost to Follow-up|0|||
155295662|NCT02020616|560511595|FG000|Overall Study|Early Termination Criteria Met|0|||
155295663|NCT02020616|560511596|FG001|Overall Study|Early Termination Criteria Met|0|||
155295664|NCT02020616|560511597|FG002|Overall Study|Early Termination Criteria Met|1|||
155295665|NCT02020616|560511598|FG003|Overall Study|Early Termination Criteria Met|0|||
155295666|NCT02020616|560511599|FG004|Overall Study|Early Termination Criteria Met|0|||
155295667|NCT02020616|560511600|FG005|Overall Study|Early Termination Criteria Met|1|||
155295668|NCT02020616|560511601|FG006|Overall Study|Early Termination Criteria Met|0|||
155295669|NCT02020616|560511595|FG000|Overall Study|Randomized in Error|0|||
155295670|NCT02020616|560511596|FG001|Overall Study|Randomized in Error|0|||
155295671|NCT02020616|560511597|FG002|Overall Study|Randomized in Error|0|||
155295672|NCT02020616|560511598|FG003|Overall Study|Randomized in Error|1|||
155295673|NCT02020616|560511599|FG004|Overall Study|Randomized in Error|0|||
155295674|NCT02020616|560511600|FG005|Overall Study|Randomized in Error|0|||
155295675|NCT02020616|560511601|FG006|Overall Study|Randomized in Error|0|||
155295676|NCT02020616|560511595|FG000|Overall Study|Lack of Efficacy|0|||
155295677|NCT02020616|560511596|FG001|Overall Study|Lack of Efficacy|0|||
155295678|NCT02020616|560511597|FG002|Overall Study|Lack of Efficacy|0|||
155295679|NCT02020616|560511598|FG003|Overall Study|Lack of Efficacy|0|||
155295680|NCT02020616|560511599|FG004|Overall Study|Lack of Efficacy|1|||
155295681|NCT02020616|560511600|FG005|Overall Study|Lack of Efficacy|0|||
155295682|NCT02020616|560511601|FG006|Overall Study|Lack of Efficacy|0|||
155295683|NCT05019729|560511602|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295684|NCT05019729|560511603|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295685|NCT05019729|560511604|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295686|NCT05019729|560511605|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295687|NCT05019729|560511606|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
155295688|NCT05019729|560511607|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155744974|NCT01433250|562165287|FG000|Overall Study|Withdrawal by Subject|3|||
155744975|NCT01433250|562165288|FG001|Overall Study|Withdrawal by Subject|2|||
155744976|NCT03148691|562165289|FG000|Overall Study|Protocol Violation|1|||
155295689|NCT02770248|560511609|FG000|Overall Study|Adverse Event|0|||
155295690|NCT02770248|560511610|FG001|Overall Study|Adverse Event|1|||
155496564|NCT00366678|561242332|FG001|After Infant|Withdrawal by Subject|4|||
155496565|NCT00366678|561242333|FG002|After Infant|Withdrawal by Subject|0|||
155744977|NCT03148691|562165290|FG001|Overall Study|Protocol Violation|2|||
155744978|NCT03148691|562165291|FG002|Overall Study|Protocol Violation|7|||
155295691|NCT02770248|560511609|FG000|Overall Study|Randomized in error, prior to treatment|0|||
155295692|NCT02770248|560511610|FG001|Overall Study|Randomized in error, prior to treatment|1|||
155295693|NCT01579916|560511611|FG000|Overall Study|Lost to Follow-up|6|||
155295694|NCT01579916|560511612|FG001|Overall Study|Lost to Follow-up|1|||
155295695|NCT01579916|560511611|FG000|Overall Study|Withdrawal by Subject|1|||
155295696|NCT01579916|560511612|FG001|Overall Study|Withdrawal by Subject|1|||
155295697|NCT01579916|560511611|FG000|Overall Study|Death|1|||
155295698|NCT01579916|560511612|FG001|Overall Study|Death|0|||
155295699|NCT03351075|560513122|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
155295700|NCT03351075|560513123|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
155295701|NCT03351075|560513122|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
155295702|NCT03351075|560513123|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
155295703|NCT03351075|560513122|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
155295704|NCT03351075|560513123|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
155295705|NCT03351075|560513122|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
155295706|NCT03351075|560513123|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
155295707|NCT05219253|560513128|FG000|Overall Study|Withdrawal by Subject|1|||
155295708|NCT05219253|560513129|FG001|Overall Study|Withdrawal by Subject|2|||
155295709|NCT03086369|560513130|FG000|Overall Study|Lost to Follow-up|1|||
155295710|NCT03086369|560513131|FG001|Overall Study|Lost to Follow-up|0|||
155295711|NCT03086369|560513132|FG002|Overall Study|Lost to Follow-up|0|||
155295712|NCT03086369|560513133|FG003|Overall Study|Lost to Follow-up|2|||
155295713|NCT03086369|560513134|FG004|Overall Study|Lost to Follow-up|1|||
155295714|NCT03086369|560513130|FG000|Overall Study|Physician Decision|0|||
155295715|NCT03086369|560513131|FG001|Overall Study|Physician Decision|0|||
155295716|NCT03086369|560513132|FG002|Overall Study|Physician Decision|0|||
155295717|NCT03086369|560513133|FG003|Overall Study|Physician Decision|1|||
155295718|NCT03086369|560513134|FG004|Overall Study|Physician Decision|2|||
155295719|NCT03086369|560513130|FG000|Overall Study|Withdrawal by Subject|0|||
155295720|NCT03086369|560513131|FG001|Overall Study|Withdrawal by Subject|0|||
155295721|NCT03086369|560513132|FG002|Overall Study|Withdrawal by Subject|0|||
155295722|NCT03086369|560513133|FG003|Overall Study|Withdrawal by Subject|5|||
155295723|NCT03086369|560513134|FG004|Overall Study|Withdrawal by Subject|3|||
155295724|NCT03086369|560513130|FG000|Overall Study|Progressive Disease|0|||
155295725|NCT03086369|560513131|FG001|Overall Study|Progressive Disease|0|||
155295726|NCT03086369|560513132|FG002|Overall Study|Progressive Disease|0|||
155295727|NCT03086369|560513133|FG003|Overall Study|Progressive Disease|1|||
155295728|NCT03086369|560513134|FG004|Overall Study|Progressive Disease|1|||
155295729|NCT05011396|560513135|FG000|Overall Study|Lost to Follow-up|3|||
155295730|NCT05011396|560513136|FG001|Overall Study|Lost to Follow-up|1|||
155295731|NCT05011396|560513135|FG000|Overall Study|Withdrawal by Subject|0|||
155295732|NCT05011396|560513136|FG001|Overall Study|Withdrawal by Subject|1|||
155295733|NCT05011396|560513135|FG000|Overall Study|Positive Drug Screen|0|||
155295734|NCT05011396|560513136|FG001|Overall Study|Positive Drug Screen|1|||
155295735|NCT04668339|560513137|FG000|Overall Study|Physician Decision|1|||
155295736|NCT04668339|560513138|FG001|Overall Study|Physician Decision|0|||
155295737|NCT04668339|560513139|FG002|Overall Study|Physician Decision|1|||
155295738|NCT04668339|560513140|FG003|Overall Study|Physician Decision|1|||
155295739|NCT04668339|560513137|FG000|Overall Study|Lost to Follow-up|14|||
155295740|NCT04668339|560513138|FG001|Overall Study|Lost to Follow-up|12|||
155295741|NCT04668339|560513139|FG002|Overall Study|Lost to Follow-up|8|||
155295742|NCT04668339|560513140|FG003|Overall Study|Lost to Follow-up|5|||
155295743|NCT04668339|560513137|FG000|Overall Study|Adverse Event|0|||
155295744|NCT04668339|560513138|FG001|Overall Study|Adverse Event|0|||
155295745|NCT04668339|560513139|FG002|Overall Study|Adverse Event|1|||
155295746|NCT04668339|560513140|FG003|Overall Study|Adverse Event|0|||
155295747|NCT04668339|560513137|FG000|Overall Study|Other than specified|3|||
155295748|NCT04668339|560513138|FG001|Overall Study|Other than specified|0|||
155295749|NCT04668339|560513139|FG002|Overall Study|Other than specified|1|||
155295750|NCT04668339|560513140|FG003|Overall Study|Other than specified|0|||
155295751|NCT04668339|560513137|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
155295752|NCT04668339|560513138|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
155639927|NCT02903914|561771842|FG007|Overall Study|Lost to Follow-up|0|||
155295753|NCT04668339|560513139|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
155295754|NCT04668339|560513140|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
155295755|NCT04668339|560513137|FG000|Overall Study|Vaccine not Administered|0|||
155639928|NCT02903914|561771835|FG000|Overall Study|Physician Decision|0|||
155295756|NCT04668339|560513138|FG001|Overall Study|Vaccine not Administered|0|||
155295757|NCT04668339|560513139|FG002|Overall Study|Vaccine not Administered|1|||
155295758|NCT04668339|560513140|FG003|Overall Study|Vaccine not Administered|0|||
155295759|NCT04668339|560513137|FG000|Overall Study|Protocol Violation|18|||
155295760|NCT04668339|560513138|FG001|Overall Study|Protocol Violation|23|||
155639929|NCT02903914|561771836|FG001|Overall Study|Physician Decision|0|||
155639930|NCT02903914|561771837|FG002|Overall Study|Physician Decision|1|||
155295761|NCT04668339|560513139|FG002|Overall Study|Protocol Violation|12|||
155295762|NCT04668339|560513140|FG003|Overall Study|Protocol Violation|20|||
155295763|NCT04668339|560513137|FG000|Overall Study|Withdrawal by Subject|45|||
155295764|NCT04668339|560513138|FG001|Overall Study|Withdrawal by Subject|46|||
155295765|NCT04668339|560513139|FG002|Overall Study|Withdrawal by Subject|46|||
155295766|NCT04668339|560513140|FG003|Overall Study|Withdrawal by Subject|27|||
155295767|NCT04668339|560513137|FG000|Overall Study|Study Terminated by Sponsor|59|||
155295768|NCT04668339|560513138|FG001|Overall Study|Study Terminated by Sponsor|59|||
155295769|NCT04668339|560513139|FG002|Overall Study|Study Terminated by Sponsor|71|||
155295770|NCT04668339|560513140|FG003|Overall Study|Study Terminated by Sponsor|1|||
155295771|NCT03253848|560513144|FG000|Overall Study|Adverse Event|7|||
155295772|NCT03253848|560513144|FG000|Overall Study|Death|5|||
155295773|NCT03253848|560513144|FG000|Overall Study|initiation of other treatments|3|||
155295774|NCT03253848|560513144|FG000|Overall Study|Other complicating disease|1|||
155295775|NCT03253848|560513144|FG000|Overall Study|Withdrawal by Subject|1|||
155295776|NCT03253848|560513144|FG000|Overall Study|Declining health|1|||
155295777|NCT00941655|560513147|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
155295778|NCT00941655|560513148|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
155295779|NCT00941655|560513147|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
155295780|NCT00941655|560513148|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
155295781|NCT00941655|560513147|FG000|Overall Study|progressed while on chemo|0|||
155295782|NCT00941655|560513148|FG001|Overall Study|progressed while on chemo|2|||
155295783|NCT00941655|560513147|FG000|Overall Study|refused further treatment|0|||
155295784|NCT00941655|560513148|FG001|Overall Study|refused further treatment|1|||
155295785|NCT00941655|560513147|FG000|Overall Study|withdrew consent|0|||
155295786|NCT00941655|560513148|FG001|Overall Study|withdrew consent|1|||
155295787|NCT00941655|560513147|FG000|Overall Study|non-compliant|0|||
155295788|NCT00941655|560513148|FG001|Overall Study|non-compliant|1|||
155295789|NCT02698891|560513151|FG000|Overall Study|Withdrawal by Subject|2|||
155295790|NCT02698891|560513151|FG000|Overall Study|deemed ineligible|1|||
155295791|NCT02698891|560513151|FG000|Overall Study|Adverse Event|9|||
155295792|NCT04218110|560513152|FG000|Overall Study|Withdrawal by Subject|0|||
155295793|NCT04218110|560513153|FG001|Overall Study|Withdrawal by Subject|0|||
155295794|NCT04218110|560513154|FG002|Overall Study|Withdrawal by Subject|0|||
155295795|NCT04218110|560513155|FG003|Overall Study|Withdrawal by Subject|1|||
155295796|NCT00516386|560513156|FG000|Overall Study|not interested in the study|4|||
155295797|NCT00516386|560513156|FG000|Overall Study|Lost to Follow-up|2|||
155295798|NCT03262935|560513159|FG000|Overall Study|Withdrawal by Subject|6|||
155295799|NCT03262935|560513160|FG001|Overall Study|Withdrawal by Subject|7|||
155295800|NCT03262935|560513159|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
155295801|NCT03262935|560513160|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
155295802|NCT03262935|560513159|FG000|Overall Study|Death|181|||
155295803|NCT03262935|560513160|FG001|Overall Study|Death|94|||
155295804|NCT03262935|560513159|FG000|Overall Study|Lost to Follow-up|9|||
155295805|NCT03262935|560513160|FG001|Overall Study|Lost to Follow-up|4|||
155295806|NCT03262935|560513159|FG000|Overall Study|Other reason|5|||
155295807|NCT03262935|560513160|FG001|Overall Study|Other reason|0|||
155295808|NCT00831415|560513163|FG000|Overall Study|Adverse Event|14|||
155295809|NCT00831415|560513163|FG000|Overall Study|Failed to return|3|||
155295810|NCT00831415|560513163|FG000|Overall Study|Physician Decision|6|||
155295811|NCT00831415|560513163|FG000|Overall Study|Lost to Follow-up|9|||
155295812|NCT00831415|560513163|FG000|Overall Study|Protocol Violation|3|||
155295813|NCT00831415|560513163|FG000|Overall Study|Withdrawal by Subject|35|||
155295814|NCT00831415|560513163|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
155639931|NCT02903914|561771838|FG003|Overall Study|Physician Decision|0|||
155639932|NCT02903914|561771839|FG004|Overall Study|Physician Decision|0|||
155639933|NCT02903914|561771840|FG005|Overall Study|Physician Decision|0|||
155639934|NCT02903914|561771841|FG006|Overall Study|Physician Decision|1|||
155639935|NCT02903914|561771842|FG007|Overall Study|Physician Decision|0|||
155639936|NCT02903914|561771835|FG000|Overall Study|Symptomatic Deterioration|0|||
155295815|NCT00831415|560513163|FG000|Overall Study|Death|1|||
155295816|NCT01290224|560513164|FG000|Overall Study|Adverse Event|1|||
155295817|NCT01290224|560513164|FG000|Overall Study|Refused Further Treatment|4|||
155295818|NCT05694065|560513165|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
155295819|NCT05694065|560513165|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
155295820|NCT05694065|560513165|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
155295821|NCT00424762|560513166|FG000|Overall Study|Withdrawal by Subject|18|||
155295822|NCT00424762|560513167|FG001|Overall Study|Withdrawal by Subject|19|||
155639937|NCT02903914|561771836|FG001|Overall Study|Symptomatic Deterioration|0|||
155295823|NCT00424762|560513166|FG000|Overall Study|Lost to Follow-up|2|||
155639938|NCT02903914|561771837|FG002|Overall Study|Symptomatic Deterioration|1|||
155639939|NCT02903914|561771838|FG003|Overall Study|Symptomatic Deterioration|0|||
155639940|NCT02903914|561771839|FG004|Overall Study|Symptomatic Deterioration|0|||
155639941|NCT02903914|561771840|FG005|Overall Study|Symptomatic Deterioration|0|||
155639942|NCT02903914|561771841|FG006|Overall Study|Symptomatic Deterioration|0|||
155639943|NCT02903914|561771842|FG007|Overall Study|Symptomatic Deterioration|0|||
155639944|NCT02903914|561771835|FG000|Overall Study|New Cancer Therapy|2|||
155639945|NCT02903914|561771836|FG001|Overall Study|New Cancer Therapy|2|||
155639946|NCT02903914|561771837|FG002|Overall Study|New Cancer Therapy|21|||
155639947|NCT02903914|561771838|FG003|Overall Study|New Cancer Therapy|4|||
155639948|NCT02903914|561771839|FG004|Overall Study|New Cancer Therapy|3|||
155639949|NCT02903914|561771840|FG005|Overall Study|New Cancer Therapy|6|||
155639950|NCT02903914|561771841|FG006|Overall Study|New Cancer Therapy|56|||
155639951|NCT02903914|561771842|FG007|Overall Study|New Cancer Therapy|3|||
155639952|NCT02903914|561771835|FG000|Overall Study|Didn't Return to Site|1|||
155639953|NCT02903914|561771836|FG001|Overall Study|Didn't Return to Site|0|||
155639954|NCT02903914|561771837|FG002|Overall Study|Didn't Return to Site|1|||
155639955|NCT02903914|561771838|FG003|Overall Study|Didn't Return to Site|1|||
155639956|NCT02903914|561771839|FG004|Overall Study|Didn't Return to Site|0|||
155639957|NCT02903914|561771840|FG005|Overall Study|Didn't Return to Site|0|||
155639958|NCT02903914|561771841|FG006|Overall Study|Didn't Return to Site|2|||
155639959|NCT02903914|561771842|FG007|Overall Study|Didn't Return to Site|0|||
155639960|NCT02903914|561771835|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
155639961|NCT02903914|561771836|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
155639962|NCT02903914|561771837|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
155639963|NCT02903914|561771838|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
155639964|NCT02903914|561771839|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
155639965|NCT02903914|561771840|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
155639966|NCT02903914|561771841|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
155639967|NCT02903914|561771842|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
155639968|NCT02903914|561771835|FG000|Overall Study|Follow-up Did Not Occur|0|||
155639969|NCT02903914|561771836|FG001|Overall Study|Follow-up Did Not Occur|1|||
155639970|NCT02903914|561771837|FG002|Overall Study|Follow-up Did Not Occur|1|||
155639971|NCT02903914|561771838|FG003|Overall Study|Follow-up Did Not Occur|0|||
155639972|NCT02903914|561771839|FG004|Overall Study|Follow-up Did Not Occur|2|||
155639973|NCT02903914|561771840|FG005|Overall Study|Follow-up Did Not Occur|0|||
155639974|NCT02903914|561771841|FG006|Overall Study|Follow-up Did Not Occur|8|||
155639975|NCT02903914|561771842|FG007|Overall Study|Follow-up Did Not Occur|0|||
155639976|NCT02903914|561771835|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
155639977|NCT02903914|561771836|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
155639978|NCT02903914|561771837|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
155639979|NCT02903914|561771838|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
155639980|NCT02903914|561771839|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
155639981|NCT02903914|561771840|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
155639982|NCT02903914|561771841|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
155639983|NCT02903914|561771842|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
155639984|NCT02903914|561771835|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639985|NCT02903914|561771836|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639986|NCT02903914|561771837|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
155639987|NCT02903914|561771838|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639988|NCT02903914|561771839|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639989|NCT02903914|561771840|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
155639990|NCT02903914|561771841|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639991|NCT02903914|561771842|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
155639992|NCT02903914|561771835|FG000|Overall Study|Clinical Disease Progression|0|||
155639993|NCT02903914|561771836|FG001|Overall Study|Clinical Disease Progression|0|||
155639994|NCT02903914|561771837|FG002|Overall Study|Clinical Disease Progression|2|||
155639995|NCT02903914|561771838|FG003|Overall Study|Clinical Disease Progression|0|||
155639996|NCT02903914|561771839|FG004|Overall Study|Clinical Disease Progression|0|||
155639997|NCT02903914|561771840|FG005|Overall Study|Clinical Disease Progression|0|||
155639998|NCT02903914|561771841|FG006|Overall Study|Clinical Disease Progression|0|||
155639999|NCT02903914|561771842|FG007|Overall Study|Clinical Disease Progression|0|||
155640000|NCT02903914|561771835|FG000|Overall Study|Completed Follow-up Period|0|||
155640001|NCT02903914|561771836|FG001|Overall Study|Completed Follow-up Period|0|||
155640002|NCT02903914|561771837|FG002|Overall Study|Completed Follow-up Period|6|||
155640003|NCT02903914|561771838|FG003|Overall Study|Completed Follow-up Period|2|||
155640004|NCT02903914|561771839|FG004|Overall Study|Completed Follow-up Period|1|||
155640005|NCT02903914|561771840|FG005|Overall Study|Completed Follow-up Period|0|||
155640006|NCT02903914|561771841|FG006|Overall Study|Completed Follow-up Period|9|||
155640007|NCT02903914|561771842|FG007|Overall Study|Completed Follow-up Period|1|||
155640008|NCT02903914|561771835|FG000|Overall Study|Taken off Treatment per Protocol|0|||
155640009|NCT02903914|561771836|FG001|Overall Study|Taken off Treatment per Protocol|0|||
155744979|NCT03148691|562165289|FG000|Overall Study|Lost to Follow-up|0|||
155295824|NCT00424762|560513167|FG001|Overall Study|Lost to Follow-up|3|||
155295825|NCT04347954|560513177|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
155295826|NCT04347954|560513178|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
155295827|NCT04347954|560513179|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
155295828|NCT04347954|560513177|FG000|Overall Study|Lost to Follow-up|0|||
155295829|NCT04347954|560513178|FG001|Overall Study|Lost to Follow-up|1|||
155295830|NCT04347954|560513179|FG002|Overall Study|Lost to Follow-up|0|||
155295831|NCT05641311|560513180|FG000|Dosing Period 1|Adverse Event|1|||
155295832|NCT05641311|560513181|FG001|Dosing Period 1|Adverse Event|0|||
155295833|NCT00922207|560513182|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
155295834|NCT00922207|560513183|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
155295835|NCT00922207|560513184|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
155295836|NCT00922207|560513182|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155295837|NCT00922207|560513183|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155295838|NCT00922207|560513184|FG002|Overall Study|Insufficient Therapeutic Response|1|||
155295839|NCT00922207|560513182|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155295840|NCT00922207|560513183|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155295841|NCT00922207|560513184|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
155295842|NCT00922207|560513182|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
155295843|NCT00922207|560513183|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155295844|NCT00922207|560513184|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155295845|NCT00922207|560513182|FG000|Overall Study|Withdrew Consent|2|||
155295846|NCT00922207|560513183|FG001|Overall Study|Withdrew Consent|5|||
155295847|NCT00922207|560513184|FG002|Overall Study|Withdrew Consent|2|||
155295848|NCT00922207|560513182|FG000|Overall Study|Abnormality of Laboratory Test|0|||
155295849|NCT00922207|560513183|FG001|Overall Study|Abnormality of Laboratory Test|1|||
155295850|NCT00922207|560513184|FG002|Overall Study|Abnormality of Laboratory Test|1|||
155295851|NCT00367991|560513185|FG000|Overall Study|Withdrawal by Subject|1|||
155295852|NCT00367991|560513186|FG001|Overall Study|Withdrawal by Subject|1|||
155295853|NCT00367991|560513185|FG000|Overall Study|Adverse Event|1|||
155295854|NCT00367991|560513186|FG001|Overall Study|Adverse Event|1|||
155295855|NCT03515304|560513187|FG000|Overall Study|Lost to Follow-up|0|||
155295856|NCT03515304|560513188|FG001|Overall Study|Lost to Follow-up|3|||
155295857|NCT02969863|560513193|FG000|Overall Study|Physician Decision|1|||
155295858|NCT02969863|560513194|FG001|Overall Study|Physician Decision|0|||
155295859|NCT02969863|560513195|FG002|Overall Study|Physician Decision|0|||
155295860|NCT02969863|560513196|FG003|Overall Study|Physician Decision|0|||
155295861|NCT02969863|560513197|FG004|Overall Study|Physician Decision|0|||
155295862|NCT02969863|560513198|FG005|Overall Study|Physician Decision|0|||
155295863|NCT02705586|560513199|FG000|Overall Study|Health Issues|2|||
155295864|NCT02705586|560513199|FG000|Overall Study|Transportation Difficulties|5|||
155295865|NCT02705586|560513199|FG000|Overall Study|Vacation/Planned Absence|1|||
155295866|NCT02045836|560513200|FG000|Overall Study|Adverse Event|4|||
155295867|NCT02045836|560513201|FG001|Overall Study|Adverse Event|4|||
155295868|NCT02045836|560513200|FG000|Overall Study|Withdrawal by Subject|1|||
155295869|NCT02045836|560513201|FG001|Overall Study|Withdrawal by Subject|1|||
155295870|NCT02045836|560513200|FG000|Overall Study|Lost to Follow-up|4|||
155295871|NCT02045836|560513201|FG001|Overall Study|Lost to Follow-up|7|||
155295872|NCT02045836|560513200|FG000|Overall Study|Migrated from study area|0|||
155295873|NCT02045836|560513201|FG001|Overall Study|Migrated from study area|2|||
155295874|NCT00057837|560513202|FG000|Overall Study|Progression/relapse|12|||
155295875|NCT00057837|560513203|FG001|Overall Study|Progression/relapse|14|||
155295876|NCT00057837|560513202|FG000|Overall Study|Adverse Event|2|||
155295877|NCT00057837|560513203|FG001|Overall Study|Adverse Event|12|||
155295878|NCT00057837|560513202|FG000|Overall Study|Death|5|||
155295879|NCT00057837|560513203|FG001|Overall Study|Death|4|||
155295880|NCT00057837|560513202|FG000|Overall Study|Withdrawal by Subject|5|||
155295881|NCT00057837|560513203|FG001|Overall Study|Withdrawal by Subject|3|||
155640010|NCT02903914|561771837|FG002|Overall Study|Taken off Treatment per Protocol|0|||
155295882|NCT00057837|560513202|FG000|Overall Study|Alternative therapy|0|||
155295883|NCT00057837|560513203|FG001|Overall Study|Alternative therapy|1|||
155295884|NCT00057837|560513202|FG000|Overall Study|Other complicating disease|2|||
155295885|NCT00057837|560513203|FG001|Overall Study|Other complicating disease|1|||
155640011|NCT02903914|561771838|FG003|Overall Study|Taken off Treatment per Protocol|0|||
155295886|NCT00057837|560513202|FG000|Overall Study|Physician Decision|1|||
155295887|NCT00057837|560513203|FG001|Overall Study|Physician Decision|0|||
155295888|NCT00057837|560513202|FG000|Overall Study|Ineligible|3|||
155295889|NCT00057837|560513203|FG001|Overall Study|Ineligible|3|||
155640012|NCT02903914|561771839|FG004|Overall Study|Taken off Treatment per Protocol|0|||
155640013|NCT02903914|561771840|FG005|Overall Study|Taken off Treatment per Protocol|1|||
155640014|NCT02903914|561771841|FG006|Overall Study|Taken off Treatment per Protocol|0|||
155640015|NCT02903914|561771842|FG007|Overall Study|Taken off Treatment per Protocol|0|||
155640016|NCT02903914|561771835|FG000|Overall Study|Refused Further Treatment/Contact|0|||
155640017|NCT02903914|561771836|FG001|Overall Study|Refused Further Treatment/Contact|0|||
155640018|NCT02903914|561771837|FG002|Overall Study|Refused Further Treatment/Contact|0|||
155295890|NCT00057837|560513202|FG000|Overall Study|Never started treatment|1|||
155295891|NCT00057837|560513203|FG001|Overall Study|Never started treatment|1|||
155295892|NCT02000817|560513204|FG000|Overall Study|Withdrawal by Subject|2|||
155295893|NCT02000817|560513205|FG001|Overall Study|Withdrawal by Subject|0|||
155295894|NCT02000817|560513206|FG002|Overall Study|Withdrawal by Subject|0|||
155295895|NCT02000817|560513207|FG003|Overall Study|Withdrawal by Subject|0|||
155295896|NCT02000817|560513204|FG000|Overall Study|Adverse Event|0|||
155295897|NCT02000817|560513205|FG001|Overall Study|Adverse Event|1|||
155640019|NCT02903914|561771838|FG003|Overall Study|Refused Further Treatment/Contact|0|||
155640020|NCT02903914|561771839|FG004|Overall Study|Refused Further Treatment/Contact|0|||
155640021|NCT02903914|561771840|FG005|Overall Study|Refused Further Treatment/Contact|0|||
155295898|NCT02000817|560513206|FG002|Overall Study|Adverse Event|0|||
155295899|NCT02000817|560513207|FG003|Overall Study|Adverse Event|0|||
155295900|NCT02000817|560513204|FG000|Overall Study|Lost to Follow-up|0|||
155295901|NCT02000817|560513205|FG001|Overall Study|Lost to Follow-up|0|||
155640022|NCT02903914|561771841|FG006|Overall Study|Refused Further Treatment/Contact|1|||
155295902|NCT02000817|560513206|FG002|Overall Study|Lost to Follow-up|1|||
155295903|NCT02000817|560513207|FG003|Overall Study|Lost to Follow-up|0|||
155295904|NCT05686421|560513208|FG000|Overall Study|Screen failure|22|||
155295905|NCT05686421|560513209|FG001|Overall Study|Screen failure|0|||
155295906|NCT05686421|560513210|FG002|Overall Study|Screen failure|0|||
155295907|NCT05686421|560513211|FG003|Overall Study|Screen failure|0|||
155295908|NCT00367055|560513212|FG000|Overall Study|Adverse Event|6|||
155295909|NCT00367055|560513213|FG001|Overall Study|Adverse Event|3|||
155295910|NCT00367055|560513212|FG000|Overall Study|Patient's Willing|3|||
155295911|NCT00367055|560513213|FG001|Overall Study|Patient's Willing|2|||
155295912|NCT00367055|560513212|FG000|Overall Study|Lack of Efficacy|1|||
155295913|NCT00367055|560513213|FG001|Overall Study|Lack of Efficacy|2|||
155295914|NCT00367055|560513212|FG000|Overall Study|Lost to Follow-up|1|||
155295915|NCT00367055|560513213|FG001|Overall Study|Lost to Follow-up|1|||
155295916|NCT00367055|560513212|FG000|Overall Study|Protocol Violation|0|||
155295917|NCT00367055|560513213|FG001|Overall Study|Protocol Violation|1|||
155295918|NCT00367055|560513212|FG000|Overall Study|Stopping Criterion Met|0|||
155295919|NCT00367055|560513213|FG001|Overall Study|Stopping Criterion Met|1|||
155295920|NCT00367055|560513212|FG000|Overall Study|Participant Living too Far from Hospital|0|||
155295921|NCT00367055|560513213|FG001|Overall Study|Participant Living too Far from Hospital|1|||
155295922|NCT00539292|560513214|FG000|Overall Study|Physician Decision|1|||
155295923|NCT00539292|560513215|FG001|Overall Study|Physician Decision|0|||
155295924|NCT00324038|560513224|FG000|Overall Study|Adverse Event|38|||
155295925|NCT00324038|560513225|FG001|Overall Study|Adverse Event|23|||
155295926|NCT00324038|560513224|FG000|Overall Study|Lack of Efficacy|5|||
155295927|NCT00324038|560513225|FG001|Overall Study|Lack of Efficacy|13|||
155295928|NCT00324038|560513224|FG000|Overall Study|Lost to Follow-up|0|||
155295929|NCT00324038|560513225|FG001|Overall Study|Lost to Follow-up|2|||
155295930|NCT00324038|560513224|FG000|Overall Study|Other|6|||
155295931|NCT00324038|560513225|FG001|Overall Study|Other|13|||
155295932|NCT00361283|560513227|FG000|Overall Study|Lost to Follow-up|27|||
155295933|NCT01837641|560513228|FG000|Overall Study|Sponsor decision|1|||
155295934|NCT01837641|560513229|FG001|Overall Study|Sponsor decision|0|||
155295935|NCT01837641|560513230|FG002|Overall Study|Sponsor decision|0|||
155295936|NCT01837641|560513231|FG003|Overall Study|Sponsor decision|0|||
155295937|NCT01837641|560513232|FG004|Overall Study|Sponsor decision|0|||
155295938|NCT01837641|560513233|FG005|Overall Study|Sponsor decision|1|||
155295939|NCT01837641|560513234|FG006|Overall Study|Sponsor decision|0|||
155295940|NCT01837641|560513235|FG007|Overall Study|Sponsor decision|0|||
155295941|NCT01837641|560513228|FG000|Overall Study|Adverse Event|0|||
155295942|NCT01837641|560513229|FG001|Overall Study|Adverse Event|0|||
155295943|NCT01837641|560513230|FG002|Overall Study|Adverse Event|0|||
155295944|NCT01837641|560513231|FG003|Overall Study|Adverse Event|0|||
155295945|NCT01837641|560513232|FG004|Overall Study|Adverse Event|0|||
155295946|NCT01837641|560513233|FG005|Overall Study|Adverse Event|1|||
155295947|NCT01837641|560513234|FG006|Overall Study|Adverse Event|0|||
155295948|NCT01837641|560513235|FG007|Overall Study|Adverse Event|0|||
155295949|NCT01837641|560513228|FG000|Overall Study|Withdrawal by Subject|0|||
155295950|NCT01837641|560513229|FG001|Overall Study|Withdrawal by Subject|0|||
155295951|NCT01837641|560513230|FG002|Overall Study|Withdrawal by Subject|0|||
155295952|NCT01837641|560513231|FG003|Overall Study|Withdrawal by Subject|0|||
155295953|NCT01837641|560513232|FG004|Overall Study|Withdrawal by Subject|1|||
155295954|NCT01837641|560513233|FG005|Overall Study|Withdrawal by Subject|0|||
155295955|NCT01837641|560513234|FG006|Overall Study|Withdrawal by Subject|1|||
155295956|NCT01837641|560513235|FG007|Overall Study|Withdrawal by Subject|0|||
155295957|NCT03264456|560513236|FG000|Overall Study|Withdrawal by Subject|3|||
155295958|NCT03264456|560513236|FG000|Overall Study|Lost to Follow-up|1|||
155295959|NCT01123083|560513237|FG000|Overall Study|Investigator recommendation|1|||
155295960|NCT01123083|560513238|FG001|Overall Study|Investigator recommendation|1|||
155295961|NCT01123083|560513237|FG000|Overall Study|Administrative reasons|0|||
155295962|NCT01123083|560513238|FG001|Overall Study|Administrative reasons|4|||
155295963|NCT01123083|560513237|FG000|Overall Study|Lost to Follow-up|2|||
155295964|NCT01123083|560513238|FG001|Overall Study|Lost to Follow-up|6|||
155295965|NCT01123083|560513237|FG000|Overall Study|Adverse Event|1|||
155295966|NCT01123083|560513238|FG001|Overall Study|Adverse Event|0|||
155295967|NCT01123083|560513237|FG000|Overall Study|Withdrew for another reason not covered|0|||
155295968|NCT01123083|560513238|FG001|Overall Study|Withdrew for another reason not covered|1|||
155295969|NCT01123083|560513237|FG000|Overall Study|Participant/legal representative request|7|||
155295970|NCT01123083|560513238|FG001|Overall Study|Participant/legal representative request|3|||
155295971|NCT00961636|560513239|FG000|Overall Study|Adverse Event|35|||
155295972|NCT00961636|560513240|FG001|Overall Study|Adverse Event|54|||
155295973|NCT00961636|560513241|FG002|Overall Study|Adverse Event|13|||
155295974|NCT00961636|560513239|FG000|Overall Study|Flushing Symptoms|29|||
155295975|NCT00961636|560513240|FG001|Overall Study|Flushing Symptoms|46|||
155295976|NCT00961636|560513241|FG002|Overall Study|Flushing Symptoms|3|||
155295977|NCT00961636|560513239|FG000|Overall Study|Lost to Follow-up|2|||
155295978|NCT00961636|560513240|FG001|Overall Study|Lost to Follow-up|3|||
155295979|NCT00961636|560513241|FG002|Overall Study|Lost to Follow-up|1|||
155295980|NCT00961636|560513239|FG000|Overall Study|Physician Decision|3|||
155295981|NCT00961636|560513240|FG001|Overall Study|Physician Decision|1|||
155295982|NCT00961636|560513241|FG002|Overall Study|Physician Decision|1|||
155295983|NCT00961636|560513239|FG000|Overall Study|Protocol Violation|9|||
155295984|NCT00961636|560513240|FG001|Overall Study|Protocol Violation|5|||
155295985|NCT00961636|560513241|FG002|Overall Study|Protocol Violation|1|||
155295986|NCT00961636|560513239|FG000|Overall Study|Withdrawal by Subject|29|||
155295987|NCT00961636|560513240|FG001|Overall Study|Withdrawal by Subject|22|||
155295988|NCT00961636|560513241|FG002|Overall Study|Withdrawal by Subject|13|||
155295989|NCT00290706|560513244|FG000|Overall Study|Withdrawal by Subject|2|||
155295990|NCT00290706|560513245|FG001|Overall Study|Withdrawal by Subject|0|||
155295991|NCT00290706|560513246|FG002|Overall Study|Withdrawal by Subject|0|||
155295992|NCT00290706|560513247|FG003|Overall Study|Withdrawal by Subject|0|||
155295993|NCT00290706|560513244|FG000|Overall Study|Progressive Disease|3|||
155295994|NCT00290706|560513245|FG001|Overall Study|Progressive Disease|5|||
155295995|NCT00290706|560513246|FG002|Overall Study|Progressive Disease|4|||
155295996|NCT00290706|560513247|FG003|Overall Study|Progressive Disease|10|||
155295997|NCT00290706|560513244|FG000|Overall Study|Adverse Event|0|||
155295998|NCT00290706|560513245|FG001|Overall Study|Adverse Event|1|||
155295999|NCT00290706|560513246|FG002|Overall Study|Adverse Event|2|||
155296000|NCT00290706|560513247|FG003|Overall Study|Adverse Event|0|||
155296001|NCT00290706|560513244|FG000|Overall Study|Receive auto transplant or radiation|0|||
155296002|NCT00290706|560513245|FG001|Overall Study|Receive auto transplant or radiation|0|||
155296003|NCT00290706|560513246|FG002|Overall Study|Receive auto transplant or radiation|0|||
155296004|NCT00290706|560513247|FG003|Overall Study|Receive auto transplant or radiation|1|||
155296005|NCT00290706|560513244|FG000|Overall Study|Physician Decision|0|||
155296006|NCT00290706|560513245|FG001|Overall Study|Physician Decision|0|||
155296007|NCT00290706|560513246|FG002|Overall Study|Physician Decision|0|||
155296008|NCT00290706|560513247|FG003|Overall Study|Physician Decision|1|||
155296009|NCT01196429|560513249|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155296010|NCT01196429|560513250|FG001|Overall Study|Ineligible - inadequate pathology|0|||
155296011|NCT01196429|560513249|FG000|Overall Study|Ineligible - wrong cell type|1|||
155296012|NCT01196429|560513250|FG001|Overall Study|Ineligible - wrong cell type|0|||
155296013|NCT01196429|560513249|FG000|Overall Study|Refused - Never Treated|1|||
155296014|NCT01196429|560513250|FG001|Overall Study|Refused - Never Treated|0|||
155296015|NCT00688519|560513251|FG000|Overall Study|Adverse Event|2|||
155296016|NCT00688519|560513252|FG001|Overall Study|Adverse Event|3|||
155296017|NCT00688519|560513251|FG000|Overall Study|Lost to Follow-up|3|||
155296018|NCT00688519|560513252|FG001|Overall Study|Lost to Follow-up|3|||
155296019|NCT00688519|560513251|FG000|Overall Study|Lack of Efficacy|3|||
155296020|NCT00688519|560513252|FG001|Overall Study|Lack of Efficacy|1|||
155296021|NCT00688519|560513251|FG000|Overall Study|Withdrawal by Subject|7|||
155296022|NCT00688519|560513252|FG001|Overall Study|Withdrawal by Subject|6|||
155296023|NCT00688519|560513251|FG000|Overall Study|Prohibited medication|1|||
155296024|NCT00688519|560513252|FG001|Overall Study|Prohibited medication|0|||
155296025|NCT00688519|560513251|FG000|Overall Study|Non-compliance|0|||
155296026|NCT00688519|560513252|FG001|Overall Study|Non-compliance|1|||
155296027|NCT00688519|560513251|FG000|Overall Study|Subject moved out of state|1|||
155296028|NCT00688519|560513252|FG001|Overall Study|Subject moved out of state|0|||
155296029|NCT00688519|560513251|FG000|Overall Study|Investigator decision|1|||
155296030|NCT00688519|560513252|FG001|Overall Study|Investigator decision|0|||
155296031|NCT00688519|560513251|FG000|Overall Study|Subject moved out of area|1|||
155296032|NCT00688519|560513252|FG001|Overall Study|Subject moved out of area|0|||
155496566|NCT00366678|561242331|FG000|After Infant|Lost to Follow-up|2|||
155496567|NCT00366678|561242332|FG001|After Infant|Lost to Follow-up|1|||
155296033|NCT00688519|560513251|FG000|Overall Study|Pregnancy|0|||
155496568|NCT00366678|561242333|FG002|After Infant|Lost to Follow-up|0|||
155496569|NCT00366678|561242331|FG000|After Infant|Failed to return|5|||
155496570|NCT00366678|561242332|FG001|After Infant|Failed to return|5|||
155496571|NCT00366678|561242333|FG002|After Infant|Failed to return|0|||
155496572|NCT00366678|561242331|FG000|After Infant|Adverse Event|1|||
155496573|NCT00366678|561242332|FG001|After Infant|Adverse Event|0|||
155496574|NCT00366678|561242333|FG002|After Infant|Adverse Event|0|||
155296034|NCT00688519|560513252|FG001|Overall Study|Pregnancy|1|||
155296035|NCT02486588|560513253|FG000|Overall Study|Randomized in error- ineligible|738|||
155296036|NCT02486588|560513254|FG001|Overall Study|Randomized in error- ineligible|750|||
155296037|NCT02486588|560513255|FG002|Overall Study|Randomized in error- ineligible|755|||
155296038|NCT02486588|560513256|FG003|Overall Study|Randomized in error- ineligible|738|||
155296039|NCT02486588|560513257|FG004|Overall Study|Randomized in error- ineligible|746|||
155496575|NCT00366678|561242331|FG000|After Infant|Protocol Violation|1|||
155496576|NCT00366678|561242332|FG001|After Infant|Protocol Violation|0|||
155496577|NCT00366678|561242333|FG002|After Infant|Protocol Violation|0|||
155296040|NCT02486588|560513258|FG005|Overall Study|Randomized in error- ineligible|746|||
155296041|NCT02551055|560513261|FG000|Overall Study|Death|2|||
155496578|NCT00366678|561242331|FG000|Toddler Dose|Protocol Violation|2|||
155496579|NCT00366678|561242332|FG001|Toddler Dose|Protocol Violation|1|||
155296042|NCT02551055|560513262|FG001|Overall Study|Death|4|||
155496580|NCT00366678|561242333|FG002|Toddler Dose|Protocol Violation|0|||
155296043|NCT02551055|560513263|FG002|Overall Study|Death|2|||
155296044|NCT02551055|560513264|FG003|Overall Study|Death|2|||
155296045|NCT02551055|560513265|FG004|Overall Study|Death|2|||
155296046|NCT02551055|560513266|FG005|Overall Study|Death|1|||
155296047|NCT02551055|560513267|FG006|Overall Study|Death|2|||
155296048|NCT02551055|560513268|FG007|Overall Study|Death|0|||
155296049|NCT02551055|560513261|FG000|Overall Study|Study Terminated by Sponsor|1|||
155296050|NCT02551055|560513262|FG001|Overall Study|Study Terminated by Sponsor|1|||
155296051|NCT02551055|560513263|FG002|Overall Study|Study Terminated by Sponsor|0|||
155296052|NCT02551055|560513264|FG003|Overall Study|Study Terminated by Sponsor|2|||
155296053|NCT02551055|560513265|FG004|Overall Study|Study Terminated by Sponsor|2|||
155296054|NCT02551055|560513266|FG005|Overall Study|Study Terminated by Sponsor|0|||
155296055|NCT02551055|560513267|FG006|Overall Study|Study Terminated by Sponsor|0|||
155296056|NCT02551055|560513268|FG007|Overall Study|Study Terminated by Sponsor|0|||
155296057|NCT02551055|560513261|FG000|Overall Study|Withdrawal by Subject|1|||
155296058|NCT02551055|560513262|FG001|Overall Study|Withdrawal by Subject|1|||
155296059|NCT02551055|560513263|FG002|Overall Study|Withdrawal by Subject|0|||
155296060|NCT02551055|560513264|FG003|Overall Study|Withdrawal by Subject|1|||
155296061|NCT02551055|560513265|FG004|Overall Study|Withdrawal by Subject|2|||
155296062|NCT02551055|560513266|FG005|Overall Study|Withdrawal by Subject|0|||
155296063|NCT02551055|560513267|FG006|Overall Study|Withdrawal by Subject|0|||
155296064|NCT02551055|560513268|FG007|Overall Study|Withdrawal by Subject|0|||
155296065|NCT02551055|560513261|FG000|Overall Study|Reason not specified|0|||
155296066|NCT02551055|560513262|FG001|Overall Study|Reason not specified|0|||
155296067|NCT02551055|560513263|FG002|Overall Study|Reason not specified|0|||
155296068|NCT02551055|560513264|FG003|Overall Study|Reason not specified|0|||
155296069|NCT02551055|560513265|FG004|Overall Study|Reason not specified|1|||
155296070|NCT02551055|560513266|FG005|Overall Study|Reason not specified|0|||
155296071|NCT02551055|560513267|FG006|Overall Study|Reason not specified|1|||
155296072|NCT02551055|560513268|FG007|Overall Study|Reason not specified|0|||
155296073|NCT00430300|560513269|FG000|Overall Study|Adverse Event|0|||
155296074|NCT00430300|560513270|FG001|Overall Study|Adverse Event|2|||
155296075|NCT00430300|560513271|FG002|Overall Study|Adverse Event|1|||
155296076|NCT00430300|560513272|FG003|Overall Study|Adverse Event|1|||
155296077|NCT00430300|560513269|FG000|Overall Study|Withdrawal by Subject|1|||
155296078|NCT00430300|560513270|FG001|Overall Study|Withdrawal by Subject|0|||
155296079|NCT00430300|560513271|FG002|Overall Study|Withdrawal by Subject|5|||
155296080|NCT00430300|560513272|FG003|Overall Study|Withdrawal by Subject|0|||
155296081|NCT00430300|560513269|FG000|Overall Study|Laboratory abnormality|1|||
155296082|NCT00430300|560513270|FG001|Overall Study|Laboratory abnormality|0|||
155296083|NCT00430300|560513271|FG002|Overall Study|Laboratory abnormality|0|||
155296084|NCT00430300|560513272|FG003|Overall Study|Laboratory abnormality|0|||
155640023|NCT02903914|561771842|FG007|Overall Study|Refused Further Treatment/Contact|0|||
155640024|NCT02903914|561771835|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640025|NCT02903914|561771836|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640026|NCT02903914|561771837|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640027|NCT02903914|561771838|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640028|NCT02903914|561771839|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640029|NCT02903914|561771840|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640030|NCT02903914|561771841|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
155640031|NCT02903914|561771842|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155640032|NCT02989389|561771843|FG000|Period 1|Lost to Follow-up|0|||
155640033|NCT02989389|561771844|FG001|Period 1|Lost to Follow-up|1|||
155640034|NCT02989389|561771845|FG002|Period 1|Lost to Follow-up|0|||
155640035|NCT02989389|561771846|FG003|Period 1|Lost to Follow-up|0|||
155640036|NCT02989389|561771847|FG004|Period 1|Lost to Follow-up|0|||
155640037|NCT02989389|561771848|FG005|Period 1|Lost to Follow-up|0|||
155640038|NCT02989389|561771849|FG006|Period 1|Lost to Follow-up|0|||
155640039|NCT02989389|561771850|FG007|Period 1|Lost to Follow-up|0|||
155640040|NCT02989389|561771851|FG008|Period 1|Lost to Follow-up|0|||
155640041|NCT02989389|561771852|FG009|Period 1|Lost to Follow-up|0|||
155640042|NCT02989389|561771843|FG000|Period 1|Physician Decision|0|||
155640043|NCT02989389|561771844|FG001|Period 1|Physician Decision|0|||
155640044|NCT02989389|561771845|FG002|Period 1|Physician Decision|0|||
155640045|NCT02989389|561771846|FG003|Period 1|Physician Decision|0|||
155640046|NCT02989389|561771847|FG004|Period 1|Physician Decision|0|||
155640047|NCT02989389|561771848|FG005|Period 1|Physician Decision|0|||
155640048|NCT02989389|561771849|FG006|Period 1|Physician Decision|0|||
155640049|NCT02989389|561771850|FG007|Period 1|Physician Decision|0|||
155640050|NCT02989389|561771851|FG008|Period 1|Physician Decision|1|||
155640051|NCT02989389|561771852|FG009|Period 1|Physician Decision|0|||
155640052|NCT02246777|561771855|FG000|Overall Study|Adverse Event|2|||
155640053|NCT02246777|561771855|FG000|Overall Study|Change of residence|1|||
155640054|NCT01063114|561771861|FG000|Overall Study|Lost to Follow-up|1|||
155640055|NCT06239610|561771867|FG000|Overall Study|no usable migration data for minimum of one day|11|||
155296085|NCT00430300|560513269|FG000|Overall Study|Other|0|||
155296086|NCT00430300|560513270|FG001|Overall Study|Other|0|||
155296087|NCT00430300|560513271|FG002|Overall Study|Other|0|||
155296088|NCT00430300|560513272|FG003|Overall Study|Other|1|||
155296089|NCT01063517|560513277|FG000|Overall Study|Consent withdrawal|1|||
155296090|NCT01063517|560513278|FG001|Overall Study|Consent withdrawal|0|||
155296091|NCT01063517|560513277|FG000|Overall Study|Study reached data cut-off|19|||
155296092|NCT01063517|560513278|FG001|Overall Study|Study reached data cut-off|7|||
155296093|NCT01063517|560513277|FG000|Overall Study|Lost to Follow-up|4|||
155296094|NCT01063517|560513278|FG001|Overall Study|Lost to Follow-up|3|||
155296095|NCT01063517|560513277|FG000|Overall Study|Withdrawal by Subject|1|||
155296096|NCT01063517|560513278|FG001|Overall Study|Withdrawal by Subject|2|||
155296097|NCT01063517|560513277|FG000|Overall Study|Death|33|||
155296098|NCT01063517|560513278|FG001|Overall Study|Death|48|||
155296099|NCT02041104|560513279|FG000|Overall Study|Lost to Follow-up|1|||
155296100|NCT02041104|560513280|FG001|Overall Study|Lost to Follow-up|4|||
155296101|NCT02041104|560513279|FG000|Overall Study|discomfort during OGTT|0|||
155296102|NCT02041104|560513280|FG001|Overall Study|discomfort during OGTT|3|||
155296103|NCT02106442|560513281|FG000|Overall Study|Case Report Forms Uncollected|7|||
155296104|NCT02106442|560513281|FG000|Overall Study|Protocol Deviation|30|||
155410710|NCT05048719|560937469|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155410711|NCT05048719|560937461|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410712|NCT05048719|560937462|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
155410713|NCT05048719|560937463|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410714|NCT05048719|560937464|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410715|NCT05048719|560937465|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410716|NCT05048719|560937466|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410717|NCT05048719|560937467|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410718|NCT05048719|560937468|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410719|NCT05048719|560937469|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
155410720|NCT05048719|560937461|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410721|NCT05048719|560937462|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410722|NCT05048719|560937463|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410723|NCT05048719|560937464|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
155410724|NCT05048719|560937465|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410725|NCT05048719|560937466|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410726|NCT05048719|560937467|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410727|NCT05048719|560937468|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410728|NCT05048719|560937469|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
155410729|NCT05048719|560937461|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410730|NCT05048719|560937462|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410731|NCT05048719|560937463|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410732|NCT05048719|560937464|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410733|NCT05048719|560937465|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410734|NCT05048719|560937466|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
155640056|NCT00462462|561771868|FG000|Overall Study|Physician Decision|0|||
155640057|NCT00462462|561771869|FG001|Overall Study|Physician Decision|1|||
155640058|NCT01163617|561771870|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640059|NCT01163617|561771871|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
155640060|NCT01163617|561771872|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640061|NCT01163617|561771873|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640062|NCT01163617|561771874|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640063|NCT01163617|561771875|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640064|NCT01163617|561771876|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640065|NCT01163617|561771877|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155640066|NCT01163617|561771870|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640067|NCT01163617|561771871|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
155640068|NCT01163617|561771872|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640069|NCT01163617|561771873|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640070|NCT01163617|561771874|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640071|NCT01163617|561771875|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640072|NCT01163617|561771876|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155640073|NCT01163617|561771877|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155744980|NCT03148691|562165290|FG001|Overall Study|Lost to Follow-up|0|||
155744981|NCT03148691|562165291|FG002|Overall Study|Lost to Follow-up|1|||
155640074|NCT01163617|561771870|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640075|NCT01163617|561771871|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640076|NCT01163617|561771872|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
155640077|NCT01163617|561771873|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640078|NCT01163617|561771874|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640079|NCT01163617|561771875|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640080|NCT01163617|561771876|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640081|NCT01163617|561771877|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155640082|NCT02875080|561771878|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
155640083|NCT02875080|561771879|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
155640084|NCT02875080|561771880|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
155640085|NCT02394756|561771881|FG000|Period 1|Lens Discomfort|0|||
155640086|NCT02394756|561771882|FG001|Period 1|Lens Discomfort|0|||
155640087|NCT02394756|561771883|FG002|Period 1|Lens Discomfort|0|||
155640088|NCT02394756|561771884|FG003|Period 1|Lens Discomfort|0|||
155640089|NCT02394756|561771885|FG004|Period 1|Lens Discomfort|0|||
155640090|NCT02394756|561771886|FG005|Period 1|Lens Discomfort|1|||
155640091|NCT02394756|561771881|FG000|Period 1|Withdrawal by Subject|0|||
155640092|NCT02394756|561771882|FG001|Period 1|Withdrawal by Subject|1|||
155640093|NCT02394756|561771883|FG002|Period 1|Withdrawal by Subject|1|||
155640094|NCT02394756|561771884|FG003|Period 1|Withdrawal by Subject|1|||
155640095|NCT02394756|561771885|FG004|Period 1|Withdrawal by Subject|0|||
155640096|NCT02394756|561771886|FG005|Period 1|Withdrawal by Subject|0|||
155296105|NCT03215927|560514640|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
155296106|NCT03215927|560514641|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
155296107|NCT03215927|560514640|FG000|Open Label Extension|Adverse Event|1|||
155296108|NCT03215927|560514641|FG001|Open Label Extension|Adverse Event|0|||
155296109|NCT03215927|560514640|FG000|Open Label Extension|Lack of Efficacy|1|||
155296110|NCT03215927|560514641|FG001|Open Label Extension|Lack of Efficacy|0|||
155296111|NCT03215927|560514640|FG000|Open Label Extension|Death|0|||
155296112|NCT03215927|560514641|FG001|Open Label Extension|Death|1|||
155296113|NCT04001829|560514644|FG000|Overall Study|Never start protocol therapy|5|||
155296114|NCT04001829|560514645|FG001|Overall Study|Never start protocol therapy|5|||
155296115|NCT04001829|560514644|FG000|Overall Study|Adverse Event|11|||
155296116|NCT04001829|560514645|FG001|Overall Study|Adverse Event|7|||
155296117|NCT04001829|560514644|FG000|Overall Study|Alternative therapy|1|||
155296118|NCT04001829|560514645|FG001|Overall Study|Alternative therapy|2|||
155296119|NCT04001829|560514644|FG000|Overall Study|Disease progression/relapse|2|||
155296120|NCT04001829|560514645|FG001|Overall Study|Disease progression/relapse|1|||
155296121|NCT04001829|560514644|FG000|Overall Study|Other complicating disease|1|||
155296122|NCT04001829|560514645|FG001|Overall Study|Other complicating disease|0|||
155296123|NCT04001829|560514644|FG000|Overall Study|Withdrawal by Subject|1|||
155296124|NCT04001829|560514645|FG001|Overall Study|Withdrawal by Subject|4|||
155296125|NCT04001829|560514644|FG000|Overall Study|Ineligible|2|||
155296126|NCT04001829|560514645|FG001|Overall Study|Ineligible|2|||
155296127|NCT04001829|560514644|FG000|Overall Study|Reason missing due to delinquent data|1|||
155296128|NCT04001829|560514645|FG001|Overall Study|Reason missing due to delinquent data|0|||
155296129|NCT03175172|560514646|FG000|Overall Study|Death|3|||
155296130|NCT03175172|560514646|FG000|Overall Study|Withdrawal by Subject|3|||
155296131|NCT03175172|560514646|FG000|Overall Study|Lost to Follow-up|1|||
155296132|NCT03175172|560514646|FG000|Overall Study|Study Terminated by Sponsor|3|||
155296133|NCT02974634|560514647|FG000|Overall Study|Advanced disease|12|||
155296134|NCT02974634|560514648|FG001|Overall Study|Advanced disease|3|||
155296135|NCT02974634|560514647|FG000|Overall Study|Noncompliance|3|||
155296136|NCT02974634|560514648|FG001|Overall Study|Noncompliance|7|||
155296137|NCT02974634|560514647|FG000|Overall Study|intervention technology related issues|5|||
155296138|NCT02974634|560514648|FG001|Overall Study|intervention technology related issues|0|||
155296139|NCT02974634|560514647|FG000|Overall Study|Death|8|||
155296140|NCT02974634|560514648|FG001|Overall Study|Death|11|||
155296141|NCT01393119|560514649|FG000|Overall Study|Adverse Event|1|||
155296142|NCT01393119|560514650|FG001|Overall Study|Adverse Event|1|||
155296143|NCT01393119|560514651|FG002|Overall Study|Adverse Event|0|||
155296144|NCT01393119|560514652|FG003|Overall Study|Adverse Event|1|||
155296145|NCT01393119|560514649|FG000|Overall Study|Withdrawal by Subject|0|||
155296146|NCT01393119|560514650|FG001|Overall Study|Withdrawal by Subject|1|||
155296147|NCT01393119|560514651|FG002|Overall Study|Withdrawal by Subject|1|||
155296148|NCT01393119|560514652|FG003|Overall Study|Withdrawal by Subject|0|||
155296149|NCT01393119|560514649|FG000|Overall Study|Lack of Efficacy|1|||
155296150|NCT01393119|560514650|FG001|Overall Study|Lack of Efficacy|0|||
155296151|NCT01393119|560514651|FG002|Overall Study|Lack of Efficacy|2|||
155296152|NCT01393119|560514652|FG003|Overall Study|Lack of Efficacy|1|||
155296153|NCT01393119|560514649|FG000|Overall Study|Protocol Violation|0|||
155296154|NCT01393119|560514650|FG001|Overall Study|Protocol Violation|0|||
155296155|NCT01393119|560514651|FG002|Overall Study|Protocol Violation|1|||
155296156|NCT01393119|560514652|FG003|Overall Study|Protocol Violation|0|||
155296157|NCT01393119|560514649|FG000|Overall Study|Death|0|||
155296158|NCT01393119|560514650|FG001|Overall Study|Death|0|||
155296159|NCT01393119|560514651|FG002|Overall Study|Death|0|||
155296160|NCT01393119|560514652|FG003|Overall Study|Death|1|||
155296161|NCT01393119|560514649|FG000|Overall Study|Randomized but Not treated|1|||
155296162|NCT01393119|560514650|FG001|Overall Study|Randomized but Not treated|0|||
155296163|NCT01393119|560514651|FG002|Overall Study|Randomized but Not treated|1|||
155296164|NCT01393119|560514652|FG003|Overall Study|Randomized but Not treated|1|||
155296165|NCT01393119|560514649|FG000|Overall Study|Sponsor Termination of Study|11|||
155296166|NCT01393119|560514650|FG001|Overall Study|Sponsor Termination of Study|12|||
155296167|NCT01393119|560514651|FG002|Overall Study|Sponsor Termination of Study|9|||
155296168|NCT01393119|560514652|FG003|Overall Study|Sponsor Termination of Study|12|||
155296169|NCT01266265|560514653|FG000|Overall Study|Death|95|||
155296170|NCT01266265|560514654|FG001|Overall Study|Death|73|||
155640097|NCT02394756|561771881|FG000|Period 2|Unsatisfactory Visual Response|0|||
155296171|NCT01266265|560514653|FG000|Overall Study|Lost to Follow-up|23|||
155296172|NCT01266265|560514654|FG001|Overall Study|Lost to Follow-up|28|||
155296173|NCT01266265|560514653|FG000|Overall Study|Withdrawal by Subject|13|||
155296174|NCT01266265|560514654|FG001|Overall Study|Withdrawal by Subject|11|||
155640098|NCT02394756|561771882|FG001|Period 2|Unsatisfactory Visual Response|0|||
155640099|NCT02394756|561771883|FG002|Period 2|Unsatisfactory Visual Response|0|||
155640100|NCT02394756|561771884|FG003|Period 2|Unsatisfactory Visual Response|0|||
155640101|NCT02394756|561771885|FG004|Period 2|Unsatisfactory Visual Response|1|||
155640102|NCT02394756|561771886|FG005|Period 2|Unsatisfactory Visual Response|0|||
155640103|NCT01164475|561771887|FG000|Overall Study|Lack of Efficacy|1|||
155640104|NCT01164475|561771888|FG001|Overall Study|Lack of Efficacy|0|||
155296175|NCT01266265|560514653|FG000|Overall Study|Respiratory-related adverse event|2|||
155296176|NCT01266265|560514654|FG001|Overall Study|Respiratory-related adverse event|1|||
155296177|NCT01266265|560514653|FG000|Overall Study|Transferred care to another provider|22|||
155296178|NCT01266265|560514654|FG001|Overall Study|Transferred care to another provider|28|||
155296179|NCT01266265|560514653|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
155296180|NCT01266265|560514654|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
155296181|NCT01266265|560514653|FG000|Overall Study|Enrolled in another clinical study|15|||
155296182|NCT01266265|560514654|FG001|Overall Study|Enrolled in another clinical study|26|||
155296183|NCT01266265|560514653|FG000|Overall Study|Non-compliance|8|||
155296184|NCT01266265|560514654|FG001|Overall Study|Non-compliance|5|||
155296185|NCT01266265|560514653|FG000|Overall Study|Lung transplant|6|||
155296186|NCT01266265|560514654|FG001|Overall Study|Lung transplant|5|||
155296187|NCT01266265|560514653|FG000|Overall Study|Site closed early|4|||
155296188|NCT01266265|560514654|FG001|Overall Study|Site closed early|3|||
155296189|NCT01266265|560514653|FG000|Overall Study|Clinical worsening|1|||
155296190|NCT01266265|560514654|FG001|Overall Study|Clinical worsening|1|||
155296191|NCT01580293|560514655|FG000|Part A_Main Trial|Adverse Event|0|||
155296192|NCT01580293|560514656|FG001|Part A_Main Trial|Adverse Event|2|||
155296193|NCT01580293|560514657|FG002|Part A_Main Trial|Adverse Event|0|||
155296194|NCT01580293|560514655|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
155296195|NCT01580293|560514656|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
155296196|NCT01580293|560514657|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
155296197|NCT01580293|560514655|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
155296198|NCT01580293|560514656|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
155296199|NCT01580293|560514657|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
155296200|NCT01580293|560514655|FG000|Part A_Extension|Adverse Event|0|||
155296201|NCT01580293|560514656|FG001|Part A_Extension|Adverse Event|2|||
155296202|NCT01580293|560514657|FG002|Part A_Extension|Adverse Event|0|||
155296203|NCT01580293|560514655|FG000|Part A_Extension|Withdrawal by Subject|0|||
155296204|NCT01580293|560514656|FG001|Part A_Extension|Withdrawal by Subject|3|||
155296205|NCT01580293|560514657|FG002|Part A_Extension|Withdrawal by Subject|0|||
155296206|NCT01580293|560514655|FG000|Part A_Extension|Lost to Follow-up|0|||
155296207|NCT01580293|560514656|FG001|Part A_Extension|Lost to Follow-up|1|||
155296208|NCT01580293|560514657|FG002|Part A_Extension|Lost to Follow-up|0|||
155296209|NCT01580293|560514655|FG000|Part A_Extension|Other Reason|0|||
155296210|NCT01580293|560514656|FG001|Part A_Extension|Other Reason|1|||
155296211|NCT01580293|560514657|FG002|Part A_Extension|Other Reason|0|||
155296212|NCT01580293|560514655|FG000|Part A_Extension|Completed Japan only|0|||
155296213|NCT01580293|560514656|FG001|Part A_Extension|Completed Japan only|5|||
155296214|NCT01580293|560514657|FG002|Part A_Extension|Completed Japan only|0|||
155296215|NCT01580293|560514655|FG000|Part B|Withdrawal by Subject|0|||
155296216|NCT01580293|560514656|FG001|Part B|Withdrawal by Subject|0|||
155296217|NCT01580293|560514657|FG002|Part B|Withdrawal by Subject|1|||
155296218|NCT01580293|560514655|FG000|Part B|Other reason|0|||
155296219|NCT01580293|560514656|FG001|Part B|Other reason|0|||
155296220|NCT01580293|560514657|FG002|Part B|Other reason|1|||
155296221|NCT01400776|560514658|FG000|Overall Study|Adverse Event|7|||
155296222|NCT01400776|560514659|FG001|Overall Study|Adverse Event|2|||
155296223|NCT01400776|560514660|FG002|Overall Study|Adverse Event|9|||
155296224|NCT01400776|560514661|FG003|Overall Study|Adverse Event|2|||
155296225|NCT01400776|560514658|FG000|Overall Study|Lost to Follow-up|1|||
155296226|NCT01400776|560514659|FG001|Overall Study|Lost to Follow-up|0|||
155296227|NCT01400776|560514660|FG002|Overall Study|Lost to Follow-up|4|||
155296228|NCT01400776|560514661|FG003|Overall Study|Lost to Follow-up|1|||
155296229|NCT01400776|560514658|FG000|Overall Study|Withdrew Consent|4|||
155296230|NCT01400776|560514659|FG001|Overall Study|Withdrew Consent|2|||
155296231|NCT01400776|560514660|FG002|Overall Study|Withdrew Consent|6|||
155296232|NCT01400776|560514661|FG003|Overall Study|Withdrew Consent|1|||
155296233|NCT01400776|560514658|FG000|Overall Study|Protocol Deviation|6|||
155296234|NCT01400776|560514659|FG001|Overall Study|Protocol Deviation|1|||
155296235|NCT01400776|560514660|FG002|Overall Study|Protocol Deviation|5|||
155296236|NCT01400776|560514661|FG003|Overall Study|Protocol Deviation|2|||
155296237|NCT01400776|560514658|FG000|Overall Study|Reason not Specified|3|||
155296238|NCT01400776|560514659|FG001|Overall Study|Reason not Specified|0|||
155640105|NCT01164475|561771887|FG000|Overall Study|Other|0|||
155640106|NCT01164475|561771888|FG001|Overall Study|Other|1|||
155640107|NCT01164475|561771887|FG000|Overall Study|Progressive disease|0|||
155296239|NCT01400776|560514660|FG002|Overall Study|Reason not Specified|4|||
155296240|NCT01400776|560514661|FG003|Overall Study|Reason not Specified|3|||
155296241|NCT02983617|560514673|FG000|Overall Study|Adverse Event|0|||
155296242|NCT02983617|560514674|FG001|Overall Study|Adverse Event|7|||
155296243|NCT02983617|560514673|FG000|Overall Study|Death|0|||
155296244|NCT02983617|560514674|FG001|Overall Study|Death|1|||
155296245|NCT02983617|560514673|FG000|Overall Study|Investigator's Discretion|0|||
155296246|NCT02983617|560514674|FG001|Overall Study|Investigator's Discretion|1|||
155296247|NCT00002842|560514675|FG000|Overall Study|ineligible for surgical resection|27|||
155296248|NCT02383472|560514676|FG000|Overall Study|Withdrawal by Subject|1|||
155436095|NCT01059812|561024510|FG001|Overall Study|Protocol Violation|1|||
155640108|NCT01164475|561771888|FG001|Overall Study|Progressive disease|1|||
155640109|NCT01164475|561771887|FG000|Overall Study|Protocol Violation|1|||
155640110|NCT01164475|561771888|FG001|Overall Study|Protocol Violation|0|||
155640111|NCT02335944|561771889|FG000|Treatment Phase|Progressive Disease|2|||
155640112|NCT02335944|561771890|FG001|Treatment Phase|Progressive Disease|5|||
155640113|NCT02335944|561771891|FG002|Treatment Phase|Progressive Disease|2|||
155640114|NCT02335944|561771892|FG003|Treatment Phase|Progressive Disease|11|||
155640115|NCT02335944|561771893|FG004|Treatment Phase|Progressive Disease|4|||
155640116|NCT02335944|561771894|FG005|Treatment Phase|Progressive Disease|25|||
155640117|NCT02335944|561771895|FG006|Treatment Phase|Progressive Disease|2|||
155640118|NCT02335944|561771896|FG007|Treatment Phase|Progressive Disease|30|||
155640119|NCT02335944|561771897|FG008|Treatment Phase|Progressive Disease|27|||
155640120|NCT02335944|561771898|FG009|Treatment Phase|Progressive Disease|0|||
155640121|NCT02335944|561771889|FG000|Treatment Phase|Adverse Event|2|||
155640122|NCT02335944|561771890|FG001|Treatment Phase|Adverse Event|0|||
155640123|NCT02335944|561771891|FG002|Treatment Phase|Adverse Event|0|||
155640124|NCT02335944|561771892|FG003|Treatment Phase|Adverse Event|2|||
155640125|NCT02335944|561771893|FG004|Treatment Phase|Adverse Event|1|||
155640126|NCT02335944|561771894|FG005|Treatment Phase|Adverse Event|15|||
155640127|NCT02335944|561771895|FG006|Treatment Phase|Adverse Event|0|||
155640128|NCT02335944|561771896|FG007|Treatment Phase|Adverse Event|5|||
155640129|NCT02335944|561771897|FG008|Treatment Phase|Adverse Event|7|||
155640130|NCT02335944|561771898|FG009|Treatment Phase|Adverse Event|0|||
155640131|NCT02335944|561771889|FG000|Treatment Phase|Physician Decision|0|||
155640132|NCT02335944|561771890|FG001|Treatment Phase|Physician Decision|0|||
155640133|NCT02335944|561771891|FG002|Treatment Phase|Physician Decision|0|||
155640134|NCT02335944|561771892|FG003|Treatment Phase|Physician Decision|1|||
155640135|NCT02335944|561771893|FG004|Treatment Phase|Physician Decision|0|||
155640136|NCT02335944|561771894|FG005|Treatment Phase|Physician Decision|6|||
155640137|NCT02335944|561771895|FG006|Treatment Phase|Physician Decision|1|||
155640138|NCT02335944|561771896|FG007|Treatment Phase|Physician Decision|2|||
155640139|NCT02335944|561771897|FG008|Treatment Phase|Physician Decision|1|||
155640140|NCT02335944|561771898|FG009|Treatment Phase|Physician Decision|0|||
155640141|NCT02335944|561771889|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
155640142|NCT02335944|561771890|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
155640143|NCT02335944|561771891|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
155640144|NCT02335944|561771892|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
155640145|NCT02335944|561771893|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
155640146|NCT02335944|561771894|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
155640147|NCT02335944|561771895|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
155640148|NCT02335944|561771896|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
155640149|NCT02335944|561771897|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
155640150|NCT02335944|561771898|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
155640151|NCT02335944|561771889|FG000|Treatment Phase|Subject/Guardian Decision|0|||
155640152|NCT02335944|561771890|FG001|Treatment Phase|Subject/Guardian Decision|0|||
155640153|NCT02335944|561771891|FG002|Treatment Phase|Subject/Guardian Decision|1|||
155640154|NCT02335944|561771892|FG003|Treatment Phase|Subject/Guardian Decision|0|||
155640155|NCT02335944|561771893|FG004|Treatment Phase|Subject/Guardian Decision|0|||
155640156|NCT02335944|561771894|FG005|Treatment Phase|Subject/Guardian Decision|1|||
155640157|NCT02335944|561771895|FG006|Treatment Phase|Subject/Guardian Decision|0|||
155640158|NCT02335944|561771896|FG007|Treatment Phase|Subject/Guardian Decision|4|||
155640159|NCT02335944|561771897|FG008|Treatment Phase|Subject/Guardian Decision|0|||
155640160|NCT02335944|561771898|FG009|Treatment Phase|Subject/Guardian Decision|0|||
155640161|NCT02335944|561771889|FG000|Post-treatment Follow-up|Progressive Disease|0|||
155640162|NCT02335944|561771890|FG001|Post-treatment Follow-up|Progressive Disease|0|||
155640163|NCT02335944|561771891|FG002|Post-treatment Follow-up|Progressive Disease|0|||
155640164|NCT02335944|561771892|FG003|Post-treatment Follow-up|Progressive Disease|1|||
155640165|NCT02335944|561771893|FG004|Post-treatment Follow-up|Progressive Disease|0|||
155640166|NCT02335944|561771894|FG005|Post-treatment Follow-up|Progressive Disease|9|||
155640167|NCT02335944|561771895|FG006|Post-treatment Follow-up|Progressive Disease|0|||
155640168|NCT02335944|561771896|FG007|Post-treatment Follow-up|Progressive Disease|2|||
155496581|NCT00366678|561242331|FG000|Toddler Dose|Failed to return|1|||
155496582|NCT00366678|561242332|FG001|Toddler Dose|Failed to return|0|||
155496583|NCT00366678|561242333|FG002|Toddler Dose|Failed to return|0|||
155496584|NCT00366678|561242331|FG000|Toddler Dose|Withdrawal by Subject|1|||
155496585|NCT00366678|561242332|FG001|Toddler Dose|Withdrawal by Subject|0|||
155496586|NCT00366678|561242333|FG002|Toddler Dose|Withdrawal by Subject|0|||
155496587|NCT00366678|561242331|FG000|Toddler Dose|protocol deviation|1|||
155496588|NCT00366678|561242332|FG001|Toddler Dose|protocol deviation|0|||
155496589|NCT00366678|561242333|FG002|Toddler Dose|protocol deviation|0|||
155496590|NCT04465916|561242340|FG000|Overall Study|Withdrawal by Subject|0|||
155640169|NCT02335944|561771897|FG008|Post-treatment Follow-up|Progressive Disease|3|||
155640170|NCT02335944|561771898|FG009|Post-treatment Follow-up|Progressive Disease|0|||
155640171|NCT02335944|561771889|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640172|NCT02335944|561771890|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155296249|NCT02383472|560514677|FG001|Overall Study|Withdrawal by Subject|1|||
155296250|NCT02013830|560514678|FG000|Overall Study|Adverse Event|3|||
155296251|NCT02013830|560514678|FG000|Overall Study|Death|1|||
155296252|NCT02013830|560514678|FG000|Overall Study|Insufficient therapeutic response|25|||
155296253|NCT02013830|560514678|FG000|Overall Study|Refused treatment|1|||
155296254|NCT01111526|560514679|FG000|Overall Study|GVHD Disease Progression|0|||
155296255|NCT01111526|560514680|FG001|Overall Study|GVHD Disease Progression|1|||
155296256|NCT01111526|560514681|FG002|Overall Study|GVHD Disease Progression|2|||
155296257|NCT01171625|560514682|FG000|Overall Study|On-Protocol|67|||
155296258|NCT01171625|560514682|FG000|Overall Study|Death|38|||
155296259|NCT01171625|560514682|FG000|Overall Study|Withdrawal by Subject|31|||
155296260|NCT01171625|560514682|FG000|Overall Study|Explanted|10|||
155296261|NCT01171625|560514682|FG000|Overall Study|Lost to Follow-up|5|||
155296262|NCT01171625|560514682|FG000|Overall Study|Patient received valve-in-valve|3|||
155296263|NCT01171625|560514682|FG000|Overall Study|Other|1|||
155296264|NCT01171625|560514682|FG000|Overall Study|Consented but did not receive device|25|||
155296265|NCT01867216|560514683|FG000|Overall Study|Withdrawal by Subject|2|||
155296266|NCT01867216|560514684|FG001|Overall Study|Withdrawal by Subject|0|||
155296267|NCT01867216|560514685|FG002|Overall Study|Withdrawal by Subject|0|||
155296268|NCT01867216|560514686|FG003|Overall Study|Withdrawal by Subject|0|||
155296269|NCT01867216|560514687|FG004|Overall Study|Withdrawal by Subject|1|||
155296270|NCT01867216|560514688|FG005|Overall Study|Withdrawal by Subject|0|||
155296271|NCT01867216|560514689|FG006|Overall Study|Withdrawal by Subject|1|||
155296272|NCT01867216|560514683|FG000|Overall Study|Physician Decision|1|||
155296273|NCT01867216|560514684|FG001|Overall Study|Physician Decision|0|||
155296274|NCT01867216|560514685|FG002|Overall Study|Physician Decision|0|||
155296275|NCT01867216|560514686|FG003|Overall Study|Physician Decision|0|||
155296276|NCT01867216|560514687|FG004|Overall Study|Physician Decision|0|||
155296277|NCT01867216|560514688|FG005|Overall Study|Physician Decision|0|||
155296278|NCT01867216|560514689|FG006|Overall Study|Physician Decision|0|||
155296279|NCT01867216|560514683|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
155296280|NCT01867216|560514684|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296281|NCT01867216|560514685|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296282|NCT01867216|560514686|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296283|NCT01867216|560514687|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296284|NCT01867216|560514688|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296285|NCT01867216|560514689|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296286|NCT01337635|560514696|FG000|Overall Study|Lost to Follow-up|0|||
155296287|NCT01337635|560514697|FG001|Overall Study|Lost to Follow-up|1|||
155296288|NCT01113931|560514698|FG000|Overall Study|Adverse Event|2|||
155296289|NCT01113931|560514699|FG001|Overall Study|Adverse Event|2|||
155296290|NCT01113931|560514698|FG000|Overall Study|Physician Decision|0|||
155296291|NCT01113931|560514699|FG001|Overall Study|Physician Decision|2|||
155296292|NCT01113931|560514698|FG000|Overall Study|Lost to Follow-up|12|||
155296293|NCT01113931|560514699|FG001|Overall Study|Lost to Follow-up|9|||
155296294|NCT01113931|560514698|FG000|Overall Study|Various|2|||
155296295|NCT01113931|560514699|FG001|Overall Study|Various|4|||
155296296|NCT01113931|560514698|FG000|Overall Study|Withdrawal by Subject|3|||
155296297|NCT01113931|560514699|FG001|Overall Study|Withdrawal by Subject|0|||
155296298|NCT00842257|560514704|FG000|Overall Study|Adverse Event|1|||
155296299|NCT00909363|560514705|FG000|Overall Study|Withdrawal by Subject|1|||
155296300|NCT00909363|560514706|FG001|Overall Study|Withdrawal by Subject|0|||
155296301|NCT00909363|560514707|FG002|Overall Study|Withdrawal by Subject|0|||
155296302|NCT00909363|560514705|FG000|Overall Study|Lack of Efficacy|1|||
155296303|NCT00909363|560514706|FG001|Overall Study|Lack of Efficacy|0|||
155640173|NCT02335944|561771891|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640174|NCT02335944|561771892|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640175|NCT02335944|561771893|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640176|NCT02335944|561771894|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
155640177|NCT02335944|561771895|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640178|NCT02335944|561771896|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155296304|NCT00909363|560514707|FG002|Overall Study|Lack of Efficacy|0|||
155296305|NCT02547922|560514722|FG000|Overall Study|Withdrawal by Subject|9|||
155296306|NCT02547922|560514723|FG001|Overall Study|Withdrawal by Subject|6|||
155296307|NCT02547922|560514724|FG002|Overall Study|Withdrawal by Subject|10|||
155296308|NCT02547922|560514722|FG000|Overall Study|Adverse Event|3|||
155296309|NCT02547922|560514723|FG001|Overall Study|Adverse Event|1|||
155296310|NCT02547922|560514724|FG002|Overall Study|Adverse Event|2|||
155296311|NCT02547922|560514722|FG000|Overall Study|Lost to Follow-up|1|||
155296312|NCT02547922|560514723|FG001|Overall Study|Lost to Follow-up|0|||
155296313|NCT02547922|560514724|FG002|Overall Study|Lost to Follow-up|0|||
155296314|NCT02547922|560514722|FG000|Overall Study|Lack of Efficacy|5|||
155296315|NCT02547922|560514723|FG001|Overall Study|Lack of Efficacy|7|||
155296316|NCT02547922|560514724|FG002|Overall Study|Lack of Efficacy|4|||
155296317|NCT02547922|560514722|FG000|Overall Study|Death|1|||
155296318|NCT02547922|560514723|FG001|Overall Study|Death|0|||
155296319|NCT02547922|560514724|FG002|Overall Study|Death|0|||
155296320|NCT02547922|560514722|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
155296321|NCT02547922|560514723|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
155296322|NCT02547922|560514724|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
155296323|NCT02547922|560514722|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
155296324|NCT02547922|560514723|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
155296325|NCT02547922|560514724|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
155296326|NCT02547922|560514722|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
155296327|NCT02547922|560514723|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
155296328|NCT02547922|560514724|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
155296329|NCT02547922|560514722|FG000|Overall Study|Physician Decision|2|||
155296330|NCT02547922|560514723|FG001|Overall Study|Physician Decision|1|||
155296331|NCT02547922|560514724|FG002|Overall Study|Physician Decision|2|||
155296332|NCT02547922|560514722|FG000|Overall Study|Patients did not receive IP|1|||
155296333|NCT02547922|560514723|FG001|Overall Study|Patients did not receive IP|1|||
155296334|NCT02547922|560514724|FG002|Overall Study|Patients did not receive IP|0|||
155296335|NCT00468052|560514725|FG000|Overall Study|Protocol Violation|7|||
155296336|NCT00468052|560514726|FG001|Overall Study|Protocol Violation|8|||
155296337|NCT00857649|560514727|FG000|Overall Study|Adverse Event|15|||
155296338|NCT00857649|560514728|FG001|Overall Study|Adverse Event|10|||
155296339|NCT00857649|560514727|FG000|Overall Study|Non-compliance|1|||
155296340|NCT00857649|560514728|FG001|Overall Study|Non-compliance|1|||
155296341|NCT00857649|560514727|FG000|Overall Study|Protocol Violation|2|||
155296342|NCT00857649|560514728|FG001|Overall Study|Protocol Violation|2|||
155296343|NCT00857649|560514727|FG000|Overall Study|Withdrawal of Consent|10|||
155296344|NCT00857649|560514728|FG001|Overall Study|Withdrawal of Consent|7|||
155296345|NCT00857649|560514727|FG000|Overall Study|Nursing Home Placement|2|||
155296346|NCT00857649|560514728|FG001|Overall Study|Nursing Home Placement|9|||
155296347|NCT00857649|560514727|FG000|Overall Study|Other Reasons|1|||
155296348|NCT00857649|560514728|FG001|Overall Study|Other Reasons|3|||
155296349|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
155296350|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
155296351|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
155296352|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
155296353|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
155296354|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
155296355|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
155296356|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
155296357|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
155296358|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296359|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296360|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155640179|NCT02335944|561771897|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640180|NCT02335944|561771898|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155640181|NCT02335944|561771889|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640182|NCT02335944|561771890|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640183|NCT02335944|561771891|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640184|NCT02335944|561771892|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640185|NCT02335944|561771893|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640186|NCT02335944|561771894|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640187|NCT02335944|561771895|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
155640188|NCT02335944|561771896|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
155640189|NCT02335944|561771897|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
155296361|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296362|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
155296363|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
155296364|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296365|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296366|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
155296367|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296368|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296369|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296370|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296371|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296372|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155640190|NCT02335944|561771898|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
155296373|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296374|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296375|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
155296376|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
155296377|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
155296378|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
155296379|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
155296380|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296381|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
155296382|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296383|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296384|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296385|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296386|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296387|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296388|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296389|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
155296390|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
155296391|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296392|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
155296393|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296394|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296395|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296396|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296397|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296398|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296399|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296400|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296401|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296402|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
155296403|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296404|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296405|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
155296406|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296407|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296408|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296409|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296410|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296411|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296412|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296413|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296414|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296415|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296416|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296417|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296418|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296419|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296420|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
155296421|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296422|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296423|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296424|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296425|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296426|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296427|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
155296428|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
155296429|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
155296430|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
155296431|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
155640191|NCT02335944|561771889|FG000|Post-treatment Follow-up|Adverse Event|0|||
155640192|NCT02335944|561771890|FG001|Post-treatment Follow-up|Adverse Event|0|||
155640193|NCT02335944|561771891|FG002|Post-treatment Follow-up|Adverse Event|0|||
155640194|NCT02335944|561771892|FG003|Post-treatment Follow-up|Adverse Event|0|||
155640195|NCT02335944|561771893|FG004|Post-treatment Follow-up|Adverse Event|0|||
155640196|NCT02335944|561771894|FG005|Post-treatment Follow-up|Adverse Event|1|||
155640197|NCT02335944|561771895|FG006|Post-treatment Follow-up|Adverse Event|0|||
155640198|NCT02335944|561771896|FG007|Post-treatment Follow-up|Adverse Event|0|||
155296432|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296433|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
155296434|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296435|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296436|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296437|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296438|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296439|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296440|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296441|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296442|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
155296443|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296444|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296445|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296446|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296447|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
155296448|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296449|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296450|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296451|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296452|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296453|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296454|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296455|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296456|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296457|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296458|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296459|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296460|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296461|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296462|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296463|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
155296464|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
155296465|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
155296466|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296467|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296468|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296469|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296470|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296471|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296472|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296473|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296474|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296475|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
155296476|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
155296477|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
155296478|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296479|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296480|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296481|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296482|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296483|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296484|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296485|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296486|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296487|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296488|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
155296489|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
155296490|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
155296491|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
155296492|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296493|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296494|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296495|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296496|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
155640199|NCT02335944|561771897|FG008|Post-treatment Follow-up|Adverse Event|0|||
155640200|NCT02335944|561771898|FG009|Post-treatment Follow-up|Adverse Event|0|||
155640201|NCT02335944|561771889|FG000|Post-treatment Follow-up|Death|0|||
155640202|NCT02335944|561771890|FG001|Post-treatment Follow-up|Death|0|||
155296497|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296498|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296499|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296500|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296501|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296502|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
155296503|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296504|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
155296505|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296506|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296507|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296508|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296509|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296510|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155410735|NCT05048719|560937467|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410736|NCT05048719|560937468|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410737|NCT05048719|560937469|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
155410738|NCT04541004|560937470|FG000|Overall Study|Adverse Event|2|||
155410739|NCT00605085|560937471|FG000|Overall Study|Withdrawal by Subject|8|||
155410740|NCT00605085|560937472|FG001|Overall Study|Withdrawal by Subject|5|||
155410741|NCT00605085|560937471|FG000|Overall Study|Adverse Event|9|||
155410742|NCT00605085|560937472|FG001|Overall Study|Adverse Event|5|||
155410743|NCT00605085|560937471|FG000|Overall Study|Pregnancy|2|||
155410744|NCT00605085|560937472|FG001|Overall Study|Pregnancy|0|||
155410745|NCT00605085|560937471|FG000|Overall Study|Protocol Violation|3|||
155410746|NCT00605085|560937472|FG001|Overall Study|Protocol Violation|2|||
155496591|NCT04465916|561242341|FG001|Overall Study|Withdrawal by Subject|1|||
155496592|NCT00826176|561242344|FG000|Overall Study|Lost to Follow-up|1|||
155496593|NCT00826176|561242345|FG001|Overall Study|Lost to Follow-up|0|||
155496594|NCT00826176|561242344|FG000|Overall Study|Subject Withdrew Consent|3|||
155496595|NCT00826176|561242345|FG001|Overall Study|Subject Withdrew Consent|0|||
155496596|NCT00826176|561242344|FG000|Overall Study|Administrative|9|||
155496597|NCT00826176|561242345|FG001|Overall Study|Administrative|0|||
155496598|NCT03079869|561242347|FG000|Overall Study|Adverse Event|6|||
155496599|NCT03079869|561242348|FG001|Overall Study|Adverse Event|8|||
155496600|NCT03079869|561242347|FG000|Overall Study|Withdrawal by Subject|4|||
155496601|NCT03079869|561242348|FG001|Overall Study|Withdrawal by Subject|1|||
155496602|NCT03079869|561242347|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
155496603|NCT03079869|561242348|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
155496604|NCT01325701|561242349|FG000|Overall Study|Adverse Event|12|||
155496605|NCT01325701|561242350|FG001|Overall Study|Adverse Event|0|||
155496606|NCT01325701|561242349|FG000|Overall Study|Protocol Violation|1|||
155496607|NCT01325701|561242350|FG001|Overall Study|Protocol Violation|0|||
155496608|NCT01325701|561242349|FG000|Overall Study|Physician Decision|2|||
155496609|NCT01325701|561242350|FG001|Overall Study|Physician Decision|2|||
155496610|NCT01325701|561242349|FG000|Overall Study|Withdrawal by Subject|2|||
155496611|NCT01325701|561242350|FG001|Overall Study|Withdrawal by Subject|1|||
155496612|NCT01325701|561242349|FG000|Overall Study|Rollerover Extension Study|4|||
155496613|NCT01325701|561242350|FG001|Overall Study|Rollerover Extension Study|0|||
155496614|NCT00568776|561242353|FG000|Overall Study|Adverse Event|8|||
155496615|NCT00568776|561242354|FG001|Overall Study|Adverse Event|8|||
155496616|NCT00568776|561242355|FG002|Overall Study|Adverse Event|10|||
155496617|NCT00568776|561242356|FG003|Overall Study|Adverse Event|8|||
155496618|NCT00568776|561242353|FG000|Overall Study|Death|0|||
155496619|NCT00568776|561242354|FG001|Overall Study|Death|1|||
155496620|NCT00568776|561242355|FG002|Overall Study|Death|4|||
155496621|NCT00568776|561242356|FG003|Overall Study|Death|3|||
155496622|NCT00568776|561242353|FG000|Overall Study|Physician Decision|0|||
155496623|NCT00568776|561242354|FG001|Overall Study|Physician Decision|2|||
155496624|NCT00568776|561242355|FG002|Overall Study|Physician Decision|0|||
155496625|NCT00568776|561242356|FG003|Overall Study|Physician Decision|0|||
155496626|NCT00568776|561242353|FG000|Overall Study|Lack of Efficacy|2|||
155496627|NCT00568776|561242354|FG001|Overall Study|Lack of Efficacy|2|||
155496628|NCT00568776|561242355|FG002|Overall Study|Lack of Efficacy|2|||
155496629|NCT00568776|561242356|FG003|Overall Study|Lack of Efficacy|4|||
155296511|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296512|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155410747|NCT00605085|560937471|FG000|Overall Study|Lost to Follow-up|10|||
155496630|NCT00568776|561242353|FG000|Overall Study|Lost to Follow-up|1|||
155496631|NCT00568776|561242354|FG001|Overall Study|Lost to Follow-up|1|||
155496632|NCT00568776|561242355|FG002|Overall Study|Lost to Follow-up|1|||
155496633|NCT00568776|561242356|FG003|Overall Study|Lost to Follow-up|1|||
155496634|NCT00568776|561242353|FG000|Overall Study|Protocol Violation|1|||
155496635|NCT00568776|561242354|FG001|Overall Study|Protocol Violation|0|||
155496636|NCT00568776|561242355|FG002|Overall Study|Protocol Violation|1|||
155496637|NCT00568776|561242356|FG003|Overall Study|Protocol Violation|1|||
155296513|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296514|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
155296515|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
155296516|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296517|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296518|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296519|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296520|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296521|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296522|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296523|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296524|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296525|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296526|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296527|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
155296528|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
155296529|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
155296530|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
155296531|NCT00940992|560514742|FG000|Overall Study|Adverse Event|2|||
155296532|NCT00940992|560514743|FG001|Overall Study|Adverse Event|0|||
155296533|NCT00940992|560514744|FG002|Overall Study|Adverse Event|1|||
155296534|NCT00940992|560514742|FG000|Overall Study|subject request|2|||
155296535|NCT00940992|560514743|FG001|Overall Study|subject request|1|||
155296536|NCT00940992|560514744|FG002|Overall Study|subject request|0|||
155296537|NCT00940992|560514742|FG000|Overall Study|Lost to Follow-up|0|||
155296538|NCT00940992|560514743|FG001|Overall Study|Lost to Follow-up|1|||
155296539|NCT00940992|560514744|FG002|Overall Study|Lost to Follow-up|1|||
155296540|NCT04221438|560514745|FG000|Overall Study|Adverse Event|1|||
155296541|NCT04221438|560514745|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
155296542|NCT02248480|560514748|FG000|Overall Study|Lack of Efficacy|4|||
155296543|NCT02248480|560514749|FG001|Overall Study|Lack of Efficacy|6|||
155296544|NCT02248480|560514748|FG000|Overall Study|Adverse Event|11|||
155296545|NCT02248480|560514749|FG001|Overall Study|Adverse Event|2|||
155296546|NCT02248480|560514748|FG000|Overall Study|Withdrawal by Subject|2|||
155296547|NCT02248480|560514749|FG001|Overall Study|Withdrawal by Subject|4|||
155296548|NCT02248480|560514748|FG000|Overall Study|Entry Criteria Not Met|0|||
155296549|NCT02248480|560514749|FG001|Overall Study|Entry Criteria Not Met|1|||
155296550|NCT02248480|560514748|FG000|Overall Study|Other:Physician Decision|0|||
155296551|NCT02248480|560514749|FG001|Overall Study|Other:Physician Decision|1|||
155296552|NCT00546871|560514759|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
155296553|NCT00546871|560514760|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
155296554|NCT00546871|560514759|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
155296555|NCT00546871|560514760|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
155296556|NCT00546871|560514759|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
155296557|NCT00546871|560514760|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
155296558|NCT00546871|560514759|FG000|Study Extension Period|Protocol Violation|1|||
155296559|NCT00546871|560514760|FG001|Study Extension Period|Protocol Violation|0|||
155296560|NCT00546871|560514759|FG000|Study Extension Period|Withdrawal by Subject|0|||
155296561|NCT00546871|560514760|FG001|Study Extension Period|Withdrawal by Subject|1|||
155296562|NCT01713946|560514761|FG000|Overall Study|Death|0|||
155296563|NCT01713946|560514762|FG001|Overall Study|Death|2|||
155296564|NCT01713946|560514763|FG002|Overall Study|Death|2|||
155296565|NCT01713946|560514761|FG000|Overall Study|Adverse Event|19|||
155296566|NCT01713946|560514762|FG001|Overall Study|Adverse Event|14|||
155296567|NCT01713946|560514763|FG002|Overall Study|Adverse Event|13|||
155296568|NCT01713946|560514761|FG000|Overall Study|Withdrawal by Subject|12|||
155296569|NCT01713946|560514762|FG001|Overall Study|Withdrawal by Subject|12|||
155296570|NCT01713946|560514763|FG002|Overall Study|Withdrawal by Subject|8|||
155296571|NCT01713946|560514761|FG000|Overall Study|Lack of Efficacy|8|||
155296572|NCT01713946|560514762|FG001|Overall Study|Lack of Efficacy|8|||
155296573|NCT01713946|560514763|FG002|Overall Study|Lack of Efficacy|14|||
155296574|NCT01713946|560514761|FG000|Overall Study|Protocol Violation|2|||
155296575|NCT01713946|560514762|FG001|Overall Study|Protocol Violation|4|||
155296576|NCT01713946|560514763|FG002|Overall Study|Protocol Violation|1|||
155296577|NCT01713946|560514761|FG000|Overall Study|Lost to Follow-up|0|||
155296578|NCT01713946|560514762|FG001|Overall Study|Lost to Follow-up|0|||
155296579|NCT01713946|560514763|FG002|Overall Study|Lost to Follow-up|1|||
155296580|NCT01713946|560514761|FG000|Overall Study|Administrative problems|1|||
155640203|NCT02335944|561771891|FG002|Post-treatment Follow-up|Death|0|||
155640204|NCT02335944|561771892|FG003|Post-treatment Follow-up|Death|1|||
155640205|NCT02335944|561771893|FG004|Post-treatment Follow-up|Death|0|||
155640206|NCT02335944|561771894|FG005|Post-treatment Follow-up|Death|1|||
155640207|NCT02335944|561771895|FG006|Post-treatment Follow-up|Death|0|||
155640208|NCT02335944|561771896|FG007|Post-treatment Follow-up|Death|0|||
155640209|NCT02335944|561771897|FG008|Post-treatment Follow-up|Death|0|||
155640210|NCT02335944|561771898|FG009|Post-treatment Follow-up|Death|0|||
155640211|NCT02335944|561771889|FG000|Post-treatment Follow-up|Physician Decision|1|||
155640212|NCT02335944|561771890|FG001|Post-treatment Follow-up|Physician Decision|0|||
155640213|NCT02335944|561771891|FG002|Post-treatment Follow-up|Physician Decision|0|||
155640214|NCT02335944|561771892|FG003|Post-treatment Follow-up|Physician Decision|0|||
155640215|NCT02335944|561771893|FG004|Post-treatment Follow-up|Physician Decision|0|||
155640216|NCT02335944|561771894|FG005|Post-treatment Follow-up|Physician Decision|0|||
155640217|NCT02335944|561771895|FG006|Post-treatment Follow-up|Physician Decision|0|||
155640218|NCT02335944|561771896|FG007|Post-treatment Follow-up|Physician Decision|1|||
155640219|NCT02335944|561771897|FG008|Post-treatment Follow-up|Physician Decision|0|||
155640220|NCT02335944|561771898|FG009|Post-treatment Follow-up|Physician Decision|0|||
155640221|NCT02406612|561771899|FG000|Overall Study|Screening Failure|3|||
155640222|NCT02406612|561771900|FG001|Overall Study|Screening Failure|0|||
155640223|NCT02406612|561771899|FG000|Overall Study|Intra-procedural Exclusion|1|||
155640224|NCT02406612|561771900|FG001|Overall Study|Intra-procedural Exclusion|3|||
155640225|NCT02406612|561771899|FG000|Overall Study|Guidewire Failure|0|||
155640226|NCT02406612|561771900|FG001|Overall Study|Guidewire Failure|1|||
155640227|NCT02916771|561771905|FG000|Overall Study|Withdrawal by Subject|9|||
155640228|NCT02916771|561771905|FG000|Overall Study|Physician Decision|1|||
155640229|NCT02916771|561771905|FG000|Overall Study|Began treatment for another active malignancy|1|||
155640230|NCT03043573|561771913|FG000|Overall Study|Lost to Follow-up|3|||
155640231|NCT03043573|561771914|FG001|Overall Study|Lost to Follow-up|3|||
155640232|NCT03043573|561771913|FG000|Overall Study|Physician Decision|0|||
155640233|NCT03043573|561771914|FG001|Overall Study|Physician Decision|5|||
155640234|NCT03043573|561771913|FG000|Overall Study|Withdrawal by Subject|0|||
155640235|NCT03043573|561771914|FG001|Overall Study|Withdrawal by Subject|4|||
155640236|NCT02337686|561771915|FG000|Overall Study|Adverse Event|1|||
155640237|NCT04333498|561773260|FG000|Overall Study|Lost to Follow-up|1|||
155640238|NCT04333498|561773261|FG001|Overall Study|Lost to Follow-up|0|||
155640239|NCT04333498|561773260|FG000|Overall Study|Lost to Follow-up|0|||
155640240|NCT04333498|561773261|FG001|Overall Study|Lost to Follow-up|1|||
155640241|NCT00484159|561773263|FG000|Overall Study|Lost to Follow-up|1|||
155640242|NCT00484159|561773264|FG001|Overall Study|Lost to Follow-up|1|||
155640243|NCT00484159|561773265|FG002|Overall Study|Lost to Follow-up|0|||
155640244|NCT04766333|561773266|FG000|Overall Study|Lost to Follow-up|40|||
155640245|NCT04766333|561773267|FG001|Overall Study|Lost to Follow-up|826|||
155640246|NCT04398134|561773268|FG000|Overall Study|Adverse Event|0|||
155640247|NCT04398134|561773269|FG001|Overall Study|Adverse Event|0|||
155640248|NCT04398134|561773270|FG002|Overall Study|Adverse Event|1|||
155640249|NCT04398134|561773271|FG003|Overall Study|Adverse Event|0|||
155640250|NCT04398134|561773268|FG000|Overall Study|Withdrawal by Subject|2|||
155640251|NCT04398134|561773269|FG001|Overall Study|Withdrawal by Subject|0|||
155640252|NCT04398134|561773270|FG002|Overall Study|Withdrawal by Subject|0|||
155640253|NCT04398134|561773271|FG003|Overall Study|Withdrawal by Subject|1|||
155640254|NCT04398134|561773268|FG000|Overall Study|Study Terminated by Sponsor|30|||
155640255|NCT04398134|561773269|FG001|Overall Study|Study Terminated by Sponsor|11|||
155640256|NCT04398134|561773270|FG002|Overall Study|Study Terminated by Sponsor|32|||
155640257|NCT04398134|561773271|FG003|Overall Study|Study Terminated by Sponsor|11|||
155640258|NCT00221104|561773277|FG000|Overall Study|Adverse Event|1|||
155640259|NCT00221104|561773278|FG001|Overall Study|Adverse Event|0|||
155640260|NCT00221104|561773277|FG000|Overall Study|Physician Decision|1|||
155640261|NCT00221104|561773278|FG001|Overall Study|Physician Decision|0|||
155640262|NCT00221104|561773277|FG000|Overall Study|Protocol Violation|2|||
155640263|NCT00221104|561773278|FG001|Overall Study|Protocol Violation|0|||
155640264|NCT00221104|561773277|FG000|Overall Study|Withdrawal by Subject|42|||
155640265|NCT00221104|561773278|FG001|Overall Study|Withdrawal by Subject|29|||
155640266|NCT00221104|561773277|FG000|Overall Study|Others|37|||
155640267|NCT00221104|561773278|FG001|Overall Study|Others|47|||
155640268|NCT01666652|561773279|FG000|Overall Study|Serious Adverse Event|0|||
155640269|NCT01666652|561773280|FG001|Overall Study|Serious Adverse Event|0|||
155640270|NCT01666652|561773281|FG002|Overall Study|Serious Adverse Event|0|||
155640271|NCT01666652|561773282|FG003|Overall Study|Serious Adverse Event|1|||
155640272|NCT01666652|561773283|FG004|Overall Study|Serious Adverse Event|0|||
155640273|NCT01666652|561773279|FG000|Overall Study|Withdrawal by Subject|0|||
155640274|NCT01666652|561773280|FG001|Overall Study|Withdrawal by Subject|0|||
155640275|NCT01666652|561773281|FG002|Overall Study|Withdrawal by Subject|0|||
155296581|NCT01713946|560514762|FG001|Overall Study|Administrative problems|0|||
155296582|NCT01713946|560514763|FG002|Overall Study|Administrative problems|0|||
155296583|NCT01713946|560514761|FG000|Overall Study|Did not continue in Ext|0|||
155296584|NCT01713946|560514762|FG001|Overall Study|Did not continue in Ext|3|||
155296585|NCT01713946|560514763|FG002|Overall Study|Did not continue in Ext|0|||
155296586|NCT01713946|560514761|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
155296587|NCT01713946|560514762|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
155296588|NCT01713946|560514763|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
155296589|NCT01713946|560514761|FG000|Overall Study|Patients never switched to everolimus|0|||
155296590|NCT01713946|560514762|FG001|Overall Study|Patients never switched to everolimus|0|||
155296591|NCT01713946|560514763|FG002|Overall Study|Patients never switched to everolimus|5|||
155296592|NCT03516942|560514764|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
155296593|NCT03516942|560514764|FG000|Registration through baseline survey com|Death|8|||
155296594|NCT03516942|560514764|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
155296595|NCT03516942|560514764|FG000|T0: Baseline|LOST|13|||
155296596|NCT03516942|560514764|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
155296597|NCT03516942|560514764|FG000|T1: 3 Months Survey|Death|10|||
155296598|NCT03516942|560514764|FG000|T1: 3 Months Survey|Lost|163|||
155296599|NCT03516942|560514764|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
155296600|NCT03516942|560514764|FG000|T2: 6 Month Survey|Death|14|||
155296601|NCT03516942|560514764|FG000|T2: 6 Month Survey|Lost|180|||
155296602|NCT03516942|560514764|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
155296603|NCT03516942|560514764|FG000|T3: 12 Month Survey|Death|19|||
155296604|NCT03516942|560514764|FG000|T3: 12 Month Survey|Lost|209|||
155296605|NCT03779048|560516459|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
155296606|NCT03779048|560516460|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
155296607|NCT03779048|560516461|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
155296608|NCT03779048|560516459|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
155296609|NCT03779048|560516460|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
155296610|NCT03779048|560516461|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
155296611|NCT03779048|560516459|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
155296612|NCT03779048|560516460|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
155296613|NCT03779048|560516461|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
155296614|NCT01286272|560516462|FG000|Overall Study|Ineligible after beginning treatment|1|||
155296615|NCT01286272|560516463|FG001|Overall Study|Ineligible after beginning treatment|3|||
155296616|NCT04496960|560516464|FG000|Overall Study|Physician Decision|0|||
155296617|NCT04496960|560516465|FG001|Overall Study|Physician Decision|1|||
155296618|NCT02932410|560516466|FG000|Overall Study|Death|7|||
155296619|NCT02932410|560516467|FG001|Overall Study|Death|6|||
155296620|NCT02932410|560516468|FG002|Overall Study|Death|0|||
155296621|NCT02932410|560516469|FG003|Overall Study|Death|0|||
155296622|NCT02932410|560516466|FG000|Overall Study|Lost to Follow-up|1|||
155296623|NCT02932410|560516467|FG001|Overall Study|Lost to Follow-up|2|||
155296624|NCT02932410|560516468|FG002|Overall Study|Lost to Follow-up|0|||
155296625|NCT02932410|560516469|FG003|Overall Study|Lost to Follow-up|0|||
155296626|NCT02932410|560516466|FG000|Overall Study|Parent/Subjects decision|6|||
155296627|NCT02932410|560516467|FG001|Overall Study|Parent/Subjects decision|6|||
155296628|NCT02932410|560516468|FG002|Overall Study|Parent/Subjects decision|1|||
155296629|NCT02932410|560516469|FG003|Overall Study|Parent/Subjects decision|0|||
155296630|NCT02932410|560516466|FG000|Overall Study|Physician Decision|0|||
155296631|NCT02932410|560516467|FG001|Overall Study|Physician Decision|1|||
155296632|NCT02932410|560516468|FG002|Overall Study|Physician Decision|0|||
155296633|NCT02932410|560516469|FG003|Overall Study|Physician Decision|0|||
155296634|NCT05758415|560516473|FG000|Overall Study|Subject Decision|2|||
155296635|NCT05758415|560516474|FG001|Overall Study|Subject Decision|5|||
155496638|NCT00568776|561242353|FG000|Overall Study|Withdrawal by Subject|13|||
155496639|NCT00568776|561242354|FG001|Overall Study|Withdrawal by Subject|15|||
155496640|NCT00568776|561242355|FG002|Overall Study|Withdrawal by Subject|13|||
155496641|NCT00568776|561242356|FG003|Overall Study|Withdrawal by Subject|7|||
155496642|NCT00568776|561242353|FG000|Overall Study|Loss of Caregiver|0|||
155496643|NCT00568776|561242354|FG001|Overall Study|Loss of Caregiver|2|||
155496644|NCT00568776|561242355|FG002|Overall Study|Loss of Caregiver|1|||
155496645|NCT00568776|561242356|FG003|Overall Study|Loss of Caregiver|2|||
155496646|NCT00568776|561242353|FG000|Overall Study|Sponsor Decision|2|||
155496647|NCT00568776|561242354|FG001|Overall Study|Sponsor Decision|2|||
155496648|NCT00568776|561242355|FG002|Overall Study|Sponsor Decision|41|||
155496649|NCT00568776|561242356|FG003|Overall Study|Sponsor Decision|42|||
155296636|NCT05758415|560516473|FG000|Overall Study|Lost to Follow-up|0|||
155296637|NCT05758415|560516474|FG001|Overall Study|Lost to Follow-up|1|||
155296638|NCT03622593|560516475|FG000|Overall Study|Withdrawal by Subject|11|||
155296639|NCT03622593|560516476|FG001|Overall Study|Withdrawal by Subject|9|||
155296640|NCT03622593|560516477|FG002|Overall Study|Withdrawal by Subject|13|||
155496650|NCT00568776|561242353|FG000|Overall Study|Miscellaeneous|3|||
155496651|NCT00568776|561242354|FG001|Overall Study|Miscellaeneous|3|||
155296641|NCT03622593|560516475|FG000|Overall Study|Death|12|||
155296642|NCT03622593|560516476|FG001|Overall Study|Death|9|||
155296643|NCT03622593|560516477|FG002|Overall Study|Death|10|||
155296644|NCT03622593|560516475|FG000|Overall Study|Lost to Follow-up|11|||
155296645|NCT03622593|560516476|FG001|Overall Study|Lost to Follow-up|5|||
155296646|NCT03622593|560516477|FG002|Overall Study|Lost to Follow-up|8|||
155296647|NCT03622593|560516475|FG000|Overall Study|Adverse Event|4|||
155296648|NCT03622593|560516476|FG001|Overall Study|Adverse Event|5|||
155296649|NCT03622593|560516477|FG002|Overall Study|Adverse Event|6|||
155296650|NCT03622593|560516475|FG000|Overall Study|Physician Decision|2|||
155296651|NCT03622593|560516476|FG001|Overall Study|Physician Decision|1|||
155296652|NCT03622593|560516477|FG002|Overall Study|Physician Decision|6|||
155296653|NCT03622593|560516475|FG000|Overall Study|Other|2|||
155296654|NCT03622593|560516476|FG001|Overall Study|Other|2|||
155296655|NCT03622593|560516477|FG002|Overall Study|Other|3|||
155296656|NCT03622593|560516475|FG000|Overall Study|Protocol Violation|0|||
155296657|NCT03622593|560516476|FG001|Overall Study|Protocol Violation|0|||
155296658|NCT03622593|560516477|FG002|Overall Study|Protocol Violation|1|||
155296659|NCT03622593|560516475|FG000|Overall Study|Pregnancy|0|||
155296660|NCT03622593|560516476|FG001|Overall Study|Pregnancy|0|||
155296661|NCT03622593|560516477|FG002|Overall Study|Pregnancy|1|||
155296662|NCT01134562|560516480|FG000|Overall Study|Adverse Event|0|||
155296663|NCT01134562|560516481|FG001|Overall Study|Adverse Event|1|||
155296664|NCT01134562|560516482|FG002|Overall Study|Adverse Event|0|||
155296665|NCT01134562|560516483|FG003|Overall Study|Adverse Event|0|||
155296666|NCT01134562|560516484|FG004|Overall Study|Adverse Event|0|||
155296667|NCT00423098|560516485|FG000|Overall Study|Adverse Event|1|||
155296668|NCT00423098|560516486|FG001|Overall Study|Adverse Event|2|||
155296669|NCT00423098|560516485|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155296670|NCT00423098|560516486|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155296671|NCT00423098|560516485|FG000|Overall Study|Administrative problems|0|||
155296672|NCT00423098|560516486|FG001|Overall Study|Administrative problems|1|||
155296673|NCT00423098|560516485|FG000|Overall Study|Death|2|||
155296674|NCT00423098|560516486|FG001|Overall Study|Death|0|||
155296675|NCT00711958|560516488|FG000|Overall Study|Withdrawal by Subject|6|||
155296676|NCT00711958|560516489|FG001|Overall Study|Withdrawal by Subject|8|||
155296677|NCT00711958|560516488|FG000|Overall Study|Lack of Efficacy|3|||
155296678|NCT00711958|560516489|FG001|Overall Study|Lack of Efficacy|1|||
155296679|NCT00711958|560516488|FG000|Overall Study|Clinical deterioration|1|||
155296680|NCT00711958|560516489|FG001|Overall Study|Clinical deterioration|0|||
155296681|NCT00711958|560516488|FG000|Overall Study|Adverse Event|9|||
155296682|NCT00711958|560516489|FG001|Overall Study|Adverse Event|7|||
155296683|NCT00711958|560516488|FG000|Overall Study|Protocol Violation|1|||
155296684|NCT00711958|560516489|FG001|Overall Study|Protocol Violation|0|||
155296685|NCT00711958|560516488|FG000|Overall Study|Lost to Follow-up|2|||
155296686|NCT00711958|560516489|FG001|Overall Study|Lost to Follow-up|2|||
155296687|NCT00711958|560516488|FG000|Overall Study|Death|10|||
155296688|NCT00711958|560516489|FG001|Overall Study|Death|5|||
155296689|NCT00711958|560516488|FG000|Overall Study|Progression of disease|1|||
155296690|NCT00711958|560516489|FG001|Overall Study|Progression of disease|0|||
155296691|NCT02015546|560516490|FG000|Overall Study|Withdrawal by Subject|1|||
155296692|NCT02015546|560516491|FG001|Overall Study|Withdrawal by Subject|1|||
155296693|NCT02015546|560516492|FG002|Overall Study|Withdrawal by Subject|1|||
155296694|NCT02015546|560516490|FG000|Overall Study|Screem Failure|2|||
155296695|NCT02015546|560516491|FG001|Overall Study|Screem Failure|1|||
155296696|NCT02015546|560516492|FG002|Overall Study|Screem Failure|3|||
155296697|NCT04424641|560516493|FG000|Overall Study|Death|1|||
155296698|NCT04424641|560516494|FG001|Overall Study|Death|2|||
155296699|NCT04424641|560516495|FG002|Overall Study|Death|3|||
155296700|NCT04424641|560516496|FG003|Overall Study|Death|0|||
155640276|NCT01666652|561773282|FG003|Overall Study|Withdrawal by Subject|0|||
155640277|NCT01666652|561773283|FG004|Overall Study|Withdrawal by Subject|1|||
155640278|NCT01666652|561773279|FG000|Overall Study|Moved from study area|1|||
155296701|NCT04424641|560516497|FG004|Overall Study|Death|3|||
155296702|NCT04424641|560516498|FG005|Overall Study|Death|0|||
155640279|NCT01666652|561773280|FG001|Overall Study|Moved from study area|0|||
155640280|NCT01666652|561773281|FG002|Overall Study|Moved from study area|0|||
155296703|NCT04424641|560516499|FG006|Overall Study|Death|1|||
155296704|NCT04424641|560516500|FG007|Overall Study|Death|2|||
155296705|NCT04424641|560516493|FG000|Overall Study|Sponsor decision|0|||
155296706|NCT04424641|560516494|FG001|Overall Study|Sponsor decision|2|||
155296707|NCT04424641|560516495|FG002|Overall Study|Sponsor decision|3|||
155296708|NCT04424641|560516496|FG003|Overall Study|Sponsor decision|7|||
155296709|NCT04424641|560516497|FG004|Overall Study|Sponsor decision|2|||
155296710|NCT04424641|560516498|FG005|Overall Study|Sponsor decision|2|||
155296711|NCT04424641|560516499|FG006|Overall Study|Sponsor decision|3|||
155296712|NCT04424641|560516500|FG007|Overall Study|Sponsor decision|4|||
155296713|NCT04424641|560516493|FG000|Overall Study|Withdrawal by Subject|0|||
155296714|NCT04424641|560516494|FG001|Overall Study|Withdrawal by Subject|0|||
155296715|NCT04424641|560516495|FG002|Overall Study|Withdrawal by Subject|0|||
155296716|NCT04424641|560516496|FG003|Overall Study|Withdrawal by Subject|0|||
155296717|NCT04424641|560516497|FG004|Overall Study|Withdrawal by Subject|1|||
155296718|NCT04424641|560516498|FG005|Overall Study|Withdrawal by Subject|0|||
155296719|NCT04424641|560516499|FG006|Overall Study|Withdrawal by Subject|0|||
155296720|NCT04424641|560516500|FG007|Overall Study|Withdrawal by Subject|0|||
155296721|NCT04424641|560516493|FG000|Overall Study|Other|0|||
155296722|NCT04424641|560516494|FG001|Overall Study|Other|0|||
155296723|NCT04424641|560516495|FG002|Overall Study|Other|1|||
155296724|NCT04424641|560516496|FG003|Overall Study|Other|0|||
155296725|NCT04424641|560516497|FG004|Overall Study|Other|0|||
155296726|NCT04424641|560516498|FG005|Overall Study|Other|0|||
155296727|NCT04424641|560516499|FG006|Overall Study|Other|0|||
155296728|NCT04424641|560516500|FG007|Overall Study|Other|0|||
155296729|NCT05855655|560516503|FG000|Overall Study|Withdrawal by Subject|0|||
155296730|NCT05855655|560516504|FG001|Overall Study|Withdrawal by Subject|1|||
155296731|NCT05855655|560516503|FG000|Overall Study|Lost to Follow-up|4|||
155296732|NCT05855655|560516504|FG001|Overall Study|Lost to Follow-up|0|||
155296733|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Adverse Event|5|||
155296734|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Adverse Event|0|||
155296735|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Adverse Event|0|||
155496652|NCT00568776|561242355|FG002|Overall Study|Miscellaeneous|1|||
155496653|NCT00568776|561242356|FG003|Overall Study|Miscellaeneous|4|||
155496654|NCT04484805|561242359|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
155496655|NCT04484805|561242360|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
155496656|NCT04484805|561242359|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
155496657|NCT04484805|561242360|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
155296736|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
155296737|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
155296738|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
155296739|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
155296740|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
155296741|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
155296742|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
155296743|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
155296744|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
155296745|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Pregnancy|1|||
155296746|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Pregnancy|0|||
155296747|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Pregnancy|0|||
155296748|NCT01426269|560516505|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
155296749|NCT01426269|560516506|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
155296750|NCT01426269|560516507|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
155296751|NCT01426269|560516505|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
155296752|NCT01426269|560516506|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
155296753|NCT01426269|560516507|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
155296754|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Adverse Event|0|||
155296755|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Adverse Event|1|||
155296756|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Adverse Event|2|||
155296757|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
155296758|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
155296759|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
155496658|NCT00539006|561242361|FG000|Pre-treatment|Other|0|||
155496659|NCT00539006|561242362|FG001|Pre-treatment|Other|1|||
155496660|NCT00539006|561242363|FG002|Pre-treatment|Other|0|||
155296760|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
155296761|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
155296762|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
155296763|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
155296764|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
155496661|NCT00539006|561242364|FG003|Pre-treatment|Other|0|||
155296765|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
155296766|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Site closed|0|||
155296767|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Site closed|6|||
155296768|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Site closed|5|||
155296769|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Relapsed|0|||
155296770|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Relapsed|9|||
155496662|NCT00539006|561242361|FG000|Treatment Period 1|Lost to Follow-up|0|||
155496663|NCT00539006|561242362|FG001|Treatment Period 1|Lost to Follow-up|0|||
155496664|NCT00539006|561242363|FG002|Treatment Period 1|Lost to Follow-up|1|||
155496665|NCT00539006|561242364|FG003|Treatment Period 1|Lost to Follow-up|0|||
155496666|NCT00539006|561242361|FG000|Treatment Period 1|Protocol Violation|0|||
155496667|NCT00539006|561242362|FG001|Treatment Period 1|Protocol Violation|0|||
155496668|NCT00539006|561242363|FG002|Treatment Period 1|Protocol Violation|1|||
155496669|NCT00539006|561242364|FG003|Treatment Period 1|Protocol Violation|0|||
155496670|NCT00539006|561242361|FG000|Treatment Period 1|Lack of Efficacy|0|||
155296771|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Relapsed|18|||
155296772|NCT02296424|560516510|FG000|Part 1|New therapy for study indication|0|||
155296773|NCT02296424|560516511|FG001|Part 1|New therapy for study indication|1|||
155296774|NCT02296424|560516512|FG002|Part 1|New therapy for study indication|0|||
155296775|NCT02296424|560516513|FG003|Part 1|New therapy for study indication|0|||
155296776|NCT02296424|560516510|FG000|Part 1|Protocol Violation|0|||
155296777|NCT02296424|560516511|FG001|Part 1|Protocol Violation|1|||
155296778|NCT02296424|560516512|FG002|Part 1|Protocol Violation|0|||
155296779|NCT02296424|560516513|FG003|Part 1|Protocol Violation|0|||
155296780|NCT02296424|560516510|FG000|Part 1|Withdrawal by Subject|0|||
155296781|NCT02296424|560516511|FG001|Part 1|Withdrawal by Subject|2|||
155296782|NCT02296424|560516512|FG002|Part 1|Withdrawal by Subject|0|||
155296783|NCT02296424|560516513|FG003|Part 1|Withdrawal by Subject|0|||
155296784|NCT02296424|560516510|FG000|Part 1|Study terminated by sponsor|0|||
155296785|NCT02296424|560516511|FG001|Part 1|Study terminated by sponsor|1|||
155296786|NCT02296424|560516512|FG002|Part 1|Study terminated by sponsor|0|||
155296787|NCT02296424|560516513|FG003|Part 1|Study terminated by sponsor|0|||
155296788|NCT02296424|560516510|FG000|Part 1|Adverse Event|2|||
155296789|NCT02296424|560516511|FG001|Part 1|Adverse Event|11|||
155296790|NCT02296424|560516512|FG002|Part 1|Adverse Event|0|||
155296791|NCT02296424|560516513|FG003|Part 1|Adverse Event|0|||
155296792|NCT02296424|560516510|FG000|Part 1|Lack of Efficacy|5|||
155296793|NCT02296424|560516511|FG001|Part 1|Lack of Efficacy|17|||
155296794|NCT02296424|560516512|FG002|Part 1|Lack of Efficacy|0|||
155296795|NCT02296424|560516513|FG003|Part 1|Lack of Efficacy|0|||
155296796|NCT02296424|560516510|FG000|Part 1|16 directly started part II|16|||
155296797|NCT02296424|560516511|FG001|Part 1|16 directly started part II|0|||
155296798|NCT02296424|560516512|FG002|Part 1|16 directly started part II|0|||
155296799|NCT02296424|560516513|FG003|Part 1|16 directly started part II|0|||
155296800|NCT02296424|560516510|FG000|Part 2|Lack of Efficacy|0|||
155296801|NCT02296424|560516511|FG001|Part 2|Lack of Efficacy|0|||
155296802|NCT02296424|560516512|FG002|Part 2|Lack of Efficacy|1|||
155296803|NCT02296424|560516513|FG003|Part 2|Lack of Efficacy|0|||
155296804|NCT02296424|560516510|FG000|Part 2|Adverse Event|0|||
155296805|NCT02296424|560516511|FG001|Part 2|Adverse Event|0|||
155296806|NCT02296424|560516512|FG002|Part 2|Adverse Event|1|||
155410748|NCT00605085|560937472|FG001|Overall Study|Lost to Follow-up|5|||
155640281|NCT01666652|561773282|FG003|Overall Study|Moved from study area|2|||
155640282|NCT01666652|561773283|FG004|Overall Study|Moved from study area|0|||
155640283|NCT01666652|561773279|FG000|Overall Study|Lost to Follow-up|1|||
155640284|NCT01666652|561773280|FG001|Overall Study|Lost to Follow-up|1|||
155640285|NCT01666652|561773281|FG002|Overall Study|Lost to Follow-up|1|||
155640286|NCT01666652|561773282|FG003|Overall Study|Lost to Follow-up|1|||
155640287|NCT01666652|561773283|FG004|Overall Study|Lost to Follow-up|0|||
155640288|NCT01018979|561773284|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
155640289|NCT01018979|561773285|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
155296807|NCT02296424|560516513|FG003|Part 2|Adverse Event|0|||
155296808|NCT02296424|560516510|FG000|Part 2|Lost to Follow-up|0|||
155640290|NCT01018979|561773284|FG000|Overall Study|Not received at least one dose|0|||
155640291|NCT01018979|561773285|FG001|Overall Study|Not received at least one dose|1|||
155640292|NCT03506477|561773291|FG000|Overall Study|Withdrawal by Subject|1|||
155640293|NCT03506477|561773292|FG001|Overall Study|Withdrawal by Subject|0|||
155640294|NCT03462680|561773293|FG000|Overall Study|Withdrawal by Subject|3|||
155640295|NCT03462680|561773294|FG001|Overall Study|Withdrawal by Subject|5|||
155640296|NCT01757847|561773295|FG000|Overall Study|Withdrawal by Subject|3|||
155640297|NCT01757847|561773296|FG001|Overall Study|Withdrawal by Subject|4|||
155640298|NCT02516241|561773297|FG000|Overall Study|Death|255|||
155640299|NCT02516241|561773298|FG001|Overall Study|Death|262|||
155640300|NCT02516241|561773299|FG002|Overall Study|Death|270|||
155640301|NCT02516241|561773297|FG000|Overall Study|Lost to Follow-up|1|||
155640302|NCT02516241|561773298|FG001|Overall Study|Lost to Follow-up|1|||
155640303|NCT02516241|561773299|FG002|Overall Study|Lost to Follow-up|3|||
155640304|NCT02516241|561773297|FG000|Overall Study|Withdrawal by Subject|2|||
155640305|NCT02516241|561773298|FG001|Overall Study|Withdrawal by Subject|7|||
155640306|NCT02516241|561773299|FG002|Overall Study|Withdrawal by Subject|12|||
155296809|NCT02296424|560516511|FG001|Part 2|Lost to Follow-up|0|||
155296810|NCT02296424|560516512|FG002|Part 2|Lost to Follow-up|1|||
155296811|NCT02296424|560516513|FG003|Part 2|Lost to Follow-up|0|||
155296812|NCT00854906|560516514|FG000|Overall Study|One person had no ocular history|1|||
155296813|NCT00814346|560516519|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
155296814|NCT00814346|560516520|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
155296815|NCT00814346|560516519|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
155296816|NCT00814346|560516520|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
155296817|NCT00814346|560516519|FG000|Open Phase (17 Months)|Adverse Event|5|||
155296818|NCT00814346|560516520|FG001|Open Phase (17 Months)|Adverse Event|0|||
155296819|NCT00814346|560516519|FG000|Open Phase (17 Months)|Consent|2|||
155296820|NCT00814346|560516520|FG001|Open Phase (17 Months)|Consent|0|||
155640307|NCT02516241|561773297|FG000|Overall Study|participants ongoing at data cut-off|84|||
155640308|NCT02516241|561773298|FG001|Overall Study|participants ongoing at data cut-off|76|||
155296821|NCT00814346|560516519|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
155296822|NCT00814346|560516520|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
155296823|NCT00814346|560516519|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
155296824|NCT00814346|560516520|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
155296825|NCT05136443|560516522|FG000|Overall Study|Lost to Follow-up|2|||
155296826|NCT05136443|560516522|FG000|Overall Study|Adverse Event|2|||
155296827|NCT00507689|560516525|FG000|Pre-Randomization Period|Adverse Event|1|||
155296828|NCT00507689|560516526|FG001|Pre-Randomization Period|Adverse Event|0|||
155296829|NCT00507689|560516525|FG000|Pre-Randomization Period|Physician Decision|1|||
155296830|NCT00507689|560516526|FG001|Pre-Randomization Period|Physician Decision|0|||
155296831|NCT00507689|560516525|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
155296832|NCT00507689|560516526|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
155296833|NCT00507689|560516525|FG000|Randomized Period|Adverse Event|1|||
155296834|NCT00507689|560516526|FG001|Randomized Period|Adverse Event|1|||
155296835|NCT00507689|560516525|FG000|Randomized Period|Withdrawal by Subject|0|||
155296836|NCT00507689|560516526|FG001|Randomized Period|Withdrawal by Subject|1|||
155296837|NCT01145885|560516532|FG000|Overall Study|Progressive Disease|7|||
155296838|NCT05299606|560516533|FG000|Overall Study|Death|1|||
155296839|NCT03946670|560516537|FG000|Overall Study|Progressive Disease|34|||
155296840|NCT03946670|560516538|FG001|Overall Study|Progressive Disease|27|||
155296841|NCT03946670|560516537|FG000|Overall Study|Adverse Event|7|||
155296842|NCT03946670|560516538|FG001|Overall Study|Adverse Event|10|||
155296843|NCT03946670|560516537|FG000|Overall Study|Physician Decision|6|||
155296844|NCT03946670|560516538|FG001|Overall Study|Physician Decision|5|||
155296845|NCT03946670|560516537|FG000|Overall Study|Death|5|||
155296846|NCT03946670|560516538|FG001|Overall Study|Death|8|||
155296847|NCT03946670|560516537|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
155296848|NCT03946670|560516538|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
155296849|NCT03946670|560516537|FG000|Overall Study|Subject Decision|4|||
155296850|NCT03946670|560516538|FG001|Overall Study|Subject Decision|5|||
155296851|NCT03946670|560516537|FG000|Overall Study|Study Terminated By Sponsor|2|||
155296852|NCT03946670|560516538|FG001|Overall Study|Study Terminated By Sponsor|0|||
155296853|NCT03946670|560516537|FG000|Overall Study|New Therapy For Study Indication|1|||
155296854|NCT03946670|560516538|FG001|Overall Study|New Therapy For Study Indication|0|||
155296855|NCT03946670|560516537|FG000|Overall Study|Not Treated|1|||
155296856|NCT03946670|560516538|FG001|Overall Study|Not Treated|1|||
155296857|NCT01135511|560516542|FG000|Overall Study|Adverse Event|0|||
155296858|NCT01135511|560516543|FG001|Overall Study|Adverse Event|1|||
155296859|NCT01135511|560516544|FG002|Overall Study|Adverse Event|2|||
155296860|NCT01135511|560516545|FG003|Overall Study|Adverse Event|0|||
155296861|NCT01135511|560516546|FG004|Overall Study|Adverse Event|0|||
155296862|NCT01135511|560516547|FG005|Overall Study|Adverse Event|1|||
155296863|NCT01135511|560516548|FG006|Overall Study|Adverse Event|0|||
155296864|NCT01135511|560516549|FG007|Overall Study|Adverse Event|1|||
155296865|NCT01135511|560516550|FG008|Overall Study|Adverse Event|0|||
155296866|NCT01135511|560516542|FG000|Overall Study|Lack of Efficacy|0|||
155296867|NCT01135511|560516543|FG001|Overall Study|Lack of Efficacy|1|||
155496671|NCT00539006|561242362|FG001|Treatment Period 1|Lack of Efficacy|0|||
155496672|NCT00539006|561242363|FG002|Treatment Period 1|Lack of Efficacy|0|||
155496673|NCT00539006|561242364|FG003|Treatment Period 1|Lack of Efficacy|1|||
155296868|NCT01135511|560516544|FG002|Overall Study|Lack of Efficacy|1|||
155296869|NCT01135511|560516545|FG003|Overall Study|Lack of Efficacy|2|||
155296870|NCT01135511|560516546|FG004|Overall Study|Lack of Efficacy|0|||
155296871|NCT01135511|560516547|FG005|Overall Study|Lack of Efficacy|0|||
155296872|NCT01135511|560516548|FG006|Overall Study|Lack of Efficacy|0|||
155296873|NCT01135511|560516549|FG007|Overall Study|Lack of Efficacy|0|||
155296874|NCT01135511|560516550|FG008|Overall Study|Lack of Efficacy|0|||
155296875|NCT01135511|560516542|FG000|Overall Study|Protocol Violation|0|||
155296876|NCT01135511|560516543|FG001|Overall Study|Protocol Violation|0|||
155296877|NCT01135511|560516544|FG002|Overall Study|Protocol Violation|3|||
155296878|NCT01135511|560516545|FG003|Overall Study|Protocol Violation|0|||
155296879|NCT01135511|560516546|FG004|Overall Study|Protocol Violation|0|||
155296880|NCT01135511|560516547|FG005|Overall Study|Protocol Violation|0|||
155296881|NCT01135511|560516548|FG006|Overall Study|Protocol Violation|0|||
155296882|NCT01135511|560516549|FG007|Overall Study|Protocol Violation|0|||
155296883|NCT01135511|560516550|FG008|Overall Study|Protocol Violation|0|||
155296884|NCT01135511|560516542|FG000|Overall Study|Pregnancy|0|||
155744982|NCT03148691|562165289|FG000|Overall Study|Other|1|||
155296885|NCT01135511|560516543|FG001|Overall Study|Pregnancy|0|||
155296886|NCT01135511|560516544|FG002|Overall Study|Pregnancy|0|||
155296887|NCT01135511|560516545|FG003|Overall Study|Pregnancy|1|||
155296888|NCT01135511|560516546|FG004|Overall Study|Pregnancy|0|||
155296889|NCT01135511|560516547|FG005|Overall Study|Pregnancy|0|||
155296890|NCT01135511|560516548|FG006|Overall Study|Pregnancy|0|||
155296891|NCT01135511|560516549|FG007|Overall Study|Pregnancy|0|||
155296892|NCT01135511|560516550|FG008|Overall Study|Pregnancy|0|||
155296893|NCT01135511|560516542|FG000|Overall Study|could not visit the clinic|0|||
155296894|NCT01135511|560516543|FG001|Overall Study|could not visit the clinic|1|||
155496674|NCT00539006|561242361|FG000|Washout|Adverse Event|2|||
155296895|NCT01135511|560516544|FG002|Overall Study|could not visit the clinic|2|||
155296896|NCT01135511|560516545|FG003|Overall Study|could not visit the clinic|0|||
155296897|NCT01135511|560516546|FG004|Overall Study|could not visit the clinic|0|||
155296898|NCT01135511|560516547|FG005|Overall Study|could not visit the clinic|0|||
155296899|NCT01135511|560516548|FG006|Overall Study|could not visit the clinic|0|||
155296900|NCT01135511|560516549|FG007|Overall Study|could not visit the clinic|0|||
155296901|NCT01135511|560516550|FG008|Overall Study|could not visit the clinic|0|||
155296902|NCT01135511|560516542|FG000|Overall Study|noncompliance with study drug taken|0|||
155296903|NCT01135511|560516543|FG001|Overall Study|noncompliance with study drug taken|0|||
155296904|NCT01135511|560516544|FG002|Overall Study|noncompliance with study drug taken|0|||
155296905|NCT01135511|560516545|FG003|Overall Study|noncompliance with study drug taken|0|||
155296906|NCT01135511|560516546|FG004|Overall Study|noncompliance with study drug taken|1|||
155296907|NCT01135511|560516547|FG005|Overall Study|noncompliance with study drug taken|0|||
155296908|NCT01135511|560516548|FG006|Overall Study|noncompliance with study drug taken|0|||
155296909|NCT01135511|560516549|FG007|Overall Study|noncompliance with study drug taken|0|||
155296910|NCT01135511|560516550|FG008|Overall Study|noncompliance with study drug taken|0|||
155296911|NCT01135511|560516542|FG000|Overall Study|Withdrawal by Subject|0|||
155296912|NCT01135511|560516543|FG001|Overall Study|Withdrawal by Subject|0|||
155296913|NCT01135511|560516544|FG002|Overall Study|Withdrawal by Subject|0|||
155296914|NCT01135511|560516545|FG003|Overall Study|Withdrawal by Subject|0|||
155296915|NCT01135511|560516546|FG004|Overall Study|Withdrawal by Subject|0|||
155296916|NCT01135511|560516547|FG005|Overall Study|Withdrawal by Subject|0|||
155296917|NCT01135511|560516548|FG006|Overall Study|Withdrawal by Subject|1|||
155296918|NCT01135511|560516549|FG007|Overall Study|Withdrawal by Subject|0|||
155296919|NCT01135511|560516550|FG008|Overall Study|Withdrawal by Subject|1|||
155296920|NCT02537522|560516555|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
155296921|NCT02537522|560516556|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
155296922|NCT02537522|560516557|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
155296923|NCT02537522|560516558|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
155296924|NCT02537522|560516555|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
155296925|NCT02537522|560516556|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
155296926|NCT02537522|560516557|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
155296927|NCT02537522|560516558|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
155296928|NCT02537522|560516555|FG000|Phase I - Contralateral|incorrect randomization|0|||
155296929|NCT02537522|560516556|FG001|Phase I - Contralateral|incorrect randomization|1|||
155496675|NCT00539006|561242362|FG001|Washout|Adverse Event|1|||
155496676|NCT00539006|561242363|FG002|Washout|Adverse Event|0|||
155496677|NCT00539006|561242364|FG003|Washout|Adverse Event|0|||
155496678|NCT00539006|561242361|FG000|Washout|Protocol Violation|1|||
155496679|NCT00539006|561242362|FG001|Washout|Protocol Violation|1|||
155496680|NCT00539006|561242363|FG002|Washout|Protocol Violation|0|||
155496681|NCT00539006|561242364|FG003|Washout|Protocol Violation|0|||
155496682|NCT00539006|561242361|FG000|Washout|Withdrawal by Subject|0|||
155496683|NCT00539006|561242362|FG001|Washout|Withdrawal by Subject|2|||
155496684|NCT00539006|561242363|FG002|Washout|Withdrawal by Subject|0|||
155496685|NCT00539006|561242364|FG003|Washout|Withdrawal by Subject|0|||
155496686|NCT00539006|561242361|FG000|Washout|Failed to meet continuation criteria|16|||
155496687|NCT00539006|561242362|FG001|Washout|Failed to meet continuation criteria|5|||
155496688|NCT00539006|561242363|FG002|Washout|Failed to meet continuation criteria|14|||
155496689|NCT00539006|561242364|FG003|Washout|Failed to meet continuation criteria|6|||
155496690|NCT00539006|561242361|FG000|Washout|Other|1|||
155496691|NCT00539006|561242362|FG001|Washout|Other|1|||
155496692|NCT00539006|561242363|FG002|Washout|Other|2|||
155496693|NCT00539006|561242364|FG003|Washout|Other|3|||
155496694|NCT00539006|561242361|FG000|Treatment Period 2|Protocol Violation|1|||
155496695|NCT00539006|561242362|FG001|Treatment Period 2|Protocol Violation|0|||
155496696|NCT00539006|561242363|FG002|Treatment Period 2|Protocol Violation|0|||
155496697|NCT00539006|561242364|FG003|Treatment Period 2|Protocol Violation|0|||
155496698|NCT00539006|561242361|FG000|Treatment Period 2|Other|0|||
155296930|NCT02537522|560516557|FG002|Phase I - Contralateral|incorrect randomization|0|||
155496699|NCT00539006|561242362|FG001|Treatment Period 2|Other|1|||
155296931|NCT02537522|560516558|FG003|Phase I - Contralateral|incorrect randomization|0|||
155296932|NCT02537522|560516555|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155296933|NCT02537522|560516556|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
155296934|NCT02537522|560516557|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155496700|NCT00539006|561242363|FG002|Treatment Period 2|Other|0|||
155496701|NCT00539006|561242364|FG003|Treatment Period 2|Other|0|||
155496702|NCT02050373|561242365|FG000|Overall Study|Adverse Event|4|||
155296935|NCT02537522|560516558|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155296936|NCT02537522|560516555|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
155296937|NCT02537522|560516556|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
155496703|NCT02050373|561242366|FG001|Overall Study|Adverse Event|7|||
155496704|NCT02050373|561242365|FG000|Overall Study|Death|3|||
155496705|NCT02050373|561242366|FG001|Overall Study|Death|3|||
155496706|NCT04764669|561242368|FG000|Overall Study|Adverse Event|1|||
155296938|NCT02537522|560516557|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
155296939|NCT02537522|560516558|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
155296940|NCT03920215|560516560|FG000|Overall Study|Lost to Follow-up|1|||
155296941|NCT03920215|560516561|FG001|Overall Study|Lost to Follow-up|2|||
155296942|NCT03920215|560516562|FG002|Overall Study|Lost to Follow-up|0|||
155296943|NCT03920215|560516563|FG003|Overall Study|Lost to Follow-up|0|||
155296944|NCT03920215|560516560|FG000|Overall Study|Death|0|||
155296945|NCT03920215|560516561|FG001|Overall Study|Death|0|||
155296946|NCT03920215|560516562|FG002|Overall Study|Death|0|||
155296947|NCT03920215|560516563|FG003|Overall Study|Death|1|||
155296948|NCT02425111|560516566|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
155296949|NCT02425111|560516566|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
155296950|NCT02425111|560516566|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
155296951|NCT02425111|560516566|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
155296952|NCT02425111|560516566|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
155296953|NCT02425111|560516566|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
155296954|NCT00585533|560516567|FG000|Overall Study|objective or symptomatic progression|9|||
155296955|NCT02798835|560516568|FG000|Overall Study|Protocol Violation|0|||
155296956|NCT02798835|560516569|FG001|Overall Study|Protocol Violation|0|||
155296957|NCT02798835|560516570|FG002|Overall Study|Protocol Violation|3|||
155296958|NCT03024606|560516571|FG000|Overall Study|Withdrawal by Subject|9|||
155296959|NCT03024606|560516572|FG001|Overall Study|Withdrawal by Subject|10|||
155296960|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
155296961|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
155296962|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
155296963|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
155640309|NCT02516241|561773299|FG002|Overall Study|participants ongoing at data cut-off|59|||
155296964|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155296965|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155296966|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155296967|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155296968|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
155640310|NCT01078662|561773302|FG000|Overall Study|Death|41|||
155296969|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
155296970|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296971|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296972|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296973|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296974|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296975|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296976|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296977|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
155296978|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296979|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296980|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296981|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296982|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296983|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296984|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
155296985|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
155296986|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
155640311|NCT01078662|561773303|FG001|Overall Study|Death|103|||
155640312|NCT01078662|561773304|FG002|Overall Study|Death|18|||
155640313|NCT01078662|561773305|FG003|Overall Study|Death|5|||
155640314|NCT01078662|561773306|FG004|Overall Study|Death|8|||
155640315|NCT01078662|561773302|FG000|Overall Study|Patients reached data cut-off|12|||
155640316|NCT01078662|561773303|FG001|Overall Study|Patients reached data cut-off|53|||
155640317|NCT01078662|561773304|FG002|Overall Study|Patients reached data cut-off|2|||
155640318|NCT01078662|561773305|FG003|Overall Study|Patients reached data cut-off|2|||
155296987|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
155296988|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
155296989|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
155296990|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
155496707|NCT04764669|561242369|FG001|Overall Study|Adverse Event|0|||
155296991|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
155296992|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155296993|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
155296994|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296995|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296996|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296997|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296998|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296999|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155297000|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297001|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297002|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297003|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297004|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297005|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
155297006|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
155297007|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
155297008|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297009|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297010|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297011|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
155297012|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297013|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297014|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297015|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
155297016|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297017|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297018|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297019|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297020|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
155297021|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297022|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297023|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
155297024|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297025|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297026|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297027|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297028|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297029|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297030|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297031|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297032|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297033|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297034|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297035|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
155297036|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297037|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
155297038|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297039|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297040|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297041|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297042|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297043|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
155297044|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297045|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
155297046|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
155297047|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
155297048|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297049|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297050|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297051|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297052|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297053|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297054|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
155297055|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
155297056|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297057|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297058|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
155297059|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
155297060|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155496708|NCT04764669|561242370|FG002|Overall Study|Adverse Event|1|||
155496709|NCT04764669|561242371|FG003|Overall Study|Adverse Event|0|||
155496710|NCT04764669|561242368|FG000|Overall Study|Subject Choice|0|||
155496711|NCT04764669|561242369|FG001|Overall Study|Subject Choice|0|||
155496712|NCT04764669|561242370|FG002|Overall Study|Subject Choice|1|||
155496713|NCT04764669|561242371|FG003|Overall Study|Subject Choice|0|||
155496714|NCT04764669|561242368|FG000|Overall Study|Withdrawal by Subject|2|||
155496715|NCT04764669|561242369|FG001|Overall Study|Withdrawal by Subject|0|||
155496716|NCT04764669|561242370|FG002|Overall Study|Withdrawal by Subject|0|||
155496717|NCT04764669|561242371|FG003|Overall Study|Withdrawal by Subject|0|||
155496718|NCT00557830|561242373|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
155496719|NCT00557830|561242374|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
155496720|NCT00557830|561242375|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
155496721|NCT00557830|561242373|FG000|Screening Treatment Phase|Adverse Event|2|||
155496722|NCT00557830|561242374|FG001|Screening Treatment Phase|Adverse Event|0|||
155496723|NCT00557830|561242375|FG002|Screening Treatment Phase|Adverse Event|0|||
155496724|NCT00557830|561242373|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
155496725|NCT00557830|561242374|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
155496726|NCT00557830|561242375|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
155496727|NCT02860039|561242376|FG000|Overall Study|Death|4|||
155496728|NCT02860039|561242377|FG001|Overall Study|Death|0|||
155496729|NCT02860039|561242376|FG000|Overall Study|Lost to Follow-up|2|||
155496730|NCT02860039|561242377|FG001|Overall Study|Lost to Follow-up|2|||
155496731|NCT02860039|561242376|FG000|Overall Study|Protocol Violation|3|||
155496732|NCT02860039|561242377|FG001|Overall Study|Protocol Violation|1|||
155496733|NCT02860039|561242376|FG000|Overall Study|Withdrawal by Subject|1|||
155496734|NCT02860039|561242377|FG001|Overall Study|Withdrawal by Subject|0|||
155496735|NCT02860039|561242376|FG000|Overall Study|Not otherwise eligible|1|||
155496736|NCT02860039|561242377|FG001|Overall Study|Not otherwise eligible|1|||
155496737|NCT03170271|561242378|FG000|Overall Study|Adverse Event|7|||
155496738|NCT03170271|561242379|FG001|Overall Study|Adverse Event|2|||
155496739|NCT03170271|561242378|FG000|Overall Study|Lost to Follow-up|0|||
155496740|NCT03170271|561242379|FG001|Overall Study|Lost to Follow-up|1|||
155496741|NCT03170271|561242378|FG000|Overall Study|Physician Decision|1|||
155496742|NCT03170271|561242379|FG001|Overall Study|Physician Decision|0|||
155496743|NCT03170271|561242378|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
155496744|NCT03170271|561242379|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
155496745|NCT03170271|561242378|FG000|Overall Study|Withdrawal by Subject|17|||
155496746|NCT03170271|561242379|FG001|Overall Study|Withdrawal by Subject|5|||
155496747|NCT03170271|561242378|FG000|Overall Study|Other|2|||
155496748|NCT03170271|561242379|FG001|Overall Study|Other|2|||
155496749|NCT03170271|561242378|FG000|Overall Study|Randomized in error|4|||
155496750|NCT03170271|561242379|FG001|Overall Study|Randomized in error|0|||
155496751|NCT03466060|561242380|FG000|Period 1|Test Lens Damage|0|||
155496752|NCT03466060|561242381|FG001|Period 1|Test Lens Damage|2|||
155496753|NCT03466060|561242382|FG002|Period 1|Test Lens Damage|0|||
155496754|NCT03466060|561242383|FG003|Period 1|Test Lens Damage|0|||
155496755|NCT03466060|561242384|FG004|Period 1|Test Lens Damage|0|||
155496756|NCT03466060|561242385|FG005|Period 1|Test Lens Damage|0|||
155496757|NCT03466060|561242380|FG000|Period 1|Withdrawal by Subject|0|||
155496758|NCT03466060|561242381|FG001|Period 1|Withdrawal by Subject|0|||
155496759|NCT03466060|561242382|FG002|Period 1|Withdrawal by Subject|2|||
155496760|NCT03466060|561242383|FG003|Period 1|Withdrawal by Subject|0|||
155496761|NCT03466060|561242384|FG004|Period 1|Withdrawal by Subject|0|||
155496762|NCT03466060|561242385|FG005|Period 1|Withdrawal by Subject|0|||
155297061|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297062|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297063|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
155297064|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297065|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297066|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297067|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297068|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297069|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297070|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297071|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
155496763|NCT03466060|561242380|FG000|Period 1|Lost to Follow-up|0|||
155496764|NCT03466060|561242381|FG001|Period 1|Lost to Follow-up|0|||
155496765|NCT03466060|561242382|FG002|Period 1|Lost to Follow-up|0|||
155496766|NCT03466060|561242383|FG003|Period 1|Lost to Follow-up|1|||
155496767|NCT03466060|561242384|FG004|Period 1|Lost to Follow-up|0|||
155496768|NCT03466060|561242385|FG005|Period 1|Lost to Follow-up|0|||
155297072|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155496769|NCT03466060|561242380|FG000|Period 1|Grade 2 Conjunctivitis|0|||
155496770|NCT03466060|561242381|FG001|Period 1|Grade 2 Conjunctivitis|0|||
155496771|NCT03466060|561242382|FG002|Period 1|Grade 2 Conjunctivitis|1|||
155496772|NCT03466060|561242383|FG003|Period 1|Grade 2 Conjunctivitis|0|||
155496773|NCT03466060|561242384|FG004|Period 1|Grade 2 Conjunctivitis|0|||
155297073|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297074|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297075|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297076|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297077|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297078|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297079|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
155297080|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
155297081|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297082|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297083|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297084|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297085|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
155297086|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297087|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297088|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297089|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297090|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
155297091|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297092|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297093|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297094|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297095|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
155297096|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297097|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297098|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297099|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297100|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
155297101|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297102|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297103|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297104|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297105|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
155297106|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297107|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297108|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297109|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297110|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
155297111|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297112|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297113|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297114|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297115|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
155297116|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297117|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297118|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297119|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297120|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
155297121|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297122|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297123|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297124|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297125|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
155297126|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
155297127|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
155297128|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
155297129|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
155297130|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
155297131|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
155297132|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
155297133|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
155640319|NCT01078662|561773306|FG004|Overall Study|Patients reached data cut-off|3|||
155297134|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
155297135|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
155297136|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
155436096|NCT01059812|561024509|FG000|Overall Study|Withdrawal Criteria|9|||
155640320|NCT01078662|561773302|FG000|Overall Study|Withdrawal by Subject|4|||
155640321|NCT01078662|561773303|FG001|Overall Study|Withdrawal by Subject|11|||
155297137|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
155297138|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
155297139|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
155297140|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297141|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
155297142|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297143|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297144|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297145|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
155297146|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297147|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297148|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297149|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
155297150|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297151|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
155297152|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297153|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
155297154|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297155|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
155297156|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
155297157|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
155297158|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
155297159|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
155297160|NCT00102063|560516596|FG000|Overall Study|Lack of Efficacy|5|||
155297161|NCT00102063|560516597|FG001|Overall Study|Lack of Efficacy|1|||
155496774|NCT03466060|561242385|FG005|Period 1|Grade 2 Conjunctivitis|0|||
155496775|NCT03466060|561242380|FG000|Period 2|Lens Handling Difficulties|0|||
155297162|NCT00102063|560516598|FG002|Overall Study|Lack of Efficacy|1|||
155297163|NCT00102063|560516596|FG000|Overall Study|Adverse Event|7|||
155297164|NCT00102063|560516597|FG001|Overall Study|Adverse Event|4|||
155297165|NCT00102063|560516598|FG002|Overall Study|Adverse Event|2|||
155297166|NCT00102063|560516596|FG000|Overall Study|Withdrawal by Subject|4|||
155297167|NCT00102063|560516597|FG001|Overall Study|Withdrawal by Subject|12|||
155297168|NCT00102063|560516598|FG002|Overall Study|Withdrawal by Subject|5|||
155297169|NCT00102063|560516596|FG000|Overall Study|Lost to Follow-up|0|||
155297170|NCT00102063|560516597|FG001|Overall Study|Lost to Follow-up|0|||
155297171|NCT00102063|560516598|FG002|Overall Study|Lost to Follow-up|1|||
155297172|NCT00102063|560516596|FG000|Overall Study|Protocol Violation|0|||
155297173|NCT00102063|560516597|FG001|Overall Study|Protocol Violation|1|||
155297174|NCT00102063|560516598|FG002|Overall Study|Protocol Violation|1|||
155297175|NCT00630786|560516602|FG000|Overall Study|Physician Decision|0|||
155297176|NCT00630786|560516603|FG001|Overall Study|Physician Decision|0|||
155297177|NCT00630786|560516604|FG002|Overall Study|Physician Decision|1|||
155297178|NCT00630786|560516602|FG000|Overall Study|Withdrawal by Subject|0|||
155297179|NCT00630786|560516603|FG001|Overall Study|Withdrawal by Subject|1|||
155297180|NCT00630786|560516604|FG002|Overall Study|Withdrawal by Subject|1|||
155297181|NCT00630786|560516602|FG000|Overall Study|Lost to Follow-up|0|||
155297182|NCT00630786|560516603|FG001|Overall Study|Lost to Follow-up|1|||
155297183|NCT00630786|560516604|FG002|Overall Study|Lost to Follow-up|0|||
155297184|NCT00630786|560516602|FG000|Overall Study|Other|1|||
155297185|NCT00630786|560516603|FG001|Overall Study|Other|0|||
155496776|NCT03466060|561242381|FG001|Period 2|Lens Handling Difficulties|0|||
155496777|NCT03466060|561242382|FG002|Period 2|Lens Handling Difficulties|1|||
155496778|NCT03466060|561242383|FG003|Period 2|Lens Handling Difficulties|0|||
155496779|NCT03466060|561242384|FG004|Period 2|Lens Handling Difficulties|0|||
155496780|NCT03466060|561242385|FG005|Period 2|Lens Handling Difficulties|0|||
155297186|NCT00630786|560516604|FG002|Overall Study|Other|0|||
155297187|NCT02031471|560516605|FG000|24 Week Treatment Period|Adverse Event|6|||
155297188|NCT02031471|560516605|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
155297189|NCT02031471|560516605|FG000|24 Week Treatment Period|Protocol Violation|1|||
155297190|NCT02031471|560516605|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
155297191|NCT02031471|560516605|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
155297192|NCT02031471|560516605|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
155297193|NCT02031471|560516605|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
155297194|NCT03070483|560516606|FG000|Overall Study|Lost to Follow-up|2|||
155297195|NCT06269640|560517736|FG000|Overall Study|Death|1|||
155297196|NCT03723616|560517739|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
155297197|NCT03723616|560517740|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
155297198|NCT03723616|560517741|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
155297199|NCT03723616|560517742|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
155297200|NCT03723616|560517743|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
155496781|NCT01610284|561242386|FG000|Randomization Phase|Adverse Event|1|||
155297201|NCT03723616|560517744|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
155297202|NCT03979365|560517745|FG000|Overall Study|Death|1|||
155297203|NCT03979365|560517746|FG001|Overall Study|Death|3|||
155297204|NCT03979365|560517745|FG000|Overall Study|Withdrawal by Subject|0|||
155297205|NCT03979365|560517746|FG001|Overall Study|Withdrawal by Subject|1|||
155297206|NCT03979365|560517745|FG000|Overall Study|Drug Conversion|0|||
155297207|NCT03979365|560517746|FG001|Overall Study|Drug Conversion|3|||
155297208|NCT06001177|560517749|FG000|Treatment Phase|Adverse Event|1|||
155297209|NCT06001177|560517750|FG001|Treatment Phase|Adverse Event|0|||
155297210|NCT06001177|560517749|FG000|Treatment Phase|Withdrawal by Subject|1|||
155297211|NCT06001177|560517750|FG001|Treatment Phase|Withdrawal by Subject|0|||
155297212|NCT06001177|560517749|FG000|Observation Phase|Adverse Event|1|||
155297213|NCT06001177|560517750|FG001|Observation Phase|Adverse Event|1|||
155297214|NCT06001177|560517749|FG000|Observation Phase|Withdrawal by Subject|0|||
155297215|NCT06001177|560517750|FG001|Observation Phase|Withdrawal by Subject|1|||
155297216|NCT00799396|560517753|FG000|Clopidogrel Treatment|Adverse Event|6|||
155297217|NCT00799396|560517753|FG000|Clopidogrel Treatment|Physician Decision|5|||
155297218|NCT00799396|560517753|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
155297219|NCT00799396|560517753|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
155297220|NCT00799396|560517753|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
155297221|NCT03593876|560517754|FG000|Overall Study|Withdrawal by Subject|1|||
155297222|NCT03593876|560517754|FG000|Overall Study|Discharged home before intervention completion|2|||
155297223|NCT06119113|560517757|FG000|Overall Study|Lost to Follow-up|15|||
155297224|NCT06119113|560517758|FG001|Overall Study|Lost to Follow-up|13|||
155297225|NCT06119113|560517759|FG002|Overall Study|Lost to Follow-up|21|||
155297226|NCT05309668|560517760|FG000|Overall Study|Ongoing at data cut-off|14|||
155297227|NCT05309668|560517761|FG001|Overall Study|Ongoing at data cut-off|17|||
155297228|NCT05309668|560517762|FG002|Overall Study|Ongoing at data cut-off|4|||
155297229|NCT02696707|560517763|FG000|Per Protocol Population|Physician Decision|2|||
155297230|NCT02696707|560517764|FG001|Per Protocol Population|Physician Decision|1|||
155297231|NCT02696707|560517763|FG000|Per Protocol Population|Participant Decision|0|||
155297232|NCT02696707|560517764|FG001|Per Protocol Population|Participant Decision|2|||
155297233|NCT02696707|560517763|FG000|Completed Study as Planned|Reason = LVEF|2|||
155297234|NCT02696707|560517764|FG001|Completed Study as Planned|Reason = LVEF|2|||
155297235|NCT02696707|560517763|FG000|Completed Study as Planned|Protocol Violation|2|||
155297236|NCT02696707|560517764|FG001|Completed Study as Planned|Protocol Violation|6|||
155297237|NCT02696707|560517763|FG000|Completed Study as Planned|Metastatic disease|3|||
155297238|NCT02696707|560517764|FG001|Completed Study as Planned|Metastatic disease|0|||
155297239|NCT02696707|560517763|FG000|Completed Study as Planned|Location|1|||
155297240|NCT02696707|560517764|FG001|Completed Study as Planned|Location|1|||
155297241|NCT00071799|560517765|FG000|Overall Study|Adverse Event|19|||
155297242|NCT00071799|560517766|FG001|Overall Study|Adverse Event|10|||
155297243|NCT00071799|560517765|FG000|Overall Study|Protocol Violation|1|||
155297244|NCT00071799|560517766|FG001|Overall Study|Protocol Violation|7|||
155297245|NCT00071799|560517765|FG000|Overall Study|Lost to Follow-up|1|||
155297246|NCT00071799|560517766|FG001|Overall Study|Lost to Follow-up|1|||
155297247|NCT00071799|560517765|FG000|Overall Study|Withdrawal by Subject|15|||
155297248|NCT00071799|560517766|FG001|Overall Study|Withdrawal by Subject|37|||
155297249|NCT00071799|560517765|FG000|Overall Study|Physician Decision|0|||
155297250|NCT00071799|560517766|FG001|Overall Study|Physician Decision|2|||
155640322|NCT01078662|561773304|FG002|Overall Study|Withdrawal by Subject|1|||
155640323|NCT01078662|561773305|FG003|Overall Study|Withdrawal by Subject|0|||
155640324|NCT01078662|561773306|FG004|Overall Study|Withdrawal by Subject|0|||
155640325|NCT01078662|561773302|FG000|Overall Study|Protocol Violation|0|||
155640326|NCT01078662|561773303|FG001|Overall Study|Protocol Violation|1|||
155640327|NCT01078662|561773304|FG002|Overall Study|Protocol Violation|0|||
155640328|NCT01078662|561773305|FG003|Overall Study|Protocol Violation|0|||
155640329|NCT01078662|561773306|FG004|Overall Study|Protocol Violation|0|||
155640330|NCT01078662|561773302|FG000|Overall Study|Lost to Follow-up|1|||
155297251|NCT00071799|560517765|FG000|Overall Study|Lack of Efficacy|11|||
155297252|NCT00071799|560517766|FG001|Overall Study|Lack of Efficacy|18|||
155297253|NCT00071799|560517765|FG000|Overall Study|Disease Progression|23|||
155297254|NCT00071799|560517766|FG001|Overall Study|Disease Progression|20|||
155297255|NCT00071799|560517765|FG000|Overall Study|Different Central+Local Pathology Review|0|||
155297256|NCT00071799|560517766|FG001|Overall Study|Different Central+Local Pathology Review|1|||
155297257|NCT00071799|560517765|FG000|Overall Study|Not Documented|0|||
155297258|NCT00071799|560517766|FG001|Overall Study|Not Documented|2|||
155297259|NCT05526248|560517767|FG000|Overall Study|Lost to Follow-up|1|||
155640331|NCT01078662|561773303|FG001|Overall Study|Lost to Follow-up|0|||
155640332|NCT01078662|561773304|FG002|Overall Study|Lost to Follow-up|0|||
155640333|NCT01078662|561773305|FG003|Overall Study|Lost to Follow-up|0|||
155297260|NCT05526248|560517767|FG000|Overall Study|Adverse Event|2|||
155297261|NCT05526248|560517767|FG000|Overall Study|Withdrawal by Subject|1|||
155297262|NCT04527549|560517768|FG000|Overall Study|Withdrawal by Subject|1|||
155297263|NCT04527549|560517769|FG001|Overall Study|Withdrawal by Subject|1|||
155297264|NCT05764161|560517770|FG000|12-week DBVC Period|Lack of Efficacy|2|||
155297265|NCT05764161|560517771|FG001|12-week DBVC Period|Lack of Efficacy|1|||
155297266|NCT05764161|560517770|FG000|12-week DBVC Period|Lost to Follow-up|0|||
155297267|NCT05764161|560517771|FG001|12-week DBVC Period|Lost to Follow-up|2|||
155297268|NCT05764161|560517770|FG000|12-week DBVC Period|Protocol Violation|2|||
155297269|NCT05764161|560517771|FG001|12-week DBVC Period|Protocol Violation|4|||
155297270|NCT05764161|560517770|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
155297271|NCT05764161|560517771|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
155297272|NCT05764161|560517770|FG000|40-week OLE Period|Lack of Efficacy|0|||
155297273|NCT05764161|560517771|FG001|40-week OLE Period|Lack of Efficacy|1|||
155297274|NCT05764161|560517770|FG000|40-week OLE Period|Lost to Follow-up|1|||
155297275|NCT05764161|560517771|FG001|40-week OLE Period|Lost to Follow-up|4|||
155297276|NCT05764161|560517770|FG000|40-week OLE Period|Withdrawal by Subject|2|||
155297277|NCT05764161|560517771|FG001|40-week OLE Period|Withdrawal by Subject|7|||
155297278|NCT05764161|560517770|FG000|40-week OLE Period|Extended Travel|0|||
155297279|NCT05764161|560517771|FG001|40-week OLE Period|Extended Travel|1|||
155297280|NCT05764161|560517770|FG000|40-week OLE Period|Ongoing|66|||
155297281|NCT05764161|560517771|FG001|40-week OLE Period|Ongoing|59|||
155297282|NCT03460756|560517780|FG000|Overall Study|Adverse Event|0|||
155297283|NCT03460756|560517781|FG001|Overall Study|Adverse Event|0|||
155297284|NCT03460756|560517782|FG002|Overall Study|Adverse Event|0|||
155297285|NCT03460756|560517783|FG003|Overall Study|Adverse Event|1|||
155297286|NCT03460756|560517780|FG000|Overall Study|Lack of Efficacy|0|||
155297287|NCT03460756|560517781|FG001|Overall Study|Lack of Efficacy|0|||
155297288|NCT03460756|560517782|FG002|Overall Study|Lack of Efficacy|0|||
155297289|NCT03460756|560517783|FG003|Overall Study|Lack of Efficacy|2|||
155297290|NCT03460756|560517780|FG000|Overall Study|Lost to Follow-up|0|||
155297291|NCT03460756|560517781|FG001|Overall Study|Lost to Follow-up|1|||
155297292|NCT03460756|560517782|FG002|Overall Study|Lost to Follow-up|2|||
155297293|NCT03460756|560517783|FG003|Overall Study|Lost to Follow-up|1|||
155297294|NCT03460756|560517780|FG000|Overall Study|Pregnancy|0|||
155297295|NCT03460756|560517781|FG001|Overall Study|Pregnancy|0|||
155297296|NCT03460756|560517782|FG002|Overall Study|Pregnancy|0|||
155297297|NCT03460756|560517783|FG003|Overall Study|Pregnancy|1|||
155297298|NCT03460756|560517780|FG000|Overall Study|Protocol Violation|0|||
155297299|NCT03460756|560517781|FG001|Overall Study|Protocol Violation|0|||
155297300|NCT03460756|560517782|FG002|Overall Study|Protocol Violation|0|||
155297301|NCT03460756|560517783|FG003|Overall Study|Protocol Violation|1|||
155297302|NCT03460756|560517780|FG000|Overall Study|Withdrawal by Subject|0|||
155297303|NCT03460756|560517781|FG001|Overall Study|Withdrawal by Subject|4|||
155297304|NCT03460756|560517782|FG002|Overall Study|Withdrawal by Subject|7|||
155297305|NCT03460756|560517783|FG003|Overall Study|Withdrawal by Subject|3|||
155297306|NCT00723450|560517785|FG000|Open-Label Phase|Adverse Event|26|||
155297307|NCT00723450|560517786|FG001|Open-Label Phase|Adverse Event|0|||
155297308|NCT00723450|560517787|FG002|Open-Label Phase|Adverse Event|0|||
155297309|NCT00723450|560517785|FG000|Open-Label Phase|Lack of Efficacy|18|||
155297310|NCT00723450|560517786|FG001|Open-Label Phase|Lack of Efficacy|0|||
155297311|NCT00723450|560517787|FG002|Open-Label Phase|Lack of Efficacy|0|||
155297312|NCT00723450|560517785|FG000|Open-Label Phase|Protocol Violation|35|||
155297313|NCT00723450|560517786|FG001|Open-Label Phase|Protocol Violation|0|||
155297314|NCT00723450|560517787|FG002|Open-Label Phase|Protocol Violation|0|||
155297315|NCT00723450|560517785|FG000|Open-Label Phase|Lost to Follow-up|7|||
155297316|NCT00723450|560517786|FG001|Open-Label Phase|Lost to Follow-up|0|||
155297317|NCT00723450|560517787|FG002|Open-Label Phase|Lost to Follow-up|0|||
155297318|NCT00723450|560517785|FG000|Open-Label Phase|Physician Decision|2|||
155297319|NCT00723450|560517786|FG001|Open-Label Phase|Physician Decision|0|||
155297320|NCT00723450|560517787|FG002|Open-Label Phase|Physician Decision|0|||
155297321|NCT00723450|560517785|FG000|Open-Label Phase|Withdrawal by Subject|37|||
155297322|NCT00723450|560517786|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155297323|NCT00723450|560517787|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155297324|NCT00723450|560517785|FG000|Randomized Phase|Adverse Event|0|||
155297325|NCT00723450|560517786|FG001|Randomized Phase|Adverse Event|26|||
155297326|NCT00723450|560517787|FG002|Randomized Phase|Adverse Event|17|||
155297327|NCT00723450|560517785|FG000|Randomized Phase|Lack of Efficacy|0|||
155297328|NCT00723450|560517786|FG001|Randomized Phase|Lack of Efficacy|11|||
155297329|NCT00723450|560517787|FG002|Randomized Phase|Lack of Efficacy|11|||
155297330|NCT00723450|560517785|FG000|Randomized Phase|Protocol Violation|0|||
155297331|NCT00723450|560517786|FG001|Randomized Phase|Protocol Violation|9|||
155297332|NCT00723450|560517787|FG002|Randomized Phase|Protocol Violation|13|||
155297333|NCT00723450|560517785|FG000|Randomized Phase|Lost to Follow-up|0|||
155297334|NCT00723450|560517786|FG001|Randomized Phase|Lost to Follow-up|2|||
155297335|NCT00723450|560517787|FG002|Randomized Phase|Lost to Follow-up|3|||
155297336|NCT00723450|560517785|FG000|Randomized Phase|Physician Decision|0|||
155297337|NCT00723450|560517786|FG001|Randomized Phase|Physician Decision|3|||
155297338|NCT00723450|560517787|FG002|Randomized Phase|Physician Decision|1|||
155496782|NCT01610284|561242387|FG001|Randomization Phase|Adverse Event|0|||
155496783|NCT01610284|561242386|FG000|Randomization Phase|Physician Decision|1|||
155496784|NCT01610284|561242387|FG001|Randomization Phase|Physician Decision|1|||
155297339|NCT00723450|560517785|FG000|Randomized Phase|Withdrawal by Subject|0|||
155297340|NCT00723450|560517786|FG001|Randomized Phase|Withdrawal by Subject|14|||
155297341|NCT00723450|560517787|FG002|Randomized Phase|Withdrawal by Subject|22|||
155496785|NCT01610284|561242386|FG000|Randomization Phase|Death|0|||
155496786|NCT01610284|561242387|FG001|Randomization Phase|Death|1|||
155496787|NCT01610284|561242386|FG000|Treatment Phase|Adverse Event|80|||
155496788|NCT01610284|561242387|FG001|Treatment Phase|Adverse Event|12|||
155496789|NCT01610284|561242386|FG000|Treatment Phase|Lost to Follow-up|1|||
155496790|NCT01610284|561242387|FG001|Treatment Phase|Lost to Follow-up|0|||
155496791|NCT01610284|561242386|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
155496792|NCT01610284|561242387|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
155496793|NCT01610284|561242386|FG000|Treatment Phase|Physician Decision|27|||
155496794|NCT01610284|561242387|FG001|Treatment Phase|Physician Decision|24|||
155496795|NCT01610284|561242386|FG000|Treatment Phase|Progressive Disease|377|||
155496796|NCT01610284|561242387|FG001|Treatment Phase|Progressive Disease|486|||
155496797|NCT01610284|561242386|FG000|Treatment Phase|Protocol Deviation|2|||
155496798|NCT01610284|561242387|FG001|Treatment Phase|Protocol Deviation|3|||
155496799|NCT01610284|561242386|FG000|Treatment Phase|Study terminated by Sponsor|18|||
155496800|NCT01610284|561242387|FG001|Treatment Phase|Study terminated by Sponsor|15|||
155496801|NCT01610284|561242386|FG000|Treatment Phase|Subject/Guardian Decision|55|||
155496802|NCT01610284|561242387|FG001|Treatment Phase|Subject/Guardian Decision|23|||
155496803|NCT01610284|561242386|FG000|Treatment Phase|Death|6|||
155496804|NCT01610284|561242387|FG001|Treatment Phase|Death|5|||
155496805|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
155496806|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155496807|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
155496808|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
155496809|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
155496810|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
155496811|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
155496812|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
155496813|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
155496814|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
155496815|NCT01610284|561242386|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
155496816|NCT01610284|561242387|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
155496817|NCT01856257|561242388|FG000|Overall Study|Death|2|||
155496818|NCT01856257|561242389|FG001|Overall Study|Death|0|||
155496819|NCT01856257|561242390|FG002|Overall Study|Death|0|||
155496820|NCT01856257|561242391|FG003|Overall Study|Death|0|||
155496821|NCT01856257|561242388|FG000|Overall Study|Physician Decision|0|||
155496822|NCT01856257|561242389|FG001|Overall Study|Physician Decision|0|||
155496823|NCT01856257|561242390|FG002|Overall Study|Physician Decision|0|||
155496824|NCT01856257|561242391|FG003|Overall Study|Physician Decision|1|||
155496825|NCT01856257|561242388|FG000|Overall Study|Withdrawal by Subject|1|||
155496826|NCT01856257|561242389|FG001|Overall Study|Withdrawal by Subject|1|||
155496827|NCT01856257|561242390|FG002|Overall Study|Withdrawal by Subject|0|||
155496828|NCT01856257|561242391|FG003|Overall Study|Withdrawal by Subject|0|||
155496829|NCT01856257|561242388|FG000|Overall Study|Donor complication|0|||
155496830|NCT01856257|561242389|FG001|Overall Study|Donor complication|0|||
155496831|NCT01856257|561242390|FG002|Overall Study|Donor complication|0|||
155496832|NCT01856257|561242391|FG003|Overall Study|Donor complication|1|||
155496833|NCT05168657|561242392|FG000|Overall Study|Adverse Event|0|||
155496834|NCT05168657|561242393|FG001|Overall Study|Adverse Event|0|||
155496835|NCT05168657|561242394|FG002|Overall Study|Adverse Event|1|||
155496836|NCT05168657|561242395|FG003|Overall Study|Adverse Event|0|||
155496837|NCT05168657|561242396|FG004|Overall Study|Adverse Event|0|||
155496838|NCT05168657|561242397|FG005|Overall Study|Adverse Event|0|||
155297342|NCT02459899|560517788|FG000|Overall Study|Adverse Event|1|||
155297343|NCT02459899|560517789|FG001|Overall Study|Adverse Event|1|||
155496839|NCT05168657|561242398|FG006|Overall Study|Adverse Event|0|||
155496840|NCT05168657|561242399|FG007|Overall Study|Adverse Event|0|||
155297344|NCT02459899|560517790|FG002|Overall Study|Adverse Event|0|||
155496841|NCT04935931|561242400|FG000|Overall Study|Withdrawal by Subject|1|||
155496842|NCT00077766|561242403|FG000|Overall Study|Adverse Event|1|||
155496843|NCT00077766|561242404|FG001|Overall Study|Adverse Event|1|||
155496844|NCT00077766|561242403|FG000|Overall Study|Withdrawal by Subject|4|||
155496845|NCT00077766|561242404|FG001|Overall Study|Withdrawal by Subject|3|||
155496846|NCT00077766|561242403|FG000|Overall Study|Death|12|||
155496847|NCT00077766|561242404|FG001|Overall Study|Death|10|||
155496848|NCT00077766|561242403|FG000|Overall Study|Lost to Follow-up|2|||
155496849|NCT00077766|561242404|FG001|Overall Study|Lost to Follow-up|0|||
155496850|NCT00077766|561242403|FG000|Overall Study|Protocol Violation|1|||
155297345|NCT02459899|560517791|FG003|Overall Study|Adverse Event|0|||
155297346|NCT02459899|560517788|FG000|Overall Study|Lost to Follow-up|1|||
155297347|NCT02459899|560517789|FG001|Overall Study|Lost to Follow-up|2|||
155297348|NCT02459899|560517790|FG002|Overall Study|Lost to Follow-up|0|||
155297349|NCT02459899|560517791|FG003|Overall Study|Lost to Follow-up|1|||
155297350|NCT02459899|560517788|FG000|Overall Study|Non-compliance with the treatment|0|||
155297351|NCT02459899|560517789|FG001|Overall Study|Non-compliance with the treatment|0|||
155297352|NCT02459899|560517790|FG002|Overall Study|Non-compliance with the treatment|0|||
155297353|NCT02459899|560517791|FG003|Overall Study|Non-compliance with the treatment|1|||
155297354|NCT02459899|560517788|FG000|Overall Study|Withdrawal by Subject|1|||
155297355|NCT02459899|560517789|FG001|Overall Study|Withdrawal by Subject|3|||
155297356|NCT02459899|560517790|FG002|Overall Study|Withdrawal by Subject|0|||
155297357|NCT02459899|560517791|FG003|Overall Study|Withdrawal by Subject|0|||
155297358|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
155297359|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
155297360|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
155297361|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
155297362|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
155297363|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
155297364|NCT02739035|560517794|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
155297365|NCT02739035|560517795|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
155297366|NCT04177394|560517805|FG000|Overall Study|Death|16|||
155297367|NCT04177394|560517805|FG000|Overall Study|Withdrawal by Subject|19|||
155297368|NCT04177394|560517805|FG000|Overall Study|Missed visits|61|||
155297369|NCT04177394|560517805|FG000|Overall Study|Expected Visits|15|||
155297370|NCT00843882|560517806|FG000|Step 1|Lack of Efficacy|14|||
155297371|NCT00843882|560517807|FG001|Step 1|Lack of Efficacy|10|||
155297372|NCT00843882|560517808|FG002|Step 1|Lack of Efficacy|21|||
155297373|NCT00843882|560517806|FG000|Step 1|Adverse Event|8|||
155297374|NCT00843882|560517807|FG001|Step 1|Adverse Event|17|||
155297375|NCT00843882|560517808|FG002|Step 1|Adverse Event|20|||
155297376|NCT00843882|560517806|FG000|Step 1|Death|1|||
155297377|NCT00843882|560517807|FG001|Step 1|Death|2|||
155297378|NCT00843882|560517808|FG002|Step 1|Death|4|||
155297379|NCT00843882|560517806|FG000|Step 1|Withdrawal by Subject|6|||
155297380|NCT00843882|560517807|FG001|Step 1|Withdrawal by Subject|12|||
155297381|NCT00843882|560517808|FG002|Step 1|Withdrawal by Subject|9|||
155297382|NCT00843882|560517806|FG000|Step 1|Physician Decision|0|||
155297383|NCT00843882|560517807|FG001|Step 1|Physician Decision|5|||
155297384|NCT00843882|560517808|FG002|Step 1|Physician Decision|1|||
155297385|NCT00843882|560517806|FG000|Step 1|Patient and physician's decision|0|||
155297386|NCT00843882|560517807|FG001|Step 1|Patient and physician's decision|0|||
155297387|NCT00843882|560517808|FG002|Step 1|Patient and physician's decision|1|||
155496851|NCT00077766|561242404|FG001|Overall Study|Protocol Violation|0|||
155496852|NCT00077766|561242403|FG000|Overall Study|Kidney Transplantation|9|||
155496853|NCT00077766|561242404|FG001|Overall Study|Kidney Transplantation|5|||
155496854|NCT00077766|561242403|FG000|Overall Study|Transplantation|5|||
155496855|NCT00077766|561242404|FG001|Overall Study|Transplantation|1|||
155496856|NCT00077766|561242403|FG000|Overall Study|Investigators Discretion|1|||
155496857|NCT00077766|561242404|FG001|Overall Study|Investigators Discretion|0|||
155496858|NCT00077766|561242403|FG000|Overall Study|Participant's decision|1|||
155496859|NCT00077766|561242404|FG001|Overall Study|Participant's decision|0|||
155496860|NCT00077766|561242403|FG000|Overall Study|Dialysis Discontinued|1|||
155496861|NCT00077766|561242404|FG001|Overall Study|Dialysis Discontinued|0|||
155496862|NCT00077766|561242403|FG000|Overall Study|Dialysis|0|||
155496863|NCT00077766|561242404|FG001|Overall Study|Dialysis|1|||
155496864|NCT00077766|561242403|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
155496865|NCT00077766|561242404|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
155496866|NCT00077766|561242403|FG000|Overall Study|Started Nocturnal Dialysis|0|||
155496867|NCT00077766|561242404|FG001|Overall Study|Started Nocturnal Dialysis|1|||
155297388|NCT00843882|560517806|FG000|Step 1|Other complicating disease|1|||
155496868|NCT00077766|561242403|FG000|Overall Study|Stop Dialysis|0|||
155496869|NCT00077766|561242404|FG001|Overall Study|Stop Dialysis|1|||
155496870|NCT00077766|561242403|FG000|Overall Study|Participants Vacation|2|||
155297389|NCT00843882|560517807|FG001|Step 1|Other complicating disease|3|||
155297390|NCT00843882|560517808|FG002|Step 1|Other complicating disease|4|||
155297391|NCT00843882|560517806|FG000|Step 1|Alternative therapy|0|||
155297392|NCT00843882|560517807|FG001|Step 1|Alternative therapy|1|||
155297393|NCT00843882|560517808|FG002|Step 1|Alternative therapy|1|||
155297394|NCT00843882|560517806|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
155297395|NCT00843882|560517807|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
155297396|NCT00843882|560517808|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
155496871|NCT00077766|561242404|FG001|Overall Study|Participants Vacation|1|||
155297397|NCT00843882|560517806|FG000|Step 1|Off treatment reason unknown|0|||
155297398|NCT00843882|560517807|FG001|Step 1|Off treatment reason unknown|1|||
155297399|NCT00843882|560517808|FG002|Step 1|Off treatment reason unknown|4|||
155496872|NCT02057549|561242406|FG000|Overall Study|Lost to Follow-up|1|||
155496873|NCT02057549|561242407|FG001|Overall Study|Lost to Follow-up|0|||
155496874|NCT02057549|561242406|FG000|Overall Study|Physician Decision|1|||
155744983|NCT03148691|562165290|FG001|Overall Study|Other|0|||
155744984|NCT03148691|562165291|FG002|Overall Study|Other|0|||
155744985|NCT03148691|562165289|FG000|Overall Study|Withdrawal by Subject|1|||
155744986|NCT03148691|562165290|FG001|Overall Study|Withdrawal by Subject|0|||
155744987|NCT03148691|562165291|FG002|Overall Study|Withdrawal by Subject|0|||
155744988|NCT00321646|562165298|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
155744989|NCT00321646|562165298|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
155744990|NCT00321646|562165298|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
155744991|NCT00392379|562165302|FG000|Overall Study|Withdrawal by Subject|17|||
155744992|NCT00392379|562165303|FG001|Overall Study|Withdrawal by Subject|28|||
155744993|NCT00392379|562165302|FG000|Overall Study|Lost to Follow-up|4|||
155744994|NCT00392379|562165303|FG001|Overall Study|Lost to Follow-up|9|||
155744995|NCT00392379|562165302|FG000|Overall Study|Adverse Event|1|||
155744996|NCT00392379|562165303|FG001|Overall Study|Adverse Event|1|||
155744997|NCT01700387|562165309|FG000|Overall Study|Withdrawal by Subject|1|||
155744998|NCT01700387|562165310|FG001|Overall Study|Withdrawal by Subject|2|||
155744999|NCT01700387|562165309|FG000|Overall Study|Adverse Event|1|||
155745000|NCT01700387|562165310|FG001|Overall Study|Adverse Event|1|||
155745001|NCT01700387|562165309|FG000|Overall Study|Lost to Follow-up|2|||
155745002|NCT01700387|562165310|FG001|Overall Study|Lost to Follow-up|1|||
155745003|NCT00934843|562165313|FG000|Overall Study|Protocol Violation|0|||
155745004|NCT00934843|562165314|FG001|Overall Study|Protocol Violation|1|||
155745005|NCT01375075|562165322|FG000|Overall Study|Adverse Event|0|||
155745006|NCT01375075|562165323|FG001|Overall Study|Adverse Event|0|||
155745007|NCT01375075|562165324|FG002|Overall Study|Adverse Event|3|||
155745008|NCT01375075|562165325|FG003|Overall Study|Adverse Event|1|||
155745009|NCT01375075|562165326|FG004|Overall Study|Adverse Event|0|||
155745010|NCT01375075|562165327|FG005|Overall Study|Adverse Event|1|||
155745011|NCT01375075|562165322|FG000|Overall Study|Entry Criterion Not Met|1|||
155745012|NCT01375075|562165323|FG001|Overall Study|Entry Criterion Not Met|0|||
155745013|NCT01375075|562165324|FG002|Overall Study|Entry Criterion Not Met|0|||
155745014|NCT01375075|562165325|FG003|Overall Study|Entry Criterion Not Met|0|||
155745015|NCT01375075|562165326|FG004|Overall Study|Entry Criterion Not Met|0|||
155745016|NCT01375075|562165327|FG005|Overall Study|Entry Criterion Not Met|1|||
155745017|NCT01375075|562165322|FG000|Overall Study|Withdrawal by Subject|0|||
155745018|NCT01375075|562165323|FG001|Overall Study|Withdrawal by Subject|1|||
155745019|NCT01375075|562165324|FG002|Overall Study|Withdrawal by Subject|0|||
155745020|NCT01375075|562165325|FG003|Overall Study|Withdrawal by Subject|0|||
155745021|NCT01375075|562165326|FG004|Overall Study|Withdrawal by Subject|0|||
155745022|NCT01375075|562165327|FG005|Overall Study|Withdrawal by Subject|1|||
155745023|NCT01576159|562165328|FG000|Overall Study|Withdrawal by Subject|0|||
155745024|NCT01576159|562165329|FG001|Overall Study|Withdrawal by Subject|1|||
155745025|NCT01576159|562165330|FG002|Overall Study|Withdrawal by Subject|0|||
155745026|NCT01576159|562165331|FG003|Overall Study|Withdrawal by Subject|0|||
155745027|NCT01576159|562165328|FG000|Overall Study|Physician Decision|0|||
155745028|NCT01576159|562165329|FG001|Overall Study|Physician Decision|0|||
155745029|NCT01576159|562165330|FG002|Overall Study|Physician Decision|1|||
155745030|NCT01576159|562165331|FG003|Overall Study|Physician Decision|0|||
155745031|NCT01576159|562165328|FG000|Overall Study|Lost to Follow-up|0|||
155745032|NCT01576159|562165329|FG001|Overall Study|Lost to Follow-up|0|||
155745033|NCT01576159|562165330|FG002|Overall Study|Lost to Follow-up|0|||
155745034|NCT01576159|562165331|FG003|Overall Study|Lost to Follow-up|1|||
155745035|NCT01576159|562165328|FG000|Overall Study|Protocol Violation|1|||
155745036|NCT01576159|562165329|FG001|Overall Study|Protocol Violation|0|||
155745037|NCT01576159|562165330|FG002|Overall Study|Protocol Violation|0|||
155745038|NCT01576159|562165331|FG003|Overall Study|Protocol Violation|0|||
155745039|NCT00311584|562165332|FG000|Overall Study|Death|1|||
155745040|NCT00311584|562165333|FG001|Overall Study|Death|0|||
155745041|NCT00311584|562165332|FG000|Overall Study|Lack of Efficacy|12|||
155745042|NCT00311584|562165333|FG001|Overall Study|Lack of Efficacy|15|||
155745043|NCT00311584|562165332|FG000|Overall Study|Physician Decision|4|||
155745044|NCT00311584|562165333|FG001|Overall Study|Physician Decision|5|||
155745045|NCT00311584|562165332|FG000|Overall Study|Withdrawal by Subject|1|||
155745046|NCT00311584|562165333|FG001|Overall Study|Withdrawal by Subject|1|||
155410749|NCT00605085|560937471|FG000|Overall Study|administrative reasons|18|||
155745047|NCT00311584|562165332|FG000|Overall Study|ineligible|2|||
155745048|NCT00311584|562165333|FG001|Overall Study|ineligible|2|||
155745049|NCT01454778|562165334|FG000|Overall Study|Lost to Follow-up|2|||
155745050|NCT01454778|562165334|FG000|Overall Study|Death|1|||
155745051|NCT01475071|562167418|FG000|Overall Study|Physician Decision|1|||
155745052|NCT01475071|562167418|FG000|Overall Study|Withdrawal by Subject|6|||
155745053|NCT01475071|562167418|FG000|Overall Study|Lost to Follow-up|1|||
155745054|NCT02278471|562167419|FG000|Overall Study|Lost to Follow-up|6|||
155745055|NCT02278471|562167420|FG001|Overall Study|Lost to Follow-up|15|||
155745056|NCT02278471|562167419|FG000|Overall Study|Death|2|||
155745057|NCT02278471|562167420|FG001|Overall Study|Death|2|||
155745058|NCT02278471|562167419|FG000|Overall Study|Withdrawal by Subject|0|||
155745059|NCT02278471|562167420|FG001|Overall Study|Withdrawal by Subject|3|||
155745060|NCT01437995|562167423|FG000|Overall Study|Lost to Follow-up|11|||
155745061|NCT01437995|562167424|FG001|Overall Study|Lost to Follow-up|18|||
155745062|NCT01437995|562167425|FG002|Overall Study|Lost to Follow-up|20|||
155745063|NCT04618770|562167426|FG000|Overall Study|Censored from Analysis|12|||
155745064|NCT04618770|562167426|FG000|Overall Study|Early Termination|25|||
155745065|NCT04456673|562167427|FG000|Overall Study|Adverse Event|7|||
155745066|NCT04456673|562167428|FG001|Overall Study|Adverse Event|14|||
155745067|NCT04456673|562167427|FG000|Overall Study|Poor compliance to protocol|1|||
155745068|NCT04456673|562167428|FG001|Overall Study|Poor compliance to protocol|0|||
155745069|NCT04456673|562167427|FG000|Overall Study|Withdrawal by Subject|31|||
155745070|NCT04456673|562167428|FG001|Overall Study|Withdrawal by Subject|23|||
155745071|NCT04456673|562167427|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
155745072|NCT04456673|562167428|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
155297400|NCT00843882|560517806|FG000|Step 1|Never started treatment|2|||
155297401|NCT00843882|560517807|FG001|Step 1|Never started treatment|0|||
155297402|NCT00843882|560517808|FG002|Step 1|Never started treatment|0|||
155297403|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
155297404|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
155297405|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
155297406|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
155297407|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
155297408|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
155297409|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
155297410|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
155297411|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
155297412|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
155297413|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
155297414|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
155297415|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
155297416|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
155297417|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
155297418|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
155297419|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
155297420|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
155297421|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
155297422|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
155297423|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
155297424|NCT01582269|560517809|FG000|Overall Study|Withdrawal by Subject|1|||
155297425|NCT01582269|560517810|FG001|Overall Study|Withdrawal by Subject|0|||
155745073|NCT04391049|562167429|FG000|Overall Study|Protocol Violation|1|||
155745074|NCT03874429|562167430|FG000|Overall Study|Adverse Event|2|||
155745075|NCT03874429|562167431|FG001|Overall Study|Adverse Event|2|||
155745076|NCT03874429|562167430|FG000|Overall Study|Lack of Efficacy|0|||
155745077|NCT03874429|562167431|FG001|Overall Study|Lack of Efficacy|1|||
155745078|NCT03874429|562167430|FG000|Overall Study|Covid-19 pandemic|4|||
155745079|NCT03874429|562167431|FG001|Overall Study|Covid-19 pandemic|2|||
155745080|NCT03337490|562167432|FG000|Overall Study|Withdrawal by Subject|1|||
155745081|NCT03337490|562167433|FG001|Overall Study|Withdrawal by Subject|0|||
155745082|NCT03337490|562167434|FG002|Overall Study|Withdrawal by Subject|0|||
155745083|NCT03337490|562167432|FG000|Overall Study|Lack of Efficacy|10|||
155745084|NCT03337490|562167433|FG001|Overall Study|Lack of Efficacy|12|||
155745085|NCT03337490|562167434|FG002|Overall Study|Lack of Efficacy|35|||
155745086|NCT03337490|562167432|FG000|Overall Study|Physician Decision|0|||
155745087|NCT03337490|562167433|FG001|Overall Study|Physician Decision|1|||
155745088|NCT03337490|562167434|FG002|Overall Study|Physician Decision|0|||
155745089|NCT03337490|562167432|FG000|Overall Study|Lost to Follow-up|0|||
155745090|NCT03337490|562167433|FG001|Overall Study|Lost to Follow-up|1|||
155745091|NCT03337490|562167434|FG002|Overall Study|Lost to Follow-up|0|||
155745092|NCT01689532|562167435|FG000|Overall Study|Adverse Event|9|||
155745093|NCT01689532|562167436|FG001|Overall Study|Adverse Event|5|||
155745094|NCT01689532|562167435|FG000|Overall Study|Lack of Efficacy|2|||
155745095|NCT01689532|562167436|FG001|Overall Study|Lack of Efficacy|2|||
155745096|NCT01689532|562167435|FG000|Overall Study|Withdrawal by Subject|1|||
155745097|NCT01689532|562167436|FG001|Overall Study|Withdrawal by Subject|2|||
155297426|NCT01582269|560517811|FG002|Overall Study|Withdrawal by Subject|0|||
155297427|NCT06218251|560517812|FG000|Overall Study|Lost to Follow-up|4|||
155297428|NCT05076266|560517813|FG000|Overall Study|Survey not complete - Participant refusal|2|||
155297429|NCT05076266|560517814|FG001|Overall Study|Survey not complete - Participant refusal|0|||
155640334|NCT01078662|561773306|FG004|Overall Study|Lost to Follow-up|0|||
155640335|NCT00325416|561773307|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
155297430|NCT00997386|560517815|FG000|Overall Study|Death|7|||
155640336|NCT00325416|561773308|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
155640337|NCT00325416|561773307|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
155640338|NCT00325416|561773308|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
155640339|NCT00325416|561773307|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
155640340|NCT00325416|561773308|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
155640341|NCT00325416|561773307|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
155640342|NCT00325416|561773308|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
155745098|NCT01689532|562167435|FG000|Overall Study|Physician Decision|2|||
155745099|NCT01689532|562167436|FG001|Overall Study|Physician Decision|0|||
155297431|NCT05797155|560517816|FG000|Overall Study|Lost to Follow-up|33|||
155640343|NCT00325416|561773307|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
155640344|NCT00325416|561773308|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
155640345|NCT00325416|561773307|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
155640346|NCT00325416|561773308|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
155640347|NCT01260948|561773311|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155640348|NCT01260948|561773312|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
155640349|NCT01260948|561773311|FG000|Second Intervention|Emesis|0|||
155745100|NCT01363349|562167437|FG000|Overall Study|Adverse Event|6|||
155745101|NCT01363349|562167438|FG001|Overall Study|Adverse Event|7|||
155745102|NCT01363349|562167437|FG000|Overall Study|Lack of Efficacy|3|||
155745103|NCT01363349|562167438|FG001|Overall Study|Lack of Efficacy|10|||
155745104|NCT01363349|562167437|FG000|Overall Study|Non compliance/Protocol deviations|2|||
155745105|NCT01363349|562167438|FG001|Overall Study|Non compliance/Protocol deviations|2|||
155745106|NCT01363349|562167437|FG000|Overall Study|Withdrawal by Subject|14|||
155297432|NCT05797155|560517817|FG001|Overall Study|Lost to Follow-up|12|||
155297433|NCT00617201|560517818|FG000|Overall Study|Lost to Follow-up|9|||
155297434|NCT00617201|560517819|FG001|Overall Study|Lost to Follow-up|13|||
155297435|NCT01350804|560517820|FG000|Core Study|Withdrawal by Subject|11|||
155297436|NCT01350804|560517821|FG001|Core Study|Withdrawal by Subject|17|||
155297437|NCT01350804|560517822|FG002|Core Study|Withdrawal by Subject|16|||
155297438|NCT01350804|560517823|FG003|Core Study|Withdrawal by Subject|7|||
155297439|NCT01350804|560517820|FG000|Core Study|Study terminated by Sponsor|0|||
155297440|NCT01350804|560517821|FG001|Core Study|Study terminated by Sponsor|0|||
155297441|NCT01350804|560517822|FG002|Core Study|Study terminated by Sponsor|0|||
155297442|NCT01350804|560517823|FG003|Core Study|Study terminated by Sponsor|2|||
155297443|NCT01350804|560517820|FG000|Core Study|Protocol deviation|1|||
155297444|NCT01350804|560517821|FG001|Core Study|Protocol deviation|0|||
155297445|NCT01350804|560517822|FG002|Core Study|Protocol deviation|1|||
155297446|NCT01350804|560517823|FG003|Core Study|Protocol deviation|0|||
155496875|NCT02057549|561242407|FG001|Overall Study|Physician Decision|0|||
155745107|NCT01363349|562167438|FG001|Overall Study|Withdrawal by Subject|6|||
155745108|NCT01363349|562167437|FG000|Overall Study|Lost to Follow-up|5|||
155745109|NCT01363349|562167438|FG001|Overall Study|Lost to Follow-up|6|||
155745110|NCT01363349|562167437|FG000|Overall Study|Not reported|36|||
155745111|NCT01363349|562167438|FG001|Overall Study|Not reported|37|||
155745112|NCT01363349|562167437|FG000|Overall Study|missing|1|||
155745113|NCT01363349|562167438|FG001|Overall Study|missing|2|||
155745114|NCT01958489|562167439|FG000|Period 2|Adverse Event|0|||
155745115|NCT01958489|562167440|FG001|Period 2|Adverse Event|1|||
155745116|NCT00917644|562167441|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
155745117|NCT00917644|562167442|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
155745118|NCT00917644|562167441|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
155745119|NCT00917644|562167442|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
155745120|NCT00917644|562167441|FG000|Period 2: Second Intervention|family emergency|1|||
155745121|NCT00917644|562167442|FG001|Period 2: Second Intervention|family emergency|0|||
155745122|NCT01101308|562167443|FG000|Period 1|Adverse Event|2|||
155745123|NCT01101308|562167444|FG001|Period 1|Adverse Event|1|||
155745124|NCT01101308|562167443|FG000|Period 1|Positive for cotinine|1|||
155745125|NCT01101308|562167444|FG001|Period 1|Positive for cotinine|0|||
155745126|NCT02282345|562167449|FG000|Overall Study|Progression|0|||
155745127|NCT02282345|562167450|FG001|Overall Study|Progression|1|||
155745128|NCT00711516|562167451|FG000|Overall Study|Adverse Event|1|||
155745129|NCT00711516|562167452|FG001|Overall Study|Adverse Event|1|||
155745130|NCT00711516|562167451|FG000|Overall Study|Withdrawal by Subject|0|||
155745131|NCT00711516|562167452|FG001|Overall Study|Withdrawal by Subject|1|||
155745132|NCT00711516|562167451|FG000|Overall Study|Protocol Violation|0|||
155745133|NCT00711516|562167452|FG001|Overall Study|Protocol Violation|1|||
155745134|NCT04575597|562167453|FG000|Overall Study|Death|0|||
155745135|NCT04575597|562167454|FG001|Overall Study|Death|0|||
155745136|NCT04575597|562167455|FG002|Overall Study|Death|0|||
155745137|NCT04575597|562167456|FG003|Overall Study|Death|1|||
155745138|NCT04575597|562167457|FG004|Overall Study|Death|3|||
155745139|NCT04575597|562167458|FG005|Overall Study|Death|14|||
155745140|NCT04575597|562167453|FG000|Overall Study|Lost to Follow-up|2|||
155745141|NCT04575597|562167454|FG001|Overall Study|Lost to Follow-up|1|||
155745142|NCT04575597|562167455|FG002|Overall Study|Lost to Follow-up|1|||
155745143|NCT04575597|562167456|FG003|Overall Study|Lost to Follow-up|2|||
155745144|NCT04575597|562167457|FG004|Overall Study|Lost to Follow-up|10|||
155745145|NCT04575597|562167458|FG005|Overall Study|Lost to Follow-up|8|||
155745146|NCT04575597|562167453|FG000|Overall Study|Withdrawal by Subject|2|||
155745147|NCT04575597|562167454|FG001|Overall Study|Withdrawal by Subject|2|||
155745148|NCT04575597|562167455|FG002|Overall Study|Withdrawal by Subject|4|||
155745149|NCT04575597|562167456|FG003|Overall Study|Withdrawal by Subject|2|||
155745150|NCT04575597|562167457|FG004|Overall Study|Withdrawal by Subject|25|||
155745151|NCT04575597|562167458|FG005|Overall Study|Withdrawal by Subject|28|||
155745152|NCT04575597|562167453|FG000|Overall Study|Not Recorded|0|||
155745153|NCT04575597|562167454|FG001|Overall Study|Not Recorded|0|||
155745154|NCT04575597|562167455|FG002|Overall Study|Not Recorded|0|||
155745155|NCT04575597|562167456|FG003|Overall Study|Not Recorded|0|||
155745156|NCT04575597|562167457|FG004|Overall Study|Not Recorded|0|||
155745157|NCT04575597|562167458|FG005|Overall Study|Not Recorded|2|||
155745158|NCT04575597|562167453|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155745159|NCT04575597|562167454|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155745160|NCT04575597|562167455|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155745161|NCT04575597|562167456|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155745162|NCT04575597|562167457|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
155745163|NCT04575597|562167458|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155745164|NCT02095132|562167461|FG000|Overall Study|Adverse Event|0|||
155745165|NCT02095132|562167462|FG001|Overall Study|Adverse Event|0|||
155745166|NCT02095132|562167463|FG002|Overall Study|Adverse Event|0|||
155745167|NCT02095132|562167464|FG003|Overall Study|Adverse Event|0|||
155745168|NCT02095132|562167465|FG004|Overall Study|Adverse Event|1|||
155745169|NCT02095132|562167466|FG005|Overall Study|Adverse Event|0|||
155745170|NCT02095132|562167467|FG006|Overall Study|Adverse Event|1|||
155745171|NCT02095132|562167468|FG007|Overall Study|Adverse Event|0|||
155745172|NCT02095132|562167469|FG008|Overall Study|Adverse Event|0|||
155745173|NCT02095132|562167461|FG000|Overall Study|Death|0|||
155745174|NCT02095132|562167462|FG001|Overall Study|Death|0|||
155745175|NCT02095132|562167463|FG002|Overall Study|Death|0|||
155745176|NCT02095132|562167464|FG003|Overall Study|Death|0|||
155745177|NCT02095132|562167465|FG004|Overall Study|Death|0|||
155745178|NCT02095132|562167466|FG005|Overall Study|Death|0|||
155745179|NCT02095132|562167467|FG006|Overall Study|Death|1|||
155745180|NCT02095132|562167468|FG007|Overall Study|Death|0|||
155745181|NCT02095132|562167469|FG008|Overall Study|Death|0|||
155745182|NCT02095132|562167461|FG000|Overall Study|Lack of Efficacy|3|||
155745183|NCT02095132|562167462|FG001|Overall Study|Lack of Efficacy|5|||
155745184|NCT02095132|562167463|FG002|Overall Study|Lack of Efficacy|2|||
155745185|NCT02095132|562167464|FG003|Overall Study|Lack of Efficacy|8|||
155745186|NCT02095132|562167465|FG004|Overall Study|Lack of Efficacy|3|||
155745187|NCT02095132|562167466|FG005|Overall Study|Lack of Efficacy|6|||
155745188|NCT02095132|562167467|FG006|Overall Study|Lack of Efficacy|10|||
155745189|NCT02095132|562167468|FG007|Overall Study|Lack of Efficacy|9|||
155745190|NCT02095132|562167469|FG008|Overall Study|Lack of Efficacy|8|||
155745191|NCT02095132|562167461|FG000|Overall Study|Physician Decision|1|||
155745192|NCT02095132|562167462|FG001|Overall Study|Physician Decision|0|||
155745193|NCT02095132|562167463|FG002|Overall Study|Physician Decision|0|||
155745194|NCT02095132|562167464|FG003|Overall Study|Physician Decision|0|||
155745195|NCT02095132|562167465|FG004|Overall Study|Physician Decision|0|||
155640350|NCT01260948|561773312|FG001|Second Intervention|Emesis|1|||
155640351|NCT02830087|561773313|FG000|Overall Study|No study staff to follow-up patients|4|||
155640352|NCT02830087|561773314|FG001|Overall Study|No study staff to follow-up patients|4|||
155640353|NCT02830087|561773315|FG002|Overall Study|No study staff to follow-up patients|4|||
155640354|NCT02830087|561773316|FG003|Overall Study|No study staff to follow-up patients|3|||
155640355|NCT02830087|561773317|FG004|Overall Study|No study staff to follow-up patients|3|||
155640356|NCT02830087|561773318|FG005|Overall Study|No study staff to follow-up patients|3|||
155640357|NCT06455111|561773321|FG000|Overall Study|Withdrawal by Subject|11|||
155640358|NCT06455111|561773322|FG001|Overall Study|Withdrawal by Subject|4|||
155640359|NCT03611946|561773325|FG000|Overall Study|Withdrawal by Subject|0|||
155640360|NCT03611946|561773326|FG001|Overall Study|Withdrawal by Subject|0|||
155640361|NCT03611946|561773327|FG002|Overall Study|Withdrawal by Subject|1|||
155640362|NCT03611946|561773328|FG003|Overall Study|Withdrawal by Subject|0|||
155640363|NCT06717399|561773336|FG000|Overall Study|Death|1|||
155640364|NCT00479232|561774330|FG000|Overall Study|Adverse Event|0|||
155640365|NCT00479232|561774331|FG001|Overall Study|Adverse Event|0|||
155640366|NCT00479232|561774332|FG002|Overall Study|Adverse Event|5|||
155640367|NCT00479232|561774333|FG003|Overall Study|Adverse Event|0|||
155640368|NCT00479232|561774334|FG004|Overall Study|Adverse Event|0|||
155640369|NCT00479232|561774335|FG005|Overall Study|Adverse Event|10|||
155640370|NCT00479232|561774330|FG000|Overall Study|Deviation from Protocol|0|||
155640371|NCT00479232|561774331|FG001|Overall Study|Deviation from Protocol|0|||
155640372|NCT00479232|561774332|FG002|Overall Study|Deviation from Protocol|1|||
155640373|NCT00479232|561774333|FG003|Overall Study|Deviation from Protocol|0|||
155640374|NCT00479232|561774334|FG004|Overall Study|Deviation from Protocol|0|||
155640375|NCT00479232|561774335|FG005|Overall Study|Deviation from Protocol|0|||
155640376|NCT00479232|561774330|FG000|Overall Study|Lack of Efficacy|0|||
155640377|NCT00479232|561774331|FG001|Overall Study|Lack of Efficacy|0|||
155640378|NCT00479232|561774332|FG002|Overall Study|Lack of Efficacy|2|||
155640379|NCT00479232|561774333|FG003|Overall Study|Lack of Efficacy|0|||
155640380|NCT00479232|561774334|FG004|Overall Study|Lack of Efficacy|0|||
155745196|NCT02095132|562167466|FG005|Overall Study|Physician Decision|0|||
155745197|NCT02095132|562167467|FG006|Overall Study|Physician Decision|1|||
155297447|NCT01350804|560517820|FG000|Core Study|Physician Decision|1|||
155640381|NCT00479232|561774335|FG005|Overall Study|Lack of Efficacy|4|||
155640382|NCT00479232|561774330|FG000|Overall Study|Physician Decision|0|||
155640383|NCT00479232|561774331|FG001|Overall Study|Physician Decision|0|||
155640384|NCT00479232|561774332|FG002|Overall Study|Physician Decision|2|||
155745198|NCT02095132|562167468|FG007|Overall Study|Physician Decision|0|||
155745199|NCT02095132|562167469|FG008|Overall Study|Physician Decision|2|||
155745200|NCT02095132|562167461|FG000|Overall Study|Withdrawal by Subject|0|||
155745201|NCT02095132|562167462|FG001|Overall Study|Withdrawal by Subject|0|||
155745202|NCT02095132|562167463|FG002|Overall Study|Withdrawal by Subject|2|||
155745203|NCT02095132|562167464|FG003|Overall Study|Withdrawal by Subject|2|||
155745204|NCT02095132|562167465|FG004|Overall Study|Withdrawal by Subject|3|||
155745205|NCT02095132|562167466|FG005|Overall Study|Withdrawal by Subject|0|||
155745206|NCT02095132|562167467|FG006|Overall Study|Withdrawal by Subject|5|||
155745207|NCT02095132|562167468|FG007|Overall Study|Withdrawal by Subject|0|||
155745208|NCT02095132|562167469|FG008|Overall Study|Withdrawal by Subject|0|||
155745209|NCT01029405|562167470|FG000|Overall Study|Withdrawal by Subject|0|||
155745210|NCT01029405|562167471|FG001|Overall Study|Withdrawal by Subject|1|||
155745211|NCT01029405|562167472|FG002|Overall Study|Withdrawal by Subject|2|||
155745212|NCT01029405|562167473|FG003|Overall Study|Withdrawal by Subject|0|||
155745213|NCT01029405|562167470|FG000|Overall Study|Protocol Violation|0|||
155745214|NCT01029405|562167471|FG001|Overall Study|Protocol Violation|0|||
155745215|NCT01029405|562167472|FG002|Overall Study|Protocol Violation|0|||
155745216|NCT01029405|562167473|FG003|Overall Study|Protocol Violation|1|||
155745217|NCT01029405|562167470|FG000|Overall Study|Adverse Event|0|||
155745218|NCT01029405|562167471|FG001|Overall Study|Adverse Event|0|||
155745219|NCT01029405|562167472|FG002|Overall Study|Adverse Event|1|||
155745220|NCT01029405|562167473|FG003|Overall Study|Adverse Event|1|||
155745221|NCT01029405|562167470|FG000|Overall Study|Lost to Follow-up|2|||
155745222|NCT01029405|562167471|FG001|Overall Study|Lost to Follow-up|1|||
155745223|NCT01029405|562167472|FG002|Overall Study|Lost to Follow-up|1|||
155745224|NCT01029405|562167473|FG003|Overall Study|Lost to Follow-up|2|||
155745225|NCT01029405|562167470|FG000|Overall Study|Other|0|||
155745226|NCT01029405|562167471|FG001|Overall Study|Other|1|||
155745227|NCT01029405|562167472|FG002|Overall Study|Other|0|||
155745228|NCT01029405|562167473|FG003|Overall Study|Other|1|||
155745229|NCT00409175|562167474|FG000|Overall Study|Adverse Event|4|||
155745230|NCT00409175|562167475|FG001|Overall Study|Adverse Event|3|||
155745231|NCT00409175|562167474|FG000|Overall Study|Withdrawal by Subject|1|||
155745232|NCT00409175|562167475|FG001|Overall Study|Withdrawal by Subject|2|||
155745233|NCT00409175|562167474|FG000|Overall Study|Negative genotype|0|||
155745234|NCT00409175|562167475|FG001|Overall Study|Negative genotype|1|||
155745235|NCT00409175|562167474|FG000|Overall Study|Liver transplantation|13|||
155745236|NCT00409175|562167475|FG001|Overall Study|Liver transplantation|13|||
155745237|NCT02108262|562167480|FG000|Overall Study|Non-compliance|0|||
155745238|NCT02108262|562167481|FG001|Overall Study|Non-compliance|2|||
155745239|NCT02108262|562167482|FG002|Overall Study|Non-compliance|1|||
155745240|NCT02108262|562167483|FG003|Overall Study|Non-compliance|1|||
155745241|NCT02108262|562167480|FG000|Overall Study|Randomized by error/screen failure|0|||
155745242|NCT02108262|562167481|FG001|Overall Study|Randomized by error/screen failure|0|||
155745243|NCT02108262|562167482|FG002|Overall Study|Randomized by error/screen failure|1|||
155745244|NCT02108262|562167483|FG003|Overall Study|Randomized by error/screen failure|0|||
155745245|NCT02108262|562167480|FG000|Overall Study|Distance to center|0|||
155745246|NCT02108262|562167481|FG001|Overall Study|Distance to center|1|||
155745247|NCT02108262|562167482|FG002|Overall Study|Distance to center|1|||
155745248|NCT02108262|562167483|FG003|Overall Study|Distance to center|0|||
155745249|NCT02108262|562167480|FG000|Overall Study|Adverse Event|0|||
155745250|NCT02108262|562167481|FG001|Overall Study|Adverse Event|11|||
155745251|NCT02108262|562167482|FG002|Overall Study|Adverse Event|6|||
155745252|NCT02108262|562167483|FG003|Overall Study|Adverse Event|12|||
155745253|NCT02108262|562167480|FG000|Overall Study|Death|0|||
155745254|NCT02108262|562167481|FG001|Overall Study|Death|2|||
155745255|NCT02108262|562167482|FG002|Overall Study|Death|2|||
155745256|NCT02108262|562167483|FG003|Overall Study|Death|1|||
155745257|NCT02108262|562167480|FG000|Overall Study|Lost to Follow-up|0|||
155297448|NCT01350804|560517821|FG001|Core Study|Physician Decision|0|||
155745258|NCT02108262|562167481|FG001|Overall Study|Lost to Follow-up|0|||
155745259|NCT02108262|562167482|FG002|Overall Study|Lost to Follow-up|1|||
155745260|NCT02108262|562167483|FG003|Overall Study|Lost to Follow-up|0|||
155745261|NCT02108262|562167480|FG000|Overall Study|Physician Decision|0|||
155745262|NCT02108262|562167481|FG001|Overall Study|Physician Decision|0|||
155745263|NCT02108262|562167482|FG002|Overall Study|Physician Decision|2|||
155745264|NCT02108262|562167483|FG003|Overall Study|Physician Decision|0|||
155745265|NCT02108262|562167480|FG000|Overall Study|Withdrawal by Subject|0|||
155745266|NCT02108262|562167481|FG001|Overall Study|Withdrawal by Subject|7|||
155297449|NCT01350804|560517822|FG002|Core Study|Physician Decision|1|||
155297450|NCT01350804|560517823|FG003|Core Study|Physician Decision|3|||
155297451|NCT01350804|560517820|FG000|Core Study|Lost to Follow-up|3|||
155297452|NCT01350804|560517821|FG001|Core Study|Lost to Follow-up|0|||
155297453|NCT01350804|560517822|FG002|Core Study|Lost to Follow-up|2|||
155297454|NCT01350804|560517823|FG003|Core Study|Lost to Follow-up|1|||
155297455|NCT01350804|560517820|FG000|Core Study|Lack of Efficacy|16|||
155297456|NCT01350804|560517821|FG001|Core Study|Lack of Efficacy|19|||
155297457|NCT01350804|560517822|FG002|Core Study|Lack of Efficacy|18|||
155297458|NCT01350804|560517823|FG003|Core Study|Lack of Efficacy|5|||
155297459|NCT01350804|560517820|FG000|Core Study|Death|1|||
155297460|NCT01350804|560517821|FG001|Core Study|Death|1|||
155297461|NCT01350804|560517822|FG002|Core Study|Death|1|||
155297462|NCT01350804|560517823|FG003|Core Study|Death|0|||
155297463|NCT01350804|560517820|FG000|Core Study|Adverse Event|8|||
155297464|NCT01350804|560517821|FG001|Core Study|Adverse Event|10|||
155297465|NCT01350804|560517822|FG002|Core Study|Adverse Event|8|||
155297466|NCT01350804|560517823|FG003|Core Study|Adverse Event|8|||
155297467|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
155297468|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
155297469|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
155297470|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
155297471|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
155297472|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
155297473|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
155297474|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
155297475|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
155297476|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
155297477|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
155297478|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
155297479|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297480|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
155297481|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297482|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297483|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
155297484|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
155297485|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
155297486|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
155297487|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
155297488|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
155297489|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
155297490|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
155297491|NCT01307267|560519189|FG000|Overall Study|Death|4|||
155297492|NCT01307267|560519190|FG001|Overall Study|Death|3|||
155297493|NCT01307267|560519191|FG002|Overall Study|Death|5|||
155297494|NCT01307267|560519192|FG003|Overall Study|Death|3|||
155297495|NCT01307267|560519193|FG004|Overall Study|Death|1|||
155297496|NCT01307267|560519194|FG005|Overall Study|Death|26|||
155297497|NCT01307267|560519195|FG006|Overall Study|Death|2|||
155297498|NCT01307267|560519196|FG007|Overall Study|Death|2|||
155297499|NCT01307267|560519197|FG008|Overall Study|Death|21|||
155297500|NCT01307267|560519198|FG009|Overall Study|Death|2|||
155297501|NCT01307267|560519199|FG010|Overall Study|Death|3|||
155297502|NCT01307267|560519200|FG011|Overall Study|Death|9|||
155297503|NCT01307267|560519201|FG012|Overall Study|Death|0|||
155297504|NCT01307267|560519202|FG013|Overall Study|Death|0|||
155297505|NCT01307267|560519203|FG014|Overall Study|Death|0|||
155297506|NCT01307267|560519204|FG015|Overall Study|Death|0|||
155297507|NCT01307267|560519205|FG016|Overall Study|Death|1|||
155297508|NCT01307267|560519206|FG017|Overall Study|Death|1|||
155297509|NCT01307267|560519207|FG018|Overall Study|Death|2|||
155297510|NCT01307267|560519208|FG019|Overall Study|Death|8|||
155297511|NCT01307267|560519209|FG020|Overall Study|Death|1|||
155297512|NCT01307267|560519210|FG021|Overall Study|Death|2|||
155297513|NCT01307267|560519211|FG022|Overall Study|Death|2|||
155297514|NCT01307267|560519189|FG000|Overall Study|Lost to Follow-up|0|||
155297515|NCT01307267|560519190|FG001|Overall Study|Lost to Follow-up|0|||
155297516|NCT01307267|560519191|FG002|Overall Study|Lost to Follow-up|0|||
155297517|NCT01307267|560519192|FG003|Overall Study|Lost to Follow-up|0|||
155297518|NCT01307267|560519193|FG004|Overall Study|Lost to Follow-up|0|||
155297519|NCT01307267|560519194|FG005|Overall Study|Lost to Follow-up|7|||
155297520|NCT01307267|560519195|FG006|Overall Study|Lost to Follow-up|0|||
155297521|NCT01307267|560519196|FG007|Overall Study|Lost to Follow-up|0|||
155297522|NCT01307267|560519197|FG008|Overall Study|Lost to Follow-up|1|||
155297523|NCT01307267|560519198|FG009|Overall Study|Lost to Follow-up|2|||
155297524|NCT01307267|560519199|FG010|Overall Study|Lost to Follow-up|1|||
155297525|NCT01307267|560519200|FG011|Overall Study|Lost to Follow-up|0|||
155297526|NCT01307267|560519201|FG012|Overall Study|Lost to Follow-up|0|||
155297527|NCT01307267|560519202|FG013|Overall Study|Lost to Follow-up|0|||
155297528|NCT01307267|560519203|FG014|Overall Study|Lost to Follow-up|0|||
155297529|NCT01307267|560519204|FG015|Overall Study|Lost to Follow-up|0|||
155297530|NCT01307267|560519205|FG016|Overall Study|Lost to Follow-up|0|||
155297531|NCT01307267|560519206|FG017|Overall Study|Lost to Follow-up|0|||
155297532|NCT01307267|560519207|FG018|Overall Study|Lost to Follow-up|0|||
155297533|NCT01307267|560519208|FG019|Overall Study|Lost to Follow-up|2|||
155297534|NCT01307267|560519209|FG020|Overall Study|Lost to Follow-up|0|||
155297535|NCT01307267|560519210|FG021|Overall Study|Lost to Follow-up|0|||
155297536|NCT01307267|560519211|FG022|Overall Study|Lost to Follow-up|0|||
155297537|NCT01307267|560519189|FG000|Overall Study|Withdrawal by Subject|0|||
155297538|NCT01307267|560519190|FG001|Overall Study|Withdrawal by Subject|0|||
155297539|NCT01307267|560519191|FG002|Overall Study|Withdrawal by Subject|0|||
155297540|NCT01307267|560519192|FG003|Overall Study|Withdrawal by Subject|0|||
155297541|NCT01307267|560519193|FG004|Overall Study|Withdrawal by Subject|0|||
155297542|NCT01307267|560519194|FG005|Overall Study|Withdrawal by Subject|1|||
155297543|NCT01307267|560519195|FG006|Overall Study|Withdrawal by Subject|0|||
155297544|NCT01307267|560519196|FG007|Overall Study|Withdrawal by Subject|1|||
155297545|NCT01307267|560519197|FG008|Overall Study|Withdrawal by Subject|5|||
155297546|NCT01307267|560519198|FG009|Overall Study|Withdrawal by Subject|1|||
155297547|NCT01307267|560519199|FG010|Overall Study|Withdrawal by Subject|1|||
155297548|NCT01307267|560519200|FG011|Overall Study|Withdrawal by Subject|1|||
155297549|NCT01307267|560519201|FG012|Overall Study|Withdrawal by Subject|0|||
155297550|NCT01307267|560519202|FG013|Overall Study|Withdrawal by Subject|0|||
155297551|NCT01307267|560519203|FG014|Overall Study|Withdrawal by Subject|0|||
155297552|NCT01307267|560519204|FG015|Overall Study|Withdrawal by Subject|0|||
155297553|NCT01307267|560519205|FG016|Overall Study|Withdrawal by Subject|0|||
155297554|NCT01307267|560519206|FG017|Overall Study|Withdrawal by Subject|0|||
155297555|NCT01307267|560519207|FG018|Overall Study|Withdrawal by Subject|0|||
155297556|NCT01307267|560519208|FG019|Overall Study|Withdrawal by Subject|3|||
155297557|NCT01307267|560519209|FG020|Overall Study|Withdrawal by Subject|0|||
155297558|NCT01307267|560519210|FG021|Overall Study|Withdrawal by Subject|0|||
155297559|NCT01307267|560519211|FG022|Overall Study|Withdrawal by Subject|0|||
155297560|NCT01307267|560519189|FG000|Overall Study|Other|0|||
155297561|NCT01307267|560519190|FG001|Overall Study|Other|0|||
155297562|NCT01307267|560519191|FG002|Overall Study|Other|0|||
155297563|NCT01307267|560519192|FG003|Overall Study|Other|0|||
155297564|NCT01307267|560519193|FG004|Overall Study|Other|0|||
155297565|NCT01307267|560519194|FG005|Overall Study|Other|7|||
155297566|NCT01307267|560519195|FG006|Overall Study|Other|0|||
155297567|NCT01307267|560519196|FG007|Overall Study|Other|1|||
155297568|NCT01307267|560519197|FG008|Overall Study|Other|3|||
155297569|NCT01307267|560519198|FG009|Overall Study|Other|0|||
155297570|NCT01307267|560519199|FG010|Overall Study|Other|1|||
155297571|NCT01307267|560519200|FG011|Overall Study|Other|1|||
155297572|NCT01307267|560519201|FG012|Overall Study|Other|1|||
155297573|NCT01307267|560519202|FG013|Overall Study|Other|0|||
155297574|NCT01307267|560519203|FG014|Overall Study|Other|2|||
155297575|NCT01307267|560519204|FG015|Overall Study|Other|1|||
155297576|NCT01307267|560519205|FG016|Overall Study|Other|0|||
155297577|NCT01307267|560519206|FG017|Overall Study|Other|0|||
155297578|NCT01307267|560519207|FG018|Overall Study|Other|0|||
155297579|NCT01307267|560519208|FG019|Overall Study|Other|19|||
155297580|NCT01307267|560519209|FG020|Overall Study|Other|2|||
155297581|NCT01307267|560519210|FG021|Overall Study|Other|3|||
155297582|NCT01307267|560519211|FG022|Overall Study|Other|2|||
155297583|NCT04956575|560519212|FG000|Overall Study|Death|1|||
155297584|NCT04956575|560519213|FG001|Overall Study|Death|0|||
155297585|NCT04956575|560519214|FG002|Overall Study|Death|0|||
155297586|NCT04956575|560519215|FG003|Overall Study|Death|0|||
155297587|NCT04956575|560519216|FG004|Overall Study|Death|0|||
155297588|NCT04956575|560519217|FG005|Overall Study|Death|0|||
155297589|NCT04956575|560519218|FG006|Overall Study|Death|0|||
155297590|NCT04956575|560519219|FG007|Overall Study|Death|1|||
155297591|NCT04956575|560519220|FG008|Overall Study|Death|0|||
155297592|NCT04956575|560519221|FG009|Overall Study|Death|1|||
155297593|NCT04956575|560519222|FG010|Overall Study|Death|0|||
155297594|NCT04956575|560519223|FG011|Overall Study|Death|0|||
155297595|NCT04956575|560519212|FG000|Overall Study|Lost to Follow-up|3|||
155297596|NCT04956575|560519213|FG001|Overall Study|Lost to Follow-up|4|||
155297597|NCT04956575|560519214|FG002|Overall Study|Lost to Follow-up|2|||
155297598|NCT04956575|560519215|FG003|Overall Study|Lost to Follow-up|3|||
155297599|NCT04956575|560519216|FG004|Overall Study|Lost to Follow-up|1|||
155297600|NCT04956575|560519217|FG005|Overall Study|Lost to Follow-up|10|||
155297601|NCT04956575|560519218|FG006|Overall Study|Lost to Follow-up|11|||
155297602|NCT04956575|560519219|FG007|Overall Study|Lost to Follow-up|7|||
155297603|NCT04956575|560519220|FG008|Overall Study|Lost to Follow-up|4|||
155297604|NCT04956575|560519221|FG009|Overall Study|Lost to Follow-up|2|||
155297605|NCT04956575|560519222|FG010|Overall Study|Lost to Follow-up|3|||
155297606|NCT04956575|560519223|FG011|Overall Study|Lost to Follow-up|8|||
155297607|NCT04956575|560519212|FG000|Overall Study|Withdrawal by Subject|1|||
155297608|NCT04956575|560519213|FG001|Overall Study|Withdrawal by Subject|2|||
155297609|NCT04956575|560519214|FG002|Overall Study|Withdrawal by Subject|1|||
155297610|NCT04956575|560519215|FG003|Overall Study|Withdrawal by Subject|4|||
155297611|NCT04956575|560519216|FG004|Overall Study|Withdrawal by Subject|2|||
155297612|NCT04956575|560519217|FG005|Overall Study|Withdrawal by Subject|8|||
155297613|NCT04956575|560519218|FG006|Overall Study|Withdrawal by Subject|5|||
155297614|NCT04956575|560519219|FG007|Overall Study|Withdrawal by Subject|1|||
155297615|NCT04956575|560519220|FG008|Overall Study|Withdrawal by Subject|1|||
155297616|NCT04956575|560519221|FG009|Overall Study|Withdrawal by Subject|0|||
155297617|NCT04956575|560519222|FG010|Overall Study|Withdrawal by Subject|3|||
155297618|NCT04956575|560519223|FG011|Overall Study|Withdrawal by Subject|1|||
155297619|NCT01786564|560519224|FG000|Overall Study|Lost to Follow-up|47|||
155297620|NCT01786564|560519224|FG000|Overall Study|Ineligible|17|||
155297621|NCT03034915|560519225|FG000|Overall Study|Adverse Event|29|||
155297622|NCT03034915|560519226|FG001|Overall Study|Adverse Event|32|||
155297623|NCT03034915|560519227|FG002|Overall Study|Adverse Event|22|||
155297624|NCT03034915|560519225|FG000|Overall Study|Lost to Follow-up|5|||
155297625|NCT03034915|560519226|FG001|Overall Study|Lost to Follow-up|13|||
155297626|NCT03034915|560519227|FG002|Overall Study|Lost to Follow-up|3|||
155297627|NCT03034915|560519225|FG000|Overall Study|Withdrawal by Subject|29|||
155297628|NCT03034915|560519226|FG001|Overall Study|Withdrawal by Subject|46|||
155297629|NCT03034915|560519227|FG002|Overall Study|Withdrawal by Subject|41|||
155297630|NCT03034915|560519225|FG000|Overall Study|Protocol Deviation|2|||
155297631|NCT03034915|560519226|FG001|Overall Study|Protocol Deviation|14|||
155297632|NCT03034915|560519227|FG002|Overall Study|Protocol Deviation|7|||
155297633|NCT03034915|560519225|FG000|Overall Study|Lack of Efficacy|8|||
155297634|NCT03034915|560519226|FG001|Overall Study|Lack of Efficacy|16|||
155297635|NCT03034915|560519227|FG002|Overall Study|Lack of Efficacy|18|||
155297636|NCT03034915|560519225|FG000|Overall Study|Site closed|2|||
155297637|NCT03034915|560519226|FG001|Overall Study|Site closed|2|||
155297638|NCT03034915|560519227|FG002|Overall Study|Site closed|4|||
155745267|NCT02108262|562167482|FG002|Overall Study|Withdrawal by Subject|3|||
155745268|NCT02108262|562167483|FG003|Overall Study|Withdrawal by Subject|4|||
155745269|NCT02108262|562167480|FG000|Overall Study|Due to key hepatic values|0|||
155745270|NCT02108262|562167481|FG001|Overall Study|Due to key hepatic values|1|||
155745271|NCT02108262|562167482|FG002|Overall Study|Due to key hepatic values|0|||
155745272|NCT02108262|562167483|FG003|Overall Study|Due to key hepatic values|0|||
155297639|NCT03034915|560519225|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
155297640|NCT03034915|560519226|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
155297641|NCT03034915|560519227|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
155297642|NCT03034915|560519225|FG000|Overall Study|Physician Decision|1|||
155745273|NCT02108262|562167480|FG000|Overall Study|Unable to contact patient|0|||
155297643|NCT03034915|560519226|FG001|Overall Study|Physician Decision|5|||
155297644|NCT03034915|560519227|FG002|Overall Study|Physician Decision|2|||
155297645|NCT03861767|560519230|FG000|Overall Study|Withdrawal by Subject|2|||
155297646|NCT03861767|560519231|FG001|Overall Study|Withdrawal by Subject|1|||
155297647|NCT03861767|560519232|FG002|Overall Study|Withdrawal by Subject|0|||
155297648|NCT03861767|560519233|FG003|Overall Study|Withdrawal by Subject|5|||
155297649|NCT03861767|560519234|FG004|Overall Study|Withdrawal by Subject|2|||
155745274|NCT02108262|562167481|FG001|Overall Study|Unable to contact patient|3|||
155745275|NCT02108262|562167482|FG002|Overall Study|Unable to contact patient|1|||
155745276|NCT02108262|562167483|FG003|Overall Study|Unable to contact patient|2|||
155745277|NCT02108262|562167480|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
155745278|NCT02108262|562167481|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
155745279|NCT02108262|562167482|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
155297650|NCT03861767|560519235|FG005|Overall Study|Withdrawal by Subject|1|||
155297651|NCT03861767|560519236|FG006|Overall Study|Withdrawal by Subject|3|||
155297652|NCT03861767|560519237|FG007|Overall Study|Withdrawal by Subject|1|||
155297653|NCT03861767|560519238|FG008|Overall Study|Withdrawal by Subject|0|||
155297654|NCT03861767|560519239|FG009|Overall Study|Withdrawal by Subject|5|||
155297655|NCT00346333|560519240|FG000|Overall Study|Death|1|||
155297656|NCT00346333|560519241|FG001|Overall Study|Death|0|||
155297657|NCT00346333|560519240|FG000|Overall Study|unwilling or unable to continue|4|||
155297658|NCT00346333|560519241|FG001|Overall Study|unwilling or unable to continue|8|||
155297659|NCT00117286|560519242|FG000|Overall Study|Adverse Event|12|||
155297660|NCT00117286|560519243|FG001|Overall Study|Adverse Event|6|||
155297661|NCT00117286|560519242|FG000|Overall Study|Lost to Follow-up|2|||
155297662|NCT00117286|560519243|FG001|Overall Study|Lost to Follow-up|0|||
155297663|NCT00117286|560519242|FG000|Overall Study|Protocol Violation|3|||
155297664|NCT00117286|560519243|FG001|Overall Study|Protocol Violation|3|||
155297665|NCT00117286|560519242|FG000|Overall Study|Withdrawal by Subject|6|||
155297666|NCT00117286|560519243|FG001|Overall Study|Withdrawal by Subject|2|||
155297667|NCT00117286|560519242|FG000|Overall Study|Physician Decision|3|||
155297668|NCT00117286|560519243|FG001|Overall Study|Physician Decision|7|||
155297669|NCT00117286|560519242|FG000|Overall Study|Lack of Efficacy|2|||
155297670|NCT00117286|560519243|FG001|Overall Study|Lack of Efficacy|1|||
155297671|NCT00117286|560519242|FG000|Overall Study|Research site closing|0|||
155297672|NCT00117286|560519243|FG001|Overall Study|Research site closing|2|||
155297673|NCT00189202|560519244|FG000|Overall Study|Physician Decision|5|||
155297674|NCT04446117|560519247|FG000|Overall Study|No Study Treatment Given|4|||
155297675|NCT04446117|560519248|FG001|Overall Study|No Study Treatment Given|3|||
155297676|NCT04446117|560519247|FG000|Overall Study|Radiographic Disease Progression|132|||
155297677|NCT04446117|560519248|FG001|Overall Study|Radiographic Disease Progression|158|||
155297678|NCT04446117|560519247|FG000|Overall Study|Adverse Event|79|||
155297679|NCT04446117|560519248|FG001|Overall Study|Adverse Event|43|||
155297680|NCT04446117|560519247|FG000|Overall Study|Lack of Clinical Benefit|1|||
155297681|NCT04446117|560519248|FG001|Overall Study|Lack of Clinical Benefit|1|||
155297682|NCT04446117|560519247|FG000|Overall Study|Withdrawal by Subject|24|||
155297683|NCT04446117|560519248|FG001|Overall Study|Withdrawal by Subject|22|||
155297684|NCT04446117|560519247|FG000|Overall Study|Lost to Follow-up|0|||
155297685|NCT04446117|560519248|FG001|Overall Study|Lost to Follow-up|3|||
155297686|NCT04446117|560519247|FG000|Overall Study|Miscellaneous|26|||
155297687|NCT04446117|560519248|FG001|Overall Study|Miscellaneous|36|||
155297688|NCT04446117|560519247|FG000|Overall Study|Missing Data/Data not yet Received|1|||
155297689|NCT04446117|560519248|FG001|Overall Study|Missing Data/Data not yet Received|0|||
155297690|NCT03654768|560519249|FG000|Overall Study|Adverse Event|1|||
155297691|NCT03654768|560519250|FG001|Overall Study|Adverse Event|6|||
155297692|NCT03654768|560519249|FG000|Overall Study|Loss of response|2|||
155297693|NCT03654768|560519250|FG001|Overall Study|Loss of response|2|||
155297694|NCT03654768|560519249|FG000|Overall Study|Non-compliance|0|||
155297695|NCT03654768|560519250|FG001|Overall Study|Non-compliance|1|||
155297696|NCT03654768|560519249|FG000|Overall Study|Refusal not related to toxicity|1|||
155297697|NCT03654768|560519250|FG001|Overall Study|Refusal not related to toxicity|5|||
155297698|NCT03654768|560519249|FG000|Overall Study|Did not receive protocol therapy|1|||
155297699|NCT03654768|560519250|FG001|Overall Study|Did not receive protocol therapy|1|||
155297700|NCT00588770|560519251|FG000|Overall Study|Disease progression|85|||
155297701|NCT00588770|560519252|FG001|Overall Study|Disease progression|68|||
155297702|NCT00588770|560519251|FG000|Overall Study|Adverse Event|29|||
155297703|NCT00588770|560519252|FG001|Overall Study|Adverse Event|58|||
155297704|NCT00588770|560519251|FG000|Overall Study|Death|13|||
155297705|NCT00588770|560519252|FG001|Overall Study|Death|22|||
155297706|NCT00588770|560519251|FG000|Overall Study|Withdrawal by Subject|15|||
155297707|NCT00588770|560519252|FG001|Overall Study|Withdrawal by Subject|25|||
155297708|NCT00588770|560519251|FG000|Overall Study|Alternative therapy|2|||
155640385|NCT00479232|561774333|FG003|Overall Study|Physician Decision|0|||
155640386|NCT00479232|561774334|FG004|Overall Study|Physician Decision|0|||
155640387|NCT00479232|561774335|FG005|Overall Study|Physician Decision|1|||
155640388|NCT00479232|561774330|FG000|Overall Study|Progressive Disease|3|||
155640389|NCT00479232|561774331|FG001|Overall Study|Progressive Disease|1|||
155640390|NCT00479232|561774332|FG002|Overall Study|Progressive Disease|12|||
155640391|NCT00479232|561774333|FG003|Overall Study|Progressive Disease|3|||
155640392|NCT00479232|561774334|FG004|Overall Study|Progressive Disease|3|||
155640393|NCT00479232|561774335|FG005|Overall Study|Progressive Disease|12|||
155640394|NCT00479232|561774330|FG000|Overall Study|Withdrew Consent|0|||
155640395|NCT00479232|561774331|FG001|Overall Study|Withdrew Consent|2|||
155640396|NCT00479232|561774332|FG002|Overall Study|Withdrew Consent|6|||
155640397|NCT00479232|561774333|FG003|Overall Study|Withdrew Consent|0|||
155297709|NCT00588770|560519252|FG001|Overall Study|Alternative therapy|4|||
155297710|NCT00588770|560519251|FG000|Overall Study|Other complicating disease|3|||
155297711|NCT00588770|560519252|FG001|Overall Study|Other complicating disease|2|||
155297712|NCT00588770|560519251|FG000|Overall Study|Not start protocol therapy|0|||
155640398|NCT00479232|561774334|FG004|Overall Study|Withdrew Consent|1|||
155640399|NCT00479232|561774335|FG005|Overall Study|Withdrew Consent|3|||
155297713|NCT00588770|560519252|FG001|Overall Study|Not start protocol therapy|9|||
155297714|NCT00588770|560519251|FG000|Overall Study|Lack of Efficacy|8|||
155297715|NCT00588770|560519252|FG001|Overall Study|Lack of Efficacy|10|||
155297716|NCT00588770|560519251|FG000|Overall Study|Physician discretion|2|||
155297717|NCT00588770|560519252|FG001|Overall Study|Physician discretion|0|||
155297718|NCT00588770|560519251|FG000|Overall Study|Patient non-compliance|2|||
155297719|NCT00588770|560519252|FG001|Overall Study|Patient non-compliance|2|||
155297720|NCT04697628|560519253|FG000|Overall Study|Withdrawal by Subject|17|||
155297721|NCT04697628|560519254|FG001|Overall Study|Withdrawal by Subject|23|||
155297722|NCT04697628|560519253|FG000|Overall Study|Lost to Follow-up|0|||
155297723|NCT04697628|560519254|FG001|Overall Study|Lost to Follow-up|4|||
155297724|NCT04697628|560519253|FG000|Overall Study|On-going in study|122|||
155297725|NCT04697628|560519254|FG001|Overall Study|On-going in study|91|||
155297726|NCT03388632|560519257|FG000|Triplet C|Clinical progression|0|||
155297727|NCT03388632|560519258|FG001|Triplet C|Clinical progression|0|||
155297728|NCT03388632|560519259|FG002|Triplet C|Clinical progression|0|||
155297729|NCT03388632|560519260|FG003|Triplet C|Clinical progression|0|||
155297730|NCT03388632|560519261|FG004|Triplet C|Clinical progression|1|||
155297731|NCT03388632|560519262|FG005|Triplet C|Clinical progression|0|||
155297732|NCT03388632|560519263|FG006|Triplet C|Clinical progression|0|||
155297733|NCT03388632|560519264|FG007|Triplet C|Clinical progression|0|||
155297734|NCT03388632|560519265|FG008|Triplet C|Clinical progression|0|||
155297735|NCT03388632|560519257|FG000|Triplet C|42-day lapse in tx|0|||
155297736|NCT03388632|560519258|FG001|Triplet C|42-day lapse in tx|0|||
155297737|NCT03388632|560519259|FG002|Triplet C|42-day lapse in tx|0|||
155297738|NCT03388632|560519260|FG003|Triplet C|42-day lapse in tx|0|||
155297739|NCT03388632|560519261|FG004|Triplet C|42-day lapse in tx|1|||
155297740|NCT03388632|560519262|FG005|Triplet C|42-day lapse in tx|0|||
155297741|NCT03388632|560519263|FG006|Triplet C|42-day lapse in tx|0|||
155297742|NCT03388632|560519264|FG007|Triplet C|42-day lapse in tx|0|||
155297743|NCT03388632|560519265|FG008|Triplet C|42-day lapse in tx|0|||
155297744|NCT03388632|560519257|FG000|Triplet C|Adverse Event|0|||
155297745|NCT03388632|560519258|FG001|Triplet C|Adverse Event|0|||
155297746|NCT03388632|560519259|FG002|Triplet C|Adverse Event|0|||
155297747|NCT03388632|560519260|FG003|Triplet C|Adverse Event|0|||
155297748|NCT03388632|560519261|FG004|Triplet C|Adverse Event|0|||
155297749|NCT03388632|560519262|FG005|Triplet C|Adverse Event|0|||
155297750|NCT03388632|560519263|FG006|Triplet C|Adverse Event|0|||
155297751|NCT03388632|560519264|FG007|Triplet C|Adverse Event|0|||
155297752|NCT03388632|560519265|FG008|Triplet C|Adverse Event|1|||
155297753|NCT03388632|560519257|FG000|Triplet C|Switched to alternative treatment|0|||
155297754|NCT03388632|560519258|FG001|Triplet C|Switched to alternative treatment|0|||
155297755|NCT03388632|560519259|FG002|Triplet C|Switched to alternative treatment|0|||
155297756|NCT03388632|560519260|FG003|Triplet C|Switched to alternative treatment|0|||
155297757|NCT03388632|560519261|FG004|Triplet C|Switched to alternative treatment|0|||
155297758|NCT03388632|560519262|FG005|Triplet C|Switched to alternative treatment|0|||
155297759|NCT03388632|560519263|FG006|Triplet C|Switched to alternative treatment|0|||
155297760|NCT03388632|560519264|FG007|Triplet C|Switched to alternative treatment|1|||
155297761|NCT03388632|560519265|FG008|Triplet C|Switched to alternative treatment|0|||
155297762|NCT03388632|560519257|FG000|Triplet C|Participant choice|0|||
155297763|NCT03388632|560519258|FG001|Triplet C|Participant choice|0|||
155297764|NCT03388632|560519259|FG002|Triplet C|Participant choice|0|||
155745280|NCT02108262|562167483|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
155745281|NCT02108262|562167480|FG000|Overall Study|Patient did not want another infusion|0|||
155745282|NCT02108262|562167481|FG001|Overall Study|Patient did not want another infusion|3|||
155745283|NCT02108262|562167482|FG002|Overall Study|Patient did not want another infusion|3|||
155745284|NCT02108262|562167483|FG003|Overall Study|Patient did not want another infusion|2|||
155745285|NCT02108262|562167480|FG000|Overall Study|Vacation|0|||
155745286|NCT02108262|562167481|FG001|Overall Study|Vacation|1|||
155297765|NCT03388632|560519260|FG003|Triplet C|Participant choice|0|||
155297766|NCT03388632|560519261|FG004|Triplet C|Participant choice|0|||
155297767|NCT03388632|560519262|FG005|Triplet C|Participant choice|1|||
155297768|NCT03388632|560519263|FG006|Triplet C|Participant choice|0|||
155297769|NCT03388632|560519264|FG007|Triplet C|Participant choice|0|||
155297770|NCT03388632|560519265|FG008|Triplet C|Participant choice|0|||
155297771|NCT04108208|560519266|FG000|Overall Study|Withdrawal by Subject|2|||
155297772|NCT04108208|560519267|FG001|Overall Study|Withdrawal by Subject|6|||
155297773|NCT04108208|560519266|FG000|Overall Study|other-ongoing|20|||
155297774|NCT04108208|560519267|FG001|Overall Study|other-ongoing|40|||
155297775|NCT04108208|560519266|FG000|Overall Study|Death|1|||
155297776|NCT04108208|560519267|FG001|Overall Study|Death|4|||
155297777|NCT04108208|560519266|FG000|Overall Study|Lost to Follow-up|2|||
155297778|NCT04108208|560519267|FG001|Overall Study|Lost to Follow-up|0|||
155297779|NCT02115282|560519268|FG000|Overall Study|Disease progression during treatment|216|||
155297780|NCT02115282|560519269|FG001|Overall Study|Disease progression during treatment|229|||
155297781|NCT02115282|560519268|FG000|Overall Study|Adverse Event|49|||
155297782|NCT02115282|560519269|FG001|Overall Study|Adverse Event|23|||
155745287|NCT02108262|562167482|FG002|Overall Study|Vacation|0|||
155745288|NCT02108262|562167483|FG003|Overall Study|Vacation|0|||
155297783|NCT02115282|560519268|FG000|Overall Study|Death|1|||
155297784|NCT02115282|560519269|FG001|Overall Study|Death|3|||
155297785|NCT02115282|560519268|FG000|Overall Study|Alternative therapy|1|||
155297786|NCT02115282|560519269|FG001|Overall Study|Alternative therapy|1|||
155297787|NCT02115282|560519268|FG000|Overall Study|Complicating disease|0|||
155297788|NCT02115282|560519269|FG001|Overall Study|Complicating disease|3|||
155297789|NCT02115282|560519268|FG000|Overall Study|Withdrawal by Subject|12|||
155297790|NCT02115282|560519269|FG001|Overall Study|Withdrawal by Subject|10|||
155297791|NCT02115282|560519268|FG000|Overall Study|Symptomatic progression/deterioration|7|||
155297792|NCT02115282|560519269|FG001|Overall Study|Symptomatic progression/deterioration|18|||
155297793|NCT02115282|560519268|FG000|Overall Study|Non-compliance|5|||
155297794|NCT02115282|560519269|FG001|Overall Study|Non-compliance|1|||
155297795|NCT02115282|560519268|FG000|Overall Study|Protocol Violation|2|||
155297796|NCT02115282|560519269|FG001|Overall Study|Protocol Violation|2|||
155297797|NCT02115282|560519268|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
155297798|NCT02115282|560519269|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
155297799|NCT02115282|560519268|FG000|Overall Study|Not start protocol therapy|9|||
155297800|NCT02115282|560519269|FG001|Overall Study|Not start protocol therapy|10|||
155297801|NCT04795752|560519271|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
155297802|NCT04795752|560519272|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
155297803|NCT04795752|560519271|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
155297804|NCT04795752|560519272|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
155297805|NCT04795752|560519271|FG000|Primary Endpoint Phase|Physician Decision|2|||
155297806|NCT04795752|560519272|FG001|Primary Endpoint Phase|Physician Decision|0|||
155297807|NCT04795752|560519271|FG000|Primary Endpoint Phase|Other|4|||
155297808|NCT04795752|560519272|FG001|Primary Endpoint Phase|Other|1|||
155297809|NCT04795752|560519271|FG000|Primary Endpoint Phase|Protocol Violation|1|||
155297810|NCT04795752|560519272|FG001|Primary Endpoint Phase|Protocol Violation|0|||
155297811|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
155297812|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
155297813|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
155297814|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
155297815|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
155297816|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
155297817|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
155297818|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
155297819|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
155297820|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
155297821|NCT06129045|560519273|FG000|Overall Study|Lost to Follow-up|1|||
155297822|NCT06129045|560519274|FG001|Overall Study|Lost to Follow-up|1|||
155297823|NCT06129045|560519275|FG002|Overall Study|Lost to Follow-up|4|||
155297824|NCT03492177|560519282|FG000|Overall Study|Adverse Event|1|||
155297825|NCT03492177|560519283|FG001|Overall Study|Adverse Event|0|||
155297826|NCT03492177|560519284|FG002|Overall Study|Adverse Event|0|||
155297827|NCT03492177|560519282|FG000|Overall Study|Death|3|||
155297828|NCT03492177|560519283|FG001|Overall Study|Death|0|||
155297829|NCT03492177|560519284|FG002|Overall Study|Death|3|||
155297830|NCT03492177|560519282|FG000|Overall Study|Lack of Efficacy|1|||
155297831|NCT03492177|560519283|FG001|Overall Study|Lack of Efficacy|2|||
155297832|NCT03492177|560519284|FG002|Overall Study|Lack of Efficacy|0|||
155297833|NCT03492177|560519282|FG000|Overall Study|Other|1|||
155297834|NCT03492177|560519283|FG001|Overall Study|Other|0|||
155297835|NCT03492177|560519284|FG002|Overall Study|Other|0|||
155297836|NCT03492177|560519282|FG000|Overall Study|Ongoing|16|||
155297837|NCT03492177|560519283|FG001|Overall Study|Ongoing|19|||
155297838|NCT03492177|560519284|FG002|Overall Study|Ongoing|17|||
155297839|NCT02320123|560519859|FG000|Overall Study|Lost to Follow-up|4|||
155297840|NCT02320123|560519860|FG001|Overall Study|Lost to Follow-up|6|||
155297841|NCT02320123|560519859|FG000|Overall Study|Death|6|||
155297842|NCT02320123|560519860|FG001|Overall Study|Death|5|||
155297843|NCT01765543|560519865|FG000|Overall Study|Death|1|||
155297844|NCT01765543|560519865|FG000|Overall Study|Withdrawal by Subject|2|||
155297845|NCT03718767|560519866|FG000|Overall Study|Declined to participate (before treatment started)|0|||
155297846|NCT03718767|560519867|FG001|Overall Study|Declined to participate (before treatment started)|0|||
155297847|NCT03718767|560519868|FG002|Overall Study|Declined to participate (before treatment started)|7|||
155297848|NCT03718767|560519866|FG000|Overall Study|Ineligible|0|||
155297849|NCT03718767|560519867|FG001|Overall Study|Ineligible|0|||
155297850|NCT03718767|560519868|FG002|Overall Study|Ineligible|17|||
155297851|NCT01241292|560519869|FG000|Overall Study|Administrative Reason by Sponsor|1|||
155297852|NCT01241292|560519870|FG001|Overall Study|Administrative Reason by Sponsor|0|||
155297853|NCT01241292|560519869|FG000|Overall Study|Disease Progression|2|||
155297854|NCT01241292|560519870|FG001|Overall Study|Disease Progression|0|||
155297855|NCT01241292|560519869|FG000|Overall Study|Study Drug Toxicity|0|||
155297856|NCT01241292|560519870|FG001|Overall Study|Study Drug Toxicity|1|||
155297857|NCT01241292|560519869|FG000|Overall Study|Participant Discontinued Treatment|0|||
155297858|NCT01241292|560519870|FG001|Overall Study|Participant Discontinued Treatment|2|||
155297859|NCT01190007|560519873|FG000|Overall Study|Withdrawal by Subject|4|||
155297860|NCT01190007|560519873|FG000|Overall Study|Adverse Event|8|||
155297861|NCT01190007|560519873|FG000|Overall Study|Difficulty of visit for complications|1|||
155297862|NCT01190007|560519873|FG000|Overall Study|Participant was arrested|1|||
155297863|NCT01254019|560519875|FG000|Overall Study|Adverse Event|0|||
155297864|NCT01254019|560519876|FG001|Overall Study|Adverse Event|2|||
155297865|NCT01254019|560519875|FG000|Overall Study|Protocol Violation|1|||
155297866|NCT01254019|560519876|FG001|Overall Study|Protocol Violation|0|||
155297867|NCT01254019|560519875|FG000|Overall Study|Withdrawal by Subject|0|||
155297868|NCT01254019|560519876|FG001|Overall Study|Withdrawal by Subject|2|||
155297869|NCT00792948|560519879|FG000|Overall Study|Adverse Event|6|||
155297870|NCT00792948|560519879|FG000|Overall Study|Death|4|||
155297871|NCT00792948|560519879|FG000|Overall Study|Withdrawal by Subject|3|||
155745289|NCT02108262|562167480|FG000|Overall Study|Patient decision|0|||
155745290|NCT02108262|562167481|FG001|Overall Study|Patient decision|7|||
155745291|NCT02108262|562167482|FG002|Overall Study|Patient decision|9|||
155745292|NCT02108262|562167483|FG003|Overall Study|Patient decision|14|||
155745293|NCT02108262|562167480|FG000|Overall Study|Missed IV due to pharmacy error|0|||
155745294|NCT02108262|562167481|FG001|Overall Study|Missed IV due to pharmacy error|0|||
155745295|NCT02108262|562167482|FG002|Overall Study|Missed IV due to pharmacy error|1|||
155745296|NCT02108262|562167483|FG003|Overall Study|Missed IV due to pharmacy error|0|||
155745297|NCT01119937|562167484|FG000|Overall Study|Adverse Event|11|||
155745298|NCT01119937|562167485|FG001|Overall Study|Adverse Event|5|||
155745299|NCT01119937|562167484|FG000|Overall Study|Protocol deviation|3|||
155745300|NCT01119937|562167485|FG001|Overall Study|Protocol deviation|1|||
155745301|NCT01119937|562167484|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155745302|NCT01119937|562167485|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155745303|NCT01119937|562167484|FG000|Overall Study|Withdrawal by Subject|2|||
155745304|NCT01119937|562167485|FG001|Overall Study|Withdrawal by Subject|1|||
155745305|NCT03316911|562167486|FG000|Overall Study|Lost to Follow-up|33|||
155745306|NCT03316911|562167487|FG001|Overall Study|Lost to Follow-up|29|||
155745307|NCT01270802|562167488|FG000|Overall Study|Withdrawal by Subject|1|||
155745308|NCT01270802|562167489|FG001|Overall Study|Withdrawal by Subject|0|||
155745309|NCT01270802|562167488|FG000|Overall Study|Adverse Event|1|||
155745310|NCT01270802|562167489|FG001|Overall Study|Adverse Event|0|||
155745311|NCT01270802|562167488|FG000|Overall Study|Lost to Follow-up|0|||
155745312|NCT01270802|562167489|FG001|Overall Study|Lost to Follow-up|1|||
155745313|NCT05027971|562167502|FG000|Overall Study|Physician Decision|7|||
155745314|NCT05027971|562167503|FG001|Overall Study|Physician Decision|3|||
155745315|NCT05027971|562167502|FG000|Overall Study|Lost to Follow-up|1|||
155745316|NCT05027971|562167503|FG001|Overall Study|Lost to Follow-up|1|||
155745317|NCT05027971|562167502|FG000|Overall Study|Withdrawal by Subject|0|||
155745318|NCT05027971|562167503|FG001|Overall Study|Withdrawal by Subject|2|||
155745319|NCT05027971|562167502|FG000|Overall Study|Non-study fiber used.|0|||
155745320|NCT05027971|562167503|FG001|Overall Study|Non-study fiber used.|1|||
155297872|NCT00792948|560519879|FG000|Overall Study|Ineligible|2|||
155297873|NCT00792948|560519879|FG000|Overall Study|Insurance denial - not treated|1|||
155297874|NCT00792948|560519879|FG000|Overall Study|Physician Decision|11|||
155745321|NCT05027971|562167502|FG000|Overall Study|Protocol Violation|0|||
155745322|NCT05027971|562167503|FG001|Overall Study|Protocol Violation|2|||
155745323|NCT02025556|562167504|FG000|Overall Study|Adverse Event|0|||
155745324|NCT02025556|562167505|FG001|Overall Study|Adverse Event|4|||
155745325|NCT02025556|562167506|FG002|Overall Study|Adverse Event|2|||
155745326|NCT02025556|562167504|FG000|Overall Study|Lack of Efficacy|2|||
155745327|NCT02025556|562167505|FG001|Overall Study|Lack of Efficacy|1|||
155745328|NCT02025556|562167506|FG002|Overall Study|Lack of Efficacy|0|||
155745329|NCT02025556|562167504|FG000|Overall Study|Protocol Violation|2|||
155745330|NCT02025556|562167505|FG001|Overall Study|Protocol Violation|1|||
155745331|NCT02025556|562167506|FG002|Overall Study|Protocol Violation|0|||
155745332|NCT02025556|562167504|FG000|Overall Study|Withdrawal by Subject|0|||
155745333|NCT02025556|562167505|FG001|Overall Study|Withdrawal by Subject|3|||
155745334|NCT02025556|562167506|FG002|Overall Study|Withdrawal by Subject|6|||
155745335|NCT02025556|562167504|FG000|Overall Study|Lost to Follow-up|2|||
155745336|NCT02025556|562167505|FG001|Overall Study|Lost to Follow-up|4|||
155745337|NCT02025556|562167506|FG002|Overall Study|Lost to Follow-up|0|||
155745338|NCT02025556|562167504|FG000|Overall Study|Reason not reported|0|||
155745339|NCT02025556|562167505|FG001|Overall Study|Reason not reported|0|||
155745340|NCT02025556|562167506|FG002|Overall Study|Reason not reported|1|||
155745341|NCT00627445|562167508|FG000|Overall Study|Adverse Event|3|||
155745342|NCT00627445|562167509|FG001|Overall Study|Adverse Event|3|||
155745343|NCT00627445|562167508|FG000|Overall Study|Lack of Efficacy|0|||
155745344|NCT00627445|562167509|FG001|Overall Study|Lack of Efficacy|1|||
155745345|NCT00627445|562167508|FG000|Overall Study|Other|6|||
155745346|NCT00627445|562167509|FG001|Overall Study|Other|8|||
155745347|NCT01238588|562167511|FG000|Overall Study|Withdrawal by Subject|1|||
155297875|NCT00792948|560519879|FG000|Overall Study|Protocol Violation|1|||
155297876|NCT01390402|560519886|FG000|Overall Study|Death|1|||
155297877|NCT01390402|560519886|FG000|Overall Study|Disease Progression|4|||
155297878|NCT02445391|560519887|FG000|Overall Study|No active protocol treatment|3|||
155297879|NCT02445391|560519888|FG001|Overall Study|No active protocol treatment|0|||
155297880|NCT02445391|560519889|FG002|Overall Study|No active protocol treatment|0|||
155297881|NCT02445391|560519887|FG000|Overall Study|Adverse Event|0|||
155297882|NCT02445391|560519888|FG001|Overall Study|Adverse Event|21|||
155297883|NCT02445391|560519889|FG002|Overall Study|Adverse Event|12|||
155297884|NCT02445391|560519887|FG000|Overall Study|Alternative therapy|0|||
155297885|NCT02445391|560519888|FG001|Overall Study|Alternative therapy|0|||
155297886|NCT02445391|560519889|FG002|Overall Study|Alternative therapy|1|||
155297887|NCT02445391|560519887|FG000|Overall Study|Disease progression|0|||
155297888|NCT02445391|560519888|FG001|Overall Study|Disease progression|7|||
155297889|NCT02445391|560519889|FG002|Overall Study|Disease progression|22|||
155297890|NCT02445391|560519887|FG000|Overall Study|Complicating disease|0|||
155297891|NCT02445391|560519888|FG001|Overall Study|Complicating disease|2|||
155297892|NCT02445391|560519889|FG002|Overall Study|Complicating disease|1|||
155297893|NCT02445391|560519887|FG000|Overall Study|Withdrawal by Subject|0|||
155297894|NCT02445391|560519888|FG001|Overall Study|Withdrawal by Subject|4|||
155297895|NCT02445391|560519889|FG002|Overall Study|Withdrawal by Subject|9|||
155297896|NCT02445391|560519887|FG000|Overall Study|Financial issue|0|||
155297897|NCT02445391|560519888|FG001|Overall Study|Financial issue|0|||
155297898|NCT02445391|560519889|FG002|Overall Study|Financial issue|2|||
155297899|NCT02445391|560519887|FG000|Overall Study|Still on treatment|0|||
155297900|NCT02445391|560519888|FG001|Overall Study|Still on treatment|7|||
155297901|NCT02445391|560519889|FG002|Overall Study|Still on treatment|16|||
155297902|NCT02445391|560519887|FG000|Overall Study|Not start protocol therapy|0|||
155297903|NCT02445391|560519888|FG001|Overall Study|Not start protocol therapy|12|||
155297904|NCT02445391|560519889|FG002|Overall Study|Not start protocol therapy|9|||
155297905|NCT02611037|560519890|FG000|Overall Study|Withdrawal prior to treatment|2|||
155297906|NCT02611037|560519891|FG001|Overall Study|Withdrawal prior to treatment|0|||
155297907|NCT05850520|560519892|FG000|Overall Study|Withdrawal by Subject|8|||
155297908|NCT05850520|560519893|FG001|Overall Study|Withdrawal by Subject|8|||
155297909|NCT05850520|560519894|FG002|Overall Study|Withdrawal by Subject|16|||
155297910|NCT05850520|560519892|FG000|Overall Study|Lost to Follow-up|2|||
155297911|NCT05850520|560519893|FG001|Overall Study|Lost to Follow-up|2|||
155297912|NCT05850520|560519894|FG002|Overall Study|Lost to Follow-up|2|||
155297913|NCT05850520|560519892|FG000|Overall Study|Death|2|||
155297914|NCT05850520|560519893|FG001|Overall Study|Death|2|||
155297915|NCT05850520|560519894|FG002|Overall Study|Death|3|||
155297916|NCT05850520|560519892|FG000|Overall Study|Adverse Event|2|||
155297917|NCT05850520|560519893|FG001|Overall Study|Adverse Event|0|||
155297918|NCT05850520|560519894|FG002|Overall Study|Adverse Event|1|||
155297919|NCT05850520|560519892|FG000|Overall Study|Physician Decision|0|||
155297920|NCT05850520|560519893|FG001|Overall Study|Physician Decision|1|||
155297921|NCT05850520|560519894|FG002|Overall Study|Physician Decision|0|||
155297922|NCT05850520|560519892|FG000|Overall Study|Protocol deviation|0|||
155297923|NCT05850520|560519893|FG001|Overall Study|Protocol deviation|0|||
155297924|NCT05850520|560519894|FG002|Overall Study|Protocol deviation|1|||
155297925|NCT05850520|560519892|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
155297926|NCT05850520|560519893|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
155297927|NCT05850520|560519894|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
155297928|NCT03889925|560520675|FG000|Overall Study|Lost to Follow-up|11|||
155297929|NCT03889925|560520676|FG001|Overall Study|Lost to Follow-up|10|||
155297930|NCT00925899|560520682|FG000|Part 1|Death|1|||
155297931|NCT00925899|560520683|FG001|Part 1|Death|2|||
155297932|NCT00925899|560520682|FG000|Part 1|Withdrawal by Subject|10|||
155297933|NCT00925899|560520683|FG001|Part 1|Withdrawal by Subject|9|||
155297934|NCT03648762|560520684|FG000|Overall Study|Lost to Follow-up|1|||
155297935|NCT03648762|560520685|FG001|Overall Study|Lost to Follow-up|2|||
155297936|NCT03648762|560520686|FG002|Overall Study|Lost to Follow-up|0|||
155297937|NCT03648762|560520684|FG000|Overall Study|Withdrawal by Subject|5|||
155297938|NCT03648762|560520685|FG001|Overall Study|Withdrawal by Subject|2|||
155297939|NCT03648762|560520686|FG002|Overall Study|Withdrawal by Subject|1|||
155297940|NCT04480827|560520694|FG000|Overall Study|Adverse Event|0|||
155297941|NCT04480827|560520695|FG001|Overall Study|Adverse Event|0|||
155297942|NCT04480827|560520696|FG002|Overall Study|Adverse Event|0|||
155297943|NCT04480827|560520697|FG003|Overall Study|Adverse Event|0|||
155297944|NCT04480827|560520698|FG004|Overall Study|Adverse Event|0|||
155297945|NCT04480827|560520699|FG005|Overall Study|Adverse Event|1|||
155297946|NCT04480827|560520700|FG006|Overall Study|Adverse Event|0|||
155297947|NCT01582100|560520703|FG000|Overall Study|Adverse Event|1|||
155297948|NCT01582100|560520703|FG000|Overall Study|Withdrawal by Subject|1|||
155297949|NCT00360698|560520704|FG000|Run-In|Physician Decision|0|||
155297950|NCT00360698|560520705|FG001|Run-In|Physician Decision|1|||
155297951|NCT00360698|560520704|FG000|Run-In|Withdrawal by Subject|0|||
155297952|NCT00360698|560520705|FG001|Run-In|Withdrawal by Subject|2|||
155297953|NCT00360698|560520704|FG000|Run-In|Non compliance with treatment procedure|0|||
155297954|NCT00360698|560520705|FG001|Run-In|Non compliance with treatment procedure|1|||
155297955|NCT00360698|560520704|FG000|Run-In|Sponsor request|0|||
155297956|NCT00360698|560520705|FG001|Run-In|Sponsor request|2|||
155297957|NCT00360698|560520704|FG000|Run-In|Patient did not meet inclusion criteria|0|||
155297958|NCT00360698|560520705|FG001|Run-In|Patient did not meet inclusion criteria|1|||
155297959|NCT00360698|560520704|FG000|Run-In|Patient personal reasons|0|||
155297960|NCT00360698|560520705|FG001|Run-In|Patient personal reasons|2|||
155297961|NCT00360698|560520704|FG000|Run-In|Need of insulin with meals|0|||
155297962|NCT00360698|560520705|FG001|Run-In|Need of insulin with meals|1|||
155297963|NCT00360698|560520704|FG000|Treatment Period|Non compliance with treatment procedure|1|||
155297964|NCT00360698|560520705|FG001|Treatment Period|Non compliance with treatment procedure|0|||
155297965|NCT00360698|560520704|FG000|Treatment Period|Early termination by error|0|||
155297966|NCT00360698|560520705|FG001|Treatment Period|Early termination by error|1|||
155297967|NCT03401112|560520712|FG000|Overall Study|Adverse Event|1|||
155297968|NCT03401112|560520713|FG001|Overall Study|Adverse Event|2|||
155297969|NCT03401112|560520714|FG002|Overall Study|Adverse Event|3|||
155640400|NCT05399771|561774336|FG000|Overall Study|Physician Decision|3|||
155297970|NCT03401112|560520715|FG003|Overall Study|Adverse Event|2|||
155297971|NCT03401112|560520716|FG004|Overall Study|Adverse Event|0|||
155297972|NCT03401112|560520712|FG000|Overall Study|Lost to Follow-up|1|||
155297973|NCT03401112|560520713|FG001|Overall Study|Lost to Follow-up|0|||
155297974|NCT03401112|560520714|FG002|Overall Study|Lost to Follow-up|0|||
155297975|NCT03401112|560520715|FG003|Overall Study|Lost to Follow-up|0|||
155297976|NCT03401112|560520716|FG004|Overall Study|Lost to Follow-up|0|||
155297977|NCT03401112|560520712|FG000|Overall Study|Noncompliance|1|||
155297978|NCT03401112|560520713|FG001|Overall Study|Noncompliance|2|||
155297979|NCT03401112|560520714|FG002|Overall Study|Noncompliance|3|||
155297980|NCT03401112|560520715|FG003|Overall Study|Noncompliance|0|||
155297981|NCT03401112|560520716|FG004|Overall Study|Noncompliance|0|||
155297982|NCT03401112|560520712|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
155297983|NCT03401112|560520713|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
155640401|NCT05399771|561774336|FG000|Overall Study|Adverse Event|1|||
155297984|NCT03401112|560520714|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
155297985|NCT03401112|560520715|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
155297986|NCT03401112|560520716|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
155297987|NCT03401112|560520712|FG000|Overall Study|Withdrawal by Subject|0|||
155297988|NCT03401112|560520713|FG001|Overall Study|Withdrawal by Subject|3|||
155297989|NCT03401112|560520714|FG002|Overall Study|Withdrawal by Subject|2|||
155297990|NCT03401112|560520715|FG003|Overall Study|Withdrawal by Subject|1|||
155297991|NCT03401112|560520716|FG004|Overall Study|Withdrawal by Subject|0|||
155297992|NCT03401112|560520712|FG000|Overall Study|Physician Decision|0|||
155297993|NCT03401112|560520713|FG001|Overall Study|Physician Decision|0|||
155297994|NCT03401112|560520714|FG002|Overall Study|Physician Decision|0|||
155297995|NCT03401112|560520715|FG003|Overall Study|Physician Decision|2|||
155297996|NCT03401112|560520716|FG004|Overall Study|Physician Decision|0|||
155297997|NCT03401112|560520712|FG000|Overall Study|Study was Terminated by Sponsor|0|||
155297998|NCT03401112|560520713|FG001|Overall Study|Study was Terminated by Sponsor|0|||
155297999|NCT03401112|560520714|FG002|Overall Study|Study was Terminated by Sponsor|0|||
155298000|NCT03401112|560520715|FG003|Overall Study|Study was Terminated by Sponsor|1|||
155298001|NCT03401112|560520716|FG004|Overall Study|Study was Terminated by Sponsor|0|||
155298002|NCT03401112|560520712|FG000|Overall Study|Day 1 Assessment not Done|1|||
155298003|NCT03401112|560520713|FG001|Overall Study|Day 1 Assessment not Done|0|||
155298004|NCT03401112|560520714|FG002|Overall Study|Day 1 Assessment not Done|0|||
155298005|NCT03401112|560520715|FG003|Overall Study|Day 1 Assessment not Done|0|||
155298006|NCT03401112|560520716|FG004|Overall Study|Day 1 Assessment not Done|0|||
155298007|NCT03401112|560520712|FG000|Overall Study|Not Dosed|0|||
155298008|NCT03401112|560520713|FG001|Overall Study|Not Dosed|0|||
155298009|NCT03401112|560520714|FG002|Overall Study|Not Dosed|1|||
155298010|NCT03401112|560520715|FG003|Overall Study|Not Dosed|0|||
155298011|NCT03401112|560520716|FG004|Overall Study|Not Dosed|0|||
155298012|NCT03401112|560520712|FG000|Overall Study|Missed Clinical Visit|0|||
155298013|NCT03401112|560520713|FG001|Overall Study|Missed Clinical Visit|0|||
155298014|NCT03401112|560520714|FG002|Overall Study|Missed Clinical Visit|1|||
155298015|NCT03401112|560520715|FG003|Overall Study|Missed Clinical Visit|0|||
155298016|NCT03401112|560520716|FG004|Overall Study|Missed Clinical Visit|0|||
155298017|NCT03401112|560520712|FG000|Overall Study|Missed Doses|0|||
155298018|NCT03401112|560520713|FG001|Overall Study|Missed Doses|0|||
155298019|NCT03401112|560520714|FG002|Overall Study|Missed Doses|1|||
155298020|NCT03401112|560520715|FG003|Overall Study|Missed Doses|0|||
155298021|NCT03401112|560520716|FG004|Overall Study|Missed Doses|0|||
155298022|NCT01264679|560520717|FG000|Overall Study|Participation in Another Clinical Trial|1|||
155298023|NCT01264679|560520717|FG000|Overall Study|Physician Decision|1|||
155298024|NCT01264679|560520717|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
155298025|NCT01264679|560520717|FG000|Overall Study|Withdrawal by Subject|1|||
155298026|NCT03475316|560520718|FG000|6 Month Intervention|Adverse Event|2|||
155745348|NCT01238588|562167511|FG000|Overall Study|Physician Decision|2|||
155745349|NCT00796991|562167516|FG000|Overall Study|Adverse Event|0|||
155745350|NCT00796991|562167517|FG001|Overall Study|Adverse Event|0|||
155745351|NCT00796991|562167518|FG002|Overall Study|Adverse Event|1|||
155745352|NCT00796991|562167516|FG000|Overall Study|Death|2|||
155745353|NCT00796991|562167517|FG001|Overall Study|Death|0|||
155745354|NCT00796991|562167518|FG002|Overall Study|Death|0|||
155298027|NCT03475316|560520719|FG001|6 Month Intervention|Adverse Event|1|||
155298028|NCT03475316|560520718|FG000|6 Month Intervention|Withdrawal by Subject|2|||
155298029|NCT03475316|560520719|FG001|6 Month Intervention|Withdrawal by Subject|0|||
155745355|NCT00796991|562167516|FG000|Overall Study|Disease Progression|10|||
155745356|NCT00796991|562167517|FG001|Overall Study|Disease Progression|9|||
155745357|NCT00796991|562167518|FG002|Overall Study|Disease Progression|7|||
155745358|NCT00796991|562167516|FG000|Overall Study|Study Drug Toxicity|3|||
155745359|NCT00796991|562167517|FG001|Overall Study|Study Drug Toxicity|3|||
155745360|NCT00796991|562167518|FG002|Overall Study|Study Drug Toxicity|5|||
155745361|NCT00796991|562167516|FG000|Overall Study|Withdrawal by Subject|0|||
155745362|NCT00796991|562167517|FG001|Overall Study|Withdrawal by Subject|0|||
155745363|NCT00796991|562167518|FG002|Overall Study|Withdrawal by Subject|1|||
155745364|NCT00834080|562167520|FG000|Overall Study|Adverse Event|7|||
155745365|NCT00834080|562167520|FG000|Overall Study|Lost to Follow-up|7|||
155745366|NCT00834080|562167520|FG000|Overall Study|Withdrawal by Subject|5|||
155745367|NCT00834080|562167520|FG000|Overall Study|Other - Pregnancy|1|||
155745368|NCT00834080|562167520|FG000|Overall Study|Other - False positive tests of the UDS|1|||
155745369|NCT00834080|562167520|FG000|Overall Study|Physician Decision|1|||
155745370|NCT00834080|562167520|FG000|Overall Study|Subject Relocated|1|||
155745371|NCT04345367|562167522|FG000|Overall Study|Other|3|||
155745372|NCT04345367|562167523|FG001|Overall Study|Other|4|||
155745373|NCT04345367|562167522|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
155745374|NCT04345367|562167523|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
155745375|NCT04345367|562167522|FG000|Overall Study|Withdrawal by Subject|11|||
155745376|NCT04345367|562167523|FG001|Overall Study|Withdrawal by Subject|11|||
155745377|NCT04345367|562167522|FG000|Overall Study|Protocol Violation|4|||
155745378|NCT04345367|562167523|FG001|Overall Study|Protocol Violation|3|||
155745379|NCT04345367|562167522|FG000|Overall Study|Lost to Follow-up|2|||
155745380|NCT04345367|562167523|FG001|Overall Study|Lost to Follow-up|4|||
155745381|NCT04345367|562167522|FG000|Overall Study|Lack of Efficacy|2|||
155298030|NCT03475316|560520718|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
155745382|NCT04345367|562167523|FG001|Overall Study|Lack of Efficacy|0|||
155298031|NCT03475316|560520719|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
155298032|NCT03475316|560520718|FG000|9 Months|Study stopped due to COVID pandemic|3|||
155298033|NCT03475316|560520719|FG001|9 Months|Study stopped due to COVID pandemic|4|||
155298034|NCT00424645|560520720|FG000|Overall Study|Death|1|||
155298035|NCT00424645|560520721|FG001|Overall Study|Death|0|||
155298036|NCT01595061|560520722|FG000|Overall Study|Never Treated|3|||
155298037|NCT01595061|560520722|FG000|Overall Study|Inadequate Pathology|1|||
155298038|NCT03194958|560520725|FG000|Overall Study|Death|0|||
155298039|NCT03194958|560520726|FG001|Overall Study|Death|1|||
155298040|NCT03194958|560520727|FG002|Overall Study|Death|1|||
155298041|NCT03194958|560520728|FG003|Overall Study|Death|1|||
155298042|NCT03194958|560520725|FG000|Overall Study|Withdrawal by Subject|24|||
155298043|NCT03194958|560520726|FG001|Overall Study|Withdrawal by Subject|27|||
155298044|NCT03194958|560520727|FG002|Overall Study|Withdrawal by Subject|7|||
155298045|NCT03194958|560520728|FG003|Overall Study|Withdrawal by Subject|22|||
155298046|NCT03194958|560520725|FG000|Overall Study|Lost to Follow-up|168|||
155298047|NCT03194958|560520726|FG001|Overall Study|Lost to Follow-up|196|||
155298048|NCT03194958|560520727|FG002|Overall Study|Lost to Follow-up|174|||
155298049|NCT03194958|560520728|FG003|Overall Study|Lost to Follow-up|186|||
155298050|NCT01179334|560520731|FG000|Treatment Period|Adverse Event|1|||
155298051|NCT01179334|560520732|FG001|Treatment Period|Adverse Event|0|||
155298052|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
155298053|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
155298054|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Death|3|||
155298055|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Death|0|||
155298056|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
155298057|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
155298058|NCT00256243|560520733|FG000|Overall Study|Lost to Follow-up|2|||
155298059|NCT00256243|560520733|FG000|Overall Study|Death|7|||
155298060|NCT00256243|560520733|FG000|Overall Study|Not treated|1|||
155298061|NCT01152190|560520734|FG000|Overall Study|Adverse Event|2|||
155298062|NCT01152190|560520735|FG001|Overall Study|Adverse Event|4|||
155298063|NCT01152190|560520734|FG000|Overall Study|Death|1|||
155298064|NCT01152190|560520735|FG001|Overall Study|Death|0|||
155298065|NCT01152190|560520734|FG000|Overall Study|Protocol Violation|1|||
155298066|NCT01152190|560520735|FG001|Overall Study|Protocol Violation|1|||
155298067|NCT01152190|560520734|FG000|Overall Study|Withdrawal by Subject|1|||
155745383|NCT04345367|562167522|FG000|Overall Study|Death|2|||
155745384|NCT04345367|562167523|FG001|Overall Study|Death|0|||
155745385|NCT04345367|562167522|FG000|Overall Study|Adverse Event|10|||
155745386|NCT04345367|562167523|FG001|Overall Study|Adverse Event|9|||
155745387|NCT00796523|562167524|FG000|Overall Study|Lost to Follow-up|9|||
155745388|NCT00796523|562167525|FG001|Overall Study|Lost to Follow-up|7|||
155745389|NCT02431260|562167526|FG000|Overall Study|Subject Decision|0|||
155745390|NCT02431260|562167527|FG001|Overall Study|Subject Decision|1|||
155745391|NCT02431260|562167528|FG002|Overall Study|Subject Decision|1|||
155298068|NCT01152190|560520735|FG001|Overall Study|Withdrawal by Subject|3|||
155298069|NCT01595321|560520738|FG000|Overall Study|Adverse Event|1|||
155298070|NCT01595321|560520739|FG001|Overall Study|Adverse Event|1|||
155298071|NCT01595321|560520740|FG002|Overall Study|Adverse Event|1|||
155298072|NCT01595321|560520738|FG000|Overall Study|Lack of Efficacy|0|||
155298073|NCT01595321|560520739|FG001|Overall Study|Lack of Efficacy|0|||
155298074|NCT01595321|560520740|FG002|Overall Study|Lack of Efficacy|4|||
155298075|NCT00834834|560520741|FG000|Overall Study|Withdrawal by Subject|4|||
155298076|NCT00834834|560520742|FG001|Overall Study|Withdrawal by Subject|3|||
155298077|NCT00373529|560520743|FG000|Overall Study|Physician Decision|19|||
155298078|NCT00373529|560520743|FG000|Overall Study|Withdrawal by Subject|7|||
155298079|NCT00373529|560520743|FG000|Overall Study|Adverse Event|7|||
155298080|NCT00373529|560520743|FG000|Overall Study|Treatment failure|36|||
155298081|NCT00373529|560520743|FG000|Overall Study|Disease recurrence|10|||
155298082|NCT00373529|560520743|FG000|Overall Study|Death|16|||
155298083|NCT00373529|560520743|FG000|Overall Study|Need for treatment prohibited by study|1|||
155298084|NCT00373529|560520743|FG000|Overall Study|Other|8|||
155298085|NCT00373529|560520743|FG000|Overall Study|Failed independent confirmation of AML|3|||
155298086|NCT00373529|560520743|FG000|Overall Study|Consent violation|1|||
155298087|NCT01585558|560520746|FG000|Overall Study|Withdrawal by Subject|4|||
155298088|NCT01585558|560520747|FG001|Overall Study|Withdrawal by Subject|5|||
155298089|NCT01585558|560520748|FG002|Overall Study|Withdrawal by Subject|8|||
155298090|NCT01585558|560520746|FG000|Overall Study|Lost to Follow-up|2|||
155298091|NCT01585558|560520747|FG001|Overall Study|Lost to Follow-up|0|||
155298092|NCT01585558|560520748|FG002|Overall Study|Lost to Follow-up|3|||
155298093|NCT01585558|560520746|FG000|Overall Study|Adverse Event|3|||
155298094|NCT01585558|560520747|FG001|Overall Study|Adverse Event|4|||
155745392|NCT02431260|562167529|FG003|Overall Study|Subject Decision|0|||
155298095|NCT01585558|560520748|FG002|Overall Study|Adverse Event|1|||
155298096|NCT01585558|560520746|FG000|Overall Study|Protocol Violation|4|||
155298097|NCT01585558|560520747|FG001|Overall Study|Protocol Violation|3|||
155298098|NCT01585558|560520748|FG002|Overall Study|Protocol Violation|2|||
155745393|NCT02431260|562167530|FG004|Overall Study|Subject Decision|0|||
155298099|NCT01585558|560520746|FG000|Overall Study|Lack of Efficacy|0|||
155298100|NCT01585558|560520747|FG001|Overall Study|Lack of Efficacy|0|||
155298101|NCT01585558|560520748|FG002|Overall Study|Lack of Efficacy|1|||
155298102|NCT01810263|560520762|FG000|Overall Study|Lost to Follow-up|8|||
155298103|NCT01810263|560520763|FG001|Overall Study|Lost to Follow-up|7|||
155298104|NCT00026312|560520764|FG000|Overall Study|Adverse Event|0|||
155298105|NCT00026312|560520765|FG001|Overall Study|Adverse Event|32|||
155298106|NCT00026312|560520764|FG000|Overall Study|Death|1|||
155640402|NCT01312129|561774341|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
155640403|NCT01312129|561774342|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
155640404|NCT01239680|561774343|FG000|Overall Study|Withdrawal by Subject|2|||
155640405|NCT01239680|561774344|FG001|Overall Study|Withdrawal by Subject|0|||
155640406|NCT05177094|561774347|FG000|Overall Study|Adverse Event|5|||
155640407|NCT05177094|561774348|FG001|Overall Study|Adverse Event|5|||
155640408|NCT05177094|561774347|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
155640409|NCT05177094|561774348|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
155640410|NCT05177094|561774347|FG000|Overall Study|Protocol Deviation|3|||
155640411|NCT05177094|561774348|FG001|Overall Study|Protocol Deviation|0|||
155640412|NCT05177094|561774347|FG000|Overall Study|Withdrawal by Subject|6|||
155640413|NCT05177094|561774348|FG001|Overall Study|Withdrawal by Subject|3|||
155640414|NCT05177094|561774347|FG000|Overall Study|Participant could not tolerate long study visits|1|||
155640415|NCT05177094|561774348|FG001|Overall Study|Participant could not tolerate long study visits|0|||
155640416|NCT02260986|561774349|FG000|Overall Study|Adverse Event|24|||
155640417|NCT02260986|561774350|FG001|Overall Study|Adverse Event|0|||
155640418|NCT02260986|561774351|FG002|Overall Study|Adverse Event|11|||
155640419|NCT02260986|561774349|FG000|Overall Study|Lack of Efficacy|27|||
155640420|NCT02260986|561774350|FG001|Overall Study|Lack of Efficacy|3|||
155640421|NCT02260986|561774351|FG002|Overall Study|Lack of Efficacy|0|||
155640422|NCT02260986|561774349|FG000|Overall Study|Protocol Violation|14|||
155640423|NCT02260986|561774350|FG001|Overall Study|Protocol Violation|5|||
155640424|NCT02260986|561774351|FG002|Overall Study|Protocol Violation|16|||
155640425|NCT02260986|561774349|FG000|Overall Study|Car accident|0|||
155640426|NCT02260986|561774350|FG001|Overall Study|Car accident|0|||
155640427|NCT02260986|561774351|FG002|Overall Study|Car accident|1|||
155640428|NCT02260986|561774349|FG000|Overall Study|Withdrawal by Subject|17|||
155640429|NCT02260986|561774350|FG001|Overall Study|Withdrawal by Subject|4|||
155640430|NCT02260986|561774351|FG002|Overall Study|Withdrawal by Subject|9|||
155640431|NCT02260986|561774349|FG000|Overall Study|Incorrect randomization|0|||
155640432|NCT02260986|561774350|FG001|Overall Study|Incorrect randomization|1|||
155640433|NCT02260986|561774351|FG002|Overall Study|Incorrect randomization|0|||
155640434|NCT02260986|561774349|FG000|Overall Study|Lack of investigation product supply|2|||
155640435|NCT02260986|561774350|FG001|Overall Study|Lack of investigation product supply|0|||
155640436|NCT02260986|561774351|FG002|Overall Study|Lack of investigation product supply|1|||
155640437|NCT02260986|561774349|FG000|Overall Study|Lost to Follow-up|4|||
155640438|NCT02260986|561774350|FG001|Overall Study|Lost to Follow-up|0|||
155640439|NCT02260986|561774351|FG002|Overall Study|Lost to Follow-up|3|||
155640440|NCT02260986|561774349|FG000|Overall Study|Pregnancy|2|||
155640441|NCT02260986|561774350|FG001|Overall Study|Pregnancy|0|||
155640442|NCT02260986|561774351|FG002|Overall Study|Pregnancy|0|||
155640443|NCT00313170|561774353|FG000|Overall Study|Death|2|||
155640444|NCT00313170|561774354|FG001|Overall Study|Death|4|||
155640445|NCT00313170|561774355|FG002|Overall Study|Death|2|||
155640446|NCT00313170|561774353|FG000|Overall Study|Adverse Event|1|||
155640447|NCT00313170|561774354|FG001|Overall Study|Adverse Event|2|||
155640448|NCT00313170|561774355|FG002|Overall Study|Adverse Event|0|||
155640449|NCT00313170|561774353|FG000|Overall Study|Disease progression|31|||
155640450|NCT00313170|561774354|FG001|Overall Study|Disease progression|26|||
155640451|NCT00313170|561774355|FG002|Overall Study|Disease progression|27|||
155640452|NCT00313170|561774353|FG000|Overall Study|Withdrawal by Subject|1|||
155640453|NCT00313170|561774354|FG001|Overall Study|Withdrawal by Subject|0|||
155640454|NCT00313170|561774355|FG002|Overall Study|Withdrawal by Subject|1|||
155640455|NCT00313170|561774353|FG000|Overall Study|Incorrect enrollment|0|||
155640456|NCT00313170|561774354|FG001|Overall Study|Incorrect enrollment|2|||
155640457|NCT00313170|561774355|FG002|Overall Study|Incorrect enrollment|1|||
155640458|NCT00313170|561774353|FG000|Overall Study|Lost to Follow-up|0|||
155640459|NCT00313170|561774354|FG001|Overall Study|Lost to Follow-up|0|||
155640460|NCT00313170|561774355|FG002|Overall Study|Lost to Follow-up|1|||
155640461|NCT00313170|561774353|FG000|Overall Study|Progression (investigators opinion)|1|||
155640462|NCT00313170|561774354|FG001|Overall Study|Progression (investigators opinion)|0|||
155640463|NCT00313170|561774355|FG002|Overall Study|Progression (investigators opinion)|0|||
155640464|NCT02827708|561774356|FG000|Overall Study|Lost to Follow-up|3|||
155640465|NCT02827708|561774357|FG001|Overall Study|Lost to Follow-up|1|||
155640466|NCT02827708|561774356|FG000|Overall Study|Withdrawal by Subject|1|||
155640467|NCT02827708|561774357|FG001|Overall Study|Withdrawal by Subject|2|||
155640468|NCT02827708|561774356|FG000|Overall Study|Death|1|||
155745394|NCT02431260|562167531|FG005|Overall Study|Subject Decision|0|||
155298107|NCT00026312|560520765|FG001|Overall Study|Death|7|||
155298108|NCT00026312|560520764|FG000|Overall Study|Lack of Efficacy|19|||
155745395|NCT02431260|562167532|FG006|Overall Study|Subject Decision|0|||
155745396|NCT02431260|562167533|FG007|Overall Study|Subject Decision|0|||
155745397|NCT02431260|562167534|FG008|Overall Study|Subject Decision|1|||
155745398|NCT02431260|562167535|FG009|Overall Study|Subject Decision|1|||
155745399|NCT02431260|562167536|FG010|Overall Study|Subject Decision|0|||
155745400|NCT02431260|562167537|FG011|Overall Study|Subject Decision|1|||
155745401|NCT02431260|562167538|FG012|Overall Study|Subject Decision|0|||
155745402|NCT02431260|562167539|FG013|Overall Study|Subject Decision|0|||
155745403|NCT02431260|562167526|FG000|Overall Study|Death|4|||
155745404|NCT02431260|562167527|FG001|Overall Study|Death|4|||
155745405|NCT02431260|562167528|FG002|Overall Study|Death|3|||
155745406|NCT02431260|562167529|FG003|Overall Study|Death|4|||
155745407|NCT02431260|562167530|FG004|Overall Study|Death|2|||
155745408|NCT02431260|562167531|FG005|Overall Study|Death|2|||
155745409|NCT02431260|562167532|FG006|Overall Study|Death|3|||
155745410|NCT02431260|562167533|FG007|Overall Study|Death|1|||
155640469|NCT02827708|561774357|FG001|Overall Study|Death|2|||
155640470|NCT00898807|561774359|FG000|Overall Study|Withdrawal by Subject|5|||
155640471|NCT00898807|561774360|FG001|Overall Study|Withdrawal by Subject|3|||
155640472|NCT00898807|561774359|FG000|Overall Study|Family pressure to discontinue|2|||
155640473|NCT00898807|561774360|FG001|Overall Study|Family pressure to discontinue|2|||
155640474|NCT00898807|561774359|FG000|Overall Study|Lost to Follow-up|1|||
155640475|NCT00898807|561774360|FG001|Overall Study|Lost to Follow-up|3|||
155640476|NCT00898807|561774359|FG000|Overall Study|Death|0|||
155640477|NCT00898807|561774360|FG001|Overall Study|Death|1|||
155640478|NCT00407511|561774361|FG000|Overall Study|Adverse Event|9|||
155640479|NCT00407511|561774361|FG000|Overall Study|Lost to Follow-up|4|||
155640480|NCT00407511|561774361|FG000|Overall Study|Other|5|||
155640481|NCT00407511|561774361|FG000|Overall Study|Withdrawal by Subject|4|||
155640482|NCT00529035|561774362|FG000|Overall Study|Withdrawal by Subject|1|||
155640483|NCT01521364|561774363|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
155640484|NCT01521364|561774363|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
155640485|NCT02636283|561774364|FG000|Overall Study|Adverse Event|2|||
155640486|NCT02636283|561774365|FG001|Overall Study|Adverse Event|0|||
155640487|NCT02636283|561774364|FG000|Overall Study|Trial Terminated Prematurely|0|||
155640488|NCT02636283|561774365|FG001|Overall Study|Trial Terminated Prematurely|3|||
155640489|NCT03418675|561774366|FG000|Overall Study|Lost to Follow-up|13|||
155640490|NCT03418675|561774367|FG001|Overall Study|Lost to Follow-up|10|||
155640491|NCT03418675|561774366|FG000|Overall Study|Adverse Event|2|||
155640492|NCT03418675|561774367|FG001|Overall Study|Adverse Event|0|||
155640493|NCT01879852|561774368|FG000|Overall Study|Withdrawal by Subject|2|||
155640494|NCT01879852|561774369|FG001|Overall Study|Withdrawal by Subject|0|||
155640495|NCT02115386|561774370|FG000|Overall Study|Protocol Violation|1|||
155640496|NCT02115386|561774370|FG000|Overall Study|Administrative - trial was terminated|6|||
155640497|NCT02493855|561774373|FG000|Overall Study|Non-compliance|1|||
155640498|NCT02493855|561774374|FG001|Overall Study|Non-compliance|0|||
155640499|NCT02493855|561774375|FG002|Overall Study|Non-compliance|0|||
155640500|NCT02493855|561774373|FG000|Overall Study|Adverse Event|0|||
155640501|NCT02493855|561774374|FG001|Overall Study|Adverse Event|1|||
155640502|NCT02493855|561774375|FG002|Overall Study|Adverse Event|0|||
155640503|NCT02493855|561774373|FG000|Overall Study|Withdrawal by Subject|1|||
155640504|NCT02493855|561774374|FG001|Overall Study|Withdrawal by Subject|0|||
155745411|NCT02431260|562167534|FG008|Overall Study|Death|6|||
155745412|NCT02431260|562167535|FG009|Overall Study|Death|6|||
155745413|NCT02431260|562167536|FG010|Overall Study|Death|3|||
155745414|NCT02431260|562167537|FG011|Overall Study|Death|2|||
155745415|NCT02431260|562167538|FG012|Overall Study|Death|5|||
155745416|NCT02431260|562167539|FG013|Overall Study|Death|1|||
155745417|NCT02431260|562167526|FG000|Overall Study|Lost to Follow-up|0|||
155745418|NCT02431260|562167527|FG001|Overall Study|Lost to Follow-up|0|||
155745419|NCT02431260|562167528|FG002|Overall Study|Lost to Follow-up|0|||
155745420|NCT02431260|562167529|FG003|Overall Study|Lost to Follow-up|0|||
155640505|NCT02493855|561774375|FG002|Overall Study|Withdrawal by Subject|0|||
155640506|NCT05059080|561774380|FG000|Overall Study|Withdrawal by Subject|3|||
155640507|NCT05059080|561774380|FG000|Overall Study|Study Terminated by Sponsor|64|||
155745421|NCT02431260|562167530|FG004|Overall Study|Lost to Follow-up|0|||
155745422|NCT02431260|562167531|FG005|Overall Study|Lost to Follow-up|1|||
155640508|NCT01047501|561774381|FG000|Overall Study|Adverse Event|7|||
155745423|NCT02431260|562167532|FG006|Overall Study|Lost to Follow-up|0|||
155745424|NCT02431260|562167533|FG007|Overall Study|Lost to Follow-up|0|||
155298109|NCT00026312|560520765|FG001|Overall Study|Lack of Efficacy|114|||
155298110|NCT00026312|560520764|FG000|Overall Study|Lost to Follow-up|0|||
155298111|NCT00026312|560520765|FG001|Overall Study|Lost to Follow-up|5|||
155298112|NCT00026312|560520764|FG000|Overall Study|Physician Decision|1|||
155298113|NCT00026312|560520765|FG001|Overall Study|Physician Decision|37|||
155298114|NCT00026312|560520764|FG000|Overall Study|Protocol Violation|0|||
155298115|NCT00026312|560520765|FG001|Overall Study|Protocol Violation|3|||
155298116|NCT00026312|560520764|FG000|Overall Study|Withdrawal by Subject|1|||
155298117|NCT00026312|560520765|FG001|Overall Study|Withdrawal by Subject|6|||
155298118|NCT00026312|560520764|FG000|Overall Study|Ineligible|4|||
155298119|NCT00026312|560520765|FG001|Overall Study|Ineligible|5|||
155298120|NCT00026312|560520764|FG000|Overall Study|Entry onto another COG study|0|||
155298121|NCT00026312|560520765|FG001|Overall Study|Entry onto another COG study|1|||
155298122|NCT00026312|560520764|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
155298123|NCT00026312|560520765|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
155298124|NCT03785782|560521771|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
155298125|NCT03785782|560521772|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
155298126|NCT03785782|560521771|FG000|Overall Study|Withdrawal by Subject|1|||
155298127|NCT03785782|560521772|FG001|Overall Study|Withdrawal by Subject|1|||
155298128|NCT03785782|560521771|FG000|Overall Study|insufficient image quality.|3|||
155298129|NCT03785782|560521772|FG001|Overall Study|insufficient image quality.|0|||
155298130|NCT05777785|560521773|FG000|Overall Study|Withdrawal by Subject|5|||
155298131|NCT05777785|560521773|FG000|Overall Study|Lost to Follow-up|1|||
155640509|NCT01047501|561774382|FG001|Overall Study|Adverse Event|8|||
155640510|NCT01047501|561774383|FG002|Overall Study|Adverse Event|5|||
155298132|NCT05644444|560521774|FG000|Tolerance Phase|Adverse Event|0|||
155298133|NCT05644444|560521775|FG001|Tolerance Phase|Adverse Event|2|||
155298134|NCT05644444|560521774|FG000|Treatment Phase|Adverse Event|0|||
155298135|NCT05644444|560521775|FG001|Treatment Phase|Adverse Event|2|||
155298136|NCT00493649|560521776|FG000|Overall Study|Adverse Event|44|||
155298137|NCT00493649|560521776|FG000|Overall Study|Patient Request|21|||
155298138|NCT00493649|560521776|FG000|Overall Study|Investigator Request|2|||
155298139|NCT00493649|560521776|FG000|Overall Study|Disease Progression|1|||
155298140|NCT00493649|560521776|FG000|Overall Study|Lost to Follow-up|1|||
155298141|NCT00493649|560521776|FG000|Overall Study|Other|13|||
155298142|NCT01823536|560521781|FG000|Overall Study|Lost to Follow-up|1|||
155298143|NCT01823536|560521782|FG001|Overall Study|Lost to Follow-up|0|||
155298144|NCT01823536|560521783|FG002|Overall Study|Lost to Follow-up|0|||
155298145|NCT01823536|560521784|FG003|Overall Study|Lost to Follow-up|1|||
155298146|NCT01823536|560521785|FG004|Overall Study|Lost to Follow-up|1|||
155298147|NCT01823536|560521786|FG005|Overall Study|Lost to Follow-up|0|||
155298148|NCT01823536|560521781|FG000|Overall Study|Protocol Violation|0|||
155298149|NCT01823536|560521782|FG001|Overall Study|Protocol Violation|1|||
155298150|NCT01823536|560521783|FG002|Overall Study|Protocol Violation|0|||
155298151|NCT01823536|560521784|FG003|Overall Study|Protocol Violation|0|||
155298152|NCT01823536|560521785|FG004|Overall Study|Protocol Violation|0|||
155298153|NCT01823536|560521786|FG005|Overall Study|Protocol Violation|0|||
155298154|NCT01823536|560521781|FG000|Overall Study|Withdrawal by Subject|1|||
155298155|NCT01823536|560521782|FG001|Overall Study|Withdrawal by Subject|1|||
155298156|NCT01823536|560521783|FG002|Overall Study|Withdrawal by Subject|0|||
155298157|NCT01823536|560521784|FG003|Overall Study|Withdrawal by Subject|0|||
155298158|NCT01823536|560521785|FG004|Overall Study|Withdrawal by Subject|0|||
155298159|NCT01823536|560521786|FG005|Overall Study|Withdrawal by Subject|0|||
155298160|NCT01823536|560521781|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298161|NCT01823536|560521782|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298162|NCT01823536|560521783|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
155298163|NCT01823536|560521784|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298164|NCT01823536|560521785|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298165|NCT01823536|560521786|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155640511|NCT01047501|561774381|FG000|Overall Study|Withdrew Consent|6|||
155640512|NCT01047501|561774382|FG001|Overall Study|Withdrew Consent|2|||
155640513|NCT01047501|561774383|FG002|Overall Study|Withdrew Consent|4|||
155640514|NCT01047501|561774381|FG000|Overall Study|Lost to Follow-up|0|||
155298166|NCT01823536|560521781|FG000|Overall Study|Met exclusion criterion No 6|0|||
155298167|NCT01823536|560521782|FG001|Overall Study|Met exclusion criterion No 6|0|||
155640515|NCT01047501|561774382|FG001|Overall Study|Lost to Follow-up|1|||
155640516|NCT01047501|561774383|FG002|Overall Study|Lost to Follow-up|1|||
155640517|NCT01047501|561774381|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
155298168|NCT01823536|560521783|FG002|Overall Study|Met exclusion criterion No 6|0|||
155298169|NCT01823536|560521784|FG003|Overall Study|Met exclusion criterion No 6|1|||
155298170|NCT01823536|560521785|FG004|Overall Study|Met exclusion criterion No 6|0|||
155298171|NCT01823536|560521786|FG005|Overall Study|Met exclusion criterion No 6|0|||
155298172|NCT01823536|560521781|FG000|Overall Study|Subject moved out of the state|0|||
155436097|NCT01059812|561024510|FG001|Overall Study|Withdrawal Criteria|4|||
155640518|NCT01047501|561774382|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
155640519|NCT01047501|561774383|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
155640520|NCT01047501|561774381|FG000|Overall Study|Death|1|||
155640521|NCT01047501|561774382|FG001|Overall Study|Death|0|||
155640522|NCT01047501|561774383|FG002|Overall Study|Death|0|||
155640523|NCT01047501|561774381|FG000|Overall Study|Other discontinuation|1|||
155640524|NCT01047501|561774382|FG001|Overall Study|Other discontinuation|0|||
155640525|NCT01047501|561774383|FG002|Overall Study|Other discontinuation|1|||
155640526|NCT01047501|561774381|FG000|Overall Study|Investigator judgement|0|||
155640527|NCT01047501|561774382|FG001|Overall Study|Investigator judgement|0|||
155640528|NCT01047501|561774383|FG002|Overall Study|Investigator judgement|1|||
155640529|NCT03600428|561774386|FG000|Overall Study|Not eligible|0|||
155640530|NCT03600428|561774387|FG001|Overall Study|Not eligible|1|||
155640531|NCT03600428|561774386|FG000|Overall Study|Lost to Follow-up|5|||
155640532|NCT03600428|561774387|FG001|Overall Study|Lost to Follow-up|4|||
155640533|NCT00770484|561774388|FG000|Overall Study|Withdrawal by Subject|1|||
155640534|NCT00770484|561774389|FG001|Overall Study|Withdrawal by Subject|0|||
155640535|NCT00088153|561774393|FG000|Overall Study|Physician Decision|3|||
155640536|NCT00088153|561774394|FG001|Overall Study|Physician Decision|3|||
155640537|NCT00088153|561774393|FG000|Overall Study|Withdrawal by Subject|10|||
155640538|NCT00088153|561774394|FG001|Overall Study|Withdrawal by Subject|10|||
155640539|NCT00088153|561774393|FG000|Overall Study|Lost to Follow-up|11|||
155640540|NCT00088153|561774394|FG001|Overall Study|Lost to Follow-up|12|||
155640541|NCT01695746|561774395|FG000|Overall Study|Adverse Event|1|||
155640542|NCT01695746|561774395|FG000|Overall Study|Non-compliance by the participant|3|||
155640543|NCT01695746|561774395|FG000|Overall Study|Protocol Violation|5|||
155640544|NCT01695746|561774395|FG000|Overall Study|Participant not willing to participate|3|||
155640545|NCT02324153|561774397|FG000|Overall Study|Withdrawal by Subject|4|||
155640546|NCT02324153|561774398|FG001|Overall Study|Withdrawal by Subject|1|||
155640547|NCT02324153|561774397|FG000|Overall Study|Surgery postponed after randomization|3|||
155640548|NCT02324153|561774398|FG001|Overall Study|Surgery postponed after randomization|0|||
155640549|NCT02324153|561774397|FG000|Overall Study|Developed delirium preoperatively|1|||
155640550|NCT02324153|561774398|FG001|Overall Study|Developed delirium preoperatively|0|||
155640551|NCT01937299|561774402|FG000|Overall Study|Adverse Event|13|||
155640552|NCT01937299|561774403|FG001|Overall Study|Adverse Event|0|||
155640553|NCT01937299|561774402|FG000|Overall Study|Lack of Efficacy|0|||
155640554|NCT01937299|561774403|FG001|Overall Study|Lack of Efficacy|4|||
155640555|NCT01937299|561774402|FG000|Overall Study|Withdrawal by Subject|1|||
155640556|NCT01937299|561774403|FG001|Overall Study|Withdrawal by Subject|0|||
155640557|NCT00700635|561774404|FG000|Overall Study|Adverse Event|1|||
155640558|NCT00700635|561774405|FG001|Overall Study|Adverse Event|0|||
155640559|NCT00700635|561774406|FG002|Overall Study|Adverse Event|0|||
155640560|NCT00700635|561774404|FG000|Overall Study|Lost to Follow-up|1|||
155640561|NCT00700635|561774405|FG001|Overall Study|Lost to Follow-up|3|||
155640562|NCT00700635|561774406|FG002|Overall Study|Lost to Follow-up|0|||
155640563|NCT00700635|561774404|FG000|Overall Study|Protocol Violation|2|||
155640564|NCT00700635|561774405|FG001|Overall Study|Protocol Violation|2|||
155640565|NCT00700635|561774406|FG002|Overall Study|Protocol Violation|0|||
155640566|NCT00700635|561774404|FG000|Overall Study|Withdrawal by Subject|7|||
155640567|NCT00700635|561774405|FG001|Overall Study|Withdrawal by Subject|3|||
155640568|NCT00700635|561774406|FG002|Overall Study|Withdrawal by Subject|1|||
155640569|NCT00768053|561774408|FG000|Overall Study|Adverse Event|10|||
155640570|NCT00768053|561774408|FG000|Overall Study|Lost to Follow-up|1|||
155640571|NCT03018938|561774409|FG000|Overall Study|Death|0|||
155640572|NCT03018938|561774410|FG001|Overall Study|Death|1|||
155640573|NCT03018938|561774409|FG000|Overall Study|Lost to Follow-up|21|||
155640574|NCT03018938|561774410|FG001|Overall Study|Lost to Follow-up|32|||
155640575|NCT03018938|561774409|FG000|Overall Study|Withdrawal by Subject|38|||
155640576|NCT03018938|561774410|FG001|Overall Study|Withdrawal by Subject|45|||
155640577|NCT03018938|561774409|FG000|Overall Study|Physician Decision|3|||
155640578|NCT03018938|561774410|FG001|Overall Study|Physician Decision|2|||
155640579|NCT03018938|561774409|FG000|Overall Study|Sponsor Decision|0|||
155640580|NCT03018938|561774410|FG001|Overall Study|Sponsor Decision|1|||
155298173|NCT01823536|560521782|FG001|Overall Study|Subject moved out of the state|0|||
155298174|NCT01823536|560521783|FG002|Overall Study|Subject moved out of the state|0|||
155298175|NCT01823536|560521784|FG003|Overall Study|Subject moved out of the state|0|||
155298176|NCT01823536|560521785|FG004|Overall Study|Subject moved out of the state|1|||
155298177|NCT01823536|560521786|FG005|Overall Study|Subject moved out of the state|0|||
155298178|NCT00768664|560521787|FG000|Overall Study|Death|57|||
155298179|NCT00768664|560521787|FG000|Overall Study|Lost to Follow-up|2|||
155298180|NCT00768664|560521787|FG000|Overall Study|Other|9|||
155298181|NCT00768664|560521787|FG000|Overall Study|Participant refused|1|||
155298182|NCT02544152|560521788|FG000|Overall Study|Adverse Event|0|||
155298183|NCT02544152|560521789|FG001|Overall Study|Adverse Event|4|||
155298184|NCT02544152|560521788|FG000|Overall Study|Withdrawal by Subject|0|||
155298185|NCT02544152|560521789|FG001|Overall Study|Withdrawal by Subject|3|||
155298186|NCT02544152|560521788|FG000|Overall Study|Other|1|||
155298187|NCT02544152|560521789|FG001|Overall Study|Other|0|||
155298188|NCT00465816|560521790|FG000|Overall Study|Lost to Follow-up|0|||
155298189|NCT00465816|560521791|FG001|Overall Study|Lost to Follow-up|0|||
155298190|NCT00465816|560521792|FG002|Overall Study|Lost to Follow-up|2|||
155298191|NCT02139046|560521793|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155298192|NCT02139046|560521794|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
155298193|NCT02139046|560521795|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
155298194|NCT02139046|560521796|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
155298195|NCT02139046|560521797|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
155298196|NCT02139046|560521793|FG000|Overall Study|Major Protocol Deviation|9|||
155298197|NCT02139046|560521794|FG001|Overall Study|Major Protocol Deviation|10|||
155298198|NCT02139046|560521795|FG002|Overall Study|Major Protocol Deviation|16|||
155298199|NCT02139046|560521796|FG003|Overall Study|Major Protocol Deviation|12|||
155298200|NCT02139046|560521797|FG004|Overall Study|Major Protocol Deviation|6|||
155298201|NCT02139046|560521793|FG000|Overall Study|Lost to Follow-up|13|||
155298202|NCT02139046|560521794|FG001|Overall Study|Lost to Follow-up|16|||
155298203|NCT02139046|560521795|FG002|Overall Study|Lost to Follow-up|16|||
155298204|NCT02139046|560521796|FG003|Overall Study|Lost to Follow-up|18|||
155298205|NCT02139046|560521797|FG004|Overall Study|Lost to Follow-up|13|||
155298206|NCT02139046|560521793|FG000|Overall Study|Voluntary Withdrawal|20|||
155298207|NCT02139046|560521794|FG001|Overall Study|Voluntary Withdrawal|8|||
155298208|NCT02139046|560521795|FG002|Overall Study|Voluntary Withdrawal|10|||
155298209|NCT02139046|560521796|FG003|Overall Study|Voluntary Withdrawal|15|||
155298210|NCT02139046|560521797|FG004|Overall Study|Voluntary Withdrawal|16|||
155298211|NCT02139046|560521793|FG000|Overall Study|Lack of Efficacy|0|||
155298212|NCT02139046|560521794|FG001|Overall Study|Lack of Efficacy|1|||
155298213|NCT02139046|560521795|FG002|Overall Study|Lack of Efficacy|2|||
155298214|NCT02139046|560521796|FG003|Overall Study|Lack of Efficacy|1|||
155298215|NCT02139046|560521797|FG004|Overall Study|Lack of Efficacy|2|||
155298216|NCT02139046|560521793|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
155298217|NCT02139046|560521794|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
155298218|NCT02139046|560521795|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
155298219|NCT02139046|560521796|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
155298220|NCT02139046|560521797|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
155298221|NCT02139046|560521793|FG000|Overall Study|Other Miscellaneous Reasons|10|||
155298222|NCT02139046|560521794|FG001|Overall Study|Other Miscellaneous Reasons|9|||
155298223|NCT02139046|560521795|FG002|Overall Study|Other Miscellaneous Reasons|4|||
155298224|NCT02139046|560521796|FG003|Overall Study|Other Miscellaneous Reasons|9|||
155298225|NCT02139046|560521797|FG004|Overall Study|Other Miscellaneous Reasons|12|||
155298226|NCT00818454|560521800|FG000|Treatment Period 1|Adverse Event|0|||
155298227|NCT00818454|560521801|FG001|Treatment Period 1|Adverse Event|1|||
155298228|NCT00818454|560521802|FG002|Treatment Period 1|Adverse Event|0|||
155298229|NCT00818454|560521803|FG003|Treatment Period 1|Adverse Event|0|||
155298230|NCT00818454|560521800|FG000|Treatment Period 1|Other|3|||
155298231|NCT00818454|560521801|FG001|Treatment Period 1|Other|0|||
155298232|NCT00818454|560521802|FG002|Treatment Period 1|Other|0|||
155298233|NCT00818454|560521803|FG003|Treatment Period 1|Other|0|||
155298234|NCT00818454|560521800|FG000|Washout Period of 1 Week|Adverse Event|1|||
155298235|NCT00818454|560521801|FG001|Washout Period of 1 Week|Adverse Event|1|||
155298236|NCT00818454|560521802|FG002|Washout Period of 1 Week|Adverse Event|0|||
155298237|NCT00818454|560521803|FG003|Washout Period of 1 Week|Adverse Event|0|||
155298238|NCT00818454|560521800|FG000|Washout Period of 1 Week|Protocol Violation|2|||
155298239|NCT00818454|560521801|FG001|Washout Period of 1 Week|Protocol Violation|0|||
155298240|NCT00818454|560521802|FG002|Washout Period of 1 Week|Protocol Violation|0|||
155298241|NCT00818454|560521803|FG003|Washout Period of 1 Week|Protocol Violation|0|||
155298242|NCT00818454|560521800|FG000|Washout Period of 1 Week|Other|1|||
155298243|NCT00818454|560521801|FG001|Washout Period of 1 Week|Other|2|||
155298244|NCT00818454|560521802|FG002|Washout Period of 1 Week|Other|0|||
155298245|NCT00818454|560521803|FG003|Washout Period of 1 Week|Other|0|||
155298246|NCT00818454|560521800|FG000|Treatment Period 2|Other|2|||
155298247|NCT00818454|560521801|FG001|Treatment Period 2|Other|1|||
155298248|NCT00818454|560521802|FG002|Treatment Period 2|Other|0|||
155298249|NCT00818454|560521803|FG003|Treatment Period 2|Other|0|||
155298250|NCT00818454|560521800|FG000|Treatment Period 3|Adverse Event|0|||
155298251|NCT00818454|560521801|FG001|Treatment Period 3|Adverse Event|0|||
155298252|NCT00818454|560521802|FG002|Treatment Period 3|Adverse Event|0|||
155298253|NCT00818454|560521803|FG003|Treatment Period 3|Adverse Event|1|||
155298254|NCT03454529|560521804|FG000|Overall Study|Did not receive treatment|6|||
155298255|NCT03454529|560521804|FG000|Overall Study|Received < 80% doses|1|||
155298256|NCT01040689|560521809|FG000|Overall Study|Adverse Event|0|||
155298257|NCT01040689|560521810|FG001|Overall Study|Adverse Event|0|||
155298258|NCT01040689|560521811|FG002|Overall Study|Adverse Event|2|||
155298259|NCT01040689|560521812|FG003|Overall Study|Adverse Event|4|||
155298260|NCT01040689|560521809|FG000|Overall Study|Lack of Efficacy|0|||
155298261|NCT01040689|560521810|FG001|Overall Study|Lack of Efficacy|0|||
155298262|NCT01040689|560521811|FG002|Overall Study|Lack of Efficacy|1|||
155298263|NCT01040689|560521812|FG003|Overall Study|Lack of Efficacy|0|||
155298264|NCT01040689|560521809|FG000|Overall Study|Lost to Follow-up|1|||
155298265|NCT01040689|560521810|FG001|Overall Study|Lost to Follow-up|0|||
155298266|NCT01040689|560521811|FG002|Overall Study|Lost to Follow-up|0|||
155298267|NCT01040689|560521812|FG003|Overall Study|Lost to Follow-up|0|||
155298268|NCT01040689|560521809|FG000|Overall Study|Withdrawal by Subject|2|||
155298269|NCT01040689|560521810|FG001|Overall Study|Withdrawal by Subject|1|||
155298270|NCT01040689|560521811|FG002|Overall Study|Withdrawal by Subject|1|||
155298271|NCT01040689|560521812|FG003|Overall Study|Withdrawal by Subject|0|||
155298272|NCT01040689|560521809|FG000|Overall Study|Other reasons not listed above|0|||
155298273|NCT01040689|560521810|FG001|Overall Study|Other reasons not listed above|1|||
155298274|NCT01040689|560521811|FG002|Overall Study|Other reasons not listed above|0|||
155298275|NCT01040689|560521812|FG003|Overall Study|Other reasons not listed above|0|||
155298276|NCT00494442|560521819|FG000|Overall Study|Death|1|||
155298277|NCT00494442|560521820|FG001|Overall Study|Death|1|||
155298278|NCT00494442|560521819|FG000|Overall Study|Lack of Efficacy|16|||
155298279|NCT00494442|560521820|FG001|Overall Study|Lack of Efficacy|10|||
155298280|NCT00494442|560521819|FG000|Overall Study|Adverse Event|0|||
155298281|NCT00494442|560521820|FG001|Overall Study|Adverse Event|2|||
155298282|NCT00494442|560521819|FG000|Overall Study|Physician Decision|0|||
155298283|NCT00494442|560521820|FG001|Overall Study|Physician Decision|1|||
155298284|NCT00494442|560521819|FG000|Overall Study|Non-compliance|0|||
155298285|NCT00494442|560521820|FG001|Overall Study|Non-compliance|1|||
155298286|NCT00494442|560521819|FG000|Overall Study|Intercurrent illness|0|||
155298287|NCT00494442|560521820|FG001|Overall Study|Intercurrent illness|1|||
155298288|NCT03184558|560521823|FG000|Overall Study|Withdrawal by Subject|2|||
155298289|NCT03184558|560521823|FG000|Overall Study|Death|16|||
155298290|NCT03184558|560521823|FG000|Overall Study|Lost to Follow-up|2|||
155298291|NCT03184558|560521823|FG000|Overall Study|Other|9|||
155298292|NCT03061474|560521828|FG000|Overall Study|Adverse Event|2|||
155298293|NCT03061474|560521829|FG001|Overall Study|Adverse Event|0|||
155298294|NCT03061474|560521828|FG000|Overall Study|Safety Risk|0|||
155298295|NCT03061474|560521829|FG001|Overall Study|Safety Risk|1|||
155298296|NCT03061474|560521828|FG000|Overall Study|Participant unwilling or unable to participate|0|||
155298297|NCT03061474|560521829|FG001|Overall Study|Participant unwilling or unable to participate|2|||
155298298|NCT03061474|560521828|FG000|Overall Study|Lost to Follow-up|0|||
155298299|NCT03061474|560521829|FG001|Overall Study|Lost to Follow-up|1|||
155298300|NCT01391130|560521832|FG000|Overall Study|Withdrawal by Subject|3|||
155298301|NCT01391130|560521833|FG001|Overall Study|Withdrawal by Subject|2|||
155298302|NCT01391130|560521832|FG000|Overall Study|Physician Decision|2|||
155298303|NCT01391130|560521833|FG001|Overall Study|Physician Decision|3|||
155298304|NCT01391130|560521832|FG000|Overall Study|Did not Receive Drug|1|||
155298305|NCT01391130|560521833|FG001|Overall Study|Did not Receive Drug|1|||
155298306|NCT03520413|560521840|FG000|Overall Study|Lost to Follow-up|1|||
155298307|NCT03520413|560521841|FG001|Overall Study|Lost to Follow-up|1|||
155298308|NCT03520413|560521840|FG000|Overall Study|Withdrawal by Subject|1|||
155298309|NCT03520413|560521841|FG001|Overall Study|Withdrawal by Subject|2|||
155298310|NCT03520413|560521840|FG000|Overall Study|Death|0|||
155298311|NCT03520413|560521841|FG001|Overall Study|Death|1|||
155298312|NCT03520413|560521840|FG000|Overall Study|Physician Decision|3|||
155298313|NCT03520413|560521841|FG001|Overall Study|Physician Decision|3|||
155298314|NCT03520413|560521840|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
155298315|NCT03520413|560521841|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
155298316|NCT00638963|560521842|FG000|Overall Study|Withdrawal by Subject|1|||
155298317|NCT00638963|560521843|FG001|Overall Study|Withdrawal by Subject|0|||
155298318|NCT00463788|560521845|FG000|Overall Study|Progressive Disease|86|||
155298319|NCT00463788|560521846|FG001|Overall Study|Progressive Disease|42|||
155298320|NCT00463788|560521845|FG000|Overall Study|Adverse Event|6|||
155298321|NCT00463788|560521846|FG001|Overall Study|Adverse Event|2|||
155298322|NCT00463788|560521845|FG000|Overall Study|Withdrawal by Subject|6|||
155298323|NCT00463788|560521846|FG001|Overall Study|Withdrawal by Subject|2|||
155298324|NCT00463788|560521845|FG000|Overall Study|Death|4|||
155298325|NCT00463788|560521846|FG001|Overall Study|Death|3|||
155298326|NCT00463788|560521845|FG000|Overall Study|Symptomatic Deterioration|2|||
155298327|NCT00463788|560521846|FG001|Overall Study|Symptomatic Deterioration|3|||
155298328|NCT00463788|560521845|FG000|Overall Study|Lost to Follow-up|1|||
155298329|NCT00463788|560521846|FG001|Overall Study|Lost to Follow-up|0|||
155298330|NCT00463788|560521845|FG000|Overall Study|Protocol Violation|0|||
155298331|NCT00463788|560521846|FG001|Overall Study|Protocol Violation|1|||
155298332|NCT00463788|560521845|FG000|Overall Study|Other|3|||
155298333|NCT00463788|560521846|FG001|Overall Study|Other|0|||
155298334|NCT00463788|560521845|FG000|Overall Study|Randomized but not treated|1|||
155298335|NCT00463788|560521846|FG001|Overall Study|Randomized but not treated|1|||
155298336|NCT02755116|560521848|FG000|Overall Study|surgery converted to open, pt admitted|3|||
155298337|NCT02755116|560521849|FG001|Overall Study|surgery converted to open, pt admitted|1|||
155298338|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
155298339|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
155298340|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
155298341|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
155298342|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
155298343|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
155298344|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Other|1|||
155298345|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Other|2|||
155298346|NCT02200770|560521850|FG000|Open-label Period (OLP)|Adverse Event|1|||
155298347|NCT02200770|560521851|FG001|Open-label Period (OLP)|Adverse Event|2|||
155298348|NCT02200770|560521850|FG000|Open-label Period (OLP)|Death|1|||
155298349|NCT02200770|560521851|FG001|Open-label Period (OLP)|Death|2|||
155298350|NCT02200770|560521850|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
155298351|NCT02200770|560521851|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
155298352|NCT02200770|560521850|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
155298353|NCT02200770|560521851|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
155298354|NCT02200770|560521850|FG000|Open-label Period (OLP)|Other|6|||
155410750|NCT00605085|560937472|FG001|Overall Study|administrative reasons|8|||
155298355|NCT02200770|560521851|FG001|Open-label Period (OLP)|Other|15|||
155298356|NCT05283395|560521856|FG000|Overall Study|Adverse Event|4|||
155298357|NCT05283395|560521857|FG001|Overall Study|Adverse Event|4|||
155298358|NCT05283395|560521858|FG002|Overall Study|Adverse Event|0|||
155298359|NCT05283395|560521856|FG000|Overall Study|Patient Lost to Follow-Up|0|||
155298360|NCT05283395|560521857|FG001|Overall Study|Patient Lost to Follow-Up|0|||
155298361|NCT05283395|560521858|FG002|Overall Study|Patient Lost to Follow-Up|1|||
155298362|NCT05283395|560521856|FG000|Overall Study|Patient Withdrawal|2|||
155298363|NCT05283395|560521857|FG001|Overall Study|Patient Withdrawal|4|||
155298364|NCT05283395|560521858|FG002|Overall Study|Patient Withdrawal|2|||
155298365|NCT05283395|560521856|FG000|Overall Study|Investigator Decision|1|||
155298366|NCT05283395|560521857|FG001|Overall Study|Investigator Decision|0|||
155298367|NCT05283395|560521858|FG002|Overall Study|Investigator Decision|1|||
155298368|NCT05283395|560521856|FG000|Overall Study|Enrolled in error|0|||
155298369|NCT05283395|560521857|FG001|Overall Study|Enrolled in error|0|||
155298370|NCT05283395|560521858|FG002|Overall Study|Enrolled in error|1|||
155298371|NCT00712335|560521860|FG000|Overall Study|Withdrawal by Subject|0|||
155298372|NCT00712335|560521861|FG001|Overall Study|Withdrawal by Subject|7|||
155298373|NCT00712335|560521862|FG002|Overall Study|Withdrawal by Subject|2|||
155298374|NCT00712335|560521863|FG003|Overall Study|Withdrawal by Subject|3|||
155298375|NCT00712335|560521864|FG004|Overall Study|Withdrawal by Subject|0|||
155298376|NCT00712335|560521860|FG000|Overall Study|Lost to Follow-up|2|||
155298377|NCT00712335|560521861|FG001|Overall Study|Lost to Follow-up|5|||
155298378|NCT00712335|560521862|FG002|Overall Study|Lost to Follow-up|0|||
155298379|NCT00712335|560521863|FG003|Overall Study|Lost to Follow-up|1|||
155298380|NCT00712335|560521864|FG004|Overall Study|Lost to Follow-up|0|||
155298381|NCT00712335|560521860|FG000|Overall Study|Protocol Violation|1|||
155298382|NCT00712335|560521861|FG001|Overall Study|Protocol Violation|2|||
155298383|NCT00712335|560521862|FG002|Overall Study|Protocol Violation|1|||
155298384|NCT00712335|560521863|FG003|Overall Study|Protocol Violation|0|||
155298385|NCT00712335|560521864|FG004|Overall Study|Protocol Violation|0|||
155298386|NCT00712335|560521860|FG000|Overall Study|Lack of Efficacy|0|||
155298387|NCT00712335|560521861|FG001|Overall Study|Lack of Efficacy|0|||
155298388|NCT00712335|560521862|FG002|Overall Study|Lack of Efficacy|1|||
155298389|NCT00712335|560521863|FG003|Overall Study|Lack of Efficacy|1|||
155298390|NCT00712335|560521864|FG004|Overall Study|Lack of Efficacy|0|||
155298391|NCT00712335|560521860|FG000|Overall Study|Other Reason|0|||
155298392|NCT00712335|560521861|FG001|Overall Study|Other Reason|3|||
155298393|NCT00712335|560521862|FG002|Overall Study|Other Reason|1|||
155298394|NCT00712335|560521863|FG003|Overall Study|Other Reason|0|||
155298395|NCT00712335|560521864|FG004|Overall Study|Other Reason|0|||
155298396|NCT00356265|560521866|FG000|Overall Study|Withdrawal by Subject|0|||
155298397|NCT00356265|560521867|FG001|Overall Study|Withdrawal by Subject|0|||
155298398|NCT00356265|560521868|FG002|Overall Study|Withdrawal by Subject|1|||
155298399|NCT02115139|560521872|FG000|Overall Study|Protocol Violation|1|||
155298400|NCT02115139|560521872|FG000|Overall Study|treatment discontinuation|6|||
155298401|NCT00258895|560521873|FG000|Overall Study|Lost to Follow-up|3|||
155298402|NCT00258895|560521874|FG001|Overall Study|Lost to Follow-up|1|||
155298403|NCT00258895|560521873|FG000|Overall Study|Protocol Violation|6|||
155298404|NCT00258895|560521874|FG001|Overall Study|Protocol Violation|2|||
155298405|NCT00258895|560521873|FG000|Overall Study|Withdrawal by Subject|1|||
155298406|NCT00258895|560521874|FG001|Overall Study|Withdrawal by Subject|0|||
155298407|NCT00547118|560521875|FG000|Overall Study|Did not qualify prior to starting drug|1|||
155298408|NCT00547118|560521876|FG001|Overall Study|Did not qualify prior to starting drug|1|||
155298409|NCT00547118|560521875|FG000|Overall Study|Study suspended|7|||
155298410|NCT00547118|560521876|FG001|Overall Study|Study suspended|8|||
155298411|NCT00433199|560521877|FG000|Double-Blind Period|Adverse Event|0|||
155298412|NCT00433199|560521878|FG001|Double-Blind Period|Adverse Event|25|||
155298413|NCT00433199|560521877|FG000|Double-Blind Period|Lack of Efficacy|0|||
155298414|NCT00433199|560521878|FG001|Double-Blind Period|Lack of Efficacy|2|||
155298415|NCT00433199|560521877|FG000|Double-Blind Period|Lost to Follow-up|2|||
155298416|NCT00433199|560521878|FG001|Double-Blind Period|Lost to Follow-up|5|||
155298417|NCT00433199|560521877|FG000|Double-Blind Period|Withdrawal by Subject|8|||
155298418|NCT00433199|560521878|FG001|Double-Blind Period|Withdrawal by Subject|19|||
155298419|NCT00433199|560521877|FG000|Double-Blind Period|Protocol Violation|1|||
155298420|NCT00433199|560521878|FG001|Double-Blind Period|Protocol Violation|10|||
155298421|NCT00433199|560521877|FG000|Double-Blind Period|Administrative|1|||
155298422|NCT00433199|560521878|FG001|Double-Blind Period|Administrative|5|||
155298423|NCT00433199|560521877|FG000|Open-Label Period|Adverse Event|0|||
155298424|NCT00433199|560521878|FG001|Open-Label Period|Adverse Event|19|||
155298425|NCT00433199|560521877|FG000|Open-Label Period|Lack of Efficacy|0|||
155298426|NCT00433199|560521878|FG001|Open-Label Period|Lack of Efficacy|2|||
155298427|NCT00433199|560521877|FG000|Open-Label Period|Lost to Follow-up|0|||
155298428|NCT00433199|560521878|FG001|Open-Label Period|Lost to Follow-up|3|||
155298429|NCT00433199|560521877|FG000|Open-Label Period|Withdrawal by Subject|0|||
155298430|NCT00433199|560521878|FG001|Open-Label Period|Withdrawal by Subject|7|||
155298431|NCT00433199|560521877|FG000|Open-Label Period|Protocol Violation|0|||
155298432|NCT00433199|560521878|FG001|Open-Label Period|Protocol Violation|2|||
155298433|NCT00433199|560521877|FG000|Open-Label Period|Administrative|0|||
155298434|NCT00433199|560521878|FG001|Open-Label Period|Administrative|1|||
155298435|NCT03603717|560521881|FG000|Overall Study|Lost to Follow-up|20|||
155298436|NCT03603717|560521882|FG001|Overall Study|Lost to Follow-up|20|||
155298437|NCT03603717|560521881|FG000|Overall Study|Withdrawal by Subject|16|||
155298438|NCT03603717|560521882|FG001|Overall Study|Withdrawal by Subject|10|||
155298439|NCT00732381|560521883|FG000|Overall Study|Adverse Event|1|||
155298440|NCT00732381|560521884|FG001|Overall Study|Adverse Event|0|||
155298441|NCT00732381|560521883|FG000|Overall Study|Treatment Failure|1|||
155298442|NCT00732381|560521884|FG001|Overall Study|Treatment Failure|1|||
155298443|NCT01170026|560523118|FG000|Overall Study|Lost to Follow-up|4|||
155298444|NCT01170026|560523119|FG001|Overall Study|Lost to Follow-up|2|||
155298445|NCT04817670|560523120|FG000|Overall Study|Withdrawal by Subject|1|||
155298446|NCT04817670|560523121|FG001|Overall Study|Withdrawal by Subject|0|||
155298447|NCT04817670|560523122|FG002|Overall Study|Withdrawal by Subject|0|||
155298448|NCT04817670|560523123|FG003|Overall Study|Withdrawal by Subject|0|||
155298449|NCT04817670|560523124|FG004|Overall Study|Withdrawal by Subject|0|||
155298450|NCT04817670|560523120|FG000|Overall Study|Lost to Follow-up|0|||
155298451|NCT04817670|560523121|FG001|Overall Study|Lost to Follow-up|0|||
155298452|NCT04817670|560523122|FG002|Overall Study|Lost to Follow-up|1|||
155298453|NCT04817670|560523123|FG003|Overall Study|Lost to Follow-up|0|||
155298454|NCT04817670|560523124|FG004|Overall Study|Lost to Follow-up|0|||
155298455|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
155298456|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
155298457|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
155298458|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
155298459|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
155298460|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
155298461|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
155298462|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
155298463|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
155298464|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
155298465|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
155298466|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
155298467|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
155298468|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
155298469|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
155298470|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
155298471|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
155298472|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
155298473|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
155298474|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
155298475|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
155298476|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
155298477|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
155298478|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
155298479|NCT00304031|560523125|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
155298480|NCT00304031|560523126|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
155298481|NCT00304031|560523127|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
155298482|NCT01188655|560523128|FG000|Overall Study|Lack of Efficacy|1|||
155298483|NCT01188655|560523128|FG000|Overall Study|Lost to Follow-up|1|||
155298484|NCT01188655|560523128|FG000|Overall Study|Other|11|||
155298485|NCT00683696|560523129|FG000|Overall Study|Withdrawn due to study closure|337|||
155298486|NCT00683696|560523130|FG001|Overall Study|Withdrawn due to study closure|338|||
155298487|NCT00683696|560523129|FG000|Overall Study|Withdrawn prior to study closure|13|||
155298488|NCT00683696|560523130|FG001|Overall Study|Withdrawn prior to study closure|28|||
155298489|NCT00683696|560523129|FG000|Overall Study|Lost to Follow-up|5|||
155298490|NCT00683696|560523130|FG001|Overall Study|Lost to Follow-up|6|||
155298491|NCT00683696|560523129|FG000|Overall Study|Vital status follow-up only|3|||
155298492|NCT00683696|560523130|FG001|Overall Study|Vital status follow-up only|3|||
155298493|NCT00683696|560523129|FG000|Overall Study|Death|46|||
155298494|NCT00683696|560523130|FG001|Overall Study|Death|30|||
155298495|NCT00089544|560523131|FG000|Overall Study|Ineligible|1|||
155298496|NCT00089544|560523132|FG001|Overall Study|Ineligible|0|||
155298497|NCT02396316|560523133|FG000|Overall Study|Physician Decision|1|||
155298498|NCT02396316|560523134|FG001|Overall Study|Physician Decision|0|||
155298499|NCT02396316|560523133|FG000|Overall Study|Progressive disease|6|||
155298500|NCT02396316|560523134|FG001|Overall Study|Progressive disease|3|||
155298501|NCT02396316|560523133|FG000|Overall Study|Protocol Violation|0|||
155298502|NCT02396316|560523134|FG001|Overall Study|Protocol Violation|1|||
155298503|NCT02396316|560523133|FG000|Overall Study|Treatment unblinded|0|||
155298504|NCT02396316|560523134|FG001|Overall Study|Treatment unblinded|1|||
155298505|NCT01662336|560523140|FG000|Overall Study|Adverse Event|1|||
155298506|NCT01662336|560523140|FG000|Overall Study|No longer on LPV/r|30|||
155298507|NCT01662336|560523140|FG000|Overall Study|Other|29|||
155298508|NCT01662336|560523140|FG000|Overall Study|Withdrawal by Subject|6|||
155298509|NCT02189252|560523141|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298510|NCT02189252|560523142|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
155298511|NCT02189252|560523143|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298512|NCT02189252|560523144|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298513|NCT02189252|560523141|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298514|NCT02189252|560523142|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
155298515|NCT02189252|560523143|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298516|NCT02189252|560523144|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298517|NCT00566735|560523145|FG000|Overall Study|Withdrawal by Subject|0|||
155298518|NCT00566735|560523146|FG001|Overall Study|Withdrawal by Subject|1|||
155298519|NCT00566735|560523145|FG000|Overall Study|Refused neuropsychological testing|2|||
155298520|NCT00566735|560523146|FG001|Overall Study|Refused neuropsychological testing|5|||
155298521|NCT00566735|560523145|FG000|Overall Study|Switched into a manic episode|0|||
155298522|NCT00566735|560523146|FG001|Overall Study|Switched into a manic episode|1|||
155298523|NCT05876949|560523147|FG000|Overall Study|Withdrawal by Subject|1|||
155298524|NCT05876949|560523148|FG001|Overall Study|Withdrawal by Subject|3|||
155298525|NCT05876949|560523147|FG000|Overall Study|Physician Decision|0|||
155298526|NCT05876949|560523148|FG001|Overall Study|Physician Decision|2|||
155298527|NCT05876949|560523147|FG000|Overall Study|Death|0|||
155298528|NCT05876949|560523148|FG001|Overall Study|Death|1|||
155298529|NCT00508924|560523149|FG000|Overall Study|Protocol Violation|0|||
155298530|NCT00508924|560523150|FG001|Overall Study|Protocol Violation|0|||
155298531|NCT00508924|560523151|FG002|Overall Study|Protocol Violation|1|||
155298532|NCT00508924|560523152|FG003|Overall Study|Protocol Violation|1|||
155298533|NCT02755805|560523153|FG000|Overall Study|Lost to Follow-up|1|||
155298534|NCT02755805|560523154|FG001|Overall Study|Lost to Follow-up|2|||
155298535|NCT02755805|560523153|FG000|Overall Study|Refused assessments|1|||
155298536|NCT02755805|560523154|FG001|Overall Study|Refused assessments|0|||
155298537|NCT02755805|560523153|FG000|Overall Study|Withdrawal by Subject|0|||
155298538|NCT02755805|560523154|FG001|Overall Study|Withdrawal by Subject|2|||
155298539|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
155298540|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298541|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298542|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298543|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
155298544|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298545|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298546|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298547|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
155298548|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298549|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298550|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298551|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
155298552|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298553|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298554|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298555|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
155298556|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
155298557|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
155298558|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
155298559|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
155298560|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298561|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298562|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298563|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
155496876|NCT02057549|561242406|FG000|Overall Study|Withdrawal by Subject|1|||
155298564|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298565|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298566|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298567|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
155298568|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298569|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298570|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298571|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
155298572|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298573|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298574|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298575|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
155298576|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298577|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298578|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298579|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
155298580|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
155298581|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
155298582|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
155298583|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
155298584|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
155298585|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
155298586|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
155298587|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
155298588|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
155298589|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
155298590|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
155298591|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
155298592|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
155298593|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
155298594|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
155298595|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298596|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298597|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298598|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
155298599|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
155298600|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
155298601|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
155298602|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
155298603|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
155298604|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
155298605|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
155298606|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
155298607|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
155298608|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
155298609|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
155298610|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
155298611|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
155298612|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
155298613|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
155298614|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
155298615|NCT01831791|560523164|FG000|Overall Study|Withdrawal by Subject|10|||
155298616|NCT00494780|560523165|FG000|Overall Study|Adverse Event|1|||
155298617|NCT00494780|560523166|FG001|Overall Study|Adverse Event|0|||
155298618|NCT00494780|560523165|FG000|Overall Study|Withdrew before Dosed|0|||
155298619|NCT00494780|560523166|FG001|Overall Study|Withdrew before Dosed|1|||
155298620|NCT00494780|560523165|FG000|Overall Study|Progression of Study Disease|7|||
155298621|NCT00494780|560523166|FG001|Overall Study|Progression of Study Disease|8|||
155298622|NCT00494780|560523165|FG000|Overall Study|New Treatment|2|||
155298623|NCT00494780|560523166|FG001|Overall Study|New Treatment|2|||
155298624|NCT00494780|560523165|FG000|Overall Study|Non-compliance|1|||
155298625|NCT00494780|560523166|FG001|Overall Study|Non-compliance|0|||
155298626|NCT00494780|560523165|FG000|Overall Study|Residual Tumour Mass|0|||
155298627|NCT00494780|560523166|FG001|Overall Study|Residual Tumour Mass|1|||
155298628|NCT00494780|560523165|FG000|Overall Study|Insurance Issues|0|||
155298629|NCT00494780|560523166|FG001|Overall Study|Insurance Issues|1|||
155298630|NCT00845832|560523167|FG000|Treatment Period|Adverse Event|0|||
155298631|NCT00845832|560523168|FG001|Treatment Period|Adverse Event|2|||
155298632|NCT00845832|560523169|FG002|Treatment Period|Adverse Event|0|||
155298633|NCT00845832|560523167|FG000|Treatment Period|Protocol Violation|1|||
155298634|NCT00845832|560523168|FG001|Treatment Period|Protocol Violation|1|||
155298635|NCT00845832|560523169|FG002|Treatment Period|Protocol Violation|0|||
155298636|NCT00845832|560523167|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
155298637|NCT00845832|560523168|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
155298638|NCT00845832|560523169|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
155298639|NCT00845832|560523167|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
155298640|NCT00845832|560523168|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
155298641|NCT00845832|560523169|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
155298642|NCT00869323|560523172|FG000|Maintenance Therapy|concurrent illness|1|||
155298643|NCT02880241|560523175|FG000|Overall Study|Lack of Efficacy|1|||
155298644|NCT02880241|560523176|FG001|Overall Study|Lack of Efficacy|0|||
155298645|NCT02880241|560523177|FG002|Overall Study|Lack of Efficacy|0|||
155298646|NCT02880241|560523178|FG003|Overall Study|Lack of Efficacy|0|||
155298647|NCT02880241|560523179|FG004|Overall Study|Lack of Efficacy|0|||
155298648|NCT02880241|560523180|FG005|Overall Study|Lack of Efficacy|0|||
155298649|NCT02570711|560523186|FG000|Overall Study|Death|1|||
155298650|NCT02570711|560523187|FG001|Overall Study|Death|0|||
155298651|NCT02570711|560523186|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
155298652|NCT02570711|560523187|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
155298653|NCT01254188|560523188|FG000|Overall Study|Disease Progression|6|||
155298654|NCT01254188|560523188|FG000|Overall Study|Protocol Violation|6|||
155298655|NCT01254188|560523188|FG000|Overall Study|Pregnancy|2|||
155298656|NCT01254188|560523188|FG000|Overall Study|Death|4|||
155298657|NCT01254188|560523188|FG000|Overall Study|Lost to Follow-up|5|||
155298658|NCT01254188|560523188|FG000|Overall Study|Withdrawal by Subject|7|||
155298659|NCT01254188|560523188|FG000|Overall Study|Adverse Event|43|||
155298660|NCT01254188|560523188|FG000|Overall Study|per investigator discretion|20|||
155298661|NCT00545077|560523190|FG000|Overall Study|Treatment not received|5|||
155298662|NCT00545077|560523191|FG001|Overall Study|Treatment not received|1|||
155298663|NCT00545077|560523190|FG000|Overall Study|Disease Progression|131|||
155298664|NCT00545077|560523191|FG001|Overall Study|Disease Progression|98|||
155298665|NCT00545077|560523190|FG000|Overall Study|Withdrawal by Subject|3|||
155298666|NCT00545077|560523191|FG001|Overall Study|Withdrawal by Subject|14|||
155298667|NCT00545077|560523190|FG000|Overall Study|Physician Decision|6|||
155298668|NCT00545077|560523191|FG001|Overall Study|Physician Decision|3|||
155298669|NCT00545077|560523190|FG000|Overall Study|Lost to Follow-up|2|||
155298670|NCT00545077|560523191|FG001|Overall Study|Lost to Follow-up|0|||
155298671|NCT00545077|560523190|FG000|Overall Study|Protocol Violation|1|||
155298672|NCT00545077|560523191|FG001|Overall Study|Protocol Violation|0|||
155298673|NCT00545077|560523190|FG000|Overall Study|Adverse Event|0|||
155298674|NCT00545077|560523191|FG001|Overall Study|Adverse Event|31|||
155298675|NCT00545077|560523190|FG000|Overall Study|Death|0|||
155298676|NCT00545077|560523191|FG001|Overall Study|Death|8|||
155298677|NCT03260140|560523192|FG000|Overall Study|Death|4|||
155298678|NCT03260140|560523193|FG001|Overall Study|Death|1|||
155298679|NCT03260140|560523192|FG000|Overall Study|Withdrawal by Subject|1|||
155298680|NCT03260140|560523193|FG001|Overall Study|Withdrawal by Subject|4|||
155298681|NCT01692938|560523196|FG000|Overall Study|Protocol Deviation|1|||
155298682|NCT01692938|560523197|FG001|Overall Study|Protocol Deviation|1|||
155640581|NCT03018938|561774409|FG000|Overall Study|Screen failure-After randomization|4|||
155640582|NCT03018938|561774410|FG001|Overall Study|Screen failure-After randomization|2|||
155640583|NCT03018938|561774409|FG000|Overall Study|Not recorded|0|||
155640584|NCT03018938|561774410|FG001|Overall Study|Not recorded|2|||
155298683|NCT01692938|560523196|FG000|Overall Study|Study completed prior to site completion|3|||
155298684|NCT01692938|560523197|FG001|Overall Study|Study completed prior to site completion|3|||
155640585|NCT01202591|561774411|FG000|Overall Study|Adverse Event|2|||
155640586|NCT01202591|561774412|FG001|Overall Study|Adverse Event|1|||
155298685|NCT02423291|560523201|FG000|Overall Study|Lack of Efficacy|14|||
155496877|NCT02057549|561242407|FG001|Overall Study|Withdrawal by Subject|0|||
155298686|NCT02423291|560523201|FG000|Overall Study|Adverse Event|1|||
155298687|NCT01063972|560523202|FG000|Overall Study|Death|12|||
155298688|NCT01063972|560523203|FG001|Overall Study|Death|11|||
155298689|NCT01063972|560523202|FG000|Overall Study|Incarcerated|2|||
155298690|NCT01063972|560523203|FG001|Overall Study|Incarcerated|1|||
155298691|NCT00959946|560523204|FG000|Overall Study|Adverse Event|0|||
155298692|NCT00959946|560523205|FG001|Overall Study|Adverse Event|0|||
155298693|NCT00959946|560523206|FG002|Overall Study|Adverse Event|2|||
155298694|NCT00959946|560523207|FG003|Overall Study|Adverse Event|1|||
155298695|NCT00959946|560523208|FG004|Overall Study|Adverse Event|0|||
155298696|NCT00959946|560523209|FG005|Overall Study|Adverse Event|1|||
155640587|NCT01202591|561774413|FG002|Overall Study|Adverse Event|4|||
155298697|NCT00959946|560523210|FG006|Overall Study|Adverse Event|0|||
155298698|NCT00959946|560523211|FG007|Overall Study|Adverse Event|0|||
155298699|NCT00959946|560523204|FG000|Overall Study|Death|0|||
155298700|NCT00959946|560523205|FG001|Overall Study|Death|0|||
155298701|NCT00959946|560523206|FG002|Overall Study|Death|0|||
155298702|NCT00959946|560523207|FG003|Overall Study|Death|0|||
155298703|NCT00959946|560523208|FG004|Overall Study|Death|0|||
155298704|NCT00959946|560523209|FG005|Overall Study|Death|1|||
155298705|NCT00959946|560523210|FG006|Overall Study|Death|0|||
155298706|NCT00959946|560523211|FG007|Overall Study|Death|0|||
155298707|NCT00959946|560523204|FG000|Overall Study|Disease Progression|2|||
155298708|NCT00959946|560523205|FG001|Overall Study|Disease Progression|4|||
155298709|NCT00959946|560523206|FG002|Overall Study|Disease Progression|2|||
155298710|NCT00959946|560523207|FG003|Overall Study|Disease Progression|4|||
155298711|NCT00959946|560523208|FG004|Overall Study|Disease Progression|4|||
155298712|NCT00959946|560523209|FG005|Overall Study|Disease Progression|6|||
155298713|NCT00959946|560523210|FG006|Overall Study|Disease Progression|2|||
155298714|NCT00959946|560523211|FG007|Overall Study|Disease Progression|2|||
155298715|NCT00959946|560523204|FG000|Overall Study|Withdrawal by Subject|0|||
155298716|NCT00959946|560523205|FG001|Overall Study|Withdrawal by Subject|0|||
155298717|NCT00959946|560523206|FG002|Overall Study|Withdrawal by Subject|0|||
155298718|NCT00959946|560523207|FG003|Overall Study|Withdrawal by Subject|0|||
155298719|NCT00959946|560523208|FG004|Overall Study|Withdrawal by Subject|0|||
155298720|NCT00959946|560523209|FG005|Overall Study|Withdrawal by Subject|1|||
155298721|NCT00959946|560523210|FG006|Overall Study|Withdrawal by Subject|0|||
155298722|NCT00959946|560523211|FG007|Overall Study|Withdrawal by Subject|0|||
155298723|NCT00566527|560523212|FG000|Overall Study|Reason not provided|3|||
155298724|NCT00566527|560523213|FG001|Overall Study|Reason not provided|11|||
155298725|NCT00566527|560523214|FG002|Overall Study|Reason not provided|10|||
155298726|NCT00566527|560523212|FG000|Overall Study|Adverse Event|2|||
155298727|NCT00566527|560523213|FG001|Overall Study|Adverse Event|0|||
155298728|NCT00566527|560523214|FG002|Overall Study|Adverse Event|1|||
155298729|NCT00566527|560523212|FG000|Overall Study|Physician Decision|3|||
155298730|NCT00566527|560523213|FG001|Overall Study|Physician Decision|8|||
155298731|NCT00566527|560523214|FG002|Overall Study|Physician Decision|20|||
155298732|NCT00566527|560523212|FG000|Overall Study|Lost to Follow-up|3|||
155298733|NCT00566527|560523213|FG001|Overall Study|Lost to Follow-up|4|||
155298734|NCT00566527|560523214|FG002|Overall Study|Lost to Follow-up|4|||
155298735|NCT00566527|560523212|FG000|Overall Study|Withdrawal by Subject|6|||
155298736|NCT00566527|560523213|FG001|Overall Study|Withdrawal by Subject|43|||
155298737|NCT00566527|560523214|FG002|Overall Study|Withdrawal by Subject|43|||
155298738|NCT01837966|560523215|FG000|Overall Study|Withdrawal by Subject|2|||
155298739|NCT01837966|560523216|FG001|Overall Study|Withdrawal by Subject|1|||
155298740|NCT04975308|560523220|FG000|Overall Study|Withdrawal by Subject|6|||
155298741|NCT04975308|560523221|FG001|Overall Study|Withdrawal by Subject|16|||
155298742|NCT04975308|560523222|FG002|Overall Study|Withdrawal by Subject|6|||
155298743|NCT04975308|560523220|FG000|Overall Study|Physician Decision|0|||
155298744|NCT04975308|560523221|FG001|Overall Study|Physician Decision|3|||
155298745|NCT04975308|560523222|FG002|Overall Study|Physician Decision|1|||
155298746|NCT04975308|560523220|FG000|Overall Study|Adverse Event|10|||
155298747|NCT04975308|560523221|FG001|Overall Study|Adverse Event|1|||
155298748|NCT04975308|560523222|FG002|Overall Study|Adverse Event|12|||
155298749|NCT04975308|560523220|FG000|Overall Study|On study treatment (Ongoing)|65|||
155298750|NCT04975308|560523221|FG001|Overall Study|On study treatment (Ongoing)|43|||
155298751|NCT04975308|560523222|FG002|Overall Study|On study treatment (Ongoing)|75|||
155298752|NCT04975308|560523220|FG000|Overall Study|Protocol Deviation|4|||
155298753|NCT04975308|560523221|FG001|Overall Study|Protocol Deviation|3|||
155298754|NCT04975308|560523222|FG002|Overall Study|Protocol Deviation|2|||
155298755|NCT00841035|560523228|FG000|Phase 1 Overall Study|Physician Decision|13|||
155298756|NCT00357097|560523233|FG000|Overall Study|Did not meet inclusion criteria|5|||
155298757|NCT00357097|560523234|FG001|Overall Study|Did not meet inclusion criteria|3|||
155298758|NCT00357097|560523233|FG000|Overall Study|Adverse Event|34|||
155298759|NCT00357097|560523234|FG001|Overall Study|Adverse Event|6|||
155298760|NCT00357097|560523233|FG000|Overall Study|Withdrawal by Subject|8|||
155298761|NCT00357097|560523234|FG001|Overall Study|Withdrawal by Subject|7|||
155298762|NCT00357097|560523233|FG000|Overall Study|Non-compliance|1|||
155298763|NCT00357097|560523234|FG001|Overall Study|Non-compliance|2|||
155298764|NCT00357097|560523233|FG000|Overall Study|Lack of Efficacy|2|||
155298765|NCT00357097|560523234|FG001|Overall Study|Lack of Efficacy|8|||
155298766|NCT00357097|560523233|FG000|Overall Study|Met Exclusion Criteria|3|||
155298767|NCT00357097|560523234|FG001|Overall Study|Met Exclusion Criteria|1|||
155298768|NCT00357097|560523233|FG000|Overall Study|Other|1|||
155298769|NCT00357097|560523234|FG001|Overall Study|Other|1|||
155298770|NCT00357097|560523233|FG000|Overall Study|Increase of RLS Symptoms|0|||
155298771|NCT00357097|560523234|FG001|Overall Study|Increase of RLS Symptoms|1|||
155298772|NCT00658996|560523235|FG000|First Intervention|Positive slit lamp finding|1|||
155298773|NCT00658996|560523236|FG001|First Intervention|Positive slit lamp finding|0|||
155298774|NCT00658996|560523235|FG000|First Intervention|Lack of lenses|0|||
155298775|NCT00658996|560523236|FG001|First Intervention|Lack of lenses|1|||
155298776|NCT00658996|560523235|FG000|Crossover Period|Physician Decision|1|||
155298777|NCT00658996|560523236|FG001|Crossover Period|Physician Decision|0|||
155298778|NCT00658996|560523235|FG000|Crossover Period|Ineligible|1|||
155298779|NCT00658996|560523236|FG001|Crossover Period|Ineligible|1|||
155298780|NCT00658996|560523235|FG000|Second Intervention|Developed a stye on upper lid|1|||
155298781|NCT00658996|560523236|FG001|Second Intervention|Developed a stye on upper lid|0|||
155298782|NCT00658996|560523235|FG000|Second Intervention|Positive slit lamp finding|0|||
155298783|NCT00658996|560523236|FG001|Second Intervention|Positive slit lamp finding|1|||
155298784|NCT02994654|560523238|FG000|Overall Study|Lost to Follow-up|1|||
155298785|NCT01121549|560523247|FG000|Overall Study|Adverse Event|10|||
155298786|NCT01121549|560523247|FG000|Overall Study|Lack of Efficacy|11|||
155298787|NCT01121549|560523247|FG000|Overall Study|Lost to Follow-up|12|||
155298788|NCT01121549|560523247|FG000|Overall Study|Did not meet entrance criteria|9|||
155298789|NCT01121549|560523247|FG000|Overall Study|Study terminated by sponsor|197|||
155298790|NCT01121549|560523247|FG000|Overall Study|Pregnancy|1|||
155298791|NCT01121549|560523247|FG000|Overall Study|Protocol Violation|33|||
155298792|NCT01121549|560523247|FG000|Overall Study|Withdrawal by Subject|16|||
155298793|NCT01121549|560523247|FG000|Overall Study|Other|58|||
155298794|NCT04250883|560524470|FG000|Overall Study|Lost to Follow-up|1|||
155298795|NCT04250883|560524471|FG001|Overall Study|Lost to Follow-up|0|||
155298796|NCT02763319|560524475|FG000|Overall Study|Adverse Event|12|||
155298797|NCT02763319|560524476|FG001|Overall Study|Adverse Event|3|||
155298798|NCT02763319|560524475|FG000|Overall Study|Death|123|||
155298799|NCT02763319|560524476|FG001|Overall Study|Death|123|||
155298800|NCT02763319|560524475|FG000|Overall Study|Lost to Follow-up|6|||
155298801|NCT02763319|560524476|FG001|Overall Study|Lost to Follow-up|7|||
155298802|NCT02763319|560524475|FG000|Overall Study|Noncompliance with Study Drug|2|||
155298803|NCT02763319|560524476|FG001|Overall Study|Noncompliance with Study Drug|0|||
155298804|NCT02763319|560524475|FG000|Overall Study|"Captured as Other in Database"|29|||
155298805|NCT02763319|560524476|FG001|Overall Study|"Captured as Other in Database"|34|||
155298806|NCT02763319|560524475|FG000|Overall Study|Physician Decision|1|||
155298807|NCT02763319|560524476|FG001|Overall Study|Physician Decision|7|||
155298808|NCT02763319|560524475|FG000|Overall Study|Progressive Disease|24|||
155298809|NCT02763319|560524476|FG001|Overall Study|Progressive Disease|27|||
155298810|NCT02763319|560524475|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
155298811|NCT02763319|560524476|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
155298812|NCT02763319|560524475|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
155298813|NCT02763319|560524476|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
155298814|NCT02763319|560524475|FG000|Overall Study|Withdrawal by Subject|26|||
155298815|NCT02763319|560524476|FG001|Overall Study|Withdrawal by Subject|25|||
155298816|NCT04603924|560524478|FG000|Overall Study|Not Dosed|2|||
155298817|NCT04603924|560524479|FG001|Overall Study|Not Dosed|1|||
155298818|NCT04603924|560524478|FG000|Overall Study|Withdrawal by Subject|6|||
155298819|NCT04603924|560524479|FG001|Overall Study|Withdrawal by Subject|6|||
155298820|NCT04603924|560524478|FG000|Overall Study|Adverse Event|2|||
155298821|NCT04603924|560524479|FG001|Overall Study|Adverse Event|2|||
155298822|NCT03762668|560524482|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
155298823|NCT03762668|560524483|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
155298824|NCT00686855|560524487|FG000|Overall Study|Lost to Follow-up|1|||
155298825|NCT00686855|560524488|FG001|Overall Study|Lost to Follow-up|0|||
155298826|NCT00686855|560524487|FG000|Overall Study|Progressive GVHD|0|||
155298827|NCT00686855|560524488|FG001|Overall Study|Progressive GVHD|1|||
155298828|NCT02731755|560524491|FG000|First Intervention|Withdrawal by Subject|0|||
155298829|NCT02731755|560524492|FG001|First Intervention|Withdrawal by Subject|2|||
155298830|NCT01460446|560524493|FG000|Overall Study|Non-compliance|2|||
155298831|NCT01460446|560524494|FG001|Overall Study|Non-compliance|9|||
155298832|NCT01460446|560524493|FG000|Overall Study|Consent Withdrawn|0|||
155298833|NCT01460446|560524494|FG001|Overall Study|Consent Withdrawn|4|||
155298834|NCT01460446|560524493|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
155298835|NCT01460446|560524494|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
155298836|NCT01460446|560524493|FG000|Overall Study|Surgery/Illness|1|||
155298837|NCT01460446|560524494|FG001|Overall Study|Surgery/Illness|1|||
155298838|NCT01460446|560524493|FG000|Overall Study|Pregnancy|1|||
155298839|NCT01460446|560524494|FG001|Overall Study|Pregnancy|0|||
155298840|NCT01460446|560524493|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
155298841|NCT01460446|560524494|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
155298842|NCT00714714|560524495|FG000|Overall Study|Adverse Event|1|||
155496878|NCT04636437|561242410|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
155298843|NCT02616900|560524496|FG000|Overall Study|Lack of Efficacy|7|||
155298844|NCT02616900|560524496|FG000|Overall Study|Lost to Follow-up|2|||
155298845|NCT02616900|560524496|FG000|Overall Study|Protocol Violation|5|||
155298846|NCT02616900|560524496|FG000|Overall Study|Withdrawal by Subject|3|||
155298847|NCT02616900|560524496|FG000|Overall Study|Incomplete data|6|||
155298848|NCT03644849|560524499|FG000|Overall Study|Lost to Follow-up|1|||
155298849|NCT03644849|560524500|FG001|Overall Study|Lost to Follow-up|3|||
155298850|NCT02613871|560524501|FG000|Overall Study|Death|2|||
155298851|NCT02613871|560524501|FG000|Overall Study|Withdrew Consent|1|||
155298852|NCT00980330|560524502|FG000|Overall Study|Adverse Event|0|||
155298853|NCT00980330|560524503|FG001|Overall Study|Adverse Event|0|||
155298854|NCT00980330|560524504|FG002|Overall Study|Adverse Event|0|||
155298855|NCT00980330|560524505|FG003|Overall Study|Adverse Event|1|||
155298856|NCT00980330|560524506|FG004|Overall Study|Adverse Event|0|||
155298857|NCT00980330|560524507|FG005|Overall Study|Adverse Event|0|||
155298858|NCT00980330|560524508|FG006|Overall Study|Adverse Event|0|||
155298859|NCT00980330|560524502|FG000|Overall Study|Lost to Follow-up|1|||
155298860|NCT00980330|560524503|FG001|Overall Study|Lost to Follow-up|1|||
155298861|NCT00980330|560524504|FG002|Overall Study|Lost to Follow-up|4|||
155298862|NCT00980330|560524505|FG003|Overall Study|Lost to Follow-up|2|||
155298863|NCT00980330|560524506|FG004|Overall Study|Lost to Follow-up|1|||
155298864|NCT00980330|560524507|FG005|Overall Study|Lost to Follow-up|1|||
155298865|NCT00980330|560524508|FG006|Overall Study|Lost to Follow-up|2|||
155298866|NCT00980330|560524502|FG000|Overall Study|Withdrawal by Subject|2|||
155298867|NCT00980330|560524503|FG001|Overall Study|Withdrawal by Subject|4|||
155298868|NCT00980330|560524504|FG002|Overall Study|Withdrawal by Subject|4|||
155298869|NCT00980330|560524505|FG003|Overall Study|Withdrawal by Subject|1|||
155298870|NCT00980330|560524506|FG004|Overall Study|Withdrawal by Subject|3|||
155298871|NCT00980330|560524507|FG005|Overall Study|Withdrawal by Subject|2|||
155298872|NCT00980330|560524508|FG006|Overall Study|Withdrawal by Subject|5|||
155298873|NCT00980330|560524502|FG000|Overall Study|(not specified)|2|||
155298874|NCT00980330|560524503|FG001|Overall Study|(not specified)|0|||
155298875|NCT00980330|560524504|FG002|Overall Study|(not specified)|0|||
155298876|NCT00980330|560524505|FG003|Overall Study|(not specified)|1|||
155298877|NCT00980330|560524506|FG004|Overall Study|(not specified)|1|||
155298878|NCT00980330|560524507|FG005|Overall Study|(not specified)|1|||
155298879|NCT00980330|560524508|FG006|Overall Study|(not specified)|0|||
155298880|NCT04054635|560524509|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
155298881|NCT04054635|560524510|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
155298882|NCT04054635|560524511|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
155298883|NCT04054635|560524509|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
155298884|NCT04054635|560524510|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
155298885|NCT04054635|560524511|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
155298886|NCT03737240|560524512|FG000|Overall Study|Lost to Follow-up|16|||
155298887|NCT03737240|560524513|FG001|Overall Study|Lost to Follow-up|15|||
155298888|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
155298889|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
155298890|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
155298891|NCT00891930|560524514|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
155298892|NCT00891930|560524514|FG000|Part 2 Panitumumab + AMG479|Death|30|||
155298893|NCT05001945|560524515|FG000|Overall Study|Adverse Event|0|||
155298894|NCT05001945|560524516|FG001|Overall Study|Adverse Event|0|||
155298895|NCT05001945|560524517|FG002|Overall Study|Adverse Event|0|||
155298896|NCT05001945|560524518|FG003|Overall Study|Adverse Event|1|||
155298897|NCT05001945|560524519|FG004|Overall Study|Adverse Event|0|||
155298898|NCT05001945|560524520|FG005|Overall Study|Adverse Event|0|||
155298899|NCT05001945|560524521|FG006|Overall Study|Adverse Event|0|||
155298900|NCT05001945|560524522|FG007|Overall Study|Adverse Event|0|||
155298901|NCT05001945|560524515|FG000|Overall Study|Lost to Follow-up|0|||
155298902|NCT05001945|560524516|FG001|Overall Study|Lost to Follow-up|1|||
155298903|NCT05001945|560524517|FG002|Overall Study|Lost to Follow-up|1|||
155298904|NCT05001945|560524518|FG003|Overall Study|Lost to Follow-up|2|||
155298905|NCT05001945|560524519|FG004|Overall Study|Lost to Follow-up|0|||
155298906|NCT05001945|560524520|FG005|Overall Study|Lost to Follow-up|1|||
155298907|NCT05001945|560524521|FG006|Overall Study|Lost to Follow-up|0|||
155298908|NCT05001945|560524522|FG007|Overall Study|Lost to Follow-up|0|||
155298909|NCT05001945|560524515|FG000|Overall Study|Protocol Violation|1|||
155298910|NCT05001945|560524516|FG001|Overall Study|Protocol Violation|0|||
155298911|NCT05001945|560524517|FG002|Overall Study|Protocol Violation|1|||
155298912|NCT05001945|560524518|FG003|Overall Study|Protocol Violation|1|||
155640588|NCT01202591|561774414|FG003|Overall Study|Adverse Event|4|||
155640589|NCT01202591|561774415|FG004|Overall Study|Adverse Event|0|||
155640590|NCT01202591|561774416|FG005|Overall Study|Adverse Event|0|||
155640591|NCT01202591|561774411|FG000|Overall Study|Other reason as per investigator|3|||
155640592|NCT01202591|561774412|FG001|Overall Study|Other reason as per investigator|4|||
155640593|NCT01202591|561774413|FG002|Overall Study|Other reason as per investigator|7|||
155640594|NCT01202591|561774414|FG003|Overall Study|Other reason as per investigator|3|||
155640595|NCT01202591|561774415|FG004|Overall Study|Other reason as per investigator|1|||
155640596|NCT01202591|561774416|FG005|Overall Study|Other reason as per investigator|3|||
155640597|NCT01202591|561774411|FG000|Overall Study|Withdrawal by Subject|0|||
155640598|NCT01202591|561774412|FG001|Overall Study|Withdrawal by Subject|0|||
155640599|NCT01202591|561774413|FG002|Overall Study|Withdrawal by Subject|0|||
155640600|NCT01202591|561774414|FG003|Overall Study|Withdrawal by Subject|0|||
155640601|NCT01202591|561774415|FG004|Overall Study|Withdrawal by Subject|2|||
155640602|NCT01202591|561774416|FG005|Overall Study|Withdrawal by Subject|1|||
155640603|NCT01202591|561774411|FG000|Overall Study|Objective Disease Progression|0|||
155298913|NCT05001945|560524519|FG004|Overall Study|Protocol Violation|0|||
155298914|NCT05001945|560524520|FG005|Overall Study|Protocol Violation|1|||
155640604|NCT01202591|561774412|FG001|Overall Study|Objective Disease Progression|0|||
155640605|NCT01202591|561774413|FG002|Overall Study|Objective Disease Progression|0|||
155640606|NCT01202591|561774414|FG003|Overall Study|Objective Disease Progression|0|||
155745425|NCT02431260|562167534|FG008|Overall Study|Lost to Follow-up|0|||
155745426|NCT02431260|562167535|FG009|Overall Study|Lost to Follow-up|0|||
155745427|NCT02431260|562167536|FG010|Overall Study|Lost to Follow-up|0|||
155745428|NCT02431260|562167537|FG011|Overall Study|Lost to Follow-up|0|||
155745429|NCT02431260|562167538|FG012|Overall Study|Lost to Follow-up|0|||
155745430|NCT02431260|562167539|FG013|Overall Study|Lost to Follow-up|0|||
155745431|NCT02431260|562167526|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155298915|NCT05001945|560524521|FG006|Overall Study|Protocol Violation|0|||
155298916|NCT05001945|560524522|FG007|Overall Study|Protocol Violation|0|||
155298917|NCT05001945|560524515|FG000|Overall Study|Withdrawal by Subject|0|||
155298918|NCT05001945|560524516|FG001|Overall Study|Withdrawal by Subject|0|||
155298919|NCT05001945|560524517|FG002|Overall Study|Withdrawal by Subject|0|||
155298920|NCT05001945|560524518|FG003|Overall Study|Withdrawal by Subject|1|||
155745432|NCT02431260|562167527|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155745433|NCT02431260|562167528|FG002|Overall Study|Study Terminated by the Sponsor|2|||
155298921|NCT05001945|560524519|FG004|Overall Study|Withdrawal by Subject|1|||
155298922|NCT05001945|560524520|FG005|Overall Study|Withdrawal by Subject|1|||
155298923|NCT05001945|560524521|FG006|Overall Study|Withdrawal by Subject|0|||
155298924|NCT05001945|560524522|FG007|Overall Study|Withdrawal by Subject|1|||
155298925|NCT05001945|560524515|FG000|Overall Study|Not specified by Investigator|0|||
155298926|NCT05001945|560524516|FG001|Overall Study|Not specified by Investigator|3|||
155745434|NCT02431260|562167529|FG003|Overall Study|Study Terminated by the Sponsor|1|||
155298927|NCT05001945|560524517|FG002|Overall Study|Not specified by Investigator|0|||
155298928|NCT05001945|560524518|FG003|Overall Study|Not specified by Investigator|0|||
155745435|NCT02431260|562167530|FG004|Overall Study|Study Terminated by the Sponsor|1|||
155745436|NCT02431260|562167531|FG005|Overall Study|Study Terminated by the Sponsor|0|||
155745437|NCT02431260|562167532|FG006|Overall Study|Study Terminated by the Sponsor|1|||
155298929|NCT05001945|560524519|FG004|Overall Study|Not specified by Investigator|1|||
155298930|NCT05001945|560524520|FG005|Overall Study|Not specified by Investigator|0|||
155298931|NCT05001945|560524521|FG006|Overall Study|Not specified by Investigator|0|||
155298932|NCT05001945|560524522|FG007|Overall Study|Not specified by Investigator|0|||
155298933|NCT02448446|560524523|FG000|Overall Study|Withdrawal by Subject|1|||
155298934|NCT02448446|560524524|FG001|Overall Study|Withdrawal by Subject|0|||
155298935|NCT02957136|560524530|FG000|Overall Study|Withdrawal by Subject|2|||
155298936|NCT02957136|560524531|FG001|Overall Study|Withdrawal by Subject|1|||
155745438|NCT02431260|562167533|FG007|Overall Study|Study Terminated by the Sponsor|2|||
155745439|NCT02431260|562167534|FG008|Overall Study|Study Terminated by the Sponsor|1|||
155298937|NCT00439569|560524532|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
155298938|NCT00439569|560524532|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
155298939|NCT00439569|560524532|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
155298940|NCT02214160|560524533|FG000|Overall Study|Withdrawal by Subject|1|||
155298941|NCT02214160|560524534|FG001|Overall Study|Withdrawal by Subject|0|||
155640607|NCT01202591|561774415|FG004|Overall Study|Objective Disease Progression|2|||
155640608|NCT01202591|561774416|FG005|Overall Study|Objective Disease Progression|0|||
155640609|NCT00191100|561774419|FG000|Overall Study|Adverse Event|18|||
155745440|NCT02431260|562167535|FG009|Overall Study|Study Terminated by the Sponsor|1|||
155745441|NCT02431260|562167536|FG010|Overall Study|Study Terminated by the Sponsor|1|||
155298942|NCT02214160|560524535|FG002|Overall Study|Withdrawal by Subject|6|||
155298943|NCT02214160|560524533|FG000|Overall Study|Death|2|||
155298944|NCT02214160|560524534|FG001|Overall Study|Death|2|||
155298945|NCT02214160|560524535|FG002|Overall Study|Death|1|||
155298946|NCT02214160|560524533|FG000|Overall Study|Subject Non-Compliance|0|||
155298947|NCT02214160|560524534|FG001|Overall Study|Subject Non-Compliance|3|||
155298948|NCT02214160|560524535|FG002|Overall Study|Subject Non-Compliance|1|||
155298949|NCT02214160|560524533|FG000|Overall Study|Adverse Event|0|||
155298950|NCT02214160|560524534|FG001|Overall Study|Adverse Event|1|||
155298951|NCT02214160|560524535|FG002|Overall Study|Adverse Event|1|||
155298952|NCT02214160|560524533|FG000|Overall Study|Sponsor Decision|0|||
155298953|NCT02214160|560524534|FG001|Overall Study|Sponsor Decision|2|||
155298954|NCT02214160|560524535|FG002|Overall Study|Sponsor Decision|0|||
155298955|NCT02214160|560524533|FG000|Overall Study|Protocol Violation|1|||
155298956|NCT02214160|560524534|FG001|Overall Study|Protocol Violation|0|||
155298957|NCT02214160|560524535|FG002|Overall Study|Protocol Violation|0|||
155298958|NCT02214160|560524533|FG000|Overall Study|Physician Decision|0|||
155298959|NCT02214160|560524534|FG001|Overall Study|Physician Decision|0|||
155298960|NCT02214160|560524535|FG002|Overall Study|Physician Decision|1|||
155298961|NCT01510717|560524536|FG000|Overall Study|Adverse Event|1|||
155298962|NCT01510717|560524537|FG001|Overall Study|Adverse Event|2|||
155298963|NCT01510717|560524536|FG000|Overall Study|Death|1|||
155298964|NCT01510717|560524537|FG001|Overall Study|Death|0|||
155298965|NCT01510717|560524536|FG000|Overall Study|Lost to Follow-up|0|||
155298966|NCT01510717|560524537|FG001|Overall Study|Lost to Follow-up|1|||
155298967|NCT01510717|560524536|FG000|Overall Study|Withdrawal by Subject|0|||
155298968|NCT01510717|560524537|FG001|Overall Study|Withdrawal by Subject|2|||
155298969|NCT02555215|560524543|FG000|Overall Study|Other|1|||
155298970|NCT02555215|560524543|FG000|Overall Study|Investigator Decision|2|||
155298971|NCT00529789|560524544|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
155298972|NCT00529789|560524544|FG000|Study Period II/III|Adverse Event|3|||
155298973|NCT00529789|560524544|FG000|Study Period II/III|Lack of Efficacy|2|||
155298974|NCT00529789|560524544|FG000|Study Period II/III|Withdrawal by Subject|1|||
155298975|NCT00529789|560524544|FG000|Study Period II/III|Protocol Violation|3|||
155298976|NCT00529789|560524544|FG000|Study Period II/III|Physician Decision|3|||
155298977|NCT00529789|560524544|FG000|Study Period II/III|Lost to Follow-up|3|||
155298978|NCT00529789|560524544|FG000|Study Period IV|Parent/Caregiver Decision|1|||
155298979|NCT00529789|560524544|FG000|Study Period IV|Adverse Event|1|||
155298980|NCT00529789|560524544|FG000|Study Period IV|Lack of Efficacy|1|||
155298981|NCT00529789|560524544|FG000|Study Period IV|Lost to Follow-up|3|||
155298982|NCT01968226|560524545|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
155298983|NCT00457743|560524549|FG000|Overall Study|Adverse Event|0|||
155298984|NCT00457743|560524550|FG001|Overall Study|Adverse Event|4|||
155298985|NCT00457743|560524551|FG002|Overall Study|Adverse Event|0|||
155298986|NCT00457743|560524549|FG000|Overall Study|Lack of Efficacy|3|||
155298987|NCT00457743|560524550|FG001|Overall Study|Lack of Efficacy|23|||
155298988|NCT00457743|560524551|FG002|Overall Study|Lack of Efficacy|3|||
155298989|NCT01202955|560524552|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
155298990|NCT01202955|560524553|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
155298991|NCT02928224|560524554|FG000|Overall Study|Lost to Follow-up|1|||
155298992|NCT02928224|560524555|FG001|Overall Study|Lost to Follow-up|1|||
155298993|NCT02928224|560524556|FG002|Overall Study|Lost to Follow-up|3|||
155298994|NCT02928224|560524557|FG003|Overall Study|Lost to Follow-up|0|||
155298995|NCT02928224|560524554|FG000|Overall Study|Death|30|||
155298996|NCT02928224|560524555|FG001|Overall Study|Death|209|||
155298997|NCT02928224|560524556|FG002|Overall Study|Death|193|||
155298998|NCT02928224|560524557|FG003|Overall Study|Death|198|||
155298999|NCT02928224|560524554|FG000|Overall Study|Withdrawal by Subject|0|||
155299000|NCT02928224|560524555|FG001|Overall Study|Withdrawal by Subject|3|||
155745442|NCT02431260|562167537|FG011|Overall Study|Study Terminated by the Sponsor|0|||
155745443|NCT02431260|562167538|FG012|Overall Study|Study Terminated by the Sponsor|4|||
155745444|NCT02431260|562167539|FG013|Overall Study|Study Terminated by the Sponsor|0|||
155745445|NCT02431260|562167526|FG000|Overall Study|Physician Decision|0|||
155745446|NCT02431260|562167527|FG001|Overall Study|Physician Decision|0|||
155745447|NCT02431260|562167528|FG002|Overall Study|Physician Decision|0|||
155745448|NCT02431260|562167529|FG003|Overall Study|Physician Decision|0|||
155745449|NCT02431260|562167530|FG004|Overall Study|Physician Decision|0|||
155745450|NCT02431260|562167531|FG005|Overall Study|Physician Decision|1|||
155745451|NCT02431260|562167532|FG006|Overall Study|Physician Decision|0|||
155745452|NCT02431260|562167533|FG007|Overall Study|Physician Decision|0|||
155745453|NCT02431260|562167534|FG008|Overall Study|Physician Decision|0|||
155745454|NCT02431260|562167535|FG009|Overall Study|Physician Decision|0|||
155745455|NCT02431260|562167536|FG010|Overall Study|Physician Decision|0|||
155745456|NCT02431260|562167537|FG011|Overall Study|Physician Decision|0|||
155745457|NCT02431260|562167538|FG012|Overall Study|Physician Decision|0|||
155745458|NCT02431260|562167539|FG013|Overall Study|Physician Decision|0|||
155745459|NCT02431260|562167526|FG000|Overall Study|Other Unspecified|0|||
155745460|NCT02431260|562167527|FG001|Overall Study|Other Unspecified|0|||
155299001|NCT02928224|560524556|FG002|Overall Study|Withdrawal by Subject|7|||
155299002|NCT02928224|560524557|FG003|Overall Study|Withdrawal by Subject|20|||
155299003|NCT02928224|560524554|FG000|Overall Study|Study participation terminated by sponsor|3|||
155299004|NCT02928224|560524555|FG001|Overall Study|Study participation terminated by sponsor|8|||
155299005|NCT02928224|560524556|FG002|Overall Study|Study participation terminated by sponsor|12|||
155299006|NCT02928224|560524557|FG003|Overall Study|Study participation terminated by sponsor|3|||
155299007|NCT02928224|560524554|FG000|Overall Study|Other|3|||
155299008|NCT02928224|560524555|FG001|Overall Study|Other|3|||
155299009|NCT02928224|560524556|FG002|Overall Study|Other|5|||
155299010|NCT02928224|560524557|FG003|Overall Study|Other|0|||
155299011|NCT01278394|560524558|FG000|Overall Study|Lost to Follow-up|1|||
155299012|NCT00468910|560524559|FG000|Overall Study|Lost to Follow-up|2|||
155299013|NCT00468910|560524560|FG001|Overall Study|Lost to Follow-up|1|||
155299014|NCT00468910|560524559|FG000|Overall Study|Withdrawal by Subject|2|||
155299015|NCT00468910|560524560|FG001|Overall Study|Withdrawal by Subject|1|||
155299016|NCT00468910|560524559|FG000|Overall Study|Medical Contraindication|0|||
155299017|NCT00468910|560524560|FG001|Overall Study|Medical Contraindication|1|||
155299018|NCT01909778|560524561|FG000|Overall Study|failed screening|1|||
155299019|NCT05323734|560524563|FG000|Overall Study|Adverse Event|5|||
155299020|NCT05323734|560524564|FG001|Overall Study|Adverse Event|2|||
155299021|NCT05323734|560524563|FG000|Overall Study|Physician Decision|1|||
155299022|NCT05323734|560524564|FG001|Overall Study|Physician Decision|0|||
155299023|NCT05323734|560524563|FG000|Overall Study|Lack of Efficacy|1|||
155299024|NCT05323734|560524564|FG001|Overall Study|Lack of Efficacy|2|||
155299025|NCT05323734|560524563|FG000|Overall Study|Withdrawal by Subject|2|||
155299026|NCT05323734|560524564|FG001|Overall Study|Withdrawal by Subject|0|||
155299027|NCT05323734|560524563|FG000|Overall Study|Participant Withdrawn Due|0|||
155299028|NCT05323734|560524564|FG001|Overall Study|Participant Withdrawn Due|1|||
155299029|NCT00457691|560524568|FG000|Overall Study|Adverse Event|4|||
155299030|NCT00457691|560524569|FG001|Overall Study|Adverse Event|1|||
155299031|NCT00457691|560524568|FG000|Overall Study|Death|163|||
155299032|NCT00457691|560524569|FG001|Overall Study|Death|148|||
155299033|NCT00457691|560524568|FG000|Overall Study|Protocol Violation|1|||
155299034|NCT00457691|560524569|FG001|Overall Study|Protocol Violation|3|||
155299035|NCT00457691|560524568|FG000|Overall Study|Lost to Follow-up|23|||
155299036|NCT00457691|560524569|FG001|Overall Study|Lost to Follow-up|14|||
155299037|NCT00457691|560524568|FG000|Overall Study|Study terminated by Sponsor|1|||
155299038|NCT00457691|560524569|FG001|Overall Study|Study terminated by Sponsor|1|||
155299039|NCT00457691|560524568|FG000|Overall Study|Subject refused (reason other than AE)|14|||
155299040|NCT00457691|560524569|FG001|Overall Study|Subject refused (reason other than AE)|19|||
155299041|NCT00457691|560524568|FG000|Overall Study|Disease progression, study terminated|180|||
155299042|NCT00457691|560524569|FG001|Overall Study|Disease progression, study terminated|196|||
155299043|NCT01353963|560524570|FG000|Overall Study|Adverse Event|2|||
155299044|NCT01420549|560524571|FG000|Overall Study|Adverse Event|1|||
155299045|NCT01420549|560524572|FG001|Overall Study|Adverse Event|1|||
155299046|NCT01420549|560524571|FG000|Overall Study|Lost to Follow-up|2|||
155299047|NCT01420549|560524572|FG001|Overall Study|Lost to Follow-up|2|||
155299048|NCT01420549|560524571|FG000|Overall Study|Protocol Violation|0|||
155299049|NCT01420549|560524572|FG001|Overall Study|Protocol Violation|1|||
155299050|NCT01420549|560524571|FG000|Overall Study|Non-adherence to medication|4|||
155299051|NCT01420549|560524572|FG001|Overall Study|Non-adherence to medication|1|||
155299052|NCT03073941|560526336|FG000|Overall Study|Received non-study device intraoperatively|0|||
155299053|NCT03073941|560526337|FG001|Overall Study|Received non-study device intraoperatively|2|||
155299054|NCT03073941|560526336|FG000|Overall Study|Death|1|||
155299055|NCT03073941|560526337|FG001|Overall Study|Death|0|||
155299056|NCT03073941|560526336|FG000|Overall Study|Withdrawal by Subject|1|||
155299057|NCT03073941|560526337|FG001|Overall Study|Withdrawal by Subject|3|||
155745461|NCT02431260|562167528|FG002|Overall Study|Other Unspecified|0|||
155299058|NCT03073941|560526336|FG000|Overall Study|Lost to Follow-up|5|||
155299059|NCT03073941|560526337|FG001|Overall Study|Lost to Follow-up|4|||
155299060|NCT03073941|560526336|FG000|Overall Study|Adverse Event|4|||
155299061|NCT03073941|560526337|FG001|Overall Study|Adverse Event|2|||
155299062|NCT03073941|560526336|FG000|Overall Study|Met an exclusion criterion|0|||
155299063|NCT03073941|560526337|FG001|Overall Study|Met an exclusion criterion|1|||
155299064|NCT03936660|560526339|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
155299065|NCT03936660|560526340|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
155745462|NCT02431260|562167529|FG003|Overall Study|Other Unspecified|0|||
155745463|NCT02431260|562167530|FG004|Overall Study|Other Unspecified|0|||
155745464|NCT02431260|562167531|FG005|Overall Study|Other Unspecified|0|||
155745465|NCT02431260|562167532|FG006|Overall Study|Other Unspecified|0|||
155745466|NCT02431260|562167533|FG007|Overall Study|Other Unspecified|0|||
155745467|NCT02431260|562167534|FG008|Overall Study|Other Unspecified|0|||
155745468|NCT02431260|562167535|FG009|Overall Study|Other Unspecified|0|||
155745469|NCT02431260|562167536|FG010|Overall Study|Other Unspecified|0|||
155745470|NCT02431260|562167537|FG011|Overall Study|Other Unspecified|1|||
155745471|NCT02431260|562167538|FG012|Overall Study|Other Unspecified|1|||
155299066|NCT01391832|560526341|FG000|Overall Study|Withdrawal by Subject|21|||
155299067|NCT01391832|560526342|FG001|Overall Study|Withdrawal by Subject|22|||
155745472|NCT02431260|562167539|FG013|Overall Study|Other Unspecified|0|||
155299068|NCT01391832|560526341|FG000|Overall Study|Lost to Follow-up|0|||
155299069|NCT01391832|560526342|FG001|Overall Study|Lost to Follow-up|1|||
155299070|NCT00722046|560526345|FG000|Overall Study|Adverse Event|0|||
155299071|NCT00722046|560526346|FG001|Overall Study|Adverse Event|1|||
155299072|NCT00722046|560526347|FG002|Overall Study|Adverse Event|2|||
155299073|NCT00722046|560526348|FG003|Overall Study|Adverse Event|1|||
155299074|NCT00722046|560526349|FG004|Overall Study|Adverse Event|2|||
155299075|NCT00722046|560526350|FG005|Overall Study|Adverse Event|1|||
155299076|NCT00722046|560526351|FG006|Overall Study|Adverse Event|0|||
155299077|NCT00722046|560526345|FG000|Overall Study|Death|0|||
155299078|NCT00722046|560526346|FG001|Overall Study|Death|1|||
155299079|NCT00722046|560526347|FG002|Overall Study|Death|0|||
155299080|NCT00722046|560526348|FG003|Overall Study|Death|0|||
155299081|NCT00722046|560526349|FG004|Overall Study|Death|0|||
155299082|NCT00722046|560526350|FG005|Overall Study|Death|0|||
155299083|NCT00722046|560526351|FG006|Overall Study|Death|2|||
155299084|NCT00722046|560526345|FG000|Overall Study|Protocol Violation|1|||
155299085|NCT00722046|560526346|FG001|Overall Study|Protocol Violation|0|||
155299086|NCT00722046|560526347|FG002|Overall Study|Protocol Violation|0|||
155299087|NCT00722046|560526348|FG003|Overall Study|Protocol Violation|0|||
155299088|NCT00722046|560526349|FG004|Overall Study|Protocol Violation|0|||
155299089|NCT00722046|560526350|FG005|Overall Study|Protocol Violation|1|||
155299090|NCT00722046|560526351|FG006|Overall Study|Protocol Violation|0|||
155299091|NCT00722046|560526345|FG000|Overall Study|Withdrawal by Subject|3|||
155299092|NCT00722046|560526346|FG001|Overall Study|Withdrawal by Subject|3|||
155299093|NCT00722046|560526347|FG002|Overall Study|Withdrawal by Subject|4|||
155299094|NCT00722046|560526348|FG003|Overall Study|Withdrawal by Subject|4|||
155299095|NCT00722046|560526349|FG004|Overall Study|Withdrawal by Subject|4|||
155299096|NCT00722046|560526350|FG005|Overall Study|Withdrawal by Subject|7|||
155299097|NCT00722046|560526351|FG006|Overall Study|Withdrawal by Subject|3|||
155299098|NCT00722046|560526345|FG000|Overall Study|Randomized, but not treated|1|||
155299099|NCT00722046|560526346|FG001|Overall Study|Randomized, but not treated|1|||
155299100|NCT00722046|560526347|FG002|Overall Study|Randomized, but not treated|0|||
155299101|NCT00722046|560526348|FG003|Overall Study|Randomized, but not treated|2|||
155299102|NCT00722046|560526349|FG004|Overall Study|Randomized, but not treated|0|||
155299103|NCT00722046|560526350|FG005|Overall Study|Randomized, but not treated|0|||
155299104|NCT00722046|560526351|FG006|Overall Study|Randomized, but not treated|0|||
155299105|NCT00722046|560526345|FG000|Overall Study|Other|0|||
155299106|NCT00722046|560526346|FG001|Overall Study|Other|0|||
155299107|NCT00722046|560526347|FG002|Overall Study|Other|1|||
155299108|NCT00722046|560526348|FG003|Overall Study|Other|1|||
155299109|NCT00722046|560526349|FG004|Overall Study|Other|3|||
155299110|NCT00722046|560526350|FG005|Overall Study|Other|2|||
155299111|NCT00722046|560526351|FG006|Overall Study|Other|1|||
155299112|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
155299113|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
155299114|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
155640610|NCT00191100|561774420|FG001|Overall Study|Adverse Event|1|||
155299115|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
155299116|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
155299117|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
155299118|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
155299119|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
155410751|NCT03257267|560937475|FG000|Overall Study|Adverse Event|17|||
155299120|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
155299121|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
155299122|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
155299123|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
155299124|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
155299125|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
155299126|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
155299127|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
155299128|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
155299129|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
155299130|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
155299131|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
155299132|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
155299133|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
155299134|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
155299135|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
155299136|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
155299137|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
155299138|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
155299139|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
155299140|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
155299141|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
155299142|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
155299143|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
155299144|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
155299145|NCT01599104|560526366|FG000|Overall Study|Withdrawal by Subject|1|||
155299146|NCT01599104|560526367|FG001|Overall Study|Withdrawal by Subject|1|||
155299147|NCT01599104|560526368|FG002|Overall Study|Withdrawal by Subject|2|||
155299148|NCT01599104|560526366|FG000|Overall Study|Technical Problems|1|||
155299149|NCT01599104|560526367|FG001|Overall Study|Technical Problems|0|||
155299150|NCT01599104|560526368|FG002|Overall Study|Technical Problems|0|||
155299151|NCT01599104|560526366|FG000|Overall Study|Physician Decision|3|||
155299152|NCT01599104|560526367|FG001|Overall Study|Physician Decision|2|||
155299153|NCT01599104|560526368|FG002|Overall Study|Physician Decision|2|||
155299154|NCT01599104|560526366|FG000|Overall Study|Non-compliance with study treatment|0|||
155299155|NCT01599104|560526367|FG001|Overall Study|Non-compliance with study treatment|1|||
155299156|NCT01599104|560526368|FG002|Overall Study|Non-compliance with study treatment|0|||
155299157|NCT01599104|560526366|FG000|Overall Study|Lack of Efficacy|4|||
155299158|NCT01599104|560526367|FG001|Overall Study|Lack of Efficacy|4|||
155299159|NCT01599104|560526368|FG002|Overall Study|Lack of Efficacy|10|||
155299160|NCT01599104|560526366|FG000|Overall Study|Adverse Event|7|||
155299161|NCT01599104|560526367|FG001|Overall Study|Adverse Event|6|||
155299162|NCT01599104|560526368|FG002|Overall Study|Adverse Event|12|||
155299163|NCT02271854|560526371|FG000|Overall Study|Withdrawal by Subject|2|||
155299164|NCT02271854|560526371|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
155299165|NCT02271854|560526371|FG000|Overall Study|Lost to Follow-up|1|||
155299166|NCT01185561|560526374|FG000|Overall Study|Lost to Follow-up|0|||
155299167|NCT01185561|560526375|FG001|Overall Study|Lost to Follow-up|4|||
155299168|NCT01185561|560526374|FG000|Overall Study|Withdrawal by Subject|2|||
155299169|NCT01185561|560526375|FG001|Overall Study|Withdrawal by Subject|8|||
155299170|NCT01078116|560526376|FG000|Overall Study|Lost to Follow-up|17|||
155299171|NCT01078116|560526376|FG000|Overall Study|Adverse Event|5|||
155299172|NCT01078116|560526376|FG000|Overall Study|Withdrawal by Subject|8|||
155299173|NCT01078116|560526376|FG000|Overall Study|Lack of effectiveness|15|||
155299174|NCT01078116|560526376|FG000|Overall Study|Case report form not completed|3|||
155299175|NCT02499159|560526377|FG000|Randomization|Protocol Violation|1|||
155299176|NCT02499159|560526378|FG001|Randomization|Protocol Violation|1|||
155299177|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
155299178|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
155299179|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
155299180|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
155299181|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
155640611|NCT00191100|561774419|FG000|Overall Study|Lost to Follow-up|2|||
155640612|NCT00191100|561774420|FG001|Overall Study|Lost to Follow-up|0|||
155640613|NCT00191100|561774419|FG000|Overall Study|Patient Moved|0|||
155299182|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
155299183|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Other|1|||
155299184|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Other|0|||
155299185|NCT02242487|560526379|FG000|Overall Study|Adverse Event|13|||
155299186|NCT02242487|560526380|FG001|Overall Study|Adverse Event|15|||
155410752|NCT03257267|560937476|FG001|Overall Study|Adverse Event|7|||
155640614|NCT00191100|561774420|FG001|Overall Study|Patient Moved|1|||
155299187|NCT02242487|560526379|FG000|Overall Study|Lack of Efficacy|4|||
155299188|NCT02242487|560526380|FG001|Overall Study|Lack of Efficacy|6|||
155299189|NCT02242487|560526379|FG000|Overall Study|Protocol Violation|2|||
155299190|NCT02242487|560526380|FG001|Overall Study|Protocol Violation|0|||
155299191|NCT02242487|560526379|FG000|Overall Study|Lost to Follow-up|2|||
155299192|NCT02242487|560526380|FG001|Overall Study|Lost to Follow-up|1|||
155299193|NCT02242487|560526379|FG000|Overall Study|Other - Miscellaneous|4|||
155299194|NCT02242487|560526380|FG001|Overall Study|Other - Miscellaneous|6|||
155299195|NCT02242487|560526379|FG000|Overall Study|Withdrawal by Subject|37|||
155299196|NCT02242487|560526380|FG001|Overall Study|Withdrawal by Subject|19|||
155299197|NCT02564744|560526383|FG000|Overall Study|Investigator decision|0|||
155299198|NCT02564744|560526384|FG001|Overall Study|Investigator decision|0|||
155299199|NCT02564744|560526385|FG002|Overall Study|Investigator decision|0|||
155299200|NCT02564744|560526386|FG003|Overall Study|Investigator decision|0|||
155299201|NCT02564744|560526387|FG004|Overall Study|Investigator decision|1|||
155299202|NCT02564744|560526383|FG000|Overall Study|Death|10|||
155299203|NCT02564744|560526384|FG001|Overall Study|Death|5|||
155299204|NCT02564744|560526385|FG002|Overall Study|Death|4|||
155299205|NCT02564744|560526386|FG003|Overall Study|Death|16|||
155299206|NCT02564744|560526387|FG004|Overall Study|Death|16|||
155299207|NCT02564744|560526383|FG000|Overall Study|End of study Page Missing|0|||
155299208|NCT02564744|560526384|FG001|Overall Study|End of study Page Missing|0|||
155299209|NCT02564744|560526385|FG002|Overall Study|End of study Page Missing|3|||
155299210|NCT02564744|560526386|FG003|Overall Study|End of study Page Missing|3|||
155299211|NCT02564744|560526387|FG004|Overall Study|End of study Page Missing|0|||
155299212|NCT02564744|560526383|FG000|Overall Study|Subject Withdrew Consent|1|||
155299213|NCT02564744|560526384|FG001|Overall Study|Subject Withdrew Consent|1|||
155299214|NCT02564744|560526385|FG002|Overall Study|Subject Withdrew Consent|1|||
155299215|NCT02564744|560526386|FG003|Overall Study|Subject Withdrew Consent|0|||
155299216|NCT02564744|560526387|FG004|Overall Study|Subject Withdrew Consent|2|||
155299217|NCT02564744|560526383|FG000|Overall Study|Lost to Follow-up|0|||
155299218|NCT02564744|560526384|FG001|Overall Study|Lost to Follow-up|1|||
155299219|NCT02564744|560526385|FG002|Overall Study|Lost to Follow-up|0|||
155299220|NCT02564744|560526386|FG003|Overall Study|Lost to Follow-up|0|||
155299221|NCT02564744|560526387|FG004|Overall Study|Lost to Follow-up|1|||
155299222|NCT02564744|560526383|FG000|Overall Study|Reason not specified|1|||
155299223|NCT02564744|560526384|FG001|Overall Study|Reason not specified|0|||
155299224|NCT02564744|560526385|FG002|Overall Study|Reason not specified|0|||
155299225|NCT02564744|560526386|FG003|Overall Study|Reason not specified|0|||
155299226|NCT02564744|560526387|FG004|Overall Study|Reason not specified|0|||
155299227|NCT02252042|560526392|FG000|Overall Study|Adverse Event|9|||
155299228|NCT02252042|560526393|FG001|Overall Study|Adverse Event|6|||
155299229|NCT02252042|560526392|FG000|Overall Study|Death|209|||
155299230|NCT02252042|560526393|FG001|Overall Study|Death|217|||
155299231|NCT02252042|560526392|FG000|Overall Study|Physician Decision|0|||
155299232|NCT02252042|560526393|FG001|Overall Study|Physician Decision|2|||
155299233|NCT02252042|560526392|FG000|Overall Study|Transferred to Extension Study|7|||
155299234|NCT02252042|560526393|FG001|Overall Study|Transferred to Extension Study|1|||
155299235|NCT02252042|560526392|FG000|Overall Study|Did Not Continue on Extension Study|7|||
155299236|NCT02252042|560526393|FG001|Overall Study|Did Not Continue on Extension Study|2|||
155299237|NCT02252042|560526392|FG000|Overall Study|Withdrawal by Subject|15|||
155299238|NCT02252042|560526393|FG001|Overall Study|Withdrawal by Subject|20|||
155299239|NCT02593149|560526394|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
155299240|NCT02593149|560526395|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
155745473|NCT00439738|562167541|FG000|Overall Study|Withdrawal by Subject|16|||
155745474|NCT00439738|562167542|FG001|Overall Study|Withdrawal by Subject|13|||
155745475|NCT00439738|562167541|FG000|Overall Study|Adverse Event|6|||
155745476|NCT00439738|562167542|FG001|Overall Study|Adverse Event|4|||
155745477|NCT00439738|562167541|FG000|Overall Study|Lost to Follow-up|5|||
155745478|NCT00439738|562167542|FG001|Overall Study|Lost to Follow-up|6|||
155745479|NCT00439738|562167541|FG000|Overall Study|Protocol Violation|6|||
155745480|NCT00439738|562167542|FG001|Overall Study|Protocol Violation|3|||
155745481|NCT00439738|562167541|FG000|Overall Study|Lack of Efficacy|2|||
155745482|NCT00439738|562167542|FG001|Overall Study|Lack of Efficacy|2|||
155745483|NCT00439738|562167541|FG000|Overall Study|Abnormal Lab Values|1|||
155745484|NCT00439738|562167542|FG001|Overall Study|Abnormal Lab Values|0|||
155299241|NCT02593149|560526394|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
155299242|NCT02593149|560526395|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
155299243|NCT01177670|560526397|FG000|Overall Study|Study Terminated|115|||
155299244|NCT01177670|560526397|FG000|Overall Study|Physician Decision|50|||
155299245|NCT01177670|560526397|FG000|Overall Study|Withdrawal by Subject|4|||
155299246|NCT00979992|560526398|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155745485|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
155745486|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
155745487|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
155745488|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
155745489|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
155299247|NCT00979992|560526398|FG000|Overall Study|Ineligible - wrong cell type|2|||
155299248|NCT00979992|560526398|FG000|Overall Study|Refused - Never Treated|2|||
155299249|NCT04532528|560526404|FG000|Overall Study|Adverse Event|12|||
155299250|NCT04532528|560526405|FG001|Overall Study|Adverse Event|17|||
155299251|NCT04532528|560526404|FG000|Overall Study|Withdrawal of consent|16|||
155299252|NCT04532528|560526405|FG001|Overall Study|Withdrawal of consent|17|||
155299253|NCT04532528|560526404|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
155299254|NCT04532528|560526405|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
155299255|NCT04532528|560526404|FG000|Overall Study|Lost to Follow-up|69|||
155299256|NCT04532528|560526405|FG001|Overall Study|Lost to Follow-up|68|||
155299257|NCT04532528|560526404|FG000|Overall Study|Administrative problems|12|||
155299258|NCT04532528|560526405|FG001|Overall Study|Administrative problems|14|||
155299259|NCT04532528|560526404|FG000|Overall Study|Death|3|||
155299260|NCT04532528|560526405|FG001|Overall Study|Death|3|||
155299261|NCT04532528|560526404|FG000|Overall Study|Other|38|||
155299262|NCT04532528|560526405|FG001|Overall Study|Other|46|||
155299263|NCT01636687|560526406|FG000|Induction Period|Withdrawal by Subject|1|||
155299264|NCT01636687|560526407|FG001|Induction Period|Withdrawal by Subject|0|||
155299265|NCT01636687|560526408|FG002|Induction Period|Withdrawal by Subject|0|||
155299266|NCT01636687|560526409|FG003|Induction Period|Withdrawal by Subject|0|||
155299267|NCT01636687|560526410|FG004|Induction Period|Withdrawal by Subject|0|||
155299268|NCT01636687|560526406|FG000|Induction Period|Adverse Event|1|||
155299269|NCT01636687|560526407|FG001|Induction Period|Adverse Event|0|||
155299270|NCT01636687|560526408|FG002|Induction Period|Adverse Event|0|||
155299271|NCT01636687|560526409|FG003|Induction Period|Adverse Event|0|||
155299272|NCT01636687|560526410|FG004|Induction Period|Adverse Event|1|||
155299273|NCT01636687|560526406|FG000|Induction Period|Lack of Efficacy|0|||
155299274|NCT01636687|560526407|FG001|Induction Period|Lack of Efficacy|0|||
155299275|NCT01636687|560526408|FG002|Induction Period|Lack of Efficacy|0|||
155299276|NCT01636687|560526409|FG003|Induction Period|Lack of Efficacy|0|||
155299277|NCT01636687|560526410|FG004|Induction Period|Lack of Efficacy|1|||
155299278|NCT01636687|560526406|FG000|Induction Period|Physician Decision|1|||
155299279|NCT01636687|560526407|FG001|Induction Period|Physician Decision|0|||
155299280|NCT01636687|560526408|FG002|Induction Period|Physician Decision|0|||
155299281|NCT01636687|560526409|FG003|Induction Period|Physician Decision|0|||
155299282|NCT01636687|560526410|FG004|Induction Period|Physician Decision|0|||
155299283|NCT01636687|560526406|FG000|Maintenance Period|Withdrawal by Subject|2|||
155299284|NCT01636687|560526407|FG001|Maintenance Period|Withdrawal by Subject|0|||
155299285|NCT01636687|560526408|FG002|Maintenance Period|Withdrawal by Subject|2|||
155299286|NCT01636687|560526409|FG003|Maintenance Period|Withdrawal by Subject|0|||
155299287|NCT01636687|560526410|FG004|Maintenance Period|Withdrawal by Subject|0|||
155299288|NCT01636687|560526406|FG000|Maintenance Period|Adverse Event|1|||
155299289|NCT01636687|560526407|FG001|Maintenance Period|Adverse Event|0|||
155299290|NCT01636687|560526408|FG002|Maintenance Period|Adverse Event|0|||
155299291|NCT01636687|560526409|FG003|Maintenance Period|Adverse Event|0|||
155299292|NCT01636687|560526410|FG004|Maintenance Period|Adverse Event|0|||
155299293|NCT01636687|560526406|FG000|Maintenance Period|Lack of Efficacy|4|||
155299294|NCT01636687|560526407|FG001|Maintenance Period|Lack of Efficacy|1|||
155299295|NCT01636687|560526408|FG002|Maintenance Period|Lack of Efficacy|0|||
155299296|NCT01636687|560526409|FG003|Maintenance Period|Lack of Efficacy|0|||
155299297|NCT01636687|560526410|FG004|Maintenance Period|Lack of Efficacy|0|||
155299298|NCT01636687|560526406|FG000|Maintenance Period|Lost to Follow-up|1|||
155299299|NCT01636687|560526407|FG001|Maintenance Period|Lost to Follow-up|1|||
155299300|NCT01636687|560526408|FG002|Maintenance Period|Lost to Follow-up|0|||
155299301|NCT01636687|560526409|FG003|Maintenance Period|Lost to Follow-up|0|||
155299302|NCT01636687|560526410|FG004|Maintenance Period|Lost to Follow-up|1|||
155299303|NCT01636687|560526406|FG000|Maintenance Period|Physician Decision|0|||
155299304|NCT01636687|560526407|FG001|Maintenance Period|Physician Decision|0|||
155299305|NCT01636687|560526408|FG002|Maintenance Period|Physician Decision|0|||
155299306|NCT01636687|560526409|FG003|Maintenance Period|Physician Decision|0|||
155299307|NCT01636687|560526410|FG004|Maintenance Period|Physician Decision|1|||
155299308|NCT01636687|560526406|FG000|Extension Period|technical problems|0|||
155299309|NCT01636687|560526407|FG001|Extension Period|technical problems|1|||
155299310|NCT01636687|560526408|FG002|Extension Period|technical problems|2|||
155299311|NCT01636687|560526409|FG003|Extension Period|technical problems|1|||
155299312|NCT01636687|560526410|FG004|Extension Period|technical problems|0|||
155299313|NCT01636687|560526406|FG000|Extension Period|Adverse Event|4|||
155299314|NCT01636687|560526407|FG001|Extension Period|Adverse Event|3|||
155299315|NCT01636687|560526408|FG002|Extension Period|Adverse Event|2|||
155299316|NCT01636687|560526409|FG003|Extension Period|Adverse Event|1|||
155299317|NCT01636687|560526410|FG004|Extension Period|Adverse Event|0|||
155745490|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
155299318|NCT01636687|560526406|FG000|Extension Period|Lack of Efficacy|7|||
155299319|NCT01636687|560526407|FG001|Extension Period|Lack of Efficacy|0|||
155299320|NCT01636687|560526408|FG002|Extension Period|Lack of Efficacy|2|||
155299321|NCT01636687|560526409|FG003|Extension Period|Lack of Efficacy|1|||
155299322|NCT01636687|560526410|FG004|Extension Period|Lack of Efficacy|0|||
155299323|NCT01636687|560526406|FG000|Extension Period|Lost to Follow-up|1|||
155299324|NCT01636687|560526407|FG001|Extension Period|Lost to Follow-up|0|||
155299325|NCT01636687|560526408|FG002|Extension Period|Lost to Follow-up|1|||
155299326|NCT01636687|560526409|FG003|Extension Period|Lost to Follow-up|0|||
155299327|NCT01636687|560526410|FG004|Extension Period|Lost to Follow-up|0|||
155299328|NCT01636687|560526406|FG000|Extension Period|Physician Decision|1|||
155299329|NCT01636687|560526407|FG001|Extension Period|Physician Decision|0|||
155299330|NCT01636687|560526408|FG002|Extension Period|Physician Decision|0|||
155299331|NCT01636687|560526409|FG003|Extension Period|Physician Decision|1|||
155299332|NCT01636687|560526410|FG004|Extension Period|Physician Decision|0|||
155299333|NCT01636687|560526406|FG000|Extension Period|study terminated by sponsor|33|||
155299334|NCT01636687|560526407|FG001|Extension Period|study terminated by sponsor|50|||
155299335|NCT01636687|560526408|FG002|Extension Period|study terminated by sponsor|17|||
155299336|NCT01636687|560526409|FG003|Extension Period|study terminated by sponsor|23|||
155299337|NCT01636687|560526410|FG004|Extension Period|study terminated by sponsor|0|||
155299338|NCT01636687|560526406|FG000|Extension Period|Withdrawal by Subject|1|||
155299339|NCT01636687|560526407|FG001|Extension Period|Withdrawal by Subject|0|||
155299340|NCT01636687|560526408|FG002|Extension Period|Withdrawal by Subject|1|||
155299341|NCT01636687|560526409|FG003|Extension Period|Withdrawal by Subject|1|||
155299342|NCT01636687|560526410|FG004|Extension Period|Withdrawal by Subject|0|||
155299343|NCT01636687|560526406|FG000|Follow-up Period|Withdrawal by Subject|1|||
155299344|NCT01636687|560526407|FG001|Follow-up Period|Withdrawal by Subject|0|||
155299345|NCT01636687|560526408|FG002|Follow-up Period|Withdrawal by Subject|0|||
155299346|NCT01636687|560526409|FG003|Follow-up Period|Withdrawal by Subject|0|||
155299347|NCT01636687|560526410|FG004|Follow-up Period|Withdrawal by Subject|1|||
155299348|NCT03691428|560526418|FG000|Overall Study|Withdrawal by Subject|6|||
155299349|NCT03691428|560526419|FG001|Overall Study|Withdrawal by Subject|8|||
155299350|NCT01460290|560526420|FG000|Overall Study|Adverse Event|3|||
155299351|NCT01460290|560526420|FG000|Overall Study|Elevated liver function|1|||
155299352|NCT02527148|560526421|FG000|Overall Study|Did not receive study intervention|1|||
155299353|NCT02527148|560526422|FG001|Overall Study|Did not receive study intervention|0|||
155299354|NCT02918279|560526423|FG000|Overall Study|Lost to Follow-up|3|||
155299355|NCT02918279|560526424|FG001|Overall Study|Lost to Follow-up|6|||
155299356|NCT02918279|560526423|FG000|Overall Study|Withdrawal by Subject|5|||
155299357|NCT02918279|560526424|FG001|Overall Study|Withdrawal by Subject|15|||
155299358|NCT02918279|560526423|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155299359|NCT02918279|560526424|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155299360|NCT02918279|560526423|FG000|Overall Study|Other|3|||
155299361|NCT02918279|560526424|FG001|Overall Study|Other|1|||
155299362|NCT00309907|560526425|FG000|Overall Study|Death|4|||
155299363|NCT00309907|560526425|FG000|Overall Study|Physician Decision|1|||
155299364|NCT00309907|560526425|FG000|Overall Study|Ineligible|11|||
155299365|NCT00309907|560526425|FG000|Overall Study|Major infectious event|4|||
155299366|NCT00869258|560526426|FG000|Overall Study|Physician Decision|1|||
155299367|NCT02888080|560526427|FG000|Overall Study|Subject / Guardian decision|1|||
155299368|NCT02888080|560526428|FG001|Overall Study|Subject / Guardian decision|3|||
155299369|NCT02888080|560526427|FG000|Overall Study|New Therapy for study indication|1|||
155299370|NCT02888080|560526428|FG001|Overall Study|New Therapy for study indication|0|||
155299371|NCT02888080|560526427|FG000|Overall Study|Lack of Efficacy|0|||
155299372|NCT02888080|560526428|FG001|Overall Study|Lack of Efficacy|1|||
155299373|NCT02888080|560526427|FG000|Overall Study|Adverse Event|0|||
155299374|NCT02888080|560526428|FG001|Overall Study|Adverse Event|1|||
155299375|NCT01641198|560526429|FG000|After 12 Months of Function|Lost to Follow-up|3|||
155299376|NCT01641198|560526430|FG001|After 12 Months of Function|Lost to Follow-up|2|||
155299377|NCT01641198|560526431|FG002|After 12 Months of Function|Lost to Follow-up|2|||
155299378|NCT01641198|560526429|FG000|After 12 Months of Function|Protocol Violation|1|||
155299379|NCT01641198|560526430|FG001|After 12 Months of Function|Protocol Violation|0|||
155299380|NCT01641198|560526431|FG002|After 12 Months of Function|Protocol Violation|0|||
155299381|NCT01641198|560526429|FG000|After 12 Months of Function|Adverse Event|0|||
155299382|NCT01641198|560526430|FG001|After 12 Months of Function|Adverse Event|1|||
155299383|NCT01641198|560526431|FG002|After 12 Months of Function|Adverse Event|0|||
155299384|NCT01641198|560526429|FG000|After 24 Months of Function|Lost to Follow-up|4|||
155299385|NCT01641198|560526430|FG001|After 24 Months of Function|Lost to Follow-up|9|||
155299386|NCT01641198|560526431|FG002|After 24 Months of Function|Lost to Follow-up|6|||
155299387|NCT01641198|560526429|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
155299388|NCT01641198|560526430|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
155299389|NCT01641198|560526431|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
155299390|NCT01641198|560526429|FG000|At 15-20 Years of Function|Death|1|||
155299391|NCT01641198|560526430|FG001|At 15-20 Years of Function|Death|0|||
155299392|NCT01641198|560526431|FG002|At 15-20 Years of Function|Death|1|||
155299393|NCT01039688|560526432|FG000|Overall Study|Adverse Event|38|||
155299394|NCT01039688|560526433|FG001|Overall Study|Adverse Event|39|||
155299395|NCT01039688|560526434|FG002|Overall Study|Adverse Event|24|||
155299396|NCT01039688|560526432|FG000|Overall Study|Lack of Efficacy|20|||
155745491|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
155745492|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
155745493|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
155745494|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
155745495|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
155745496|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
155745497|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
155745498|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
155745499|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
155745500|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
155745501|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
155745502|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
155745503|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
155745504|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
155745505|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
155745506|NCT01227824|562167545|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
155745507|NCT01227824|562167546|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
155745508|NCT01227824|562167547|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
155745509|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
155745510|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
155745511|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
155745512|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
155745513|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
155745514|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
155745515|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
155745516|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
155745517|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
155745518|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
155745519|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
155745520|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
155745521|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
155745522|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
155745523|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
155745524|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
155745525|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
155745526|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
155745527|NCT01227824|562167545|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
155745528|NCT01227824|562167546|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
155745529|NCT01227824|562167547|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
155745530|NCT02576145|562167548|FG000|Overall Study|Adverse Event|1|||
155745531|NCT02576145|562167549|FG001|Overall Study|Adverse Event|0|||
155745532|NCT02576145|562167548|FG000|Overall Study|Withdrawal by Subject|1|||
155745533|NCT02576145|562167549|FG001|Overall Study|Withdrawal by Subject|0|||
155745534|NCT02576145|562167548|FG000|Overall Study|Acute rejection|1|||
155745535|NCT02576145|562167549|FG001|Overall Study|Acute rejection|0|||
155745536|NCT02576145|562167548|FG000|Overall Study|Tetanus Titers Decreased|0|||
155745537|NCT02576145|562167549|FG001|Overall Study|Tetanus Titers Decreased|1|||
155745538|NCT00781885|562167550|FG000|Overall Study|Physician Decision|1|||
155745539|NCT01755026|562167551|FG000|Overall Study|Adverse Event|1|||
155745540|NCT01755026|562167552|FG001|Overall Study|Adverse Event|0|||
155745541|NCT01755026|562167551|FG000|Overall Study|Withdrawal by Subject|1|||
155745542|NCT01755026|562167552|FG001|Overall Study|Withdrawal by Subject|1|||
155745543|NCT02730793|562167555|FG000|Overall Study|Physician Decision|0|||
155745544|NCT02730793|562167556|FG001|Overall Study|Physician Decision|1|||
155745545|NCT02730793|562167555|FG000|Overall Study|Withdrawal by Subject|0|||
155745546|NCT02730793|562167556|FG001|Overall Study|Withdrawal by Subject|1|||
155745547|NCT02365233|562167557|FG000|Overall Study|IRB withheld the data|1|||
155745548|NCT02365233|562167558|FG001|Overall Study|IRB withheld the data|2|||
155745549|NCT02365233|562167559|FG002|Overall Study|IRB withheld the data|2|||
155745550|NCT00160667|562167560|FG000|Overall Study|Adverse Event|3|||
155745551|NCT00160667|562167561|FG001|Overall Study|Adverse Event|1|||
155745552|NCT00160667|562167562|FG002|Overall Study|Adverse Event|4|||
155745553|NCT00160667|562167560|FG000|Overall Study|Withdrawal by Subject|2|||
155745554|NCT00160667|562167561|FG001|Overall Study|Withdrawal by Subject|0|||
155745555|NCT00160667|562167562|FG002|Overall Study|Withdrawal by Subject|1|||
155745556|NCT00160667|562167560|FG000|Overall Study|Lack of Efficacy|0|||
155745557|NCT00160667|562167561|FG001|Overall Study|Lack of Efficacy|1|||
155745558|NCT00160667|562167562|FG002|Overall Study|Lack of Efficacy|0|||
155745559|NCT00160667|562167560|FG000|Overall Study|Protocol Violation|0|||
155299397|NCT01039688|560526433|FG001|Overall Study|Lack of Efficacy|11|||
155299398|NCT01039688|560526434|FG002|Overall Study|Lack of Efficacy|26|||
155299399|NCT01039688|560526432|FG000|Overall Study|Lost to Follow-up|11|||
155299400|NCT01039688|560526433|FG001|Overall Study|Lost to Follow-up|9|||
155299401|NCT01039688|560526434|FG002|Overall Study|Lost to Follow-up|5|||
155299402|NCT01039688|560526432|FG000|Overall Study|Other|13|||
155299403|NCT01039688|560526433|FG001|Overall Study|Other|25|||
155299404|NCT01039688|560526434|FG002|Overall Study|Other|12|||
155299405|NCT01039688|560526432|FG000|Overall Study|Withdrawal by Subject|23|||
155299406|NCT01039688|560526433|FG001|Overall Study|Withdrawal by Subject|27|||
155299407|NCT01039688|560526434|FG002|Overall Study|Withdrawal by Subject|13|||
155299408|NCT01039688|560526432|FG000|Overall Study|Death|2|||
155299409|NCT01039688|560526433|FG001|Overall Study|Death|0|||
155299410|NCT01039688|560526434|FG002|Overall Study|Death|0|||
155299411|NCT00346151|560526435|FG000|Overall Study|Withdrawal by Subject|3|||
155299412|NCT00535145|560526438|FG000|Phase I|Adverse Event|3|||
155299413|NCT00535145|560526438|FG000|Phase I|Lost to Follow-up|7|||
155299414|NCT00535145|560526438|FG000|Phase I|Withdrawal by Subject|6|||
155299415|NCT00535145|560526438|FG000|Phase I|(eligibility)|8|||
155299416|NCT00535145|560526438|FG000|Phase I|(protocol violation)|1|||
155299417|NCT00535145|560526438|FG000|Phase I|(PI decision)|1|||
155299418|NCT00535145|560526438|FG000|Phase I|(diagnosis)|3|||
155299419|NCT00535145|560526438|FG000|Phase II|Adverse Event|2|||
155299420|NCT00535145|560526438|FG000|Phase II|Lack of Efficacy|1|||
155299421|NCT00535145|560526438|FG000|Phase II|Lost to Follow-up|5|||
155299422|NCT00535145|560526438|FG000|Phase II|Withdrawal by Subject|5|||
155299423|NCT00535145|560526438|FG000|Phase II|Subject non-compliance|2|||
155299424|NCT01124734|560526440|FG000|Overall Study|Disease progression|13|||
155299425|NCT01124734|560526440|FG000|Overall Study|Adverse Event|1|||
155299426|NCT01124734|560526440|FG000|Overall Study|Withdrawal by Subject|1|||
155299427|NCT01124734|560526440|FG000|Overall Study|Elected for alternative treatment|2|||
155299428|NCT02423798|560526441|FG000|Overall Study|Withdrawal by Subject|3|||
155299429|NCT01430611|560526445|FG000|Overall Study|Adverse Event|0|||
155299430|NCT01430611|560526446|FG001|Overall Study|Adverse Event|1|||
155299431|NCT01430611|560526445|FG000|Overall Study|Protocol Violation|1|||
155299432|NCT01430611|560526446|FG001|Overall Study|Protocol Violation|0|||
155299433|NCT01430611|560526445|FG000|Overall Study|Lost to Follow-up|1|||
155299434|NCT01430611|560526446|FG001|Overall Study|Lost to Follow-up|0|||
155299435|NCT01430611|560526445|FG000|Overall Study|Withdrawal by Subject|15|||
155299436|NCT01430611|560526446|FG001|Overall Study|Withdrawal by Subject|14|||
155299437|NCT02204982|560526447|FG000|Overall Study|Patient ineligible-medical monitor|1|||
155299438|NCT02204982|560526448|FG001|Overall Study|Patient ineligible-medical monitor|0|||
155299439|NCT02204982|560526447|FG000|Overall Study|Withdrawal by Subject|1|||
155299440|NCT02204982|560526448|FG001|Overall Study|Withdrawal by Subject|0|||
155299441|NCT02204982|560526447|FG000|Overall Study|Adverse Event|1|||
155299442|NCT02204982|560526448|FG001|Overall Study|Adverse Event|0|||
155299443|NCT02204982|560526447|FG000|Overall Study|Adverse Event and Investigator decision|1|||
155299444|NCT02204982|560526448|FG001|Overall Study|Adverse Event and Investigator decision|0|||
155299445|NCT02204982|560526447|FG000|Overall Study|Physician Decision|0|||
155299446|NCT02204982|560526448|FG001|Overall Study|Physician Decision|2|||
155299447|NCT02204982|560526447|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
155299448|NCT02204982|560526448|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
155299449|NCT02204982|560526447|FG000|Overall Study|Termination of Study bySponsor|0|||
155299450|NCT02204982|560526448|FG001|Overall Study|Termination of Study bySponsor|1|||
155299451|NCT01943916|560526453|FG000|Overall Study|Technically invalid images|10|||
155299452|NCT01943916|560526453|FG000|Overall Study|Enrollment Failure|23|||
155299453|NCT01943916|560526453|FG000|Overall Study|Pilot Phase exclusion|100|||
155299454|NCT01943916|560526453|FG000|Overall Study|Quality Assurance Reader Fail|130|||
155299455|NCT01943916|560526453|FG000|Overall Study|Technical Failure|39|||
155299456|NCT01943916|560526453|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
155299457|NCT01943916|560526453|FG000|Overall Study|No Truth Panel Review|38|||
155299458|NCT01943916|560526453|FG000|Overall Study|Protocol Deviation|1|||
155299459|NCT00919763|560526454|FG000|Overall Study|Adverse Event|7|||
155640615|NCT00191100|561774419|FG000|Overall Study|Withdrawal by Subject|9|||
155640616|NCT00191100|561774420|FG001|Overall Study|Withdrawal by Subject|3|||
155640617|NCT00191100|561774419|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
155640618|NCT00191100|561774420|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
155640619|NCT00191100|561774419|FG000|Overall Study|Clinical Relapse|2|||
155640620|NCT00191100|561774420|FG001|Overall Study|Clinical Relapse|1|||
155640621|NCT00191100|561774419|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
155640622|NCT00191100|561774420|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
155640623|NCT00191100|561774419|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
155640624|NCT00191100|561774420|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
155299460|NCT00919763|560526455|FG001|Overall Study|Adverse Event|1|||
155299461|NCT00919763|560526454|FG000|Overall Study|Lost to Follow-up|1|||
155640625|NCT00191100|561774419|FG000|Overall Study|Physician Decision|3|||
155640626|NCT00191100|561774420|FG001|Overall Study|Physician Decision|1|||
155640627|NCT00191100|561774419|FG000|Overall Study|Death from Study Drug Toxicity|2|||
155299462|NCT00919763|560526455|FG001|Overall Study|Lost to Follow-up|0|||
155299463|NCT00919763|560526454|FG000|Overall Study|Protocol Violation|1|||
155299464|NCT00919763|560526455|FG001|Overall Study|Protocol Violation|1|||
155299465|NCT00919763|560526454|FG000|Overall Study|Withdrawal by Subject|3|||
155299466|NCT00919763|560526455|FG001|Overall Study|Withdrawal by Subject|1|||
155299467|NCT00919763|560526454|FG000|Overall Study|Non-compliance|0|||
155299468|NCT00919763|560526455|FG001|Overall Study|Non-compliance|1|||
155299469|NCT04740164|560526456|FG000|Overall Study|Lack of Efficacy|4|||
155299470|NCT04740164|560526457|FG001|Overall Study|Lack of Efficacy|0|||
155299471|NCT04740164|560526456|FG000|Overall Study|Physician Decision|3|||
155299472|NCT04740164|560526457|FG001|Overall Study|Physician Decision|3|||
155299473|NCT00442117|560526461|FG000|Overall Study|Adverse Event|3|||
155299474|NCT00442117|560526462|FG001|Overall Study|Adverse Event|2|||
155299475|NCT00442117|560526461|FG000|Overall Study|Lack of Efficacy|2|||
155299476|NCT00442117|560526462|FG001|Overall Study|Lack of Efficacy|6|||
155299477|NCT00442117|560526461|FG000|Overall Study|Lost to Follow-up|1|||
155299478|NCT00442117|560526462|FG001|Overall Study|Lost to Follow-up|2|||
155299479|NCT00442117|560526461|FG000|Overall Study|Withdrawal by Subject|2|||
155299480|NCT00442117|560526462|FG001|Overall Study|Withdrawal by Subject|2|||
155299481|NCT00442117|560526461|FG000|Overall Study|Major Deviation|25|||
155299482|NCT00442117|560526462|FG001|Overall Study|Major Deviation|20|||
155299483|NCT00442117|560526461|FG000|Overall Study|Non compliance with protocol|3|||
155299484|NCT00442117|560526462|FG001|Overall Study|Non compliance with protocol|5|||
155299485|NCT00442117|560526461|FG000|Overall Study|Met Withdrawal Criteria|2|||
155299486|NCT00442117|560526462|FG001|Overall Study|Met Withdrawal Criteria|1|||
155299487|NCT00206375|560526463|FG000|Overall Study|Lost to Follow-up|1|||
155299488|NCT00206375|560526464|FG001|Overall Study|Lost to Follow-up|0|||
155299489|NCT00206375|560526465|FG002|Overall Study|Lost to Follow-up|0|||
155299490|NCT00206375|560526463|FG000|Overall Study|Withdrawal by Subject|2|||
155299491|NCT00206375|560526464|FG001|Overall Study|Withdrawal by Subject|1|||
155299492|NCT00206375|560526465|FG002|Overall Study|Withdrawal by Subject|3|||
155299493|NCT00206375|560526463|FG000|Overall Study|Study terminated due to lack of funds|0|||
155299494|NCT00206375|560526464|FG001|Overall Study|Study terminated due to lack of funds|1|||
155299495|NCT00206375|560526465|FG002|Overall Study|Study terminated due to lack of funds|1|||
155299496|NCT04789408|560526466|FG000|Overall Study|Death|4|||
155299497|NCT04789408|560526467|FG001|Overall Study|Death|3|||
155299498|NCT04789408|560526468|FG002|Overall Study|Death|6|||
155299499|NCT04789408|560526466|FG000|Overall Study|Did not meet eligibility criteria|1|||
155299500|NCT04789408|560526467|FG001|Overall Study|Did not meet eligibility criteria|0|||
155299501|NCT04789408|560526468|FG002|Overall Study|Did not meet eligibility criteria|0|||
155299502|NCT04789408|560526466|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
155299503|NCT04789408|560526467|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
155299504|NCT04789408|560526468|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
155299505|NCT00840177|560527921|FG000|Overall Study|Adverse Event|5|||
155299506|NCT00840177|560527922|FG001|Overall Study|Adverse Event|1|||
155299507|NCT00840177|560527923|FG002|Overall Study|Adverse Event|1|||
155299508|NCT00840177|560527921|FG000|Overall Study|Refusal unrelated to adverse events|1|||
155299509|NCT00840177|560527922|FG001|Overall Study|Refusal unrelated to adverse events|0|||
155299510|NCT00840177|560527923|FG002|Overall Study|Refusal unrelated to adverse events|1|||
155299511|NCT00840177|560527921|FG000|Overall Study|Progression/relapse|2|||
155299512|NCT00840177|560527922|FG001|Overall Study|Progression/relapse|0|||
155299513|NCT00840177|560527923|FG002|Overall Study|Progression/relapse|0|||
155299514|NCT00840177|560527921|FG000|Overall Study|Death|4|||
155299515|NCT00840177|560527922|FG001|Overall Study|Death|5|||
155299516|NCT00840177|560527923|FG002|Overall Study|Death|5|||
155299517|NCT00840177|560527921|FG000|Overall Study|not protocol specified|6|||
155299518|NCT00840177|560527922|FG001|Overall Study|not protocol specified|3|||
155299519|NCT00840177|560527923|FG002|Overall Study|not protocol specified|0|||
155299520|NCT00840177|560527921|FG000|Overall Study|Ineligible|0|||
155299521|NCT00840177|560527922|FG001|Overall Study|Ineligible|0|||
155299522|NCT00840177|560527923|FG002|Overall Study|Ineligible|3|||
155299523|NCT00840177|560527921|FG000|Overall Study|Did not start treatment|0|||
155299524|NCT00840177|560527922|FG001|Overall Study|Did not start treatment|0|||
155299525|NCT00840177|560527923|FG002|Overall Study|Did not start treatment|1|||
155299526|NCT03345901|560527927|FG000|Overall Study|The study was terminated|18|||
155299527|NCT00925587|560527928|FG000|Overall Study|Protocol Specified Criteria|6|||
155745560|NCT00160667|562167561|FG001|Overall Study|Protocol Violation|1|||
155745561|NCT00160667|562167562|FG002|Overall Study|Protocol Violation|0|||
155745562|NCT00160667|562167560|FG000|Overall Study|Patient decision|0|||
155745563|NCT00160667|562167561|FG001|Overall Study|Patient decision|0|||
155745564|NCT00160667|562167562|FG002|Overall Study|Patient decision|1|||
155745565|NCT00995566|562167565|FG000|Overall Study|Adverse Event|2|||
155745566|NCT00995566|562167565|FG000|Overall Study|Early study termination|52|||
155745567|NCT00384111|562167570|FG000|Overall Study|Disease Progression|3|||
155745568|NCT00384111|562167570|FG000|Overall Study|Adverse Event|1|||
155745569|NCT00384111|562167570|FG000|Overall Study|Investigator Decision|3|||
155745570|NCT00384111|562167570|FG000|Overall Study|Study Terminated by the Sponsor|19|||
155640628|NCT00191100|561774420|FG001|Overall Study|Death from Study Drug Toxicity|0|||
155640629|NCT00191100|561774419|FG000|Overall Study|Protocol Violation|1|||
155640630|NCT00191100|561774420|FG001|Overall Study|Protocol Violation|1|||
155640631|NCT00191100|561774419|FG000|Overall Study|Death from Other Cause|1|||
155640632|NCT00191100|561774420|FG001|Overall Study|Death from Other Cause|0|||
155640633|NCT00191100|561774419|FG000|Overall Study|Reason Not Specified|0|||
155640634|NCT00191100|561774420|FG001|Overall Study|Reason Not Specified|1|||
155640635|NCT02872714|561774421|FG000|Overall Study|Progressive Disease|1|||
155640636|NCT02872714|561774422|FG001|Overall Study|Progressive Disease|2|||
155640637|NCT02872714|561774423|FG002|Overall Study|Progressive Disease|0|||
155640638|NCT02872714|561774424|FG003|Overall Study|Progressive Disease|0|||
155640639|NCT02872714|561774425|FG004|Overall Study|Progressive Disease|0|||
155640640|NCT02872714|561774421|FG000|Overall Study|Death|87|||
155640641|NCT02872714|561774422|FG001|Overall Study|Death|36|||
155640642|NCT02872714|561774423|FG002|Overall Study|Death|8|||
155640643|NCT02872714|561774424|FG003|Overall Study|Death|81|||
155640644|NCT02872714|561774425|FG004|Overall Study|Death|2|||
155640645|NCT02872714|561774421|FG000|Overall Study|Lost to Follow-up|2|||
155640646|NCT02872714|561774422|FG001|Overall Study|Lost to Follow-up|1|||
155640647|NCT02872714|561774423|FG002|Overall Study|Lost to Follow-up|0|||
155640648|NCT02872714|561774424|FG003|Overall Study|Lost to Follow-up|3|||
155640649|NCT02872714|561774425|FG004|Overall Study|Lost to Follow-up|0|||
155640650|NCT02872714|561774421|FG000|Overall Study|Physician Decision|0|||
155640651|NCT02872714|561774422|FG001|Overall Study|Physician Decision|0|||
155640652|NCT02872714|561774423|FG002|Overall Study|Physician Decision|0|||
155640653|NCT02872714|561774424|FG003|Overall Study|Physician Decision|1|||
155640654|NCT02872714|561774425|FG004|Overall Study|Physician Decision|0|||
155640655|NCT02872714|561774421|FG000|Overall Study|Withdrawal by Subject|1|||
155640656|NCT02872714|561774422|FG001|Overall Study|Withdrawal by Subject|3|||
155640657|NCT02872714|561774423|FG002|Overall Study|Withdrawal by Subject|0|||
155640658|NCT02872714|561774424|FG003|Overall Study|Withdrawal by Subject|2|||
155640659|NCT02872714|561774425|FG004|Overall Study|Withdrawal by Subject|0|||
155640660|NCT02872714|561774421|FG000|Overall Study|Captured as Other|2|||
155640661|NCT02872714|561774422|FG001|Overall Study|Captured as Other|0|||
155640662|NCT02872714|561774423|FG002|Overall Study|Captured as Other|0|||
155640663|NCT02872714|561774424|FG003|Overall Study|Captured as Other|1|||
155640664|NCT02872714|561774425|FG004|Overall Study|Captured as Other|0|||
155640665|NCT04633447|561775459|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
155640666|NCT04633447|561775460|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
155640667|NCT04633447|561775459|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
155640668|NCT04633447|561775460|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
155640669|NCT04633447|561775459|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
155640670|NCT04633447|561775460|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
155640671|NCT04633447|561775459|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
155640672|NCT04633447|561775460|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
155640673|NCT04633447|561775459|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
155640674|NCT04633447|561775460|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
155640675|NCT04633447|561775459|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
155640676|NCT04633447|561775460|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
155640677|NCT01565694|561775461|FG000|Dose-Titration Period|Adverse Event|4|||
155640678|NCT01565694|561775461|FG000|Dose-Titration Period|Protocol Violation|10|||
155640679|NCT01565694|561775461|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
155640680|NCT00541229|561775462|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
155640681|NCT00541229|561775463|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
155640682|NCT00541229|561775464|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
155640683|NCT00541229|561775465|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
155640684|NCT00541229|561775466|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
155640685|NCT00541229|561775467|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
155299528|NCT00925587|560527929|FG001|Overall Study|Protocol Specified Criteria|6|||
155299529|NCT00925587|560527928|FG000|Overall Study|Physician Decision|4|||
155299530|NCT00925587|560527929|FG001|Overall Study|Physician Decision|1|||
155299531|NCT00925587|560527928|FG000|Overall Study|Protocol Violation|6|||
155299532|NCT00925587|560527929|FG001|Overall Study|Protocol Violation|4|||
155299533|NCT00925587|560527928|FG000|Overall Study|Withdrawal by Subject|9|||
155299534|NCT00925587|560527929|FG001|Overall Study|Withdrawal by Subject|6|||
155299535|NCT00925587|560527928|FG000|Overall Study|Death|5|||
155299536|NCT00925587|560527929|FG001|Overall Study|Death|5|||
155299537|NCT00925587|560527928|FG000|Overall Study|Adverse Event|6|||
155299538|NCT00925587|560527929|FG001|Overall Study|Adverse Event|2|||
155299539|NCT00925587|560527928|FG000|Overall Study|Lost to Follow-up|0|||
155299540|NCT00925587|560527929|FG001|Overall Study|Lost to Follow-up|1|||
155299541|NCT00414544|560527930|FG000|Overall Study|Lost to Follow-up|14|||
155299542|NCT01318382|560527932|FG000|Overall Study|Physician Decision|2|||
155299543|NCT01318382|560527932|FG000|Overall Study|Device Malfunction|10|||
155299544|NCT01318382|560527932|FG000|Overall Study|Protocol Violation|1|||
155299545|NCT01308567|560527935|FG000|Overall Study|Lost to Follow-up|2|||
155299546|NCT01308567|560527936|FG001|Overall Study|Lost to Follow-up|4|||
155299547|NCT01308567|560527937|FG002|Overall Study|Lost to Follow-up|4|||
155299548|NCT01571596|560527938|FG000|Overall Study|Adverse Event|2|||
155299549|NCT01571596|560527939|FG001|Overall Study|Adverse Event|0|||
155299550|NCT01571596|560527940|FG002|Overall Study|Adverse Event|0|||
155299551|NCT01571596|560527938|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155299552|NCT01571596|560527939|FG001|Overall Study|Study Terminated by the Sponsor|1|||
155299553|NCT01571596|560527940|FG002|Overall Study|Study Terminated by the Sponsor|1|||
155299554|NCT00585052|560527949|FG000|Overall Study|Withdrawal by Subject|1|||
155299555|NCT04425863|560527950|FG000|Overall Study|Death|0|||
155299556|NCT04425863|560527951|FG001|Overall Study|Death|0|||
155299557|NCT04425863|560527952|FG002|Overall Study|Death|1|||
155299558|NCT00277355|560527957|FG000|Overall Study|Withdrawal by Subject|3|||
155299559|NCT00277355|560527958|FG001|Overall Study|Withdrawal by Subject|3|||
155299560|NCT00277355|560527957|FG000|Overall Study|Lost to Follow-up|2|||
155299561|NCT00277355|560527958|FG001|Overall Study|Lost to Follow-up|2|||
155299562|NCT00277355|560527957|FG000|Overall Study|Adverse Event|5|||
155299563|NCT00277355|560527958|FG001|Overall Study|Adverse Event|0|||
155299564|NCT00277355|560527957|FG000|Overall Study|Death|3|||
155299565|NCT00277355|560527958|FG001|Overall Study|Death|0|||
155299566|NCT00277355|560527957|FG000|Overall Study|Physician Decision|1|||
155299567|NCT00277355|560527958|FG001|Overall Study|Physician Decision|0|||
155299568|NCT01140048|560527961|FG000|Overall Study|Physician Decision|1|||
155299569|NCT01140048|560527961|FG000|Overall Study|Withdrawal by Subject|13|||
155299570|NCT01140048|560527961|FG000|Overall Study|Lost to Follow-up|31|||
155299571|NCT00636207|560527962|FG000|Overall Study|Adverse Event|1|||
155299572|NCT00636207|560527963|FG001|Overall Study|Adverse Event|0|||
155299573|NCT00636207|560527964|FG002|Overall Study|Adverse Event|0|||
155299574|NCT00636207|560527965|FG003|Overall Study|Adverse Event|0|||
155299575|NCT00636207|560527966|FG004|Overall Study|Adverse Event|0|||
155299576|NCT00636207|560527967|FG005|Overall Study|Adverse Event|0|||
155299577|NCT00636207|560527968|FG006|Overall Study|Adverse Event|0|||
155299578|NCT00636207|560527962|FG000|Overall Study|Withdrawal by Subject|0|||
155299579|NCT00636207|560527963|FG001|Overall Study|Withdrawal by Subject|1|||
155299580|NCT00636207|560527964|FG002|Overall Study|Withdrawal by Subject|0|||
155299581|NCT00636207|560527965|FG003|Overall Study|Withdrawal by Subject|0|||
155299582|NCT00636207|560527966|FG004|Overall Study|Withdrawal by Subject|1|||
155299583|NCT00636207|560527967|FG005|Overall Study|Withdrawal by Subject|0|||
155299584|NCT00636207|560527968|FG006|Overall Study|Withdrawal by Subject|0|||
155299585|NCT00666276|560527972|FG000|Overall Study|Protocol Violation|34|||
155299586|NCT02594735|560527973|FG000|Overall Study|Adverse Event|1|||
155299587|NCT00668863|560527974|FG000|Overall Study|Objective Progression or Relapse|42|||
155299588|NCT00668863|560527974|FG000|Overall Study|Adverse Event|13|||
155299589|NCT00668863|560527974|FG000|Overall Study|Study Terminated by Sponsor|8|||
155299590|NCT00668863|560527974|FG000|Overall Study|Global Deterioration of Health Status|4|||
155299591|NCT00668863|560527974|FG000|Overall Study|Withdrawal by Subject|1|||
155299592|NCT00668863|560527974|FG000|Overall Study|Surgery|1|||
155299593|NCT00668863|560527974|FG000|Overall Study|Subject's work scheduling problem|1|||
155299594|NCT00668863|560527974|FG000|Overall Study|Physician Decision|1|||
155299595|NCT03844269|560527980|FG000|Overall Study|Withdrawal pre-intervention|1|||
155299596|NCT03844269|560527980|FG000|Overall Study|Did not complete the intervention|2|||
155299597|NCT01075217|560527986|FG000|Overall Study|Adverse Event|1|||
155299598|NCT01075217|560527987|FG001|Overall Study|Adverse Event|1|||
155299599|NCT01075217|560527986|FG000|Overall Study|Physician Decision|1|||
155299600|NCT01075217|560527987|FG001|Overall Study|Physician Decision|0|||
155299601|NCT01068743|560527992|FG000|Period 3|Adverse Event|0|||
155299602|NCT01068743|560527993|FG001|Period 3|Adverse Event|1|||
155299603|NCT01068743|560527994|FG002|Period 3|Adverse Event|0|||
155299604|NCT01068743|560527995|FG003|Period 3|Adverse Event|0|||
155299605|NCT00293293|560527996|FG000|Overall Study|Withdrawal by Subject|1|||
155299606|NCT00293293|560527997|FG001|Overall Study|Withdrawal by Subject|1|||
155299607|NCT00293293|560527996|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
155299608|NCT00293293|560527997|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
155299609|NCT00293293|560527996|FG000|Overall Study|Patient discontinued chemotherapy|0|||
155299610|NCT00293293|560527997|FG001|Overall Study|Patient discontinued chemotherapy|1|||
155299611|NCT02512965|560527999|FG000|Overall Study|Withdrawal by Subject|0|||
155299612|NCT02512965|560528000|FG001|Overall Study|Withdrawal by Subject|4|||
155299613|NCT00835770|560528001|FG000|Overall Study|MS Relapse|17|||
155299614|NCT00835770|560528002|FG001|Overall Study|MS Relapse|23|||
155299615|NCT00835770|560528001|FG000|Overall Study|MS Progression|14|||
155299616|NCT00835770|560528002|FG001|Overall Study|MS Progression|9|||
155299617|NCT00835770|560528001|FG000|Overall Study|Adverse Event|113|||
155299618|NCT00835770|560528002|FG001|Overall Study|Adverse Event|124|||
155299619|NCT00835770|560528001|FG000|Overall Study|Lost to Follow-up|22|||
155299620|NCT00835770|560528002|FG001|Overall Study|Lost to Follow-up|19|||
155299621|NCT00835770|560528001|FG000|Overall Study|Consent Withdrawn|144|||
155299622|NCT00835770|560528002|FG001|Overall Study|Consent Withdrawn|156|||
155299623|NCT00835770|560528001|FG000|Overall Study|Investigator Decision|42|||
155299624|NCT00835770|560528002|FG001|Overall Study|Investigator Decision|42|||
155299625|NCT00835770|560528001|FG000|Overall Study|Participant Non-Compliance|11|||
155299626|NCT00835770|560528002|FG001|Overall Study|Participant Non-Compliance|9|||
155299627|NCT00835770|560528001|FG000|Overall Study|Death|4|||
155299628|NCT00835770|560528002|FG001|Overall Study|Death|6|||
155299629|NCT00835770|560528001|FG000|Overall Study|Other|115|||
155299630|NCT00835770|560528002|FG001|Overall Study|Other|104|||
155299631|NCT00835770|560528001|FG000|Overall Study|Other|2|||
155299632|NCT00835770|560528002|FG001|Overall Study|Other|1|||
155299633|NCT02507752|560528003|FG000|Overall Study|Adverse Event|1|||
155299634|NCT02507752|560528003|FG000|Overall Study|Protocol Violation|6|||
155299635|NCT02507752|560528003|FG000|Overall Study|Lost to Follow-up|7|||
155299636|NCT02507752|560528003|FG000|Overall Study|Infusion reaction at first infusion|1|||
155299637|NCT02507752|560528003|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
155299638|NCT02507752|560528003|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
155640686|NCT00541229|561775462|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155640687|NCT00541229|561775463|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155640688|NCT00541229|561775464|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155640689|NCT00541229|561775465|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155640690|NCT00541229|561775466|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155299639|NCT01369498|560528004|FG000|Overall Study|Lack of Efficacy|9|||
155299640|NCT01369498|560528005|FG001|Overall Study|Lack of Efficacy|9|||
155299641|NCT01369498|560528006|FG002|Overall Study|Lack of Efficacy|1|||
155299642|NCT01369498|560528007|FG003|Overall Study|Lack of Efficacy|3|||
155299643|NCT01369498|560528004|FG000|Overall Study|Adverse Event|1|||
155299644|NCT01369498|560528005|FG001|Overall Study|Adverse Event|2|||
155299645|NCT01369498|560528006|FG002|Overall Study|Adverse Event|0|||
155299646|NCT01369498|560528007|FG003|Overall Study|Adverse Event|1|||
155640691|NCT00541229|561775467|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
155640692|NCT00541229|561775462|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155640693|NCT00541229|561775463|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155299647|NCT01369498|560528004|FG000|Overall Study|Withdrawal of Consent|0|||
155299648|NCT01369498|560528005|FG001|Overall Study|Withdrawal of Consent|1|||
155299649|NCT01369498|560528006|FG002|Overall Study|Withdrawal of Consent|1|||
155299650|NCT01369498|560528007|FG003|Overall Study|Withdrawal of Consent|1|||
155299651|NCT01369498|560528004|FG000|Overall Study|Death|0|||
155299652|NCT01369498|560528005|FG001|Overall Study|Death|0|||
155299653|NCT01369498|560528006|FG002|Overall Study|Death|1|||
155299654|NCT01369498|560528007|FG003|Overall Study|Death|0|||
155299655|NCT01369498|560528004|FG000|Overall Study|Investigator's Discretion|1|||
155299656|NCT01369498|560528005|FG001|Overall Study|Investigator's Discretion|0|||
155299657|NCT01369498|560528006|FG002|Overall Study|Investigator's Discretion|1|||
155299658|NCT01369498|560528007|FG003|Overall Study|Investigator's Discretion|3|||
155299659|NCT01369498|560528004|FG000|Overall Study|Unknown Reason|1|||
155299660|NCT01369498|560528005|FG001|Overall Study|Unknown Reason|0|||
155299661|NCT01369498|560528006|FG002|Overall Study|Unknown Reason|11|||
155299662|NCT01369498|560528007|FG003|Overall Study|Unknown Reason|6|||
155299663|NCT01369498|560528004|FG000|Overall Study|Disease Progression|0|||
155299664|NCT01369498|560528005|FG001|Overall Study|Disease Progression|0|||
155299665|NCT01369498|560528006|FG002|Overall Study|Disease Progression|0|||
155299666|NCT01369498|560528007|FG003|Overall Study|Disease Progression|1|||
155299667|NCT02202499|560528014|FG000|Overall Study|Cancer diagnosis|0|||
155299668|NCT02202499|560528015|FG001|Overall Study|Cancer diagnosis|0|||
155299669|NCT02202499|560528016|FG002|Overall Study|Cancer diagnosis|1|||
155299670|NCT02202499|560528014|FG000|Overall Study|Moved from area|0|||
155299671|NCT02202499|560528015|FG001|Overall Study|Moved from area|0|||
155299672|NCT02202499|560528016|FG002|Overall Study|Moved from area|1|||
155299673|NCT02202499|560528014|FG000|Overall Study|Declined before randomization|1|||
155299674|NCT02202499|560528015|FG001|Overall Study|Declined before randomization|0|||
155299675|NCT02202499|560528016|FG002|Overall Study|Declined before randomization|0|||
155299676|NCT02202499|560528014|FG000|Overall Study|Auto accident|1|||
155299677|NCT02202499|560528015|FG001|Overall Study|Auto accident|0|||
155299678|NCT02202499|560528016|FG002|Overall Study|Auto accident|0|||
155299679|NCT00159783|560528020|FG000|Overall Study|Adverse Event|5|||
155299680|NCT00159783|560528021|FG001|Overall Study|Adverse Event|7|||
155299681|NCT00159783|560528022|FG002|Overall Study|Adverse Event|9|||
155299682|NCT00159783|560528020|FG000|Overall Study|Lack of Efficacy|1|||
155299683|NCT00159783|560528021|FG001|Overall Study|Lack of Efficacy|2|||
155299684|NCT00159783|560528022|FG002|Overall Study|Lack of Efficacy|3|||
155299685|NCT00159783|560528020|FG000|Overall Study|Withdrawal by Subject|7|||
155299686|NCT00159783|560528021|FG001|Overall Study|Withdrawal by Subject|11|||
155299687|NCT00159783|560528022|FG002|Overall Study|Withdrawal by Subject|12|||
155299688|NCT00159783|560528020|FG000|Overall Study|Lost to Follow-up|6|||
155299689|NCT00159783|560528021|FG001|Overall Study|Lost to Follow-up|5|||
155299690|NCT00159783|560528022|FG002|Overall Study|Lost to Follow-up|11|||
155299691|NCT00159783|560528020|FG000|Overall Study|Other|0|||
155299692|NCT00159783|560528021|FG001|Overall Study|Other|2|||
155299693|NCT00159783|560528022|FG002|Overall Study|Other|4|||
155299694|NCT02538107|560528023|FG000|Overall Study|Did not receive any Mircera dose|11|||
155299695|NCT02538107|560528023|FG000|Overall Study|Missing|5|||
155299696|NCT02538107|560528023|FG000|Overall Study|Necessity of dialysis|20|||
155299697|NCT02538107|560528023|FG000|Overall Study|Administration of other ESA|11|||
155299698|NCT02538107|560528023|FG000|Overall Study|No further treatment necessary|18|||
155299699|NCT02538107|560528023|FG000|Overall Study|Withdrawal by Subject|17|||
155640694|NCT00541229|561775464|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155640695|NCT00541229|561775465|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155640696|NCT00541229|561775466|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155640697|NCT00541229|561775467|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
155640698|NCT00541229|561775462|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155640699|NCT00541229|561775463|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
155640700|NCT00541229|561775464|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
155640701|NCT00541229|561775465|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
155640702|NCT00541229|561775466|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155299700|NCT02538107|560528023|FG000|Overall Study|Death|4|||
155299701|NCT02538107|560528023|FG000|Overall Study|Administrative reason|5|||
155299702|NCT02538107|560528023|FG000|Overall Study|Adverse Event|4|||
155299703|NCT02538107|560528023|FG000|Overall Study|Surgery|1|||
155745571|NCT01227629|562167572|FG000|Overall Study|Adverse Event|2|||
155745572|NCT01227629|562167573|FG001|Overall Study|Adverse Event|2|||
155745573|NCT01227629|562167574|FG002|Overall Study|Adverse Event|1|||
155299704|NCT02538107|560528023|FG000|Overall Study|Other|7|||
155299705|NCT02538107|560528023|FG000|Overall Study|Not recorded|7|||
155299706|NCT01236560|560528024|FG000|Overall Study|Adverse Event|0|||
155299707|NCT01236560|560528025|FG001|Overall Study|Adverse Event|2|||
155299708|NCT01236560|560528026|FG002|Overall Study|Adverse Event|1|||
155299709|NCT01236560|560528027|FG003|Overall Study|Adverse Event|3|||
155299710|NCT01236560|560528028|FG004|Overall Study|Adverse Event|0|||
155299711|NCT01236560|560528029|FG005|Overall Study|Adverse Event|0|||
155299712|NCT01236560|560528024|FG000|Overall Study|Death|0|||
155299713|NCT01236560|560528025|FG001|Overall Study|Death|1|||
155299714|NCT01236560|560528026|FG002|Overall Study|Death|0|||
155299715|NCT01236560|560528027|FG003|Overall Study|Death|1|||
155299716|NCT01236560|560528028|FG004|Overall Study|Death|0|||
155299717|NCT01236560|560528029|FG005|Overall Study|Death|0|||
155299718|NCT01236560|560528024|FG000|Overall Study|Lost to Follow-up|0|||
155299719|NCT01236560|560528025|FG001|Overall Study|Lost to Follow-up|1|||
155299720|NCT01236560|560528026|FG002|Overall Study|Lost to Follow-up|1|||
155299721|NCT01236560|560528027|FG003|Overall Study|Lost to Follow-up|0|||
155299722|NCT01236560|560528028|FG004|Overall Study|Lost to Follow-up|0|||
155299723|NCT01236560|560528029|FG005|Overall Study|Lost to Follow-up|0|||
155299724|NCT01236560|560528024|FG000|Overall Study|Physician Decision|0|||
155299725|NCT01236560|560528025|FG001|Overall Study|Physician Decision|1|||
155299726|NCT01236560|560528026|FG002|Overall Study|Physician Decision|8|||
155299727|NCT01236560|560528027|FG003|Overall Study|Physician Decision|0|||
155299728|NCT01236560|560528028|FG004|Overall Study|Physician Decision|0|||
155299729|NCT01236560|560528029|FG005|Overall Study|Physician Decision|0|||
155299730|NCT01236560|560528024|FG000|Overall Study|Withdrawal by Subject|0|||
155299731|NCT01236560|560528025|FG001|Overall Study|Withdrawal by Subject|0|||
155299732|NCT01236560|560528026|FG002|Overall Study|Withdrawal by Subject|1|||
155299733|NCT01236560|560528027|FG003|Overall Study|Withdrawal by Subject|2|||
155299734|NCT01236560|560528028|FG004|Overall Study|Withdrawal by Subject|0|||
155299735|NCT01236560|560528029|FG005|Overall Study|Withdrawal by Subject|0|||
155299736|NCT01236560|560528024|FG000|Overall Study|Progressive disease|5|||
155299737|NCT01236560|560528025|FG001|Overall Study|Progressive disease|19|||
155299738|NCT01236560|560528026|FG002|Overall Study|Progressive disease|9|||
155299739|NCT01236560|560528027|FG003|Overall Study|Progressive disease|16|||
155299740|NCT01236560|560528028|FG004|Overall Study|Progressive disease|0|||
155299741|NCT01236560|560528029|FG005|Overall Study|Progressive disease|0|||
155299742|NCT02471755|560528030|FG000|Overall Study|Withdrawal by Subject|1|||
155299743|NCT02471755|560528031|FG001|Overall Study|Withdrawal by Subject|0|||
155299744|NCT02471755|560528030|FG000|Overall Study|Lost to Follow-up|0|||
155299745|NCT02471755|560528031|FG001|Overall Study|Lost to Follow-up|1|||
155299746|NCT01576484|560528032|FG000|Overall Study|Adverse Event|1|||
155299747|NCT01576484|560528033|FG001|Overall Study|Adverse Event|1|||
155299748|NCT01576484|560528032|FG000|Overall Study|Protocol Violation|0|||
155299749|NCT01576484|560528033|FG001|Overall Study|Protocol Violation|2|||
155299750|NCT01576484|560528032|FG000|Overall Study|Sponsor Decision|2|||
155299751|NCT01576484|560528033|FG001|Overall Study|Sponsor Decision|8|||
155299752|NCT01576484|560528032|FG000|Overall Study|Withdrawal by Subject|0|||
155299753|NCT01576484|560528033|FG001|Overall Study|Withdrawal by Subject|3|||
155299754|NCT01576484|560528032|FG000|Overall Study|Other|2|||
155299755|NCT01576484|560528033|FG001|Overall Study|Other|5|||
155299756|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
155299757|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
155299758|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
155299759|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
155299760|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
155299761|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
155299762|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
155299763|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
155299764|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
155299765|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
155299766|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
155299767|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
155299768|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
155299769|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
155299770|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
155299771|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
155299772|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
155299773|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
155299774|NCT00958633|560528035|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
155299775|NCT00958633|560528036|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
155299776|NCT00958633|560528037|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
155299777|NCT00094575|560528044|FG000|Overall Study|Death|146|||
155299778|NCT00094575|560528045|FG001|Overall Study|Death|146|||
155299779|NCT00794118|560528046|FG000|Overall Study|Lost to Follow-up|16|||
155299780|NCT00794118|560528046|FG000|Overall Study|Withdrawal by Subject|9|||
155299781|NCT00794118|560528046|FG000|Overall Study|Changed hospital center|2|||
155299782|NCT00837616|560528047|FG000|Overall Study|Withdrawal by Subject|0|||
155299783|NCT00837616|560528048|FG001|Overall Study|Withdrawal by Subject|1|||
155299784|NCT03512756|560528052|FG000|Part 1|Death|23|||
155299785|NCT03512756|560528053|FG001|Part 1|Death|18|||
155299786|NCT03512756|560528054|FG002|Part 1|Death|0|||
155299787|NCT03512756|560528055|FG003|Part 1|Death|0|||
155299788|NCT03512756|560528052|FG000|Part 1|Lost to Follow-up|0|||
155299789|NCT03512756|560528053|FG001|Part 1|Lost to Follow-up|3|||
155299790|NCT03512756|560528054|FG002|Part 1|Lost to Follow-up|0|||
155299791|NCT03512756|560528055|FG003|Part 1|Lost to Follow-up|0|||
155299792|NCT03512756|560528052|FG000|Part 1|Physician Decision|0|||
155299793|NCT03512756|560528053|FG001|Part 1|Physician Decision|1|||
155299794|NCT03512756|560528054|FG002|Part 1|Physician Decision|0|||
155299795|NCT03512756|560528055|FG003|Part 1|Physician Decision|0|||
155299796|NCT03512756|560528052|FG000|Part 1|Withdrawal by Subject|2|||
155299797|NCT03512756|560528053|FG001|Part 1|Withdrawal by Subject|2|||
155299798|NCT03512756|560528054|FG002|Part 1|Withdrawal by Subject|0|||
155299799|NCT03512756|560528055|FG003|Part 1|Withdrawal by Subject|0|||
155299800|NCT03512756|560528052|FG000|Part 2|Death|0|||
155299801|NCT03512756|560528053|FG001|Part 2|Death|0|||
155299802|NCT03512756|560528054|FG002|Part 2|Death|32|||
155299803|NCT03512756|560528055|FG003|Part 2|Death|21|||
155299804|NCT03512756|560528052|FG000|Part 2|Lost to Follow-up|0|||
155299805|NCT03512756|560528053|FG001|Part 2|Lost to Follow-up|0|||
155299806|NCT03512756|560528054|FG002|Part 2|Lost to Follow-up|1|||
155299807|NCT03512756|560528055|FG003|Part 2|Lost to Follow-up|0|||
155299808|NCT03512756|560528052|FG000|Part 2|Physician Decision|0|||
155299809|NCT03512756|560528053|FG001|Part 2|Physician Decision|0|||
155299810|NCT03512756|560528054|FG002|Part 2|Physician Decision|2|||
155299811|NCT03512756|560528055|FG003|Part 2|Physician Decision|4|||
155299812|NCT03512756|560528052|FG000|Part 2|Study Terminated by Sponsor|0|||
155299813|NCT03512756|560528053|FG001|Part 2|Study Terminated by Sponsor|0|||
155299814|NCT03512756|560528054|FG002|Part 2|Study Terminated by Sponsor|2|||
155299815|NCT03512756|560528055|FG003|Part 2|Study Terminated by Sponsor|6|||
155299816|NCT03512756|560528052|FG000|Part 2|Protocol Violation|0|||
155299817|NCT03512756|560528053|FG001|Part 2|Protocol Violation|0|||
155299818|NCT03512756|560528054|FG002|Part 2|Protocol Violation|1|||
155299819|NCT03512756|560528055|FG003|Part 2|Protocol Violation|0|||
155299820|NCT03512756|560528052|FG000|Part 2|Withdrawal by Subject|0|||
155299821|NCT03512756|560528053|FG001|Part 2|Withdrawal by Subject|0|||
155299822|NCT03512756|560528054|FG002|Part 2|Withdrawal by Subject|3|||
155640703|NCT00541229|561775467|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155640704|NCT00541229|561775462|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
155640705|NCT00541229|561775463|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
155640706|NCT00541229|561775464|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
155640707|NCT00541229|561775465|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
155640708|NCT00541229|561775466|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
155640709|NCT00541229|561775467|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
155640710|NCT00541229|561775462|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
155640711|NCT00541229|561775463|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
155640712|NCT00541229|561775464|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
155640713|NCT00541229|561775465|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
155640714|NCT00541229|561775466|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
155640715|NCT00541229|561775467|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
155640716|NCT00541229|561775462|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
155299823|NCT03512756|560528055|FG003|Part 2|Withdrawal by Subject|9|||
155299824|NCT03312907|560529588|FG000|Overall Study|Adverse Event|1|||
155640717|NCT00541229|561775463|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
155640718|NCT00541229|561775464|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
155299825|NCT03312907|560529589|FG001|Overall Study|Adverse Event|6|||
155299826|NCT03312907|560529590|FG002|Overall Study|Adverse Event|1|||
155299827|NCT03312907|560529588|FG000|Overall Study|Protocol Violation|2|||
155299828|NCT03312907|560529589|FG001|Overall Study|Protocol Violation|3|||
155299829|NCT03312907|560529590|FG002|Overall Study|Protocol Violation|4|||
155745574|NCT01227629|562167575|FG003|Overall Study|Adverse Event|6|||
155745575|NCT01227629|562167576|FG004|Overall Study|Adverse Event|1|||
155745576|NCT01227629|562167577|FG005|Overall Study|Adverse Event|1|||
155745577|NCT01227629|562167578|FG006|Overall Study|Adverse Event|6|||
155745578|NCT01227629|562167579|FG007|Overall Study|Adverse Event|6|||
155745579|NCT01227629|562167580|FG008|Overall Study|Adverse Event|4|||
155745580|NCT01227629|562167581|FG009|Overall Study|Adverse Event|0|||
155745581|NCT01227629|562167572|FG000|Overall Study|Protocol Violation|0|||
155745582|NCT01227629|562167573|FG001|Overall Study|Protocol Violation|0|||
155745583|NCT01227629|562167574|FG002|Overall Study|Protocol Violation|0|||
155745584|NCT01227629|562167575|FG003|Overall Study|Protocol Violation|1|||
155745585|NCT01227629|562167576|FG004|Overall Study|Protocol Violation|0|||
155745586|NCT01227629|562167577|FG005|Overall Study|Protocol Violation|0|||
155745587|NCT01227629|562167578|FG006|Overall Study|Protocol Violation|0|||
155745588|NCT01227629|562167579|FG007|Overall Study|Protocol Violation|0|||
155299830|NCT03312907|560529588|FG000|Overall Study|Lost to Follow-up|2|||
155299831|NCT03312907|560529589|FG001|Overall Study|Lost to Follow-up|3|||
155299832|NCT03312907|560529590|FG002|Overall Study|Lost to Follow-up|2|||
155299833|NCT03312907|560529588|FG000|Overall Study|Physician Decision|3|||
155299834|NCT03312907|560529589|FG001|Overall Study|Physician Decision|4|||
155299835|NCT03312907|560529590|FG002|Overall Study|Physician Decision|2|||
155745589|NCT01227629|562167580|FG008|Overall Study|Protocol Violation|0|||
155745590|NCT01227629|562167581|FG009|Overall Study|Protocol Violation|0|||
155745591|NCT01227629|562167572|FG000|Overall Study|Lost to Follow-up|0|||
155745592|NCT01227629|562167573|FG001|Overall Study|Lost to Follow-up|0|||
155745593|NCT01227629|562167574|FG002|Overall Study|Lost to Follow-up|0|||
155745594|NCT01227629|562167575|FG003|Overall Study|Lost to Follow-up|0|||
155745595|NCT01227629|562167576|FG004|Overall Study|Lost to Follow-up|1|||
155745596|NCT01227629|562167577|FG005|Overall Study|Lost to Follow-up|0|||
155745597|NCT01227629|562167578|FG006|Overall Study|Lost to Follow-up|0|||
155299836|NCT03312907|560529588|FG000|Overall Study|Withdrawal by Subject|9|||
155299837|NCT03312907|560529589|FG001|Overall Study|Withdrawal by Subject|14|||
155745598|NCT01227629|562167579|FG007|Overall Study|Lost to Follow-up|0|||
155745599|NCT01227629|562167580|FG008|Overall Study|Lost to Follow-up|0|||
155745600|NCT01227629|562167581|FG009|Overall Study|Lost to Follow-up|0|||
155745601|NCT01227629|562167572|FG000|Overall Study|Withdrawal by Subject|0|||
155745602|NCT01227629|562167573|FG001|Overall Study|Withdrawal by Subject|0|||
155745603|NCT01227629|562167574|FG002|Overall Study|Withdrawal by Subject|0|||
155745604|NCT01227629|562167575|FG003|Overall Study|Withdrawal by Subject|0|||
155745605|NCT01227629|562167576|FG004|Overall Study|Withdrawal by Subject|0|||
155745606|NCT01227629|562167577|FG005|Overall Study|Withdrawal by Subject|0|||
155745607|NCT01227629|562167578|FG006|Overall Study|Withdrawal by Subject|2|||
155745608|NCT01227629|562167579|FG007|Overall Study|Withdrawal by Subject|0|||
155745609|NCT01227629|562167580|FG008|Overall Study|Withdrawal by Subject|0|||
155745610|NCT01227629|562167581|FG009|Overall Study|Withdrawal by Subject|1|||
155745611|NCT01227629|562167572|FG000|Overall Study|Other|0|||
155745612|NCT01227629|562167573|FG001|Overall Study|Other|0|||
155745613|NCT01227629|562167574|FG002|Overall Study|Other|0|||
155745614|NCT01227629|562167575|FG003|Overall Study|Other|1|||
155745615|NCT01227629|562167576|FG004|Overall Study|Other|0|||
155745616|NCT01227629|562167577|FG005|Overall Study|Other|0|||
155745617|NCT01227629|562167578|FG006|Overall Study|Other|0|||
155745618|NCT01227629|562167579|FG007|Overall Study|Other|0|||
155745619|NCT01227629|562167580|FG008|Overall Study|Other|2|||
155745620|NCT01227629|562167581|FG009|Overall Study|Other|1|||
155299838|NCT03312907|560529590|FG002|Overall Study|Withdrawal by Subject|10|||
155299839|NCT04688450|560529591|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
155299840|NCT04688450|560529591|FG000|Overall Study|Withdrawal by Subject|1|||
155299841|NCT03189524|560529593|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
155299842|NCT03189524|560529594|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
155299843|NCT03189524|560529595|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
155299844|NCT03189524|560529593|FG000|Overall Study|Death|2|||
155299845|NCT03189524|560529594|FG001|Overall Study|Death|2|||
155299846|NCT03189524|560529595|FG002|Overall Study|Death|1|||
155299847|NCT03189524|560529593|FG000|Overall Study|Lost to Follow-up|1|||
155299848|NCT03189524|560529594|FG001|Overall Study|Lost to Follow-up|0|||
155299849|NCT03189524|560529595|FG002|Overall Study|Lost to Follow-up|8|||
155299850|NCT03189524|560529593|FG000|Overall Study|Withdrawal by Subject|1|||
155745621|NCT02055365|562169695|FG000|Overall Study|Prematurely Withdrawn|1|||
155745622|NCT01258998|562169698|FG000|Overall Study|Ineligible|1|||
155745623|NCT03224598|562169699|FG000|Overall Study|Lost to Follow-up|0|||
155745624|NCT03224598|562169700|FG001|Overall Study|Lost to Follow-up|2|||
155745625|NCT03224598|562169701|FG002|Overall Study|Lost to Follow-up|0|||
155745626|NCT03224598|562169699|FG000|Overall Study|Other|0|||
155745627|NCT03224598|562169700|FG001|Overall Study|Other|1|||
155745628|NCT03224598|562169701|FG002|Overall Study|Other|0|||
155745629|NCT01264081|562169711|FG000|Participants Screened|Screening failures|30|||
155745630|NCT01264081|562169711|FG000|Started Treatment|Withdrawal by Subject|1|||
155745631|NCT01264081|562169711|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
155745632|NCT02716896|562169712|FG000|Overall Study|Physician Decision|0|||
155745633|NCT02716896|562169713|FG001|Overall Study|Physician Decision|1|||
155745634|NCT02054481|562169719|FG000|Overall Study|Adverse Event|1|||
155745635|NCT02054481|562169720|FG001|Overall Study|Adverse Event|1|||
155745636|NCT02054481|562169721|FG002|Overall Study|Adverse Event|0|||
155745637|NCT02054481|562169722|FG003|Overall Study|Adverse Event|1|||
155745638|NCT02054481|562169719|FG000|Overall Study|Lost to Follow-up|1|||
155745639|NCT02054481|562169720|FG001|Overall Study|Lost to Follow-up|0|||
155745640|NCT02054481|562169721|FG002|Overall Study|Lost to Follow-up|0|||
155745641|NCT02054481|562169722|FG003|Overall Study|Lost to Follow-up|0|||
155745642|NCT02054481|562169719|FG000|Overall Study|Other reason|2|||
155745643|NCT02054481|562169720|FG001|Overall Study|Other reason|1|||
155745644|NCT02054481|562169721|FG002|Overall Study|Other reason|2|||
155745645|NCT02054481|562169722|FG003|Overall Study|Other reason|0|||
155745646|NCT02320903|562169723|FG000|Overall Study|Withdrawal by Subject|0|||
155745647|NCT02320903|562169724|FG001|Overall Study|Withdrawal by Subject|9|||
155745648|NCT02320903|562169725|FG002|Overall Study|Withdrawal by Subject|9|||
155745649|NCT02320903|562169723|FG000|Overall Study|Exited therapy; no longer eligible|8|||
155745650|NCT02320903|562169724|FG001|Overall Study|Exited therapy; no longer eligible|2|||
155745651|NCT02320903|562169725|FG002|Overall Study|Exited therapy; no longer eligible|2|||
155745652|NCT02320903|562169723|FG000|Overall Study|Lost to Follow-up|0|||
155745653|NCT02320903|562169724|FG001|Overall Study|Lost to Follow-up|5|||
155745654|NCT02320903|562169725|FG002|Overall Study|Lost to Follow-up|5|||
155745655|NCT00883688|562169742|FG000|Overall Study|Ineligible|2|||
155299851|NCT03189524|560529594|FG001|Overall Study|Withdrawal by Subject|1|||
155299852|NCT03189524|560529595|FG002|Overall Study|Withdrawal by Subject|3|||
155299853|NCT03189524|560529593|FG000|Overall Study|Progressive Disease|0|||
155299854|NCT03189524|560529594|FG001|Overall Study|Progressive Disease|2|||
155299855|NCT03189524|560529595|FG002|Overall Study|Progressive Disease|0|||
155299856|NCT01780298|560529597|FG000|Overall Study|Physician Decision|1|||
155299857|NCT01780298|560529598|FG001|Overall Study|Physician Decision|5|||
155299858|NCT01780298|560529599|FG002|Overall Study|Physician Decision|1|||
155299859|NCT01780298|560529600|FG003|Overall Study|Physician Decision|1|||
155299860|NCT01780298|560529597|FG000|Overall Study|Subject not matched|1|||
155745656|NCT03811093|562169743|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
155745657|NCT03811093|562169744|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
155745658|NCT03811093|562169743|FG000|Overall Study|Unable to measure body fat percentage|2|||
155745659|NCT03811093|562169744|FG001|Overall Study|Unable to measure body fat percentage|0|||
155745660|NCT01095094|562169745|FG000|Overall Study|Withdrawal by Subject|1|||
155745661|NCT01095094|562169745|FG000|Overall Study|Death|1|||
155745662|NCT01095094|562169745|FG000|Overall Study|Physician Decision|1|||
155745663|NCT00464490|562169746|FG000|Overall Study|Physician Decision|11|||
155745664|NCT00464490|562169747|FG001|Overall Study|Physician Decision|11|||
155745665|NCT03188042|562169750|FG000|Overall Study|Withdrawal by Subject|1|||
155745666|NCT03188042|562169751|FG001|Overall Study|Withdrawal by Subject|1|||
155745667|NCT00137839|562169758|FG000|Overall Study|Adverse Event|7|||
155745668|NCT00137839|562169758|FG000|Overall Study|Physician Decision|7|||
155745669|NCT00137839|562169758|FG000|Overall Study|Death|8|||
155745670|NCT00137839|562169758|FG000|Overall Study|Disease Progression|60|||
155745671|NCT00137839|562169758|FG000|Overall Study|Not Start Treatment|1|||
155745672|NCT00137839|562169758|FG000|Overall Study|Prolonged Treatment Delay|1|||
155745673|NCT02446743|562169759|FG000|Overall Study|Withdrawal by Subject|1|||
155745674|NCT02446743|562169760|FG001|Overall Study|Withdrawal by Subject|1|||
155745675|NCT02446743|562169759|FG000|Overall Study|Lost to Follow-up|1|||
155745676|NCT02446743|562169760|FG001|Overall Study|Lost to Follow-up|0|||
155745677|NCT02446743|562169759|FG000|Overall Study|Adverse Event|1|||
155745678|NCT02446743|562169760|FG001|Overall Study|Adverse Event|1|||
155745679|NCT02446743|562169759|FG000|Overall Study|Other|2|||
155745680|NCT02446743|562169760|FG001|Overall Study|Other|3|||
155745681|NCT03086967|562169761|FG000|Overall Study|Screen Failure|2|||
155745682|NCT03086967|562169762|FG001|Overall Study|Screen Failure|2|||
155745683|NCT01752036|562169764|FG000|Overall Study|Death|2|||
155745684|NCT02230527|562169765|FG000|Overall Study|Withdrawal by Subject|1|||
155745685|NCT02230527|562169766|FG001|Overall Study|Withdrawal by Subject|1|||
155745686|NCT02230527|562169765|FG000|Overall Study|Death|1|||
155745687|NCT02230527|562169766|FG001|Overall Study|Death|0|||
155745688|NCT02230527|562169765|FG000|Overall Study|Lost to Follow-up|2|||
155745689|NCT02230527|562169766|FG001|Overall Study|Lost to Follow-up|1|||
155745690|NCT02230527|562169765|FG000|Overall Study|Other|1|||
155745691|NCT02230527|562169766|FG001|Overall Study|Other|0|||
155745692|NCT01205581|562169768|FG000|Overall Study|Withdrawal by Subject|1|||
155745693|NCT01205581|562169769|FG001|Overall Study|Withdrawal by Subject|0|||
155745694|NCT01205581|562169770|FG002|Overall Study|Withdrawal by Subject|0|||
155745695|NCT01205581|562169771|FG003|Overall Study|Withdrawal by Subject|0|||
155745696|NCT01205581|562169772|FG004|Overall Study|Withdrawal by Subject|0|||
155745697|NCT01205581|562169773|FG005|Overall Study|Withdrawal by Subject|0|||
155745698|NCT04896229|562169775|FG000|Overall Study|Lost to Follow-up|113|||
155745699|NCT04896229|562169776|FG001|Overall Study|Lost to Follow-up|113|||
155299861|NCT01780298|560529598|FG001|Overall Study|Subject not matched|0|||
155299862|NCT01780298|560529599|FG002|Overall Study|Subject not matched|1|||
155299863|NCT01780298|560529600|FG003|Overall Study|Subject not matched|0|||
155299864|NCT01780298|560529597|FG000|Overall Study|Adverse Event|0|||
155299865|NCT01780298|560529598|FG001|Overall Study|Adverse Event|0|||
155299866|NCT01780298|560529599|FG002|Overall Study|Adverse Event|2|||
155299867|NCT01780298|560529600|FG003|Overall Study|Adverse Event|0|||
155299868|NCT01875848|560529607|FG000|Overall Study|Withdrawal by Subject|2|||
155299869|NCT01875848|560529608|FG001|Overall Study|Withdrawal by Subject|0|||
155299870|NCT02407249|560529609|FG000|Overall Study|Did not complete 12-month follow-up|13|||
155299871|NCT02407249|560529609|FG000|Overall Study|Not treated|13|||
155299872|NCT01622868|560529610|FG000|Overall Study|Protocol Violation|7|||
155299873|NCT01622868|560529611|FG001|Overall Study|Protocol Violation|0|||
155299874|NCT04252586|560529612|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155299875|NCT04252586|560529612|FG000|Overall Study|Adverse Event|1|||
155299876|NCT04252586|560529612|FG000|Overall Study|Death|2|||
155299877|NCT04252586|560529612|FG000|Overall Study|Study terminated by sponsor|4|||
155299878|NCT04252586|560529612|FG000|Overall Study|Sponsor request|10|||
155299879|NCT04252586|560529612|FG000|Overall Study|Did not complete treatment period|1|||
155299880|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Death|186|||
155299881|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Death|222|||
155299882|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Death|0|||
155299883|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
155299884|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
155299885|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
155299886|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
155299887|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
155299888|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
155299889|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
155299890|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
155299891|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
155299892|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Adverse Event|83|||
155299893|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Adverse Event|100|||
155299894|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Adverse Event|0|||
155745700|NCT00045942|562169777|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
155745701|NCT00045942|562169778|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745702|NCT00045942|562169779|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745703|NCT00045942|562169780|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745704|NCT00045942|562169781|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745705|NCT00045942|562169782|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745706|NCT00045942|562169783|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745707|NCT00045942|562169784|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745708|NCT00045942|562169785|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155745709|NCT00045942|562169777|FG000|PKC412A2104 (Core)|Adverse Event|5|||
155745710|NCT00045942|562169778|FG001|PKC412A2104 (Core)|Adverse Event|0|||
155745711|NCT00045942|562169779|FG002|PKC412A2104 (Core)|Adverse Event|0|||
155745712|NCT00045942|562169780|FG003|PKC412A2104 (Core)|Adverse Event|0|||
155745713|NCT00045942|562169781|FG004|PKC412A2104 (Core)|Adverse Event|0|||
155745714|NCT00045942|562169782|FG005|PKC412A2104 (Core)|Adverse Event|0|||
155745715|NCT00045942|562169783|FG006|PKC412A2104 (Core)|Adverse Event|0|||
155745716|NCT00045942|562169784|FG007|PKC412A2104 (Core)|Adverse Event|0|||
155745717|NCT00045942|562169785|FG008|PKC412A2104 (Core)|Adverse Event|0|||
155745718|NCT00045942|562169777|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
155745719|NCT00045942|562169778|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
155299895|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Other|70|||
155299896|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Other|75|||
155299897|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Other|0|||
155299898|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
155299899|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
155299900|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
155299901|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
155299902|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
155299903|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
155299904|NCT00232180|560529613|FG000|Open Label Phase|Death|0|||
155745720|NCT00045942|562169779|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745721|NCT00045942|562169780|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745722|NCT00045942|562169781|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745723|NCT00045942|562169782|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745724|NCT00045942|562169783|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745725|NCT00045942|562169784|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745726|NCT00045942|562169785|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
155745727|NCT00045942|562169777|FG000|PKC412A2104 (Core)|Death|1|||
155745728|NCT00045942|562169778|FG001|PKC412A2104 (Core)|Death|0|||
155745729|NCT00045942|562169779|FG002|PKC412A2104 (Core)|Death|0|||
155745730|NCT00045942|562169780|FG003|PKC412A2104 (Core)|Death|0|||
155745731|NCT00045942|562169781|FG004|PKC412A2104 (Core)|Death|0|||
155745732|NCT00045942|562169782|FG005|PKC412A2104 (Core)|Death|0|||
155745733|NCT00045942|562169783|FG006|PKC412A2104 (Core)|Death|0|||
155745734|NCT00045942|562169784|FG007|PKC412A2104 (Core)|Death|0|||
155745735|NCT00045942|562169785|FG008|PKC412A2104 (Core)|Death|0|||
155745736|NCT00045942|562169777|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
155745737|NCT00045942|562169778|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
155745738|NCT00045942|562169779|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
155745739|NCT00045942|562169780|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
155299905|NCT00232180|560529614|FG001|Open Label Phase|Death|0|||
155299906|NCT00232180|560529615|FG002|Open Label Phase|Death|48|||
155299907|NCT00232180|560529613|FG000|Open Label Phase|Lost to Follow-up|0|||
155745740|NCT00045942|562169781|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
155745741|NCT00045942|562169782|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
155745742|NCT00045942|562169783|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
155745743|NCT00045942|562169784|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
155745744|NCT00045942|562169785|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
155745745|NCT00045942|562169777|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
155745746|NCT00045942|562169778|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
155745747|NCT00045942|562169779|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
155745748|NCT00045942|562169780|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
155745749|NCT00045942|562169781|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
155745750|NCT00045942|562169782|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
155745751|NCT00045942|562169783|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
155745752|NCT00045942|562169784|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
155745753|NCT00045942|562169785|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
155745754|NCT00045942|562169777|FG000|PKC412A2104E1|Lack of Efficacy|0|||
155745755|NCT00045942|562169778|FG001|PKC412A2104E1|Lack of Efficacy|11|||
155745756|NCT00045942|562169779|FG002|PKC412A2104E1|Lack of Efficacy|11|||
155745757|NCT00045942|562169780|FG003|PKC412A2104E1|Lack of Efficacy|23|||
155745758|NCT00045942|562169781|FG004|PKC412A2104E1|Lack of Efficacy|17|||
155745759|NCT00045942|562169782|FG005|PKC412A2104E1|Lack of Efficacy|0|||
155745760|NCT00045942|562169783|FG006|PKC412A2104E1|Lack of Efficacy|0|||
155299908|NCT00232180|560529614|FG001|Open Label Phase|Lost to Follow-up|0|||
155299909|NCT00232180|560529615|FG002|Open Label Phase|Lost to Follow-up|5|||
155299910|NCT00232180|560529613|FG000|Open Label Phase|Protocol Violation|0|||
155299911|NCT00232180|560529614|FG001|Open Label Phase|Protocol Violation|0|||
155299912|NCT00232180|560529615|FG002|Open Label Phase|Protocol Violation|3|||
155299913|NCT00232180|560529613|FG000|Open Label Phase|Study terminated by sponsor|0|||
155299914|NCT00232180|560529614|FG001|Open Label Phase|Study terminated by sponsor|0|||
155299915|NCT00232180|560529615|FG002|Open Label Phase|Study terminated by sponsor|3|||
155299916|NCT00232180|560529613|FG000|Open Label Phase|Withdrawal by Subject|0|||
155299917|NCT00232180|560529614|FG001|Open Label Phase|Withdrawal by Subject|0|||
155299918|NCT00232180|560529615|FG002|Open Label Phase|Withdrawal by Subject|37|||
155299919|NCT00232180|560529613|FG000|Open Label Phase|Other|0|||
155299920|NCT00232180|560529614|FG001|Open Label Phase|Other|0|||
155299921|NCT00232180|560529615|FG002|Open Label Phase|Other|16|||
155299922|NCT00232180|560529613|FG000|Open Label Phase|Adverse Event|0|||
155299923|NCT00232180|560529614|FG001|Open Label Phase|Adverse Event|0|||
155299924|NCT00232180|560529615|FG002|Open Label Phase|Adverse Event|25|||
155299925|NCT00232180|560529613|FG000|Open Label Phase|Laboratory abnormality|0|||
155299926|NCT00232180|560529614|FG001|Open Label Phase|Laboratory abnormality|0|||
155299927|NCT00232180|560529615|FG002|Open Label Phase|Laboratory abnormality|10|||
155299928|NCT00232180|560529613|FG000|Open Label Phase|Randomized but not treated|0|||
155299929|NCT00232180|560529614|FG001|Open Label Phase|Randomized but not treated|0|||
155299930|NCT00232180|560529615|FG002|Open Label Phase|Randomized but not treated|1|||
155299931|NCT02748317|560529616|FG000|Overall Study|Withdrawal by Subject|14|||
155299932|NCT02748317|560529616|FG000|Overall Study|Lost to Follow-up|8|||
155640719|NCT00541229|561775465|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
155640720|NCT00541229|561775466|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
155640721|NCT00541229|561775467|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
155640722|NCT00541229|561775462|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155640723|NCT00541229|561775463|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
155640724|NCT00541229|561775464|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155640725|NCT00541229|561775465|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155299933|NCT02748317|560529616|FG000|Overall Study|Death|1|||
155299934|NCT01149369|560529619|FG000|Overall Study|Adverse Event|6|||
155299935|NCT01149369|560529620|FG001|Overall Study|Adverse Event|3|||
155299936|NCT02767765|560529621|FG000|Overall Study|Adverse Event|4|||
155299937|NCT02767765|560529621|FG000|Overall Study|Death|1|||
155299938|NCT02767765|560529621|FG000|Overall Study|Insufficient response|1|||
155299939|NCT02767765|560529621|FG000|Overall Study|Lost to Follow-up|2|||
155299940|NCT02767765|560529621|FG000|Overall Study|Investigator decision|1|||
155299941|NCT02767765|560529621|FG000|Overall Study|Non-Compliance|1|||
155299942|NCT02767765|560529621|FG000|Overall Study|Withdrawal by Subject|1|||
155299943|NCT04723394|560529622|FG000|Overall Study|Adverse Event|0|||
155299944|NCT04723394|560529623|FG001|Overall Study|Adverse Event|3|||
155640726|NCT00541229|561775466|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
155640727|NCT00541229|561775467|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
155640728|NCT00541229|561775462|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
155640729|NCT00541229|561775463|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
155640730|NCT00541229|561775464|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
155640731|NCT00541229|561775465|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
155640732|NCT00541229|561775466|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
155640733|NCT00541229|561775467|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
155640734|NCT00541229|561775462|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
155640735|NCT00541229|561775463|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155640736|NCT00541229|561775464|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155640737|NCT00541229|561775465|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155640738|NCT00541229|561775466|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155299945|NCT04723394|560529622|FG000|Overall Study|Death|8|||
155299946|NCT04723394|560529623|FG001|Overall Study|Death|8|||
155299947|NCT04723394|560529622|FG000|Overall Study|Lost to Follow-up|20|||
155745761|NCT00045942|562169784|FG007|PKC412A2104E1|Lack of Efficacy|0|||
155745762|NCT00045942|562169785|FG008|PKC412A2104E1|Lack of Efficacy|0|||
155745763|NCT00045942|562169777|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
155745764|NCT00045942|562169778|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
155745765|NCT00045942|562169779|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
155745766|NCT00045942|562169780|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
155745767|NCT00045942|562169781|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
155745768|NCT00045942|562169782|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
155745769|NCT00045942|562169783|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
155745770|NCT00045942|562169784|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
155745771|NCT00045942|562169785|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
155745772|NCT00045942|562169777|FG000|PKC412A2104E1|Adverse Event|0|||
155745773|NCT00045942|562169778|FG001|PKC412A2104E1|Adverse Event|1|||
155745774|NCT00045942|562169779|FG002|PKC412A2104E1|Adverse Event|1|||
155745775|NCT00045942|562169780|FG003|PKC412A2104E1|Adverse Event|3|||
155745776|NCT00045942|562169781|FG004|PKC412A2104E1|Adverse Event|6|||
155745777|NCT00045942|562169782|FG005|PKC412A2104E1|Adverse Event|0|||
155745778|NCT00045942|562169783|FG006|PKC412A2104E1|Adverse Event|0|||
155745779|NCT00045942|562169784|FG007|PKC412A2104E1|Adverse Event|0|||
155745780|NCT00045942|562169785|FG008|PKC412A2104E1|Adverse Event|0|||
155745781|NCT00045942|562169777|FG000|PKC412A2104E1|Death|0|||
155745782|NCT00045942|562169778|FG001|PKC412A2104E1|Death|4|||
155745783|NCT00045942|562169779|FG002|PKC412A2104E1|Death|1|||
155745784|NCT00045942|562169780|FG003|PKC412A2104E1|Death|1|||
155745785|NCT00045942|562169781|FG004|PKC412A2104E1|Death|1|||
155745786|NCT00045942|562169782|FG005|PKC412A2104E1|Death|0|||
155745787|NCT00045942|562169783|FG006|PKC412A2104E1|Death|0|||
155745788|NCT00045942|562169784|FG007|PKC412A2104E1|Death|0|||
155745789|NCT00045942|562169785|FG008|PKC412A2104E1|Death|0|||
155745790|NCT00045942|562169777|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745791|NCT00045942|562169778|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745792|NCT00045942|562169779|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
155745793|NCT00045942|562169780|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
155745794|NCT00045942|562169781|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745795|NCT00045942|562169782|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745796|NCT00045942|562169783|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745797|NCT00045942|562169784|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745798|NCT00045942|562169785|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155745799|NCT00045942|562169777|FG000|PKC412A2104E2|Lost to Follow-up|0|||
155745800|NCT00045942|562169778|FG001|PKC412A2104E2|Lost to Follow-up|0|||
155745801|NCT00045942|562169779|FG002|PKC412A2104E2|Lost to Follow-up|0|||
155745802|NCT00045942|562169780|FG003|PKC412A2104E2|Lost to Follow-up|0|||
155299948|NCT04723394|560529623|FG001|Overall Study|Lost to Follow-up|17|||
155299949|NCT04723394|560529622|FG000|Overall Study|Physician Decision|1|||
155299950|NCT04723394|560529623|FG001|Overall Study|Physician Decision|0|||
155299951|NCT04723394|560529622|FG000|Overall Study|Withdrawal by Subject|20|||
155299952|NCT04723394|560529623|FG001|Overall Study|Withdrawal by Subject|34|||
155299953|NCT04723394|560529622|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
155299954|NCT04723394|560529623|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
155299955|NCT00774397|560529624|FG000|Overall Study|Adverse Event|1|||
155299956|NCT00774397|560529625|FG001|Overall Study|Adverse Event|3|||
155299957|NCT00774397|560529626|FG002|Overall Study|Adverse Event|16|||
155299958|NCT00774397|560529627|FG003|Overall Study|Adverse Event|8|||
155299959|NCT00774397|560529628|FG004|Overall Study|Adverse Event|8|||
155299960|NCT00774397|560529629|FG005|Overall Study|Adverse Event|3|||
155299961|NCT00774397|560529630|FG006|Overall Study|Adverse Event|16|||
155299962|NCT00774397|560529624|FG000|Overall Study|Lack of Efficacy|11|||
155299963|NCT00774397|560529625|FG001|Overall Study|Lack of Efficacy|4|||
155299964|NCT00774397|560529626|FG002|Overall Study|Lack of Efficacy|5|||
155299965|NCT00774397|560529627|FG003|Overall Study|Lack of Efficacy|3|||
155299966|NCT00774397|560529628|FG004|Overall Study|Lack of Efficacy|27|||
155299967|NCT00774397|560529629|FG005|Overall Study|Lack of Efficacy|15|||
155299968|NCT00774397|560529630|FG006|Overall Study|Lack of Efficacy|9|||
155299969|NCT00774397|560529624|FG000|Overall Study|Protocol Violation|0|||
155299970|NCT00774397|560529625|FG001|Overall Study|Protocol Violation|1|||
155299971|NCT00774397|560529626|FG002|Overall Study|Protocol Violation|3|||
155299972|NCT00774397|560529627|FG003|Overall Study|Protocol Violation|1|||
155299973|NCT00774397|560529628|FG004|Overall Study|Protocol Violation|2|||
155745803|NCT00045942|562169781|FG004|PKC412A2104E2|Lost to Follow-up|0|||
155745804|NCT00045942|562169782|FG005|PKC412A2104E2|Lost to Follow-up|0|||
155745805|NCT00045942|562169783|FG006|PKC412A2104E2|Lost to Follow-up|0|||
155745806|NCT00045942|562169784|FG007|PKC412A2104E2|Lost to Follow-up|3|||
155745807|NCT00045942|562169785|FG008|PKC412A2104E2|Lost to Follow-up|0|||
155745808|NCT00045942|562169777|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
155745809|NCT00045942|562169778|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
155745810|NCT00045942|562169779|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
155745811|NCT00045942|562169780|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
155745812|NCT00045942|562169781|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
155299974|NCT00774397|560529629|FG005|Overall Study|Protocol Violation|1|||
155745813|NCT00045942|562169782|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
155745814|NCT00045942|562169783|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
155745815|NCT00045942|562169784|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
155745816|NCT00045942|562169785|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
155745817|NCT00045942|562169777|FG000|PKC412A2104E2|Lack of Efficacy|0|||
155745818|NCT00045942|562169778|FG001|PKC412A2104E2|Lack of Efficacy|0|||
155745819|NCT00045942|562169779|FG002|PKC412A2104E2|Lack of Efficacy|0|||
155745820|NCT00045942|562169780|FG003|PKC412A2104E2|Lack of Efficacy|0|||
155745821|NCT00045942|562169781|FG004|PKC412A2104E2|Lack of Efficacy|0|||
155745822|NCT00045942|562169782|FG005|PKC412A2104E2|Lack of Efficacy|3|||
155745823|NCT00045942|562169783|FG006|PKC412A2104E2|Lack of Efficacy|2|||
155745824|NCT00045942|562169784|FG007|PKC412A2104E2|Lack of Efficacy|2|||
155745825|NCT00045942|562169785|FG008|PKC412A2104E2|Lack of Efficacy|6|||
155745826|NCT00045942|562169777|FG000|PKC412A2104E2|Adverse Event|0|||
155745827|NCT00045942|562169778|FG001|PKC412A2104E2|Adverse Event|0|||
155745828|NCT00045942|562169779|FG002|PKC412A2104E2|Adverse Event|0|||
155745829|NCT00045942|562169780|FG003|PKC412A2104E2|Adverse Event|0|||
155745830|NCT00045942|562169781|FG004|PKC412A2104E2|Adverse Event|0|||
155745831|NCT00045942|562169782|FG005|PKC412A2104E2|Adverse Event|4|||
155745832|NCT00045942|562169783|FG006|PKC412A2104E2|Adverse Event|3|||
155745833|NCT00045942|562169784|FG007|PKC412A2104E2|Adverse Event|1|||
155745834|NCT00045942|562169785|FG008|PKC412A2104E2|Adverse Event|0|||
155745835|NCT00045942|562169777|FG000|PKC412A2104E2|Death|0|||
155745836|NCT00045942|562169778|FG001|PKC412A2104E2|Death|0|||
155299975|NCT00774397|560529630|FG006|Overall Study|Protocol Violation|0|||
155299976|NCT00774397|560529624|FG000|Overall Study|Lost to Follow-up|0|||
155299977|NCT00774397|560529625|FG001|Overall Study|Lost to Follow-up|1|||
155299978|NCT00774397|560529626|FG002|Overall Study|Lost to Follow-up|1|||
155299979|NCT00774397|560529627|FG003|Overall Study|Lost to Follow-up|1|||
155299980|NCT00774397|560529628|FG004|Overall Study|Lost to Follow-up|0|||
155299981|NCT00774397|560529629|FG005|Overall Study|Lost to Follow-up|1|||
155299982|NCT00774397|560529630|FG006|Overall Study|Lost to Follow-up|0|||
155299983|NCT00774397|560529624|FG000|Overall Study|Refused to continue trial medication|1|||
155299984|NCT00774397|560529625|FG001|Overall Study|Refused to continue trial medication|3|||
155745837|NCT00045942|562169779|FG002|PKC412A2104E2|Death|0|||
155745838|NCT00045942|562169780|FG003|PKC412A2104E2|Death|0|||
155745839|NCT00045942|562169781|FG004|PKC412A2104E2|Death|0|||
155745840|NCT00045942|562169782|FG005|PKC412A2104E2|Death|1|||
155745841|NCT00045942|562169783|FG006|PKC412A2104E2|Death|2|||
155745842|NCT00045942|562169784|FG007|PKC412A2104E2|Death|0|||
155745843|NCT00045942|562169785|FG008|PKC412A2104E2|Death|0|||
155299985|NCT00774397|560529626|FG002|Overall Study|Refused to continue trial medication|2|||
155299986|NCT00774397|560529627|FG003|Overall Study|Refused to continue trial medication|2|||
155299987|NCT00774397|560529628|FG004|Overall Study|Refused to continue trial medication|6|||
155299988|NCT00774397|560529629|FG005|Overall Study|Refused to continue trial medication|2|||
155299989|NCT00774397|560529630|FG006|Overall Study|Refused to continue trial medication|3|||
155745844|NCT05508074|562169786|FG000|Overall Study|Death|2|||
155745845|NCT05508074|562169787|FG001|Overall Study|Death|5|||
155745846|NCT05508074|562169786|FG000|Overall Study|Withdrawal by Subject|1|||
155745847|NCT05508074|562169787|FG001|Overall Study|Withdrawal by Subject|2|||
155745848|NCT05508074|562169786|FG000|Overall Study|Adverse Event|0|||
155745849|NCT05508074|562169787|FG001|Overall Study|Adverse Event|1|||
155745850|NCT05508074|562169786|FG000|Overall Study|Physician Decision|0|||
155745851|NCT05508074|562169787|FG001|Overall Study|Physician Decision|1|||
155745852|NCT05508074|562169786|FG000|Overall Study|wrongly randomized|0|||
155745853|NCT05508074|562169787|FG001|Overall Study|wrongly randomized|1|||
155745854|NCT05508074|562169786|FG000|Overall Study|non-compliance|0|||
155299990|NCT00774397|560529624|FG000|Overall Study|Not treated|0|||
155299991|NCT00774397|560529625|FG001|Overall Study|Not treated|0|||
155299992|NCT00774397|560529626|FG002|Overall Study|Not treated|0|||
155299993|NCT00774397|560529627|FG003|Overall Study|Not treated|0|||
155299994|NCT00774397|560529628|FG004|Overall Study|Not treated|1|||
155299995|NCT00774397|560529629|FG005|Overall Study|Not treated|0|||
155299996|NCT00774397|560529630|FG006|Overall Study|Not treated|1|||
155745855|NCT05508074|562169787|FG001|Overall Study|non-compliance|1|||
155745856|NCT02395302|562169788|FG000|Overall Study|Screen Failure|3|||
155745857|NCT02395302|562169788|FG000|Overall Study|Run In Failure|7|||
155745858|NCT02395302|562169788|FG000|Overall Study|Withdrawal by Subject|2|||
155745859|NCT02395302|562169788|FG000|Overall Study|Physician Decision|2|||
155745860|NCT01806662|562169789|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
155745861|NCT01806662|562169790|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
155745862|NCT01806662|562169789|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
155745863|NCT01806662|562169790|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
155745864|NCT01806662|562169789|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
155745865|NCT01806662|562169790|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
155745866|NCT01806662|562169789|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
155745867|NCT01806662|562169790|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
155745868|NCT00043550|562169791|FG000|Overall Study|Withdrawal by Subject|22|||
155745869|NCT00043550|562169792|FG001|Overall Study|Withdrawal by Subject|12|||
155745870|NCT00043550|562169793|FG002|Overall Study|Withdrawal by Subject|20|||
155745871|NCT02285062|562169796|FG000|Pre-Treatment Period|Protocol Violation|0|||
155745872|NCT02285062|562169797|FG001|Pre-Treatment Period|Protocol Violation|2|||
155745873|NCT02285062|562169796|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
155745874|NCT02285062|562169797|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155745875|NCT00545129|562169803|FG000|Overall Study|Lack of Efficacy|2|||
155745876|NCT00545129|562169804|FG001|Overall Study|Lack of Efficacy|5|||
155745877|NCT00545129|562169803|FG000|Overall Study|Death|2|||
155745878|NCT00545129|562169804|FG001|Overall Study|Death|1|||
155745879|NCT00545129|562169803|FG000|Overall Study|Adverse Event|1|||
155745880|NCT00545129|562169804|FG001|Overall Study|Adverse Event|1|||
155745881|NCT00545129|562169803|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
155299997|NCT00774397|560529624|FG000|Overall Study|Other than those stated above|1|||
155640739|NCT00541229|561775467|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
155640740|NCT00541229|561775462|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
155640741|NCT00541229|561775463|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
155640742|NCT00541229|561775464|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
155640743|NCT00541229|561775465|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
155640744|NCT00541229|561775466|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
155640745|NCT00541229|561775467|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
155640746|NCT00541229|561775462|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155640747|NCT00541229|561775463|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155640748|NCT00541229|561775464|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155640749|NCT00541229|561775465|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155640750|NCT00541229|561775466|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
155640751|NCT00541229|561775467|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155640752|NCT00541229|561775462|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155640753|NCT00541229|561775463|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
155640754|NCT00541229|561775464|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
155640755|NCT00541229|561775465|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
155640756|NCT00541229|561775466|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155640757|NCT00541229|561775467|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155640758|NCT00541229|561775462|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
155640759|NCT00541229|561775463|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
155640760|NCT00541229|561775464|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
155640761|NCT00541229|561775465|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
155640762|NCT00541229|561775466|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
155640763|NCT00541229|561775467|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
155640764|NCT00541229|561775462|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155640765|NCT00541229|561775463|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155640766|NCT00541229|561775464|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155640767|NCT00541229|561775465|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155640768|NCT00541229|561775466|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155640769|NCT00541229|561775467|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
155640770|NCT00541229|561775462|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155640771|NCT00541229|561775463|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155640772|NCT00541229|561775464|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
155640773|NCT00541229|561775465|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155640774|NCT00541229|561775466|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155640775|NCT00541229|561775467|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155640776|NCT03807843|561775468|FG000|Overall Study|Lost to Follow-up|1|||
155640777|NCT03807843|561775469|FG001|Overall Study|Lost to Follow-up|0|||
155640778|NCT01033942|561775472|FG000|Overall Study|Withdrawal by Subject|1|||
155640779|NCT01033942|561775473|FG001|Overall Study|Withdrawal by Subject|1|||
155640780|NCT01033942|561775474|FG002|Overall Study|Withdrawal by Subject|1|||
155640781|NCT01033942|561775472|FG000|Overall Study|Lost to Follow-up|1|||
155640782|NCT01033942|561775473|FG001|Overall Study|Lost to Follow-up|0|||
155640783|NCT01033942|561775474|FG002|Overall Study|Lost to Follow-up|0|||
155640784|NCT01033942|561775472|FG000|Overall Study|Enrolled in Extension Study|0|||
155640785|NCT01033942|561775473|FG001|Overall Study|Enrolled in Extension Study|3|||
155640786|NCT01033942|561775474|FG002|Overall Study|Enrolled in Extension Study|0|||
155299998|NCT00774397|560529625|FG001|Overall Study|Other than those stated above|1|||
155640787|NCT02737618|561775475|FG000|Overall Study|Withdrawal by Subject|9|||
155640788|NCT01178411|561775484|FG000|Overall Study|Adverse Event|5|||
155640789|NCT01178411|561775484|FG000|Overall Study|Withdrawal by Subject|4|||
155640790|NCT01178411|561775484|FG000|Overall Study|Protocol Violation|1|||
155640791|NCT01178411|561775484|FG000|Overall Study|Progressive disease per RECIST|32|||
155640792|NCT01178411|561775484|FG000|Overall Study|Progressive disease per clinician|9|||
155640793|NCT01178411|561775484|FG000|Overall Study|Physician Decision|6|||
155640794|NCT01178411|561775484|FG000|Overall Study|Death|1|||
155640795|NCT01178411|561775484|FG000|Overall Study|No reason provided|1|||
155640796|NCT01178411|561775484|FG000|Overall Study|Drug manufacturing ended|1|||
155640797|NCT02453048|561775485|FG000|Overall Study|Only part of initial 6 mo. study|0|||
155640798|NCT02453048|561775486|FG001|Overall Study|Only part of initial 6 mo. study|0|||
155640799|NCT02453048|561775487|FG002|Overall Study|Only part of initial 6 mo. study|0|||
155640800|NCT02453048|561775488|FG003|Overall Study|Only part of initial 6 mo. study|0|||
155640801|NCT02453048|561775489|FG004|Overall Study|Only part of initial 6 mo. study|6|||
155640802|NCT02453048|561775485|FG000|Overall Study|Lost to Follow-up|0|||
155640803|NCT02453048|561775486|FG001|Overall Study|Lost to Follow-up|1|||
155640804|NCT02453048|561775487|FG002|Overall Study|Lost to Follow-up|2|||
155640805|NCT02453048|561775488|FG003|Overall Study|Lost to Follow-up|0|||
155640806|NCT02453048|561775489|FG004|Overall Study|Lost to Follow-up|0|||
155640807|NCT01482221|561775490|FG000|Overall Study|Lack of Efficacy|1|||
155640808|NCT01482221|561775491|FG001|Overall Study|Lack of Efficacy|0|||
155640809|NCT01482221|561775492|FG002|Overall Study|Lack of Efficacy|1|||
155640810|NCT01482221|561775490|FG000|Overall Study|Lost to Follow-up|3|||
155640811|NCT01482221|561775491|FG001|Overall Study|Lost to Follow-up|2|||
155640812|NCT01482221|561775492|FG002|Overall Study|Lost to Follow-up|1|||
155640813|NCT01482221|561775490|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
155640814|NCT01482221|561775491|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
155640815|NCT01482221|561775492|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
155640816|NCT01482221|561775490|FG000|Overall Study|Condition under Investigation Worsened|3|||
155640817|NCT01482221|561775491|FG001|Overall Study|Condition under Investigation Worsened|2|||
155640818|NCT01482221|561775492|FG002|Overall Study|Condition under Investigation Worsened|4|||
155640819|NCT01482221|561775490|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155640820|NCT01482221|561775491|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
155640821|NCT01482221|561775492|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
155640822|NCT01482221|561775490|FG000|Overall Study|Adverse Event|1|||
155640823|NCT01482221|561775491|FG001|Overall Study|Adverse Event|7|||
155640824|NCT01482221|561775492|FG002|Overall Study|Adverse Event|3|||
155640825|NCT01482221|561775490|FG000|Overall Study|Withdrawal by Subject|10|||
155640826|NCT01482221|561775491|FG001|Overall Study|Withdrawal by Subject|7|||
155640827|NCT01482221|561775492|FG002|Overall Study|Withdrawal by Subject|12|||
155640828|NCT01482221|561775490|FG000|Overall Study|Incorrect randomization|0|||
155640829|NCT01482221|561775491|FG001|Overall Study|Incorrect randomization|1|||
155640830|NCT01482221|561775492|FG002|Overall Study|Incorrect randomization|0|||
155640831|NCT01482221|561775490|FG000|Overall Study|Physician Decision|0|||
155640832|NCT01482221|561775491|FG001|Overall Study|Physician Decision|1|||
155640833|NCT01482221|561775492|FG002|Overall Study|Physician Decision|0|||
155640834|NCT04900272|561775493|FG000|Overall Study|Lost to Follow-up|2|||
155640835|NCT04900272|561775493|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
155640836|NCT04900272|561775493|FG000|Overall Study|Withdrawal by Subject|1|||
155640837|NCT03086343|561775494|FG000|Period 1|Adverse Event|7|||
155640838|NCT03086343|561775495|FG001|Period 1|Adverse Event|7|||
155640839|NCT03086343|561775496|FG002|Period 1|Adverse Event|0|||
155640840|NCT03086343|561775497|FG003|Period 1|Adverse Event|1|||
155640841|NCT03086343|561775494|FG000|Period 1|Withdrawal by Subject|6|||
155640842|NCT03086343|561775495|FG001|Period 1|Withdrawal by Subject|10|||
155640843|NCT03086343|561775496|FG002|Period 1|Withdrawal by Subject|0|||
155640844|NCT03086343|561775497|FG003|Period 1|Withdrawal by Subject|0|||
155640845|NCT03086343|561775494|FG000|Period 1|Lost to Follow-up|1|||
155640846|NCT03086343|561775495|FG001|Period 1|Lost to Follow-up|3|||
155640847|NCT03086343|561775496|FG002|Period 1|Lost to Follow-up|1|||
155640848|NCT03086343|561775497|FG003|Period 1|Lost to Follow-up|0|||
155640849|NCT03086343|561775494|FG000|Period 1|Other, Not Specified|10|||
155640850|NCT03086343|561775495|FG001|Period 1|Other, Not Specified|12|||
155640851|NCT03086343|561775496|FG002|Period 1|Other, Not Specified|2|||
155640852|NCT03086343|561775497|FG003|Period 1|Other, Not Specified|1|||
155640853|NCT03086343|561775494|FG000|Period 1|Missing|1|||
155640854|NCT03086343|561775495|FG001|Period 1|Missing|0|||
155640855|NCT03086343|561775496|FG002|Period 1|Missing|0|||
155640856|NCT03086343|561775497|FG003|Period 1|Missing|0|||
155299999|NCT00774397|560529626|FG002|Overall Study|Other than those stated above|3|||
155300000|NCT00774397|560529627|FG003|Overall Study|Other than those stated above|2|||
155410753|NCT03257267|560937475|FG000|Overall Study|Death|96|||
155640857|NCT03086343|561775494|FG000|Period 2|Adverse Event|20|||
155640858|NCT03086343|561775495|FG001|Period 2|Adverse Event|11|||
155640859|NCT03086343|561775496|FG002|Period 2|Adverse Event|1|||
155640860|NCT03086343|561775497|FG003|Period 2|Adverse Event|2|||
155745882|NCT00545129|562169804|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
155745883|NCT00545129|562169803|FG000|Overall Study|Other|3|||
155745884|NCT00545129|562169804|FG001|Overall Study|Other|3|||
155745885|NCT00821509|562169805|FG000|Overall Study|Withdrawal by Subject|12|||
155745886|NCT00821509|562169806|FG001|Overall Study|Withdrawal by Subject|11|||
155745887|NCT00821509|562169807|FG002|Overall Study|Withdrawal by Subject|34|||
155745888|NCT00807573|562169809|FG000|Overall Study|Withdrawal by Subject|1|||
155745889|NCT00807573|562169809|FG000|Overall Study|Adverse Event|1|||
155745890|NCT01551420|562169810|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
155745891|NCT01551420|562169811|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
155745892|NCT01551420|562169810|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
155745893|NCT01551420|562169811|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
155745894|NCT01551420|562169810|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
155745895|NCT01551420|562169811|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
155745896|NCT01551420|562169810|FG000|Screened for Part B Eligibility|Declined participation|8|||
155745897|NCT01551420|562169811|FG001|Screened for Part B Eligibility|Declined participation|1|||
155745898|NCT01551420|562169810|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
155745899|NCT01551420|562169811|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
155745900|NCT01551420|562169810|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
155300001|NCT00774397|560529628|FG004|Overall Study|Other than those stated above|2|||
155745901|NCT01551420|562169811|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
155745902|NCT01551420|562169810|FG000|Home Use (Part B)|Withdrawal by staff|0|||
155745903|NCT01551420|562169811|FG001|Home Use (Part B)|Withdrawal by staff|1|||
155745904|NCT00169442|562169812|FG000|Overall Study|Withdrawal by Subject|0|||
155745905|NCT00169442|562169813|FG001|Overall Study|Withdrawal by Subject|0|||
155745906|NCT00169442|562169814|FG002|Overall Study|Withdrawal by Subject|1|||
155745907|NCT00169442|562169815|FG003|Overall Study|Withdrawal by Subject|0|||
155745908|NCT00169442|562169816|FG004|Overall Study|Withdrawal by Subject|0|||
155745909|NCT00169442|562169817|FG005|Overall Study|Withdrawal by Subject|0|||
155745910|NCT00169442|562169812|FG000|Overall Study|Migrated/moved from study area|0|||
155745911|NCT00169442|562169813|FG001|Overall Study|Migrated/moved from study area|0|||
155745912|NCT00169442|562169814|FG002|Overall Study|Migrated/moved from study area|0|||
155745913|NCT00169442|562169815|FG003|Overall Study|Migrated/moved from study area|0|||
155745914|NCT00169442|562169816|FG004|Overall Study|Migrated/moved from study area|0|||
155745915|NCT00169442|562169817|FG005|Overall Study|Migrated/moved from study area|2|||
155745916|NCT00169442|562169812|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155745917|NCT00169442|562169813|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155745918|NCT00169442|562169814|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155745919|NCT00169442|562169815|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155745920|NCT00169442|562169816|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
155745921|NCT00169442|562169817|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155745922|NCT00169442|562169812|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155745923|NCT00169442|562169813|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
155745924|NCT00169442|562169814|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155745925|NCT00169442|562169815|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155745926|NCT00169442|562169816|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155745927|NCT00169442|562169817|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155745928|NCT01426789|562169818|FG000|Part 1|Protocol deviation|0|||
155745929|NCT01426789|562169819|FG001|Part 1|Protocol deviation|1|||
155745930|NCT01426789|562169820|FG002|Part 1|Protocol deviation|0|||
155745931|NCT01426789|562169821|FG003|Part 1|Protocol deviation|0|||
155745932|NCT01426789|562169822|FG004|Part 1|Protocol deviation|0|||
155745933|NCT01426789|562169823|FG005|Part 1|Protocol deviation|0|||
155745934|NCT01426789|562169818|FG000|Part 1|Lost to Follow-up|1|||
155745935|NCT01426789|562169819|FG001|Part 1|Lost to Follow-up|2|||
155745936|NCT01426789|562169820|FG002|Part 1|Lost to Follow-up|0|||
155745937|NCT01426789|562169821|FG003|Part 1|Lost to Follow-up|0|||
155745938|NCT01426789|562169822|FG004|Part 1|Lost to Follow-up|0|||
155745939|NCT01426789|562169823|FG005|Part 1|Lost to Follow-up|0|||
155745940|NCT01426789|562169818|FG000|Part 1|Lack of Efficacy|2|||
155745941|NCT01426789|562169819|FG001|Part 1|Lack of Efficacy|1|||
155745942|NCT01426789|562169820|FG002|Part 1|Lack of Efficacy|0|||
155745943|NCT01426789|562169821|FG003|Part 1|Lack of Efficacy|0|||
155745944|NCT01426789|562169822|FG004|Part 1|Lack of Efficacy|0|||
155745945|NCT01426789|562169823|FG005|Part 1|Lack of Efficacy|0|||
155745946|NCT01426789|562169818|FG000|Part 1|Adverse Event|3|||
155745947|NCT01426789|562169819|FG001|Part 1|Adverse Event|0|||
155745948|NCT01426789|562169820|FG002|Part 1|Adverse Event|0|||
155745949|NCT01426789|562169821|FG003|Part 1|Adverse Event|0|||
155745950|NCT01426789|562169822|FG004|Part 1|Adverse Event|0|||
155745951|NCT01426789|562169823|FG005|Part 1|Adverse Event|0|||
155745952|NCT01426789|562169818|FG000|Part 2|Protocol deviation|0|||
155745953|NCT01426789|562169819|FG001|Part 2|Protocol deviation|0|||
155745954|NCT01426789|562169820|FG002|Part 2|Protocol deviation|1|||
155745955|NCT01426789|562169821|FG003|Part 2|Protocol deviation|0|||
155745956|NCT01426789|562169822|FG004|Part 2|Protocol deviation|0|||
155745957|NCT01426789|562169823|FG005|Part 2|Protocol deviation|0|||
155745958|NCT01426789|562169818|FG000|Part 2|Death|0|||
155745959|NCT01426789|562169819|FG001|Part 2|Death|0|||
155745960|NCT01426789|562169820|FG002|Part 2|Death|1|||
155745961|NCT01426789|562169821|FG003|Part 2|Death|0|||
155745962|NCT01426789|562169822|FG004|Part 2|Death|1|||
155745963|NCT01426789|562169823|FG005|Part 2|Death|0|||
155745964|NCT01426789|562169818|FG000|Part 2|Administrative problems|0|||
155745965|NCT01426789|562169819|FG001|Part 2|Administrative problems|0|||
155745966|NCT01426789|562169820|FG002|Part 2|Administrative problems|2|||
155745967|NCT01426789|562169821|FG003|Part 2|Administrative problems|0|||
155745968|NCT01426789|562169822|FG004|Part 2|Administrative problems|1|||
155745969|NCT01426789|562169823|FG005|Part 2|Administrative problems|0|||
155745970|NCT01426789|562169818|FG000|Part 2|Lost to Follow-up|0|||
155745971|NCT01426789|562169819|FG001|Part 2|Lost to Follow-up|0|||
155745972|NCT01426789|562169820|FG002|Part 2|Lost to Follow-up|4|||
155745973|NCT01426789|562169821|FG003|Part 2|Lost to Follow-up|0|||
155745974|NCT01426789|562169822|FG004|Part 2|Lost to Follow-up|1|||
155745975|NCT01426789|562169823|FG005|Part 2|Lost to Follow-up|0|||
155745976|NCT01426789|562169818|FG000|Part 2|Withdrawal by Subject|0|||
155745977|NCT01426789|562169819|FG001|Part 2|Withdrawal by Subject|0|||
155745978|NCT01426789|562169820|FG002|Part 2|Withdrawal by Subject|0|||
155745979|NCT01426789|562169821|FG003|Part 2|Withdrawal by Subject|1|||
155745980|NCT01426789|562169822|FG004|Part 2|Withdrawal by Subject|2|||
155745981|NCT01426789|562169823|FG005|Part 2|Withdrawal by Subject|0|||
155745982|NCT01426789|562169818|FG000|Part 2|Lack of Efficacy|0|||
155745983|NCT01426789|562169819|FG001|Part 2|Lack of Efficacy|0|||
155745984|NCT01426789|562169820|FG002|Part 2|Lack of Efficacy|5|||
155745985|NCT01426789|562169821|FG003|Part 2|Lack of Efficacy|0|||
155745986|NCT01426789|562169822|FG004|Part 2|Lack of Efficacy|2|||
155745987|NCT01426789|562169823|FG005|Part 2|Lack of Efficacy|0|||
155745988|NCT01426789|562169818|FG000|Part 2|Adverse Event|0|||
155745989|NCT01426789|562169819|FG001|Part 2|Adverse Event|0|||
155745990|NCT01426789|562169820|FG002|Part 2|Adverse Event|2|||
155745991|NCT01426789|562169821|FG003|Part 2|Adverse Event|0|||
155745992|NCT01426789|562169822|FG004|Part 2|Adverse Event|1|||
155745993|NCT01426789|562169823|FG005|Part 2|Adverse Event|0|||
155745994|NCT04054947|562169824|FG000|Overall Study|Withdrawal by Subject|1|||
155745995|NCT04054947|562169825|FG001|Overall Study|Withdrawal by Subject|0|||
155745996|NCT04054947|562169824|FG000|Overall Study|Lost to Follow-up|2|||
155745997|NCT04054947|562169825|FG001|Overall Study|Lost to Follow-up|5|||
155745998|NCT04463069|562169828|FG000|Overall Study|Withdrawal by Subject|2|||
155745999|NCT04463069|562169829|FG001|Overall Study|Withdrawal by Subject|10|||
155746000|NCT04463069|562169828|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
155746001|NCT04463069|562169829|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
155746002|NCT03073733|562169836|FG000|Overall Study|Lost to Follow-up|1|||
155746003|NCT03073733|562169837|FG001|Overall Study|Lost to Follow-up|0|||
155746004|NCT03073733|562169838|FG002|Overall Study|Lost to Follow-up|0|||
155746005|NCT03073733|562169836|FG000|Overall Study|Physician Decision|0|||
155746006|NCT03073733|562169837|FG001|Overall Study|Physician Decision|1|||
155746007|NCT03073733|562169838|FG002|Overall Study|Physician Decision|0|||
155746008|NCT03073733|562169836|FG000|Overall Study|Withdrawal by Subject|0|||
155746009|NCT03073733|562169837|FG001|Overall Study|Withdrawal by Subject|0|||
155746010|NCT03073733|562169838|FG002|Overall Study|Withdrawal by Subject|1|||
155746011|NCT00835731|562169839|FG000|Overall Study|Withdrawal by Subject|1|||
155746012|NCT00835731|562169840|FG001|Overall Study|Withdrawal by Subject|0|||
155746013|NCT00835731|562169839|FG000|Overall Study|Physician Decision|1|||
155746014|NCT00835731|562169840|FG001|Overall Study|Physician Decision|1|||
155746015|NCT00348881|562169841|FG000|Overall Study|Lost to Follow-up|12|||
155746016|NCT00348881|562169842|FG001|Overall Study|Lost to Follow-up|6|||
155746017|NCT00348881|562169841|FG000|Overall Study|Withdrawal by Subject|3|||
155746018|NCT00348881|562169842|FG001|Overall Study|Withdrawal by Subject|4|||
155746019|NCT00348881|562169841|FG000|Overall Study|Adverse Event|2|||
155746020|NCT00348881|562169842|FG001|Overall Study|Adverse Event|0|||
155746021|NCT00348881|562169841|FG000|Overall Study|Serious Adverse Event|0|||
155746022|NCT00348881|562169842|FG001|Overall Study|Serious Adverse Event|2|||
155746023|NCT00129311|562169843|FG000|Overall Study|Withdrawal by Subject|12|||
155746024|NCT00129311|562169844|FG001|Overall Study|Withdrawal by Subject|19|||
155746025|NCT00881868|562169847|FG000|Overall Study|Adverse Event|0|||
155746026|NCT00881868|562169848|FG001|Overall Study|Adverse Event|1|||
155746027|NCT00881868|562169847|FG000|Overall Study|Lost to Follow-up|2|||
155746028|NCT00881868|562169848|FG001|Overall Study|Lost to Follow-up|1|||
155746029|NCT00881868|562169847|FG000|Overall Study|Physician Decision|4|||
155746030|NCT00881868|562169848|FG001|Overall Study|Physician Decision|0|||
155746031|NCT00881868|562169847|FG000|Overall Study|Protocol Violation|2|||
155746032|NCT00881868|562169848|FG001|Overall Study|Protocol Violation|0|||
155746033|NCT01981551|562169849|FG000|Overall Study|Refused further treatment|8|||
155746034|NCT01981551|562169849|FG000|Overall Study|Adverse Event|1|||
155746035|NCT02880956|562169850|FG000|Overall Study|Adverse Event|3|||
155746036|NCT02880956|562169851|FG001|Overall Study|Adverse Event|6|||
155746037|NCT02880956|562169852|FG002|Overall Study|Adverse Event|5|||
155746038|NCT02880956|562169853|FG003|Overall Study|Adverse Event|4|||
155746039|NCT02880956|562169850|FG000|Overall Study|Withdrawal by Subject|9|||
155746040|NCT02880956|562169851|FG001|Overall Study|Withdrawal by Subject|4|||
155746041|NCT02880956|562169852|FG002|Overall Study|Withdrawal by Subject|6|||
155746042|NCT02880956|562169853|FG003|Overall Study|Withdrawal by Subject|11|||
155746043|NCT02880956|562169850|FG000|Overall Study|Lost to Follow-up|0|||
155746044|NCT02880956|562169851|FG001|Overall Study|Lost to Follow-up|1|||
155746045|NCT02880956|562169852|FG002|Overall Study|Lost to Follow-up|0|||
155746046|NCT02880956|562169853|FG003|Overall Study|Lost to Follow-up|0|||
155746047|NCT02880956|562169850|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155746048|NCT02880956|562169851|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
155746049|NCT02880956|562169852|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155746050|NCT02880956|562169853|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
155746051|NCT02880956|562169850|FG000|Overall Study|Other, Not Specified|4|||
155746052|NCT02880956|562169851|FG001|Overall Study|Other, Not Specified|2|||
155746053|NCT02880956|562169852|FG002|Overall Study|Other, Not Specified|0|||
155746054|NCT02880956|562169853|FG003|Overall Study|Other, Not Specified|3|||
155746055|NCT02081859|562169854|FG000|Overall Study|No fertilization|2|||
155746056|NCT02081859|562169855|FG001|Overall Study|No fertilization|2|||
155746057|NCT02081859|562169854|FG000|Overall Study|No sperm|1|||
155746058|NCT02081859|562169855|FG001|Overall Study|No sperm|0|||
155746059|NCT02081859|562169854|FG000|Overall Study|Unanticipated freeze all cycle|2|||
155746060|NCT02081859|562169855|FG001|Overall Study|Unanticipated freeze all cycle|6|||
155746061|NCT02081859|562169854|FG000|Overall Study|< 4 embryos|27|||
155746062|NCT02081859|562169855|FG001|Overall Study|< 4 embryos|23|||
155746063|NCT02081859|562169854|FG000|Overall Study|Other reasons|2|||
155746064|NCT02081859|562169855|FG001|Overall Study|Other reasons|0|||
155746065|NCT00336583|562171144|FG000|Overall Study|Lost to Follow-up|1|||
155746066|NCT00336583|562171144|FG000|Overall Study|Death|1|||
155746067|NCT03603509|562171145|FG000|Overall Study|Lost to Follow-up|3|||
155746068|NCT03603509|562171146|FG001|Overall Study|Lost to Follow-up|4|||
155746069|NCT01143389|562171149|FG000|Overall Study|Lost to Follow-up|26|||
155746070|NCT01143389|562171150|FG001|Overall Study|Lost to Follow-up|25|||
155746071|NCT04966910|562171151|FG000|Baseline|Participant did not complete measure|0|||
155746072|NCT04966910|562171152|FG001|Baseline|Participant did not complete measure|0|||
155746073|NCT04966910|562171153|FG002|Baseline|Participant did not complete measure|1|||
155746074|NCT04966910|562171154|FG003|Baseline|Participant did not complete measure|0|||
155746075|NCT04966910|562171151|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
155746076|NCT04966910|562171152|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
155746077|NCT04966910|562171153|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
155746078|NCT04966910|562171154|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
155746079|NCT04966910|562171151|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
155746080|NCT04966910|562171152|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
155746081|NCT04966910|562171153|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
155746082|NCT04966910|562171154|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
155746083|NCT04966910|562171151|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
155746084|NCT04966910|562171152|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
155746085|NCT04966910|562171153|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
155746086|NCT04966910|562171154|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
155746087|NCT02446171|562171157|FG000|Overall Study|Withdrawal by Subject|0|||
155746088|NCT02446171|562171158|FG001|Overall Study|Withdrawal by Subject|0|||
155746089|NCT02446171|562171159|FG002|Overall Study|Withdrawal by Subject|2|||
155300002|NCT00774397|560529629|FG005|Overall Study|Other than those stated above|0|||
155300003|NCT00774397|560529630|FG006|Overall Study|Other than those stated above|1|||
155300004|NCT01599793|560529631|FG000|Overall Study|Adverse Event|2|||
155300005|NCT00665444|560529633|FG000|Overall Study|Physician Decision|1|||
155300006|NCT00665444|560529633|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
155300007|NCT00101010|560529634|FG000|Overall Study|Physician Decision|1|||
155300008|NCT01185782|560529635|FG000|Overall Study|Adverse Event|0|||
155300009|NCT01185782|560529636|FG001|Overall Study|Adverse Event|1|||
155746090|NCT02446171|562171160|FG003|Overall Study|Withdrawal by Subject|0|||
155746091|NCT03328182|562171161|FG000|Overall Study|Withdrawal by Subject|1|||
155746092|NCT03328182|562171161|FG000|Overall Study|Protocol Violation|2|||
155746093|NCT03328182|562171161|FG000|Overall Study|No Product Evaluated|1|||
155300010|NCT01185782|560529635|FG000|Overall Study|Protocol Violation|1|||
155300011|NCT01185782|560529636|FG001|Overall Study|Protocol Violation|0|||
155300012|NCT01185782|560529635|FG000|Overall Study|Poor Response to Treatment|3|||
155300013|NCT01185782|560529636|FG001|Overall Study|Poor Response to Treatment|1|||
155300014|NCT01185782|560529635|FG000|Overall Study|Other|2|||
155300015|NCT01185782|560529636|FG001|Overall Study|Other|5|||
155300016|NCT01185782|560529635|FG000|Overall Study|Randomized but not treated|0|||
155300017|NCT01185782|560529636|FG001|Overall Study|Randomized but not treated|4|||
155300018|NCT03740009|560529641|FG000|Overall Study|Physician Decision|9|||
155300019|NCT03740009|560529641|FG000|Overall Study|Lost to Follow-up|1|||
155300020|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
155300021|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
155300022|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
155300023|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
155300024|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
155300025|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
155300026|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
155300027|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
155300028|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
155300029|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
155300030|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
155300031|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
155640861|NCT03086343|561775494|FG000|Period 2|Withdrawal by Subject|15|||
155640862|NCT03086343|561775495|FG001|Period 2|Withdrawal by Subject|25|||
155640863|NCT03086343|561775496|FG002|Period 2|Withdrawal by Subject|2|||
155640864|NCT03086343|561775497|FG003|Period 2|Withdrawal by Subject|2|||
155640865|NCT03086343|561775494|FG000|Period 2|Lost to Follow-up|6|||
155640866|NCT03086343|561775495|FG001|Period 2|Lost to Follow-up|11|||
155300032|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
155300033|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
155640867|NCT03086343|561775496|FG002|Period 2|Lost to Follow-up|1|||
155640868|NCT03086343|561775497|FG003|Period 2|Lost to Follow-up|0|||
155640869|NCT03086343|561775494|FG000|Period 2|COVID-19 Infection|5|||
155640870|NCT03086343|561775495|FG001|Period 2|COVID-19 Infection|0|||
155640871|NCT03086343|561775496|FG002|Period 2|COVID-19 Infection|0|||
155640872|NCT03086343|561775497|FG003|Period 2|COVID-19 Infection|0|||
155640873|NCT03086343|561775494|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
155640874|NCT03086343|561775495|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
155640875|NCT03086343|561775496|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
155640876|NCT03086343|561775497|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
155640877|NCT03086343|561775494|FG000|Period 2|Other, Not Specified|23|||
155640878|NCT03086343|561775495|FG001|Period 2|Other, Not Specified|22|||
155640879|NCT03086343|561775496|FG002|Period 2|Other, Not Specified|2|||
155640880|NCT03086343|561775497|FG003|Period 2|Other, Not Specified|4|||
155640881|NCT01625182|561775499|FG000|Overall Study|Administrative problems|1|||
155640882|NCT01625182|561775500|FG001|Overall Study|Administrative problems|0|||
155640883|NCT01625182|561775499|FG000|Overall Study|Protocol deviation|0|||
155640884|NCT01625182|561775500|FG001|Overall Study|Protocol deviation|2|||
155640885|NCT01625182|561775499|FG000|Overall Study|Adverse Event|2|||
155640886|NCT01625182|561775500|FG001|Overall Study|Adverse Event|0|||
155640887|NCT01625182|561775499|FG000|Overall Study|Withdrawal by Subject|5|||
155640888|NCT01625182|561775500|FG001|Overall Study|Withdrawal by Subject|1|||
155640889|NCT01625182|561775499|FG000|Overall Study|Lack of Efficacy|12|||
155640890|NCT01625182|561775500|FG001|Overall Study|Lack of Efficacy|8|||
155640891|NCT00263562|561775501|FG000|Overall Study|Protocol Violation|3|||
155300034|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
155300035|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
155300036|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
155300037|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
155300038|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
155300039|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
155300040|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
155300041|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
155300042|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
155300043|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
155300044|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
155300045|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
155640892|NCT00263562|561775502|FG001|Overall Study|Protocol Violation|0|||
155640893|NCT02447029|561775503|FG000|Overall Study|Withdrawal by Subject|3|||
155640894|NCT02447029|561775504|FG001|Overall Study|Withdrawal by Subject|2|||
155640895|NCT01257542|561775505|FG000|Overall Study|Protocol Violation|3|||
155640896|NCT01257542|561775506|FG001|Overall Study|Protocol Violation|5|||
155640897|NCT01257542|561775505|FG000|Overall Study|Withdrawal by Subject|0|||
155300046|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
155300047|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
155300048|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
155300049|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
155300050|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
155300051|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
155300052|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
155300053|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300054|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300055|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300056|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
155300057|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
155300058|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
155300059|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
155300060|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
155300061|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
155300062|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
155640898|NCT01257542|561775506|FG001|Overall Study|Withdrawal by Subject|2|||
155640899|NCT00549328|561775511|FG000|Overall Study|Adverse Event|2|||
155640900|NCT00549328|561775511|FG000|Overall Study|Disease Progression|10|||
155640901|NCT00549328|561775511|FG000|Overall Study|Death|1|||
155640902|NCT00549328|561775511|FG000|Overall Study|Use of Prohibited Medication|1|||
155640903|NCT00153920|561775512|FG000|Overall Study|Adverse Event|9|||
155640904|NCT00153920|561775512|FG000|Overall Study|Progressive Disease|9|||
155640905|NCT00153920|561775512|FG000|Overall Study|Physician Decision|3|||
155640906|NCT00153920|561775512|FG000|Overall Study|Lack of Response|3|||
155640907|NCT00153920|561775512|FG000|Overall Study|Death|2|||
155640908|NCT00153920|561775512|FG000|Overall Study|Withdrawal by Subject|1|||
155640909|NCT00153920|561775512|FG000|Overall Study|Non-Protocol Therapy|1|||
155640910|NCT00153920|561775512|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
155640911|NCT00153920|561775512|FG000|Overall Study|Progressive Disease before Trt|1|||
155640912|NCT05630755|561775513|FG000|Overall Study|Lost to Follow-up|7|||
155640913|NCT05630755|561775514|FG001|Overall Study|Lost to Follow-up|0|||
155640914|NCT05630755|561775513|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
155640915|NCT05630755|561775514|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
155640916|NCT05630755|561775513|FG000|Overall Study|Withdrawal by Subject|9|||
155640917|NCT05630755|561775514|FG001|Overall Study|Withdrawal by Subject|3|||
155640918|NCT05630755|561775513|FG000|Overall Study|Participant moved away from trial site|0|||
155640919|NCT05630755|561775514|FG001|Overall Study|Participant moved away from trial site|1|||
155640920|NCT05630755|561775513|FG000|Overall Study|Status not Recorded|316|||
155640921|NCT05630755|561775514|FG001|Overall Study|Status not Recorded|161|||
155640922|NCT04868682|561775515|FG000|Post-treatment|Lost to Follow-up|1|||
155640923|NCT04868682|561775516|FG001|Post-treatment|Lost to Follow-up|1|||
155640924|NCT04868682|561775515|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
155640925|NCT04868682|561775516|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
155640926|NCT04868682|561775515|FG000|Six-month Assessment|Lost to Follow-up|1|||
155640927|NCT04868682|561775516|FG001|Six-month Assessment|Lost to Follow-up|0|||
155640928|NCT04868682|561775515|FG000|Six-month Assessment|Death|1|||
155640929|NCT04868682|561775516|FG001|Six-month Assessment|Death|0|||
155640930|NCT04868682|561775515|FG000|Six-month Assessment|Refused|0|||
155640931|NCT04868682|561775516|FG001|Six-month Assessment|Refused|1|||
155640932|NCT04868682|561775515|FG000|12-month Assessment|Lost to Follow-up|2|||
155640933|NCT04868682|561775516|FG001|12-month Assessment|Lost to Follow-up|1|||
155640934|NCT04868682|561775515|FG000|12-month Assessment|Death|0|||
155640935|NCT04868682|561775516|FG001|12-month Assessment|Death|1|||
155640936|NCT03384966|561775517|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
155640937|NCT03384966|561775518|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
155640938|NCT03384966|561775519|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
155640939|NCT03384966|561775517|FG000|Follow-up Period|Adverse Event|1|||
155640940|NCT03384966|561775518|FG001|Follow-up Period|Adverse Event|0|||
155640941|NCT03384966|561775519|FG002|Follow-up Period|Adverse Event|0|||
155640942|NCT03880565|561775520|FG000|Overall Study|Withdrawal by Subject|1|||
155640943|NCT03880565|561775521|FG001|Overall Study|Withdrawal by Subject|0|||
155640944|NCT02202616|561775522|FG000|Overall Study|Screen failed|24|||
155640945|NCT02202616|561775522|FG000|Overall Study|Adverse Event|32|||
155640946|NCT02202616|561775522|FG000|Overall Study|Protocol deviation|18|||
155640947|NCT02202616|561775522|FG000|Overall Study|Patient withdrew consent|12|||
155640948|NCT02202616|561775522|FG000|Overall Study|Lost to Follow-up|6|||
155640949|NCT02202616|561775522|FG000|Overall Study|Administrative problems|6|||
155640950|NCT02202616|561775522|FG000|Overall Study|Abnormal test procedure result|1|||
155640951|NCT02202616|561775522|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155640952|NCT00367458|561775523|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
155746094|NCT00504582|562171162|FG000|Overall Study|Lost to Follow-up|1|||
155746095|NCT00504582|562171163|FG001|Overall Study|Lost to Follow-up|0|||
155746096|NCT00504582|562171164|FG002|Overall Study|Lost to Follow-up|0|||
155746097|NCT00773383|562171166|FG000|Overall Study|Adverse Event|4|||
155746098|NCT00773383|562171166|FG000|Overall Study|Death|1|||
155746099|NCT00773383|562171166|FG000|Overall Study|Progression of Disease|23|||
155746100|NCT00773383|562171166|FG000|Overall Study|Other|2|||
155746101|NCT00773383|562171166|FG000|Overall Study|No study dose received|1|||
155746102|NCT02984943|562171169|FG000|Overall Study|Withdrawal by Subject|3|||
155746103|NCT02984943|562171169|FG000|Overall Study|Physician Decision|1|||
155746104|NCT02480712|562171170|FG000|Overall Study|Enrolled but Never Treated|1|||
155746105|NCT02480712|562171170|FG000|Overall Study|Lost to Follow-up|5|||
155746106|NCT02480712|562171170|FG000|Overall Study|Withdrew Consent|3|||
155746107|NCT02480712|562171170|FG000|Overall Study|Death|1|||
155746108|NCT02480712|562171170|FG000|Overall Study|Lack of Efficacy|1|||
155746109|NCT01860846|562171177|FG000|Overall Study|Lost to Follow-up|33|||
155746110|NCT00466687|562171178|FG000|Overall Study|Adverse Event|1|||
155746111|NCT00466687|562171178|FG000|Overall Study|Other complicating illness|3|||
155746112|NCT00466687|562171178|FG000|Overall Study|Withdrawal by Subject|1|||
155746113|NCT00466687|562171178|FG000|Overall Study|Disease progression|29|||
155746114|NCT01944839|562171182|FG000|Overall Study|Physician Decision|2|||
155746115|NCT01944839|562171183|FG001|Overall Study|Physician Decision|2|||
155746116|NCT01944839|562171182|FG000|Overall Study|Protocol Violation|0|||
155746117|NCT01944839|562171183|FG001|Overall Study|Protocol Violation|1|||
155746118|NCT01944839|562171182|FG000|Overall Study|Adverse Event|10|||
155746119|NCT01944839|562171183|FG001|Overall Study|Adverse Event|5|||
155746120|NCT01944839|562171182|FG000|Overall Study|Withdrawal by Subject|9|||
155746121|NCT01944839|562171183|FG001|Overall Study|Withdrawal by Subject|17|||
155746122|NCT01944839|562171182|FG000|Overall Study|Lost to Follow-up|1|||
155746123|NCT01944839|562171183|FG001|Overall Study|Lost to Follow-up|0|||
155746124|NCT01944839|562171182|FG000|Overall Study|Subject non-compliance|0|||
155746125|NCT01944839|562171183|FG001|Overall Study|Subject non-compliance|3|||
155746126|NCT00171834|562171184|FG000|Overall Study|Adverse Event|2|||
155746127|NCT00171834|562171185|FG001|Overall Study|Adverse Event|1|||
155746128|NCT00171834|562171186|FG002|Overall Study|Adverse Event|3|||
155746129|NCT00171834|562171187|FG003|Overall Study|Adverse Event|2|||
155746130|NCT00171834|562171188|FG004|Overall Study|Adverse Event|2|||
155746131|NCT00171834|562171189|FG005|Overall Study|Adverse Event|15|||
155746132|NCT00171834|562171190|FG006|Overall Study|Adverse Event|1|||
155746133|NCT00171834|562171184|FG000|Overall Study|Withdrawal by Subject|0|||
155746134|NCT00171834|562171185|FG001|Overall Study|Withdrawal by Subject|2|||
155746135|NCT00171834|562171186|FG002|Overall Study|Withdrawal by Subject|0|||
155746136|NCT00171834|562171187|FG003|Overall Study|Withdrawal by Subject|1|||
155746137|NCT00171834|562171188|FG004|Overall Study|Withdrawal by Subject|1|||
155746138|NCT00171834|562171189|FG005|Overall Study|Withdrawal by Subject|1|||
155746139|NCT00171834|562171190|FG006|Overall Study|Withdrawal by Subject|0|||
155746140|NCT00171834|562171184|FG000|Overall Study|Death from study indication|0|||
155746141|NCT00171834|562171185|FG001|Overall Study|Death from study indication|1|||
155746142|NCT00171834|562171186|FG002|Overall Study|Death from study indication|0|||
155746143|NCT00171834|562171187|FG003|Overall Study|Death from study indication|0|||
155746144|NCT00171834|562171188|FG004|Overall Study|Death from study indication|1|||
155746145|NCT00171834|562171189|FG005|Overall Study|Death from study indication|0|||
155746146|NCT00171834|562171190|FG006|Overall Study|Death from study indication|0|||
155746147|NCT00171834|562171184|FG000|Overall Study|Disease Progression|4|||
155746148|NCT00171834|562171185|FG001|Overall Study|Disease Progression|8|||
155746149|NCT00171834|562171186|FG002|Overall Study|Disease Progression|8|||
155746150|NCT00171834|562171187|FG003|Overall Study|Disease Progression|9|||
155746151|NCT00171834|562171188|FG004|Overall Study|Disease Progression|2|||
155746152|NCT00171834|562171189|FG005|Overall Study|Disease Progression|18|||
155746153|NCT00171834|562171190|FG006|Overall Study|Disease Progression|3|||
155746154|NCT00171834|562171184|FG000|Overall Study|Treatment Duration Completed|0|||
155746155|NCT00171834|562171185|FG001|Overall Study|Treatment Duration Completed|0|||
155746156|NCT00171834|562171186|FG002|Overall Study|Treatment Duration Completed|1|||
155746157|NCT00171834|562171187|FG003|Overall Study|Treatment Duration Completed|0|||
155746158|NCT00171834|562171188|FG004|Overall Study|Treatment Duration Completed|2|||
155746159|NCT00171834|562171189|FG005|Overall Study|Treatment Duration Completed|1|||
155746160|NCT00171834|562171190|FG006|Overall Study|Treatment Duration Completed|0|||
155746161|NCT01284491|562171193|FG000|Overall Study|Study termination|13|||
155746162|NCT01978938|562171194|FG000|Overall Study|Lost to Follow-up|12|||
155746163|NCT01978938|562171195|FG001|Overall Study|Lost to Follow-up|6|||
155746164|NCT01978938|562171194|FG000|Overall Study|Withdrawal by Subject|8|||
155746165|NCT01978938|562171195|FG001|Overall Study|Withdrawal by Subject|4|||
155746166|NCT01978938|562171194|FG000|Overall Study|Adverse Event, non-fatal|2|||
155746167|NCT01978938|562171195|FG001|Overall Study|Adverse Event, non-fatal|1|||
155746168|NCT01978938|562171194|FG000|Overall Study|Participant noncompliance|1|||
155746169|NCT01978938|562171195|FG001|Overall Study|Participant noncompliance|1|||
155746170|NCT01978938|562171194|FG000|Overall Study|Did not meet inclusion criteria|0|||
155746171|NCT01978938|562171195|FG001|Overall Study|Did not meet inclusion criteria|1|||
155746172|NCT01978938|562171194|FG000|Overall Study|Previously scheduled procedure|0|||
155746173|NCT01978938|562171195|FG001|Overall Study|Previously scheduled procedure|1|||
155746174|NCT02694757|562171196|FG000|Overall Study|Lack of Efficacy|3|||
155746175|NCT02650921|562171197|FG000|Overall Study|Withdrawal by Subject|4|||
155746176|NCT02650921|562171197|FG000|Overall Study|Lost to Follow-up|2|||
155746177|NCT02650921|562171197|FG000|Overall Study|Adverse Event|1|||
155746178|NCT02650921|562171197|FG000|Overall Study|Due to Medical Condition|1|||
155746179|NCT00783302|562171198|FG000|Overall Study|Lost to Follow-up|17|||
155746180|NCT00783302|562171198|FG000|Overall Study|Technical Problems|11|||
155746181|NCT00783302|562171198|FG000|Overall Study|Protocol Violation|3|||
155746182|NCT00783302|562171198|FG000|Overall Study|Physician Decision|1|||
155746183|NCT00783302|562171198|FG000|Overall Study|Withdrawal by Subject|3|||
155746184|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
155746185|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
155746186|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
155746187|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
155746188|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
155746189|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
155746190|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
155746191|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
155746192|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
155746193|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
155746194|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
155746195|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
155300063|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
155300064|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
155300065|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
155300066|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
155300067|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
155300068|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
155300069|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
155300070|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
155300071|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
155300072|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
155300073|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
155300074|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
155300075|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
155300076|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
155300077|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
155300078|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
155300079|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
155300080|NCT01236001|560529647|FG000|Overall Study|Adverse Event|5|||
155300081|NCT01236001|560529648|FG001|Overall Study|Adverse Event|14|||
155300082|NCT01236001|560529647|FG000|Overall Study|Lack of Efficacy|6|||
155300083|NCT01236001|560529648|FG001|Overall Study|Lack of Efficacy|6|||
155300084|NCT01236001|560529647|FG000|Overall Study|Lost to Follow-up|6|||
155300085|NCT01236001|560529648|FG001|Overall Study|Lost to Follow-up|1|||
155300086|NCT01236001|560529647|FG000|Overall Study|Incompliance|1|||
155300087|NCT01236001|560529648|FG001|Overall Study|Incompliance|0|||
155300088|NCT01236001|560529647|FG000|Overall Study|Planned Visit After End of Study|0|||
155300089|NCT01236001|560529648|FG001|Overall Study|Planned Visit After End of Study|1|||
155300090|NCT05082935|560529651|FG000|Overall Study|Lost to Follow-up|549|||
155300091|NCT05082935|560529652|FG001|Overall Study|Lost to Follow-up|631|||
155746196|NCT01087788|562171199|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
155746197|NCT01087788|562171200|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
155746198|NCT01087788|562171201|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
155746199|NCT01087788|562171199|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
155746200|NCT01087788|562171200|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
155746201|NCT01087788|562171201|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
155746202|NCT01087788|562171199|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
155300092|NCT05082935|560529651|FG000|Overall Study|Withdrawal by Subject|27|||
155300093|NCT05082935|560529652|FG001|Overall Study|Withdrawal by Subject|58|||
155746203|NCT01087788|562171200|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
155746204|NCT01087788|562171201|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
155746205|NCT01087788|562171199|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
155746206|NCT01087788|562171200|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
155746207|NCT01087788|562171201|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
155746208|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
155746209|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
155746210|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
155746211|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
155746212|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
155746213|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
155746214|NCT01087788|562171199|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
155746215|NCT01087788|562171200|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
155746216|NCT01087788|562171201|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
155746217|NCT01087788|562171199|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
155746218|NCT01087788|562171200|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
155746219|NCT01087788|562171201|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
155746220|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
155746221|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
155746222|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
155746223|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
155746224|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
155746225|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
155746226|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
155746227|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
155746228|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
155746229|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
155746230|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
155746231|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
155746232|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
155746233|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
155746234|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
155746235|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
155746236|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
155746237|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
155746238|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
155746239|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
155746240|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
155746241|NCT01087788|562171199|FG000|24-weeks Dose-blind Period|Patient moved|0|||
155746242|NCT01087788|562171200|FG001|24-weeks Dose-blind Period|Patient moved|0|||
155746243|NCT01087788|562171201|FG002|24-weeks Dose-blind Period|Patient moved|1|||
155746244|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
155746245|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
155746246|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
155746247|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
155746248|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
155746249|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
155746250|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
155746251|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
155746252|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
155746253|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
155746254|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
155746255|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
155746256|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
155746257|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
155746258|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
155746259|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
155746260|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
155746261|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
155746262|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
155746263|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
155746264|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
155746265|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
155746266|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
155746267|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
155300094|NCT01444417|560529655|FG000|Overall Study|Ineligibility Determined|0|||
155300095|NCT01444417|560529656|FG001|Overall Study|Ineligibility Determined|1|||
155746268|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
155746269|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
155300096|NCT01444417|560529655|FG000|Overall Study|Withdrawal by Subject|2|||
155300097|NCT01444417|560529656|FG001|Overall Study|Withdrawal by Subject|0|||
155300098|NCT03531840|560529658|FG000|Overall Study|Death on study|3|||
155746270|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
155746271|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
155746272|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
155746273|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
155746274|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
155746275|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
155746276|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
155746277|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
155746278|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
155746279|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
155746280|NCT01087788|562171199|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
155746281|NCT01087788|562171200|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
155746282|NCT01087788|562171201|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
155746283|NCT01917656|562171208|FG000|Overall Study|Adverse Event|11|||
155746284|NCT01917656|562171209|FG001|Overall Study|Adverse Event|0|||
155746285|NCT01917656|562171208|FG000|Overall Study|Withdrawal criteria|8|||
155746286|NCT01917656|562171209|FG001|Overall Study|Withdrawal criteria|14|||
155746287|NCT01917656|562171208|FG000|Overall Study|Unclassified|0|||
155746288|NCT01917656|562171209|FG001|Overall Study|Unclassified|3|||
155746289|NCT01917656|562171208|FG000|Overall Study|Withdrawal by Subject|4|||
155746290|NCT01917656|562171209|FG001|Overall Study|Withdrawal by Subject|3|||
155746291|NCT01917656|562171208|FG000|Overall Study|Lost to Follow-up|3|||
155746292|NCT01917656|562171209|FG001|Overall Study|Lost to Follow-up|4|||
155746293|NCT02015221|562171210|FG000|Overall Study|Withdrawal by Subject|8|||
155746294|NCT02015221|562171211|FG001|Overall Study|Withdrawal by Subject|6|||
155746295|NCT02015221|562171210|FG000|Overall Study|Lost to Follow-up|1|||
155746296|NCT02015221|562171211|FG001|Overall Study|Lost to Follow-up|0|||
155746297|NCT01306929|562171212|FG000|Overall Study|Withdrawal by Subject|23|||
155746298|NCT01306929|562171212|FG000|Overall Study|Adverse Event|21|||
155746299|NCT01306929|562171212|FG000|Overall Study|Physician Decision|13|||
155746300|NCT01306929|562171212|FG000|Overall Study|Death|8|||
155746301|NCT01306929|562171212|FG000|Overall Study|Withdrawal by parent/guardian|5|||
155746302|NCT01306929|562171212|FG000|Overall Study|Protocol Violation|3|||
155746303|NCT01306929|562171212|FG000|Overall Study|Non-compliance with study drug|2|||
155746304|NCT01306929|562171212|FG000|Overall Study|Lost to Follow-up|2|||
155746305|NCT01306929|562171212|FG000|Overall Study|Various|17|||
155746306|NCT03709576|562171213|FG000|Overall Study|progression prior to enrollment|1|||
155300099|NCT03531840|560529659|FG001|Overall Study|Death on study|2|||
155300100|NCT03531840|560529660|FG002|Overall Study|Death on study|1|||
155300101|NCT03531840|560529661|FG003|Overall Study|Death on study|2|||
155300102|NCT03531840|560529658|FG000|Overall Study|Death during follow up|2|||
155300103|NCT03531840|560529659|FG001|Overall Study|Death during follow up|3|||
155300104|NCT03531840|560529660|FG002|Overall Study|Death during follow up|4|||
155300105|NCT03531840|560529661|FG003|Overall Study|Death during follow up|1|||
155300106|NCT02092116|560529662|FG000|Overall Study|Withdrawal by Subject|0|||
155300107|NCT02092116|560529663|FG001|Overall Study|Withdrawal by Subject|3|||
155300108|NCT02092116|560529662|FG000|Overall Study|Adverse Event|0|||
155300109|NCT02092116|560529663|FG001|Overall Study|Adverse Event|1|||
155300110|NCT01546753|560529665|FG000|Overall Study|anxiety|1|||
155300111|NCT01546753|560529666|FG001|Overall Study|anxiety|1|||
155746307|NCT03041129|562171221|FG000|Overall Study|Withdrawal by Subject|2|||
155746308|NCT03041129|562171222|FG001|Overall Study|Withdrawal by Subject|0|||
155746309|NCT03041129|562171223|FG002|Overall Study|Withdrawal by Subject|0|||
155746310|NCT03041129|562171224|FG003|Overall Study|Withdrawal by Subject|0|||
155746311|NCT00510653|562171227|FG000|Overall Study|Withdrawal by Subject|8|||
155300112|NCT01546753|560529665|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
155300113|NCT01546753|560529666|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
155300114|NCT00939510|560529667|FG000|Overall Study|Withdrawal by Subject|1|||
155300115|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155410754|NCT03257267|560937476|FG001|Overall Study|Death|98|||
155746312|NCT00510653|562171227|FG000|Overall Study|Monetary|3|||
155746313|NCT00483756|562171230|FG000|Overall Study|Death|2|||
155746314|NCT00483756|562171231|FG001|Overall Study|Death|0|||
155746315|NCT00483756|562171232|FG002|Overall Study|Death|1|||
155300116|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155300117|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155300118|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300119|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300120|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300121|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300122|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300123|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300124|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300125|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300126|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300127|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
155300128|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
155300129|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
155300130|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
155300131|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
155300132|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
155300133|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
155300134|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
155300135|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
155300136|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
155300137|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
155300138|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
155300139|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
155300140|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300141|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155640953|NCT00367458|561775524|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
155640954|NCT05221866|561775525|FG000|Overall Study|Withdrawal by Subject|5|||
155640955|NCT05221866|561775526|FG001|Overall Study|Withdrawal by Subject|7|||
155640956|NCT05221866|561775527|FG002|Overall Study|Withdrawal by Subject|6|||
155640957|NCT05221866|561775528|FG003|Overall Study|Withdrawal by Subject|4|||
155640958|NCT05221866|561775525|FG000|Overall Study|Physician Decision|3|||
155640959|NCT05221866|561775526|FG001|Overall Study|Physician Decision|2|||
155640960|NCT05221866|561775527|FG002|Overall Study|Physician Decision|1|||
155640961|NCT05221866|561775528|FG003|Overall Study|Physician Decision|4|||
155640962|NCT05221866|561775525|FG000|Overall Study|Lost to Follow-up|12|||
155640963|NCT05221866|561775526|FG001|Overall Study|Lost to Follow-up|17|||
155640964|NCT05221866|561775527|FG002|Overall Study|Lost to Follow-up|14|||
155640965|NCT05221866|561775528|FG003|Overall Study|Lost to Follow-up|14|||
155640966|NCT05221866|561775525|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
155640967|NCT05221866|561775526|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
155640968|NCT05221866|561775527|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
155640969|NCT05221866|561775528|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
155640970|NCT04470427|561775529|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
155640971|NCT04470427|561775530|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
155640972|NCT04470427|561775531|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
155640973|NCT04470427|561775532|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
155640974|NCT04470427|561775533|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
155640975|NCT04470427|561775534|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
155640976|NCT04470427|561775529|FG000|Part B :Open-label|Other than specified|0|||
155640977|NCT04470427|561775530|FG001|Part B :Open-label|Other than specified|0|||
155640978|NCT04470427|561775531|FG002|Part B :Open-label|Other than specified|788|||
155640979|NCT04470427|561775532|FG003|Part B :Open-label|Other than specified|0|||
155640980|NCT04470427|561775533|FG004|Part B :Open-label|Other than specified|523|||
155640981|NCT04470427|561775534|FG005|Part B :Open-label|Other than specified|0|||
155640982|NCT04470427|561775529|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
155640983|NCT04470427|561775530|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
155640984|NCT04470427|561775531|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
155640985|NCT04470427|561775532|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
155640986|NCT04470427|561775533|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
155640987|NCT04470427|561775534|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
155640988|NCT04470427|561775529|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
155640989|NCT04470427|561775530|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
155640990|NCT04470427|561775531|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
155746316|NCT00483756|562171230|FG000|Overall Study|Adverse Event|19|||
155746317|NCT00483756|562171231|FG001|Overall Study|Adverse Event|38|||
155746318|NCT00483756|562171232|FG002|Overall Study|Adverse Event|40|||
155746319|NCT00483756|562171230|FG000|Overall Study|Lack of Efficacy|1|||
155746320|NCT00483756|562171231|FG001|Overall Study|Lack of Efficacy|0|||
155300142|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300143|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300144|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300145|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300146|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300147|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300148|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300149|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300150|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155640991|NCT04470427|561775532|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
155300151|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155640992|NCT04470427|561775533|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
155640993|NCT04470427|561775534|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
155640994|NCT04598828|561775535|FG000|Overall Study|Physician Decision|1|||
155640995|NCT04598828|561775536|FG001|Overall Study|Physician Decision|0|||
155640996|NCT04598828|561775535|FG000|Overall Study|Withdrawal by Subject|0|||
155640997|NCT04598828|561775536|FG001|Overall Study|Withdrawal by Subject|1|||
155640998|NCT04598828|561775535|FG000|Overall Study|Withdrawal by Subject|0|||
155640999|NCT04598828|561775536|FG001|Overall Study|Withdrawal by Subject|1|||
155641000|NCT04818112|561775537|FG000|Overall Study|Withdrawal by Subject|54|||
155641001|NCT04818112|561775538|FG001|Overall Study|Withdrawal by Subject|12|||
155641002|NCT04818112|561775537|FG000|Overall Study|Lost to Follow-up|38|||
155641003|NCT04818112|561775538|FG001|Overall Study|Lost to Follow-up|10|||
155641004|NCT01913353|561775539|FG000|Overall Study|Adverse Event|2|||
155641005|NCT01913353|561775540|FG001|Overall Study|Adverse Event|0|||
155641006|NCT01913353|561775539|FG000|Overall Study|Physician Decision|0|||
155641007|NCT01913353|561775540|FG001|Overall Study|Physician Decision|2|||
155641008|NCT01913353|561775539|FG000|Overall Study|Withdrawal by Subject|20|||
155641009|NCT01913353|561775540|FG001|Overall Study|Withdrawal by Subject|6|||
155641010|NCT01913353|561775539|FG000|Overall Study|multiple reasons|10|||
155641011|NCT01913353|561775540|FG001|Overall Study|multiple reasons|7|||
155641012|NCT00385840|561775541|FG000|Overall Study|Adverse Event|1|||
155641013|NCT00385840|561775542|FG001|Overall Study|Adverse Event|1|||
155641014|NCT00385840|561775541|FG000|Overall Study|Lost to Follow-up|3|||
155641015|NCT00385840|561775542|FG001|Overall Study|Lost to Follow-up|13|||
155641016|NCT04017962|561775543|FG000|Overall Study|Death|2|||
155641017|NCT04017962|561775544|FG001|Overall Study|Death|0|||
155641018|NCT04017962|561775543|FG000|Overall Study|Lost to Follow-up|2|||
155641019|NCT04017962|561775544|FG001|Overall Study|Lost to Follow-up|0|||
155641020|NCT04017962|561775543|FG000|Overall Study|Physician Decision|1|||
155641021|NCT04017962|561775544|FG001|Overall Study|Physician Decision|0|||
155641022|NCT04017962|561775543|FG000|Overall Study|Discontinued LTV|5|||
155641023|NCT04017962|561775544|FG001|Overall Study|Discontinued LTV|0|||
155641024|NCT00632359|561775545|FG000|Overall Study|Withdrawal by Subject|2|||
155641025|NCT03580928|561775548|FG000|Overall Study|Death|0|||
155641026|NCT03580928|561775549|FG001|Overall Study|Death|3|||
155746321|NCT00483756|562171232|FG002|Overall Study|Lack of Efficacy|0|||
155746322|NCT00483756|562171230|FG000|Overall Study|Lost to Follow-up|3|||
155746323|NCT00483756|562171231|FG001|Overall Study|Lost to Follow-up|1|||
155746324|NCT00483756|562171232|FG002|Overall Study|Lost to Follow-up|0|||
155746325|NCT00483756|562171230|FG000|Overall Study|Withdrawal by Subject|5|||
155746326|NCT00483756|562171231|FG001|Overall Study|Withdrawal by Subject|3|||
155746327|NCT00483756|562171232|FG002|Overall Study|Withdrawal by Subject|4|||
155746328|NCT00483756|562171230|FG000|Overall Study|Other|2|||
155746329|NCT00483756|562171231|FG001|Overall Study|Other|4|||
155746330|NCT00483756|562171232|FG002|Overall Study|Other|3|||
155746331|NCT00483756|562171230|FG000|Overall Study|Randomized, Not Treated|1|||
155746332|NCT00483756|562171231|FG001|Overall Study|Randomized, Not Treated|4|||
155746333|NCT00483756|562171232|FG002|Overall Study|Randomized, Not Treated|4|||
155746334|NCT00710762|562171233|FG000|Overall Study|Progressive disease|27|||
155746335|NCT00710762|562171234|FG001|Overall Study|Progressive disease|30|||
155746336|NCT00710762|562171233|FG000|Overall Study|Adverse Event other disease worsening|2|||
155746337|NCT00710762|562171234|FG001|Overall Study|Adverse Event other disease worsening|1|||
155746338|NCT00710762|562171233|FG000|Overall Study|Other Adverse Event|7|||
155746339|NCT00710762|562171234|FG001|Overall Study|Other Adverse Event|7|||
155746340|NCT00710762|562171233|FG000|Overall Study|Lost to Follow-up|1|||
155746341|NCT00710762|562171234|FG001|Overall Study|Lost to Follow-up|0|||
155746342|NCT00710762|562171233|FG000|Overall Study|Reason other than listed above|2|||
155746343|NCT00710762|562171234|FG001|Overall Study|Reason other than listed above|2|||
155746344|NCT00436501|562171235|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
155746345|NCT00436501|562171236|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
155746346|NCT00436501|562171235|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
155746347|NCT00436501|562171236|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
155746348|NCT00495040|562171237|FG000|Overall Study|Withdrawal by Subject|3|||
155746349|NCT03011892|562171242|FG000|Double Blind (DB) Period|Adverse Event|0|||
155746350|NCT03011892|562171243|FG001|Double Blind (DB) Period|Adverse Event|1|||
155746351|NCT03011892|562171244|FG002|Double Blind (DB) Period|Adverse Event|1|||
155746352|NCT03011892|562171245|FG003|Double Blind (DB) Period|Adverse Event|0|||
155746353|NCT03011892|562171246|FG004|Double Blind (DB) Period|Adverse Event|0|||
155746354|NCT03011892|562171247|FG005|Double Blind (DB) Period|Adverse Event|0|||
155746355|NCT03011892|562171248|FG006|Double Blind (DB) Period|Adverse Event|0|||
155746356|NCT03011892|562171249|FG007|Double Blind (DB) Period|Adverse Event|0|||
155746357|NCT03011892|562171250|FG008|Double Blind (DB) Period|Adverse Event|0|||
155746358|NCT03011892|562171251|FG009|Double Blind (DB) Period|Adverse Event|0|||
155746359|NCT03011892|562171252|FG010|Double Blind (DB) Period|Adverse Event|0|||
155746360|NCT03011892|562171253|FG011|Double Blind (DB) Period|Adverse Event|0|||
155746361|NCT03011892|562171242|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
155746362|NCT03011892|562171243|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
155746363|NCT03011892|562171244|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
155746364|NCT03011892|562171245|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
155746365|NCT03011892|562171246|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
155746366|NCT03011892|562171247|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
155746367|NCT03011892|562171248|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
155746368|NCT03011892|562171249|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
155746369|NCT03011892|562171250|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
155746370|NCT03011892|562171251|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
155746371|NCT03011892|562171252|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
155746372|NCT03011892|562171253|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
155746373|NCT03011892|562171242|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
155746374|NCT03011892|562171243|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
155746375|NCT03011892|562171244|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
155746376|NCT03011892|562171245|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
155746377|NCT03011892|562171246|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
155746378|NCT03011892|562171247|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
155746379|NCT03011892|562171248|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
155746380|NCT03011892|562171249|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
155746381|NCT03011892|562171250|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
155746382|NCT03011892|562171251|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
155746383|NCT03011892|562171252|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
155746384|NCT03011892|562171253|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
155746385|NCT03011892|562171242|FG000|Double Blind (DB) Period|Other|1|||
155746386|NCT03011892|562171243|FG001|Double Blind (DB) Period|Other|1|||
155746387|NCT03011892|562171244|FG002|Double Blind (DB) Period|Other|1|||
155746388|NCT03011892|562171245|FG003|Double Blind (DB) Period|Other|0|||
155746389|NCT03011892|562171246|FG004|Double Blind (DB) Period|Other|1|||
155746390|NCT03011892|562171247|FG005|Double Blind (DB) Period|Other|0|||
155746391|NCT03011892|562171248|FG006|Double Blind (DB) Period|Other|0|||
155746392|NCT03011892|562171249|FG007|Double Blind (DB) Period|Other|0|||
155746393|NCT03011892|562171250|FG008|Double Blind (DB) Period|Other|0|||
155746394|NCT03011892|562171251|FG009|Double Blind (DB) Period|Other|0|||
155746395|NCT03011892|562171252|FG010|Double Blind (DB) Period|Other|0|||
155746396|NCT03011892|562171253|FG011|Double Blind (DB) Period|Other|0|||
155746397|NCT03011892|562171242|FG000|Double Blind (DB) Period|Physician Decision|1|||
155746398|NCT03011892|562171243|FG001|Double Blind (DB) Period|Physician Decision|0|||
155746399|NCT03011892|562171244|FG002|Double Blind (DB) Period|Physician Decision|1|||
155746400|NCT03011892|562171245|FG003|Double Blind (DB) Period|Physician Decision|0|||
155746401|NCT03011892|562171246|FG004|Double Blind (DB) Period|Physician Decision|0|||
155746402|NCT03011892|562171247|FG005|Double Blind (DB) Period|Physician Decision|0|||
155746403|NCT03011892|562171248|FG006|Double Blind (DB) Period|Physician Decision|0|||
155746404|NCT03011892|562171249|FG007|Double Blind (DB) Period|Physician Decision|0|||
155746405|NCT03011892|562171250|FG008|Double Blind (DB) Period|Physician Decision|0|||
155746406|NCT03011892|562171251|FG009|Double Blind (DB) Period|Physician Decision|0|||
155746407|NCT03011892|562171252|FG010|Double Blind (DB) Period|Physician Decision|0|||
155746408|NCT03011892|562171253|FG011|Double Blind (DB) Period|Physician Decision|0|||
155746409|NCT03011892|562171242|FG000|Double Blind (DB) Period|Pregnancy|0|||
155746410|NCT03011892|562171243|FG001|Double Blind (DB) Period|Pregnancy|0|||
155746411|NCT03011892|562171244|FG002|Double Blind (DB) Period|Pregnancy|0|||
155746412|NCT03011892|562171245|FG003|Double Blind (DB) Period|Pregnancy|0|||
155746413|NCT03011892|562171246|FG004|Double Blind (DB) Period|Pregnancy|1|||
155746414|NCT03011892|562171247|FG005|Double Blind (DB) Period|Pregnancy|0|||
155746415|NCT03011892|562171248|FG006|Double Blind (DB) Period|Pregnancy|0|||
155746416|NCT03011892|562171249|FG007|Double Blind (DB) Period|Pregnancy|0|||
155746417|NCT03011892|562171250|FG008|Double Blind (DB) Period|Pregnancy|0|||
155746418|NCT03011892|562171251|FG009|Double Blind (DB) Period|Pregnancy|0|||
155746419|NCT03011892|562171252|FG010|Double Blind (DB) Period|Pregnancy|0|||
155746420|NCT03011892|562171253|FG011|Double Blind (DB) Period|Pregnancy|0|||
155746421|NCT03011892|562171242|FG000|Double Blind (DB) Period|Protocol Violation|1|||
155746422|NCT03011892|562171243|FG001|Double Blind (DB) Period|Protocol Violation|0|||
155746423|NCT03011892|562171244|FG002|Double Blind (DB) Period|Protocol Violation|0|||
155746424|NCT03011892|562171245|FG003|Double Blind (DB) Period|Protocol Violation|0|||
155746425|NCT03011892|562171246|FG004|Double Blind (DB) Period|Protocol Violation|0|||
155746426|NCT03011892|562171247|FG005|Double Blind (DB) Period|Protocol Violation|0|||
155746427|NCT03011892|562171248|FG006|Double Blind (DB) Period|Protocol Violation|0|||
155746428|NCT03011892|562171249|FG007|Double Blind (DB) Period|Protocol Violation|0|||
155746429|NCT03011892|562171250|FG008|Double Blind (DB) Period|Protocol Violation|0|||
155746430|NCT03011892|562171251|FG009|Double Blind (DB) Period|Protocol Violation|0|||
155746431|NCT03011892|562171252|FG010|Double Blind (DB) Period|Protocol Violation|0|||
155746432|NCT03011892|562171253|FG011|Double Blind (DB) Period|Protocol Violation|0|||
155746433|NCT03011892|562171242|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
155746434|NCT03011892|562171243|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
155746435|NCT03011892|562171244|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
155746436|NCT03011892|562171245|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
155746437|NCT03011892|562171246|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
155746438|NCT03011892|562171247|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
155746439|NCT03011892|562171248|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746440|NCT03011892|562171249|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746441|NCT03011892|562171250|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746442|NCT03011892|562171251|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746443|NCT03011892|562171252|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746444|NCT03011892|562171253|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
155746445|NCT03011892|562171242|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
155746446|NCT03011892|562171243|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
155746447|NCT03011892|562171244|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
155746448|NCT03011892|562171245|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
155746449|NCT03011892|562171246|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
155746450|NCT03011892|562171247|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
155746451|NCT03011892|562171248|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
155746452|NCT03011892|562171249|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
155746453|NCT03011892|562171250|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
155746454|NCT03011892|562171251|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
155746455|NCT03011892|562171252|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
155746456|NCT03011892|562171253|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
155746457|NCT03011892|562171242|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
155746458|NCT03011892|562171243|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
155746459|NCT03011892|562171244|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
155746460|NCT03011892|562171245|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
155746461|NCT03011892|562171246|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
155746462|NCT03011892|562171247|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
155746463|NCT03011892|562171248|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
155746464|NCT03011892|562171249|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
155746465|NCT03011892|562171250|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
155746466|NCT03011892|562171251|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
155746467|NCT03011892|562171252|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
155746468|NCT03011892|562171253|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
155746469|NCT03011892|562171242|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
155746470|NCT03011892|562171243|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
155746471|NCT03011892|562171244|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
155746472|NCT03011892|562171245|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
155746473|NCT03011892|562171246|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
155746474|NCT03011892|562171247|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
155746475|NCT03011892|562171248|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
155746476|NCT03011892|562171249|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
155746477|NCT03011892|562171250|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
155746478|NCT03011892|562171251|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
155746479|NCT03011892|562171252|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
155746480|NCT03011892|562171253|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
155746481|NCT03011892|562171242|FG000|Open Label (OL) Period|Reason not specified|0|||
155746482|NCT03011892|562171243|FG001|Open Label (OL) Period|Reason not specified|0|||
155746483|NCT03011892|562171244|FG002|Open Label (OL) Period|Reason not specified|0|||
155746484|NCT03011892|562171245|FG003|Open Label (OL) Period|Reason not specified|0|||
155746485|NCT03011892|562171246|FG004|Open Label (OL) Period|Reason not specified|0|||
155746486|NCT03011892|562171247|FG005|Open Label (OL) Period|Reason not specified|0|||
155746487|NCT03011892|562171248|FG006|Open Label (OL) Period|Reason not specified|0|||
155746488|NCT03011892|562171249|FG007|Open Label (OL) Period|Reason not specified|1|||
155746489|NCT03011892|562171250|FG008|Open Label (OL) Period|Reason not specified|0|||
155746490|NCT03011892|562171251|FG009|Open Label (OL) Period|Reason not specified|0|||
155746491|NCT03011892|562171252|FG010|Open Label (OL) Period|Reason not specified|0|||
155746492|NCT03011892|562171253|FG011|Open Label (OL) Period|Reason not specified|0|||
155746493|NCT02282293|562171254|FG000|Overall Study|Lost to Follow-up|2|||
155746494|NCT02282293|562171255|FG001|Overall Study|Lost to Follow-up|2|||
155746495|NCT02282293|562171254|FG000|Overall Study|Unable to comply with study procedures|1|||
155746496|NCT02282293|562171255|FG001|Overall Study|Unable to comply with study procedures|0|||
155746497|NCT02282293|562171254|FG000|Overall Study|Moved out of study area|0|||
155746498|NCT02282293|562171255|FG001|Overall Study|Moved out of study area|1|||
155746499|NCT00906971|562171264|FG000|Overall Study|Withdrawal by Subject|8|||
155746500|NCT00906971|562171265|FG001|Overall Study|Withdrawal by Subject|2|||
155746501|NCT00906971|562171264|FG000|Overall Study|Lost to Follow-up|0|||
155746502|NCT00906971|562171265|FG001|Overall Study|Lost to Follow-up|1|||
155746503|NCT03678870|562171268|FG000|Overall Study|prescribed non- protocol medications|10|||
155746504|NCT03678870|562171269|FG001|Overall Study|prescribed non- protocol medications|6|||
155746505|NCT03678870|562171268|FG000|Overall Study|Lost to Follow-up|3|||
155746506|NCT03678870|562171269|FG001|Overall Study|Lost to Follow-up|2|||
155746507|NCT03104816|562171270|FG000|Overall Study|Lack of Efficacy|0|||
155746508|NCT03104816|562171271|FG001|Overall Study|Lack of Efficacy|2|||
155746509|NCT03104816|562171272|FG002|Overall Study|Lack of Efficacy|0|||
155746510|NCT03104816|562171270|FG000|Overall Study|Protocol Violation|2|||
155746511|NCT03104816|562171271|FG001|Overall Study|Protocol Violation|0|||
155746512|NCT03104816|562171272|FG002|Overall Study|Protocol Violation|2|||
155746513|NCT01894568|562171275|FG000|Overall Study|Adverse Event|2|||
155746514|NCT01894568|562171276|FG001|Overall Study|Adverse Event|3|||
155746515|NCT01894568|562171275|FG000|Overall Study|Protocol required discontinuation|2|||
155746516|NCT01894568|562171276|FG001|Overall Study|Protocol required discontinuation|1|||
155746517|NCT01894568|562171275|FG000|Overall Study|Withdrawal by Subject|5|||
155746518|NCT01894568|562171276|FG001|Overall Study|Withdrawal by Subject|5|||
155300152|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155746519|NCT01894568|562171275|FG000|Overall Study|Physician Decision|1|||
155746520|NCT01894568|562171276|FG001|Overall Study|Physician Decision|0|||
155746521|NCT01894568|562171275|FG000|Overall Study|Lost to Follow-up|0|||
155746522|NCT01894568|562171276|FG001|Overall Study|Lost to Follow-up|1|||
155300153|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
155300154|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300155|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300156|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300157|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300158|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300159|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155746523|NCT03720652|562171277|FG000|Overall Study|Withdrawal by Subject|2|||
155746524|NCT03720652|562171278|FG001|Overall Study|Withdrawal by Subject|7|||
155746525|NCT03720652|562171277|FG000|Overall Study|Lost to Follow-up|0|||
155746526|NCT03720652|562171278|FG001|Overall Study|Lost to Follow-up|4|||
155746527|NCT03353740|562171282|FG000|Overall Study|Images for these participants not viable|52|||
155746528|NCT03976648|562171283|FG000|Overall Study|Adverse Event|0|||
155746529|NCT03976648|562171284|FG001|Overall Study|Adverse Event|2|||
155746530|NCT03976648|562171283|FG000|Overall Study|Study terminated by sponsor|21|||
155746531|NCT03976648|562171284|FG001|Overall Study|Study terminated by sponsor|8|||
155746532|NCT01155167|562171285|FG000|Overall Study|Insufficient ultrasound data|2|||
155746533|NCT01155167|562171286|FG001|Overall Study|Insufficient ultrasound data|0|||
155746534|NCT01155167|562171285|FG000|Overall Study|Access site changed to femoral artery|1|||
155746535|NCT01155167|562171286|FG001|Overall Study|Access site changed to femoral artery|0|||
155746536|NCT02276027|562172697|FG000|Overall Study|Death|1|||
155641027|NCT03580928|561775548|FG000|Overall Study|Withdrawal by Subject|2|||
155746537|NCT02276027|562172698|FG001|Overall Study|Death|0|||
155746538|NCT02276027|562172699|FG002|Overall Study|Death|0|||
155746539|NCT02276027|562172700|FG003|Overall Study|Death|2|||
155746540|NCT02276027|562172697|FG000|Overall Study|Physician Decision|0|||
155746541|NCT02276027|562172698|FG001|Overall Study|Physician Decision|0|||
155746542|NCT02276027|562172699|FG002|Overall Study|Physician Decision|0|||
155746543|NCT02276027|562172700|FG003|Overall Study|Physician Decision|1|||
155746544|NCT02276027|562172697|FG000|Overall Study|Progressive disease|1|||
155746545|NCT02276027|562172698|FG001|Overall Study|Progressive disease|13|||
155746546|NCT02276027|562172699|FG002|Overall Study|Progressive disease|12|||
155746547|NCT02276027|562172700|FG003|Overall Study|Progressive disease|14|||
155746548|NCT02276027|562172697|FG000|Overall Study|Subject/guardian decision|0|||
155746549|NCT02276027|562172698|FG001|Overall Study|Subject/guardian decision|1|||
155746550|NCT02276027|562172699|FG002|Overall Study|Subject/guardian decision|0|||
155746551|NCT02276027|562172700|FG003|Overall Study|Subject/guardian decision|3|||
155746552|NCT02276027|562172697|FG000|Overall Study|Adverse Event|0|||
155746553|NCT02276027|562172698|FG001|Overall Study|Adverse Event|2|||
155746554|NCT02276027|562172699|FG002|Overall Study|Adverse Event|8|||
155746555|NCT02276027|562172700|FG003|Overall Study|Adverse Event|2|||
155746556|NCT00003830|562172702|FG000|Overall Study|No follow up data|3|||
155746557|NCT00003830|562172703|FG001|Overall Study|No follow up data|0|||
155746558|NCT00003830|562172702|FG000|Overall Study|Sentinel node positive patients|829|||
155746559|NCT00003830|562172703|FG001|Overall Study|Sentinel node positive patients|793|||
155746560|NCT03860935|562172704|FG000|Overall Study|Withdrawal of Consent|15|||
155641028|NCT03580928|561775549|FG001|Overall Study|Withdrawal by Subject|1|||
155641029|NCT03580928|561775548|FG000|Overall Study|Lost to Follow-up|2|||
155641030|NCT03580928|561775549|FG001|Overall Study|Lost to Follow-up|0|||
155641031|NCT03580928|561775548|FG000|Overall Study|Progressive Disease|0|||
155641032|NCT03580928|561775549|FG001|Overall Study|Progressive Disease|1|||
155641033|NCT01127061|561776742|FG000|Overall Study|Lost to Follow-up|7|||
155641034|NCT01127061|561776743|FG001|Overall Study|Lost to Follow-up|10|||
155641035|NCT01127061|561776742|FG000|Overall Study|Physician Decision|3|||
155641036|NCT01127061|561776743|FG001|Overall Study|Physician Decision|3|||
155641037|NCT03921541|561776746|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
155641038|NCT03921541|561776747|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
155641039|NCT00420407|561776749|FG000|Overall Study|Lost to Follow-up|0|||
155641040|NCT00420407|561776750|FG001|Overall Study|Lost to Follow-up|3|||
155641041|NCT00420407|561776749|FG000|Overall Study|Physician Decision|2|||
155641042|NCT00420407|561776750|FG001|Overall Study|Physician Decision|1|||
155641043|NCT00420407|561776749|FG000|Overall Study|subject identified as detainee|1|||
155641044|NCT00420407|561776750|FG001|Overall Study|subject identified as detainee|0|||
155746561|NCT03860935|562172705|FG001|Overall Study|Withdrawal of Consent|6|||
155746562|NCT03860935|562172704|FG000|Overall Study|Death|75|||
155746563|NCT03860935|562172705|FG001|Overall Study|Death|51|||
155746564|NCT01122394|562172709|FG000|Overall Study|Withdrawal by Subject|1|||
155746565|NCT01122394|562172710|FG001|Overall Study|Withdrawal by Subject|1|||
155746566|NCT01122394|562172709|FG000|Overall Study|Lost to Follow-up|2|||
155746567|NCT01122394|562172710|FG001|Overall Study|Lost to Follow-up|2|||
155746568|NCT01122394|562172709|FG000|Overall Study|Adverse Event|0|||
155746569|NCT01122394|562172710|FG001|Overall Study|Adverse Event|1|||
155746570|NCT03739242|562172711|FG000|Overall Study|Withdrawal by Subject|1|||
155746571|NCT03739242|562172712|FG001|Overall Study|Withdrawal by Subject|1|||
155746572|NCT03739242|562172711|FG000|Overall Study|Protocol Violation|0|||
155746573|NCT03739242|562172712|FG001|Overall Study|Protocol Violation|1|||
155746574|NCT00039871|562172713|FG000|Overall Study|Adverse Event|165|||
155746575|NCT00039871|562172713|FG000|Overall Study|Lost to Follow-up|18|||
155746576|NCT00039871|562172713|FG000|Overall Study|Protocol Violation|24|||
155746577|NCT00039871|562172713|FG000|Overall Study|Withdrawal by Subject|97|||
155746578|NCT00039871|562172713|FG000|Overall Study|Did not meet eligibility criteria|11|||
155746579|NCT00039871|562172713|FG000|Overall Study|Administrative|1|||
155746580|NCT00039871|562172713|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
155746581|NCT00039871|562172713|FG000|Overall Study|Never entered follow-up|7|||
155746582|NCT03361176|562172714|FG000|Overall Study|Lost to Follow-up|1|||
155746583|NCT03361176|562172715|FG001|Overall Study|Lost to Follow-up|2|||
155746584|NCT03361176|562172714|FG000|Overall Study|Adverse Event|0|||
155746585|NCT03361176|562172715|FG001|Overall Study|Adverse Event|2|||
155746586|NCT03361176|562172714|FG000|Overall Study|Withdrawal by Subject|0|||
155746587|NCT03361176|562172715|FG001|Overall Study|Withdrawal by Subject|1|||
155746588|NCT02478398|562172716|FG000|Overall Study|Adverse Event|20|||
155746589|NCT02478398|562172717|FG001|Overall Study|Adverse Event|5|||
155746590|NCT02478398|562172716|FG000|Overall Study|Lost to Follow-up|5|||
155746591|NCT02478398|562172717|FG001|Overall Study|Lost to Follow-up|4|||
155746592|NCT02478398|562172716|FG000|Overall Study|Non-Compliance With Study Drug|5|||
155746593|NCT02478398|562172717|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155746594|NCT02478398|562172716|FG000|Overall Study|Protocol Violation|3|||
155746595|NCT02478398|562172717|FG001|Overall Study|Protocol Violation|1|||
155746596|NCT02478398|562172716|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
155746597|NCT02478398|562172717|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155746598|NCT02478398|562172716|FG000|Overall Study|Withdrawal By Participant|10|||
155746599|NCT02478398|562172717|FG001|Overall Study|Withdrawal By Participant|4|||
155746600|NCT02160002|562172720|FG000|Overall Study|Withdrawal by Subject|2|||
155746601|NCT02160002|562172721|FG001|Overall Study|Withdrawal by Subject|1|||
155746602|NCT00704522|562172722|FG000|Overall Study|Lack of Efficacy|65|||
155746603|NCT00704522|562172723|FG001|Overall Study|Lack of Efficacy|17|||
155746604|NCT00704522|562172722|FG000|Overall Study|Failure to appear again at hospital|56|||
155746605|NCT00704522|562172723|FG001|Overall Study|Failure to appear again at hospital|10|||
155746606|NCT00704522|562172722|FG000|Overall Study|Withdrawal by Subject|17|||
155746607|NCT00704522|562172723|FG001|Overall Study|Withdrawal by Subject|8|||
155746608|NCT00704522|562172722|FG000|Overall Study|Adverse Event|9|||
155746609|NCT00704522|562172723|FG001|Overall Study|Adverse Event|1|||
155746610|NCT00704522|562172722|FG000|Overall Study|Undefined causes|9|||
155746611|NCT00704522|562172723|FG001|Overall Study|Undefined causes|7|||
155746612|NCT00704522|562172722|FG000|Overall Study|No information on therapy end|27|||
155746613|NCT00704522|562172723|FG001|Overall Study|No information on therapy end|2|||
155746614|NCT04395001|562172724|FG000|Overall Study|Lost to Follow-up|8|||
155746615|NCT04395001|562172725|FG001|Overall Study|Lost to Follow-up|9|||
155746616|NCT04395001|562172726|FG002|Overall Study|Lost to Follow-up|5|||
155746617|NCT04395001|562172724|FG000|Overall Study|Withdrawal by Subject|3|||
155746618|NCT04395001|562172725|FG001|Overall Study|Withdrawal by Subject|1|||
155746619|NCT04395001|562172726|FG002|Overall Study|Withdrawal by Subject|3|||
155746620|NCT04395001|562172724|FG000|Overall Study|missed appointment|7|||
155746621|NCT04395001|562172725|FG001|Overall Study|missed appointment|4|||
155746622|NCT04395001|562172726|FG002|Overall Study|missed appointment|1|||
155746623|NCT04418661|562172727|FG000|Overall Study|Adverse Event|0|||
155746624|NCT04418661|562172728|FG001|Overall Study|Adverse Event|1|||
155746625|NCT04418661|562172729|FG002|Overall Study|Adverse Event|5|||
155746626|NCT04418661|562172730|FG003|Overall Study|Adverse Event|3|||
155746627|NCT04418661|562172731|FG004|Overall Study|Adverse Event|0|||
155746628|NCT04418661|562172732|FG005|Overall Study|Adverse Event|2|||
155746629|NCT04418661|562172727|FG000|Overall Study|Progressive disease|4|||
155746630|NCT04418661|562172728|FG001|Overall Study|Progressive disease|11|||
155746631|NCT04418661|562172729|FG002|Overall Study|Progressive disease|6|||
155746632|NCT04418661|562172730|FG003|Overall Study|Progressive disease|11|||
155746633|NCT04418661|562172731|FG004|Overall Study|Progressive disease|1|||
155746634|NCT04418661|562172732|FG005|Overall Study|Progressive disease|12|||
155746635|NCT04418661|562172727|FG000|Overall Study|Withdrawal by Subject|0|||
155746636|NCT04418661|562172728|FG001|Overall Study|Withdrawal by Subject|1|||
155746637|NCT04418661|562172729|FG002|Overall Study|Withdrawal by Subject|0|||
155746638|NCT04418661|562172730|FG003|Overall Study|Withdrawal by Subject|1|||
155746639|NCT04418661|562172731|FG004|Overall Study|Withdrawal by Subject|0|||
155746640|NCT04418661|562172732|FG005|Overall Study|Withdrawal by Subject|0|||
155746641|NCT04418661|562172727|FG000|Overall Study|Other|0|||
155746642|NCT04418661|562172728|FG001|Overall Study|Other|0|||
155746643|NCT04418661|562172729|FG002|Overall Study|Other|1|||
155746644|NCT04418661|562172730|FG003|Overall Study|Other|3|||
155746645|NCT04418661|562172731|FG004|Overall Study|Other|0|||
155746646|NCT04418661|562172732|FG005|Overall Study|Other|1|||
155746647|NCT00992589|562172734|FG000|Open-Label Phase|Adverse Event|4|||
155746648|NCT00992589|562172735|FG001|Open-Label Phase|Adverse Event|0|||
155746649|NCT00992589|562172736|FG002|Open-Label Phase|Adverse Event|0|||
155746650|NCT00992589|562172737|FG003|Open-Label Phase|Adverse Event|0|||
155746651|NCT00992589|562172734|FG000|Open-Label Phase|Withdrawal by Subject|20|||
155746652|NCT00992589|562172735|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155746653|NCT00992589|562172736|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155746654|NCT00992589|562172737|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155746655|NCT00992589|562172734|FG000|Open-Label Phase|Lost to Follow-up|1|||
155746656|NCT00992589|562172735|FG001|Open-Label Phase|Lost to Follow-up|0|||
155746657|NCT00992589|562172736|FG002|Open-Label Phase|Lost to Follow-up|0|||
155746658|NCT00992589|562172737|FG003|Open-Label Phase|Lost to Follow-up|0|||
155746659|NCT00992589|562172734|FG000|Open-Label Phase|Protocol Violation|3|||
155746660|NCT00992589|562172735|FG001|Open-Label Phase|Protocol Violation|0|||
155746661|NCT00992589|562172736|FG002|Open-Label Phase|Protocol Violation|0|||
155746662|NCT00992589|562172737|FG003|Open-Label Phase|Protocol Violation|0|||
155746663|NCT00992589|562172734|FG000|Open-Label Phase|Physician Decision|4|||
155746664|NCT00992589|562172735|FG001|Open-Label Phase|Physician Decision|0|||
155746665|NCT00992589|562172736|FG002|Open-Label Phase|Physician Decision|0|||
155746666|NCT00992589|562172737|FG003|Open-Label Phase|Physician Decision|0|||
155746667|NCT00992589|562172734|FG000|Open-Label Phase|Other|45|||
155746668|NCT00992589|562172735|FG001|Open-Label Phase|Other|0|||
155746669|NCT00992589|562172736|FG002|Open-Label Phase|Other|0|||
155746670|NCT00992589|562172737|FG003|Open-Label Phase|Other|0|||
155746671|NCT00992589|562172734|FG000|Double-Blind Phase|Adverse Event|0|||
155746672|NCT00992589|562172735|FG001|Double-Blind Phase|Adverse Event|6|||
155746673|NCT00992589|562172736|FG002|Double-Blind Phase|Adverse Event|2|||
155746674|NCT00992589|562172737|FG003|Double-Blind Phase|Adverse Event|3|||
155746675|NCT00992589|562172734|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155746676|NCT00992589|562172735|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
155746677|NCT00992589|562172736|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
155746678|NCT00992589|562172737|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
155746679|NCT00992589|562172734|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155746680|NCT00992589|562172735|FG001|Double-Blind Phase|Lost to Follow-up|0|||
155746681|NCT00992589|562172736|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155746682|NCT00992589|562172737|FG003|Double-Blind Phase|Lost to Follow-up|2|||
155746683|NCT00992589|562172734|FG000|Double-Blind Phase|Other|0|||
155746684|NCT00992589|562172735|FG001|Double-Blind Phase|Other|1|||
155746685|NCT00992589|562172736|FG002|Double-Blind Phase|Other|6|||
155746686|NCT00992589|562172737|FG003|Double-Blind Phase|Other|3|||
155300160|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155746687|NCT02142387|562172738|FG000|Overall Study|<19 years old|49|||
155746688|NCT02142387|562172739|FG001|Overall Study|<19 years old|326|||
155746689|NCT02142387|562172738|FG000|Overall Study|non-cardiac etiology|504|||
155746690|NCT02142387|562172739|FG001|Overall Study|non-cardiac etiology|3431|||
155746691|NCT02142387|562172738|FG000|Overall Study|CPR not performed|74|||
155746692|NCT02142387|562172739|FG001|Overall Study|CPR not performed|473|||
155746693|NCT02142387|562172738|FG000|Overall Study|witnessed by paramedic|139|||
155746694|NCT02142387|562172739|FG001|Overall Study|witnessed by paramedic|917|||
155746695|NCT02142387|562172738|FG000|Overall Study|incomplete data|1|||
155746696|NCT02142387|562172739|FG001|Overall Study|incomplete data|9|||
155746697|NCT02142387|562172738|FG000|Overall Study|occurred not at home|298|||
155746698|NCT02142387|562172739|FG001|Overall Study|occurred not at home|2474|||
155746699|NCT01895361|562172743|FG000|Overall Study|Adverse Event|1|||
155300161|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300162|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300163|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155300164|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155300165|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155746700|NCT01895361|562172744|FG001|Overall Study|Adverse Event|1|||
155746701|NCT01895361|562172745|FG002|Overall Study|Adverse Event|3|||
155300166|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
155300167|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300168|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300169|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155746702|NCT01895361|562172743|FG000|Overall Study|Death|2|||
155746703|NCT01895361|562172744|FG001|Overall Study|Death|1|||
155746704|NCT01895361|562172745|FG002|Overall Study|Death|2|||
155746705|NCT01895361|562172743|FG000|Overall Study|Lost to Follow-up|4|||
155746706|NCT01895361|562172744|FG001|Overall Study|Lost to Follow-up|4|||
155746707|NCT01895361|562172745|FG002|Overall Study|Lost to Follow-up|6|||
155746708|NCT01895361|562172743|FG000|Overall Study|Non-compliance with study|1|||
155746709|NCT01895361|562172744|FG001|Overall Study|Non-compliance with study|3|||
155746710|NCT01895361|562172745|FG002|Overall Study|Non-compliance with study|1|||
155746711|NCT01895361|562172743|FG000|Overall Study|Physician Decision|2|||
155746712|NCT01895361|562172744|FG001|Overall Study|Physician Decision|2|||
155746713|NCT01895361|562172745|FG002|Overall Study|Physician Decision|2|||
155746714|NCT01895361|562172743|FG000|Overall Study|Withdrawal by Subject|7|||
155746715|NCT01895361|562172744|FG001|Overall Study|Withdrawal by Subject|6|||
155746716|NCT01895361|562172745|FG002|Overall Study|Withdrawal by Subject|6|||
155746717|NCT01895361|562172743|FG000|Overall Study|Lack of Efficacy|0|||
155746718|NCT01895361|562172744|FG001|Overall Study|Lack of Efficacy|1|||
155746719|NCT01895361|562172745|FG002|Overall Study|Lack of Efficacy|0|||
155746720|NCT01895361|562172743|FG000|Overall Study|Reasons different from categories above|7|||
155746721|NCT01895361|562172744|FG001|Overall Study|Reasons different from categories above|3|||
155746722|NCT01895361|562172745|FG002|Overall Study|Reasons different from categories above|4|||
155746723|NCT01209832|562172749|FG000|Period 1|Sponsor Decision and was not dosed|1|||
155746724|NCT01209832|562172749|FG000|Period 2|Sponsor Decision|1|||
155746725|NCT01268579|562172750|FG000|Overall Study|Adverse Event|1|||
155746726|NCT01268579|562172750|FG000|Overall Study|Withdrawal by Subject|2|||
155746727|NCT02692651|562172751|FG000|Study Treatment|Death|7|||
155746728|NCT02692651|562172752|FG001|Study Treatment|Death|3|||
155746729|NCT02692651|562172751|FG000|Study Treatment|comfort care|1|||
155746730|NCT02692651|562172752|FG001|Study Treatment|comfort care|1|||
155746731|NCT02692651|562172751|FG000|Study Treatment|Protocol violation per treating team preference|8|||
155746732|NCT02692651|562172752|FG001|Study Treatment|Protocol violation per treating team preference|6|||
155746733|NCT02692651|562172751|FG000|Post Study Treatment Follow-up|Death|4|||
155746734|NCT02692651|562172752|FG001|Post Study Treatment Follow-up|Death|4|||
155746735|NCT03490981|562172753|FG000|Overall Study|Lost to Follow-up|1|||
155746736|NCT03490981|562172754|FG001|Overall Study|Lost to Follow-up|2|||
155746737|NCT05463198|562172755|FG000|Overall Study|Withdrawal by Subject|19|||
155746738|NCT05463198|562172755|FG000|Overall Study|Procedure Notes Missing|18|||
155746739|NCT02239120|562172758|FG000|Overall Study|Death|56|||
155746740|NCT02239120|562172759|FG001|Overall Study|Death|58|||
155746741|NCT02239120|562172758|FG000|Overall Study|Lost to Follow-up|19|||
155746742|NCT02239120|562172759|FG001|Overall Study|Lost to Follow-up|14|||
155746743|NCT00046891|562172762|FG000|Overall Study|Cancels|5|||
155746744|NCT00046891|562172763|FG001|Overall Study|Cancels|9|||
155746745|NCT00046891|562172762|FG000|Overall Study|Ineligible|1|||
155746746|NCT00046891|562172763|FG001|Overall Study|Ineligible|1|||
155746747|NCT00046891|562172762|FG000|Overall Study|Withdrawal by Subject|18|||
155746748|NCT00046891|562172763|FG001|Overall Study|Withdrawal by Subject|15|||
155746749|NCT00046891|562172762|FG000|Overall Study|Adverse Event|5|||
155746750|NCT00046891|562172763|FG001|Overall Study|Adverse Event|5|||
155746751|NCT00420641|562172766|FG000|Overall Study|Adverse Event|3|||
155746752|NCT00420641|562172767|FG001|Overall Study|Adverse Event|25|||
155746753|NCT00420641|562172768|FG002|Overall Study|Adverse Event|10|||
155746754|NCT00420641|562172766|FG000|Overall Study|Lost to Follow-up|2|||
155746755|NCT00420641|562172767|FG001|Overall Study|Lost to Follow-up|4|||
155746756|NCT00420641|562172768|FG002|Overall Study|Lost to Follow-up|2|||
155746757|NCT00420641|562172766|FG000|Overall Study|Protocol Violation|8|||
155746758|NCT00420641|562172767|FG001|Overall Study|Protocol Violation|8|||
155746759|NCT00420641|562172768|FG002|Overall Study|Protocol Violation|7|||
155746760|NCT00420641|562172766|FG000|Overall Study|Withdrawal by Subject|15|||
155746761|NCT00420641|562172767|FG001|Overall Study|Withdrawal by Subject|21|||
155746762|NCT00420641|562172768|FG002|Overall Study|Withdrawal by Subject|14|||
155746763|NCT00420641|562172766|FG000|Overall Study|Lack of Efficacy|6|||
155746764|NCT00420641|562172767|FG001|Overall Study|Lack of Efficacy|5|||
155746765|NCT00420641|562172768|FG002|Overall Study|Lack of Efficacy|4|||
155746766|NCT00420641|562172766|FG000|Overall Study|Non-compliance|7|||
155746767|NCT00420641|562172767|FG001|Overall Study|Non-compliance|5|||
155746768|NCT00420641|562172768|FG002|Overall Study|Non-compliance|4|||
155746769|NCT00420641|562172766|FG000|Overall Study|Other|4|||
155746770|NCT00420641|562172767|FG001|Overall Study|Other|4|||
155746771|NCT00420641|562172768|FG002|Overall Study|Other|3|||
155746772|NCT02586506|562172774|FG000|Overall Study|Protocol Violation|6|||
155746773|NCT02586506|562172774|FG000|Overall Study|Lost to Follow-up|1|||
155746774|NCT02586506|562172774|FG000|Overall Study|Other Reason|2|||
155746775|NCT02815280|562172778|FG000|Double-Blind Phase|Adverse Event|1|||
155746776|NCT02815280|562172779|FG001|Double-Blind Phase|Adverse Event|1|||
155746777|NCT02815280|562172778|FG000|Double-Blind Phase|Lost to Follow-up|10|||
155746778|NCT02815280|562172779|FG001|Double-Blind Phase|Lost to Follow-up|9|||
155746779|NCT02815280|562172778|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
155746780|NCT02815280|562172779|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
155746781|NCT02815280|562172778|FG000|Double-Blind Phase|Protocol Violation|2|||
155746782|NCT02815280|562172779|FG001|Double-Blind Phase|Protocol Violation|2|||
155746783|NCT02815280|562172778|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
155746784|NCT02815280|562172779|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
155746785|NCT02815280|562172778|FG000|Open-Label Phase|Adverse Event|2|||
155746786|NCT02815280|562172779|FG001|Open-Label Phase|Adverse Event|3|||
155746787|NCT02815280|562172778|FG000|Open-Label Phase|Lost to Follow-up|18|||
155746788|NCT02815280|562172779|FG001|Open-Label Phase|Lost to Follow-up|9|||
155746789|NCT02815280|562172778|FG000|Open-Label Phase|Withdrawal by Subject|33|||
155746790|NCT02815280|562172779|FG001|Open-Label Phase|Withdrawal by Subject|18|||
155746791|NCT02815280|562172778|FG000|Open-Label Phase|Protocol Violation|3|||
155746792|NCT02815280|562172779|FG001|Open-Label Phase|Protocol Violation|0|||
155746793|NCT02815280|562172778|FG000|Open-Label Phase|Administrative|26|||
155746794|NCT02815280|562172779|FG001|Open-Label Phase|Administrative|12|||
155746795|NCT02815280|562172778|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
155746796|NCT02815280|562172779|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
155746797|NCT02514473|562172787|FG000|Overall Study|Adverse Event|0|||
155746798|NCT02514473|562172788|FG001|Overall Study|Adverse Event|2|||
155746799|NCT02514473|562172787|FG000|Overall Study|Withdrawal by Subject|2|||
155746800|NCT02514473|562172788|FG001|Overall Study|Withdrawal by Subject|1|||
155746801|NCT02514473|562172787|FG000|Overall Study|Lost to Follow-up|0|||
155300170|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300171|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300172|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300173|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300174|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300175|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300176|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
155300177|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300178|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300179|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300180|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300181|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300182|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300183|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300184|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300185|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300186|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300187|NCT05061693|560529670|FG000|24-week Extension Period|Adverse Event|0|||
155300188|NCT05061693|560529671|FG001|24-week Extension Period|Adverse Event|0|||
155300189|NCT05061693|560529672|FG002|24-week Extension Period|Adverse Event|0|||
155300190|NCT05061693|560529673|FG003|24-week Extension Period|Adverse Event|0|||
155300191|NCT05061693|560529674|FG004|24-week Extension Period|Adverse Event|0|||
155300192|NCT05061693|560529675|FG005|24-week Extension Period|Adverse Event|0|||
155300193|NCT05061693|560529676|FG006|24-week Extension Period|Adverse Event|0|||
155746802|NCT02514473|562172788|FG001|Overall Study|Lost to Follow-up|1|||
155746803|NCT02514473|562172787|FG000|Overall Study|Other|1|||
155746804|NCT02514473|562172788|FG001|Overall Study|Other|1|||
155746805|NCT02158364|562172789|FG000|Overall Study|Case report forms uncollected|10|||
155746806|NCT02158364|562172789|FG000|Overall Study|Protocol Deviation|50|||
155746807|NCT04381988|562172792|FG000|Overall Study|The study was terminated|4|||
155746808|NCT04381988|562172793|FG001|Overall Study|The study was terminated|0|||
155746809|NCT00609362|562172794|FG000|Overall Study|Withdrawal by Subject|2|||
155746810|NCT00609362|562172795|FG001|Overall Study|Withdrawal by Subject|1|||
155746811|NCT00609362|562172794|FG000|Overall Study|Adverse Event|1|||
155746812|NCT00609362|562172795|FG001|Overall Study|Adverse Event|0|||
155746813|NCT05093790|562172796|FG000|Overall Study|Failure to meet continuation criteria|0|||
155746814|NCT05093790|562172797|FG001|Overall Study|Failure to meet continuation criteria|0|||
155746815|NCT05093790|562172798|FG002|Overall Study|Failure to meet continuation criteria|1|||
155746816|NCT05093790|562172799|FG003|Overall Study|Failure to meet continuation criteria|0|||
155746817|NCT05093790|562172796|FG000|Overall Study|Adverse Event|1|||
155746818|NCT05093790|562172797|FG001|Overall Study|Adverse Event|0|||
155746819|NCT05093790|562172798|FG002|Overall Study|Adverse Event|0|||
155746820|NCT05093790|562172799|FG003|Overall Study|Adverse Event|0|||
155746821|NCT01624870|562172800|FG000|Overall Study|Death|19|||
155746822|NCT01624870|562172800|FG000|Overall Study|Withdrawal by Subject|1|||
155746823|NCT01624870|562172800|FG000|Overall Study|CoreValve not implanted|6|||
155746824|NCT01624870|562172800|FG000|Overall Study|Lost to follow up|1|||
155300194|NCT05061693|560529677|FG007|24-week Extension Period|Adverse Event|2|||
155300195|NCT05061693|560529678|FG008|24-week Extension Period|Adverse Event|2|||
155300196|NCT05061693|560529679|FG009|24-week Extension Period|Adverse Event|0|||
155746825|NCT00827931|562172801|FG000|Overall Study|Death|3|||
155300197|NCT05061693|560529680|FG010|24-week Extension Period|Adverse Event|1|||
155300198|NCT05061693|560529681|FG011|24-week Extension Period|Adverse Event|3|||
155300199|NCT05061693|560529670|FG000|24-week Extension Period|Lack of Efficacy|0|||
155300200|NCT05061693|560529671|FG001|24-week Extension Period|Lack of Efficacy|0|||
155300201|NCT05061693|560529672|FG002|24-week Extension Period|Lack of Efficacy|0|||
155746826|NCT00827931|562172802|FG001|Overall Study|Death|5|||
155746827|NCT00827931|562172801|FG000|Overall Study|Adverse Event|1|||
155746828|NCT00827931|562172802|FG001|Overall Study|Adverse Event|0|||
155746829|NCT00827931|562172801|FG000|Overall Study|Lost to Follow-up|1|||
155746830|NCT00827931|562172802|FG001|Overall Study|Lost to Follow-up|0|||
155300202|NCT05061693|560529673|FG003|24-week Extension Period|Lack of Efficacy|0|||
155300203|NCT05061693|560529674|FG004|24-week Extension Period|Lack of Efficacy|0|||
155300204|NCT05061693|560529675|FG005|24-week Extension Period|Lack of Efficacy|0|||
155300205|NCT05061693|560529676|FG006|24-week Extension Period|Lack of Efficacy|0|||
155300206|NCT05061693|560529677|FG007|24-week Extension Period|Lack of Efficacy|0|||
155300207|NCT05061693|560529678|FG008|24-week Extension Period|Lack of Efficacy|0|||
155300208|NCT05061693|560529679|FG009|24-week Extension Period|Lack of Efficacy|0|||
155300209|NCT05061693|560529680|FG010|24-week Extension Period|Lack of Efficacy|2|||
155300210|NCT05061693|560529681|FG011|24-week Extension Period|Lack of Efficacy|0|||
155300211|NCT05061693|560529670|FG000|24-week Extension Period|Lost to Follow-up|0|||
155300212|NCT05061693|560529671|FG001|24-week Extension Period|Lost to Follow-up|0|||
155300213|NCT05061693|560529672|FG002|24-week Extension Period|Lost to Follow-up|0|||
155300214|NCT05061693|560529673|FG003|24-week Extension Period|Lost to Follow-up|0|||
155300215|NCT05061693|560529674|FG004|24-week Extension Period|Lost to Follow-up|0|||
155300216|NCT05061693|560529675|FG005|24-week Extension Period|Lost to Follow-up|0|||
155300217|NCT05061693|560529676|FG006|24-week Extension Period|Lost to Follow-up|1|||
155300218|NCT05061693|560529677|FG007|24-week Extension Period|Lost to Follow-up|0|||
155300219|NCT05061693|560529678|FG008|24-week Extension Period|Lost to Follow-up|1|||
155300220|NCT05061693|560529679|FG009|24-week Extension Period|Lost to Follow-up|1|||
155300221|NCT05061693|560529680|FG010|24-week Extension Period|Lost to Follow-up|0|||
155300222|NCT05061693|560529681|FG011|24-week Extension Period|Lost to Follow-up|0|||
155300223|NCT05061693|560529670|FG000|24-week Extension Period|Withdrawal by Subject|0|||
155300224|NCT05061693|560529671|FG001|24-week Extension Period|Withdrawal by Subject|0|||
155300225|NCT05061693|560529672|FG002|24-week Extension Period|Withdrawal by Subject|0|||
155300226|NCT05061693|560529673|FG003|24-week Extension Period|Withdrawal by Subject|0|||
155300227|NCT05061693|560529674|FG004|24-week Extension Period|Withdrawal by Subject|0|||
155300228|NCT05061693|560529675|FG005|24-week Extension Period|Withdrawal by Subject|0|||
155300229|NCT05061693|560529676|FG006|24-week Extension Period|Withdrawal by Subject|0|||
155300230|NCT05061693|560529677|FG007|24-week Extension Period|Withdrawal by Subject|0|||
155300231|NCT05061693|560529678|FG008|24-week Extension Period|Withdrawal by Subject|1|||
155300232|NCT05061693|560529679|FG009|24-week Extension Period|Withdrawal by Subject|2|||
155300233|NCT05061693|560529680|FG010|24-week Extension Period|Withdrawal by Subject|2|||
155300234|NCT05061693|560529681|FG011|24-week Extension Period|Withdrawal by Subject|1|||
155300235|NCT05061693|560529670|FG000|24-week Extension Period|Sponsor Decision|0|||
155300236|NCT05061693|560529671|FG001|24-week Extension Period|Sponsor Decision|0|||
155300237|NCT05061693|560529672|FG002|24-week Extension Period|Sponsor Decision|0|||
155300238|NCT05061693|560529673|FG003|24-week Extension Period|Sponsor Decision|0|||
155300239|NCT05061693|560529674|FG004|24-week Extension Period|Sponsor Decision|0|||
155300240|NCT05061693|560529675|FG005|24-week Extension Period|Sponsor Decision|0|||
155300241|NCT05061693|560529676|FG006|24-week Extension Period|Sponsor Decision|0|||
155300242|NCT05061693|560529677|FG007|24-week Extension Period|Sponsor Decision|1|||
155300243|NCT05061693|560529678|FG008|24-week Extension Period|Sponsor Decision|0|||
155300244|NCT05061693|560529679|FG009|24-week Extension Period|Sponsor Decision|0|||
155300245|NCT05061693|560529680|FG010|24-week Extension Period|Sponsor Decision|0|||
155300246|NCT05061693|560529681|FG011|24-week Extension Period|Sponsor Decision|0|||
155746831|NCT00827931|562172801|FG000|Overall Study|Withdrawal by Subject|0|||
155746832|NCT00827931|562172802|FG001|Overall Study|Withdrawal by Subject|1|||
155746833|NCT00827931|562172801|FG000|Overall Study|Other|1|||
155300247|NCT05061693|560529670|FG000|24-week Extension Period|Site Closure|0|||
155746834|NCT00827931|562172802|FG001|Overall Study|Other|0|||
155746835|NCT02312687|562172805|FG000|Overall Study|Other, Not Specified|1|||
155746836|NCT01514370|562172808|FG000|Overall Study|Protocol Violation|2|||
155746837|NCT01514370|562172809|FG001|Overall Study|Protocol Violation|3|||
155746838|NCT01514370|562172808|FG000|Overall Study|Lost to Follow-up|0|||
155746839|NCT01514370|562172809|FG001|Overall Study|Lost to Follow-up|2|||
155746840|NCT01514370|562172808|FG000|Overall Study|Withdrawal by Subject|2|||
155746841|NCT01514370|562172809|FG001|Overall Study|Withdrawal by Subject|1|||
155746842|NCT01514370|562172808|FG000|Overall Study|Adverse Event|1|||
155746843|NCT01514370|562172809|FG001|Overall Study|Adverse Event|3|||
155746844|NCT01514370|562172808|FG000|Overall Study|Other|6|||
155746845|NCT01514370|562172809|FG001|Overall Study|Other|7|||
155300248|NCT05061693|560529671|FG001|24-week Extension Period|Site Closure|0|||
155300249|NCT05061693|560529672|FG002|24-week Extension Period|Site Closure|0|||
155746846|NCT01089361|562172810|FG000|Overall Study|Death|1|||
155746847|NCT01089361|562172811|FG001|Overall Study|Death|0|||
155746848|NCT03645434|562172814|FG000|Period 1|Adverse Event|0|||
155300250|NCT05061693|560529673|FG003|24-week Extension Period|Site Closure|0|||
155300251|NCT05061693|560529674|FG004|24-week Extension Period|Site Closure|0|||
155300252|NCT05061693|560529675|FG005|24-week Extension Period|Site Closure|0|||
155300253|NCT05061693|560529676|FG006|24-week Extension Period|Site Closure|0|||
155300254|NCT05061693|560529677|FG007|24-week Extension Period|Site Closure|0|||
155300255|NCT05061693|560529678|FG008|24-week Extension Period|Site Closure|1|||
155300256|NCT05061693|560529679|FG009|24-week Extension Period|Site Closure|0|||
155300257|NCT05061693|560529680|FG010|24-week Extension Period|Site Closure|0|||
155300258|NCT05061693|560529681|FG011|24-week Extension Period|Site Closure|1|||
155300259|NCT03823911|560529682|FG000|Overall Study|Lost to Follow-up|1|||
155300260|NCT03823911|560529683|FG001|Overall Study|Lost to Follow-up|5|||
155300261|NCT03823911|560529684|FG002|Overall Study|Lost to Follow-up|2|||
155300262|NCT03823911|560529682|FG000|Overall Study|Did not meet eligibility criteria|13|||
155300263|NCT03823911|560529683|FG001|Overall Study|Did not meet eligibility criteria|7|||
155300264|NCT03823911|560529684|FG002|Overall Study|Did not meet eligibility criteria|4|||
155300265|NCT03823911|560529682|FG000|Overall Study|Death|0|||
155300266|NCT03823911|560529683|FG001|Overall Study|Death|1|||
155300267|NCT03823911|560529684|FG002|Overall Study|Death|0|||
155300268|NCT04009577|560529685|FG000|Core Study|Adverse Event|1|||
155300269|NCT04009577|560529686|FG001|Core Study|Adverse Event|0|||
155300270|NCT04009577|560529687|FG002|Core Study|Adverse Event|2|||
155300271|NCT04009577|560529688|FG003|Core Study|Adverse Event|4|||
155300272|NCT04009577|560529685|FG000|Core Study|Withdrawal by Subject|0|||
155300273|NCT04009577|560529686|FG001|Core Study|Withdrawal by Subject|0|||
155300274|NCT04009577|560529687|FG002|Core Study|Withdrawal by Subject|2|||
155300275|NCT04009577|560529688|FG003|Core Study|Withdrawal by Subject|0|||
155300276|NCT04009577|560529685|FG000|Core Study|Other|0|||
155746849|NCT03645434|562172815|FG001|Period 1|Adverse Event|0|||
155746850|NCT03645434|562172816|FG002|Period 1|Adverse Event|0|||
155746851|NCT03645434|562172817|FG003|Period 1|Adverse Event|1|||
155746852|NCT03645434|562172818|FG004|Period 1|Adverse Event|0|||
155746853|NCT03645434|562172819|FG005|Period 1|Adverse Event|0|||
155746854|NCT03645434|562172814|FG000|Period 1|COPD exacerbation|0|||
155746855|NCT03645434|562172815|FG001|Period 1|COPD exacerbation|0|||
155746856|NCT03645434|562172816|FG002|Period 1|COPD exacerbation|0|||
155746857|NCT03645434|562172817|FG003|Period 1|COPD exacerbation|0|||
155746858|NCT03645434|562172818|FG004|Period 1|COPD exacerbation|1|||
155746859|NCT03645434|562172819|FG005|Period 1|COPD exacerbation|0|||
155746860|NCT02654717|562172820|FG000|Overall Study|Adverse Event|2|||
155746861|NCT02654717|562172821|FG001|Overall Study|Adverse Event|2|||
155746862|NCT02654717|562172820|FG000|Overall Study|Protocol Violation|1|||
155746863|NCT02654717|562172821|FG001|Overall Study|Protocol Violation|2|||
155746864|NCT02654717|562172820|FG000|Overall Study|Withdrawal by Subject|0|||
155746865|NCT02654717|562172821|FG001|Overall Study|Withdrawal by Subject|1|||
155746866|NCT02654717|562172820|FG000|Overall Study|Non-permitted medication|3|||
155746867|NCT02654717|562172821|FG001|Overall Study|Non-permitted medication|0|||
155746868|NCT00960570|562172824|FG000|21 Day Washout Period|Adverse Event|1|||
155746869|NCT00960570|562172824|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
155746870|NCT00960570|562172824|FG000|1 Day Period Between Dosing|Adverse Event|2|||
155746871|NCT00960570|562172824|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
155300277|NCT04009577|560529686|FG001|Core Study|Other|0|||
155300278|NCT04009577|560529687|FG002|Core Study|Other|0|||
155300279|NCT04009577|560529688|FG003|Core Study|Other|1|||
155300280|NCT04009577|560529685|FG000|Extension Phase|Adverse Event|0|||
155300281|NCT04009577|560529686|FG001|Extension Phase|Adverse Event|0|||
155746872|NCT01451437|562172825|FG000|Overall Study|Adverse Event|0|||
155746873|NCT01451437|562172826|FG001|Overall Study|Adverse Event|0|||
155746874|NCT01451437|562172827|FG002|Overall Study|Adverse Event|0|||
155746875|NCT01451437|562172828|FG003|Overall Study|Adverse Event|0|||
155300282|NCT04009577|560529687|FG002|Extension Phase|Adverse Event|0|||
155300283|NCT04009577|560529688|FG003|Extension Phase|Adverse Event|1|||
155300284|NCT04009577|560529685|FG000|Extension Phase|Inadequate therapeutic effect|0|||
155300285|NCT04009577|560529686|FG001|Extension Phase|Inadequate therapeutic effect|0|||
155300286|NCT04009577|560529687|FG002|Extension Phase|Inadequate therapeutic effect|1|||
155300287|NCT04009577|560529688|FG003|Extension Phase|Inadequate therapeutic effect|0|||
155300288|NCT04009577|560529685|FG000|Extension Phase|Withdrawal by Subject|0|||
155300289|NCT04009577|560529686|FG001|Extension Phase|Withdrawal by Subject|0|||
155300290|NCT04009577|560529687|FG002|Extension Phase|Withdrawal by Subject|1|||
155300291|NCT04009577|560529688|FG003|Extension Phase|Withdrawal by Subject|0|||
155300292|NCT04009577|560529685|FG000|Extension Phase|Not Treated|0|||
155300293|NCT04009577|560529686|FG001|Extension Phase|Not Treated|0|||
155300294|NCT04009577|560529687|FG002|Extension Phase|Not Treated|2|||
155300295|NCT04009577|560529688|FG003|Extension Phase|Not Treated|0|||
155300296|NCT00305695|560529698|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
155300297|NCT00305695|560529699|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
155300298|NCT00305695|560529698|FG000|Overall Study|Did not have baseline scan|1|||
155300299|NCT00305695|560529699|FG001|Overall Study|Did not have baseline scan|1|||
155300300|NCT04305405|560529703|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155300301|NCT04305405|560529704|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155300302|NCT02674750|560529707|FG000|Overall Study|Death|4|||
155300303|NCT02674750|560529708|FG001|Overall Study|Death|5|||
155300304|NCT02674750|560529709|FG002|Overall Study|Death|8|||
155300305|NCT02674750|560529707|FG000|Overall Study|Lost to Follow-up|0|||
155300306|NCT02674750|560529708|FG001|Overall Study|Lost to Follow-up|8|||
155300307|NCT02674750|560529709|FG002|Overall Study|Lost to Follow-up|0|||
155300308|NCT02674750|560529707|FG000|Overall Study|Lack of Efficacy|1|||
155300309|NCT02674750|560529708|FG001|Overall Study|Lack of Efficacy|17|||
155300310|NCT02674750|560529709|FG002|Overall Study|Lack of Efficacy|3|||
155300311|NCT02674750|560529707|FG000|Overall Study|Withdrawal by Subject|0|||
155300312|NCT02674750|560529708|FG001|Overall Study|Withdrawal by Subject|7|||
155300313|NCT02674750|560529709|FG002|Overall Study|Withdrawal by Subject|1|||
155300314|NCT02674750|560529707|FG000|Overall Study|Other|0|||
155300315|NCT02674750|560529708|FG001|Overall Study|Other|8|||
155300316|NCT02674750|560529709|FG002|Overall Study|Other|0|||
155300317|NCT01685606|560529712|FG000|Overall Study|Withdrawal by Subject|1|||
155300318|NCT01787760|560529715|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
155300319|NCT01787760|560529716|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
155300320|NCT01787760|560529717|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
155300321|NCT01787760|560529715|FG000|Overall Study|Decompensated on left exotropia|0|||
155300322|NCT01787760|560529716|FG001|Overall Study|Decompensated on left exotropia|0|||
155300323|NCT01787760|560529717|FG002|Overall Study|Decompensated on left exotropia|1|||
155300324|NCT01787760|560529715|FG000|Overall Study|Dryness|0|||
155300325|NCT01787760|560529716|FG001|Overall Study|Dryness|1|||
155300326|NCT01787760|560529717|FG002|Overall Study|Dryness|0|||
155300327|NCT01787760|560529715|FG000|Overall Study|Relocation|1|||
155300328|NCT01787760|560529716|FG001|Overall Study|Relocation|1|||
155300329|NCT01787760|560529717|FG002|Overall Study|Relocation|0|||
155300330|NCT01787760|560529715|FG000|Overall Study|Lens discomfort|3|||
155300331|NCT01787760|560529716|FG001|Overall Study|Lens discomfort|0|||
155300332|NCT01787760|560529717|FG002|Overall Study|Lens discomfort|0|||
155300333|NCT01787760|560529715|FG000|Overall Study|Lens handling difficulty|1|||
155300334|NCT01787760|560529716|FG001|Overall Study|Lens handling difficulty|2|||
155300335|NCT01787760|560529717|FG002|Overall Study|Lens handling difficulty|0|||
155300336|NCT01787760|560529715|FG000|Overall Study|Protocol Violation|6|||
155300337|NCT01787760|560529716|FG001|Overall Study|Protocol Violation|0|||
155300338|NCT01787760|560529717|FG002|Overall Study|Protocol Violation|1|||
155300339|NCT01787760|560529715|FG000|Overall Study|Withdrawal by Subject|5|||
155300340|NCT01787760|560529716|FG001|Overall Study|Withdrawal by Subject|1|||
155300341|NCT01787760|560529717|FG002|Overall Study|Withdrawal by Subject|2|||
155300342|NCT01787760|560529715|FG000|Overall Study|Lost to Follow-up|1|||
155300343|NCT01787760|560529716|FG001|Overall Study|Lost to Follow-up|0|||
155300344|NCT01787760|560529717|FG002|Overall Study|Lost to Follow-up|1|||
155300345|NCT01787760|560529715|FG000|Overall Study|Stroke|1|||
155300346|NCT01787760|560529716|FG001|Overall Study|Stroke|0|||
155300347|NCT01787760|560529717|FG002|Overall Study|Stroke|0|||
155300348|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
155300349|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
155300350|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
155300351|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory physiological response|2|||
155300352|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory physiological response|4|||
155300353|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory physiological response|0|||
155300354|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory visual response|1|||
155746876|NCT01451437|562172829|FG004|Overall Study|Adverse Event|0|||
155746877|NCT01451437|562172830|FG005|Overall Study|Adverse Event|1|||
155300355|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory visual response|1|||
155746878|NCT01451437|562172831|FG006|Overall Study|Adverse Event|1|||
155300356|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory visual response|0|||
155300357|NCT01787760|560529715|FG000|Overall Study|Near vision blur|1|||
155300358|NCT01787760|560529716|FG001|Overall Study|Near vision blur|0|||
155300359|NCT01787760|560529717|FG002|Overall Study|Near vision blur|0|||
155300360|NCT01597258|560529718|FG000|Overall Study|No Drug Administration|1|||
155300361|NCT01212991|560529719|FG000|Double-blind|Lost to Follow-up|8|||
155300362|NCT01212991|560529720|FG001|Double-blind|Lost to Follow-up|4|||
155300363|NCT01212991|560529721|FG002|Double-blind|Lost to Follow-up|0|||
155300364|NCT01212991|560529719|FG000|Double-blind|Death|699|||
155300365|NCT01212991|560529720|FG001|Double-blind|Death|550|||
155300366|NCT01212991|560529721|FG002|Double-blind|Death|0|||
155300367|NCT01212991|560529719|FG000|Double-blind|Withdrawal by Subject|16|||
155300368|NCT01212991|560529720|FG001|Double-blind|Withdrawal by Subject|19|||
155300369|NCT01212991|560529721|FG002|Double-blind|Withdrawal by Subject|0|||
155300370|NCT01212991|560529719|FG000|Double-blind|Other|7|||
155300371|NCT01212991|560529720|FG001|Double-blind|Other|0|||
155300372|NCT01212991|560529721|FG002|Double-blind|Other|0|||
155300373|NCT01212991|560529719|FG000|Double-blind|Sponsor decision|142|||
155300374|NCT01212991|560529720|FG001|Double-blind|Sponsor decision|38|||
155300375|NCT01212991|560529721|FG002|Double-blind|Sponsor decision|0|||
155300376|NCT01212991|560529719|FG000|Open-label|Death|0|||
155300377|NCT01212991|560529720|FG001|Open-label|Death|0|||
155300378|NCT01212991|560529721|FG002|Open-label|Death|166|||
155300379|NCT01212991|560529719|FG000|Open-label|Lost to Follow-up|0|||
155300380|NCT01212991|560529720|FG001|Open-label|Lost to Follow-up|0|||
155300381|NCT01212991|560529721|FG002|Open-label|Lost to Follow-up|5|||
155300382|NCT01212991|560529719|FG000|Open-label|Withdrawal by Subject|0|||
155300383|NCT01212991|560529720|FG001|Open-label|Withdrawal by Subject|0|||
155300384|NCT01212991|560529721|FG002|Open-label|Withdrawal by Subject|7|||
155300385|NCT01212991|560529719|FG000|Open-label|Sponsor decision|0|||
155300386|NCT01212991|560529720|FG001|Open-label|Sponsor decision|0|||
155300387|NCT01212991|560529721|FG002|Open-label|Sponsor decision|53|||
155300388|NCT01212991|560529719|FG000|Open-label|Other|0|||
155300389|NCT01212991|560529720|FG001|Open-label|Other|0|||
155300390|NCT01212991|560529721|FG002|Open-label|Other|3|||
155300391|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
155300392|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
155300393|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
155300394|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
155300395|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
155300396|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
155300397|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
155300398|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
155300399|NCT04411056|560530866|FG000|Overall Study|surgery cancelled|1|||
155300400|NCT04411056|560530867|FG001|Overall Study|surgery cancelled|0|||
155300401|NCT04411056|560530866|FG000|Overall Study|Equipment problem during intubation|0|||
155300402|NCT04411056|560530867|FG001|Overall Study|Equipment problem during intubation|1|||
155300403|NCT04623008|560530868|FG000|Baseline to T2|Withdrawal by Subject|4|||
155300404|NCT04623008|560530869|FG001|Baseline to T2|Withdrawal by Subject|2|||
155300405|NCT04623008|560530868|FG000|Baseline to T3|Withdrawal by Subject|4|||
155300406|NCT04623008|560530869|FG001|Baseline to T3|Withdrawal by Subject|2|||
155300407|NCT03122886|560530878|FG000|Overall Study|Withdrawal by Subject|1|||
155300408|NCT03122886|560530879|FG001|Overall Study|Withdrawal by Subject|2|||
155300409|NCT02279095|560530885|FG000|Overall Study|Non-Compliance|1|||
155300410|NCT02279095|560530885|FG000|Overall Study|Withdrawal by Subject|8|||
155746879|NCT01451437|562172832|FG007|Overall Study|Adverse Event|2|||
155746880|NCT01451437|562172833|FG008|Overall Study|Adverse Event|1|||
155746881|NCT01451437|562172825|FG000|Overall Study|Physician Decision|1|||
155746882|NCT01451437|562172826|FG001|Overall Study|Physician Decision|1|||
155746883|NCT01451437|562172827|FG002|Overall Study|Physician Decision|2|||
155746884|NCT01451437|562172828|FG003|Overall Study|Physician Decision|0|||
155746885|NCT01451437|562172829|FG004|Overall Study|Physician Decision|0|||
155746886|NCT01451437|562172830|FG005|Overall Study|Physician Decision|0|||
155746887|NCT01451437|562172831|FG006|Overall Study|Physician Decision|0|||
155746888|NCT01451437|562172832|FG007|Overall Study|Physician Decision|0|||
155300411|NCT02279095|560530885|FG000|Overall Study|Adverse Event|2|||
155300412|NCT02279095|560530885|FG000|Overall Study|Other|7|||
155300413|NCT02279095|560530885|FG000|Overall Study|Lost to Follow-up|1|||
155300414|NCT05938413|560530886|FG000|Overall Study|Lost to Follow-up|1|||
155300415|NCT05938413|560530887|FG001|Overall Study|Lost to Follow-up|7|||
155300416|NCT05938413|560530886|FG000|Overall Study|Withdrawal by Subject|1|||
155300417|NCT05938413|560530887|FG001|Overall Study|Withdrawal by Subject|1|||
155300418|NCT03481777|560530888|FG000|Overall Study|Withdrawal by Subject|36|||
155300419|NCT03481777|560530889|FG001|Overall Study|Withdrawal by Subject|31|||
155300420|NCT03481777|560530888|FG000|Overall Study|Non stroke = non target population|277|||
155300421|NCT03481777|560530889|FG001|Overall Study|Non stroke = non target population|254|||
155746889|NCT01451437|562172833|FG008|Overall Study|Physician Decision|0|||
155746890|NCT01451437|562172825|FG000|Overall Study|Disease Progression|0|||
155746891|NCT01451437|562172826|FG001|Overall Study|Disease Progression|0|||
155300422|NCT03613740|560530900|FG000|Overall Study|Lost to Follow-up|1|||
155300423|NCT03613740|560530901|FG001|Overall Study|Lost to Follow-up|1|||
155300424|NCT03452189|560530902|FG000|First Intervention (3 Months)|Adverse Event|1|||
155300425|NCT03452189|560530903|FG001|First Intervention (3 Months)|Adverse Event|0|||
155300426|NCT03452189|560530902|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
155300427|NCT03452189|560530903|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
155300428|NCT02724592|560530904|FG000|Overall Study|Lost to Follow-up|4|||
155300429|NCT02724592|560530905|FG001|Overall Study|Lost to Follow-up|1|||
155300430|NCT02374463|560530908|FG000|Overall Study|Withdrawal by Subject|3|||
155300431|NCT02374463|560530909|FG001|Overall Study|Withdrawal by Subject|3|||
155300432|NCT01424397|560530910|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300433|NCT01424397|560530911|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300434|NCT01424397|560530912|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
155300435|NCT01424397|560530913|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300436|NCT01424397|560530914|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300437|NCT01424397|560530915|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300438|NCT01424397|560530916|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300439|NCT01424397|560530917|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300440|NCT01424397|560530918|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300441|NCT01424397|560530919|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300442|NCT01424397|560530920|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300443|NCT01424397|560530921|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300444|NCT01951170|560530922|FG000|Overall Study|Investigator decision|1|||
155300445|NCT00077675|560530927|FG000|Overall Study|Adverse Event|1|||
155300446|NCT00077675|560530928|FG001|Overall Study|Adverse Event|2|||
155300447|NCT00077675|560530927|FG000|Overall Study|Lost to Follow-up|6|||
155300448|NCT00077675|560530928|FG001|Overall Study|Lost to Follow-up|3|||
155300449|NCT00077675|560530927|FG000|Overall Study|Withdrawal by Subject|1|||
155300450|NCT00077675|560530928|FG001|Overall Study|Withdrawal by Subject|0|||
155300451|NCT00077675|560530927|FG000|Overall Study|Other|0|||
155300452|NCT00077675|560530928|FG001|Overall Study|Other|1|||
155300453|NCT00077675|560530927|FG000|Overall Study|Never received study treatment|3|||
155300454|NCT00077675|560530928|FG001|Overall Study|Never received study treatment|3|||
155300455|NCT02601820|560530930|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
155300456|NCT02601820|560530930|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
155300457|NCT02601820|560530930|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
155300458|NCT02601820|560530930|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
155300459|NCT01972724|560530931|FG000|Double-Blind|Rescue Criteria Met|1|||
155300460|NCT01972724|560530932|FG001|Double-Blind|Rescue Criteria Met|0|||
155300461|NCT01972724|560530933|FG002|Double-Blind|Rescue Criteria Met|0|||
155300462|NCT01972724|560530931|FG000|Double-Blind|Adverse Event|1|||
155300463|NCT01972724|560530932|FG001|Double-Blind|Adverse Event|0|||
155300464|NCT01972724|560530933|FG002|Double-Blind|Adverse Event|0|||
155300465|NCT01972724|560530931|FG000|Double-Blind|Withdrawal of Consent|2|||
155300466|NCT01972724|560530932|FG001|Double-Blind|Withdrawal of Consent|1|||
155300467|NCT01972724|560530933|FG002|Double-Blind|Withdrawal of Consent|0|||
155300468|NCT01972724|560530931|FG000|Double-Blind|Significant Protocol Deviation|5|||
155300469|NCT01972724|560530932|FG001|Double-Blind|Significant Protocol Deviation|8|||
155300470|NCT01972724|560530933|FG002|Double-Blind|Significant Protocol Deviation|0|||
155300471|NCT01972724|560530931|FG000|Open-Label|Withdrew Consent|0|||
155300472|NCT01972724|560530932|FG001|Open-Label|Withdrew Consent|0|||
155300473|NCT01972724|560530933|FG002|Open-Label|Withdrew Consent|3|||
155300474|NCT01972724|560530931|FG000|Open-Label|Significant Protocol Deviation|0|||
155300475|NCT01972724|560530932|FG001|Open-Label|Significant Protocol Deviation|0|||
155300476|NCT01972724|560530933|FG002|Open-Label|Significant Protocol Deviation|2|||
155300477|NCT02652442|560530938|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
155300478|NCT00244855|560530939|FG000|Overall Study|Withdrawal by Subject|0|||
155300479|NCT00244855|560530940|FG001|Overall Study|Withdrawal by Subject|1|||
155300480|NCT00364013|560530943|FG000|Overall Study|Ineligibility determined|4|||
155300481|NCT00364013|560530944|FG001|Overall Study|Ineligibility determined|2|||
155300482|NCT00364013|560530943|FG000|Overall Study|Adverse Event|4|||
155300483|NCT00364013|560530944|FG001|Overall Study|Adverse Event|3|||
155300484|NCT00364013|560530943|FG000|Overall Study|Withdrawal by Subject|13|||
155300485|NCT00364013|560530944|FG001|Overall Study|Withdrawal by Subject|18|||
155300486|NCT00364013|560530943|FG000|Overall Study|Physician Decision|3|||
155300487|NCT00364013|560530944|FG001|Overall Study|Physician Decision|3|||
155300488|NCT00364013|560530943|FG000|Overall Study|Lost to Follow-up|10|||
155300489|NCT00364013|560530944|FG001|Overall Study|Lost to Follow-up|3|||
155300490|NCT00364013|560530943|FG000|Overall Study|Protocol-specified criteria|6|||
155300491|NCT00364013|560530944|FG001|Overall Study|Protocol-specified criteria|6|||
155300492|NCT00364013|560530943|FG000|Overall Study|Other|41|||
155300493|NCT00364013|560530944|FG001|Overall Study|Other|47|||
155300494|NCT00364013|560530943|FG000|Overall Study|Ongoing|20|||
155300495|NCT00364013|560530944|FG001|Overall Study|Ongoing|13|||
155300496|NCT04530747|560530948|FG000|Overall Study|Withdrawal by Subject|1|||
155300497|NCT04530747|560530949|FG001|Overall Study|Withdrawal by Subject|0|||
155300498|NCT03292913|560530950|FG000|Overall Study|Death|9|||
155300499|NCT03292913|560530951|FG001|Overall Study|Death|3|||
155300500|NCT03292913|560530950|FG000|Overall Study|Lost to Follow-up|49|||
155300501|NCT03292913|560530951|FG001|Overall Study|Lost to Follow-up|49|||
155300502|NCT03292913|560530950|FG000|Overall Study|Withdrawal by Subject|2|||
155300503|NCT03292913|560530951|FG001|Overall Study|Withdrawal by Subject|0|||
155300504|NCT03292913|560530950|FG000|Overall Study|Clinic closed due to COVID|22|||
155300505|NCT03292913|560530951|FG001|Overall Study|Clinic closed due to COVID|36|||
155300506|NCT03950622|560530952|FG000|Overall Study|Withdrawal by Subject|1|||
155300507|NCT03950622|560530953|FG001|Overall Study|Withdrawal by Subject|0|||
155300508|NCT03950622|560530952|FG000|Overall Study|Protocol Deviation|0|||
155300509|NCT03950622|560530953|FG001|Overall Study|Protocol Deviation|1|||
155300510|NCT03950622|560530952|FG000|Overall Study|Physician Decision|1|||
155300511|NCT03950622|560530953|FG001|Overall Study|Physician Decision|0|||
155300512|NCT03950622|560530952|FG000|Overall Study|Lost to Follow-up|5|||
155300513|NCT03950622|560530953|FG001|Overall Study|Lost to Follow-up|5|||
155300514|NCT03950622|560530952|FG000|Overall Study|Death|1|||
155300515|NCT03950622|560530953|FG001|Overall Study|Death|1|||
155300516|NCT04056624|560530954|FG000|Overall Study|Withdrawal by Subject|0|||
155300517|NCT04056624|560530955|FG001|Overall Study|Withdrawal by Subject|0|||
155300518|NCT04056624|560530956|FG002|Overall Study|Withdrawal by Subject|1|||
155300519|NCT04056624|560530954|FG000|Overall Study|Protocol Violation|1|||
155300520|NCT04056624|560530955|FG001|Overall Study|Protocol Violation|2|||
155300521|NCT04056624|560530956|FG002|Overall Study|Protocol Violation|0|||
155300522|NCT02267824|560530959|FG000|Overall Study|Pregnancy|1|||
155300523|NCT02267824|560530960|FG001|Overall Study|Pregnancy|1|||
155300524|NCT02267824|560530959|FG000|Overall Study|Lost to Follow-up|4|||
155300525|NCT02267824|560530960|FG001|Overall Study|Lost to Follow-up|0|||
155300526|NCT02267824|560530959|FG000|Overall Study|Protocol Violation|3|||
155300527|NCT02267824|560530960|FG001|Overall Study|Protocol Violation|0|||
155300528|NCT02267824|560530959|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
155300529|NCT02267824|560530960|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
155300530|NCT01832480|560530969|FG000|Overall Study|Lost to Follow-up|33|||
155300531|NCT01832480|560530970|FG001|Overall Study|Lost to Follow-up|30|||
155300532|NCT01832480|560530969|FG000|Overall Study|Withdrawal by Subject|0|||
155300533|NCT01832480|560530970|FG001|Overall Study|Withdrawal by Subject|2|||
155300534|NCT01832480|560530969|FG000|Overall Study|post randomization ineligible|8|||
155300535|NCT01832480|560530970|FG001|Overall Study|post randomization ineligible|10|||
155300536|NCT02261467|560530971|FG000|Overall Study|Enrolled in Error|1|||
155300537|NCT02261467|560530972|FG001|Overall Study|Enrolled in Error|0|||
155300538|NCT02261467|560530971|FG000|Overall Study|Protocol Violation|0|||
155300539|NCT02261467|560530972|FG001|Overall Study|Protocol Violation|1|||
155300540|NCT02261467|560530971|FG000|Overall Study|Personal Reasons|17|||
155300541|NCT02261467|560530972|FG001|Overall Study|Personal Reasons|22|||
155300542|NCT02261467|560530971|FG000|Overall Study|Lost to Follow-up|2|||
155300543|NCT02261467|560530972|FG001|Overall Study|Lost to Follow-up|13|||
155300544|NCT02261467|560530971|FG000|Overall Study|Adverse Event|1|||
155300545|NCT02261467|560530972|FG001|Overall Study|Adverse Event|1|||
155746892|NCT01451437|562172827|FG002|Overall Study|Disease Progression|1|||
155746893|NCT01451437|562172828|FG003|Overall Study|Disease Progression|1|||
155300546|NCT00736853|560530973|FG000|Open-Label Period|Physician Decision|2|||
155300547|NCT00736853|560530974|FG001|Open-Label Period|Physician Decision|0|||
155300548|NCT00736853|560530975|FG002|Open-Label Period|Physician Decision|0|||
155300549|NCT00736853|560530973|FG000|Open-Label Period|Adverse Event|31|||
155300550|NCT00736853|560530974|FG001|Open-Label Period|Adverse Event|0|||
155300551|NCT00736853|560530975|FG002|Open-Label Period|Adverse Event|0|||
155300552|NCT00736853|560530973|FG000|Open-Label Period|Withdrawal by Subject|16|||
155300553|NCT00736853|560530974|FG001|Open-Label Period|Withdrawal by Subject|0|||
155746894|NCT01451437|562172829|FG004|Overall Study|Disease Progression|3|||
155746895|NCT01451437|562172830|FG005|Overall Study|Disease Progression|2|||
155746896|NCT01451437|562172831|FG006|Overall Study|Disease Progression|3|||
155746897|NCT01451437|562172832|FG007|Overall Study|Disease Progression|1|||
155746898|NCT01451437|562172833|FG008|Overall Study|Disease Progression|3|||
155746899|NCT01451437|562172825|FG000|Overall Study|Protocol Violation|0|||
155746900|NCT01451437|562172826|FG001|Overall Study|Protocol Violation|0|||
155746901|NCT01451437|562172827|FG002|Overall Study|Protocol Violation|0|||
155300554|NCT00736853|560530975|FG002|Open-Label Period|Withdrawal by Subject|0|||
155300555|NCT00736853|560530973|FG000|Open-Label Period|Started but not treated|42|||
155300556|NCT00736853|560530974|FG001|Open-Label Period|Started but not treated|0|||
155300557|NCT00736853|560530975|FG002|Open-Label Period|Started but not treated|0|||
155300558|NCT00736853|560530973|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
155300559|NCT00736853|560530974|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
155300560|NCT00736853|560530975|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
155300561|NCT00736853|560530973|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
155300562|NCT00736853|560530974|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
155300563|NCT00736853|560530975|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
155300564|NCT00736853|560530973|FG000|Double-Blind Period|Lack of Efficacy|0|||
155300565|NCT00736853|560530974|FG001|Double-Blind Period|Lack of Efficacy|19|||
155300566|NCT00736853|560530975|FG002|Double-Blind Period|Lack of Efficacy|42|||
155300567|NCT00736853|560530973|FG000|Double-Blind Period|Adverse Event|0|||
155300568|NCT00736853|560530974|FG001|Double-Blind Period|Adverse Event|3|||
155300569|NCT00736853|560530975|FG002|Double-Blind Period|Adverse Event|2|||
155300570|NCT00736853|560530973|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155300571|NCT00736853|560530974|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155300572|NCT00736853|560530975|FG002|Double-Blind Period|Withdrawal by Subject|4|||
155300573|NCT00736853|560530973|FG000|Double-Blind Period|Ineligible to participate the study|0|||
155300574|NCT00736853|560530974|FG001|Double-Blind Period|Ineligible to participate the study|1|||
155300575|NCT00736853|560530975|FG002|Double-Blind Period|Ineligible to participate the study|0|||
155746902|NCT01451437|562172828|FG003|Overall Study|Protocol Violation|0|||
155746903|NCT01451437|562172829|FG004|Overall Study|Protocol Violation|0|||
155746904|NCT01451437|562172830|FG005|Overall Study|Protocol Violation|0|||
155746905|NCT01451437|562172831|FG006|Overall Study|Protocol Violation|1|||
155746906|NCT01451437|562172832|FG007|Overall Study|Protocol Violation|0|||
155746907|NCT01451437|562172833|FG008|Overall Study|Protocol Violation|0|||
155746908|NCT01451437|562172825|FG000|Overall Study|Withdrawal by Subject|0|||
155746909|NCT01451437|562172826|FG001|Overall Study|Withdrawal by Subject|0|||
155746910|NCT01451437|562172827|FG002|Overall Study|Withdrawal by Subject|0|||
155746911|NCT01451437|562172828|FG003|Overall Study|Withdrawal by Subject|0|||
155746912|NCT01451437|562172829|FG004|Overall Study|Withdrawal by Subject|1|||
155746913|NCT01451437|562172830|FG005|Overall Study|Withdrawal by Subject|0|||
155746914|NCT01451437|562172831|FG006|Overall Study|Withdrawal by Subject|1|||
155746915|NCT01451437|562172832|FG007|Overall Study|Withdrawal by Subject|0|||
155746916|NCT01451437|562172833|FG008|Overall Study|Withdrawal by Subject|0|||
155746917|NCT00853970|562172841|FG000|Overall Study|Withdrawal by Subject|2|||
155746918|NCT00853970|562172842|FG001|Overall Study|Withdrawal by Subject|1|||
155746919|NCT00853970|562172841|FG000|Overall Study|Cancelled surgery|4|||
155746920|NCT00853970|562172842|FG001|Overall Study|Cancelled surgery|2|||
155746921|NCT05347147|562174740|FG000|Overall Study|Lost to Follow-up|0|||
155746922|NCT05347147|562174741|FG001|Overall Study|Lost to Follow-up|1|||
155746923|NCT05347147|562174740|FG000|Overall Study|Sponsor request|3|||
155746924|NCT05347147|562174741|FG001|Overall Study|Sponsor request|3|||
155746925|NCT05347147|562174740|FG000|Overall Study|Study termination|2|||
155746926|NCT05347147|562174741|FG001|Overall Study|Study termination|1|||
155746927|NCT00923364|562174750|FG000|Overall Study|Death|3|||
155746928|NCT00923364|562174751|FG001|Overall Study|Death|0|||
155746929|NCT00923364|562174750|FG000|Overall Study|Did not go to transplant|1|||
155746930|NCT00923364|562174751|FG001|Overall Study|Did not go to transplant|0|||
155746931|NCT04352127|562174752|FG000|Overall Study|Unable to obtain readings|4|||
155746932|NCT04352127|562174753|FG001|Overall Study|Unable to obtain readings|1|||
155746933|NCT03023046|562174754|FG000|Overall Study|Withdrawal by Subject|1|||
155746934|NCT00640835|562174755|FG000|Overall Study|Adverse Event|5|||
155746935|NCT00640835|562174756|FG001|Overall Study|Adverse Event|3|||
155746936|NCT00640835|562174755|FG000|Overall Study|Withdrawal by Subject|12|||
155746937|NCT00640835|562174756|FG001|Overall Study|Withdrawal by Subject|14|||
155300576|NCT01764464|560530976|FG000|First Intervention|Withdrawal by Subject|1|||
155300577|NCT01764464|560530977|FG001|First Intervention|Withdrawal by Subject|0|||
155300578|NCT01764464|560530976|FG000|First Intervention|Lost to Follow-up|1|||
155300579|NCT01764464|560530977|FG001|First Intervention|Lost to Follow-up|0|||
155300580|NCT01764464|560530976|FG000|First Intervention|Adverse Event|0|||
155746938|NCT00640835|562174755|FG000|Overall Study|Physician Decision|10|||
155746939|NCT00640835|562174756|FG001|Overall Study|Physician Decision|14|||
155746940|NCT00640835|562174755|FG000|Overall Study|Sponsor's Decision|11|||
155746941|NCT00640835|562174756|FG001|Overall Study|Sponsor's Decision|7|||
155746942|NCT00640835|562174755|FG000|Overall Study|Protocol Violation|2|||
155746943|NCT00640835|562174756|FG001|Overall Study|Protocol Violation|2|||
155746944|NCT00640835|562174755|FG000|Overall Study|Lost to Follow-up|17|||
155300581|NCT01764464|560530977|FG001|First Intervention|Adverse Event|2|||
155300582|NCT01764464|560530976|FG000|First Intervention|did not receive study drug|0|||
155300583|NCT01764464|560530977|FG001|First Intervention|did not receive study drug|1|||
155300584|NCT01764464|560530976|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
155300585|NCT01764464|560530977|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
155300586|NCT02918071|560530980|FG000|Overall Study|Withdrawal by Subject|2|||
155300587|NCT02918071|560530980|FG000|Overall Study|Lost to Follow-up|1|||
155300588|NCT03473340|560530981|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
155300589|NCT03473340|560530982|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
155300590|NCT03473340|560530981|FG000|Overall Study|Withdrawal by Subject|1|||
155300591|NCT03473340|560530982|FG001|Overall Study|Withdrawal by Subject|0|||
155300592|NCT03473340|560530981|FG000|Overall Study|Lost to Follow-up|1|||
155300593|NCT03473340|560530982|FG001|Overall Study|Lost to Follow-up|2|||
155300594|NCT02079844|560530983|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
155300595|NCT02079844|560530984|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
155300596|NCT02079844|560530985|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
155300597|NCT02079844|560530983|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
155300598|NCT02079844|560530984|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
155300599|NCT02079844|560530985|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
155300600|NCT03394885|560530987|FG000|Overall Study|Adverse Event|4|||
155300601|NCT03394885|560530987|FG000|Overall Study|Lack of Efficacy|1|||
155300602|NCT03394885|560530987|FG000|Overall Study|Physician Decision|1|||
155300603|NCT03394885|560530987|FG000|Overall Study|Withdrawal by Subject|8|||
155300604|NCT03394885|560530987|FG000|Overall Study|Alternative Therapy|1|||
155300605|NCT00203411|560530988|FG000|Follow-up|Progressive Disease|4|||
155300606|NCT04980755|560530989|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
155300607|NCT04980755|560530989|FG000|Body Reprogramming Courses|Work commitment|2|||
155300608|NCT04980755|560530989|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
155300609|NCT04980755|560530989|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
155300610|NCT00632424|560530996|FG000|Overall Study|Disease Progression|17|||
155300611|NCT00632424|560530996|FG000|Overall Study|Study Drug Toxicity|1|||
155300612|NCT00801983|560530997|FG000|Period 1|Lost to Follow-up|2|||
155300613|NCT00801983|560530998|FG001|Period 1|Lost to Follow-up|0|||
155300614|NCT00801983|560530997|FG000|Period 1|Withdrawal by Subject|2|||
155300615|NCT00801983|560530998|FG001|Period 1|Withdrawal by Subject|8|||
155300616|NCT00801983|560530997|FG000|Period 2|Withdrawal by Subject|2|||
155300617|NCT00801983|560530998|FG001|Period 2|Withdrawal by Subject|1|||
155300618|NCT05985044|560533600|FG000|Overall Study|Death|6|||
155641045|NCT00420407|561776749|FG000|Overall Study|subject identified as Jehovah's witness|1|||
155641046|NCT00420407|561776750|FG001|Overall Study|subject identified as Jehovah's witness|0|||
155641047|NCT00420407|561776749|FG000|Overall Study|Withdrawal by Subject|0|||
155300619|NCT05985044|560533600|FG000|Overall Study|Lost to Follow-up|4|||
155300620|NCT05985044|560533600|FG000|Overall Study|Incapacitation|3|||
155300621|NCT05985044|560533600|FG000|Overall Study|Withdrawal by Subject|2|||
155300622|NCT04714320|560533609|FG000|Overall Study|Voluntary Withdrawal|4|||
155300623|NCT04714320|560533610|FG001|Overall Study|Voluntary Withdrawal|1|||
155300624|NCT04714320|560533611|FG002|Overall Study|Voluntary Withdrawal|2|||
155746945|NCT00640835|562174756|FG001|Overall Study|Lost to Follow-up|13|||
155746946|NCT00640835|562174755|FG000|Overall Study|Other Reason|19|||
155746947|NCT00640835|562174756|FG001|Overall Study|Other Reason|4|||
155746948|NCT00775203|562174757|FG000|Overall Study|Adverse Event|25|||
155746949|NCT00775203|562174758|FG001|Overall Study|Adverse Event|6|||
155746950|NCT00775203|562174757|FG000|Overall Study|Lack of Efficacy|8|||
155746951|NCT00775203|562174758|FG001|Overall Study|Lack of Efficacy|9|||
155746952|NCT00775203|562174757|FG000|Overall Study|Withdrawal by Subject|11|||
155746953|NCT00775203|562174758|FG001|Overall Study|Withdrawal by Subject|9|||
155746954|NCT00775203|562174757|FG000|Overall Study|Lost to Follow-up|11|||
155746955|NCT00775203|562174758|FG001|Overall Study|Lost to Follow-up|15|||
155746956|NCT00775203|562174757|FG000|Overall Study|Administrative reason|2|||
155746957|NCT00775203|562174758|FG001|Overall Study|Administrative reason|0|||
155746958|NCT00775203|562174757|FG000|Overall Study|Noncompliance|4|||
155746959|NCT00775203|562174758|FG001|Overall Study|Noncompliance|2|||
155746960|NCT00775203|562174757|FG000|Overall Study|Protocol Violation|0|||
155746961|NCT00775203|562174758|FG001|Overall Study|Protocol Violation|1|||
155746962|NCT00775203|562174757|FG000|Overall Study|Entered other study|1|||
155746963|NCT00775203|562174758|FG001|Overall Study|Entered other study|0|||
155746964|NCT00775203|562174757|FG000|Overall Study|Physician Decision|0|||
155746965|NCT00775203|562174758|FG001|Overall Study|Physician Decision|1|||
155746966|NCT00635024|562174761|FG000|Overall Study|Adverse Event|1|||
155746967|NCT00713310|562174762|FG000|Overall Study|Adverse Event|5|||
155746968|NCT00713310|562174763|FG001|Overall Study|Adverse Event|2|||
155746969|NCT00713310|562174762|FG000|Overall Study|Lack of Efficacy|0|||
155300625|NCT04714320|560533609|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155300626|NCT04714320|560533610|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155300627|NCT04714320|560533611|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
155300628|NCT04714320|560533609|FG000|Overall Study|Reason Not Specified|1|||
155300629|NCT04714320|560533610|FG001|Overall Study|Reason Not Specified|3|||
155300630|NCT04714320|560533611|FG002|Overall Study|Reason Not Specified|3|||
155300631|NCT04425629|560533613|FG000|Overall Study|Adverse Event|0|||
155300632|NCT04425629|560533614|FG001|Overall Study|Adverse Event|0|||
155300633|NCT04425629|560533615|FG002|Overall Study|Adverse Event|0|||
155300634|NCT04425629|560533616|FG003|Overall Study|Adverse Event|0|||
155300635|NCT04425629|560533617|FG004|Overall Study|Adverse Event|1|||
155300636|NCT04425629|560533618|FG005|Overall Study|Adverse Event|0|||
155300637|NCT04425629|560533619|FG006|Overall Study|Adverse Event|0|||
155300638|NCT04425629|560533620|FG007|Overall Study|Adverse Event|0|||
155300639|NCT04425629|560533621|FG008|Overall Study|Adverse Event|0|||
155300640|NCT04425629|560533622|FG009|Overall Study|Adverse Event|3|||
155300641|NCT04425629|560533623|FG010|Overall Study|Adverse Event|2|||
155300642|NCT04425629|560533624|FG011|Overall Study|Adverse Event|1|||
155300643|NCT04425629|560533625|FG012|Overall Study|Adverse Event|1|||
155300644|NCT04425629|560533626|FG013|Overall Study|Adverse Event|0|||
155300645|NCT04425629|560533627|FG014|Overall Study|Adverse Event|0|||
155300646|NCT04425629|560533628|FG015|Overall Study|Adverse Event|0|||
155300647|NCT04425629|560533629|FG016|Overall Study|Adverse Event|0|||
155300648|NCT04425629|560533630|FG017|Overall Study|Adverse Event|0|||
155300649|NCT04425629|560533631|FG018|Overall Study|Adverse Event|0|||
155300650|NCT04425629|560533613|FG000|Overall Study|Lost to Follow-up|1|||
155300651|NCT04425629|560533614|FG001|Overall Study|Lost to Follow-up|3|||
155300652|NCT04425629|560533615|FG002|Overall Study|Lost to Follow-up|1|||
155300653|NCT04425629|560533616|FG003|Overall Study|Lost to Follow-up|7|||
155300654|NCT04425629|560533617|FG004|Overall Study|Lost to Follow-up|1|||
155300655|NCT04425629|560533618|FG005|Overall Study|Lost to Follow-up|2|||
155300656|NCT04425629|560533619|FG006|Overall Study|Lost to Follow-up|1|||
155300657|NCT04425629|560533620|FG007|Overall Study|Lost to Follow-up|0|||
155300658|NCT04425629|560533621|FG008|Overall Study|Lost to Follow-up|1|||
155300659|NCT04425629|560533622|FG009|Overall Study|Lost to Follow-up|64|||
155300660|NCT04425629|560533623|FG010|Overall Study|Lost to Follow-up|70|||
155300661|NCT04425629|560533624|FG011|Overall Study|Lost to Follow-up|98|||
155300662|NCT04425629|560533625|FG012|Overall Study|Lost to Follow-up|30|||
155300663|NCT04425629|560533626|FG013|Overall Study|Lost to Follow-up|0|||
155300664|NCT04425629|560533627|FG014|Overall Study|Lost to Follow-up|5|||
155300665|NCT04425629|560533628|FG015|Overall Study|Lost to Follow-up|4|||
155300666|NCT04425629|560533629|FG016|Overall Study|Lost to Follow-up|0|||
155300667|NCT04425629|560533630|FG017|Overall Study|Lost to Follow-up|3|||
155300668|NCT04425629|560533631|FG018|Overall Study|Lost to Follow-up|1|||
155300669|NCT04425629|560533613|FG000|Overall Study|Subject Decision|0|||
155300670|NCT04425629|560533614|FG001|Overall Study|Subject Decision|2|||
155300671|NCT04425629|560533615|FG002|Overall Study|Subject Decision|1|||
155300672|NCT04425629|560533616|FG003|Overall Study|Subject Decision|3|||
155300673|NCT04425629|560533617|FG004|Overall Study|Subject Decision|6|||
155300674|NCT04425629|560533618|FG005|Overall Study|Subject Decision|6|||
155300675|NCT04425629|560533619|FG006|Overall Study|Subject Decision|3|||
155300676|NCT04425629|560533620|FG007|Overall Study|Subject Decision|3|||
155300677|NCT04425629|560533621|FG008|Overall Study|Subject Decision|1|||
155300678|NCT04425629|560533622|FG009|Overall Study|Subject Decision|70|||
155300679|NCT04425629|560533623|FG010|Overall Study|Subject Decision|95|||
155300680|NCT04425629|560533624|FG011|Overall Study|Subject Decision|124|||
155300681|NCT04425629|560533625|FG012|Overall Study|Subject Decision|25|||
155300682|NCT04425629|560533626|FG013|Overall Study|Subject Decision|0|||
155300683|NCT04425629|560533627|FG014|Overall Study|Subject Decision|1|||
155300684|NCT04425629|560533628|FG015|Overall Study|Subject Decision|4|||
155300685|NCT04425629|560533629|FG016|Overall Study|Subject Decision|1|||
155300686|NCT04425629|560533630|FG017|Overall Study|Subject Decision|0|||
155300687|NCT04425629|560533631|FG018|Overall Study|Subject Decision|2|||
155300688|NCT04425629|560533613|FG000|Overall Study|Death|0|||
155300689|NCT04425629|560533614|FG001|Overall Study|Death|0|||
155300690|NCT04425629|560533615|FG002|Overall Study|Death|0|||
155300691|NCT04425629|560533616|FG003|Overall Study|Death|0|||
155300692|NCT04425629|560533617|FG004|Overall Study|Death|0|||
155300693|NCT04425629|560533618|FG005|Overall Study|Death|0|||
155300694|NCT04425629|560533619|FG006|Overall Study|Death|0|||
155300695|NCT04425629|560533620|FG007|Overall Study|Death|0|||
155300696|NCT04425629|560533621|FG008|Overall Study|Death|0|||
155300697|NCT04425629|560533622|FG009|Overall Study|Death|11|||
155300698|NCT04425629|560533623|FG010|Overall Study|Death|2|||
155300699|NCT04425629|560533624|FG011|Overall Study|Death|4|||
155300700|NCT04425629|560533625|FG012|Overall Study|Death|0|||
155300701|NCT04425629|560533626|FG013|Overall Study|Death|0|||
155300702|NCT04425629|560533627|FG014|Overall Study|Death|0|||
155300703|NCT04425629|560533628|FG015|Overall Study|Death|0|||
155300704|NCT04425629|560533629|FG016|Overall Study|Death|0|||
155300705|NCT04425629|560533630|FG017|Overall Study|Death|0|||
155300706|NCT04425629|560533631|FG018|Overall Study|Death|0|||
155300707|NCT04425629|560533613|FG000|Overall Study|Sponsor Request|0|||
155300708|NCT04425629|560533614|FG001|Overall Study|Sponsor Request|0|||
155300709|NCT04425629|560533615|FG002|Overall Study|Sponsor Request|0|||
155300710|NCT04425629|560533616|FG003|Overall Study|Sponsor Request|2|||
155300711|NCT04425629|560533617|FG004|Overall Study|Sponsor Request|2|||
155300712|NCT04425629|560533618|FG005|Overall Study|Sponsor Request|2|||
155300713|NCT04425629|560533619|FG006|Overall Study|Sponsor Request|1|||
155300714|NCT04425629|560533620|FG007|Overall Study|Sponsor Request|0|||
155300715|NCT04425629|560533621|FG008|Overall Study|Sponsor Request|0|||
155300716|NCT04425629|560533622|FG009|Overall Study|Sponsor Request|9|||
155300717|NCT04425629|560533623|FG010|Overall Study|Sponsor Request|9|||
155300718|NCT04425629|560533624|FG011|Overall Study|Sponsor Request|10|||
155300719|NCT04425629|560533625|FG012|Overall Study|Sponsor Request|8|||
155300720|NCT04425629|560533626|FG013|Overall Study|Sponsor Request|0|||
155300721|NCT04425629|560533627|FG014|Overall Study|Sponsor Request|0|||
155300722|NCT04425629|560533628|FG015|Overall Study|Sponsor Request|1|||
155300723|NCT04425629|560533629|FG016|Overall Study|Sponsor Request|0|||
155300724|NCT04425629|560533630|FG017|Overall Study|Sponsor Request|0|||
155300725|NCT04425629|560533631|FG018|Overall Study|Sponsor Request|0|||
155300726|NCT04425629|560533613|FG000|Overall Study|Physician Decision|0|||
155300727|NCT04425629|560533614|FG001|Overall Study|Physician Decision|0|||
155300728|NCT04425629|560533615|FG002|Overall Study|Physician Decision|0|||
155300729|NCT04425629|560533616|FG003|Overall Study|Physician Decision|0|||
155300730|NCT04425629|560533617|FG004|Overall Study|Physician Decision|0|||
155300731|NCT04425629|560533618|FG005|Overall Study|Physician Decision|0|||
155300732|NCT04425629|560533619|FG006|Overall Study|Physician Decision|0|||
155300733|NCT04425629|560533620|FG007|Overall Study|Physician Decision|0|||
155300734|NCT04425629|560533621|FG008|Overall Study|Physician Decision|0|||
155300735|NCT04425629|560533622|FG009|Overall Study|Physician Decision|4|||
155300736|NCT04425629|560533623|FG010|Overall Study|Physician Decision|3|||
155300737|NCT04425629|560533624|FG011|Overall Study|Physician Decision|5|||
155300738|NCT04425629|560533625|FG012|Overall Study|Physician Decision|1|||
155300739|NCT04425629|560533626|FG013|Overall Study|Physician Decision|0|||
155300740|NCT04425629|560533627|FG014|Overall Study|Physician Decision|0|||
155300741|NCT04425629|560533628|FG015|Overall Study|Physician Decision|1|||
155300742|NCT04425629|560533629|FG016|Overall Study|Physician Decision|0|||
155300743|NCT04425629|560533630|FG017|Overall Study|Physician Decision|0|||
155300744|NCT04425629|560533631|FG018|Overall Study|Physician Decision|0|||
155300745|NCT04425629|560533613|FG000|Overall Study|Lack of Efficacy|0|||
155300746|NCT04425629|560533614|FG001|Overall Study|Lack of Efficacy|0|||
155300747|NCT04425629|560533615|FG002|Overall Study|Lack of Efficacy|0|||
155300748|NCT04425629|560533616|FG003|Overall Study|Lack of Efficacy|0|||
155300749|NCT04425629|560533617|FG004|Overall Study|Lack of Efficacy|0|||
155300750|NCT04425629|560533618|FG005|Overall Study|Lack of Efficacy|0|||
155300751|NCT04425629|560533619|FG006|Overall Study|Lack of Efficacy|0|||
155300752|NCT04425629|560533620|FG007|Overall Study|Lack of Efficacy|0|||
155300753|NCT04425629|560533621|FG008|Overall Study|Lack of Efficacy|0|||
155300754|NCT04425629|560533622|FG009|Overall Study|Lack of Efficacy|0|||
155300755|NCT04425629|560533623|FG010|Overall Study|Lack of Efficacy|1|||
155300756|NCT04425629|560533624|FG011|Overall Study|Lack of Efficacy|0|||
155300757|NCT04425629|560533625|FG012|Overall Study|Lack of Efficacy|0|||
155300758|NCT04425629|560533626|FG013|Overall Study|Lack of Efficacy|0|||
155300759|NCT04425629|560533627|FG014|Overall Study|Lack of Efficacy|0|||
155300760|NCT04425629|560533628|FG015|Overall Study|Lack of Efficacy|0|||
155300761|NCT04425629|560533629|FG016|Overall Study|Lack of Efficacy|0|||
155300762|NCT04425629|560533630|FG017|Overall Study|Lack of Efficacy|0|||
155300763|NCT04425629|560533631|FG018|Overall Study|Lack of Efficacy|0|||
155300764|NCT04259450|560533633|FG000|Overall Study|Adverse event/ Toxicity|0|||
155300765|NCT04259450|560533634|FG001|Overall Study|Adverse event/ Toxicity|3|||
155300766|NCT04259450|560533635|FG002|Overall Study|Adverse event/ Toxicity|0|||
155300767|NCT04259450|560533636|FG003|Overall Study|Adverse event/ Toxicity|1|||
155300768|NCT04259450|560533637|FG004|Overall Study|Adverse event/ Toxicity|0|||
155300769|NCT04259450|560533638|FG005|Overall Study|Adverse event/ Toxicity|0|||
155300770|NCT04259450|560533639|FG006|Overall Study|Adverse event/ Toxicity|0|||
155300771|NCT04259450|560533640|FG007|Overall Study|Adverse event/ Toxicity|1|||
155300772|NCT04259450|560533641|FG008|Overall Study|Adverse event/ Toxicity|0|||
155300773|NCT04259450|560533642|FG009|Overall Study|Adverse event/ Toxicity|3|||
155300774|NCT04259450|560533633|FG000|Overall Study|Disease progression|2|||
155300775|NCT04259450|560533634|FG001|Overall Study|Disease progression|3|||
155300776|NCT04259450|560533635|FG002|Overall Study|Disease progression|4|||
155300777|NCT04259450|560533636|FG003|Overall Study|Disease progression|4|||
155300778|NCT04259450|560533637|FG004|Overall Study|Disease progression|6|||
155300779|NCT04259450|560533638|FG005|Overall Study|Disease progression|6|||
155300780|NCT04259450|560533639|FG006|Overall Study|Disease progression|6|||
155300781|NCT04259450|560533640|FG007|Overall Study|Disease progression|15|||
155300782|NCT04259450|560533641|FG008|Overall Study|Disease progression|6|||
155300783|NCT04259450|560533642|FG009|Overall Study|Disease progression|18|||
155300784|NCT04259450|560533633|FG000|Overall Study|Death|0|||
155300785|NCT04259450|560533634|FG001|Overall Study|Death|0|||
155300786|NCT04259450|560533635|FG002|Overall Study|Death|0|||
155300787|NCT04259450|560533636|FG003|Overall Study|Death|0|||
155300788|NCT04259450|560533637|FG004|Overall Study|Death|0|||
155300789|NCT04259450|560533638|FG005|Overall Study|Death|0|||
155300790|NCT04259450|560533639|FG006|Overall Study|Death|0|||
155300791|NCT04259450|560533640|FG007|Overall Study|Death|1|||
155300792|NCT04259450|560533641|FG008|Overall Study|Death|1|||
155300793|NCT04259450|560533642|FG009|Overall Study|Death|0|||
155300794|NCT04259450|560533633|FG000|Overall Study|Withdrawal by Subject|0|||
155300795|NCT04259450|560533634|FG001|Overall Study|Withdrawal by Subject|0|||
155300796|NCT04259450|560533635|FG002|Overall Study|Withdrawal by Subject|0|||
155300797|NCT04259450|560533636|FG003|Overall Study|Withdrawal by Subject|0|||
155300798|NCT04259450|560533637|FG004|Overall Study|Withdrawal by Subject|0|||
155300799|NCT04259450|560533638|FG005|Overall Study|Withdrawal by Subject|0|||
155300800|NCT04259450|560533639|FG006|Overall Study|Withdrawal by Subject|0|||
155300801|NCT04259450|560533640|FG007|Overall Study|Withdrawal by Subject|1|||
155300802|NCT04259450|560533641|FG008|Overall Study|Withdrawal by Subject|0|||
155300803|NCT04259450|560533642|FG009|Overall Study|Withdrawal by Subject|0|||
155300804|NCT04259450|560533633|FG000|Overall Study|Other than listed|0|||
155300805|NCT04259450|560533634|FG001|Overall Study|Other than listed|0|||
155300806|NCT04259450|560533635|FG002|Overall Study|Other than listed|0|||
155300807|NCT04259450|560533636|FG003|Overall Study|Other than listed|0|||
155300808|NCT04259450|560533637|FG004|Overall Study|Other than listed|0|||
155300809|NCT04259450|560533638|FG005|Overall Study|Other than listed|0|||
155300810|NCT04259450|560533639|FG006|Overall Study|Other than listed|0|||
155300811|NCT04259450|560533640|FG007|Overall Study|Other than listed|1|||
155300812|NCT04259450|560533641|FG008|Overall Study|Other than listed|1|||
155300813|NCT04259450|560533642|FG009|Overall Study|Other than listed|2|||
155300814|NCT00542789|560533649|FG000|Overall Study|Adverse Event|18|||
155300815|NCT00542789|560533650|FG001|Overall Study|Adverse Event|17|||
155300816|NCT00542789|560533649|FG000|Overall Study|Withdrawal by Subject|7|||
155300817|NCT00542789|560533650|FG001|Overall Study|Withdrawal by Subject|3|||
155300818|NCT00542789|560533649|FG000|Overall Study|Protocol Violation|8|||
155300819|NCT00542789|560533650|FG001|Overall Study|Protocol Violation|1|||
155300820|NCT00542789|560533649|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
155300821|NCT00542789|560533650|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
155300822|NCT02584829|560533652|FG000|Overall Study|Physician Decision|1|||
155300823|NCT02584829|560533653|FG001|Overall Study|Physician Decision|0|||
155300824|NCT02584829|560533652|FG000|Overall Study|Withdrawal by Subject|0|||
155300825|NCT02584829|560533653|FG001|Overall Study|Withdrawal by Subject|1|||
155300826|NCT02584829|560533652|FG000|Overall Study|Progressive Disease|0|||
155300827|NCT02584829|560533653|FG001|Overall Study|Progressive Disease|3|||
155300828|NCT00434304|560533655|FG000|Overall Study|Adverse Event|14|||
155300829|NCT00434304|560533655|FG000|Overall Study|Lack of Efficacy|2|||
155300830|NCT00434304|560533655|FG000|Overall Study|Withdrawal by Subject|4|||
155300831|NCT05262738|560533656|FG000|Overall Study|Withdrawal by Subject|1|||
155300832|NCT05262738|560533657|FG001|Overall Study|Withdrawal by Subject|0|||
155300833|NCT00446459|560533670|FG000|8 Months|Protocol Violation|12|||
155300834|NCT00446459|560533670|FG000|12 Months|Protocol Violation|4|||
155746970|NCT00713310|562174763|FG001|Overall Study|Lack of Efficacy|2|||
155746971|NCT00713310|562174762|FG000|Overall Study|Withdrawal by Subject|0|||
155746972|NCT00713310|562174763|FG001|Overall Study|Withdrawal by Subject|2|||
155746973|NCT00779259|562174764|FG000|Quinine Alone|Adverse Event|2|||
155746974|NCT00686634|562174765|FG000|Overall Study|Protocol Violation|6|||
155746975|NCT03312751|562174768|FG000|Overall Study|Death|7|||
155746976|NCT03312751|562174769|FG001|Overall Study|Death|9|||
155746977|NCT03312751|562174768|FG000|Overall Study|Study discontinuation due to other reason|0|||
155746978|NCT03312751|562174769|FG001|Overall Study|Study discontinuation due to other reason|1|||
155746979|NCT00282464|562174770|FG000|Overall Study|Adverse Event|26|||
155746980|NCT00282464|562174771|FG001|Overall Study|Adverse Event|20|||
155746981|NCT00282464|562174770|FG000|Overall Study|Lack of Efficacy|8|||
155746982|NCT00282464|562174771|FG001|Overall Study|Lack of Efficacy|8|||
155746983|NCT00282464|562174770|FG000|Overall Study|Lost to Follow-up|10|||
155746984|NCT00282464|562174771|FG001|Overall Study|Lost to Follow-up|10|||
155746985|NCT00282464|562174770|FG000|Overall Study|Withdrawal by Subject|24|||
155746986|NCT00282464|562174771|FG001|Overall Study|Withdrawal by Subject|10|||
155746987|NCT00282464|562174770|FG000|Overall Study|laboratory abnormality|1|||
155746988|NCT00282464|562174771|FG001|Overall Study|laboratory abnormality|2|||
155746989|NCT00282464|562174770|FG000|Overall Study|Protocol Violation|0|||
155746990|NCT00282464|562174771|FG001|Overall Study|Protocol Violation|7|||
155300835|NCT00446459|560533670|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
155300836|NCT00858117|560533673|FG000|Treatment on Study|Adverse Event|2|||
155300837|NCT00858117|560533673|FG000|Follow up for 5 Years|Death|4|||
155300838|NCT00858117|560533673|FG000|Follow up for 5 Years|No further data collected for study|9|||
155300839|NCT00371787|560533674|FG000|Overall Study|Withdrawal by Subject|3|||
155300840|NCT00371787|560533675|FG001|Overall Study|Withdrawal by Subject|1|||
155746991|NCT00282464|562174770|FG000|Overall Study|Patient moved|1|||
155746992|NCT00282464|562174771|FG001|Overall Study|Patient moved|0|||
155746993|NCT00282464|562174770|FG000|Overall Study|patient non-compliant|3|||
155746994|NCT00282464|562174771|FG001|Overall Study|patient non-compliant|0|||
155746995|NCT00282464|562174770|FG000|Overall Study|patient no show|0|||
155746996|NCT00282464|562174771|FG001|Overall Study|patient no show|1|||
155300841|NCT02765100|560533677|FG000|Overall Study|subject found ineligible after baseline|1|||
155300842|NCT02765100|560533678|FG001|Overall Study|subject found ineligible after baseline|1|||
155300843|NCT02765100|560533677|FG000|Overall Study|Lost to Follow-up|0|||
155300844|NCT02765100|560533678|FG001|Overall Study|Lost to Follow-up|1|||
155300845|NCT02597920|560533684|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155300846|NCT02597920|560533685|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155300847|NCT02597920|560533686|FG002|Overall Study|Worsening of other pre-existing disease|0|||
155300848|NCT02597920|560533684|FG000|Overall Study|Other adverse event|20|||
155300849|NCT02597920|560533685|FG001|Overall Study|Other adverse event|30|||
155300850|NCT02597920|560533686|FG002|Overall Study|Other adverse event|0|||
155300851|NCT02597920|560533684|FG000|Overall Study|Lost to Follow-up|7|||
155300852|NCT02597920|560533685|FG001|Overall Study|Lost to Follow-up|9|||
155300853|NCT02597920|560533686|FG002|Overall Study|Lost to Follow-up|0|||
155300854|NCT02597920|560533684|FG000|Overall Study|Refuse to continue in the study|3|||
155300855|NCT02597920|560533685|FG001|Overall Study|Refuse to continue in the study|13|||
155300856|NCT02597920|560533686|FG002|Overall Study|Refuse to continue in the study|1|||
155300857|NCT02597920|560533684|FG000|Overall Study|Other than specified|10|||
155300858|NCT02597920|560533685|FG001|Overall Study|Other than specified|31|||
155300859|NCT02597920|560533686|FG002|Overall Study|Other than specified|5|||
155300860|NCT02597920|560533684|FG000|Overall Study|Other|1|||
155300861|NCT02597920|560533685|FG001|Overall Study|Other|0|||
155300862|NCT02597920|560533686|FG002|Overall Study|Other|0|||
155300863|NCT02675244|560533689|FG000|Overall Study|Death|9|||
155300864|NCT02675244|560533690|FG001|Overall Study|Death|6|||
155300865|NCT02675244|560533689|FG000|Overall Study|Withdrawal by Subject|3|||
155300866|NCT02675244|560533690|FG001|Overall Study|Withdrawal by Subject|6|||
155300867|NCT02675244|560533689|FG000|Overall Study|Lost to Follow-up|1|||
155300868|NCT02675244|560533690|FG001|Overall Study|Lost to Follow-up|1|||
155300869|NCT02675244|560533689|FG000|Overall Study|Ongoing at 2 Years|190|||
155300870|NCT02675244|560533690|FG001|Overall Study|Ongoing at 2 Years|185|||
155300871|NCT00391898|560533696|FG000|Overall Study|Adverse Event|3|||
155300872|NCT00391898|560533697|FG001|Overall Study|Adverse Event|0|||
155300873|NCT00391898|560533696|FG000|Overall Study|Other|8|||
155300874|NCT00391898|560533697|FG001|Overall Study|Other|10|||
155300875|NCT02529995|560533702|FG000|Part A|Ongoing Study at Data Cut-off|14|||
155300876|NCT02529995|560533703|FG001|Part A|Ongoing Study at Data Cut-off|16|||
155300877|NCT02529995|560533702|FG000|Part A|Discontinued Study|1|||
155300878|NCT02529995|560533703|FG001|Part A|Discontinued Study|0|||
155300879|NCT02529995|560533702|FG000|Part B|Ongoing Study at Data Cut-off|0|||
155300880|NCT02529995|560533703|FG001|Part B|Ongoing Study at Data Cut-off|7|||
155300881|NCT02529995|560533702|FG000|Part B|Discontinued Study|6|||
155300882|NCT02529995|560533703|FG001|Part B|Discontinued Study|5|||
155300883|NCT02988817|560533704|FG000|Overall Study|Withdrawal by Subject|1|||
155300884|NCT02988817|560533705|FG001|Overall Study|Withdrawal by Subject|0|||
155300885|NCT02988817|560533706|FG002|Overall Study|Withdrawal by Subject|0|||
155300886|NCT02988817|560533707|FG003|Overall Study|Withdrawal by Subject|1|||
155300887|NCT02988817|560533708|FG004|Overall Study|Withdrawal by Subject|3|||
155300888|NCT02988817|560533709|FG005|Overall Study|Withdrawal by Subject|1|||
155300889|NCT02988817|560533710|FG006|Overall Study|Withdrawal by Subject|2|||
155300890|NCT02988817|560533711|FG007|Overall Study|Withdrawal by Subject|1|||
155300891|NCT02988817|560533712|FG008|Overall Study|Withdrawal by Subject|1|||
155300892|NCT02988817|560533713|FG009|Overall Study|Withdrawal by Subject|1|||
155300893|NCT02988817|560533714|FG010|Overall Study|Withdrawal by Subject|1|||
155300894|NCT02988817|560533715|FG011|Overall Study|Withdrawal by Subject|12|||
155300895|NCT02988817|560533716|FG012|Overall Study|Withdrawal by Subject|6|||
155300896|NCT02988817|560533717|FG013|Overall Study|Withdrawal by Subject|6|||
155300897|NCT02988817|560533718|FG014|Overall Study|Withdrawal by Subject|4|||
155300898|NCT02988817|560533719|FG015|Overall Study|Withdrawal by Subject|5|||
155300899|NCT02988817|560533720|FG016|Overall Study|Withdrawal by Subject|4|||
155300900|NCT02988817|560533721|FG017|Overall Study|Withdrawal by Subject|11|||
155300901|NCT02988817|560533722|FG018|Overall Study|Withdrawal by Subject|4|||
155300902|NCT02988817|560533723|FG019|Overall Study|Withdrawal by Subject|2|||
155300903|NCT02988817|560533704|FG000|Overall Study|Death|0|||
155300904|NCT02988817|560533705|FG001|Overall Study|Death|1|||
155300905|NCT02988817|560533706|FG002|Overall Study|Death|3|||
155300906|NCT02988817|560533707|FG003|Overall Study|Death|1|||
155300907|NCT02988817|560533708|FG004|Overall Study|Death|6|||
155300908|NCT02988817|560533709|FG005|Overall Study|Death|10|||
155300909|NCT02988817|560533710|FG006|Overall Study|Death|1|||
155300910|NCT02988817|560533711|FG007|Overall Study|Death|2|||
155300911|NCT02988817|560533712|FG008|Overall Study|Death|1|||
155300912|NCT02988817|560533713|FG009|Overall Study|Death|5|||
155300913|NCT02988817|560533714|FG010|Overall Study|Death|1|||
155300914|NCT02988817|560533715|FG011|Overall Study|Death|8|||
155300915|NCT02988817|560533716|FG012|Overall Study|Death|9|||
155300916|NCT02988817|560533717|FG013|Overall Study|Death|17|||
155300917|NCT02988817|560533718|FG014|Overall Study|Death|18|||
155300918|NCT02988817|560533719|FG015|Overall Study|Death|30|||
155300919|NCT02988817|560533720|FG016|Overall Study|Death|17|||
155300920|NCT02988817|560533721|FG017|Overall Study|Death|38|||
155300921|NCT02988817|560533722|FG018|Overall Study|Death|14|||
155300922|NCT02988817|560533723|FG019|Overall Study|Death|16|||
155300923|NCT02988817|560533704|FG000|Overall Study|Other|0|||
155300924|NCT02988817|560533705|FG001|Overall Study|Other|0|||
155300925|NCT02988817|560533706|FG002|Overall Study|Other|0|||
155300926|NCT02988817|560533707|FG003|Overall Study|Other|1|||
155300927|NCT02988817|560533708|FG004|Overall Study|Other|1|||
155300928|NCT02988817|560533709|FG005|Overall Study|Other|0|||
155300929|NCT02988817|560533710|FG006|Overall Study|Other|0|||
155300930|NCT02988817|560533711|FG007|Overall Study|Other|0|||
155300931|NCT02988817|560533712|FG008|Overall Study|Other|0|||
155300932|NCT02988817|560533713|FG009|Overall Study|Other|0|||
155300933|NCT02988817|560533714|FG010|Overall Study|Other|0|||
155300934|NCT02988817|560533715|FG011|Overall Study|Other|0|||
155300935|NCT02988817|560533716|FG012|Overall Study|Other|0|||
155300936|NCT02988817|560533717|FG013|Overall Study|Other|0|||
155300937|NCT02988817|560533718|FG014|Overall Study|Other|0|||
155300938|NCT02988817|560533719|FG015|Overall Study|Other|1|||
155300939|NCT02988817|560533720|FG016|Overall Study|Other|0|||
155300940|NCT02988817|560533721|FG017|Overall Study|Other|0|||
155300941|NCT02988817|560533722|FG018|Overall Study|Other|0|||
155300942|NCT02988817|560533723|FG019|Overall Study|Other|0|||
155300943|NCT02988817|560533704|FG000|Overall Study|Lost to Follow-up|0|||
155300944|NCT02988817|560533705|FG001|Overall Study|Lost to Follow-up|0|||
155300945|NCT02988817|560533706|FG002|Overall Study|Lost to Follow-up|0|||
155300946|NCT02988817|560533707|FG003|Overall Study|Lost to Follow-up|0|||
155300947|NCT02988817|560533708|FG004|Overall Study|Lost to Follow-up|0|||
155300948|NCT02988817|560533709|FG005|Overall Study|Lost to Follow-up|0|||
155300949|NCT02988817|560533710|FG006|Overall Study|Lost to Follow-up|0|||
155300950|NCT02988817|560533711|FG007|Overall Study|Lost to Follow-up|0|||
155300951|NCT02988817|560533712|FG008|Overall Study|Lost to Follow-up|1|||
155300952|NCT02988817|560533713|FG009|Overall Study|Lost to Follow-up|0|||
155300953|NCT02988817|560533714|FG010|Overall Study|Lost to Follow-up|1|||
155300954|NCT02988817|560533715|FG011|Overall Study|Lost to Follow-up|1|||
155300955|NCT02988817|560533716|FG012|Overall Study|Lost to Follow-up|0|||
155300956|NCT02988817|560533717|FG013|Overall Study|Lost to Follow-up|0|||
155300957|NCT02988817|560533718|FG014|Overall Study|Lost to Follow-up|1|||
155300958|NCT02988817|560533719|FG015|Overall Study|Lost to Follow-up|1|||
155300959|NCT02988817|560533720|FG016|Overall Study|Lost to Follow-up|2|||
155300960|NCT02988817|560533721|FG017|Overall Study|Lost to Follow-up|3|||
155746997|NCT00282464|562174770|FG000|Overall Study|patient incarcerated|0|||
155746998|NCT00282464|562174771|FG001|Overall Study|patient incarcerated|1|||
155746999|NCT00282464|562174770|FG000|Overall Study|family crisis|0|||
155300961|NCT02988817|560533722|FG018|Overall Study|Lost to Follow-up|0|||
155300962|NCT02988817|560533723|FG019|Overall Study|Lost to Follow-up|0|||
155300963|NCT02988817|560533704|FG000|Overall Study|Sponsor decision|0|||
155300964|NCT02988817|560533705|FG001|Overall Study|Sponsor decision|0|||
155300965|NCT02988817|560533706|FG002|Overall Study|Sponsor decision|0|||
155300966|NCT02988817|560533707|FG003|Overall Study|Sponsor decision|0|||
155300967|NCT02988817|560533708|FG004|Overall Study|Sponsor decision|0|||
155300968|NCT02988817|560533709|FG005|Overall Study|Sponsor decision|0|||
155300969|NCT02988817|560533710|FG006|Overall Study|Sponsor decision|0|||
155300970|NCT02988817|560533711|FG007|Overall Study|Sponsor decision|0|||
155300971|NCT02988817|560533712|FG008|Overall Study|Sponsor decision|0|||
155300972|NCT02988817|560533713|FG009|Overall Study|Sponsor decision|0|||
155300973|NCT02988817|560533714|FG010|Overall Study|Sponsor decision|0|||
155300974|NCT02988817|560533715|FG011|Overall Study|Sponsor decision|1|||
155300975|NCT02988817|560533716|FG012|Overall Study|Sponsor decision|1|||
155300976|NCT02988817|560533717|FG013|Overall Study|Sponsor decision|2|||
155300977|NCT02988817|560533718|FG014|Overall Study|Sponsor decision|2|||
155300978|NCT02988817|560533719|FG015|Overall Study|Sponsor decision|6|||
155300979|NCT02988817|560533720|FG016|Overall Study|Sponsor decision|2|||
155300980|NCT02988817|560533721|FG017|Overall Study|Sponsor decision|3|||
155300981|NCT02988817|560533722|FG018|Overall Study|Sponsor decision|2|||
155300982|NCT02988817|560533723|FG019|Overall Study|Sponsor decision|7|||
155300983|NCT02988817|560533704|FG000|Overall Study|Physician Decision|0|||
155300984|NCT02988817|560533705|FG001|Overall Study|Physician Decision|0|||
155300985|NCT02988817|560533706|FG002|Overall Study|Physician Decision|0|||
155300986|NCT02988817|560533707|FG003|Overall Study|Physician Decision|0|||
155747000|NCT00282464|562174771|FG001|Overall Study|family crisis|1|||
155300987|NCT02988817|560533708|FG004|Overall Study|Physician Decision|0|||
155300988|NCT02988817|560533709|FG005|Overall Study|Physician Decision|0|||
155300989|NCT02988817|560533710|FG006|Overall Study|Physician Decision|0|||
155300990|NCT02988817|560533711|FG007|Overall Study|Physician Decision|0|||
155300991|NCT02988817|560533712|FG008|Overall Study|Physician Decision|0|||
155300992|NCT02988817|560533713|FG009|Overall Study|Physician Decision|0|||
155300993|NCT02988817|560533714|FG010|Overall Study|Physician Decision|0|||
155300994|NCT02988817|560533715|FG011|Overall Study|Physician Decision|0|||
155300995|NCT02988817|560533716|FG012|Overall Study|Physician Decision|0|||
155300996|NCT02988817|560533717|FG013|Overall Study|Physician Decision|0|||
155300997|NCT02988817|560533718|FG014|Overall Study|Physician Decision|0|||
155300998|NCT02988817|560533719|FG015|Overall Study|Physician Decision|1|||
155300999|NCT02988817|560533720|FG016|Overall Study|Physician Decision|0|||
155301000|NCT02988817|560533721|FG017|Overall Study|Physician Decision|0|||
155301001|NCT02988817|560533722|FG018|Overall Study|Physician Decision|1|||
155301002|NCT02988817|560533723|FG019|Overall Study|Physician Decision|1|||
155301003|NCT03036813|560533726|FG000|Overall Study|Adverse Event|6|||
155301004|NCT03036813|560533727|FG001|Overall Study|Adverse Event|11|||
155301005|NCT03036813|560533728|FG002|Overall Study|Adverse Event|6|||
155301006|NCT03036813|560533726|FG000|Overall Study|Withdrawal by Subject|12|||
155301007|NCT03036813|560533727|FG001|Overall Study|Withdrawal by Subject|6|||
155301008|NCT03036813|560533728|FG002|Overall Study|Withdrawal by Subject|10|||
155301009|NCT03036813|560533726|FG000|Overall Study|Lost to Follow-up|1|||
155301010|NCT03036813|560533727|FG001|Overall Study|Lost to Follow-up|1|||
155301011|NCT03036813|560533728|FG002|Overall Study|Lost to Follow-up|0|||
155301012|NCT03036813|560533726|FG000|Overall Study|Physician Decision|2|||
155301013|NCT03036813|560533727|FG001|Overall Study|Physician Decision|1|||
155301014|NCT03036813|560533728|FG002|Overall Study|Physician Decision|1|||
155301015|NCT03036813|560533726|FG000|Overall Study|Non-Compliance|1|||
155301016|NCT03036813|560533727|FG001|Overall Study|Non-Compliance|5|||
155301017|NCT03036813|560533728|FG002|Overall Study|Non-Compliance|3|||
155301018|NCT03036813|560533726|FG000|Overall Study|Pregnancy|0|||
155301019|NCT03036813|560533727|FG001|Overall Study|Pregnancy|0|||
155301020|NCT03036813|560533728|FG002|Overall Study|Pregnancy|1|||
155301021|NCT03036813|560533726|FG000|Overall Study|Other|0|||
155301022|NCT03036813|560533727|FG001|Overall Study|Other|3|||
155301023|NCT03036813|560533728|FG002|Overall Study|Other|5|||
155301024|NCT01102231|560533729|FG000|Overall Study|Protocol Violation|3|||
155301025|NCT01102231|560533729|FG000|Overall Study|Lack of Efficacy|2|||
155301026|NCT01102231|560533729|FG000|Overall Study|Death|2|||
155301027|NCT01102231|560533729|FG000|Overall Study|Adverse Event|3|||
155301028|NCT01102231|560533729|FG000|Overall Study|Withdrawal by Subject|1|||
155301029|NCT01102231|560533729|FG000|Overall Study|Did not received the treatment|4|||
155301030|NCT00546754|560533730|FG000|Overall Study|Serious Adverse Event|1|||
155301031|NCT00546754|560533731|FG001|Overall Study|Serious Adverse Event|1|||
155301032|NCT00546754|560533730|FG000|Overall Study|Adverse Event|11|||
155301033|NCT00546754|560533731|FG001|Overall Study|Adverse Event|16|||
155301034|NCT00546754|560533730|FG000|Overall Study|Lack of Efficacy|1|||
155301035|NCT00546754|560533731|FG001|Overall Study|Lack of Efficacy|1|||
155301036|NCT00546754|560533730|FG000|Overall Study|Lost to Follow-up|9|||
155301037|NCT00546754|560533731|FG001|Overall Study|Lost to Follow-up|15|||
155301038|NCT00546754|560533730|FG000|Overall Study|Protocol Violation|3|||
155301039|NCT00546754|560533731|FG001|Overall Study|Protocol Violation|0|||
155641048|NCT00420407|561776750|FG001|Overall Study|Withdrawal by Subject|2|||
155641049|NCT03641924|561776751|FG000|Overall Study|Withdrawal by Subject|26|||
155641050|NCT03641924|561776751|FG000|Overall Study|Lost to Follow-up|16|||
155641051|NCT03641924|561776751|FG000|Overall Study|Protocol Violation|10|||
155641052|NCT01373229|561776753|FG000|Overall Study|Death|3|||
155641053|NCT01373229|561776753|FG000|Overall Study|Physician Decision|3|||
155641054|NCT03720847|561776754|FG000|Washout|Physician Decision|1|||
155641055|NCT03720847|561776755|FG001|Washout|Physician Decision|2|||
155641056|NCT03033901|561776758|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
155641057|NCT03033901|561776758|FG000|Overall Study|Refused PSG|23|||
155641058|NCT03033901|561776758|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
155641059|NCT03033901|561776758|FG000|Overall Study|Missing Oximetry Data|3|||
155641060|NCT00924651|561776759|FG000|Overall Study|Chemo started too soon|2|||
155641061|NCT00924651|561776760|FG001|Overall Study|Chemo started too soon|3|||
155641062|NCT00924651|561776759|FG000|Overall Study|No Reason|3|||
155641063|NCT00924651|561776760|FG001|Overall Study|No Reason|7|||
155641064|NCT00924651|561776759|FG000|Overall Study|Overwhelmed|6|||
155641065|NCT00924651|561776760|FG001|Overall Study|Overwhelmed|6|||
155301040|NCT00546754|560533730|FG000|Overall Study|Withdrawal by Subject|6|||
155301041|NCT00546754|560533731|FG001|Overall Study|Withdrawal by Subject|7|||
155301042|NCT00546754|560533730|FG000|Overall Study|Dyspnea|1|||
155641066|NCT00924651|561776759|FG000|Overall Study|Noncompliant|1|||
155641067|NCT00924651|561776760|FG001|Overall Study|Noncompliant|4|||
155641068|NCT00924651|561776759|FG000|Overall Study|Medical|1|||
155641069|NCT00924651|561776760|FG001|Overall Study|Medical|3|||
155301043|NCT00546754|560533731|FG001|Overall Study|Dyspnea|0|||
155301044|NCT00546754|560533730|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
155301045|NCT00546754|560533731|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
155747001|NCT00282464|562174770|FG000|Overall Study|dispensed wrong kit|0|||
155747002|NCT00282464|562174771|FG001|Overall Study|dispensed wrong kit|1|||
155747003|NCT00282464|562174770|FG000|Overall Study|dropped due to missed visits|0|||
155747004|NCT00282464|562174771|FG001|Overall Study|dropped due to missed visits|1|||
155747005|NCT04098224|562174776|FG000|Overall Study|Adverse Event|1|||
155747006|NCT04098224|562174777|FG001|Overall Study|Adverse Event|0|||
155747007|NCT04098224|562174776|FG000|Overall Study|Physician Decision|1|||
155747008|NCT04098224|562174777|FG001|Overall Study|Physician Decision|0|||
155747009|NCT04098224|562174776|FG000|Overall Study|Patient not required enteral feeding|1|||
155747010|NCT04098224|562174777|FG001|Overall Study|Patient not required enteral feeding|0|||
155747011|NCT04098224|562174776|FG000|Overall Study|Patient failure nasogastric tube|1|||
155301046|NCT00546754|560533730|FG000|Overall Study|Hip Replacement|1|||
155301047|NCT00546754|560533731|FG001|Overall Study|Hip Replacement|0|||
155301048|NCT00546754|560533730|FG000|Overall Study|Suicide|1|||
155301049|NCT00546754|560533731|FG001|Overall Study|Suicide|0|||
155301050|NCT00546754|560533730|FG000|Overall Study|Missing Cooperation|1|||
155301051|NCT00546754|560533731|FG001|Overall Study|Missing Cooperation|0|||
155301052|NCT00546754|560533730|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
155301053|NCT00546754|560533731|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
155301054|NCT00546754|560533730|FG000|Overall Study|Patient's Decision|0|||
155301055|NCT00546754|560533731|FG001|Overall Study|Patient's Decision|1|||
155301056|NCT00546754|560533730|FG000|Overall Study|Missing|14|||
155301057|NCT00546754|560533731|FG001|Overall Study|Missing|7|||
155301058|NCT01792830|560533741|FG000|Overall Study|Withdrawal by Subject|22|||
155301059|NCT01792830|560533742|FG001|Overall Study|Withdrawal by Subject|0|||
155301060|NCT01792830|560533743|FG002|Overall Study|Withdrawal by Subject|0|||
155301061|NCT01792830|560533744|FG003|Overall Study|Withdrawal by Subject|2|||
155301062|NCT01792830|560533745|FG004|Overall Study|Withdrawal by Subject|1|||
155301063|NCT01792830|560533746|FG005|Overall Study|Withdrawal by Subject|1|||
155301064|NCT01792830|560533747|FG006|Overall Study|Withdrawal by Subject|1|||
155301065|NCT01792830|560533748|FG007|Overall Study|Withdrawal by Subject|1|||
155301066|NCT01792830|560533749|FG008|Overall Study|Withdrawal by Subject|7|||
155301067|NCT01792830|560533750|FG009|Overall Study|Withdrawal by Subject|0|||
155301068|NCT01792830|560533751|FG010|Overall Study|Withdrawal by Subject|2|||
155301069|NCT01792830|560533741|FG000|Overall Study|Death|3|||
155301070|NCT01792830|560533742|FG001|Overall Study|Death|0|||
155301071|NCT01792830|560533743|FG002|Overall Study|Death|0|||
155301072|NCT01792830|560533744|FG003|Overall Study|Death|1|||
155301073|NCT01792830|560533745|FG004|Overall Study|Death|0|||
155301074|NCT01792830|560533746|FG005|Overall Study|Death|0|||
155301075|NCT01792830|560533747|FG006|Overall Study|Death|1|||
155301076|NCT01792830|560533748|FG007|Overall Study|Death|0|||
155301077|NCT01792830|560533749|FG008|Overall Study|Death|1|||
155301078|NCT01792830|560533750|FG009|Overall Study|Death|0|||
155301079|NCT01792830|560533751|FG010|Overall Study|Death|1|||
155301080|NCT01792830|560533741|FG000|Overall Study|Adverse Event|0|||
155301081|NCT01792830|560533742|FG001|Overall Study|Adverse Event|0|||
155301082|NCT01792830|560533743|FG002|Overall Study|Adverse Event|0|||
155301083|NCT01792830|560533744|FG003|Overall Study|Adverse Event|0|||
155301084|NCT01792830|560533745|FG004|Overall Study|Adverse Event|0|||
155301085|NCT01792830|560533746|FG005|Overall Study|Adverse Event|0|||
155301086|NCT01792830|560533747|FG006|Overall Study|Adverse Event|0|||
155301087|NCT01792830|560533748|FG007|Overall Study|Adverse Event|0|||
155301088|NCT01792830|560533749|FG008|Overall Study|Adverse Event|1|||
155301089|NCT01792830|560533750|FG009|Overall Study|Adverse Event|0|||
155301090|NCT01792830|560533751|FG010|Overall Study|Adverse Event|0|||
155301091|NCT01943799|560533767|FG000|Overall Study|Lost to Follow-up|0|||
155301092|NCT01943799|560533768|FG001|Overall Study|Lost to Follow-up|1|||
155301093|NCT01943799|560533769|FG002|Overall Study|Lost to Follow-up|1|||
155301094|NCT01943799|560533770|FG003|Overall Study|Lost to Follow-up|0|||
155301095|NCT01943799|560533767|FG000|Overall Study|Protocol Violation|1|||
155301096|NCT01943799|560533768|FG001|Overall Study|Protocol Violation|0|||
155301097|NCT01943799|560533769|FG002|Overall Study|Protocol Violation|0|||
155301098|NCT01943799|560533770|FG003|Overall Study|Protocol Violation|0|||
155301099|NCT01943799|560533767|FG000|Overall Study|Withdrawal by Subject|4|||
155301100|NCT01943799|560533768|FG001|Overall Study|Withdrawal by Subject|2|||
155301101|NCT01943799|560533769|FG002|Overall Study|Withdrawal by Subject|1|||
155301102|NCT01943799|560533770|FG003|Overall Study|Withdrawal by Subject|0|||
155301103|NCT04594759|560533771|FG000|Overall Study|Lost to Follow-up|3|||
155301104|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
155301105|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
155301106|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
155301107|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
155301108|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
155301109|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
155301110|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
155301111|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
155301112|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
155301113|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
155301114|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
155301115|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
155301116|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
155301117|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
155301118|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
155301119|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
155301120|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
155301121|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
155301122|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
155301123|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
155301124|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
155301125|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
155301126|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
155301127|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
155301128|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Death|1|||
155301129|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Death|0|||
155301130|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Death|0|||
155301131|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
155301132|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
155301133|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
155301134|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
155301135|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
155301136|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155301137|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
155301138|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
155301139|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
155301140|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
155301141|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
155301142|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
155301143|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
155301144|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
155301145|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
155301146|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
155301147|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
155301148|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
155301149|NCT00396084|560533777|FG000|Overall Study|Adverse Event|0|||
155301150|NCT00396084|560533778|FG001|Overall Study|Adverse Event|0|||
155301151|NCT00396084|560533779|FG002|Overall Study|Adverse Event|0|||
155301152|NCT00396084|560533780|FG003|Overall Study|Adverse Event|0|||
155301153|NCT00396084|560533781|FG004|Overall Study|Adverse Event|1|||
155301154|NCT00396084|560533782|FG005|Overall Study|Adverse Event|2|||
155301155|NCT00396084|560533777|FG000|Overall Study|Withdrawal by Subject|0|||
155301156|NCT00396084|560533778|FG001|Overall Study|Withdrawal by Subject|0|||
155301157|NCT00396084|560533779|FG002|Overall Study|Withdrawal by Subject|0|||
155301158|NCT00396084|560533780|FG003|Overall Study|Withdrawal by Subject|1|||
155301159|NCT00396084|560533781|FG004|Overall Study|Withdrawal by Subject|0|||
155301160|NCT00396084|560533782|FG005|Overall Study|Withdrawal by Subject|0|||
155301161|NCT03811574|560533783|FG000|Overall Study|Withdrawal by Subject|2|||
155301162|NCT03811574|560533784|FG001|Overall Study|Withdrawal by Subject|4|||
155301163|NCT03811574|560533785|FG002|Overall Study|Withdrawal by Subject|0|||
155301164|NCT01697969|560533786|FG000|Overall Study|Did not meet inc/exc criteria|3|||
155301165|NCT03144674|560533791|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
155301166|NCT03144674|560533792|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
155301167|NCT03144674|560533793|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
155301168|NCT03144674|560533794|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
155301169|NCT03144674|560533791|FG000|Overall Study|Death|3|||
155301170|NCT03144674|560533792|FG001|Overall Study|Death|2|||
155301171|NCT03144674|560533793|FG002|Overall Study|Death|6|||
155301172|NCT03144674|560533794|FG003|Overall Study|Death|24|||
155301173|NCT03144674|560533791|FG000|Overall Study|Lost to Follow-up|0|||
155301174|NCT03144674|560533792|FG001|Overall Study|Lost to Follow-up|1|||
155301175|NCT03144674|560533793|FG002|Overall Study|Lost to Follow-up|0|||
155301176|NCT03144674|560533794|FG003|Overall Study|Lost to Follow-up|4|||
155301177|NCT03144674|560533791|FG000|Overall Study|Withdrawal by Participant|0|||
155301178|NCT03144674|560533792|FG001|Overall Study|Withdrawal by Participant|0|||
155301179|NCT03144674|560533793|FG002|Overall Study|Withdrawal by Participant|2|||
155301180|NCT03144674|560533794|FG003|Overall Study|Withdrawal by Participant|6|||
155301181|NCT03144674|560533791|FG000|Overall Study|Discharged from the Trust|0|||
155301182|NCT03144674|560533792|FG001|Overall Study|Discharged from the Trust|0|||
155301183|NCT03144674|560533793|FG002|Overall Study|Discharged from the Trust|1|||
155301184|NCT03144674|560533794|FG003|Overall Study|Discharged from the Trust|0|||
155301185|NCT03144674|560533791|FG000|Overall Study|Exclusion Criteria Met|0|||
155301186|NCT03144674|560533792|FG001|Overall Study|Exclusion Criteria Met|0|||
155301187|NCT03144674|560533793|FG002|Overall Study|Exclusion Criteria Met|1|||
155301188|NCT03144674|560533794|FG003|Overall Study|Exclusion Criteria Met|0|||
155301189|NCT03144674|560533791|FG000|Overall Study|Changed Physicians|0|||
155301190|NCT03144674|560533792|FG001|Overall Study|Changed Physicians|0|||
155301191|NCT03144674|560533793|FG002|Overall Study|Changed Physicians|0|||
155301192|NCT03144674|560533794|FG003|Overall Study|Changed Physicians|1|||
155301193|NCT03144674|560533791|FG000|Overall Study|Removed for Safety|0|||
155301194|NCT03144674|560533792|FG001|Overall Study|Removed for Safety|0|||
155301195|NCT03144674|560533793|FG002|Overall Study|Removed for Safety|0|||
155301196|NCT03144674|560533794|FG003|Overall Study|Removed for Safety|1|||
155301197|NCT03144674|560533791|FG000|Overall Study|Site Closed|0|||
155301198|NCT03144674|560533792|FG001|Overall Study|Site Closed|0|||
155301199|NCT03144674|560533793|FG002|Overall Study|Site Closed|0|||
155301200|NCT03144674|560533794|FG003|Overall Study|Site Closed|1|||
155301201|NCT03144674|560533791|FG000|Overall Study|Histological Criteria Not Met|0|||
155301202|NCT03144674|560533792|FG001|Overall Study|Histological Criteria Not Met|0|||
155301203|NCT03144674|560533793|FG002|Overall Study|Histological Criteria Not Met|0|||
155301204|NCT03144674|560533794|FG003|Overall Study|Histological Criteria Not Met|1|||
155301205|NCT03144674|560533791|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
155301206|NCT03144674|560533792|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
155301207|NCT03144674|560533793|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
155301208|NCT03144674|560533794|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
155301209|NCT03144674|560533791|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301210|NCT03144674|560533792|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301211|NCT03144674|560533793|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301212|NCT03144674|560533794|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
155301213|NCT01395758|560533795|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
155301214|NCT01395758|560533796|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155301215|NCT01395758|560533797|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155301216|NCT01759771|560533798|FG000|Overall Study|Withdrawal by Subject|1|||
155301217|NCT01759771|560533799|FG001|Overall Study|Withdrawal by Subject|1|||
155301218|NCT00933400|560533804|FG000|Overall Study|Withdrawal by Subject|21|||
155301219|NCT00933400|560533805|FG001|Overall Study|Withdrawal by Subject|1|||
155301220|NCT02139943|560533806|FG000|Overall Study|Adverse Event|0|||
155301221|NCT02139943|560533807|FG001|Overall Study|Adverse Event|1|||
155301222|NCT02139943|560533808|FG002|Overall Study|Adverse Event|2|||
155301223|NCT02139943|560533806|FG000|Overall Study|Lost to Follow-up|3|||
155301224|NCT02139943|560533807|FG001|Overall Study|Lost to Follow-up|2|||
155301225|NCT02139943|560533808|FG002|Overall Study|Lost to Follow-up|2|||
155301226|NCT02139943|560533806|FG000|Overall Study|Withdrawal by Subject|4|||
155301227|NCT02139943|560533807|FG001|Overall Study|Withdrawal by Subject|3|||
155301228|NCT02139943|560533808|FG002|Overall Study|Withdrawal by Subject|0|||
155301229|NCT02139943|560533806|FG000|Overall Study|Other|0|||
155301230|NCT02139943|560533807|FG001|Overall Study|Other|0|||
155301231|NCT02139943|560533808|FG002|Overall Study|Other|1|||
155301232|NCT02139943|560533806|FG000|Overall Study|Participant wishes to discontinue|2|||
155301233|NCT02139943|560533807|FG001|Overall Study|Participant wishes to discontinue|0|||
155301234|NCT02139943|560533808|FG002|Overall Study|Participant wishes to discontinue|0|||
155301235|NCT02139943|560533806|FG000|Overall Study|Participant in Poor Compliance|1|||
155301236|NCT02139943|560533807|FG001|Overall Study|Participant in Poor Compliance|0|||
155301237|NCT02139943|560533808|FG002|Overall Study|Participant in Poor Compliance|1|||
155301238|NCT02139943|560533806|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
155301239|NCT02139943|560533807|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
155301240|NCT02139943|560533808|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
155301241|NCT01041417|560533809|FG000|Overall Study|Adverse Event|5|||
155301242|NCT01041417|560533810|FG001|Overall Study|Adverse Event|2|||
155301243|NCT01041417|560533809|FG000|Overall Study|Lost to Follow-up|1|||
155301244|NCT01041417|560533810|FG001|Overall Study|Lost to Follow-up|1|||
155301245|NCT01041417|560533809|FG000|Overall Study|Death|1|||
155301246|NCT01041417|560533810|FG001|Overall Study|Death|0|||
155301247|NCT01616459|560533816|FG000|Overall Study|Adverse Event|1|||
155301248|NCT01616459|560533817|FG001|Overall Study|Adverse Event|1|||
155301249|NCT01616459|560533818|FG002|Overall Study|Adverse Event|2|||
155301250|NCT01616459|560533819|FG003|Overall Study|Adverse Event|0|||
155301251|NCT01616459|560533816|FG000|Overall Study|Lost to Follow-up|1|||
155301252|NCT01616459|560533817|FG001|Overall Study|Lost to Follow-up|11|||
155301253|NCT01616459|560533818|FG002|Overall Study|Lost to Follow-up|3|||
155301254|NCT01616459|560533819|FG003|Overall Study|Lost to Follow-up|2|||
155301255|NCT01616459|560533816|FG000|Overall Study|Protocol Violation|0|||
155301256|NCT01616459|560533817|FG001|Overall Study|Protocol Violation|0|||
155301257|NCT01616459|560533818|FG002|Overall Study|Protocol Violation|0|||
155301258|NCT01616459|560533819|FG003|Overall Study|Protocol Violation|2|||
155301259|NCT01616459|560533816|FG000|Overall Study|Withdrawal by Subject|2|||
155301260|NCT01616459|560533817|FG001|Overall Study|Withdrawal by Subject|4|||
155301261|NCT01616459|560533818|FG002|Overall Study|Withdrawal by Subject|4|||
155301262|NCT01616459|560533819|FG003|Overall Study|Withdrawal by Subject|4|||
155301263|NCT01616459|560533816|FG000|Overall Study|Other reason|0|||
155301264|NCT01616459|560533817|FG001|Overall Study|Other reason|1|||
155301265|NCT01616459|560533818|FG002|Overall Study|Other reason|1|||
155301266|NCT01616459|560533819|FG003|Overall Study|Other reason|0|||
155301267|NCT04300647|560534866|FG000|Pre-Crossover|Death|19|||
155301268|NCT04300647|560534867|FG001|Pre-Crossover|Death|58|||
155301269|NCT04300647|560534868|FG002|Pre-Crossover|Death|0|||
155301270|NCT04300647|560534866|FG000|Pre-Crossover|Lost to Follow-up|0|||
155301271|NCT04300647|560534867|FG001|Pre-Crossover|Lost to Follow-up|3|||
155301272|NCT04300647|560534868|FG002|Pre-Crossover|Lost to Follow-up|0|||
155301273|NCT04300647|560534866|FG000|Pre-Crossover|Withdrawal by Subject|2|||
155301274|NCT04300647|560534867|FG001|Pre-Crossover|Withdrawal by Subject|4|||
155301275|NCT04300647|560534868|FG002|Pre-Crossover|Withdrawal by Subject|0|||
155301276|NCT04300647|560534866|FG000|Pre-Crossover|On-going in Study|24|||
155301277|NCT04300647|560534867|FG001|Pre-Crossover|On-going in Study|61|||
155301278|NCT04300647|560534868|FG002|Pre-Crossover|On-going in Study|0|||
155301279|NCT04300647|560534866|FG000|Post-Crossover|Death|0|||
155301280|NCT04300647|560534867|FG001|Post-Crossover|Death|0|||
155301281|NCT04300647|560534868|FG002|Post-Crossover|Death|3|||
155301282|NCT04300647|560534866|FG000|Post-Crossover|Lost to Follow-up|0|||
155301283|NCT04300647|560534867|FG001|Post-Crossover|Lost to Follow-up|0|||
155301284|NCT04300647|560534868|FG002|Post-Crossover|Lost to Follow-up|1|||
155301285|NCT04300647|560534866|FG000|Post-Crossover|Withdrawal by Subject|0|||
155301286|NCT04300647|560534867|FG001|Post-Crossover|Withdrawal by Subject|0|||
155301287|NCT04300647|560534868|FG002|Post-Crossover|Withdrawal by Subject|1|||
155301288|NCT04300647|560534866|FG000|Post-Crossover|On-going in Study|0|||
155301289|NCT04300647|560534867|FG001|Post-Crossover|On-going in Study|0|||
155301290|NCT04300647|560534868|FG002|Post-Crossover|On-going in Study|8|||
155641070|NCT00924651|561776759|FG000|Overall Study|Changed Mind|10|||
155641071|NCT00924651|561776760|FG001|Overall Study|Changed Mind|1|||
155301291|NCT05386238|560534869|FG000|Overall Study|Lost to Follow-up|3|||
155301292|NCT05386238|560534870|FG001|Overall Study|Lost to Follow-up|2|||
155301293|NCT05386238|560534869|FG000|Overall Study|Withdrawal by Subject|0|||
155301294|NCT05386238|560534870|FG001|Overall Study|Withdrawal by Subject|1|||
155301295|NCT04907474|560534871|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
155301296|NCT04907474|560534872|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
155301297|NCT01353313|560534874|FG000|Overall Study|Lost to Follow-up|22|||
155641072|NCT00924651|561776759|FG000|Overall Study|Incomplete Form|2|||
155641073|NCT00924651|561776760|FG001|Overall Study|Incomplete Form|1|||
155301298|NCT01353313|560534875|FG001|Overall Study|Lost to Follow-up|23|||
155301299|NCT01353313|560534874|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
155301300|NCT01353313|560534875|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
155301301|NCT04755660|560534876|FG000|Overall Study|Lost to Follow-up|1|||
155301302|NCT04755660|560534877|FG001|Overall Study|Lost to Follow-up|1|||
155301303|NCT04755660|560534878|FG002|Overall Study|Lost to Follow-up|0|||
155301304|NCT04755660|560534876|FG000|Overall Study|Withdrawal by Subject|0|||
155301305|NCT04755660|560534877|FG001|Overall Study|Withdrawal by Subject|1|||
155301306|NCT04755660|560534878|FG002|Overall Study|Withdrawal by Subject|1|||
155747012|NCT04098224|562174777|FG001|Overall Study|Patient failure nasogastric tube|0|||
155747013|NCT04098224|562174776|FG000|Overall Study|Patient early extubation|1|||
155301307|NCT04755660|560534876|FG000|Overall Study|Physician Decision|0|||
155301308|NCT04755660|560534877|FG001|Overall Study|Physician Decision|0|||
155747014|NCT04098224|562174777|FG001|Overall Study|Patient early extubation|3|||
155747015|NCT01587898|562174787|FG000|Overall Study|Adverse Event|1|||
155747016|NCT01587898|562174788|FG001|Overall Study|Adverse Event|1|||
155747017|NCT01587898|562174789|FG002|Overall Study|Adverse Event|0|||
155747018|NCT01587898|562174790|FG003|Overall Study|Adverse Event|0|||
155747019|NCT01587898|562174787|FG000|Overall Study|Protocol Violation|0|||
155747020|NCT01587898|562174788|FG001|Overall Study|Protocol Violation|2|||
155747021|NCT01587898|562174789|FG002|Overall Study|Protocol Violation|1|||
155747022|NCT01587898|562174790|FG003|Overall Study|Protocol Violation|1|||
155747023|NCT01587898|562174787|FG000|Overall Study|Lost to Follow-up|0|||
155747024|NCT01587898|562174788|FG001|Overall Study|Lost to Follow-up|0|||
155747025|NCT01587898|562174789|FG002|Overall Study|Lost to Follow-up|0|||
155747026|NCT01587898|562174790|FG003|Overall Study|Lost to Follow-up|1|||
155301309|NCT04755660|560534878|FG002|Overall Study|Physician Decision|1|||
155301310|NCT02824029|560534879|FG000|Overall Study|Didn't receive treatment|2|||
155301311|NCT02824029|560534879|FG000|Overall Study|Patient decision to discontinue treatment|3|||
155301312|NCT02824029|560534879|FG000|Overall Study|Non-compliant|5|||
155301313|NCT02824029|560534879|FG000|Overall Study|Progression of disease|15|||
155301314|NCT02824029|560534879|FG000|Overall Study|Inadequate response to therapy|2|||
155301315|NCT02824029|560534879|FG000|Overall Study|Possible progression per treating physician|1|||
155301316|NCT05672667|560534880|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
155301317|NCT04524390|560534881|FG000|Double Blind|Consent Withdrawal by subject|2|||
155301318|NCT04524390|560534882|FG001|Double Blind|Consent Withdrawal by subject|1|||
155301319|NCT04524390|560534883|FG002|Double Blind|Consent Withdrawal by subject|0|||
155301320|NCT04524390|560534881|FG000|Double Blind|Adverse Event|5|||
155301321|NCT04524390|560534882|FG001|Double Blind|Adverse Event|3|||
155301322|NCT04524390|560534883|FG002|Double Blind|Adverse Event|0|||
155301323|NCT04524390|560534881|FG000|Double Blind|Liver Transplant|5|||
155301324|NCT04524390|560534882|FG001|Double Blind|Liver Transplant|6|||
155301325|NCT04524390|560534883|FG002|Double Blind|Liver Transplant|0|||
155301326|NCT04524390|560534881|FG000|Double Blind|Disease Progression|0|||
155301327|NCT04524390|560534882|FG001|Double Blind|Disease Progression|1|||
155301328|NCT04524390|560534883|FG002|Double Blind|Disease Progression|0|||
155301329|NCT04524390|560534881|FG000|Open-Label|Drug interruption criteria|0|||
155301330|NCT04524390|560534882|FG001|Open-Label|Drug interruption criteria|0|||
155301331|NCT04524390|560534883|FG002|Open-Label|Drug interruption criteria|1|||
155301332|NCT04524390|560534881|FG000|Open-Label|Liver Transplant|0|||
155301333|NCT04524390|560534882|FG001|Open-Label|Liver Transplant|0|||
155301334|NCT04524390|560534883|FG002|Open-Label|Liver Transplant|1|||
155301335|NCT04524390|560534881|FG000|Open-Label|Disease Progression|0|||
155301336|NCT04524390|560534882|FG001|Open-Label|Disease Progression|0|||
155301337|NCT04524390|560534883|FG002|Open-Label|Disease Progression|1|||
155301338|NCT04524390|560534881|FG000|Open-Label|Adverse Event|0|||
155301339|NCT04524390|560534882|FG001|Open-Label|Adverse Event|0|||
155301340|NCT04524390|560534883|FG002|Open-Label|Adverse Event|3|||
155301341|NCT04524390|560534881|FG000|Open-Label|Study Termination by sponsor|0|||
155301342|NCT04524390|560534882|FG001|Open-Label|Study Termination by sponsor|0|||
155301343|NCT04524390|560534883|FG002|Open-Label|Study Termination by sponsor|45|||
155301344|NCT03873779|560534884|FG000|Overall Study|Withdrawal by Subject|1|||
155301345|NCT02581215|560534885|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
155301346|NCT02581215|560534886|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
155301347|NCT02581215|560534885|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155301348|NCT02581215|560534886|FG001|Overall Study|Eligibility Criteria Not Met|1|||
155301349|NCT01693120|560534895|FG000|Enrollment|Lost to Follow-up|1|||
155301350|NCT01693120|560534895|FG000|Enrollment|Withdrawal by Subject|10|||
155301351|NCT01693120|560534895|FG000|Enrollment|Protocol Violation|46|||
155301352|NCT01693120|560534895|FG000|Enrollment|Physician Decision|3|||
155301353|NCT01693120|560534895|FG000|Enrollment|Adverse Event|1|||
155301354|NCT01693120|560534895|FG000|Enrollment|Study closed|8|||
155301355|NCT01693120|560534895|FG000|Enrollment|Other|1|||
155301356|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
155301357|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
155301358|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
155301359|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
155301360|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
155301361|NCT04153565|560534896|FG000|Overall Study|Death|13|||
155301362|NCT02300298|560534904|FG000|Disposition for Nintedanib|Progressive disease|10|||
155301363|NCT02300298|560534905|FG001|Disposition for Nintedanib|Progressive disease|0|||
155410755|NCT03257267|560937475|FG000|Overall Study|Lost to Follow-up|2|||
155301364|NCT02300298|560534904|FG000|Disposition for Docetaxel|Progressive disease|0|||
155301365|NCT02300298|560534905|FG001|Disposition for Docetaxel|Progressive disease|6|||
155301366|NCT02300298|560534904|FG000|Disposition for Docetaxel|other adverse event|0|||
155301367|NCT02300298|560534905|FG001|Disposition for Docetaxel|other adverse event|4|||
155301368|NCT03285763|560534906|FG000|Overall Study|Death|470|||
155301369|NCT03285763|560534906|FG000|Overall Study|Lost to Follow-up|18|||
155301370|NCT03285763|560534906|FG000|Overall Study|Physician Decision|2|||
155301371|NCT03285763|560534906|FG000|Overall Study|Study Terminated By Sponsor|79|||
155301372|NCT03285763|560534906|FG000|Overall Study|Withdrawal by Subject|33|||
155747027|NCT01587898|562174787|FG000|Overall Study|Withdrawal by Subject|2|||
155747028|NCT01587898|562174788|FG001|Overall Study|Withdrawal by Subject|1|||
155747029|NCT01587898|562174789|FG002|Overall Study|Withdrawal by Subject|0|||
155747030|NCT01587898|562174790|FG003|Overall Study|Withdrawal by Subject|0|||
155747031|NCT01587898|562174787|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
155747032|NCT01587898|562174788|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
155747033|NCT01587898|562174789|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
155301373|NCT00610649|560534907|FG000|Overall Study|Adverse Event|1|||
155301374|NCT00610649|560534908|FG001|Overall Study|Adverse Event|0|||
155301375|NCT00610649|560534909|FG002|Overall Study|Adverse Event|0|||
155301376|NCT00610649|560534910|FG003|Overall Study|Adverse Event|0|||
155301377|NCT00610649|560534911|FG004|Overall Study|Adverse Event|0|||
155301378|NCT00610649|560534912|FG005|Overall Study|Adverse Event|0|||
155301379|NCT00610649|560534913|FG006|Overall Study|Adverse Event|0|||
155301380|NCT00610649|560534914|FG007|Overall Study|Adverse Event|0|||
155301381|NCT00610649|560534915|FG008|Overall Study|Adverse Event|0|||
155301382|NCT00610649|560534916|FG009|Overall Study|Adverse Event|0|||
155301383|NCT00610649|560534917|FG010|Overall Study|Adverse Event|1|||
155301384|NCT00610649|560534907|FG000|Overall Study|Family Emergency|0|||
155301385|NCT00610649|560534908|FG001|Overall Study|Family Emergency|1|||
155301386|NCT00610649|560534909|FG002|Overall Study|Family Emergency|0|||
155301387|NCT00610649|560534910|FG003|Overall Study|Family Emergency|0|||
155301388|NCT00610649|560534911|FG004|Overall Study|Family Emergency|0|||
155301389|NCT00610649|560534912|FG005|Overall Study|Family Emergency|0|||
155747034|NCT01587898|562174790|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
155747035|NCT01738477|562174791|FG000|Overall Study|Lost to Follow-up|1|||
155747036|NCT01738477|562174792|FG001|Overall Study|Lost to Follow-up|4|||
155747037|NCT02437110|562174793|FG000|Screening|Lost to Follow-up|3|||
155747038|NCT02437110|562174793|FG000|Screening|Physician Decision|1|||
155747039|NCT02437110|562174793|FG000|ART|Adverse Event|3|||
155301390|NCT00610649|560534913|FG006|Overall Study|Family Emergency|0|||
155301391|NCT00610649|560534914|FG007|Overall Study|Family Emergency|0|||
155301392|NCT00610649|560534915|FG008|Overall Study|Family Emergency|0|||
155301393|NCT00610649|560534916|FG009|Overall Study|Family Emergency|0|||
155301394|NCT00610649|560534917|FG010|Overall Study|Family Emergency|0|||
155747040|NCT02437110|562174793|FG000|ART|Protocol Violation|3|||
155747041|NCT02437110|562174793|FG000|ART|Withdrawal by Subject|4|||
155747042|NCT02437110|562174793|FG000|ART|Lost to follow-up prior to start of intervention|1|||
155747043|NCT02437110|562174793|FG000|ART|Physician decision prior to start of intervention|2|||
155301395|NCT00610649|560534907|FG000|Overall Study|Withdrawal by Subject|0|||
155747044|NCT02437110|562174793|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
155747045|NCT02437110|562174793|FG000|Post-ART|Lost to Follow-up|3|||
155747046|NCT02437110|562174793|FG000|Post-ART|Protocol Violation|4|||
155747047|NCT02437110|562174793|FG000|Post-ART|Withdrawal by Subject|3|||
155747048|NCT03735238|562174794|FG000|Overall Study|Did not want to participate in research|3|||
155747049|NCT03735238|562174794|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
155747050|NCT01261780|562174795|FG000|Overall Study|Withdrawal by Subject|1|||
155301396|NCT00610649|560534908|FG001|Overall Study|Withdrawal by Subject|0|||
155301397|NCT00610649|560534909|FG002|Overall Study|Withdrawal by Subject|0|||
155301398|NCT00610649|560534910|FG003|Overall Study|Withdrawal by Subject|0|||
155301399|NCT00610649|560534911|FG004|Overall Study|Withdrawal by Subject|0|||
155301400|NCT00610649|560534912|FG005|Overall Study|Withdrawal by Subject|0|||
155410756|NCT03257267|560937476|FG001|Overall Study|Lost to Follow-up|2|||
155301401|NCT00610649|560534913|FG006|Overall Study|Withdrawal by Subject|0|||
155301402|NCT00610649|560534914|FG007|Overall Study|Withdrawal by Subject|0|||
155301403|NCT00610649|560534915|FG008|Overall Study|Withdrawal by Subject|0|||
155301404|NCT00610649|560534916|FG009|Overall Study|Withdrawal by Subject|1|||
155301405|NCT00610649|560534917|FG010|Overall Study|Withdrawal by Subject|0|||
155301406|NCT02379819|560534925|FG000|Overall Study|Withdrawal by Subject|10|||
155301407|NCT02379819|560534925|FG000|Overall Study|Death|2|||
155301408|NCT02379819|560534925|FG000|Overall Study|Lack of Efficacy|1|||
155301409|NCT02379819|560534925|FG000|Overall Study|Lost to Follow-up|1|||
155301410|NCT01839331|560534926|FG000|Overall Study|Early Termination|3|||
155301411|NCT01839331|560534927|FG001|Overall Study|Early Termination|0|||
155301412|NCT01839331|560534928|FG002|Overall Study|Early Termination|1|||
155301413|NCT01839331|560534929|FG003|Overall Study|Early Termination|2|||
155301414|NCT01839331|560534926|FG000|Overall Study|Protocol Violation|1|||
155301415|NCT01839331|560534927|FG001|Overall Study|Protocol Violation|6|||
155301416|NCT01839331|560534928|FG002|Overall Study|Protocol Violation|4|||
155301417|NCT01839331|560534929|FG003|Overall Study|Protocol Violation|3|||
155301418|NCT03074331|560534935|FG000|Overall Study|Enrolled but Not Treated|1|||
155301419|NCT03074331|560534935|FG000|Overall Study|Lost to Follow-up|5|||
155301420|NCT03074331|560534935|FG000|Overall Study|Withdrew Consent|1|||
155301421|NCT00350792|560534937|FG000|Overall Study|Adverse Event|11|||
155301422|NCT00350792|560534937|FG000|Overall Study|Death from Study Disease|1|||
155301423|NCT00350792|560534937|FG000|Overall Study|Death from Study Drug Toxicity|1|||
155301424|NCT00350792|560534937|FG000|Overall Study|Death Not Study Drug Related|2|||
155301425|NCT00350792|560534937|FG000|Overall Study|Protocol Violation|1|||
155301426|NCT00350792|560534937|FG000|Overall Study|Withdrawal by Subject|4|||
155301427|NCT00350792|560534937|FG000|Overall Study|Physician Decision|2|||
155301428|NCT00350792|560534937|FG000|Overall Study|Lack of Efficacy|11|||
155301429|NCT03451721|560534938|FG000|Overall Study|Death|1|||
155301430|NCT00960141|560534939|FG000|Overall Study|Adverse Event|4|||
155301431|NCT00960141|560534940|FG001|Overall Study|Adverse Event|8|||
155301432|NCT00960141|560534941|FG002|Overall Study|Adverse Event|2|||
155301433|NCT00960141|560534939|FG000|Overall Study|Lack of Efficacy|3|||
155301434|NCT00960141|560534940|FG001|Overall Study|Lack of Efficacy|4|||
155301435|NCT00960141|560534941|FG002|Overall Study|Lack of Efficacy|2|||
155301436|NCT00960141|560534939|FG000|Overall Study|Lost to Follow-up|1|||
155301437|NCT00960141|560534940|FG001|Overall Study|Lost to Follow-up|0|||
155301438|NCT00960141|560534941|FG002|Overall Study|Lost to Follow-up|0|||
155301439|NCT00960141|560534939|FG000|Overall Study|Protocol Violation|1|||
155301440|NCT00960141|560534940|FG001|Overall Study|Protocol Violation|3|||
155301441|NCT00960141|560534941|FG002|Overall Study|Protocol Violation|2|||
155301442|NCT00960141|560534939|FG000|Overall Study|Withdrawal by Subject|1|||
155301443|NCT00960141|560534940|FG001|Overall Study|Withdrawal by Subject|2|||
155301444|NCT00960141|560534941|FG002|Overall Study|Withdrawal by Subject|1|||
155301445|NCT05274217|560534942|FG000|Overall Study|Study terminated.|11|||
155301446|NCT05274217|560534943|FG001|Overall Study|Study terminated.|0|||
155301447|NCT04556981|560534945|FG000|Overall Study|Death|0|||
155301448|NCT04556981|560534946|FG001|Overall Study|Death|1|||
155301449|NCT04556981|560534945|FG000|Overall Study|Lost to Follow-up|2|||
155301450|NCT04556981|560534946|FG001|Overall Study|Lost to Follow-up|11|||
155641074|NCT01797185|561776761|FG000|Overall Study|Adverse Event|5|||
155641075|NCT01797185|561776762|FG001|Overall Study|Adverse Event|15|||
155641076|NCT01797185|561776763|FG002|Overall Study|Adverse Event|6|||
155641077|NCT01797185|561776761|FG000|Overall Study|Withdrawal by Subject|6|||
155641078|NCT01797185|561776762|FG001|Overall Study|Withdrawal by Subject|9|||
155641079|NCT01797185|561776763|FG002|Overall Study|Withdrawal by Subject|5|||
155641080|NCT01797185|561776761|FG000|Overall Study|Site terminated|8|||
155641081|NCT01797185|561776762|FG001|Overall Study|Site terminated|4|||
155641082|NCT01797185|561776763|FG002|Overall Study|Site terminated|0|||
155641083|NCT01797185|561776761|FG000|Overall Study|Lost to Follow-up|2|||
155301451|NCT04556981|560534945|FG000|Overall Study|Moved from the study area|1|||
155301452|NCT04556981|560534946|FG001|Overall Study|Moved from the study area|4|||
155301453|NCT04556981|560534945|FG000|Overall Study|Withdrawal by Subject|2|||
155301454|NCT04556981|560534946|FG001|Overall Study|Withdrawal by Subject|2|||
155301455|NCT04556981|560534945|FG000|Overall Study|Other|2|||
155301456|NCT04556981|560534946|FG001|Overall Study|Other|1|||
155301457|NCT03764475|560534947|FG000|Overall Study|Adverse Event|11|||
155301458|NCT03764475|560534948|FG001|Overall Study|Adverse Event|2|||
155301459|NCT03764475|560534947|FG000|Overall Study|Lost to Follow-up|24|||
155301460|NCT03764475|560534948|FG001|Overall Study|Lost to Follow-up|10|||
155641084|NCT01797185|561776762|FG001|Overall Study|Lost to Follow-up|6|||
155641085|NCT01797185|561776763|FG002|Overall Study|Lost to Follow-up|1|||
155641086|NCT01797185|561776761|FG000|Overall Study|Withdrawn per sponsor|5|||
155301461|NCT03764475|560534947|FG000|Overall Study|Withdrawal by Subject|26|||
155301462|NCT03764475|560534948|FG001|Overall Study|Withdrawal by Subject|10|||
155301463|NCT03764475|560534947|FG000|Overall Study|Lack of Efficacy|3|||
155301464|NCT03764475|560534948|FG001|Overall Study|Lack of Efficacy|0|||
155641087|NCT01797185|561776762|FG001|Overall Study|Withdrawn per sponsor|0|||
155641088|NCT01797185|561776763|FG002|Overall Study|Withdrawn per sponsor|0|||
155301465|NCT03764475|560534947|FG000|Overall Study|COVID-19 Disruption|2|||
155301466|NCT03764475|560534948|FG001|Overall Study|COVID-19 Disruption|0|||
155301467|NCT00580866|560534949|FG000|Overall Study|Lost to Follow-up|2|||
155301468|NCT00580866|560534950|FG001|Overall Study|Lost to Follow-up|2|||
155301469|NCT02574455|560534954|FG000|Overall Study|Death|197|||
155301470|NCT02574455|560534955|FG001|Overall Study|Death|210|||
155301471|NCT02574455|560534954|FG000|Overall Study|Withdrawal of Consent|11|||
155301472|NCT02574455|560534955|FG001|Overall Study|Withdrawal of Consent|28|||
155301473|NCT02574455|560534954|FG000|Overall Study|Lost to Follow-up|4|||
155301474|NCT02574455|560534955|FG001|Overall Study|Lost to Follow-up|4|||
155301475|NCT02574455|560534954|FG000|Overall Study|Sponsor's Decision|55|||
155301476|NCT02574455|560534955|FG001|Overall Study|Sponsor's Decision|20|||
155301477|NCT05510245|560534959|FG000|Overall Study|Withdrawal by Subject|1|||
155301478|NCT05510245|560534960|FG001|Overall Study|Withdrawal by Subject|0|||
155301479|NCT05510245|560534961|FG002|Overall Study|Withdrawal by Subject|0|||
155301480|NCT01415349|560534967|FG000|Treatment Period 1|Adverse Event|0|||
155301481|NCT01415349|560534968|FG001|Treatment Period 1|Adverse Event|1|||
155301482|NCT01415349|560534967|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155301483|NCT01415349|560534968|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155301484|NCT00716859|560534971|FG000|Overall Study|Adverse Event|4|||
155301485|NCT00716859|560534972|FG001|Overall Study|Adverse Event|1|||
155301486|NCT00716859|560534971|FG000|Overall Study|Lack of Efficacy|3|||
155301487|NCT00716859|560534972|FG001|Overall Study|Lack of Efficacy|0|||
155301488|NCT00716859|560534971|FG000|Overall Study|Withdrawal by Subject|1|||
155301489|NCT00716859|560534972|FG001|Overall Study|Withdrawal by Subject|3|||
155301490|NCT00716859|560534971|FG000|Overall Study|Not treated|1|||
155301491|NCT00716859|560534972|FG001|Overall Study|Not treated|1|||
155301492|NCT00411216|560534973|FG000|Overall Study|Ten participants were entered into the c|0|||
155301493|NCT00411216|560534974|FG001|Overall Study|Ten participants were entered into the c|2|||
155301494|NCT04922021|560536304|FG000|Overall Study|Withdrawal by Subject|4|||
155301495|NCT04922021|560536305|FG001|Overall Study|Withdrawal by Subject|10|||
155301496|NCT04922021|560536304|FG000|Overall Study|Adverse Event|2|||
155301497|NCT04922021|560536305|FG001|Overall Study|Adverse Event|2|||
155301498|NCT04922021|560536304|FG000|Overall Study|Lack of Efficacy|0|||
155301499|NCT04922021|560536305|FG001|Overall Study|Lack of Efficacy|1|||
155301500|NCT04922021|560536304|FG000|Overall Study|Multiple reasons|1|||
155301501|NCT04922021|560536305|FG001|Overall Study|Multiple reasons|0|||
155301502|NCT03237481|560536308|FG000|Overall Study|Lost to Follow-up|1|||
155301503|NCT03237481|560536309|FG001|Overall Study|Lost to Follow-up|0|||
155301504|NCT03237481|560536310|FG002|Overall Study|Lost to Follow-up|0|||
155301505|NCT03237481|560536308|FG000|Overall Study|Protocol Violation|1|||
155301506|NCT03237481|560536309|FG001|Overall Study|Protocol Violation|0|||
155301507|NCT03237481|560536310|FG002|Overall Study|Protocol Violation|0|||
155301508|NCT03237481|560536308|FG000|Overall Study|Withdrawal by Subject|3|||
155301509|NCT03237481|560536309|FG001|Overall Study|Withdrawal by Subject|2|||
155301510|NCT03237481|560536310|FG002|Overall Study|Withdrawal by Subject|1|||
155301511|NCT02544074|560536311|FG000|Overall Study|Withdrawal by Subject|0|||
155301512|NCT02544074|560536312|FG001|Overall Study|Withdrawal by Subject|1|||
155301513|NCT02544074|560536313|FG002|Overall Study|Withdrawal by Subject|0|||
155301514|NCT02544074|560536314|FG003|Overall Study|Withdrawal by Subject|0|||
155301515|NCT02544074|560536315|FG004|Overall Study|Withdrawal by Subject|0|||
155301516|NCT02544074|560536316|FG005|Overall Study|Withdrawal by Subject|0|||
155301517|NCT02544074|560536317|FG006|Overall Study|Withdrawal by Subject|0|||
155301518|NCT02544074|560536318|FG007|Overall Study|Withdrawal by Subject|0|||
155301519|NCT02544074|560536319|FG008|Overall Study|Withdrawal by Subject|0|||
155301520|NCT02544074|560536320|FG009|Overall Study|Withdrawal by Subject|0|||
155301521|NCT02544074|560536321|FG010|Overall Study|Withdrawal by Subject|0|||
155301522|NCT02544074|560536322|FG011|Overall Study|Withdrawal by Subject|0|||
155301523|NCT02544074|560536323|FG012|Overall Study|Withdrawal by Subject|0|||
155301524|NCT02544074|560536324|FG013|Overall Study|Withdrawal by Subject|0|||
155301525|NCT02544074|560536325|FG014|Overall Study|Withdrawal by Subject|0|||
155301526|NCT02544074|560536326|FG015|Overall Study|Withdrawal by Subject|0|||
155301527|NCT02544074|560536327|FG016|Overall Study|Withdrawal by Subject|0|||
155301528|NCT02544074|560536328|FG017|Overall Study|Withdrawal by Subject|0|||
155301529|NCT02544074|560536329|FG018|Overall Study|Withdrawal by Subject|0|||
155301530|NCT02544074|560536330|FG019|Overall Study|Withdrawal by Subject|0|||
155301531|NCT02544074|560536331|FG020|Overall Study|Withdrawal by Subject|0|||
155301532|NCT02544074|560536311|FG000|Overall Study|Tablet error|0|||
155301533|NCT02544074|560536312|FG001|Overall Study|Tablet error|0|||
155301534|NCT02544074|560536313|FG002|Overall Study|Tablet error|0|||
155301535|NCT02544074|560536314|FG003|Overall Study|Tablet error|0|||
155301536|NCT02544074|560536315|FG004|Overall Study|Tablet error|0|||
155301537|NCT02544074|560536316|FG005|Overall Study|Tablet error|1|||
155301538|NCT02544074|560536317|FG006|Overall Study|Tablet error|0|||
155301539|NCT02544074|560536318|FG007|Overall Study|Tablet error|0|||
155301540|NCT02544074|560536319|FG008|Overall Study|Tablet error|0|||
155301541|NCT02544074|560536320|FG009|Overall Study|Tablet error|1|||
155301542|NCT02544074|560536321|FG010|Overall Study|Tablet error|0|||
155301543|NCT02544074|560536322|FG011|Overall Study|Tablet error|0|||
155301544|NCT02544074|560536323|FG012|Overall Study|Tablet error|0|||
155301545|NCT02544074|560536324|FG013|Overall Study|Tablet error|0|||
155301546|NCT02544074|560536325|FG014|Overall Study|Tablet error|0|||
155301547|NCT02544074|560536326|FG015|Overall Study|Tablet error|0|||
155301548|NCT02544074|560536327|FG016|Overall Study|Tablet error|0|||
155301549|NCT02544074|560536328|FG017|Overall Study|Tablet error|0|||
155301550|NCT02544074|560536329|FG018|Overall Study|Tablet error|0|||
155301551|NCT02544074|560536330|FG019|Overall Study|Tablet error|0|||
155301552|NCT02544074|560536331|FG020|Overall Study|Tablet error|0|||
155301553|NCT01998984|560536332|FG000|Overall Study|Adverse Event|0|||
155301554|NCT01998984|560536333|FG001|Overall Study|Adverse Event|0|||
155301555|NCT01998984|560536334|FG002|Overall Study|Adverse Event|0|||
155301556|NCT01998984|560536335|FG003|Overall Study|Adverse Event|1|||
155301557|NCT01998984|560536332|FG000|Overall Study|Lost to Follow-up|0|||
155301558|NCT01998984|560536333|FG001|Overall Study|Lost to Follow-up|1|||
155301559|NCT01998984|560536334|FG002|Overall Study|Lost to Follow-up|0|||
155301560|NCT01998984|560536335|FG003|Overall Study|Lost to Follow-up|1|||
155301561|NCT01998984|560536332|FG000|Overall Study|Withdrawal by Subject|0|||
155301562|NCT01998984|560536333|FG001|Overall Study|Withdrawal by Subject|0|||
155301563|NCT01998984|560536334|FG002|Overall Study|Withdrawal by Subject|1|||
155301564|NCT01998984|560536335|FG003|Overall Study|Withdrawal by Subject|0|||
155301565|NCT01998984|560536332|FG000|Overall Study|Other|0|||
155301566|NCT01998984|560536333|FG001|Overall Study|Other|0|||
155301567|NCT01998984|560536334|FG002|Overall Study|Other|0|||
155301568|NCT01998984|560536335|FG003|Overall Study|Other|1|||
155301569|NCT04279574|560536337|FG000|Overall Study|Death|1|||
155301570|NCT04279574|560536338|FG001|Overall Study|Death|0|||
155301571|NCT04279574|560536337|FG000|Overall Study|lost restoration, tooth fracture|1|||
155301572|NCT04279574|560536338|FG001|Overall Study|lost restoration, tooth fracture|0|||
155301573|NCT04279574|560536337|FG000|Overall Study|Lost to Follow-up|0|||
155301574|NCT04279574|560536338|FG001|Overall Study|Lost to Follow-up|1|||
155301575|NCT02566902|560536340|FG000|Overall Study|Protocol Violation|2|||
155301576|NCT02566902|560536341|FG001|Overall Study|Protocol Violation|1|||
155301577|NCT02411084|560536342|FG000|Overall Study|Lack of Efficacy|6|||
155301578|NCT02411084|560536343|FG001|Overall Study|Lack of Efficacy|3|||
155301579|NCT02411084|560536342|FG000|Overall Study|Death|5|||
155301580|NCT02411084|560536343|FG001|Overall Study|Death|4|||
155301581|NCT02411084|560536342|FG000|Overall Study|Adverse Event|2|||
155301582|NCT02411084|560536343|FG001|Overall Study|Adverse Event|1|||
155301583|NCT02411084|560536342|FG000|Overall Study|Other reasons|0|||
155301584|NCT02411084|560536343|FG001|Overall Study|Other reasons|5|||
155301585|NCT03624972|560536344|FG000|Overall Study|Lost to Follow-up|2|||
155301586|NCT03624972|560536345|FG001|Overall Study|Lost to Follow-up|0|||
155301587|NCT03624972|560536346|FG002|Overall Study|Lost to Follow-up|0|||
155301588|NCT03624972|560536344|FG000|Overall Study|Withdrawal by Subject|0|||
155301589|NCT03624972|560536345|FG001|Overall Study|Withdrawal by Subject|2|||
155301590|NCT03624972|560536346|FG002|Overall Study|Withdrawal by Subject|0|||
155301591|NCT02647905|560536359|FG000|Overall Study|Lost to Follow-up|1|||
155301592|NCT02647905|560536359|FG000|Overall Study|Withdrawal by Subject|2|||
155301593|NCT00642850|560536361|FG000|Overall Study|Death|7|||
155301594|NCT00642850|560536361|FG000|Overall Study|Adverse Event|2|||
155301595|NCT00642850|560536361|FG000|Overall Study|Lack of Efficacy|1|||
155301596|NCT00642850|560536361|FG000|Overall Study|Protocol Violation|2|||
155301597|NCT00642850|560536361|FG000|Overall Study|Kidney transplantation|8|||
155301598|NCT00642850|560536361|FG000|Overall Study|Blood transfusion|6|||
155301599|NCT00642850|560536361|FG000|Overall Study|Other reasons|7|||
155301600|NCT05489484|560536364|FG000|Overall Study|withdrawn|1|||
155301601|NCT00444600|560536370|FG000|Overall Study|Death|7|||
155301602|NCT00444600|560536371|FG001|Overall Study|Death|5|||
155301603|NCT00444600|560536372|FG002|Overall Study|Death|3|||
155301604|NCT00444600|560536373|FG003|Overall Study|Death|2|||
155301605|NCT00444600|560536370|FG000|Overall Study|Dropped|11|||
155301606|NCT00444600|560536371|FG001|Overall Study|Dropped|11|||
155301607|NCT00444600|560536372|FG002|Overall Study|Dropped|7|||
155301608|NCT00444600|560536373|FG003|Overall Study|Dropped|7|||
155301609|NCT00444600|560536370|FG000|Overall Study|Missed visit|1|||
155301610|NCT00444600|560536371|FG001|Overall Study|Missed visit|0|||
155301611|NCT00444600|560536372|FG002|Overall Study|Missed visit|0|||
155301612|NCT00444600|560536373|FG003|Overall Study|Missed visit|1|||
155301613|NCT05132478|560536374|FG000|Overall Study|did not complete survey after consent|1|||
155301614|NCT05132478|560536375|FG001|Overall Study|did not complete survey after consent|1|||
155301615|NCT05132478|560536374|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
155301616|NCT05132478|560536375|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
155301617|NCT00106080|560536376|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
155301618|NCT00106080|560536377|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
155301619|NCT01414738|560536379|FG000|Overall Study|Death|26|||
155301620|NCT01414738|560536379|FG000|Overall Study|Refused testing|5|||
155301621|NCT01414738|560536379|FG000|Overall Study|Lost to Follow-up|2|||
155301622|NCT01414738|560536379|FG000|Overall Study|Refused, disease progression|8|||
155301623|NCT01414738|560536379|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
155301624|NCT01266122|560536380|FG000|Overall Study|Lost to Follow-up|6|||
155301625|NCT01266122|560536381|FG001|Overall Study|Lost to Follow-up|6|||
155301626|NCT00421889|560536382|FG000|Overall Study|Adverse Event|1|||
155301627|NCT00421889|560536383|FG001|Overall Study|Adverse Event|0|||
155301628|NCT00421889|560536384|FG002|Overall Study|Adverse Event|1|||
155301629|NCT00421889|560536385|FG003|Overall Study|Adverse Event|1|||
155301630|NCT00421889|560536386|FG004|Overall Study|Adverse Event|1|||
155301631|NCT00421889|560536387|FG005|Overall Study|Adverse Event|4|||
155301632|NCT00421889|560536388|FG006|Overall Study|Adverse Event|1|||
155301633|NCT00421889|560536389|FG007|Overall Study|Adverse Event|0|||
155301634|NCT00421889|560536390|FG008|Overall Study|Adverse Event|2|||
155301635|NCT00421889|560536382|FG000|Overall Study|Withdrawal by Subject|1|||
155301636|NCT00421889|560536383|FG001|Overall Study|Withdrawal by Subject|3|||
155301637|NCT00421889|560536384|FG002|Overall Study|Withdrawal by Subject|0|||
155301638|NCT00421889|560536385|FG003|Overall Study|Withdrawal by Subject|0|||
155301639|NCT00421889|560536386|FG004|Overall Study|Withdrawal by Subject|2|||
155301640|NCT00421889|560536387|FG005|Overall Study|Withdrawal by Subject|0|||
155301641|NCT00421889|560536388|FG006|Overall Study|Withdrawal by Subject|0|||
155301642|NCT00421889|560536389|FG007|Overall Study|Withdrawal by Subject|0|||
155301643|NCT00421889|560536390|FG008|Overall Study|Withdrawal by Subject|0|||
155301644|NCT00421889|560536382|FG000|Overall Study|Death|0|||
155301645|NCT00421889|560536383|FG001|Overall Study|Death|0|||
155301646|NCT00421889|560536384|FG002|Overall Study|Death|0|||
155301647|NCT00421889|560536385|FG003|Overall Study|Death|0|||
155301648|NCT00421889|560536386|FG004|Overall Study|Death|1|||
155301649|NCT00421889|560536387|FG005|Overall Study|Death|1|||
155301650|NCT00421889|560536388|FG006|Overall Study|Death|0|||
155301651|NCT00421889|560536389|FG007|Overall Study|Death|0|||
155301652|NCT00421889|560536390|FG008|Overall Study|Death|0|||
155301653|NCT00421889|560536382|FG000|Overall Study|Progressive disease|3|||
155301654|NCT00421889|560536383|FG001|Overall Study|Progressive disease|2|||
155301655|NCT00421889|560536384|FG002|Overall Study|Progressive disease|2|||
155301656|NCT00421889|560536385|FG003|Overall Study|Progressive disease|3|||
155301657|NCT00421889|560536386|FG004|Overall Study|Progressive disease|2|||
155301658|NCT00421889|560536387|FG005|Overall Study|Progressive disease|21|||
155301659|NCT00421889|560536388|FG006|Overall Study|Progressive disease|3|||
155301660|NCT00421889|560536389|FG007|Overall Study|Progressive disease|1|||
155301661|NCT00421889|560536390|FG008|Overall Study|Progressive disease|5|||
155301662|NCT00421889|560536382|FG000|Overall Study|Patient/Investigator request|0|||
155301663|NCT00421889|560536383|FG001|Overall Study|Patient/Investigator request|0|||
155301664|NCT00421889|560536384|FG002|Overall Study|Patient/Investigator request|0|||
155301665|NCT00421889|560536385|FG003|Overall Study|Patient/Investigator request|0|||
155301666|NCT00421889|560536386|FG004|Overall Study|Patient/Investigator request|0|||
155301667|NCT00421889|560536387|FG005|Overall Study|Patient/Investigator request|9|||
155301668|NCT00421889|560536388|FG006|Overall Study|Patient/Investigator request|0|||
155301669|NCT00421889|560536389|FG007|Overall Study|Patient/Investigator request|1|||
155301670|NCT00421889|560536390|FG008|Overall Study|Patient/Investigator request|3|||
155301671|NCT00421889|560536382|FG000|Overall Study|Lost to Follow-up|0|||
155301672|NCT00421889|560536383|FG001|Overall Study|Lost to Follow-up|0|||
155301673|NCT00421889|560536384|FG002|Overall Study|Lost to Follow-up|0|||
155301674|NCT00421889|560536385|FG003|Overall Study|Lost to Follow-up|0|||
155301675|NCT00421889|560536386|FG004|Overall Study|Lost to Follow-up|0|||
155301676|NCT00421889|560536387|FG005|Overall Study|Lost to Follow-up|0|||
155301677|NCT00421889|560536388|FG006|Overall Study|Lost to Follow-up|0|||
155301678|NCT00421889|560536389|FG007|Overall Study|Lost to Follow-up|0|||
155301679|NCT00421889|560536390|FG008|Overall Study|Lost to Follow-up|1|||
155301680|NCT03756571|560536391|FG000|Overall Study|Lost to Follow-up|1|||
155301681|NCT03756571|560536392|FG001|Overall Study|Lost to Follow-up|1|||
155301682|NCT00978042|560536393|FG000|Initial Treatment Period|Treated in Error|0|||
155301683|NCT00978042|560536394|FG001|Initial Treatment Period|Treated in Error|3|||
155301684|NCT00978042|560536393|FG000|Initial Treatment Period|Ineligibility|1|||
155301685|NCT00978042|560536394|FG001|Initial Treatment Period|Ineligibility|0|||
155301686|NCT00978042|560536393|FG000|Initial Treatment Period|Lost to Follow-up|21|||
155301687|NCT00978042|560536394|FG001|Initial Treatment Period|Lost to Follow-up|3|||
155301688|NCT00978042|560536393|FG000|Initial Treatment Period|Adverse Event|2|||
155301689|NCT00978042|560536394|FG001|Initial Treatment Period|Adverse Event|0|||
155301690|NCT00978042|560536393|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
155301691|NCT00978042|560536394|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
155301692|NCT00978042|560536393|FG000|Initial Treatment Period|Consent withdrawn|22|||
155747051|NCT01261780|562174796|FG001|Overall Study|Withdrawal by Subject|0|||
155747052|NCT01261780|562174795|FG000|Overall Study|Event not related to subject|1|||
155747053|NCT01261780|562174796|FG001|Overall Study|Event not related to subject|2|||
155747054|NCT01239732|562174797|FG000|Overall Study|Termination of study per protocol|667|||
155301693|NCT00978042|560536394|FG001|Initial Treatment Period|Consent withdrawn|9|||
155301694|NCT00978042|560536393|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
155301695|NCT00978042|560536394|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
155301696|NCT00529516|560536395|FG000|Overall Study|Adverse Event|2|||
155301697|NCT00529516|560536396|FG001|Overall Study|Adverse Event|1|||
155301698|NCT00529516|560536397|FG002|Overall Study|Adverse Event|0|||
155301699|NCT00529516|560536395|FG000|Overall Study|Withdrawal by Subject|1|||
155301700|NCT00529516|560536396|FG001|Overall Study|Withdrawal by Subject|1|||
155301701|NCT00529516|560536397|FG002|Overall Study|Withdrawal by Subject|0|||
155301702|NCT00529516|560536395|FG000|Overall Study|Lost to Follow-up|0|||
155301703|NCT00529516|560536396|FG001|Overall Study|Lost to Follow-up|0|||
155301704|NCT00529516|560536397|FG002|Overall Study|Lost to Follow-up|1|||
155301705|NCT03752151|560536398|FG000|Overall Study|Withdrawal by Subject|1|||
155301706|NCT03752151|560536398|FG000|Overall Study|Protocol Violation|1|||
155301707|NCT00703820|560536401|FG000|Overall Study|Adverse Event|12|||
155301708|NCT00703820|560536402|FG001|Overall Study|Adverse Event|17|||
155301709|NCT00703820|560536401|FG000|Overall Study|Death|5|||
155301710|NCT00703820|560536402|FG001|Overall Study|Death|0|||
155301711|NCT00703820|560536401|FG000|Overall Study|Lack of Efficacy|11|||
155301712|NCT00703820|560536402|FG001|Overall Study|Lack of Efficacy|11|||
155301713|NCT00703820|560536401|FG000|Overall Study|Received non-protocol therapy|1|||
155301714|NCT00703820|560536402|FG001|Overall Study|Received non-protocol therapy|0|||
155301715|NCT00703820|560536401|FG000|Overall Study|Physician Decision|4|||
155301716|NCT00703820|560536402|FG001|Overall Study|Physician Decision|5|||
155301717|NCT00703820|560536401|FG000|Overall Study|Withdrawal by Subject|2|||
155301718|NCT00703820|560536402|FG001|Overall Study|Withdrawal by Subject|1|||
155301719|NCT00761605|560536403|FG000|Overall Study|Adverse Event|26|||
155301720|NCT00761605|560536403|FG000|Overall Study|Death|2|||
155301721|NCT00761605|560536403|FG000|Overall Study|Lack of Efficacy|26|||
155301722|NCT00761605|560536403|FG000|Overall Study|Lost to Follow-up|29|||
155301723|NCT00761605|560536403|FG000|Overall Study|Withdrawal by Subject|37|||
155301724|NCT00761605|560536403|FG000|Overall Study|Other|21|||
155301725|NCT01007396|560536404|FG000|Overall Study|Lost to Follow-up|47|||
155301726|NCT03283371|560536407|FG000|Placebo-controlled|Adverse Event|1|||
155747055|NCT01239732|562174797|FG000|Overall Study|Death|226|||
155747056|NCT01239732|562174797|FG000|Overall Study|Withdrawal by Subject|87|||
155301727|NCT03283371|560536408|FG001|Placebo-controlled|Adverse Event|1|||
155301728|NCT03283371|560536409|FG002|Placebo-controlled|Adverse Event|0|||
155301729|NCT03283371|560536410|FG003|Placebo-controlled|Adverse Event|0|||
155301730|NCT03283371|560536407|FG000|Placebo-controlled|Lack of Efficacy|1|||
155301731|NCT03283371|560536408|FG001|Placebo-controlled|Lack of Efficacy|0|||
155301732|NCT03283371|560536409|FG002|Placebo-controlled|Lack of Efficacy|0|||
155301733|NCT03283371|560536410|FG003|Placebo-controlled|Lack of Efficacy|0|||
155301734|NCT03283371|560536407|FG000|Placebo-controlled|Withdrawal by Subject|1|||
155747057|NCT01239732|562174797|FG000|Overall Study|Adverse Event|6|||
155301735|NCT03283371|560536408|FG001|Placebo-controlled|Withdrawal by Subject|1|||
155301736|NCT03283371|560536409|FG002|Placebo-controlled|Withdrawal by Subject|0|||
155301737|NCT03283371|560536410|FG003|Placebo-controlled|Withdrawal by Subject|0|||
155301738|NCT03283371|560536407|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301739|NCT03283371|560536408|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
155301740|NCT03283371|560536409|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301741|NCT03283371|560536410|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301742|NCT03283371|560536407|FG000|Open-label Phase|Adverse Event|0|||
155301743|NCT03283371|560536408|FG001|Open-label Phase|Adverse Event|0|||
155301744|NCT03283371|560536409|FG002|Open-label Phase|Adverse Event|2|||
155301745|NCT03283371|560536410|FG003|Open-label Phase|Adverse Event|0|||
155301746|NCT03283371|560536407|FG000|Open-label Phase|Withdrawal by Subject|0|||
155301747|NCT03283371|560536408|FG001|Open-label Phase|Withdrawal by Subject|0|||
155301748|NCT03283371|560536409|FG002|Open-label Phase|Withdrawal by Subject|1|||
155301749|NCT03283371|560536410|FG003|Open-label Phase|Withdrawal by Subject|0|||
155301750|NCT03283371|560536407|FG000|Open-label Phase|Other|0|||
155301751|NCT03283371|560536408|FG001|Open-label Phase|Other|0|||
155301752|NCT03283371|560536409|FG002|Open-label Phase|Other|1|||
155301753|NCT03283371|560536410|FG003|Open-label Phase|Other|1|||
155301754|NCT01373346|560536411|FG000|Overall Study|Death|1|||
155301755|NCT01198028|560536412|FG000|Overall Study|Adverse Event|5|||
155301756|NCT01198028|560536412|FG000|Overall Study|Death|3|||
155301757|NCT01198028|560536412|FG000|Overall Study|Physician Decision|2|||
155301758|NCT00970359|560536414|FG000|Overall Study|Not Treated|4|||
155301759|NCT03887650|560536417|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
155301760|NCT03887650|560536418|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
155301761|NCT03887650|560536417|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
155301762|NCT03887650|560536418|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
155301763|NCT03887650|560536417|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
155301764|NCT03887650|560536418|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
155301765|NCT03942042|560536421|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
155301766|NCT03942042|560536422|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
155301767|NCT03942042|560536421|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
155301768|NCT03942042|560536422|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
155301769|NCT01499199|560536423|FG000|Overall Study|Adverse Event|1|||
155301770|NCT01499199|560536423|FG000|Overall Study|Lack of Efficacy|1|||
155301771|NCT01199705|560536424|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
155301772|NCT01692730|560536425|FG000|Overall Study|Lost to Follow-up|225|||
155301773|NCT01692730|560536426|FG001|Overall Study|Lost to Follow-up|227|||
155301774|NCT01199575|560536427|FG000|Overall Study|Withdrawal by Subject|5|||
155301775|NCT00704184|560536430|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
155301776|NCT00704184|560536431|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
155301777|NCT00704184|560536432|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
155301778|NCT00704184|560536433|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
155301779|NCT00704184|560536434|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
155301780|NCT00704184|560536430|FG000|Open-Label Treatment|Adverse Event|0|||
155301781|NCT00704184|560536431|FG001|Open-Label Treatment|Adverse Event|0|||
155301782|NCT00704184|560536432|FG002|Open-Label Treatment|Adverse Event|2|||
155301783|NCT00704184|560536433|FG003|Open-Label Treatment|Adverse Event|0|||
155301784|NCT00704184|560536434|FG004|Open-Label Treatment|Adverse Event|1|||
155301785|NCT00704184|560536430|FG000|Open-Label Treatment|Lack of Efficacy|0|||
155301786|NCT00704184|560536431|FG001|Open-Label Treatment|Lack of Efficacy|2|||
155301787|NCT00704184|560536432|FG002|Open-Label Treatment|Lack of Efficacy|2|||
155301788|NCT00704184|560536433|FG003|Open-Label Treatment|Lack of Efficacy|2|||
155301789|NCT00704184|560536434|FG004|Open-Label Treatment|Lack of Efficacy|1|||
155301790|NCT00704184|560536430|FG000|Open-Label Treatment|Physician Decision|0|||
155301791|NCT00704184|560536431|FG001|Open-Label Treatment|Physician Decision|0|||
155301792|NCT00704184|560536432|FG002|Open-Label Treatment|Physician Decision|0|||
155301793|NCT00704184|560536433|FG003|Open-Label Treatment|Physician Decision|0|||
155301794|NCT00704184|560536434|FG004|Open-Label Treatment|Physician Decision|1|||
155301795|NCT00704184|560536430|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
155301796|NCT00704184|560536431|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155301797|NCT00704184|560536432|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
155301798|NCT00704184|560536433|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
155436098|NCT01059812|561024509|FG000|Overall Study|Unclassified|14|||
155641089|NCT01797185|561776761|FG000|Overall Study|Physician Decision|1|||
155641090|NCT01797185|561776762|FG001|Overall Study|Physician Decision|3|||
155641091|NCT01797185|561776763|FG002|Overall Study|Physician Decision|0|||
155641092|NCT01797185|561776761|FG000|Overall Study|Protocol Violation|1|||
155641093|NCT01797185|561776762|FG001|Overall Study|Protocol Violation|1|||
155641094|NCT01797185|561776763|FG002|Overall Study|Protocol Violation|0|||
155641095|NCT01847209|561776764|FG000|Overall Study|Withdrawal by Subject|1|||
155641096|NCT01847209|561776764|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
155641097|NCT00729586|561776765|FG000|Overall Study|Ineligible|0|||
155747058|NCT01239732|562174797|FG000|Overall Study|Protocol Violation|3|||
155747059|NCT01239732|562174797|FG000|Overall Study|Participant non compliance|5|||
155747060|NCT01239732|562174797|FG000|Overall Study|Study termination by sponsor|2|||
155747061|NCT01239732|562174797|FG000|Overall Study|Investigator's decision|4|||
155301799|NCT00704184|560536434|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
155301800|NCT01251354|560536444|FG000|Overall Study|Adverse Event|1|||
155301801|NCT01251354|560536444|FG000|Overall Study|Investigator's Decision|1|||
155301802|NCT01251354|560536444|FG000|Overall Study|Disease Progression|4|||
155301803|NCT03960463|560538358|FG000|Overall Study|Withdrawal by Subject|2|||
155301804|NCT03960463|560538359|FG001|Overall Study|Withdrawal by Subject|0|||
155301805|NCT03422276|560538360|FG000|Overall Study|Withdrawal by Subject|21|||
155301806|NCT03422276|560538361|FG001|Overall Study|Withdrawal by Subject|25|||
155301807|NCT03422276|560538362|FG002|Overall Study|Withdrawal by Subject|14|||
155301808|NCT03422276|560538363|FG003|Overall Study|Withdrawal by Subject|16|||
155301809|NCT03422276|560538360|FG000|Overall Study|Death|14|||
155301810|NCT03422276|560538361|FG001|Overall Study|Death|21|||
155301811|NCT03422276|560538362|FG002|Overall Study|Death|3|||
155301812|NCT03422276|560538363|FG003|Overall Study|Death|1|||
155301813|NCT03422276|560538360|FG000|Overall Study|Discontinued, ineligible|4|||
155301814|NCT03422276|560538361|FG001|Overall Study|Discontinued, ineligible|3|||
155301815|NCT03422276|560538362|FG002|Overall Study|Discontinued, ineligible|0|||
155301816|NCT03422276|560538363|FG003|Overall Study|Discontinued, ineligible|0|||
155301817|NCT03422276|560538360|FG000|Overall Study|Lost to Follow-up|15|||
155301818|NCT03422276|560538361|FG001|Overall Study|Lost to Follow-up|8|||
155301819|NCT03422276|560538362|FG002|Overall Study|Lost to Follow-up|13|||
155301820|NCT03422276|560538363|FG003|Overall Study|Lost to Follow-up|4|||
155301821|NCT03422276|560538360|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
155301822|NCT03422276|560538361|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
155301823|NCT03422276|560538362|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
155301824|NCT03422276|560538363|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
155301825|NCT03422276|560538360|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
155301826|NCT03422276|560538361|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
155301827|NCT03422276|560538362|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
155301828|NCT03422276|560538363|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
155301829|NCT03422276|560538360|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
155301830|NCT03422276|560538361|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
155301831|NCT03422276|560538362|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
155301832|NCT03422276|560538363|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
155301833|NCT03422276|560538360|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
155301834|NCT03422276|560538361|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
155301835|NCT03422276|560538362|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
155301836|NCT03422276|560538363|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
155301837|NCT03422276|560538360|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301838|NCT03422276|560538361|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301839|NCT03422276|560538362|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
155301840|NCT03422276|560538363|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301841|NCT05194917|560538364|FG000|Overall Study|Lost to Follow-up|7|||
155301842|NCT05194917|560538365|FG001|Overall Study|Lost to Follow-up|5|||
155301843|NCT05194917|560538366|FG002|Overall Study|Lost to Follow-up|6|||
155301844|NCT05194917|560538367|FG003|Overall Study|Lost to Follow-up|5|||
155301845|NCT04941287|560538379|FG000|Overall Study|Rapid decline before starting treatment|3|||
155301846|NCT04941287|560538380|FG001|Overall Study|Rapid decline before starting treatment|1|||
155301847|NCT02991807|560538385|FG000|Overall Study|Withdrawal by Subject|2|||
155301848|NCT02991807|560538386|FG001|Overall Study|Withdrawal by Subject|1|||
155301849|NCT02991807|560538385|FG000|Overall Study|Physician Decision|0|||
155301850|NCT02991807|560538386|FG001|Overall Study|Physician Decision|1|||
155301851|NCT02991807|560538385|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
155301852|NCT02991807|560538386|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
155301853|NCT00332241|560538391|FG000|Overall Study|Lack of Efficacy|6|||
155301854|NCT00332241|560538392|FG001|Overall Study|Lack of Efficacy|1|||
155301855|NCT00332241|560538391|FG000|Overall Study|Adverse Event|3|||
155301856|NCT00332241|560538392|FG001|Overall Study|Adverse Event|5|||
155301857|NCT00332241|560538391|FG000|Overall Study|Withdrawal by Subject|2|||
155301858|NCT00332241|560538392|FG001|Overall Study|Withdrawal by Subject|1|||
155301859|NCT00332241|560538391|FG000|Overall Study|Lost to Follow-up|4|||
155301860|NCT00332241|560538392|FG001|Overall Study|Lost to Follow-up|1|||
155301861|NCT00802464|560538393|FG000|Month 0 - Month 8|Adverse Event|0|||
155747062|NCT01239732|562174797|FG000|Overall Study|Treatment failure|2|||
155747063|NCT01239732|562174797|FG000|Overall Study|Other|19|||
155301862|NCT00802464|560538394|FG001|Month 0 - Month 8|Adverse Event|1|||
155301863|NCT00802464|560538395|FG002|Month 0 - Month 8|Adverse Event|1|||
155301864|NCT00802464|560538396|FG003|Month 0 - Month 8|Adverse Event|2|||
155301865|NCT00802464|560538393|FG000|Month 0 - Month 8|Protocol Violation|0|||
155301866|NCT00802464|560538394|FG001|Month 0 - Month 8|Protocol Violation|0|||
155301867|NCT00802464|560538395|FG002|Month 0 - Month 8|Protocol Violation|1|||
155301868|NCT00802464|560538396|FG003|Month 0 - Month 8|Protocol Violation|0|||
155301869|NCT00802464|560538393|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
155301870|NCT00802464|560538394|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
155301871|NCT00802464|560538395|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
155301872|NCT00802464|560538396|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
155301873|NCT00802464|560538393|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
155301874|NCT00802464|560538394|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
155301875|NCT00802464|560538395|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
155301876|NCT00802464|560538396|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
155301877|NCT00802464|560538393|FG000|Month 0 - Month 8|Other|0|||
155301878|NCT00802464|560538394|FG001|Month 0 - Month 8|Other|0|||
155301879|NCT00802464|560538395|FG002|Month 0 - Month 8|Other|1|||
155301880|NCT00802464|560538396|FG003|Month 0 - Month 8|Other|0|||
155301881|NCT00802464|560538393|FG000|Month 8 - Month 14|Adverse Event|0|||
155301882|NCT00802464|560538394|FG001|Month 8 - Month 14|Adverse Event|1|||
155301883|NCT00802464|560538395|FG002|Month 8 - Month 14|Adverse Event|0|||
155301884|NCT00802464|560538396|FG003|Month 8 - Month 14|Adverse Event|0|||
155301885|NCT00802464|560538393|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
155301886|NCT00802464|560538394|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
155301887|NCT00802464|560538395|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
155301888|NCT00802464|560538396|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
155301889|NCT00802464|560538393|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
155301890|NCT00802464|560538394|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
155301891|NCT00802464|560538395|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
155301892|NCT00802464|560538396|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
155301893|NCT00402246|560538397|FG000|Overall Study|Death|62|||
155301894|NCT00402246|560538398|FG001|Overall Study|Death|58|||
155301895|NCT00402246|560538397|FG000|Overall Study|Lost to Follow-up|20|||
155301896|NCT00402246|560538398|FG001|Overall Study|Lost to Follow-up|28|||
155301897|NCT00402246|560538397|FG000|Overall Study|Withdrawal by Subject|72|||
155301898|NCT00402246|560538398|FG001|Overall Study|Withdrawal by Subject|87|||
155301899|NCT00402246|560538397|FG000|Overall Study|Physician Decision|24|||
155301900|NCT00402246|560538398|FG001|Overall Study|Physician Decision|26|||
155301901|NCT00402246|560538397|FG000|Overall Study|Protocol Violation|25|||
155301902|NCT00402246|560538398|FG001|Overall Study|Protocol Violation|24|||
155301903|NCT00402246|560538397|FG000|Overall Study|Missed Final Visit|1|||
155301904|NCT00402246|560538398|FG001|Overall Study|Missed Final Visit|2|||
155301905|NCT00402246|560538397|FG000|Overall Study|Insurance Issues|2|||
155301906|NCT00402246|560538398|FG001|Overall Study|Insurance Issues|1|||
155301907|NCT00402246|560538397|FG000|Overall Study|Heart Transplant|0|||
155301908|NCT00402246|560538398|FG001|Overall Study|Heart Transplant|1|||
155301909|NCT00402246|560538397|FG000|Overall Study|Patient's device explanted|6|||
155301910|NCT00402246|560538398|FG001|Overall Study|Patient's device explanted|2|||
155301911|NCT00402246|560538397|FG000|Overall Study|Center Closure|5|||
155301912|NCT00402246|560538398|FG001|Overall Study|Center Closure|3|||
155301913|NCT00402246|560538397|FG000|Overall Study|Deterioriating Condition|3|||
155301914|NCT00402246|560538398|FG001|Overall Study|Deterioriating Condition|2|||
155301915|NCT02622568|560538399|FG000|Overall Study|Lost to Follow-up|5|||
155301916|NCT02622568|560538400|FG001|Overall Study|Lost to Follow-up|5|||
155301917|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155301918|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155301919|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
155301920|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155301921|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
155301922|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301923|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301924|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301925|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301926|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301927|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
155301928|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301929|NCT01985334|560538407|FG000|Overall Study|Administrative problems|1|||
155301930|NCT01985334|560538408|FG001|Overall Study|Administrative problems|1|||
155301931|NCT01985334|560538409|FG002|Overall Study|Administrative problems|0|||
155301932|NCT01985334|560538410|FG003|Overall Study|Administrative problems|2|||
155301933|NCT01985334|560538411|FG004|Overall Study|Administrative problems|0|||
155301934|NCT01985334|560538412|FG005|Overall Study|Administrative problems|1|||
155301935|NCT01985334|560538413|FG006|Overall Study|Administrative problems|1|||
155301936|NCT01985334|560538414|FG007|Overall Study|Administrative problems|3|||
155301937|NCT01985334|560538407|FG000|Overall Study|Death|1|||
155301938|NCT01985334|560538408|FG001|Overall Study|Death|0|||
155301939|NCT01985334|560538409|FG002|Overall Study|Death|0|||
155301940|NCT01985334|560538410|FG003|Overall Study|Death|3|||
155301941|NCT01985334|560538411|FG004|Overall Study|Death|0|||
155301942|NCT01985334|560538412|FG005|Overall Study|Death|0|||
155301943|NCT01985334|560538413|FG006|Overall Study|Death|1|||
155301944|NCT01985334|560538414|FG007|Overall Study|Death|2|||
155301945|NCT01985334|560538407|FG000|Overall Study|Worsening of disease|0|||
155301946|NCT01985334|560538408|FG001|Overall Study|Worsening of disease|0|||
155301947|NCT01985334|560538409|FG002|Overall Study|Worsening of disease|0|||
155301948|NCT01985334|560538410|FG003|Overall Study|Worsening of disease|1|||
155301949|NCT01985334|560538411|FG004|Overall Study|Worsening of disease|0|||
155301950|NCT01985334|560538412|FG005|Overall Study|Worsening of disease|3|||
155301951|NCT01985334|560538413|FG006|Overall Study|Worsening of disease|0|||
155301952|NCT01985334|560538414|FG007|Overall Study|Worsening of disease|1|||
155301953|NCT01985334|560538407|FG000|Overall Study|Other|2|||
155301954|NCT01985334|560538408|FG001|Overall Study|Other|9|||
155301955|NCT01985334|560538409|FG002|Overall Study|Other|7|||
155301956|NCT01985334|560538410|FG003|Overall Study|Other|17|||
155747064|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
155747065|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
155747066|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
155747067|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
155747068|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
155747069|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
155747070|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
155747071|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
155747072|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
155747073|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
155747074|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
155747075|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
155747076|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
155747077|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
155747078|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
155747079|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
155747080|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
155747081|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
155747082|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
155747083|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
155747084|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
155747085|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155747086|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
155747087|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155747088|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155747089|NCT00095147|562174804|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
155747090|NCT00095147|562174805|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
155747091|NCT00095147|562174806|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155747092|NCT00095147|562174807|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155747093|NCT00095147|562174808|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155747094|NCT00095147|562174804|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
155747095|NCT00095147|562174805|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
155747096|NCT00095147|562174806|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
155747097|NCT00095147|562174807|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
155301957|NCT01985334|560538411|FG004|Overall Study|Other|4|||
155301958|NCT01985334|560538412|FG005|Overall Study|Other|8|||
155301959|NCT01985334|560538413|FG006|Overall Study|Other|4|||
155301960|NCT01985334|560538414|FG007|Overall Study|Other|7|||
155301961|NCT01985334|560538407|FG000|Overall Study|Protocol deviation|6|||
155301962|NCT01985334|560538408|FG001|Overall Study|Protocol deviation|31|||
155301963|NCT01985334|560538409|FG002|Overall Study|Protocol deviation|25|||
155301964|NCT01985334|560538410|FG003|Overall Study|Protocol deviation|84|||
155301965|NCT01985334|560538411|FG004|Overall Study|Protocol deviation|17|||
155301966|NCT01985334|560538412|FG005|Overall Study|Protocol deviation|47|||
155301967|NCT01985334|560538413|FG006|Overall Study|Protocol deviation|15|||
155301968|NCT01985334|560538414|FG007|Overall Study|Protocol deviation|42|||
155301969|NCT01985334|560538407|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
155641098|NCT00729586|561776766|FG001|Overall Study|Ineligible|1|||
155641099|NCT00729586|561776765|FG000|Overall Study|never treated|1|||
155641100|NCT00729586|561776766|FG001|Overall Study|never treated|0|||
155641101|NCT02513199|561776769|FG000|Treatment|Death|1|||
155641102|NCT02513199|561776769|FG000|Treatment|Lost to Follow-up|1|||
155641103|NCT02513199|561776769|FG000|Follow-Up|Death|11|||
155641104|NCT02397837|561776771|FG000|Overall Study|Withdrawal by Subject|6|||
155641105|NCT02397837|561776772|FG001|Overall Study|Withdrawal by Subject|5|||
155641106|NCT02397837|561776771|FG000|Overall Study|Physician Decision|1|||
155641107|NCT02397837|561776772|FG001|Overall Study|Physician Decision|1|||
155301970|NCT01985334|560538408|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
155301971|NCT01985334|560538409|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
155301972|NCT01985334|560538410|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
155301973|NCT01985334|560538411|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
155301974|NCT01985334|560538412|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
155301975|NCT01985334|560538413|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
155301976|NCT01985334|560538414|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
155301977|NCT01985334|560538407|FG000|Overall Study|Subject withdrawal of consent|3|||
155301978|NCT01985334|560538408|FG001|Overall Study|Subject withdrawal of consent|6|||
155301979|NCT01985334|560538409|FG002|Overall Study|Subject withdrawal of consent|2|||
155301980|NCT01985334|560538410|FG003|Overall Study|Subject withdrawal of consent|28|||
155301981|NCT01985334|560538411|FG004|Overall Study|Subject withdrawal of consent|4|||
155301982|NCT01985334|560538412|FG005|Overall Study|Subject withdrawal of consent|19|||
155301983|NCT01985334|560538413|FG006|Overall Study|Subject withdrawal of consent|0|||
155301984|NCT01985334|560538414|FG007|Overall Study|Subject withdrawal of consent|20|||
155301985|NCT01985334|560538407|FG000|Overall Study|Adverse Event|0|||
155301986|NCT01985334|560538408|FG001|Overall Study|Adverse Event|8|||
155301987|NCT01985334|560538409|FG002|Overall Study|Adverse Event|2|||
155301988|NCT01985334|560538410|FG003|Overall Study|Adverse Event|26|||
155301989|NCT01985334|560538411|FG004|Overall Study|Adverse Event|3|||
155301990|NCT01985334|560538412|FG005|Overall Study|Adverse Event|18|||
155301991|NCT01985334|560538413|FG006|Overall Study|Adverse Event|3|||
155301992|NCT01985334|560538414|FG007|Overall Study|Adverse Event|15|||
155301993|NCT01985334|560538407|FG000|Overall Study|Other|4|||
155301994|NCT01985334|560538408|FG001|Overall Study|Other|2|||
155301995|NCT01985334|560538409|FG002|Overall Study|Other|3|||
155301996|NCT01985334|560538410|FG003|Overall Study|Other|10|||
155301997|NCT01985334|560538411|FG004|Overall Study|Other|1|||
155301998|NCT01985334|560538412|FG005|Overall Study|Other|6|||
155301999|NCT01985334|560538413|FG006|Overall Study|Other|2|||
155302000|NCT01985334|560538414|FG007|Overall Study|Other|2|||
155302001|NCT01985334|560538407|FG000|Overall Study|Medication non-compliance|0|||
155302002|NCT01985334|560538408|FG001|Overall Study|Medication non-compliance|4|||
155302003|NCT01985334|560538409|FG002|Overall Study|Medication non-compliance|1|||
155302004|NCT01985334|560538410|FG003|Overall Study|Medication non-compliance|6|||
155302005|NCT01985334|560538411|FG004|Overall Study|Medication non-compliance|2|||
155302006|NCT01985334|560538412|FG005|Overall Study|Medication non-compliance|3|||
155302007|NCT01985334|560538413|FG006|Overall Study|Medication non-compliance|1|||
155302008|NCT01985334|560538414|FG007|Overall Study|Medication non-compliance|3|||
155302009|NCT01985334|560538407|FG000|Overall Study|Use of prohibited treatment|1|||
155302010|NCT01985334|560538408|FG001|Overall Study|Use of prohibited treatment|4|||
155302011|NCT01985334|560538409|FG002|Overall Study|Use of prohibited treatment|1|||
155302012|NCT01985334|560538410|FG003|Overall Study|Use of prohibited treatment|2|||
155302013|NCT01985334|560538411|FG004|Overall Study|Use of prohibited treatment|1|||
155302014|NCT01985334|560538412|FG005|Overall Study|Use of prohibited treatment|6|||
155302015|NCT01985334|560538413|FG006|Overall Study|Use of prohibited treatment|2|||
155302016|NCT01985334|560538414|FG007|Overall Study|Use of prohibited treatment|0|||
155641108|NCT02536794|561776778|FG000|Reached 1st Response Assessment|Adverse Event|2|||
155641109|NCT02536794|561776778|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
155302017|NCT01985334|560538407|FG000|Overall Study|Investigator decision|0|||
155302018|NCT01985334|560538408|FG001|Overall Study|Investigator decision|3|||
155302019|NCT01985334|560538409|FG002|Overall Study|Investigator decision|0|||
155302020|NCT01985334|560538410|FG003|Overall Study|Investigator decision|7|||
155641110|NCT02536794|561776778|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
155747098|NCT00095147|562174808|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
155747099|NCT00095147|562174804|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
155747100|NCT00095147|562174805|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
155747101|NCT00095147|562174806|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155747102|NCT00095147|562174807|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155747103|NCT00095147|562174808|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155747104|NCT00095147|562174804|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
155747105|NCT00095147|562174805|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
155747106|NCT00095147|562174806|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
155747107|NCT00095147|562174807|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
155747108|NCT00095147|562174808|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
155747109|NCT00095147|562174804|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
155747110|NCT00095147|562174805|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
155747111|NCT00095147|562174806|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155747112|NCT00095147|562174807|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155747113|NCT00095147|562174808|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155747114|NCT00095147|562174804|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
155747115|NCT00095147|562174805|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155747116|NCT00095147|562174806|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155747117|NCT00095147|562174807|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
155747118|NCT00095147|562174808|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155747119|NCT00095147|562174804|FG000|Long-term Extension Period|Death|0|||
155747120|NCT00095147|562174805|FG001|Long-term Extension Period|Death|0|||
155747121|NCT00095147|562174806|FG002|Long-term Extension Period|Death|0|||
155747122|NCT00095147|562174807|FG003|Long-term Extension Period|Death|0|||
155302021|NCT01985334|560538411|FG004|Overall Study|Investigator decision|1|||
155302022|NCT01985334|560538412|FG005|Overall Study|Investigator decision|1|||
155302023|NCT01985334|560538413|FG006|Overall Study|Investigator decision|0|||
155302024|NCT01985334|560538414|FG007|Overall Study|Investigator decision|4|||
155302025|NCT01985334|560538407|FG000|Overall Study|Lost to Follow-up|0|||
155302026|NCT01985334|560538408|FG001|Overall Study|Lost to Follow-up|2|||
155302027|NCT01985334|560538409|FG002|Overall Study|Lost to Follow-up|0|||
155302028|NCT01985334|560538410|FG003|Overall Study|Lost to Follow-up|3|||
155747123|NCT00095147|562174808|FG004|Long-term Extension Period|Death|3|||
155747124|NCT00095147|562174804|FG000|Long-term Extension Period|Adverse Event|0|||
155747125|NCT00095147|562174805|FG001|Long-term Extension Period|Adverse Event|0|||
155302029|NCT01985334|560538411|FG004|Overall Study|Lost to Follow-up|1|||
155302030|NCT01985334|560538412|FG005|Overall Study|Lost to Follow-up|4|||
155302031|NCT01985334|560538413|FG006|Overall Study|Lost to Follow-up|0|||
155302032|NCT01985334|560538414|FG007|Overall Study|Lost to Follow-up|3|||
155302033|NCT03988023|560538415|FG000|Overall Study|Non-compliance|3|||
155302034|NCT03988023|560538416|FG001|Overall Study|Non-compliance|0|||
155302035|NCT03988023|560538415|FG000|Overall Study|Withdrawal by Subject|39|||
155302036|NCT03988023|560538416|FG001|Overall Study|Withdrawal by Subject|37|||
155302037|NCT03988023|560538415|FG000|Overall Study|Adverse Event|0|||
155302038|NCT03988023|560538416|FG001|Overall Study|Adverse Event|2|||
155302039|NCT03988023|560538415|FG000|Overall Study|Physician Decision|0|||
155302040|NCT03988023|560538416|FG001|Overall Study|Physician Decision|1|||
155302041|NCT03988023|560538415|FG000|Overall Study|Lost to Follow-up|5|||
155302042|NCT03988023|560538416|FG001|Overall Study|Lost to Follow-up|8|||
155302043|NCT03988023|560538415|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
155641111|NCT02536794|561776778|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
155641112|NCT02536794|561776778|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
155302044|NCT03988023|560538416|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
155302045|NCT03988023|560538415|FG000|Overall Study|Lack of Efficacy|3|||
155302046|NCT03988023|560538416|FG001|Overall Study|Lack of Efficacy|1|||
155641113|NCT02536794|561776778|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
155302047|NCT03988023|560538415|FG000|Overall Study|COVID-19 pandemic|225|||
155302048|NCT03988023|560538416|FG001|Overall Study|COVID-19 pandemic|227|||
155302049|NCT00174382|560538421|FG000|Overall Study|Death|2|||
155302050|NCT00174382|560538421|FG000|Overall Study|Adverse Event|19|||
155747126|NCT00095147|562174806|FG002|Long-term Extension Period|Adverse Event|0|||
155747127|NCT00095147|562174807|FG003|Long-term Extension Period|Adverse Event|0|||
155747128|NCT00095147|562174808|FG004|Long-term Extension Period|Adverse Event|11|||
155747129|NCT00095147|562174804|FG000|Long-term Extension Period|Lack of Efficacy|0|||
155747130|NCT00095147|562174805|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155747131|NCT00095147|562174806|FG002|Long-term Extension Period|Lack of Efficacy|0|||
155747132|NCT00095147|562174807|FG003|Long-term Extension Period|Lack of Efficacy|0|||
155747133|NCT00095147|562174808|FG004|Long-term Extension Period|Lack of Efficacy|9|||
155747134|NCT00095147|562174804|FG000|Long-term Extension Period|Lost to Follow-up|0|||
155747135|NCT00095147|562174805|FG001|Long-term Extension Period|Lost to Follow-up|0|||
155747136|NCT00095147|562174806|FG002|Long-term Extension Period|Lost to Follow-up|0|||
155747137|NCT00095147|562174807|FG003|Long-term Extension Period|Lost to Follow-up|0|||
155747138|NCT00095147|562174808|FG004|Long-term Extension Period|Lost to Follow-up|6|||
155302051|NCT00174382|560538421|FG000|Overall Study|Withdrawal by Subject|6|||
155302052|NCT00174382|560538421|FG000|Overall Study|Protocol Violation|3|||
155302053|NCT00174382|560538421|FG000|Overall Study|Arrived early for last visit in error|1|||
155302054|NCT00174382|560538421|FG000|Overall Study|Subject felt pill not effective enough|1|||
155747139|NCT00095147|562174804|FG000|Long-term Extension Period|Withdrawal of consent|0|||
155747140|NCT00095147|562174805|FG001|Long-term Extension Period|Withdrawal of consent|0|||
155747141|NCT00095147|562174806|FG002|Long-term Extension Period|Withdrawal of consent|0|||
155747142|NCT00095147|562174807|FG003|Long-term Extension Period|Withdrawal of consent|0|||
155747143|NCT00095147|562174808|FG004|Long-term Extension Period|Withdrawal of consent|12|||
155747144|NCT00095147|562174804|FG000|Long-term Extension Period|Pregnancy|0|||
155747145|NCT00095147|562174805|FG001|Long-term Extension Period|Pregnancy|0|||
155747146|NCT00095147|562174806|FG002|Long-term Extension Period|Pregnancy|0|||
155747147|NCT00095147|562174807|FG003|Long-term Extension Period|Pregnancy|0|||
155747148|NCT00095147|562174808|FG004|Long-term Extension Period|Pregnancy|1|||
155747149|NCT00095147|562174804|FG000|Long-term Extension Period|No longer meets study criteria|0|||
155747150|NCT00095147|562174805|FG001|Long-term Extension Period|No longer meets study criteria|0|||
155302055|NCT00174382|560538421|FG000|Overall Study|Lost to Follow-up|1|||
155302056|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
155302057|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
155302058|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302059|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302060|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302061|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
155302062|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302063|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
155302064|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302065|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302066|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302067|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302068|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
155302069|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
155302070|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302071|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302072|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302073|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302074|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302075|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302076|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302077|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302078|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
155302079|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
155302080|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302081|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
155302082|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302083|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302084|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302085|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302086|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302087|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302088|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302089|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302090|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302091|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
155747151|NCT00095147|562174806|FG002|Long-term Extension Period|No longer meets study criteria|0|||
155747152|NCT00095147|562174807|FG003|Long-term Extension Period|No longer meets study criteria|0|||
155302092|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
155302093|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302094|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302095|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302096|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302097|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302098|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302099|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
155302100|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155641114|NCT05276804|561776779|FG000|Overall Study|screen failure|23|||
155641115|NCT05276804|561776780|FG001|Overall Study|screen failure|0|||
155302101|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302102|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302103|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302104|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302105|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
155302106|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302107|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302108|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
155302109|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302110|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
155302111|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
155302112|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
155302113|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302114|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302115|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302116|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302117|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
155302118|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302119|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302120|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Other|2|||
155302121|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Other|1|||
155302122|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Other|0|||
155302123|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Other|0|||
155302124|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Other|1|||
155302125|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Other|1|||
155302126|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Other|0|||
155302127|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Other|0|||
155302128|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
155302129|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
155302130|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302131|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302132|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
155302133|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
155302134|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302135|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
155302136|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302137|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302138|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302139|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302140|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
155302141|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302142|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302143|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302144|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
155302145|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302146|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302147|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302148|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302149|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302150|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
155302151|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
155302152|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302153|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302154|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302155|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
155302156|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
155302157|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302158|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302159|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302160|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302161|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
155302162|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302163|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302164|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302165|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302166|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302167|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302168|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302169|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302170|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302171|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155747153|NCT00095147|562174808|FG004|Long-term Extension Period|No longer meets study criteria|1|||
155747154|NCT00095147|562174804|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
155747155|NCT00095147|562174805|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
155747156|NCT00095147|562174806|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
155747157|NCT00095147|562174807|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
155747158|NCT00095147|562174808|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
155747159|NCT00095147|562174804|FG000|Long-term Extension Period|Leaving country|0|||
155747160|NCT00095147|562174805|FG001|Long-term Extension Period|Leaving country|0|||
155747161|NCT00095147|562174806|FG002|Long-term Extension Period|Leaving country|0|||
155747162|NCT00095147|562174807|FG003|Long-term Extension Period|Leaving country|0|||
155747163|NCT00095147|562174808|FG004|Long-term Extension Period|Leaving country|1|||
155747164|NCT03400956|562174809|FG000|Treatment Period 1|Adverse Event|0|||
155747165|NCT03400956|562174810|FG001|Treatment Period 1|Adverse Event|1|||
155747166|NCT03400956|562174811|FG002|Treatment Period 1|Adverse Event|0|||
155747167|NCT03400956|562174809|FG000|Treatment Period 1|Lost to Follow-up|0|||
155747168|NCT03400956|562174810|FG001|Treatment Period 1|Lost to Follow-up|0|||
155747169|NCT03400956|562174811|FG002|Treatment Period 1|Lost to Follow-up|1|||
155747170|NCT03400956|562174809|FG000|Treatment Period 1|Protocol Violation|0|||
155747171|NCT03400956|562174810|FG001|Treatment Period 1|Protocol Violation|2|||
155747172|NCT03400956|562174811|FG002|Treatment Period 1|Protocol Violation|0|||
155747173|NCT03400956|562174809|FG000|Treatment Period 1|Study terminated by sponsor|3|||
155747174|NCT03400956|562174810|FG001|Treatment Period 1|Study terminated by sponsor|1|||
155747175|NCT03400956|562174811|FG002|Treatment Period 1|Study terminated by sponsor|1|||
155747176|NCT03400956|562174809|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155747177|NCT03400956|562174810|FG001|Treatment Period 1|Withdrawal by Subject|2|||
155747178|NCT03400956|562174811|FG002|Treatment Period 1|Withdrawal by Subject|4|||
155747179|NCT03400956|562174809|FG000|Treatment Period 1|Other|1|||
155747180|NCT03400956|562174810|FG001|Treatment Period 1|Other|2|||
155747181|NCT03400956|562174811|FG002|Treatment Period 1|Other|3|||
155747182|NCT03400956|562174809|FG000|Post-treatment Period 1|Adverse Event|0|||
155747183|NCT03400956|562174810|FG001|Post-treatment Period 1|Adverse Event|0|||
155747184|NCT03400956|562174811|FG002|Post-treatment Period 1|Adverse Event|1|||
155747185|NCT03400956|562174809|FG000|Post-treatment Period 1|Physician Decision|2|||
155747186|NCT03400956|562174810|FG001|Post-treatment Period 1|Physician Decision|3|||
155747187|NCT03400956|562174811|FG002|Post-treatment Period 1|Physician Decision|0|||
155747188|NCT03400956|562174809|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
155747189|NCT03400956|562174810|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
155747190|NCT03400956|562174811|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
155747191|NCT03400956|562174809|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
155747192|NCT03400956|562174810|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
155747193|NCT03400956|562174811|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
155747194|NCT03400956|562174809|FG000|Post-treatment Period 1|Other|4|||
155747195|NCT03400956|562174810|FG001|Post-treatment Period 1|Other|3|||
155747196|NCT03400956|562174811|FG002|Post-treatment Period 1|Other|4|||
155747197|NCT03400956|562174809|FG000|Treatment Period 2|Adverse Event|2|||
155747198|NCT03400956|562174810|FG001|Treatment Period 2|Adverse Event|1|||
155747199|NCT03400956|562174811|FG002|Treatment Period 2|Adverse Event|1|||
155747200|NCT03400956|562174809|FG000|Treatment Period 2|Lost to Follow-up|1|||
155747201|NCT03400956|562174810|FG001|Treatment Period 2|Lost to Follow-up|1|||
155747202|NCT03400956|562174811|FG002|Treatment Period 2|Lost to Follow-up|0|||
155747203|NCT03400956|562174809|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155747204|NCT03400956|562174810|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155747205|NCT03400956|562174811|FG002|Treatment Period 2|Withdrawal by Subject|3|||
155747206|NCT03400956|562174809|FG000|Treatment Period 2|Other|1|||
155747207|NCT03400956|562174810|FG001|Treatment Period 2|Other|1|||
155747208|NCT03400956|562174811|FG002|Treatment Period 2|Other|0|||
155747209|NCT03400956|562174809|FG000|Follow-up Period|Withdrawal by Subject|0|||
155747210|NCT03400956|562174810|FG001|Follow-up Period|Withdrawal by Subject|0|||
155747211|NCT03400956|562174811|FG002|Follow-up Period|Withdrawal by Subject|1|||
155747212|NCT03400956|562174809|FG000|Follow-up Period|Other|0|||
155747213|NCT03400956|562174810|FG001|Follow-up Period|Other|0|||
155747214|NCT03400956|562174811|FG002|Follow-up Period|Other|1|||
155747215|NCT02048241|562174812|FG000|Overall Study|Withdrawal by Subject|0|||
155747216|NCT02048241|562174813|FG001|Overall Study|Withdrawal by Subject|1|||
155747217|NCT00534313|562174814|FG000|Short-term Period|Adverse Event|1|||
155747218|NCT00534313|562174815|FG001|Short-term Period|Adverse Event|2|||
155302172|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302173|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
155302174|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302175|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302176|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Other|1|||
155302177|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Other|1|||
155302178|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Other|0|||
155747219|NCT00534313|562174816|FG002|Short-term Period|Adverse Event|1|||
155747220|NCT00534313|562174817|FG003|Short-term Period|Adverse Event|3|||
155302179|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Other|0|||
155302180|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Other|0|||
155302181|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Other|0|||
155302182|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Other|0|||
155302183|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Other|0|||
155302184|NCT00785512|560538432|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
155302185|NCT00785512|560538433|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
155302186|NCT00785512|560538432|FG000|Overall Study|Adverse Event|0|||
155302187|NCT00785512|560538433|FG001|Overall Study|Adverse Event|0|||
155302188|NCT00785512|560538432|FG000|Overall Study|Lack of Efficacy|0|||
155302189|NCT00785512|560538433|FG001|Overall Study|Lack of Efficacy|2|||
155302190|NCT00785512|560538432|FG000|Overall Study|Withdrawal by Subject|0|||
155302191|NCT00785512|560538433|FG001|Overall Study|Withdrawal by Subject|1|||
155302192|NCT00785512|560538432|FG000|Overall Study|Lost to Follow-up|3|||
155302193|NCT00785512|560538433|FG001|Overall Study|Lost to Follow-up|0|||
155302194|NCT00785512|560538432|FG000|Overall Study|Precedure Refused|0|||
155302195|NCT00785512|560538433|FG001|Overall Study|Precedure Refused|0|||
155302196|NCT00785512|560538432|FG000|Overall Study|IVRS Programing Error|0|||
155302197|NCT00785512|560538433|FG001|Overall Study|IVRS Programing Error|0|||
155302198|NCT00785512|560538432|FG000|Overall Study|Physician Decision|0|||
155302199|NCT00785512|560538433|FG001|Overall Study|Physician Decision|0|||
155302200|NCT00785512|560538432|FG000|Overall Study|Lack of compliance|0|||
155302201|NCT00785512|560538433|FG001|Overall Study|Lack of compliance|1|||
155302202|NCT03403413|560538434|FG000|Overall Study|Lack of Efficacy|2|||
155302203|NCT05609032|560538442|FG000|Overall Study|Lost to Follow-up|3|||
155302204|NCT05609032|560538443|FG001|Overall Study|Lost to Follow-up|1|||
155302205|NCT05609032|560538442|FG000|Overall Study|Withdrawal by Subject|1|||
155302206|NCT05609032|560538443|FG001|Overall Study|Withdrawal by Subject|0|||
155302207|NCT02477605|560538447|FG000|Overall Study|Discontinued prior to treatment|1|||
155302208|NCT02477605|560538448|FG001|Overall Study|Discontinued prior to treatment|0|||
155302209|NCT02477605|560538447|FG000|Overall Study|Lost to Follow-up|0|||
155302210|NCT02477605|560538448|FG001|Overall Study|Lost to Follow-up|2|||
155302211|NCT02477605|560538447|FG000|Overall Study|Withdrawal by Subject|0|||
155302212|NCT02477605|560538448|FG001|Overall Study|Withdrawal by Subject|1|||
155302213|NCT02477605|560538447|FG000|Overall Study|Administered gas during surgery|0|||
155302214|NCT02477605|560538448|FG001|Overall Study|Administered gas during surgery|1|||
155302215|NCT01565148|560538451|FG000|Overall Study|Withdrawal by Subject|1|||
155302216|NCT01565148|560538452|FG001|Overall Study|Withdrawal by Subject|1|||
155302217|NCT01565148|560538453|FG002|Overall Study|Withdrawal by Subject|1|||
155302218|NCT01565148|560538454|FG003|Overall Study|Withdrawal by Subject|2|||
155302219|NCT01565148|560538451|FG000|Overall Study|Lost to Follow-up|4|||
155747221|NCT00534313|562174814|FG000|Short-term Period|Lack of Efficacy|3|||
155747222|NCT00534313|562174815|FG001|Short-term Period|Lack of Efficacy|4|||
155302220|NCT01565148|560538452|FG001|Overall Study|Lost to Follow-up|4|||
155302221|NCT01565148|560538453|FG002|Overall Study|Lost to Follow-up|0|||
155302222|NCT01565148|560538454|FG003|Overall Study|Lost to Follow-up|3|||
155302223|NCT01565148|560538451|FG000|Overall Study|Rescue Therapy|8|||
155302224|NCT01565148|560538452|FG001|Overall Study|Rescue Therapy|5|||
155302225|NCT01565148|560538453|FG002|Overall Study|Rescue Therapy|5|||
155302226|NCT01565148|560538454|FG003|Overall Study|Rescue Therapy|8|||
155302227|NCT01565148|560538451|FG000|Overall Study|Death|0|||
155302228|NCT01565148|560538452|FG001|Overall Study|Death|0|||
155302229|NCT01565148|560538453|FG002|Overall Study|Death|1|||
155302230|NCT01565148|560538454|FG003|Overall Study|Death|0|||
155302231|NCT01565148|560538451|FG000|Overall Study|Physician Decision|2|||
155302232|NCT01565148|560538452|FG001|Overall Study|Physician Decision|5|||
155302233|NCT01565148|560538453|FG002|Overall Study|Physician Decision|0|||
155302234|NCT01565148|560538454|FG003|Overall Study|Physician Decision|0|||
155302235|NCT01388361|560538455|FG000|Overall Study|Adverse Event|0|||
155302236|NCT01388361|560538456|FG001|Overall Study|Adverse Event|5|||
155302237|NCT01388361|560538457|FG002|Overall Study|Adverse Event|1|||
155302238|NCT01388361|560538455|FG000|Overall Study|Protocol Violation|0|||
155302239|NCT01388361|560538456|FG001|Overall Study|Protocol Violation|0|||
155302240|NCT01388361|560538457|FG002|Overall Study|Protocol Violation|2|||
155302241|NCT01388361|560538455|FG000|Overall Study|Withdrawal criteria|12|||
155302242|NCT01388361|560538456|FG001|Overall Study|Withdrawal criteria|7|||
155302243|NCT01388361|560538457|FG002|Overall Study|Withdrawal criteria|10|||
155302244|NCT01388361|560538455|FG000|Overall Study|Unclassified|0|||
155302245|NCT01388361|560538456|FG001|Overall Study|Unclassified|0|||
155302246|NCT01388361|560538457|FG002|Overall Study|Unclassified|1|||
155302247|NCT02528188|560538459|FG000|Overall Study|Adverse Event|23|||
155302248|NCT02528188|560538460|FG001|Overall Study|Adverse Event|22|||
155302249|NCT02528188|560538461|FG002|Overall Study|Adverse Event|8|||
155302250|NCT02528188|560538459|FG000|Overall Study|Protocol Violation|4|||
155302251|NCT02528188|560538460|FG001|Overall Study|Protocol Violation|6|||
155302252|NCT02528188|560538461|FG002|Overall Study|Protocol Violation|4|||
155302253|NCT02528188|560538459|FG000|Overall Study|Lack of Efficacy|19|||
155302254|NCT02528188|560538460|FG001|Overall Study|Lack of Efficacy|21|||
155302255|NCT02528188|560538461|FG002|Overall Study|Lack of Efficacy|22|||
155302256|NCT02528188|560538459|FG000|Overall Study|Withdrawal by Subject|97|||
155302257|NCT02528188|560538460|FG001|Overall Study|Withdrawal by Subject|104|||
155302258|NCT02528188|560538461|FG002|Overall Study|Withdrawal by Subject|100|||
155302259|NCT02528188|560538459|FG000|Overall Study|Lost to Follow-up|25|||
155302260|NCT02528188|560538460|FG001|Overall Study|Lost to Follow-up|21|||
155302261|NCT02528188|560538461|FG002|Overall Study|Lost to Follow-up|31|||
155302262|NCT02528188|560538459|FG000|Overall Study|Death|4|||
155302263|NCT02528188|560538460|FG001|Overall Study|Death|4|||
155302264|NCT02528188|560538461|FG002|Overall Study|Death|0|||
155302265|NCT02528188|560538459|FG000|Overall Study|Other|89|||
155302266|NCT02528188|560538460|FG001|Overall Study|Other|91|||
155302267|NCT02528188|560538461|FG002|Overall Study|Other|74|||
155747223|NCT00534313|562174816|FG002|Short-term Period|Lack of Efficacy|0|||
155747224|NCT00534313|562174817|FG003|Short-term Period|Lack of Efficacy|3|||
155747225|NCT00534313|562174814|FG000|Short-term Period|Participant not meeting study criteria|0|||
155747226|NCT00534313|562174815|FG001|Short-term Period|Participant not meeting study criteria|0|||
155747227|NCT00534313|562174816|FG002|Short-term Period|Participant not meeting study criteria|0|||
155747228|NCT00534313|562174817|FG003|Short-term Period|Participant not meeting study criteria|1|||
155747229|NCT00534313|562174814|FG000|Short-term Period|Participant withdrew consent|2|||
155747230|NCT00534313|562174815|FG001|Short-term Period|Participant withdrew consent|0|||
155747231|NCT00534313|562174816|FG002|Short-term Period|Participant withdrew consent|0|||
155747232|NCT00534313|562174817|FG003|Short-term Period|Participant withdrew consent|2|||
155747233|NCT00534313|562174814|FG000|Short-term Period|Pregnancy|0|||
155747234|NCT00534313|562174815|FG001|Short-term Period|Pregnancy|0|||
155747235|NCT00534313|562174816|FG002|Short-term Period|Pregnancy|1|||
155747236|NCT00534313|562174817|FG003|Short-term Period|Pregnancy|0|||
155747237|NCT00534313|562174814|FG000|Long-term Period|Adverse Event|2|||
155747238|NCT00534313|562174815|FG001|Long-term Period|Adverse Event|1|||
155747239|NCT00534313|562174816|FG002|Long-term Period|Adverse Event|0|||
155747240|NCT00534313|562174817|FG003|Long-term Period|Adverse Event|1|||
155747241|NCT00534313|562174814|FG000|Long-term Period|Lack of Efficacy|14|||
155302268|NCT02528188|560538459|FG000|Overall Study|Randomized but not treated|6|||
155302269|NCT02528188|560538460|FG001|Overall Study|Randomized but not treated|7|||
155302270|NCT02528188|560538461|FG002|Overall Study|Randomized but not treated|12|||
155747242|NCT00534313|562174815|FG001|Long-term Period|Lack of Efficacy|10|||
155747243|NCT00534313|562174816|FG002|Long-term Period|Lack of Efficacy|14|||
155747244|NCT00534313|562174817|FG003|Long-term Period|Lack of Efficacy|12|||
155747245|NCT00534313|562174814|FG000|Long-term Period|Lost to Follow-up|1|||
155747246|NCT00534313|562174815|FG001|Long-term Period|Lost to Follow-up|2|||
155747247|NCT00534313|562174816|FG002|Long-term Period|Lost to Follow-up|0|||
155747248|NCT00534313|562174817|FG003|Long-term Period|Lost to Follow-up|0|||
155302271|NCT00529659|560538464|FG000|Overall Study|Adverse Event|8|||
155302272|NCT00529659|560538465|FG001|Overall Study|Adverse Event|7|||
155747249|NCT00534313|562174814|FG000|Long-term Period|Withdrawal by Subject|2|||
155747250|NCT00534313|562174815|FG001|Long-term Period|Withdrawal by Subject|2|||
155302273|NCT00529659|560538464|FG000|Overall Study|Lost to Follow-up|0|||
155302274|NCT00529659|560538465|FG001|Overall Study|Lost to Follow-up|2|||
155302275|NCT00529659|560538464|FG000|Overall Study|Physician Decision|0|||
155302276|NCT00529659|560538465|FG001|Overall Study|Physician Decision|2|||
155302277|NCT00529659|560538464|FG000|Overall Study|Protocol Violation|2|||
155302278|NCT00529659|560538465|FG001|Overall Study|Protocol Violation|6|||
155302279|NCT00529659|560538464|FG000|Overall Study|Withdrawal by Subject|1|||
155302280|NCT00529659|560538465|FG001|Overall Study|Withdrawal by Subject|6|||
155302281|NCT03565315|560538466|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302282|NCT03565315|560538467|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302283|NCT03565315|560538468|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302284|NCT03565315|560538469|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
155302285|NCT01170962|560538470|FG000|Treatment Period|Lack of Efficacy|96|||
155302286|NCT01170962|560538471|FG001|Treatment Period|Lack of Efficacy|91|||
155302287|NCT01170962|560538472|FG002|Treatment Period|Lack of Efficacy|7|||
155302288|NCT01170962|560538470|FG000|Treatment Period|Adverse Event|11|||
155302289|NCT01170962|560538471|FG001|Treatment Period|Adverse Event|12|||
155302290|NCT01170962|560538472|FG002|Treatment Period|Adverse Event|3|||
155302291|NCT01170962|560538470|FG000|Treatment Period|Withdrawal by Subject|2|||
155302292|NCT01170962|560538471|FG001|Treatment Period|Withdrawal by Subject|1|||
155302293|NCT01170962|560538472|FG002|Treatment Period|Withdrawal by Subject|0|||
155302294|NCT01170962|560538470|FG000|Treatment Period|Lost to Follow-up|1|||
155302295|NCT01170962|560538471|FG001|Treatment Period|Lost to Follow-up|1|||
155302296|NCT01170962|560538472|FG002|Treatment Period|Lost to Follow-up|1|||
155302297|NCT01170962|560538470|FG000|Treatment Period|Participant no longer meets criteria|0|||
155302298|NCT01170962|560538471|FG001|Treatment Period|Participant no longer meets criteria|1|||
155302299|NCT01170962|560538472|FG002|Treatment Period|Participant no longer meets criteria|0|||
155302300|NCT01170962|560538470|FG000|Treatment Period|Request to discontinue treatment|7|||
155302301|NCT01170962|560538471|FG001|Treatment Period|Request to discontinue treatment|3|||
155302302|NCT01170962|560538472|FG002|Treatment Period|Request to discontinue treatment|1|||
155302303|NCT01170962|560538470|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
155302304|NCT01170962|560538471|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
155302305|NCT01170962|560538472|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
155302306|NCT01170962|560538470|FG000|Follow up Period|Withdrawal by Subject|14|||
155302307|NCT01170962|560538471|FG001|Follow up Period|Withdrawal by Subject|10|||
155302308|NCT01170962|560538472|FG002|Follow up Period|Withdrawal by Subject|2|||
155302309|NCT01170962|560538470|FG000|Follow up Period|Lost to Follow-up|13|||
155302310|NCT01170962|560538471|FG001|Follow up Period|Lost to Follow-up|8|||
155302311|NCT01170962|560538472|FG002|Follow up Period|Lost to Follow-up|1|||
155302312|NCT01170962|560538470|FG000|Follow up Period|Death|2|||
155302313|NCT01170962|560538471|FG001|Follow up Period|Death|2|||
155302314|NCT01170962|560538472|FG002|Follow up Period|Death|0|||
155302315|NCT01170962|560538470|FG000|Follow up Period|Others|10|||
155302316|NCT01170962|560538471|FG001|Follow up Period|Others|7|||
155302317|NCT01170962|560538472|FG002|Follow up Period|Others|3|||
155302318|NCT00440011|560538473|FG000|Overall Study|Adverse Event|2|||
155302319|NCT00440011|560538474|FG001|Overall Study|Adverse Event|0|||
155302320|NCT00440011|560538473|FG000|Overall Study|Lost to Follow-up|0|||
155302321|NCT00440011|560538474|FG001|Overall Study|Lost to Follow-up|2|||
155302322|NCT00440011|560538473|FG000|Overall Study|Protocol Violation|1|||
155302323|NCT00440011|560538474|FG001|Overall Study|Protocol Violation|1|||
155302324|NCT00440011|560538473|FG000|Overall Study|Withdrawal by Subject|1|||
155302325|NCT00440011|560538474|FG001|Overall Study|Withdrawal by Subject|0|||
155302326|NCT01083316|560538478|FG000|Overall Study|Adverse Event|2|||
155302327|NCT01083316|560538478|FG000|Overall Study|Withdrawal by Subject|1|||
155302328|NCT01849055|560538488|FG000|Overall Study|Withdrawal by Subject|0|||
155302329|NCT01849055|560538489|FG001|Overall Study|Withdrawal by Subject|0|||
155302330|NCT01849055|560538490|FG002|Overall Study|Withdrawal by Subject|1|||
155302331|NCT01849055|560538491|FG003|Overall Study|Withdrawal by Subject|0|||
155302332|NCT01849055|560538492|FG004|Overall Study|Withdrawal by Subject|0|||
155302333|NCT01849055|560538493|FG005|Overall Study|Withdrawal by Subject|0|||
155641116|NCT01410604|561776782|FG000|Overall Study|Adverse Event|2|||
155302334|NCT00223795|560538498|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
155302335|NCT00223795|560538499|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
155302336|NCT00223795|560538498|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
155302337|NCT00223795|560538499|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
155302338|NCT01239316|560538500|FG000|Overall Study|Progression/Relapse|11|||
155302339|NCT01239316|560538500|FG000|Overall Study|Adverse Event|1|||
155302340|NCT02299375|560538506|FG000|Overall Study|Adverse Event, serious fatal|1|||
155302341|NCT02299375|560538507|FG001|Overall Study|Adverse Event, serious fatal|3|||
155302342|NCT02299375|560538506|FG000|Overall Study|Adverse Event, non-fatal|8|||
155302343|NCT02299375|560538507|FG001|Overall Study|Adverse Event, non-fatal|9|||
155302344|NCT02299375|560538506|FG000|Overall Study|Lack of Efficacy|1|||
155302345|NCT02299375|560538507|FG001|Overall Study|Lack of Efficacy|3|||
155302346|NCT02299375|560538506|FG000|Overall Study|Protocol Violation|1|||
155302347|NCT02299375|560538507|FG001|Overall Study|Protocol Violation|3|||
155302348|NCT02299375|560538506|FG000|Overall Study|Other: Met stopping criteria|1|||
155302349|NCT02299375|560538507|FG001|Overall Study|Other: Met stopping criteria|0|||
155302350|NCT02299375|560538506|FG000|Overall Study|Other: Study closed/terminated|66|||
155302351|NCT02299375|560538507|FG001|Overall Study|Other: Study closed/terminated|55|||
155302352|NCT02299375|560538506|FG000|Overall Study|Lost to Follow-up|0|||
155641117|NCT01410604|561776783|FG001|Overall Study|Adverse Event|1|||
155641118|NCT01410604|561776782|FG000|Overall Study|Lost to Follow-up|1|||
155641119|NCT01410604|561776783|FG001|Overall Study|Lost to Follow-up|0|||
155641120|NCT01410604|561776782|FG000|Overall Study|Physician Decision|0|||
155641121|NCT01410604|561776783|FG001|Overall Study|Physician Decision|1|||
155641122|NCT04602000|561776790|FG000|Overall Study|Withdrawal by Subject|3|||
155641123|NCT04602000|561776791|FG001|Overall Study|Withdrawal by Subject|6|||
155641124|NCT04602000|561776792|FG002|Overall Study|Withdrawal by Subject|3|||
155641125|NCT04602000|561776793|FG003|Overall Study|Withdrawal by Subject|27|||
155641126|NCT04602000|561776794|FG004|Overall Study|Withdrawal by Subject|39|||
155641127|NCT04602000|561776790|FG000|Overall Study|Physician Decision|1|||
155641128|NCT04602000|561776791|FG001|Overall Study|Physician Decision|0|||
155641129|NCT04602000|561776792|FG002|Overall Study|Physician Decision|0|||
155641130|NCT04602000|561776793|FG003|Overall Study|Physician Decision|2|||
155641131|NCT04602000|561776794|FG004|Overall Study|Physician Decision|2|||
155641132|NCT04602000|561776790|FG000|Overall Study|Death|0|||
155641133|NCT04602000|561776791|FG001|Overall Study|Death|1|||
155641134|NCT04602000|561776792|FG002|Overall Study|Death|0|||
155641135|NCT04602000|561776793|FG003|Overall Study|Death|1|||
155641136|NCT04602000|561776794|FG004|Overall Study|Death|2|||
155641137|NCT04602000|561776790|FG000|Overall Study|Lost to Follow-up|0|||
155641138|NCT04602000|561776791|FG001|Overall Study|Lost to Follow-up|0|||
155302353|NCT02299375|560538507|FG001|Overall Study|Lost to Follow-up|2|||
155641139|NCT04602000|561776792|FG002|Overall Study|Lost to Follow-up|0|||
155641140|NCT04602000|561776793|FG003|Overall Study|Lost to Follow-up|3|||
155641141|NCT04602000|561776794|FG004|Overall Study|Lost to Follow-up|4|||
155641142|NCT04602000|561776790|FG000|Overall Study|Other|4|||
155641143|NCT04602000|561776791|FG001|Overall Study|Other|1|||
155641144|NCT04602000|561776792|FG002|Overall Study|Other|2|||
155641145|NCT04602000|561776793|FG003|Overall Study|Other|5|||
155641146|NCT04602000|561776794|FG004|Overall Study|Other|4|||
155641147|NCT04602000|561776790|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155641148|NCT04602000|561776791|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155641149|NCT04602000|561776792|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
155641150|NCT04602000|561776793|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155641151|NCT04602000|561776794|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155641152|NCT05607043|561776795|FG000|Overall Study|Lost to Follow-up|2|||
155641153|NCT05427916|561776802|FG000|Overall Study|Adverse Event|3|||
155747251|NCT00534313|562174816|FG002|Long-term Period|Withdrawal by Subject|0|||
155747252|NCT00534313|562174817|FG003|Long-term Period|Withdrawal by Subject|0|||
155747253|NCT00534313|562174814|FG000|Long-term Period|No longer meets study criteria|0|||
155747254|NCT00534313|562174815|FG001|Long-term Period|No longer meets study criteria|1|||
155747255|NCT00534313|562174816|FG002|Long-term Period|No longer meets study criteria|0|||
155747256|NCT00534313|562174817|FG003|Long-term Period|No longer meets study criteria|0|||
155747257|NCT00534313|562174814|FG000|Long-term Period|Poor compliance/noncompliance|0|||
155747258|NCT00534313|562174815|FG001|Long-term Period|Poor compliance/noncompliance|1|||
155747259|NCT00534313|562174816|FG002|Long-term Period|Poor compliance/noncompliance|1|||
155747260|NCT00534313|562174817|FG003|Long-term Period|Poor compliance/noncompliance|0|||
155747261|NCT00534313|562174814|FG000|Long-term Period|Administrative reason by sponsor|17|||
155747262|NCT00534313|562174815|FG001|Long-term Period|Administrative reason by sponsor|15|||
155747263|NCT00534313|562174816|FG002|Long-term Period|Administrative reason by sponsor|26|||
155747264|NCT00534313|562174817|FG003|Long-term Period|Administrative reason by sponsor|18|||
155302354|NCT02299375|560538506|FG000|Overall Study|Physician Decision|1|||
155641154|NCT05427916|561776803|FG001|Overall Study|Adverse Event|0|||
155641155|NCT05427916|561776802|FG000|Overall Study|Lack of Efficacy|6|||
155641156|NCT05427916|561776803|FG001|Overall Study|Lack of Efficacy|0|||
155641157|NCT05427916|561776802|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
155641158|NCT05427916|561776803|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
155641159|NCT00429299|561776806|FG000|Overall Study|Disease Progression|1|||
155641160|NCT00429299|561776807|FG001|Overall Study|Disease Progression|1|||
155641161|NCT00429299|561776808|FG002|Overall Study|Disease Progression|0|||
155641162|NCT00429299|561776806|FG000|Overall Study|Adverse Event|2|||
155641163|NCT00429299|561776807|FG001|Overall Study|Adverse Event|5|||
155641164|NCT00429299|561776808|FG002|Overall Study|Adverse Event|1|||
155641165|NCT00429299|561776806|FG000|Overall Study|Protocol Violation|1|||
155641166|NCT00429299|561776807|FG001|Overall Study|Protocol Violation|0|||
155641167|NCT00429299|561776808|FG002|Overall Study|Protocol Violation|0|||
155641168|NCT00429299|561776806|FG000|Overall Study|Withdrawal by Subject|0|||
155641169|NCT00429299|561776807|FG001|Overall Study|Withdrawal by Subject|1|||
155641170|NCT00429299|561776808|FG002|Overall Study|Withdrawal by Subject|3|||
155641171|NCT04871113|561776809|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641172|NCT04871113|561776810|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641173|NCT04871113|561776811|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641174|NCT04871113|561776812|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641175|NCT04871113|561776813|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641176|NCT04871113|561776814|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
155641177|NCT04871113|561776815|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641178|NCT04871113|561776816|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641179|NCT04871113|561776817|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641180|NCT04871113|561776818|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155641181|NCT04871113|561776809|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641182|NCT04871113|561776810|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641183|NCT04871113|561776811|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641184|NCT04871113|561776812|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641185|NCT04871113|561776813|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641186|NCT04871113|561776814|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641187|NCT04871113|561776815|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
155641188|NCT04871113|561776816|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
155747265|NCT00534313|562174814|FG000|Long-term Period|Other|1|||
155641189|NCT04871113|561776817|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641190|NCT04871113|561776818|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155641191|NCT00081458|561776823|FG000|Overall Study|Adverse Event|1|||
155641192|NCT00081458|561776824|FG001|Overall Study|Adverse Event|5|||
155641193|NCT00081458|561776825|FG002|Overall Study|Adverse Event|2|||
155641194|NCT00081458|561776823|FG000|Overall Study|Withdrawal by Subject|0|||
155641195|NCT00081458|561776824|FG001|Overall Study|Withdrawal by Subject|3|||
155641196|NCT00081458|561776825|FG002|Overall Study|Withdrawal by Subject|1|||
155641197|NCT00081458|561776823|FG000|Overall Study|Randomized but not dosed|0|||
155641198|NCT00081458|561776824|FG001|Overall Study|Randomized but not dosed|0|||
155641199|NCT00081458|561776825|FG002|Overall Study|Randomized but not dosed|1|||
155641200|NCT01946802|561776830|FG000|Overall Study|Death|1|||
155641201|NCT01946802|561776830|FG000|Overall Study|Withdrawal by Subject|2|||
155641202|NCT01946802|561776830|FG000|Overall Study|Combined septic shock|1|||
155641203|NCT01946802|561776830|FG000|Overall Study|Protocol Violation|1|||
155641204|NCT03097315|561776831|FG000|Overall Study|Withdrawal by Subject|1|||
155641205|NCT00195429|561776832|FG000|Overall Study|Adverse Event|2|||
155641206|NCT00195429|561776833|FG001|Overall Study|Adverse Event|4|||
155641207|NCT00195429|561776832|FG000|Overall Study|Lack of Efficacy|2|||
155641208|NCT00195429|561776833|FG001|Overall Study|Lack of Efficacy|1|||
155302355|NCT02299375|560538507|FG001|Overall Study|Physician Decision|1|||
155302356|NCT02299375|560538506|FG000|Overall Study|Withdrawal by Subject|1|||
155302357|NCT02299375|560538507|FG001|Overall Study|Withdrawal by Subject|4|||
155302358|NCT05135000|560538513|FG000|Overall Study|Adverse Event|2|||
155302359|NCT05135000|560538514|FG001|Overall Study|Adverse Event|0|||
155302360|NCT05135000|560538513|FG000|Overall Study|Lost to Follow-up|1|||
155302361|NCT05135000|560538514|FG001|Overall Study|Lost to Follow-up|0|||
155302362|NCT05135000|560538513|FG000|Overall Study|Study Terminated by Sponsor|6|||
155302363|NCT05135000|560538514|FG001|Overall Study|Study Terminated by Sponsor|3|||
155302364|NCT04201834|560540102|FG000|Overall Study|Screen fail|1|||
155302365|NCT04104321|560540106|FG000|Overall Study|didn't take the study drug|3|||
155302366|NCT01903811|560540118|FG000|Overall Study|No measurable disease|1|||
155302367|NCT01903811|560540119|FG001|Overall Study|No measurable disease|1|||
155302368|NCT01903811|560540118|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
155302369|NCT01903811|560540119|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
155302370|NCT01903811|560540118|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
155302371|NCT01903811|560540119|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
155302372|NCT01903811|560540118|FG000|Overall Study|Withdrawal by Subject|0|||
155302373|NCT01903811|560540119|FG001|Overall Study|Withdrawal by Subject|1|||
155641209|NCT00195429|561776832|FG000|Overall Study|Lost to Follow-up|1|||
155641210|NCT00195429|561776833|FG001|Overall Study|Lost to Follow-up|0|||
155747266|NCT00534313|562174815|FG001|Long-term Period|Other|2|||
155747267|NCT00534313|562174816|FG002|Long-term Period|Other|2|||
155747268|NCT00534313|562174817|FG003|Long-term Period|Other|2|||
155747269|NCT00402233|562174818|FG000|Overall Study|Adverse Event|1|||
155747270|NCT00402233|562174819|FG001|Overall Study|Adverse Event|7|||
155747271|NCT00402233|562174820|FG002|Overall Study|Adverse Event|9|||
155747272|NCT00402233|562174821|FG003|Overall Study|Adverse Event|9|||
155747273|NCT00402233|562174818|FG000|Overall Study|Protocol Violation|0|||
155747274|NCT00402233|562174819|FG001|Overall Study|Protocol Violation|1|||
155747275|NCT00402233|562174820|FG002|Overall Study|Protocol Violation|0|||
155747276|NCT00402233|562174821|FG003|Overall Study|Protocol Violation|0|||
155747277|NCT00402233|562174818|FG000|Overall Study|Withdrawal by Subject|2|||
155747278|NCT00402233|562174819|FG001|Overall Study|Withdrawal by Subject|1|||
155747279|NCT00402233|562174820|FG002|Overall Study|Withdrawal by Subject|2|||
155747280|NCT00402233|562174821|FG003|Overall Study|Withdrawal by Subject|2|||
155747281|NCT00402233|562174818|FG000|Overall Study|Worsening of disease under study|2|||
155747282|NCT00402233|562174819|FG001|Overall Study|Worsening of disease under study|0|||
155747283|NCT00402233|562174820|FG002|Overall Study|Worsening of disease under study|0|||
155747284|NCT00402233|562174821|FG003|Overall Study|Worsening of disease under study|0|||
155747285|NCT00402233|562174818|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155747286|NCT00402233|562174819|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155747287|NCT00402233|562174820|FG002|Overall Study|Worsening of other pre-existing disease|0|||
155747288|NCT00402233|562174821|FG003|Overall Study|Worsening of other pre-existing disease|0|||
155747289|NCT00927940|562174822|FG000|Overall Study|Death|1|||
155747290|NCT03007888|562174824|FG000|First Intervention (14 Days)|Adverse Event|1|||
155747291|NCT03007888|562174825|FG001|First Intervention (14 Days)|Adverse Event|0|||
155747292|NCT00492063|562174827|FG000|Overall Study|Death|0|||
155747293|NCT00492063|562174828|FG001|Overall Study|Death|0|||
155747294|NCT00492063|562174829|FG002|Overall Study|Death|1|||
155747295|NCT00492063|562174830|FG003|Overall Study|Death|2|||
155747296|NCT00492063|562174827|FG000|Overall Study|Withdrawal by Subject|4|||
155747297|NCT00492063|562174828|FG001|Overall Study|Withdrawal by Subject|3|||
155747298|NCT00492063|562174829|FG002|Overall Study|Withdrawal by Subject|5|||
155747299|NCT00492063|562174830|FG003|Overall Study|Withdrawal by Subject|4|||
155747300|NCT00492063|562174827|FG000|Overall Study|Lost to Follow-up|6|||
155747301|NCT00492063|562174828|FG001|Overall Study|Lost to Follow-up|11|||
155747302|NCT00492063|562174829|FG002|Overall Study|Lost to Follow-up|5|||
155747303|NCT00492063|562174830|FG003|Overall Study|Lost to Follow-up|3|||
155747304|NCT00492063|562174827|FG000|Overall Study|Protocol Violation|0|||
155747305|NCT00492063|562174828|FG001|Overall Study|Protocol Violation|0|||
155747306|NCT00492063|562174829|FG002|Overall Study|Protocol Violation|0|||
155747307|NCT00492063|562174830|FG003|Overall Study|Protocol Violation|1|||
155747308|NCT01870076|562174831|FG000|Overall Study|Withdrawal by Subject|1|||
155747309|NCT01870076|562174832|FG001|Overall Study|Withdrawal by Subject|0|||
155747310|NCT01870076|562174833|FG002|Overall Study|Withdrawal by Subject|1|||
155747311|NCT01870076|562174834|FG003|Overall Study|Withdrawal by Subject|0|||
155747312|NCT00890045|562174839|FG000|Overall Study|Death|0|||
155747313|NCT00890045|562174840|FG001|Overall Study|Death|1|||
155747314|NCT00890045|562174839|FG000|Overall Study|Did not receive HeRO Graft|0|||
155747315|NCT00890045|562174840|FG001|Overall Study|Did not receive HeRO Graft|2|||
155747316|NCT00890045|562174839|FG000|Overall Study|Lost to Follow-up|5|||
155747317|NCT00890045|562174840|FG001|Overall Study|Lost to Follow-up|7|||
155747318|NCT01947855|562174841|FG000|Overall Study|Withdrawal by Subject|1|||
155747319|NCT01947855|562174842|FG001|Overall Study|Withdrawal by Subject|0|||
155747320|NCT01947855|562174843|FG002|Overall Study|Withdrawal by Subject|0|||
155747321|NCT01892384|562174847|FG000|Overall Study|Withdrawal by Subject|1|||
155747322|NCT01892384|562174848|FG001|Overall Study|Withdrawal by Subject|1|||
155747323|NCT01892384|562174849|FG002|Overall Study|Withdrawal by Subject|0|||
155747324|NCT01892384|562174850|FG003|Overall Study|Withdrawal by Subject|0|||
155747325|NCT01700439|562174851|FG000|Overall Study|Lost to Follow-up|47|||
155747326|NCT01700439|562174851|FG000|Overall Study|Withdrawal by Subject|183|||
155747327|NCT01700439|562174851|FG000|Overall Study|Death|186|||
155747328|NCT00592774|562174852|FG000|Overall Study|Adverse Event|5|||
155747329|NCT00592774|562174853|FG001|Overall Study|Adverse Event|19|||
155747330|NCT00592774|562174854|FG002|Overall Study|Adverse Event|2|||
155747331|NCT00592774|562174855|FG003|Overall Study|Adverse Event|14|||
155747332|NCT00592774|562174856|FG004|Overall Study|Adverse Event|8|||
155747333|NCT00592774|562174852|FG000|Overall Study|Protocol Violation|0|||
155747334|NCT00592774|562174853|FG001|Overall Study|Protocol Violation|1|||
155747335|NCT00592774|562174854|FG002|Overall Study|Protocol Violation|0|||
155747336|NCT00592774|562174855|FG003|Overall Study|Protocol Violation|0|||
155747337|NCT00592774|562174856|FG004|Overall Study|Protocol Violation|1|||
155747338|NCT00592774|562174852|FG000|Overall Study|Withdrawal by Subject|3|||
155747339|NCT00592774|562174853|FG001|Overall Study|Withdrawal by Subject|7|||
155747340|NCT00592774|562174854|FG002|Overall Study|Withdrawal by Subject|0|||
155747341|NCT00592774|562174855|FG003|Overall Study|Withdrawal by Subject|0|||
155747342|NCT00592774|562174856|FG004|Overall Study|Withdrawal by Subject|0|||
155747343|NCT00592774|562174852|FG000|Overall Study|Lack of Efficacy|3|||
155436099|NCT01059812|561024510|FG001|Overall Study|Unclassified|4|||
155747344|NCT00592774|562174853|FG001|Overall Study|Lack of Efficacy|3|||
155747345|NCT00592774|562174854|FG002|Overall Study|Lack of Efficacy|0|||
155747346|NCT00592774|562174855|FG003|Overall Study|Lack of Efficacy|0|||
155747347|NCT00592774|562174856|FG004|Overall Study|Lack of Efficacy|2|||
155747348|NCT00592774|562174852|FG000|Overall Study|Physician Decision|0|||
155747349|NCT00592774|562174853|FG001|Overall Study|Physician Decision|1|||
155747350|NCT00592774|562174854|FG002|Overall Study|Physician Decision|1|||
155747351|NCT00592774|562174855|FG003|Overall Study|Physician Decision|0|||
155747352|NCT00592774|562174856|FG004|Overall Study|Physician Decision|1|||
155747353|NCT00592774|562174852|FG000|Overall Study|Other|0|||
155747354|NCT00592774|562174853|FG001|Overall Study|Other|1|||
155747355|NCT00592774|562174854|FG002|Overall Study|Other|1|||
155747356|NCT00592774|562174855|FG003|Overall Study|Other|0|||
155747357|NCT00592774|562174856|FG004|Overall Study|Other|2|||
155747358|NCT00621621|562174865|FG000|Overall Study|Subjects were exited at EP study|30|||
155747359|NCT00621621|562174866|FG001|Overall Study|Subjects were exited at EP study|0|||
155747360|NCT01829243|562174867|FG000|First Intervention|Screen Failure|4|||
155747361|NCT01829243|562174868|FG001|First Intervention|Screen Failure|2|||
155747362|NCT00608569|562174871|FG000|Overall Study|Death|4|||
155747363|NCT00608569|562174872|FG001|Overall Study|Death|3|||
155747364|NCT00608569|562174871|FG000|Overall Study|Lost to Follow-up|4|||
155747365|NCT00608569|562174872|FG001|Overall Study|Lost to Follow-up|5|||
155747366|NCT00608569|562174871|FG000|Overall Study|Withdrawal by Subject|1|||
155747367|NCT00608569|562174872|FG001|Overall Study|Withdrawal by Subject|0|||
155747368|NCT00608569|562174871|FG000|Overall Study|Adverse Event|1|||
155747369|NCT00608569|562174872|FG001|Overall Study|Adverse Event|0|||
155747370|NCT00608569|562174871|FG000|Overall Study|Unable to adhere with study requirements|0|||
155747371|NCT00608569|562174872|FG001|Overall Study|Unable to adhere with study requirements|1|||
155747372|NCT03985878|562174880|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
155747373|NCT03985878|562174880|FG000|Overall Study|Study Terminated by Sponsor|12|||
155747374|NCT03985878|562174880|FG000|Overall Study|Withdrawal by Subject|1|||
155747375|NCT01606878|562174881|FG000|Overall Study|Adverse Event|1|||
155747376|NCT01606878|562174882|FG001|Overall Study|Adverse Event|1|||
155747377|NCT01606878|562174883|FG002|Overall Study|Adverse Event|0|||
155747378|NCT01606878|562174884|FG003|Overall Study|Adverse Event|0|||
155747379|NCT01606878|562174885|FG004|Overall Study|Adverse Event|0|||
155747380|NCT01606878|562174886|FG005|Overall Study|Adverse Event|0|||
155747381|NCT01606878|562174887|FG006|Overall Study|Adverse Event|1|||
155747382|NCT01606878|562174888|FG007|Overall Study|Adverse Event|0|||
155747383|NCT01606878|562174889|FG008|Overall Study|Adverse Event|1|||
155747384|NCT01606878|562174890|FG009|Overall Study|Adverse Event|3|||
155747385|NCT01606878|562174891|FG010|Overall Study|Adverse Event|0|||
155747386|NCT01606878|562174881|FG000|Overall Study|Lack of Efficacy|1|||
155747387|NCT01606878|562174882|FG001|Overall Study|Lack of Efficacy|1|||
155747388|NCT01606878|562174883|FG002|Overall Study|Lack of Efficacy|1|||
155747389|NCT01606878|562174884|FG003|Overall Study|Lack of Efficacy|2|||
155747390|NCT01606878|562174885|FG004|Overall Study|Lack of Efficacy|1|||
155747391|NCT01606878|562174886|FG005|Overall Study|Lack of Efficacy|2|||
155747392|NCT01606878|562174887|FG006|Overall Study|Lack of Efficacy|1|||
155747393|NCT01606878|562174888|FG007|Overall Study|Lack of Efficacy|2|||
155747394|NCT01606878|562174889|FG008|Overall Study|Lack of Efficacy|2|||
155747395|NCT01606878|562174890|FG009|Overall Study|Lack of Efficacy|0|||
155747396|NCT01606878|562174891|FG010|Overall Study|Lack of Efficacy|1|||
155747397|NCT01606878|562174881|FG000|Overall Study|Physician Decision|1|||
155747398|NCT01606878|562174882|FG001|Overall Study|Physician Decision|0|||
155747399|NCT01606878|562174883|FG002|Overall Study|Physician Decision|2|||
155747400|NCT01606878|562174884|FG003|Overall Study|Physician Decision|1|||
155747401|NCT01606878|562174885|FG004|Overall Study|Physician Decision|1|||
155747402|NCT01606878|562174886|FG005|Overall Study|Physician Decision|1|||
155747403|NCT01606878|562174887|FG006|Overall Study|Physician Decision|2|||
155747404|NCT01606878|562174888|FG007|Overall Study|Physician Decision|0|||
155747405|NCT01606878|562174889|FG008|Overall Study|Physician Decision|1|||
155747406|NCT01606878|562174890|FG009|Overall Study|Physician Decision|0|||
155747407|NCT01606878|562174891|FG010|Overall Study|Physician Decision|0|||
155747408|NCT01606878|562174881|FG000|Overall Study|Withdrawal by Subject|3|||
155747409|NCT01606878|562174882|FG001|Overall Study|Withdrawal by Subject|2|||
155747410|NCT01606878|562174883|FG002|Overall Study|Withdrawal by Subject|2|||
155747411|NCT01606878|562174884|FG003|Overall Study|Withdrawal by Subject|0|||
155747412|NCT01606878|562174885|FG004|Overall Study|Withdrawal by Subject|1|||
155747413|NCT01606878|562174886|FG005|Overall Study|Withdrawal by Subject|1|||
155747414|NCT01606878|562174887|FG006|Overall Study|Withdrawal by Subject|2|||
155747415|NCT01606878|562174888|FG007|Overall Study|Withdrawal by Subject|1|||
155747416|NCT01606878|562174889|FG008|Overall Study|Withdrawal by Subject|2|||
155747417|NCT01606878|562174890|FG009|Overall Study|Withdrawal by Subject|0|||
155747418|NCT01606878|562174891|FG010|Overall Study|Withdrawal by Subject|2|||
155747419|NCT01007253|562174892|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
155747420|NCT01007253|562174893|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
155747421|NCT01007253|562174894|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
155747422|NCT01007253|562174895|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
155641211|NCT01334515|561776838|FG000|Overall Study|Adverse Event|1|||
155641212|NCT01334515|561776839|FG001|Overall Study|Adverse Event|6|||
155641213|NCT01334515|561776838|FG000|Overall Study|Death|1|||
155641214|NCT01334515|561776839|FG001|Overall Study|Death|0|||
155641215|NCT01334515|561776838|FG000|Overall Study|Lack of Efficacy|8|||
155641216|NCT01334515|561776839|FG001|Overall Study|Lack of Efficacy|21|||
155641217|NCT01334515|561776838|FG000|Overall Study|Physician Decision|1|||
155641218|NCT01334515|561776839|FG001|Overall Study|Physician Decision|1|||
155641219|NCT01334515|561776838|FG000|Overall Study|Withdrawal by Subject|1|||
155641220|NCT01334515|561776839|FG001|Overall Study|Withdrawal by Subject|1|||
155641221|NCT04327271|561776840|FG000|Overall Study|Death|1|||
155641222|NCT04327271|561776841|FG001|Overall Study|Death|0|||
155641223|NCT04327271|561776840|FG000|Overall Study|Withdrawal by Subject|1|||
155641224|NCT04327271|561776841|FG001|Overall Study|Withdrawal by Subject|0|||
155641225|NCT04327271|561776840|FG000|Overall Study|randomization error (data capture)|4|||
155641226|NCT04327271|561776841|FG001|Overall Study|randomization error (data capture)|3|||
155641227|NCT04339972|561776842|FG000|Overall Study|Scheduling Issues|3|||
155641228|NCT04339972|561776843|FG001|Overall Study|Scheduling Issues|3|||
155641229|NCT04339972|561776842|FG000|Overall Study|dropout|1|||
155641230|NCT04339972|561776843|FG001|Overall Study|dropout|1|||
155641231|NCT04339972|561776842|FG000|Overall Study|Technical issues|1|||
155641232|NCT04339972|561776843|FG001|Overall Study|Technical issues|0|||
155641233|NCT04339972|561776842|FG000|Overall Study|Claustraphobia|0|||
155641234|NCT04339972|561776843|FG001|Overall Study|Claustraphobia|1|||
155641235|NCT00776997|561776846|FG000|Overall Study|Adverse Event|2|||
155641236|NCT01716156|561776847|FG000|Overall Study|Protocol Violation|1|||
155747423|NCT01159431|562174898|FG000|Overall Study|Adverse Event|1|||
155747424|NCT01159431|562174899|FG001|Overall Study|Adverse Event|2|||
155410757|NCT03257267|560937475|FG000|Overall Study|Non-compliance with Study Drug|0|||
155410758|NCT03257267|560937476|FG001|Overall Study|Non-compliance with Study Drug|2|||
155410759|NCT03257267|560937475|FG000|Overall Study|Participant Decision|35|||
155410760|NCT03257267|560937476|FG001|Overall Study|Participant Decision|43|||
155410761|NCT03257267|560937475|FG000|Overall Study|Sponsor Decision|1|||
155747425|NCT01159431|562174898|FG000|Overall Study|non-compliance|1|||
155747426|NCT01159431|562174899|FG001|Overall Study|non-compliance|1|||
155747427|NCT01159431|562174898|FG000|Overall Study|Lack of Efficacy|0|||
155747428|NCT01159431|562174899|FG001|Overall Study|Lack of Efficacy|3|||
155747429|NCT02232880|562174902|FG000|Overall Study|study stopped prior to randomization|1|||
155747430|NCT00604214|562174903|FG000|Baseline to Day 28|Death|223|||
155747431|NCT00604214|562174904|FG001|Baseline to Day 28|Death|202|||
155747432|NCT00604214|562174903|FG000|Baseline to Day 28|Lost to Follow-up|2|||
155747433|NCT00604214|562174904|FG001|Baseline to Day 28|Lost to Follow-up|4|||
155747434|NCT00604214|562174903|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
155747435|NCT00604214|562174904|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
155747436|NCT00604214|562174903|FG000|Day 29 to Day 90|Death|64|||
155747437|NCT00604214|562174904|FG001|Day 29 to Day 90|Death|67|||
155747438|NCT00604214|562174903|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
155747439|NCT00604214|562174904|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
155410762|NCT03257267|560937476|FG001|Overall Study|Sponsor Decision|0|||
155410763|NCT03257267|560937475|FG000|Overall Study|Physician Decision|1|||
155410764|NCT03257267|560937476|FG001|Overall Study|Physician Decision|3|||
155410765|NCT03257267|560937475|FG000|Overall Study|Disease Progression|109|||
155410766|NCT03257267|560937476|FG001|Overall Study|Disease Progression|121|||
155410767|NCT03257267|560937475|FG000|Overall Study|Withdrawal by Subject|8|||
155410768|NCT03257267|560937476|FG001|Overall Study|Withdrawal by Subject|26|||
155747440|NCT00604214|562174903|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
155747441|NCT00604214|562174904|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
155410769|NCT03257267|560937475|FG000|Overall Study|Other|0|||
155410770|NCT03257267|560937476|FG001|Overall Study|Other|2|||
155410771|NCT02229552|560937477|FG000|Baseline|Withdrawal by Subject|6|||
155410772|NCT02229552|560937477|FG000|1-year Follow up|Withdrawal by Subject|7|||
155747442|NCT00604214|562174903|FG000|Day 91 to Day 180|Death|19|||
155747443|NCT00604214|562174904|FG001|Day 91 to Day 180|Death|23|||
155747444|NCT00604214|562174903|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
155747445|NCT00604214|562174904|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
155747446|NCT00604214|562174903|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
155747447|NCT00604214|562174904|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
155747448|NCT00534599|562174905|FG000|Overall Study|Adverse Event|25|||
155747449|NCT00534599|562174906|FG001|Overall Study|Adverse Event|4|||
155747450|NCT00534599|562174905|FG000|Overall Study|Incorrect enrollment|2|||
155747451|NCT00534599|562174906|FG001|Overall Study|Incorrect enrollment|1|||
155747452|NCT00534599|562174905|FG000|Overall Study|Mis-randomization|2|||
155747453|NCT00534599|562174906|FG001|Overall Study|Mis-randomization|2|||
155747454|NCT00534599|562174905|FG000|Overall Study|Developed study-specific d/c criteria|5|||
155747455|NCT00534599|562174906|FG001|Overall Study|Developed study-specific d/c criteria|0|||
155747456|NCT00534599|562174905|FG000|Overall Study|Lack of Efficacy|0|||
155747457|NCT00534599|562174906|FG001|Overall Study|Lack of Efficacy|1|||
155747458|NCT00534599|562174905|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
155747459|NCT00534599|562174906|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
155747460|NCT00534599|562174905|FG000|Overall Study|Protocol Violation|1|||
155747461|NCT00534599|562174906|FG001|Overall Study|Protocol Violation|3|||
155747462|NCT00534599|562174905|FG000|Overall Study|Lost to Follow-up|11|||
155747463|NCT00534599|562174906|FG001|Overall Study|Lost to Follow-up|14|||
155747464|NCT00534599|562174905|FG000|Overall Study|Withdrawal by Subject|4|||
155747465|NCT00534599|562174906|FG001|Overall Study|Withdrawal by Subject|6|||
155747466|NCT00534599|562174905|FG000|Overall Study|Other|7|||
155747467|NCT00534599|562174906|FG001|Overall Study|Other|0|||
155747468|NCT00167778|562174909|FG000|Overall Study|Withdrawal by Subject|1|||
155747469|NCT00814333|562176455|FG000|Enrollment|Lost to Follow-up|1|||
155747470|NCT00814333|562176456|FG001|Enrollment|Lost to Follow-up|0|||
155747471|NCT01879579|562176457|FG000|Overall Study|Phone incompatible with texting platform|3|||
155747472|NCT01879579|562176458|FG001|Overall Study|Phone incompatible with texting platform|0|||
155747473|NCT01879579|562176457|FG000|Overall Study|Did not enroll in texting platform|1|||
155747474|NCT01879579|562176458|FG001|Overall Study|Did not enroll in texting platform|0|||
155747475|NCT01879579|562176457|FG000|Overall Study|Did not initiate insulin treatment|1|||
155747476|NCT01879579|562176458|FG001|Overall Study|Did not initiate insulin treatment|0|||
155747477|NCT01879579|562176457|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
155747478|NCT01879579|562176458|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
155747479|NCT01879579|562176457|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
155747480|NCT01879579|562176458|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
155747481|NCT02927067|562176459|FG000|Overall Study|Withdrawn Consent|20|||
155747482|NCT02927067|562176460|FG001|Overall Study|Withdrawn Consent|12|||
155747483|NCT02927067|562176459|FG000|Overall Study|Death|18|||
155747484|NCT02927067|562176460|FG001|Overall Study|Death|31|||
155747485|NCT02927067|562176459|FG000|Overall Study|Adverse Event|13|||
155747486|NCT02927067|562176460|FG001|Overall Study|Adverse Event|10|||
155747487|NCT02927067|562176459|FG000|Overall Study|Noncompliance|5|||
155747488|NCT02927067|562176460|FG001|Overall Study|Noncompliance|2|||
155747489|NCT02927067|562176459|FG000|Overall Study|Reason not Specified|4|||
155747490|NCT02927067|562176460|FG001|Overall Study|Reason not Specified|6|||
155747491|NCT00134784|562176463|FG000|Overall Study|Withdrawal by Subject|2|||
155747492|NCT00134784|562176464|FG001|Overall Study|Withdrawal by Subject|2|||
155747493|NCT00134784|562176465|FG002|Overall Study|Withdrawal by Subject|2|||
155747494|NCT00134784|562176466|FG003|Overall Study|Withdrawal by Subject|1|||
155747495|NCT03384693|562176467|FG000|Overall Study|Adverse Event|3|||
155747496|NCT01099709|562176470|FG000|Period 1|Withdrawal by Subject|0|||
155747497|NCT01099709|562176471|FG001|Period 1|Withdrawal by Subject|1|||
155747498|NCT01099709|562176470|FG000|Period 1|Positive cotinine test|0|||
155747499|NCT01099709|562176471|FG001|Period 1|Positive cotinine test|1|||
155747500|NCT01099709|562176470|FG000|Period 1|Adverse Event|1|||
155410773|NCT02229552|560937477|FG000|1-year Follow up|Lost to Follow-up|18|||
155410774|NCT02229552|560937477|FG000|2-Year Follow up|Withdrawal by Subject|9|||
155410775|NCT02229552|560937477|FG000|2-Year Follow up|Lost to Follow-up|17|||
155410776|NCT04872101|560937478|FG000|Overall Study|Withdrawal by Subject|10|||
155410777|NCT04872101|560937479|FG001|Overall Study|Withdrawal by Subject|16|||
155410778|NCT04872101|560937478|FG000|Overall Study|Lack of Efficacy|6|||
155747501|NCT01099709|562176471|FG001|Period 1|Adverse Event|0|||
155410779|NCT04872101|560937479|FG001|Overall Study|Lack of Efficacy|14|||
155747502|NCT01275339|562176474|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
155747503|NCT01275339|562176475|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
155747504|NCT01275339|562176476|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
155747505|NCT01275339|562176477|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
155410780|NCT04872101|560937478|FG000|Overall Study|Adverse Event|1|||
155747506|NCT01275339|562176474|FG000|Overall Study|Withdrawal by Subject|0|||
155747507|NCT01275339|562176475|FG001|Overall Study|Withdrawal by Subject|0|||
155747508|NCT01275339|562176476|FG002|Overall Study|Withdrawal by Subject|1|||
155747509|NCT01275339|562176477|FG003|Overall Study|Withdrawal by Subject|0|||
155747510|NCT03718299|562176478|FG000|Overall Study|Adverse Event|1|||
155410781|NCT04872101|560937479|FG001|Overall Study|Adverse Event|6|||
155747511|NCT03718299|562176478|FG000|Overall Study|Withdrawal by Subject|6|||
155747512|NCT03718299|562176478|FG000|Overall Study|Physician Decision|2|||
155747513|NCT03718299|562176478|FG000|Overall Study|Lost to Follow-up|1|||
155747514|NCT04389970|562176479|FG000|Overall Study|Lost to Follow-up|1|||
155747515|NCT03123185|562176480|FG000|Overall Study|Withdrawal by Subject|0|||
155747516|NCT03123185|562176481|FG001|Overall Study|Withdrawal by Subject|0|||
155747517|NCT03123185|562176482|FG002|Overall Study|Withdrawal by Subject|0|||
155747518|NCT03123185|562176483|FG003|Overall Study|Withdrawal by Subject|0|||
155747519|NCT03123185|562176484|FG004|Overall Study|Withdrawal by Subject|0|||
155747520|NCT03123185|562176485|FG005|Overall Study|Withdrawal by Subject|0|||
155747521|NCT03123185|562176486|FG006|Overall Study|Withdrawal by Subject|0|||
155747522|NCT03123185|562176487|FG007|Overall Study|Withdrawal by Subject|0|||
155747523|NCT03123185|562176488|FG008|Overall Study|Withdrawal by Subject|0|||
155747524|NCT03123185|562176489|FG009|Overall Study|Withdrawal by Subject|0|||
155747525|NCT03123185|562176490|FG010|Overall Study|Withdrawal by Subject|0|||
155747526|NCT03123185|562176491|FG011|Overall Study|Withdrawal by Subject|0|||
155747527|NCT03123185|562176492|FG012|Overall Study|Withdrawal by Subject|1|||
155747528|NCT03123185|562176493|FG013|Overall Study|Withdrawal by Subject|0|||
155747529|NCT01397825|562176497|FG000|Overall Study|Progressive Disease|10|||
155747530|NCT01397825|562176498|FG001|Overall Study|Progressive Disease|3|||
155747531|NCT01397825|562176499|FG002|Overall Study|Progressive Disease|11|||
155747532|NCT01397825|562176500|FG003|Overall Study|Progressive Disease|1|||
155747533|NCT01397825|562176501|FG004|Overall Study|Progressive Disease|0|||
155410782|NCT04872101|560937478|FG000|Overall Study|Lost to Follow-up|2|||
155410783|NCT04872101|560937479|FG001|Overall Study|Lost to Follow-up|1|||
155410784|NCT04872101|560937478|FG000|Overall Study|Pregnancy|2|||
155410785|NCT04872101|560937479|FG001|Overall Study|Pregnancy|0|||
155410786|NCT04872101|560937478|FG000|Overall Study|Prohibited Medication|1|||
155410787|NCT04872101|560937479|FG001|Overall Study|Prohibited Medication|0|||
155410788|NCT04872101|560937478|FG000|Overall Study|Not dosed|1|||
155410789|NCT04872101|560937479|FG001|Overall Study|Not dosed|0|||
155410790|NCT00879229|560937480|FG000|Overall Study|Study terminated by Sponsor|13|||
155410791|NCT00879229|560937481|FG001|Overall Study|Study terminated by Sponsor|12|||
155410792|NCT00879229|560937480|FG000|Overall Study|Death|4|||
155410793|NCT00879229|560937481|FG001|Overall Study|Death|2|||
155410794|NCT00879229|560937480|FG000|Overall Study|Adverse Event|2|||
155410795|NCT00879229|560937481|FG001|Overall Study|Adverse Event|0|||
155410796|NCT00879229|560937480|FG000|Overall Study|Withdrawal by Subject|1|||
155410797|NCT00879229|560937481|FG001|Overall Study|Withdrawal by Subject|0|||
155410798|NCT00879229|560937480|FG000|Overall Study|Clinical status did not improve|1|||
155410799|NCT00879229|560937481|FG001|Overall Study|Clinical status did not improve|0|||
155410800|NCT00879229|560937480|FG000|Overall Study|Other|1|||
155410801|NCT00879229|560937481|FG001|Overall Study|Other|0|||
155410802|NCT02475681|560937482|FG000|Overall Study|Death|16|||
155410803|NCT02475681|560937483|FG001|Overall Study|Death|6|||
155410804|NCT02475681|560937484|FG002|Overall Study|Death|9|||
155410805|NCT02475681|560937482|FG000|Overall Study|Physician Decision|0|||
155410806|NCT02475681|560937483|FG001|Overall Study|Physician Decision|3|||
155410807|NCT02475681|560937484|FG002|Overall Study|Physician Decision|1|||
155410808|NCT02475681|560937482|FG000|Overall Study|Withdrawal by Subject|12|||
155410809|NCT02475681|560937483|FG001|Overall Study|Withdrawal by Subject|6|||
155410810|NCT02475681|560937484|FG002|Overall Study|Withdrawal by Subject|9|||
155410811|NCT02475681|560937482|FG000|Overall Study|Lost to Follow-up|2|||
155410812|NCT02475681|560937483|FG001|Overall Study|Lost to Follow-up|1|||
155410813|NCT02475681|560937484|FG002|Overall Study|Lost to Follow-up|3|||
155410814|NCT02475681|560937482|FG000|Overall Study|Ongoing in Study|0|||
155410815|NCT02475681|560937483|FG001|Overall Study|Ongoing in Study|163|||
155410816|NCT02475681|560937484|FG002|Overall Study|Ongoing in Study|157|||
155410817|NCT02475681|560937482|FG000|Overall Study|Reasons other than above listed|2|||
155410818|NCT02475681|560937483|FG001|Overall Study|Reasons other than above listed|0|||
155410819|NCT02475681|560937484|FG002|Overall Study|Reasons other than above listed|0|||
155410820|NCT01652287|560937494|FG000|Overall Study|Withdrawal by Subject|2|||
155410821|NCT01652287|560937495|FG001|Overall Study|Withdrawal by Subject|0|||
155410822|NCT02605642|560937496|FG000|Overall Study|Other|11|||
155410823|NCT02605642|560937497|FG001|Overall Study|Other|1|||
155410824|NCT02605642|560937496|FG000|Overall Study|Participant non-compliance|2|||
155410825|NCT02605642|560937497|FG001|Overall Study|Participant non-compliance|4|||
155410826|NCT02605642|560937496|FG000|Overall Study|Physician Decision|10|||
155747534|NCT01397825|562176497|FG000|Overall Study|Symptomatic Deterioration|2|||
155747535|NCT01397825|562176498|FG001|Overall Study|Symptomatic Deterioration|0|||
155747536|NCT01397825|562176499|FG002|Overall Study|Symptomatic Deterioration|4|||
155747537|NCT01397825|562176500|FG003|Overall Study|Symptomatic Deterioration|0|||
155747538|NCT01397825|562176501|FG004|Overall Study|Symptomatic Deterioration|0|||
155747539|NCT01397825|562176497|FG000|Overall Study|Adverse Event|0|||
155410827|NCT02605642|560937497|FG001|Overall Study|Physician Decision|0|||
155410828|NCT02605642|560937496|FG000|Overall Study|Lost to Follow-up|12|||
155410829|NCT02605642|560937497|FG001|Overall Study|Lost to Follow-up|1|||
155410830|NCT02605642|560937496|FG000|Overall Study|Adverse Event|14|||
155410831|NCT02605642|560937497|FG001|Overall Study|Adverse Event|2|||
155410832|NCT02605642|560937496|FG000|Overall Study|Withdrawal by Subject|23|||
155410833|NCT02605642|560937497|FG001|Overall Study|Withdrawal by Subject|2|||
155410834|NCT02605642|560937496|FG000|Overall Study|Lack of response|24|||
155410835|NCT02605642|560937497|FG001|Overall Study|Lack of response|11|||
155410836|NCT02354703|560937500|FG000|Overall Study|Withdrawal by Subject|1|||
155410837|NCT02354703|560937501|FG001|Overall Study|Withdrawal by Subject|1|||
155410838|NCT02354703|560937502|FG002|Overall Study|Withdrawal by Subject|1|||
155410839|NCT02354703|560937503|FG003|Overall Study|Withdrawal by Subject|1|||
155410840|NCT02354703|560937500|FG000|Overall Study|Lost to Follow-up|2|||
155410841|NCT02354703|560937501|FG001|Overall Study|Lost to Follow-up|7|||
155410842|NCT02354703|560937502|FG002|Overall Study|Lost to Follow-up|9|||
155410843|NCT02354703|560937503|FG003|Overall Study|Lost to Follow-up|2|||
155410844|NCT02354703|560937500|FG000|Overall Study|Adverse Event|0|||
155410845|NCT02354703|560937501|FG001|Overall Study|Adverse Event|0|||
155410846|NCT02354703|560937502|FG002|Overall Study|Adverse Event|1|||
155410847|NCT02354703|560937503|FG003|Overall Study|Adverse Event|0|||
155410848|NCT02597855|560937507|FG000|Overall Study|Lost to Follow-up|2|||
155410849|NCT02597855|560937508|FG001|Overall Study|Lost to Follow-up|1|||
155410850|NCT03704194|560937512|FG000|Overall Study|Withdrawal by Subject|0|||
155410851|NCT03704194|560937513|FG001|Overall Study|Withdrawal by Subject|1|||
155410852|NCT00179309|560937518|FG000|Treatment|Toxicity|2|||
155410853|NCT00179309|560937519|FG001|Treatment|Toxicity|3|||
155410854|NCT00179309|560937518|FG000|Treatment|Withdrawal by Subject|1|||
155410855|NCT00179309|560937519|FG001|Treatment|Withdrawal by Subject|2|||
155410856|NCT00179309|560937518|FG000|Treatment|Allergy|1|||
155410857|NCT00179309|560937519|FG001|Treatment|Allergy|0|||
155410858|NCT04681170|560937520|FG000|Stratified Enrolment & run-in|Death|1|||
155410859|NCT04681170|560937521|FG001|Stratified Enrolment & run-in|Death|0|||
155410860|NCT04681170|560937520|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
155410861|NCT04681170|560937521|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
155410862|NCT04681170|560937520|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
155410863|NCT04681170|560937521|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
155410864|NCT04681170|560937520|FG000|Open Label Efficacy Phase|Adverse Event|0|||
155410865|NCT04681170|560937521|FG001|Open Label Efficacy Phase|Adverse Event|2|||
155410866|NCT04681170|560937520|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
155410867|NCT04681170|560937521|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
155410868|NCT04681170|560937520|FG000|Open Label Safety Phase|AEs and none compliance|0|||
155410869|NCT04681170|560937521|FG001|Open Label Safety Phase|AEs and none compliance|1|||
155410870|NCT01407926|560937526|FG000|Overall Study|Lost to Follow-up|55|||
155410871|NCT05131204|560937527|FG000|Overall Study|Sponsor request|2|||
155410872|NCT05131204|560937528|FG001|Overall Study|Sponsor request|1|||
155410873|NCT00488982|560937529|FG000|Course 1|Physician Decision|0|||
155410874|NCT00488982|560937530|FG001|Course 1|Physician Decision|2|||
155410875|NCT00488982|560937531|FG002|Course 1|Physician Decision|4|||
155410876|NCT00488982|560937529|FG000|Course 1|Withdrawal by Subject|0|||
155410877|NCT00488982|560937530|FG001|Course 1|Withdrawal by Subject|8|||
155410878|NCT00488982|560937531|FG002|Course 1|Withdrawal by Subject|2|||
155410879|NCT00488982|560937529|FG000|Course 1|nonprotocol therapy|0|||
155410880|NCT00488982|560937530|FG001|Course 1|nonprotocol therapy|2|||
155410881|NCT00488982|560937531|FG002|Course 1|nonprotocol therapy|2|||
155410882|NCT00488982|560937529|FG000|Course 1|Adverse Event|0|||
155410883|NCT00488982|560937530|FG001|Course 1|Adverse Event|0|||
155410884|NCT00488982|560937531|FG002|Course 1|Adverse Event|6|||
155410885|NCT01368835|560937532|FG000|Overall Study|Inclusion criteria/photography quality|22|||
155410886|NCT01368835|560937532|FG000|Overall Study|Lost to Follow-up|11|||
155410887|NCT01885000|560937533|FG000|Overall Study|Adverse Event|1|||
155410888|NCT01885000|560937534|FG001|Overall Study|Adverse Event|0|||
155410889|NCT01885000|560937533|FG000|Overall Study|Withdrawal by Subject|1|||
155410890|NCT01885000|560937534|FG001|Overall Study|Withdrawal by Subject|1|||
155410891|NCT01885000|560937533|FG000|Overall Study|Protocol Violation|0|||
155410892|NCT01885000|560937534|FG001|Overall Study|Protocol Violation|1|||
155410893|NCT02363686|560937538|FG000|Overall Study|Withdrawal by Subject|22|||
155410894|NCT02363686|560937538|FG000|Overall Study|incomplete FEES examinations|13|||
155410895|NCT02469090|560937544|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
155410896|NCT02469090|560937545|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
155410897|NCT02469090|560937546|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
155410898|NCT02469090|560937544|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
155410899|NCT02469090|560937545|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
155410900|NCT02469090|560937546|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
155410901|NCT02469090|560937544|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
155410902|NCT02469090|560937545|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
155410903|NCT02469090|560937546|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
155410904|NCT02469090|560937544|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
155410905|NCT02469090|560937545|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
155410906|NCT02469090|560937546|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
155410907|NCT02469090|560937544|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
155410908|NCT02469090|560937545|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
155410909|NCT02469090|560937546|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
155410910|NCT02469090|560937544|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
155410911|NCT02469090|560937545|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
155747540|NCT01397825|562176498|FG001|Overall Study|Adverse Event|1|||
155747541|NCT01397825|562176499|FG002|Overall Study|Adverse Event|5|||
155410912|NCT02469090|560937546|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
155410913|NCT02469090|560937544|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
155410914|NCT02469090|560937545|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
155410915|NCT02469090|560937546|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
155410916|NCT02469090|560937544|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
155410917|NCT02469090|560937545|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
155410918|NCT02469090|560937546|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
155410919|NCT03806127|560937548|FG000|Overall Study|Withdrawal by Subject|4|||
155410920|NCT03806127|560937549|FG001|Overall Study|Withdrawal by Subject|5|||
155410921|NCT03806127|560937548|FG000|Overall Study|Protocol Violation|3|||
155410922|NCT03806127|560937549|FG001|Overall Study|Protocol Violation|1|||
155410923|NCT03806127|560937548|FG000|Overall Study|Adverse Event|3|||
155410924|NCT03806127|560937549|FG001|Overall Study|Adverse Event|0|||
155410925|NCT03806127|560937548|FG000|Overall Study|Unable to Complete Procedures|0|||
155410926|NCT03806127|560937549|FG001|Overall Study|Unable to Complete Procedures|1|||
155410927|NCT03806127|560937548|FG000|Overall Study|Pregnancy|0|||
155410928|NCT03806127|560937549|FG001|Overall Study|Pregnancy|1|||
155410929|NCT03806127|560937548|FG000|Overall Study|Lost to Follow-up|5|||
155410930|NCT03806127|560937549|FG001|Overall Study|Lost to Follow-up|1|||
155410931|NCT03806127|560937548|FG000|Overall Study|Physician Decision|1|||
155410932|NCT03806127|560937549|FG001|Overall Study|Physician Decision|1|||
155410933|NCT03806127|560937548|FG000|Overall Study|Could Not Come Due to Covid|1|||
155410934|NCT03806127|560937549|FG001|Overall Study|Could Not Come Due to Covid|0|||
155410935|NCT03806127|560937548|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
155410936|NCT03806127|560937549|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
155410937|NCT03806127|560937548|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
155410938|NCT03806127|560937549|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
155410939|NCT03806127|560937548|FG000|Overall Study|Covid 19 Restrictions|2|||
155410940|NCT03806127|560937549|FG001|Overall Study|Covid 19 Restrictions|0|||
155410941|NCT03806127|560937548|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
155410942|NCT03806127|560937549|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
155410943|NCT03806127|560937548|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
155410944|NCT03806127|560937549|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
155410945|NCT03446885|560937551|FG000|Overall Study|Lost to Follow-up|1|||
155410946|NCT03446885|560937552|FG001|Overall Study|Lost to Follow-up|0|||
155410947|NCT03446885|560937551|FG000|Overall Study|Did not complete entire visit|1|||
155410948|NCT03446885|560937552|FG001|Overall Study|Did not complete entire visit|0|||
155410949|NCT05882318|560937561|FG000|Overall Study|Withdrawal by Subject|1|||
155410950|NCT05882318|560937562|FG001|Overall Study|Withdrawal by Subject|0|||
155410951|NCT05882318|560937561|FG000|Overall Study|Protocol Violation|0|||
155410952|NCT05882318|560937562|FG001|Overall Study|Protocol Violation|1|||
155410953|NCT05030311|560937563|FG000|Overall Study|Technical problems|0|||
155410954|NCT05030311|560937564|FG001|Overall Study|Technical problems|1|||
155410955|NCT05030311|560937563|FG000|Overall Study|Withdrawal by Subject|31|||
155410956|NCT05030311|560937564|FG001|Overall Study|Withdrawal by Subject|17|||
155410957|NCT05030311|560937563|FG000|Overall Study|Adverse Event|13|||
155410958|NCT05030311|560937564|FG001|Overall Study|Adverse Event|5|||
155410959|NCT05030311|560937563|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155410960|NCT05030311|560937564|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155410961|NCT05030311|560937563|FG000|Overall Study|Physician Decision|5|||
155410962|NCT05030311|560937564|FG001|Overall Study|Physician Decision|2|||
155410963|NCT05030311|560937563|FG000|Overall Study|Lost to Follow-up|5|||
155410964|NCT05030311|560937564|FG001|Overall Study|Lost to Follow-up|1|||
155410965|NCT05030311|560937563|FG000|Overall Study|Protocol Violation|4|||
155410966|NCT05030311|560937564|FG001|Overall Study|Protocol Violation|4|||
155410967|NCT03042468|560937565|FG000|Overall Study|Death|0|||
155410968|NCT03042468|560937566|FG001|Overall Study|Death|1|||
155410969|NCT03042468|560937567|FG002|Overall Study|Death|1|||
155410970|NCT03042468|560937568|FG003|Overall Study|Death|0|||
155410971|NCT03042468|560937569|FG004|Overall Study|Death|0|||
155410972|NCT03042468|560937570|FG005|Overall Study|Death|0|||
155410973|NCT03042468|560937565|FG000|Overall Study|Withdrawal by Subject|0|||
155410974|NCT03042468|560937566|FG001|Overall Study|Withdrawal by Subject|0|||
155410975|NCT03042468|560937567|FG002|Overall Study|Withdrawal by Subject|0|||
155410976|NCT03042468|560937568|FG003|Overall Study|Withdrawal by Subject|0|||
155410977|NCT03042468|560937569|FG004|Overall Study|Withdrawal by Subject|0|||
155410978|NCT03042468|560937570|FG005|Overall Study|Withdrawal by Subject|1|||
155410979|NCT03042468|560937565|FG000|Overall Study|Lost to Follow-up|0|||
155410980|NCT03042468|560937566|FG001|Overall Study|Lost to Follow-up|0|||
155410981|NCT03042468|560937567|FG002|Overall Study|Lost to Follow-up|0|||
155747542|NCT01397825|562176500|FG003|Overall Study|Adverse Event|1|||
155747543|NCT01397825|562176501|FG004|Overall Study|Adverse Event|0|||
155747544|NCT01397825|562176497|FG000|Overall Study|Withdrawal by Subject|1|||
155410982|NCT03042468|560937568|FG003|Overall Study|Lost to Follow-up|0|||
155410983|NCT03042468|560937569|FG004|Overall Study|Lost to Follow-up|1|||
155410984|NCT03042468|560937570|FG005|Overall Study|Lost to Follow-up|1|||
155410985|NCT01662895|560937571|FG000|Overall Study|Lost to Follow-up|0|||
155410986|NCT01662895|560937572|FG001|Overall Study|Lost to Follow-up|1|||
155410987|NCT02275338|560937573|FG000|Overall Study|Adverse Event|15|||
155410988|NCT02275338|560937573|FG000|Overall Study|Lack of Efficacy|3|||
155410989|NCT02275338|560937573|FG000|Overall Study|Withdrawal by Subject|4|||
155410990|NCT02275338|560937573|FG000|Overall Study|Disease progression (death)|1|||
155410991|NCT02275338|560937573|FG000|Overall Study|Ineligible to start Phase 2|4|||
155410992|NCT02275338|560937573|FG000|Overall Study|Reason not specified|5|||
155410993|NCT02275338|560937573|FG000|Overall Study|Does not meet entry criteria|1|||
155410994|NCT01665807|560937574|FG000|Overall Study|Withdrawal by Subject|2|||
155410995|NCT01665807|560937575|FG001|Overall Study|Withdrawal by Subject|0|||
155410996|NCT01665807|560937576|FG002|Overall Study|Withdrawal by Subject|1|||
155410997|NCT00623428|560937577|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
155410998|NCT00623428|560937578|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
155410999|NCT00623428|560937577|FG000|Treatment Period|Death|0|||
155411000|NCT00623428|560937578|FG001|Treatment Period|Death|1|||
155411001|NCT00623428|560937577|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
155411002|NCT00623428|560937578|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
155411003|NCT00623428|560937577|FG000|Treatment Period|Insufficient therapeutic response|0|||
155411004|NCT00623428|560937578|FG001|Treatment Period|Insufficient therapeutic response|2|||
155411005|NCT00623428|560937577|FG000|Treatment Period|Other|0|||
155411006|NCT00623428|560937578|FG001|Treatment Period|Other|1|||
155411007|NCT00623428|560937577|FG000|Treatment Period|Withdrawal by Subject|0|||
155411008|NCT00623428|560937578|FG001|Treatment Period|Withdrawal by Subject|1|||
155411009|NCT00623428|560937577|FG000|Follow-up Period|Relapse post-treatment|11|||
155411010|NCT00623428|560937578|FG001|Follow-up Period|Relapse post-treatment|3|||
155411011|NCT00623428|560937577|FG000|Follow-up Period|Failure to return|10|||
155411012|NCT00623428|560937578|FG001|Follow-up Period|Failure to return|2|||
155411013|NCT00623428|560937577|FG000|Follow-up Period|Patient withdrew consent|5|||
155411014|NCT00623428|560937578|FG001|Follow-up Period|Patient withdrew consent|4|||
155411015|NCT00623428|560937577|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
155411016|NCT00623428|560937578|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
155411017|NCT00623428|560937577|FG000|Follow-up Period|Did not cooperate|0|||
155411018|NCT00623428|560937578|FG001|Follow-up Period|Did not cooperate|3|||
155411019|NCT00623428|560937577|FG000|Follow-up Period|Reason not specified|1|||
155411020|NCT00623428|560937578|FG001|Follow-up Period|Reason not specified|1|||
155411021|NCT00623428|560937577|FG000|Follow-up Period|Death|0|||
155411022|NCT00623428|560937578|FG001|Follow-up Period|Death|1|||
155411023|NCT01692301|560937579|FG000|Overall Study|Adverse Event|15|||
155411024|NCT01692301|560937580|FG001|Overall Study|Adverse Event|12|||
155411025|NCT01692301|560937579|FG000|Overall Study|Death|1|||
155411026|NCT01692301|560937580|FG001|Overall Study|Death|2|||
155411027|NCT01692301|560937579|FG000|Overall Study|Lack of Efficacy|0|||
155411028|NCT01692301|560937580|FG001|Overall Study|Lack of Efficacy|5|||
155411029|NCT01692301|560937579|FG000|Overall Study|Non-compliance with study treatment|1|||
155411030|NCT01692301|560937580|FG001|Overall Study|Non-compliance with study treatment|2|||
155411031|NCT01692301|560937579|FG000|Overall Study|Protocol deviation|9|||
155411032|NCT01692301|560937580|FG001|Overall Study|Protocol deviation|2|||
155411033|NCT01692301|560937579|FG000|Overall Study|Patient/guardian decision|16|||
155411034|NCT01692301|560937580|FG001|Overall Study|Patient/guardian decision|15|||
155411035|NCT01692301|560937579|FG000|Overall Study|Technical problems|0|||
155411036|NCT01692301|560937580|FG001|Overall Study|Technical problems|1|||
155411037|NCT01692301|560937579|FG000|Overall Study|Physician Decision|2|||
155411038|NCT01692301|560937580|FG001|Overall Study|Physician Decision|2|||
155411039|NCT01692301|560937579|FG000|Overall Study|Lost to Follow-up|1|||
155411040|NCT01692301|560937580|FG001|Overall Study|Lost to Follow-up|1|||
155411041|NCT01142726|560937581|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
155411042|NCT01142726|560937582|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
155411043|NCT01142726|560937583|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
155411044|NCT01142726|560937581|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
155411045|NCT01142726|560937582|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
155411046|NCT01142726|560937583|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
155411047|NCT01142726|560937581|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
155411048|NCT01142726|560937582|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
155411049|NCT01142726|560937583|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
155411050|NCT01142726|560937581|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
155411051|NCT01142726|560937582|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
155411052|NCT01142726|560937583|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
155411053|NCT01142726|560937581|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
155411054|NCT01142726|560937582|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
155411055|NCT01142726|560937583|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
155411056|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
155411057|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
155411058|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
155411059|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
155411060|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
155411061|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
155411062|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
155411063|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
155411064|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
155411065|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
155411066|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
155411067|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
155411068|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
155411069|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
155411070|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
155411071|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
155411072|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
155411073|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
155411074|NCT01142726|560937581|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
155411075|NCT01142726|560937582|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
155411076|NCT01142726|560937583|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
155411077|NCT01142726|560937581|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
155411078|NCT01142726|560937582|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
155411079|NCT01142726|560937583|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
155411080|NCT01142726|560937581|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
155411081|NCT01142726|560937582|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
155411082|NCT01142726|560937583|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
155411083|NCT01142726|560937581|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
155411084|NCT01142726|560937582|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
155411085|NCT01142726|560937583|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
155747545|NCT01397825|562176498|FG001|Overall Study|Withdrawal by Subject|0|||
155747546|NCT01397825|562176499|FG002|Overall Study|Withdrawal by Subject|5|||
155747547|NCT01397825|562176500|FG003|Overall Study|Withdrawal by Subject|1|||
155747548|NCT01397825|562176501|FG004|Overall Study|Withdrawal by Subject|0|||
155747549|NCT00976508|562176502|FG000|Overall Study|Death|7|||
155747550|NCT00976508|562176503|FG001|Overall Study|Death|1|||
155747551|NCT00976508|562176502|FG000|Overall Study|Lost to Follow-up|1|||
155747552|NCT00976508|562176503|FG001|Overall Study|Lost to Follow-up|0|||
155747553|NCT00976508|562176502|FG000|Overall Study|Withdrawal by Subject|1|||
155747554|NCT00976508|562176503|FG001|Overall Study|Withdrawal by Subject|0|||
155747555|NCT00976508|562176502|FG000|Overall Study|Disease Progression|4|||
155747556|NCT00976508|562176503|FG001|Overall Study|Disease Progression|4|||
155747557|NCT00976508|562176502|FG000|Overall Study|Subject Enrolled in Hospice|1|||
155747558|NCT00976508|562176503|FG001|Overall Study|Subject Enrolled in Hospice|0|||
155747559|NCT00976508|562176502|FG000|Overall Study|Terminated by the Sponsor|0|||
155747560|NCT00976508|562176503|FG001|Overall Study|Terminated by the Sponsor|1|||
155747561|NCT01993836|562176504|FG000|Overall Study|Surgery Cancelled|3|||
155747562|NCT01993836|562176505|FG001|Overall Study|Surgery Cancelled|0|||
155747563|NCT01993836|562176506|FG002|Overall Study|Surgery Cancelled|0|||
155747564|NCT01993836|562176504|FG000|Overall Study|Physician Decision|2|||
155747565|NCT01993836|562176505|FG001|Overall Study|Physician Decision|1|||
155747566|NCT01993836|562176506|FG002|Overall Study|Physician Decision|0|||
155747567|NCT01993836|562176504|FG000|Overall Study|Death|0|||
155747568|NCT01993836|562176505|FG001|Overall Study|Death|2|||
155411086|NCT01142726|560937581|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
155411087|NCT01142726|560937582|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
155411088|NCT01142726|560937583|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
155411089|NCT01568593|560937584|FG000|Overall Study|Lack of Efficacy|4|||
155411090|NCT01568593|560937585|FG001|Overall Study|Lack of Efficacy|1|||
155411091|NCT01568593|560937584|FG000|Overall Study|Adverse Event|3|||
155411092|NCT01568593|560937585|FG001|Overall Study|Adverse Event|2|||
155747569|NCT01993836|562176506|FG002|Overall Study|Death|0|||
155747570|NCT01993836|562176504|FG000|Overall Study|Withdrawal by Subject|12|||
155747571|NCT01993836|562176505|FG001|Overall Study|Withdrawal by Subject|10|||
155747572|NCT01993836|562176506|FG002|Overall Study|Withdrawal by Subject|5|||
155747573|NCT02677324|562176507|FG000|Overall Study|Disease Progression|6|||
155747574|NCT02677324|562176507|FG000|Overall Study|Inability to Swallow pills|1|||
155747575|NCT02677324|562176507|FG000|Overall Study|Non-compliance|1|||
155747576|NCT02677324|562176507|FG000|Overall Study|Lack of Efficacy|1|||
155411093|NCT01097863|560937586|FG000|Overall Study|Discomfort|1|||
155411094|NCT01097863|560937587|FG001|Overall Study|Discomfort|0|||
155411095|NCT01097863|560937588|FG002|Overall Study|Discomfort|1|||
155411096|NCT01097863|560937586|FG000|Overall Study|Did not return for final visit|0|||
155411097|NCT01097863|560937587|FG001|Overall Study|Did not return for final visit|0|||
155411098|NCT01097863|560937588|FG002|Overall Study|Did not return for final visit|1|||
155411099|NCT02788747|560937593|FG000|Overall Study|Adverse Event|1|||
155411100|NCT02788747|560937594|FG001|Overall Study|Adverse Event|0|||
155411101|NCT02788747|560937595|FG002|Overall Study|Adverse Event|0|||
155411102|NCT01026831|560937596|FG000|Overall Study|Adverse Event|4|||
155411103|NCT01026831|560937597|FG001|Overall Study|Adverse Event|3|||
155411104|NCT01026831|560937596|FG000|Overall Study|Lost to Follow-up|2|||
155411105|NCT01026831|560937597|FG001|Overall Study|Lost to Follow-up|0|||
155411106|NCT01026831|560937596|FG000|Overall Study|Physician Decision|1|||
155411107|NCT01026831|560937597|FG001|Overall Study|Physician Decision|1|||
155411108|NCT01026831|560937596|FG000|Overall Study|Protocol Violation|0|||
155411109|NCT01026831|560937597|FG001|Overall Study|Protocol Violation|2|||
155411110|NCT01026831|560937596|FG000|Overall Study|Withdrawal by Subject|7|||
155411111|NCT01026831|560937597|FG001|Overall Study|Withdrawal by Subject|5|||
155411112|NCT01079182|560937598|FG000|Overall Study|Lost to Follow-up|1634|||
155411113|NCT01079182|560937598|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
155411114|NCT01079182|560937598|FG000|Overall Study|Lack of Efficacy|514|||
155411115|NCT01079182|560937598|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
155411116|NCT01079182|560937598|FG000|Overall Study|Reasons not Evaluated|271|||
155411117|NCT04417894|560937599|FG000|Overall Study|Lost to Follow-up|3|||
155411118|NCT04417894|560937600|FG001|Overall Study|Lost to Follow-up|0|||
155411119|NCT04417894|560937599|FG000|Overall Study|Withdrawal by Subject|7|||
155411120|NCT04417894|560937600|FG001|Overall Study|Withdrawal by Subject|6|||
155411121|NCT04417894|560937599|FG000|Overall Study|Lack of Efficacy|3|||
155411122|NCT04417894|560937600|FG001|Overall Study|Lack of Efficacy|1|||
155411123|NCT04472429|560937601|FG000|Randomized Period|Ongoing|90|||
155411124|NCT04472429|560937602|FG001|Randomized Period|Ongoing|40|||
155411125|NCT04472429|560937603|FG002|Randomized Period|Ongoing|0|||
155411126|NCT04472429|560937601|FG000|Randomized Period|Death|52|||
155411127|NCT04472429|560937602|FG001|Randomized Period|Death|37|||
155411128|NCT04472429|560937603|FG002|Randomized Period|Death|0|||
155411129|NCT04472429|560937601|FG000|Randomized Period|Lost to Follow-up|4|||
155411130|NCT04472429|560937602|FG001|Randomized Period|Lost to Follow-up|0|||
155411131|NCT04472429|560937603|FG002|Randomized Period|Lost to Follow-up|0|||
155411132|NCT04472429|560937601|FG000|Randomized Period|Physician Decision|1|||
155411133|NCT04472429|560937602|FG001|Randomized Period|Physician Decision|2|||
155411134|NCT04472429|560937603|FG002|Randomized Period|Physician Decision|0|||
155411135|NCT04472429|560937601|FG000|Randomized Period|Withdrawal by Subject|6|||
155747577|NCT02677324|562176507|FG000|Overall Study|Medical insurance coverage|1|||
155747578|NCT02677324|562176507|FG000|Overall Study|Adverse Event|1|||
155747579|NCT02677324|562176507|FG000|Overall Study|IgM Myeloma diagnosis|1|||
155747580|NCT00761150|562176510|FG000|Open-label Period|Adverse Event|36|||
155747581|NCT00761150|562176511|FG001|Open-label Period|Adverse Event|0|||
155747582|NCT00761150|562176512|FG002|Open-label Period|Adverse Event|0|||
155747583|NCT00761150|562176510|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
155747584|NCT00761150|562176511|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
155747585|NCT00761150|562176512|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
155747586|NCT00761150|562176510|FG000|Open-label Period|Lost to Follow-up|7|||
155747587|NCT00761150|562176511|FG001|Open-label Period|Lost to Follow-up|0|||
155747588|NCT00761150|562176512|FG002|Open-label Period|Lost to Follow-up|0|||
155747589|NCT00761150|562176510|FG000|Open-label Period|Lack of Efficacy|4|||
155747590|NCT00761150|562176511|FG001|Open-label Period|Lack of Efficacy|0|||
155747591|NCT00761150|562176512|FG002|Open-label Period|Lack of Efficacy|0|||
155747592|NCT00761150|562176510|FG000|Open-label Period|Withdrawal by Subject|5|||
155747593|NCT00761150|562176511|FG001|Open-label Period|Withdrawal by Subject|0|||
155747594|NCT00761150|562176512|FG002|Open-label Period|Withdrawal by Subject|0|||
155747595|NCT00761150|562176510|FG000|Open-label Period|Noncompliance|2|||
155747596|NCT00761150|562176511|FG001|Open-label Period|Noncompliance|0|||
155411136|NCT04472429|560937602|FG001|Randomized Period|Withdrawal by Subject|5|||
155411137|NCT04472429|560937603|FG002|Randomized Period|Withdrawal by Subject|0|||
155411138|NCT04472429|560937601|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
155411139|NCT04472429|560937602|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
155411140|NCT04472429|560937603|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
155411141|NCT04472429|560937601|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
155411142|NCT04472429|560937602|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
155411143|NCT04472429|560937603|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
155747597|NCT00761150|562176512|FG002|Open-label Period|Noncompliance|0|||
155411144|NCT04472429|560937601|FG000|Open-label Monotherapy Period|Ongoing|0|||
155747598|NCT00761150|562176510|FG000|Open-label Period|Other|5|||
155411145|NCT04472429|560937602|FG001|Open-label Monotherapy Period|Ongoing|0|||
155747599|NCT00761150|562176511|FG001|Open-label Period|Other|0|||
155747600|NCT00761150|562176512|FG002|Open-label Period|Other|0|||
155747601|NCT00761150|562176510|FG000|Double-blind Period|Lack of Efficacy|0|||
155747602|NCT00761150|562176511|FG001|Double-blind Period|Lack of Efficacy|2|||
155747603|NCT00761150|562176512|FG002|Double-blind Period|Lack of Efficacy|19|||
155747604|NCT00761150|562176510|FG000|Double-blind Period|Adverse Event|0|||
155747605|NCT00761150|562176511|FG001|Double-blind Period|Adverse Event|3|||
155747606|NCT00761150|562176512|FG002|Double-blind Period|Adverse Event|3|||
155302374|NCT04440176|560540120|FG000|Overall Study|Withdrawal by Subject|5|||
155302375|NCT04440176|560540121|FG001|Overall Study|Withdrawal by Subject|3|||
155302376|NCT04440176|560540120|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155302377|NCT04440176|560540121|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155302378|NCT04440176|560540120|FG000|Overall Study|Adverse Event|2|||
155411146|NCT04472429|560937603|FG002|Open-label Monotherapy Period|Ongoing|32|||
155411147|NCT04472429|560937601|FG000|Open-label Monotherapy Period|Death|0|||
155411148|NCT04472429|560937602|FG001|Open-label Monotherapy Period|Death|0|||
155411149|NCT04472429|560937603|FG002|Open-label Monotherapy Period|Death|35|||
155411150|NCT04472429|560937601|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
155411151|NCT04472429|560937602|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
155411152|NCT04472429|560937603|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
155411153|NCT01180660|560937604|FG000|Overall Study|Changed to open surgery|1|||
155411154|NCT01180660|560937605|FG001|Overall Study|Changed to open surgery|0|||
155411155|NCT02425826|560937606|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
155411156|NCT02425826|560937607|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
155411157|NCT02425826|560937608|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
155411158|NCT02425826|560937606|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
155411159|NCT02425826|560937607|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
155411160|NCT02425826|560937608|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
155411161|NCT02425826|560937606|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
155411162|NCT02425826|560937607|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
155411163|NCT02425826|560937608|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
155411164|NCT02425826|560937606|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
155411165|NCT02425826|560937607|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
155411166|NCT02425826|560937608|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
155411167|NCT02425826|560937606|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
155411168|NCT02425826|560937607|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
155411169|NCT02425826|560937608|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
155411170|NCT02425826|560937606|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
155411171|NCT02425826|560937607|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
155411172|NCT02425826|560937608|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
155411173|NCT02425826|560937606|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
155411174|NCT02425826|560937607|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
155411175|NCT02425826|560937608|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
155411176|NCT02425826|560937606|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
155411177|NCT02425826|560937607|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
155411178|NCT02425826|560937608|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
155411179|NCT02425826|560937606|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
155411180|NCT02425826|560937607|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
155411181|NCT02425826|560937608|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
155411182|NCT02425826|560937606|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
155411183|NCT02425826|560937607|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
155411184|NCT02425826|560937608|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
155411185|NCT04942925|560937615|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
155411186|NCT04942925|560937616|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
155411187|NCT04942925|560937615|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
155411188|NCT04942925|560937616|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
155411189|NCT02043548|560937619|FG000|Overall Study|Lack of Efficacy|1|||
155411190|NCT02043548|560937620|FG001|Overall Study|Lack of Efficacy|0|||
155411191|NCT02043548|560937619|FG000|Overall Study|Adverse Event|0|||
155411192|NCT02043548|560937620|FG001|Overall Study|Adverse Event|1|||
155411193|NCT01344876|560937621|FG000|Overall Study|Adverse Event|0|||
155411194|NCT01344876|560937622|FG001|Overall Study|Adverse Event|0|||
155411195|NCT01344876|560937623|FG002|Overall Study|Adverse Event|0|||
155302379|NCT04440176|560540121|FG001|Overall Study|Adverse Event|6|||
155302380|NCT04440176|560540120|FG000|Overall Study|Lost to Follow-up|22|||
155302381|NCT04440176|560540121|FG001|Overall Study|Lost to Follow-up|23|||
155302382|NCT04440176|560540120|FG000|Overall Study|Medication error without associated adverse event|0|||
155411196|NCT01344876|560937624|FG003|Overall Study|Adverse Event|0|||
155411197|NCT01344876|560937625|FG004|Overall Study|Adverse Event|1|||
155747607|NCT00761150|562176510|FG000|Double-blind Period|Withdrawal by Subject|0|||
155747608|NCT00761150|562176511|FG001|Double-blind Period|Withdrawal by Subject|3|||
155747609|NCT00761150|562176512|FG002|Double-blind Period|Withdrawal by Subject|2|||
155747610|NCT00761150|562176510|FG000|Double-blind Period|Lost to Follow-up|0|||
155747611|NCT00761150|562176511|FG001|Double-blind Period|Lost to Follow-up|2|||
155747612|NCT00761150|562176512|FG002|Double-blind Period|Lost to Follow-up|1|||
155747613|NCT00761150|562176510|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
155747614|NCT00761150|562176511|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
155747615|NCT00761150|562176512|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
155411198|NCT01344876|560937621|FG000|Overall Study|Withdrawal by Subject|0|||
155411199|NCT01344876|560937622|FG001|Overall Study|Withdrawal by Subject|0|||
155411200|NCT01344876|560937623|FG002|Overall Study|Withdrawal by Subject|1|||
155411201|NCT01344876|560937624|FG003|Overall Study|Withdrawal by Subject|0|||
155411202|NCT01344876|560937625|FG004|Overall Study|Withdrawal by Subject|0|||
155411203|NCT01344876|560937621|FG000|Overall Study|Definite progression of primary disease|1|||
155411204|NCT01344876|560937622|FG001|Overall Study|Definite progression of primary disease|0|||
155411205|NCT01344876|560937623|FG002|Overall Study|Definite progression of primary disease|0|||
155411206|NCT01344876|560937624|FG003|Overall Study|Definite progression of primary disease|3|||
155411207|NCT01344876|560937625|FG004|Overall Study|Definite progression of primary disease|0|||
155411208|NCT05107765|560937626|FG000|Overall Study|Lost to Follow-up|4|||
155411209|NCT05107765|560937627|FG001|Overall Study|Lost to Follow-up|1|||
155411210|NCT05107765|560937626|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
155411211|NCT05107765|560937627|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
155411212|NCT05107765|560937626|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
155411213|NCT05107765|560937627|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
155411214|NCT00562588|560937628|FG000|Overall Study|Adverse Event|40|||
155411215|NCT00562588|560937629|FG001|Overall Study|Adverse Event|58|||
155411216|NCT00562588|560937628|FG000|Overall Study|Protocol Violation|30|||
155411217|NCT00562588|560937629|FG001|Overall Study|Protocol Violation|26|||
155411218|NCT00562588|560937628|FG000|Overall Study|Lost to Follow-up|12|||
155411219|NCT00562588|560937629|FG001|Overall Study|Lost to Follow-up|4|||
155411220|NCT00562588|560937628|FG000|Overall Study|Withdrawal by Subject|10|||
155411221|NCT00562588|560937629|FG001|Overall Study|Withdrawal by Subject|9|||
155411222|NCT00562588|560937628|FG000|Overall Study|Other|0|||
155411223|NCT00562588|560937629|FG001|Overall Study|Other|2|||
155411224|NCT01777152|560939087|FG000|Overall Study|Withdrawal by Subject|22|||
155411225|NCT01777152|560939088|FG001|Overall Study|Withdrawal by Subject|16|||
155411226|NCT01777152|560939087|FG000|Overall Study|Lost to Follow-up|3|||
155411227|NCT01777152|560939088|FG001|Overall Study|Lost to Follow-up|5|||
155411228|NCT01777152|560939087|FG000|Overall Study|Death|68|||
155411229|NCT01777152|560939088|FG001|Overall Study|Death|89|||
155411230|NCT01777152|560939087|FG000|Overall Study|Not eligible, no study drug received|1|||
155411231|NCT01777152|560939088|FG001|Overall Study|Not eligible, no study drug received|0|||
155411232|NCT01777152|560939087|FG000|Overall Study|Change of diagnosis|1|||
155411233|NCT01777152|560939088|FG001|Overall Study|Change of diagnosis|0|||
155411234|NCT03823391|560939093|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
155411235|NCT03823391|560939094|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
155411236|NCT03823391|560939093|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
155411237|NCT03823391|560939094|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
155411238|NCT03557359|560939100|FG000|Dose 1: 240 mg|Adverse Event|1|||
155411239|NCT03557359|560939101|FG001|Dose 1: 240 mg|Adverse Event|0|||
155411240|NCT05980299|560939106|FG000|Overall Study|Death|28|||
155411241|NCT05980299|560939107|FG001|Overall Study|Death|0|||
155411242|NCT05980299|560939106|FG000|Overall Study|Discharged from Nursing Home|9|||
155411243|NCT05980299|560939107|FG001|Overall Study|Discharged from Nursing Home|0|||
155411244|NCT05980299|560939106|FG000|Overall Study|Lost to Follow-up|0|||
155411245|NCT05980299|560939107|FG001|Overall Study|Lost to Follow-up|10|||
155411246|NCT02264990|560939108|FG000|Overall Study|Death|255|||
155411247|NCT02264990|560939109|FG001|Overall Study|Death|250|||
155411248|NCT02264990|560939108|FG000|Overall Study|Withdrawal by Subject|4|||
155411249|NCT02264990|560939109|FG001|Overall Study|Withdrawal by Subject|5|||
155411250|NCT02264990|560939108|FG000|Overall Study|Lost to Follow-up|1|||
155411251|NCT02264990|560939109|FG001|Overall Study|Lost to Follow-up|3|||
155411252|NCT02264990|560939108|FG000|Overall Study|Other|0|||
155411253|NCT02264990|560939109|FG001|Overall Study|Other|1|||
155411254|NCT03031301|560939111|FG000|Overall Study|Protocol Violation|4|||
155411255|NCT03031301|560939112|FG001|Overall Study|Protocol Violation|8|||
155411256|NCT03031301|560939111|FG000|Overall Study|Withdrawal by Subject|7|||
155411257|NCT03031301|560939112|FG001|Overall Study|Withdrawal by Subject|4|||
155411258|NCT03031301|560939111|FG000|Overall Study|Lost to Follow-up|4|||
155747616|NCT00761150|562176510|FG000|Double-blind Period|Noncompliance|0|||
155411259|NCT03031301|560939112|FG001|Overall Study|Lost to Follow-up|12|||
155411260|NCT03031301|560939111|FG000|Overall Study|Noncompliance|1|||
155411261|NCT03031301|560939112|FG001|Overall Study|Noncompliance|3|||
155411262|NCT03031301|560939111|FG000|Overall Study|Technical issue|1|||
155411263|NCT03031301|560939112|FG001|Overall Study|Technical issue|1|||
155411264|NCT03031301|560939111|FG000|Overall Study|Adverse Event|1|||
155411265|NCT03031301|560939112|FG001|Overall Study|Adverse Event|0|||
155411266|NCT01294800|560939113|FG000|Overall Study|Adverse Event|7|||
155411267|NCT01294800|560939114|FG001|Overall Study|Adverse Event|6|||
155411268|NCT01294800|560939115|FG002|Overall Study|Adverse Event|12|||
155411269|NCT01294800|560939116|FG003|Overall Study|Adverse Event|5|||
155411270|NCT01294800|560939113|FG000|Overall Study|Subject Withdrew Consent|2|||
155411271|NCT01294800|560939114|FG001|Overall Study|Subject Withdrew Consent|2|||
155411272|NCT01294800|560939115|FG002|Overall Study|Subject Withdrew Consent|2|||
155411273|NCT01294800|560939116|FG003|Overall Study|Subject Withdrew Consent|11|||
155411274|NCT01294800|560939113|FG000|Overall Study|Lost to Follow-up|0|||
155411275|NCT01294800|560939114|FG001|Overall Study|Lost to Follow-up|0|||
155411276|NCT01294800|560939115|FG002|Overall Study|Lost to Follow-up|1|||
155411277|NCT01294800|560939116|FG003|Overall Study|Lost to Follow-up|0|||
155411278|NCT01294800|560939113|FG000|Overall Study|Non-compliance With Protocol|0|||
155411279|NCT01294800|560939114|FG001|Overall Study|Non-compliance With Protocol|1|||
155411280|NCT01294800|560939115|FG002|Overall Study|Non-compliance With Protocol|1|||
155411281|NCT01294800|560939116|FG003|Overall Study|Non-compliance With Protocol|0|||
155411282|NCT01294800|560939113|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
155411283|NCT01294800|560939114|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
155411284|NCT01294800|560939115|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
155411285|NCT01294800|560939116|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
155411286|NCT05048342|560939118|FG000|Overall Study|Adverse Event|1|||
155411287|NCT05048342|560939118|FG000|Overall Study|Subject decision|2|||
155411288|NCT00493038|560939119|FG000|Treatment|Adverse Event|8|||
155411289|NCT00493038|560939120|FG001|Treatment|Adverse Event|4|||
155411290|NCT00493038|560939119|FG000|Treatment|Lost to Follow-up|5|||
155411291|NCT00493038|560939120|FG001|Treatment|Lost to Follow-up|3|||
155411292|NCT00493038|560939119|FG000|Treatment|Withdrawal by Subject|11|||
155411293|NCT00493038|560939120|FG001|Treatment|Withdrawal by Subject|12|||
155411294|NCT00493038|560939119|FG000|Treatment|Other|0|||
155411295|NCT00493038|560939120|FG001|Treatment|Other|1|||
155411296|NCT00493038|560939119|FG000|Follow-up|Lost to Follow-up|1|||
155411297|NCT00493038|560939120|FG001|Follow-up|Lost to Follow-up|0|||
155411298|NCT01441063|560939121|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
155411299|NCT01441063|560939121|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
155411300|NCT03345472|560939126|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
155411301|NCT03345472|560939126|FG000|Implant to 3 Months|Physician Decision|1|||
155411302|NCT03345472|560939126|FG000|Implant to 3 Months|Adverse Event|1|||
155411303|NCT03345472|560939126|FG000|3 Months to 12 Months|Physician Decision|3|||
155411304|NCT03345472|560939126|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
155411305|NCT03345472|560939126|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
155411306|NCT03345472|560939126|FG000|3 Months to 12 Months|Adverse Event|1|||
155411307|NCT03345472|560939126|FG000|3 Months to 12 Months|Death|1|||
155411308|NCT01926782|560939127|FG000|Overall Study|Participant moved|2|||
155411309|NCT01926782|560939128|FG001|Overall Study|Participant moved|0|||
155411310|NCT01926782|560939129|FG002|Overall Study|Participant moved|1|||
155411311|NCT01926782|560939130|FG003|Overall Study|Participant moved|1|||
155411312|NCT01926782|560939131|FG004|Overall Study|Participant moved|0|||
155411313|NCT01926782|560939132|FG005|Overall Study|Participant moved|3|||
155411314|NCT01926782|560939127|FG000|Overall Study|Physician Decision|0|||
155411315|NCT01926782|560939128|FG001|Overall Study|Physician Decision|2|||
155411316|NCT01926782|560939129|FG002|Overall Study|Physician Decision|1|||
155411317|NCT01926782|560939130|FG003|Overall Study|Physician Decision|1|||
155411318|NCT01926782|560939131|FG004|Overall Study|Physician Decision|0|||
155411319|NCT01926782|560939132|FG005|Overall Study|Physician Decision|0|||
155411320|NCT01926782|560939127|FG000|Overall Study|Other than specified|2|||
155411321|NCT01926782|560939128|FG001|Overall Study|Other than specified|3|||
155411322|NCT01926782|560939129|FG002|Overall Study|Other than specified|5|||
155411323|NCT01926782|560939130|FG003|Overall Study|Other than specified|12|||
155411324|NCT01926782|560939131|FG004|Overall Study|Other than specified|4|||
155411325|NCT01926782|560939132|FG005|Overall Study|Other than specified|11|||
155411326|NCT01926782|560939127|FG000|Overall Study|Adverse Event|13|||
155411327|NCT01926782|560939128|FG001|Overall Study|Adverse Event|4|||
155411328|NCT01926782|560939129|FG002|Overall Study|Adverse Event|17|||
155411329|NCT01926782|560939130|FG003|Overall Study|Adverse Event|4|||
155411330|NCT01926782|560939131|FG004|Overall Study|Adverse Event|3|||
155411331|NCT01926782|560939132|FG005|Overall Study|Adverse Event|14|||
155411332|NCT01926782|560939127|FG000|Overall Study|Poor compliance to protocol|5|||
155411333|NCT01926782|560939128|FG001|Overall Study|Poor compliance to protocol|3|||
155411334|NCT01926782|560939129|FG002|Overall Study|Poor compliance to protocol|8|||
155411335|NCT01926782|560939130|FG003|Overall Study|Poor compliance to protocol|0|||
155411336|NCT01926782|560939131|FG004|Overall Study|Poor compliance to protocol|1|||
155641237|NCT01716156|561776848|FG001|Overall Study|Protocol Violation|0|||
155411337|NCT01926782|560939132|FG005|Overall Study|Poor compliance to protocol|6|||
155411338|NCT01926782|560939127|FG000|Overall Study|Randomized and not treated|0|||
155411339|NCT01926782|560939128|FG001|Overall Study|Randomized and not treated|0|||
155411340|NCT01926782|560939129|FG002|Overall Study|Randomized and not treated|0|||
155411341|NCT01926782|560939130|FG003|Overall Study|Randomized and not treated|1|||
155411342|NCT01926782|560939131|FG004|Overall Study|Randomized and not treated|0|||
155411343|NCT01926782|560939132|FG005|Overall Study|Randomized and not treated|0|||
155411344|NCT01926782|560939127|FG000|Overall Study|Withdrawal by Subject|6|||
155411345|NCT01926782|560939128|FG001|Overall Study|Withdrawal by Subject|1|||
155411346|NCT01926782|560939129|FG002|Overall Study|Withdrawal by Subject|8|||
155411347|NCT01926782|560939130|FG003|Overall Study|Withdrawal by Subject|1|||
155411348|NCT01926782|560939131|FG004|Overall Study|Withdrawal by Subject|0|||
155411349|NCT01926782|560939132|FG005|Overall Study|Withdrawal by Subject|5|||
155411350|NCT01926782|560939127|FG000|Overall Study|Related to study drug administration|0|||
155411351|NCT01926782|560939128|FG001|Overall Study|Related to study drug administration|0|||
155411352|NCT01926782|560939129|FG002|Overall Study|Related to study drug administration|0|||
155411353|NCT01926782|560939130|FG003|Overall Study|Related to study drug administration|0|||
155411354|NCT01926782|560939131|FG004|Overall Study|Related to study drug administration|0|||
155411355|NCT01926782|560939132|FG005|Overall Study|Related to study drug administration|2|||
155411356|NCT01100944|560939137|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
155411357|NCT01100944|560939138|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
155411358|NCT01100944|560939139|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
155411359|NCT01100944|560939137|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
155411360|NCT01100944|560939138|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
155411361|NCT01100944|560939139|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
155411362|NCT01100944|560939137|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
155411363|NCT01100944|560939138|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
155411364|NCT01100944|560939139|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
155411365|NCT01100944|560939137|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
155411366|NCT01100944|560939138|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
155411367|NCT01100944|560939139|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
155411368|NCT04607733|560939142|FG000|Overall Study|Lost to Follow-up|1|||
155411369|NCT04607733|560939143|FG001|Overall Study|Lost to Follow-up|0|||
155411370|NCT04607733|560939144|FG002|Overall Study|Lost to Follow-up|0|||
155411371|NCT04607733|560939145|FG003|Overall Study|Lost to Follow-up|1|||
155411372|NCT04607733|560939146|FG004|Overall Study|Lost to Follow-up|1|||
155411373|NCT04607733|560939147|FG005|Overall Study|Lost to Follow-up|0|||
155411374|NCT04607733|560939142|FG000|Overall Study|Withdrawal by Subject|0|||
155411375|NCT04607733|560939143|FG001|Overall Study|Withdrawal by Subject|0|||
155411376|NCT04607733|560939144|FG002|Overall Study|Withdrawal by Subject|0|||
155411377|NCT04607733|560939145|FG003|Overall Study|Withdrawal by Subject|0|||
155411378|NCT04607733|560939146|FG004|Overall Study|Withdrawal by Subject|1|||
155411379|NCT04607733|560939147|FG005|Overall Study|Withdrawal by Subject|0|||
155411380|NCT01639833|560939173|FG000|Overall Study|Death|4|||
155411381|NCT01639833|560939174|FG001|Overall Study|Death|2|||
155411382|NCT01639833|560939173|FG000|Overall Study|Withdrawal by Subject|2|||
155411383|NCT01639833|560939174|FG001|Overall Study|Withdrawal by Subject|2|||
155411384|NCT00070941|560939176|FG000|Overall Study|Adverse Event|10|||
155411385|NCT00070941|560939177|FG001|Overall Study|Adverse Event|8|||
155411386|NCT00070941|560939178|FG002|Overall Study|Adverse Event|4|||
155411387|NCT00075504|560939182|FG000|Overall Study|Withdrawal by Subject|9|||
155411388|NCT00075504|560939183|FG001|Overall Study|Withdrawal by Subject|7|||
155411389|NCT01290692|560939184|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
155411390|NCT03099707|560939192|FG000|Overall Study|Withdrawal by Subject|0|||
155411391|NCT03099707|560939193|FG001|Overall Study|Withdrawal by Subject|3|||
155411392|NCT03099707|560939192|FG000|Overall Study|Lost to Follow-up|0|||
155411393|NCT03099707|560939193|FG001|Overall Study|Lost to Follow-up|1|||
155411394|NCT03167073|560939194|FG000|Overall Study|Stillbirth|1|||
155411395|NCT03167073|560939195|FG001|Overall Study|Stillbirth|0|||
155411396|NCT00689871|560939199|FG000|Overall Study|Lost to Follow-up|123|||
155411397|NCT00689871|560939200|FG001|Overall Study|Lost to Follow-up|13|||
155411398|NCT00689871|560939201|FG002|Overall Study|Lost to Follow-up|37|||
155411399|NCT00689871|560939202|FG003|Overall Study|Lost to Follow-up|1|||
155411400|NCT00689871|560939199|FG000|Overall Study|Explanted of All Study Devices|36|||
155411401|NCT00689871|560939200|FG001|Overall Study|Explanted of All Study Devices|25|||
155411402|NCT00689871|560939201|FG002|Overall Study|Explanted of All Study Devices|29|||
155411403|NCT00689871|560939202|FG003|Overall Study|Explanted of All Study Devices|3|||
155411404|NCT00689871|560939199|FG000|Overall Study|Withdrawal by Subject|13|||
155411405|NCT00689871|560939200|FG001|Overall Study|Withdrawal by Subject|3|||
155411406|NCT00689871|560939201|FG002|Overall Study|Withdrawal by Subject|4|||
155411407|NCT00689871|560939202|FG003|Overall Study|Withdrawal by Subject|1|||
155411408|NCT00689871|560939199|FG000|Overall Study|Death|1|||
155411409|NCT00689871|560939200|FG001|Overall Study|Death|10|||
155411410|NCT00689871|560939201|FG002|Overall Study|Death|2|||
155411411|NCT00689871|560939202|FG003|Overall Study|Death|2|||
155641238|NCT01716156|561776849|FG002|Overall Study|Protocol Violation|0|||
155641239|NCT01716156|561776847|FG000|Overall Study|Withdrawal by Subject|0|||
155411412|NCT00689871|560939199|FG000|Overall Study|Physician Decision|2|||
155641240|NCT01716156|561776848|FG001|Overall Study|Withdrawal by Subject|1|||
155641241|NCT01716156|561776849|FG002|Overall Study|Withdrawal by Subject|2|||
155302383|NCT04440176|560540121|FG001|Overall Study|Medication error without associated adverse event|1|||
155302384|NCT04440176|560540120|FG000|Overall Study|No longer met eligibility criteria|7|||
155302385|NCT04440176|560540121|FG001|Overall Study|No longer met eligibility criteria|1|||
155302386|NCT04440176|560540120|FG000|Overall Study|Other|1|||
155302387|NCT04440176|560540121|FG001|Overall Study|Other|2|||
155411413|NCT00689871|560939200|FG001|Overall Study|Physician Decision|1|||
155411414|NCT00689871|560939201|FG002|Overall Study|Physician Decision|1|||
155411415|NCT00689871|560939202|FG003|Overall Study|Physician Decision|0|||
155411416|NCT00562354|560939203|FG000|Overall Study|Physician Decision|0|||
155411417|NCT00562354|560939204|FG001|Overall Study|Physician Decision|1|||
155411418|NCT00562354|560939203|FG000|Overall Study|Lost to Follow-up|0|||
155411419|NCT00562354|560939204|FG001|Overall Study|Lost to Follow-up|1|||
155411420|NCT00371865|560939209|FG000|Overall Study|Lack of Efficacy|0|||
155411421|NCT00371865|560939210|FG001|Overall Study|Lack of Efficacy|2|||
155411422|NCT00371865|560939209|FG000|Overall Study|Protocol Violation|3|||
155411423|NCT00371865|560939210|FG001|Overall Study|Protocol Violation|2|||
155411424|NCT00371865|560939209|FG000|Overall Study|Withdrawal by Subject|12|||
155411425|NCT00371865|560939210|FG001|Overall Study|Withdrawal by Subject|10|||
155411426|NCT01430455|560939219|FG000|Overall Study|Withdrawal by Subject|1|||
155411427|NCT01430455|560939219|FG000|Overall Study|Switched to follow-up phase|1|||
155411428|NCT01425008|560939222|FG000|Dose Escalation Phase|Progressive Disease|2|||
155411429|NCT01425008|560939223|FG001|Dose Escalation Phase|Progressive Disease|3|||
155411430|NCT01425008|560939224|FG002|Dose Escalation Phase|Progressive Disease|2|||
155411431|NCT01425008|560939225|FG003|Dose Escalation Phase|Progressive Disease|3|||
155411432|NCT01425008|560939226|FG004|Dose Escalation Phase|Progressive Disease|5|||
155411433|NCT01425008|560939227|FG005|Dose Escalation Phase|Progressive Disease|4|||
155411434|NCT01425008|560939228|FG006|Dose Escalation Phase|Progressive Disease|0|||
155411435|NCT01425008|560939229|FG007|Dose Escalation Phase|Progressive Disease|2|||
155411436|NCT01425008|560939230|FG008|Dose Escalation Phase|Progressive Disease|6|||
155411437|NCT01425008|560939231|FG009|Dose Escalation Phase|Progressive Disease|2|||
155411438|NCT01425008|560939232|FG010|Dose Escalation Phase|Progressive Disease|0|||
155411439|NCT01425008|560939233|FG011|Dose Escalation Phase|Progressive Disease|0|||
155411440|NCT01425008|560939234|FG012|Dose Escalation Phase|Progressive Disease|0|||
155411441|NCT01425008|560939235|FG013|Dose Escalation Phase|Progressive Disease|0|||
155411442|NCT01425008|560939236|FG014|Dose Escalation Phase|Progressive Disease|0|||
155411443|NCT01425008|560939237|FG015|Dose Escalation Phase|Progressive Disease|0|||
155411444|NCT01425008|560939238|FG016|Dose Escalation Phase|Progressive Disease|0|||
155411445|NCT01425008|560939239|FG017|Dose Escalation Phase|Progressive Disease|0|||
155411446|NCT01425008|560939240|FG018|Dose Escalation Phase|Progressive Disease|0|||
155411447|NCT01425008|560939222|FG000|Dose Escalation Phase|Adverse Event|2|||
155411448|NCT01425008|560939223|FG001|Dose Escalation Phase|Adverse Event|0|||
155411449|NCT01425008|560939224|FG002|Dose Escalation Phase|Adverse Event|0|||
155411450|NCT01425008|560939225|FG003|Dose Escalation Phase|Adverse Event|0|||
155411451|NCT01425008|560939226|FG004|Dose Escalation Phase|Adverse Event|0|||
155411452|NCT01425008|560939227|FG005|Dose Escalation Phase|Adverse Event|2|||
155302388|NCT04440176|560540120|FG000|Overall Study|Protocol deviation|6|||
155302389|NCT04440176|560540121|FG001|Overall Study|Protocol deviation|8|||
155302390|NCT04440176|560540120|FG000|Overall Study|Randomized but not vaccinated|6|||
155302391|NCT04440176|560540121|FG001|Overall Study|Randomized but not vaccinated|3|||
155302392|NCT01631214|560540125|FG000|Overall Study|Withdrawal by Subject|276|||
155302393|NCT01631214|560540126|FG001|Overall Study|Withdrawal by Subject|290|||
155302394|NCT01631214|560540125|FG000|Overall Study|Death|113|||
155302395|NCT01631214|560540126|FG001|Overall Study|Death|106|||
155302396|NCT01631214|560540125|FG000|Overall Study|Lost to Follow-up|54|||
155302397|NCT01631214|560540126|FG001|Overall Study|Lost to Follow-up|40|||
155302398|NCT01631214|560540125|FG000|Overall Study|Adverse Event|45|||
155302399|NCT01631214|560540126|FG001|Overall Study|Adverse Event|45|||
155302400|NCT01631214|560540125|FG000|Overall Study|Other|22|||
155302401|NCT01631214|560540126|FG001|Overall Study|Other|19|||
155302402|NCT01631214|560540125|FG000|Overall Study|Noncompliance|16|||
155302403|NCT01631214|560540126|FG001|Overall Study|Noncompliance|15|||
155302404|NCT01631214|560540125|FG000|Overall Study|Requirement for Alternative Therapy|8|||
155302405|NCT01631214|560540126|FG001|Overall Study|Requirement for Alternative Therapy|3|||
155302406|NCT01631214|560540125|FG000|Overall Study|Protocol Deviation|4|||
155302407|NCT01631214|560540126|FG001|Overall Study|Protocol Deviation|3|||
155302408|NCT01631214|560540125|FG000|Overall Study|Ineligibility determined|5|||
155302409|NCT01631214|560540126|FG001|Overall Study|Ineligibility determined|2|||
155302410|NCT01631214|560540125|FG000|Overall Study|Administrative Decision|1|||
155411453|NCT01425008|560939228|FG006|Dose Escalation Phase|Adverse Event|0|||
155411454|NCT01425008|560939229|FG007|Dose Escalation Phase|Adverse Event|0|||
155411455|NCT01425008|560939230|FG008|Dose Escalation Phase|Adverse Event|2|||
155411456|NCT01425008|560939231|FG009|Dose Escalation Phase|Adverse Event|0|||
155411457|NCT01425008|560939232|FG010|Dose Escalation Phase|Adverse Event|0|||
155411458|NCT01425008|560939233|FG011|Dose Escalation Phase|Adverse Event|0|||
155302411|NCT01631214|560540126|FG001|Overall Study|Administrative Decision|0|||
155302412|NCT03575052|560540127|FG000|Overall Study|Adverse Event|6|||
155302413|NCT03575052|560540128|FG001|Overall Study|Adverse Event|10|||
155411459|NCT01425008|560939234|FG012|Dose Escalation Phase|Adverse Event|0|||
155411460|NCT01425008|560939235|FG013|Dose Escalation Phase|Adverse Event|0|||
155411461|NCT01425008|560939236|FG014|Dose Escalation Phase|Adverse Event|0|||
155411462|NCT01425008|560939237|FG015|Dose Escalation Phase|Adverse Event|0|||
155411463|NCT01425008|560939238|FG016|Dose Escalation Phase|Adverse Event|0|||
155411464|NCT01425008|560939239|FG017|Dose Escalation Phase|Adverse Event|0|||
155411465|NCT01425008|560939240|FG018|Dose Escalation Phase|Adverse Event|0|||
155411466|NCT01425008|560939222|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411467|NCT01425008|560939223|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411468|NCT01425008|560939224|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411469|NCT01425008|560939225|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411470|NCT01425008|560939226|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
155411471|NCT01425008|560939227|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411472|NCT01425008|560939228|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
155411473|NCT01425008|560939229|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
155411474|NCT01425008|560939230|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
155411475|NCT01425008|560939231|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411476|NCT01425008|560939232|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411477|NCT01425008|560939233|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411478|NCT01425008|560939234|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411479|NCT01425008|560939235|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411480|NCT01425008|560939236|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411481|NCT01425008|560939237|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411482|NCT01425008|560939238|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411483|NCT01425008|560939239|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411484|NCT01425008|560939240|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155411485|NCT01425008|560939222|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155411486|NCT01425008|560939223|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155411487|NCT01425008|560939224|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155411488|NCT01425008|560939225|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155411489|NCT01425008|560939226|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
155411490|NCT01425008|560939227|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
155411491|NCT01425008|560939228|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
155411492|NCT01425008|560939229|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
155411493|NCT01425008|560939230|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
155411494|NCT01425008|560939231|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
155411495|NCT01425008|560939232|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
155411496|NCT01425008|560939233|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
155411497|NCT01425008|560939234|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
155411498|NCT01425008|560939235|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
155411499|NCT01425008|560939236|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
155411500|NCT01425008|560939237|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
155411501|NCT01425008|560939238|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
155411502|NCT01425008|560939239|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
155411503|NCT01425008|560939240|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
155411504|NCT01425008|560939222|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411505|NCT01425008|560939223|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411506|NCT01425008|560939224|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
155411507|NCT01425008|560939225|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411508|NCT01425008|560939226|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411509|NCT01425008|560939227|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411510|NCT01425008|560939228|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411511|NCT01425008|560939229|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411512|NCT01425008|560939230|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
155411513|NCT01425008|560939231|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
155411514|NCT01425008|560939232|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411515|NCT01425008|560939233|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411516|NCT01425008|560939234|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411517|NCT01425008|560939235|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411518|NCT01425008|560939236|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411519|NCT01425008|560939237|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411520|NCT01425008|560939238|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
155641242|NCT01716156|561776847|FG000|Overall Study|Lost to Follow-up|1|||
155411521|NCT01425008|560939239|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411522|NCT01425008|560939240|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
155411523|NCT01425008|560939222|FG000|Dose Escalation Phase|Other|0|||
155411524|NCT01425008|560939223|FG001|Dose Escalation Phase|Other|0|||
155641243|NCT01716156|561776848|FG001|Overall Study|Lost to Follow-up|0|||
155641244|NCT01716156|561776849|FG002|Overall Study|Lost to Follow-up|0|||
155641245|NCT04057365|561776852|FG000|Overall Study|Withdrawal by Subject|2|||
155411525|NCT01425008|560939224|FG002|Dose Escalation Phase|Other|0|||
155411526|NCT01425008|560939225|FG003|Dose Escalation Phase|Other|0|||
155411527|NCT01425008|560939226|FG004|Dose Escalation Phase|Other|0|||
155411528|NCT01425008|560939227|FG005|Dose Escalation Phase|Other|0|||
155411529|NCT01425008|560939228|FG006|Dose Escalation Phase|Other|0|||
155411530|NCT01425008|560939229|FG007|Dose Escalation Phase|Other|0|||
155411531|NCT01425008|560939230|FG008|Dose Escalation Phase|Other|1|||
155411532|NCT01425008|560939231|FG009|Dose Escalation Phase|Other|0|||
155411533|NCT01425008|560939232|FG010|Dose Escalation Phase|Other|0|||
155411534|NCT01425008|560939233|FG011|Dose Escalation Phase|Other|0|||
155411535|NCT01425008|560939234|FG012|Dose Escalation Phase|Other|0|||
155411536|NCT01425008|560939235|FG013|Dose Escalation Phase|Other|0|||
155411537|NCT01425008|560939236|FG014|Dose Escalation Phase|Other|0|||
155411538|NCT01425008|560939237|FG015|Dose Escalation Phase|Other|0|||
155411539|NCT01425008|560939238|FG016|Dose Escalation Phase|Other|0|||
155411540|NCT01425008|560939239|FG017|Dose Escalation Phase|Other|0|||
155411541|NCT01425008|560939240|FG018|Dose Escalation Phase|Other|0|||
155411542|NCT01425008|560939222|FG000|Dose Expansion Phase|Progressive Disease|0|||
155411543|NCT01425008|560939223|FG001|Dose Expansion Phase|Progressive Disease|0|||
155411544|NCT01425008|560939224|FG002|Dose Expansion Phase|Progressive Disease|0|||
155411545|NCT01425008|560939225|FG003|Dose Expansion Phase|Progressive Disease|0|||
155411546|NCT01425008|560939226|FG004|Dose Expansion Phase|Progressive Disease|0|||
155411547|NCT01425008|560939227|FG005|Dose Expansion Phase|Progressive Disease|0|||
155411548|NCT01425008|560939228|FG006|Dose Expansion Phase|Progressive Disease|0|||
155411549|NCT01425008|560939229|FG007|Dose Expansion Phase|Progressive Disease|0|||
155411550|NCT01425008|560939230|FG008|Dose Expansion Phase|Progressive Disease|0|||
155411551|NCT01425008|560939231|FG009|Dose Expansion Phase|Progressive Disease|0|||
155411552|NCT01425008|560939232|FG010|Dose Expansion Phase|Progressive Disease|10|||
155411553|NCT01425008|560939233|FG011|Dose Expansion Phase|Progressive Disease|4|||
155411554|NCT01425008|560939234|FG012|Dose Expansion Phase|Progressive Disease|12|||
155411555|NCT01425008|560939235|FG013|Dose Expansion Phase|Progressive Disease|1|||
155411556|NCT01425008|560939236|FG014|Dose Expansion Phase|Progressive Disease|5|||
155411557|NCT01425008|560939237|FG015|Dose Expansion Phase|Progressive Disease|8|||
155411558|NCT01425008|560939238|FG016|Dose Expansion Phase|Progressive Disease|9|||
155411559|NCT01425008|560939239|FG017|Dose Expansion Phase|Progressive Disease|2|||
155411560|NCT01425008|560939240|FG018|Dose Expansion Phase|Progressive Disease|10|||
155411561|NCT01425008|560939222|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
155411562|NCT01425008|560939223|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
155411563|NCT01425008|560939224|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
155411564|NCT01425008|560939225|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
155411565|NCT01425008|560939226|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
155411566|NCT01425008|560939227|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
155411567|NCT01425008|560939228|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
155411568|NCT01425008|560939229|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
155411569|NCT01425008|560939230|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
155411570|NCT01425008|560939231|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
155411571|NCT01425008|560939232|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
155411572|NCT01425008|560939233|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
155411573|NCT01425008|560939234|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
155411574|NCT01425008|560939235|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
155411575|NCT01425008|560939236|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
155411576|NCT01425008|560939237|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
155411577|NCT01425008|560939238|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
155411578|NCT01425008|560939239|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
155411579|NCT01425008|560939240|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
155411580|NCT01425008|560939222|FG000|Dose Expansion Phase|Other|0|||
155411581|NCT01425008|560939223|FG001|Dose Expansion Phase|Other|0|||
155411582|NCT01425008|560939224|FG002|Dose Expansion Phase|Other|0|||
155411583|NCT01425008|560939225|FG003|Dose Expansion Phase|Other|0|||
155411584|NCT01425008|560939226|FG004|Dose Expansion Phase|Other|0|||
155411585|NCT01425008|560939227|FG005|Dose Expansion Phase|Other|0|||
155411586|NCT01425008|560939228|FG006|Dose Expansion Phase|Other|0|||
155411587|NCT01425008|560939229|FG007|Dose Expansion Phase|Other|0|||
155411588|NCT01425008|560939230|FG008|Dose Expansion Phase|Other|0|||
155411589|NCT01425008|560939231|FG009|Dose Expansion Phase|Other|0|||
155411590|NCT01425008|560939232|FG010|Dose Expansion Phase|Other|0|||
155411591|NCT01425008|560939233|FG011|Dose Expansion Phase|Other|0|||
155411592|NCT01425008|560939234|FG012|Dose Expansion Phase|Other|1|||
155411593|NCT01425008|560939235|FG013|Dose Expansion Phase|Other|0|||
155411594|NCT01425008|560939236|FG014|Dose Expansion Phase|Other|0|||
155411595|NCT01425008|560939237|FG015|Dose Expansion Phase|Other|0|||
155411596|NCT01425008|560939238|FG016|Dose Expansion Phase|Other|2|||
155411597|NCT01425008|560939239|FG017|Dose Expansion Phase|Other|0|||
155411598|NCT01425008|560939240|FG018|Dose Expansion Phase|Other|4|||
155411599|NCT01425008|560939222|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411600|NCT01425008|560939223|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411601|NCT01425008|560939224|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411602|NCT01425008|560939225|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411603|NCT01425008|560939226|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411604|NCT01425008|560939227|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411605|NCT01425008|560939228|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411606|NCT01425008|560939229|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411607|NCT01425008|560939230|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411608|NCT01425008|560939231|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411609|NCT01425008|560939232|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
155411610|NCT01425008|560939233|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
155411611|NCT01425008|560939234|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411612|NCT01425008|560939235|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411613|NCT01425008|560939236|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411614|NCT01425008|560939237|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
155411615|NCT01425008|560939238|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
155411616|NCT01425008|560939239|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
155411617|NCT01425008|560939240|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
155411618|NCT01425008|560939222|FG000|Dose Expansion Phase|Adverse Event|0|||
155411619|NCT01425008|560939223|FG001|Dose Expansion Phase|Adverse Event|0|||
155411620|NCT01425008|560939224|FG002|Dose Expansion Phase|Adverse Event|0|||
155411621|NCT01425008|560939225|FG003|Dose Expansion Phase|Adverse Event|0|||
155411622|NCT01425008|560939226|FG004|Dose Expansion Phase|Adverse Event|0|||
155411623|NCT01425008|560939227|FG005|Dose Expansion Phase|Adverse Event|0|||
155411624|NCT01425008|560939228|FG006|Dose Expansion Phase|Adverse Event|0|||
155411625|NCT01425008|560939229|FG007|Dose Expansion Phase|Adverse Event|0|||
155411626|NCT01425008|560939230|FG008|Dose Expansion Phase|Adverse Event|0|||
155411627|NCT01425008|560939231|FG009|Dose Expansion Phase|Adverse Event|0|||
155302414|NCT03575052|560540127|FG000|Overall Study|Not further specified|5|||
155302415|NCT03575052|560540128|FG001|Overall Study|Not further specified|7|||
155302416|NCT03575052|560540127|FG000|Overall Study|Withdrawal by Subject|5|||
155302417|NCT03575052|560540128|FG001|Overall Study|Withdrawal by Subject|6|||
155302418|NCT03575052|560540127|FG000|Overall Study|Lost to Follow-up|3|||
155302419|NCT03575052|560540128|FG001|Overall Study|Lost to Follow-up|0|||
155302420|NCT03575052|560540127|FG000|Overall Study|Death|2|||
155302421|NCT03575052|560540128|FG001|Overall Study|Death|1|||
155302422|NCT03575052|560540127|FG000|Overall Study|Lack of Efficacy|2|||
155302423|NCT03575052|560540128|FG001|Overall Study|Lack of Efficacy|1|||
155302424|NCT03575052|560540127|FG000|Overall Study|Study drug noncompliance|1|||
155302425|NCT03575052|560540128|FG001|Overall Study|Study drug noncompliance|2|||
155302426|NCT03575052|560540127|FG000|Overall Study|Protocol Violation|0|||
155302427|NCT03575052|560540128|FG001|Overall Study|Protocol Violation|2|||
155302428|NCT03575052|560540127|FG000|Overall Study|Physician Decision|1|||
155302429|NCT03575052|560540128|FG001|Overall Study|Physician Decision|0|||
155302430|NCT04188379|560540129|FG000|Overall Study|Withdrawal by Subject|10|||
155302431|NCT04188379|560540130|FG001|Overall Study|Withdrawal by Subject|3|||
155302432|NCT04188379|560540129|FG000|Overall Study|Physician Decision|0|||
155302433|NCT04188379|560540130|FG001|Overall Study|Physician Decision|1|||
155302434|NCT04188379|560540129|FG000|Overall Study|Adverse Event|3|||
155302435|NCT04188379|560540130|FG001|Overall Study|Adverse Event|1|||
155302436|NCT04188379|560540129|FG000|Overall Study|Pregnancy|1|||
155302437|NCT04188379|560540130|FG001|Overall Study|Pregnancy|0|||
155302438|NCT04188379|560540129|FG000|Overall Study|Lack of Efficacy|8|||
155302439|NCT04188379|560540130|FG001|Overall Study|Lack of Efficacy|5|||
155302440|NCT04188379|560540129|FG000|Overall Study|Other|0|||
155302441|NCT04188379|560540130|FG001|Overall Study|Other|3|||
155302442|NCT05288283|560540132|FG000|Overall Study|Study Terminated Early|1|||
155302443|NCT05288283|560540133|FG001|Overall Study|Study Terminated Early|1|||
155302444|NCT03112174|560540134|FG000|Overall Study|Withdrawal by Subject|3|||
155302445|NCT03112174|560540135|FG001|Overall Study|Withdrawal by Subject|0|||
155302446|NCT03112174|560540136|FG002|Overall Study|Withdrawal by Subject|11|||
155302447|NCT03112174|560540137|FG003|Overall Study|Withdrawal by Subject|9|||
155302448|NCT03112174|560540138|FG004|Overall Study|Withdrawal by Subject|7|||
155302449|NCT03112174|560540134|FG000|Overall Study|Lost to Follow-up|1|||
155302450|NCT03112174|560540135|FG001|Overall Study|Lost to Follow-up|1|||
155302451|NCT03112174|560540136|FG002|Overall Study|Lost to Follow-up|2|||
155302452|NCT03112174|560540137|FG003|Overall Study|Lost to Follow-up|3|||
155302453|NCT03112174|560540138|FG004|Overall Study|Lost to Follow-up|2|||
155302454|NCT03112174|560540134|FG000|Overall Study|Death|8|||
155302455|NCT03112174|560540135|FG001|Overall Study|Death|3|||
155302456|NCT03112174|560540136|FG002|Overall Study|Death|67|||
155302457|NCT03112174|560540137|FG003|Overall Study|Death|73|||
155302458|NCT03112174|560540138|FG004|Overall Study|Death|18|||
155302459|NCT03112174|560540134|FG000|Overall Study|Other, Not Specified|1|||
155302460|NCT03112174|560540135|FG001|Overall Study|Other, Not Specified|0|||
155302461|NCT03112174|560540136|FG002|Overall Study|Other, Not Specified|1|||
155302462|NCT03112174|560540137|FG003|Overall Study|Other, Not Specified|2|||
155302463|NCT03112174|560540138|FG004|Overall Study|Other, Not Specified|0|||
155411628|NCT01425008|560939232|FG010|Dose Expansion Phase|Adverse Event|2|||
155411629|NCT01425008|560939233|FG011|Dose Expansion Phase|Adverse Event|3|||
155411630|NCT01425008|560939234|FG012|Dose Expansion Phase|Adverse Event|3|||
155411631|NCT01425008|560939235|FG013|Dose Expansion Phase|Adverse Event|0|||
155411632|NCT01425008|560939236|FG014|Dose Expansion Phase|Adverse Event|1|||
155411633|NCT01425008|560939237|FG015|Dose Expansion Phase|Adverse Event|1|||
155411634|NCT01425008|560939238|FG016|Dose Expansion Phase|Adverse Event|5|||
155641246|NCT04057365|561776853|FG001|Overall Study|Withdrawal by Subject|0|||
155641247|NCT04738487|561776854|FG000|Overall Study|Participant Ongoing in Study|298|||
155641248|NCT04738487|561776855|FG001|Overall Study|Participant Ongoing in Study|297|||
155641249|NCT04738487|561776854|FG000|Overall Study|Withdrawal by Subject|7|||
155641250|NCT04738487|561776855|FG001|Overall Study|Withdrawal by Subject|9|||
155641251|NCT04738487|561776854|FG000|Overall Study|Lost to Follow-up|2|||
155641252|NCT04738487|561776855|FG001|Overall Study|Lost to Follow-up|0|||
155641253|NCT04738487|561776854|FG000|Overall Study|Death|287|||
155641254|NCT04738487|561776855|FG001|Overall Study|Death|306|||
155302464|NCT05773313|560540141|FG000|Overall Study|Lost to Follow-up|3|||
155302465|NCT01534494|560540142|FG000|Overall Study|Withdrawal by Subject|1|||
155302466|NCT05137236|560540143|FG000|Part A|Other than Specified|1|||
155302467|NCT05137236|560540144|FG001|Part A|Other than Specified|0|||
155302468|NCT05137236|560540145|FG002|Part A|Other than Specified|0|||
155302469|NCT05137236|560540146|FG003|Part A|Other than Specified|0|||
155302470|NCT05137236|560540147|FG004|Part A|Other than Specified|0|||
155302471|NCT05137236|560540148|FG005|Part A|Other than Specified|0|||
155302472|NCT05137236|560540149|FG006|Part A|Other than Specified|0|||
155302473|NCT05137236|560540150|FG007|Part A|Other than Specified|0|||
155302474|NCT05137236|560540143|FG000|Part A|Withdrawal by Subject|0|||
155302475|NCT05137236|560540144|FG001|Part A|Withdrawal by Subject|4|||
155302476|NCT05137236|560540145|FG002|Part A|Withdrawal by Subject|1|||
155302477|NCT05137236|560540146|FG003|Part A|Withdrawal by Subject|1|||
155302478|NCT05137236|560540147|FG004|Part A|Withdrawal by Subject|3|||
155302479|NCT05137236|560540148|FG005|Part A|Withdrawal by Subject|2|||
155302480|NCT05137236|560540149|FG006|Part A|Withdrawal by Subject|0|||
155302481|NCT05137236|560540150|FG007|Part A|Withdrawal by Subject|0|||
155302482|NCT05137236|560540143|FG000|Part A|Lost to Follow-up|5|||
155302483|NCT05137236|560540144|FG001|Part A|Lost to Follow-up|7|||
155302484|NCT05137236|560540145|FG002|Part A|Lost to Follow-up|1|||
155302485|NCT05137236|560540146|FG003|Part A|Lost to Follow-up|3|||
155302486|NCT05137236|560540147|FG004|Part A|Lost to Follow-up|3|||
155302487|NCT05137236|560540148|FG005|Part A|Lost to Follow-up|8|||
155302488|NCT05137236|560540149|FG006|Part A|Lost to Follow-up|0|||
155302489|NCT05137236|560540150|FG007|Part A|Lost to Follow-up|0|||
155302490|NCT05137236|560540143|FG000|Part B|Withdrawal by Subject|0|||
155302491|NCT05137236|560540144|FG001|Part B|Withdrawal by Subject|0|||
155302492|NCT05137236|560540145|FG002|Part B|Withdrawal by Subject|0|||
155302493|NCT05137236|560540146|FG003|Part B|Withdrawal by Subject|0|||
155302494|NCT05137236|560540147|FG004|Part B|Withdrawal by Subject|0|||
155302495|NCT05137236|560540148|FG005|Part B|Withdrawal by Subject|0|||
155302496|NCT05137236|560540149|FG006|Part B|Withdrawal by Subject|0|||
155302497|NCT05137236|560540150|FG007|Part B|Withdrawal by Subject|2|||
155302498|NCT05137236|560540143|FG000|Part B|Lost to Follow-up|0|||
155302499|NCT05137236|560540144|FG001|Part B|Lost to Follow-up|0|||
155302500|NCT05137236|560540145|FG002|Part B|Lost to Follow-up|0|||
155302501|NCT05137236|560540146|FG003|Part B|Lost to Follow-up|0|||
155302502|NCT05137236|560540147|FG004|Part B|Lost to Follow-up|0|||
155302503|NCT05137236|560540148|FG005|Part B|Lost to Follow-up|0|||
155302504|NCT05137236|560540149|FG006|Part B|Lost to Follow-up|5|||
155302505|NCT05137236|560540150|FG007|Part B|Lost to Follow-up|5|||
155302506|NCT05137236|560540143|FG000|Part B|Death|0|||
155302507|NCT05137236|560540144|FG001|Part B|Death|0|||
155302508|NCT05137236|560540145|FG002|Part B|Death|0|||
155302509|NCT05137236|560540146|FG003|Part B|Death|0|||
155411635|NCT01425008|560939239|FG017|Dose Expansion Phase|Adverse Event|0|||
155411636|NCT01425008|560939240|FG018|Dose Expansion Phase|Adverse Event|3|||
155411637|NCT01425008|560939222|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
155411638|NCT01425008|560939223|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
155411639|NCT01425008|560939224|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
155411640|NCT01425008|560939225|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
155411641|NCT01425008|560939226|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
155411642|NCT01425008|560939227|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
155411643|NCT01425008|560939228|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
155411644|NCT01425008|560939229|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
155411645|NCT01425008|560939230|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
155411646|NCT01425008|560939231|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
155411647|NCT01425008|560939232|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
155411648|NCT01425008|560939233|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
155411649|NCT01425008|560939234|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
155411650|NCT01425008|560939235|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
155411651|NCT01425008|560939236|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
155411652|NCT01425008|560939237|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
155436100|NCT00149214|561024514|FG000|Overall Study|Adverse Event|12|||
155411653|NCT01425008|560939238|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
155411654|NCT01425008|560939239|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
155411655|NCT01425008|560939240|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
155411656|NCT01425008|560939222|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411657|NCT01425008|560939223|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411658|NCT01425008|560939224|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155641255|NCT02717611|561776856|FG000|Overall Study|Death|13|||
155641256|NCT02717611|561776856|FG000|Overall Study|Withdrawal by Subject|6|||
155641257|NCT02717611|561776856|FG000|Overall Study|Active, not recruiting|40|||
155641258|NCT02717611|561776856|FG000|Overall Study|Complicating disease|1|||
155641259|NCT02676973|561776857|FG000|Overall Study|Withdrawal by Subject|9|||
155641260|NCT02676973|561776858|FG001|Overall Study|Withdrawal by Subject|8|||
155641261|NCT02676973|561776859|FG002|Overall Study|Withdrawal by Subject|11|||
155641262|NCT02676973|561776857|FG000|Overall Study|Lost to Follow-up|8|||
155641263|NCT02676973|561776858|FG001|Overall Study|Lost to Follow-up|12|||
155641264|NCT02676973|561776859|FG002|Overall Study|Lost to Follow-up|8|||
155641265|NCT02676973|561776857|FG000|Overall Study|Death|2|||
155641266|NCT02676973|561776858|FG001|Overall Study|Death|1|||
155641267|NCT02676973|561776859|FG002|Overall Study|Death|5|||
155641268|NCT05172570|561776860|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
155641269|NCT05172570|561776861|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
155641270|NCT05172570|561776862|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
155641271|NCT05172570|561776860|FG000|Overall Study|PI Decision due to equipment shortages|0|||
155641272|NCT05172570|561776861|FG001|Overall Study|PI Decision due to equipment shortages|0|||
155641273|NCT05172570|561776862|FG002|Overall Study|PI Decision due to equipment shortages|1|||
155641274|NCT06170827|561776869|FG000|Overall Study|Withdrawal by Subject|1|||
155641275|NCT06170827|561776870|FG001|Overall Study|Withdrawal by Subject|1|||
155641276|NCT00182637|561777859|FG000|Overall Study|Adverse Event|2|||
155641277|NCT00182637|561777859|FG000|Overall Study|Disease Progression|1|||
155641278|NCT04941898|561777860|FG000|Overall Study|Protocol Violation|1|||
155641279|NCT00003456|561777861|FG000|Overall Study|Not evaluable|8|||
155641280|NCT00587457|561777864|FG000|Overall Study|Adverse Event|1|||
155641281|NCT00587457|561777865|FG001|Overall Study|Adverse Event|2|||
155641282|NCT00587457|561777866|FG002|Overall Study|Adverse Event|1|||
155641283|NCT00587457|561777864|FG000|Overall Study|Disease progression|2|||
155641284|NCT00587457|561777865|FG001|Overall Study|Disease progression|0|||
155641285|NCT00587457|561777866|FG002|Overall Study|Disease progression|2|||
155641286|NCT00587457|561777864|FG000|Overall Study|Initiation of alternative therapy|0|||
155641287|NCT00587457|561777865|FG001|Overall Study|Initiation of alternative therapy|1|||
155641288|NCT00587457|561777866|FG002|Overall Study|Initiation of alternative therapy|0|||
155641289|NCT00587457|561777864|FG000|Overall Study|Undefined|0|||
155641290|NCT00587457|561777865|FG001|Overall Study|Undefined|0|||
155641291|NCT00587457|561777866|FG002|Overall Study|Undefined|1|||
155641292|NCT00587457|561777864|FG000|Overall Study|Development of neutralizing Abs|0|||
155641293|NCT00587457|561777865|FG001|Overall Study|Development of neutralizing Abs|0|||
155641294|NCT00587457|561777866|FG002|Overall Study|Development of neutralizing Abs|1|||
155641295|NCT03234881|561777867|FG000|Overall Study|Lost to Follow-up|9|||
155641296|NCT03234881|561777868|FG001|Overall Study|Lost to Follow-up|3|||
155641297|NCT01500096|561777873|FG000|Overall Study|Lost to Follow-up|1|||
155641298|NCT01500096|561777874|FG001|Overall Study|Lost to Follow-up|0|||
155641299|NCT01500096|561777875|FG002|Overall Study|Lost to Follow-up|0|||
155641300|NCT01500096|561777876|FG003|Overall Study|Lost to Follow-up|2|||
155641301|NCT00639379|561777877|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
155641302|NCT00639379|561777878|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
155641303|NCT00639379|561777877|FG000|Period 1 - 2 Weeks|lens issue|3|||
155641304|NCT00639379|561777878|FG001|Period 1 - 2 Weeks|lens issue|0|||
155641305|NCT00723944|561777879|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
155641306|NCT00723944|561777880|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
155641307|NCT00723944|561777879|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
155641308|NCT00723944|561777880|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
155641309|NCT00723944|561777879|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
155641310|NCT00723944|561777880|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
155641311|NCT02506036|561777883|FG000|First Intervention (4-6 Weeks)|Death|1|||
155641312|NCT02506036|561777884|FG001|First Intervention (4-6 Weeks)|Death|0|||
155641313|NCT02506036|561777883|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
155641314|NCT02506036|561777884|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
155641315|NCT02506036|561777883|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
155641316|NCT02506036|561777884|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
155641317|NCT02383173|561777885|FG000|Overall Study|Palliative Care Team withdrew|0|||
155641318|NCT02383173|561777886|FG001|Overall Study|Palliative Care Team withdrew|2|||
155641319|NCT00800540|561777887|FG000|Period One: 6 Weeks|Noncompliance|1|||
155302510|NCT05137236|560540147|FG004|Part B|Death|0|||
155302511|NCT05137236|560540148|FG005|Part B|Death|0|||
155302512|NCT05137236|560540149|FG006|Part B|Death|0|||
155302513|NCT05137236|560540150|FG007|Part B|Death|2|||
155302514|NCT04512482|560540156|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
155302515|NCT04512482|560540157|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
155302516|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Death|0|||
155302517|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Death|3|||
155302518|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Death|1|||
155302519|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Death|0|||
155302520|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Death|0|||
155641320|NCT00800540|561777888|FG001|Period One: 6 Weeks|Noncompliance|0|||
155641321|NCT00800540|561777887|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
155641322|NCT00800540|561777888|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
155641323|NCT00800540|561777887|FG000|Period 2: 6 Weeks|Adverse Event|0|||
155641324|NCT00800540|561777888|FG001|Period 2: 6 Weeks|Adverse Event|1|||
155302521|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
155302522|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
155302523|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
155641325|NCT01239745|561777889|FG000|Overall Study|Study terminated by sponsor|45|||
155641326|NCT01239745|561777889|FG000|Overall Study|Adverse Event|1|||
155641327|NCT00726557|561777890|FG000|Overall Study|Screening failure|4|||
155641328|NCT00726557|561777890|FG000|Overall Study|No end of treatment documentation|37|||
155302524|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
155302525|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
155302526|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Other|0|||
155302527|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Other|0|||
155302528|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Other|1|||
155302529|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Other|0|||
155302530|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Other|0|||
155302531|NCT01939899|560540158|FG000|Phase 2|Withdrawal by Subject|0|||
155302532|NCT01939899|560540159|FG001|Phase 2|Withdrawal by Subject|0|||
155302533|NCT01939899|560540160|FG002|Phase 2|Withdrawal by Subject|0|||
155302534|NCT01939899|560540161|FG003|Phase 2|Withdrawal by Subject|2|||
155302535|NCT01939899|560540162|FG004|Phase 2|Withdrawal by Subject|0|||
155302536|NCT01939899|560540158|FG000|Phase 2|Disease Progression|0|||
155302537|NCT01939899|560540159|FG001|Phase 2|Disease Progression|0|||
155302538|NCT01939899|560540160|FG002|Phase 2|Disease Progression|0|||
155302539|NCT01939899|560540161|FG003|Phase 2|Disease Progression|9|||
155302540|NCT01939899|560540162|FG004|Phase 2|Disease Progression|1|||
155302541|NCT05119855|560540166|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
155302542|NCT05119855|560540167|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
155302543|NCT05119855|560540166|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
155302544|NCT05119855|560540167|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
155302545|NCT05119855|560540166|FG000|Overall Study|Lost to Follow-up|6|||
155302546|NCT05119855|560540167|FG001|Overall Study|Lost to Follow-up|8|||
155302547|NCT02932579|560540168|FG000|Overall Study|Withdrawal by Subject|4|||
155302548|NCT02932579|560540169|FG001|Overall Study|Withdrawal by Subject|1|||
155302549|NCT02706717|560540172|FG000|Overall Study|Withdrawal by Subject|1|||
155302550|NCT02706717|560540173|FG001|Overall Study|Withdrawal by Subject|8|||
155302551|NCT02706717|560540172|FG000|Overall Study|Lost to Follow-up|0|||
155302552|NCT02706717|560540173|FG001|Overall Study|Lost to Follow-up|1|||
155302553|NCT02706717|560540172|FG000|Overall Study|Physician Decision|0|||
155302554|NCT02706717|560540173|FG001|Overall Study|Physician Decision|1|||
155302555|NCT02706717|560540172|FG000|Overall Study|Death|0|||
155302556|NCT02706717|560540173|FG001|Overall Study|Death|1|||
155302557|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
155302558|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
155302559|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302560|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302561|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302562|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
155302563|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
155302564|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302565|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302566|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302567|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
155302568|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
155302569|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
155302570|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
155436101|NCT00149214|561024515|FG001|Overall Study|Adverse Event|9|||
155641329|NCT00726557|561777890|FG000|Overall Study|No follow-up documentation available|55|||
155747617|NCT00761150|562176511|FG001|Double-blind Period|Noncompliance|1|||
155747618|NCT00761150|562176512|FG002|Double-blind Period|Noncompliance|0|||
155747619|NCT00761150|562176510|FG000|Double-blind Period|Other|0|||
155747620|NCT00761150|562176511|FG001|Double-blind Period|Other|3|||
155747621|NCT00761150|562176512|FG002|Double-blind Period|Other|3|||
155747622|NCT00475423|562176513|FG000|Overall Study|Protocol Violation|5|||
155747623|NCT00475423|562176513|FG000|Overall Study|Adverse Event|4|||
155747624|NCT00475423|562176513|FG000|Overall Study|Withdrawal by Subject|6|||
155747625|NCT00475423|562176513|FG000|Overall Study|Lack of Efficacy|8|||
155747626|NCT00475423|562176513|FG000|Overall Study|Death|1|||
155747627|NCT00475423|562176513|FG000|Overall Study|Reason not specified|1|||
155747628|NCT00475423|562176513|FG000|Overall Study|Lost to Follow-up|7|||
155747629|NCT01214174|562176514|FG000|Overall Study|Withdrawal by Subject|0|||
155747630|NCT01214174|562176515|FG001|Overall Study|Withdrawal by Subject|0|||
155747631|NCT01214174|562176516|FG002|Overall Study|Withdrawal by Subject|1|||
155747632|NCT00290407|562176517|FG000|Overall Study|Physician Decision|2|||
155747633|NCT01925989|562176526|FG000|Period 1|Sponsor Decision|1|||
155747634|NCT01925989|562176527|FG001|Period 1|Sponsor Decision|1|||
155747635|NCT01925989|562176528|FG002|Period 1|Sponsor Decision|0|||
155747636|NCT01925989|562176526|FG000|Period 1|Withdrawal by Subject|0|||
155747637|NCT01925989|562176527|FG001|Period 1|Withdrawal by Subject|1|||
155747638|NCT01925989|562176528|FG002|Period 1|Withdrawal by Subject|0|||
155747639|NCT00868517|562176530|FG000|Overall Study|Withdrawal by Subject|3|||
155747640|NCT00868517|562176531|FG001|Overall Study|Withdrawal by Subject|3|||
155747641|NCT00868517|562176532|FG002|Overall Study|Withdrawal by Subject|2|||
155747642|NCT00868517|562176530|FG000|Overall Study|Protocol Violation|1|||
155747643|NCT00868517|562176531|FG001|Overall Study|Protocol Violation|1|||
155747644|NCT00868517|562176532|FG002|Overall Study|Protocol Violation|0|||
155747645|NCT02496676|562176534|FG000|Phase 1 - Period 1|Adverse Event|0|||
155747646|NCT02496676|562176535|FG001|Phase 1 - Period 1|Adverse Event|1|||
155747647|NCT02496676|562176534|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
155747648|NCT02496676|562176535|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
155747649|NCT05442775|562176536|FG000|Overall Study|Trial terminated|61|||
155747650|NCT05442775|562176536|FG000|Overall Study|Lack of Efficacy|4|||
155747651|NCT05442775|562176536|FG000|Overall Study|Withdrawal by Subject|4|||
155747652|NCT05442775|562176536|FG000|Overall Study|Death|1|||
155747653|NCT05442775|562176536|FG000|Overall Study|Participant removed at Sponsor request|1|||
155747654|NCT03459690|562176538|FG000|Overall Study|Lost to Follow-up|0|||
155747655|NCT03459690|562176539|FG001|Overall Study|Lost to Follow-up|1|||
155747656|NCT03459690|562176538|FG000|Overall Study|Withdrawal by Subject|1|||
155747657|NCT03459690|562176539|FG001|Overall Study|Withdrawal by Subject|1|||
155747658|NCT02963831|562176540|FG000|Overall Study|Progressive Disease|3|||
155747659|NCT02963831|562176541|FG001|Overall Study|Progressive Disease|3|||
155747660|NCT02963831|562176542|FG002|Overall Study|Progressive Disease|16|||
155747661|NCT02963831|562176543|FG003|Overall Study|Progressive Disease|27|||
155747662|NCT02963831|562176540|FG000|Overall Study|Withdrawal by Subject|1|||
155747663|NCT02963831|562176541|FG001|Overall Study|Withdrawal by Subject|0|||
155747664|NCT02963831|562176542|FG002|Overall Study|Withdrawal by Subject|2|||
155747665|NCT02963831|562176543|FG003|Overall Study|Withdrawal by Subject|4|||
155747666|NCT02963831|562176540|FG000|Overall Study|Adverse Event|0|||
155747667|NCT02963831|562176541|FG001|Overall Study|Adverse Event|1|||
155747668|NCT02963831|562176542|FG002|Overall Study|Adverse Event|1|||
155747669|NCT02963831|562176543|FG003|Overall Study|Adverse Event|2|||
155747670|NCT02963831|562176540|FG000|Overall Study|Death|0|||
155747671|NCT02963831|562176541|FG001|Overall Study|Death|0|||
155747672|NCT02963831|562176542|FG002|Overall Study|Death|0|||
155747673|NCT02963831|562176543|FG003|Overall Study|Death|2|||
155747674|NCT01966432|562176544|FG000|Overall Study|Lost to Follow-up|3|||
155747675|NCT01966432|562176545|FG001|Overall Study|Lost to Follow-up|2|||
155747676|NCT01966432|562176546|FG002|Overall Study|Lost to Follow-up|5|||
155747677|NCT01966432|562176544|FG000|Overall Study|Withdrawal by Subject|1|||
155747678|NCT01966432|562176545|FG001|Overall Study|Withdrawal by Subject|3|||
155747679|NCT01966432|562176546|FG002|Overall Study|Withdrawal by Subject|0|||
155747680|NCT01966432|562176544|FG000|Overall Study|Subject Incarcerated|0|||
155747681|NCT01966432|562176545|FG001|Overall Study|Subject Incarcerated|0|||
155747682|NCT01966432|562176546|FG002|Overall Study|Subject Incarcerated|1|||
155747683|NCT01966432|562176544|FG000|Overall Study|SBIRT program ended|1|||
155747684|NCT01966432|562176545|FG001|Overall Study|SBIRT program ended|8|||
155747685|NCT01966432|562176546|FG002|Overall Study|SBIRT program ended|20|||
155747686|NCT02536404|562176556|FG000|Overall Study|Adverse Event|5|||
155747687|NCT02536404|562176557|FG001|Overall Study|Adverse Event|0|||
155747688|NCT02536404|562176556|FG000|Overall Study|Withdrawal by Subject|4|||
155747689|NCT02536404|562176557|FG001|Overall Study|Withdrawal by Subject|1|||
155747690|NCT02536404|562176556|FG000|Overall Study|Physician Decision|10|||
155747691|NCT02536404|562176557|FG001|Overall Study|Physician Decision|0|||
155747692|NCT02536404|562176556|FG000|Overall Study|Sponsor decision|1|||
155747693|NCT02536404|562176557|FG001|Overall Study|Sponsor decision|0|||
155747694|NCT03915860|562176558|FG000|Overall Study|Adverse Event|3|||
155747695|NCT03915860|562176558|FG000|Overall Study|Withdrawal by Subject|6|||
155747696|NCT03915860|562176558|FG000|Overall Study|Lost to Follow-up|2|||
155302571|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
155302572|NCT03051165|560540181|FG000|Overall Study|Withdrawal by Subject|1|||
155302573|NCT03051165|560540181|FG000|Overall Study|Early termination of study|12|||
155302574|NCT00818246|560540182|FG000|Overall Study|Impossible to match pictures|5|||
155302575|NCT02121002|560540183|FG000|Overall Study|Physician Decision|2|||
155302576|NCT02121002|560540184|FG001|Overall Study|Physician Decision|0|||
155302577|NCT02121002|560540185|FG002|Overall Study|Physician Decision|0|||
155302578|NCT02121002|560540183|FG000|Overall Study|Withdrawal by Subject|3|||
155302579|NCT02121002|560540184|FG001|Overall Study|Withdrawal by Subject|1|||
155302580|NCT02121002|560540185|FG002|Overall Study|Withdrawal by Subject|4|||
155302581|NCT02121002|560540183|FG000|Overall Study|Protocol Violation|1|||
155302582|NCT02121002|560540184|FG001|Overall Study|Protocol Violation|2|||
155302583|NCT02121002|560540185|FG002|Overall Study|Protocol Violation|4|||
155302584|NCT02121002|560540183|FG000|Overall Study|Concomitant therapy|0|||
155302585|NCT02121002|560540184|FG001|Overall Study|Concomitant therapy|1|||
155302586|NCT02121002|560540185|FG002|Overall Study|Concomitant therapy|1|||
155302587|NCT02121002|560540183|FG000|Overall Study|Others|1|||
155411659|NCT01425008|560939225|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411660|NCT01425008|560939226|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411661|NCT01425008|560939227|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411662|NCT01425008|560939228|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411663|NCT01425008|560939229|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411664|NCT01425008|560939230|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411665|NCT01425008|560939231|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411666|NCT01425008|560939232|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411667|NCT01425008|560939233|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411668|NCT01425008|560939234|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411669|NCT01425008|560939235|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411670|NCT01425008|560939236|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411671|NCT01425008|560939237|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411672|NCT01425008|560939238|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411673|NCT01425008|560939239|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155411674|NCT01425008|560939240|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
155411675|NCT00264238|560939241|FG000|Overall Study|Protocol Violation|1|||
155411676|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
155411677|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
155411678|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
155411679|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
155411680|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
155411681|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
155411682|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
155411683|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
155411684|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
155411685|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
155411686|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
155411687|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
155411688|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
155411689|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
155411690|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
155411691|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
155411692|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
155411693|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
155411694|NCT02600494|560939242|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
155411695|NCT02600494|560939243|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
155747697|NCT03915860|562176558|FG000|Overall Study|Other than specified|3|||
155747698|NCT04559529|562176559|FG000|First Intervention (1 Day)|Adverse Event|0|||
155747699|NCT04559529|562176560|FG001|First Intervention (1 Day)|Adverse Event|0|||
155302588|NCT02121002|560540184|FG001|Overall Study|Others|0|||
155302589|NCT02121002|560540185|FG002|Overall Study|Others|1|||
155411696|NCT02600494|560939244|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
155411697|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
155747700|NCT04559529|562176561|FG002|First Intervention (1 Day)|Adverse Event|0|||
155302590|NCT00409838|560540186|FG000|Short-term Period|Adverse Event|0|||
155302591|NCT00409838|560540187|FG001|Short-term Period|Adverse Event|1|||
155302592|NCT00409838|560540186|FG000|Short-term Period|Lost to Follow-up|0|||
155302593|NCT00409838|560540187|FG001|Short-term Period|Lost to Follow-up|1|||
155302594|NCT00409838|560540186|FG000|Short-term Period|Withdrawal by Subject|2|||
155302595|NCT00409838|560540187|FG001|Short-term Period|Withdrawal by Subject|3|||
155302596|NCT00409838|560540186|FG000|Short-term Period|Never Treated|1|||
155302597|NCT00409838|560540187|FG001|Short-term Period|Never Treated|0|||
155302598|NCT00409838|560540186|FG000|Long-term Extension Period|Adverse Event|10|||
155302599|NCT00409838|560540187|FG001|Long-term Extension Period|Adverse Event|0|||
155302600|NCT00409838|560540186|FG000|Long-term Extension Period|Death|1|||
155302601|NCT00409838|560540187|FG001|Long-term Extension Period|Death|0|||
155302602|NCT00409838|560540186|FG000|Long-term Extension Period|Lack of Efficacy|2|||
155747701|NCT04559529|562176562|FG003|First Intervention (1 Day)|Adverse Event|1|||
155747702|NCT04559529|562176559|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155302603|NCT00409838|560540187|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155302604|NCT00409838|560540186|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
155747703|NCT04559529|562176560|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155747704|NCT04559529|562176561|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
155747705|NCT04559529|562176562|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155747706|NCT04559529|562176559|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
155747707|NCT04559529|562176560|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
155747708|NCT04559529|562176561|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
155747709|NCT04559529|562176562|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
155747710|NCT01009281|562176563|FG000|Overall Study|Administrative problems|7|||
155747711|NCT03901456|562176566|FG000|Overall Study|Withdrawal by Subject|0|||
155747712|NCT03901456|562176567|FG001|Overall Study|Withdrawal by Subject|0|||
155747713|NCT03901456|562176568|FG002|Overall Study|Withdrawal by Subject|1|||
155747714|NCT03901456|562176566|FG000|Overall Study|Lost to Follow-up|0|||
155747715|NCT03901456|562176567|FG001|Overall Study|Lost to Follow-up|1|||
155747716|NCT03901456|562176568|FG002|Overall Study|Lost to Follow-up|0|||
155747717|NCT02217527|562176569|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
155747718|NCT02217527|562176570|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
155747719|NCT02217527|562176569|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
155747720|NCT02217527|562176570|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
155747721|NCT01203852|562176571|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
155747722|NCT01203852|562176571|FG000|Washout 2 Weeks|Physician Decision|46|||
155747723|NCT02582684|562176572|FG000|Overall Study|Unable to contact subject/parent|4|||
155747724|NCT02582684|562176572|FG000|Overall Study|Subject not able to get to clinic|10|||
155747725|NCT02582684|562176572|FG000|Overall Study|Subject withdrew consent|1|||
155747726|NCT02582684|562176572|FG000|Overall Study|Found to be ineligible after enrollment|2|||
155747727|NCT01878149|562176573|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
155747728|NCT01878149|562176574|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155747729|NCT06390839|562176579|FG000|Overall Study|Ineligible|2|||
155747730|NCT06390839|562176579|FG000|Overall Study|Never start protocol therapy|3|||
155747731|NCT06390839|562176579|FG000|Overall Study|Adverse Event|1|||
155747732|NCT06390839|562176579|FG000|Overall Study|Alternative therapy|2|||
155747733|NCT06390839|562176579|FG000|Overall Study|Death|3|||
155747734|NCT06390839|562176579|FG000|Overall Study|Disease progression|28|||
155747735|NCT06390839|562176579|FG000|Overall Study|Withdrawal by Subject|2|||
155747736|NCT06390839|562176579|FG000|Overall Study|Complicating disease|1|||
155747737|NCT06390839|562176579|FG000|Overall Study|Noncompliance|1|||
155747738|NCT00502203|562176582|FG000|Overall Study|Inevaluable|1|||
155747739|NCT02720094|562176583|FG000|Overall Study|Ongoing|2210|||
155747740|NCT02720094|562176584|FG001|Overall Study|Ongoing|2203|||
155747741|NCT02720094|562176583|FG000|Overall Study|Scheduled exit visit/end of study|2|||
155747742|NCT02720094|562176584|FG001|Overall Study|Scheduled exit visit/end of study|1|||
155747743|NCT02720094|562176583|FG000|Overall Study|Death|4|||
155747744|NCT02720094|562176584|FG001|Overall Study|Death|7|||
155747745|NCT02720094|562176583|FG000|Overall Study|Withdrawal by Subject|55|||
155747746|NCT02720094|562176584|FG001|Overall Study|Withdrawal by Subject|56|||
155747747|NCT02720094|562176583|FG000|Overall Study|Lost to Follow-up|2|||
155747748|NCT02720094|562176584|FG001|Overall Study|Lost to Follow-up|7|||
155747749|NCT02720094|562176583|FG000|Overall Study|Physician Decision|1|||
155747750|NCT02720094|562176584|FG001|Overall Study|Physician Decision|3|||
155302605|NCT00409838|560540187|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
155302606|NCT00409838|560540186|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
155302607|NCT00409838|560540187|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
155302608|NCT00409838|560540186|FG000|Long-term Extension Period|Pregnancy|1|||
155302609|NCT00409838|560540187|FG001|Long-term Extension Period|Pregnancy|0|||
155302610|NCT01250769|560540189|FG000|Overall Study|Withdrawal by Subject|0|||
155747751|NCT02720094|562176583|FG000|Overall Study|Inappropriate enrollment|1|||
155747752|NCT02720094|562176584|FG001|Overall Study|Inappropriate enrollment|3|||
155747753|NCT02720094|562176583|FG000|Overall Study|Relocation|1|||
155747754|NCT02720094|562176584|FG001|Overall Study|Relocation|1|||
155747755|NCT01431638|562176589|FG000|Overall Study|Adverse Event|1|||
155747756|NCT01431638|562176590|FG001|Overall Study|Adverse Event|3|||
155747757|NCT01431638|562176591|FG002|Overall Study|Adverse Event|1|||
155747758|NCT01431638|562176589|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155747759|NCT01431638|562176590|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155302611|NCT01250769|560540190|FG001|Overall Study|Withdrawal by Subject|1|||
155302612|NCT01250769|560540191|FG002|Overall Study|Withdrawal by Subject|1|||
155302613|NCT01250769|560540192|FG003|Overall Study|Withdrawal by Subject|0|||
155302614|NCT01250769|560540189|FG000|Overall Study|Adverse Event|0|||
155302615|NCT01250769|560540190|FG001|Overall Study|Adverse Event|0|||
155302616|NCT01250769|560540191|FG002|Overall Study|Adverse Event|1|||
155302617|NCT01250769|560540192|FG003|Overall Study|Adverse Event|0|||
155302618|NCT01290341|560540193|FG000|Overall Study|Protocol Violation|7|||
155302619|NCT01290341|560540194|FG001|Overall Study|Protocol Violation|3|||
155302620|NCT01290341|560540193|FG000|Overall Study|Adverse Event|1|||
155302621|NCT01290341|560540194|FG001|Overall Study|Adverse Event|0|||
155302622|NCT01290341|560540193|FG000|Overall Study|Lost to Follow-up|21|||
155302623|NCT01290341|560540194|FG001|Overall Study|Lost to Follow-up|10|||
155302624|NCT01290341|560540193|FG000|Overall Study|Withdrawal by Subject|19|||
155302625|NCT01290341|560540194|FG001|Overall Study|Withdrawal by Subject|5|||
155641330|NCT00726557|561777890|FG000|Overall Study|Treatment less than 3 months|17|||
155641331|NCT00726557|561777890|FG000|Overall Study|Inclusion criteria not met|15|||
155641332|NCT02143778|561777893|FG000|Overall Study|Withdrawal by Subject|2|||
155641333|NCT02143778|561777893|FG000|Overall Study|Device malfunction|1|||
155641334|NCT03637374|561777894|FG000|Overall Study|Death|2|||
155641335|NCT03637374|561777895|FG001|Overall Study|Death|0|||
155641336|NCT02403271|561777900|FG000|Period 1|Other varied reasons|1|||
155641337|NCT02403271|561777901|FG001|Period 1|Other varied reasons|0|||
155641338|NCT02403271|561777900|FG000|Period 2|Withdrawal by Subject|0|||
155641339|NCT02403271|561777901|FG001|Period 2|Withdrawal by Subject|14|||
155641340|NCT02403271|561777900|FG000|Period 2|Death|0|||
155641341|NCT02403271|561777901|FG001|Period 2|Death|84|||
155641342|NCT02403271|561777900|FG000|Period 2|Lost to Follow-up|0|||
155641343|NCT02403271|561777901|FG001|Period 2|Lost to Follow-up|2|||
155641344|NCT02403271|561777900|FG000|Period 2|Study Terminated by Sponsor|0|||
155641345|NCT02403271|561777901|FG001|Period 2|Study Terminated by Sponsor|14|||
155641346|NCT02403271|561777900|FG000|Period 2|Other varied reasons|0|||
155641347|NCT02403271|561777901|FG001|Period 2|Other varied reasons|10|||
155641348|NCT05561140|561777902|FG000|Randomized Treatment Period|Adverse Event|1|||
155641349|NCT05561140|561777903|FG001|Randomized Treatment Period|Adverse Event|0|||
155641350|NCT05561140|561777902|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155641351|NCT05561140|561777903|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155641352|NCT05561140|561777902|FG000|Open Label Treatment Period|Adverse Event|6|||
155641353|NCT05561140|561777903|FG001|Open Label Treatment Period|Adverse Event|4|||
155641354|NCT05561140|561777902|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
155641355|NCT05561140|561777903|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
155641356|NCT05561140|561777902|FG000|Open Label Treatment Period|Physician Decision|0|||
155641357|NCT05561140|561777903|FG001|Open Label Treatment Period|Physician Decision|1|||
155641358|NCT05561140|561777902|FG000|Open Label Treatment Period|Pregnancy|1|||
155641359|NCT05561140|561777903|FG001|Open Label Treatment Period|Pregnancy|0|||
155641360|NCT05561140|561777902|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
155641361|NCT05561140|561777903|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
155641362|NCT05561140|561777902|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
155641363|NCT05561140|561777903|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
155641364|NCT05561140|561777902|FG000|Open Label Treatment Period|Other|1|||
155641365|NCT05561140|561777903|FG001|Open Label Treatment Period|Other|0|||
155641366|NCT03301714|561777907|FG000|Overall Study|Lost to Follow-up|10|||
155641367|NCT03301714|561777908|FG001|Overall Study|Lost to Follow-up|4|||
155641368|NCT03301714|561777909|FG002|Overall Study|Lost to Follow-up|4|||
155641369|NCT03301714|561777907|FG000|Overall Study|Did not receive allocated intervention|0|||
155641370|NCT03301714|561777908|FG001|Overall Study|Did not receive allocated intervention|2|||
155641371|NCT03301714|561777909|FG002|Overall Study|Did not receive allocated intervention|3|||
155641372|NCT02112552|561777912|FG000|Overall Study|Withdrawal by Subject|1|||
155641373|NCT02112552|561777912|FG000|Overall Study|Adverse Event|1|||
155641374|NCT00825175|561777914|FG000|Overall Study|Withdrawal by Subject|0|||
155641375|NCT00825175|561777915|FG001|Overall Study|Withdrawal by Subject|5|||
155641376|NCT04822194|561777916|FG000|Overall Study|Withdrawal by Subject|5|||
155641377|NCT04822194|561777917|FG001|Overall Study|Withdrawal by Subject|4|||
155641378|NCT04822194|561777916|FG000|Overall Study|Technical issues with MR scanner|1|||
155641379|NCT04822194|561777917|FG001|Overall Study|Technical issues with MR scanner|0|||
155641380|NCT04822194|561777916|FG000|Overall Study|Lost to Follow-up|5|||
155641381|NCT04822194|561777917|FG001|Overall Study|Lost to Follow-up|7|||
155641382|NCT00118287|561777920|FG000|Overall Study|Intracranial haemorrhage|1|||
155641383|NCT00118287|561777920|FG000|Overall Study|Muscle pain|1|||
155641384|NCT03976375|561777921|FG000|Overall Study|Death|158|||
155641385|NCT03976375|561777922|FG001|Overall Study|Death|160|||
155641386|NCT03976375|561777923|FG002|Overall Study|Death|42|||
155641387|NCT03976375|561777921|FG000|Overall Study|Lost to Follow-up|2|||
155641388|NCT03976375|561777922|FG001|Overall Study|Lost to Follow-up|1|||
155641389|NCT03976375|561777923|FG002|Overall Study|Lost to Follow-up|1|||
155302626|NCT01290341|560540193|FG000|Overall Study|Negative baseline culture and others|44|||
155302627|NCT01290341|560540194|FG001|Overall Study|Negative baseline culture and others|11|||
155302628|NCT03951805|560540195|FG000|Overall Study|Adverse Event|1|||
155302629|NCT03951805|560540196|FG001|Overall Study|Adverse Event|0|||
155747760|NCT01431638|562176591|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
155747761|NCT01431638|562176589|FG000|Overall Study|Participants condition no longer requires study drug|0|||
155747762|NCT01431638|562176590|FG001|Overall Study|Participants condition no longer requires study drug|1|||
155747763|NCT01431638|562176591|FG002|Overall Study|Participants condition no longer requires study drug|0|||
155747764|NCT01431638|562176589|FG000|Overall Study|Participant withdrew consent|14|||
155747765|NCT01431638|562176590|FG001|Overall Study|Participant withdrew consent|5|||
155747766|NCT01431638|562176591|FG002|Overall Study|Participant withdrew consent|8|||
155747767|NCT01431638|562176589|FG000|Overall Study|Lost to Follow-up|7|||
155747768|NCT01431638|562176590|FG001|Overall Study|Lost to Follow-up|9|||
155747769|NCT01431638|562176591|FG002|Overall Study|Lost to Follow-up|7|||
155747770|NCT01431638|562176589|FG000|Overall Study|Administrative problems|1|||
155747771|NCT01431638|562176590|FG001|Overall Study|Administrative problems|4|||
155747772|NCT01431638|562176591|FG002|Overall Study|Administrative problems|6|||
155747773|NCT01431638|562176589|FG000|Overall Study|Death|1|||
155747774|NCT01431638|562176590|FG001|Overall Study|Death|0|||
155747775|NCT01431638|562176591|FG002|Overall Study|Death|0|||
155747776|NCT01431638|562176589|FG000|Overall Study|Protocol deviation|1|||
155747777|NCT01431638|562176590|FG001|Overall Study|Protocol deviation|1|||
155747778|NCT01431638|562176591|FG002|Overall Study|Protocol deviation|4|||
155747779|NCT01431638|562176589|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
155747780|NCT01431638|562176590|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
155747781|NCT01431638|562176591|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
155747782|NCT03836001|562176592|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
155747783|NCT03836001|562176593|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
155747784|NCT03836001|562176594|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
155747785|NCT03836001|562176592|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
155747786|NCT03836001|562176593|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
155747787|NCT03836001|562176594|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
155747788|NCT03836001|562176592|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
155747789|NCT03836001|562176593|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
155747790|NCT03836001|562176594|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
155747791|NCT03836001|562176592|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
155747792|NCT03836001|562176593|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
155747793|NCT03836001|562176594|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
155747794|NCT01381562|562176595|FG000|Overall Study|Adverse Event|0|||
155747795|NCT01381562|562176596|FG001|Overall Study|Adverse Event|1|||
155747796|NCT01381562|562176597|FG002|Overall Study|Adverse Event|0|||
155747797|NCT02660138|562176598|FG000|Overall Study|Adverse Event|0|||
155747798|NCT02660138|562176599|FG001|Overall Study|Adverse Event|3|||
155747799|NCT02660138|562176600|FG002|Overall Study|Adverse Event|2|||
155747800|NCT02660138|562176598|FG000|Overall Study|Lack of Efficacy|1|||
155747801|NCT02660138|562176599|FG001|Overall Study|Lack of Efficacy|2|||
155747802|NCT02660138|562176600|FG002|Overall Study|Lack of Efficacy|1|||
155747803|NCT02660138|562176598|FG000|Overall Study|Withdrawal by Subject|7|||
155747804|NCT02660138|562176599|FG001|Overall Study|Withdrawal by Subject|6|||
155747805|NCT02660138|562176600|FG002|Overall Study|Withdrawal by Subject|6|||
155747806|NCT02660138|562176598|FG000|Overall Study|Lost to Follow-up|4|||
155747807|NCT02660138|562176599|FG001|Overall Study|Lost to Follow-up|4|||
155747808|NCT02660138|562176600|FG002|Overall Study|Lost to Follow-up|1|||
155747809|NCT02660138|562176598|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
155747810|NCT02660138|562176599|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
155302630|NCT03951805|560540197|FG002|Overall Study|Adverse Event|0|||
155302631|NCT03951805|560540198|FG003|Overall Study|Adverse Event|0|||
155302632|NCT03684044|560540199|FG000|Overall Study|Adverse Event|3|||
155302633|NCT03684044|560540200|FG001|Overall Study|Adverse Event|0|||
155302634|NCT03684044|560540199|FG000|Overall Study|Death|4|||
155302635|NCT03684044|560540200|FG001|Overall Study|Death|7|||
155302636|NCT03684044|560540199|FG000|Overall Study|Lost to Follow-up|3|||
155302637|NCT03684044|560540200|FG001|Overall Study|Lost to Follow-up|2|||
155302638|NCT03684044|560540199|FG000|Overall Study|Patient Not Available|0|||
155302639|NCT03684044|560540200|FG001|Overall Study|Patient Not Available|2|||
155302640|NCT03684044|560540199|FG000|Overall Study|Physician Decision|1|||
155302641|NCT03684044|560540200|FG001|Overall Study|Physician Decision|0|||
155302642|NCT03684044|560540199|FG000|Overall Study|Withdrawal by Subject|11|||
155302643|NCT03684044|560540200|FG001|Overall Study|Withdrawal by Subject|9|||
155302644|NCT03703336|560540201|FG000|Overall Study|Parent withdrew consent|29|||
155747811|NCT02660138|562176600|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
155747812|NCT02660138|562176598|FG000|Overall Study|Other|1|||
155747813|NCT02660138|562176599|FG001|Overall Study|Other|1|||
155747814|NCT02660138|562176600|FG002|Overall Study|Other|0|||
155747815|NCT02660138|562176598|FG000|Overall Study|Not treated|0|||
155747816|NCT02660138|562176599|FG001|Overall Study|Not treated|1|||
155302645|NCT03703336|560540202|FG001|Overall Study|Parent withdrew consent|8|||
155302646|NCT03703336|560540201|FG000|Overall Study|Migration|3|||
155302647|NCT03703336|560540202|FG001|Overall Study|Migration|3|||
155747817|NCT02660138|562176600|FG002|Overall Study|Not treated|0|||
155747818|NCT00308581|562176602|FG000|Induction Phase|Adverse Event|0|||
155747819|NCT00308581|562176603|FG001|Induction Phase|Adverse Event|0|||
155747820|NCT00308581|562176604|FG002|Induction Phase|Adverse Event|37|||
155747821|NCT00308581|562176602|FG000|Induction Phase|Lack of Efficacy|0|||
155747822|NCT00308581|562176603|FG001|Induction Phase|Lack of Efficacy|0|||
155747823|NCT00308581|562176604|FG002|Induction Phase|Lack of Efficacy|121|||
155747824|NCT00308581|562176602|FG000|Induction Phase|Withdrawal by Subject|0|||
155747825|NCT00308581|562176603|FG001|Induction Phase|Withdrawal by Subject|0|||
155747826|NCT00308581|562176604|FG002|Induction Phase|Withdrawal by Subject|5|||
155747827|NCT00308581|562176602|FG000|Induction Phase|Unknown reason|0|||
155747828|NCT00308581|562176603|FG001|Induction Phase|Unknown reason|0|||
155747829|NCT00308581|562176604|FG002|Induction Phase|Unknown reason|3|||
155747830|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Adverse Event|10|||
155747831|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Adverse Event|17|||
155747832|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Adverse Event|0|||
155747833|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
155747834|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
155747835|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
155747836|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
155747837|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
155747838|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
155747839|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
155747840|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
155747841|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
155747842|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
155747843|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
155747844|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
155747845|NCT00308581|562176602|FG000|Randomized Maintenance Phase|Unknown reason|3|||
155747846|NCT00308581|562176603|FG001|Randomized Maintenance Phase|Unknown reason|0|||
155747847|NCT00308581|562176604|FG002|Randomized Maintenance Phase|Unknown reason|0|||
155747848|NCT00899353|562176607|FG000|Overall Study|Adverse Event|2|||
155747849|NCT00899353|562176607|FG000|Overall Study|Lost to Follow-up|1|||
155747850|NCT00899353|562176607|FG000|Overall Study|Withdrawal by Subject|2|||
155747851|NCT04604132|562176613|FG000|Overall Study|Adverse Event|2|||
155747852|NCT04604132|562176614|FG001|Overall Study|Adverse Event|0|||
155747853|NCT04604132|562176615|FG002|Overall Study|Adverse Event|0|||
155747854|NCT04604132|562176616|FG003|Overall Study|Adverse Event|1|||
155747855|NCT04604132|562176617|FG004|Overall Study|Adverse Event|2|||
155747856|NCT04604132|562176613|FG000|Overall Study|Study terminated by sponsor|0|||
155747857|NCT04604132|562176614|FG001|Overall Study|Study terminated by sponsor|0|||
155747858|NCT04604132|562176615|FG002|Overall Study|Study terminated by sponsor|0|||
155747859|NCT04604132|562176616|FG003|Overall Study|Study terminated by sponsor|0|||
155747860|NCT04604132|562176617|FG004|Overall Study|Study terminated by sponsor|1|||
155747861|NCT04604132|562176613|FG000|Overall Study|Progressive disease: Clinical progression|0|||
155302648|NCT03703336|560540201|FG000|Overall Study|Protocol Violation|3|||
155302649|NCT03703336|560540202|FG001|Overall Study|Protocol Violation|1|||
155302650|NCT03703336|560540201|FG000|Overall Study|Physician Decision|2|||
155302651|NCT03703336|560540202|FG001|Overall Study|Physician Decision|0|||
155302652|NCT03703336|560540201|FG000|Overall Study|Adverse Event|0|||
155302653|NCT03703336|560540202|FG001|Overall Study|Adverse Event|2|||
155747862|NCT04604132|562176614|FG001|Overall Study|Progressive disease: Clinical progression|0|||
155747863|NCT04604132|562176615|FG002|Overall Study|Progressive disease: Clinical progression|1|||
155747864|NCT04604132|562176616|FG003|Overall Study|Progressive disease: Clinical progression|0|||
155747865|NCT04604132|562176617|FG004|Overall Study|Progressive disease: Clinical progression|0|||
155747866|NCT04604132|562176613|FG000|Overall Study|Progressive disease: Radiological progression|8|||
155747867|NCT04604132|562176614|FG001|Overall Study|Progressive disease: Radiological progression|7|||
155747868|NCT04604132|562176615|FG002|Overall Study|Progressive disease: Radiological progression|10|||
155747869|NCT04604132|562176616|FG003|Overall Study|Progressive disease: Radiological progression|4|||
155747870|NCT04604132|562176617|FG004|Overall Study|Progressive disease: Radiological progression|3|||
155747871|NCT04604132|562176613|FG000|Overall Study|Death|3|||
155747872|NCT04604132|562176614|FG001|Overall Study|Death|1|||
155747873|NCT04604132|562176615|FG002|Overall Study|Death|2|||
155747874|NCT04604132|562176616|FG003|Overall Study|Death|1|||
155747875|NCT04604132|562176617|FG004|Overall Study|Death|0|||
155747876|NCT00952380|562176618|FG000|Overall Study|Other|0|||
155747877|NCT00952380|562176619|FG001|Overall Study|Other|0|||
155302654|NCT03703336|560540201|FG000|Overall Study|Lost to Follow-up|1|||
155302655|NCT03703336|560540202|FG001|Overall Study|Lost to Follow-up|0|||
155747878|NCT00952380|562176620|FG002|Overall Study|Other|0|||
155302656|NCT00595413|560540203|FG000|Overall Study|Adverse Event|0|||
155411698|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
155411699|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
155411700|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
155411701|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
155411702|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
155411703|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
155411704|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
155411705|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
155411706|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
155641390|NCT03976375|561777921|FG000|Overall Study|Withdrawal by Subject|5|||
155641391|NCT03976375|561777922|FG001|Overall Study|Withdrawal by Subject|9|||
155641392|NCT03976375|561777923|FG002|Overall Study|Withdrawal by Subject|4|||
155641393|NCT03976375|561777921|FG000|Overall Study|Sponsor decision|20|||
155641394|NCT03976375|561777922|FG001|Overall Study|Sponsor decision|19|||
155641395|NCT03976375|561777923|FG002|Overall Study|Sponsor decision|1|||
155641396|NCT03091439|561777924|FG000|Overall Study|Study Terminated by the Sponsor|1|||
155641397|NCT03091439|561777925|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155641398|NCT03122106|561777926|FG000|Overall Study|Not enough tissue|1|||
155641399|NCT03122106|561777926|FG000|Overall Study|Disease progression during screening|2|||
155641400|NCT03122106|561777926|FG000|Overall Study|Poor RNA quality for vaccine|1|||
155641401|NCT00640289|561777927|FG000|Overall Study|Death|3|||
155641402|NCT00640289|561777927|FG000|Overall Study|Withdrawal by Subject|1|||
155641403|NCT00640289|561777927|FG000|Overall Study|Lost to Follow-up|1|||
155641404|NCT00640289|561777927|FG000|Overall Study|Data collected under different amendment|2|||
155641405|NCT00640289|561777927|FG000|Overall Study|Transferred to another center|1|||
155641406|NCT00640289|561777927|FG000|Overall Study|Missing status|5|||
155641407|NCT03550209|561777928|FG000|Overall Study|Lost to Follow-up|1|||
155641408|NCT03550209|561777929|FG001|Overall Study|Lost to Follow-up|0|||
155641409|NCT03550209|561777930|FG002|Overall Study|Lost to Follow-up|1|||
155641410|NCT03550209|561777931|FG003|Overall Study|Lost to Follow-up|0|||
155641411|NCT03550209|561777928|FG000|Overall Study|Withdrawal by Subject|0|||
155641412|NCT03550209|561777929|FG001|Overall Study|Withdrawal by Subject|3|||
155641413|NCT03550209|561777930|FG002|Overall Study|Withdrawal by Subject|1|||
155641414|NCT03550209|561777931|FG003|Overall Study|Withdrawal by Subject|2|||
155641415|NCT03550209|561777928|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
155641416|NCT03550209|561777929|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
155641417|NCT03550209|561777930|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
155641418|NCT03550209|561777931|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
155641419|NCT02347787|561777934|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
155641420|NCT02347787|561777935|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
155641421|NCT02347787|561777934|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
155641422|NCT02347787|561777935|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
155641423|NCT02347787|561777934|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
155641424|NCT02347787|561777935|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
155641425|NCT02347787|561777934|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
155641426|NCT02347787|561777935|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
155641427|NCT03244189|561777937|FG000|Overall Study|Death|0|||
155641428|NCT03244189|561777938|FG001|Overall Study|Death|2|||
155641429|NCT03244189|561777937|FG000|Overall Study|Lost to Follow-up|92|||
155641430|NCT03244189|561777938|FG001|Overall Study|Lost to Follow-up|107|||
155641431|NCT03244189|561777937|FG000|Overall Study|Physician Decision|4|||
155641432|NCT03244189|561777938|FG001|Overall Study|Physician Decision|2|||
155641433|NCT03244189|561777937|FG000|Overall Study|Pregnancy|7|||
155641434|NCT03244189|561777938|FG001|Overall Study|Pregnancy|5|||
155641435|NCT03244189|561777937|FG000|Overall Study|Protocol Violation|0|||
155641436|NCT03244189|561777938|FG001|Overall Study|Protocol Violation|2|||
155641437|NCT03244189|561777937|FG000|Overall Study|Withdrawal by Subject|45|||
155641438|NCT03244189|561777938|FG001|Overall Study|Withdrawal by Subject|23|||
155641439|NCT03244189|561777937|FG000|Overall Study|Technical Problems|2|||
155641440|NCT03244189|561777938|FG001|Overall Study|Technical Problems|0|||
155641441|NCT03599713|561777941|FG000|Overall Study|Death|38|||
155641442|NCT03599713|561777942|FG001|Overall Study|Death|3|||
155641443|NCT03599713|561777941|FG000|Overall Study|Withdrawal by Subject|17|||
155641444|NCT03599713|561777942|FG001|Overall Study|Withdrawal by Subject|0|||
155747879|NCT00952380|562176621|FG003|Overall Study|Other|0|||
155641445|NCT03599713|561777941|FG000|Overall Study|Lost to Follow-up|4|||
155641446|NCT03599713|561777942|FG001|Overall Study|Lost to Follow-up|0|||
155641447|NCT03599713|561777941|FG000|Overall Study|Discontinued Due to End of Study|42|||
155641448|NCT03599713|561777942|FG001|Overall Study|Discontinued Due to End of Study|3|||
155641449|NCT02850406|561777947|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641450|NCT02850406|561777948|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641451|NCT02850406|561777949|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641452|NCT02850406|561777950|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
155641453|NCT02850406|561777951|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641454|NCT02850406|561777952|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
155747880|NCT00952380|562176622|FG004|Overall Study|Other|1|||
155747881|NCT00952380|562176618|FG000|Overall Study|Withdrawal by Subject|0|||
155747882|NCT00952380|562176619|FG001|Overall Study|Withdrawal by Subject|0|||
155747883|NCT00952380|562176620|FG002|Overall Study|Withdrawal by Subject|1|||
155747884|NCT00952380|562176621|FG003|Overall Study|Withdrawal by Subject|0|||
155747885|NCT00952380|562176622|FG004|Overall Study|Withdrawal by Subject|2|||
155747886|NCT00952380|562176618|FG000|Overall Study|Adverse Event|0|||
155747887|NCT00952380|562176619|FG001|Overall Study|Adverse Event|1|||
155747888|NCT00952380|562176620|FG002|Overall Study|Adverse Event|0|||
155747889|NCT00952380|562176621|FG003|Overall Study|Adverse Event|0|||
155747890|NCT00952380|562176622|FG004|Overall Study|Adverse Event|3|||
155747891|NCT00952380|562176618|FG000|Overall Study|Physician Decision|0|||
155747892|NCT00952380|562176619|FG001|Overall Study|Physician Decision|0|||
155747893|NCT00952380|562176620|FG002|Overall Study|Physician Decision|1|||
155747894|NCT00952380|562176621|FG003|Overall Study|Physician Decision|2|||
155747895|NCT00952380|562176622|FG004|Overall Study|Physician Decision|0|||
155747896|NCT00952380|562176618|FG000|Overall Study|Non-compliant to protocol|0|||
155747897|NCT00952380|562176619|FG001|Overall Study|Non-compliant to protocol|0|||
155747898|NCT00952380|562176620|FG002|Overall Study|Non-compliant to protocol|0|||
155747899|NCT00952380|562176621|FG003|Overall Study|Non-compliant to protocol|1|||
155747900|NCT00952380|562176622|FG004|Overall Study|Non-compliant to protocol|0|||
155747901|NCT00053898|562176624|FG000|Overall Study|No follow-up data from any source|9|||
155747902|NCT00053898|562176625|FG001|Overall Study|No follow-up data from any source|12|||
155747903|NCT00053898|562176624|FG000|Overall Study|Follow-up from telephone contact only|5|||
155747904|NCT00053898|562176625|FG001|Overall Study|Follow-up from telephone contact only|1|||
155747905|NCT04085367|562177990|FG000|Overall Study|Adverse Event|1|||
155747906|NCT04085367|562177991|FG001|Overall Study|Adverse Event|1|||
155747907|NCT04085367|562177990|FG000|Overall Study|Withdrawal by Subject|13|||
155747908|NCT04085367|562177991|FG001|Overall Study|Withdrawal by Subject|4|||
155747909|NCT04085367|562177990|FG000|Overall Study|Lost to Follow-up|3|||
155747910|NCT04085367|562177991|FG001|Overall Study|Lost to Follow-up|1|||
155747911|NCT04085367|562177990|FG000|Overall Study|Other unspecified|2|||
155747912|NCT04085367|562177991|FG001|Overall Study|Other unspecified|1|||
155747913|NCT04085367|562177990|FG000|Overall Study|Status Unknown|1|||
155747914|NCT04085367|562177991|FG001|Overall Study|Status Unknown|1|||
155747915|NCT00130442|562177992|FG000|Overall Study|Withdrawal by Subject|0|||
155747916|NCT00130442|562177993|FG001|Overall Study|Withdrawal by Subject|1|||
155747917|NCT00130442|562177992|FG000|Overall Study|did not meet criteria|1|||
155747918|NCT00130442|562177993|FG001|Overall Study|did not meet criteria|1|||
155747919|NCT02233946|562177994|FG000|Baseline|Withdrawal by Subject|2|||
155747920|NCT02233946|562177995|FG001|Baseline|Withdrawal by Subject|0|||
155747921|NCT02233946|562177994|FG000|3-months Follow-up|Lost to Follow-up|53|||
155747922|NCT02233946|562177995|FG001|3-months Follow-up|Lost to Follow-up|29|||
155747923|NCT02233946|562177994|FG000|6-months Follow-up|Lost to Follow-up|21|||
155302657|NCT00595413|560540204|FG001|Overall Study|Adverse Event|2|||
155302658|NCT00595413|560540205|FG002|Overall Study|Adverse Event|1|||
155302659|NCT00595413|560540206|FG003|Overall Study|Adverse Event|1|||
155302660|NCT00595413|560540203|FG000|Overall Study|Lost to Follow-up|2|||
155747924|NCT02233946|562177995|FG001|6-months Follow-up|Lost to Follow-up|2|||
155747925|NCT02233946|562177994|FG000|9-month Follow-up|Lost to Follow-up|20|||
155747926|NCT02233946|562177995|FG001|9-month Follow-up|Lost to Follow-up|11|||
155747927|NCT02233946|562177994|FG000|12-month Follow-up|Lost to Follow-up|28|||
155747928|NCT02233946|562177995|FG001|12-month Follow-up|Lost to Follow-up|11|||
155747929|NCT00910247|562177996|FG000|Overall Study|Adverse Event|15|||
155747930|NCT00910247|562177996|FG000|Overall Study|Death|2|||
155747931|NCT00910247|562177996|FG000|Overall Study|Lost to Follow-up|10|||
155747932|NCT00910247|562177996|FG000|Overall Study|Physician Decision|3|||
155747933|NCT00910247|562177996|FG000|Overall Study|Protocol Violation|10|||
155747934|NCT00910247|562177996|FG000|Overall Study|Withdrawal by Subject|25|||
155747935|NCT00910247|562177996|FG000|Overall Study|Not collected|4|||
155747936|NCT02292784|562177997|FG000|Overall Study|Lost to Follow-up|1|||
155747937|NCT02292784|562177998|FG001|Overall Study|Lost to Follow-up|17|||
155747938|NCT02292784|562177999|FG002|Overall Study|Lost to Follow-up|18|||
155302661|NCT00595413|560540204|FG001|Overall Study|Lost to Follow-up|2|||
155302662|NCT00595413|560540205|FG002|Overall Study|Lost to Follow-up|1|||
155302663|NCT00595413|560540206|FG003|Overall Study|Lost to Follow-up|3|||
155302664|NCT00595413|560540203|FG000|Overall Study|Death|0|||
155302665|NCT00595413|560540204|FG001|Overall Study|Death|0|||
155302666|NCT00595413|560540205|FG002|Overall Study|Death|1|||
155302667|NCT00595413|560540206|FG003|Overall Study|Death|0|||
155302668|NCT00595413|560540203|FG000|Overall Study|Other|5|||
155302669|NCT00595413|560540204|FG001|Overall Study|Other|1|||
155302670|NCT00595413|560540205|FG002|Overall Study|Other|5|||
155302671|NCT00595413|560540206|FG003|Overall Study|Other|0|||
155302672|NCT03233633|560540207|FG000|Overall Study|Adverse Event|2|||
155302673|NCT03233633|560540207|FG000|Overall Study|Less Than 3 Days of Data|6|||
155302674|NCT02088853|560540208|FG000|Overall Study|Pregnancy|1|||
155747939|NCT02292784|562177997|FG000|Overall Study|Withdrawal by Subject|0|||
155747940|NCT02292784|562177998|FG001|Overall Study|Withdrawal by Subject|3|||
155747941|NCT02292784|562177999|FG002|Overall Study|Withdrawal by Subject|3|||
155747942|NCT00622739|562178000|FG000|Overall Study|Physician Decision|1|||
155747943|NCT00622739|562178001|FG001|Overall Study|Physician Decision|0|||
155747944|NCT00622739|562178000|FG000|Overall Study|Adverse Event|1|||
155747945|NCT00622739|562178001|FG001|Overall Study|Adverse Event|2|||
155747946|NCT00622739|562178000|FG000|Overall Study|Lack of Efficacy|0|||
155747947|NCT00622739|562178001|FG001|Overall Study|Lack of Efficacy|2|||
155747948|NCT00622739|562178000|FG000|Overall Study|Withdrawal by Subject|0|||
155747949|NCT00622739|562178001|FG001|Overall Study|Withdrawal by Subject|1|||
155747950|NCT00622739|562178000|FG000|Overall Study|Lost to Follow-up|0|||
155747951|NCT00622739|562178001|FG001|Overall Study|Lost to Follow-up|1|||
155747952|NCT02519855|562178002|FG000|Overall Study|Adverse Event|0|||
155747953|NCT02519855|562178003|FG001|Overall Study|Adverse Event|1|||
155747954|NCT02519855|562178002|FG000|Overall Study|Lost to Follow-up|3|||
155747955|NCT02519855|562178003|FG001|Overall Study|Lost to Follow-up|3|||
155747956|NCT00706849|562178010|FG000|Treatment Period|Adverse Event|0|||
155747957|NCT00706849|562178011|FG001|Treatment Period|Adverse Event|9|||
155747958|NCT00706849|562178010|FG000|Treatment Period|Other|0|||
155747959|NCT00706849|562178011|FG001|Treatment Period|Other|1|||
155747960|NCT00706849|562178010|FG000|Follow-up Period|Withdrawal by Subject|0|||
155747961|NCT00706849|562178011|FG001|Follow-up Period|Withdrawal by Subject|2|||
155747962|NCT00706849|562178010|FG000|Follow-up Period|Protocol non-compliance|0|||
155747963|NCT00706849|562178011|FG001|Follow-up Period|Protocol non-compliance|1|||
155747964|NCT01611454|562178012|FG000|Overall Study|Lack of Efficacy|18|||
155747965|NCT01611454|562178013|FG001|Overall Study|Lack of Efficacy|10|||
155747966|NCT00920907|562178015|FG000|Induction Period|Adverse Event|0|||
155747967|NCT00920907|562178016|FG001|Induction Period|Adverse Event|2|||
155747968|NCT00920907|562178015|FG000|Induction Period|Death|1|||
155747969|NCT00920907|562178016|FG001|Induction Period|Death|1|||
155747970|NCT00920907|562178015|FG000|Induction Period|Disease Progression|12|||
155747971|NCT00920907|562178016|FG001|Induction Period|Disease Progression|11|||
155747972|NCT00920907|562178015|FG000|Induction Period|Study Drug Toxicity|8|||
155411707|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
155411708|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
155411709|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
155411710|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
155411711|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
155411712|NCT02600494|560939242|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
155411713|NCT02600494|560939243|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
155411714|NCT02600494|560939244|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
155411715|NCT03124563|560939245|FG000|Overall Study|Lost to Follow-up|1|||
155411716|NCT03124563|560939246|FG001|Overall Study|Lost to Follow-up|1|||
155411717|NCT03124563|560939245|FG000|Overall Study|Withdrawal by Subject|1|||
155747973|NCT00920907|562178016|FG001|Induction Period|Study Drug Toxicity|6|||
155747974|NCT00920907|562178015|FG000|Induction Period|No longer meets study criteria|0|||
155747975|NCT00920907|562178016|FG001|Induction Period|No longer meets study criteria|1|||
155747976|NCT00920907|562178015|FG000|Induction Period|Withdrawal by Subject|1|||
155747977|NCT00920907|562178016|FG001|Induction Period|Withdrawal by Subject|1|||
155747978|NCT00920907|562178015|FG000|Maintenance Period|Disease Progression|3|||
155747979|NCT00920907|562178016|FG001|Maintenance Period|Disease Progression|7|||
155747980|NCT00920907|562178015|FG000|Maintenance Period|Administrative (study closure)|7|||
155747981|NCT00920907|562178016|FG001|Maintenance Period|Administrative (study closure)|2|||
155747982|NCT00920907|562178015|FG000|Maintenance Period|Study Drug Toxicity|0|||
155747983|NCT00920907|562178016|FG001|Maintenance Period|Study Drug Toxicity|2|||
155747984|NCT00920907|562178015|FG000|Maintenance Period|Death|1|||
155747985|NCT00920907|562178016|FG001|Maintenance Period|Death|1|||
155747986|NCT00920907|562178015|FG000|Maintenance Period|Withdrawal by Subject|1|||
155411718|NCT03124563|560939246|FG001|Overall Study|Withdrawal by Subject|1|||
155411719|NCT05061719|560939249|FG000|Overall Study|Adverse Event|60|||
155747987|NCT00920907|562178016|FG001|Maintenance Period|Withdrawal by Subject|0|||
155747988|NCT00920907|562178015|FG000|Maintenance Period|Adverse Event|0|||
155747989|NCT00920907|562178016|FG001|Maintenance Period|Adverse Event|1|||
155747990|NCT02616601|562178017|FG000|Overall Study|Withdrawal by Subject|4|||
155747991|NCT02616601|562178018|FG001|Overall Study|Withdrawal by Subject|4|||
155411720|NCT05061719|560939249|FG000|Overall Study|Death|1|||
155411721|NCT05061719|560939249|FG000|Overall Study|Lack of Efficacy|7|||
155411722|NCT05061719|560939249|FG000|Overall Study|Lost to Follow-up|5|||
155641455|NCT02850406|561777953|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641456|NCT02850406|561777954|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
155641457|NCT02850406|561777947|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641458|NCT02850406|561777948|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641459|NCT02850406|561777949|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
155641460|NCT02850406|561777950|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
155641461|NCT02850406|561777951|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641462|NCT02850406|561777952|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641463|NCT02850406|561777953|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641464|NCT02850406|561777954|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155641465|NCT02850406|561777947|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641466|NCT02850406|561777948|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641467|NCT02850406|561777949|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
155641468|NCT02850406|561777950|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641469|NCT02850406|561777951|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641470|NCT02850406|561777952|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641471|NCT02850406|561777953|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641472|NCT02850406|561777954|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155641473|NCT02850406|561777947|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
155641474|NCT02850406|561777948|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
155641475|NCT02850406|561777949|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
155641476|NCT02850406|561777950|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
155641477|NCT02850406|561777951|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
155641478|NCT02850406|561777952|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
155641479|NCT02850406|561777953|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
155641480|NCT02850406|561777954|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
155641481|NCT02850406|561777947|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641482|NCT02850406|561777948|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641483|NCT02850406|561777949|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641484|NCT02850406|561777950|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641485|NCT02850406|561777951|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
155641486|NCT02850406|561777952|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
155641487|NCT02850406|561777953|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641488|NCT02850406|561777954|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
155641489|NCT02850406|561777947|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641490|NCT02850406|561777948|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641491|NCT02850406|561777949|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641492|NCT02850406|561777950|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641493|NCT02850406|561777951|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
155641494|NCT02850406|561777952|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
155641495|NCT02850406|561777953|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641496|NCT02850406|561777954|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155411723|NCT05061719|560939249|FG000|Overall Study|Pregnancy|1|||
155641497|NCT02850406|561777947|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
155641498|NCT02850406|561777948|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
155747992|NCT02616601|562178019|FG002|Overall Study|Withdrawal by Subject|3|||
155747993|NCT02616601|562178017|FG000|Overall Study|Adverse Event|2|||
155747994|NCT02616601|562178018|FG001|Overall Study|Adverse Event|0|||
155747995|NCT02616601|562178019|FG002|Overall Study|Adverse Event|2|||
155747996|NCT02616601|562178017|FG000|Overall Study|Death|1|||
155747997|NCT02616601|562178018|FG001|Overall Study|Death|0|||
155747998|NCT02616601|562178019|FG002|Overall Study|Death|0|||
155747999|NCT02616601|562178017|FG000|Overall Study|Lost to Follow-up|1|||
155748000|NCT02616601|562178018|FG001|Overall Study|Lost to Follow-up|0|||
155748001|NCT02616601|562178019|FG002|Overall Study|Lost to Follow-up|1|||
155748002|NCT02616601|562178017|FG000|Overall Study|Non-Compliance with Test Article|1|||
155748003|NCT02616601|562178018|FG001|Overall Study|Non-Compliance with Test Article|0|||
155748004|NCT02616601|562178019|FG002|Overall Study|Non-Compliance with Test Article|1|||
155748005|NCT00718081|562178020|FG000|Overall Study|Adverse Event|0|||
155748006|NCT00718081|562178021|FG001|Overall Study|Adverse Event|1|||
155748007|NCT00718081|562178022|FG002|Overall Study|Adverse Event|0|||
155748008|NCT00718081|562178020|FG000|Overall Study|Lack of Efficacy|7|||
155748009|NCT00718081|562178021|FG001|Overall Study|Lack of Efficacy|3|||
155748010|NCT00718081|562178022|FG002|Overall Study|Lack of Efficacy|21|||
155748011|NCT01931670|562178025|FG000|Treatment Period|Exclusionary Medication Received|1|||
155748012|NCT01931670|562178026|FG001|Treatment Period|Exclusionary Medication Received|1|||
155748013|NCT01931670|562178027|FG002|Treatment Period|Exclusionary Medication Received|1|||
155748014|NCT01931670|562178025|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
155748015|NCT01931670|562178026|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
155748016|NCT01931670|562178027|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
155748017|NCT01931670|562178025|FG000|Treatment Period|Subject Noncompliant|4|||
155748018|NCT01931670|562178026|FG001|Treatment Period|Subject Noncompliant|9|||
155748019|NCT01931670|562178027|FG002|Treatment Period|Subject Noncompliant|5|||
155748020|NCT01931670|562178025|FG000|Treatment Period|Adverse Event|19|||
155748021|NCT01931670|562178026|FG001|Treatment Period|Adverse Event|8|||
155748022|NCT01931670|562178027|FG002|Treatment Period|Adverse Event|21|||
155748023|NCT01931670|562178025|FG000|Treatment Period|Lack of Efficacy|11|||
155748024|NCT01931670|562178026|FG001|Treatment Period|Lack of Efficacy|2|||
155748025|NCT01931670|562178027|FG002|Treatment Period|Lack of Efficacy|2|||
155748026|NCT01931670|562178025|FG000|Treatment Period|Pregnancy|7|||
155748027|NCT01931670|562178026|FG001|Treatment Period|Pregnancy|2|||
155748028|NCT01931670|562178027|FG002|Treatment Period|Pregnancy|0|||
155748029|NCT01931670|562178025|FG000|Treatment Period|Other|8|||
155748030|NCT01931670|562178026|FG001|Treatment Period|Other|7|||
155748031|NCT01931670|562178027|FG002|Treatment Period|Other|2|||
155748032|NCT01931670|562178025|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
155748033|NCT01931670|562178026|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
155748034|NCT01931670|562178027|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
155748035|NCT01931670|562178025|FG000|Treatment Period|Lost to Follow-up|19|||
155748036|NCT01931670|562178026|FG001|Treatment Period|Lost to Follow-up|5|||
155748037|NCT01931670|562178027|FG002|Treatment Period|Lost to Follow-up|7|||
155302675|NCT02088853|560540209|FG001|Overall Study|Pregnancy|0|||
155748038|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
155748039|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
155748040|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
155748041|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
155748042|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
155748043|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
155748044|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
155748045|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
155748046|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
155748047|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
155748048|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
155748049|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
155748050|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
155748051|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
155748052|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
155748053|NCT01931670|562178025|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
155748054|NCT01931670|562178026|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
155748055|NCT01931670|562178027|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
155748056|NCT00815516|562178028|FG000|Overall Study|Death|3|||
155748057|NCT00815516|562178029|FG001|Overall Study|Death|1|||
155748058|NCT00815516|562178028|FG000|Overall Study|Physician Decision|1|||
155748059|NCT00815516|562178029|FG001|Overall Study|Physician Decision|0|||
155748060|NCT00329901|562178040|FG000|Overall Study|Withdrawal by Subject|4|||
155748061|NCT00329901|562178041|FG001|Overall Study|Withdrawal by Subject|3|||
155748062|NCT00329901|562178042|FG002|Overall Study|Withdrawal by Subject|2|||
155748063|NCT00329901|562178040|FG000|Overall Study|Lost to Follow-up|2|||
155302676|NCT00603954|560540210|FG000|Overall Study|Protocol Violation|1|||
155748064|NCT00329901|562178041|FG001|Overall Study|Lost to Follow-up|0|||
155748065|NCT00329901|562178042|FG002|Overall Study|Lost to Follow-up|1|||
155748066|NCT00329901|562178040|FG000|Overall Study|Protocol Violation|1|||
155748067|NCT00329901|562178041|FG001|Overall Study|Protocol Violation|0|||
155748068|NCT00329901|562178042|FG002|Overall Study|Protocol Violation|1|||
155748069|NCT00329901|562178040|FG000|Overall Study|Unable to classify|2|||
155748070|NCT00329901|562178041|FG001|Overall Study|Unable to classify|2|||
155748071|NCT00329901|562178042|FG002|Overall Study|Unable to classify|0|||
155748072|NCT05028361|562178043|FG000|Overall Study|Withdrawal by Subject|1|||
155748073|NCT05028361|562178044|FG001|Overall Study|Withdrawal by Subject|0|||
155748074|NCT02195687|562178045|FG000|Overall Study|Personal Reasons|1|||
155748075|NCT02195687|562178046|FG001|Overall Study|Personal Reasons|1|||
155748076|NCT02195687|562178045|FG000|Overall Study|Lost to Follow-up|4|||
155748077|NCT02195687|562178046|FG001|Overall Study|Lost to Follow-up|1|||
155748078|NCT02296138|562178049|FG000|Overall Study|Adverse Event|348|||
155748079|NCT02296138|562178050|FG001|Overall Study|Adverse Event|259|||
155748080|NCT02296138|562178049|FG000|Overall Study|Lack of Efficacy|59|||
155748081|NCT02296138|562178050|FG001|Overall Study|Lack of Efficacy|37|||
155748082|NCT02296138|562178049|FG000|Overall Study|Protocol Violation|35|||
155748083|NCT02296138|562178050|FG001|Overall Study|Protocol Violation|36|||
155748084|NCT02296138|562178049|FG000|Overall Study|Lost to Follow-up|9|||
155748085|NCT02296138|562178050|FG001|Overall Study|Lost to Follow-up|12|||
155748086|NCT02296138|562178049|FG000|Overall Study|Withdrawal by Subject|184|||
155302677|NCT00603954|560540211|FG001|Overall Study|Protocol Violation|2|||
155302678|NCT02708108|560540212|FG000|Overall Study|Death|1|||
155302679|NCT02708108|560540213|FG001|Overall Study|Death|2|||
155302680|NCT02708108|560540212|FG000|Overall Study|Regimen change|1|||
155302681|NCT02708108|560540213|FG001|Overall Study|Regimen change|0|||
155302682|NCT02708108|560540212|FG000|Overall Study|No MRD and no imaging available|0|||
155302683|NCT02708108|560540213|FG001|Overall Study|No MRD and no imaging available|1|||
155302684|NCT05368831|560540214|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
155302685|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
155302686|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Adverse Event|2|||
155302687|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
155302688|NCT00419341|560540216|FG000|Efficacy Period|Withdrawal by Subject|6|||
155302689|NCT00419341|560540216|FG000|Efficacy Period|Protocol Violation|1|||
155302690|NCT00419341|560540216|FG000|Efficacy Period|Lost to Follow-up|1|||
155748087|NCT02296138|562178050|FG001|Overall Study|Withdrawal by Subject|131|||
155748088|NCT02296138|562178049|FG000|Overall Study|Not Treated|1|||
155748089|NCT02296138|562178050|FG001|Overall Study|Not Treated|1|||
155748090|NCT02296138|562178049|FG000|Overall Study|Patients with data irregularities|10|||
155748091|NCT02296138|562178050|FG001|Overall Study|Patients with data irregularities|11|||
155748092|NCT02296138|562178049|FG000|Overall Study|Other than specified|15|||
155748093|NCT02296138|562178050|FG001|Overall Study|Other than specified|13|||
155302691|NCT00419341|560540216|FG000|Efficacy Period|Non-compliance|1|||
155302692|NCT00419341|560540216|FG000|Efficacy Period|Termination of study site|1|||
155302693|NCT04200365|560540217|FG000|Overall Study|Adverse Event|2|||
155302694|NCT04200365|560540217|FG000|Overall Study|Progressive Disease|4|||
155302695|NCT04200365|560540217|FG000|Overall Study|Lack of Efficacy|1|||
155302696|NCT04200365|560540217|FG000|Overall Study|Study Closure|4|||
155748094|NCT04369924|562178051|FG000|Overall Study|Lost to Follow-up|302|||
155748095|NCT04369924|562178052|FG001|Overall Study|Lost to Follow-up|339|||
155748096|NCT01653132|562178053|FG000|First Intervention|Protocol Violation|1|||
155748097|NCT01653132|562178054|FG001|First Intervention|Protocol Violation|0|||
155748098|NCT03828370|562178055|FG000|3 Month Follow-up|Lost to Follow-up|4|||
155748099|NCT03828370|562178056|FG001|3 Month Follow-up|Lost to Follow-up|12|||
155302697|NCT03783026|560542617|FG000|Treatment Phase|Adverse Event|15|||
155302698|NCT03783026|560542617|FG000|Treatment Phase|Lack of Efficacy|11|||
155302699|NCT03783026|560542617|FG000|Treatment Phase|Withdrawal by Subject|6|||
155748100|NCT03828370|562178055|FG000|9 Month Follow up|Lost to Follow-up|12|||
155748101|NCT03828370|562178056|FG001|9 Month Follow up|Lost to Follow-up|20|||
155748102|NCT00584740|562178058|FG000|Overall Study|Adverse Event|1|||
155748103|NCT00584740|562178059|FG001|Overall Study|Adverse Event|1|||
155748104|NCT00584740|562178058|FG000|Overall Study|Lack of Efficacy|8|||
155748105|NCT00584740|562178059|FG001|Overall Study|Lack of Efficacy|2|||
155748106|NCT00584740|562178058|FG000|Overall Study|Withdrawal by Subject|3|||
155748107|NCT00584740|562178059|FG001|Overall Study|Withdrawal by Subject|2|||
155302700|NCT03783026|560542617|FG000|Treatment Phase|Lost to Follow-up|2|||
155748108|NCT00584740|562178058|FG000|Overall Study|Lost to Follow-up|0|||
155748109|NCT00584740|562178059|FG001|Overall Study|Lost to Follow-up|1|||
155748110|NCT02106923|562178060|FG000|Overall Study|Protocol Violation|0|||
155748111|NCT02106923|562178061|FG001|Overall Study|Protocol Violation|0|||
155748112|NCT02106923|562178062|FG002|Overall Study|Protocol Violation|0|||
155302701|NCT03783026|560542617|FG000|Treatment Phase|Protocol Deviation|8|||
155302702|NCT03783026|560542617|FG000|Treatment Phase|Did Not Receive Treatment|1|||
155302703|NCT03783026|560542617|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
155302704|NCT04814186|560542618|FG000|Treatment Phase|Adverse Event|1|||
155302705|NCT04814186|560542618|FG000|Treatment Phase|Death|6|||
155748113|NCT02106923|562178063|FG003|Overall Study|Protocol Violation|0|||
155748114|NCT02106923|562178064|FG004|Overall Study|Protocol Violation|0|||
155748115|NCT02106923|562178065|FG005|Overall Study|Protocol Violation|1|||
155748116|NCT03485495|562178066|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
155748117|NCT03485495|562178067|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
155748118|NCT01107379|562178071|FG000|Overall Study|Withdrawal by Subject|18|||
155748119|NCT01107379|562178071|FG000|Overall Study|Lost to Follow-up|3|||
155748120|NCT00548405|562178072|FG000|Overall Study|Adverse Event|6|||
155748121|NCT00548405|562178073|FG001|Overall Study|Adverse Event|2|||
155748122|NCT00548405|562178074|FG002|Overall Study|Adverse Event|0|||
155748123|NCT00548405|562178072|FG000|Overall Study|Lack of Efficacy|6|||
155748124|NCT00548405|562178073|FG001|Overall Study|Lack of Efficacy|0|||
155748125|NCT00548405|562178074|FG002|Overall Study|Lack of Efficacy|0|||
155748126|NCT00548405|562178072|FG000|Overall Study|Physician Decision|3|||
155748127|NCT00548405|562178073|FG001|Overall Study|Physician Decision|4|||
155748128|NCT00548405|562178074|FG002|Overall Study|Physician Decision|1|||
155748129|NCT00548405|562178072|FG000|Overall Study|Pregnancy|1|||
155748130|NCT00548405|562178073|FG001|Overall Study|Pregnancy|0|||
155748131|NCT00548405|562178074|FG002|Overall Study|Pregnancy|0|||
155748132|NCT00548405|562178072|FG000|Overall Study|Protocol Violation|1|||
155748133|NCT00548405|562178073|FG001|Overall Study|Protocol Violation|0|||
155748134|NCT00548405|562178074|FG002|Overall Study|Protocol Violation|0|||
155748135|NCT00548405|562178072|FG000|Overall Study|Withdrawal by Subject|36|||
155748136|NCT00548405|562178073|FG001|Overall Study|Withdrawal by Subject|12|||
155748137|NCT00548405|562178074|FG002|Overall Study|Withdrawal by Subject|5|||
155748138|NCT00548405|562178072|FG000|Overall Study|Lost to Follow-up|1|||
155748139|NCT00548405|562178073|FG001|Overall Study|Lost to Follow-up|1|||
155748140|NCT00548405|562178074|FG002|Overall Study|Lost to Follow-up|2|||
155748141|NCT00548405|562178072|FG000|Overall Study|Death|0|||
155748142|NCT00548405|562178073|FG001|Overall Study|Death|1|||
155748143|NCT00548405|562178074|FG002|Overall Study|Death|1|||
155748144|NCT00548405|562178072|FG000|Overall Study|Sponsor decision|1|||
155748145|NCT00548405|562178073|FG001|Overall Study|Sponsor decision|0|||
155748146|NCT00548405|562178074|FG002|Overall Study|Sponsor decision|0|||
155748147|NCT00548405|562178072|FG000|Overall Study|Randomized but not treated|1|||
155748148|NCT00548405|562178073|FG001|Overall Study|Randomized but not treated|0|||
155748149|NCT00548405|562178074|FG002|Overall Study|Randomized but not treated|0|||
155748150|NCT00924170|562178075|FG000|Overall Study|Refused further treatment|0|||
155748151|NCT00924170|562178076|FG001|Overall Study|Refused further treatment|1|||
155748152|NCT00924170|562178075|FG000|Overall Study|Physician Decision|0|||
155748153|NCT00924170|562178076|FG001|Overall Study|Physician Decision|1|||
155748154|NCT00924170|562178075|FG000|Overall Study|Progressive disease|3|||
155748155|NCT00924170|562178076|FG001|Overall Study|Progressive disease|6|||
155748156|NCT00924170|562178075|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
155748157|NCT00924170|562178076|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
155748158|NCT00924170|562178075|FG000|Overall Study|Death|1|||
155748159|NCT00924170|562178076|FG001|Overall Study|Death|0|||
155748160|NCT05318183|562178077|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
155748161|NCT05318183|562178078|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
155748162|NCT05318183|562178077|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
155748163|NCT05318183|562178078|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155748164|NCT05318183|562178077|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
155748165|NCT05318183|562178078|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
155748166|NCT05318183|562178077|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155748167|NCT05318183|562178078|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
155748168|NCT06400251|562178079|FG000|Overall Study|Never Start Protocol Therapy|1|||
155748169|NCT06400251|562178079|FG000|Overall Study|Ineligible|2|||
155748170|NCT06400251|562178079|FG000|Overall Study|Mutation Status Not Confirmed|3|||
155748171|NCT06400251|562178079|FG000|Overall Study|Disease Progression|25|||
155748172|NCT06400251|562178079|FG000|Overall Study|Adverse Event|1|||
155748173|NCT06400251|562178079|FG000|Overall Study|Complicating Disease|1|||
155748174|NCT06400251|562178079|FG000|Overall Study|Physician Decision|2|||
155748175|NCT04672252|562178080|FG000|Overall Study|Protocol Violation|1|||
155748176|NCT04672252|562178081|FG001|Overall Study|Protocol Violation|0|||
155748177|NCT00899392|562178082|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
155748178|NCT00899392|562178083|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
155748179|NCT01903252|562178084|FG000|Double-Blind Induction|Adverse Event|20|||
155748180|NCT01903252|562178085|FG001|Double-Blind Induction|Adverse Event|18|||
155748181|NCT01903252|562178086|FG002|Double-Blind Induction|Adverse Event|0|||
155302706|NCT04814186|560542618|FG000|Treatment Phase|Withdrawal by Subject|2|||
155302707|NCT04814186|560542618|FG000|Treatment Phase|Other|1|||
155302708|NCT04814186|560542618|FG000|Follow-Up Phase|Adverse Event|1|||
155748182|NCT01903252|562178087|FG003|Double-Blind Induction|Adverse Event|0|||
155302709|NCT04814186|560542618|FG000|Follow-Up Phase|Death|6|||
155748183|NCT01903252|562178088|FG004|Double-Blind Induction|Adverse Event|0|||
155748184|NCT01903252|562178089|FG005|Double-Blind Induction|Adverse Event|0|||
155748185|NCT01903252|562178084|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
155748186|NCT01903252|562178085|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
155748187|NCT01903252|562178086|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
155748188|NCT01903252|562178087|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
155748189|NCT01903252|562178088|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
155748190|NCT01903252|562178089|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
155748191|NCT01903252|562178084|FG000|Double-Blind Induction|Physician Decision|2|||
155748192|NCT01903252|562178085|FG001|Double-Blind Induction|Physician Decision|3|||
155748193|NCT01903252|562178086|FG002|Double-Blind Induction|Physician Decision|0|||
155748194|NCT01903252|562178087|FG003|Double-Blind Induction|Physician Decision|0|||
155748195|NCT01903252|562178088|FG004|Double-Blind Induction|Physician Decision|0|||
155748196|NCT01903252|562178089|FG005|Double-Blind Induction|Physician Decision|0|||
155748197|NCT01903252|562178084|FG000|Double-Blind Induction|non-compliance,|7|||
155748198|NCT01903252|562178085|FG001|Double-Blind Induction|non-compliance,|7|||
155748199|NCT01903252|562178086|FG002|Double-Blind Induction|non-compliance,|0|||
155748200|NCT01903252|562178087|FG003|Double-Blind Induction|non-compliance,|0|||
155748201|NCT01903252|562178088|FG004|Double-Blind Induction|non-compliance,|0|||
155748202|NCT01903252|562178089|FG005|Double-Blind Induction|non-compliance,|0|||
155748203|NCT01903252|562178084|FG000|Extended Induction, Open-Label|Adverse Event|0|||
155748204|NCT01903252|562178085|FG001|Extended Induction, Open-Label|Adverse Event|0|||
155748205|NCT01903252|562178086|FG002|Extended Induction, Open-Label|Adverse Event|17|||
155748206|NCT01903252|562178087|FG003|Extended Induction, Open-Label|Adverse Event|0|||
155748207|NCT01903252|562178088|FG004|Extended Induction, Open-Label|Adverse Event|0|||
155748208|NCT01903252|562178089|FG005|Extended Induction, Open-Label|Adverse Event|0|||
155748209|NCT01903252|562178084|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155748210|NCT01903252|562178085|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155748211|NCT01903252|562178086|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
155748212|NCT01903252|562178087|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155748213|NCT01903252|562178088|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155748214|NCT01903252|562178089|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155748215|NCT01903252|562178084|FG000|Extended Induction, Open-Label|Physician Decision|0|||
155748216|NCT01903252|562178085|FG001|Extended Induction, Open-Label|Physician Decision|0|||
155748217|NCT01903252|562178086|FG002|Extended Induction, Open-Label|Physician Decision|1|||
155302710|NCT04814186|560542618|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
155302711|NCT04814186|560542618|FG000|Follow-Up Phase|Other|1|||
155302712|NCT01853748|560542621|FG000|Allocation|Withdrawal by Subject|1|||
155302713|NCT01853748|560542622|FG001|Allocation|Withdrawal by Subject|13|||
155302714|NCT01853748|560542621|FG000|Allocation|not sufficient to receive intervention|0|||
155302715|NCT01853748|560542622|FG001|Allocation|not sufficient to receive intervention|1|||
155302716|NCT01853748|560542621|FG000|Follow-Up|Withdrawal by Subject|7|||
155302717|NCT01853748|560542622|FG001|Follow-Up|Withdrawal by Subject|6|||
155302718|NCT01853748|560542621|FG000|Follow-Up|Adverse Event|67|||
155302719|NCT01853748|560542622|FG001|Follow-Up|Adverse Event|7|||
155302720|NCT01853748|560542621|FG000|Follow-Up|not available for data collection|16|||
155748218|NCT01903252|562178087|FG003|Extended Induction, Open-Label|Physician Decision|0|||
155302721|NCT01853748|560542622|FG001|Follow-Up|not available for data collection|4|||
155302722|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
155748219|NCT01903252|562178088|FG004|Extended Induction, Open-Label|Physician Decision|0|||
155748220|NCT01903252|562178089|FG005|Extended Induction, Open-Label|Physician Decision|0|||
155748221|NCT01903252|562178084|FG000|Maintenance, Open-Label|Adverse Event|0|||
155302723|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
155748222|NCT01903252|562178085|FG001|Maintenance, Open-Label|Adverse Event|0|||
155748223|NCT01903252|562178086|FG002|Maintenance, Open-Label|Adverse Event|0|||
155748224|NCT01903252|562178087|FG003|Maintenance, Open-Label|Adverse Event|3|||
155748225|NCT01903252|562178088|FG004|Maintenance, Open-Label|Adverse Event|9|||
155748226|NCT01903252|562178089|FG005|Maintenance, Open-Label|Adverse Event|14|||
155748227|NCT01903252|562178084|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
155748228|NCT01903252|562178085|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
155748229|NCT01903252|562178086|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
155748230|NCT01903252|562178087|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
155748231|NCT01903252|562178088|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
155302724|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
155302725|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
155302726|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
155302727|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
155302728|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
155302729|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
155748232|NCT01903252|562178089|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
155748233|NCT01903252|562178084|FG000|Maintenance, Open-Label|Other|0|||
155748234|NCT01903252|562178085|FG001|Maintenance, Open-Label|Other|0|||
155748235|NCT01903252|562178086|FG002|Maintenance, Open-Label|Other|0|||
155748236|NCT01903252|562178087|FG003|Maintenance, Open-Label|Other|2|||
155748237|NCT01903252|562178088|FG004|Maintenance, Open-Label|Other|6|||
155748238|NCT01903252|562178089|FG005|Maintenance, Open-Label|Other|2|||
155748239|NCT01642732|562178090|FG000|Overall Study|Withdrawal by Subject|1|||
155748240|NCT04658940|562178098|FG000|Overall Study|Withdrawal by Subject|1|||
155748241|NCT03579602|562178099|FG000|Overall Study|Subject unable to receive study drug|0|||
155748242|NCT03579602|562178100|FG001|Overall Study|Subject unable to receive study drug|2|||
155748243|NCT03579602|562178099|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
155748244|NCT03579602|562178100|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
155748245|NCT03044574|562178101|FG000|Overall Study|Lost to Follow-up|37|||
155748246|NCT03044574|562178102|FG001|Overall Study|Lost to Follow-up|45|||
155748247|NCT01077375|562178105|FG000|Overall Study|Adverse Event|2|||
155748248|NCT01077375|562178106|FG001|Overall Study|Adverse Event|15|||
155748249|NCT01077375|562178105|FG000|Overall Study|Lack of Efficacy|6|||
155748250|NCT01077375|562178106|FG001|Overall Study|Lack of Efficacy|8|||
155748251|NCT01077375|562178105|FG000|Overall Study|Withdrawal by Subject|0|||
155302730|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
155748252|NCT01077375|562178106|FG001|Overall Study|Withdrawal by Subject|6|||
155748253|NCT01077375|562178105|FG000|Overall Study|Lost to Follow-up|2|||
155748254|NCT01077375|562178106|FG001|Overall Study|Lost to Follow-up|5|||
155748255|NCT01077375|562178105|FG000|Overall Study|Other Reason|0|||
155748256|NCT01077375|562178106|FG001|Overall Study|Other Reason|1|||
155748257|NCT01924429|562178109|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
155748258|NCT01924429|562178110|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
155748259|NCT02889562|562178111|FG000|Overall Study|Physician Decision|0|||
155748260|NCT02889562|562178112|FG001|Overall Study|Physician Decision|1|||
155748261|NCT02889562|562178111|FG000|Overall Study|Withdrawal by Subject|0|||
155748262|NCT02889562|562178112|FG001|Overall Study|Withdrawal by Subject|1|||
155748263|NCT00217464|562178116|FG000|Overall Study|Progression|15|||
155748264|NCT00217464|562178116|FG000|Overall Study|Other|2|||
155748265|NCT00278915|562178121|FG000|Overall Study|Disease progression|1|||
155748266|NCT05214573|562178122|FG000|Overall Study|Physician Decision|5924|||
155748267|NCT05214573|562178123|FG001|Overall Study|Physician Decision|0|||
155748268|NCT02520089|562178124|FG000|Overall Study|Lost to Follow-up|3|||
155748269|NCT02520089|562178125|FG001|Overall Study|Lost to Follow-up|4|||
155748270|NCT00884377|562179769|FG000|Overall Study|Withdrawal by Subject|1|||
155748271|NCT00884377|562179770|FG001|Overall Study|Withdrawal by Subject|0|||
155748272|NCT00884377|562179769|FG000|Overall Study|Could not confirm diagnosis|1|||
155748273|NCT00884377|562179770|FG001|Overall Study|Could not confirm diagnosis|0|||
155748274|NCT00884377|562179769|FG000|Overall Study|Physician Decision|0|||
155748275|NCT00884377|562179770|FG001|Overall Study|Physician Decision|1|||
155748276|NCT01527357|562179773|FG000|Overall Study|Death|8|||
155748277|NCT01527357|562179774|FG001|Overall Study|Death|2|||
155748278|NCT01527357|562179773|FG000|Overall Study|Lost to Follow-up|6|||
155748279|NCT01527357|562179774|FG001|Overall Study|Lost to Follow-up|4|||
155748280|NCT01527357|562179773|FG000|Overall Study|Withdrew Consent|1|||
155748281|NCT01527357|562179774|FG001|Overall Study|Withdrew Consent|1|||
155748282|NCT01527357|562179773|FG000|Overall Study|Non-compliance|0|||
155748283|NCT01527357|562179774|FG001|Overall Study|Non-compliance|1|||
155748284|NCT01527357|562179773|FG000|Overall Study|No Day 29 Visit|0|||
155748285|NCT01527357|562179774|FG001|Overall Study|No Day 29 Visit|1|||
155748286|NCT01527357|562179773|FG000|Overall Study|Did Not Receive Treatment|2|||
155748287|NCT01527357|562179774|FG001|Overall Study|Did Not Receive Treatment|0|||
155748288|NCT02919969|562179777|FG000|Overall Study|Lack of Efficacy|22|||
155748289|NCT02919969|562179777|FG000|Overall Study|Death|4|||
155748290|NCT02919969|562179777|FG000|Overall Study|Physician Decision|3|||
155748291|NCT02919969|562179777|FG000|Overall Study|Withdrawal by Subject|2|||
155748292|NCT03621475|562179778|FG000|Overall Study|No longer required restraints at initiation|0|||
155748293|NCT03621475|562179779|FG001|Overall Study|No longer required restraints at initiation|1|||
155748294|NCT02093351|562179783|FG000|Part A|Adverse Event|0|||
155748295|NCT02093351|562179784|FG001|Part A|Adverse Event|1|||
155748296|NCT02093351|562179785|FG002|Part A|Adverse Event|1|||
155748297|NCT02093351|562179786|FG003|Part A|Adverse Event|0|||
155748298|NCT02093351|562179783|FG000|Part A|Condition under investigation worsened|2|||
155748299|NCT02093351|562179784|FG001|Part A|Condition under investigation worsened|0|||
155748300|NCT02093351|562179785|FG002|Part A|Condition under investigation worsened|2|||
155748301|NCT02093351|562179786|FG003|Part A|Condition under investigation worsened|0|||
155748302|NCT02093351|562179783|FG000|Part A|Death|0|||
155748303|NCT02093351|562179784|FG001|Part A|Death|1|||
155748304|NCT02093351|562179785|FG002|Part A|Death|0|||
155748305|NCT02093351|562179786|FG003|Part A|Death|0|||
155748306|NCT02093351|562179783|FG000|Part B|Patient decision|0|||
155748307|NCT02093351|562179784|FG001|Part B|Patient decision|0|||
155748308|NCT02093351|562179785|FG002|Part B|Patient decision|0|||
155748309|NCT02093351|562179786|FG003|Part B|Patient decision|3|||
155748310|NCT02093351|562179783|FG000|Part B|Disease progression|0|||
155748311|NCT02093351|562179784|FG001|Part B|Disease progression|0|||
155748312|NCT02093351|562179785|FG002|Part B|Disease progression|0|||
155748313|NCT02093351|562179786|FG003|Part B|Disease progression|4|||
155748314|NCT02093351|562179783|FG000|Part B|Complete response|0|||
155748315|NCT02093351|562179784|FG001|Part B|Complete response|0|||
155748316|NCT02093351|562179785|FG002|Part B|Complete response|0|||
155748317|NCT02093351|562179786|FG003|Part B|Complete response|1|||
155748318|NCT02093351|562179783|FG000|Part B|Adverse event + disease progression|0|||
155748319|NCT02093351|562179784|FG001|Part B|Adverse event + disease progression|0|||
155748320|NCT02093351|562179785|FG002|Part B|Adverse event + disease progression|0|||
155748321|NCT02093351|562179786|FG003|Part B|Adverse event + disease progression|1|||
155748322|NCT02093351|562179783|FG000|Part B|Lack of therapeutic response|0|||
155748323|NCT02093351|562179784|FG001|Part B|Lack of therapeutic response|0|||
155748324|NCT02093351|562179785|FG002|Part B|Lack of therapeutic response|0|||
155748325|NCT02093351|562179786|FG003|Part B|Lack of therapeutic response|12|||
155748326|NCT02093351|562179783|FG000|Part B|Condition under investigation worsened|0|||
155748327|NCT02093351|562179784|FG001|Part B|Condition under investigation worsened|0|||
155748328|NCT02093351|562179785|FG002|Part B|Condition under investigation worsened|0|||
155748329|NCT02093351|562179786|FG003|Part B|Condition under investigation worsened|39|||
155748330|NCT02093351|562179783|FG000|Part B|Adverse Event|0|||
155748331|NCT02093351|562179784|FG001|Part B|Adverse Event|0|||
155748332|NCT02093351|562179785|FG002|Part B|Adverse Event|0|||
155748333|NCT02093351|562179786|FG003|Part B|Adverse Event|2|||
155748334|NCT02093351|562179783|FG000|Part B|Death|0|||
155748335|NCT02093351|562179784|FG001|Part B|Death|0|||
155748336|NCT02093351|562179785|FG002|Part B|Death|0|||
155748337|NCT02093351|562179786|FG003|Part B|Death|1|||
155748338|NCT03565367|562179787|FG000|Overall Study|No scan due to technical issues|4|||
155748339|NCT03565367|562179788|FG001|Overall Study|No scan due to technical issues|0|||
155748340|NCT01992159|562179789|FG000|Overall Study|Withdrawal by Subject|4|||
155748341|NCT01992159|562179790|FG001|Overall Study|Withdrawal by Subject|7|||
155748342|NCT01992159|562179791|FG002|Overall Study|Withdrawal by Subject|0|||
155748343|NCT01992159|562179792|FG003|Overall Study|Withdrawal by Subject|3|||
155748344|NCT01992159|562179789|FG000|Overall Study|Adverse Event|0|||
155748345|NCT01992159|562179790|FG001|Overall Study|Adverse Event|1|||
155748346|NCT01992159|562179791|FG002|Overall Study|Adverse Event|0|||
155748347|NCT01992159|562179792|FG003|Overall Study|Adverse Event|1|||
155748348|NCT01992159|562179789|FG000|Overall Study|Death|0|||
155748349|NCT01992159|562179790|FG001|Overall Study|Death|0|||
155411724|NCT05061719|560939249|FG000|Overall Study|Protocol Violation|8|||
155411725|NCT05061719|560939249|FG000|Overall Study|Withdrawal by Subject|41|||
155411726|NCT05061719|560939249|FG000|Overall Study|Site Closure|2|||
155411727|NCT05804877|560940801|FG000|Overall Study|Lost to Follow-up|1|||
155411728|NCT05804877|560940802|FG001|Overall Study|Lost to Follow-up|3|||
155411729|NCT05804877|560940801|FG000|Overall Study|Withdrawal by Subject|1|||
155411730|NCT05804877|560940802|FG001|Overall Study|Withdrawal by Subject|0|||
155411731|NCT05804877|560940801|FG000|Overall Study|Withdrawal by Subject|1|||
155411732|NCT05804877|560940802|FG001|Overall Study|Withdrawal by Subject|0|||
155411733|NCT01745146|560940804|FG000|Overall Study|Withdrawal by Subject|1|||
155411734|NCT01745146|560940805|FG001|Overall Study|Withdrawal by Subject|3|||
155411735|NCT01745146|560940804|FG000|Overall Study|Lost to Follow-up|2|||
155411736|NCT01745146|560940805|FG001|Overall Study|Lost to Follow-up|0|||
155411737|NCT01262365|560940806|FG000|Overall Study|Lack of Efficacy|35|||
155411738|NCT01262365|560940807|FG001|Overall Study|Lack of Efficacy|30|||
155411739|NCT01262365|560940808|FG002|Overall Study|Lack of Efficacy|47|||
155411740|NCT01262365|560940806|FG000|Overall Study|Protocol Violation|3|||
155411741|NCT01262365|560940807|FG001|Overall Study|Protocol Violation|1|||
155411742|NCT01262365|560940808|FG002|Overall Study|Protocol Violation|1|||
155411743|NCT01262365|560940806|FG000|Overall Study|Lost to Follow-up|3|||
155411744|NCT01262365|560940807|FG001|Overall Study|Lost to Follow-up|7|||
155411745|NCT01262365|560940808|FG002|Overall Study|Lost to Follow-up|6|||
155411746|NCT01262365|560940806|FG000|Overall Study|Withdrawal by Subject|17|||
155411747|NCT01262365|560940807|FG001|Overall Study|Withdrawal by Subject|22|||
155411748|NCT01262365|560940808|FG002|Overall Study|Withdrawal by Subject|22|||
155411749|NCT01262365|560940806|FG000|Overall Study|Death|1|||
155411750|NCT01262365|560940807|FG001|Overall Study|Death|2|||
155411751|NCT01262365|560940808|FG002|Overall Study|Death|1|||
155411752|NCT01262365|560940806|FG000|Overall Study|Adverse Event|26|||
155411753|NCT01262365|560940807|FG001|Overall Study|Adverse Event|16|||
155411754|NCT01262365|560940808|FG002|Overall Study|Adverse Event|11|||
155411755|NCT01262365|560940806|FG000|Overall Study|sponsor decision|1|||
155411756|NCT01262365|560940807|FG001|Overall Study|sponsor decision|1|||
155411757|NCT01262365|560940808|FG002|Overall Study|sponsor decision|0|||
155411758|NCT01262365|560940806|FG000|Overall Study|Randomization error|1|||
155411759|NCT01262365|560940807|FG001|Overall Study|Randomization error|0|||
155411760|NCT01262365|560940808|FG002|Overall Study|Randomization error|2|||
155411761|NCT01262365|560940806|FG000|Overall Study|Non-compliance|1|||
155411762|NCT01262365|560940807|FG001|Overall Study|Non-compliance|0|||
155748350|NCT01992159|562179791|FG002|Overall Study|Death|1|||
155748351|NCT01992159|562179792|FG003|Overall Study|Death|0|||
155748352|NCT00470158|562179800|FG000|Overall Study|Death|0|||
155748353|NCT00470158|562179801|FG001|Overall Study|Death|0|||
155748354|NCT00470158|562179802|FG002|Overall Study|Death|0|||
155748355|NCT00470158|562179803|FG003|Overall Study|Death|0|||
155748356|NCT00470158|562179804|FG004|Overall Study|Death|2|||
155748357|NCT00470158|562179800|FG000|Overall Study|Lost to Follow-up|7|||
155748358|NCT00470158|562179801|FG001|Overall Study|Lost to Follow-up|8|||
155748359|NCT00470158|562179802|FG002|Overall Study|Lost to Follow-up|8|||
155748360|NCT00470158|562179803|FG003|Overall Study|Lost to Follow-up|5|||
155748361|NCT00470158|562179804|FG004|Overall Study|Lost to Follow-up|4|||
155748362|NCT00470158|562179800|FG000|Overall Study|Protocol Violation|1|||
155748363|NCT00470158|562179801|FG001|Overall Study|Protocol Violation|0|||
155748364|NCT00470158|562179802|FG002|Overall Study|Protocol Violation|0|||
155748365|NCT00470158|562179803|FG003|Overall Study|Protocol Violation|0|||
155748366|NCT00470158|562179804|FG004|Overall Study|Protocol Violation|0|||
155748367|NCT00880685|562179805|FG000|Memantine 10mg|Lost to Follow-up|2|||
155748368|NCT00880685|562179805|FG000|Memantine 20mg|Withdrawal by Subject|1|||
155748369|NCT04179890|562179806|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
155748370|NCT04179890|562179807|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
155411763|NCT01262365|560940808|FG002|Overall Study|Non-compliance|2|||
155411764|NCT01262365|560940806|FG000|Overall Study|Suspected pregnancy|1|||
155411765|NCT01262365|560940807|FG001|Overall Study|Suspected pregnancy|0|||
155748371|NCT04179890|562179806|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
155748372|NCT04179890|562179807|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
155748373|NCT04179890|562179806|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
155748374|NCT04179890|562179807|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
155748375|NCT04179890|562179806|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
155748376|NCT04179890|562179807|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
155748377|NCT04179890|562179806|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
155748378|NCT04179890|562179807|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
155748379|NCT04179890|562179806|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
155748380|NCT04179890|562179807|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
155748381|NCT04179890|562179806|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
155748382|NCT04179890|562179807|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
155748383|NCT04179890|562179806|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
155748384|NCT04179890|562179807|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
155748385|NCT04179890|562179806|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
155748386|NCT04179890|562179807|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
155748387|NCT01236118|562179808|FG000|Overall Study|Adverse Event|2|||
155748388|NCT01236118|562179809|FG001|Overall Study|Adverse Event|0|||
155748389|NCT01236118|562179810|FG002|Overall Study|Adverse Event|2|||
155748390|NCT01236118|562179808|FG000|Overall Study|Physician Decision|0|||
155748391|NCT01236118|562179809|FG001|Overall Study|Physician Decision|1|||
155748392|NCT01236118|562179810|FG002|Overall Study|Physician Decision|0|||
155748393|NCT01236118|562179808|FG000|Overall Study|Withdrawal by Subject|0|||
155748394|NCT01236118|562179809|FG001|Overall Study|Withdrawal by Subject|0|||
155748395|NCT01236118|562179810|FG002|Overall Study|Withdrawal by Subject|1|||
155748396|NCT04535167|562179811|FG000|Treatment|Adverse Event|0|||
155748397|NCT04535167|562179812|FG001|Treatment|Adverse Event|0|||
155748398|NCT04535167|562179813|FG002|Treatment|Adverse Event|0|||
155748399|NCT04535167|562179814|FG003|Treatment|Adverse Event|0|||
155748400|NCT04535167|562179815|FG004|Treatment|Adverse Event|0|||
155748401|NCT04535167|562179816|FG005|Treatment|Adverse Event|0|||
155748402|NCT04535167|562179817|FG006|Treatment|Adverse Event|1|||
155748403|NCT04535167|562179811|FG000|Follow-Up|Death|0|||
155748404|NCT04535167|562179812|FG001|Follow-Up|Death|0|||
155748405|NCT04535167|562179813|FG002|Follow-Up|Death|0|||
155748406|NCT04535167|562179814|FG003|Follow-Up|Death|0|||
155748407|NCT04535167|562179815|FG004|Follow-Up|Death|0|||
155748408|NCT04535167|562179816|FG005|Follow-Up|Death|0|||
155748409|NCT04535167|562179817|FG006|Follow-Up|Death|1|||
155748410|NCT04535167|562179811|FG000|Follow-Up|Lost to Follow-up|0|||
155748411|NCT04535167|562179812|FG001|Follow-Up|Lost to Follow-up|0|||
155748412|NCT04535167|562179813|FG002|Follow-Up|Lost to Follow-up|0|||
155748413|NCT04535167|562179814|FG003|Follow-Up|Lost to Follow-up|1|||
155748414|NCT04535167|562179815|FG004|Follow-Up|Lost to Follow-up|0|||
155748415|NCT04535167|562179816|FG005|Follow-Up|Lost to Follow-up|0|||
155748416|NCT04535167|562179817|FG006|Follow-Up|Lost to Follow-up|0|||
155748417|NCT00978432|562179818|FG000|Overall Study|Withdrawal by Subject|0|||
155748418|NCT00978432|562179819|FG001|Overall Study|Withdrawal by Subject|0|||
155748419|NCT00978432|562179820|FG002|Overall Study|Withdrawal by Subject|1|||
155748420|NCT00978432|562179818|FG000|Overall Study|Lack of Efficacy|1|||
155748421|NCT00978432|562179819|FG001|Overall Study|Lack of Efficacy|1|||
155748422|NCT00978432|562179820|FG002|Overall Study|Lack of Efficacy|3|||
155748423|NCT00978432|562179818|FG000|Overall Study|Adverse Event|2|||
155748424|NCT00978432|562179819|FG001|Overall Study|Adverse Event|0|||
155748425|NCT00978432|562179820|FG002|Overall Study|Adverse Event|1|||
155748426|NCT02579928|562179821|FG000|Overall Study|Withdrawal by Subject|1|||
155748427|NCT02579928|562179822|FG001|Overall Study|Withdrawal by Subject|0|||
155748428|NCT03404960|562179826|FG000|Overall Study|Adverse Event|0|||
155748429|NCT03404960|562179827|FG001|Overall Study|Adverse Event|2|||
155748430|NCT03404960|562179826|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
155748431|NCT03404960|562179827|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
155748432|NCT03404960|562179826|FG000|Overall Study|Bowel obstruction|0|||
155748433|NCT03404960|562179827|FG001|Overall Study|Bowel obstruction|1|||
155748434|NCT03404960|562179826|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
155748435|NCT03404960|562179827|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
155748436|NCT00075270|562179830|FG000|Overall Study|Withdrawal by Subject|28|||
155748437|NCT00075270|562179831|FG001|Overall Study|Withdrawal by Subject|21|||
155748438|NCT00075270|562179830|FG000|Overall Study|Lost to Follow-up|25|||
155748439|NCT00075270|562179831|FG001|Overall Study|Lost to Follow-up|28|||
155748440|NCT00075270|562179830|FG000|Overall Study|Protocol Violation|0|||
155748441|NCT00075270|562179831|FG001|Overall Study|Protocol Violation|2|||
155748442|NCT00075270|562179830|FG000|Overall Study|Death|198|||
155748443|NCT00075270|562179831|FG001|Overall Study|Death|215|||
155748444|NCT00075270|562179830|FG000|Overall Study|Other/Unknown|9|||
155748445|NCT00075270|562179831|FG001|Overall Study|Other/Unknown|5|||
155748446|NCT00075270|562179830|FG000|Overall Study|Missing|26|||
155748447|NCT00075270|562179831|FG001|Overall Study|Missing|13|||
155748448|NCT00246571|562179832|FG000|Overall Study|Adverse Event|7|||
155748449|NCT00246571|562179833|FG001|Overall Study|Adverse Event|0|||
155748450|NCT00246571|562179832|FG000|Overall Study|Protocol Violation|0|||
155748451|NCT00246571|562179833|FG001|Overall Study|Protocol Violation|1|||
155748452|NCT00246571|562179832|FG000|Overall Study|Withdrawal by Subject|2|||
155748453|NCT00246571|562179833|FG001|Overall Study|Withdrawal by Subject|3|||
155748454|NCT00246571|562179832|FG000|Overall Study|Lack of Efficacy|84|||
155748455|NCT00246571|562179833|FG001|Overall Study|Lack of Efficacy|21|||
155748456|NCT00246571|562179832|FG000|Overall Study|Death|17|||
155748457|NCT00246571|562179833|FG001|Overall Study|Death|3|||
155748458|NCT00246571|562179832|FG000|Overall Study|Sponsor|0|||
155748459|NCT00246571|562179833|FG001|Overall Study|Sponsor|1|||
155748460|NCT00246571|562179832|FG000|Overall Study|Did not meet entrance criteria|2|||
155748461|NCT00246571|562179833|FG001|Overall Study|Did not meet entrance criteria|1|||
155748462|NCT00246571|562179832|FG000|Overall Study|Laboratory abnormalities|1|||
155748463|NCT00246571|562179833|FG001|Overall Study|Laboratory abnormalities|0|||
155748464|NCT00246571|562179832|FG000|Overall Study|Crossover participants|0|||
155748465|NCT00246571|562179833|FG001|Overall Study|Crossover participants|74|||
155748466|NCT05247398|562179837|FG000|Overall Study|Withdrawal by Subject|1|||
155748467|NCT04251156|562179838|FG000|Overall Study|Lost to Follow-up|1|||
155748468|NCT04251156|562179839|FG001|Overall Study|Lost to Follow-up|1|||
155748469|NCT04251156|562179838|FG000|Overall Study|Withdrawal by Subject|4|||
155748470|NCT04251156|562179839|FG001|Overall Study|Withdrawal by Subject|4|||
155748471|NCT02455557|562179840|FG000|Overall Study|Withdrawal by Subject|2|||
155748472|NCT04656275|562179841|FG000|Overall Study|Study terminated by sponsor|2|||
155748473|NCT04656275|562179842|FG001|Overall Study|Study terminated by sponsor|4|||
155748474|NCT05954143|562179846|FG000|Overall Study|Progressive Disease|1|||
155748475|NCT05954143|562179847|FG001|Overall Study|Progressive Disease|0|||
155748476|NCT05954143|562179846|FG000|Overall Study|Physician Decision|1|||
155748477|NCT05954143|562179847|FG001|Overall Study|Physician Decision|0|||
155748478|NCT05954143|562179846|FG000|Overall Study|Study Terminated by Sponsor|2|||
155748479|NCT05954143|562179847|FG001|Overall Study|Study Terminated by Sponsor|4|||
155748480|NCT05954143|562179846|FG000|Overall Study|Death|1|||
155748481|NCT05954143|562179847|FG001|Overall Study|Death|0|||
155748482|NCT05954143|562179846|FG000|Overall Study|Withdrawal by Subject|0|||
155748483|NCT05954143|562179847|FG001|Overall Study|Withdrawal by Subject|1|||
155748484|NCT05954143|562179846|FG000|Overall Study|Other|1|||
155748485|NCT05954143|562179847|FG001|Overall Study|Other|0|||
155748486|NCT01129024|562179850|FG000|Overall Study|Physician Decision|5|||
155748487|NCT01129024|562179850|FG000|Overall Study|Study Terminated by Sponsor|8|||
155748488|NCT01129024|562179850|FG000|Overall Study|Withdrawal by Subject|2|||
155748489|NCT01129024|562179850|FG000|Overall Study|Lack of Efficacy|3|||
155748490|NCT01129024|562179850|FG000|Overall Study|Needed a Platelet Transfusion|1|||
155748491|NCT00708201|562179858|FG000|Overall Study|Adverse Event|4|||
155748492|NCT00708201|562179859|FG001|Overall Study|Adverse Event|4|||
155748493|NCT00708201|562179858|FG000|Overall Study|Withdrawal by Subject|1|||
155748494|NCT00708201|562179859|FG001|Overall Study|Withdrawal by Subject|1|||
155748495|NCT00708201|562179858|FG000|Overall Study|Lost to Follow-up|2|||
155748496|NCT00708201|562179859|FG001|Overall Study|Lost to Follow-up|0|||
155748497|NCT00708201|562179858|FG000|Overall Study|Protocol Violation|0|||
155748498|NCT00708201|562179859|FG001|Overall Study|Protocol Violation|1|||
155748499|NCT00761748|562179860|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
155748500|NCT00761748|562179861|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
155748501|NCT00761748|562179860|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
155748502|NCT00761748|562179861|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
155748503|NCT01857310|562179862|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
155748504|NCT01857310|562179863|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
155748505|NCT02554279|562179864|FG000|Overall Study|Adverse Event|2|||
155748506|NCT02554279|562179865|FG001|Overall Study|Adverse Event|5|||
155748507|NCT02554279|562179864|FG000|Overall Study|Lost to Follow-up|3|||
155748508|NCT02554279|562179865|FG001|Overall Study|Lost to Follow-up|2|||
155748509|NCT02554279|562179864|FG000|Overall Study|Withdrawal by Subject|6|||
155748510|NCT02554279|562179865|FG001|Overall Study|Withdrawal by Subject|4|||
155411766|NCT01262365|560940808|FG002|Overall Study|Suspected pregnancy|0|||
155411767|NCT01262365|560940806|FG000|Overall Study|Patient pregnant|1|||
155748511|NCT02554279|562179864|FG000|Overall Study|Protocol Violation|2|||
155748512|NCT02554279|562179865|FG001|Overall Study|Protocol Violation|1|||
155748513|NCT02554279|562179864|FG000|Overall Study|Other reason|19|||
155748514|NCT02554279|562179865|FG001|Overall Study|Other reason|6|||
155748515|NCT00812487|562179866|FG000|Overall Study|Lost to Follow-up|2|||
155748516|NCT00812487|562179867|FG001|Overall Study|Lost to Follow-up|0|||
155748517|NCT00812487|562179866|FG000|Overall Study|Withdrawal by Subject|3|||
155748518|NCT00812487|562179867|FG001|Overall Study|Withdrawal by Subject|2|||
155748519|NCT00812487|562179866|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
155748520|NCT00812487|562179867|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
155748521|NCT00812487|562179866|FG000|Overall Study|Protocol Violation|0|||
155748522|NCT00812487|562179867|FG001|Overall Study|Protocol Violation|1|||
155748523|NCT00998764|562179868|FG000|Overall Study|Lack of Efficacy|3|||
155748524|NCT00998764|562179869|FG001|Overall Study|Lack of Efficacy|6|||
155748525|NCT00998764|562179868|FG000|Overall Study|Adverse Event|17|||
155748526|NCT00998764|562179869|FG001|Overall Study|Adverse Event|12|||
155748527|NCT00998764|562179868|FG000|Overall Study|Withdrawal by Subject|19|||
155748528|NCT00998764|562179869|FG001|Overall Study|Withdrawal by Subject|25|||
155748529|NCT00998764|562179868|FG000|Overall Study|Physician Decision|3|||
155748530|NCT00998764|562179869|FG001|Overall Study|Physician Decision|3|||
155748531|NCT00998764|562179868|FG000|Overall Study|Death|3|||
155748532|NCT00998764|562179869|FG001|Overall Study|Death|1|||
155748533|NCT00998764|562179868|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
155748534|NCT00998764|562179869|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
155748535|NCT00998764|562179868|FG000|Overall Study|Protocol Violation|0|||
155748536|NCT00998764|562179869|FG001|Overall Study|Protocol Violation|1|||
155748537|NCT00998764|562179868|FG000|Overall Study|Failed to Return|1|||
155748538|NCT00998764|562179869|FG001|Overall Study|Failed to Return|1|||
155748539|NCT00998764|562179868|FG000|Overall Study|Lost to Follow-up|1|||
155748540|NCT00998764|562179869|FG001|Overall Study|Lost to Follow-up|1|||
155748541|NCT00998764|562179868|FG000|Overall Study|Loss of Caregiver|0|||
155748542|NCT00998764|562179869|FG001|Overall Study|Loss of Caregiver|3|||
155748543|NCT00998764|562179868|FG000|Overall Study|Other|4|||
155748544|NCT00998764|562179869|FG001|Overall Study|Other|4|||
155748545|NCT00998764|562179868|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
155748546|NCT00998764|562179869|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
155748547|NCT04761627|562179872|FG000|Run-in Period|Death|1|||
155748548|NCT04761627|562179873|FG001|Run-in Period|Death|0|||
155748549|NCT04761627|562179874|FG002|Run-in Period|Death|0|||
155748550|NCT04761627|562179872|FG000|Run-in Period|Required alternative therapy|2|||
155748551|NCT04761627|562179873|FG001|Run-in Period|Required alternative therapy|0|||
155748552|NCT04761627|562179874|FG002|Run-in Period|Required alternative therapy|0|||
155748553|NCT04761627|562179872|FG000|Run-in Period|Lost to Follow-up|2|||
155748554|NCT04761627|562179873|FG001|Run-in Period|Lost to Follow-up|0|||
155748555|NCT04761627|562179874|FG002|Run-in Period|Lost to Follow-up|0|||
155748556|NCT04761627|562179872|FG000|Run-in Period|Protocol Violation|3|||
155748557|NCT04761627|562179873|FG001|Run-in Period|Protocol Violation|0|||
155748558|NCT04761627|562179874|FG002|Run-in Period|Protocol Violation|0|||
155748559|NCT04761627|562179872|FG000|Run-in Period|Abnormal liver function|1|||
155748560|NCT04761627|562179873|FG001|Run-in Period|Abnormal liver function|0|||
155748561|NCT04761627|562179874|FG002|Run-in Period|Abnormal liver function|0|||
155748562|NCT04761627|562179872|FG000|Run-in Period|Adverse Event|6|||
155302731|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
155302732|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
155302733|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
155302734|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302735|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
155302736|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
155302737|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302738|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302739|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302740|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
155302741|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
155302742|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
155302743|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302744|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302745|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302746|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302747|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
155748563|NCT04761627|562179873|FG001|Run-in Period|Adverse Event|0|||
155748564|NCT04761627|562179874|FG002|Run-in Period|Adverse Event|0|||
155748565|NCT04761627|562179872|FG000|Run-in Period|Withdrawal by Subject|7|||
155748566|NCT04761627|562179873|FG001|Run-in Period|Withdrawal by Subject|0|||
155748567|NCT04761627|562179874|FG002|Run-in Period|Withdrawal by Subject|0|||
155748568|NCT04761627|562179872|FG000|Run-in Period|Did not meet PASI 50|15|||
155748569|NCT04761627|562179873|FG001|Run-in Period|Did not meet PASI 50|0|||
155748570|NCT04761627|562179874|FG002|Run-in Period|Did not meet PASI 50|0|||
155748571|NCT04761627|562179872|FG000|Run-in Period|Study site closure|2|||
155748572|NCT04761627|562179873|FG001|Run-in Period|Study site closure|0|||
155748573|NCT04761627|562179874|FG002|Run-in Period|Study site closure|0|||
155748574|NCT04761627|562179872|FG000|Run-in Period|Pregnancy|2|||
155748575|NCT04761627|562179873|FG001|Run-in Period|Pregnancy|0|||
155748576|NCT04761627|562179874|FG002|Run-in Period|Pregnancy|0|||
155748577|NCT04761627|562179872|FG000|Post-randomization Period|Military service|0|||
155748578|NCT04761627|562179873|FG001|Post-randomization Period|Military service|1|||
155748579|NCT04761627|562179874|FG002|Post-randomization Period|Military service|0|||
155748580|NCT04761627|562179872|FG000|Post-randomization Period|Adverse Event|0|||
155748581|NCT04761627|562179873|FG001|Post-randomization Period|Adverse Event|4|||
155748582|NCT04761627|562179874|FG002|Post-randomization Period|Adverse Event|2|||
155748583|NCT04761627|562179872|FG000|Post-randomization Period|Lost to Follow-up|0|||
155748584|NCT04761627|562179873|FG001|Post-randomization Period|Lost to Follow-up|6|||
155748585|NCT04761627|562179874|FG002|Post-randomization Period|Lost to Follow-up|6|||
155748586|NCT04761627|562179872|FG000|Post-randomization Period|Withdrawal by Subject|0|||
155748587|NCT04761627|562179873|FG001|Post-randomization Period|Withdrawal by Subject|7|||
155748588|NCT04761627|562179874|FG002|Post-randomization Period|Withdrawal by Subject|6|||
155411768|NCT01262365|560940807|FG001|Overall Study|Patient pregnant|0|||
155411769|NCT01262365|560940808|FG002|Overall Study|Patient pregnant|1|||
155411770|NCT01262365|560940806|FG000|Overall Study|Toxicity related to study drug|0|||
155411771|NCT01262365|560940807|FG001|Overall Study|Toxicity related to study drug|1|||
155411772|NCT01262365|560940808|FG002|Overall Study|Toxicity related to study drug|0|||
155411773|NCT01262365|560940806|FG000|Overall Study|Cannot tolerate the protocol|0|||
155411774|NCT01262365|560940807|FG001|Overall Study|Cannot tolerate the protocol|1|||
155411775|NCT01262365|560940808|FG002|Overall Study|Cannot tolerate the protocol|0|||
155411776|NCT01262365|560940806|FG000|Overall Study|Patient unavailable|0|||
155411777|NCT01262365|560940807|FG001|Overall Study|Patient unavailable|0|||
155411778|NCT01262365|560940808|FG002|Overall Study|Patient unavailable|1|||
155411779|NCT00130832|560940812|FG000|Overall Study|Adverse Event|1|||
155411780|NCT00130832|560940813|FG001|Overall Study|Adverse Event|1|||
155411781|NCT00130832|560940812|FG000|Overall Study|Lost to Follow-up|1|||
155411782|NCT00130832|560940813|FG001|Overall Study|Lost to Follow-up|2|||
155411783|NCT00130832|560940812|FG000|Overall Study|Protocol Violation|6|||
155411784|NCT00130832|560940813|FG001|Overall Study|Protocol Violation|8|||
155411785|NCT00130832|560940812|FG000|Overall Study|Withdrawal by Subject|6|||
155411786|NCT00130832|560940813|FG001|Overall Study|Withdrawal by Subject|1|||
155411787|NCT00130832|560940812|FG000|Overall Study|Moved|2|||
155411788|NCT00130832|560940813|FG001|Overall Study|Moved|2|||
155411789|NCT00130832|560940812|FG000|Overall Study|Other|0|||
155411790|NCT00130832|560940813|FG001|Overall Study|Other|3|||
155411791|NCT00699348|560940815|FG000|Overall Study|Death|6|||
155411792|NCT00699348|560940815|FG000|Overall Study|Adverse Event|15|||
155411793|NCT00699348|560940815|FG000|Overall Study|Withdrawal by Subject|11|||
155411794|NCT00699348|560940815|FG000|Overall Study|Protocol Violation|10|||
155411795|NCT00699348|560940815|FG000|Overall Study|Lack of Efficacy|8|||
155411796|NCT00699348|560940815|FG000|Overall Study|Failure to return|1|||
155411797|NCT00699348|560940815|FG000|Overall Study|Blood transfusion|24|||
155411798|NCT00699348|560940815|FG000|Overall Study|Renal transplantation|10|||
155411799|NCT00699348|560940815|FG000|Overall Study|Other|5|||
155411800|NCT04478708|560940816|FG000|Overall Study|Lost to Follow-up|0|||
155411801|NCT04478708|560940817|FG001|Overall Study|Lost to Follow-up|0|||
155411802|NCT04478708|560940818|FG002|Overall Study|Lost to Follow-up|0|||
155411803|NCT04478708|560940819|FG003|Overall Study|Lost to Follow-up|0|||
155411804|NCT04478708|560940820|FG004|Overall Study|Lost to Follow-up|0|||
155748589|NCT04761627|562179872|FG000|Post-randomization Period|Pregnancy|0|||
155748590|NCT04761627|562179873|FG001|Post-randomization Period|Pregnancy|0|||
155748591|NCT04761627|562179874|FG002|Post-randomization Period|Pregnancy|1|||
155748592|NCT04761627|562179872|FG000|Post-randomization Period|Study site closure|0|||
155748593|NCT04761627|562179873|FG001|Post-randomization Period|Study site closure|0|||
155748594|NCT04761627|562179874|FG002|Post-randomization Period|Study site closure|1|||
155748595|NCT04761627|562179872|FG000|Post-randomization Period|Family planning|0|||
155748596|NCT04761627|562179873|FG001|Post-randomization Period|Family planning|1|||
155748597|NCT04761627|562179874|FG002|Post-randomization Period|Family planning|0|||
155748598|NCT01933789|562179875|FG000|Overall Study|Death|0|||
155748599|NCT01933789|562179876|FG001|Overall Study|Death|0|||
155748600|NCT01933789|562179877|FG002|Overall Study|Death|0|||
155748601|NCT01933789|562179878|FG003|Overall Study|Death|0|||
155748602|NCT01933789|562179879|FG004|Overall Study|Death|21|||
155748603|NCT01933789|562179880|FG005|Overall Study|Death|32|||
155748604|NCT01933789|562179881|FG006|Overall Study|Death|0|||
155748605|NCT01933789|562179882|FG007|Overall Study|Death|0|||
155748606|NCT01933789|562179883|FG008|Overall Study|Death|0|||
155748607|NCT01933789|562179875|FG000|Overall Study|Lost to Follow-up|0|||
155748608|NCT01933789|562179876|FG001|Overall Study|Lost to Follow-up|0|||
155748609|NCT01933789|562179877|FG002|Overall Study|Lost to Follow-up|0|||
155748610|NCT01933789|562179878|FG003|Overall Study|Lost to Follow-up|1|||
155748611|NCT01933789|562179879|FG004|Overall Study|Lost to Follow-up|8|||
155748612|NCT01933789|562179880|FG005|Overall Study|Lost to Follow-up|9|||
155748613|NCT01933789|562179881|FG006|Overall Study|Lost to Follow-up|1|||
155748614|NCT01933789|562179882|FG007|Overall Study|Lost to Follow-up|4|||
155748615|NCT01933789|562179883|FG008|Overall Study|Lost to Follow-up|0|||
155748616|NCT01933789|562179875|FG000|Overall Study|Withdrawal by Subject|2|||
155748617|NCT01933789|562179876|FG001|Overall Study|Withdrawal by Subject|1|||
155748618|NCT01933789|562179877|FG002|Overall Study|Withdrawal by Subject|0|||
155748619|NCT01933789|562179878|FG003|Overall Study|Withdrawal by Subject|0|||
155748620|NCT01933789|562179879|FG004|Overall Study|Withdrawal by Subject|17|||
155748621|NCT01933789|562179880|FG005|Overall Study|Withdrawal by Subject|16|||
155748622|NCT01933789|562179881|FG006|Overall Study|Withdrawal by Subject|1|||
155748623|NCT01933789|562179882|FG007|Overall Study|Withdrawal by Subject|4|||
155748624|NCT01933789|562179883|FG008|Overall Study|Withdrawal by Subject|0|||
155748625|NCT01933789|562179875|FG000|Overall Study|Became Ineligible|4|||
155748626|NCT01933789|562179876|FG001|Overall Study|Became Ineligible|0|||
155748627|NCT01933789|562179877|FG002|Overall Study|Became Ineligible|0|||
155748628|NCT01933789|562179878|FG003|Overall Study|Became Ineligible|0|||
155748629|NCT01933789|562179879|FG004|Overall Study|Became Ineligible|13|||
155748630|NCT01933789|562179880|FG005|Overall Study|Became Ineligible|10|||
155748631|NCT01933789|562179881|FG006|Overall Study|Became Ineligible|13|||
155748632|NCT01933789|562179882|FG007|Overall Study|Became Ineligible|6|||
155748633|NCT01933789|562179883|FG008|Overall Study|Became Ineligible|0|||
155748634|NCT00723203|562179888|FG000|Overall Study|Withdrawal by Subject|3|||
155748635|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
155748636|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
155748637|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
155748638|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
155748639|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
155748640|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
155748641|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
155748642|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
155748643|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
155748644|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
155748645|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
155748646|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
155748647|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
155748648|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
155748649|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
155748650|NCT00274924|562179889|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
155748651|NCT00274924|562179890|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
155748652|NCT00274924|562179891|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
155748653|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
155748654|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
155748655|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
155748656|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
155748657|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
155748658|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
155748659|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
155748660|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
155748661|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
155748662|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
155748663|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
155748664|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
155748665|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
155748666|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
155748667|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
155748668|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
155748669|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
155748670|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
155748671|NCT00274924|562179889|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
155748672|NCT00274924|562179890|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
155748673|NCT00274924|562179891|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
155748674|NCT01055496|562179892|FG000|Overall Study|Withdrawal by Subject|2|||
155748675|NCT01055496|562179893|FG001|Overall Study|Withdrawal by Subject|4|||
155748676|NCT01055496|562179892|FG000|Overall Study|Death|13|||
155748677|NCT01055496|562179893|FG001|Overall Study|Death|23|||
155748678|NCT01055496|562179892|FG000|Overall Study|Lost to Follow-up|0|||
155748679|NCT01055496|562179893|FG001|Overall Study|Lost to Follow-up|2|||
155748680|NCT01055496|562179892|FG000|Overall Study|Other - Unspecified|0|||
155748681|NCT01055496|562179893|FG001|Overall Study|Other - Unspecified|1|||
155748682|NCT02915874|562179897|FG000|Overall Study|Lost to Follow-up|5|||
155748683|NCT02915874|562179898|FG001|Overall Study|Lost to Follow-up|4|||
155748684|NCT02915874|562179897|FG000|Overall Study|Withdrawal by Subject|1|||
155748685|NCT02915874|562179898|FG001|Overall Study|Withdrawal by Subject|1|||
155748686|NCT02915874|562179897|FG000|Overall Study|Started New Anxiety Medication|0|||
155748687|NCT02915874|562179898|FG001|Overall Study|Started New Anxiety Medication|1|||
155748688|NCT02518464|562179906|FG000|Overall Study|Adverse Event|2|||
155748689|NCT00266877|562179910|FG000|Overall Study|Death|1|||
155748690|NCT00266877|562179911|FG001|Overall Study|Death|1|||
155748691|NCT00266877|562179912|FG002|Overall Study|Death|1|||
155748692|NCT00266877|562179910|FG000|Overall Study|Adverse Event|6|||
155748693|NCT00266877|562179911|FG001|Overall Study|Adverse Event|4|||
155748694|NCT00266877|562179912|FG002|Overall Study|Adverse Event|1|||
155748695|NCT00266877|562179910|FG000|Overall Study|Physician Decision|2|||
155748696|NCT00266877|562179911|FG001|Overall Study|Physician Decision|1|||
155748697|NCT00266877|562179912|FG002|Overall Study|Physician Decision|1|||
155748698|NCT00266877|562179910|FG000|Overall Study|Withdrawal by Subject|3|||
155748699|NCT00266877|562179911|FG001|Overall Study|Withdrawal by Subject|1|||
155748700|NCT00266877|562179912|FG002|Overall Study|Withdrawal by Subject|1|||
155748701|NCT00266877|562179910|FG000|Overall Study|Disease Progression|72|||
155748702|NCT00266877|562179911|FG001|Overall Study|Disease Progression|37|||
155748703|NCT00266877|562179912|FG002|Overall Study|Disease Progression|23|||
155748704|NCT00266877|562179910|FG000|Overall Study|Symptomatic Deterioration|6|||
155748705|NCT00266877|562179911|FG001|Overall Study|Symptomatic Deterioration|3|||
155748706|NCT00266877|562179912|FG002|Overall Study|Symptomatic Deterioration|1|||
155748707|NCT00266877|562179910|FG000|Overall Study|Hospitalization|1|||
155748708|NCT00266877|562179911|FG001|Overall Study|Hospitalization|0|||
155748709|NCT00266877|562179912|FG002|Overall Study|Hospitalization|0|||
155748710|NCT00266877|562179910|FG000|Overall Study|Concomitant Radiotherapy|0|||
155748711|NCT00266877|562179911|FG001|Overall Study|Concomitant Radiotherapy|1|||
155748712|NCT00266877|562179912|FG002|Overall Study|Concomitant Radiotherapy|0|||
155748713|NCT04268823|562179914|FG000|Overall Study|Adverse Event|1|||
155748714|NCT04268823|562179915|FG001|Overall Study|Adverse Event|0|||
155748715|NCT04268823|562179914|FG000|Overall Study|Participant Decision|1|||
155748716|NCT04268823|562179915|FG001|Overall Study|Participant Decision|0|||
155748717|NCT01842633|562181318|FG000|Overall Study|Screen Failure|1|||
155748718|NCT01842633|562181319|FG001|Overall Study|Screen Failure|0|||
155748719|NCT01842633|562181320|FG002|Overall Study|Screen Failure|0|||
155748720|NCT01842633|562181318|FG000|Overall Study|Adverse Event|1|||
155748721|NCT01842633|562181319|FG001|Overall Study|Adverse Event|1|||
155411805|NCT04478708|560940821|FG005|Overall Study|Lost to Follow-up|0|||
155411806|NCT04478708|560940822|FG006|Overall Study|Lost to Follow-up|0|||
155411807|NCT04478708|560940823|FG007|Overall Study|Lost to Follow-up|0|||
155748722|NCT01842633|562181320|FG002|Overall Study|Adverse Event|0|||
155748723|NCT01842633|562181318|FG000|Overall Study|Withdrawal by Subject|0|||
155748724|NCT01842633|562181319|FG001|Overall Study|Withdrawal by Subject|1|||
155748725|NCT01842633|562181320|FG002|Overall Study|Withdrawal by Subject|0|||
155748726|NCT01842633|562181318|FG000|Overall Study|Technical issues|1|||
155748727|NCT01842633|562181319|FG001|Overall Study|Technical issues|0|||
155748728|NCT01842633|562181320|FG002|Overall Study|Technical issues|0|||
155411808|NCT04478708|560940824|FG008|Overall Study|Lost to Follow-up|1|||
155411809|NCT04478708|560940825|FG009|Overall Study|Lost to Follow-up|1|||
155748729|NCT00371761|562181321|FG000|Overall Study|Adverse Event|1|||
155748730|NCT00371761|562181322|FG001|Overall Study|Adverse Event|1|||
155748731|NCT00371761|562181321|FG000|Overall Study|Withdrawal by Subject|1|||
155748732|NCT00371761|562181322|FG001|Overall Study|Withdrawal by Subject|3|||
155748733|NCT00371761|562181321|FG000|Overall Study|Investigator Judgment|2|||
155748734|NCT00371761|562181322|FG001|Overall Study|Investigator Judgment|3|||
155748735|NCT00371761|562181321|FG000|Overall Study|Study termination|4|||
155748736|NCT00371761|562181322|FG001|Overall Study|Study termination|3|||
155411810|NCT04478708|560940826|FG010|Overall Study|Lost to Follow-up|1|||
155411811|NCT04478708|560940827|FG011|Overall Study|Lost to Follow-up|2|||
155411812|NCT04478708|560940828|FG012|Overall Study|Lost to Follow-up|1|||
155411813|NCT04478708|560940829|FG013|Overall Study|Lost to Follow-up|0|||
155411814|NCT04478708|560940830|FG014|Overall Study|Lost to Follow-up|0|||
155411815|NCT04478708|560940831|FG015|Overall Study|Lost to Follow-up|0|||
155411816|NCT04478708|560940832|FG016|Overall Study|Lost to Follow-up|0|||
155411817|NCT04478708|560940816|FG000|Overall Study|Withdrawal of consent from study|0|||
155411818|NCT04478708|560940817|FG001|Overall Study|Withdrawal of consent from study|1|||
155411819|NCT04478708|560940818|FG002|Overall Study|Withdrawal of consent from study|2|||
155411820|NCT04478708|560940819|FG003|Overall Study|Withdrawal of consent from study|0|||
155411821|NCT04478708|560940820|FG004|Overall Study|Withdrawal of consent from study|1|||
155411822|NCT04478708|560940821|FG005|Overall Study|Withdrawal of consent from study|1|||
155411823|NCT04478708|560940822|FG006|Overall Study|Withdrawal of consent from study|1|||
155411824|NCT04478708|560940823|FG007|Overall Study|Withdrawal of consent from study|0|||
155411825|NCT04478708|560940824|FG008|Overall Study|Withdrawal of consent from study|0|||
155411826|NCT04478708|560940825|FG009|Overall Study|Withdrawal of consent from study|0|||
155411827|NCT04478708|560940826|FG010|Overall Study|Withdrawal of consent from study|4|||
155411828|NCT04478708|560940827|FG011|Overall Study|Withdrawal of consent from study|3|||
155411829|NCT04478708|560940828|FG012|Overall Study|Withdrawal of consent from study|0|||
155411830|NCT04478708|560940829|FG013|Overall Study|Withdrawal of consent from study|0|||
155411831|NCT04478708|560940830|FG014|Overall Study|Withdrawal of consent from study|1|||
155411832|NCT04478708|560940831|FG015|Overall Study|Withdrawal of consent from study|0|||
155411833|NCT04478708|560940832|FG016|Overall Study|Withdrawal of consent from study|4|||
155411834|NCT01869114|560940835|FG000|Overall Study|Death|19|||
155411835|NCT01869114|560940836|FG001|Overall Study|Death|18|||
155411836|NCT01869114|560940837|FG002|Overall Study|Death|8|||
155411837|NCT01869114|560940835|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
155411838|NCT01869114|560940836|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
155411839|NCT01869114|560940837|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
155411840|NCT01869114|560940835|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
155411841|NCT01869114|560940836|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
155411842|NCT01869114|560940837|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
155748737|NCT01479985|562181326|FG000|Overall Study|Tablet malfunction, no data saved|1|||
155411843|NCT01869114|560940835|FG000|Overall Study|Withdrawal by Subject|0|||
155411844|NCT01869114|560940836|FG001|Overall Study|Withdrawal by Subject|3|||
155411845|NCT01869114|560940837|FG002|Overall Study|Withdrawal by Subject|0|||
155411846|NCT01869114|560940835|FG000|Overall Study|Disease Progression|0|||
155411847|NCT01869114|560940836|FG001|Overall Study|Disease Progression|1|||
155411848|NCT01869114|560940837|FG002|Overall Study|Disease Progression|0|||
155411849|NCT00559507|560940838|FG000|Overall Study|Not treated, patient ineligible|3|||
155411850|NCT02468648|560940839|FG000|Overall Study|Death|1|||
155411851|NCT02118792|560940840|FG000|Overall Study|Withdrawal by Subject|6|||
155411852|NCT02118792|560940841|FG001|Overall Study|Withdrawal by Subject|3|||
155411853|NCT02118792|560940840|FG000|Overall Study|Lost to Follow-up|4|||
155411854|NCT02118792|560940841|FG001|Overall Study|Lost to Follow-up|4|||
155411855|NCT02118792|560940840|FG000|Overall Study|Adverse Event|5|||
155411856|NCT02118792|560940841|FG001|Overall Study|Adverse Event|4|||
155411857|NCT02118792|560940840|FG000|Overall Study|Withdrawal by parent/guardian|14|||
155411858|NCT02118792|560940841|FG001|Overall Study|Withdrawal by parent/guardian|20|||
155411859|NCT02118792|560940840|FG000|Overall Study|Other|1|||
155411860|NCT02118792|560940841|FG001|Overall Study|Other|6|||
155411861|NCT02118792|560940840|FG000|Overall Study|Randomised but not treated|1|||
155411862|NCT02118792|560940841|FG001|Overall Study|Randomised but not treated|0|||
155411863|NCT04232696|560940843|FG000|Overall Study|Implant attempted but not completed|5|||
155411864|NCT04232696|560940844|FG001|Overall Study|Implant attempted but not completed|2|||
155411865|NCT04232696|560940843|FG000|Overall Study|Not satisfied with therapy outcome|0|||
155411866|NCT04232696|560940844|FG001|Overall Study|Not satisfied with therapy outcome|8|||
155748738|NCT01479985|562181327|FG001|Overall Study|Tablet malfunction, no data saved|1|||
155748739|NCT01479985|562181326|FG000|Overall Study|No decisional conflict scale responses|0|||
155748740|NCT01479985|562181327|FG001|Overall Study|No decisional conflict scale responses|2|||
155748741|NCT01479985|562181326|FG000|Overall Study|No post-visit survey|5|||
155748742|NCT01479985|562181327|FG001|Overall Study|No post-visit survey|3|||
155748743|NCT01117792|562181328|FG000|Overall Study|Death|1|||
155748744|NCT01117792|562181328|FG000|Overall Study|Adverse Event|3|||
155748745|NCT01721577|562181329|FG000|Overall Study|Lack of Efficacy|1|||
155748746|NCT01721577|562181330|FG001|Overall Study|Lack of Efficacy|0|||
155748747|NCT01721577|562181329|FG000|Overall Study|Death|1|||
155748748|NCT01721577|562181330|FG001|Overall Study|Death|0|||
155748749|NCT01721577|562181329|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
155748750|NCT01721577|562181330|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
155411867|NCT04232696|560940843|FG000|Overall Study|Adverse Event|0|||
155411868|NCT04232696|560940844|FG001|Overall Study|Adverse Event|3|||
155411869|NCT04232696|560940843|FG000|Overall Study|Withdrawal by Subject|0|||
155411870|NCT04232696|560940844|FG001|Overall Study|Withdrawal by Subject|3|||
155411871|NCT04232696|560940843|FG000|Overall Study|Missed Visit|0|||
155411872|NCT04232696|560940844|FG001|Overall Study|Missed Visit|2|||
155411873|NCT04232696|560940843|FG000|Overall Study|Other reason|0|||
155411874|NCT04232696|560940844|FG001|Overall Study|Other reason|1|||
155411875|NCT01678144|560940845|FG000|Stage 1: MAR Classic|Adverse Event|1|||
155411876|NCT03118297|560940846|FG000|Overall Study|Lost to Follow-up|0|||
155411877|NCT03118297|560940847|FG001|Overall Study|Lost to Follow-up|2|||
155411884|NCT02754726|560940850|FG000|Overall Study|Progressive Disease by RECIST|13|||
155411885|NCT02754726|560940850|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
155411886|NCT02754726|560940850|FG000|Overall Study|Clinical Disease Progression|5|||
155411887|NCT02754726|560940850|FG000|Overall Study|Adverse Event|3|||
155411888|NCT02754726|560940850|FG000|Overall Study|Withdrawal by Subject|1|||
155411889|NCT02754726|560940850|FG000|Overall Study|Tolerability|1|||
155411890|NCT05587296|560940855|FG000|Overall Study|Adverse Event|15|||
155411891|NCT05587296|560940856|FG001|Overall Study|Adverse Event|7|||
155411892|NCT05587296|560940855|FG000|Overall Study|Lack of Efficacy|2|||
155411893|NCT05587296|560940856|FG001|Overall Study|Lack of Efficacy|0|||
155411894|NCT05587296|560940855|FG000|Overall Study|Lost to Follow-up|1|||
155411895|NCT05587296|560940856|FG001|Overall Study|Lost to Follow-up|0|||
155411896|NCT05587296|560940855|FG000|Overall Study|Withdrawal by Subject|14|||
155411897|NCT05587296|560940856|FG001|Overall Study|Withdrawal by Subject|4|||
155411898|NCT05587296|560940855|FG000|Overall Study|miscellaneous|3|||
155411899|NCT05587296|560940856|FG001|Overall Study|miscellaneous|6|||
155411900|NCT05587296|560940855|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
155411901|NCT05587296|560940856|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
155411902|NCT05617911|560940859|FG000|Overall Study|Withdrawal by Subject|1|||
155411903|NCT05617911|560940860|FG001|Overall Study|Withdrawal by Subject|0|||
155411904|NCT04868903|560940861|FG000|Overall Study|Adverse Event|0|||
155748751|NCT01721577|562181329|FG000|Overall Study|Adverse Event|0|||
155411905|NCT04868903|560940862|FG001|Overall Study|Adverse Event|0|||
155411906|NCT04868903|560940863|FG002|Overall Study|Adverse Event|0|||
155411907|NCT04868903|560940864|FG003|Overall Study|Adverse Event|1|||
155411908|NCT04868903|560940861|FG000|Overall Study|Withdrawal by Subject|29|||
155411909|NCT04868903|560940862|FG001|Overall Study|Withdrawal by Subject|44|||
155411910|NCT04868903|560940863|FG002|Overall Study|Withdrawal by Subject|17|||
155411911|NCT04868903|560940864|FG003|Overall Study|Withdrawal by Subject|12|||
155411912|NCT04868903|560940861|FG000|Overall Study|Hyperparathyroidism|3|||
155411913|NCT04868903|560940862|FG001|Overall Study|Hyperparathyroidism|5|||
155411914|NCT04868903|560940863|FG002|Overall Study|Hyperparathyroidism|2|||
155411915|NCT04868903|560940864|FG003|Overall Study|Hyperparathyroidism|3|||
155411916|NCT03092726|560940867|FG000|Overall Study|Adverse Event|3|||
155411917|NCT03092726|560940868|FG001|Overall Study|Adverse Event|10|||
155411918|NCT03092726|560940867|FG000|Overall Study|Lack of Efficacy|0|||
155411919|NCT03092726|560940868|FG001|Overall Study|Lack of Efficacy|1|||
155411920|NCT03092726|560940867|FG000|Overall Study|Lost to Follow-up|1|||
155411921|NCT03092726|560940868|FG001|Overall Study|Lost to Follow-up|0|||
155411922|NCT03092726|560940867|FG000|Overall Study|Withdrawal by Subject|5|||
155748752|NCT01721577|562181330|FG001|Overall Study|Adverse Event|2|||
155302748|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302749|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302750|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302751|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302752|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
155302753|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302754|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302755|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302756|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302757|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302758|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302759|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
155302760|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302761|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302762|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155411923|NCT03092726|560940868|FG001|Overall Study|Withdrawal by Subject|3|||
155411924|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
155411925|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
155411926|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
155411927|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
155411928|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
155411929|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
155411930|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
155411931|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
155411932|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
155411933|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
155411934|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
155411935|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
155411936|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
155411937|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
155411938|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
155411939|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
155411940|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
155411941|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
155411942|NCT04418765|560940870|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
155411943|NCT04418765|560940871|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
155411944|NCT04418765|560940872|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
155411945|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
155411946|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
155411947|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
155411948|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
155411949|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
155411950|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
155411951|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
155411952|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
155411953|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
155411954|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
155411955|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
155411956|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
155411957|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
155411958|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
155411959|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
155411960|NCT04418765|560940870|FG000|Extension Period (48 Weeks)|Other than specified|0|||
155411961|NCT04418765|560940871|FG001|Extension Period (48 Weeks)|Other than specified|5|||
155411962|NCT04418765|560940872|FG002|Extension Period (48 Weeks)|Other than specified|2|||
155411963|NCT02296242|560940873|FG000|Overall Study|Death|1|||
155411964|NCT02296242|560940874|FG001|Overall Study|Death|1|||
155411965|NCT02296242|560940875|FG002|Overall Study|Death|1|||
155411966|NCT02296242|560940876|FG003|Overall Study|Death|1|||
155411967|NCT02296242|560940877|FG004|Overall Study|Death|1|||
155411968|NCT02296242|560940873|FG000|Overall Study|Withdrawal by Subject|0|||
155411969|NCT02296242|560940874|FG001|Overall Study|Withdrawal by Subject|0|||
155411970|NCT02296242|560940875|FG002|Overall Study|Withdrawal by Subject|1|||
155411971|NCT02296242|560940876|FG003|Overall Study|Withdrawal by Subject|1|||
155411972|NCT02296242|560940877|FG004|Overall Study|Withdrawal by Subject|3|||
155411973|NCT02296242|560940873|FG000|Overall Study|Disease Progression|1|||
155411974|NCT02296242|560940874|FG001|Overall Study|Disease Progression|3|||
155411975|NCT02296242|560940875|FG002|Overall Study|Disease Progression|2|||
155411976|NCT02296242|560940876|FG003|Overall Study|Disease Progression|8|||
155411977|NCT02296242|560940877|FG004|Overall Study|Disease Progression|11|||
155411978|NCT02296242|560940873|FG000|Overall Study|Unacceptable Toxicity|0|||
155411979|NCT02296242|560940874|FG001|Overall Study|Unacceptable Toxicity|0|||
155411980|NCT02296242|560940875|FG002|Overall Study|Unacceptable Toxicity|0|||
155411981|NCT02296242|560940876|FG003|Overall Study|Unacceptable Toxicity|0|||
155411982|NCT02296242|560940877|FG004|Overall Study|Unacceptable Toxicity|1|||
155302763|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302764|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302765|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302766|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302767|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302768|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302769|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
155302770|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302771|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302772|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302773|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155411983|NCT02296242|560940873|FG000|Overall Study|Patient Condition Changed|0|||
155411984|NCT02296242|560940874|FG001|Overall Study|Patient Condition Changed|0|||
155411985|NCT02296242|560940875|FG002|Overall Study|Patient Condition Changed|2|||
155411986|NCT02296242|560940876|FG003|Overall Study|Patient Condition Changed|0|||
155411987|NCT02296242|560940877|FG004|Overall Study|Patient Condition Changed|1|||
155411988|NCT02296242|560940873|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
155411989|NCT02296242|560940874|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
155411990|NCT02296242|560940875|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
155411991|NCT02296242|560940876|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
155411992|NCT02296242|560940877|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
155411993|NCT02296242|560940873|FG000|Overall Study|Lost to Follow-up|1|||
155411994|NCT02296242|560940874|FG001|Overall Study|Lost to Follow-up|0|||
155411995|NCT02296242|560940875|FG002|Overall Study|Lost to Follow-up|0|||
155411996|NCT02296242|560940876|FG003|Overall Study|Lost to Follow-up|0|||
155411997|NCT02296242|560940877|FG004|Overall Study|Lost to Follow-up|0|||
155411998|NCT02296242|560940873|FG000|Overall Study|Need for Hydroxyurea|2|||
155411999|NCT02296242|560940874|FG001|Overall Study|Need for Hydroxyurea|0|||
155412000|NCT02296242|560940875|FG002|Overall Study|Need for Hydroxyurea|0|||
155412001|NCT02296242|560940876|FG003|Overall Study|Need for Hydroxyurea|0|||
155412002|NCT02296242|560940877|FG004|Overall Study|Need for Hydroxyurea|0|||
155412003|NCT02296242|560940873|FG000|Overall Study|Screened for Other Protocol|0|||
155412004|NCT02296242|560940874|FG001|Overall Study|Screened for Other Protocol|1|||
155412005|NCT02296242|560940875|FG002|Overall Study|Screened for Other Protocol|0|||
155412006|NCT02296242|560940876|FG003|Overall Study|Screened for Other Protocol|0|||
155412007|NCT02296242|560940877|FG004|Overall Study|Screened for Other Protocol|0|||
155412008|NCT02296242|560940873|FG000|Overall Study|Physician Decision|0|||
155412009|NCT02296242|560940874|FG001|Overall Study|Physician Decision|1|||
155412010|NCT02296242|560940875|FG002|Overall Study|Physician Decision|0|||
155412011|NCT02296242|560940876|FG003|Overall Study|Physician Decision|1|||
155412012|NCT02296242|560940877|FG004|Overall Study|Physician Decision|0|||
155412013|NCT02296242|560940873|FG000|Overall Study|Alternative Treatment|0|||
155412014|NCT02296242|560940874|FG001|Overall Study|Alternative Treatment|0|||
155412015|NCT02296242|560940875|FG002|Overall Study|Alternative Treatment|0|||
155412016|NCT02296242|560940876|FG003|Overall Study|Alternative Treatment|1|||
155412017|NCT02296242|560940877|FG004|Overall Study|Alternative Treatment|0|||
155412018|NCT02296242|560940873|FG000|Overall Study|Adverse Event|0|||
155412019|NCT02296242|560940874|FG001|Overall Study|Adverse Event|0|||
155412020|NCT02296242|560940875|FG002|Overall Study|Adverse Event|0|||
155412021|NCT02296242|560940876|FG003|Overall Study|Adverse Event|1|||
155412022|NCT02296242|560940877|FG004|Overall Study|Adverse Event|0|||
155412023|NCT02296242|560940873|FG000|Overall Study|Lack of Efficacy|0|||
155412024|NCT02296242|560940874|FG001|Overall Study|Lack of Efficacy|0|||
155412025|NCT02296242|560940875|FG002|Overall Study|Lack of Efficacy|0|||
155412026|NCT02296242|560940876|FG003|Overall Study|Lack of Efficacy|0|||
155412027|NCT02296242|560940877|FG004|Overall Study|Lack of Efficacy|3|||
155412028|NCT02217566|560940878|FG000|Overall Study|Lost to Follow-up|2|||
155412029|NCT02217566|560940878|FG000|Overall Study|Death|3|||
155412030|NCT02217566|560940878|FG000|Overall Study|Early study termination|6|||
155412031|NCT03504397|560940879|FG000|Overall Study|Progressive Disease|151|||
155412032|NCT03504397|560940880|FG001|Overall Study|Progressive Disease|199|||
155412033|NCT03504397|560940879|FG000|Overall Study|Withdrawal by Subject|29|||
155412034|NCT03504397|560940880|FG001|Overall Study|Withdrawal by Subject|17|||
155412035|NCT03504397|560940879|FG000|Overall Study|Lost to Follow-up|1|||
155412036|NCT03504397|560940880|FG001|Overall Study|Lost to Follow-up|0|||
155412037|NCT03504397|560940879|FG000|Overall Study|Death|14|||
155412038|NCT03504397|560940880|FG001|Overall Study|Death|16|||
155412039|NCT03504397|560940879|FG000|Overall Study|Adverse Event|40|||
155412040|NCT03504397|560940880|FG001|Overall Study|Adverse Event|14|||
155412041|NCT03504397|560940879|FG000|Overall Study|miscellaneous|17|||
155412042|NCT03504397|560940880|FG001|Overall Study|miscellaneous|15|||
155412043|NCT03504397|560940879|FG000|Overall Study|Protocol deviation|1|||
155412044|NCT03504397|560940880|FG001|Overall Study|Protocol deviation|0|||
155412045|NCT03504397|560940879|FG000|Overall Study|Participants who did not take the study drug|4|||
155412046|NCT03504397|560940880|FG001|Overall Study|Participants who did not take the study drug|4|||
155412047|NCT02064387|560940881|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412048|NCT02064387|560940882|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412049|NCT02064387|560940883|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412050|NCT02064387|560940884|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412051|NCT02064387|560940885|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412052|NCT02064387|560940886|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412053|NCT02064387|560940887|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412054|NCT02064387|560940888|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
155412055|NCT02064387|560940889|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412056|NCT02064387|560940890|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
155412057|NCT02064387|560940891|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155748753|NCT01673282|562181331|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
155748754|NCT01673282|562181332|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
155748755|NCT01673282|562181331|FG000|Overall Study|Lack of Efficacy|9|||
155748756|NCT01673282|562181332|FG001|Overall Study|Lack of Efficacy|2|||
155412058|NCT02064387|560940892|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
155412059|NCT02064387|560940881|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412060|NCT02064387|560940882|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412061|NCT02064387|560940883|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412062|NCT02064387|560940884|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412063|NCT02064387|560940885|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412064|NCT02064387|560940886|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412065|NCT02064387|560940887|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412066|NCT02064387|560940888|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
155412067|NCT02064387|560940889|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412068|NCT02064387|560940890|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412069|NCT02064387|560940891|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412070|NCT02064387|560940892|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
155412071|NCT02064387|560940881|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412072|NCT02064387|560940882|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412073|NCT02064387|560940883|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412074|NCT02064387|560940884|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412075|NCT02064387|560940885|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412076|NCT02064387|560940886|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412077|NCT02064387|560940887|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155748757|NCT01673282|562181331|FG000|Overall Study|Lost to Follow-up|11|||
155748758|NCT01673282|562181332|FG001|Overall Study|Lost to Follow-up|10|||
155748759|NCT01673282|562181331|FG000|Overall Study|Withdrawal by Subject|3|||
155748760|NCT01673282|562181332|FG001|Overall Study|Withdrawal by Subject|3|||
155748761|NCT01673282|562181331|FG000|Overall Study|Other|1|||
155748762|NCT01673282|562181332|FG001|Overall Study|Other|6|||
155748763|NCT00732940|562181341|FG000|Overall Study|Withdrawal by Subject|1|||
155748764|NCT00732940|562181342|FG001|Overall Study|Withdrawal by Subject|2|||
155748765|NCT00732940|562181341|FG000|Overall Study|Adverse Event|0|||
155748766|NCT00732940|562181342|FG001|Overall Study|Adverse Event|1|||
155748767|NCT00732940|562181341|FG000|Overall Study|Lost to Follow-up|1|||
155748768|NCT00732940|562181342|FG001|Overall Study|Lost to Follow-up|0|||
155748769|NCT03562767|562181343|FG000|Overall Study|Physician Decision|2|||
155748770|NCT03562767|562181344|FG001|Overall Study|Physician Decision|0|||
155748771|NCT03562767|562181345|FG002|Overall Study|Physician Decision|0|||
155748772|NCT03562767|562181343|FG000|Overall Study|Logistic Reason|1|||
155748773|NCT03562767|562181344|FG001|Overall Study|Logistic Reason|3|||
155748774|NCT03562767|562181345|FG002|Overall Study|Logistic Reason|0|||
155748775|NCT01589770|562181346|FG000|Overall Study|EGFR <60ml/min|6|||
155748776|NCT01589770|562181347|FG001|Overall Study|EGFR <60ml/min|4|||
155748777|NCT01589770|562181346|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
155748778|NCT01589770|562181347|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
155748779|NCT00938886|562181350|FG000|Overall Study|Death|0|||
155748780|NCT00938886|562181351|FG001|Overall Study|Death|1|||
155748781|NCT00938886|562181350|FG000|Overall Study|Withdrawal by Subject|4|||
155748782|NCT00938886|562181351|FG001|Overall Study|Withdrawal by Subject|7|||
155748783|NCT00938886|562181350|FG000|Overall Study|Lost to Follow-up|3|||
155748784|NCT00938886|562181351|FG001|Overall Study|Lost to Follow-up|2|||
155748785|NCT01120067|562181352|FG000|Overall Study|Lost to Follow-up|3|||
155748786|NCT01120067|562181353|FG001|Overall Study|Lost to Follow-up|1|||
155412078|NCT02064387|560940888|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412079|NCT02064387|560940889|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
155412080|NCT02064387|560940890|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412081|NCT02064387|560940891|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412082|NCT02064387|560940892|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
155412083|NCT02064387|560940881|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
155412084|NCT02064387|560940882|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
155412085|NCT02064387|560940883|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
155412086|NCT02064387|560940884|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
155412087|NCT02064387|560940885|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
155412088|NCT02064387|560940886|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
155412089|NCT02064387|560940887|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
155412090|NCT02064387|560940888|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
155412091|NCT02064387|560940889|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
155412092|NCT02064387|560940890|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
155412093|NCT02064387|560940891|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
155412094|NCT02064387|560940892|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
155412095|NCT02064387|560940881|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412096|NCT02064387|560940882|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412097|NCT02064387|560940883|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412098|NCT02064387|560940884|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412099|NCT02064387|560940885|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412100|NCT02064387|560940886|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412101|NCT02064387|560940887|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412102|NCT02064387|560940888|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412103|NCT02064387|560940889|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155748787|NCT01120067|562181352|FG000|Overall Study|fail to engage >3 sessions|2|||
155748788|NCT01120067|562181353|FG001|Overall Study|fail to engage >3 sessions|0|||
155748789|NCT03761797|562181354|FG000|Overall Study|Changing hospital|11|||
155748790|NCT03761797|562181354|FG000|Overall Study|Improvement/remission|6|||
155412104|NCT02064387|560940890|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412105|NCT02064387|560940891|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
155412106|NCT02064387|560940892|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
155412107|NCT02436876|560940894|FG000|Overall Study|Lost to Follow-up|0|||
155412108|NCT02436876|560940895|FG001|Overall Study|Lost to Follow-up|1|||
155412109|NCT02436876|560940896|FG002|Overall Study|Lost to Follow-up|1|||
155412110|NCT02436876|560940897|FG003|Overall Study|Lost to Follow-up|1|||
155412111|NCT02436876|560940894|FG000|Overall Study|Withdrawal by Subject|1|||
155412112|NCT02436876|560940895|FG001|Overall Study|Withdrawal by Subject|0|||
155412113|NCT02436876|560940896|FG002|Overall Study|Withdrawal by Subject|0|||
155412114|NCT02436876|560940897|FG003|Overall Study|Withdrawal by Subject|1|||
155412115|NCT02436876|560940894|FG000|Overall Study|Physician Decision|0|||
155412116|NCT02436876|560940895|FG001|Overall Study|Physician Decision|2|||
155412117|NCT02436876|560940896|FG002|Overall Study|Physician Decision|1|||
155412118|NCT02436876|560940897|FG003|Overall Study|Physician Decision|0|||
155412119|NCT02436876|560940894|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
155748791|NCT03761797|562181354|FG000|Overall Study|Withdrawal by Subject|19|||
155748792|NCT03761797|562181354|FG000|Overall Study|Lost to Follow-up|33|||
155748793|NCT03761797|562181354|FG000|Overall Study|Adverse Event|37|||
155748794|NCT03761797|562181354|FG000|Overall Study|Case report form (CRF) not collected|5|||
155748795|NCT03761797|562181354|FG000|Overall Study|No patient visit after entry|13|||
155748796|NCT03761797|562181354|FG000|Overall Study|Switch to other diabetes medication|10|||
155748797|NCT03761797|562181354|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
155748798|NCT03761797|562181354|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
155748799|NCT03761797|562181354|FG000|Overall Study|Insufficient effectives|2|||
155748800|NCT03761797|562181354|FG000|Overall Study|Excessive alcohol intake|1|||
155748801|NCT01150474|562181357|FG000|Overall Study|Withdrawal by Subject|5|||
155748802|NCT01150474|562181358|FG001|Overall Study|Withdrawal by Subject|2|||
155748803|NCT01150474|562181357|FG000|Overall Study|Cancer found|1|||
155748804|NCT01150474|562181358|FG001|Overall Study|Cancer found|0|||
155748805|NCT01150474|562181357|FG000|Overall Study|Multiple Studies|0|||
155748806|NCT01150474|562181358|FG001|Overall Study|Multiple Studies|1|||
155412120|NCT02436876|560940895|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
155412121|NCT02436876|560940896|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
155412122|NCT02436876|560940897|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
155412123|NCT01276236|560940900|FG000|Overall Study|Lack of Efficacy|2|||
155412124|NCT01276236|560940900|FG000|Overall Study|Withdrawal by Subject|4|||
155748807|NCT01150474|562181357|FG000|Overall Study|Rectotomy|1|||
155748808|NCT01150474|562181358|FG001|Overall Study|Rectotomy|0|||
155748809|NCT01150474|562181357|FG000|Overall Study|Drug did not arrive in time|1|||
155412125|NCT03215771|560940901|FG000|Overall Study|Withdrawal by Subject|2|||
155412126|NCT03215771|560940901|FG000|Overall Study|Physician Decision|1|||
155412127|NCT00343889|560940913|FG000|Overall Study|Lost to Follow-up|2|||
155412128|NCT00343889|560940914|FG001|Overall Study|Lost to Follow-up|0|||
155412129|NCT00343889|560940913|FG000|Overall Study|Withdrawal by Subject|0|||
155412130|NCT00343889|560940914|FG001|Overall Study|Withdrawal by Subject|1|||
155412131|NCT00343889|560940913|FG000|Overall Study|Protocol Violation|1|||
155412132|NCT00343889|560940914|FG001|Overall Study|Protocol Violation|0|||
155412133|NCT01294579|560940919|FG000|Overall Study|Disease progression|12|||
155412134|NCT01294579|560940919|FG000|Overall Study|Adverse Event|11|||
155412135|NCT01294579|560940919|FG000|Overall Study|Study closed/terminated|3|||
155412136|NCT01294579|560940919|FG000|Overall Study|Lost to Follow-up|1|||
155412137|NCT01294579|560940919|FG000|Overall Study|Physician Decision|3|||
155412138|NCT01294579|560940919|FG000|Overall Study|Withdrawal by Subject|5|||
155412139|NCT00137111|560940920|FG000|Total Therapy|Death|35|||
155412140|NCT00137111|560940921|FG001|Total Therapy|Death|0|||
155412141|NCT00137111|560940922|FG002|Total Therapy|Death|0|||
155412142|NCT00137111|560940923|FG003|Total Therapy|Death|0|||
155412143|NCT00137111|560940920|FG000|Total Therapy|Non Compliance|5|||
155412144|NCT00137111|560940921|FG001|Total Therapy|Non Compliance|0|||
155412145|NCT00137111|560940922|FG002|Total Therapy|Non Compliance|0|||
155412146|NCT00137111|560940923|FG003|Total Therapy|Non Compliance|0|||
155412147|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
155412148|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
155412149|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
155412150|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
155412151|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
155412152|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
155412153|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
155412154|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
155412155|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
155412156|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
155412157|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
155412158|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
155412159|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
155412160|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
155412161|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
155412162|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
155412163|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
155412164|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
155412165|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
155412166|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
155412167|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
155412168|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
155412169|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
155412170|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
155412171|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
155412172|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
155412173|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
155412174|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
155412175|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
155412176|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
155412177|NCT00784654|560940924|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
155412178|NCT00784654|560940925|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
155412179|NCT00784654|560940926|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
155412180|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
155412181|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
155412182|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
155412183|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
155412184|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
155412185|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
155412186|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155412187|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
155412188|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
155412189|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
155412190|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
155412191|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
155412192|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Adverse Event|0|||
155412193|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Adverse Event|1|||
155412194|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Adverse Event|1|||
155412195|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
155412196|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
155412197|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
155412198|NCT00784654|560940924|FG000|Randomized Withdrawal Period|Family reasons|0|||
155412199|NCT00784654|560940925|FG001|Randomized Withdrawal Period|Family reasons|0|||
155412200|NCT00784654|560940926|FG002|Randomized Withdrawal Period|Family reasons|1|||
155412201|NCT00844753|560940927|FG000|Overall Study|Lack of Efficacy|1|||
155412202|NCT00844753|560940928|FG001|Overall Study|Lack of Efficacy|0|||
155412203|NCT00844753|560940929|FG002|Overall Study|Lack of Efficacy|2|||
155412204|NCT00844753|560940930|FG003|Overall Study|Lack of Efficacy|2|||
155412205|NCT00844753|560940927|FG000|Overall Study|Adverse Event|3|||
155412206|NCT00844753|560940928|FG001|Overall Study|Adverse Event|2|||
155412207|NCT00844753|560940929|FG002|Overall Study|Adverse Event|5|||
155412208|NCT00844753|560940930|FG003|Overall Study|Adverse Event|5|||
155412209|NCT00844753|560940927|FG000|Overall Study|Lost to Follow-up|1|||
155412210|NCT00844753|560940928|FG001|Overall Study|Lost to Follow-up|1|||
155412211|NCT00844753|560940929|FG002|Overall Study|Lost to Follow-up|0|||
155412212|NCT00844753|560940930|FG003|Overall Study|Lost to Follow-up|1|||
155412213|NCT00844753|560940927|FG000|Overall Study|could not swallow medication|2|||
155412214|NCT00844753|560940928|FG001|Overall Study|could not swallow medication|0|||
155412215|NCT00844753|560940929|FG002|Overall Study|could not swallow medication|0|||
155412216|NCT00844753|560940930|FG003|Overall Study|could not swallow medication|0|||
155412217|NCT00844753|560940927|FG000|Overall Study|Withdrawal by Subject|1|||
155412218|NCT00844753|560940928|FG001|Overall Study|Withdrawal by Subject|0|||
155412219|NCT00844753|560940929|FG002|Overall Study|Withdrawal by Subject|0|||
155412220|NCT00844753|560940930|FG003|Overall Study|Withdrawal by Subject|3|||
155412221|NCT00903175|560940931|FG000|Period 1 - First Line|Adverse Event|36|||
155412222|NCT00903175|560940932|FG001|Period 1 - First Line|Adverse Event|50|||
155412223|NCT00903175|560940931|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
155412224|NCT00903175|560940932|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
155412225|NCT00903175|560940931|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
155412226|NCT00903175|560940932|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
155412227|NCT00903175|560940931|FG000|Period 1 - First Line|Protocol Violation|3|||
155412228|NCT00903175|560940932|FG001|Period 1 - First Line|Protocol Violation|3|||
155748810|NCT01150474|562181358|FG001|Overall Study|Drug did not arrive in time|0|||
155748811|NCT01150474|562181357|FG000|Overall Study|Drug not administered|1|||
155412229|NCT00903175|560940931|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
155412230|NCT00903175|560940932|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
155412231|NCT00903175|560940931|FG000|Period 1 - First Line|Administrative problems|12|||
155412232|NCT00903175|560940932|FG001|Period 1 - First Line|Administrative problems|13|||
155412233|NCT00903175|560940931|FG000|Period 1 - First Line|Death|17|||
155412234|NCT00903175|560940932|FG001|Period 1 - First Line|Death|10|||
155412235|NCT00903175|560940931|FG000|Period 2 - Second Line|Missing|1|||
155412236|NCT00903175|560940932|FG001|Period 2 - Second Line|Missing|0|||
155412237|NCT00903175|560940931|FG000|Period 2 - Second Line|Adverse Event|16|||
155412238|NCT00903175|560940932|FG001|Period 2 - Second Line|Adverse Event|20|||
155748812|NCT01150474|562181358|FG001|Overall Study|Drug not administered|0|||
155748813|NCT01150474|562181357|FG000|Overall Study|Surgery Changed|1|||
155748814|NCT01150474|562181358|FG001|Overall Study|Surgery Changed|0|||
155748815|NCT03021564|562181359|FG000|Overall Study|Death|84|||
155302774|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
155302775|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
155748816|NCT03021564|562181360|FG001|Overall Study|Death|466|||
155748817|NCT03021564|562181359|FG000|Overall Study|Lost to Follow-up|0|||
155748818|NCT03021564|562181360|FG001|Overall Study|Lost to Follow-up|2|||
155748819|NCT00969280|562181361|FG000|Overall Study|Protocol Violation|2|||
155748820|NCT00969280|562181362|FG001|Overall Study|Protocol Violation|1|||
155748821|NCT00969280|562181361|FG000|Overall Study|Withdrawal by Subject|0|||
155748822|NCT00969280|562181362|FG001|Overall Study|Withdrawal by Subject|1|||
155748823|NCT00969280|562181361|FG000|Overall Study|infection of influenza A(H1N1)|0|||
155748824|NCT00969280|562181362|FG001|Overall Study|infection of influenza A(H1N1)|1|||
155748825|NCT00821327|562181363|FG000|Overall Study|Adverse Event|13|||
155302776|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302777|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302778|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302779|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302780|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
155748826|NCT00821327|562181363|FG000|Overall Study|Patient Request|1|||
155412239|NCT00903175|560940931|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
155412240|NCT00903175|560940932|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
155412241|NCT00903175|560940931|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
155412242|NCT00903175|560940932|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
155302781|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302782|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302783|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302784|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302785|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302786|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
155302787|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
155748827|NCT00821327|562181363|FG000|Overall Study|Investigator Request|2|||
155748828|NCT00821327|562181363|FG000|Overall Study|Sponsor Request|1|||
155748829|NCT00821327|562181363|FG000|Overall Study|Disease Progression|13|||
155748830|NCT00821327|562181363|FG000|Overall Study|Other/Unknown|5|||
155748831|NCT00459979|562181364|FG000|Overall Study|Withdrawal by Subject|1|||
155412243|NCT00903175|560940931|FG000|Period 2 - Second Line|Administrative problems|19|||
155412244|NCT00903175|560940932|FG001|Period 2 - Second Line|Administrative problems|9|||
155412245|NCT00903175|560940931|FG000|Period 2 - Second Line|Death|5|||
155412246|NCT00903175|560940932|FG001|Period 2 - Second Line|Death|2|||
155412247|NCT03074474|560940933|FG000|Overall Study|Lost to Follow-up|10|||
155412248|NCT03074474|560940933|FG000|Overall Study|Withdrawal by Subject|10|||
155412249|NCT03074474|560940933|FG000|Overall Study|Death|4|||
155412250|NCT03074474|560940933|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
155412251|NCT05073458|560940938|FG000|24-week Double-blind Period|Adverse Event|1|||
155412252|NCT05073458|560940939|FG001|24-week Double-blind Period|Adverse Event|0|||
155412253|NCT05073458|560940938|FG000|24-week Double-blind Period|Physician Decision|1|||
155412254|NCT05073458|560940939|FG001|24-week Double-blind Period|Physician Decision|0|||
155412255|NCT05073458|560940938|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
155412256|NCT05073458|560940939|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
155412257|NCT05073458|560940938|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
155412258|NCT05073458|560940939|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
155412259|NCT05073458|560940938|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
155412260|NCT05073458|560940939|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
155412261|NCT05073458|560940938|FG000|24-week Open-label Period|Adverse Event|1|||
155412262|NCT05073458|560940939|FG001|24-week Open-label Period|Adverse Event|2|||
155412263|NCT01627899|560940948|FG000|Overall Study|Study terminated early by sponsor.|5|||
155412264|NCT04818593|560940950|FG000|Overall Study|Low Oocyte Yield|8|||
155412265|NCT04818593|560940951|FG001|Overall Study|Low Oocyte Yield|8|||
155412266|NCT04818593|560940950|FG000|Overall Study|Not ICSI Insemination|7|||
155412267|NCT04818593|560940951|FG001|Overall Study|Not ICSI Insemination|7|||
155412268|NCT04818593|560940950|FG000|Overall Study|Poor Sperm Quality|2|||
155412269|NCT04818593|560940951|FG001|Overall Study|Poor Sperm Quality|2|||
155412270|NCT04818593|560940950|FG000|Overall Study|Withdrawal by Subject|2|||
155412271|NCT04818593|560940951|FG001|Overall Study|Withdrawal by Subject|2|||
155412272|NCT04818593|560940950|FG000|Overall Study|Conversion to IUI due to low response|1|||
155412273|NCT04818593|560940951|FG001|Overall Study|Conversion to IUI due to low response|1|||
155412274|NCT03809611|560940952|FG000|Overall Study|Withdrawal by Subject|1|||
155412275|NCT03809611|560940953|FG001|Overall Study|Withdrawal by Subject|1|||
155412276|NCT04179175|560942486|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
155412277|NCT04179175|560942487|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
155412278|NCT04179175|560942488|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
155412279|NCT04179175|560942489|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
155412280|NCT04179175|560942490|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
155412281|NCT04179175|560942491|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
155412282|NCT04179175|560942486|FG000|Overall Study|Adverse Event|5|||
155412283|NCT04179175|560942487|FG001|Overall Study|Adverse Event|3|||
155412284|NCT04179175|560942488|FG002|Overall Study|Adverse Event|3|||
155412285|NCT04179175|560942489|FG003|Overall Study|Adverse Event|4|||
155412286|NCT04179175|560942490|FG004|Overall Study|Adverse Event|6|||
155412287|NCT04179175|560942491|FG005|Overall Study|Adverse Event|6|||
155412288|NCT04179175|560942486|FG000|Overall Study|Lack of Efficacy|5|||
155412289|NCT04179175|560942487|FG001|Overall Study|Lack of Efficacy|1|||
155748832|NCT00459979|562181364|FG000|Overall Study|Protocol Violation|1|||
155748833|NCT00989573|562181365|FG000|Overall Study|Adverse Event|8|||
155748834|NCT00989573|562181366|FG001|Overall Study|Adverse Event|12|||
155302790|NCT05505045|560542634|FG000|Overall Study|Withdrawal by Subject|2|||
155302791|NCT05505045|560542635|FG001|Overall Study|Withdrawal by Subject|1|||
155302792|NCT01643070|560542636|FG000|Overall Study|Withdrawal by Subject|3|||
155748835|NCT00989573|562181367|FG002|Overall Study|Adverse Event|4|||
155748836|NCT00989573|562181365|FG000|Overall Study|Physician Decision|0|||
155748837|NCT00989573|562181366|FG001|Overall Study|Physician Decision|2|||
155748838|NCT00989573|562181367|FG002|Overall Study|Physician Decision|0|||
155748839|NCT00989573|562181365|FG000|Overall Study|Protocol Violation|1|||
155748840|NCT00989573|562181366|FG001|Overall Study|Protocol Violation|1|||
155748841|NCT00989573|562181367|FG002|Overall Study|Protocol Violation|1|||
155748842|NCT00989573|562181365|FG000|Overall Study|Withdrawal by Subject|4|||
155412290|NCT04179175|560942488|FG002|Overall Study|Lack of Efficacy|3|||
155412291|NCT04179175|560942489|FG003|Overall Study|Lack of Efficacy|2|||
155412292|NCT04179175|560942490|FG004|Overall Study|Lack of Efficacy|18|||
155412293|NCT04179175|560942491|FG005|Overall Study|Lack of Efficacy|7|||
155412294|NCT04179175|560942486|FG000|Overall Study|Lost to Follow-up|5|||
155412295|NCT04179175|560942487|FG001|Overall Study|Lost to Follow-up|3|||
155412296|NCT04179175|560942488|FG002|Overall Study|Lost to Follow-up|2|||
155412297|NCT04179175|560942489|FG003|Overall Study|Lost to Follow-up|2|||
155412298|NCT04179175|560942490|FG004|Overall Study|Lost to Follow-up|4|||
155412299|NCT04179175|560942491|FG005|Overall Study|Lost to Follow-up|5|||
155412300|NCT04179175|560942486|FG000|Overall Study|Physician Decision|2|||
155412301|NCT04179175|560942487|FG001|Overall Study|Physician Decision|0|||
155412302|NCT04179175|560942488|FG002|Overall Study|Physician Decision|2|||
155412303|NCT04179175|560942489|FG003|Overall Study|Physician Decision|3|||
155412304|NCT04179175|560942490|FG004|Overall Study|Physician Decision|1|||
155412305|NCT04179175|560942491|FG005|Overall Study|Physician Decision|1|||
155412306|NCT04179175|560942486|FG000|Overall Study|Pregnancy|3|||
155412307|NCT04179175|560942487|FG001|Overall Study|Pregnancy|0|||
155412308|NCT04179175|560942488|FG002|Overall Study|Pregnancy|3|||
155412309|NCT04179175|560942489|FG003|Overall Study|Pregnancy|0|||
155412310|NCT04179175|560942490|FG004|Overall Study|Pregnancy|1|||
155412311|NCT04179175|560942491|FG005|Overall Study|Pregnancy|2|||
155412312|NCT04179175|560942486|FG000|Overall Study|Withdrawal by Subject|22|||
155412313|NCT04179175|560942487|FG001|Overall Study|Withdrawal by Subject|10|||
155412314|NCT04179175|560942488|FG002|Overall Study|Withdrawal by Subject|12|||
155412315|NCT04179175|560942489|FG003|Overall Study|Withdrawal by Subject|8|||
155412316|NCT04179175|560942490|FG004|Overall Study|Withdrawal by Subject|23|||
155412317|NCT04179175|560942491|FG005|Overall Study|Withdrawal by Subject|31|||
155412318|NCT04179175|560942486|FG000|Overall Study|Technical problems|0|||
155412319|NCT04179175|560942487|FG001|Overall Study|Technical problems|0|||
155412320|NCT04179175|560942488|FG002|Overall Study|Technical problems|1|||
155412321|NCT04179175|560942489|FG003|Overall Study|Technical problems|1|||
155412322|NCT04179175|560942490|FG004|Overall Study|Technical problems|0|||
155412323|NCT04179175|560942491|FG005|Overall Study|Technical problems|0|||
155412324|NCT03215030|560942500|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
155412325|NCT03215030|560942501|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
155412326|NCT03215030|560942502|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412327|NCT03215030|560942503|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
155412328|NCT03215030|560942504|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412329|NCT03215030|560942505|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412330|NCT03215030|560942506|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412331|NCT03215030|560942507|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412332|NCT03215030|560942508|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412333|NCT03215030|560942509|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412334|NCT03215030|560942510|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412335|NCT03215030|560942511|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
155412336|NCT03215030|560942500|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155412337|NCT03215030|560942501|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412338|NCT03215030|560942502|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412339|NCT03215030|560942503|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155412340|NCT03215030|560942504|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412341|NCT03215030|560942505|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412342|NCT03215030|560942506|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412343|NCT03215030|560942507|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412344|NCT03215030|560942508|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412345|NCT03215030|560942509|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412346|NCT03215030|560942510|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412347|NCT03215030|560942511|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155412348|NCT03215030|560942500|FG000|Part 1: Dose Escalation|Death|15|||
155412349|NCT03215030|560942501|FG001|Part 1: Dose Escalation|Death|6|||
155412350|NCT03215030|560942502|FG002|Part 1: Dose Escalation|Death|6|||
155412351|NCT03215030|560942503|FG003|Part 1: Dose Escalation|Death|8|||
155412352|NCT03215030|560942504|FG004|Part 1: Dose Escalation|Death|0|||
155412353|NCT03215030|560942505|FG005|Part 1: Dose Escalation|Death|0|||
155412354|NCT03215030|560942506|FG006|Part 1: Dose Escalation|Death|0|||
155412355|NCT03215030|560942507|FG007|Part 1: Dose Escalation|Death|0|||
155496879|NCT04636437|561242411|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
155748843|NCT00989573|562181366|FG001|Overall Study|Withdrawal by Subject|7|||
155748844|NCT00989573|562181367|FG002|Overall Study|Withdrawal by Subject|3|||
155748845|NCT00814801|562181368|FG000|Overall Study|Adverse Event|15|||
155412356|NCT03215030|560942508|FG008|Part 1: Dose Escalation|Death|0|||
155412357|NCT03215030|560942509|FG009|Part 1: Dose Escalation|Death|0|||
155412358|NCT03215030|560942510|FG010|Part 1: Dose Escalation|Death|0|||
155412359|NCT03215030|560942511|FG011|Part 1: Dose Escalation|Death|0|||
155412360|NCT03215030|560942500|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
155412361|NCT03215030|560942501|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
155412362|NCT03215030|560942502|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
155412363|NCT03215030|560942503|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
155412364|NCT03215030|560942504|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
155412365|NCT03215030|560942505|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
155412366|NCT03215030|560942506|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
155412367|NCT03215030|560942507|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
155412368|NCT03215030|560942508|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
155412369|NCT03215030|560942509|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
155412370|NCT03215030|560942510|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
155412371|NCT03215030|560942511|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
155412372|NCT03215030|560942500|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412373|NCT03215030|560942501|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412374|NCT03215030|560942502|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412375|NCT03215030|560942503|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412376|NCT03215030|560942504|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412377|NCT03215030|560942505|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412378|NCT03215030|560942506|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412379|NCT03215030|560942507|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
155412380|NCT03215030|560942508|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412381|NCT03215030|560942509|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412382|NCT03215030|560942510|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412383|NCT03215030|560942511|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
155412384|NCT03215030|560942500|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412385|NCT03215030|560942501|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412386|NCT03215030|560942502|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412387|NCT03215030|560942503|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155748846|NCT00814801|562181369|FG001|Overall Study|Adverse Event|16|||
155748847|NCT00814801|562181370|FG002|Overall Study|Adverse Event|19|||
155748848|NCT00814801|562181368|FG000|Overall Study|Withdrawal by Subject|9|||
155748849|NCT00814801|562181369|FG001|Overall Study|Withdrawal by Subject|11|||
155748850|NCT00814801|562181370|FG002|Overall Study|Withdrawal by Subject|14|||
155412388|NCT03215030|560942504|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155412389|NCT03215030|560942505|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155412390|NCT03215030|560942506|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
155412391|NCT03215030|560942507|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
155412392|NCT03215030|560942508|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412393|NCT03215030|560942509|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412394|NCT03215030|560942510|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412395|NCT03215030|560942511|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155412396|NCT03215030|560942500|FG000|Part 2: Dose Expansion|Death|0|||
155412397|NCT03215030|560942501|FG001|Part 2: Dose Expansion|Death|0|||
155412398|NCT03215030|560942502|FG002|Part 2: Dose Expansion|Death|0|||
155412399|NCT03215030|560942503|FG003|Part 2: Dose Expansion|Death|0|||
155412400|NCT03215030|560942504|FG004|Part 2: Dose Expansion|Death|3|||
155412401|NCT03215030|560942505|FG005|Part 2: Dose Expansion|Death|1|||
155412402|NCT03215030|560942506|FG006|Part 2: Dose Expansion|Death|5|||
155412403|NCT03215030|560942507|FG007|Part 2: Dose Expansion|Death|4|||
155412404|NCT03215030|560942508|FG008|Part 2: Dose Expansion|Death|0|||
155412405|NCT03215030|560942509|FG009|Part 2: Dose Expansion|Death|0|||
155412406|NCT03215030|560942510|FG010|Part 2: Dose Expansion|Death|0|||
155412407|NCT03215030|560942511|FG011|Part 2: Dose Expansion|Death|0|||
155412408|NCT03215030|560942500|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
155412409|NCT03215030|560942501|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
155412410|NCT03215030|560942502|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
155412411|NCT03215030|560942503|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
155412412|NCT03215030|560942504|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
155412413|NCT03215030|560942505|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
155412414|NCT03215030|560942506|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
155412415|NCT03215030|560942507|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
155412416|NCT03215030|560942508|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
155412417|NCT03215030|560942509|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
155412418|NCT03215030|560942510|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
155412419|NCT03215030|560942511|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
155412420|NCT03215030|560942500|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
155412421|NCT03215030|560942501|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
155412422|NCT03215030|560942502|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
155412423|NCT03215030|560942503|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
155412424|NCT03215030|560942504|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
155412425|NCT03215030|560942505|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
155412426|NCT03215030|560942506|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
155412427|NCT03215030|560942507|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
155412428|NCT03215030|560942508|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
155412429|NCT03215030|560942509|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
155412430|NCT03215030|560942510|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
155412431|NCT03215030|560942511|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
155412432|NCT03215030|560942500|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412433|NCT03215030|560942501|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412434|NCT03215030|560942502|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412435|NCT03215030|560942503|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412436|NCT03215030|560942504|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412437|NCT03215030|560942505|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412438|NCT03215030|560942506|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412439|NCT03215030|560942507|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412440|NCT03215030|560942508|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
155412441|NCT03215030|560942509|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
155412442|NCT03215030|560942510|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412443|NCT03215030|560942511|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
155412444|NCT03215030|560942500|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412445|NCT03215030|560942501|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412446|NCT03215030|560942502|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412447|NCT03215030|560942503|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412448|NCT03215030|560942504|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412449|NCT03215030|560942505|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412450|NCT03215030|560942506|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412451|NCT03215030|560942507|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412452|NCT03215030|560942508|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
155748851|NCT00814801|562181368|FG000|Overall Study|Inappropriate as a subject|1|||
155748852|NCT00814801|562181369|FG001|Overall Study|Inappropriate as a subject|1|||
155412453|NCT03215030|560942509|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
155412454|NCT03215030|560942510|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
155748853|NCT00814801|562181370|FG002|Overall Study|Inappropriate as a subject|1|||
155748854|NCT00814801|562181368|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
155748855|NCT00814801|562181369|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
155748856|NCT00814801|562181370|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
155748857|NCT00814801|562181368|FG000|Overall Study|Missing or change of caregiver|6|||
155748858|NCT00814801|562181369|FG001|Overall Study|Missing or change of caregiver|2|||
155748859|NCT00814801|562181370|FG002|Overall Study|Missing or change of caregiver|4|||
155748860|NCT00814801|562181368|FG000|Overall Study|Non-compliance|0|||
155748861|NCT00814801|562181369|FG001|Overall Study|Non-compliance|1|||
155748862|NCT00814801|562181370|FG002|Overall Study|Non-compliance|1|||
155748863|NCT00814801|562181368|FG000|Overall Study|Other|2|||
155748864|NCT00814801|562181369|FG001|Overall Study|Other|6|||
155748865|NCT00814801|562181370|FG002|Overall Study|Other|4|||
155748866|NCT02486718|562181373|FG000|Enrollment Phase|Death|19|||
155748867|NCT02486718|562181374|FG001|Enrollment Phase|Death|0|||
155748868|NCT02486718|562181375|FG002|Enrollment Phase|Death|0|||
155748869|NCT02486718|562181373|FG000|Enrollment Phase|Symptomatic deterioration|1|||
155748870|NCT02486718|562181374|FG001|Enrollment Phase|Symptomatic deterioration|0|||
155748871|NCT02486718|562181375|FG002|Enrollment Phase|Symptomatic deterioration|0|||
155748872|NCT02486718|562181373|FG000|Enrollment Phase|Withdrawal by Subject|86|||
155748873|NCT02486718|562181374|FG001|Enrollment Phase|Withdrawal by Subject|0|||
155748874|NCT02486718|562181375|FG002|Enrollment Phase|Withdrawal by Subject|0|||
155748875|NCT02486718|562181373|FG000|Enrollment Phase|Protocol Violation|18|||
155748876|NCT02486718|562181374|FG001|Enrollment Phase|Protocol Violation|0|||
155748877|NCT02486718|562181375|FG002|Enrollment Phase|Protocol Violation|0|||
155748878|NCT02486718|562181373|FG000|Enrollment Phase|Physician Decision|18|||
155748879|NCT02486718|562181374|FG001|Enrollment Phase|Physician Decision|0|||
155748880|NCT02486718|562181375|FG002|Enrollment Phase|Physician Decision|0|||
155748881|NCT02486718|562181373|FG000|Enrollment Phase|Reason not provided|41|||
155748882|NCT02486718|562181374|FG001|Enrollment Phase|Reason not provided|0|||
155748883|NCT02486718|562181375|FG002|Enrollment Phase|Reason not provided|0|||
155748884|NCT02486718|562181373|FG000|Enrollment Phase|Disease relapse|54|||
155748885|NCT02486718|562181374|FG001|Enrollment Phase|Disease relapse|0|||
155748886|NCT02486718|562181375|FG002|Enrollment Phase|Disease relapse|0|||
155748887|NCT02486718|562181373|FG000|Enrollment Phase|Lost to Follow-up|4|||
155748888|NCT02486718|562181374|FG001|Enrollment Phase|Lost to Follow-up|0|||
155748889|NCT02486718|562181375|FG002|Enrollment Phase|Lost to Follow-up|0|||
155748890|NCT02486718|562181373|FG000|Enrollment Phase|Adverse Event|34|||
155748891|NCT02486718|562181374|FG001|Enrollment Phase|Adverse Event|0|||
155748892|NCT02486718|562181375|FG002|Enrollment Phase|Adverse Event|0|||
155748893|NCT02486718|562181373|FG000|Randomized Phase|Withdrawal by Subject|0|||
155748894|NCT02486718|562181374|FG001|Randomized Phase|Withdrawal by Subject|44|||
155748895|NCT02486718|562181375|FG002|Randomized Phase|Withdrawal by Subject|47|||
155748896|NCT02486718|562181373|FG000|Randomized Phase|Protocol Violation|0|||
155748897|NCT02486718|562181374|FG001|Randomized Phase|Protocol Violation|2|||
155748898|NCT02486718|562181375|FG002|Randomized Phase|Protocol Violation|0|||
155748899|NCT02486718|562181373|FG000|Randomized Phase|Physician Decision|0|||
155748900|NCT02486718|562181374|FG001|Randomized Phase|Physician Decision|0|||
155748901|NCT02486718|562181375|FG002|Randomized Phase|Physician Decision|3|||
155748902|NCT02486718|562181373|FG000|Randomized Phase|Lost to Follow-up|0|||
155748903|NCT02486718|562181374|FG001|Randomized Phase|Lost to Follow-up|5|||
155748904|NCT02486718|562181375|FG002|Randomized Phase|Lost to Follow-up|11|||
155748905|NCT02486718|562181373|FG000|Randomized Phase|Disease Relapse|0|||
155748906|NCT02486718|562181374|FG001|Randomized Phase|Disease Relapse|1|||
155748907|NCT02486718|562181375|FG002|Randomized Phase|Disease Relapse|0|||
155748908|NCT02486718|562181373|FG000|Randomized Phase|Death|0|||
155748909|NCT02486718|562181374|FG001|Randomized Phase|Death|154|||
155748910|NCT02486718|562181375|FG002|Randomized Phase|Death|155|||
155748911|NCT02486718|562181373|FG000|Randomized Phase|Ongoing|0|||
155748912|NCT02486718|562181374|FG001|Randomized Phase|Ongoing|301|||
155748913|NCT02486718|562181375|FG002|Randomized Phase|Ongoing|282|||
155748914|NCT01037088|562181378|FG000|Overall Study|Withdrawal by Subject|3|||
155748915|NCT02216812|562181381|FG000|Overall Study|Lost to Follow-up|10|||
155748916|NCT02216812|562181382|FG001|Overall Study|Lost to Follow-up|5|||
155748917|NCT00527488|562181387|FG000|Overall Study|Withdrawn prior to dosing|0|||
155748918|NCT00527488|562181388|FG001|Overall Study|Withdrawn prior to dosing|1|||
155748919|NCT00527488|562181389|FG002|Overall Study|Withdrawn prior to dosing|1|||
155748920|NCT00527488|562181390|FG003|Overall Study|Withdrawn prior to dosing|0|||
155748921|NCT01958827|562181391|FG000|Overall Study|Adverse Event|3|||
155748922|NCT01958827|562181391|FG000|Overall Study|Lack of Efficacy|6|||
155748923|NCT01958827|562181391|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
155748924|NCT03036800|562181392|FG000|Overall Study|Protocol Violation|1|||
155748925|NCT03036800|562181393|FG001|Overall Study|Protocol Violation|0|||
155748926|NCT03036800|562181392|FG000|Overall Study|Non-compliance|1|||
155748927|NCT03036800|562181393|FG001|Overall Study|Non-compliance|0|||
155748928|NCT03036800|562181392|FG000|Overall Study|Lost to Follow-up|1|||
155748929|NCT03036800|562181393|FG001|Overall Study|Lost to Follow-up|0|||
155748930|NCT03036800|562181392|FG000|Overall Study|Death|1|||
155748931|NCT03036800|562181393|FG001|Overall Study|Death|0|||
155748932|NCT03036800|562181392|FG000|Overall Study|Tolerance|5|||
155748933|NCT03036800|562181393|FG001|Overall Study|Tolerance|0|||
155748934|NCT03036800|562181392|FG000|Overall Study|Unknown/no reason given|50|||
155748935|NCT03036800|562181393|FG001|Overall Study|Unknown/no reason given|39|||
155748936|NCT01986933|562181394|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
155748937|NCT01986933|562181395|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
155748938|NCT01986933|562181396|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
155748939|NCT01986933|562181397|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
155748940|NCT01986933|562181398|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
155748941|NCT01986933|562181394|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
155748942|NCT01986933|562181395|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155748943|NCT01986933|562181396|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155748944|NCT01986933|562181397|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
155748945|NCT01986933|562181398|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155748946|NCT01986933|562181394|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
155748947|NCT01986933|562181395|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
155748948|NCT01986933|562181396|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
155748949|NCT01986933|562181397|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
155748950|NCT01986933|562181398|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
155748951|NCT01986933|562181394|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155748952|NCT01986933|562181395|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
155748953|NCT01986933|562181396|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155748954|NCT01986933|562181397|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
155748955|NCT01986933|562181398|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155748956|NCT01986933|562181394|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155748957|NCT01986933|562181395|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155748958|NCT01986933|562181396|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155748959|NCT01986933|562181397|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155748960|NCT01986933|562181398|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
155748961|NCT01986933|562181394|FG000|Active-to-active (Part B)|Adverse Event|0|||
155748962|NCT01986933|562181395|FG001|Active-to-active (Part B)|Adverse Event|2|||
155748963|NCT01986933|562181396|FG002|Active-to-active (Part B)|Adverse Event|0|||
155748964|NCT01986933|562181397|FG003|Active-to-active (Part B)|Adverse Event|1|||
155748965|NCT01986933|562181398|FG004|Active-to-active (Part B)|Adverse Event|3|||
155748966|NCT01986933|562181394|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
155748967|NCT01986933|562181395|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
155748968|NCT01986933|562181396|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
155748969|NCT01986933|562181397|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
155748970|NCT01986933|562181398|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
155748971|NCT01986933|562181394|FG000|Active-to-active (Part B)|Pregnancy|0|||
155748972|NCT01986933|562181395|FG001|Active-to-active (Part B)|Pregnancy|0|||
155748973|NCT01986933|562181396|FG002|Active-to-active (Part B)|Pregnancy|0|||
155748974|NCT01986933|562181397|FG003|Active-to-active (Part B)|Pregnancy|0|||
155748975|NCT01986933|562181398|FG004|Active-to-active (Part B)|Pregnancy|1|||
155748976|NCT01986933|562181394|FG000|Active-to-active (Part B)|Physician Decision|0|||
155748977|NCT01986933|562181395|FG001|Active-to-active (Part B)|Physician Decision|0|||
155748978|NCT01986933|562181396|FG002|Active-to-active (Part B)|Physician Decision|1|||
155748979|NCT01986933|562181397|FG003|Active-to-active (Part B)|Physician Decision|1|||
155748980|NCT01986933|562181398|FG004|Active-to-active (Part B)|Physician Decision|0|||
155748981|NCT01986933|562181394|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
155748982|NCT01986933|562181395|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
155748983|NCT01986933|562181396|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
155748984|NCT01986933|562181397|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
155748985|NCT01986933|562181398|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
155748986|NCT01986933|562181394|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
155748987|NCT01986933|562181395|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
155748988|NCT01986933|562181396|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
155748989|NCT01986933|562181397|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
155748990|NCT01986933|562181398|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
155748991|NCT01986933|562181394|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
155748992|NCT01986933|562181395|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155748993|NCT01986933|562181396|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
155748994|NCT01986933|562181397|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155748995|NCT01986933|562181398|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155748996|NCT01986933|562181394|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
155748997|NCT01986933|562181395|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
155748998|NCT01986933|562181396|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
155748999|NCT01986933|562181397|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
155749000|NCT01986933|562181398|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
155749001|NCT01986933|562181394|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155749002|NCT01986933|562181395|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155412455|NCT03215030|560942511|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
155412456|NCT03215030|560942500|FG000|Part 3: Dose Extension|Death|0|||
155412457|NCT03215030|560942501|FG001|Part 3: Dose Extension|Death|0|||
155412458|NCT03215030|560942502|FG002|Part 3: Dose Extension|Death|0|||
155412459|NCT03215030|560942503|FG003|Part 3: Dose Extension|Death|0|||
155412460|NCT03215030|560942504|FG004|Part 3: Dose Extension|Death|0|||
155412461|NCT03215030|560942505|FG005|Part 3: Dose Extension|Death|0|||
155412462|NCT03215030|560942506|FG006|Part 3: Dose Extension|Death|0|||
155412463|NCT03215030|560942507|FG007|Part 3: Dose Extension|Death|0|||
155412464|NCT03215030|560942508|FG008|Part 3: Dose Extension|Death|19|||
155412465|NCT03215030|560942509|FG009|Part 3: Dose Extension|Death|20|||
155412466|NCT03215030|560942510|FG010|Part 3: Dose Extension|Death|0|||
155412467|NCT03215030|560942511|FG011|Part 3: Dose Extension|Death|0|||
155412468|NCT03215030|560942500|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
155412469|NCT03215030|560942501|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
155412470|NCT03215030|560942502|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
155412471|NCT03215030|560942503|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
155412472|NCT03215030|560942504|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
155412473|NCT03215030|560942505|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
155412474|NCT03215030|560942506|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
155412475|NCT03215030|560942507|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
155412476|NCT03215030|560942508|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
155412477|NCT03215030|560942509|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
155412478|NCT03215030|560942510|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
155749003|NCT01986933|562181396|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155749004|NCT01986933|562181397|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
155749005|NCT01986933|562181398|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155749006|NCT01986933|562181394|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
155749007|NCT01986933|562181395|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
155749008|NCT01986933|562181396|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
155749009|NCT01986933|562181397|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
155749010|NCT01986933|562181398|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
155749011|NCT01986933|562181394|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
155749012|NCT01986933|562181395|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
155749013|NCT01986933|562181396|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
155412479|NCT03215030|560942511|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
155412480|NCT03215030|560942500|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412481|NCT03215030|560942501|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412482|NCT03215030|560942502|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412483|NCT03215030|560942503|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412484|NCT03215030|560942504|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412485|NCT03215030|560942505|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412486|NCT03215030|560942506|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412487|NCT03215030|560942507|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412488|NCT03215030|560942508|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412489|NCT03215030|560942509|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
155412490|NCT03215030|560942510|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
155412491|NCT03215030|560942511|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
155412492|NCT05416138|560942512|FG000|Overall Study|Withdrawal by Subject|2|||
155412493|NCT05416138|560942513|FG001|Overall Study|Withdrawal by Subject|1|||
155412494|NCT01284114|560942514|FG000|Overall Study|viral infection|1|||
155412495|NCT01284114|560942514|FG000|Overall Study|From the results of ALLTITUDE study|1|||
155412496|NCT01284114|560942514|FG000|Overall Study|Symptomatic hypotension|1|||
155412497|NCT01284114|560942514|FG000|Overall Study|dizziness|1|||
155412498|NCT00598975|560942515|FG000|Overall Study|Adverse Event|1|||
155412499|NCT00598975|560942516|FG001|Overall Study|Adverse Event|1|||
155412500|NCT00598975|560942515|FG000|Overall Study|Brain metastases|1|||
155412501|NCT00598975|560942516|FG001|Overall Study|Brain metastases|0|||
155412502|NCT00598975|560942515|FG000|Overall Study|Withdrawal by Subject|1|||
155412503|NCT00598975|560942516|FG001|Overall Study|Withdrawal by Subject|1|||
155412504|NCT00598975|560942515|FG000|Overall Study|Withdrawal of consent|0|||
155412505|NCT00598975|560942516|FG001|Overall Study|Withdrawal of consent|1|||
155412506|NCT00598975|560942515|FG000|Overall Study|Disease progression|8|||
155412507|NCT00598975|560942516|FG001|Overall Study|Disease progression|3|||
155412508|NCT00598975|560942515|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
155412509|NCT00598975|560942516|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
155412510|NCT03409744|560942525|FG000|Overall Study|Death|2|||
155412511|NCT03409744|560942525|FG000|Overall Study|Physician Decision|5|||
155412512|NCT03409744|560942525|FG000|Overall Study|Pregnancy|1|||
155412513|NCT03409744|560942525|FG000|Overall Study|Lost to Follow-up|1|||
155412514|NCT03409744|560942525|FG000|Overall Study|Protocol Violation|1|||
155749014|NCT01986933|562181397|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
155749015|NCT01986933|562181398|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
155749016|NCT01986933|562181394|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155749017|NCT01986933|562181395|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
155749018|NCT01986933|562181396|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155749019|NCT01986933|562181397|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155749020|NCT01986933|562181398|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155749021|NCT01077154|562181399|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
155749022|NCT01077154|562181400|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
155749023|NCT01077154|562181399|FG000|Overall Study|Withdrawal by Subject|369|||
155749024|NCT01077154|562181400|FG001|Overall Study|Withdrawal by Subject|385|||
155749025|NCT01077154|562181399|FG000|Overall Study|Death|215|||
155749026|NCT01077154|562181400|FG001|Overall Study|Death|214|||
155749027|NCT01077154|562181399|FG000|Overall Study|Lost to Follow-up|43|||
155749028|NCT01077154|562181400|FG001|Overall Study|Lost to Follow-up|35|||
155749029|NCT01077154|562181399|FG000|Overall Study|Noncompliance|22|||
155412515|NCT00494091|560942526|FG000|Overall Study|Death|5|||
155412516|NCT00494091|560942527|FG001|Overall Study|Death|54|||
155412517|NCT00494091|560942526|FG000|Overall Study|Lost to Follow-up|0|||
155412518|NCT00494091|560942527|FG001|Overall Study|Lost to Follow-up|4|||
155412519|NCT00494091|560942526|FG000|Overall Study|Other|1|||
155412520|NCT00494091|560942527|FG001|Overall Study|Other|11|||
155412521|NCT00494091|560942526|FG000|Overall Study|Withdrawal by Subject|0|||
155412522|NCT00494091|560942527|FG001|Overall Study|Withdrawal by Subject|7|||
155412523|NCT00984204|560942528|FG000|Overall Study|Death|1|||
155412524|NCT00984204|560942528|FG000|Overall Study|Lost to Follow-up|4|||
155412525|NCT00984204|560942528|FG000|Overall Study|Lack of Efficacy|10|||
155412526|NCT00122135|560942530|FG000|Overall Study|Withdrawal by Subject|3|||
155412527|NCT00122135|560942531|FG001|Overall Study|Withdrawal by Subject|0|||
155412528|NCT02770326|560942535|FG000|Overall Study|Death|3|||
155412529|NCT02770326|560942535|FG000|Overall Study|Lost to Follow-up|1|||
155412530|NCT02814565|560942539|FG000|Overall Study|Lack of Efficacy|0|||
155412531|NCT02814565|560942540|FG001|Overall Study|Lack of Efficacy|1|||
155412532|NCT02814565|560942539|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
155412533|NCT02814565|560942540|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
155412534|NCT02792842|560942543|FG000|Overall Study|Adverse Event|4|||
155412535|NCT02792842|560942544|FG001|Overall Study|Adverse Event|2|||
155412536|NCT02792842|560942545|FG002|Overall Study|Adverse Event|3|||
155412537|NCT02792842|560942543|FG000|Overall Study|Withdrawal by Subject|0|||
155412538|NCT02792842|560942544|FG001|Overall Study|Withdrawal by Subject|1|||
155412539|NCT02792842|560942545|FG002|Overall Study|Withdrawal by Subject|2|||
155412540|NCT02792842|560942543|FG000|Overall Study|Lost to Follow-up|0|||
155412541|NCT02792842|560942544|FG001|Overall Study|Lost to Follow-up|0|||
155412542|NCT02792842|560942545|FG002|Overall Study|Lost to Follow-up|1|||
155749030|NCT01077154|562181400|FG001|Overall Study|Noncompliance|20|||
155412543|NCT02792842|560942543|FG000|Overall Study|Schedule delay|0|||
155412544|NCT02792842|560942544|FG001|Overall Study|Schedule delay|1|||
155412545|NCT02792842|560942545|FG002|Overall Study|Schedule delay|1|||
155412546|NCT01046825|560942550|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
155412547|NCT01046825|560942551|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
155641499|NCT02850406|561777949|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
155641500|NCT02850406|561777950|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
155412548|NCT01046825|560942552|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
155641501|NCT02850406|561777951|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
155641502|NCT02850406|561777952|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
155641503|NCT02850406|561777953|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
155641504|NCT02850406|561777954|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
155641505|NCT02850406|561777947|FG000|Part C (Up to 52 Weeks)|Other|0|||
155641506|NCT02850406|561777948|FG001|Part C (Up to 52 Weeks)|Other|0|||
155641507|NCT02850406|561777949|FG002|Part C (Up to 52 Weeks)|Other|0|||
155641508|NCT02850406|561777950|FG003|Part C (Up to 52 Weeks)|Other|0|||
155641509|NCT02850406|561777951|FG004|Part C (Up to 52 Weeks)|Other|1|||
155641510|NCT02850406|561777952|FG005|Part C (Up to 52 Weeks)|Other|3|||
155641511|NCT02850406|561777953|FG006|Part C (Up to 52 Weeks)|Other|0|||
155641512|NCT02850406|561777954|FG007|Part C (Up to 52 Weeks)|Other|0|||
155641513|NCT02850406|561777947|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641514|NCT02850406|561777948|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641515|NCT02850406|561777949|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641516|NCT02850406|561777950|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641517|NCT02850406|561777951|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641518|NCT02850406|561777952|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641519|NCT02850406|561777953|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
155641520|NCT02850406|561777954|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
155641521|NCT02850406|561777947|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641522|NCT02850406|561777948|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641523|NCT02850406|561777949|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641524|NCT02850406|561777950|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641525|NCT02850406|561777951|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641526|NCT02850406|561777952|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641527|NCT02850406|561777953|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155641528|NCT02850406|561777954|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
155641529|NCT02850406|561777947|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641530|NCT02850406|561777948|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641531|NCT02850406|561777949|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641532|NCT02850406|561777950|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641533|NCT02850406|561777951|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641534|NCT02850406|561777952|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
155641535|NCT02850406|561777953|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
155641536|NCT02850406|561777954|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
155641537|NCT02850406|561777947|FG000|Part D (Up to 52 Weeks)|Other|0|||
155641538|NCT02850406|561777948|FG001|Part D (Up to 52 Weeks)|Other|0|||
155641539|NCT02850406|561777949|FG002|Part D (Up to 52 Weeks)|Other|0|||
155641540|NCT02850406|561777950|FG003|Part D (Up to 52 Weeks)|Other|0|||
155641541|NCT02850406|561777951|FG004|Part D (Up to 52 Weeks)|Other|0|||
155641542|NCT02850406|561777952|FG005|Part D (Up to 52 Weeks)|Other|0|||
155641543|NCT02850406|561777953|FG006|Part D (Up to 52 Weeks)|Other|0|||
155641544|NCT02850406|561777954|FG007|Part D (Up to 52 Weeks)|Other|1|||
155641545|NCT05578872|561777955|FG000|Overall Study|Withdrawal by Subject|2|||
155641546|NCT05578872|561777956|FG001|Overall Study|Withdrawal by Subject|1|||
155641547|NCT05578872|561777955|FG000|Overall Study|Adverse Event|1|||
155641548|NCT05578872|561777956|FG001|Overall Study|Adverse Event|1|||
155641549|NCT05578872|561777955|FG000|Overall Study|Physician Decision|1|||
155641550|NCT05578872|561777956|FG001|Overall Study|Physician Decision|2|||
155641551|NCT05578872|561777955|FG000|Overall Study|Progressive disease|10|||
155641552|NCT05578872|561777956|FG001|Overall Study|Progressive disease|9|||
155641553|NCT05578872|561777955|FG000|Overall Study|Sponsor decision|0|||
155641554|NCT05578872|561777956|FG001|Overall Study|Sponsor decision|1|||
155641555|NCT05578872|561777955|FG000|Overall Study|Toxicity and Patient's decision|0|||
155641556|NCT05578872|561777956|FG001|Overall Study|Toxicity and Patient's decision|1|||
155641557|NCT04795323|561779042|FG000|Overall Study|Did not interact with TARA|1|||
155641558|NCT04795323|561779043|FG001|Overall Study|Did not interact with TARA|0|||
155641559|NCT01479530|561779044|FG000|Overall Study|Adverse Event|5|||
155641560|NCT01479530|561779045|FG001|Overall Study|Adverse Event|6|||
155641561|NCT01479530|561779044|FG000|Overall Study|Lack of Efficacy|0|||
155641562|NCT01479530|561779045|FG001|Overall Study|Lack of Efficacy|1|||
155641563|NCT01479530|561779044|FG000|Overall Study|Protocol Violation|2|||
155641564|NCT01479530|561779045|FG001|Overall Study|Protocol Violation|3|||
155641565|NCT01479530|561779044|FG000|Overall Study|Withdrawal of Consent|3|||
155641566|NCT01479530|561779045|FG001|Overall Study|Withdrawal of Consent|2|||
155641567|NCT02836769|561779046|FG000|Overall Study|Lost to Follow-up|10|||
155641568|NCT02836769|561779046|FG000|Overall Study|Medical withdrawal|2|||
155496880|NCT04636437|561242412|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
155412549|NCT01046825|560942553|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
155412550|NCT01046825|560942554|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
155412551|NCT01046825|560942550|FG000|Overall Study|Physician Decision|0|||
155412552|NCT01046825|560942551|FG001|Overall Study|Physician Decision|1|||
155412553|NCT01046825|560942552|FG002|Overall Study|Physician Decision|2|||
155412554|NCT01046825|560942553|FG003|Overall Study|Physician Decision|0|||
155412555|NCT01046825|560942554|FG004|Overall Study|Physician Decision|0|||
155412556|NCT01046825|560942550|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
155412557|NCT01046825|560942551|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
155412558|NCT01046825|560942552|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
155412559|NCT01046825|560942553|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
155412560|NCT01046825|560942554|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
155749031|NCT01077154|562181399|FG000|Overall Study|Disease Progression|18|||
155749032|NCT01077154|562181400|FG001|Overall Study|Disease Progression|20|||
155412561|NCT01046825|560942550|FG000|Overall Study|Found to be ineligible|0|||
155412562|NCT01046825|560942551|FG001|Overall Study|Found to be ineligible|1|||
155412563|NCT01046825|560942552|FG002|Overall Study|Found to be ineligible|0|||
155412564|NCT01046825|560942553|FG003|Overall Study|Found to be ineligible|0|||
155749033|NCT01077154|562181399|FG000|Overall Study|Ineligibility Determined|10|||
155749034|NCT01077154|562181400|FG001|Overall Study|Ineligibility Determined|14|||
155749035|NCT01077154|562181399|FG000|Overall Study|Other|14|||
155749036|NCT01077154|562181400|FG001|Overall Study|Other|11|||
155412565|NCT01046825|560942554|FG004|Overall Study|Found to be ineligible|0|||
155412566|NCT01046825|560942550|FG000|Overall Study|Death|0|||
155302793|NCT01643070|560542637|FG001|Overall Study|Withdrawal by Subject|1|||
155302794|NCT01643070|560542636|FG000|Overall Study|Death|1|||
155302795|NCT01643070|560542637|FG001|Overall Study|Death|0|||
155302796|NCT01643070|560542636|FG000|Overall Study|Pregressive disease|0|||
155302797|NCT01643070|560542637|FG001|Overall Study|Pregressive disease|2|||
155302798|NCT04842500|560542640|FG000|Overall Study|Withdrawal by Subject|4|||
155302799|NCT04842500|560542641|FG001|Overall Study|Withdrawal by Subject|1|||
155302800|NCT04842500|560542642|FG002|Overall Study|Withdrawal by Subject|2|||
155302801|NCT04842500|560542643|FG003|Overall Study|Withdrawal by Subject|3|||
155302802|NCT04842500|560542640|FG000|Overall Study|Protocol Violation|1|||
155302803|NCT04842500|560542641|FG001|Overall Study|Protocol Violation|0|||
155302804|NCT04842500|560542642|FG002|Overall Study|Protocol Violation|0|||
155302805|NCT04842500|560542643|FG003|Overall Study|Protocol Violation|1|||
155302806|NCT02980276|560542644|FG000|Overall Study|Withdrawal by Subject|4|||
155302807|NCT02980276|560542645|FG001|Overall Study|Withdrawal by Subject|4|||
155302808|NCT02980276|560542644|FG000|Overall Study|Physician Decision|0|||
155302809|NCT02980276|560542645|FG001|Overall Study|Physician Decision|1|||
155302810|NCT02980276|560542644|FG000|Overall Study|Lost to Follow-up|18|||
155302811|NCT02980276|560542645|FG001|Overall Study|Lost to Follow-up|18|||
155302812|NCT02980276|560542644|FG000|Overall Study|Death|1|||
155302813|NCT02980276|560542645|FG001|Overall Study|Death|0|||
155302814|NCT02980276|560542644|FG000|Overall Study|Miscellaneous other|10|||
155302815|NCT02980276|560542645|FG001|Overall Study|Miscellaneous other|4|||
155302816|NCT04139668|560542647|FG000|Overall Study|Withdrawal by Subject|1|||
155302817|NCT03025789|560542648|FG000|Overall Study|Lack of Efficacy|6|||
155302818|NCT03025789|560542649|FG001|Overall Study|Lack of Efficacy|1|||
155302819|NCT03025789|560542648|FG000|Overall Study|Death|1|||
155302820|NCT03025789|560542649|FG001|Overall Study|Death|0|||
155302821|NCT03025789|560542648|FG000|Overall Study|Withdrawal by Subject|0|||
155302822|NCT03025789|560542649|FG001|Overall Study|Withdrawal by Subject|2|||
155302823|NCT03554265|560542650|FG000|Overall Study|Withdrawal by Subject|2|||
155302824|NCT03554265|560542651|FG001|Overall Study|Withdrawal by Subject|2|||
155302825|NCT03554265|560542652|FG002|Overall Study|Withdrawal by Subject|3|||
155302826|NCT03554265|560542650|FG000|Overall Study|Physician Decision|0|||
155302827|NCT03554265|560542651|FG001|Overall Study|Physician Decision|0|||
155302828|NCT03554265|560542652|FG002|Overall Study|Physician Decision|1|||
155302829|NCT02652260|560542653|FG000|Base Study|Pregnancy|0|||
155302830|NCT02652260|560542654|FG001|Base Study|Pregnancy|1|||
155412567|NCT01046825|560942551|FG001|Overall Study|Death|0|||
155749037|NCT01077154|562181399|FG000|Overall Study|Adverse Event|9|||
155302831|NCT02652260|560542653|FG000|Base Study|Withdrawal by Subject|0|||
155302832|NCT02652260|560542654|FG001|Base Study|Withdrawal by Subject|1|||
155302833|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
155302834|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
155749038|NCT01077154|562181400|FG001|Overall Study|Adverse Event|9|||
155749039|NCT01077154|562181399|FG000|Overall Study|Administrative Decision|1|||
155302835|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
155302836|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
155302837|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
155302838|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
155302839|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
155302840|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
155302841|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
155302842|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
155302843|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
155302844|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
155302845|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
155302846|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
155302847|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
155302848|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
155302849|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
155302850|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
155412568|NCT01046825|560942552|FG002|Overall Study|Death|0|||
155412569|NCT01046825|560942553|FG003|Overall Study|Death|1|||
155412570|NCT01046825|560942554|FG004|Overall Study|Death|0|||
155412571|NCT01046825|560942550|FG000|Overall Study|Did not submit biology samples|0|||
155412572|NCT01046825|560942551|FG001|Overall Study|Did not submit biology samples|0|||
155412573|NCT01046825|560942552|FG002|Overall Study|Did not submit biology samples|0|||
155412574|NCT01046825|560942553|FG003|Overall Study|Did not submit biology samples|0|||
155412575|NCT01046825|560942554|FG004|Overall Study|Did not submit biology samples|13|||
155412576|NCT04735653|560942555|FG000|Overall Study|Lost to Follow-up|17|||
155412577|NCT04735653|560942556|FG001|Overall Study|Lost to Follow-up|7|||
155412578|NCT04735653|560942555|FG000|Overall Study|Withdrawal by Subject|8|||
155412579|NCT04735653|560942556|FG001|Overall Study|Withdrawal by Subject|2|||
155412580|NCT04735653|560942555|FG000|Overall Study|Death|0|||
155412581|NCT04735653|560942556|FG001|Overall Study|Death|2|||
155412582|NCT04735653|560942555|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
155412583|NCT04735653|560942556|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
155412584|NCT03975647|560942557|FG000|Overall Study|Death|71|||
155412585|NCT03975647|560942558|FG001|Overall Study|Death|63|||
155412586|NCT03975647|560942557|FG000|Overall Study|Lost to Follow-up|2|||
155412587|NCT03975647|560942558|FG001|Overall Study|Lost to Follow-up|2|||
155412588|NCT03975647|560942557|FG000|Overall Study|Subject withdrawal of consent|7|||
155412589|NCT03975647|560942558|FG001|Overall Study|Subject withdrawal of consent|11|||
155412590|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
155412591|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
155412592|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
155412593|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
155412594|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
155412595|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
155412596|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
155412597|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
155412598|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
155412599|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
155412600|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
155412601|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
155302851|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
155302852|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
155302853|NCT02652260|560542653|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
155412602|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
155412603|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
155302854|NCT02652260|560542654|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
155302855|NCT02652260|560542653|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
155302856|NCT02652260|560542654|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
155302857|NCT02723955|560542655|FG000|Escalation Phase|Death|1|||
155302858|NCT02723955|560542656|FG001|Escalation Phase|Death|1|||
155302859|NCT02723955|560542657|FG002|Escalation Phase|Death|2|||
155302860|NCT02723955|560542658|FG003|Escalation Phase|Death|7|||
155302861|NCT02723955|560542659|FG004|Escalation Phase|Death|18|||
155749040|NCT01077154|562181400|FG001|Overall Study|Administrative Decision|6|||
155749041|NCT01077154|562181399|FG000|Overall Study|Protocol Deviation|1|||
155749042|NCT01077154|562181400|FG001|Overall Study|Protocol Deviation|0|||
155749043|NCT04030026|562181401|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
155749044|NCT04030026|562181402|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
155302862|NCT02723955|560542660|FG005|Escalation Phase|Death|17|||
155302863|NCT02723955|560542661|FG006|Escalation Phase|Death|11|||
155302864|NCT02723955|560542662|FG007|Escalation Phase|Death|21|||
155302865|NCT02723955|560542663|FG008|Escalation Phase|Death|3|||
155302866|NCT02723955|560542664|FG009|Escalation Phase|Death|0|||
155412604|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
155749045|NCT04030026|562181401|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
155302867|NCT02723955|560542665|FG010|Escalation Phase|Death|0|||
155302868|NCT02723955|560542666|FG011|Escalation Phase|Death|0|||
155302869|NCT02723955|560542667|FG012|Escalation Phase|Death|2|||
155302870|NCT02723955|560542668|FG013|Escalation Phase|Death|4|||
155302871|NCT02723955|560542669|FG014|Escalation Phase|Death|5|||
155302872|NCT02723955|560542670|FG015|Escalation Phase|Death|6|||
155302873|NCT02723955|560542671|FG016|Escalation Phase|Death|6|||
155302874|NCT02723955|560542672|FG017|Escalation Phase|Death|7|||
155302875|NCT02723955|560542673|FG018|Escalation Phase|Death|1|||
155302876|NCT02723955|560542674|FG019|Escalation Phase|Death|3|||
155302877|NCT02723955|560542675|FG020|Escalation Phase|Death|13|||
155302878|NCT02723955|560542676|FG021|Escalation Phase|Death|3|||
155302879|NCT02723955|560542677|FG022|Escalation Phase|Death|2|||
155302880|NCT02723955|560542678|FG023|Escalation Phase|Death|4|||
155302881|NCT02723955|560542679|FG024|Escalation Phase|Death|31|||
155302882|NCT02723955|560542680|FG025|Escalation Phase|Death|7|||
155641569|NCT02836769|561779046|FG000|Overall Study|Withdrawal by Subject|3|||
155641570|NCT03142750|561779053|FG000|Overall Study|Lost to Follow-up|4|||
155641571|NCT03142750|561779054|FG001|Overall Study|Lost to Follow-up|1|||
155641572|NCT00303628|561779057|FG000|Overall Study|Disease progression|0|||
155641573|NCT00303628|561779058|FG001|Overall Study|Disease progression|1|||
155641574|NCT00303628|561779057|FG000|Overall Study|Adverse Event|26|||
155641575|NCT00303628|561779058|FG001|Overall Study|Adverse Event|36|||
155641576|NCT00303628|561779057|FG000|Overall Study|Death|0|||
155641577|NCT00303628|561779058|FG001|Overall Study|Death|1|||
155641578|NCT00303628|561779057|FG000|Overall Study|Withdrawal by Subject|11|||
155641579|NCT00303628|561779058|FG001|Overall Study|Withdrawal by Subject|20|||
155641580|NCT00303628|561779057|FG000|Overall Study|Alternative therapy|2|||
155641581|NCT00303628|561779058|FG001|Overall Study|Alternative therapy|0|||
155641582|NCT00303628|561779057|FG000|Overall Study|Other complicating disease|0|||
155641583|NCT00303628|561779058|FG001|Overall Study|Other complicating disease|1|||
155641584|NCT00303628|561779057|FG000|Overall Study|Not start protocol therapy|3|||
155641585|NCT00303628|561779058|FG001|Overall Study|Not start protocol therapy|5|||
155641586|NCT00303628|561779057|FG000|Overall Study|Other|8|||
155641587|NCT00303628|561779058|FG001|Overall Study|Other|9|||
155641588|NCT04925934|561779059|FG000|Overall Study|Adverse Event|1|||
155641589|NCT04925934|561779060|FG001|Overall Study|Adverse Event|0|||
155641590|NCT04925934|561779061|FG002|Overall Study|Adverse Event|0|||
155641591|NCT04925934|561779059|FG000|Overall Study|Lost to Follow-up|2|||
155641592|NCT04925934|561779060|FG001|Overall Study|Lost to Follow-up|0|||
155641593|NCT04925934|561779061|FG002|Overall Study|Lost to Follow-up|1|||
155641594|NCT04925934|561779059|FG000|Overall Study|Death|0|||
155641595|NCT04925934|561779060|FG001|Overall Study|Death|1|||
155302883|NCT02723955|560542681|FG026|Escalation Phase|Death|13|||
155302884|NCT02723955|560542682|FG027|Escalation Phase|Death|0|||
155302885|NCT02723955|560542683|FG028|Escalation Phase|Death|1|||
155412605|NCT03735667|560942559|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
155412606|NCT03735667|560942560|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
155412607|NCT03735667|560942561|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
155302886|NCT02723955|560542684|FG029|Escalation Phase|Death|0|||
155412608|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
155412609|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
155412610|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
155641596|NCT04925934|561779061|FG002|Overall Study|Death|0|||
155641597|NCT04925934|561779059|FG000|Overall Study|Withdrawal by Subject|8|||
155641598|NCT04925934|561779060|FG001|Overall Study|Withdrawal by Subject|5|||
155641599|NCT04925934|561779061|FG002|Overall Study|Withdrawal by Subject|9|||
155641600|NCT04925934|561779059|FG000|Overall Study|Other|2|||
155641601|NCT04925934|561779060|FG001|Overall Study|Other|2|||
155302887|NCT02723955|560542685|FG030|Escalation Phase|Death|0|||
155302888|NCT02723955|560542686|FG031|Escalation Phase|Death|0|||
155302889|NCT02723955|560542687|FG032|Escalation Phase|Death|0|||
155302890|NCT02723955|560542688|FG033|Escalation Phase|Death|0|||
155302891|NCT02723955|560542689|FG034|Escalation Phase|Death|0|||
155302892|NCT02723955|560542690|FG035|Escalation Phase|Death|0|||
155641602|NCT04925934|561779061|FG002|Overall Study|Other|2|||
155641603|NCT04925934|561779059|FG000|Overall Study|Eastern European Conflict|7|||
155302893|NCT02723955|560542691|FG036|Escalation Phase|Death|0|||
155641604|NCT04925934|561779060|FG001|Overall Study|Eastern European Conflict|3|||
155641605|NCT04925934|561779061|FG002|Overall Study|Eastern European Conflict|2|||
155641606|NCT03158688|561779062|FG000|Overall Study|Withdrawal by Subject|14|||
155641607|NCT03158688|561779063|FG001|Overall Study|Withdrawal by Subject|28|||
155641608|NCT03158688|561779062|FG000|Overall Study|Decision by sponsor|13|||
155641609|NCT03158688|561779063|FG001|Overall Study|Decision by sponsor|37|||
155641610|NCT03158688|561779062|FG000|Overall Study|Lost to Follow-up|4|||
155641611|NCT03158688|561779063|FG001|Overall Study|Lost to Follow-up|3|||
155641612|NCT03158688|561779062|FG000|Overall Study|Death|74|||
155641613|NCT03158688|561779063|FG001|Overall Study|Death|142|||
155641614|NCT00933166|561779065|FG000|Overall Study|Lost to Follow-up|4|||
155641615|NCT00933166|561779065|FG000|Overall Study|Lack of Efficacy|9|||
155641616|NCT00933166|561779065|FG000|Overall Study|Unavailable|4|||
155641617|NCT00933166|561779065|FG000|Overall Study|Withdrawal by Subject|1|||
155641618|NCT02948400|561779067|FG000|Overall Study|Withdrawal by Subject|17|||
155641619|NCT02948400|561779068|FG001|Overall Study|Withdrawal by Subject|10|||
155641620|NCT02948400|561779067|FG000|Overall Study|failed to attend appointments|47|||
155641621|NCT02948400|561779068|FG001|Overall Study|failed to attend appointments|34|||
155641622|NCT02948400|561779067|FG000|Overall Study|COVID-related closure|6|||
155641623|NCT02948400|561779068|FG001|Overall Study|COVID-related closure|2|||
155641624|NCT02948400|561779067|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
155641625|NCT02948400|561779068|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
155641626|NCT02948400|561779067|FG000|Overall Study|motion sickness in virtual reality|2|||
155641627|NCT02948400|561779068|FG001|Overall Study|motion sickness in virtual reality|0|||
155641628|NCT03925220|561779069|FG000|Overall Study|Withdrawal by Subject|4|||
155641629|NCT03925220|561779070|FG001|Overall Study|Withdrawal by Subject|4|||
155641630|NCT03925220|561779071|FG002|Overall Study|Withdrawal by Subject|4|||
155641631|NCT03925220|561779072|FG003|Overall Study|Withdrawal by Subject|4|||
155641632|NCT03925220|561779069|FG000|Overall Study|Lost to Follow-up|40|||
155641633|NCT03925220|561779070|FG001|Overall Study|Lost to Follow-up|46|||
155641634|NCT03925220|561779071|FG002|Overall Study|Lost to Follow-up|37|||
155641635|NCT03925220|561779072|FG003|Overall Study|Lost to Follow-up|38|||
155641636|NCT05774977|561779073|FG000|Overall Study|Withdrawal by Subject|2|||
155641637|NCT03349515|561779076|FG000|Overall Study|Lack of Efficacy|2|||
155641638|NCT03349515|561779077|FG001|Overall Study|Lack of Efficacy|0|||
155641639|NCT03349515|561779076|FG000|Overall Study|Physician Decision|3|||
155641640|NCT03349515|561779077|FG001|Overall Study|Physician Decision|1|||
155641641|NCT02503865|561779082|FG000|Overall Study|Moved out of area|1|||
155641642|NCT02503865|561779083|FG001|Overall Study|Moved out of area|8|||
155641643|NCT02503865|561779084|FG002|Overall Study|Moved out of area|0|||
155641644|NCT02503865|561779082|FG000|Overall Study|Refused treatment|4|||
155641645|NCT02503865|561779083|FG001|Overall Study|Refused treatment|39|||
155641646|NCT02503865|561779084|FG002|Overall Study|Refused treatment|2|||
155641647|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
155641648|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
155641649|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
155641650|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Death|1|||
155641651|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Death|0|||
155641652|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Death|0|||
155641653|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
155641654|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
155641655|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
155641656|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
155641657|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
155641658|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
155641659|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
155641660|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
155641661|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
155641662|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
155641663|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
155641664|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
155641665|NCT05073315|561779085|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
155641666|NCT05073315|561779086|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
155641667|NCT05073315|561779087|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
155641668|NCT05073315|561779085|FG000|Period 2|Adverse Event|0|||
155641669|NCT05073315|561779086|FG001|Period 2|Adverse Event|3|||
155641670|NCT05073315|561779087|FG002|Period 2|Adverse Event|6|||
155641671|NCT05073315|561779085|FG000|Period 2|Lost to Follow-up|0|||
155641672|NCT05073315|561779086|FG001|Period 2|Lost to Follow-up|5|||
155641673|NCT05073315|561779087|FG002|Period 2|Lost to Follow-up|5|||
155641674|NCT05073315|561779085|FG000|Period 2|Withdrawal by Subject|0|||
155641675|NCT05073315|561779086|FG001|Period 2|Withdrawal by Subject|4|||
155641676|NCT05073315|561779087|FG002|Period 2|Withdrawal by Subject|9|||
155641677|NCT05073315|561779085|FG000|Period 2|Protocol Violation|0|||
155496881|NCT04636437|561242410|FG000|Overall Study|Started weight loss drug/program|2|||
155749046|NCT04030026|562181402|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
155749047|NCT04030026|562181401|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
155749048|NCT04030026|562181402|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
155749049|NCT04030026|562181401|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
155749050|NCT04030026|562181402|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
155749051|NCT04030026|562181401|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
155749052|NCT04030026|562181402|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
155749053|NCT04030026|562181401|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
155749054|NCT04030026|562181402|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
155749055|NCT04030026|562181401|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
155749056|NCT04030026|562181402|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
155749057|NCT02207946|562181403|FG000|Overall Study|Lost to Follow-up|1|||
155749058|NCT02207946|562181404|FG001|Overall Study|Lost to Follow-up|0|||
155749059|NCT02207946|562181403|FG000|Overall Study|Adverse Event|0|||
155749060|NCT02207946|562181404|FG001|Overall Study|Adverse Event|1|||
155749061|NCT02545543|562181405|FG000|Overall Study|Lost to Follow-up|67|||
155749062|NCT02545543|562181406|FG001|Overall Study|Lost to Follow-up|25|||
155302894|NCT02723955|560542692|FG037|Escalation Phase|Death|0|||
155302895|NCT02723955|560542693|FG038|Escalation Phase|Death|0|||
155302896|NCT02723955|560542694|FG039|Escalation Phase|Death|0|||
155302897|NCT02723955|560542695|FG040|Escalation Phase|Death|0|||
155496882|NCT04636437|561242411|FG001|Overall Study|Started weight loss drug/program|1|||
155496883|NCT04636437|561242412|FG002|Overall Study|Started weight loss drug/program|1|||
155496884|NCT04636437|561242410|FG000|Overall Study|Lost to Follow-up|3|||
155302898|NCT02723955|560542696|FG041|Escalation Phase|Death|0|||
155302899|NCT02723955|560542697|FG042|Escalation Phase|Death|0|||
155302900|NCT02723955|560542655|FG000|Escalation Phase|Lost to Follow-up|0|||
155302901|NCT02723955|560542656|FG001|Escalation Phase|Lost to Follow-up|0|||
155302902|NCT02723955|560542657|FG002|Escalation Phase|Lost to Follow-up|0|||
155302903|NCT02723955|560542658|FG003|Escalation Phase|Lost to Follow-up|0|||
155302904|NCT02723955|560542659|FG004|Escalation Phase|Lost to Follow-up|0|||
155302905|NCT02723955|560542660|FG005|Escalation Phase|Lost to Follow-up|2|||
155302906|NCT02723955|560542661|FG006|Escalation Phase|Lost to Follow-up|1|||
155302907|NCT02723955|560542662|FG007|Escalation Phase|Lost to Follow-up|1|||
155302908|NCT02723955|560542663|FG008|Escalation Phase|Lost to Follow-up|1|||
155302909|NCT02723955|560542664|FG009|Escalation Phase|Lost to Follow-up|0|||
155302910|NCT02723955|560542665|FG010|Escalation Phase|Lost to Follow-up|0|||
155302911|NCT02723955|560542666|FG011|Escalation Phase|Lost to Follow-up|0|||
155302912|NCT02723955|560542667|FG012|Escalation Phase|Lost to Follow-up|1|||
155302913|NCT02723955|560542668|FG013|Escalation Phase|Lost to Follow-up|0|||
155302914|NCT02723955|560542669|FG014|Escalation Phase|Lost to Follow-up|0|||
155302915|NCT02723955|560542670|FG015|Escalation Phase|Lost to Follow-up|0|||
155302916|NCT02723955|560542671|FG016|Escalation Phase|Lost to Follow-up|1|||
155302917|NCT02723955|560542672|FG017|Escalation Phase|Lost to Follow-up|2|||
155302918|NCT02723955|560542673|FG018|Escalation Phase|Lost to Follow-up|0|||
155302919|NCT02723955|560542674|FG019|Escalation Phase|Lost to Follow-up|1|||
155302920|NCT02723955|560542675|FG020|Escalation Phase|Lost to Follow-up|2|||
155302921|NCT02723955|560542676|FG021|Escalation Phase|Lost to Follow-up|1|||
155302922|NCT02723955|560542677|FG022|Escalation Phase|Lost to Follow-up|0|||
155302923|NCT02723955|560542678|FG023|Escalation Phase|Lost to Follow-up|0|||
155302924|NCT02723955|560542679|FG024|Escalation Phase|Lost to Follow-up|1|||
155302925|NCT02723955|560542680|FG025|Escalation Phase|Lost to Follow-up|1|||
155302926|NCT02723955|560542681|FG026|Escalation Phase|Lost to Follow-up|3|||
155302927|NCT02723955|560542682|FG027|Escalation Phase|Lost to Follow-up|0|||
155302928|NCT02723955|560542683|FG028|Escalation Phase|Lost to Follow-up|1|||
155302929|NCT02723955|560542684|FG029|Escalation Phase|Lost to Follow-up|0|||
155302930|NCT02723955|560542685|FG030|Escalation Phase|Lost to Follow-up|0|||
155302931|NCT02723955|560542686|FG031|Escalation Phase|Lost to Follow-up|0|||
155302932|NCT02723955|560542687|FG032|Escalation Phase|Lost to Follow-up|0|||
155302933|NCT02723955|560542688|FG033|Escalation Phase|Lost to Follow-up|0|||
155302934|NCT02723955|560542689|FG034|Escalation Phase|Lost to Follow-up|0|||
155302935|NCT02723955|560542690|FG035|Escalation Phase|Lost to Follow-up|0|||
155302936|NCT02723955|560542691|FG036|Escalation Phase|Lost to Follow-up|0|||
155302937|NCT02723955|560542692|FG037|Escalation Phase|Lost to Follow-up|0|||
155302938|NCT02723955|560542693|FG038|Escalation Phase|Lost to Follow-up|0|||
155302939|NCT02723955|560542694|FG039|Escalation Phase|Lost to Follow-up|0|||
155302940|NCT02723955|560542695|FG040|Escalation Phase|Lost to Follow-up|0|||
155302941|NCT02723955|560542696|FG041|Escalation Phase|Lost to Follow-up|0|||
155302942|NCT02723955|560542697|FG042|Escalation Phase|Lost to Follow-up|0|||
155302943|NCT02723955|560542655|FG000|Escalation Phase|Physician Decision|0|||
155302944|NCT02723955|560542656|FG001|Escalation Phase|Physician Decision|0|||
155749063|NCT02545543|562181405|FG000|Overall Study|Physician Decision|3|||
155749064|NCT02545543|562181406|FG001|Overall Study|Physician Decision|0|||
155749065|NCT02545543|562181405|FG000|Overall Study|Withdrawal by Subject|9|||
155749066|NCT02545543|562181406|FG001|Overall Study|Withdrawal by Subject|8|||
155412611|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
155412612|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
155412613|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
155302945|NCT02723955|560542657|FG002|Escalation Phase|Physician Decision|0|||
155302946|NCT02723955|560542658|FG003|Escalation Phase|Physician Decision|0|||
155302947|NCT02723955|560542659|FG004|Escalation Phase|Physician Decision|0|||
155302948|NCT02723955|560542660|FG005|Escalation Phase|Physician Decision|2|||
155302949|NCT02723955|560542661|FG006|Escalation Phase|Physician Decision|0|||
155302950|NCT02723955|560542662|FG007|Escalation Phase|Physician Decision|0|||
155302951|NCT02723955|560542663|FG008|Escalation Phase|Physician Decision|0|||
155302952|NCT02723955|560542664|FG009|Escalation Phase|Physician Decision|0|||
155302953|NCT02723955|560542665|FG010|Escalation Phase|Physician Decision|0|||
155302954|NCT02723955|560542666|FG011|Escalation Phase|Physician Decision|0|||
155302955|NCT02723955|560542667|FG012|Escalation Phase|Physician Decision|0|||
155302956|NCT02723955|560542668|FG013|Escalation Phase|Physician Decision|0|||
155302957|NCT02723955|560542669|FG014|Escalation Phase|Physician Decision|0|||
155302958|NCT02723955|560542670|FG015|Escalation Phase|Physician Decision|0|||
155302959|NCT02723955|560542671|FG016|Escalation Phase|Physician Decision|0|||
155302960|NCT02723955|560542672|FG017|Escalation Phase|Physician Decision|0|||
155302961|NCT02723955|560542673|FG018|Escalation Phase|Physician Decision|0|||
155302962|NCT02723955|560542674|FG019|Escalation Phase|Physician Decision|0|||
155302963|NCT02723955|560542675|FG020|Escalation Phase|Physician Decision|0|||
155302964|NCT02723955|560542676|FG021|Escalation Phase|Physician Decision|0|||
155302965|NCT02723955|560542677|FG022|Escalation Phase|Physician Decision|0|||
155302966|NCT02723955|560542678|FG023|Escalation Phase|Physician Decision|0|||
155302967|NCT02723955|560542679|FG024|Escalation Phase|Physician Decision|0|||
155412614|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
155412615|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
155412616|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
155412617|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
155412618|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
155412619|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
155412620|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
155412621|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
155412622|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
155412623|NCT03735667|560942559|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
155412624|NCT03735667|560942560|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
155412625|NCT03735667|560942561|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
155412626|NCT00999908|560942562|FG000|Treatment Period 1|Subject withdrew consent|2|||
155412627|NCT00999908|560942563|FG001|Treatment Period 1|Subject withdrew consent|0|||
155412628|NCT00999908|560942564|FG002|Treatment Period 1|Subject withdrew consent|0|||
155412629|NCT00999908|560942562|FG000|Treatment Period 2|Protocol Violation|1|||
155412630|NCT00999908|560942563|FG001|Treatment Period 2|Protocol Violation|0|||
155412631|NCT00999908|560942564|FG002|Treatment Period 2|Protocol Violation|0|||
155412632|NCT02780648|560942565|FG000|Overall Study|Disease Progression|1|||
155412633|NCT02780648|560942566|FG001|Overall Study|Disease Progression|0|||
155412634|NCT00293579|560942567|FG000|Overall Study|Withdrawal by Subject|1|||
155412635|NCT03127384|560942568|FG000|Overall Study|Lost to Follow-up|4|||
155412636|NCT03127384|560942568|FG000|Overall Study|Subject request|2|||
155412637|NCT02703311|560942569|FG000|Overall Study|Death|5|||
155412638|NCT02703311|560942569|FG000|Overall Study|Withdrawal by Subject|3|||
155412639|NCT00262873|560942570|FG000|Overall Study|Adverse Event|3|||
155496885|NCT04636437|561242411|FG001|Overall Study|Lost to Follow-up|1|||
155496886|NCT04636437|561242412|FG002|Overall Study|Lost to Follow-up|4|||
155496887|NCT04636437|561242410|FG000|Overall Study|Participant or physician decision|3|||
155496888|NCT04636437|561242411|FG001|Overall Study|Participant or physician decision|1|||
155496889|NCT04636437|561242412|FG002|Overall Study|Participant or physician decision|1|||
155496890|NCT00816166|561242413|FG000|Overall Study|Lost to Follow-up|6|||
155496891|NCT00816166|561242414|FG001|Overall Study|Lost to Follow-up|10|||
155496892|NCT00816166|561242413|FG000|Overall Study|Death|4|||
155496893|NCT00816166|561242414|FG001|Overall Study|Death|2|||
155496894|NCT01071278|561242415|FG000|Overall Study|Premature Discontinuation|254|||
155496895|NCT01071278|561242415|FG000|Overall Study|Completion Status Unknown|459|||
155496896|NCT02851069|561242416|FG000|Overall Study|Failure to Return|3|||
155496897|NCT02851069|561242416|FG000|Overall Study|Other|3|||
155496898|NCT00352664|561242417|FG000|Overall Study|Withdrawal by Subject|7|||
155496899|NCT00352664|561242418|FG001|Overall Study|Withdrawal by Subject|0|||
155302968|NCT02723955|560542680|FG025|Escalation Phase|Physician Decision|0|||
155302969|NCT02723955|560542681|FG026|Escalation Phase|Physician Decision|2|||
155496900|NCT03539952|561242419|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
155496901|NCT03539952|561242420|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
155302970|NCT02723955|560542682|FG027|Escalation Phase|Physician Decision|0|||
155302971|NCT02723955|560542683|FG028|Escalation Phase|Physician Decision|0|||
155302972|NCT02723955|560542684|FG029|Escalation Phase|Physician Decision|0|||
155412640|NCT00262873|560942570|FG000|Overall Study|Withdrawal by Subject|5|||
155412641|NCT03440814|560942571|FG000|Overall Study|Adverse Event|2|||
155412642|NCT03440814|560942572|FG001|Overall Study|Adverse Event|1|||
155412643|NCT03440814|560942571|FG000|Overall Study|Lost to Follow-up|2|||
155641678|NCT05073315|561779086|FG001|Period 2|Protocol Violation|0|||
155641679|NCT05073315|561779087|FG002|Period 2|Protocol Violation|1|||
155641680|NCT01529268|561779088|FG000|Overall Study|Lost to Follow-up|9|||
155641681|NCT01529268|561779089|FG001|Overall Study|Lost to Follow-up|3|||
155641682|NCT01529268|561779088|FG000|Overall Study|Moved|3|||
155641683|NCT01529268|561779089|FG001|Overall Study|Moved|0|||
155641684|NCT00303953|561779090|FG000|Overall Study|Ineligible|1|||
155641685|NCT00303953|561779090|FG000|Overall Study|Death|1|||
155641686|NCT00303953|561779090|FG000|Overall Study|Adverse Event|4|||
155641687|NCT00303953|561779090|FG000|Overall Study|Lack of Efficacy|12|||
155641688|NCT00303953|561779090|FG000|Overall Study|Physician Decision|1|||
155641689|NCT00021255|561779091|FG000|Overall Study|Death|1|||
155641690|NCT00021255|561779092|FG001|Overall Study|Death|0|||
155641691|NCT00021255|561779093|FG002|Overall Study|Death|2|||
155641692|NCT00021255|561779091|FG000|Overall Study|Breast cancer relapse|5|||
155641693|NCT00021255|561779092|FG001|Overall Study|Breast cancer relapse|18|||
155641694|NCT00021255|561779093|FG002|Overall Study|Breast cancer relapse|11|||
155641695|NCT00021255|561779091|FG000|Overall Study|Second primary malignancy|0|||
155641696|NCT00021255|561779092|FG001|Overall Study|Second primary malignancy|4|||
155641697|NCT00021255|561779093|FG002|Overall Study|Second primary malignancy|1|||
155641698|NCT00021255|561779091|FG000|Overall Study|Withdrawal by Subject|41|||
155641699|NCT00021255|561779092|FG001|Overall Study|Withdrawal by Subject|64|||
155641700|NCT00021255|561779093|FG002|Overall Study|Withdrawal by Subject|26|||
155641701|NCT00021255|561779091|FG000|Overall Study|Lost to Follow-up|0|||
155641702|NCT00021255|561779092|FG001|Overall Study|Lost to Follow-up|2|||
155641703|NCT00021255|561779093|FG002|Overall Study|Lost to Follow-up|3|||
155641704|NCT00021255|561779091|FG000|Overall Study|Cardiac toxicity|0|||
155641705|NCT00021255|561779092|FG001|Overall Study|Cardiac toxicity|61|||
155641706|NCT00021255|561779093|FG002|Overall Study|Cardiac toxicity|32|||
155641707|NCT00021255|561779091|FG000|Overall Study|Herceptin toxicity|0|||
155641708|NCT00021255|561779092|FG001|Overall Study|Herceptin toxicity|22|||
155641709|NCT00021255|561779093|FG002|Overall Study|Herceptin toxicity|6|||
155641710|NCT00021255|561779091|FG000|Overall Study|Adverse Event|46|||
155641711|NCT00021255|561779092|FG001|Overall Study|Adverse Event|30|||
155641712|NCT00021255|561779093|FG002|Overall Study|Adverse Event|18|||
155641713|NCT00021255|561779091|FG000|Overall Study|Protocol Violation|0|||
155641714|NCT00021255|561779092|FG001|Overall Study|Protocol Violation|2|||
155641715|NCT00021255|561779093|FG002|Overall Study|Protocol Violation|0|||
155641716|NCT00021255|561779091|FG000|Overall Study|Other than specified above|0|||
155641717|NCT00021255|561779092|FG001|Overall Study|Other than specified above|38|||
155641718|NCT00021255|561779093|FG002|Overall Study|Other than specified above|19|||
155641719|NCT00021255|561779091|FG000|Overall Study|Missing|0|||
155641720|NCT00021255|561779092|FG001|Overall Study|Missing|27|||
155641721|NCT00021255|561779093|FG002|Overall Study|Missing|13|||
155641722|NCT00021255|561779091|FG000|Overall Study|Randomized but not treated|28|||
155641723|NCT00021255|561779092|FG001|Overall Study|Randomized but not treated|2|||
155641724|NCT00021255|561779093|FG002|Overall Study|Randomized but not treated|18|||
155641725|NCT01132755|561779096|FG000|Overall Study|Procedure not done due to medical reason|23|||
155641726|NCT01132755|561779096|FG000|Overall Study|Protocol Violation|15|||
155641727|NCT01132755|561779096|FG000|Overall Study|Withdrawal by Subject|4|||
155641728|NCT02232698|561779097|FG000|Overall Study|Pregnancy|1|||
155641729|NCT02232698|561779098|FG001|Overall Study|Pregnancy|1|||
155641730|NCT02232698|561779097|FG000|Overall Study|Met exclusion criteria|1|||
155641731|NCT02232698|561779098|FG001|Overall Study|Met exclusion criteria|1|||
155641732|NCT02232698|561779097|FG000|Overall Study|Had device-associated symptoms|7|||
155641733|NCT02232698|561779098|FG001|Overall Study|Had device-associated symptoms|0|||
155641734|NCT02232698|561779097|FG000|Overall Study|Non-compliance with study device|1|||
155641735|NCT02232698|561779098|FG001|Overall Study|Non-compliance with study device|4|||
155641736|NCT02232698|561779097|FG000|Overall Study|Allocated to control group|0|||
155641737|NCT02232698|561779098|FG001|Overall Study|Allocated to control group|3|||
155641738|NCT02232698|561779097|FG000|Overall Study|Withdrawal by Subject|0|||
155641739|NCT02232698|561779098|FG001|Overall Study|Withdrawal by Subject|11|||
155641740|NCT02393755|561779099|FG000|Overall Study|Withdrawal by Subject|0|||
155641741|NCT02393755|561779100|FG001|Overall Study|Withdrawal by Subject|3|||
155641742|NCT02393755|561779099|FG000|Overall Study|Adverse Event|0|||
155641743|NCT02393755|561779100|FG001|Overall Study|Adverse Event|2|||
155641744|NCT02393755|561779099|FG000|Overall Study|Physician Decision|0|||
155641745|NCT02393755|561779100|FG001|Overall Study|Physician Decision|2|||
155641746|NCT01131585|561779102|FG000|Overall Study|Adverse Event|0|||
155641747|NCT01131585|561779103|FG001|Overall Study|Adverse Event|2|||
155641748|NCT01131585|561779102|FG000|Overall Study|Abnormal laboratory value|1|||
155641749|NCT01131585|561779103|FG001|Overall Study|Abnormal laboratory value|0|||
155641750|NCT01131585|561779102|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155641751|NCT01131585|561779103|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155412644|NCT03440814|560942572|FG001|Overall Study|Lost to Follow-up|0|||
155302973|NCT02723955|560542685|FG030|Escalation Phase|Physician Decision|0|||
155302974|NCT02723955|560542686|FG031|Escalation Phase|Physician Decision|0|||
155302975|NCT02723955|560542687|FG032|Escalation Phase|Physician Decision|0|||
155302976|NCT02723955|560542688|FG033|Escalation Phase|Physician Decision|0|||
155302977|NCT02723955|560542689|FG034|Escalation Phase|Physician Decision|0|||
155302978|NCT02723955|560542690|FG035|Escalation Phase|Physician Decision|0|||
155302979|NCT02723955|560542691|FG036|Escalation Phase|Physician Decision|0|||
155302980|NCT02723955|560542692|FG037|Escalation Phase|Physician Decision|0|||
155302981|NCT02723955|560542693|FG038|Escalation Phase|Physician Decision|0|||
155302982|NCT02723955|560542694|FG039|Escalation Phase|Physician Decision|0|||
155302983|NCT02723955|560542695|FG040|Escalation Phase|Physician Decision|0|||
155641752|NCT01131585|561779102|FG000|Overall Study|Protocol Violation|2|||
155641753|NCT01131585|561779103|FG001|Overall Study|Protocol Violation|1|||
155641754|NCT01131585|561779102|FG000|Overall Study|Withdrawal by Subject|3|||
155641755|NCT01131585|561779103|FG001|Overall Study|Withdrawal by Subject|3|||
155641756|NCT01131585|561779102|FG000|Overall Study|Lost to Follow-up|0|||
155641757|NCT01131585|561779103|FG001|Overall Study|Lost to Follow-up|1|||
155641758|NCT01131585|561779102|FG000|Overall Study|Administrative problems|1|||
155641759|NCT01131585|561779103|FG001|Overall Study|Administrative problems|1|||
155641760|NCT01131585|561779102|FG000|Overall Study|Study termination|78|||
155641761|NCT01131585|561779103|FG001|Overall Study|Study termination|32|||
155641762|NCT00812097|561779104|FG000|Overall Study|Death|3|||
155641763|NCT00812097|561779105|FG001|Overall Study|Death|10|||
155641764|NCT00812097|561779106|FG002|Overall Study|Death|3|||
155641765|NCT00812097|561779107|FG003|Overall Study|Death|3|||
155641766|NCT00812097|561779104|FG000|Overall Study|Withdrawal by Subject|14|||
155641767|NCT00812097|561779105|FG001|Overall Study|Withdrawal by Subject|12|||
155641768|NCT00812097|561779106|FG002|Overall Study|Withdrawal by Subject|8|||
155641769|NCT00812097|561779107|FG003|Overall Study|Withdrawal by Subject|2|||
155641770|NCT00812097|561779104|FG000|Overall Study|Lost to Follow-up|90|||
155641771|NCT00812097|561779105|FG001|Overall Study|Lost to Follow-up|14|||
155641772|NCT00812097|561779106|FG002|Overall Study|Lost to Follow-up|17|||
155641773|NCT00812097|561779107|FG003|Overall Study|Lost to Follow-up|5|||
155641774|NCT00812097|561779104|FG000|Overall Study|Explantation of study device(s)|27|||
155641775|NCT00812097|561779105|FG001|Overall Study|Explantation of study device(s)|29|||
155641776|NCT00812097|561779106|FG002|Overall Study|Explantation of study device(s)|14|||
155641777|NCT00812097|561779107|FG003|Overall Study|Explantation of study device(s)|20|||
155641778|NCT00812097|561779104|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
155641779|NCT00812097|561779105|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
155641780|NCT00812097|561779106|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
155641781|NCT00812097|561779107|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
155641782|NCT00927082|561779108|FG000|Overall Study|Lost to Follow-up|9|||
155641783|NCT00927082|561779109|FG001|Overall Study|Lost to Follow-up|8|||
155641784|NCT00927082|561779110|FG002|Overall Study|Lost to Follow-up|12|||
155641785|NCT00927082|561779111|FG003|Overall Study|Lost to Follow-up|16|||
155641786|NCT00927082|561779108|FG000|Overall Study|Withdrawal by Subject|3|||
155641787|NCT00927082|561779109|FG001|Overall Study|Withdrawal by Subject|2|||
155641788|NCT00927082|561779110|FG002|Overall Study|Withdrawal by Subject|7|||
155641789|NCT00927082|561779111|FG003|Overall Study|Withdrawal by Subject|2|||
155641790|NCT00927082|561779108|FG000|Overall Study|Death|0|||
155641791|NCT00927082|561779109|FG001|Overall Study|Death|0|||
155641792|NCT00927082|561779110|FG002|Overall Study|Death|1|||
155641793|NCT00927082|561779111|FG003|Overall Study|Death|0|||
155641794|NCT00927082|561779108|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
155641795|NCT00927082|561779109|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
155641796|NCT00927082|561779110|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
155641797|NCT00927082|561779111|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
155641798|NCT01786109|561779113|FG000|Overall Study|fail manometry barostat tube placement|1|||
155641799|NCT01786109|561779114|FG001|Overall Study|fail manometry barostat tube placement|0|||
155641800|NCT01786109|561779115|FG002|Overall Study|fail manometry barostat tube placement|0|||
155641801|NCT01786109|561779113|FG000|Overall Study|unrelated illness|0|||
155641802|NCT01786109|561779114|FG001|Overall Study|unrelated illness|0|||
155641803|NCT01786109|561779115|FG002|Overall Study|unrelated illness|1|||
155641804|NCT01786109|561779113|FG000|Overall Study|adverse effects colon preparation|0|||
155641805|NCT01786109|561779114|FG001|Overall Study|adverse effects colon preparation|0|||
155302984|NCT02723955|560542696|FG041|Escalation Phase|Physician Decision|0|||
155302985|NCT02723955|560542697|FG042|Escalation Phase|Physician Decision|0|||
155641806|NCT01786109|561779115|FG002|Overall Study|adverse effects colon preparation|1|||
155641807|NCT02949934|561779122|FG000|Natural Drinking Period|Adverse Event|1|||
155641808|NCT02949934|561779123|FG001|Natural Drinking Period|Adverse Event|0|||
155641809|NCT02949934|561779124|FG002|Natural Drinking Period|Adverse Event|0|||
155641810|NCT02949934|561779125|FG003|Natural Drinking Period|Adverse Event|1|||
155641811|NCT02949934|561779126|FG004|Natural Drinking Period|Adverse Event|0|||
155641812|NCT02949934|561779127|FG005|Natural Drinking Period|Adverse Event|0|||
155641813|NCT02949934|561779122|FG000|Natural Drinking Period|Lost to Follow-up|0|||
155749067|NCT02545543|562181405|FG000|Overall Study|Noncomplaince|1|||
155302986|NCT02723955|560542655|FG000|Escalation Phase|Withdrawal by Subject|0|||
155302987|NCT02723955|560542656|FG001|Escalation Phase|Withdrawal by Subject|0|||
155302988|NCT02723955|560542657|FG002|Escalation Phase|Withdrawal by Subject|0|||
155302989|NCT02723955|560542658|FG003|Escalation Phase|Withdrawal by Subject|0|||
155302990|NCT02723955|560542659|FG004|Escalation Phase|Withdrawal by Subject|1|||
155496902|NCT03539952|561242419|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
155412645|NCT03440814|560942571|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
155412646|NCT03440814|560942572|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
155412647|NCT00088374|560942573|FG000|Overall Study|patient did not receive any 17AAG|1|||
155412648|NCT00088374|560942573|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
155412649|NCT03205995|560942583|FG000|Overall Study|Adverse Event|1|||
155496903|NCT03539952|561242420|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
155412650|NCT03205995|560942583|FG000|Overall Study|Death|1|||
155412651|NCT03205995|560942583|FG000|Overall Study|Physician Decision|2|||
155412652|NCT03205995|560942583|FG000|Overall Study|Protocol Violation|2|||
155412653|NCT05913232|560942585|FG000|Overall Study|Adverse Event|0|||
155412654|NCT05913232|560942586|FG001|Overall Study|Adverse Event|2|||
155412655|NCT05913232|560942587|FG002|Overall Study|Adverse Event|1|||
155412656|NCT05913232|560942588|FG003|Overall Study|Adverse Event|1|||
155412657|NCT05103332|560942591|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412658|NCT05103332|560942592|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
155412659|NCT05103332|560942593|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
155412660|NCT05103332|560942594|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412661|NCT05103332|560942595|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412662|NCT05103332|560942596|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
155412663|NCT05103332|560942597|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412664|NCT05103332|560942598|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412665|NCT05103332|560942599|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412666|NCT05103332|560942600|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412667|NCT05103332|560942601|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412668|NCT05103332|560942602|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155302991|NCT02723955|560542660|FG005|Escalation Phase|Withdrawal by Subject|1|||
155302992|NCT02723955|560542661|FG006|Escalation Phase|Withdrawal by Subject|1|||
155302993|NCT02723955|560542662|FG007|Escalation Phase|Withdrawal by Subject|1|||
155302994|NCT02723955|560542663|FG008|Escalation Phase|Withdrawal by Subject|0|||
155302995|NCT02723955|560542664|FG009|Escalation Phase|Withdrawal by Subject|0|||
155302996|NCT02723955|560542665|FG010|Escalation Phase|Withdrawal by Subject|0|||
155302997|NCT02723955|560542666|FG011|Escalation Phase|Withdrawal by Subject|0|||
155302998|NCT02723955|560542667|FG012|Escalation Phase|Withdrawal by Subject|1|||
155302999|NCT02723955|560542668|FG013|Escalation Phase|Withdrawal by Subject|0|||
155303000|NCT02723955|560542669|FG014|Escalation Phase|Withdrawal by Subject|0|||
155303001|NCT02723955|560542670|FG015|Escalation Phase|Withdrawal by Subject|0|||
155303002|NCT02723955|560542671|FG016|Escalation Phase|Withdrawal by Subject|1|||
155303003|NCT02723955|560542672|FG017|Escalation Phase|Withdrawal by Subject|0|||
155303004|NCT02723955|560542673|FG018|Escalation Phase|Withdrawal by Subject|0|||
155303005|NCT02723955|560542674|FG019|Escalation Phase|Withdrawal by Subject|0|||
155303006|NCT02723955|560542675|FG020|Escalation Phase|Withdrawal by Subject|0|||
155303007|NCT02723955|560542676|FG021|Escalation Phase|Withdrawal by Subject|0|||
155303008|NCT02723955|560542677|FG022|Escalation Phase|Withdrawal by Subject|0|||
155303009|NCT02723955|560542678|FG023|Escalation Phase|Withdrawal by Subject|2|||
155303010|NCT02723955|560542679|FG024|Escalation Phase|Withdrawal by Subject|0|||
155412669|NCT05103332|560942603|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155303011|NCT02723955|560542680|FG025|Escalation Phase|Withdrawal by Subject|1|||
155303012|NCT02723955|560542681|FG026|Escalation Phase|Withdrawal by Subject|0|||
155303013|NCT02723955|560542682|FG027|Escalation Phase|Withdrawal by Subject|0|||
155303014|NCT02723955|560542683|FG028|Escalation Phase|Withdrawal by Subject|1|||
155303015|NCT02723955|560542684|FG029|Escalation Phase|Withdrawal by Subject|0|||
155303016|NCT02723955|560542685|FG030|Escalation Phase|Withdrawal by Subject|0|||
155303017|NCT02723955|560542686|FG031|Escalation Phase|Withdrawal by Subject|0|||
155303018|NCT02723955|560542687|FG032|Escalation Phase|Withdrawal by Subject|0|||
155303019|NCT02723955|560542688|FG033|Escalation Phase|Withdrawal by Subject|0|||
155303020|NCT02723955|560542689|FG034|Escalation Phase|Withdrawal by Subject|0|||
155303021|NCT02723955|560542690|FG035|Escalation Phase|Withdrawal by Subject|0|||
155303022|NCT02723955|560542691|FG036|Escalation Phase|Withdrawal by Subject|0|||
155303023|NCT02723955|560542692|FG037|Escalation Phase|Withdrawal by Subject|0|||
155412670|NCT05103332|560942604|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412671|NCT05103332|560942605|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412672|NCT05103332|560942606|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412673|NCT05103332|560942607|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412674|NCT05103332|560942608|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412675|NCT05103332|560942591|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412676|NCT05103332|560942592|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
155412677|NCT05103332|560942593|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
155303024|NCT02723955|560542693|FG038|Escalation Phase|Withdrawal by Subject|0|||
155303025|NCT02723955|560542694|FG039|Escalation Phase|Withdrawal by Subject|0|||
155303026|NCT02723955|560542695|FG040|Escalation Phase|Withdrawal by Subject|0|||
155303027|NCT02723955|560542696|FG041|Escalation Phase|Withdrawal by Subject|0|||
155303028|NCT02723955|560542697|FG042|Escalation Phase|Withdrawal by Subject|0|||
155303029|NCT02723955|560542655|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303030|NCT02723955|560542656|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303031|NCT02723955|560542657|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303032|NCT02723955|560542658|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303033|NCT02723955|560542659|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
155303034|NCT02723955|560542660|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
155303035|NCT02723955|560542661|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
155303036|NCT02723955|560542662|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
155303037|NCT02723955|560542663|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
155303038|NCT02723955|560542664|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303039|NCT02723955|560542665|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303040|NCT02723955|560542666|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303041|NCT02723955|560542667|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303042|NCT02723955|560542668|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303043|NCT02723955|560542669|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303044|NCT02723955|560542670|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303045|NCT02723955|560542671|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303046|NCT02723955|560542672|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303047|NCT02723955|560542673|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303048|NCT02723955|560542674|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303049|NCT02723955|560542675|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303050|NCT02723955|560542676|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303051|NCT02723955|560542677|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303052|NCT02723955|560542678|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303053|NCT02723955|560542679|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303054|NCT02723955|560542680|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303055|NCT02723955|560542681|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303056|NCT02723955|560542682|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303057|NCT02723955|560542683|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303058|NCT02723955|560542684|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303059|NCT02723955|560542685|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303060|NCT02723955|560542686|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303061|NCT02723955|560542687|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303062|NCT02723955|560542688|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303063|NCT02723955|560542689|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303064|NCT02723955|560542690|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303065|NCT02723955|560542691|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303066|NCT02723955|560542692|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303067|NCT02723955|560542693|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303068|NCT02723955|560542694|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303069|NCT02723955|560542695|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155412678|NCT05103332|560942594|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
155412679|NCT05103332|560942595|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412680|NCT05103332|560942596|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412681|NCT05103332|560942597|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412682|NCT05103332|560942598|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412683|NCT05103332|560942599|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412684|NCT05103332|560942600|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412685|NCT05103332|560942601|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412686|NCT05103332|560942602|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
155496904|NCT03539952|561242419|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
155303070|NCT02723955|560542696|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303071|NCT02723955|560542697|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303072|NCT02723955|560542655|FG000|Escalation Phase|Site Closed|0|||
155303073|NCT02723955|560542656|FG001|Escalation Phase|Site Closed|0|||
155303074|NCT02723955|560542657|FG002|Escalation Phase|Site Closed|0|||
155303075|NCT02723955|560542658|FG003|Escalation Phase|Site Closed|0|||
155303076|NCT02723955|560542659|FG004|Escalation Phase|Site Closed|0|||
155303077|NCT02723955|560542660|FG005|Escalation Phase|Site Closed|0|||
155303078|NCT02723955|560542661|FG006|Escalation Phase|Site Closed|0|||
155303079|NCT02723955|560542662|FG007|Escalation Phase|Site Closed|0|||
155303080|NCT02723955|560542663|FG008|Escalation Phase|Site Closed|0|||
155303081|NCT02723955|560542664|FG009|Escalation Phase|Site Closed|0|||
155303082|NCT02723955|560542665|FG010|Escalation Phase|Site Closed|0|||
155303083|NCT02723955|560542666|FG011|Escalation Phase|Site Closed|0|||
155303084|NCT02723955|560542667|FG012|Escalation Phase|Site Closed|0|||
155303085|NCT02723955|560542668|FG013|Escalation Phase|Site Closed|0|||
155303086|NCT02723955|560542669|FG014|Escalation Phase|Site Closed|0|||
155303087|NCT02723955|560542670|FG015|Escalation Phase|Site Closed|1|||
155303088|NCT02723955|560542671|FG016|Escalation Phase|Site Closed|0|||
155303089|NCT02723955|560542672|FG017|Escalation Phase|Site Closed|2|||
155303090|NCT02723955|560542673|FG018|Escalation Phase|Site Closed|0|||
155303091|NCT02723955|560542674|FG019|Escalation Phase|Site Closed|0|||
155303092|NCT02723955|560542675|FG020|Escalation Phase|Site Closed|1|||
155303093|NCT02723955|560542676|FG021|Escalation Phase|Site Closed|0|||
155303094|NCT02723955|560542677|FG022|Escalation Phase|Site Closed|0|||
155303095|NCT02723955|560542678|FG023|Escalation Phase|Site Closed|0|||
155303096|NCT02723955|560542679|FG024|Escalation Phase|Site Closed|3|||
155303097|NCT02723955|560542680|FG025|Escalation Phase|Site Closed|1|||
155303098|NCT02723955|560542681|FG026|Escalation Phase|Site Closed|3|||
155303099|NCT02723955|560542682|FG027|Escalation Phase|Site Closed|1|||
155303100|NCT02723955|560542683|FG028|Escalation Phase|Site Closed|1|||
155303101|NCT02723955|560542684|FG029|Escalation Phase|Site Closed|0|||
155303102|NCT02723955|560542685|FG030|Escalation Phase|Site Closed|0|||
155303103|NCT02723955|560542686|FG031|Escalation Phase|Site Closed|0|||
155303104|NCT02723955|560542687|FG032|Escalation Phase|Site Closed|0|||
155303105|NCT02723955|560542688|FG033|Escalation Phase|Site Closed|0|||
155303106|NCT02723955|560542689|FG034|Escalation Phase|Site Closed|0|||
155303107|NCT02723955|560542690|FG035|Escalation Phase|Site Closed|0|||
155303108|NCT02723955|560542691|FG036|Escalation Phase|Site Closed|0|||
155303109|NCT02723955|560542692|FG037|Escalation Phase|Site Closed|0|||
155303110|NCT02723955|560542693|FG038|Escalation Phase|Site Closed|0|||
155303111|NCT02723955|560542694|FG039|Escalation Phase|Site Closed|0|||
155303112|NCT02723955|560542695|FG040|Escalation Phase|Site Closed|0|||
155303113|NCT02723955|560542696|FG041|Escalation Phase|Site Closed|0|||
155303114|NCT02723955|560542697|FG042|Escalation Phase|Site Closed|0|||
155303115|NCT02723955|560542655|FG000|Expansion Phase|Death|0|||
155303116|NCT02723955|560542656|FG001|Expansion Phase|Death|0|||
155303117|NCT02723955|560542657|FG002|Expansion Phase|Death|0|||
155303118|NCT02723955|560542658|FG003|Expansion Phase|Death|0|||
155303119|NCT02723955|560542659|FG004|Expansion Phase|Death|0|||
155303120|NCT02723955|560542660|FG005|Expansion Phase|Death|0|||
155303121|NCT02723955|560542661|FG006|Expansion Phase|Death|0|||
155303122|NCT02723955|560542662|FG007|Expansion Phase|Death|0|||
155303123|NCT02723955|560542663|FG008|Expansion Phase|Death|0|||
155303124|NCT02723955|560542664|FG009|Expansion Phase|Death|25|||
155303125|NCT02723955|560542665|FG010|Expansion Phase|Death|69|||
155303126|NCT02723955|560542666|FG011|Expansion Phase|Death|48|||
155303127|NCT02723955|560542667|FG012|Expansion Phase|Death|0|||
155303128|NCT02723955|560542668|FG013|Expansion Phase|Death|0|||
155303129|NCT02723955|560542669|FG014|Expansion Phase|Death|0|||
155303130|NCT02723955|560542670|FG015|Expansion Phase|Death|0|||
155303131|NCT02723955|560542671|FG016|Expansion Phase|Death|0|||
155303132|NCT02723955|560542672|FG017|Expansion Phase|Death|0|||
155303133|NCT02723955|560542673|FG018|Expansion Phase|Death|0|||
155303134|NCT02723955|560542674|FG019|Expansion Phase|Death|0|||
155303135|NCT02723955|560542675|FG020|Expansion Phase|Death|0|||
155303136|NCT02723955|560542676|FG021|Expansion Phase|Death|0|||
155749068|NCT02545543|562181406|FG001|Overall Study|Noncomplaince|0|||
155303137|NCT02723955|560542677|FG022|Expansion Phase|Death|0|||
155303138|NCT02723955|560542678|FG023|Expansion Phase|Death|0|||
155412687|NCT05103332|560942603|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412688|NCT05103332|560942604|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
155303139|NCT02723955|560542679|FG024|Expansion Phase|Death|0|||
155303140|NCT02723955|560542680|FG025|Expansion Phase|Death|0|||
155303141|NCT02723955|560542681|FG026|Expansion Phase|Death|0|||
155303142|NCT02723955|560542682|FG027|Expansion Phase|Death|0|||
155303143|NCT02723955|560542683|FG028|Expansion Phase|Death|0|||
155303144|NCT02723955|560542684|FG029|Expansion Phase|Death|12|||
155303145|NCT02723955|560542685|FG030|Expansion Phase|Death|202|||
155303146|NCT02723955|560542686|FG031|Expansion Phase|Death|31|||
155303147|NCT02723955|560542687|FG032|Expansion Phase|Death|17|||
155303148|NCT02723955|560542688|FG033|Expansion Phase|Death|2|||
155303149|NCT02723955|560542689|FG034|Expansion Phase|Death|3|||
155303150|NCT02723955|560542690|FG035|Expansion Phase|Death|3|||
155303151|NCT02723955|560542691|FG036|Expansion Phase|Death|1|||
155303152|NCT02723955|560542692|FG037|Expansion Phase|Death|0|||
155303153|NCT02723955|560542693|FG038|Expansion Phase|Death|0|||
155303154|NCT02723955|560542694|FG039|Expansion Phase|Death|0|||
155303155|NCT02723955|560542695|FG040|Expansion Phase|Death|0|||
155303156|NCT02723955|560542696|FG041|Expansion Phase|Death|0|||
155303157|NCT02723955|560542697|FG042|Expansion Phase|Death|0|||
155303158|NCT02723955|560542655|FG000|Expansion Phase|Lost to Follow-up|0|||
155303159|NCT02723955|560542656|FG001|Expansion Phase|Lost to Follow-up|0|||
155303160|NCT02723955|560542657|FG002|Expansion Phase|Lost to Follow-up|0|||
155303161|NCT02723955|560542658|FG003|Expansion Phase|Lost to Follow-up|0|||
155303162|NCT02723955|560542659|FG004|Expansion Phase|Lost to Follow-up|0|||
155303163|NCT02723955|560542660|FG005|Expansion Phase|Lost to Follow-up|0|||
155303164|NCT02723955|560542661|FG006|Expansion Phase|Lost to Follow-up|0|||
155303165|NCT02723955|560542662|FG007|Expansion Phase|Lost to Follow-up|0|||
155303166|NCT02723955|560542663|FG008|Expansion Phase|Lost to Follow-up|0|||
155303167|NCT02723955|560542664|FG009|Expansion Phase|Lost to Follow-up|0|||
155303168|NCT02723955|560542665|FG010|Expansion Phase|Lost to Follow-up|4|||
155303169|NCT02723955|560542666|FG011|Expansion Phase|Lost to Follow-up|1|||
155303170|NCT02723955|560542667|FG012|Expansion Phase|Lost to Follow-up|0|||
155303171|NCT02723955|560542668|FG013|Expansion Phase|Lost to Follow-up|0|||
155303172|NCT02723955|560542669|FG014|Expansion Phase|Lost to Follow-up|0|||
155303173|NCT02723955|560542670|FG015|Expansion Phase|Lost to Follow-up|0|||
155303174|NCT02723955|560542671|FG016|Expansion Phase|Lost to Follow-up|0|||
155303175|NCT02723955|560542672|FG017|Expansion Phase|Lost to Follow-up|0|||
155303176|NCT02723955|560542673|FG018|Expansion Phase|Lost to Follow-up|0|||
155303177|NCT02723955|560542674|FG019|Expansion Phase|Lost to Follow-up|0|||
155303178|NCT02723955|560542675|FG020|Expansion Phase|Lost to Follow-up|0|||
155303179|NCT02723955|560542676|FG021|Expansion Phase|Lost to Follow-up|0|||
155303180|NCT02723955|560542677|FG022|Expansion Phase|Lost to Follow-up|0|||
155303181|NCT02723955|560542678|FG023|Expansion Phase|Lost to Follow-up|0|||
155412689|NCT05103332|560942605|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412690|NCT05103332|560942606|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412691|NCT05103332|560942607|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412692|NCT05103332|560942608|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
155412693|NCT05103332|560942591|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
155303182|NCT02723955|560542679|FG024|Expansion Phase|Lost to Follow-up|0|||
155412694|NCT05103332|560942592|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
155412695|NCT05103332|560942593|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
155412696|NCT05103332|560942594|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
155412697|NCT05103332|560942595|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
155412698|NCT05103332|560942596|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
155412699|NCT05103332|560942597|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412700|NCT05103332|560942598|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412701|NCT05103332|560942599|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412702|NCT05103332|560942600|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412703|NCT05103332|560942601|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412704|NCT05103332|560942602|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412705|NCT05103332|560942603|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412706|NCT05103332|560942604|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412707|NCT05103332|560942605|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155641814|NCT02949934|561779123|FG001|Natural Drinking Period|Lost to Follow-up|0|||
155303183|NCT02723955|560542680|FG025|Expansion Phase|Lost to Follow-up|0|||
155303184|NCT02723955|560542681|FG026|Expansion Phase|Lost to Follow-up|0|||
155303185|NCT02723955|560542682|FG027|Expansion Phase|Lost to Follow-up|0|||
155303186|NCT02723955|560542683|FG028|Expansion Phase|Lost to Follow-up|0|||
155303187|NCT02723955|560542684|FG029|Expansion Phase|Lost to Follow-up|1|||
155303188|NCT02723955|560542685|FG030|Expansion Phase|Lost to Follow-up|19|||
155303189|NCT02723955|560542686|FG031|Expansion Phase|Lost to Follow-up|2|||
155641815|NCT02949934|561779124|FG002|Natural Drinking Period|Lost to Follow-up|0|||
155641816|NCT02949934|561779125|FG003|Natural Drinking Period|Lost to Follow-up|0|||
155641817|NCT02949934|561779126|FG004|Natural Drinking Period|Lost to Follow-up|1|||
155641818|NCT02949934|561779127|FG005|Natural Drinking Period|Lost to Follow-up|0|||
155303190|NCT02723955|560542687|FG032|Expansion Phase|Lost to Follow-up|1|||
155303191|NCT02723955|560542688|FG033|Expansion Phase|Lost to Follow-up|0|||
155303192|NCT02723955|560542689|FG034|Expansion Phase|Lost to Follow-up|0|||
155303193|NCT02723955|560542690|FG035|Expansion Phase|Lost to Follow-up|0|||
155303194|NCT02723955|560542691|FG036|Expansion Phase|Lost to Follow-up|0|||
155303195|NCT02723955|560542692|FG037|Expansion Phase|Lost to Follow-up|0|||
155303196|NCT02723955|560542693|FG038|Expansion Phase|Lost to Follow-up|0|||
155303197|NCT02723955|560542694|FG039|Expansion Phase|Lost to Follow-up|0|||
155303198|NCT02723955|560542695|FG040|Expansion Phase|Lost to Follow-up|0|||
155303199|NCT02723955|560542696|FG041|Expansion Phase|Lost to Follow-up|0|||
155303200|NCT02723955|560542697|FG042|Expansion Phase|Lost to Follow-up|0|||
155303201|NCT02723955|560542655|FG000|Expansion Phase|Physician Decision|0|||
155303202|NCT02723955|560542656|FG001|Expansion Phase|Physician Decision|0|||
155303203|NCT02723955|560542657|FG002|Expansion Phase|Physician Decision|0|||
155303204|NCT02723955|560542658|FG003|Expansion Phase|Physician Decision|0|||
155303205|NCT02723955|560542659|FG004|Expansion Phase|Physician Decision|0|||
155303206|NCT02723955|560542660|FG005|Expansion Phase|Physician Decision|0|||
155303207|NCT02723955|560542661|FG006|Expansion Phase|Physician Decision|0|||
155303208|NCT02723955|560542662|FG007|Expansion Phase|Physician Decision|0|||
155303209|NCT02723955|560542663|FG008|Expansion Phase|Physician Decision|0|||
155303210|NCT02723955|560542664|FG009|Expansion Phase|Physician Decision|0|||
155303211|NCT02723955|560542665|FG010|Expansion Phase|Physician Decision|0|||
155303212|NCT02723955|560542666|FG011|Expansion Phase|Physician Decision|0|||
155303213|NCT02723955|560542667|FG012|Expansion Phase|Physician Decision|0|||
155303214|NCT02723955|560542668|FG013|Expansion Phase|Physician Decision|0|||
155303215|NCT02723955|560542669|FG014|Expansion Phase|Physician Decision|0|||
155303216|NCT02723955|560542670|FG015|Expansion Phase|Physician Decision|0|||
155303217|NCT02723955|560542671|FG016|Expansion Phase|Physician Decision|0|||
155303218|NCT02723955|560542672|FG017|Expansion Phase|Physician Decision|0|||
155303219|NCT02723955|560542673|FG018|Expansion Phase|Physician Decision|0|||
155303220|NCT02723955|560542674|FG019|Expansion Phase|Physician Decision|0|||
155303221|NCT02723955|560542675|FG020|Expansion Phase|Physician Decision|0|||
155303222|NCT02723955|560542676|FG021|Expansion Phase|Physician Decision|0|||
155303223|NCT02723955|560542677|FG022|Expansion Phase|Physician Decision|0|||
155303224|NCT02723955|560542678|FG023|Expansion Phase|Physician Decision|0|||
155303225|NCT02723955|560542679|FG024|Expansion Phase|Physician Decision|0|||
155303226|NCT02723955|560542680|FG025|Expansion Phase|Physician Decision|0|||
155303227|NCT02723955|560542681|FG026|Expansion Phase|Physician Decision|0|||
155303228|NCT02723955|560542682|FG027|Expansion Phase|Physician Decision|0|||
155303229|NCT02723955|560542683|FG028|Expansion Phase|Physician Decision|0|||
155303230|NCT02723955|560542684|FG029|Expansion Phase|Physician Decision|0|||
155303231|NCT02723955|560542685|FG030|Expansion Phase|Physician Decision|1|||
155303232|NCT02723955|560542686|FG031|Expansion Phase|Physician Decision|1|||
155303233|NCT02723955|560542687|FG032|Expansion Phase|Physician Decision|0|||
155303234|NCT02723955|560542688|FG033|Expansion Phase|Physician Decision|0|||
155303235|NCT02723955|560542689|FG034|Expansion Phase|Physician Decision|0|||
155303236|NCT02723955|560542690|FG035|Expansion Phase|Physician Decision|0|||
155303237|NCT02723955|560542691|FG036|Expansion Phase|Physician Decision|0|||
155749069|NCT02545543|562181405|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
155749070|NCT02545543|562181406|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
155749071|NCT00811642|562181411|FG000|Overall Study|Adverse Event|3|||
155749072|NCT00811642|562181411|FG000|Overall Study|Protocol Violation|1|||
155749073|NCT00811642|562181411|FG000|Overall Study|Death|2|||
155749074|NCT00811642|562181411|FG000|Overall Study|Withdrawal by Subject|7|||
155749075|NCT00811642|562181411|FG000|Overall Study|Cumulative use of antifungal agent|2|||
155749076|NCT02829944|562181415|FG000|Overall Study|Physician Decision|0|||
155749077|NCT02829944|562181416|FG001|Overall Study|Physician Decision|1|||
155749078|NCT02829944|562181415|FG000|Overall Study|Screen Failure|2|||
155749079|NCT02829944|562181416|FG001|Overall Study|Screen Failure|2|||
155749080|NCT02829944|562181415|FG000|Overall Study|Inadequate Neuraxial Block|1|||
155749081|NCT02829944|562181416|FG001|Overall Study|Inadequate Neuraxial Block|1|||
155749082|NCT02829944|562181415|FG000|Overall Study|Withdrawal by Subject|2|||
155749083|NCT02829944|562181416|FG001|Overall Study|Withdrawal by Subject|1|||
155749084|NCT02829944|562181415|FG000|Overall Study|Catheter Displacement|1|||
155749085|NCT02829944|562181416|FG001|Overall Study|Catheter Displacement|0|||
155749086|NCT02829944|562181415|FG000|Overall Study|Catheter broke|0|||
155749087|NCT02829944|562181416|FG001|Overall Study|Catheter broke|1|||
155749088|NCT02829944|562181415|FG000|Overall Study|Staff unavailable|0|||
155749089|NCT02829944|562181416|FG001|Overall Study|Staff unavailable|1|||
155303238|NCT02723955|560542692|FG037|Expansion Phase|Physician Decision|0|||
155303239|NCT02723955|560542693|FG038|Expansion Phase|Physician Decision|0|||
155303240|NCT02723955|560542694|FG039|Expansion Phase|Physician Decision|0|||
155303241|NCT02723955|560542695|FG040|Expansion Phase|Physician Decision|0|||
155303242|NCT02723955|560542696|FG041|Expansion Phase|Physician Decision|0|||
155303243|NCT02723955|560542697|FG042|Expansion Phase|Physician Decision|0|||
155303244|NCT02723955|560542655|FG000|Expansion Phase|Withdrawal by Subject|0|||
155303245|NCT02723955|560542656|FG001|Expansion Phase|Withdrawal by Subject|0|||
155436102|NCT00149214|561024514|FG000|Overall Study|Withdrawal by Subject|4|||
155749090|NCT04675151|562181420|FG000|Overall Study|Protocol Violation|1|||
155749091|NCT04675151|562181421|FG001|Overall Study|Protocol Violation|0|||
155749092|NCT04675151|562181422|FG002|Overall Study|Protocol Violation|0|||
155749093|NCT04675151|562181423|FG003|Overall Study|Protocol Violation|1|||
155749094|NCT01730937|562181424|FG000|Overall Study|Protocol Violation|5|||
155303246|NCT02723955|560542657|FG002|Expansion Phase|Withdrawal by Subject|0|||
155303247|NCT02723955|560542658|FG003|Expansion Phase|Withdrawal by Subject|0|||
155303248|NCT02723955|560542659|FG004|Expansion Phase|Withdrawal by Subject|0|||
155303249|NCT02723955|560542660|FG005|Expansion Phase|Withdrawal by Subject|0|||
155303250|NCT02723955|560542661|FG006|Expansion Phase|Withdrawal by Subject|0|||
155303251|NCT02723955|560542662|FG007|Expansion Phase|Withdrawal by Subject|0|||
155303252|NCT02723955|560542663|FG008|Expansion Phase|Withdrawal by Subject|0|||
155303253|NCT02723955|560542664|FG009|Expansion Phase|Withdrawal by Subject|2|||
155303254|NCT02723955|560542665|FG010|Expansion Phase|Withdrawal by Subject|1|||
155303255|NCT02723955|560542666|FG011|Expansion Phase|Withdrawal by Subject|0|||
155303256|NCT02723955|560542667|FG012|Expansion Phase|Withdrawal by Subject|0|||
155303257|NCT02723955|560542668|FG013|Expansion Phase|Withdrawal by Subject|0|||
155303258|NCT02723955|560542669|FG014|Expansion Phase|Withdrawal by Subject|0|||
155303259|NCT02723955|560542670|FG015|Expansion Phase|Withdrawal by Subject|0|||
155303260|NCT02723955|560542671|FG016|Expansion Phase|Withdrawal by Subject|0|||
155303261|NCT02723955|560542672|FG017|Expansion Phase|Withdrawal by Subject|0|||
155303262|NCT02723955|560542673|FG018|Expansion Phase|Withdrawal by Subject|0|||
155303263|NCT02723955|560542674|FG019|Expansion Phase|Withdrawal by Subject|0|||
155303264|NCT02723955|560542675|FG020|Expansion Phase|Withdrawal by Subject|0|||
155303265|NCT02723955|560542676|FG021|Expansion Phase|Withdrawal by Subject|0|||
155303266|NCT02723955|560542677|FG022|Expansion Phase|Withdrawal by Subject|0|||
155303267|NCT02723955|560542678|FG023|Expansion Phase|Withdrawal by Subject|0|||
155303268|NCT02723955|560542679|FG024|Expansion Phase|Withdrawal by Subject|0|||
155303269|NCT02723955|560542680|FG025|Expansion Phase|Withdrawal by Subject|0|||
155303270|NCT02723955|560542681|FG026|Expansion Phase|Withdrawal by Subject|0|||
155303271|NCT02723955|560542682|FG027|Expansion Phase|Withdrawal by Subject|0|||
155303272|NCT02723955|560542683|FG028|Expansion Phase|Withdrawal by Subject|0|||
155303273|NCT02723955|560542684|FG029|Expansion Phase|Withdrawal by Subject|0|||
155303274|NCT02723955|560542685|FG030|Expansion Phase|Withdrawal by Subject|8|||
155303275|NCT02723955|560542686|FG031|Expansion Phase|Withdrawal by Subject|4|||
155303276|NCT02723955|560542687|FG032|Expansion Phase|Withdrawal by Subject|0|||
155303277|NCT02723955|560542688|FG033|Expansion Phase|Withdrawal by Subject|0|||
155303278|NCT02723955|560542689|FG034|Expansion Phase|Withdrawal by Subject|0|||
155303279|NCT02723955|560542690|FG035|Expansion Phase|Withdrawal by Subject|1|||
155303280|NCT02723955|560542691|FG036|Expansion Phase|Withdrawal by Subject|0|||
155303281|NCT02723955|560542692|FG037|Expansion Phase|Withdrawal by Subject|0|||
155303282|NCT02723955|560542693|FG038|Expansion Phase|Withdrawal by Subject|0|||
155303283|NCT02723955|560542694|FG039|Expansion Phase|Withdrawal by Subject|0|||
155303284|NCT02723955|560542695|FG040|Expansion Phase|Withdrawal by Subject|0|||
155303285|NCT02723955|560542696|FG041|Expansion Phase|Withdrawal by Subject|0|||
155303286|NCT02723955|560542697|FG042|Expansion Phase|Withdrawal by Subject|0|||
155303287|NCT02723955|560542655|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303288|NCT02723955|560542656|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303289|NCT02723955|560542657|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303290|NCT02723955|560542658|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303291|NCT02723955|560542659|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303292|NCT02723955|560542660|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303293|NCT02723955|560542661|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303294|NCT02723955|560542662|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303295|NCT02723955|560542663|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303296|NCT02723955|560542664|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
155303297|NCT02723955|560542665|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
155303298|NCT02723955|560542666|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
155303299|NCT02723955|560542667|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303300|NCT02723955|560542668|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303301|NCT02723955|560542669|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303302|NCT02723955|560542670|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303303|NCT02723955|560542671|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303304|NCT02723955|560542672|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303305|NCT02723955|560542673|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155412708|NCT05103332|560942606|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412709|NCT05103332|560942607|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412710|NCT05103332|560942608|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412711|NCT05103332|560942591|FG000|DB Period (6 Months=168 Days)|Other|0|||
155412712|NCT05103332|560942592|FG001|DB Period (6 Months=168 Days)|Other|0|||
155412713|NCT05103332|560942593|FG002|DB Period (6 Months=168 Days)|Other|0|||
155303306|NCT02723955|560542674|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303307|NCT02723955|560542675|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303308|NCT02723955|560542676|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303309|NCT02723955|560542677|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303310|NCT02723955|560542678|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303311|NCT02723955|560542679|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303312|NCT02723955|560542680|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303313|NCT02723955|560542681|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303314|NCT02723955|560542682|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303315|NCT02723955|560542683|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303316|NCT02723955|560542684|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303317|NCT02723955|560542685|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
155303318|NCT02723955|560542686|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303319|NCT02723955|560542687|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303320|NCT02723955|560542688|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303321|NCT02723955|560542689|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303322|NCT02723955|560542690|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303323|NCT02723955|560542691|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303324|NCT02723955|560542692|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303325|NCT02723955|560542693|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303326|NCT02723955|560542694|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303327|NCT02723955|560542695|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303328|NCT02723955|560542696|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303329|NCT02723955|560542697|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303330|NCT02723955|560542655|FG000|Expansion Phase|Site Closed|0|||
155303331|NCT02723955|560542656|FG001|Expansion Phase|Site Closed|0|||
155303332|NCT02723955|560542657|FG002|Expansion Phase|Site Closed|0|||
155303333|NCT02723955|560542658|FG003|Expansion Phase|Site Closed|0|||
155303334|NCT02723955|560542659|FG004|Expansion Phase|Site Closed|0|||
155303335|NCT02723955|560542660|FG005|Expansion Phase|Site Closed|0|||
155303336|NCT02723955|560542661|FG006|Expansion Phase|Site Closed|0|||
155303337|NCT02723955|560542662|FG007|Expansion Phase|Site Closed|0|||
155412714|NCT05103332|560942594|FG003|DB Period (6 Months=168 Days)|Other|1|||
155412715|NCT05103332|560942595|FG004|DB Period (6 Months=168 Days)|Other|0|||
155412716|NCT05103332|560942596|FG005|DB Period (6 Months=168 Days)|Other|0|||
155749095|NCT01730937|562181425|FG001|Overall Study|Protocol Violation|11|||
155749096|NCT03947684|562181426|FG000|Overall Study|Lost to Follow-up|13|||
155749097|NCT03947684|562181427|FG001|Overall Study|Lost to Follow-up|5|||
155749098|NCT03947684|562181428|FG002|Overall Study|Lost to Follow-up|1|||
155749099|NCT03947684|562181426|FG000|Overall Study|Withdrawal by Subject|11|||
155749100|NCT03947684|562181427|FG001|Overall Study|Withdrawal by Subject|4|||
155749101|NCT03947684|562181428|FG002|Overall Study|Withdrawal by Subject|0|||
155749102|NCT03947684|562181426|FG000|Overall Study|Physician Decision|1|||
155749103|NCT03947684|562181427|FG001|Overall Study|Physician Decision|0|||
155749104|NCT03947684|562181428|FG002|Overall Study|Physician Decision|0|||
155749105|NCT03947684|562181426|FG000|Overall Study|Lack of adherence to study protocol|2|||
155303338|NCT02723955|560542663|FG008|Expansion Phase|Site Closed|0|||
155303339|NCT02723955|560542664|FG009|Expansion Phase|Site Closed|1|||
155303340|NCT02723955|560542665|FG010|Expansion Phase|Site Closed|2|||
155303341|NCT02723955|560542666|FG011|Expansion Phase|Site Closed|6|||
155303342|NCT02723955|560542667|FG012|Expansion Phase|Site Closed|0|||
155412717|NCT05103332|560942597|FG006|DB Period (6 Months=168 Days)|Other|0|||
155412718|NCT05103332|560942598|FG007|DB Period (6 Months=168 Days)|Other|0|||
155749106|NCT03947684|562181427|FG001|Overall Study|Lack of adherence to study protocol|0|||
155749107|NCT03947684|562181428|FG002|Overall Study|Lack of adherence to study protocol|0|||
155749108|NCT03875235|562181430|FG000|Overall Study|Ongoing study treatment|63|||
155303343|NCT02723955|560542668|FG013|Expansion Phase|Site Closed|0|||
155303344|NCT02723955|560542669|FG014|Expansion Phase|Site Closed|0|||
155303345|NCT02723955|560542670|FG015|Expansion Phase|Site Closed|0|||
155303346|NCT02723955|560542671|FG016|Expansion Phase|Site Closed|0|||
155303347|NCT02723955|560542672|FG017|Expansion Phase|Site Closed|0|||
155303348|NCT02723955|560542673|FG018|Expansion Phase|Site Closed|0|||
155303349|NCT02723955|560542674|FG019|Expansion Phase|Site Closed|0|||
155303350|NCT02723955|560542675|FG020|Expansion Phase|Site Closed|0|||
155303351|NCT02723955|560542676|FG021|Expansion Phase|Site Closed|0|||
155303352|NCT02723955|560542677|FG022|Expansion Phase|Site Closed|0|||
155412719|NCT05103332|560942599|FG008|DB Period (6 Months=168 Days)|Other|0|||
155412720|NCT05103332|560942600|FG009|DB Period (6 Months=168 Days)|Other|0|||
155412721|NCT05103332|560942601|FG010|DB Period (6 Months=168 Days)|Other|0|||
155303353|NCT02723955|560542678|FG023|Expansion Phase|Site Closed|0|||
155303354|NCT02723955|560542679|FG024|Expansion Phase|Site Closed|0|||
155303355|NCT02723955|560542680|FG025|Expansion Phase|Site Closed|0|||
155303356|NCT02723955|560542681|FG026|Expansion Phase|Site Closed|0|||
155303357|NCT02723955|560542682|FG027|Expansion Phase|Site Closed|0|||
155303358|NCT02723955|560542683|FG028|Expansion Phase|Site Closed|0|||
155303359|NCT02723955|560542684|FG029|Expansion Phase|Site Closed|0|||
155303360|NCT02723955|560542685|FG030|Expansion Phase|Site Closed|8|||
155303361|NCT02723955|560542686|FG031|Expansion Phase|Site Closed|4|||
155303362|NCT02723955|560542687|FG032|Expansion Phase|Site Closed|2|||
155303363|NCT02723955|560542688|FG033|Expansion Phase|Site Closed|2|||
155303364|NCT02723955|560542689|FG034|Expansion Phase|Site Closed|0|||
155303365|NCT02723955|560542690|FG035|Expansion Phase|Site Closed|0|||
155303366|NCT02723955|560542691|FG036|Expansion Phase|Site Closed|0|||
155303367|NCT02723955|560542692|FG037|Expansion Phase|Site Closed|0|||
155303368|NCT02723955|560542693|FG038|Expansion Phase|Site Closed|0|||
155303369|NCT02723955|560542694|FG039|Expansion Phase|Site Closed|0|||
155303370|NCT02723955|560542695|FG040|Expansion Phase|Site Closed|0|||
155303371|NCT02723955|560542696|FG041|Expansion Phase|Site Closed|0|||
155303372|NCT02723955|560542697|FG042|Expansion Phase|Site Closed|0|||
155303373|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Death|0|||
155303374|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Death|0|||
155303375|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Death|0|||
155303376|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Death|0|||
155303377|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Death|0|||
155303378|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Death|0|||
155303379|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Death|0|||
155303380|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Death|0|||
155303381|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Death|0|||
155303382|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Death|0|||
155303383|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Death|0|||
155303384|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Death|0|||
155303385|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Death|0|||
155303386|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Death|0|||
155303387|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Death|0|||
155303388|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Death|0|||
155303389|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Death|0|||
155303390|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Death|0|||
155303391|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Death|0|||
155303392|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Death|0|||
155303393|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Death|0|||
155303394|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Death|0|||
155303395|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Death|0|||
155303396|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Death|0|||
155412722|NCT05103332|560942602|FG011|DB Period (6 Months=168 Days)|Other|0|||
155303397|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Death|0|||
155303398|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Death|0|||
155303399|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Death|0|||
155303400|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Death|0|||
155303401|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Death|0|||
155303402|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Death|0|||
155303403|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Death|0|||
155303404|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Death|0|||
155303405|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Death|0|||
155303406|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Death|0|||
155303407|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Death|0|||
155303408|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Death|0|||
155303409|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Death|0|||
155303410|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Death|1|||
155303411|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Death|14|||
155303412|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Death|32|||
155303413|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Death|2|||
155303414|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Death|1|||
155303415|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Death|0|||
155303416|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303417|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303418|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303419|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303420|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303421|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303422|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303423|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303424|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303425|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303426|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303427|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303428|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303429|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303430|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303431|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303432|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303433|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303434|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303435|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303436|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303437|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303438|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303439|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303440|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303441|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303442|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303443|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303444|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303445|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303446|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303447|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303448|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303449|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303450|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303451|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303452|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303453|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303454|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303455|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
155303456|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303457|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303458|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303459|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303460|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303461|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303462|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303463|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303464|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303465|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303466|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303467|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303468|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
155412723|NCT05103332|560942603|FG012|DB Period (6 Months=168 Days)|Other|0|||
155641819|NCT02949934|561779122|FG000|Neuroimaging|Protocol Violation|2|||
155303469|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303470|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
155412724|NCT05103332|560942604|FG013|DB Period (6 Months=168 Days)|Other|0|||
155412725|NCT05103332|560942605|FG014|DB Period (6 Months=168 Days)|Other|0|||
155641820|NCT02949934|561779123|FG001|Neuroimaging|Protocol Violation|0|||
155303471|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303472|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303473|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303474|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303475|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303476|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303477|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303478|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303479|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303480|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303481|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303482|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303483|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303484|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303485|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303486|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303487|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303488|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303489|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303490|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303491|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303492|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303493|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303494|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303495|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303496|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303497|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303498|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303499|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303500|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303501|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303502|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
155303503|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
155303504|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
155303505|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
155303506|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
155303507|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
155303508|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
155412726|NCT05103332|560942606|FG015|DB Period (6 Months=168 Days)|Other|0|||
155412727|NCT05103332|560942607|FG016|DB Period (6 Months=168 Days)|Other|0|||
155412728|NCT05103332|560942608|FG017|DB Period (6 Months=168 Days)|Other|0|||
155412729|NCT05103332|560942591|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412730|NCT05103332|560942592|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412731|NCT05103332|560942593|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412732|NCT05103332|560942594|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412733|NCT05103332|560942595|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412734|NCT05103332|560942596|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155303509|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
155303510|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
155303511|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
155412735|NCT05103332|560942597|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412736|NCT05103332|560942598|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412737|NCT05103332|560942599|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412738|NCT05103332|560942600|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155303512|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
155303513|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
155303514|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
155303515|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
155303516|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
155412739|NCT05103332|560942601|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
155412740|NCT05103332|560942602|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412741|NCT05103332|560942603|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412742|NCT05103332|560942604|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412743|NCT05103332|560942605|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412744|NCT05103332|560942606|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155303517|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
155412745|NCT05103332|560942607|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412746|NCT05103332|560942608|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
155412747|NCT05103332|560942591|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155303518|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
155303519|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
155303520|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
155641821|NCT02949934|561779124|FG002|Neuroimaging|Protocol Violation|0|||
155303521|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
155303522|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
155303523|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
155303524|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
155303525|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
155303526|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
155303527|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
155303528|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
155303529|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
155303530|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
155303531|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
155303532|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
155303533|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
155303534|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
155303535|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
155303536|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
155303537|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
155303538|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
155303539|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
155303540|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
155303541|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
155303542|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
155303543|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
155303544|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
155303545|NCT04999085|560542700|FG000|Overall Study|Death|1|||
155303546|NCT05056246|560542703|FG000|Overall Study|Adverse Event|0|||
155303547|NCT05056246|560542704|FG001|Overall Study|Adverse Event|0|||
155303548|NCT05056246|560542705|FG002|Overall Study|Adverse Event|0|||
155303549|NCT05056246|560542706|FG003|Overall Study|Adverse Event|0|||
155303550|NCT05056246|560542707|FG004|Overall Study|Adverse Event|1|||
155303551|NCT05056246|560542703|FG000|Overall Study|Lost to Follow-up|0|||
155303552|NCT05056246|560542704|FG001|Overall Study|Lost to Follow-up|0|||
155303553|NCT05056246|560542705|FG002|Overall Study|Lost to Follow-up|0|||
155303554|NCT05056246|560542706|FG003|Overall Study|Lost to Follow-up|2|||
155303555|NCT05056246|560542707|FG004|Overall Study|Lost to Follow-up|0|||
155303556|NCT05056246|560542703|FG000|Overall Study|Withdrawal by Subject|0|||
155303557|NCT05056246|560542704|FG001|Overall Study|Withdrawal by Subject|1|||
155303558|NCT05056246|560542705|FG002|Overall Study|Withdrawal by Subject|0|||
155303559|NCT05056246|560542706|FG003|Overall Study|Withdrawal by Subject|0|||
155303560|NCT05056246|560542707|FG004|Overall Study|Withdrawal by Subject|0|||
155303561|NCT05057897|560542708|FG000|Overall Study|Site closure|2|||
155303562|NCT05057897|560542709|FG001|Overall Study|Site closure|2|||
155303563|NCT05057897|560542708|FG000|Overall Study|Death|1|||
155303564|NCT05057897|560542709|FG001|Overall Study|Death|0|||
155303565|NCT05096819|560542714|FG000|Overall Study|Withdrawal by Subject|3|||
155303566|NCT05096819|560542715|FG001|Overall Study|Withdrawal by Subject|0|||
155303567|NCT03324984|560542716|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
155303568|NCT03324984|560542717|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
155303569|NCT03346538|560542718|FG000|Overall Study|Physician Decision|0|||
155303570|NCT03346538|560542719|FG001|Overall Study|Physician Decision|1|||
155303571|NCT03346538|560542720|FG002|Overall Study|Physician Decision|0|||
155303572|NCT03346538|560542718|FG000|Overall Study|Withdrawal by Subject|3|||
155303573|NCT03346538|560542719|FG001|Overall Study|Withdrawal by Subject|2|||
155303574|NCT03346538|560542720|FG002|Overall Study|Withdrawal by Subject|0|||
155303575|NCT03346538|560542718|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
155303576|NCT03346538|560542719|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
155303577|NCT03346538|560542720|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
155303578|NCT03088813|560542721|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303579|NCT03088813|560542722|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
155303580|NCT03088813|560542723|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303581|NCT03088813|560542724|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303582|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303583|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303584|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
155641822|NCT02949934|561779125|FG003|Neuroimaging|Protocol Violation|0|||
155641823|NCT02949934|561779126|FG004|Neuroimaging|Protocol Violation|1|||
155303585|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303586|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
155303587|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
155303588|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
155496905|NCT03539952|561242420|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
155641824|NCT02949934|561779127|FG005|Neuroimaging|Protocol Violation|0|||
155303589|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
155303590|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
155303591|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
155303592|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
155303593|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
155303594|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
155303595|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
155303596|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
155303597|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
155303598|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303599|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303600|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303601|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
155303602|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303603|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303604|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
155303605|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303606|NCT01808339|560542738|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303607|NCT01808339|560542739|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303608|NCT01808339|560542740|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303609|NCT01808339|560542741|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303610|NCT01808339|560542742|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
155303611|NCT01808339|560542743|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303612|NCT01808339|560542738|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303613|NCT01808339|560542739|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155303614|NCT01808339|560542740|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303615|NCT01808339|560542741|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155303616|NCT01808339|560542742|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303617|NCT01808339|560542743|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303618|NCT01808339|560542738|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303619|NCT01808339|560542739|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303620|NCT01808339|560542740|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303621|NCT01808339|560542741|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303622|NCT01808339|560542742|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303623|NCT01808339|560542743|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155412748|NCT05103332|560942592|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412749|NCT05103332|560942593|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412750|NCT05103332|560942594|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412751|NCT05103332|560942595|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412752|NCT05103332|560942596|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412753|NCT05103332|560942597|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412754|NCT05103332|560942598|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412755|NCT05103332|560942599|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
155412756|NCT05103332|560942600|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412757|NCT05103332|560942601|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412758|NCT05103332|560942602|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412759|NCT05103332|560942603|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412760|NCT05103332|560942604|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412761|NCT05103332|560942605|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412762|NCT05103332|560942606|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412763|NCT05103332|560942607|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155412764|NCT05103332|560942608|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
155641825|NCT02949934|561779122|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
155641826|NCT02949934|561779123|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
155641827|NCT02949934|561779124|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
155641828|NCT02949934|561779125|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
155641829|NCT02949934|561779126|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
155641830|NCT02949934|561779127|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
155641831|NCT02949934|561779122|FG000|Neuroimaging|Not scanned|0|||
155641832|NCT02949934|561779123|FG001|Neuroimaging|Not scanned|0|||
155641833|NCT02949934|561779124|FG002|Neuroimaging|Not scanned|1|||
155641834|NCT02949934|561779125|FG003|Neuroimaging|Not scanned|0|||
155641835|NCT02949934|561779126|FG004|Neuroimaging|Not scanned|0|||
155641836|NCT02949934|561779127|FG005|Neuroimaging|Not scanned|2|||
155641837|NCT02949934|561779122|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
155303624|NCT00111813|560542753|FG000|Overall Study|Adverse Event|1|||
155303625|NCT00111813|560542754|FG001|Overall Study|Adverse Event|2|||
155303626|NCT00111813|560542755|FG002|Overall Study|Adverse Event|4|||
155303627|NCT00111813|560542756|FG003|Overall Study|Adverse Event|2|||
155303628|NCT00111813|560542757|FG004|Overall Study|Adverse Event|2|||
155303629|NCT00111813|560542758|FG005|Overall Study|Adverse Event|2|||
155303630|NCT00111813|560542753|FG000|Overall Study|Progressive disease|2|||
155303631|NCT00111813|560542754|FG001|Overall Study|Progressive disease|1|||
155303632|NCT00111813|560542755|FG002|Overall Study|Progressive disease|5|||
155303633|NCT00111813|560542756|FG003|Overall Study|Progressive disease|3|||
155303634|NCT00111813|560542757|FG004|Overall Study|Progressive disease|4|||
155303635|NCT00111813|560542758|FG005|Overall Study|Progressive disease|3|||
155303636|NCT00111813|560542753|FG000|Overall Study|Lack of Efficacy|0|||
155303637|NCT00111813|560542754|FG001|Overall Study|Lack of Efficacy|0|||
155303638|NCT00111813|560542755|FG002|Overall Study|Lack of Efficacy|0|||
155303639|NCT00111813|560542756|FG003|Overall Study|Lack of Efficacy|0|||
155303640|NCT00111813|560542757|FG004|Overall Study|Lack of Efficacy|0|||
155303641|NCT00111813|560542758|FG005|Overall Study|Lack of Efficacy|1|||
155303642|NCT00111813|560542753|FG000|Overall Study|Other|0|||
155303643|NCT00111813|560542754|FG001|Overall Study|Other|0|||
155303644|NCT00111813|560542755|FG002|Overall Study|Other|1|||
155303645|NCT00111813|560542756|FG003|Overall Study|Other|0|||
155641838|NCT02949934|561779123|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155641839|NCT02949934|561779124|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155641840|NCT02949934|561779125|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
155303646|NCT00111813|560542757|FG004|Overall Study|Other|0|||
155303647|NCT00111813|560542758|FG005|Overall Study|Other|0|||
155303648|NCT00093015|560542766|FG000|Overall Study|Withdrawal by Subject|194|||
155303649|NCT00093015|560542767|FG001|Overall Study|Withdrawal by Subject|171|||
155303650|NCT00093015|560542766|FG000|Overall Study|Lost to Follow-up|96|||
155303651|NCT00093015|560542767|FG001|Overall Study|Lost to Follow-up|108|||
155303652|NCT00093015|560542766|FG000|Overall Study|Death|375|||
155303653|NCT00093015|560542767|FG001|Overall Study|Death|385|||
155303654|NCT03076515|560542770|FG000|Overall Study|DMC decision based on interim analysis|25|||
155303655|NCT03076515|560542771|FG001|Overall Study|DMC decision based on interim analysis|29|||
155303656|NCT02101281|560542772|FG000|Overall Study|Adverse Event|0|||
155303657|NCT02101281|560542773|FG001|Overall Study|Adverse Event|1|||
155303658|NCT00296036|560542774|FG000|Overall Study|Withdrawal by Subject|1|||
155303659|NCT00296036|560542775|FG001|Overall Study|Withdrawal by Subject|0|||
155303660|NCT00296036|560542776|FG002|Overall Study|Withdrawal by Subject|2|||
155303661|NCT00296036|560542777|FG003|Overall Study|Withdrawal by Subject|1|||
155303662|NCT00296036|560542778|FG004|Overall Study|Withdrawal by Subject|2|||
155303663|NCT00296036|560542779|FG005|Overall Study|Withdrawal by Subject|1|||
155303664|NCT00296036|560542774|FG000|Overall Study|Protocol Violation|0|||
155303665|NCT00296036|560542775|FG001|Overall Study|Protocol Violation|0|||
155303666|NCT00296036|560542776|FG002|Overall Study|Protocol Violation|0|||
155303667|NCT00296036|560542777|FG003|Overall Study|Protocol Violation|0|||
155303668|NCT00296036|560542778|FG004|Overall Study|Protocol Violation|0|||
155303669|NCT00296036|560542779|FG005|Overall Study|Protocol Violation|3|||
155303670|NCT00529100|560542784|FG000|Overall Study|Adverse Event|0|||
155303671|NCT00529100|560542785|FG001|Overall Study|Adverse Event|5|||
155303672|NCT00529100|560542784|FG000|Overall Study|Protocol Violation|0|||
155303673|NCT00529100|560542785|FG001|Overall Study|Protocol Violation|1|||
155303674|NCT00529100|560542784|FG000|Overall Study|Progressive Disease|0|||
155303675|NCT00529100|560542785|FG001|Overall Study|Progressive Disease|1|||
155303676|NCT00529100|560542784|FG000|Overall Study|Withdrawal by Subject|0|||
155303677|NCT00529100|560542785|FG001|Overall Study|Withdrawal by Subject|1|||
155303678|NCT00529100|560542784|FG000|Overall Study|Participant Ineligibility|0|||
155303679|NCT00529100|560542785|FG001|Overall Study|Participant Ineligibility|1|||
155412765|NCT05103332|560942591|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412766|NCT05103332|560942592|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412767|NCT05103332|560942593|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412768|NCT05103332|560942594|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412769|NCT05103332|560942595|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155303680|NCT03733119|560542786|FG000|Overall Study|Physician Decision|2|||
155303681|NCT03733119|560542787|FG001|Overall Study|Physician Decision|1|||
155303682|NCT03733119|560542786|FG000|Overall Study|ineligible to treat per protocol|0|||
155303683|NCT03733119|560542787|FG001|Overall Study|ineligible to treat per protocol|1|||
155303684|NCT00807937|560542788|FG000|Overall Study|Adverse Event|12|||
155303685|NCT00807937|560542789|FG001|Overall Study|Adverse Event|12|||
155412770|NCT05103332|560942596|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412771|NCT05103332|560942597|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412772|NCT05103332|560942598|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412773|NCT05103332|560942599|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412774|NCT05103332|560942600|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155303686|NCT00807937|560542790|FG002|Overall Study|Adverse Event|5|||
155303687|NCT00807937|560542791|FG003|Overall Study|Adverse Event|4|||
155303688|NCT00807937|560542788|FG000|Overall Study|Protocol Violation|4|||
155303689|NCT00807937|560542789|FG001|Overall Study|Protocol Violation|5|||
155303690|NCT00807937|560542790|FG002|Overall Study|Protocol Violation|3|||
155303691|NCT00807937|560542791|FG003|Overall Study|Protocol Violation|3|||
155303692|NCT00807937|560542788|FG000|Overall Study|Withdrawal by Subject|5|||
155303693|NCT00807937|560542789|FG001|Overall Study|Withdrawal by Subject|4|||
155303694|NCT00807937|560542790|FG002|Overall Study|Withdrawal by Subject|1|||
155303695|NCT00807937|560542791|FG003|Overall Study|Withdrawal by Subject|4|||
155303696|NCT00807937|560542788|FG000|Overall Study|Lost to Follow-up|4|||
155303697|NCT00807937|560542789|FG001|Overall Study|Lost to Follow-up|0|||
155303698|NCT00807937|560542790|FG002|Overall Study|Lost to Follow-up|2|||
155303699|NCT00807937|560542791|FG003|Overall Study|Lost to Follow-up|1|||
155303700|NCT00807937|560542788|FG000|Overall Study|Lack of Efficacy|0|||
155303701|NCT00807937|560542789|FG001|Overall Study|Lack of Efficacy|0|||
155303702|NCT00807937|560542790|FG002|Overall Study|Lack of Efficacy|1|||
155303703|NCT00807937|560542791|FG003|Overall Study|Lack of Efficacy|2|||
155303704|NCT00807937|560542788|FG000|Overall Study|Intake of prohibited medicine|0|||
155303705|NCT00807937|560542789|FG001|Overall Study|Intake of prohibited medicine|0|||
155303706|NCT00807937|560542790|FG002|Overall Study|Intake of prohibited medicine|2|||
155303707|NCT00807937|560542791|FG003|Overall Study|Intake of prohibited medicine|0|||
155303708|NCT00807937|560542788|FG000|Overall Study|All other reasons (not provided)|2|||
155303709|NCT00807937|560542789|FG001|Overall Study|All other reasons (not provided)|4|||
155303710|NCT00807937|560542790|FG002|Overall Study|All other reasons (not provided)|0|||
155303711|NCT00807937|560542791|FG003|Overall Study|All other reasons (not provided)|1|||
155303712|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
155303713|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
155303714|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
155303715|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
155303716|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303717|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
155303718|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303719|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303720|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303721|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
155303722|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303723|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303724|NCT04629950|560542794|FG000|Extension Study|Withdrawal by Subject|0|||
155303725|NCT04629950|560542795|FG001|Extension Study|Withdrawal by Subject|0|||
155303726|NCT04629950|560542796|FG002|Extension Study|Withdrawal by Subject|1|||
155303727|NCT04629950|560542797|FG003|Extension Study|Withdrawal by Subject|0|||
155303728|NCT04629950|560542794|FG000|Extension Study|Adverse Event|0|||
155303729|NCT04629950|560542795|FG001|Extension Study|Adverse Event|0|||
155303730|NCT04629950|560542796|FG002|Extension Study|Adverse Event|0|||
155303731|NCT04629950|560542797|FG003|Extension Study|Adverse Event|1|||
155303732|NCT01198145|560542798|FG000|Overall Study|Withdrawal by Subject|1|||
155303733|NCT01198145|560542799|FG001|Overall Study|Withdrawal by Subject|1|||
155303734|NCT02568683|560542801|FG000|Overall Study|Death|0|||
155303735|NCT02568683|560542802|FG001|Overall Study|Death|2|||
155303736|NCT02568683|560542801|FG000|Overall Study|Withdrew Consent|1|||
155303737|NCT02568683|560542802|FG001|Overall Study|Withdrew Consent|0|||
155303738|NCT02568683|560542801|FG000|Overall Study|Study Terminated By Sponsor|5|||
155303739|NCT02568683|560542802|FG001|Overall Study|Study Terminated By Sponsor|2|||
155303740|NCT01561989|560542805|FG000|Overall Study|accural target not met.|5|||
155303741|NCT01561989|560542806|FG001|Overall Study|accural target not met.|6|||
155303742|NCT03485950|560542811|FG000|Overall Study|Adverse Event|1|||
155303743|NCT03485950|560542812|FG001|Overall Study|Adverse Event|0|||
155303744|NCT03485950|560542811|FG000|Overall Study|Death|3|||
155303745|NCT03485950|560542812|FG001|Overall Study|Death|2|||
155303746|NCT03485950|560542811|FG000|Overall Study|Withdrawal by Subject|3|||
155303747|NCT03485950|560542812|FG001|Overall Study|Withdrawal by Subject|0|||
155303748|NCT03930420|560542813|FG000|Overall Study|Withdrawal by Subject|7|||
155303749|NCT03930420|560542814|FG001|Overall Study|Withdrawal by Subject|9|||
155303750|NCT00609336|560542815|FG000|Overall Study|Protocol Violation|3|||
155303751|NCT00609336|560542815|FG000|Overall Study|Death|1|||
155303752|NCT00609336|560542815|FG000|Overall Study|LA or Met at Surgery|9|||
155303753|NCT00567489|560542816|FG000|Overall Study|Adverse Event|6|||
155303754|NCT00567489|560542817|FG001|Overall Study|Adverse Event|14|||
155303755|NCT00567489|560542816|FG000|Overall Study|Physician Decision|0|||
155303756|NCT00567489|560542817|FG001|Overall Study|Physician Decision|4|||
155303757|NCT00567489|560542816|FG000|Overall Study|Withdrawal by Subject|0|||
155303758|NCT00567489|560542817|FG001|Overall Study|Withdrawal by Subject|2|||
155303759|NCT00567489|560542816|FG000|Overall Study|Renal Transplantation|0|||
155303760|NCT00567489|560542817|FG001|Overall Study|Renal Transplantation|3|||
155303761|NCT00567489|560542816|FG000|Overall Study|Other|1|||
155303762|NCT00567489|560542817|FG001|Overall Study|Other|0|||
155303763|NCT00068601|560542820|FG000|Overall Study|Ineligible|11|||
155303764|NCT00068601|560542821|FG001|Overall Study|Ineligible|13|||
155303765|NCT00068601|560542820|FG000|Overall Study|Not evaluable: withdrew consent|5|||
155303766|NCT00068601|560542821|FG001|Overall Study|Not evaluable: withdrew consent|4|||
155303767|NCT00068601|560542820|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
155303768|NCT00068601|560542821|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
155303769|NCT00068601|560542820|FG000|Overall Study|Death|11|||
155303770|NCT00068601|560542821|FG001|Overall Study|Death|3|||
155303771|NCT00068601|560542820|FG000|Overall Study|Lost to Follow-up|3|||
155303772|NCT00068601|560542821|FG001|Overall Study|Lost to Follow-up|2|||
155303773|NCT00068601|560542820|FG000|Overall Study|Missing primary outcome data|30|||
155303774|NCT00068601|560542821|FG001|Overall Study|Missing primary outcome data|34|||
155303775|NCT01061671|560542822|FG000|Overall Study|Withdrawal by Subject|16|||
155303776|NCT01061671|560542823|FG001|Overall Study|Withdrawal by Subject|20|||
155303777|NCT01061671|560542822|FG000|Overall Study|Lost to Follow-up|3|||
155303778|NCT01061671|560542823|FG001|Overall Study|Lost to Follow-up|5|||
155303779|NCT01061671|560542822|FG000|Overall Study|Death|28|||
155303780|NCT01061671|560542823|FG001|Overall Study|Death|30|||
155303781|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
155303782|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303783|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303784|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303785|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303786|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
155303787|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303788|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303789|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303790|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303791|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
155303792|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303793|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303794|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303795|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303796|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
155303797|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303798|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303799|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303800|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303801|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
155303802|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303803|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303804|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303805|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303806|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
155303807|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303808|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303809|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303810|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303811|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
155303812|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303813|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303814|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155412775|NCT05103332|560942601|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412776|NCT05103332|560942602|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
155412777|NCT05103332|560942603|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412778|NCT05103332|560942604|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155749109|NCT03875235|562181431|FG001|Overall Study|Ongoing study treatment|20|||
155749110|NCT03875235|562181430|FG000|Overall Study|Off treatment|77|||
155412779|NCT05103332|560942605|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412780|NCT05103332|560942606|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155303815|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303816|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
155303817|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155412781|NCT05103332|560942607|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155412782|NCT05103332|560942608|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
155303818|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155496906|NCT03539952|561242419|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
155303819|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303820|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303821|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
155303822|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303823|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303824|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303825|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303826|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
155303827|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
155303828|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
155303829|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
155303830|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
155303831|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303832|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303833|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303834|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
155303835|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303836|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
155303837|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
155303838|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
155303839|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
155303840|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
155303841|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303842|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
155303843|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
155303844|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303845|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303846|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
155303847|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
155303848|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
155303849|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
155303850|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
155303851|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303852|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303853|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
155303854|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303855|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
155303856|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303857|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303858|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
155303859|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303860|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303861|NCT01205048|560542833|FG000|Overall Study|Withdrawal by Subject|14|||
155303862|NCT01205048|560542833|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
155303863|NCT01205048|560542833|FG000|Overall Study|Lost to Follow-up|4|||
155303864|NCT01205048|560542833|FG000|Overall Study|Other|2|||
155303865|NCT01255670|560542834|FG000|Overall Study|Adverse Event|10|||
155303866|NCT01255670|560542835|FG001|Overall Study|Adverse Event|10|||
155303867|NCT01255670|560542834|FG000|Overall Study|Lost to Follow-up|16|||
155303868|NCT01255670|560542835|FG001|Overall Study|Lost to Follow-up|10|||
155303869|NCT00823472|560542836|FG000|Overall Study|Physician Decision|24|||
155412783|NCT05103332|560942591|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412784|NCT05103332|560942592|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412785|NCT05103332|560942593|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412786|NCT05103332|560942594|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412787|NCT05103332|560942595|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412788|NCT05103332|560942596|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412789|NCT05103332|560942597|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
155412790|NCT05103332|560942598|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
155412791|NCT05103332|560942599|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412792|NCT05103332|560942600|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
155412793|NCT05103332|560942601|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
155412794|NCT05103332|560942602|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
155412795|NCT05103332|560942603|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412796|NCT05103332|560942604|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155496907|NCT03539952|561242420|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
155303870|NCT00823472|560542837|FG001|Overall Study|Physician Decision|28|||
155303871|NCT04992390|560542845|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
155303872|NCT04992390|560542846|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
155303873|NCT04992390|560542847|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
155303874|NCT04992390|560542845|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
155303875|NCT04992390|560542846|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
155303876|NCT04992390|560542847|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
155303877|NCT04992390|560542845|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
155303878|NCT04992390|560542846|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
155303879|NCT04992390|560542847|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
155303880|NCT04992390|560542845|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
155303881|NCT04992390|560542846|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
155303882|NCT04992390|560542847|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
155303883|NCT04992390|560542845|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
155303884|NCT04992390|560542846|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
155303885|NCT04992390|560542847|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
155303886|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
155303887|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
155303888|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
155303889|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
155303890|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
155303891|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
155303892|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
155303893|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
155303894|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
155303895|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
155303896|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
155303897|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
155303898|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
155303899|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
155303900|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
155303901|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
155303902|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
155303903|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
155303904|NCT04992390|560542845|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
155303905|NCT04992390|560542846|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
155303906|NCT04992390|560542847|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
155303907|NCT04992390|560542845|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
155303908|NCT04992390|560542846|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
155303909|NCT04992390|560542847|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
155303910|NCT04992390|560542845|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
155303911|NCT04992390|560542846|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
155303912|NCT04992390|560542847|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
155303913|NCT04992390|560542845|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
155303914|NCT04992390|560542846|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
155303915|NCT04992390|560542847|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
155303916|NCT04992390|560542845|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
155303917|NCT04992390|560542846|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
155303918|NCT04992390|560542847|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
155303919|NCT02769858|560542850|FG000|Overall Study|Withdrawal by Subject|2|||
155303920|NCT02152137|560544453|FG000|Overall Study|Withdrawal by Subject|1|||
155303921|NCT02152137|560544453|FG000|Overall Study|Originally assigned to Arm B|3|||
155303922|NCT04878354|560544454|FG000|Overall Study|Adverse Event|4|||
155303923|NCT04878354|560544455|FG001|Overall Study|Adverse Event|13|||
155303924|NCT04878354|560544454|FG000|Overall Study|Withdrawal by Subject|14|||
155303925|NCT04878354|560544455|FG001|Overall Study|Withdrawal by Subject|12|||
155303926|NCT04878354|560544454|FG000|Overall Study|Lost to Follow-up|4|||
155303927|NCT04878354|560544455|FG001|Overall Study|Lost to Follow-up|1|||
155303928|NCT04878354|560544454|FG000|Overall Study|Lack of Efficacy|1|||
155303929|NCT04878354|560544455|FG001|Overall Study|Lack of Efficacy|0|||
155303930|NCT04878354|560544454|FG000|Overall Study|Protocol Violation|0|||
155303931|NCT04878354|560544455|FG001|Overall Study|Protocol Violation|1|||
155303932|NCT04878354|560544454|FG000|Overall Study|"Reason stated as other in CRF"|2|||
155303933|NCT04878354|560544455|FG001|Overall Study|"Reason stated as other in CRF"|3|||
155303934|NCT03358875|560544456|FG000|Overall Study|Death|409|||
155303935|NCT03358875|560544457|FG001|Overall Study|Death|223|||
155303936|NCT03358875|560544456|FG000|Overall Study|Study Closed by Sponsor|66|||
155496908|NCT03539952|561242419|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
155749111|NCT03875235|562181431|FG001|Overall Study|Off treatment|91|||
155303937|NCT03358875|560544457|FG001|Overall Study|Study Closed by Sponsor|29|||
155303938|NCT03358875|560544456|FG000|Overall Study|Withdrawal by Subject|13|||
155303939|NCT03358875|560544457|FG001|Overall Study|Withdrawal by Subject|16|||
155303940|NCT03358875|560544456|FG000|Overall Study|Lost to Follow-up|13|||
155303941|NCT03358875|560544457|FG001|Overall Study|Lost to Follow-up|2|||
155303942|NCT03358875|560544456|FG000|Overall Study|Miscellaneous|33|||
155303943|NCT03358875|560544457|FG001|Overall Study|Miscellaneous|0|||
155303944|NCT03358875|560544456|FG000|Overall Study|Remained on Study|1|||
155303945|NCT03358875|560544457|FG001|Overall Study|Remained on Study|0|||
155303946|NCT05307783|560544470|FG000|Overall Study|Death|7|||
155303947|NCT05307783|560544470|FG000|Overall Study|Lost to Follow-up|4|||
155303948|NCT04883645|560544471|FG000|Overall Study|Death|1|||
155303949|NCT03460236|560544476|FG000|Overall Study|failed radiographic screening|16|||
155303950|NCT03460236|560544476|FG000|Overall Study|Withdrawal by Subject|11|||
155303951|NCT06194214|560544477|FG000|Overall Study|Adverse Event|1|||
155303952|NCT04540913|560544478|FG000|Overall Study|Withdrawal by Subject|14|||
155303953|NCT04540913|560544479|FG001|Overall Study|Withdrawal by Subject|3|||
155303954|NCT05687903|560544480|FG000|Overall Study|Protocol Deviation|1|||
155303955|NCT05687903|560544481|FG001|Overall Study|Protocol Deviation|1|||
155303956|NCT05687903|560544482|FG002|Overall Study|Protocol Deviation|0|||
155303957|NCT05687903|560544483|FG003|Overall Study|Protocol Deviation|1|||
155303958|NCT05687903|560544484|FG004|Overall Study|Protocol Deviation|0|||
155303959|NCT05613205|560544485|FG000|Overall Study|Lost to Follow-up|0|||
155303960|NCT05613205|560544486|FG001|Overall Study|Lost to Follow-up|0|||
155303961|NCT05613205|560544487|FG002|Overall Study|Lost to Follow-up|1|||
155303962|NCT05613205|560544488|FG003|Overall Study|Lost to Follow-up|1|||
155303963|NCT05613205|560544489|FG004|Overall Study|Lost to Follow-up|0|||
155303964|NCT05613205|560544485|FG000|Overall Study|Withdrawal by Subject|0|||
155303965|NCT05613205|560544486|FG001|Overall Study|Withdrawal by Subject|0|||
155303966|NCT05613205|560544487|FG002|Overall Study|Withdrawal by Subject|1|||
155303967|NCT05613205|560544488|FG003|Overall Study|Withdrawal by Subject|1|||
155303968|NCT05613205|560544489|FG004|Overall Study|Withdrawal by Subject|0|||
155303969|NCT04300231|560544490|FG000|Overall Study|Protocol Violation|4|||
155303970|NCT04300231|560544491|FG001|Overall Study|Protocol Violation|3|||
155303971|NCT04300231|560544492|FG002|Overall Study|Protocol Violation|0|||
155303972|NCT04300231|560544493|FG003|Overall Study|Protocol Violation|2|||
155303973|NCT03050814|560544495|FG000|Overall Study|Screen failures|0|||
155303974|NCT03050814|560544496|FG001|Overall Study|Screen failures|0|||
155303975|NCT03050814|560544497|FG002|Overall Study|Screen failures|4|||
155303976|NCT00431834|560544501|FG000|Overall Study|Withdrawal by Subject|7|||
155303977|NCT00431834|560544501|FG000|Overall Study|Death|3|||
155303978|NCT00431834|560544501|FG000|Overall Study|Missed Endpoint Visit|2|||
155303979|NCT00431834|560544501|FG000|Overall Study|Lost to Follow-up|1|||
155303980|NCT01610297|560544502|FG000|Overall Study|Lost to Follow-up|1|||
155303981|NCT00243503|560544503|FG000|Overall Study|Adverse Event|11|||
155303982|NCT00243503|560544503|FG000|Overall Study|Withdrawal by Subject|1|||
155303983|NCT00243503|560544503|FG000|Overall Study|Lack of Efficacy|44|||
155303984|NCT00243503|560544503|FG000|Overall Study|Death|1|||
155303985|NCT00243503|560544503|FG000|Overall Study|Other|1|||
155303986|NCT00914589|560544504|FG000|Overall Study|Adverse Event|1|||
155303987|NCT00914589|560544505|FG001|Overall Study|Adverse Event|0|||
155303988|NCT00914589|560544506|FG002|Overall Study|Adverse Event|1|||
155303989|NCT00914589|560544504|FG000|Overall Study|Protocol Violation|8|||
155303990|NCT00914589|560544505|FG001|Overall Study|Protocol Violation|6|||
155303991|NCT00914589|560544506|FG002|Overall Study|Protocol Violation|3|||
155303992|NCT00914589|560544504|FG000|Overall Study|unclassified|16|||
155303993|NCT00914589|560544505|FG001|Overall Study|unclassified|9|||
155303994|NCT00914589|560544506|FG002|Overall Study|unclassified|7|||
155303995|NCT00914589|560544504|FG000|Overall Study|Death|0|||
155303996|NCT00914589|560544505|FG001|Overall Study|Death|1|||
155303997|NCT00914589|560544506|FG002|Overall Study|Death|1|||
155303998|NCT00510887|560544507|FG000|Overall Study|Lost to Follow-up|1|||
155303999|NCT02238483|560544511|FG000|Overall Study|Withdrawal by Subject|2|||
155304000|NCT02238483|560544512|FG001|Overall Study|Withdrawal by Subject|7|||
155304001|NCT02238483|560544511|FG000|Overall Study|Lost to Follow-up|1|||
155304002|NCT02238483|560544512|FG001|Overall Study|Lost to Follow-up|1|||
155304003|NCT02238483|560544511|FG000|Overall Study|Protocol Violation|1|||
155304004|NCT02238483|560544512|FG001|Overall Study|Protocol Violation|2|||
155304005|NCT02238483|560544511|FG000|Overall Study|Death|1|||
155304006|NCT02238483|560544512|FG001|Overall Study|Death|0|||
155304007|NCT02238483|560544511|FG000|Overall Study|Adverse Event|7|||
155304008|NCT02238483|560544512|FG001|Overall Study|Adverse Event|3|||
155304009|NCT02238483|560544511|FG000|Overall Study|Withdrawn due to physician decision|1|||
155304010|NCT02238483|560544512|FG001|Overall Study|Withdrawn due to physician decision|0|||
155304011|NCT02238483|560544511|FG000|Overall Study|Completion status not recorded|1|||
155304012|NCT02238483|560544512|FG001|Overall Study|Completion status not recorded|1|||
155304013|NCT02238483|560544511|FG000|Overall Study|Illness in family member|1|||
155304014|NCT02238483|560544512|FG001|Overall Study|Illness in family member|0|||
155304015|NCT02321514|560544518|FG000|Overall Study|Death|15|||
155304016|NCT02321514|560544518|FG000|Overall Study|Missed Visit|7|||
155304017|NCT02321514|560544518|FG000|Overall Study|Study Exit|3|||
155304018|NCT02372253|560544526|FG000|Overall Study|Non Compliance|2|||
155304019|NCT02372253|560544527|FG001|Overall Study|Non Compliance|0|||
155304020|NCT01803555|560544530|FG000|Overall Study|Adverse Event|3|||
155304021|NCT01803555|560544531|FG001|Overall Study|Adverse Event|2|||
155304022|NCT01803555|560544530|FG000|Overall Study|Withdrawal by Subject|3|||
155304023|NCT01803555|560544531|FG001|Overall Study|Withdrawal by Subject|3|||
155304024|NCT01803555|560544530|FG000|Overall Study|Non-compliance|1|||
155304025|NCT01803555|560544531|FG001|Overall Study|Non-compliance|1|||
155304026|NCT01803555|560544530|FG000|Overall Study|Protocol Violation|3|||
155304027|NCT01803555|560544531|FG001|Overall Study|Protocol Violation|5|||
155304028|NCT01803555|560544530|FG000|Overall Study|Lost to Follow-up|0|||
155304029|NCT01803555|560544531|FG001|Overall Study|Lost to Follow-up|2|||
155304030|NCT01803555|560544530|FG000|Overall Study|Other than specified|3|||
155304031|NCT01803555|560544531|FG001|Overall Study|Other than specified|5|||
155304032|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
155304033|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
155304034|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
155304035|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
155304036|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
155304037|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
155304038|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
155304039|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
155304040|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
155304041|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
155304042|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
155304043|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
155304044|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
155304045|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
155304046|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
155304047|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
155304048|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
155304049|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
155304050|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
155304051|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
155304052|NCT02178098|560544539|FG000|Overall Study|Withdrawal by Subject|0|||
155304053|NCT02178098|560544540|FG001|Overall Study|Withdrawal by Subject|6|||
155304054|NCT02178098|560544539|FG000|Overall Study|Adverse Event|1|||
155304055|NCT02178098|560544540|FG001|Overall Study|Adverse Event|2|||
155304056|NCT02178098|560544539|FG000|Overall Study|Protocol Violation|1|||
155304057|NCT02178098|560544540|FG001|Overall Study|Protocol Violation|1|||
155304058|NCT02178098|560544539|FG000|Overall Study|Lost to Follow-up|0|||
155304059|NCT02178098|560544540|FG001|Overall Study|Lost to Follow-up|1|||
155304060|NCT02178098|560544539|FG000|Overall Study|Sponsor Request|1|||
155304061|NCT02178098|560544540|FG001|Overall Study|Sponsor Request|0|||
155304062|NCT02178098|560544539|FG000|Overall Study|Other|2|||
155304063|NCT02178098|560544540|FG001|Overall Study|Other|2|||
155304064|NCT01109524|560544543|FG000|Overall Study|Disease Progression|29|||
155304065|NCT01109524|560544543|FG000|Overall Study|Study Drug toxicity|6|||
155304066|NCT01109524|560544543|FG000|Overall Study|Adverse Event|4|||
155304067|NCT01109524|560544543|FG000|Overall Study|Withdrawal by Subject|2|||
155304068|NCT01109524|560544543|FG000|Overall Study|Maximum clinical benefit|3|||
155304069|NCT01109524|560544543|FG000|Overall Study|Death|2|||
155304070|NCT01109524|560544543|FG000|Overall Study|No longer meets criteria|2|||
155304071|NCT01109524|560544543|FG000|Overall Study|Participant requested to end treatment|4|||
155304072|NCT01109524|560544543|FG000|Overall Study|Other|5|||
155304073|NCT01551355|560544550|FG000|Overall Study|Lost to Follow-up|51|||
155304074|NCT01551355|560544551|FG001|Overall Study|Lost to Follow-up|49|||
155304075|NCT01551355|560544552|FG002|Overall Study|Lost to Follow-up|34|||
155304076|NCT01551355|560544553|FG003|Overall Study|Lost to Follow-up|24|||
155304077|NCT01551355|560544554|FG004|Overall Study|Lost to Follow-up|9|||
155304078|NCT01551355|560544555|FG005|Overall Study|Lost to Follow-up|6|||
155412797|NCT05103332|560942605|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155304079|NCT02318134|560544556|FG000|Overall Study|Withdrawal by Subject|2|||
155304080|NCT02318134|560544557|FG001|Overall Study|Withdrawal by Subject|1|||
155412798|NCT05103332|560942606|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155304081|NCT01925339|560544558|FG000|Overall Study|Adverse Event|2|||
155304082|NCT01925339|560544559|FG001|Overall Study|Adverse Event|0|||
155304083|NCT03664960|560544560|FG000|Overall Study|Adverse Event|0|||
155304084|NCT03664960|560544561|FG001|Overall Study|Adverse Event|3|||
155304085|NCT03664960|560544560|FG000|Overall Study|Lost to Follow-up|3|||
155304086|NCT03664960|560544561|FG001|Overall Study|Lost to Follow-up|2|||
155412799|NCT05103332|560942607|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155304087|NCT03664960|560544560|FG000|Overall Study|Physician Decision|1|||
155304088|NCT03664960|560544561|FG001|Overall Study|Physician Decision|0|||
155304089|NCT03664960|560544560|FG000|Overall Study|Withdrawal by Subject|3|||
155304090|NCT03664960|560544561|FG001|Overall Study|Withdrawal by Subject|14|||
155304091|NCT03664960|560544560|FG000|Overall Study|Sponsor Decision|1|||
155304092|NCT03664960|560544561|FG001|Overall Study|Sponsor Decision|1|||
155304093|NCT03664960|560544560|FG000|Overall Study|Other|1|||
155304094|NCT03664960|560544561|FG001|Overall Study|Other|2|||
155304095|NCT04019444|560544562|FG000|Overall Study|Withdrawal by Subject|0|||
155304096|NCT04019444|560544563|FG001|Overall Study|Withdrawal by Subject|1|||
155304097|NCT04019444|560544564|FG002|Overall Study|Withdrawal by Subject|0|||
155496909|NCT03539952|561242420|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
155641841|NCT02949934|561779126|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155304098|NCT04019444|560544565|FG003|Overall Study|Withdrawal by Subject|1|||
155304099|NCT04019444|560544562|FG000|Overall Study|Solicited Event|0|||
155304100|NCT04019444|560544563|FG001|Overall Study|Solicited Event|0|||
155304101|NCT04019444|560544564|FG002|Overall Study|Solicited Event|2|||
155304102|NCT04019444|560544565|FG003|Overall Study|Solicited Event|0|||
155304103|NCT03997916|560544572|FG000|Overall Study|Protocol Violation|35|||
155304104|NCT03807778|560544575|FG000|Overall Study|Adverse Event|0|||
155304105|NCT03807778|560544576|FG001|Overall Study|Adverse Event|0|||
155304106|NCT03807778|560544577|FG002|Overall Study|Adverse Event|3|||
155304107|NCT03807778|560544578|FG003|Overall Study|Adverse Event|5|||
155304108|NCT03807778|560544575|FG000|Overall Study|Progressive Disease|4|||
155304109|NCT03807778|560544576|FG001|Overall Study|Progressive Disease|2|||
155304110|NCT03807778|560544577|FG002|Overall Study|Progressive Disease|8|||
155304111|NCT03807778|560544578|FG003|Overall Study|Progressive Disease|15|||
155304112|NCT03807778|560544575|FG000|Overall Study|Symptomatic Deterioration|0|||
155304113|NCT03807778|560544576|FG001|Overall Study|Symptomatic Deterioration|1|||
155304114|NCT03807778|560544577|FG002|Overall Study|Symptomatic Deterioration|0|||
155304115|NCT03807778|560544578|FG003|Overall Study|Symptomatic Deterioration|1|||
155304116|NCT03807778|560544575|FG000|Overall Study|Withdrawal by Subject|0|||
155304117|NCT03807778|560544576|FG001|Overall Study|Withdrawal by Subject|1|||
155304118|NCT03807778|560544577|FG002|Overall Study|Withdrawal by Subject|0|||
155304119|NCT03807778|560544578|FG003|Overall Study|Withdrawal by Subject|1|||
155304120|NCT03807778|560544575|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
155304121|NCT03807778|560544576|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
155304122|NCT03807778|560544577|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
155304123|NCT03807778|560544578|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
155304124|NCT05028582|560544580|FG000|Overall Study|Lost to Follow-up|11|||
155304125|NCT05028582|560544581|FG001|Overall Study|Lost to Follow-up|9|||
155304126|NCT05028582|560544580|FG000|Overall Study|Withdrawal by Subject|9|||
155304127|NCT05028582|560544581|FG001|Overall Study|Withdrawal by Subject|10|||
155304128|NCT05028582|560544580|FG000|Overall Study|Adverse Event|5|||
155304129|NCT05028582|560544581|FG001|Overall Study|Adverse Event|2|||
155304130|NCT05028582|560544580|FG000|Overall Study|Miscellaneous|3|||
155304131|NCT05028582|560544581|FG001|Overall Study|Miscellaneous|2|||
155304132|NCT05028582|560544580|FG000|Overall Study|Lack of Efficacy|3|||
155304133|NCT05028582|560544581|FG001|Overall Study|Lack of Efficacy|1|||
155304134|NCT05028582|560544580|FG000|Overall Study|Physician Decision|0|||
155304135|NCT05028582|560544581|FG001|Overall Study|Physician Decision|1|||
155304136|NCT04939246|560544582|FG000|After Treatment|Death|4|||
155304137|NCT04939246|560544582|FG000|After Treatment|Lost to Follow-up|1|||
155304138|NCT04939246|560544582|FG000|After Treatment|Discharged to hospice|2|||
155304139|NCT04337372|560545983|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
155304140|NCT04337372|560545984|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
155304141|NCT04337372|560545985|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
155304142|NCT04337372|560545986|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
155304143|NCT04337372|560545983|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
155304144|NCT04337372|560545984|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
155304145|NCT04337372|560545985|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
155304146|NCT04337372|560545986|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
155304147|NCT04337372|560545983|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
155304148|NCT04337372|560545984|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
155304149|NCT04337372|560545985|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
155304150|NCT04337372|560545986|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
155304151|NCT04337372|560545983|FG000|Day 2: EEG Measures|Protocol Violation|6|||
155304152|NCT04337372|560545984|FG001|Day 2: EEG Measures|Protocol Violation|6|||
155304153|NCT04337372|560545985|FG002|Day 2: EEG Measures|Protocol Violation|5|||
155304154|NCT04337372|560545986|FG003|Day 2: EEG Measures|Protocol Violation|17|||
155304155|NCT04869982|560545990|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
155304156|NCT04869982|560545991|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
155304157|NCT04869982|560545990|FG000|Overall Study|Migrated / moved from the study area|1|||
155304158|NCT04869982|560545991|FG001|Overall Study|Migrated / moved from the study area|1|||
155304159|NCT04869982|560545990|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
155304160|NCT04869982|560545991|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
155304161|NCT04869982|560545990|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
155304162|NCT04869982|560545991|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
155304163|NCT04869982|560545990|FG000|Overall Study|Solicited adverse event|2|||
155304164|NCT04869982|560545991|FG001|Overall Study|Solicited adverse event|1|||
155304165|NCT04608045|560545992|FG000|Overall Study|Physician Decision|1|||
155304166|NCT02473250|560545994|FG000|Overall Study|Lost to Follow-up|10|||
155304167|NCT02473250|560545994|FG000|Overall Study|Physician Decision|5|||
155304168|NCT02473250|560545994|FG000|Overall Study|Did not tolerate medication washout|3|||
155304169|NCT02473250|560545994|FG000|Overall Study|Antidepressant effect of divalproex|2|||
155304170|NCT03103321|560545995|FG000|Overall Study|Protocol Violation|1|||
155304171|NCT03103321|560545996|FG001|Overall Study|Protocol Violation|1|||
155304172|NCT03103321|560545997|FG002|Overall Study|Protocol Violation|1|||
155304173|NCT03103321|560545998|FG003|Overall Study|Protocol Violation|0|||
155304174|NCT04847999|560545999|FG000|Overall Study|Lost to Follow-up|0|||
155304175|NCT04847999|560546000|FG001|Overall Study|Lost to Follow-up|1|||
155304176|NCT02879448|560546001|FG000|Overall Study|Death|251|||
155304177|NCT02879448|560546002|FG001|Overall Study|Death|263|||
155304178|NCT02879448|560546001|FG000|Overall Study|Lost to Follow-up|23|||
155304179|NCT02879448|560546002|FG001|Overall Study|Lost to Follow-up|28|||
155304180|NCT02879448|560546001|FG000|Overall Study|Withdrawal by Subject|42|||
155304181|NCT02879448|560546002|FG001|Overall Study|Withdrawal by Subject|79|||
155304182|NCT02879448|560546001|FG000|Overall Study|Other Reasons|8|||
155304183|NCT02879448|560546002|FG001|Overall Study|Other Reasons|12|||
155304184|NCT03602014|560546004|FG000|Overall Study|Lost to Follow-up|2|||
155304185|NCT03602014|560546005|FG001|Overall Study|Lost to Follow-up|0|||
155304186|NCT03602014|560546006|FG002|Overall Study|Lost to Follow-up|0|||
155304187|NCT06629454|560546007|FG000|Overall Study|Withdraw by Clinician Decision|1|||
155304188|NCT01704079|560546008|FG000|Overall Study|Withdrawal by Subject|5|||
155304189|NCT01704079|560546009|FG001|Overall Study|Withdrawal by Subject|7|||
155304190|NCT01704079|560546008|FG000|Overall Study|Lost to Follow-up|2|||
155304191|NCT01704079|560546009|FG001|Overall Study|Lost to Follow-up|5|||
155304192|NCT01704079|560546008|FG000|Overall Study|Adverse Event|4|||
155304193|NCT01704079|560546009|FG001|Overall Study|Adverse Event|7|||
155304194|NCT01704079|560546008|FG000|Overall Study|Protocol Violation|1|||
155304195|NCT01704079|560546009|FG001|Overall Study|Protocol Violation|0|||
155304196|NCT01704079|560546008|FG000|Overall Study|Subject noncompliance|2|||
155304197|NCT01704079|560546009|FG001|Overall Study|Subject noncompliance|3|||
155304198|NCT01704079|560546008|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
155304199|NCT01704079|560546009|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
155304200|NCT06023082|560546010|FG000|Overall Study|Withdrawal by Subject|2|||
155304201|NCT06023082|560546010|FG000|Overall Study|Lost to Follow-up|15|||
155304202|NCT06023082|560546010|FG000|Overall Study|Side effects|5|||
155304203|NCT03584516|560546016|FG000|Part 1|Death|2|||
155304204|NCT03584516|560546017|FG001|Part 1|Death|3|||
155304205|NCT03584516|560546018|FG002|Part 1|Death|0|||
155304206|NCT03584516|560546019|FG003|Part 1|Death|0|||
155304207|NCT03584516|560546020|FG004|Part 1|Death|0|||
155304208|NCT03584516|560546021|FG005|Part 1|Death|0|||
155304209|NCT03584516|560546016|FG000|Part 1|Withdrawal by Subject|2|||
155304210|NCT03584516|560546017|FG001|Part 1|Withdrawal by Subject|0|||
155304211|NCT03584516|560546018|FG002|Part 1|Withdrawal by Subject|0|||
155304212|NCT03584516|560546019|FG003|Part 1|Withdrawal by Subject|0|||
155304213|NCT03584516|560546020|FG004|Part 1|Withdrawal by Subject|0|||
155304214|NCT03584516|560546021|FG005|Part 1|Withdrawal by Subject|0|||
155304215|NCT03584516|560546016|FG000|Part 1|Lost to Follow-up|1|||
155304216|NCT03584516|560546017|FG001|Part 1|Lost to Follow-up|0|||
155304217|NCT03584516|560546018|FG002|Part 1|Lost to Follow-up|0|||
155304218|NCT03584516|560546019|FG003|Part 1|Lost to Follow-up|0|||
155304219|NCT03584516|560546020|FG004|Part 1|Lost to Follow-up|0|||
155304220|NCT03584516|560546021|FG005|Part 1|Lost to Follow-up|0|||
155304221|NCT03584516|560546016|FG000|Part 1|Study Terminated by Sponsor|0|||
155304222|NCT03584516|560546017|FG001|Part 1|Study Terminated by Sponsor|2|||
155304223|NCT03584516|560546018|FG002|Part 1|Study Terminated by Sponsor|0|||
155304224|NCT03584516|560546019|FG003|Part 1|Study Terminated by Sponsor|0|||
155304225|NCT03584516|560546020|FG004|Part 1|Study Terminated by Sponsor|0|||
155304226|NCT03584516|560546021|FG005|Part 1|Study Terminated by Sponsor|0|||
155304227|NCT03584516|560546016|FG000|Part 1 Expansion|Death|0|||
155412800|NCT05103332|560942608|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
155412801|NCT05103332|560942591|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412802|NCT05103332|560942592|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155304228|NCT03584516|560546017|FG001|Part 1 Expansion|Death|0|||
155304229|NCT03584516|560546018|FG002|Part 1 Expansion|Death|9|||
155304230|NCT03584516|560546019|FG003|Part 1 Expansion|Death|8|||
155304231|NCT03584516|560546020|FG004|Part 1 Expansion|Death|4|||
155304232|NCT03584516|560546021|FG005|Part 1 Expansion|Death|5|||
155304233|NCT03584516|560546016|FG000|Part 1 Expansion|Lost to Follow-up|0|||
155304234|NCT03584516|560546017|FG001|Part 1 Expansion|Lost to Follow-up|0|||
155304235|NCT03584516|560546018|FG002|Part 1 Expansion|Lost to Follow-up|0|||
155304236|NCT03584516|560546019|FG003|Part 1 Expansion|Lost to Follow-up|1|||
155304237|NCT03584516|560546020|FG004|Part 1 Expansion|Lost to Follow-up|0|||
155304238|NCT03584516|560546021|FG005|Part 1 Expansion|Lost to Follow-up|0|||
155304239|NCT03584516|560546016|FG000|Part 1 Expansion|Physician Decision|0|||
155304240|NCT03584516|560546017|FG001|Part 1 Expansion|Physician Decision|0|||
155304241|NCT03584516|560546018|FG002|Part 1 Expansion|Physician Decision|4|||
155304242|NCT03584516|560546019|FG003|Part 1 Expansion|Physician Decision|3|||
155304243|NCT03584516|560546020|FG004|Part 1 Expansion|Physician Decision|2|||
155304244|NCT03584516|560546021|FG005|Part 1 Expansion|Physician Decision|3|||
155304245|NCT03584516|560546016|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
155304246|NCT03584516|560546017|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
155304247|NCT03584516|560546018|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
155304248|NCT03584516|560546019|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
155304249|NCT03584516|560546020|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
155304250|NCT03584516|560546021|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
155304251|NCT03584516|560546016|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
155304252|NCT03584516|560546017|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
155304253|NCT03584516|560546018|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
155304254|NCT03584516|560546019|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
155304255|NCT03584516|560546020|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
155304256|NCT03584516|560546021|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
155304257|NCT03584516|560546016|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304258|NCT03584516|560546017|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304259|NCT03584516|560546018|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304260|NCT03584516|560546019|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
155304261|NCT03584516|560546020|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304262|NCT03584516|560546021|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304263|NCT03584516|560546016|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304264|NCT03584516|560546017|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304265|NCT03584516|560546018|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304266|NCT03584516|560546019|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304267|NCT03584516|560546020|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304268|NCT03584516|560546021|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
155304269|NCT05846646|560546022|FG000|Overall Study|Physician Decision|1|||
155304270|NCT05846646|560546023|FG001|Overall Study|Physician Decision|0|||
155304271|NCT05846646|560546024|FG002|Overall Study|Physician Decision|0|||
155304272|NCT05846646|560546022|FG000|Overall Study|Lack of Efficacy|1|||
155304273|NCT05846646|560546023|FG001|Overall Study|Lack of Efficacy|1|||
155304274|NCT05846646|560546024|FG002|Overall Study|Lack of Efficacy|0|||
155304275|NCT05846646|560546022|FG000|Overall Study|Early Study Termination|1|||
155304276|NCT05846646|560546023|FG001|Overall Study|Early Study Termination|2|||
155304277|NCT05846646|560546024|FG002|Overall Study|Early Study Termination|0|||
155304278|NCT00670046|560546025|FG000|Overall Study|Lost to Follow-up|1|||
155304279|NCT00670046|560546026|FG001|Overall Study|Lost to Follow-up|1|||
155304280|NCT00670046|560546025|FG000|Overall Study|Withdrawal by Subject|0|||
155304281|NCT00670046|560546026|FG001|Overall Study|Withdrawal by Subject|1|||
155304282|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
155304283|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
155304284|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
155304285|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
155304286|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
155304287|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
155304288|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
155304289|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
155304290|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
155304291|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
155304292|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
155304293|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
155304294|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
155304295|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
155304296|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
155304297|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
155304298|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
155304299|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
155304300|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
155412803|NCT05103332|560942593|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155304301|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
155304302|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
155304303|NCT01443845|560546030|FG000|Overall Study|Protocol Violation|43|||
155304304|NCT01443845|560546031|FG001|Overall Study|Protocol Violation|45|||
155304305|NCT01443845|560546030|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
155304306|NCT01443845|560546031|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
155304307|NCT01443845|560546030|FG000|Overall Study|Deterioration in pulmonary function|1|||
155304308|NCT01443845|560546031|FG001|Overall Study|Deterioration in pulmonary function|4|||
155304309|NCT01443845|560546030|FG000|Overall Study|Lack of Efficacy|10|||
155304310|NCT01443845|560546031|FG001|Overall Study|Lack of Efficacy|5|||
155304311|NCT01443845|560546030|FG000|Overall Study|Adverse Event|64|||
155304312|NCT01443845|560546031|FG001|Overall Study|Adverse Event|138|||
155304313|NCT01443845|560546030|FG000|Overall Study|Withdrawal by Subject|63|||
155304314|NCT01443845|560546031|FG001|Overall Study|Withdrawal by Subject|67|||
155304315|NCT01443845|560546030|FG000|Overall Study|Military Conflict - Site Terminated|20|||
155304316|NCT01443845|560546031|FG001|Overall Study|Military Conflict - Site Terminated|21|||
155304317|NCT01443845|560546030|FG000|Overall Study|Lost to Follow-up|9|||
155304318|NCT01443845|560546031|FG001|Overall Study|Lost to Follow-up|13|||
155304319|NCT01471691|560546032|FG000|Overall Study|Lack of Efficacy|0|||
155304320|NCT01471691|560546033|FG001|Overall Study|Lack of Efficacy|1|||
155304321|NCT02461628|560546034|FG000|Overall Study|Refused to complete survey|4|||
155304322|NCT02461628|560546035|FG001|Overall Study|Refused to complete survey|7|||
155304323|NCT02015520|560546036|FG000|Overall Study|Lack of Efficacy|1|||
155304324|NCT02015520|560546037|FG001|Overall Study|Lack of Efficacy|0|||
155304325|NCT02015520|560546038|FG002|Overall Study|Lack of Efficacy|3|||
155304326|NCT02015520|560546039|FG003|Overall Study|Lack of Efficacy|2|||
155304327|NCT02015520|560546036|FG000|Overall Study|Adverse Event|0|||
155304328|NCT02015520|560546037|FG001|Overall Study|Adverse Event|0|||
155304329|NCT02015520|560546038|FG002|Overall Study|Adverse Event|0|||
155304330|NCT02015520|560546039|FG003|Overall Study|Adverse Event|1|||
155304331|NCT02015520|560546036|FG000|Overall Study|Withdrawal by Subject|2|||
155304332|NCT02015520|560546037|FG001|Overall Study|Withdrawal by Subject|2|||
155304333|NCT02015520|560546038|FG002|Overall Study|Withdrawal by Subject|1|||
155304334|NCT02015520|560546039|FG003|Overall Study|Withdrawal by Subject|0|||
155304335|NCT02015520|560546036|FG000|Overall Study|Death|1|||
155304336|NCT02015520|560546037|FG001|Overall Study|Death|0|||
155304337|NCT02015520|560546038|FG002|Overall Study|Death|0|||
155304338|NCT02015520|560546039|FG003|Overall Study|Death|0|||
155304339|NCT02015520|560546036|FG000|Overall Study|Lost to Follow-up|0|||
155304340|NCT02015520|560546037|FG001|Overall Study|Lost to Follow-up|0|||
155304341|NCT02015520|560546038|FG002|Overall Study|Lost to Follow-up|1|||
155304342|NCT02015520|560546039|FG003|Overall Study|Lost to Follow-up|0|||
155304343|NCT02015520|560546036|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304344|NCT02015520|560546037|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304345|NCT02015520|560546038|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
155304346|NCT02015520|560546039|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304347|NCT02015520|560546036|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304348|NCT02015520|560546037|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
155304349|NCT02015520|560546038|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304350|NCT02015520|560546039|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304351|NCT01854385|560546040|FG000|Pre-Treatment|Withdrawal by Subject|4|||
155304352|NCT01854385|560546040|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
155304353|NCT01854385|560546040|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
155304354|NCT01854385|560546040|FG000|Pre-Treatment|Unable to come for study visits|1|||
155304355|NCT01854385|560546040|FG000|Treatment|Lost to Follow-up|1|||
155304356|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
155304357|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
155304358|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
155304359|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
155304360|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
155304361|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304362|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304363|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
155304364|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304365|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304366|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
155304367|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
155641842|NCT02949934|561779127|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
155304368|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
155304369|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
155304370|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
155304371|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304372|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
155304373|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
155304374|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304375|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304376|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
155304377|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
155304378|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
155304379|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
155304380|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
155304381|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304382|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304383|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
155304384|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304385|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304386|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304387|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
155304388|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304389|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304390|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304391|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304392|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304393|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304394|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
155304395|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
155304396|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304397|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304398|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304399|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304400|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
155304401|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304402|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304403|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304404|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
155304405|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
155304406|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304407|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304408|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304409|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
155304410|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
155304411|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304412|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304413|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304414|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
155304415|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
155304416|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304417|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304418|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304419|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
155412804|NCT05103332|560942594|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412805|NCT05103332|560942595|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412806|NCT05103332|560942596|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412807|NCT05103332|560942597|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412808|NCT05103332|560942598|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412809|NCT05103332|560942599|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412810|NCT05103332|560942600|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412811|NCT05103332|560942601|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412812|NCT05103332|560942602|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155412813|NCT05103332|560942603|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
155412814|NCT05103332|560942604|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
155412815|NCT05103332|560942605|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
155304420|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
155304421|NCT02590432|560546050|FG000|Open-label Treatment Period|Adverse Event|97|||
155304422|NCT02590432|560546051|FG001|Open-label Treatment Period|Adverse Event|79|||
155304423|NCT02590432|560546052|FG002|Open-label Treatment Period|Adverse Event|0|||
155304424|NCT02590432|560546053|FG003|Open-label Treatment Period|Adverse Event|0|||
155304425|NCT02590432|560546054|FG004|Open-label Treatment Period|Adverse Event|0|||
155304426|NCT02590432|560546055|FG005|Open-label Treatment Period|Adverse Event|0|||
155304427|NCT02590432|560546056|FG006|Open-label Treatment Period|Adverse Event|0|||
155304428|NCT02590432|560546057|FG007|Open-label Treatment Period|Adverse Event|0|||
155304429|NCT02590432|560546058|FG008|Open-label Treatment Period|Adverse Event|0|||
155304430|NCT02590432|560546050|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
155304431|NCT02590432|560546051|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
155304432|NCT02590432|560546052|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
155304433|NCT02590432|560546053|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
155304434|NCT02590432|560546054|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
155304435|NCT02590432|560546055|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
155304436|NCT02590432|560546056|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
155304437|NCT02590432|560546057|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
155304438|NCT02590432|560546058|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
155304439|NCT02590432|560546050|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
155304440|NCT02590432|560546051|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
155304441|NCT02590432|560546052|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
155304442|NCT02590432|560546053|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
155304443|NCT02590432|560546054|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
155304444|NCT02590432|560546055|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
155304445|NCT02590432|560546056|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
155304446|NCT02590432|560546057|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
155304447|NCT02590432|560546058|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
155304448|NCT02590432|560546050|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
155304449|NCT02590432|560546051|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
155304450|NCT02590432|560546052|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155304451|NCT02590432|560546053|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155304452|NCT02590432|560546054|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
155304453|NCT02590432|560546055|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
155304454|NCT02590432|560546056|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
155304455|NCT02590432|560546057|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
155304456|NCT02590432|560546058|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
155304457|NCT02590432|560546050|FG000|Open-label Treatment Period|Protocol Violation|10|||
155304458|NCT02590432|560546051|FG001|Open-label Treatment Period|Protocol Violation|4|||
155304459|NCT02590432|560546052|FG002|Open-label Treatment Period|Protocol Violation|0|||
155304460|NCT02590432|560546053|FG003|Open-label Treatment Period|Protocol Violation|0|||
155304461|NCT02590432|560546054|FG004|Open-label Treatment Period|Protocol Violation|0|||
155304462|NCT02590432|560546055|FG005|Open-label Treatment Period|Protocol Violation|0|||
155304463|NCT02590432|560546056|FG006|Open-label Treatment Period|Protocol Violation|0|||
155304464|NCT02590432|560546057|FG007|Open-label Treatment Period|Protocol Violation|0|||
155304465|NCT02590432|560546058|FG008|Open-label Treatment Period|Protocol Violation|0|||
155304466|NCT02590432|560546050|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
155304467|NCT02590432|560546051|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
155304468|NCT02590432|560546052|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304469|NCT02590432|560546053|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304470|NCT02590432|560546054|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304471|NCT02590432|560546055|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304472|NCT02590432|560546056|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304473|NCT02590432|560546057|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304474|NCT02590432|560546058|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304475|NCT02590432|560546050|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
155304476|NCT02590432|560546051|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
155304477|NCT02590432|560546052|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155412816|NCT05103332|560942606|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
155412817|NCT05103332|560942607|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
155412818|NCT05103332|560942608|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
155412819|NCT05103332|560942591|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412820|NCT05103332|560942592|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412821|NCT05103332|560942593|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155641843|NCT02949934|561779122|FG000|Bar Laboratory|Adverse Event|1|||
155304478|NCT02590432|560546053|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304479|NCT02590432|560546054|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304480|NCT02590432|560546055|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304481|NCT02590432|560546056|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304482|NCT02590432|560546057|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304483|NCT02590432|560546058|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304484|NCT02590432|560546050|FG000|Double-blind Treatment Period|Adverse Event|0|||
155304485|NCT02590432|560546051|FG001|Double-blind Treatment Period|Adverse Event|0|||
155304486|NCT02590432|560546052|FG002|Double-blind Treatment Period|Adverse Event|14|||
155304487|NCT02590432|560546053|FG003|Double-blind Treatment Period|Adverse Event|12|||
155304488|NCT02590432|560546054|FG004|Double-blind Treatment Period|Adverse Event|6|||
155304489|NCT02590432|560546055|FG005|Double-blind Treatment Period|Adverse Event|22|||
155304490|NCT02590432|560546056|FG006|Double-blind Treatment Period|Adverse Event|20|||
155304491|NCT02590432|560546057|FG007|Double-blind Treatment Period|Adverse Event|0|||
155304492|NCT02590432|560546058|FG008|Double-blind Treatment Period|Adverse Event|0|||
155304493|NCT02590432|560546050|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155304494|NCT02590432|560546051|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155304495|NCT02590432|560546052|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155304496|NCT02590432|560546053|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
155304497|NCT02590432|560546054|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
155304498|NCT02590432|560546055|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
155304499|NCT02590432|560546056|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
155304500|NCT02590432|560546057|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
155304501|NCT02590432|560546058|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
155304502|NCT02590432|560546050|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304503|NCT02590432|560546051|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304504|NCT02590432|560546052|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304505|NCT02590432|560546053|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
155304506|NCT02590432|560546054|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
155304507|NCT02590432|560546055|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304508|NCT02590432|560546056|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304509|NCT02590432|560546057|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304510|NCT02590432|560546058|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304511|NCT02590432|560546050|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155304512|NCT02590432|560546051|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155412822|NCT05103332|560942594|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412823|NCT05103332|560942595|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412824|NCT05103332|560942596|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412825|NCT05103332|560942597|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412826|NCT05103332|560942598|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412827|NCT05103332|560942599|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412828|NCT05103332|560942600|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155304513|NCT02590432|560546052|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155304514|NCT02590432|560546053|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155304515|NCT02590432|560546054|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
155304516|NCT02590432|560546055|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
155304517|NCT02590432|560546056|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
155304518|NCT02590432|560546057|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
155412829|NCT05103332|560942601|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155304519|NCT02590432|560546058|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
155304520|NCT02590432|560546050|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304521|NCT02590432|560546051|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304522|NCT02590432|560546052|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304523|NCT02590432|560546053|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304524|NCT02590432|560546054|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304525|NCT02590432|560546055|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
155304526|NCT02590432|560546056|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304527|NCT02590432|560546057|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304528|NCT02590432|560546058|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304529|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155412830|NCT05103332|560942602|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412831|NCT05103332|560942603|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412832|NCT05103332|560942604|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412833|NCT05103332|560942605|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412834|NCT05103332|560942606|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412835|NCT05103332|560942607|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
155412836|NCT05103332|560942608|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
155412837|NCT05103332|560942591|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412838|NCT05103332|560942592|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412839|NCT05103332|560942593|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412840|NCT05103332|560942594|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412841|NCT05103332|560942595|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412842|NCT05103332|560942596|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412843|NCT05103332|560942597|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412844|NCT05103332|560942598|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412845|NCT05103332|560942599|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155304530|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304531|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304532|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304533|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304534|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304535|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304536|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
155304537|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
155304538|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304539|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304540|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304541|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304542|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304543|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304544|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304545|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
155304546|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155412846|NCT05103332|560942600|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412847|NCT05103332|560942601|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155304547|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304548|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304549|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304550|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304551|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304552|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304553|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304554|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
155304555|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
155304556|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304557|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304558|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304559|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304560|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304561|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304562|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304563|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304564|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
155304565|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304566|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304567|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304568|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304569|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304570|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304571|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304572|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304573|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
155304574|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304575|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304576|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304577|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304578|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304579|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304580|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304581|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
155304582|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304583|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304584|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304585|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304586|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304587|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304588|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304589|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304590|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
155304591|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304592|NCT02006758|560546059|FG000|Overall Study|Protocol Violation|1|||
155304593|NCT02006758|560546059|FG000|Overall Study|Death|1|||
155304594|NCT02006758|560546059|FG000|Overall Study|Lost to Follow-up|4|||
155304595|NCT02006758|560546059|FG000|Overall Study|Withdrawal by Subject|4|||
155641844|NCT02949934|561779123|FG001|Bar Laboratory|Adverse Event|0|||
155641845|NCT02949934|561779124|FG002|Bar Laboratory|Adverse Event|2|||
155641846|NCT02949934|561779125|FG003|Bar Laboratory|Adverse Event|0|||
155641847|NCT02949934|561779126|FG004|Bar Laboratory|Adverse Event|1|||
155641848|NCT02949934|561779127|FG005|Bar Laboratory|Adverse Event|0|||
155641849|NCT02949934|561779122|FG000|Bar Laboratory|Protocol Violation|0|||
155641850|NCT02949934|561779123|FG001|Bar Laboratory|Protocol Violation|0|||
155641851|NCT02949934|561779124|FG002|Bar Laboratory|Protocol Violation|0|||
155641852|NCT02949934|561779125|FG003|Bar Laboratory|Protocol Violation|1|||
155641853|NCT02949934|561779126|FG004|Bar Laboratory|Protocol Violation|0|||
155641854|NCT02949934|561779127|FG005|Bar Laboratory|Protocol Violation|0|||
155641855|NCT04069520|561779131|FG000|Overall Study|Lost to Follow-up|0|||
155304596|NCT02006758|560546059|FG000|Overall Study|Procedurally excluded|1|||
155304597|NCT02006758|560546059|FG000|Overall Study|Other|2|||
155304598|NCT00520546|560546061|FG000|Overall Study|Withdrawal by Subject|1|||
155304599|NCT00520546|560546061|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
155304600|NCT02554786|560546066|FG000|Overall Study|Subject/guardian decision|29|||
155304601|NCT02554786|560546067|FG001|Overall Study|Subject/guardian decision|17|||
155304602|NCT02554786|560546068|FG002|Overall Study|Subject/guardian decision|18|||
155304603|NCT02554786|560546069|FG003|Overall Study|Subject/guardian decision|30|||
155304604|NCT02554786|560546070|FG004|Overall Study|Subject/guardian decision|20|||
155304605|NCT02554786|560546066|FG000|Overall Study|Lost to Follow-up|4|||
155304606|NCT02554786|560546067|FG001|Overall Study|Lost to Follow-up|3|||
155304607|NCT02554786|560546068|FG002|Overall Study|Lost to Follow-up|4|||
155304608|NCT02554786|560546069|FG003|Overall Study|Lost to Follow-up|2|||
155304609|NCT02554786|560546070|FG004|Overall Study|Lost to Follow-up|2|||
155304610|NCT02554786|560546066|FG000|Overall Study|Protocol deviation|1|||
155304611|NCT02554786|560546067|FG001|Overall Study|Protocol deviation|3|||
155304612|NCT02554786|560546068|FG002|Overall Study|Protocol deviation|3|||
155304613|NCT02554786|560546069|FG003|Overall Study|Protocol deviation|4|||
155304614|NCT02554786|560546070|FG004|Overall Study|Protocol deviation|2|||
155304615|NCT02554786|560546066|FG000|Overall Study|Technical problems|1|||
155304616|NCT02554786|560546067|FG001|Overall Study|Technical problems|1|||
155304617|NCT02554786|560546068|FG002|Overall Study|Technical problems|0|||
155304618|NCT02554786|560546069|FG003|Overall Study|Technical problems|2|||
155304619|NCT02554786|560546070|FG004|Overall Study|Technical problems|1|||
155304620|NCT02554786|560546066|FG000|Overall Study|Adverse Event|0|||
155304621|NCT02554786|560546067|FG001|Overall Study|Adverse Event|0|||
155304622|NCT02554786|560546068|FG002|Overall Study|Adverse Event|0|||
155304623|NCT02554786|560546069|FG003|Overall Study|Adverse Event|0|||
155641856|NCT04069520|561779132|FG001|Overall Study|Lost to Follow-up|2|||
155304624|NCT02554786|560546070|FG004|Overall Study|Adverse Event|2|||
155304625|NCT02554786|560546066|FG000|Overall Study|Death|0|||
155304626|NCT02554786|560546067|FG001|Overall Study|Death|0|||
155304627|NCT02554786|560546068|FG002|Overall Study|Death|0|||
155304628|NCT02554786|560546069|FG003|Overall Study|Death|1|||
155304629|NCT02554786|560546070|FG004|Overall Study|Death|0|||
155304630|NCT02554786|560546066|FG000|Overall Study|Non-compliance with study treatment|0|||
155304631|NCT02554786|560546067|FG001|Overall Study|Non-compliance with study treatment|1|||
155304632|NCT02554786|560546068|FG002|Overall Study|Non-compliance with study treatment|1|||
155304633|NCT02554786|560546069|FG003|Overall Study|Non-compliance with study treatment|0|||
155304634|NCT02554786|560546070|FG004|Overall Study|Non-compliance with study treatment|1|||
155304635|NCT02554786|560546066|FG000|Overall Study|Physician Decision|0|||
155304636|NCT02554786|560546067|FG001|Overall Study|Physician Decision|1|||
155304637|NCT02554786|560546068|FG002|Overall Study|Physician Decision|4|||
155304638|NCT02554786|560546069|FG003|Overall Study|Physician Decision|1|||
155304639|NCT02554786|560546070|FG004|Overall Study|Physician Decision|1|||
155304640|NCT02554786|560546066|FG000|Overall Study|Pregnancy|0|||
155304641|NCT02554786|560546067|FG001|Overall Study|Pregnancy|0|||
155304642|NCT02554786|560546068|FG002|Overall Study|Pregnancy|0|||
155304643|NCT02554786|560546069|FG003|Overall Study|Pregnancy|1|||
155304644|NCT02554786|560546070|FG004|Overall Study|Pregnancy|1|||
155304645|NCT05052996|560546071|FG000|Overall Study|Still on study|0|||
155304646|NCT05052996|560546072|FG001|Overall Study|Still on study|0|||
155304647|NCT05052996|560546073|FG002|Overall Study|Still on study|47|||
155304648|NCT05052996|560546074|FG003|Overall Study|Still on study|44|||
155304649|NCT05052996|560546071|FG000|Overall Study|Cohort terminated by sponsor|21|||
155304650|NCT05052996|560546072|FG001|Overall Study|Cohort terminated by sponsor|12|||
155304651|NCT05052996|560546073|FG002|Overall Study|Cohort terminated by sponsor|0|||
155304652|NCT05052996|560546074|FG003|Overall Study|Cohort terminated by sponsor|0|||
155304653|NCT05052996|560546071|FG000|Overall Study|Withdrew consent|1|||
155304654|NCT05052996|560546072|FG001|Overall Study|Withdrew consent|0|||
155304655|NCT05052996|560546073|FG002|Overall Study|Withdrew consent|1|||
155304656|NCT05052996|560546074|FG003|Overall Study|Withdrew consent|2|||
155304657|NCT05052996|560546071|FG000|Overall Study|Lost to Follow-up|1|||
155412848|NCT05103332|560942602|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155412849|NCT05103332|560942603|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
155641857|NCT04069520|561779131|FG000|Overall Study|Withdrawal by Subject|0|||
155641858|NCT04069520|561779132|FG001|Overall Study|Withdrawal by Subject|1|||
155641859|NCT04069520|561779131|FG000|Overall Study|Prior Injury|1|||
155641860|NCT04069520|561779132|FG001|Overall Study|Prior Injury|0|||
155641861|NCT04069520|561779131|FG000|Overall Study|Orthodontia|1|||
155641862|NCT04069520|561779132|FG001|Overall Study|Orthodontia|0|||
155641863|NCT04069520|561779131|FG000|Overall Study|Cut from team|0|||
155641864|NCT04069520|561779132|FG001|Overall Study|Cut from team|2|||
155641865|NCT00849472|561779133|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
155641866|NCT00849472|561779133|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
155641867|NCT00849472|561779133|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
155641868|NCT00849472|561779133|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
155641869|NCT00849472|561779133|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
155641870|NCT00849472|561779133|FG000|Weekly Paclitaxel|Disease Progression|1|||
155641871|NCT00849472|561779133|FG000|Weekly Paclitaxel|Adverse Event|11|||
155641872|NCT00849472|561779133|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
155641873|NCT00849472|561779133|FG000|Weekly Paclitaxel|Physician Decision|3|||
155641874|NCT00849472|561779133|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
155641875|NCT00849472|561779133|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
155641876|NCT00849472|561779133|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
155641877|NCT00849472|561779133|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
155641878|NCT00849472|561779133|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
155641879|NCT00849472|561779133|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
155641880|NCT00849472|561779133|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
155641881|NCT00849472|561779133|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
155641882|NCT03998462|561779137|FG000|Overall Study|Withdrawal by Subject|10|||
155641883|NCT03998462|561779138|FG001|Overall Study|Withdrawal by Subject|4|||
155641884|NCT03998462|561779137|FG000|Overall Study|Lost to Follow-up|1|||
155641885|NCT03998462|561779138|FG001|Overall Study|Lost to Follow-up|0|||
155641886|NCT03998462|561779137|FG000|Overall Study|Technical Difficulties|1|||
155641887|NCT03998462|561779138|FG001|Overall Study|Technical Difficulties|2|||
155641888|NCT05710224|561779139|FG000|Overall Study|Death|1|||
155641889|NCT05710224|561779140|FG001|Overall Study|Death|0|||
155641890|NCT05710224|561779139|FG000|Overall Study|Lost to Follow-up|16|||
155641891|NCT05710224|561779140|FG001|Overall Study|Lost to Follow-up|7|||
155641892|NCT05710224|561779139|FG000|Overall Study|Withdrawal by Subject|4|||
155641893|NCT05710224|561779140|FG001|Overall Study|Withdrawal by Subject|6|||
155641894|NCT05710224|561779139|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155641895|NCT05710224|561779140|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155641896|NCT05710224|561779139|FG000|Overall Study|Participants Left The City|0|||
155641897|NCT05710224|561779140|FG001|Overall Study|Participants Left The City|2|||
155641898|NCT03369223|561779143|FG000|Overall Study|Lost to Follow-up|0|||
155641899|NCT03369223|561779144|FG001|Overall Study|Lost to Follow-up|0|||
155641900|NCT03369223|561779145|FG002|Overall Study|Lost to Follow-up|0|||
155641901|NCT03369223|561779146|FG003|Overall Study|Lost to Follow-up|0|||
155641902|NCT03369223|561779147|FG004|Overall Study|Lost to Follow-up|0|||
155641903|NCT03369223|561779148|FG005|Overall Study|Lost to Follow-up|0|||
155641904|NCT03369223|561779149|FG006|Overall Study|Lost to Follow-up|0|||
155641905|NCT03369223|561779150|FG007|Overall Study|Lost to Follow-up|0|||
155641906|NCT03369223|561779151|FG008|Overall Study|Lost to Follow-up|0|||
155641907|NCT03369223|561779152|FG009|Overall Study|Lost to Follow-up|0|||
155641908|NCT03369223|561779153|FG010|Overall Study|Lost to Follow-up|0|||
155641909|NCT03369223|561779154|FG011|Overall Study|Lost to Follow-up|0|||
155641910|NCT03369223|561779155|FG012|Overall Study|Lost to Follow-up|0|||
155641911|NCT03369223|561779156|FG013|Overall Study|Lost to Follow-up|0|||
155641912|NCT03369223|561779157|FG014|Overall Study|Lost to Follow-up|0|||
155641913|NCT03369223|561779158|FG015|Overall Study|Lost to Follow-up|0|||
155641914|NCT03369223|561779159|FG016|Overall Study|Lost to Follow-up|0|||
155641915|NCT03369223|561779160|FG017|Overall Study|Lost to Follow-up|0|||
155641916|NCT03369223|561779161|FG018|Overall Study|Lost to Follow-up|2|||
155641917|NCT03369223|561779162|FG019|Overall Study|Lost to Follow-up|1|||
155641918|NCT03369223|561779143|FG000|Overall Study|Participant no longer meets study criteria|0|||
155641919|NCT03369223|561779144|FG001|Overall Study|Participant no longer meets study criteria|0|||
155304658|NCT05052996|560546072|FG001|Overall Study|Lost to Follow-up|0|||
155304659|NCT05052996|560546073|FG002|Overall Study|Lost to Follow-up|0|||
155304660|NCT05052996|560546074|FG003|Overall Study|Lost to Follow-up|2|||
155304661|NCT05052996|560546071|FG000|Overall Study|Adverse Event|0|||
155412850|NCT05103332|560942604|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
155412851|NCT05103332|560942605|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
155412852|NCT05103332|560942606|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
155412853|NCT05103332|560942607|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
155412854|NCT05103332|560942608|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
155412855|NCT05103332|560942591|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412856|NCT05103332|560942592|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412857|NCT05103332|560942593|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412858|NCT05103332|560942594|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412859|NCT05103332|560942595|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412860|NCT05103332|560942596|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412861|NCT05103332|560942597|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412862|NCT05103332|560942598|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412863|NCT05103332|560942599|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412864|NCT05103332|560942600|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412865|NCT05103332|560942601|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412866|NCT05103332|560942602|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412867|NCT05103332|560942603|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412868|NCT05103332|560942604|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412869|NCT05103332|560942605|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
155412870|NCT05103332|560942606|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
155412871|NCT05103332|560942607|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
155412872|NCT05103332|560942608|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
155412873|NCT05103332|560942591|FG000|SFU Period (6 Months=168 Days)|Death|0|||
155412874|NCT05103332|560942592|FG001|SFU Period (6 Months=168 Days)|Death|0|||
155412875|NCT05103332|560942593|FG002|SFU Period (6 Months=168 Days)|Death|0|||
155412876|NCT05103332|560942594|FG003|SFU Period (6 Months=168 Days)|Death|0|||
155412877|NCT05103332|560942595|FG004|SFU Period (6 Months=168 Days)|Death|0|||
155412878|NCT05103332|560942596|FG005|SFU Period (6 Months=168 Days)|Death|0|||
155412879|NCT05103332|560942597|FG006|SFU Period (6 Months=168 Days)|Death|0|||
155412880|NCT05103332|560942598|FG007|SFU Period (6 Months=168 Days)|Death|0|||
155412881|NCT05103332|560942599|FG008|SFU Period (6 Months=168 Days)|Death|0|||
155412882|NCT05103332|560942600|FG009|SFU Period (6 Months=168 Days)|Death|0|||
155412883|NCT05103332|560942601|FG010|SFU Period (6 Months=168 Days)|Death|0|||
155412884|NCT05103332|560942602|FG011|SFU Period (6 Months=168 Days)|Death|0|||
155412885|NCT05103332|560942603|FG012|SFU Period (6 Months=168 Days)|Death|0|||
155412886|NCT05103332|560942604|FG013|SFU Period (6 Months=168 Days)|Death|0|||
155412887|NCT05103332|560942605|FG014|SFU Period (6 Months=168 Days)|Death|1|||
155412888|NCT05103332|560942606|FG015|SFU Period (6 Months=168 Days)|Death|0|||
155412889|NCT05103332|560942607|FG016|SFU Period (6 Months=168 Days)|Death|0|||
155412890|NCT05103332|560942608|FG017|SFU Period (6 Months=168 Days)|Death|1|||
155412891|NCT04428476|560942609|FG000|Overall Study|Withdrawal by Subject|1|||
155412892|NCT04428476|560942609|FG000|Overall Study|Still on treatment|12|||
155412893|NCT01358864|560942616|FG000|Overall Study|Adverse Event|0|||
155412894|NCT01358864|560942617|FG001|Overall Study|Adverse Event|6|||
155412895|NCT01358864|560942618|FG002|Overall Study|Adverse Event|9|||
155412896|NCT01358864|560942619|FG003|Overall Study|Adverse Event|0|||
155641920|NCT03369223|561779145|FG002|Overall Study|Participant no longer meets study criteria|0|||
155641921|NCT03369223|561779146|FG003|Overall Study|Participant no longer meets study criteria|0|||
155641922|NCT03369223|561779147|FG004|Overall Study|Participant no longer meets study criteria|0|||
155641923|NCT03369223|561779148|FG005|Overall Study|Participant no longer meets study criteria|0|||
155641924|NCT03369223|561779149|FG006|Overall Study|Participant no longer meets study criteria|0|||
155641925|NCT03369223|561779150|FG007|Overall Study|Participant no longer meets study criteria|0|||
155304662|NCT05052996|560546072|FG001|Overall Study|Adverse Event|0|||
155304663|NCT05052996|560546073|FG002|Overall Study|Adverse Event|2|||
155304664|NCT05052996|560546074|FG003|Overall Study|Adverse Event|0|||
155304665|NCT05052996|560546071|FG000|Overall Study|Randomized but never treated|0|||
155412897|NCT01358864|560942620|FG004|Overall Study|Adverse Event|4|||
155412898|NCT01358864|560942621|FG005|Overall Study|Adverse Event|8|||
155412899|NCT01358864|560942622|FG006|Overall Study|Adverse Event|12|||
155412900|NCT01358864|560942623|FG007|Overall Study|Adverse Event|7|||
155412901|NCT01358864|560942616|FG000|Overall Study|Lack of Efficacy|26|||
155412902|NCT01358864|560942617|FG001|Overall Study|Lack of Efficacy|3|||
155641926|NCT03369223|561779151|FG008|Overall Study|Participant no longer meets study criteria|0|||
155641927|NCT03369223|561779152|FG009|Overall Study|Participant no longer meets study criteria|0|||
155641928|NCT03369223|561779153|FG010|Overall Study|Participant no longer meets study criteria|0|||
155412903|NCT01358864|560942618|FG002|Overall Study|Lack of Efficacy|4|||
155412904|NCT01358864|560942619|FG003|Overall Study|Lack of Efficacy|19|||
155412905|NCT01358864|560942620|FG004|Overall Study|Lack of Efficacy|7|||
155412906|NCT01358864|560942621|FG005|Overall Study|Lack of Efficacy|4|||
155412907|NCT01358864|560942622|FG006|Overall Study|Lack of Efficacy|49|||
155412908|NCT01358864|560942623|FG007|Overall Study|Lack of Efficacy|44|||
155412909|NCT01358864|560942616|FG000|Overall Study|Lost to Follow-up|0|||
155412910|NCT01358864|560942617|FG001|Overall Study|Lost to Follow-up|0|||
155412911|NCT01358864|560942618|FG002|Overall Study|Lost to Follow-up|1|||
155412912|NCT01358864|560942619|FG003|Overall Study|Lost to Follow-up|0|||
155412913|NCT01358864|560942620|FG004|Overall Study|Lost to Follow-up|0|||
155412914|NCT01358864|560942621|FG005|Overall Study|Lost to Follow-up|0|||
155412915|NCT01358864|560942622|FG006|Overall Study|Lost to Follow-up|0|||
155412916|NCT01358864|560942623|FG007|Overall Study|Lost to Follow-up|1|||
155412917|NCT01358864|560942616|FG000|Overall Study|Withdrawal by Subject|3|||
155412918|NCT01358864|560942617|FG001|Overall Study|Withdrawal by Subject|4|||
155412919|NCT01358864|560942618|FG002|Overall Study|Withdrawal by Subject|2|||
155412920|NCT01358864|560942619|FG003|Overall Study|Withdrawal by Subject|0|||
155412921|NCT01358864|560942620|FG004|Overall Study|Withdrawal by Subject|0|||
155412922|NCT01358864|560942621|FG005|Overall Study|Withdrawal by Subject|1|||
155641929|NCT03369223|561779154|FG011|Overall Study|Participant no longer meets study criteria|0|||
155412923|NCT01358864|560942622|FG006|Overall Study|Withdrawal by Subject|1|||
155412924|NCT01358864|560942623|FG007|Overall Study|Withdrawal by Subject|3|||
155412925|NCT01358864|560942616|FG000|Overall Study|Other reason not defined above|2|||
155412926|NCT01358864|560942617|FG001|Overall Study|Other reason not defined above|0|||
155412927|NCT01358864|560942618|FG002|Overall Study|Other reason not defined above|0|||
155412928|NCT01358864|560942619|FG003|Overall Study|Other reason not defined above|0|||
155412929|NCT01358864|560942620|FG004|Overall Study|Other reason not defined above|0|||
155412930|NCT01358864|560942621|FG005|Overall Study|Other reason not defined above|0|||
155412931|NCT01358864|560942622|FG006|Overall Study|Other reason not defined above|2|||
155412932|NCT01358864|560942623|FG007|Overall Study|Other reason not defined above|0|||
155412933|NCT01358864|560942616|FG000|Overall Study|Not treated|0|||
155412934|NCT01358864|560942617|FG001|Overall Study|Not treated|0|||
155412935|NCT01358864|560942618|FG002|Overall Study|Not treated|0|||
155749112|NCT03875235|562181430|FG000|Overall Study|Withdrawal by Subject|3|||
155749113|NCT03875235|562181431|FG001|Overall Study|Withdrawal by Subject|10|||
155749114|NCT03875235|562181430|FG000|Overall Study|Death|198|||
155749115|NCT03875235|562181431|FG001|Overall Study|Death|223|||
155641930|NCT03369223|561779155|FG012|Overall Study|Participant no longer meets study criteria|0|||
155641931|NCT03369223|561779156|FG013|Overall Study|Participant no longer meets study criteria|0|||
155641932|NCT03369223|561779157|FG014|Overall Study|Participant no longer meets study criteria|2|||
155641933|NCT03369223|561779158|FG015|Overall Study|Participant no longer meets study criteria|0|||
155641934|NCT03369223|561779159|FG016|Overall Study|Participant no longer meets study criteria|2|||
155641935|NCT03369223|561779160|FG017|Overall Study|Participant no longer meets study criteria|0|||
155641936|NCT03369223|561779161|FG018|Overall Study|Participant no longer meets study criteria|0|||
155641937|NCT03369223|561779162|FG019|Overall Study|Participant no longer meets study criteria|0|||
155641938|NCT03369223|561779143|FG000|Overall Study|Other reasons|0|||
155641939|NCT03369223|561779144|FG001|Overall Study|Other reasons|0|||
155641940|NCT03369223|561779145|FG002|Overall Study|Other reasons|0|||
155641941|NCT03369223|561779146|FG003|Overall Study|Other reasons|0|||
155641942|NCT03369223|561779147|FG004|Overall Study|Other reasons|0|||
155641943|NCT03369223|561779148|FG005|Overall Study|Other reasons|0|||
155641944|NCT03369223|561779149|FG006|Overall Study|Other reasons|0|||
155641945|NCT03369223|561779150|FG007|Overall Study|Other reasons|0|||
155641946|NCT03369223|561779151|FG008|Overall Study|Other reasons|0|||
155641947|NCT03369223|561779152|FG009|Overall Study|Other reasons|0|||
155641948|NCT03369223|561779153|FG010|Overall Study|Other reasons|0|||
155641949|NCT03369223|561779154|FG011|Overall Study|Other reasons|0|||
155641950|NCT03369223|561779155|FG012|Overall Study|Other reasons|0|||
155749116|NCT01395784|562181443|FG000|Overall Study|Lost to Follow-up|7|||
155749117|NCT01395784|562181443|FG000|Overall Study|Withdrawal by Subject|3|||
155749118|NCT01395784|562181443|FG000|Overall Study|Physician Decision|5|||
155749119|NCT05772702|562181444|FG000|Overall Study|Adverse Event|1|||
155749120|NCT04153149|562181445|FG000|Double Blind Period|Death|63|||
155749121|NCT04153149|562181446|FG001|Double Blind Period|Death|49|||
155749122|NCT04153149|562181447|FG002|Double Blind Period|Death|0|||
155749123|NCT04153149|562181448|FG003|Double Blind Period|Death|0|||
155412936|NCT01358864|560942619|FG003|Overall Study|Not treated|0|||
155412937|NCT01358864|560942620|FG004|Overall Study|Not treated|0|||
155412938|NCT01358864|560942621|FG005|Overall Study|Not treated|0|||
155641951|NCT03369223|561779156|FG013|Overall Study|Other reasons|1|||
155749124|NCT04153149|562181445|FG000|Double Blind Period|Withdrawal by Subject|16|||
155749125|NCT04153149|562181446|FG001|Double Blind Period|Withdrawal by Subject|11|||
155749126|NCT04153149|562181447|FG002|Double Blind Period|Withdrawal by Subject|0|||
155749127|NCT04153149|562181448|FG003|Double Blind Period|Withdrawal by Subject|0|||
155749128|NCT04153149|562181445|FG000|Double Blind Period|Adverse Event|6|||
155749129|NCT04153149|562181446|FG001|Double Blind Period|Adverse Event|2|||
155749130|NCT04153149|562181447|FG002|Double Blind Period|Adverse Event|0|||
155749131|NCT04153149|562181448|FG003|Double Blind Period|Adverse Event|0|||
155749132|NCT04153149|562181445|FG000|Double Blind Period|Lost to Follow-up|2|||
155749133|NCT04153149|562181446|FG001|Double Blind Period|Lost to Follow-up|1|||
155749134|NCT04153149|562181447|FG002|Double Blind Period|Lost to Follow-up|0|||
155749135|NCT04153149|562181448|FG003|Double Blind Period|Lost to Follow-up|0|||
155749136|NCT04153149|562181445|FG000|Double Blind Period|Withdrawal by guardian|0|||
155749137|NCT04153149|562181446|FG001|Double Blind Period|Withdrawal by guardian|2|||
155749138|NCT04153149|562181447|FG002|Double Blind Period|Withdrawal by guardian|0|||
155749139|NCT04153149|562181448|FG003|Double Blind Period|Withdrawal by guardian|0|||
155749140|NCT04153149|562181445|FG000|Double Blind Period|Reason Not Specified|5|||
155749141|NCT04153149|562181446|FG001|Double Blind Period|Reason Not Specified|4|||
155749142|NCT04153149|562181447|FG002|Double Blind Period|Reason Not Specified|0|||
155749143|NCT04153149|562181448|FG003|Double Blind Period|Reason Not Specified|0|||
155749144|NCT04153149|562181445|FG000|Double Blind Period|Physician Decision|2|||
155749145|NCT04153149|562181446|FG001|Double Blind Period|Physician Decision|0|||
155749146|NCT04153149|562181447|FG002|Double Blind Period|Physician Decision|0|||
155749147|NCT04153149|562181448|FG003|Double Blind Period|Physician Decision|0|||
155749148|NCT04153149|562181445|FG000|Open Label Extension Period|Death|0|||
155749149|NCT04153149|562181446|FG001|Open Label Extension Period|Death|0|||
155749150|NCT04153149|562181447|FG002|Open Label Extension Period|Death|7|||
155749151|NCT04153149|562181448|FG003|Open Label Extension Period|Death|3|||
155749152|NCT04153149|562181445|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
155749153|NCT04153149|562181446|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
155749154|NCT04153149|562181447|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
155749155|NCT04153149|562181448|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
155749156|NCT04153149|562181445|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155749157|NCT04153149|562181446|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155749158|NCT04153149|562181447|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155749159|NCT04153149|562181448|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
155749160|NCT04153149|562181445|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
155749161|NCT04153149|562181446|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
155749162|NCT04153149|562181447|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
155749163|NCT04153149|562181448|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
155749164|NCT00625742|562182735|FG000|Overall Study|Disease Progression|2|||
155749165|NCT00625742|562182735|FG000|Overall Study|Withdrawal by Subject|1|||
155749166|NCT00625742|562182735|FG000|Overall Study|Adverse Event|4|||
155749167|NCT00625742|562182735|FG000|Overall Study|Lost to Follow-up|4|||
155749168|NCT00625742|562182735|FG000|Overall Study|Ineligible|1|||
155749169|NCT02316548|562182736|FG000|Overall Study|Protocol Violation|0|||
155749170|NCT02316548|562182737|FG001|Overall Study|Protocol Violation|1|||
155749171|NCT01343823|562182738|FG000|Overall Study|Study Terminated|1|||
155749172|NCT01343823|562182739|FG001|Overall Study|Study Terminated|0|||
155749173|NCT01343823|562182740|FG002|Overall Study|Study Terminated|0|||
155749174|NCT01343823|562182741|FG003|Overall Study|Study Terminated|1|||
155749175|NCT01343823|562182738|FG000|Overall Study|Withdrawal by Subject|1|||
155749176|NCT01343823|562182739|FG001|Overall Study|Withdrawal by Subject|0|||
155749177|NCT01343823|562182740|FG002|Overall Study|Withdrawal by Subject|0|||
155749178|NCT01343823|562182741|FG003|Overall Study|Withdrawal by Subject|0|||
155304666|NCT05052996|560546072|FG001|Overall Study|Randomized but never treated|0|||
155304667|NCT05052996|560546073|FG002|Overall Study|Randomized but never treated|1|||
155304668|NCT05052996|560546074|FG003|Overall Study|Randomized but never treated|1|||
155304669|NCT05052996|560546071|FG000|Overall Study|Protocol Violation|1|||
155304670|NCT05052996|560546072|FG001|Overall Study|Protocol Violation|0|||
155304671|NCT05052996|560546073|FG002|Overall Study|Protocol Violation|0|||
155304672|NCT05052996|560546074|FG003|Overall Study|Protocol Violation|0|||
155304673|NCT03830866|560546078|FG000|Overall Study|Death|90|||
155304674|NCT03830866|560546079|FG001|Overall Study|Death|111|||
155749179|NCT03468543|562182742|FG000|Overall Study|Protocol stopping rules met|3|||
155749180|NCT01249118|562182743|FG000|First Washout Period|Physician Decision|0|||
155749181|NCT01249118|562182744|FG001|First Washout Period|Physician Decision|1|||
155304675|NCT03830866|560546078|FG000|Overall Study|Lost to Follow-up|7|||
155304676|NCT03830866|560546079|FG001|Overall Study|Lost to Follow-up|7|||
155749182|NCT01249118|562182745|FG002|First Washout Period|Physician Decision|0|||
155749183|NCT00997438|562182746|FG000|Overall Study|Blood draw difficulty|2|||
155749184|NCT00997438|562182747|FG001|Overall Study|Blood draw difficulty|0|||
155749185|NCT00997438|562182748|FG002|Overall Study|Blood draw difficulty|1|||
155749186|NCT00997438|562182746|FG000|Overall Study|Withdrawal by Subject|1|||
155749187|NCT00997438|562182747|FG001|Overall Study|Withdrawal by Subject|1|||
155749188|NCT00997438|562182748|FG002|Overall Study|Withdrawal by Subject|0|||
155641952|NCT03369223|561779157|FG014|Overall Study|Other reasons|2|||
155641953|NCT03369223|561779158|FG015|Overall Study|Other reasons|0|||
155641954|NCT03369223|561779159|FG016|Overall Study|Other reasons|1|||
155641955|NCT03369223|561779160|FG017|Overall Study|Other reasons|0|||
155641956|NCT03369223|561779161|FG018|Overall Study|Other reasons|0|||
155641957|NCT03369223|561779162|FG019|Overall Study|Other reasons|2|||
155641958|NCT03369223|561779143|FG000|Overall Study|Death|0|||
155641959|NCT03369223|561779144|FG001|Overall Study|Death|0|||
155304677|NCT03830866|560546078|FG000|Overall Study|Withdrawal by Subject|19|||
155304678|NCT03830866|560546079|FG001|Overall Study|Withdrawal by Subject|16|||
155304679|NCT03830866|560546078|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
155304680|NCT03830866|560546079|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
155304681|NCT03830866|560546078|FG000|Overall Study|Other|1|||
155304682|NCT03830866|560546079|FG001|Overall Study|Other|1|||
155304683|NCT01736215|560546089|FG000|Overall Study|Early termination of erythropoietin use|1|||
155304684|NCT01736215|560546089|FG000|Overall Study|Adverse Event|4|||
155304685|NCT01736215|560546089|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
155304686|NCT01736215|560546089|FG000|Overall Study|Insufficient data to perform analysis|8|||
155304687|NCT01248936|560546090|FG000|Overall Study|Sponsor Decision|259|||
155304688|NCT01248936|560546090|FG000|Overall Study|Progression of Disease|50|||
155304689|NCT01248936|560546090|FG000|Overall Study|Death|26|||
155304690|NCT01248936|560546090|FG000|Overall Study|Withdrawal of Consent|20|||
155304691|NCT01248936|560546090|FG000|Overall Study|Adverse Event|8|||
155304692|NCT01248936|560546090|FG000|Overall Study|Lost to Follow-up|7|||
155304693|NCT01248936|560546090|FG000|Overall Study|Refused Treatment|1|||
155304694|NCT01248936|560546090|FG000|Overall Study|Other reason|3|||
155304695|NCT00331136|560546093|FG000|Overall Study|Adverse Event|3|||
155304696|NCT00331136|560546094|FG001|Overall Study|Adverse Event|5|||
155304697|NCT00331136|560546095|FG002|Overall Study|Adverse Event|0|||
155304698|NCT00331136|560546096|FG003|Overall Study|Adverse Event|1|||
155304699|NCT00331136|560546093|FG000|Overall Study|Withdrawal by Subject|0|||
155304700|NCT00331136|560546094|FG001|Overall Study|Withdrawal by Subject|1|||
155304701|NCT00331136|560546095|FG002|Overall Study|Withdrawal by Subject|0|||
155304702|NCT00331136|560546096|FG003|Overall Study|Withdrawal by Subject|0|||
155304703|NCT00331136|560546093|FG000|Overall Study|Lost to Follow-up|0|||
155304704|NCT00331136|560546094|FG001|Overall Study|Lost to Follow-up|1|||
155304705|NCT00331136|560546095|FG002|Overall Study|Lost to Follow-up|0|||
155304706|NCT00331136|560546096|FG003|Overall Study|Lost to Follow-up|0|||
155304707|NCT00331136|560546093|FG000|Overall Study|Protocol Violation|1|||
155304708|NCT00331136|560546094|FG001|Overall Study|Protocol Violation|0|||
155304709|NCT00331136|560546095|FG002|Overall Study|Protocol Violation|0|||
155304710|NCT00331136|560546096|FG003|Overall Study|Protocol Violation|0|||
155304711|NCT00331136|560546093|FG000|Overall Study|Not treated|1|||
155304712|NCT00331136|560546094|FG001|Overall Study|Not treated|0|||
155412939|NCT01358864|560942622|FG006|Overall Study|Not treated|1|||
155412940|NCT01358864|560942623|FG007|Overall Study|Not treated|0|||
155412941|NCT04042103|560942628|FG000|Overall Study|Lost to Follow-up|1|||
155412942|NCT04042103|560942628|FG000|Overall Study|Withdrawal by Subject|1|||
155412943|NCT04209855|560942629|FG000|Overall Study|Death|161|||
155412944|NCT04209855|560942630|FG001|Overall Study|Death|177|||
155412945|NCT04209855|560942629|FG000|Overall Study|PI Discretion|1|||
155412946|NCT04209855|560942630|FG001|Overall Study|PI Discretion|1|||
155412947|NCT04209855|560942629|FG000|Overall Study|Lost to Follow-up|5|||
155412948|NCT04209855|560942630|FG001|Overall Study|Lost to Follow-up|2|||
155412949|NCT04209855|560942629|FG000|Overall Study|Withdrew consent|10|||
155641960|NCT03369223|561779145|FG002|Overall Study|Death|0|||
155304713|NCT00331136|560546095|FG002|Overall Study|Not treated|0|||
155412950|NCT04209855|560942630|FG001|Overall Study|Withdrew consent|24|||
155412951|NCT04209855|560942629|FG000|Overall Study|Sponsor decision|44|||
155641961|NCT03369223|561779146|FG003|Overall Study|Death|0|||
155641962|NCT03369223|561779147|FG004|Overall Study|Death|0|||
155641963|NCT03369223|561779148|FG005|Overall Study|Death|0|||
155641964|NCT03369223|561779149|FG006|Overall Study|Death|0|||
155641965|NCT03369223|561779150|FG007|Overall Study|Death|0|||
155641966|NCT03369223|561779151|FG008|Overall Study|Death|0|||
155641967|NCT03369223|561779152|FG009|Overall Study|Death|0|||
155641968|NCT03369223|561779153|FG010|Overall Study|Death|0|||
155641969|NCT03369223|561779154|FG011|Overall Study|Death|0|||
155641970|NCT03369223|561779155|FG012|Overall Study|Death|0|||
155641971|NCT03369223|561779156|FG013|Overall Study|Death|1|||
155641972|NCT03369223|561779157|FG014|Overall Study|Death|0|||
155641973|NCT03369223|561779158|FG015|Overall Study|Death|0|||
155641974|NCT03369223|561779159|FG016|Overall Study|Death|0|||
155641975|NCT03369223|561779160|FG017|Overall Study|Death|0|||
155641976|NCT03369223|561779161|FG018|Overall Study|Death|1|||
155641977|NCT03369223|561779162|FG019|Overall Study|Death|0|||
155641978|NCT03369223|561779143|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155641979|NCT03369223|561779144|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155641980|NCT03369223|561779145|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155304714|NCT00331136|560546096|FG003|Overall Study|Not treated|0|||
155304715|NCT02692417|560546097|FG000|Overall Study|Withdrawal by Subject|5|||
155304716|NCT02692417|560546098|FG001|Overall Study|Withdrawal by Subject|1|||
155412952|NCT04209855|560942630|FG001|Overall Study|Sponsor decision|18|||
155641981|NCT03369223|561779146|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155641982|NCT03369223|561779147|FG004|Overall Study|Adverse event unrelated to study drug|0|||
155641983|NCT03369223|561779148|FG005|Overall Study|Adverse event unrelated to study drug|0|||
155641984|NCT03369223|561779149|FG006|Overall Study|Adverse event unrelated to study drug|1|||
155641985|NCT03369223|561779150|FG007|Overall Study|Adverse event unrelated to study drug|0|||
155304717|NCT02692417|560546097|FG000|Overall Study|Adverse Event|1|||
155304718|NCT02692417|560546098|FG001|Overall Study|Adverse Event|0|||
155304719|NCT03201562|560546103|FG000|Overall Study|Physician Decision|0|||
155304720|NCT03201562|560546104|FG001|Overall Study|Physician Decision|0|||
155304721|NCT03201562|560546105|FG002|Overall Study|Physician Decision|1|||
155304722|NCT03201562|560546103|FG000|Overall Study|Adverse Event|0|||
155304723|NCT03201562|560546104|FG001|Overall Study|Adverse Event|0|||
155304724|NCT03201562|560546105|FG002|Overall Study|Adverse Event|1|||
155304725|NCT03201562|560546103|FG000|Overall Study|Lost to Follow-up|0|||
155304726|NCT03201562|560546104|FG001|Overall Study|Lost to Follow-up|1|||
155304727|NCT03201562|560546105|FG002|Overall Study|Lost to Follow-up|2|||
155304728|NCT01094184|560546111|FG000|Overall Study|Death|35|||
155304729|NCT01094184|560546112|FG001|Overall Study|Death|11|||
155304730|NCT00031694|560546113|FG000|Overall Study|Adverse Event|12|||
155304731|NCT00031694|560546113|FG000|Overall Study|Death|2|||
155304732|NCT00031694|560546113|FG000|Overall Study|Withdrawal by Subject|5|||
155304733|NCT03892564|560546114|FG000|Overall Study|Withdrawal by Subject|2|||
155304734|NCT01207492|560546115|FG000|Overall Study|Still on study|1|||
155304735|NCT01207492|560546115|FG000|Overall Study|Withdrawal by Subject|9|||
155304736|NCT01207492|560546115|FG000|Overall Study|Physician Decision|1|||
155304737|NCT01207492|560546115|FG000|Overall Study|Progressive disease|3|||
155304738|NCT01207492|560546115|FG000|Overall Study|Toxicity|1|||
155304739|NCT00212355|560547524|FG000|Overall Study|Adverse Event|1|||
155304740|NCT00212355|560547524|FG000|Overall Study|Withdrawal by Subject|1|||
155304741|NCT00212355|560547524|FG000|Overall Study|A change of address|1|||
155304742|NCT04310735|560547527|FG000|Overall Study|Withdrawal by Subject|1|||
155304743|NCT04310735|560547528|FG001|Overall Study|Withdrawal by Subject|3|||
155304744|NCT04310735|560547529|FG002|Overall Study|Withdrawal by Subject|8|||
155304745|NCT04310735|560547527|FG000|Overall Study|Equipment malfunction|0|||
155304746|NCT04310735|560547528|FG001|Overall Study|Equipment malfunction|1|||
155304747|NCT04310735|560547529|FG002|Overall Study|Equipment malfunction|0|||
155304748|NCT03012841|560547530|FG000|Overall Study|Protocol Violation|0|||
155304749|NCT03012841|560547531|FG001|Overall Study|Protocol Violation|10|||
155304750|NCT03012841|560547530|FG000|Overall Study|Lost to Follow-up|6|||
155304751|NCT03012841|560547531|FG001|Overall Study|Lost to Follow-up|1|||
155304752|NCT03012841|560547530|FG000|Overall Study|Withdrawal by Subject|6|||
155304753|NCT03012841|560547531|FG001|Overall Study|Withdrawal by Subject|0|||
155304754|NCT03012841|560547530|FG000|Overall Study|Unable to complete 12 month visit|6|||
155304755|NCT03012841|560547531|FG001|Overall Study|Unable to complete 12 month visit|0|||
155304756|NCT03012841|560547530|FG000|Overall Study|Subject relocation|1|||
155304757|NCT03012841|560547531|FG001|Overall Study|Subject relocation|0|||
155304758|NCT03012841|560547530|FG000|Overall Study|Seasonal winter travel|1|||
155304759|NCT03012841|560547531|FG001|Overall Study|Seasonal winter travel|0|||
155304760|NCT03012841|560547530|FG000|Overall Study|Physician Decision|0|||
155304761|NCT03012841|560547531|FG001|Overall Study|Physician Decision|2|||
155304762|NCT03012841|560547530|FG000|Overall Study|No ablation performed|0|||
155304763|NCT03012841|560547531|FG001|Overall Study|No ablation performed|2|||
155304764|NCT03012841|560547530|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
155304765|NCT03012841|560547531|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
155641986|NCT03369223|561779151|FG008|Overall Study|Adverse event unrelated to study drug|0|||
155749189|NCT00997438|562182746|FG000|Overall Study|Exclusion criteria at visit 1|2|||
155749190|NCT00997438|562182747|FG001|Overall Study|Exclusion criteria at visit 1|2|||
155749191|NCT00997438|562182748|FG002|Overall Study|Exclusion criteria at visit 1|3|||
155749192|NCT00095238|562182749|FG000|Overall Study|Lack of Efficacy|9|||
155749193|NCT00095238|562182750|FG001|Overall Study|Lack of Efficacy|9|||
155749194|NCT00095238|562182749|FG000|Overall Study|Adverse Event|331|||
155749195|NCT00095238|562182750|FG001|Overall Study|Adverse Event|287|||
155749196|NCT00095238|562182749|FG000|Overall Study|Subject Withdrew Consent|208|||
155749197|NCT00095238|562182750|FG001|Overall Study|Subject Withdrew Consent|223|||
155749198|NCT00095238|562182749|FG000|Overall Study|Death|154|||
155749199|NCT00095238|562182750|FG001|Overall Study|Death|170|||
155749200|NCT00095238|562182749|FG000|Overall Study|Lost to Follow-up|19|||
155749201|NCT00095238|562182750|FG001|Overall Study|Lost to Follow-up|24|||
155749202|NCT00095238|562182749|FG000|Overall Study|Noncompliance|44|||
155749203|NCT00095238|562182750|FG001|Overall Study|Noncompliance|45|||
155749204|NCT00095238|562182749|FG000|Overall Study|No longer met study criteria|4|||
155749205|NCT00095238|562182750|FG001|Overall Study|No longer met study criteria|5|||
155749206|NCT00095238|562182749|FG000|Overall Study|Study terminated by sponsor|0|||
155749207|NCT00095238|562182750|FG001|Overall Study|Study terminated by sponsor|1|||
155304766|NCT03012841|560547530|FG000|Overall Study|Insurance change|0|||
155304767|NCT03012841|560547531|FG001|Overall Study|Insurance change|1|||
155304768|NCT00186992|560547532|FG000|Overall Study|Withdrawal by Subject|5|||
155304769|NCT00186992|560547532|FG000|Overall Study|Physician's discretion|13|||
155304770|NCT00186992|560547532|FG000|Overall Study|PI Discretion|4|||
155749208|NCT00095238|562182749|FG000|Overall Study|Missing|1|||
155749209|NCT00095238|562182750|FG001|Overall Study|Missing|0|||
155749210|NCT00095238|562182749|FG000|Overall Study|Other Reasons|87|||
155749211|NCT00095238|562182750|FG001|Overall Study|Other Reasons|88|||
155749212|NCT04300751|562182751|FG000|Overall Study|Withdrawal by Subject|1|||
155749213|NCT02311582|562182754|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155749214|NCT02311582|562182755|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155749215|NCT02311582|562182756|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155749216|NCT02311582|562182757|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
155749217|NCT02311582|562182758|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
155749218|NCT04972630|562182759|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
155749219|NCT04972630|562182760|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
155749220|NCT04972630|562182761|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
155749221|NCT03422627|562182764|FG000|Overall Study|Protocol-specified Criteria|1|||
155749222|NCT03422627|562182765|FG001|Overall Study|Protocol-specified Criteria|1|||
155749223|NCT03422627|562182766|FG002|Overall Study|Protocol-specified Criteria|0|||
155749224|NCT03422627|562182767|FG003|Overall Study|Protocol-specified Criteria|0|||
155749225|NCT03422627|562182768|FG004|Overall Study|Protocol-specified Criteria|2|||
155749226|NCT03422627|562182764|FG000|Overall Study|Requirement for Alternative Therapy|1|||
155749227|NCT03422627|562182765|FG001|Overall Study|Requirement for Alternative Therapy|1|||
155749228|NCT03422627|562182766|FG002|Overall Study|Requirement for Alternative Therapy|2|||
155749229|NCT03422627|562182767|FG003|Overall Study|Requirement for Alternative Therapy|0|||
155749230|NCT03422627|562182768|FG004|Overall Study|Requirement for Alternative Therapy|0|||
155749231|NCT03422627|562182764|FG000|Overall Study|Disease Progression|1|||
155749232|NCT03422627|562182765|FG001|Overall Study|Disease Progression|0|||
155749233|NCT03422627|562182766|FG002|Overall Study|Disease Progression|1|||
155749234|NCT03422627|562182767|FG003|Overall Study|Disease Progression|2|||
155749235|NCT03422627|562182768|FG004|Overall Study|Disease Progression|0|||
155749236|NCT03422627|562182764|FG000|Overall Study|Adverse Event|2|||
155749237|NCT03422627|562182765|FG001|Overall Study|Adverse Event|1|||
155749238|NCT03422627|562182766|FG002|Overall Study|Adverse Event|0|||
155749239|NCT03422627|562182767|FG003|Overall Study|Adverse Event|0|||
155412953|NCT04209855|560942629|FG000|Overall Study|Other than specified|6|||
155304771|NCT00186992|560547532|FG000|Overall Study|Ineligible|2|||
155304772|NCT00186992|560547532|FG000|Overall Study|Lost to Follow-up|2|||
155304773|NCT00186992|560547532|FG000|Overall Study|Still on Study|9|||
155304774|NCT05696080|560547533|FG000|Overall Study|Lost to Follow-up|2|||
155304775|NCT05696080|560547534|FG001|Overall Study|Lost to Follow-up|1|||
155412954|NCT04209855|560942630|FG001|Overall Study|Other than specified|4|||
155412955|NCT00271817|560942631|FG000|Part 1|Adverse Event|68|||
155304776|NCT05696080|560547533|FG000|Overall Study|Physician Decision|1|||
155304777|NCT05696080|560547534|FG001|Overall Study|Physician Decision|0|||
155412956|NCT00271817|560942632|FG001|Part 1|Adverse Event|25|||
155412957|NCT00271817|560942633|FG002|Part 1|Adverse Event|156|||
155749240|NCT03422627|562182768|FG004|Overall Study|Adverse Event|2|||
155749241|NCT03422627|562182764|FG000|Overall Study|Ineligibility Determined|0|||
155749242|NCT03422627|562182765|FG001|Overall Study|Ineligibility Determined|1|||
155749243|NCT03422627|562182766|FG002|Overall Study|Ineligibility Determined|0|||
155749244|NCT03422627|562182767|FG003|Overall Study|Ineligibility Determined|0|||
155749245|NCT03422627|562182768|FG004|Overall Study|Ineligibility Determined|0|||
155749246|NCT03422627|562182764|FG000|Overall Study|Death|0|||
155304778|NCT05696080|560547533|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155304779|NCT05696080|560547534|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155304780|NCT05696080|560547533|FG000|Overall Study|Withdrawal by Subject|12|||
155304781|NCT05696080|560547534|FG001|Overall Study|Withdrawal by Subject|0|||
155412958|NCT00271817|560942631|FG000|Part 1|Lost to Follow-up|6|||
155412959|NCT00271817|560942632|FG001|Part 1|Lost to Follow-up|8|||
155412960|NCT00271817|560942633|FG002|Part 1|Lost to Follow-up|24|||
155412961|NCT00271817|560942631|FG000|Part 1|Protocol Violation|5|||
155412962|NCT00271817|560942632|FG001|Part 1|Protocol Violation|4|||
155412963|NCT00271817|560942633|FG002|Part 1|Protocol Violation|7|||
155412964|NCT00271817|560942631|FG000|Part 1|Patient Moved|3|||
155412965|NCT00271817|560942632|FG001|Part 1|Patient Moved|1|||
155412966|NCT00271817|560942633|FG002|Part 1|Patient Moved|5|||
155412967|NCT00271817|560942631|FG000|Part 1|Withdrawal by Subject|23|||
155412968|NCT00271817|560942632|FG001|Part 1|Withdrawal by Subject|17|||
155412969|NCT00271817|560942633|FG002|Part 1|Withdrawal by Subject|45|||
155412970|NCT00271817|560942631|FG000|Part 1|LDL < 50 mg/dL|1|||
155412971|NCT00271817|560942632|FG001|Part 1|LDL < 50 mg/dL|4|||
155412972|NCT00271817|560942633|FG002|Part 1|LDL < 50 mg/dL|48|||
155412973|NCT00271817|560942631|FG000|Part 2|Adverse Event|0|||
155412974|NCT00271817|560942632|FG001|Part 2|Adverse Event|17|||
155412975|NCT00271817|560942633|FG002|Part 2|Adverse Event|33|||
155412976|NCT00271817|560942631|FG000|Part 2|Lack of Efficacy|0|||
155412977|NCT00271817|560942632|FG001|Part 2|Lack of Efficacy|1|||
155304782|NCT03954184|560547535|FG000|Overall Study|Lost to Follow-up|500|||
155304783|NCT03954184|560547536|FG001|Overall Study|Lost to Follow-up|0|||
155304784|NCT03398200|560547537|FG000|Overall Study|Withdrawal by Subject|0|||
155304785|NCT03398200|560547538|FG001|Overall Study|Withdrawal by Subject|1|||
155304786|NCT04065048|560547541|FG000|Overall Study|Withdrawal by Subject|1|||
155304787|NCT04065048|560547542|FG001|Overall Study|Withdrawal by Subject|2|||
155304788|NCT04065048|560547543|FG002|Overall Study|Withdrawal by Subject|1|||
155304789|NCT04065048|560547544|FG003|Overall Study|Withdrawal by Subject|1|||
155304790|NCT04065048|560547541|FG000|Overall Study|Adverse Event|1|||
155304791|NCT04065048|560547542|FG001|Overall Study|Adverse Event|0|||
155304792|NCT04065048|560547543|FG002|Overall Study|Adverse Event|1|||
155304793|NCT04065048|560547544|FG003|Overall Study|Adverse Event|0|||
155304794|NCT03397108|560547545|FG000|Overall Study|Lost to Follow-up|15|||
155304795|NCT03397108|560547546|FG001|Overall Study|Lost to Follow-up|0|||
155304796|NCT03397108|560547545|FG000|Overall Study|Insufficient milk production|3|||
155304797|NCT03397108|560547546|FG001|Overall Study|Insufficient milk production|2|||
155304798|NCT03397108|560547545|FG000|Overall Study|Withdrawal by Subject|2|||
155304799|NCT03397108|560547546|FG001|Overall Study|Withdrawal by Subject|0|||
155304800|NCT02728557|560547552|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
155304801|NCT02728557|560547553|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
155304802|NCT02728557|560547552|FG000|Overall Study|Dissatisfaction with research tasks|0|||
155304803|NCT02728557|560547553|FG001|Overall Study|Dissatisfaction with research tasks|1|||
155304804|NCT02728557|560547552|FG000|Overall Study|Scheduling or change in availability|1|||
155304805|NCT02728557|560547553|FG001|Overall Study|Scheduling or change in availability|1|||
155304806|NCT01718743|560547554|FG000|Overall Study|Physician Decision|7|||
155304807|NCT01718743|560547554|FG000|Overall Study|Withdrawal by Subject|14|||
155304808|NCT01718743|560547554|FG000|Overall Study|Progressive Disease|22|||
155304809|NCT01718743|560547554|FG000|Overall Study|Toxicity|1|||
155304810|NCT01718743|560547554|FG000|Overall Study|Malignancy|1|||
155412978|NCT00271817|560942633|FG002|Part 2|Lack of Efficacy|6|||
155412979|NCT00271817|560942631|FG000|Part 2|Lost to Follow-up|0|||
155412980|NCT00271817|560942632|FG001|Part 2|Lost to Follow-up|6|||
155412981|NCT00271817|560942633|FG002|Part 2|Lost to Follow-up|18|||
155412982|NCT00271817|560942631|FG000|Part 2|Protocol Violation|0|||
155749247|NCT03422627|562182765|FG001|Overall Study|Death|1|||
155749248|NCT03422627|562182766|FG002|Overall Study|Death|1|||
155749249|NCT03422627|562182767|FG003|Overall Study|Death|0|||
155749250|NCT03422627|562182768|FG004|Overall Study|Death|0|||
155749251|NCT03422627|562182764|FG000|Overall Study|Withdrawal by Subject|0|||
155749252|NCT03422627|562182765|FG001|Overall Study|Withdrawal by Subject|0|||
155749253|NCT03422627|562182766|FG002|Overall Study|Withdrawal by Subject|0|||
155749254|NCT03422627|562182767|FG003|Overall Study|Withdrawal by Subject|1|||
155749255|NCT03422627|562182768|FG004|Overall Study|Withdrawal by Subject|0|||
155749256|NCT05171816|562182769|FG000|Overall Study|Death|18|||
155749257|NCT05171816|562182770|FG001|Overall Study|Death|16|||
155749258|NCT02937571|562182771|FG000|Overall Study|Adverse Event|0|||
155749259|NCT02937571|562182772|FG001|Overall Study|Adverse Event|0|||
155749260|NCT02937571|562182773|FG002|Overall Study|Adverse Event|4|||
155749261|NCT02937571|562182771|FG000|Overall Study|Withdrawal by Subject|0|||
155749262|NCT02937571|562182772|FG001|Overall Study|Withdrawal by Subject|0|||
155749263|NCT02937571|562182773|FG002|Overall Study|Withdrawal by Subject|3|||
155749264|NCT04214288|562182774|FG000|Overall Study|Ongoing in the study|41|||
155749265|NCT04214288|562182775|FG001|Overall Study|Ongoing in the study|51|||
155749266|NCT04214288|562182776|FG002|Overall Study|Ongoing in the study|12|||
155749267|NCT04214288|562182777|FG003|Overall Study|Ongoing in the study|39|||
155749268|NCT04214288|562182774|FG000|Overall Study|Adverse Event|1|||
155412983|NCT00271817|560942632|FG001|Part 2|Protocol Violation|3|||
155412984|NCT00271817|560942633|FG002|Part 2|Protocol Violation|5|||
155412985|NCT00271817|560942631|FG000|Part 2|Patient Moved|0|||
155412986|NCT00271817|560942632|FG001|Part 2|Patient Moved|0|||
155412987|NCT00271817|560942633|FG002|Part 2|Patient Moved|5|||
155412988|NCT00271817|560942631|FG000|Part 2|Withdrawal by Subject|0|||
155412989|NCT00271817|560942632|FG001|Part 2|Withdrawal by Subject|2|||
155412990|NCT00271817|560942633|FG002|Part 2|Withdrawal by Subject|13|||
155412991|NCT00271817|560942631|FG000|Part 2|LDL < 50 mg/dL|0|||
155412992|NCT00271817|560942632|FG001|Part 2|LDL < 50 mg/dL|3|||
155412993|NCT00271817|560942633|FG002|Part 2|LDL < 50 mg/dL|4|||
155412994|NCT01471782|560942635|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
155412995|NCT01471782|560942636|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
155412996|NCT01471782|560942637|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
155412997|NCT01471782|560942638|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
155412998|NCT01471782|560942639|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
155412999|NCT01471782|560942640|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
155413000|NCT01471782|560942635|FG000|Overall Study|Lack of Efficacy|1|||
155413001|NCT01471782|560942636|FG001|Overall Study|Lack of Efficacy|2|||
155413002|NCT01471782|560942637|FG002|Overall Study|Lack of Efficacy|1|||
155413003|NCT01471782|560942638|FG003|Overall Study|Lack of Efficacy|1|||
155413004|NCT01471782|560942639|FG004|Overall Study|Lack of Efficacy|5|||
155413005|NCT01471782|560942640|FG005|Overall Study|Lack of Efficacy|18|||
155413006|NCT01471782|560942635|FG000|Overall Study|Adverse Event|1|||
155413007|NCT01471782|560942636|FG001|Overall Study|Adverse Event|1|||
155413008|NCT01471782|560942637|FG002|Overall Study|Adverse Event|2|||
155413009|NCT01471782|560942638|FG003|Overall Study|Adverse Event|2|||
155413010|NCT01471782|560942639|FG004|Overall Study|Adverse Event|3|||
155413011|NCT01471782|560942640|FG005|Overall Study|Adverse Event|1|||
155413012|NCT01471782|560942635|FG000|Overall Study|Other|0|||
155413013|NCT01471782|560942636|FG001|Overall Study|Other|0|||
155413014|NCT01471782|560942637|FG002|Overall Study|Other|1|||
155413015|NCT01471782|560942638|FG003|Overall Study|Other|1|||
155413016|NCT01471782|560942639|FG004|Overall Study|Other|6|||
155413017|NCT01471782|560942640|FG005|Overall Study|Other|5|||
155413018|NCT01471782|560942635|FG000|Overall Study|Change of Chemotherapy|1|||
155413019|NCT01471782|560942636|FG001|Overall Study|Change of Chemotherapy|1|||
155413020|NCT01471782|560942637|FG002|Overall Study|Change of Chemotherapy|0|||
155413021|NCT01471782|560942638|FG003|Overall Study|Change of Chemotherapy|0|||
155413022|NCT01471782|560942639|FG004|Overall Study|Change of Chemotherapy|1|||
155413023|NCT01471782|560942640|FG005|Overall Study|Change of Chemotherapy|4|||
155413024|NCT01471782|560942635|FG000|Overall Study|Disease Relapse|0|||
155413025|NCT01471782|560942636|FG001|Overall Study|Disease Relapse|0|||
155413026|NCT01471782|560942637|FG002|Overall Study|Disease Relapse|0|||
155413027|NCT01471782|560942638|FG003|Overall Study|Disease Relapse|1|||
155413028|NCT01471782|560942639|FG004|Overall Study|Disease Relapse|2|||
155413029|NCT01471782|560942640|FG005|Overall Study|Disease Relapse|1|||
155413030|NCT01471782|560942635|FG000|Overall Study|Physician Decision|0|||
155413031|NCT01471782|560942636|FG001|Overall Study|Physician Decision|0|||
155413032|NCT01471782|560942637|FG002|Overall Study|Physician Decision|0|||
155413033|NCT01471782|560942638|FG003|Overall Study|Physician Decision|0|||
155413034|NCT01471782|560942639|FG004|Overall Study|Physician Decision|3|||
155413035|NCT01471782|560942640|FG005|Overall Study|Physician Decision|8|||
155413036|NCT01471782|560942635|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155413037|NCT01471782|560942636|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155413038|NCT01471782|560942637|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155413039|NCT01471782|560942638|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155413040|NCT01471782|560942639|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
155413041|NCT01471782|560942640|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155413042|NCT01471782|560942635|FG000|Overall Study|Death|0|||
155413043|NCT01471782|560942636|FG001|Overall Study|Death|0|||
155413044|NCT01471782|560942637|FG002|Overall Study|Death|0|||
155749269|NCT04214288|562182775|FG001|Overall Study|Adverse Event|0|||
155749270|NCT04214288|562182776|FG002|Overall Study|Adverse Event|0|||
155413045|NCT01471782|560942638|FG003|Overall Study|Death|0|||
155413046|NCT01471782|560942639|FG004|Overall Study|Death|0|||
155413047|NCT01471782|560942640|FG005|Overall Study|Death|1|||
155413048|NCT00936208|560942641|FG000|Overall Study|Protocol Violation|37|||
155413049|NCT00936208|560942642|FG001|Overall Study|Protocol Violation|22|||
155413050|NCT04428424|560942643|FG000|Overall Study|Does not meet entrance criteria|132|||
155413051|NCT04428424|560942643|FG000|Overall Study|Lost to Follow-up|115|||
155749271|NCT04214288|562182777|FG003|Overall Study|Adverse Event|0|||
155413052|NCT01564862|560942644|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
155413053|NCT01564862|560942645|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
155413054|NCT01564862|560942646|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
155413055|NCT01564862|560942644|FG000|Overall Study|Major Protocol Deviation|3|||
155413056|NCT01564862|560942645|FG001|Overall Study|Major Protocol Deviation|3|||
155413057|NCT01564862|560942646|FG002|Overall Study|Major Protocol Deviation|4|||
155413058|NCT01564862|560942644|FG000|Overall Study|Lost to Follow-up|10|||
155304811|NCT03416010|560547555|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
155304812|NCT03416010|560547556|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
155304813|NCT03416010|560547555|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
155304814|NCT03416010|560547556|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
155304815|NCT03416010|560547555|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
155304816|NCT03416010|560547556|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
155304817|NCT03416010|560547555|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
155304818|NCT03416010|560547556|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
155304819|NCT03416010|560547555|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
155304820|NCT03416010|560547556|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
155304821|NCT03416010|560547555|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
155304822|NCT03416010|560547556|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
155304823|NCT03416010|560547555|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
155304824|NCT03416010|560547556|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
155304825|NCT03948763|560547560|FG000|Overall Study|Sponsor's decision|0|||
155304826|NCT03948763|560547561|FG001|Overall Study|Sponsor's decision|2|||
155304827|NCT03948763|560547562|FG002|Overall Study|Sponsor's decision|6|||
155304828|NCT03948763|560547563|FG003|Overall Study|Sponsor's decision|4|||
155304829|NCT03948763|560547564|FG004|Overall Study|Sponsor's decision|0|||
155304830|NCT03948763|560547560|FG000|Overall Study|Physician Decision|0|||
155304831|NCT03948763|560547561|FG001|Overall Study|Physician Decision|0|||
155304832|NCT03948763|560547562|FG002|Overall Study|Physician Decision|1|||
155304833|NCT03948763|560547563|FG003|Overall Study|Physician Decision|0|||
155304834|NCT03948763|560547564|FG004|Overall Study|Physician Decision|0|||
155304835|NCT03948763|560547560|FG000|Overall Study|Lost to Follow-up|0|||
155304836|NCT03948763|560547561|FG001|Overall Study|Lost to Follow-up|0|||
155304837|NCT03948763|560547562|FG002|Overall Study|Lost to Follow-up|0|||
155304838|NCT03948763|560547563|FG003|Overall Study|Lost to Follow-up|0|||
155304839|NCT03948763|560547564|FG004|Overall Study|Lost to Follow-up|1|||
155304840|NCT03948763|560547560|FG000|Overall Study|Death|2|||
155641987|NCT03369223|561779152|FG009|Overall Study|Adverse event unrelated to study drug|1|||
155641988|NCT03369223|561779153|FG010|Overall Study|Adverse event unrelated to study drug|0|||
155641989|NCT03369223|561779154|FG011|Overall Study|Adverse event unrelated to study drug|0|||
155641990|NCT03369223|561779155|FG012|Overall Study|Adverse event unrelated to study drug|0|||
155641991|NCT03369223|561779156|FG013|Overall Study|Adverse event unrelated to study drug|4|||
155641992|NCT03369223|561779157|FG014|Overall Study|Adverse event unrelated to study drug|2|||
155641993|NCT03369223|561779158|FG015|Overall Study|Adverse event unrelated to study drug|0|||
155641994|NCT03369223|561779159|FG016|Overall Study|Adverse event unrelated to study drug|2|||
155641995|NCT03369223|561779160|FG017|Overall Study|Adverse event unrelated to study drug|1|||
155641996|NCT03369223|561779161|FG018|Overall Study|Adverse event unrelated to study drug|3|||
155641997|NCT03369223|561779162|FG019|Overall Study|Adverse event unrelated to study drug|2|||
155641998|NCT03369223|561779143|FG000|Overall Study|Disease progression|6|||
155641999|NCT03369223|561779144|FG001|Overall Study|Disease progression|8|||
155642000|NCT03369223|561779145|FG002|Overall Study|Disease progression|5|||
155642001|NCT03369223|561779146|FG003|Overall Study|Disease progression|1|||
155642002|NCT03369223|561779147|FG004|Overall Study|Disease progression|9|||
155642003|NCT03369223|561779148|FG005|Overall Study|Disease progression|9|||
155642004|NCT03369223|561779149|FG006|Overall Study|Disease progression|4|||
155642005|NCT03369223|561779150|FG007|Overall Study|Disease progression|6|||
155642006|NCT03369223|561779151|FG008|Overall Study|Disease progression|10|||
155642007|NCT03369223|561779152|FG009|Overall Study|Disease progression|7|||
155642008|NCT03369223|561779153|FG010|Overall Study|Disease progression|4|||
155642009|NCT03369223|561779154|FG011|Overall Study|Disease progression|1|||
155642010|NCT03369223|561779155|FG012|Overall Study|Disease progression|1|||
155642011|NCT03369223|561779156|FG013|Overall Study|Disease progression|25|||
155642012|NCT03369223|561779157|FG014|Overall Study|Disease progression|22|||
155642013|NCT03369223|561779158|FG015|Overall Study|Disease progression|2|||
155642014|NCT03369223|561779159|FG016|Overall Study|Disease progression|10|||
155642015|NCT03369223|561779160|FG017|Overall Study|Disease progression|1|||
155642016|NCT03369223|561779161|FG018|Overall Study|Disease progression|18|||
155642017|NCT03369223|561779162|FG019|Overall Study|Disease progression|28|||
155642018|NCT03369223|561779143|FG000|Overall Study|Study drug toxicity|0|||
155642019|NCT03369223|561779144|FG001|Overall Study|Study drug toxicity|1|||
155642020|NCT03369223|561779145|FG002|Overall Study|Study drug toxicity|4|||
155642021|NCT03369223|561779146|FG003|Overall Study|Study drug toxicity|0|||
155642022|NCT03369223|561779147|FG004|Overall Study|Study drug toxicity|1|||
155642023|NCT03369223|561779148|FG005|Overall Study|Study drug toxicity|2|||
155642024|NCT03369223|561779149|FG006|Overall Study|Study drug toxicity|4|||
155642025|NCT03369223|561779150|FG007|Overall Study|Study drug toxicity|2|||
155642026|NCT03369223|561779151|FG008|Overall Study|Study drug toxicity|2|||
155642027|NCT03369223|561779152|FG009|Overall Study|Study drug toxicity|0|||
155642028|NCT03369223|561779153|FG010|Overall Study|Study drug toxicity|6|||
155642029|NCT03369223|561779154|FG011|Overall Study|Study drug toxicity|1|||
155642030|NCT03369223|561779155|FG012|Overall Study|Study drug toxicity|2|||
155642031|NCT03369223|561779156|FG013|Overall Study|Study drug toxicity|19|||
155642032|NCT03369223|561779157|FG014|Overall Study|Study drug toxicity|19|||
155642033|NCT03369223|561779158|FG015|Overall Study|Study drug toxicity|0|||
155642034|NCT03369223|561779159|FG016|Overall Study|Study drug toxicity|18|||
155642035|NCT03369223|561779160|FG017|Overall Study|Study drug toxicity|3|||
155642036|NCT03369223|561779161|FG018|Overall Study|Study drug toxicity|11|||
155642037|NCT03369223|561779162|FG019|Overall Study|Study drug toxicity|7|||
155642038|NCT03369223|561779143|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155642039|NCT03369223|561779144|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155642040|NCT03369223|561779145|FG002|Overall Study|Participant request to discontinue study treatment|0|||
155642041|NCT03369223|561779146|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155642042|NCT03369223|561779147|FG004|Overall Study|Participant request to discontinue study treatment|1|||
155642043|NCT03369223|561779148|FG005|Overall Study|Participant request to discontinue study treatment|1|||
155642044|NCT03369223|561779149|FG006|Overall Study|Participant request to discontinue study treatment|1|||
155642045|NCT03369223|561779150|FG007|Overall Study|Participant request to discontinue study treatment|0|||
155642046|NCT03369223|561779151|FG008|Overall Study|Participant request to discontinue study treatment|0|||
155642047|NCT03369223|561779152|FG009|Overall Study|Participant request to discontinue study treatment|0|||
155642048|NCT03369223|561779153|FG010|Overall Study|Participant request to discontinue study treatment|0|||
155642049|NCT03369223|561779154|FG011|Overall Study|Participant request to discontinue study treatment|0|||
155642050|NCT03369223|561779155|FG012|Overall Study|Participant request to discontinue study treatment|0|||
155642051|NCT03369223|561779156|FG013|Overall Study|Participant request to discontinue study treatment|1|||
155642052|NCT03369223|561779157|FG014|Overall Study|Participant request to discontinue study treatment|1|||
155642053|NCT03369223|561779158|FG015|Overall Study|Participant request to discontinue study treatment|0|||
155642054|NCT03369223|561779159|FG016|Overall Study|Participant request to discontinue study treatment|0|||
155642055|NCT03369223|561779160|FG017|Overall Study|Participant request to discontinue study treatment|0|||
155642056|NCT03369223|561779161|FG018|Overall Study|Participant request to discontinue study treatment|1|||
155642057|NCT03369223|561779162|FG019|Overall Study|Participant request to discontinue study treatment|0|||
155642058|NCT03369223|561779143|FG000|Overall Study|Participant withdrew consent|0|||
155642059|NCT03369223|561779144|FG001|Overall Study|Participant withdrew consent|1|||
155642060|NCT03369223|561779145|FG002|Overall Study|Participant withdrew consent|1|||
155642061|NCT03369223|561779146|FG003|Overall Study|Participant withdrew consent|0|||
155642062|NCT03369223|561779147|FG004|Overall Study|Participant withdrew consent|0|||
155642063|NCT03369223|561779148|FG005|Overall Study|Participant withdrew consent|0|||
155642064|NCT03369223|561779149|FG006|Overall Study|Participant withdrew consent|1|||
155642065|NCT03369223|561779150|FG007|Overall Study|Participant withdrew consent|1|||
155749272|NCT04214288|562182774|FG000|Overall Study|Death|22|||
155749273|NCT04214288|562182775|FG001|Overall Study|Death|13|||
155749274|NCT04214288|562182776|FG002|Overall Study|Death|7|||
155749275|NCT04214288|562182777|FG003|Overall Study|Death|19|||
155304841|NCT03948763|560547561|FG001|Overall Study|Death|12|||
155304842|NCT03948763|560547562|FG002|Overall Study|Death|13|||
155304843|NCT03948763|560547563|FG003|Overall Study|Death|10|||
155304844|NCT03948763|560547564|FG004|Overall Study|Death|11|||
155304845|NCT03948763|560547560|FG000|Overall Study|Withdrawal by Subject|1|||
155304846|NCT03948763|560547561|FG001|Overall Study|Withdrawal by Subject|1|||
155304847|NCT03948763|560547562|FG002|Overall Study|Withdrawal by Subject|0|||
155304848|NCT03948763|560547563|FG003|Overall Study|Withdrawal by Subject|2|||
155304849|NCT03948763|560547564|FG004|Overall Study|Withdrawal by Subject|4|||
155304850|NCT05986565|560547568|FG000|Overall Study|Lost to Follow-up|8|||
155304851|NCT05986565|560547569|FG001|Overall Study|Lost to Follow-up|3|||
155304852|NCT05986565|560547568|FG000|Overall Study|Withdrawal by Subject|0|||
155304853|NCT05986565|560547569|FG001|Overall Study|Withdrawal by Subject|1|||
155304854|NCT03446157|560547572|FG000|Overall Study|Death|11|||
155304855|NCT03446157|560547573|FG001|Overall Study|Death|9|||
155304856|NCT03446157|560547572|FG000|Overall Study|Lost to Follow-up|0|||
155304857|NCT03446157|560547573|FG001|Overall Study|Lost to Follow-up|1|||
155304858|NCT03446157|560547572|FG000|Overall Study|Withdrawal by Subject|2|||
155304859|NCT03446157|560547573|FG001|Overall Study|Withdrawal by Subject|1|||
155304860|NCT02386553|560547574|FG000|Overall Study|Reason Not Specified|1|||
155304861|NCT02386553|560547575|FG001|Overall Study|Reason Not Specified|1|||
155304862|NCT02386553|560547574|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
155749276|NCT04214288|562182774|FG000|Overall Study|Lost to Follow-up|1|||
155749277|NCT04214288|562182775|FG001|Overall Study|Lost to Follow-up|2|||
155749278|NCT04214288|562182776|FG002|Overall Study|Lost to Follow-up|1|||
155749279|NCT04214288|562182777|FG003|Overall Study|Lost to Follow-up|0|||
155749280|NCT04214288|562182774|FG000|Overall Study|Other|1|||
155749281|NCT04214288|562182775|FG001|Overall Study|Other|2|||
155749282|NCT04214288|562182776|FG002|Overall Study|Other|0|||
155749283|NCT04214288|562182777|FG003|Overall Study|Other|6|||
155749284|NCT04214288|562182774|FG000|Overall Study|Protocol Violation|0|||
155749285|NCT04214288|562182775|FG001|Overall Study|Protocol Violation|1|||
155749286|NCT04214288|562182776|FG002|Overall Study|Protocol Violation|0|||
155749287|NCT04214288|562182777|FG003|Overall Study|Protocol Violation|0|||
155749288|NCT04214288|562182774|FG000|Overall Study|Withdrawal by Subject|8|||
155749289|NCT04214288|562182775|FG001|Overall Study|Withdrawal by Subject|4|||
155749290|NCT04214288|562182776|FG002|Overall Study|Withdrawal by Subject|0|||
155749291|NCT04214288|562182777|FG003|Overall Study|Withdrawal by Subject|9|||
155749292|NCT03675321|562182778|FG000|Overall Study|Lack of Efficacy|2|||
155749293|NCT03675321|562182779|FG001|Overall Study|Lack of Efficacy|2|||
155749294|NCT03675321|562182778|FG000|Overall Study|Withdrawal by Subject|1|||
155749295|NCT03675321|562182779|FG001|Overall Study|Withdrawal by Subject|3|||
155749296|NCT00807027|562182780|FG000|Overall Study|Withdrawal by Subject|13|||
155749297|NCT00807027|562182781|FG001|Overall Study|Withdrawal by Subject|14|||
155749298|NCT00807027|562182780|FG000|Overall Study|Protocol Violation|1|||
155749299|NCT00807027|562182781|FG001|Overall Study|Protocol Violation|1|||
155749300|NCT00807027|562182780|FG000|Overall Study|Adverse Event|2|||
155749301|NCT00807027|562182781|FG001|Overall Study|Adverse Event|2|||
155749302|NCT03997383|562182782|FG000|Double-blind Treatment Period|Adverse Event|4|||
155749303|NCT03997383|562182783|FG001|Double-blind Treatment Period|Adverse Event|3|||
155749304|NCT03997383|562182782|FG000|Double-blind Treatment Period|Death|4|||
155749305|NCT03997383|562182783|FG001|Double-blind Treatment Period|Death|4|||
155749306|NCT03997383|562182782|FG000|Double-blind Treatment Period|Physician Decision|2|||
155749307|NCT03997383|562182783|FG001|Double-blind Treatment Period|Physician Decision|0|||
155749308|NCT03997383|562182782|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
155749309|NCT03997383|562182783|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
155749310|NCT03997383|562182782|FG000|Open-label Extension Period|Ongoing|148|||
155749311|NCT03997383|562182783|FG001|Open-label Extension Period|Ongoing|151|||
155749312|NCT03997383|562182782|FG000|Open-label Extension Period|Adverse Event|4|||
155749313|NCT03997383|562182783|FG001|Open-label Extension Period|Adverse Event|1|||
155749314|NCT03997383|562182782|FG000|Open-label Extension Period|Death|8|||
155749315|NCT03997383|562182783|FG001|Open-label Extension Period|Death|9|||
155749316|NCT03997383|562182782|FG000|Open-label Extension Period|Physician Decision|1|||
155749317|NCT03997383|562182783|FG001|Open-label Extension Period|Physician Decision|1|||
155749318|NCT03997383|562182782|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
155749319|NCT03997383|562182783|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
155749320|NCT03997383|562182782|FG000|Open-label Extension Period|Reason Not Specified|2|||
155749321|NCT03997383|562182783|FG001|Open-label Extension Period|Reason Not Specified|0|||
155749322|NCT02278341|562182784|FG000|Overall Study|Randomized but never received study drug|1|||
155749323|NCT02278341|562182785|FG001|Overall Study|Randomized but never received study drug|1|||
155749324|NCT02278341|562182784|FG000|Overall Study|Adverse Event|3|||
155749325|NCT02278341|562182785|FG001|Overall Study|Adverse Event|0|||
155749326|NCT02278341|562182784|FG000|Overall Study|Death|68|||
155749327|NCT02278341|562182785|FG001|Overall Study|Death|56|||
155749328|NCT02278341|562182784|FG000|Overall Study|Withdrawal by Subject|30|||
155749329|NCT02278341|562182785|FG001|Overall Study|Withdrawal by Subject|19|||
155749330|NCT02278341|562182784|FG000|Overall Study|Lost to Follow-up|0|||
155749331|NCT02278341|562182785|FG001|Overall Study|Lost to Follow-up|1|||
155749332|NCT02278341|562182784|FG000|Overall Study|Physician Decision|1|||
155749333|NCT02278341|562182785|FG001|Overall Study|Physician Decision|1|||
155304863|NCT02386553|560547575|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
155304864|NCT00998881|560547579|FG000|Overall Study|Adverse Event|2|||
155304865|NCT00998881|560547580|FG001|Overall Study|Adverse Event|2|||
155304866|NCT00998881|560547579|FG000|Overall Study|Lack of Efficacy|1|||
155749334|NCT02278341|562182784|FG000|Overall Study|Miscellaneous|15|||
155304867|NCT00998881|560547580|FG001|Overall Study|Lack of Efficacy|0|||
155749335|NCT02278341|562182785|FG001|Overall Study|Miscellaneous|14|||
155749336|NCT04902326|562182788|FG000|Overall Study|Withdrawal by Subject|1|||
155304868|NCT00998881|560547579|FG000|Overall Study|Physician Decision|3|||
155304869|NCT00998881|560547580|FG001|Overall Study|Physician Decision|0|||
155304870|NCT00998881|560547579|FG000|Overall Study|Withdrawal by Subject|1|||
155304871|NCT00998881|560547580|FG001|Overall Study|Withdrawal by Subject|0|||
155749337|NCT04902326|562182789|FG001|Overall Study|Withdrawal by Subject|3|||
155749338|NCT04902326|562182790|FG002|Overall Study|Withdrawal by Subject|0|||
155749339|NCT04902326|562182791|FG003|Overall Study|Withdrawal by Subject|1|||
155749340|NCT04902326|562182788|FG000|Overall Study|Lost to Follow-up|14|||
155749341|NCT04902326|562182789|FG001|Overall Study|Lost to Follow-up|14|||
155749342|NCT04902326|562182790|FG002|Overall Study|Lost to Follow-up|14|||
155304872|NCT00998881|560547579|FG000|Overall Study|Personal matter|1|||
155304873|NCT00998881|560547580|FG001|Overall Study|Personal matter|0|||
155304874|NCT01121991|560547581|FG000|Overall Study|Lack of Ovarian Response|2|||
155304875|NCT01121991|560547581|FG000|Overall Study|No Oocytes Retrieved|3|||
155304876|NCT01121991|560547581|FG000|Overall Study|No Fertilization|1|||
155304877|NCT01619410|560547582|FG000|Overall Study|Lost to Follow-up|7|||
155304878|NCT01619410|560547583|FG001|Overall Study|Lost to Follow-up|4|||
155304879|NCT02462759|560547584|FG000|Part 1: Double Blind|Death|1|||
155304880|NCT02462759|560547585|FG001|Part 1: Double Blind|Death|0|||
155304881|NCT02462759|560547586|FG002|Part 1: Double Blind|Death|0|||
155304882|NCT02740231|560547587|FG000|Overall Study|Withdrawal by Subject|1|||
155304883|NCT02740231|560547588|FG001|Overall Study|Withdrawal by Subject|1|||
155304884|NCT02740231|560547589|FG002|Overall Study|Withdrawal by Subject|1|||
155304885|NCT02740231|560547590|FG003|Overall Study|Withdrawal by Subject|0|||
155304886|NCT02740231|560547587|FG000|Overall Study|Lack of Efficacy|0|||
155304887|NCT02740231|560547588|FG001|Overall Study|Lack of Efficacy|1|||
155304888|NCT02740231|560547589|FG002|Overall Study|Lack of Efficacy|0|||
155304889|NCT02740231|560547590|FG003|Overall Study|Lack of Efficacy|4|||
155304890|NCT02740231|560547587|FG000|Overall Study|Lost to Follow-up|1|||
155304891|NCT02740231|560547588|FG001|Overall Study|Lost to Follow-up|3|||
155304892|NCT02740231|560547589|FG002|Overall Study|Lost to Follow-up|0|||
155304893|NCT02740231|560547590|FG003|Overall Study|Lost to Follow-up|3|||
155304894|NCT02740231|560547587|FG000|Overall Study|Adverse Event|0|||
155304895|NCT02740231|560547588|FG001|Overall Study|Adverse Event|1|||
155304896|NCT02740231|560547589|FG002|Overall Study|Adverse Event|0|||
155304897|NCT02740231|560547590|FG003|Overall Study|Adverse Event|1|||
155304898|NCT04110054|560547591|FG000|Overall Study|COVID-19 reason other than AE|0|||
155304899|NCT04110054|560547592|FG001|Overall Study|COVID-19 reason other than AE|0|||
155304900|NCT04110054|560547593|FG002|Overall Study|COVID-19 reason other than AE|2|||
155304901|NCT04110054|560547594|FG003|Overall Study|COVID-19 reason other than AE|0|||
155304902|NCT04110054|560547591|FG000|Overall Study|Withdrawal by Subject|0|||
155304903|NCT04110054|560547592|FG001|Overall Study|Withdrawal by Subject|3|||
155304904|NCT04110054|560547593|FG002|Overall Study|Withdrawal by Subject|2|||
155304905|NCT04110054|560547594|FG003|Overall Study|Withdrawal by Subject|0|||
155304906|NCT04110054|560547591|FG000|Overall Study|Adverse Event|1|||
155304907|NCT04110054|560547592|FG001|Overall Study|Adverse Event|1|||
155304908|NCT04110054|560547593|FG002|Overall Study|Adverse Event|4|||
155304909|NCT04110054|560547594|FG003|Overall Study|Adverse Event|3|||
155304910|NCT03655262|560547597|FG000|Overall Study|Withdrawal by Subject|0|||
155304911|NCT03655262|560547598|FG001|Overall Study|Withdrawal by Subject|0|||
155304912|NCT03655262|560547599|FG002|Overall Study|Withdrawal by Subject|1|||
155304913|NCT01695954|560547603|FG000|Overall Study|Withdrawal by Subject|4|||
155304914|NCT01695954|560547604|FG001|Overall Study|Withdrawal by Subject|0|||
155304915|NCT01695954|560547603|FG000|Overall Study|Adverse Event|0|||
155304916|NCT01695954|560547604|FG001|Overall Study|Adverse Event|2|||
155304917|NCT04583423|560547616|FG000|Overall Study|Lost to Follow-up|0|||
155304918|NCT04583423|560547617|FG001|Overall Study|Lost to Follow-up|1|||
155304919|NCT04583423|560547618|FG002|Overall Study|Lost to Follow-up|0|||
155304920|NCT04583423|560547619|FG003|Overall Study|Lost to Follow-up|2|||
155304921|NCT04583423|560547616|FG000|Overall Study|Study Terminated by Sponsor|32|||
155304922|NCT04583423|560547617|FG001|Overall Study|Study Terminated by Sponsor|35|||
155304923|NCT04583423|560547618|FG002|Overall Study|Study Terminated by Sponsor|36|||
155304924|NCT04583423|560547619|FG003|Overall Study|Study Terminated by Sponsor|33|||
155304925|NCT04583423|560547616|FG000|Overall Study|Withdrawal by Subject|3|||
155304926|NCT04583423|560547617|FG001|Overall Study|Withdrawal by Subject|1|||
155304927|NCT04583423|560547618|FG002|Overall Study|Withdrawal by Subject|2|||
155304928|NCT04583423|560547619|FG003|Overall Study|Withdrawal by Subject|1|||
155304929|NCT04704284|560547625|FG000|Overall Study|Withdrawal by Subject|1|||
155304930|NCT03330795|560547627|FG000|Overall Study|Death|3|||
155304931|NCT03330795|560547627|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
155304932|NCT05782231|560547628|FG000|Overall Study|Withdrawal by Subject|1|||
155304933|NCT05575076|560547629|FG000|Overall Study|Adverse Event|24|||
155304934|NCT05575076|560547629|FG000|Overall Study|Death|7|||
155749343|NCT04902326|562182791|FG003|Overall Study|Lost to Follow-up|6|||
155749344|NCT00934648|562182793|FG000|Overall Study|Failure to return|8|||
155749345|NCT00934648|562182793|FG000|Overall Study|Withdrawal by Subject|1|||
155749346|NCT02361580|562182794|FG000|Overall Study|Lost to Follow-up|6|||
155749347|NCT02361580|562182795|FG001|Overall Study|Lost to Follow-up|3|||
155749348|NCT02047318|562182796|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
155749349|NCT02047318|562182796|FG000|Core Study Period|Adverse Event|1|||
155749350|NCT02047318|562182796|FG000|Core Study Period|Withdrawal by caregiver|3|||
155749351|NCT02047318|562182796|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
155749352|NCT00924781|562182797|FG000|Overall Study|Study terminated by sponsor|12|||
155304935|NCT05575076|560547629|FG000|Overall Study|Lost to Follow-up|16|||
155304936|NCT05575076|560547629|FG000|Overall Study|Non-Compliance|3|||
155304937|NCT05575076|560547629|FG000|Overall Study|Physician Decision|6|||
155749353|NCT00924781|562182798|FG001|Overall Study|Study terminated by sponsor|10|||
155749354|NCT01487577|562182799|FG000|Overall Study|Became ineligible after signing consent|1|||
155304938|NCT05575076|560547629|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
155304939|NCT05575076|560547629|FG000|Overall Study|Withdrawal by Subject|71|||
155304940|NCT05575076|560547629|FG000|Overall Study|Study Terminated by Sponsor|630|||
155304941|NCT05575076|560547629|FG000|Overall Study|Other|17|||
155304942|NCT02538341|560547637|FG000|Overall Study|Lost to Follow-up|51|||
155304943|NCT02538341|560547638|FG001|Overall Study|Lost to Follow-up|46|||
155304944|NCT02538341|560547637|FG000|Overall Study|Withdrawal by Subject|3|||
155304945|NCT02538341|560547638|FG001|Overall Study|Withdrawal by Subject|1|||
155304946|NCT02538341|560547637|FG000|Overall Study|Death|2|||
155304947|NCT02538341|560547638|FG001|Overall Study|Death|0|||
155304948|NCT00065260|560547640|FG000|Overall Study|Death|0|||
155304949|NCT00065260|560547641|FG001|Overall Study|Death|1|||
155304950|NCT03750968|560547642|FG000|Overall Study|Adverse Event|2|||
155304951|NCT03750968|560547643|FG001|Overall Study|Adverse Event|0|||
155304952|NCT03750968|560547642|FG000|Overall Study|Lost to Follow-up|1|||
155304953|NCT03750968|560547643|FG001|Overall Study|Lost to Follow-up|3|||
155304954|NCT04766034|560547648|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304955|NCT04766034|560547649|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304956|NCT04766034|560547650|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304957|NCT04766034|560547651|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304958|NCT04766034|560547652|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
155304959|NCT04766034|560547648|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304960|NCT04766034|560547649|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304961|NCT04766034|560547650|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304962|NCT04766034|560547651|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304963|NCT04766034|560547652|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
155304964|NCT04766034|560547648|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
155304965|NCT04766034|560547649|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
155304966|NCT04766034|560547650|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
155304967|NCT04766034|560547651|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
155304968|NCT04766034|560547652|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
155304969|NCT04766034|560547648|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
155304970|NCT04766034|560547649|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
155304971|NCT04766034|560547650|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
155304972|NCT04766034|560547651|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
155304973|NCT04766034|560547652|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
155304974|NCT05094141|560547656|FG000|Overall Study|Death|0|||
155304975|NCT05094141|560547657|FG001|Overall Study|Death|0|||
155304976|NCT05094141|560547658|FG002|Overall Study|Death|1|||
155304977|NCT05094141|560547656|FG000|Overall Study|Withdrawal by Subject|0|||
155304978|NCT05094141|560547657|FG001|Overall Study|Withdrawal by Subject|0|||
155304979|NCT05094141|560547658|FG002|Overall Study|Withdrawal by Subject|1|||
155304980|NCT05094141|560547656|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
155304981|NCT05094141|560547657|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
155304982|NCT05094141|560547658|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
155304983|NCT05094141|560547656|FG000|Overall Study|Did not participate in randomization|0|||
155304984|NCT05094141|560547657|FG001|Overall Study|Did not participate in randomization|0|||
155304985|NCT05094141|560547658|FG002|Overall Study|Did not participate in randomization|33|||
155304986|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
155304987|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
155304988|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
155304989|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
155413059|NCT01564862|560942645|FG001|Overall Study|Lost to Follow-up|8|||
155304990|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
155304991|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
155304992|NCT02576509|560549294|FG000|Treatment Period|Disease progression|263|||
155304993|NCT02576509|560549295|FG001|Treatment Period|Disease progression|244|||
155304994|NCT02576509|560549294|FG000|Treatment Period|Study drug toxicity|37|||
155304995|NCT02576509|560549295|FG001|Treatment Period|Study drug toxicity|41|||
155304996|NCT02576509|560549294|FG000|Treatment Period|Death|1|||
155304997|NCT02576509|560549295|FG001|Treatment Period|Death|1|||
155304998|NCT02576509|560549294|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
155304999|NCT02576509|560549295|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
155305000|NCT02576509|560549294|FG000|Treatment Period|Participant request to stop treatment|8|||
155305001|NCT02576509|560549295|FG001|Treatment Period|Participant request to stop treatment|18|||
155305002|NCT02576509|560549294|FG000|Treatment Period|Participant withdrew consent|3|||
155305003|NCT02576509|560549295|FG001|Treatment Period|Participant withdrew consent|7|||
155413060|NCT01564862|560942646|FG002|Overall Study|Lost to Follow-up|6|||
155413061|NCT01564862|560942644|FG000|Overall Study|Voluntary Withdrawal|9|||
155413062|NCT01564862|560942645|FG001|Overall Study|Voluntary Withdrawal|6|||
155413063|NCT01564862|560942646|FG002|Overall Study|Voluntary Withdrawal|8|||
155413064|NCT01564862|560942644|FG000|Overall Study|Lack of Efficacy|1|||
155413065|NCT01564862|560942645|FG001|Overall Study|Lack of Efficacy|5|||
155413066|NCT01564862|560942646|FG002|Overall Study|Lack of Efficacy|6|||
155413067|NCT01564862|560942644|FG000|Overall Study|Other reason(s)|1|||
155413068|NCT01564862|560942645|FG001|Overall Study|Other reason(s)|0|||
155413069|NCT01564862|560942646|FG002|Overall Study|Other reason(s)|0|||
155413070|NCT02193074|560942649|FG000|Overall Study|Withdrawal by Subject|1|||
155413071|NCT02193074|560942650|FG001|Overall Study|Withdrawal by Subject|2|||
155413072|NCT02193074|560942649|FG000|Overall Study|Adverse Event|16|||
155413073|NCT02193074|560942650|FG001|Overall Study|Adverse Event|13|||
155413074|NCT02872311|560944678|FG000|Overall Study|Death|2|||
155749355|NCT01653782|562182802|FG000|Overall Study|Withdrawal by Subject|9|||
155749356|NCT01653782|562182803|FG001|Overall Study|Withdrawal by Subject|15|||
155749357|NCT01653782|562182804|FG002|Overall Study|Withdrawal by Subject|4|||
155749358|NCT01653782|562182802|FG000|Overall Study|Lost to Follow-up|7|||
155749359|NCT01653782|562182803|FG001|Overall Study|Lost to Follow-up|3|||
155749360|NCT01653782|562182804|FG002|Overall Study|Lost to Follow-up|2|||
155749361|NCT01155479|562182810|FG000|Part I|Adverse Event|13|||
155749362|NCT01155479|562182811|FG001|Part I|Adverse Event|8|||
155749363|NCT01155479|562182812|FG002|Part I|Adverse Event|18|||
155749364|NCT01155479|562182813|FG003|Part I|Adverse Event|7|||
155749365|NCT01155479|562182814|FG004|Part I|Adverse Event|6|||
155749366|NCT01155479|562182810|FG000|Part I|Administrative|2|||
155749367|NCT01155479|562182811|FG001|Part I|Administrative|2|||
155749368|NCT01155479|562182812|FG002|Part I|Administrative|2|||
155749369|NCT01155479|562182813|FG003|Part I|Administrative|0|||
155749370|NCT01155479|562182814|FG004|Part I|Administrative|0|||
155749371|NCT01155479|562182810|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
155749372|NCT01155479|562182811|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
155749373|NCT01155479|562182812|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
155749374|NCT01155479|562182813|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
155749375|NCT01155479|562182814|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
155749376|NCT01155479|562182810|FG000|Part I|Withdrawal by Subject|11|||
155749377|NCT01155479|562182811|FG001|Part I|Withdrawal by Subject|13|||
155749378|NCT01155479|562182812|FG002|Part I|Withdrawal by Subject|8|||
155749379|NCT01155479|562182813|FG003|Part I|Withdrawal by Subject|8|||
155749380|NCT01155479|562182814|FG004|Part I|Withdrawal by Subject|9|||
155749381|NCT01155479|562182810|FG000|Part I|Lost to Follow-up|0|||
155749382|NCT01155479|562182811|FG001|Part I|Lost to Follow-up|0|||
155749383|NCT01155479|562182812|FG002|Part I|Lost to Follow-up|1|||
155749384|NCT01155479|562182813|FG003|Part I|Lost to Follow-up|1|||
155749385|NCT01155479|562182814|FG004|Part I|Lost to Follow-up|0|||
155749386|NCT01155479|562182810|FG000|Part I|Treatment Failure|3|||
155749387|NCT01155479|562182811|FG001|Part I|Treatment Failure|0|||
155305004|NCT02576509|560549294|FG000|Treatment Period|Lost to Follow-up|0|||
155749388|NCT01155479|562182812|FG002|Part I|Treatment Failure|3|||
155749389|NCT01155479|562182813|FG003|Part I|Treatment Failure|1|||
155749390|NCT01155479|562182814|FG004|Part I|Treatment Failure|2|||
155749391|NCT01155479|562182810|FG000|Part I|Did Not Receive Treatment|4|||
155749392|NCT01155479|562182811|FG001|Part I|Did Not Receive Treatment|2|||
155749393|NCT01155479|562182812|FG002|Part I|Did Not Receive Treatment|2|||
155749394|NCT01155479|562182813|FG003|Part I|Did Not Receive Treatment|6|||
155749395|NCT01155479|562182814|FG004|Part I|Did Not Receive Treatment|1|||
155749396|NCT01155479|562182810|FG000|Part I|Non-Compliance with Protocol|2|||
155749397|NCT01155479|562182811|FG001|Part I|Non-Compliance with Protocol|1|||
155749398|NCT01155479|562182812|FG002|Part I|Non-Compliance with Protocol|3|||
155749399|NCT01155479|562182813|FG003|Part I|Non-Compliance with Protocol|3|||
155749400|NCT01155479|562182814|FG004|Part I|Non-Compliance with Protocol|2|||
155749401|NCT01155479|562182810|FG000|Part II|Adverse Event|7|||
155749402|NCT01155479|562182811|FG001|Part II|Adverse Event|6|||
155749403|NCT01155479|562182812|FG002|Part II|Adverse Event|8|||
155749404|NCT01155479|562182813|FG003|Part II|Adverse Event|3|||
155749405|NCT01155479|562182814|FG004|Part II|Adverse Event|4|||
155749406|NCT01155479|562182810|FG000|Part II|Administrative|43|||
155749407|NCT01155479|562182811|FG001|Part II|Administrative|49|||
155749408|NCT01155479|562182812|FG002|Part II|Administrative|36|||
155749409|NCT01155479|562182813|FG003|Part II|Administrative|38|||
155749410|NCT01155479|562182814|FG004|Part II|Administrative|46|||
155749411|NCT01155479|562182810|FG000|Part II|Withdrawal by Subject|8|||
155749412|NCT01155479|562182811|FG001|Part II|Withdrawal by Subject|4|||
155749413|NCT01155479|562182812|FG002|Part II|Withdrawal by Subject|12|||
155749414|NCT01155479|562182813|FG003|Part II|Withdrawal by Subject|7|||
155749415|NCT01155479|562182814|FG004|Part II|Withdrawal by Subject|3|||
155749416|NCT01155479|562182810|FG000|Part II|Lost to Follow-up|1|||
155749417|NCT01155479|562182811|FG001|Part II|Lost to Follow-up|0|||
155749418|NCT01155479|562182812|FG002|Part II|Lost to Follow-up|0|||
155749419|NCT01155479|562182813|FG003|Part II|Lost to Follow-up|0|||
155749420|NCT01155479|562182814|FG004|Part II|Lost to Follow-up|1|||
155749421|NCT01155479|562182810|FG000|Part II|Treatment Failure|0|||
155749422|NCT01155479|562182811|FG001|Part II|Treatment Failure|1|||
155749423|NCT01155479|562182812|FG002|Part II|Treatment Failure|2|||
155749424|NCT01155479|562182813|FG003|Part II|Treatment Failure|0|||
155749425|NCT01155479|562182814|FG004|Part II|Treatment Failure|1|||
155749426|NCT01155479|562182810|FG000|Part II|Non-Compliance with Protocol|0|||
155749427|NCT01155479|562182811|FG001|Part II|Non-Compliance with Protocol|1|||
155749428|NCT01155479|562182812|FG002|Part II|Non-Compliance with Protocol|0|||
155749429|NCT01155479|562182813|FG003|Part II|Non-Compliance with Protocol|2|||
155749430|NCT01155479|562182814|FG004|Part II|Non-Compliance with Protocol|0|||
155749431|NCT02360605|562182815|FG000|Overall Study|Withdrawal by Subject|4|||
155749432|NCT02360605|562182816|FG001|Overall Study|Withdrawal by Subject|9|||
155749433|NCT02360605|562182815|FG000|Overall Study|Lost to Follow-up|7|||
155305005|NCT02576509|560549295|FG001|Treatment Period|Lost to Follow-up|1|||
155305006|NCT02576509|560549294|FG000|Treatment Period|Maximum clinical benefit|1|||
155305007|NCT02576509|560549295|FG001|Treatment Period|Maximum clinical benefit|0|||
155305008|NCT02576509|560549294|FG000|Treatment Period|Poor/non-compliance|1|||
155305009|NCT02576509|560549295|FG001|Treatment Period|Poor/non-compliance|1|||
155305010|NCT02576509|560549294|FG000|Treatment Period|Participant no longer meets criteria|1|||
155305011|NCT02576509|560549295|FG001|Treatment Period|Participant no longer meets criteria|0|||
155305012|NCT02576509|560549294|FG000|Treatment Period|Other reason|12|||
155305013|NCT02576509|560549295|FG001|Treatment Period|Other reason|8|||
155749434|NCT02360605|562182816|FG001|Overall Study|Lost to Follow-up|8|||
155749435|NCT02360605|562182815|FG000|Overall Study|Death|0|||
155749436|NCT02360605|562182816|FG001|Overall Study|Death|1|||
155749437|NCT05867342|562182819|FG000|Overall Study|Investigator Decision|3|||
155749438|NCT05867342|562182820|FG001|Overall Study|Investigator Decision|3|||
155749439|NCT04365257|562182821|FG000|Overall Study|Physician Decision|1|||
155749440|NCT04365257|562182822|FG001|Overall Study|Physician Decision|0|||
155749441|NCT04365257|562182821|FG000|Overall Study|Patient Noncompliance|1|||
155749442|NCT04365257|562182822|FG001|Overall Study|Patient Noncompliance|0|||
155749443|NCT04365257|562182821|FG000|Overall Study|Withdrawal by Subject|0|||
155749444|NCT04365257|562182822|FG001|Overall Study|Withdrawal by Subject|1|||
155749445|NCT02129777|562182823|FG000|Double-Blind Period|Adverse Event|0|||
155749446|NCT02129777|562182824|FG001|Double-Blind Period|Adverse Event|0|||
155413075|NCT02872311|560944679|FG001|Overall Study|Death|0|||
155749447|NCT02129777|562182825|FG002|Double-Blind Period|Adverse Event|0|||
155749448|NCT02129777|562182826|FG003|Double-Blind Period|Adverse Event|0|||
155749449|NCT02129777|562182827|FG004|Double-Blind Period|Adverse Event|1|||
155749450|NCT02129777|562182828|FG005|Double-Blind Period|Adverse Event|0|||
155749451|NCT02129777|562182829|FG006|Double-Blind Period|Adverse Event|0|||
155749452|NCT02129777|562182823|FG000|Double-Blind Period|Lost to Follow-up|1|||
155749453|NCT02129777|562182824|FG001|Double-Blind Period|Lost to Follow-up|1|||
155749454|NCT02129777|562182825|FG002|Double-Blind Period|Lost to Follow-up|1|||
155749455|NCT02129777|562182826|FG003|Double-Blind Period|Lost to Follow-up|2|||
155749456|NCT02129777|562182827|FG004|Double-Blind Period|Lost to Follow-up|0|||
155749457|NCT02129777|562182828|FG005|Double-Blind Period|Lost to Follow-up|0|||
155749458|NCT02129777|562182829|FG006|Double-Blind Period|Lost to Follow-up|0|||
155305014|NCT02576509|560549294|FG000|Treatment Period|NOT REPORTED|1|||
155749459|NCT02129777|562182823|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155749460|NCT02129777|562182824|FG001|Double-Blind Period|Withdrawal by Subject|4|||
155749461|NCT02129777|562182825|FG002|Double-Blind Period|Withdrawal by Subject|3|||
155749462|NCT02129777|562182826|FG003|Double-Blind Period|Withdrawal by Subject|2|||
155749463|NCT02129777|562182827|FG004|Double-Blind Period|Withdrawal by Subject|3|||
155749464|NCT02129777|562182828|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155305015|NCT02576509|560549295|FG001|Treatment Period|NOT REPORTED|0|||
155305016|NCT02576509|560549294|FG000|Treatment Period|Administrative reason by sponsor|0|||
155305017|NCT02576509|560549295|FG001|Treatment Period|Administrative reason by sponsor|1|||
155305018|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
155305019|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
155305020|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
155305021|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
155305022|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
155305023|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
155305024|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
155305025|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
155305026|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
155305027|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
155305028|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
155305029|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
155305030|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
155305031|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
155305032|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
155305033|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
155305034|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
155305035|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
155305036|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
155305037|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
155642066|NCT03369223|561779151|FG008|Overall Study|Participant withdrew consent|1|||
155642067|NCT03369223|561779152|FG009|Overall Study|Participant withdrew consent|0|||
155642068|NCT03369223|561779153|FG010|Overall Study|Participant withdrew consent|0|||
155642069|NCT03369223|561779154|FG011|Overall Study|Participant withdrew consent|1|||
155642070|NCT03369223|561779155|FG012|Overall Study|Participant withdrew consent|0|||
155642071|NCT03369223|561779156|FG013|Overall Study|Participant withdrew consent|0|||
155642072|NCT03369223|561779157|FG014|Overall Study|Participant withdrew consent|3|||
155642073|NCT03369223|561779158|FG015|Overall Study|Participant withdrew consent|0|||
155642074|NCT03369223|561779159|FG016|Overall Study|Participant withdrew consent|1|||
155642075|NCT03369223|561779160|FG017|Overall Study|Participant withdrew consent|0|||
155642076|NCT03369223|561779161|FG018|Overall Study|Participant withdrew consent|4|||
155642077|NCT03369223|561779162|FG019|Overall Study|Participant withdrew consent|2|||
155642078|NCT03369223|561779143|FG000|Overall Study|Randomized but not treated|0|||
155642079|NCT03369223|561779144|FG001|Overall Study|Randomized but not treated|0|||
155642080|NCT03369223|561779145|FG002|Overall Study|Randomized but not treated|0|||
155642081|NCT03369223|561779146|FG003|Overall Study|Randomized but not treated|0|||
155642082|NCT03369223|561779147|FG004|Overall Study|Randomized but not treated|0|||
155642083|NCT03369223|561779148|FG005|Overall Study|Randomized but not treated|0|||
155642084|NCT03369223|561779149|FG006|Overall Study|Randomized but not treated|0|||
155642085|NCT03369223|561779150|FG007|Overall Study|Randomized but not treated|0|||
155642086|NCT03369223|561779151|FG008|Overall Study|Randomized but not treated|0|||
155749465|NCT02129777|562182829|FG006|Double-Blind Period|Withdrawal by Subject|0|||
155749466|NCT02129777|562182823|FG000|Double-Blind Period|Pregnancy|0|||
155749467|NCT02129777|562182824|FG001|Double-Blind Period|Pregnancy|0|||
155749468|NCT02129777|562182825|FG002|Double-Blind Period|Pregnancy|0|||
155749469|NCT02129777|562182826|FG003|Double-Blind Period|Pregnancy|0|||
155749470|NCT02129777|562182827|FG004|Double-Blind Period|Pregnancy|1|||
155749471|NCT02129777|562182828|FG005|Double-Blind Period|Pregnancy|0|||
155749472|NCT02129777|562182829|FG006|Double-Blind Period|Pregnancy|0|||
155749473|NCT02129777|562182823|FG000|Double-Blind Period|Lack of Efficacy|3|||
155749474|NCT02129777|562182824|FG001|Double-Blind Period|Lack of Efficacy|1|||
155749475|NCT02129777|562182825|FG002|Double-Blind Period|Lack of Efficacy|0|||
155749476|NCT02129777|562182826|FG003|Double-Blind Period|Lack of Efficacy|3|||
155749477|NCT02129777|562182827|FG004|Double-Blind Period|Lack of Efficacy|2|||
155749478|NCT02129777|562182828|FG005|Double-Blind Period|Lack of Efficacy|0|||
155749479|NCT02129777|562182829|FG006|Double-Blind Period|Lack of Efficacy|0|||
155749480|NCT02129777|562182823|FG000|Double-Blind Period|Other|1|||
155749481|NCT02129777|562182824|FG001|Double-Blind Period|Other|2|||
155749482|NCT02129777|562182825|FG002|Double-Blind Period|Other|0|||
155749483|NCT02129777|562182826|FG003|Double-Blind Period|Other|0|||
155749484|NCT02129777|562182827|FG004|Double-Blind Period|Other|0|||
155749485|NCT02129777|562182828|FG005|Double-Blind Period|Other|0|||
155749486|NCT02129777|562182829|FG006|Double-Blind Period|Other|0|||
155749487|NCT02129777|562182823|FG000|Open-Label Period|Lack of Efficacy|0|||
155749488|NCT02129777|562182824|FG001|Open-Label Period|Lack of Efficacy|0|||
155749489|NCT02129777|562182825|FG002|Open-Label Period|Lack of Efficacy|0|||
155749490|NCT02129777|562182826|FG003|Open-Label Period|Lack of Efficacy|0|||
155749491|NCT02129777|562182827|FG004|Open-Label Period|Lack of Efficacy|0|||
155749492|NCT02129777|562182828|FG005|Open-Label Period|Lack of Efficacy|0|||
155413076|NCT02872311|560944680|FG002|Overall Study|Death|0|||
155413077|NCT02872311|560944681|FG003|Overall Study|Death|0|||
155413078|NCT02872311|560944682|FG004|Overall Study|Death|0|||
155413079|NCT02872311|560944678|FG000|Overall Study|Lost to Follow-up|2|||
155413080|NCT02872311|560944679|FG001|Overall Study|Lost to Follow-up|0|||
155413081|NCT02872311|560944680|FG002|Overall Study|Lost to Follow-up|0|||
155413082|NCT02872311|560944681|FG003|Overall Study|Lost to Follow-up|0|||
155413083|NCT02872311|560944682|FG004|Overall Study|Lost to Follow-up|0|||
155413084|NCT02872311|560944678|FG000|Overall Study|Protocol Violation|0|||
155413085|NCT02872311|560944679|FG001|Overall Study|Protocol Violation|2|||
155413086|NCT02872311|560944680|FG002|Overall Study|Protocol Violation|1|||
155413087|NCT02872311|560944681|FG003|Overall Study|Protocol Violation|0|||
155413088|NCT02872311|560944682|FG004|Overall Study|Protocol Violation|0|||
155413089|NCT01121393|560944689|FG000|Overall Study|Progressive disease|201|||
155413090|NCT01121393|560944690|FG001|Overall Study|Progressive disease|20|||
155413091|NCT01121393|560944689|FG000|Overall Study|Other Adverse events|24|||
155413092|NCT01121393|560944690|FG001|Overall Study|Other Adverse events|45|||
155413093|NCT01121393|560944689|FG000|Overall Study|Non-compliant with protocol|0|||
155642087|NCT03369223|561779152|FG009|Overall Study|Randomized but not treated|0|||
155642088|NCT03369223|561779153|FG010|Overall Study|Randomized but not treated|0|||
155642089|NCT03369223|561779154|FG011|Overall Study|Randomized but not treated|0|||
155642090|NCT03369223|561779155|FG012|Overall Study|Randomized but not treated|0|||
155642091|NCT03369223|561779156|FG013|Overall Study|Randomized but not treated|1|||
155642092|NCT03369223|561779157|FG014|Overall Study|Randomized but not treated|1|||
155642093|NCT03369223|561779158|FG015|Overall Study|Randomized but not treated|0|||
155642094|NCT03369223|561779159|FG016|Overall Study|Randomized but not treated|0|||
155642095|NCT03369223|561779160|FG017|Overall Study|Randomized but not treated|0|||
155642096|NCT03369223|561779161|FG018|Overall Study|Randomized but not treated|0|||
155642097|NCT03369223|561779162|FG019|Overall Study|Randomized but not treated|0|||
155642098|NCT04615507|561779164|FG000|Period 1|Covid-19 exposure|2|||
155642099|NCT04615507|561779165|FG001|Period 1|Covid-19 exposure|1|||
155642100|NCT04615507|561779164|FG000|Period 2|Covid-19 exposure|0|||
155642101|NCT04615507|561779165|FG001|Period 2|Covid-19 exposure|1|||
155642102|NCT04615507|561779164|FG000|Period 2|Protocol Violation|1|||
155642103|NCT04615507|561779165|FG001|Period 2|Protocol Violation|0|||
155642104|NCT04615507|561779164|FG000|Period 2|Withdrawal by Subject|1|||
155642105|NCT04615507|561779165|FG001|Period 2|Withdrawal by Subject|0|||
155642106|NCT04615507|561779164|FG000|Period 2|Adverse Event|0|||
155642107|NCT04615507|561779165|FG001|Period 2|Adverse Event|1|||
155642108|NCT04615507|561779164|FG000|Period 3|Covid-19 exposure|0|||
155642109|NCT04615507|561779165|FG001|Period 3|Covid-19 exposure|1|||
155642110|NCT00308685|561779168|FG000|Overall Study|Lost to Follow-up|1|||
155642111|NCT00308685|561779169|FG001|Overall Study|Lost to Follow-up|0|||
155642112|NCT00308685|561779168|FG000|Overall Study|Need to administer prohibited medication|1|||
155642113|NCT00308685|561779169|FG001|Overall Study|Need to administer prohibited medication|2|||
155642114|NCT00308685|561779168|FG000|Overall Study|Other than specified|1|||
155642115|NCT00308685|561779169|FG001|Overall Study|Other than specified|3|||
155642116|NCT04937387|561779170|FG000|Overall Study|Adverse Event|1|||
155642117|NCT04937387|561779171|FG001|Overall Study|Adverse Event|0|||
155642118|NCT04937387|561779172|FG002|Overall Study|Adverse Event|2|||
155642119|NCT04937387|561779173|FG003|Overall Study|Adverse Event|0|||
155642120|NCT04937387|561779170|FG000|Overall Study|Lack of Efficacy|1|||
155642121|NCT04937387|561779171|FG001|Overall Study|Lack of Efficacy|0|||
155642122|NCT04937387|561779172|FG002|Overall Study|Lack of Efficacy|0|||
155642123|NCT04937387|561779173|FG003|Overall Study|Lack of Efficacy|1|||
155642124|NCT04937387|561779170|FG000|Overall Study|Withdrawal by Subject|1|||
155642125|NCT04937387|561779171|FG001|Overall Study|Withdrawal by Subject|0|||
155642126|NCT04937387|561779172|FG002|Overall Study|Withdrawal by Subject|1|||
155642127|NCT04937387|561779173|FG003|Overall Study|Withdrawal by Subject|1|||
155642128|NCT04937387|561779170|FG000|Overall Study|Randomized in error|0|||
155642129|NCT04937387|561779171|FG001|Overall Study|Randomized in error|0|||
155642130|NCT04937387|561779172|FG002|Overall Study|Randomized in error|0|||
155642131|NCT04937387|561779173|FG003|Overall Study|Randomized in error|1|||
155642132|NCT03439839|561780710|FG000|Overall Study|Death|3|||
155642133|NCT03439839|561780711|FG001|Overall Study|Death|0|||
155642134|NCT03298061|561780720|FG000|Overall Study|Adverse Event|3|||
155642135|NCT03298061|561780720|FG000|Overall Study|Lack of Efficacy|6|||
155413094|NCT01121393|560944690|FG001|Overall Study|Non-compliant with protocol|3|||
155642136|NCT03298061|561780720|FG000|Overall Study|Protocol Violation|1|||
155642137|NCT03298061|561780720|FG000|Overall Study|Physician Decision|7|||
155642138|NCT03298061|561780720|FG000|Overall Study|Withdrawal by Subject|10|||
155642139|NCT04307394|561780723|FG000|Overall Study|Lost to Follow-up|3|||
155642140|NCT04307394|561780723|FG000|Overall Study|Withdrawal by Subject|2|||
155642141|NCT00416949|561780725|FG000|Overall Study|Patients refused to participate|5|||
155642142|NCT01471574|561780732|FG000|Treatment Period|Lack of Efficacy|12|||
155642143|NCT01471574|561780733|FG001|Treatment Period|Lack of Efficacy|4|||
155642144|NCT01471574|561780734|FG002|Treatment Period|Lack of Efficacy|14|||
155642145|NCT01471574|561780735|FG003|Treatment Period|Lack of Efficacy|1|||
155642146|NCT01471574|561780732|FG000|Treatment Period|Adverse Event|7|||
155413095|NCT01121393|560944689|FG000|Overall Study|Lost to Follow-up|1|||
155413096|NCT01121393|560944690|FG001|Overall Study|Lost to Follow-up|0|||
155305038|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
155305039|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
155305040|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
155305041|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
155305042|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
155305043|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
155305044|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
155305045|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
155305046|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
155305047|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
155305048|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
155305049|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
155305050|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
155305051|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
155305052|NCT03481660|560549300|FG000|Overall Study|Adverse Event|5|||
155305053|NCT03481660|560549301|FG001|Overall Study|Adverse Event|4|||
155305054|NCT03481660|560549300|FG000|Overall Study|Death|13|||
155305055|NCT03481660|560549301|FG001|Overall Study|Death|9|||
155305056|NCT03481660|560549300|FG000|Overall Study|Lost to Follow-up|2|||
155305057|NCT03481660|560549301|FG001|Overall Study|Lost to Follow-up|2|||
155305058|NCT03481660|560549300|FG000|Overall Study|Physician Decision|2|||
155305059|NCT03481660|560549301|FG001|Overall Study|Physician Decision|3|||
155305060|NCT03481660|560549300|FG000|Overall Study|Withdrawal by Subject|14|||
155305061|NCT03481660|560549301|FG001|Overall Study|Withdrawal by Subject|7|||
155305062|NCT03398148|560549302|FG000|Substudy 1 Period 1|Adverse Event|5|||
155305063|NCT03398148|560549303|FG001|Substudy 1 Period 1|Adverse Event|2|||
155305064|NCT03398148|560549304|FG002|Substudy 1 Period 1|Adverse Event|2|||
155305065|NCT03398148|560549305|FG003|Substudy 1 Period 1|Adverse Event|0|||
155305066|NCT03398148|560549306|FG004|Substudy 1 Period 1|Adverse Event|8|||
155305067|NCT03398148|560549307|FG005|Substudy 1 Period 1|Adverse Event|0|||
155305068|NCT03398148|560549308|FG006|Substudy 1 Period 1|Adverse Event|0|||
155305069|NCT03398148|560549309|FG007|Substudy 1 Period 1|Adverse Event|0|||
155305070|NCT03398148|560549310|FG008|Substudy 1 Period 1|Adverse Event|0|||
155305071|NCT03398148|560549311|FG009|Substudy 1 Period 1|Adverse Event|0|||
155305072|NCT03398148|560549312|FG010|Substudy 1 Period 1|Adverse Event|0|||
155305073|NCT03398148|560549313|FG011|Substudy 1 Period 1|Adverse Event|0|||
155305074|NCT03398148|560549314|FG012|Substudy 1 Period 1|Adverse Event|0|||
155305075|NCT03398148|560549315|FG013|Substudy 1 Period 1|Adverse Event|0|||
155305076|NCT03398148|560549316|FG014|Substudy 1 Period 1|Adverse Event|0|||
155305077|NCT03398148|560549302|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
155305078|NCT03398148|560549303|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
155305079|NCT03398148|560549304|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305080|NCT03398148|560549305|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
155305081|NCT03398148|560549306|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
155305082|NCT03398148|560549307|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305083|NCT03398148|560549308|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305084|NCT03398148|560549309|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305085|NCT03398148|560549310|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305086|NCT03398148|560549311|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305087|NCT03398148|560549312|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305088|NCT03398148|560549313|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155413097|NCT01121393|560944689|FG000|Overall Study|Refused cont. medication|7|||
155413098|NCT01121393|560944690|FG001|Overall Study|Refused cont. medication|7|||
155413099|NCT01121393|560944689|FG000|Overall Study|Not treated|3|||
155413100|NCT01121393|560944690|FG001|Overall Study|Not treated|9|||
155413101|NCT01121393|560944689|FG000|Overall Study|Other than listed|6|||
155413102|NCT01121393|560944690|FG001|Overall Study|Other than listed|0|||
155305089|NCT03398148|560549314|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305090|NCT03398148|560549315|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155413103|NCT04372927|560944691|FG000|Overall Study|Death|1|||
155305091|NCT03398148|560549316|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305092|NCT03398148|560549302|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
155305093|NCT03398148|560549303|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
155305094|NCT03398148|560549304|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
155305095|NCT03398148|560549305|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
155305096|NCT03398148|560549306|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
155413104|NCT00577993|560944692|FG000|Overall Study|Adverse Event|1|||
155413105|NCT00577993|560944693|FG001|Overall Study|Adverse Event|0|||
155749493|NCT02129777|562182829|FG006|Open-Label Period|Lack of Efficacy|5|||
155305097|NCT03398148|560549307|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
155305098|NCT03398148|560549308|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
155305099|NCT03398148|560549309|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
155413106|NCT00577993|560944694|FG002|Overall Study|Adverse Event|0|||
155305100|NCT03398148|560549310|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
155305101|NCT03398148|560549311|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
155305102|NCT03398148|560549312|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
155305103|NCT03398148|560549313|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
155305104|NCT03398148|560549314|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
155305105|NCT03398148|560549315|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
155305106|NCT03398148|560549316|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
155305107|NCT03398148|560549302|FG000|Substudy 1 Period 1|Other|0|||
155413107|NCT00577993|560944692|FG000|Overall Study|Death|0|||
155413108|NCT00577993|560944693|FG001|Overall Study|Death|1|||
155413109|NCT00577993|560944694|FG002|Overall Study|Death|1|||
155413110|NCT00577993|560944692|FG000|Overall Study|Lack of Efficacy|0|||
155413111|NCT00577993|560944693|FG001|Overall Study|Lack of Efficacy|1|||
155413112|NCT00577993|560944694|FG002|Overall Study|Lack of Efficacy|0|||
155413113|NCT00577993|560944692|FG000|Overall Study|Protocol Violation|2|||
155413114|NCT00577993|560944693|FG001|Overall Study|Protocol Violation|3|||
155413115|NCT00577993|560944694|FG002|Overall Study|Protocol Violation|0|||
155413116|NCT00577993|560944692|FG000|Overall Study|Withdrawal by Subject|1|||
155413117|NCT00577993|560944693|FG001|Overall Study|Withdrawal by Subject|0|||
155413118|NCT00577993|560944694|FG002|Overall Study|Withdrawal by Subject|2|||
155413119|NCT00577993|560944692|FG000|Overall Study|Conversion|2|||
155413120|NCT00577993|560944693|FG001|Overall Study|Conversion|5|||
155413121|NCT00577993|560944694|FG002|Overall Study|Conversion|0|||
155413122|NCT00577993|560944692|FG000|Overall Study|Uninsured|1|||
155413123|NCT00577993|560944693|FG001|Overall Study|Uninsured|0|||
155413124|NCT00577993|560944694|FG002|Overall Study|Uninsured|0|||
155413125|NCT00608985|560944701|FG000|Overall Study|Adverse Event|2|||
155413126|NCT00608985|560944702|FG001|Overall Study|Adverse Event|7|||
155413127|NCT00608985|560944703|FG002|Overall Study|Adverse Event|4|||
155413128|NCT00608985|560944704|FG003|Overall Study|Adverse Event|6|||
155413129|NCT00608985|560944701|FG000|Overall Study|Administrative/Other|7|||
155413130|NCT00608985|560944702|FG001|Overall Study|Administrative/Other|4|||
155413131|NCT00608985|560944703|FG002|Overall Study|Administrative/Other|1|||
155413132|NCT00608985|560944704|FG003|Overall Study|Administrative/Other|2|||
155413133|NCT00608985|560944701|FG000|Overall Study|Withdrawal of Consent|5|||
155413134|NCT00608985|560944702|FG001|Overall Study|Withdrawal of Consent|1|||
155413135|NCT00608985|560944703|FG002|Overall Study|Withdrawal of Consent|1|||
155413136|NCT00608985|560944704|FG003|Overall Study|Withdrawal of Consent|1|||
155413137|NCT00608985|560944701|FG000|Overall Study|Lost to Follow-up|2|||
155413138|NCT00608985|560944702|FG001|Overall Study|Lost to Follow-up|1|||
155413139|NCT00608985|560944703|FG002|Overall Study|Lost to Follow-up|0|||
155413140|NCT00608985|560944704|FG003|Overall Study|Lost to Follow-up|0|||
155413141|NCT03033745|560944705|FG000|Overall Study|Protocol Violation|0|||
155413142|NCT03033745|560944706|FG001|Overall Study|Protocol Violation|0|||
155413143|NCT03033745|560944707|FG002|Overall Study|Protocol Violation|1|||
155413144|NCT03033745|560944705|FG000|Overall Study|Adverse Event|1|||
155413145|NCT03033745|560944706|FG001|Overall Study|Adverse Event|0|||
155413146|NCT03033745|560944707|FG002|Overall Study|Adverse Event|1|||
155413147|NCT03033745|560944705|FG000|Overall Study|Withdrawal by Subject|0|||
155413148|NCT03033745|560944706|FG001|Overall Study|Withdrawal by Subject|1|||
155413149|NCT03033745|560944707|FG002|Overall Study|Withdrawal by Subject|0|||
155413150|NCT01999582|560944708|FG000|Overall Study|Withdrawal by Subject|0|||
155413151|NCT01999582|560944709|FG001|Overall Study|Withdrawal by Subject|0|||
155413152|NCT01999582|560944710|FG002|Overall Study|Withdrawal by Subject|0|||
155413153|NCT01999582|560944711|FG003|Overall Study|Withdrawal by Subject|1|||
155305108|NCT03398148|560549303|FG001|Substudy 1 Period 1|Other|1|||
155305109|NCT03398148|560549304|FG002|Substudy 1 Period 1|Other|0|||
155305110|NCT03398148|560549305|FG003|Substudy 1 Period 1|Other|0|||
155305111|NCT03398148|560549306|FG004|Substudy 1 Period 1|Other|3|||
155305112|NCT03398148|560549307|FG005|Substudy 1 Period 1|Other|0|||
155413154|NCT01999582|560944712|FG004|Overall Study|Withdrawal by Subject|0|||
155413155|NCT01999582|560944713|FG005|Overall Study|Withdrawal by Subject|0|||
155413156|NCT01999582|560944708|FG000|Overall Study|Adverse Event|0|||
155413157|NCT01999582|560944709|FG001|Overall Study|Adverse Event|0|||
155413158|NCT01999582|560944710|FG002|Overall Study|Adverse Event|3|||
155305113|NCT03398148|560549308|FG006|Substudy 1 Period 1|Other|0|||
155305114|NCT03398148|560549309|FG007|Substudy 1 Period 1|Other|0|||
155413159|NCT01999582|560944711|FG003|Overall Study|Adverse Event|0|||
155413160|NCT01999582|560944712|FG004|Overall Study|Adverse Event|1|||
155413161|NCT01999582|560944713|FG005|Overall Study|Adverse Event|0|||
155413162|NCT01999582|560944708|FG000|Overall Study|Other Reasons|1|||
155305115|NCT03398148|560549310|FG008|Substudy 1 Period 1|Other|0|||
155305116|NCT03398148|560549311|FG009|Substudy 1 Period 1|Other|0|||
155305117|NCT03398148|560549312|FG010|Substudy 1 Period 1|Other|0|||
155413163|NCT01999582|560944709|FG001|Overall Study|Other Reasons|0|||
155413164|NCT01999582|560944710|FG002|Overall Study|Other Reasons|3|||
155413165|NCT01999582|560944711|FG003|Overall Study|Other Reasons|1|||
155413166|NCT01999582|560944712|FG004|Overall Study|Other Reasons|1|||
155413167|NCT01999582|560944713|FG005|Overall Study|Other Reasons|2|||
155305118|NCT03398148|560549313|FG011|Substudy 1 Period 1|Other|0|||
155305119|NCT03398148|560549314|FG012|Substudy 1 Period 1|Other|0|||
155413168|NCT01999582|560944708|FG000|Overall Study|Protocol Violation|1|||
155413169|NCT01999582|560944709|FG001|Overall Study|Protocol Violation|0|||
155413170|NCT01999582|560944710|FG002|Overall Study|Protocol Violation|0|||
155413171|NCT01999582|560944711|FG003|Overall Study|Protocol Violation|0|||
155413172|NCT01999582|560944712|FG004|Overall Study|Protocol Violation|0|||
155413173|NCT01999582|560944713|FG005|Overall Study|Protocol Violation|1|||
155413174|NCT01999582|560944708|FG000|Overall Study|Lack of Efficacy|1|||
155413175|NCT01999582|560944709|FG001|Overall Study|Lack of Efficacy|3|||
155413176|NCT01999582|560944710|FG002|Overall Study|Lack of Efficacy|0|||
155413177|NCT01999582|560944711|FG003|Overall Study|Lack of Efficacy|1|||
155413178|NCT01999582|560944712|FG004|Overall Study|Lack of Efficacy|0|||
155305120|NCT03398148|560549315|FG013|Substudy 1 Period 1|Other|0|||
155305121|NCT03398148|560549316|FG014|Substudy 1 Period 1|Other|0|||
155305122|NCT03398148|560549302|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305123|NCT03398148|560549303|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305124|NCT03398148|560549304|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305125|NCT03398148|560549305|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305126|NCT03398148|560549306|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
155413179|NCT01999582|560944713|FG005|Overall Study|Lack of Efficacy|0|||
155413180|NCT00661271|560944714|FG000|Overall Study|Lost to Follow-up|28|||
155413181|NCT00661271|560944715|FG001|Overall Study|Lost to Follow-up|25|||
155413182|NCT03728309|560944719|FG000|Overall Study|Randomized but not Treated|0|||
155413183|NCT03728309|560944720|FG001|Overall Study|Randomized but not Treated|1|||
155413184|NCT03728309|560944719|FG000|Overall Study|Adverse Event|0|||
155413185|NCT03728309|560944720|FG001|Overall Study|Adverse Event|1|||
155413186|NCT03728309|560944719|FG000|Overall Study|Withdrawal by Subject|2|||
155413187|NCT03728309|560944720|FG001|Overall Study|Withdrawal by Subject|8|||
155413188|NCT03728309|560944719|FG000|Overall Study|Lost to Follow-up|9|||
155413189|NCT03728309|560944720|FG001|Overall Study|Lost to Follow-up|10|||
155413190|NCT03728309|560944719|FG000|Overall Study|Protocol Deviation|0|||
155413191|NCT03728309|560944720|FG001|Overall Study|Protocol Deviation|1|||
155413192|NCT03728309|560944719|FG000|Overall Study|Due to COVID|1|||
155413193|NCT03728309|560944720|FG001|Overall Study|Due to COVID|3|||
155413194|NCT00953758|560944721|FG000|Overall Study|Death|2|||
155413195|NCT00953758|560944722|FG001|Overall Study|Death|0|||
155496910|NCT03539952|561242419|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
155496911|NCT03539952|561242420|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
155496912|NCT03539952|561242419|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
155496913|NCT03539952|561242420|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
155496914|NCT02184988|561242421|FG000|Overall Study|Pregnancy|2|||
155496915|NCT02184988|561242421|FG000|Overall Study|Adverse Event|2|||
155496916|NCT02184988|561242421|FG000|Overall Study|moving away/travelling/unable to complet|6|||
155496917|NCT02184988|561242421|FG000|Overall Study|work scheduling issues|4|||
155496918|NCT02184988|561242421|FG000|Overall Study|various other reasons|9|||
155496919|NCT02184988|561242421|FG000|Overall Study|Lost to Follow-up|32|||
155496920|NCT03075215|561242422|FG000|12-Month Primary Endpoint|Death|152|||
155496921|NCT03075215|561242422|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
155496922|NCT03075215|561242422|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
155496923|NCT03075215|561242422|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
155496924|NCT01821391|561242423|FG000|Overall Study|Adverse Event|1|||
155496925|NCT01821391|561242424|FG001|Overall Study|Adverse Event|0|||
155496926|NCT02146365|561242425|FG000|Overall Study|Lost to Follow-up|2|||
155496927|NCT02146365|561242426|FG001|Overall Study|Lost to Follow-up|1|||
155496928|NCT02146365|561242427|FG002|Overall Study|Lost to Follow-up|3|||
155496929|NCT02146365|561242428|FG003|Overall Study|Lost to Follow-up|3|||
155496930|NCT02146365|561242429|FG004|Overall Study|Lost to Follow-up|1|||
155496931|NCT02146365|561242430|FG005|Overall Study|Lost to Follow-up|1|||
155496932|NCT02146365|561242431|FG006|Overall Study|Lost to Follow-up|0|||
155496933|NCT02146365|561242432|FG007|Overall Study|Lost to Follow-up|1|||
155496934|NCT02146365|561242425|FG000|Overall Study|Withdrawal by Subject|1|||
155496935|NCT02146365|561242426|FG001|Overall Study|Withdrawal by Subject|2|||
155496936|NCT02146365|561242427|FG002|Overall Study|Withdrawal by Subject|1|||
155496937|NCT02146365|561242428|FG003|Overall Study|Withdrawal by Subject|5|||
155496938|NCT02146365|561242429|FG004|Overall Study|Withdrawal by Subject|1|||
155496939|NCT02146365|561242430|FG005|Overall Study|Withdrawal by Subject|0|||
155496940|NCT02146365|561242431|FG006|Overall Study|Withdrawal by Subject|0|||
155496941|NCT02146365|561242432|FG007|Overall Study|Withdrawal by Subject|0|||
155496942|NCT02146365|561242425|FG000|Overall Study|Unable to Comply with Protocol|0|||
155496943|NCT02146365|561242426|FG001|Overall Study|Unable to Comply with Protocol|1|||
155496944|NCT02146365|561242427|FG002|Overall Study|Unable to Comply with Protocol|1|||
155496945|NCT02146365|561242428|FG003|Overall Study|Unable to Comply with Protocol|0|||
155496946|NCT02146365|561242429|FG004|Overall Study|Unable to Comply with Protocol|0|||
155305127|NCT03398148|560549307|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305128|NCT03398148|560549308|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
155413196|NCT00953758|560944723|FG002|Overall Study|Death|1|||
155413197|NCT00953758|560944724|FG003|Overall Study|Death|1|||
155413198|NCT00953758|560944725|FG004|Overall Study|Death|1|||
155749494|NCT02129777|562182823|FG000|Open-Label Period|Lost to Follow-up|0|||
155749495|NCT02129777|562182824|FG001|Open-Label Period|Lost to Follow-up|0|||
155305129|NCT03398148|560549309|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305130|NCT03398148|560549310|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305131|NCT03398148|560549311|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305132|NCT03398148|560549312|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305133|NCT03398148|560549313|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305134|NCT03398148|560549314|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305135|NCT03398148|560549315|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305136|NCT03398148|560549316|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305137|NCT03398148|560549302|FG000|Substudy 1 Period 2|Adverse Event|0|||
155305138|NCT03398148|560549303|FG001|Substudy 1 Period 2|Adverse Event|0|||
155305139|NCT03398148|560549304|FG002|Substudy 1 Period 2|Adverse Event|0|||
155305140|NCT03398148|560549305|FG003|Substudy 1 Period 2|Adverse Event|0|||
155305141|NCT03398148|560549306|FG004|Substudy 1 Period 2|Adverse Event|0|||
155413199|NCT00953758|560944726|FG005|Overall Study|Death|1|||
155413200|NCT00953758|560944727|FG006|Overall Study|Death|1|||
155413201|NCT00953758|560944728|FG007|Overall Study|Death|3|||
155413202|NCT00953758|560944729|FG008|Overall Study|Death|1|||
155413203|NCT00953758|560944730|FG009|Overall Study|Death|0|||
155413204|NCT00953758|560944721|FG000|Overall Study|Participant refused further follow-up|0|||
155413205|NCT00953758|560944722|FG001|Overall Study|Participant refused further follow-up|0|||
155413206|NCT00953758|560944723|FG002|Overall Study|Participant refused further follow-up|1|||
155413207|NCT00953758|560944724|FG003|Overall Study|Participant refused further follow-up|0|||
155413208|NCT00953758|560944725|FG004|Overall Study|Participant refused further follow-up|3|||
155413209|NCT00953758|560944726|FG005|Overall Study|Participant refused further follow-up|0|||
155413210|NCT00953758|560944727|FG006|Overall Study|Participant refused further follow-up|0|||
155413211|NCT00953758|560944728|FG007|Overall Study|Participant refused further follow-up|0|||
155413212|NCT00953758|560944729|FG008|Overall Study|Participant refused further follow-up|1|||
155413213|NCT00953758|560944730|FG009|Overall Study|Participant refused further follow-up|0|||
155413214|NCT00953758|560944721|FG000|Overall Study|Lost to Follow-up|0|||
155413215|NCT00953758|560944722|FG001|Overall Study|Lost to Follow-up|0|||
155413216|NCT00953758|560944723|FG002|Overall Study|Lost to Follow-up|0|||
155413217|NCT00953758|560944724|FG003|Overall Study|Lost to Follow-up|1|||
155413218|NCT00953758|560944725|FG004|Overall Study|Lost to Follow-up|0|||
155413219|NCT00953758|560944726|FG005|Overall Study|Lost to Follow-up|0|||
155413220|NCT00953758|560944727|FG006|Overall Study|Lost to Follow-up|0|||
155413221|NCT00953758|560944728|FG007|Overall Study|Lost to Follow-up|1|||
155413222|NCT00953758|560944729|FG008|Overall Study|Lost to Follow-up|0|||
155413223|NCT00953758|560944730|FG009|Overall Study|Lost to Follow-up|1|||
155413224|NCT00953758|560944721|FG000|Overall Study|Physician Decision|0|||
155413225|NCT00953758|560944722|FG001|Overall Study|Physician Decision|0|||
155413226|NCT00953758|560944723|FG002|Overall Study|Physician Decision|0|||
155413227|NCT00953758|560944724|FG003|Overall Study|Physician Decision|0|||
155413228|NCT00953758|560944725|FG004|Overall Study|Physician Decision|1|||
155413229|NCT00953758|560944726|FG005|Overall Study|Physician Decision|0|||
155413230|NCT00953758|560944727|FG006|Overall Study|Physician Decision|0|||
155413231|NCT00953758|560944728|FG007|Overall Study|Physician Decision|0|||
155413232|NCT00953758|560944729|FG008|Overall Study|Physician Decision|0|||
155413233|NCT00953758|560944730|FG009|Overall Study|Physician Decision|0|||
155413234|NCT00953758|560944721|FG000|Overall Study|Disease progression|0|||
155413235|NCT00953758|560944722|FG001|Overall Study|Disease progression|0|||
155413236|NCT00953758|560944723|FG002|Overall Study|Disease progression|0|||
155413237|NCT00953758|560944724|FG003|Overall Study|Disease progression|0|||
155413238|NCT00953758|560944725|FG004|Overall Study|Disease progression|1|||
155413239|NCT00953758|560944726|FG005|Overall Study|Disease progression|0|||
155413240|NCT00953758|560944727|FG006|Overall Study|Disease progression|0|||
155413241|NCT00953758|560944728|FG007|Overall Study|Disease progression|0|||
155413242|NCT00953758|560944729|FG008|Overall Study|Disease progression|0|||
155413243|NCT00953758|560944730|FG009|Overall Study|Disease progression|0|||
155413244|NCT00953758|560944721|FG000|Overall Study|Participant went for transplant|0|||
155413245|NCT00953758|560944722|FG001|Overall Study|Participant went for transplant|0|||
155413246|NCT00953758|560944723|FG002|Overall Study|Participant went for transplant|0|||
155413247|NCT00953758|560944724|FG003|Overall Study|Participant went for transplant|0|||
155413248|NCT00953758|560944725|FG004|Overall Study|Participant went for transplant|0|||
155413249|NCT00953758|560944726|FG005|Overall Study|Participant went for transplant|0|||
155413250|NCT00953758|560944727|FG006|Overall Study|Participant went for transplant|0|||
155413251|NCT00953758|560944728|FG007|Overall Study|Participant went for transplant|0|||
155413252|NCT00953758|560944729|FG008|Overall Study|Participant went for transplant|1|||
155413253|NCT00953758|560944730|FG009|Overall Study|Participant went for transplant|0|||
155413254|NCT00927095|560944733|FG000|Overall Study|Adverse Event|3|||
155413255|NCT00927095|560944734|FG001|Overall Study|Adverse Event|1|||
155413256|NCT00927095|560944735|FG002|Overall Study|Adverse Event|0|||
155413257|NCT00927095|560944733|FG000|Overall Study|Withdrawal by Subject|2|||
155413258|NCT00927095|560944734|FG001|Overall Study|Withdrawal by Subject|1|||
155413259|NCT00927095|560944735|FG002|Overall Study|Withdrawal by Subject|1|||
155496947|NCT02146365|561242430|FG005|Overall Study|Unable to Comply with Protocol|0|||
155496948|NCT02146365|561242431|FG006|Overall Study|Unable to Comply with Protocol|0|||
155496949|NCT02146365|561242432|FG007|Overall Study|Unable to Comply with Protocol|0|||
155496950|NCT02146365|561242425|FG000|Overall Study|Other|1|||
155496951|NCT02146365|561242426|FG001|Overall Study|Other|0|||
155496952|NCT02146365|561242427|FG002|Overall Study|Other|2|||
155496953|NCT02146365|561242428|FG003|Overall Study|Other|1|||
155496954|NCT02146365|561242429|FG004|Overall Study|Other|0|||
155496955|NCT02146365|561242430|FG005|Overall Study|Other|0|||
155496956|NCT02146365|561242431|FG006|Overall Study|Other|0|||
155496957|NCT02146365|561242432|FG007|Overall Study|Other|0|||
155496958|NCT01608321|561242433|FG000|Overall Study|Withdrawal by Subject|1|||
155496959|NCT01608321|561242434|FG001|Overall Study|Withdrawal by Subject|0|||
155496960|NCT03222856|561242437|FG000|Overall Study|Adverse Event|6|||
155496961|NCT03222856|561242437|FG000|Overall Study|Death|1|||
155496962|NCT02545868|561243991|FG000|Overall Study|Lack of Efficacy|1|||
155496963|NCT02545868|561243992|FG001|Overall Study|Lack of Efficacy|1|||
155496964|NCT02545868|561243993|FG002|Overall Study|Lack of Efficacy|0|||
155496965|NCT02545868|561243991|FG000|Overall Study|Lost to Follow-up|1|||
155496966|NCT02545868|561243992|FG001|Overall Study|Lost to Follow-up|5|||
155496967|NCT02545868|561243993|FG002|Overall Study|Lost to Follow-up|1|||
155496968|NCT02545868|561243991|FG000|Overall Study|Non-compliance|1|||
155496969|NCT02545868|561243992|FG001|Overall Study|Non-compliance|1|||
155496970|NCT02545868|561243993|FG002|Overall Study|Non-compliance|1|||
155496971|NCT02545868|561243991|FG000|Overall Study|Treatment change|21|||
155496972|NCT02545868|561243992|FG001|Overall Study|Treatment change|19|||
155496973|NCT02545868|561243993|FG002|Overall Study|Treatment change|22|||
155496974|NCT02545868|561243991|FG000|Overall Study|Physician Decision|1|||
155496975|NCT02545868|561243992|FG001|Overall Study|Physician Decision|1|||
155496976|NCT02545868|561243993|FG002|Overall Study|Physician Decision|1|||
155496977|NCT02545868|561243991|FG000|Overall Study|Withdrawal by Subject|6|||
155496978|NCT02545868|561243992|FG001|Overall Study|Withdrawal by Subject|7|||
155496979|NCT02545868|561243993|FG002|Overall Study|Withdrawal by Subject|9|||
155496980|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
155496981|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
155496982|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
155496983|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
155496984|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
155496985|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
155496986|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
155496987|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
155496988|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
155496989|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
155496990|NCT01777191|561243994|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
155496991|NCT01777191|561243995|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
155496992|NCT01777191|561243994|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
155496993|NCT01777191|561243995|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
155496994|NCT01777191|561243994|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
155496995|NCT01777191|561243995|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
155496996|NCT01777191|561243994|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
155496997|NCT01777191|561243995|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
155496998|NCT01777191|561243994|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
155496999|NCT01777191|561243995|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
155497000|NCT01777191|561243994|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
155497001|NCT01777191|561243995|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
155497002|NCT03286400|561244000|FG000|Overall Study|Death|10|||
155497003|NCT03286400|561244000|FG000|Overall Study|Lost to Follow-up|10|||
155497004|NCT03286400|561244000|FG000|Overall Study|Physician Decision|1|||
155497005|NCT03286400|561244000|FG000|Overall Study|Scheduling difficulty|4|||
155497006|NCT01856686|561244001|FG000|Overall Study|Lost to Follow-up|5|||
155497007|NCT01856686|561244002|FG001|Overall Study|Lost to Follow-up|11|||
155497008|NCT01461369|561244003|FG000|Overall Study|Lack of Efficacy|2|||
155497009|NCT01461369|561244004|FG001|Overall Study|Lack of Efficacy|0|||
155497010|NCT01461369|561244005|FG002|Overall Study|Lack of Efficacy|6|||
155497011|NCT01461369|561244003|FG000|Overall Study|Lost to Follow-up|0|||
155497012|NCT01461369|561244004|FG001|Overall Study|Lost to Follow-up|0|||
155497013|NCT01461369|561244005|FG002|Overall Study|Lost to Follow-up|3|||
155497014|NCT01461369|561244003|FG000|Overall Study|Adverse Event|9|||
155497015|NCT01461369|561244004|FG001|Overall Study|Adverse Event|12|||
155497016|NCT01461369|561244005|FG002|Overall Study|Adverse Event|4|||
155642147|NCT01471574|561780733|FG001|Treatment Period|Adverse Event|3|||
155497017|NCT01461369|561244003|FG000|Overall Study|Protocol Violation|1|||
155497018|NCT01461369|561244004|FG001|Overall Study|Protocol Violation|2|||
155497019|NCT01461369|561244005|FG002|Overall Study|Protocol Violation|2|||
155642148|NCT01471574|561780734|FG002|Treatment Period|Adverse Event|6|||
155305142|NCT03398148|560549307|FG005|Substudy 1 Period 2|Adverse Event|2|||
155305143|NCT03398148|560549308|FG006|Substudy 1 Period 2|Adverse Event|4|||
155305144|NCT03398148|560549309|FG007|Substudy 1 Period 2|Adverse Event|0|||
155305145|NCT03398148|560549310|FG008|Substudy 1 Period 2|Adverse Event|0|||
155305146|NCT03398148|560549311|FG009|Substudy 1 Period 2|Adverse Event|0|||
155305147|NCT03398148|560549312|FG010|Substudy 1 Period 2|Adverse Event|0|||
155305148|NCT03398148|560549313|FG011|Substudy 1 Period 2|Adverse Event|0|||
155305149|NCT03398148|560549314|FG012|Substudy 1 Period 2|Adverse Event|0|||
155305150|NCT03398148|560549315|FG013|Substudy 1 Period 2|Adverse Event|0|||
155305151|NCT03398148|560549316|FG014|Substudy 1 Period 2|Adverse Event|0|||
155305152|NCT03398148|560549302|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305153|NCT03398148|560549303|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305154|NCT03398148|560549304|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305155|NCT03398148|560549305|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305156|NCT03398148|560549306|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305157|NCT03398148|560549307|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305158|NCT03398148|560549308|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
155305159|NCT03398148|560549309|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
155497020|NCT01461369|561244003|FG000|Overall Study|Withdrawal by Subject|1|||
155497021|NCT01461369|561244004|FG001|Overall Study|Withdrawal by Subject|3|||
155497022|NCT01461369|561244005|FG002|Overall Study|Withdrawal by Subject|2|||
155497023|NCT00388674|561244008|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
155497024|NCT00388674|561244009|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
155305160|NCT03398148|560549310|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305161|NCT03398148|560549311|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305162|NCT03398148|560549312|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305163|NCT03398148|560549313|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305164|NCT03398148|560549314|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305165|NCT03398148|560549315|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305166|NCT03398148|560549316|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305167|NCT03398148|560549302|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
155305168|NCT03398148|560549303|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
155305169|NCT03398148|560549304|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
155305170|NCT03398148|560549305|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
155305171|NCT03398148|560549306|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
155305172|NCT03398148|560549307|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
155305173|NCT03398148|560549308|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
155305174|NCT03398148|560549309|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
155305175|NCT03398148|560549310|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
155305176|NCT03398148|560549311|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
155305177|NCT03398148|560549312|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
155305178|NCT03398148|560549313|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
155305179|NCT03398148|560549314|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
155305180|NCT03398148|560549315|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
155305181|NCT03398148|560549316|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
155305182|NCT03398148|560549302|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305183|NCT03398148|560549303|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305184|NCT03398148|560549304|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305185|NCT03398148|560549305|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305186|NCT03398148|560549306|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305187|NCT03398148|560549307|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305188|NCT03398148|560549308|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
155305189|NCT03398148|560549309|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305190|NCT03398148|560549310|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305191|NCT03398148|560549311|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305192|NCT03398148|560549312|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305193|NCT03398148|560549313|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305194|NCT03398148|560549314|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305195|NCT03398148|560549315|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305196|NCT03398148|560549316|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305197|NCT03398148|560549302|FG000|Substudy 1 Period 2|Other|0|||
155305198|NCT03398148|560549303|FG001|Substudy 1 Period 2|Other|0|||
155305199|NCT03398148|560549304|FG002|Substudy 1 Period 2|Other|0|||
155305200|NCT03398148|560549305|FG003|Substudy 1 Period 2|Other|0|||
155305201|NCT03398148|560549306|FG004|Substudy 1 Period 2|Other|0|||
155305202|NCT03398148|560549307|FG005|Substudy 1 Period 2|Other|0|||
155305203|NCT03398148|560549308|FG006|Substudy 1 Period 2|Other|1|||
155305204|NCT03398148|560549309|FG007|Substudy 1 Period 2|Other|0|||
155305205|NCT03398148|560549310|FG008|Substudy 1 Period 2|Other|0|||
155305206|NCT03398148|560549311|FG009|Substudy 1 Period 2|Other|0|||
155305207|NCT03398148|560549312|FG010|Substudy 1 Period 2|Other|0|||
155497025|NCT00388674|561244008|FG000|Initial Treatment|Adverse Event|22|||
155305208|NCT03398148|560549313|FG011|Substudy 1 Period 2|Other|0|||
155305209|NCT03398148|560549314|FG012|Substudy 1 Period 2|Other|0|||
155305210|NCT03398148|560549315|FG013|Substudy 1 Period 2|Other|0|||
155497026|NCT00388674|561244009|FG001|Initial Treatment|Adverse Event|87|||
155305211|NCT03398148|560549316|FG014|Substudy 1 Period 2|Other|0|||
155305212|NCT03398148|560549302|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305213|NCT03398148|560549303|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305214|NCT03398148|560549304|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305215|NCT03398148|560549305|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305216|NCT03398148|560549306|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305217|NCT03398148|560549307|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305218|NCT03398148|560549308|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
155305219|NCT03398148|560549309|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305220|NCT03398148|560549310|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305221|NCT03398148|560549311|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305222|NCT03398148|560549312|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
155413260|NCT00927095|560944733|FG000|Overall Study|Physician Decision|1|||
155413261|NCT00927095|560944734|FG001|Overall Study|Physician Decision|2|||
155413262|NCT00927095|560944735|FG002|Overall Study|Physician Decision|1|||
155413263|NCT00044512|560944742|FG000|Follow Up|Lost to Follow-up|2|||
155413264|NCT05130463|560944747|FG000|Overall Study|Unspecified reasons|2|||
155413265|NCT05130463|560944747|FG000|Overall Study|off-label indication dose|435|||
155413266|NCT03652662|560944748|FG000|Overall Study|Withdrawal by Subject|2|||
155413267|NCT03652662|560944749|FG001|Overall Study|Withdrawal by Subject|1|||
155413268|NCT03652662|560944748|FG000|Overall Study|Lost to Follow-up|1|||
155413269|NCT03652662|560944749|FG001|Overall Study|Lost to Follow-up|0|||
155413270|NCT00487539|560944750|FG000|Overall Study|Adverse Event|3|||
155413271|NCT00487539|560944751|FG001|Overall Study|Adverse Event|2|||
155413272|NCT00487539|560944752|FG002|Overall Study|Adverse Event|1|||
155413273|NCT00487539|560944753|FG003|Overall Study|Adverse Event|1|||
155413274|NCT00487539|560944750|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155413275|NCT00487539|560944751|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155413276|NCT00487539|560944752|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155413277|NCT00487539|560944753|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
155413278|NCT00487539|560944750|FG000|Overall Study|Other|3|||
155305223|NCT03398148|560549313|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
155413279|NCT00487539|560944751|FG001|Overall Study|Other|1|||
155413280|NCT00487539|560944752|FG002|Overall Study|Other|2|||
155305224|NCT03398148|560549314|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305225|NCT03398148|560549315|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305226|NCT03398148|560549316|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305227|NCT03398148|560549302|FG000|Substudy 2 Period 1|Adverse Event|0|||
155305228|NCT03398148|560549303|FG001|Substudy 2 Period 1|Adverse Event|0|||
155305229|NCT03398148|560549304|FG002|Substudy 2 Period 1|Adverse Event|0|||
155305230|NCT03398148|560549305|FG003|Substudy 2 Period 1|Adverse Event|0|||
155305231|NCT03398148|560549306|FG004|Substudy 2 Period 1|Adverse Event|0|||
155305232|NCT03398148|560549307|FG005|Substudy 2 Period 1|Adverse Event|0|||
155305233|NCT03398148|560549308|FG006|Substudy 2 Period 1|Adverse Event|0|||
155305234|NCT03398148|560549309|FG007|Substudy 2 Period 1|Adverse Event|0|||
155305235|NCT03398148|560549310|FG008|Substudy 2 Period 1|Adverse Event|0|||
155305236|NCT03398148|560549311|FG009|Substudy 2 Period 1|Adverse Event|12|||
155305237|NCT03398148|560549312|FG010|Substudy 2 Period 1|Adverse Event|2|||
155305238|NCT03398148|560549313|FG011|Substudy 2 Period 1|Adverse Event|0|||
155305239|NCT03398148|560549314|FG012|Substudy 2 Period 1|Adverse Event|0|||
155305240|NCT03398148|560549315|FG013|Substudy 2 Period 1|Adverse Event|0|||
155305241|NCT03398148|560549316|FG014|Substudy 2 Period 1|Adverse Event|0|||
155305242|NCT03398148|560549302|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305243|NCT03398148|560549303|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305244|NCT03398148|560549304|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305245|NCT03398148|560549305|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305246|NCT03398148|560549306|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305247|NCT03398148|560549307|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305248|NCT03398148|560549308|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305249|NCT03398148|560549309|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305250|NCT03398148|560549310|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305251|NCT03398148|560549311|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
155305252|NCT03398148|560549312|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
155305253|NCT03398148|560549313|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305254|NCT03398148|560549314|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305255|NCT03398148|560549315|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305256|NCT03398148|560549316|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305257|NCT03398148|560549302|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
155305258|NCT03398148|560549303|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
155305259|NCT03398148|560549304|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
155305260|NCT03398148|560549305|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
155305261|NCT03398148|560549306|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
155305262|NCT03398148|560549307|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
155305263|NCT03398148|560549308|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
155305264|NCT03398148|560549309|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
155305265|NCT03398148|560549310|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
155305266|NCT03398148|560549311|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
155305267|NCT03398148|560549312|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
155305268|NCT03398148|560549313|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
155305269|NCT03398148|560549314|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
155305270|NCT03398148|560549315|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
155305271|NCT03398148|560549316|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
155305272|NCT03398148|560549302|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305273|NCT03398148|560549303|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305274|NCT03398148|560549304|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305275|NCT03398148|560549305|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305276|NCT03398148|560549306|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305277|NCT03398148|560549307|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305278|NCT03398148|560549308|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305279|NCT03398148|560549309|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305280|NCT03398148|560549310|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305281|NCT03398148|560549311|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155497027|NCT00388674|561244008|FG000|Initial Treatment|Death|215|||
155497028|NCT00388674|561244009|FG001|Initial Treatment|Death|216|||
155497029|NCT00388674|561244008|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
155305282|NCT03398148|560549312|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
155305283|NCT03398148|560549313|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305284|NCT03398148|560549314|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305285|NCT03398148|560549315|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305286|NCT03398148|560549316|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305287|NCT03398148|560549302|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305288|NCT03398148|560549303|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305289|NCT03398148|560549304|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305290|NCT03398148|560549305|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305291|NCT03398148|560549306|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305292|NCT03398148|560549307|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155497030|NCT00388674|561244009|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
155305293|NCT03398148|560549308|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305294|NCT03398148|560549309|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305295|NCT03398148|560549310|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305296|NCT03398148|560549311|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305297|NCT03398148|560549312|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
155305298|NCT03398148|560549313|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305299|NCT03398148|560549314|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305300|NCT03398148|560549315|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305301|NCT03398148|560549316|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305302|NCT03398148|560549302|FG000|Substudy 2 Period 1|Other|0|||
155305303|NCT03398148|560549303|FG001|Substudy 2 Period 1|Other|0|||
155305304|NCT03398148|560549304|FG002|Substudy 2 Period 1|Other|0|||
155305305|NCT03398148|560549305|FG003|Substudy 2 Period 1|Other|0|||
155305306|NCT03398148|560549306|FG004|Substudy 2 Period 1|Other|0|||
155305307|NCT03398148|560549307|FG005|Substudy 2 Period 1|Other|0|||
155305308|NCT03398148|560549308|FG006|Substudy 2 Period 1|Other|0|||
155305309|NCT03398148|560549309|FG007|Substudy 2 Period 1|Other|0|||
155305310|NCT03398148|560549310|FG008|Substudy 2 Period 1|Other|0|||
155305311|NCT03398148|560549311|FG009|Substudy 2 Period 1|Other|4|||
155305312|NCT03398148|560549312|FG010|Substudy 2 Period 1|Other|4|||
155305313|NCT03398148|560549313|FG011|Substudy 2 Period 1|Other|0|||
155305314|NCT03398148|560549314|FG012|Substudy 2 Period 1|Other|0|||
155305315|NCT03398148|560549315|FG013|Substudy 2 Period 1|Other|0|||
155305316|NCT03398148|560549316|FG014|Substudy 2 Period 1|Other|0|||
155305317|NCT03398148|560549302|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305318|NCT03398148|560549303|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305319|NCT03398148|560549304|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305320|NCT03398148|560549305|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305321|NCT03398148|560549306|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305322|NCT03398148|560549307|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305323|NCT03398148|560549308|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305324|NCT03398148|560549309|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305325|NCT03398148|560549310|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305326|NCT03398148|560549311|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305327|NCT03398148|560549312|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
155305328|NCT03398148|560549313|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305329|NCT03398148|560549314|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305330|NCT03398148|560549315|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305331|NCT03398148|560549316|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305332|NCT03398148|560549302|FG000|Substudy 2 Period 2|Adverse Event|0|||
155305333|NCT03398148|560549303|FG001|Substudy 2 Period 2|Adverse Event|0|||
155305334|NCT03398148|560549304|FG002|Substudy 2 Period 2|Adverse Event|0|||
155305335|NCT03398148|560549305|FG003|Substudy 2 Period 2|Adverse Event|0|||
155305336|NCT03398148|560549306|FG004|Substudy 2 Period 2|Adverse Event|0|||
155305337|NCT03398148|560549307|FG005|Substudy 2 Period 2|Adverse Event|0|||
155305338|NCT03398148|560549308|FG006|Substudy 2 Period 2|Adverse Event|0|||
155305339|NCT03398148|560549309|FG007|Substudy 2 Period 2|Adverse Event|0|||
155305340|NCT03398148|560549310|FG008|Substudy 2 Period 2|Adverse Event|0|||
155305341|NCT03398148|560549311|FG009|Substudy 2 Period 2|Adverse Event|0|||
155305342|NCT03398148|560549312|FG010|Substudy 2 Period 2|Adverse Event|0|||
155305343|NCT03398148|560549313|FG011|Substudy 2 Period 2|Adverse Event|0|||
155305344|NCT03398148|560549314|FG012|Substudy 2 Period 2|Adverse Event|0|||
155305345|NCT03398148|560549315|FG013|Substudy 2 Period 2|Adverse Event|1|||
155305346|NCT03398148|560549316|FG014|Substudy 2 Period 2|Adverse Event|3|||
155305347|NCT03398148|560549302|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
155305348|NCT03398148|560549303|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
155305349|NCT03398148|560549304|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
155305350|NCT03398148|560549305|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
155305351|NCT03398148|560549306|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
155305352|NCT03398148|560549307|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
155305353|NCT03398148|560549308|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
155305354|NCT03398148|560549309|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
155305355|NCT03398148|560549310|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
155305356|NCT03398148|560549311|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
155305357|NCT03398148|560549312|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
155305358|NCT03398148|560549313|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
155305359|NCT03398148|560549314|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
155305360|NCT03398148|560549315|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
155305361|NCT03398148|560549316|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
155305362|NCT03398148|560549302|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305363|NCT03398148|560549303|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305364|NCT03398148|560549304|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305365|NCT03398148|560549305|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305366|NCT03398148|560549306|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305367|NCT03398148|560549307|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155497031|NCT00388674|561244008|FG000|Initial Treatment|HCC|12|||
155305368|NCT03398148|560549308|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305369|NCT03398148|560549309|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155497032|NCT00388674|561244009|FG001|Initial Treatment|HCC|20|||
155497033|NCT00388674|561244008|FG000|Initial Treatment|Lost to Follow-up|526|||
155497034|NCT00388674|561244009|FG001|Initial Treatment|Lost to Follow-up|624|||
155497035|NCT00388674|561244008|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
155497036|NCT00388674|561244009|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
155497037|NCT00388674|561244008|FG000|Initial Treatment|Never Treated with Study Medication|1|||
155497038|NCT00388674|561244009|FG001|Initial Treatment|Never Treated with Study Medication|7|||
155497039|NCT00388674|561244008|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
155497040|NCT00388674|561244009|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
155497041|NCT00388674|561244008|FG000|Initial Treatment|Not Defined|125|||
155497042|NCT00388674|561244009|FG001|Initial Treatment|Not Defined|172|||
155497043|NCT00388674|561244008|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
155497044|NCT00388674|561244009|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
155497045|NCT00388674|561244008|FG000|Initial Treatment|Pregnancy|26|||
155497046|NCT00388674|561244009|FG001|Initial Treatment|Pregnancy|16|||
155642149|NCT01471574|561780735|FG003|Treatment Period|Adverse Event|1|||
155642150|NCT01471574|561780732|FG000|Treatment Period|Withdrawal by Subject|5|||
155305370|NCT03398148|560549310|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305371|NCT03398148|560549311|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305372|NCT03398148|560549312|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305373|NCT03398148|560549313|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
155305374|NCT03398148|560549314|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305375|NCT03398148|560549315|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
155305376|NCT03398148|560549316|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
155305377|NCT03398148|560549302|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
155305378|NCT03398148|560549303|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
155305379|NCT03398148|560549304|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
155305380|NCT03398148|560549305|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
155305381|NCT03398148|560549306|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
155305382|NCT03398148|560549307|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
155305383|NCT03398148|560549308|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
155305384|NCT03398148|560549309|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
155305385|NCT03398148|560549310|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
155305386|NCT03398148|560549311|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
155305387|NCT03398148|560549312|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
155305388|NCT03398148|560549313|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
155305389|NCT03398148|560549314|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
155305390|NCT03398148|560549315|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
155305391|NCT03398148|560549316|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
155305392|NCT03398148|560549302|FG000|Substudy 2 Period 2|Other|0|||
155305393|NCT03398148|560549303|FG001|Substudy 2 Period 2|Other|0|||
155305394|NCT03398148|560549304|FG002|Substudy 2 Period 2|Other|0|||
155305395|NCT03398148|560549305|FG003|Substudy 2 Period 2|Other|0|||
155305396|NCT03398148|560549306|FG004|Substudy 2 Period 2|Other|0|||
155305397|NCT03398148|560549307|FG005|Substudy 2 Period 2|Other|0|||
155305398|NCT03398148|560549308|FG006|Substudy 2 Period 2|Other|0|||
155305399|NCT03398148|560549309|FG007|Substudy 2 Period 2|Other|0|||
155305400|NCT03398148|560549310|FG008|Substudy 2 Period 2|Other|0|||
155305401|NCT03398148|560549311|FG009|Substudy 2 Period 2|Other|0|||
155305402|NCT03398148|560549312|FG010|Substudy 2 Period 2|Other|0|||
155305403|NCT03398148|560549313|FG011|Substudy 2 Period 2|Other|0|||
155305404|NCT03398148|560549314|FG012|Substudy 2 Period 2|Other|0|||
155305405|NCT03398148|560549315|FG013|Substudy 2 Period 2|Other|1|||
155305406|NCT03398148|560549316|FG014|Substudy 2 Period 2|Other|1|||
155305407|NCT03398148|560549302|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305408|NCT03398148|560549303|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305409|NCT03398148|560549304|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305410|NCT03398148|560549305|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305411|NCT03398148|560549306|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305412|NCT03398148|560549307|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305413|NCT03398148|560549308|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305414|NCT03398148|560549309|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305415|NCT03398148|560549310|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305416|NCT03398148|560549311|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305417|NCT03398148|560549312|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305418|NCT03398148|560549313|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305419|NCT03398148|560549314|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
155497047|NCT00388674|561244008|FG000|Initial Treatment|Study Drug Toxicity|5|||
155497048|NCT00388674|561244009|FG001|Initial Treatment|Study Drug Toxicity|92|||
155497049|NCT00388674|561244008|FG000|Initial Treatment|Participant Request|501|||
155305420|NCT03398148|560549315|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305421|NCT03398148|560549316|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
155305422|NCT04278586|560549317|FG000|Overall Study|Withdrawal by Subject|13|||
155305423|NCT04278586|560549318|FG001|Overall Study|Withdrawal by Subject|6|||
155497050|NCT00388674|561244009|FG001|Initial Treatment|Participant Request|673|||
155642151|NCT01471574|561780733|FG001|Treatment Period|Withdrawal by Subject|1|||
155305424|NCT04278586|560549317|FG000|Overall Study|Lost to Follow-up|37|||
155305425|NCT04278586|560549318|FG001|Overall Study|Lost to Follow-up|24|||
155305426|NCT04607044|560549328|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
155305427|NCT04607044|560549328|FG000|Overall Study|Adverse Event|1|||
155305428|NCT04607044|560549328|FG000|Overall Study|Did not receive study device|3|||
155305429|NCT04607044|560549328|FG000|Overall Study|Death|1|||
155305430|NCT05403801|560549329|FG000|Overall Study|Withdrawal by Subject|2|||
155305431|NCT05075408|560549330|FG000|Overall Study|Withdrawal by Subject|5|||
155305432|NCT05075408|560549331|FG001|Overall Study|Withdrawal by Subject|3|||
155305433|NCT05075408|560549332|FG002|Overall Study|Withdrawal by Subject|4|||
155305434|NCT05075408|560549330|FG000|Overall Study|Adverse Event|5|||
155305435|NCT05075408|560549331|FG001|Overall Study|Adverse Event|7|||
155305436|NCT05075408|560549332|FG002|Overall Study|Adverse Event|8|||
155305437|NCT05075408|560549330|FG000|Overall Study|Protocol Violation|0|||
155305438|NCT05075408|560549331|FG001|Overall Study|Protocol Violation|1|||
155305439|NCT05075408|560549332|FG002|Overall Study|Protocol Violation|0|||
155305440|NCT05075408|560549330|FG000|Overall Study|Lost to Follow-up|2|||
155305441|NCT05075408|560549331|FG001|Overall Study|Lost to Follow-up|1|||
155305442|NCT05075408|560549332|FG002|Overall Study|Lost to Follow-up|1|||
155305443|NCT05075408|560549330|FG000|Overall Study|Physician Decision|1|||
155305444|NCT05075408|560549331|FG001|Overall Study|Physician Decision|0|||
155305445|NCT05075408|560549332|FG002|Overall Study|Physician Decision|0|||
155305446|NCT05075408|560549330|FG000|Overall Study|Other-unspecified|3|||
155305447|NCT05075408|560549331|FG001|Overall Study|Other-unspecified|2|||
155305448|NCT05075408|560549332|FG002|Overall Study|Other-unspecified|0|||
155305449|NCT03416023|560549333|FG000|Overall Study|Exclusion criteria failure|1|||
155305450|NCT03416023|560549333|FG000|Overall Study|Withdrawal by Subject|6|||
155305451|NCT03416023|560549333|FG000|Overall Study|Explanted|7|||
155305452|NCT03416023|560549333|FG000|Overall Study|Physician Decision|1|||
155305453|NCT03416023|560549333|FG000|Overall Study|Lost to Follow-up|1|||
155305454|NCT03416023|560549333|FG000|Overall Study|Death|1|||
155305455|NCT04468776|560549334|FG000|Overall Study|Lost to Follow-up|4|||
155305456|NCT04468776|560549335|FG001|Overall Study|Lost to Follow-up|3|||
155305457|NCT04468776|560549336|FG002|Overall Study|Lost to Follow-up|4|||
155305458|NCT04468776|560549334|FG000|Overall Study|Withdrawal by Subject|1|||
155305459|NCT04468776|560549335|FG001|Overall Study|Withdrawal by Subject|10|||
155497051|NCT00388674|561244008|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
155497052|NCT00388674|561244009|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
155749496|NCT02129777|562182825|FG002|Open-Label Period|Lost to Follow-up|0|||
155749497|NCT02129777|562182826|FG003|Open-Label Period|Lost to Follow-up|0|||
155305460|NCT04468776|560549336|FG002|Overall Study|Withdrawal by Subject|4|||
155305461|NCT04468776|560549334|FG000|Overall Study|Physician Decision|0|||
155305462|NCT04468776|560549335|FG001|Overall Study|Physician Decision|1|||
155305463|NCT04468776|560549336|FG002|Overall Study|Physician Decision|1|||
155305464|NCT00505934|560549347|FG000|Overall Study|Adverse Event|1|||
155305465|NCT00505934|560549347|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
155305466|NCT00505934|560549347|FG000|Overall Study|Other: IV dose needed to be changed|1|||
155305467|NCT05384730|560549350|FG000|Overall Study|Adverse Event|1|||
155305468|NCT05384730|560549351|FG001|Overall Study|Adverse Event|0|||
155305469|NCT05384730|560549350|FG000|Overall Study|Lack of social support|2|||
155305470|NCT05384730|560549351|FG001|Overall Study|Lack of social support|0|||
155305471|NCT05384730|560549350|FG000|Overall Study|Hospital readmission|2|||
155305472|NCT05384730|560549351|FG001|Overall Study|Hospital readmission|0|||
155305473|NCT05384730|560549350|FG000|Overall Study|Disease progression|5|||
155305474|NCT05384730|560549351|FG001|Overall Study|Disease progression|0|||
155305475|NCT05384730|560549350|FG000|Overall Study|Overwhelmed with College commitments|0|||
155305476|NCT05384730|560549351|FG001|Overall Study|Overwhelmed with College commitments|2|||
155305477|NCT01000480|560549352|FG000|Induction Phase|Adverse Event|2|||
155305478|NCT01000480|560549352|FG000|Induction Phase|Lost to Follow-up|1|||
155305479|NCT01000480|560549352|FG000|Induction Phase|Physician Decision|1|||
155305480|NCT01000480|560549352|FG000|Induction Phase|Entry Criteria Not Met|3|||
155305481|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Adverse Event|4|||
155305482|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
155305483|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
155305484|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Physician Decision|1|||
155305485|NCT04328727|560549358|FG000|Overall Study|Guardian Decision|1|||
155305486|NCT04328727|560549358|FG000|Overall Study|Participant decision|4|||
155305487|NCT04328727|560549358|FG000|Overall Study|Death|3|||
155305488|NCT04149002|560549362|FG000|Overall Study|Lost to Follow-up|1|||
155305489|NCT04149002|560549363|FG001|Overall Study|Lost to Follow-up|0|||
155305490|NCT04149002|560549362|FG000|Overall Study|Withdrawal by Subject|1|||
155305491|NCT04149002|560549363|FG001|Overall Study|Withdrawal by Subject|0|||
155305492|NCT02252172|560549364|FG000|Overall Study|Lost to Follow-up|9|||
155305493|NCT02252172|560549365|FG001|Overall Study|Lost to Follow-up|6|||
155305494|NCT02252172|560549364|FG000|Overall Study|Death|218|||
155749498|NCT02129777|562182827|FG004|Open-Label Period|Lost to Follow-up|0|||
155305495|NCT02252172|560549365|FG001|Overall Study|Death|175|||
155305496|NCT02252172|560549364|FG000|Overall Study|Withdrawal by Subject|20|||
155305497|NCT02252172|560549365|FG001|Overall Study|Withdrawal by Subject|15|||
155305498|NCT02252172|560549364|FG000|Overall Study|Physician Decision|0|||
155749499|NCT02129777|562182828|FG005|Open-Label Period|Lost to Follow-up|1|||
155749500|NCT02129777|562182829|FG006|Open-Label Period|Lost to Follow-up|1|||
155749501|NCT02129777|562182823|FG000|Open-Label Period|Withdrawal by Subject|0|||
155305499|NCT02252172|560549365|FG001|Overall Study|Physician Decision|1|||
155305500|NCT02252172|560549364|FG000|Overall Study|End of data collection|122|||
155305501|NCT02252172|560549365|FG001|Overall Study|End of data collection|170|||
155305502|NCT02252172|560549364|FG000|Overall Study|Site closure|0|||
155305503|NCT02252172|560549365|FG001|Overall Study|Site closure|1|||
155305504|NCT03447249|560549369|FG000|Overall Study|Adverse Event|1|||
155305505|NCT03447249|560549370|FG001|Overall Study|Adverse Event|0|||
155749502|NCT02129777|562182824|FG001|Open-Label Period|Withdrawal by Subject|0|||
155497053|NCT00388674|561244008|FG000|Initial Treatment|Not Reported|10|||
155497054|NCT00388674|561244009|FG001|Initial Treatment|Not Reported|12|||
155497055|NCT00388674|561244008|FG000|End of Study|Administrative Reason By Sponsor|299|||
155497056|NCT00388674|561244009|FG001|End of Study|Administrative Reason By Sponsor|253|||
155497057|NCT00388674|561244008|FG000|End of Study|Death|239|||
155497058|NCT00388674|561244009|FG001|End of Study|Death|262|||
155497059|NCT00388674|561244008|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
155497060|NCT00388674|561244009|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
155497061|NCT00388674|561244008|FG000|End of Study|HCC|8|||
155497062|NCT00388674|561244009|FG001|End of Study|HCC|7|||
155497063|NCT00388674|561244008|FG000|End of Study|Lost to Follow-up|587|||
155497064|NCT00388674|561244009|FG001|End of Study|Lost to Follow-up|715|||
155497065|NCT00388674|561244008|FG000|End of Study|Malignancy (Non-HCC)|1|||
155497066|NCT00388674|561244009|FG001|End of Study|Malignancy (Non-HCC)|1|||
155497067|NCT00388674|561244008|FG000|End of Study|Non-Study Related Comorbidities|3|||
155497068|NCT00388674|561244009|FG001|End of Study|Non-Study Related Comorbidities|4|||
155497069|NCT00388674|561244008|FG000|End of Study|Not Defined|135|||
155497070|NCT00388674|561244009|FG001|End of Study|Not Defined|214|||
155497071|NCT00388674|561244008|FG000|End of Study|Participant Withdrew Consent|437|||
155497072|NCT00388674|561244009|FG001|End of Study|Participant Withdrew Consent|673|||
155497073|NCT00388674|561244008|FG000|End of Study|No Off-Treatment Status Data|22|||
155497074|NCT00388674|561244009|FG001|End of Study|No Off-Treatment Status Data|30|||
155497075|NCT00388674|561244008|FG000|End of Study|Not Reported|0|||
155497076|NCT00388674|561244009|FG001|End of Study|Not Reported|1|||
155497077|NCT03576131|561244012|FG000|Overall Study|Investigator decision|0|||
155497078|NCT03576131|561244013|FG001|Overall Study|Investigator decision|0|||
155749503|NCT02129777|562182825|FG002|Open-Label Period|Withdrawal by Subject|0|||
155749504|NCT02129777|562182826|FG003|Open-Label Period|Withdrawal by Subject|0|||
155749505|NCT02129777|562182827|FG004|Open-Label Period|Withdrawal by Subject|0|||
155749506|NCT02129777|562182828|FG005|Open-Label Period|Withdrawal by Subject|1|||
155749507|NCT02129777|562182829|FG006|Open-Label Period|Withdrawal by Subject|3|||
155749508|NCT02129777|562182823|FG000|Open-Label Period|Study Termination|0|||
155497079|NCT03576131|561244014|FG002|Overall Study|Investigator decision|0|||
155497080|NCT03576131|561244015|FG003|Overall Study|Investigator decision|1|||
155497081|NCT03576131|561244016|FG004|Overall Study|Investigator decision|0|||
155497082|NCT03576131|561244017|FG005|Overall Study|Investigator decision|1|||
155497083|NCT03576131|561244018|FG006|Overall Study|Investigator decision|0|||
155497084|NCT03576131|561244019|FG007|Overall Study|Investigator decision|0|||
155497085|NCT03576131|561244012|FG000|Overall Study|Withdrawal by Subject|1|||
155497086|NCT03576131|561244013|FG001|Overall Study|Withdrawal by Subject|1|||
155497087|NCT03576131|561244014|FG002|Overall Study|Withdrawal by Subject|0|||
155497088|NCT03576131|561244015|FG003|Overall Study|Withdrawal by Subject|1|||
155497089|NCT03576131|561244016|FG004|Overall Study|Withdrawal by Subject|2|||
155497090|NCT03576131|561244017|FG005|Overall Study|Withdrawal by Subject|3|||
155497091|NCT03576131|561244018|FG006|Overall Study|Withdrawal by Subject|1|||
155497092|NCT03576131|561244019|FG007|Overall Study|Withdrawal by Subject|0|||
155497093|NCT03576131|561244012|FG000|Overall Study|Death|3|||
155497094|NCT03576131|561244013|FG001|Overall Study|Death|3|||
155497095|NCT03576131|561244014|FG002|Overall Study|Death|1|||
155497096|NCT03576131|561244015|FG003|Overall Study|Death|5|||
155305506|NCT03447249|560549369|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155305507|NCT03447249|560549370|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155305508|NCT03447249|560549369|FG000|Overall Study|Other|3|||
155497097|NCT03576131|561244016|FG004|Overall Study|Death|4|||
155749509|NCT02129777|562182824|FG001|Open-Label Period|Study Termination|0|||
155497098|NCT03576131|561244017|FG005|Overall Study|Death|1|||
155749510|NCT02129777|562182825|FG002|Open-Label Period|Study Termination|0|||
155305509|NCT03447249|560549370|FG001|Overall Study|Other|0|||
155305510|NCT01426412|560549371|FG000|Overall Study|Withdrawal by Subject|1|||
155497099|NCT03576131|561244018|FG006|Overall Study|Death|0|||
155497100|NCT03576131|561244019|FG007|Overall Study|Death|1|||
155497101|NCT03576131|561244012|FG000|Overall Study|New anti-cancer treatment|5|||
155497102|NCT03576131|561244013|FG001|Overall Study|New anti-cancer treatment|1|||
155497103|NCT03576131|561244014|FG002|Overall Study|New anti-cancer treatment|2|||
155497104|NCT03576131|561244015|FG003|Overall Study|New anti-cancer treatment|3|||
155497105|NCT03576131|561244016|FG004|Overall Study|New anti-cancer treatment|0|||
155497106|NCT03576131|561244017|FG005|Overall Study|New anti-cancer treatment|0|||
155497107|NCT03576131|561244018|FG006|Overall Study|New anti-cancer treatment|0|||
155305511|NCT01426412|560549372|FG001|Overall Study|Withdrawal by Subject|0|||
155305512|NCT01426412|560549373|FG002|Overall Study|Withdrawal by Subject|0|||
155305513|NCT01426412|560549374|FG003|Overall Study|Withdrawal by Subject|0|||
155305514|NCT01426412|560549375|FG004|Overall Study|Withdrawal by Subject|1|||
155305515|NCT01426412|560549376|FG005|Overall Study|Withdrawal by Subject|0|||
155305516|NCT01426412|560549377|FG006|Overall Study|Withdrawal by Subject|0|||
155305517|NCT01426412|560549378|FG007|Overall Study|Withdrawal by Subject|3|||
155305518|NCT01426412|560549379|FG008|Overall Study|Withdrawal by Subject|1|||
155305519|NCT00988858|560549381|FG000|Overall Study|Adverse Event|7|||
155305520|NCT00988858|560549381|FG000|Overall Study|Death|1|||
155305521|NCT00988858|560549381|FG000|Overall Study|Physician Decision|1|||
155305522|NCT00988858|560549381|FG000|Overall Study|Sponsor Decision|1|||
155305523|NCT02376790|560549382|FG000|Overall Study|Withdrawal by Subject|43|||
155305524|NCT02376790|560549383|FG001|Overall Study|Withdrawal by Subject|36|||
155305525|NCT02376790|560549384|FG002|Overall Study|Withdrawal by Subject|37|||
155305526|NCT02376790|560549382|FG000|Overall Study|Decision by Sponsor|2|||
155305527|NCT02376790|560549383|FG001|Overall Study|Decision by Sponsor|1|||
155305528|NCT02376790|560549384|FG002|Overall Study|Decision by Sponsor|4|||
155305529|NCT02376790|560549382|FG000|Overall Study|Lost to Follow-up|15|||
155305530|NCT02376790|560549383|FG001|Overall Study|Lost to Follow-up|10|||
155305531|NCT02376790|560549384|FG002|Overall Study|Lost to Follow-up|12|||
155305532|NCT03014453|560549385|FG000|Overall Study|Lost to Follow-up|12|||
155305533|NCT03014453|560549385|FG000|Overall Study|Discontinued GER|3|||
155305534|NCT03014453|560549385|FG000|Overall Study|Excluded|19|||
155305535|NCT03014453|560549385|FG000|Overall Study|Refused to take part in|37|||
155413281|NCT00487539|560944753|FG003|Overall Study|Other|2|||
155413282|NCT02751502|560944754|FG000|Overall Study|Lack of funding|4|||
155413283|NCT00852995|560944755|FG000|Overall Study|Adverse Event|1|||
155413284|NCT00852995|560944756|FG001|Overall Study|Adverse Event|0|||
155413285|NCT00852995|560944757|FG002|Overall Study|Adverse Event|4|||
155497108|NCT03576131|561244019|FG007|Overall Study|New anti-cancer treatment|0|||
155413286|NCT00852995|560944758|FG003|Overall Study|Adverse Event|0|||
155413287|NCT00852995|560944759|FG004|Overall Study|Adverse Event|0|||
155413288|NCT00852995|560944755|FG000|Overall Study|Lost to Follow-up|0|||
155413289|NCT00852995|560944756|FG001|Overall Study|Lost to Follow-up|1|||
155413290|NCT00852995|560944757|FG002|Overall Study|Lost to Follow-up|1|||
155413291|NCT00852995|560944758|FG003|Overall Study|Lost to Follow-up|0|||
155413292|NCT00852995|560944759|FG004|Overall Study|Lost to Follow-up|0|||
155413293|NCT00852995|560944755|FG000|Overall Study|Withdrawal by Subject|4|||
155413294|NCT00852995|560944756|FG001|Overall Study|Withdrawal by Subject|0|||
155413295|NCT00852995|560944757|FG002|Overall Study|Withdrawal by Subject|0|||
155413296|NCT00852995|560944758|FG003|Overall Study|Withdrawal by Subject|1|||
155413297|NCT00852995|560944759|FG004|Overall Study|Withdrawal by Subject|2|||
155413298|NCT00852995|560944755|FG000|Overall Study|Non-Compliance|0|||
155413299|NCT00852995|560944756|FG001|Overall Study|Non-Compliance|0|||
155413300|NCT00852995|560944757|FG002|Overall Study|Non-Compliance|0|||
155413301|NCT00852995|560944758|FG003|Overall Study|Non-Compliance|2|||
155413302|NCT00852995|560944759|FG004|Overall Study|Non-Compliance|0|||
155413303|NCT00852995|560944755|FG000|Overall Study|Progressive Disease|1|||
155413304|NCT00852995|560944756|FG001|Overall Study|Progressive Disease|0|||
155413305|NCT00852995|560944757|FG002|Overall Study|Progressive Disease|0|||
155413306|NCT00852995|560944758|FG003|Overall Study|Progressive Disease|2|||
155413307|NCT00852995|560944759|FG004|Overall Study|Progressive Disease|1|||
155413308|NCT00852995|560944755|FG000|Overall Study|Physician Decision|1|||
155413309|NCT00852995|560944756|FG001|Overall Study|Physician Decision|0|||
155413310|NCT00852995|560944757|FG002|Overall Study|Physician Decision|0|||
155413311|NCT00852995|560944758|FG003|Overall Study|Physician Decision|0|||
155497109|NCT03576131|561244012|FG000|Overall Study|Unspecified reason|0|||
155497110|NCT03576131|561244013|FG001|Overall Study|Unspecified reason|0|||
155305536|NCT00390299|560549386|FG000|Overall Study|Cancellation|1|||
155305537|NCT00390299|560549387|FG001|Overall Study|Cancellation|0|||
155305538|NCT00390299|560549388|FG002|Overall Study|Cancellation|0|||
155305539|NCT00390299|560549389|FG003|Overall Study|Cancellation|0|||
155305540|NCT00390299|560549390|FG004|Overall Study|Cancellation|0|||
155305541|NCT01070069|560549392|FG000|Overall Study|Death|1|||
155305542|NCT01070069|560549393|FG001|Overall Study|Death|0|||
155305543|NCT01070069|560549394|FG002|Overall Study|Death|2|||
155305544|NCT01070069|560549395|FG003|Overall Study|Death|0|||
155305545|NCT01070069|560549396|FG004|Overall Study|Death|1|||
155413312|NCT00852995|560944759|FG004|Overall Study|Physician Decision|0|||
155413313|NCT00852995|560944755|FG000|Overall Study|Protocol Violation|0|||
155413314|NCT00852995|560944756|FG001|Overall Study|Protocol Violation|0|||
155305546|NCT01070069|560549392|FG000|Overall Study|Withdrawal by Subject|1|||
155305547|NCT01070069|560549393|FG001|Overall Study|Withdrawal by Subject|1|||
155413315|NCT00852995|560944757|FG002|Overall Study|Protocol Violation|0|||
155497111|NCT03576131|561244014|FG002|Overall Study|Unspecified reason|1|||
155305548|NCT01070069|560549394|FG002|Overall Study|Withdrawal by Subject|4|||
155305549|NCT01070069|560549395|FG003|Overall Study|Withdrawal by Subject|0|||
155305550|NCT01070069|560549396|FG004|Overall Study|Withdrawal by Subject|0|||
155305551|NCT01070069|560549392|FG000|Overall Study|Lost to Follow-up|4|||
155305552|NCT01070069|560549393|FG001|Overall Study|Lost to Follow-up|1|||
155305553|NCT01070069|560549394|FG002|Overall Study|Lost to Follow-up|0|||
155305554|NCT01070069|560549395|FG003|Overall Study|Lost to Follow-up|0|||
155305555|NCT01070069|560549396|FG004|Overall Study|Lost to Follow-up|3|||
155305556|NCT03101930|560549399|FG000|Overall Study|Withdrawal by Subject|2|||
155305557|NCT03101930|560549400|FG001|Overall Study|Withdrawal by Subject|1|||
155305558|NCT03101930|560549401|FG002|Overall Study|Withdrawal by Subject|2|||
155305559|NCT00262301|560549402|FG000|Double-blind Phase|Lost to Follow-up|1|||
155305560|NCT00262301|560549403|FG001|Double-blind Phase|Lost to Follow-up|0|||
155305561|NCT00262301|560549404|FG002|Double-blind Phase|Lost to Follow-up|0|||
155305562|NCT00262301|560549402|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
155305563|NCT00262301|560549403|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
155305564|NCT00262301|560549404|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
155305565|NCT04732338|560549410|FG000|Overall Study|Lost to Follow-up|3|||
155305566|NCT04732338|560549411|FG001|Overall Study|Lost to Follow-up|3|||
155305567|NCT00001277|560549412|FG000|Overall Study|Adverse Event|0|||
155305568|NCT00001277|560549413|FG001|Overall Study|Adverse Event|0|||
155305569|NCT00001277|560549414|FG002|Overall Study|Adverse Event|1|||
155305570|NCT00001277|560549412|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
155305571|NCT00001277|560549413|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
155305572|NCT00001277|560549414|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
155305573|NCT00088413|560549420|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305574|NCT00088413|560549421|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305575|NCT00088413|560549422|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
155305576|NCT00088413|560549423|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305577|NCT00088413|560549420|FG000|Overall Study|Adverse Events/Side Effects|0|||
155305578|NCT00088413|560549421|FG001|Overall Study|Adverse Events/Side Effects|1|||
155305579|NCT00088413|560549422|FG002|Overall Study|Adverse Events/Side Effects|1|||
155305580|NCT00088413|560549423|FG003|Overall Study|Adverse Events/Side Effects|0|||
155305581|NCT00088413|560549420|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
155305582|NCT00088413|560549421|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
155305583|NCT00088413|560549422|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
155305584|NCT00088413|560549423|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
155305585|NCT00088413|560549420|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
155305586|NCT00088413|560549421|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
155305587|NCT00088413|560549422|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
155305588|NCT00088413|560549423|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
155305589|NCT00088413|560549420|FG000|Overall Study|Death|0|||
155305590|NCT00088413|560549421|FG001|Overall Study|Death|1|||
155305591|NCT00088413|560549422|FG002|Overall Study|Death|0|||
155305592|NCT00088413|560549423|FG003|Overall Study|Death|0|||
155305593|NCT00088413|560549420|FG000|Overall Study|Progressive disease|9|||
155305594|NCT00088413|560549421|FG001|Overall Study|Progressive disease|11|||
155305595|NCT00088413|560549422|FG002|Overall Study|Progressive disease|8|||
155305596|NCT00088413|560549423|FG003|Overall Study|Progressive disease|14|||
155305597|NCT00088413|560549420|FG000|Overall Study|Other|0|||
155305598|NCT00088413|560549421|FG001|Overall Study|Other|1|||
155305599|NCT00088413|560549422|FG002|Overall Study|Other|0|||
155305600|NCT00088413|560549423|FG003|Overall Study|Other|0|||
155305601|NCT00088413|560549420|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
155305602|NCT00088413|560549421|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
155305603|NCT00088413|560549422|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
155305604|NCT00088413|560549423|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
155305605|NCT02539225|560549424|FG000|Part A|Adverse Event|13|||
155305606|NCT02539225|560549425|FG001|Part A|Adverse Event|4|||
155305607|NCT02539225|560549424|FG000|Part A|Withdrawal by Subject|2|||
155305608|NCT02539225|560549425|FG001|Part A|Withdrawal by Subject|4|||
155305609|NCT02539225|560549424|FG000|Part A|Physician Decision|4|||
155413316|NCT00852995|560944758|FG003|Overall Study|Protocol Violation|0|||
155413317|NCT00852995|560944759|FG004|Overall Study|Protocol Violation|1|||
155413318|NCT00852995|560944755|FG000|Overall Study|Moved Out of Area|1|||
155413319|NCT00852995|560944756|FG001|Overall Study|Moved Out of Area|0|||
155413320|NCT00852995|560944757|FG002|Overall Study|Moved Out of Area|0|||
155413321|NCT00852995|560944758|FG003|Overall Study|Moved Out of Area|0|||
155413322|NCT00852995|560944759|FG004|Overall Study|Moved Out of Area|0|||
155413323|NCT03499028|560944760|FG000|Overall Study|Lost to Follow-up|12|||
155305610|NCT02539225|560549425|FG001|Part A|Physician Decision|7|||
155305611|NCT02539225|560549424|FG000|Part A|Did Not Receive study Drug|1|||
155305612|NCT02539225|560549425|FG001|Part A|Did Not Receive study Drug|1|||
155305613|NCT02539225|560549424|FG000|Pre Treatment for Part B|Progressive disease|1|||
155305614|NCT02539225|560549425|FG001|Pre Treatment for Part B|Progressive disease|1|||
155413324|NCT03499028|560944761|FG001|Overall Study|Lost to Follow-up|9|||
155497112|NCT03576131|561244015|FG003|Overall Study|Unspecified reason|1|||
155497113|NCT03576131|561244016|FG004|Overall Study|Unspecified reason|1|||
155497114|NCT03576131|561244017|FG005|Overall Study|Unspecified reason|1|||
155497115|NCT03576131|561244018|FG006|Overall Study|Unspecified reason|0|||
155497116|NCT03576131|561244019|FG007|Overall Study|Unspecified reason|0|||
155497117|NCT03576131|561244012|FG000|Overall Study|Subject non-compliance|0|||
155497118|NCT03576131|561244013|FG001|Overall Study|Subject non-compliance|0|||
155497119|NCT03576131|561244014|FG002|Overall Study|Subject non-compliance|0|||
155497120|NCT03576131|561244015|FG003|Overall Study|Subject non-compliance|0|||
155497121|NCT03576131|561244016|FG004|Overall Study|Subject non-compliance|0|||
155497122|NCT03576131|561244017|FG005|Overall Study|Subject non-compliance|1|||
155749511|NCT02129777|562182826|FG003|Open-Label Period|Study Termination|0|||
155749512|NCT02129777|562182827|FG004|Open-Label Period|Study Termination|0|||
155749513|NCT02129777|562182828|FG005|Open-Label Period|Study Termination|10|||
155749514|NCT02129777|562182829|FG006|Open-Label Period|Study Termination|39|||
155749515|NCT04391569|562182830|FG000|Overall Study|Death|15|||
155749516|NCT04391569|562182831|FG001|Overall Study|Death|10|||
155749517|NCT04391569|562182830|FG000|Overall Study|Withdrawal by Subject|1|||
155749518|NCT04391569|562182831|FG001|Overall Study|Withdrawal by Subject|0|||
155749519|NCT04391569|562182830|FG000|Overall Study|Lost to Follow-up|3|||
155749520|NCT04391569|562182831|FG001|Overall Study|Lost to Follow-up|2|||
155749521|NCT04391569|562182830|FG000|Overall Study|Lack of Efficacy|0|||
155749522|NCT04391569|562182831|FG001|Overall Study|Lack of Efficacy|1|||
155749523|NCT04391569|562182830|FG000|Overall Study|Participant discharged to hospice facility|0|||
155749524|NCT04391569|562182831|FG001|Overall Study|Participant discharged to hospice facility|1|||
155749525|NCT04391569|562182830|FG000|Overall Study|Participant family decision|1|||
155749526|NCT04391569|562182831|FG001|Overall Study|Participant family decision|0|||
155497123|NCT03576131|561244018|FG006|Overall Study|Subject non-compliance|0|||
155497124|NCT03576131|561244019|FG007|Overall Study|Subject non-compliance|0|||
155497125|NCT02118896|561244024|FG000|Overall Study|Death|4|||
155497126|NCT02118896|561244025|FG001|Overall Study|Death|0|||
155497127|NCT02118896|561244026|FG002|Overall Study|Death|4|||
155497128|NCT02118896|561244027|FG003|Overall Study|Death|6|||
155749527|NCT04391569|562182830|FG000|Overall Study|Participant discharged prematurely|1|||
155749528|NCT04391569|562182831|FG001|Overall Study|Participant discharged prematurely|0|||
155749529|NCT01470989|562182851|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
155305615|NCT02539225|560549424|FG000|Pre Treatment for Part B|Adverse Event|1|||
155305616|NCT02539225|560549425|FG001|Pre Treatment for Part B|Adverse Event|1|||
155305617|NCT02539225|560549424|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
155305618|NCT02539225|560549425|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
155305619|NCT02539225|560549424|FG000|Pre Treatment for Part B|Physician Decision|2|||
155305620|NCT02539225|560549425|FG001|Pre Treatment for Part B|Physician Decision|0|||
155305621|NCT02539225|560549424|FG000|Part B|Adverse Event|4|||
155305622|NCT02539225|560549425|FG001|Part B|Adverse Event|4|||
155305623|NCT02539225|560549424|FG000|Part B|Withdrawal by Subject|0|||
155305624|NCT02539225|560549425|FG001|Part B|Withdrawal by Subject|3|||
155305625|NCT02539225|560549424|FG000|Part B|Physician Decision|0|||
155305626|NCT02539225|560549425|FG001|Part B|Physician Decision|9|||
155305627|NCT03101371|560549428|FG000|Overall Study|Physician Decision|0|||
155305628|NCT03101371|560549429|FG001|Overall Study|Physician Decision|1|||
155305629|NCT03101371|560549428|FG000|Overall Study|Lost to Follow-up|1|||
155305630|NCT03101371|560549429|FG001|Overall Study|Lost to Follow-up|4|||
155305631|NCT03101371|560549428|FG000|Overall Study|Did not meet eligibility criteria|2|||
155305632|NCT03101371|560549429|FG001|Overall Study|Did not meet eligibility criteria|1|||
155305633|NCT03988842|560549430|FG000|Overall Study|Death|1|||
155305634|NCT01976312|560549431|FG000|Overall Study|Pregnancy|0|||
155305635|NCT01976312|560549432|FG001|Overall Study|Pregnancy|1|||
155305636|NCT01976312|560549431|FG000|Overall Study|Lost to Follow-up|2|||
155305637|NCT01976312|560549432|FG001|Overall Study|Lost to Follow-up|0|||
155305638|NCT01976312|560549431|FG000|Overall Study|Withdrawal by Subject|7|||
155305639|NCT01976312|560549432|FG001|Overall Study|Withdrawal by Subject|2|||
155305640|NCT01976312|560549431|FG000|Overall Study|Adverse Event|6|||
155305641|NCT01976312|560549432|FG001|Overall Study|Adverse Event|6|||
155305642|NCT01976312|560549431|FG000|Overall Study|Protocol Violation|2|||
155305643|NCT01976312|560549432|FG001|Overall Study|Protocol Violation|0|||
155305644|NCT01538719|560549433|FG000|Overall Study|Lost to Follow-up|2|||
155305645|NCT01538719|560549434|FG001|Overall Study|Lost to Follow-up|0|||
155305646|NCT02556138|560549439|FG000|Overall Study|Withdrawal by Subject|1|||
155305647|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
155305648|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
155305649|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
155305650|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
155497129|NCT02118896|561244028|FG004|Overall Study|Death|3|||
155497130|NCT02118896|561244029|FG005|Overall Study|Death|1|||
155305651|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
155497131|NCT02118896|561244030|FG006|Overall Study|Death|0|||
155497132|NCT02118896|561244031|FG007|Overall Study|Death|0|||
155749530|NCT01470989|562182852|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
155749531|NCT01470989|562182851|FG000|Overall Study|Adverse Event|2|||
155749532|NCT01470989|562182852|FG001|Overall Study|Adverse Event|5|||
155749533|NCT01470989|562182851|FG000|Overall Study|Abnormal laboratory value|1|||
155749534|NCT01470989|562182852|FG001|Overall Study|Abnormal laboratory value|1|||
155749535|NCT01470989|562182851|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155749536|NCT01470989|562182852|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155749537|NCT01470989|562182851|FG000|Overall Study|Withdrawal by Subject|19|||
155749538|NCT01470989|562182852|FG001|Overall Study|Withdrawal by Subject|17|||
155749539|NCT01470989|562182851|FG000|Overall Study|Lost to Follow-up|18|||
155749540|NCT01470989|562182852|FG001|Overall Study|Lost to Follow-up|13|||
155749541|NCT01470989|562182851|FG000|Overall Study|Administrative problems|2|||
155749542|NCT01470989|562182852|FG001|Overall Study|Administrative problems|4|||
155749543|NCT01470989|562182851|FG000|Overall Study|Death|2|||
155749544|NCT01470989|562182852|FG001|Overall Study|Death|2|||
155749545|NCT01470989|562182851|FG000|Overall Study|Protocol deviation|1|||
155749546|NCT01470989|562182852|FG001|Overall Study|Protocol deviation|2|||
155749547|NCT02119676|562182853|FG000|Overall Study|Adverse Event|9|||
155749548|NCT02119676|562182854|FG001|Overall Study|Adverse Event|17|||
155749549|NCT02119676|562182855|FG002|Overall Study|Adverse Event|10|||
155749550|NCT02119676|562182856|FG003|Overall Study|Adverse Event|10|||
155749551|NCT02119676|562182853|FG000|Overall Study|Disease progression|53|||
155749552|NCT02119676|562182854|FG001|Overall Study|Disease progression|55|||
155749553|NCT02119676|562182855|FG002|Overall Study|Disease progression|68|||
155749554|NCT02119676|562182856|FG003|Overall Study|Disease progression|73|||
155749555|NCT02119676|562182853|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
155749556|NCT02119676|562182854|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
155749557|NCT02119676|562182855|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
155749558|NCT02119676|562182856|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
155749559|NCT02119676|562182853|FG000|Overall Study|Physician Decision|4|||
155749560|NCT02119676|562182854|FG001|Overall Study|Physician Decision|2|||
155749561|NCT02119676|562182855|FG002|Overall Study|Physician Decision|3|||
155749562|NCT02119676|562182856|FG003|Overall Study|Physician Decision|2|||
155749563|NCT02119676|562182853|FG000|Overall Study|Death|9|||
155413325|NCT03499028|560944760|FG000|Overall Study|Withdrawal by Subject|5|||
155413326|NCT03499028|560944761|FG001|Overall Study|Withdrawal by Subject|8|||
155413327|NCT03499028|560944760|FG000|Overall Study|Unplanned SNF discharge|5|||
155413328|NCT03499028|560944761|FG001|Overall Study|Unplanned SNF discharge|8|||
155413329|NCT01110200|560944762|FG000|Overall Study|Adverse Event|28|||
155413330|NCT01110200|560944763|FG001|Overall Study|Adverse Event|28|||
155413331|NCT01110200|560944762|FG000|Overall Study|Withdrawal by Subject|25|||
155413332|NCT01110200|560944763|FG001|Overall Study|Withdrawal by Subject|32|||
155413333|NCT01110200|560944762|FG000|Overall Study|Lack of Efficacy|16|||
155413334|NCT01110200|560944763|FG001|Overall Study|Lack of Efficacy|25|||
155413335|NCT01110200|560944762|FG000|Overall Study|Protocol Violation|14|||
155413336|NCT01110200|560944763|FG001|Overall Study|Protocol Violation|12|||
155413337|NCT01110200|560944762|FG000|Overall Study|Physician Decision|13|||
155413338|NCT01110200|560944763|FG001|Overall Study|Physician Decision|17|||
155413339|NCT01110200|560944762|FG000|Overall Study|Lost to Follow-up|10|||
155413340|NCT01110200|560944763|FG001|Overall Study|Lost to Follow-up|7|||
155413341|NCT01437397|560944764|FG000|Overall Study|Lost to Follow-up|9|||
155413342|NCT01437397|560944765|FG001|Overall Study|Lost to Follow-up|4|||
155413343|NCT01437397|560944766|FG002|Overall Study|Lost to Follow-up|2|||
155413344|NCT01437397|560944767|FG003|Overall Study|Lost to Follow-up|4|||
155413345|NCT01437397|560944768|FG004|Overall Study|Lost to Follow-up|5|||
155413346|NCT01437397|560944764|FG000|Overall Study|Withdrawal by Subject|11|||
155413347|NCT01437397|560944765|FG001|Overall Study|Withdrawal by Subject|12|||
155413348|NCT01437397|560944766|FG002|Overall Study|Withdrawal by Subject|24|||
155413349|NCT01437397|560944767|FG003|Overall Study|Withdrawal by Subject|11|||
155413350|NCT01437397|560944768|FG004|Overall Study|Withdrawal by Subject|22|||
155749564|NCT02119676|562182854|FG001|Overall Study|Death|3|||
155749565|NCT02119676|562182855|FG002|Overall Study|Death|2|||
155749566|NCT02119676|562182856|FG003|Overall Study|Death|1|||
155305652|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
155305653|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
155305654|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
155305655|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
155305656|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
155305657|NCT03939312|560549440|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
155305658|NCT03939312|560549440|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
155305659|NCT03481816|560549442|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
155305660|NCT03481816|560549443|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
155305661|NCT03481816|560549442|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
155305662|NCT03481816|560549443|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
155305663|NCT03481816|560549442|FG000|Dose Expansion|Withdrawal by Subject|0|||
155305664|NCT03481816|560549443|FG001|Dose Expansion|Withdrawal by Subject|2|||
155305665|NCT03481816|560549442|FG000|Dose Expansion|Physician Decision|0|||
155642152|NCT01471574|561780734|FG002|Treatment Period|Withdrawal by Subject|1|||
155642153|NCT01471574|561780735|FG003|Treatment Period|Withdrawal by Subject|0|||
155642154|NCT01471574|561780732|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
155642155|NCT01471574|561780733|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
155642156|NCT01471574|561780734|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
155642157|NCT01471574|561780735|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
155642158|NCT01471574|561780732|FG000|Treatment Period|Lost to Follow-up|1|||
155642159|NCT01471574|561780733|FG001|Treatment Period|Lost to Follow-up|2|||
155642160|NCT01471574|561780734|FG002|Treatment Period|Lost to Follow-up|2|||
155642161|NCT01471574|561780735|FG003|Treatment Period|Lost to Follow-up|0|||
155642162|NCT01471574|561780732|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
155642163|NCT01471574|561780733|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155642164|NCT01471574|561780734|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155642165|NCT01471574|561780735|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155642166|NCT01471574|561780732|FG000|Treatment Period|Other|1|||
155642167|NCT01471574|561780733|FG001|Treatment Period|Other|0|||
155642168|NCT01471574|561780734|FG002|Treatment Period|Other|0|||
155642169|NCT01471574|561780735|FG003|Treatment Period|Other|0|||
155642170|NCT01471574|561780732|FG000|Follow-up Period|Withdrawal by Subject|3|||
155642171|NCT01471574|561780733|FG001|Follow-up Period|Withdrawal by Subject|0|||
155642172|NCT01471574|561780734|FG002|Follow-up Period|Withdrawal by Subject|3|||
155642173|NCT01471574|561780735|FG003|Follow-up Period|Withdrawal by Subject|1|||
155642174|NCT01471574|561780732|FG000|Follow-up Period|Lost to Follow-up|4|||
155642175|NCT01471574|561780733|FG001|Follow-up Period|Lost to Follow-up|1|||
155642176|NCT01471574|561780734|FG002|Follow-up Period|Lost to Follow-up|3|||
155642177|NCT01471574|561780735|FG003|Follow-up Period|Lost to Follow-up|2|||
155642178|NCT01471574|561780732|FG000|Follow-up Period|Death|0|||
155642179|NCT01471574|561780733|FG001|Follow-up Period|Death|0|||
155642180|NCT01471574|561780734|FG002|Follow-up Period|Death|1|||
155642181|NCT01471574|561780735|FG003|Follow-up Period|Death|0|||
155305666|NCT03481816|560549443|FG001|Dose Expansion|Physician Decision|5|||
155305667|NCT01216176|560551115|FG000|Overall Study|Adverse Event|0|||
155305668|NCT01216176|560551116|FG001|Overall Study|Adverse Event|8|||
155305669|NCT01216176|560551117|FG002|Overall Study|Adverse Event|0|||
155305670|NCT01216176|560551115|FG000|Overall Study|Physician Decision|0|||
155305671|NCT01216176|560551116|FG001|Overall Study|Physician Decision|0|||
155305672|NCT01216176|560551117|FG002|Overall Study|Physician Decision|1|||
155305673|NCT02791230|560551118|FG000|Overall Study|Adverse Event|10|||
155305674|NCT02791230|560551119|FG001|Overall Study|Adverse Event|9|||
155305675|NCT02791230|560551120|FG002|Overall Study|Adverse Event|66|||
155305676|NCT02791230|560551118|FG000|Overall Study|Death|38|||
155305677|NCT02791230|560551119|FG001|Overall Study|Death|25|||
155305678|NCT02791230|560551120|FG002|Overall Study|Death|184|||
155305679|NCT02791230|560551118|FG000|Overall Study|Lack of Efficacy|1|||
155305680|NCT02791230|560551119|FG001|Overall Study|Lack of Efficacy|0|||
155305681|NCT02791230|560551120|FG002|Overall Study|Lack of Efficacy|3|||
155305682|NCT02791230|560551118|FG000|Overall Study|Lost to Follow-up|0|||
155305683|NCT02791230|560551119|FG001|Overall Study|Lost to Follow-up|0|||
155305684|NCT02791230|560551120|FG002|Overall Study|Lost to Follow-up|10|||
155305685|NCT02791230|560551118|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
155305686|NCT02791230|560551119|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155305687|NCT02791230|560551120|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
155305688|NCT02791230|560551118|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
155305689|NCT02791230|560551119|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
155305690|NCT02791230|560551120|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
155305691|NCT02791230|560551118|FG000|Overall Study|Study sites terminated by sponsor|1|||
155305692|NCT02791230|560551119|FG001|Overall Study|Study sites terminated by sponsor|0|||
155305693|NCT02791230|560551120|FG002|Overall Study|Study sites terminated by sponsor|5|||
155305694|NCT02791230|560551118|FG000|Overall Study|Other|9|||
155305695|NCT02791230|560551119|FG001|Overall Study|Other|1|||
155305696|NCT02791230|560551120|FG002|Overall Study|Other|28|||
155305697|NCT02791230|560551118|FG000|Overall Study|Protocol Violation|0|||
155305698|NCT02791230|560551119|FG001|Overall Study|Protocol Violation|0|||
155305699|NCT02791230|560551120|FG002|Overall Study|Protocol Violation|4|||
155305700|NCT02791230|560551118|FG000|Overall Study|Withdrawal by Subject|24|||
155305701|NCT02791230|560551119|FG001|Overall Study|Withdrawal by Subject|13|||
155305702|NCT02791230|560551120|FG002|Overall Study|Withdrawal by Subject|172|||
155305703|NCT02791230|560551118|FG000|Overall Study|Enrolled but not treated|0|||
155305704|NCT02791230|560551119|FG001|Overall Study|Enrolled but not treated|0|||
155305705|NCT02791230|560551120|FG002|Overall Study|Enrolled but not treated|5|||
155305706|NCT05756075|560551125|FG000|Overall Study|Withdrawal by Subject|16|||
155305707|NCT05756075|560551126|FG001|Overall Study|Withdrawal by Subject|9|||
155305708|NCT03821844|560551128|FG000|Overall Study|Death|37|||
155305709|NCT03821844|560551129|FG001|Overall Study|Death|31|||
155305710|NCT03821844|560551128|FG000|Overall Study|Discharged|10|||
155305711|NCT03821844|560551129|FG001|Overall Study|Discharged|14|||
155305712|NCT03821844|560551128|FG000|Overall Study|Not present in facility at followup|2|||
155305713|NCT03821844|560551129|FG001|Overall Study|Not present in facility at followup|3|||
155305714|NCT02605837|560551130|FG000|Overall Study|Adverse Event|3|||
155305715|NCT02605837|560551131|FG001|Overall Study|Adverse Event|1|||
155305716|NCT02605837|560551130|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155305717|NCT02605837|560551131|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155305718|NCT02605837|560551130|FG000|Overall Study|Withdrawal by Subject|8|||
155413351|NCT01437397|560944764|FG000|Overall Study|Protocol Violation|10|||
155413352|NCT01437397|560944765|FG001|Overall Study|Protocol Violation|12|||
155413353|NCT01437397|560944766|FG002|Overall Study|Protocol Violation|13|||
155413354|NCT01437397|560944767|FG003|Overall Study|Protocol Violation|21|||
155413355|NCT01437397|560944768|FG004|Overall Study|Protocol Violation|19|||
155413356|NCT01437397|560944764|FG000|Overall Study|Lack of Efficacy|5|||
155413357|NCT01437397|560944765|FG001|Overall Study|Lack of Efficacy|4|||
155413358|NCT01437397|560944766|FG002|Overall Study|Lack of Efficacy|8|||
155413359|NCT01437397|560944767|FG003|Overall Study|Lack of Efficacy|10|||
155413360|NCT01437397|560944768|FG004|Overall Study|Lack of Efficacy|20|||
155413361|NCT01437397|560944764|FG000|Overall Study|Adverse Event|21|||
155305719|NCT02605837|560551131|FG001|Overall Study|Withdrawal by Subject|8|||
155305720|NCT02605837|560551130|FG000|Overall Study|Physician Decision|0|||
155305721|NCT02605837|560551131|FG001|Overall Study|Physician Decision|1|||
155305722|NCT05104697|560551132|FG000|Overall Study|Withdrawal by Subject|0|||
155305723|NCT05104697|560551133|FG001|Overall Study|Withdrawal by Subject|1|||
155305724|NCT03899961|560551134|FG000|Overall Study|-delivery prior to|2|||
155305725|NCT03899961|560551135|FG001|Overall Study|-delivery prior to|7|||
155305726|NCT03899961|560551134|FG000|Overall Study|req general anesth|1|||
155305727|NCT03899961|560551135|FG001|Overall Study|req general anesth|2|||
155305728|NCT03899961|560551134|FG000|Overall Study|capacity|5|||
155305729|NCT03899961|560551135|FG001|Overall Study|capacity|6|||
155305730|NCT03899961|560551134|FG000|Overall Study|Withdrawal by Subject|1|||
155305731|NCT03899961|560551135|FG001|Overall Study|Withdrawal by Subject|1|||
155305732|NCT05307978|560551136|FG000|Overall Study|Lost to Follow-up|0|||
155305733|NCT05307978|560551137|FG001|Overall Study|Lost to Follow-up|1|||
155305734|NCT05307978|560551138|FG002|Overall Study|Lost to Follow-up|0|||
155305735|NCT05307978|560551139|FG003|Overall Study|Lost to Follow-up|4|||
155305736|NCT05307978|560551140|FG004|Overall Study|Lost to Follow-up|0|||
155305737|NCT05307978|560551141|FG005|Overall Study|Lost to Follow-up|0|||
155305738|NCT05307978|560551142|FG006|Overall Study|Lost to Follow-up|1|||
155305739|NCT03651895|560551143|FG000|First Drug Assignment|Adverse Event|4|||
155305740|NCT03651895|560551144|FG001|First Drug Assignment|Adverse Event|5|||
155305741|NCT03651895|560551143|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
155305742|NCT03651895|560551144|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
155305743|NCT02837510|560551145|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
155305744|NCT02837510|560551146|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
155305745|NCT02837510|560551145|FG000|Washout (2 Weeks)|Adverse Event|0|||
155413362|NCT01437397|560944765|FG001|Overall Study|Adverse Event|22|||
155305746|NCT02837510|560551146|FG001|Washout (2 Weeks)|Adverse Event|1|||
155305747|NCT02837510|560551145|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155305748|NCT02837510|560551146|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155305749|NCT02837510|560551145|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
155305750|NCT02837510|560551146|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
155413363|NCT01437397|560944766|FG002|Overall Study|Adverse Event|16|||
155413364|NCT01437397|560944767|FG003|Overall Study|Adverse Event|14|||
155305751|NCT02837510|560551145|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
155305752|NCT02837510|560551146|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
155305753|NCT02837510|560551145|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
155305754|NCT02837510|560551146|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
155305755|NCT05419505|560551148|FG000|Overall Study|Adverse Event|0|||
155305756|NCT05419505|560551149|FG001|Overall Study|Adverse Event|0|||
155305757|NCT05419505|560551150|FG002|Overall Study|Adverse Event|0|||
155413365|NCT01437397|560944768|FG004|Overall Study|Adverse Event|21|||
155749567|NCT02119676|562182853|FG000|Overall Study|Noncompliance|0|||
155749568|NCT02119676|562182854|FG001|Overall Study|Noncompliance|1|||
155749569|NCT02119676|562182855|FG002|Overall Study|Noncompliance|0|||
155749570|NCT02119676|562182856|FG003|Overall Study|Noncompliance|0|||
155749571|NCT02119676|562182853|FG000|Overall Study|Lost to Follow-up|0|||
155749572|NCT02119676|562182854|FG001|Overall Study|Lost to Follow-up|0|||
155749573|NCT02119676|562182855|FG002|Overall Study|Lost to Follow-up|1|||
155305758|NCT05419505|560551151|FG003|Overall Study|Adverse Event|1|||
155305759|NCT05419505|560551152|FG004|Overall Study|Adverse Event|0|||
155305760|NCT05419505|560551153|FG005|Overall Study|Adverse Event|0|||
155305761|NCT05419505|560551154|FG006|Overall Study|Adverse Event|0|||
155305762|NCT05419505|560551155|FG007|Overall Study|Adverse Event|0|||
155305763|NCT05419505|560551148|FG000|Overall Study|Withdrawal by Subject|1|||
155305764|NCT05419505|560551149|FG001|Overall Study|Withdrawal by Subject|2|||
155305765|NCT05419505|560551150|FG002|Overall Study|Withdrawal by Subject|0|||
155305766|NCT05419505|560551151|FG003|Overall Study|Withdrawal by Subject|0|||
155305767|NCT05419505|560551152|FG004|Overall Study|Withdrawal by Subject|0|||
155305768|NCT05419505|560551153|FG005|Overall Study|Withdrawal by Subject|0|||
155305769|NCT05419505|560551154|FG006|Overall Study|Withdrawal by Subject|1|||
155305770|NCT05419505|560551155|FG007|Overall Study|Withdrawal by Subject|0|||
155305771|NCT05419505|560551148|FG000|Overall Study|Lost to Follow-up|2|||
155305772|NCT05419505|560551149|FG001|Overall Study|Lost to Follow-up|1|||
155305773|NCT05419505|560551150|FG002|Overall Study|Lost to Follow-up|0|||
155305774|NCT05419505|560551151|FG003|Overall Study|Lost to Follow-up|0|||
155305775|NCT05419505|560551152|FG004|Overall Study|Lost to Follow-up|1|||
155305776|NCT05419505|560551153|FG005|Overall Study|Lost to Follow-up|2|||
155305777|NCT05419505|560551154|FG006|Overall Study|Lost to Follow-up|0|||
155305778|NCT05419505|560551155|FG007|Overall Study|Lost to Follow-up|1|||
155305779|NCT02780388|560551158|FG000|Overall Study|Lost to Follow-up|0|||
155305780|NCT02780388|560551159|FG001|Overall Study|Lost to Follow-up|1|||
155305781|NCT02780388|560551160|FG002|Overall Study|Lost to Follow-up|0|||
155305782|NCT02780388|560551161|FG003|Overall Study|Lost to Follow-up|0|||
155305783|NCT02780388|560551162|FG004|Overall Study|Lost to Follow-up|0|||
155305784|NCT02780388|560551158|FG000|Overall Study|Withdrawal by Subject|1|||
155305785|NCT02780388|560551159|FG001|Overall Study|Withdrawal by Subject|1|||
155305786|NCT02780388|560551160|FG002|Overall Study|Withdrawal by Subject|0|||
155305787|NCT02780388|560551161|FG003|Overall Study|Withdrawal by Subject|0|||
155305788|NCT02780388|560551162|FG004|Overall Study|Withdrawal by Subject|0|||
155305789|NCT04527146|560551163|FG000|Overall Study|Withdrawal by Subject|12|||
155305790|NCT04527146|560551164|FG001|Overall Study|Withdrawal by Subject|15|||
155305791|NCT04527146|560551165|FG002|Overall Study|Withdrawal by Subject|7|||
155305792|NCT04527146|560551166|FG003|Overall Study|Withdrawal by Subject|16|||
155305793|NCT04527146|560551163|FG000|Overall Study|Lost to Follow-up|13|||
155305794|NCT04527146|560551164|FG001|Overall Study|Lost to Follow-up|9|||
155305795|NCT04527146|560551165|FG002|Overall Study|Lost to Follow-up|16|||
155305796|NCT04527146|560551166|FG003|Overall Study|Lost to Follow-up|13|||
155305797|NCT04527146|560551163|FG000|Overall Study|Death|0|||
155305798|NCT04527146|560551164|FG001|Overall Study|Death|1|||
155305799|NCT04527146|560551165|FG002|Overall Study|Death|1|||
155305800|NCT04527146|560551166|FG003|Overall Study|Death|0|||
155305801|NCT04527146|560551163|FG000|Overall Study|Adverse Event|0|||
155305802|NCT04527146|560551164|FG001|Overall Study|Adverse Event|0|||
155305803|NCT04527146|560551165|FG002|Overall Study|Adverse Event|1|||
155305804|NCT04527146|560551166|FG003|Overall Study|Adverse Event|0|||
155305805|NCT04527146|560551163|FG000|Overall Study|Ineligible after randomization|2|||
155305806|NCT04527146|560551164|FG001|Overall Study|Ineligible after randomization|0|||
155305807|NCT04527146|560551165|FG002|Overall Study|Ineligible after randomization|2|||
155305808|NCT04527146|560551166|FG003|Overall Study|Ineligible after randomization|2|||
155305809|NCT04527146|560551163|FG000|Overall Study|Moved to a different group|6|||
155305810|NCT04527146|560551164|FG001|Overall Study|Moved to a different group|3|||
155305811|NCT04527146|560551165|FG002|Overall Study|Moved to a different group|0|||
155305812|NCT04527146|560551166|FG003|Overall Study|Moved to a different group|2|||
155305813|NCT05107401|560551167|FG000|Overall Study|Lost to Follow-up|13|||
155749574|NCT02119676|562182856|FG003|Overall Study|Lost to Follow-up|0|||
155749575|NCT02119676|562182853|FG000|Overall Study|Protocol deviation|0|||
155305814|NCT05107401|560551168|FG001|Overall Study|Lost to Follow-up|12|||
155305815|NCT05510232|560551169|FG000|Overall Study|Withdrawal by Subject|2|||
155749576|NCT02119676|562182854|FG001|Overall Study|Protocol deviation|0|||
155749577|NCT02119676|562182855|FG002|Overall Study|Protocol deviation|1|||
155305816|NCT05510232|560551170|FG001|Overall Study|Withdrawal by Subject|7|||
155305817|NCT05510232|560551171|FG002|Overall Study|Withdrawal by Subject|6|||
155305818|NCT05952076|560551183|FG000|Overall Study|Death|1|||
155305819|NCT05952076|560551184|FG001|Overall Study|Death|1|||
155305820|NCT05952076|560551183|FG000|Overall Study|Lost to Follow-up|0|||
155305821|NCT05952076|560551184|FG001|Overall Study|Lost to Follow-up|1|||
155305822|NCT04143061|560551185|FG000|Overall Study|Protocol Deviation|0|||
155305823|NCT04143061|560551186|FG001|Overall Study|Protocol Deviation|0|||
155305824|NCT04143061|560551187|FG002|Overall Study|Protocol Deviation|0|||
155749578|NCT02119676|562182856|FG003|Overall Study|Protocol deviation|0|||
155305825|NCT04143061|560551188|FG003|Overall Study|Protocol Deviation|0|||
155305826|NCT04143061|560551189|FG004|Overall Study|Protocol Deviation|0|||
155305827|NCT04143061|560551190|FG005|Overall Study|Protocol Deviation|0|||
155305828|NCT04143061|560551191|FG006|Overall Study|Protocol Deviation|5|||
155305829|NCT04143061|560551192|FG007|Overall Study|Protocol Deviation|5|||
155305830|NCT04143061|560551185|FG000|Overall Study|Withdrawal by Subject|2|||
155305831|NCT04143061|560551186|FG001|Overall Study|Withdrawal by Subject|0|||
155305832|NCT04143061|560551187|FG002|Overall Study|Withdrawal by Subject|0|||
155305833|NCT04143061|560551188|FG003|Overall Study|Withdrawal by Subject|0|||
155305834|NCT04143061|560551189|FG004|Overall Study|Withdrawal by Subject|0|||
155305835|NCT04143061|560551190|FG005|Overall Study|Withdrawal by Subject|1|||
155305836|NCT04143061|560551191|FG006|Overall Study|Withdrawal by Subject|0|||
155305837|NCT04143061|560551192|FG007|Overall Study|Withdrawal by Subject|0|||
155305838|NCT04143061|560551185|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155305839|NCT04143061|560551186|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155305840|NCT04143061|560551187|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155305841|NCT04143061|560551188|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155305842|NCT04143061|560551189|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
155305843|NCT04143061|560551190|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
155305844|NCT04143061|560551191|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
155305845|NCT04143061|560551192|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
155305846|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305847|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305848|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305849|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305850|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
155305851|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305852|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305853|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305854|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305855|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
155305856|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305857|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305858|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305859|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305860|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
155305861|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305862|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305863|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305864|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305865|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
155305866|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305867|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305868|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305869|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305870|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
155305871|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305872|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305873|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305874|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305875|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
155305876|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305877|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305878|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155413366|NCT01437397|560944764|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
155413367|NCT01437397|560944765|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
155413368|NCT01437397|560944766|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
155413369|NCT01437397|560944767|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
155413370|NCT01437397|560944768|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
155413371|NCT00866307|560944770|FG000|Induction|Adverse Event|5|||
155305879|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155413372|NCT00866307|560944771|FG001|Induction|Adverse Event|0|||
155413373|NCT00866307|560944772|FG002|Induction|Adverse Event|0|||
155413374|NCT00866307|560944770|FG000|Induction|Death|2|||
155305880|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
155413375|NCT00866307|560944771|FG001|Induction|Death|0|||
155413376|NCT00866307|560944772|FG002|Induction|Death|0|||
155413377|NCT00866307|560944770|FG000|Induction|Physician Decision|5|||
155305881|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305882|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155413378|NCT00866307|560944771|FG001|Induction|Physician Decision|0|||
155305883|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305884|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305885|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
155305886|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305887|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305888|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
155305889|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
155305890|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305891|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155305892|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155497133|NCT02118896|561244032|FG008|Overall Study|Death|0|||
155497134|NCT02118896|561244033|FG009|Overall Study|Death|0|||
155497135|NCT02118896|561244024|FG000|Overall Study|Adverse Event|5|||
155497136|NCT02118896|561244025|FG001|Overall Study|Adverse Event|4|||
155497137|NCT02118896|561244026|FG002|Overall Study|Adverse Event|4|||
155497138|NCT02118896|561244027|FG003|Overall Study|Adverse Event|5|||
155497139|NCT02118896|561244028|FG004|Overall Study|Adverse Event|5|||
155497140|NCT02118896|561244029|FG005|Overall Study|Adverse Event|9|||
155497141|NCT02118896|561244030|FG006|Overall Study|Adverse Event|1|||
155497142|NCT02118896|561244031|FG007|Overall Study|Adverse Event|1|||
155497143|NCT02118896|561244032|FG008|Overall Study|Adverse Event|4|||
155497144|NCT02118896|561244033|FG009|Overall Study|Adverse Event|0|||
155497145|NCT02118896|561244024|FG000|Overall Study|Consent withdrawn|2|||
155497146|NCT02118896|561244025|FG001|Overall Study|Consent withdrawn|0|||
155497147|NCT02118896|561244026|FG002|Overall Study|Consent withdrawn|3|||
155497148|NCT02118896|561244027|FG003|Overall Study|Consent withdrawn|4|||
155497149|NCT02118896|561244028|FG004|Overall Study|Consent withdrawn|1|||
155497150|NCT02118896|561244029|FG005|Overall Study|Consent withdrawn|4|||
155413379|NCT00866307|560944772|FG002|Induction|Physician Decision|0|||
155413380|NCT00866307|560944770|FG000|Induction|Progressive Disease|1|||
155413381|NCT00866307|560944771|FG001|Induction|Progressive Disease|0|||
155413382|NCT00866307|560944772|FG002|Induction|Progressive Disease|0|||
155413383|NCT00866307|560944770|FG000|Induction|Identification of Patients with Day 29 M|3|||
155413384|NCT00866307|560944771|FG001|Induction|Identification of Patients with Day 29 M|0|||
155413385|NCT00866307|560944772|FG002|Induction|Identification of Patients with Day 29 M|0|||
155413386|NCT00866307|560944770|FG000|Induction|Inadequate cytognetic samples th|1|||
155413387|NCT00866307|560944771|FG001|Induction|Inadequate cytognetic samples th|0|||
155413388|NCT00866307|560944772|FG002|Induction|Inadequate cytognetic samples th|0|||
155413389|NCT00866307|560944770|FG000|Induction|Improper post-induction consent|2|||
155413390|NCT00866307|560944771|FG001|Induction|Improper post-induction consent|0|||
155413391|NCT00866307|560944772|FG002|Induction|Improper post-induction consent|0|||
155413392|NCT00866307|560944770|FG000|Induction|Study was closed at the time|1|||
155413393|NCT00866307|560944771|FG001|Induction|Study was closed at the time|0|||
155413394|NCT00866307|560944772|FG002|Induction|Study was closed at the time|0|||
155413395|NCT00866307|560944770|FG000|Consolidation/Maintenance|Adverse Event|0|||
155413396|NCT00866307|560944771|FG001|Consolidation/Maintenance|Adverse Event|0|||
155413397|NCT00866307|560944772|FG002|Consolidation/Maintenance|Adverse Event|8|||
155413398|NCT00866307|560944770|FG000|Consolidation/Maintenance|Death|0|||
155413399|NCT00866307|560944771|FG001|Consolidation/Maintenance|Death|0|||
155413400|NCT00866307|560944772|FG002|Consolidation/Maintenance|Death|1|||
155413401|NCT00866307|560944770|FG000|Consolidation/Maintenance|Physician Decision|0|||
155413402|NCT00866307|560944771|FG001|Consolidation/Maintenance|Physician Decision|3|||
155413403|NCT00866307|560944772|FG002|Consolidation/Maintenance|Physician Decision|2|||
155413404|NCT00866307|560944770|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
155413405|NCT00866307|560944771|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
155413406|NCT00866307|560944772|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
155413407|NCT00866307|560944770|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
155413408|NCT00866307|560944771|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
155413409|NCT00866307|560944772|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
155413410|NCT00866307|560944770|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
155413411|NCT00866307|560944771|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
155413412|NCT00866307|560944772|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
155413413|NCT00866307|560944770|FG000|Consolidation/Maintenance|Therapy error|0|||
155413414|NCT00866307|560944771|FG001|Consolidation/Maintenance|Therapy error|1|||
155413415|NCT00866307|560944772|FG002|Consolidation/Maintenance|Therapy error|0|||
155413416|NCT00866307|560944770|FG000|Consolidation/Maintenance|Non-compliance|0|||
155497151|NCT02118896|561244030|FG006|Overall Study|Consent withdrawn|0|||
155497152|NCT02118896|561244031|FG007|Overall Study|Consent withdrawn|0|||
155413417|NCT00866307|560944771|FG001|Consolidation/Maintenance|Non-compliance|0|||
155413418|NCT00866307|560944772|FG002|Consolidation/Maintenance|Non-compliance|1|||
155497153|NCT02118896|561244032|FG008|Overall Study|Consent withdrawn|0|||
155497154|NCT02118896|561244033|FG009|Overall Study|Consent withdrawn|0|||
155497155|NCT02118896|561244024|FG000|Overall Study|Non-compliance|2|||
155305893|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
155305894|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
155305895|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155305896|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
155305897|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
155305898|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
155305899|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
155305900|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
155305901|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305902|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
155305903|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305904|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305905|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305906|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305907|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305908|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
155305909|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305910|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305911|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
155305912|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
155305913|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
155305914|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
155305915|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
155305916|NCT03289039|560551207|FG000|Overall Study|Withdrawal by Subject|0|||
155305917|NCT03289039|560551208|FG001|Overall Study|Withdrawal by Subject|1|||
155305918|NCT03289039|560551207|FG000|Overall Study|Became ineligible prior to treatment start|0|||
155305919|NCT03289039|560551208|FG001|Overall Study|Became ineligible prior to treatment start|1|||
155305920|NCT03289039|560551207|FG000|Overall Study|progressed before treatment start|1|||
155305921|NCT03289039|560551208|FG001|Overall Study|progressed before treatment start|0|||
155305922|NCT02819843|560551209|FG000|Overall Study|Disease progression before RT|0|||
155305923|NCT02819843|560551210|FG001|Overall Study|Disease progression before RT|1|||
155305924|NCT04732494|560551211|FG000|Overall Study|Death|39|||
155305925|NCT04732494|560551212|FG001|Overall Study|Death|36|||
155305926|NCT04732494|560551211|FG000|Overall Study|Study Closed by Sponsor|20|||
155305927|NCT04732494|560551212|FG001|Overall Study|Study Closed by Sponsor|15|||
155305928|NCT04732494|560551211|FG000|Overall Study|Withdrawal by Subject|2|||
155305929|NCT04732494|560551212|FG001|Overall Study|Withdrawal by Subject|7|||
155305930|NCT04732494|560551211|FG000|Overall Study|Lost to Follow-up|1|||
155305931|NCT04732494|560551212|FG001|Overall Study|Lost to Follow-up|5|||
155305932|NCT03055858|560551213|FG000|Overall Study|Death|9|||
155305933|NCT03055858|560551213|FG000|Overall Study|Withdrawal by Subject|11|||
155305934|NCT03055858|560551213|FG000|Overall Study|Lost to Follow-up|6|||
155305935|NCT03055858|560551213|FG000|Overall Study|Missed Follow-Up Visits|18|||
155305936|NCT04586920|560551214|FG000|Overall Study|Lost to Follow-up|0|||
155305937|NCT04586920|560551215|FG001|Overall Study|Lost to Follow-up|0|||
155305938|NCT04586920|560551216|FG002|Overall Study|Lost to Follow-up|0|||
155305939|NCT04586920|560551217|FG003|Overall Study|Lost to Follow-up|0|||
155305940|NCT04586920|560551218|FG004|Overall Study|Lost to Follow-up|0|||
155305941|NCT04586920|560551219|FG005|Overall Study|Lost to Follow-up|0|||
155305942|NCT04586920|560551220|FG006|Overall Study|Lost to Follow-up|1|||
155305943|NCT04586920|560551221|FG007|Overall Study|Lost to Follow-up|1|||
155305944|NCT04586920|560551222|FG008|Overall Study|Lost to Follow-up|0|||
155305945|NCT04586920|560551223|FG009|Overall Study|Lost to Follow-up|1|||
155305946|NCT04586920|560551224|FG010|Overall Study|Lost to Follow-up|0|||
155305947|NCT04586920|560551225|FG011|Overall Study|Lost to Follow-up|0|||
155305948|NCT04586920|560551226|FG012|Overall Study|Lost to Follow-up|0|||
155305949|NCT04586920|560551227|FG013|Overall Study|Lost to Follow-up|1|||
155305950|NCT04586920|560551228|FG014|Overall Study|Lost to Follow-up|0|||
155305951|NCT04586920|560551229|FG015|Overall Study|Lost to Follow-up|0|||
155305952|NCT04586920|560551230|FG016|Overall Study|Lost to Follow-up|0|||
155305953|NCT04586920|560551231|FG017|Overall Study|Lost to Follow-up|0|||
155305954|NCT04586920|560551214|FG000|Overall Study|Withdrawal by Subject|0|||
155305955|NCT04586920|560551215|FG001|Overall Study|Withdrawal by Subject|0|||
155305956|NCT04586920|560551216|FG002|Overall Study|Withdrawal by Subject|0|||
155305957|NCT04586920|560551217|FG003|Overall Study|Withdrawal by Subject|0|||
155305958|NCT04586920|560551218|FG004|Overall Study|Withdrawal by Subject|0|||
155305959|NCT04586920|560551219|FG005|Overall Study|Withdrawal by Subject|0|||
155305960|NCT04586920|560551220|FG006|Overall Study|Withdrawal by Subject|0|||
155305961|NCT04586920|560551221|FG007|Overall Study|Withdrawal by Subject|1|||
155305962|NCT04586920|560551222|FG008|Overall Study|Withdrawal by Subject|0|||
155305963|NCT04586920|560551223|FG009|Overall Study|Withdrawal by Subject|1|||
155305964|NCT04586920|560551224|FG010|Overall Study|Withdrawal by Subject|0|||
155305965|NCT04586920|560551225|FG011|Overall Study|Withdrawal by Subject|1|||
155305966|NCT04586920|560551226|FG012|Overall Study|Withdrawal by Subject|0|||
155305967|NCT04586920|560551227|FG013|Overall Study|Withdrawal by Subject|0|||
155305968|NCT04586920|560551228|FG014|Overall Study|Withdrawal by Subject|0|||
155305969|NCT04586920|560551229|FG015|Overall Study|Withdrawal by Subject|0|||
155305970|NCT04586920|560551230|FG016|Overall Study|Withdrawal by Subject|0|||
155305971|NCT04586920|560551231|FG017|Overall Study|Withdrawal by Subject|0|||
155305972|NCT05136404|560551237|FG000|Period 1|Adverse Event|0|||
155305973|NCT05136404|560551238|FG001|Period 1|Adverse Event|1|||
155305974|NCT05136404|560551239|FG002|Period 1|Adverse Event|1|||
155305975|NCT05136404|560551237|FG000|Period 2|Inappropriate Behavior|0|||
155305976|NCT05136404|560551238|FG001|Period 2|Inappropriate Behavior|0|||
155305977|NCT05136404|560551239|FG002|Period 2|Inappropriate Behavior|1|||
155305978|NCT05136404|560551237|FG000|Period 3|Adverse Event|0|||
155305979|NCT05136404|560551238|FG001|Period 3|Adverse Event|0|||
155305980|NCT05136404|560551239|FG002|Period 3|Adverse Event|1|||
155305981|NCT02553642|560551240|FG000|Overall Study|Withdrawal by Subject|0|||
155305982|NCT02553642|560551241|FG001|Overall Study|Withdrawal by Subject|3|||
155413419|NCT00866307|560944770|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
155413420|NCT00866307|560944771|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
155413421|NCT00866307|560944772|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
155497156|NCT02118896|561244025|FG001|Overall Study|Non-compliance|1|||
155497157|NCT02118896|561244026|FG002|Overall Study|Non-compliance|1|||
155497158|NCT02118896|561244027|FG003|Overall Study|Non-compliance|5|||
155497159|NCT02118896|561244028|FG004|Overall Study|Non-compliance|0|||
155413422|NCT02573155|560944773|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
155413423|NCT02573155|560944774|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
155413424|NCT02573155|560944773|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
155413425|NCT02573155|560944774|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
155413426|NCT02573155|560944773|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
155413427|NCT02573155|560944774|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
155413428|NCT02573155|560944773|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
155413429|NCT02573155|560944774|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
155413430|NCT02573155|560944773|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
155413431|NCT02573155|560944774|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
155413432|NCT02573155|560944773|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
155413433|NCT02573155|560944774|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
155413434|NCT02573155|560944773|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
155413435|NCT02573155|560944774|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
155413436|NCT02573155|560944773|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
155413437|NCT02573155|560944774|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
155413438|NCT02508194|560944778|FG000|Overall Study|Death|5|||
155413439|NCT02508194|560944779|FG001|Overall Study|Death|3|||
155413440|NCT02508194|560944778|FG000|Overall Study|Lost to Follow-up|25|||
155413441|NCT02508194|560944779|FG001|Overall Study|Lost to Follow-up|18|||
155413442|NCT02508194|560944778|FG000|Overall Study|Withdrawal by Subject|20|||
155413443|NCT02508194|560944779|FG001|Overall Study|Withdrawal by Subject|18|||
155413444|NCT02508194|560944778|FG000|Overall Study|Error in Randomization|1|||
155413445|NCT02508194|560944779|FG001|Overall Study|Error in Randomization|3|||
155413446|NCT02508194|560944778|FG000|Overall Study|Principal Investigator Decision|1|||
155413447|NCT02508194|560944779|FG001|Overall Study|Principal Investigator Decision|2|||
155413448|NCT00511355|560944780|FG000|Overall Study|Adverse Event|4|||
155413449|NCT00511355|560944781|FG001|Overall Study|Adverse Event|4|||
155413450|NCT00511355|560944780|FG000|Overall Study|Pregnancy Wish|1|||
155413451|NCT00511355|560944781|FG001|Overall Study|Pregnancy Wish|0|||
155413452|NCT00511355|560944780|FG000|Overall Study|Lost to Follow-up|2|||
155413453|NCT00511355|560944781|FG001|Overall Study|Lost to Follow-up|1|||
155413454|NCT00511355|560944780|FG000|Overall Study|Other Reason|0|||
155413455|NCT00511355|560944781|FG001|Overall Study|Other Reason|1|||
155413456|NCT00511355|560944780|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
155413457|NCT00511355|560944781|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
155413458|NCT00511355|560944780|FG000|Overall Study|Withdrawal of informed consent|0|||
155413459|NCT00511355|560944781|FG001|Overall Study|Withdrawal of informed consent|1|||
155413460|NCT00511355|560944780|FG000|Overall Study|Other reason pre-treatment|0|||
155413461|NCT00511355|560944781|FG001|Overall Study|Other reason pre-treatment|1|||
155413462|NCT00454805|560944783|FG000|Overall Study|Withdrawal by Subject|9|||
155413463|NCT00454805|560944784|FG001|Overall Study|Withdrawal by Subject|2|||
155413464|NCT00454805|560944783|FG000|Overall Study|Death|0|||
155497160|NCT02118896|561244029|FG005|Overall Study|Non-compliance|1|||
155497161|NCT02118896|561244030|FG006|Overall Study|Non-compliance|0|||
155305983|NCT02553642|560551240|FG000|Overall Study|Physician Decision|0|||
155305984|NCT02553642|560551241|FG001|Overall Study|Physician Decision|1|||
155305985|NCT02553642|560551240|FG000|Overall Study|Additional cancer dx|0|||
155305986|NCT02553642|560551241|FG001|Overall Study|Additional cancer dx|1|||
155305987|NCT02553642|560551240|FG000|Overall Study|Never started treatment|0|||
155305988|NCT02553642|560551241|FG001|Overall Study|Never started treatment|1|||
155305989|NCT01820260|560551244|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305990|NCT01820260|560551245|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305991|NCT01820260|560551246|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305992|NCT01820260|560551247|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305993|NCT01820260|560551248|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305994|NCT01820260|560551249|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305995|NCT01820260|560551250|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
155305996|NCT01820260|560551251|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305997|NCT01820260|560551252|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305998|NCT01820260|560551253|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305999|NCT01820260|560551254|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306000|NCT01820260|560551255|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306001|NCT01820260|560551256|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306002|NCT01820260|560551257|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306003|NCT01820260|560551244|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306004|NCT01820260|560551245|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306005|NCT01820260|560551246|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306006|NCT01820260|560551247|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306007|NCT01820260|560551248|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155413465|NCT00454805|560944784|FG001|Overall Study|Death|2|||
155413466|NCT00454805|560944783|FG000|Overall Study|Disease progression|16|||
155413467|NCT00454805|560944784|FG001|Overall Study|Disease progression|19|||
155413468|NCT00454805|560944783|FG000|Overall Study|In order to begin radiotherapy|1|||
155413469|NCT00454805|560944784|FG001|Overall Study|In order to begin radiotherapy|0|||
155413470|NCT00217087|560944785|FG000|Overall Study|decided to have esophagectomy|1|||
155413471|NCT00217087|560944786|FG001|Overall Study|decided to have esophagectomy|2|||
155413472|NCT00217087|560944785|FG000|Overall Study|completed less than 12 months return|10|||
155413473|NCT00217087|560944786|FG001|Overall Study|completed less than 12 months return|18|||
155497162|NCT02118896|561244031|FG007|Overall Study|Non-compliance|1|||
155497163|NCT02118896|561244032|FG008|Overall Study|Non-compliance|0|||
155497164|NCT02118896|561244033|FG009|Overall Study|Non-compliance|0|||
155497165|NCT02118896|561244024|FG000|Overall Study|Pregnancy|1|||
155497166|NCT02118896|561244025|FG001|Overall Study|Pregnancy|1|||
155497167|NCT02118896|561244026|FG002|Overall Study|Pregnancy|0|||
155497168|NCT02118896|561244027|FG003|Overall Study|Pregnancy|0|||
155497169|NCT02118896|561244028|FG004|Overall Study|Pregnancy|1|||
155497170|NCT02118896|561244029|FG005|Overall Study|Pregnancy|3|||
155497171|NCT02118896|561244030|FG006|Overall Study|Pregnancy|1|||
155497172|NCT02118896|561244031|FG007|Overall Study|Pregnancy|0|||
155497173|NCT02118896|561244032|FG008|Overall Study|Pregnancy|0|||
155497174|NCT02118896|561244033|FG009|Overall Study|Pregnancy|0|||
155497175|NCT02118896|561244024|FG000|Overall Study|Lost to Follow-up|1|||
155497176|NCT02118896|561244025|FG001|Overall Study|Lost to Follow-up|2|||
155497177|NCT02118896|561244026|FG002|Overall Study|Lost to Follow-up|1|||
155497178|NCT02118896|561244027|FG003|Overall Study|Lost to Follow-up|0|||
155497179|NCT02118896|561244028|FG004|Overall Study|Lost to Follow-up|2|||
155497180|NCT02118896|561244029|FG005|Overall Study|Lost to Follow-up|1|||
155413474|NCT04947800|560944793|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
155413475|NCT04947800|560944794|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
155413476|NCT04947800|560944795|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
155413477|NCT03892746|560944796|FG000|Overall Study|Withdrawal by Subject|2|||
155413478|NCT03892746|560944797|FG001|Overall Study|Withdrawal by Subject|1|||
155413479|NCT03892746|560944796|FG000|Overall Study|Lost to Follow-up|2|||
155413480|NCT03892746|560944797|FG001|Overall Study|Lost to Follow-up|0|||
155413481|NCT02158091|560944798|FG000|Overall Study|DLT|2|||
155413482|NCT02158091|560944799|FG001|Overall Study|DLT|1|||
155497181|NCT02118896|561244030|FG006|Overall Study|Lost to Follow-up|0|||
155497182|NCT02118896|561244031|FG007|Overall Study|Lost to Follow-up|0|||
155497183|NCT02118896|561244032|FG008|Overall Study|Lost to Follow-up|0|||
155497184|NCT02118896|561244033|FG009|Overall Study|Lost to Follow-up|0|||
155497185|NCT02118896|561244024|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
155497186|NCT02118896|561244025|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
155497187|NCT02118896|561244026|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
155306008|NCT01820260|560551249|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306009|NCT01820260|560551250|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306010|NCT01820260|560551251|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306011|NCT01820260|560551252|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306012|NCT01820260|560551253|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
155306013|NCT01820260|560551254|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306014|NCT01820260|560551255|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306015|NCT01820260|560551256|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155497188|NCT02118896|561244027|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
155306016|NCT01820260|560551257|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306017|NCT05444192|560551258|FG000|Overall Study|Lost to Follow-up|1|||
155306018|NCT05444192|560551259|FG001|Overall Study|Lost to Follow-up|0|||
155306019|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
155306020|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
155306021|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
155306022|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
155306023|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
155306024|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
155306025|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306026|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
155413483|NCT02158091|560944800|FG002|Overall Study|DLT|0|||
155497189|NCT02118896|561244028|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
155497190|NCT02118896|561244029|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
155497191|NCT02118896|561244030|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
155413484|NCT03977467|560944801|FG000|Overall Study|Disease Progression|1|||
155413485|NCT03977467|560944802|FG001|Overall Study|Disease Progression|1|||
155413486|NCT03977467|560944803|FG002|Overall Study|Disease Progression|30|||
155413487|NCT03977467|560944804|FG003|Overall Study|Disease Progression|0|||
155413488|NCT03977467|560944801|FG000|Overall Study|Adverse Event|0|||
155413489|NCT03977467|560944802|FG001|Overall Study|Adverse Event|1|||
155413490|NCT03977467|560944803|FG002|Overall Study|Adverse Event|0|||
155413491|NCT03977467|560944804|FG003|Overall Study|Adverse Event|0|||
155413492|NCT03977467|560944801|FG000|Overall Study|Death|0|||
155413493|NCT03977467|560944802|FG001|Overall Study|Death|0|||
155413494|NCT03977467|560944803|FG002|Overall Study|Death|3|||
155413495|NCT03977467|560944804|FG003|Overall Study|Death|0|||
155413496|NCT03977467|560944801|FG000|Overall Study|Lack of Efficacy|0|||
155413497|NCT03977467|560944802|FG001|Overall Study|Lack of Efficacy|0|||
155413498|NCT03977467|560944803|FG002|Overall Study|Lack of Efficacy|1|||
155413499|NCT03977467|560944804|FG003|Overall Study|Lack of Efficacy|0|||
155413500|NCT03977467|560944801|FG000|Overall Study|Withdrawal by Subject|2|||
155413501|NCT03977467|560944802|FG001|Overall Study|Withdrawal by Subject|1|||
155413502|NCT03977467|560944803|FG002|Overall Study|Withdrawal by Subject|4|||
155413503|NCT03977467|560944804|FG003|Overall Study|Withdrawal by Subject|0|||
155413504|NCT03977467|560944801|FG000|Overall Study|Study Terminated|1|||
155413505|NCT03977467|560944802|FG001|Overall Study|Study Terminated|0|||
155413506|NCT03977467|560944803|FG002|Overall Study|Study Terminated|0|||
155413507|NCT03977467|560944804|FG003|Overall Study|Study Terminated|1|||
155413508|NCT01318109|560944805|FG000|Overall Study|Adverse Event|0|||
155413509|NCT01318109|560944806|FG001|Overall Study|Adverse Event|2|||
155413510|NCT01318109|560944807|FG002|Overall Study|Adverse Event|0|||
155413511|NCT01318109|560944805|FG000|Overall Study|Withdrawal by Subject|1|||
155413512|NCT01318109|560944806|FG001|Overall Study|Withdrawal by Subject|0|||
155413513|NCT01318109|560944807|FG002|Overall Study|Withdrawal by Subject|0|||
155413514|NCT01318109|560944805|FG000|Overall Study|Schedule Conflict|0|||
155413515|NCT01318109|560944806|FG001|Overall Study|Schedule Conflict|1|||
155413516|NCT01318109|560944807|FG002|Overall Study|Schedule Conflict|0|||
155413517|NCT01328951|560944808|FG000|Overall Study|Disease Progression|17|||
155413518|NCT01328951|560944809|FG001|Overall Study|Disease Progression|14|||
155413519|NCT01328951|560944808|FG000|Overall Study|Adverse Event|2|||
155413520|NCT01328951|560944809|FG001|Overall Study|Adverse Event|0|||
155413521|NCT01328951|560944808|FG000|Overall Study|Death|243|||
155413522|NCT01328951|560944809|FG001|Overall Study|Death|258|||
155413523|NCT01328951|560944808|FG000|Overall Study|Lost to Follow-up|6|||
155413524|NCT01328951|560944809|FG001|Overall Study|Lost to Follow-up|7|||
155413525|NCT01328951|560944808|FG000|Overall Study|Withdrawal by Subject|6|||
155497192|NCT02118896|561244031|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
155749579|NCT02119676|562182853|FG000|Overall Study|Other, unspecified|2|||
155306027|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306028|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306029|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
155306030|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306031|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306032|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306033|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306034|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
155413526|NCT01328951|560944809|FG001|Overall Study|Withdrawal by Subject|6|||
155413527|NCT01328951|560944808|FG000|Overall Study|Study Closed by the Sponsor|36|||
155413528|NCT01328951|560944809|FG001|Overall Study|Study Closed by the Sponsor|31|||
155413529|NCT01328951|560944808|FG000|Overall Study|Other|11|||
155413530|NCT01328951|560944809|FG001|Overall Study|Other|6|||
155413531|NCT00861744|560944825|FG000|Overall Study|Adverse Event|0|||
155413532|NCT00861744|560944826|FG001|Overall Study|Adverse Event|0|||
155413533|NCT00861744|560944827|FG002|Overall Study|Adverse Event|0|||
155413534|NCT00861744|560944828|FG003|Overall Study|Adverse Event|1|||
155413535|NCT00861744|560944825|FG000|Overall Study|Lost to Follow-up|7|||
155413536|NCT00861744|560944826|FG001|Overall Study|Lost to Follow-up|19|||
155642182|NCT01471574|561780732|FG000|Follow-up Period|Follow-up no longer required|0|||
155642183|NCT01471574|561780733|FG001|Follow-up Period|Follow-up no longer required|1|||
155642184|NCT01471574|561780734|FG002|Follow-up Period|Follow-up no longer required|0|||
155642185|NCT01471574|561780735|FG003|Follow-up Period|Follow-up no longer required|0|||
155642186|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
155306035|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306036|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306037|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306038|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306039|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306040|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
155306041|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
155306042|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306043|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306044|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
155306045|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
155306046|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
155306047|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
155306048|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
155306049|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306050|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
155306051|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306052|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306053|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
155306054|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Other|0|||
155306055|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Other|1|||
155306056|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Other|3|||
155306057|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Other|1|||
155306058|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Other|0|||
155306059|NCT00894543|560551272|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
155306060|NCT00894543|560551273|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
155306061|NCT00894543|560551272|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
155306062|NCT00894543|560551273|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
155306063|NCT04048681|560551274|FG000|Overall Study|family emergency|0|||
155306064|NCT04048681|560551275|FG001|Overall Study|family emergency|0|||
155306065|NCT04048681|560551276|FG002|Overall Study|family emergency|0|||
155306066|NCT04048681|560551277|FG003|Overall Study|family emergency|1|||
155306067|NCT04048681|560551278|FG004|Overall Study|family emergency|0|||
155306068|NCT03380390|560551279|FG000|Overall Study|Adverse Event|3|||
155306069|NCT02886286|560551280|FG000|Overall Study|pump motor stall|0|||
155306070|NCT02886286|560551281|FG001|Overall Study|pump motor stall|1|||
155306071|NCT01771731|560551282|FG000|Overall Study|Physician Decision|1|||
155306072|NCT01771731|560551283|FG001|Overall Study|Physician Decision|0|||
155306073|NCT01771731|560551282|FG000|Overall Study|Protocol Violation|0|||
155306074|NCT01771731|560551283|FG001|Overall Study|Protocol Violation|1|||
155306075|NCT01771731|560551282|FG000|Overall Study|Adverse event: Pain Crisis|1|||
155306076|NCT01771731|560551283|FG001|Overall Study|Adverse event: Pain Crisis|1|||
155306077|NCT00976495|560551284|FG000|Overall Study|Withdrawal by Subject|0|||
155306078|NCT00976495|560551285|FG001|Overall Study|Withdrawal by Subject|1|||
155642187|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
155642188|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
155642189|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
155306079|NCT00976495|560551286|FG002|Overall Study|Withdrawal by Subject|0|||
155306080|NCT05321069|560551287|FG000|Overall Study|Adverse Event|52|||
155306081|NCT05321069|560551288|FG001|Overall Study|Adverse Event|52|||
155306082|NCT05321069|560551289|FG002|Overall Study|Adverse Event|64|||
155306083|NCT05321069|560551287|FG000|Overall Study|Protocol Violation|1|||
155306084|NCT05321069|560551288|FG001|Overall Study|Protocol Violation|1|||
155306085|NCT05321069|560551289|FG002|Overall Study|Protocol Violation|0|||
155306086|NCT05321069|560551287|FG000|Overall Study|Withdrawal by Subject|23|||
155306087|NCT05321069|560551288|FG001|Overall Study|Withdrawal by Subject|18|||
155306088|NCT05321069|560551289|FG002|Overall Study|Withdrawal by Subject|12|||
155306089|NCT05321069|560551287|FG000|Overall Study|Lost to Follow-up|1|||
155306090|NCT05321069|560551288|FG001|Overall Study|Lost to Follow-up|0|||
155306091|NCT05321069|560551289|FG002|Overall Study|Lost to Follow-up|1|||
155306092|NCT05321069|560551287|FG000|Overall Study|No reason stated by the participants|23|||
155306093|NCT05321069|560551288|FG001|Overall Study|No reason stated by the participants|22|||
155306094|NCT05321069|560551289|FG002|Overall Study|No reason stated by the participants|16|||
155306095|NCT05321069|560551287|FG000|Overall Study|Lack of Efficacy|1|||
155306096|NCT05321069|560551288|FG001|Overall Study|Lack of Efficacy|1|||
155413537|NCT00861744|560944827|FG002|Overall Study|Lost to Follow-up|17|||
155306097|NCT05321069|560551289|FG002|Overall Study|Lack of Efficacy|0|||
155749580|NCT02119676|562182854|FG001|Overall Study|Other, unspecified|1|||
155306098|NCT01044303|560551292|FG000|Overall Study|Lost to Follow-up|2|||
155306099|NCT01609218|560551293|FG000|Period 1|Adverse Event|3|||
155306100|NCT01609218|560551294|FG001|Period 1|Adverse Event|5|||
155306101|NCT01609218|560551293|FG000|Period 1|Sponsor Decision|0|||
155306102|NCT01609218|560551294|FG001|Period 1|Sponsor Decision|1|||
155306103|NCT01609218|560551293|FG000|Period 2|Adverse Event|1|||
155306104|NCT01609218|560551294|FG001|Period 2|Adverse Event|0|||
155306105|NCT00774852|560551297|FG000|Overall Study|Adverse Event|9|||
155306106|NCT00774852|560551298|FG001|Overall Study|Adverse Event|6|||
155642190|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
155642191|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
155642192|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
155642193|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
155306107|NCT00774852|560551297|FG000|Overall Study|Death|2|||
155642194|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
155306108|NCT00774852|560551298|FG001|Overall Study|Death|1|||
155306109|NCT00774852|560551297|FG000|Overall Study|Lack of Efficacy|3|||
155306110|NCT00774852|560551298|FG001|Overall Study|Lack of Efficacy|7|||
155306111|NCT00774852|560551297|FG000|Overall Study|Lost to Follow-up|9|||
155306112|NCT00774852|560551298|FG001|Overall Study|Lost to Follow-up|5|||
155306113|NCT00774852|560551297|FG000|Overall Study|Physician Decision|2|||
155306114|NCT00774852|560551298|FG001|Overall Study|Physician Decision|6|||
155642195|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
155642196|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
155306115|NCT00774852|560551297|FG000|Overall Study|Pregnancy|1|||
155306116|NCT00774852|560551298|FG001|Overall Study|Pregnancy|2|||
155306117|NCT00774852|560551297|FG000|Overall Study|Withdrawal by Subject|2|||
155306118|NCT00774852|560551298|FG001|Overall Study|Withdrawal by Subject|2|||
155306119|NCT00774852|560551297|FG000|Overall Study|Non-responder|15|||
155306120|NCT00774852|560551298|FG001|Overall Study|Non-responder|11|||
155306121|NCT00774852|560551297|FG000|Overall Study|Subject non-compliance|0|||
155306122|NCT00774852|560551298|FG001|Overall Study|Subject non-compliance|1|||
155306123|NCT00774852|560551297|FG000|Overall Study|Protocol Violation|1|||
155306124|NCT00774852|560551298|FG001|Overall Study|Protocol Violation|0|||
155306125|NCT00774852|560551297|FG000|Overall Study|Subject received prohibited medication|1|||
155306126|NCT00774852|560551298|FG001|Overall Study|Subject received prohibited medication|0|||
155306127|NCT04428112|560551299|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
155306128|NCT04428112|560551300|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
155306129|NCT04428112|560551299|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
155306130|NCT04428112|560551300|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
155306131|NCT04428112|560551299|FG000|Overall Study|Withdrawal by Subject|9|||
155306132|NCT04428112|560551300|FG001|Overall Study|Withdrawal by Subject|4|||
155306133|NCT04428112|560551299|FG000|Overall Study|Lost to Follow-up|27|||
155306134|NCT04428112|560551300|FG001|Overall Study|Lost to Follow-up|7|||
155306135|NCT02807779|560551302|FG000|Overall Study|Lost to Follow-up|1|||
155306136|NCT02807779|560551303|FG001|Overall Study|Lost to Follow-up|0|||
155306137|NCT02807779|560551304|FG002|Overall Study|Lost to Follow-up|0|||
155306138|NCT02807779|560551302|FG000|Overall Study|Physician Decision|2|||
155306139|NCT02807779|560551303|FG001|Overall Study|Physician Decision|0|||
155306140|NCT02807779|560551304|FG002|Overall Study|Physician Decision|1|||
155306141|NCT02807779|560551302|FG000|Overall Study|Death|1|||
155306142|NCT02807779|560551303|FG001|Overall Study|Death|1|||
155306143|NCT02807779|560551304|FG002|Overall Study|Death|0|||
155306144|NCT03582722|560551305|FG000|Overall Study|Lost to Follow-up|1|||
155306145|NCT03582722|560551306|FG001|Overall Study|Lost to Follow-up|4|||
155306146|NCT03582722|560551305|FG000|Overall Study|Withdrawal by Subject|3|||
155306147|NCT03582722|560551306|FG001|Overall Study|Withdrawal by Subject|3|||
155306148|NCT06024174|560551307|FG000|Overall Study|Other Reasons|1|||
155306149|NCT06024174|560551307|FG000|Overall Study|Study terminated by Sponsor|4|||
155306150|NCT01649271|560553310|FG000|Overall Study|Progressive disease|4|||
155306151|NCT01649271|560553311|FG001|Overall Study|Progressive disease|5|||
155306152|NCT01649271|560553310|FG000|Overall Study|Other Adverse Event|0|||
155306153|NCT01649271|560553311|FG001|Overall Study|Other Adverse Event|2|||
155306154|NCT01649271|560553310|FG000|Overall Study|Withdrawal by Subject|1|||
155306155|NCT01649271|560553311|FG001|Overall Study|Withdrawal by Subject|0|||
155306156|NCT01649271|560553310|FG000|Overall Study|Other than stated above|1|||
155306157|NCT01649271|560553311|FG001|Overall Study|Other than stated above|0|||
155306158|NCT05644002|560553312|FG000|Overall Study|Lost to Follow-up|1|||
155306159|NCT05644002|560553313|FG001|Overall Study|Lost to Follow-up|2|||
155306160|NCT05644002|560553312|FG000|Overall Study|Withdrawal by Subject|0|||
155306161|NCT05644002|560553313|FG001|Overall Study|Withdrawal by Subject|1|||
155306162|NCT04038957|560553316|FG000|Overall Study|Withdrawal by Subject|1|||
155306163|NCT04038957|560553316|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
155306164|NCT03913195|560553317|FG000|Overall Study|Adverse Event|0|||
155306165|NCT03913195|560553318|FG001|Overall Study|Adverse Event|0|||
155642197|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
155306166|NCT03913195|560553319|FG002|Overall Study|Adverse Event|1|||
155306167|NCT03913195|560553320|FG003|Overall Study|Adverse Event|1|||
155306168|NCT03913195|560553321|FG004|Overall Study|Adverse Event|0|||
155306169|NCT03913195|560553317|FG000|Overall Study|Withdrawal by Subject|0|||
155306170|NCT03913195|560553318|FG001|Overall Study|Withdrawal by Subject|0|||
155306171|NCT03913195|560553319|FG002|Overall Study|Withdrawal by Subject|1|||
155306172|NCT03913195|560553320|FG003|Overall Study|Withdrawal by Subject|0|||
155306173|NCT03913195|560553321|FG004|Overall Study|Withdrawal by Subject|1|||
155306174|NCT03913195|560553317|FG000|Overall Study|non adherence to study|0|||
155306175|NCT03913195|560553318|FG001|Overall Study|non adherence to study|0|||
155306176|NCT03913195|560553319|FG002|Overall Study|non adherence to study|1|||
155306177|NCT03913195|560553320|FG003|Overall Study|non adherence to study|0|||
155306178|NCT03913195|560553321|FG004|Overall Study|non adherence to study|0|||
155306179|NCT04840199|560553322|FG000|Overall Study|Study Terminated by Sponsor|8|||
155306180|NCT04840199|560553323|FG001|Overall Study|Study Terminated by Sponsor|9|||
155306181|NCT04840199|560553322|FG000|Overall Study|Lost to Follow-up|0|||
155306182|NCT04840199|560553323|FG001|Overall Study|Lost to Follow-up|2|||
155306183|NCT04840199|560553322|FG000|Overall Study|Withdrawal by Subject|2|||
155306184|NCT04840199|560553323|FG001|Overall Study|Withdrawal by Subject|0|||
155306185|NCT04840199|560553322|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
155306186|NCT04840199|560553323|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
155306187|NCT03857620|560553324|FG000|Overall Study|Death|4|||
155306188|NCT03857620|560553325|FG001|Overall Study|Death|5|||
155306189|NCT03857620|560553326|FG002|Overall Study|Death|7|||
155306190|NCT03857620|560553324|FG000|Overall Study|Lost to Follow-up|2|||
155306191|NCT03857620|560553325|FG001|Overall Study|Lost to Follow-up|5|||
155306192|NCT03857620|560553326|FG002|Overall Study|Lost to Follow-up|3|||
155306193|NCT03857620|560553324|FG000|Overall Study|Disease progression or relapse after study registration|1|||
155306194|NCT03857620|560553325|FG001|Overall Study|Disease progression or relapse after study registration|5|||
155306195|NCT03857620|560553326|FG002|Overall Study|Disease progression or relapse after study registration|1|||
155306196|NCT03857620|560553324|FG000|Overall Study|Ineligible|5|||
155306197|NCT03857620|560553325|FG001|Overall Study|Ineligible|0|||
155306198|NCT03857620|560553326|FG002|Overall Study|Ineligible|2|||
155306199|NCT03857620|560553324|FG000|Overall Study|No malignancy|1|||
155306200|NCT03857620|560553325|FG001|Overall Study|No malignancy|0|||
155306201|NCT03857620|560553326|FG002|Overall Study|No malignancy|1|||
155306202|NCT03857620|560553324|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
155306203|NCT03857620|560553325|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
155306204|NCT03857620|560553326|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
155306205|NCT03857620|560553324|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
155306206|NCT03857620|560553325|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
155306207|NCT03857620|560553326|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
155306208|NCT03857620|560553324|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
155306209|NCT03857620|560553325|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
155413538|NCT00861744|560944828|FG003|Overall Study|Lost to Follow-up|12|||
155413539|NCT00861744|560944825|FG000|Overall Study|Withdrawal by Subject|10|||
155413540|NCT00861744|560944826|FG001|Overall Study|Withdrawal by Subject|6|||
155413541|NCT00861744|560944827|FG002|Overall Study|Withdrawal by Subject|6|||
155413542|NCT00861744|560944828|FG003|Overall Study|Withdrawal by Subject|19|||
155413543|NCT00861744|560944825|FG000|Overall Study|Protocol Violation|0|||
155413544|NCT00861744|560944826|FG001|Overall Study|Protocol Violation|1|||
155413545|NCT00861744|560944827|FG002|Overall Study|Protocol Violation|0|||
155413546|NCT00861744|560944828|FG003|Overall Study|Protocol Violation|0|||
155749581|NCT02119676|562182855|FG002|Overall Study|Other, unspecified|3|||
155306210|NCT03857620|560553326|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
155306211|NCT03857620|560553324|FG000|Overall Study|Surgery not performed, patient decision|0|||
155306212|NCT03857620|560553325|FG001|Overall Study|Surgery not performed, patient decision|3|||
155306213|NCT03857620|560553326|FG002|Overall Study|Surgery not performed, patient decision|1|||
155306214|NCT03857620|560553324|FG000|Overall Study|Surgery not performed, other reason|3|||
155306215|NCT03857620|560553325|FG001|Overall Study|Surgery not performed, other reason|1|||
155306216|NCT03857620|560553326|FG002|Overall Study|Surgery not performed, other reason|4|||
155306217|NCT03857620|560553324|FG000|Overall Study|Worsening performance status after surgery performed|0|||
155306218|NCT03857620|560553325|FG001|Overall Study|Worsening performance status after surgery performed|1|||
155306219|NCT03857620|560553326|FG002|Overall Study|Worsening performance status after surgery performed|1|||
155306220|NCT03271151|560553327|FG000|Overall Study|Lost to Follow-up|1|||
155306221|NCT03271151|560553328|FG001|Overall Study|Lost to Follow-up|3|||
155306222|NCT03271151|560553327|FG000|Overall Study|Withdrawal by Subject|1|||
155306223|NCT03271151|560553328|FG001|Overall Study|Withdrawal by Subject|0|||
155306224|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
155413547|NCT00861744|560944825|FG000|Overall Study|Migration from study area|0|||
155413548|NCT00861744|560944826|FG001|Overall Study|Migration from study area|3|||
155306225|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
155306226|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
155306227|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
155306228|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
155306229|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
155306230|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
155306231|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
155306232|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
155306233|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
155306234|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
155306235|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
155306236|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
155306237|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
155497193|NCT02118896|561244032|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
155497194|NCT02118896|561244033|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
155497195|NCT02118896|561244024|FG000|Overall Study|Prohibited medication|0|||
155497196|NCT02118896|561244025|FG001|Overall Study|Prohibited medication|0|||
155497197|NCT02118896|561244026|FG002|Overall Study|Prohibited medication|0|||
155497198|NCT02118896|561244027|FG003|Overall Study|Prohibited medication|0|||
155497199|NCT02118896|561244028|FG004|Overall Study|Prohibited medication|1|||
155497200|NCT02118896|561244029|FG005|Overall Study|Prohibited medication|3|||
155497201|NCT02118896|561244030|FG006|Overall Study|Prohibited medication|0|||
155497202|NCT02118896|561244031|FG007|Overall Study|Prohibited medication|0|||
155497203|NCT02118896|561244032|FG008|Overall Study|Prohibited medication|0|||
155497204|NCT02118896|561244033|FG009|Overall Study|Prohibited medication|0|||
155497205|NCT02118896|561244024|FG000|Overall Study|Miscellaneous|1|||
155497206|NCT02118896|561244025|FG001|Overall Study|Miscellaneous|2|||
155497207|NCT02118896|561244026|FG002|Overall Study|Miscellaneous|0|||
155497208|NCT02118896|561244027|FG003|Overall Study|Miscellaneous|2|||
155497209|NCT02118896|561244028|FG004|Overall Study|Miscellaneous|0|||
155497210|NCT02118896|561244029|FG005|Overall Study|Miscellaneous|4|||
155497211|NCT02118896|561244030|FG006|Overall Study|Miscellaneous|0|||
155497212|NCT02118896|561244031|FG007|Overall Study|Miscellaneous|0|||
155497213|NCT02118896|561244032|FG008|Overall Study|Miscellaneous|0|||
155497214|NCT02118896|561244033|FG009|Overall Study|Miscellaneous|0|||
155497215|NCT00572910|561244034|FG000|Overall Study|Adverse Event|1|||
155497216|NCT00572910|561244035|FG001|Overall Study|Adverse Event|2|||
155497217|NCT00572910|561244036|FG002|Overall Study|Adverse Event|0|||
155497218|NCT00572910|561244037|FG003|Overall Study|Adverse Event|2|||
155497219|NCT00572910|561244038|FG004|Overall Study|Adverse Event|0|||
155497220|NCT00572910|561244039|FG005|Overall Study|Adverse Event|0|||
155497221|NCT00572910|561244040|FG006|Overall Study|Adverse Event|4|||
155497222|NCT00572910|561244041|FG007|Overall Study|Adverse Event|2|||
155497223|NCT00572910|561244042|FG008|Overall Study|Adverse Event|1|||
155497224|NCT00572910|561244043|FG009|Overall Study|Adverse Event|3|||
155306238|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
155306239|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Other reason|4|||
155306240|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Other reason|7|||
155306241|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Other reason|0|||
155306242|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
155306243|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
155306244|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
155306245|NCT02201108|560553331|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
155306246|NCT02201108|560553332|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
155306247|NCT02201108|560553333|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
155306248|NCT02201108|560553331|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
155306249|NCT02201108|560553332|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
155306250|NCT02201108|560553333|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
155306251|NCT04118452|560553334|FG000|Overall Study|Lost to Follow-up|5|||
155306252|NCT04118452|560553335|FG001|Overall Study|Lost to Follow-up|5|||
155306253|NCT04118452|560553334|FG000|Overall Study|Withdrawal by Subject|17|||
155306254|NCT04118452|560553335|FG001|Overall Study|Withdrawal by Subject|17|||
155306255|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
155306256|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
155497225|NCT00572910|561244044|FG010|Overall Study|Adverse Event|2|||
155497226|NCT00572910|561244034|FG000|Overall Study|Lost to Follow-up|0|||
155497227|NCT00572910|561244035|FG001|Overall Study|Lost to Follow-up|1|||
155497228|NCT00572910|561244036|FG002|Overall Study|Lost to Follow-up|1|||
155497229|NCT00572910|561244037|FG003|Overall Study|Lost to Follow-up|2|||
155497230|NCT00572910|561244038|FG004|Overall Study|Lost to Follow-up|1|||
155497231|NCT00572910|561244039|FG005|Overall Study|Lost to Follow-up|0|||
155497232|NCT00572910|561244040|FG006|Overall Study|Lost to Follow-up|0|||
155497233|NCT00572910|561244041|FG007|Overall Study|Lost to Follow-up|0|||
155497234|NCT00572910|561244042|FG008|Overall Study|Lost to Follow-up|0|||
155497235|NCT00572910|561244043|FG009|Overall Study|Lost to Follow-up|1|||
155497236|NCT00572910|561244044|FG010|Overall Study|Lost to Follow-up|0|||
155497237|NCT00572910|561244034|FG000|Overall Study|Withdrawal by Subject|3|||
155497238|NCT00572910|561244035|FG001|Overall Study|Withdrawal by Subject|0|||
155497239|NCT00572910|561244036|FG002|Overall Study|Withdrawal by Subject|1|||
155497240|NCT00572910|561244037|FG003|Overall Study|Withdrawal by Subject|0|||
155497241|NCT00572910|561244038|FG004|Overall Study|Withdrawal by Subject|1|||
155497242|NCT00572910|561244039|FG005|Overall Study|Withdrawal by Subject|3|||
155497243|NCT00572910|561244040|FG006|Overall Study|Withdrawal by Subject|0|||
155497244|NCT00572910|561244041|FG007|Overall Study|Withdrawal by Subject|2|||
155497245|NCT00572910|561244042|FG008|Overall Study|Withdrawal by Subject|2|||
155497246|NCT00572910|561244043|FG009|Overall Study|Withdrawal by Subject|2|||
155497247|NCT00572910|561244044|FG010|Overall Study|Withdrawal by Subject|1|||
155497248|NCT02230332|561244045|FG000|Overall Study|Adverse Event|2|||
155497249|NCT02230332|561244046|FG001|Overall Study|Adverse Event|1|||
155497250|NCT02230332|561244045|FG000|Overall Study|Lost to Follow-up|1|||
155497251|NCT02230332|561244046|FG001|Overall Study|Lost to Follow-up|0|||
155497252|NCT02230332|561244045|FG000|Overall Study|Protocol Violation|1|||
155497253|NCT02230332|561244046|FG001|Overall Study|Protocol Violation|0|||
155497254|NCT01260194|561244049|FG000|Overall Study|Withdrawal of Consent|1|||
155497255|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
155497256|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
155497257|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
155497258|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
155497259|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
155497260|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
155413549|NCT00861744|560944827|FG002|Overall Study|Migration from study area|1|||
155413550|NCT00861744|560944828|FG003|Overall Study|Migration from study area|0|||
155413551|NCT00861744|560944825|FG000|Overall Study|Blood draws|0|||
155413552|NCT00861744|560944826|FG001|Overall Study|Blood draws|0|||
155497261|NCT00566631|561244050|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
155642198|NCT00447278|561780738|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
155642199|NCT00447278|561780739|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
155642200|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
155413553|NCT00861744|560944827|FG002|Overall Study|Blood draws|0|||
155413554|NCT00861744|560944828|FG003|Overall Study|Blood draws|1|||
155413555|NCT03359759|560944829|FG000|Overall Study|Death|3|||
155413556|NCT03359759|560944829|FG000|Overall Study|Lost to Follow-up|2|||
155413557|NCT05568888|560944830|FG000|Overall Study|Physician Decision|1|||
155413558|NCT05568888|560944831|FG001|Overall Study|Physician Decision|0|||
155413559|NCT05568888|560944830|FG000|Overall Study|Protocol Deviation|2|||
155413560|NCT05568888|560944831|FG001|Overall Study|Protocol Deviation|1|||
155413561|NCT05568888|560944830|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
155413562|NCT05568888|560944831|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
155413563|NCT05568888|560944830|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
155413564|NCT05568888|560944831|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
155413565|NCT05568888|560944830|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
155413566|NCT05568888|560944831|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
155413567|NCT02396589|560944833|FG000|Intervention|Lost to Follow-up|1|||
155413568|NCT02396589|560944834|FG001|Intervention|Lost to Follow-up|0|||
155413569|NCT02396589|560944833|FG000|6 Month Follow-up|change in health status|0|||
155413570|NCT02396589|560944834|FG001|6 Month Follow-up|change in health status|1|||
155413571|NCT02396589|560944833|FG000|9 Month Follow-up|Death|0|||
155413572|NCT02396589|560944834|FG001|9 Month Follow-up|Death|1|||
155413573|NCT02396589|560944833|FG000|12 Month Follow up|Lost to Follow-up|0|||
155413574|NCT02396589|560944834|FG001|12 Month Follow up|Lost to Follow-up|2|||
155413575|NCT04381650|560944835|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413576|NCT04381650|560944836|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413577|NCT04381650|560944837|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413578|NCT04381650|560944838|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
155413579|NCT04381650|560944839|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413580|NCT04381650|560944840|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413581|NCT04381650|560944841|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155642201|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
155642202|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
155642203|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
155413582|NCT04381650|560944842|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155497262|NCT00566631|561244050|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
155497263|NCT00566631|561244050|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
155497264|NCT00566631|561244050|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
155497265|NCT00566631|561244050|FG000|Part 2: Extension Phase|Adverse Event|11|||
155497266|NCT00566631|561244050|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
155306257|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
155306258|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
155306259|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
155306260|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
155306261|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
155306262|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
155306263|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
155306264|NCT03438188|560553336|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
155306265|NCT03438188|560553337|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
155306266|NCT03438188|560553338|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
155306267|NCT03438188|560553336|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
155306268|NCT03438188|560553337|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
155306269|NCT03438188|560553338|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
155306270|NCT05215847|560553339|FG000|Overall Study|Lost to Follow-up|1|||
155306271|NCT03433339|560553340|FG000|Overall Study|Lost to Follow-up|2|||
155306272|NCT03433339|560553341|FG001|Overall Study|Lost to Follow-up|0|||
155306273|NCT03433339|560553340|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
155306274|NCT03433339|560553341|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
155306275|NCT03433339|560553340|FG000|Overall Study|Withdrawal by Subject|0|||
155306276|NCT03433339|560553341|FG001|Overall Study|Withdrawal by Subject|2|||
155306277|NCT00150813|560553356|FG000|Overall Study|Adverse Event|1|||
155306278|NCT00150813|560553356|FG000|Overall Study|Lack of Efficacy|1|||
155306279|NCT00150813|560553356|FG000|Overall Study|Lost to Follow-up|5|||
155306280|NCT00150813|560553356|FG000|Overall Study|Withdrawal by Subject|5|||
155306281|NCT00150813|560553356|FG000|Overall Study|Remission|3|||
155306282|NCT00150813|560553356|FG000|Overall Study|Planned pregancy|1|||
155306283|NCT00150813|560553356|FG000|Overall Study|Switch to commercially available LEV|2|||
155306284|NCT01046136|560553364|FG000|Overall Study|Withdrawal by Subject|0|||
155306285|NCT01046136|560553365|FG001|Overall Study|Withdrawal by Subject|4|||
155306286|NCT01046136|560553364|FG000|Overall Study|Physician Decision|1|||
155306287|NCT01046136|560553365|FG001|Overall Study|Physician Decision|1|||
155306288|NCT01046136|560553364|FG000|Overall Study|Lost to Follow-up|3|||
155306289|NCT01046136|560553365|FG001|Overall Study|Lost to Follow-up|3|||
155306290|NCT04579250|560553366|FG000|Overall Study|Withdrawal by Subject|1|||
155306291|NCT04579250|560553367|FG001|Overall Study|Withdrawal by Subject|1|||
155306292|NCT04579250|560553368|FG002|Overall Study|Withdrawal by Subject|0|||
155306293|NCT04579250|560553366|FG000|Overall Study|Lost to Follow-up|1|||
155306294|NCT04579250|560553367|FG001|Overall Study|Lost to Follow-up|1|||
155306295|NCT04579250|560553368|FG002|Overall Study|Lost to Follow-up|0|||
155306296|NCT04579250|560553366|FG000|Overall Study|Moved from area|0|||
155306297|NCT04579250|560553367|FG001|Overall Study|Moved from area|1|||
155306298|NCT04579250|560553368|FG002|Overall Study|Moved from area|2|||
155306299|NCT02919449|560553369|FG000|Overall Study|Withdrawal by Subject|1|||
155306300|NCT02919449|560553369|FG000|Overall Study|Investigator decision|1|||
155306301|NCT02058108|560553370|FG000|Overall Study|Abnormal Laboratory Values|0|||
155306302|NCT02058108|560553371|FG001|Overall Study|Abnormal Laboratory Values|1|||
155306303|NCT02058108|560553370|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
155306304|NCT02058108|560553371|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155306305|NCT02058108|560553370|FG000|Overall Study|No longer requires study drug|0|||
155306306|NCT02058108|560553371|FG001|Overall Study|No longer requires study drug|1|||
155306307|NCT02058108|560553370|FG000|Overall Study|Withdrawal by Subject|1|||
155642204|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
155306308|NCT02058108|560553371|FG001|Overall Study|Withdrawal by Subject|0|||
155306309|NCT02058108|560553370|FG000|Overall Study|Administrative problems|3|||
155306310|NCT02058108|560553371|FG001|Overall Study|Administrative problems|3|||
155306311|NCT02058108|560553370|FG000|Overall Study|Protocol Violation|0|||
155497267|NCT00566631|561244050|FG000|Part 2: Extension Phase|Death|1|||
155497268|NCT00566631|561244050|FG000|Part 2: Extension Phase|Other|5|||
155497269|NCT00877799|561244051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
155497270|NCT00877799|561244052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
155497271|NCT00877799|561244053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
155497272|NCT00877799|561244054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
155497273|NCT00877799|561244055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
155497274|NCT00877799|561244051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
155497275|NCT00877799|561244052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
155497276|NCT00877799|561244053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
155497277|NCT00877799|561244054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
155497278|NCT00877799|561244055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
155497279|NCT00877799|561244051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
155497280|NCT00877799|561244052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
155497281|NCT00877799|561244053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
155497282|NCT00877799|561244054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
155497283|NCT00877799|561244055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
155497284|NCT00877799|561244051|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
155413583|NCT04381650|560944843|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413584|NCT04381650|560944844|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413585|NCT04381650|560944845|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
155413586|NCT04381650|560944835|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413587|NCT04381650|560944836|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413588|NCT04381650|560944837|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413589|NCT04381650|560944838|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
155413590|NCT04381650|560944839|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413591|NCT04381650|560944840|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413592|NCT04381650|560944841|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413593|NCT04381650|560944842|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413594|NCT04381650|560944843|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413595|NCT04381650|560944844|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413596|NCT04381650|560944845|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
155413597|NCT04381650|560944835|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
155413598|NCT04381650|560944836|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
155413599|NCT04381650|560944837|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
155413600|NCT04381650|560944838|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
155413601|NCT04381650|560944839|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413602|NCT04381650|560944840|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413603|NCT04381650|560944841|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413604|NCT04381650|560944842|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413605|NCT04381650|560944843|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413606|NCT04381650|560944844|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413607|NCT04381650|560944845|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
155413608|NCT04381650|560944835|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413609|NCT04381650|560944836|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413610|NCT04381650|560944837|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
155413611|NCT04381650|560944838|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
155413612|NCT04381650|560944839|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413613|NCT04381650|560944840|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413614|NCT04381650|560944841|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413615|NCT04381650|560944842|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413616|NCT04381650|560944843|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413617|NCT04381650|560944844|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413618|NCT04381650|560944845|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
155413619|NCT04381650|560944835|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155413620|NCT04381650|560944836|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
155413621|NCT04381650|560944837|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
155413622|NCT04381650|560944838|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
155413623|NCT04381650|560944839|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155497285|NCT00877799|561244052|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
155413624|NCT04381650|560944840|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155413625|NCT04381650|560944841|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155413626|NCT04381650|560944842|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155413627|NCT04381650|560944843|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155413628|NCT04381650|560944844|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155642205|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
155413629|NCT04381650|560944845|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
155497286|NCT00877799|561244053|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
155306312|NCT02058108|560553371|FG001|Overall Study|Protocol Violation|1|||
155306313|NCT01376700|560553375|FG000|Overall Study|Sponsor terminated study early|8|||
155306314|NCT01376700|560553375|FG000|Overall Study|Low or high titer inhibitor|8|||
155306315|NCT00727909|560553376|FG000|Overall Study|Withdrawal by Subject|5|||
155306316|NCT00727909|560553377|FG001|Overall Study|Withdrawal by Subject|11|||
155306317|NCT00727909|560553378|FG002|Overall Study|Withdrawal by Subject|8|||
155306318|NCT00727909|560553379|FG003|Overall Study|Withdrawal by Subject|5|||
155306319|NCT00727909|560553376|FG000|Overall Study|Death|0|||
155306320|NCT00727909|560553377|FG001|Overall Study|Death|0|||
155306321|NCT00727909|560553378|FG002|Overall Study|Death|1|||
155306322|NCT00727909|560553379|FG003|Overall Study|Death|0|||
155306323|NCT01696773|560553380|FG000|Days 15-27, Washout|Adverse Event|1|||
155306324|NCT01696773|560553381|FG001|Days 15-27, Washout|Adverse Event|0|||
155306325|NCT05623345|560553390|FG000|Overall Study|Withdrawal by Subject|14|||
155306326|NCT05623345|560553391|FG001|Overall Study|Withdrawal by Subject|0|||
155413630|NCT04381650|560944835|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413631|NCT04381650|560944836|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413632|NCT04381650|560944837|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413633|NCT04381650|560944838|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413634|NCT04381650|560944839|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
155413635|NCT04381650|560944840|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
155413636|NCT04381650|560944841|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413637|NCT04381650|560944842|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413638|NCT04381650|560944843|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413639|NCT04381650|560944844|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
155413640|NCT04381650|560944845|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
155413641|NCT04381650|560944835|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413642|NCT04381650|560944836|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413643|NCT04381650|560944837|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413644|NCT04381650|560944838|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413645|NCT04381650|560944839|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413646|NCT04381650|560944840|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413647|NCT04381650|560944841|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413648|NCT04381650|560944842|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155413649|NCT04381650|560944843|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155413650|NCT04381650|560944844|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155413651|NCT04381650|560944845|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155413652|NCT04381650|560944835|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
155413653|NCT04381650|560944836|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
155413654|NCT04381650|560944837|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
155413655|NCT04381650|560944838|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
155413656|NCT04381650|560944839|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
155413657|NCT04381650|560944840|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
155413658|NCT04381650|560944841|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
155413659|NCT04381650|560944842|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
155413660|NCT04381650|560944843|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
155413661|NCT04381650|560944844|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
155413662|NCT04381650|560944845|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
155413663|NCT04381650|560944835|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
155413664|NCT04381650|560944836|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
155413665|NCT04381650|560944837|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
155413666|NCT04381650|560944838|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
155413667|NCT04381650|560944839|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
155413668|NCT04381650|560944840|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
155413669|NCT04381650|560944841|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
155413670|NCT04381650|560944842|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
155413671|NCT04381650|560944843|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
155413672|NCT04381650|560944844|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
155413673|NCT04381650|560944845|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
155413674|NCT04381650|560944835|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413675|NCT04381650|560944836|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155497287|NCT00877799|561244054|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
155413676|NCT04381650|560944837|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413677|NCT04381650|560944838|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413678|NCT04381650|560944839|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413679|NCT04381650|560944840|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155497288|NCT00877799|561244055|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
155306327|NCT05623345|560553392|FG002|Overall Study|Withdrawal by Subject|9|||
155306328|NCT05623345|560553393|FG003|Overall Study|Withdrawal by Subject|20|||
155306329|NCT05623345|560553390|FG000|Overall Study|Lost to Follow-up|3|||
155413680|NCT04381650|560944841|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413681|NCT04381650|560944842|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
155306330|NCT05623345|560553391|FG001|Overall Study|Lost to Follow-up|0|||
155306331|NCT05623345|560553392|FG002|Overall Study|Lost to Follow-up|7|||
155306332|NCT05623345|560553393|FG003|Overall Study|Lost to Follow-up|2|||
155306333|NCT05623345|560553390|FG000|Overall Study|Termination of Study By Sponsor|37|||
155306334|NCT05623345|560553391|FG001|Overall Study|Termination of Study By Sponsor|4|||
155306335|NCT05623345|560553392|FG002|Overall Study|Termination of Study By Sponsor|40|||
155306336|NCT05623345|560553393|FG003|Overall Study|Termination of Study By Sponsor|38|||
155306337|NCT00411151|560553394|FG000|Overall Study|Death|38|||
155306338|NCT00411151|560553394|FG000|Overall Study|Withdrawal by Subject|2|||
155306339|NCT00411151|560553394|FG000|Overall Study|Lost to Follow-up|2|||
155306340|NCT00411151|560553394|FG000|Overall Study|Protocol Violation|1|||
155306341|NCT00411151|560553394|FG000|Overall Study|Trial prematurely closed|4|||
155306342|NCT02374307|560553404|FG000|3-months Follow-up|Lost to Follow-up|1|||
155306343|NCT02374307|560553405|FG001|3-months Follow-up|Lost to Follow-up|2|||
155306344|NCT02374307|560553404|FG000|3-months Follow-up|Withdrawal by Subject|1|||
155306345|NCT02374307|560553405|FG001|3-months Follow-up|Withdrawal by Subject|4|||
155306346|NCT02374307|560553404|FG000|3-months Follow-up|Death|1|||
155306347|NCT02374307|560553405|FG001|3-months Follow-up|Death|2|||
155306348|NCT02374307|560553404|FG000|3-months Follow-up|Missed first follow-up|5|||
155306349|NCT02374307|560553405|FG001|3-months Follow-up|Missed first follow-up|1|||
155306350|NCT02374307|560553404|FG000|6-months Follow-up|Lost to Follow-up|1|||
155306351|NCT02374307|560553405|FG001|6-months Follow-up|Lost to Follow-up|2|||
155306352|NCT02374307|560553404|FG000|6-months Follow-up|Death|2|||
155306353|NCT02374307|560553405|FG001|6-months Follow-up|Death|1|||
155306354|NCT02374307|560553404|FG000|6-months Follow-up|Withdrawal by Subject|0|||
155306355|NCT02374307|560553405|FG001|6-months Follow-up|Withdrawal by Subject|3|||
155306356|NCT04452318|560553406|FG000|Overall Study|Physician Decision|1|||
155306357|NCT04452318|560553407|FG001|Overall Study|Physician Decision|2|||
155306358|NCT04452318|560553408|FG002|Overall Study|Physician Decision|0|||
155306359|NCT04452318|560553409|FG003|Overall Study|Physician Decision|2|||
155306360|NCT04452318|560553410|FG004|Overall Study|Physician Decision|0|||
155306361|NCT04452318|560553411|FG005|Overall Study|Physician Decision|2|||
155306362|NCT04452318|560553412|FG006|Overall Study|Physician Decision|5|||
155306363|NCT04452318|560553406|FG000|Overall Study|Death|2|||
155306364|NCT04452318|560553407|FG001|Overall Study|Death|3|||
155306365|NCT04452318|560553408|FG002|Overall Study|Death|0|||
155306366|NCT04452318|560553409|FG003|Overall Study|Death|0|||
155306367|NCT04452318|560553410|FG004|Overall Study|Death|0|||
155306368|NCT04452318|560553411|FG005|Overall Study|Death|0|||
155306369|NCT04452318|560553412|FG006|Overall Study|Death|0|||
155306370|NCT04452318|560553406|FG000|Overall Study|Lost to Follow-up|38|||
155306371|NCT04452318|560553407|FG001|Overall Study|Lost to Follow-up|28|||
155306372|NCT04452318|560553408|FG002|Overall Study|Lost to Follow-up|0|||
155306373|NCT04452318|560553409|FG003|Overall Study|Lost to Follow-up|3|||
155306374|NCT04452318|560553410|FG004|Overall Study|Lost to Follow-up|3|||
155306375|NCT04452318|560553411|FG005|Overall Study|Lost to Follow-up|2|||
155306376|NCT04452318|560553412|FG006|Overall Study|Lost to Follow-up|1|||
155306377|NCT04452318|560553406|FG000|Overall Study|Withdrawal by Subject|46|||
155306378|NCT04452318|560553407|FG001|Overall Study|Withdrawal by Subject|40|||
155306379|NCT04452318|560553408|FG002|Overall Study|Withdrawal by Subject|0|||
155306380|NCT04452318|560553409|FG003|Overall Study|Withdrawal by Subject|18|||
155306381|NCT04452318|560553410|FG004|Overall Study|Withdrawal by Subject|6|||
155306382|NCT04452318|560553411|FG005|Overall Study|Withdrawal by Subject|8|||
155306383|NCT04452318|560553412|FG006|Overall Study|Withdrawal by Subject|6|||
155306384|NCT02638337|560553413|FG000|Overall Study|Adverse Event|6|||
155306385|NCT02638337|560553414|FG001|Overall Study|Adverse Event|10|||
155306386|NCT02638337|560553413|FG000|Overall Study|Protocol Violation|3|||
155306387|NCT02638337|560553414|FG001|Overall Study|Protocol Violation|0|||
155306388|NCT02638337|560553413|FG000|Overall Study|Withdrawal by Subject|13|||
155306389|NCT02638337|560553414|FG001|Overall Study|Withdrawal by Subject|16|||
155306390|NCT02638337|560553413|FG000|Overall Study|Lost to Follow-up|7|||
155413682|NCT04381650|560944843|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413683|NCT04381650|560944844|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413684|NCT04381650|560944845|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
155413685|NCT05593016|560946189|FG000|Overall Study|Death|1|||
155413686|NCT05593016|560946190|FG001|Overall Study|Death|1|||
155413687|NCT05593016|560946191|FG002|Overall Study|Death|1|||
155413688|NCT05593016|560946192|FG003|Overall Study|Death|0|||
155413689|NCT05593016|560946193|FG004|Overall Study|Death|0|||
155413690|NCT05593016|560946189|FG000|Overall Study|Lost to Follow-up|1|||
155306391|NCT02638337|560553414|FG001|Overall Study|Lost to Follow-up|7|||
155306392|NCT02638337|560553413|FG000|Overall Study|Other - Miscellaneous|4|||
155306393|NCT02638337|560553414|FG001|Overall Study|Other - Miscellaneous|3|||
155306394|NCT00604669|560553415|FG000|Overall Study|lack of information in chart|7|||
155306395|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Adverse Event|4|||
155306396|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Adverse Event|1|||
155306397|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
155306398|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
155413691|NCT05593016|560946190|FG001|Overall Study|Lost to Follow-up|1|||
155306399|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
155306400|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
155306401|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
155497289|NCT00877799|561244051|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
155306402|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
155306403|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
155306404|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
155306405|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Other|6|||
155306406|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Other|1|||
155306407|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Missing|1|||
155306408|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Missing|0|||
155306409|NCT03271489|560553421|FG000|Open-Label (OL) Period|Adverse Event|2|||
155306410|NCT03271489|560553422|FG001|Open-Label (OL) Period|Adverse Event|0|||
155306411|NCT03271489|560553421|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
155306412|NCT03271489|560553422|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
155306413|NCT03271489|560553421|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
155306414|NCT03271489|560553422|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
155306415|NCT03271489|560553421|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
155306416|NCT03271489|560553422|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
155306417|NCT03271489|560553421|FG000|Open-Label (OL) Period|No Specified|2|||
155306418|NCT03271489|560553422|FG001|Open-Label (OL) Period|No Specified|2|||
155306419|NCT03271489|560553421|FG000|Open-Label (OL) Period|Missing|2|||
155306420|NCT03271489|560553422|FG001|Open-Label (OL) Period|Missing|0|||
155306421|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
155306422|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
155306423|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
155306424|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
155306425|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
155306426|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
155306427|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
155306428|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
155306429|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
155306430|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
155306431|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
155306432|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
155306433|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
155306434|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
155306435|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
155306436|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
155306437|NCT06061081|560553423|FG000|Overall Study|Withdrawal by Subject|1|||
155306438|NCT06061081|560553424|FG001|Overall Study|Withdrawal by Subject|0|||
155306439|NCT06061081|560553425|FG002|Overall Study|Withdrawal by Subject|0|||
155306440|NCT06061081|560553426|FG003|Overall Study|Withdrawal by Subject|0|||
155306441|NCT06061081|560553427|FG004|Overall Study|Withdrawal by Subject|0|||
155306442|NCT01127373|560553428|FG000|Overall Study|Not Treated|3|||
155306443|NCT01127373|560553428|FG000|Overall Study|Lost to Follow-up|7|||
155306444|NCT01127373|560553428|FG000|Overall Study|Withdrawal by Subject|1|||
155306445|NCT01127373|560553428|FG000|Overall Study|Disease progression|1|||
155306446|NCT05450458|560553429|FG000|Overall Study|Lost to Follow-up|4|||
155306447|NCT02965846|560553434|FG000|Overall Study|Lost to Follow-up|1|||
155306448|NCT02965846|560553435|FG001|Overall Study|Lost to Follow-up|0|||
155306449|NCT02965846|560553436|FG002|Overall Study|Lost to Follow-up|0|||
155306450|NCT02965846|560553434|FG000|Overall Study|Withdrawal by Subject|0|||
155306451|NCT02965846|560553435|FG001|Overall Study|Withdrawal by Subject|1|||
155306452|NCT02965846|560553436|FG002|Overall Study|Withdrawal by Subject|0|||
155306453|NCT02965846|560553434|FG000|Overall Study|Study Terminated By Sponsor|4|||
155306454|NCT02965846|560553435|FG001|Overall Study|Study Terminated By Sponsor|4|||
155306455|NCT02965846|560553436|FG002|Overall Study|Study Terminated By Sponsor|0|||
155306456|NCT02965846|560553434|FG000|Overall Study|Participants not randomized|0|||
155306457|NCT02965846|560553435|FG001|Overall Study|Participants not randomized|0|||
155413692|NCT05593016|560946191|FG002|Overall Study|Lost to Follow-up|1|||
155413693|NCT05593016|560946192|FG003|Overall Study|Lost to Follow-up|2|||
155413694|NCT05593016|560946193|FG004|Overall Study|Lost to Follow-up|0|||
155413695|NCT04705051|560946194|FG000|Overall Study|Enrolled but not treated|1|||
155413696|NCT04705051|560946194|FG000|Overall Study|Study terminated by sponsor|23|||
155413697|NCT00482014|560946195|FG000|Overall Study|Withdrawal by Subject|1|||
155413698|NCT00482014|560946196|FG001|Overall Study|Withdrawal by Subject|2|||
155413699|NCT00482014|560946197|FG002|Overall Study|Withdrawal by Subject|3|||
155413700|NCT00482014|560946198|FG003|Overall Study|Withdrawal by Subject|4|||
155413701|NCT00482014|560946195|FG000|Overall Study|Adverse Event|3|||
155497290|NCT00877799|561244052|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
155306458|NCT02965846|560553436|FG002|Overall Study|Participants not randomized|33|||
155306459|NCT00539734|560553437|FG000|Overall Study|Protocol Violation|1|||
155306460|NCT02814838|560553438|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
155306461|NCT02814838|560553439|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
155306462|NCT02814838|560553438|FG000|Overall Study|Consent withdrawal|1|||
155306463|NCT02814838|560553439|FG001|Overall Study|Consent withdrawal|1|||
155306464|NCT00073749|560553440|FG000|Overall Study|Disease Progression|2|||
155306465|NCT00073749|560553441|FG001|Overall Study|Disease Progression|0|||
155306466|NCT00073749|560553442|FG002|Overall Study|Disease Progression|3|||
155306467|NCT00073749|560553443|FG003|Overall Study|Disease Progression|2|||
155306468|NCT00073749|560553444|FG004|Overall Study|Disease Progression|3|||
155306469|NCT00073749|560553445|FG005|Overall Study|Disease Progression|1|||
155306470|NCT00073749|560553446|FG006|Overall Study|Disease Progression|3|||
155306471|NCT00073749|560553440|FG000|Overall Study|Death|0|||
155306472|NCT00073749|560553441|FG001|Overall Study|Death|1|||
155306473|NCT00073749|560553442|FG002|Overall Study|Death|1|||
155306474|NCT00073749|560553443|FG003|Overall Study|Death|0|||
155306475|NCT00073749|560553444|FG004|Overall Study|Death|0|||
155306476|NCT00073749|560553445|FG005|Overall Study|Death|0|||
155306477|NCT00073749|560553446|FG006|Overall Study|Death|29|||
155306478|NCT00073749|560553440|FG000|Overall Study|Adverse Event|0|||
155306479|NCT00073749|560553441|FG001|Overall Study|Adverse Event|3|||
155306480|NCT00073749|560553442|FG002|Overall Study|Adverse Event|6|||
155306481|NCT00073749|560553443|FG003|Overall Study|Adverse Event|4|||
155306482|NCT00073749|560553444|FG004|Overall Study|Adverse Event|2|||
155306483|NCT00073749|560553445|FG005|Overall Study|Adverse Event|1|||
155306484|NCT00073749|560553446|FG006|Overall Study|Adverse Event|0|||
155306485|NCT00073749|560553440|FG000|Overall Study|Physician Decision|0|||
155306486|NCT00073749|560553441|FG001|Overall Study|Physician Decision|0|||
155306487|NCT00073749|560553442|FG002|Overall Study|Physician Decision|1|||
155306488|NCT00073749|560553443|FG003|Overall Study|Physician Decision|0|||
155306489|NCT00073749|560553444|FG004|Overall Study|Physician Decision|0|||
155306490|NCT00073749|560553445|FG005|Overall Study|Physician Decision|2|||
155306491|NCT00073749|560553446|FG006|Overall Study|Physician Decision|0|||
155306492|NCT00073749|560553440|FG000|Overall Study|Withdrawal by Subject|0|||
155306493|NCT00073749|560553441|FG001|Overall Study|Withdrawal by Subject|1|||
155306494|NCT00073749|560553442|FG002|Overall Study|Withdrawal by Subject|0|||
155306495|NCT00073749|560553443|FG003|Overall Study|Withdrawal by Subject|0|||
155306496|NCT00073749|560553444|FG004|Overall Study|Withdrawal by Subject|1|||
155306497|NCT00073749|560553445|FG005|Overall Study|Withdrawal by Subject|0|||
155306498|NCT00073749|560553446|FG006|Overall Study|Withdrawal by Subject|2|||
155306499|NCT00073749|560553440|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155306500|NCT00073749|560553441|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155306501|NCT00073749|560553442|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155306502|NCT00073749|560553443|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155306503|NCT00073749|560553444|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155306504|NCT00073749|560553445|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155306505|NCT00073749|560553446|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
155306506|NCT00073749|560553440|FG000|Overall Study|Lost to Follow-up|0|||
155306507|NCT00073749|560553441|FG001|Overall Study|Lost to Follow-up|0|||
155306508|NCT00073749|560553442|FG002|Overall Study|Lost to Follow-up|0|||
155306509|NCT00073749|560553443|FG003|Overall Study|Lost to Follow-up|0|||
155306510|NCT00073749|560553444|FG004|Overall Study|Lost to Follow-up|0|||
155306511|NCT00073749|560553445|FG005|Overall Study|Lost to Follow-up|0|||
155306512|NCT00073749|560553446|FG006|Overall Study|Lost to Follow-up|2|||
155306513|NCT00073749|560553440|FG000|Overall Study|Other|0|||
155306514|NCT00073749|560553441|FG001|Overall Study|Other|0|||
155306515|NCT00073749|560553442|FG002|Overall Study|Other|0|||
155497291|NCT00877799|561244053|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
155497292|NCT00877799|561244054|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
155306516|NCT00073749|560553443|FG003|Overall Study|Other|0|||
155497293|NCT00877799|561244055|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
155749582|NCT02119676|562182856|FG003|Overall Study|Other, unspecified|4|||
155306517|NCT00073749|560553444|FG004|Overall Study|Other|0|||
155306518|NCT00073749|560553445|FG005|Overall Study|Other|2|||
155306519|NCT00073749|560553446|FG006|Overall Study|Other|0|||
155306520|NCT04154384|560553447|FG000|Overall Study|Lost to Follow-up|24|||
155306521|NCT04154384|560553448|FG001|Overall Study|Lost to Follow-up|33|||
155306522|NCT04154384|560553449|FG002|Overall Study|Lost to Follow-up|0|||
155306523|NCT04154384|560553447|FG000|Overall Study|Withdrawal by Subject|7|||
155306524|NCT04154384|560553448|FG001|Overall Study|Withdrawal by Subject|18|||
155306525|NCT04154384|560553449|FG002|Overall Study|Withdrawal by Subject|0|||
155306526|NCT04154384|560553447|FG000|Overall Study|Missing outcome data|1|||
155306527|NCT04154384|560553448|FG001|Overall Study|Missing outcome data|0|||
155306528|NCT04154384|560553449|FG002|Overall Study|Missing outcome data|0|||
155306529|NCT01136876|560553450|FG000|Overall Study|Lost to Follow-up|0|||
155306530|NCT01136876|560553451|FG001|Overall Study|Lost to Follow-up|1|||
155497294|NCT04054011|561244056|FG000|Overall Study|COVID|3|||
155497295|NCT00592007|561244057|FG000|Overall Study|Withdrawal by Subject|1|||
155497296|NCT00592007|561244057|FG000|Overall Study|patient ineligible (out of lab range)|1|||
155497297|NCT00595127|561244058|FG000|Overall Study|Death|6|||
155497298|NCT00595127|561244058|FG000|Overall Study|Relapsed|3|||
155497299|NCT00595127|561244058|FG000|Overall Study|joined another trial|1|||
155497300|NCT00538473|561244060|FG000|Overall Study|Adverse Event|1|||
155497301|NCT00538473|561244061|FG001|Overall Study|Adverse Event|0|||
155497302|NCT01569074|561244062|FG000|Overall Study|Study stopped|6|||
155497303|NCT01569074|561244063|FG001|Overall Study|Study stopped|6|||
155497304|NCT01569074|561244064|FG002|Overall Study|Study stopped|8|||
155497305|NCT01569074|561244065|FG003|Overall Study|Study stopped|7|||
155497306|NCT01569074|561244066|FG004|Overall Study|Study stopped|7|||
155497307|NCT01569074|561244062|FG000|Overall Study|Study-specific discontinuation criteria|0|||
155497308|NCT01569074|561244063|FG001|Overall Study|Study-specific discontinuation criteria|1|||
155306531|NCT01136876|560553450|FG000|Overall Study|Physician Decision|3|||
155306532|NCT01136876|560553451|FG001|Overall Study|Physician Decision|5|||
155497309|NCT01569074|561244064|FG002|Overall Study|Study-specific discontinuation criteria|0|||
155497310|NCT01569074|561244065|FG003|Overall Study|Study-specific discontinuation criteria|0|||
155749583|NCT02119676|562182853|FG000|Overall Study|Did not receive study med|2|||
155749584|NCT02119676|562182854|FG001|Overall Study|Did not receive study med|2|||
155749585|NCT02119676|562182855|FG002|Overall Study|Did not receive study med|4|||
155749586|NCT02119676|562182856|FG003|Overall Study|Did not receive study med|5|||
155749587|NCT00219544|562182857|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
155749588|NCT00219544|562182858|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
155306533|NCT01136876|560553450|FG000|Overall Study|Missing NGAL measurement|2|||
155306534|NCT01136876|560553451|FG001|Overall Study|Missing NGAL measurement|5|||
155306535|NCT04128319|560553452|FG000|Overall Study|Death|3|||
155306536|NCT04484935|560553453|FG000|Overall Study|Other|0|||
155306537|NCT04484935|560553454|FG001|Overall Study|Other|1|||
155306538|NCT04484935|560553453|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155306539|NCT04484935|560553454|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155306540|NCT04484935|560553453|FG000|Overall Study|Lost to Follow-up|1|||
155306541|NCT04484935|560553454|FG001|Overall Study|Lost to Follow-up|0|||
155306542|NCT04484935|560553453|FG000|Overall Study|Death|2|||
155306543|NCT04484935|560553454|FG001|Overall Study|Death|1|||
155306544|NCT04820686|560553455|FG000|Overall Study|Withdrawal by Subject|5|||
155306545|NCT04820686|560553456|FG001|Overall Study|Withdrawal by Subject|2|||
155306546|NCT04820686|560553457|FG002|Overall Study|Withdrawal by Subject|3|||
155306547|NCT04820686|560553455|FG000|Overall Study|Study Termination|25|||
155306548|NCT04820686|560553456|FG001|Overall Study|Study Termination|13|||
155306549|NCT04820686|560553457|FG002|Overall Study|Study Termination|14|||
155306550|NCT04820686|560553455|FG000|Overall Study|Adverse Event|0|||
155306551|NCT04820686|560553456|FG001|Overall Study|Adverse Event|1|||
155306552|NCT04820686|560553457|FG002|Overall Study|Adverse Event|0|||
155306553|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
155306554|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
155306555|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
155306556|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
155306557|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
155306558|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
155306559|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
155306560|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
155306561|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
155306562|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
155306563|NCT01424670|560553458|FG000|Continuation Period|Adverse Event|13|||
155306564|NCT01424670|560553459|FG001|Continuation Period|Adverse Event|5|||
155306565|NCT01424670|560553458|FG000|Continuation Period|Lost to Follow-up|2|||
155306566|NCT01424670|560553459|FG001|Continuation Period|Lost to Follow-up|0|||
155306567|NCT01424670|560553458|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
155306568|NCT01424670|560553459|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
155306569|NCT01424670|560553458|FG000|Continuation Period|Physician Decision|5|||
155306570|NCT01424670|560553459|FG001|Continuation Period|Physician Decision|4|||
155306571|NCT01424670|560553458|FG000|Continuation Period|Withdrawal by Subject|13|||
155306572|NCT01424670|560553459|FG001|Continuation Period|Withdrawal by Subject|4|||
155749589|NCT00219544|562182857|FG000|Single Blind Treatment Period|Adverse Event|9|||
155749590|NCT00219544|562182858|FG001|Single Blind Treatment Period|Adverse Event|0|||
155306573|NCT02759016|560553460|FG000|Overall Study|Not treated with BI 836826|1|||
155306574|NCT02759016|560553461|FG001|Overall Study|Not treated with BI 836826|0|||
155306575|NCT02759016|560553460|FG000|Overall Study|Progressive disease|1|||
155306576|NCT02759016|560553461|FG001|Overall Study|Progressive disease|0|||
155306577|NCT02759016|560553460|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
155306578|NCT02759016|560553461|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
155497311|NCT01569074|561244066|FG004|Overall Study|Study-specific discontinuation criteria|0|||
155497312|NCT01569074|561244062|FG000|Overall Study|Severe non-compliance to protocol|0|||
155306579|NCT02759016|560553460|FG000|Overall Study|Other not defined above|2|||
155306580|NCT02759016|560553461|FG001|Overall Study|Other not defined above|1|||
155306581|NCT04377308|560553462|FG000|Overall Study|Withdrawal by Subject|0|||
155306582|NCT04377308|560553463|FG001|Overall Study|Withdrawal by Subject|1|||
155306583|NCT02891915|560553470|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
155306584|NCT02891915|560553471|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
155306585|NCT02891915|560553470|FG000|Overall Study|Withdrawal by Subject|3|||
155306586|NCT02891915|560553471|FG001|Overall Study|Withdrawal by Subject|3|||
155306587|NCT02891915|560553470|FG000|Overall Study|Became Ineligible After Enrollment|2|||
155306588|NCT02891915|560553471|FG001|Overall Study|Became Ineligible After Enrollment|1|||
155306589|NCT02891915|560553470|FG000|Overall Study|Lost to Follow-up|1|||
155306590|NCT02891915|560553471|FG001|Overall Study|Lost to Follow-up|4|||
155306591|NCT02891915|560553470|FG000|Overall Study|Physician Decision|1|||
155306592|NCT02891915|560553471|FG001|Overall Study|Physician Decision|0|||
155306593|NCT04048382|560553477|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
155306594|NCT04048382|560553478|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
155306595|NCT04048382|560553477|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
155306596|NCT04048382|560553478|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
155306597|NCT04048382|560553477|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
155306598|NCT04048382|560553478|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
155306599|NCT00709098|560553480|FG000|Double-blind Period|Withdrawal of consent|3|||
155306600|NCT00709098|560553481|FG001|Double-blind Period|Withdrawal of consent|3|||
155306601|NCT00709098|560553482|FG002|Double-blind Period|Withdrawal of consent|0|||
155306602|NCT00709098|560553480|FG000|Double-blind Period|Administrative reason|1|||
155306603|NCT00709098|560553481|FG001|Double-blind Period|Administrative reason|3|||
155306604|NCT00709098|560553482|FG002|Double-blind Period|Administrative reason|0|||
155306605|NCT00709098|560553480|FG000|Double-blind Period|Death|1|||
155306606|NCT00709098|560553481|FG001|Double-blind Period|Death|1|||
155306607|NCT00709098|560553482|FG002|Double-blind Period|Death|0|||
155306608|NCT00709098|560553480|FG000|Double-blind Period|Lost to Follow-up|1|||
155306609|NCT00709098|560553481|FG001|Double-blind Period|Lost to Follow-up|1|||
155306610|NCT00709098|560553482|FG002|Double-blind Period|Lost to Follow-up|0|||
155306611|NCT00709098|560553480|FG000|Open-label Period|Withdrawal of consent|0|||
155306612|NCT00709098|560553481|FG001|Open-label Period|Withdrawal of consent|0|||
155306613|NCT00709098|560553482|FG002|Open-label Period|Withdrawal of consent|7|||
155306614|NCT00709098|560553480|FG000|Open-label Period|Administrative reason|0|||
155306615|NCT00709098|560553481|FG001|Open-label Period|Administrative reason|0|||
155306616|NCT00709098|560553482|FG002|Open-label Period|Administrative reason|5|||
155306617|NCT00709098|560553480|FG000|Open-label Period|Death|0|||
155306618|NCT00709098|560553481|FG001|Open-label Period|Death|0|||
155306619|NCT00709098|560553482|FG002|Open-label Period|Death|1|||
155306620|NCT00709098|560553480|FG000|Open-label Period|Lost to Follow-up|0|||
155306621|NCT00709098|560553481|FG001|Open-label Period|Lost to Follow-up|0|||
155306622|NCT00709098|560553482|FG002|Open-label Period|Lost to Follow-up|1|||
155749591|NCT00219544|562182857|FG000|Single Blind Treatment Period|Protocol Violation|4|||
155749592|NCT00219544|562182858|FG001|Single Blind Treatment Period|Protocol Violation|0|||
155749593|NCT00219544|562182857|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
155749594|NCT00219544|562182858|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
155306623|NCT02119650|560553484|FG000|Overall Study|Adverse Event|3|||
155497313|NCT01569074|561244063|FG001|Overall Study|Severe non-compliance to protocol|0|||
155497314|NCT01569074|561244064|FG002|Overall Study|Severe non-compliance to protocol|1|||
155497315|NCT01569074|561244065|FG003|Overall Study|Severe non-compliance to protocol|0|||
155497316|NCT01569074|561244066|FG004|Overall Study|Severe non-compliance to protocol|0|||
155497317|NCT01569074|561244062|FG000|Overall Study|eg change in circumstances|0|||
155497318|NCT01569074|561244063|FG001|Overall Study|eg change in circumstances|2|||
155497319|NCT01569074|561244064|FG002|Overall Study|eg change in circumstances|0|||
155306624|NCT02119650|560553485|FG001|Overall Study|Adverse Event|4|||
155306625|NCT02119650|560553484|FG000|Overall Study|Subject decision|2|||
155306626|NCT02119650|560553485|FG001|Overall Study|Subject decision|3|||
155306627|NCT02119650|560553484|FG000|Overall Study|Disease progression|11|||
155306628|NCT02119650|560553485|FG001|Overall Study|Disease progression|14|||
155306629|NCT02119650|560553484|FG000|Overall Study|Death|5|||
155306630|NCT02119650|560553485|FG001|Overall Study|Death|1|||
155306631|NCT02119650|560553484|FG000|Overall Study|Noncompliance with study treatment|1|||
155306632|NCT02119650|560553485|FG001|Overall Study|Noncompliance with study treatment|1|||
155306633|NCT02119650|560553484|FG000|Overall Study|Study terminated by the sponsor|1|||
155306634|NCT02119650|560553485|FG001|Overall Study|Study terminated by the sponsor|0|||
155306635|NCT02119650|560553484|FG000|Overall Study|Physician Decision|0|||
155306636|NCT02119650|560553485|FG001|Overall Study|Physician Decision|2|||
155306637|NCT02119650|560553484|FG000|Overall Study|Multiple reasons for termination|2|||
155306638|NCT02119650|560553485|FG001|Overall Study|Multiple reasons for termination|1|||
155306639|NCT04994509|560553487|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
155306640|NCT04994509|560553488|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
155749595|NCT00219544|562182857|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
155306641|NCT04994509|560553489|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
155306642|NCT04994509|560553487|FG000|Overall Study|Withdrew Consent|73|||
155306643|NCT04994509|560553488|FG001|Overall Study|Withdrew Consent|72|||
155306644|NCT04994509|560553489|FG002|Overall Study|Withdrew Consent|46|||
155306645|NCT04994509|560553487|FG000|Overall Study|Lost to Follow-up|39|||
155306646|NCT04994509|560553488|FG001|Overall Study|Lost to Follow-up|36|||
155306647|NCT04994509|560553489|FG002|Overall Study|Lost to Follow-up|26|||
155306648|NCT04994509|560553487|FG000|Overall Study|HIV-1 Infection|4|||
155306649|NCT04994509|560553488|FG001|Overall Study|HIV-1 Infection|20|||
155306650|NCT04994509|560553489|FG002|Overall Study|HIV-1 Infection|12|||
155306651|NCT04994509|560553487|FG000|Overall Study|Investigator's Discretion|9|||
155306652|NCT04994509|560553488|FG001|Overall Study|Investigator's Discretion|8|||
155306653|NCT04994509|560553489|FG002|Overall Study|Investigator's Discretion|11|||
155306654|NCT04994509|560553487|FG000|Overall Study|Randomized but Never Treated|10|||
155306655|NCT04994509|560553488|FG001|Overall Study|Randomized but Never Treated|10|||
155306656|NCT04994509|560553489|FG002|Overall Study|Randomized but Never Treated|3|||
155306657|NCT04994509|560553487|FG000|Overall Study|Pregnancy|5|||
155306658|NCT04994509|560553488|FG001|Overall Study|Pregnancy|5|||
155306659|NCT04994509|560553489|FG002|Overall Study|Pregnancy|0|||
155306660|NCT04994509|560553487|FG000|Overall Study|Death|0|||
155306661|NCT04994509|560553488|FG001|Overall Study|Death|5|||
155306662|NCT04994509|560553489|FG002|Overall Study|Death|0|||
155306663|NCT04994509|560553487|FG000|Overall Study|Adverse Event|2|||
155306664|NCT04994509|560553488|FG001|Overall Study|Adverse Event|1|||
155306665|NCT04994509|560553489|FG002|Overall Study|Adverse Event|0|||
155306666|NCT04994509|560553487|FG000|Overall Study|Non-compliance With Study Drug|1|||
155306667|NCT04994509|560553488|FG001|Overall Study|Non-compliance With Study Drug|1|||
155306668|NCT04994509|560553489|FG002|Overall Study|Non-compliance With Study Drug|1|||
155306669|NCT04994509|560553487|FG000|Overall Study|Withdrew Assent|3|||
155306670|NCT04994509|560553488|FG001|Overall Study|Withdrew Assent|0|||
155306671|NCT04994509|560553489|FG002|Overall Study|Withdrew Assent|0|||
155306672|NCT04994509|560553487|FG000|Overall Study|Protocol Violation|1|||
155306673|NCT04994509|560553488|FG001|Overall Study|Protocol Violation|0|||
155306674|NCT04994509|560553489|FG002|Overall Study|Protocol Violation|0|||
155306675|NCT04402294|560553490|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
155306676|NCT04402294|560553491|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
155306677|NCT04402294|560553490|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
155306678|NCT04402294|560553491|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
155306679|NCT04459416|560555864|FG000|Overall Study|Lost to Follow-up|2|||
155306680|NCT04459416|560555865|FG001|Overall Study|Lost to Follow-up|0|||
155306681|NCT04459416|560555864|FG000|Overall Study|Withdrawal by Subject|8|||
155306682|NCT04459416|560555865|FG001|Overall Study|Withdrawal by Subject|10|||
155306683|NCT04459416|560555864|FG000|Overall Study|Disease progression|0|||
155306684|NCT04459416|560555865|FG001|Overall Study|Disease progression|3|||
155306685|NCT03744312|560555866|FG000|Overall Study|Withdrawal by Subject|0|||
155306686|NCT03744312|560555867|FG001|Overall Study|Withdrawal by Subject|1|||
155306687|NCT03744312|560555866|FG000|Overall Study|Screen fail|0|||
155306688|NCT03744312|560555867|FG001|Overall Study|Screen fail|1|||
155306689|NCT05134337|560555868|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
155306690|NCT05134337|560555869|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
155306691|NCT03725722|560555870|FG000|Overall Study|Lack of Efficacy|2|||
155306692|NCT03725722|560555871|FG001|Overall Study|Lack of Efficacy|1|||
155306693|NCT03725722|560555872|FG002|Overall Study|Lack of Efficacy|2|||
155306694|NCT03725722|560555873|FG003|Overall Study|Lack of Efficacy|0|||
155306695|NCT03725722|560555874|FG004|Overall Study|Lack of Efficacy|2|||
155306696|NCT03725722|560555870|FG000|Overall Study|Adverse Event|2|||
155306697|NCT03725722|560555871|FG001|Overall Study|Adverse Event|2|||
155306698|NCT03725722|560555872|FG002|Overall Study|Adverse Event|1|||
155306699|NCT03725722|560555873|FG003|Overall Study|Adverse Event|0|||
155306700|NCT03725722|560555874|FG004|Overall Study|Adverse Event|6|||
155306701|NCT03725722|560555870|FG000|Overall Study|Withdrawal by Subject|4|||
155306702|NCT03725722|560555871|FG001|Overall Study|Withdrawal by Subject|1|||
155306703|NCT03725722|560555872|FG002|Overall Study|Withdrawal by Subject|0|||
155306704|NCT03725722|560555873|FG003|Overall Study|Withdrawal by Subject|4|||
155306705|NCT03725722|560555874|FG004|Overall Study|Withdrawal by Subject|4|||
155306706|NCT03725722|560555870|FG000|Overall Study|Lost to Follow-up|3|||
155306707|NCT03725722|560555871|FG001|Overall Study|Lost to Follow-up|1|||
155306708|NCT03725722|560555872|FG002|Overall Study|Lost to Follow-up|2|||
155306709|NCT03725722|560555873|FG003|Overall Study|Lost to Follow-up|2|||
155306710|NCT03725722|560555874|FG004|Overall Study|Lost to Follow-up|1|||
155306711|NCT03725722|560555870|FG000|Overall Study|Personal reasons|0|||
155306712|NCT03725722|560555871|FG001|Overall Study|Personal reasons|0|||
155306713|NCT03725722|560555872|FG002|Overall Study|Personal reasons|1|||
155306714|NCT03725722|560555873|FG003|Overall Study|Personal reasons|0|||
155306715|NCT03725722|560555874|FG004|Overall Study|Personal reasons|1|||
155306716|NCT03725722|560555870|FG000|Overall Study|COVID-19 situation|0|||
155306717|NCT03725722|560555871|FG001|Overall Study|COVID-19 situation|1|||
155306718|NCT03725722|560555872|FG002|Overall Study|COVID-19 situation|0|||
155306719|NCT03725722|560555873|FG003|Overall Study|COVID-19 situation|0|||
155306720|NCT03725722|560555874|FG004|Overall Study|COVID-19 situation|0|||
155306721|NCT01259401|560555878|FG000|4-month Follow-up|Death|0|||
155306722|NCT01259401|560555879|FG001|4-month Follow-up|Death|1|||
155497320|NCT01569074|561244065|FG003|Overall Study|eg change in circumstances|1|||
155306723|NCT01259401|560555878|FG000|4-month Follow-up|Lost to Follow-up|0|||
155306724|NCT01259401|560555879|FG001|4-month Follow-up|Lost to Follow-up|1|||
155306725|NCT03683069|560555880|FG000|Overall Study|see limitations|12|||
155306726|NCT03683069|560555881|FG001|Overall Study|see limitations|13|||
155306727|NCT05478525|560555884|FG000|Overall Study|Withdrawal by Subject|0|||
155306728|NCT05478525|560555885|FG001|Overall Study|Withdrawal by Subject|1|||
155306729|NCT05478525|560555886|FG002|Overall Study|Withdrawal by Subject|2|||
155413702|NCT00482014|560946196|FG001|Overall Study|Adverse Event|0|||
155413703|NCT00482014|560946197|FG002|Overall Study|Adverse Event|2|||
155413704|NCT00482014|560946198|FG003|Overall Study|Adverse Event|8|||
155413705|NCT00482014|560946195|FG000|Overall Study|Death|1|||
155413706|NCT00482014|560946196|FG001|Overall Study|Death|2|||
155413707|NCT00482014|560946197|FG002|Overall Study|Death|1|||
155413708|NCT00482014|560946198|FG003|Overall Study|Death|4|||
155413709|NCT00482014|560946195|FG000|Overall Study|Lack of Efficacy|1|||
155413710|NCT00482014|560946196|FG001|Overall Study|Lack of Efficacy|0|||
155413711|NCT00482014|560946197|FG002|Overall Study|Lack of Efficacy|4|||
155413712|NCT00482014|560946198|FG003|Overall Study|Lack of Efficacy|6|||
155413713|NCT00482014|560946195|FG000|Overall Study|Sponsor Decision|1|||
155413714|NCT00482014|560946196|FG001|Overall Study|Sponsor Decision|2|||
155413715|NCT00482014|560946197|FG002|Overall Study|Sponsor Decision|1|||
155413716|NCT00482014|560946198|FG003|Overall Study|Sponsor Decision|1|||
155413717|NCT03686397|560946199|FG000|Overall Study|Lack of Efficacy|3|||
155413718|NCT03686397|560946200|FG001|Overall Study|Lack of Efficacy|5|||
155413719|NCT03686397|560946199|FG000|Overall Study|Adverse Event|0|||
155413720|NCT03686397|560946200|FG001|Overall Study|Adverse Event|1|||
155413721|NCT03686397|560946199|FG000|Overall Study|Protocol Violation|0|||
155413722|NCT03686397|560946200|FG001|Overall Study|Protocol Violation|1|||
155413723|NCT03686397|560946199|FG000|Overall Study|Withdrawal by Subject|0|||
155413724|NCT03686397|560946200|FG001|Overall Study|Withdrawal by Subject|1|||
155413725|NCT03686397|560946199|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
155413726|NCT03686397|560946200|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
155413727|NCT04161131|560946207|FG000|Overall Study|Ineligible|2|||
155413728|NCT04161131|560946207|FG000|Overall Study|Lost to Follow-up|4|||
155413729|NCT03733392|560946208|FG000|Overall Study|Withdrawal by Subject|11|||
155413730|NCT03733392|560946209|FG001|Overall Study|Withdrawal by Subject|1|||
155413731|NCT03733392|560946208|FG000|Overall Study|Death|1|||
155413732|NCT03733392|560946209|FG001|Overall Study|Death|0|||
155413733|NCT03733392|560946208|FG000|Overall Study|Lost to Follow-up|5|||
155413734|NCT03733392|560946209|FG001|Overall Study|Lost to Follow-up|0|||
155413735|NCT03733392|560946208|FG000|Overall Study|Protocol Violation|0|||
155413736|NCT03733392|560946209|FG001|Overall Study|Protocol Violation|1|||
155413737|NCT03733392|560946208|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
155413738|NCT03733392|560946209|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
155413739|NCT03733392|560946208|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
155413740|NCT03733392|560946209|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
155413741|NCT03733392|560946208|FG000|Overall Study|Patient Non-Compliance|2|||
155413742|NCT03733392|560946209|FG001|Overall Study|Patient Non-Compliance|1|||
155413743|NCT03733392|560946208|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
155413744|NCT03733392|560946209|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
155413745|NCT03733392|560946208|FG000|Overall Study|Withdrawal prior to procedure|5|||
155413746|NCT03733392|560946209|FG001|Overall Study|Withdrawal prior to procedure|2|||
155413747|NCT02740478|560946210|FG000|Overall Study|Withdrawal by Subject|1|||
155413748|NCT04316585|560946211|FG000|Overall Study|Adverse Event|2|||
155413749|NCT04316585|560946212|FG001|Overall Study|Adverse Event|1|||
155413750|NCT04316585|560946211|FG000|Overall Study|Lost to Follow-up|1|||
155413751|NCT04316585|560946212|FG001|Overall Study|Lost to Follow-up|0|||
155413752|NCT04316585|560946211|FG000|Overall Study|Withdrawal by Subject|2|||
155413753|NCT04316585|560946212|FG001|Overall Study|Withdrawal by Subject|3|||
155413754|NCT04316585|560946211|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
155413755|NCT04316585|560946212|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
155497321|NCT01569074|561244066|FG004|Overall Study|eg change in circumstances|1|||
155306730|NCT05478525|560555887|FG003|Overall Study|Withdrawal by Subject|0|||
155306731|NCT05478525|560555884|FG000|Overall Study|COVID-19 Infection|2|||
155413756|NCT04316585|560946211|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
155413757|NCT04316585|560946212|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
155413758|NCT00618748|560946214|FG000|Overall Study|Adverse Event|4|||
155413759|NCT00618748|560946215|FG001|Overall Study|Adverse Event|3|||
155413760|NCT00618748|560946216|FG002|Overall Study|Adverse Event|8|||
155497322|NCT01569074|561244062|FG000|Overall Study|Adverse Event|1|||
155306732|NCT05478525|560555885|FG001|Overall Study|COVID-19 Infection|0|||
155306733|NCT05478525|560555886|FG002|Overall Study|COVID-19 Infection|1|||
155306734|NCT05478525|560555887|FG003|Overall Study|COVID-19 Infection|1|||
155306735|NCT01991977|560555890|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
155306736|NCT01991977|560555890|FG000|Overall Study|Withdrew after start of treatment|5|||
155306737|NCT03845465|560555892|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
155642206|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
155642207|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
155642208|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
155642209|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
155642210|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
155642211|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
155642212|NCT00447278|561780738|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
155642213|NCT00447278|561780739|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
155642214|NCT03927157|561780741|FG000|Overall Study|Adverse Event|1|||
155642215|NCT03927157|561780742|FG001|Overall Study|Adverse Event|3|||
155642216|NCT03927157|561780741|FG000|Overall Study|Protocol Violation|1|||
155642217|NCT03927157|561780742|FG001|Overall Study|Protocol Violation|2|||
155642218|NCT03927157|561780741|FG000|Overall Study|Withdrawal by Subject|8|||
155642219|NCT03927157|561780742|FG001|Overall Study|Withdrawal by Subject|21|||
155642220|NCT03927157|561780741|FG000|Overall Study|Due to COVID-19 pandemic|5|||
155642221|NCT03927157|561780742|FG001|Overall Study|Due to COVID-19 pandemic|2|||
155642222|NCT03927157|561780741|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
155642223|NCT03927157|561780742|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
155642224|NCT03927157|561780741|FG000|Overall Study|Other than above|0|||
155642225|NCT03927157|561780742|FG001|Overall Study|Other than above|1|||
155642226|NCT06262607|561780743|FG000|Overall Study|Physician Decision|0|||
155306738|NCT03845465|560555893|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
155642227|NCT06262607|561780744|FG001|Overall Study|Physician Decision|1|||
155642228|NCT06262607|561780743|FG000|Overall Study|Withdrawal by Subject|2|||
155642229|NCT06262607|561780744|FG001|Overall Study|Withdrawal by Subject|0|||
155642230|NCT05950906|561780746|FG000|Overall Study|Adverse Event|0|||
155642231|NCT05950906|561780747|FG001|Overall Study|Adverse Event|0|||
155642232|NCT05950906|561780748|FG002|Overall Study|Adverse Event|0|||
155642233|NCT05950906|561780749|FG003|Overall Study|Adverse Event|0|||
155642234|NCT05950906|561780750|FG004|Overall Study|Adverse Event|0|||
155642235|NCT05950906|561780751|FG005|Overall Study|Adverse Event|0|||
155642236|NCT05950906|561780752|FG006|Overall Study|Adverse Event|0|||
155642237|NCT05950906|561780753|FG007|Overall Study|Adverse Event|0|||
155642238|NCT05950906|561780754|FG008|Overall Study|Adverse Event|0|||
155642239|NCT05950906|561780755|FG009|Overall Study|Adverse Event|0|||
155642240|NCT05950906|561780756|FG010|Overall Study|Adverse Event|0|||
155642241|NCT05950906|561780757|FG011|Overall Study|Adverse Event|0|||
155642242|NCT05950906|561780758|FG012|Overall Study|Adverse Event|1|||
155642243|NCT05950906|561780759|FG013|Overall Study|Adverse Event|0|||
155642244|NCT05950906|561780746|FG000|Overall Study|Physician Decision|0|||
155642245|NCT05950906|561780747|FG001|Overall Study|Physician Decision|0|||
155642246|NCT05950906|561780748|FG002|Overall Study|Physician Decision|0|||
155306739|NCT03845465|560555892|FG000|6-month Data Collection|Withdrawal by Subject|0|||
155306740|NCT03845465|560555893|FG001|6-month Data Collection|Withdrawal by Subject|2|||
155306741|NCT03845465|560555892|FG000|12-month Data Collection|Withdrawal by Subject|0|||
155306742|NCT03845465|560555893|FG001|12-month Data Collection|Withdrawal by Subject|2|||
155306743|NCT05656911|560555896|FG000|Treatment Phase|Physician Decision|2|||
155306744|NCT05656911|560555897|FG001|Treatment Phase|Physician Decision|0|||
155306745|NCT05656911|560555896|FG000|Treatment Phase|Lack of Efficacy|6|||
155306746|NCT05656911|560555897|FG001|Treatment Phase|Lack of Efficacy|3|||
155306747|NCT05656911|560555896|FG000|Treatment Phase|Subject Decision|4|||
155306748|NCT05656911|560555897|FG001|Treatment Phase|Subject Decision|2|||
155306749|NCT05656911|560555896|FG000|Treatment Phase|Other Reasons|1|||
155306750|NCT05656911|560555897|FG001|Treatment Phase|Other Reasons|0|||
155306751|NCT05656911|560555896|FG000|Treatment Phase|Adverse Event|3|||
155306752|NCT05656911|560555897|FG001|Treatment Phase|Adverse Event|1|||
155306753|NCT05656911|560555896|FG000|Follow-up Phase|Subject Decision|0|||
155306754|NCT05656911|560555897|FG001|Follow-up Phase|Subject Decision|1|||
155306755|NCT05656911|560555896|FG000|Follow-up Phase|Missing|1|||
155306756|NCT05656911|560555897|FG001|Follow-up Phase|Missing|0|||
155306757|NCT02525692|560555901|FG000|Overall Study|Withdrawal by Subject|1|||
155306758|NCT02525692|560555902|FG001|Overall Study|Withdrawal by Subject|1|||
155306759|NCT02525692|560555903|FG002|Overall Study|Withdrawal by Subject|0|||
155306760|NCT02525692|560555904|FG003|Overall Study|Withdrawal by Subject|5|||
155306761|NCT02525692|560555905|FG004|Overall Study|Withdrawal by Subject|0|||
155306762|NCT02525692|560555906|FG005|Overall Study|Withdrawal by Subject|1|||
155642247|NCT05950906|561780749|FG003|Overall Study|Physician Decision|0|||
155642248|NCT05950906|561780750|FG004|Overall Study|Physician Decision|0|||
155642249|NCT05950906|561780751|FG005|Overall Study|Physician Decision|0|||
155642250|NCT05950906|561780752|FG006|Overall Study|Physician Decision|0|||
155497323|NCT01569074|561244063|FG001|Overall Study|Adverse Event|0|||
155497324|NCT01569074|561244064|FG002|Overall Study|Adverse Event|3|||
155497325|NCT01569074|561244065|FG003|Overall Study|Adverse Event|0|||
155497326|NCT01569074|561244066|FG004|Overall Study|Adverse Event|0|||
155497327|NCT02723786|561244074|FG000|Overall Study|Lost to Follow-up|1|||
155497328|NCT00127192|561244077|FG000|Overall Study|Adverse Event|0|||
155497329|NCT00127192|561244078|FG001|Overall Study|Adverse Event|1|||
155497330|NCT00127192|561244079|FG002|Overall Study|Adverse Event|1|||
155497331|NCT00127192|561244080|FG003|Overall Study|Adverse Event|1|||
155497332|NCT00127192|561244081|FG004|Overall Study|Adverse Event|0|||
155497333|NCT00127192|561244077|FG000|Overall Study|Lack of Efficacy|2|||
155497334|NCT00127192|561244078|FG001|Overall Study|Lack of Efficacy|0|||
155497335|NCT00127192|561244079|FG002|Overall Study|Lack of Efficacy|0|||
155497336|NCT00127192|561244080|FG003|Overall Study|Lack of Efficacy|0|||
155497337|NCT00127192|561244081|FG004|Overall Study|Lack of Efficacy|2|||
155497338|NCT00127192|561244077|FG000|Overall Study|Withdrawal by Subject|0|||
155497339|NCT00127192|561244078|FG001|Overall Study|Withdrawal by Subject|0|||
155497340|NCT00127192|561244079|FG002|Overall Study|Withdrawal by Subject|1|||
155497341|NCT00127192|561244080|FG003|Overall Study|Withdrawal by Subject|0|||
155497342|NCT00127192|561244081|FG004|Overall Study|Withdrawal by Subject|3|||
155497343|NCT00127192|561244077|FG000|Overall Study|Adverse event in pre-treatment period|1|||
155497344|NCT00127192|561244078|FG001|Overall Study|Adverse event in pre-treatment period|0|||
155497345|NCT00127192|561244079|FG002|Overall Study|Adverse event in pre-treatment period|0|||
155497346|NCT00127192|561244080|FG003|Overall Study|Adverse event in pre-treatment period|0|||
155497347|NCT00127192|561244081|FG004|Overall Study|Adverse event in pre-treatment period|0|||
155497348|NCT01036594|561244091|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
155497349|NCT01036594|561244092|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
155497350|NCT01036594|561244091|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
155497351|NCT01036594|561244092|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
155497352|NCT01036594|561244091|FG000|Week 12 Evaluation|Adverse Event|5|||
155497353|NCT01036594|561244092|FG001|Week 12 Evaluation|Adverse Event|0|||
155497354|NCT01036594|561244091|FG000|Week 12 Evaluation|Physician Decision|1|||
155497355|NCT01036594|561244092|FG001|Week 12 Evaluation|Physician Decision|0|||
155497356|NCT01036594|561244091|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
155497357|NCT01036594|561244092|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
155497358|NCT01036594|561244091|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
155497359|NCT01036594|561244092|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
155642251|NCT05950906|561780753|FG007|Overall Study|Physician Decision|0|||
155642252|NCT05950906|561780754|FG008|Overall Study|Physician Decision|0|||
155642253|NCT05950906|561780755|FG009|Overall Study|Physician Decision|0|||
155642254|NCT05950906|561780756|FG010|Overall Study|Physician Decision|0|||
155497360|NCT01036594|561244091|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
155497361|NCT01036594|561244092|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
155306763|NCT02525692|560555901|FG000|Overall Study|Death|16|||
155306764|NCT02525692|560555902|FG001|Overall Study|Death|18|||
155306765|NCT02525692|560555903|FG002|Overall Study|Death|7|||
155306766|NCT02525692|560555904|FG003|Overall Study|Death|20|||
155306767|NCT02525692|560555905|FG004|Overall Study|Death|3|||
155306768|NCT02525692|560555906|FG005|Overall Study|Death|6|||
155306769|NCT02525692|560555901|FG000|Overall Study|Lost to Follow-up|0|||
155306770|NCT02525692|560555902|FG001|Overall Study|Lost to Follow-up|0|||
155306771|NCT02525692|560555903|FG002|Overall Study|Lost to Follow-up|1|||
155306772|NCT02525692|560555904|FG003|Overall Study|Lost to Follow-up|5|||
155306773|NCT02525692|560555905|FG004|Overall Study|Lost to Follow-up|0|||
155306774|NCT02525692|560555906|FG005|Overall Study|Lost to Follow-up|0|||
155306775|NCT00567398|560555909|FG000|Overall Study|Adverse Event|6|||
155306776|NCT00567398|560555910|FG001|Overall Study|Adverse Event|14|||
155306777|NCT00567398|560555909|FG000|Overall Study|Physician Decision|0|||
155306778|NCT00567398|560555910|FG001|Overall Study|Physician Decision|4|||
155497362|NCT01036594|561244091|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
155642255|NCT05950906|561780757|FG011|Overall Study|Physician Decision|0|||
155642256|NCT05950906|561780758|FG012|Overall Study|Physician Decision|1|||
155642257|NCT05950906|561780759|FG013|Overall Study|Physician Decision|0|||
155642258|NCT02969018|561780764|FG000|Overall Study|Adverse Event|2|||
155642259|NCT02969018|561780765|FG001|Overall Study|Adverse Event|4|||
155642260|NCT02969018|561780766|FG002|Overall Study|Adverse Event|1|||
155642261|NCT02969018|561780767|FG003|Overall Study|Adverse Event|2|||
155642262|NCT02969018|561780768|FG004|Overall Study|Adverse Event|0|||
155306779|NCT00567398|560555909|FG000|Overall Study|Withdrawal by Subject|0|||
155306780|NCT00567398|560555910|FG001|Overall Study|Withdrawal by Subject|2|||
155306781|NCT00567398|560555909|FG000|Overall Study|Renal Transplantation|0|||
155306782|NCT00567398|560555910|FG001|Overall Study|Renal Transplantation|3|||
155497363|NCT01036594|561244092|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
155497364|NCT01036594|561244091|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
155642263|NCT02969018|561780769|FG005|Overall Study|Adverse Event|1|||
155642264|NCT02969018|561780770|FG006|Overall Study|Adverse Event|2|||
155642265|NCT02969018|561780771|FG007|Overall Study|Adverse Event|0|||
155497365|NCT01036594|561244092|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
155497366|NCT03345485|561244093|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
155497367|NCT03345485|561244094|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
155497368|NCT03345485|561244095|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
155497369|NCT03345485|561244096|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
155497370|NCT03345485|561244097|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
155497371|NCT03345485|561244098|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
155497372|NCT03345485|561244099|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
155497373|NCT03345485|561244100|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
155497374|NCT03345485|561244101|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
155497375|NCT03345485|561244102|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
155497376|NCT03345485|561244103|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
155497377|NCT03345485|561244104|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
155497378|NCT03345485|561244105|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
155497379|NCT01125358|561244109|FG000|Overall Study|Adverse Event|3|||
155497380|NCT01125358|561244110|FG001|Overall Study|Adverse Event|0|||
155497381|NCT01125358|561244111|FG002|Overall Study|Adverse Event|0|||
155497382|NCT01125358|561244112|FG003|Overall Study|Adverse Event|2|||
155497383|NCT01125358|561244109|FG000|Overall Study|Perceived Lack of Efficacy|6|||
155497384|NCT01125358|561244110|FG001|Overall Study|Perceived Lack of Efficacy|3|||
155497385|NCT01125358|561244111|FG002|Overall Study|Perceived Lack of Efficacy|7|||
155497386|NCT01125358|561244112|FG003|Overall Study|Perceived Lack of Efficacy|4|||
155497387|NCT01125358|561244109|FG000|Overall Study|Protocol Violation|1|||
155497388|NCT01125358|561244110|FG001|Overall Study|Protocol Violation|0|||
155497389|NCT01125358|561244111|FG002|Overall Study|Protocol Violation|0|||
155497390|NCT01125358|561244112|FG003|Overall Study|Protocol Violation|0|||
155497391|NCT01125358|561244109|FG000|Overall Study|Sponsor Decision|0|||
155497392|NCT01125358|561244110|FG001|Overall Study|Sponsor Decision|0|||
155306783|NCT00567398|560555909|FG000|Overall Study|Other|1|||
155306784|NCT00567398|560555910|FG001|Overall Study|Other|0|||
155306785|NCT03517553|560555911|FG000|Overall Study|Withdrawal by Subject|2|||
155306786|NCT04093362|560555914|FG000|Overall Study|Study Termination|1|||
155497393|NCT01125358|561244111|FG002|Overall Study|Sponsor Decision|1|||
155497394|NCT01125358|561244112|FG003|Overall Study|Sponsor Decision|1|||
155497395|NCT01125358|561244109|FG000|Overall Study|Withdrawal by Subject|2|||
155497396|NCT01125358|561244110|FG001|Overall Study|Withdrawal by Subject|1|||
155497397|NCT01125358|561244111|FG002|Overall Study|Withdrawal by Subject|1|||
155497398|NCT01125358|561244112|FG003|Overall Study|Withdrawal by Subject|1|||
155497399|NCT00962013|561244118|FG000|Overall Study|Did not have surgery|1|||
155497400|NCT00962013|561244118|FG000|Overall Study|Death|8|||
155306787|NCT04093362|560555915|FG001|Overall Study|Study Termination|1|||
155306788|NCT04093362|560555914|FG000|Overall Study|Withdrawal of Consent|1|||
155306789|NCT04093362|560555915|FG001|Overall Study|Withdrawal of Consent|0|||
155306790|NCT04093362|560555914|FG000|Overall Study|Death|1|||
155306791|NCT04093362|560555915|FG001|Overall Study|Death|3|||
155306792|NCT04093362|560555914|FG000|Overall Study|Reason not Specified|1|||
155306793|NCT04093362|560555915|FG001|Overall Study|Reason not Specified|2|||
155306794|NCT04247542|560555916|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
155306795|NCT04247542|560555917|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
155306796|NCT04247542|560555918|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
155306797|NCT04247542|560555916|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
155306798|NCT04247542|560555917|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
155306799|NCT04247542|560555918|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
155642266|NCT02969018|561780764|FG000|Overall Study|Lack of Efficacy|0|||
155306800|NCT02597946|560555919|FG000|Overall Study|Withdrawal by Subject|1|||
155306801|NCT02597946|560555919|FG000|Overall Study|Progressive disease|16|||
155497401|NCT00962013|561244118|FG000|Overall Study|Lost to Follow-up|12|||
155497402|NCT00962013|561244118|FG000|Overall Study|Unable/Unwilling to return|6|||
155497403|NCT00962013|561244118|FG000|Overall Study|Withdrawal by Subject|8|||
155497404|NCT00962013|561244118|FG000|Overall Study|Removal of study device|3|||
155642267|NCT02969018|561780765|FG001|Overall Study|Lack of Efficacy|1|||
155642268|NCT02969018|561780766|FG002|Overall Study|Lack of Efficacy|0|||
155642269|NCT02969018|561780767|FG003|Overall Study|Lack of Efficacy|0|||
155642270|NCT02969018|561780768|FG004|Overall Study|Lack of Efficacy|1|||
155642271|NCT02969018|561780769|FG005|Overall Study|Lack of Efficacy|1|||
155642272|NCT02969018|561780770|FG006|Overall Study|Lack of Efficacy|1|||
155642273|NCT02969018|561780771|FG007|Overall Study|Lack of Efficacy|1|||
155642274|NCT02969018|561780764|FG000|Overall Study|Lost to Follow-up|1|||
155642275|NCT02969018|561780765|FG001|Overall Study|Lost to Follow-up|2|||
155642276|NCT02969018|561780766|FG002|Overall Study|Lost to Follow-up|2|||
155497405|NCT00962013|561244118|FG000|Overall Study|Site Termination|24|||
155642277|NCT02969018|561780767|FG003|Overall Study|Lost to Follow-up|0|||
155642278|NCT02969018|561780768|FG004|Overall Study|Lost to Follow-up|1|||
155642279|NCT02969018|561780769|FG005|Overall Study|Lost to Follow-up|1|||
155306802|NCT02597946|560555919|FG000|Overall Study|Other than above|1|||
155306803|NCT01938547|560555926|FG000|Overall Study|Physician Decision|1|||
155306804|NCT01673984|560555932|FG000|Overall Study|Adverse Event|1|||
155306805|NCT01673984|560555933|FG001|Overall Study|Adverse Event|0|||
155306806|NCT01673984|560555932|FG000|Overall Study|Study termination|9|||
155306807|NCT01673984|560555933|FG001|Overall Study|Study termination|6|||
155306808|NCT04600752|560555938|FG000|Overall Study|Physician Decision|0|||
155306809|NCT04600752|560555939|FG001|Overall Study|Physician Decision|0|||
155306810|NCT04600752|560555940|FG002|Overall Study|Physician Decision|1|||
155306811|NCT04600752|560555938|FG000|Overall Study|Adverse Event|0|||
155306812|NCT04600752|560555939|FG001|Overall Study|Adverse Event|1|||
155306813|NCT04600752|560555940|FG002|Overall Study|Adverse Event|0|||
155306814|NCT04600752|560555938|FG000|Overall Study|Withdrawal by Subject|2|||
155306815|NCT04600752|560555939|FG001|Overall Study|Withdrawal by Subject|1|||
155306816|NCT04600752|560555940|FG002|Overall Study|Withdrawal by Subject|0|||
155306817|NCT04600752|560555938|FG000|Overall Study|Lack of Efficacy|1|||
155306818|NCT04600752|560555939|FG001|Overall Study|Lack of Efficacy|0|||
155306819|NCT04600752|560555940|FG002|Overall Study|Lack of Efficacy|0|||
155306820|NCT03732820|560555941|FG000|Overall Study|Death|168|||
155306821|NCT03732820|560555942|FG001|Overall Study|Death|203|||
155306822|NCT03732820|560555941|FG000|Overall Study|Other|2|||
155306823|NCT03732820|560555942|FG001|Overall Study|Other|2|||
155306824|NCT03732820|560555941|FG000|Overall Study|Failure to meet randomisation criteria|1|||
155306825|NCT03732820|560555942|FG001|Overall Study|Failure to meet randomisation criteria|1|||
155306826|NCT03732820|560555941|FG000|Overall Study|Patient decision|14|||
155306827|NCT03732820|560555942|FG001|Overall Study|Patient decision|10|||
155306828|NCT03732820|560555941|FG000|Overall Study|Screen failure|0|||
155306829|NCT03732820|560555942|FG001|Overall Study|Screen failure|1|||
155306830|NCT03732820|560555941|FG000|Overall Study|Patients ongoing study at data cut off|210|||
155306831|NCT03732820|560555942|FG001|Overall Study|Patients ongoing study at data cut off|178|||
155306832|NCT03732820|560555941|FG000|Overall Study|Lost to Follow-up|4|||
155306833|NCT03732820|560555942|FG001|Overall Study|Lost to Follow-up|2|||
155306834|NCT04436107|560555943|FG000|Overall Study|Sponsor Ended Study|2|||
155306835|NCT04436107|560555944|FG001|Overall Study|Sponsor Ended Study|4|||
155306836|NCT04436107|560555945|FG002|Overall Study|Sponsor Ended Study|8|||
155306837|NCT04436107|560555946|FG003|Overall Study|Sponsor Ended Study|20|||
155306838|NCT04436107|560555943|FG000|Overall Study|Death|3|||
155306839|NCT04436107|560555944|FG001|Overall Study|Death|5|||
155306840|NCT04436107|560555945|FG002|Overall Study|Death|3|||
155306841|NCT04436107|560555946|FG003|Overall Study|Death|18|||
155306842|NCT04436107|560555943|FG000|Overall Study|Withdrawal by Subject|1|||
155306843|NCT04436107|560555944|FG001|Overall Study|Withdrawal by Subject|1|||
155306844|NCT04436107|560555945|FG002|Overall Study|Withdrawal by Subject|0|||
155306845|NCT04436107|560555946|FG003|Overall Study|Withdrawal by Subject|1|||
155306846|NCT01095796|560555947|FG000|Overall Study|Randomized but Not Treated|5|||
155306847|NCT01095796|560555948|FG001|Overall Study|Randomized but Not Treated|2|||
155306848|NCT01095796|560555947|FG000|Overall Study|Adverse Event|9|||
155306849|NCT01095796|560555948|FG001|Overall Study|Adverse Event|19|||
155306850|NCT01095796|560555947|FG000|Overall Study|Death|3|||
155306851|NCT01095796|560555948|FG001|Overall Study|Death|2|||
155306852|NCT01095796|560555947|FG000|Overall Study|Pregnancy|2|||
155306853|NCT01095796|560555948|FG001|Overall Study|Pregnancy|0|||
155306854|NCT01095796|560555947|FG000|Overall Study|Lack of Efficacy|5|||
155306855|NCT01095796|560555948|FG001|Overall Study|Lack of Efficacy|3|||
155306856|NCT01095796|560555947|FG000|Overall Study|Investigator's Discretion|7|||
155306857|NCT01095796|560555948|FG001|Overall Study|Investigator's Discretion|2|||
155306858|NCT01095796|560555947|FG000|Overall Study|Withdrew Consent|16|||
155306859|NCT01095796|560555948|FG001|Overall Study|Withdrew Consent|22|||
155306860|NCT01095796|560555947|FG000|Overall Study|Lost to Follow-up|27|||
155306861|NCT01095796|560555948|FG001|Overall Study|Lost to Follow-up|29|||
155413761|NCT00618748|560946214|FG000|Overall Study|Physician Decision|3|||
155413762|NCT00618748|560946215|FG001|Overall Study|Physician Decision|1|||
155413763|NCT00618748|560946216|FG002|Overall Study|Physician Decision|1|||
155642280|NCT02969018|561780770|FG006|Overall Study|Lost to Follow-up|0|||
155642281|NCT02969018|561780771|FG007|Overall Study|Lost to Follow-up|1|||
155306862|NCT01095796|560555947|FG000|Overall Study|Participant Noncompliance|5|||
155306863|NCT01095796|560555948|FG001|Overall Study|Participant Noncompliance|10|||
155642282|NCT02969018|561780764|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155306864|NCT01095796|560555947|FG000|Overall Study|Protocol Violation|1|||
155306865|NCT01095796|560555948|FG001|Overall Study|Protocol Violation|0|||
155306866|NCT01095796|560555947|FG000|Overall Study|Participant Transferred to Another Study|215|||
155306867|NCT01095796|560555948|FG001|Overall Study|Participant Transferred to Another Study|200|||
155306868|NCT01989455|560555949|FG000|Overall Study|Adverse Event|0|||
155306869|NCT01989455|560555950|FG001|Overall Study|Adverse Event|1|||
155306870|NCT01989455|560555951|FG002|Overall Study|Adverse Event|0|||
155306871|NCT01989455|560555952|FG003|Overall Study|Adverse Event|0|||
155306872|NCT01989455|560555953|FG004|Overall Study|Adverse Event|0|||
155306873|NCT01989455|560555949|FG000|Overall Study|Withdrawal by Subject|0|||
155306874|NCT01989455|560555950|FG001|Overall Study|Withdrawal by Subject|1|||
155306875|NCT01989455|560555951|FG002|Overall Study|Withdrawal by Subject|0|||
155306876|NCT01989455|560555952|FG003|Overall Study|Withdrawal by Subject|0|||
155306877|NCT01989455|560555953|FG004|Overall Study|Withdrawal by Subject|0|||
155306878|NCT01989455|560555949|FG000|Overall Study|Technical problems with infusion|0|||
155306879|NCT01989455|560555950|FG001|Overall Study|Technical problems with infusion|0|||
155306880|NCT01989455|560555951|FG002|Overall Study|Technical problems with infusion|1|||
155306881|NCT01989455|560555952|FG003|Overall Study|Technical problems with infusion|0|||
155306882|NCT01989455|560555953|FG004|Overall Study|Technical problems with infusion|1|||
155306883|NCT00632203|560555954|FG000|Overall Study|Did not start study treatment|1|||
155306884|NCT00632203|560555955|FG001|Overall Study|Did not start study treatment|0|||
155306885|NCT00448669|560555963|FG000|Overall Study|Lost to Follow-up|52|||
155306886|NCT00448669|560555964|FG001|Overall Study|Lost to Follow-up|63|||
155306887|NCT00448669|560555963|FG000|Overall Study|Withdrawal by Subject|90|||
155306888|NCT00448669|560555964|FG001|Overall Study|Withdrawal by Subject|74|||
155306889|NCT00448669|560555963|FG000|Overall Study|Relocated|49|||
155306890|NCT00448669|560555964|FG001|Overall Study|Relocated|36|||
155306891|NCT00448669|560555963|FG000|Overall Study|Were withdrawn by investigator|10|||
155306892|NCT00448669|560555964|FG001|Overall Study|Were withdrawn by investigator|6|||
155306893|NCT00448669|560555963|FG000|Overall Study|Death|2|||
155306894|NCT00448669|560555964|FG001|Overall Study|Death|4|||
155306895|NCT00448669|560555963|FG000|Overall Study|Had other reasons|5|||
155306896|NCT00448669|560555964|FG001|Overall Study|Had other reasons|6|||
155306897|NCT00448669|560555963|FG000|Overall Study|HIV-infected at enrollment|1|||
155306898|NCT00448669|560555964|FG001|Overall Study|HIV-infected at enrollment|2|||
155306899|NCT00448669|560555963|FG000|Overall Study|Never started drug|9|||
155306900|NCT00448669|560555964|FG001|Overall Study|Never started drug|7|||
155306901|NCT04287985|560555965|FG000|Overall Study|Adverse Event|1|||
155306902|NCT04287985|560555966|FG001|Overall Study|Adverse Event|0|||
155306903|NCT04287985|560555967|FG002|Overall Study|Adverse Event|0|||
155306904|NCT04287985|560555968|FG003|Overall Study|Adverse Event|0|||
155306905|NCT04287985|560555965|FG000|Overall Study|Protocol Violation|0|||
155306906|NCT04287985|560555966|FG001|Overall Study|Protocol Violation|1|||
155306907|NCT04287985|560555967|FG002|Overall Study|Protocol Violation|0|||
155306908|NCT04287985|560555968|FG003|Overall Study|Protocol Violation|0|||
155306909|NCT04287985|560555965|FG000|Overall Study|Physician Decision|0|||
155306910|NCT04287985|560555966|FG001|Overall Study|Physician Decision|0|||
155306911|NCT04287985|560555967|FG002|Overall Study|Physician Decision|0|||
155306912|NCT04287985|560555968|FG003|Overall Study|Physician Decision|1|||
155306913|NCT04287985|560555965|FG000|Overall Study|Withdrawal by Subject|2|||
155306914|NCT04287985|560555966|FG001|Overall Study|Withdrawal by Subject|1|||
155306915|NCT04287985|560555967|FG002|Overall Study|Withdrawal by Subject|1|||
155306916|NCT04287985|560555968|FG003|Overall Study|Withdrawal by Subject|2|||
155306917|NCT01340066|560555973|FG000|Placebo Run in Period|Screen Failures|27|||
155306918|NCT01340066|560555974|FG001|Placebo Run in Period|Screen Failures|0|||
155306919|NCT01340066|560555975|FG002|Placebo Run in Period|Screen Failures|0|||
155306920|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
155306921|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
155306922|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
155306923|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
155306924|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
155306925|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
155306926|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
155306927|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
155306928|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
155306929|NCT03771352|560555983|FG000|Overall Study|Screen failure|2|||
155306930|NCT03771352|560555983|FG000|Overall Study|Withdrawal by Subject|2|||
155306931|NCT00274469|560555984|FG000|Overall Study|Death|63|||
155306932|NCT00274469|560555985|FG001|Overall Study|Death|74|||
155306933|NCT00274469|560555984|FG000|Overall Study|Did not consent to OS follow-up|16|||
155413764|NCT00618748|560946214|FG000|Overall Study|Withdrawal by Subject|4|||
155413765|NCT00618748|560946215|FG001|Overall Study|Withdrawal by Subject|1|||
155413766|NCT00618748|560946216|FG002|Overall Study|Withdrawal by Subject|5|||
155306934|NCT00274469|560555985|FG001|Overall Study|Did not consent to OS follow-up|19|||
155306935|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306936|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306937|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
155306938|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306939|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
155306940|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
155413767|NCT03269344|560946217|FG000|Overall Study|Protocol Violation|4|||
155306941|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
155306942|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
155306943|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155306944|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155497406|NCT00962013|561244118|FG000|Overall Study|No 5 year evaluation|6|||
155497407|NCT00424632|561244121|FG000|Overall Study|Death|0|||
155497408|NCT00424632|561244122|FG001|Overall Study|Death|0|||
155497409|NCT00424632|561244123|FG002|Overall Study|Death|0|||
155306945|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
155306946|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155306947|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306948|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306949|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
155306950|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306951|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
155306952|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
155306953|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
155306954|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
155306955|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
155306956|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
155306957|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
155497410|NCT00424632|561244124|FG003|Overall Study|Death|0|||
155497411|NCT00424632|561244125|FG004|Overall Study|Death|0|||
155497412|NCT00424632|561244126|FG005|Overall Study|Death|2|||
155497413|NCT00424632|561244127|FG006|Overall Study|Death|0|||
155497414|NCT00424632|561244128|FG007|Overall Study|Death|0|||
155497415|NCT00424632|561244129|FG008|Overall Study|Death|0|||
155497416|NCT00424632|561244130|FG009|Overall Study|Death|0|||
155497417|NCT00424632|561244121|FG000|Overall Study|Adverse Event|0|||
155497418|NCT00424632|561244122|FG001|Overall Study|Adverse Event|0|||
155497419|NCT00424632|561244123|FG002|Overall Study|Adverse Event|0|||
155497420|NCT00424632|561244124|FG003|Overall Study|Adverse Event|0|||
155497421|NCT00424632|561244125|FG004|Overall Study|Adverse Event|0|||
155306958|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
155306959|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306960|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306961|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306962|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
155306963|NCT05494788|560555999|FG000|Initial Treatment Period|Adverse Event|2|||
155306964|NCT05494788|560555999|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155306965|NCT05494788|560555999|FG000|Extension Period|Adverse Event|1|||
155306966|NCT05494788|560555999|FG000|Extension Period|Withdrawal by Subject|1|||
155497422|NCT00424632|561244126|FG005|Overall Study|Adverse Event|0|||
155497423|NCT00424632|561244127|FG006|Overall Study|Adverse Event|0|||
155497424|NCT00424632|561244128|FG007|Overall Study|Adverse Event|0|||
155497425|NCT00424632|561244129|FG008|Overall Study|Adverse Event|3|||
155497426|NCT00424632|561244130|FG009|Overall Study|Adverse Event|2|||
155497427|NCT00424632|561244121|FG000|Overall Study|Global deterioration of health status|0|||
155497428|NCT00424632|561244122|FG001|Overall Study|Global deterioration of health status|0|||
155642283|NCT02969018|561780765|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155306967|NCT00136435|560556000|FG000|Overall Study|Ineligible|8|||
155497429|NCT00424632|561244123|FG002|Overall Study|Global deterioration of health status|0|||
155497430|NCT00424632|561244124|FG003|Overall Study|Global deterioration of health status|1|||
155497431|NCT00424632|561244125|FG004|Overall Study|Global deterioration of health status|1|||
155497432|NCT00424632|561244126|FG005|Overall Study|Global deterioration of health status|0|||
155497433|NCT00424632|561244127|FG006|Overall Study|Global deterioration of health status|0|||
155642284|NCT02969018|561780766|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155642285|NCT02969018|561780767|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155642286|NCT02969018|561780768|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155642287|NCT02969018|561780769|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155642288|NCT02969018|561780770|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
155642289|NCT02969018|561780771|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155642290|NCT02969018|561780764|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155642291|NCT02969018|561780765|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155642292|NCT02969018|561780766|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155642293|NCT02969018|561780767|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155642294|NCT02969018|561780768|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155642295|NCT02969018|561780769|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155642296|NCT02969018|561780770|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155642297|NCT02969018|561780771|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155642298|NCT02969018|561780764|FG000|Overall Study|Other|0|||
155642299|NCT02969018|561780765|FG001|Overall Study|Other|0|||
155642300|NCT02969018|561780766|FG002|Overall Study|Other|0|||
155642301|NCT02969018|561780767|FG003|Overall Study|Other|1|||
155642302|NCT02969018|561780768|FG004|Overall Study|Other|0|||
155642303|NCT02969018|561780769|FG005|Overall Study|Other|0|||
155306968|NCT00136435|560556000|FG000|Overall Study|Induction Death|1|||
155306969|NCT00136435|560556000|FG000|Overall Study|Induction Failure|10|||
155306970|NCT00136435|560556000|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
155306971|NCT00136435|560556000|FG000|Overall Study|Withdrawal by Subject|3|||
155306972|NCT00136435|560556000|FG000|Overall Study|Adverse Event|19|||
155306973|NCT00136435|560556000|FG000|Overall Study|Relapse|4|||
155306974|NCT00136435|560556000|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
155306975|NCT01017146|560556001|FG000|Overall Study|Adverse Event|11|||
155306976|NCT01017146|560556002|FG001|Overall Study|Adverse Event|1|||
155306977|NCT01017146|560556001|FG000|Overall Study|Lost to Follow-up|14|||
155497434|NCT00424632|561244128|FG007|Overall Study|Global deterioration of health status|0|||
155497435|NCT00424632|561244129|FG008|Overall Study|Global deterioration of health status|0|||
155306978|NCT01017146|560556002|FG001|Overall Study|Lost to Follow-up|14|||
155306979|NCT01017146|560556001|FG000|Overall Study|Noncompliance with Study Product|1|||
155306980|NCT01017146|560556002|FG001|Overall Study|Noncompliance with Study Product|1|||
155306981|NCT01017146|560556001|FG000|Overall Study|Withdrawal by Subject|32|||
155306982|NCT01017146|560556002|FG001|Overall Study|Withdrawal by Subject|16|||
155497436|NCT00424632|561244130|FG009|Overall Study|Global deterioration of health status|0|||
155497437|NCT00424632|561244121|FG000|Overall Study|Objective progression or relapse|1|||
155497438|NCT00424632|561244122|FG001|Overall Study|Objective progression or relapse|1|||
155497439|NCT00424632|561244123|FG002|Overall Study|Objective progression or relapse|1|||
155497440|NCT00424632|561244124|FG003|Overall Study|Objective progression or relapse|2|||
155497441|NCT00424632|561244125|FG004|Overall Study|Objective progression or relapse|2|||
155497442|NCT00424632|561244126|FG005|Overall Study|Objective progression or relapse|13|||
155497443|NCT00424632|561244127|FG006|Overall Study|Objective progression or relapse|7|||
155497444|NCT00424632|561244128|FG007|Overall Study|Objective progression or relapse|3|||
155497445|NCT00424632|561244129|FG008|Overall Study|Objective progression or relapse|12|||
155497446|NCT00424632|561244130|FG009|Overall Study|Objective progression or relapse|4|||
155497447|NCT00424632|561244121|FG000|Overall Study|Other|0|||
155497448|NCT00424632|561244122|FG001|Overall Study|Other|0|||
155497449|NCT00424632|561244123|FG002|Overall Study|Other|0|||
155497450|NCT00424632|561244124|FG003|Overall Study|Other|1|||
155497451|NCT00424632|561244125|FG004|Overall Study|Other|0|||
155497452|NCT00424632|561244126|FG005|Overall Study|Other|0|||
155497453|NCT00424632|561244127|FG006|Overall Study|Other|0|||
155497454|NCT00424632|561244128|FG007|Overall Study|Other|0|||
155497455|NCT00424632|561244129|FG008|Overall Study|Other|1|||
155497456|NCT00424632|561244130|FG009|Overall Study|Other|0|||
155497457|NCT02628418|561244131|FG000|Overall Study|Lost to Follow-up|1|||
155497458|NCT02628418|561244132|FG001|Overall Study|Lost to Follow-up|2|||
155497459|NCT01984229|561244135|FG000|Safety Follow-up Period|Adverse Event|1|||
155497460|NCT01984229|561244136|FG001|Safety Follow-up Period|Adverse Event|1|||
155497461|NCT01984229|561244135|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
155497462|NCT01984229|561244136|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
155497463|NCT01418365|561244143|FG000|First Intervention|Withdrawal by Subject|0|||
155497464|NCT01418365|561244144|FG001|First Intervention|Withdrawal by Subject|1|||
155497465|NCT01418365|561244143|FG000|First Intervention|Non-compliance|1|||
155497466|NCT01418365|561244144|FG001|First Intervention|Non-compliance|0|||
155497467|NCT01418365|561244143|FG000|Second Intervention|Withdrawal by Subject|0|||
155497468|NCT01418365|561244144|FG001|Second Intervention|Withdrawal by Subject|1|||
155497469|NCT03319368|561244149|FG000|Overall Study|Discharge swabs not collected from resident|57|||
155497470|NCT03319368|561244150|FG001|Overall Study|Discharge swabs not collected from resident|46|||
155497471|NCT04150107|561244155|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
155497472|NCT04150107|561244156|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
155497473|NCT04150107|561244155|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
155497474|NCT04150107|561244156|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
155497475|NCT00824993|561244157|FG000|Overall Study|Withdrawal by Subject|1|||
155497476|NCT00824993|561244158|FG001|Overall Study|Withdrawal by Subject|1|||
155306983|NCT01017146|560556001|FG000|Overall Study|Relocation|0|||
155306984|NCT01017146|560556002|FG001|Overall Study|Relocation|4|||
155497477|NCT00824993|561244157|FG000|Overall Study|Malignancy Relapse|9|||
155306985|NCT01017146|560556001|FG000|Overall Study|Pregnancy|2|||
155306986|NCT01017146|560556002|FG001|Overall Study|Pregnancy|1|||
155306987|NCT01017146|560556001|FG000|Overall Study|Protocol Violation|2|||
155497478|NCT00824993|561244158|FG001|Overall Study|Malignancy Relapse|10|||
155497479|NCT00824993|561244157|FG000|Overall Study|Rapid Bone Loss|0|||
155497480|NCT00824993|561244158|FG001|Overall Study|Rapid Bone Loss|1|||
155497481|NCT00824993|561244157|FG000|Overall Study|Non-Compliant|2|||
155497482|NCT00824993|561244158|FG001|Overall Study|Non-Compliant|1|||
155497483|NCT00824993|561244157|FG000|Overall Study|Insurance Issue|2|||
155497484|NCT00824993|561244158|FG001|Overall Study|Insurance Issue|1|||
155497485|NCT00824993|561244157|FG000|Overall Study|Death|0|||
155306988|NCT01017146|560556002|FG001|Overall Study|Protocol Violation|0|||
155306989|NCT01017146|560556001|FG000|Overall Study|Took Excluded Medication|2|||
155306990|NCT01017146|560556002|FG001|Overall Study|Took Excluded Medication|0|||
155497486|NCT00824993|561244158|FG001|Overall Study|Death|3|||
155497487|NCT00996632|561245427|FG000|Overall Study|Physician Decision|0|||
155497488|NCT00996632|561245428|FG001|Overall Study|Physician Decision|0|||
155497489|NCT01569594|561245431|FG000|Overall Study|Physician Decision|4|||
155497490|NCT01569594|561245431|FG000|Overall Study|Death|13|||
155497491|NCT01569594|561245431|FG000|Overall Study|Lost to Follow-up|22|||
155497492|NCT01569594|561245431|FG000|Overall Study|Adverse Event|2|||
155497493|NCT01569594|561245431|FG000|Overall Study|Withdrawal by Subject|13|||
155497494|NCT01569594|561245431|FG000|Overall Study|Other|4|||
155497495|NCT01569594|561245431|FG000|Overall Study|No ECM used|9|||
155497496|NCT03069365|561245432|FG000|Overall Study|Adverse Event|1|||
155497497|NCT02886494|561245433|FG000|Overall Study|Adverse Event|1|||
155497498|NCT02886494|561245434|FG001|Overall Study|Adverse Event|0|||
155497499|NCT02886494|561245433|FG000|Overall Study|Withdrawal by Subject|12|||
155497500|NCT02886494|561245434|FG001|Overall Study|Withdrawal by Subject|3|||
155497501|NCT02886494|561245433|FG000|Overall Study|Protocol Violation|4|||
155497502|NCT02886494|561245434|FG001|Overall Study|Protocol Violation|1|||
155306991|NCT01017146|560556001|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155306992|NCT01017146|560556002|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155306993|NCT01017146|560556001|FG000|Overall Study|Change in Work Situation|1|||
155306994|NCT01017146|560556002|FG001|Overall Study|Change in Work Situation|0|||
155306995|NCT00087139|560556003|FG000|Overall Study|Adverse Event|18|||
155306996|NCT00087139|560556004|FG001|Overall Study|Adverse Event|17|||
155306997|NCT00087139|560556005|FG002|Overall Study|Adverse Event|13|||
155306998|NCT00087139|560556003|FG000|Overall Study|Death|2|||
155306999|NCT00087139|560556004|FG001|Overall Study|Death|1|||
155307000|NCT00087139|560556005|FG002|Overall Study|Death|0|||
155307001|NCT00087139|560556003|FG000|Overall Study|Withdrawal by Subject|3|||
155307002|NCT00087139|560556004|FG001|Overall Study|Withdrawal by Subject|2|||
155307003|NCT00087139|560556005|FG002|Overall Study|Withdrawal by Subject|2|||
155307004|NCT00087139|560556003|FG000|Overall Study|Physician Decision|1|||
155307005|NCT00087139|560556004|FG001|Overall Study|Physician Decision|1|||
155307006|NCT00087139|560556005|FG002|Overall Study|Physician Decision|1|||
155307007|NCT00087139|560556003|FG000|Overall Study|Disease progression|9|||
155307008|NCT00087139|560556004|FG001|Overall Study|Disease progression|19|||
155307009|NCT00087139|560556005|FG002|Overall Study|Disease progression|12|||
155307010|NCT00087139|560556003|FG000|Overall Study|Ineligible|4|||
155307011|NCT00087139|560556004|FG001|Overall Study|Ineligible|7|||
155307012|NCT00087139|560556005|FG002|Overall Study|Ineligible|4|||
155307013|NCT00087139|560556003|FG000|Overall Study|Symptomatic deterioration|1|||
155307014|NCT00087139|560556004|FG001|Overall Study|Symptomatic deterioration|1|||
155307015|NCT00087139|560556005|FG002|Overall Study|Symptomatic deterioration|3|||
155307016|NCT00087139|560556003|FG000|Overall Study|Use of coumadin|1|||
155307017|NCT00087139|560556004|FG001|Overall Study|Use of coumadin|0|||
155307018|NCT00087139|560556005|FG002|Overall Study|Use of coumadin|0|||
155307019|NCT00087139|560556003|FG000|Overall Study|Response achieved|0|||
155307020|NCT00087139|560556004|FG001|Overall Study|Response achieved|1|||
155307021|NCT00087139|560556005|FG002|Overall Study|Response achieved|0|||
155307022|NCT00087139|560556003|FG000|Overall Study|Extradural disease|0|||
155307023|NCT00087139|560556004|FG001|Overall Study|Extradural disease|0|||
155307024|NCT00087139|560556005|FG002|Overall Study|Extradural disease|1|||
155307025|NCT02671435|560556014|FG000|Overall Study|Death|1|||
155307026|NCT02671435|560556015|FG001|Overall Study|Death|3|||
155307027|NCT02671435|560556016|FG002|Overall Study|Death|0|||
155307028|NCT02671435|560556017|FG003|Overall Study|Death|16|||
155307029|NCT02671435|560556018|FG004|Overall Study|Death|14|||
155307030|NCT02671435|560556019|FG005|Overall Study|Death|29|||
155307031|NCT02671435|560556020|FG006|Overall Study|Death|34|||
155307032|NCT02671435|560556021|FG007|Overall Study|Death|28|||
155307033|NCT02671435|560556022|FG008|Overall Study|Death|19|||
155307034|NCT02671435|560556023|FG009|Overall Study|Death|10|||
155642304|NCT02969018|561780770|FG006|Overall Study|Other|0|||
155642305|NCT02969018|561780771|FG007|Overall Study|Other|2|||
155642306|NCT02969018|561780764|FG000|Overall Study|Pregnancy|0|||
155307035|NCT02671435|560556024|FG010|Overall Study|Death|8|||
155497503|NCT00537056|561245438|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
155497504|NCT00203892|561245440|FG000|Overall Study|Physician Decision|1|||
155642307|NCT02969018|561780765|FG001|Overall Study|Pregnancy|0|||
155642308|NCT02969018|561780766|FG002|Overall Study|Pregnancy|0|||
155642309|NCT02969018|561780767|FG003|Overall Study|Pregnancy|0|||
155497505|NCT00203892|561245441|FG001|Overall Study|Physician Decision|2|||
155642310|NCT02969018|561780768|FG004|Overall Study|Pregnancy|0|||
155642311|NCT02969018|561780769|FG005|Overall Study|Pregnancy|1|||
155307036|NCT02671435|560556025|FG011|Overall Study|Death|29|||
155307037|NCT02671435|560556026|FG012|Overall Study|Death|29|||
155307038|NCT02671435|560556027|FG013|Overall Study|Death|29|||
155307039|NCT02671435|560556028|FG014|Overall Study|Death|27|||
155307040|NCT02671435|560556014|FG000|Overall Study|Lost to Follow-up|0|||
155307041|NCT02671435|560556015|FG001|Overall Study|Lost to Follow-up|0|||
155307042|NCT02671435|560556016|FG002|Overall Study|Lost to Follow-up|1|||
155307043|NCT02671435|560556017|FG003|Overall Study|Lost to Follow-up|0|||
155307044|NCT02671435|560556018|FG004|Overall Study|Lost to Follow-up|1|||
155497506|NCT00203892|561245442|FG002|Overall Study|Physician Decision|0|||
155497507|NCT00203892|561245440|FG000|Overall Study|Death|1|||
155307045|NCT02671435|560556019|FG005|Overall Study|Lost to Follow-up|1|||
155307046|NCT02671435|560556020|FG006|Overall Study|Lost to Follow-up|2|||
155307047|NCT02671435|560556021|FG007|Overall Study|Lost to Follow-up|2|||
155307048|NCT02671435|560556022|FG008|Overall Study|Lost to Follow-up|0|||
155307049|NCT02671435|560556023|FG009|Overall Study|Lost to Follow-up|2|||
155307050|NCT02671435|560556024|FG010|Overall Study|Lost to Follow-up|0|||
155307051|NCT02671435|560556025|FG011|Overall Study|Lost to Follow-up|3|||
155307052|NCT02671435|560556026|FG012|Overall Study|Lost to Follow-up|3|||
155307053|NCT02671435|560556027|FG013|Overall Study|Lost to Follow-up|2|||
155307054|NCT02671435|560556028|FG014|Overall Study|Lost to Follow-up|0|||
155307055|NCT02671435|560556014|FG000|Overall Study|Withdrawal by Subject|2|||
155307056|NCT02671435|560556015|FG001|Overall Study|Withdrawal by Subject|0|||
155307057|NCT02671435|560556016|FG002|Overall Study|Withdrawal by Subject|2|||
155307058|NCT02671435|560556017|FG003|Overall Study|Withdrawal by Subject|2|||
155307059|NCT02671435|560556018|FG004|Overall Study|Withdrawal by Subject|2|||
155307060|NCT02671435|560556019|FG005|Overall Study|Withdrawal by Subject|7|||
155307061|NCT02671435|560556020|FG006|Overall Study|Withdrawal by Subject|2|||
155307062|NCT02671435|560556021|FG007|Overall Study|Withdrawal by Subject|7|||
155307063|NCT02671435|560556022|FG008|Overall Study|Withdrawal by Subject|1|||
155307064|NCT02671435|560556023|FG009|Overall Study|Withdrawal by Subject|1|||
155307065|NCT02671435|560556024|FG010|Overall Study|Withdrawal by Subject|2|||
155307066|NCT02671435|560556025|FG011|Overall Study|Withdrawal by Subject|4|||
155307067|NCT02671435|560556026|FG012|Overall Study|Withdrawal by Subject|4|||
155307068|NCT02671435|560556027|FG013|Overall Study|Withdrawal by Subject|4|||
155307069|NCT02671435|560556028|FG014|Overall Study|Withdrawal by Subject|2|||
155307070|NCT02671435|560556014|FG000|Overall Study|Un-specified|0|||
155307071|NCT02671435|560556015|FG001|Overall Study|Un-specified|0|||
155307072|NCT02671435|560556016|FG002|Overall Study|Un-specified|0|||
155307073|NCT02671435|560556017|FG003|Overall Study|Un-specified|0|||
155307074|NCT02671435|560556018|FG004|Overall Study|Un-specified|1|||
155307075|NCT02671435|560556019|FG005|Overall Study|Un-specified|3|||
155307076|NCT02671435|560556020|FG006|Overall Study|Un-specified|2|||
155307077|NCT02671435|560556021|FG007|Overall Study|Un-specified|3|||
155307078|NCT02671435|560556022|FG008|Overall Study|Un-specified|0|||
155307079|NCT02671435|560556023|FG009|Overall Study|Un-specified|5|||
155307080|NCT02671435|560556024|FG010|Overall Study|Un-specified|8|||
155307081|NCT02671435|560556025|FG011|Overall Study|Un-specified|4|||
155307082|NCT02671435|560556026|FG012|Overall Study|Un-specified|5|||
155413768|NCT03269344|560946218|FG001|Overall Study|Protocol Violation|3|||
155413769|NCT02479802|560946223|FG000|Overall Study|Lost to Follow-up|1|||
155413770|NCT02479802|560946223|FG000|Overall Study|Adverse Event|1|||
155413771|NCT03124784|560946228|FG000|Overall Study|Adverse Event|1|||
155413772|NCT03124784|560946228|FG000|Overall Study|Computer/Equip Malfunction|1|||
155413773|NCT05702515|560946229|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
155413774|NCT02162732|560946230|FG000|Overall Study|Biopsy not performed.|18|||
155413775|NCT01784965|560946231|FG000|Overall Study|Withdrawal by Subject|6|||
155413776|NCT01784965|560946232|FG001|Overall Study|Withdrawal by Subject|3|||
155413777|NCT01784965|560946231|FG000|Overall Study|Adverse Event|0|||
155413778|NCT01784965|560946232|FG001|Overall Study|Adverse Event|8|||
155413779|NCT03757988|560946235|FG000|Overall Study|Withdrawal by Subject|1|||
155413780|NCT05289830|560946236|FG000|Overall Study|Lost to Follow-up|1|||
155413781|NCT05289830|560946237|FG001|Overall Study|Lost to Follow-up|1|||
155413782|NCT05289830|560946236|FG000|Overall Study|Physician Decision|0|||
155413783|NCT05289830|560946237|FG001|Overall Study|Physician Decision|1|||
155413784|NCT02847624|560946238|FG000|Overall Study|Lost to Follow-up|28|||
155413785|NCT02847624|560946238|FG000|Overall Study|Protocol Violation|98|||
155413786|NCT02847624|560946238|FG000|Overall Study|Case report failures|4|||
155413787|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
155413788|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
155413789|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
155413790|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
155413791|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155413792|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155413793|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
155413794|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155413795|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
155413796|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155413797|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155413798|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155413799|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
155413800|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
155413801|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
155413802|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
155497508|NCT00203892|561245441|FG001|Overall Study|Death|0|||
155497509|NCT00203892|561245442|FG002|Overall Study|Death|0|||
155497510|NCT00556166|561245453|FG000|Overall Study|Withdrawal by Subject|1|||
155497511|NCT01612780|561245454|FG000|Overall Study|Treatment not completed|1|||
155497512|NCT01612780|561245454|FG000|Overall Study|Withdrawal by Subject|5|||
155497513|NCT00244881|561245457|FG000|Overall Study|Withdrawal by Subject|3|||
155497514|NCT02985515|561245458|FG000|Olfaction Testing|Lost to Follow-up|0|||
155497515|NCT02985515|561245459|FG001|Olfaction Testing|Lost to Follow-up|5|||
155497516|NCT02985515|561245458|FG000|Olfaction Testing|Protocol Violation|0|||
155497517|NCT02985515|561245459|FG001|Olfaction Testing|Protocol Violation|3|||
155497518|NCT03020966|561245460|FG000|Overall Study|Withdrawal by Subject|2|||
155497519|NCT03020966|561245461|FG001|Overall Study|Withdrawal by Subject|0|||
155497520|NCT01060007|561245464|FG000|Overall Study|Withdrawal by Subject|1|||
155497521|NCT01060007|561245464|FG000|Overall Study|Inevaluable for response at surgery|3|||
155497522|NCT03159611|561245468|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
155497523|NCT03159611|561245469|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
155497524|NCT03159611|561245468|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
155497525|NCT03159611|561245469|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
155497526|NCT03159611|561245468|FG000|Overall Study|Protocol Violation|7|||
155497527|NCT03159611|561245469|FG001|Overall Study|Protocol Violation|4|||
155497528|NCT03159611|561245468|FG000|Overall Study|Adverse Event|1|||
155497529|NCT03159611|561245469|FG001|Overall Study|Adverse Event|0|||
155497530|NCT03159611|561245468|FG000|Overall Study|Withdrawal by Subject|1|||
155497531|NCT03159611|561245469|FG001|Overall Study|Withdrawal by Subject|1|||
155497532|NCT03159611|561245468|FG000|Overall Study|Non-compliance with protocol requirement|3|||
155497533|NCT03159611|561245469|FG001|Overall Study|Non-compliance with protocol requirement|2|||
155497534|NCT03159611|561245468|FG000|Overall Study|Inability to perform procedures|1|||
155497535|NCT03159611|561245469|FG001|Overall Study|Inability to perform procedures|0|||
155497536|NCT02072174|561245470|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
155497537|NCT02072174|561245471|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
155497538|NCT02072174|561245470|FG000|Overall Study|Protocol Violation|16|||
155497539|NCT02072174|561245471|FG001|Overall Study|Protocol Violation|23|||
155497540|NCT02072174|561245470|FG000|Overall Study|Physician Decision|0|||
155497541|NCT02072174|561245471|FG001|Overall Study|Physician Decision|1|||
155497542|NCT02072174|561245470|FG000|Overall Study|Non-compliance with protocol requirement|2|||
155497543|NCT02072174|561245471|FG001|Overall Study|Non-compliance with protocol requirement|0|||
155497544|NCT05674721|561245472|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
155497545|NCT05674721|561245473|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
155497546|NCT05674721|561245472|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
155497547|NCT05674721|561245473|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
155497548|NCT03506425|561245483|FG000|Overall Study|Adverse Event|1|||
155497549|NCT03506425|561245484|FG001|Overall Study|Adverse Event|3|||
155497550|NCT03506425|561245485|FG002|Overall Study|Adverse Event|0|||
155497551|NCT03506425|561245483|FG000|Overall Study|Death|1|||
155497552|NCT03506425|561245484|FG001|Overall Study|Death|0|||
155497553|NCT03506425|561245485|FG002|Overall Study|Death|0|||
155497554|NCT03506425|561245483|FG000|Overall Study|Withdrawal by Subject|0|||
155497555|NCT03506425|561245484|FG001|Overall Study|Withdrawal by Subject|0|||
155497556|NCT03506425|561245485|FG002|Overall Study|Withdrawal by Subject|1|||
155497557|NCT03409328|561245486|FG000|Overall Study|Lost to Follow-up|6|||
155497558|NCT03409328|561245487|FG001|Overall Study|Lost to Follow-up|3|||
155497559|NCT02998645|561245488|FG000|Treatment Period 1|Adverse Event|6|||
155307083|NCT02671435|560556027|FG013|Overall Study|Un-specified|9|||
155307084|NCT02671435|560556028|FG014|Overall Study|Un-specified|8|||
155307085|NCT04095104|560556029|FG000|Overall Study|Withdrawal by Subject|0|||
155307086|NCT04095104|560556030|FG001|Overall Study|Withdrawal by Subject|1|||
155307087|NCT05048186|560556033|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
155307088|NCT05048186|560556034|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
155307089|NCT05048186|560556033|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
155307090|NCT05048186|560556034|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
155307091|NCT02412748|560556035|FG000|Overall Study|Lost to Follow-up|38|||
155307092|NCT02412748|560556036|FG001|Overall Study|Lost to Follow-up|39|||
155307093|NCT00976937|560556037|FG000|Overall Study|Adverse Event|4|||
155307094|NCT00976937|560556038|FG001|Overall Study|Adverse Event|5|||
155497560|NCT02998645|561245488|FG000|Treatment Period 1|Death|5|||
155497561|NCT02998645|561245488|FG000|Treatment Period 1|Technical Problems|4|||
155497562|NCT02998645|561245488|FG000|Treatment Period 1|Lack of Efficacy|2|||
155497563|NCT02998645|561245488|FG000|Treatment Period 1|Progressive disease|1|||
155497564|NCT02998645|561245488|FG000|Treatment Period 1|Subject/guardian decision|1|||
155497565|NCT02998645|561245488|FG000|Treatment Period 2|Lack of Efficacy|5|||
155497566|NCT02998645|561245488|FG000|Treatment Period 2|Adverse Event|2|||
155497567|NCT02998645|561245488|FG000|Treatment Period 2|Progressive disease|2|||
155497568|NCT02998645|561245488|FG000|Treatment Period 2|Physician Decision|1|||
155307095|NCT00976937|560556037|FG000|Overall Study|Lost to Follow-up|2|||
155497569|NCT03701516|561245489|FG000|Period 1|Lost to Follow-up|0|||
155497570|NCT03701516|561245490|FG001|Period 1|Lost to Follow-up|1|||
155497571|NCT03701516|561245489|FG000|Period 1|Adverse Event|0|||
155497572|NCT03701516|561245490|FG001|Period 1|Adverse Event|2|||
155497573|NCT03701516|561245489|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
155497574|NCT03701516|561245490|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
155497575|NCT03701516|561245489|FG000|Period 1|Non Compliance to Protocol|2|||
155497576|NCT03701516|561245490|FG001|Period 1|Non Compliance to Protocol|1|||
155497577|NCT03701516|561245489|FG000|Period 1|Withdrawal by Subject|0|||
155497578|NCT03701516|561245490|FG001|Period 1|Withdrawal by Subject|1|||
155497579|NCT03701516|561245489|FG000|Period 2|failed to meet all eligibility creiteria|1|||
155497580|NCT03701516|561245490|FG001|Period 2|failed to meet all eligibility creiteria|0|||
155497581|NCT03701516|561245489|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
155497582|NCT03701516|561245490|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
155497583|NCT00478673|561245491|FG000|30-Days Post-Procedure|Death|2|||
155497584|NCT00478673|561245491|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
155497585|NCT00478673|561245491|FG000|30-Days Post-Procedure|Missed Visit|7|||
155497586|NCT00478673|561245491|FG000|12-Months Post-Procedure|Death|23|||
155497587|NCT00478673|561245491|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
155497588|NCT00478673|561245491|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
155497589|NCT00478673|561245491|FG000|12-Months Post-Procedure|Missed Visit|25|||
155497590|NCT00478673|561245491|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
155497591|NCT03930615|561245492|FG000|Overall Study|Death|9|||
155497592|NCT03930615|561245493|FG001|Overall Study|Death|3|||
155497593|NCT03930615|561245492|FG000|Overall Study|Lost to Follow-up|1|||
155497594|NCT03930615|561245493|FG001|Overall Study|Lost to Follow-up|2|||
155497595|NCT03930615|561245492|FG000|Overall Study|Physician Decision|3|||
155307096|NCT00976937|560556038|FG001|Overall Study|Lost to Follow-up|1|||
155307097|NCT00976937|560556037|FG000|Overall Study|Withdrawal by Subject|5|||
155307098|NCT00976937|560556038|FG001|Overall Study|Withdrawal by Subject|3|||
155307099|NCT00976937|560556037|FG000|Overall Study|Poor compliance to protocol|3|||
155307100|NCT00976937|560556038|FG001|Overall Study|Poor compliance to protocol|0|||
155307101|NCT00976937|560556037|FG000|Overall Study|Personal and Familial Reason|2|||
155413803|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
155497596|NCT03930615|561245493|FG001|Overall Study|Physician Decision|4|||
155497597|NCT03930615|561245492|FG000|Overall Study|Withdrawal by Subject|13|||
155307102|NCT00976937|560556038|FG001|Overall Study|Personal and Familial Reason|2|||
155413804|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
155413805|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
155413806|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
155413807|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
155413808|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
155413809|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
155413810|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
155413811|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
155413812|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
155413813|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
155413814|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
155413815|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
155413816|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
155413817|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
155413818|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
155413819|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
155413820|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
155413821|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
155413822|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
155413823|NCT03403205|560946247|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
155413824|NCT03403205|560946248|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
155413825|NCT03403205|560946249|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
155413826|NCT03403205|560946250|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
155413827|NCT03403205|560946251|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
155413828|NCT03403205|560946252|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
155413829|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
155497598|NCT03930615|561245493|FG001|Overall Study|Withdrawal by Subject|2|||
155497599|NCT03930615|561245492|FG000|Overall Study|Not treated|1|||
155497600|NCT03930615|561245493|FG001|Overall Study|Not treated|1|||
155497601|NCT03644927|561245498|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
155497602|NCT03644927|561245499|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
155307103|NCT04218266|560556039|FG000|Overall Study|Death|1|||
155307104|NCT04218266|560556040|FG001|Overall Study|Death|2|||
155307105|NCT04218266|560556041|FG002|Overall Study|Death|3|||
155307106|NCT04218266|560556039|FG000|Overall Study|Adverse Event|13|||
155307107|NCT04218266|560556040|FG001|Overall Study|Adverse Event|14|||
155307108|NCT04218266|560556041|FG002|Overall Study|Adverse Event|11|||
155307109|NCT04218266|560556039|FG000|Overall Study|Other|7|||
155307110|NCT04218266|560556040|FG001|Overall Study|Other|5|||
155307111|NCT04218266|560556041|FG002|Overall Study|Other|14|||
155307112|NCT04218266|560556039|FG000|Overall Study|Physician Decision|1|||
155307113|NCT04218266|560556040|FG001|Overall Study|Physician Decision|3|||
155307114|NCT04218266|560556041|FG002|Overall Study|Physician Decision|2|||
155307115|NCT04218266|560556039|FG000|Overall Study|Non-compliance with study drug|0|||
155307116|NCT04218266|560556040|FG001|Overall Study|Non-compliance with study drug|0|||
155307117|NCT04218266|560556041|FG002|Overall Study|Non-compliance with study drug|1|||
155307118|NCT04218266|560556039|FG000|Overall Study|Withdrawal by Subject|1|||
155307119|NCT04218266|560556040|FG001|Overall Study|Withdrawal by Subject|3|||
155307120|NCT04218266|560556041|FG002|Overall Study|Withdrawal by Subject|1|||
155307121|NCT04218266|560556039|FG000|Overall Study|Study drug never administered|2|||
155307122|NCT04218266|560556040|FG001|Overall Study|Study drug never administered|0|||
155307123|NCT04218266|560556041|FG002|Overall Study|Study drug never administered|0|||
155307124|NCT00761189|560556043|FG000|Overall Study|Adverse Event|42|||
155307125|NCT00761189|560556043|FG000|Overall Study|Lack of Efficacy|45|||
155307126|NCT00761189|560556043|FG000|Overall Study|Lost to Follow-up|36|||
155307127|NCT00761189|560556043|FG000|Overall Study|Withdrawal by Subject|49|||
155307128|NCT00761189|560556043|FG000|Overall Study|Other|13|||
155307129|NCT01494922|560556044|FG000|Overall Study|Adverse Event|1|||
155307130|NCT01227265|560556046|FG000|Overall Study|Did Not Receive Treatment|1|||
155307131|NCT01227265|560556047|FG001|Overall Study|Did Not Receive Treatment|2|||
155307132|NCT01227265|560556048|FG002|Overall Study|Did Not Receive Treatment|0|||
155307133|NCT01227265|560556046|FG000|Overall Study|Administrative|1|||
155307134|NCT01227265|560556047|FG001|Overall Study|Administrative|0|||
155307135|NCT01227265|560556048|FG002|Overall Study|Administrative|2|||
155307136|NCT01227265|560556046|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
155307137|NCT01227265|560556047|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155307138|NCT01227265|560556048|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
155307139|NCT01227265|560556046|FG000|Overall Study|Protocol Violation|2|||
155307140|NCT01227265|560556047|FG001|Overall Study|Protocol Violation|1|||
155307141|NCT01227265|560556048|FG002|Overall Study|Protocol Violation|0|||
155307142|NCT01227265|560556046|FG000|Overall Study|Withdrawal by Subject|7|||
155307143|NCT01227265|560556047|FG001|Overall Study|Withdrawal by Subject|7|||
155307144|NCT01227265|560556048|FG002|Overall Study|Withdrawal by Subject|3|||
155307145|NCT01227265|560556046|FG000|Overall Study|Lost to Follow-up|2|||
155307146|NCT01227265|560556047|FG001|Overall Study|Lost to Follow-up|0|||
155413830|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
155413831|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
155413832|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
155413833|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
155413834|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
155413835|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
155413836|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
155413837|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
155413838|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
155413839|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
155413840|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
155413841|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Death|1|||
155413842|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Death|0|||
155413843|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Death|0|||
155413844|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Death|0|||
155413845|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Death|0|||
155413846|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Death|0|||
155307147|NCT01227265|560556048|FG002|Overall Study|Lost to Follow-up|3|||
155307148|NCT01227265|560556046|FG000|Overall Study|Adverse Event|6|||
155307149|NCT01227265|560556047|FG001|Overall Study|Adverse Event|10|||
155307150|NCT01227265|560556048|FG002|Overall Study|Adverse Event|5|||
155413847|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
155413848|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
155413849|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
155413850|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
155413851|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
155413852|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
155413853|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
155307151|NCT02269475|560556049|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
155307152|NCT02269475|560556050|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
155307153|NCT02269475|560556049|FG000|Overall Study|Withdrawal by Subject|0|||
155307154|NCT02269475|560556050|FG001|Overall Study|Withdrawal by Subject|1|||
155307155|NCT01037985|560556051|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
155413854|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
155413855|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
155413856|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
155413857|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
155413858|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
155413859|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
155413860|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
155413861|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
155413862|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
155413863|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
155413864|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
155413865|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
155413866|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
155413867|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
155413868|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
155413869|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
155413870|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
155413871|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
155413872|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
155413873|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
155413874|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
155413875|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
155413876|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
155413877|NCT03403205|560946247|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
155413878|NCT03403205|560946248|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
155413879|NCT03403205|560946249|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
155413880|NCT03403205|560946250|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
155413881|NCT03403205|560946251|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
155413882|NCT03403205|560946252|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
155413883|NCT00706030|560946253|FG000|Overall Study|Disease Progression|4|||
155413884|NCT00706030|560946254|FG001|Overall Study|Disease Progression|6|||
155413885|NCT00706030|560946255|FG002|Overall Study|Disease Progression|46|||
155413886|NCT00706030|560946256|FG003|Overall Study|Disease Progression|12|||
155413887|NCT00706030|560946253|FG000|Overall Study|Adverse Event|1|||
155413888|NCT00706030|560946254|FG001|Overall Study|Adverse Event|0|||
155413889|NCT00706030|560946255|FG002|Overall Study|Adverse Event|4|||
155413890|NCT00706030|560946256|FG003|Overall Study|Adverse Event|2|||
155413891|NCT00706030|560946253|FG000|Overall Study|Withdrawal by Subject|1|||
155413892|NCT00706030|560946254|FG001|Overall Study|Withdrawal by Subject|0|||
155413893|NCT00706030|560946255|FG002|Overall Study|Withdrawal by Subject|2|||
155413894|NCT00706030|560946256|FG003|Overall Study|Withdrawal by Subject|0|||
155413895|NCT00706030|560946253|FG000|Overall Study|Physician Decision|0|||
155413896|NCT00706030|560946254|FG001|Overall Study|Physician Decision|0|||
155413897|NCT00706030|560946255|FG002|Overall Study|Physician Decision|2|||
155413898|NCT00706030|560946256|FG003|Overall Study|Physician Decision|0|||
155413899|NCT00706030|560946253|FG000|Overall Study|Not recorded|0|||
155413900|NCT00706030|560946254|FG001|Overall Study|Not recorded|0|||
155413901|NCT00706030|560946255|FG002|Overall Study|Not recorded|2|||
155413902|NCT00706030|560946256|FG003|Overall Study|Not recorded|0|||
155413903|NCT00706030|560946253|FG000|Overall Study|Protocol Violation|0|||
155413904|NCT00706030|560946254|FG001|Overall Study|Protocol Violation|0|||
155413905|NCT00706030|560946255|FG002|Overall Study|Protocol Violation|1|||
155413906|NCT00706030|560946256|FG003|Overall Study|Protocol Violation|1|||
155413907|NCT00706030|560946253|FG000|Overall Study|Failed to return|0|||
155413908|NCT00706030|560946254|FG001|Overall Study|Failed to return|0|||
155413909|NCT00706030|560946255|FG002|Overall Study|Failed to return|1|||
155413910|NCT00706030|560946256|FG003|Overall Study|Failed to return|0|||
155413911|NCT00706030|560946253|FG000|Overall Study|Symptomatic Deterioration|0|||
155413912|NCT00706030|560946254|FG001|Overall Study|Symptomatic Deterioration|0|||
155413913|NCT00706030|560946255|FG002|Overall Study|Symptomatic Deterioration|1|||
155413914|NCT00706030|560946256|FG003|Overall Study|Symptomatic Deterioration|0|||
155413915|NCT00706030|560946253|FG000|Overall Study|No treatment received|0|||
155413916|NCT00706030|560946254|FG001|Overall Study|No treatment received|0|||
155413917|NCT00706030|560946255|FG002|Overall Study|No treatment received|0|||
155642312|NCT02969018|561780770|FG006|Overall Study|Pregnancy|0|||
155642313|NCT02969018|561780771|FG007|Overall Study|Pregnancy|0|||
155642314|NCT02969018|561780764|FG000|Overall Study|Protocol Violation|0|||
155413918|NCT00706030|560946256|FG003|Overall Study|No treatment received|1|||
155413919|NCT00706030|560946253|FG000|Overall Study|Death|0|||
155413920|NCT00706030|560946254|FG001|Overall Study|Death|0|||
155413921|NCT00706030|560946255|FG002|Overall Study|Death|1|||
155413922|NCT00706030|560946256|FG003|Overall Study|Death|0|||
155413923|NCT05779072|560946257|FG000|Overall Study|Lost to Follow-up|0|||
155642315|NCT02969018|561780765|FG001|Overall Study|Protocol Violation|0|||
155413924|NCT05779072|560946258|FG001|Overall Study|Lost to Follow-up|1|||
155413925|NCT05779072|560946257|FG000|Overall Study|Withdrawal by Subject|1|||
155413926|NCT05779072|560946258|FG001|Overall Study|Withdrawal by Subject|5|||
155413927|NCT03847610|560946259|FG000|Overall Study|Withdrawal by Subject|1|||
155413928|NCT02004873|560946260|FG000|Overall Study|Implant unsuccessful|6|||
155413929|NCT02004873|560946260|FG000|Overall Study|Awaiting 6-month visit|390|||
155413930|NCT02004873|560946260|FG000|Overall Study|Missed 6-month visit|4|||
155413931|NCT02004873|560946260|FG000|Overall Study|Death|23|||
155413932|NCT02004873|560946260|FG000|Overall Study|Withdrawal by Subject|1|||
155413933|NCT01445769|560946261|FG000|Overall Study|Consent Withdrawn|2|||
155413934|NCT01445769|560946261|FG000|Overall Study|Disease Progression|1|||
155413935|NCT01445769|560946261|FG000|Overall Study|Lost to Follow-up|5|||
155413936|NCT02799069|560946264|FG000|Overall Study|Adverse Event|0|||
155413937|NCT02799069|560946265|FG001|Overall Study|Adverse Event|2|||
155413938|NCT02799069|560946266|FG002|Overall Study|Adverse Event|2|||
155413939|NCT02799069|560946264|FG000|Overall Study|Lack of Efficacy|2|||
155413940|NCT02799069|560946265|FG001|Overall Study|Lack of Efficacy|0|||
155413941|NCT02799069|560946266|FG002|Overall Study|Lack of Efficacy|0|||
155413942|NCT02799069|560946264|FG000|Overall Study|Lost to Follow-up|1|||
155413943|NCT02799069|560946265|FG001|Overall Study|Lost to Follow-up|1|||
155413944|NCT02799069|560946266|FG002|Overall Study|Lost to Follow-up|0|||
155413945|NCT02799069|560946264|FG000|Overall Study|Withdrawal by Subject|4|||
155413946|NCT02799069|560946265|FG001|Overall Study|Withdrawal by Subject|4|||
155413947|NCT02799069|560946266|FG002|Overall Study|Withdrawal by Subject|3|||
155413948|NCT02799069|560946264|FG000|Overall Study|Protocol Violation|1|||
155413949|NCT02799069|560946265|FG001|Overall Study|Protocol Violation|0|||
155413950|NCT02799069|560946266|FG002|Overall Study|Protocol Violation|2|||
155413951|NCT03212170|560946275|FG000|Overall Study|Withdrawal by Subject|1|||
155413952|NCT02678390|560946277|FG000|AE (1 Day)|Withdrawal by Subject|0|||
155413953|NCT02678390|560946278|FG001|AE (1 Day)|Withdrawal by Subject|1|||
155413954|NCT02925156|560946279|FG000|Overall Study|Lost to Follow-up|27|||
155413955|NCT02925156|560946280|FG001|Overall Study|Lost to Follow-up|53|||
155413956|NCT02925156|560946281|FG002|Overall Study|Lost to Follow-up|51|||
155413957|NCT02925156|560946282|FG003|Overall Study|Lost to Follow-up|59|||
155413958|NCT02925156|560946283|FG004|Overall Study|Lost to Follow-up|89|||
155413959|NCT02925156|560946284|FG005|Overall Study|Lost to Follow-up|107|||
155413960|NCT02925156|560946285|FG006|Overall Study|Lost to Follow-up|34|||
155413961|NCT02925156|560946286|FG007|Overall Study|Lost to Follow-up|36|||
155413962|NCT02925156|560946287|FG008|Overall Study|Lost to Follow-up|73|||
155413963|NCT02925156|560946288|FG009|Overall Study|Lost to Follow-up|34|||
155413964|NCT01681433|560946291|FG000|Overall Study|Lack of Efficacy|23|||
155413965|NCT01681433|560946292|FG001|Overall Study|Lack of Efficacy|23|||
155413966|NCT01681433|560946291|FG000|Overall Study|Withdrawal by Subject|5|||
155413967|NCT01681433|560946292|FG001|Overall Study|Withdrawal by Subject|5|||
155413968|NCT01681433|560946291|FG000|Overall Study|Protocol Violation|2|||
155413969|NCT01681433|560946292|FG001|Overall Study|Protocol Violation|0|||
155413970|NCT01681433|560946291|FG000|Overall Study|Adverse Event|2|||
155497603|NCT00956813|561245500|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
155642316|NCT02969018|561780766|FG002|Overall Study|Protocol Violation|1|||
155642317|NCT02969018|561780767|FG003|Overall Study|Protocol Violation|1|||
155642318|NCT02969018|561780768|FG004|Overall Study|Protocol Violation|0|||
155642319|NCT02969018|561780769|FG005|Overall Study|Protocol Violation|0|||
155642320|NCT02969018|561780770|FG006|Overall Study|Protocol Violation|0|||
155642321|NCT02969018|561780771|FG007|Overall Study|Protocol Violation|0|||
155642322|NCT02969018|561780764|FG000|Overall Study|Withdrawal by Subject|0|||
155642323|NCT02969018|561780765|FG001|Overall Study|Withdrawal by Subject|1|||
155642324|NCT02969018|561780766|FG002|Overall Study|Withdrawal by Subject|2|||
155642325|NCT02969018|561780767|FG003|Overall Study|Withdrawal by Subject|1|||
155413971|NCT01681433|560946292|FG001|Overall Study|Adverse Event|4|||
155413972|NCT01681433|560946291|FG000|Overall Study|Lost to Follow-up|0|||
155413973|NCT01681433|560946292|FG001|Overall Study|Lost to Follow-up|1|||
155413974|NCT00730639|560946293|FG000|Overall Study|Adverse Event|3|||
155413975|NCT00730639|560946294|FG001|Overall Study|Adverse Event|0|||
155413976|NCT00730639|560946295|FG002|Overall Study|Adverse Event|9|||
155413977|NCT00730639|560946296|FG003|Overall Study|Adverse Event|8|||
155413978|NCT00730639|560946297|FG004|Overall Study|Adverse Event|23|||
155413979|NCT00730639|560946293|FG000|Overall Study|Complete Response|0|||
155413980|NCT00730639|560946294|FG001|Overall Study|Complete Response|0|||
155413981|NCT00730639|560946295|FG002|Overall Study|Complete Response|2|||
155413982|NCT00730639|560946296|FG003|Overall Study|Complete Response|2|||
155413983|NCT00730639|560946297|FG004|Overall Study|Complete Response|1|||
155413984|NCT00730639|560946293|FG000|Overall Study|Completed Maximum Cycles|0|||
155413985|NCT00730639|560946294|FG001|Overall Study|Completed Maximum Cycles|0|||
155413986|NCT00730639|560946295|FG002|Overall Study|Completed Maximum Cycles|11|||
155413987|NCT00730639|560946296|FG003|Overall Study|Completed Maximum Cycles|3|||
155413988|NCT00730639|560946297|FG004|Overall Study|Completed Maximum Cycles|6|||
155642326|NCT02969018|561780768|FG004|Overall Study|Withdrawal by Subject|0|||
155307156|NCT01037985|560556052|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
155307157|NCT01037985|560556051|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
155307158|NCT01037985|560556052|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
155307159|NCT01037985|560556051|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
155307160|NCT01037985|560556052|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
155307161|NCT01037985|560556051|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
155307162|NCT01037985|560556052|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
155307163|NCT02730871|560556055|FG000|Overall Study|Adverse Event|6|||
155307164|NCT02730871|560556056|FG001|Overall Study|Adverse Event|0|||
155307165|NCT05368558|560556057|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
155307166|NCT05368558|560556058|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
155307167|NCT05368558|560556059|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
155307168|NCT05368558|560556060|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307169|NCT05368558|560556061|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307170|NCT05368558|560556062|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307171|NCT05368558|560556063|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307172|NCT05368558|560556064|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307173|NCT05368558|560556065|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307174|NCT05368558|560556066|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307175|NCT05368558|560556067|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307176|NCT05368558|560556068|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155497604|NCT00956813|561245501|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
155497605|NCT00956813|561245500|FG000|Flaxseed and Placebo|Ineligible|3|||
155497606|NCT00956813|561245501|FG001|Flaxseed and Placebo|Ineligible|1|||
155497607|NCT02380248|561245502|FG000|Overall Study|Lost to Follow-up|11|||
155497608|NCT02380248|561245502|FG000|Overall Study|Withdrawal by Subject|3|||
155642327|NCT02969018|561780769|FG005|Overall Study|Withdrawal by Subject|4|||
155642328|NCT02969018|561780770|FG006|Overall Study|Withdrawal by Subject|4|||
155642329|NCT02969018|561780771|FG007|Overall Study|Withdrawal by Subject|3|||
155642330|NCT04790201|561780772|FG000|Overall Study|Lost to Follow-up|0|||
155642331|NCT04790201|561780773|FG001|Overall Study|Lost to Follow-up|0|||
155642332|NCT04790201|561780774|FG002|Overall Study|Lost to Follow-up|2|||
155642333|NCT04790201|561780772|FG000|Overall Study|Death|0|||
155642334|NCT04790201|561780773|FG001|Overall Study|Death|1|||
155642335|NCT04790201|561780774|FG002|Overall Study|Death|0|||
155642336|NCT04790201|561780772|FG000|Overall Study|Protocol Violation|1|||
155642337|NCT04790201|561780773|FG001|Overall Study|Protocol Violation|0|||
155642338|NCT04790201|561780774|FG002|Overall Study|Protocol Violation|1|||
155642339|NCT00376506|561780776|FG000|Overall Study|Death|0|||
155642340|NCT00376506|561780777|FG001|Overall Study|Death|2|||
155642341|NCT02942407|561780778|FG000|Overall Study|Lost to Follow-up|3|||
155642342|NCT02942407|561780779|FG001|Overall Study|Lost to Follow-up|2|||
155642343|NCT02942407|561780778|FG000|Overall Study|Withdrawal by Subject|7|||
155642344|NCT02942407|561780779|FG001|Overall Study|Withdrawal by Subject|9|||
155642345|NCT02942407|561780778|FG000|Overall Study|Death|16|||
155642346|NCT02942407|561780779|FG001|Overall Study|Death|13|||
155642347|NCT00374868|561780780|FG000|Overall Study|Adverse Event|12|||
155642348|NCT00374868|561780780|FG000|Overall Study|Progressive Disease|7|||
155642349|NCT00374868|561780780|FG000|Overall Study|Physician Decision|13|||
155642350|NCT00374868|561780780|FG000|Overall Study|Lost to Follow-up|1|||
155642351|NCT00374868|561780780|FG000|Overall Study|Death|2|||
155642352|NCT00374868|561780780|FG000|Overall Study|Other - Not Specified|1|||
155642353|NCT03188185|561780781|FG000|Stage 1|Adverse Event|4|||
155642354|NCT03188185|561780782|FG001|Stage 1|Adverse Event|12|||
155642355|NCT03188185|561780783|FG002|Stage 1|Adverse Event|0|||
155642356|NCT03188185|561780784|FG003|Stage 1|Adverse Event|0|||
155642357|NCT03188185|561780781|FG000|Stage 1|Lack of Efficacy|0|||
155642358|NCT03188185|561780782|FG001|Stage 1|Lack of Efficacy|2|||
155642359|NCT03188185|561780783|FG002|Stage 1|Lack of Efficacy|0|||
155642360|NCT03188185|561780784|FG003|Stage 1|Lack of Efficacy|0|||
155642361|NCT03188185|561780781|FG000|Stage 1|Lost to Follow-up|6|||
155642362|NCT03188185|561780782|FG001|Stage 1|Lost to Follow-up|1|||
155642363|NCT03188185|561780783|FG002|Stage 1|Lost to Follow-up|0|||
155642364|NCT03188185|561780784|FG003|Stage 1|Lost to Follow-up|0|||
155642365|NCT03188185|561780781|FG000|Stage 1|Withdrawal by Subject|9|||
155642366|NCT03188185|561780782|FG001|Stage 1|Withdrawal by Subject|0|||
155642367|NCT03188185|561780783|FG002|Stage 1|Withdrawal by Subject|0|||
155642368|NCT03188185|561780784|FG003|Stage 1|Withdrawal by Subject|0|||
155642369|NCT03188185|561780781|FG000|Stage 1|Identified as a professional patient|0|||
155642370|NCT03188185|561780782|FG001|Stage 1|Identified as a professional patient|1|||
155642371|NCT03188185|561780783|FG002|Stage 1|Identified as a professional patient|0|||
155642372|NCT03188185|561780784|FG003|Stage 1|Identified as a professional patient|0|||
155642373|NCT03188185|561780781|FG000|Stage 2|Adverse Event|0|||
155642374|NCT03188185|561780782|FG001|Stage 2|Adverse Event|0|||
155642375|NCT03188185|561780783|FG002|Stage 2|Adverse Event|2|||
155642376|NCT03188185|561780784|FG003|Stage 2|Adverse Event|4|||
155642377|NCT03188185|561780781|FG000|Stage 2|Lack of Efficacy|0|||
155642378|NCT03188185|561780782|FG001|Stage 2|Lack of Efficacy|0|||
155307177|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307178|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307179|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307180|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
155307181|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307182|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
155307183|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307184|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307185|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307186|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307187|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307188|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307189|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307190|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307191|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307192|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
155307193|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307194|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307195|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307196|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307197|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307198|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307199|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307200|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307201|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|other|0|||
155307202|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|other|0|||
155307203|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|other|0|||
155307204|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|other|0|||
155307205|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|other|0|||
155307206|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|other|1|||
155307207|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|other|0|||
155307208|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|other|0|||
155307209|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|other|0|||
155307210|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|other|0|||
155307211|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|other|0|||
155307212|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|other|0|||
155307213|NCT01303445|560556071|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
155307214|NCT01303445|560556072|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
155307215|NCT01303445|560556071|FG000|Second Intervention (7 Days)|Adverse Event|0|||
155307216|NCT01303445|560556072|FG001|Second Intervention (7 Days)|Adverse Event|2|||
155307217|NCT01303445|560556071|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
155307218|NCT01303445|560556072|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
155307219|NCT01303445|560556071|FG000|Washout (14 Days)|Protocol Violation|1|||
155307220|NCT01303445|560556072|FG001|Washout (14 Days)|Protocol Violation|0|||
155307221|NCT01303445|560556071|FG000|Washout (14 Days)|Lost to Follow-up|0|||
155307222|NCT01303445|560556072|FG001|Washout (14 Days)|Lost to Follow-up|2|||
155307223|NCT01303445|560556071|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
155307224|NCT01303445|560556072|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
155307225|NCT01303445|560556071|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
155307226|NCT01303445|560556072|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
155307227|NCT04923347|560557357|FG000|Overall Study|Withdrawal by Subject|14|||
155307228|NCT03547908|560557360|FG000|Blinded Phase|Lost to Follow-up|3|||
155307229|NCT03547908|560557361|FG001|Blinded Phase|Lost to Follow-up|3|||
155307230|NCT03547908|560557362|FG002|Blinded Phase|Lost to Follow-up|0|||
155307231|NCT03547908|560557363|FG003|Blinded Phase|Lost to Follow-up|0|||
155307232|NCT03547908|560557360|FG000|Blinded Phase|Withdrew Consent|2|||
155307233|NCT03547908|560557361|FG001|Blinded Phase|Withdrew Consent|3|||
155307234|NCT03547908|560557362|FG002|Blinded Phase|Withdrew Consent|0|||
155307235|NCT03547908|560557363|FG003|Blinded Phase|Withdrew Consent|0|||
155307236|NCT03547908|560557360|FG000|Blinded Phase|Investigator's Discretion|2|||
155307237|NCT03547908|560557361|FG001|Blinded Phase|Investigator's Discretion|1|||
155307238|NCT03547908|560557362|FG002|Blinded Phase|Investigator's Discretion|0|||
155642379|NCT03188185|561780783|FG002|Stage 2|Lack of Efficacy|3|||
155307239|NCT03547908|560557363|FG003|Blinded Phase|Investigator's Discretion|0|||
155307240|NCT03547908|560557360|FG000|Blinded Phase|Death|2|||
155307241|NCT03547908|560557361|FG001|Blinded Phase|Death|0|||
155307242|NCT03547908|560557362|FG002|Blinded Phase|Death|0|||
155307243|NCT03547908|560557363|FG003|Blinded Phase|Death|0|||
155307244|NCT03547908|560557360|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
155307245|NCT03547908|560557361|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
155413989|NCT00730639|560946293|FG000|Overall Study|Death|0|||
155307246|NCT03547908|560557362|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
155307247|NCT03547908|560557363|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
155307248|NCT03547908|560557360|FG000|Blinded Phase|Adverse Event|1|||
155307249|NCT03547908|560557361|FG001|Blinded Phase|Adverse Event|0|||
155307250|NCT03547908|560557362|FG002|Blinded Phase|Adverse Event|0|||
155307251|NCT03547908|560557363|FG003|Blinded Phase|Adverse Event|0|||
155307252|NCT03547908|560557360|FG000|Blinded Phase|Randomized But Never Treated|1|||
155307253|NCT03547908|560557361|FG001|Blinded Phase|Randomized But Never Treated|0|||
155307254|NCT03547908|560557362|FG002|Blinded Phase|Randomized But Never Treated|0|||
155307255|NCT03547908|560557363|FG003|Blinded Phase|Randomized But Never Treated|0|||
155307256|NCT03547908|560557360|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
155307257|NCT03547908|560557361|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
155307258|NCT03547908|560557362|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
155307259|NCT03547908|560557363|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
155307260|NCT03547908|560557360|FG000|Open-label Extension Phase|Death|0|||
155307261|NCT03547908|560557361|FG001|Open-label Extension Phase|Death|0|||
155307262|NCT03547908|560557362|FG002|Open-label Extension Phase|Death|1|||
155307263|NCT03547908|560557363|FG003|Open-label Extension Phase|Death|0|||
155307264|NCT04059354|560557366|FG000|Overall Study|COVID-19 pandemic|3|||
155307265|NCT02396199|560557367|FG000|Overall Study|Lost to Follow-up|1|||
155307266|NCT02396199|560557367|FG000|Overall Study|Death|4|||
155307267|NCT02349412|560557368|FG000|Overall Study|Withdrawal by Subject|7|||
155307268|NCT02349412|560557369|FG001|Overall Study|Withdrawal by Subject|7|||
155307269|NCT00979576|560557372|FG000|Combination Treatment Phase|Progressive disease|3|||
155307270|NCT00979576|560557373|FG001|Combination Treatment Phase|Progressive disease|1|||
155307271|NCT00979576|560557374|FG002|Combination Treatment Phase|Progressive disease|5|||
155307272|NCT00979576|560557372|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
155307273|NCT00979576|560557373|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
155307274|NCT00979576|560557374|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
155307275|NCT00979576|560557372|FG000|Combination Treatment Phase|Adverse Event|0|||
155307276|NCT00979576|560557373|FG001|Combination Treatment Phase|Adverse Event|2|||
155307277|NCT00979576|560557374|FG002|Combination Treatment Phase|Adverse Event|2|||
155307278|NCT00979576|560557372|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
155307279|NCT00979576|560557373|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
155307280|NCT00979576|560557374|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
155307281|NCT04855760|560557375|FG000|Overall Study|Adverse Event|21|||
155307282|NCT04855760|560557375|FG000|Overall Study|Withdrawal by Subject|116|||
155307283|NCT04855760|560557375|FG000|Overall Study|Lack of Efficacy|21|||
155307284|NCT04855760|560557375|FG000|Overall Study|Lost to Follow-up|49|||
155307285|NCT04855760|560557375|FG000|Overall Study|Protocol Violation|2|||
155413990|NCT00730639|560946294|FG001|Overall Study|Death|0|||
155413991|NCT00730639|560946295|FG002|Overall Study|Death|0|||
155413992|NCT00730639|560946296|FG003|Overall Study|Death|0|||
155413993|NCT00730639|560946297|FG004|Overall Study|Death|2|||
155413994|NCT00730639|560946293|FG000|Overall Study|Disease Progression|12|||
155413995|NCT00730639|560946294|FG001|Overall Study|Disease Progression|13|||
155413996|NCT00730639|560946295|FG002|Overall Study|Disease Progression|48|||
155413997|NCT00730639|560946296|FG003|Overall Study|Disease Progression|32|||
155413998|NCT00730639|560946297|FG004|Overall Study|Disease Progression|88|||
155413999|NCT00730639|560946293|FG000|Overall Study|non-specified|0|||
155414000|NCT00730639|560946294|FG001|Overall Study|non-specified|0|||
155414001|NCT00730639|560946295|FG002|Overall Study|non-specified|4|||
155414002|NCT00730639|560946296|FG003|Overall Study|non-specified|2|||
155414003|NCT00730639|560946297|FG004|Overall Study|non-specified|3|||
155414004|NCT00730639|560946293|FG000|Overall Study|Protocol Violation|0|||
155414005|NCT00730639|560946294|FG001|Overall Study|Protocol Violation|0|||
155414006|NCT00730639|560946295|FG002|Overall Study|Protocol Violation|1|||
155414007|NCT00730639|560946296|FG003|Overall Study|Protocol Violation|0|||
155414008|NCT00730639|560946297|FG004|Overall Study|Protocol Violation|0|||
155414009|NCT00730639|560946293|FG000|Overall Study|Withdrawal by Subject|0|||
155414010|NCT00730639|560946294|FG001|Overall Study|Withdrawal by Subject|0|||
155497609|NCT01275170|561245505|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
155307286|NCT04855760|560557375|FG000|Overall Study|Physician Decision|5|||
155307287|NCT04855760|560557375|FG000|Overall Study|Pregnancy|1|||
155307288|NCT04855760|560557375|FG000|Overall Study|Non-Compliance with Study Drug|11|||
155414011|NCT00730639|560946295|FG002|Overall Study|Withdrawal by Subject|6|||
155414012|NCT00730639|560946296|FG003|Overall Study|Withdrawal by Subject|3|||
155307289|NCT04855760|560557375|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
155307290|NCT04855760|560557375|FG000|Overall Study|Study Completed by Sponsor|202|||
155414013|NCT00730639|560946297|FG004|Overall Study|Withdrawal by Subject|4|||
155642380|NCT03188185|561780784|FG003|Stage 2|Lack of Efficacy|0|||
155307291|NCT04855760|560557375|FG000|Overall Study|Other|13|||
155307292|NCT03424811|560557380|FG000|Overall Study|Lost to Follow-up|9|||
155414014|NCT00730639|560946293|FG000|Overall Study|Treatment on-going|2|||
155307293|NCT03424811|560557381|FG001|Overall Study|Lost to Follow-up|0|||
155307294|NCT03055377|560557383|FG000|Treatment Phase|Lost to Follow-up|28|||
155307295|NCT03055377|560557384|FG001|Treatment Phase|Lost to Follow-up|24|||
155307296|NCT03055377|560557383|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
155307297|NCT03055377|560557384|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
155307298|NCT03157167|560557387|FG000|Overall Study|Withdrawal by Subject|1|||
155307299|NCT03157167|560557388|FG001|Overall Study|Withdrawal by Subject|0|||
155307300|NCT03157167|560557389|FG002|Overall Study|Withdrawal by Subject|0|||
155307301|NCT04905407|560557390|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
155307302|NCT04905407|560557391|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
155307303|NCT04905407|560557392|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
155307304|NCT04905407|560557393|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
155307305|NCT04905407|560557390|FG000|Part 1 and Part 2|Death|7|||
155307306|NCT04905407|560557391|FG001|Part 1 and Part 2|Death|7|||
155414015|NCT00730639|560946294|FG001|Overall Study|Treatment on-going|5|||
155414016|NCT00730639|560946295|FG002|Overall Study|Treatment on-going|5|||
155414017|NCT00730639|560946296|FG003|Overall Study|Treatment on-going|4|||
155414018|NCT00730639|560946297|FG004|Overall Study|Treatment on-going|4|||
155414019|NCT01632566|560946299|FG000|Overall Study|Withdrawal by Subject|0|||
155497610|NCT01275170|561245506|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497611|NCT01275170|561245507|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497612|NCT01275170|561245508|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497613|NCT01275170|561245509|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497614|NCT01275170|561245510|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497615|NCT01275170|561245511|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497616|NCT01275170|561245512|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
155497617|NCT02864953|561245513|FG000|Overall Study|Adverse Event|22|||
155497618|NCT02864953|561245514|FG001|Overall Study|Adverse Event|19|||
155414020|NCT01632566|560946300|FG001|Overall Study|Withdrawal by Subject|1|||
155414021|NCT01632566|560946301|FG002|Overall Study|Withdrawal by Subject|0|||
155414022|NCT01632566|560946302|FG003|Overall Study|Withdrawal by Subject|0|||
155414023|NCT01632566|560946303|FG004|Overall Study|Withdrawal by Subject|0|||
155414024|NCT01632566|560946299|FG000|Overall Study|Sponsor Decision|0|||
155414025|NCT01632566|560946300|FG001|Overall Study|Sponsor Decision|2|||
155414026|NCT01632566|560946301|FG002|Overall Study|Sponsor Decision|9|||
155414027|NCT01632566|560946302|FG003|Overall Study|Sponsor Decision|2|||
155414028|NCT01632566|560946303|FG004|Overall Study|Sponsor Decision|2|||
155414029|NCT03208231|560946304|FG000|Overall Study|Death|1|||
155414030|NCT03208231|560946305|FG001|Overall Study|Death|2|||
155414031|NCT03208231|560946304|FG000|Overall Study|Moved and unable to get to clinic|1|||
155414032|NCT03208231|560946305|FG001|Overall Study|Moved and unable to get to clinic|0|||
155414033|NCT03208231|560946304|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
155414034|NCT03208231|560946305|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
155414035|NCT04982250|560946311|FG000|Overall Study|Lost to Follow-up|0|||
155414036|NCT04982250|560946312|FG001|Overall Study|Lost to Follow-up|26|||
155414037|NCT04982250|560946313|FG002|Overall Study|Lost to Follow-up|0|||
155414038|NCT04982250|560946314|FG003|Overall Study|Lost to Follow-up|0|||
155414039|NCT04982250|560946315|FG004|Overall Study|Lost to Follow-up|72|||
155414040|NCT04982250|560946316|FG005|Overall Study|Lost to Follow-up|69|||
155414041|NCT04982250|560946311|FG000|Overall Study|Not Eligible to Enroll|0|||
155414042|NCT04982250|560946312|FG001|Overall Study|Not Eligible to Enroll|0|||
155414043|NCT04982250|560946313|FG002|Overall Study|Not Eligible to Enroll|0|||
155414044|NCT04982250|560946314|FG003|Overall Study|Not Eligible to Enroll|0|||
155414045|NCT04982250|560946315|FG004|Overall Study|Not Eligible to Enroll|10|||
155414046|NCT04982250|560946316|FG005|Overall Study|Not Eligible to Enroll|7|||
155414047|NCT02289950|560946319|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
155497619|NCT02864953|561245513|FG000|Overall Study|Withdrawal by Subject|1|||
155497620|NCT02864953|561245514|FG001|Overall Study|Withdrawal by Subject|0|||
155497621|NCT02864953|561245513|FG000|Overall Study|Physician Decision|4|||
155497622|NCT02864953|561245514|FG001|Overall Study|Physician Decision|2|||
155497623|NCT02864953|561245513|FG000|Overall Study|Death|3|||
155307307|NCT04905407|560557392|FG002|Part 1 and Part 2|Death|7|||
155414048|NCT02289950|560946320|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
155414049|NCT02289950|560946319|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
155414050|NCT02289950|560946320|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
155414051|NCT02289950|560946319|FG000|Overall Study|Lost to Follow-up|1|||
155414052|NCT02289950|560946320|FG001|Overall Study|Lost to Follow-up|0|||
155414053|NCT02289950|560946319|FG000|Overall Study|Physician Decision|9|||
155497624|NCT02864953|561245514|FG001|Overall Study|Death|13|||
155497625|NCT02864953|561245513|FG000|Overall Study|Reason not specified|14|||
155497626|NCT02864953|561245514|FG001|Overall Study|Reason not specified|12|||
155307308|NCT04905407|560557393|FG003|Part 1 and Part 2|Death|0|||
155307309|NCT04905407|560557390|FG000|Part 1 and Part 2|Other than specified|0|||
155307310|NCT04905407|560557391|FG001|Part 1 and Part 2|Other than specified|0|||
155307311|NCT04905407|560557392|FG002|Part 1 and Part 2|Other than specified|1|||
155414054|NCT02289950|560946320|FG001|Overall Study|Physician Decision|3|||
155307312|NCT04905407|560557393|FG003|Part 1 and Part 2|Other than specified|0|||
155307313|NCT04905407|560557390|FG000|Part 3|Death|0|||
155307314|NCT04905407|560557391|FG001|Part 3|Death|0|||
155307315|NCT04905407|560557392|FG002|Part 3|Death|0|||
155307316|NCT04905407|560557393|FG003|Part 3|Death|2|||
155307317|NCT03263026|560557396|FG000|Overall Study|Withdrawal by Subject|1|||
155307318|NCT03263026|560557397|FG001|Overall Study|Withdrawal by Subject|0|||
155642381|NCT03188185|561780781|FG000|Stage 2|Lost to Follow-up|0|||
155642382|NCT03188185|561780782|FG001|Stage 2|Lost to Follow-up|0|||
155642383|NCT03188185|561780783|FG002|Stage 2|Lost to Follow-up|1|||
155642384|NCT03188185|561780784|FG003|Stage 2|Lost to Follow-up|0|||
155642385|NCT03188185|561780781|FG000|Stage 2|Physician Decision|0|||
155307319|NCT03263026|560557396|FG000|Overall Study|Death|1|||
155307320|NCT03263026|560557397|FG001|Overall Study|Death|0|||
155307321|NCT03263026|560557396|FG000|Overall Study|Other/ Various|41|||
155307322|NCT03263026|560557397|FG001|Overall Study|Other/ Various|29|||
155307323|NCT04868110|560557398|FG000|Overall Study|Withdrawal by Subject|3|||
155307324|NCT04868110|560557399|FG001|Overall Study|Withdrawal by Subject|4|||
155307325|NCT04178733|560557406|FG000|Overall Study|Investigator Decision|0|||
155307326|NCT04178733|560557407|FG001|Overall Study|Investigator Decision|0|||
155307327|NCT04178733|560557408|FG002|Overall Study|Investigator Decision|0|||
155307328|NCT04178733|560557409|FG003|Overall Study|Investigator Decision|1|||
155307329|NCT04178733|560557410|FG004|Overall Study|Investigator Decision|2|||
155307330|NCT03655132|560557413|FG000|Overall Study|Lost to Follow-up|2|||
155307331|NCT03655132|560557414|FG001|Overall Study|Lost to Follow-up|1|||
155307332|NCT03655132|560557413|FG000|Overall Study|Withdrawal by Subject|0|||
155307333|NCT03655132|560557414|FG001|Overall Study|Withdrawal by Subject|1|||
155307334|NCT03655132|560557413|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
155307335|NCT03655132|560557414|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
155307336|NCT02651324|560557416|FG000|Overall Study|drug not administered, due dispensing issue|1|||
155307337|NCT02651324|560557417|FG001|Overall Study|drug not administered, due dispensing issue|0|||
155307338|NCT05919082|560557418|FG000|Overall Study|Adverse Event|3|||
155642386|NCT03188185|561780782|FG001|Stage 2|Physician Decision|0|||
155642387|NCT03188185|561780783|FG002|Stage 2|Physician Decision|0|||
155642388|NCT03188185|561780784|FG003|Stage 2|Physician Decision|1|||
155307339|NCT05919082|560557419|FG001|Overall Study|Adverse Event|0|||
155307340|NCT05919082|560557418|FG000|Overall Study|Lost to Follow-up|0|||
155307341|NCT05919082|560557419|FG001|Overall Study|Lost to Follow-up|1|||
155307342|NCT05919082|560557418|FG000|Overall Study|Withdrawal by Subject|8|||
155642389|NCT03188185|561780781|FG000|Stage 2|Withdrawal by Subject|0|||
155642390|NCT03188185|561780782|FG001|Stage 2|Withdrawal by Subject|0|||
155642391|NCT03188185|561780783|FG002|Stage 2|Withdrawal by Subject|3|||
155642392|NCT03188185|561780784|FG003|Stage 2|Withdrawal by Subject|1|||
155642393|NCT00774748|561780785|FG000|Overall Study|Lost to Follow-up|3|||
155642394|NCT02965456|561780786|FG000|Overall Study|Lost to Follow-up|40|||
155642395|NCT02965456|561780787|FG001|Overall Study|Lost to Follow-up|18|||
155642396|NCT02965456|561780786|FG000|Overall Study|Subject Request|22|||
155642397|NCT02965456|561780787|FG001|Overall Study|Subject Request|13|||
155642398|NCT02965456|561780786|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
155642399|NCT02965456|561780787|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
155642400|NCT02965456|561780786|FG000|Overall Study|Adverse Event|3|||
155642401|NCT02965456|561780787|FG001|Overall Study|Adverse Event|0|||
155642402|NCT02965456|561780786|FG000|Overall Study|Noncompliance with Study Drug|1|||
155642403|NCT02965456|561780787|FG001|Overall Study|Noncompliance with Study Drug|1|||
155642404|NCT02965456|561780786|FG000|Overall Study|Worsening Condition|0|||
155642405|NCT02965456|561780787|FG001|Overall Study|Worsening Condition|2|||
155642406|NCT02965456|561780786|FG000|Overall Study|Lack of Efficacy|1|||
155642407|NCT02965456|561780787|FG001|Overall Study|Lack of Efficacy|0|||
155642408|NCT02965456|561780786|FG000|Overall Study|Physician Decision|0|||
155642409|NCT02965456|561780787|FG001|Overall Study|Physician Decision|1|||
155642410|NCT02965456|561780786|FG000|Overall Study|Pregnancy|1|||
155642411|NCT02965456|561780787|FG001|Overall Study|Pregnancy|0|||
155642412|NCT02965456|561780786|FG000|Overall Study|Protocol Violation|0|||
155642413|NCT02965456|561780787|FG001|Overall Study|Protocol Violation|1|||
155642414|NCT02965456|561780786|FG000|Overall Study|Participant ran out of study drug|0|||
155642415|NCT02965456|561780787|FG001|Overall Study|Participant ran out of study drug|1|||
155642416|NCT04465955|561780788|FG000|Overall Study|Withdrew consent|6|||
155307343|NCT05919082|560557419|FG001|Overall Study|Withdrawal by Subject|9|||
155307344|NCT05919082|560557418|FG000|Overall Study|Lack of Efficacy|0|||
155307345|NCT05919082|560557419|FG001|Overall Study|Lack of Efficacy|1|||
155642417|NCT04465955|561780789|FG001|Overall Study|Withdrew consent|10|||
155642418|NCT04465955|561780790|FG002|Overall Study|Withdrew consent|7|||
155642419|NCT04465955|561780788|FG000|Overall Study|Adverse Event|6|||
155642420|NCT04465955|561780789|FG001|Overall Study|Adverse Event|5|||
155642421|NCT04465955|561780790|FG002|Overall Study|Adverse Event|1|||
155642422|NCT04465955|561780788|FG000|Overall Study|Lost to Follow-up|2|||
155642423|NCT04465955|561780789|FG001|Overall Study|Lost to Follow-up|0|||
155642424|NCT04465955|561780790|FG002|Overall Study|Lost to Follow-up|3|||
155414055|NCT02289950|560946319|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
155414056|NCT02289950|560946320|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
155414057|NCT02289950|560946319|FG000|Overall Study|Withdrawal by Subject|1|||
155414058|NCT02289950|560946320|FG001|Overall Study|Withdrawal by Subject|3|||
155414059|NCT02289950|560946319|FG000|Overall Study|Test article held for greater than 28 days|0|||
155414060|NCT02289950|560946320|FG001|Overall Study|Test article held for greater than 28 days|1|||
155414061|NCT02289950|560946319|FG000|Overall Study|Adverse Event|11|||
155414062|NCT02289950|560946320|FG001|Overall Study|Adverse Event|3|||
155414063|NCT02289950|560946319|FG000|Overall Study|Death|1|||
155414064|NCT02289950|560946320|FG001|Overall Study|Death|1|||
155414065|NCT02289950|560946319|FG000|Overall Study|Other|5|||
155414066|NCT02289950|560946320|FG001|Overall Study|Other|2|||
155414067|NCT02289950|560946319|FG000|Overall Study|Not Treated|2|||
155414068|NCT02289950|560946320|FG001|Overall Study|Not Treated|1|||
155414069|NCT04518462|560946321|FG000|Overall Study|Withdrawal by Subject|0|||
155414070|NCT04518462|560946322|FG001|Overall Study|Withdrawal by Subject|0|||
155414071|NCT04518462|560946323|FG002|Overall Study|Withdrawal by Subject|1|||
155414072|NCT04518462|560946321|FG000|Overall Study|Physician Decision|1|||
155414073|NCT04518462|560946322|FG001|Overall Study|Physician Decision|1|||
155414074|NCT04518462|560946323|FG002|Overall Study|Physician Decision|0|||
155414075|NCT01003210|560946324|FG000|Overall Study|Lost to Follow-up|1|||
155414076|NCT01003210|560946325|FG001|Overall Study|Lost to Follow-up|3|||
155414077|NCT01411085|560946326|FG000|Overall Study|Physician Decision|1|||
155414078|NCT01411085|560946326|FG000|Overall Study|Protocol Violation|1|||
155414079|NCT01411085|560946326|FG000|Overall Study|Adverse Event|1|||
155414080|NCT05036083|560946327|FG000|Overall Study|Physician Decision|1|||
155414081|NCT05036083|560946327|FG000|Overall Study|Withdrawal by Subject|1|||
155414082|NCT05036083|560946327|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
155414083|NCT05036083|560946327|FG000|Overall Study|IV not sustainable|1|||
155414084|NCT04745689|560946328|FG000|Overall Study|Death|9|||
155414085|NCT04745689|560946329|FG001|Overall Study|Death|6|||
155414086|NCT04745689|560946328|FG000|Overall Study|Lost to Follow-up|1|||
155414087|NCT04745689|560946329|FG001|Overall Study|Lost to Follow-up|0|||
155414088|NCT04745689|560946328|FG000|Overall Study|Withdrawal by Subject|2|||
155414089|NCT04745689|560946329|FG001|Overall Study|Withdrawal by Subject|0|||
155414090|NCT04745689|560946328|FG000|Overall Study|Study terminated by sponsor|10|||
155414091|NCT04745689|560946329|FG001|Overall Study|Study terminated by sponsor|3|||
155414092|NCT02553460|560946330|FG000|Overall Study|Death|3|||
155414093|NCT02553460|560946330|FG000|Overall Study|Withdrawal by Subject|1|||
155414094|NCT02553460|560946330|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
155414095|NCT02553460|560946330|FG000|Overall Study|Relapse or Transplant|14|||
155414096|NCT02553460|560946330|FG000|Overall Study|No response to treatment|2|||
155414097|NCT02553460|560946330|FG000|Overall Study|CAR T cells|2|||
155414098|NCT07099521|560946333|FG000|Overall Study|Incompeleted stimulus program|1|||
155414099|NCT07099521|560946334|FG001|Overall Study|Incompeleted stimulus program|0|||
155414100|NCT07099521|560946333|FG000|Overall Study|Non-social anxiety symtpoms|0|||
155414101|NCT07099521|560946334|FG001|Overall Study|Non-social anxiety symtpoms|1|||
155414102|NCT07099521|560946333|FG000|Overall Study|Extreme values|2|||
155414103|NCT07099521|560946334|FG001|Overall Study|Extreme values|4|||
155414104|NCT01178138|560948141|FG000|Overall Study|Lost to Follow-up|8|||
155414105|NCT01178138|560948141|FG000|Overall Study|Withdrawal by Subject|7|||
155414106|NCT01178138|560948141|FG000|Overall Study|Physician Decision|8|||
155414107|NCT01790503|560948142|FG000|Overall Study|Adverse Event|1|||
155414108|NCT01790503|560948143|FG001|Overall Study|Adverse Event|0|||
155414109|NCT01790503|560948144|FG002|Overall Study|Adverse Event|0|||
155414110|NCT01790503|560948145|FG003|Overall Study|Adverse Event|0|||
155414111|NCT01790503|560948146|FG004|Overall Study|Adverse Event|0|||
155414112|NCT01790503|560948147|FG005|Overall Study|Adverse Event|2|||
155642425|NCT04465955|561780788|FG000|Overall Study|Other|1|||
155642426|NCT04465955|561780789|FG001|Overall Study|Other|1|||
155642427|NCT04465955|561780790|FG002|Overall Study|Other|3|||
155414113|NCT01790503|560948148|FG006|Overall Study|Adverse Event|0|||
155414114|NCT01790503|560948149|FG007|Overall Study|Adverse Event|0|||
155414115|NCT01790503|560948150|FG008|Overall Study|Adverse Event|2|||
155642428|NCT01327703|561780791|FG000|Second Treatment Period|Adverse Event|1|||
155642429|NCT01327703|561780792|FG001|Second Treatment Period|Adverse Event|1|||
155642430|NCT01327703|561780791|FG000|Second Treatment Period|Protocol Violation|0|||
155642431|NCT01327703|561780792|FG001|Second Treatment Period|Protocol Violation|1|||
155642432|NCT05324371|561780793|FG000|Overall Study|Withdrawal by Subject|1|||
155642433|NCT05324371|561780793|FG000|Overall Study|Death|1|||
155642434|NCT00317369|561780794|FG000|Overall Study|Adverse Event|2|||
155414116|NCT01790503|560948151|FG009|Overall Study|Adverse Event|4|||
155414117|NCT01790503|560948152|FG010|Overall Study|Adverse Event|7|||
155414118|NCT01790503|560948142|FG000|Overall Study|Withdrawal by Subject|0|||
155642435|NCT00317369|561780795|FG001|Overall Study|Adverse Event|1|||
155642436|NCT00317369|561780796|FG002|Overall Study|Adverse Event|0|||
155642437|NCT00317369|561780794|FG000|Overall Study|Lack of Efficacy|0|||
155642438|NCT00317369|561780795|FG001|Overall Study|Lack of Efficacy|1|||
155307346|NCT05919082|560557418|FG000|Overall Study|Investigator Decision|1|||
155307347|NCT05919082|560557419|FG001|Overall Study|Investigator Decision|0|||
155307348|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Death|2|||
155307349|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Death|0|||
155307350|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Death|0|||
155307351|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Death|3|||
155307352|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Death|0|||
155307353|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Death|0|||
155307354|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Death|1|||
155307355|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Death|0|||
155307356|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Death|0|||
155307357|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307358|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307359|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307360|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
155307361|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307362|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307363|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
155307364|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307365|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307366|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
155307367|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
155307368|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
155307369|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
155307370|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
155307371|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
155307372|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
155307373|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
155307374|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
155307375|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Death|0|||
155307376|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Death|2|||
155307377|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Death|0|||
155307378|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Death|0|||
155307379|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Death|2|||
155307380|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Death|0|||
155307381|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Death|0|||
155307382|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Death|2|||
155307383|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Death|0|||
155307384|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155414119|NCT01790503|560948143|FG001|Overall Study|Withdrawal by Subject|0|||
155414120|NCT01790503|560948144|FG002|Overall Study|Withdrawal by Subject|1|||
155414121|NCT01790503|560948145|FG003|Overall Study|Withdrawal by Subject|1|||
155414122|NCT01790503|560948146|FG004|Overall Study|Withdrawal by Subject|1|||
155414123|NCT01790503|560948147|FG005|Overall Study|Withdrawal by Subject|2|||
155414124|NCT01790503|560948148|FG006|Overall Study|Withdrawal by Subject|1|||
155414125|NCT01790503|560948149|FG007|Overall Study|Withdrawal by Subject|0|||
155414126|NCT01790503|560948150|FG008|Overall Study|Withdrawal by Subject|0|||
155414127|NCT01790503|560948151|FG009|Overall Study|Withdrawal by Subject|0|||
155414128|NCT01790503|560948152|FG010|Overall Study|Withdrawal by Subject|1|||
155414129|NCT01790503|560948142|FG000|Overall Study|Disease progression|2|||
155414130|NCT01790503|560948143|FG001|Overall Study|Disease progression|1|||
155414131|NCT01790503|560948144|FG002|Overall Study|Disease progression|0|||
155414132|NCT01790503|560948145|FG003|Overall Study|Disease progression|1|||
155414133|NCT01790503|560948146|FG004|Overall Study|Disease progression|2|||
155414134|NCT01790503|560948147|FG005|Overall Study|Disease progression|1|||
155414135|NCT01790503|560948148|FG006|Overall Study|Disease progression|0|||
155414136|NCT01790503|560948149|FG007|Overall Study|Disease progression|1|||
155414137|NCT01790503|560948150|FG008|Overall Study|Disease progression|0|||
155414138|NCT01790503|560948151|FG009|Overall Study|Disease progression|17|||
155414139|NCT01790503|560948152|FG010|Overall Study|Disease progression|7|||
155414140|NCT01790503|560948142|FG000|Overall Study|Protocol Violation|0|||
155307385|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155414141|NCT01790503|560948143|FG001|Overall Study|Protocol Violation|0|||
155414142|NCT01790503|560948144|FG002|Overall Study|Protocol Violation|0|||
155414143|NCT01790503|560948145|FG003|Overall Study|Protocol Violation|0|||
155414144|NCT01790503|560948146|FG004|Overall Study|Protocol Violation|0|||
155414145|NCT01790503|560948147|FG005|Overall Study|Protocol Violation|0|||
155414146|NCT01790503|560948148|FG006|Overall Study|Protocol Violation|0|||
155307386|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307387|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307388|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
155307389|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307390|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307391|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307392|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155414147|NCT01790503|560948149|FG007|Overall Study|Protocol Violation|0|||
155307393|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307394|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
155497627|NCT02864953|561245513|FG000|Overall Study|Withdrew Prior to Dosing|9|||
155497628|NCT02864953|561245514|FG001|Overall Study|Withdrew Prior to Dosing|8|||
155497629|NCT00981019|561245515|FG000|Overall Study|Did not respond|65|||
155497630|NCT00981019|561245515|FG000|Overall Study|Did not match target population|94|||
155497631|NCT00981019|561245515|FG000|Overall Study|Inadvertent exclusion|239|||
155497632|NCT00981019|561245515|FG000|Overall Study|Hit the survey after closure|79|||
155497633|NCT00358670|561245516|FG000|Overall Study|Adverse Event|26|||
155497634|NCT00358670|561245517|FG001|Overall Study|Adverse Event|29|||
155497635|NCT00358670|561245516|FG000|Overall Study|Lack of Efficacy|20|||
155497636|NCT00358670|561245517|FG001|Overall Study|Lack of Efficacy|23|||
155497637|NCT00358670|561245516|FG000|Overall Study|Protocol Violation|6|||
155497638|NCT00358670|561245517|FG001|Overall Study|Protocol Violation|9|||
155497639|NCT00358670|561245516|FG000|Overall Study|Lost to Follow-up|4|||
155497640|NCT00358670|561245517|FG001|Overall Study|Lost to Follow-up|5|||
155497641|NCT00358670|561245516|FG000|Overall Study|Withdrawal by Subject|13|||
155497642|NCT00358670|561245517|FG001|Overall Study|Withdrawal by Subject|24|||
155497643|NCT00358670|561245516|FG000|Overall Study|Protocol Defined Clinical Event|0|||
155497644|NCT00358670|561245517|FG001|Overall Study|Protocol Defined Clinical Event|1|||
155497645|NCT00358670|561245516|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
155497646|NCT00358670|561245517|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
155497647|NCT00358670|561245516|FG000|Overall Study|Administrative|153|||
155497648|NCT00358670|561245517|FG001|Overall Study|Administrative|125|||
155497649|NCT00865306|561245518|FG000|Controlled Trial|Lost to Follow-up|1|||
155497650|NCT00865306|561245519|FG001|Controlled Trial|Lost to Follow-up|1|||
155497651|NCT00865306|561245518|FG000|Controlled Trial|Difficulty commuting|2|||
155497652|NCT00865306|561245519|FG001|Controlled Trial|Difficulty commuting|0|||
155497653|NCT00865306|561245518|FG000|Controlled Trial|Improved btw baseline and first session|1|||
155497654|NCT00865306|561245519|FG001|Controlled Trial|Improved btw baseline and first session|0|||
155497655|NCT00865306|561245518|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
155497656|NCT00865306|561245519|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
155497657|NCT00865306|561245518|FG000|Controlled Trial|Withdrawal by Subject|0|||
155497658|NCT00865306|561245519|FG001|Controlled Trial|Withdrawal by Subject|1|||
155497659|NCT05083559|561245520|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
155497660|NCT05083559|561245521|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
155497661|NCT05083559|561245520|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
155497662|NCT05083559|561245521|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
155497663|NCT05083559|561245520|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
155497664|NCT05083559|561245521|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
155497665|NCT02704130|561245523|FG000|Overall Study|Physician Decision|5|||
155497666|NCT02704130|561245524|FG001|Overall Study|Physician Decision|3|||
155497667|NCT01216319|561245527|FG000|Overall Study|Lost to Follow-up|2|||
155497668|NCT01216319|561245527|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
155497669|NCT02666768|561245528|FG000|Overall Study|Withdrawal by Subject|4|||
155497670|NCT03728257|561245531|FG000|Overall Study|Death|3|||
155497671|NCT03728257|561245532|FG001|Overall Study|Death|0|||
155497672|NCT00905437|561245534|FG000|Overall Study|Adverse Event|3|||
155497673|NCT00905437|561245535|FG001|Overall Study|Adverse Event|2|||
155497674|NCT00905437|561245534|FG000|Overall Study|Lost to Follow-up|0|||
155497675|NCT00905437|561245535|FG001|Overall Study|Lost to Follow-up|1|||
155497676|NCT00905437|561245534|FG000|Overall Study|Withdrawal by Subject|0|||
155497677|NCT00905437|561245535|FG001|Overall Study|Withdrawal by Subject|1|||
155497678|NCT00905437|561245534|FG000|Overall Study|Other|5|||
155497679|NCT00905437|561245535|FG001|Overall Study|Other|6|||
155497680|NCT01306968|561245536|FG000|Overall Study|Lost to Follow-up|1|||
155497681|NCT01306968|561245537|FG001|Overall Study|Lost to Follow-up|1|||
155497682|NCT01306968|561245538|FG002|Overall Study|Lost to Follow-up|0|||
155497683|NCT01306968|561245539|FG003|Overall Study|Lost to Follow-up|0|||
155497684|NCT01306968|561245536|FG000|Overall Study|Physician Decision|0|||
155497685|NCT01306968|561245537|FG001|Overall Study|Physician Decision|1|||
155497686|NCT01306968|561245538|FG002|Overall Study|Physician Decision|0|||
155497687|NCT01306968|561245539|FG003|Overall Study|Physician Decision|0|||
155497688|NCT01306968|561245536|FG000|Overall Study|Relocated and left active duty|0|||
155497689|NCT01306968|561245537|FG001|Overall Study|Relocated and left active duty|1|||
155497690|NCT01306968|561245538|FG002|Overall Study|Relocated and left active duty|1|||
155497691|NCT01306968|561245539|FG003|Overall Study|Relocated and left active duty|1|||
155497692|NCT01306968|561245536|FG000|Overall Study|Withdrew - time commitment|0|||
155497693|NCT01306968|561245537|FG001|Overall Study|Withdrew - time commitment|0|||
155497694|NCT01306968|561245538|FG002|Overall Study|Withdrew - time commitment|0|||
155497695|NCT01306968|561245539|FG003|Overall Study|Withdrew - time commitment|2|||
155497696|NCT01306968|561245536|FG000|Overall Study|Withdrew over privacy concerns|0|||
155497697|NCT01306968|561245537|FG001|Overall Study|Withdrew over privacy concerns|0|||
155497698|NCT01306968|561245538|FG002|Overall Study|Withdrew over privacy concerns|0|||
155497699|NCT01306968|561245539|FG003|Overall Study|Withdrew over privacy concerns|1|||
155497700|NCT03252015|561245542|FG000|Overall Study|Withdrawal by Subject|0|||
155414148|NCT01790503|560948150|FG008|Overall Study|Protocol Violation|0|||
155414149|NCT01790503|560948151|FG009|Overall Study|Protocol Violation|1|||
155414150|NCT01790503|560948152|FG010|Overall Study|Protocol Violation|0|||
155414151|NCT01790503|560948142|FG000|Overall Study|Physician Decision|0|||
155414152|NCT01790503|560948143|FG001|Overall Study|Physician Decision|0|||
155414153|NCT01790503|560948144|FG002|Overall Study|Physician Decision|0|||
155414154|NCT01790503|560948145|FG003|Overall Study|Physician Decision|0|||
155414155|NCT01790503|560948146|FG004|Overall Study|Physician Decision|0|||
155414156|NCT01790503|560948147|FG005|Overall Study|Physician Decision|0|||
155414157|NCT01790503|560948148|FG006|Overall Study|Physician Decision|0|||
155414158|NCT01790503|560948149|FG007|Overall Study|Physician Decision|0|||
155414159|NCT01790503|560948150|FG008|Overall Study|Physician Decision|0|||
155414160|NCT01790503|560948151|FG009|Overall Study|Physician Decision|1|||
155414161|NCT01790503|560948152|FG010|Overall Study|Physician Decision|1|||
155414162|NCT01790503|560948142|FG000|Overall Study|Death|0|||
155414163|NCT01790503|560948143|FG001|Overall Study|Death|0|||
155414164|NCT01790503|560948144|FG002|Overall Study|Death|0|||
155414165|NCT01790503|560948145|FG003|Overall Study|Death|0|||
155414166|NCT01790503|560948146|FG004|Overall Study|Death|0|||
155414167|NCT01790503|560948147|FG005|Overall Study|Death|0|||
155414168|NCT01790503|560948148|FG006|Overall Study|Death|0|||
155414169|NCT01790503|560948149|FG007|Overall Study|Death|0|||
155414170|NCT01790503|560948150|FG008|Overall Study|Death|0|||
155414171|NCT01790503|560948151|FG009|Overall Study|Death|1|||
155414172|NCT01790503|560948152|FG010|Overall Study|Death|0|||
155414173|NCT01790503|560948142|FG000|Overall Study|Non Compliance|0|||
155414174|NCT01790503|560948143|FG001|Overall Study|Non Compliance|0|||
155414175|NCT01790503|560948144|FG002|Overall Study|Non Compliance|0|||
155414176|NCT01790503|560948145|FG003|Overall Study|Non Compliance|0|||
155414177|NCT01790503|560948146|FG004|Overall Study|Non Compliance|1|||
155414178|NCT01790503|560948147|FG005|Overall Study|Non Compliance|0|||
155414179|NCT01790503|560948148|FG006|Overall Study|Non Compliance|0|||
155414180|NCT01790503|560948149|FG007|Overall Study|Non Compliance|0|||
155414181|NCT01790503|560948150|FG008|Overall Study|Non Compliance|0|||
155414182|NCT01790503|560948151|FG009|Overall Study|Non Compliance|0|||
155414183|NCT01790503|560948152|FG010|Overall Study|Non Compliance|0|||
155414184|NCT01790503|560948142|FG000|Overall Study|Other|0|||
155414185|NCT01790503|560948143|FG001|Overall Study|Other|0|||
155414186|NCT01790503|560948144|FG002|Overall Study|Other|0|||
155414187|NCT01790503|560948145|FG003|Overall Study|Other|0|||
155414188|NCT01790503|560948146|FG004|Overall Study|Other|1|||
155414189|NCT01790503|560948147|FG005|Overall Study|Other|0|||
155414190|NCT01790503|560948148|FG006|Overall Study|Other|0|||
155414191|NCT01790503|560948149|FG007|Overall Study|Other|0|||
155414192|NCT01790503|560948150|FG008|Overall Study|Other|1|||
155414193|NCT01790503|560948151|FG009|Overall Study|Other|2|||
155414194|NCT01790503|560948152|FG010|Overall Study|Other|0|||
155414195|NCT02322710|560948154|FG000|Overall Study|No efficacy assessment post-baseline|0|||
155414196|NCT02322710|560948155|FG001|Overall Study|No efficacy assessment post-baseline|1|||
155414197|NCT02322710|560948154|FG000|Overall Study|Protocol Violation|20|||
155414198|NCT02322710|560948155|FG001|Overall Study|Protocol Violation|25|||
155414199|NCT02615990|560948156|FG000|Overall Study|study terminated|1|||
155414200|NCT02615990|560948157|FG001|Overall Study|study terminated|1|||
155414201|NCT00808444|560948164|FG000|Overall Study|Withdrawal by Subject|1|||
155414202|NCT00808444|560948165|FG001|Overall Study|Withdrawal by Subject|0|||
155414203|NCT00808444|560948164|FG000|Overall Study|Lost to Follow-up|0|||
155414204|NCT00808444|560948165|FG001|Overall Study|Lost to Follow-up|1|||
155414205|NCT01461044|560948166|FG000|Overall Study|Death|58|||
155414206|NCT01461044|560948167|FG001|Overall Study|Death|35|||
155414207|NCT01461044|560948166|FG000|Overall Study|Lost to Follow-up|12|||
155414208|NCT01461044|560948167|FG001|Overall Study|Lost to Follow-up|5|||
155414209|NCT04401267|560948168|FG000|Overall Study|Death|0|||
155414210|NCT04401267|560948169|FG001|Overall Study|Death|1|||
155414211|NCT04401267|560948168|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
155414212|NCT04401267|560948169|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
155414213|NCT04401267|560948168|FG000|Overall Study|Found to be Ineligible|1|||
155414214|NCT04401267|560948169|FG001|Overall Study|Found to be Ineligible|0|||
155414215|NCT04294459|560948175|FG000|Overall Study|Adverse Event|0|||
155414216|NCT04294459|560948176|FG001|Overall Study|Adverse Event|1|||
155414217|NCT02787863|560948177|FG000|Overall Study|Death|1|||
155414218|NCT02787863|560948178|FG001|Overall Study|Death|0|||
155414219|NCT02787863|560948179|FG002|Overall Study|Death|1|||
155414220|NCT02787863|560948180|FG003|Overall Study|Death|0|||
155414221|NCT02787863|560948181|FG004|Overall Study|Death|0|||
155414222|NCT02787863|560948182|FG005|Overall Study|Death|0|||
155414223|NCT02787863|560948183|FG006|Overall Study|Death|0|||
155414224|NCT02787863|560948184|FG007|Overall Study|Death|0|||
155414225|NCT02787863|560948177|FG000|Overall Study|Withdrawal by Subject|0|||
155414226|NCT02787863|560948178|FG001|Overall Study|Withdrawal by Subject|1|||
155414227|NCT02787863|560948179|FG002|Overall Study|Withdrawal by Subject|1|||
155414228|NCT02787863|560948180|FG003|Overall Study|Withdrawal by Subject|0|||
155414229|NCT02787863|560948181|FG004|Overall Study|Withdrawal by Subject|0|||
155497701|NCT03252015|561245543|FG001|Overall Study|Withdrawal by Subject|1|||
155497702|NCT03252015|561245544|FG002|Overall Study|Withdrawal by Subject|1|||
155497703|NCT03252015|561245545|FG003|Overall Study|Withdrawal by Subject|0|||
155497704|NCT03252015|561245542|FG000|Overall Study|Adverse Event|1|||
155497705|NCT03252015|561245543|FG001|Overall Study|Adverse Event|0|||
155497706|NCT03252015|561245544|FG002|Overall Study|Adverse Event|0|||
155497707|NCT03252015|561245545|FG003|Overall Study|Adverse Event|1|||
155497708|NCT03128931|561245546|FG000|Overall Study|Physician Decision|1|||
155497709|NCT03128931|561245546|FG000|Overall Study|Equipment Issues|3|||
155497710|NCT04993339|561245547|FG000|Overall Study|Lost to Follow-up|0|||
155497711|NCT04993339|561245548|FG001|Overall Study|Lost to Follow-up|1|||
155497712|NCT04993339|561245547|FG000|Overall Study|no MRI scan|3|||
155497713|NCT04993339|561245548|FG001|Overall Study|no MRI scan|1|||
155497714|NCT00903409|561245549|FG000|Overall Study|Adverse Event|11|||
155497715|NCT00903409|561245550|FG001|Overall Study|Adverse Event|9|||
155497716|NCT00903409|561245549|FG000|Overall Study|Non-compliance with Protocol|1|||
155497717|NCT00903409|561245550|FG001|Overall Study|Non-compliance with Protocol|1|||
155497718|NCT00903409|561245549|FG000|Overall Study|Laboratory Abnormality|2|||
155497719|NCT00903409|561245550|FG001|Overall Study|Laboratory Abnormality|0|||
155497720|NCT00903409|561245549|FG000|Overall Study|Withdrawal by Subject|8|||
155497721|NCT00903409|561245550|FG001|Overall Study|Withdrawal by Subject|8|||
155497722|NCT00903409|561245549|FG000|Overall Study|Other|2|||
155497723|NCT00903409|561245550|FG001|Overall Study|Other|3|||
155497724|NCT00903409|561245549|FG000|Overall Study|Lost to Follow-up|2|||
155497725|NCT00903409|561245550|FG001|Overall Study|Lost to Follow-up|6|||
155497726|NCT00797316|561245551|FG000|Overall Study|Administrative problems|1|||
155497727|NCT00797316|561245552|FG001|Overall Study|Administrative problems|0|||
155497728|NCT00797316|561245551|FG000|Overall Study|Adverse Event|5|||
155497729|NCT00797316|561245552|FG001|Overall Study|Adverse Event|3|||
155497730|NCT00797316|561245551|FG000|Overall Study|Lost to Follow-up|4|||
155497731|NCT00797316|561245552|FG001|Overall Study|Lost to Follow-up|8|||
155497732|NCT00797316|561245551|FG000|Overall Study|Protocol Deviation|1|||
155497733|NCT00797316|561245552|FG001|Overall Study|Protocol Deviation|2|||
155497734|NCT00797316|561245551|FG000|Overall Study|Patient withdrew consent|12|||
155497735|NCT00797316|561245552|FG001|Overall Study|Patient withdrew consent|6|||
155497736|NCT00797316|561245551|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155497737|NCT00797316|561245552|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
155497738|NCT01721369|561245555|FG000|Overall Study|Not initial etiological diagnosis|12|||
155497739|NCT01819467|561247041|FG000|Overall Study|Physician Decision|20|||
155497740|NCT01819467|561247042|FG001|Overall Study|Physician Decision|9|||
155497741|NCT00734617|561247047|FG000|Overall Study|Adverse Event|4|||
155497742|NCT00734617|561247048|FG001|Overall Study|Adverse Event|7|||
155497743|NCT00734617|561247047|FG000|Overall Study|Withdrawal by Subject|103|||
155497744|NCT00734617|561247048|FG001|Overall Study|Withdrawal by Subject|95|||
155497745|NCT03692078|561247051|FG000|Overall Study|Adverse Event|0|||
155497746|NCT03692078|561247052|FG001|Overall Study|Adverse Event|0|||
155497747|NCT03692078|561247053|FG002|Overall Study|Adverse Event|0|||
155497748|NCT03692078|561247054|FG003|Overall Study|Adverse Event|0|||
155497749|NCT03692078|561247055|FG004|Overall Study|Adverse Event|0|||
155497750|NCT03692078|561247056|FG005|Overall Study|Adverse Event|1|||
155497751|NCT03692078|561247057|FG006|Overall Study|Adverse Event|0|||
155497752|NCT03692078|561247051|FG000|Overall Study|Enrollment Closed|5|||
155497753|NCT03692078|561247052|FG001|Overall Study|Enrollment Closed|0|||
155497754|NCT03692078|561247053|FG002|Overall Study|Enrollment Closed|0|||
155497755|NCT03692078|561247054|FG003|Overall Study|Enrollment Closed|0|||
155497756|NCT03692078|561247055|FG004|Overall Study|Enrollment Closed|0|||
155497757|NCT03692078|561247056|FG005|Overall Study|Enrollment Closed|0|||
155497758|NCT03692078|561247057|FG006|Overall Study|Enrollment Closed|0|||
155497759|NCT03692078|561247051|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
155497760|NCT03692078|561247052|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
155749596|NCT00219544|562182858|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
155749597|NCT00219544|562182857|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
155749598|NCT00219544|562182858|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
155749599|NCT05856760|562182859|FG000|Overall Study|Adverse Event|2|||
155749600|NCT05856760|562182859|FG000|Overall Study|Physician Decision|1|||
155749601|NCT05856760|562182859|FG000|Overall Study|Protocol Violation|1|||
155749602|NCT05856760|562182859|FG000|Overall Study|Withdrawal by Subject|3|||
155749603|NCT04035486|562182860|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
155749604|NCT04035486|562182861|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
155749605|NCT04035486|562182862|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
155749606|NCT04035486|562182863|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
155749607|NCT04035486|562182860|FG000|Overall Study|Death|6|||
155749608|NCT04035486|562182861|FG001|Overall Study|Death|3|||
155749609|NCT04035486|562182862|FG002|Overall Study|Death|70|||
155749610|NCT04035486|562182863|FG003|Overall Study|Death|77|||
155497761|NCT03692078|561247053|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
155497762|NCT03692078|561247054|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
155307395|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307396|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307397|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307398|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307399|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307400|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307401|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307402|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|Death|0|||
155307403|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|Death|0|||
155307404|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|Death|4|||
155307405|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|Death|0|||
155307406|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|Death|0|||
155307407|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|Death|4|||
155307408|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|Death|0|||
155307409|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|Death|0|||
155307410|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|Death|2|||
155307411|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307412|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307413|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
155307414|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307415|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307416|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
155307417|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307418|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307419|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307420|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307421|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307422|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307423|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307424|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307425|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
155307426|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307427|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307428|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
155307429|NCT05415410|560557433|FG000|Overall Study|Death|3|||
155307430|NCT05415410|560557434|FG001|Overall Study|Death|6|||
155307431|NCT05415410|560557435|FG002|Overall Study|Death|1|||
155307432|NCT05415410|560557433|FG000|Overall Study|Trial Terminated by Sponsor|1|||
155307433|NCT05415410|560557434|FG001|Overall Study|Trial Terminated by Sponsor|5|||
155307434|NCT05415410|560557435|FG002|Overall Study|Trial Terminated by Sponsor|0|||
155307435|NCT05415410|560557433|FG000|Overall Study|Adverse Event|2|||
155307436|NCT05415410|560557434|FG001|Overall Study|Adverse Event|1|||
155307437|NCT05415410|560557435|FG002|Overall Study|Adverse Event|0|||
155307438|NCT05415410|560557433|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
155307439|NCT05415410|560557434|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
155307440|NCT05415410|560557435|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
155307441|NCT05415410|560557433|FG000|Overall Study|Withdrawal by Subject|1|||
155307442|NCT05415410|560557434|FG001|Overall Study|Withdrawal by Subject|0|||
155307443|NCT05415410|560557435|FG002|Overall Study|Withdrawal by Subject|0|||
155307444|NCT05415410|560557433|FG000|Overall Study|Pregnancy|5|||
155307445|NCT05415410|560557434|FG001|Overall Study|Pregnancy|2|||
155307446|NCT05415410|560557435|FG002|Overall Study|Pregnancy|0|||
155307447|NCT02365766|560557436|FG000|Overall Study|Withdrawal by Subject|0|||
155307448|NCT02365766|560557437|FG001|Overall Study|Withdrawal by Subject|0|||
155307449|NCT02365766|560557438|FG002|Overall Study|Withdrawal by Subject|1|||
155307450|NCT02365766|560557436|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155307451|NCT02365766|560557437|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155307452|NCT02365766|560557438|FG002|Overall Study|Eligibility Criteria Not Met|1|||
155307453|NCT04791709|560557445|FG000|Overall Study|Withdrawal by Subject|3|||
155307454|NCT02724956|560557446|FG000|Overall Study|Physician Decision|1|||
155307455|NCT02724956|560557447|FG001|Overall Study|Physician Decision|0|||
155307456|NCT02724956|560557446|FG000|Overall Study|Lack of Efficacy|0|||
155307457|NCT02724956|560557447|FG001|Overall Study|Lack of Efficacy|1|||
155307458|NCT02724956|560557446|FG000|Overall Study|Withdrawal by Subject|0|||
155307459|NCT02724956|560557447|FG001|Overall Study|Withdrawal by Subject|1|||
155307460|NCT00650104|560557448|FG000|Overall Study|Adverse Event|17|||
155307461|NCT00650104|560557448|FG000|Overall Study|Death|2|||
155307462|NCT00650104|560557448|FG000|Overall Study|Withdrawal by Subject|11|||
155307463|NCT00650104|560557448|FG000|Overall Study|Physician Decision|7|||
155307464|NCT00650104|560557448|FG000|Overall Study|Lost to Follow-up|1|||
155307465|NCT00650104|560557448|FG000|Overall Study|Non-compliance|2|||
155307466|NCT00650104|560557448|FG000|Overall Study|Sponsor Terminated Dosing|1|||
155307467|NCT03385629|560557449|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
155307468|NCT03385629|560557450|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
155307469|NCT03385629|560557449|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
155307470|NCT03385629|560557450|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
155749611|NCT04035486|562182860|FG000|Overall Study|Screen Failure|0|||
155749612|NCT04035486|562182861|FG001|Overall Study|Screen Failure|0|||
155749613|NCT04035486|562182862|FG002|Overall Study|Screen Failure|1|||
155497763|NCT03692078|561247055|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
155497764|NCT03692078|561247056|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
155497765|NCT03692078|561247057|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
155497766|NCT03692078|561247051|FG000|Overall Study|Withdrawal by Subject|0|||
155497767|NCT03692078|561247052|FG001|Overall Study|Withdrawal by Subject|2|||
155497768|NCT03692078|561247053|FG002|Overall Study|Withdrawal by Subject|0|||
155497769|NCT03692078|561247054|FG003|Overall Study|Withdrawal by Subject|1|||
155497770|NCT03692078|561247055|FG004|Overall Study|Withdrawal by Subject|5|||
155497771|NCT03692078|561247056|FG005|Overall Study|Withdrawal by Subject|3|||
155497772|NCT03692078|561247057|FG006|Overall Study|Withdrawal by Subject|3|||
155497773|NCT01563029|561247058|FG000|Overall Study|Adverse Event|1|||
155497774|NCT01563029|561247059|FG001|Overall Study|Adverse Event|0|||
155497775|NCT01563029|561247060|FG002|Overall Study|Adverse Event|1|||
155497776|NCT01563029|561247061|FG003|Overall Study|Adverse Event|2|||
155497777|NCT01563029|561247062|FG004|Overall Study|Adverse Event|1|||
155307471|NCT03385629|560557449|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
155307472|NCT03385629|560557450|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
155307473|NCT01532388|560557451|FG000|3-month Follow-up|Lost to Follow-up|68|||
155307474|NCT01532388|560557452|FG001|3-month Follow-up|Lost to Follow-up|68|||
155307475|NCT01532388|560557451|FG000|6-month Follow-up|Lost to Follow-up|74|||
155307476|NCT01532388|560557452|FG001|6-month Follow-up|Lost to Follow-up|66|||
155307477|NCT01532388|560557451|FG000|12-month Follow-up|Lost to Follow-up|69|||
155307478|NCT01532388|560557452|FG001|12-month Follow-up|Lost to Follow-up|67|||
155307479|NCT02697136|560557456|FG000|Overall Study|Adverse Event|3|||
155307480|NCT02697136|560557457|FG001|Overall Study|Adverse Event|0|||
155307481|NCT03578536|560557458|FG000|Overall Study|Lost to Follow-up|1|||
155307482|NCT02538900|560557459|FG000|Overall Study|Death|2|||
155307483|NCT02538900|560557460|FG001|Overall Study|Death|2|||
155307484|NCT02538900|560557461|FG002|Overall Study|Death|2|||
155307485|NCT02538900|560557459|FG000|Overall Study|Withdrawal by Subject|18|||
155307486|NCT02538900|560557460|FG001|Overall Study|Withdrawal by Subject|16|||
155307487|NCT02538900|560557461|FG002|Overall Study|Withdrawal by Subject|15|||
155307488|NCT00999167|560557462|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
155307489|NCT00999167|560557463|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
155307490|NCT00999167|560557464|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
155307491|NCT00999167|560557462|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
155307492|NCT00999167|560557463|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
155307493|NCT00999167|560557464|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
155307494|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
155307495|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
155307496|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
155307497|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
155307498|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
155307499|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
155307500|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
155414230|NCT02787863|560948182|FG005|Overall Study|Withdrawal by Subject|0|||
155414231|NCT02787863|560948183|FG006|Overall Study|Withdrawal by Subject|0|||
155414232|NCT02787863|560948184|FG007|Overall Study|Withdrawal by Subject|0|||
155414233|NCT02450487|560948185|FG000|Overall Study|Lost to Follow-up|3|||
155414234|NCT04142983|560948187|FG000|Overall Study|Lost to Follow-up|73|||
155414235|NCT04142983|560948187|FG000|Overall Study|Withdrawal by Subject|10|||
155414236|NCT04142983|560948187|FG000|Overall Study|Physician Decision|1|||
155414237|NCT04142983|560948187|FG000|Overall Study|Adverse Event|1|||
155414238|NCT04142983|560948187|FG000|Overall Study|No longer eligible|4|||
155414239|NCT04142983|560948187|FG000|Overall Study|Screen Failure|10|||
155414240|NCT01789970|560948188|FG000|Open-label Titration Period|Adverse Event|68|||
155497778|NCT01563029|561247058|FG000|Overall Study|Lack of Efficacy|42|||
155497779|NCT01563029|561247059|FG001|Overall Study|Lack of Efficacy|16|||
155497780|NCT01563029|561247060|FG002|Overall Study|Lack of Efficacy|23|||
155497781|NCT01563029|561247061|FG003|Overall Study|Lack of Efficacy|21|||
155497782|NCT01563029|561247062|FG004|Overall Study|Lack of Efficacy|19|||
155497783|NCT01563029|561247058|FG000|Overall Study|Protocol Violation|1|||
155497784|NCT01563029|561247059|FG001|Overall Study|Protocol Violation|2|||
155749614|NCT04035486|562182863|FG003|Overall Study|Screen Failure|1|||
155749615|NCT04035486|562182860|FG000|Overall Study|Withdrawal by Subject|1|||
155749616|NCT04035486|562182861|FG001|Overall Study|Withdrawal by Subject|1|||
155749617|NCT04035486|562182862|FG002|Overall Study|Withdrawal by Subject|11|||
155749618|NCT04035486|562182863|FG003|Overall Study|Withdrawal by Subject|9|||
155749619|NCT01006603|562182864|FG000|Overall Study|Withdrawal by Subject|17|||
155749620|NCT01006603|562182865|FG001|Overall Study|Withdrawal by Subject|19|||
155749621|NCT01006603|562182864|FG000|Overall Study|Lost to Follow-up|0|||
155307501|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
155307502|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
155307503|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
155307504|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
155307505|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
155307506|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
155307507|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
155307508|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
155307509|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
155307510|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
155307511|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
155307512|NCT02789020|560557465|FG000|Overall Study|Withdrawal by Subject|6|||
155307513|NCT02789020|560557466|FG001|Overall Study|Withdrawal by Subject|5|||
155307514|NCT04238247|560557467|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
155307515|NCT04238247|560557468|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
155307516|NCT04238247|560557469|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
155307517|NCT04238247|560557470|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
155307518|NCT04238247|560557467|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
155307519|NCT04238247|560557468|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
155307520|NCT04238247|560557469|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
155307521|NCT04238247|560557470|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
155307522|NCT04238247|560557467|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
155307523|NCT04238247|560557468|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
155307524|NCT04238247|560557469|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
155307525|NCT04238247|560557470|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
155307526|NCT04238247|560557467|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
155307527|NCT04238247|560557468|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
155307528|NCT04238247|560557469|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
155307529|NCT04238247|560557470|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
155307530|NCT05512962|560557471|FG000|Overall Study|Withdrawal by Subject|1|||
155307531|NCT05512962|560557472|FG001|Overall Study|Withdrawal by Subject|0|||
155307532|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
155307533|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
155307534|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307535|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307536|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307537|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307538|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
155307539|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
155307540|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307541|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307542|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307543|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307544|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
155307545|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
155307546|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307547|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307548|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307549|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307550|NCT04950127|560557473|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155414241|NCT01789970|560948189|FG001|Open-label Titration Period|Adverse Event|0|||
155414242|NCT01789970|560948190|FG002|Open-label Titration Period|Adverse Event|0|||
155414243|NCT01789970|560948188|FG000|Open-label Titration Period|Lack of Efficacy|31|||
155414244|NCT01789970|560948189|FG001|Open-label Titration Period|Lack of Efficacy|0|||
155414245|NCT01789970|560948190|FG002|Open-label Titration Period|Lack of Efficacy|0|||
155414246|NCT01789970|560948188|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
155414247|NCT01789970|560948189|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
155414248|NCT01789970|560948190|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
155414249|NCT01789970|560948188|FG000|Open-label Titration Period|Protocol Violation|18|||
155414250|NCT01789970|560948189|FG001|Open-label Titration Period|Protocol Violation|0|||
155414251|NCT01789970|560948190|FG002|Open-label Titration Period|Protocol Violation|0|||
155414252|NCT01789970|560948188|FG000|Open-label Titration Period|Lost to Follow-up|5|||
155414253|NCT01789970|560948189|FG001|Open-label Titration Period|Lost to Follow-up|0|||
155414254|NCT01789970|560948190|FG002|Open-label Titration Period|Lost to Follow-up|0|||
155414255|NCT01789970|560948188|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
155414256|NCT01789970|560948189|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
155497785|NCT01563029|561247060|FG002|Overall Study|Protocol Violation|3|||
155497786|NCT01563029|561247061|FG003|Overall Study|Protocol Violation|1|||
155307551|NCT04950127|560557474|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307552|NCT04950127|560557475|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307553|NCT04950127|560557476|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307554|NCT04950127|560557477|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307555|NCT04950127|560557478|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
155307556|NCT04950127|560557473|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307557|NCT04950127|560557474|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307558|NCT04950127|560557475|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307559|NCT04950127|560557476|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307560|NCT04950127|560557477|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
155414257|NCT01789970|560948190|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
155414258|NCT01789970|560948188|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
155414259|NCT01789970|560948189|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
155414260|NCT01789970|560948190|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
155414261|NCT01789970|560948188|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
155414262|NCT01789970|560948189|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
155414263|NCT01789970|560948190|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
155414264|NCT01789970|560948188|FG000|Open-label Titration Period|Pregnancy|2|||
155414265|NCT01789970|560948189|FG001|Open-label Titration Period|Pregnancy|0|||
155414266|NCT01789970|560948190|FG002|Open-label Titration Period|Pregnancy|0|||
155414267|NCT01789970|560948188|FG000|Open-label Titration Period|Other|76|||
155414268|NCT01789970|560948189|FG001|Open-label Titration Period|Other|0|||
155414269|NCT01789970|560948190|FG002|Open-label Titration Period|Other|0|||
155414270|NCT01789970|560948188|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
155414271|NCT01789970|560948189|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
155414272|NCT01789970|560948190|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
155414273|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
155414274|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
155414275|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
155414276|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155414277|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
155414278|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
155414279|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155414280|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
155414281|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
155414282|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155414283|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
155414284|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
155414285|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
155414286|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
155414287|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
155414288|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
155414289|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
155414290|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
155414291|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155414292|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155414293|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
155414294|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
155414295|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
155414296|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
155414297|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
155414298|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
155414299|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
155497787|NCT01563029|561247062|FG004|Overall Study|Protocol Violation|3|||
155497788|NCT01563029|561247058|FG000|Overall Study|Protocol defined stopping criteria|1|||
155497789|NCT01563029|561247059|FG001|Overall Study|Protocol defined stopping criteria|0|||
155497790|NCT01563029|561247060|FG002|Overall Study|Protocol defined stopping criteria|0|||
155497791|NCT01563029|561247061|FG003|Overall Study|Protocol defined stopping criteria|0|||
155497792|NCT01563029|561247062|FG004|Overall Study|Protocol defined stopping criteria|0|||
155497793|NCT01563029|561247058|FG000|Overall Study|Lost to Follow-up|1|||
155749622|NCT01006603|562182865|FG001|Overall Study|Lost to Follow-up|1|||
155307561|NCT04950127|560557478|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
155307562|NCT01711632|560557479|FG000|Overall Study|Adverse Event|4|||
155307563|NCT01711632|560557479|FG000|Overall Study|Death|3|||
155749623|NCT01006603|562182864|FG000|Overall Study|Safety reason|1|||
155307564|NCT01711632|560557479|FG000|Overall Study|Lost to Follow-up|3|||
155307565|NCT01711632|560557479|FG000|Overall Study|Withdrawal by Subject|4|||
155307566|NCT01711632|560557479|FG000|Overall Study|Progressive disease|2|||
155307567|NCT01711632|560557479|FG000|Overall Study|No follow up required in re-treatment|3|||
155307568|NCT01711632|560557479|FG000|Overall Study|No follow up required in re-treatment|3|||
155307569|NCT04315181|560557480|FG000|Overall Study|Non-responsive to drug conditions.|1|||
155307570|NCT01948661|560557481|FG000|Overall Study|Withdrawal by Subject|2|||
155307571|NCT01948661|560557482|FG001|Overall Study|Withdrawal by Subject|4|||
155307572|NCT03517969|560557483|FG000|Overall Study|Never started protocol treatment|3|||
155307573|NCT03517969|560557484|FG001|Overall Study|Never started protocol treatment|5|||
155307574|NCT03517969|560557483|FG000|Overall Study|Disease progression|11|||
155307575|NCT03517969|560557484|FG001|Overall Study|Disease progression|16|||
155307576|NCT03517969|560557483|FG000|Overall Study|PSA progression|8|||
155307577|NCT03517969|560557484|FG001|Overall Study|PSA progression|1|||
155307578|NCT03517969|560557483|FG000|Overall Study|Clinical progression|4|||
155307579|NCT03517969|560557484|FG001|Overall Study|Clinical progression|2|||
155307580|NCT03517969|560557483|FG000|Overall Study|Adverse Event|5|||
155307581|NCT03517969|560557484|FG001|Overall Study|Adverse Event|4|||
155307582|NCT03517969|560557483|FG000|Overall Study|Intercurrent illness|1|||
155414300|NCT01789970|560948188|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
155414301|NCT01789970|560948189|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
155414302|NCT01789970|560948190|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
155414303|NCT01847885|560948193|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
155414304|NCT01847885|560948194|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
155414305|NCT01847885|560948195|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
155414306|NCT01847885|560948193|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
155414307|NCT01847885|560948194|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
155414308|NCT01847885|560948195|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
155414309|NCT01847885|560948193|FG000|Initial Enrollment (Consented)|Screen failure|39|||
155414310|NCT01847885|560948194|FG001|Initial Enrollment (Consented)|Screen failure|0|||
155414311|NCT01847885|560948195|FG002|Initial Enrollment (Consented)|Screen failure|0|||
155414312|NCT01847885|560948193|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
155414313|NCT01847885|560948194|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
155414314|NCT01847885|560948195|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
155414315|NCT01847885|560948193|FG000|Randomization|Protocol Violation|0|||
155414316|NCT01847885|560948194|FG001|Randomization|Protocol Violation|1|||
155414317|NCT01847885|560948195|FG002|Randomization|Protocol Violation|0|||
155414318|NCT01847885|560948193|FG000|Randomization|Withdrawal by Subject|0|||
155414319|NCT01847885|560948194|FG001|Randomization|Withdrawal by Subject|0|||
155414320|NCT01847885|560948195|FG002|Randomization|Withdrawal by Subject|2|||
155414321|NCT01847885|560948193|FG000|Randomization|Screen Failure|0|||
155414322|NCT01847885|560948194|FG001|Randomization|Screen Failure|3|||
155414323|NCT01847885|560948195|FG002|Randomization|Screen Failure|0|||
155414324|NCT02574637|560948196|FG000|Double-blind Period|Adverse Event|1|||
155414325|NCT02574637|560948197|FG001|Double-blind Period|Adverse Event|0|||
155414326|NCT02574637|560948198|FG002|Double-blind Period|Adverse Event|0|||
155414327|NCT02574637|560948199|FG003|Double-blind Period|Adverse Event|0|||
155414328|NCT02574637|560948200|FG004|Double-blind Period|Adverse Event|0|||
155414329|NCT02574637|560948201|FG005|Double-blind Period|Adverse Event|0|||
155414330|NCT02574637|560948202|FG006|Double-blind Period|Adverse Event|0|||
155414331|NCT02574637|560948203|FG007|Double-blind Period|Adverse Event|0|||
155414332|NCT02574637|560948204|FG008|Double-blind Period|Adverse Event|0|||
155414333|NCT02574637|560948205|FG009|Double-blind Period|Adverse Event|0|||
155414334|NCT02574637|560948196|FG000|Double-blind Period|Lack of Efficacy|0|||
155414335|NCT02574637|560948197|FG001|Double-blind Period|Lack of Efficacy|0|||
155414336|NCT02574637|560948198|FG002|Double-blind Period|Lack of Efficacy|2|||
155414337|NCT02574637|560948199|FG003|Double-blind Period|Lack of Efficacy|0|||
155414338|NCT02574637|560948200|FG004|Double-blind Period|Lack of Efficacy|0|||
155414339|NCT02574637|560948201|FG005|Double-blind Period|Lack of Efficacy|0|||
155414340|NCT02574637|560948202|FG006|Double-blind Period|Lack of Efficacy|0|||
155414341|NCT02574637|560948203|FG007|Double-blind Period|Lack of Efficacy|0|||
155414342|NCT02574637|560948204|FG008|Double-blind Period|Lack of Efficacy|0|||
155307583|NCT03517969|560557484|FG001|Overall Study|Intercurrent illness|2|||
155414343|NCT02574637|560948205|FG009|Double-blind Period|Lack of Efficacy|0|||
155414344|NCT02574637|560948196|FG000|Double-blind Period|Protocol Deviation|1|||
155414345|NCT02574637|560948197|FG001|Double-blind Period|Protocol Deviation|0|||
155414346|NCT02574637|560948198|FG002|Double-blind Period|Protocol Deviation|0|||
155414347|NCT02574637|560948199|FG003|Double-blind Period|Protocol Deviation|0|||
155414348|NCT02574637|560948200|FG004|Double-blind Period|Protocol Deviation|0|||
155414349|NCT02574637|560948201|FG005|Double-blind Period|Protocol Deviation|0|||
155414350|NCT02574637|560948202|FG006|Double-blind Period|Protocol Deviation|0|||
155414351|NCT02574637|560948203|FG007|Double-blind Period|Protocol Deviation|0|||
155307584|NCT03517969|560557483|FG000|Overall Study|Death|1|||
155307585|NCT03517969|560557484|FG001|Overall Study|Death|1|||
155414352|NCT02574637|560948204|FG008|Double-blind Period|Protocol Deviation|0|||
155414353|NCT02574637|560948205|FG009|Double-blind Period|Protocol Deviation|0|||
155414354|NCT02574637|560948196|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
155414355|NCT02574637|560948197|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
155414356|NCT02574637|560948198|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
155414357|NCT02574637|560948199|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
155414358|NCT02574637|560948200|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
155414359|NCT02574637|560948201|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
155414360|NCT02574637|560948202|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
155414361|NCT02574637|560948203|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
155414362|NCT02574637|560948204|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
155414363|NCT02574637|560948205|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
155414364|NCT02574637|560948196|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
155414365|NCT02574637|560948197|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
155414366|NCT02574637|560948198|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
155414367|NCT02574637|560948199|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
155414368|NCT02574637|560948200|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
155414369|NCT02574637|560948201|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
155414370|NCT02574637|560948202|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
155414371|NCT02574637|560948203|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
155414372|NCT02574637|560948204|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
155414373|NCT02574637|560948205|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
155414374|NCT02574637|560948196|FG000|Double-blind Period|Reason Not Specified|0|||
155414375|NCT02574637|560948197|FG001|Double-blind Period|Reason Not Specified|0|||
155414376|NCT02574637|560948198|FG002|Double-blind Period|Reason Not Specified|0|||
155414377|NCT02574637|560948199|FG003|Double-blind Period|Reason Not Specified|1|||
155414378|NCT02574637|560948200|FG004|Double-blind Period|Reason Not Specified|0|||
155414379|NCT02574637|560948201|FG005|Double-blind Period|Reason Not Specified|0|||
155414380|NCT02574637|560948202|FG006|Double-blind Period|Reason Not Specified|0|||
155414381|NCT02574637|560948203|FG007|Double-blind Period|Reason Not Specified|0|||
155414382|NCT02574637|560948204|FG008|Double-blind Period|Reason Not Specified|0|||
155414383|NCT02574637|560948205|FG009|Double-blind Period|Reason Not Specified|0|||
155414384|NCT02574637|560948196|FG000|Open-label (OL) Period|Adverse Event|0|||
155414385|NCT02574637|560948197|FG001|Open-label (OL) Period|Adverse Event|0|||
155414386|NCT02574637|560948198|FG002|Open-label (OL) Period|Adverse Event|0|||
155414387|NCT02574637|560948199|FG003|Open-label (OL) Period|Adverse Event|0|||
155414388|NCT02574637|560948200|FG004|Open-label (OL) Period|Adverse Event|0|||
155414389|NCT02574637|560948201|FG005|Open-label (OL) Period|Adverse Event|0|||
155414390|NCT02574637|560948202|FG006|Open-label (OL) Period|Adverse Event|0|||
155414391|NCT02574637|560948203|FG007|Open-label (OL) Period|Adverse Event|0|||
155414392|NCT02574637|560948204|FG008|Open-label (OL) Period|Adverse Event|1|||
155414393|NCT02574637|560948205|FG009|Open-label (OL) Period|Adverse Event|0|||
155414394|NCT02574637|560948196|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
155414395|NCT02574637|560948197|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
155414396|NCT02574637|560948198|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
155414397|NCT02574637|560948199|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
155414398|NCT02574637|560948200|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
155414399|NCT02574637|560948201|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
155414400|NCT02574637|560948202|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
155414401|NCT02574637|560948203|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
155414402|NCT02574637|560948204|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
155414403|NCT02574637|560948205|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
155414404|NCT02574637|560948196|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414405|NCT02574637|560948197|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414406|NCT02574637|560948198|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414407|NCT02574637|560948199|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414408|NCT02574637|560948200|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414409|NCT02574637|560948201|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
155414410|NCT02574637|560948202|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
155414411|NCT02574637|560948203|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
155414412|NCT02574637|560948204|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
155414413|NCT02574637|560948205|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
155414414|NCT02499029|560948209|FG000|Overall Study|Lost to Follow-up|2|||
155749624|NCT01006603|562182865|FG001|Overall Study|Safety reason|1|||
155749625|NCT01006603|562182864|FG000|Overall Study|Protocol Violation|1|||
155414415|NCT02499029|560948210|FG001|Overall Study|Lost to Follow-up|2|||
155414416|NCT02499029|560948209|FG000|Overall Study|Physician Decision|2|||
155749626|NCT01006603|562182865|FG001|Overall Study|Protocol Violation|3|||
155414417|NCT02499029|560948210|FG001|Overall Study|Physician Decision|1|||
155414418|NCT02499029|560948209|FG000|Overall Study|Death|1|||
155414419|NCT02499029|560948210|FG001|Overall Study|Death|0|||
155749627|NCT01006603|562182864|FG000|Overall Study|Incorrect enrolment|0|||
155307586|NCT03517969|560557483|FG000|Overall Study|Withdrawal by Subject|1|||
155307587|NCT03517969|560557484|FG001|Overall Study|Withdrawal by Subject|2|||
155307588|NCT03517969|560557483|FG000|Overall Study|Physician Decision|1|||
155307589|NCT03517969|560557484|FG001|Overall Study|Physician Decision|1|||
155307590|NCT03517969|560557483|FG000|Overall Study|No clinical benefit|1|||
155414420|NCT04823949|560948211|FG000|Overall Study|Withdrawal by Subject|0|||
155414421|NCT04823949|560948212|FG001|Overall Study|Withdrawal by Subject|4|||
155414422|NCT04823949|560948211|FG000|Overall Study|Physician Decision|0|||
155414423|NCT04823949|560948212|FG001|Overall Study|Physician Decision|1|||
155414424|NCT00756938|560948213|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
155414425|NCT00756938|560948214|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
155414426|NCT00756938|560948215|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
155414427|NCT00756938|560948216|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
155414428|NCT00756938|560948213|FG000|12-week Base Study|Protocol Violation|0|||
155414429|NCT00756938|560948214|FG001|12-week Base Study|Protocol Violation|0|||
155414430|NCT00756938|560948215|FG002|12-week Base Study|Protocol Violation|1|||
155414431|NCT00756938|560948216|FG003|12-week Base Study|Protocol Violation|0|||
155414432|NCT00756938|560948213|FG000|12-week Base Study|Lost to Follow-up|1|||
155414433|NCT00756938|560948214|FG001|12-week Base Study|Lost to Follow-up|0|||
155414434|NCT00756938|560948215|FG002|12-week Base Study|Lost to Follow-up|0|||
155414435|NCT00756938|560948216|FG003|12-week Base Study|Lost to Follow-up|0|||
155414436|NCT00756938|560948213|FG000|Optional Extension|Lack of Efficacy|0|||
155414437|NCT00756938|560948214|FG001|Optional Extension|Lack of Efficacy|0|||
155414438|NCT00756938|560948215|FG002|Optional Extension|Lack of Efficacy|0|||
155414439|NCT00756938|560948216|FG003|Optional Extension|Lack of Efficacy|1|||
155414440|NCT00756938|560948213|FG000|Optional Extension|End of Study|0|||
155414441|NCT00756938|560948214|FG001|Optional Extension|End of Study|0|||
155414442|NCT00756938|560948215|FG002|Optional Extension|End of Study|0|||
155414443|NCT00756938|560948216|FG003|Optional Extension|End of Study|11|||
155414444|NCT00756938|560948213|FG000|Optional Extension|Protocol-specific criteria met|0|||
155414445|NCT00756938|560948214|FG001|Optional Extension|Protocol-specific criteria met|0|||
155414446|NCT00756938|560948215|FG002|Optional Extension|Protocol-specific criteria met|0|||
155414447|NCT00756938|560948216|FG003|Optional Extension|Protocol-specific criteria met|9|||
155414448|NCT00756938|560948213|FG000|Optional Extension|Physician Decision|0|||
155414449|NCT00756938|560948214|FG001|Optional Extension|Physician Decision|0|||
155414450|NCT00756938|560948215|FG002|Optional Extension|Physician Decision|0|||
155414451|NCT00756938|560948216|FG003|Optional Extension|Physician Decision|3|||
155414452|NCT00756938|560948213|FG000|Optional Extension|Lost to Follow-up|0|||
155414453|NCT00756938|560948214|FG001|Optional Extension|Lost to Follow-up|0|||
155414454|NCT00756938|560948215|FG002|Optional Extension|Lost to Follow-up|0|||
155414455|NCT00756938|560948216|FG003|Optional Extension|Lost to Follow-up|1|||
155414456|NCT00756938|560948213|FG000|Optional Extension|Protocol Violation|0|||
155642439|NCT00317369|561780796|FG002|Overall Study|Lack of Efficacy|1|||
155642440|NCT00317369|561780794|FG000|Overall Study|Withdrawal by Subject|0|||
155642441|NCT00317369|561780795|FG001|Overall Study|Withdrawal by Subject|0|||
155642442|NCT00317369|561780796|FG002|Overall Study|Withdrawal by Subject|1|||
155642443|NCT01068912|561780799|FG000|Overall Study|Adverse Event|2|||
155642444|NCT01068912|561780800|FG001|Overall Study|Adverse Event|3|||
155642445|NCT01068912|561780801|FG002|Overall Study|Adverse Event|2|||
155642446|NCT01068912|561780799|FG000|Overall Study|Withdrawal by Subject|5|||
155642447|NCT01068912|561780800|FG001|Overall Study|Withdrawal by Subject|6|||
155642448|NCT01068912|561780801|FG002|Overall Study|Withdrawal by Subject|6|||
155642449|NCT01068912|561780799|FG000|Overall Study|Lost to Follow-up|3|||
155642450|NCT01068912|561780800|FG001|Overall Study|Lost to Follow-up|7|||
155642451|NCT01068912|561780801|FG002|Overall Study|Lost to Follow-up|3|||
155642452|NCT01068912|561780799|FG000|Overall Study|Protocol Violation|0|||
155642453|NCT01068912|561780800|FG001|Overall Study|Protocol Violation|2|||
155642454|NCT01068912|561780801|FG002|Overall Study|Protocol Violation|0|||
155642455|NCT01068912|561780799|FG000|Overall Study|aggravation influenza|1|||
155642456|NCT01068912|561780800|FG001|Overall Study|aggravation influenza|1|||
155642457|NCT01068912|561780801|FG002|Overall Study|aggravation influenza|1|||
155642458|NCT01068912|561780799|FG000|Overall Study|other underlying illness|0|||
155642459|NCT01068912|561780800|FG001|Overall Study|other underlying illness|3|||
155749628|NCT01006603|562182865|FG001|Overall Study|Incorrect enrolment|2|||
155307591|NCT03517969|560557484|FG001|Overall Study|No clinical benefit|0|||
155307592|NCT03517969|560557483|FG000|Overall Study|Delayed treatment for dental treatment|1|||
155307593|NCT03517969|560557484|FG001|Overall Study|Delayed treatment for dental treatment|0|||
155414457|NCT00756938|560948214|FG001|Optional Extension|Protocol Violation|0|||
155414458|NCT00756938|560948215|FG002|Optional Extension|Protocol Violation|0|||
155414459|NCT00756938|560948216|FG003|Optional Extension|Protocol Violation|1|||
155414460|NCT00756938|560948213|FG000|Optional Extension|Withdrawal by Subject|0|||
155414461|NCT00756938|560948214|FG001|Optional Extension|Withdrawal by Subject|0|||
155642460|NCT01068912|561780801|FG002|Overall Study|other underlying illness|3|||
155642461|NCT02965833|561780802|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
155642462|NCT02965833|561780803|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
155642463|NCT02965833|561780802|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155749629|NCT01006603|562182864|FG000|Overall Study|Adverse Event|15|||
155749630|NCT01006603|562182865|FG001|Overall Study|Adverse Event|7|||
155749631|NCT01006603|562182864|FG000|Overall Study|Death|1|||
155749632|NCT01006603|562182865|FG001|Overall Study|Death|1|||
155497794|NCT01563029|561247059|FG001|Overall Study|Lost to Follow-up|0|||
155497795|NCT01563029|561247060|FG002|Overall Study|Lost to Follow-up|1|||
155497796|NCT01563029|561247061|FG003|Overall Study|Lost to Follow-up|1|||
155749633|NCT01006603|562182864|FG000|Overall Study|Study specific discontinuation criteria|33|||
155749634|NCT01006603|562182865|FG001|Overall Study|Study specific discontinuation criteria|34|||
155749635|NCT01006603|562182864|FG000|Overall Study|Other|3|||
155749636|NCT01006603|562182865|FG001|Overall Study|Other|7|||
155414462|NCT00756938|560948215|FG002|Optional Extension|Withdrawal by Subject|0|||
155414463|NCT00756938|560948216|FG003|Optional Extension|Withdrawal by Subject|10|||
155497797|NCT01563029|561247062|FG004|Overall Study|Lost to Follow-up|1|||
155497798|NCT01563029|561247058|FG000|Overall Study|Physician Decision|3|||
155497799|NCT01563029|561247059|FG001|Overall Study|Physician Decision|5|||
155497800|NCT01563029|561247060|FG002|Overall Study|Physician Decision|2|||
155497801|NCT01563029|561247061|FG003|Overall Study|Physician Decision|4|||
155497802|NCT01563029|561247062|FG004|Overall Study|Physician Decision|2|||
155497803|NCT01563029|561247058|FG000|Overall Study|Withdrawal by Subject|4|||
155497804|NCT01563029|561247059|FG001|Overall Study|Withdrawal by Subject|1|||
155497805|NCT01563029|561247060|FG002|Overall Study|Withdrawal by Subject|3|||
155497806|NCT01563029|561247061|FG003|Overall Study|Withdrawal by Subject|4|||
155497807|NCT01563029|561247062|FG004|Overall Study|Withdrawal by Subject|3|||
155497808|NCT02861534|561247063|FG000|Overall Study|Death|541|||
155497809|NCT02861534|561247064|FG001|Overall Study|Death|552|||
155497810|NCT02861534|561247063|FG000|Overall Study|Lost to Follow-up|14|||
155497811|NCT02861534|561247064|FG001|Overall Study|Lost to Follow-up|14|||
155497812|NCT02861534|561247063|FG000|Overall Study|Site Terminated by Sponsor|4|||
155497813|NCT02861534|561247064|FG001|Overall Study|Site Terminated by Sponsor|3|||
155497814|NCT02861534|561247063|FG000|Overall Study|Withdrawal by Subject|15|||
155497815|NCT02861534|561247064|FG001|Overall Study|Withdrawal by Subject|18|||
155497816|NCT02780115|561247065|FG000|Overall Study|Withdrawal by Subject|0|||
155497817|NCT02780115|561247066|FG001|Overall Study|Withdrawal by Subject|1|||
155497818|NCT02780115|561247067|FG002|Overall Study|Withdrawal by Subject|1|||
155497819|NCT02780115|561247068|FG003|Overall Study|Withdrawal by Subject|0|||
155497820|NCT02780115|561247069|FG004|Overall Study|Withdrawal by Subject|0|||
155497821|NCT02780115|561247065|FG000|Overall Study|Adverse Event|0|||
155497822|NCT02780115|561247066|FG001|Overall Study|Adverse Event|0|||
155497823|NCT02780115|561247067|FG002|Overall Study|Adverse Event|0|||
155497824|NCT02780115|561247068|FG003|Overall Study|Adverse Event|1|||
155497825|NCT02780115|561247069|FG004|Overall Study|Adverse Event|1|||
155414464|NCT00756938|560948213|FG000|Optional Extension|Adverse Event|0|||
155414465|NCT00756938|560948214|FG001|Optional Extension|Adverse Event|0|||
155414466|NCT00756938|560948215|FG002|Optional Extension|Adverse Event|0|||
155414467|NCT00756938|560948216|FG003|Optional Extension|Adverse Event|1|||
155414468|NCT00094055|560948217|FG000|Overall Study|Adverse Event|11|||
155414469|NCT00094055|560948217|FG000|Overall Study|Death|4|||
155414470|NCT00094055|560948217|FG000|Overall Study|Lack of Efficacy|17|||
155414471|NCT00094055|560948217|FG000|Overall Study|Lost to Follow-up|2|||
155414472|NCT00094055|560948217|FG000|Overall Study|progressive disease|2|||
155414473|NCT00094055|560948217|FG000|Overall Study|clinical progression|1|||
155414474|NCT00094055|560948217|FG000|Overall Study|roll-over to another study|14|||
155414475|NCT00094055|560948217|FG000|Overall Study|Withdrawal by Subject|9|||
155414476|NCT00441545|560948218|FG000|First Intervention|Adverse Event|6|||
155414477|NCT00441545|560948219|FG001|First Intervention|Adverse Event|5|||
155414478|NCT00441545|560948218|FG000|First Intervention|Protocol Violation|2|||
155414479|NCT00441545|560948219|FG001|First Intervention|Protocol Violation|2|||
155414480|NCT00441545|560948218|FG000|First Intervention|Withdrawal by Subject|3|||
155414481|NCT00441545|560948219|FG001|First Intervention|Withdrawal by Subject|3|||
155414482|NCT00441545|560948218|FG000|First Intervention|Kidney transplant|1|||
155414483|NCT00441545|560948219|FG001|First Intervention|Kidney transplant|1|||
155414484|NCT00441545|560948218|FG000|First Intervention|Lack of Efficacy|2|||
155414485|NCT00441545|560948219|FG001|First Intervention|Lack of Efficacy|0|||
155414486|NCT00441545|560948218|FG000|First Intervention|Subject exceeded safety criteria|0|||
155414487|NCT00441545|560948219|FG001|First Intervention|Subject exceeded safety criteria|1|||
155414488|NCT00441545|560948218|FG000|First Intervention|Subject met an exclusionary criteria|1|||
155414489|NCT00441545|560948219|FG001|First Intervention|Subject met an exclusionary criteria|0|||
155414490|NCT00441545|560948218|FG000|First Intervention|Extended hospitalization|1|||
155414491|NCT00441545|560948219|FG001|First Intervention|Extended hospitalization|0|||
155414492|NCT00441545|560948218|FG000|First Intervention|Site error|1|||
155414493|NCT00441545|560948219|FG001|First Intervention|Site error|0|||
155414494|NCT00441545|560948218|FG000|First Intervention|Sponsor's request|1|||
155497826|NCT00916617|561247072|FG000|Overall Study|Adverse Event|3|||
155497827|NCT00916617|561247073|FG001|Overall Study|Adverse Event|2|||
155497828|NCT00916617|561247074|FG002|Overall Study|Adverse Event|6|||
155497829|NCT00916617|561247075|FG003|Overall Study|Adverse Event|3|||
155749637|NCT00562627|562184122|FG000|Overall Study|Protocol Violation|1|||
155414495|NCT00441545|560948219|FG001|First Intervention|Sponsor's request|0|||
155414496|NCT00441545|560948218|FG000|Second Intervention|Adverse Event|5|||
155414497|NCT00441545|560948219|FG001|Second Intervention|Adverse Event|2|||
155414498|NCT00441545|560948218|FG000|Second Intervention|Protocol Violation|4|||
155414499|NCT00441545|560948219|FG001|Second Intervention|Protocol Violation|1|||
155414500|NCT00441545|560948218|FG000|Second Intervention|Withdrawal by Subject|1|||
155414501|NCT00441545|560948219|FG001|Second Intervention|Withdrawal by Subject|1|||
155414502|NCT00441545|560948218|FG000|Second Intervention|Kidney Transplant|1|||
155414503|NCT00441545|560948219|FG001|Second Intervention|Kidney Transplant|1|||
155414504|NCT00441545|560948218|FG000|Second Intervention|Lack of Efficacy|0|||
155414505|NCT00441545|560948219|FG001|Second Intervention|Lack of Efficacy|1|||
155497830|NCT00916617|561247072|FG000|Overall Study|Withdrawal by Subject|3|||
155497831|NCT00916617|561247073|FG001|Overall Study|Withdrawal by Subject|2|||
155497832|NCT00916617|561247074|FG002|Overall Study|Withdrawal by Subject|0|||
155414506|NCT00441545|560948218|FG000|Second Intervention|Subject exceeded safety criteria|1|||
155414507|NCT00441545|560948219|FG001|Second Intervention|Subject exceeded safety criteria|0|||
155414508|NCT00441545|560948218|FG000|Second Intervention|Subject moved|0|||
155414509|NCT00441545|560948219|FG001|Second Intervention|Subject moved|1|||
155414510|NCT01707693|560948220|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
155414511|NCT01707693|560948221|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
155414512|NCT01707693|560948220|FG000|Overall Study Allocation|Protocol Violation|4|||
155414513|NCT01707693|560948221|FG001|Overall Study Allocation|Protocol Violation|3|||
155414514|NCT01707693|560948220|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
155414515|NCT01707693|560948221|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
155414516|NCT01707693|560948220|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
155414517|NCT01707693|560948221|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
155414518|NCT02556255|560948223|FG000|Overall Study|Lost to Follow-up|4|||
155414519|NCT03115151|560948224|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
155414520|NCT03115151|560948225|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
155414521|NCT03115151|560948224|FG000|Overall Study|Epidural catheter removal|1|||
155414522|NCT03115151|560948225|FG001|Overall Study|Epidural catheter removal|0|||
155414523|NCT03115151|560948224|FG000|Overall Study|Withdrawal by Subject|0|||
155414524|NCT03115151|560948225|FG001|Overall Study|Withdrawal by Subject|1|||
155414525|NCT03115151|560948224|FG000|Overall Study|Intervention not received according to the protocol.|1|||
155414526|NCT03115151|560948225|FG001|Overall Study|Intervention not received according to the protocol.|1|||
155414527|NCT03115151|560948224|FG000|Overall Study|Physician Decision|1|||
155414528|NCT03115151|560948225|FG001|Overall Study|Physician Decision|0|||
155414529|NCT03115151|560948224|FG000|Overall Study|Randomization not applied|1|||
155414530|NCT03115151|560948225|FG001|Overall Study|Randomization not applied|1|||
155414531|NCT01325428|560948226|FG000|Part A|Progressive disease according to RECIST|9|||
155414532|NCT01325428|560948226|FG000|Part A|Clinical signs, symptoms of progression|2|||
155414533|NCT01325428|560948226|FG000|Part A|Other adverse event|1|||
155414534|NCT01325428|560948226|FG000|Part A|Refused continue taking trial medication|2|||
155414535|NCT01325428|560948226|FG000|Part A|Other reason not defined above|2|||
155414536|NCT01325428|560948226|FG000|Part B|Refused continue taking trial medication|2|||
155414537|NCT01325428|560948226|FG000|Part B|Other reason not defined above|1|||
155414538|NCT02682901|560948227|FG000|Overall Study|Adverse Event|10|||
155414539|NCT02682901|560948228|FG001|Overall Study|Adverse Event|3|||
155414540|NCT02682901|560948227|FG000|Overall Study|Lack of Efficacy|0|||
155414541|NCT02682901|560948228|FG001|Overall Study|Lack of Efficacy|1|||
155414542|NCT03870555|560948229|FG000|Period 3 (2 Days)|Adverse Event|1|||
155414543|NCT03870555|560948230|FG001|Period 3 (2 Days)|Adverse Event|0|||
155497833|NCT00916617|561247075|FG003|Overall Study|Withdrawal by Subject|1|||
155497834|NCT00916617|561247072|FG000|Overall Study|Caregiver Request|3|||
155497835|NCT00916617|561247073|FG001|Overall Study|Caregiver Request|2|||
155497836|NCT00916617|561247074|FG002|Overall Study|Caregiver Request|1|||
155497837|NCT00916617|561247075|FG003|Overall Study|Caregiver Request|0|||
155497838|NCT00916617|561247072|FG000|Overall Study|Physician Decision|1|||
155497839|NCT00916617|561247073|FG001|Overall Study|Physician Decision|1|||
155497840|NCT00916617|561247074|FG002|Overall Study|Physician Decision|0|||
155497841|NCT00916617|561247075|FG003|Overall Study|Physician Decision|0|||
155497842|NCT00916617|561247072|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
155497843|NCT00916617|561247073|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
155414544|NCT03870555|560948231|FG002|Period 3 (2 Days)|Adverse Event|0|||
155414545|NCT03713944|560948232|FG000|Study Treatment|Patient non-compliance|1|||
155414546|NCT03713944|560948232|FG000|Study Treatment|Alternative Cancer Therapy|3|||
155414547|NCT03713944|560948232|FG000|Study Treatment|Disease Progression|18|||
155414548|NCT03713944|560948232|FG000|Study Treatment|AE/Side Effects/Complications|2|||
155414549|NCT03713944|560948232|FG000|Study Treatment|Death|2|||
155414550|NCT03713944|560948232|FG000|Study Treatment|Withdrawal by Subject|1|||
155497844|NCT00916617|561247074|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
155497845|NCT00916617|561247075|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
155497846|NCT00916617|561247072|FG000|Overall Study|Lost to Follow-up|2|||
155497847|NCT00916617|561247073|FG001|Overall Study|Lost to Follow-up|1|||
155497848|NCT00916617|561247074|FG002|Overall Study|Lost to Follow-up|0|||
155414551|NCT03713944|560948232|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
155414552|NCT03713944|560948232|FG000|Study Treatment|Symptomatic Deterioration|2|||
155414553|NCT03713944|560948232|FG000|Follow up|Withdrawal by Subject|2|||
155414554|NCT03713944|560948232|FG000|Follow up|Death|11|||
155414555|NCT03713944|560948232|FG000|Follow up|Study Terminated|3|||
155414556|NCT02695628|560948250|FG000|Overall Study|Withdrawal by Subject|1|||
155414557|NCT00720109|560948251|FG000|Induction Period|Did not meet eligibility criteria|3|||
155414558|NCT00720109|560948252|FG001|Induction Period|Did not meet eligibility criteria|0|||
155414559|NCT00720109|560948253|FG002|Induction Period|Did not meet eligibility criteria|0|||
155414560|NCT00720109|560948251|FG000|Induction Period|Bone Marrow Transplant|2|||
155414561|NCT00720109|560948252|FG001|Induction Period|Bone Marrow Transplant|0|||
155414562|NCT00720109|560948253|FG002|Induction Period|Bone Marrow Transplant|0|||
155414563|NCT00720109|560948251|FG000|Induction Period|Physician Decision|1|||
155414564|NCT00720109|560948252|FG001|Induction Period|Physician Decision|0|||
155414565|NCT00720109|560948253|FG002|Induction Period|Physician Decision|0|||
155414566|NCT00720109|560948251|FG000|Risk Stratification Period|Adverse Event|0|||
155414567|NCT00720109|560948252|FG001|Risk Stratification Period|Adverse Event|1|||
155414568|NCT00720109|560948253|FG002|Risk Stratification Period|Adverse Event|0|||
155414569|NCT00720109|560948251|FG000|Risk Stratification Period|Physician Decision|0|||
155414570|NCT00720109|560948252|FG001|Risk Stratification Period|Physician Decision|2|||
155414571|NCT00720109|560948253|FG002|Risk Stratification Period|Physician Decision|1|||
155414572|NCT00720109|560948251|FG000|Risk Stratification Period|Bone marrow transplant|0|||
155414573|NCT00720109|560948252|FG001|Risk Stratification Period|Bone marrow transplant|9|||
155414574|NCT00720109|560948253|FG002|Risk Stratification Period|Bone marrow transplant|7|||
155414575|NCT00720109|560948251|FG000|Risk Stratification Period|Disease progression or relapse|0|||
155414576|NCT00720109|560948252|FG001|Risk Stratification Period|Disease progression or relapse|2|||
155414577|NCT00720109|560948253|FG002|Risk Stratification Period|Disease progression or relapse|0|||
155414578|NCT00720109|560948251|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
155414579|NCT00720109|560948252|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
155414580|NCT00720109|560948253|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
155414581|NCT03595553|560948254|FG000|Overall Study|Withdrawal by Subject|20|||
155414582|NCT03595553|560948255|FG001|Overall Study|Withdrawal by Subject|8|||
155414583|NCT03595553|560948254|FG000|Overall Study|Physician Decision|3|||
155414584|NCT03595553|560948255|FG001|Overall Study|Physician Decision|2|||
155414585|NCT03595553|560948254|FG000|Overall Study|Adverse Event|2|||
155414586|NCT03595553|560948255|FG001|Overall Study|Adverse Event|5|||
155414587|NCT03595553|560948254|FG000|Overall Study|Death|24|||
155414588|NCT03595553|560948255|FG001|Overall Study|Death|22|||
155414589|NCT03595553|560948254|FG000|Overall Study|Lost to Follow-up|6|||
155414590|NCT03595553|560948255|FG001|Overall Study|Lost to Follow-up|7|||
155414591|NCT03595553|560948254|FG000|Overall Study|Other as indicated in CSR|3|||
155414592|NCT03595553|560948255|FG001|Overall Study|Other as indicated in CSR|3|||
155414593|NCT03595553|560948254|FG000|Overall Study|Sponsor Decision|0|||
155414594|NCT03595553|560948255|FG001|Overall Study|Sponsor Decision|1|||
155414595|NCT00903929|560948256|FG000|Overall Study|Withdrawal by Subject|0|||
155414596|NCT00903929|560948257|FG001|Overall Study|Withdrawal by Subject|0|||
155414597|NCT00903929|560948258|FG002|Overall Study|Withdrawal by Subject|1|||
155414598|NCT00903929|560948259|FG003|Overall Study|Withdrawal by Subject|2|||
155414599|NCT00903929|560948256|FG000|Overall Study|Adverse Event|0|||
155414600|NCT00903929|560948257|FG001|Overall Study|Adverse Event|0|||
155414601|NCT00903929|560948258|FG002|Overall Study|Adverse Event|0|||
155414602|NCT00903929|560948259|FG003|Overall Study|Adverse Event|1|||
155414603|NCT02665286|560948260|FG000|Overall Study|Lost to Follow-up|3|||
155414604|NCT02665286|560948261|FG001|Overall Study|Lost to Follow-up|2|||
155414605|NCT02665286|560948262|FG002|Overall Study|Lost to Follow-up|1|||
155414606|NCT00626093|560948264|FG000|Overall Study|Lost to Follow-up|5|||
155414607|NCT00626093|560948264|FG000|Overall Study|Death|1|||
155414608|NCT00626093|560948264|FG000|Overall Study|Physician Decision|4|||
155414609|NCT00626093|560948264|FG000|Overall Study|Withdrawal by Subject|6|||
155414610|NCT00626093|560948264|FG000|Overall Study|Protocol Violation|1|||
155414611|NCT00626093|560948264|FG000|Overall Study|One of the required devices not implante|6|||
155414612|NCT04153188|560948273|FG000|Overall Study|Lost to Follow-up|1|||
155414613|NCT04153188|560948274|FG001|Overall Study|Lost to Follow-up|1|||
155414614|NCT04153188|560948273|FG000|Overall Study|Withdrawal by Subject|2|||
155414615|NCT04153188|560948274|FG001|Overall Study|Withdrawal by Subject|0|||
155414616|NCT04153188|560948273|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
155414617|NCT04153188|560948274|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
155414618|NCT01489527|560948275|FG000|Overall Study|Pregnancy|9|||
155414619|NCT01489527|560948276|FG001|Overall Study|Pregnancy|14|||
155414620|NCT01489527|560948275|FG000|Overall Study|Participant moved|6|||
155414621|NCT01489527|560948276|FG001|Overall Study|Participant moved|7|||
155414622|NCT01489527|560948275|FG000|Overall Study|Withdrawal by Subject|0|||
155414623|NCT01489527|560948276|FG001|Overall Study|Withdrawal by Subject|4|||
155414624|NCT01489527|560948275|FG000|Overall Study|Lost to Follow-up|5|||
155307594|NCT03517969|560557483|FG000|Overall Study|Difficult to maintain appointment|0|||
155307595|NCT03517969|560557484|FG001|Overall Study|Difficult to maintain appointment|1|||
155307596|NCT03517969|560557483|FG000|Overall Study|Protocol Violation|0|||
155307597|NCT03517969|560557484|FG001|Overall Study|Protocol Violation|1|||
155307598|NCT00522951|560557487|FG000|Period 1|body motion|0|||
155307599|NCT00522951|560557488|FG001|Period 1|body motion|1|||
155307600|NCT00522951|560557487|FG000|Washout Period|Adverse Event|0|||
155307601|NCT00522951|560557488|FG001|Washout Period|Adverse Event|1|||
155307602|NCT00522951|560557487|FG000|Washout Period|Death|0|||
155307603|NCT00522951|560557488|FG001|Washout Period|Death|1|||
155307604|NCT00522951|560557487|FG000|Period 2|Withdrawal by Subject|1|||
155307605|NCT00522951|560557488|FG001|Period 2|Withdrawal by Subject|0|||
155307606|NCT00522951|560557487|FG000|Period 2|residual contrast medium|1|||
155307607|NCT00522951|560557488|FG001|Period 2|residual contrast medium|1|||
155307608|NCT01101451|560557492|FG000|Overall Study|Eligible and never treated|0|||
155307609|NCT01101451|560557493|FG001|Overall Study|Eligible and never treated|5|||
155307610|NCT01101451|560557492|FG000|Overall Study|Ineligible and treated|12|||
155307611|NCT01101451|560557493|FG001|Overall Study|Ineligible and treated|8|||
155307612|NCT01101451|560557492|FG000|Overall Study|Ineligible and never treated|2|||
155307613|NCT01101451|560557493|FG001|Overall Study|Ineligible and never treated|2|||
155307614|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
155307615|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
155307616|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
155307617|NCT05480943|560557494|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
155307618|NCT02272816|560557495|FG000|Overall Study|Adverse Event|1|||
155307619|NCT04999592|560557496|FG000|Overall Study|Withdrawal by Subject|1|||
155307620|NCT04999592|560557497|FG001|Overall Study|Withdrawal by Subject|0|||
155307621|NCT04924062|560559038|FG000|Overall Study|Death|49|||
155307622|NCT04924062|560559039|FG001|Overall Study|Death|63|||
155307623|NCT04924062|560559038|FG000|Overall Study|Participant On-going|26|||
155307624|NCT04924062|560559039|FG001|Overall Study|Participant On-going|20|||
155307625|NCT04823611|560559049|FG000|Overall Study|Adverse Event|2|||
155307626|NCT04823611|560559050|FG001|Overall Study|Adverse Event|0|||
155307627|NCT04823611|560559051|FG002|Overall Study|Adverse Event|1|||
155307628|NCT04823611|560559052|FG003|Overall Study|Adverse Event|0|||
155307629|NCT04823611|560559053|FG004|Overall Study|Adverse Event|0|||
155307630|NCT04823611|560559054|FG005|Overall Study|Adverse Event|0|||
155307631|NCT04823611|560559055|FG006|Overall Study|Adverse Event|0|||
155307632|NCT05320432|560559056|FG000|Overall Study|Withdrawal by Subject|0|||
155307633|NCT05320432|560559057|FG001|Overall Study|Withdrawal by Subject|2|||
155307634|NCT05038566|560559058|FG000|Overall Study|Technical Difficulties with the Device|0|||
155307635|NCT05038566|560559059|FG001|Overall Study|Technical Difficulties with the Device|1|||
155307636|NCT03739996|560559064|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
155307637|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
155307638|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
155307639|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
155307640|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
155307641|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
155307642|NCT03739996|560559064|FG000|Step 3 (SOC ART)|Death|1|||
155307643|NCT03739996|560559064|FG000|Step 3 (SOC ART)|Participant moved|1|||
155307644|NCT05141903|560559065|FG000|Overall Study|Withdrawal by Subject|0|||
155307645|NCT05141903|560559066|FG001|Overall Study|Withdrawal by Subject|1|||
155307646|NCT05141903|560559067|FG002|Overall Study|Withdrawal by Subject|1|||
155307647|NCT05141903|560559068|FG003|Overall Study|Withdrawal by Subject|0|||
155307648|NCT05141903|560559069|FG004|Overall Study|Withdrawal by Subject|0|||
155307649|NCT05141903|560559065|FG000|Overall Study|Other|1|||
155307650|NCT05141903|560559066|FG001|Overall Study|Other|1|||
155307651|NCT05141903|560559067|FG002|Overall Study|Other|0|||
155307652|NCT05141903|560559068|FG003|Overall Study|Other|0|||
155307653|NCT05141903|560559069|FG004|Overall Study|Other|0|||
155307654|NCT05387447|560559073|FG000|Overall Study|Participants changed their minds about study participation.|3|||
155307655|NCT05387447|560559074|FG001|Overall Study|Participants changed their minds about study participation.|5|||
155307656|NCT05461131|560559080|FG000|Overall Study|Lost to Follow-up|0|||
155307657|NCT05461131|560559081|FG001|Overall Study|Lost to Follow-up|2|||
155307658|NCT05054374|560559102|FG000|Overall Study|Withdrawal by Subject|1|||
155307659|NCT05054374|560559103|FG001|Overall Study|Withdrawal by Subject|0|||
155307660|NCT05054374|560559104|FG002|Overall Study|Withdrawal by Subject|0|||
155307661|NCT05054374|560559105|FG003|Overall Study|Withdrawal by Subject|0|||
155307662|NCT05054374|560559102|FG000|Overall Study|Progressive Disease|5|||
155307663|NCT05054374|560559103|FG001|Overall Study|Progressive Disease|0|||
155307664|NCT05054374|560559104|FG002|Overall Study|Progressive Disease|0|||
155307665|NCT05054374|560559105|FG003|Overall Study|Progressive Disease|0|||
155307666|NCT05691309|560559106|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
155307667|NCT05691309|560559106|FG000|Overall Study|vancomycin levels not evaluable|2|||
155307668|NCT01707030|560559107|FG000|Overall Study|Death|1|||
155307669|NCT01707030|560559108|FG001|Overall Study|Death|1|||
155307670|NCT01707030|560559107|FG000|Overall Study|Withdrawal by Subject|2|||
155307671|NCT01707030|560559108|FG001|Overall Study|Withdrawal by Subject|3|||
155307672|NCT01707030|560559107|FG000|Overall Study|Lost to Follow-up|8|||
155307673|NCT01707030|560559108|FG001|Overall Study|Lost to Follow-up|13|||
155307674|NCT04437433|560559110|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
155307675|NCT04437433|560559111|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
155307676|NCT04437433|560559110|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
155307677|NCT04437433|560559111|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
155307678|NCT04437433|560559110|FG000|Overall Study|Adverse Event|9|||
155307679|NCT04437433|560559111|FG001|Overall Study|Adverse Event|0|||
155307680|NCT04437433|560559110|FG000|Overall Study|Lack of Efficacy|4|||
155307681|NCT04437433|560559111|FG001|Overall Study|Lack of Efficacy|0|||
155307682|NCT04437433|560559110|FG000|Overall Study|Withdrawal by Subject|4|||
155307683|NCT04437433|560559111|FG001|Overall Study|Withdrawal by Subject|1|||
155307684|NCT04437433|560559110|FG000|Overall Study|Protocol Deviation|0|||
155307685|NCT04437433|560559111|FG001|Overall Study|Protocol Deviation|1|||
155307686|NCT04437433|560559110|FG000|Overall Study|Other, not specified|0|||
155307687|NCT04437433|560559111|FG001|Overall Study|Other, not specified|1|||
155307688|NCT00792636|560559112|FG000|Overall Study|Protocol Violation|17|||
155307689|NCT00792636|560559113|FG001|Overall Study|Protocol Violation|23|||
155307690|NCT00792636|560559114|FG002|Overall Study|Protocol Violation|20|||
155307691|NCT00792636|560559112|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
155307692|NCT00792636|560559113|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
155307693|NCT00792636|560559114|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
155307694|NCT00792636|560559112|FG000|Overall Study|Lost to Follow-up|13|||
155307695|NCT00792636|560559113|FG001|Overall Study|Lost to Follow-up|19|||
155307696|NCT00792636|560559114|FG002|Overall Study|Lost to Follow-up|14|||
155307697|NCT00792636|560559112|FG000|Overall Study|Withdrew Consent|10|||
155307698|NCT00792636|560559113|FG001|Overall Study|Withdrew Consent|13|||
155307699|NCT00792636|560559114|FG002|Overall Study|Withdrew Consent|9|||
155307700|NCT00792636|560559112|FG000|Overall Study|Lack of Efficacy|3|||
155307701|NCT00792636|560559113|FG001|Overall Study|Lack of Efficacy|4|||
155497849|NCT00916617|561247075|FG003|Overall Study|Lost to Follow-up|0|||
155307702|NCT00792636|560559114|FG002|Overall Study|Lack of Efficacy|13|||
155307703|NCT00792636|560559112|FG000|Overall Study|Adverse Event|4|||
155307704|NCT00792636|560559113|FG001|Overall Study|Adverse Event|2|||
155307705|NCT00792636|560559114|FG002|Overall Study|Adverse Event|3|||
155307706|NCT00792636|560559112|FG000|Overall Study|Investigator Discretion|2|||
155307707|NCT00792636|560559113|FG001|Overall Study|Investigator Discretion|0|||
155307708|NCT00792636|560559114|FG002|Overall Study|Investigator Discretion|2|||
155307709|NCT04711135|560559118|FG000|Overall Study|Physician Decision|0|||
155497850|NCT00916617|561247072|FG000|Overall Study|Lack of Efficacy|1|||
155497851|NCT00916617|561247073|FG001|Overall Study|Lack of Efficacy|0|||
155497852|NCT00916617|561247074|FG002|Overall Study|Lack of Efficacy|0|||
155497853|NCT00916617|561247075|FG003|Overall Study|Lack of Efficacy|0|||
155497854|NCT00916617|561247072|FG000|Overall Study|Other|2|||
155497855|NCT00916617|561247073|FG001|Overall Study|Other|0|||
155497856|NCT00916617|561247074|FG002|Overall Study|Other|0|||
155307710|NCT04711135|560559119|FG001|Overall Study|Physician Decision|1|||
155307711|NCT04711135|560559118|FG000|Overall Study|Ongoing treatment|0|||
155307712|NCT04711135|560559119|FG001|Overall Study|Ongoing treatment|1|||
155307713|NCT04431726|560559128|FG000|Overall Study|Ongoing in the Study|55|||
155307714|NCT02860130|560559133|FG000|Overall Study|Adverse Event|2|||
155307715|NCT02860130|560559134|FG001|Overall Study|Adverse Event|3|||
155307716|NCT02860130|560559133|FG000|Overall Study|Protocol Violation|1|||
155307717|NCT02860130|560559134|FG001|Overall Study|Protocol Violation|1|||
155307718|NCT02860130|560559133|FG000|Overall Study|Withdrawal by Subject|0|||
155307719|NCT02860130|560559134|FG001|Overall Study|Withdrawal by Subject|2|||
155307720|NCT02860130|560559133|FG000|Overall Study|Physician Decision|2|||
155307721|NCT02860130|560559134|FG001|Overall Study|Physician Decision|2|||
155307722|NCT02860130|560559133|FG000|Overall Study|Other|2|||
155307723|NCT02860130|560559134|FG001|Overall Study|Other|1|||
155307724|NCT02140645|560559137|FG000|Overall Study|Not linked|5489|||
155307725|NCT02140645|560559138|FG001|Overall Study|Not linked|61654|||
155307726|NCT02140645|560559139|FG002|Overall Study|Not linked|4236|||
155307727|NCT02140645|560559140|FG003|Overall Study|Not linked|13833|||
155307728|NCT02140645|560559141|FG004|Overall Study|Not linked|3286|||
155307729|NCT02140645|560559142|FG005|Overall Study|Not linked|70896|||
155307730|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307731|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307732|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
155307733|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307734|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155497857|NCT00916617|561247075|FG003|Overall Study|Other|2|||
155497858|NCT00769132|561247078|FG000|Period 1|Adverse Event|1|||
155497859|NCT00769132|561247079|FG001|Period 1|Adverse Event|0|||
155497860|NCT00769132|561247080|FG002|Period 1|Adverse Event|0|||
155497861|NCT00769132|561247081|FG003|Period 1|Adverse Event|1|||
155307735|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155307736|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
155307737|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155307738|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307739|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307740|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307741|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
155307742|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155307743|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
155307744|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155307745|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155307746|NCT02794480|560559143|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155307747|NCT02794480|560559144|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155307748|NCT02794480|560559145|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155307749|NCT02794480|560559146|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155307750|NCT00593489|560559147|FG000|Allocation|did not attend workshop; allocation not|2|||
155307751|NCT00593489|560559148|FG001|Allocation|did not attend workshop; allocation not|1|||
155307752|NCT01747486|560559152|FG000|Stage 1|Physician Decision|3|||
155307753|NCT01747486|560559153|FG001|Stage 1|Physician Decision|0|||
155307754|NCT01747486|560559152|FG000|Stage 1|Withdrawal by Subject|4|||
155307755|NCT01747486|560559153|FG001|Stage 1|Withdrawal by Subject|3|||
155307756|NCT01747486|560559152|FG000|Stage 1|Disease progression|4|||
155307757|NCT01747486|560559153|FG001|Stage 1|Disease progression|9|||
155307758|NCT01747486|560559152|FG000|Stage 1|Death|1|||
155307759|NCT01747486|560559153|FG001|Stage 1|Death|1|||
155307760|NCT01747486|560559152|FG000|Stage 2|Physician Decision|2|||
155307761|NCT01747486|560559153|FG001|Stage 2|Physician Decision|0|||
155307762|NCT01747486|560559152|FG000|Stage 2|Withdrawal by Subject|1|||
155307763|NCT01747486|560559153|FG001|Stage 2|Withdrawal by Subject|0|||
155307764|NCT01747486|560559152|FG000|Stage 2|New Cancer Therapy|3|||
155307765|NCT01747486|560559153|FG001|Stage 2|New Cancer Therapy|0|||
155307766|NCT01747486|560559152|FG000|Stage 2|Disease Progression|3|||
155307767|NCT01747486|560559153|FG001|Stage 2|Disease Progression|0|||
155307768|NCT00632749|560559154|FG000|Overall Study|Progressive disease|3|||
155307769|NCT00632749|560559155|FG001|Overall Study|Progressive disease|2|||
155307770|NCT00632749|560559156|FG002|Overall Study|Progressive disease|2|||
155307771|NCT00632749|560559157|FG003|Overall Study|Progressive disease|2|||
155307772|NCT00632749|560559158|FG004|Overall Study|Progressive disease|4|||
155307773|NCT00632749|560559159|FG005|Overall Study|Progressive disease|4|||
155307774|NCT00632749|560559160|FG006|Overall Study|Progressive disease|3|||
155307775|NCT00632749|560559161|FG007|Overall Study|Progressive disease|2|||
155307776|NCT00632749|560559162|FG008|Overall Study|Progressive disease|3|||
155307777|NCT00632749|560559163|FG009|Overall Study|Progressive disease|2|||
155307778|NCT00632749|560559164|FG010|Overall Study|Progressive disease|4|||
155307779|NCT00632749|560559165|FG011|Overall Study|Progressive disease|3|||
155307780|NCT00632749|560559166|FG012|Overall Study|Progressive disease|2|||
155307781|NCT00632749|560559167|FG013|Overall Study|Progressive disease|4|||
155307782|NCT00632749|560559154|FG000|Overall Study|Other Adverse event|1|||
155307783|NCT00632749|560559155|FG001|Overall Study|Other Adverse event|1|||
155307784|NCT00632749|560559156|FG002|Overall Study|Other Adverse event|1|||
155307785|NCT00632749|560559157|FG003|Overall Study|Other Adverse event|1|||
155307786|NCT00632749|560559158|FG004|Overall Study|Other Adverse event|2|||
155307787|NCT00632749|560559159|FG005|Overall Study|Other Adverse event|4|||
155307788|NCT00632749|560559160|FG006|Overall Study|Other Adverse event|1|||
155307789|NCT00632749|560559161|FG007|Overall Study|Other Adverse event|2|||
155307790|NCT00632749|560559162|FG008|Overall Study|Other Adverse event|2|||
155307791|NCT00632749|560559163|FG009|Overall Study|Other Adverse event|0|||
155307792|NCT00632749|560559164|FG010|Overall Study|Other Adverse event|1|||
155414625|NCT01489527|560948276|FG001|Overall Study|Lost to Follow-up|1|||
155414626|NCT01489527|560948275|FG000|Overall Study|Procedures|1|||
155414627|NCT01489527|560948276|FG001|Overall Study|Procedures|0|||
155414628|NCT01489527|560948275|FG000|Overall Study|Not compliant|1|||
155414629|NCT01489527|560948276|FG001|Overall Study|Not compliant|0|||
155414630|NCT04899232|560948277|FG000|Screening Period|Physician Decision|1|||
155414631|NCT04899232|560948278|FG001|Screening Period|Physician Decision|0|||
155414632|NCT04899232|560948279|FG002|Screening Period|Physician Decision|0|||
155414633|NCT04899232|560948277|FG000|Screening Period|Withdrawal by Subject|1|||
155414634|NCT04899232|560948278|FG001|Screening Period|Withdrawal by Subject|0|||
155414635|NCT04899232|560948279|FG002|Screening Period|Withdrawal by Subject|0|||
155414636|NCT04899232|560948277|FG000|Screening Period|Participant discharged before receiving intervention|3|||
155497862|NCT00769132|561247078|FG000|Period 2|Withdrawal by Subject|0|||
155307793|NCT00632749|560559165|FG011|Overall Study|Other Adverse event|0|||
155307794|NCT00632749|560559166|FG012|Overall Study|Other Adverse event|1|||
155307795|NCT00632749|560559167|FG013|Overall Study|Other Adverse event|0|||
155307796|NCT00632749|560559154|FG000|Overall Study|Refuse to continue medication|0|||
155307797|NCT00632749|560559155|FG001|Overall Study|Refuse to continue medication|0|||
155497863|NCT00769132|561247079|FG001|Period 2|Withdrawal by Subject|0|||
155497864|NCT00769132|561247080|FG002|Period 2|Withdrawal by Subject|0|||
155497865|NCT00769132|561247081|FG003|Period 2|Withdrawal by Subject|1|||
155307798|NCT00632749|560559156|FG002|Overall Study|Refuse to continue medication|0|||
155307799|NCT00632749|560559157|FG003|Overall Study|Refuse to continue medication|1|||
155307800|NCT00632749|560559158|FG004|Overall Study|Refuse to continue medication|0|||
155307801|NCT00632749|560559159|FG005|Overall Study|Refuse to continue medication|0|||
155307802|NCT00632749|560559160|FG006|Overall Study|Refuse to continue medication|0|||
155307803|NCT00632749|560559161|FG007|Overall Study|Refuse to continue medication|0|||
155307804|NCT00632749|560559162|FG008|Overall Study|Refuse to continue medication|0|||
155307805|NCT00632749|560559163|FG009|Overall Study|Refuse to continue medication|1|||
155307806|NCT00632749|560559164|FG010|Overall Study|Refuse to continue medication|0|||
155307807|NCT00632749|560559165|FG011|Overall Study|Refuse to continue medication|0|||
155307808|NCT00632749|560559166|FG012|Overall Study|Refuse to continue medication|0|||
155307809|NCT00632749|560559167|FG013|Overall Study|Refuse to continue medication|0|||
155307810|NCT00632749|560559154|FG000|Overall Study|Reason other than those specified above|0|||
155307811|NCT00632749|560559155|FG001|Overall Study|Reason other than those specified above|2|||
155307812|NCT00632749|560559156|FG002|Overall Study|Reason other than those specified above|0|||
155307813|NCT00632749|560559157|FG003|Overall Study|Reason other than those specified above|0|||
155307814|NCT00632749|560559158|FG004|Overall Study|Reason other than those specified above|1|||
155307815|NCT00632749|560559159|FG005|Overall Study|Reason other than those specified above|0|||
155307816|NCT00632749|560559160|FG006|Overall Study|Reason other than those specified above|1|||
155307817|NCT00632749|560559161|FG007|Overall Study|Reason other than those specified above|0|||
155307818|NCT00632749|560559162|FG008|Overall Study|Reason other than those specified above|0|||
155307819|NCT00632749|560559163|FG009|Overall Study|Reason other than those specified above|0|||
155307820|NCT00632749|560559164|FG010|Overall Study|Reason other than those specified above|2|||
155307821|NCT00632749|560559165|FG011|Overall Study|Reason other than those specified above|1|||
155307822|NCT00632749|560559166|FG012|Overall Study|Reason other than those specified above|0|||
155414637|NCT04899232|560948278|FG001|Screening Period|Participant discharged before receiving intervention|0|||
155414638|NCT04899232|560948279|FG002|Screening Period|Participant discharged before receiving intervention|0|||
155414639|NCT00700271|560948280|FG000|Overall Study|Adverse Event|4|||
155414640|NCT00700271|560948281|FG001|Overall Study|Adverse Event|6|||
155414641|NCT00700271|560948280|FG000|Overall Study|Protocol Violation|1|||
155414642|NCT00700271|560948281|FG001|Overall Study|Protocol Violation|0|||
155414643|NCT00700271|560948280|FG000|Overall Study|Administrative Reasons|1|||
155414644|NCT00700271|560948281|FG001|Overall Study|Administrative Reasons|0|||
155414645|NCT00700271|560948280|FG000|Overall Study|Withdrawal by Subject|6|||
155414646|NCT00700271|560948281|FG001|Overall Study|Withdrawal by Subject|4|||
155414647|NCT00700271|560948280|FG000|Overall Study|Lost to Follow-up|2|||
155414648|NCT00700271|560948281|FG001|Overall Study|Lost to Follow-up|2|||
155414649|NCT02406781|560948282|FG000|Overall Study|Protocol Violation|2|||
155414650|NCT02406781|560948283|FG001|Overall Study|Protocol Violation|2|||
155414651|NCT02406781|560948284|FG002|Overall Study|Protocol Violation|2|||
155414652|NCT02406781|560948285|FG003|Overall Study|Protocol Violation|2|||
155414653|NCT02406781|560948286|FG004|Overall Study|Protocol Violation|1|||
155414654|NCT02406781|560948287|FG005|Overall Study|Protocol Violation|5|||
155414655|NCT02406781|560948288|FG006|Overall Study|Protocol Violation|3|||
155414656|NCT02926950|560948289|FG000|Overall Study|Adverse Event|4|||
155414657|NCT02926950|560948290|FG001|Overall Study|Adverse Event|6|||
155414658|NCT02926950|560948289|FG000|Overall Study|At the participant's own request|21|||
155414659|NCT02926950|560948290|FG001|Overall Study|At the participant's own request|25|||
155414660|NCT02926950|560948289|FG000|Overall Study|Reason not Specified|17|||
155414661|NCT02926950|560948290|FG001|Overall Study|Reason not Specified|9|||
155414662|NCT02926950|560948289|FG000|Overall Study|Lost to Follow-up|7|||
155414663|NCT02926950|560948290|FG001|Overall Study|Lost to Follow-up|8|||
155414664|NCT04622046|560948298|FG000|Intervention Period|Adverse Event|1|||
155414665|NCT04622046|560948298|FG000|Intervention Period|Withdrawal by Subject|2|||
155414666|NCT04622046|560948298|FG000|Extension Period|Ongoing in the Extension Period|21|||
155414667|NCT03505021|560948299|FG000|Overall Study|Protocol Violation|1|||
155414668|NCT03505021|560948300|FG001|Overall Study|Protocol Violation|0|||
155414669|NCT03505021|560948299|FG000|Overall Study|Death|9|||
155414670|NCT03505021|560948300|FG001|Overall Study|Death|8|||
155414671|NCT03505021|560948299|FG000|Overall Study|Consent withdrawn by subject|6|||
155414672|NCT03505021|560948300|FG001|Overall Study|Consent withdrawn by subject|1|||
155414673|NCT03505021|560948299|FG000|Overall Study|Lost to Follow-up|5|||
155497866|NCT00769132|561247078|FG000|Period 3|Withdrawal by Subject|1|||
155414674|NCT03505021|560948300|FG001|Overall Study|Lost to Follow-up|3|||
155414675|NCT03505021|560948299|FG000|Overall Study|Adverse Event|26|||
155414676|NCT03505021|560948300|FG001|Overall Study|Adverse Event|9|||
155414677|NCT03505021|560948299|FG000|Overall Study|Disease progression|33|||
155414678|NCT03505021|560948300|FG001|Overall Study|Disease progression|17|||
155497867|NCT00769132|561247079|FG001|Period 3|Withdrawal by Subject|0|||
155307823|NCT00632749|560559167|FG013|Overall Study|Reason other than those specified above|2|||
155414679|NCT03505021|560948299|FG000|Overall Study|Other|11|||
155307824|NCT00611559|560559168|FG000|Overall Study|Lost to Follow-up|0|||
155307825|NCT00611559|560559169|FG001|Overall Study|Lost to Follow-up|1|||
155307826|NCT00611559|560559170|FG002|Overall Study|Lost to Follow-up|0|||
155307827|NCT00611559|560559168|FG000|Overall Study|Protocol Violation|1|||
155307828|NCT00611559|560559169|FG001|Overall Study|Protocol Violation|0|||
155307829|NCT00611559|560559170|FG002|Overall Study|Protocol Violation|1|||
155307830|NCT00879333|560559171|FG000|Overall Study|Adverse Event|94|||
155307831|NCT00879333|560559172|FG001|Overall Study|Adverse Event|34|||
155307832|NCT00879333|560559171|FG000|Overall Study|Abnormal Laboratory Value|1|||
155307833|NCT00879333|560559172|FG001|Overall Study|Abnormal Laboratory Value|0|||
155307834|NCT00879333|560559171|FG000|Overall Study|Withdrawal by Subject|20|||
155307835|NCT00879333|560559172|FG001|Overall Study|Withdrawal by Subject|7|||
155307836|NCT00879333|560559171|FG000|Overall Study|Lost to Follow-up|2|||
155307837|NCT00879333|560559172|FG001|Overall Study|Lost to Follow-up|1|||
155307838|NCT00879333|560559171|FG000|Overall Study|Administrative Problems|2|||
155307839|NCT00879333|560559172|FG001|Overall Study|Administrative Problems|0|||
155307840|NCT00879333|560559171|FG000|Overall Study|Death|16|||
155307841|NCT00879333|560559172|FG001|Overall Study|Death|5|||
155307842|NCT00879333|560559171|FG000|Overall Study|Disease Progression|292|||
155307843|NCT00879333|560559172|FG001|Overall Study|Disease Progression|169|||
155307844|NCT00879333|560559171|FG000|Overall Study|Protocol Violation|1|||
155307845|NCT00879333|560559172|FG001|Overall Study|Protocol Violation|1|||
155307846|NCT03069313|560559173|FG000|Overall Study|Adverse Event|5|||
155307847|NCT01011946|560559175|FG000|Overall Study|Transferred to another hospital|2|||
155307848|NCT01011946|560559175|FG000|Overall Study|No pathological lab value|1|||
155307849|NCT01872078|560559177|FG000|Overall Study|Adverse Event|0|||
155307850|NCT01872078|560559178|FG001|Overall Study|Adverse Event|0|||
155307851|NCT01872078|560559179|FG002|Overall Study|Adverse Event|1|||
155307852|NCT01872078|560559180|FG003|Overall Study|Adverse Event|0|||
155307853|NCT01872078|560559177|FG000|Overall Study|Dose administration non-compliance|0|||
155307854|NCT01872078|560559178|FG001|Overall Study|Dose administration non-compliance|0|||
155307855|NCT01872078|560559179|FG002|Overall Study|Dose administration non-compliance|0|||
155307856|NCT01872078|560559180|FG003|Overall Study|Dose administration non-compliance|1|||
155307857|NCT01872078|560559177|FG000|Overall Study|Protocol Violation|0|||
155307858|NCT01872078|560559178|FG001|Overall Study|Protocol Violation|0|||
155307859|NCT01872078|560559179|FG002|Overall Study|Protocol Violation|1|||
155749638|NCT00562627|562184123|FG001|Overall Study|Protocol Violation|1|||
155307860|NCT01872078|560559180|FG003|Overall Study|Protocol Violation|0|||
155307861|NCT01872078|560559177|FG000|Overall Study|Withdrawal by Subject|0|||
155307862|NCT01872078|560559178|FG001|Overall Study|Withdrawal by Subject|0|||
155307863|NCT01872078|560559179|FG002|Overall Study|Withdrawal by Subject|1|||
155307864|NCT01872078|560559180|FG003|Overall Study|Withdrawal by Subject|0|||
155307865|NCT01872078|560559177|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
155307866|NCT01872078|560559178|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
155307867|NCT01872078|560559179|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
155307868|NCT01872078|560559180|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
155307869|NCT02910713|560559181|FG000|Overall Study|Protocol Violation|2|||
155307870|NCT02910713|560559181|FG000|Overall Study|Subject Choice|4|||
155307871|NCT02910713|560559181|FG000|Overall Study|Received One Application|10|||
155307872|NCT02910713|560559181|FG000|Overall Study|Received Neither Application|18|||
155307873|NCT02910713|560559181|FG000|Overall Study|Enrollment cap|7|||
155307874|NCT02910713|560559181|FG000|Overall Study|Investigator Discretion|1|||
155307875|NCT04442126|560559185|FG000|Overall Study|Withdrawal by Subject|0|||
155307876|NCT04442126|560559186|FG001|Overall Study|Withdrawal by Subject|0|||
155307877|NCT04442126|560559187|FG002|Overall Study|Withdrawal by Subject|0|||
155307878|NCT04442126|560559188|FG003|Overall Study|Withdrawal by Subject|2|||
155307879|NCT04442126|560559189|FG004|Overall Study|Withdrawal by Subject|1|||
155307880|NCT04442126|560559190|FG005|Overall Study|Withdrawal by Subject|0|||
155307881|NCT04442126|560559191|FG006|Overall Study|Withdrawal by Subject|1|||
155307882|NCT04442126|560559192|FG007|Overall Study|Withdrawal by Subject|1|||
155307883|NCT04442126|560559193|FG008|Overall Study|Withdrawal by Subject|3|||
155307884|NCT04442126|560559185|FG000|Overall Study|Death|1|||
155307885|NCT04442126|560559186|FG001|Overall Study|Death|0|||
155307886|NCT04442126|560559187|FG002|Overall Study|Death|0|||
155414680|NCT03505021|560948300|FG001|Overall Study|Other|5|||
155414681|NCT03505021|560948299|FG000|Overall Study|Personal reason|21|||
155307887|NCT04442126|560559188|FG003|Overall Study|Death|1|||
155307888|NCT04442126|560559189|FG004|Overall Study|Death|2|||
155307889|NCT04442126|560559190|FG005|Overall Study|Death|2|||
155307890|NCT04442126|560559191|FG006|Overall Study|Death|4|||
155307891|NCT04442126|560559192|FG007|Overall Study|Death|1|||
155307892|NCT04442126|560559193|FG008|Overall Study|Death|5|||
155307893|NCT04442126|560559185|FG000|Overall Study|Study Terminated by Sponsor|0|||
155307894|NCT04442126|560559186|FG001|Overall Study|Study Terminated by Sponsor|0|||
155307895|NCT04442126|560559187|FG002|Overall Study|Study Terminated by Sponsor|0|||
155307896|NCT04442126|560559188|FG003|Overall Study|Study Terminated by Sponsor|0|||
155307897|NCT04442126|560559189|FG004|Overall Study|Study Terminated by Sponsor|0|||
155307898|NCT04442126|560559190|FG005|Overall Study|Study Terminated by Sponsor|1|||
155307899|NCT04442126|560559191|FG006|Overall Study|Study Terminated by Sponsor|4|||
155307900|NCT04442126|560559192|FG007|Overall Study|Study Terminated by Sponsor|2|||
155307901|NCT04442126|560559193|FG008|Overall Study|Study Terminated by Sponsor|10|||
155307902|NCT04442126|560559185|FG000|Overall Study|Lost to Follow-up|0|||
155307903|NCT04442126|560559186|FG001|Overall Study|Lost to Follow-up|0|||
155307904|NCT04442126|560559187|FG002|Overall Study|Lost to Follow-up|0|||
155307905|NCT04442126|560559188|FG003|Overall Study|Lost to Follow-up|0|||
155307906|NCT04442126|560559189|FG004|Overall Study|Lost to Follow-up|0|||
155307907|NCT04442126|560559190|FG005|Overall Study|Lost to Follow-up|0|||
155307908|NCT04442126|560559191|FG006|Overall Study|Lost to Follow-up|0|||
155307909|NCT04442126|560559192|FG007|Overall Study|Lost to Follow-up|1|||
155307910|NCT04442126|560559193|FG008|Overall Study|Lost to Follow-up|2|||
155307911|NCT04442126|560559185|FG000|Overall Study|Progressive Disease|0|||
155307912|NCT04442126|560559186|FG001|Overall Study|Progressive Disease|1|||
155307913|NCT04442126|560559187|FG002|Overall Study|Progressive Disease|3|||
155307914|NCT04442126|560559188|FG003|Overall Study|Progressive Disease|0|||
155307915|NCT04442126|560559189|FG004|Overall Study|Progressive Disease|3|||
155307916|NCT04442126|560559190|FG005|Overall Study|Progressive Disease|0|||
155307917|NCT04442126|560559191|FG006|Overall Study|Progressive Disease|0|||
155307918|NCT04442126|560559192|FG007|Overall Study|Progressive Disease|0|||
155307919|NCT04442126|560559193|FG008|Overall Study|Progressive Disease|0|||
155307920|NCT04442126|560559185|FG000|Overall Study|Other|0|||
155307921|NCT04442126|560559186|FG001|Overall Study|Other|0|||
155307922|NCT04442126|560559187|FG002|Overall Study|Other|0|||
155307923|NCT04442126|560559188|FG003|Overall Study|Other|0|||
155307924|NCT04442126|560559189|FG004|Overall Study|Other|0|||
155307925|NCT04442126|560559190|FG005|Overall Study|Other|0|||
155307926|NCT04442126|560559191|FG006|Overall Study|Other|0|||
155307927|NCT04442126|560559192|FG007|Overall Study|Other|0|||
155307928|NCT04442126|560559193|FG008|Overall Study|Other|1|||
155307929|NCT06450405|560559194|FG000|Overall Study|Study funding terminated.|0|||
155307930|NCT06450405|560559195|FG001|Overall Study|Study funding terminated.|2|||
155307931|NCT03767517|560559196|FG000|Overall Study|Lost to Follow-up|16|||
155307932|NCT03767517|560559197|FG001|Overall Study|Lost to Follow-up|10|||
155307933|NCT03767517|560559196|FG000|Overall Study|Death|2|||
155307934|NCT03767517|560559197|FG001|Overall Study|Death|3|||
155307935|NCT03152786|560560722|FG000|Overall Study|Withdrawal by Subject|2|||
155307936|NCT03152786|560560723|FG001|Overall Study|Withdrawal by Subject|1|||
155307937|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
155307938|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307939|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307940|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307941|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307942|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
155307943|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
155307944|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307945|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307946|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307947|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
155307948|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
155307949|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307950|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307951|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307952|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
155307953|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307954|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307955|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307956|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307957|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
155307958|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
155307959|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307960|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307961|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307962|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
155307963|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
155307964|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
155307965|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
155307966|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
155307967|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Death|0|||
155307968|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Death|0|||
155414682|NCT03505021|560948300|FG001|Overall Study|Personal reason|12|||
155307969|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Death|1|||
155307970|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Death|0|||
155307971|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Death|0|||
155307972|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
155307973|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
155307974|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
155307975|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
155307976|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
155307977|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307978|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307979|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
155307980|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307981|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307982|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
155307983|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
155307984|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
155307985|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
155307986|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
155307987|NCT04112316|560560729|FG000|First Period (8 Weeks)|Protocol Violation|1|||
155307988|NCT04112316|560560730|FG001|First Period (8 Weeks)|Protocol Violation|0|||
155307989|NCT04112316|560560729|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
155307990|NCT04112316|560560730|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
155307991|NCT06066541|560560740|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
155307992|NCT06066541|560560741|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
155307993|NCT06066541|560560742|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
155307994|NCT06066541|560560743|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
155307995|NCT06066541|560560744|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
155307996|NCT06066541|560560745|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
155749639|NCT00562627|562184124|FG002|Overall Study|Protocol Violation|1|||
155307997|NCT06066541|560560746|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
155307998|NCT06066541|560560740|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
155307999|NCT06066541|560560741|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
155308000|NCT06066541|560560742|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
155308001|NCT06066541|560560743|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
155308002|NCT06066541|560560744|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
155308003|NCT06066541|560560745|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
155414683|NCT01844986|560948301|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
155414684|NCT01844986|560948302|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
155414685|NCT01844986|560948301|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
155414686|NCT01844986|560948302|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
155414687|NCT01844986|560948301|FG000|Overall Study (Global Cohort)|Death|55|||
155414688|NCT01844986|560948302|FG001|Overall Study (Global Cohort)|Death|26|||
155414689|NCT01844986|560948301|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
155414690|NCT01844986|560948302|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
155414691|NCT01844986|560948301|FG000|Overall Study (China Cohort)|Death|10|||
155414692|NCT01844986|560948302|FG001|Overall Study (China Cohort)|Death|6|||
155749640|NCT03387150|562184126|FG000|Overall Study|Withdrawal by Subject|3|||
155749641|NCT03387150|562184127|FG001|Overall Study|Withdrawal by Subject|0|||
155749642|NCT03387150|562184128|FG002|Overall Study|Withdrawal by Subject|3|||
155308004|NCT06066541|560560746|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
155308005|NCT04533022|560560747|FG000|Overall Study|Withdrawal by Subject|15|||
155308006|NCT04533022|560560747|FG000|Overall Study|Adverse Event|6|||
155308007|NCT04533022|560560747|FG000|Overall Study|Death|1|||
155308008|NCT04533022|560560747|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
155308009|NCT04533022|560560747|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
155308010|NCT02163447|560560748|FG000|Overall Study|Withdrawal by Subject|2|||
155308011|NCT02163447|560560749|FG001|Overall Study|Withdrawal by Subject|0|||
155308012|NCT02163447|560560750|FG002|Overall Study|Withdrawal by Subject|1|||
155749643|NCT03387150|562184129|FG003|Overall Study|Withdrawal by Subject|4|||
155749644|NCT03387150|562184130|FG004|Overall Study|Withdrawal by Subject|1|||
155749645|NCT03387150|562184131|FG005|Overall Study|Withdrawal by Subject|2|||
155308013|NCT02163447|560560748|FG000|Overall Study|Lost to Follow-up|1|||
155749646|NCT03387150|562184132|FG006|Overall Study|Withdrawal by Subject|0|||
155414701|NCT02028455|560948305|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414702|NCT02028455|560948306|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414703|NCT02028455|560948307|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414704|NCT02028455|560948308|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414705|NCT02028455|560948309|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414706|NCT02028455|560948310|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
155414707|NCT02028455|560948311|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
155414708|NCT02028455|560948312|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
155414709|NCT02028455|560948305|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
155414710|NCT02028455|560948306|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
155414711|NCT02028455|560948307|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
155414712|NCT02028455|560948308|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
155414713|NCT02028455|560948309|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
155414714|NCT02028455|560948310|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
155414715|NCT02028455|560948311|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
155414716|NCT02028455|560948312|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
155414717|NCT02028455|560948305|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414718|NCT02028455|560948306|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414719|NCT02028455|560948307|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414720|NCT02028455|560948308|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414721|NCT02028455|560948309|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414722|NCT02028455|560948310|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
155414723|NCT02028455|560948311|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
155414724|NCT02028455|560948312|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
155414725|NCT02028455|560948305|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
155414726|NCT02028455|560948306|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
155414727|NCT02028455|560948307|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
155414728|NCT02028455|560948308|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
155414729|NCT02028455|560948309|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
155414730|NCT02028455|560948310|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
155414731|NCT02028455|560948311|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
155414732|NCT02028455|560948312|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
155414733|NCT02392429|560950579|FG000|Screening|Screen failure|15|||
155414734|NCT02392429|560950579|FG000|Enrolled Participants|Ineligible due to disease|3|||
155414735|NCT02392429|560950579|FG000|Enrolled Participants|Withdrawal by Subject|4|||
155414736|NCT02392429|560950579|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
155414737|NCT02392429|560950579|FG000|Evaluable|Death|5|||
155414738|NCT02392429|560950579|FG000|Evaluable|Withdrawal by Subject|1|||
155414739|NCT02392429|560950579|FG000|Evaluable|Adverse Event|1|||
155414740|NCT02392429|560950579|FG000|Evaluable|remission bone marrow biopsy|3|||
155414741|NCT01241708|560950580|FG000|Overall Study|Withdrawal by Subject|6|||
155414742|NCT01241708|560950580|FG000|Overall Study|Screen Failure|6|||
155414743|NCT01241708|560950580|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
155414744|NCT01241708|560950580|FG000|Overall Study|Lost to Follow-up|5|||
155414745|NCT04137887|560950581|FG000|Overall Study|Death|102|||
155414746|NCT04137887|560950582|FG001|Overall Study|Death|92|||
155414747|NCT04137887|560950581|FG000|Overall Study|Withdrawal by Subject|2|||
155414748|NCT04137887|560950582|FG001|Overall Study|Withdrawal by Subject|3|||
155414749|NCT04137887|560950581|FG000|Overall Study|Randomized but not treated|0|||
155414750|NCT04137887|560950582|FG001|Overall Study|Randomized but not treated|1|||
155414751|NCT04183335|560950585|FG000|Overall Study|Adverse Event|1|||
155414752|NCT04183335|560950586|FG001|Overall Study|Adverse Event|0|||
155414753|NCT04183335|560950585|FG000|Overall Study|Withdrawal by Subject|12|||
155414754|NCT04183335|560950586|FG001|Overall Study|Withdrawal by Subject|3|||
155414755|NCT00049673|560950587|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
155414756|NCT00049673|560950588|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
155414757|NCT05064059|560950591|FG000|Overall Study|Death|199|||
155414758|NCT05064059|560950592|FG001|Overall Study|Death|196|||
155414759|NCT05064059|560950591|FG000|Overall Study|Physician Decision|4|||
155414760|NCT05064059|560950592|FG001|Overall Study|Physician Decision|2|||
155414761|NCT05064059|560950591|FG000|Overall Study|Sponsor Decision|14|||
155414762|NCT05064059|560950592|FG001|Overall Study|Sponsor Decision|11|||
155414763|NCT05064059|560950591|FG000|Overall Study|Withdrawal by Subject|4|||
155414764|NCT05064059|560950592|FG001|Overall Study|Withdrawal by Subject|11|||
155308014|NCT02163447|560560749|FG001|Overall Study|Lost to Follow-up|3|||
155642464|NCT02965833|561780803|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155642465|NCT02965833|561780802|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
155642466|NCT02965833|561780803|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
155642467|NCT02965833|561780802|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
155308015|NCT02163447|560560750|FG002|Overall Study|Lost to Follow-up|0|||
155308016|NCT02163447|560560748|FG000|Overall Study|Moved out of study area|2|||
155308017|NCT02163447|560560749|FG001|Overall Study|Moved out of study area|3|||
155308018|NCT02163447|560560750|FG002|Overall Study|Moved out of study area|2|||
155308019|NCT02163447|560560748|FG000|Overall Study|Became HIV infected at time of delivery|1|||
155308020|NCT02163447|560560749|FG001|Overall Study|Became HIV infected at time of delivery|0|||
155308021|NCT02163447|560560750|FG002|Overall Study|Became HIV infected at time of delivery|0|||
155308022|NCT04850807|560560760|FG000|Overall Study|Death|50|||
155308023|NCT04850807|560560761|FG001|Overall Study|Death|55|||
155308024|NCT04850807|560560760|FG000|Overall Study|Discharged|17|||
155308025|NCT04850807|560560761|FG001|Overall Study|Discharged|13|||
155308026|NCT04850807|560560760|FG000|Overall Study|Incomplete baseline data|3|||
155308027|NCT04850807|560560761|FG001|Overall Study|Incomplete baseline data|2|||
155308028|NCT05439603|560560770|FG000|Overall Study|met withdrawal criteria|2|||
155308029|NCT03896516|560560771|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
155308030|NCT03896516|560560772|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
155308031|NCT03896516|560560771|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
155308032|NCT03896516|560560772|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
155308033|NCT03896516|560560771|FG000|Washout Period|Physician Decision|3|||
155308034|NCT03896516|560560772|FG001|Washout Period|Physician Decision|1|||
155308035|NCT03896516|560560771|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
155308036|NCT03896516|560560772|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
155308037|NCT04549168|560560780|FG000|Randomization Phase|Adverse Event|0|||
155308038|NCT04549168|560560781|FG001|Randomization Phase|Adverse Event|0|||
155308039|NCT04549168|560560782|FG002|Randomization Phase|Adverse Event|1|||
155308040|NCT04549168|560560780|FG000|Randomization Phase|Other|0|||
155308041|NCT04549168|560560781|FG001|Randomization Phase|Other|2|||
155308042|NCT04549168|560560782|FG002|Randomization Phase|Other|0|||
155308043|NCT04549168|560560780|FG000|Randomization Phase|Withdrawal by Subject|0|||
155308044|NCT04549168|560560781|FG001|Randomization Phase|Withdrawal by Subject|2|||
155308045|NCT04549168|560560782|FG002|Randomization Phase|Withdrawal by Subject|1|||
155308046|NCT02323321|560560787|FG000|Overall Study|Re-Transplant|1|||
155308047|NCT02323321|560560787|FG000|Overall Study|Death|12|||
155308048|NCT04281485|560560788|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
155308049|NCT04281485|560560789|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
155308050|NCT04281485|560560788|FG000|Overall Study|Ongoing (Safety data collection)|10|||
155308051|NCT04281485|560560789|FG001|Overall Study|Ongoing (Safety data collection)|5|||
155308052|NCT04093752|560560792|FG000|Overall Study|Adverse Event|7|||
155308053|NCT04093752|560560793|FG001|Overall Study|Adverse Event|19|||
155308054|NCT04093752|560560794|FG002|Overall Study|Adverse Event|18|||
155308055|NCT04093752|560560795|FG003|Overall Study|Adverse Event|4|||
155308056|NCT04093752|560560792|FG000|Overall Study|Withdrawal by Subject|6|||
155308057|NCT04093752|560560793|FG001|Overall Study|Withdrawal by Subject|6|||
155308058|NCT04093752|560560794|FG002|Overall Study|Withdrawal by Subject|8|||
155308059|NCT04093752|560560795|FG003|Overall Study|Withdrawal by Subject|20|||
155308060|NCT04093752|560560792|FG000|Overall Study|Lost to Follow-up|2|||
155308061|NCT04093752|560560793|FG001|Overall Study|Lost to Follow-up|1|||
155308062|NCT04093752|560560794|FG002|Overall Study|Lost to Follow-up|1|||
155308063|NCT04093752|560560795|FG003|Overall Study|Lost to Follow-up|1|||
155414765|NCT01934140|560950593|FG000|Persistence Phase (Year 6-10)|Other|24|||
155414766|NCT01934140|560950594|FG001|Persistence Phase (Year 6-10)|Other|6|||
155414767|NCT01934140|560950593|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
155414768|NCT01934140|560950594|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
155414769|NCT01934140|560950593|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
155414770|NCT01934140|560950594|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
155414771|NCT01934140|560950593|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
155414772|NCT01934140|560950594|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
155414773|NCT01934140|560950593|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
155414774|NCT01934140|560950594|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
155414775|NCT01934140|560950593|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
155414776|NCT01934140|560950594|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
155414777|NCT01934140|560950593|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
155414778|NCT01934140|560950594|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
155414779|NCT01934140|560950593|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
155414780|NCT01934140|560950594|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
155414781|NCT00200850|560950600|FG000|Overall Study|relocation|1|||
155308064|NCT04093752|560560792|FG000|Overall Study|Death|0|||
155308065|NCT04093752|560560793|FG001|Overall Study|Death|0|||
155308066|NCT04093752|560560794|FG002|Overall Study|Death|1|||
155308067|NCT04093752|560560795|FG003|Overall Study|Death|2|||
155308068|NCT04093752|560560792|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
155308069|NCT04093752|560560793|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
155308070|NCT04093752|560560794|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
155308071|NCT04093752|560560795|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
155308072|NCT04093752|560560792|FG000|Overall Study|Covid 19|0|||
155308073|NCT04093752|560560793|FG001|Overall Study|Covid 19|0|||
155308074|NCT04093752|560560794|FG002|Overall Study|Covid 19|0|||
155308075|NCT04093752|560560795|FG003|Overall Study|Covid 19|1|||
155308076|NCT04093752|560560792|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308077|NCT04093752|560560793|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308078|NCT04093752|560560794|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
155308079|NCT04093752|560560795|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308080|NCT04093752|560560792|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
155308081|NCT04093752|560560793|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
155308082|NCT04093752|560560794|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
155308083|NCT04093752|560560795|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
155308084|NCT04093752|560560792|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
155308085|NCT04093752|560560793|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
155308086|NCT04093752|560560794|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
155308087|NCT04093752|560560795|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
155308088|NCT01084707|560560796|FG000|Overall Study|Withdrawal by Subject|6|||
155308089|NCT00901901|560560797|FG000|Treatment Period|Adverse Event|120|||
155308090|NCT00901901|560560798|FG001|Treatment Period|Adverse Event|128|||
155308091|NCT00901901|560560797|FG000|Treatment Period|Withdrawal by Subject|26|||
155308092|NCT00901901|560560798|FG001|Treatment Period|Withdrawal by Subject|24|||
155308093|NCT00901901|560560797|FG000|Treatment Period|Physician Decision|2|||
155308094|NCT00901901|560560798|FG001|Treatment Period|Physician Decision|2|||
155308095|NCT00901901|560560797|FG000|Treatment Period|Lost to Follow-up|3|||
155308096|NCT00901901|560560798|FG001|Treatment Period|Lost to Follow-up|5|||
155308097|NCT00901901|560560797|FG000|Treatment Period|Noncompliance with study medication|4|||
155308098|NCT00901901|560560798|FG001|Treatment Period|Noncompliance with study medication|1|||
155308099|NCT00901901|560560797|FG000|Treatment Period|Missing|1|||
155642468|NCT02965833|561780803|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
155642469|NCT02965833|561780802|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
155642470|NCT02965833|561780803|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
155642471|NCT03370302|561780804|FG000|Dose Escalation Phase|Other|0|||
155642472|NCT03370302|561780805|FG001|Dose Escalation Phase|Other|1|||
155642473|NCT03370302|561780806|FG002|Dose Escalation Phase|Other|1|||
155642474|NCT03370302|561780807|FG003|Dose Escalation Phase|Other|0|||
155642475|NCT03370302|561780808|FG004|Dose Escalation Phase|Other|0|||
155642476|NCT03370302|561780809|FG005|Dose Escalation Phase|Other|0|||
155642477|NCT03370302|561780804|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155642478|NCT03370302|561780805|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
155642479|NCT03370302|561780806|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
155642480|NCT03370302|561780807|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155642481|NCT03370302|561780808|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
155642482|NCT03370302|561780809|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
155642483|NCT03370302|561780804|FG000|Dose Escalation Phase|Adverse Event|1|||
155642484|NCT03370302|561780805|FG001|Dose Escalation Phase|Adverse Event|0|||
155642485|NCT03370302|561780806|FG002|Dose Escalation Phase|Adverse Event|2|||
155642486|NCT03370302|561780807|FG003|Dose Escalation Phase|Adverse Event|0|||
155642487|NCT03370302|561780808|FG004|Dose Escalation Phase|Adverse Event|0|||
155642488|NCT03370302|561780809|FG005|Dose Escalation Phase|Adverse Event|0|||
155642489|NCT03370302|561780804|FG000|Dose Escalation Phase|Progressive Disease|2|||
155642490|NCT03370302|561780805|FG001|Dose Escalation Phase|Progressive Disease|4|||
155642491|NCT03370302|561780806|FG002|Dose Escalation Phase|Progressive Disease|2|||
155642492|NCT03370302|561780807|FG003|Dose Escalation Phase|Progressive Disease|0|||
155642493|NCT03370302|561780808|FG004|Dose Escalation Phase|Progressive Disease|3|||
155642494|NCT03370302|561780809|FG005|Dose Escalation Phase|Progressive Disease|1|||
155642495|NCT03370302|561780804|FG000|Dose Expansion Phase|Progressive Disease|0|||
155642496|NCT03370302|561780805|FG001|Dose Expansion Phase|Progressive Disease|0|||
155642497|NCT03370302|561780806|FG002|Dose Expansion Phase|Progressive Disease|0|||
155642498|NCT03370302|561780807|FG003|Dose Expansion Phase|Progressive Disease|6|||
155642499|NCT03370302|561780808|FG004|Dose Expansion Phase|Progressive Disease|0|||
155642500|NCT03370302|561780809|FG005|Dose Expansion Phase|Progressive Disease|0|||
155642501|NCT03407482|561780810|FG000|Overall Study|Adverse Event|12|||
155642502|NCT03407482|561780810|FG000|Overall Study|Disease Relapse|1|||
155642503|NCT03407482|561780810|FG000|Overall Study|Lost to Follow-up|1|||
155642504|NCT03407482|561780810|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155642505|NCT03407482|561780810|FG000|Overall Study|Pregnancy|2|||
155642506|NCT03407482|561780810|FG000|Overall Study|Protocol Violation|1|||
155414782|NCT00200850|560950601|FG001|Overall Study|relocation|0|||
155414783|NCT00200850|560950602|FG002|Overall Study|relocation|1|||
155414784|NCT00200850|560950600|FG000|Overall Study|too busy|1|||
155414785|NCT00200850|560950601|FG001|Overall Study|too busy|0|||
155414786|NCT00200850|560950602|FG002|Overall Study|too busy|0|||
155414787|NCT00200850|560950600|FG000|Overall Study|Pregnancy|0|||
155414788|NCT00200850|560950601|FG001|Overall Study|Pregnancy|0|||
155642507|NCT03407482|561780810|FG000|Overall Study|Study Terminated By Sponsor|106|||
155642508|NCT03407482|561780810|FG000|Overall Study|Withdrawal by Subject|6|||
155642509|NCT03407482|561780810|FG000|Overall Study|Data Entry Error|1|||
155642510|NCT03442569|561780813|FG000|Overall Study|Subject was ineligible after enrollment|1|||
155642511|NCT03010501|561780816|FG000|Study Week 1|Withdrawal by Subject|2|||
155642512|NCT03010501|561780817|FG001|Study Week 1|Withdrawal by Subject|1|||
155642513|NCT03010501|561780818|FG002|Study Week 1|Withdrawal by Subject|0|||
155642514|NCT03010501|561780819|FG003|Study Week 1|Withdrawal by Subject|2|||
155642515|NCT03010501|561780820|FG004|Study Week 1|Withdrawal by Subject|0|||
155642516|NCT03010501|561780821|FG005|Study Week 1|Withdrawal by Subject|0|||
155642517|NCT03010501|561780816|FG000|Study Week 3|Withdrawal by Subject|0|||
155642518|NCT03010501|561780817|FG001|Study Week 3|Withdrawal by Subject|0|||
155642519|NCT03010501|561780818|FG002|Study Week 3|Withdrawal by Subject|0|||
155642520|NCT03010501|561780819|FG003|Study Week 3|Withdrawal by Subject|1|||
155642521|NCT03010501|561780820|FG004|Study Week 3|Withdrawal by Subject|0|||
155642522|NCT03010501|561780821|FG005|Study Week 3|Withdrawal by Subject|0|||
155642523|NCT00544882|561780826|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
155642524|NCT00544882|561780827|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
155642525|NCT00544882|561780828|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
155642526|NCT00544882|561780826|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
155642527|NCT00544882|561780827|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
155642528|NCT00544882|561780828|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
155642529|NCT00544882|561780826|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
155642530|NCT00544882|561780827|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
155642531|NCT00544882|561780828|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
155642532|NCT00544882|561780826|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
155642533|NCT00544882|561780827|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
155642534|NCT00544882|561780828|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
155642535|NCT00544882|561780826|FG000|Cycle 3: Follow-up|Noncompliance|0|||
155642536|NCT00544882|561780827|FG001|Cycle 3: Follow-up|Noncompliance|1|||
155642537|NCT00544882|561780828|FG002|Cycle 3: Follow-up|Noncompliance|0|||
155642538|NCT00544882|561780826|FG000|Cycle 3: Follow-up|Pregnancy|0|||
155642539|NCT00544882|561780827|FG001|Cycle 3: Follow-up|Pregnancy|1|||
155642540|NCT00544882|561780828|FG002|Cycle 3: Follow-up|Pregnancy|0|||
155414789|NCT00200850|560950602|FG002|Overall Study|Pregnancy|1|||
155414790|NCT00200850|560950600|FG000|Overall Study|Poor adherence|0|||
155414791|NCT00200850|560950601|FG001|Overall Study|Poor adherence|0|||
155414792|NCT00200850|560950602|FG002|Overall Study|Poor adherence|1|||
155414793|NCT00200850|560950600|FG000|Overall Study|optic neuritis|0|||
155414794|NCT00200850|560950601|FG001|Overall Study|optic neuritis|0|||
155414795|NCT00200850|560950602|FG002|Overall Study|optic neuritis|1|||
155642541|NCT02583269|561780829|FG000|Overall Study|Patient hospitalized prior to start|1|||
155642542|NCT02583269|561780830|FG001|Overall Study|Patient hospitalized prior to start|0|||
155642543|NCT02583269|561780831|FG002|Overall Study|Patient hospitalized prior to start|0|||
155749647|NCT03387150|562184126|FG000|Overall Study|Lost to Follow-up|3|||
155749648|NCT03387150|562184127|FG001|Overall Study|Lost to Follow-up|2|||
155749649|NCT03387150|562184128|FG002|Overall Study|Lost to Follow-up|2|||
155749650|NCT03387150|562184129|FG003|Overall Study|Lost to Follow-up|3|||
155749651|NCT03387150|562184130|FG004|Overall Study|Lost to Follow-up|3|||
155749652|NCT03387150|562184131|FG005|Overall Study|Lost to Follow-up|3|||
155749653|NCT03387150|562184132|FG006|Overall Study|Lost to Follow-up|0|||
155749654|NCT03387150|562184126|FG000|Overall Study|Participant unable to adhere to visit|0|||
155749655|NCT03387150|562184127|FG001|Overall Study|Participant unable to adhere to visit|1|||
155749656|NCT03387150|562184128|FG002|Overall Study|Participant unable to adhere to visit|0|||
155749657|NCT03387150|562184129|FG003|Overall Study|Participant unable to adhere to visit|0|||
155749658|NCT03387150|562184130|FG004|Overall Study|Participant unable to adhere to visit|2|||
155749659|NCT03387150|562184131|FG005|Overall Study|Participant unable to adhere to visit|2|||
155749660|NCT03387150|562184132|FG006|Overall Study|Participant unable to adhere to visit|0|||
155749661|NCT04078178|562184133|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
155749662|NCT04078178|562184134|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
155749663|NCT04078178|562184133|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
155749664|NCT04078178|562184134|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
155749665|NCT04078178|562184133|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
155749666|NCT04078178|562184134|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
155749667|NCT04078178|562184133|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
155749668|NCT04078178|562184134|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
155749669|NCT04078178|562184133|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
155749670|NCT04078178|562184134|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
155749671|NCT04006119|562184135|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
155749672|NCT04006119|562184135|FG000|End of Treatment Veledimex|Adverse Event|2|||
155749673|NCT04006119|562184135|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
155749674|NCT04006119|562184135|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
155749675|NCT04006119|562184135|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
155749676|NCT04006119|562184135|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
155749677|NCT02186301|562184136|FG000|Overall Study|Progressive Disease|7|||
155749678|NCT02186301|562184137|FG001|Overall Study|Progressive Disease|22|||
155749679|NCT02186301|562184138|FG002|Overall Study|Progressive Disease|27|||
155749680|NCT02186301|562184136|FG000|Overall Study|Adverse Event|5|||
155749681|NCT02186301|562184137|FG001|Overall Study|Adverse Event|5|||
155749682|NCT02186301|562184138|FG002|Overall Study|Adverse Event|5|||
155749683|NCT02186301|562184136|FG000|Overall Study|Death|1|||
155749684|NCT02186301|562184137|FG001|Overall Study|Death|0|||
155749685|NCT02186301|562184138|FG002|Overall Study|Death|0|||
155749686|NCT02186301|562184136|FG000|Overall Study|Withdrawal by Subject|5|||
155749687|NCT02186301|562184137|FG001|Overall Study|Withdrawal by Subject|1|||
155749688|NCT02186301|562184138|FG002|Overall Study|Withdrawal by Subject|3|||
155749689|NCT02186301|562184136|FG000|Overall Study|Physician Decision|1|||
155749690|NCT02186301|562184137|FG001|Overall Study|Physician Decision|0|||
155497868|NCT00769132|561247080|FG002|Period 3|Withdrawal by Subject|0|||
155497869|NCT00769132|561247081|FG003|Period 3|Withdrawal by Subject|0|||
155749691|NCT02186301|562184138|FG002|Overall Study|Physician Decision|1|||
155749692|NCT02186301|562184136|FG000|Overall Study|Study Terminated by Sponsor|1|||
155749693|NCT02186301|562184137|FG001|Overall Study|Study Terminated by Sponsor|0|||
155749694|NCT02186301|562184138|FG002|Overall Study|Study Terminated by Sponsor|11|||
155749695|NCT02186301|562184136|FG000|Overall Study|Protocol Deviation|0|||
155749696|NCT02186301|562184137|FG001|Overall Study|Protocol Deviation|2|||
155749697|NCT02186301|562184138|FG002|Overall Study|Protocol Deviation|0|||
155749698|NCT02186301|562184136|FG000|Overall Study|Missing|0|||
155749699|NCT02186301|562184137|FG001|Overall Study|Missing|0|||
155749700|NCT02186301|562184138|FG002|Overall Study|Missing|2|||
155749701|NCT02186301|562184136|FG000|Overall Study|Other|0|||
155749702|NCT02186301|562184137|FG001|Overall Study|Other|0|||
155749703|NCT02186301|562184138|FG002|Overall Study|Other|1|||
155749704|NCT02497976|562184140|FG000|Overall Study|Withdrawal by Subject|2|||
155749705|NCT02497976|562184141|FG001|Overall Study|Withdrawal by Subject|0|||
155749706|NCT02497976|562184140|FG000|Overall Study|Moved out of area|0|||
155749707|NCT02497976|562184141|FG001|Overall Study|Moved out of area|1|||
155749708|NCT00058539|562184145|FG000|Overall Study|Disease progression|24|||
155749709|NCT00058539|562184145|FG000|Overall Study|Adverse Event|3|||
155749710|NCT00058539|562184145|FG000|Overall Study|Withdrawal by Subject|5|||
155497870|NCT00769132|561247078|FG000|Period 4|Withdrawal by Subject|0|||
155497871|NCT00769132|561247079|FG001|Period 4|Withdrawal by Subject|1|||
155497872|NCT00769132|561247080|FG002|Period 4|Withdrawal by Subject|0|||
155497873|NCT00769132|561247081|FG003|Period 4|Withdrawal by Subject|0|||
155497874|NCT00499252|561247082|FG000|Overall Study|Adverse Event|3|||
155497875|NCT00499252|561247082|FG000|Overall Study|Refused further treatment|2|||
155497876|NCT00499252|561247082|FG000|Overall Study|Ineligible|4|||
155497877|NCT00499252|561247082|FG000|Overall Study|<no further label>|3|||
155497878|NCT01785472|561247083|FG000|Overall Study|Adverse Event|5|||
155497879|NCT01785472|561247084|FG001|Overall Study|Adverse Event|4|||
155497880|NCT01785472|561247085|FG002|Overall Study|Adverse Event|6|||
155497881|NCT01785472|561247083|FG000|Overall Study|Lack of Efficacy|2|||
155497882|NCT01785472|561247084|FG001|Overall Study|Lack of Efficacy|0|||
155497883|NCT01785472|561247085|FG002|Overall Study|Lack of Efficacy|1|||
155414796|NCT00200850|560950600|FG000|Overall Study|Adverse Event|1|||
155414797|NCT00200850|560950601|FG001|Overall Study|Adverse Event|1|||
155414798|NCT00200850|560950602|FG002|Overall Study|Adverse Event|2|||
155414799|NCT01449708|560950603|FG000|Overall Study|Protocol Violation|0|||
155414800|NCT01449708|560950604|FG001|Overall Study|Protocol Violation|1|||
155414801|NCT01449708|560950603|FG000|Overall Study|surgical complication|1|||
155414802|NCT01449708|560950604|FG001|Overall Study|surgical complication|2|||
155497884|NCT01785472|561247083|FG000|Overall Study|Lost to Follow-up|1|||
155497885|NCT01785472|561247084|FG001|Overall Study|Lost to Follow-up|2|||
155497886|NCT01785472|561247085|FG002|Overall Study|Lost to Follow-up|0|||
155497887|NCT01785472|561247083|FG000|Overall Study|Physician Decision|1|||
155497888|NCT01785472|561247084|FG001|Overall Study|Physician Decision|1|||
155497889|NCT01785472|561247085|FG002|Overall Study|Physician Decision|1|||
155414803|NCT01449708|560950603|FG000|Overall Study|respiratory failure|1|||
155414804|NCT01449708|560950604|FG001|Overall Study|respiratory failure|0|||
155414805|NCT02889796|560950605|FG000|Overall Study|Withdrew Consent|18|||
155414806|NCT02889796|560950606|FG001|Overall Study|Withdrew Consent|29|||
155414807|NCT02889796|560950607|FG002|Overall Study|Withdrew Consent|20|||
155414808|NCT02889796|560950608|FG003|Overall Study|Withdrew Consent|1|||
155414809|NCT02889796|560950609|FG004|Overall Study|Withdrew Consent|2|||
155414810|NCT02889796|560950610|FG005|Overall Study|Withdrew Consent|35|||
155414811|NCT02889796|560950605|FG000|Overall Study|Investigator's Discretion|10|||
155414812|NCT02889796|560950606|FG001|Overall Study|Investigator's Discretion|9|||
155414813|NCT02889796|560950607|FG002|Overall Study|Investigator's Discretion|10|||
155414814|NCT02889796|560950608|FG003|Overall Study|Investigator's Discretion|3|||
155414815|NCT02889796|560950609|FG004|Overall Study|Investigator's Discretion|0|||
155414816|NCT02889796|560950610|FG005|Overall Study|Investigator's Discretion|15|||
155414817|NCT02889796|560950605|FG000|Overall Study|Adverse Event|17|||
155308100|NCT00901901|560560798|FG001|Treatment Period|Missing|0|||
155308101|NCT00901901|560560797|FG000|Treatment Period|Never treated|0|||
155308102|NCT00901901|560560798|FG001|Treatment Period|Never treated|3|||
155308103|NCT00901901|560560797|FG000|Treatment Period|Protocol driven decision point|0|||
155308104|NCT00901901|560560798|FG001|Treatment Period|Protocol driven decision point|2|||
155414818|NCT02889796|560950606|FG001|Overall Study|Adverse Event|8|||
155414819|NCT02889796|560950607|FG002|Overall Study|Adverse Event|8|||
155414820|NCT02889796|560950608|FG003|Overall Study|Adverse Event|4|||
155414821|NCT02889796|560950609|FG004|Overall Study|Adverse Event|1|||
155414822|NCT02889796|560950610|FG005|Overall Study|Adverse Event|7|||
155414823|NCT02889796|560950605|FG000|Overall Study|Lost to Follow-up|5|||
155414824|NCT02889796|560950606|FG001|Overall Study|Lost to Follow-up|7|||
155414825|NCT02889796|560950607|FG002|Overall Study|Lost to Follow-up|2|||
155414826|NCT02889796|560950608|FG003|Overall Study|Lost to Follow-up|0|||
155414827|NCT02889796|560950609|FG004|Overall Study|Lost to Follow-up|2|||
155414828|NCT02889796|560950610|FG005|Overall Study|Lost to Follow-up|6|||
155414829|NCT02889796|560950605|FG000|Overall Study|Protocol Violation|0|||
155414830|NCT02889796|560950606|FG001|Overall Study|Protocol Violation|1|||
155414831|NCT02889796|560950607|FG002|Overall Study|Protocol Violation|3|||
155414832|NCT02889796|560950608|FG003|Overall Study|Protocol Violation|0|||
155414833|NCT02889796|560950609|FG004|Overall Study|Protocol Violation|0|||
155414834|NCT02889796|560950610|FG005|Overall Study|Protocol Violation|4|||
155414835|NCT02889796|560950605|FG000|Overall Study|Non-compliance With Study Drug|0|||
155414836|NCT02889796|560950606|FG001|Overall Study|Non-compliance With Study Drug|2|||
155414837|NCT02889796|560950607|FG002|Overall Study|Non-compliance With Study Drug|0|||
155414838|NCT02889796|560950608|FG003|Overall Study|Non-compliance With Study Drug|0|||
155414839|NCT02889796|560950609|FG004|Overall Study|Non-compliance With Study Drug|1|||
155414840|NCT02889796|560950610|FG005|Overall Study|Non-compliance With Study Drug|2|||
155414841|NCT02889796|560950605|FG000|Overall Study|Death|1|||
155414842|NCT02889796|560950606|FG001|Overall Study|Death|1|||
155414843|NCT02889796|560950607|FG002|Overall Study|Death|0|||
155414844|NCT02889796|560950608|FG003|Overall Study|Death|1|||
155414845|NCT02889796|560950609|FG004|Overall Study|Death|0|||
155414846|NCT02889796|560950610|FG005|Overall Study|Death|1|||
155414847|NCT02889796|560950605|FG000|Overall Study|Pregnancy|0|||
155414848|NCT02889796|560950606|FG001|Overall Study|Pregnancy|1|||
155414849|NCT02889796|560950607|FG002|Overall Study|Pregnancy|1|||
155414850|NCT02889796|560950608|FG003|Overall Study|Pregnancy|0|||
155414851|NCT02889796|560950609|FG004|Overall Study|Pregnancy|0|||
155414852|NCT02889796|560950610|FG005|Overall Study|Pregnancy|0|||
155414853|NCT02889796|560950605|FG000|Overall Study|Randomized but not Dosed|2|||
155414854|NCT02889796|560950606|FG001|Overall Study|Randomized but not Dosed|0|||
155414855|NCT02889796|560950607|FG002|Overall Study|Randomized but not Dosed|0|||
155414856|NCT02889796|560950608|FG003|Overall Study|Randomized but not Dosed|0|||
155414857|NCT02889796|560950609|FG004|Overall Study|Randomized but not Dosed|0|||
155414858|NCT02889796|560950610|FG005|Overall Study|Randomized but not Dosed|2|||
155414859|NCT01414257|560950611|FG000|Overall Study|No Visit After First Day of Treatment|12|||
155308105|NCT00901901|560560797|FG000|Treatment Period|Study terminated by sponsor|2|||
155308106|NCT00901901|560560798|FG001|Treatment Period|Study terminated by sponsor|0|||
155308107|NCT00901901|560560797|FG000|Treatment Period|Protocol Violation|5|||
155308108|NCT00901901|560560798|FG001|Treatment Period|Protocol Violation|9|||
155308109|NCT00901901|560560797|FG000|Treatment Period|Switch to commercial drug|1|||
155308110|NCT00901901|560560798|FG001|Treatment Period|Switch to commercial drug|1|||
155308111|NCT00901901|560560797|FG000|Treatment Period|Transfer to treatment continuation study|5|||
155308112|NCT00901901|560560798|FG001|Treatment Period|Transfer to treatment continuation study|2|||
155308113|NCT00901901|560560797|FG000|Follow-up Period|Death|181|||
155308114|NCT00901901|560560798|FG001|Follow-up Period|Death|208|||
155308115|NCT00901901|560560797|FG000|Follow-up Period|Protocol driven decision point|47|||
155308116|NCT00901901|560560798|FG001|Follow-up Period|Protocol driven decision point|36|||
155308117|NCT00901901|560560797|FG000|Follow-up Period|Withdrawal by Subject|6|||
155414860|NCT01414257|560950611|FG000|Overall Study|Protocol Violation|10|||
155414861|NCT02421887|560950612|FG000|Overall Study|Lost to Follow-up|5|||
155414862|NCT02421887|560950613|FG001|Overall Study|Lost to Follow-up|0|||
155414863|NCT02421887|560950612|FG000|Overall Study|Withdrawal by Subject|8|||
155642544|NCT02583269|561780832|FG003|Overall Study|Patient hospitalized prior to start|0|||
155642545|NCT02583269|561780833|FG004|Overall Study|Patient hospitalized prior to start|0|||
155642546|NCT02369458|561780835|FG000|Overall Study|Determined to be not eligible|1|||
155642547|NCT02369458|561780836|FG001|Overall Study|Determined to be not eligible|0|||
155642548|NCT03853798|561780839|FG000|Overall Study|Death|0|||
155642549|NCT03853798|561780840|FG001|Overall Study|Death|0|||
155642550|NCT03853798|561780841|FG002|Overall Study|Death|0|||
155642551|NCT03853798|561780842|FG003|Overall Study|Death|0|||
155308118|NCT00901901|560560798|FG001|Follow-up Period|Withdrawal by Subject|9|||
155414864|NCT02421887|560950613|FG001|Overall Study|Withdrawal by Subject|5|||
155414865|NCT02421887|560950612|FG000|Overall Study|Physician Decision|2|||
155414866|NCT02421887|560950613|FG001|Overall Study|Physician Decision|4|||
155414867|NCT02421887|560950612|FG000|Overall Study|Adverse Event|2|||
155642552|NCT03853798|561780843|FG004|Overall Study|Death|0|||
155497890|NCT01785472|561247083|FG000|Overall Study|Protocol deviation|0|||
155497891|NCT01785472|561247084|FG001|Overall Study|Protocol deviation|2|||
155497892|NCT01785472|561247085|FG002|Overall Study|Protocol deviation|2|||
155497893|NCT01785472|561247083|FG000|Overall Study|Subject/guardian decision|15|||
155497894|NCT01785472|561247084|FG001|Overall Study|Subject/guardian decision|10|||
155497895|NCT01785472|561247085|FG002|Overall Study|Subject/guardian decision|11|||
155497896|NCT01785472|561247083|FG000|Overall Study|Technical problems|0|||
155497897|NCT01785472|561247084|FG001|Overall Study|Technical problems|0|||
155497898|NCT01785472|561247085|FG002|Overall Study|Technical problems|1|||
155497899|NCT01257737|561247090|FG000|Overall Study|Lost to Follow-up|1|||
155497900|NCT01257737|561247091|FG001|Overall Study|Lost to Follow-up|2|||
155497901|NCT01257737|561247090|FG000|Overall Study|Liver transplant|1|||
155497902|NCT01257737|561247091|FG001|Overall Study|Liver transplant|0|||
155497903|NCT01257737|561247090|FG000|Overall Study|Relocation out of the country|0|||
155497904|NCT01257737|561247091|FG001|Overall Study|Relocation out of the country|1|||
155497905|NCT01257737|561247090|FG000|Overall Study|Withdrew from study|0|||
155497906|NCT01257737|561247091|FG001|Overall Study|Withdrew from study|1|||
155497907|NCT00938015|561247102|FG000|Overall Study|Death|2|||
155497908|NCT00938015|561247102|FG000|Overall Study|Lost to Follow-up|32|||
155497909|NCT00938015|561247102|FG000|Overall Study|Adverse Event|32|||
155497910|NCT00938015|561247102|FG000|Overall Study|Non-responder|52|||
155497911|NCT00938015|561247102|FG000|Overall Study|Reason not related to Etanercept|29|||
155497912|NCT00664066|561247105|FG000|Overall Study|Study terminated|3|||
155497913|NCT02575807|561247106|FG000|Overall Study|Death|8|||
155497914|NCT02575807|561247107|FG001|Overall Study|Death|3|||
155497915|NCT02575807|561247108|FG002|Overall Study|Death|7|||
155497916|NCT02575807|561247109|FG003|Overall Study|Death|0|||
155497917|NCT02575807|561247110|FG004|Overall Study|Death|1|||
155497918|NCT02575807|561247106|FG000|Overall Study|Study terminated by Sponsor|0|||
155497919|NCT02575807|561247107|FG001|Overall Study|Study terminated by Sponsor|1|||
155497920|NCT02575807|561247108|FG002|Overall Study|Study terminated by Sponsor|7|||
155497921|NCT02575807|561247109|FG003|Overall Study|Study terminated by Sponsor|0|||
155497922|NCT02575807|561247110|FG004|Overall Study|Study terminated by Sponsor|1|||
155497923|NCT02575807|561247106|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
155497924|NCT02575807|561247107|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
155497925|NCT02575807|561247108|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
155497926|NCT02575807|561247109|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
155497927|NCT02575807|561247110|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
155497928|NCT02575807|561247106|FG000|Overall Study|Terminated due to physician decision|0|||
155497929|NCT02575807|561247107|FG001|Overall Study|Terminated due to physician decision|0|||
155497930|NCT02575807|561247108|FG002|Overall Study|Terminated due to physician decision|1|||
155497931|NCT02575807|561247109|FG003|Overall Study|Terminated due to physician decision|0|||
155497932|NCT02575807|561247110|FG004|Overall Study|Terminated due to physician decision|0|||
155497933|NCT02575807|561247106|FG000|Overall Study|Subject ineligible - medical implant|0|||
155497934|NCT02575807|561247107|FG001|Overall Study|Subject ineligible - medical implant|0|||
155497935|NCT02575807|561247108|FG002|Overall Study|Subject ineligible - medical implant|0|||
155642553|NCT03853798|561780844|FG005|Overall Study|Death|1|||
155642554|NCT03853798|561780845|FG006|Overall Study|Death|0|||
155642555|NCT03853798|561780846|FG007|Overall Study|Death|0|||
155642556|NCT03853798|561780847|FG008|Overall Study|Death|0|||
155642557|NCT03853798|561780839|FG000|Overall Study|Adverse Event|0|||
155642558|NCT03853798|561780840|FG001|Overall Study|Adverse Event|0|||
155642559|NCT03853798|561780841|FG002|Overall Study|Adverse Event|2|||
155642560|NCT03853798|561780842|FG003|Overall Study|Adverse Event|0|||
155642561|NCT03853798|561780843|FG004|Overall Study|Adverse Event|0|||
155642562|NCT03853798|561780844|FG005|Overall Study|Adverse Event|0|||
155642563|NCT03853798|561780845|FG006|Overall Study|Adverse Event|0|||
155642564|NCT03853798|561780846|FG007|Overall Study|Adverse Event|0|||
155642565|NCT03853798|561780847|FG008|Overall Study|Adverse Event|0|||
155642566|NCT03853798|561780839|FG000|Overall Study|Withdrawal by Subject|0|||
155642567|NCT03853798|561780840|FG001|Overall Study|Withdrawal by Subject|1|||
155642568|NCT03853798|561780841|FG002|Overall Study|Withdrawal by Subject|4|||
155642569|NCT03853798|561780842|FG003|Overall Study|Withdrawal by Subject|0|||
155642570|NCT03853798|561780843|FG004|Overall Study|Withdrawal by Subject|0|||
155642571|NCT03853798|561780844|FG005|Overall Study|Withdrawal by Subject|5|||
155642572|NCT03853798|561780845|FG006|Overall Study|Withdrawal by Subject|0|||
155642573|NCT03853798|561780846|FG007|Overall Study|Withdrawal by Subject|0|||
155642574|NCT03853798|561780847|FG008|Overall Study|Withdrawal by Subject|4|||
155497936|NCT02575807|561247109|FG003|Overall Study|Subject ineligible - medical implant|1|||
155497937|NCT02575807|561247110|FG004|Overall Study|Subject ineligible - medical implant|0|||
155497938|NCT02575807|561247106|FG000|Overall Study|Withdrawal by Subject|0|||
155497939|NCT02575807|561247107|FG001|Overall Study|Withdrawal by Subject|0|||
155642575|NCT03853798|561780839|FG000|Overall Study|Physician Decision|1|||
155642576|NCT03853798|561780840|FG001|Overall Study|Physician Decision|0|||
155642577|NCT03853798|561780841|FG002|Overall Study|Physician Decision|0|||
155642578|NCT03853798|561780842|FG003|Overall Study|Physician Decision|0|||
155642579|NCT03853798|561780843|FG004|Overall Study|Physician Decision|0|||
155497940|NCT02575807|561247108|FG002|Overall Study|Withdrawal by Subject|1|||
155497941|NCT02575807|561247109|FG003|Overall Study|Withdrawal by Subject|1|||
155497942|NCT02575807|561247110|FG004|Overall Study|Withdrawal by Subject|2|||
155497943|NCT02180659|561247111|FG000|Overall Study|Adverse Event|1|||
155497944|NCT02180659|561247112|FG001|Overall Study|Adverse Event|0|||
155497945|NCT02180659|561247111|FG000|Overall Study|Lost to Follow-up|4|||
155497946|NCT02180659|561247112|FG001|Overall Study|Lost to Follow-up|2|||
155497947|NCT02180659|561247111|FG000|Overall Study|Subject incarcerated during conduct|1|||
155497948|NCT02180659|561247112|FG001|Overall Study|Subject incarcerated during conduct|0|||
155497949|NCT02180659|561247111|FG000|Overall Study|Withdrawal by Subject|0|||
155497950|NCT02180659|561247112|FG001|Overall Study|Withdrawal by Subject|2|||
155497951|NCT02180659|561247111|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
155497952|NCT02180659|561247112|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
155497953|NCT03000075|561247113|FG000|Part A|Adverse Event|4|||
155497954|NCT03000075|561247114|FG001|Part A|Adverse Event|0|||
155497955|NCT03000075|561247115|FG002|Part A|Adverse Event|0|||
155497956|NCT03000075|561247116|FG003|Part A|Adverse Event|0|||
155497957|NCT03000075|561247117|FG004|Part A|Adverse Event|0|||
155497958|NCT03000075|561247118|FG005|Part A|Adverse Event|0|||
155497959|NCT03000075|561247119|FG006|Part A|Adverse Event|0|||
155497960|NCT03000075|561247113|FG000|Part B|Not dosed due to AE|0|||
155497961|NCT03000075|561247114|FG001|Part B|Not dosed due to AE|0|||
155497962|NCT03000075|561247115|FG002|Part B|Not dosed due to AE|0|||
155497963|NCT03000075|561247116|FG003|Part B|Not dosed due to AE|0|||
155497964|NCT03000075|561247117|FG004|Part B|Not dosed due to AE|0|||
155497965|NCT03000075|561247118|FG005|Part B|Not dosed due to AE|2|||
155497966|NCT03000075|561247119|FG006|Part B|Not dosed due to AE|1|||
155497967|NCT03000075|561247113|FG000|Part B|Adverse Event|0|||
155497968|NCT03000075|561247114|FG001|Part B|Adverse Event|0|||
155497969|NCT03000075|561247115|FG002|Part B|Adverse Event|0|||
155497970|NCT03000075|561247116|FG003|Part B|Adverse Event|0|||
155497971|NCT03000075|561247117|FG004|Part B|Adverse Event|1|||
155497972|NCT03000075|561247118|FG005|Part B|Adverse Event|0|||
155497973|NCT03000075|561247119|FG006|Part B|Adverse Event|0|||
155497974|NCT00440193|561247120|FG000|Treatment Period|Adverse Event|74|||
155497975|NCT00440193|561247121|FG001|Treatment Period|Adverse Event|67|||
155497976|NCT00440193|561247120|FG000|Treatment Period|Death|19|||
155497977|NCT00440193|561247121|FG001|Treatment Period|Death|22|||
155497978|NCT00440193|561247120|FG000|Treatment Period|Lack of Efficacy|0|||
155497979|NCT00440193|561247121|FG001|Treatment Period|Lack of Efficacy|1|||
155497980|NCT00440193|561247120|FG000|Treatment Period|Lost to Follow-up|12|||
155497981|NCT00440193|561247121|FG001|Treatment Period|Lost to Follow-up|18|||
155497982|NCT00440193|561247120|FG000|Treatment Period|Physician Decision|3|||
155497983|NCT00440193|561247121|FG001|Treatment Period|Physician Decision|6|||
155497984|NCT00440193|561247120|FG000|Treatment Period|Protocol Violation|16|||
155497985|NCT00440193|561247121|FG001|Treatment Period|Protocol Violation|19|||
155497986|NCT00440193|561247120|FG000|Treatment Period|Withdrawal by Subject|36|||
155497987|NCT00440193|561247121|FG001|Treatment Period|Withdrawal by Subject|77|||
155497988|NCT00440193|561247120|FG000|Treatment Period|Clinical endpoint reached|28|||
155497989|NCT00440193|561247121|FG001|Treatment Period|Clinical endpoint reached|25|||
155497990|NCT00440193|561247120|FG000|Treatment Period|Study terminated by sponsor|102|||
155497991|NCT00440193|561247121|FG001|Treatment Period|Study terminated by sponsor|94|||
155497992|NCT00440193|561247120|FG000|Treatment Period|Protocol driven decision point|2|||
155497993|NCT00440193|561247121|FG001|Treatment Period|Protocol driven decision point|2|||
155497994|NCT00440193|561247120|FG000|Treatment Period|Switch to commercial drug|0|||
155497995|NCT00440193|561247121|FG001|Treatment Period|Switch to commercial drug|2|||
155497996|NCT00440193|561247120|FG000|Treatment Period|Technical problems|1|||
155497997|NCT00440193|561247121|FG001|Treatment Period|Technical problems|1|||
155497998|NCT00440193|561247120|FG000|Treatment Period|Participant convenience|5|||
155497999|NCT00440193|561247121|FG001|Treatment Period|Participant convenience|2|||
155498000|NCT00440193|561247120|FG000|Treatment Period|Participant did not receive treatment|7|||
155498001|NCT00440193|561247121|FG001|Treatment Period|Participant did not receive treatment|13|||
155498002|NCT00440193|561247120|FG000|Treatment Period|Site closed by investigator|0|||
155498003|NCT00440193|561247121|FG001|Treatment Period|Site closed by investigator|2|||
155498004|NCT00440193|561247120|FG000|Observational Period|Adverse Event|2|||
155498005|NCT00440193|561247121|FG001|Observational Period|Adverse Event|2|||
155498006|NCT00440193|561247120|FG000|Observational Period|Death|15|||
155498007|NCT00440193|561247121|FG001|Observational Period|Death|20|||
155498008|NCT00440193|561247120|FG000|Observational Period|Lost to Follow-up|12|||
155498009|NCT00440193|561247121|FG001|Observational Period|Lost to Follow-up|8|||
155498010|NCT00440193|561247120|FG000|Observational Period|Protocol Violation|1|||
155498011|NCT00440193|561247121|FG001|Observational Period|Protocol Violation|0|||
155498012|NCT00440193|561247120|FG000|Observational Period|Withdrawal by Subject|11|||
155498013|NCT00440193|561247121|FG001|Observational Period|Withdrawal by Subject|8|||
155498014|NCT00440193|561247120|FG000|Observational Period|Physician Decision|1|||
155498015|NCT00440193|561247121|FG001|Observational Period|Physician Decision|0|||
155498016|NCT00440193|561247120|FG000|Observational Period|Clinical endpoint reached|1|||
155498017|NCT00440193|561247121|FG001|Observational Period|Clinical endpoint reached|0|||
155498018|NCT00440193|561247120|FG000|Observational Period|Participant convenience|2|||
155498019|NCT00440193|561247121|FG001|Observational Period|Participant convenience|0|||
155498020|NCT00834366|561247122|FG000|Treatment Period 1|Adverse Event|1|||
155498021|NCT00834366|561247123|FG001|Treatment Period 1|Adverse Event|1|||
155498022|NCT03014570|561247124|FG000|Overall Study|COVID-19 Restrictions|38|||
155498023|NCT03014570|561247125|FG001|Overall Study|COVID-19 Restrictions|24|||
155498024|NCT03014570|561247124|FG000|Overall Study|Death|70|||
155498025|NCT03014570|561247125|FG001|Overall Study|Death|79|||
155498026|NCT03014570|561247124|FG000|Overall Study|Transfer from facility|11|||
155498027|NCT03014570|561247125|FG001|Overall Study|Transfer from facility|14|||
155498028|NCT03014570|561247124|FG000|Overall Study|Hospitalized|5|||
155498029|NCT03014570|561247125|FG001|Overall Study|Hospitalized|3|||
155498030|NCT03014570|561247124|FG000|Overall Study|Transfer within facility|1|||
155498031|NCT03014570|561247125|FG001|Overall Study|Transfer within facility|0|||
155498032|NCT03014570|561247124|FG000|Overall Study|Site refusal|0|||
155498033|NCT03014570|561247125|FG001|Overall Study|Site refusal|11|||
155498034|NCT01154673|561247126|FG000|Overall Study|Lost to Follow-up|1|||
155498035|NCT01154673|561247127|FG001|Overall Study|Lost to Follow-up|0|||
155498036|NCT01154673|561247126|FG000|Overall Study|moved out of province|1|||
155498037|NCT01154673|561247127|FG001|Overall Study|moved out of province|0|||
155498038|NCT00518011|561247133|FG000|Overall Study|Death|1|||
155498039|NCT00518011|561247134|FG001|Overall Study|Death|1|||
155498040|NCT00518011|561247133|FG000|Overall Study|Adverse Event|2|||
155498041|NCT00518011|561247134|FG001|Overall Study|Adverse Event|3|||
155498042|NCT00518011|561247133|FG000|Overall Study|Disease Progression|2|||
155498043|NCT00518011|561247134|FG001|Overall Study|Disease Progression|2|||
155498044|NCT00518011|561247133|FG000|Overall Study|Other Reasons|3|||
155498045|NCT00518011|561247134|FG001|Overall Study|Other Reasons|2|||
155498046|NCT00518011|561247133|FG000|Overall Study|Withdrawal by Subject|1|||
155498047|NCT00518011|561247134|FG001|Overall Study|Withdrawal by Subject|0|||
155498048|NCT00090259|561247135|FG000|Overall Study|Lost to Follow-up|30|||
155498049|NCT00090259|561247136|FG001|Overall Study|Lost to Follow-up|26|||
155498050|NCT00090259|561247135|FG000|Overall Study|Withdrawal by Subject|21|||
155498051|NCT00090259|561247136|FG001|Overall Study|Withdrawal by Subject|15|||
155498052|NCT00090259|561247135|FG000|Overall Study|Investigator site closed|11|||
155498053|NCT00090259|561247136|FG001|Overall Study|Investigator site closed|7|||
155498054|NCT04797637|561247138|FG000|Overall Study|Lost to Follow-up|23|||
155498055|NCT04797637|561247139|FG001|Overall Study|Lost to Follow-up|32|||
155498056|NCT04797637|561247138|FG000|Overall Study|Withdrawal by Subject|0|||
155498057|NCT04797637|561247139|FG001|Overall Study|Withdrawal by Subject|1|||
155498058|NCT03083639|561247140|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
155498059|NCT03083639|561247141|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
155498060|NCT03083639|561247140|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
155498061|NCT03083639|561247141|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
155498062|NCT00960687|561247145|FG000|Washout Period of 7 Days|Adverse Event|3|||
155498063|NCT00960687|561247146|FG001|Washout Period of 7 Days|Adverse Event|2|||
155498064|NCT00960687|561247145|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
155498065|NCT00960687|561247146|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155498066|NCT01023022|561247150|FG000|Overall Study|Death|5|||
155498067|NCT01023022|561247150|FG000|Overall Study|Lost to Follow-up|7|||
155498068|NCT01023022|561247150|FG000|Overall Study|due to technical issues|2|||
155498069|NCT03239340|561247151|FG000|Overall Study|Other|26|||
155498070|NCT03239340|561247151|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
155498071|NCT03239340|561247151|FG000|Overall Study|Death|40|||
155498072|NCT03239340|561247151|FG000|Overall Study|Lost to Follow-up|2|||
155498073|NCT03239340|561247151|FG000|Overall Study|Physician Decision|16|||
155498074|NCT03239340|561247151|FG000|Overall Study|Withdrawal by Subject|27|||
155498075|NCT02332655|561247162|FG000|Overall Study|Lack of Efficacy|1|||
155498076|NCT01843660|561247163|FG000|Overall Study|Other|30|||
155498077|NCT01977482|561247164|FG000|Overall Study|Adverse Event|0|||
155498078|NCT01977482|561247165|FG001|Overall Study|Adverse Event|1|||
155498079|NCT01977482|561247166|FG002|Overall Study|Adverse Event|1|||
155498080|NCT01977482|561247167|FG003|Overall Study|Adverse Event|0|||
155498081|NCT01977482|561247168|FG004|Overall Study|Adverse Event|2|||
155498082|NCT01977482|561247169|FG005|Overall Study|Adverse Event|0|||
155498083|NCT01977482|561247164|FG000|Overall Study|Lost to Follow-up|1|||
155498084|NCT01977482|561247165|FG001|Overall Study|Lost to Follow-up|0|||
155498085|NCT01977482|561247166|FG002|Overall Study|Lost to Follow-up|0|||
155498086|NCT01977482|561247167|FG003|Overall Study|Lost to Follow-up|0|||
155749711|NCT00058539|562184145|FG000|Overall Study|Physician Decision|9|||
155498087|NCT01977482|561247168|FG004|Overall Study|Lost to Follow-up|0|||
155498088|NCT01977482|561247169|FG005|Overall Study|Lost to Follow-up|0|||
155498089|NCT01977482|561247164|FG000|Overall Study|Physician Decision|0|||
155498090|NCT01977482|561247165|FG001|Overall Study|Physician Decision|1|||
155498091|NCT01977482|561247166|FG002|Overall Study|Physician Decision|0|||
155498092|NCT01977482|561247167|FG003|Overall Study|Physician Decision|0|||
155498093|NCT01977482|561247168|FG004|Overall Study|Physician Decision|0|||
155498094|NCT01977482|561247169|FG005|Overall Study|Physician Decision|0|||
155498095|NCT01977482|561247164|FG000|Overall Study|Protocol Violation|0|||
155498096|NCT01977482|561247165|FG001|Overall Study|Protocol Violation|0|||
155498097|NCT01977482|561247166|FG002|Overall Study|Protocol Violation|1|||
155498098|NCT01977482|561247167|FG003|Overall Study|Protocol Violation|0|||
155498099|NCT01977482|561247168|FG004|Overall Study|Protocol Violation|0|||
155498100|NCT01977482|561247169|FG005|Overall Study|Protocol Violation|0|||
155498101|NCT01977482|561247164|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
155498102|NCT01977482|561247165|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
155498103|NCT01977482|561247166|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
155498104|NCT01977482|561247167|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
155498105|NCT01977482|561247168|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
155498106|NCT01977482|561247169|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
155498107|NCT01977482|561247164|FG000|Overall Study|Withdrawal by Subject|2|||
155498108|NCT01977482|561247165|FG001|Overall Study|Withdrawal by Subject|4|||
155498109|NCT01977482|561247166|FG002|Overall Study|Withdrawal by Subject|1|||
155498110|NCT01977482|561247167|FG003|Overall Study|Withdrawal by Subject|3|||
155498111|NCT01977482|561247168|FG004|Overall Study|Withdrawal by Subject|1|||
155498112|NCT01977482|561247169|FG005|Overall Study|Withdrawal by Subject|5|||
155498113|NCT00209560|561247170|FG000|Overall Study|Lack of Efficacy|1|||
155498114|NCT00209560|561247171|FG001|Overall Study|Lack of Efficacy|0|||
155498115|NCT01525407|561247176|FG000|Overall Study|Change in recipient treatment plan|2|||
155498116|NCT01525407|561247177|FG001|Overall Study|Change in recipient treatment plan|2|||
155498117|NCT01525407|561247176|FG000|Overall Study|Withdrawal by Subject|0|||
155498118|NCT01525407|561247177|FG001|Overall Study|Withdrawal by Subject|1|||
155498119|NCT01525407|561247176|FG000|Overall Study|Transplant was delayed|0|||
155498120|NCT01525407|561247177|FG001|Overall Study|Transplant was delayed|1|||
155498121|NCT01525407|561247176|FG000|Overall Study|Delay in Transplant|1|||
155498122|NCT01525407|561247177|FG001|Overall Study|Delay in Transplant|0|||
155498123|NCT00359073|561248426|FG000|Overall Study|Withdrawal by Subject|1|||
155498124|NCT00359073|561248427|FG001|Overall Study|Withdrawal by Subject|1|||
155498125|NCT00359073|561248426|FG000|Overall Study|Eligibility criteria no longer met|3|||
155498126|NCT00359073|561248427|FG001|Overall Study|Eligibility criteria no longer met|0|||
155498127|NCT00359073|561248426|FG000|Overall Study|developed RV16 antibody|0|||
155498128|NCT00359073|561248427|FG001|Overall Study|developed RV16 antibody|1|||
155498129|NCT00684645|561248428|FG000|Overall Study|Death|2|||
155498130|NCT00684645|561248428|FG000|Overall Study|Progressive disease|67|||
155498131|NCT00684645|561248428|FG000|Overall Study|Adverse Event|27|||
155498132|NCT00684645|561248428|FG000|Overall Study|Lost to Follow-up|3|||
155498133|NCT00684645|561248428|FG000|Overall Study|Other|15|||
155498134|NCT03256526|561248429|FG000|Overall Study|Adverse Event|1|||
155498135|NCT03256526|561248430|FG001|Overall Study|Adverse Event|0|||
155498136|NCT03256526|561248431|FG002|Overall Study|Adverse Event|1|||
155642580|NCT03853798|561780844|FG005|Overall Study|Physician Decision|0|||
155642581|NCT03853798|561780845|FG006|Overall Study|Physician Decision|0|||
155642582|NCT03853798|561780846|FG007|Overall Study|Physician Decision|0|||
155642583|NCT03853798|561780847|FG008|Overall Study|Physician Decision|1|||
155642584|NCT03853798|561780839|FG000|Overall Study|Lack of Efficacy|0|||
155642585|NCT03853798|561780840|FG001|Overall Study|Lack of Efficacy|0|||
155642586|NCT03853798|561780841|FG002|Overall Study|Lack of Efficacy|2|||
155642587|NCT03853798|561780842|FG003|Overall Study|Lack of Efficacy|0|||
155642588|NCT03853798|561780843|FG004|Overall Study|Lack of Efficacy|0|||
155642589|NCT03853798|561780844|FG005|Overall Study|Lack of Efficacy|0|||
155642590|NCT03853798|561780845|FG006|Overall Study|Lack of Efficacy|0|||
155642591|NCT03853798|561780846|FG007|Overall Study|Lack of Efficacy|0|||
155642592|NCT03853798|561780847|FG008|Overall Study|Lack of Efficacy|1|||
155642593|NCT03853798|561780839|FG000|Overall Study|Approved Drug Available for Indication|0|||
155642594|NCT03853798|561780840|FG001|Overall Study|Approved Drug Available for Indication|0|||
155642595|NCT03853798|561780841|FG002|Overall Study|Approved Drug Available for Indication|1|||
155642596|NCT03853798|561780842|FG003|Overall Study|Approved Drug Available for Indication|0|||
155642597|NCT03853798|561780843|FG004|Overall Study|Approved Drug Available for Indication|0|||
155749712|NCT00058539|562184145|FG000|Overall Study|Death|1|||
155498137|NCT03256526|561248429|FG000|Overall Study|Lost to Follow-up|1|||
155498138|NCT03256526|561248430|FG001|Overall Study|Lost to Follow-up|0|||
155498139|NCT03256526|561248431|FG002|Overall Study|Lost to Follow-up|2|||
155498140|NCT01607398|561248432|FG000|Overall Study|Adverse Event|0|||
155498141|NCT01607398|561248433|FG001|Overall Study|Adverse Event|2|||
155498142|NCT01607398|561248432|FG000|Overall Study|Severe COPD|2|||
155498143|NCT01607398|561248433|FG001|Overall Study|Severe COPD|0|||
155498144|NCT03515837|561248437|FG000|Overall Study|Death|219|||
155498145|NCT03515837|561248438|FG001|Overall Study|Death|227|||
155498146|NCT03515837|561248437|FG000|Overall Study|Lost to Follow-up|0|||
155498147|NCT03515837|561248438|FG001|Overall Study|Lost to Follow-up|1|||
155642598|NCT03853798|561780844|FG005|Overall Study|Approved Drug Available for Indication|1|||
155642599|NCT03853798|561780845|FG006|Overall Study|Approved Drug Available for Indication|0|||
155642600|NCT03853798|561780846|FG007|Overall Study|Approved Drug Available for Indication|0|||
155749713|NCT01903525|562184146|FG000|Overall Study|Lost to Follow-up|5|||
155642601|NCT03853798|561780847|FG008|Overall Study|Approved Drug Available for Indication|0|||
155414868|NCT02421887|560950613|FG001|Overall Study|Adverse Event|0|||
155414869|NCT01882907|560950614|FG000|Overall Study|Adverse Event|3|||
155414870|NCT01882907|560950615|FG001|Overall Study|Adverse Event|1|||
155414871|NCT01882907|560950614|FG000|Overall Study|Lack of Efficacy|0|||
155414872|NCT01882907|560950615|FG001|Overall Study|Lack of Efficacy|3|||
155414873|NCT01882907|560950614|FG000|Overall Study|Lost to Follow-up|1|||
155414874|NCT01882907|560950615|FG001|Overall Study|Lost to Follow-up|4|||
155414875|NCT01882907|560950614|FG000|Overall Study|Protocol Violation|10|||
155414876|NCT01882907|560950615|FG001|Overall Study|Protocol Violation|14|||
155414877|NCT01882907|560950614|FG000|Overall Study|Withdrawal by Subject|0|||
155414878|NCT01882907|560950615|FG001|Overall Study|Withdrawal by Subject|6|||
155414879|NCT01978093|560950616|FG000|Overall Study|Death|1|||
155414880|NCT01978093|560950617|FG001|Overall Study|Death|0|||
155414881|NCT01978093|560950616|FG000|Overall Study|Adverse Event|0|||
155414882|NCT01978093|560950617|FG001|Overall Study|Adverse Event|5|||
155414883|NCT01978093|560950616|FG000|Overall Study|Protocol Violation|8|||
155414884|NCT01978093|560950617|FG001|Overall Study|Protocol Violation|2|||
155414885|NCT01978093|560950616|FG000|Overall Study|Withdrawal by Subject|29|||
155414886|NCT01978093|560950617|FG001|Overall Study|Withdrawal by Subject|25|||
155414887|NCT01978093|560950616|FG000|Overall Study|Lost to Follow-up|11|||
155414888|NCT01978093|560950617|FG001|Overall Study|Lost to Follow-up|15|||
155414889|NCT01978093|560950616|FG000|Overall Study|Migrated/moved from study area|11|||
155414890|NCT01978093|560950617|FG001|Overall Study|Migrated/moved from study area|13|||
155414891|NCT01978093|560950616|FG000|Overall Study|Loss of kaiser coverage|4|||
155414892|NCT01978093|560950617|FG001|Overall Study|Loss of kaiser coverage|10|||
155414893|NCT01978093|560950616|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
155414894|NCT01978093|560950617|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
155414895|NCT01978093|560950616|FG000|Overall Study|Mother lost custody of child|0|||
155414896|NCT01978093|560950617|FG001|Overall Study|Mother lost custody of child|1|||
155414897|NCT01978093|560950616|FG000|Overall Study|Child was in care of grandmother|0|||
155414898|NCT01978093|560950617|FG001|Overall Study|Child was in care of grandmother|1|||
155414899|NCT01978093|560950616|FG000|Overall Study|N/A for vaccine administration|0|||
155414900|NCT01978093|560950617|FG001|Overall Study|N/A for vaccine administration|1|||
155414901|NCT01467492|560950618|FG000|Overall Study|Withdrawal by Subject|6|||
155414902|NCT01467492|560950619|FG001|Overall Study|Withdrawal by Subject|4|||
155414903|NCT01467492|560950618|FG000|Overall Study|Study Terminated by Sponsor|6|||
155414904|NCT01467492|560950619|FG001|Overall Study|Study Terminated by Sponsor|4|||
155414905|NCT01467492|560950618|FG000|Overall Study|Adverse Event|4|||
155414906|NCT01467492|560950619|FG001|Overall Study|Adverse Event|3|||
155414907|NCT01467492|560950618|FG000|Overall Study|Lost to Follow-up|3|||
155642602|NCT03853798|561780839|FG000|Overall Study|Other un-specified|0|||
155642603|NCT03853798|561780840|FG001|Overall Study|Other un-specified|0|||
155642604|NCT03853798|561780841|FG002|Overall Study|Other un-specified|2|||
155642605|NCT03853798|561780842|FG003|Overall Study|Other un-specified|0|||
155642606|NCT03853798|561780843|FG004|Overall Study|Other un-specified|0|||
155308119|NCT00901901|560560797|FG000|Follow-up Period|Lost to Follow-up|12|||
155308120|NCT00901901|560560798|FG001|Follow-up Period|Lost to Follow-up|8|||
155308121|NCT00901901|560560797|FG000|Follow-up Period|Missing|94|||
155308122|NCT00901901|560560798|FG001|Follow-up Period|Missing|80|||
155308123|NCT00951379|560560799|FG000|Overall Study|Adverse Event|4|||
155308124|NCT00951379|560560800|FG001|Overall Study|Adverse Event|1|||
155308125|NCT00951379|560560799|FG000|Overall Study|Withdrawal by Subject|1|||
155308126|NCT00951379|560560800|FG001|Overall Study|Withdrawal by Subject|0|||
155308127|NCT00951379|560560799|FG000|Overall Study|Noncompliance|1|||
155308128|NCT00951379|560560800|FG001|Overall Study|Noncompliance|0|||
155308129|NCT00951379|560560799|FG000|Overall Study|Disease Progression|0|||
155308130|NCT00951379|560560800|FG001|Overall Study|Disease Progression|1|||
155308131|NCT02742519|560560801|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
155642607|NCT03853798|561780844|FG005|Overall Study|Other un-specified|1|||
155642608|NCT03853798|561780845|FG006|Overall Study|Other un-specified|0|||
155642609|NCT03853798|561780846|FG007|Overall Study|Other un-specified|0|||
155642610|NCT03853798|561780847|FG008|Overall Study|Other un-specified|0|||
155642611|NCT02743494|561780848|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
155749714|NCT01903525|562184147|FG001|Overall Study|Lost to Follow-up|9|||
155308132|NCT02742519|560560802|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
155308133|NCT02742519|560560803|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
155308134|NCT02742519|560560801|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
155414908|NCT01467492|560950619|FG001|Overall Study|Lost to Follow-up|2|||
155414909|NCT01467492|560950618|FG000|Overall Study|Undefined|2|||
155414910|NCT01467492|560950619|FG001|Overall Study|Undefined|0|||
155414911|NCT01467492|560950618|FG000|Overall Study|Enrolled But Not Treated|1|||
155414912|NCT01467492|560950619|FG001|Overall Study|Enrolled But Not Treated|0|||
155414913|NCT04269395|560950620|FG000|Overall Study|Lost to Follow-up|1|||
155642612|NCT02743494|561780849|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
155642613|NCT02743494|561780848|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
155414914|NCT04269395|560950621|FG001|Overall Study|Lost to Follow-up|0|||
155414915|NCT04269395|560950620|FG000|Overall Study|Study terminated by Sponsor|13|||
155414916|NCT04269395|560950621|FG001|Overall Study|Study terminated by Sponsor|10|||
155414917|NCT01491178|560950622|FG000|Overall Study|Adverse Event|1016|||
155414918|NCT01491178|560950622|FG000|Overall Study|Improvement of NVAF|210|||
155414919|NCT01491178|560950622|FG000|Overall Study|To conduct invasive treatment|59|||
155414920|NCT01491178|560950622|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
155414921|NCT01491178|560950622|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
155414922|NCT01491178|560950622|FG000|Overall Study|To take a contraindication|20|||
155414923|NCT01491178|560950622|FG000|Overall Study|Other than specified above|657|||
155414924|NCT05689047|560950625|FG000|Overall Study|Lost to Follow-up|0|||
155414925|NCT05689047|560950626|FG001|Overall Study|Lost to Follow-up|1|||
155414926|NCT05689047|560950625|FG000|Overall Study|Protocol Deviation|1|||
155414927|NCT05689047|560950626|FG001|Overall Study|Protocol Deviation|0|||
155414928|NCT01604512|560950627|FG000|Overall Study|Withdrawal by Subject|3|||
155414929|NCT01604512|560950627|FG000|Overall Study|Not treated|4|||
155414930|NCT01415752|560950628|FG000|Induction (Step 1)|Ineligible|4|||
155414931|NCT01415752|560950629|FG001|Induction (Step 1)|Ineligible|3|||
155414932|NCT01415752|560950630|FG002|Induction (Step 1)|Ineligible|4|||
155414933|NCT01415752|560950631|FG003|Induction (Step 1)|Ineligible|4|||
155414934|NCT01415752|560950628|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
155414935|NCT01415752|560950629|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
155414936|NCT01415752|560950630|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
155414937|NCT01415752|560950631|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
155414938|NCT01415752|560950628|FG000|Maintenance (Step 2)|Adverse Event|3|||
155414939|NCT01415752|560950629|FG001|Maintenance (Step 2)|Adverse Event|4|||
155414940|NCT01415752|560950630|FG002|Maintenance (Step 2)|Adverse Event|9|||
155414941|NCT01415752|560950631|FG003|Maintenance (Step 2)|Adverse Event|6|||
155414942|NCT01415752|560950628|FG000|Maintenance (Step 2)|Death|1|||
155414943|NCT01415752|560950629|FG001|Maintenance (Step 2)|Death|1|||
155414944|NCT01415752|560950630|FG002|Maintenance (Step 2)|Death|2|||
155414945|NCT01415752|560950631|FG003|Maintenance (Step 2)|Death|0|||
155414946|NCT01415752|560950628|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
155414947|NCT01415752|560950629|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
155414948|NCT01415752|560950630|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
155414949|NCT01415752|560950631|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
155414950|NCT01415752|560950628|FG000|Maintenance (Step 2)|Alternative therapy|0|||
155414951|NCT01415752|560950629|FG001|Maintenance (Step 2)|Alternative therapy|1|||
155414952|NCT01415752|560950630|FG002|Maintenance (Step 2)|Alternative therapy|0|||
155414953|NCT01415752|560950631|FG003|Maintenance (Step 2)|Alternative therapy|0|||
155414954|NCT01415752|560950628|FG000|Maintenance (Step 2)|Other reasons|3|||
155414955|NCT01415752|560950629|FG001|Maintenance (Step 2)|Other reasons|6|||
155414956|NCT01415752|560950630|FG002|Maintenance (Step 2)|Other reasons|4|||
155414957|NCT01415752|560950631|FG003|Maintenance (Step 2)|Other reasons|6|||
155414958|NCT01415752|560950628|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
155414959|NCT01415752|560950629|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
155414960|NCT01415752|560950630|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
155414961|NCT01415752|560950631|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
155414962|NCT01415752|560950628|FG000|Maintenance (Step 2)|ineligible|1|||
155414963|NCT01415752|560950629|FG001|Maintenance (Step 2)|ineligible|1|||
155414964|NCT01415752|560950630|FG002|Maintenance (Step 2)|ineligible|1|||
155414965|NCT01415752|560950631|FG003|Maintenance (Step 2)|ineligible|0|||
155414966|NCT01415752|560950628|FG000|Maintenance (Step 2)|Missing|4|||
155414967|NCT01415752|560950629|FG001|Maintenance (Step 2)|Missing|1|||
155414968|NCT01415752|560950630|FG002|Maintenance (Step 2)|Missing|4|||
155414969|NCT01415752|560950631|FG003|Maintenance (Step 2)|Missing|3|||
155414970|NCT03286842|560950632|FG000|Overall Study|Patients rolled over to another study|80|||
155414971|NCT00252057|560950633|FG000|Overall Study|Withdrawal by Subject|2|||
155414972|NCT00252057|560950634|FG001|Overall Study|Withdrawal by Subject|5|||
155414973|NCT00252057|560950633|FG000|Overall Study|Death|1|||
155414974|NCT00252057|560950634|FG001|Overall Study|Death|2|||
155414975|NCT00252057|560950633|FG000|Overall Study|Participant previously enrolled|0|||
155414976|NCT00252057|560950634|FG001|Overall Study|Participant previously enrolled|1|||
155414977|NCT01496066|560950636|FG000|Overall Study|Lost to Follow-up|8|||
155414978|NCT01496066|560950637|FG001|Overall Study|Lost to Follow-up|5|||
155414979|NCT01496066|560950636|FG000|Overall Study|Explant|3|||
155414980|NCT01496066|560950637|FG001|Overall Study|Explant|0|||
155414981|NCT01496066|560950636|FG000|Overall Study|Death|1|||
155414982|NCT01496066|560950637|FG001|Overall Study|Death|4|||
155414983|NCT02926209|560950638|FG000|Study Cohort|Poor Bowel Preparation|1|||
155414984|NCT02926209|560950639|FG001|Study Cohort|Poor Bowel Preparation|0|||
155414985|NCT01587079|560950640|FG000|Overall Study|Protocol-specified criteria|9|||
155414986|NCT01587079|560950640|FG000|Overall Study|Protocol Violation|5|||
155414987|NCT01587079|560950640|FG000|Overall Study|Lost to Follow-up|2|||
155414988|NCT01587079|560950640|FG000|Overall Study|Physician Decision|2|||
155414989|NCT01587079|560950640|FG000|Overall Study|Withdrawal by Subject|7|||
155414990|NCT01587079|560950640|FG000|Overall Study|Adverse Event|14|||
155642614|NCT02743494|561780849|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
155642615|NCT02743494|561780848|FG000|Treatment Period|Disease recurrence|152|||
155642616|NCT02743494|561780849|FG001|Treatment Period|Disease recurrence|115|||
155642617|NCT02743494|561780848|FG000|Treatment Period|Study drug toxicity|56|||
155642618|NCT02743494|561780849|FG001|Treatment Period|Study drug toxicity|8|||
155642619|NCT02743494|561780848|FG000|Treatment Period|Death|1|||
155642620|NCT02743494|561780849|FG001|Treatment Period|Death|1|||
155642621|NCT02743494|561780848|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
155642622|NCT02743494|561780849|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
155642623|NCT02743494|561780848|FG000|Treatment Period|Participant request to discontinue treatment|31|||
155642624|NCT02743494|561780849|FG001|Treatment Period|Participant request to discontinue treatment|5|||
155642625|NCT02743494|561780848|FG000|Treatment Period|Participant withdrew consent|11|||
155642626|NCT02743494|561780849|FG001|Treatment Period|Participant withdrew consent|4|||
155749715|NCT01903525|562184146|FG000|Overall Study|Adverse Event|0|||
155749716|NCT01903525|562184147|FG001|Overall Study|Adverse Event|1|||
155308135|NCT02742519|560560802|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
155308136|NCT02742519|560560803|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
155498148|NCT03515837|561248437|FG000|Overall Study|Withdrawal by Subject|0|||
155498149|NCT03515837|561248438|FG001|Overall Study|Withdrawal by Subject|4|||
155498150|NCT03515837|561248437|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
155498151|NCT03515837|561248438|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
155498152|NCT01964898|561248439|FG000|Overall Study|ineligible post-randomization|1|||
155498153|NCT01964898|561248440|FG001|Overall Study|ineligible post-randomization|1|||
155498154|NCT01964898|561248439|FG000|Overall Study|did not receive the allocated interventi|2|||
155498155|NCT01964898|561248440|FG001|Overall Study|did not receive the allocated interventi|1|||
155498156|NCT01964898|561248439|FG000|Overall Study|Lost to Follow-up|3|||
155498157|NCT01964898|561248440|FG001|Overall Study|Lost to Follow-up|5|||
155498158|NCT01964898|561248439|FG000|Overall Study|Withdrawal by Subject|1|||
155498159|NCT01964898|561248440|FG001|Overall Study|Withdrawal by Subject|0|||
155498160|NCT02325401|561248441|FG000|Overall Study|Withdrawal by Subject|0|||
155498161|NCT02325401|561248442|FG001|Overall Study|Withdrawal by Subject|1|||
155498162|NCT02325401|561248443|FG002|Overall Study|Withdrawal by Subject|1|||
155498163|NCT00391092|561248444|FG000|Overall Study|Death|78|||
155498164|NCT00391092|561248445|FG001|Overall Study|Death|81|||
155498165|NCT00391092|561248444|FG000|Overall Study|Lost to Follow-up|13|||
155498166|NCT00391092|561248445|FG001|Overall Study|Lost to Follow-up|18|||
155498167|NCT00391092|561248444|FG000|Overall Study|Alive on treatment|29|||
155498168|NCT00391092|561248445|FG001|Overall Study|Alive on treatment|33|||
155498169|NCT00391092|561248444|FG000|Overall Study|Alive in follow-up|88|||
155498170|NCT00391092|561248445|FG001|Overall Study|Alive in follow-up|84|||
155498171|NCT02428231|561248448|FG000|Overall Study|Other|10|||
155498172|NCT02428231|561248449|FG001|Overall Study|Other|16|||
155498173|NCT02428231|561248448|FG000|Overall Study|Required Symptomatic Therapy|0|||
155498174|NCT02428231|561248449|FG001|Overall Study|Required Symptomatic Therapy|1|||
155498175|NCT02428231|561248448|FG000|Overall Study|Adverse Event|3|||
155498176|NCT02428231|561248449|FG001|Overall Study|Adverse Event|0|||
155498177|NCT00602979|561248454|FG000|Overall Study|Lost to Follow-up|3|||
155498178|NCT00602979|561248455|FG001|Overall Study|Lost to Follow-up|2|||
155498179|NCT00602979|561248456|FG002|Overall Study|Lost to Follow-up|3|||
155498180|NCT00602979|561248457|FG003|Overall Study|Lost to Follow-up|2|||
155498181|NCT00602979|561248458|FG004|Overall Study|Lost to Follow-up|3|||
155498182|NCT00602979|561248454|FG000|Overall Study|Failed Intubation|0|||
155498183|NCT00602979|561248455|FG001|Overall Study|Failed Intubation|1|||
155498184|NCT00602979|561248456|FG002|Overall Study|Failed Intubation|0|||
155498185|NCT00602979|561248457|FG003|Overall Study|Failed Intubation|1|||
155498186|NCT00602979|561248458|FG004|Overall Study|Failed Intubation|0|||
155498187|NCT03976076|561248459|FG000|Overall Study|Withdrawal by Subject|2|||
155498188|NCT02406742|561248460|FG000|Overall Study|Progression of Disease|5|||
155498189|NCT02406742|561248461|FG001|Overall Study|Progression of Disease|1|||
155498190|NCT02406742|561248462|FG002|Overall Study|Progression of Disease|6|||
155498191|NCT02406742|561248460|FG000|Overall Study|Adverse Event|3|||
155498192|NCT02406742|561248461|FG001|Overall Study|Adverse Event|0|||
155498193|NCT02406742|561248462|FG002|Overall Study|Adverse Event|2|||
155498194|NCT02406742|561248460|FG000|Overall Study|Death|1|||
155498195|NCT02406742|561248461|FG001|Overall Study|Death|0|||
155498196|NCT02406742|561248462|FG002|Overall Study|Death|0|||
155308137|NCT02742519|560560801|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
155498197|NCT02406742|561248460|FG000|Overall Study|Lack of Efficacy|0|||
155498198|NCT02406742|561248461|FG001|Overall Study|Lack of Efficacy|0|||
155498199|NCT02406742|561248462|FG002|Overall Study|Lack of Efficacy|1|||
155498200|NCT02406742|561248460|FG000|Overall Study|Withdrawal by Participant|1|||
155498201|NCT02406742|561248461|FG001|Overall Study|Withdrawal by Participant|2|||
155498202|NCT02406742|561248462|FG002|Overall Study|Withdrawal by Participant|0|||
155498203|NCT02406742|561248460|FG000|Overall Study|Physician Decision|1|||
155642627|NCT02743494|561780848|FG000|Treatment Period|Lost to Follow-up|0|||
155642628|NCT02743494|561780849|FG001|Treatment Period|Lost to Follow-up|1|||
155498204|NCT02406742|561248461|FG001|Overall Study|Physician Decision|2|||
155498205|NCT02406742|561248462|FG002|Overall Study|Physician Decision|1|||
155498206|NCT02406742|561248460|FG000|Overall Study|Transition to other treatment|2|||
155498207|NCT02406742|561248461|FG001|Overall Study|Transition to other treatment|0|||
155498208|NCT02406742|561248462|FG002|Overall Study|Transition to other treatment|1|||
155498209|NCT02406742|561248460|FG000|Overall Study|Other Reasons|1|||
155498210|NCT02406742|561248461|FG001|Overall Study|Other Reasons|11|||
155498211|NCT02406742|561248462|FG002|Overall Study|Other Reasons|5|||
155498212|NCT02367729|561248467|FG000|Overall Study|Organic disorder diagnosed|2|||
155498213|NCT02367729|561248468|FG001|Overall Study|Organic disorder diagnosed|1|||
155498214|NCT02367729|561248467|FG000|Overall Study|Adverse Event|1|||
155498215|NCT02367729|561248468|FG001|Overall Study|Adverse Event|2|||
155498216|NCT02367729|561248467|FG000|Overall Study|Withdrawal by Subject|0|||
155498217|NCT02367729|561248468|FG001|Overall Study|Withdrawal by Subject|5|||
155498218|NCT00457418|561248478|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
155498219|NCT00457418|561248478|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
155498220|NCT00457418|561248478|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
155498221|NCT00457418|561248478|FG000|Post PK Maintenance|Adverse Event|10|||
155498222|NCT00457418|561248478|FG000|Post PK Maintenance|Progression of Disease|6|||
155498223|NCT00457418|561248478|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
155498224|NCT00457418|561248478|FG000|Post PK Maintenance|Lost to Follow-up|1|||
155498225|NCT02086968|561248479|FG000|Overall Study|Adverse Event|1|||
155498226|NCT02086968|561248480|FG001|Overall Study|Adverse Event|5|||
155498227|NCT02086968|561248479|FG000|Overall Study|Lost to Follow-up|2|||
155498228|NCT02086968|561248480|FG001|Overall Study|Lost to Follow-up|3|||
155498229|NCT02086968|561248479|FG000|Overall Study|Study drug received outside protocol|0|||
155498230|NCT02086968|561248480|FG001|Overall Study|Study drug received outside protocol|1|||
155498231|NCT02086968|561248479|FG000|Overall Study|Physician Decision|4|||
155498232|NCT02086968|561248480|FG001|Overall Study|Physician Decision|0|||
155498233|NCT02086968|561248479|FG000|Overall Study|Withdrawal by Subject|1|||
155498234|NCT02086968|561248480|FG001|Overall Study|Withdrawal by Subject|4|||
155498235|NCT03359473|561248481|FG000|Overall Study|Adverse Event|0|||
155498236|NCT03359473|561248482|FG001|Overall Study|Adverse Event|2|||
155308138|NCT02742519|560560802|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
155498237|NCT03359473|561248483|FG002|Overall Study|Adverse Event|5|||
155498238|NCT03359473|561248484|FG003|Overall Study|Adverse Event|3|||
155749717|NCT03977454|562184148|FG000|Overall Study|immediate postoperative revision|2|||
155749718|NCT03977454|562184149|FG001|Overall Study|immediate postoperative revision|2|||
155749719|NCT01323920|562184154|FG000|Overall Study|Death|5|||
155749720|NCT01323920|562184154|FG000|Overall Study|Withdrawal by Subject|1|||
155308139|NCT02742519|560560803|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
155308140|NCT03432858|560560805|FG000|Overall Study|Protocol Violation|2|||
155308141|NCT03432858|560560806|FG001|Overall Study|Protocol Violation|1|||
155749721|NCT01609478|562184161|FG000|Overall Study|Adverse Event|3|||
155749722|NCT01609478|562184162|FG001|Overall Study|Adverse Event|1|||
155749723|NCT01609478|562184163|FG002|Overall Study|Adverse Event|5|||
155308142|NCT03432858|560560807|FG002|Overall Study|Protocol Violation|9|||
155308143|NCT03432858|560560805|FG000|Overall Study|Withdrawal by Subject|0|||
155308144|NCT03432858|560560806|FG001|Overall Study|Withdrawal by Subject|1|||
155308145|NCT03432858|560560807|FG002|Overall Study|Withdrawal by Subject|1|||
155308146|NCT03432858|560560805|FG000|Overall Study|Procedure canceled/rescheduled|0|||
155308147|NCT03432858|560560806|FG001|Overall Study|Procedure canceled/rescheduled|9|||
155308148|NCT03432858|560560807|FG002|Overall Study|Procedure canceled/rescheduled|6|||
155308149|NCT03432858|560560805|FG000|Overall Study|Required postop mobilization with splinting|0|||
155308150|NCT03432858|560560806|FG001|Overall Study|Required postop mobilization with splinting|0|||
155308151|NCT03432858|560560807|FG002|Overall Study|Required postop mobilization with splinting|1|||
155308152|NCT03580369|560560810|FG000|Overall Study|No treatment due to mis-randomization|1|||
155308153|NCT03580369|560560811|FG001|Overall Study|No treatment due to mis-randomization|0|||
155308154|NCT03580369|560560812|FG002|Overall Study|No treatment due to mis-randomization|0|||
155308155|NCT03580369|560560813|FG003|Overall Study|No treatment due to mis-randomization|0|||
155308156|NCT03580369|560560814|FG004|Overall Study|No treatment due to mis-randomization|3|||
155308157|NCT03580369|560560815|FG005|Overall Study|No treatment due to mis-randomization|0|||
155749724|NCT01609478|562184161|FG000|Overall Study|Protocol Deviation|0|||
155749725|NCT01609478|562184162|FG001|Overall Study|Protocol Deviation|1|||
155749726|NCT01609478|562184163|FG002|Overall Study|Protocol Deviation|1|||
155749727|NCT01609478|562184161|FG000|Overall Study|Non-Compliance with study treatment|1|||
155308158|NCT03580369|560560816|FG006|Overall Study|No treatment due to mis-randomization|0|||
155308159|NCT03580369|560560817|FG007|Overall Study|No treatment due to mis-randomization|0|||
155308160|NCT03580369|560560810|FG000|Overall Study|Reason unknown|0|||
155308161|NCT03580369|560560811|FG001|Overall Study|Reason unknown|0|||
155308162|NCT03580369|560560812|FG002|Overall Study|Reason unknown|1|||
155308163|NCT03580369|560560813|FG003|Overall Study|Reason unknown|0|||
155308164|NCT03580369|560560814|FG004|Overall Study|Reason unknown|0|||
155308165|NCT03580369|560560815|FG005|Overall Study|Reason unknown|0|||
155498239|NCT03359473|561248481|FG000|Overall Study|Lost to Follow-up|0|||
155498240|NCT03359473|561248482|FG001|Overall Study|Lost to Follow-up|1|||
155498241|NCT03359473|561248483|FG002|Overall Study|Lost to Follow-up|0|||
155498242|NCT03359473|561248484|FG003|Overall Study|Lost to Follow-up|0|||
155498243|NCT03359473|561248481|FG000|Overall Study|Physician Decision|0|||
155498244|NCT03359473|561248482|FG001|Overall Study|Physician Decision|1|||
155498245|NCT03359473|561248483|FG002|Overall Study|Physician Decision|0|||
155498246|NCT03359473|561248484|FG003|Overall Study|Physician Decision|1|||
155498247|NCT03359473|561248481|FG000|Overall Study|Withdrawal by Subject|1|||
155498248|NCT03359473|561248482|FG001|Overall Study|Withdrawal by Subject|2|||
155498249|NCT03359473|561248483|FG002|Overall Study|Withdrawal by Subject|1|||
155498250|NCT03359473|561248484|FG003|Overall Study|Withdrawal by Subject|0|||
155498251|NCT03359473|561248481|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155642629|NCT02743494|561780848|FG000|Treatment Period|Poor/Non-compliance|2|||
155642630|NCT02743494|561780849|FG001|Treatment Period|Poor/Non-compliance|0|||
155642631|NCT02743494|561780848|FG000|Treatment Period|Other reasons|4|||
155642632|NCT02743494|561780849|FG001|Treatment Period|Other reasons|1|||
155642633|NCT02207608|561780850|FG000|Overall Study|Adverse Event|1|||
155642634|NCT02207608|561780851|FG001|Overall Study|Adverse Event|0|||
155642635|NCT05800145|561780852|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
155642636|NCT05800145|561780853|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155642637|NCT05800145|561780854|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155642638|NCT05800145|561780855|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
155642639|NCT05800145|561780856|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155642640|NCT05800145|561780857|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155642641|NCT05800145|561780852|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
155642642|NCT05800145|561780853|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155642643|NCT05800145|561780854|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155642644|NCT05800145|561780855|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
155642645|NCT05800145|561780856|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155642646|NCT05800145|561780857|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155642647|NCT05800145|561780852|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155642648|NCT05800145|561780853|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
155642649|NCT05800145|561780854|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
155642650|NCT05800145|561780855|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
155642651|NCT05800145|561780856|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
155642652|NCT05800145|561780857|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155642653|NCT05643794|561782273|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
155642654|NCT05643794|561782274|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
155642655|NCT05643794|561782275|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155642656|NCT05643794|561782273|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155642657|NCT05643794|561782274|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155642658|NCT05643794|561782275|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155642659|NCT05643794|561782273|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155642660|NCT05643794|561782274|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
155642661|NCT05643794|561782275|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155642662|NCT05643794|561782273|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155642663|NCT05643794|561782274|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155642664|NCT05643794|561782275|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155642665|NCT05643794|561782273|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
155642666|NCT05643794|561782274|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155642667|NCT05643794|561782275|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155642668|NCT05643794|561782273|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
155642669|NCT05643794|561782274|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
155642670|NCT05643794|561782275|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
155642671|NCT04167670|561782278|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
155642672|NCT04167670|561782279|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
155642673|NCT04167670|561782280|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
155642674|NCT04167670|561782278|FG000|Overall Study|Significant protocol deviation|3|||
155642675|NCT04167670|561782279|FG001|Overall Study|Significant protocol deviation|1|||
155642676|NCT04167670|561782280|FG002|Overall Study|Significant protocol deviation|0|||
155642677|NCT04167670|561782278|FG000|Overall Study|Lost to Follow-up|0|||
155642678|NCT04167670|561782279|FG001|Overall Study|Lost to Follow-up|3|||
155642679|NCT04167670|561782280|FG002|Overall Study|Lost to Follow-up|3|||
155642680|NCT04167670|561782278|FG000|Overall Study|Voluntary Withdrawal|0|||
155498252|NCT03359473|561248482|FG001|Overall Study|Protocol-defined stopping criteria|0|||
155642681|NCT04167670|561782279|FG001|Overall Study|Voluntary Withdrawal|1|||
155642682|NCT04167670|561782280|FG002|Overall Study|Voluntary Withdrawal|1|||
155642683|NCT04167670|561782278|FG000|Overall Study|Withdrawal of Consent|4|||
155642684|NCT04167670|561782279|FG001|Overall Study|Withdrawal of Consent|1|||
155642685|NCT04167670|561782280|FG002|Overall Study|Withdrawal of Consent|3|||
155642686|NCT04167670|561782278|FG000|Overall Study|Miscellaneous|7|||
155642687|NCT04167670|561782279|FG001|Overall Study|Miscellaneous|5|||
155642688|NCT04167670|561782280|FG002|Overall Study|Miscellaneous|3|||
155642689|NCT04827446|561782281|FG000|Overall Study|Lost to Follow-up|1|||
155642690|NCT04827446|561782282|FG001|Overall Study|Lost to Follow-up|1|||
155642691|NCT04827446|561782281|FG000|Overall Study|Death|2|||
155642692|NCT04827446|561782282|FG001|Overall Study|Death|0|||
155642693|NCT04827446|561782281|FG000|Overall Study|Withdrawal by Subject|2|||
155642694|NCT04827446|561782282|FG001|Overall Study|Withdrawal by Subject|2|||
155642695|NCT05399485|561782283|FG000|DBT Phase|Other|6|||
155642696|NCT05399485|561782284|FG001|DBT Phase|Other|5|||
155642697|NCT05399485|561782283|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
155642698|NCT05399485|561782284|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
155642699|NCT05399485|561782283|FG000|DBT Phase|Withdrawal by Subject|3|||
155642700|NCT05399485|561782284|FG001|DBT Phase|Withdrawal by Subject|2|||
155642701|NCT05399485|561782283|FG000|DBT Phase|Protocol Violation|2|||
155642702|NCT05399485|561782284|FG001|DBT Phase|Protocol Violation|1|||
155642703|NCT05399485|561782283|FG000|DBT Phase|Physician Decision|0|||
155642704|NCT05399485|561782284|FG001|DBT Phase|Physician Decision|1|||
155642705|NCT05399485|561782283|FG000|DBT Phase|Adverse Event|2|||
155642706|NCT05399485|561782284|FG001|DBT Phase|Adverse Event|1|||
155642707|NCT05399485|561782283|FG000|OLE Phase|Protocol deviation|1|||
155642708|NCT05399485|561782284|FG001|OLE Phase|Protocol deviation|0|||
155642709|NCT05399485|561782283|FG000|OLE Phase|Other|5|||
155642710|NCT05399485|561782284|FG001|OLE Phase|Other|5|||
155642711|NCT05399485|561782283|FG000|OLE Phase|Withdrawal by Subject|12|||
155414991|NCT01764633|560950641|FG000|Overall Study|Withdrawal by Subject|105|||
155414992|NCT01764633|560950642|FG001|Overall Study|Withdrawal by Subject|88|||
155414993|NCT01764633|560950641|FG000|Overall Study|Lost to Follow-up|13|||
155414994|NCT01764633|560950642|FG001|Overall Study|Lost to Follow-up|5|||
155414995|NCT02268058|560950643|FG000|Overall Study|Protocol Violation|1|||
155414996|NCT02268058|560950644|FG001|Overall Study|Protocol Violation|0|||
155414997|NCT02268058|560950645|FG002|Overall Study|Protocol Violation|0|||
155414998|NCT02268058|560950646|FG003|Overall Study|Protocol Violation|0|||
155414999|NCT04781816|560950652|FG000|Overall Study|Adverse Event|0|||
155415000|NCT04781816|560950653|FG001|Overall Study|Adverse Event|1|||
155415001|NCT04781816|560950652|FG000|Overall Study|Withdrawal by Subject|1|||
155415002|NCT04781816|560950653|FG001|Overall Study|Withdrawal by Subject|1|||
155415003|NCT04781816|560950652|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
155498253|NCT03359473|561248483|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155498254|NCT03359473|561248484|FG003|Overall Study|Protocol-defined stopping criteria|1|||
155498255|NCT04101721|561248486|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
155498256|NCT04101721|561248487|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
155498257|NCT04101721|561248486|FG000|Overall Study|Death|0|||
155498258|NCT04101721|561248487|FG001|Overall Study|Death|1|||
155498259|NCT04101721|561248486|FG000|Overall Study|Lost to Follow-up|0|||
155498260|NCT04101721|561248487|FG001|Overall Study|Lost to Follow-up|3|||
155498261|NCT01215955|561248488|FG000|Overall Study|Adverse Event|1|||
155498262|NCT01215955|561248489|FG001|Overall Study|Adverse Event|4|||
155498263|NCT01215955|561248490|FG002|Overall Study|Adverse Event|2|||
155498264|NCT01215955|561248491|FG003|Overall Study|Adverse Event|3|||
155498265|NCT01215955|561248488|FG000|Overall Study|Death|2|||
155498266|NCT01215955|561248489|FG001|Overall Study|Death|0|||
155498267|NCT01215955|561248490|FG002|Overall Study|Death|1|||
155498268|NCT01215955|561248491|FG003|Overall Study|Death|3|||
155498269|NCT01215955|561248488|FG000|Overall Study|Entry Criteria Not Met|1|||
155498270|NCT01215955|561248489|FG001|Overall Study|Entry Criteria Not Met|3|||
155498271|NCT01215955|561248490|FG002|Overall Study|Entry Criteria Not Met|4|||
155498272|NCT01215955|561248491|FG003|Overall Study|Entry Criteria Not Met|7|||
155642712|NCT05399485|561782284|FG001|OLE Phase|Withdrawal by Subject|7|||
155642713|NCT05399485|561782283|FG000|OLE Phase|Pregnancy|0|||
155642714|NCT05399485|561782284|FG001|OLE Phase|Pregnancy|2|||
155642715|NCT05399485|561782283|FG000|OLE Phase|Physician Decision|3|||
155415004|NCT04781816|560950653|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
155415005|NCT00643994|560950654|FG000|Overall Study|Death|24|||
155498273|NCT01215955|561248488|FG000|Overall Study|Lack of Efficacy|1|||
155498274|NCT01215955|561248489|FG001|Overall Study|Lack of Efficacy|2|||
155498275|NCT01215955|561248490|FG002|Overall Study|Lack of Efficacy|1|||
155498276|NCT01215955|561248491|FG003|Overall Study|Lack of Efficacy|0|||
155642716|NCT05399485|561782284|FG001|OLE Phase|Physician Decision|0|||
155642717|NCT05399485|561782283|FG000|OLE Phase|Adverse Event|2|||
155642718|NCT05399485|561782284|FG001|OLE Phase|Adverse Event|2|||
155642719|NCT01363076|561782287|FG000|Overall Study|Withdrawal by Subject|0|||
155642720|NCT01363076|561782288|FG001|Overall Study|Withdrawal by Subject|1|||
155642721|NCT04706403|561782289|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
155642722|NCT04706403|561782290|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
155308166|NCT03580369|560560816|FG006|Overall Study|Reason unknown|0|||
155308167|NCT03580369|560560817|FG007|Overall Study|Reason unknown|0|||
155308168|NCT03580369|560560810|FG000|Overall Study|Technical problems|0|||
155308169|NCT03580369|560560811|FG001|Overall Study|Technical problems|0|||
155308170|NCT03580369|560560812|FG002|Overall Study|Technical problems|0|||
155308171|NCT03580369|560560813|FG003|Overall Study|Technical problems|0|||
155308172|NCT03580369|560560814|FG004|Overall Study|Technical problems|1|||
155308173|NCT03580369|560560815|FG005|Overall Study|Technical problems|0|||
155308174|NCT03580369|560560816|FG006|Overall Study|Technical problems|2|||
155308175|NCT03580369|560560817|FG007|Overall Study|Technical problems|0|||
155308176|NCT03580369|560560810|FG000|Overall Study|Pregnancy|2|||
155308177|NCT03580369|560560811|FG001|Overall Study|Pregnancy|0|||
155308178|NCT03580369|560560812|FG002|Overall Study|Pregnancy|3|||
155308179|NCT03580369|560560813|FG003|Overall Study|Pregnancy|0|||
155308180|NCT03580369|560560814|FG004|Overall Study|Pregnancy|2|||
155308181|NCT03580369|560560815|FG005|Overall Study|Pregnancy|0|||
155308182|NCT03580369|560560816|FG006|Overall Study|Pregnancy|0|||
155308183|NCT03580369|560560817|FG007|Overall Study|Pregnancy|0|||
155308184|NCT03580369|560560810|FG000|Overall Study|Lost to Follow-up|2|||
155308185|NCT03580369|560560811|FG001|Overall Study|Lost to Follow-up|0|||
155308186|NCT03580369|560560812|FG002|Overall Study|Lost to Follow-up|2|||
155308187|NCT03580369|560560813|FG003|Overall Study|Lost to Follow-up|0|||
155308188|NCT03580369|560560814|FG004|Overall Study|Lost to Follow-up|3|||
155308189|NCT03580369|560560815|FG005|Overall Study|Lost to Follow-up|0|||
155308190|NCT03580369|560560816|FG006|Overall Study|Lost to Follow-up|1|||
155308191|NCT03580369|560560817|FG007|Overall Study|Lost to Follow-up|0|||
155308192|NCT03580369|560560810|FG000|Overall Study|Physician Decision|4|||
155308193|NCT03580369|560560811|FG001|Overall Study|Physician Decision|0|||
155308194|NCT03580369|560560812|FG002|Overall Study|Physician Decision|4|||
155308195|NCT03580369|560560813|FG003|Overall Study|Physician Decision|1|||
155308196|NCT03580369|560560814|FG004|Overall Study|Physician Decision|1|||
155308197|NCT03580369|560560815|FG005|Overall Study|Physician Decision|0|||
155308198|NCT03580369|560560816|FG006|Overall Study|Physician Decision|0|||
155308199|NCT03580369|560560817|FG007|Overall Study|Physician Decision|0|||
155308200|NCT03580369|560560810|FG000|Overall Study|Lack of Efficacy|3|||
155308201|NCT03580369|560560811|FG001|Overall Study|Lack of Efficacy|0|||
155308202|NCT03580369|560560812|FG002|Overall Study|Lack of Efficacy|7|||
155308203|NCT03580369|560560813|FG003|Overall Study|Lack of Efficacy|0|||
155308204|NCT03580369|560560814|FG004|Overall Study|Lack of Efficacy|2|||
155308205|NCT03580369|560560815|FG005|Overall Study|Lack of Efficacy|0|||
155308206|NCT03580369|560560816|FG006|Overall Study|Lack of Efficacy|3|||
155308207|NCT03580369|560560817|FG007|Overall Study|Lack of Efficacy|0|||
155308208|NCT03580369|560560810|FG000|Overall Study|Protocol Violation|6|||
155308209|NCT03580369|560560811|FG001|Overall Study|Protocol Violation|0|||
155308210|NCT03580369|560560812|FG002|Overall Study|Protocol Violation|6|||
155308211|NCT03580369|560560813|FG003|Overall Study|Protocol Violation|1|||
155308212|NCT03580369|560560814|FG004|Overall Study|Protocol Violation|8|||
155308213|NCT03580369|560560815|FG005|Overall Study|Protocol Violation|2|||
155308214|NCT03580369|560560816|FG006|Overall Study|Protocol Violation|1|||
155308215|NCT03580369|560560817|FG007|Overall Study|Protocol Violation|0|||
155308216|NCT03580369|560560810|FG000|Overall Study|Adverse Event|7|||
155308217|NCT03580369|560560811|FG001|Overall Study|Adverse Event|0|||
155308218|NCT03580369|560560812|FG002|Overall Study|Adverse Event|14|||
155308219|NCT03580369|560560813|FG003|Overall Study|Adverse Event|1|||
155308220|NCT03580369|560560814|FG004|Overall Study|Adverse Event|6|||
155308221|NCT03580369|560560815|FG005|Overall Study|Adverse Event|0|||
155308222|NCT03580369|560560816|FG006|Overall Study|Adverse Event|1|||
155308223|NCT03580369|560560817|FG007|Overall Study|Adverse Event|0|||
155308224|NCT03580369|560560810|FG000|Overall Study|Withdrawal by Subject|19|||
155308225|NCT03580369|560560811|FG001|Overall Study|Withdrawal by Subject|0|||
155308226|NCT03580369|560560812|FG002|Overall Study|Withdrawal by Subject|17|||
155308227|NCT03580369|560560813|FG003|Overall Study|Withdrawal by Subject|0|||
155308228|NCT03580369|560560814|FG004|Overall Study|Withdrawal by Subject|16|||
155308229|NCT03580369|560560815|FG005|Overall Study|Withdrawal by Subject|1|||
155308230|NCT03580369|560560816|FG006|Overall Study|Withdrawal by Subject|7|||
155308231|NCT03580369|560560817|FG007|Overall Study|Withdrawal by Subject|0|||
155308232|NCT03912831|560560818|FG000|Overall Study|Death|1|||
155308233|NCT03912831|560560819|FG001|Overall Study|Death|1|||
155308234|NCT03912831|560560820|FG002|Overall Study|Death|1|||
155308235|NCT03912831|560560821|FG003|Overall Study|Death|1|||
155308236|NCT03912831|560560822|FG004|Overall Study|Death|1|||
155308237|NCT03912831|560560823|FG005|Overall Study|Death|1|||
155308238|NCT03912831|560560818|FG000|Overall Study|Reason not Specified|0|||
155308239|NCT03912831|560560819|FG001|Overall Study|Reason not Specified|0|||
155308240|NCT03912831|560560820|FG002|Overall Study|Reason not Specified|0|||
155308241|NCT03912831|560560821|FG003|Overall Study|Reason not Specified|0|||
155308242|NCT03912831|560560822|FG004|Overall Study|Reason not Specified|1|||
155308243|NCT03912831|560560823|FG005|Overall Study|Reason not Specified|0|||
155308244|NCT03912831|560560818|FG000|Overall Study|Withdrawal by Participant|0|||
155308245|NCT03912831|560560819|FG001|Overall Study|Withdrawal by Participant|0|||
155308246|NCT03912831|560560820|FG002|Overall Study|Withdrawal by Participant|0|||
155308247|NCT03912831|560560821|FG003|Overall Study|Withdrawal by Participant|0|||
155308248|NCT03912831|560560822|FG004|Overall Study|Withdrawal by Participant|1|||
155308249|NCT03912831|560560823|FG005|Overall Study|Withdrawal by Participant|0|||
155308250|NCT03527160|560560824|FG000|Overall Study|No urine collected|13|||
155308251|NCT03527160|560560824|FG000|Overall Study|No clinical serum creatinine collected|6|||
155308252|NCT03527160|560560824|FG000|Overall Study|Did not meet inclusion|2|||
155308253|NCT01721291|560560826|FG000|Overall Study|Withdrawal by Subject|1|||
155308254|NCT01721291|560560827|FG001|Overall Study|Withdrawal by Subject|0|||
155308255|NCT01721291|560560826|FG000|Overall Study|did not like the treatment|1|||
155415006|NCT00643994|560950654|FG000|Overall Study|Lost to Follow-up|72|||
155415007|NCT02706730|560950658|FG000|Overall Study|Adverse Event|3|||
155415008|NCT02706730|560950658|FG000|Overall Study|Lack of Efficacy|5|||
155415009|NCT02706730|560950658|FG000|Overall Study|Withdrawal by Subject|11|||
155415010|NCT02706730|560950658|FG000|Overall Study|Study Terminated by Sponsor|11|||
155415011|NCT02706730|560950658|FG000|Overall Study|Subject chose not to receive injection|3|||
155415012|NCT02347176|560950663|FG000|Overall Study|Lost to Follow-up|2|||
155415013|NCT02347176|560950664|FG001|Overall Study|Lost to Follow-up|3|||
155415014|NCT02347176|560950665|FG002|Overall Study|Lost to Follow-up|1|||
155415015|NCT02347176|560950666|FG003|Overall Study|Lost to Follow-up|1|||
155415016|NCT02347176|560950663|FG000|Overall Study|Withdrawal by Subject|9|||
155415017|NCT02347176|560950664|FG001|Overall Study|Withdrawal by Subject|5|||
155415018|NCT02347176|560950665|FG002|Overall Study|Withdrawal by Subject|5|||
155415019|NCT02347176|560950666|FG003|Overall Study|Withdrawal by Subject|3|||
155415020|NCT02347176|560950663|FG000|Overall Study|Other|1|||
155415021|NCT02347176|560950664|FG001|Overall Study|Other|2|||
155415022|NCT02347176|560950665|FG002|Overall Study|Other|2|||
155415023|NCT02347176|560950666|FG003|Overall Study|Other|0|||
155415024|NCT00411554|560950669|FG000|Overall Study|Adverse Event|2|||
155415025|NCT00411554|560950670|FG001|Overall Study|Adverse Event|4|||
155415026|NCT00411554|560950669|FG000|Overall Study|Lack of Efficacy|2|||
155415027|NCT00411554|560950670|FG001|Overall Study|Lack of Efficacy|5|||
155415028|NCT00411554|560950669|FG000|Overall Study|Withdrawal by Subject|3|||
155415029|NCT00411554|560950670|FG001|Overall Study|Withdrawal by Subject|0|||
155415030|NCT00411554|560950669|FG000|Overall Study|Patient Moved|1|||
155415031|NCT00411554|560950670|FG001|Overall Study|Patient Moved|0|||
155415032|NCT01081795|560950675|FG000|Overall Study|Adverse Event|18|||
155415033|NCT01081795|560950676|FG001|Overall Study|Adverse Event|23|||
155415034|NCT01081795|560950677|FG002|Overall Study|Adverse Event|6|||
155415035|NCT01081795|560950675|FG000|Overall Study|Lack of Efficacy|7|||
155415036|NCT01081795|560950676|FG001|Overall Study|Lack of Efficacy|5|||
155415037|NCT01081795|560950677|FG002|Overall Study|Lack of Efficacy|19|||
155415038|NCT01081795|560950675|FG000|Overall Study|Subject's schedule|1|||
155415039|NCT01081795|560950676|FG001|Overall Study|Subject's schedule|1|||
155415040|NCT01081795|560950677|FG002|Overall Study|Subject's schedule|2|||
155415041|NCT01081795|560950675|FG000|Overall Study|Revocation of informed consent|2|||
155415042|NCT01081795|560950676|FG001|Overall Study|Revocation of informed consent|0|||
155415043|NCT01081795|560950677|FG002|Overall Study|Revocation of informed consent|0|||
155415044|NCT01081795|560950675|FG000|Overall Study|Ineligible for participation|1|||
155415045|NCT01081795|560950676|FG001|Overall Study|Ineligible for participation|0|||
155415046|NCT01081795|560950677|FG002|Overall Study|Ineligible for participation|0|||
155498277|NCT01215955|561248488|FG000|Overall Study|Lost to Follow-up|4|||
155308256|NCT01721291|560560827|FG001|Overall Study|did not like the treatment|0|||
155498278|NCT01215955|561248489|FG001|Overall Study|Lost to Follow-up|4|||
155498279|NCT01215955|561248490|FG002|Overall Study|Lost to Follow-up|8|||
155498280|NCT01215955|561248491|FG003|Overall Study|Lost to Follow-up|9|||
155498281|NCT01215955|561248488|FG000|Overall Study|Physician Decision|4|||
155308257|NCT01091168|560560828|FG000|Overall Study|Progressive disease|250|||
155308258|NCT01091168|560560829|FG001|Overall Study|Progressive disease|234|||
155308259|NCT01091168|560560828|FG000|Overall Study|Adverse Event|21|||
155308260|NCT01091168|560560829|FG001|Overall Study|Adverse Event|24|||
155308261|NCT01091168|560560828|FG000|Overall Study|Lost to Follow-up|0|||
155308262|NCT01091168|560560829|FG001|Overall Study|Lost to Follow-up|1|||
155308263|NCT01091168|560560828|FG000|Overall Study|Physician, patient's decision, other|27|||
155415047|NCT01081795|560950675|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
155415048|NCT01081795|560950676|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
155415049|NCT01081795|560950677|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
155415050|NCT01081795|560950675|FG000|Overall Study|Using drug with restricted days of use|2|||
155415051|NCT01081795|560950676|FG001|Overall Study|Using drug with restricted days of use|3|||
155498282|NCT01215955|561248489|FG001|Overall Study|Physician Decision|10|||
155308264|NCT01091168|560560829|FG001|Overall Study|Physician, patient's decision, other|37|||
155308265|NCT04623775|560560839|FG000|Randomization|No Longer Meets Study Criteria|2|||
155308266|NCT04623775|560560840|FG001|Randomization|No Longer Meets Study Criteria|1|||
155308267|NCT04623775|560560841|FG002|Randomization|No Longer Meets Study Criteria|0|||
155308268|NCT04623775|560560842|FG003|Randomization|No Longer Meets Study Criteria|0|||
155308269|NCT04623775|560560839|FG000|Randomization|Withdrew Consent|0|||
155308270|NCT04623775|560560840|FG001|Randomization|Withdrew Consent|0|||
155308271|NCT04623775|560560841|FG002|Randomization|Withdrew Consent|0|||
155308272|NCT04623775|560560842|FG003|Randomization|Withdrew Consent|1|||
155308273|NCT04623775|560560839|FG000|Randomization|Other Reasons|0|||
155308274|NCT04623775|560560840|FG001|Randomization|Other Reasons|0|||
155308275|NCT04623775|560560841|FG002|Randomization|Other Reasons|0|||
155308276|NCT04623775|560560842|FG003|Randomization|Other Reasons|1|||
155308277|NCT04623775|560560839|FG000|Treatment Period|participant withdrew consent|4|||
155308278|NCT04623775|560560840|FG001|Treatment Period|participant withdrew consent|0|||
155308279|NCT04623775|560560841|FG002|Treatment Period|participant withdrew consent|1|||
155308280|NCT04623775|560560842|FG003|Treatment Period|participant withdrew consent|2|||
155308281|NCT04623775|560560839|FG000|Treatment Period|Death|3|||
155308282|NCT04623775|560560840|FG001|Treatment Period|Death|1|||
155308283|NCT04623775|560560841|FG002|Treatment Period|Death|4|||
155308284|NCT04623775|560560842|FG003|Treatment Period|Death|2|||
155308285|NCT04623775|560560839|FG000|Treatment Period|Lost to Follow-up|0|||
155308286|NCT04623775|560560840|FG001|Treatment Period|Lost to Follow-up|2|||
155308287|NCT04623775|560560841|FG002|Treatment Period|Lost to Follow-up|0|||
155308288|NCT04623775|560560842|FG003|Treatment Period|Lost to Follow-up|0|||
155308289|NCT04623775|560560839|FG000|Treatment Period|poor/non compliance|0|||
155308290|NCT04623775|560560840|FG001|Treatment Period|poor/non compliance|0|||
155308291|NCT04623775|560560841|FG002|Treatment Period|poor/non compliance|1|||
155308292|NCT04623775|560560842|FG003|Treatment Period|poor/non compliance|0|||
155308293|NCT04623775|560560839|FG000|Treatment Period|participant no longer meets study criteria|0|||
155642723|NCT04706403|561782291|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
155308294|NCT04623775|560560840|FG001|Treatment Period|participant no longer meets study criteria|1|||
155308295|NCT04623775|560560841|FG002|Treatment Period|participant no longer meets study criteria|0|||
155308296|NCT04623775|560560842|FG003|Treatment Period|participant no longer meets study criteria|0|||
155308297|NCT04623775|560560839|FG000|Treatment Period|administrative reasons by sponsor|3|||
155308298|NCT04623775|560560840|FG001|Treatment Period|administrative reasons by sponsor|2|||
155308299|NCT04623775|560560841|FG002|Treatment Period|administrative reasons by sponsor|0|||
155308300|NCT04623775|560560842|FG003|Treatment Period|administrative reasons by sponsor|0|||
155308301|NCT04623775|560560839|FG000|Treatment Period|other reasons|2|||
155308302|NCT04623775|560560840|FG001|Treatment Period|other reasons|0|||
155308303|NCT04623775|560560841|FG002|Treatment Period|other reasons|1|||
155308304|NCT04623775|560560842|FG003|Treatment Period|other reasons|1|||
155308305|NCT04623775|560560839|FG000|Treatment Period|disease progression|40|||
155308306|NCT04623775|560560840|FG001|Treatment Period|disease progression|35|||
155308307|NCT04623775|560560841|FG002|Treatment Period|disease progression|63|||
155308308|NCT04623775|560560842|FG003|Treatment Period|disease progression|63|||
155308309|NCT04623775|560560839|FG000|Treatment Period|study drug toxicity|12|||
155308310|NCT04623775|560560840|FG001|Treatment Period|study drug toxicity|15|||
155308311|NCT04623775|560560841|FG002|Treatment Period|study drug toxicity|13|||
155308312|NCT04623775|560560842|FG003|Treatment Period|study drug toxicity|12|||
155308313|NCT04623775|560560839|FG000|Treatment Period|AE unrelated to study drug|4|||
155308314|NCT04623775|560560840|FG001|Treatment Period|AE unrelated to study drug|9|||
155308315|NCT04623775|560560841|FG002|Treatment Period|AE unrelated to study drug|12|||
155308316|NCT04623775|560560842|FG003|Treatment Period|AE unrelated to study drug|9|||
155308317|NCT04623775|560560839|FG000|Treatment Period|participant request to discontinue treatment|0|||
155308318|NCT04623775|560560840|FG001|Treatment Period|participant request to discontinue treatment|2|||
155308319|NCT04623775|560560841|FG002|Treatment Period|participant request to discontinue treatment|2|||
155308320|NCT04623775|560560842|FG003|Treatment Period|participant request to discontinue treatment|0|||
155308321|NCT03978637|560560845|FG000|Overall Study|Death|0|||
155308322|NCT03978637|560560846|FG001|Overall Study|Death|2|||
155308323|NCT03978637|560560847|FG002|Overall Study|Death|2|||
155308324|NCT03978637|560560848|FG003|Overall Study|Death|0|||
155308325|NCT03978637|560560845|FG000|Overall Study|Withdrawal by Subject|0|||
155415052|NCT01081795|560950677|FG002|Overall Study|Using drug with restricted days of use|2|||
155415053|NCT01081795|560950675|FG000|Overall Study|Other|1|||
155642724|NCT04706403|561782292|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
155308326|NCT03978637|560560846|FG001|Overall Study|Withdrawal by Subject|0|||
155308327|NCT03978637|560560847|FG002|Overall Study|Withdrawal by Subject|1|||
155308328|NCT03978637|560560848|FG003|Overall Study|Withdrawal by Subject|0|||
155308329|NCT03978637|560560845|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
155415054|NCT01081795|560950676|FG001|Overall Study|Other|2|||
155415055|NCT01081795|560950677|FG002|Overall Study|Other|0|||
155498283|NCT01215955|561248490|FG002|Overall Study|Physician Decision|8|||
155498284|NCT01215955|561248491|FG003|Overall Study|Physician Decision|11|||
155498285|NCT01215955|561248488|FG000|Overall Study|Protocol Violation|17|||
155498286|NCT01215955|561248489|FG001|Overall Study|Protocol Violation|13|||
155498287|NCT01215955|561248490|FG002|Overall Study|Protocol Violation|8|||
155498288|NCT01215955|561248491|FG003|Overall Study|Protocol Violation|8|||
155498289|NCT01215955|561248488|FG000|Overall Study|Sponsor Decision|1|||
155498290|NCT01215955|561248489|FG001|Overall Study|Sponsor Decision|2|||
155498291|NCT01215955|561248490|FG002|Overall Study|Sponsor Decision|0|||
155498292|NCT01215955|561248491|FG003|Overall Study|Sponsor Decision|1|||
155498293|NCT01215955|561248488|FG000|Overall Study|Withdrawal by Subject|14|||
155498294|NCT01215955|561248489|FG001|Overall Study|Withdrawal by Subject|15|||
155498295|NCT01215955|561248490|FG002|Overall Study|Withdrawal by Subject|13|||
155749728|NCT01609478|562184162|FG001|Overall Study|Non-Compliance with study treatment|0|||
155749729|NCT01609478|562184163|FG002|Overall Study|Non-Compliance with study treatment|0|||
155498296|NCT01215955|561248491|FG003|Overall Study|Withdrawal by Subject|9|||
155498297|NCT01215955|561248488|FG000|Overall Study|Quality Issues|0|||
155498298|NCT01215955|561248489|FG001|Overall Study|Quality Issues|0|||
155415056|NCT02462473|560950678|FG000|Overall Study|Death|1|||
155415057|NCT02462473|560950678|FG000|Overall Study|Other|3|||
155415058|NCT01536860|560950679|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
155415059|NCT01536860|560950680|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
155498299|NCT01215955|561248490|FG002|Overall Study|Quality Issues|3|||
155498300|NCT01215955|561248491|FG003|Overall Study|Quality Issues|2|||
155498301|NCT00445458|561248492|FG000|Overall Study|Disease Progression|3|||
155498302|NCT00445458|561248493|FG001|Overall Study|Disease Progression|4|||
155498303|NCT00445458|561248494|FG002|Overall Study|Disease Progression|54|||
155498304|NCT00445458|561248495|FG003|Overall Study|Disease Progression|27|||
155498305|NCT00445458|561248492|FG000|Overall Study|Withdrawal by Subject|0|||
155498306|NCT00445458|561248493|FG001|Overall Study|Withdrawal by Subject|0|||
155415060|NCT01536860|560950681|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
155415061|NCT01543087|560950686|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
155415062|NCT01543087|560950687|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
155415063|NCT01543087|560950688|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
155415064|NCT01543087|560950689|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
155415065|NCT01543087|560950690|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
155415066|NCT01543087|560950691|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
155415067|NCT01543087|560950686|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
155415068|NCT01543087|560950687|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
155415069|NCT01543087|560950688|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
155415070|NCT01543087|560950689|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
155415071|NCT01543087|560950690|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
155415072|NCT01543087|560950691|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
155415073|NCT01543087|560950686|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
155415074|NCT01543087|560950687|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
155415075|NCT01543087|560950688|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
155415076|NCT01543087|560950689|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
155415077|NCT01543087|560950690|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
155415078|NCT01543087|560950691|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
155415079|NCT01543087|560950686|FG000|Stage 1 (48 Months)|Other than specified|5|||
155415080|NCT01543087|560950687|FG001|Stage 1 (48 Months)|Other than specified|0|||
155415081|NCT01543087|560950688|FG002|Stage 1 (48 Months)|Other than specified|9|||
155415082|NCT01543087|560950689|FG003|Stage 1 (48 Months)|Other than specified|0|||
155415083|NCT01543087|560950690|FG004|Stage 1 (48 Months)|Other than specified|0|||
155415084|NCT01543087|560950691|FG005|Stage 1 (48 Months)|Other than specified|0|||
155415085|NCT01543087|560950686|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
155498307|NCT00445458|561248494|FG002|Overall Study|Withdrawal by Subject|7|||
155498308|NCT00445458|561248495|FG003|Overall Study|Withdrawal by Subject|0|||
155498309|NCT00445458|561248492|FG000|Overall Study|Adverse Event|0|||
155498310|NCT00445458|561248493|FG001|Overall Study|Adverse Event|0|||
155498311|NCT00445458|561248494|FG002|Overall Study|Adverse Event|3|||
155498312|NCT00445458|561248495|FG003|Overall Study|Adverse Event|0|||
155498313|NCT00445458|561248492|FG000|Overall Study|Death|0|||
155498314|NCT00445458|561248493|FG001|Overall Study|Death|1|||
155415086|NCT01543087|560950687|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
155415087|NCT01543087|560950688|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
155415088|NCT01543087|560950689|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
155498315|NCT00445458|561248494|FG002|Overall Study|Death|2|||
155749730|NCT01609478|562184161|FG000|Overall Study|Physician Decision|1|||
155415089|NCT01543087|560950690|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
155498316|NCT00445458|561248495|FG003|Overall Study|Death|0|||
155498317|NCT00445458|561248492|FG000|Overall Study|Physician Decision|0|||
155498318|NCT00445458|561248493|FG001|Overall Study|Physician Decision|0|||
155498319|NCT00445458|561248494|FG002|Overall Study|Physician Decision|1|||
155498320|NCT00445458|561248495|FG003|Overall Study|Physician Decision|1|||
155498321|NCT00445458|561248492|FG000|Overall Study|Surgery|0|||
155308330|NCT03978637|560560846|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
155308331|NCT03978637|560560847|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
155308332|NCT03978637|560560848|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
155308333|NCT01959698|560560849|FG000|Overall Study|Adverse Event|0|||
155308334|NCT01959698|560560850|FG001|Overall Study|Adverse Event|0|||
155308335|NCT01959698|560560851|FG002|Overall Study|Adverse Event|0|||
155308336|NCT01959698|560560852|FG003|Overall Study|Adverse Event|0|||
155308337|NCT01959698|560560853|FG004|Overall Study|Adverse Event|0|||
155308338|NCT01959698|560560854|FG005|Overall Study|Adverse Event|0|||
155308339|NCT01959698|560560855|FG006|Overall Study|Adverse Event|1|||
155308340|NCT01959698|560560849|FG000|Overall Study|Physician Decision|1|||
155308341|NCT01959698|560560850|FG001|Overall Study|Physician Decision|0|||
155308342|NCT01959698|560560851|FG002|Overall Study|Physician Decision|1|||
155308343|NCT01959698|560560852|FG003|Overall Study|Physician Decision|2|||
155308344|NCT01959698|560560853|FG004|Overall Study|Physician Decision|0|||
155498322|NCT00445458|561248493|FG001|Overall Study|Surgery|0|||
155308345|NCT01959698|560560854|FG005|Overall Study|Physician Decision|3|||
155308346|NCT01959698|560560855|FG006|Overall Study|Physician Decision|3|||
155308347|NCT05415436|560562120|FG000|Overall Study|Surgeon cancelled procedure|1|||
155308348|NCT05415436|560562121|FG001|Overall Study|Surgeon cancelled procedure|0|||
155308349|NCT05415436|560562120|FG000|Overall Study|Death|1|||
155308350|NCT05415436|560562121|FG001|Overall Study|Death|0|||
155308351|NCT05386355|560562132|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308352|NCT05386355|560562133|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308353|NCT05386355|560562134|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308354|NCT05386355|560562135|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308355|NCT03775109|560562138|FG000|Overall Study|Adverse Event|1|||
155308356|NCT03775109|560562139|FG001|Overall Study|Adverse Event|0|||
155308357|NCT03775109|560562138|FG000|Overall Study|COVID-19 outbreak|2|||
155308358|NCT03775109|560562139|FG001|Overall Study|COVID-19 outbreak|0|||
155308359|NCT03775109|560562138|FG000|Overall Study|Lost to Follow-up|0|||
155308360|NCT03775109|560562139|FG001|Overall Study|Lost to Follow-up|2|||
155308361|NCT03775109|560562138|FG000|Overall Study|Withdrawal by Subject|1|||
155308362|NCT03775109|560562139|FG001|Overall Study|Withdrawal by Subject|1|||
155308363|NCT03775109|560562138|FG000|Overall Study|Death|0|||
155308364|NCT03775109|560562139|FG001|Overall Study|Death|1|||
155308365|NCT03775109|560562138|FG000|Overall Study|Lack of Efficacy|1|||
155308366|NCT03775109|560562139|FG001|Overall Study|Lack of Efficacy|0|||
155308367|NCT03484702|560562142|FG000|Treatment Period|Death|3|||
155308368|NCT03484702|560562143|FG001|Treatment Period|Death|1|||
155308369|NCT03484702|560562144|FG002|Treatment Period|Death|0|||
155308370|NCT03484702|560562145|FG003|Treatment Period|Death|0|||
155308371|NCT03484702|560562146|FG004|Treatment Period|Death|0|||
155308372|NCT03484702|560562147|FG005|Treatment Period|Death|0|||
155308373|NCT03484702|560562142|FG000|Treatment Period|Adverse Event|1|||
155308374|NCT03484702|560562143|FG001|Treatment Period|Adverse Event|0|||
155308375|NCT03484702|560562144|FG002|Treatment Period|Adverse Event|0|||
155308376|NCT03484702|560562145|FG003|Treatment Period|Adverse Event|0|||
155308377|NCT03484702|560562146|FG004|Treatment Period|Adverse Event|0|||
155308378|NCT03484702|560562147|FG005|Treatment Period|Adverse Event|0|||
155308379|NCT03484702|560562142|FG000|Treatment Period|Participant Withdrew from Study|0|||
155308380|NCT03484702|560562143|FG001|Treatment Period|Participant Withdrew from Study|1|||
155308381|NCT03484702|560562144|FG002|Treatment Period|Participant Withdrew from Study|0|||
155308382|NCT03484702|560562145|FG003|Treatment Period|Participant Withdrew from Study|0|||
155308383|NCT03484702|560562146|FG004|Treatment Period|Participant Withdrew from Study|0|||
155308384|NCT03484702|560562147|FG005|Treatment Period|Participant Withdrew from Study|0|||
155308385|NCT03484702|560562142|FG000|Treatment Period|Physician Decision|0|||
155308386|NCT03484702|560562143|FG001|Treatment Period|Physician Decision|1|||
155308387|NCT03484702|560562144|FG002|Treatment Period|Physician Decision|0|||
155308388|NCT03484702|560562145|FG003|Treatment Period|Physician Decision|0|||
155308389|NCT03484702|560562146|FG004|Treatment Period|Physician Decision|0|||
155308390|NCT03484702|560562147|FG005|Treatment Period|Physician Decision|1|||
155308391|NCT01894061|560562152|FG000|Overall Study|Screen failure|1|||
155308392|NCT01894061|560562152|FG000|Overall Study|Withdrawal by Subject|1|||
155308393|NCT00739648|560562153|FG000|Overall Study|Adverse Event|3|||
155308394|NCT00739648|560562154|FG001|Overall Study|Adverse Event|15|||
155308395|NCT00739648|560562153|FG000|Overall Study|Withdrawal by Subject|13|||
155308396|NCT00739648|560562154|FG001|Overall Study|Withdrawal by Subject|25|||
155308397|NCT00739648|560562153|FG000|Overall Study|Lost to Follow-up|4|||
155308398|NCT00739648|560562154|FG001|Overall Study|Lost to Follow-up|7|||
155308399|NCT00739648|560562153|FG000|Overall Study|Death|2|||
155308400|NCT00739648|560562154|FG001|Overall Study|Death|0|||
155308401|NCT00739648|560562153|FG000|Overall Study|Do not know|4|||
155308402|NCT00739648|560562154|FG001|Overall Study|Do not know|6|||
155642725|NCT04706403|561782293|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
155642726|NCT02642679|561782294|FG000|Overall Study|Withdrawal by Subject|1|||
155642727|NCT02642679|561782294|FG000|Overall Study|Physician Decision|1|||
155642728|NCT02642679|561782294|FG000|Overall Study|Physician Decision|1|||
155642729|NCT03735498|561782295|FG000|Overall Study|Withdrawal by Subject|3|||
155642730|NCT03735498|561782295|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
155642731|NCT01653262|561782296|FG000|Overall Study|Lack of Efficacy|1|||
155642732|NCT01653262|561782296|FG000|Overall Study|SAE, non-fatal|1|||
155642733|NCT01653262|561782296|FG000|Overall Study|AE, non-serious non-fatal|1|||
155642734|NCT01112267|561782298|FG000|Overall Study|Adverse Event|24|||
155642735|NCT01112267|561782299|FG001|Overall Study|Adverse Event|6|||
155642736|NCT01112267|561782298|FG000|Overall Study|Withdrawal by Subject|3|||
155642737|NCT01112267|561782299|FG001|Overall Study|Withdrawal by Subject|5|||
155642738|NCT01112267|561782298|FG000|Overall Study|Protocol Violation|5|||
155642739|NCT01112267|561782299|FG001|Overall Study|Protocol Violation|3|||
155642740|NCT01112267|561782298|FG000|Overall Study|Participants not compliant|1|||
155642741|NCT01112267|561782299|FG001|Overall Study|Participants not compliant|2|||
155642742|NCT01112267|561782298|FG000|Overall Study|Participants not receive any study drug|1|||
155642743|NCT01112267|561782299|FG001|Overall Study|Participants not receive any study drug|2|||
155642744|NCT00160615|561782300|FG000|Overall Study|Adverse Event|5|||
155642745|NCT00160615|561782301|FG001|Overall Study|Adverse Event|12|||
155642746|NCT00160615|561782300|FG000|Overall Study|Withdrawal by Subject|0|||
155642747|NCT00160615|561782301|FG001|Overall Study|Withdrawal by Subject|2|||
155642748|NCT00160615|561782300|FG000|Overall Study|Lack of Efficacy|11|||
155642749|NCT00160615|561782301|FG001|Overall Study|Lack of Efficacy|23|||
155642750|NCT00160615|561782300|FG000|Overall Study|Patient decision|1|||
155642751|NCT00160615|561782301|FG001|Overall Study|Patient decision|2|||
155642752|NCT00160615|561782300|FG000|Overall Study|Investigator decision|1|||
155642753|NCT00160615|561782301|FG001|Overall Study|Investigator decision|1|||
155642754|NCT00160615|561782300|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
155642755|NCT00160615|561782301|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
155642756|NCT00160615|561782300|FG000|Overall Study|Switch to surgical treatment|0|||
155642757|NCT00160615|561782301|FG001|Overall Study|Switch to surgical treatment|2|||
155642758|NCT00160615|561782300|FG000|Overall Study|Non-compliance was suspected|0|||
155642759|NCT00160615|561782301|FG001|Overall Study|Non-compliance was suspected|1|||
155642760|NCT00160615|561782300|FG000|Overall Study|Poor compliance|0|||
155642761|NCT00160615|561782301|FG001|Overall Study|Poor compliance|1|||
155642762|NCT02014103|561782302|FG000|Overall Study|Protocol Violation|7|||
155642763|NCT02014103|561782303|FG001|Overall Study|Protocol Violation|7|||
155642764|NCT02014103|561782302|FG000|Overall Study|Adverse Event|1|||
155642765|NCT02014103|561782303|FG001|Overall Study|Adverse Event|0|||
155642766|NCT02014103|561782302|FG000|Overall Study|Lost venous access|1|||
155642767|NCT02014103|561782303|FG001|Overall Study|Lost venous access|0|||
155642768|NCT02014103|561782302|FG000|Overall Study|Withdrawal by Subject|0|||
155642769|NCT02014103|561782303|FG001|Overall Study|Withdrawal by Subject|2|||
155642770|NCT05638737|561782304|FG000|Overall Study|Withdrawal by Subject|4|||
155642771|NCT05638737|561782305|FG001|Overall Study|Withdrawal by Subject|7|||
155642772|NCT02068794|561782306|FG000|Overall Study|Withdrawal by Subject|0|||
155642773|NCT02068794|561782307|FG001|Overall Study|Withdrawal by Subject|1|||
155642774|NCT02068794|561782308|FG002|Overall Study|Withdrawal by Subject|2|||
155642775|NCT02068794|561782306|FG000|Overall Study|Early Progression|1|||
155642776|NCT02068794|561782307|FG001|Overall Study|Early Progression|0|||
155642777|NCT02068794|561782308|FG002|Overall Study|Early Progression|1|||
155642778|NCT02068794|561782306|FG000|Overall Study|Ineligible|0|||
155642779|NCT02068794|561782307|FG001|Overall Study|Ineligible|0|||
155642780|NCT02068794|561782308|FG002|Overall Study|Ineligible|1|||
155642781|NCT04439175|561782311|FG000|Overall Study|Never started treatment|4|||
155642782|NCT04439175|561782311|FG000|Overall Study|Ineligible|5|||
155642783|NCT04439175|561782311|FG000|Overall Study|Adverse Event|6|||
155642784|NCT04439175|561782311|FG000|Overall Study|Death|4|||
155642785|NCT04439175|561782311|FG000|Overall Study|Disease progression|44|||
155642786|NCT04439175|561782311|FG000|Overall Study|Withdrawal by Subject|4|||
155642787|NCT04439175|561782311|FG000|Overall Study|Alternative Therapy|1|||
155642788|NCT04439175|561782311|FG000|Overall Study|Other|2|||
155642789|NCT01022580|561782312|FG000|Overall Study|Death|18|||
155642790|NCT01022580|561782313|FG001|Overall Study|Death|22|||
155642791|NCT00835978|561782314|FG000|Overall Study|Death|33|||
155642792|NCT00835978|561782315|FG001|Overall Study|Death|40|||
155642793|NCT00835978|561782316|FG002|Overall Study|Death|49|||
155642794|NCT00835978|561782317|FG003|Overall Study|Death|4|||
155642795|NCT00835978|561782314|FG000|Overall Study|Lost to Follow-up|3|||
155642796|NCT00835978|561782315|FG001|Overall Study|Lost to Follow-up|4|||
155642797|NCT00835978|561782316|FG002|Overall Study|Lost to Follow-up|2|||
155642798|NCT00835978|561782317|FG003|Overall Study|Lost to Follow-up|1|||
155642799|NCT00835978|561782314|FG000|Overall Study|Other|5|||
155642800|NCT00835978|561782315|FG001|Overall Study|Other|1|||
155642801|NCT00835978|561782316|FG002|Overall Study|Other|8|||
155642802|NCT00835978|561782317|FG003|Overall Study|Other|0|||
155498323|NCT00445458|561248494|FG002|Overall Study|Surgery|1|||
155498324|NCT00445458|561248495|FG003|Overall Study|Surgery|0|||
155498325|NCT03186794|561248496|FG000|Overall Study|Physician Decision|2|||
155498326|NCT03186794|561248496|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
155498327|NCT01329562|561248501|FG000|Overall Study|Protocol Violation|5|||
155498328|NCT01329562|561248502|FG001|Overall Study|Protocol Violation|3|||
155498329|NCT01329562|561248501|FG000|Overall Study|Lost to Follow-up|1|||
155498330|NCT01329562|561248502|FG001|Overall Study|Lost to Follow-up|1|||
155498331|NCT01329562|561248501|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
155498332|NCT01329562|561248502|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
155498333|NCT01329562|561248501|FG000|Overall Study|Physician Decision|0|||
155498334|NCT01329562|561248502|FG001|Overall Study|Physician Decision|1|||
155498335|NCT03151226|561248503|FG000|Overall Study|Withdrawal by Subject|2|||
155498336|NCT03151226|561248503|FG000|Overall Study|not wear device correctly|1|||
155498337|NCT00061568|561248504|FG000|Overall Study|Lost to Follow-up|12|||
155498338|NCT00061568|561248505|FG001|Overall Study|Lost to Follow-up|0|||
155498339|NCT00061568|561248504|FG000|Overall Study|Death|6|||
155498340|NCT00061568|561248505|FG001|Overall Study|Death|0|||
155498341|NCT00061568|561248504|FG000|Overall Study|Withdrawal by Subject|1|||
155498342|NCT00061568|561248505|FG001|Overall Study|Withdrawal by Subject|0|||
155498343|NCT01381068|561248506|FG000|Overall Study|Death|1|||
155498344|NCT01381068|561248507|FG001|Overall Study|Death|0|||
155498345|NCT00402779|561248510|FG000|Overall Study|Screen Failure|77|||
155498346|NCT00402779|561248511|FG001|Overall Study|Screen Failure|76|||
155498347|NCT00690573|561248518|FG000|Overall Study|Lack of Efficacy|8|||
155498348|NCT00690573|561248518|FG000|Overall Study|Withdrawal by Subject|1|||
155498349|NCT00777920|561248519|FG000|Overall Study|Adverse Event|39|||
155498350|NCT00777920|561248519|FG000|Overall Study|Withdrawal of Consent|4|||
155498351|NCT00777920|561248519|FG000|Overall Study|Lost to Follow-up|1|||
155498352|NCT00777920|561248519|FG000|Overall Study|Investigator's discretion|1|||
155498353|NCT00777920|561248519|FG000|Overall Study|Clinical status did not improve|1|||
155498354|NCT00777920|561248519|FG000|Overall Study|Other, not specified|4|||
155498355|NCT02392377|561248520|FG000|Overall Study|Withdrawal by Subject|0|||
155498356|NCT02392377|561248521|FG001|Overall Study|Withdrawal by Subject|1|||
155498357|NCT01126359|561248524|FG000|First Intervention (20-minutes)|Physician Decision|0|||
155498358|NCT01126359|561248525|FG001|First Intervention (20-minutes)|Physician Decision|1|||
155498359|NCT00902486|561248526|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
155498360|NCT00902486|561248527|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
155498361|NCT00902486|561248528|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
155498362|NCT00902486|561248529|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
155498363|NCT00902486|561248530|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
155498364|NCT00902486|561248531|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
155498365|NCT00902486|561248526|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
155498366|NCT00902486|561248527|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
155498367|NCT00902486|561248528|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
155498368|NCT00902486|561248529|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
155498369|NCT00902486|561248530|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
155498370|NCT00902486|561248531|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
155498371|NCT00902486|561248526|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
155498372|NCT00902486|561248527|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
155498373|NCT00902486|561248528|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
155498374|NCT00902486|561248529|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
155498375|NCT00902486|561248530|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
155498376|NCT00902486|561248531|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
155498377|NCT00902486|561248526|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
155498378|NCT00902486|561248527|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
155498379|NCT00902486|561248528|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
155498380|NCT00902486|561248529|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
155498381|NCT00902486|561248530|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
155498382|NCT00902486|561248531|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
155498383|NCT00902486|561248526|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
155498384|NCT00902486|561248527|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
155498385|NCT00902486|561248528|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
155498386|NCT00902486|561248529|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
155498387|NCT00902486|561248530|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
155498388|NCT00902486|561248531|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
155498389|NCT00902486|561248526|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
155498390|NCT00902486|561248527|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
155308403|NCT05110495|560562155|FG000|Overall Study|Lost to Follow-up|1|||
155308404|NCT05110495|560562155|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
155308405|NCT04173663|560562156|FG000|Overall Study|Withdrawal by Subject|1|||
155308406|NCT04173663|560562157|FG001|Overall Study|Withdrawal by Subject|6|||
155308407|NCT04173663|560562156|FG000|Overall Study|Lost to Follow-up|17|||
155308408|NCT04173663|560562157|FG001|Overall Study|Lost to Follow-up|24|||
155308409|NCT02840474|560562159|FG000|Overall Study|Lost to Follow-up|1|||
155308410|NCT02840474|560562160|FG001|Overall Study|Lost to Follow-up|0|||
155308411|NCT04716634|560562161|FG000|Overall Study|Death|24|||
155308412|NCT04716634|560562162|FG001|Overall Study|Death|24|||
155308413|NCT04716634|560562163|FG002|Overall Study|Death|8|||
155308414|NCT04716634|560562161|FG000|Overall Study|Closed by Sponsor|4|||
155308415|NCT04716634|560562162|FG001|Overall Study|Closed by Sponsor|4|||
155308416|NCT04716634|560562163|FG002|Overall Study|Closed by Sponsor|5|||
155308417|NCT04716634|560562161|FG000|Overall Study|Lost to Follow-up|1|||
155308418|NCT04716634|560562162|FG001|Overall Study|Lost to Follow-up|0|||
155308419|NCT04716634|560562163|FG002|Overall Study|Lost to Follow-up|1|||
155308420|NCT04716634|560562161|FG000|Overall Study|Withdrawal by Subject|0|||
155308421|NCT04716634|560562162|FG001|Overall Study|Withdrawal by Subject|0|||
155308422|NCT04716634|560562163|FG002|Overall Study|Withdrawal by Subject|1|||
155308423|NCT03089398|560562166|FG000|Overall Study|Death|4|||
155308424|NCT03089398|560562167|FG001|Overall Study|Death|9|||
155308425|NCT03089398|560562166|FG000|Overall Study|Lost to Follow-up|21|||
155308426|NCT03089398|560562167|FG001|Overall Study|Lost to Follow-up|30|||
155308427|NCT03089398|560562166|FG000|Overall Study|Withdrawal by Subject|2|||
155308428|NCT03089398|560562167|FG001|Overall Study|Withdrawal by Subject|2|||
155308429|NCT05418296|560562172|FG000|Overall Study|Withdrawal by Subject|4|||
155308430|NCT05418296|560562173|FG001|Overall Study|Withdrawal by Subject|1|||
155308431|NCT04419168|560562176|FG000|Overall Study|Protocol Violation|1|||
155308432|NCT04419168|560562177|FG001|Overall Study|Protocol Violation|1|||
155308433|NCT04419168|560562176|FG000|Overall Study|Lost to Follow-up|7|||
155308434|NCT04419168|560562177|FG001|Overall Study|Lost to Follow-up|7|||
155308435|NCT04419168|560562176|FG000|Overall Study|Missed 6-month Visit|48|||
155308436|NCT04419168|560562177|FG001|Overall Study|Missed 6-month Visit|45|||
155308437|NCT03713086|560562181|FG000|Overall Study|Withdrawal by Subject|0|||
155308438|NCT03713086|560562182|FG001|Overall Study|Withdrawal by Subject|2|||
155308439|NCT03713086|560562183|FG002|Overall Study|Withdrawal by Subject|1|||
155308440|NCT03713086|560562184|FG003|Overall Study|Withdrawal by Subject|0|||
155308441|NCT03713086|560562181|FG000|Overall Study|Lost to Follow-up|0|||
155498391|NCT00902486|561248528|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
155498392|NCT00902486|561248529|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
155498393|NCT00902486|561248530|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
155498394|NCT00902486|561248531|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
155498395|NCT00902486|561248526|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
155498396|NCT00902486|561248527|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
155642803|NCT00835978|561782314|FG000|Overall Study|Objective progression or relapse|2|||
155642804|NCT00835978|561782315|FG001|Overall Study|Objective progression or relapse|0|||
155642805|NCT00835978|561782316|FG002|Overall Study|Objective progression or relapse|1|||
155642806|NCT00835978|561782317|FG003|Overall Study|Objective progression or relapse|0|||
155642807|NCT00835978|561782314|FG000|Overall Study|Adverse Event|1|||
155642808|NCT00835978|561782315|FG001|Overall Study|Adverse Event|0|||
155642809|NCT00835978|561782316|FG002|Overall Study|Adverse Event|1|||
155642810|NCT00835978|561782317|FG003|Overall Study|Adverse Event|0|||
155642811|NCT00835978|561782314|FG000|Overall Study|Withdrawal by Subject|0|||
155642812|NCT00835978|561782315|FG001|Overall Study|Withdrawal by Subject|3|||
155642813|NCT00835978|561782316|FG002|Overall Study|Withdrawal by Subject|0|||
155308442|NCT03713086|560562182|FG001|Overall Study|Lost to Follow-up|1|||
155308443|NCT03713086|560562183|FG002|Overall Study|Lost to Follow-up|0|||
155642814|NCT00835978|561782317|FG003|Overall Study|Withdrawal by Subject|5|||
155642815|NCT00835978|561782314|FG000|Overall Study|Study terminated by sponsor|12|||
155308444|NCT03713086|560562184|FG003|Overall Study|Lost to Follow-up|1|||
155308445|NCT04737772|560562188|FG000|Phase 2 Study|Lost to Follow-up|15|||
155308446|NCT04737772|560562189|FG001|Phase 2 Study|Lost to Follow-up|15|||
155642816|NCT00835978|561782315|FG001|Overall Study|Study terminated by sponsor|8|||
155642817|NCT00835978|561782316|FG002|Overall Study|Study terminated by sponsor|30|||
155308447|NCT04737772|560562188|FG000|Phase 2 Study|Withdrawal by Subject|0|||
155308448|NCT04737772|560562189|FG001|Phase 2 Study|Withdrawal by Subject|1|||
155308449|NCT04737772|560562188|FG000|Phase 2 Study|Did not take any coaching calls|4|||
155308450|NCT04737772|560562189|FG001|Phase 2 Study|Did not take any coaching calls|0|||
155308451|NCT04737772|560562188|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
155308452|NCT04737772|560562189|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
155308453|NCT04737772|560562188|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
155308454|NCT04737772|560562189|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
155642818|NCT00835978|561782317|FG003|Overall Study|Study terminated by sponsor|0|||
155642819|NCT01105130|561782318|FG000|Overall Study|Withdrawal by Subject|4|||
155642820|NCT01105130|561782319|FG001|Overall Study|Withdrawal by Subject|6|||
155308455|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
155308456|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
155308457|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
155308458|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
155308459|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
155308460|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
155308461|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
155308462|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
155308463|NCT02549339|560562190|FG000|12-month Follow-up|Lack of Efficacy|0|||
155308464|NCT02549339|560562191|FG001|12-month Follow-up|Lack of Efficacy|2|||
155308465|NCT02549339|560562190|FG000|12-month Follow-up|Withdrawal by Subject|8|||
155308466|NCT02549339|560562191|FG001|12-month Follow-up|Withdrawal by Subject|3|||
155308467|NCT02549339|560562190|FG000|12-month Follow-up|Lost to Follow-up|1|||
155308468|NCT02549339|560562191|FG001|12-month Follow-up|Lost to Follow-up|3|||
155308469|NCT02549339|560562190|FG000|12-month Follow-up|Other|0|||
155308470|NCT02549339|560562191|FG001|12-month Follow-up|Other|3|||
155308471|NCT02728076|560562192|FG000|Overall Study|Physician Decision|4|||
155308472|NCT04820855|560562193|FG000|Overall Study|Lost to Follow-up|6|||
155308473|NCT04820855|560562194|FG001|Overall Study|Lost to Follow-up|9|||
155308474|NCT04838262|560562195|FG000|Overall Study|Withdrawal by Subject|9|||
155308475|NCT04838262|560562196|FG001|Overall Study|Withdrawal by Subject|4|||
155308476|NCT02927769|560562197|FG000|Induction Phase|Study drug toxicity|1|||
155308477|NCT02927769|560562198|FG001|Induction Phase|Study drug toxicity|1|||
155415090|NCT01543087|560950691|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
155415091|NCT01543087|560950686|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
155308478|NCT02927769|560562197|FG000|Induction Phase|Disease progression|0|||
155308479|NCT02927769|560562198|FG001|Induction Phase|Disease progression|1|||
155308480|NCT02927769|560562197|FG000|Intensification Phase|Study drug toxicity|1|||
155308481|NCT02927769|560562198|FG001|Intensification Phase|Study drug toxicity|0|||
155308482|NCT05956002|560562199|FG000|Treatment Period 3|Adverse Event|0|||
155415092|NCT01543087|560950687|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
155415093|NCT01543087|560950688|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
155415094|NCT01543087|560950689|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
155415095|NCT01543087|560950690|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
155415096|NCT01543087|560950691|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
155415097|NCT01543087|560950686|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
155415098|NCT01543087|560950687|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
155415099|NCT01543087|560950688|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
155415100|NCT01543087|560950689|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
155415101|NCT01543087|560950690|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
155415102|NCT01543087|560950691|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
155415103|NCT04673786|560950695|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
155415104|NCT04673786|560950696|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
155415105|NCT04673786|560950697|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
155415106|NCT04673786|560950695|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
155415107|NCT04673786|560950696|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
155415108|NCT04673786|560950697|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
155415109|NCT04673786|560950695|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
155415110|NCT04673786|560950696|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
155415111|NCT04673786|560950697|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
155415112|NCT04673786|560950695|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
155415113|NCT04673786|560950696|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
155415114|NCT04673786|560950697|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
155415115|NCT04673786|560950695|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
155415116|NCT04673786|560950696|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
155415117|NCT04673786|560950697|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
155415118|NCT04673786|560950695|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
155415119|NCT04673786|560950696|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
155415120|NCT04673786|560950697|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
155415121|NCT00143455|560950698|FG000|Cohort 1|Adverse Event|8|||
155498397|NCT00902486|561248528|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
155498398|NCT00902486|561248529|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
155415122|NCT00143455|560950699|FG001|Cohort 1|Adverse Event|4|||
155308483|NCT05956002|560562200|FG001|Treatment Period 3|Adverse Event|0|||
155308484|NCT05956002|560562201|FG002|Treatment Period 3|Adverse Event|1|||
155308485|NCT05956002|560562202|FG003|Treatment Period 3|Adverse Event|0|||
155308486|NCT02307565|560562203|FG000|Overall Study|Adverse Event|3|||
155308487|NCT02307565|560562204|FG001|Overall Study|Adverse Event|2|||
155308488|NCT02307565|560562203|FG000|Overall Study|Withdrawal by Subject|2|||
155415123|NCT00143455|560950700|FG002|Cohort 1|Adverse Event|0|||
155415124|NCT00143455|560950701|FG003|Cohort 1|Adverse Event|0|||
155308489|NCT02307565|560562204|FG001|Overall Study|Withdrawal by Subject|2|||
155308490|NCT04838613|560562207|FG000|Overall Study|Withdrawal by Subject|3|||
155415125|NCT00143455|560950698|FG000|Cohort 1|Death|5|||
155415126|NCT00143455|560950699|FG001|Cohort 1|Death|2|||
155415127|NCT00143455|560950700|FG002|Cohort 1|Death|0|||
155415128|NCT00143455|560950701|FG003|Cohort 1|Death|0|||
155415129|NCT00143455|560950698|FG000|Cohort 1|Progressive Disease|0|||
155415130|NCT00143455|560950699|FG001|Cohort 1|Progressive Disease|6|||
155415131|NCT00143455|560950700|FG002|Cohort 1|Progressive Disease|0|||
155415132|NCT00143455|560950701|FG003|Cohort 1|Progressive Disease|0|||
155415133|NCT00143455|560950698|FG000|Cohort 1|Withdrawal by Subject|1|||
155415134|NCT00143455|560950699|FG001|Cohort 1|Withdrawal by Subject|4|||
155415135|NCT00143455|560950700|FG002|Cohort 1|Withdrawal by Subject|0|||
155415136|NCT00143455|560950701|FG003|Cohort 1|Withdrawal by Subject|0|||
155415137|NCT00143455|560950698|FG000|Cohort 1|Randomized But Not Treated|0|||
155415138|NCT00143455|560950699|FG001|Cohort 1|Randomized But Not Treated|1|||
155415139|NCT00143455|560950700|FG002|Cohort 1|Randomized But Not Treated|0|||
155415140|NCT00143455|560950701|FG003|Cohort 1|Randomized But Not Treated|0|||
155415141|NCT00143455|560950698|FG000|Cohort 2|Adverse Event|0|||
155415142|NCT00143455|560950699|FG001|Cohort 2|Adverse Event|0|||
155415143|NCT00143455|560950700|FG002|Cohort 2|Adverse Event|42|||
155415144|NCT00143455|560950701|FG003|Cohort 2|Adverse Event|30|||
155415145|NCT00143455|560950698|FG000|Cohort 2|No Longer Required Study Treatment|0|||
155308491|NCT04838613|560562208|FG001|Overall Study|Withdrawal by Subject|6|||
155308492|NCT04838613|560562207|FG000|Overall Study|Protocol Deviation|3|||
155308493|NCT04838613|560562208|FG001|Overall Study|Protocol Deviation|2|||
155308494|NCT04838613|560562207|FG000|Overall Study|Technical Problems|0|||
155308495|NCT04838613|560562208|FG001|Overall Study|Technical Problems|5|||
155308496|NCT04838613|560562207|FG000|Overall Study|Physician Decision|2|||
155308497|NCT04838613|560562208|FG001|Overall Study|Physician Decision|0|||
155308498|NCT04970654|560562209|FG000|Overall Study|Withdrawal by parents/guardian|1|||
155308499|NCT04970654|560562210|FG001|Overall Study|Withdrawal by parents/guardian|2|||
155308500|NCT04970654|560562209|FG000|Overall Study|Unclassified|2|||
155308501|NCT04970654|560562210|FG001|Overall Study|Unclassified|1|||
155308502|NCT04970654|560562209|FG000|Overall Study|Lost to Follow-up|1|||
155308503|NCT04970654|560562210|FG001|Overall Study|Lost to Follow-up|0|||
155308504|NCT05239039|560562223|FG000|Overall Study|Withdrawal by Subject|0|||
155308505|NCT05239039|560562224|FG001|Overall Study|Withdrawal by Subject|1|||
155308506|NCT03690206|560562225|FG000|Overall Study|Withdrawal by Subject|2|||
155308507|NCT03690206|560562226|FG001|Overall Study|Withdrawal by Subject|0|||
155308508|NCT03690206|560562227|FG002|Overall Study|Withdrawal by Subject|0|||
155308509|NCT03690206|560562225|FG000|Overall Study|ICF withdrawal|2|||
155308510|NCT03690206|560562226|FG001|Overall Study|ICF withdrawal|0|||
155308511|NCT03690206|560562227|FG002|Overall Study|ICF withdrawal|0|||
155308512|NCT03897686|560563623|FG000|Overall Study|Protocol Violation|1|||
155308513|NCT03897686|560563624|FG001|Overall Study|Protocol Violation|1|||
155308514|NCT03897686|560563623|FG000|Overall Study|Withdrawal by Subject|1|||
155308515|NCT03897686|560563624|FG001|Overall Study|Withdrawal by Subject|1|||
155308516|NCT04052516|560563625|FG000|Overall Study|Withdrawal by Subject|4|||
155308517|NCT04052516|560563626|FG001|Overall Study|Withdrawal by Subject|5|||
155308518|NCT04052516|560563627|FG002|Overall Study|Withdrawal by Subject|6|||
155308519|NCT04052516|560563625|FG000|Overall Study|Adverse Event|3|||
155308520|NCT04052516|560563626|FG001|Overall Study|Adverse Event|2|||
155308521|NCT04052516|560563627|FG002|Overall Study|Adverse Event|8|||
155308522|NCT04052516|560563625|FG000|Overall Study|Lost to Follow-up|2|||
155308523|NCT04052516|560563626|FG001|Overall Study|Lost to Follow-up|5|||
155308524|NCT04052516|560563627|FG002|Overall Study|Lost to Follow-up|3|||
155308525|NCT04052516|560563625|FG000|Overall Study|Protocol Violation|1|||
155308526|NCT04052516|560563626|FG001|Overall Study|Protocol Violation|1|||
155308527|NCT04052516|560563627|FG002|Overall Study|Protocol Violation|0|||
155308528|NCT04052516|560563625|FG000|Overall Study|Death|1|||
155308529|NCT04052516|560563626|FG001|Overall Study|Death|0|||
155415146|NCT00143455|560950699|FG001|Cohort 2|No Longer Required Study Treatment|0|||
155415147|NCT00143455|560950700|FG002|Cohort 2|No Longer Required Study Treatment|1|||
155415148|NCT00143455|560950701|FG003|Cohort 2|No Longer Required Study Treatment|0|||
155308530|NCT04052516|560563627|FG002|Overall Study|Death|0|||
155308531|NCT04052516|560563625|FG000|Overall Study|Physician Decision|0|||
155308532|NCT04052516|560563626|FG001|Overall Study|Physician Decision|1|||
155308533|NCT04052516|560563627|FG002|Overall Study|Physician Decision|0|||
155308534|NCT04052516|560563625|FG000|Overall Study|Pregnancy|1|||
155308535|NCT04052516|560563626|FG001|Overall Study|Pregnancy|0|||
155308536|NCT04052516|560563627|FG002|Overall Study|Pregnancy|0|||
155308537|NCT04052516|560563625|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
155308538|NCT04052516|560563626|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
155415149|NCT00143455|560950698|FG000|Cohort 2|Protocol Violation|0|||
155415150|NCT00143455|560950699|FG001|Cohort 2|Protocol Violation|0|||
155415151|NCT00143455|560950700|FG002|Cohort 2|Protocol Violation|1|||
155415152|NCT00143455|560950701|FG003|Cohort 2|Protocol Violation|1|||
155415153|NCT00143455|560950698|FG000|Cohort 2|Lost to Follow-up|0|||
155308539|NCT04052516|560563627|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
155308540|NCT04052516|560563625|FG000|Overall Study|Reason not recorded|0|||
155308541|NCT04052516|560563626|FG001|Overall Study|Reason not recorded|1|||
155308542|NCT04052516|560563627|FG002|Overall Study|Reason not recorded|0|||
155308543|NCT06143670|560563629|FG000|Overall Study|Lost to Follow-up|0|||
155308544|NCT06143670|560563630|FG001|Overall Study|Lost to Follow-up|1|||
155308545|NCT06143670|560563629|FG000|Overall Study|Withdrawal by Subject|3|||
155308546|NCT06143670|560563630|FG001|Overall Study|Withdrawal by Subject|0|||
155308547|NCT03625882|560563632|FG000|Overall Study|Protocol Violation|3|||
155308548|NCT05058391|560563633|FG000|Overall Study|Adverse Event|1|||
155308549|NCT05009251|560563634|FG000|Overall Study|Protocol Violation|100|||
155308550|NCT05009251|560563635|FG001|Overall Study|Protocol Violation|105|||
155308551|NCT05009251|560563636|FG002|Overall Study|Protocol Violation|119|||
155308552|NCT05009251|560563637|FG003|Overall Study|Protocol Violation|120|||
155308553|NCT05009251|560563638|FG004|Overall Study|Protocol Violation|119|||
155308554|NCT05009251|560563634|FG000|Overall Study|Death|25|||
155308555|NCT05009251|560563635|FG001|Overall Study|Death|22|||
155308556|NCT05009251|560563636|FG002|Overall Study|Death|24|||
155308557|NCT05009251|560563637|FG003|Overall Study|Death|19|||
155308558|NCT05009251|560563638|FG004|Overall Study|Death|15|||
155308559|NCT02662062|560563644|FG000|Overall Study|Withdrawal by Subject|1|||
155308560|NCT05249439|560563650|FG000|Overall Study|Withdrawal by Subject|2|||
155308561|NCT05249439|560563651|FG001|Overall Study|Withdrawal by Subject|5|||
155308562|NCT05249439|560563650|FG000|Overall Study|Physician Decision|3|||
155308563|NCT05249439|560563651|FG001|Overall Study|Physician Decision|1|||
155308564|NCT00616967|560563652|FG000|Overall Study|Withdrawal by Subject|0|||
155308565|NCT00616967|560563653|FG001|Overall Study|Withdrawal by Subject|0|||
155308566|NCT00616967|560563654|FG002|Overall Study|Withdrawal by Subject|1|||
155308567|NCT02910583|560563655|FG000|Overall Study|Death|7|||
155308568|NCT02910583|560563656|FG001|Overall Study|Death|3|||
155308569|NCT02910583|560563655|FG000|Overall Study|Lost to Follow-up|1|||
155308570|NCT02910583|560563656|FG001|Overall Study|Lost to Follow-up|0|||
155308571|NCT02910583|560563655|FG000|Overall Study|Withdrawal by Subject|12|||
155308572|NCT02910583|560563656|FG001|Overall Study|Withdrawal by Subject|8|||
155308573|NCT02910583|560563655|FG000|Overall Study|Other, Not Specified|6|||
155308574|NCT02910583|560563656|FG001|Overall Study|Other, Not Specified|3|||
155308575|NCT02249949|560563657|FG000|Overall Study|Cancelled prior to treatment|2|||
155308576|NCT02097420|560563660|FG000|Overall Study|Death|6|||
155308577|NCT02097420|560563660|FG000|Overall Study|Valve explanted|13|||
155308578|NCT02097420|560563660|FG000|Overall Study|Other Reason|1|||
155308579|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
155308580|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
155308581|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
155308582|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
155308583|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
155308584|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
155308585|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
155308586|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
155308587|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
155308588|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
155308589|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
155308590|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
155308591|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
155308592|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
155308593|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
155308594|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
155308595|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
155308596|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
155308597|NCT04263311|560563663|FG000|Overall Study|Lost to Follow-up|1|||
155308598|NCT04263311|560563664|FG001|Overall Study|Lost to Follow-up|2|||
155308599|NCT04263311|560563665|FG002|Overall Study|Lost to Follow-up|0|||
155308600|NCT04263311|560563663|FG000|Overall Study|Health Issues|1|||
155308601|NCT04263311|560563664|FG001|Overall Study|Health Issues|0|||
155308602|NCT04263311|560563665|FG002|Overall Study|Health Issues|0|||
155308603|NCT04263311|560563663|FG000|Overall Study|Left the country|1|||
155308604|NCT04263311|560563664|FG001|Overall Study|Left the country|0|||
155308605|NCT04263311|560563665|FG002|Overall Study|Left the country|0|||
155308606|NCT04263311|560563663|FG000|Overall Study|Unable to maintain time commitment|1|||
155308607|NCT04263311|560563664|FG001|Overall Study|Unable to maintain time commitment|0|||
155308608|NCT04263311|560563665|FG002|Overall Study|Unable to maintain time commitment|0|||
155308609|NCT04263311|560563663|FG000|Overall Study|No longer interested|1|||
155308610|NCT04263311|560563664|FG001|Overall Study|No longer interested|0|||
155308611|NCT04263311|560563665|FG002|Overall Study|No longer interested|0|||
155308612|NCT04263311|560563663|FG000|Overall Study|Ineligible post consent|0|||
155308613|NCT04263311|560563664|FG001|Overall Study|Ineligible post consent|0|||
155308614|NCT04263311|560563665|FG002|Overall Study|Ineligible post consent|5|||
155308615|NCT03315754|560563669|FG000|Overall Study|COVID-19 complications leading to death|1|||
155308616|NCT03315754|560563669|FG000|Overall Study|insurance coverage issue|1|||
155308617|NCT02954341|560563670|FG000|Overall Study|Attempted Implant unsuccessful|5|||
155308618|NCT02954341|560563670|FG000|Overall Study|Death|90|||
155308619|NCT02954341|560563670|FG000|Overall Study|Withdrawal by Subject|4|||
155308620|NCT02954341|560563670|FG000|Overall Study|Physician Decision|13|||
155308621|NCT02954341|560563670|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
155308622|NCT02954341|560563670|FG000|Overall Study|Not implanted due to physician's decision|1|||
155308623|NCT02954341|560563670|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
155308624|NCT04245501|560563688|FG000|Overall Study|Adverse Event|2|||
155308625|NCT04245501|560563689|FG001|Overall Study|Adverse Event|0|||
155308626|NCT04245501|560563688|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
155308627|NCT04245501|560563689|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
155308628|NCT03526861|560563691|FG000|Initial Treatment Period|Not dosed|1|||
155308629|NCT03526861|560563692|FG001|Initial Treatment Period|Not dosed|1|||
155308630|NCT03526861|560563693|FG002|Initial Treatment Period|Not dosed|1|||
155308631|NCT03526861|560563694|FG003|Initial Treatment Period|Not dosed|0|||
155308632|NCT03526861|560563695|FG004|Initial Treatment Period|Not dosed|0|||
155308633|NCT03526861|560563696|FG005|Initial Treatment Period|Not dosed|0|||
155308634|NCT03526861|560563697|FG006|Initial Treatment Period|Not dosed|0|||
155308635|NCT03526861|560563698|FG007|Initial Treatment Period|Not dosed|0|||
155308636|NCT03526861|560563699|FG008|Initial Treatment Period|Not dosed|0|||
155308637|NCT03526861|560563691|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
155308638|NCT03526861|560563692|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
155308639|NCT03526861|560563693|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
155308640|NCT03526861|560563694|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308641|NCT03526861|560563695|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308642|NCT03526861|560563696|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308643|NCT03526861|560563697|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308644|NCT03526861|560563698|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308645|NCT03526861|560563699|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308646|NCT03526861|560563691|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
155308647|NCT03526861|560563692|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
155308648|NCT03526861|560563693|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
155308649|NCT03526861|560563694|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308650|NCT03526861|560563695|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308651|NCT03526861|560563696|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308652|NCT03526861|560563697|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308653|NCT03526861|560563698|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308654|NCT03526861|560563699|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308655|NCT03526861|560563691|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308656|NCT03526861|560563692|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308657|NCT03526861|560563693|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308658|NCT03526861|560563694|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308659|NCT03526861|560563695|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308660|NCT03526861|560563696|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308661|NCT03526861|560563697|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308662|NCT03526861|560563698|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308663|NCT03526861|560563699|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308664|NCT03526861|560563691|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308665|NCT03526861|560563692|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308666|NCT03526861|560563693|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308667|NCT03526861|560563694|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
155308668|NCT03526861|560563695|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
155308669|NCT03526861|560563696|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
155308670|NCT03526861|560563697|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
155308671|NCT03526861|560563698|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
155308672|NCT03526861|560563699|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308673|NCT03526861|560563691|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308674|NCT03526861|560563692|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308675|NCT03526861|560563693|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308676|NCT03526861|560563694|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
155308677|NCT03526861|560563695|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308678|NCT03526861|560563696|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308679|NCT03526861|560563697|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308680|NCT03526861|560563698|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308681|NCT03526861|560563699|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308682|NCT03526861|560563691|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308683|NCT03526861|560563692|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308684|NCT03526861|560563693|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308685|NCT03526861|560563694|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308686|NCT03526861|560563695|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308687|NCT03526861|560563696|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308688|NCT03526861|560563697|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308689|NCT03526861|560563698|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308690|NCT03526861|560563699|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
155308691|NCT03526861|560563691|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308692|NCT03526861|560563692|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308693|NCT03526861|560563693|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308694|NCT03526861|560563694|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308695|NCT03526861|560563695|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155415154|NCT00143455|560950699|FG001|Cohort 2|Lost to Follow-up|0|||
155415155|NCT00143455|560950700|FG002|Cohort 2|Lost to Follow-up|1|||
155415156|NCT00143455|560950701|FG003|Cohort 2|Lost to Follow-up|4|||
155415157|NCT00143455|560950698|FG000|Cohort 2|Death|0|||
155415158|NCT00143455|560950699|FG001|Cohort 2|Death|0|||
155415159|NCT00143455|560950700|FG002|Cohort 2|Death|20|||
155415160|NCT00143455|560950701|FG003|Cohort 2|Death|12|||
155415161|NCT00143455|560950698|FG000|Cohort 2|Progressive Disease|0|||
155415162|NCT00143455|560950699|FG001|Cohort 2|Progressive Disease|0|||
155415163|NCT00143455|560950700|FG002|Cohort 2|Progressive Disease|20|||
155415164|NCT00143455|560950701|FG003|Cohort 2|Progressive Disease|27|||
155415165|NCT00143455|560950698|FG000|Cohort 2|Withdrawal by Subject|0|||
155415166|NCT00143455|560950699|FG001|Cohort 2|Withdrawal by Subject|0|||
155415167|NCT00143455|560950700|FG002|Cohort 2|Withdrawal by Subject|13|||
155415168|NCT00143455|560950701|FG003|Cohort 2|Withdrawal by Subject|12|||
155415169|NCT00143455|560950698|FG000|Cohort 2|Other|0|||
155415170|NCT00143455|560950699|FG001|Cohort 2|Other|0|||
155415171|NCT00143455|560950700|FG002|Cohort 2|Other|7|||
155415172|NCT00143455|560950701|FG003|Cohort 2|Other|6|||
155415173|NCT00143455|560950698|FG000|Cohort 2|Randomized But Not Treated|0|||
155415174|NCT00143455|560950699|FG001|Cohort 2|Randomized But Not Treated|0|||
155415175|NCT00143455|560950700|FG002|Cohort 2|Randomized But Not Treated|1|||
155415176|NCT00143455|560950701|FG003|Cohort 2|Randomized But Not Treated|1|||
155415177|NCT01298492|560950702|FG000|Overall Study|Death|2|||
155415178|NCT01298492|560950702|FG000|Overall Study|Insufficient Clinical Response|22|||
155415179|NCT01298492|560950702|FG000|Overall Study|Lost to Follow-up|12|||
155415180|NCT01298492|560950702|FG000|Overall Study|Withdrawal by Subject|47|||
155498399|NCT00902486|561248530|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
155498400|NCT00902486|561248531|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
155498401|NCT00902486|561248526|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
155415181|NCT01298492|560950702|FG000|Overall Study|Other (Unspecified)|7|||
155415182|NCT01298492|560950702|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
155415183|NCT01298492|560950702|FG000|Overall Study|Protocol Violation|2|||
155415184|NCT01298492|560950702|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
155415185|NCT01298492|560950702|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
155415186|NCT02902120|560950703|FG000|Overall Study|Lack of Efficacy|1|||
155415187|NCT03298022|560950705|FG000|Overall Study|Lack of Efficacy|4|||
155415188|NCT03298022|560950705|FG000|Overall Study|Withdrawal by Subject|7|||
155415189|NCT03298022|560950705|FG000|Overall Study|Adverse Event|1|||
155415190|NCT03298022|560950705|FG000|Overall Study|disease relapse|1|||
155415191|NCT03694925|560950706|FG000|Overall Study|Inadequate laboratory testing|0|||
155498402|NCT00902486|561248527|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
155308696|NCT03526861|560563696|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308697|NCT03526861|560563697|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308698|NCT03526861|560563698|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308699|NCT03526861|560563699|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
155308700|NCT03526861|560563691|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308701|NCT03526861|560563692|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308702|NCT03526861|560563693|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308703|NCT03526861|560563694|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308704|NCT03526861|560563695|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308705|NCT03526861|560563696|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308706|NCT03526861|560563697|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308707|NCT03526861|560563698|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308708|NCT03526861|560563699|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
155308709|NCT05524233|560563702|FG000|Overall Study|Lost to Follow-up|2|||
155308710|NCT05524233|560563702|FG000|Overall Study|Adverse Event|2|||
155308711|NCT05524233|560563702|FG000|Overall Study|Withdrawal by Subject|1|||
155308712|NCT04382898|560563704|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
155308713|NCT04382898|560563705|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308714|NCT04382898|560563706|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308715|NCT04382898|560563707|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308716|NCT04382898|560563708|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308717|NCT04382898|560563704|FG000|Part 1: Dose Titration|Death|6|||
155308718|NCT04382898|560563705|FG001|Part 1: Dose Titration|Death|0|||
155308719|NCT04382898|560563706|FG002|Part 1: Dose Titration|Death|0|||
155308720|NCT04382898|560563707|FG003|Part 1: Dose Titration|Death|0|||
155308721|NCT04382898|560563708|FG004|Part 1: Dose Titration|Death|0|||
155308722|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308723|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308724|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155308725|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308726|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308727|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308728|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308729|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
155308730|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308731|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308732|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Death|0|||
155308733|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Death|17|||
155308734|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Death|13|||
155308735|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Death|1|||
155308736|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Death|0|||
155308737|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
155308738|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
155308739|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
155308740|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
155308741|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
155308742|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
155308743|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
155308744|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
155415192|NCT03694925|560950707|FG001|Overall Study|Inadequate laboratory testing|3|||
155415193|NCT03694925|560950708|FG002|Overall Study|Inadequate laboratory testing|0|||
155642821|NCT01105130|561782320|FG002|Overall Study|Withdrawal by Subject|2|||
155308745|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
155415194|NCT01422239|560950709|FG000|Overall Study|Lost to Follow-up|4|||
155415195|NCT01422239|560950710|FG001|Overall Study|Lost to Follow-up|3|||
155415196|NCT03467958|560950711|FG000|Overall Study|Adverse Event|20|||
155642822|NCT01105130|561782318|FG000|Overall Study|Never Started|2|||
155642823|NCT01105130|561782319|FG001|Overall Study|Never Started|2|||
155642824|NCT01105130|561782320|FG002|Overall Study|Never Started|4|||
155642825|NCT01105130|561782318|FG000|Overall Study|Toxicity|1|||
155642826|NCT01105130|561782319|FG001|Overall Study|Toxicity|3|||
155642827|NCT01105130|561782320|FG002|Overall Study|Toxicity|2|||
155642828|NCT01105130|561782318|FG000|Overall Study|Multiple Reasons|3|||
155642829|NCT01105130|561782319|FG001|Overall Study|Multiple Reasons|0|||
155642830|NCT01105130|561782320|FG002|Overall Study|Multiple Reasons|2|||
155642831|NCT02927145|561782322|FG000|Initial Recruitment|Withdrawal by Subject|0|||
155642832|NCT02927145|561782323|FG001|Initial Recruitment|Withdrawal by Subject|1|||
155642833|NCT02927145|561782324|FG002|Initial Recruitment|Withdrawal by Subject|1|||
155642834|NCT02927145|561782325|FG003|Initial Recruitment|Withdrawal by Subject|4|||
155642835|NCT02927145|561782326|FG004|Initial Recruitment|Withdrawal by Subject|1|||
155308746|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
155308747|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Other|0|||
155308748|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Other|0|||
155308749|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Other|1|||
155308750|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Other|0|||
155308751|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Other|0|||
155308752|NCT01772472|560563709|FG000|Overall Study|Death|126|||
155308753|NCT01772472|560563710|FG001|Overall Study|Death|94|||
155308754|NCT01772472|560563709|FG000|Overall Study|Lost to Follow-up|51|||
155308755|NCT01772472|560563710|FG001|Overall Study|Lost to Follow-up|50|||
155308756|NCT01772472|560563709|FG000|Overall Study|Other|9|||
155308757|NCT01772472|560563710|FG001|Overall Study|Other|7|||
155308758|NCT01772472|560563709|FG000|Overall Study|Physician Decision|1|||
155308759|NCT01772472|560563710|FG001|Overall Study|Physician Decision|7|||
155308760|NCT01772472|560563709|FG000|Overall Study|Withdrawal by Subject|115|||
155308761|NCT01772472|560563710|FG001|Overall Study|Withdrawal by Subject|90|||
155308762|NCT01772472|560563709|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
155308763|NCT01772472|560563710|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
155308764|NCT04391894|560563711|FG000|Overall Study|Adverse Event|1|||
155308765|NCT04391894|560563712|FG001|Overall Study|Adverse Event|1|||
155308766|NCT04391894|560563713|FG002|Overall Study|Adverse Event|1|||
155308767|NCT04391894|560563714|FG003|Overall Study|Adverse Event|1|||
155308768|NCT04391894|560563715|FG004|Overall Study|Adverse Event|1|||
155308769|NCT04391894|560563711|FG000|Overall Study|Lost to Follow-up|1|||
155308770|NCT04391894|560563712|FG001|Overall Study|Lost to Follow-up|0|||
155308771|NCT04391894|560563713|FG002|Overall Study|Lost to Follow-up|0|||
155308772|NCT04391894|560563714|FG003|Overall Study|Lost to Follow-up|0|||
155642836|NCT02927145|561782327|FG005|Initial Recruitment|Withdrawal by Subject|1|||
155642837|NCT02927145|561782328|FG006|Initial Recruitment|Withdrawal by Subject|0|||
155642838|NCT02927145|561782329|FG007|Initial Recruitment|Withdrawal by Subject|0|||
155308773|NCT04391894|560563715|FG004|Overall Study|Lost to Follow-up|0|||
155308774|NCT04391894|560563711|FG000|Overall Study|Protocol Violation|0|||
155308775|NCT04391894|560563712|FG001|Overall Study|Protocol Violation|0|||
155308776|NCT04391894|560563713|FG002|Overall Study|Protocol Violation|0|||
155308777|NCT04391894|560563714|FG003|Overall Study|Protocol Violation|1|||
155308778|NCT04391894|560563715|FG004|Overall Study|Protocol Violation|0|||
155308779|NCT04391894|560563711|FG000|Overall Study|Withdrawal by Subject|2|||
155308780|NCT04391894|560563712|FG001|Overall Study|Withdrawal by Subject|0|||
155308781|NCT04391894|560563713|FG002|Overall Study|Withdrawal by Subject|3|||
155308782|NCT04391894|560563714|FG003|Overall Study|Withdrawal by Subject|0|||
155308783|NCT04391894|560563715|FG004|Overall Study|Withdrawal by Subject|1|||
155308784|NCT04391894|560563711|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308785|NCT04391894|560563712|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308786|NCT04391894|560563713|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308787|NCT04391894|560563714|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308788|NCT04391894|560563715|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
155308789|NCT00446225|560563719|FG000|Overall Study|Protocol Violation|1|||
155308790|NCT00446225|560563720|FG001|Overall Study|Protocol Violation|0|||
155308791|NCT04450342|560563721|FG000|Overall Study|Adverse Event|1|||
155308792|NCT04450342|560563722|FG001|Overall Study|Adverse Event|1|||
155308793|NCT04450342|560563723|FG002|Overall Study|Adverse Event|0|||
155308794|NCT04450342|560563721|FG000|Overall Study|Device not used|1|||
155308795|NCT04450342|560563722|FG001|Overall Study|Device not used|0|||
155308796|NCT04450342|560563723|FG002|Overall Study|Device not used|0|||
155308797|NCT04450342|560563721|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
155308798|NCT04450342|560563722|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
155308799|NCT04450342|560563723|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
155308800|NCT04450342|560563721|FG000|Overall Study|Physician Decision|1|||
155308801|NCT04450342|560563722|FG001|Overall Study|Physician Decision|0|||
155308802|NCT04450342|560563723|FG002|Overall Study|Physician Decision|1|||
155308803|NCT04450342|560563721|FG000|Overall Study|Protocol Deviation|0|||
155308804|NCT04450342|560563722|FG001|Overall Study|Protocol Deviation|1|||
155308805|NCT04450342|560563723|FG002|Overall Study|Protocol Deviation|0|||
155308806|NCT04450342|560563721|FG000|Overall Study|Reoperation|1|||
155308807|NCT04450342|560563722|FG001|Overall Study|Reoperation|1|||
155308808|NCT04450342|560563723|FG002|Overall Study|Reoperation|0|||
155308809|NCT04450342|560563721|FG000|Overall Study|Screen Failures|0|||
155308810|NCT04450342|560563722|FG001|Overall Study|Screen Failures|0|||
155308811|NCT04450342|560563723|FG002|Overall Study|Screen Failures|2|||
155308812|NCT04450342|560563721|FG000|Overall Study|Site Terminated by Sponsor|1|||
155308813|NCT04450342|560563722|FG001|Overall Study|Site Terminated by Sponsor|1|||
155308814|NCT04450342|560563723|FG002|Overall Study|Site Terminated by Sponsor|1|||
155642839|NCT02927145|561782330|FG008|Initial Recruitment|Withdrawal by Subject|2|||
155415197|NCT03467958|560950712|FG001|Overall Study|Adverse Event|32|||
155415198|NCT03467958|560950713|FG002|Overall Study|Adverse Event|5|||
155415199|NCT03467958|560950714|FG003|Overall Study|Adverse Event|3|||
155415200|NCT03467958|560950715|FG004|Overall Study|Adverse Event|3|||
155415201|NCT03467958|560950716|FG005|Overall Study|Adverse Event|3|||
155415202|NCT03467958|560950717|FG006|Overall Study|Adverse Event|6|||
155415203|NCT03467958|560950718|FG007|Overall Study|Adverse Event|5|||
155415204|NCT03467958|560950719|FG008|Overall Study|Adverse Event|0|||
155498403|NCT00902486|561248528|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
155498404|NCT00902486|561248529|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
155498405|NCT00902486|561248530|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
155498406|NCT00902486|561248531|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
155498407|NCT00902486|561248526|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
155415205|NCT03467958|560950711|FG000|Overall Study|Lack of Efficacy|59|||
155415206|NCT03467958|560950712|FG001|Overall Study|Lack of Efficacy|120|||
155415207|NCT03467958|560950713|FG002|Overall Study|Lack of Efficacy|6|||
155415208|NCT03467958|560950714|FG003|Overall Study|Lack of Efficacy|9|||
155415209|NCT03467958|560950715|FG004|Overall Study|Lack of Efficacy|8|||
155498408|NCT00902486|561248527|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
155498409|NCT00902486|561248528|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
155498410|NCT00902486|561248529|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
155498411|NCT00902486|561248530|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
155498412|NCT00902486|561248531|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
155498413|NCT00902486|561248526|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
155498414|NCT00902486|561248527|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
155498415|NCT00902486|561248528|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
155498416|NCT00902486|561248529|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
155498417|NCT00902486|561248530|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
155498418|NCT00902486|561248531|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
155498419|NCT00902486|561248526|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
155498420|NCT00902486|561248527|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
155498421|NCT00902486|561248528|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
155498422|NCT00902486|561248529|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
155749731|NCT01609478|562184162|FG001|Overall Study|Physician Decision|0|||
155749732|NCT01609478|562184163|FG002|Overall Study|Physician Decision|1|||
155749733|NCT01609478|562184161|FG000|Overall Study|Withdrawal by Subject|2|||
155749734|NCT01609478|562184162|FG001|Overall Study|Withdrawal by Subject|0|||
155749735|NCT01609478|562184163|FG002|Overall Study|Withdrawal by Subject|2|||
155749736|NCT05040971|562184164|FG000|Overall Study|Withdrawal by Subject|0|||
155749737|NCT05040971|562184165|FG001|Overall Study|Withdrawal by Subject|2|||
155749738|NCT05040971|562184164|FG000|Overall Study|Lost to Follow-up|8|||
155749739|NCT05040971|562184165|FG001|Overall Study|Lost to Follow-up|3|||
155749740|NCT05040971|562184164|FG000|Overall Study|Death|2|||
155308815|NCT04450342|560563721|FG000|Overall Study|Study Terminated by Sponsor|31|||
155308816|NCT04450342|560563722|FG001|Overall Study|Study Terminated by Sponsor|29|||
155308817|NCT04450342|560563723|FG002|Overall Study|Study Terminated by Sponsor|6|||
155308818|NCT04450342|560563721|FG000|Overall Study|Withdrawal by Subject|0|||
155498423|NCT00902486|561248530|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
155498424|NCT00902486|561248531|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
155498425|NCT05378269|561250602|FG000|Overall Study|Protocol Violation|1|||
155498426|NCT05378269|561250603|FG001|Overall Study|Protocol Violation|0|||
155498427|NCT05378269|561250604|FG002|Overall Study|Protocol Violation|2|||
155498428|NCT05378269|561250605|FG003|Overall Study|Protocol Violation|0|||
155498429|NCT05378269|561250606|FG004|Overall Study|Protocol Violation|0|||
155498430|NCT01371006|561250607|FG000|Overall Study|Adverse Event|1|||
155498431|NCT01371006|561250608|FG001|Overall Study|Adverse Event|0|||
155498432|NCT00891527|561250609|FG000|Overall Study|Withdrawal by Subject|2|||
155498433|NCT01186744|561250610|FG000|Overall Study|Lack of Efficacy|156|||
155498434|NCT01186744|561250611|FG001|Overall Study|Lack of Efficacy|99|||
155498435|NCT01186744|561250612|FG002|Overall Study|Lack of Efficacy|0|||
155498436|NCT01186744|561250613|FG003|Overall Study|Lack of Efficacy|2|||
155498437|NCT01186744|561250614|FG004|Overall Study|Lack of Efficacy|2|||
155498438|NCT01186744|561250615|FG005|Overall Study|Lack of Efficacy|5|||
155498439|NCT01186744|561250610|FG000|Overall Study|Protocol Violation|1|||
155498440|NCT01186744|561250611|FG001|Overall Study|Protocol Violation|2|||
155498441|NCT01186744|561250612|FG002|Overall Study|Protocol Violation|0|||
155498442|NCT01186744|561250613|FG003|Overall Study|Protocol Violation|1|||
155498443|NCT01186744|561250614|FG004|Overall Study|Protocol Violation|1|||
155498444|NCT01186744|561250615|FG005|Overall Study|Protocol Violation|2|||
155498445|NCT01186744|561250610|FG000|Overall Study|Lost to Follow-up|15|||
155498446|NCT01186744|561250611|FG001|Overall Study|Lost to Follow-up|16|||
155498447|NCT01186744|561250612|FG002|Overall Study|Lost to Follow-up|2|||
155308819|NCT04450342|560563722|FG001|Overall Study|Withdrawal by Subject|1|||
155308820|NCT04450342|560563723|FG002|Overall Study|Withdrawal by Subject|2|||
155308821|NCT05633407|560563724|FG000|Overall Study|Physician Decision|2|||
155308822|NCT05633407|560563725|FG001|Overall Study|Physician Decision|0|||
155308823|NCT05633407|560563724|FG000|Overall Study|Adverse Event|1|||
155308824|NCT05633407|560563725|FG001|Overall Study|Adverse Event|0|||
155308825|NCT05633407|560563724|FG000|Overall Study|Withdrawal by Subject|1|||
155308826|NCT05633407|560563725|FG001|Overall Study|Withdrawal by Subject|0|||
155308827|NCT05633407|560563724|FG000|Overall Study|Other|1|||
155308828|NCT05633407|560563725|FG001|Overall Study|Other|1|||
155498448|NCT01186744|561250613|FG003|Overall Study|Lost to Follow-up|1|||
155498449|NCT01186744|561250614|FG004|Overall Study|Lost to Follow-up|1|||
155498450|NCT01186744|561250615|FG005|Overall Study|Lost to Follow-up|4|||
155498451|NCT01186744|561250610|FG000|Overall Study|Screen failure|1|||
155498452|NCT01186744|561250611|FG001|Overall Study|Screen failure|1|||
155498453|NCT01186744|561250612|FG002|Overall Study|Screen failure|0|||
155498454|NCT01186744|561250613|FG003|Overall Study|Screen failure|1|||
155498455|NCT01186744|561250614|FG004|Overall Study|Screen failure|0|||
155498456|NCT01186744|561250615|FG005|Overall Study|Screen failure|0|||
155308829|NCT02500758|560563728|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
155308830|NCT02500758|560563729|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
155308831|NCT02500758|560563728|FG000|Washout (1 Week)|Lost to Follow-up|2|||
155308832|NCT02500758|560563729|FG001|Washout (1 Week)|Lost to Follow-up|2|||
155308833|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
155308834|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
155308835|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
155308836|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
155308837|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
155308838|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
155308839|NCT00220740|560563730|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
155308840|NCT00220740|560563731|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
155308841|NCT00220740|560563730|FG000|Efficacy Period|Adverse Event|1|||
155308842|NCT00220740|560563731|FG001|Efficacy Period|Adverse Event|1|||
155308843|NCT00220740|560563730|FG000|Efficacy Period|Withdrawal by Subject|1|||
155498457|NCT01186744|561250610|FG000|Overall Study|Withdrawal by Subject|14|||
155498458|NCT01186744|561250611|FG001|Overall Study|Withdrawal by Subject|10|||
155498459|NCT01186744|561250612|FG002|Overall Study|Withdrawal by Subject|2|||
155642840|NCT02927145|561782322|FG000|Initial Recruitment|Adverse Event|0|||
155642841|NCT02927145|561782323|FG001|Initial Recruitment|Adverse Event|0|||
155642842|NCT02927145|561782324|FG002|Initial Recruitment|Adverse Event|0|||
155308844|NCT00220740|560563731|FG001|Efficacy Period|Withdrawal by Subject|0|||
155308845|NCT00220740|560563730|FG000|Efficacy Period|Protocol Violation|1|||
155498460|NCT01186744|561250613|FG003|Overall Study|Withdrawal by Subject|5|||
155498461|NCT01186744|561250614|FG004|Overall Study|Withdrawal by Subject|0|||
155308846|NCT00220740|560563731|FG001|Efficacy Period|Protocol Violation|0|||
155498462|NCT01186744|561250615|FG005|Overall Study|Withdrawal by Subject|6|||
155498463|NCT01186744|561250610|FG000|Overall Study|Study terminated by Sponsor|1|||
155642843|NCT02927145|561782325|FG003|Initial Recruitment|Adverse Event|0|||
155308847|NCT00220740|560563730|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
155308848|NCT00220740|560563731|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
155308849|NCT01057433|560563732|FG000|Overall Study|Adverse Event|1|||
155308850|NCT02874534|560563734|FG000|Overall Study|Withdrawal by Subject|5|||
155308851|NCT02874534|560563735|FG001|Overall Study|Withdrawal by Subject|8|||
155308852|NCT02874534|560563734|FG000|Overall Study|Lost to Follow-up|2|||
155308853|NCT02874534|560563735|FG001|Overall Study|Lost to Follow-up|2|||
155308854|NCT02874534|560563734|FG000|Overall Study|Ongoing in study|1|||
155308855|NCT02874534|560563735|FG001|Overall Study|Ongoing in study|1|||
155308856|NCT02923180|560563736|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
155308857|NCT02923180|560563736|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
155308858|NCT05198310|560563737|FG000|Overall Study|Lost to Follow-up|0|||
155308859|NCT05198310|560563738|FG001|Overall Study|Lost to Follow-up|1|||
155308860|NCT05198310|560563739|FG002|Overall Study|Lost to Follow-up|0|||
155308861|NCT05198310|560563740|FG003|Overall Study|Lost to Follow-up|0|||
155308862|NCT05198310|560563741|FG004|Overall Study|Lost to Follow-up|0|||
155308863|NCT05198310|560563742|FG005|Overall Study|Lost to Follow-up|0|||
155308864|NCT05198310|560563743|FG006|Overall Study|Lost to Follow-up|0|||
155308865|NCT05198310|560563744|FG007|Overall Study|Lost to Follow-up|0|||
155308866|NCT05198310|560563737|FG000|Overall Study|Withdrawal by Subject|0|||
155308867|NCT05198310|560563738|FG001|Overall Study|Withdrawal by Subject|0|||
155308868|NCT05198310|560563739|FG002|Overall Study|Withdrawal by Subject|0|||
155308869|NCT05198310|560563740|FG003|Overall Study|Withdrawal by Subject|2|||
155308870|NCT05198310|560563741|FG004|Overall Study|Withdrawal by Subject|0|||
155308871|NCT05198310|560563742|FG005|Overall Study|Withdrawal by Subject|2|||
155308872|NCT05198310|560563743|FG006|Overall Study|Withdrawal by Subject|1|||
155308873|NCT05198310|560563744|FG007|Overall Study|Withdrawal by Subject|3|||
155308874|NCT04116736|560563745|FG000|Overall Study|Withdrew consent during study|3|||
155308875|NCT04116736|560563746|FG001|Overall Study|Withdrew consent during study|1|||
155308876|NCT04116736|560563745|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
155308877|NCT04116736|560563746|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
155308878|NCT04116736|560563745|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
155308879|NCT04116736|560563746|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
155308880|NCT04116736|560563745|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
155308881|NCT04116736|560563746|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
155308882|NCT04116736|560563745|FG000|Overall Study|Subject was enrolled in error|2|||
155308883|NCT04116736|560563746|FG001|Overall Study|Subject was enrolled in error|0|||
155308884|NCT04116736|560563745|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
155308885|NCT04116736|560563746|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
155308886|NCT04116736|560563745|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
155308887|NCT04116736|560563746|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
155308888|NCT04116736|560563745|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
155308889|NCT04116736|560563746|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
155308890|NCT03361748|560563753|FG000|Overall Study|Death|77|||
155308891|NCT03361748|560563753|FG000|Overall Study|Lost to Follow-up|4|||
155415210|NCT03467958|560950716|FG005|Overall Study|Lack of Efficacy|9|||
155415211|NCT03467958|560950717|FG006|Overall Study|Lack of Efficacy|11|||
155415212|NCT03467958|560950718|FG007|Overall Study|Lack of Efficacy|9|||
155415213|NCT03467958|560950719|FG008|Overall Study|Lack of Efficacy|3|||
155415214|NCT03467958|560950711|FG000|Overall Study|Lost to Follow-up|1|||
155415215|NCT03467958|560950712|FG001|Overall Study|Lost to Follow-up|2|||
155415216|NCT03467958|560950713|FG002|Overall Study|Lost to Follow-up|1|||
155415217|NCT03467958|560950714|FG003|Overall Study|Lost to Follow-up|0|||
155415218|NCT03467958|560950715|FG004|Overall Study|Lost to Follow-up|4|||
155415219|NCT03467958|560950716|FG005|Overall Study|Lost to Follow-up|0|||
155642844|NCT02927145|561782326|FG004|Initial Recruitment|Adverse Event|2|||
155308892|NCT03361748|560563753|FG000|Overall Study|Withdrawal by Subject|20|||
155308893|NCT04854096|560563755|FG000|Overall Study|Adverse Event|1|||
155308894|NCT04854096|560563756|FG001|Overall Study|Adverse Event|0|||
155308895|NCT04854096|560563755|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
155308896|NCT04854096|560563756|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
155308897|NCT04854096|560563755|FG000|Overall Study|Withdrawal by Subject|1|||
155415220|NCT03467958|560950717|FG006|Overall Study|Lost to Follow-up|0|||
155642845|NCT02927145|561782327|FG005|Initial Recruitment|Adverse Event|0|||
155642846|NCT02927145|561782328|FG006|Initial Recruitment|Adverse Event|0|||
155642847|NCT02927145|561782329|FG007|Initial Recruitment|Adverse Event|0|||
155642848|NCT02927145|561782330|FG008|Initial Recruitment|Adverse Event|0|||
155642849|NCT02927145|561782322|FG000|Invitation for Additional Challenge|Pregnancy|0|||
155415221|NCT03467958|560950718|FG007|Overall Study|Lost to Follow-up|0|||
155415222|NCT03467958|560950719|FG008|Overall Study|Lost to Follow-up|0|||
155415223|NCT03467958|560950711|FG000|Overall Study|Other reasons|8|||
155415224|NCT03467958|560950712|FG001|Overall Study|Other reasons|14|||
155749741|NCT05040971|562184165|FG001|Overall Study|Death|0|||
155308898|NCT04854096|560563756|FG001|Overall Study|Withdrawal by Subject|0|||
155308899|NCT04854096|560563755|FG000|Overall Study|Other reasons|1|||
155308900|NCT04854096|560563756|FG001|Overall Study|Other reasons|0|||
155308901|NCT04757610|560563757|FG000|Overall Study|Adverse Event|13|||
155308902|NCT04757610|560563758|FG001|Overall Study|Adverse Event|10|||
155308903|NCT04757610|560563759|FG002|Overall Study|Adverse Event|5|||
155308904|NCT04757610|560563757|FG000|Overall Study|Death|5|||
155308905|NCT04757610|560563758|FG001|Overall Study|Death|13|||
155308906|NCT04757610|560563759|FG002|Overall Study|Death|8|||
155308907|NCT04757610|560563757|FG000|Overall Study|Lack of Efficacy|1|||
155308908|NCT04757610|560563758|FG001|Overall Study|Lack of Efficacy|2|||
155308909|NCT04757610|560563759|FG002|Overall Study|Lack of Efficacy|3|||
155308910|NCT04757610|560563757|FG000|Overall Study|Lost to Follow-up|7|||
155308911|NCT04757610|560563758|FG001|Overall Study|Lost to Follow-up|2|||
155308912|NCT04757610|560563759|FG002|Overall Study|Lost to Follow-up|7|||
155308913|NCT04757610|560563757|FG000|Overall Study|Physician Decision|4|||
155308914|NCT04757610|560563758|FG001|Overall Study|Physician Decision|1|||
155308915|NCT04757610|560563759|FG002|Overall Study|Physician Decision|2|||
155308916|NCT04757610|560563757|FG000|Overall Study|Withdrawal by Subject|26|||
155308917|NCT04757610|560563758|FG001|Overall Study|Withdrawal by Subject|25|||
155308918|NCT04757610|560563759|FG002|Overall Study|Withdrawal by Subject|25|||
155308919|NCT04757610|560563757|FG000|Overall Study|Study Terminated by Sponsor|105|||
155308920|NCT04757610|560563758|FG001|Overall Study|Study Terminated by Sponsor|105|||
155308921|NCT04757610|560563759|FG002|Overall Study|Study Terminated by Sponsor|110|||
155308922|NCT04757610|560563757|FG000|Overall Study|Randomized in Error|1|||
155308923|NCT04757610|560563758|FG001|Overall Study|Randomized in Error|0|||
155308924|NCT04757610|560563759|FG002|Overall Study|Randomized in Error|0|||
155308925|NCT03819686|560565376|FG000|Overall Study|Lost to Follow-up|2|||
155308926|NCT03819686|560565377|FG001|Overall Study|Lost to Follow-up|3|||
155308927|NCT03747484|560565378|FG000|Overall Study|Lack of Efficacy|0|||
155308928|NCT03747484|560565379|FG001|Overall Study|Lack of Efficacy|1|||
155308929|NCT03747484|560565380|FG002|Overall Study|Lack of Efficacy|1|||
155308930|NCT03747484|560565381|FG003|Overall Study|Lack of Efficacy|2|||
155308931|NCT03747484|560565382|FG004|Overall Study|Lack of Efficacy|2|||
155308932|NCT03833245|560565386|FG000|Overall Study|Death|0|||
155308933|NCT03833245|560565387|FG001|Overall Study|Death|1|||
155308934|NCT03347383|560565388|FG000|Overall Study|Death|39|||
155308935|NCT03347383|560565388|FG000|Overall Study|Withdrawal by Subject|3|||
155308936|NCT03347383|560565388|FG000|Overall Study|Lost to Follow-up|9|||
155308937|NCT05691452|560565390|FG000|Overall Study|Withdrawal by Subject|1|||
155308938|NCT05691452|560565391|FG001|Overall Study|Withdrawal by Subject|1|||
155308939|NCT05691452|560565392|FG002|Overall Study|Withdrawal by Subject|0|||
155308940|NCT05691452|560565390|FG000|Overall Study|Physician Decision|1|||
155308941|NCT05691452|560565391|FG001|Overall Study|Physician Decision|0|||
155308942|NCT05691452|560565392|FG002|Overall Study|Physician Decision|0|||
155308943|NCT05691452|560565390|FG000|Overall Study|Lost to Follow-up|0|||
155308944|NCT05691452|560565391|FG001|Overall Study|Lost to Follow-up|0|||
155308945|NCT05691452|560565392|FG002|Overall Study|Lost to Follow-up|1|||
155308946|NCT05691452|560565390|FG000|Overall Study|Adverse Event|0|||
155308947|NCT05691452|560565391|FG001|Overall Study|Adverse Event|0|||
155308948|NCT05691452|560565392|FG002|Overall Study|Adverse Event|1|||
155308949|NCT04842643|560565395|FG000|Overall Study|Physician Decision|1|||
155308950|NCT04842643|560565395|FG000|Overall Study|Other|1|||
155308952|NCT02630823|560565398|FG000|Overall Study|Withdrawal by Subject|1|||
155308953|NCT02630823|560565398|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
155308954|NCT05062265|560565401|FG000|Overall Study|Withdrawal by Subject|1|||
155308955|NCT05062265|560565402|FG001|Overall Study|Withdrawal by Subject|0|||
155308956|NCT04630262|560565406|FG000|Overall Study|Intraoperative Screen Failure|5|||
155308957|NCT04630262|560565406|FG000|Overall Study|Study terminated prematurely|71|||
155308958|NCT04630262|560565406|FG000|Overall Study|Withdrawal by Subject|2|||
155308959|NCT04630262|560565406|FG000|Overall Study|Physician Decision|2|||
155308960|NCT04703322|560565408|FG000|Overall Study|Ongoing|8|||
155308961|NCT04703322|560565408|FG000|Overall Study|Withdrawal by Subject|1|||
155308962|NCT04638998|560565409|FG000|Overall Study|Withdrawal by Subject|1|||
155308963|NCT04638998|560565410|FG001|Overall Study|Withdrawal by Subject|3|||
155308964|NCT03988634|560565411|FG000|Double-Blind|Adverse Event|4|||
155308965|NCT03988634|560565412|FG001|Double-Blind|Adverse Event|0|||
155308966|NCT03988634|560565413|FG002|Double-Blind|Adverse Event|0|||
155308967|NCT03988634|560565411|FG000|Double-Blind|Death|18|||
155308968|NCT03988634|560565412|FG001|Double-Blind|Death|26|||
155308969|NCT03988634|560565413|FG002|Double-Blind|Death|0|||
155308970|NCT03988634|560565411|FG000|Double-Blind|Lost to Follow-up|6|||
155308971|NCT03988634|560565412|FG001|Double-Blind|Lost to Follow-up|7|||
155308972|NCT03988634|560565413|FG002|Double-Blind|Lost to Follow-up|0|||
155308973|NCT03988634|560565411|FG000|Double-Blind|Physician Decision|9|||
155308974|NCT03988634|560565412|FG001|Double-Blind|Physician Decision|5|||
155308975|NCT03988634|560565413|FG002|Double-Blind|Physician Decision|0|||
155308976|NCT03988634|560565411|FG000|Double-Blind|Subject decision|24|||
155308977|NCT03988634|560565412|FG001|Double-Blind|Subject decision|13|||
155642850|NCT02927145|561782323|FG001|Invitation for Additional Challenge|Pregnancy|0|||
155642851|NCT02927145|561782324|FG002|Invitation for Additional Challenge|Pregnancy|0|||
155749742|NCT02283177|562184173|FG000|Overall Study|Withdrawal by Subject|1|||
155749743|NCT02283177|562184174|FG001|Overall Study|Withdrawal by Subject|1|||
155749744|NCT01101191|562184175|FG000|Period 1|Withdrawal by Subject|1|||
155749745|NCT01101191|562184176|FG001|Period 1|Withdrawal by Subject|0|||
155749746|NCT01101191|562184175|FG000|Period 1|Adverse Event|1|||
155749747|NCT01101191|562184176|FG001|Period 1|Adverse Event|2|||
155749748|NCT00645788|562184178|FG000|Overall Study|Did not receive study drug|1|||
155749749|NCT00645788|562184179|FG001|Overall Study|Did not receive study drug|1|||
155749750|NCT00645788|562184180|FG002|Overall Study|Did not receive study drug|0|||
155749751|NCT00645788|562184181|FG003|Overall Study|Did not receive study drug|0|||
155498464|NCT01186744|561250611|FG001|Overall Study|Study terminated by Sponsor|0|||
155749752|NCT00645788|562184178|FG000|Overall Study|Adverse Event|4|||
155749753|NCT00645788|562184179|FG001|Overall Study|Adverse Event|9|||
155749754|NCT00645788|562184180|FG002|Overall Study|Adverse Event|5|||
155415225|NCT03467958|560950713|FG002|Overall Study|Other reasons|2|||
155415226|NCT03467958|560950714|FG003|Overall Study|Other reasons|1|||
155415227|NCT03467958|560950715|FG004|Overall Study|Other reasons|4|||
155415228|NCT03467958|560950716|FG005|Overall Study|Other reasons|0|||
155415229|NCT03467958|560950717|FG006|Overall Study|Other reasons|1|||
155415230|NCT03467958|560950718|FG007|Overall Study|Other reasons|0|||
155415231|NCT03467958|560950719|FG008|Overall Study|Other reasons|1|||
155415232|NCT03467958|560950711|FG000|Overall Study|Pregnancy|1|||
155415233|NCT03467958|560950712|FG001|Overall Study|Pregnancy|0|||
155415234|NCT03467958|560950713|FG002|Overall Study|Pregnancy|0|||
155415235|NCT03467958|560950714|FG003|Overall Study|Pregnancy|0|||
155642852|NCT02927145|561782325|FG003|Invitation for Additional Challenge|Pregnancy|0|||
155642853|NCT02927145|561782326|FG004|Invitation for Additional Challenge|Pregnancy|0|||
155642854|NCT02927145|561782327|FG005|Invitation for Additional Challenge|Pregnancy|0|||
155642855|NCT02927145|561782328|FG006|Invitation for Additional Challenge|Pregnancy|1|||
155642856|NCT02927145|561782329|FG007|Invitation for Additional Challenge|Pregnancy|0|||
155642857|NCT02927145|561782330|FG008|Invitation for Additional Challenge|Pregnancy|0|||
155642858|NCT02582632|561782331|FG000|Overall Study|Other|1|||
155642859|NCT00327171|561782335|FG000|Overall Study|Did not receive study medication|3|||
155642860|NCT00327171|561782336|FG001|Overall Study|Did not receive study medication|0|||
155642861|NCT00327171|561782335|FG000|Overall Study|Adverse Event|23|||
155642862|NCT00327171|561782336|FG001|Overall Study|Adverse Event|23|||
155642863|NCT00327171|561782335|FG000|Overall Study|Disease progression/lack of efficacy|68|||
155642864|NCT00327171|561782336|FG001|Overall Study|Disease progression/lack of efficacy|69|||
155642865|NCT00327171|561782335|FG000|Overall Study|Investigator/participant request|1|||
155642866|NCT00327171|561782336|FG001|Overall Study|Investigator/participant request|8|||
155642867|NCT00327171|561782335|FG000|Overall Study|Clinical progression|12|||
155642868|NCT00327171|561782336|FG001|Overall Study|Clinical progression|8|||
155642869|NCT00327171|561782335|FG000|Overall Study|Undisclosed history of ischemia|0|||
155642870|NCT00327171|561782336|FG001|Overall Study|Undisclosed history of ischemia|1|||
155642871|NCT00327171|561782335|FG000|Overall Study|Other|1|||
155642872|NCT00327171|561782336|FG001|Overall Study|Other|0|||
155642873|NCT03677401|561782338|FG000|Overall Study|Adverse Event|4|||
155642874|NCT03677401|561782339|FG001|Overall Study|Adverse Event|14|||
155642875|NCT03677401|561782338|FG000|Overall Study|Lack of Efficacy|3|||
155642876|NCT03677401|561782339|FG001|Overall Study|Lack of Efficacy|1|||
155642877|NCT03677401|561782338|FG000|Overall Study|Withdrawal by Subject|2|||
155642878|NCT03677401|561782339|FG001|Overall Study|Withdrawal by Subject|2|||
155642879|NCT03677401|561782338|FG000|Overall Study|Sponsor decision|0|||
155642880|NCT03677401|561782339|FG001|Overall Study|Sponsor decision|1|||
155642881|NCT03677401|561782338|FG000|Overall Study|Reason Unspecified|1|||
155642882|NCT03677401|561782339|FG001|Overall Study|Reason Unspecified|0|||
155642883|NCT01177410|561782342|FG000|Overall Study|Adverse Event|0|||
155642884|NCT01177410|561782343|FG001|Overall Study|Adverse Event|2|||
155642885|NCT01177410|561782344|FG002|Overall Study|Adverse Event|2|||
155642886|NCT01177410|561782342|FG000|Overall Study|Withdrawal by Subject|1|||
155642887|NCT01177410|561782343|FG001|Overall Study|Withdrawal by Subject|4|||
155642888|NCT01177410|561782344|FG002|Overall Study|Withdrawal by Subject|3|||
155642889|NCT01177410|561782342|FG000|Overall Study|Lost to Follow-up|0|||
155749755|NCT00645788|562184181|FG003|Overall Study|Adverse Event|3|||
155749756|NCT00645788|562184178|FG000|Overall Study|Lost to Follow-up|1|||
155415236|NCT03467958|560950715|FG004|Overall Study|Pregnancy|0|||
155415237|NCT03467958|560950716|FG005|Overall Study|Pregnancy|1|||
155642890|NCT01177410|561782343|FG001|Overall Study|Lost to Follow-up|1|||
155642891|NCT01177410|561782344|FG002|Overall Study|Lost to Follow-up|0|||
155642892|NCT00471354|561782348|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
155642893|NCT00471354|561782348|FG000|Overall Study|Adverse Event|13|||
155642894|NCT00471354|561782348|FG000|Overall Study|Protocol Violation|12|||
155642895|NCT00471354|561782348|FG000|Overall Study|Withdrawal by Subject|1|||
155642896|NCT00471354|561782348|FG000|Overall Study|Physician Decision|4|||
155642897|NCT00471354|561782348|FG000|Overall Study|Sponsor Decision|1|||
155749757|NCT00645788|562184179|FG001|Overall Study|Lost to Follow-up|0|||
155308978|NCT03988634|560565413|FG002|Double-Blind|Subject decision|0|||
155308979|NCT03988634|560565411|FG000|Open-Label|Adverse Event|0|||
155308980|NCT03988634|560565412|FG001|Open-Label|Adverse Event|0|||
155308981|NCT03988634|560565413|FG002|Open-Label|Adverse Event|7|||
155308982|NCT03988634|560565411|FG000|Open-Label|Physician Decision|0|||
155308983|NCT03988634|560565412|FG001|Open-Label|Physician Decision|0|||
155415238|NCT03467958|560950717|FG006|Overall Study|Pregnancy|0|||
155415239|NCT03467958|560950718|FG007|Overall Study|Pregnancy|0|||
155415240|NCT03467958|560950719|FG008|Overall Study|Pregnancy|0|||
155415241|NCT03467958|560950711|FG000|Overall Study|Study terminated by sponsor|65|||
155415242|NCT03467958|560950712|FG001|Overall Study|Study terminated by sponsor|117|||
155415243|NCT03467958|560950713|FG002|Overall Study|Study terminated by sponsor|45|||
155415244|NCT03467958|560950714|FG003|Overall Study|Study terminated by sponsor|64|||
155415245|NCT03467958|560950715|FG004|Overall Study|Study terminated by sponsor|66|||
155415246|NCT03467958|560950716|FG005|Overall Study|Study terminated by sponsor|17|||
155415247|NCT03467958|560950717|FG006|Overall Study|Study terminated by sponsor|11|||
155415248|NCT03467958|560950718|FG007|Overall Study|Study terminated by sponsor|5|||
155415249|NCT03467958|560950719|FG008|Overall Study|Study terminated by sponsor|5|||
155415250|NCT03467958|560950711|FG000|Overall Study|Withdrawal by Subject|25|||
155415251|NCT03467958|560950712|FG001|Overall Study|Withdrawal by Subject|44|||
155415252|NCT03467958|560950713|FG002|Overall Study|Withdrawal by Subject|7|||
155415253|NCT03467958|560950714|FG003|Overall Study|Withdrawal by Subject|8|||
155415254|NCT03467958|560950715|FG004|Overall Study|Withdrawal by Subject|6|||
155415255|NCT03467958|560950716|FG005|Overall Study|Withdrawal by Subject|8|||
155415256|NCT03467958|560950717|FG006|Overall Study|Withdrawal by Subject|4|||
155415257|NCT03467958|560950718|FG007|Overall Study|Withdrawal by Subject|1|||
155415258|NCT03467958|560950719|FG008|Overall Study|Withdrawal by Subject|4|||
155415259|NCT01687712|560950720|FG000|Cycle 1|Not Biochemically Pregnant|386|||
155415260|NCT01687712|560950721|FG001|Cycle 1|Not Biochemically Pregnant|348|||
155415261|NCT01687712|560950720|FG000|Cycle 1|Early Pregnancy Loss|43|||
155415262|NCT01687712|560950721|FG001|Cycle 1|Early Pregnancy Loss|60|||
155415263|NCT01687712|560950720|FG000|Cycle 1|Ectopic Pregnancy|5|||
155415264|NCT01687712|560950721|FG001|Cycle 1|Ectopic Pregnancy|5|||
155415265|NCT01687712|560950720|FG000|Cycle 1|Heterotropic Pregnancy|1|||
155415266|NCT01687712|560950721|FG001|Cycle 1|Heterotropic Pregnancy|0|||
155415267|NCT01687712|560950720|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
155415268|NCT01687712|560950721|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
155415269|NCT01687712|560950720|FG000|Cycle 1|Abortion|3|||
155415270|NCT01687712|560950721|FG001|Cycle 1|Abortion|0|||
155415271|NCT01687712|560950720|FG000|Cycle 1|Intrauterine Fetal Death|0|||
155415272|NCT01687712|560950721|FG001|Cycle 1|Intrauterine Fetal Death|1|||
155415273|NCT01687712|560950720|FG000|Cycle 1|Lost to Follow-up|1|||
155415274|NCT01687712|560950721|FG001|Cycle 1|Lost to Follow-up|1|||
155415275|NCT01687712|560950720|FG000|Cycle 2|Not Biochemically Pregnant|74|||
155415276|NCT01687712|560950721|FG001|Cycle 2|Not Biochemically Pregnant|77|||
155415277|NCT01687712|560950720|FG000|Cycle 2|Early Pregnancy Loss|18|||
155415278|NCT01687712|560950721|FG001|Cycle 2|Early Pregnancy Loss|16|||
155415279|NCT01687712|560950720|FG000|Cycle 2|Ectopic Pregnancy|0|||
155415280|NCT01687712|560950721|FG001|Cycle 2|Ectopic Pregnancy|1|||
155415281|NCT01687712|560950720|FG000|Cycle 2|Still Birth|1|||
155415282|NCT01687712|560950721|FG001|Cycle 2|Still Birth|0|||
155415283|NCT01687712|560950720|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
155415284|NCT01687712|560950721|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
155415285|NCT01687712|560950720|FG000|Cycle 3|Not Biochemically Pregnant|21|||
155415286|NCT01687712|560950721|FG001|Cycle 3|Not Biochemically Pregnant|22|||
155415287|NCT01687712|560950720|FG000|Cycle 3|Early Pregnancy Loss|1|||
155415288|NCT01687712|560950721|FG001|Cycle 3|Early Pregnancy Loss|2|||
155415289|NCT01687712|560950720|FG000|Cycle 3|Ectopic Pregnancy|1|||
155415290|NCT01687712|560950721|FG001|Cycle 3|Ectopic Pregnancy|0|||
155415291|NCT01687712|560950720|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
155415292|NCT01687712|560950721|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
155415293|NCT00516737|560950726|FG000|Overall Study|Lost to Follow-up|2|||
155415294|NCT00516737|560950727|FG001|Overall Study|Lost to Follow-up|0|||
155415295|NCT00516737|560950726|FG000|Overall Study|Physician Decision|0|||
155415296|NCT00516737|560950727|FG001|Overall Study|Physician Decision|1|||
155308984|NCT03988634|560565413|FG002|Open-Label|Physician Decision|1|||
155308985|NCT03988634|560565411|FG000|Open-Label|Technical problems|0|||
155308986|NCT03988634|560565412|FG001|Open-Label|Technical problems|0|||
155308987|NCT03988634|560565413|FG002|Open-Label|Technical problems|1|||
155308988|NCT05374837|560565414|FG000|Overall Study|Lost to Follow-up|17|||
155308989|NCT05374837|560565415|FG001|Overall Study|Lost to Follow-up|18|||
155415297|NCT00516737|560950726|FG000|Overall Study|Withdrawal by Subject|0|||
155415298|NCT00516737|560950727|FG001|Overall Study|Withdrawal by Subject|1|||
155415299|NCT00516737|560950726|FG000|Overall Study|Lack of Qualifying Event|9|||
155415300|NCT00516737|560950727|FG001|Overall Study|Lack of Qualifying Event|6|||
155415301|NCT01844895|560950728|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
155415302|NCT01844895|560950728|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
155642898|NCT00471354|561782348|FG000|Overall Study|Lost to Follow-up|3|||
155642899|NCT00471354|561782348|FG000|Overall Study|Lack of Efficacy|5|||
155415303|NCT01844895|560950728|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
155415304|NCT01844895|560950728|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
155415305|NCT01844895|560950728|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
155415306|NCT01844895|560950728|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
155415307|NCT01844895|560950728|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
155415308|NCT00848354|560950729|FG000|Phase 1|Adverse Event|5|||
155415309|NCT00848354|560950730|FG001|Phase 1|Adverse Event|4|||
155415310|NCT00848354|560950729|FG000|Phase 1|Discontinuation of study by sponsor|2|||
155415311|NCT00848354|560950730|FG001|Phase 1|Discontinuation of study by sponsor|1|||
155415312|NCT00848354|560950729|FG000|Phase 1|Failed to return|0|||
155415313|NCT00848354|560950730|FG001|Phase 1|Failed to return|1|||
155415314|NCT00848354|560950729|FG000|Phase 1|Lost to Follow-up|1|||
155415315|NCT00848354|560950730|FG001|Phase 1|Lost to Follow-up|1|||
155415316|NCT00848354|560950729|FG000|Phase 1|Unspecified Reason|1|||
155415317|NCT00848354|560950730|FG001|Phase 1|Unspecified Reason|1|||
155415318|NCT00848354|560950729|FG000|Phase 1|Protocol Violation|1|||
155415319|NCT00848354|560950730|FG001|Phase 1|Protocol Violation|1|||
155415320|NCT00848354|560950729|FG000|Phase 1|Withdrawal by Subject|2|||
155415321|NCT00848354|560950730|FG001|Phase 1|Withdrawal by Subject|4|||
155415322|NCT00848354|560950729|FG000|Phase 1|Lack of Efficacy|0|||
155415323|NCT00848354|560950730|FG001|Phase 1|Lack of Efficacy|1|||
155415324|NCT00848354|560950729|FG000|Phase 2 Year 1|Adverse Event|7|||
155415325|NCT00848354|560950730|FG001|Phase 2 Year 1|Adverse Event|2|||
155415326|NCT00848354|560950729|FG000|Phase 2 Year 1|Death|1|||
155415327|NCT00848354|560950730|FG001|Phase 2 Year 1|Death|0|||
155415328|NCT00848354|560950729|FG000|Phase 2 Year 1|Failed to Return|1|||
155415329|NCT00848354|560950730|FG001|Phase 2 Year 1|Failed to Return|1|||
155415330|NCT00848354|560950729|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
155415331|NCT00848354|560950730|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
155415332|NCT00848354|560950729|FG000|Phase 2 Year 1|Unspecified Reason|3|||
155415333|NCT00848354|560950730|FG001|Phase 2 Year 1|Unspecified Reason|0|||
155415334|NCT00848354|560950729|FG000|Phase 2 Year 1|Protocol Violation|4|||
155415335|NCT00848354|560950730|FG001|Phase 2 Year 1|Protocol Violation|1|||
155415336|NCT00848354|560950729|FG000|Phase 2 Year 1|Subject Request|1|||
155415337|NCT00848354|560950730|FG001|Phase 2 Year 1|Subject Request|2|||
155415338|NCT00848354|560950729|FG000|Phase 2 Year 2|Adverse Event|12|||
155415339|NCT00848354|560950730|FG001|Phase 2 Year 2|Adverse Event|2|||
155415340|NCT00848354|560950729|FG000|Phase 2 Year 2|Death|2|||
155415341|NCT00848354|560950730|FG001|Phase 2 Year 2|Death|0|||
155415342|NCT00848354|560950729|FG000|Phase 2 Year 2|Failed to return|3|||
155415343|NCT00848354|560950730|FG001|Phase 2 Year 2|Failed to return|0|||
155415344|NCT00848354|560950729|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
155415345|NCT00848354|560950730|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
155415346|NCT00848354|560950729|FG000|Phase 2 Year 2|Unspecified Reason|1|||
155415347|NCT00848354|560950730|FG001|Phase 2 Year 2|Unspecified Reason|0|||
155415348|NCT00848354|560950729|FG000|Phase 2 Year 2|Protocol Violation|1|||
155415349|NCT00848354|560950730|FG001|Phase 2 Year 2|Protocol Violation|1|||
155415350|NCT00848354|560950729|FG000|Phase 2 Year 2|Subject Request|1|||
155415351|NCT00848354|560950730|FG001|Phase 2 Year 2|Subject Request|1|||
155415352|NCT00848354|560950729|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
155415353|NCT00848354|560950730|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
155415354|NCT00512798|560950733|FG000|Overall Study|Death|0|||
155415355|NCT00512798|560950734|FG001|Overall Study|Death|3|||
155415356|NCT00512798|560950733|FG000|Overall Study|Adverse Event|2|||
155415357|NCT00512798|560950734|FG001|Overall Study|Adverse Event|4|||
155415358|NCT00512798|560950733|FG000|Overall Study|Progression of disease|14|||
155415359|NCT00512798|560950734|FG001|Overall Study|Progression of disease|20|||
155415360|NCT00512798|560950733|FG000|Overall Study|Withdrawal by Subject|3|||
155415361|NCT00512798|560950734|FG001|Overall Study|Withdrawal by Subject|0|||
155415362|NCT00915343|560950735|FG000|Part B - Open Label Period|Treatment switch|0|||
155415363|NCT00915343|560950736|FG001|Part B - Open Label Period|Treatment switch|0|||
155415364|NCT00915343|560950737|FG002|Part B - Open Label Period|Treatment switch|1|||
155415365|NCT00915343|560950735|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
155415366|NCT00915343|560950736|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
155415367|NCT00915343|560950737|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
155415368|NCT00911989|560950738|FG000|Overall Study|Adverse Event|1|||
155415369|NCT03434977|560950739|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
155308990|NCT05406921|560565420|FG000|Overall Study|Withdrawal by Subject|25|||
155308991|NCT05406921|560565421|FG001|Overall Study|Withdrawal by Subject|0|||
155308992|NCT05406921|560565422|FG002|Overall Study|Withdrawal by Subject|25|||
155308993|NCT05406921|560565420|FG000|Overall Study|Protocol Violation|0|||
155308994|NCT05406921|560565421|FG001|Overall Study|Protocol Violation|12|||
155308995|NCT05406921|560565422|FG002|Overall Study|Protocol Violation|0|||
155308996|NCT00676715|560565425|FG000|Treatment Period (TP)|Adverse Event|0|||
155308997|NCT00676715|560565426|FG001|Treatment Period (TP)|Adverse Event|3|||
155308998|NCT00676715|560565427|FG002|Treatment Period (TP)|Adverse Event|2|||
155308999|NCT00676715|560565428|FG003|Treatment Period (TP)|Adverse Event|2|||
155309000|NCT00676715|560565425|FG000|Treatment Period (TP)|Death|0|||
155309001|NCT00676715|560565426|FG001|Treatment Period (TP)|Death|0|||
155309002|NCT00676715|560565427|FG002|Treatment Period (TP)|Death|1|||
155309003|NCT00676715|560565428|FG003|Treatment Period (TP)|Death|0|||
155309004|NCT00676715|560565425|FG000|Treatment Period (TP)|Failure to return|1|||
155309005|NCT00676715|560565426|FG001|Treatment Period (TP)|Failure to return|0|||
155309006|NCT00676715|560565427|FG002|Treatment Period (TP)|Failure to return|0|||
155309007|NCT00676715|560565428|FG003|Treatment Period (TP)|Failure to return|0|||
155309008|NCT00676715|560565425|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309009|NCT00676715|560565426|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309010|NCT00676715|560565427|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
155309011|NCT00676715|560565428|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309012|NCT00676715|560565425|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
155309013|NCT00676715|560565426|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
155309014|NCT00676715|560565427|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
155309015|NCT00676715|560565428|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
155309016|NCT00676715|560565425|FG000|Treatment Period (TP)|Withdrew consent|3|||
155309017|NCT00676715|560565426|FG001|Treatment Period (TP)|Withdrew consent|3|||
155309018|NCT00676715|560565427|FG002|Treatment Period (TP)|Withdrew consent|3|||
155309019|NCT00676715|560565428|FG003|Treatment Period (TP)|Withdrew consent|3|||
155309020|NCT00676715|560565425|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309021|NCT00676715|560565426|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309022|NCT00676715|560565427|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
155309023|NCT00676715|560565428|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309024|NCT00676715|560565425|FG000|Treatment Period (TP)|Administrative|0|||
155309025|NCT00676715|560565426|FG001|Treatment Period (TP)|Administrative|0|||
155309026|NCT00676715|560565427|FG002|Treatment Period (TP)|Administrative|0|||
155309027|NCT00676715|560565428|FG003|Treatment Period (TP)|Administrative|1|||
155309028|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
155309029|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
155309030|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
155309031|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
155309032|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
155309033|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
155309034|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
155309035|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
155309036|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309037|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309038|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
155309039|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309040|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
155309041|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
155309042|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
155309043|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
155415370|NCT03434977|560950740|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
155415371|NCT03064841|560950741|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
155749758|NCT00645788|562184180|FG002|Overall Study|Lost to Follow-up|0|||
155749759|NCT00645788|562184181|FG003|Overall Study|Lost to Follow-up|0|||
155749760|NCT00645788|562184178|FG000|Overall Study|Protocol Violation|1|||
155749761|NCT00645788|562184179|FG001|Overall Study|Protocol Violation|0|||
155415372|NCT03064841|560950741|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
155415373|NCT03064841|560950741|FG000|Overall Study|Screen failure|2|||
155749762|NCT00645788|562184180|FG002|Overall Study|Protocol Violation|2|||
155749763|NCT00645788|562184181|FG003|Overall Study|Protocol Violation|0|||
155309044|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Death|1|||
155309045|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Death|1|||
155309046|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Death|1|||
155309047|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Death|0|||
155309048|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Reason not provided|3|||
155309049|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Reason not provided|4|||
155415374|NCT01250379|560950742|FG000|Overall Study|Death|141|||
155749764|NCT00645788|562184178|FG000|Overall Study|Withdrawal by Subject|0|||
155749765|NCT00645788|562184179|FG001|Overall Study|Withdrawal by Subject|1|||
155309050|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Reason not provided|1|||
155309051|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Reason not provided|4|||
155309052|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
155309053|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
155309054|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
155309055|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
155309056|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
155309057|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
155309058|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
155309059|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
155309060|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Adverse Event|0|||
155309061|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Adverse Event|3|||
155309062|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Adverse Event|1|||
155309063|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Adverse Event|0|||
155309064|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Death|2|||
155309065|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Death|0|||
155309066|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Death|2|||
155309067|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Death|2|||
155309068|NCT04831281|560565432|FG000|Overall Study|Adverse Event|1|||
155309069|NCT04831281|560565433|FG001|Overall Study|Adverse Event|0|||
155309070|NCT04831281|560565434|FG002|Overall Study|Adverse Event|3|||
155309071|NCT04831281|560565432|FG000|Overall Study|Withdrawal by Subject|0|||
155309072|NCT04831281|560565433|FG001|Overall Study|Withdrawal by Subject|1|||
155309073|NCT04831281|560565434|FG002|Overall Study|Withdrawal by Subject|2|||
155309074|NCT04831281|560565432|FG000|Overall Study|Undetermined|1|||
155309075|NCT04831281|560565433|FG001|Overall Study|Undetermined|1|||
155309076|NCT04831281|560565434|FG002|Overall Study|Undetermined|0|||
155309077|NCT03161379|560565435|FG000|Overall Study|Withdrawal by Subject|4|||
155309078|NCT03161379|560565435|FG000|Overall Study|disease progression during chemotherapy|5|||
155309079|NCT03161379|560565435|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
155309080|NCT03161379|560565435|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
155309081|NCT03393975|560565437|FG000|Urgent Treatment Period|Physician Decision|0|||
155309082|NCT03393975|560565438|FG001|Urgent Treatment Period|Physician Decision|0|||
155309083|NCT03393975|560565439|FG002|Urgent Treatment Period|Physician Decision|0|||
155309084|NCT03393975|560565440|FG003|Urgent Treatment Period|Physician Decision|1|||
155309085|NCT03393975|560565437|FG000|Prophylaxis Period 1|Reason not Specified|0|||
155309086|NCT03393975|560565438|FG001|Prophylaxis Period 1|Reason not Specified|1|||
155309087|NCT03393975|560565439|FG002|Prophylaxis Period 1|Reason not Specified|0|||
155309088|NCT03393975|560565440|FG003|Prophylaxis Period 1|Reason not Specified|0|||
155309089|NCT03393975|560565437|FG000|Prophylaxis Period 2|Reason not Specified|0|||
155309090|NCT03393975|560565438|FG001|Prophylaxis Period 2|Reason not Specified|1|||
155309091|NCT03393975|560565439|FG002|Prophylaxis Period 2|Reason not Specified|0|||
155309092|NCT03393975|560565440|FG003|Prophylaxis Period 2|Reason not Specified|0|||
155309093|NCT05021640|560565441|FG000|Overall Study|Lost to Follow-up|0|||
155309094|NCT05021640|560565442|FG001|Overall Study|Lost to Follow-up|0|||
155309095|NCT05021640|560565443|FG002|Overall Study|Lost to Follow-up|0|||
155309096|NCT05021640|560565444|FG003|Overall Study|Lost to Follow-up|0|||
155309097|NCT05021640|560565445|FG004|Overall Study|Lost to Follow-up|1|||
155309098|NCT02312960|560565446|FG000|Overall Study|Death|24|||
155309099|NCT02312960|560565447|FG001|Overall Study|Death|32|||
155309100|NCT02312960|560565448|FG002|Overall Study|Death|25|||
155309101|NCT02312960|560565449|FG003|Overall Study|Death|11|||
155309102|NCT02312960|560565450|FG004|Overall Study|Death|5|||
155309103|NCT02312960|560565451|FG005|Overall Study|Death|5|||
155309104|NCT02312960|560565452|FG006|Overall Study|Death|8|||
155309105|NCT02312960|560565453|FG007|Overall Study|Death|5|||
155309106|NCT02312960|560565454|FG008|Overall Study|Death|7|||
155309107|NCT02312960|560565455|FG009|Overall Study|Death|3|||
155309108|NCT02312960|560565456|FG010|Overall Study|Death|3|||
155309109|NCT02312960|560565457|FG011|Overall Study|Death|1|||
155309110|NCT02312960|560565458|FG012|Overall Study|Death|25|||
155309111|NCT02312960|560565459|FG013|Overall Study|Death|19|||
155309112|NCT02312960|560565446|FG000|Overall Study|Missing|0|||
155309113|NCT02312960|560565447|FG001|Overall Study|Missing|0|||
155309114|NCT02312960|560565448|FG002|Overall Study|Missing|2|||
155309115|NCT02312960|560565449|FG003|Overall Study|Missing|0|||
155309116|NCT02312960|560565450|FG004|Overall Study|Missing|0|||
155309117|NCT02312960|560565451|FG005|Overall Study|Missing|0|||
155309118|NCT02312960|560565452|FG006|Overall Study|Missing|0|||
155309119|NCT02312960|560565453|FG007|Overall Study|Missing|0|||
155309120|NCT02312960|560565454|FG008|Overall Study|Missing|0|||
155309121|NCT02312960|560565455|FG009|Overall Study|Missing|0|||
155309122|NCT02312960|560565456|FG010|Overall Study|Missing|0|||
155309123|NCT02312960|560565457|FG011|Overall Study|Missing|0|||
155309124|NCT02312960|560565458|FG012|Overall Study|Missing|0|||
155309125|NCT02312960|560565459|FG013|Overall Study|Missing|0|||
155309126|NCT02312960|560565446|FG000|Overall Study|Lost to Follow-up|0|||
155309127|NCT02312960|560565447|FG001|Overall Study|Lost to Follow-up|0|||
155309128|NCT02312960|560565448|FG002|Overall Study|Lost to Follow-up|1|||
155309129|NCT02312960|560565449|FG003|Overall Study|Lost to Follow-up|0|||
155309130|NCT02312960|560565450|FG004|Overall Study|Lost to Follow-up|0|||
155309131|NCT02312960|560565451|FG005|Overall Study|Lost to Follow-up|0|||
155309132|NCT02312960|560565452|FG006|Overall Study|Lost to Follow-up|1|||
155309133|NCT02312960|560565453|FG007|Overall Study|Lost to Follow-up|1|||
155309134|NCT02312960|560565454|FG008|Overall Study|Lost to Follow-up|0|||
155309135|NCT02312960|560565455|FG009|Overall Study|Lost to Follow-up|1|||
155309136|NCT02312960|560565456|FG010|Overall Study|Lost to Follow-up|0|||
155309137|NCT02312960|560565457|FG011|Overall Study|Lost to Follow-up|0|||
155309138|NCT02312960|560565458|FG012|Overall Study|Lost to Follow-up|1|||
155309139|NCT02312960|560565459|FG013|Overall Study|Lost to Follow-up|0|||
155309140|NCT02312960|560565446|FG000|Overall Study|Withdrawal by Subject|1|||
155309141|NCT02312960|560565447|FG001|Overall Study|Withdrawal by Subject|2|||
155309142|NCT02312960|560565448|FG002|Overall Study|Withdrawal by Subject|0|||
155309143|NCT02312960|560565449|FG003|Overall Study|Withdrawal by Subject|0|||
155309144|NCT02312960|560565450|FG004|Overall Study|Withdrawal by Subject|1|||
155309145|NCT02312960|560565451|FG005|Overall Study|Withdrawal by Subject|0|||
155309146|NCT02312960|560565452|FG006|Overall Study|Withdrawal by Subject|1|||
155309147|NCT02312960|560565453|FG007|Overall Study|Withdrawal by Subject|2|||
155309148|NCT02312960|560565454|FG008|Overall Study|Withdrawal by Subject|2|||
155309149|NCT02312960|560565455|FG009|Overall Study|Withdrawal by Subject|3|||
155309150|NCT02312960|560565456|FG010|Overall Study|Withdrawal by Subject|0|||
155309151|NCT02312960|560565457|FG011|Overall Study|Withdrawal by Subject|0|||
155309152|NCT02312960|560565458|FG012|Overall Study|Withdrawal by Subject|2|||
155309153|NCT02312960|560565459|FG013|Overall Study|Withdrawal by Subject|0|||
155309154|NCT02807636|560565461|FG000|Overall Study|Lost to Follow-up|10|||
155309155|NCT02807636|560565462|FG001|Overall Study|Lost to Follow-up|13|||
155309156|NCT02807636|560565463|FG002|Overall Study|Lost to Follow-up|6|||
155309157|NCT02807636|560565461|FG000|Overall Study|Protocol Deviation|1|||
155309158|NCT02807636|560565462|FG001|Overall Study|Protocol Deviation|0|||
155309159|NCT02807636|560565463|FG002|Overall Study|Protocol Deviation|0|||
155309160|NCT02807636|560565461|FG000|Overall Study|Symptomatic Deterioration|0|||
155309161|NCT02807636|560565462|FG001|Overall Study|Symptomatic Deterioration|1|||
155309162|NCT02807636|560565463|FG002|Overall Study|Symptomatic Deterioration|0|||
155309163|NCT02807636|560565461|FG000|Overall Study|Withdrawal by Subject|39|||
155309164|NCT02807636|560565462|FG001|Overall Study|Withdrawal by Subject|28|||
155309165|NCT02807636|560565463|FG002|Overall Study|Withdrawal by Subject|24|||
155309166|NCT02807636|560565461|FG000|Overall Study|Death|303|||
155309167|NCT02807636|560565462|FG001|Overall Study|Death|332|||
155309168|NCT02807636|560565463|FG002|Overall Study|Death|272|||
155309169|NCT02807636|560565461|FG000|Overall Study|Study Terminated By Sponsor|47|||
155309170|NCT02807636|560565462|FG001|Overall Study|Study Terminated By Sponsor|76|||
155309171|NCT02807636|560565463|FG002|Overall Study|Study Terminated By Sponsor|60|||
155309172|NCT02807636|560565461|FG000|Overall Study|Physician Decision|0|||
155309173|NCT02807636|560565462|FG001|Overall Study|Physician Decision|1|||
155309174|NCT02807636|560565463|FG002|Overall Study|Physician Decision|0|||
155309175|NCT05227209|560565464|FG000|Overall Study|Adverse Event|11|||
155309176|NCT05227209|560565464|FG000|Overall Study|Lost to Follow-up|1|||
155415375|NCT01250379|560950743|FG001|Overall Study|Death|148|||
155415376|NCT01250379|560950742|FG000|Overall Study|Withdrawal by Subject|32|||
155415377|NCT01250379|560950743|FG001|Overall Study|Withdrawal by Subject|20|||
155415378|NCT01250379|560950742|FG000|Overall Study|Physician Decision|11|||
155415379|NCT01250379|560950743|FG001|Overall Study|Physician Decision|3|||
155415380|NCT01250379|560950742|FG000|Overall Study|Protocol Violation|2|||
155415381|NCT01250379|560950743|FG001|Overall Study|Protocol Violation|8|||
155415382|NCT01250379|560950742|FG000|Overall Study|Lost to Follow-up|9|||
155642900|NCT00471354|561782348|FG000|Overall Study|Patient/Caregiver Decision|12|||
155642901|NCT05558410|561782349|FG000|Overall Study|Adverse Event|1|||
155642902|NCT05558410|561782350|FG001|Overall Study|Adverse Event|2|||
155642903|NCT05558410|561782351|FG002|Overall Study|Adverse Event|0|||
155642904|NCT05558410|561782349|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
155642905|NCT05558410|561782350|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155642906|NCT05558410|561782351|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
155642907|NCT05558410|561782349|FG000|Overall Study|Lost to Follow-up|10|||
155642908|NCT05558410|561782350|FG001|Overall Study|Lost to Follow-up|17|||
155309177|NCT05227209|560565464|FG000|Overall Study|Withdrawal by Subject|7|||
155309178|NCT05227209|560565464|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
155309179|NCT05633953|560565465|FG000|Overall Study|Adverse Event|7|||
155309180|NCT05633953|560565465|FG000|Overall Study|Death|30|||
155309181|NCT05633953|560565465|FG000|Overall Study|Lost to Follow-up|1|||
155309182|NCT05633953|560565465|FG000|Overall Study|Osilodrostat discontinued|4|||
155309183|NCT05633953|560565465|FG000|Overall Study|Physician Decision|1|||
155309184|NCT05633953|560565465|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
155309185|NCT05633953|560565465|FG000|Overall Study|Progressive disease|2|||
155642909|NCT05558410|561782351|FG002|Overall Study|Lost to Follow-up|19|||
155309186|NCT05337748|560565471|FG000|Overall Study|Withdrawal by Subject|1|||
155309187|NCT05337748|560565472|FG001|Overall Study|Withdrawal by Subject|0|||
155642910|NCT05558410|561782349|FG000|Overall Study|Death|1|||
155309188|NCT05337748|560565471|FG000|Overall Study|Death|1|||
155309189|NCT05337748|560565472|FG001|Overall Study|Death|0|||
155309190|NCT02506959|560565473|FG000|Overall Study|Physician Decision|2|||
155309191|NCT02506959|560565474|FG001|Overall Study|Physician Decision|1|||
155309192|NCT03453619|560565477|FG000|Core Study (Part A)|Physician Decision|0|||
155309193|NCT03453619|560565478|FG001|Core Study (Part A)|Physician Decision|0|||
155309194|NCT03453619|560565479|FG002|Core Study (Part A)|Physician Decision|2|||
155309195|NCT03453619|560565480|FG003|Core Study (Part A)|Physician Decision|0|||
155309196|NCT03453619|560565477|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
155309197|NCT03453619|560565478|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
155309198|NCT03453619|560565479|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
155309199|NCT03453619|560565480|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
155309200|NCT03453619|560565477|FG000|Core Study (Part A)|Other|0|||
155309201|NCT03453619|560565478|FG001|Core Study (Part A)|Other|1|||
155309202|NCT03453619|560565479|FG002|Core Study (Part A)|Other|0|||
155309203|NCT03453619|560565480|FG003|Core Study (Part A)|Other|0|||
155309204|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
155309205|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
155309206|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
155309207|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
155309208|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
155309209|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
155309210|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
155309211|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
155309212|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309213|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309214|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309215|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
155309216|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
155309217|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
155309218|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
155309219|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
155309220|NCT04089371|560565481|FG000|Overall Study|Withdrawal by Subject|0|||
155309221|NCT04089371|560565482|FG001|Overall Study|Withdrawal by Subject|1|||
155309222|NCT04089371|560565481|FG000|Overall Study|Study terminated early|0|||
155415383|NCT01250379|560950743|FG001|Overall Study|Lost to Follow-up|6|||
155415384|NCT01250379|560950742|FG000|Overall Study|Adverse Event|5|||
155415385|NCT01250379|560950743|FG001|Overall Study|Adverse Event|4|||
155415386|NCT01250379|560950742|FG000|Overall Study|Other|0|||
155415387|NCT01250379|560950743|FG001|Overall Study|Other|4|||
155415388|NCT01250379|560950742|FG000|Overall Study|Participant noncompliance|2|||
155415389|NCT01250379|560950743|FG001|Overall Study|Participant noncompliance|0|||
155415390|NCT01314716|560950744|FG000|Double-Blind Phase|Randomized but not treated|1|||
155415391|NCT01314716|560950745|FG001|Double-Blind Phase|Randomized but not treated|1|||
155415392|NCT01314716|560950744|FG000|Double-Blind Phase|Adverse Event|10|||
155415393|NCT01314716|560950745|FG001|Double-Blind Phase|Adverse Event|4|||
155415394|NCT01314716|560950744|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
155415395|NCT01314716|560950745|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
155415396|NCT01314716|560950744|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155415397|NCT01314716|560950745|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155415398|NCT01314716|560950744|FG000|Double-Blind Phase|Sponsor request|1|||
155415399|NCT01314716|560950745|FG001|Double-Blind Phase|Sponsor request|2|||
155415400|NCT01314716|560950744|FG000|Double-Blind Phase|Physician Decision|0|||
155415401|NCT01314716|560950745|FG001|Double-Blind Phase|Physician Decision|1|||
155415402|NCT01314716|560950744|FG000|Open-Label Phase|Adverse Event|4|||
155415403|NCT01314716|560950745|FG001|Open-Label Phase|Adverse Event|6|||
155415404|NCT01314716|560950744|FG000|Open-Label Phase|Withdrawal by Subject|1|||
155749766|NCT00645788|562184180|FG002|Overall Study|Withdrawal by Subject|0|||
155749767|NCT00645788|562184181|FG003|Overall Study|Withdrawal by Subject|2|||
155415405|NCT01314716|560950745|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155415406|NCT01314716|560950744|FG000|Open-Label Phase|Physician Decision|5|||
155749768|NCT00645788|562184178|FG000|Overall Study|Pulmonary exacerbation|13|||
155749769|NCT00645788|562184179|FG001|Overall Study|Pulmonary exacerbation|16|||
155309223|NCT04089371|560565482|FG001|Overall Study|Study terminated early|9|||
155309224|NCT05229120|560565483|FG000|Overall Study|Withdrawal by Subject|8|||
155309225|NCT03932682|560565486|FG000|Overall Study|Death|1|||
155415407|NCT01314716|560950745|FG001|Open-Label Phase|Physician Decision|4|||
155415408|NCT03087955|560952257|FG000|Overall Study|Death|4|||
155415409|NCT03087955|560952258|FG001|Overall Study|Death|0|||
155415410|NCT03087955|560952257|FG000|Overall Study|Lack of Efficacy|2|||
155415411|NCT03087955|560952258|FG001|Overall Study|Lack of Efficacy|0|||
155415412|NCT03087955|560952257|FG000|Overall Study|Lost to Follow-up|1|||
155415413|NCT03087955|560952258|FG001|Overall Study|Lost to Follow-up|0|||
155309226|NCT03932682|560565487|FG001|Overall Study|Death|2|||
155309227|NCT03932682|560565486|FG000|Overall Study|Withdrawal by Subject|37|||
155415414|NCT03266016|560952265|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
155498465|NCT01186744|561250612|FG002|Overall Study|Study terminated by Sponsor|0|||
155498466|NCT01186744|561250613|FG003|Overall Study|Study terminated by Sponsor|0|||
155498467|NCT01186744|561250614|FG004|Overall Study|Study terminated by Sponsor|0|||
155498468|NCT01186744|561250615|FG005|Overall Study|Study terminated by Sponsor|0|||
155498469|NCT01186744|561250610|FG000|Overall Study|Other|9|||
155498470|NCT01186744|561250611|FG001|Overall Study|Other|10|||
155498471|NCT01186744|561250612|FG002|Overall Study|Other|1|||
155498472|NCT01186744|561250613|FG003|Overall Study|Other|2|||
155498473|NCT01186744|561250614|FG004|Overall Study|Other|1|||
155498474|NCT01186744|561250615|FG005|Overall Study|Other|5|||
155498475|NCT01186744|561250610|FG000|Overall Study|Adverse Event|10|||
155498476|NCT01186744|561250611|FG001|Overall Study|Adverse Event|14|||
155498477|NCT01186744|561250612|FG002|Overall Study|Adverse Event|1|||
155498478|NCT01186744|561250613|FG003|Overall Study|Adverse Event|0|||
155498479|NCT01186744|561250614|FG004|Overall Study|Adverse Event|1|||
155498480|NCT01186744|561250615|FG005|Overall Study|Adverse Event|4|||
155498481|NCT01186744|561250610|FG000|Overall Study|Death|1|||
155498482|NCT01186744|561250611|FG001|Overall Study|Death|0|||
155498483|NCT01186744|561250612|FG002|Overall Study|Death|0|||
155498484|NCT01186744|561250613|FG003|Overall Study|Death|0|||
155498485|NCT01186744|561250614|FG004|Overall Study|Death|0|||
155498486|NCT01186744|561250615|FG005|Overall Study|Death|0|||
155498487|NCT00858234|561250618|FG000|Overall Study|Adverse Event|6|||
155498488|NCT00858234|561250618|FG000|Overall Study|Progressive disease|2|||
155498489|NCT00858234|561250618|FG000|Overall Study|Status unknown|1|||
155498490|NCT02957682|561250619|FG000|Overall Study|Adverse Event|64|||
155498491|NCT02957682|561250620|FG001|Overall Study|Adverse Event|67|||
155498492|NCT02957682|561250619|FG000|Overall Study|Poor Compliance to Protocol|30|||
155498493|NCT02957682|561250620|FG001|Overall Study|Poor Compliance to Protocol|26|||
155498494|NCT02957682|561250619|FG000|Overall Study|Physician Decision|4|||
155498495|NCT02957682|561250620|FG001|Overall Study|Physician Decision|4|||
155309228|NCT03932682|560565487|FG001|Overall Study|Withdrawal by Subject|45|||
155498496|NCT02957682|561250619|FG000|Overall Study|Study Terminated by Sponsor|4|||
155498497|NCT02957682|561250620|FG001|Overall Study|Study Terminated by Sponsor|3|||
155498498|NCT02957682|561250619|FG000|Overall Study|Subject Moved|10|||
155498499|NCT02957682|561250620|FG001|Overall Study|Subject Moved|16|||
155498500|NCT02957682|561250619|FG000|Overall Study|Withdrawal by Subject|64|||
155498501|NCT02957682|561250620|FG001|Overall Study|Withdrawal by Subject|33|||
155498502|NCT02957682|561250619|FG000|Overall Study|Related to IMP Administration|3|||
155498503|NCT02957682|561250620|FG001|Overall Study|Related to IMP Administration|6|||
155498504|NCT02957682|561250619|FG000|Overall Study|Non-disclosed|16|||
155498505|NCT02957682|561250620|FG001|Overall Study|Non-disclosed|12|||
155498506|NCT02957682|561250619|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
155498507|NCT02957682|561250620|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
155498508|NCT02953262|561250628|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
155498509|NCT02953262|561250629|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
155498510|NCT02953262|561250630|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
155498511|NCT02953262|561250631|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
155498512|NCT00934622|561250632|FG000|Overall Study|Lost to Follow-up|7|||
155498513|NCT00934622|561250632|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
155498514|NCT00468312|561250633|FG000|Overall Study|Adverse Event|2|||
155498515|NCT00468312|561250634|FG001|Overall Study|Adverse Event|1|||
155498516|NCT00468312|561250633|FG000|Overall Study|Lack of Efficacy|0|||
155498517|NCT00468312|561250634|FG001|Overall Study|Lack of Efficacy|1|||
155498518|NCT00468312|561250633|FG000|Overall Study|Withdrawal by Subject|0|||
155498519|NCT00468312|561250634|FG001|Overall Study|Withdrawal by Subject|1|||
155498520|NCT00468312|561250633|FG000|Overall Study|Protocol Violation|2|||
155498521|NCT00468312|561250634|FG001|Overall Study|Protocol Violation|1|||
155498522|NCT00468312|561250633|FG000|Overall Study|Did not meet protocol eligibility|0|||
155498523|NCT00468312|561250634|FG001|Overall Study|Did not meet protocol eligibility|1|||
155498524|NCT03387735|561250639|FG000|Overall Study|Lost to Follow-up|4|||
155498525|NCT03387735|561250640|FG001|Overall Study|Lost to Follow-up|8|||
155498526|NCT03387735|561250639|FG000|Overall Study|Death|4|||
155498527|NCT03387735|561250640|FG001|Overall Study|Death|8|||
155498528|NCT01346501|561250647|FG000|Overall Study|Initiated Other Biological Agents|3|||
155309229|NCT03932682|560565486|FG000|Overall Study|Lost to Follow-up|19|||
155498529|NCT01346501|561250648|FG001|Overall Study|Initiated Other Biological Agents|1|||
155498530|NCT01346501|561250647|FG000|Overall Study|Other|8|||
155498531|NCT01346501|561250648|FG001|Overall Study|Other|12|||
155498532|NCT00756652|561250649|FG000|Original Phase|Withdrawal by Subject|864|||
155498533|NCT00756652|561250650|FG001|Original Phase|Withdrawal by Subject|23|||
155498534|NCT00756652|561250649|FG000|Original Phase|Lost to Follow-up|601|||
155498535|NCT00756652|561250650|FG001|Original Phase|Lost to Follow-up|0|||
155498536|NCT00756652|561250649|FG000|Original Phase|Other Discontinuation|797|||
155498537|NCT00756652|561250650|FG001|Original Phase|Other Discontinuation|5|||
155498538|NCT00756652|561250649|FG000|Original Phase|Participant Noncompliance|18622|||
155498539|NCT00756652|561250650|FG001|Original Phase|Participant Noncompliance|424|||
155498540|NCT00756652|561250649|FG000|Original Phase|Unknown Discontinuation Reason|2|||
155309230|NCT03932682|560565487|FG001|Overall Study|Lost to Follow-up|25|||
155309231|NCT03932682|560565486|FG000|Overall Study|Protocol Violation|0|||
155309232|NCT03932682|560565487|FG001|Overall Study|Protocol Violation|2|||
155309233|NCT03932682|560565486|FG000|Overall Study|Other|9|||
155309234|NCT03932682|560565487|FG001|Overall Study|Other|23|||
155309235|NCT05323084|560565491|FG000|Period 2 - Washout|Lost to Follow-up|0|||
155309236|NCT05323084|560565492|FG001|Period 2 - Washout|Lost to Follow-up|1|||
155309237|NCT04401800|560565499|FG000|Overall Study|Death|17|||
155309238|NCT04401800|560565499|FG000|Overall Study|Lost to Follow-up|5|||
155309239|NCT04401800|560565499|FG000|Overall Study|Withdrawal by Subject|4|||
155309240|NCT03941860|560565504|FG000|Overall Study|Withdrawal by Subject|0|||
155309241|NCT03941860|560565505|FG001|Overall Study|Withdrawal by Subject|1|||
155309242|NCT05792423|560565511|FG000|Overall Study|Withdrawal by Subject|2|||
155415415|NCT03266016|560952266|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
155415416|NCT03266016|560952267|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
155415417|NCT03266016|560952268|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
155415418|NCT03266016|560952265|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
155415419|NCT03266016|560952266|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
155415420|NCT03266016|560952267|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
155415421|NCT03266016|560952268|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
155415422|NCT00403260|560952271|FG000|Overall Study|Adverse Event|5|||
155415423|NCT00403260|560952272|FG001|Overall Study|Adverse Event|4|||
155415424|NCT00403260|560952271|FG000|Overall Study|Withdrawal by Subject|5|||
155415425|NCT00403260|560952272|FG001|Overall Study|Withdrawal by Subject|6|||
155415426|NCT00403260|560952271|FG000|Overall Study|Lost to Follow-up|49|||
155415427|NCT00403260|560952272|FG001|Overall Study|Lost to Follow-up|25|||
155415428|NCT00403260|560952271|FG000|Overall Study|Re-appearance of P. falciparum|34|||
155415429|NCT00403260|560952272|FG001|Overall Study|Re-appearance of P. falciparum|25|||
155415430|NCT00403260|560952271|FG000|Overall Study|P. vivax infection|26|||
155415431|NCT00403260|560952272|FG001|Overall Study|P. vivax infection|4|||
155415432|NCT00403260|560952271|FG000|Overall Study|Mixed infection with P. vivax|2|||
155415433|NCT00403260|560952272|FG001|Overall Study|Mixed infection with P. vivax|0|||
155415434|NCT00403260|560952271|FG000|Overall Study|Mixed infection with P. falciparum|1|||
155415435|NCT00403260|560952272|FG001|Overall Study|Mixed infection with P. falciparum|0|||
155415436|NCT00403260|560952271|FG000|Overall Study|P. vivax infection at screening|1|||
155415437|NCT00403260|560952272|FG001|Overall Study|P. vivax infection at screening|0|||
155415438|NCT00403260|560952271|FG000|Overall Study|P. ovale infection|1|||
155415439|NCT00403260|560952272|FG001|Overall Study|P. ovale infection|0|||
155415440|NCT00403260|560952271|FG000|Overall Study|Gametocyte re-appearance|1|||
155415441|NCT00403260|560952272|FG001|Overall Study|Gametocyte re-appearance|1|||
155415442|NCT00403260|560952271|FG000|Overall Study|Withdrawn from study accidentally|0|||
155415443|NCT00403260|560952272|FG001|Overall Study|Withdrawn from study accidentally|1|||
155415444|NCT02968810|560952273|FG000|Overall Study|Lost to Follow-up|1|||
155415445|NCT02968810|560952274|FG001|Overall Study|Lost to Follow-up|0|||
155415446|NCT02968810|560952273|FG000|Overall Study|Physician Decision|1|||
155415447|NCT02968810|560952274|FG001|Overall Study|Physician Decision|0|||
155415448|NCT02968810|560952273|FG000|Overall Study|Withdrawal by Subject|1|||
155415449|NCT02968810|560952274|FG001|Overall Study|Withdrawal by Subject|3|||
155415450|NCT02968810|560952273|FG000|Overall Study|Disease Progression|0|||
155415451|NCT02968810|560952274|FG001|Overall Study|Disease Progression|1|||
155642911|NCT05558410|561782350|FG001|Overall Study|Death|0|||
155642912|NCT05558410|561782351|FG002|Overall Study|Death|0|||
155642913|NCT05558410|561782349|FG000|Overall Study|Other non-compliance|0|||
155642914|NCT05558410|561782350|FG001|Overall Study|Other non-compliance|1|||
155415452|NCT01535729|560952275|FG000|Overall Study|Withdrawal by Subject|2|||
155309273|NCT04833777|560567260|FG000|Overall Study|Lost to Follow-up|1|||
155309274|NCT04833777|560567261|FG001|Overall Study|Lost to Follow-up|0|||
155309275|NCT02682316|560567266|FG000|Overall Study|Benign Final Pathology|27|||
155309276|NCT02682316|560567267|FG001|Overall Study|Benign Final Pathology|26|||
155309277|NCT02682316|560567266|FG000|Overall Study|Reoperation before 30 days|7|||
155309278|NCT02682316|560567267|FG001|Overall Study|Reoperation before 30 days|6|||
155309279|NCT02682316|560567266|FG000|Overall Study|Ineligible|1|||
155309280|NCT02682316|560567267|FG001|Overall Study|Ineligible|0|||
155309281|NCT02682316|560567266|FG000|Overall Study|Death|1|||
155309282|NCT02682316|560567267|FG001|Overall Study|Death|0|||
155309283|NCT02682316|560567266|FG000|Overall Study|Lost to Follow-up|7|||
155309284|NCT02682316|560567267|FG001|Overall Study|Lost to Follow-up|3|||
155309285|NCT03101904|560567268|FG000|Wash Out (10 Days)|Adverse Event|1|||
155309286|NCT03101904|560567269|FG001|Wash Out (10 Days)|Adverse Event|0|||
155309287|NCT03101904|560567268|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
155309288|NCT03101904|560567269|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
155309289|NCT04538417|560567270|FG000|Overall Study|Withdrawal by Subject|2|||
155309290|NCT06311084|560567272|FG000|Overall Study|Lost to Follow-up|14|||
155309291|NCT01331005|560567274|FG000|Overall Study|Lost to Follow-up|2|||
155309292|NCT01331005|560567275|FG001|Overall Study|Lost to Follow-up|1|||
155309293|NCT01331005|560567274|FG000|Overall Study|Withdrawal by Subject|2|||
155309294|NCT01331005|560567275|FG001|Overall Study|Withdrawal by Subject|3|||
155309295|NCT03131648|560567293|FG000|Initial Treatment Period|Not dosed|2|||
155309296|NCT03131648|560567294|FG001|Initial Treatment Period|Not dosed|2|||
155309297|NCT03131648|560567295|FG002|Initial Treatment Period|Not dosed|0|||
155309298|NCT03131648|560567296|FG003|Initial Treatment Period|Not dosed|0|||
155309299|NCT03131648|560567297|FG004|Initial Treatment Period|Not dosed|0|||
155309300|NCT03131648|560567298|FG005|Initial Treatment Period|Not dosed|0|||
155309301|NCT03131648|560567299|FG006|Initial Treatment Period|Not dosed|0|||
155309302|NCT03131648|560567300|FG007|Initial Treatment Period|Not dosed|0|||
155309303|NCT03131648|560567293|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
155309304|NCT03131648|560567294|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
155749770|NCT00645788|562184180|FG002|Overall Study|Pulmonary exacerbation|11|||
155749771|NCT00645788|562184181|FG003|Overall Study|Pulmonary exacerbation|9|||
155749772|NCT04231981|562184184|FG000|Overall Study|Adverse Event|1|||
155749773|NCT04231981|562184184|FG000|Overall Study|Death|16|||
155749774|NCT04231981|562184184|FG000|Overall Study|Lost to Follow-up|1|||
155749775|NCT01233687|562184185|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
155749776|NCT01233687|562184185|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
155309305|NCT03131648|560567295|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309306|NCT03131648|560567296|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309307|NCT03131648|560567297|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309308|NCT03131648|560567298|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309309|NCT03131648|560567299|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309310|NCT03131648|560567300|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309311|NCT03131648|560567293|FG000|Open-label Treatment|Discontinued IMP|0|||
155309312|NCT03131648|560567294|FG001|Open-label Treatment|Discontinued IMP|0|||
155309313|NCT03131648|560567295|FG002|Open-label Treatment|Discontinued IMP|0|||
155309314|NCT03131648|560567296|FG003|Open-label Treatment|Discontinued IMP|0|||
155309315|NCT03131648|560567297|FG004|Open-label Treatment|Discontinued IMP|0|||
155309316|NCT03131648|560567298|FG005|Open-label Treatment|Discontinued IMP|0|||
155309317|NCT03131648|560567299|FG006|Open-label Treatment|Discontinued IMP|112|||
155309318|NCT03131648|560567300|FG007|Open-label Treatment|Discontinued IMP|0|||
155309319|NCT03131648|560567293|FG000|Open-label Treatment|Completed Week 50|0|||
155309320|NCT03131648|560567294|FG001|Open-label Treatment|Completed Week 50|0|||
155415453|NCT01535729|560952275|FG000|Overall Study|Disease progression|230|||
155309321|NCT03131648|560567295|FG002|Open-label Treatment|Completed Week 50|0|||
155309322|NCT03131648|560567296|FG003|Open-label Treatment|Completed Week 50|0|||
155309323|NCT03131648|560567297|FG004|Open-label Treatment|Completed Week 50|0|||
155309324|NCT03131648|560567298|FG005|Open-label Treatment|Completed Week 50|0|||
155309325|NCT03131648|560567299|FG006|Open-label Treatment|Completed Week 50|6|||
155309326|NCT03131648|560567300|FG007|Open-label Treatment|Completed Week 50|0|||
155309327|NCT03131648|560567293|FG000|Maintenance Treatment Period|Not dosed|0|||
155309328|NCT03131648|560567294|FG001|Maintenance Treatment Period|Not dosed|0|||
155309329|NCT03131648|560567295|FG002|Maintenance Treatment Period|Not dosed|3|||
155309330|NCT03131648|560567296|FG003|Maintenance Treatment Period|Not dosed|2|||
155309331|NCT03131648|560567297|FG004|Maintenance Treatment Period|Not dosed|1|||
155309332|NCT03131648|560567298|FG005|Maintenance Treatment Period|Not dosed|0|||
155309333|NCT03131648|560567299|FG006|Maintenance Treatment Period|Not dosed|0|||
155309334|NCT03131648|560567300|FG007|Maintenance Treatment Period|Not dosed|0|||
155309335|NCT03131648|560567293|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
155309336|NCT03131648|560567294|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
155309337|NCT03131648|560567295|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
155309338|NCT03131648|560567296|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
155309339|NCT03131648|560567297|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
155309340|NCT03131648|560567298|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
155309341|NCT03131648|560567299|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
155309342|NCT03131648|560567300|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
155309343|NCT03131648|560567293|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309344|NCT03131648|560567294|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309345|NCT03131648|560567295|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
155309346|NCT03131648|560567296|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
155309347|NCT03131648|560567297|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
155309348|NCT03131648|560567298|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
155309349|NCT03131648|560567299|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309350|NCT03131648|560567300|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309351|NCT03131648|560567293|FG000|Maintenance Treatment Period|Completed Week 50|0|||
155309352|NCT03131648|560567294|FG001|Maintenance Treatment Period|Completed Week 50|0|||
155309353|NCT03131648|560567295|FG002|Maintenance Treatment Period|Completed Week 50|0|||
155309354|NCT03131648|560567296|FG003|Maintenance Treatment Period|Completed Week 50|0|||
155309355|NCT03131648|560567297|FG004|Maintenance Treatment Period|Completed Week 50|1|||
155309356|NCT03131648|560567298|FG005|Maintenance Treatment Period|Completed Week 50|0|||
155309357|NCT03131648|560567299|FG006|Maintenance Treatment Period|Completed Week 50|0|||
155309358|NCT03131648|560567300|FG007|Maintenance Treatment Period|Completed Week 50|0|||
155309359|NCT03131648|560567293|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309360|NCT03131648|560567294|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309361|NCT03131648|560567295|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309362|NCT03131648|560567296|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309363|NCT03131648|560567297|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309364|NCT03131648|560567298|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309365|NCT03131648|560567299|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309366|NCT03131648|560567300|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
155309367|NCT02724878|560567301|FG000|Overall Study|Still on Active Therapy|15|||
155309368|NCT02724878|560567301|FG000|Overall Study|Disease Progression|31|||
155309369|NCT02724878|560567301|FG000|Overall Study|Toxicity|5|||
155309370|NCT02724878|560567301|FG000|Overall Study|Death|1|||
155309371|NCT02724878|560567301|FG000|Overall Study|Withdrawal by Subject|4|||
155309372|NCT02724878|560567301|FG000|Overall Study|Lost to Follow-up|2|||
155309373|NCT02724878|560567301|FG000|Overall Study|Protocol Violation|1|||
155309374|NCT02724878|560567301|FG000|Overall Study|Ineligible for Study Drug|5|||
155309375|NCT02724878|560567301|FG000|Overall Study|not started|1|||
155309376|NCT04421378|560567306|FG000|Overall Study|Adverse Event|2|||
155309377|NCT04421378|560567307|FG001|Overall Study|Adverse Event|7|||
155309378|NCT04421378|560567308|FG002|Overall Study|Adverse Event|0|||
155309379|NCT04421378|560567309|FG003|Overall Study|Adverse Event|1|||
155309380|NCT04421378|560567310|FG004|Overall Study|Adverse Event|0|||
155309381|NCT04421378|560567306|FG000|Overall Study|Physician Decision|1|||
155415454|NCT01535729|560952275|FG000|Overall Study|Discontinued treatment|25|||
155415455|NCT01535729|560952275|FG000|Overall Study|Lost to Follow-up|8|||
155415456|NCT01535729|560952275|FG000|Overall Study|Death|52|||
155415457|NCT01535729|560952275|FG000|Overall Study|Other|19|||
155415458|NCT01535729|560952275|FG000|Overall Study|Did not sign informed consent|1|||
155415459|NCT01535729|560952275|FG000|Overall Study|No previous chemotherapy|33|||
155415460|NCT01535729|560952275|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
155415461|NCT01535729|560952275|FG000|Overall Study|Protocol Violation|11|||
155415462|NCT01535729|560952275|FG000|Overall Study|Screening failure|1|||
155309382|NCT04421378|560567307|FG001|Overall Study|Physician Decision|2|||
155309383|NCT04421378|560567308|FG002|Overall Study|Physician Decision|0|||
155415463|NCT01535729|560952275|FG000|Overall Study|Not treated|9|||
155309384|NCT04421378|560567309|FG003|Overall Study|Physician Decision|0|||
155309385|NCT04421378|560567310|FG004|Overall Study|Physician Decision|0|||
155309386|NCT04421378|560567306|FG000|Overall Study|Progressive Disease|16|||
155415464|NCT01535729|560952275|FG000|Overall Study|No participant record available|5|||
155749777|NCT01233687|562184185|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
155749778|NCT02197234|562184188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
155749779|NCT02197234|562184188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
155749780|NCT02197234|562184188|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
155749781|NCT02197234|562184188|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
155749782|NCT02197234|562184188|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
155749783|NCT02197234|562184188|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
155749784|NCT01445886|562184190|FG000|Overall Study|Lost to Follow-up|2|||
155749785|NCT01445886|562184190|FG000|Overall Study|Protocol Violation|3|||
155749786|NCT01163032|562184191|FG000|Randomization Phase|Withdrawal by Subject|2|||
155749787|NCT01163032|562184192|FG001|Randomization Phase|Withdrawal by Subject|3|||
155749788|NCT01163032|562184193|FG002|Randomization Phase|Withdrawal by Subject|0|||
155749789|NCT01163032|562184191|FG000|Randomization Phase|Adverse Event|3|||
155749790|NCT01163032|562184192|FG001|Randomization Phase|Adverse Event|3|||
155749791|NCT01163032|562184193|FG002|Randomization Phase|Adverse Event|0|||
155749792|NCT01163032|562184191|FG000|Randomization Phase|Protocol Violation|0|||
155749793|NCT01163032|562184192|FG001|Randomization Phase|Protocol Violation|1|||
155749794|NCT01163032|562184193|FG002|Randomization Phase|Protocol Violation|0|||
155749795|NCT01163032|562184191|FG000|Randomization Phase|Various*|5|||
155749796|NCT01163032|562184192|FG001|Randomization Phase|Various*|4|||
155749797|NCT01163032|562184193|FG002|Randomization Phase|Various*|0|||
155749798|NCT01163032|562184191|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
155749799|NCT01163032|562184192|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
155749800|NCT01163032|562184193|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
155749801|NCT01163032|562184191|FG000|Open Label Extension Phase|Adverse Event|0|||
155749802|NCT01163032|562184192|FG001|Open Label Extension Phase|Adverse Event|0|||
155749803|NCT01163032|562184193|FG002|Open Label Extension Phase|Adverse Event|3|||
155749804|NCT01163032|562184191|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
155749805|NCT01163032|562184192|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155749806|NCT01163032|562184193|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
155749807|NCT01163032|562184191|FG000|Open Label Extension Phase|Protocol Violation|0|||
155749808|NCT01163032|562184192|FG001|Open Label Extension Phase|Protocol Violation|0|||
155749809|NCT01163032|562184193|FG002|Open Label Extension Phase|Protocol Violation|1|||
155749810|NCT01163032|562184191|FG000|Open Label Extension Phase|Study Termination|0|||
155749811|NCT01163032|562184192|FG001|Open Label Extension Phase|Study Termination|0|||
155749812|NCT01163032|562184193|FG002|Open Label Extension Phase|Study Termination|7|||
155749813|NCT01163032|562184191|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
155749814|NCT01163032|562184192|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
155749815|NCT01163032|562184193|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
155749816|NCT02751931|562184194|FG000|Overall Study|Adverse Event|3|||
155749817|NCT02751931|562184195|FG001|Overall Study|Adverse Event|0|||
155749818|NCT02751931|562184194|FG000|Overall Study|Other: Miscelleneous|10|||
155749819|NCT02751931|562184195|FG001|Overall Study|Other: Miscelleneous|8|||
155749820|NCT03326206|562184201|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
155749821|NCT03326206|562184202|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
155749822|NCT03326206|562184201|FG000|Overall Study - 24 months|Death|8|||
155749823|NCT03326206|562184202|FG001|Overall Study - 24 months|Death|92|||
155415465|NCT02944448|560952279|FG000|Overall Study|Adverse Event|37|||
155415466|NCT02944448|560952280|FG001|Overall Study|Adverse Event|6|||
155415467|NCT02944448|560952279|FG000|Overall Study|Lack of Efficacy|8|||
155415468|NCT02944448|560952280|FG001|Overall Study|Lack of Efficacy|5|||
155415469|NCT02944448|560952279|FG000|Overall Study|Lost to Follow-up|3|||
155749824|NCT03326206|562184201|FG000|Overall Study - 24 months|Observational data not available|43|||
155749825|NCT03326206|562184202|FG001|Overall Study - 24 months|Observational data not available|2879|||
155749826|NCT03326206|562184201|FG000|12 months|Unable to match cases with controls|17|||
155749827|NCT03326206|562184202|FG001|12 months|Unable to match cases with controls|22721|||
155749828|NCT03326206|562184201|FG000|12 months|Death|2|||
155749829|NCT03326206|562184202|FG001|12 months|Death|50|||
155749830|NCT03326206|562184201|FG000|12 months|Observational data not available|49|||
155749831|NCT03326206|562184202|FG001|12 months|Observational data not available|2921|||
155415470|NCT02944448|560952280|FG001|Overall Study|Lost to Follow-up|1|||
155415471|NCT02944448|560952279|FG000|Overall Study|Protocol Violation|25|||
155415472|NCT02944448|560952280|FG001|Overall Study|Protocol Violation|7|||
155749832|NCT04090411|562184203|FG000|Induction Period|Adverse Event|3|||
155749833|NCT04090411|562184204|FG001|Induction Period|Adverse Event|1|||
155749834|NCT04090411|562184205|FG002|Induction Period|Adverse Event|1|||
155415473|NCT02944448|560952279|FG000|Overall Study|Withdrawal by Subject|14|||
155415474|NCT02944448|560952280|FG001|Overall Study|Withdrawal by Subject|4|||
155415475|NCT02944448|560952279|FG000|Overall Study|Sponsor did not supply drug in time|0|||
155749835|NCT04090411|562184206|FG003|Induction Period|Adverse Event|1|||
155415476|NCT02944448|560952280|FG001|Overall Study|Sponsor did not supply drug in time|1|||
155415477|NCT02944448|560952279|FG000|Overall Study|Noncompliant with dosing|1|||
155415478|NCT02944448|560952280|FG001|Overall Study|Noncompliant with dosing|0|||
155415479|NCT02944448|560952279|FG000|Overall Study|Abnormal laboratory values|1|||
155415480|NCT02944448|560952280|FG001|Overall Study|Abnormal laboratory values|0|||
155415481|NCT00716976|560952283|FG000|Overall Study|Adverse Event|2|||
155415482|NCT00716976|560952284|FG001|Overall Study|Adverse Event|0|||
155415483|NCT00716976|560952283|FG000|Overall Study|Death|1|||
155415484|NCT00716976|560952284|FG001|Overall Study|Death|0|||
155415485|NCT00716976|560952283|FG000|Overall Study|Physician Decision|2|||
155415486|NCT00716976|560952284|FG001|Overall Study|Physician Decision|2|||
155415487|NCT00716976|560952283|FG000|Overall Study|Withdrawal by Subject|5|||
155415488|NCT00716976|560952284|FG001|Overall Study|Withdrawal by Subject|1|||
155415489|NCT00716976|560952283|FG000|Overall Study|Premature discontinuation cisplatin|5|||
155415490|NCT00716976|560952284|FG001|Overall Study|Premature discontinuation cisplatin|4|||
155415491|NCT00716976|560952283|FG000|Overall Study|Radiation during protocol|1|||
155415492|NCT00716976|560952284|FG001|Overall Study|Radiation during protocol|0|||
155415493|NCT00716976|560952283|FG000|Overall Study|Ineligibles|4|||
155415494|NCT00716976|560952284|FG001|Overall Study|Ineligibles|2|||
155415495|NCT00805740|560952289|FG000|Overall Study|Death|7|||
155415496|NCT00805740|560952290|FG001|Overall Study|Death|4|||
155415497|NCT00805740|560952289|FG000|Overall Study|Withdrawal by Subject|1|||
155415498|NCT00805740|560952290|FG001|Overall Study|Withdrawal by Subject|0|||
155415499|NCT00805740|560952289|FG000|Overall Study|Lost to Follow-up|1|||
155415500|NCT00805740|560952290|FG001|Overall Study|Lost to Follow-up|0|||
155415501|NCT00805740|560952289|FG000|Overall Study|Randomized, but not treated|2|||
155415502|NCT00805740|560952290|FG001|Overall Study|Randomized, but not treated|0|||
155415503|NCT05227690|560952298|FG000|Overall Study|Adverse Event|5|||
155749836|NCT04090411|562184207|FG004|Induction Period|Adverse Event|0|||
155415504|NCT05227690|560952299|FG001|Overall Study|Adverse Event|6|||
155415505|NCT05227690|560952300|FG002|Overall Study|Adverse Event|10|||
155415506|NCT05227690|560952298|FG000|Overall Study|Lack of Efficacy|2|||
155415507|NCT05227690|560952299|FG001|Overall Study|Lack of Efficacy|4|||
155415508|NCT05227690|560952300|FG002|Overall Study|Lack of Efficacy|1|||
155415509|NCT05227690|560952298|FG000|Overall Study|Physician Decision|6|||
155749837|NCT04090411|562184208|FG005|Induction Period|Adverse Event|0|||
155749838|NCT04090411|562184209|FG006|Induction Period|Adverse Event|0|||
155749839|NCT04090411|562184210|FG007|Induction Period|Adverse Event|0|||
155749840|NCT04090411|562184211|FG008|Induction Period|Adverse Event|0|||
155749841|NCT04090411|562184212|FG009|Induction Period|Adverse Event|0|||
155749842|NCT04090411|562184213|FG010|Induction Period|Adverse Event|0|||
155749843|NCT04090411|562184214|FG011|Induction Period|Adverse Event|0|||
155749844|NCT04090411|562184215|FG012|Induction Period|Adverse Event|0|||
155749845|NCT04090411|562184203|FG000|Induction Period|Lack of Efficacy|0|||
155749846|NCT04090411|562184204|FG001|Induction Period|Lack of Efficacy|0|||
155749847|NCT04090411|562184205|FG002|Induction Period|Lack of Efficacy|1|||
155749848|NCT04090411|562184206|FG003|Induction Period|Lack of Efficacy|1|||
155749849|NCT04090411|562184207|FG004|Induction Period|Lack of Efficacy|0|||
155749850|NCT04090411|562184208|FG005|Induction Period|Lack of Efficacy|0|||
155749851|NCT04090411|562184209|FG006|Induction Period|Lack of Efficacy|0|||
155749852|NCT04090411|562184210|FG007|Induction Period|Lack of Efficacy|0|||
155749853|NCT04090411|562184211|FG008|Induction Period|Lack of Efficacy|0|||
155749854|NCT04090411|562184212|FG009|Induction Period|Lack of Efficacy|0|||
155749855|NCT04090411|562184213|FG010|Induction Period|Lack of Efficacy|0|||
155749856|NCT04090411|562184214|FG011|Induction Period|Lack of Efficacy|0|||
155749857|NCT04090411|562184215|FG012|Induction Period|Lack of Efficacy|0|||
155749858|NCT04090411|562184203|FG000|Induction Period|Physician Decision|0|||
155749859|NCT04090411|562184204|FG001|Induction Period|Physician Decision|0|||
155749860|NCT04090411|562184205|FG002|Induction Period|Physician Decision|1|||
155749861|NCT04090411|562184206|FG003|Induction Period|Physician Decision|0|||
155749862|NCT04090411|562184207|FG004|Induction Period|Physician Decision|0|||
155749863|NCT04090411|562184208|FG005|Induction Period|Physician Decision|0|||
155749864|NCT04090411|562184209|FG006|Induction Period|Physician Decision|0|||
155749865|NCT04090411|562184210|FG007|Induction Period|Physician Decision|0|||
155749866|NCT04090411|562184211|FG008|Induction Period|Physician Decision|0|||
155749867|NCT04090411|562184212|FG009|Induction Period|Physician Decision|0|||
155749868|NCT04090411|562184213|FG010|Induction Period|Physician Decision|0|||
155749869|NCT04090411|562184214|FG011|Induction Period|Physician Decision|0|||
155749870|NCT04090411|562184215|FG012|Induction Period|Physician Decision|0|||
155749871|NCT04090411|562184203|FG000|Induction Period|Protocol Violation|0|||
155749872|NCT04090411|562184204|FG001|Induction Period|Protocol Violation|0|||
155749873|NCT04090411|562184205|FG002|Induction Period|Protocol Violation|0|||
155749874|NCT04090411|562184206|FG003|Induction Period|Protocol Violation|1|||
155749875|NCT04090411|562184207|FG004|Induction Period|Protocol Violation|0|||
155749876|NCT04090411|562184208|FG005|Induction Period|Protocol Violation|0|||
155749877|NCT04090411|562184209|FG006|Induction Period|Protocol Violation|0|||
155749878|NCT04090411|562184210|FG007|Induction Period|Protocol Violation|0|||
155415510|NCT05227690|560952299|FG001|Overall Study|Physician Decision|0|||
155415511|NCT05227690|560952300|FG002|Overall Study|Physician Decision|4|||
155415512|NCT05227690|560952298|FG000|Overall Study|Withdrawal of consent|28|||
155415513|NCT05227690|560952299|FG001|Overall Study|Withdrawal of consent|27|||
155749879|NCT04090411|562184211|FG008|Induction Period|Protocol Violation|0|||
155749880|NCT04090411|562184212|FG009|Induction Period|Protocol Violation|0|||
155749881|NCT04090411|562184213|FG010|Induction Period|Protocol Violation|0|||
155749882|NCT04090411|562184214|FG011|Induction Period|Protocol Violation|0|||
155749883|NCT04090411|562184215|FG012|Induction Period|Protocol Violation|0|||
155749884|NCT04090411|562184203|FG000|Induction Period|Withdrawal by Subject|2|||
155749885|NCT04090411|562184204|FG001|Induction Period|Withdrawal by Subject|0|||
155749886|NCT04090411|562184205|FG002|Induction Period|Withdrawal by Subject|1|||
155749887|NCT04090411|562184206|FG003|Induction Period|Withdrawal by Subject|5|||
155749888|NCT04090411|562184207|FG004|Induction Period|Withdrawal by Subject|0|||
155749889|NCT04090411|562184208|FG005|Induction Period|Withdrawal by Subject|0|||
155749890|NCT04090411|562184209|FG006|Induction Period|Withdrawal by Subject|0|||
155749891|NCT04090411|562184210|FG007|Induction Period|Withdrawal by Subject|0|||
155749892|NCT04090411|562184211|FG008|Induction Period|Withdrawal by Subject|0|||
155749893|NCT04090411|562184212|FG009|Induction Period|Withdrawal by Subject|0|||
155749894|NCT04090411|562184213|FG010|Induction Period|Withdrawal by Subject|0|||
155749895|NCT04090411|562184214|FG011|Induction Period|Withdrawal by Subject|0|||
155749896|NCT04090411|562184215|FG012|Induction Period|Withdrawal by Subject|0|||
155309387|NCT04421378|560567307|FG001|Overall Study|Progressive Disease|4|||
155309388|NCT04421378|560567308|FG002|Overall Study|Progressive Disease|18|||
155309389|NCT04421378|560567309|FG003|Overall Study|Progressive Disease|11|||
155309390|NCT04421378|560567310|FG004|Overall Study|Progressive Disease|3|||
155309391|NCT04421378|560567306|FG000|Overall Study|Study Terminated by Sponsor|0|||
155309392|NCT04421378|560567307|FG001|Overall Study|Study Terminated by Sponsor|1|||
155309393|NCT04421378|560567308|FG002|Overall Study|Study Terminated by Sponsor|1|||
155309394|NCT04421378|560567309|FG003|Overall Study|Study Terminated by Sponsor|0|||
155309395|NCT04421378|560567310|FG004|Overall Study|Study Terminated by Sponsor|0|||
155309396|NCT04421378|560567306|FG000|Overall Study|Withdrawal by Subject|3|||
155309397|NCT04421378|560567307|FG001|Overall Study|Withdrawal by Subject|1|||
155309398|NCT04421378|560567308|FG002|Overall Study|Withdrawal by Subject|0|||
155309399|NCT04421378|560567309|FG003|Overall Study|Withdrawal by Subject|2|||
155309400|NCT04421378|560567310|FG004|Overall Study|Withdrawal by Subject|0|||
155309401|NCT04421378|560567306|FG000|Overall Study|Other|1|||
155309402|NCT04421378|560567307|FG001|Overall Study|Other|0|||
155309403|NCT04421378|560567308|FG002|Overall Study|Other|0|||
155309404|NCT04421378|560567309|FG003|Overall Study|Other|0|||
155309405|NCT04421378|560567310|FG004|Overall Study|Other|0|||
155749897|NCT04090411|562184203|FG000|Chronic Period|Adverse Event|0|||
155749898|NCT04090411|562184204|FG001|Chronic Period|Adverse Event|0|||
155749899|NCT04090411|562184205|FG002|Chronic Period|Adverse Event|0|||
155749900|NCT04090411|562184206|FG003|Chronic Period|Adverse Event|0|||
155309406|NCT04258709|560567311|FG000|Overall Study|Lost to Follow-up|10|||
155309407|NCT04258709|560567312|FG001|Overall Study|Lost to Follow-up|4|||
155309408|NCT04258709|560567311|FG000|Overall Study|Withdrawal by Subject|1|||
155309409|NCT04258709|560567312|FG001|Overall Study|Withdrawal by Subject|0|||
155309410|NCT04258709|560567311|FG000|Overall Study|Fetal demise|0|||
155309411|NCT04258709|560567312|FG001|Overall Study|Fetal demise|1|||
155309412|NCT04258709|560567311|FG000|Overall Study|Protocol Violation|1|||
155309413|NCT04258709|560567312|FG001|Overall Study|Protocol Violation|1|||
155749901|NCT04090411|562184207|FG004|Chronic Period|Adverse Event|0|||
155309414|NCT02592330|560567313|FG000|Overall Study|Withdrawal by Subject|1|||
155309415|NCT02592330|560567314|FG001|Overall Study|Withdrawal by Subject|0|||
155309416|NCT02592330|560567313|FG000|Overall Study|Failed Biopsy|1|||
155309417|NCT02592330|560567314|FG001|Overall Study|Failed Biopsy|0|||
155309418|NCT03090152|560567315|FG000|Overall Study|Withdrawal by Subject|0|||
155309419|NCT03090152|560567316|FG001|Overall Study|Withdrawal by Subject|2|||
155309420|NCT03090152|560567317|FG002|Overall Study|Withdrawal by Subject|1|||
155309421|NCT03090152|560567315|FG000|Overall Study|Surgery Canceled|1|||
155309422|NCT03090152|560567316|FG001|Overall Study|Surgery Canceled|0|||
155309423|NCT03090152|560567317|FG002|Overall Study|Surgery Canceled|0|||
155309424|NCT03090152|560567315|FG000|Overall Study|Epidural catheter could not be placed|0|||
155309425|NCT03090152|560567316|FG001|Overall Study|Epidural catheter could not be placed|2|||
155309426|NCT03090152|560567317|FG002|Overall Study|Epidural catheter could not be placed|0|||
155309427|NCT01566695|560567318|FG000|Overall Study|Lack of Efficacy|1|||
155309428|NCT01566695|560567319|FG001|Overall Study|Lack of Efficacy|0|||
155749902|NCT04090411|562184208|FG005|Chronic Period|Adverse Event|1|||
155749903|NCT04090411|562184209|FG006|Chronic Period|Adverse Event|0|||
155749904|NCT04090411|562184210|FG007|Chronic Period|Adverse Event|3|||
155309429|NCT01566695|560567318|FG000|Overall Study|Adverse Event|3|||
155309430|NCT01566695|560567319|FG001|Overall Study|Adverse Event|0|||
155309431|NCT01566695|560567318|FG000|Overall Study|Death|79|||
155309432|NCT01566695|560567319|FG001|Overall Study|Death|86|||
155309433|NCT01566695|560567318|FG000|Overall Study|Withdrawal by Subject|13|||
155309434|NCT01566695|560567319|FG001|Overall Study|Withdrawal by Subject|12|||
155309435|NCT01566695|560567318|FG000|Overall Study|Lost to Follow-up|0|||
155309436|NCT01566695|560567319|FG001|Overall Study|Lost to Follow-up|3|||
155749905|NCT04090411|562184211|FG008|Chronic Period|Adverse Event|0|||
155749906|NCT04090411|562184212|FG009|Chronic Period|Adverse Event|0|||
155749907|NCT04090411|562184213|FG010|Chronic Period|Adverse Event|5|||
155749908|NCT04090411|562184214|FG011|Chronic Period|Adverse Event|1|||
155749909|NCT04090411|562184215|FG012|Chronic Period|Adverse Event|1|||
155749910|NCT04090411|562184203|FG000|Chronic Period|Lack of Efficacy|0|||
155749911|NCT04090411|562184204|FG001|Chronic Period|Lack of Efficacy|0|||
155749912|NCT04090411|562184205|FG002|Chronic Period|Lack of Efficacy|0|||
155749913|NCT04090411|562184206|FG003|Chronic Period|Lack of Efficacy|0|||
155749914|NCT04090411|562184207|FG004|Chronic Period|Lack of Efficacy|0|||
155749915|NCT04090411|562184208|FG005|Chronic Period|Lack of Efficacy|0|||
155749916|NCT04090411|562184209|FG006|Chronic Period|Lack of Efficacy|1|||
155309437|NCT01566695|560567318|FG000|Overall Study|Other reasons|11|||
155309438|NCT01566695|560567319|FG001|Overall Study|Other reasons|8|||
155309439|NCT05470400|560567320|FG000|Overall Study|Lost to Follow-up|0|||
155309440|NCT05470400|560567321|FG001|Overall Study|Lost to Follow-up|0|||
155309441|NCT05470400|560567322|FG002|Overall Study|Lost to Follow-up|0|||
155309442|NCT05470400|560567323|FG003|Overall Study|Lost to Follow-up|0|||
155309443|NCT05470400|560567324|FG004|Overall Study|Lost to Follow-up|0|||
155309444|NCT05470400|560567325|FG005|Overall Study|Lost to Follow-up|0|||
155309445|NCT05470400|560567326|FG006|Overall Study|Lost to Follow-up|0|||
155309446|NCT05470400|560567327|FG007|Overall Study|Lost to Follow-up|1|||
155309447|NCT05470400|560567320|FG000|Overall Study|Withdrawal by Subject|1|||
155309448|NCT05470400|560567321|FG001|Overall Study|Withdrawal by Subject|0|||
155309449|NCT05470400|560567322|FG002|Overall Study|Withdrawal by Subject|0|||
155309450|NCT05470400|560567323|FG003|Overall Study|Withdrawal by Subject|0|||
155309451|NCT05470400|560567324|FG004|Overall Study|Withdrawal by Subject|0|||
155309452|NCT05470400|560567325|FG005|Overall Study|Withdrawal by Subject|1|||
155309453|NCT05470400|560567326|FG006|Overall Study|Withdrawal by Subject|0|||
155309454|NCT05470400|560567327|FG007|Overall Study|Withdrawal by Subject|2|||
155309455|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
155309456|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
155309457|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
155309458|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
155309459|NCT04294225|560567329|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
155309460|NCT04812535|560567331|FG000|Overall Study|Withdrawal by Subject|0|||
155309461|NCT04812535|560567332|FG001|Overall Study|Withdrawal by Subject|0|||
155309462|NCT04812535|560567333|FG002|Overall Study|Withdrawal by Subject|0|||
155309463|NCT04812535|560567334|FG003|Overall Study|Withdrawal by Subject|1|||
155309464|NCT04812535|560567331|FG000|Overall Study|Death|7|||
155309465|NCT04812535|560567332|FG001|Overall Study|Death|2|||
155309466|NCT04812535|560567333|FG002|Overall Study|Death|4|||
155309467|NCT04812535|560567334|FG003|Overall Study|Death|1|||
155309468|NCT04812535|560567331|FG000|Overall Study|Due to premature study termination by sponsor|2|||
155309469|NCT04812535|560567332|FG001|Overall Study|Due to premature study termination by sponsor|0|||
155309470|NCT04812535|560567333|FG002|Overall Study|Due to premature study termination by sponsor|1|||
155309471|NCT04812535|560567334|FG003|Overall Study|Due to premature study termination by sponsor|3|||
155309472|NCT03436745|560567335|FG000|Overall Study|Ineligible|0|||
155309473|NCT03436745|560567336|FG001|Overall Study|Ineligible|0|||
155309474|NCT03436745|560567337|FG002|Overall Study|Ineligible|1|||
155309475|NCT00931710|560567342|FG000|Overall Study|Adverse Event|16|||
155309476|NCT00931710|560567343|FG001|Overall Study|Adverse Event|10|||
155309477|NCT00931710|560567342|FG000|Overall Study|Abnormal test procedure results|2|||
155309478|NCT00931710|560567343|FG001|Overall Study|Abnormal test procedure results|0|||
155309479|NCT00931710|560567342|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
155309480|NCT00931710|560567343|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
155309481|NCT00931710|560567342|FG000|Overall Study|Patient withdrew consent|4|||
155309482|NCT00931710|560567343|FG001|Overall Study|Patient withdrew consent|9|||
155309483|NCT00931710|560567342|FG000|Overall Study|Lost to Follow-up|6|||
155309484|NCT00931710|560567343|FG001|Overall Study|Lost to Follow-up|5|||
155309485|NCT00931710|560567342|FG000|Overall Study|Protocol deviation|1|||
155309486|NCT00931710|560567343|FG001|Overall Study|Protocol deviation|2|||
155309487|NCT04927065|560567344|FG000|First Booster|Adverse Event|1|||
155749917|NCT04090411|562184210|FG007|Chronic Period|Lack of Efficacy|4|||
155749918|NCT04090411|562184211|FG008|Chronic Period|Lack of Efficacy|2|||
155749919|NCT04090411|562184212|FG009|Chronic Period|Lack of Efficacy|2|||
155749920|NCT04090411|562184213|FG010|Chronic Period|Lack of Efficacy|2|||
155749921|NCT04090411|562184214|FG011|Chronic Period|Lack of Efficacy|1|||
155749922|NCT04090411|562184215|FG012|Chronic Period|Lack of Efficacy|2|||
155749923|NCT04090411|562184203|FG000|Chronic Period|Relocation|0|||
155498541|NCT00756652|561250650|FG001|Original Phase|Unknown Discontinuation Reason|0|||
155498542|NCT00756652|561250649|FG000|Original Phase|Participants without data|3259|||
155498543|NCT00756652|561250650|FG001|Original Phase|Participants without data|466|||
155498544|NCT00756652|561250649|FG000|Original Phase|Death|168|||
155498545|NCT00756652|561250650|FG001|Original Phase|Death|1|||
155498546|NCT00756652|561250649|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
155498547|NCT00756652|561250650|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
155498548|NCT00756652|561250649|FG000|Re-Op Phase|Withdrawal by Subject|62|||
155498549|NCT00756652|561250650|FG001|Re-Op Phase|Withdrawal by Subject|0|||
155498550|NCT00756652|561250649|FG000|Re-Op Phase|Death|6|||
155498551|NCT00756652|561250650|FG001|Re-Op Phase|Death|0|||
155498552|NCT00756652|561250649|FG000|Re-Op Phase|Lost to Follow-up|340|||
155498553|NCT00756652|561250650|FG001|Re-Op Phase|Lost to Follow-up|0|||
155498554|NCT00756652|561250649|FG000|Re-Op Phase|Site Closed|2454|||
155498555|NCT00756652|561250650|FG001|Re-Op Phase|Site Closed|0|||
155498556|NCT00756652|561250649|FG000|Re-Op Phase|Withdrawn after explant|14|||
155498557|NCT00756652|561250650|FG001|Re-Op Phase|Withdrawn after explant|0|||
155498558|NCT02564952|561250651|FG000|Overall Study|Adverse Event|6|||
155498559|NCT02564952|561250651|FG000|Overall Study|Lost to Follow-up|1|||
155498560|NCT02564952|561250651|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
155749924|NCT04090411|562184204|FG001|Chronic Period|Relocation|0|||
155749925|NCT04090411|562184205|FG002|Chronic Period|Relocation|0|||
155749926|NCT04090411|562184206|FG003|Chronic Period|Relocation|0|||
155498561|NCT02564952|561250651|FG000|Overall Study|Withdrawal by Subject|1|||
155498562|NCT02564952|561250651|FG000|Overall Study|Low Efficacy|1|||
155498563|NCT02564952|561250651|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155498564|NCT03972709|561250662|FG000|Overall Study|Withdrawal by Subject|18|||
155498565|NCT03972709|561250663|FG001|Overall Study|Withdrawal by Subject|7|||
155498566|NCT03972709|561250664|FG002|Overall Study|Withdrawal by Subject|14|||
155498567|NCT03972709|561250662|FG000|Overall Study|Study Terminated by Sponsor|48|||
155498568|NCT03972709|561250663|FG001|Overall Study|Study Terminated by Sponsor|25|||
155498569|NCT03972709|561250664|FG002|Overall Study|Study Terminated by Sponsor|50|||
155498570|NCT03972709|561250662|FG000|Overall Study|Physician Decision|1|||
155498571|NCT03972709|561250663|FG001|Overall Study|Physician Decision|0|||
155498572|NCT03972709|561250664|FG002|Overall Study|Physician Decision|0|||
155498573|NCT03972709|561250662|FG000|Overall Study|COVID-19|0|||
155498574|NCT03972709|561250663|FG001|Overall Study|COVID-19|1|||
155498575|NCT03972709|561250664|FG002|Overall Study|COVID-19|1|||
155498576|NCT03972709|561250662|FG000|Overall Study|Lost to Follow-up|6|||
155498577|NCT03972709|561250663|FG001|Overall Study|Lost to Follow-up|1|||
155498578|NCT03972709|561250664|FG002|Overall Study|Lost to Follow-up|2|||
155498579|NCT03972709|561250662|FG000|Overall Study|Death|5|||
155498580|NCT03972709|561250663|FG001|Overall Study|Death|1|||
155498581|NCT03972709|561250664|FG002|Overall Study|Death|4|||
155498582|NCT03972709|561250662|FG000|Overall Study|Adverse Event|3|||
155498583|NCT03972709|561250663|FG001|Overall Study|Adverse Event|1|||
155498584|NCT03972709|561250664|FG002|Overall Study|Adverse Event|4|||
155498585|NCT03972709|561250662|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
155498586|NCT03972709|561250663|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
155498587|NCT03972709|561250664|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
155498588|NCT03972709|561250662|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
155749927|NCT04090411|562184207|FG004|Chronic Period|Relocation|0|||
155749928|NCT04090411|562184208|FG005|Chronic Period|Relocation|0|||
155749929|NCT04090411|562184209|FG006|Chronic Period|Relocation|0|||
155749930|NCT04090411|562184210|FG007|Chronic Period|Relocation|1|||
155749931|NCT04090411|562184211|FG008|Chronic Period|Relocation|0|||
155749932|NCT04090411|562184212|FG009|Chronic Period|Relocation|0|||
155749933|NCT04090411|562184213|FG010|Chronic Period|Relocation|0|||
155749934|NCT04090411|562184214|FG011|Chronic Period|Relocation|0|||
155498589|NCT03972709|561250663|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
155498590|NCT03972709|561250664|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
155498591|NCT03972709|561250662|FG000|Overall Study|Subject Unable to be Contacted|0|||
155498592|NCT03972709|561250663|FG001|Overall Study|Subject Unable to be Contacted|1|||
155498593|NCT03972709|561250664|FG002|Overall Study|Subject Unable to be Contacted|0|||
155498594|NCT03972709|561250662|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
155498595|NCT03972709|561250663|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
155498596|NCT03972709|561250664|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
155749935|NCT04090411|562184215|FG012|Chronic Period|Relocation|0|||
155749936|NCT04090411|562184203|FG000|Chronic Period|Physician Decision|0|||
155749937|NCT04090411|562184204|FG001|Chronic Period|Physician Decision|0|||
155749938|NCT04090411|562184205|FG002|Chronic Period|Physician Decision|0|||
155498597|NCT03972709|561250662|FG000|Overall Study|Subject Moved|0|||
155498598|NCT03972709|561250663|FG001|Overall Study|Subject Moved|1|||
155498599|NCT03972709|561250664|FG002|Overall Study|Subject Moved|0|||
155498600|NCT03972709|561250662|FG000|Overall Study|Missed Study Visits|1|||
155498601|NCT03972709|561250663|FG001|Overall Study|Missed Study Visits|0|||
155498602|NCT03972709|561250664|FG002|Overall Study|Missed Study Visits|0|||
155498603|NCT01523301|561250665|FG000|Overall Study|Adverse Event|25|||
155498604|NCT01523301|561250666|FG001|Overall Study|Adverse Event|16|||
155498605|NCT01523301|561250665|FG000|Overall Study|Lack of Efficacy|0|||
155498606|NCT01523301|561250666|FG001|Overall Study|Lack of Efficacy|2|||
155498607|NCT01523301|561250665|FG000|Overall Study|Protocol Violation|3|||
155498608|NCT01523301|561250666|FG001|Overall Study|Protocol Violation|4|||
155498609|NCT01523301|561250665|FG000|Overall Study|Lost to Follow-up|1|||
155498610|NCT01523301|561250666|FG001|Overall Study|Lost to Follow-up|0|||
155498611|NCT01523301|561250665|FG000|Overall Study|Withdrawal by Subject|6|||
155498612|NCT01523301|561250666|FG001|Overall Study|Withdrawal by Subject|8|||
155498613|NCT01523301|561250665|FG000|Overall Study|Other Reason|0|||
155498614|NCT01523301|561250666|FG001|Overall Study|Other Reason|2|||
155498615|NCT00728988|561250667|FG000|Overall Study|Not Treated|2|||
155498616|NCT00728988|561250668|FG001|Overall Study|Not Treated|2|||
155498617|NCT00728988|561250667|FG000|Overall Study|Death|1|||
155498618|NCT00728988|561250668|FG001|Overall Study|Death|1|||
155498619|NCT00728988|561250667|FG000|Overall Study|Adverse Event|3|||
155498620|NCT00728988|561250668|FG001|Overall Study|Adverse Event|2|||
155498621|NCT00728988|561250667|FG000|Overall Study|Other|85|||
155498622|NCT00728988|561250668|FG001|Overall Study|Other|77|||
155498623|NCT00728988|561250667|FG000|Overall Study|Withdrawal by Subject|2|||
155498624|NCT00728988|561250668|FG001|Overall Study|Withdrawal by Subject|6|||
155498625|NCT05013749|561250674|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
155498626|NCT05013749|561250675|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
155498627|NCT05013749|561250674|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
155498628|NCT05013749|561250675|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
155498629|NCT01393626|561250676|FG000|Overall Study|Adverse Event|2|||
155498630|NCT01393626|561250677|FG001|Overall Study|Adverse Event|1|||
155498631|NCT01393626|561250678|FG002|Overall Study|Adverse Event|5|||
155498632|NCT01393626|561250679|FG003|Overall Study|Adverse Event|0|||
155498633|NCT01393626|561250676|FG000|Overall Study|Did not meet entrance criteria|1|||
155498634|NCT01393626|561250677|FG001|Overall Study|Did not meet entrance criteria|0|||
155498635|NCT01393626|561250678|FG002|Overall Study|Did not meet entrance criteria|0|||
155498636|NCT01393626|561250679|FG003|Overall Study|Did not meet entrance criteria|0|||
155498637|NCT01393626|561250676|FG000|Overall Study|Lack of Efficacy|6|||
155498638|NCT01393626|561250677|FG001|Overall Study|Lack of Efficacy|6|||
155498639|NCT01393626|561250678|FG002|Overall Study|Lack of Efficacy|4|||
155498640|NCT01393626|561250679|FG003|Overall Study|Lack of Efficacy|1|||
155498641|NCT01393626|561250676|FG000|Overall Study|Lost to Follow-up|1|||
155498642|NCT01393626|561250677|FG001|Overall Study|Lost to Follow-up|1|||
155498643|NCT01393626|561250678|FG002|Overall Study|Lost to Follow-up|1|||
155498644|NCT01393626|561250679|FG003|Overall Study|Lost to Follow-up|0|||
155498645|NCT01393626|561250676|FG000|Overall Study|Withdrawal by Subject|6|||
155498646|NCT01393626|561250677|FG001|Overall Study|Withdrawal by Subject|4|||
155498647|NCT01393626|561250678|FG002|Overall Study|Withdrawal by Subject|0|||
155498648|NCT01393626|561250679|FG003|Overall Study|Withdrawal by Subject|0|||
155498649|NCT01393626|561250676|FG000|Overall Study|Other|1|||
155498650|NCT01393626|561250677|FG001|Overall Study|Other|0|||
155498651|NCT01393626|561250678|FG002|Overall Study|Other|0|||
155498652|NCT01393626|561250679|FG003|Overall Study|Other|0|||
155498653|NCT01393626|561250676|FG000|Overall Study|Protocol Violation|1|||
155498654|NCT01393626|561250677|FG001|Overall Study|Protocol Violation|0|||
155749939|NCT04090411|562184206|FG003|Chronic Period|Physician Decision|0|||
155749940|NCT04090411|562184207|FG004|Chronic Period|Physician Decision|1|||
155749941|NCT04090411|562184208|FG005|Chronic Period|Physician Decision|0|||
155749942|NCT04090411|562184209|FG006|Chronic Period|Physician Decision|0|||
155749943|NCT04090411|562184210|FG007|Chronic Period|Physician Decision|1|||
155749944|NCT04090411|562184211|FG008|Chronic Period|Physician Decision|0|||
155498655|NCT01393626|561250678|FG002|Overall Study|Protocol Violation|2|||
155498656|NCT01393626|561250679|FG003|Overall Study|Protocol Violation|0|||
155498657|NCT02426125|561250680|FG000|Overall Study|Lost to Follow-up|14|||
155498658|NCT02426125|561250681|FG001|Overall Study|Lost to Follow-up|12|||
155498659|NCT02426125|561250680|FG000|Overall Study|Withdrawal by Subject|13|||
155498660|NCT02426125|561250681|FG001|Overall Study|Withdrawal by Subject|14|||
155498661|NCT02426125|561250680|FG000|Overall Study|Death|185|||
155498662|NCT02426125|561250681|FG001|Overall Study|Death|200|||
155498663|NCT02426125|561250680|FG000|Overall Study|Randomized, But Never Treated|5|||
155498664|NCT02426125|561250681|FG001|Overall Study|Randomized, But Never Treated|2|||
155498665|NCT02858076|561250682|FG000|Overall Study|Death|6|||
155498666|NCT02858076|561250683|FG001|Overall Study|Death|3|||
155749945|NCT04090411|562184212|FG009|Chronic Period|Physician Decision|0|||
155749946|NCT04090411|562184213|FG010|Chronic Period|Physician Decision|0|||
155309488|NCT04927065|560567345|FG001|First Booster|Adverse Event|0|||
155309489|NCT04927065|560567346|FG002|First Booster|Adverse Event|0|||
155309490|NCT04927065|560567347|FG003|First Booster|Adverse Event|0|||
155309491|NCT04927065|560567348|FG004|First Booster|Adverse Event|0|||
155309492|NCT04927065|560567349|FG005|First Booster|Adverse Event|0|||
155309493|NCT04927065|560567350|FG006|First Booster|Adverse Event|0|||
155309494|NCT04927065|560567351|FG007|First Booster|Adverse Event|1|||
155309495|NCT04927065|560567352|FG008|First Booster|Adverse Event|0|||
155309496|NCT04927065|560567353|FG009|First Booster|Adverse Event|0|||
155309497|NCT04927065|560567354|FG010|First Booster|Adverse Event|0|||
155309498|NCT04927065|560567355|FG011|First Booster|Adverse Event|0|||
155309499|NCT04927065|560567356|FG012|First Booster|Adverse Event|0|||
155309500|NCT04927065|560567357|FG013|First Booster|Adverse Event|0|||
155309501|NCT04927065|560567358|FG014|First Booster|Adverse Event|0|||
155309502|NCT04927065|560567359|FG015|First Booster|Adverse Event|0|||
155309503|NCT04927065|560567344|FG000|First Booster|Death|1|||
155309504|NCT04927065|560567345|FG001|First Booster|Death|0|||
155309505|NCT04927065|560567346|FG002|First Booster|Death|0|||
155309506|NCT04927065|560567347|FG003|First Booster|Death|1|||
155309507|NCT04927065|560567348|FG004|First Booster|Death|0|||
155309508|NCT04927065|560567349|FG005|First Booster|Death|1|||
155309509|NCT04927065|560567350|FG006|First Booster|Death|0|||
155309510|NCT04927065|560567351|FG007|First Booster|Death|0|||
155309511|NCT04927065|560567352|FG008|First Booster|Death|0|||
155309512|NCT04927065|560567353|FG009|First Booster|Death|0|||
155309513|NCT04927065|560567354|FG010|First Booster|Death|0|||
155309514|NCT04927065|560567355|FG011|First Booster|Death|0|||
155309515|NCT04927065|560567356|FG012|First Booster|Death|0|||
155309516|NCT04927065|560567357|FG013|First Booster|Death|0|||
155309517|NCT04927065|560567358|FG014|First Booster|Death|0|||
155309518|NCT04927065|560567359|FG015|First Booster|Death|0|||
155309519|NCT04927065|560567344|FG000|First Booster|Lost to Follow-up|8|||
155309520|NCT04927065|560567345|FG001|First Booster|Lost to Follow-up|20|||
155309521|NCT04927065|560567346|FG002|First Booster|Lost to Follow-up|0|||
155309522|NCT04927065|560567347|FG003|First Booster|Lost to Follow-up|11|||
155309523|NCT04927065|560567348|FG004|First Booster|Lost to Follow-up|43|||
155309524|NCT04927065|560567349|FG005|First Booster|Lost to Follow-up|30|||
155309525|NCT04927065|560567350|FG006|First Booster|Lost to Follow-up|28|||
155309526|NCT04927065|560567351|FG007|First Booster|Lost to Follow-up|23|||
155309527|NCT04927065|560567352|FG008|First Booster|Lost to Follow-up|4|||
155309528|NCT04927065|560567353|FG009|First Booster|Lost to Follow-up|15|||
155309529|NCT04927065|560567354|FG010|First Booster|Lost to Follow-up|0|||
155309530|NCT04927065|560567355|FG011|First Booster|Lost to Follow-up|0|||
155309531|NCT04927065|560567356|FG012|First Booster|Lost to Follow-up|0|||
155309532|NCT04927065|560567357|FG013|First Booster|Lost to Follow-up|0|||
155309533|NCT04927065|560567358|FG014|First Booster|Lost to Follow-up|0|||
155309534|NCT04927065|560567359|FG015|First Booster|Lost to Follow-up|0|||
155309535|NCT04927065|560567344|FG000|First Booster|Physician Decision|1|||
155309536|NCT04927065|560567345|FG001|First Booster|Physician Decision|0|||
155309537|NCT04927065|560567346|FG002|First Booster|Physician Decision|0|||
155309538|NCT04927065|560567347|FG003|First Booster|Physician Decision|3|||
155309539|NCT04927065|560567348|FG004|First Booster|Physician Decision|1|||
155309540|NCT04927065|560567349|FG005|First Booster|Physician Decision|1|||
155309541|NCT04927065|560567350|FG006|First Booster|Physician Decision|0|||
155309542|NCT04927065|560567351|FG007|First Booster|Physician Decision|3|||
155309543|NCT04927065|560567352|FG008|First Booster|Physician Decision|0|||
155309544|NCT04927065|560567353|FG009|First Booster|Physician Decision|0|||
155309545|NCT04927065|560567354|FG010|First Booster|Physician Decision|0|||
155309546|NCT04927065|560567355|FG011|First Booster|Physician Decision|0|||
155309547|NCT04927065|560567356|FG012|First Booster|Physician Decision|0|||
155309548|NCT04927065|560567357|FG013|First Booster|Physician Decision|0|||
155415514|NCT05227690|560952300|FG002|Overall Study|Withdrawal of consent|21|||
155415515|NCT05227690|560952298|FG000|Overall Study|Other, not specified|2|||
155415516|NCT05227690|560952299|FG001|Overall Study|Other, not specified|2|||
155415517|NCT05227690|560952300|FG002|Overall Study|Other, not specified|1|||
155309549|NCT04927065|560567358|FG014|First Booster|Physician Decision|0|||
155415518|NCT04033367|560952301|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
155415519|NCT04033367|560952302|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
155309550|NCT04927065|560567359|FG015|First Booster|Physician Decision|0|||
155309551|NCT04927065|560567344|FG000|First Booster|Protocol Violation|4|||
155309552|NCT04927065|560567345|FG001|First Booster|Protocol Violation|4|||
155309553|NCT04927065|560567346|FG002|First Booster|Protocol Violation|0|||
155309554|NCT04927065|560567347|FG003|First Booster|Protocol Violation|3|||
155415520|NCT04033367|560952301|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
155309555|NCT04927065|560567348|FG004|First Booster|Protocol Violation|0|||
155309556|NCT04927065|560567349|FG005|First Booster|Protocol Violation|0|||
155309557|NCT04927065|560567350|FG006|First Booster|Protocol Violation|0|||
155309558|NCT04927065|560567351|FG007|First Booster|Protocol Violation|2|||
155309559|NCT04927065|560567352|FG008|First Booster|Protocol Violation|0|||
155309560|NCT04927065|560567353|FG009|First Booster|Protocol Violation|0|||
155309561|NCT04927065|560567354|FG010|First Booster|Protocol Violation|0|||
155309562|NCT04927065|560567355|FG011|First Booster|Protocol Violation|0|||
155309563|NCT04927065|560567356|FG012|First Booster|Protocol Violation|0|||
155309564|NCT04927065|560567357|FG013|First Booster|Protocol Violation|0|||
155309565|NCT04927065|560567358|FG014|First Booster|Protocol Violation|0|||
155415521|NCT04033367|560952302|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155415522|NCT04033367|560952301|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
155415523|NCT04033367|560952302|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
155415524|NCT04033367|560952301|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
155415525|NCT04033367|560952302|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
155415526|NCT01191697|560952303|FG000|Overall Study|Death|1|||
155415527|NCT01191697|560952303|FG000|Overall Study|Physician Decision|2|||
155415528|NCT01191697|560952303|FG000|Overall Study|Pursue chemoradiation|2|||
155415529|NCT01191697|560952303|FG000|Overall Study|Break from chemotherapy|2|||
155415530|NCT01191697|560952303|FG000|Overall Study|Withdrawal by Subject|1|||
155415531|NCT01191697|560952303|FG000|Overall Study|Surveillance|1|||
155415532|NCT01191697|560952303|FG000|Overall Study|Adverse Event|2|||
155415533|NCT01191697|560952303|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
155415534|NCT01191697|560952303|FG000|Overall Study|Not completed but analyzed|25|||
155415535|NCT01534676|560952304|FG000|Overall Study|Study closed due to poor enrollment|2|||
155415536|NCT01534676|560952305|FG001|Overall Study|Study closed due to poor enrollment|1|||
155415537|NCT02634580|560952306|FG000|Double-blind Treatment Period|Subject Request|1|||
155415538|NCT02634580|560952307|FG001|Double-blind Treatment Period|Subject Request|0|||
155415539|NCT02634580|560952308|FG002|Double-blind Treatment Period|Subject Request|1|||
155415540|NCT02634580|560952309|FG003|Double-blind Treatment Period|Subject Request|1|||
155498667|NCT02858076|561250682|FG000|Overall Study|Withdrawal by Subject|1|||
155498668|NCT02858076|561250683|FG001|Overall Study|Withdrawal by Subject|5|||
155498669|NCT02858076|561250682|FG000|Overall Study|Lost to Follow-up|2|||
155309566|NCT04927065|560567359|FG015|First Booster|Protocol Violation|0|||
155309567|NCT04927065|560567344|FG000|First Booster|Withdrawal by Subject|8|||
155309568|NCT04927065|560567345|FG001|First Booster|Withdrawal by Subject|23|||
155309569|NCT04927065|560567346|FG002|First Booster|Withdrawal by Subject|0|||
155309570|NCT04927065|560567347|FG003|First Booster|Withdrawal by Subject|19|||
155309571|NCT04927065|560567348|FG004|First Booster|Withdrawal by Subject|20|||
155309572|NCT04927065|560567349|FG005|First Booster|Withdrawal by Subject|15|||
155309573|NCT04927065|560567350|FG006|First Booster|Withdrawal by Subject|6|||
155309574|NCT04927065|560567351|FG007|First Booster|Withdrawal by Subject|24|||
155309575|NCT04927065|560567352|FG008|First Booster|Withdrawal by Subject|0|||
155309576|NCT04927065|560567353|FG009|First Booster|Withdrawal by Subject|4|||
155309577|NCT04927065|560567354|FG010|First Booster|Withdrawal by Subject|0|||
155309578|NCT04927065|560567355|FG011|First Booster|Withdrawal by Subject|0|||
155309579|NCT04927065|560567356|FG012|First Booster|Withdrawal by Subject|0|||
155309580|NCT04927065|560567357|FG013|First Booster|Withdrawal by Subject|0|||
155309581|NCT04927065|560567358|FG014|First Booster|Withdrawal by Subject|0|||
155309582|NCT04927065|560567359|FG015|First Booster|Withdrawal by Subject|0|||
155309583|NCT04927065|560567344|FG000|First Booster|Other Than Specified|1|||
155309584|NCT04927065|560567345|FG001|First Booster|Other Than Specified|1|||
155309585|NCT04927065|560567346|FG002|First Booster|Other Than Specified|0|||
155309586|NCT04927065|560567347|FG003|First Booster|Other Than Specified|1|||
155309587|NCT04927065|560567348|FG004|First Booster|Other Than Specified|2|||
155309588|NCT04927065|560567349|FG005|First Booster|Other Than Specified|3|||
155309589|NCT04927065|560567350|FG006|First Booster|Other Than Specified|2|||
155309590|NCT04927065|560567351|FG007|First Booster|Other Than Specified|6|||
155309591|NCT04927065|560567352|FG008|First Booster|Other Than Specified|0|||
155309592|NCT04927065|560567353|FG009|First Booster|Other Than Specified|4|||
155309593|NCT04927065|560567354|FG010|First Booster|Other Than Specified|0|||
155309594|NCT04927065|560567355|FG011|First Booster|Other Than Specified|0|||
155309595|NCT04927065|560567356|FG012|First Booster|Other Than Specified|0|||
155309596|NCT04927065|560567357|FG013|First Booster|Other Than Specified|0|||
155309597|NCT04927065|560567358|FG014|First Booster|Other Than Specified|0|||
155309598|NCT04927065|560567359|FG015|First Booster|Other Than Specified|0|||
155309599|NCT04927065|560567344|FG000|Second Booster|Death|0|||
155309600|NCT04927065|560567345|FG001|Second Booster|Death|0|||
155309601|NCT04927065|560567346|FG002|Second Booster|Death|0|||
155309602|NCT04927065|560567347|FG003|Second Booster|Death|0|||
155309603|NCT04927065|560567348|FG004|Second Booster|Death|0|||
155309604|NCT04927065|560567349|FG005|Second Booster|Death|0|||
155309605|NCT04927065|560567350|FG006|Second Booster|Death|0|||
155309606|NCT04927065|560567351|FG007|Second Booster|Death|0|||
155309607|NCT04927065|560567352|FG008|Second Booster|Death|0|||
155309608|NCT04927065|560567353|FG009|Second Booster|Death|0|||
155309609|NCT04927065|560567354|FG010|Second Booster|Death|2|||
155415541|NCT02634580|560952306|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155415542|NCT02634580|560952307|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
155415543|NCT02634580|560952308|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
155309610|NCT04927065|560567355|FG011|Second Booster|Death|0|||
155309611|NCT04927065|560567356|FG012|Second Booster|Death|2|||
155309612|NCT04927065|560567357|FG013|Second Booster|Death|2|||
155309613|NCT04927065|560567358|FG014|Second Booster|Death|0|||
155749947|NCT04090411|562184214|FG011|Chronic Period|Physician Decision|1|||
155749948|NCT04090411|562184215|FG012|Chronic Period|Physician Decision|1|||
155749949|NCT04090411|562184203|FG000|Chronic Period|Protocol Violation|0|||
155749950|NCT04090411|562184204|FG001|Chronic Period|Protocol Violation|0|||
155749951|NCT04090411|562184205|FG002|Chronic Period|Protocol Violation|0|||
155309614|NCT04927065|560567359|FG015|Second Booster|Death|0|||
155309615|NCT04927065|560567344|FG000|Second Booster|Lost to Follow-up|0|||
155309616|NCT04927065|560567345|FG001|Second Booster|Lost to Follow-up|0|||
155309617|NCT04927065|560567346|FG002|Second Booster|Lost to Follow-up|3|||
155309618|NCT04927065|560567347|FG003|Second Booster|Lost to Follow-up|0|||
155309619|NCT04927065|560567348|FG004|Second Booster|Lost to Follow-up|0|||
155309620|NCT04927065|560567349|FG005|Second Booster|Lost to Follow-up|0|||
155309621|NCT04927065|560567350|FG006|Second Booster|Lost to Follow-up|0|||
155309622|NCT04927065|560567351|FG007|Second Booster|Lost to Follow-up|0|||
155309623|NCT04927065|560567352|FG008|Second Booster|Lost to Follow-up|0|||
155309624|NCT04927065|560567353|FG009|Second Booster|Lost to Follow-up|0|||
155309625|NCT04927065|560567354|FG010|Second Booster|Lost to Follow-up|14|||
155309626|NCT04927065|560567355|FG011|Second Booster|Lost to Follow-up|10|||
155309627|NCT04927065|560567356|FG012|Second Booster|Lost to Follow-up|13|||
155309628|NCT04927065|560567357|FG013|Second Booster|Lost to Follow-up|16|||
155309629|NCT04927065|560567358|FG014|Second Booster|Lost to Follow-up|0|||
155309630|NCT04927065|560567359|FG015|Second Booster|Lost to Follow-up|0|||
155309631|NCT04927065|560567344|FG000|Second Booster|Physician Decision|0|||
155309632|NCT04927065|560567345|FG001|Second Booster|Physician Decision|0|||
155309633|NCT04927065|560567346|FG002|Second Booster|Physician Decision|0|||
155309634|NCT04927065|560567347|FG003|Second Booster|Physician Decision|0|||
155309635|NCT04927065|560567348|FG004|Second Booster|Physician Decision|0|||
155309636|NCT04927065|560567349|FG005|Second Booster|Physician Decision|0|||
155309637|NCT04927065|560567350|FG006|Second Booster|Physician Decision|0|||
155309638|NCT04927065|560567351|FG007|Second Booster|Physician Decision|0|||
155309639|NCT04927065|560567352|FG008|Second Booster|Physician Decision|0|||
155309640|NCT04927065|560567353|FG009|Second Booster|Physician Decision|0|||
155309641|NCT04927065|560567354|FG010|Second Booster|Physician Decision|0|||
155309642|NCT04927065|560567355|FG011|Second Booster|Physician Decision|3|||
155309643|NCT04927065|560567356|FG012|Second Booster|Physician Decision|0|||
155309644|NCT04927065|560567357|FG013|Second Booster|Physician Decision|1|||
155309645|NCT04927065|560567358|FG014|Second Booster|Physician Decision|0|||
155309646|NCT04927065|560567359|FG015|Second Booster|Physician Decision|0|||
155309647|NCT04927065|560567344|FG000|Second Booster|Withdrawal by Subject|0|||
155309648|NCT04927065|560567345|FG001|Second Booster|Withdrawal by Subject|0|||
155309649|NCT04927065|560567346|FG002|Second Booster|Withdrawal by Subject|4|||
155309650|NCT04927065|560567347|FG003|Second Booster|Withdrawal by Subject|0|||
155309651|NCT04927065|560567348|FG004|Second Booster|Withdrawal by Subject|0|||
155309652|NCT04927065|560567349|FG005|Second Booster|Withdrawal by Subject|0|||
155309653|NCT04927065|560567350|FG006|Second Booster|Withdrawal by Subject|0|||
155309654|NCT04927065|560567351|FG007|Second Booster|Withdrawal by Subject|0|||
155309655|NCT04927065|560567352|FG008|Second Booster|Withdrawal by Subject|0|||
155309656|NCT04927065|560567353|FG009|Second Booster|Withdrawal by Subject|0|||
155309657|NCT04927065|560567354|FG010|Second Booster|Withdrawal by Subject|3|||
155309658|NCT04927065|560567355|FG011|Second Booster|Withdrawal by Subject|16|||
155309659|NCT04927065|560567356|FG012|Second Booster|Withdrawal by Subject|13|||
155309660|NCT04927065|560567357|FG013|Second Booster|Withdrawal by Subject|9|||
155309661|NCT04927065|560567358|FG014|Second Booster|Withdrawal by Subject|0|||
155309662|NCT04927065|560567359|FG015|Second Booster|Withdrawal by Subject|0|||
155309663|NCT04927065|560567344|FG000|Second Booster|Other Than Specified|0|||
155309664|NCT04927065|560567345|FG001|Second Booster|Other Than Specified|0|||
155309665|NCT04927065|560567346|FG002|Second Booster|Other Than Specified|0|||
155309666|NCT04927065|560567347|FG003|Second Booster|Other Than Specified|0|||
155309667|NCT04927065|560567348|FG004|Second Booster|Other Than Specified|0|||
155309668|NCT04927065|560567349|FG005|Second Booster|Other Than Specified|0|||
155309669|NCT04927065|560567350|FG006|Second Booster|Other Than Specified|0|||
155309670|NCT04927065|560567351|FG007|Second Booster|Other Than Specified|0|||
155309671|NCT04927065|560567352|FG008|Second Booster|Other Than Specified|0|||
155309672|NCT04927065|560567353|FG009|Second Booster|Other Than Specified|0|||
155309673|NCT04927065|560567354|FG010|Second Booster|Other Than Specified|1|||
155309674|NCT04927065|560567355|FG011|Second Booster|Other Than Specified|1|||
155309675|NCT04927065|560567356|FG012|Second Booster|Other Than Specified|4|||
155309676|NCT04927065|560567357|FG013|Second Booster|Other Than Specified|0|||
155309677|NCT04927065|560567358|FG014|Second Booster|Other Than Specified|0|||
155309678|NCT04927065|560567359|FG015|Second Booster|Other Than Specified|0|||
155309679|NCT04927065|560567344|FG000|Third Booster|Lost to Follow-up|0|||
155309680|NCT04927065|560567345|FG001|Third Booster|Lost to Follow-up|0|||
155309681|NCT04927065|560567346|FG002|Third Booster|Lost to Follow-up|0|||
155309682|NCT04927065|560567347|FG003|Third Booster|Lost to Follow-up|0|||
155309683|NCT04927065|560567348|FG004|Third Booster|Lost to Follow-up|0|||
155309684|NCT04927065|560567349|FG005|Third Booster|Lost to Follow-up|0|||
155749952|NCT04090411|562184206|FG003|Chronic Period|Protocol Violation|0|||
155498670|NCT02858076|561250683|FG001|Overall Study|Lost to Follow-up|7|||
155498671|NCT02858076|561250682|FG000|Overall Study|Completed Out of Window|1|||
155498672|NCT02858076|561250683|FG001|Overall Study|Completed Out of Window|3|||
155498673|NCT02643394|561250684|FG000|Overall Study|Protocol Violation|4|||
155498674|NCT02643394|561250685|FG001|Overall Study|Protocol Violation|5|||
155498675|NCT00943384|561250686|FG000|Overall Study|Dispositioned prior to treatment|23|||
155498676|NCT00943384|561250686|FG000|Overall Study|Treated off protocol-protocol violation|5|||
155498677|NCT00943384|561250686|FG000|Overall Study|Lost to Follow-up|16|||
155498678|NCT00943384|561250686|FG000|Overall Study|Withdrawal by Subject|5|||
155498679|NCT00096200|561250687|FG000|Overall Study|Adverse Event|0|||
155498680|NCT00096200|561250688|FG001|Overall Study|Adverse Event|4|||
155498681|NCT00096200|561250689|FG002|Overall Study|Adverse Event|0|||
155498682|NCT00096200|561250687|FG000|Overall Study|Withdrawal by Subject|1|||
155498683|NCT00096200|561250688|FG001|Overall Study|Withdrawal by Subject|2|||
155498684|NCT00096200|561250689|FG002|Overall Study|Withdrawal by Subject|0|||
155498685|NCT00096200|561250687|FG000|Overall Study|Ineligible pathology|0|||
155498686|NCT00096200|561250688|FG001|Overall Study|Ineligible pathology|1|||
155498687|NCT00096200|561250689|FG002|Overall Study|Ineligible pathology|0|||
155498688|NCT02341482|561250693|FG000|Overall Study|Adverse Event|1|||
155498689|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
155498690|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
155498691|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Death|5|||
155498692|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Death|2|||
155498693|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
155498694|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
155498695|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
155498696|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
155498697|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
155498698|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
155498699|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Relapse|1|||
155498700|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Relapse|0|||
155498701|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
155498702|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
155498703|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
155498704|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
155498705|NCT00111007|561250694|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
155498706|NCT00111007|561250695|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
155498707|NCT00111007|561250694|FG000|Active Follow-up|Adverse Event|1|||
155498708|NCT00111007|561250695|FG001|Active Follow-up|Adverse Event|0|||
155498709|NCT00111007|561250694|FG000|Active Follow-up|Death|2|||
155498710|NCT00111007|561250695|FG001|Active Follow-up|Death|0|||
155498711|NCT00111007|561250694|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
155498712|NCT00111007|561250695|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
155498713|NCT00111007|561250694|FG000|Long Term Follow-up|Death|34|||
155498714|NCT00111007|561250695|FG001|Long Term Follow-up|Death|39|||
155498715|NCT00111007|561250694|FG000|Long Term Follow-up|Lost to Follow-up|1|||
155498716|NCT00111007|561250695|FG001|Long Term Follow-up|Lost to Follow-up|1|||
155498717|NCT00111007|561250694|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
155498718|NCT00111007|561250695|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
155498719|NCT00111007|561250694|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
155498720|NCT00111007|561250695|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
155498721|NCT00111007|561250694|FG000|Long Term Follow-up|Missing|10|||
155498722|NCT00111007|561250695|FG001|Long Term Follow-up|Missing|3|||
155498723|NCT01495793|561250696|FG000|Overall Study|Lost to Follow-up|1|||
155498724|NCT01495793|561250696|FG000|Overall Study|Violation of inclusion criteria|1|||
155498725|NCT02362646|561250698|FG000|Overall Study|Death|15|||
155498726|NCT02362646|561250699|FG001|Overall Study|Death|8|||
155498727|NCT02362646|561250698|FG000|Overall Study|Withdrawal by Subject|2|||
155498728|NCT02362646|561250699|FG001|Overall Study|Withdrawal by Subject|2|||
155498729|NCT02362646|561250698|FG000|Overall Study|received transplant|21|||
155498730|NCT02362646|561250699|FG001|Overall Study|received transplant|14|||
155498731|NCT03611751|561250703|FG000|Pre-treatment|Randomized but not treated|1|||
155498732|NCT03611751|561250704|FG001|Pre-treatment|Randomized but not treated|1|||
155498733|NCT03611751|561250705|FG002|Pre-treatment|Randomized but not treated|0|||
155498734|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
155498735|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
155498736|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
155498737|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
155498738|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
155498739|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
155498740|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
155498741|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
155498742|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
155749953|NCT04090411|562184207|FG004|Chronic Period|Protocol Violation|0|||
155309685|NCT04927065|560567350|FG006|Third Booster|Lost to Follow-up|0|||
155309686|NCT04927065|560567351|FG007|Third Booster|Lost to Follow-up|0|||
155309687|NCT04927065|560567352|FG008|Third Booster|Lost to Follow-up|0|||
155309688|NCT04927065|560567353|FG009|Third Booster|Lost to Follow-up|0|||
155309689|NCT04927065|560567354|FG010|Third Booster|Lost to Follow-up|0|||
155309690|NCT04927065|560567355|FG011|Third Booster|Lost to Follow-up|0|||
155309691|NCT04927065|560567356|FG012|Third Booster|Lost to Follow-up|0|||
155309692|NCT04927065|560567357|FG013|Third Booster|Lost to Follow-up|0|||
155309693|NCT04927065|560567358|FG014|Third Booster|Lost to Follow-up|0|||
155309694|NCT04927065|560567359|FG015|Third Booster|Lost to Follow-up|1|||
155309695|NCT04927065|560567344|FG000|Third Booster|Withdrawal by Subject|0|||
155309696|NCT04927065|560567345|FG001|Third Booster|Withdrawal by Subject|0|||
155309697|NCT04927065|560567346|FG002|Third Booster|Withdrawal by Subject|0|||
155309698|NCT04927065|560567347|FG003|Third Booster|Withdrawal by Subject|0|||
155309699|NCT04927065|560567348|FG004|Third Booster|Withdrawal by Subject|0|||
155309700|NCT04927065|560567349|FG005|Third Booster|Withdrawal by Subject|0|||
155309701|NCT04927065|560567350|FG006|Third Booster|Withdrawal by Subject|0|||
155309702|NCT04927065|560567351|FG007|Third Booster|Withdrawal by Subject|0|||
155309703|NCT04927065|560567352|FG008|Third Booster|Withdrawal by Subject|0|||
155309704|NCT04927065|560567353|FG009|Third Booster|Withdrawal by Subject|0|||
155309705|NCT04927065|560567354|FG010|Third Booster|Withdrawal by Subject|0|||
155309706|NCT04927065|560567355|FG011|Third Booster|Withdrawal by Subject|0|||
155309707|NCT04927065|560567356|FG012|Third Booster|Withdrawal by Subject|0|||
155309708|NCT04927065|560567357|FG013|Third Booster|Withdrawal by Subject|0|||
155309709|NCT04927065|560567358|FG014|Third Booster|Withdrawal by Subject|0|||
155309710|NCT04927065|560567359|FG015|Third Booster|Withdrawal by Subject|1|||
155309711|NCT03338790|560567363|FG000|Overall Study|Disease Progression|65|||
155309712|NCT03338790|560567364|FG001|Overall Study|Disease Progression|43|||
155309713|NCT03338790|560567365|FG002|Overall Study|Disease Progression|50|||
155309714|NCT03338790|560567366|FG003|Overall Study|Disease Progression|37|||
155309715|NCT03338790|560567363|FG000|Overall Study|Study Drug Toxicity|9|||
155309716|NCT03338790|560567364|FG001|Overall Study|Study Drug Toxicity|8|||
155309717|NCT03338790|560567365|FG002|Overall Study|Study Drug Toxicity|15|||
155309718|NCT03338790|560567366|FG003|Overall Study|Study Drug Toxicity|0|||
155309719|NCT03338790|560567363|FG000|Overall Study|Death|1|||
155309720|NCT03338790|560567364|FG001|Overall Study|Death|1|||
155309721|NCT03338790|560567365|FG002|Overall Study|Death|1|||
155309722|NCT03338790|560567366|FG003|Overall Study|Death|0|||
155309723|NCT03338790|560567363|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309724|NCT03338790|560567364|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309725|NCT03338790|560567365|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
155309726|NCT03338790|560567366|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309727|NCT03338790|560567363|FG000|Overall Study|Participant request to discontinue study treatment|3|||
155309728|NCT03338790|560567364|FG001|Overall Study|Participant request to discontinue study treatment|3|||
155309729|NCT03338790|560567365|FG002|Overall Study|Participant request to discontinue study treatment|2|||
155309730|NCT03338790|560567366|FG003|Overall Study|Participant request to discontinue study treatment|1|||
155309731|NCT03338790|560567363|FG000|Overall Study|Poor/non-compliance|0|||
155309732|NCT03338790|560567364|FG001|Overall Study|Poor/non-compliance|1|||
155309733|NCT03338790|560567365|FG002|Overall Study|Poor/non-compliance|0|||
155309734|NCT03338790|560567366|FG003|Overall Study|Poor/non-compliance|0|||
155309735|NCT03338790|560567363|FG000|Overall Study|Participant withdrew consent|1|||
155309736|NCT03338790|560567364|FG001|Overall Study|Participant withdrew consent|0|||
155309737|NCT03338790|560567365|FG002|Overall Study|Participant withdrew consent|1|||
155309738|NCT03338790|560567366|FG003|Overall Study|Participant withdrew consent|1|||
155309739|NCT03338790|560567363|FG000|Overall Study|Other reasons|0|||
155309740|NCT03338790|560567364|FG001|Overall Study|Other reasons|5|||
155309741|NCT03338790|560567365|FG002|Overall Study|Other reasons|0|||
155309742|NCT03338790|560567366|FG003|Overall Study|Other reasons|2|||
155309743|NCT03338790|560567363|FG000|Overall Study|Not reported|0|||
155309744|NCT03338790|560567364|FG001|Overall Study|Not reported|0|||
155309745|NCT03338790|560567365|FG002|Overall Study|Not reported|1|||
155309746|NCT03338790|560567366|FG003|Overall Study|Not reported|0|||
155309747|NCT03338790|560567363|FG000|Overall Study|Completed treatment period|1|||
155309748|NCT03338790|560567364|FG001|Overall Study|Completed treatment period|2|||
155309749|NCT03338790|560567365|FG002|Overall Study|Completed treatment period|0|||
155309750|NCT03338790|560567366|FG003|Overall Study|Completed treatment period|0|||
155309751|NCT03846505|560567367|FG000|Treatment Phase|Withdrawal by Subject|9|||
155309752|NCT03846505|560567368|FG001|Treatment Phase|Withdrawal by Subject|11|||
155309753|NCT03846505|560567367|FG000|Treatment Phase|Lost to Follow-up|6|||
155309754|NCT03846505|560567368|FG001|Treatment Phase|Lost to Follow-up|2|||
155309755|NCT03846505|560567367|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
155309756|NCT03846505|560567368|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
155309757|NCT03846505|560567367|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
155309758|NCT03846505|560567368|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
155309759|NCT00601900|560567369|FG000|Overall Study|Withdrawal by Subject|0|||
155309760|NCT00601900|560567370|FG001|Overall Study|Withdrawal by Subject|3|||
155309761|NCT03924986|560567371|FG000|Overall Study|Death|57|||
155309762|NCT03924986|560567372|FG001|Overall Study|Death|66|||
155309763|NCT03924986|560567371|FG000|Overall Study|Study Concluded by Sponsor|51|||
155309764|NCT03924986|560567372|FG001|Overall Study|Study Concluded by Sponsor|41|||
155309765|NCT03924986|560567371|FG000|Overall Study|Withdrawal by Subject|15|||
155309766|NCT03924986|560567372|FG001|Overall Study|Withdrawal by Subject|20|||
155309767|NCT03924986|560567371|FG000|Overall Study|Lost to Follow-up|7|||
155309768|NCT03924986|560567372|FG001|Overall Study|Lost to Follow-up|5|||
155309769|NCT03924986|560567371|FG000|Overall Study|Miscellaneous|1|||
155309770|NCT03924986|560567372|FG001|Overall Study|Miscellaneous|0|||
155309771|NCT05592418|560567378|FG000|Overall Study|Adverse Event|1|||
155309772|NCT05592418|560567379|FG001|Overall Study|Adverse Event|0|||
155309773|NCT05592418|560567378|FG000|Overall Study|Lost to Follow-up|1|||
155309774|NCT05592418|560567379|FG001|Overall Study|Lost to Follow-up|3|||
155309775|NCT05592418|560567378|FG000|Overall Study|Withdrawal by Subject|2|||
155309776|NCT05592418|560567379|FG001|Overall Study|Withdrawal by Subject|7|||
155309777|NCT01494662|560567382|FG000|Overall Study|Withdrawal by Subject|0|||
155309778|NCT01494662|560567383|FG001|Overall Study|Withdrawal by Subject|0|||
155309779|NCT01494662|560567384|FG002|Overall Study|Withdrawal by Subject|1|||
155309780|NCT01494662|560567385|FG003|Overall Study|Withdrawal by Subject|0|||
155309781|NCT01494662|560567386|FG004|Overall Study|Withdrawal by Subject|0|||
155309782|NCT01494662|560567387|FG005|Overall Study|Withdrawal by Subject|0|||
155309783|NCT01494662|560567388|FG006|Overall Study|Withdrawal by Subject|0|||
155309784|NCT01494662|560567382|FG000|Overall Study|Physician Decision|0|||
155309785|NCT01494662|560567383|FG001|Overall Study|Physician Decision|0|||
155309786|NCT01494662|560567384|FG002|Overall Study|Physician Decision|1|||
155309787|NCT01494662|560567385|FG003|Overall Study|Physician Decision|0|||
155309788|NCT01494662|560567386|FG004|Overall Study|Physician Decision|0|||
155309789|NCT01494662|560567387|FG005|Overall Study|Physician Decision|0|||
155309790|NCT01494662|560567388|FG006|Overall Study|Physician Decision|0|||
155309791|NCT04072822|560567389|FG000|Treatment|Adverse Event|9|||
155309792|NCT04072822|560567390|FG001|Treatment|Adverse Event|5|||
155309793|NCT04072822|560567389|FG000|Treatment|Met Stopping Criteria|13|||
155309794|NCT04072822|560567390|FG001|Treatment|Met Stopping Criteria|24|||
155309795|NCT04072822|560567389|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
155309796|NCT04072822|560567390|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
155309797|NCT04072822|560567389|FG000|Treatment|Withdrawal by Subject|0|||
155309798|NCT04072822|560567390|FG001|Treatment|Withdrawal by Subject|2|||
155309799|NCT04072822|560567389|FG000|Treatment|Death|0|||
155309800|NCT04072822|560567390|FG001|Treatment|Death|2|||
155309801|NCT04072822|560567389|FG000|Treatment|Lost to Follow-up|11|||
155309802|NCT04072822|560567390|FG001|Treatment|Lost to Follow-up|3|||
155309803|NCT04072822|560567389|FG000|Treatment|Physician Decision|1|||
155309804|NCT04072822|560567390|FG001|Treatment|Physician Decision|0|||
155309805|NCT04072822|560567389|FG000|Treatment|Other|7|||
155309806|NCT04072822|560567390|FG001|Treatment|Other|9|||
155309807|NCT04072822|560567389|FG000|Follow-up|Withdrawal by Subject|1|||
155309808|NCT04072822|560567390|FG001|Follow-up|Withdrawal by Subject|0|||
155309809|NCT04072822|560567389|FG000|Follow-up|Lost to Follow-up|5|||
155309810|NCT04072822|560567390|FG001|Follow-up|Lost to Follow-up|4|||
155309811|NCT05481320|560567391|FG000|Overall Study|Withdrawal by Subject|1|||
155309812|NCT05481320|560567392|FG001|Overall Study|Withdrawal by Subject|1|||
155309813|NCT05481320|560567391|FG000|Overall Study|Care recipent passed away|0|||
155309814|NCT05481320|560567392|FG001|Overall Study|Care recipent passed away|1|||
155309815|NCT05481320|560567391|FG000|Overall Study|Out-of-window assessment|0|||
155309816|NCT05481320|560567392|FG001|Overall Study|Out-of-window assessment|1|||
155309817|NCT05481320|560567391|FG000|Overall Study|No longer a primary caregiver|3|||
155309818|NCT05481320|560567392|FG001|Overall Study|No longer a primary caregiver|0|||
155309819|NCT05481320|560567391|FG000|Overall Study|Unable to contact|1|||
155309820|NCT05481320|560567392|FG001|Overall Study|Unable to contact|0|||
155309821|NCT04314895|560567398|FG000|Overall Study|Lost to Follow-up|1|||
155309822|NCT04314895|560567398|FG000|Overall Study|Death|10|||
155309823|NCT04314895|560567398|FG000|Overall Study|Physician Decision|2|||
155309824|NCT03930342|560567402|FG000|Overall Study|Lost to Follow-up|70|||
155309825|NCT03930342|560567403|FG001|Overall Study|Lost to Follow-up|77|||
155309826|NCT02596126|560567404|FG000|Overall Study|Lost to Follow-up|12|||
155309827|NCT02596126|560567405|FG001|Overall Study|Lost to Follow-up|21|||
155309828|NCT02596126|560567404|FG000|Overall Study|Protocol Violation|7|||
155309829|NCT02596126|560567405|FG001|Overall Study|Protocol Violation|9|||
155309830|NCT04774237|560567406|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309831|NCT04774237|560567407|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309832|NCT04774237|560567408|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309833|NCT04774237|560567409|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309834|NCT04774237|560567410|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
155309835|NCT04774237|560567411|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309836|NCT04521478|560569134|FG000|Overall Study|Protocol Violation|2|||
155309837|NCT04521478|560569135|FG001|Overall Study|Protocol Violation|0|||
155309838|NCT04521478|560569136|FG002|Overall Study|Protocol Violation|1|||
155309839|NCT04521478|560569137|FG003|Overall Study|Protocol Violation|0|||
155309840|NCT04521478|560569138|FG004|Overall Study|Protocol Violation|0|||
155309841|NCT04521478|560569139|FG005|Overall Study|Protocol Violation|0|||
155309842|NCT04521478|560569134|FG000|Overall Study|Technical Problems|0|||
155309843|NCT04521478|560569135|FG001|Overall Study|Technical Problems|0|||
155309844|NCT04521478|560569136|FG002|Overall Study|Technical Problems|0|||
155309845|NCT04521478|560569137|FG003|Overall Study|Technical Problems|1|||
155309846|NCT04521478|560569138|FG004|Overall Study|Technical Problems|0|||
155309847|NCT04521478|560569139|FG005|Overall Study|Technical Problems|0|||
155309848|NCT04521478|560569134|FG000|Overall Study|Burden of Study Procedures|1|||
155309849|NCT04521478|560569135|FG001|Overall Study|Burden of Study Procedures|0|||
155309850|NCT04521478|560569136|FG002|Overall Study|Burden of Study Procedures|0|||
155309851|NCT04521478|560569137|FG003|Overall Study|Burden of Study Procedures|1|||
155309852|NCT04521478|560569138|FG004|Overall Study|Burden of Study Procedures|0|||
155309853|NCT04521478|560569139|FG005|Overall Study|Burden of Study Procedures|1|||
155309854|NCT04521478|560569134|FG000|Overall Study|Lack of Efficacy|0|||
155309855|NCT04521478|560569135|FG001|Overall Study|Lack of Efficacy|0|||
155309856|NCT04521478|560569136|FG002|Overall Study|Lack of Efficacy|0|||
155309857|NCT04521478|560569137|FG003|Overall Study|Lack of Efficacy|0|||
155309858|NCT04521478|560569138|FG004|Overall Study|Lack of Efficacy|1|||
155309859|NCT04521478|560569139|FG005|Overall Study|Lack of Efficacy|1|||
155309860|NCT04521478|560569134|FG000|Overall Study|Adverse Event|7|||
155309861|NCT04521478|560569135|FG001|Overall Study|Adverse Event|0|||
155309862|NCT04521478|560569136|FG002|Overall Study|Adverse Event|2|||
155309863|NCT04521478|560569137|FG003|Overall Study|Adverse Event|1|||
155309864|NCT04521478|560569138|FG004|Overall Study|Adverse Event|2|||
155309865|NCT04521478|560569139|FG005|Overall Study|Adverse Event|7|||
155309866|NCT04521478|560569134|FG000|Overall Study|No Reason Available|0|||
155309867|NCT04521478|560569135|FG001|Overall Study|No Reason Available|2|||
155309868|NCT04521478|560569136|FG002|Overall Study|No Reason Available|0|||
155309869|NCT04521478|560569137|FG003|Overall Study|No Reason Available|0|||
155309870|NCT04521478|560569138|FG004|Overall Study|No Reason Available|1|||
155309871|NCT04521478|560569139|FG005|Overall Study|No Reason Available|0|||
155309872|NCT04521478|560569134|FG000|Overall Study|Other than listed|3|||
155309873|NCT04521478|560569135|FG001|Overall Study|Other than listed|3|||
155309874|NCT04521478|560569136|FG002|Overall Study|Other than listed|3|||
155309875|NCT04521478|560569137|FG003|Overall Study|Other than listed|2|||
155309876|NCT04521478|560569138|FG004|Overall Study|Other than listed|3|||
155309877|NCT04521478|560569139|FG005|Overall Study|Other than listed|3|||
155309878|NCT04521478|560569134|FG000|Overall Study|Not treated|0|||
155309879|NCT04521478|560569135|FG001|Overall Study|Not treated|0|||
155309880|NCT04521478|560569136|FG002|Overall Study|Not treated|0|||
155309881|NCT04521478|560569137|FG003|Overall Study|Not treated|0|||
155309882|NCT04521478|560569138|FG004|Overall Study|Not treated|0|||
155309883|NCT04521478|560569139|FG005|Overall Study|Not treated|1|||
155309884|NCT02187003|560569143|FG000|Overall Study|Adverse Event|2|||
155309885|NCT02187003|560569144|FG001|Overall Study|Adverse Event|0|||
155309886|NCT02187003|560569143|FG000|Overall Study|Lost to Follow-up|14|||
155309887|NCT02187003|560569144|FG001|Overall Study|Lost to Follow-up|10|||
155309888|NCT02187003|560569143|FG000|Overall Study|Withdrawal by Subject|3|||
155309889|NCT02187003|560569144|FG001|Overall Study|Withdrawal by Subject|7|||
155309890|NCT02187003|560569143|FG000|Overall Study|Protocol Violation|2|||
155309891|NCT02187003|560569144|FG001|Overall Study|Protocol Violation|4|||
155309892|NCT02187003|560569143|FG000|Overall Study|Other|5|||
155309893|NCT02187003|560569144|FG001|Overall Study|Other|5|||
155309894|NCT02187003|560569143|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155415544|NCT02634580|560952309|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
155415545|NCT01396005|560952310|FG000|Overall Study|Withdrawal by Subject|0|||
155415546|NCT01396005|560952311|FG001|Overall Study|Withdrawal by Subject|1|||
155415547|NCT01396005|560952310|FG000|Overall Study|Non-compliance with protocol|0|||
155415548|NCT01396005|560952311|FG001|Overall Study|Non-compliance with protocol|1|||
155309895|NCT02187003|560569144|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
155309896|NCT01195831|560569152|FG000|Overall Study|Lost to Follow-up|2|||
155309897|NCT01195831|560569153|FG001|Overall Study|Lost to Follow-up|4|||
155309898|NCT01195831|560569152|FG000|Overall Study|Withdrawal by Subject|2|||
155309899|NCT01195831|560569153|FG001|Overall Study|Withdrawal by Subject|2|||
155415549|NCT03132636|560952314|FG000|Overall Study|Adverse Event|1|||
155309900|NCT01195831|560569152|FG000|Overall Study|Adverse Event|4|||
155309901|NCT01195831|560569153|FG001|Overall Study|Adverse Event|2|||
155309902|NCT01195831|560569152|FG000|Overall Study|Protocol Violation|0|||
155309903|NCT01195831|560569153|FG001|Overall Study|Protocol Violation|2|||
155309904|NCT04725240|560569154|FG000|Overall Study|Adverse Event|2|||
155309905|NCT01140880|560569155|FG000|Overall Study|Death|0|||
155309906|NCT01140880|560569156|FG001|Overall Study|Death|1|||
155309907|NCT01140880|560569155|FG000|Overall Study|Withdrawal by Subject|6|||
155309908|NCT01140880|560569156|FG001|Overall Study|Withdrawal by Subject|3|||
155309909|NCT01140880|560569155|FG000|Overall Study|Lost to Follow-up|8|||
155309910|NCT01140880|560569156|FG001|Overall Study|Lost to Follow-up|10|||
155309911|NCT01140880|560569155|FG000|Overall Study|Protocol Violation|0|||
155309912|NCT01140880|560569156|FG001|Overall Study|Protocol Violation|30|||
155309913|NCT03779204|560569157|FG000|Overall Study|Lost to Follow-up|2|||
155309914|NCT03779204|560569158|FG001|Overall Study|Lost to Follow-up|0|||
155309915|NCT03958955|560569159|FG000|Overall Study|Adverse Event|1|||
155309916|NCT04673929|560569160|FG000|Overall Study|Death|73|||
155309917|NCT04673929|560569160|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
155309918|NCT05082909|560569161|FG000|Overall Study|Protocol Violation|0|||
155309919|NCT05082909|560569162|FG001|Overall Study|Protocol Violation|0|||
155309920|NCT05082909|560569163|FG002|Overall Study|Protocol Violation|1|||
155309921|NCT05082909|560569164|FG003|Overall Study|Protocol Violation|0|||
155309922|NCT05082909|560569165|FG004|Overall Study|Protocol Violation|0|||
155749954|NCT04090411|562184208|FG005|Chronic Period|Protocol Violation|0|||
155749955|NCT04090411|562184209|FG006|Chronic Period|Protocol Violation|0|||
155749956|NCT04090411|562184210|FG007|Chronic Period|Protocol Violation|0|||
155749957|NCT04090411|562184211|FG008|Chronic Period|Protocol Violation|0|||
155749958|NCT04090411|562184212|FG009|Chronic Period|Protocol Violation|0|||
155749959|NCT04090411|562184213|FG010|Chronic Period|Protocol Violation|0|||
155749960|NCT04090411|562184214|FG011|Chronic Period|Protocol Violation|0|||
155749961|NCT04090411|562184215|FG012|Chronic Period|Protocol Violation|1|||
155749962|NCT04090411|562184203|FG000|Chronic Period|Withdrawal by Subject|0|||
155749963|NCT04090411|562184204|FG001|Chronic Period|Withdrawal by Subject|0|||
155749964|NCT04090411|562184205|FG002|Chronic Period|Withdrawal by Subject|0|||
155749965|NCT04090411|562184206|FG003|Chronic Period|Withdrawal by Subject|0|||
155749966|NCT04090411|562184207|FG004|Chronic Period|Withdrawal by Subject|0|||
155749967|NCT04090411|562184208|FG005|Chronic Period|Withdrawal by Subject|1|||
155749968|NCT04090411|562184209|FG006|Chronic Period|Withdrawal by Subject|1|||
155749969|NCT04090411|562184210|FG007|Chronic Period|Withdrawal by Subject|3|||
155749970|NCT04090411|562184211|FG008|Chronic Period|Withdrawal by Subject|3|||
155749971|NCT04090411|562184212|FG009|Chronic Period|Withdrawal by Subject|3|||
155749972|NCT04090411|562184213|FG010|Chronic Period|Withdrawal by Subject|1|||
155749973|NCT04090411|562184214|FG011|Chronic Period|Withdrawal by Subject|3|||
155749974|NCT04090411|562184215|FG012|Chronic Period|Withdrawal by Subject|0|||
155749975|NCT03473548|562184217|FG000|Overall Study|Did not attempt HST testing|3|||
155749976|NCT03473548|562184218|FG001|Overall Study|Did not attempt HST testing|0|||
155749977|NCT02477696|562184229|FG000|Overall Study|Death|89|||
155749978|NCT02477696|562184230|FG001|Overall Study|Death|106|||
155749979|NCT02477696|562184229|FG000|Overall Study|Lost to Follow-up|7|||
155749980|NCT02477696|562184230|FG001|Overall Study|Lost to Follow-up|5|||
155749981|NCT02477696|562184229|FG000|Overall Study|Withdrawal by Subject|37|||
155749982|NCT02477696|562184230|FG001|Overall Study|Withdrawal by Subject|34|||
155749983|NCT02477696|562184229|FG000|Overall Study|Physician Decision|7|||
155749984|NCT02477696|562184230|FG001|Overall Study|Physician Decision|9|||
155749985|NCT02477696|562184229|FG000|Overall Study|Study terminated by sponsor|103|||
155749986|NCT02477696|562184230|FG001|Overall Study|Study terminated by sponsor|99|||
155749987|NCT02477696|562184229|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
155749988|NCT02477696|562184230|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
155749989|NCT02477696|562184229|FG000|Overall Study|Missing/Unknown|2|||
155749990|NCT02477696|562184230|FG001|Overall Study|Missing/Unknown|0|||
155749991|NCT03587727|562184231|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
155749992|NCT03587727|562184231|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
155749993|NCT02003365|562185278|FG000|Overall Study|Lost to Follow-up|0|||
155749994|NCT02003365|562185279|FG001|Overall Study|Lost to Follow-up|0|||
155415550|NCT03132636|560952315|FG001|Overall Study|Adverse Event|2|||
155415551|NCT03132636|560952314|FG000|Overall Study|Death|4|||
155749995|NCT02003365|562185280|FG002|Overall Study|Lost to Follow-up|1|||
155749996|NCT05710185|562185284|FG000|Overall Study|Adverse Event|1|||
155749997|NCT05710185|562185284|FG000|Overall Study|Lack of Efficacy|1|||
155749998|NCT04617795|562185287|FG000|Main Study|Lost to Follow-up|1|||
155749999|NCT04617795|562185288|FG001|Main Study|Lost to Follow-up|0|||
155750000|NCT00472459|562185289|FG000|Overall Study|Adverse Event|13|||
155750001|NCT00472459|562185290|FG001|Overall Study|Adverse Event|13|||
155750002|NCT00472459|562185289|FG000|Overall Study|Withdrawal by Subject|5|||
155750003|NCT00472459|562185290|FG001|Overall Study|Withdrawal by Subject|5|||
155750004|NCT00472459|562185289|FG000|Overall Study|Protocol Violation|3|||
155309923|NCT05082909|560569166|FG005|Overall Study|Protocol Violation|0|||
155309924|NCT04088630|560569167|FG000|Overall Study|Lost to Follow-up|3|||
155309925|NCT04088630|560569168|FG001|Overall Study|Lost to Follow-up|2|||
155309926|NCT04088630|560569169|FG002|Overall Study|Lost to Follow-up|6|||
155309927|NCT04088630|560569167|FG000|Overall Study|Death|3|||
155415552|NCT03132636|560952315|FG001|Overall Study|Death|7|||
155750005|NCT00472459|562185290|FG001|Overall Study|Protocol Violation|3|||
155750006|NCT00472459|562185289|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
155750007|NCT00472459|562185290|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
155750008|NCT00472459|562185289|FG000|Overall Study|Lost to Follow-up|1|||
155309928|NCT04088630|560569168|FG001|Overall Study|Death|1|||
155309929|NCT04088630|560569169|FG002|Overall Study|Death|1|||
155309930|NCT04088630|560569167|FG000|Overall Study|Physician Decision|0|||
155309931|NCT04088630|560569168|FG001|Overall Study|Physician Decision|1|||
155309932|NCT04088630|560569169|FG002|Overall Study|Physician Decision|1|||
155309933|NCT04024813|560569172|FG000|Overall Study|Study terminated by Sponsor|1|||
155309934|NCT02729311|560569173|FG000|Overall Study|Withdrawal by Subject|8|||
155309935|NCT02729311|560569174|FG001|Overall Study|Withdrawal by Subject|2|||
155309936|NCT02287610|560569175|FG000|Overall Study|Lost to Follow-up|3|||
155415553|NCT03132636|560952314|FG000|Overall Study|Lost to Follow-up|3|||
155415554|NCT03132636|560952315|FG001|Overall Study|Lost to Follow-up|2|||
155415555|NCT03132636|560952314|FG000|Overall Study|Non compliance with protocol by participant|1|||
155415556|NCT03132636|560952315|FG001|Overall Study|Non compliance with protocol by participant|1|||
155415557|NCT03132636|560952314|FG000|Overall Study|Subject decision|1|||
155415558|NCT03132636|560952315|FG001|Overall Study|Subject decision|9|||
155415559|NCT03132636|560952314|FG000|Overall Study|Sponsor decision|0|||
155415560|NCT03132636|560952315|FG001|Overall Study|Sponsor decision|1|||
155415561|NCT03132636|560952314|FG000|Overall Study|Physician Decision|1|||
155309937|NCT02287610|560569175|FG000|Overall Study|Withdrawal by Subject|8|||
155309938|NCT02287610|560569175|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
155415562|NCT03132636|560952315|FG001|Overall Study|Physician Decision|0|||
155415563|NCT03132636|560952314|FG000|Overall Study|Progressive disease|33|||
155415564|NCT03132636|560952315|FG001|Overall Study|Progressive disease|36|||
155415565|NCT03132636|560952314|FG000|Overall Study|Withdrawal of consent|2|||
155415566|NCT03132636|560952315|FG001|Overall Study|Withdrawal of consent|5|||
155415567|NCT03132636|560952314|FG000|Overall Study|Did not re-consent|1|||
155309939|NCT06074523|560569176|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
155309940|NCT06074523|560569176|FG000|Overall Study|Withdrawal by Subject|1|||
155309941|NCT00512070|560569182|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
155309942|NCT00512070|560569183|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
155309943|NCT00512070|560569184|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
155309944|NCT00512070|560569182|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
155309945|NCT00512070|560569183|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
155309946|NCT00512070|560569184|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
155309947|NCT00961571|560569185|FG000|Overall Study|Physician Decision|39|||
155309948|NCT05862870|560569191|FG000|Overall Study|Lost to Follow-up|3|||
155309949|NCT04321031|560569192|FG000|Overall Study|Adverse Event|0|||
155309950|NCT04321031|560569193|FG001|Overall Study|Adverse Event|2|||
155309951|NCT04321031|560569194|FG002|Overall Study|Adverse Event|2|||
155309952|NCT04321031|560569195|FG003|Overall Study|Adverse Event|2|||
155309953|NCT04321031|560569196|FG004|Overall Study|Adverse Event|2|||
155309954|NCT04321031|560569197|FG005|Overall Study|Adverse Event|2|||
155309955|NCT04321031|560569198|FG006|Overall Study|Adverse Event|0|||
155309956|NCT04321031|560569192|FG000|Overall Study|Lost to Follow-up|0|||
155309957|NCT04321031|560569193|FG001|Overall Study|Lost to Follow-up|0|||
155309958|NCT04321031|560569194|FG002|Overall Study|Lost to Follow-up|0|||
155309959|NCT04321031|560569195|FG003|Overall Study|Lost to Follow-up|1|||
155309960|NCT04321031|560569196|FG004|Overall Study|Lost to Follow-up|0|||
155309961|NCT04321031|560569197|FG005|Overall Study|Lost to Follow-up|2|||
155309962|NCT04321031|560569198|FG006|Overall Study|Lost to Follow-up|1|||
155309963|NCT04321031|560569192|FG000|Overall Study|Withdrawal by Subject|2|||
155309964|NCT04321031|560569193|FG001|Overall Study|Withdrawal by Subject|2|||
155309965|NCT04321031|560569194|FG002|Overall Study|Withdrawal by Subject|1|||
155309966|NCT04321031|560569195|FG003|Overall Study|Withdrawal by Subject|3|||
155309967|NCT04321031|560569196|FG004|Overall Study|Withdrawal by Subject|1|||
155309968|NCT04321031|560569197|FG005|Overall Study|Withdrawal by Subject|0|||
155309969|NCT04321031|560569198|FG006|Overall Study|Withdrawal by Subject|1|||
155309970|NCT04321031|560569192|FG000|Overall Study|Non-compliance with study drug|0|||
155309971|NCT04321031|560569193|FG001|Overall Study|Non-compliance with study drug|0|||
155309972|NCT04321031|560569194|FG002|Overall Study|Non-compliance with study drug|0|||
155309973|NCT04321031|560569195|FG003|Overall Study|Non-compliance with study drug|0|||
155309974|NCT04321031|560569196|FG004|Overall Study|Non-compliance with study drug|0|||
155309975|NCT04321031|560569197|FG005|Overall Study|Non-compliance with study drug|1|||
155309976|NCT04321031|560569198|FG006|Overall Study|Non-compliance with study drug|0|||
155309977|NCT04321031|560569192|FG000|Overall Study|Other|0|||
155309978|NCT04321031|560569193|FG001|Overall Study|Other|0|||
155309979|NCT04321031|560569194|FG002|Overall Study|Other|0|||
155309980|NCT04321031|560569195|FG003|Overall Study|Other|1|||
155309981|NCT04321031|560569196|FG004|Overall Study|Other|0|||
155309982|NCT04321031|560569197|FG005|Overall Study|Other|0|||
155309983|NCT04321031|560569198|FG006|Overall Study|Other|0|||
155309984|NCT02900924|560569199|FG000|Overall Study|Death|52|||
155309985|NCT02900924|560569199|FG000|Overall Study|Lost to Follow-up|4|||
155309986|NCT02900924|560569199|FG000|Overall Study|Withdrawal by Subject|20|||
155309987|NCT02900924|560569199|FG000|Overall Study|Missed Visit|33|||
155309988|NCT03143153|560569202|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
155309989|NCT03143153|560569203|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
155309990|NCT03143153|560569204|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
155309991|NCT03143153|560569202|FG000|Pre-Treatment|Participant withdrew consent|0|||
155309992|NCT03143153|560569203|FG001|Pre-Treatment|Participant withdrew consent|1|||
155309993|NCT03143153|560569204|FG002|Pre-Treatment|Participant withdrew consent|12|||
155309994|NCT03143153|560569202|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
155309995|NCT03143153|560569203|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
155309996|NCT03143153|560569204|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
155309997|NCT03143153|560569202|FG000|Pre-Treatment|Other Reasons|1|||
155309998|NCT03143153|560569203|FG001|Pre-Treatment|Other Reasons|2|||
155309999|NCT03143153|560569204|FG002|Pre-Treatment|Other Reasons|1|||
155310000|NCT03143153|560569202|FG000|Pre-Treatment|Disease Progression|1|||
155310001|NCT03143153|560569203|FG001|Pre-Treatment|Disease Progression|1|||
155310002|NCT03143153|560569204|FG002|Pre-Treatment|Disease Progression|2|||
155310003|NCT03143153|560569202|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
155310004|NCT03143153|560569203|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
155310005|NCT03143153|560569204|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
155310006|NCT03143153|560569202|FG000|Treatment|Disease progression|174|||
155310007|NCT03143153|560569203|FG001|Treatment|Disease progression|184|||
155310008|NCT03143153|560569204|FG002|Treatment|Disease progression|193|||
155415568|NCT03132636|560952315|FG001|Overall Study|Did not re-consent|0|||
155415569|NCT03132636|560952314|FG000|Overall Study|Lost insurance coverage|1|||
155310009|NCT03143153|560569202|FG000|Treatment|Study drug toxicity|59|||
155310010|NCT03143153|560569203|FG001|Treatment|Study drug toxicity|33|||
155310011|NCT03143153|560569204|FG002|Treatment|Study drug toxicity|40|||
155310012|NCT03143153|560569202|FG000|Treatment|Death|5|||
155310013|NCT03143153|560569203|FG001|Treatment|Death|3|||
155310014|NCT03143153|560569204|FG002|Treatment|Death|4|||
155310015|NCT03143153|560569202|FG000|Treatment|Adverse event unrelated to study drug|19|||
155310016|NCT03143153|560569203|FG001|Treatment|Adverse event unrelated to study drug|28|||
155310017|NCT03143153|560569204|FG002|Treatment|Adverse event unrelated to study drug|12|||
155310018|NCT03143153|560569202|FG000|Treatment|Participant request to discontinue study treatment|13|||
155310019|NCT03143153|560569203|FG001|Treatment|Participant request to discontinue study treatment|15|||
155310020|NCT03143153|560569204|FG002|Treatment|Participant request to discontinue study treatment|20|||
155310021|NCT03143153|560569202|FG000|Treatment|Participant withdrew consent|3|||
155310022|NCT03143153|560569203|FG001|Treatment|Participant withdrew consent|4|||
155310023|NCT03143153|560569204|FG002|Treatment|Participant withdrew consent|12|||
155310024|NCT03143153|560569202|FG000|Treatment|Pregnancy|1|||
155310025|NCT03143153|560569203|FG001|Treatment|Pregnancy|0|||
155310026|NCT03143153|560569204|FG002|Treatment|Pregnancy|0|||
155310027|NCT03143153|560569202|FG000|Treatment|Maximum clinical benefit|1|||
155310028|NCT03143153|560569203|FG001|Treatment|Maximum clinical benefit|3|||
155310029|NCT03143153|560569204|FG002|Treatment|Maximum clinical benefit|4|||
155310030|NCT03143153|560569202|FG000|Treatment|Completed treatment as per Protocol|13|||
155310031|NCT03143153|560569203|FG001|Treatment|Completed treatment as per Protocol|8|||
155310032|NCT03143153|560569204|FG002|Treatment|Completed treatment as per Protocol|0|||
155310033|NCT03143153|560569202|FG000|Treatment|Other reasons|12|||
155310034|NCT03143153|560569203|FG001|Treatment|Other reasons|7|||
155310035|NCT03143153|560569204|FG002|Treatment|Other reasons|15|||
155310036|NCT03143153|560569202|FG000|Treatment|Not reported|1|||
155310037|NCT03143153|560569203|FG001|Treatment|Not reported|0|||
155310038|NCT03143153|560569204|FG002|Treatment|Not reported|0|||
155310039|NCT04237298|560569205|FG000|Overall Study|Lost to Follow-up|4|||
155310040|NCT04237298|560569206|FG001|Overall Study|Lost to Follow-up|5|||
155310041|NCT04556656|560569209|FG000|Overall Study|Withdrawal by Subject|14|||
155310042|NCT04556656|560569210|FG001|Overall Study|Withdrawal by Subject|12|||
155310043|NCT04556656|560569209|FG000|Overall Study|Physician Decision|1|||
155310044|NCT04556656|560569210|FG001|Overall Study|Physician Decision|0|||
155310045|NCT04556656|560569209|FG000|Overall Study|Adverse Event|4|||
155310046|NCT04556656|560569210|FG001|Overall Study|Adverse Event|7|||
155310047|NCT04556656|560569209|FG000|Overall Study|Death|4|||
155310048|NCT04556656|560569210|FG001|Overall Study|Death|0|||
155310049|NCT04556656|560569209|FG000|Overall Study|Lost to Follow-up|3|||
155310050|NCT04556656|560569210|FG001|Overall Study|Lost to Follow-up|2|||
155310051|NCT04556656|560569209|FG000|Overall Study|Not further specified|2|||
155310052|NCT04556656|560569210|FG001|Overall Study|Not further specified|1|||
155310053|NCT04541706|560569211|FG000|Overall Study|Withdrawal by Subject|3|||
155310054|NCT04541706|560569211|FG000|Overall Study|Progressive disease|33|||
155310055|NCT04541706|560569211|FG000|Overall Study|Physician Decision|1|||
155310056|NCT04541706|560569211|FG000|Overall Study|Lost to Follow-up|2|||
155310057|NCT04541706|560569211|FG000|Overall Study|Death|5|||
155310058|NCT04541706|560569211|FG000|Overall Study|Adverse Event|1|||
155310059|NCT05536440|560569212|FG000|Overall Study|Adverse Event|0|||
155310060|NCT05536440|560569213|FG001|Overall Study|Adverse Event|0|||
155310061|NCT05536440|560569214|FG002|Overall Study|Adverse Event|0|||
155310062|NCT05536440|560569215|FG003|Overall Study|Adverse Event|0|||
155310063|NCT05536440|560569216|FG004|Overall Study|Adverse Event|0|||
155310064|NCT05536440|560569217|FG005|Overall Study|Adverse Event|0|||
155310065|NCT05536440|560569218|FG006|Overall Study|Adverse Event|0|||
155310066|NCT05536440|560569219|FG007|Overall Study|Adverse Event|0|||
155310067|NCT05536440|560569220|FG008|Overall Study|Adverse Event|1|||
155310068|NCT01416831|560569223|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
155310069|NCT01416831|560569224|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
155310070|NCT04784559|560569225|FG000|Overall Study|Withdrawal by Subject|3|||
155310071|NCT04784559|560569226|FG001|Overall Study|Withdrawal by Subject|2|||
155310072|NCT04784559|560569227|FG002|Overall Study|Withdrawal by Subject|1|||
155310073|NCT04784559|560569225|FG000|Overall Study|Death|2|||
155310074|NCT04784559|560569226|FG001|Overall Study|Death|1|||
155415570|NCT03132636|560952315|FG001|Overall Study|Lost insurance coverage|0|||
155415571|NCT03132636|560952314|FG000|Overall Study|Related to radiological outcomes|0|||
155415572|NCT03132636|560952315|FG001|Overall Study|Related to radiological outcomes|1|||
155415573|NCT03132636|560952314|FG000|Overall Study|Unable to come to site for continued visits|0|||
155310075|NCT04784559|560569227|FG002|Overall Study|Death|2|||
155310076|NCT04784559|560569225|FG000|Overall Study|Lost to Follow-up|0|||
155310077|NCT04784559|560569226|FG001|Overall Study|Lost to Follow-up|0|||
155310078|NCT04784559|560569227|FG002|Overall Study|Lost to Follow-up|2|||
155310079|NCT04784559|560569225|FG000|Overall Study|Participant worsened, PI decision|1|||
155310080|NCT04784559|560569226|FG001|Overall Study|Participant worsened, PI decision|0|||
155310081|NCT04784559|560569227|FG002|Overall Study|Participant worsened, PI decision|0|||
155310082|NCT04784559|560569225|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
155310083|NCT04784559|560569226|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
155310084|NCT04784559|560569227|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
155310085|NCT04784559|560569225|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
155310086|NCT04784559|560569226|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
155310087|NCT04784559|560569227|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
155310088|NCT04784559|560569225|FG000|Overall Study|Did not meet all inclusion criteria|0|||
155310089|NCT04784559|560569226|FG001|Overall Study|Did not meet all inclusion criteria|1|||
155310090|NCT04784559|560569227|FG002|Overall Study|Did not meet all inclusion criteria|0|||
155310091|NCT04784559|560569225|FG000|Overall Study|The participant was transferred to IRCU|0|||
155310092|NCT04784559|560569226|FG001|Overall Study|The participant was transferred to IRCU|1|||
155310093|NCT04784559|560569227|FG002|Overall Study|The participant was transferred to IRCU|0|||
155310094|NCT04784559|560569225|FG000|Overall Study|SAE|0|||
155310095|NCT04784559|560569226|FG001|Overall Study|SAE|1|||
155310096|NCT04784559|560569227|FG002|Overall Study|SAE|0|||
155310097|NCT04784559|560569225|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
155310098|NCT04784559|560569226|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
155310099|NCT04784559|560569227|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
155310100|NCT04588298|560569232|FG000|Overall Study|Adverse Event|0|||
155310101|NCT04588298|560569233|FG001|Overall Study|Adverse Event|0|||
155310102|NCT04588298|560569234|FG002|Overall Study|Adverse Event|1|||
155310103|NCT04588298|560569235|FG003|Overall Study|Adverse Event|0|||
155310104|NCT04588298|560569236|FG004|Overall Study|Adverse Event|2|||
155310105|NCT04588298|560569232|FG000|Overall Study|Withdrawal by Subject|1|||
155310106|NCT04588298|560569233|FG001|Overall Study|Withdrawal by Subject|0|||
155310107|NCT04588298|560569234|FG002|Overall Study|Withdrawal by Subject|0|||
155310108|NCT04588298|560569235|FG003|Overall Study|Withdrawal by Subject|1|||
155310109|NCT04588298|560569236|FG004|Overall Study|Withdrawal by Subject|0|||
155310110|NCT04021602|560569241|FG000|Overall Study|Lost to Follow-up|3|||
155310111|NCT04021602|560569242|FG001|Overall Study|Lost to Follow-up|3|||
155310112|NCT04021602|560569243|FG002|Overall Study|Lost to Follow-up|1|||
155310113|NCT04021602|560569241|FG000|Overall Study|Adverse Event|1|||
155310114|NCT04021602|560569242|FG001|Overall Study|Adverse Event|0|||
155310115|NCT04021602|560569243|FG002|Overall Study|Adverse Event|1|||
155310116|NCT03892616|560569244|FG000|Washout Period 2|Met discontinuation criterion|0|||
155310117|NCT03892616|560569245|FG001|Washout Period 2|Met discontinuation criterion|0|||
155310118|NCT03892616|560569246|FG002|Washout Period 2|Met discontinuation criterion|0|||
155310119|NCT03892616|560569247|FG003|Washout Period 2|Met discontinuation criterion|0|||
155310120|NCT03892616|560569248|FG004|Washout Period 2|Met discontinuation criterion|0|||
155310121|NCT03892616|560569249|FG005|Washout Period 2|Met discontinuation criterion|0|||
155310122|NCT03892616|560569250|FG006|Washout Period 2|Met discontinuation criterion|0|||
155310123|NCT03892616|560569251|FG007|Washout Period 2|Met discontinuation criterion|0|||
155310124|NCT03892616|560569252|FG008|Washout Period 2|Met discontinuation criterion|1|||
155310125|NCT03892616|560569253|FG009|Washout Period 2|Met discontinuation criterion|0|||
155310126|NCT03892616|560569254|FG010|Washout Period 2|Met discontinuation criterion|0|||
155310127|NCT03892616|560569255|FG011|Washout Period 2|Met discontinuation criterion|0|||
155310128|NCT02243709|560569256|FG000|Phase 1|Lost to Follow-up|0|||
155310129|NCT02243709|560569257|FG001|Phase 1|Lost to Follow-up|1|||
155310130|NCT02243709|560569256|FG000|Phase 1|Withdrawal by Subject|1|||
155310131|NCT02243709|560569257|FG001|Phase 1|Withdrawal by Subject|0|||
155310132|NCT02243709|560569256|FG000|Phase 1|Protocol Violation|0|||
155310133|NCT02243709|560569257|FG001|Phase 1|Protocol Violation|1|||
155310134|NCT02243709|560569256|FG000|Phase 1|Adverse Event|0|||
155310135|NCT02243709|560569257|FG001|Phase 1|Adverse Event|1|||
155310136|NCT03683719|560569258|FG000|Overall Study|Lack of Efficacy|1|||
155310137|NCT03683719|560569259|FG001|Overall Study|Lack of Efficacy|3|||
155310138|NCT03683719|560569260|FG002|Overall Study|Lack of Efficacy|4|||
155310139|NCT03683719|560569261|FG003|Overall Study|Lack of Efficacy|0|||
155310140|NCT03683719|560569262|FG004|Overall Study|Lack of Efficacy|4|||
155310141|NCT03683719|560569258|FG000|Overall Study|Adverse Event|6|||
155310142|NCT03683719|560569259|FG001|Overall Study|Adverse Event|6|||
155310143|NCT03683719|560569260|FG002|Overall Study|Adverse Event|0|||
155310144|NCT03683719|560569261|FG003|Overall Study|Adverse Event|1|||
155310145|NCT03683719|560569262|FG004|Overall Study|Adverse Event|3|||
155310146|NCT03683719|560569258|FG000|Overall Study|Withdrawal by Subject|4|||
155310147|NCT03683719|560569259|FG001|Overall Study|Withdrawal by Subject|4|||
155310148|NCT03683719|560569260|FG002|Overall Study|Withdrawal by Subject|3|||
155310149|NCT03683719|560569261|FG003|Overall Study|Withdrawal by Subject|5|||
155310150|NCT03683719|560569262|FG004|Overall Study|Withdrawal by Subject|5|||
155310151|NCT03683719|560569258|FG000|Overall Study|Lost to Follow-up|1|||
155310152|NCT03683719|560569259|FG001|Overall Study|Lost to Follow-up|0|||
155310153|NCT03683719|560569260|FG002|Overall Study|Lost to Follow-up|0|||
155310154|NCT03683719|560569261|FG003|Overall Study|Lost to Follow-up|1|||
155310155|NCT03683719|560569262|FG004|Overall Study|Lost to Follow-up|1|||
155310156|NCT03683719|560569258|FG000|Overall Study|Other personal reasons|0|||
155310157|NCT03683719|560569259|FG001|Overall Study|Other personal reasons|0|||
155498743|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
155498744|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
155498745|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
155498746|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
155642915|NCT05558410|561782351|FG002|Overall Study|Other non-compliance|2|||
155642916|NCT05558410|561782349|FG000|Overall Study|Sponsor Decision|1|||
155750009|NCT00472459|562185290|FG001|Overall Study|Lost to Follow-up|1|||
155750010|NCT04850313|562185291|FG000|Overall Study|Withdrawal by Subject|0|||
155750011|NCT04850313|562185292|FG001|Overall Study|Withdrawal by Subject|1|||
155750012|NCT05313009|562185293|FG000|Overall Study|Death|1|||
155310158|NCT03683719|560569260|FG002|Overall Study|Other personal reasons|1|||
155750013|NCT05313009|562185294|FG001|Overall Study|Death|0|||
155750014|NCT03269552|562185297|FG000|Overall Study|Adverse Event|2|||
155750015|NCT03505671|562185300|FG000|Overall Study|Withdrawal by Subject|2|||
155750016|NCT03505671|562185301|FG001|Overall Study|Withdrawal by Subject|1|||
155750017|NCT03505671|562185300|FG000|Overall Study|Lost to Follow-up|1|||
155750018|NCT03505671|562185301|FG001|Overall Study|Lost to Follow-up|0|||
155750019|NCT02038829|562185304|FG000|Washout Period 1|Death|0|||
155750020|NCT02038829|562185305|FG001|Washout Period 1|Death|0|||
155750021|NCT02038829|562185306|FG002|Washout Period 1|Death|0|||
155750022|NCT02038829|562185307|FG003|Washout Period 1|Death|0|||
155750023|NCT02038829|562185308|FG004|Washout Period 1|Death|1|||
155750024|NCT02038829|562185309|FG005|Washout Period 1|Death|0|||
155750025|NCT02038829|562185310|FG006|Washout Period 1|Death|0|||
155750026|NCT02038829|562185311|FG007|Washout Period 1|Death|0|||
155750027|NCT02038829|562185312|FG008|Washout Period 1|Death|0|||
155750028|NCT02038829|562185313|FG009|Washout Period 1|Death|0|||
155750029|NCT02038829|562185314|FG010|Washout Period 1|Death|0|||
155750030|NCT02038829|562185315|FG011|Washout Period 1|Death|0|||
155750031|NCT02038829|562185304|FG000|Treatment Period 2|Adverse Event|0|||
155750032|NCT02038829|562185305|FG001|Treatment Period 2|Adverse Event|0|||
155750033|NCT02038829|562185306|FG002|Treatment Period 2|Adverse Event|0|||
155750034|NCT02038829|562185307|FG003|Treatment Period 2|Adverse Event|0|||
155750035|NCT02038829|562185308|FG004|Treatment Period 2|Adverse Event|0|||
155750036|NCT02038829|562185309|FG005|Treatment Period 2|Adverse Event|0|||
155750037|NCT02038829|562185310|FG006|Treatment Period 2|Adverse Event|0|||
155750038|NCT02038829|562185311|FG007|Treatment Period 2|Adverse Event|0|||
155750039|NCT02038829|562185312|FG008|Treatment Period 2|Adverse Event|0|||
155750040|NCT02038829|562185313|FG009|Treatment Period 2|Adverse Event|0|||
155750041|NCT02038829|562185314|FG010|Treatment Period 2|Adverse Event|1|||
155750042|NCT02038829|562185315|FG011|Treatment Period 2|Adverse Event|0|||
155750043|NCT02038829|562185304|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155750044|NCT02038829|562185305|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155750045|NCT02038829|562185306|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155750046|NCT02038829|562185307|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155750047|NCT02038829|562185308|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155750048|NCT02038829|562185309|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155750049|NCT02038829|562185310|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155750050|NCT02038829|562185311|FG007|Treatment Period 2|Withdrawal by Subject|0|||
155750051|NCT02038829|562185312|FG008|Treatment Period 2|Withdrawal by Subject|0|||
155750052|NCT02038829|562185313|FG009|Treatment Period 2|Withdrawal by Subject|0|||
155750053|NCT02038829|562185314|FG010|Treatment Period 2|Withdrawal by Subject|0|||
155750054|NCT02038829|562185315|FG011|Treatment Period 2|Withdrawal by Subject|0|||
155750055|NCT02038829|562185304|FG000|Washout Period 2|Adverse Event|0|||
155750056|NCT02038829|562185305|FG001|Washout Period 2|Adverse Event|0|||
155750057|NCT02038829|562185306|FG002|Washout Period 2|Adverse Event|0|||
155750058|NCT02038829|562185307|FG003|Washout Period 2|Adverse Event|0|||
155750059|NCT02038829|562185308|FG004|Washout Period 2|Adverse Event|0|||
155750060|NCT02038829|562185309|FG005|Washout Period 2|Adverse Event|0|||
155750061|NCT02038829|562185310|FG006|Washout Period 2|Adverse Event|0|||
155750062|NCT02038829|562185311|FG007|Washout Period 2|Adverse Event|0|||
155750063|NCT02038829|562185312|FG008|Washout Period 2|Adverse Event|1|||
155750064|NCT02038829|562185313|FG009|Washout Period 2|Adverse Event|0|||
155750065|NCT02038829|562185314|FG010|Washout Period 2|Adverse Event|0|||
155750066|NCT02038829|562185315|FG011|Washout Period 2|Adverse Event|0|||
155750067|NCT02038829|562185304|FG000|Washout Period 2|Withdrawal by Subject|0|||
155750068|NCT02038829|562185305|FG001|Washout Period 2|Withdrawal by Subject|0|||
155750069|NCT02038829|562185306|FG002|Washout Period 2|Withdrawal by Subject|0|||
155750070|NCT02038829|562185307|FG003|Washout Period 2|Withdrawal by Subject|0|||
155750071|NCT02038829|562185308|FG004|Washout Period 2|Withdrawal by Subject|0|||
155750072|NCT02038829|562185309|FG005|Washout Period 2|Withdrawal by Subject|1|||
155750073|NCT02038829|562185310|FG006|Washout Period 2|Withdrawal by Subject|0|||
155750074|NCT02038829|562185311|FG007|Washout Period 2|Withdrawal by Subject|0|||
155750075|NCT02038829|562185312|FG008|Washout Period 2|Withdrawal by Subject|0|||
155750076|NCT02038829|562185313|FG009|Washout Period 2|Withdrawal by Subject|0|||
155750077|NCT02038829|562185314|FG010|Washout Period 2|Withdrawal by Subject|0|||
155750078|NCT02038829|562185315|FG011|Washout Period 2|Withdrawal by Subject|0|||
155750079|NCT02038829|562185304|FG000|Treatment Period 4|Adverse Event|0|||
155750080|NCT02038829|562185305|FG001|Treatment Period 4|Adverse Event|1|||
155750081|NCT02038829|562185306|FG002|Treatment Period 4|Adverse Event|0|||
155750082|NCT02038829|562185307|FG003|Treatment Period 4|Adverse Event|0|||
155750083|NCT02038829|562185308|FG004|Treatment Period 4|Adverse Event|0|||
155310159|NCT03683719|560569261|FG003|Overall Study|Other personal reasons|0|||
155750084|NCT02038829|562185309|FG005|Treatment Period 4|Adverse Event|0|||
155750085|NCT02038829|562185310|FG006|Treatment Period 4|Adverse Event|0|||
155750086|NCT02038829|562185311|FG007|Treatment Period 4|Adverse Event|0|||
155310160|NCT03683719|560569262|FG004|Overall Study|Other personal reasons|1|||
155310161|NCT02689284|560569263|FG000|Overall Study|Adverse Event|1|||
155310162|NCT02689284|560569264|FG001|Overall Study|Adverse Event|8|||
155310163|NCT02689284|560569263|FG000|Overall Study|Death|0|||
155310164|NCT02689284|560569264|FG001|Overall Study|Death|1|||
155310165|NCT02689284|560569263|FG000|Overall Study|Physician Decision|1|||
155310166|NCT02689284|560569264|FG001|Overall Study|Physician Decision|2|||
155310167|NCT02689284|560569263|FG000|Overall Study|Withdrawal by Subject|0|||
155310168|NCT02689284|560569264|FG001|Overall Study|Withdrawal by Subject|1|||
155310169|NCT02689284|560569263|FG000|Overall Study|progression of cancer|1|||
155310170|NCT02689284|560569264|FG001|Overall Study|progression of cancer|72|||
155310171|NCT02689284|560569263|FG000|Overall Study|decreased heart function|0|||
155310172|NCT02689284|560569264|FG001|Overall Study|decreased heart function|1|||
155310173|NCT02689284|560569263|FG000|Overall Study|concern for anemia|0|||
155310174|NCT02689284|560569264|FG001|Overall Study|concern for anemia|1|||
155310175|NCT02689284|560569263|FG000|Overall Study|no measurable cancer for evaluation|0|||
155310176|NCT02689284|560569264|FG001|Overall Study|no measurable cancer for evaluation|1|||
155310177|NCT05569252|560569265|FG000|Overall Study|Adverse event (central vision loss)|1|||
155310178|NCT05569252|560569266|FG001|Overall Study|Adverse event (central vision loss)|0|||
155310179|NCT05569252|560569267|FG002|Overall Study|Adverse event (central vision loss)|0|||
155310180|NCT05569252|560569268|FG003|Overall Study|Adverse event (central vision loss)|0|||
155310181|NCT03665597|560569269|FG000|Period 1|Adverse Event|1|||
155310182|NCT03665597|560569270|FG001|Period 1|Adverse Event|0|||
155310183|NCT03665597|560569271|FG002|Period 1|Adverse Event|0|||
155310184|NCT03665597|560569272|FG003|Period 1|Adverse Event|1|||
155310185|NCT03665597|560569273|FG004|Period 1|Adverse Event|0|||
155310186|NCT03665597|560569274|FG005|Period 1|Adverse Event|0|||
155310187|NCT03665597|560569275|FG006|Period 1|Adverse Event|0|||
155310188|NCT03665597|560569269|FG000|Period 1|Screen Failure|0|||
155310189|NCT03665597|560569270|FG001|Period 1|Screen Failure|0|||
155310190|NCT03665597|560569271|FG002|Period 1|Screen Failure|0|||
155310191|NCT03665597|560569272|FG003|Period 1|Screen Failure|1|||
155310192|NCT03665597|560569273|FG004|Period 1|Screen Failure|0|||
155310193|NCT03665597|560569274|FG005|Period 1|Screen Failure|0|||
155310194|NCT03665597|560569275|FG006|Period 1|Screen Failure|0|||
155310195|NCT03665597|560569269|FG000|Period 1|Death|0|||
155310196|NCT03665597|560569270|FG001|Period 1|Death|0|||
155310197|NCT03665597|560569271|FG002|Period 1|Death|0|||
155310198|NCT03665597|560569272|FG003|Period 1|Death|0|||
155310199|NCT03665597|560569273|FG004|Period 1|Death|0|||
155310200|NCT03665597|560569274|FG005|Period 1|Death|0|||
155310201|NCT03665597|560569275|FG006|Period 1|Death|45|||
155415574|NCT03132636|560952315|FG001|Overall Study|Unable to come to site for continued visits|1|||
155415575|NCT03083886|560952316|FG000|Overall Study|Withdrawal by Subject|51|||
155415576|NCT03083886|560952317|FG001|Overall Study|Withdrawal by Subject|73|||
155415577|NCT03083886|560952318|FG002|Overall Study|Withdrawal by Subject|104|||
155415578|NCT03083886|560952316|FG000|Overall Study|Missing Baseline data|43|||
155415579|NCT03083886|560952317|FG001|Overall Study|Missing Baseline data|42|||
155415580|NCT03083886|560952318|FG002|Overall Study|Missing Baseline data|31|||
155415581|NCT03083886|560952316|FG000|Overall Study|Investigator terminated|1|||
155415582|NCT03083886|560952317|FG001|Overall Study|Investigator terminated|6|||
155415583|NCT03083886|560952318|FG002|Overall Study|Investigator terminated|3|||
155415584|NCT01391507|560952319|FG000|Overall Study|Death|0|||
155415585|NCT01391507|560952320|FG001|Overall Study|Death|0|||
155415586|NCT01391507|560952321|FG002|Overall Study|Death|0|||
155415587|NCT01391507|560952322|FG003|Overall Study|Death|1|||
155415588|NCT01391507|560952319|FG000|Overall Study|Adverse Event|1|||
155415589|NCT01391507|560952320|FG001|Overall Study|Adverse Event|1|||
155415590|NCT01391507|560952321|FG002|Overall Study|Adverse Event|2|||
155415591|NCT01391507|560952322|FG003|Overall Study|Adverse Event|2|||
155415592|NCT01391507|560952319|FG000|Overall Study|Withdrawal by Subject|1|||
155415593|NCT01391507|560952320|FG001|Overall Study|Withdrawal by Subject|2|||
155415594|NCT01391507|560952321|FG002|Overall Study|Withdrawal by Subject|1|||
155498747|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
155415595|NCT01391507|560952322|FG003|Overall Study|Withdrawal by Subject|1|||
155498748|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
155310202|NCT03665597|560569269|FG000|Period 1|Withdrawal by Subject|0|||
155310203|NCT03665597|560569270|FG001|Period 1|Withdrawal by Subject|0|||
155310204|NCT03665597|560569271|FG002|Period 1|Withdrawal by Subject|0|||
155415596|NCT01391507|560952319|FG000|Overall Study|Lack of Efficacy|0|||
155415597|NCT01391507|560952320|FG001|Overall Study|Lack of Efficacy|0|||
155415598|NCT01391507|560952321|FG002|Overall Study|Lack of Efficacy|0|||
155415599|NCT01391507|560952322|FG003|Overall Study|Lack of Efficacy|1|||
155415600|NCT01391507|560952319|FG000|Overall Study|Protocol Violation|2|||
155498749|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
155310205|NCT03665597|560569272|FG003|Period 1|Withdrawal by Subject|0|||
155310206|NCT03665597|560569273|FG004|Period 1|Withdrawal by Subject|0|||
155310207|NCT03665597|560569274|FG005|Period 1|Withdrawal by Subject|0|||
155310208|NCT03665597|560569275|FG006|Period 1|Withdrawal by Subject|5|||
155310209|NCT03665597|560569269|FG000|Period 2|Adverse Event|0|||
155415601|NCT01391507|560952320|FG001|Overall Study|Protocol Violation|1|||
155415602|NCT01391507|560952321|FG002|Overall Study|Protocol Violation|1|||
155415603|NCT01391507|560952322|FG003|Overall Study|Protocol Violation|2|||
155415604|NCT01453855|560952323|FG000|Overall Study|Adverse Event|3|||
155415605|NCT01453855|560952324|FG001|Overall Study|Adverse Event|4|||
155415606|NCT01453855|560952323|FG000|Overall Study|Lost to Follow-up|2|||
155415607|NCT01453855|560952324|FG001|Overall Study|Lost to Follow-up|1|||
155415608|NCT01453855|560952323|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
155415609|NCT01453855|560952324|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
155415610|NCT01453855|560952323|FG000|Overall Study|Noncompliance|1|||
155415611|NCT01453855|560952324|FG001|Overall Study|Noncompliance|0|||
155415612|NCT01453855|560952323|FG000|Overall Study|Inadequate Control of IOP|1|||
155415613|NCT01453855|560952324|FG001|Overall Study|Inadequate Control of IOP|5|||
155415614|NCT01453855|560952323|FG000|Overall Study|Other|0|||
155415615|NCT01453855|560952324|FG001|Overall Study|Other|1|||
155415616|NCT04161495|560952325|FG000|Overall Study|Withdrawal by Subject|3|||
155415617|NCT04161495|560952326|FG001|Overall Study|Withdrawal by Subject|0|||
155415618|NCT04161495|560952325|FG000|Overall Study|Protocol Violation|1|||
155415619|NCT04161495|560952326|FG001|Overall Study|Protocol Violation|0|||
155415620|NCT04161495|560952325|FG000|Overall Study|Prohibited concomitant medication|3|||
155415621|NCT04161495|560952326|FG001|Overall Study|Prohibited concomitant medication|0|||
155415622|NCT04161495|560952325|FG000|Overall Study|Adverse Event|1|||
155415623|NCT04161495|560952326|FG001|Overall Study|Adverse Event|0|||
155415624|NCT04161495|560952325|FG000|Overall Study|Other - Unspecified|1|||
155415625|NCT04161495|560952326|FG001|Overall Study|Other - Unspecified|0|||
155415626|NCT04161495|560952325|FG000|Overall Study|Death|0|||
155415627|NCT04161495|560952326|FG001|Overall Study|Death|1|||
155415628|NCT01562548|560952327|FG000|Overall Study|Lost to Follow-up|0|||
155415629|NCT01562548|560952328|FG001|Overall Study|Lost to Follow-up|0|||
155415630|NCT01562548|560952329|FG002|Overall Study|Lost to Follow-up|1|||
155415631|NCT01562548|560952330|FG003|Overall Study|Lost to Follow-up|0|||
155415632|NCT03655756|560952331|FG000|Overall Study|Death|1|||
155415633|NCT01340209|560952332|FG000|Overall Study|Adverse Event|1|||
155415634|NCT01340209|560952333|FG001|Overall Study|Adverse Event|1|||
155642917|NCT05558410|561782350|FG001|Overall Study|Sponsor Decision|0|||
155642918|NCT05558410|561782351|FG002|Overall Study|Sponsor Decision|0|||
155642919|NCT05558410|561782349|FG000|Overall Study|Other|1|||
155642920|NCT05558410|561782350|FG001|Overall Study|Other|0|||
155415635|NCT01340209|560952334|FG002|Overall Study|Adverse Event|2|||
155415636|NCT01340209|560952332|FG000|Overall Study|Protocol Violation|1|||
155415637|NCT01340209|560952333|FG001|Overall Study|Protocol Violation|2|||
155415638|NCT01340209|560952334|FG002|Overall Study|Protocol Violation|1|||
155415639|NCT01340209|560952332|FG000|Overall Study|Withdrawal by Subject|0|||
155415640|NCT01340209|560952333|FG001|Overall Study|Withdrawal by Subject|0|||
155415641|NCT01340209|560952334|FG002|Overall Study|Withdrawal by Subject|1|||
155415642|NCT01340209|560952332|FG000|Overall Study|Other reason not defined above|3|||
155642921|NCT05558410|561782351|FG002|Overall Study|Other|1|||
155642922|NCT02265744|561782354|FG000|Overall Study|Poor/Non-compliance|1|||
155642923|NCT02265744|561782355|FG001|Overall Study|Poor/Non-compliance|1|||
155642924|NCT02265744|561782356|FG002|Overall Study|Poor/Non-compliance|0|||
155642925|NCT02265744|561782357|FG003|Overall Study|Poor/Non-compliance|0|||
155642926|NCT02265744|561782358|FG004|Overall Study|Poor/Non-compliance|2|||
155642927|NCT02265744|561782354|FG000|Overall Study|Lost to Follow-up|0|||
155642928|NCT02265744|561782355|FG001|Overall Study|Lost to Follow-up|0|||
155642929|NCT02265744|561782356|FG002|Overall Study|Lost to Follow-up|0|||
155310210|NCT03665597|560569270|FG001|Period 2|Adverse Event|0|||
155310211|NCT03665597|560569271|FG002|Period 2|Adverse Event|0|||
155310212|NCT03665597|560569272|FG003|Period 2|Adverse Event|0|||
155310213|NCT03665597|560569273|FG004|Period 2|Adverse Event|0|||
155310214|NCT03665597|560569274|FG005|Period 2|Adverse Event|1|||
155310215|NCT03665597|560569275|FG006|Period 2|Adverse Event|0|||
155310216|NCT03665597|560569269|FG000|Period 3|Adverse Event|0|||
155310217|NCT03665597|560569270|FG001|Period 3|Adverse Event|1|||
155310218|NCT03665597|560569271|FG002|Period 3|Adverse Event|0|||
155310219|NCT03665597|560569272|FG003|Period 3|Adverse Event|0|||
155310220|NCT03665597|560569273|FG004|Period 3|Adverse Event|0|||
155310221|NCT03665597|560569274|FG005|Period 3|Adverse Event|0|||
155415643|NCT01340209|560952333|FG001|Overall Study|Other reason not defined above|5|||
155415644|NCT01340209|560952334|FG002|Overall Study|Other reason not defined above|4|||
155415645|NCT00253630|560952335|FG000|Overall Study|ineligible|2|||
155415646|NCT00209339|560952336|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
155415647|NCT00209339|560952336|FG000|At 12 Months Follow-up|Death|1|||
155415648|NCT00209339|560952336|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
155750087|NCT02038829|562185312|FG008|Treatment Period 4|Adverse Event|0|||
155750088|NCT02038829|562185313|FG009|Treatment Period 4|Adverse Event|0|||
155750089|NCT02038829|562185314|FG010|Treatment Period 4|Adverse Event|0|||
155750090|NCT02038829|562185315|FG011|Treatment Period 4|Adverse Event|0|||
155750091|NCT02038829|562185304|FG000|Washout Period 4|Adverse Event|0|||
155750092|NCT02038829|562185305|FG001|Washout Period 4|Adverse Event|0|||
155750093|NCT02038829|562185306|FG002|Washout Period 4|Adverse Event|0|||
155750094|NCT02038829|562185307|FG003|Washout Period 4|Adverse Event|0|||
155750095|NCT02038829|562185308|FG004|Washout Period 4|Adverse Event|0|||
155750096|NCT02038829|562185309|FG005|Washout Period 4|Adverse Event|0|||
155750097|NCT02038829|562185310|FG006|Washout Period 4|Adverse Event|1|||
155750098|NCT02038829|562185311|FG007|Washout Period 4|Adverse Event|0|||
155750099|NCT02038829|562185312|FG008|Washout Period 4|Adverse Event|0|||
155750100|NCT02038829|562185313|FG009|Washout Period 4|Adverse Event|0|||
155750101|NCT02038829|562185314|FG010|Washout Period 4|Adverse Event|0|||
155750102|NCT02038829|562185315|FG011|Washout Period 4|Adverse Event|0|||
155750103|NCT02038829|562185304|FG000|Treatment Period 6|Adverse Event|0|||
155750104|NCT02038829|562185305|FG001|Treatment Period 6|Adverse Event|0|||
155750105|NCT02038829|562185306|FG002|Treatment Period 6|Adverse Event|1|||
155750106|NCT02038829|562185307|FG003|Treatment Period 6|Adverse Event|0|||
155750107|NCT02038829|562185308|FG004|Treatment Period 6|Adverse Event|0|||
155750108|NCT02038829|562185309|FG005|Treatment Period 6|Adverse Event|0|||
155750109|NCT02038829|562185310|FG006|Treatment Period 6|Adverse Event|0|||
155750110|NCT02038829|562185311|FG007|Treatment Period 6|Adverse Event|0|||
155750111|NCT02038829|562185312|FG008|Treatment Period 6|Adverse Event|0|||
155750112|NCT02038829|562185313|FG009|Treatment Period 6|Adverse Event|0|||
155750113|NCT02038829|562185314|FG010|Treatment Period 6|Adverse Event|0|||
155750114|NCT02038829|562185315|FG011|Treatment Period 6|Adverse Event|0|||
155750115|NCT00749580|562185316|FG000|Overall Study|Lost to Follow-up|4|||
155750116|NCT00749580|562185317|FG001|Overall Study|Lost to Follow-up|8|||
155750117|NCT00749580|562185316|FG000|Overall Study|Adverse Event|0|||
155750118|NCT00749580|562185317|FG001|Overall Study|Adverse Event|1|||
155750119|NCT04393298|562185318|FG000|Overall Study|Adverse Event|0|||
155750120|NCT04393298|562185319|FG001|Overall Study|Adverse Event|0|||
155750121|NCT04393298|562185320|FG002|Overall Study|Adverse Event|0|||
155750122|NCT04393298|562185321|FG003|Overall Study|Adverse Event|0|||
155750123|NCT04393298|562185322|FG004|Overall Study|Adverse Event|1|||
155750124|NCT04393298|562185323|FG005|Overall Study|Adverse Event|0|||
155750125|NCT04393298|562185324|FG006|Overall Study|Adverse Event|0|||
155750126|NCT04393298|562185325|FG007|Overall Study|Adverse Event|0|||
155750127|NCT04393298|562185326|FG008|Overall Study|Adverse Event|2|||
155750128|NCT04393298|562185327|FG009|Overall Study|Adverse Event|0|||
155750129|NCT04393298|562185328|FG010|Overall Study|Adverse Event|0|||
155750130|NCT04393298|562185329|FG011|Overall Study|Adverse Event|0|||
155750131|NCT04393298|562185330|FG012|Overall Study|Adverse Event|1|||
155750132|NCT04393298|562185331|FG013|Overall Study|Adverse Event|1|||
155750133|NCT04393298|562185332|FG014|Overall Study|Adverse Event|0|||
155750134|NCT04393298|562185318|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750135|NCT04393298|562185319|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750136|NCT04393298|562185320|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
155750137|NCT04393298|562185321|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310222|NCT03665597|560569275|FG006|Period 3|Adverse Event|0|||
155310223|NCT03665597|560569269|FG000|Period 3|Death|0|||
155310224|NCT03665597|560569270|FG001|Period 3|Death|0|||
155750138|NCT04393298|562185322|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750139|NCT04393298|562185323|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750140|NCT04393298|562185324|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750141|NCT04393298|562185325|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310225|NCT03665597|560569271|FG002|Period 3|Death|0|||
155310226|NCT03665597|560569272|FG003|Period 3|Death|0|||
155310227|NCT03665597|560569273|FG004|Period 3|Death|1|||
155310228|NCT03665597|560569274|FG005|Period 3|Death|0|||
155310229|NCT03665597|560569275|FG006|Period 3|Death|0|||
155310230|NCT03665597|560569269|FG000|Period 4|Adverse Event|2|||
155310231|NCT03665597|560569270|FG001|Period 4|Adverse Event|2|||
155310232|NCT03665597|560569271|FG002|Period 4|Adverse Event|2|||
155310233|NCT03665597|560569272|FG003|Period 4|Adverse Event|2|||
155310234|NCT03665597|560569273|FG004|Period 4|Adverse Event|1|||
155310235|NCT03665597|560569274|FG005|Period 4|Adverse Event|0|||
155310236|NCT03665597|560569275|FG006|Period 4|Adverse Event|0|||
155310237|NCT03665597|560569269|FG000|Period 4|Death|0|||
155310238|NCT03665597|560569270|FG001|Period 4|Death|0|||
155310239|NCT03665597|560569271|FG002|Period 4|Death|2|||
155310240|NCT03665597|560569272|FG003|Period 4|Death|0|||
155310241|NCT03665597|560569273|FG004|Period 4|Death|0|||
155750142|NCT04393298|562185326|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310242|NCT03665597|560569274|FG005|Period 4|Death|0|||
155310243|NCT03665597|560569275|FG006|Period 4|Death|0|||
155310244|NCT03665597|560569269|FG000|Period 4|Physician Decision|1|||
155310245|NCT03665597|560569270|FG001|Period 4|Physician Decision|2|||
155310246|NCT03665597|560569271|FG002|Period 4|Physician Decision|0|||
155310247|NCT03665597|560569272|FG003|Period 4|Physician Decision|0|||
155310248|NCT03665597|560569273|FG004|Period 4|Physician Decision|0|||
155310249|NCT03665597|560569274|FG005|Period 4|Physician Decision|0|||
155310250|NCT03665597|560569275|FG006|Period 4|Physician Decision|0|||
155310251|NCT05516147|560569276|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
155310252|NCT05371652|560569280|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
155310253|NCT05371652|560569280|FG000|Overall Study|Withdrawal by Subject|12|||
155310254|NCT05371652|560569280|FG000|Overall Study|Adverse Event|1|||
155310255|NCT05371652|560569280|FG000|Overall Study|Other|11|||
155310256|NCT05256706|560569281|FG000|Overall Study|Lost to Follow-up|9|||
155310257|NCT05256706|560569282|FG001|Overall Study|Lost to Follow-up|3|||
155310258|NCT05256706|560569281|FG000|Overall Study|Withdrawal by Subject|7|||
155310259|NCT05256706|560569282|FG001|Overall Study|Withdrawal by Subject|11|||
155310260|NCT05256706|560569281|FG000|Overall Study|Screen Failures|3|||
155310261|NCT05256706|560569282|FG001|Overall Study|Screen Failures|0|||
155310262|NCT04410042|560569284|FG000|Overall Study|Not Eligible|1|||
155310263|NCT04410042|560569285|FG001|Overall Study|Not Eligible|1|||
155310264|NCT03302494|560569286|FG000|Overall Study|Other|7|||
155310265|NCT03302494|560569287|FG001|Overall Study|Other|4|||
155310266|NCT03302494|560569288|FG002|Overall Study|Other|6|||
155310267|NCT03302494|560569286|FG000|Overall Study|Withdrawal by Subject|10|||
155310268|NCT03302494|560569287|FG001|Overall Study|Withdrawal by Subject|2|||
155310269|NCT03302494|560569288|FG002|Overall Study|Withdrawal by Subject|9|||
155310270|NCT03302494|560569286|FG000|Overall Study|Study Terminated by Sponsor|32|||
155310271|NCT03302494|560569287|FG001|Overall Study|Study Terminated by Sponsor|29|||
155310272|NCT03302494|560569288|FG002|Overall Study|Study Terminated by Sponsor|30|||
155310273|NCT03302494|560569286|FG000|Overall Study|Physician Decision|1|||
155310274|NCT03302494|560569287|FG001|Overall Study|Physician Decision|0|||
155310275|NCT03302494|560569288|FG002|Overall Study|Physician Decision|1|||
155310276|NCT03302494|560569286|FG000|Overall Study|Lost to Follow-up|1|||
155310277|NCT03302494|560569287|FG001|Overall Study|Lost to Follow-up|3|||
155310278|NCT03302494|560569288|FG002|Overall Study|Lost to Follow-up|3|||
155310279|NCT03302494|560569286|FG000|Overall Study|Death|13|||
155310280|NCT03302494|560569287|FG001|Overall Study|Death|11|||
155310281|NCT03302494|560569288|FG002|Overall Study|Death|4|||
155310282|NCT03302494|560569286|FG000|Overall Study|Adverse Event|1|||
155750143|NCT04393298|562185327|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310283|NCT03302494|560569287|FG001|Overall Study|Adverse Event|2|||
155310284|NCT03302494|560569288|FG002|Overall Study|Adverse Event|0|||
155310285|NCT03302494|560569286|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
155310286|NCT03302494|560569287|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
155310287|NCT03302494|560569288|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
155310288|NCT03978871|560569289|FG000|Overall Study|Lost to Follow-up|11|||
155310289|NCT03978871|560569290|FG001|Overall Study|Lost to Follow-up|12|||
155310290|NCT05710107|560569291|FG000|Overall Study|Withdrawal by Subject|1|||
155310291|NCT05710107|560569292|FG001|Overall Study|Withdrawal by Subject|1|||
155310292|NCT05710107|560569291|FG000|Overall Study|Lost to Follow-up|8|||
155750144|NCT04393298|562185328|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310293|NCT05710107|560569292|FG001|Overall Study|Lost to Follow-up|9|||
155310294|NCT05710107|560569291|FG000|Overall Study|Unable to place assigned block|2|||
155310295|NCT05710107|560569292|FG001|Overall Study|Unable to place assigned block|0|||
155310296|NCT05710107|560569291|FG000|Overall Study|Withdrawn by study team|0|||
155310297|NCT05710107|560569292|FG001|Overall Study|Withdrawn by study team|1|||
155310298|NCT04166773|560569293|FG000|Overall Study|Adverse Event|2|||
155310299|NCT04166773|560569294|FG001|Overall Study|Adverse Event|0|||
155310300|NCT04166773|560569295|FG002|Overall Study|Adverse Event|2|||
155310301|NCT04166773|560569296|FG003|Overall Study|Adverse Event|1|||
155310302|NCT04166773|560569293|FG000|Overall Study|Lost to Follow-up|4|||
155310303|NCT04166773|560569294|FG001|Overall Study|Lost to Follow-up|2|||
155310304|NCT04166773|560569295|FG002|Overall Study|Lost to Follow-up|1|||
155310305|NCT04166773|560569296|FG003|Overall Study|Lost to Follow-up|3|||
155310306|NCT04166773|560569293|FG000|Overall Study|Physician Decision|0|||
155310307|NCT04166773|560569294|FG001|Overall Study|Physician Decision|0|||
155310308|NCT04166773|560569295|FG002|Overall Study|Physician Decision|0|||
155310309|NCT04166773|560569296|FG003|Overall Study|Physician Decision|1|||
155310310|NCT04166773|560569293|FG000|Overall Study|Withdrawal by Subject|1|||
155310311|NCT04166773|560569294|FG001|Overall Study|Withdrawal by Subject|1|||
155310312|NCT04166773|560569295|FG002|Overall Study|Withdrawal by Subject|2|||
155310313|NCT04166773|560569296|FG003|Overall Study|Withdrawal by Subject|5|||
155310314|NCT05268302|560569297|FG000|Overall Study|Death|0|||
155310315|NCT05268302|560569298|FG001|Overall Study|Death|1|||
155310316|NCT02811679|560569299|FG000|Overall Study|Adverse Event|1|||
155310317|NCT02811679|560569299|FG000|Overall Study|Lack of Efficacy|6|||
155310318|NCT02811679|560569299|FG000|Overall Study|Early study closure due to slow accrual|3|||
155310319|NCT05319860|560569300|FG000|Overall Study|Death|1|||
155310320|NCT05319860|560569301|FG001|Overall Study|Death|1|||
155310321|NCT05319860|560569300|FG000|Overall Study|Lost to Follow-up|3|||
155310322|NCT05319860|560569301|FG001|Overall Study|Lost to Follow-up|1|||
155310323|NCT05319860|560569300|FG000|Overall Study|Withdrawal by Subject|1|||
155310324|NCT05319860|560569301|FG001|Overall Study|Withdrawal by Subject|7|||
155310325|NCT01361711|560569302|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
155310326|NCT01361711|560569302|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
155310327|NCT01361711|560569302|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
155310328|NCT01361711|560569302|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
155310329|NCT01361711|560569302|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
155310330|NCT01361711|560569302|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
155310331|NCT01361711|560569302|FG000|Completed Week 18 of Treatment|Other|9|||
155310332|NCT01361711|560569302|FG000|10 Year Follow-up|Still in follow-up|22|||
155310333|NCT01361711|560569302|FG000|10 Year Follow-up|Death|7|||
155310334|NCT01361711|560569302|FG000|10 Year Follow-up|Developed new cancer|1|||
155310335|NCT01361711|560569302|FG000|10 Year Follow-up|Lost to Follow-up|2|||
155310336|NCT01361711|560569302|FG000|10 Year Follow-up|New treatment started|6|||
155310337|NCT01361711|560569302|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
155310338|NCT01361711|560569302|FG000|10 Year Follow-up|Progressive Disease|1|||
155310339|NCT00753090|560570486|FG000|Overall Study|Withdrawal by Subject|10|||
155310340|NCT00753090|560570487|FG001|Overall Study|Withdrawal by Subject|10|||
155310341|NCT00753090|560570486|FG000|Overall Study|Death|17|||
155310342|NCT00753090|560570487|FG001|Overall Study|Death|6|||
155310343|NCT00753090|560570486|FG000|Overall Study|Study Prosthesis Removed|12|||
155310344|NCT00753090|560570487|FG001|Overall Study|Study Prosthesis Removed|3|||
155310345|NCT00753090|560570486|FG000|Overall Study|Lost to Follow-up|2|||
155310346|NCT00753090|560570487|FG001|Overall Study|Lost to Follow-up|2|||
155310347|NCT00753090|560570486|FG000|Overall Study|Other|127|||
155310348|NCT00753090|560570487|FG001|Overall Study|Other|75|||
155310349|NCT05113966|560570488|FG000|Overall Study|Death|21|||
155310350|NCT05113966|560570488|FG000|Overall Study|Study Terminated by Sponsor|9|||
155310351|NCT05816551|560570491|FG000|Overall Study|Withdrawal by Subject|0|||
155310352|NCT05816551|560570492|FG001|Overall Study|Withdrawal by Subject|1|||
155310353|NCT05816551|560570491|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
155310354|NCT05816551|560570492|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
155310355|NCT04593472|560570493|FG000|Overall Study|Death|31|||
155310356|NCT04593472|560570494|FG001|Overall Study|Death|27|||
155310357|NCT04593472|560570493|FG000|Overall Study|Withdrawal by Subject|12|||
155310358|NCT04593472|560570494|FG001|Overall Study|Withdrawal by Subject|12|||
155498750|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
155310359|NCT04593472|560570493|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
155310360|NCT04593472|560570494|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
155642930|NCT02265744|561782357|FG003|Overall Study|Lost to Follow-up|1|||
155310361|NCT04593472|560570493|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
155310362|NCT04593472|560570494|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
155310363|NCT04593472|560570493|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
155310364|NCT04593472|560570494|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
155310365|NCT04593472|560570493|FG000|Overall Study|Lost to Follow-up|0|||
155310366|NCT04593472|560570494|FG001|Overall Study|Lost to Follow-up|2|||
155310367|NCT04593472|560570493|FG000|Overall Study|Still collecting 24-month assessment|17|||
155310368|NCT04593472|560570494|FG001|Overall Study|Still collecting 24-month assessment|10|||
155310369|NCT03648840|560570495|FG000|First IV Infusion Session|Adverse Event|0|||
155310370|NCT03648840|560570496|FG001|First IV Infusion Session|Adverse Event|2|||
155310371|NCT03648840|560570495|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
155642931|NCT02265744|561782358|FG004|Overall Study|Lost to Follow-up|0|||
155642932|NCT02265744|561782354|FG000|Overall Study|Death|0|||
155642933|NCT02265744|561782355|FG001|Overall Study|Death|0|||
155642934|NCT02265744|561782356|FG002|Overall Study|Death|0|||
155642935|NCT02265744|561782357|FG003|Overall Study|Death|2|||
155310372|NCT03648840|560570496|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
155310373|NCT03648840|560570495|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
155310374|NCT03648840|560570496|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
155310375|NCT03648840|560570495|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
155310376|NCT03648840|560570496|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
155310377|NCT05382936|560570498|FG000|Overall Study|Progressive Disease|3|||
155310378|NCT05382936|560570499|FG001|Overall Study|Progressive Disease|5|||
155310379|NCT05382936|560570500|FG002|Overall Study|Progressive Disease|2|||
155310380|NCT05382936|560570501|FG003|Overall Study|Progressive Disease|5|||
155310381|NCT05382936|560570498|FG000|Overall Study|Adverse Event|0|||
155310382|NCT05382936|560570499|FG001|Overall Study|Adverse Event|1|||
155310383|NCT05382936|560570500|FG002|Overall Study|Adverse Event|1|||
155310384|NCT05382936|560570501|FG003|Overall Study|Adverse Event|0|||
155310385|NCT05382936|560570498|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310386|NCT05382936|560570499|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
155310387|NCT05382936|560570500|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310388|NCT05382936|560570501|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310389|NCT05382936|560570498|FG000|Overall Study|Withdrawal by Subject|0|||
155310390|NCT05382936|560570499|FG001|Overall Study|Withdrawal by Subject|0|||
155310391|NCT05382936|560570500|FG002|Overall Study|Withdrawal by Subject|1|||
155310392|NCT05382936|560570501|FG003|Overall Study|Withdrawal by Subject|1|||
155310393|NCT05063994|560570502|FG000|Cortef Run-In|Withdrawal of Consent|1|||
155310394|NCT05063994|560570503|FG001|Cortef Run-In|Withdrawal of Consent|0|||
155310395|NCT05063994|560570504|FG002|Cortef Run-In|Withdrawal of Consent|0|||
155310396|NCT05063994|560570502|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
155310397|NCT05063994|560570503|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
155310398|NCT05063994|560570504|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
155310399|NCT05063994|560570502|FG000|Treatment|Physician Decision|0|||
155310400|NCT05063994|560570503|FG001|Treatment|Physician Decision|0|||
155310401|NCT05063994|560570504|FG002|Treatment|Physician Decision|1|||
155310402|NCT05063994|560570502|FG000|Treatment|Withdrawal by Subject|0|||
155310403|NCT05063994|560570503|FG001|Treatment|Withdrawal by Subject|0|||
155310404|NCT05063994|560570504|FG002|Treatment|Withdrawal by Subject|1|||
155310405|NCT05063994|560570502|FG000|Treatment|Withdrawal of Consent|0|||
155310406|NCT05063994|560570503|FG001|Treatment|Withdrawal of Consent|0|||
155310407|NCT05063994|560570504|FG002|Treatment|Withdrawal of Consent|1|||
155310408|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior use|4424|||
155310409|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior use|24726|||
155310410|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior use|0|||
155310411|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior use|0|||
155310412|NCT03692676|560570510|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
155310413|NCT03692676|560570511|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
155310414|NCT03692676|560570512|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
155310415|NCT03692676|560570513|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
155310416|NCT03692676|560570510|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
155310417|NCT03692676|560570511|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
155310418|NCT03692676|560570512|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
155310419|NCT03692676|560570513|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
155310420|NCT03692676|560570510|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
155310421|NCT03692676|560570511|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
155310422|NCT03692676|560570512|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
155310423|NCT03692676|560570513|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
155310424|NCT03692676|560570510|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
155310425|NCT03692676|560570511|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
155310426|NCT03692676|560570512|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
155310427|NCT03692676|560570513|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
155310428|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
155498751|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
155498752|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
155498753|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
155310429|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
155310430|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
155310431|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
155310432|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
155310433|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
155310434|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
155310435|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
155310436|NCT03692676|560570510|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
155310437|NCT03692676|560570511|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
155310438|NCT03692676|560570512|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
155310439|NCT03692676|560570513|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
155310440|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
155310441|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
155310442|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
155310443|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
155310444|NCT03692676|560570510|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
155310445|NCT03692676|560570511|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
155310446|NCT03692676|560570512|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
155310447|NCT03692676|560570513|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
155310448|NCT03692676|560570510|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310449|NCT03692676|560570511|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310450|NCT03692676|560570512|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310451|NCT03692676|560570513|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
155415649|NCT00209339|560952336|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
155415650|NCT00209339|560952336|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
155415651|NCT00209339|560952336|FG000|At 24 Months Follow-up|Death|1|||
155415652|NCT00209339|560952336|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
155415653|NCT00209339|560952336|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
155415654|NCT00209339|560952336|FG000|At 4 Years Follow-up|Death|1|||
155415655|NCT00209339|560952336|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
155415656|NCT00209339|560952336|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
155415657|NCT00209339|560952336|FG000|At 5 Years Follow-up|Death|1|||
155415658|NCT01239160|560952337|FG000|Overall Study|Lost to Follow-up|3|||
155415659|NCT01239160|560952338|FG001|Overall Study|Lost to Follow-up|5|||
155415660|NCT01239160|560952339|FG002|Overall Study|Lost to Follow-up|0|||
155415661|NCT01239160|560952337|FG000|Overall Study|Withdrawal by Subject|17|||
155415662|NCT01239160|560952338|FG001|Overall Study|Withdrawal by Subject|6|||
155415663|NCT01239160|560952339|FG002|Overall Study|Withdrawal by Subject|2|||
155415664|NCT01239160|560952337|FG000|Overall Study|Physician Decision|5|||
155415665|NCT01239160|560952338|FG001|Overall Study|Physician Decision|7|||
155415666|NCT01239160|560952339|FG002|Overall Study|Physician Decision|2|||
155415667|NCT01239160|560952337|FG000|Overall Study|Early Termination Due to Study Closure|0|||
155415668|NCT01239160|560952338|FG001|Overall Study|Early Termination Due to Study Closure|1|||
155415669|NCT01239160|560952339|FG002|Overall Study|Early Termination Due to Study Closure|6|||
155415670|NCT02062658|560952340|FG000|Overall Study|Withdrawal by Subject|1|||
155415671|NCT02062658|560952340|FG000|Overall Study|Lack of Efficacy|1|||
155415672|NCT04016311|560952347|FG000|Overall Study|Withdrawal by Subject|1|||
155415673|NCT04016311|560952348|FG001|Overall Study|Withdrawal by Subject|0|||
155415674|NCT04029519|560952351|FG000|Overall Study|Protocol Violation|1|||
155415675|NCT04029519|560952351|FG000|Overall Study|Withdrawal by Subject|3|||
155415676|NCT04029519|560952351|FG000|Overall Study|Lost to Follow-up|1|||
155415677|NCT00939692|560952360|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
155415678|NCT00939692|560952361|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
155415679|NCT00939692|560952360|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
155415680|NCT00939692|560952361|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
155415681|NCT02161211|560952362|FG000|Overall Study|Lost to Follow-up|21|||
155415682|NCT02161211|560952363|FG001|Overall Study|Lost to Follow-up|27|||
155415683|NCT02161211|560952364|FG002|Overall Study|Lost to Follow-up|21|||
155415684|NCT02161211|560952362|FG000|Overall Study|Dropped|12|||
155415685|NCT02161211|560952363|FG001|Overall Study|Dropped|5|||
155415686|NCT02161211|560952364|FG002|Overall Study|Dropped|9|||
155415687|NCT00430508|560952366|FG000|Overall Study|Adverse Event|2|||
155415688|NCT00430508|560952367|FG001|Overall Study|Adverse Event|3|||
155415689|NCT00430508|560952368|FG002|Overall Study|Adverse Event|5|||
155415690|NCT00430508|560952369|FG003|Overall Study|Adverse Event|3|||
155415691|NCT00430508|560952366|FG000|Overall Study|Withdrawal by Subject|0|||
155415692|NCT00430508|560952367|FG001|Overall Study|Withdrawal by Subject|1|||
155415693|NCT00430508|560952368|FG002|Overall Study|Withdrawal by Subject|1|||
155415694|NCT00430508|560952369|FG003|Overall Study|Withdrawal by Subject|1|||
155415695|NCT00430508|560952366|FG000|Overall Study|responder at visit 4|0|||
155415696|NCT00430508|560952367|FG001|Overall Study|responder at visit 4|0|||
155415697|NCT00430508|560952368|FG002|Overall Study|responder at visit 4|2|||
155415698|NCT00430508|560952369|FG003|Overall Study|responder at visit 4|0|||
155642936|NCT02265744|561782358|FG004|Overall Study|Death|0|||
155310452|NCT03692676|560570510|FG000|Overall Study|Other|0|||
155310453|NCT03692676|560570511|FG001|Overall Study|Other|805|||
155310454|NCT03692676|560570512|FG002|Overall Study|Other|758|||
155310455|NCT03692676|560570513|FG003|Overall Study|Other|277|||
155310456|NCT03692676|560570510|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310457|NCT03692676|560570511|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310458|NCT03692676|560570512|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310459|NCT03692676|560570513|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
155310460|NCT01180634|560570514|FG000|Overall Study|Adverse Event|4|||
155310461|NCT01180634|560570515|FG001|Overall Study|Adverse Event|1|||
155310462|NCT01180634|560570514|FG000|Overall Study|Miscellaneous|2|||
155310463|NCT01180634|560570515|FG001|Overall Study|Miscellaneous|0|||
155310464|NCT01180634|560570514|FG000|Overall Study|Withdrawal by Subject|4|||
155310465|NCT01180634|560570515|FG001|Overall Study|Withdrawal by Subject|0|||
155310466|NCT03692611|560570516|FG000|Overall Study|Found to be ineligible postrandomization|3|||
155310467|NCT03692611|560570517|FG001|Overall Study|Found to be ineligible postrandomization|0|||
155310468|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
155310469|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155310470|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155310471|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155310472|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155310473|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
155310474|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
155310475|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
155310476|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
155310477|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
155310478|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
155310479|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
155310480|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
155310481|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
155310482|NCT04083235|560570527|FG000|Overall Study|Death|252|||
155310483|NCT04083235|560570528|FG001|Overall Study|Death|277|||
155310484|NCT04083235|560570527|FG000|Overall Study|Withdrawal by Subject|13|||
155310485|NCT04083235|560570528|FG001|Overall Study|Withdrawal by Subject|17|||
155310486|NCT04083235|560570527|FG000|Overall Study|Lost to Follow-up|1|||
155310487|NCT04083235|560570528|FG001|Overall Study|Lost to Follow-up|1|||
155310488|NCT04083235|560570527|FG000|Overall Study|Does not meet entry criteria|1|||
155310489|NCT04083235|560570528|FG001|Overall Study|Does not meet entry criteria|0|||
155310490|NCT04083235|560570527|FG000|Overall Study|Did not receive treatment|13|||
155310491|NCT04083235|560570528|FG001|Overall Study|Did not receive treatment|8|||
155310492|NCT04083235|560570527|FG000|Overall Study|Ongoing at the time of DCO|44|||
155310493|NCT04083235|560570528|FG001|Overall Study|Ongoing at the time of DCO|7|||
155310494|NCT03016169|560570529|FG000|Overall Study|Lost to Follow-up|4|||
155310495|NCT03016169|560570529|FG000|Overall Study|Death|54|||
155310496|NCT03016169|560570529|FG000|Overall Study|Device Explant|11|||
155310497|NCT03016169|560570529|FG000|Overall Study|Withdrawal by Subject|19|||
155498754|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
155498755|NCT03611751|561250703|FG000|Treatment Week 0 - Week 16|Death|0|||
155498756|NCT03611751|561250704|FG001|Treatment Week 0 - Week 16|Death|0|||
155498757|NCT03611751|561250705|FG002|Treatment Week 0 - Week 16|Death|1|||
155498758|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
155498759|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
155498760|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
155498761|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
155498762|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
155498763|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
155498764|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
155498765|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155498766|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155498767|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
155498768|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
155498769|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
155750145|NCT04393298|562185329|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750146|NCT04393298|562185330|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155310498|NCT03016169|560570529|FG000|Overall Study|Other Reasons|1|||
155310499|NCT04060355|560570530|FG000|Overall Study|Lost to Follow-up|41|||
155310500|NCT04150718|560570534|FG000|Overall Study|Withdrawal by Subject|2|||
155310501|NCT04150718|560570535|FG001|Overall Study|Withdrawal by Subject|7|||
155310502|NCT04150718|560570536|FG002|Overall Study|Withdrawal by Subject|1|||
155310503|NCT04150718|560570534|FG000|Overall Study|Lost to Follow-up|1|||
155310504|NCT04150718|560570535|FG001|Overall Study|Lost to Follow-up|2|||
155310505|NCT04150718|560570536|FG002|Overall Study|Lost to Follow-up|0|||
155310506|NCT04150718|560570534|FG000|Overall Study|Ineligible|1|||
155310507|NCT04150718|560570535|FG001|Overall Study|Ineligible|0|||
155310508|NCT04150718|560570536|FG002|Overall Study|Ineligible|10|||
155310509|NCT05324124|560570537|FG000|Period 1|Withdrawal by Subject|1|||
155310510|NCT05324124|560570538|FG001|Period 1|Withdrawal by Subject|0|||
155310511|NCT05324124|560570537|FG000|Period 1|Physician Decision|0|||
155310512|NCT05324124|560570538|FG001|Period 1|Physician Decision|1|||
155310513|NCT05034952|560570539|FG000|Overall Study|Adverse Event|1|||
155310514|NCT05034952|560570540|FG001|Overall Study|Adverse Event|0|||
155310515|NCT05034952|560570541|FG002|Overall Study|Adverse Event|0|||
155310516|NCT05034952|560570542|FG003|Overall Study|Adverse Event|0|||
155310517|NCT05034952|560570539|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155310518|NCT05034952|560570540|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155310519|NCT05034952|560570541|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
155310520|NCT05034952|560570542|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
155310521|NCT05034952|560570539|FG000|Overall Study|Lost to Follow-up|1|||
155310522|NCT05034952|560570540|FG001|Overall Study|Lost to Follow-up|4|||
155310523|NCT05034952|560570541|FG002|Overall Study|Lost to Follow-up|3|||
155310524|NCT05034952|560570542|FG003|Overall Study|Lost to Follow-up|3|||
155310525|NCT05034952|560570539|FG000|Overall Study|Other|0|||
155310526|NCT05034952|560570540|FG001|Overall Study|Other|0|||
155310527|NCT05034952|560570541|FG002|Overall Study|Other|0|||
155310528|NCT05034952|560570542|FG003|Overall Study|Other|1|||
155310529|NCT04783935|560570549|FG000|Overall Study|Withdrawal by Subject|6|||
155310530|NCT04783935|560570549|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
155310531|NCT04783935|560570549|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
155310532|NCT04783935|560570549|FG000|Overall Study|Lost to Follow-up|3|||
155310533|NCT04783935|560570549|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
155310534|NCT00920621|560570553|FG000|Overall Study|Lost to Follow-up|16|||
155310535|NCT00920621|560570554|FG001|Overall Study|Lost to Follow-up|17|||
155310536|NCT00920621|560570555|FG002|Overall Study|Lost to Follow-up|19|||
155310537|NCT00920621|560570556|FG003|Overall Study|Lost to Follow-up|21|||
155310538|NCT00920621|560570553|FG000|Overall Study|Fetal/neonatal deaths|16|||
155310539|NCT00920621|560570554|FG001|Overall Study|Fetal/neonatal deaths|14|||
155310540|NCT00920621|560570555|FG002|Overall Study|Fetal/neonatal deaths|16|||
155310541|NCT00920621|560570556|FG003|Overall Study|Fetal/neonatal deaths|14|||
155310542|NCT00920621|560570553|FG000|Overall Study|Blood sample not collected|22|||
155310543|NCT00920621|560570554|FG001|Overall Study|Blood sample not collected|14|||
155310544|NCT00920621|560570555|FG002|Overall Study|Blood sample not collected|0|||
155310545|NCT00920621|560570556|FG003|Overall Study|Blood sample not collected|0|||
155310546|NCT01426425|560570557|FG000|Overall Study|Exited prior to EP study|22|||
155310547|NCT01426425|560570557|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
155310548|NCT01426425|560570557|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
155310549|NCT03763708|560570559|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
155310550|NCT03763708|560570560|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310551|NCT03763708|560570561|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310552|NCT03763708|560570562|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310553|NCT03763708|560570563|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310554|NCT03763708|560570564|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310555|NCT03763708|560570565|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310556|NCT03763708|560570566|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310557|NCT03763708|560570567|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310558|NCT03763708|560570559|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310559|NCT03763708|560570560|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310560|NCT03763708|560570561|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
155310561|NCT03763708|560570562|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310562|NCT03763708|560570563|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310563|NCT03763708|560570564|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310564|NCT03763708|560570565|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310565|NCT03763708|560570566|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310566|NCT03763708|560570567|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310567|NCT03763708|560570559|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155498770|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
155498771|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
155310568|NCT03763708|560570560|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310569|NCT03763708|560570561|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310570|NCT03763708|560570562|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
155310571|NCT03763708|560570563|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310572|NCT03763708|560570564|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310573|NCT03763708|560570565|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310574|NCT03763708|560570566|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310575|NCT03763708|560570567|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310576|NCT03763708|560570559|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310577|NCT03763708|560570560|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310578|NCT03763708|560570561|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310579|NCT03763708|560570562|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310580|NCT03763708|560570563|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
155310581|NCT03763708|560570564|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310582|NCT03763708|560570565|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310583|NCT03763708|560570566|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310584|NCT03763708|560570567|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310585|NCT03763708|560570559|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310586|NCT03763708|560570560|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310587|NCT03763708|560570561|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310588|NCT03763708|560570562|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310589|NCT03763708|560570563|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310590|NCT03763708|560570564|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
155310591|NCT03763708|560570565|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310592|NCT03763708|560570566|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310593|NCT03763708|560570567|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310594|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310595|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310596|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310597|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310598|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310599|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310600|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
155310601|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310602|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310603|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
155310604|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
155310605|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
155310606|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
155310607|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
155310608|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
155310609|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
155310610|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
155310611|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
155310612|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
155310613|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
155310614|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
155310615|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
155310616|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
155310617|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
155310618|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
155310619|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
155310620|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
155310621|NCT03763708|560570559|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
155310622|NCT03763708|560570560|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
155310623|NCT03763708|560570561|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
155310624|NCT03763708|560570562|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
155310625|NCT03763708|560570563|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
155310626|NCT03763708|560570564|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
155310627|NCT03763708|560570565|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
155642937|NCT02265744|561782354|FG000|Overall Study|Withdrawal by Subject|2|||
155310628|NCT03763708|560570566|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
155310629|NCT03763708|560570567|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
155310630|NCT04382404|560570568|FG000|Overall Study|Adverse Event|1|||
155310631|NCT04382404|560570568|FG000|Overall Study|Lost to Follow-up|2|||
155310632|NCT05687916|560570569|FG000|Overall Study|Adverse Event|1|||
155310633|NCT05687916|560570570|FG001|Overall Study|Adverse Event|2|||
155310634|NCT05687916|560570571|FG002|Overall Study|Adverse Event|0|||
155310635|NCT05687916|560570569|FG000|Overall Study|Withdrawal by Subject|1|||
155310636|NCT05687916|560570570|FG001|Overall Study|Withdrawal by Subject|0|||
155498772|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
155642938|NCT02265744|561782355|FG001|Overall Study|Withdrawal by Subject|0|||
155642939|NCT02265744|561782356|FG002|Overall Study|Withdrawal by Subject|0|||
155642940|NCT02265744|561782357|FG003|Overall Study|Withdrawal by Subject|2|||
155310637|NCT05687916|560570571|FG002|Overall Study|Withdrawal by Subject|1|||
155310638|NCT05687916|560570569|FG000|Overall Study|Protocol Violation|0|||
155310639|NCT05687916|560570570|FG001|Overall Study|Protocol Violation|2|||
155310640|NCT05687916|560570571|FG002|Overall Study|Protocol Violation|1|||
155310641|NCT05687916|560570569|FG000|Overall Study|Reason not Specified|1|||
155310642|NCT05687916|560570570|FG001|Overall Study|Reason not Specified|0|||
155310643|NCT05687916|560570571|FG002|Overall Study|Reason not Specified|0|||
155642941|NCT02265744|561782358|FG004|Overall Study|Withdrawal by Subject|0|||
155642942|NCT02265744|561782354|FG000|Overall Study|Participant request to discontinue|2|||
155310644|NCT03332017|560570572|FG000|Overall Study|Lost to Follow-up|1|||
155310645|NCT03332017|560570573|FG001|Overall Study|Lost to Follow-up|2|||
155310646|NCT03332017|560570572|FG000|Overall Study|Death|17|||
155310647|NCT03332017|560570573|FG001|Overall Study|Death|16|||
155310648|NCT03332017|560570572|FG000|Overall Study|Withdrawal by Subject|6|||
155310649|NCT03332017|560570573|FG001|Overall Study|Withdrawal by Subject|14|||
155310650|NCT03332017|560570572|FG000|Overall Study|Other|1|||
155310651|NCT03332017|560570573|FG001|Overall Study|Other|3|||
155310652|NCT03332017|560570572|FG000|Overall Study|Remained in Study (Ongoing)|47|||
155310653|NCT03332017|560570573|FG001|Overall Study|Remained in Study (Ongoing)|110|||
155310654|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
155310655|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
155310656|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
155310657|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310658|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310659|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310660|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310661|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310662|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310663|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310664|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310665|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310666|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310667|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
155310668|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
155310669|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310670|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310671|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310672|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310673|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310674|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310675|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310676|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310677|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310678|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310679|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310680|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
155310681|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
155310682|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310683|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310684|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310685|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310686|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310687|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310688|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310689|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310690|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310691|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310692|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310693|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
155310694|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
155310695|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310696|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310697|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310698|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155415699|NCT00430508|560952366|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
155310699|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310700|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310701|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310702|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310703|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310704|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310705|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310706|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
155310707|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
155310708|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
155310709|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310710|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310711|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310712|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310713|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310714|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310715|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310716|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310717|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310718|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310719|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310720|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310721|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310722|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310723|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310724|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310725|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310726|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310727|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310728|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310729|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310730|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310731|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310732|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
155310733|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310734|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
155310735|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310736|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310737|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310738|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310739|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310740|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310741|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310742|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310743|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310744|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310745|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310746|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310747|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310748|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
155310749|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
155750147|NCT04393298|562185331|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155750148|NCT04393298|562185332|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
155750149|NCT04393298|562185318|FG000|Overall Study|Lack of Efficacy|0|||
155750150|NCT04393298|562185319|FG001|Overall Study|Lack of Efficacy|0|||
155750151|NCT04393298|562185320|FG002|Overall Study|Lack of Efficacy|0|||
155750152|NCT04393298|562185321|FG003|Overall Study|Lack of Efficacy|0|||
155750153|NCT04393298|562185322|FG004|Overall Study|Lack of Efficacy|0|||
155750154|NCT04393298|562185323|FG005|Overall Study|Lack of Efficacy|0|||
155750155|NCT04393298|562185324|FG006|Overall Study|Lack of Efficacy|0|||
155750156|NCT04393298|562185325|FG007|Overall Study|Lack of Efficacy|0|||
155750157|NCT04393298|562185326|FG008|Overall Study|Lack of Efficacy|0|||
155750158|NCT04393298|562185327|FG009|Overall Study|Lack of Efficacy|0|||
155310750|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
155310751|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310752|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310753|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310754|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310755|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310756|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310757|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310758|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310759|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310760|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310761|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310762|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
155310763|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
155310764|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310765|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310766|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310767|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310768|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310769|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310770|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310771|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310772|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310773|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310774|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310775|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
155310776|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
155310777|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310778|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310779|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310780|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310781|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310782|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310783|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310784|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310785|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310786|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310787|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
155310788|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
155642943|NCT02265744|561782355|FG001|Overall Study|Participant request to discontinue|2|||
155750159|NCT04393298|562185328|FG010|Overall Study|Lack of Efficacy|0|||
155310789|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
155310790|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310791|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310792|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310793|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310794|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310795|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310796|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310797|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310798|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155642944|NCT02265744|561782356|FG002|Overall Study|Participant request to discontinue|2|||
155642945|NCT02265744|561782357|FG003|Overall Study|Participant request to discontinue|0|||
155642946|NCT02265744|561782358|FG004|Overall Study|Participant request to discontinue|0|||
155642947|NCT02265744|561782354|FG000|Overall Study|Adverse Event|8|||
155642948|NCT02265744|561782355|FG001|Overall Study|Adverse Event|4|||
155642949|NCT02265744|561782356|FG002|Overall Study|Adverse Event|9|||
155642950|NCT02265744|561782357|FG003|Overall Study|Adverse Event|8|||
155642951|NCT02265744|561782358|FG004|Overall Study|Adverse Event|2|||
155642952|NCT02265744|561782354|FG000|Overall Study|Lack of Efficacy|2|||
155642953|NCT02265744|561782355|FG001|Overall Study|Lack of Efficacy|4|||
155642954|NCT02265744|561782356|FG002|Overall Study|Lack of Efficacy|3|||
155310799|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310800|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310801|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310802|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
155310803|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310804|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155642955|NCT02265744|561782357|FG003|Overall Study|Lack of Efficacy|4|||
155642956|NCT02265744|561782358|FG004|Overall Study|Lack of Efficacy|5|||
155642957|NCT02265744|561782354|FG000|Overall Study|Reason not provided by Investigator|1|||
155310805|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310806|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310807|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310808|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310809|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310810|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310811|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310812|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310813|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
155310814|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
155310815|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
155310816|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310817|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310818|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310819|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310820|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310821|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310822|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310823|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310824|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310825|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310826|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
155310827|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
155310828|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
155310829|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310830|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310831|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310832|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310833|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310834|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310835|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310836|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310837|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310838|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310839|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310840|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310841|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310842|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
155310843|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
155310844|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
155310845|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310846|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310847|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310848|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310849|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310850|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310851|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310852|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310853|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310854|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310855|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310856|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
155310857|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
155310858|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155415700|NCT00430508|560952367|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
155642958|NCT02265744|561782355|FG001|Overall Study|Reason not provided by Investigator|0|||
155642959|NCT02265744|561782356|FG002|Overall Study|Reason not provided by Investigator|0|||
155642960|NCT02265744|561782357|FG003|Overall Study|Reason not provided by Investigator|2|||
155642961|NCT02265744|561782358|FG004|Overall Study|Reason not provided by Investigator|0|||
155642962|NCT02265744|561782354|FG000|Overall Study|Administrative reason by sponsor|3|||
155642963|NCT02265744|561782355|FG001|Overall Study|Administrative reason by sponsor|2|||
155642964|NCT02265744|561782356|FG002|Overall Study|Administrative reason by sponsor|2|||
155310859|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310860|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310861|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310862|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310863|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310864|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310865|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310866|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310867|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310868|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310869|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310870|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310871|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310872|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310873|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310874|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310875|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
155310876|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
155310877|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
155310878|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
155310879|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
155310880|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
155310881|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
155310882|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
155310883|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
155310884|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
155310885|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
155310886|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
155310887|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
155310888|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310889|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310890|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310891|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310892|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155750160|NCT04393298|562185329|FG011|Overall Study|Lack of Efficacy|0|||
155310893|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310894|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
155750161|NCT04393298|562185330|FG012|Overall Study|Lack of Efficacy|0|||
155750162|NCT04393298|562185331|FG013|Overall Study|Lack of Efficacy|0|||
155310895|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
155310896|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
155310897|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310898|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310899|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155750163|NCT04393298|562185332|FG014|Overall Study|Lack of Efficacy|1|||
155750164|NCT04393298|562185318|FG000|Overall Study|Progression|1|||
155750165|NCT04393298|562185319|FG001|Overall Study|Progression|0|||
155750166|NCT04393298|562185320|FG002|Overall Study|Progression|0|||
155750167|NCT04393298|562185321|FG003|Overall Study|Progression|0|||
155310900|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310901|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310902|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310903|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310904|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310905|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310906|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310907|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
155310908|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
155310909|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
155310910|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310911|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310912|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310913|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310914|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310915|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155750168|NCT04393298|562185322|FG004|Overall Study|Progression|0|||
155750169|NCT04393298|562185323|FG005|Overall Study|Progression|0|||
155750170|NCT04393298|562185324|FG006|Overall Study|Progression|0|||
155750171|NCT04393298|562185325|FG007|Overall Study|Progression|0|||
155750172|NCT04393298|562185326|FG008|Overall Study|Progression|0|||
155310916|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310917|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310918|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310919|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310920|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
155310921|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
155310922|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
155310923|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310924|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310925|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310926|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310927|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310928|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310929|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310930|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310931|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310932|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310933|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155498773|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
155310934|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310935|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310936|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
155310937|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
155498774|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
155498775|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
155498776|NCT03611751|561250703|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
155498777|NCT03611751|561250704|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
155498778|NCT03611751|561250705|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
155498779|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
155498780|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
155498781|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
155750173|NCT04393298|562185327|FG009|Overall Study|Progression|0|||
155310938|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
155310939|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
155310940|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310941|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310942|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310943|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310944|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310945|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310946|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310947|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310948|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310949|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
155310950|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310951|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
155310952|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
155310953|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310954|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310955|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310956|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310957|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310958|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310959|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310960|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310961|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155498782|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
155498783|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
155498784|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
155750174|NCT04393298|562185328|FG010|Overall Study|Progression|1|||
155750175|NCT04393298|562185329|FG011|Overall Study|Progression|1|||
155750176|NCT04393298|562185330|FG012|Overall Study|Progression|0|||
155750177|NCT04393298|562185331|FG013|Overall Study|Progression|0|||
155750178|NCT04393298|562185332|FG014|Overall Study|Progression|0|||
155750179|NCT04393298|562185318|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
155750180|NCT04393298|562185319|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750181|NCT04393298|562185320|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750182|NCT04393298|562185321|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
155310962|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
155310963|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
155310964|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
155310965|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
155310966|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310967|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310968|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310969|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310970|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310971|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310972|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310973|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310974|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310975|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
155310976|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
155310977|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
155310978|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
155310979|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310980|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310981|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310982|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310983|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310984|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310985|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310986|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310987|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310988|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
155310989|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
155310990|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
155310991|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
155310992|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310993|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310994|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310995|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310996|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310997|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310998|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310999|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155311000|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155311001|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
155311002|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
155311003|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
155311004|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
155311005|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311006|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311007|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311008|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311009|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311010|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311011|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311012|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311013|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311014|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311015|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311016|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311017|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
155311018|NCT01809691|560570591|FG000|Overall Study|Currently on Treatment|192|||
155311019|NCT01809691|560570592|FG001|Overall Study|Currently on Treatment|100|||
155311020|NCT01809691|560570591|FG000|Overall Study|No Protocol Treatment|10|||
155311021|NCT01809691|560570592|FG001|Overall Study|No Protocol Treatment|11|||
155415701|NCT00430508|560952368|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
155642965|NCT02265744|561782357|FG003|Overall Study|Administrative reason by sponsor|3|||
155642966|NCT02265744|561782358|FG004|Overall Study|Administrative reason by sponsor|3|||
155642967|NCT02265744|561782354|FG000|Overall Study|Subject no longer meets study criteria|0|||
155311022|NCT01809691|560570591|FG000|Overall Study|Adverse Event|80|||
155311023|NCT01809691|560570592|FG001|Overall Study|Adverse Event|21|||
155311024|NCT01809691|560570591|FG000|Overall Study|Disease Progression|226|||
155311025|NCT01809691|560570592|FG001|Overall Study|Disease Progression|372|||
155311026|NCT01809691|560570591|FG000|Overall Study|Death|26|||
155311027|NCT01809691|560570592|FG001|Overall Study|Death|13|||
155311028|NCT01809691|560570591|FG000|Overall Study|Participant Refusal|70|||
155311029|NCT01809691|560570592|FG001|Overall Study|Participant Refusal|72|||
155311030|NCT01809691|560570591|FG000|Overall Study|Other, Not Specified|34|||
155311031|NCT01809691|560570592|FG001|Overall Study|Other, Not Specified|52|||
155311032|NCT01580488|560570593|FG000|Overall Study|Withdrawal by Subject|1|||
155311033|NCT03336333|560570594|FG000|Overall Study|Remained on study at time of data cut-off|202|||
155311034|NCT03336333|560570595|FG001|Overall Study|Remained on study at time of data cut-off|219|||
155311035|NCT03336333|560570596|FG002|Overall Study|Remained on study at time of data cut-off|102|||
155311036|NCT03336333|560570594|FG000|Overall Study|Death|14|||
155311037|NCT03336333|560570595|FG001|Overall Study|Death|16|||
155311038|NCT03336333|560570596|FG002|Overall Study|Death|8|||
155311039|NCT03336333|560570594|FG000|Overall Study|Withdrawal by Subject|16|||
155311040|NCT03336333|560570595|FG001|Overall Study|Withdrawal by Subject|5|||
155311041|NCT03336333|560570596|FG002|Overall Study|Withdrawal by Subject|1|||
155311042|NCT03336333|560570594|FG000|Overall Study|Physician Decision|5|||
155311043|NCT03336333|560570595|FG001|Overall Study|Physician Decision|1|||
155311044|NCT03336333|560570596|FG002|Overall Study|Physician Decision|0|||
155311045|NCT03336333|560570594|FG000|Overall Study|Lost to Follow-up|1|||
155311046|NCT03336333|560570595|FG001|Overall Study|Lost to Follow-up|0|||
155311047|NCT03336333|560570596|FG002|Overall Study|Lost to Follow-up|0|||
155311048|NCT03406871|560570600|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
155311049|NCT03406871|560570601|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
155311050|NCT03406871|560570602|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
155311051|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
155311052|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
155311053|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
155311054|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
155311055|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
155311056|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
155311057|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
155311058|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
155311059|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
155311060|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Death|0|||
155311061|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Death|1|||
155311062|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Death|0|||
155311063|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
155311064|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
155311065|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
155311066|NCT02281955|560570603|FG000|Overall Study|Death|1|||
155311067|NCT01748448|560570607|FG000|Treatment Period|Consent withdrawn by subject|1|||
155311068|NCT01748448|560570608|FG001|Treatment Period|Consent withdrawn by subject|0|||
155311069|NCT01748448|560570607|FG000|Treatment Period|Adverse Event|1|||
155311070|NCT01748448|560570608|FG001|Treatment Period|Adverse Event|0|||
155311071|NCT01748448|560570607|FG000|Treatment Period|Personal|0|||
155311072|NCT01748448|560570608|FG001|Treatment Period|Personal|1|||
155311073|NCT03699709|560570609|FG000|Overall Study|Death|1|||
155311074|NCT03699709|560570610|FG001|Overall Study|Death|2|||
155311075|NCT03699709|560570609|FG000|Overall Study|Lost to Follow-up|10|||
155311076|NCT03699709|560570610|FG001|Overall Study|Lost to Follow-up|3|||
155311077|NCT03699709|560570609|FG000|Overall Study|Withdrawal by Subject|5|||
155311078|NCT03699709|560570610|FG001|Overall Study|Withdrawal by Subject|0|||
155311079|NCT03699709|560570609|FG000|Overall Study|incarcerated|1|||
155311080|NCT03699709|560570610|FG001|Overall Study|incarcerated|0|||
155311081|NCT03699709|560570609|FG000|Overall Study|scheduled, but no show|0|||
155311082|NCT03699709|560570610|FG001|Overall Study|scheduled, but no show|1|||
155311083|NCT02907099|560570611|FG000|Overall Study|Adverse Event|1|||
155311084|NCT02907099|560570611|FG000|Overall Study|Withdrawal by Subject|2|||
155311085|NCT02907099|560570611|FG000|Overall Study|Screen Fail|2|||
155311086|NCT03110315|560570612|FG000|Overall Study|Withdrawal by Subject|1|||
155311087|NCT03110315|560570613|FG001|Overall Study|Withdrawal by Subject|0|||
155311088|NCT02992925|560572863|FG000|Cohort 2|Physician Decision|0|||
155311089|NCT02992925|560572864|FG001|Cohort 2|Physician Decision|0|||
155311090|NCT02992925|560572865|FG002|Cohort 2|Physician Decision|1|||
155311091|NCT02992925|560572866|FG003|Cohort 2|Physician Decision|0|||
155311092|NCT02992925|560572863|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
155311093|NCT02992925|560572864|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
155311094|NCT02992925|560572865|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
155311095|NCT02992925|560572866|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
155311096|NCT03175029|560572869|FG000|Overall Study|Withdrawal by Subject|2|||
155311097|NCT03175029|560572870|FG001|Overall Study|Withdrawal by Subject|1|||
155311098|NCT03175029|560572869|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155311099|NCT03175029|560572870|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
155311100|NCT03047928|560572874|FG000|Overall Study|Adverse Event|0|||
155311101|NCT03047928|560572875|FG001|Overall Study|Adverse Event|2|||
155311102|NCT03047928|560572876|FG002|Overall Study|Adverse Event|0|||
155311103|NCT03047928|560572874|FG000|Overall Study|Protocol Violation|0|||
155311104|NCT03047928|560572875|FG001|Overall Study|Protocol Violation|1|||
155311105|NCT03047928|560572876|FG002|Overall Study|Protocol Violation|0|||
155311106|NCT03047928|560572874|FG000|Overall Study|included in another protocol|0|||
155311107|NCT03047928|560572875|FG001|Overall Study|included in another protocol|1|||
155311108|NCT03047928|560572876|FG002|Overall Study|included in another protocol|0|||
155311109|NCT04034251|560572877|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
155311110|NCT04034251|560572878|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
155311111|NCT04034251|560572879|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
155311112|NCT04950660|560572880|FG000|Overall Study|Protocol Violation|4|||
155311113|NCT04950660|560572881|FG001|Overall Study|Protocol Violation|2|||
155311114|NCT04950660|560572880|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
155311115|NCT04950660|560572881|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
155311116|NCT04950660|560572880|FG000|Overall Study|Withdrawal by Subject|0|||
155311117|NCT04950660|560572881|FG001|Overall Study|Withdrawal by Subject|1|||
155311118|NCT04950660|560572880|FG000|Overall Study|Hypotension|1|||
155311119|NCT04950660|560572881|FG001|Overall Study|Hypotension|0|||
155311120|NCT02437318|560572882|FG000|Overall Study|Progressive disease|207|||
155311121|NCT02437318|560572883|FG001|Overall Study|Progressive disease|240|||
155750183|NCT04393298|562185322|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750184|NCT04393298|562185323|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750185|NCT04393298|562185324|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750186|NCT04393298|562185325|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750187|NCT04393298|562185326|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750188|NCT04393298|562185327|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750189|NCT04393298|562185328|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750190|NCT04393298|562185329|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750191|NCT04393298|562185330|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
155311122|NCT02437318|560572882|FG000|Overall Study|Subject/guardian decision|24|||
155311123|NCT02437318|560572883|FG001|Overall Study|Subject/guardian decision|11|||
155311124|NCT02437318|560572882|FG000|Overall Study|Physician Decision|29|||
155311125|NCT02437318|560572883|FG001|Overall Study|Physician Decision|22|||
155311126|NCT02437318|560572882|FG000|Overall Study|Adverse Event|14|||
155311127|NCT02437318|560572883|FG001|Overall Study|Adverse Event|4|||
155311128|NCT02437318|560572882|FG000|Overall Study|Death|4|||
155311129|NCT02437318|560572883|FG001|Overall Study|Death|4|||
155311130|NCT02437318|560572882|FG000|Overall Study|Protocol deviation|5|||
155311131|NCT02437318|560572883|FG001|Overall Study|Protocol deviation|7|||
155311132|NCT02437318|560572882|FG000|Overall Study|Sponsor decision|1|||
155311133|NCT02437318|560572883|FG001|Overall Study|Sponsor decision|0|||
155311134|NCT05273749|560572885|FG000|Overall Study|Adverse Event|14|||
155311135|NCT05273749|560572886|FG001|Overall Study|Adverse Event|8|||
155311136|NCT05273749|560572885|FG000|Overall Study|Lack of Efficacy|2|||
155311137|NCT05273749|560572886|FG001|Overall Study|Lack of Efficacy|8|||
155311138|NCT05273749|560572885|FG000|Overall Study|Physician Decision|0|||
155311139|NCT05273749|560572886|FG001|Overall Study|Physician Decision|2|||
155311140|NCT05273749|560572885|FG000|Overall Study|Withdrawal by Subject|14|||
155311141|NCT05273749|560572886|FG001|Overall Study|Withdrawal by Subject|16|||
155311142|NCT05273749|560572885|FG000|Overall Study|Lost to Follow-up|10|||
155311143|NCT05273749|560572886|FG001|Overall Study|Lost to Follow-up|10|||
155311144|NCT05273749|560572885|FG000|Overall Study|Pregnancy|1|||
155311145|NCT05273749|560572886|FG001|Overall Study|Pregnancy|0|||
155311146|NCT05273749|560572885|FG000|Overall Study|Non-Compliance|3|||
155311147|NCT05273749|560572886|FG001|Overall Study|Non-Compliance|2|||
155311148|NCT05273749|560572885|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
155311149|NCT05273749|560572886|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
155311150|NCT03281291|560572887|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
155750192|NCT04393298|562185331|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
155750193|NCT04393298|562185332|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
155311151|NCT03281291|560572888|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
155311152|NCT03281291|560572889|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
155311153|NCT03281291|560572890|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
155311154|NCT03281291|560572891|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
155311155|NCT03281291|560572887|FG000|Overall Study|Protocol Deviation|2|||
155311156|NCT03281291|560572888|FG001|Overall Study|Protocol Deviation|0|||
155311157|NCT03281291|560572889|FG002|Overall Study|Protocol Deviation|1|||
155311158|NCT03281291|560572890|FG003|Overall Study|Protocol Deviation|2|||
155311159|NCT03281291|560572891|FG004|Overall Study|Protocol Deviation|1|||
155311160|NCT03281291|560572887|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
155311161|NCT03281291|560572888|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155311162|NCT03281291|560572889|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
155311163|NCT03281291|560572890|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155311164|NCT03281291|560572891|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
155311165|NCT03281291|560572887|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
155311166|NCT03281291|560572888|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
155311167|NCT03281291|560572889|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
155311168|NCT03281291|560572890|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
155311169|NCT03281291|560572891|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
155311170|NCT03281291|560572887|FG000|Overall Study|Lost to Follow-up|10|||
155311171|NCT03281291|560572888|FG001|Overall Study|Lost to Follow-up|10|||
155311172|NCT03281291|560572889|FG002|Overall Study|Lost to Follow-up|4|||
155311173|NCT03281291|560572890|FG003|Overall Study|Lost to Follow-up|6|||
155311174|NCT03281291|560572891|FG004|Overall Study|Lost to Follow-up|10|||
155311175|NCT03281291|560572887|FG000|Overall Study|Other|0|||
155311176|NCT03281291|560572888|FG001|Overall Study|Other|2|||
155311177|NCT03281291|560572889|FG002|Overall Study|Other|0|||
155311178|NCT03281291|560572890|FG003|Overall Study|Other|2|||
155311179|NCT03281291|560572891|FG004|Overall Study|Other|1|||
155311180|NCT04956861|560572892|FG000|Overall Study|Withdrawal by Subject|4|||
155311181|NCT04956861|560572893|FG001|Overall Study|Withdrawal by Subject|4|||
155311182|NCT04956861|560572894|FG002|Overall Study|Withdrawal by Subject|2|||
155311183|NCT04956861|560572892|FG000|Overall Study|Physician Decision|4|||
155311184|NCT04956861|560572893|FG001|Overall Study|Physician Decision|5|||
155311185|NCT04956861|560572894|FG002|Overall Study|Physician Decision|1|||
155311186|NCT02530671|560572895|FG000|Overall Study|Lost to Follow-up|2|||
155642968|NCT02265744|561782355|FG001|Overall Study|Subject no longer meets study criteria|0|||
155642969|NCT02265744|561782356|FG002|Overall Study|Subject no longer meets study criteria|0|||
155642970|NCT02265744|561782357|FG003|Overall Study|Subject no longer meets study criteria|0|||
155642971|NCT02265744|561782358|FG004|Overall Study|Subject no longer meets study criteria|1|||
155642972|NCT02265744|561782354|FG000|Overall Study|Pregnancy|1|||
155642973|NCT02265744|561782355|FG001|Overall Study|Pregnancy|2|||
155642974|NCT02265744|561782356|FG002|Overall Study|Pregnancy|1|||
155642975|NCT02265744|561782357|FG003|Overall Study|Pregnancy|1|||
155642976|NCT02265744|561782358|FG004|Overall Study|Pregnancy|0|||
155642977|NCT00574951|561782359|FG000|Overall Study|Ineligible - improper prior treatment|1|||
155642978|NCT00923702|561782360|FG000|Overall Study|Ongoing enrollment|0|||
155642979|NCT00923702|561782361|FG001|Overall Study|Ongoing enrollment|0|||
155642980|NCT00923702|561782362|FG002|Overall Study|Ongoing enrollment|0|||
155642981|NCT00923702|561782363|FG003|Overall Study|Ongoing enrollment|0|||
155642982|NCT00923702|561782364|FG004|Overall Study|Ongoing enrollment|354|||
155642983|NCT05161936|561782365|FG000|Overall Study|Study terminated by Sponsor|1|||
155642984|NCT05161936|561782366|FG001|Overall Study|Study terminated by Sponsor|0|||
155642985|NCT05161936|561782367|FG002|Overall Study|Study terminated by Sponsor|0|||
155642986|NCT05161936|561782365|FG000|Overall Study|Withdrawal by Subject|0|||
155642987|NCT05161936|561782366|FG001|Overall Study|Withdrawal by Subject|0|||
155642988|NCT05161936|561782367|FG002|Overall Study|Withdrawal by Subject|1|||
155642989|NCT02541903|561782370|FG000|Overall Study|Death|1|||
155642990|NCT02448043|561782371|FG000|Overall Study|Withdrawal by Subject|2|||
155642991|NCT02448043|561782372|FG001|Overall Study|Withdrawal by Subject|2|||
155642992|NCT02448043|561782371|FG000|Overall Study|Protocol Violation|1|||
155642993|NCT02448043|561782372|FG001|Overall Study|Protocol Violation|2|||
155642994|NCT00827242|561782374|FG000|Overall Study|Withdrawal by Subject|2|||
155642995|NCT00827242|561782375|FG001|Overall Study|Withdrawal by Subject|4|||
155642996|NCT00827242|561782374|FG000|Overall Study|Protocol Violation|1|||
155642997|NCT00827242|561782375|FG001|Overall Study|Protocol Violation|3|||
155642998|NCT00827242|561782374|FG000|Overall Study|Lost to Follow-up|0|||
155642999|NCT00827242|561782375|FG001|Overall Study|Lost to Follow-up|3|||
155643000|NCT00827242|561782374|FG000|Overall Study|Adverse Event Excluding Death|2|||
155643001|NCT00827242|561782375|FG001|Overall Study|Adverse Event Excluding Death|1|||
155643002|NCT00827242|561782374|FG000|Overall Study|Entry Criteria Not Met|4|||
155643003|NCT00827242|561782375|FG001|Overall Study|Entry Criteria Not Met|1|||
155643004|NCT00827242|561782374|FG000|Overall Study|Physician Decision|2|||
155643005|NCT00827242|561782375|FG001|Overall Study|Physician Decision|0|||
155643006|NCT00827242|561782374|FG000|Overall Study|Death|1|||
155643007|NCT00827242|561782375|FG001|Overall Study|Death|0|||
155311187|NCT02530671|560572896|FG001|Overall Study|Lost to Follow-up|0|||
155311188|NCT02530671|560572895|FG000|Overall Study|Withdrawal by Subject|1|||
155311189|NCT02530671|560572896|FG001|Overall Study|Withdrawal by Subject|0|||
155311190|NCT02736409|560572902|FG000|Overall Study|Withdrawal by Subject|4|||
155311191|NCT02736409|560572903|FG001|Overall Study|Withdrawal by Subject|2|||
155311192|NCT02736409|560572904|FG002|Overall Study|Withdrawal by Subject|17|||
155311193|NCT02736409|560572905|FG003|Overall Study|Withdrawal by Subject|3|||
155311194|NCT02736409|560572902|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155311195|NCT02736409|560572903|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155311196|NCT02736409|560572904|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155311197|NCT02736409|560572905|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155311198|NCT02736409|560572902|FG000|Overall Study|Adverse Event|0|||
155311199|NCT02736409|560572903|FG001|Overall Study|Adverse Event|1|||
155311200|NCT02736409|560572904|FG002|Overall Study|Adverse Event|5|||
155311201|NCT02736409|560572905|FG003|Overall Study|Adverse Event|4|||
155311202|NCT02736409|560572902|FG000|Overall Study|Other|0|||
155311203|NCT02736409|560572903|FG001|Overall Study|Other|0|||
155311204|NCT02736409|560572904|FG002|Overall Study|Other|1|||
155311205|NCT02736409|560572905|FG003|Overall Study|Other|1|||
155311206|NCT02736409|560572902|FG000|Overall Study|Pregnancy|0|||
155311207|NCT02736409|560572903|FG001|Overall Study|Pregnancy|0|||
155311208|NCT02736409|560572904|FG002|Overall Study|Pregnancy|1|||
155311209|NCT02736409|560572905|FG003|Overall Study|Pregnancy|0|||
155311210|NCT02736409|560572902|FG000|Overall Study|Lost to Follow-up|0|||
155311211|NCT02736409|560572903|FG001|Overall Study|Lost to Follow-up|0|||
155311212|NCT02736409|560572904|FG002|Overall Study|Lost to Follow-up|2|||
155311213|NCT02736409|560572905|FG003|Overall Study|Lost to Follow-up|1|||
155311214|NCT02736409|560572902|FG000|Overall Study|Physician Decision|0|||
155311215|NCT02736409|560572903|FG001|Overall Study|Physician Decision|0|||
155311216|NCT02736409|560572904|FG002|Overall Study|Physician Decision|0|||
155311217|NCT02736409|560572905|FG003|Overall Study|Physician Decision|2|||
155311218|NCT01415154|560572906|FG000|Overall Study|Lack of Efficacy|4|||
155311219|NCT01415154|560572907|FG001|Overall Study|Lack of Efficacy|5|||
155311220|NCT01415154|560572906|FG000|Overall Study|Withdrawal by Subject|7|||
155311221|NCT01415154|560572907|FG001|Overall Study|Withdrawal by Subject|8|||
155311222|NCT01415154|560572906|FG000|Overall Study|Lost to Follow-up|1|||
155311223|NCT01415154|560572907|FG001|Overall Study|Lost to Follow-up|4|||
155311224|NCT01415154|560572906|FG000|Overall Study|Protocol Violation|0|||
155311225|NCT01415154|560572907|FG001|Overall Study|Protocol Violation|1|||
155311226|NCT01415154|560572906|FG000|Overall Study|Satisfactory Response|0|||
155311227|NCT01415154|560572907|FG001|Overall Study|Satisfactory Response|1|||
155311228|NCT01415154|560572906|FG000|Overall Study|Adverse Event|1|||
155311229|NCT01415154|560572907|FG001|Overall Study|Adverse Event|1|||
155311230|NCT03126019|560572909|FG000|Overall Study|Death|5|||
155311231|NCT03126019|560572910|FG001|Overall Study|Death|27|||
155311232|NCT03126019|560572909|FG000|Overall Study|Lost to Follow-up|2|||
155311233|NCT03126019|560572910|FG001|Overall Study|Lost to Follow-up|4|||
155311234|NCT03126019|560572909|FG000|Overall Study|Withdrawal by Subject|1|||
155311235|NCT03126019|560572910|FG001|Overall Study|Withdrawal by Subject|9|||
155415702|NCT00430508|560952369|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
155415703|NCT00430508|560952366|FG000|Overall Study|Other|1|||
155643008|NCT00827242|561782374|FG000|Overall Study|Lack of Efficacy|1|||
155643009|NCT00827242|561782375|FG001|Overall Study|Lack of Efficacy|0|||
155643010|NCT05762679|561782376|FG000|Overall Study|Withdrawal by Subject|1|||
155643011|NCT05762679|561782376|FG000|Overall Study|No analyzable imaging data|1|||
155643012|NCT01944774|561782381|FG000|Overall Study|Withdrawal by Subject|2|||
155643013|NCT01944774|561782382|FG001|Overall Study|Withdrawal by Subject|3|||
155643014|NCT01944774|561782383|FG002|Overall Study|Withdrawal by Subject|3|||
155643015|NCT01944774|561782381|FG000|Overall Study|Adverse Event|3|||
155643016|NCT01944774|561782382|FG001|Overall Study|Adverse Event|2|||
155643017|NCT01944774|561782383|FG002|Overall Study|Adverse Event|3|||
155643018|NCT01944774|561782381|FG000|Overall Study|Lack of Efficacy|1|||
155643019|NCT01944774|561782382|FG001|Overall Study|Lack of Efficacy|2|||
155643020|NCT01944774|561782383|FG002|Overall Study|Lack of Efficacy|2|||
155643021|NCT01944774|561782381|FG000|Overall Study|Lost to Follow-up|0|||
155643022|NCT01944774|561782382|FG001|Overall Study|Lost to Follow-up|1|||
155643023|NCT01944774|561782383|FG002|Overall Study|Lost to Follow-up|0|||
155643024|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
155643025|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
155750194|NCT04393298|562185318|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155311236|NCT03126019|560572909|FG000|Overall Study|Physician Decision|1|||
155311237|NCT03126019|560572910|FG001|Overall Study|Physician Decision|0|||
155311238|NCT03126019|560572909|FG000|Overall Study|Transitioned to Rollover Study|0|||
155311239|NCT03126019|560572910|FG001|Overall Study|Transitioned to Rollover Study|11|||
155643026|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
155643027|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
155643028|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
155643029|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
155750195|NCT04393298|562185319|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
155750196|NCT04393298|562185320|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155415704|NCT00430508|560952367|FG001|Overall Study|Other|1|||
155415705|NCT00430508|560952368|FG002|Overall Study|Other|3|||
155415706|NCT00430508|560952369|FG003|Overall Study|Other|0|||
155415707|NCT01164722|560952370|FG000|Overall Study|Adverse Event|0|||
155415708|NCT01164722|560952371|FG001|Overall Study|Adverse Event|1|||
155415709|NCT01164722|560952370|FG000|Overall Study|Withdrawal by Subject|3|||
155415710|NCT01164722|560952371|FG001|Overall Study|Withdrawal by Subject|4|||
155415711|NCT01164722|560952370|FG000|Overall Study|Lost to Follow-up|3|||
155415712|NCT01164722|560952371|FG001|Overall Study|Lost to Follow-up|6|||
155415713|NCT01164722|560952370|FG000|Overall Study|met protocol criteria for non-treatment|11|||
155415714|NCT01164722|560952371|FG001|Overall Study|met protocol criteria for non-treatment|1|||
155415715|NCT01164722|560952370|FG000|Overall Study|enrolled on other study, concomitant med|1|||
155415716|NCT01164722|560952371|FG001|Overall Study|enrolled on other study, concomitant med|3|||
155415717|NCT03889639|560952372|FG000|Overall Study|Withdrawal by Subject|0|||
155415718|NCT03889639|560952373|FG001|Overall Study|Withdrawal by Subject|0|||
155415719|NCT03889639|560952374|FG002|Overall Study|Withdrawal by Subject|0|||
155415720|NCT03889639|560952375|FG003|Overall Study|Withdrawal by Subject|0|||
155415721|NCT03889639|560952376|FG004|Overall Study|Withdrawal by Subject|0|||
155415722|NCT03889639|560952377|FG005|Overall Study|Withdrawal by Subject|0|||
155415723|NCT03889639|560952378|FG006|Overall Study|Withdrawal by Subject|0|||
155415724|NCT03889639|560952379|FG007|Overall Study|Withdrawal by Subject|1|||
155415725|NCT01703858|560952380|FG000|Overall Study|Withdrawal by Subject|0|||
155415726|NCT01703858|560952381|FG001|Overall Study|Withdrawal by Subject|1|||
155415727|NCT01703858|560952382|FG002|Overall Study|Withdrawal by Subject|0|||
155415728|NCT00993031|560952383|FG000|Overall Study|Death|0|||
155415729|NCT00993031|560952384|FG001|Overall Study|Death|1|||
155415730|NCT00993031|560952383|FG000|Overall Study|Physician Decision|0|||
155415731|NCT00993031|560952384|FG001|Overall Study|Physician Decision|2|||
155415732|NCT00993031|560952383|FG000|Overall Study|Withdrawal by Subject|3|||
155415733|NCT00993031|560952384|FG001|Overall Study|Withdrawal by Subject|3|||
155415734|NCT00993031|560952383|FG000|Overall Study|Lost to Follow-up|19|||
155415735|NCT00993031|560952384|FG001|Overall Study|Lost to Follow-up|13|||
155415736|NCT01834729|560952387|FG000|Overall Study|Did not return bowel diaries|0|||
155415737|NCT01834729|560952388|FG001|Overall Study|Did not return bowel diaries|0|||
155415738|NCT01834729|560952389|FG002|Overall Study|Did not return bowel diaries|3|||
155415739|NCT01834729|560952390|FG003|Overall Study|Did not return bowel diaries|0|||
155415740|NCT01834729|560952387|FG000|Overall Study|Withdrawal by Subject|1|||
155415741|NCT01834729|560952388|FG001|Overall Study|Withdrawal by Subject|1|||
155415742|NCT01834729|560952389|FG002|Overall Study|Withdrawal by Subject|0|||
155415743|NCT01834729|560952390|FG003|Overall Study|Withdrawal by Subject|0|||
155415744|NCT01834729|560952387|FG000|Overall Study|Adverse Event|0|||
155415745|NCT01834729|560952388|FG001|Overall Study|Adverse Event|0|||
155415746|NCT01834729|560952389|FG002|Overall Study|Adverse Event|0|||
155415747|NCT01834729|560952390|FG003|Overall Study|Adverse Event|2|||
155415748|NCT03403192|560952391|FG000|Overall Study|Lost to Follow-up|1|||
155415749|NCT03403192|560952392|FG001|Overall Study|Lost to Follow-up|2|||
155415750|NCT03403192|560952393|FG002|Overall Study|Lost to Follow-up|0|||
155415751|NCT03403192|560952394|FG003|Overall Study|Lost to Follow-up|0|||
155415752|NCT03403192|560952391|FG000|Overall Study|Unable to respond|0|||
155415753|NCT03403192|560952392|FG001|Overall Study|Unable to respond|1|||
155415754|NCT03403192|560952393|FG002|Overall Study|Unable to respond|0|||
155415755|NCT03403192|560952394|FG003|Overall Study|Unable to respond|0|||
155415756|NCT03403192|560952391|FG000|Overall Study|Incomplete|3|||
155415757|NCT03403192|560952392|FG001|Overall Study|Incomplete|1|||
155415758|NCT03403192|560952393|FG002|Overall Study|Incomplete|3|||
155415759|NCT03403192|560952394|FG003|Overall Study|Incomplete|6|||
155750197|NCT04393298|562185321|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750198|NCT04393298|562185322|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750199|NCT04393298|562185323|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750200|NCT04393298|562185324|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750201|NCT04393298|562185325|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750202|NCT04393298|562185326|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750203|NCT04393298|562185327|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750204|NCT04393298|562185328|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750205|NCT04393298|562185329|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750206|NCT04393298|562185330|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750207|NCT04393298|562185331|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750208|NCT04393298|562185332|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155750209|NCT04393298|562185318|FG000|Overall Study|Clinical Progression|0|||
155750210|NCT04393298|562185319|FG001|Overall Study|Clinical Progression|2|||
155415760|NCT02340663|560952396|FG000|Overall Study|Lost to Follow-up|1|||
155415761|NCT02340663|560952397|FG001|Overall Study|Lost to Follow-up|0|||
155415762|NCT02340663|560952396|FG000|Overall Study|Protocol Violation|1|||
155415763|NCT02340663|560952397|FG001|Overall Study|Protocol Violation|0|||
155415764|NCT02340663|560952396|FG000|Overall Study|Withdrawal by Subject|3|||
155415765|NCT02340663|560952397|FG001|Overall Study|Withdrawal by Subject|1|||
155415766|NCT01353703|560952398|FG000|Overall Study|Migrated/moved from study area|1|||
155415767|NCT01353703|560952399|FG001|Overall Study|Migrated/moved from study area|0|||
155415768|NCT03033875|560952400|FG000|Overall Study|Withdrawal by Subject|5|||
155415769|NCT03033875|560952401|FG001|Overall Study|Withdrawal by Subject|9|||
155415770|NCT03033875|560952402|FG002|Overall Study|Withdrawal by Subject|4|||
155415771|NCT03033875|560952400|FG000|Overall Study|Other|14|||
155415772|NCT03033875|560952401|FG001|Overall Study|Other|15|||
155415773|NCT03033875|560952402|FG002|Overall Study|Other|8|||
155415774|NCT01928381|560952412|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
155415775|NCT01928381|560952413|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155415776|NCT01928381|560952414|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155415777|NCT01928381|560952415|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155311240|NCT03126019|560572909|FG000|Overall Study|Did Not Return to Site for Care|0|||
155311241|NCT03126019|560572910|FG001|Overall Study|Did Not Return to Site for Care|1|||
155311242|NCT03126019|560572909|FG000|Overall Study|Site Closed|0|||
155311243|NCT03126019|560572910|FG001|Overall Study|Site Closed|1|||
155311244|NCT00170573|560572914|FG000|Overall Study|Violation of inclusion criteria|13|||
155311245|NCT06283173|560572947|FG000|Overall Study|Did not show for first visit|10|||
155311246|NCT06283173|560572947|FG000|Overall Study|Lost to Follow-up|12|||
155311247|NCT06283173|560572947|FG000|Overall Study|Physician Decision|7|||
155311248|NCT05563246|560572955|FG000|Overall Study|Withdrawal by Subject|1|||
155311249|NCT05563246|560572956|FG001|Overall Study|Withdrawal by Subject|2|||
155311250|NCT05563246|560572957|FG002|Overall Study|Withdrawal by Subject|0|||
155311251|NCT05563246|560572958|FG003|Overall Study|Withdrawal by Subject|0|||
155311252|NCT05563246|560572955|FG000|Overall Study|Protocol Deviation|0|||
155311253|NCT05563246|560572956|FG001|Overall Study|Protocol Deviation|1|||
155311254|NCT05563246|560572957|FG002|Overall Study|Protocol Deviation|0|||
155311255|NCT05563246|560572958|FG003|Overall Study|Protocol Deviation|0|||
155311256|NCT05563246|560572955|FG000|Overall Study|Physician Decision|0|||
155311257|NCT05563246|560572956|FG001|Overall Study|Physician Decision|1|||
155311258|NCT05563246|560572957|FG002|Overall Study|Physician Decision|0|||
155311259|NCT05563246|560572958|FG003|Overall Study|Physician Decision|0|||
155311260|NCT05563246|560572955|FG000|Overall Study|Adverse Event|0|||
155311261|NCT05563246|560572956|FG001|Overall Study|Adverse Event|0|||
155311262|NCT05563246|560572957|FG002|Overall Study|Adverse Event|2|||
155311263|NCT05563246|560572958|FG003|Overall Study|Adverse Event|0|||
155311264|NCT05563246|560572955|FG000|Overall Study|Lost to Follow-up|0|||
155311265|NCT05563246|560572956|FG001|Overall Study|Lost to Follow-up|0|||
155311266|NCT05563246|560572957|FG002|Overall Study|Lost to Follow-up|1|||
155311267|NCT05563246|560572958|FG003|Overall Study|Lost to Follow-up|0|||
155311268|NCT03138512|560572963|FG000|Randomization|Participants withdrew consent|0|||
155311269|NCT03138512|560572964|FG001|Randomization|Participants withdrew consent|1|||
155311270|NCT03138512|560572965|FG002|Randomization|Participants withdrew consent|1|||
155311271|NCT03138512|560572966|FG003|Randomization|Participants withdrew consent|0|||
155311272|NCT03138512|560572967|FG004|Randomization|Participants withdrew consent|0|||
155311273|NCT03138512|560572963|FG000|Randomization|Participant no longer meets study criteria|0|||
155311274|NCT03138512|560572964|FG001|Randomization|Participant no longer meets study criteria|3|||
155311275|NCT03138512|560572965|FG002|Randomization|Participant no longer meets study criteria|1|||
155311276|NCT03138512|560572966|FG003|Randomization|Participant no longer meets study criteria|1|||
155311277|NCT03138512|560572967|FG004|Randomization|Participant no longer meets study criteria|3|||
155311278|NCT03138512|560572963|FG000|Randomization|Other reasons|1|||
155311279|NCT03138512|560572964|FG001|Randomization|Other reasons|0|||
155311280|NCT03138512|560572965|FG002|Randomization|Other reasons|0|||
155311281|NCT03138512|560572966|FG003|Randomization|Other reasons|0|||
155311282|NCT03138512|560572967|FG004|Randomization|Other reasons|0|||
155311283|NCT03138512|560572963|FG000|Treatment Part A|Disease recurrence|10|||
155311284|NCT03138512|560572964|FG001|Treatment Part A|Disease recurrence|20|||
155311285|NCT03138512|560572965|FG002|Treatment Part A|Disease recurrence|0|||
155311286|NCT03138512|560572966|FG003|Treatment Part A|Disease recurrence|0|||
155311287|NCT03138512|560572967|FG004|Treatment Part A|Disease recurrence|0|||
155311288|NCT03138512|560572963|FG000|Treatment Part A|Study Drug Toxicity|132|||
155415778|NCT01928381|560952416|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155311289|NCT03138512|560572964|FG001|Treatment Part A|Study Drug Toxicity|5|||
155311290|NCT03138512|560572965|FG002|Treatment Part A|Study Drug Toxicity|0|||
155311291|NCT03138512|560572966|FG003|Treatment Part A|Study Drug Toxicity|0|||
155415779|NCT01928381|560952417|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155415780|NCT01928381|560952418|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
155415781|NCT01928381|560952412|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
155415782|NCT01928381|560952413|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
155415783|NCT01928381|560952414|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
155415784|NCT01928381|560952415|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
155415785|NCT01928381|560952416|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
155415786|NCT01928381|560952417|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
155415787|NCT01928381|560952418|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
155415788|NCT01928381|560952412|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
155415789|NCT01928381|560952413|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415790|NCT01928381|560952414|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415791|NCT01928381|560952415|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415792|NCT01928381|560952416|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415793|NCT01928381|560952417|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415794|NCT01928381|560952418|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
155415795|NCT01928381|560952412|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
155415796|NCT01928381|560952413|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
155415797|NCT01928381|560952414|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
155415798|NCT01928381|560952415|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
155415799|NCT01928381|560952416|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
155415800|NCT01928381|560952417|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
155415801|NCT01928381|560952418|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
155415802|NCT01928381|560952412|FG000|Part 1 - Pain Training|Protocol Violation|1|||
155415803|NCT01928381|560952413|FG001|Part 1 - Pain Training|Protocol Violation|0|||
155415804|NCT01928381|560952414|FG002|Part 1 - Pain Training|Protocol Violation|0|||
155498785|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
155643030|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
155643031|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
155415805|NCT01928381|560952415|FG003|Part 1 - Pain Training|Protocol Violation|0|||
155750211|NCT04393298|562185320|FG002|Overall Study|Clinical Progression|0|||
155750212|NCT04393298|562185321|FG003|Overall Study|Clinical Progression|0|||
155750213|NCT04393298|562185322|FG004|Overall Study|Clinical Progression|0|||
155750214|NCT04393298|562185323|FG005|Overall Study|Clinical Progression|0|||
155750215|NCT04393298|562185324|FG006|Overall Study|Clinical Progression|0|||
155750216|NCT04393298|562185325|FG007|Overall Study|Clinical Progression|0|||
155750217|NCT04393298|562185326|FG008|Overall Study|Clinical Progression|0|||
155750218|NCT04393298|562185327|FG009|Overall Study|Clinical Progression|0|||
155750219|NCT04393298|562185328|FG010|Overall Study|Clinical Progression|0|||
155750220|NCT04393298|562185329|FG011|Overall Study|Clinical Progression|0|||
155750221|NCT04393298|562185330|FG012|Overall Study|Clinical Progression|0|||
155750222|NCT04393298|562185331|FG013|Overall Study|Clinical Progression|0|||
155750223|NCT04393298|562185332|FG014|Overall Study|Clinical Progression|0|||
155750224|NCT04393298|562185318|FG000|Overall Study|Disease Progression|0|||
155750225|NCT04393298|562185319|FG001|Overall Study|Disease Progression|1|||
155750226|NCT04393298|562185320|FG002|Overall Study|Disease Progression|0|||
155750227|NCT04393298|562185321|FG003|Overall Study|Disease Progression|0|||
155750228|NCT04393298|562185322|FG004|Overall Study|Disease Progression|0|||
155750229|NCT04393298|562185323|FG005|Overall Study|Disease Progression|3|||
155750230|NCT04393298|562185324|FG006|Overall Study|Disease Progression|2|||
155750231|NCT04393298|562185325|FG007|Overall Study|Disease Progression|1|||
155750232|NCT04393298|562185326|FG008|Overall Study|Disease Progression|2|||
155750233|NCT04393298|562185327|FG009|Overall Study|Disease Progression|1|||
155750234|NCT04393298|562185328|FG010|Overall Study|Disease Progression|0|||
155750235|NCT04393298|562185329|FG011|Overall Study|Disease Progression|3|||
155750236|NCT04393298|562185330|FG012|Overall Study|Disease Progression|0|||
155750237|NCT04393298|562185331|FG013|Overall Study|Disease Progression|0|||
155750238|NCT04393298|562185332|FG014|Overall Study|Disease Progression|1|||
155750239|NCT04393298|562185318|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750240|NCT04393298|562185319|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750241|NCT04393298|562185320|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
155750242|NCT04393298|562185321|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750243|NCT04393298|562185322|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750244|NCT04393298|562185323|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750245|NCT04393298|562185324|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750246|NCT04393298|562185325|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750247|NCT04393298|562185326|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750248|NCT04393298|562185327|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750249|NCT04393298|562185328|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750250|NCT04393298|562185329|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750251|NCT04393298|562185330|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750252|NCT04393298|562185331|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750253|NCT04393298|562185332|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155750254|NCT04393298|562185318|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750255|NCT04393298|562185319|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750256|NCT04393298|562185320|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
155750257|NCT04393298|562185321|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750258|NCT04393298|562185322|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750259|NCT04393298|562185323|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750260|NCT04393298|562185324|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750261|NCT04393298|562185325|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750262|NCT04393298|562185326|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750263|NCT04393298|562185327|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750264|NCT04393298|562185328|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750265|NCT04393298|562185329|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750266|NCT04393298|562185330|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750267|NCT04393298|562185331|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750268|NCT04393298|562185332|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
155750269|NCT04393298|562185318|FG000|Overall Study|Progressive Disease (PD)|0|||
155750270|NCT04393298|562185319|FG001|Overall Study|Progressive Disease (PD)|0|||
155750271|NCT04393298|562185320|FG002|Overall Study|Progressive Disease (PD)|0|||
155750272|NCT04393298|562185321|FG003|Overall Study|Progressive Disease (PD)|3|||
155750273|NCT04393298|562185322|FG004|Overall Study|Progressive Disease (PD)|0|||
155750274|NCT04393298|562185323|FG005|Overall Study|Progressive Disease (PD)|0|||
155750275|NCT04393298|562185324|FG006|Overall Study|Progressive Disease (PD)|0|||
155750276|NCT04393298|562185325|FG007|Overall Study|Progressive Disease (PD)|0|||
155750277|NCT04393298|562185326|FG008|Overall Study|Progressive Disease (PD)|0|||
155750278|NCT04393298|562185327|FG009|Overall Study|Progressive Disease (PD)|0|||
155750279|NCT04393298|562185328|FG010|Overall Study|Progressive Disease (PD)|0|||
155750280|NCT04393298|562185329|FG011|Overall Study|Progressive Disease (PD)|0|||
155750281|NCT04393298|562185330|FG012|Overall Study|Progressive Disease (PD)|0|||
155750282|NCT04393298|562185331|FG013|Overall Study|Progressive Disease (PD)|0|||
155750283|NCT04393298|562185332|FG014|Overall Study|Progressive Disease (PD)|0|||
155750284|NCT04393298|562185318|FG000|Overall Study|Started a New Cancer Treatment|0|||
155750285|NCT04393298|562185319|FG001|Overall Study|Started a New Cancer Treatment|0|||
155750286|NCT04393298|562185320|FG002|Overall Study|Started a New Cancer Treatment|0|||
155750287|NCT04393298|562185321|FG003|Overall Study|Started a New Cancer Treatment|0|||
155750288|NCT04393298|562185322|FG004|Overall Study|Started a New Cancer Treatment|1|||
155750289|NCT04393298|562185323|FG005|Overall Study|Started a New Cancer Treatment|0|||
155750290|NCT04393298|562185324|FG006|Overall Study|Started a New Cancer Treatment|0|||
155750291|NCT04393298|562185325|FG007|Overall Study|Started a New Cancer Treatment|0|||
155750292|NCT04393298|562185326|FG008|Overall Study|Started a New Cancer Treatment|0|||
155750293|NCT04393298|562185327|FG009|Overall Study|Started a New Cancer Treatment|0|||
155750294|NCT04393298|562185328|FG010|Overall Study|Started a New Cancer Treatment|0|||
155750295|NCT04393298|562185329|FG011|Overall Study|Started a New Cancer Treatment|0|||
155311292|NCT03138512|560572967|FG004|Treatment Part A|Study Drug Toxicity|0|||
155311293|NCT03138512|560572963|FG000|Treatment Part A|Death|1|||
155311294|NCT03138512|560572964|FG001|Treatment Part A|Death|0|||
155311295|NCT03138512|560572965|FG002|Treatment Part A|Death|0|||
155311296|NCT03138512|560572966|FG003|Treatment Part A|Death|0|||
155311297|NCT03138512|560572967|FG004|Treatment Part A|Death|0|||
155311298|NCT03138512|560572963|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
155311299|NCT03138512|560572964|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
155311300|NCT03138512|560572965|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
155311301|NCT03138512|560572966|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
155311302|NCT03138512|560572967|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
155311303|NCT03138512|560572963|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
155311304|NCT03138512|560572964|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
155311305|NCT03138512|560572965|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
155311306|NCT03138512|560572966|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
155311307|NCT03138512|560572967|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
155311308|NCT03138512|560572963|FG000|Treatment Part A|Participant withdrew consent|2|||
155311309|NCT03138512|560572964|FG001|Treatment Part A|Participant withdrew consent|4|||
155311310|NCT03138512|560572965|FG002|Treatment Part A|Participant withdrew consent|0|||
155311311|NCT03138512|560572966|FG003|Treatment Part A|Participant withdrew consent|0|||
155311312|NCT03138512|560572967|FG004|Treatment Part A|Participant withdrew consent|0|||
155750296|NCT04393298|562185330|FG012|Overall Study|Started a New Cancer Treatment|0|||
155750297|NCT04393298|562185331|FG013|Overall Study|Started a New Cancer Treatment|0|||
155750298|NCT04393298|562185332|FG014|Overall Study|Started a New Cancer Treatment|0|||
155750299|NCT04393298|562185318|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155311313|NCT03138512|560572963|FG000|Treatment Part A|Lost to Follow-up|0|||
155311314|NCT03138512|560572964|FG001|Treatment Part A|Lost to Follow-up|1|||
155311315|NCT03138512|560572965|FG002|Treatment Part A|Lost to Follow-up|0|||
155311316|NCT03138512|560572966|FG003|Treatment Part A|Lost to Follow-up|0|||
155311317|NCT03138512|560572967|FG004|Treatment Part A|Lost to Follow-up|0|||
155311318|NCT03138512|560572963|FG000|Treatment Part A|Poor/non-compliance|1|||
155311319|NCT03138512|560572964|FG001|Treatment Part A|Poor/non-compliance|0|||
155750300|NCT04393298|562185319|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155311320|NCT03138512|560572965|FG002|Treatment Part A|Poor/non-compliance|0|||
155311321|NCT03138512|560572966|FG003|Treatment Part A|Poor/non-compliance|0|||
155311322|NCT03138512|560572967|FG004|Treatment Part A|Poor/non-compliance|0|||
155311323|NCT03138512|560572963|FG000|Treatment Part A|Pregnancy|0|||
155311324|NCT03138512|560572964|FG001|Treatment Part A|Pregnancy|1|||
155311325|NCT03138512|560572965|FG002|Treatment Part A|Pregnancy|0|||
155311326|NCT03138512|560572966|FG003|Treatment Part A|Pregnancy|0|||
155311327|NCT03138512|560572967|FG004|Treatment Part A|Pregnancy|0|||
155311328|NCT03138512|560572963|FG000|Treatment Part A|Other reasons|11|||
155311329|NCT03138512|560572964|FG001|Treatment Part A|Other reasons|8|||
155311330|NCT03138512|560572965|FG002|Treatment Part A|Other reasons|0|||
155750301|NCT04393298|562185320|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155311331|NCT03138512|560572966|FG003|Treatment Part A|Other reasons|0|||
155311332|NCT03138512|560572967|FG004|Treatment Part A|Other reasons|0|||
155311333|NCT03138512|560572963|FG000|Treatment Part B|Disease recurrence|0|||
155311334|NCT03138512|560572964|FG001|Treatment Part B|Disease recurrence|0|||
155311335|NCT03138512|560572965|FG002|Treatment Part B|Disease recurrence|6|||
155311336|NCT03138512|560572966|FG003|Treatment Part B|Disease recurrence|12|||
155311337|NCT03138512|560572967|FG004|Treatment Part B|Disease recurrence|10|||
155750302|NCT04393298|562185321|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750303|NCT04393298|562185322|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
155750304|NCT04393298|562185323|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750305|NCT04393298|562185324|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750306|NCT04393298|562185325|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155311338|NCT03138512|560572963|FG000|Treatment Part B|Study drug toxicity|0|||
155311339|NCT03138512|560572964|FG001|Treatment Part B|Study drug toxicity|0|||
155311340|NCT03138512|560572965|FG002|Treatment Part B|Study drug toxicity|63|||
155311341|NCT03138512|560572966|FG003|Treatment Part B|Study drug toxicity|3|||
155311342|NCT03138512|560572967|FG004|Treatment Part B|Study drug toxicity|45|||
155311343|NCT03138512|560572963|FG000|Treatment Part B|Death|0|||
155311344|NCT03138512|560572964|FG001|Treatment Part B|Death|0|||
155311345|NCT03138512|560572965|FG002|Treatment Part B|Death|1|||
155311346|NCT03138512|560572966|FG003|Treatment Part B|Death|0|||
155311347|NCT03138512|560572967|FG004|Treatment Part B|Death|0|||
155311348|NCT03138512|560572963|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
155311349|NCT03138512|560572964|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
155311350|NCT03138512|560572965|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
155311351|NCT03138512|560572966|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
155311352|NCT03138512|560572967|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
155311353|NCT03138512|560572963|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
155311354|NCT03138512|560572964|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
155311355|NCT03138512|560572965|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
155311356|NCT03138512|560572966|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
155311357|NCT03138512|560572967|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
155415806|NCT01928381|560952416|FG004|Part 1 - Pain Training|Protocol Violation|0|||
155415807|NCT01928381|560952417|FG005|Part 1 - Pain Training|Protocol Violation|0|||
155311358|NCT03138512|560572963|FG000|Treatment Part B|Participant withdrew consent|0|||
155311359|NCT03138512|560572964|FG001|Treatment Part B|Participant withdrew consent|0|||
155415808|NCT01928381|560952418|FG006|Part 1 - Pain Training|Protocol Violation|0|||
155750307|NCT04393298|562185326|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750308|NCT04393298|562185327|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750309|NCT04393298|562185328|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750310|NCT04393298|562185329|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750311|NCT04393298|562185330|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750312|NCT04393298|562185331|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750313|NCT04393298|562185332|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155750314|NCT04393298|562185318|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750315|NCT04393298|562185319|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750316|NCT04393298|562185320|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750317|NCT04393298|562185321|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750318|NCT04393298|562185322|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750319|NCT04393298|562185323|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
155750320|NCT04393298|562185324|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750321|NCT04393298|562185325|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750322|NCT04393298|562185326|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750323|NCT04393298|562185327|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750324|NCT04393298|562185328|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750325|NCT04393298|562185329|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750326|NCT04393298|562185330|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750327|NCT04393298|562185331|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750328|NCT04393298|562185332|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155750329|NCT04393298|562185318|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750330|NCT04393298|562185319|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750331|NCT04393298|562185320|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750332|NCT04393298|562185321|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750333|NCT04393298|562185322|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750334|NCT04393298|562185323|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
155750335|NCT04393298|562185324|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750336|NCT04393298|562185325|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750337|NCT04393298|562185326|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750338|NCT04393298|562185327|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750339|NCT04393298|562185328|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750340|NCT04393298|562185329|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750341|NCT04393298|562185330|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750342|NCT04393298|562185331|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155750343|NCT04393298|562185332|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
155750344|NCT04393298|562185318|FG000|Overall Study|Death|0|||
155750345|NCT04393298|562185319|FG001|Overall Study|Death|0|||
155750346|NCT04393298|562185320|FG002|Overall Study|Death|0|||
155311360|NCT03138512|560572965|FG002|Treatment Part B|Participant withdrew consent|1|||
155415809|NCT01928381|560952412|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
155311361|NCT03138512|560572966|FG003|Treatment Part B|Participant withdrew consent|1|||
155311362|NCT03138512|560572967|FG004|Treatment Part B|Participant withdrew consent|2|||
155311363|NCT03138512|560572963|FG000|Treatment Part B|Lost to Follow-up|0|||
155311364|NCT03138512|560572964|FG001|Treatment Part B|Lost to Follow-up|0|||
155311365|NCT03138512|560572965|FG002|Treatment Part B|Lost to Follow-up|0|||
155311366|NCT03138512|560572966|FG003|Treatment Part B|Lost to Follow-up|1|||
155311367|NCT03138512|560572967|FG004|Treatment Part B|Lost to Follow-up|0|||
155311368|NCT03138512|560572963|FG000|Treatment Part B|Poor/non-compliance|0|||
155498786|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
155498787|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
155498788|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
155498789|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
155498790|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
155498791|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
155498792|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
155498793|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
155498794|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
155498795|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
155498796|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
155498797|NCT03611751|561250703|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
155498798|NCT03611751|561250704|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
155498799|NCT03611751|561250705|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
155498800|NCT00929864|561250706|FG000|Overall Study|Death|1|||
155498801|NCT00929864|561250707|FG001|Overall Study|Death|1|||
155498802|NCT00929864|561250706|FG000|Overall Study|Adverse Event|11|||
155498803|NCT00929864|561250707|FG001|Overall Study|Adverse Event|30|||
155498804|NCT00929864|561250706|FG000|Overall Study|Lack of Efficacy|19|||
155498805|NCT00929864|561250707|FG001|Overall Study|Lack of Efficacy|16|||
155498806|NCT00929864|561250706|FG000|Overall Study|Lost to Follow-up|7|||
155498807|NCT00929864|561250707|FG001|Overall Study|Lost to Follow-up|12|||
155498808|NCT00929864|561250706|FG000|Overall Study|Withdrawal by Subject|20|||
155498809|NCT00929864|561250707|FG001|Overall Study|Withdrawal by Subject|9|||
155498810|NCT00929864|561250706|FG000|Overall Study|No longer met criteria|2|||
155498811|NCT00929864|561250707|FG001|Overall Study|No longer met criteria|1|||
155498812|NCT00929864|561250706|FG000|Overall Study|Poor or non-compliance|3|||
155498813|NCT00929864|561250707|FG001|Overall Study|Poor or non-compliance|3|||
155498814|NCT00929864|561250706|FG000|Overall Study|Pregnancy|0|||
155498815|NCT00929864|561250707|FG001|Overall Study|Pregnancy|3|||
155498816|NCT00929864|561250706|FG000|Overall Study|Administrative reason by Sponsor|1|||
155498817|NCT00929864|561250707|FG001|Overall Study|Administrative reason by Sponsor|1|||
155498818|NCT00929864|561250706|FG000|Overall Study|Non-specified|2|||
155498819|NCT00929864|561250707|FG001|Overall Study|Non-specified|7|||
155498820|NCT03940742|561250710|FG000|Overall Study|Lost to Follow-up|0|||
155498821|NCT03940742|561250711|FG001|Overall Study|Lost to Follow-up|0|||
155498822|NCT03940742|561250712|FG002|Overall Study|Lost to Follow-up|0|||
155498823|NCT03940742|561250713|FG003|Overall Study|Lost to Follow-up|1|||
155498824|NCT03428217|561250715|FG000|Overall Study|Death|89|||
155498825|NCT03428217|561250716|FG001|Overall Study|Death|93|||
155498826|NCT03428217|561250715|FG000|Overall Study|Withdrawal by Subject|8|||
155498827|NCT03428217|561250716|FG001|Overall Study|Withdrawal by Subject|7|||
155311369|NCT03138512|560572964|FG001|Treatment Part B|Poor/non-compliance|0|||
155311370|NCT03138512|560572965|FG002|Treatment Part B|Poor/non-compliance|1|||
155311371|NCT03138512|560572966|FG003|Treatment Part B|Poor/non-compliance|1|||
155311372|NCT03138512|560572967|FG004|Treatment Part B|Poor/non-compliance|1|||
155311373|NCT03138512|560572963|FG000|Treatment Part B|Other reasons|0|||
155311374|NCT03138512|560572964|FG001|Treatment Part B|Other reasons|0|||
155498828|NCT03428217|561250715|FG000|Overall Study|Lost to Follow-up|1|||
155498829|NCT03428217|561250716|FG001|Overall Study|Lost to Follow-up|3|||
155498830|NCT03428217|561250715|FG000|Overall Study|Study terminated by sponsor|124|||
155498831|NCT03428217|561250716|FG001|Overall Study|Study terminated by sponsor|118|||
155498832|NCT03428217|561250715|FG000|Overall Study|Other, Not Specified|1|||
155498833|NCT03428217|561250716|FG001|Overall Study|Other, Not Specified|0|||
155498834|NCT03889197|561250717|FG000|Overall Study|Withdrawal by Subject|1|||
155498835|NCT03889197|561250718|FG001|Overall Study|Withdrawal by Subject|0|||
155498836|NCT03889197|561250717|FG000|Overall Study|Physician Decision|0|||
155415810|NCT01928381|560952413|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415811|NCT01928381|560952414|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415812|NCT01928381|560952415|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415813|NCT01928381|560952416|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415814|NCT01928381|560952417|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415815|NCT01928381|560952418|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
155415816|NCT01928381|560952412|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
155415817|NCT01928381|560952413|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415818|NCT01928381|560952414|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415819|NCT01928381|560952415|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415820|NCT01928381|560952416|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415821|NCT01928381|560952417|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415822|NCT01928381|560952418|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
155415823|NCT01928381|560952412|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
155415824|NCT01928381|560952413|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415825|NCT01928381|560952414|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415826|NCT01928381|560952415|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415827|NCT01928381|560952416|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415828|NCT01928381|560952417|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415829|NCT01928381|560952418|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
155415830|NCT01928381|560952412|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
155415831|NCT01928381|560952413|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155415832|NCT01928381|560952414|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155415833|NCT01928381|560952415|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155750347|NCT04393298|562185321|FG003|Overall Study|Death|0|||
155750348|NCT04393298|562185322|FG004|Overall Study|Death|0|||
155750349|NCT04393298|562185323|FG005|Overall Study|Death|1|||
155750350|NCT04393298|562185324|FG006|Overall Study|Death|1|||
155750351|NCT04393298|562185325|FG007|Overall Study|Death|0|||
155750352|NCT04393298|562185326|FG008|Overall Study|Death|1|||
155750353|NCT04393298|562185327|FG009|Overall Study|Death|1|||
155750354|NCT04393298|562185328|FG010|Overall Study|Death|0|||
155750355|NCT04393298|562185329|FG011|Overall Study|Death|1|||
155750356|NCT04393298|562185330|FG012|Overall Study|Death|1|||
155750357|NCT04393298|562185331|FG013|Overall Study|Death|0|||
155750358|NCT04393298|562185332|FG014|Overall Study|Death|1|||
155750359|NCT04393298|562185318|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750360|NCT04393298|562185319|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750361|NCT04393298|562185320|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155415834|NCT01928381|560952416|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155498837|NCT03889197|561250718|FG001|Overall Study|Physician Decision|1|||
155750362|NCT04393298|562185321|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750363|NCT04393298|562185322|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155311375|NCT03138512|560572965|FG002|Treatment Part B|Other reasons|3|||
155311376|NCT03138512|560572966|FG003|Treatment Part B|Other reasons|1|||
155415835|NCT01928381|560952417|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155415836|NCT01928381|560952418|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
155415837|NCT01928381|560952412|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415838|NCT01928381|560952413|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415839|NCT01928381|560952414|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
155415840|NCT01928381|560952415|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415841|NCT01928381|560952416|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415842|NCT01928381|560952417|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415843|NCT01928381|560952418|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
155415844|NCT01928381|560952412|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155415845|NCT01928381|560952413|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155311377|NCT03138512|560572967|FG004|Treatment Part B|Other reasons|5|||
155311378|NCT04177823|560572976|FG000|Overall Study|Physician Decision|1|||
155415846|NCT01928381|560952414|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
155415847|NCT01928381|560952415|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155415848|NCT01928381|560952416|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155415849|NCT01928381|560952417|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155415850|NCT01928381|560952418|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
155415851|NCT01928381|560952412|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
155498838|NCT03889197|561250717|FG000|Overall Study|met exclusion criteria|0|||
155311379|NCT04177823|560572976|FG000|Overall Study|Withdrawal by Subject|1|||
155311380|NCT04229992|560572977|FG000|Overall Study|Withdrawal by Subject|0|||
155311381|NCT04229992|560572978|FG001|Overall Study|Withdrawal by Subject|2|||
155311382|NCT04229992|560572979|FG002|Overall Study|Withdrawal by Subject|1|||
155311383|NCT04229992|560572980|FG003|Overall Study|Withdrawal by Subject|1|||
155311384|NCT04229992|560572977|FG000|Overall Study|Adverse Event|1|||
155311385|NCT04229992|560572978|FG001|Overall Study|Adverse Event|1|||
155311386|NCT04229992|560572979|FG002|Overall Study|Adverse Event|3|||
155311387|NCT04229992|560572980|FG003|Overall Study|Adverse Event|1|||
155311388|NCT04229992|560572977|FG000|Overall Study|Lost to Follow-up|0|||
155311389|NCT04229992|560572978|FG001|Overall Study|Lost to Follow-up|0|||
155311390|NCT04229992|560572979|FG002|Overall Study|Lost to Follow-up|0|||
155311391|NCT04229992|560572980|FG003|Overall Study|Lost to Follow-up|1|||
155311392|NCT04169373|560572981|FG000|Week 1 to Week 14|Adverse Event|1|||
155311393|NCT04169373|560572982|FG001|Week 1 to Week 14|Adverse Event|0|||
155311394|NCT04169373|560572983|FG002|Week 1 to Week 14|Adverse Event|1|||
155311395|NCT04169373|560572984|FG003|Week 1 to Week 14|Adverse Event|2|||
155311396|NCT04169373|560572981|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
155311397|NCT04169373|560572982|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
155311398|NCT04169373|560572983|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
155311399|NCT04169373|560572984|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
155311400|NCT04169373|560572981|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
155311401|NCT04169373|560572982|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
155311402|NCT04169373|560572983|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
155311403|NCT04169373|560572984|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
155311404|NCT04169373|560572981|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311405|NCT04169373|560572982|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
155311406|NCT04169373|560572983|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311407|NCT04169373|560572984|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311408|NCT04169373|560572981|FG000|Week 1 to Week 14|Other|1|||
155311409|NCT04169373|560572982|FG001|Week 1 to Week 14|Other|3|||
155311410|NCT04169373|560572983|FG002|Week 1 to Week 14|Other|3|||
155311411|NCT04169373|560572984|FG003|Week 1 to Week 14|Other|5|||
155311412|NCT04169373|560572981|FG000|Week 14 to Week 52|Adverse Event|1|||
155311413|NCT04169373|560572982|FG001|Week 14 to Week 52|Adverse Event|0|||
155311414|NCT04169373|560572983|FG002|Week 14 to Week 52|Adverse Event|0|||
155311415|NCT04169373|560572984|FG003|Week 14 to Week 52|Adverse Event|1|||
155311416|NCT04169373|560572981|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
155311417|NCT04169373|560572982|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
155311418|NCT04169373|560572983|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
155311419|NCT04169373|560572984|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
155311420|NCT04169373|560572981|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
155311421|NCT04169373|560572982|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
155415852|NCT01928381|560952413|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
155415853|NCT01928381|560952414|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
155415854|NCT01928381|560952415|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
155415855|NCT01928381|560952416|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
155415856|NCT01928381|560952417|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
155415857|NCT01928381|560952418|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
155311422|NCT04169373|560572983|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
155311423|NCT04169373|560572984|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
155311424|NCT04169373|560572981|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
155311425|NCT04169373|560572982|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311426|NCT04169373|560572983|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311427|NCT04169373|560572984|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311428|NCT04169373|560572981|FG000|Week 14 to Week 52|Other|4|||
155311429|NCT04169373|560572982|FG001|Week 14 to Week 52|Other|5|||
155311430|NCT04169373|560572983|FG002|Week 14 to Week 52|Other|4|||
155311431|NCT04169373|560572984|FG003|Week 14 to Week 52|Other|5|||
155311432|NCT04169373|560572981|FG000|Week 14 to Week 52|Ongoing|0|||
155311433|NCT04169373|560572982|FG001|Week 14 to Week 52|Ongoing|1|||
155311434|NCT04169373|560572983|FG002|Week 14 to Week 52|Ongoing|0|||
155311435|NCT04169373|560572984|FG003|Week 14 to Week 52|Ongoing|0|||
155311436|NCT04610892|560572985|FG000|Overall Study|Adverse Event|1|||
155311437|NCT04610892|560572986|FG001|Overall Study|Adverse Event|0|||
155311438|NCT04610892|560572987|FG002|Overall Study|Adverse Event|0|||
155311439|NCT04610892|560572988|FG003|Overall Study|Adverse Event|1|||
155311440|NCT04610892|560572989|FG004|Overall Study|Adverse Event|3|||
155311441|NCT04610892|560572985|FG000|Overall Study|Death|0|||
155311442|NCT04610892|560572986|FG001|Overall Study|Death|1|||
155311443|NCT04610892|560572987|FG002|Overall Study|Death|0|||
155750364|NCT04393298|562185323|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
155750365|NCT04393298|562185324|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750366|NCT04393298|562185325|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750367|NCT04393298|562185326|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750368|NCT04393298|562185327|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750369|NCT04393298|562185328|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750370|NCT04393298|562185329|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750371|NCT04393298|562185330|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750372|NCT04393298|562185331|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750373|NCT04393298|562185332|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155750374|NCT04393298|562185318|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
155750375|NCT04393298|562185319|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
155750376|NCT04393298|562185320|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
155750377|NCT04393298|562185321|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
155750378|NCT04393298|562185322|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
155750379|NCT04393298|562185323|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
155750380|NCT04393298|562185324|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
155750381|NCT04393298|562185325|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
155750382|NCT04393298|562185326|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
155750383|NCT04393298|562185327|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
155750384|NCT04393298|562185328|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
155750385|NCT04393298|562185329|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
155750386|NCT04393298|562185330|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
155750387|NCT04393298|562185331|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
155750388|NCT04393298|562185332|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
155750389|NCT04393298|562185318|FG000|Overall Study|Patient Passed Away|0|||
155750390|NCT04393298|562185319|FG001|Overall Study|Patient Passed Away|0|||
155750391|NCT04393298|562185320|FG002|Overall Study|Patient Passed Away|0|||
155750392|NCT04393298|562185321|FG003|Overall Study|Patient Passed Away|0|||
155750393|NCT04393298|562185322|FG004|Overall Study|Patient Passed Away|0|||
155750394|NCT04393298|562185323|FG005|Overall Study|Patient Passed Away|0|||
155750395|NCT04393298|562185324|FG006|Overall Study|Patient Passed Away|0|||
155750396|NCT04393298|562185325|FG007|Overall Study|Patient Passed Away|1|||
155750397|NCT04393298|562185326|FG008|Overall Study|Patient Passed Away|0|||
155750398|NCT04393298|562185327|FG009|Overall Study|Patient Passed Away|0|||
155750399|NCT04393298|562185328|FG010|Overall Study|Patient Passed Away|0|||
155750400|NCT04393298|562185329|FG011|Overall Study|Patient Passed Away|0|||
155750401|NCT04393298|562185330|FG012|Overall Study|Patient Passed Away|0|||
155750402|NCT04393298|562185331|FG013|Overall Study|Patient Passed Away|0|||
155750403|NCT04393298|562185332|FG014|Overall Study|Patient Passed Away|0|||
155750404|NCT04393298|562185318|FG000|Overall Study|Patient Deceased|0|||
155415858|NCT01928381|560952412|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
155415859|NCT01928381|560952413|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
155415860|NCT01928381|560952414|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
155415861|NCT01928381|560952415|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
155415862|NCT01928381|560952416|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
155415863|NCT01928381|560952417|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
155415864|NCT01928381|560952418|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
155415865|NCT01928381|560952412|FG000|Washout First Intervention|Protocol Violation|0|||
155750405|NCT04393298|562185319|FG001|Overall Study|Patient Deceased|0|||
155750406|NCT04393298|562185320|FG002|Overall Study|Patient Deceased|0|||
155750407|NCT04393298|562185321|FG003|Overall Study|Patient Deceased|0|||
155750408|NCT04393298|562185322|FG004|Overall Study|Patient Deceased|0|||
155750409|NCT04393298|562185323|FG005|Overall Study|Patient Deceased|0|||
155750410|NCT04393298|562185324|FG006|Overall Study|Patient Deceased|0|||
155750411|NCT04393298|562185325|FG007|Overall Study|Patient Deceased|1|||
155750412|NCT04393298|562185326|FG008|Overall Study|Patient Deceased|0|||
155750413|NCT04393298|562185327|FG009|Overall Study|Patient Deceased|0|||
155750414|NCT04393298|562185328|FG010|Overall Study|Patient Deceased|0|||
155750415|NCT04393298|562185329|FG011|Overall Study|Patient Deceased|0|||
155750416|NCT04393298|562185330|FG012|Overall Study|Patient Deceased|0|||
155750417|NCT04393298|562185331|FG013|Overall Study|Patient Deceased|0|||
155750418|NCT04393298|562185332|FG014|Overall Study|Patient Deceased|0|||
155750419|NCT04393298|562185318|FG000|Overall Study|Patient Discharged to Hospice|0|||
155750420|NCT04393298|562185319|FG001|Overall Study|Patient Discharged to Hospice|0|||
155750421|NCT04393298|562185320|FG002|Overall Study|Patient Discharged to Hospice|0|||
155750422|NCT04393298|562185321|FG003|Overall Study|Patient Discharged to Hospice|0|||
155750423|NCT04393298|562185322|FG004|Overall Study|Patient Discharged to Hospice|0|||
155750424|NCT04393298|562185323|FG005|Overall Study|Patient Discharged to Hospice|0|||
155750425|NCT04393298|562185324|FG006|Overall Study|Patient Discharged to Hospice|0|||
155750426|NCT04393298|562185325|FG007|Overall Study|Patient Discharged to Hospice|0|||
155750427|NCT04393298|562185326|FG008|Overall Study|Patient Discharged to Hospice|1|||
155643032|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
155415866|NCT01928381|560952413|FG001|Washout First Intervention|Protocol Violation|0|||
155415867|NCT01928381|560952414|FG002|Washout First Intervention|Protocol Violation|0|||
155415868|NCT01928381|560952415|FG003|Washout First Intervention|Protocol Violation|0|||
155415869|NCT01928381|560952416|FG004|Washout First Intervention|Protocol Violation|1|||
155415870|NCT01928381|560952417|FG005|Washout First Intervention|Protocol Violation|0|||
155415871|NCT01928381|560952418|FG006|Washout First Intervention|Protocol Violation|0|||
155415872|NCT01928381|560952412|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
155415873|NCT01928381|560952413|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
155415874|NCT01928381|560952414|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
155415875|NCT01928381|560952415|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
155415876|NCT01928381|560952416|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
155415877|NCT01928381|560952417|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
155415878|NCT01928381|560952418|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
155415879|NCT01928381|560952412|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415880|NCT01928381|560952413|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415881|NCT01928381|560952414|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
155415882|NCT01928381|560952415|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415883|NCT01928381|560952416|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415884|NCT01928381|560952417|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415885|NCT01928381|560952418|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
155415886|NCT04484285|560954644|FG000|Overall Study|Unable to operate stimulator|3|||
155415887|NCT04484285|560954645|FG001|Overall Study|Unable to operate stimulator|0|||
155415888|NCT01227902|560954647|FG000|Overall Study|Adverse Event|12|||
155415889|NCT01227902|560954648|FG001|Overall Study|Adverse Event|8|||
155415890|NCT01227902|560954649|FG002|Overall Study|Adverse Event|11|||
155415891|NCT01227902|560954650|FG003|Overall Study|Adverse Event|4|||
155415892|NCT01227902|560954647|FG000|Overall Study|Lack of Efficacy|1|||
155415893|NCT01227902|560954648|FG001|Overall Study|Lack of Efficacy|2|||
155415894|NCT01227902|560954649|FG002|Overall Study|Lack of Efficacy|2|||
155415895|NCT01227902|560954650|FG003|Overall Study|Lack of Efficacy|1|||
155415896|NCT01227902|560954647|FG000|Overall Study|Protocol Violation|1|||
155415897|NCT01227902|560954648|FG001|Overall Study|Protocol Violation|0|||
155415898|NCT01227902|560954649|FG002|Overall Study|Protocol Violation|0|||
155415899|NCT01227902|560954650|FG003|Overall Study|Protocol Violation|0|||
155415900|NCT01227902|560954647|FG000|Overall Study|Lost to Follow-up|0|||
155415901|NCT01227902|560954648|FG001|Overall Study|Lost to Follow-up|0|||
155415902|NCT01227902|560954649|FG002|Overall Study|Lost to Follow-up|1|||
155415903|NCT01227902|560954650|FG003|Overall Study|Lost to Follow-up|2|||
155415904|NCT01227902|560954647|FG000|Overall Study|Physician Decision|0|||
155415905|NCT01227902|560954648|FG001|Overall Study|Physician Decision|1|||
155415906|NCT01227902|560954649|FG002|Overall Study|Physician Decision|1|||
155415907|NCT01227902|560954650|FG003|Overall Study|Physician Decision|0|||
155415908|NCT01227902|560954647|FG000|Overall Study|Withdrawal by Subject|4|||
155415909|NCT01227902|560954648|FG001|Overall Study|Withdrawal by Subject|2|||
155415910|NCT01227902|560954649|FG002|Overall Study|Withdrawal by Subject|4|||
155415911|NCT01227902|560954650|FG003|Overall Study|Withdrawal by Subject|3|||
155415912|NCT05280756|560954651|FG000|Overall Study|Lost to Follow-up|1|||
155415913|NCT05280756|560954652|FG001|Overall Study|Lost to Follow-up|1|||
155415914|NCT00768898|560954653|FG000|Overall Study|Unrelated injury|1|||
155415915|NCT00768898|560954653|FG000|Overall Study|Headache|1|||
155415916|NCT00542997|560954656|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
155415917|NCT00542997|560954656|FG000|Wash in / Wash Out Period|Adverse Event|3|||
155415918|NCT00542997|560954656|FG000|Efficacy Period|Adverse Event|3|||
155415919|NCT03160560|560954659|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
155415920|NCT03160560|560954660|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155415921|NCT03160560|560954661|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155415922|NCT03160560|560954662|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155415923|NCT03160560|560954659|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
155415924|NCT03160560|560954660|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155643033|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
155643034|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
155643035|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
155643036|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
155415925|NCT03160560|560954661|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155415926|NCT03160560|560954662|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155643037|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
155415927|NCT01777763|560954673|FG000|Overall Study|Adverse Event|2|||
155415928|NCT01777763|560954674|FG001|Overall Study|Adverse Event|32|||
155415929|NCT01777763|560954673|FG000|Overall Study|Protocol Violation|1|||
155415930|NCT01777763|560954674|FG001|Overall Study|Protocol Violation|7|||
155643038|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
155643039|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
155643040|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
155643041|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
155311444|NCT04610892|560572988|FG003|Overall Study|Death|1|||
155311445|NCT04610892|560572989|FG004|Overall Study|Death|0|||
155311446|NCT04610892|560572985|FG000|Overall Study|Withdrawal by Subject|3|||
155311447|NCT04610892|560572986|FG001|Overall Study|Withdrawal by Subject|2|||
155311448|NCT04610892|560572987|FG002|Overall Study|Withdrawal by Subject|0|||
155311449|NCT04610892|560572988|FG003|Overall Study|Withdrawal by Subject|6|||
155311450|NCT04610892|560572989|FG004|Overall Study|Withdrawal by Subject|6|||
155311451|NCT04610892|560572985|FG000|Overall Study|Subjects who did not receive treatment|1|||
155311452|NCT04610892|560572986|FG001|Overall Study|Subjects who did not receive treatment|0|||
155311453|NCT04610892|560572987|FG002|Overall Study|Subjects who did not receive treatment|0|||
155311454|NCT04610892|560572988|FG003|Overall Study|Subjects who did not receive treatment|0|||
155311455|NCT04610892|560572989|FG004|Overall Study|Subjects who did not receive treatment|2|||
155311456|NCT04760678|560572991|FG000|Overall Study|Death|13|||
155311457|NCT04760678|560572991|FG000|Overall Study|Lost to Follow-up|48|||
155311458|NCT04760678|560572991|FG000|Overall Study|Withdrawal by Subject|1|||
155311459|NCT03720795|560572994|FG000|Phase 1|Lost to Follow-up|4|||
155311460|NCT03720795|560572994|FG000|Phase 1|Withdrawal by Subject|6|||
155311461|NCT03720795|560572994|FG000|Phase 1|Protocol Violation|1|||
155311462|NCT03720795|560572994|FG000|Phase 1|Other|1|||
155311463|NCT03720795|560572994|FG000|Phase 2|Lost to Follow-up|5|||
155311464|NCT03720795|560572994|FG000|Phase 2|Withdrawal by Subject|10|||
155311465|NCT03720795|560572994|FG000|Phase 2|Protocol Violation|2|||
155311466|NCT03720795|560572994|FG000|3 Month Follow Up|Lost to Follow-up|2|||
155311467|NCT04322643|560572995|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
155311468|NCT05486078|560572998|FG000|Overall Study|4 drop out and one withdrawn|5|||
155311469|NCT05134233|560572999|FG000|Overall Study|Pregnancy|1|||
155311470|NCT05134233|560572999|FG000|Overall Study|MEP value too low|2|||
155311471|NCT05134233|560572999|FG000|Overall Study|Lost to Follow-up|1|||
155311472|NCT01573442|560573000|FG000|Overall Study|Cancels|9|||
155311473|NCT01573442|560573001|FG001|Overall Study|Cancels|10|||
155311474|NCT04763265|560573007|FG000|Overall Study|Adverse Event|1|||
155311475|NCT04763265|560573008|FG001|Overall Study|Adverse Event|0|||
155311476|NCT04763265|560573007|FG000|Overall Study|Lost to Follow-up|2|||
155311477|NCT04763265|560573008|FG001|Overall Study|Lost to Follow-up|4|||
155311478|NCT04763265|560573007|FG000|Overall Study|Withdrawal by Subject|0|||
155311479|NCT04763265|560573008|FG001|Overall Study|Withdrawal by Subject|1|||
155311480|NCT02908477|560573009|FG000|Overall Study|Withdrawal by Subject|8|||
155311481|NCT02908477|560573010|FG001|Overall Study|Withdrawal by Subject|28|||
155311482|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Other|0|||
155311483|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Other|0|||
155311484|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Other|0|||
155311485|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Other|0|||
155311486|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Other|0|||
155311487|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Other|0|||
155311488|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Other|0|||
155311489|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Other|0|||
155311490|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Other|0|||
155311491|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Other|0|||
155311492|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Other|1|||
155311493|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Other|1|||
155311494|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Other|1|||
155311495|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Other|0|||
155311496|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Other|3|||
155311497|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Other|1|||
155311498|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Other|1|||
155311499|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Other|0|||
155311500|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311501|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311502|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311503|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311504|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311505|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311506|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311507|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311508|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311509|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311510|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311511|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311512|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311513|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311514|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311515|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311516|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311517|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
155415931|NCT01777763|560954673|FG000|Overall Study|Withdrawal by Subject|0|||
155415932|NCT01777763|560954674|FG001|Overall Study|Withdrawal by Subject|2|||
155415933|NCT01777763|560954673|FG000|Overall Study|Treatment Failure|1|||
155415934|NCT01777763|560954674|FG001|Overall Study|Treatment Failure|6|||
155415935|NCT02787850|560954679|FG000|Overall Study|Withdrawal by Subject|0|||
155415936|NCT02787850|560954680|FG001|Overall Study|Withdrawal by Subject|1|||
155415937|NCT03718143|560954681|FG000|Overall Study|Death|1|||
155415938|NCT03718143|560954682|FG001|Overall Study|Death|0|||
155415939|NCT03718143|560954683|FG002|Overall Study|Death|0|||
155415940|NCT03718143|560954681|FG000|Overall Study|Progression of Disease|1|||
155415941|NCT03718143|560954682|FG001|Overall Study|Progression of Disease|0|||
155415942|NCT03718143|560954683|FG002|Overall Study|Progression of Disease|0|||
155415943|NCT03718143|560954681|FG000|Overall Study|Withdrawal of Informed Consent|1|||
155415944|NCT03718143|560954682|FG001|Overall Study|Withdrawal of Informed Consent|2|||
155415945|NCT03718143|560954683|FG002|Overall Study|Withdrawal of Informed Consent|1|||
155415946|NCT03905863|560954684|FG000|Overall Study|Adverse Event|2|||
155415947|NCT03905863|560954685|FG001|Overall Study|Adverse Event|4|||
155415948|NCT03905863|560954684|FG000|Overall Study|Withdrawal by Subject|2|||
155415949|NCT03905863|560954685|FG001|Overall Study|Withdrawal by Subject|2|||
155415950|NCT03905863|560954684|FG000|Overall Study|Physician Decision|0|||
155415951|NCT03905863|560954685|FG001|Overall Study|Physician Decision|3|||
155415952|NCT03905863|560954684|FG000|Overall Study|Lost to Follow-up|1|||
155415953|NCT03905863|560954685|FG001|Overall Study|Lost to Follow-up|0|||
155415954|NCT03905863|560954684|FG000|Overall Study|Protocol Violation|0|||
155415955|NCT03905863|560954685|FG001|Overall Study|Protocol Violation|2|||
155415956|NCT03905863|560954684|FG000|Overall Study|Death|0|||
155415957|NCT03905863|560954685|FG001|Overall Study|Death|1|||
155415958|NCT01072344|560954686|FG000|Overall Study|Relasped-reached end point|7|||
155415959|NCT01072344|560954687|FG001|Overall Study|Relasped-reached end point|12|||
155415960|NCT01072344|560954686|FG000|Overall Study|Protocol Violation|1|||
155415961|NCT01072344|560954687|FG001|Overall Study|Protocol Violation|2|||
155415962|NCT01072344|560954686|FG000|Overall Study|Lost to Follow-up|3|||
155415963|NCT01072344|560954687|FG001|Overall Study|Lost to Follow-up|4|||
155415964|NCT02723201|560954690|FG000|Second Intervention Period|Protocol Violation|1|||
155415965|NCT02723201|560954691|FG001|Second Intervention Period|Protocol Violation|0|||
155415966|NCT02723201|560954692|FG002|Second Intervention Period|Protocol Violation|0|||
155415967|NCT02723201|560954690|FG000|Second Intervention Period|Adverse Event|1|||
155415968|NCT02723201|560954691|FG001|Second Intervention Period|Adverse Event|0|||
155415969|NCT02723201|560954692|FG002|Second Intervention Period|Adverse Event|0|||
155415970|NCT03472560|560954693|FG000|Overall Study|Subject transfer to continuation protocol|0|||
155415971|NCT03472560|560954694|FG001|Overall Study|Subject transfer to continuation protocol|1|||
155415972|NCT03472560|560954693|FG000|Overall Study|Withdrawal by Subject|4|||
155415973|NCT03472560|560954694|FG001|Overall Study|Withdrawal by Subject|0|||
155415974|NCT03472560|560954693|FG000|Overall Study|Progressive disease|24|||
155415975|NCT03472560|560954694|FG001|Overall Study|Progressive disease|8|||
155415976|NCT03472560|560954693|FG000|Overall Study|Physician Decision|1|||
155415977|NCT03472560|560954694|FG001|Overall Study|Physician Decision|0|||
155415978|NCT03472560|560954693|FG000|Overall Study|Death|7|||
155415979|NCT03472560|560954694|FG001|Overall Study|Death|4|||
155415980|NCT03472560|560954693|FG000|Overall Study|Adverse Event|5|||
155415981|NCT03472560|560954694|FG001|Overall Study|Adverse Event|3|||
155415982|NCT03472560|560954693|FG000|Overall Study|Global deterioration of health status|0|||
155415983|NCT03472560|560954694|FG001|Overall Study|Global deterioration of health status|4|||
155415984|NCT02908880|560954701|FG000|Overall Study|Lost to Follow-up|4|||
155415985|NCT02908880|560954701|FG000|Overall Study|Explantation of the device|1|||
155415986|NCT02908880|560954701|FG000|Overall Study|Withdrawal by Subject|17|||
155415987|NCT02908880|560954701|FG000|Overall Study|Death|5|||
155415988|NCT00424827|560954702|FG000|Overall Study|Adverse Event|1|||
155415989|NCT02397473|560954705|FG000|Treatment Phase|Adverse Event|1|||
155415990|NCT02397473|560954706|FG001|Treatment Phase|Adverse Event|2|||
155415991|NCT02397473|560954705|FG000|Treatment Phase|Lack of Efficacy|8|||
155415992|NCT02397473|560954706|FG001|Treatment Phase|Lack of Efficacy|1|||
155415993|NCT02397473|560954705|FG000|Treatment Phase|Lost to Follow-up|1|||
155415994|NCT02397473|560954706|FG001|Treatment Phase|Lost to Follow-up|0|||
155415995|NCT02397473|560954705|FG000|Treatment Phase|Withdrawal by Subject|2|||
155415996|NCT02397473|560954706|FG001|Treatment Phase|Withdrawal by Subject|1|||
155415997|NCT02397473|560954705|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
155415998|NCT02397473|560954706|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
155415999|NCT02397473|560954705|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
155416000|NCT02397473|560954706|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
155416001|NCT02397473|560954705|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
155416002|NCT02397473|560954706|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
155416003|NCT02397473|560954705|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
155416004|NCT02397473|560954706|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
155416005|NCT02397473|560954705|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
155416006|NCT02397473|560954706|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
155416007|NCT00491179|560954707|FG000|Overall Study|Adverse Event|5|||
155416008|NCT00491179|560954708|FG001|Overall Study|Adverse Event|1|||
155416009|NCT00491179|560954707|FG000|Overall Study|Withdrawal by Subject|2|||
155416010|NCT00491179|560954708|FG001|Overall Study|Withdrawal by Subject|1|||
155416011|NCT02009878|560954712|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
155416012|NCT02009878|560954713|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
155416013|NCT02009878|560954714|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
155416014|NCT01790048|560954716|FG000|Overall Study|Incorrect Age|9|||
155416015|NCT01790048|560954717|FG001|Overall Study|Incorrect Age|14|||
155416016|NCT01790048|560954716|FG000|Overall Study|data entry error|0|||
155416017|NCT01790048|560954717|FG001|Overall Study|data entry error|1|||
155416018|NCT01790048|560954716|FG000|Overall Study|Other|0|||
155416019|NCT01790048|560954717|FG001|Overall Study|Other|2|||
155416020|NCT01790048|560954716|FG000|Overall Study|SAM at Enrollment|2|||
155416021|NCT01790048|560954717|FG001|Overall Study|SAM at Enrollment|0|||
155416022|NCT01790048|560954716|FG000|Overall Study|Measurement error|1|||
155416023|NCT01790048|560954717|FG001|Overall Study|Measurement error|0|||
155416024|NCT00584233|560954718|FG000|Overall Study|Withdrawal by Subject|5|||
155416025|NCT00584233|560954718|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
155416026|NCT03178487|560954722|FG000|Period 1|Adverse Event|1|||
155416027|NCT03178487|560954723|FG001|Period 1|Adverse Event|2|||
155416028|NCT03178487|560954722|FG000|Period 1|Withdrawal by Subject|2|||
155416029|NCT03178487|560954723|FG001|Period 1|Withdrawal by Subject|1|||
155416030|NCT03178487|560954722|FG000|Period 1|Lost to Follow-up|1|||
155416031|NCT03178487|560954723|FG001|Period 1|Lost to Follow-up|0|||
155416032|NCT03178487|560954722|FG000|Period 1|Other|0|||
155416033|NCT03178487|560954723|FG001|Period 1|Other|1|||
155416034|NCT03178487|560954722|FG000|Period 2|Adverse Event|4|||
155416035|NCT03178487|560954723|FG001|Period 2|Adverse Event|4|||
155416036|NCT03178487|560954722|FG000|Period 2|Withdrawal by Subject|6|||
155416037|NCT03178487|560954723|FG001|Period 2|Withdrawal by Subject|6|||
155416038|NCT03178487|560954722|FG000|Period 2|Lost to Follow-up|2|||
155416039|NCT03178487|560954723|FG001|Period 2|Lost to Follow-up|2|||
155416040|NCT03178487|560954722|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
155416041|NCT03178487|560954723|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
155416042|NCT03178487|560954722|FG000|Period 2|Other|8|||
155416043|NCT03178487|560954723|FG001|Period 2|Other|7|||
155416044|NCT01285908|560954730|FG000|Baseline Measurement|unable to insert catheter|1|||
155416045|NCT01285908|560954731|FG001|Baseline Measurement|unable to insert catheter|0|||
155416046|NCT01285908|560954732|FG002|Baseline Measurement|unable to insert catheter|0|||
155416047|NCT01285908|560954730|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
155416048|NCT01285908|560954731|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
155416049|NCT01285908|560954732|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
155416050|NCT01285908|560954730|FG000|Baseline Measurement|unable to tolerate procedure|1|||
155416051|NCT01285908|560954731|FG001|Baseline Measurement|unable to tolerate procedure|0|||
155416052|NCT01285908|560954732|FG002|Baseline Measurement|unable to tolerate procedure|0|||
155750428|NCT04393298|562185327|FG009|Overall Study|Patient Discharged to Hospice|0|||
155750429|NCT04393298|562185328|FG010|Overall Study|Patient Discharged to Hospice|0|||
155750430|NCT04393298|562185329|FG011|Overall Study|Patient Discharged to Hospice|0|||
155750431|NCT04393298|562185330|FG012|Overall Study|Patient Discharged to Hospice|0|||
155750432|NCT04393298|562185331|FG013|Overall Study|Patient Discharged to Hospice|0|||
155750433|NCT04393298|562185332|FG014|Overall Study|Patient Discharged to Hospice|0|||
155750434|NCT04393298|562185318|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750435|NCT04393298|562185319|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750436|NCT04393298|562185320|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750437|NCT04393298|562185321|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750438|NCT04393298|562185322|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750439|NCT04393298|562185323|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750440|NCT04393298|562185324|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750441|NCT04393298|562185325|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750442|NCT04393298|562185326|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750443|NCT04393298|562185327|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
155750444|NCT04393298|562185328|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750445|NCT04393298|562185329|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750446|NCT04393298|562185330|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750447|NCT04393298|562185331|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155416053|NCT03529773|560954733|FG000|Overall Study|Adverse Event|0|||
155416054|NCT03529773|560954734|FG001|Overall Study|Adverse Event|0|||
155416055|NCT03529773|560954735|FG002|Overall Study|Adverse Event|0|||
155416056|NCT03529773|560954736|FG003|Overall Study|Adverse Event|0|||
155416057|NCT03529773|560954737|FG004|Overall Study|Adverse Event|0|||
155416058|NCT03529773|560954738|FG005|Overall Study|Adverse Event|0|||
155416059|NCT03529773|560954739|FG006|Overall Study|Adverse Event|0|||
155498839|NCT03889197|561250718|FG001|Overall Study|met exclusion criteria|1|||
155498840|NCT03889197|561250717|FG000|Overall Study|Protocol Violation|1|||
155498841|NCT03889197|561250718|FG001|Overall Study|Protocol Violation|0|||
155498842|NCT00621309|561250719|FG000|Overall Study|Withdrawal by Subject|2|||
155498843|NCT00621309|561250720|FG001|Overall Study|Withdrawal by Subject|0|||
155498844|NCT00621309|561250721|FG002|Overall Study|Withdrawal by Subject|1|||
155498845|NCT00621309|561250722|FG003|Overall Study|Withdrawal by Subject|1|||
155498846|NCT00621309|561250723|FG004|Overall Study|Withdrawal by Subject|1|||
155498847|NCT00621309|561250724|FG005|Overall Study|Withdrawal by Subject|1|||
155498848|NCT05246111|561250725|FG000|Period 01|NOT ELIGIBLE IC5|1|||
155498849|NCT05246111|561250726|FG001|Period 01|NOT ELIGIBLE IC5|0|||
155498850|NCT05004181|561250729|FG000|Overall Study|Withdrawal of consent|0|||
155498851|NCT05004181|561250730|FG001|Overall Study|Withdrawal of consent|0|||
155498852|NCT05004181|561250731|FG002|Overall Study|Withdrawal of consent|1|||
155498853|NCT05004181|561250732|FG003|Overall Study|Withdrawal of consent|3|||
155498854|NCT05004181|561250733|FG004|Overall Study|Withdrawal of consent|3|||
155498855|NCT05004181|561250734|FG005|Overall Study|Withdrawal of consent|0|||
155498856|NCT05004181|561250735|FG006|Overall Study|Withdrawal of consent|30|||
155498857|NCT05004181|561250736|FG007|Overall Study|Withdrawal of consent|9|||
155498858|NCT05004181|561250737|FG008|Overall Study|Withdrawal of consent|3|||
155498859|NCT05004181|561250738|FG009|Overall Study|Withdrawal of consent|2|||
155498860|NCT05004181|561250739|FG010|Overall Study|Withdrawal of consent|5|||
155498861|NCT05004181|561250740|FG011|Overall Study|Withdrawal of consent|1|||
155498862|NCT05004181|561250729|FG000|Overall Study|Lost to Follow-up|2|||
155498863|NCT05004181|561250730|FG001|Overall Study|Lost to Follow-up|4|||
155498864|NCT05004181|561250731|FG002|Overall Study|Lost to Follow-up|2|||
155498865|NCT05004181|561250732|FG003|Overall Study|Lost to Follow-up|3|||
155498866|NCT05004181|561250733|FG004|Overall Study|Lost to Follow-up|5|||
155498867|NCT05004181|561250734|FG005|Overall Study|Lost to Follow-up|2|||
155498868|NCT05004181|561250735|FG006|Overall Study|Lost to Follow-up|15|||
155498869|NCT05004181|561250736|FG007|Overall Study|Lost to Follow-up|12|||
155498870|NCT05004181|561250737|FG008|Overall Study|Lost to Follow-up|38|||
155498871|NCT05004181|561250738|FG009|Overall Study|Lost to Follow-up|6|||
155498872|NCT05004181|561250739|FG010|Overall Study|Lost to Follow-up|6|||
155498873|NCT05004181|561250740|FG011|Overall Study|Lost to Follow-up|0|||
155498874|NCT05004181|561250729|FG000|Overall Study|Death|0|||
155498875|NCT05004181|561250730|FG001|Overall Study|Death|0|||
155498876|NCT05004181|561250731|FG002|Overall Study|Death|0|||
155498877|NCT05004181|561250732|FG003|Overall Study|Death|0|||
155498878|NCT05004181|561250733|FG004|Overall Study|Death|0|||
155498879|NCT05004181|561250734|FG005|Overall Study|Death|0|||
155498880|NCT05004181|561250735|FG006|Overall Study|Death|1|||
155498881|NCT05004181|561250736|FG007|Overall Study|Death|0|||
155498882|NCT05004181|561250737|FG008|Overall Study|Death|2|||
155498883|NCT05004181|561250738|FG009|Overall Study|Death|0|||
155498884|NCT05004181|561250739|FG010|Overall Study|Death|0|||
155498885|NCT05004181|561250740|FG011|Overall Study|Death|0|||
155498886|NCT05004181|561250729|FG000|Overall Study|Physician Decision|0|||
155498887|NCT05004181|561250730|FG001|Overall Study|Physician Decision|0|||
155498888|NCT05004181|561250731|FG002|Overall Study|Physician Decision|0|||
155498889|NCT05004181|561250732|FG003|Overall Study|Physician Decision|0|||
155498890|NCT05004181|561250733|FG004|Overall Study|Physician Decision|0|||
155498891|NCT05004181|561250734|FG005|Overall Study|Physician Decision|0|||
155498892|NCT05004181|561250735|FG006|Overall Study|Physician Decision|2|||
155498893|NCT05004181|561250736|FG007|Overall Study|Physician Decision|0|||
155498894|NCT05004181|561250737|FG008|Overall Study|Physician Decision|7|||
155498895|NCT05004181|561250738|FG009|Overall Study|Physician Decision|0|||
155498896|NCT05004181|561250739|FG010|Overall Study|Physician Decision|0|||
155498897|NCT05004181|561250740|FG011|Overall Study|Physician Decision|0|||
155750448|NCT04393298|562185332|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155750449|NCT04393298|562185318|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
155750450|NCT04393298|562185319|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
155750451|NCT04393298|562185320|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
155750452|NCT04393298|562185321|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
155750453|NCT04393298|562185322|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
155498898|NCT05004181|561250729|FG000|Overall Study|Withdrawal by Subject|2|||
155498899|NCT05004181|561250730|FG001|Overall Study|Withdrawal by Subject|3|||
155498900|NCT05004181|561250731|FG002|Overall Study|Withdrawal by Subject|2|||
155498901|NCT05004181|561250732|FG003|Overall Study|Withdrawal by Subject|2|||
155498902|NCT05004181|561250733|FG004|Overall Study|Withdrawal by Subject|4|||
155498903|NCT05004181|561250734|FG005|Overall Study|Withdrawal by Subject|2|||
155498904|NCT05004181|561250735|FG006|Overall Study|Withdrawal by Subject|4|||
155498905|NCT05004181|561250736|FG007|Overall Study|Withdrawal by Subject|22|||
155498906|NCT05004181|561250737|FG008|Overall Study|Withdrawal by Subject|8|||
155498907|NCT05004181|561250738|FG009|Overall Study|Withdrawal by Subject|1|||
155498908|NCT05004181|561250739|FG010|Overall Study|Withdrawal by Subject|3|||
155498909|NCT05004181|561250740|FG011|Overall Study|Withdrawal by Subject|2|||
155498910|NCT05004181|561250729|FG000|Overall Study|Protocol Violation|2|||
155311518|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311519|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311520|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311521|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311522|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311523|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311524|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311525|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
155311526|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311527|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311528|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311529|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311530|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311531|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311532|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311533|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311534|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311535|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311536|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311537|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311538|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311539|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311540|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311541|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311542|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311543|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311544|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311545|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
155311546|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311547|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311548|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311549|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311550|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311551|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311552|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311553|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311554|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Death|0|||
155311555|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Death|0|||
155311556|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Death|0|||
155311557|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Death|0|||
155311558|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Death|0|||
155311559|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Death|0|||
155311560|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Death|0|||
155311561|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Death|0|||
155311562|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Death|0|||
155311563|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Death|1|||
155311564|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Death|0|||
155311565|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Death|1|||
155311566|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Death|0|||
155311567|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Death|1|||
155311568|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Death|0|||
155311569|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Death|0|||
155311570|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Death|2|||
155311571|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Death|0|||
155311572|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
155311573|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
155311574|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
155311575|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
155311576|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
155311577|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
155311578|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
155311579|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
155311580|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
155311581|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
155311582|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
155311583|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
155311584|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
155311585|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
155311586|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
155311587|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
155311588|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
155311589|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
155416060|NCT03529773|560954740|FG007|Overall Study|Adverse Event|0|||
155311590|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Adverse Event|0|||
155311591|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Adverse Event|0|||
155311592|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Adverse Event|0|||
155311593|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Adverse Event|0|||
155311594|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Adverse Event|0|||
155311595|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Adverse Event|0|||
155311596|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Adverse Event|2|||
155311597|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Adverse Event|0|||
155311598|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Adverse Event|0|||
155311599|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Adverse Event|0|||
155311600|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Adverse Event|1|||
155311601|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Adverse Event|2|||
155311602|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Adverse Event|0|||
155311603|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Adverse Event|1|||
155311604|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Adverse Event|0|||
155311605|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Adverse Event|0|||
155311606|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Adverse Event|1|||
155311607|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Adverse Event|0|||
155311608|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
155311609|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
155311610|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
155311611|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
155311612|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
155311613|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
155311614|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
155311615|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
155311616|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
155311617|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
155311618|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
155311619|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
155311620|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
155311621|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
155311622|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
155311623|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
155311624|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
155311625|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
155311626|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311627|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311628|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311629|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311630|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311631|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311632|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311633|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311634|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311635|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311636|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311637|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311638|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155311639|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155311640|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155311641|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311642|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155311643|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311644|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Other|0|||
155311645|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Other|0|||
155311646|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Other|0|||
155311647|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Other|0|||
155311648|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Other|0|||
155311649|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Other|0|||
155311650|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Other|0|||
155311651|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Other|0|||
155311652|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Other|0|||
155311653|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Other|0|||
155416061|NCT03529773|560954741|FG008|Overall Study|Adverse Event|0|||
155416062|NCT03529773|560954742|FG009|Overall Study|Adverse Event|0|||
155416063|NCT03529773|560954743|FG010|Overall Study|Adverse Event|0|||
155416064|NCT03529773|560954744|FG011|Overall Study|Adverse Event|0|||
155416065|NCT03529773|560954745|FG012|Overall Study|Adverse Event|0|||
155416066|NCT03529773|560954746|FG013|Overall Study|Adverse Event|0|||
155643042|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
155643043|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
155643044|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
155643045|NCT02337946|561782390|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
155416067|NCT03529773|560954747|FG014|Overall Study|Adverse Event|0|||
155416068|NCT03529773|560954748|FG015|Overall Study|Adverse Event|0|||
155416069|NCT03529773|560954749|FG016|Overall Study|Adverse Event|0|||
155416070|NCT03529773|560954750|FG017|Overall Study|Adverse Event|0|||
155416071|NCT03529773|560954751|FG018|Overall Study|Adverse Event|0|||
155416072|NCT03529773|560954752|FG019|Overall Study|Adverse Event|0|||
155416073|NCT03529773|560954753|FG020|Overall Study|Adverse Event|0|||
155416074|NCT03529773|560954754|FG021|Overall Study|Adverse Event|0|||
155416075|NCT03529773|560954755|FG022|Overall Study|Adverse Event|0|||
155416076|NCT03529773|560954756|FG023|Overall Study|Adverse Event|0|||
155416077|NCT03529773|560954757|FG024|Overall Study|Adverse Event|0|||
155416078|NCT03529773|560954758|FG025|Overall Study|Adverse Event|0|||
155416079|NCT03529773|560954759|FG026|Overall Study|Adverse Event|0|||
155416080|NCT03529773|560954760|FG027|Overall Study|Adverse Event|0|||
155416081|NCT03529773|560954761|FG028|Overall Study|Adverse Event|0|||
155416082|NCT03529773|560954762|FG029|Overall Study|Adverse Event|0|||
155416083|NCT03529773|560954763|FG030|Overall Study|Adverse Event|1|||
155416084|NCT03529773|560954764|FG031|Overall Study|Adverse Event|0|||
155416085|NCT03529773|560954765|FG032|Overall Study|Adverse Event|0|||
155416086|NCT03529773|560954766|FG033|Overall Study|Adverse Event|0|||
155416087|NCT03529773|560954767|FG034|Overall Study|Adverse Event|0|||
155416088|NCT03529773|560954768|FG035|Overall Study|Adverse Event|1|||
155416089|NCT03529773|560954769|FG036|Overall Study|Adverse Event|0|||
155416090|NCT03529773|560954770|FG037|Overall Study|Adverse Event|0|||
155416091|NCT03529773|560954771|FG038|Overall Study|Adverse Event|1|||
155416092|NCT03529773|560954772|FG039|Overall Study|Adverse Event|1|||
155643046|NCT02337946|561782391|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
155643047|NCT02337946|561782392|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
155643048|NCT02337946|561782390|FG000|In-between Period|Without Informed Consent|1|||
155643049|NCT02337946|561782391|FG001|In-between Period|Without Informed Consent|0|||
155643050|NCT02337946|561782392|FG002|In-between Period|Without Informed Consent|0|||
155643051|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
155643052|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
155643053|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
155643054|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
155643055|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
155416093|NCT03529773|560954733|FG000|Overall Study|Death|0|||
155416094|NCT03529773|560954734|FG001|Overall Study|Death|0|||
155416095|NCT03529773|560954735|FG002|Overall Study|Death|0|||
155416096|NCT03529773|560954736|FG003|Overall Study|Death|0|||
155643056|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
155643057|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
155750454|NCT04393298|562185323|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
155750455|NCT04393298|562185324|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
155750456|NCT04393298|562185325|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
155750457|NCT04393298|562185326|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
155750458|NCT04393298|562185327|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
155750459|NCT04393298|562185328|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
155750460|NCT04393298|562185329|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
155750461|NCT04393298|562185330|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
155416097|NCT03529773|560954737|FG004|Overall Study|Death|0|||
155416098|NCT03529773|560954738|FG005|Overall Study|Death|0|||
155416099|NCT03529773|560954739|FG006|Overall Study|Death|0|||
155416100|NCT03529773|560954740|FG007|Overall Study|Death|0|||
155416101|NCT03529773|560954741|FG008|Overall Study|Death|0|||
155416102|NCT03529773|560954742|FG009|Overall Study|Death|0|||
155416103|NCT03529773|560954743|FG010|Overall Study|Death|0|||
155416104|NCT03529773|560954744|FG011|Overall Study|Death|0|||
155416105|NCT03529773|560954745|FG012|Overall Study|Death|1|||
155416106|NCT03529773|560954746|FG013|Overall Study|Death|0|||
155416107|NCT03529773|560954747|FG014|Overall Study|Death|0|||
155416108|NCT03529773|560954748|FG015|Overall Study|Death|0|||
155416109|NCT03529773|560954749|FG016|Overall Study|Death|0|||
155416110|NCT03529773|560954750|FG017|Overall Study|Death|0|||
155416111|NCT03529773|560954751|FG018|Overall Study|Death|0|||
155416112|NCT03529773|560954752|FG019|Overall Study|Death|1|||
155416113|NCT03529773|560954753|FG020|Overall Study|Death|0|||
155416114|NCT03529773|560954754|FG021|Overall Study|Death|0|||
155416115|NCT03529773|560954755|FG022|Overall Study|Death|1|||
155416116|NCT03529773|560954756|FG023|Overall Study|Death|0|||
155416117|NCT03529773|560954757|FG024|Overall Study|Death|0|||
155416118|NCT03529773|560954758|FG025|Overall Study|Death|0|||
155416119|NCT03529773|560954759|FG026|Overall Study|Death|0|||
155416120|NCT03529773|560954760|FG027|Overall Study|Death|0|||
155416121|NCT03529773|560954761|FG028|Overall Study|Death|0|||
155416122|NCT03529773|560954762|FG029|Overall Study|Death|0|||
155416123|NCT03529773|560954763|FG030|Overall Study|Death|0|||
155416124|NCT03529773|560954764|FG031|Overall Study|Death|0|||
155416125|NCT03529773|560954765|FG032|Overall Study|Death|0|||
155416126|NCT03529773|560954766|FG033|Overall Study|Death|1|||
155416127|NCT03529773|560954767|FG034|Overall Study|Death|1|||
155416128|NCT03529773|560954768|FG035|Overall Study|Death|0|||
155498911|NCT05004181|561250730|FG001|Overall Study|Protocol Violation|3|||
155750462|NCT04393298|562185331|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
155498912|NCT05004181|561250731|FG002|Overall Study|Protocol Violation|0|||
155498913|NCT05004181|561250732|FG003|Overall Study|Protocol Violation|0|||
155416129|NCT03529773|560954769|FG036|Overall Study|Death|1|||
155416130|NCT03529773|560954770|FG037|Overall Study|Death|0|||
155416131|NCT03529773|560954771|FG038|Overall Study|Death|0|||
155416132|NCT03529773|560954772|FG039|Overall Study|Death|0|||
155416133|NCT03529773|560954733|FG000|Overall Study|Lost to Follow-up|0|||
155416134|NCT03529773|560954734|FG001|Overall Study|Lost to Follow-up|0|||
155416135|NCT03529773|560954735|FG002|Overall Study|Lost to Follow-up|1|||
155416136|NCT03529773|560954736|FG003|Overall Study|Lost to Follow-up|0|||
155416137|NCT03529773|560954737|FG004|Overall Study|Lost to Follow-up|1|||
155416138|NCT03529773|560954738|FG005|Overall Study|Lost to Follow-up|1|||
155416139|NCT03529773|560954739|FG006|Overall Study|Lost to Follow-up|0|||
155416140|NCT03529773|560954740|FG007|Overall Study|Lost to Follow-up|0|||
155416141|NCT03529773|560954741|FG008|Overall Study|Lost to Follow-up|0|||
155416142|NCT03529773|560954742|FG009|Overall Study|Lost to Follow-up|0|||
155416143|NCT03529773|560954743|FG010|Overall Study|Lost to Follow-up|0|||
155416144|NCT03529773|560954744|FG011|Overall Study|Lost to Follow-up|0|||
155416145|NCT03529773|560954745|FG012|Overall Study|Lost to Follow-up|0|||
155416146|NCT03529773|560954746|FG013|Overall Study|Lost to Follow-up|1|||
155416147|NCT03529773|560954747|FG014|Overall Study|Lost to Follow-up|4|||
155416148|NCT03529773|560954748|FG015|Overall Study|Lost to Follow-up|1|||
155416149|NCT03529773|560954749|FG016|Overall Study|Lost to Follow-up|1|||
155416150|NCT03529773|560954750|FG017|Overall Study|Lost to Follow-up|0|||
155416151|NCT03529773|560954751|FG018|Overall Study|Lost to Follow-up|1|||
155416152|NCT03529773|560954752|FG019|Overall Study|Lost to Follow-up|1|||
155416153|NCT03529773|560954753|FG020|Overall Study|Lost to Follow-up|2|||
155416154|NCT03529773|560954754|FG021|Overall Study|Lost to Follow-up|4|||
155416155|NCT03529773|560954755|FG022|Overall Study|Lost to Follow-up|3|||
155416156|NCT03529773|560954756|FG023|Overall Study|Lost to Follow-up|4|||
155416157|NCT03529773|560954757|FG024|Overall Study|Lost to Follow-up|3|||
155416158|NCT03529773|560954758|FG025|Overall Study|Lost to Follow-up|5|||
155416159|NCT03529773|560954759|FG026|Overall Study|Lost to Follow-up|5|||
155416160|NCT03529773|560954760|FG027|Overall Study|Lost to Follow-up|0|||
155416161|NCT03529773|560954761|FG028|Overall Study|Lost to Follow-up|0|||
155416162|NCT03529773|560954762|FG029|Overall Study|Lost to Follow-up|0|||
155416163|NCT03529773|560954763|FG030|Overall Study|Lost to Follow-up|1|||
155416164|NCT03529773|560954764|FG031|Overall Study|Lost to Follow-up|0|||
155416165|NCT03529773|560954765|FG032|Overall Study|Lost to Follow-up|0|||
155416166|NCT03529773|560954766|FG033|Overall Study|Lost to Follow-up|1|||
155416167|NCT03529773|560954767|FG034|Overall Study|Lost to Follow-up|1|||
155416168|NCT03529773|560954768|FG035|Overall Study|Lost to Follow-up|0|||
155416169|NCT03529773|560954769|FG036|Overall Study|Lost to Follow-up|0|||
155416170|NCT03529773|560954770|FG037|Overall Study|Lost to Follow-up|3|||
155416171|NCT03529773|560954771|FG038|Overall Study|Lost to Follow-up|1|||
155416172|NCT03529773|560954772|FG039|Overall Study|Lost to Follow-up|1|||
155416173|NCT03529773|560954733|FG000|Overall Study|No longer meets eligibility criteria|0|||
155416174|NCT03529773|560954734|FG001|Overall Study|No longer meets eligibility criteria|0|||
155416175|NCT03529773|560954735|FG002|Overall Study|No longer meets eligibility criteria|0|||
155416176|NCT03529773|560954736|FG003|Overall Study|No longer meets eligibility criteria|0|||
155416177|NCT03529773|560954737|FG004|Overall Study|No longer meets eligibility criteria|0|||
155416178|NCT03529773|560954738|FG005|Overall Study|No longer meets eligibility criteria|0|||
155416179|NCT03529773|560954739|FG006|Overall Study|No longer meets eligibility criteria|0|||
155416180|NCT03529773|560954740|FG007|Overall Study|No longer meets eligibility criteria|0|||
155416181|NCT03529773|560954741|FG008|Overall Study|No longer meets eligibility criteria|0|||
155416182|NCT03529773|560954742|FG009|Overall Study|No longer meets eligibility criteria|0|||
155416183|NCT03529773|560954743|FG010|Overall Study|No longer meets eligibility criteria|0|||
155416184|NCT03529773|560954744|FG011|Overall Study|No longer meets eligibility criteria|0|||
155416185|NCT03529773|560954745|FG012|Overall Study|No longer meets eligibility criteria|0|||
155416186|NCT03529773|560954746|FG013|Overall Study|No longer meets eligibility criteria|0|||
155416187|NCT03529773|560954747|FG014|Overall Study|No longer meets eligibility criteria|0|||
155416188|NCT03529773|560954748|FG015|Overall Study|No longer meets eligibility criteria|0|||
155416189|NCT03529773|560954749|FG016|Overall Study|No longer meets eligibility criteria|0|||
155416190|NCT03529773|560954750|FG017|Overall Study|No longer meets eligibility criteria|0|||
155416191|NCT03529773|560954751|FG018|Overall Study|No longer meets eligibility criteria|0|||
155416192|NCT03529773|560954752|FG019|Overall Study|No longer meets eligibility criteria|0|||
155416193|NCT03529773|560954753|FG020|Overall Study|No longer meets eligibility criteria|0|||
155416194|NCT03529773|560954754|FG021|Overall Study|No longer meets eligibility criteria|0|||
155498914|NCT05004181|561250733|FG004|Overall Study|Protocol Violation|1|||
155498915|NCT05004181|561250734|FG005|Overall Study|Protocol Violation|0|||
155498916|NCT05004181|561250735|FG006|Overall Study|Protocol Violation|16|||
155643058|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
155416195|NCT03529773|560954755|FG022|Overall Study|No longer meets eligibility criteria|1|||
155416196|NCT03529773|560954756|FG023|Overall Study|No longer meets eligibility criteria|0|||
155416197|NCT03529773|560954757|FG024|Overall Study|No longer meets eligibility criteria|0|||
155416198|NCT03529773|560954758|FG025|Overall Study|No longer meets eligibility criteria|0|||
155416199|NCT03529773|560954759|FG026|Overall Study|No longer meets eligibility criteria|0|||
155416200|NCT03529773|560954760|FG027|Overall Study|No longer meets eligibility criteria|0|||
155416201|NCT03529773|560954761|FG028|Overall Study|No longer meets eligibility criteria|0|||
155416202|NCT03529773|560954762|FG029|Overall Study|No longer meets eligibility criteria|0|||
155416203|NCT03529773|560954763|FG030|Overall Study|No longer meets eligibility criteria|0|||
155311654|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Other|0|||
155311655|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Other|0|||
155311656|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Other|0|||
155311657|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Other|0|||
155311658|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Other|0|||
155311659|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Other|0|||
155311660|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Other|0|||
155311661|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Other|1|||
155311662|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311663|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311664|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311665|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311666|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311667|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311668|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311669|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311670|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311671|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311672|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311673|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311674|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311675|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311676|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311677|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311678|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311679|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
155311680|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
155311681|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
155311682|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
155311683|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
155311684|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
155311685|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
155311686|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
155311687|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
155311688|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
155311689|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
155311690|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
155311691|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
155311692|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
155311693|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
155311694|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
155311695|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
155311696|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
155311697|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
155311698|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
155311699|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
155311700|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
155416204|NCT03529773|560954764|FG031|Overall Study|No longer meets eligibility criteria|0|||
155416205|NCT03529773|560954765|FG032|Overall Study|No longer meets eligibility criteria|0|||
155416206|NCT03529773|560954766|FG033|Overall Study|No longer meets eligibility criteria|0|||
155416207|NCT03529773|560954767|FG034|Overall Study|No longer meets eligibility criteria|0|||
155416208|NCT03529773|560954768|FG035|Overall Study|No longer meets eligibility criteria|0|||
155416209|NCT03529773|560954769|FG036|Overall Study|No longer meets eligibility criteria|0|||
155416210|NCT03529773|560954770|FG037|Overall Study|No longer meets eligibility criteria|0|||
155311701|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
155311702|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
155311703|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
155311704|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
155311705|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
155311706|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
155311707|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
155416211|NCT03529773|560954771|FG038|Overall Study|No longer meets eligibility criteria|1|||
155416212|NCT03529773|560954772|FG039|Overall Study|No longer meets eligibility criteria|0|||
155416213|NCT03529773|560954733|FG000|Overall Study|Other|0|||
155416214|NCT03529773|560954734|FG001|Overall Study|Other|0|||
155416215|NCT03529773|560954735|FG002|Overall Study|Other|0|||
155416216|NCT03529773|560954736|FG003|Overall Study|Other|0|||
155416217|NCT03529773|560954737|FG004|Overall Study|Other|0|||
155416218|NCT03529773|560954738|FG005|Overall Study|Other|0|||
155311708|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
155311709|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
155311710|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
155311711|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
155311712|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
155311713|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
155311714|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
155311715|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
155311716|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
155311717|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
155311718|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
155311719|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
155311720|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
155311721|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
155311722|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
155311723|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
155311724|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
155311725|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
155311726|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
155311727|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
155311728|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
155311729|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
155311730|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
155311731|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
155311732|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
155311733|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
155311734|NCT05071807|560573039|FG000|Overall Study|Withdrawal by Subject|4|||
155311735|NCT05071807|560573040|FG001|Overall Study|Withdrawal by Subject|0|||
155311736|NCT05071807|560573039|FG000|Overall Study|Unrelated medical issues|3|||
155311737|NCT05071807|560573040|FG001|Overall Study|Unrelated medical issues|0|||
155311738|NCT05071807|560573039|FG000|Overall Study|Relocated|0|||
155311739|NCT05071807|560573040|FG001|Overall Study|Relocated|1|||
155311740|NCT04952909|560573041|FG000|Overall Study|Death|3|||
155311741|NCT04552223|560573049|FG000|Overall Study|Withdrawal by Subject|1|||
155311742|NCT04856163|560573050|FG000|Overall Study|Lost to Follow-up|97|||
155311743|NCT04856163|560573051|FG001|Overall Study|Lost to Follow-up|100|||
155311744|NCT00881621|560573052|FG000|Overall Study|Physician Decision|34|||
155311745|NCT04359108|560573056|FG000|Overall Study|Withdrawal by Subject|1|||
155750463|NCT04393298|562185332|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
155311746|NCT04359108|560573057|FG001|Overall Study|Withdrawal by Subject|0|||
155311747|NCT04359108|560573056|FG000|Overall Study|Unable or too feeble to walk independently|0|||
155311748|NCT04359108|560573057|FG001|Overall Study|Unable or too feeble to walk independently|2|||
155311749|NCT04359108|560573056|FG000|Overall Study|Argus II system stopped functioning|0|||
155311750|NCT04359108|560573057|FG001|Overall Study|Argus II system stopped functioning|1|||
155311751|NCT04359108|560573056|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
155311752|NCT04359108|560573057|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
155311753|NCT02515773|560573058|FG000|Overall Study|Withdrawal by Subject|12|||
155311754|NCT02515773|560573059|FG001|Overall Study|Withdrawal by Subject|2|||
155311755|NCT02515773|560573058|FG000|Overall Study|Lost to Follow-up|119|||
155311756|NCT02515773|560573059|FG001|Overall Study|Lost to Follow-up|126|||
155311757|NCT02515773|560573058|FG000|Overall Study|Discharged from Clinic Services|53|||
155311758|NCT02515773|560573059|FG001|Overall Study|Discharged from Clinic Services|84|||
155311759|NCT02515773|560573058|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
155311760|NCT02515773|560573059|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
155311761|NCT02515773|560573058|FG000|Overall Study|Follow-up at non-study site|8|||
155311762|NCT02515773|560573059|FG001|Overall Study|Follow-up at non-study site|16|||
155311763|NCT02515773|560573058|FG000|Overall Study|Moved from area|9|||
155311764|NCT02515773|560573059|FG001|Overall Study|Moved from area|14|||
155311765|NCT04176965|560573060|FG000|Overall Study|Death|1|||
155311766|NCT04176965|560573061|FG001|Overall Study|Death|2|||
155311767|NCT04176965|560573060|FG000|Overall Study|Lost to Follow-up|10|||
155311768|NCT04176965|560573061|FG001|Overall Study|Lost to Follow-up|2|||
155311769|NCT04176965|560573060|FG000|Overall Study|Withdrawal by Subject|6|||
155311770|NCT04176965|560573061|FG001|Overall Study|Withdrawal by Subject|1|||
155311771|NCT03468218|560573062|FG000|Overall Study|Adverse Event|5|||
155750464|NCT03754972|562185335|FG000|Overall Study|Protocol Violation|25|||
155750465|NCT06460493|562185339|FG000|Overall Study|Withdrawal by Subject|2|||
155311772|NCT03468218|560573062|FG000|Overall Study|Progressive Disease|16|||
155416219|NCT03529773|560954739|FG006|Overall Study|Other|0|||
155416220|NCT03529773|560954740|FG007|Overall Study|Other|0|||
155311773|NCT03468218|560573062|FG000|Overall Study|Death|1|||
155311774|NCT03468218|560573062|FG000|Overall Study|Alternate therapy|1|||
155311775|NCT03468218|560573062|FG000|Overall Study|Withdrawal by Subject|2|||
155311776|NCT03033576|560573063|FG000|Overall Study|Ineligible|1|||
155311777|NCT03033576|560573064|FG001|Overall Study|Ineligible|1|||
155311778|NCT03033576|560573063|FG000|Overall Study|Adverse Event|4|||
155311779|NCT03033576|560573064|FG001|Overall Study|Adverse Event|20|||
155311780|NCT03033576|560573063|FG000|Overall Study|Progression/relapse|9|||
155311781|NCT03033576|560573064|FG001|Overall Study|Progression/relapse|36|||
155311782|NCT03033576|560573063|FG000|Overall Study|Death|1|||
155311783|NCT03033576|560573064|FG001|Overall Study|Death|1|||
155311784|NCT03033576|560573063|FG000|Overall Study|Patient refusal|1|||
155311785|NCT03033576|560573064|FG001|Overall Study|Patient refusal|6|||
155311786|NCT03033576|560573063|FG000|Overall Study|Other, unspecified reasons|0|||
155311787|NCT03033576|560573064|FG001|Overall Study|Other, unspecified reasons|4|||
155311788|NCT03033576|560573063|FG000|Overall Study|Currently on protocol therapy|0|||
155311789|NCT03033576|560573064|FG001|Overall Study|Currently on protocol therapy|2|||
155311790|NCT01214616|560573065|FG000|Overall Study|Progressive disease|2|||
155311791|NCT01214616|560573066|FG001|Overall Study|Progressive disease|2|||
155311792|NCT01214616|560573067|FG002|Overall Study|Progressive disease|2|||
155311793|NCT01214616|560573068|FG003|Overall Study|Progressive disease|4|||
155311794|NCT01214616|560573065|FG000|Overall Study|Dose limiting toxicity|0|||
155750466|NCT05128929|562185340|FG000|Overall Study|Adverse Event|0|||
155311795|NCT01214616|560573066|FG001|Overall Study|Dose limiting toxicity|2|||
155311796|NCT01214616|560573067|FG002|Overall Study|Dose limiting toxicity|0|||
155311797|NCT01214616|560573068|FG003|Overall Study|Dose limiting toxicity|0|||
155311798|NCT01214616|560573065|FG000|Overall Study|Other adverse events|0|||
155311799|NCT01214616|560573066|FG001|Overall Study|Other adverse events|1|||
155311800|NCT01214616|560573067|FG002|Overall Study|Other adverse events|1|||
155311801|NCT01214616|560573068|FG003|Overall Study|Other adverse events|1|||
155311802|NCT01214616|560573065|FG000|Overall Study|Withdrawal by Subject|1|||
155311803|NCT01214616|560573066|FG001|Overall Study|Withdrawal by Subject|0|||
155311804|NCT01214616|560573067|FG002|Overall Study|Withdrawal by Subject|0|||
155311805|NCT01214616|560573068|FG003|Overall Study|Withdrawal by Subject|1|||
155311806|NCT02949362|560573069|FG000|Retrospective Period|Inform consent not signed by participant|4|||
155311807|NCT02949362|560573070|FG001|Retrospective Period|Inform consent not signed by participant|1|||
155311808|NCT02949362|560573071|FG002|Retrospective Period|Inform consent not signed by participant|0|||
155311809|NCT02949362|560573072|FG003|Retrospective Period|Inform consent not signed by participant|0|||
155311810|NCT02949362|560573069|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311811|NCT02949362|560573070|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311812|NCT02949362|560573071|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
155311813|NCT02949362|560573072|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311814|NCT02949362|560573069|FG000|Prospective Period|Other|0|||
155311815|NCT02949362|560573070|FG001|Prospective Period|Other|0|||
155311816|NCT02949362|560573071|FG002|Prospective Period|Other|0|||
155311817|NCT02949362|560573072|FG003|Prospective Period|Other|4|||
155311818|NCT02471638|560573076|FG000|Overall Study|Early Term Withdrawal|10|||
155311819|NCT00667251|560575160|FG000|Overall Study|Disease progression|232|||
155311820|NCT00667251|560575161|FG001|Overall Study|Disease progression|203|||
155311821|NCT00667251|560575160|FG000|Overall Study|Toxicity|44|||
155311822|NCT00667251|560575161|FG001|Overall Study|Toxicity|23|||
155311823|NCT00667251|560575160|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
155311824|NCT00667251|560575161|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
155311825|NCT00667251|560575160|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
155311826|NCT00667251|560575161|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
155311827|NCT00667251|560575160|FG000|Overall Study|Symptomatic progression|8|||
155311828|NCT00667251|560575161|FG001|Overall Study|Symptomatic progression|4|||
155311829|NCT00667251|560575160|FG000|Overall Study|Death|6|||
155311830|NCT00667251|560575161|FG001|Overall Study|Death|11|||
155311831|NCT00667251|560575160|FG000|Overall Study|Intercurrent illness|5|||
155311832|NCT00667251|560575161|FG001|Overall Study|Intercurrent illness|6|||
155311833|NCT00667251|560575160|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
155311834|NCT00667251|560575161|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
155311835|NCT00667251|560575160|FG000|Overall Study|Randomized not Treated|4|||
155311836|NCT00667251|560575161|FG001|Overall Study|Randomized not Treated|1|||
155311837|NCT02671903|560575167|FG000|Period 0 (Run-In)|Death|0|||
155311838|NCT02671903|560575168|FG001|Period 0 (Run-In)|Death|0|||
155311839|NCT02671903|560575169|FG002|Period 0 (Run-In)|Death|3|||
155311840|NCT02671903|560575167|FG000|Period 0 (Run-In)|Physician Decision|0|||
155311841|NCT02671903|560575168|FG001|Period 0 (Run-In)|Physician Decision|0|||
155311842|NCT02671903|560575169|FG002|Period 0 (Run-In)|Physician Decision|4|||
155311843|NCT02671903|560575167|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
155311844|NCT02671903|560575168|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
155311845|NCT02671903|560575169|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
155311846|NCT02671903|560575167|FG000|Period 0 (Run-In)|Protocol Violation|0|||
155311847|NCT02671903|560575168|FG001|Period 0 (Run-In)|Protocol Violation|0|||
155750467|NCT05128929|562185341|FG001|Overall Study|Adverse Event|1|||
155311848|NCT02671903|560575169|FG002|Period 0 (Run-In)|Protocol Violation|1|||
155311849|NCT02671903|560575167|FG000|Period 0 (Run-In)|Adverse Event|0|||
155311850|NCT02671903|560575168|FG001|Period 0 (Run-In)|Adverse Event|0|||
155498917|NCT05004181|561250736|FG007|Overall Study|Protocol Violation|18|||
155498918|NCT05004181|561250737|FG008|Overall Study|Protocol Violation|2|||
155498919|NCT05004181|561250738|FG009|Overall Study|Protocol Violation|2|||
155498920|NCT05004181|561250739|FG010|Overall Study|Protocol Violation|2|||
155498921|NCT05004181|561250740|FG011|Overall Study|Protocol Violation|1|||
155498922|NCT05004181|561250729|FG000|Overall Study|Not further specified|1|||
155498923|NCT05004181|561250730|FG001|Overall Study|Not further specified|0|||
155498924|NCT05004181|561250731|FG002|Overall Study|Not further specified|0|||
155498925|NCT05004181|561250732|FG003|Overall Study|Not further specified|0|||
155498926|NCT05004181|561250733|FG004|Overall Study|Not further specified|0|||
155498927|NCT05004181|561250734|FG005|Overall Study|Not further specified|0|||
155498928|NCT05004181|561250735|FG006|Overall Study|Not further specified|1|||
155498929|NCT05004181|561250736|FG007|Overall Study|Not further specified|0|||
155498930|NCT05004181|561250737|FG008|Overall Study|Not further specified|2|||
155498931|NCT05004181|561250738|FG009|Overall Study|Not further specified|1|||
155498932|NCT05004181|561250739|FG010|Overall Study|Not further specified|0|||
155498933|NCT05004181|561250740|FG011|Overall Study|Not further specified|1|||
155498934|NCT03205163|561250745|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
155498935|NCT03205163|561250746|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
155498936|NCT01298661|561250747|FG000|Overall Study|Withdrawal by Subject|2|||
155498937|NCT01298661|561250748|FG001|Overall Study|Withdrawal by Subject|0|||
155498938|NCT01298661|561250749|FG002|Overall Study|Withdrawal by Subject|2|||
155498939|NCT00526227|561250750|FG000|Overall Study|Device not implanted|1|||
155498940|NCT00526227|561250750|FG000|Overall Study|Death|1|||
155498941|NCT01652573|561252613|FG000|Overall Study|Adverse Event|0|||
155498942|NCT01652573|561252614|FG001|Overall Study|Adverse Event|1|||
155498943|NCT03284424|561252615|FG000|Overall Study|Death|70|||
155498944|NCT03284424|561252616|FG001|Overall Study|Death|24|||
155498945|NCT03284424|561252615|FG000|Overall Study|Lost to Follow-up|3|||
155498946|NCT03284424|561252616|FG001|Overall Study|Lost to Follow-up|1|||
155498947|NCT03284424|561252615|FG000|Overall Study|Physician Decision|1|||
155498948|NCT03284424|561252616|FG001|Overall Study|Physician Decision|2|||
155498949|NCT03284424|561252615|FG000|Overall Study|Withdrawal by Subject|4|||
155498950|NCT03284424|561252616|FG001|Overall Study|Withdrawal by Subject|5|||
155498951|NCT03284424|561252615|FG000|Overall Study|Sponsor's decision|27|||
155498952|NCT03284424|561252616|FG001|Overall Study|Sponsor's decision|22|||
155498953|NCT01052038|561252617|FG000|Overall Study|Lost to Follow-up|2|||
155498954|NCT01052038|561252618|FG001|Overall Study|Lost to Follow-up|3|||
155498955|NCT01052038|561252619|FG002|Overall Study|Lost to Follow-up|1|||
155311851|NCT02671903|560575169|FG002|Period 0 (Run-In)|Adverse Event|1|||
155311852|NCT02671903|560575167|FG000|Period 0 (Run-In)|Implantation Failure|0|||
155311853|NCT02671903|560575168|FG001|Period 0 (Run-In)|Implantation Failure|0|||
155311854|NCT02671903|560575169|FG002|Period 0 (Run-In)|Implantation Failure|2|||
155311855|NCT02671903|560575167|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
155416221|NCT03529773|560954741|FG008|Overall Study|Other|0|||
155416222|NCT03529773|560954742|FG009|Overall Study|Other|0|||
155416223|NCT03529773|560954743|FG010|Overall Study|Other|0|||
155498956|NCT01052038|561252617|FG000|Overall Study|Protocol Violation|2|||
155498957|NCT01052038|561252618|FG001|Overall Study|Protocol Violation|3|||
155498958|NCT01052038|561252619|FG002|Overall Study|Protocol Violation|3|||
155311856|NCT02671903|560575168|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
155311857|NCT02671903|560575169|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
155311858|NCT03376321|560575170|FG000|Overall Study|Other|5|||
155416224|NCT03529773|560954744|FG011|Overall Study|Other|0|||
155416225|NCT03529773|560954745|FG012|Overall Study|Other|1|||
155416226|NCT03529773|560954746|FG013|Overall Study|Other|0|||
155416227|NCT03529773|560954747|FG014|Overall Study|Other|2|||
155416228|NCT03529773|560954748|FG015|Overall Study|Other|0|||
155416229|NCT03529773|560954749|FG016|Overall Study|Other|0|||
155416230|NCT03529773|560954750|FG017|Overall Study|Other|3|||
155311859|NCT03376321|560575171|FG001|Overall Study|Other|1|||
155416231|NCT03529773|560954751|FG018|Overall Study|Other|0|||
155416232|NCT03529773|560954752|FG019|Overall Study|Other|0|||
155416233|NCT03529773|560954753|FG020|Overall Study|Other|1|||
155416234|NCT03529773|560954754|FG021|Overall Study|Other|0|||
155416235|NCT03529773|560954755|FG022|Overall Study|Other|1|||
155311860|NCT03376321|560575170|FG000|Overall Study|Withdrawal by Subject|8|||
155498959|NCT03349437|561252620|FG000|Screening|Screen Fail|4|||
155498960|NCT03349437|561252621|FG001|Screening|Screen Fail|0|||
155498961|NCT03349437|561252622|FG002|Screening|Screen Fail|0|||
155498962|NCT03349437|561252620|FG000|Screening|Withdrawn|1|||
155498963|NCT03349437|561252621|FG001|Screening|Withdrawn|0|||
155498964|NCT03349437|561252622|FG002|Screening|Withdrawn|0|||
155498965|NCT00765999|561252623|FG000|Overall Study|Adverse Event|203|||
155498966|NCT00765999|561252623|FG000|Overall Study|Insufficient Therapeutic Response|100|||
155498967|NCT00765999|561252623|FG000|Overall Study|Protocol Violation|95|||
155311861|NCT03376321|560575171|FG001|Overall Study|Withdrawal by Subject|14|||
155416236|NCT03529773|560954756|FG023|Overall Study|Other|0|||
155416237|NCT03529773|560954757|FG024|Overall Study|Other|3|||
155416238|NCT03529773|560954758|FG025|Overall Study|Other|2|||
155498968|NCT00765999|561252623|FG000|Overall Study|Consent Withdrawn|202|||
155311862|NCT03376321|560575170|FG000|Overall Study|Lost to Follow-up|1|||
155311863|NCT03376321|560575171|FG001|Overall Study|Lost to Follow-up|7|||
155311864|NCT03376321|560575170|FG000|Overall Study|Death|4|||
155311865|NCT03376321|560575171|FG001|Overall Study|Death|0|||
155311866|NCT03376321|560575170|FG000|Overall Study|Randomized, not treated|5|||
155311867|NCT03376321|560575171|FG001|Overall Study|Randomized, not treated|3|||
155311868|NCT02995434|560575172|FG000|Overall Study|Adverse Event|1|||
155311869|NCT02995434|560575173|FG001|Overall Study|Adverse Event|0|||
155311870|NCT02995434|560575172|FG000|Overall Study|Withdrawal by Subject|6|||
155311871|NCT02995434|560575173|FG001|Overall Study|Withdrawal by Subject|3|||
155311872|NCT02543281|560575180|FG000|Overall Study|Lost to Follow-up|0|||
155311873|NCT02543281|560575181|FG001|Overall Study|Lost to Follow-up|0|||
155311874|NCT02543281|560575182|FG002|Overall Study|Lost to Follow-up|1|||
155311875|NCT05247489|560575183|FG000|Overall Study|Lost to Follow-up|5|||
155311876|NCT05247489|560575184|FG001|Overall Study|Lost to Follow-up|1|||
155311877|NCT05247489|560575183|FG000|Overall Study|Withdrawal by Subject|6|||
155311878|NCT05247489|560575184|FG001|Overall Study|Withdrawal by Subject|7|||
155311879|NCT05247489|560575183|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
155311880|NCT05247489|560575184|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
155311881|NCT05247489|560575183|FG000|Overall Study|Left Country|1|||
155311882|NCT05247489|560575184|FG001|Overall Study|Left Country|0|||
155311883|NCT05247489|560575183|FG000|Overall Study|Noncompliance with Investigational Product|1|||
155311884|NCT05247489|560575184|FG001|Overall Study|Noncompliance with Investigational Product|0|||
155311885|NCT05247489|560575183|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
155311886|NCT05247489|560575184|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
155311887|NCT04390048|560575185|FG000|Overall Study|Withdrawal by Subject|1|||
155311888|NCT04390048|560575186|FG001|Overall Study|Withdrawal by Subject|3|||
155311889|NCT04179500|560575193|FG000|Treatment|Withdrawal by Subject|1|||
155311890|NCT04179500|560575193|FG000|Treatment|Adverse Event|2|||
155311891|NCT04179500|560575193|FG000|Treatment|pyrazinamide resistance|1|||
155311892|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311893|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311894|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311895|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311896|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311897|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311898|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
155311899|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311900|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311901|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311902|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311903|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311904|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311905|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311906|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311907|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311908|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311909|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311910|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311911|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155750468|NCT02987660|562185344|FG000|Overall Study|Study terminated by sponsor|10|||
155750469|NCT02987660|562185345|FG001|Overall Study|Study terminated by sponsor|10|||
155311912|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311913|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311914|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311915|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311916|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311917|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311918|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311919|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311920|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311921|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311922|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
155750470|NCT03707184|562185346|FG000|Overall Study|Withdrawal by Subject|2|||
155311923|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311924|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311925|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311926|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311927|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155750471|NCT04704154|562185347|FG000|Overall Study|Adverse Event|3|||
155311928|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155416239|NCT03529773|560954759|FG026|Overall Study|Other|2|||
155416240|NCT03529773|560954760|FG027|Overall Study|Other|0|||
155416241|NCT03529773|560954761|FG028|Overall Study|Other|0|||
155416242|NCT03529773|560954762|FG029|Overall Study|Other|0|||
155416243|NCT03529773|560954763|FG030|Overall Study|Other|0|||
155416244|NCT03529773|560954764|FG031|Overall Study|Other|0|||
155416245|NCT03529773|560954765|FG032|Overall Study|Other|0|||
155416246|NCT03529773|560954766|FG033|Overall Study|Other|0|||
155416247|NCT03529773|560954767|FG034|Overall Study|Other|1|||
155416248|NCT03529773|560954768|FG035|Overall Study|Other|1|||
155416249|NCT03529773|560954769|FG036|Overall Study|Other|0|||
155416250|NCT03529773|560954770|FG037|Overall Study|Other|0|||
155416251|NCT03529773|560954771|FG038|Overall Study|Other|0|||
155416252|NCT03529773|560954772|FG039|Overall Study|Other|0|||
155416253|NCT03529773|560954733|FG000|Overall Study|Physician Decision|0|||
155416254|NCT03529773|560954734|FG001|Overall Study|Physician Decision|0|||
155416255|NCT03529773|560954735|FG002|Overall Study|Physician Decision|0|||
155416256|NCT03529773|560954736|FG003|Overall Study|Physician Decision|0|||
155416257|NCT03529773|560954737|FG004|Overall Study|Physician Decision|0|||
155416258|NCT03529773|560954738|FG005|Overall Study|Physician Decision|0|||
155416259|NCT03529773|560954739|FG006|Overall Study|Physician Decision|0|||
155416260|NCT03529773|560954740|FG007|Overall Study|Physician Decision|0|||
155416261|NCT03529773|560954741|FG008|Overall Study|Physician Decision|0|||
155416262|NCT03529773|560954742|FG009|Overall Study|Physician Decision|0|||
155416263|NCT03529773|560954743|FG010|Overall Study|Physician Decision|0|||
155416264|NCT03529773|560954744|FG011|Overall Study|Physician Decision|0|||
155416265|NCT03529773|560954745|FG012|Overall Study|Physician Decision|0|||
155416266|NCT03529773|560954746|FG013|Overall Study|Physician Decision|0|||
155416267|NCT03529773|560954747|FG014|Overall Study|Physician Decision|0|||
155416268|NCT03529773|560954748|FG015|Overall Study|Physician Decision|0|||
155416269|NCT03529773|560954749|FG016|Overall Study|Physician Decision|0|||
155416270|NCT03529773|560954750|FG017|Overall Study|Physician Decision|0|||
155416271|NCT03529773|560954751|FG018|Overall Study|Physician Decision|0|||
155416272|NCT03529773|560954752|FG019|Overall Study|Physician Decision|1|||
155416273|NCT03529773|560954753|FG020|Overall Study|Physician Decision|1|||
155416274|NCT03529773|560954754|FG021|Overall Study|Physician Decision|0|||
155416275|NCT03529773|560954755|FG022|Overall Study|Physician Decision|0|||
155416276|NCT03529773|560954756|FG023|Overall Study|Physician Decision|0|||
155416277|NCT03529773|560954757|FG024|Overall Study|Physician Decision|0|||
155416278|NCT03529773|560954758|FG025|Overall Study|Physician Decision|0|||
155416279|NCT03529773|560954759|FG026|Overall Study|Physician Decision|0|||
155416280|NCT03529773|560954760|FG027|Overall Study|Physician Decision|0|||
155416281|NCT03529773|560954761|FG028|Overall Study|Physician Decision|0|||
155416282|NCT03529773|560954762|FG029|Overall Study|Physician Decision|0|||
155416283|NCT03529773|560954763|FG030|Overall Study|Physician Decision|0|||
155416284|NCT03529773|560954764|FG031|Overall Study|Physician Decision|0|||
155416285|NCT03529773|560954765|FG032|Overall Study|Physician Decision|0|||
155416286|NCT03529773|560954766|FG033|Overall Study|Physician Decision|0|||
155416287|NCT03529773|560954767|FG034|Overall Study|Physician Decision|0|||
155416288|NCT03529773|560954768|FG035|Overall Study|Physician Decision|0|||
155416289|NCT03529773|560954769|FG036|Overall Study|Physician Decision|0|||
155416290|NCT03529773|560954770|FG037|Overall Study|Physician Decision|0|||
155416291|NCT03529773|560954771|FG038|Overall Study|Physician Decision|0|||
155416292|NCT03529773|560954772|FG039|Overall Study|Physician Decision|0|||
155416293|NCT03529773|560954733|FG000|Overall Study|Protocol Violation|0|||
155750472|NCT04704154|562185348|FG001|Overall Study|Adverse Event|2|||
155750473|NCT04704154|562185349|FG002|Overall Study|Adverse Event|4|||
155750474|NCT04704154|562185350|FG003|Overall Study|Adverse Event|2|||
155750475|NCT04704154|562185351|FG004|Overall Study|Adverse Event|3|||
155750476|NCT04704154|562185352|FG005|Overall Study|Adverse Event|0|||
155750477|NCT04704154|562185347|FG000|Overall Study|Death|3|||
155750478|NCT04704154|562185348|FG001|Overall Study|Death|0|||
155750479|NCT04704154|562185349|FG002|Overall Study|Death|0|||
155750480|NCT04704154|562185350|FG003|Overall Study|Death|0|||
155416294|NCT03529773|560954734|FG001|Overall Study|Protocol Violation|0|||
155416295|NCT03529773|560954735|FG002|Overall Study|Protocol Violation|0|||
155416296|NCT03529773|560954736|FG003|Overall Study|Protocol Violation|0|||
155416297|NCT03529773|560954737|FG004|Overall Study|Protocol Violation|0|||
155416298|NCT03529773|560954738|FG005|Overall Study|Protocol Violation|0|||
155750481|NCT04704154|562185351|FG004|Overall Study|Death|3|||
155416299|NCT03529773|560954739|FG006|Overall Study|Protocol Violation|0|||
155416300|NCT03529773|560954740|FG007|Overall Study|Protocol Violation|0|||
155416301|NCT03529773|560954741|FG008|Overall Study|Protocol Violation|0|||
155416302|NCT03529773|560954742|FG009|Overall Study|Protocol Violation|0|||
155416303|NCT03529773|560954743|FG010|Overall Study|Protocol Violation|0|||
155750482|NCT04704154|562185352|FG005|Overall Study|Death|0|||
155750483|NCT04704154|562185347|FG000|Overall Study|Physician Decision|1|||
155416304|NCT03529773|560954744|FG011|Overall Study|Protocol Violation|0|||
155416305|NCT03529773|560954745|FG012|Overall Study|Protocol Violation|0|||
155416306|NCT03529773|560954746|FG013|Overall Study|Protocol Violation|0|||
155416307|NCT03529773|560954747|FG014|Overall Study|Protocol Violation|0|||
155750484|NCT04704154|562185348|FG001|Overall Study|Physician Decision|0|||
155750485|NCT04704154|562185349|FG002|Overall Study|Physician Decision|1|||
155311929|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311930|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311931|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311932|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311933|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311934|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311935|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311936|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311937|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311938|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311939|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311940|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311941|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311942|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311943|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311944|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311945|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311946|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
155311947|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
155311948|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
155311949|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
155311950|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
155311951|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
155311952|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
155311953|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
155311954|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
155416308|NCT03529773|560954748|FG015|Overall Study|Protocol Violation|0|||
155416309|NCT03529773|560954749|FG016|Overall Study|Protocol Violation|0|||
155416310|NCT03529773|560954750|FG017|Overall Study|Protocol Violation|0|||
155416311|NCT03529773|560954751|FG018|Overall Study|Protocol Violation|0|||
155416312|NCT03529773|560954752|FG019|Overall Study|Protocol Violation|0|||
155311955|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
155311956|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
155311957|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
155311958|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
155311959|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
155311960|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
155311961|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
155311962|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
155311963|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
155311964|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
155311965|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
155311966|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
155311967|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
155311968|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
155311969|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
155311970|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
155311971|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
155311972|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
155311973|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311974|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311975|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311976|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311977|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311978|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311979|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
155311980|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311981|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311982|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311983|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311984|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311985|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
155311986|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311987|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311988|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155416313|NCT03529773|560954753|FG020|Overall Study|Protocol Violation|0|||
155416314|NCT03529773|560954754|FG021|Overall Study|Protocol Violation|0|||
155416315|NCT03529773|560954755|FG022|Overall Study|Protocol Violation|0|||
155416316|NCT03529773|560954756|FG023|Overall Study|Protocol Violation|0|||
155498969|NCT00765999|561252623|FG000|Overall Study|Lost to Follow-up|131|||
155311989|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311990|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311991|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311992|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311993|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311994|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311995|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311996|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311997|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311998|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311999|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155312000|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312001|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312002|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312003|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312004|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312005|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312006|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312007|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312008|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312009|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312010|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312011|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312012|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
155312013|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312014|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312015|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312016|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312017|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312018|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312019|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312020|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312021|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312022|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312023|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312024|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312025|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312026|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312027|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312028|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312029|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312030|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312031|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312032|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312033|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312034|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312035|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312036|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312037|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312038|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312039|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312040|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312041|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312042|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155312043|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312044|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
155312045|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
155312046|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155750486|NCT04704154|562185350|FG003|Overall Study|Physician Decision|0|||
155750487|NCT04704154|562185351|FG004|Overall Study|Physician Decision|2|||
155750488|NCT04704154|562185352|FG005|Overall Study|Physician Decision|0|||
155750489|NCT04704154|562185347|FG000|Overall Study|Participant Decision|1|||
155750490|NCT04704154|562185348|FG001|Overall Study|Participant Decision|1|||
155750491|NCT04704154|562185349|FG002|Overall Study|Participant Decision|0|||
155750492|NCT04704154|562185350|FG003|Overall Study|Participant Decision|0|||
155312047|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312048|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312049|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312050|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312051|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155312052|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312053|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312054|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312055|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312056|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312057|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312058|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312059|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312060|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312061|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312062|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312063|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312064|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312065|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312066|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312067|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312068|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312069|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312070|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
155312071|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312072|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
155312073|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
155312074|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312075|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312076|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312077|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312078|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312079|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312080|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312081|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312082|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312083|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312084|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312085|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312086|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312087|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312088|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312089|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312090|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312091|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312092|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312093|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312094|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312095|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312096|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312097|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312098|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312099|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312100|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
155312101|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312102|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312103|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312104|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312105|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312106|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155643059|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
155312107|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312108|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312109|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312110|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312111|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312112|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312113|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312114|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312115|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312116|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312117|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312118|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312119|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312120|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312121|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312122|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312123|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
155312124|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312125|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312126|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155498970|NCT00765999|561252623|FG000|Overall Study|Study Terminated by Sponsor|2|||
155498971|NCT00765999|561252623|FG000|Overall Study|Other Miscellaneous Reasons|51|||
155498972|NCT00759174|561252626|FG000|Overall Study|Other|0|||
155498973|NCT00759174|561252627|FG001|Overall Study|Other|2|||
155498974|NCT01890109|561252628|FG000|Overall Study|Withdrawal by Subject|0|||
155498975|NCT01890109|561252629|FG001|Overall Study|Withdrawal by Subject|3|||
155498976|NCT01890109|561252628|FG000|Overall Study|Lost to Follow-up|1|||
155498977|NCT01890109|561252629|FG001|Overall Study|Lost to Follow-up|2|||
155750493|NCT04704154|562185351|FG004|Overall Study|Participant Decision|0|||
155750494|NCT04704154|562185352|FG005|Overall Study|Participant Decision|0|||
155750495|NCT04704154|562185347|FG000|Overall Study|Progressive Disease|19|||
155750496|NCT04704154|562185348|FG001|Overall Study|Progressive Disease|17|||
155750497|NCT04704154|562185349|FG002|Overall Study|Progressive Disease|20|||
155750498|NCT04704154|562185350|FG003|Overall Study|Progressive Disease|18|||
155750499|NCT04704154|562185351|FG004|Overall Study|Progressive Disease|36|||
155750500|NCT04704154|562185352|FG005|Overall Study|Progressive Disease|30|||
155750501|NCT04704154|562185347|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
155498978|NCT01643928|561252630|FG000|Overall Study|Lost to Follow-up|1|||
155498979|NCT01643928|561252631|FG001|Overall Study|Lost to Follow-up|0|||
155498980|NCT01643928|561252632|FG002|Overall Study|Lost to Follow-up|2|||
155498981|NCT01643928|561252633|FG003|Overall Study|Lost to Follow-up|0|||
155498982|NCT01643928|561252634|FG004|Overall Study|Lost to Follow-up|0|||
155498983|NCT01643928|561252630|FG000|Overall Study|Withdrawal by Subject|2|||
155498984|NCT01643928|561252631|FG001|Overall Study|Withdrawal by Subject|0|||
155498985|NCT01643928|561252632|FG002|Overall Study|Withdrawal by Subject|0|||
155498986|NCT01643928|561252633|FG003|Overall Study|Withdrawal by Subject|1|||
155498987|NCT01643928|561252634|FG004|Overall Study|Withdrawal by Subject|0|||
155498988|NCT01643928|561252630|FG000|Overall Study|Pregnancy|0|||
155750502|NCT04704154|562185348|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155750503|NCT04704154|562185349|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
155750504|NCT04704154|562185350|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155750505|NCT04704154|562185351|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
155750506|NCT04704154|562185352|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155312127|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312128|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312129|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312130|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
155312131|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312132|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312133|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312134|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155498989|NCT01643928|561252631|FG001|Overall Study|Pregnancy|0|||
155498990|NCT01643928|561252632|FG002|Overall Study|Pregnancy|0|||
155498991|NCT01643928|561252633|FG003|Overall Study|Pregnancy|1|||
155498992|NCT01643928|561252634|FG004|Overall Study|Pregnancy|0|||
155498993|NCT01643928|561252630|FG000|Overall Study|Other|5|||
155498994|NCT01643928|561252631|FG001|Overall Study|Other|1|||
155750507|NCT04704154|562185347|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
155750508|NCT04704154|562185348|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
155750509|NCT04704154|562185349|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
155750510|NCT04704154|562185350|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
155750511|NCT04704154|562185351|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
155750512|NCT04704154|562185352|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
155750513|NCT04950608|562185353|FG000|Overall Study|Withdrawal by Subject|2|||
155750514|NCT04950608|562185353|FG000|Overall Study|Physician Decision|3|||
155750515|NCT03553836|562185354|FG000|Overall Study|Ongoing in Study|460|||
155750516|NCT03553836|562185355|FG001|Overall Study|Ongoing in Study|459|||
155750517|NCT03553836|562185354|FG000|Overall Study|Withdrawal by Subject|9|||
155750518|NCT03553836|562185355|FG001|Overall Study|Withdrawal by Subject|10|||
155750519|NCT03553836|562185354|FG000|Overall Study|Lost to Follow-up|1|||
155750520|NCT03553836|562185355|FG001|Overall Study|Lost to Follow-up|3|||
155750521|NCT03553836|562185354|FG000|Overall Study|Death|17|||
155750522|NCT03553836|562185355|FG001|Overall Study|Death|17|||
155750523|NCT03220438|562185356|FG000|Overall Study|Lost to Follow-up|0|||
155750524|NCT03220438|562185357|FG001|Overall Study|Lost to Follow-up|0|||
155750525|NCT03220438|562185358|FG002|Overall Study|Lost to Follow-up|1|||
155750526|NCT03220438|562185359|FG003|Overall Study|Lost to Follow-up|0|||
155750527|NCT04190680|562185360|FG000|Overall Study|Not meeting criteria for data analysis|1|||
155750528|NCT04190680|562185361|FG001|Overall Study|Not meeting criteria for data analysis|15|||
155750529|NCT04190680|562185360|FG000|Overall Study|Administrative error|0|||
155750530|NCT04190680|562185361|FG001|Overall Study|Administrative error|18|||
155750531|NCT05660850|562185363|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
155750532|NCT05660850|562185364|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
155750533|NCT05660850|562185365|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
155750534|NCT05660850|562185366|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
155750535|NCT01634178|562185369|FG000|Treatment Period 1|Adverse Event|0|||
155750536|NCT01634178|562185370|FG001|Treatment Period 1|Adverse Event|1|||
155750537|NCT01634178|562185369|FG000|Treatment Period 2|Adverse Event|1|||
155750538|NCT01634178|562185370|FG001|Treatment Period 2|Adverse Event|0|||
155750539|NCT02483533|562185375|FG000|Overall Study|Lack of Efficacy|50|||
155750540|NCT02483533|562185376|FG001|Overall Study|Lack of Efficacy|50|||
155416317|NCT03529773|560954757|FG024|Overall Study|Protocol Violation|0|||
155416318|NCT03529773|560954758|FG025|Overall Study|Protocol Violation|0|||
155416319|NCT03529773|560954759|FG026|Overall Study|Protocol Violation|0|||
155416320|NCT03529773|560954760|FG027|Overall Study|Protocol Violation|0|||
155416321|NCT03529773|560954761|FG028|Overall Study|Protocol Violation|0|||
155416322|NCT03529773|560954762|FG029|Overall Study|Protocol Violation|0|||
155416323|NCT03529773|560954763|FG030|Overall Study|Protocol Violation|1|||
155416324|NCT03529773|560954764|FG031|Overall Study|Protocol Violation|0|||
155416325|NCT03529773|560954765|FG032|Overall Study|Protocol Violation|0|||
155416326|NCT03529773|560954766|FG033|Overall Study|Protocol Violation|0|||
155416327|NCT03529773|560954767|FG034|Overall Study|Protocol Violation|0|||
155416328|NCT03529773|560954768|FG035|Overall Study|Protocol Violation|0|||
155416329|NCT03529773|560954769|FG036|Overall Study|Protocol Violation|0|||
155416330|NCT03529773|560954770|FG037|Overall Study|Protocol Violation|0|||
155416331|NCT03529773|560954771|FG038|Overall Study|Protocol Violation|0|||
155416332|NCT03529773|560954772|FG039|Overall Study|Protocol Violation|0|||
155416333|NCT03529773|560954733|FG000|Overall Study|Withdrawal by Subject|0|||
155416334|NCT03529773|560954734|FG001|Overall Study|Withdrawal by Subject|0|||
155416335|NCT03529773|560954735|FG002|Overall Study|Withdrawal by Subject|0|||
155416336|NCT03529773|560954736|FG003|Overall Study|Withdrawal by Subject|0|||
155416337|NCT03529773|560954737|FG004|Overall Study|Withdrawal by Subject|0|||
155416338|NCT03529773|560954738|FG005|Overall Study|Withdrawal by Subject|0|||
155416339|NCT03529773|560954739|FG006|Overall Study|Withdrawal by Subject|0|||
155416340|NCT03529773|560954740|FG007|Overall Study|Withdrawal by Subject|1|||
155416341|NCT03529773|560954741|FG008|Overall Study|Withdrawal by Subject|0|||
155416342|NCT03529773|560954742|FG009|Overall Study|Withdrawal by Subject|1|||
155416343|NCT03529773|560954743|FG010|Overall Study|Withdrawal by Subject|1|||
155416344|NCT03529773|560954744|FG011|Overall Study|Withdrawal by Subject|0|||
155416345|NCT03529773|560954745|FG012|Overall Study|Withdrawal by Subject|0|||
155416346|NCT03529773|560954746|FG013|Overall Study|Withdrawal by Subject|0|||
155416347|NCT03529773|560954747|FG014|Overall Study|Withdrawal by Subject|0|||
155416348|NCT03529773|560954748|FG015|Overall Study|Withdrawal by Subject|3|||
155416349|NCT03529773|560954749|FG016|Overall Study|Withdrawal by Subject|0|||
155416350|NCT03529773|560954750|FG017|Overall Study|Withdrawal by Subject|2|||
155416351|NCT03529773|560954751|FG018|Overall Study|Withdrawal by Subject|3|||
155416352|NCT03529773|560954752|FG019|Overall Study|Withdrawal by Subject|1|||
155416353|NCT03529773|560954753|FG020|Overall Study|Withdrawal by Subject|3|||
155416354|NCT03529773|560954754|FG021|Overall Study|Withdrawal by Subject|1|||
155416355|NCT03529773|560954755|FG022|Overall Study|Withdrawal by Subject|1|||
155416356|NCT03529773|560954756|FG023|Overall Study|Withdrawal by Subject|2|||
155416357|NCT03529773|560954757|FG024|Overall Study|Withdrawal by Subject|2|||
155750541|NCT00879879|562185381|FG000|Overall Study|Death|1|||
155750542|NCT00879879|562185381|FG000|Overall Study|Withdrawal by Subject|1|||
155750543|NCT00879879|562185381|FG000|Overall Study|Physician Decision|1|||
155750544|NCT00327470|562185385|FG000|Overall Study|Randomized, but not treated|0|||
155750545|NCT00327470|562185386|FG001|Overall Study|Randomized, but not treated|2|||
155750546|NCT00327470|562185385|FG000|Overall Study|Adverse Event|9|||
155750547|NCT00327470|562185386|FG001|Overall Study|Adverse Event|14|||
155750548|NCT00327470|562185385|FG000|Overall Study|Lack of Efficacy|7|||
155750549|NCT00327470|562185386|FG001|Overall Study|Lack of Efficacy|19|||
155750550|NCT00327470|562185385|FG000|Overall Study|Other|5|||
155750551|NCT00327470|562185386|FG001|Overall Study|Other|9|||
155750552|NCT00327470|562185385|FG000|Overall Study|Lost to Follow-up|1|||
155750553|NCT00327470|562185386|FG001|Overall Study|Lost to Follow-up|3|||
155750554|NCT00327470|562185385|FG000|Overall Study|Withdrawal by Subject|6|||
155750555|NCT00327470|562185386|FG001|Overall Study|Withdrawal by Subject|12|||
155750556|NCT00327470|562185385|FG000|Overall Study|Death|1|||
155750557|NCT00327470|562185386|FG001|Overall Study|Death|4|||
155750558|NCT02581943|562185387|FG000|Overall Study|Death|5|||
155750559|NCT02581943|562185388|FG001|Overall Study|Death|2|||
155750560|NCT02581943|562185387|FG000|Overall Study|Disease Progression|12|||
155750561|NCT02581943|562185388|FG001|Overall Study|Disease Progression|15|||
155750562|NCT02581943|562185387|FG000|Overall Study|Withdrawal by Subject|1|||
155750563|NCT02581943|562185388|FG001|Overall Study|Withdrawal by Subject|2|||
155750564|NCT03783702|562185389|FG000|Overall Study|Lost to Follow-up|6|||
155750565|NCT03783702|562185390|FG001|Overall Study|Lost to Follow-up|8|||
155750566|NCT03783702|562185389|FG000|Overall Study|Protocol Violation|1|||
155750567|NCT03783702|562185390|FG001|Overall Study|Protocol Violation|3|||
155750568|NCT00745615|562185391|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
155750569|NCT00745615|562185392|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
155750570|NCT00745615|562185393|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155750571|NCT00745615|562185394|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
155750572|NCT00745615|562185395|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155312135|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312136|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312137|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312138|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312139|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312140|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312141|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312142|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312143|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312144|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155498995|NCT01643928|561252632|FG002|Overall Study|Other|1|||
155312145|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312146|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312147|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312148|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
155312149|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
155498996|NCT01643928|561252633|FG003|Overall Study|Other|0|||
155498997|NCT01643928|561252634|FG004|Overall Study|Other|0|||
155643060|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
155643061|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
155643062|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
155643063|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
155643064|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
155643065|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
155643066|NCT02337946|561782390|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
155643067|NCT02337946|561782391|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
155643068|NCT02337946|561782392|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
155643069|NCT02513563|561782393|FG000|Overall Study|Death|4|||
155643070|NCT02513563|561782393|FG000|Overall Study|Withdrawal by Subject|4|||
155643071|NCT02513563|561782393|FG000|Overall Study|Physician Decision|1|||
155643072|NCT03770455|561782401|FG000|Overall Study|Screen failures|3|||
155643073|NCT01121575|561782402|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
155750573|NCT00745615|562185396|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155750574|NCT00745615|562185391|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155312150|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
155312151|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
155312152|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155498998|NCT01643928|561252630|FG000|Overall Study|Adverse Event|2|||
155643074|NCT01121575|561782403|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
155498999|NCT01643928|561252631|FG001|Overall Study|Adverse Event|1|||
155499000|NCT01643928|561252632|FG002|Overall Study|Adverse Event|0|||
155499001|NCT01643928|561252633|FG003|Overall Study|Adverse Event|1|||
155499002|NCT01643928|561252634|FG004|Overall Study|Adverse Event|2|||
155499003|NCT05723835|561252637|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
155499004|NCT05723835|561252638|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
155499005|NCT05723835|561252639|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
155499006|NCT05723835|561252640|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
155499007|NCT05723835|561252641|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
155499008|NCT05723835|561252642|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
155750575|NCT00745615|562185392|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
155750576|NCT00745615|562185393|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155750577|NCT00745615|562185394|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155750578|NCT00745615|562185395|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155750579|NCT00745615|562185396|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155750580|NCT00745615|562185391|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
155750581|NCT00745615|562185392|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
155750582|NCT00745615|562185393|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
155750583|NCT00745615|562185394|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
155750584|NCT00745615|562185395|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
155750585|NCT00745615|562185396|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
155750586|NCT00745615|562185391|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155750587|NCT00745615|562185392|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
155750588|NCT00745615|562185393|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155750589|NCT00745615|562185394|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155750590|NCT00745615|562185395|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155750591|NCT00745615|562185396|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155750592|NCT00745615|562185391|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155750593|NCT00745615|562185392|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
155750594|NCT00745615|562185393|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155750595|NCT00745615|562185394|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155750596|NCT00745615|562185395|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155643075|NCT01121575|561782404|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
155416358|NCT03529773|560954758|FG025|Overall Study|Withdrawal by Subject|4|||
155416359|NCT03529773|560954759|FG026|Overall Study|Withdrawal by Subject|2|||
155416360|NCT03529773|560954760|FG027|Overall Study|Withdrawal by Subject|1|||
155416361|NCT03529773|560954761|FG028|Overall Study|Withdrawal by Subject|1|||
155643076|NCT01121575|561782405|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
155416362|NCT03529773|560954762|FG029|Overall Study|Withdrawal by Subject|0|||
155416363|NCT03529773|560954763|FG030|Overall Study|Withdrawal by Subject|0|||
155416364|NCT03529773|560954764|FG031|Overall Study|Withdrawal by Subject|0|||
155416365|NCT03529773|560954765|FG032|Overall Study|Withdrawal by Subject|0|||
155416366|NCT03529773|560954766|FG033|Overall Study|Withdrawal by Subject|0|||
155416367|NCT03529773|560954767|FG034|Overall Study|Withdrawal by Subject|1|||
155416368|NCT03529773|560954768|FG035|Overall Study|Withdrawal by Subject|2|||
155416369|NCT03529773|560954769|FG036|Overall Study|Withdrawal by Subject|0|||
155416370|NCT03529773|560954770|FG037|Overall Study|Withdrawal by Subject|2|||
155643077|NCT01121575|561782406|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
155643078|NCT01121575|561782407|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
155643079|NCT01121575|561782402|FG000|Overall Study|Unspecified Reasons|8|||
155643080|NCT01121575|561782403|FG001|Overall Study|Unspecified Reasons|6|||
155643081|NCT01121575|561782404|FG002|Overall Study|Unspecified Reasons|7|||
155643082|NCT01121575|561782405|FG003|Overall Study|Unspecified Reasons|5|||
155643083|NCT01121575|561782406|FG004|Overall Study|Unspecified Reasons|13|||
155643084|NCT01121575|561782407|FG005|Overall Study|Unspecified Reasons|10|||
155643085|NCT01121575|561782402|FG000|Overall Study|Death|6|||
155643086|NCT01121575|561782403|FG001|Overall Study|Death|0|||
155643087|NCT01121575|561782404|FG002|Overall Study|Death|0|||
155643088|NCT01121575|561782405|FG003|Overall Study|Death|1|||
155643089|NCT01121575|561782406|FG004|Overall Study|Death|7|||
155643090|NCT01121575|561782407|FG005|Overall Study|Death|1|||
155643091|NCT05417113|561783741|FG000|Overall Study|Lost to Follow-up|2|||
155643092|NCT05417113|561783742|FG001|Overall Study|Lost to Follow-up|2|||
155643093|NCT00134719|561783743|FG000|Primary Vaccination Phase|Adverse Event|4|||
155643094|NCT00134719|561783744|FG001|Primary Vaccination Phase|Adverse Event|0|||
155643095|NCT00134719|561783745|FG002|Primary Vaccination Phase|Adverse Event|0|||
155643096|NCT00134719|561783743|FG000|Primary Vaccination Phase|Protocol Violation|1|||
155643097|NCT00134719|561783744|FG001|Primary Vaccination Phase|Protocol Violation|0|||
155643098|NCT00134719|561783745|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155643099|NCT00134719|561783743|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
155643100|NCT00134719|561783744|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
155643101|NCT00134719|561783745|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
155643102|NCT00134719|561783743|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
155643103|NCT00134719|561783744|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
155643104|NCT00134719|561783745|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
155643105|NCT00134719|561783743|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
155643106|NCT00134719|561783744|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
155643107|NCT00134719|561783745|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
155643108|NCT00134719|561783743|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
155643109|NCT00134719|561783744|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
155643110|NCT00134719|561783745|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
155643111|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155643112|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
155643113|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
155643114|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155643115|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155643116|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155643117|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155643118|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
155643119|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155643120|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
155643121|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155643122|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155643123|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155643124|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155750597|NCT00745615|562185396|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155643125|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155643126|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155643127|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
155643128|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155643129|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155643130|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155643131|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155750598|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155750599|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155750600|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155750601|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155750602|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
155750603|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
155750604|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155750605|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155750606|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155750607|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155750608|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
155312153|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
155312154|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
155416371|NCT03529773|560954771|FG038|Overall Study|Withdrawal by Subject|1|||
155416372|NCT03529773|560954772|FG039|Overall Study|Withdrawal by Subject|1|||
155416373|NCT03529773|560954733|FG000|Overall Study|Screen Failure|0|||
155416374|NCT03529773|560954734|FG001|Overall Study|Screen Failure|0|||
155416375|NCT03529773|560954735|FG002|Overall Study|Screen Failure|0|||
155416376|NCT03529773|560954736|FG003|Overall Study|Screen Failure|0|||
155416377|NCT03529773|560954737|FG004|Overall Study|Screen Failure|0|||
155416378|NCT03529773|560954738|FG005|Overall Study|Screen Failure|0|||
155416379|NCT03529773|560954739|FG006|Overall Study|Screen Failure|0|||
155416380|NCT03529773|560954740|FG007|Overall Study|Screen Failure|0|||
155416381|NCT03529773|560954741|FG008|Overall Study|Screen Failure|0|||
155416382|NCT03529773|560954742|FG009|Overall Study|Screen Failure|0|||
155416383|NCT03529773|560954743|FG010|Overall Study|Screen Failure|0|||
155416384|NCT03529773|560954744|FG011|Overall Study|Screen Failure|0|||
155416385|NCT03529773|560954745|FG012|Overall Study|Screen Failure|0|||
155416386|NCT03529773|560954746|FG013|Overall Study|Screen Failure|0|||
155416387|NCT03529773|560954747|FG014|Overall Study|Screen Failure|0|||
155416388|NCT03529773|560954748|FG015|Overall Study|Screen Failure|0|||
155416389|NCT03529773|560954749|FG016|Overall Study|Screen Failure|0|||
155416390|NCT03529773|560954750|FG017|Overall Study|Screen Failure|0|||
155416391|NCT03529773|560954751|FG018|Overall Study|Screen Failure|0|||
155416392|NCT03529773|560954752|FG019|Overall Study|Screen Failure|0|||
155416393|NCT03529773|560954753|FG020|Overall Study|Screen Failure|0|||
155416394|NCT03529773|560954754|FG021|Overall Study|Screen Failure|0|||
155416395|NCT03529773|560954755|FG022|Overall Study|Screen Failure|0|||
155416396|NCT03529773|560954756|FG023|Overall Study|Screen Failure|0|||
155416397|NCT03529773|560954757|FG024|Overall Study|Screen Failure|0|||
155416398|NCT03529773|560954758|FG025|Overall Study|Screen Failure|0|||
155312155|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312156|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312157|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312158|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312159|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312160|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312161|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312162|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312163|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312164|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312165|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312166|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312167|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312168|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312169|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312170|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312171|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312172|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312173|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155416399|NCT03529773|560954759|FG026|Overall Study|Screen Failure|0|||
155416400|NCT03529773|560954760|FG027|Overall Study|Screen Failure|0|||
155416401|NCT03529773|560954761|FG028|Overall Study|Screen Failure|0|||
155416402|NCT03529773|560954762|FG029|Overall Study|Screen Failure|0|||
155416403|NCT03529773|560954763|FG030|Overall Study|Screen Failure|0|||
155416404|NCT03529773|560954764|FG031|Overall Study|Screen Failure|0|||
155416405|NCT03529773|560954765|FG032|Overall Study|Screen Failure|0|||
155416406|NCT03529773|560954766|FG033|Overall Study|Screen Failure|0|||
155750609|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
155750610|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155750611|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155750612|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155750613|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155750614|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
155750615|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
155750616|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155750617|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155750618|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155750619|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155750620|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
155750621|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
155750622|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155750623|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155750624|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155750625|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155750626|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
155750627|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
155750628|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155750629|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155750630|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155750631|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155750632|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
155750633|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
155750634|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155750635|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155750636|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155750637|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155750638|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155750639|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
155750640|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
155750641|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
155750642|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
155750643|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
155750644|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
155416407|NCT03529773|560954767|FG034|Overall Study|Screen Failure|0|||
155416408|NCT03529773|560954768|FG035|Overall Study|Screen Failure|0|||
155416409|NCT03529773|560954769|FG036|Overall Study|Screen Failure|1|||
155416410|NCT03529773|560954770|FG037|Overall Study|Screen Failure|1|||
155416411|NCT03529773|560954771|FG038|Overall Study|Screen Failure|0|||
155416412|NCT03529773|560954772|FG039|Overall Study|Screen Failure|1|||
155416413|NCT03529773|560954733|FG000|Overall Study|Randomized but not vaccinated|0|||
155416414|NCT03529773|560954734|FG001|Overall Study|Randomized but not vaccinated|0|||
155416415|NCT03529773|560954735|FG002|Overall Study|Randomized but not vaccinated|0|||
155416416|NCT03529773|560954736|FG003|Overall Study|Randomized but not vaccinated|0|||
155416417|NCT03529773|560954737|FG004|Overall Study|Randomized but not vaccinated|0|||
155416418|NCT03529773|560954738|FG005|Overall Study|Randomized but not vaccinated|0|||
155416419|NCT03529773|560954739|FG006|Overall Study|Randomized but not vaccinated|0|||
155416420|NCT03529773|560954740|FG007|Overall Study|Randomized but not vaccinated|0|||
155416421|NCT03529773|560954741|FG008|Overall Study|Randomized but not vaccinated|0|||
155416422|NCT03529773|560954742|FG009|Overall Study|Randomized but not vaccinated|0|||
155416423|NCT03529773|560954743|FG010|Overall Study|Randomized but not vaccinated|0|||
155416424|NCT03529773|560954744|FG011|Overall Study|Randomized but not vaccinated|0|||
155416425|NCT03529773|560954745|FG012|Overall Study|Randomized but not vaccinated|0|||
155416426|NCT03529773|560954746|FG013|Overall Study|Randomized but not vaccinated|0|||
155416427|NCT03529773|560954747|FG014|Overall Study|Randomized but not vaccinated|0|||
155416428|NCT03529773|560954748|FG015|Overall Study|Randomized but not vaccinated|0|||
155416429|NCT03529773|560954749|FG016|Overall Study|Randomized but not vaccinated|0|||
155416430|NCT03529773|560954750|FG017|Overall Study|Randomized but not vaccinated|1|||
155416431|NCT03529773|560954751|FG018|Overall Study|Randomized but not vaccinated|0|||
155750645|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
155750646|NCT00745615|562185391|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155750647|NCT00745615|562185392|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155750648|NCT00745615|562185393|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155750649|NCT00745615|562185394|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155750650|NCT00745615|562185395|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
155750651|NCT00745615|562185396|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
155750652|NCT01076075|562185397|FG000|Overall Study|Adverse Event|3|||
155750653|NCT01076075|562185398|FG001|Overall Study|Adverse Event|9|||
155312174|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312175|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
155499009|NCT05723835|561252643|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
155499010|NCT05723835|561252644|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
155499011|NCT05226286|561252645|FG000|Overall Study|Screen failures prior to implant|62|||
155499012|NCT05226286|561252645|FG000|Overall Study|Withdrawal by Subject|13|||
155499013|NCT05226286|561252645|FG000|Overall Study|Lost to Follow-up|3|||
155499014|NCT05226286|561252645|FG000|Overall Study|Physician Decision|1|||
155499015|NCT05226286|561252645|FG000|Overall Study|Adverse Event|1|||
155499016|NCT05226286|561252645|FG000|Overall Study|Death|1|||
155499017|NCT05226286|561252645|FG000|Overall Study|Device explant with no planned replacement|1|||
155499018|NCT05226286|561252645|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
155499019|NCT05226286|561252645|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
155312176|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155750654|NCT01076075|562185397|FG000|Overall Study|Lack of Efficacy|5|||
155750655|NCT01076075|562185398|FG001|Overall Study|Lack of Efficacy|4|||
155750656|NCT01076075|562185397|FG000|Overall Study|Lost to Follow-up|6|||
155312177|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312178|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155750657|NCT01076075|562185398|FG001|Overall Study|Lost to Follow-up|5|||
155750658|NCT01076075|562185397|FG000|Overall Study|other|19|||
155750659|NCT01076075|562185398|FG001|Overall Study|other|9|||
155750660|NCT01076075|562185397|FG000|Overall Study|Protocol Violation|0|||
155750661|NCT01076075|562185398|FG001|Overall Study|Protocol Violation|1|||
155750662|NCT01076075|562185397|FG000|Overall Study|Withdrawal by Subject|8|||
155750663|NCT01076075|562185398|FG001|Overall Study|Withdrawal by Subject|19|||
155750664|NCT01615029|562185405|FG000|Overall Study|Adverse Event|1|||
155750665|NCT01615029|562185406|FG001|Overall Study|Adverse Event|0|||
155750666|NCT01615029|562185407|FG002|Overall Study|Adverse Event|3|||
155750667|NCT01615029|562185408|FG003|Overall Study|Adverse Event|0|||
155750668|NCT01615029|562185409|FG004|Overall Study|Adverse Event|4|||
155750669|NCT01615029|562185405|FG000|Overall Study|Progressive disease|1|||
155750670|NCT01615029|562185406|FG001|Overall Study|Progressive disease|1|||
155750671|NCT01615029|562185407|FG002|Overall Study|Progressive disease|1|||
155750672|NCT01615029|562185408|FG003|Overall Study|Progressive disease|1|||
155750673|NCT01615029|562185409|FG004|Overall Study|Progressive disease|10|||
155312179|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312180|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312181|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
155312182|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312183|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312184|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
155312185|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312186|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312187|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
155312188|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312189|NCT02783300|560575212|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312190|NCT02783300|560575213|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312191|NCT02783300|560575214|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312192|NCT02783300|560575215|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312193|NCT02783300|560575216|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312194|NCT02783300|560575217|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312195|NCT02783300|560575218|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312196|NCT02783300|560575219|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312197|NCT02783300|560575220|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312198|NCT02783300|560575221|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312199|NCT02783300|560575222|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312200|NCT02783300|560575223|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312201|NCT02783300|560575224|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312202|NCT02783300|560575225|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312203|NCT02783300|560575226|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312204|NCT02783300|560575227|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312205|NCT02783300|560575228|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312206|NCT02783300|560575229|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312207|NCT02783300|560575230|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312208|NCT02783300|560575231|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312209|NCT02783300|560575232|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312210|NCT02783300|560575233|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312211|NCT02783300|560575234|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312212|NCT02783300|560575235|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312213|NCT02783300|560575236|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312214|NCT02783300|560575237|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312215|NCT02783300|560575238|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
155312216|NCT02783300|560575212|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312217|NCT02783300|560575213|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312218|NCT02783300|560575214|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312219|NCT02783300|560575215|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312220|NCT02783300|560575216|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312221|NCT02783300|560575217|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
155750674|NCT01615029|562185405|FG000|Overall Study|Physician Decision|0|||
155750675|NCT01615029|562185406|FG001|Overall Study|Physician Decision|0|||
155750676|NCT01615029|562185407|FG002|Overall Study|Physician Decision|0|||
155750677|NCT01615029|562185408|FG003|Overall Study|Physician Decision|0|||
155750678|NCT01615029|562185409|FG004|Overall Study|Physician Decision|2|||
155750679|NCT03764033|562185411|FG000|Treatment Phase|Withdrawal by Subject|8|||
155750680|NCT03764033|562185412|FG001|Treatment Phase|Withdrawal by Subject|3|||
155750681|NCT03764033|562185411|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
155750682|NCT03764033|562185412|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
155312222|NCT02783300|560575218|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312223|NCT02783300|560575219|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312224|NCT02783300|560575220|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312225|NCT02783300|560575221|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312226|NCT02783300|560575222|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
155750683|NCT03764033|562185411|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
155750684|NCT03764033|562185412|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
155750685|NCT01163318|562185413|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
155750686|NCT01163318|562185413|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
155750687|NCT01163318|562185413|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
155750688|NCT01163318|562185413|FG000|Overall Study|Participants Without Case Report Form|7|||
155750689|NCT01163318|562185413|FG000|Overall Study|Multiple Reasons Per Participant|224|||
155750690|NCT01892722|562185414|FG000|Overall Study|Protocol deviation|0|||
155750691|NCT01892722|562185415|FG001|Overall Study|Protocol deviation|1|||
155750692|NCT01892722|562185414|FG000|Overall Study|Administrative problems|0|||
155750693|NCT01892722|562185415|FG001|Overall Study|Administrative problems|1|||
155750694|NCT01892722|562185414|FG000|Overall Study|Patient/guardian decision|0|||
155750695|NCT01892722|562185415|FG001|Overall Study|Patient/guardian decision|2|||
155750696|NCT01892722|562185414|FG000|Overall Study|Physician Decision|1|||
155750697|NCT01892722|562185415|FG001|Overall Study|Physician Decision|2|||
155750698|NCT01892722|562185414|FG000|Overall Study|Adverse Event|3|||
155750699|NCT01892722|562185415|FG001|Overall Study|Adverse Event|2|||
155750700|NCT01892722|562185414|FG000|Overall Study|Lack of Efficacy|0|||
155750701|NCT01892722|562185415|FG001|Overall Study|Lack of Efficacy|7|||
155750702|NCT01892722|562185414|FG000|Overall Study|Withdrawal by Subject|3|||
155750703|NCT01892722|562185415|FG001|Overall Study|Withdrawal by Subject|5|||
155750704|NCT02604017|562186143|FG000|Overall Study|Withdrew Consent|0|||
155750705|NCT02604017|562186144|FG001|Overall Study|Withdrew Consent|2|||
155750706|NCT02604017|562186143|FG000|Overall Study|Lost to Follow-up|5|||
155750707|NCT02604017|562186144|FG001|Overall Study|Lost to Follow-up|6|||
155750708|NCT02604017|562186143|FG000|Overall Study|Other|1|||
155750709|NCT02604017|562186144|FG001|Overall Study|Other|0|||
155750710|NCT04104438|562186145|FG000|Overall Study|Death|2|||
155312227|NCT02783300|560575223|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312228|NCT02783300|560575224|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312229|NCT02783300|560575225|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312230|NCT02783300|560575226|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312231|NCT02783300|560575227|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312232|NCT02783300|560575228|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312233|NCT02783300|560575229|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312234|NCT02783300|560575230|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
155750711|NCT04104438|562186146|FG001|Overall Study|Death|1|||
155750712|NCT04104438|562186147|FG002|Overall Study|Death|2|||
155750713|NCT04104438|562186145|FG000|Overall Study|Adverse Event|0|||
155750714|NCT04104438|562186146|FG001|Overall Study|Adverse Event|3|||
155750715|NCT04104438|562186147|FG002|Overall Study|Adverse Event|0|||
155750716|NCT04104438|562186145|FG000|Overall Study|Withdrawal by Subject|0|||
155750717|NCT04104438|562186146|FG001|Overall Study|Withdrawal by Subject|1|||
155750718|NCT04104438|562186147|FG002|Overall Study|Withdrawal by Subject|0|||
155750719|NCT04104438|562186145|FG000|Overall Study|Disenrolled due to noncompliance|0|||
155750720|NCT04104438|562186146|FG001|Overall Study|Disenrolled due to noncompliance|1|||
155750721|NCT04104438|562186147|FG002|Overall Study|Disenrolled due to noncompliance|0|||
155750722|NCT04104438|562186145|FG000|Overall Study|stopped due to possible operation|0|||
155750723|NCT04104438|562186146|FG001|Overall Study|stopped due to possible operation|1|||
155750724|NCT04104438|562186147|FG002|Overall Study|stopped due to possible operation|0|||
155750725|NCT04104438|562186145|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
155750726|NCT04104438|562186146|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
155312235|NCT02783300|560575231|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312236|NCT02783300|560575232|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312237|NCT02783300|560575233|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312238|NCT02783300|560575234|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312239|NCT02783300|560575235|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312240|NCT02783300|560575236|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312241|NCT02783300|560575237|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312242|NCT02783300|560575238|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
155312243|NCT03535272|560575239|FG000|Overall Study|Lost to Follow-up|71|||
155312244|NCT03535272|560575240|FG001|Overall Study|Lost to Follow-up|73|||
155312245|NCT01744782|560575241|FG000|Overall Study|Death|1|||
155312246|NCT00378105|560575242|FG000|Overall Study|Adverse Event|3|||
155312247|NCT00378105|560575243|FG001|Overall Study|Adverse Event|1|||
155312248|NCT00378105|560575242|FG000|Overall Study|Withdrawal by Subject|3|||
155312249|NCT00378105|560575243|FG001|Overall Study|Withdrawal by Subject|3|||
155312250|NCT00378105|560575242|FG000|Overall Study|Death|1|||
155312251|NCT00378105|560575243|FG001|Overall Study|Death|0|||
155312252|NCT00378105|560575242|FG000|Overall Study|Going to transplant|7|||
155312253|NCT00378105|560575243|FG001|Overall Study|Going to transplant|8|||
155312254|NCT00378105|560575242|FG000|Overall Study|Progressive disease|3|||
155416432|NCT03529773|560954752|FG019|Overall Study|Randomized but not vaccinated|0|||
155416433|NCT03529773|560954753|FG020|Overall Study|Randomized but not vaccinated|0|||
155416434|NCT03529773|560954754|FG021|Overall Study|Randomized but not vaccinated|0|||
155750727|NCT04104438|562186147|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
155750728|NCT01315236|562186150|FG000|Double-blind Phase|Death|1|||
155416435|NCT03529773|560954755|FG022|Overall Study|Randomized but not vaccinated|0|||
155416436|NCT03529773|560954756|FG023|Overall Study|Randomized but not vaccinated|0|||
155416437|NCT03529773|560954757|FG024|Overall Study|Randomized but not vaccinated|0|||
155416438|NCT03529773|560954758|FG025|Overall Study|Randomized but not vaccinated|0|||
155416439|NCT03529773|560954759|FG026|Overall Study|Randomized but not vaccinated|0|||
155416440|NCT03529773|560954760|FG027|Overall Study|Randomized but not vaccinated|1|||
155416441|NCT03529773|560954761|FG028|Overall Study|Randomized but not vaccinated|0|||
155416442|NCT03529773|560954762|FG029|Overall Study|Randomized but not vaccinated|0|||
155750729|NCT01315236|562186151|FG001|Double-blind Phase|Death|0|||
155312255|NCT00378105|560575243|FG001|Overall Study|Progressive disease|3|||
155312256|NCT00378105|560575242|FG000|Overall Study|remain on study|3|||
155312257|NCT00378105|560575243|FG001|Overall Study|remain on study|11|||
155750730|NCT01315236|562186150|FG000|Double-blind Phase|Adverse Event|1|||
155750731|NCT01315236|562186151|FG001|Double-blind Phase|Adverse Event|0|||
155750732|NCT01315236|562186150|FG000|Double-blind Phase|Withdrawal of Consent|1|||
155750733|NCT01315236|562186151|FG001|Double-blind Phase|Withdrawal of Consent|0|||
155750734|NCT01315236|562186150|FG000|Double-blind Phase|Lost to Follow-up|1|||
155312258|NCT00378105|560575242|FG000|Overall Study|Physician Decision|0|||
155312259|NCT00378105|560575243|FG001|Overall Study|Physician Decision|2|||
155312260|NCT00378105|560575242|FG000|Overall Study|Going non-protocol therapy|0|||
155750735|NCT01315236|562186151|FG001|Double-blind Phase|Lost to Follow-up|0|||
155750736|NCT01315236|562186150|FG000|Open-label Phase|Death|1|||
155750737|NCT01315236|562186151|FG001|Open-label Phase|Death|0|||
155750738|NCT01315236|562186150|FG000|Open-label Phase|Adverse Event|0|||
155750739|NCT01315236|562186151|FG001|Open-label Phase|Adverse Event|1|||
155750740|NCT01315236|562186150|FG000|Open-label Phase|Other|0|||
155750741|NCT01315236|562186151|FG001|Open-label Phase|Other|1|||
155750742|NCT01315236|562186150|FG000|12-Month Follow-up Period|Death|0|||
155750743|NCT01315236|562186151|FG001|12-Month Follow-up Period|Death|1|||
155750744|NCT01315236|562186150|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
155312261|NCT00378105|560575243|FG001|Overall Study|Going non-protocol therapy|1|||
155750745|NCT01315236|562186151|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
155750746|NCT03116347|562186152|FG000|Overall Study|Withdrawal by Subject|1|||
155312262|NCT00378105|560575242|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
155312263|NCT00378105|560575243|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
155312264|NCT03623321|560575244|FG000|Overall Study|Adverse Event|32|||
155312265|NCT03623321|560575244|FG000|Overall Study|Death|9|||
155312266|NCT03623321|560575244|FG000|Overall Study|Lack of Efficacy|9|||
155312267|NCT03623321|560575244|FG000|Overall Study|Lost to Follow-up|6|||
155312268|NCT03623321|560575244|FG000|Overall Study|Noncompliance with study drug|6|||
155750747|NCT03116347|562186153|FG001|Overall Study|Withdrawal by Subject|2|||
155750748|NCT04193410|562186154|FG000|Overall Study|Lost to Follow-up|7|||
155750749|NCT04193410|562186155|FG001|Overall Study|Lost to Follow-up|6|||
155750750|NCT04973137|562186156|FG000|Double Blind Phase|Adverse Event|4|||
155750751|NCT04973137|562186157|FG001|Double Blind Phase|Adverse Event|0|||
155750752|NCT04973137|562186156|FG000|Double Blind Phase|Death|25|||
155312269|NCT03623321|560575244|FG000|Overall Study|Use of prohibited medication|3|||
155312270|NCT03623321|560575244|FG000|Overall Study|Physician Decision|5|||
155416443|NCT03529773|560954763|FG030|Overall Study|Randomized but not vaccinated|0|||
155416444|NCT03529773|560954764|FG031|Overall Study|Randomized but not vaccinated|0|||
155416445|NCT03529773|560954765|FG032|Overall Study|Randomized but not vaccinated|0|||
155416446|NCT03529773|560954766|FG033|Overall Study|Randomized but not vaccinated|0|||
155416447|NCT03529773|560954767|FG034|Overall Study|Randomized but not vaccinated|0|||
155416448|NCT03529773|560954768|FG035|Overall Study|Randomized but not vaccinated|0|||
155416449|NCT03529773|560954769|FG036|Overall Study|Randomized but not vaccinated|0|||
155416450|NCT03529773|560954770|FG037|Overall Study|Randomized but not vaccinated|0|||
155416451|NCT03529773|560954771|FG038|Overall Study|Randomized but not vaccinated|0|||
155416452|NCT03529773|560954772|FG039|Overall Study|Randomized but not vaccinated|0|||
155416453|NCT03237065|560954775|FG000|Overall Study|Adverse Event|0|||
155750753|NCT04973137|562186157|FG001|Double Blind Phase|Death|15|||
155750754|NCT04973137|562186156|FG000|Double Blind Phase|Physician Decision|5|||
155750755|NCT04973137|562186157|FG001|Double Blind Phase|Physician Decision|1|||
155312271|NCT03623321|560575244|FG000|Overall Study|Protocol Violation|1|||
155312272|NCT03623321|560575244|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
155750756|NCT04973137|562186156|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155750757|NCT04973137|562186157|FG001|Double Blind Phase|Withdrawal by Subject|1|||
155750758|NCT04973137|562186156|FG000|Double Blind Phase|Other|2|||
155750759|NCT04973137|562186157|FG001|Double Blind Phase|Other|2|||
155750760|NCT04973137|562186156|FG000|Open Label Extension Phase|Death|3|||
155312273|NCT03623321|560575244|FG000|Overall Study|Not further specified|43|||
155416454|NCT03237065|560954776|FG001|Overall Study|Adverse Event|2|||
155416455|NCT03237065|560954775|FG000|Overall Study|Protocol Violation|0|||
155416456|NCT03237065|560954776|FG001|Overall Study|Protocol Violation|1|||
155416457|NCT03237065|560954775|FG000|Overall Study|Withdrawal by Subject|3|||
155416458|NCT03237065|560954776|FG001|Overall Study|Withdrawal by Subject|0|||
155750761|NCT04973137|562186157|FG001|Open Label Extension Phase|Death|0|||
155312274|NCT04241068|560575247|FG000|Core Treatment Period|Adverse Event|91|||
155312275|NCT04241068|560575247|FG000|Core Treatment Period|Change of Treatment|4|||
155312276|NCT04241068|560575247|FG000|Core Treatment Period|Consent Withdrawn|143|||
155312277|NCT04241068|560575247|FG000|Core Treatment Period|Death|26|||
155312278|NCT04241068|560575247|FG000|Core Treatment Period|Disease Progression|67|||
155312279|NCT04241068|560575247|FG000|Core Treatment Period|Investigator Decision|40|||
155312280|NCT04241068|560575247|FG000|Core Treatment Period|Loss of Capacity|9|||
155312281|NCT04241068|560575247|FG000|Core Treatment Period|Lost to Follow-up|11|||
155312282|NCT04241068|560575247|FG000|Core Treatment Period|Relocation|4|||
155312283|NCT04241068|560575247|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
155312284|NCT04241068|560575247|FG000|Core Treatment Period|Study Visit Burden|40|||
155312285|NCT04241068|560575247|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
155416459|NCT03237065|560954775|FG000|Overall Study|Lost to Follow-up|1|||
155416460|NCT03237065|560954776|FG001|Overall Study|Lost to Follow-up|0|||
155416461|NCT03237065|560954775|FG000|Overall Study|Unable to obtain venous access|0|||
155416462|NCT03237065|560954776|FG001|Overall Study|Unable to obtain venous access|1|||
155416463|NCT00429858|560954777|FG000|Overall Study|Withdrawal by Subject|1|||
155416464|NCT00429858|560954777|FG000|Overall Study|Study Termination|1|||
155416465|NCT01537211|560954779|FG000|Overall Study|Lost to Follow-up|0|||
155416466|NCT01537211|560954780|FG001|Overall Study|Lost to Follow-up|1|||
155416467|NCT02475655|560954781|FG000|Overall Study|Lost to Follow-up|0|||
155750762|NCT04973137|562186156|FG000|Open Label Extension Phase|Physician Decision|0|||
155750763|NCT04973137|562186157|FG001|Open Label Extension Phase|Physician Decision|1|||
155750764|NCT04973137|562186156|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
155750765|NCT04973137|562186157|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155750766|NCT04973137|562186156|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
155750767|NCT04973137|562186157|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
155750768|NCT04973137|562186156|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
155750769|NCT04973137|562186157|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
155750770|NCT01293799|562186158|FG000|Overall Study|Kidney transplantation|109|||
155750771|NCT01293799|562186159|FG001|Overall Study|Kidney transplantation|96|||
155750772|NCT01293799|562186158|FG000|Overall Study|Transfer to hemodialysis|70|||
155750773|NCT01293799|562186159|FG001|Overall Study|Transfer to hemodialysis|90|||
155750774|NCT01293799|562186158|FG000|Overall Study|Death|27|||
155416468|NCT02475655|560954782|FG001|Overall Study|Lost to Follow-up|1|||
155416469|NCT00257010|560954787|FG000|Overall Study|Lack of Efficacy|11|||
155416470|NCT00257010|560954787|FG000|Overall Study|Lost to Follow-up|53|||
155416471|NCT00257010|560954787|FG000|Overall Study|Withdrawal by Subject|34|||
155416472|NCT00257010|560954787|FG000|Overall Study|Adverse Event|10|||
155416473|NCT00257010|560954787|FG000|Overall Study|various|11|||
155416474|NCT00257010|560954787|FG000|Overall Study|no headache reported|9|||
155416475|NCT00662792|560954788|FG000|Period 1|Personal Reasons|0|||
155416476|NCT00662792|560954789|FG001|Period 1|Personal Reasons|0|||
155416477|NCT00662792|560954790|FG002|Period 1|Personal Reasons|1|||
155416478|NCT00662792|560954791|FG003|Period 1|Personal Reasons|0|||
155416479|NCT00662792|560954788|FG000|Period 1|Refused continuing medication|0|||
155416480|NCT00662792|560954789|FG001|Period 1|Refused continuing medication|1|||
155416481|NCT00662792|560954790|FG002|Period 1|Refused continuing medication|1|||
155416482|NCT00662792|560954791|FG003|Period 1|Refused continuing medication|0|||
155750775|NCT01293799|562186159|FG001|Overall Study|Death|29|||
155750776|NCT01293799|562186158|FG000|Overall Study|Transfer to assisted PD|24|||
155750777|NCT01293799|562186159|FG001|Overall Study|Transfer to assisted PD|18|||
155750778|NCT01293799|562186158|FG000|Overall Study|Withdrawal by Subject|26|||
155750779|NCT01293799|562186159|FG001|Overall Study|Withdrawal by Subject|0|||
155750780|NCT01293799|562186158|FG000|Overall Study|Investigator decision|5|||
155750781|NCT01293799|562186159|FG001|Overall Study|Investigator decision|2|||
155750782|NCT01293799|562186158|FG000|Overall Study|Kidney function improved|6|||
155750783|NCT01293799|562186159|FG001|Overall Study|Kidney function improved|7|||
155750784|NCT01293799|562186158|FG000|Overall Study|Other causes|6|||
155750785|NCT01293799|562186159|FG001|Overall Study|Other causes|3|||
155750786|NCT01302834|562186168|FG000|Overall Study|Protocol Violation|17|||
155750787|NCT01302834|562186169|FG001|Overall Study|Protocol Violation|23|||
155750788|NCT01302834|562186168|FG000|Overall Study|HIV positive|1|||
155312286|NCT04241068|560575247|FG000|Core Treatment Period|Missing|2|||
155416483|NCT00662792|560954788|FG000|Period 1|Lost to Follow-up|1|||
155416484|NCT00662792|560954789|FG001|Period 1|Lost to Follow-up|0|||
155416485|NCT00662792|560954790|FG002|Period 1|Lost to Follow-up|0|||
155416486|NCT00662792|560954791|FG003|Period 1|Lost to Follow-up|0|||
155416487|NCT00662792|560954788|FG000|Period 1|Other adverse event (AE)|0|||
155416488|NCT00662792|560954789|FG001|Period 1|Other adverse event (AE)|2|||
155416489|NCT00662792|560954790|FG002|Period 1|Other adverse event (AE)|0|||
155416490|NCT00662792|560954791|FG003|Period 1|Other adverse event (AE)|0|||
155416491|NCT00662792|560954788|FG000|Period 1|Worsening of disease under study (AE)|1|||
155416492|NCT00662792|560954789|FG001|Period 1|Worsening of disease under study (AE)|3|||
155416493|NCT00662792|560954790|FG002|Period 1|Worsening of disease under study (AE)|2|||
155416494|NCT00662792|560954791|FG003|Period 1|Worsening of disease under study (AE)|0|||
155416495|NCT00662792|560954788|FG000|Period 1|Not treated|0|||
155499140|NCT00602641|561252652|FG000|Overall Study|Never started protocol therapy|6|||
155499141|NCT00602641|561252653|FG001|Overall Study|Never started protocol therapy|2|||
155499142|NCT00602641|561252652|FG000|Overall Study|Still on treatment at time of analysis|8|||
155750789|NCT01302834|562186169|FG001|Overall Study|HIV positive|3|||
155750790|NCT04779216|562186170|FG000|Overall Study|Lost to Follow-up|1|||
155750791|NCT04779216|562186171|FG001|Overall Study|Lost to Follow-up|0|||
155750792|NCT04779216|562186170|FG000|Overall Study|Withdrawal by Subject|1|||
155750793|NCT04779216|562186171|FG001|Overall Study|Withdrawal by Subject|0|||
155750794|NCT02674854|562186172|FG000|Overall Study|Adverse Event|17|||
155750795|NCT02674854|562186173|FG001|Overall Study|Adverse Event|15|||
155750796|NCT02674854|562186174|FG002|Overall Study|Adverse Event|5|||
155750797|NCT02674854|562186172|FG000|Overall Study|Withdrawal by Subject|1|||
155750798|NCT02674854|562186173|FG001|Overall Study|Withdrawal by Subject|5|||
155750799|NCT02674854|562186174|FG002|Overall Study|Withdrawal by Subject|4|||
155750800|NCT02674854|562186172|FG000|Overall Study|No-compliant subject|1|||
155750801|NCT02674854|562186173|FG001|Overall Study|No-compliant subject|0|||
155750802|NCT02674854|562186174|FG002|Overall Study|No-compliant subject|1|||
155750803|NCT02674854|562186172|FG000|Overall Study|Lost to Follow-up|1|||
155750804|NCT02674854|562186173|FG001|Overall Study|Lost to Follow-up|0|||
155750805|NCT02674854|562186174|FG002|Overall Study|Lost to Follow-up|2|||
155750806|NCT02674854|562186172|FG000|Overall Study|Lack of Efficacy|0|||
155750807|NCT02674854|562186173|FG001|Overall Study|Lack of Efficacy|3|||
155750808|NCT02674854|562186174|FG002|Overall Study|Lack of Efficacy|0|||
155750809|NCT02674854|562186172|FG000|Overall Study|Disallowed Concurrent Medication|2|||
155750810|NCT02674854|562186173|FG001|Overall Study|Disallowed Concurrent Medication|2|||
155750811|NCT02674854|562186174|FG002|Overall Study|Disallowed Concurrent Medication|0|||
155750812|NCT02674854|562186172|FG000|Overall Study|Protocol Violation|1|||
155750813|NCT02674854|562186173|FG001|Overall Study|Protocol Violation|1|||
155750814|NCT02674854|562186174|FG002|Overall Study|Protocol Violation|2|||
155750815|NCT02674854|562186172|FG000|Overall Study|Death|0|||
155750816|NCT02674854|562186173|FG001|Overall Study|Death|1|||
155750817|NCT02674854|562186174|FG002|Overall Study|Death|0|||
155750818|NCT02674854|562186172|FG000|Overall Study|Subject missed V6.2|1|||
155750819|NCT02674854|562186173|FG001|Overall Study|Subject missed V6.2|0|||
155750820|NCT02674854|562186174|FG002|Overall Study|Subject missed V6.2|0|||
155750821|NCT02274038|562186179|FG000|Overall Study|Death|1|||
155750822|NCT00570232|562186180|FG000|Overall Study|Adverse Event|10|||
155750823|NCT00570232|562186180|FG000|Overall Study|discontinued due to medical condition|3|||
155312287|NCT04241068|560575247|FG000|Core Treatment Period|Reason Not Specified|41|||
155312288|NCT04241068|560575247|FG000|LTE Period|Adverse Event|19|||
155312289|NCT04241068|560575247|FG000|LTE Period|Change of Treatment|1|||
155312290|NCT04241068|560575247|FG000|LTE Period|Consent Withdrawn|71|||
155312291|NCT04241068|560575247|FG000|LTE Period|Death|8|||
155312292|NCT04241068|560575247|FG000|LTE Period|Disease Progression|11|||
155312293|NCT04241068|560575247|FG000|LTE Period|Investigator Decision|12|||
155312294|NCT04241068|560575247|FG000|LTE Period|Loss of Capacity|2|||
155312295|NCT04241068|560575247|FG000|LTE Period|Lost to Follow-up|7|||
155312296|NCT04241068|560575247|FG000|LTE Period|Relocation|6|||
155312297|NCT04241068|560575247|FG000|LTE Period|Site Terminated by Sponsor|26|||
155312298|NCT04241068|560575247|FG000|LTE Period|Study Terminated by Sponsor|276|||
155312299|NCT04241068|560575247|FG000|LTE Period|Study Visit Burden|10|||
155312300|NCT04241068|560575247|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
155312301|NCT04241068|560575247|FG000|LTE Period|Reason Not Specified|65|||
155312302|NCT04492007|560575253|FG000|Overall Study|Lost to Follow-up|1|||
155312303|NCT04492007|560575254|FG001|Overall Study|Lost to Follow-up|1|||
155312304|NCT04492007|560575255|FG002|Overall Study|Lost to Follow-up|2|||
155312305|NCT04492007|560575256|FG003|Overall Study|Lost to Follow-up|2|||
155312306|NCT04492007|560575253|FG000|Overall Study|Protocol Violation|1|||
155312307|NCT04492007|560575254|FG001|Overall Study|Protocol Violation|1|||
155312308|NCT04492007|560575255|FG002|Overall Study|Protocol Violation|1|||
155312309|NCT04492007|560575256|FG003|Overall Study|Protocol Violation|1|||
155312310|NCT04492007|560575253|FG000|Overall Study|Withdrawal by Subject|0|||
155312311|NCT04492007|560575254|FG001|Overall Study|Withdrawal by Subject|0|||
155312312|NCT04492007|560575255|FG002|Overall Study|Withdrawal by Subject|1|||
155312313|NCT04492007|560575256|FG003|Overall Study|Withdrawal by Subject|1|||
155312314|NCT05178316|560575257|FG000|Overall Study|Adverse Event|5|||
155312315|NCT05178316|560575258|FG001|Overall Study|Adverse Event|4|||
155312316|NCT05178316|560575259|FG002|Overall Study|Adverse Event|9|||
155312317|NCT05178316|560575257|FG000|Overall Study|Enrolled in Error|1|||
155312318|NCT05178316|560575258|FG001|Overall Study|Enrolled in Error|2|||
155312319|NCT05178316|560575259|FG002|Overall Study|Enrolled in Error|1|||
155312320|NCT05178316|560575257|FG000|Overall Study|Lost to Follow-up|3|||
155312321|NCT05178316|560575258|FG001|Overall Study|Lost to Follow-up|15|||
155312322|NCT05178316|560575259|FG002|Overall Study|Lost to Follow-up|11|||
155312323|NCT05178316|560575257|FG000|Overall Study|Noncompliance|1|||
155312324|NCT05178316|560575258|FG001|Overall Study|Noncompliance|3|||
155312325|NCT05178316|560575259|FG002|Overall Study|Noncompliance|1|||
155312326|NCT05178316|560575257|FG000|Overall Study|Other|0|||
155312327|NCT05178316|560575258|FG001|Overall Study|Other|1|||
155312328|NCT05178316|560575259|FG002|Overall Study|Other|0|||
155312329|NCT05178316|560575257|FG000|Overall Study|Physician Decision|0|||
155312330|NCT05178316|560575258|FG001|Overall Study|Physician Decision|3|||
155312331|NCT05178316|560575259|FG002|Overall Study|Physician Decision|2|||
155312332|NCT05178316|560575257|FG000|Overall Study|Protocol deviation|1|||
155312333|NCT05178316|560575258|FG001|Overall Study|Protocol deviation|0|||
155312334|NCT05178316|560575259|FG002|Overall Study|Protocol deviation|1|||
155312335|NCT05178316|560575257|FG000|Overall Study|Sponsor decision|1|||
155312336|NCT05178316|560575258|FG001|Overall Study|Sponsor decision|0|||
155312337|NCT05178316|560575259|FG002|Overall Study|Sponsor decision|1|||
155312338|NCT05178316|560575257|FG000|Overall Study|Withdrawal by Subject|5|||
155312339|NCT05178316|560575258|FG001|Overall Study|Withdrawal by Subject|11|||
155312340|NCT05178316|560575259|FG002|Overall Study|Withdrawal by Subject|5|||
155312341|NCT03907397|560575262|FG000|Overall Study|Lost to Follow-up|0|||
155312342|NCT03907397|560575263|FG001|Overall Study|Lost to Follow-up|1|||
155312343|NCT03907397|560575262|FG000|Overall Study|Physician Decision|2|||
155312344|NCT03907397|560575263|FG001|Overall Study|Physician Decision|1|||
155312345|NCT03907397|560575262|FG000|Overall Study|Withdrawal by Subject|5|||
155312346|NCT03907397|560575263|FG001|Overall Study|Withdrawal by Subject|4|||
155312347|NCT03907397|560575262|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
155312348|NCT03907397|560575263|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
155312349|NCT01413100|560575264|FG000|Overall Study|Withdrawal by Subject|1|||
155312350|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
155416496|NCT00662792|560954789|FG001|Period 1|Not treated|1|||
155312351|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
155312352|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
155312353|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
155312354|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
155312355|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
155312356|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
155312357|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
155312358|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
155312359|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
155312360|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
155312361|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
155312362|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
155312363|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
155312364|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
155312365|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
155312366|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
155312367|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
155312368|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
155312369|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
155312370|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
155312371|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
155312372|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
155312373|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
155312374|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
155312375|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
155312376|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
155312377|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
155312378|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
155312379|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
155312380|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
155312381|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
155312382|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
155312383|NCT03792256|560575274|FG000|Overall Study|Death|0|||
155312384|NCT03792256|560575275|FG001|Overall Study|Death|1|||
155312385|NCT03792256|560575274|FG000|Overall Study|Lack of Efficacy|0|||
155312386|NCT03792256|560575275|FG001|Overall Study|Lack of Efficacy|1|||
155312387|NCT03792256|560575274|FG000|Overall Study|Withdrawal by Subject|0|||
155312388|NCT03792256|560575275|FG001|Overall Study|Withdrawal by Subject|1|||
155312389|NCT04831216|560575290|FG000|Overall Study|Lost to Follow-up|32|||
155312390|NCT02913872|560575295|FG000|Overall Study|Withdrawal by Subject|1|||
155312391|NCT04739956|560575298|FG000|Overall Study|Withdrawal by Subject|1|||
155312392|NCT04739956|560575299|FG001|Overall Study|Withdrawal by Subject|1|||
155312393|NCT03519581|560575302|FG000|Overall Study|Lost to Follow-up|3|||
155312394|NCT03519581|560575303|FG001|Overall Study|Lost to Follow-up|2|||
155312395|NCT03519581|560575302|FG000|Overall Study|Adverse Event|5|||
155312396|NCT03519581|560575303|FG001|Overall Study|Adverse Event|2|||
155312397|NCT03519581|560575302|FG000|Overall Study|Withdrawal by Subject|2|||
155312398|NCT03519581|560575303|FG001|Overall Study|Withdrawal by Subject|0|||
155312399|NCT03519581|560575302|FG000|Overall Study|Change to insurance|2|||
155312400|NCT03519581|560575303|FG001|Overall Study|Change to insurance|1|||
155312401|NCT03519581|560575302|FG000|Overall Study|Other|2|||
155312402|NCT03519581|560575303|FG001|Overall Study|Other|4|||
155312403|NCT05177848|560575304|FG000|Overall Study|Lost to Follow-up|1|||
155312404|NCT05177848|560575305|FG001|Overall Study|Lost to Follow-up|4|||
155312405|NCT05177848|560575304|FG000|Overall Study|Discontinued|2|||
155750824|NCT00570232|562186180|FG000|Overall Study|discontinued due to recurrence|8|||
155750825|NCT00570232|562186180|FG000|Overall Study|discontinued due to noncompliance|2|||
155750826|NCT04594369|562186182|FG000|Overall Study|Adverse Event|10|||
155750827|NCT04594369|562186183|FG001|Overall Study|Adverse Event|10|||
155750828|NCT04594369|562186184|FG002|Overall Study|Adverse Event|9|||
155750829|NCT04594369|562186182|FG000|Overall Study|Death|2|||
155750830|NCT04594369|562186183|FG001|Overall Study|Death|4|||
155750831|NCT04594369|562186184|FG002|Overall Study|Death|8|||
155750832|NCT04594369|562186182|FG000|Overall Study|Lost to Follow-up|10|||
155750833|NCT04594369|562186183|FG001|Overall Study|Lost to Follow-up|2|||
155750834|NCT04594369|562186184|FG002|Overall Study|Lost to Follow-up|4|||
155750835|NCT04594369|562186182|FG000|Overall Study|Physician Decision|2|||
155750836|NCT04594369|562186183|FG001|Overall Study|Physician Decision|2|||
155750837|NCT04594369|562186184|FG002|Overall Study|Physician Decision|3|||
155750838|NCT04594369|562186182|FG000|Overall Study|Protocol deviation|1|||
155750839|NCT04594369|562186183|FG001|Overall Study|Protocol deviation|3|||
155750840|NCT04594369|562186184|FG002|Overall Study|Protocol deviation|2|||
155750841|NCT04594369|562186182|FG000|Overall Study|Withdrawal by Subject|40|||
155750842|NCT04594369|562186183|FG001|Overall Study|Withdrawal by Subject|32|||
155750843|NCT04594369|562186184|FG002|Overall Study|Withdrawal by Subject|37|||
155750844|NCT04594369|562186182|FG000|Overall Study|Reason not specified|60|||
155750845|NCT04594369|562186183|FG001|Overall Study|Reason not specified|56|||
155750846|NCT04594369|562186184|FG002|Overall Study|Reason not specified|43|||
155750847|NCT04285580|562187136|FG000|Overall Study|Protocol Violation|0|||
155750848|NCT04285580|562187137|FG001|Overall Study|Protocol Violation|1|||
155750849|NCT02582255|562187138|FG000|Overall Study|Protocol Violation|0|||
155750850|NCT02582255|562187139|FG001|Overall Study|Protocol Violation|3|||
155750851|NCT01709578|562187141|FG000|Overall Study|Rescued and entered in long term safety|63|||
155750852|NCT01709578|562187142|FG001|Overall Study|Rescued and entered in long term safety|25|||
155750853|NCT01709578|562187143|FG002|Overall Study|Rescued and entered in long term safety|26|||
155750854|NCT01709578|562187141|FG000|Overall Study|Adverse Event|9|||
155750855|NCT01709578|562187142|FG001|Overall Study|Adverse Event|18|||
155750856|NCT01709578|562187143|FG002|Overall Study|Adverse Event|17|||
155750857|NCT01709578|562187141|FG000|Overall Study|Lack of Efficacy|5|||
155750858|NCT01709578|562187142|FG001|Overall Study|Lack of Efficacy|4|||
155750859|NCT01709578|562187143|FG002|Overall Study|Lack of Efficacy|2|||
155750860|NCT01709578|562187141|FG000|Overall Study|Poor compliance to protocol|1|||
155750861|NCT01709578|562187142|FG001|Overall Study|Poor compliance to protocol|2|||
155750862|NCT01709578|562187143|FG002|Overall Study|Poor compliance to protocol|1|||
155750863|NCT01709578|562187141|FG000|Overall Study|Other, not related to safety or efficacy|2|||
155750864|NCT01709578|562187142|FG001|Overall Study|Other, not related to safety or efficacy|7|||
155750865|NCT01709578|562187143|FG002|Overall Study|Other, not related to safety or efficacy|5|||
155750866|NCT04050371|562187144|FG000|Overall Study|Withdrawal by Subject|1|||
155750867|NCT04050371|562187145|FG001|Overall Study|Withdrawal by Subject|0|||
155750868|NCT01107418|562187146|FG000|Overall Study|Disease Progression|45|||
155750869|NCT01107418|562187146|FG000|Overall Study|Adverse Event|3|||
155750870|NCT01107418|562187146|FG000|Overall Study|Withdrawal by Subject|1|||
155312406|NCT05177848|560575305|FG001|Overall Study|Discontinued|1|||
155750871|NCT01107418|562187146|FG000|Overall Study|Study Closing|1|||
155750872|NCT01107418|562187146|FG000|Overall Study|Started Other Therapy|1|||
155750873|NCT01107418|562187146|FG000|Overall Study|Entered Extension Study|1|||
155750874|NCT00597701|562187147|FG000|Overall Study|Withdrawal by Subject|5|||
155750875|NCT00597701|562187148|FG001|Overall Study|Withdrawal by Subject|5|||
155750876|NCT00597701|562187147|FG000|Overall Study|Death|0|||
155750877|NCT00597701|562187148|FG001|Overall Study|Death|1|||
155750878|NCT00597701|562187147|FG000|Overall Study|Physician Decision|2|||
155750879|NCT00597701|562187148|FG001|Overall Study|Physician Decision|0|||
155750880|NCT00597701|562187147|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
155750881|NCT00597701|562187148|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
155750882|NCT01741012|562187150|FG000|Overall Study|Lost to Follow-up|1|||
155750883|NCT01741012|562187150|FG000|Overall Study|Withdrawal by Subject|2|||
155312407|NCT06414213|560575306|FG000|Overall Study|Lost to Follow-up|1|||
155312408|NCT06414213|560575307|FG001|Overall Study|Lost to Follow-up|1|||
155312409|NCT06414213|560575308|FG002|Overall Study|Lost to Follow-up|3|||
155312410|NCT00450658|560575310|FG000|Overall Study|Adverse Event|24|||
155750884|NCT04626310|562187161|FG000|Overall Study|4-miss from treatment|6|||
155750885|NCT04626310|562187162|FG001|Overall Study|4-miss from treatment|5|||
155750886|NCT04626310|562187163|FG002|Overall Study|4-miss from treatment|5|||
155750887|NCT04626310|562187161|FG000|Overall Study|Withdrawal by Subject|1|||
155750888|NCT04626310|562187162|FG001|Overall Study|Withdrawal by Subject|0|||
155750889|NCT04626310|562187163|FG002|Overall Study|Withdrawal by Subject|3|||
155750890|NCT02241889|562187166|FG000|Overall Study|device issues|0|||
155750891|NCT02241889|562187167|FG001|Overall Study|device issues|0|||
155750892|NCT02241889|562187168|FG002|Overall Study|device issues|1|||
155312411|NCT00450658|560575311|FG001|Overall Study|Adverse Event|15|||
155750893|NCT02241889|562187169|FG003|Overall Study|device issues|0|||
155750894|NCT02241889|562187170|FG004|Overall Study|device issues|0|||
155312412|NCT00450658|560575310|FG000|Overall Study|Withdrawal by Subject|43|||
155312413|NCT00450658|560575311|FG001|Overall Study|Withdrawal by Subject|26|||
155312414|NCT00450658|560575310|FG000|Overall Study|Lost to Follow-up|22|||
155312415|NCT00450658|560575311|FG001|Overall Study|Lost to Follow-up|5|||
155312416|NCT00450658|560575310|FG000|Overall Study|UGI ulcer|33|||
155312417|NCT00450658|560575311|FG001|Overall Study|UGI ulcer|34|||
155312418|NCT00450658|560575310|FG000|Overall Study|misc|21|||
155312419|NCT00450658|560575311|FG001|Overall Study|misc|10|||
155312420|NCT03850678|560575314|FG000|Overall Study|Withdrawal by Subject|3|||
155312421|NCT03850678|560575315|FG001|Overall Study|Withdrawal by Subject|0|||
155312422|NCT03850678|560575314|FG000|Overall Study|Experimenter Error|1|||
155312423|NCT03850678|560575315|FG001|Overall Study|Experimenter Error|1|||
155312424|NCT03850678|560575314|FG000|Overall Study|Did Not Condition To Experiment|7|||
155312425|NCT03850678|560575315|FG001|Overall Study|Did Not Condition To Experiment|2|||
155312426|NCT04072380|560575322|FG000|Overall Study|Adverse Event|4|||
155312427|NCT04072380|560575323|FG001|Overall Study|Adverse Event|6|||
155312428|NCT04072380|560575324|FG002|Overall Study|Adverse Event|0|||
155312429|NCT04072380|560575322|FG000|Overall Study|Withdrawal by Subject|3|||
155312430|NCT04072380|560575323|FG001|Overall Study|Withdrawal by Subject|1|||
155312431|NCT04072380|560575324|FG002|Overall Study|Withdrawal by Subject|1|||
155312432|NCT04072380|560575322|FG000|Overall Study|Physician Decision|2|||
155312433|NCT04072380|560575323|FG001|Overall Study|Physician Decision|0|||
155312434|NCT04072380|560575324|FG002|Overall Study|Physician Decision|0|||
155312435|NCT04072380|560575322|FG000|Overall Study|Protocol Violation|0|||
155312436|NCT04072380|560575323|FG001|Overall Study|Protocol Violation|2|||
155312437|NCT04072380|560575324|FG002|Overall Study|Protocol Violation|3|||
155312438|NCT04072380|560575322|FG000|Overall Study|Intercurrent Illness and Others|3|||
155312439|NCT04072380|560575323|FG001|Overall Study|Intercurrent Illness and Others|5|||
155312440|NCT04072380|560575324|FG002|Overall Study|Intercurrent Illness and Others|6|||
155312441|NCT04015167|560575327|FG000|Overall Study|Lost to Follow-up|40|||
155312442|NCT04015167|560575327|FG000|Overall Study|Adverse Event|5|||
155312443|NCT04015167|560575327|FG000|Overall Study|Withdrawal by Subject|2|||
155312444|NCT04015167|560575327|FG000|Overall Study|Subject went to jail|1|||
155416497|NCT00662792|560954790|FG002|Period 1|Not treated|0|||
155416498|NCT00662792|560954791|FG003|Period 1|Not treated|0|||
155416499|NCT00662792|560954788|FG000|Period 2|Worsening of disease under study|1|||
155416500|NCT00662792|560954789|FG001|Period 2|Worsening of disease under study|0|||
155416501|NCT00662792|560954790|FG002|Period 2|Worsening of disease under study|0|||
155416502|NCT00662792|560954791|FG003|Period 2|Worsening of disease under study|3|||
155499143|NCT00602641|561252653|FG001|Overall Study|Still on treatment at time of analysis|15|||
155643132|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
155643133|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643134|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643135|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643136|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643137|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643138|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155643139|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643140|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643141|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
155643142|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643143|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643144|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643145|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155643146|NCT01807520|561783746|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
155643147|NCT01807520|561783747|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643148|NCT01807520|561783748|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643149|NCT01807520|561783749|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643150|NCT01807520|561783750|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643151|NCT01807520|561783751|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643152|NCT01807520|561783752|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155643153|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
155312445|NCT03640312|560575328|FG000|Overall Study|Lost to Follow-up|3|||
155312446|NCT03640312|560575329|FG001|Overall Study|Lost to Follow-up|6|||
155312447|NCT05008835|560575331|FG000|Overall Study|Adverse Event|5|||
155312448|NCT05008835|560575332|FG001|Overall Study|Adverse Event|2|||
155312449|NCT05008835|560575333|FG002|Overall Study|Adverse Event|1|||
155312450|NCT05008835|560575331|FG000|Overall Study|Lack of Efficacy|0|||
155312451|NCT05008835|560575332|FG001|Overall Study|Lack of Efficacy|0|||
155312452|NCT05008835|560575333|FG002|Overall Study|Lack of Efficacy|1|||
155416503|NCT00662792|560954788|FG000|Period 3|Refused continuing medication|1|||
155416504|NCT00662792|560954789|FG001|Period 3|Refused continuing medication|0|||
155416505|NCT00662792|560954790|FG002|Period 3|Refused continuing medication|1|||
155643154|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
155750895|NCT02241889|562187171|FG005|Overall Study|device issues|0|||
155312453|NCT05008835|560575331|FG000|Overall Study|Study terminated by sponsor|0|||
155312454|NCT05008835|560575332|FG001|Overall Study|Study terminated by sponsor|0|||
155312455|NCT05008835|560575333|FG002|Overall Study|Study terminated by sponsor|1|||
155312456|NCT05008835|560575331|FG000|Overall Study|Not further specified|3|||
155312457|NCT05008835|560575332|FG001|Overall Study|Not further specified|2|||
155312458|NCT05008835|560575333|FG002|Overall Study|Not further specified|1|||
155312459|NCT03366649|560577360|FG000|Overall Study|Failed preoperative screening|4|||
155312460|NCT03366649|560577361|FG001|Overall Study|Failed preoperative screening|0|||
155312461|NCT03366649|560577362|FG002|Overall Study|Failed preoperative screening|0|||
155312462|NCT03366649|560577360|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
155312463|NCT03366649|560577361|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
155312464|NCT03366649|560577362|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
155312465|NCT03673111|560577364|FG000|Overall Study|Protocol Violation|0|||
155312466|NCT03673111|560577365|FG001|Overall Study|Protocol Violation|0|||
155312467|NCT03673111|560577366|FG002|Overall Study|Protocol Violation|0|||
155312468|NCT03673111|560577367|FG003|Overall Study|Protocol Violation|0|||
155312469|NCT03673111|560577368|FG004|Overall Study|Protocol Violation|0|||
155312470|NCT03673111|560577369|FG005|Overall Study|Protocol Violation|0|||
155312471|NCT03673111|560577370|FG006|Overall Study|Protocol Violation|0|||
155312472|NCT03673111|560577371|FG007|Overall Study|Protocol Violation|0|||
155312473|NCT03673111|560577372|FG008|Overall Study|Protocol Violation|0|||
155312474|NCT03673111|560577373|FG009|Overall Study|Protocol Violation|0|||
155312475|NCT03673111|560577374|FG010|Overall Study|Protocol Violation|1|||
155312476|NCT03673111|560577375|FG011|Overall Study|Protocol Violation|0|||
155312477|NCT03673111|560577376|FG012|Overall Study|Protocol Violation|0|||
155312478|NCT03673111|560577377|FG013|Overall Study|Protocol Violation|0|||
155312479|NCT03673111|560577364|FG000|Overall Study|Adverse Event|1|||
155312480|NCT03673111|560577365|FG001|Overall Study|Adverse Event|0|||
155312481|NCT03673111|560577366|FG002|Overall Study|Adverse Event|0|||
155312482|NCT03673111|560577367|FG003|Overall Study|Adverse Event|0|||
155312483|NCT03673111|560577368|FG004|Overall Study|Adverse Event|0|||
155312484|NCT03673111|560577369|FG005|Overall Study|Adverse Event|0|||
155312485|NCT03673111|560577370|FG006|Overall Study|Adverse Event|0|||
155312486|NCT03673111|560577371|FG007|Overall Study|Adverse Event|0|||
155312487|NCT03673111|560577372|FG008|Overall Study|Adverse Event|0|||
155312488|NCT03673111|560577373|FG009|Overall Study|Adverse Event|0|||
155312489|NCT03673111|560577374|FG010|Overall Study|Adverse Event|0|||
155312490|NCT03673111|560577375|FG011|Overall Study|Adverse Event|0|||
155312491|NCT03673111|560577376|FG012|Overall Study|Adverse Event|0|||
155312492|NCT03673111|560577377|FG013|Overall Study|Adverse Event|0|||
155312493|NCT03792555|560577378|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
155312494|NCT03792555|560577379|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
155312495|NCT03792555|560577380|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
155312496|NCT03792555|560577378|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
155312497|NCT03792555|560577379|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
155312498|NCT03792555|560577380|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
155312499|NCT03792555|560577378|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
155312500|NCT03792555|560577379|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
155312501|NCT03792555|560577380|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
155312502|NCT04485039|560577381|FG000|TPOXX Only|Adverse Event|2|||
155312503|NCT04485039|560577381|FG000|TPOXX Only|Physician Decision|1|||
155312504|NCT04485039|560577381|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
155312505|NCT04485039|560577381|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
155312506|NCT04005716|560577385|FG000|Overall Study|Death|175|||
155312507|NCT04005716|560577386|FG001|Overall Study|Death|196|||
155312508|NCT04005716|560577385|FG000|Overall Study|Withdrawal by Subject|1|||
155312509|NCT04005716|560577386|FG001|Overall Study|Withdrawal by Subject|6|||
155312510|NCT04005716|560577385|FG000|Overall Study|Lost to Follow-up|2|||
155312511|NCT04005716|560577386|FG001|Overall Study|Lost to Follow-up|2|||
155312512|NCT00418886|560577389|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
155312513|NCT00418886|560577390|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
155312514|NCT00418886|560577389|FG000|Randomized Period|Death|122|||
155312515|NCT00418886|560577390|FG001|Randomized Period|Death|147|||
155312516|NCT00418886|560577389|FG000|Randomized Period|Withdrawal by Subject|9|||
155312517|NCT00418886|560577390|FG001|Randomized Period|Withdrawal by Subject|10|||
155312518|NCT00418886|560577389|FG000|Randomized Period|Lost to Follow-up|4|||
155312519|NCT00418886|560577390|FG001|Randomized Period|Lost to Follow-up|6|||
155312520|NCT00418886|560577389|FG000|Randomized Period|withdrawn due to other reason|1|||
155312521|NCT00418886|560577390|FG001|Randomized Period|withdrawn due to other reason|0|||
155312522|NCT00418886|560577389|FG000|Randomized Period|randomised but no treatment received|0|||
155312523|NCT00418886|560577390|FG001|Randomized Period|randomised but no treatment received|1|||
155312524|NCT03707951|560577391|FG000|Overall Study|Lost to Follow-up|8|||
155312525|NCT03707951|560577392|FG001|Overall Study|Lost to Follow-up|17|||
155312526|NCT03707951|560577391|FG000|Overall Study|Withdrawal by Subject|6|||
155312527|NCT03707951|560577392|FG001|Overall Study|Withdrawal by Subject|6|||
155312528|NCT04347161|560577393|FG000|Overall Study|Death|0|||
155312529|NCT04347161|560577394|FG001|Overall Study|Death|2|||
155312530|NCT04347161|560577393|FG000|Overall Study|Withdrawal by Subject|1|||
155312531|NCT04347161|560577394|FG001|Overall Study|Withdrawal by Subject|0|||
155312532|NCT04347161|560577393|FG000|Overall Study|Lost to Follow-up|0|||
155312533|NCT04347161|560577394|FG001|Overall Study|Lost to Follow-up|1|||
155312534|NCT04347161|560577393|FG000|Overall Study|No longer on study medication|1|||
155312535|NCT04347161|560577394|FG001|Overall Study|No longer on study medication|1|||
155312536|NCT04533347|560577396|FG000|Overall Study|Adverse Event|1|||
155312537|NCT04533347|560577397|FG001|Overall Study|Adverse Event|2|||
155312538|NCT04533347|560577396|FG000|Overall Study|Lost to Follow-up|2|||
155312539|NCT04533347|560577397|FG001|Overall Study|Lost to Follow-up|0|||
155312540|NCT04533347|560577396|FG000|Overall Study|Withdrawal by Subject|1|||
155312541|NCT04533347|560577397|FG001|Overall Study|Withdrawal by Subject|0|||
155312542|NCT05520190|560577398|FG000|Overall Study|Lost to Follow-up|7|||
155312543|NCT05520190|560577398|FG000|Overall Study|Withdrawal by Subject|2|||
155312544|NCT01999075|560577399|FG000|Overall Study|Lost to Follow-up|0|||
155312545|NCT01999075|560577400|FG001|Overall Study|Lost to Follow-up|2|||
155312546|NCT01999075|560577399|FG000|Overall Study|Withdrawal by Subject|2|||
155312547|NCT01999075|560577400|FG001|Overall Study|Withdrawal by Subject|7|||
155312548|NCT01999075|560577399|FG000|Overall Study|Enrolled in drug trial|3|||
155312549|NCT01999075|560577400|FG001|Overall Study|Enrolled in drug trial|1|||
155312550|NCT01999075|560577399|FG000|Overall Study|Became ineligible|0|||
155312551|NCT01999075|560577400|FG001|Overall Study|Became ineligible|2|||
155312552|NCT05948670|560577405|FG000|Overall Study|Protocol Violation|6|||
155312553|NCT05948670|560577406|FG001|Overall Study|Protocol Violation|8|||
155312554|NCT05948670|560577405|FG000|Overall Study|Withdrawal by Subject|0|||
155312555|NCT05948670|560577406|FG001|Overall Study|Withdrawal by Subject|1|||
155416506|NCT00662792|560954791|FG003|Period 3|Refused continuing medication|0|||
155416507|NCT00662792|560954788|FG000|Period 3|Other adverse event (AE)|0|||
155416508|NCT00662792|560954789|FG001|Period 3|Other adverse event (AE)|0|||
155416509|NCT00662792|560954790|FG002|Period 3|Other adverse event (AE)|1|||
155416510|NCT00662792|560954791|FG003|Period 3|Other adverse event (AE)|1|||
155416511|NCT00662792|560954788|FG000|Period 4|Refused continuing medication|0|||
155416512|NCT00662792|560954789|FG001|Period 4|Refused continuing medication|1|||
155416513|NCT00662792|560954790|FG002|Period 4|Refused continuing medication|0|||
155416514|NCT00662792|560954791|FG003|Period 4|Refused continuing medication|0|||
155416515|NCT00662792|560954788|FG000|Period 4|Other adverse event (AE)|1|||
155416516|NCT00662792|560954789|FG001|Period 4|Other adverse event (AE)|0|||
155416517|NCT00662792|560954790|FG002|Period 4|Other adverse event (AE)|0|||
155416518|NCT00662792|560954791|FG003|Period 4|Other adverse event (AE)|0|||
155416519|NCT00662792|560954788|FG000|Period 4|Worsening of disease under study (AE)|0|||
155416520|NCT00662792|560954789|FG001|Period 4|Worsening of disease under study (AE)|0|||
155416521|NCT00662792|560954790|FG002|Period 4|Worsening of disease under study (AE)|0|||
155416522|NCT00662792|560954791|FG003|Period 4|Worsening of disease under study (AE)|1|||
155416523|NCT02474082|560954794|FG000|Overall Study|Adverse Event|2|||
155416524|NCT02474082|560954795|FG001|Overall Study|Adverse Event|32|||
155416525|NCT02474082|560954794|FG000|Overall Study|Withdrawal of informed consent|1|||
155416526|NCT02474082|560954795|FG001|Overall Study|Withdrawal of informed consent|11|||
155416527|NCT02474082|560954794|FG000|Overall Study|Lost to Follow-up|2|||
155416528|NCT02474082|560954795|FG001|Overall Study|Lost to Follow-up|2|||
155416529|NCT02474082|560954794|FG000|Overall Study|Dose tapering not achieved|0|||
155416530|NCT02474082|560954795|FG001|Overall Study|Dose tapering not achieved|4|||
155416531|NCT02474082|560954794|FG000|Overall Study|Participant/guardian decision|1|||
155416532|NCT02474082|560954795|FG001|Overall Study|Participant/guardian decision|2|||
155416533|NCT02474082|560954794|FG000|Overall Study|Non-compliance with study treatment|0|||
155416534|NCT02474082|560954795|FG001|Overall Study|Non-compliance with study treatment|2|||
155416535|NCT02474082|560954794|FG000|Overall Study|Protocol deviation|0|||
155416536|NCT02474082|560954795|FG001|Overall Study|Protocol deviation|1|||
155416537|NCT01463098|560954798|FG000|Part A (11 Days)|Participant Choice|2|||
155499144|NCT00602641|561252652|FG000|Overall Study|Adverse Event|62|||
155750896|NCT02241889|562187166|FG000|Overall Study|Withdrawal by Subject|0|||
155750897|NCT02241889|562187167|FG001|Overall Study|Withdrawal by Subject|0|||
155750898|NCT02241889|562187168|FG002|Overall Study|Withdrawal by Subject|0|||
155750899|NCT02241889|562187169|FG003|Overall Study|Withdrawal by Subject|0|||
155312556|NCT04562649|560577407|FG000|Overall Study|Withdrawal by Subject|11|||
155312557|NCT04562649|560577408|FG001|Overall Study|Withdrawal by Subject|8|||
155312558|NCT04562649|560577407|FG000|Overall Study|Lost to Follow-up|26|||
155312559|NCT04562649|560577408|FG001|Overall Study|Lost to Follow-up|20|||
155312560|NCT05368103|560577409|FG000|Overall Study|Withdrawal by Subject|4|||
155312561|NCT05368103|560577409|FG000|Overall Study|Lost to Follow-up|1|||
155312562|NCT05368103|560577409|FG000|Overall Study|Lack of Efficacy|3|||
155312563|NCT03675282|560577412|FG000|Overall Study|Lost to Follow-up|4|||
155312564|NCT03675282|560577413|FG001|Overall Study|Lost to Follow-up|8|||
155312565|NCT03675282|560577414|FG002|Overall Study|Lost to Follow-up|1|||
155312566|NCT03675282|560577415|FG003|Overall Study|Lost to Follow-up|0|||
155312567|NCT03675282|560577416|FG004|Overall Study|Lost to Follow-up|2|||
155312568|NCT03675282|560577417|FG005|Overall Study|Lost to Follow-up|7|||
155312569|NCT03675282|560577412|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
155312570|NCT03675282|560577413|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
155312571|NCT03675282|560577414|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
155312572|NCT03675282|560577415|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
155312573|NCT03675282|560577416|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
155312574|NCT03675282|560577417|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
155312575|NCT03675282|560577412|FG000|Overall Study|Physician Decision|1|||
155312576|NCT03675282|560577413|FG001|Overall Study|Physician Decision|0|||
155750900|NCT02241889|562187170|FG004|Overall Study|Withdrawal by Subject|0|||
155750901|NCT02241889|562187171|FG005|Overall Study|Withdrawal by Subject|1|||
155750902|NCT01658813|562187172|FG000|Overall Study|Disease progression|3|||
155750903|NCT04473482|562187173|FG000|Overall Study|Death|0|||
155750904|NCT04473482|562187174|FG001|Overall Study|Death|3|||
155750905|NCT04473482|562187173|FG000|Overall Study|Lost to Follow-up|9|||
155750906|NCT04473482|562187174|FG001|Overall Study|Lost to Follow-up|7|||
155750907|NCT04473482|562187173|FG000|Overall Study|Withdrawal by Subject|2|||
155750908|NCT04473482|562187174|FG001|Overall Study|Withdrawal by Subject|1|||
155750909|NCT01602666|562187175|FG000|Induction Chemotherapy|Death|2|||
155750910|NCT01602666|562187176|FG001|Induction Chemotherapy|Death|1|||
155750911|NCT01602666|562187175|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
155750912|NCT01602666|562187176|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
155750913|NCT01602666|562187175|FG000|Induction Chemotherapy|Physician Decision|12|||
155750914|NCT01602666|562187176|FG001|Induction Chemotherapy|Physician Decision|5|||
155750915|NCT01602666|562187175|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
155312577|NCT03675282|560577414|FG002|Overall Study|Physician Decision|0|||
155312578|NCT03675282|560577415|FG003|Overall Study|Physician Decision|0|||
155312579|NCT03675282|560577416|FG004|Overall Study|Physician Decision|0|||
155312580|NCT03675282|560577417|FG005|Overall Study|Physician Decision|0|||
155312581|NCT05784662|560577418|FG000|Overall Study|Lost to Follow-up|21|||
155750916|NCT01602666|562187176|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
155750917|NCT01602666|562187175|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
155750918|NCT01602666|562187176|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
155750919|NCT01602666|562187175|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
155750920|NCT01602666|562187176|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
155750921|NCT01602666|562187175|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
155750922|NCT01602666|562187176|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
155750923|NCT01602666|562187175|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
155750924|NCT01602666|562187176|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
155750925|NCT01602666|562187175|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
155750926|NCT01602666|562187176|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
155750927|NCT01602666|562187175|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
155750928|NCT01602666|562187176|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
155750929|NCT01602666|562187175|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
155750930|NCT01602666|562187176|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
155750931|NCT05458648|562187177|FG000|Overall Study|Physician Decision|1|||
155750932|NCT05458648|562187177|FG000|Overall Study|Patient presented in atrial flutter|1|||
155750933|NCT03610555|562187181|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
155750934|NCT03610555|562187182|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
155750935|NCT03610555|562187183|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
155750936|NCT03610555|562187184|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
155750937|NCT02275910|562187185|FG000|Overall Study|Subject Choice|0|||
155750938|NCT02275910|562187186|FG001|Overall Study|Subject Choice|0|||
155750939|NCT02275910|562187187|FG002|Overall Study|Subject Choice|0|||
155416538|NCT01463098|560954799|FG001|Part A (11 Days)|Participant Choice|0|||
155416539|NCT01463098|560954800|FG002|Part A (11 Days)|Participant Choice|0|||
155416540|NCT01463098|560954801|FG003|Part A (11 Days)|Participant Choice|0|||
155750940|NCT02275910|562187188|FG003|Overall Study|Subject Choice|0|||
155416541|NCT01463098|560954802|FG004|Part A (11 Days)|Participant Choice|0|||
155416542|NCT01463098|560954803|FG005|Part A (11 Days)|Participant Choice|0|||
155416543|NCT01463098|560954804|FG006|Part A (11 Days)|Participant Choice|0|||
155416544|NCT01463098|560954805|FG007|Part A (11 Days)|Participant Choice|0|||
155416545|NCT01463098|560954806|FG008|Part A (11 Days)|Participant Choice|1|||
155416546|NCT01463098|560954807|FG009|Part A (11 Days)|Participant Choice|0|||
155750941|NCT02275910|562187189|FG004|Overall Study|Subject Choice|0|||
155312582|NCT05784662|560577419|FG001|Overall Study|Lost to Follow-up|17|||
155312583|NCT03232138|560577420|FG000|Overall Study|Physician Decision|1|||
155312584|NCT03232138|560577421|FG001|Overall Study|Physician Decision|0|||
155312585|NCT03232138|560577420|FG000|Overall Study|Adverse Event|2|||
155750942|NCT02275910|562187190|FG005|Overall Study|Subject Choice|0|||
155750943|NCT02275910|562187191|FG006|Overall Study|Subject Choice|0|||
155750944|NCT02275910|562187192|FG007|Overall Study|Subject Choice|0|||
155312586|NCT03232138|560577421|FG001|Overall Study|Adverse Event|0|||
155312587|NCT03232138|560577420|FG000|Overall Study|Withdrawal by Subject|1|||
155312588|NCT03232138|560577421|FG001|Overall Study|Withdrawal by Subject|2|||
155312589|NCT03920111|560577422|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
155312590|NCT03920111|560577423|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
155312591|NCT03920111|560577424|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
155312592|NCT05268393|560577425|FG000|Overall Study|Withdrawal by Subject|2|||
155312593|NCT05268393|560577426|FG001|Overall Study|Withdrawal by Subject|1|||
155312594|NCT05763823|560577427|FG000|Overall Study|Death|6|||
155312595|NCT05763823|560577427|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155312596|NCT05763823|560577427|FG000|Overall Study|Withdrawal by Subject|6|||
155312597|NCT01997840|560577432|FG000|Overall Study|Lost to Follow-up|0|||
155312598|NCT01997840|560577433|FG001|Overall Study|Lost to Follow-up|0|||
155312599|NCT01997840|560577434|FG002|Overall Study|Lost to Follow-up|1|||
155312600|NCT01997840|560577435|FG003|Overall Study|Lost to Follow-up|0|||
155312601|NCT01997840|560577432|FG000|Overall Study|Withdrawal by participant|0|||
155312602|NCT01997840|560577433|FG001|Overall Study|Withdrawal by participant|0|||
155312603|NCT01997840|560577434|FG002|Overall Study|Withdrawal by participant|8|||
155312604|NCT01997840|560577435|FG003|Overall Study|Withdrawal by participant|1|||
155312605|NCT01997840|560577432|FG000|Overall Study|Physician Decision|0|||
155312606|NCT01997840|560577433|FG001|Overall Study|Physician Decision|0|||
155312607|NCT01997840|560577434|FG002|Overall Study|Physician Decision|3|||
155312608|NCT01997840|560577435|FG003|Overall Study|Physician Decision|0|||
155312609|NCT01997840|560577432|FG000|Overall Study|Progressive disease|3|||
155312610|NCT01997840|560577433|FG001|Overall Study|Progressive disease|4|||
155416547|NCT01463098|560954808|FG010|Part A (11 Days)|Participant Choice|0|||
155416548|NCT01463098|560954809|FG011|Part A (11 Days)|Participant Choice|0|||
155416549|NCT01463098|560954810|FG012|Part A (11 Days)|Participant Choice|0|||
155416550|NCT01463098|560954811|FG013|Part A (11 Days)|Participant Choice|0|||
155416551|NCT01463098|560954798|FG000|Part A (11 Days)|Lost to Follow-up|0|||
155643155|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155643156|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155643157|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
155643158|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155643159|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155643160|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643161|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643162|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643163|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
155643164|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643165|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643166|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155643167|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
155643168|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643169|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643170|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643171|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643172|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643173|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155643174|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643175|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
155643176|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643177|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643178|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643179|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643180|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155643181|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
155643182|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155643183|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155643184|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
155643185|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155643186|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155643187|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155643188|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
155643189|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
155643190|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155750945|NCT02275910|562187193|FG008|Overall Study|Subject Choice|1|||
155750946|NCT02275910|562187194|FG009|Overall Study|Subject Choice|0|||
155750947|NCT02275910|562187195|FG010|Overall Study|Subject Choice|0|||
155750948|NCT02275910|562187196|FG011|Overall Study|Subject Choice|0|||
155750949|NCT02275910|562187185|FG000|Overall Study|Radiological Disease Progression|0|||
155750950|NCT02275910|562187186|FG001|Overall Study|Radiological Disease Progression|0|||
155750951|NCT02275910|562187187|FG002|Overall Study|Radiological Disease Progression|0|||
155750952|NCT02275910|562187188|FG003|Overall Study|Radiological Disease Progression|0|||
155750953|NCT02275910|562187189|FG004|Overall Study|Radiological Disease Progression|0|||
155750954|NCT02275910|562187190|FG005|Overall Study|Radiological Disease Progression|0|||
155750955|NCT02275910|562187191|FG006|Overall Study|Radiological Disease Progression|1|||
155750956|NCT02275910|562187192|FG007|Overall Study|Radiological Disease Progression|1|||
155750957|NCT02275910|562187193|FG008|Overall Study|Radiological Disease Progression|0|||
155750958|NCT02275910|562187194|FG009|Overall Study|Radiological Disease Progression|1|||
155750959|NCT02275910|562187195|FG010|Overall Study|Radiological Disease Progression|0|||
155750960|NCT02275910|562187196|FG011|Overall Study|Radiological Disease Progression|0|||
155750961|NCT05217927|562187204|FG000|DBT Phase|Adverse Event|7|||
155750962|NCT05217927|562187205|FG001|DBT Phase|Adverse Event|2|||
155750963|NCT05217927|562187206|FG002|DBT Phase|Adverse Event|5|||
155750964|NCT05217927|562187204|FG000|DBT Phase|Lack of Efficacy|1|||
155750965|NCT05217927|562187205|FG001|DBT Phase|Lack of Efficacy|0|||
155750966|NCT05217927|562187206|FG002|DBT Phase|Lack of Efficacy|0|||
155750967|NCT05217927|562187204|FG000|DBT Phase|Lost to Follow-up|0|||
155750968|NCT05217927|562187205|FG001|DBT Phase|Lost to Follow-up|2|||
155750969|NCT05217927|562187206|FG002|DBT Phase|Lost to Follow-up|0|||
155750970|NCT05217927|562187204|FG000|DBT Phase|Non-compliance|1|||
155750971|NCT05217927|562187205|FG001|DBT Phase|Non-compliance|0|||
155750972|NCT05217927|562187206|FG002|DBT Phase|Non-compliance|0|||
155750973|NCT05217927|562187204|FG000|DBT Phase|Pregnancy|0|||
155750974|NCT05217927|562187205|FG001|DBT Phase|Pregnancy|0|||
155750975|NCT05217927|562187206|FG002|DBT Phase|Pregnancy|1|||
155750976|NCT05217927|562187204|FG000|DBT Phase|Protocol Violation|0|||
155750977|NCT05217927|562187205|FG001|DBT Phase|Protocol Violation|2|||
155750978|NCT05217927|562187206|FG002|DBT Phase|Protocol Violation|1|||
155750979|NCT05217927|562187204|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
155750980|NCT05217927|562187205|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
155750981|NCT05217927|562187206|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
155750982|NCT05217927|562187204|FG000|DBT Phase|Withdrawal of consent|8|||
155750983|NCT05217927|562187205|FG001|DBT Phase|Withdrawal of consent|5|||
155750984|NCT05217927|562187206|FG002|DBT Phase|Withdrawal of consent|7|||
155750985|NCT05217927|562187204|FG000|DBT Phase|Other|7|||
155312611|NCT01997840|560577434|FG002|Overall Study|Progressive disease|57|||
155312612|NCT01997840|560577435|FG003|Overall Study|Progressive disease|8|||
155312613|NCT01997840|560577432|FG000|Overall Study|Other reasons|0|||
155312614|NCT01997840|560577433|FG001|Overall Study|Other reasons|0|||
155312615|NCT01997840|560577434|FG002|Overall Study|Other reasons|1|||
155312616|NCT01997840|560577435|FG003|Overall Study|Other reasons|0|||
155312617|NCT01997840|560577432|FG000|Overall Study|Adverse Event|0|||
155312618|NCT01997840|560577433|FG001|Overall Study|Adverse Event|0|||
155312619|NCT01997840|560577434|FG002|Overall Study|Adverse Event|15|||
155312620|NCT01997840|560577435|FG003|Overall Study|Adverse Event|2|||
155312621|NCT05308004|560577445|FG000|Overall Study|Not seen by Palliative Care NP|0|||
155312622|NCT05308004|560577446|FG001|Overall Study|Not seen by Palliative Care NP|1|||
155312623|NCT03150810|560577448|FG000|Overall Study|Death|4|||
155312624|NCT03150810|560577449|FG001|Overall Study|Death|8|||
155312625|NCT03150810|560577450|FG002|Overall Study|Death|7|||
155312626|NCT03150810|560577451|FG003|Overall Study|Death|2|||
155312627|NCT03150810|560577452|FG004|Overall Study|Death|2|||
155312628|NCT03150810|560577453|FG005|Overall Study|Death|10|||
155312629|NCT03150810|560577454|FG006|Overall Study|Death|8|||
155312630|NCT03150810|560577455|FG007|Overall Study|Death|6|||
155312631|NCT03150810|560577456|FG008|Overall Study|Death|18|||
155312632|NCT03150810|560577457|FG009|Overall Study|Death|3|||
155750986|NCT05217927|562187205|FG001|DBT Phase|Other|3|||
155750987|NCT05217927|562187206|FG002|DBT Phase|Other|4|||
155750988|NCT05217927|562187204|FG000|DBT Phase|Randomized, not treated|2|||
155750989|NCT05217927|562187205|FG001|DBT Phase|Randomized, not treated|3|||
155750990|NCT05217927|562187206|FG002|DBT Phase|Randomized, not treated|2|||
155750991|NCT05217927|562187204|FG000|OLE Phase|Adverse Event|4|||
155750992|NCT05217927|562187205|FG001|OLE Phase|Adverse Event|1|||
155312633|NCT03150810|560577458|FG010|Overall Study|Death|19|||
155312634|NCT03150810|560577459|FG011|Overall Study|Death|1|||
155312635|NCT03150810|560577460|FG012|Overall Study|Death|19|||
155312636|NCT03150810|560577448|FG000|Overall Study|Withdrawal by Subject|0|||
155499145|NCT00602641|561252653|FG001|Overall Study|Adverse Event|53|||
155750993|NCT05217927|562187206|FG002|OLE Phase|Adverse Event|1|||
155750994|NCT05217927|562187204|FG000|OLE Phase|Extension phase eligibility failure|1|||
155750995|NCT05217927|562187205|FG001|OLE Phase|Extension phase eligibility failure|0|||
155750996|NCT05217927|562187206|FG002|OLE Phase|Extension phase eligibility failure|0|||
155750997|NCT05217927|562187204|FG000|OLE Phase|Lost to Follow-up|1|||
155750998|NCT05217927|562187205|FG001|OLE Phase|Lost to Follow-up|2|||
155416552|NCT01463098|560954799|FG001|Part A (11 Days)|Lost to Follow-up|0|||
155416553|NCT01463098|560954800|FG002|Part A (11 Days)|Lost to Follow-up|0|||
155416554|NCT01463098|560954801|FG003|Part A (11 Days)|Lost to Follow-up|0|||
155416555|NCT01463098|560954802|FG004|Part A (11 Days)|Lost to Follow-up|1|||
155416556|NCT01463098|560954803|FG005|Part A (11 Days)|Lost to Follow-up|0|||
155416557|NCT01463098|560954804|FG006|Part A (11 Days)|Lost to Follow-up|0|||
155416558|NCT01463098|560954805|FG007|Part A (11 Days)|Lost to Follow-up|0|||
155416559|NCT01463098|560954806|FG008|Part A (11 Days)|Lost to Follow-up|0|||
155416560|NCT01463098|560954807|FG009|Part A (11 Days)|Lost to Follow-up|0|||
155416561|NCT01463098|560954808|FG010|Part A (11 Days)|Lost to Follow-up|0|||
155416562|NCT01463098|560954809|FG011|Part A (11 Days)|Lost to Follow-up|0|||
155416563|NCT01463098|560954810|FG012|Part A (11 Days)|Lost to Follow-up|0|||
155416564|NCT01463098|560954811|FG013|Part A (11 Days)|Lost to Follow-up|0|||
155416565|NCT01463098|560954798|FG000|Part B (11 Days)|Participant Choice|0|||
155416566|NCT01463098|560954799|FG001|Part B (11 Days)|Participant Choice|0|||
155416567|NCT01463098|560954800|FG002|Part B (11 Days)|Participant Choice|0|||
155416568|NCT01463098|560954801|FG003|Part B (11 Days)|Participant Choice|0|||
155416569|NCT01463098|560954802|FG004|Part B (11 Days)|Participant Choice|0|||
155643191|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155643192|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
155643193|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155643194|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155643195|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155643196|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155643197|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155643198|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155643199|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155643200|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155643201|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155643202|NCT01807520|561783746|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
155643203|NCT01807520|561783747|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
155643204|NCT01807520|561783748|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155643205|NCT01807520|561783749|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
155643206|NCT01807520|561783750|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
155643207|NCT01807520|561783751|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155643208|NCT01807520|561783752|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155643209|NCT01807520|561783746|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643210|NCT01807520|561783747|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643211|NCT01807520|561783748|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643212|NCT01807520|561783749|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643213|NCT01807520|561783750|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643214|NCT01807520|561783751|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
155643215|NCT01807520|561783752|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155643216|NCT01807520|561783746|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643217|NCT01807520|561783747|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643218|NCT01807520|561783748|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643219|NCT01807520|561783749|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643220|NCT01807520|561783750|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643221|NCT01807520|561783751|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
155643222|NCT01807520|561783752|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155643223|NCT01807520|561783746|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155643224|NCT01807520|561783747|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155643225|NCT01807520|561783748|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155643226|NCT01807520|561783749|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155643227|NCT01807520|561783750|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155643228|NCT01807520|561783751|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
155750999|NCT05217927|562187206|FG002|OLE Phase|Lost to Follow-up|1|||
155751000|NCT05217927|562187204|FG000|OLE Phase|Non-compliance|0|||
155751001|NCT05217927|562187205|FG001|OLE Phase|Non-compliance|0|||
155751002|NCT05217927|562187206|FG002|OLE Phase|Non-compliance|1|||
155751003|NCT05217927|562187204|FG000|OLE Phase|Other|3|||
155751004|NCT05217927|562187205|FG001|OLE Phase|Other|5|||
155751005|NCT05217927|562187206|FG002|OLE Phase|Other|4|||
155751006|NCT05217927|562187204|FG000|OLE Phase|Withdrawal of consent|3|||
155751007|NCT05217927|562187205|FG001|OLE Phase|Withdrawal of consent|1|||
155751008|NCT05217927|562187206|FG002|OLE Phase|Withdrawal of consent|5|||
155751009|NCT06785857|562187209|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
155751010|NCT06785857|562187210|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
155751011|NCT03576274|562187212|FG000|Overall Study|Lost to Follow-up|3|||
155751012|NCT03576274|562187213|FG001|Overall Study|Lost to Follow-up|2|||
155312637|NCT03150810|560577449|FG001|Overall Study|Withdrawal by Subject|1|||
155312638|NCT03150810|560577450|FG002|Overall Study|Withdrawal by Subject|1|||
155312639|NCT03150810|560577451|FG003|Overall Study|Withdrawal by Subject|1|||
155312640|NCT03150810|560577452|FG004|Overall Study|Withdrawal by Subject|0|||
155312641|NCT03150810|560577453|FG005|Overall Study|Withdrawal by Subject|0|||
155312642|NCT03150810|560577454|FG006|Overall Study|Withdrawal by Subject|2|||
155312643|NCT03150810|560577455|FG007|Overall Study|Withdrawal by Subject|0|||
155499146|NCT00602641|561252652|FG000|Overall Study|Disease progression|38|||
155499147|NCT00602641|561252653|FG001|Overall Study|Disease progression|55|||
155499148|NCT00602641|561252652|FG000|Overall Study|Death|6|||
155499149|NCT00602641|561252653|FG001|Overall Study|Death|5|||
155499150|NCT00602641|561252652|FG000|Overall Study|Withdrawal by Subject|15|||
155499151|NCT00602641|561252653|FG001|Overall Study|Withdrawal by Subject|12|||
155499152|NCT00602641|561252652|FG000|Overall Study|Alternative therapy|5|||
155499153|NCT00602641|561252653|FG001|Overall Study|Alternative therapy|2|||
155499154|NCT00602641|561252652|FG000|Overall Study|Other Complicating Disease|5|||
155499155|NCT00602641|561252653|FG001|Overall Study|Other Complicating Disease|2|||
155499156|NCT00602641|561252652|FG000|Overall Study|Physician Decision|5|||
155499157|NCT00602641|561252653|FG001|Overall Study|Physician Decision|4|||
155499158|NCT00602641|561252652|FG000|Overall Study|Administrative Closure|1|||
155499159|NCT00602641|561252653|FG001|Overall Study|Administrative Closure|1|||
155499160|NCT00602641|561252652|FG000|Overall Study|Other|3|||
155499161|NCT00602641|561252653|FG001|Overall Study|Other|1|||
155499162|NCT01826201|561252656|FG000|Overall Study|Non compliance with protocol|4|||
155499163|NCT01615822|561252657|FG000|Period 1|Withdrawal by Subject|0|||
155499164|NCT01615822|561252658|FG001|Period 1|Withdrawal by Subject|1|||
155751013|NCT03576274|562187214|FG002|Overall Study|Lost to Follow-up|3|||
155312644|NCT03150810|560577456|FG008|Overall Study|Withdrawal by Subject|2|||
155312645|NCT03150810|560577457|FG009|Overall Study|Withdrawal by Subject|0|||
155416570|NCT01463098|560954803|FG005|Part B (11 Days)|Participant Choice|0|||
155416571|NCT01463098|560954804|FG006|Part B (11 Days)|Participant Choice|0|||
155416572|NCT01463098|560954805|FG007|Part B (11 Days)|Participant Choice|0|||
155416573|NCT01463098|560954806|FG008|Part B (11 Days)|Participant Choice|0|||
155416574|NCT01463098|560954807|FG009|Part B (11 Days)|Participant Choice|0|||
155416575|NCT01463098|560954808|FG010|Part B (11 Days)|Participant Choice|0|||
155416576|NCT01463098|560954809|FG011|Part B (11 Days)|Participant Choice|1|||
155416577|NCT01463098|560954810|FG012|Part B (11 Days)|Participant Choice|0|||
155416578|NCT01463098|560954811|FG013|Part B (11 Days)|Participant Choice|0|||
155416579|NCT04317274|560954812|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
155416580|NCT04317274|560954813|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
155416581|NCT04317274|560954814|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
155416582|NCT04317274|560954815|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
155416583|NCT00699907|560954816|FG000|Overall Study|Withdrawal by Subject|2|||
155416584|NCT00699907|560954817|FG001|Overall Study|Withdrawal by Subject|1|||
155416585|NCT00699907|560954818|FG002|Overall Study|Withdrawal by Subject|0|||
155416586|NCT00699907|560954816|FG000|Overall Study|No usable sample|0|||
155416587|NCT00699907|560954817|FG001|Overall Study|No usable sample|9|||
155416588|NCT00699907|560954818|FG002|Overall Study|No usable sample|8|||
155416589|NCT02286947|560954841|FG000|Overall Study|Withdrawal by Subject|2|||
155751014|NCT03576274|562187215|FG003|Overall Study|Lost to Follow-up|1|||
155312646|NCT03150810|560577458|FG010|Overall Study|Withdrawal by Subject|1|||
155416590|NCT01145066|560954842|FG000|Overall Study|To resume NSAIDs|2|||
155416591|NCT01145066|560954843|FG001|Overall Study|To resume NSAIDs|2|||
155499165|NCT01615822|561252659|FG002|Period 1|Withdrawal by Subject|0|||
155499166|NCT01615822|561252657|FG000|Period 1|Adverse Event|1|||
155499167|NCT01615822|561252658|FG001|Period 1|Adverse Event|1|||
155751015|NCT03576274|562187216|FG004|Overall Study|Lost to Follow-up|3|||
155751016|NCT03576274|562187212|FG000|Overall Study|Withdrawal by Subject|5|||
155312647|NCT03150810|560577459|FG011|Overall Study|Withdrawal by Subject|0|||
155751017|NCT03576274|562187213|FG001|Overall Study|Withdrawal by Subject|3|||
155312648|NCT03150810|560577460|FG012|Overall Study|Withdrawal by Subject|1|||
155312649|NCT03150810|560577448|FG000|Overall Study|Sponsor Decision|0|||
155312650|NCT03150810|560577449|FG001|Overall Study|Sponsor Decision|2|||
155312651|NCT03150810|560577450|FG002|Overall Study|Sponsor Decision|0|||
155312652|NCT03150810|560577451|FG003|Overall Study|Sponsor Decision|0|||
155312653|NCT03150810|560577452|FG004|Overall Study|Sponsor Decision|1|||
155312654|NCT03150810|560577453|FG005|Overall Study|Sponsor Decision|1|||
155312655|NCT03150810|560577454|FG006|Overall Study|Sponsor Decision|0|||
155312656|NCT03150810|560577455|FG007|Overall Study|Sponsor Decision|0|||
155312657|NCT03150810|560577456|FG008|Overall Study|Sponsor Decision|1|||
155312658|NCT03150810|560577457|FG009|Overall Study|Sponsor Decision|0|||
155312659|NCT03150810|560577458|FG010|Overall Study|Sponsor Decision|0|||
155416592|NCT01145066|560954844|FG002|Overall Study|To resume NSAIDs|1|||
155416593|NCT01145066|560954842|FG000|Overall Study|Non-related surgery|0|||
155416594|NCT01145066|560954843|FG001|Overall Study|Non-related surgery|0|||
155416595|NCT01145066|560954844|FG002|Overall Study|Non-related surgery|1|||
155416596|NCT01145066|560954842|FG000|Overall Study|Withdrawal by Subject|0|||
155416597|NCT01145066|560954843|FG001|Overall Study|Withdrawal by Subject|0|||
155416598|NCT01145066|560954844|FG002|Overall Study|Withdrawal by Subject|2|||
155416599|NCT01145066|560954842|FG000|Overall Study|To start new med|1|||
155416600|NCT01145066|560954843|FG001|Overall Study|To start new med|0|||
155416601|NCT01145066|560954844|FG002|Overall Study|To start new med|0|||
155416602|NCT01145066|560954842|FG000|Overall Study|problems swallowing capsule|1|||
155416603|NCT01145066|560954843|FG001|Overall Study|problems swallowing capsule|0|||
155416604|NCT01145066|560954844|FG002|Overall Study|problems swallowing capsule|0|||
155416605|NCT01145066|560954842|FG000|Overall Study|Abdominal discomfort|0|||
155416606|NCT01145066|560954843|FG001|Overall Study|Abdominal discomfort|1|||
155416607|NCT01145066|560954844|FG002|Overall Study|Abdominal discomfort|0|||
155416608|NCT01145066|560954842|FG000|Overall Study|Low platelet count|0|||
155416609|NCT01145066|560954843|FG001|Overall Study|Low platelet count|1|||
155416610|NCT01145066|560954844|FG002|Overall Study|Low platelet count|0|||
155416611|NCT03920670|560954845|FG000|Overall Study|Protocol Violation|2|||
155416612|NCT03920670|560954846|FG001|Overall Study|Protocol Violation|2|||
155416613|NCT03920670|560954845|FG000|Overall Study|Adverse Event|1|||
155416614|NCT03920670|560954846|FG001|Overall Study|Adverse Event|0|||
155416615|NCT00573794|560954852|FG000|Overall Study|Adverse Event|81|||
155416616|NCT00573794|560954852|FG000|Overall Study|Withdrew Consent|90|||
155416617|NCT00573794|560954852|FG000|Overall Study|Lost to Follow-up|13|||
155416618|NCT00573794|560954852|FG000|Overall Study|Protocol Violation|6|||
155416619|NCT00573794|560954852|FG000|Overall Study|Lack of Efficacy|94|||
155416620|NCT00573794|560954852|FG000|Overall Study|Other|46|||
155416621|NCT02270242|560954853|FG000|Overall Study|Withdrawal by Subject|18|||
155416622|NCT02270242|560954854|FG001|Overall Study|Withdrawal by Subject|25|||
155416623|NCT02270242|560954853|FG000|Overall Study|Lost to Follow-up|41|||
155416624|NCT02270242|560954854|FG001|Overall Study|Lost to Follow-up|27|||
155416625|NCT02270242|560954853|FG000|Overall Study|Physician Decision|0|||
155416626|NCT02270242|560954854|FG001|Overall Study|Physician Decision|1|||
155416627|NCT01984268|560954855|FG000|Overall Study|Study Terminated|15|||
155416628|NCT02527707|560956823|FG000|Overall Study|Adverse Event|1|||
155416629|NCT02527707|560956823|FG000|Overall Study|Adverse Event|1|||
155416630|NCT01641939|560956824|FG000|Overall Study|Death|90|||
155416631|NCT01641939|560956825|FG001|Overall Study|Death|187|||
155416632|NCT01641939|560956826|FG002|Overall Study|Death|61|||
155416633|NCT01641939|560956824|FG000|Overall Study|Lost to Follow-up|3|||
155416634|NCT01641939|560956825|FG001|Overall Study|Lost to Follow-up|2|||
155416635|NCT01641939|560956826|FG002|Overall Study|Lost to Follow-up|1|||
155416636|NCT01641939|560956824|FG000|Overall Study|Withdrawal by Subject|14|||
155416637|NCT01641939|560956825|FG001|Overall Study|Withdrawal by Subject|11|||
155416638|NCT01641939|560956826|FG002|Overall Study|Withdrawal by Subject|5|||
155416639|NCT01641939|560956824|FG000|Overall Study|Study Terminated by Sponsor|10|||
155416640|NCT01641939|560956825|FG001|Overall Study|Study Terminated by Sponsor|28|||
155416641|NCT01641939|560956826|FG002|Overall Study|Study Terminated by Sponsor|3|||
155416642|NCT00975156|560956834|FG000|Overall Study|Protocol Violation|0|||
155416643|NCT00975156|560956835|FG001|Overall Study|Protocol Violation|1|||
155416644|NCT05499559|560956836|FG000|Overall Study|Lost to Follow-up|467|||
155416645|NCT02971202|560956841|FG000|Overall Study|Pregnancy|1|||
155416646|NCT02971202|560956842|FG001|Overall Study|Pregnancy|0|||
155416647|NCT02971202|560956843|FG002|Overall Study|Pregnancy|0|||
155416648|NCT02971202|560956841|FG000|Overall Study|screen fail after consent|1|||
155312660|NCT03150810|560577459|FG011|Overall Study|Sponsor Decision|0|||
155416649|NCT02971202|560956842|FG001|Overall Study|screen fail after consent|0|||
155416650|NCT02971202|560956843|FG002|Overall Study|screen fail after consent|1|||
155416651|NCT01946178|560956844|FG000|Overall Study|Pregnancy|1|||
155416652|NCT01946178|560956844|FG000|Overall Study|Lost to Follow-up|1|||
155416653|NCT01001702|560956849|FG000|Overall Study|Lost to Follow-up|7|||
155312661|NCT03150810|560577460|FG012|Overall Study|Sponsor Decision|5|||
155312662|NCT03150810|560577448|FG000|Overall Study|Lost to Follow-up|0|||
155416654|NCT01001702|560956849|FG000|Overall Study|Adverse Event|7|||
155416655|NCT01001702|560956849|FG000|Overall Study|Sponsor Discontinued Study|4|||
155416656|NCT01001702|560956849|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
155499168|NCT01615822|561252659|FG002|Period 1|Adverse Event|0|||
155499169|NCT01615822|561252657|FG000|Period 2|Lost to Follow-up|0|||
155499170|NCT01615822|561252658|FG001|Period 2|Lost to Follow-up|1|||
155499171|NCT01615822|561252659|FG002|Period 2|Lost to Follow-up|2|||
155499172|NCT01988337|561252662|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
155312663|NCT03150810|560577449|FG001|Overall Study|Lost to Follow-up|1|||
155312664|NCT03150810|560577450|FG002|Overall Study|Lost to Follow-up|1|||
155312665|NCT03150810|560577451|FG003|Overall Study|Lost to Follow-up|0|||
155312666|NCT03150810|560577452|FG004|Overall Study|Lost to Follow-up|0|||
155312667|NCT03150810|560577453|FG005|Overall Study|Lost to Follow-up|0|||
155312668|NCT03150810|560577454|FG006|Overall Study|Lost to Follow-up|1|||
155312669|NCT03150810|560577455|FG007|Overall Study|Lost to Follow-up|0|||
155312670|NCT03150810|560577456|FG008|Overall Study|Lost to Follow-up|0|||
155312671|NCT03150810|560577457|FG009|Overall Study|Lost to Follow-up|0|||
155312672|NCT03150810|560577458|FG010|Overall Study|Lost to Follow-up|1|||
155312673|NCT03150810|560577459|FG011|Overall Study|Lost to Follow-up|0|||
155312674|NCT03150810|560577460|FG012|Overall Study|Lost to Follow-up|0|||
155312675|NCT03150810|560577448|FG000|Overall Study|Physician Decision|0|||
155312676|NCT03150810|560577449|FG001|Overall Study|Physician Decision|0|||
155312677|NCT03150810|560577450|FG002|Overall Study|Physician Decision|0|||
155312678|NCT03150810|560577451|FG003|Overall Study|Physician Decision|0|||
155312679|NCT03150810|560577452|FG004|Overall Study|Physician Decision|0|||
155312680|NCT03150810|560577453|FG005|Overall Study|Physician Decision|1|||
155312681|NCT03150810|560577454|FG006|Overall Study|Physician Decision|1|||
155312682|NCT03150810|560577455|FG007|Overall Study|Physician Decision|0|||
155312683|NCT03150810|560577456|FG008|Overall Study|Physician Decision|0|||
155312684|NCT03150810|560577457|FG009|Overall Study|Physician Decision|0|||
155312685|NCT03150810|560577458|FG010|Overall Study|Physician Decision|0|||
155312686|NCT03150810|560577459|FG011|Overall Study|Physician Decision|0|||
155499173|NCT02742818|561252663|FG000|Overall Study|Adverse Event|0|||
155499174|NCT02742818|561252664|FG001|Overall Study|Adverse Event|1|||
155499175|NCT02742818|561252663|FG000|Overall Study|Protocol Violation|0|||
155499176|NCT02742818|561252664|FG001|Overall Study|Protocol Violation|1|||
155499177|NCT04701658|561252665|FG000|Overall Study|Lost to Follow-up|6|||
155499178|NCT03099161|561252668|FG000|Overall Study|Adverse Event|0|||
155499179|NCT03099161|561252669|FG001|Overall Study|Adverse Event|0|||
155499180|NCT03099161|561252670|FG002|Overall Study|Adverse Event|2|||
155499181|NCT03099161|561252668|FG000|Overall Study|Physician Decision|2|||
155499182|NCT03099161|561252669|FG001|Overall Study|Physician Decision|0|||
155499183|NCT03099161|561252670|FG002|Overall Study|Physician Decision|0|||
155499184|NCT03099161|561252668|FG000|Overall Study|Progressive Disease|1|||
155499185|NCT03099161|561252669|FG001|Overall Study|Progressive Disease|4|||
155499186|NCT03099161|561252670|FG002|Overall Study|Progressive Disease|1|||
155499187|NCT00110084|561252671|FG000|Overall Study|Adverse Event|9|||
155499188|NCT00110084|561252671|FG000|Overall Study|Death|1|||
155499189|NCT00110084|561252671|FG000|Overall Study|Patient Refusal|10|||
155499190|NCT00110084|561252671|FG000|Overall Study|Alternate Therapy|5|||
155312687|NCT03150810|560577460|FG012|Overall Study|Physician Decision|0|||
155312688|NCT03150810|560577448|FG000|Overall Study|Site withdrawal from study|0|||
155312689|NCT03150810|560577449|FG001|Overall Study|Site withdrawal from study|1|||
155312690|NCT03150810|560577450|FG002|Overall Study|Site withdrawal from study|0|||
155312691|NCT03150810|560577451|FG003|Overall Study|Site withdrawal from study|0|||
155312692|NCT03150810|560577452|FG004|Overall Study|Site withdrawal from study|0|||
155312693|NCT03150810|560577453|FG005|Overall Study|Site withdrawal from study|0|||
155312694|NCT03150810|560577454|FG006|Overall Study|Site withdrawal from study|0|||
155312695|NCT03150810|560577455|FG007|Overall Study|Site withdrawal from study|0|||
155312696|NCT03150810|560577456|FG008|Overall Study|Site withdrawal from study|0|||
155312697|NCT03150810|560577457|FG009|Overall Study|Site withdrawal from study|1|||
155499191|NCT00110084|561252671|FG000|Overall Study|Intercurrent Illness|1|||
155499192|NCT00110084|561252671|FG000|Overall Study|Other|2|||
155312698|NCT03150810|560577458|FG010|Overall Study|Site withdrawal from study|1|||
155312699|NCT03150810|560577459|FG011|Overall Study|Site withdrawal from study|0|||
155312700|NCT03150810|560577460|FG012|Overall Study|Site withdrawal from study|0|||
155312701|NCT03150810|560577448|FG000|Overall Study|Hospice|0|||
155312702|NCT03150810|560577449|FG001|Overall Study|Hospice|0|||
155499193|NCT04854707|561252672|FG000|Overall Study|Lack of Efficacy|78|||
155499194|NCT04854707|561252673|FG001|Overall Study|Lack of Efficacy|59|||
155499195|NCT04854707|561252674|FG002|Overall Study|Lack of Efficacy|30|||
155499196|NCT05302414|561252676|FG000|Pretest to Posttest|Lost to Follow-up|12|||
155499197|NCT05302414|561252677|FG001|Pretest to Posttest|Lost to Follow-up|8|||
155312703|NCT03150810|560577450|FG002|Overall Study|Hospice|0|||
155312704|NCT03150810|560577451|FG003|Overall Study|Hospice|0|||
155499198|NCT05302414|561252678|FG002|Pretest to Posttest|Lost to Follow-up|8|||
155312705|NCT03150810|560577452|FG004|Overall Study|Hospice|0|||
155312706|NCT03150810|560577453|FG005|Overall Study|Hospice|1|||
155312707|NCT03150810|560577454|FG006|Overall Study|Hospice|0|||
155312708|NCT03150810|560577455|FG007|Overall Study|Hospice|0|||
155312709|NCT03150810|560577456|FG008|Overall Study|Hospice|0|||
155499199|NCT05302414|561252676|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
155416657|NCT01001702|560956849|FG000|Overall Study|Investigator withdrew Subject|10|||
155416658|NCT01001702|560956849|FG000|Overall Study|Withdrawal by Subject|19|||
155416659|NCT01001702|560956849|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
155416660|NCT02494596|560956850|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155416661|NCT02494596|560956851|FG001|Overall Study|Insufficient Therapeutic Response|3|||
155416662|NCT02494596|560956852|FG002|Overall Study|Insufficient Therapeutic Response|1|||
155416663|NCT02494596|560956850|FG000|Overall Study|Adverse Event|0|||
155416664|NCT02494596|560956851|FG001|Overall Study|Adverse Event|1|||
155416665|NCT02494596|560956852|FG002|Overall Study|Adverse Event|0|||
155416666|NCT02494596|560956850|FG000|Overall Study|Refused Treatment|0|||
155416667|NCT02494596|560956851|FG001|Overall Study|Refused Treatment|1|||
155416668|NCT02494596|560956852|FG002|Overall Study|Refused Treatment|0|||
155416669|NCT02222714|560956853|FG000|Overall Study|Death|0|||
155416670|NCT02222714|560956854|FG001|Overall Study|Death|2|||
155416671|NCT02222714|560956855|FG002|Overall Study|Death|3|||
155416672|NCT02222714|560956856|FG003|Overall Study|Death|4|||
155416673|NCT02222714|560956857|FG004|Overall Study|Death|6|||
155416674|NCT02222714|560956853|FG000|Overall Study|Withdrawal by Subject|0|||
155416675|NCT02222714|560956854|FG001|Overall Study|Withdrawal by Subject|0|||
155416676|NCT02222714|560956855|FG002|Overall Study|Withdrawal by Subject|1|||
155416677|NCT02222714|560956856|FG003|Overall Study|Withdrawal by Subject|0|||
155416678|NCT02222714|560956857|FG004|Overall Study|Withdrawal by Subject|1|||
155416679|NCT00159432|560956858|FG000|Overall Study|Adverse Event|1|||
155416680|NCT00159432|560956858|FG000|Overall Study|Death|1|||
155416681|NCT00159432|560956858|FG000|Overall Study|Lack of Efficacy|8|||
155416682|NCT04537208|560956863|FG000|Overall Study|Adverse Event|0|||
155416683|NCT04537208|560956864|FG001|Overall Study|Adverse Event|0|||
155416684|NCT04537208|560956865|FG002|Overall Study|Adverse Event|0|||
155416685|NCT04537208|560956866|FG003|Overall Study|Adverse Event|0|||
155416686|NCT04537208|560956867|FG004|Overall Study|Adverse Event|0|||
155416687|NCT04537208|560956868|FG005|Overall Study|Adverse Event|0|||
155416688|NCT04537208|560956869|FG006|Overall Study|Adverse Event|0|||
155416689|NCT04537208|560956870|FG007|Overall Study|Adverse Event|0|||
155416690|NCT04537208|560956871|FG008|Overall Study|Adverse Event|1|||
155416691|NCT04537208|560956872|FG009|Overall Study|Adverse Event|0|||
155416692|NCT04537208|560956873|FG010|Overall Study|Adverse Event|0|||
155416693|NCT04537208|560956863|FG000|Overall Study|Protocol deviation|0|||
155416694|NCT04537208|560956864|FG001|Overall Study|Protocol deviation|0|||
155416695|NCT04537208|560956865|FG002|Overall Study|Protocol deviation|2|||
155416696|NCT04537208|560956866|FG003|Overall Study|Protocol deviation|0|||
155416697|NCT04537208|560956867|FG004|Overall Study|Protocol deviation|0|||
155416698|NCT04537208|560956868|FG005|Overall Study|Protocol deviation|2|||
155416699|NCT04537208|560956869|FG006|Overall Study|Protocol deviation|4|||
155416700|NCT04537208|560956870|FG007|Overall Study|Protocol deviation|0|||
155416701|NCT04537208|560956871|FG008|Overall Study|Protocol deviation|1|||
155416702|NCT04537208|560956872|FG009|Overall Study|Protocol deviation|0|||
155416703|NCT04537208|560956873|FG010|Overall Study|Protocol deviation|2|||
155416704|NCT04537208|560956863|FG000|Overall Study|Withdrawal by Subject|4|||
155416705|NCT04537208|560956864|FG001|Overall Study|Withdrawal by Subject|2|||
155416706|NCT04537208|560956865|FG002|Overall Study|Withdrawal by Subject|1|||
155416707|NCT04537208|560956866|FG003|Overall Study|Withdrawal by Subject|3|||
155416708|NCT04537208|560956867|FG004|Overall Study|Withdrawal by Subject|5|||
155416709|NCT04537208|560956868|FG005|Overall Study|Withdrawal by Subject|1|||
155416710|NCT04537208|560956869|FG006|Overall Study|Withdrawal by Subject|6|||
155416711|NCT04537208|560956870|FG007|Overall Study|Withdrawal by Subject|1|||
155416712|NCT04537208|560956871|FG008|Overall Study|Withdrawal by Subject|7|||
155416713|NCT04537208|560956872|FG009|Overall Study|Withdrawal by Subject|2|||
155416714|NCT04537208|560956873|FG010|Overall Study|Withdrawal by Subject|4|||
155416715|NCT04537208|560956863|FG000|Overall Study|Lost to Follow-up|4|||
155416716|NCT04537208|560956864|FG001|Overall Study|Lost to Follow-up|1|||
155416717|NCT04537208|560956865|FG002|Overall Study|Lost to Follow-up|3|||
155416718|NCT04537208|560956866|FG003|Overall Study|Lost to Follow-up|4|||
155416719|NCT04537208|560956867|FG004|Overall Study|Lost to Follow-up|3|||
155416720|NCT04537208|560956868|FG005|Overall Study|Lost to Follow-up|2|||
155416721|NCT04537208|560956869|FG006|Overall Study|Lost to Follow-up|3|||
155416722|NCT04537208|560956870|FG007|Overall Study|Lost to Follow-up|2|||
155416723|NCT04537208|560956871|FG008|Overall Study|Lost to Follow-up|7|||
155416724|NCT04537208|560956872|FG009|Overall Study|Lost to Follow-up|2|||
155416725|NCT04537208|560956873|FG010|Overall Study|Lost to Follow-up|2|||
155416726|NCT00704964|560956875|FG000|Overall Study|Not completed on time|328|||
155416727|NCT02161562|560956877|FG000|Overall Study|Withdrawal by Subject|5|||
155416728|NCT02161562|560956878|FG001|Overall Study|Withdrawal by Subject|8|||
155416729|NCT02161562|560956877|FG000|Overall Study|Protocol Violation|9|||
155416730|NCT02161562|560956878|FG001|Overall Study|Protocol Violation|4|||
155416731|NCT02161562|560956877|FG000|Overall Study|Pregnancy|1|||
155416732|NCT02161562|560956878|FG001|Overall Study|Pregnancy|2|||
155416733|NCT02161562|560956877|FG000|Overall Study|Lost to Follow-up|3|||
155416734|NCT02161562|560956878|FG001|Overall Study|Lost to Follow-up|1|||
155416735|NCT02161562|560956877|FG000|Overall Study|Lack of Efficacy|4|||
155312710|NCT03150810|560577457|FG009|Overall Study|Hospice|0|||
155312711|NCT03150810|560577458|FG010|Overall Study|Hospice|0|||
155312712|NCT03150810|560577459|FG011|Overall Study|Hospice|0|||
155312713|NCT03150810|560577460|FG012|Overall Study|Hospice|0|||
155499200|NCT05302414|561252677|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
155499201|NCT05302414|561252678|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
155499202|NCT00742859|561252679|FG000|Overall Study|Adverse Event|5|||
155499203|NCT00742859|561252680|FG001|Overall Study|Adverse Event|6|||
155499204|NCT00742859|561252681|FG002|Overall Study|Adverse Event|3|||
155499205|NCT00742859|561252682|FG003|Overall Study|Adverse Event|1|||
155499206|NCT00742859|561252679|FG000|Overall Study|Death|1|||
155499207|NCT00742859|561252680|FG001|Overall Study|Death|0|||
155499208|NCT00742859|561252681|FG002|Overall Study|Death|0|||
155499209|NCT00742859|561252682|FG003|Overall Study|Death|1|||
155499210|NCT00742859|561252679|FG000|Overall Study|Physician Decision|1|||
155499211|NCT00742859|561252680|FG001|Overall Study|Physician Decision|2|||
155499212|NCT00742859|561252681|FG002|Overall Study|Physician Decision|0|||
155499213|NCT00742859|561252682|FG003|Overall Study|Physician Decision|0|||
155499214|NCT00742859|561252679|FG000|Overall Study|Withdrawal by Subject|4|||
155499215|NCT00742859|561252680|FG001|Overall Study|Withdrawal by Subject|2|||
155499216|NCT00742859|561252681|FG002|Overall Study|Withdrawal by Subject|4|||
155499217|NCT00742859|561252682|FG003|Overall Study|Withdrawal by Subject|1|||
155499218|NCT00742859|561252679|FG000|Overall Study|Endpoint|0|||
155499219|NCT00742859|561252680|FG001|Overall Study|Endpoint|1|||
155499220|NCT00742859|561252681|FG002|Overall Study|Endpoint|1|||
155499221|NCT00742859|561252682|FG003|Overall Study|Endpoint|2|||
155499222|NCT00742859|561252679|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
155499223|NCT00742859|561252680|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
155499224|NCT00742859|561252681|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
155499225|NCT00742859|561252682|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
155499226|NCT00742859|561252679|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
155499227|NCT00742859|561252680|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
155499228|NCT00742859|561252681|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
155499229|NCT00742859|561252682|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
155499230|NCT00742859|561252679|FG000|Overall Study|Sponsor request patient out of town|0|||
155499231|NCT00742859|561252680|FG001|Overall Study|Sponsor request patient out of town|0|||
155499232|NCT00742859|561252681|FG002|Overall Study|Sponsor request patient out of town|1|||
155499233|NCT00742859|561252682|FG003|Overall Study|Sponsor request patient out of town|1|||
155499234|NCT00742859|561252679|FG000|Overall Study|Site error|0|||
155499235|NCT00742859|561252680|FG001|Overall Study|Site error|0|||
155499236|NCT00742859|561252681|FG002|Overall Study|Site error|1|||
155499237|NCT00742859|561252682|FG003|Overall Study|Site error|1|||
155499238|NCT02017535|561252685|FG000|Overall Study|Withdrawal by Subject|1|||
155499239|NCT02017535|561252686|FG001|Overall Study|Withdrawal by Subject|0|||
155499240|NCT02017535|561252687|FG002|Overall Study|Withdrawal by Subject|0|||
155499241|NCT02017535|561252688|FG003|Overall Study|Withdrawal by Subject|0|||
155499242|NCT05511428|561252689|FG000|Overall Study|Withdrawal by Subject|1|||
155499243|NCT05511428|561252689|FG000|Overall Study|Adverse Event|1|||
155499244|NCT04088734|561252690|FG000|Overall Study|Other, Not Specified|5|||
155499245|NCT03829462|561252691|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
155499246|NCT03829462|561252692|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
155499247|NCT03829462|561252691|FG000|Overall Study|No treatment due to progression disease|0|||
155499248|NCT03829462|561252692|FG001|Overall Study|No treatment due to progression disease|1|||
155499249|NCT03332212|561252695|FG000|Overall Study|Not treated|0|||
155499250|NCT03332212|561252696|FG001|Overall Study|Not treated|1|||
155499251|NCT03332212|561252697|FG002|Overall Study|Not treated|0|||
155499252|NCT03332212|561252698|FG003|Overall Study|Not treated|0|||
155499253|NCT03332212|561252695|FG000|Overall Study|Adverse Event|0|||
155499254|NCT03332212|561252696|FG001|Overall Study|Adverse Event|0|||
155643229|NCT01807520|561783752|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
155643230|NCT01631188|561783753|FG000|Overall Study|Physician Decision|75|||
155312714|NCT03150810|560577448|FG000|Overall Study|Participant relocated abroad.|0|||
155312715|NCT03150810|560577449|FG001|Overall Study|Participant relocated abroad.|0|||
155312716|NCT03150810|560577450|FG002|Overall Study|Participant relocated abroad.|0|||
155312717|NCT03150810|560577451|FG003|Overall Study|Participant relocated abroad.|0|||
155312718|NCT03150810|560577452|FG004|Overall Study|Participant relocated abroad.|0|||
155312719|NCT03150810|560577453|FG005|Overall Study|Participant relocated abroad.|1|||
155312720|NCT03150810|560577454|FG006|Overall Study|Participant relocated abroad.|0|||
155643231|NCT04575324|561783756|FG000|Overall Study|Lost to Follow-up|29|||
155312721|NCT03150810|560577455|FG007|Overall Study|Participant relocated abroad.|0|||
155312722|NCT03150810|560577456|FG008|Overall Study|Participant relocated abroad.|0|||
155312723|NCT03150810|560577457|FG009|Overall Study|Participant relocated abroad.|0|||
155499255|NCT03332212|561252697|FG002|Overall Study|Adverse Event|0|||
155499256|NCT03332212|561252698|FG003|Overall Study|Adverse Event|1|||
155499257|NCT03332212|561252695|FG000|Overall Study|worsening of disease under study|1|||
155499258|NCT03332212|561252696|FG001|Overall Study|worsening of disease under study|1|||
155312724|NCT03150810|560577458|FG010|Overall Study|Participant relocated abroad.|0|||
155312725|NCT03150810|560577459|FG011|Overall Study|Participant relocated abroad.|0|||
155312726|NCT03150810|560577460|FG012|Overall Study|Participant relocated abroad.|0|||
155416736|NCT02161562|560956878|FG001|Overall Study|Lack of Efficacy|1|||
155416737|NCT02161562|560956877|FG000|Overall Study|Adverse Event|1|||
155416738|NCT02161562|560956878|FG001|Overall Study|Adverse Event|1|||
155416739|NCT02161562|560956877|FG000|Overall Study|Participant moved back to home country|1|||
155416740|NCT02161562|560956878|FG001|Overall Study|Participant moved back to home country|0|||
155416741|NCT02161562|560956877|FG000|Overall Study|Withdrew due to being out of the country|1|||
155416742|NCT02161562|560956878|FG001|Overall Study|Withdrew due to being out of the country|0|||
155416743|NCT02161562|560956877|FG000|Overall Study|Participant moved out of province|1|||
155416744|NCT02161562|560956878|FG001|Overall Study|Participant moved out of province|0|||
155416745|NCT02450578|560956881|FG000|Overall Study|ECG abnormality so not treated|1|||
155416746|NCT02450578|560956882|FG001|Overall Study|ECG abnormality so not treated|0|||
155416747|NCT02450578|560956883|FG002|Overall Study|ECG abnormality so not treated|0|||
155416748|NCT02450578|560956884|FG003|Overall Study|ECG abnormality so not treated|0|||
155416749|NCT00090545|560956886|FG000|Overall Study|Disease progression on study|21|||
155416750|NCT00090545|560956887|FG001|Overall Study|Disease progression on study|17|||
155416751|NCT00090545|560956886|FG000|Overall Study|Refused further treatment|1|||
155416752|NCT00090545|560956887|FG001|Overall Study|Refused further treatment|4|||
155416753|NCT00090545|560956886|FG000|Overall Study|Death|0|||
155416754|NCT00090545|560956887|FG001|Overall Study|Death|1|||
155416755|NCT00090545|560956886|FG000|Overall Study|Adverse Event|0|||
155416756|NCT00090545|560956887|FG001|Overall Study|Adverse Event|2|||
155416757|NCT00523991|560956889|FG000|Overall Study|Adverse Event|6|||
155416758|NCT00523991|560956890|FG001|Overall Study|Adverse Event|5|||
155416759|NCT00523991|560956889|FG000|Overall Study|Protocol Violation|1|||
155416760|NCT00523991|560956890|FG001|Overall Study|Protocol Violation|4|||
155416761|NCT00523991|560956889|FG000|Overall Study|Lost to Follow-up|4|||
155416762|NCT00523991|560956890|FG001|Overall Study|Lost to Follow-up|1|||
155416763|NCT00523991|560956889|FG000|Overall Study|Withdrawal by Subject|7|||
155416764|NCT00523991|560956890|FG001|Overall Study|Withdrawal by Subject|17|||
155416765|NCT00523991|560956889|FG000|Overall Study|Other reason (not specified)|3|||
155416766|NCT00523991|560956890|FG001|Overall Study|Other reason (not specified)|0|||
155416767|NCT02971670|560956896|FG000|Overall Study|Withdrawal by Subject|4|||
155416768|NCT02971670|560956897|FG001|Overall Study|Withdrawal by Subject|1|||
155416769|NCT02971670|560956898|FG002|Overall Study|Withdrawal by Subject|1|||
155416770|NCT02971670|560956899|FG003|Overall Study|Withdrawal by Subject|2|||
155416771|NCT00288080|560956900|FG000|Overall Study|Withdrawal by Subject|1|||
155416772|NCT00288080|560956901|FG001|Overall Study|Withdrawal by Subject|3|||
155416773|NCT00288080|560956900|FG000|Overall Study|Protocol Violation|25|||
155416774|NCT00288080|560956901|FG001|Overall Study|Protocol Violation|20|||
155416775|NCT00379795|560956902|FG000|Overall Study|Death|31|||
155416776|NCT00379795|560956903|FG001|Overall Study|Death|8|||
155416777|NCT00379795|560956904|FG002|Overall Study|Death|6|||
155416778|NCT00379795|560956905|FG003|Overall Study|Death|4|||
155416779|NCT00379795|560956906|FG004|Overall Study|Death|7|||
155416780|NCT00379795|560956902|FG000|Overall Study|Adverse Event|17|||
155416781|NCT00379795|560956903|FG001|Overall Study|Adverse Event|3|||
155416782|NCT00379795|560956904|FG002|Overall Study|Adverse Event|3|||
155416783|NCT00379795|560956905|FG003|Overall Study|Adverse Event|1|||
155416784|NCT00379795|560956906|FG004|Overall Study|Adverse Event|4|||
155416785|NCT00379795|560956902|FG000|Overall Study|Lost to Follow-up|8|||
155416786|NCT00379795|560956903|FG001|Overall Study|Lost to Follow-up|1|||
155416787|NCT00379795|560956904|FG002|Overall Study|Lost to Follow-up|2|||
155416788|NCT00379795|560956905|FG003|Overall Study|Lost to Follow-up|1|||
155416789|NCT00379795|560956906|FG004|Overall Study|Lost to Follow-up|4|||
155416790|NCT00379795|560956902|FG000|Overall Study|Physician Decision|25|||
155416791|NCT00379795|560956903|FG001|Overall Study|Physician Decision|0|||
155416792|NCT00379795|560956904|FG002|Overall Study|Physician Decision|2|||
155416793|NCT00379795|560956905|FG003|Overall Study|Physician Decision|2|||
155416794|NCT00379795|560956906|FG004|Overall Study|Physician Decision|2|||
155416795|NCT00379795|560956902|FG000|Overall Study|Withdrawal by Subject|94|||
155416796|NCT00379795|560956903|FG001|Overall Study|Withdrawal by Subject|11|||
155416797|NCT00379795|560956904|FG002|Overall Study|Withdrawal by Subject|19|||
155416798|NCT00379795|560956905|FG003|Overall Study|Withdrawal by Subject|7|||
155416799|NCT00379795|560956906|FG004|Overall Study|Withdrawal by Subject|14|||
155416800|NCT00379795|560956902|FG000|Overall Study|Subject non-compliance|7|||
155416801|NCT00379795|560956903|FG001|Overall Study|Subject non-compliance|2|||
155416802|NCT00379795|560956904|FG002|Overall Study|Subject non-compliance|0|||
155416803|NCT00379795|560956905|FG003|Overall Study|Subject non-compliance|0|||
155416804|NCT00379795|560956906|FG004|Overall Study|Subject non-compliance|1|||
155416805|NCT00379795|560956902|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
155416806|NCT00379795|560956903|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
155499259|NCT03332212|561252697|FG002|Overall Study|worsening of disease under study|0|||
155499260|NCT03332212|561252698|FG003|Overall Study|worsening of disease under study|0|||
155499261|NCT05824273|561252702|FG000|Overall Study|Lost to Follow-up|16|||
155499262|NCT05824273|561252703|FG001|Overall Study|Lost to Follow-up|13|||
155499263|NCT02736695|561252704|FG000|Overall Study|Ineligible|6|||
155499264|NCT02736695|561252705|FG001|Overall Study|Ineligible|0|||
155499265|NCT03193190|561252708|FG000|Stage 1|Arm Terminated by Sponsor|0|||
155499266|NCT03193190|561252709|FG001|Stage 1|Arm Terminated by Sponsor|0|||
155499267|NCT03193190|561252710|FG002|Stage 1|Arm Terminated by Sponsor|0|||
155499268|NCT03193190|561252711|FG003|Stage 1|Arm Terminated by Sponsor|1|||
155499269|NCT03193190|561252712|FG004|Stage 1|Arm Terminated by Sponsor|0|||
155499270|NCT03193190|561252713|FG005|Stage 1|Arm Terminated by Sponsor|2|||
155499271|NCT03193190|561252714|FG006|Stage 1|Arm Terminated by Sponsor|0|||
155499272|NCT03193190|561252715|FG007|Stage 1|Arm Terminated by Sponsor|0|||
155499273|NCT03193190|561252716|FG008|Stage 1|Arm Terminated by Sponsor|0|||
155499274|NCT03193190|561252717|FG009|Stage 1|Arm Terminated by Sponsor|0|||
155499275|NCT03193190|561252718|FG010|Stage 1|Arm Terminated by Sponsor|0|||
155499276|NCT03193190|561252719|FG011|Stage 1|Arm Terminated by Sponsor|0|||
155499277|NCT03193190|561252720|FG012|Stage 1|Arm Terminated by Sponsor|0|||
155499278|NCT03193190|561252721|FG013|Stage 1|Arm Terminated by Sponsor|0|||
155499279|NCT03193190|561252722|FG014|Stage 1|Arm Terminated by Sponsor|0|||
155499280|NCT03193190|561252723|FG015|Stage 1|Arm Terminated by Sponsor|0|||
155312727|NCT03150810|560577448|FG000|Overall Study|Transferred care to oncologist|0|||
155312728|NCT03150810|560577449|FG001|Overall Study|Transferred care to oncologist|0|||
155312729|NCT03150810|560577450|FG002|Overall Study|Transferred care to oncologist|0|||
155312730|NCT03150810|560577451|FG003|Overall Study|Transferred care to oncologist|0|||
155312731|NCT03150810|560577452|FG004|Overall Study|Transferred care to oncologist|0|||
155312732|NCT03150810|560577453|FG005|Overall Study|Transferred care to oncologist|0|||
155312733|NCT03150810|560577454|FG006|Overall Study|Transferred care to oncologist|2|||
155312734|NCT03150810|560577455|FG007|Overall Study|Transferred care to oncologist|0|||
155499281|NCT03193190|561252708|FG000|Stage 1|Death|22|||
155499282|NCT03193190|561252709|FG001|Stage 1|Death|8|||
155499283|NCT03193190|561252710|FG002|Stage 1|Death|23|||
155499284|NCT03193190|561252711|FG003|Stage 1|Death|14|||
155499285|NCT03193190|561252712|FG004|Stage 1|Death|34|||
155499286|NCT03193190|561252713|FG005|Stage 1|Death|28|||
155499287|NCT03193190|561252714|FG006|Stage 1|Death|19|||
155499288|NCT03193190|561252715|FG007|Stage 1|Death|21|||
155499289|NCT03193190|561252716|FG008|Stage 1|Death|14|||
155499290|NCT03193190|561252717|FG009|Stage 1|Death|10|||
155499291|NCT03193190|561252718|FG010|Stage 1|Death|59|||
155499292|NCT03193190|561252719|FG011|Stage 1|Death|14|||
155499293|NCT03193190|561252720|FG012|Stage 1|Death|14|||
155499294|NCT03193190|561252721|FG013|Stage 1|Death|0|||
155499295|NCT03193190|561252722|FG014|Stage 1|Death|0|||
155499296|NCT03193190|561252723|FG015|Stage 1|Death|0|||
155499297|NCT03193190|561252708|FG000|Stage 1|Lost to Follow-up|2|||
155499298|NCT03193190|561252709|FG001|Stage 1|Lost to Follow-up|1|||
155499299|NCT03193190|561252710|FG002|Stage 1|Lost to Follow-up|1|||
155499300|NCT03193190|561252711|FG003|Stage 1|Lost to Follow-up|0|||
155499301|NCT03193190|561252712|FG004|Stage 1|Lost to Follow-up|0|||
155499302|NCT03193190|561252713|FG005|Stage 1|Lost to Follow-up|0|||
155499303|NCT03193190|561252714|FG006|Stage 1|Lost to Follow-up|1|||
155499304|NCT03193190|561252715|FG007|Stage 1|Lost to Follow-up|0|||
155499305|NCT03193190|561252716|FG008|Stage 1|Lost to Follow-up|0|||
155499306|NCT03193190|561252717|FG009|Stage 1|Lost to Follow-up|0|||
155499307|NCT03193190|561252718|FG010|Stage 1|Lost to Follow-up|0|||
155499308|NCT03193190|561252719|FG011|Stage 1|Lost to Follow-up|0|||
155499309|NCT03193190|561252720|FG012|Stage 1|Lost to Follow-up|0|||
155499310|NCT03193190|561252721|FG013|Stage 1|Lost to Follow-up|0|||
155499311|NCT03193190|561252722|FG014|Stage 1|Lost to Follow-up|0|||
155499312|NCT03193190|561252723|FG015|Stage 1|Lost to Follow-up|0|||
155499313|NCT03193190|561252708|FG000|Stage 1|Reason not Specified|1|||
155499314|NCT03193190|561252709|FG001|Stage 1|Reason not Specified|0|||
155499315|NCT03193190|561252710|FG002|Stage 1|Reason not Specified|0|||
155499316|NCT03193190|561252711|FG003|Stage 1|Reason not Specified|1|||
155499317|NCT03193190|561252712|FG004|Stage 1|Reason not Specified|0|||
155643232|NCT04575324|561783757|FG001|Overall Study|Lost to Follow-up|25|||
155643233|NCT04575324|561783756|FG000|Overall Study|Death|1|||
155643234|NCT04575324|561783757|FG001|Overall Study|Death|2|||
155499318|NCT03193190|561252713|FG005|Stage 1|Reason not Specified|1|||
155499319|NCT03193190|561252714|FG006|Stage 1|Reason not Specified|2|||
155499320|NCT03193190|561252715|FG007|Stage 1|Reason not Specified|2|||
155499321|NCT03193190|561252716|FG008|Stage 1|Reason not Specified|0|||
155312735|NCT03150810|560577456|FG008|Overall Study|Transferred care to oncologist|0|||
155499322|NCT03193190|561252717|FG009|Stage 1|Reason not Specified|1|||
155499323|NCT03193190|561252718|FG010|Stage 1|Reason not Specified|3|||
155499324|NCT03193190|561252719|FG011|Stage 1|Reason not Specified|0|||
155499325|NCT03193190|561252720|FG012|Stage 1|Reason not Specified|1|||
155499326|NCT03193190|561252721|FG013|Stage 1|Reason not Specified|0|||
155499327|NCT03193190|561252722|FG014|Stage 1|Reason not Specified|0|||
155499328|NCT03193190|561252723|FG015|Stage 1|Reason not Specified|0|||
155499329|NCT03193190|561252708|FG000|Stage 1|Physician Decision|0|||
155499330|NCT03193190|561252709|FG001|Stage 1|Physician Decision|0|||
155499331|NCT03193190|561252710|FG002|Stage 1|Physician Decision|0|||
155499332|NCT03193190|561252711|FG003|Stage 1|Physician Decision|0|||
155499333|NCT03193190|561252712|FG004|Stage 1|Physician Decision|0|||
155499334|NCT03193190|561252713|FG005|Stage 1|Physician Decision|0|||
155499335|NCT03193190|561252714|FG006|Stage 1|Physician Decision|0|||
155499336|NCT03193190|561252715|FG007|Stage 1|Physician Decision|0|||
155499337|NCT03193190|561252716|FG008|Stage 1|Physician Decision|0|||
155499338|NCT03193190|561252717|FG009|Stage 1|Physician Decision|0|||
155499339|NCT03193190|561252718|FG010|Stage 1|Physician Decision|0|||
155499340|NCT03193190|561252719|FG011|Stage 1|Physician Decision|1|||
155499341|NCT03193190|561252720|FG012|Stage 1|Physician Decision|0|||
155499342|NCT03193190|561252721|FG013|Stage 1|Physician Decision|0|||
155499343|NCT03193190|561252722|FG014|Stage 1|Physician Decision|0|||
155499344|NCT03193190|561252723|FG015|Stage 1|Physician Decision|0|||
155499345|NCT03193190|561252708|FG000|Stage 1|Progressive Disease|1|||
155499346|NCT03193190|561252709|FG001|Stage 1|Progressive Disease|0|||
155499347|NCT03193190|561252710|FG002|Stage 1|Progressive Disease|0|||
155416807|NCT00379795|560956904|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
155416808|NCT00379795|560956905|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
155416809|NCT00379795|560956906|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
155416810|NCT00379795|560956902|FG000|Overall Study|Subjects condition mandated intervention|34|||
155416811|NCT00379795|560956903|FG001|Overall Study|Subjects condition mandated intervention|9|||
155416812|NCT00379795|560956904|FG002|Overall Study|Subjects condition mandated intervention|7|||
155416813|NCT00379795|560956905|FG003|Overall Study|Subjects condition mandated intervention|5|||
155416814|NCT00379795|560956906|FG004|Overall Study|Subjects condition mandated intervention|7|||
155416815|NCT00379795|560956902|FG000|Overall Study|Sponsor's decision|257|||
155416816|NCT00379795|560956903|FG001|Overall Study|Sponsor's decision|17|||
155416817|NCT00379795|560956904|FG002|Overall Study|Sponsor's decision|54|||
155416818|NCT00379795|560956905|FG003|Overall Study|Sponsor's decision|47|||
155416819|NCT00379795|560956906|FG004|Overall Study|Sponsor's decision|10|||
155416820|NCT03175549|560956907|FG000|Overall Study|Lost to Follow-up|2|||
155416821|NCT03175549|560956908|FG001|Overall Study|Lost to Follow-up|2|||
155416822|NCT03175549|560956907|FG000|Overall Study|Medication non-compliance|2|||
155416823|NCT03175549|560956908|FG001|Overall Study|Medication non-compliance|2|||
155416824|NCT00763321|560956909|FG000|Open-label Period|Adverse Event|24|||
155416825|NCT00763321|560956910|FG001|Open-label Period|Adverse Event|0|||
155416826|NCT00763321|560956911|FG002|Open-label Period|Adverse Event|0|||
155416827|NCT00763321|560956909|FG000|Open-label Period|Lost to Follow-up|14|||
155416828|NCT00763321|560956910|FG001|Open-label Period|Lost to Follow-up|0|||
155416829|NCT00763321|560956911|FG002|Open-label Period|Lost to Follow-up|0|||
155416830|NCT00763321|560956909|FG000|Open-label Period|Withdrawal by Subject|7|||
155416831|NCT00763321|560956910|FG001|Open-label Period|Withdrawal by Subject|0|||
155416832|NCT00763321|560956911|FG002|Open-label Period|Withdrawal by Subject|0|||
155416833|NCT00763321|560956909|FG000|Open-label Period|Subject noncompliant|7|||
155416834|NCT00763321|560956910|FG001|Open-label Period|Subject noncompliant|0|||
155416835|NCT00763321|560956911|FG002|Open-label Period|Subject noncompliant|0|||
155416836|NCT00763321|560956909|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
155416837|NCT00763321|560956910|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
155416838|NCT00763321|560956911|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
155416839|NCT00763321|560956909|FG000|Open-label Period|Lack of Efficacy|2|||
155416840|NCT00763321|560956910|FG001|Open-label Period|Lack of Efficacy|0|||
155416841|NCT00763321|560956911|FG002|Open-label Period|Lack of Efficacy|0|||
155416842|NCT00763321|560956909|FG000|Open-label Period|Other|4|||
155416843|NCT00763321|560956910|FG001|Open-label Period|Other|0|||
155416844|NCT00763321|560956911|FG002|Open-label Period|Other|0|||
155499348|NCT03193190|561252711|FG003|Stage 1|Progressive Disease|0|||
155499349|NCT03193190|561252712|FG004|Stage 1|Progressive Disease|0|||
155499350|NCT03193190|561252713|FG005|Stage 1|Progressive Disease|0|||
155499351|NCT03193190|561252714|FG006|Stage 1|Progressive Disease|0|||
155499352|NCT03193190|561252715|FG007|Stage 1|Progressive Disease|0|||
155751018|NCT03576274|562187214|FG002|Overall Study|Withdrawal by Subject|2|||
155751019|NCT03576274|562187215|FG003|Overall Study|Withdrawal by Subject|8|||
155416845|NCT00763321|560956909|FG000|Double-blind Period|Lack of Efficacy|0|||
155416846|NCT00763321|560956910|FG001|Double-blind Period|Lack of Efficacy|9|||
155416847|NCT00763321|560956911|FG002|Double-blind Period|Lack of Efficacy|17|||
155416848|NCT00763321|560956909|FG000|Double-blind Period|Adverse Event|0|||
155416849|NCT00763321|560956910|FG001|Double-blind Period|Adverse Event|4|||
155416850|NCT00763321|560956911|FG002|Double-blind Period|Adverse Event|4|||
155416851|NCT00763321|560956909|FG000|Double-blind Period|Lost to Follow-up|0|||
155416852|NCT00763321|560956910|FG001|Double-blind Period|Lost to Follow-up|4|||
155416853|NCT00763321|560956911|FG002|Double-blind Period|Lost to Follow-up|2|||
155416854|NCT00763321|560956909|FG000|Double-blind Period|Withdrawal by Subject|0|||
155416855|NCT00763321|560956910|FG001|Double-blind Period|Withdrawal by Subject|2|||
155416856|NCT00763321|560956911|FG002|Double-blind Period|Withdrawal by Subject|3|||
155416857|NCT00763321|560956909|FG000|Double-blind Period|Other|0|||
155499353|NCT03193190|561252716|FG008|Stage 1|Progressive Disease|0|||
155499354|NCT03193190|561252717|FG009|Stage 1|Progressive Disease|0|||
155499355|NCT03193190|561252718|FG010|Stage 1|Progressive Disease|0|||
155499356|NCT03193190|561252719|FG011|Stage 1|Progressive Disease|0|||
155499357|NCT03193190|561252720|FG012|Stage 1|Progressive Disease|0|||
155499358|NCT03193190|561252721|FG013|Stage 1|Progressive Disease|0|||
155499359|NCT03193190|561252722|FG014|Stage 1|Progressive Disease|0|||
155499360|NCT03193190|561252723|FG015|Stage 1|Progressive Disease|0|||
155499361|NCT03193190|561252708|FG000|Stage 1|Study Terminated By Sponsor|3|||
155499362|NCT03193190|561252709|FG001|Stage 1|Study Terminated By Sponsor|0|||
155499363|NCT03193190|561252710|FG002|Stage 1|Study Terminated By Sponsor|0|||
155499364|NCT03193190|561252711|FG003|Stage 1|Study Terminated By Sponsor|0|||
155499365|NCT03193190|561252712|FG004|Stage 1|Study Terminated By Sponsor|6|||
155499366|NCT03193190|561252713|FG005|Stage 1|Study Terminated By Sponsor|0|||
155499367|NCT03193190|561252714|FG006|Stage 1|Study Terminated By Sponsor|0|||
155499368|NCT03193190|561252715|FG007|Stage 1|Study Terminated By Sponsor|0|||
155499369|NCT03193190|561252716|FG008|Stage 1|Study Terminated By Sponsor|0|||
155499370|NCT03193190|561252717|FG009|Stage 1|Study Terminated By Sponsor|0|||
155499371|NCT03193190|561252718|FG010|Stage 1|Study Terminated By Sponsor|0|||
155499372|NCT03193190|561252719|FG011|Stage 1|Study Terminated By Sponsor|0|||
155499373|NCT03193190|561252720|FG012|Stage 1|Study Terminated By Sponsor|0|||
155499374|NCT03193190|561252721|FG013|Stage 1|Study Terminated By Sponsor|0|||
155499375|NCT03193190|561252722|FG014|Stage 1|Study Terminated By Sponsor|0|||
155499376|NCT03193190|561252723|FG015|Stage 1|Study Terminated By Sponsor|0|||
155499377|NCT03193190|561252708|FG000|Stage 1|Withdrawal by Subject|6|||
155499378|NCT03193190|561252709|FG001|Stage 1|Withdrawal by Subject|0|||
155499379|NCT03193190|561252710|FG002|Stage 1|Withdrawal by Subject|1|||
155499380|NCT03193190|561252711|FG003|Stage 1|Withdrawal by Subject|0|||
155499381|NCT03193190|561252712|FG004|Stage 1|Withdrawal by Subject|2|||
155499382|NCT03193190|561252713|FG005|Stage 1|Withdrawal by Subject|0|||
155499383|NCT03193190|561252714|FG006|Stage 1|Withdrawal by Subject|3|||
155499384|NCT03193190|561252715|FG007|Stage 1|Withdrawal by Subject|2|||
155499385|NCT03193190|561252716|FG008|Stage 1|Withdrawal by Subject|2|||
155499386|NCT03193190|561252717|FG009|Stage 1|Withdrawal by Subject|4|||
155499387|NCT03193190|561252718|FG010|Stage 1|Withdrawal by Subject|9|||
155499388|NCT03193190|561252719|FG011|Stage 1|Withdrawal by Subject|1|||
155499389|NCT03193190|561252720|FG012|Stage 1|Withdrawal by Subject|0|||
155499390|NCT03193190|561252721|FG013|Stage 1|Withdrawal by Subject|0|||
155499391|NCT03193190|561252722|FG014|Stage 1|Withdrawal by Subject|0|||
155499392|NCT03193190|561252723|FG015|Stage 1|Withdrawal by Subject|0|||
155499393|NCT03193190|561252708|FG000|Stage 2|Death|0|||
155499394|NCT03193190|561252709|FG001|Stage 2|Death|0|||
155499395|NCT03193190|561252710|FG002|Stage 2|Death|0|||
155499396|NCT03193190|561252711|FG003|Stage 2|Death|0|||
155499397|NCT03193190|561252712|FG004|Stage 2|Death|0|||
155499398|NCT03193190|561252713|FG005|Stage 2|Death|0|||
155499399|NCT03193190|561252714|FG006|Stage 2|Death|0|||
155499400|NCT03193190|561252715|FG007|Stage 2|Death|0|||
155499401|NCT03193190|561252716|FG008|Stage 2|Death|0|||
155499402|NCT03193190|561252717|FG009|Stage 2|Death|0|||
155499403|NCT03193190|561252718|FG010|Stage 2|Death|0|||
155499404|NCT03193190|561252719|FG011|Stage 2|Death|0|||
155499405|NCT03193190|561252720|FG012|Stage 2|Death|0|||
155499406|NCT03193190|561252721|FG013|Stage 2|Death|14|||
155499407|NCT03193190|561252722|FG014|Stage 2|Death|4|||
155499408|NCT03193190|561252723|FG015|Stage 2|Death|1|||
155499409|NCT03193190|561252708|FG000|Stage 2|Lost to Follow-up|0|||
155499410|NCT03193190|561252709|FG001|Stage 2|Lost to Follow-up|0|||
155499411|NCT03193190|561252710|FG002|Stage 2|Lost to Follow-up|0|||
155499412|NCT03193190|561252711|FG003|Stage 2|Lost to Follow-up|0|||
155499413|NCT03193190|561252712|FG004|Stage 2|Lost to Follow-up|0|||
155499414|NCT03193190|561252713|FG005|Stage 2|Lost to Follow-up|0|||
155643235|NCT04575324|561783756|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
155643236|NCT04575324|561783757|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
155499415|NCT03193190|561252714|FG006|Stage 2|Lost to Follow-up|0|||
155499416|NCT03193190|561252715|FG007|Stage 2|Lost to Follow-up|0|||
155499417|NCT03193190|561252716|FG008|Stage 2|Lost to Follow-up|0|||
155499418|NCT03193190|561252717|FG009|Stage 2|Lost to Follow-up|0|||
155499419|NCT03193190|561252718|FG010|Stage 2|Lost to Follow-up|0|||
155499420|NCT03193190|561252719|FG011|Stage 2|Lost to Follow-up|0|||
155499421|NCT03193190|561252720|FG012|Stage 2|Lost to Follow-up|0|||
155499422|NCT03193190|561252721|FG013|Stage 2|Lost to Follow-up|0|||
155499423|NCT03193190|561252722|FG014|Stage 2|Lost to Follow-up|1|||
155499424|NCT03193190|561252723|FG015|Stage 2|Lost to Follow-up|0|||
155499425|NCT03193190|561252708|FG000|Stage 2|Withdrawal by Subject|0|||
155499426|NCT03193190|561252709|FG001|Stage 2|Withdrawal by Subject|0|||
155499427|NCT03193190|561252710|FG002|Stage 2|Withdrawal by Subject|0|||
155499428|NCT03193190|561252711|FG003|Stage 2|Withdrawal by Subject|0|||
155499429|NCT03193190|561252712|FG004|Stage 2|Withdrawal by Subject|0|||
155499430|NCT03193190|561252713|FG005|Stage 2|Withdrawal by Subject|0|||
155499431|NCT03193190|561252714|FG006|Stage 2|Withdrawal by Subject|0|||
155499432|NCT03193190|561252715|FG007|Stage 2|Withdrawal by Subject|0|||
155499433|NCT03193190|561252716|FG008|Stage 2|Withdrawal by Subject|0|||
155499434|NCT03193190|561252717|FG009|Stage 2|Withdrawal by Subject|0|||
155499435|NCT03193190|561252718|FG010|Stage 2|Withdrawal by Subject|0|||
155499436|NCT03193190|561252719|FG011|Stage 2|Withdrawal by Subject|0|||
155499437|NCT03193190|561252720|FG012|Stage 2|Withdrawal by Subject|0|||
155499438|NCT03193190|561252721|FG013|Stage 2|Withdrawal by Subject|1|||
155499439|NCT03193190|561252722|FG014|Stage 2|Withdrawal by Subject|1|||
155499440|NCT03193190|561252723|FG015|Stage 2|Withdrawal by Subject|0|||
155499441|NCT03868059|561252724|FG000|Overall Study|Adverse Event|3|||
155499442|NCT03868059|561252724|FG000|Overall Study|Lost to Follow-up|3|||
155499443|NCT03868059|561252724|FG000|Overall Study|Withdrawal by Subject|6|||
155499444|NCT04278872|561252731|FG000|Overall Study|Adverse Event|1|||
155499445|NCT04278872|561252732|FG001|Overall Study|Adverse Event|0|||
155499446|NCT04278872|561252731|FG000|Overall Study|Protocol Violation|0|||
155499447|NCT04278872|561252732|FG001|Overall Study|Protocol Violation|1|||
155499448|NCT04278872|561252731|FG000|Overall Study|Study Termination|2|||
155499449|NCT04278872|561252732|FG001|Overall Study|Study Termination|0|||
155499450|NCT05838755|561252738|FG000|Overall Study|Adverse Event|1|||
155499451|NCT05838755|561252739|FG001|Overall Study|Adverse Event|0|||
155499452|NCT05838755|561252740|FG002|Overall Study|Adverse Event|0|||
155499453|NCT05838755|561252738|FG000|Overall Study|Lack of Efficacy|1|||
155499454|NCT05838755|561252739|FG001|Overall Study|Lack of Efficacy|0|||
155499455|NCT05838755|561252740|FG002|Overall Study|Lack of Efficacy|1|||
155499456|NCT05838755|561252738|FG000|Overall Study|Lost to Follow-up|0|||
155499457|NCT05838755|561252739|FG001|Overall Study|Lost to Follow-up|1|||
155499458|NCT05838755|561252740|FG002|Overall Study|Lost to Follow-up|4|||
155499459|NCT05838755|561252738|FG000|Overall Study|Withdrawal by Subject|0|||
155499460|NCT05838755|561252739|FG001|Overall Study|Withdrawal by Subject|2|||
155499461|NCT05838755|561252740|FG002|Overall Study|Withdrawal by Subject|0|||
155499462|NCT05838755|561252738|FG000|Overall Study|Study terminated by sponsor|26|||
155499463|NCT05838755|561252739|FG001|Overall Study|Study terminated by sponsor|27|||
155499464|NCT05838755|561252740|FG002|Overall Study|Study terminated by sponsor|26|||
155499465|NCT05838755|561252738|FG000|Overall Study|Randomized, not treated|2|||
155499466|NCT05838755|561252739|FG001|Overall Study|Randomized, not treated|0|||
155499467|NCT05838755|561252740|FG002|Overall Study|Randomized, not treated|1|||
155499468|NCT05838755|561252738|FG000|Overall Study|Pregnancy|0|||
155499469|NCT05838755|561252739|FG001|Overall Study|Pregnancy|1|||
155499470|NCT05838755|561252740|FG002|Overall Study|Pregnancy|0|||
155499471|NCT01283282|561252741|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
155499472|NCT01283282|561252742|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
155499473|NCT01283282|561252741|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
155312736|NCT03150810|560577457|FG009|Overall Study|Transferred care to oncologist|0|||
155312737|NCT03150810|560577458|FG010|Overall Study|Transferred care to oncologist|0|||
155312738|NCT03150810|560577459|FG011|Overall Study|Transferred care to oncologist|0|||
155312739|NCT03150810|560577460|FG012|Overall Study|Transferred care to oncologist|0|||
155312740|NCT04526704|560577461|FG000|Overall Study|Adverse Event|1|||
155312741|NCT04526704|560577462|FG001|Overall Study|Adverse Event|0|||
155312742|NCT04526704|560577461|FG000|Overall Study|Physician Decision|1|||
155312743|NCT04526704|560577462|FG001|Overall Study|Physician Decision|0|||
155312744|NCT04526704|560577461|FG000|Overall Study|Withdrawal by Subject|2|||
155312745|NCT04526704|560577462|FG001|Overall Study|Withdrawal by Subject|0|||
155312746|NCT06393088|560577463|FG000|Overall Study|Withdrawal by Subject|0|||
155312747|NCT06393088|560577464|FG001|Overall Study|Withdrawal by Subject|2|||
155312748|NCT03903146|560577465|FG000|Overall Study|Lost to Follow-up|6|||
155312749|NCT03903146|560577466|FG001|Overall Study|Lost to Follow-up|4|||
155312750|NCT03903146|560577465|FG000|Overall Study|Withdrawal by Subject|0|||
155312751|NCT03903146|560577466|FG001|Overall Study|Withdrawal by Subject|1|||
155416858|NCT00763321|560956910|FG001|Double-blind Period|Other|2|||
155416859|NCT00763321|560956911|FG002|Double-blind Period|Other|3|||
155416860|NCT02486757|560956912|FG000|Overall Study|Lost to Follow-up|1|||
155416861|NCT02793232|560956913|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416862|NCT02793232|560956914|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416863|NCT02793232|560956915|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416864|NCT02793232|560956916|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416865|NCT02793232|560956917|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
155416866|NCT02793232|560956918|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416867|NCT02793232|560956919|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
155416868|NCT02793232|560956920|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155499474|NCT01283282|561252742|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
155499475|NCT01283282|561252741|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
155499476|NCT01283282|561252742|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
155499477|NCT00096031|561252743|FG000|Overall Study|Adverse Event|3|||
155499478|NCT00096031|561252743|FG000|Overall Study|Lack of Efficacy|42|||
155499479|NCT00096031|561252743|FG000|Overall Study|Death|4|||
155499480|NCT00096031|561252743|FG000|Overall Study|Withdrawal by Subject|1|||
155312752|NCT05434078|560577467|FG000|Overall Study|Lost to Follow-up|2|||
155312753|NCT05434078|560577468|FG001|Overall Study|Lost to Follow-up|1|||
155499481|NCT00096031|561252743|FG000|Overall Study|Ineligible|8|||
155499482|NCT00096031|561252743|FG000|Overall Study|Not protocol specified|5|||
155499483|NCT00483717|561252744|FG000|Overall Study|Protocol Violation|5|||
155499484|NCT00483717|561252745|FG001|Overall Study|Protocol Violation|7|||
155499485|NCT00483717|561252744|FG000|Overall Study|Time of dosing missing|1|||
155499486|NCT00483717|561252745|FG001|Overall Study|Time of dosing missing|1|||
155499487|NCT00483717|561252744|FG000|Overall Study|No treatment for migraine|16|||
155499488|NCT00483717|561252745|FG001|Overall Study|No treatment for migraine|13|||
155499489|NCT00483717|561252744|FG000|Overall Study|Lost to Follow-up|1|||
155499490|NCT00483717|561252745|FG001|Overall Study|Lost to Follow-up|0|||
155499491|NCT00483717|561252744|FG000|Overall Study|Withdrawal by Subject|1|||
155499492|NCT00483717|561252745|FG001|Overall Study|Withdrawal by Subject|0|||
155499493|NCT00083226|561252746|FG000|Overall Study|Lack of Efficacy|19|||
155499494|NCT00083226|561252746|FG000|Overall Study|Adverse Event|9|||
155499495|NCT00083226|561252746|FG000|Overall Study|Death|4|||
155499496|NCT00083226|561252746|FG000|Overall Study|Withdrawal by Subject|4|||
155499497|NCT00083226|561252746|FG000|Overall Study|Other|2|||
155499498|NCT00083226|561252746|FG000|Overall Study|ineligible or not receiving treatment|4|||
155499499|NCT00909857|561252747|FG000|Overall Study|Withdrawal by Subject|6|||
155499500|NCT00909857|561252748|FG001|Overall Study|Withdrawal by Subject|10|||
155499501|NCT00909857|561252747|FG000|Overall Study|Adverse Event|5|||
155499502|NCT00909857|561252748|FG001|Overall Study|Adverse Event|5|||
155499503|NCT00909857|561252747|FG000|Overall Study|Lost to Follow-up|2|||
155499504|NCT00909857|561252748|FG001|Overall Study|Lost to Follow-up|5|||
155499505|NCT00909857|561252747|FG000|Overall Study|Protocol Violation|2|||
155499506|NCT00909857|561252748|FG001|Overall Study|Protocol Violation|1|||
155499507|NCT00909857|561252747|FG000|Overall Study|Pregnancy|1|||
155499508|NCT00909857|561252748|FG001|Overall Study|Pregnancy|0|||
155499509|NCT00909857|561252747|FG000|Overall Study|Other|1|||
155499510|NCT00909857|561252748|FG001|Overall Study|Other|0|||
155499511|NCT00909857|561252747|FG000|Overall Study|Did not receive study medication|19|||
155499512|NCT00909857|561252748|FG001|Overall Study|Did not receive study medication|24|||
155499513|NCT03878108|561252749|FG000|Overall Study|Adverse Event|1|||
155499514|NCT03878108|561252750|FG001|Overall Study|Adverse Event|0|||
155499515|NCT00604175|561252757|FG000|Entry Through Week 28|Death|2|||
155499516|NCT00604175|561252758|FG001|Entry Through Week 28|Death|0|||
155499517|NCT00604175|561252759|FG002|Entry Through Week 28|Death|0|||
155499518|NCT00604175|561252757|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
155499519|NCT00604175|561252758|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
155499520|NCT00604175|561252759|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
155499521|NCT00604175|561252757|FG000|Entry Through Week 28|Lost to Follow-up|4|||
155499522|NCT00604175|561252758|FG001|Entry Through Week 28|Lost to Follow-up|3|||
155499523|NCT00604175|561252759|FG002|Entry Through Week 28|Lost to Follow-up|0|||
155499524|NCT00604175|561252757|FG000|Entry Through Week 28|Ineligible|1|||
155499525|NCT00604175|561252758|FG001|Entry Through Week 28|Ineligible|0|||
155499526|NCT00604175|561252759|FG002|Entry Through Week 28|Ineligible|0|||
155499527|NCT00604175|561252757|FG000|Entry Through Week 28|Did not start intervention|2|||
155499528|NCT00604175|561252758|FG001|Entry Through Week 28|Did not start intervention|0|||
155499529|NCT00604175|561252759|FG002|Entry Through Week 28|Did not start intervention|1|||
155499530|NCT00604175|561252757|FG000|Week 29 Through Week 72|Death|0|||
155499531|NCT00604175|561252758|FG001|Week 29 Through Week 72|Death|0|||
155499532|NCT00604175|561252759|FG002|Week 29 Through Week 72|Death|1|||
155499533|NCT00604175|561252757|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
155499534|NCT00604175|561252758|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
155499535|NCT00604175|561252759|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
155499536|NCT00604175|561252757|FG000|Week 29 Through Week 72|Site closure|0|||
155499537|NCT00604175|561252758|FG001|Week 29 Through Week 72|Site closure|1|||
155499538|NCT00604175|561252759|FG002|Week 29 Through Week 72|Site closure|0|||
155499539|NCT00604175|561252757|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
155499540|NCT00604175|561252758|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
155499541|NCT00604175|561252759|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
155499542|NCT01682681|561252760|FG000|Overall Study|Lack of Efficacy|62|||
155499543|NCT01682681|561252760|FG000|Overall Study|Withdrawal by Subject|1|||
155499544|NCT01682681|561252760|FG000|Overall Study|Moved to other hospital|10|||
155499545|NCT01682681|561252760|FG000|Overall Study|Lost to Follow-up|174|||
155499546|NCT01682681|561252760|FG000|Overall Study|Adverse Event|46|||
155499547|NCT01682681|561252760|FG000|Overall Study|tapering of topiramate|5|||
155499548|NCT01682681|561252760|FG000|Overall Study|Other|21|||
155499549|NCT01682681|561252760|FG000|Overall Study|Low compliance|13|||
155499550|NCT02044094|561252763|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
155499551|NCT02044094|561252763|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
155499552|NCT02044094|561252763|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
155499553|NCT02044094|561252763|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
155499554|NCT02044094|561252763|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
155643237|NCT01363440|561783758|FG000|Overall Study|Adverse Event|5|||
155643238|NCT01363440|561783759|FG001|Overall Study|Adverse Event|4|||
155643239|NCT01363440|561783760|FG002|Overall Study|Adverse Event|4|||
155643240|NCT01363440|561783758|FG000|Overall Study|Death|3|||
155312754|NCT05434078|560577467|FG000|Overall Study|Withdrawal by Subject|1|||
155312755|NCT05434078|560577468|FG001|Overall Study|Withdrawal by Subject|0|||
155312756|NCT03652688|560577470|FG000|Baseline|Withdrawal by Subject|0|||
155312757|NCT03652688|560577471|FG001|Baseline|Withdrawal by Subject|3|||
155312758|NCT03652688|560577470|FG000|Follow-up|Lost to Follow-up|56|||
155312759|NCT03652688|560577471|FG001|Follow-up|Lost to Follow-up|54|||
155312760|NCT03719443|560577475|FG000|Overall Study|Lost to Follow-up|0|||
155312761|NCT03719443|560577476|FG001|Overall Study|Lost to Follow-up|0|||
155312762|NCT03719443|560577477|FG002|Overall Study|Lost to Follow-up|1|||
155312763|NCT03719443|560577478|FG003|Overall Study|Lost to Follow-up|0|||
155312764|NCT03719443|560577479|FG004|Overall Study|Lost to Follow-up|1|||
155312765|NCT03719443|560577480|FG005|Overall Study|Lost to Follow-up|0|||
155312766|NCT03719443|560577481|FG006|Overall Study|Lost to Follow-up|1|||
155312767|NCT03719443|560577475|FG000|Overall Study|Withdrawal by Subject|0|||
155312768|NCT03719443|560577476|FG001|Overall Study|Withdrawal by Subject|0|||
155312769|NCT03719443|560577477|FG002|Overall Study|Withdrawal by Subject|1|||
155312770|NCT03719443|560577478|FG003|Overall Study|Withdrawal by Subject|0|||
155312771|NCT03719443|560577479|FG004|Overall Study|Withdrawal by Subject|0|||
155416869|NCT02793232|560956921|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
155416870|NCT02387580|560956922|FG000|Overall Study|Withdrawal by Subject|0|||
155416871|NCT02387580|560956923|FG001|Overall Study|Withdrawal by Subject|0|||
155416872|NCT02387580|560956924|FG002|Overall Study|Withdrawal by Subject|0|||
155416873|NCT02387580|560956925|FG003|Overall Study|Withdrawal by Subject|1|||
155416874|NCT02387580|560956926|FG004|Overall Study|Withdrawal by Subject|0|||
155416875|NCT02387580|560956927|FG005|Overall Study|Withdrawal by Subject|0|||
155416876|NCT04849780|560956928|FG000|Period 1|Covid-19 Related|1|||
155416877|NCT04849780|560956929|FG001|Period 1|Covid-19 Related|0|||
155416878|NCT04849780|560956928|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
155416879|NCT04849780|560956929|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
155416880|NCT04849780|560956928|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
155416881|NCT04849780|560956929|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
155416882|NCT00725075|560956930|FG000|Overall Study|Use of Excluded Medication|0|||
155416883|NCT00725075|560956931|FG001|Overall Study|Use of Excluded Medication|1|||
155416884|NCT00725075|560956932|FG002|Overall Study|Use of Excluded Medication|0|||
155416885|NCT00725075|560956930|FG000|Overall Study|Protocol Violation|0|||
155416886|NCT00725075|560956931|FG001|Overall Study|Protocol Violation|0|||
155416887|NCT00725075|560956932|FG002|Overall Study|Protocol Violation|1|||
155416888|NCT00725075|560956930|FG000|Overall Study|Lost to Follow-up|1|||
155416889|NCT00725075|560956931|FG001|Overall Study|Lost to Follow-up|0|||
155416890|NCT00725075|560956932|FG002|Overall Study|Lost to Follow-up|0|||
155416891|NCT00725075|560956930|FG000|Overall Study|Withdrawal by Subject|4|||
155416892|NCT00725075|560956931|FG001|Overall Study|Withdrawal by Subject|5|||
155416893|NCT00725075|560956932|FG002|Overall Study|Withdrawal by Subject|4|||
155416894|NCT00725075|560956930|FG000|Overall Study|Adverse Event|2|||
155416895|NCT00725075|560956931|FG001|Overall Study|Adverse Event|1|||
155416896|NCT00725075|560956932|FG002|Overall Study|Adverse Event|1|||
155416897|NCT00725075|560956930|FG000|Overall Study|Worsening of Disease|2|||
155416898|NCT00725075|560956931|FG001|Overall Study|Worsening of Disease|1|||
155416899|NCT00725075|560956932|FG002|Overall Study|Worsening of Disease|2|||
155416900|NCT00725075|560956930|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
155416901|NCT00725075|560956931|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
155416902|NCT00725075|560956932|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
155416903|NCT00725075|560956930|FG000|Overall Study|Other|1|||
155416904|NCT00725075|560956931|FG001|Overall Study|Other|0|||
155416905|NCT00725075|560956932|FG002|Overall Study|Other|0|||
155416906|NCT00087646|560956933|FG000|Overall Study|Adverse Event|37|||
155416907|NCT00087646|560956934|FG001|Overall Study|Adverse Event|6|||
155416908|NCT00087646|560956935|FG002|Overall Study|Adverse Event|18|||
155416909|NCT00087646|560956936|FG003|Overall Study|Adverse Event|20|||
155416910|NCT00087646|560956933|FG000|Overall Study|Death|0|||
155416911|NCT00087646|560956934|FG001|Overall Study|Death|1|||
155416912|NCT00087646|560956935|FG002|Overall Study|Death|0|||
155416913|NCT00087646|560956936|FG003|Overall Study|Death|0|||
155416914|NCT00087646|560956933|FG000|Overall Study|Withdrawal by Subject|6|||
155416915|NCT00087646|560956934|FG001|Overall Study|Withdrawal by Subject|1|||
155416916|NCT00087646|560956935|FG002|Overall Study|Withdrawal by Subject|2|||
155416917|NCT00087646|560956936|FG003|Overall Study|Withdrawal by Subject|2|||
155416918|NCT00087646|560956933|FG000|Overall Study|Insufficient therapeutic response|64|||
155416919|NCT00087646|560956934|FG001|Overall Study|Insufficient therapeutic response|24|||
155416920|NCT00087646|560956935|FG002|Overall Study|Insufficient therapeutic response|38|||
155416921|NCT00087646|560956936|FG003|Overall Study|Insufficient therapeutic response|51|||
155416922|NCT00087646|560956933|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
155416923|NCT00087646|560956934|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
155312772|NCT03719443|560577480|FG005|Overall Study|Withdrawal by Subject|0|||
155312773|NCT03719443|560577481|FG006|Overall Study|Withdrawal by Subject|0|||
155312774|NCT04924660|560577482|FG000|United States|Death|29|||
155312775|NCT04924660|560577483|FG001|United States|Death|32|||
155499555|NCT02044094|561252763|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
155499556|NCT02044094|561252763|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
155499557|NCT02044094|561252763|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
155499558|NCT03353415|561252764|FG000|Masked CGM Wear|Lost to Follow-up|2|||
155499559|NCT03353415|561252764|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
155499560|NCT00975000|561252765|FG000|Overall Study|Other|1|||
155499561|NCT00975000|561252766|FG001|Overall Study|Other|0|||
155499562|NCT00975000|561252765|FG000|Overall Study|Adverse Event|1|||
155499563|NCT00975000|561252766|FG001|Overall Study|Adverse Event|1|||
155499564|NCT00975000|561252765|FG000|Overall Study|Withdrawal by Subject|2|||
155499565|NCT00975000|561252766|FG001|Overall Study|Withdrawal by Subject|2|||
155499566|NCT00975000|561252765|FG000|Overall Study|Lost to Follow-up|0|||
155499567|NCT00975000|561252766|FG001|Overall Study|Lost to Follow-up|1|||
155499568|NCT00975000|561252765|FG000|Overall Study|Protocol-specified Criteria|1|||
155499569|NCT00975000|561252766|FG001|Overall Study|Protocol-specified Criteria|0|||
155499570|NCT00975000|561252765|FG000|Overall Study|Non-compliance|0|||
155499571|NCT00975000|561252766|FG001|Overall Study|Non-compliance|1|||
155499572|NCT00005879|561252767|FG000|Overall Study|Withdrawal by Subject|8|||
155499573|NCT00005879|561252768|FG001|Overall Study|Withdrawal by Subject|10|||
155499574|NCT01238172|561252769|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
155499575|NCT01238172|561252770|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
155499576|NCT01238172|561252769|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
155499577|NCT01238172|561252770|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
155499578|NCT05257109|561252771|FG000|Overall Study|Withdrawal by Subject|1|||
155499579|NCT05257109|561252772|FG001|Overall Study|Withdrawal by Subject|0|||
155499580|NCT05257109|561252773|FG002|Overall Study|Withdrawal by Subject|0|||
155499581|NCT05257109|561252774|FG003|Overall Study|Withdrawal by Subject|0|||
155499582|NCT00981409|561253987|FG000|Overall Study|Adverse Event|4|||
155499583|NCT00981409|561253988|FG001|Overall Study|Adverse Event|0|||
155499584|NCT00981409|561253987|FG000|Overall Study|Protocol Violation|0|||
155499585|NCT00981409|561253988|FG001|Overall Study|Protocol Violation|1|||
155499586|NCT00981409|561253987|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
155499587|NCT00981409|561253988|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
155499588|NCT03869684|561253991|FG000|Overall Study|Adverse Event|0|||
155499589|NCT03869684|561253992|FG001|Overall Study|Adverse Event|3|||
155499590|NCT03869684|561253993|FG002|Overall Study|Adverse Event|1|||
155499591|NCT03869684|561253991|FG000|Overall Study|Withdrawal by Subject|1|||
155499592|NCT03869684|561253992|FG001|Overall Study|Withdrawal by Subject|0|||
155499593|NCT03869684|561253993|FG002|Overall Study|Withdrawal by Subject|0|||
155312776|NCT04924660|560577484|FG002|United States|Death|34|||
155499594|NCT03869684|561253991|FG000|Overall Study|Lost to Follow-up|1|||
155499595|NCT03869684|561253992|FG001|Overall Study|Lost to Follow-up|0|||
155499596|NCT03869684|561253993|FG002|Overall Study|Lost to Follow-up|0|||
155499597|NCT03869684|561253991|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
155499598|NCT03869684|561253992|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
155499599|NCT03869684|561253993|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
155499600|NCT04056299|561253994|FG000|Overall Study|Sponsor discontinued study|3|||
155499601|NCT04056299|561253995|FG001|Overall Study|Sponsor discontinued study|3|||
155499602|NCT01227954|561254000|FG000|Overall Study|Protocol Violation|6|||
155416924|NCT00087646|560956935|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
155416925|NCT00087646|560956936|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
155416926|NCT00087646|560956933|FG000|Overall Study|Failure to Return|5|||
155416927|NCT00087646|560956934|FG001|Overall Study|Failure to Return|2|||
155416928|NCT00087646|560956935|FG002|Overall Study|Failure to Return|2|||
155416929|NCT00087646|560956936|FG003|Overall Study|Failure to Return|3|||
155416930|NCT00087646|560956933|FG000|Overall Study|Administrative/Other|6|||
155416931|NCT00087646|560956934|FG001|Overall Study|Administrative/Other|1|||
155416932|NCT00087646|560956935|FG002|Overall Study|Administrative/Other|1|||
155416933|NCT00087646|560956936|FG003|Overall Study|Administrative/Other|2|||
155416934|NCT00087646|560956933|FG000|Overall Study|Other Protocol Violation|3|||
155416935|NCT00087646|560956934|FG001|Overall Study|Other Protocol Violation|1|||
155416936|NCT00087646|560956935|FG002|Overall Study|Other Protocol Violation|0|||
155416937|NCT00087646|560956936|FG003|Overall Study|Other Protocol Violation|0|||
155416938|NCT00087646|560956933|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155416939|NCT00087646|560956934|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155416940|NCT00087646|560956935|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
155416941|NCT00087646|560956936|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
155416942|NCT03979274|560956939|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155416943|NCT03979274|560956940|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155416944|NCT01060059|560956943|FG000|Overall Study|Adverse Event|1|||
155416945|NCT01060059|560956944|FG001|Overall Study|Adverse Event|1|||
155416946|NCT01060059|560956943|FG000|Overall Study|Death|2|||
155416947|NCT01060059|560956944|FG001|Overall Study|Death|3|||
155416948|NCT01060059|560956943|FG000|Overall Study|Lost to Follow-up|18|||
155416949|NCT01060059|560956944|FG001|Overall Study|Lost to Follow-up|34|||
155416950|NCT01060059|560956943|FG000|Overall Study|entry criteria not met|4|||
155416951|NCT01060059|560956944|FG001|Overall Study|entry criteria not met|3|||
155416952|NCT01060059|560956943|FG000|Overall Study|Withdrawal by Subject|35|||
155416953|NCT01060059|560956944|FG001|Overall Study|Withdrawal by Subject|23|||
155416954|NCT01060059|560956943|FG000|Overall Study|lack of glycemic control|2|||
155416955|NCT01060059|560956944|FG001|Overall Study|lack of glycemic control|1|||
155416956|NCT01060059|560956943|FG000|Overall Study|lack of compliance|5|||
155416957|NCT01060059|560956944|FG001|Overall Study|lack of compliance|2|||
155416958|NCT02302963|560956945|FG000|Overall Study|Withdrawal by Subject|2|||
155416959|NCT02302963|560956946|FG001|Overall Study|Withdrawal by Subject|1|||
155416960|NCT02302963|560956945|FG000|Overall Study|Steroid injection|0|||
155416961|NCT02302963|560956946|FG001|Overall Study|Steroid injection|1|||
155416962|NCT02302963|560956945|FG000|Overall Study|Physician Decision|1|||
155416963|NCT02302963|560956946|FG001|Overall Study|Physician Decision|0|||
155416964|NCT01614093|560956947|FG000|Overall Study|Withdrawal by Subject|1|||
155416965|NCT04820309|560956951|FG000|Overall Study|Adverse Event|96|||
155416966|NCT04820309|560956951|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
155416967|NCT04820309|560956951|FG000|Overall Study|Consent Withdrawn|93|||
155416968|NCT04820309|560956951|FG000|Overall Study|failure to adhere to protocol|32|||
155416969|NCT04820309|560956951|FG000|Overall Study|alcohol or drug use|6|||
155416970|NCT04820309|560956951|FG000|Overall Study|Lost to Follow-up|46|||
155416971|NCT04820309|560956951|FG000|Overall Study|Death|2|||
155416972|NCT04820309|560956951|FG000|Overall Study|Pregnancy|1|||
155416973|NCT04820309|560956951|FG000|Overall Study|Other reasons|12|||
155416974|NCT04202679|560956954|FG000|Overall Study|Adverse Event|2|||
155416975|NCT04202679|560956955|FG001|Overall Study|Adverse Event|0|||
155416976|NCT04202679|560956954|FG000|Overall Study|Poor compliance to protocol|1|||
155416977|NCT04202679|560956955|FG001|Overall Study|Poor compliance to protocol|0|||
155416978|NCT04202679|560956954|FG000|Overall Study|Withdrawal by Subject|23|||
155416979|NCT04202679|560956955|FG001|Overall Study|Withdrawal by Subject|6|||
155416980|NCT05902364|560956956|FG000|Overall Study|Adverse Event|1|||
155416981|NCT05902364|560956957|FG001|Overall Study|Adverse Event|0|||
155416982|NCT03864653|560956958|FG000|Overall Study|Withdrawal by Subject|1|||
155416983|NCT02482129|560956959|FG000|Overall Study|Adverse Event-prior to treatment|0|||
155416984|NCT02482129|560956960|FG001|Overall Study|Adverse Event-prior to treatment|1|||
155416985|NCT02482129|560956959|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
155416986|NCT02482129|560956960|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
155416987|NCT02482129|560956959|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
155416988|NCT02482129|560956960|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
155416989|NCT02482129|560956959|FG000|Overall Study|Criteria not met-prior to treatment|1|||
155416990|NCT02482129|560956960|FG001|Overall Study|Criteria not met-prior to treatment|0|||
155416991|NCT02482129|560956959|FG000|Overall Study|Adverse Event|1|||
155416992|NCT02482129|560956960|FG001|Overall Study|Adverse Event|0|||
155643241|NCT01363440|561783759|FG001|Overall Study|Death|7|||
155416993|NCT02482129|560956959|FG000|Overall Study|Withdrawal by Subject|2|||
155416994|NCT02482129|560956960|FG001|Overall Study|Withdrawal by Subject|0|||
155416995|NCT02482129|560956959|FG000|Overall Study|Criteria not met|1|||
155416996|NCT02482129|560956960|FG001|Overall Study|Criteria not met|0|||
155416997|NCT01877083|560956961|FG000|Treatment Phase|Disease Progression|10|||
155643242|NCT01363440|561783760|FG002|Overall Study|Death|5|||
155499603|NCT01227954|561254000|FG000|Overall Study|No protocol treatment|7|||
155499604|NCT00078312|561254003|FG000|Overall Study|Adverse Event|43|||
155499605|NCT00078312|561254003|FG000|Overall Study|Lack of Efficacy|15|||
155499606|NCT00078312|561254003|FG000|Overall Study|Lost to Follow-up|41|||
155499607|NCT00078312|561254003|FG000|Overall Study|Physician Decision|9|||
155499608|NCT00078312|561254003|FG000|Overall Study|Protocol Violation|3|||
155499609|NCT00078312|561254003|FG000|Overall Study|Withdrawal by Subject|33|||
155499610|NCT00078312|561254003|FG000|Overall Study|Miscellaneous|33|||
155499611|NCT01296152|561254004|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
155499612|NCT03901352|561254005|FG000|Double-blind Phase|Adverse Event|6|||
155499613|NCT03901352|561254006|FG001|Double-blind Phase|Adverse Event|4|||
155499614|NCT03901352|561254005|FG000|Double-blind Phase|Death|1|||
155499615|NCT03901352|561254006|FG001|Double-blind Phase|Death|0|||
155499616|NCT03901352|561254005|FG000|Double-blind Phase|Lack of Efficacy|0|||
155499617|NCT03901352|561254006|FG001|Double-blind Phase|Lack of Efficacy|1|||
155499618|NCT03901352|561254005|FG000|Double-blind Phase|Protocol Violation|0|||
155499619|NCT03901352|561254006|FG001|Double-blind Phase|Protocol Violation|1|||
155499620|NCT03901352|561254005|FG000|Double-blind Phase|Withdrawal by Subject|10|||
155499621|NCT03901352|561254006|FG001|Double-blind Phase|Withdrawal by Subject|8|||
155499622|NCT03901352|561254005|FG000|Open-label Extension Phase|Adverse Event|24|||
155499623|NCT03901352|561254006|FG001|Open-label Extension Phase|Adverse Event|0|||
155499624|NCT03901352|561254005|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
155499625|NCT03901352|561254006|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
155499626|NCT03901352|561254005|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
155499627|NCT03901352|561254006|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
155499628|NCT03901352|561254005|FG000|Open-label Extension Phase|Other|1|||
155499629|NCT03901352|561254006|FG001|Open-label Extension Phase|Other|0|||
155499630|NCT03901339|561254007|FG000|Overall Study|Death|220|||
155499631|NCT03901339|561254008|FG001|Overall Study|Death|192|||
155499632|NCT03901339|561254007|FG000|Overall Study|Informed consent withdrawn|13|||
155499633|NCT03901339|561254008|FG001|Overall Study|Informed consent withdrawn|40|||
155312777|NCT04924660|560577485|FG003|United States|Death|25|||
155312778|NCT04924660|560577486|FG004|United States|Death|26|||
155312779|NCT04924660|560577487|FG005|United States|Death|23|||
155312780|NCT04924660|560577482|FG000|United States|Lost to Follow-up|15|||
155312781|NCT04924660|560577483|FG001|United States|Lost to Follow-up|10|||
155312782|NCT04924660|560577484|FG002|United States|Lost to Follow-up|13|||
155312783|NCT04924660|560577485|FG003|United States|Lost to Follow-up|5|||
155312784|NCT04924660|560577486|FG004|United States|Lost to Follow-up|19|||
155312785|NCT04924660|560577487|FG005|United States|Lost to Follow-up|20|||
155312786|NCT04924660|560577482|FG000|United States|Withdrawal by Subject|8|||
155312787|NCT04924660|560577483|FG001|United States|Withdrawal by Subject|3|||
155312788|NCT04924660|560577484|FG002|United States|Withdrawal by Subject|3|||
155312789|NCT04924660|560577485|FG003|United States|Withdrawal by Subject|3|||
155312790|NCT04924660|560577486|FG004|United States|Withdrawal by Subject|8|||
155312791|NCT04924660|560577487|FG005|United States|Withdrawal by Subject|4|||
155312792|NCT04924660|560577482|FG000|Spain|Death|0|||
155312793|NCT04924660|560577483|FG001|Spain|Death|0|||
155312794|NCT04924660|560577484|FG002|Spain|Death|0|||
155312795|NCT04924660|560577485|FG003|Spain|Death|0|||
155312796|NCT04924660|560577486|FG004|Spain|Death|0|||
155312797|NCT04924660|560577487|FG005|Spain|Death|2|||
155312798|NCT04924660|560577482|FG000|Spain|Lost to Follow-up|0|||
155312799|NCT04924660|560577483|FG001|Spain|Lost to Follow-up|0|||
155312800|NCT04924660|560577484|FG002|Spain|Lost to Follow-up|0|||
155312801|NCT04924660|560577485|FG003|Spain|Lost to Follow-up|0|||
155312802|NCT04924660|560577486|FG004|Spain|Lost to Follow-up|1|||
155312803|NCT04924660|560577487|FG005|Spain|Lost to Follow-up|0|||
155312804|NCT04924660|560577482|FG000|Brazil|Death|0|||
155312805|NCT04924660|560577483|FG001|Brazil|Death|0|||
155312806|NCT04924660|560577484|FG002|Brazil|Death|0|||
155312807|NCT04924660|560577485|FG003|Brazil|Death|0|||
155312808|NCT04924660|560577486|FG004|Brazil|Death|1|||
155312809|NCT04924660|560577487|FG005|Brazil|Death|0|||
155312810|NCT04924660|560577482|FG000|Italy|Lost to Follow-up|0|||
155312811|NCT04924660|560577483|FG001|Italy|Lost to Follow-up|0|||
155499634|NCT03901339|561254007|FG000|Overall Study|Sponsor request|30|||
155499635|NCT03901339|561254008|FG001|Overall Study|Sponsor request|23|||
155499636|NCT03901339|561254007|FG000|Overall Study|Reason not specified|5|||
155312812|NCT04924660|560577484|FG002|Italy|Lost to Follow-up|0|||
155312813|NCT04924660|560577485|FG003|Italy|Lost to Follow-up|0|||
155312814|NCT04924660|560577486|FG004|Italy|Lost to Follow-up|0|||
155312815|NCT04924660|560577487|FG005|Italy|Lost to Follow-up|1|||
155312816|NCT04924660|560577482|FG000|South Africa|Death|0|||
155499637|NCT03901339|561254008|FG001|Overall Study|Reason not specified|7|||
155499638|NCT03901339|561254007|FG000|Overall Study|Lost to Follow-up|4|||
155499639|NCT03901339|561254008|FG001|Overall Study|Lost to Follow-up|7|||
155499640|NCT03901339|561254007|FG000|Overall Study|Covid19|0|||
155312817|NCT04924660|560577483|FG001|South Africa|Death|0|||
155312818|NCT04924660|560577484|FG002|South Africa|Death|0|||
155312819|NCT04924660|560577485|FG003|South Africa|Death|0|||
155312820|NCT04924660|560577486|FG004|South Africa|Death|0|||
155312821|NCT04924660|560577487|FG005|South Africa|Death|1|||
155312822|NCT04924660|560577482|FG000|South Africa|Lost to Follow-up|0|||
155312823|NCT04924660|560577483|FG001|South Africa|Lost to Follow-up|0|||
155312824|NCT04924660|560577484|FG002|South Africa|Lost to Follow-up|0|||
155312825|NCT04924660|560577485|FG003|South Africa|Lost to Follow-up|0|||
155312826|NCT04924660|560577486|FG004|South Africa|Lost to Follow-up|0|||
155312827|NCT04924660|560577487|FG005|South Africa|Lost to Follow-up|1|||
155312828|NCT00554788|560577488|FG000|Overall Study|Adverse Event|0|||
155312829|NCT00554788|560577489|FG001|Overall Study|Adverse Event|1|||
155312830|NCT00554788|560577490|FG002|Overall Study|Adverse Event|2|||
155416998|NCT01877083|560956961|FG000|Treatment Phase|Clinical Progression|1|||
155416999|NCT01877083|560956961|FG000|Treatment Phase|Adverse Event|6|||
155417000|NCT01877083|560956961|FG000|Treatment Phase|Withdrawal by Subject|2|||
155417001|NCT01877083|560956961|FG000|Treatment Phase|Lost to Follow-up|1|||
155417002|NCT01877083|560956961|FG000|Extension Phase|Disease Progression|3|||
155417003|NCT01877083|560956961|FG000|Extension Phase|Adverse Event|2|||
155417004|NCT00429585|560956964|FG000|Overall Study|Death|1|||
155417005|NCT00429585|560956965|FG001|Overall Study|Death|0|||
155417006|NCT00429585|560956964|FG000|Overall Study|Lost to Follow-up|27|||
155417007|NCT00429585|560956965|FG001|Overall Study|Lost to Follow-up|20|||
155417008|NCT00429585|560956964|FG000|Overall Study|Physician Decision|2|||
155417009|NCT00429585|560956965|FG001|Overall Study|Physician Decision|0|||
155417010|NCT01582308|560956966|FG000|Period 1|Withdrawal by Subject|0|||
155417011|NCT01582308|560956967|FG001|Period 1|Withdrawal by Subject|0|||
155417012|NCT01582308|560956968|FG002|Period 1|Withdrawal by Subject|0|||
155417013|NCT01582308|560956969|FG003|Period 1|Withdrawal by Subject|0|||
155417014|NCT01582308|560956970|FG004|Period 1|Withdrawal by Subject|0|||
155417015|NCT01582308|560956971|FG005|Period 1|Withdrawal by Subject|0|||
155417016|NCT01582308|560956972|FG006|Period 1|Withdrawal by Subject|1|||
155417017|NCT01582308|560956973|FG007|Period 1|Withdrawal by Subject|0|||
155417018|NCT01582308|560956974|FG008|Period 1|Withdrawal by Subject|0|||
155417019|NCT01582308|560956975|FG009|Period 1|Withdrawal by Subject|0|||
155417020|NCT01582308|560956966|FG000|10-day Washout Following Period 1|Physician Decision|0|||
155417021|NCT01582308|560956967|FG001|10-day Washout Following Period 1|Physician Decision|0|||
155417022|NCT01582308|560956968|FG002|10-day Washout Following Period 1|Physician Decision|0|||
155417023|NCT01582308|560956969|FG003|10-day Washout Following Period 1|Physician Decision|0|||
155417024|NCT01582308|560956970|FG004|10-day Washout Following Period 1|Physician Decision|1|||
155417025|NCT01582308|560956971|FG005|10-day Washout Following Period 1|Physician Decision|0|||
155417026|NCT01582308|560956972|FG006|10-day Washout Following Period 1|Physician Decision|0|||
155417027|NCT01582308|560956973|FG007|10-day Washout Following Period 1|Physician Decision|0|||
155417028|NCT01582308|560956974|FG008|10-day Washout Following Period 1|Physician Decision|0|||
155417029|NCT01582308|560956975|FG009|10-day Washout Following Period 1|Physician Decision|0|||
155417030|NCT01582308|560956966|FG000|Period 4|Physician Decision|1|||
155417031|NCT01582308|560956967|FG001|Period 4|Physician Decision|0|||
155417032|NCT01582308|560956968|FG002|Period 4|Physician Decision|0|||
155417033|NCT01582308|560956969|FG003|Period 4|Physician Decision|0|||
155417034|NCT01582308|560956970|FG004|Period 4|Physician Decision|0|||
155417035|NCT01582308|560956971|FG005|Period 4|Physician Decision|1|||
155417036|NCT01582308|560956972|FG006|Period 4|Physician Decision|0|||
155417037|NCT01582308|560956973|FG007|Period 4|Physician Decision|0|||
155417038|NCT01582308|560956974|FG008|Period 4|Physician Decision|0|||
155417039|NCT01582308|560956975|FG009|Period 4|Physician Decision|1|||
155417040|NCT00684957|560956979|FG000|Overall Study|Withdrawal by Subject|1|||
155417041|NCT00684957|560956980|FG001|Overall Study|Withdrawal by Subject|1|||
155417042|NCT00684957|560956979|FG000|Overall Study|Lost to Follow-up|1|||
155417043|NCT00684957|560956980|FG001|Overall Study|Lost to Follow-up|0|||
155417044|NCT04341948|560956981|FG000|Overall Study|Adverse Event|0|||
155417045|NCT04341948|560956982|FG001|Overall Study|Adverse Event|1|||
155417046|NCT04341948|560956981|FG000|Overall Study|Lost to Follow-up|6|||
155417047|NCT04341948|560956982|FG001|Overall Study|Lost to Follow-up|1|||
155417048|NCT04341948|560956981|FG000|Overall Study|Physician Decision|1|||
155417049|NCT04341948|560956982|FG001|Overall Study|Physician Decision|2|||
155417050|NCT04341948|560956981|FG000|Overall Study|Withdrawal by Participant|6|||
155417051|NCT04341948|560956982|FG001|Overall Study|Withdrawal by Participant|3|||
155417052|NCT04341948|560956981|FG000|Overall Study|Lack of compliance by Participant|1|||
155417053|NCT04341948|560956982|FG001|Overall Study|Lack of compliance by Participant|0|||
155417054|NCT03406897|560956983|FG000|Overall Study|Lost to Follow-up|1|||
155417055|NCT03406897|560956984|FG001|Overall Study|Lost to Follow-up|2|||
155417056|NCT03406897|560956983|FG000|Overall Study|Withdrawal by Subject|4|||
155417057|NCT03406897|560956984|FG001|Overall Study|Withdrawal by Subject|4|||
155417058|NCT03406897|560956983|FG000|Overall Study|Physician Decision|0|||
155312831|NCT00554788|560577488|FG000|Overall Study|Lost to Follow-up|4|||
155417059|NCT03406897|560956984|FG001|Overall Study|Physician Decision|1|||
155417060|NCT06272370|560958632|FG000|Overall Study|Lost to Follow-up|0|||
155417061|NCT06272370|560958633|FG001|Overall Study|Lost to Follow-up|3|||
155417062|NCT06272370|560958634|FG002|Overall Study|Lost to Follow-up|1|||
155417063|NCT06272370|560958635|FG003|Overall Study|Lost to Follow-up|1|||
155312832|NCT00554788|560577489|FG001|Overall Study|Lost to Follow-up|3|||
155312833|NCT00554788|560577490|FG002|Overall Study|Lost to Follow-up|3|||
155312834|NCT00554788|560577488|FG000|Overall Study|Physician Decision|1|||
155499641|NCT03901339|561254008|FG001|Overall Study|Covid19|2|||
155499642|NCT03981614|561254009|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
155499643|NCT03981614|561254010|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
155499644|NCT03981614|561254011|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
155499645|NCT01071083|561254016|FG000|Overall Study|Adverse Event|1|||
155499646|NCT01071083|561254017|FG001|Overall Study|Adverse Event|0|||
155499647|NCT01071083|561254018|FG002|Overall Study|Adverse Event|1|||
155499648|NCT01071083|561254019|FG003|Overall Study|Adverse Event|0|||
155499649|NCT01071083|561254020|FG004|Overall Study|Adverse Event|1|||
155499650|NCT01071083|561254016|FG000|Overall Study|Withdrawal by Subject|3|||
155499651|NCT01071083|561254017|FG001|Overall Study|Withdrawal by Subject|0|||
155499652|NCT01071083|561254018|FG002|Overall Study|Withdrawal by Subject|2|||
155499653|NCT01071083|561254019|FG003|Overall Study|Withdrawal by Subject|0|||
155499654|NCT01071083|561254020|FG004|Overall Study|Withdrawal by Subject|3|||
155499655|NCT01071083|561254016|FG000|Overall Study|Physician Decision|1|||
155499656|NCT01071083|561254017|FG001|Overall Study|Physician Decision|0|||
155499657|NCT01071083|561254018|FG002|Overall Study|Physician Decision|0|||
155499658|NCT01071083|561254019|FG003|Overall Study|Physician Decision|1|||
155499659|NCT01071083|561254020|FG004|Overall Study|Physician Decision|1|||
155499660|NCT01071083|561254016|FG000|Overall Study|Early Rescue|1|||
155499661|NCT01071083|561254017|FG001|Overall Study|Early Rescue|0|||
155499662|NCT01071083|561254018|FG002|Overall Study|Early Rescue|0|||
155312835|NCT00554788|560577489|FG001|Overall Study|Physician Decision|1|||
155312836|NCT00554788|560577490|FG002|Overall Study|Physician Decision|3|||
155312837|NCT00554788|560577488|FG000|Overall Study|Withdrawal by Subject|0|||
155312838|NCT00554788|560577489|FG001|Overall Study|Withdrawal by Subject|0|||
155312839|NCT00554788|560577490|FG002|Overall Study|Withdrawal by Subject|1|||
155312840|NCT00554788|560577488|FG000|Overall Study|Refusal of further protocol therapy|0|||
155312841|NCT00554788|560577489|FG001|Overall Study|Refusal of further protocol therapy|1|||
155312842|NCT00554788|560577490|FG002|Overall Study|Refusal of further protocol therapy|1|||
155312843|NCT00554788|560577488|FG000|Overall Study|Progressive disease|0|||
155312844|NCT00554788|560577489|FG001|Overall Study|Progressive disease|0|||
155312845|NCT00554788|560577490|FG002|Overall Study|Progressive disease|3|||
155312846|NCT00554788|560577488|FG000|Overall Study|Ineligible|2|||
155312847|NCT00554788|560577489|FG001|Overall Study|Ineligible|0|||
155312848|NCT00554788|560577490|FG002|Overall Study|Ineligible|1|||
155312849|NCT03557697|560577491|FG000|Overall Study|Withdrawal by Subject|2|||
155312850|NCT03557697|560577492|FG001|Overall Study|Withdrawal by Subject|4|||
155312851|NCT03197662|560577503|FG000|Overall Study|Withdrawn by family|0|||
155312852|NCT03197662|560577504|FG001|Overall Study|Withdrawn by family|2|||
155312853|NCT03721952|560577505|FG000|Overall Study|Lost to Follow-up|0|||
155312854|NCT03721952|560577506|FG001|Overall Study|Lost to Follow-up|0|||
155312855|NCT03721952|560577507|FG002|Overall Study|Lost to Follow-up|2|||
155312856|NCT03721952|560577508|FG003|Overall Study|Lost to Follow-up|0|||
155312857|NCT03721952|560577509|FG004|Overall Study|Lost to Follow-up|0|||
155312858|NCT03721952|560577505|FG000|Overall Study|Protocol Violation|0|||
155312859|NCT03721952|560577506|FG001|Overall Study|Protocol Violation|1|||
155312860|NCT03721952|560577507|FG002|Overall Study|Protocol Violation|0|||
155312861|NCT03721952|560577508|FG003|Overall Study|Protocol Violation|0|||
155312862|NCT03721952|560577509|FG004|Overall Study|Protocol Violation|0|||
155312863|NCT03721952|560577505|FG000|Overall Study|Withdrawal by Subject|1|||
155312864|NCT03721952|560577506|FG001|Overall Study|Withdrawal by Subject|0|||
155312865|NCT03721952|560577507|FG002|Overall Study|Withdrawal by Subject|40|||
155312866|NCT03721952|560577508|FG003|Overall Study|Withdrawal by Subject|28|||
155312867|NCT03721952|560577509|FG004|Overall Study|Withdrawal by Subject|0|||
155312868|NCT04495894|560577510|FG000|Overall Study|Withdrawal by Subject|2|||
155312869|NCT04495894|560577511|FG001|Overall Study|Withdrawal by Subject|0|||
155312870|NCT04495894|560577512|FG002|Overall Study|Withdrawal by Subject|2|||
155312871|NCT04495894|560577513|FG003|Overall Study|Withdrawal by Subject|3|||
155312872|NCT04495894|560577510|FG000|Overall Study|Early termination|0|||
155312873|NCT04495894|560577511|FG001|Overall Study|Early termination|0|||
155312874|NCT04495894|560577512|FG002|Overall Study|Early termination|3|||
155312875|NCT04495894|560577513|FG003|Overall Study|Early termination|0|||
155312876|NCT03364647|560577514|FG000|Overall Study|Withdrawal by Subject|3|||
155312877|NCT03364647|560577515|FG001|Overall Study|Withdrawal by Subject|1|||
155499663|NCT01071083|561254019|FG003|Overall Study|Early Rescue|0|||
155499664|NCT01071083|561254020|FG004|Overall Study|Early Rescue|1|||
155499665|NCT01071083|561254016|FG000|Overall Study|Subject Moved|0|||
155312878|NCT01000961|560577516|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155312879|NCT01000961|560577517|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155312880|NCT01000961|560577516|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
155312881|NCT01000961|560577517|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
155499666|NCT01071083|561254017|FG001|Overall Study|Subject Moved|1|||
155499667|NCT01071083|561254018|FG002|Overall Study|Subject Moved|0|||
155499668|NCT01071083|561254019|FG003|Overall Study|Subject Moved|0|||
155312882|NCT03476460|560577520|FG000|Overall Study|Withdrawal by Subject|3|||
155312883|NCT03476460|560577521|FG001|Overall Study|Withdrawal by Subject|2|||
155312884|NCT03476460|560577520|FG000|Overall Study|Non-compliance with treatment|3|||
155312885|NCT03476460|560577521|FG001|Overall Study|Non-compliance with treatment|0|||
155312886|NCT03476460|560577520|FG000|Overall Study|Missing laboratory tests|5|||
155312887|NCT03476460|560577521|FG001|Overall Study|Missing laboratory tests|5|||
155312888|NCT03476460|560577520|FG000|Overall Study|Adverse Event|0|||
155312889|NCT03476460|560577521|FG001|Overall Study|Adverse Event|1|||
155312890|NCT05746455|560577525|FG000|Overall Study|Discharged from Clinical Service|1|||
155312891|NCT05746455|560577525|FG000|Overall Study|Lost to Follow-up|1|||
155312892|NCT03447470|560577526|FG000|Overall Study|Death|0|||
155499669|NCT01071083|561254020|FG004|Overall Study|Subject Moved|0|||
155312893|NCT03447470|560577527|FG001|Overall Study|Death|1|||
155312894|NCT03447470|560577528|FG002|Overall Study|Death|3|||
155312895|NCT03447470|560577529|FG003|Overall Study|Death|0|||
155312896|NCT03447470|560577530|FG004|Overall Study|Death|1|||
155312897|NCT03447470|560577531|FG005|Overall Study|Death|0|||
155312898|NCT03447470|560577532|FG006|Overall Study|Death|3|||
155312899|NCT03447470|560577533|FG007|Overall Study|Death|3|||
155312900|NCT03447470|560577534|FG008|Overall Study|Death|1|||
155312901|NCT03447470|560577526|FG000|Overall Study|Withdrawal by Subject|1|||
155312902|NCT03447470|560577527|FG001|Overall Study|Withdrawal by Subject|0|||
155312903|NCT03447470|560577528|FG002|Overall Study|Withdrawal by Subject|0|||
155312904|NCT03447470|560577529|FG003|Overall Study|Withdrawal by Subject|0|||
155312905|NCT03447470|560577530|FG004|Overall Study|Withdrawal by Subject|1|||
155312906|NCT03447470|560577531|FG005|Overall Study|Withdrawal by Subject|0|||
155312907|NCT03447470|560577532|FG006|Overall Study|Withdrawal by Subject|1|||
155312908|NCT03447470|560577533|FG007|Overall Study|Withdrawal by Subject|1|||
155312909|NCT03447470|560577534|FG008|Overall Study|Withdrawal by Subject|3|||
155312910|NCT03447470|560577526|FG000|Overall Study|Treatment discontinued|3|||
155312911|NCT03447470|560577527|FG001|Overall Study|Treatment discontinued|2|||
155312912|NCT03447470|560577528|FG002|Overall Study|Treatment discontinued|4|||
155312913|NCT03447470|560577529|FG003|Overall Study|Treatment discontinued|6|||
155312914|NCT03447470|560577530|FG004|Overall Study|Treatment discontinued|2|||
155312915|NCT03447470|560577531|FG005|Overall Study|Treatment discontinued|1|||
155312916|NCT03447470|560577532|FG006|Overall Study|Treatment discontinued|2|||
155312917|NCT03447470|560577533|FG007|Overall Study|Treatment discontinued|4|||
155312918|NCT03447470|560577534|FG008|Overall Study|Treatment discontinued|3|||
155312919|NCT05184192|560577535|FG000|Overall Study|Lost to Follow-up|4|||
155312920|NCT05184192|560577536|FG001|Overall Study|Lost to Follow-up|7|||
155312921|NCT05184192|560577535|FG000|Overall Study|Adverse Event|1|||
155312922|NCT05184192|560577536|FG001|Overall Study|Adverse Event|4|||
155312923|NCT05184192|560577535|FG000|Overall Study|PI withdrawal|1|||
155312924|NCT05184192|560577536|FG001|Overall Study|PI withdrawal|2|||
155312925|NCT05184192|560577535|FG000|Overall Study|Withdrew due to adverse effect|1|||
155312926|NCT05184192|560577536|FG001|Overall Study|Withdrew due to adverse effect|0|||
155312927|NCT05184192|560577535|FG000|Overall Study|Medication schedule|1|||
155312928|NCT05184192|560577536|FG001|Overall Study|Medication schedule|0|||
155312929|NCT05184192|560577535|FG000|Overall Study|Concern for adverse effects|0|||
155312930|NCT05184192|560577536|FG001|Overall Study|Concern for adverse effects|4|||
155312931|NCT04624633|560577537|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
155312932|NCT04624633|560577538|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
155312933|NCT04624633|560577537|FG000|Overall Study|Death|1|||
155312934|NCT04624633|560577538|FG001|Overall Study|Death|0|||
155312935|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
155312936|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312937|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312938|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312939|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312940|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312941|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
155312942|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312943|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312944|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312945|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312946|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312947|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312948|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
155312949|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312950|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312951|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312952|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155499670|NCT01071083|561254016|FG000|Overall Study|Images Not Usable (Motion)|0|||
155499671|NCT01071083|561254017|FG001|Overall Study|Images Not Usable (Motion)|1|||
155499672|NCT01071083|561254018|FG002|Overall Study|Images Not Usable (Motion)|0|||
155499673|NCT01071083|561254019|FG003|Overall Study|Images Not Usable (Motion)|0|||
155499674|NCT01071083|561254020|FG004|Overall Study|Images Not Usable (Motion)|0|||
155499675|NCT01071083|561254016|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155499676|NCT01071083|561254017|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155499677|NCT01071083|561254018|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
155499678|NCT01071083|561254019|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
155499679|NCT01071083|561254020|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
155499680|NCT01071083|561254016|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
155499681|NCT01071083|561254017|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
155499682|NCT01071083|561254018|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
155499683|NCT01071083|561254019|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
155499684|NCT01071083|561254020|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
155499685|NCT01071083|561254016|FG000|Overall Study|Subject Refused to Continue|1|||
155499686|NCT01071083|561254017|FG001|Overall Study|Subject Refused to Continue|0|||
155499687|NCT01071083|561254018|FG002|Overall Study|Subject Refused to Continue|0|||
155499688|NCT01071083|561254019|FG003|Overall Study|Subject Refused to Continue|0|||
155499689|NCT01071083|561254020|FG004|Overall Study|Subject Refused to Continue|0|||
155499690|NCT00038467|561254021|FG000|Overall Study|Adverse Event|170|||
155499691|NCT00038467|561254022|FG001|Overall Study|Adverse Event|145|||
155499692|NCT00038467|561254021|FG000|Overall Study|Withdrawal by Subject|150|||
155499693|NCT00038467|561254022|FG001|Overall Study|Withdrawal by Subject|107|||
155499694|NCT00038467|561254021|FG000|Overall Study|Protocol Violation|19|||
155499695|NCT00038467|561254022|FG001|Overall Study|Protocol Violation|22|||
155499696|NCT00038467|561254021|FG000|Overall Study|Death|22|||
155499697|NCT00038467|561254022|FG001|Overall Study|Death|16|||
155499698|NCT00038467|561254021|FG000|Overall Study|Lost to Follow-up|15|||
155499699|NCT00038467|561254022|FG001|Overall Study|Lost to Follow-up|10|||
155499700|NCT00038467|561254021|FG000|Overall Study|Recurrence|109|||
155499701|NCT00038467|561254022|FG001|Overall Study|Recurrence|179|||
155499702|NCT00038467|561254021|FG000|Overall Study|Randomized, but not treated|31|||
155499703|NCT00038467|561254022|FG001|Overall Study|Randomized, but not treated|35|||
155499704|NCT00038467|561254021|FG000|Overall Study|Other|26|||
155499705|NCT00038467|561254022|FG001|Overall Study|Other|28|||
155499706|NCT04732728|561254023|FG000|Overall Study|Death|12|||
155499707|NCT04732728|561254023|FG000|Overall Study|Withdrawn|136|||
155499708|NCT01339000|561254024|FG000|Overall Study|study closed due to lack of drug supply|1|||
155499709|NCT01339000|561254025|FG001|Overall Study|study closed due to lack of drug supply|0|||
155499710|NCT05349188|561254026|FG000|Overall Study|Withdrawal by Subject|1|||
155499711|NCT05349188|561254027|FG001|Overall Study|Withdrawal by Subject|0|||
155499712|NCT04971226|561254030|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155499713|NCT04971226|561254031|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155499714|NCT04971226|561254032|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
155417064|NCT02363478|560958640|FG000|Overall Study|Lost to Follow-up|4|||
155417065|NCT02363478|560958640|FG000|Overall Study|Adverse Event|4|||
155417066|NCT00930059|560958641|FG000|Overall Study|Death|1|||
155417067|NCT00930059|560958642|FG001|Overall Study|Death|0|||
155417068|NCT00930059|560958641|FG000|Overall Study|Did not meet entrance criteria|1|||
155417069|NCT00930059|560958642|FG001|Overall Study|Did not meet entrance criteria|1|||
155417070|NCT00930059|560958641|FG000|Overall Study|Withdrawal by Subject|3|||
155417071|NCT00930059|560958642|FG001|Overall Study|Withdrawal by Subject|4|||
155417072|NCT00930059|560958641|FG000|Overall Study|Other|1|||
155417073|NCT00930059|560958642|FG001|Overall Study|Other|0|||
155417074|NCT00930059|560958641|FG000|Overall Study|1 site terminated by sponsor|1|||
155417075|NCT00930059|560958642|FG001|Overall Study|1 site terminated by sponsor|1|||
155417076|NCT00930059|560958641|FG000|Overall Study|Adverse Event|1|||
155417077|NCT00930059|560958642|FG001|Overall Study|Adverse Event|6|||
155417078|NCT01299766|560958644|FG000|Overall Study|Death|5|||
155417079|NCT01299766|560958645|FG001|Overall Study|Death|4|||
155417080|NCT01299766|560958644|FG000|Overall Study|Withdrawal by Subject|29|||
155417081|NCT01299766|560958645|FG001|Overall Study|Withdrawal by Subject|19|||
155417082|NCT04002310|560958646|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
155417083|NCT04002310|560958647|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
155417084|NCT04002310|560958648|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
155417085|NCT04002310|560958649|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
155499715|NCT04971226|561254033|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
155417086|NCT04002310|560958650|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
155417087|NCT00352534|560958651|FG000|Initial Staging|Ineligible|8|||
155417088|NCT00352534|560958652|FG001|Initial Staging|Ineligible|9|||
155417089|NCT00352534|560958653|FG002|Initial Staging|Ineligible|0|||
155499716|NCT04971226|561254030|FG000|Overall Study|Adverse Event|6|||
155499717|NCT04971226|561254031|FG001|Overall Study|Adverse Event|5|||
155499718|NCT04971226|561254032|FG002|Overall Study|Adverse Event|11|||
155499719|NCT04971226|561254033|FG003|Overall Study|Adverse Event|10|||
155417090|NCT00352534|560958654|FG003|Initial Staging|Ineligible|0|||
155417091|NCT00352534|560958655|FG004|Initial Staging|Ineligible|0|||
155417092|NCT00352534|560958656|FG005|Initial Staging|Ineligible|0|||
155417093|NCT00352534|560958657|FG006|Initial Staging|Ineligible|0|||
155417094|NCT00352534|560958651|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
155417095|NCT00352534|560958652|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
155417096|NCT00352534|560958653|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
155417097|NCT00352534|560958654|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
155417098|NCT00352534|560958655|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
155417099|NCT00352534|560958656|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
155417100|NCT00352534|560958657|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
155417101|NCT00352534|560958651|FG000|Final Risk Group Assignment|Physician Decision|0|||
155417102|NCT00352534|560958652|FG001|Final Risk Group Assignment|Physician Decision|0|||
155417103|NCT00352534|560958653|FG002|Final Risk Group Assignment|Physician Decision|0|||
155417104|NCT00352534|560958654|FG003|Final Risk Group Assignment|Physician Decision|0|||
155417105|NCT00352534|560958655|FG004|Final Risk Group Assignment|Physician Decision|0|||
155417106|NCT00352534|560958656|FG005|Final Risk Group Assignment|Physician Decision|8|||
155417107|NCT00352534|560958657|FG006|Final Risk Group Assignment|Physician Decision|0|||
155417108|NCT00352534|560958651|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417109|NCT00352534|560958652|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417110|NCT00352534|560958653|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417111|NCT00352534|560958654|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417112|NCT00352534|560958655|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417113|NCT00352534|560958656|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
155417114|NCT00352534|560958657|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
155417115|NCT00352534|560958651|FG000|Final Risk Group Assignment|Ineligible|0|||
155417116|NCT00352534|560958652|FG001|Final Risk Group Assignment|Ineligible|0|||
155417117|NCT00352534|560958653|FG002|Final Risk Group Assignment|Ineligible|3|||
155417118|NCT00352534|560958654|FG003|Final Risk Group Assignment|Ineligible|1|||
155417119|NCT00352534|560958655|FG004|Final Risk Group Assignment|Ineligible|0|||
155417120|NCT00352534|560958656|FG005|Final Risk Group Assignment|Ineligible|13|||
155417121|NCT00352534|560958657|FG006|Final Risk Group Assignment|Ineligible|0|||
155417122|NCT00352534|560958651|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417123|NCT00352534|560958652|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417124|NCT00352534|560958653|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417125|NCT00352534|560958654|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417126|NCT00352534|560958655|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417127|NCT00352534|560958656|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
155417128|NCT00352534|560958657|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
155417129|NCT00352534|560958651|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417130|NCT00352534|560958652|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417131|NCT00352534|560958653|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417132|NCT00352534|560958654|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417133|NCT00352534|560958655|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417134|NCT00352534|560958656|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155417135|NCT00352534|560958657|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
155417136|NCT00352534|560958651|FG000|Final Risk Group Assignment|Death|0|||
155417137|NCT00352534|560958652|FG001|Final Risk Group Assignment|Death|0|||
155417138|NCT00352534|560958653|FG002|Final Risk Group Assignment|Death|0|||
155417139|NCT00352534|560958654|FG003|Final Risk Group Assignment|Death|0|||
155417140|NCT00352534|560958655|FG004|Final Risk Group Assignment|Death|0|||
155417141|NCT00352534|560958656|FG005|Final Risk Group Assignment|Death|2|||
155417142|NCT00352534|560958657|FG006|Final Risk Group Assignment|Death|0|||
155417143|NCT02090855|560958658|FG000|Overall Study|no evaluable Standard of Truth results|2|||
155417144|NCT00544869|560958659|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
155417145|NCT00544869|560958660|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
155417146|NCT00544869|560958661|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
155417147|NCT00544869|560958659|FG000|Overall Study|Adverse Event|6|||
155417148|NCT00544869|560958660|FG001|Overall Study|Adverse Event|1|||
155417149|NCT00544869|560958661|FG002|Overall Study|Adverse Event|0|||
155417150|NCT00544869|560958659|FG000|Overall Study|Lack of Efficacy|1|||
155417151|NCT00544869|560958660|FG001|Overall Study|Lack of Efficacy|1|||
155417152|NCT00544869|560958661|FG002|Overall Study|Lack of Efficacy|0|||
155417153|NCT00544869|560958659|FG000|Overall Study|Physician Decision|2|||
155417154|NCT00544869|560958660|FG001|Overall Study|Physician Decision|0|||
155417155|NCT00544869|560958661|FG002|Overall Study|Physician Decision|0|||
155417156|NCT01354028|560958662|FG000|Overall Study|Physician Decision|0|||
155417157|NCT01354028|560958663|FG001|Overall Study|Physician Decision|2|||
155417158|NCT01354028|560958662|FG000|Overall Study|Discharged before study start|2|||
155417159|NCT01354028|560958663|FG001|Overall Study|Discharged before study start|2|||
155417160|NCT01354028|560958662|FG000|Overall Study|No quiet alert state|0|||
155417161|NCT01354028|560958663|FG001|Overall Study|No quiet alert state|1|||
155417162|NCT03968419|560958666|FG000|Treatment Period|Adverse Event|0|||
155417163|NCT03968419|560958667|FG001|Treatment Period|Adverse Event|0|||
155417164|NCT03968419|560958668|FG002|Treatment Period|Adverse Event|1|||
155417165|NCT03968419|560958666|FG000|Safety Follow-up Period|Death|3|||
155417166|NCT03968419|560958667|FG001|Safety Follow-up Period|Death|2|||
155417167|NCT03968419|560958668|FG002|Safety Follow-up Period|Death|1|||
155417168|NCT03968419|560958666|FG000|Safety Follow-up Period|Subject Decision|2|||
155417169|NCT03968419|560958667|FG001|Safety Follow-up Period|Subject Decision|1|||
155417170|NCT03968419|560958668|FG002|Safety Follow-up Period|Subject Decision|0|||
155417171|NCT00935883|560958669|FG000|Treatment Period|Physician Decision|1|||
155417172|NCT00935883|560958670|FG001|Treatment Period|Physician Decision|0|||
155417173|NCT00935883|560958669|FG000|Treatment Period|Withdrawal by Subject|0|||
155417174|NCT00935883|560958670|FG001|Treatment Period|Withdrawal by Subject|2|||
155417175|NCT02894840|560958673|FG000|Overall Study|Lost to Follow-up|1|||
155417176|NCT02894840|560958674|FG001|Overall Study|Lost to Follow-up|0|||
155417177|NCT02894840|560958675|FG002|Overall Study|Lost to Follow-up|3|||
155417178|NCT02894840|560958676|FG003|Overall Study|Lost to Follow-up|0|||
155417179|NCT00804687|560958677|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
155417180|NCT00804687|560958678|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
155417181|NCT00804687|560958679|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
155417182|NCT00804687|560958680|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
155417183|NCT00804687|560958681|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
155417184|NCT00804687|560958682|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
155417185|NCT00804687|560958677|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
155417186|NCT00804687|560958678|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
155417187|NCT00804687|560958679|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
155417188|NCT00804687|560958680|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
155417189|NCT00804687|560958681|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
155417190|NCT00804687|560958682|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
155417191|NCT00804687|560958677|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
155417192|NCT00804687|560958678|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
155417193|NCT00804687|560958679|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
155417194|NCT00804687|560958680|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
155417195|NCT00804687|560958681|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
155417196|NCT00804687|560958682|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
155417197|NCT00804687|560958677|FG000|Period 5: Treatment Period|Positive drug test|1|||
155417198|NCT00804687|560958678|FG001|Period 5: Treatment Period|Positive drug test|0|||
155417199|NCT00804687|560958679|FG002|Period 5: Treatment Period|Positive drug test|0|||
155417200|NCT00804687|560958680|FG003|Period 5: Treatment Period|Positive drug test|0|||
155417201|NCT00804687|560958681|FG004|Period 5: Treatment Period|Positive drug test|0|||
155417202|NCT00804687|560958682|FG005|Period 5: Treatment Period|Positive drug test|0|||
155417203|NCT00323557|560958696|FG000|Overall Study|Physician Decision|1|||
155417204|NCT00323557|560958697|FG001|Overall Study|Physician Decision|0|||
155417205|NCT00197054|560958698|FG000|Overall Study|Withdrawal by Subject|9|||
155417206|NCT00197054|560958699|FG001|Overall Study|Withdrawal by Subject|3|||
155417207|NCT00197054|560958700|FG002|Overall Study|Withdrawal by Subject|3|||
155417208|NCT00197054|560958698|FG000|Overall Study|Moved from area|7|||
155417209|NCT00197054|560958699|FG001|Overall Study|Moved from area|14|||
155417210|NCT00197054|560958700|FG002|Overall Study|Moved from area|9|||
155417211|NCT00197054|560958698|FG000|Overall Study|Lost to Follow-up|1|||
155417212|NCT00197054|560958699|FG001|Overall Study|Lost to Follow-up|4|||
155417213|NCT00197054|560958700|FG002|Overall Study|Lost to Follow-up|0|||
155417214|NCT00684515|560958701|FG000|Overall Study|Adverse Event|3|||
155417215|NCT00684515|560958702|FG001|Overall Study|Adverse Event|3|||
155417216|NCT00684515|560958703|FG002|Overall Study|Adverse Event|1|||
155417217|NCT00684515|560958701|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
155417218|NCT00684515|560958702|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
155417219|NCT00684515|560958703|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
155417220|NCT04428411|560958706|FG000|Overall Study|Lost to Follow-up|114|||
155417221|NCT00634569|560958707|FG000|Overall Study|Withdrawal by Subject|0|||
155417222|NCT00634569|560958708|FG001|Overall Study|Withdrawal by Subject|4|||
155417223|NCT00634569|560958707|FG000|Overall Study|Physician Decision|0|||
155417224|NCT00634569|560958708|FG001|Overall Study|Physician Decision|1|||
155417225|NCT01163786|560958709|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
155417226|NCT01163786|560958709|FG000|Treatment With Bortezomib|Adverse Event|2|||
155417227|NCT01163786|560958709|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
155417228|NCT02918019|560958710|FG000|Overall Study|Death|0|||
155417229|NCT02918019|560958711|FG001|Overall Study|Death|0|||
155417230|NCT02918019|560958712|FG002|Overall Study|Death|1|||
155417231|NCT02918019|560958713|FG003|Overall Study|Death|0|||
155417232|NCT02918019|560958710|FG000|Overall Study|Lost to Follow-up|1|||
155417233|NCT02918019|560958711|FG001|Overall Study|Lost to Follow-up|1|||
155417234|NCT02918019|560958712|FG002|Overall Study|Lost to Follow-up|0|||
155417235|NCT02918019|560958713|FG003|Overall Study|Lost to Follow-up|1|||
155499720|NCT04971226|561254030|FG000|Overall Study|Progressive disease|2|||
155499721|NCT04971226|561254031|FG001|Overall Study|Progressive disease|0|||
155499722|NCT04971226|561254032|FG002|Overall Study|Progressive disease|3|||
155499723|NCT04971226|561254033|FG003|Overall Study|Progressive disease|1|||
155499724|NCT04971226|561254030|FG000|Overall Study|Protocol Deviation|1|||
155499725|NCT04971226|561254031|FG001|Overall Study|Protocol Deviation|0|||
155499726|NCT04971226|561254032|FG002|Overall Study|Protocol Deviation|1|||
155499727|NCT04971226|561254033|FG003|Overall Study|Protocol Deviation|1|||
155499728|NCT04971226|561254030|FG000|Overall Study|Subject Decision|0|||
155499729|NCT04971226|561254031|FG001|Overall Study|Subject Decision|1|||
155499730|NCT04971226|561254032|FG002|Overall Study|Subject Decision|1|||
155499731|NCT04971226|561254033|FG003|Overall Study|Subject Decision|1|||
155499732|NCT04971226|561254030|FG000|Overall Study|Pregnancy|0|||
155499733|NCT04971226|561254031|FG001|Overall Study|Pregnancy|0|||
155499734|NCT04971226|561254032|FG002|Overall Study|Pregnancy|0|||
155499735|NCT04971226|561254033|FG003|Overall Study|Pregnancy|1|||
155499736|NCT04971226|561254030|FG000|Overall Study|Participants not treated|1|||
155499737|NCT04971226|561254031|FG001|Overall Study|Participants not treated|0|||
155499738|NCT04971226|561254032|FG002|Overall Study|Participants not treated|2|||
155499739|NCT04971226|561254033|FG003|Overall Study|Participants not treated|1|||
155499740|NCT00481871|561254034|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
155499741|NCT00481871|561254035|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
155499742|NCT00481871|561254036|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
155499743|NCT00481871|561254037|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
155499744|NCT00481871|561254038|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
155499745|NCT04439149|561254039|FG000|Overall Study|Ineligible|1|||
155499746|NCT04439149|561254039|FG000|Overall Study|Never start protocol therapy|1|||
155499747|NCT04439149|561254039|FG000|Overall Study|Adverse Event|4|||
155499748|NCT04439149|561254039|FG000|Overall Study|Disease Progression|14|||
155499749|NCT04439149|561254039|FG000|Overall Study|Complicating disease|1|||
155499750|NCT04439149|561254039|FG000|Overall Study|Withdrawal by Subject|3|||
155499751|NCT05264506|561254042|FG000|Overall Study|Adverse Event|59|||
155499752|NCT05264506|561254042|FG000|Overall Study|Lost to Follow-up|204|||
155499753|NCT05264506|561254042|FG000|Overall Study|Protocol Violation|185|||
155499754|NCT05264506|561254042|FG000|Overall Study|Pregnancy|60|||
155499755|NCT05264506|561254042|FG000|Overall Study|Physician Decision|6|||
155499756|NCT05264506|561254042|FG000|Overall Study|Non-compliance with Study Drug|29|||
155499757|NCT05264506|561254042|FG000|Overall Study|Study termination|677|||
155499758|NCT05264506|561254042|FG000|Overall Study|Withdrawal by Subject|208|||
155499759|NCT05264506|561254042|FG000|Overall Study|Discontinued prior treatment|89|||
155499760|NCT02032823|561254050|FG000|Overall Study|Death|75|||
155499761|NCT02032823|561254051|FG001|Overall Study|Death|109|||
155499762|NCT02032823|561254050|FG000|Overall Study|Lost to Follow-up|18|||
155499763|NCT02032823|561254051|FG001|Overall Study|Lost to Follow-up|17|||
155499764|NCT02032823|561254050|FG000|Overall Study|Withdrawal by Subject|70|||
155499765|NCT02032823|561254051|FG001|Overall Study|Withdrawal by Subject|53|||
155499766|NCT02032823|561254050|FG000|Overall Study|Ongoing study at data cut-off|755|||
155499767|NCT02032823|561254051|FG001|Overall Study|Ongoing study at data cut-off|731|||
155499768|NCT02032823|561254050|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
155499769|NCT02032823|561254051|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
155499770|NCT04521608|561254052|FG000|Overall Study|Death|8|||
155499771|NCT04521608|561254053|FG001|Overall Study|Death|9|||
155499772|NCT04521608|561254052|FG000|Overall Study|Withdrawal by Subject|25|||
155499773|NCT04521608|561254053|FG001|Overall Study|Withdrawal by Subject|18|||
155499774|NCT04521608|561254052|FG000|Overall Study|Disease Progression|3|||
155499775|NCT04521608|561254053|FG001|Overall Study|Disease Progression|10|||
155499776|NCT04521608|561254052|FG000|Overall Study|Complicating Disease|6|||
155499777|NCT04521608|561254053|FG001|Overall Study|Complicating Disease|3|||
155499778|NCT04521608|561254052|FG000|Overall Study|Lost Contact|25|||
155499779|NCT04521608|561254053|FG001|Overall Study|Lost Contact|27|||
155499780|NCT04521608|561254052|FG000|Overall Study|Ineligible|1|||
155499781|NCT04521608|561254053|FG001|Overall Study|Ineligible|0|||
155499782|NCT04521608|561254052|FG000|Overall Study|Refused Further Study Participation|13|||
155499783|NCT04521608|561254053|FG001|Overall Study|Refused Further Study Participation|7|||
155499784|NCT04083378|561254054|FG000|Overall Study|Death|18|||
155499785|NCT04083378|561254055|FG001|Overall Study|Death|4|||
155499786|NCT04083378|561254054|FG000|Overall Study|Lost to Follow-up|4|||
155499787|NCT04083378|561254055|FG001|Overall Study|Lost to Follow-up|0|||
155499788|NCT00644228|561254056|FG000|Randomization & Eligibility|Ineligible|31|||
155499789|NCT00644228|561254057|FG001|Randomization & Eligibility|Ineligible|21|||
155499790|NCT00644228|561254056|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
155499791|NCT00644228|561254057|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
155499792|NCT00644228|561254056|FG000|Randomization & Eligibility|Invalid Consent|0|||
155499793|NCT00644228|561254057|FG001|Randomization & Eligibility|Invalid Consent|1|||
155499794|NCT00644228|561254056|FG000|Induction Therapy|Adverse Event|22|||
155499795|NCT00644228|561254057|FG001|Induction Therapy|Adverse Event|55|||
155499796|NCT00644228|561254056|FG000|Induction Therapy|Withdrawal by Subject|10|||
155417236|NCT02918019|560958710|FG000|Overall Study|Principal investigator request|0|||
155417237|NCT02918019|560958711|FG001|Overall Study|Principal investigator request|0|||
155417238|NCT02918019|560958712|FG002|Overall Study|Principal investigator request|0|||
155417239|NCT02918019|560958713|FG003|Overall Study|Principal investigator request|1|||
155417240|NCT02918019|560958710|FG000|Overall Study|Physician Decision|1|||
155417241|NCT02918019|560958711|FG001|Overall Study|Physician Decision|3|||
155417242|NCT02918019|560958712|FG002|Overall Study|Physician Decision|2|||
155417243|NCT02918019|560958713|FG003|Overall Study|Physician Decision|0|||
155417244|NCT02918019|560958710|FG000|Overall Study|Protocol deviation|1|||
155417245|NCT02918019|560958711|FG001|Overall Study|Protocol deviation|1|||
155417246|NCT02918019|560958712|FG002|Overall Study|Protocol deviation|0|||
155417247|NCT02918019|560958713|FG003|Overall Study|Protocol deviation|2|||
155417248|NCT02918019|560958710|FG000|Overall Study|Withdrawal by Subject|3|||
155417249|NCT02918019|560958711|FG001|Overall Study|Withdrawal by Subject|4|||
155417250|NCT02918019|560958712|FG002|Overall Study|Withdrawal by Subject|6|||
155417251|NCT02918019|560958713|FG003|Overall Study|Withdrawal by Subject|4|||
155417252|NCT02918019|560958710|FG000|Overall Study|Adverse Event|0|||
155417253|NCT02918019|560958711|FG001|Overall Study|Adverse Event|1|||
155417254|NCT02918019|560958712|FG002|Overall Study|Adverse Event|0|||
155417255|NCT02918019|560958713|FG003|Overall Study|Adverse Event|1|||
155417256|NCT01212185|560958714|FG000|Overall Study|Protocol Violation|2|||
155417257|NCT01212185|560958715|FG001|Overall Study|Protocol Violation|1|||
155417258|NCT03555266|560958716|FG000|Overall Study|Protocol Violation|6|||
155417259|NCT03555266|560958717|FG001|Overall Study|Protocol Violation|4|||
155417260|NCT01699087|560958718|FG000|Overall Study|Lost to Follow-up|7|||
155417261|NCT01699087|560958718|FG000|Overall Study|Screen failure (prior to treatment)|15|||
155417262|NCT01699087|560958718|FG000|Overall Study|Unable to make future visits|2|||
155417263|NCT03370770|560958719|FG000|Overall Study|Patient was followed in another hospital center|1|||
155417264|NCT03370770|560958719|FG000|Overall Study|Progressive Disease|98|||
155417265|NCT03370770|560958719|FG000|Overall Study|Adverse Event|2|||
155417266|NCT03370770|560958719|FG000|Overall Study|Death|5|||
155417267|NCT02167945|560958723|FG000|Overall Study|Adverse Event|16|||
155417268|NCT02167945|560958723|FG000|Overall Study|Withdrew Consent|42|||
155417269|NCT02167945|560958723|FG000|Overall Study|Lost to Follow-up|122|||
155417270|NCT02167945|560958723|FG000|Overall Study|COVID-19 logistical restrictions|6|||
155417271|NCT02167945|560958723|FG000|Overall Study|Other, not specified|63|||
155417272|NCT00132730|560958724|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
155417273|NCT00132730|560958725|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
155417274|NCT00132730|560958726|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
155417275|NCT00132730|560958727|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
155417276|NCT00132730|560958728|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
155417277|NCT00132730|560958729|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
155417278|NCT00132730|560958724|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
155417279|NCT00132730|560958725|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
155417280|NCT00132730|560958726|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
155417281|NCT00132730|560958727|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
155417282|NCT00132730|560958728|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
155417283|NCT00132730|560958729|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
155417284|NCT00132730|560958724|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
155417285|NCT00132730|560958725|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
155417286|NCT00132730|560958726|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
155417287|NCT00132730|560958727|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
155417288|NCT00132730|560958728|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
155417289|NCT00132730|560958729|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
155417290|NCT00132730|560958724|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
155417291|NCT00132730|560958725|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
155417292|NCT00132730|560958726|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
155417293|NCT00132730|560958727|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
155417294|NCT00132730|560958728|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
155417295|NCT00132730|560958729|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
155417296|NCT00132730|560958724|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
155417297|NCT00132730|560958725|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
155417298|NCT00132730|560958726|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
155417299|NCT00132730|560958727|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
155417300|NCT00132730|560958728|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
155417301|NCT00132730|560958729|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
155436103|NCT00149214|561024515|FG001|Overall Study|Withdrawal by Subject|1|||
155436104|NCT00149214|561024514|FG000|Overall Study|Physician Decision|3|||
155436105|NCT00149214|561024515|FG001|Overall Study|Physician Decision|3|||
155436106|NCT00149214|561024514|FG000|Overall Study|Sponsor Decision|0|||
155312953|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312954|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
155312955|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312956|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312957|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312958|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312959|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312960|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
155312961|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312962|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312963|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312964|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312965|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312966|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312967|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
155312968|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312969|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312970|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312971|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312972|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312973|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
155312974|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312975|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312976|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312977|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312978|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312979|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312980|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
155312981|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155436107|NCT00149214|561024515|FG001|Overall Study|Sponsor Decision|1|||
155436108|NCT00149214|561024514|FG000|Overall Study|Progressive Disease|7|||
155436109|NCT00149214|561024515|FG001|Overall Study|Progressive Disease|3|||
155436110|NCT01260181|561024518|FG000|Overall Study|Decision of Investigator|1|||
155436111|NCT02088034|561024521|FG000|Overall Study|Lost to Follow-up|1|||
155436112|NCT02088034|561024522|FG001|Overall Study|Lost to Follow-up|1|||
155436113|NCT02088034|561024523|FG002|Overall Study|Lost to Follow-up|0|||
155436114|NCT02088034|561024521|FG000|Overall Study|Pregnancy|2|||
155436115|NCT02088034|561024522|FG001|Overall Study|Pregnancy|1|||
155436116|NCT02088034|561024523|FG002|Overall Study|Pregnancy|2|||
155436117|NCT03794986|561024524|FG000|Overall Study|0 Sessions Attended|34|||
155436118|NCT03794986|561024525|FG001|Overall Study|0 Sessions Attended|37|||
155436119|NCT03794986|561024524|FG000|Overall Study|Withdrawal by Subject|4|||
155436120|NCT03794986|561024525|FG001|Overall Study|Withdrawal by Subject|6|||
155436121|NCT03794986|561024524|FG000|Overall Study|Protocol Violation|1|||
155436122|NCT03794986|561024525|FG001|Overall Study|Protocol Violation|0|||
155436123|NCT03133481|561024526|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
155436124|NCT03133481|561024527|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
155436125|NCT00637728|561024532|FG000|Double-blind Phase|Adverse Event|1|||
155436126|NCT00637728|561024533|FG001|Double-blind Phase|Adverse Event|0|||
155436127|NCT00637728|561024534|FG002|Double-blind Phase|Adverse Event|0|||
155436128|NCT00637728|561024532|FG000|Double-blind Phase|Non-compliance|2|||
155436129|NCT00637728|561024533|FG001|Double-blind Phase|Non-compliance|0|||
155436130|NCT00637728|561024534|FG002|Double-blind Phase|Non-compliance|0|||
155436131|NCT00637728|561024532|FG000|Double-blind Phase|Study Discontinued|1|||
155436132|NCT00637728|561024533|FG001|Double-blind Phase|Study Discontinued|1|||
155436133|NCT00637728|561024534|FG002|Double-blind Phase|Study Discontinued|0|||
155436134|NCT01873950|561024535|FG000|Period 5|Withdrawal by Subject|0|||
155436135|NCT01873950|561024536|FG001|Period 5|Withdrawal by Subject|0|||
155436136|NCT01873950|561024537|FG002|Period 5|Withdrawal by Subject|0|||
155436137|NCT01873950|561024538|FG003|Period 5|Withdrawal by Subject|1|||
155436138|NCT01873950|561024539|FG004|Period 5|Withdrawal by Subject|0|||
155436139|NCT03894540|561024540|FG000|Overall Study|Adverse Event|0|||
155436140|NCT03894540|561024541|FG001|Overall Study|Adverse Event|0|||
155436141|NCT03894540|561024542|FG002|Overall Study|Adverse Event|0|||
155436142|NCT03894540|561024543|FG003|Overall Study|Adverse Event|0|||
155436143|NCT03894540|561024544|FG004|Overall Study|Adverse Event|1|||
155436144|NCT03894540|561024545|FG005|Overall Study|Adverse Event|0|||
155436145|NCT03894540|561024540|FG000|Overall Study|Withdrawal by Subject|0|||
155436146|NCT03894540|561024541|FG001|Overall Study|Withdrawal by Subject|0|||
155436147|NCT03894540|561024542|FG002|Overall Study|Withdrawal by Subject|0|||
155436148|NCT03894540|561024543|FG003|Overall Study|Withdrawal by Subject|0|||
155436149|NCT03894540|561024544|FG004|Overall Study|Withdrawal by Subject|1|||
155499797|NCT00644228|561254057|FG001|Induction Therapy|Withdrawal by Subject|3|||
155499798|NCT00644228|561254056|FG000|Induction Therapy|Progression/Relapse|24|||
155499799|NCT00644228|561254057|FG001|Induction Therapy|Progression/Relapse|12|||
155499800|NCT00644228|561254056|FG000|Induction Therapy|Death|3|||
155499801|NCT00644228|561254057|FG001|Induction Therapy|Death|7|||
155499802|NCT00644228|561254056|FG000|Induction Therapy|Not Protocol-Specified|24|||
155499803|NCT00644228|561254057|FG001|Induction Therapy|Not Protocol-Specified|28|||
155499804|NCT00644228|561254056|FG000|Maintenance|Adverse Event|27|||
155499805|NCT00644228|561254057|FG001|Maintenance|Adverse Event|31|||
155499806|NCT00644228|561254056|FG000|Maintenance|Withdrawal by Subject|6|||
155499807|NCT00644228|561254057|FG001|Maintenance|Withdrawal by Subject|4|||
155499808|NCT00644228|561254056|FG000|Maintenance|Progression/Relapse|67|||
155499809|NCT00644228|561254057|FG001|Maintenance|Progression/Relapse|42|||
155499810|NCT00644228|561254056|FG000|Maintenance|Death|3|||
155499811|NCT00644228|561254057|FG001|Maintenance|Death|3|||
155499812|NCT00644228|561254056|FG000|Maintenance|Not Protocol-Specified|14|||
155499813|NCT00644228|561254057|FG001|Maintenance|Not Protocol-Specified|15|||
155499814|NCT00644228|561254056|FG000|Maintenance|On Treatment|26|||
155499815|NCT00644228|561254057|FG001|Maintenance|On Treatment|40|||
155499816|NCT06078124|561254058|FG000|Overall Study|Lost to Follow-up|14|||
155499817|NCT06078124|561254059|FG001|Overall Study|Lost to Follow-up|14|||
155499818|NCT00285012|561254060|FG000|Assigned to Study Treatment (Tx)|Other|2|||
155499819|NCT00285012|561254061|FG001|Assigned to Study Treatment (Tx)|Other|3|||
155499820|NCT00285012|561254060|FG000|Received Study Tx|Death|2|||
155499821|NCT00285012|561254061|FG001|Received Study Tx|Death|1|||
155499822|NCT00285012|561254060|FG000|Received Study Tx|Adverse Event|5|||
155499823|NCT00285012|561254061|FG001|Received Study Tx|Adverse Event|11|||
155499824|NCT00285012|561254060|FG000|Received Study Tx|Lack of Efficacy|0|||
155499825|NCT00285012|561254061|FG001|Received Study Tx|Lack of Efficacy|3|||
155499826|NCT00285012|561254060|FG000|Received Study Tx|Lost to Follow-up|29|||
155499827|NCT00285012|561254061|FG001|Received Study Tx|Lost to Follow-up|31|||
155643243|NCT01363440|561783758|FG000|Overall Study|Withdrawal by Subject|9|||
155643244|NCT01363440|561783759|FG001|Overall Study|Withdrawal by Subject|11|||
155643245|NCT01363440|561783760|FG002|Overall Study|Withdrawal by Subject|11|||
155312982|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312983|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312984|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312985|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312986|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
155312987|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312988|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312989|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312990|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312991|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312992|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312993|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
155312994|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312995|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312996|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155417302|NCT00132730|560958724|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
155417303|NCT00132730|560958725|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
155417304|NCT00132730|560958726|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
155417305|NCT00132730|560958727|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
155417306|NCT00132730|560958728|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
155417307|NCT00132730|560958729|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
155417308|NCT00132730|560958724|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
155417309|NCT00132730|560958725|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
155417310|NCT00132730|560958726|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
155417311|NCT00132730|560958727|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
155417312|NCT00132730|560958728|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
155417313|NCT00132730|560958729|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
155499828|NCT00285012|561254060|FG000|Received Study Tx|Withdrawal by Subject|31|||
155499829|NCT00285012|561254061|FG001|Received Study Tx|Withdrawal by Subject|43|||
155499830|NCT00285012|561254060|FG000|Received Study Tx|Other|5|||
155499831|NCT00285012|561254061|FG001|Received Study Tx|Other|5|||
155499832|NCT04050293|561254062|FG000|Overall Study|Lost to Follow-up|1|||
155499833|NCT04050293|561254063|FG001|Overall Study|Lost to Follow-up|2|||
155499834|NCT04050293|561254062|FG000|Overall Study|Withdrawal by Subject|2|||
155499835|NCT04050293|561254063|FG001|Overall Study|Withdrawal by Subject|0|||
155499836|NCT04223193|561254068|FG000|Overall Study|Adverse Event|6|||
155499837|NCT04223193|561254069|FG001|Overall Study|Adverse Event|36|||
155499838|NCT04223193|561254068|FG000|Overall Study|Lack of Efficacy|2|||
155499839|NCT04223193|561254069|FG001|Overall Study|Lack of Efficacy|2|||
155499840|NCT04223193|561254068|FG000|Overall Study|Lost to Follow-up|1|||
155499841|NCT04223193|561254069|FG001|Overall Study|Lost to Follow-up|1|||
155499842|NCT04223193|561254068|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
155499843|NCT04223193|561254069|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155499844|NCT04223193|561254068|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
155499845|NCT04223193|561254069|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155499846|NCT04223193|561254068|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155499847|NCT04223193|561254069|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155499848|NCT04223193|561254068|FG000|Overall Study|Physician Decision|0|||
155499849|NCT04223193|561254069|FG001|Overall Study|Physician Decision|1|||
155499850|NCT04223193|561254068|FG000|Overall Study|Protocol Violation|1|||
155499851|NCT04223193|561254069|FG001|Overall Study|Protocol Violation|1|||
155499852|NCT04223193|561254068|FG000|Overall Study|Site Terminated by Sponsor|1|||
155499853|NCT04223193|561254069|FG001|Overall Study|Site Terminated by Sponsor|3|||
155499854|NCT04223193|561254068|FG000|Overall Study|Withdrawal by Subject|5|||
155499855|NCT04223193|561254069|FG001|Overall Study|Withdrawal by Subject|6|||
155499856|NCT04223193|561254068|FG000|Overall Study|Other|3|||
155499857|NCT04223193|561254069|FG001|Overall Study|Other|6|||
155499858|NCT03532295|561254075|FG000|Overall Study|Did not start treatment|0|||
155499859|NCT03532295|561254076|FG001|Overall Study|Did not start treatment|2|||
155499860|NCT01907516|561254077|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
155499861|NCT01907516|561254078|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
155499862|NCT01907516|561254077|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
155499863|NCT01907516|561254078|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
155312997|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312998|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312999|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
155313000|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155313001|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313002|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313003|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313004|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313005|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313006|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
155313007|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313008|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313009|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313010|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313011|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313012|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
155313013|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313014|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313015|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313016|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313017|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313018|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
155313019|NCT04876118|560577553|FG000|Overall Study|Pregnancy|1|||
155313020|NCT04876118|560577553|FG000|Overall Study|Withdrawal by Subject|14|||
155313021|NCT05089734|560577554|FG000|Overall Study|Still on study|122|||
155499864|NCT01907516|561254077|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
155499865|NCT01907516|561254078|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
155499866|NCT01907516|561254077|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
155499867|NCT01907516|561254078|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
155499868|NCT04644237|561254082|FG000|Overall Study|Death|4|||
155499869|NCT04644237|561254083|FG001|Overall Study|Death|2|||
155499870|NCT04644237|561254082|FG000|Overall Study|Adverse Event|18|||
155499871|NCT04644237|561254083|FG001|Overall Study|Adverse Event|19|||
155499872|NCT04644237|561254082|FG000|Overall Study|Progressive Disease|61|||
155313022|NCT05089734|560577555|FG001|Overall Study|Still on study|101|||
155313023|NCT05089734|560577554|FG000|Overall Study|Death|161|||
155499873|NCT04644237|561254083|FG001|Overall Study|Progressive Disease|23|||
155751020|NCT03576274|562187216|FG004|Overall Study|Withdrawal by Subject|6|||
155313024|NCT05089734|560577555|FG001|Overall Study|Death|179|||
155313025|NCT05089734|560577554|FG000|Overall Study|Withdrew consent|11|||
155417314|NCT00132730|560958724|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
155417315|NCT00132730|560958725|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
155417316|NCT00132730|560958726|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
155417317|NCT00132730|560958727|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
155417318|NCT00132730|560958728|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
155417319|NCT00132730|560958729|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
155417320|NCT00132730|560958724|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
155643246|NCT01363440|561783758|FG000|Overall Study|Lost to Follow-up|2|||
155643247|NCT01363440|561783759|FG001|Overall Study|Lost to Follow-up|4|||
155417321|NCT00132730|560958725|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
155417322|NCT00132730|560958726|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
155436150|NCT03894540|561024545|FG005|Overall Study|Withdrawal by Subject|0|||
155436151|NCT03894540|561024540|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
155436152|NCT03894540|561024541|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
155436153|NCT03894540|561024542|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
155436154|NCT03894540|561024543|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
155436155|NCT03894540|561024544|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
155436156|NCT03894540|561024545|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
155436157|NCT03894540|561024540|FG000|Overall Study|Progressive Disease Clinical|1|||
155436158|NCT03894540|561024541|FG001|Overall Study|Progressive Disease Clinical|1|||
155436159|NCT03894540|561024542|FG002|Overall Study|Progressive Disease Clinical|0|||
155436160|NCT03894540|561024543|FG003|Overall Study|Progressive Disease Clinical|1|||
155436161|NCT03894540|561024544|FG004|Overall Study|Progressive Disease Clinical|5|||
155436162|NCT03894540|561024545|FG005|Overall Study|Progressive Disease Clinical|1|||
155436163|NCT03894540|561024540|FG000|Overall Study|Study termination by sponsor|0|||
155436164|NCT03894540|561024541|FG001|Overall Study|Study termination by sponsor|0|||
155436165|NCT03894540|561024542|FG002|Overall Study|Study termination by sponsor|0|||
155436166|NCT03894540|561024543|FG003|Overall Study|Study termination by sponsor|0|||
155436167|NCT03894540|561024544|FG004|Overall Study|Study termination by sponsor|2|||
155436168|NCT03894540|561024545|FG005|Overall Study|Study termination by sponsor|0|||
155436169|NCT03000452|561024546|FG000|Treatment Period|Death|1|||
155436170|NCT03000452|561024546|FG000|Treatment Period|Progressive Disease (PD)|14|||
155436171|NCT03000452|561024546|FG000|Treatment Period|Physician Decision|1|||
155436172|NCT03000452|561024546|FG000|Treatment Period|Miscellaneous|2|||
155436173|NCT03000452|561024546|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
155436174|NCT03000452|561024546|FG000|Follow-Up Period|Death|3|||
155436175|NCT03000452|561024546|FG000|Follow-Up Period|Withdrawal by Subject|3|||
155436176|NCT03043365|561024547|FG000|Weeks 0 to Week 8|Adverse Event|1|||
155436177|NCT03043365|561024548|FG001|Weeks 0 to Week 8|Adverse Event|3|||
155436178|NCT03043365|561024547|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
155436179|NCT03043365|561024548|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
155436180|NCT03043365|561024547|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
155436181|NCT03043365|561024548|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
155436182|NCT00593112|561024549|FG000|Overall Study|Scan Anxiety|3|||
155436183|NCT00593112|561024550|FG001|Overall Study|Scan Anxiety|0|||
155436184|NCT00593112|561024549|FG000|Overall Study|Abnormal Scan|1|||
155436185|NCT00593112|561024550|FG001|Overall Study|Abnormal Scan|0|||
155436186|NCT00593112|561024549|FG000|Overall Study|Unreadable Scan|1|||
155436187|NCT00593112|561024550|FG001|Overall Study|Unreadable Scan|0|||
155436188|NCT00593112|561024549|FG000|Overall Study|Withdrawal by Subject|5|||
155436189|NCT00593112|561024550|FG001|Overall Study|Withdrawal by Subject|0|||
155436190|NCT02723630|561024551|FG000|Intervention Period 1|Adverse Event|1|||
155436191|NCT02723630|561024552|FG001|Intervention Period 1|Adverse Event|0|||
155436192|NCT02723630|561024553|FG002|Intervention Period 1|Adverse Event|0|||
155436193|NCT02723630|561024554|FG003|Intervention Period 1|Adverse Event|0|||
155436194|NCT02723630|561024555|FG004|Intervention Period 1|Adverse Event|0|||
155436195|NCT02723630|561024556|FG005|Intervention Period 1|Adverse Event|0|||
155436196|NCT02723630|561024551|FG000|Intervention Period 3|consumption of restricted item|0|||
155436197|NCT02723630|561024552|FG001|Intervention Period 3|consumption of restricted item|1|||
155436198|NCT02723630|561024553|FG002|Intervention Period 3|consumption of restricted item|0|||
155436199|NCT02723630|561024554|FG003|Intervention Period 3|consumption of restricted item|0|||
155436200|NCT02723630|561024555|FG004|Intervention Period 3|consumption of restricted item|0|||
155436201|NCT02723630|561024556|FG005|Intervention Period 3|consumption of restricted item|0|||
155436202|NCT00537745|561024557|FG000|Overall Study|Did not meet eligibility criteria|2|||
155436203|NCT00537745|561024557|FG000|Overall Study|Withdrawal by Subject|2|||
155436204|NCT00537745|561024557|FG000|Overall Study|Subject unable to provide Interlock info|1|||
155436205|NCT03700892|561024561|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
155499874|NCT04644237|561254082|FG000|Overall Study|Clinical Progression|4|||
155499875|NCT04644237|561254083|FG001|Overall Study|Clinical Progression|1|||
155499876|NCT04644237|561254082|FG000|Overall Study|Withdrawal by Subject|4|||
155499877|NCT04644237|561254083|FG001|Overall Study|Withdrawal by Subject|2|||
155499878|NCT04644237|561254082|FG000|Overall Study|Physician Decision|4|||
155499879|NCT04644237|561254083|FG001|Overall Study|Physician Decision|0|||
155499880|NCT04644237|561254082|FG000|Overall Study|Other|6|||
155499881|NCT04644237|561254083|FG001|Overall Study|Other|3|||
155499882|NCT04644237|561254082|FG000|Overall Study|Randomized but not Treated|1|||
155499883|NCT04644237|561254083|FG001|Overall Study|Randomized but not Treated|0|||
155499884|NCT03131817|561254084|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
155499885|NCT02061293|561254086|FG000|Overall Study|Elevated Blood Pressure|1|||
155499886|NCT02061293|561254087|FG001|Overall Study|Elevated Blood Pressure|1|||
155499887|NCT04066894|561254089|FG000|Overall Study|Lack of Efficacy|1|||
155499888|NCT04066894|561254089|FG000|Overall Study|Screen Failure|1|||
155499889|NCT02949219|561254090|FG000|Overall Study|Withdrawal by Subject|1|||
155499890|NCT05022121|561254095|FG000|Overall Study|Lack of Efficacy|1|||
155499891|NCT05022121|561254096|FG001|Overall Study|Lack of Efficacy|0|||
155499892|NCT05022121|561254095|FG000|Overall Study|Lost to Follow-up|0|||
155499893|NCT05022121|561254096|FG001|Overall Study|Lost to Follow-up|2|||
155499894|NCT04439110|561254097|FG000|Overall Study|Ineligible|2|||
155499895|NCT04439110|561254097|FG000|Overall Study|Adverse Event|4|||
155499896|NCT04439110|561254097|FG000|Overall Study|Death|2|||
155499897|NCT04439110|561254097|FG000|Overall Study|Disease proression|25|||
155499898|NCT04439110|561254097|FG000|Overall Study|Withdrawal by Subject|1|||
155499899|NCT04439110|561254097|FG000|Overall Study|Alternative therapy|1|||
155499900|NCT04439110|561254097|FG000|Overall Study|Other complicating disease|1|||
155499901|NCT04439110|561254097|FG000|Overall Study|Personal reasons|1|||
155499902|NCT04439110|561254097|FG000|Overall Study|Still on treatment|1|||
155499903|NCT00131937|561254098|FG000|Overall Study|Adverse Event|3|||
155499904|NCT00131937|561254098|FG000|Overall Study|Withdrawal by Subject|2|||
155499905|NCT00131937|561254098|FG000|Overall Study|Physician Decision|1|||
155499906|NCT00131937|561254098|FG000|Overall Study|Disease Progression|7|||
155499907|NCT00131937|561254098|FG000|Overall Study|Alternative therapy|1|||
155499908|NCT04647253|561254105|FG000|Overall Study|Death ≤ 365 Days|16|||
155499909|NCT04647253|561254106|FG001|Overall Study|Death ≤ 365 Days|7|||
155751021|NCT05952401|562187225|FG000|Overall Study|Lost to Follow-up|4|||
155313026|NCT05089734|560577555|FG001|Overall Study|Withdrew consent|24|||
155313027|NCT05089734|560577554|FG000|Overall Study|Lost to Follow-up|5|||
155313028|NCT05089734|560577555|FG001|Overall Study|Lost to Follow-up|0|||
155313029|NCT05093829|560577557|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313030|NCT05093829|560577558|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313031|NCT05093829|560577559|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
155313032|NCT05093829|560577560|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313033|NCT05093829|560577561|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313034|NCT04353661|560579439|FG000|Overall Study|Protocol Violation|0|||
155313035|NCT04353661|560579440|FG001|Overall Study|Protocol Violation|0|||
155313036|NCT04353661|560579441|FG002|Overall Study|Protocol Violation|1|||
155313037|NCT04353661|560579439|FG000|Overall Study|Study termination by the Sponsor|1|||
155313038|NCT04353661|560579440|FG001|Overall Study|Study termination by the Sponsor|1|||
155313039|NCT04353661|560579441|FG002|Overall Study|Study termination by the Sponsor|1|||
155313040|NCT05215314|560579442|FG000|Overall Study|Lost to Follow-up|2|||
155313041|NCT05215314|560579443|FG001|Overall Study|Lost to Follow-up|2|||
155313042|NCT05215314|560579442|FG000|Overall Study|Withdrawal by Subject|2|||
155313043|NCT05215314|560579443|FG001|Overall Study|Withdrawal by Subject|0|||
155313044|NCT05215314|560579442|FG000|Overall Study|Physician Decision|1|||
155313045|NCT05215314|560579443|FG001|Overall Study|Physician Decision|0|||
155313046|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Physician Decision|1|||
155313047|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Physician Decision|0|||
155313048|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
155313049|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
155313050|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
155313051|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
155313052|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Pregnancy|0|||
155313053|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Pregnancy|2|||
155313054|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
155313055|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
155499910|NCT04647253|561254105|FG000|Overall Study|Physician Decision|0|||
155499911|NCT04647253|561254106|FG001|Overall Study|Physician Decision|1|||
155499912|NCT04647253|561254105|FG000|Overall Study|Withdrawal by Subject|7|||
155499913|NCT04647253|561254106|FG001|Overall Study|Withdrawal by Subject|2|||
155499914|NCT04647253|561254105|FG000|Overall Study|Missed 12-Month Visit|9|||
155499915|NCT04647253|561254106|FG001|Overall Study|Missed 12-Month Visit|7|||
155499916|NCT04647253|561254105|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
155499917|NCT04647253|561254106|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
155499918|NCT01211613|561255546|FG000|Overall Study|Lost to Follow-up|2|||
155499919|NCT01211613|561255547|FG001|Overall Study|Lost to Follow-up|2|||
155499920|NCT01211613|561255548|FG002|Overall Study|Lost to Follow-up|2|||
155499921|NCT01211613|561255546|FG000|Overall Study|Withdrawal by Subject|1|||
155499922|NCT01211613|561255547|FG001|Overall Study|Withdrawal by Subject|0|||
155499923|NCT01211613|561255548|FG002|Overall Study|Withdrawal by Subject|0|||
155499924|NCT01020773|561255549|FG000|Overall Study|Withdrawal by Subject|4|||
155499925|NCT01020773|561255550|FG001|Overall Study|Withdrawal by Subject|3|||
155499926|NCT03853213|561255551|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
155499927|NCT03853213|561255552|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
155499928|NCT03853213|561255551|FG000|Overall Study|Other (e.g., too busy)|0|||
155499929|NCT03853213|561255552|FG001|Overall Study|Other (e.g., too busy)|2|||
155499930|NCT03302299|561255553|FG000|Overall Study|Protocol Violation|1|||
155499931|NCT01458132|561255554|FG000|Overall Study|Other|15|||
155499932|NCT01458132|561255555|FG001|Overall Study|Other|3|||
155499933|NCT02038959|561255560|FG000|Overall Study|Withdrawal by Subject|6|||
155499934|NCT02038959|561255561|FG001|Overall Study|Withdrawal by Subject|8|||
155499935|NCT00819091|561255567|FG000|Overall Study|Adverse Event|3|||
155499936|NCT00819091|561255568|FG001|Overall Study|Adverse Event|5|||
155499937|NCT00819091|561255567|FG000|Overall Study|Protocol Violation|0|||
155499938|NCT00819091|561255568|FG001|Overall Study|Protocol Violation|1|||
155499939|NCT00819091|561255567|FG000|Overall Study|Lost to Follow-up|2|||
155499940|NCT00819091|561255568|FG001|Overall Study|Lost to Follow-up|0|||
155499941|NCT00819091|561255567|FG000|Overall Study|Withdrawal by Subject|1|||
155499942|NCT00819091|561255568|FG001|Overall Study|Withdrawal by Subject|2|||
155499943|NCT00819091|561255567|FG000|Overall Study|Other|1|||
155499944|NCT00819091|561255568|FG001|Overall Study|Other|2|||
155499945|NCT01788163|561255570|FG000|Overall Study|Other|53|||
155499946|NCT01788163|561255571|FG001|Overall Study|Other|0|||
155499947|NCT01788163|561255572|FG002|Overall Study|Other|0|||
155499948|NCT01788163|561255573|FG003|Overall Study|Other|0|||
155499949|NCT01788163|561255574|FG004|Overall Study|Other|0|||
155499950|NCT01788163|561255575|FG005|Overall Study|Other|7|||
155499951|NCT01788163|561255576|FG006|Overall Study|Other|1|||
155499952|NCT01788163|561255577|FG007|Overall Study|Other|48|||
155499953|NCT01788163|561255578|FG008|Overall Study|Other|15|||
155499954|NCT01788163|561255570|FG000|Overall Study|Withdrawal by Subject|2|||
155499955|NCT01788163|561255571|FG001|Overall Study|Withdrawal by Subject|0|||
155499956|NCT01788163|561255572|FG002|Overall Study|Withdrawal by Subject|0|||
155499957|NCT01788163|561255573|FG003|Overall Study|Withdrawal by Subject|0|||
155499958|NCT01788163|561255574|FG004|Overall Study|Withdrawal by Subject|0|||
155499959|NCT01788163|561255575|FG005|Overall Study|Withdrawal by Subject|0|||
155499960|NCT01788163|561255576|FG006|Overall Study|Withdrawal by Subject|0|||
155499961|NCT01788163|561255577|FG007|Overall Study|Withdrawal by Subject|0|||
155499962|NCT01788163|561255578|FG008|Overall Study|Withdrawal by Subject|1|||
155499963|NCT00545441|561255579|FG000|Overall Study|Fistula draining at 6 months|2|||
155499964|NCT00545441|561255580|FG001|Overall Study|Fistula draining at 6 months|4|||
155499965|NCT00545441|561255579|FG000|Overall Study|Lost to Follow-up|9|||
155499966|NCT00545441|561255580|FG001|Overall Study|Lost to Follow-up|5|||
155499967|NCT00545441|561255579|FG000|Overall Study|Technical failure|0|||
155499968|NCT00545441|561255580|FG001|Overall Study|Technical failure|1|||
155499969|NCT00545441|561255579|FG000|Overall Study|Withdrawal by Subject|1|||
155499970|NCT00545441|561255580|FG001|Overall Study|Withdrawal by Subject|1|||
155499971|NCT00545441|561255579|FG000|Overall Study|Persistence or recurrence of fistula|5|||
155499972|NCT00545441|561255580|FG001|Overall Study|Persistence or recurrence of fistula|2|||
155499973|NCT00545441|561255579|FG000|Overall Study|Patients were not treated|1|||
155499974|NCT00545441|561255580|FG001|Overall Study|Patients were not treated|3|||
155499975|NCT03911960|561255581|FG000|Overall Study|Lost to Follow-up|5|||
155643248|NCT01363440|561783760|FG002|Overall Study|Lost to Follow-up|5|||
155499976|NCT03911960|561255582|FG001|Overall Study|Lost to Follow-up|3|||
155499977|NCT00424515|561255585|FG000|Overall Study|Progressive Disease|10|||
155499978|NCT00424515|561255586|FG001|Overall Study|Progressive Disease|11|||
155499979|NCT00424515|561255585|FG000|Overall Study|Adverse Event|0|||
155499980|NCT00424515|561255586|FG001|Overall Study|Adverse Event|1|||
155499981|NCT00424515|561255585|FG000|Overall Study|Intercurrent Illness|0|||
155499982|NCT00424515|561255586|FG001|Overall Study|Intercurrent Illness|1|||
155499983|NCT00424515|561255585|FG000|Overall Study|Withdrawal by Subject|1|||
155643249|NCT01363440|561783758|FG000|Overall Study|Other|4|||
155499984|NCT00424515|561255586|FG001|Overall Study|Withdrawal by Subject|0|||
155499985|NCT04071366|561255587|FG000|Part 1: Open-label (29 Days)|Death|4|||
155499986|NCT04071366|561255588|FG001|Part 1: Open-label (29 Days)|Death|2|||
155499987|NCT04071366|561255589|FG002|Part 1: Open-label (29 Days)|Death|8|||
155499988|NCT04071366|561255590|FG003|Part 1: Open-label (29 Days)|Death|0|||
155499989|NCT04071366|561255591|FG004|Part 1: Open-label (29 Days)|Death|0|||
155499990|NCT04071366|561255587|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
155499991|NCT04071366|561255588|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
155417323|NCT00132730|560958727|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
155417324|NCT00132730|560958728|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
155417325|NCT00132730|560958729|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
155417326|NCT00132730|560958724|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
155417327|NCT00132730|560958725|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
155417328|NCT00132730|560958726|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
155417329|NCT00132730|560958727|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
155417330|NCT00132730|560958728|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
155417331|NCT00132730|560958729|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
155417332|NCT00132730|560958724|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
155417333|NCT00132730|560958725|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
155417334|NCT00132730|560958726|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
155417335|NCT00132730|560958727|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
155417336|NCT00132730|560958728|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
155417337|NCT00132730|560958729|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
155417338|NCT00132730|560958724|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
155417339|NCT00132730|560958725|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
155417340|NCT00132730|560958726|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
155417341|NCT00132730|560958727|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
155417342|NCT00132730|560958728|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
155417343|NCT00132730|560958729|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
155417344|NCT03021642|560958733|FG000|Washout Period (21 Days)|Adverse Event|1|||
155417345|NCT03021642|560958734|FG001|Washout Period (21 Days)|Adverse Event|1|||
155417346|NCT00094757|560958735|FG000|Overall Study|Adverse Event|11|||
155417347|NCT00094757|560958736|FG001|Overall Study|Adverse Event|9|||
155417348|NCT00094757|560958737|FG002|Overall Study|Adverse Event|6|||
155417349|NCT00094757|560958735|FG000|Overall Study|Lack of Efficacy|11|||
155417350|NCT00094757|560958736|FG001|Overall Study|Lack of Efficacy|15|||
155417351|NCT00094757|560958737|FG002|Overall Study|Lack of Efficacy|8|||
155417352|NCT00094757|560958735|FG000|Overall Study|Lost to Follow-up|3|||
155417353|NCT00094757|560958736|FG001|Overall Study|Lost to Follow-up|5|||
155417354|NCT00094757|560958737|FG002|Overall Study|Lost to Follow-up|6|||
155417355|NCT00094757|560958735|FG000|Overall Study|Patient Moved|2|||
155417356|NCT00094757|560958736|FG001|Overall Study|Patient Moved|1|||
155417357|NCT00094757|560958737|FG002|Overall Study|Patient Moved|1|||
155417358|NCT00094757|560958735|FG000|Overall Study|Protocol Violation|8|||
155417359|NCT00094757|560958736|FG001|Overall Study|Protocol Violation|5|||
155417360|NCT00094757|560958737|FG002|Overall Study|Protocol Violation|3|||
155417361|NCT00094757|560958735|FG000|Overall Study|Withdrawal by Subject|14|||
155417362|NCT00094757|560958736|FG001|Overall Study|Withdrawal by Subject|21|||
155417363|NCT00094757|560958737|FG002|Overall Study|Withdrawal by Subject|5|||
155417364|NCT00094757|560958735|FG000|Overall Study|Other|3|||
155417365|NCT00094757|560958736|FG001|Overall Study|Other|3|||
155417366|NCT00094757|560958737|FG002|Overall Study|Other|1|||
155417367|NCT00094757|560958735|FG000|Overall Study|Protocol specified discontinuation|1|||
155417368|NCT00094757|560958736|FG001|Overall Study|Protocol specified discontinuation|3|||
155417369|NCT00094757|560958737|FG002|Overall Study|Protocol specified discontinuation|0|||
155417370|NCT01192347|560958738|FG000|Overall Study|Death|3|||
155417371|NCT01192347|560958738|FG000|Overall Study|Lost to Follow-up|3|||
155417372|NCT01192347|560958738|FG000|Overall Study|Withdrawal by Subject|1|||
155417373|NCT01192347|560958738|FG000|Overall Study|Adverse Event|1|||
155417374|NCT01192347|560958738|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
155417375|NCT01192347|560958738|FG000|Overall Study|Patient seen in different hospital|1|||
155417376|NCT01192347|560958738|FG000|Overall Study|Patient not visiting hospital regularly|1|||
155417377|NCT01192347|560958738|FG000|Overall Study|Patient did not show up for visits|1|||
155417378|NCT02623335|560958739|FG000|Overall Study|Death|8|||
155417379|NCT02623335|560958740|FG001|Overall Study|Death|7|||
155417380|NCT02623335|560958739|FG000|Overall Study|Lost to Follow-up|15|||
155417381|NCT02623335|560958740|FG001|Overall Study|Lost to Follow-up|23|||
155417382|NCT02623335|560958739|FG000|Overall Study|Withdrawal by Subject|2|||
155417383|NCT02623335|560958740|FG001|Overall Study|Withdrawal by Subject|5|||
155643250|NCT01363440|561783759|FG001|Overall Study|Other|5|||
155417384|NCT02623335|560958739|FG000|Overall Study|Protocol Violation|2|||
155417385|NCT02623335|560958740|FG001|Overall Study|Protocol Violation|1|||
155417386|NCT00395967|560958741|FG000|Treatment Period|Failed Mobilization|1|||
155417387|NCT00395967|560958741|FG000|Follow-up Period|Death|1|||
155417388|NCT00395967|560958741|FG000|Follow-up Period|Lost to Follow-up|1|||
155643251|NCT01363440|561783760|FG002|Overall Study|Other|2|||
155417389|NCT01262976|560958742|FG000|Up to Month 2|Serious Adverse Event|0|||
155417390|NCT01262976|560958743|FG001|Up to Month 2|Serious Adverse Event|0|||
155417391|NCT01262976|560958744|FG002|Up to Month 2|Serious Adverse Event|1|||
155417392|NCT01262976|560958745|FG003|Up to Month 2|Serious Adverse Event|0|||
155643252|NCT01771913|561783761|FG000|Overall Study|Withdrawal by Subject|1|||
155417393|NCT01262976|560958746|FG004|Up to Month 2|Serious Adverse Event|0|||
155417394|NCT01262976|560958747|FG005|Up to Month 2|Serious Adverse Event|0|||
155417395|NCT01262976|560958742|FG000|Up to Month 2|Withdrawal by Subject|1|||
155417396|NCT01262976|560958743|FG001|Up to Month 2|Withdrawal by Subject|0|||
155417397|NCT01262976|560958744|FG002|Up to Month 2|Withdrawal by Subject|0|||
155417398|NCT01262976|560958745|FG003|Up to Month 2|Withdrawal by Subject|0|||
155417399|NCT01262976|560958746|FG004|Up to Month 2|Withdrawal by Subject|0|||
155417400|NCT01262976|560958747|FG005|Up to Month 2|Withdrawal by Subject|0|||
155417401|NCT01262976|560958742|FG000|Up to Month 2|Migrated/moved from study area|0|||
155417402|NCT01262976|560958743|FG001|Up to Month 2|Migrated/moved from study area|1|||
155417403|NCT01262976|560958744|FG002|Up to Month 2|Migrated/moved from study area|0|||
155417404|NCT01262976|560958745|FG003|Up to Month 2|Migrated/moved from study area|0|||
155417405|NCT01262976|560958746|FG004|Up to Month 2|Migrated/moved from study area|1|||
155417406|NCT01262976|560958747|FG005|Up to Month 2|Migrated/moved from study area|1|||
155417407|NCT01262976|560958742|FG000|Up to Month 2|Lost to Follow-up|1|||
155417408|NCT01262976|560958743|FG001|Up to Month 2|Lost to Follow-up|0|||
155417409|NCT01262976|560958744|FG002|Up to Month 2|Lost to Follow-up|0|||
155417410|NCT01262976|560958745|FG003|Up to Month 2|Lost to Follow-up|1|||
155417411|NCT01262976|560958746|FG004|Up to Month 2|Lost to Follow-up|1|||
155417412|NCT01262976|560958747|FG005|Up to Month 2|Lost to Follow-up|1|||
155417413|NCT01262976|560958742|FG000|Up to Month 2|Other|1|||
155417414|NCT01262976|560958743|FG001|Up to Month 2|Other|0|||
155417415|NCT01262976|560958744|FG002|Up to Month 2|Other|0|||
155417416|NCT01262976|560958745|FG003|Up to Month 2|Other|1|||
155417417|NCT01262976|560958746|FG004|Up to Month 2|Other|0|||
155417418|NCT01262976|560958747|FG005|Up to Month 2|Other|2|||
155417419|NCT01262976|560958742|FG000|Up to Month 7|Serious Adverse Event|0|||
155417420|NCT01262976|560958743|FG001|Up to Month 7|Serious Adverse Event|0|||
155417421|NCT01262976|560958744|FG002|Up to Month 7|Serious Adverse Event|2|||
155417422|NCT01262976|560958745|FG003|Up to Month 7|Serious Adverse Event|0|||
155417423|NCT01262976|560958746|FG004|Up to Month 7|Serious Adverse Event|0|||
155417424|NCT01262976|560958747|FG005|Up to Month 7|Serious Adverse Event|0|||
155417425|NCT01262976|560958742|FG000|Up to Month 7|Withdrawal by Subject|1|||
155417426|NCT01262976|560958743|FG001|Up to Month 7|Withdrawal by Subject|0|||
155417427|NCT01262976|560958744|FG002|Up to Month 7|Withdrawal by Subject|0|||
155417428|NCT01262976|560958745|FG003|Up to Month 7|Withdrawal by Subject|0|||
155417429|NCT01262976|560958746|FG004|Up to Month 7|Withdrawal by Subject|0|||
155417430|NCT01262976|560958747|FG005|Up to Month 7|Withdrawal by Subject|0|||
155417431|NCT01262976|560958742|FG000|Up to Month 7|Migrated/moved from study area|0|||
155417432|NCT01262976|560958743|FG001|Up to Month 7|Migrated/moved from study area|0|||
155417433|NCT01262976|560958744|FG002|Up to Month 7|Migrated/moved from study area|1|||
155417434|NCT01262976|560958745|FG003|Up to Month 7|Migrated/moved from study area|3|||
155417435|NCT01262976|560958746|FG004|Up to Month 7|Migrated/moved from study area|1|||
155417436|NCT01262976|560958747|FG005|Up to Month 7|Migrated/moved from study area|1|||
155417437|NCT01262976|560958742|FG000|Up to Month 7|Lost to Follow-up|1|||
155417438|NCT01262976|560958743|FG001|Up to Month 7|Lost to Follow-up|0|||
155417439|NCT01262976|560958744|FG002|Up to Month 7|Lost to Follow-up|1|||
155417440|NCT01262976|560958745|FG003|Up to Month 7|Lost to Follow-up|3|||
155417441|NCT01262976|560958746|FG004|Up to Month 7|Lost to Follow-up|1|||
155417442|NCT01262976|560958747|FG005|Up to Month 7|Lost to Follow-up|3|||
155417443|NCT01262976|560958742|FG000|Up to Month 7|Other|3|||
155417444|NCT01262976|560958743|FG001|Up to Month 7|Other|0|||
155417445|NCT01262976|560958744|FG002|Up to Month 7|Other|2|||
155417446|NCT01262976|560958745|FG003|Up to Month 7|Other|0|||
155417447|NCT01262976|560958746|FG004|Up to Month 7|Other|0|||
155417448|NCT01262976|560958747|FG005|Up to Month 7|Other|0|||
155417449|NCT01262976|560958742|FG000|Up to Year 1|Serious Adverse Event|0|||
155417450|NCT01262976|560958743|FG001|Up to Year 1|Serious Adverse Event|0|||
155417451|NCT01262976|560958744|FG002|Up to Year 1|Serious Adverse Event|2|||
155417452|NCT01262976|560958745|FG003|Up to Year 1|Serious Adverse Event|0|||
155417453|NCT01262976|560958746|FG004|Up to Year 1|Serious Adverse Event|0|||
155417454|NCT01262976|560958747|FG005|Up to Year 1|Serious Adverse Event|0|||
155417455|NCT01262976|560958742|FG000|Up to Year 1|Withdrawal by Subject|1|||
155417456|NCT01262976|560958743|FG001|Up to Year 1|Withdrawal by Subject|0|||
155417457|NCT01262976|560958744|FG002|Up to Year 1|Withdrawal by Subject|0|||
155417458|NCT01262976|560958745|FG003|Up to Year 1|Withdrawal by Subject|0|||
155417459|NCT01262976|560958746|FG004|Up to Year 1|Withdrawal by Subject|0|||
155417460|NCT01262976|560958747|FG005|Up to Year 1|Withdrawal by Subject|0|||
155417461|NCT01262976|560958742|FG000|Up to Year 1|Migrated/moved from study area|1|||
155417462|NCT01262976|560958743|FG001|Up to Year 1|Migrated/moved from study area|0|||
155417463|NCT01262976|560958744|FG002|Up to Year 1|Migrated/moved from study area|0|||
155417464|NCT01262976|560958745|FG003|Up to Year 1|Migrated/moved from study area|3|||
155417465|NCT01262976|560958746|FG004|Up to Year 1|Migrated/moved from study area|3|||
155417466|NCT01262976|560958747|FG005|Up to Year 1|Migrated/moved from study area|2|||
155417467|NCT01262976|560958742|FG000|Up to Year 1|Lost to Follow-up|4|||
155417468|NCT01262976|560958743|FG001|Up to Year 1|Lost to Follow-up|0|||
155417469|NCT01262976|560958744|FG002|Up to Year 1|Lost to Follow-up|0|||
155313056|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
155313057|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
155313058|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
155313059|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
155313060|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
155313061|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
155313062|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
155313063|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
155313064|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
155313065|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
155313066|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
155313067|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
155313068|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
155313069|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
155313070|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
155313071|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
155313072|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
155313073|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
155313074|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
155313075|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
155313076|NCT03443323|560579449|FG000|Overall Study|Lost to Follow-up|2|||
155313077|NCT03443323|560579450|FG001|Overall Study|Lost to Follow-up|2|||
155313078|NCT03443323|560579449|FG000|Overall Study|PI withdrawal|1|||
155313079|NCT03443323|560579450|FG001|Overall Study|PI withdrawal|0|||
155313080|NCT03457142|560579453|FG000|Overall Study|Death|1|||
155313081|NCT03770273|560579454|FG000|Overall Study|Adverse Event|2|||
155313082|NCT03770273|560579455|FG001|Overall Study|Adverse Event|0|||
155313083|NCT03770273|560579454|FG000|Overall Study|Lost to Follow-up|1|||
155313084|NCT03770273|560579455|FG001|Overall Study|Lost to Follow-up|1|||
155313085|NCT04060654|560579456|FG000|Overall Study|Withdrawal by Subject|1|||
155313086|NCT04060654|560579456|FG000|Overall Study|Lost to Follow-up|5|||
155313087|NCT04887129|560579457|FG000|Overall Study|Lost to Follow-up|0|||
155313088|NCT04887129|560579458|FG001|Overall Study|Lost to Follow-up|24|||
155313089|NCT04887129|560579457|FG000|Overall Study|Withdrawal by Subject|9|||
155313090|NCT04887129|560579458|FG001|Overall Study|Withdrawal by Subject|57|||
155313091|NCT04887129|560579457|FG000|Overall Study|Other|2|||
155313092|NCT04887129|560579458|FG001|Overall Study|Other|9|||
155313093|NCT04896476|560579459|FG000|Overall Study|Withdrawal by Subject|1|||
155313094|NCT04896476|560579459|FG000|Overall Study|Lost to Follow-up|2|||
155313095|NCT03476187|560579460|FG000|Overall Study|Protocol Violation|7|||
155313096|NCT03476187|560579460|FG000|Overall Study|Physician Decision|5|||
155313097|NCT03056040|560579464|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
155313098|NCT03056040|560579465|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
155313099|NCT03056040|560579464|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
155313100|NCT03056040|560579465|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
155313101|NCT03056040|560579464|FG000|Primary Evaluation Period|Pregnancy|0|||
155313102|NCT03056040|560579465|FG001|Primary Evaluation Period|Pregnancy|1|||
155313103|NCT03056040|560579464|FG000|Primary Evaluation Period|Randomized, not treated|1|||
155313104|NCT03056040|560579465|FG001|Primary Evaluation Period|Randomized, not treated|1|||
155313105|NCT03056040|560579464|FG000|Extension Period|Physician Decision|3|||
155313106|NCT03056040|560579465|FG001|Extension Period|Physician Decision|3|||
155313107|NCT03056040|560579464|FG000|Extension Period|Lost to Follow-up|0|||
155313108|NCT03056040|560579465|FG001|Extension Period|Lost to Follow-up|1|||
155313109|NCT03056040|560579464|FG000|Extension Period|Death|0|||
155313110|NCT03056040|560579465|FG001|Extension Period|Death|3|||
155313111|NCT03056040|560579464|FG000|Extension Period|Withdrawal by Subject|1|||
155313112|NCT03056040|560579465|FG001|Extension Period|Withdrawal by Subject|0|||
155313113|NCT02921230|560579466|FG000|Overall Study|Withdrawal by Subject|20|||
155313114|NCT02921230|560579467|FG001|Overall Study|Withdrawal by Subject|8|||
155313115|NCT02921230|560579466|FG000|Overall Study|Death|12|||
155313116|NCT02921230|560579467|FG001|Overall Study|Death|3|||
155313117|NCT02921230|560579466|FG000|Overall Study|Protocol Violation|17|||
155313118|NCT02921230|560579467|FG001|Overall Study|Protocol Violation|6|||
155313119|NCT02921230|560579466|FG000|Overall Study|Early completion|5|||
155313120|NCT02921230|560579467|FG001|Overall Study|Early completion|1|||
155313121|NCT02921230|560579466|FG000|Overall Study|Pending data entry|1|||
155313122|NCT02921230|560579467|FG001|Overall Study|Pending data entry|0|||
155313123|NCT04142788|560579473|FG000|Overall Study|Trial terminated prematurely|2|||
155313124|NCT04142788|560579474|FG001|Overall Study|Trial terminated prematurely|2|||
155313125|NCT03396926|560579481|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
155417470|NCT01262976|560958745|FG003|Up to Year 1|Lost to Follow-up|1|||
155417471|NCT01262976|560958746|FG004|Up to Year 1|Lost to Follow-up|6|||
155499992|NCT04071366|561255589|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
155499993|NCT04071366|561255590|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
155499994|NCT04071366|561255591|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
155499995|NCT04071366|561255587|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
155499996|NCT04071366|561255588|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
155499997|NCT04071366|561255589|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
155499998|NCT04071366|561255590|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
155499999|NCT04071366|561255591|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
155500000|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Death|0|||
155500001|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Death|0|||
155500002|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Death|0|||
155500003|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Death|2|||
155500004|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Death|2|||
155500005|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
155500006|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
155500007|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
155313126|NCT03396926|560579482|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
155313127|NCT02035787|560579483|FG000|Overall Study- 12 Months|Adverse Event|3|||
155313128|NCT02035787|560579484|FG001|Overall Study- 12 Months|Adverse Event|0|||
155313129|NCT02035787|560579483|FG000|Overall Study- 12 Months|Complete response|4|||
155313130|NCT02035787|560579484|FG001|Overall Study- 12 Months|Complete response|1|||
155313131|NCT02035787|560579483|FG000|Overall Study- 12 Months|Protocol Violation|1|||
155313132|NCT02035787|560579484|FG001|Overall Study- 12 Months|Protocol Violation|1|||
155313133|NCT03853746|560579486|FG000|Overall Study|Withdrawal by Subject|1|||
155313134|NCT01396278|560579487|FG000|Overall Study|Adverse Event|0|||
155313135|NCT01396278|560579488|FG001|Overall Study|Adverse Event|0|||
155313136|NCT01396278|560579489|FG002|Overall Study|Adverse Event|0|||
155313137|NCT01396278|560579490|FG003|Overall Study|Adverse Event|2|||
155313138|NCT01396278|560579491|FG004|Overall Study|Adverse Event|0|||
155313139|NCT01396278|560579487|FG000|Overall Study|Withdraw due to trial termination|2|||
155313140|NCT01396278|560579488|FG001|Overall Study|Withdraw due to trial termination|1|||
155313141|NCT01396278|560579489|FG002|Overall Study|Withdraw due to trial termination|1|||
155313142|NCT01396278|560579490|FG003|Overall Study|Withdraw due to trial termination|0|||
155313143|NCT01396278|560579491|FG004|Overall Study|Withdraw due to trial termination|2|||
155313144|NCT01084876|560579493|FG000|Main Study Treatment Period|Adverse Event|12|||
155313145|NCT01084876|560579494|FG001|Main Study Treatment Period|Adverse Event|7|||
155313146|NCT01084876|560579493|FG000|Main Study Treatment Period|Disease Progression|41|||
155313147|NCT01084876|560579494|FG001|Main Study Treatment Period|Disease Progression|24|||
155313148|NCT01084876|560579493|FG000|Main Study Treatment Period|Physician Decision|2|||
155313149|NCT01084876|560579494|FG001|Main Study Treatment Period|Physician Decision|0|||
155313150|NCT01084876|560579493|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
155313151|NCT01084876|560579494|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
155313152|NCT01084876|560579493|FG000|Main Study Treatment Period|Other Reason|0|||
155313153|NCT01084876|560579494|FG001|Main Study Treatment Period|Other Reason|1|||
155313154|NCT01084876|560579493|FG000|Main Study Treatment Period|Other|0|||
155313155|NCT01084876|560579494|FG001|Main Study Treatment Period|Other|1|||
155313156|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
155313157|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
155313158|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
155313159|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
155313160|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
155313161|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
155313162|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
155313163|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
155313164|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
155313165|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
155313166|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Other|6|||
155313167|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Other|9|||
155313168|NCT04727554|560579495|FG000|Overall Study|Lost to Follow-up|0|||
155313169|NCT04727554|560579496|FG001|Overall Study|Lost to Follow-up|1|||
155313170|NCT04727554|560579495|FG000|Overall Study|Death|2|||
155313171|NCT04727554|560579496|FG001|Overall Study|Death|6|||
155313172|NCT04727554|560579495|FG000|Overall Study|Withdrawal by Subject|1|||
155313173|NCT04727554|560579496|FG001|Overall Study|Withdrawal by Subject|0|||
155313174|NCT00999804|560579497|FG000|Overall Study|Lack of Efficacy|9|||
155313175|NCT00999804|560579498|FG001|Overall Study|Lack of Efficacy|2|||
155313176|NCT00999804|560579497|FG000|Overall Study|Adverse Event|4|||
155313177|NCT00999804|560579498|FG001|Overall Study|Adverse Event|3|||
155313178|NCT00999804|560579497|FG000|Overall Study|Withdrawal by Subject|4|||
155313179|NCT00999804|560579498|FG001|Overall Study|Withdrawal by Subject|0|||
155313180|NCT00999804|560579497|FG000|Overall Study|Death|1|||
155313181|NCT00999804|560579498|FG001|Overall Study|Death|0|||
155313182|NCT00999804|560579497|FG000|Overall Study|Ineligible|3|||
155313183|NCT00999804|560579498|FG001|Overall Study|Ineligible|0|||
155313184|NCT05028634|560579499|FG000|Overall Study|Withdrawal by Subject|0|||
155313185|NCT05028634|560579500|FG001|Overall Study|Withdrawal by Subject|1|||
155313186|NCT05653427|560579501|FG000|Overall Study|Study Terminated by Sponsor|13|||
155313187|NCT05311384|560579505|FG000|Overall Study|Uncontrolled health conditions|2|||
155313188|NCT05311384|560579505|FG000|Overall Study|Withdrawal by Subject|1|||
155313189|NCT04256941|560579508|FG000|Overall Study|Withdrawal by Subject|0|||
155417472|NCT01262976|560958747|FG005|Up to Year 1|Lost to Follow-up|5|||
155417473|NCT01262976|560958742|FG000|Up to Year 1|Other|3|||
155313190|NCT04256941|560579509|FG001|Overall Study|Withdrawal by Subject|1|||
155417474|NCT01262976|560958743|FG001|Up to Year 1|Other|1|||
155417475|NCT01262976|560958744|FG002|Up to Year 1|Other|0|||
155417476|NCT01262976|560958745|FG003|Up to Year 1|Other|0|||
155417477|NCT01262976|560958746|FG004|Up to Year 1|Other|2|||
155417478|NCT01262976|560958747|FG005|Up to Year 1|Other|1|||
155313191|NCT04256941|560579508|FG000|Overall Study|Death|1|||
155313192|NCT04256941|560579509|FG001|Overall Study|Death|0|||
155313193|NCT04256941|560579508|FG000|Overall Study|Disease Progession|0|||
155313194|NCT04256941|560579509|FG001|Overall Study|Disease Progession|2|||
155313195|NCT02724631|560579522|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
155313196|NCT05076708|560579523|FG000|Overall Study|Withdrawal by Subject|4|||
155313197|NCT05076708|560579523|FG000|Overall Study|Lost to study during switch phase|8|||
155313198|NCT05590403|560579524|FG000|Overall Study|Lost to Follow-up|13|||
155313199|NCT05590403|560579525|FG001|Overall Study|Lost to Follow-up|1|||
155313200|NCT05590403|560579526|FG002|Overall Study|Lost to Follow-up|7|||
155313201|NCT05590403|560579527|FG003|Overall Study|Lost to Follow-up|3|||
155313202|NCT05590403|560579528|FG004|Overall Study|Lost to Follow-up|4|||
155313203|NCT05590403|560579524|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
155313204|NCT05590403|560579525|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
155313205|NCT05590403|560579526|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
155313206|NCT05590403|560579527|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
155313207|NCT05590403|560579528|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
155313208|NCT05590403|560579524|FG000|Overall Study|Other|2|||
155313209|NCT05590403|560579525|FG001|Overall Study|Other|0|||
155313210|NCT05590403|560579526|FG002|Overall Study|Other|2|||
155313211|NCT05590403|560579527|FG003|Overall Study|Other|2|||
155313212|NCT05590403|560579528|FG004|Overall Study|Other|0|||
155313213|NCT05590403|560579524|FG000|Overall Study|Migrated / moved from the study area|1|||
155313214|NCT05590403|560579525|FG001|Overall Study|Migrated / moved from the study area|1|||
155313215|NCT05590403|560579526|FG002|Overall Study|Migrated / moved from the study area|0|||
155313216|NCT05590403|560579527|FG003|Overall Study|Migrated / moved from the study area|3|||
155313217|NCT05590403|560579528|FG004|Overall Study|Migrated / moved from the study area|1|||
155313218|NCT05590403|560579524|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
155313219|NCT05590403|560579525|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
155313220|NCT05590403|560579526|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
155313221|NCT05590403|560579527|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
155313222|NCT05590403|560579528|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
155313223|NCT04971395|560579534|FG000|Overall Study|Withdrawal by Subject|0|||
155313224|NCT04971395|560579535|FG001|Overall Study|Withdrawal by Subject|1|||
155313225|NCT04971395|560579536|FG002|Overall Study|Withdrawal by Subject|0|||
155313226|NCT04717492|560579537|FG000|Overall Study|Withdrawal by Subject|2|||
155313227|NCT04717492|560579538|FG001|Overall Study|Withdrawal by Subject|13|||
155313228|NCT04717492|560579537|FG000|Overall Study|Lost to Follow-up|2|||
155313229|NCT04717492|560579538|FG001|Overall Study|Lost to Follow-up|9|||
155313230|NCT03766009|560579542|FG000|Usual Care|Death|0|||
155313231|NCT03766009|560579543|FG001|Usual Care|Death|0|||
155313232|NCT03766009|560579544|FG002|Usual Care|Death|0|||
155417479|NCT01262976|560958742|FG000|Up to Year 1|Subjects with unknown completion status|0|||
155417480|NCT01262976|560958743|FG001|Up to Year 1|Subjects with unknown completion status|0|||
155417481|NCT01262976|560958744|FG002|Up to Year 1|Subjects with unknown completion status|1|||
155417482|NCT01262976|560958745|FG003|Up to Year 1|Subjects with unknown completion status|0|||
155417483|NCT01262976|560958746|FG004|Up to Year 1|Subjects with unknown completion status|0|||
155417484|NCT01262976|560958747|FG005|Up to Year 1|Subjects with unknown completion status|1|||
155417485|NCT01262976|560958742|FG000|Up to Year 2|Serious Adverse Event|0|||
155417486|NCT01262976|560958743|FG001|Up to Year 2|Serious Adverse Event|0|||
155417487|NCT01262976|560958744|FG002|Up to Year 2|Serious Adverse Event|2|||
155417488|NCT01262976|560958745|FG003|Up to Year 2|Serious Adverse Event|0|||
155417489|NCT01262976|560958746|FG004|Up to Year 2|Serious Adverse Event|0|||
155417490|NCT01262976|560958747|FG005|Up to Year 2|Serious Adverse Event|0|||
155417491|NCT01262976|560958742|FG000|Up to Year 2|Withdrawal by Subject|1|||
155417492|NCT01262976|560958743|FG001|Up to Year 2|Withdrawal by Subject|0|||
155417493|NCT01262976|560958744|FG002|Up to Year 2|Withdrawal by Subject|0|||
155417494|NCT01262976|560958745|FG003|Up to Year 2|Withdrawal by Subject|0|||
155417495|NCT01262976|560958746|FG004|Up to Year 2|Withdrawal by Subject|0|||
155417496|NCT01262976|560958747|FG005|Up to Year 2|Withdrawal by Subject|0|||
155417497|NCT01262976|560958742|FG000|Up to Year 2|Migrated/moved from study area|0|||
155417498|NCT01262976|560958743|FG001|Up to Year 2|Migrated/moved from study area|0|||
155417499|NCT01262976|560958744|FG002|Up to Year 2|Migrated/moved from study area|0|||
155417500|NCT01262976|560958745|FG003|Up to Year 2|Migrated/moved from study area|2|||
155417501|NCT01262976|560958746|FG004|Up to Year 2|Migrated/moved from study area|1|||
155417502|NCT01262976|560958747|FG005|Up to Year 2|Migrated/moved from study area|2|||
155500008|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
155500009|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
155500010|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
155313233|NCT03766009|560579545|FG003|Usual Care|Death|1|||
155313234|NCT03766009|560579546|FG004|Usual Care|Death|0|||
155313235|NCT03766009|560579547|FG005|Usual Care|Death|0|||
155313236|NCT03766009|560579542|FG000|Usual Care|Lost to Follow-up|0|||
155500011|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
155313237|NCT03766009|560579543|FG001|Usual Care|Lost to Follow-up|0|||
155313238|NCT03766009|560579544|FG002|Usual Care|Lost to Follow-up|0|||
155313239|NCT03766009|560579545|FG003|Usual Care|Lost to Follow-up|1|||
155500012|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
155500013|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
155500014|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
155500015|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
155500016|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
155500017|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
155500018|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
155500019|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
155500020|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
155500021|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
155500022|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
155500023|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
155500024|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
155500025|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
155500026|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
155500027|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
155500028|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
155500029|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
155500030|NCT04071366|561255587|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
155500031|NCT04071366|561255588|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
155500032|NCT04071366|561255589|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
155500033|NCT04071366|561255590|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
155500034|NCT04071366|561255591|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
155500035|NCT02239692|561255592|FG000|Overall Study|Incomplete colonoscopy|1|||
155500036|NCT02239692|561255593|FG001|Overall Study|Incomplete colonoscopy|2|||
155500037|NCT02239692|561255592|FG000|Overall Study|Adverse Event|0|||
155500038|NCT02239692|561255593|FG001|Overall Study|Adverse Event|1|||
155500039|NCT02239692|561255592|FG000|Overall Study|Physician Decision|0|||
155500040|NCT02239692|561255593|FG001|Overall Study|Physician Decision|1|||
155500041|NCT02239692|561255592|FG000|Overall Study|Lost to Follow-up|1|||
155500042|NCT02239692|561255593|FG001|Overall Study|Lost to Follow-up|4|||
155500043|NCT02239692|561255592|FG000|Overall Study|Withdrawal by Subject|3|||
155500044|NCT02239692|561255593|FG001|Overall Study|Withdrawal by Subject|5|||
155500045|NCT02239692|561255592|FG000|Overall Study|Other reason|1|||
155500046|NCT02239692|561255593|FG001|Overall Study|Other reason|0|||
155500047|NCT04318535|561255594|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
155500048|NCT04318535|561255595|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
155500049|NCT04318535|561255596|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
155500050|NCT01678924|561255597|FG000|Overall Study|Adverse Event|1|||
155500051|NCT01678924|561255598|FG001|Overall Study|Adverse Event|1|||
155500052|NCT01678924|561255599|FG002|Overall Study|Adverse Event|0|||
155500053|NCT01678924|561255600|FG003|Overall Study|Adverse Event|1|||
155500054|NCT01678924|561255597|FG000|Overall Study|Lack of Efficacy|7|||
155500055|NCT01678924|561255598|FG001|Overall Study|Lack of Efficacy|2|||
155500056|NCT01678924|561255599|FG002|Overall Study|Lack of Efficacy|0|||
155500057|NCT01678924|561255600|FG003|Overall Study|Lack of Efficacy|5|||
155500058|NCT01678924|561255597|FG000|Overall Study|Lost to Follow-up|0|||
155500059|NCT01678924|561255598|FG001|Overall Study|Lost to Follow-up|4|||
155500060|NCT01678924|561255599|FG002|Overall Study|Lost to Follow-up|0|||
155500061|NCT01678924|561255600|FG003|Overall Study|Lost to Follow-up|2|||
155500062|NCT01678924|561255597|FG000|Overall Study|Personal Reasons|2|||
155500063|NCT01678924|561255598|FG001|Overall Study|Personal Reasons|2|||
155500064|NCT01678924|561255599|FG002|Overall Study|Personal Reasons|2|||
155500065|NCT01678924|561255600|FG003|Overall Study|Personal Reasons|7|||
155500066|NCT01678924|561255597|FG000|Overall Study|Withdrawal by Subject|0|||
155500067|NCT01678924|561255598|FG001|Overall Study|Withdrawal by Subject|3|||
155500068|NCT01678924|561255599|FG002|Overall Study|Withdrawal by Subject|0|||
155500069|NCT01678924|561255600|FG003|Overall Study|Withdrawal by Subject|2|||
155500070|NCT01678924|561255597|FG000|Overall Study|Unable to attend scheduled visits|0|||
155500071|NCT01678924|561255598|FG001|Overall Study|Unable to attend scheduled visits|0|||
155500072|NCT01678924|561255599|FG002|Overall Study|Unable to attend scheduled visits|0|||
155500073|NCT01678924|561255600|FG003|Overall Study|Unable to attend scheduled visits|1|||
155500074|NCT02156466|561255605|FG000|Overall Study|Adverse Event|0|||
155500075|NCT02156466|561255606|FG001|Overall Study|Adverse Event|0|||
155500076|NCT02156466|561255607|FG002|Overall Study|Adverse Event|1|||
155500077|NCT02156466|561255608|FG003|Overall Study|Adverse Event|1|||
155500078|NCT02156466|561255609|FG004|Overall Study|Adverse Event|0|||
155500079|NCT02156466|561255605|FG000|Overall Study|Quantiferon Positivity|0|||
155500080|NCT02156466|561255606|FG001|Overall Study|Quantiferon Positivity|0|||
155500081|NCT02156466|561255607|FG002|Overall Study|Quantiferon Positivity|0|||
155500082|NCT02156466|561255608|FG003|Overall Study|Quantiferon Positivity|1|||
155500083|NCT02156466|561255609|FG004|Overall Study|Quantiferon Positivity|0|||
155500084|NCT01784419|561255610|FG000|Overall Study|Adverse Event|3|||
155313240|NCT03766009|560579546|FG004|Usual Care|Lost to Follow-up|0|||
155313241|NCT03766009|560579547|FG005|Usual Care|Lost to Follow-up|0|||
155313242|NCT03766009|560579542|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313243|NCT03766009|560579543|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313244|NCT03766009|560579544|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
155313245|NCT03766009|560579545|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313246|NCT03766009|560579546|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
155313247|NCT03766009|560579547|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313248|NCT03766009|560579542|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313249|NCT03766009|560579543|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
155313250|NCT03766009|560579544|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313251|NCT03766009|560579545|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
155313252|NCT03766009|560579546|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313253|NCT03766009|560579547|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313254|NCT03766009|560579542|FG000|Usual Care|No treatment or declined surgery|0|||
155313255|NCT03766009|560579543|FG001|Usual Care|No treatment or declined surgery|0|||
155313256|NCT03766009|560579544|FG002|Usual Care|No treatment or declined surgery|0|||
155313257|NCT03766009|560579545|FG003|Usual Care|No treatment or declined surgery|2|||
155313258|NCT03766009|560579546|FG004|Usual Care|No treatment or declined surgery|0|||
155313259|NCT03766009|560579547|FG005|Usual Care|No treatment or declined surgery|0|||
155313260|NCT03766009|560579542|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
155313261|NCT03766009|560579543|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
155313262|NCT03766009|560579544|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
155313263|NCT03766009|560579545|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
155313264|NCT03766009|560579546|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
155313265|NCT03766009|560579547|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
155313266|NCT03766009|560579542|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313267|NCT03766009|560579543|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
155313268|NCT03766009|560579544|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313269|NCT03766009|560579545|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313270|NCT03766009|560579546|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313271|NCT03766009|560579547|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313272|NCT03766009|560579542|FG000|Usual Care|Ineligible|0|||
155313273|NCT03766009|560579543|FG001|Usual Care|Ineligible|1|||
155313274|NCT03766009|560579544|FG002|Usual Care|Ineligible|0|||
155313275|NCT03766009|560579545|FG003|Usual Care|Ineligible|0|||
155313276|NCT03766009|560579546|FG004|Usual Care|Ineligible|0|||
155313277|NCT03766009|560579547|FG005|Usual Care|Ineligible|0|||
155313278|NCT03766009|560579542|FG000|Usual Care|Other: Staff turnover|0|||
155313279|NCT03766009|560579543|FG001|Usual Care|Other: Staff turnover|0|||
155313280|NCT03766009|560579544|FG002|Usual Care|Other: Staff turnover|0|||
155313281|NCT03766009|560579545|FG003|Usual Care|Other: Staff turnover|0|||
155313282|NCT03766009|560579546|FG004|Usual Care|Other: Staff turnover|0|||
155313283|NCT03766009|560579547|FG005|Usual Care|Other: Staff turnover|2|||
155313284|NCT02924272|560579549|FG000|Overall Study|Site Terminated by Sponsor|4|||
155313285|NCT02924272|560579550|FG001|Overall Study|Site Terminated by Sponsor|1|||
155313286|NCT02924272|560579549|FG000|Overall Study|Withdrawal by Subject|2|||
155313287|NCT02924272|560579550|FG001|Overall Study|Withdrawal by Subject|0|||
155313288|NCT02924272|560579549|FG000|Overall Study|Adverse Event|3|||
155313289|NCT02924272|560579550|FG001|Overall Study|Adverse Event|0|||
155313290|NCT02924272|560579549|FG000|Overall Study|Progressive Disease|11|||
155313291|NCT02924272|560579550|FG001|Overall Study|Progressive Disease|8|||
155313292|NCT02924272|560579549|FG000|Overall Study|Clinical Deterioration|1|||
155313293|NCT02924272|560579550|FG001|Overall Study|Clinical Deterioration|0|||
155313294|NCT02924272|560579549|FG000|Overall Study|Death|1|||
155313295|NCT02924272|560579550|FG001|Overall Study|Death|0|||
155313296|NCT02924272|560579549|FG000|Overall Study|Reason Not Specified|1|||
155313297|NCT02924272|560579550|FG001|Overall Study|Reason Not Specified|0|||
155313298|NCT03575897|560579553|FG000|Overall Study|Lost to Follow-up|12|||
155313299|NCT03575897|560579554|FG001|Overall Study|Lost to Follow-up|13|||
155313300|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
155313301|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
155313302|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
155313303|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
155313304|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
155313305|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
155313306|NCT05116787|560579560|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
155417503|NCT01262976|560958742|FG000|Up to Year 2|Lost to Follow-up|1|||
155751022|NCT05952401|562187226|FG001|Overall Study|Lost to Follow-up|1|||
155313307|NCT05116787|560579561|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
155313308|NCT02737436|560579562|FG000|Washout Period|Lost to Follow-up|5|||
155313309|NCT02737436|560579563|FG001|Washout Period|Lost to Follow-up|11|||
155313310|NCT02737436|560579562|FG000|Data Analysis|Scanning data problems|5|||
155313311|NCT02737436|560579563|FG001|Data Analysis|Scanning data problems|8|||
155313312|NCT02919683|560579564|FG000|Post-Surgery Follow-Up|Death|2|||
155313313|NCT02919683|560579565|FG001|Post-Surgery Follow-Up|Death|2|||
155313314|NCT02919683|560579564|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
155313315|NCT02919683|560579565|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
155313316|NCT05551637|560579568|FG000|Overall Study|Lack of Efficacy|0|||
155313317|NCT05551637|560579569|FG001|Overall Study|Lack of Efficacy|6|||
155313318|NCT05551637|560579568|FG000|Overall Study|Lost to Follow-up|1|||
155313319|NCT05551637|560579569|FG001|Overall Study|Lost to Follow-up|1|||
155313320|NCT05179837|560579572|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
155313321|NCT05179837|560579572|FG000|Overall Study|Device malfunctioned|1|||
155313322|NCT05179837|560579572|FG000|Overall Study|Image quality too low|2|||
155313323|NCT05051124|560579573|FG000|Overall Study|Lost to Follow-up|2|||
155313324|NCT05051124|560579573|FG000|Overall Study|Withdrawal by Subject|1|||
155313325|NCT05051124|560579573|FG000|Overall Study|Residential relocation|2|||
155313326|NCT05051124|560579573|FG000|Overall Study|Death|1|||
155313327|NCT04782973|560579574|FG000|Overall Study|Withdrawal by Subject|5|||
155313328|NCT04782973|560579574|FG000|Overall Study|Protocol Violation|6|||
155313329|NCT04782973|560579574|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
155313330|NCT03307343|560579575|FG000|Overall Study|Withdrawal by Subject|1|||
155313331|NCT03307343|560579576|FG001|Overall Study|Withdrawal by Subject|2|||
155313332|NCT03307343|560579575|FG000|Overall Study|Pregnancy|0|||
155313333|NCT03307343|560579576|FG001|Overall Study|Pregnancy|2|||
155313334|NCT03307343|560579575|FG000|Overall Study|Physician Decision|1|||
155313335|NCT03307343|560579576|FG001|Overall Study|Physician Decision|0|||
155313336|NCT03307343|560579575|FG000|Overall Study|Lost to Follow-up|0|||
155313337|NCT03307343|560579576|FG001|Overall Study|Lost to Follow-up|2|||
155313338|NCT05364671|560579579|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
155313339|NCT05364671|560579580|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
155313340|NCT05364671|560579579|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
155313341|NCT05364671|560579580|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
155313342|NCT05364671|560579579|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
155313343|NCT05364671|560579580|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
155313344|NCT05364671|560579579|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
155313345|NCT05364671|560579580|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
155313346|NCT05364671|560579579|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
155313347|NCT05364671|560579580|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
155313348|NCT03536754|560579581|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
155313349|NCT03536754|560579582|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
155313350|NCT03536754|560579583|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
155313351|NCT03536754|560579584|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
155313352|NCT03536754|560579585|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
155313353|NCT03536754|560579581|FG000|Open Label Extension|Other|0|||
155313354|NCT03536754|560579582|FG001|Open Label Extension|Other|0|||
155313355|NCT03536754|560579583|FG002|Open Label Extension|Other|0|||
155313356|NCT03536754|560579584|FG003|Open Label Extension|Other|0|||
155313357|NCT03536754|560579585|FG004|Open Label Extension|Other|1|||
155313358|NCT03382652|560579588|FG000|Overall Study|Lost to Follow-up|6|||
155313359|NCT03382652|560579588|FG000|Overall Study|Death|4|||
155313360|NCT03382652|560579588|FG000|Overall Study|Revision|5|||
155313361|NCT03382652|560579588|FG000|Overall Study|Patient withdrew|3|||
155313362|NCT03382652|560579588|FG000|Overall Study|Other reasons|21|||
155313363|NCT04810650|560579590|FG000|Overall Study|Disenrolled in error|0|||
155313364|NCT04810650|560579591|FG001|Overall Study|Disenrolled in error|0|||
155313365|NCT04810650|560579592|FG002|Overall Study|Disenrolled in error|0|||
155313366|NCT04810650|560579593|FG003|Overall Study|Disenrolled in error|0|||
155313367|NCT04810650|560579594|FG004|Overall Study|Disenrolled in error|0|||
155313368|NCT04810650|560579595|FG005|Overall Study|Disenrolled in error|0|||
155313369|NCT04810650|560579596|FG006|Overall Study|Disenrolled in error|0|||
155313370|NCT04810650|560579597|FG007|Overall Study|Disenrolled in error|0|||
155313371|NCT04810650|560579598|FG008|Overall Study|Disenrolled in error|1|||
155313372|NCT04810650|560579599|FG009|Overall Study|Disenrolled in error|0|||
155313373|NCT04810650|560579600|FG010|Overall Study|Disenrolled in error|0|||
155313374|NCT04810650|560579601|FG011|Overall Study|Disenrolled in error|0|||
155313375|NCT04810650|560579602|FG012|Overall Study|Disenrolled in error|0|||
155313376|NCT04810650|560579603|FG013|Overall Study|Disenrolled in error|0|||
155313377|NCT04810650|560579590|FG000|Overall Study|Death|0|||
155313378|NCT04810650|560579591|FG001|Overall Study|Death|0|||
155313379|NCT04810650|560579592|FG002|Overall Study|Death|0|||
155417504|NCT01262976|560958743|FG001|Up to Year 2|Lost to Follow-up|1|||
155417505|NCT01262976|560958744|FG002|Up to Year 2|Lost to Follow-up|2|||
155417506|NCT01262976|560958745|FG003|Up to Year 2|Lost to Follow-up|2|||
155417507|NCT01262976|560958746|FG004|Up to Year 2|Lost to Follow-up|3|||
155417508|NCT01262976|560958747|FG005|Up to Year 2|Lost to Follow-up|3|||
155417509|NCT01262976|560958742|FG000|Up to Year 2|Subjects with unknown completion status|0|||
155417510|NCT01262976|560958743|FG001|Up to Year 2|Subjects with unknown completion status|0|||
155417511|NCT01262976|560958744|FG002|Up to Year 2|Subjects with unknown completion status|1|||
155313380|NCT04810650|560579593|FG003|Overall Study|Death|0|||
155313381|NCT04810650|560579594|FG004|Overall Study|Death|0|||
155313382|NCT04810650|560579595|FG005|Overall Study|Death|0|||
155313383|NCT04810650|560579596|FG006|Overall Study|Death|2|||
155313384|NCT04810650|560579597|FG007|Overall Study|Death|2|||
155313385|NCT04810650|560579598|FG008|Overall Study|Death|0|||
155313386|NCT04810650|560579599|FG009|Overall Study|Death|1|||
155313387|NCT04810650|560579600|FG010|Overall Study|Death|0|||
155313388|NCT04810650|560579601|FG011|Overall Study|Death|0|||
155313389|NCT04810650|560579602|FG012|Overall Study|Death|2|||
155313390|NCT04810650|560579603|FG013|Overall Study|Death|1|||
155313391|NCT04810650|560579590|FG000|Overall Study|Moved/transferred care|0|||
155417512|NCT01262976|560958745|FG003|Up to Year 2|Subjects with unknown completion status|0|||
155417513|NCT01262976|560958746|FG004|Up to Year 2|Subjects with unknown completion status|0|||
155417514|NCT01262976|560958747|FG005|Up to Year 2|Subjects with unknown completion status|0|||
155417515|NCT01262976|560958742|FG000|Up to Year 2|Other|3|||
155417516|NCT01262976|560958743|FG001|Up to Year 2|Other|0|||
155417517|NCT01262976|560958744|FG002|Up to Year 2|Other|0|||
155417518|NCT01262976|560958745|FG003|Up to Year 2|Other|0|||
155417519|NCT01262976|560958746|FG004|Up to Year 2|Other|0|||
155313392|NCT04810650|560579591|FG001|Overall Study|Moved/transferred care|0|||
155313393|NCT04810650|560579592|FG002|Overall Study|Moved/transferred care|0|||
155313394|NCT04810650|560579593|FG003|Overall Study|Moved/transferred care|0|||
155313395|NCT04810650|560579594|FG004|Overall Study|Moved/transferred care|0|||
155313396|NCT04810650|560579595|FG005|Overall Study|Moved/transferred care|0|||
155313397|NCT04810650|560579596|FG006|Overall Study|Moved/transferred care|0|||
155313398|NCT04810650|560579597|FG007|Overall Study|Moved/transferred care|1|||
155313399|NCT04810650|560579598|FG008|Overall Study|Moved/transferred care|12|||
155313400|NCT04810650|560579599|FG009|Overall Study|Moved/transferred care|10|||
155313401|NCT04810650|560579600|FG010|Overall Study|Moved/transferred care|0|||
155313402|NCT04810650|560579601|FG011|Overall Study|Moved/transferred care|0|||
155313403|NCT04810650|560579602|FG012|Overall Study|Moved/transferred care|0|||
155313404|NCT04810650|560579603|FG013|Overall Study|Moved/transferred care|0|||
155313405|NCT04810650|560579590|FG000|Overall Study|Lost to Follow-up|15|||
155313406|NCT04810650|560579591|FG001|Overall Study|Lost to Follow-up|12|||
155313407|NCT04810650|560579592|FG002|Overall Study|Lost to Follow-up|7|||
155313408|NCT04810650|560579593|FG003|Overall Study|Lost to Follow-up|9|||
155313409|NCT04810650|560579594|FG004|Overall Study|Lost to Follow-up|10|||
155313410|NCT04810650|560579595|FG005|Overall Study|Lost to Follow-up|6|||
155313411|NCT04810650|560579596|FG006|Overall Study|Lost to Follow-up|0|||
155500085|NCT00080288|561255611|FG000|Overall Study|Adverse Event|7|||
155500086|NCT00080288|561255612|FG001|Overall Study|Adverse Event|4|||
155313412|NCT04810650|560579597|FG007|Overall Study|Lost to Follow-up|0|||
155313413|NCT04810650|560579598|FG008|Overall Study|Lost to Follow-up|0|||
155313414|NCT04810650|560579599|FG009|Overall Study|Lost to Follow-up|0|||
155417520|NCT01262976|560958747|FG005|Up to Year 2|Other|0|||
155417521|NCT01262976|560958742|FG000|Up to Year 3|Serious Adverse Event|0|||
155417522|NCT01262976|560958743|FG001|Up to Year 3|Serious Adverse Event|0|||
155417523|NCT01262976|560958744|FG002|Up to Year 3|Serious Adverse Event|2|||
155417524|NCT01262976|560958745|FG003|Up to Year 3|Serious Adverse Event|0|||
155417525|NCT01262976|560958746|FG004|Up to Year 3|Serious Adverse Event|0|||
155417526|NCT01262976|560958747|FG005|Up to Year 3|Serious Adverse Event|0|||
155417527|NCT01262976|560958742|FG000|Up to Year 3|Withdrawal by Subject|1|||
155417528|NCT01262976|560958743|FG001|Up to Year 3|Withdrawal by Subject|0|||
155417529|NCT01262976|560958744|FG002|Up to Year 3|Withdrawal by Subject|0|||
155417530|NCT01262976|560958745|FG003|Up to Year 3|Withdrawal by Subject|0|||
155417531|NCT01262976|560958746|FG004|Up to Year 3|Withdrawal by Subject|0|||
155417532|NCT01262976|560958747|FG005|Up to Year 3|Withdrawal by Subject|0|||
155417533|NCT01262976|560958742|FG000|Up to Year 3|Migrated/moved from study area|0|||
155417534|NCT01262976|560958743|FG001|Up to Year 3|Migrated/moved from study area|0|||
155417535|NCT01262976|560958744|FG002|Up to Year 3|Migrated/moved from study area|0|||
155500087|NCT00080288|561255611|FG000|Overall Study|Lost to Follow-up|3|||
155500088|NCT00080288|561255612|FG001|Overall Study|Lost to Follow-up|5|||
155313415|NCT04810650|560579600|FG010|Overall Study|Lost to Follow-up|1|||
155417536|NCT01262976|560958745|FG003|Up to Year 3|Migrated/moved from study area|2|||
155313416|NCT04810650|560579601|FG011|Overall Study|Lost to Follow-up|0|||
155417537|NCT01262976|560958746|FG004|Up to Year 3|Migrated/moved from study area|1|||
155500089|NCT00080288|561255611|FG000|Overall Study|Physician Decision|6|||
155313417|NCT04810650|560579602|FG012|Overall Study|Lost to Follow-up|3|||
155313418|NCT04810650|560579603|FG013|Overall Study|Lost to Follow-up|9|||
155313419|NCT04810650|560579590|FG000|Overall Study|Participant declined|0|||
155313420|NCT04810650|560579591|FG001|Overall Study|Participant declined|0|||
155313421|NCT04810650|560579592|FG002|Overall Study|Participant declined|0|||
155313422|NCT04810650|560579593|FG003|Overall Study|Participant declined|0|||
155417538|NCT01262976|560958747|FG005|Up to Year 3|Migrated/moved from study area|1|||
155313423|NCT04810650|560579594|FG004|Overall Study|Participant declined|0|||
155313424|NCT04810650|560579595|FG005|Overall Study|Participant declined|0|||
155313425|NCT04810650|560579596|FG006|Overall Study|Participant declined|0|||
155417539|NCT01262976|560958742|FG000|Up to Year 3|Lost to Follow-up|2|||
155417540|NCT01262976|560958743|FG001|Up to Year 3|Lost to Follow-up|2|||
155417541|NCT01262976|560958744|FG002|Up to Year 3|Lost to Follow-up|4|||
155417542|NCT01262976|560958745|FG003|Up to Year 3|Lost to Follow-up|3|||
155417543|NCT01262976|560958746|FG004|Up to Year 3|Lost to Follow-up|1|||
155417544|NCT01262976|560958747|FG005|Up to Year 3|Lost to Follow-up|3|||
155417545|NCT01262976|560958742|FG000|Up to Year 3|Subjects with unknown completion status|0|||
155417546|NCT01262976|560958743|FG001|Up to Year 3|Subjects with unknown completion status|0|||
155500090|NCT00080288|561255612|FG001|Overall Study|Physician Decision|2|||
155500091|NCT00080288|561255611|FG000|Overall Study|Withdrawal by Subject|3|||
155500092|NCT00080288|561255612|FG001|Overall Study|Withdrawal by Subject|16|||
155500093|NCT00080288|561255611|FG000|Overall Study|Miscellaneous|11|||
155500094|NCT00080288|561255612|FG001|Overall Study|Miscellaneous|11|||
155500095|NCT02253654|561255613|FG000|Overall Study|Withdrawal by Subject|12|||
155500096|NCT02253654|561255614|FG001|Overall Study|Withdrawal by Subject|4|||
155500097|NCT02253654|561255613|FG000|Overall Study|Decision by Sponsor|1|||
155500098|NCT02253654|561255614|FG001|Overall Study|Decision by Sponsor|1|||
155500099|NCT02253654|561255613|FG000|Overall Study|Lost to Follow-up|2|||
155500100|NCT02253654|561255614|FG001|Overall Study|Lost to Follow-up|5|||
155417547|NCT01262976|560958744|FG002|Up to Year 3|Subjects with unknown completion status|1|||
155417548|NCT01262976|560958745|FG003|Up to Year 3|Subjects with unknown completion status|0|||
155417549|NCT01262976|560958746|FG004|Up to Year 3|Subjects with unknown completion status|0|||
155417550|NCT01262976|560958747|FG005|Up to Year 3|Subjects with unknown completion status|0|||
155417551|NCT01262976|560958742|FG000|Up to Year 3|Other|3|||
155417552|NCT01262976|560958743|FG001|Up to Year 3|Other|0|||
155417553|NCT01262976|560958744|FG002|Up to Year 3|Other|0|||
155417554|NCT01262976|560958745|FG003|Up to Year 3|Other|0|||
155417555|NCT01262976|560958746|FG004|Up to Year 3|Other|0|||
155417556|NCT01262976|560958747|FG005|Up to Year 3|Other|0|||
155417557|NCT01528787|560958748|FG000|Overall Study|Withdrawal by Subject|0|||
155417558|NCT01528787|560958749|FG001|Overall Study|Withdrawal by Subject|0|||
155417559|NCT01528787|560958750|FG002|Overall Study|Withdrawal by Subject|0|||
155417560|NCT01528787|560958751|FG003|Overall Study|Withdrawal by Subject|1|||
155417561|NCT01528787|560958748|FG000|Overall Study|Family Emergency|0|||
155417562|NCT01528787|560958749|FG001|Overall Study|Family Emergency|0|||
155417563|NCT01528787|560958750|FG002|Overall Study|Family Emergency|1|||
155417564|NCT01528787|560958751|FG003|Overall Study|Family Emergency|0|||
155417565|NCT03433781|560958754|FG000|Overall Study|Progression of Disease|1|||
155417566|NCT03433781|560958755|FG001|Overall Study|Progression of Disease|0|||
155417567|NCT03433781|560958756|FG002|Overall Study|Progression of Disease|0|||
155417568|NCT03433781|560958754|FG000|Overall Study|Physician Decision|0|||
155417569|NCT03433781|560958755|FG001|Overall Study|Physician Decision|1|||
155417570|NCT03433781|560958756|FG002|Overall Study|Physician Decision|0|||
155417571|NCT00797823|560958757|FG000|First Period (Initial Randomization)|Physician Decision|1|||
155417572|NCT00797823|560958758|FG001|First Period (Initial Randomization)|Physician Decision|0|||
155417573|NCT00797823|560958759|FG002|First Period (Initial Randomization)|Physician Decision|0|||
155417574|NCT02809833|560958760|FG000|Overall Study|Death|3|||
155417575|NCT02809833|560958760|FG000|Overall Study|Intolerance|54|||
155417576|NCT02809833|560958760|FG000|Overall Study|Lack of Efficacy|89|||
155417577|NCT02809833|560958760|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
155417578|NCT02809833|560958760|FG000|Overall Study|Noncompliance|1|||
155417579|NCT02809833|560958760|FG000|Overall Study|Withdrawal by Subject|34|||
155417580|NCT02809833|560958760|FG000|Overall Study|Lost to Follow-up|35|||
155417581|NCT02809833|560958760|FG000|Overall Study|Adverse Event (AE)|24|||
155417582|NCT02809833|560958760|FG000|Overall Study|Other|5|||
155417583|NCT02809833|560958760|FG000|Overall Study|Missing Information|52|||
155417584|NCT00408694|560958761|FG000|Overall Study|Ineligible|1|||
155417585|NCT00408694|560958761|FG000|Overall Study|No protocol treatment|1|||
155417586|NCT03261531|560958764|FG000|Overall Study|Withdrawal by Subject|4|||
155417587|NCT01700192|560958765|FG000|Overall Study|Adverse Event|73|||
155417588|NCT01700192|560958766|FG001|Overall Study|Adverse Event|18|||
155417589|NCT01700192|560958765|FG000|Overall Study|Lack of Efficacy|1|||
155417590|NCT01700192|560958766|FG001|Overall Study|Lack of Efficacy|0|||
155417591|NCT01700192|560958765|FG000|Overall Study|Lost to Follow-up|42|||
155417592|NCT01700192|560958766|FG001|Overall Study|Lost to Follow-up|29|||
155417593|NCT01700192|560958765|FG000|Overall Study|Noncompliance with study drug|0|||
155417594|NCT01700192|560958766|FG001|Overall Study|Noncompliance with study drug|5|||
155417595|NCT01700192|560958765|FG000|Overall Study|Physician Decision|2|||
155417596|NCT01700192|560958766|FG001|Overall Study|Physician Decision|3|||
155417597|NCT01700192|560958765|FG000|Overall Study|Pregnancy|1|||
155417598|NCT01700192|560958766|FG001|Overall Study|Pregnancy|4|||
155417599|NCT01700192|560958765|FG000|Overall Study|Progressive disease|1|||
155417600|NCT01700192|560958766|FG001|Overall Study|Progressive disease|0|||
155417601|NCT01700192|560958765|FG000|Overall Study|Protocol Violation|3|||
155417602|NCT01700192|560958766|FG001|Overall Study|Protocol Violation|4|||
155417603|NCT01700192|560958765|FG000|Overall Study|Technical problems|0|||
155417604|NCT01700192|560958766|FG001|Overall Study|Technical problems|1|||
155417605|NCT01700192|560958765|FG000|Overall Study|Withdrawal by Subject|56|||
155417606|NCT01700192|560958766|FG001|Overall Study|Withdrawal by Subject|64|||
155500101|NCT02253654|561255613|FG000|Overall Study|Death|4|||
155500102|NCT02253654|561255614|FG001|Overall Study|Death|7|||
155417607|NCT01700192|560958765|FG000|Overall Study|Never received study drug|1|||
155417608|NCT01700192|560958766|FG001|Overall Study|Never received study drug|0|||
155417609|NCT00744874|560958768|FG000|Overall Study|Lost to Follow-up|1|||
155417610|NCT00744874|560958768|FG000|Overall Study|Withdrawal by Subject|1|||
155500103|NCT02253654|561255613|FG000|Overall Study|Did Not Receive Study Treatment|4|||
155313426|NCT04810650|560579597|FG007|Overall Study|Participant declined|0|||
155313427|NCT04810650|560579598|FG008|Overall Study|Participant declined|0|||
155313428|NCT04810650|560579599|FG009|Overall Study|Participant declined|0|||
155313429|NCT04810650|560579600|FG010|Overall Study|Participant declined|2|||
155313430|NCT04810650|560579601|FG011|Overall Study|Participant declined|0|||
155313431|NCT04810650|560579602|FG012|Overall Study|Participant declined|0|||
155313432|NCT04810650|560579603|FG013|Overall Study|Participant declined|0|||
155313433|NCT05794243|560579604|FG000|Overall Study|Withdrawal by Subject|1|||
155313434|NCT05794243|560579605|FG001|Overall Study|Withdrawal by Subject|0|||
155313435|NCT05794243|560579606|FG002|Overall Study|Withdrawal by Subject|1|||
155313436|NCT05794243|560579604|FG000|Overall Study|Physician Decision|0|||
155313437|NCT05794243|560579605|FG001|Overall Study|Physician Decision|3|||
155313438|NCT05794243|560579606|FG002|Overall Study|Physician Decision|1|||
155313439|NCT02761057|560579607|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
155313440|NCT02761057|560579608|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
155313441|NCT02761057|560579609|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
155313442|NCT02761057|560579610|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
155313443|NCT02761057|560579607|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
155313444|NCT02761057|560579608|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
155313445|NCT02761057|560579609|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
155313446|NCT02761057|560579610|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
155313447|NCT02761057|560579607|FG000|Overall Study|Currently On Study Treatment|0|||
155313448|NCT02761057|560579608|FG001|Overall Study|Currently On Study Treatment|3|||
155313449|NCT02761057|560579609|FG002|Overall Study|Currently On Study Treatment|0|||
155313450|NCT02761057|560579610|FG003|Overall Study|Currently On Study Treatment|0|||
155313451|NCT02761057|560579607|FG000|Overall Study|Adverse Event|11|||
155313452|NCT02761057|560579608|FG001|Overall Study|Adverse Event|9|||
155313453|NCT02761057|560579609|FG002|Overall Study|Adverse Event|5|||
155313454|NCT02761057|560579610|FG003|Overall Study|Adverse Event|3|||
155313455|NCT02761057|560579607|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313456|NCT02761057|560579608|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313457|NCT02761057|560579609|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
155313458|NCT02761057|560579610|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313459|NCT02761057|560579607|FG000|Overall Study|Progression/Relapse|29|||
155313460|NCT02761057|560579608|FG001|Overall Study|Progression/Relapse|27|||
155313461|NCT02761057|560579609|FG002|Overall Study|Progression/Relapse|20|||
155313462|NCT02761057|560579610|FG003|Overall Study|Progression/Relapse|23|||
155313463|NCT02761057|560579607|FG000|Overall Study|Death|2|||
155417611|NCT00744874|560958768|FG000|Overall Study|Study Device not available at procedure|1|||
155417612|NCT00744874|560958768|FG000|Overall Study|Unable to accomodate schedule|1|||
155417613|NCT00357500|560958774|FG000|Overall Study|Adverse Event|3|||
155417614|NCT00357500|560958774|FG000|Overall Study|Withdrawal by Subject|5|||
155417615|NCT00357500|560958774|FG000|Overall Study|Progressive Disease|65|||
155417616|NCT00357500|560958774|FG000|Overall Study|Not Started Protocol Therapy|4|||
155417617|NCT02301403|560958775|FG000|Overall Study|Withdrawal by Subject|28|||
155417618|NCT02301403|560958776|FG001|Overall Study|Withdrawal by Subject|41|||
155417619|NCT01816243|560958779|FG000|Overall Study|Adverse Event|6|||
155417620|NCT01816243|560958779|FG000|Overall Study|Lost to Follow-up|1|||
155417621|NCT01816243|560958779|FG000|Overall Study|Lack of Efficacy|1|||
155417622|NCT01816243|560958779|FG000|Overall Study|Not eligible for the study|1|||
155417623|NCT01816243|560958779|FG000|Overall Study|Amputation|3|||
155417624|NCT03551743|560958780|FG000|Overall Study|Adverse Event|1|||
155417625|NCT03551743|560958781|FG001|Overall Study|Adverse Event|0|||
155417626|NCT03551743|560958782|FG002|Overall Study|Adverse Event|0|||
155417627|NCT03551743|560958783|FG003|Overall Study|Adverse Event|0|||
155417628|NCT03551743|560958780|FG000|Overall Study|Withdrawal by Subject|1|||
155417629|NCT03551743|560958781|FG001|Overall Study|Withdrawal by Subject|0|||
155417630|NCT03551743|560958782|FG002|Overall Study|Withdrawal by Subject|0|||
155417631|NCT03551743|560958783|FG003|Overall Study|Withdrawal by Subject|0|||
155417632|NCT02317562|560958784|FG000|Overall Study|Physician Decision|1|||
155417633|NCT02317562|560958784|FG000|Overall Study|early termination of the study|8|||
155417634|NCT02317562|560958784|FG000|Overall Study|Lack of Efficacy|4|||
155417635|NCT02317562|560958784|FG000|Overall Study|Withdrawal by Subject|1|||
155417636|NCT00603915|560958785|FG000|Overall Study|Physician Decision|1|||
155417637|NCT03891901|560958786|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
155417638|NCT03891901|560958787|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155313464|NCT02761057|560579608|FG001|Overall Study|Death|2|||
155313465|NCT02761057|560579609|FG002|Overall Study|Death|1|||
155313466|NCT02761057|560579610|FG003|Overall Study|Death|1|||
155313467|NCT02761057|560579607|FG000|Overall Study|Other - Not Protocol Specified|2|||
155313468|NCT02761057|560579608|FG001|Overall Study|Other - Not Protocol Specified|1|||
155313469|NCT02761057|560579609|FG002|Overall Study|Other - Not Protocol Specified|2|||
155417639|NCT03891901|560958788|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417640|NCT03891901|560958789|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155313470|NCT02761057|560579610|FG003|Overall Study|Other - Not Protocol Specified|0|||
155313471|NCT02727699|560581339|FG000|Overall Study|Adverse Event|2|||
155313472|NCT02727699|560581340|FG001|Overall Study|Adverse Event|0|||
155313473|NCT02727699|560581339|FG000|Overall Study|Withdrawal by Subject|5|||
155313474|NCT02727699|560581340|FG001|Overall Study|Withdrawal by Subject|3|||
155313475|NCT02727699|560581339|FG000|Overall Study|Protocol Violation|0|||
155313476|NCT02727699|560581340|FG001|Overall Study|Protocol Violation|1|||
155313477|NCT02727699|560581339|FG000|Overall Study|Physician Decision|0|||
155313478|NCT02727699|560581340|FG001|Overall Study|Physician Decision|1|||
155313479|NCT02727699|560581339|FG000|Overall Study|Lost to Follow-up|1|||
155313480|NCT02727699|560581340|FG001|Overall Study|Lost to Follow-up|0|||
155313481|NCT02727699|560581339|FG000|Overall Study|Sponsor Decision|1|||
155313482|NCT02727699|560581340|FG001|Overall Study|Sponsor Decision|0|||
155313483|NCT04806594|560581354|FG000|Overall Study|Withdrawal by Subject|2|||
155313484|NCT04806594|560581354|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
155313485|NCT04318548|560581355|FG000|Overall Study|Adverse Event|0|||
155313486|NCT04318548|560581356|FG001|Overall Study|Adverse Event|0|||
155313487|NCT04318548|560581357|FG002|Overall Study|Adverse Event|1|||
155313488|NCT04318548|560581355|FG000|Overall Study|Lost to Follow-up|6|||
155313489|NCT04318548|560581356|FG001|Overall Study|Lost to Follow-up|13|||
155313490|NCT04318548|560581357|FG002|Overall Study|Lost to Follow-up|9|||
155313491|NCT04318548|560581355|FG000|Overall Study|Protocol Violation|1|||
155313492|NCT04318548|560581356|FG001|Overall Study|Protocol Violation|0|||
155313493|NCT04318548|560581357|FG002|Overall Study|Protocol Violation|2|||
155313494|NCT04318548|560581355|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
155313495|NCT04318548|560581356|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
155313496|NCT04318548|560581357|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
155313497|NCT04318548|560581355|FG000|Overall Study|Migrated / moved from the study area|0|||
155313498|NCT04318548|560581356|FG001|Overall Study|Migrated / moved from the study area|0|||
155313499|NCT04318548|560581357|FG002|Overall Study|Migrated / moved from the study area|1|||
155313500|NCT04318548|560581355|FG000|Overall Study|Other|1|||
155313501|NCT04318548|560581356|FG001|Overall Study|Other|2|||
155313502|NCT04318548|560581357|FG002|Overall Study|Other|3|||
155417641|NCT03891901|560958790|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417642|NCT03891901|560958791|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417643|NCT03891901|560958792|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417644|NCT03891901|560958793|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417645|NCT03891901|560958794|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
155417646|NCT03891901|560958786|FG000|Overall Study|Adverse Event|2|||
155417647|NCT03891901|560958787|FG001|Overall Study|Adverse Event|2|||
155417648|NCT03891901|560958788|FG002|Overall Study|Adverse Event|0|||
155500104|NCT02253654|561255614|FG001|Overall Study|Did Not Receive Study Treatment|1|||
155500105|NCT03044431|561255617|FG000|Overall Study|Lost to Follow-up|59|||
155500106|NCT03456726|561255618|FG000|Overall Study|Disease Progression|6|||
155500107|NCT03456726|561255619|FG001|Overall Study|Disease Progression|1|||
155500108|NCT03456726|561255618|FG000|Overall Study|Adverse Event|4|||
155500109|NCT03456726|561255619|FG001|Overall Study|Adverse Event|2|||
155500110|NCT03456726|561255618|FG000|Overall Study|Withdrawal by Subject|1|||
155500111|NCT03456726|561255619|FG001|Overall Study|Withdrawal by Subject|0|||
155500112|NCT03456726|561255618|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
155500113|NCT03456726|561255619|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
155500114|NCT01614925|561255620|FG000|Overall Study|Withdrawal by Subject|1|||
155500115|NCT01614925|561255621|FG001|Overall Study|Withdrawal by Subject|0|||
155500116|NCT01614925|561255620|FG000|Overall Study|Protocol Violation|3|||
155500117|NCT01614925|561255621|FG001|Overall Study|Protocol Violation|2|||
155500118|NCT04470622|561255622|FG000|Overall Study|Withdrawal by Subject|0|||
155500119|NCT04470622|561255623|FG001|Overall Study|Withdrawal by Subject|1|||
155500120|NCT04470622|561255622|FG000|Overall Study|Screen Failure|0|||
155500121|NCT04470622|561255623|FG001|Overall Study|Screen Failure|1|||
155500122|NCT04470622|561255622|FG000|Overall Study|Death|0|||
155500123|NCT04470622|561255623|FG001|Overall Study|Death|1|||
155500124|NCT02576054|561255624|FG000|Overall Study|Withdrawal by Subject|1|||
155500125|NCT00791154|561255625|FG000|Overall Study|Noncompliance|0|||
155313503|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313504|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313505|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155500126|NCT00791154|561255626|FG001|Overall Study|Noncompliance|1|||
155313506|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313507|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313508|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313509|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
155313510|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313511|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313512|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313513|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313514|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313515|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313516|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313517|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313518|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
155313519|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313520|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313521|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313522|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155417649|NCT03891901|560958789|FG003|Overall Study|Adverse Event|0|||
155417650|NCT03891901|560958790|FG004|Overall Study|Adverse Event|0|||
155417651|NCT03891901|560958791|FG005|Overall Study|Adverse Event|0|||
155417652|NCT03891901|560958792|FG006|Overall Study|Adverse Event|0|||
155417653|NCT03891901|560958793|FG007|Overall Study|Adverse Event|0|||
155417654|NCT03891901|560958794|FG008|Overall Study|Adverse Event|0|||
155417655|NCT03891901|560958786|FG000|Overall Study|Poor venous access|1|||
155417656|NCT03891901|560958787|FG001|Overall Study|Poor venous access|0|||
155417657|NCT03891901|560958788|FG002|Overall Study|Poor venous access|0|||
155417658|NCT03891901|560958789|FG003|Overall Study|Poor venous access|0|||
155417659|NCT03891901|560958790|FG004|Overall Study|Poor venous access|0|||
155417660|NCT03891901|560958791|FG005|Overall Study|Poor venous access|0|||
155417661|NCT03891901|560958792|FG006|Overall Study|Poor venous access|0|||
155417662|NCT03891901|560958793|FG007|Overall Study|Poor venous access|0|||
155417663|NCT03891901|560958794|FG008|Overall Study|Poor venous access|0|||
155417664|NCT03891901|560958786|FG000|Overall Study|Withdrawal by Subject|0|||
155417665|NCT03891901|560958787|FG001|Overall Study|Withdrawal by Subject|2|||
155417666|NCT03891901|560958788|FG002|Overall Study|Withdrawal by Subject|0|||
155417667|NCT03891901|560958789|FG003|Overall Study|Withdrawal by Subject|0|||
155417668|NCT03891901|560958790|FG004|Overall Study|Withdrawal by Subject|0|||
155417669|NCT03891901|560958791|FG005|Overall Study|Withdrawal by Subject|0|||
155417670|NCT03891901|560958792|FG006|Overall Study|Withdrawal by Subject|0|||
155417671|NCT03891901|560958793|FG007|Overall Study|Withdrawal by Subject|0|||
155417672|NCT03891901|560958794|FG008|Overall Study|Withdrawal by Subject|0|||
155417673|NCT01724528|560958795|FG000|Overall Study|Death|3|||
155417674|NCT01724528|560958796|FG001|Overall Study|Death|0|||
155417675|NCT01724528|560958795|FG000|Overall Study|Withdrawal by Subject|0|||
155417676|NCT01724528|560958796|FG001|Overall Study|Withdrawal by Subject|2|||
155417677|NCT01724528|560958795|FG000|Overall Study|Protocol Violation|0|||
155417678|NCT01724528|560958796|FG001|Overall Study|Protocol Violation|1|||
155417679|NCT01724528|560958795|FG000|Overall Study|Patient refused to attend last visit|1|||
155417680|NCT01724528|560958796|FG001|Overall Study|Patient refused to attend last visit|0|||
155417681|NCT05574062|560958797|FG000|Pre Run-In|Screening failure|3|||
155417682|NCT05574062|560958798|FG001|Pre Run-In|Screening failure|0|||
155417683|NCT05574062|560958799|FG002|Pre Run-In|Screening failure|0|||
155417684|NCT05574062|560958800|FG003|Pre Run-In|Screening failure|0|||
155417685|NCT05574062|560958801|FG004|Pre Run-In|Screening failure|0|||
155417686|NCT05574062|560958797|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
155417687|NCT05574062|560958798|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
155417688|NCT05574062|560958799|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
155417689|NCT05574062|560958800|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
155417690|NCT05574062|560958801|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
155417691|NCT05574062|560958797|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
155417692|NCT05574062|560958798|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
155417693|NCT05574062|560958799|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
155417694|NCT05574062|560958800|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
155417695|NCT05574062|560958801|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
155417696|NCT05574062|560958797|FG000|Continuation Phase Period 1|Physician Decision|1|||
155417697|NCT05574062|560958798|FG001|Continuation Phase Period 1|Physician Decision|0|||
155417698|NCT05574062|560958799|FG002|Continuation Phase Period 1|Physician Decision|0|||
155417699|NCT05574062|560958800|FG003|Continuation Phase Period 1|Physician Decision|0|||
155417700|NCT05574062|560958801|FG004|Continuation Phase Period 1|Physician Decision|0|||
155417701|NCT05574062|560958797|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
155417702|NCT05574062|560958798|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
155417703|NCT05574062|560958799|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
155417704|NCT05574062|560958800|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
155417705|NCT05574062|560958801|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
155417706|NCT05574062|560958797|FG000|Continuation Phase Period 1|Adverse Event|1|||
155417707|NCT05574062|560958798|FG001|Continuation Phase Period 1|Adverse Event|0|||
155417708|NCT05574062|560958799|FG002|Continuation Phase Period 1|Adverse Event|0|||
155417709|NCT05574062|560958800|FG003|Continuation Phase Period 1|Adverse Event|0|||
155417710|NCT05574062|560958801|FG004|Continuation Phase Period 1|Adverse Event|0|||
155417711|NCT05574062|560958797|FG000|Continuation Phase Period 1|Death|1|||
155417712|NCT05574062|560958798|FG001|Continuation Phase Period 1|Death|0|||
155313523|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313524|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313525|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313526|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313527|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313528|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313529|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
155313530|NCT05192200|560581370|FG000|Treatment Period|Other|1|||
155313531|NCT05192200|560581370|FG000|Treatment Period|Lack of Efficacy|1|||
155313532|NCT05192200|560581370|FG000|Treatment Period|Withdrawal by Subject|1|||
155313533|NCT05192200|560581370|FG000|Follow-up|Withdrawal by Subject|1|||
155313534|NCT03445988|560581376|FG000|Overall Study|Lost to Follow-up|14|||
155313535|NCT03445988|560581377|FG001|Overall Study|Lost to Follow-up|26|||
155313536|NCT03445988|560581378|FG002|Overall Study|Lost to Follow-up|27|||
155313537|NCT03445988|560581379|FG003|Overall Study|Lost to Follow-up|66|||
155313538|NCT03445988|560581376|FG000|Overall Study|Withdrawal by Subject|7|||
155313539|NCT03445988|560581377|FG001|Overall Study|Withdrawal by Subject|4|||
155313540|NCT03445988|560581378|FG002|Overall Study|Withdrawal by Subject|3|||
155313541|NCT03445988|560581379|FG003|Overall Study|Withdrawal by Subject|5|||
155313542|NCT03445988|560581376|FG000|Overall Study|Death (unrelated to study)|5|||
155313543|NCT03445988|560581377|FG001|Overall Study|Death (unrelated to study)|1|||
155313544|NCT03445988|560581378|FG002|Overall Study|Death (unrelated to study)|2|||
155313545|NCT03445988|560581379|FG003|Overall Study|Death (unrelated to study)|4|||
155313546|NCT04274764|560581390|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
155313547|NCT04274764|560581391|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
155313548|NCT03611621|560581407|FG000|Overall Study|Graft loss|3|||
155313549|NCT03611621|560581407|FG000|Overall Study|Death|3|||
155313550|NCT03611621|560581407|FG000|Overall Study|Lost to Follow-up|1|||
155313551|NCT04764448|560581410|FG000|Overall Study|Study terminated by sponsor|2|||
155313552|NCT04764448|560581411|FG001|Overall Study|Study terminated by sponsor|2|||
155313553|NCT04764448|560581412|FG002|Overall Study|Study terminated by sponsor|5|||
155313554|NCT04764448|560581410|FG000|Overall Study|Withdrawal by Subject|3|||
155313555|NCT04764448|560581411|FG001|Overall Study|Withdrawal by Subject|3|||
155313556|NCT04764448|560581412|FG002|Overall Study|Withdrawal by Subject|1|||
155313557|NCT02975882|560581414|FG000|Overall Study|Adverse Event|1|||
155313558|NCT02975882|560581415|FG001|Overall Study|Adverse Event|2|||
155313559|NCT02975882|560581416|FG002|Overall Study|Adverse Event|1|||
155500127|NCT00791154|561255627|FG002|Overall Study|Noncompliance|0|||
155500128|NCT00791154|561255628|FG003|Overall Study|Noncompliance|0|||
155500129|NCT00791154|561255629|FG004|Overall Study|Noncompliance|1|||
155500130|NCT00791154|561255630|FG005|Overall Study|Noncompliance|1|||
155500131|NCT00791154|561255631|FG006|Overall Study|Noncompliance|1|||
155500132|NCT00791154|561255625|FG000|Overall Study|Adverse Event|0|||
155500133|NCT00791154|561255626|FG001|Overall Study|Adverse Event|0|||
155500134|NCT00791154|561255627|FG002|Overall Study|Adverse Event|0|||
155500135|NCT00791154|561255628|FG003|Overall Study|Adverse Event|0|||
155500136|NCT00791154|561255629|FG004|Overall Study|Adverse Event|2|||
155500137|NCT00791154|561255630|FG005|Overall Study|Adverse Event|0|||
155500138|NCT00791154|561255631|FG006|Overall Study|Adverse Event|1|||
155500139|NCT00791154|561255625|FG000|Overall Study|Full Consent withdrawn|1|||
155500140|NCT00791154|561255626|FG001|Overall Study|Full Consent withdrawn|3|||
155500141|NCT00791154|561255627|FG002|Overall Study|Full Consent withdrawn|0|||
155500142|NCT00791154|561255628|FG003|Overall Study|Full Consent withdrawn|0|||
155500143|NCT00791154|561255629|FG004|Overall Study|Full Consent withdrawn|1|||
155500144|NCT00791154|561255630|FG005|Overall Study|Full Consent withdrawn|3|||
155500145|NCT00791154|561255631|FG006|Overall Study|Full Consent withdrawn|1|||
155500146|NCT00791154|561255625|FG000|Overall Study|Lost to Follow-up|0|||
155500147|NCT00791154|561255626|FG001|Overall Study|Lost to Follow-up|0|||
155500148|NCT00791154|561255627|FG002|Overall Study|Lost to Follow-up|0|||
155500149|NCT00791154|561255628|FG003|Overall Study|Lost to Follow-up|1|||
155500150|NCT00791154|561255629|FG004|Overall Study|Lost to Follow-up|2|||
155500151|NCT00791154|561255630|FG005|Overall Study|Lost to Follow-up|0|||
155500152|NCT00791154|561255631|FG006|Overall Study|Lost to Follow-up|4|||
155313560|NCT02975882|560581417|FG003|Overall Study|Adverse Event|1|||
155500153|NCT00791154|561255625|FG000|Overall Study|Death|5|||
155500154|NCT00791154|561255626|FG001|Overall Study|Death|4|||
155500155|NCT00791154|561255627|FG002|Overall Study|Death|4|||
155643253|NCT01771913|561783762|FG001|Overall Study|Withdrawal by Subject|0|||
155643254|NCT00992836|561783763|FG000|Overall Study|Lost to Follow-up|1|||
155313561|NCT02975882|560581414|FG000|Overall Study|Death|0|||
155313562|NCT02975882|560581415|FG001|Overall Study|Death|1|||
155313563|NCT02975882|560581416|FG002|Overall Study|Death|0|||
155500156|NCT00791154|561255628|FG003|Overall Study|Death|7|||
155500157|NCT00791154|561255629|FG004|Overall Study|Death|54|||
155500158|NCT00791154|561255630|FG005|Overall Study|Death|54|||
155500159|NCT00791154|561255631|FG006|Overall Study|Death|52|||
155500160|NCT00791154|561255625|FG000|Overall Study|Other event|0|||
155313564|NCT02975882|560581417|FG003|Overall Study|Death|0|||
155313565|NCT02975882|560581414|FG000|Overall Study|Lack of Efficacy|3|||
155313566|NCT02975882|560581415|FG001|Overall Study|Lack of Efficacy|7|||
155313567|NCT02975882|560581416|FG002|Overall Study|Lack of Efficacy|4|||
155313568|NCT02975882|560581417|FG003|Overall Study|Lack of Efficacy|3|||
155313569|NCT02975882|560581414|FG000|Overall Study|Physician Decision|0|||
155313570|NCT02975882|560581415|FG001|Overall Study|Physician Decision|2|||
155313571|NCT02975882|560581416|FG002|Overall Study|Physician Decision|4|||
155313572|NCT02975882|560581417|FG003|Overall Study|Physician Decision|2|||
155313573|NCT02975882|560581414|FG000|Overall Study|Ineligible|0|||
155313574|NCT02975882|560581415|FG001|Overall Study|Ineligible|1|||
155313575|NCT02975882|560581416|FG002|Overall Study|Ineligible|0|||
155313576|NCT02975882|560581417|FG003|Overall Study|Ineligible|0|||
155313577|NCT03936322|560581418|FG000|Overall Study|Lost to Follow-up|1|||
155313578|NCT03936322|560581418|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
155313579|NCT01160211|560581420|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
155313580|NCT01160211|560581421|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
155313581|NCT01160211|560581422|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
155313582|NCT01160211|560581420|FG000|Overall Study|Lost to Follow-up|4|||
155313583|NCT01160211|560581421|FG001|Overall Study|Lost to Follow-up|8|||
155313584|NCT01160211|560581422|FG002|Overall Study|Lost to Follow-up|4|||
155313585|NCT01160211|560581420|FG000|Overall Study|Physician Decision|1|||
155313586|NCT01160211|560581421|FG001|Overall Study|Physician Decision|0|||
155313587|NCT01160211|560581422|FG002|Overall Study|Physician Decision|0|||
155313588|NCT01160211|560581420|FG000|Overall Study|Withdrawal by Subject|4|||
155313589|NCT01160211|560581421|FG001|Overall Study|Withdrawal by Subject|2|||
155313590|NCT01160211|560581422|FG002|Overall Study|Withdrawal by Subject|2|||
155313591|NCT01160211|560581420|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
155313592|NCT01160211|560581421|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
155313593|NCT01160211|560581422|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
155313594|NCT02734290|560581423|FG000|Overall Study|Adverse Event|1|||
155313595|NCT02734290|560581424|FG001|Overall Study|Adverse Event|0|||
155313596|NCT02734290|560581423|FG000|Overall Study|Death|1|||
155313597|NCT02734290|560581424|FG001|Overall Study|Death|0|||
155313598|NCT03829410|560581426|FG000|Overall Study|Adverse Event|1|||
155313599|NCT03829410|560581427|FG001|Overall Study|Adverse Event|0|||
155313600|NCT03829410|560581428|FG002|Overall Study|Adverse Event|1|||
155313601|NCT03829410|560581429|FG003|Overall Study|Adverse Event|4|||
155313602|NCT03829410|560581426|FG000|Overall Study|Physician Decision|0|||
155313603|NCT03829410|560581427|FG001|Overall Study|Physician Decision|0|||
155313604|NCT03829410|560581428|FG002|Overall Study|Physician Decision|0|||
155313605|NCT03829410|560581429|FG003|Overall Study|Physician Decision|2|||
155313606|NCT03829410|560581426|FG000|Overall Study|Disease Progressing|3|||
155313607|NCT03829410|560581427|FG001|Overall Study|Disease Progressing|4|||
155313608|NCT03829410|560581428|FG002|Overall Study|Disease Progressing|2|||
155313609|NCT03829410|560581429|FG003|Overall Study|Disease Progressing|31|||
155500161|NCT00791154|561255626|FG001|Overall Study|Other event|0|||
155500162|NCT00791154|561255627|FG002|Overall Study|Other event|2|||
155500163|NCT00791154|561255628|FG003|Overall Study|Other event|0|||
155500164|NCT00791154|561255629|FG004|Overall Study|Other event|2|||
155500165|NCT00791154|561255630|FG005|Overall Study|Other event|4|||
155500166|NCT00791154|561255631|FG006|Overall Study|Other event|2|||
155500167|NCT00450177|561255632|FG000|Overall Study|Adverse Event|7|||
155500168|NCT00450177|561255633|FG001|Overall Study|Adverse Event|4|||
155500169|NCT00450177|561255632|FG000|Overall Study|Withdrawal by Subject|1|||
155313610|NCT03829410|560581426|FG000|Overall Study|Miscellaneous|2|||
155313611|NCT03829410|560581427|FG001|Overall Study|Miscellaneous|4|||
155313612|NCT03829410|560581428|FG002|Overall Study|Miscellaneous|3|||
155313613|NCT03829410|560581429|FG003|Overall Study|Miscellaneous|10|||
155313614|NCT03158129|560581430|FG000|Overall Study|Adverse Event|0|||
155313615|NCT03158129|560581431|FG001|Overall Study|Adverse Event|1|||
155313616|NCT03158129|560581432|FG002|Overall Study|Adverse Event|0|||
155313617|NCT03158129|560581433|FG003|Overall Study|Adverse Event|0|||
155313618|NCT03158129|560581430|FG000|Overall Study|Death|0|||
155500170|NCT00450177|561255633|FG001|Overall Study|Withdrawal by Subject|6|||
155313619|NCT03158129|560581431|FG001|Overall Study|Death|0|||
155313620|NCT03158129|560581432|FG002|Overall Study|Death|0|||
155500171|NCT00450177|561255632|FG000|Overall Study|Withdrawal by Primary Team|1|||
155313621|NCT03158129|560581433|FG003|Overall Study|Death|1|||
155313622|NCT03158129|560581430|FG000|Overall Study|High surgical risk|1|||
155313623|NCT03158129|560581431|FG001|Overall Study|High surgical risk|1|||
155313624|NCT03158129|560581432|FG002|Overall Study|High surgical risk|0|||
155313625|NCT03158129|560581433|FG003|Overall Study|High surgical risk|0|||
155313626|NCT03158129|560581430|FG000|Overall Study|Progression|1|||
155313627|NCT03158129|560581431|FG001|Overall Study|Progression|1|||
155313628|NCT03158129|560581432|FG002|Overall Study|Progression|0|||
155313629|NCT03158129|560581433|FG003|Overall Study|Progression|0|||
155313630|NCT03158129|560581430|FG000|Overall Study|Lack of resectability|0|||
155313631|NCT03158129|560581431|FG001|Overall Study|Lack of resectability|1|||
155313632|NCT03158129|560581432|FG002|Overall Study|Lack of resectability|0|||
155313633|NCT03158129|560581433|FG003|Overall Study|Lack of resectability|0|||
155313634|NCT03158129|560581430|FG000|Overall Study|Declined surgery|0|||
155313635|NCT03158129|560581431|FG001|Overall Study|Declined surgery|1|||
155313636|NCT03158129|560581432|FG002|Overall Study|Declined surgery|0|||
155313637|NCT03158129|560581433|FG003|Overall Study|Declined surgery|0|||
155313638|NCT03158129|560581430|FG000|Overall Study|No longer surgical candidate|0|||
155313639|NCT03158129|560581431|FG001|Overall Study|No longer surgical candidate|0|||
155313640|NCT03158129|560581432|FG002|Overall Study|No longer surgical candidate|0|||
155313641|NCT03158129|560581433|FG003|Overall Study|No longer surgical candidate|1|||
155313642|NCT06205407|560581438|FG000|Period 2|Withdrawal by Subject|0|||
155313643|NCT06205407|560581439|FG001|Period 2|Withdrawal by Subject|1|||
155313644|NCT06205407|560581438|FG000|Period 2|Adverse Event|2|||
155643255|NCT00992836|561783763|FG000|Overall Study|Withdrawal by Subject|2|||
155313645|NCT06205407|560581439|FG001|Period 2|Adverse Event|1|||
155313646|NCT06491433|560581440|FG000|Overall Study|Protocol Violation|51|||
155313647|NCT06491433|560581440|FG000|Overall Study|consent withdrawal|2|||
155313648|NCT06491433|560581440|FG000|Overall Study|screen failure|1|||
155417713|NCT05574062|560958799|FG002|Continuation Phase Period 1|Death|0|||
155417714|NCT05574062|560958800|FG003|Continuation Phase Period 1|Death|0|||
155417715|NCT05574062|560958801|FG004|Continuation Phase Period 1|Death|0|||
155417716|NCT05574062|560958797|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
155417717|NCT05574062|560958798|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
155417718|NCT05574062|560958799|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
155417719|NCT05574062|560958800|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
155417720|NCT05574062|560958801|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
155417721|NCT01031446|560958808|FG000|Overall Study|Disease Progression|38|||
155417722|NCT01031446|560958808|FG000|Overall Study|Adverse Event|9|||
155417723|NCT01031446|560958808|FG000|Overall Study|Physician Decision|4|||
155417724|NCT01031446|560958808|FG000|Overall Study|Withdrawal by Subject|3|||
155417725|NCT01031446|560958808|FG000|Overall Study|Still on treatment|1|||
155417726|NCT03631706|560958810|FG000|Overall Study|Randomized, not treated|1|||
155417727|NCT03631706|560958811|FG001|Overall Study|Randomized, not treated|0|||
155417728|NCT00865020|560958814|FG000|Overall Study|Withdrawal by Subject|22|||
155417729|NCT00865020|560958815|FG001|Overall Study|Withdrawal by Subject|16|||
155417730|NCT00865020|560958814|FG000|Overall Study|Adverse Event|9|||
155417731|NCT00865020|560958815|FG001|Overall Study|Adverse Event|14|||
155417732|NCT00865020|560958814|FG000|Overall Study|Abnormal test procedure result(s)|6|||
155417733|NCT00865020|560958815|FG001|Overall Study|Abnormal test procedure result(s)|8|||
155417734|NCT00865020|560958814|FG000|Overall Study|Lost to Follow-up|6|||
155417735|NCT00865020|560958815|FG001|Overall Study|Lost to Follow-up|4|||
155417736|NCT00865020|560958814|FG000|Overall Study|Protocol deviation|4|||
155417737|NCT00865020|560958815|FG001|Overall Study|Protocol deviation|1|||
155417738|NCT00865020|560958814|FG000|Overall Study|Administrative problems|0|||
155417739|NCT00865020|560958815|FG001|Overall Study|Administrative problems|2|||
155417740|NCT00865020|560958814|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155417741|NCT00865020|560958815|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155417742|NCT00865020|560958814|FG000|Overall Study|Death|0|||
155417743|NCT00865020|560958815|FG001|Overall Study|Death|1|||
155417744|NCT00865020|560958814|FG000|Overall Study|Randomized but discontinued|2|||
155417745|NCT00865020|560958815|FG001|Overall Study|Randomized but discontinued|4|||
155417746|NCT00546364|560960287|FG000|Overall Study|Disease progression|5|||
155417747|NCT00546364|560960288|FG001|Overall Study|Disease progression|11|||
155417748|NCT00546364|560960289|FG002|Overall Study|Disease progression|8|||
155417749|NCT00546364|560960287|FG000|Overall Study|Completed and off treatment|1|||
155417750|NCT00546364|560960288|FG001|Overall Study|Completed and off treatment|0|||
155417751|NCT00546364|560960289|FG002|Overall Study|Completed and off treatment|2|||
155417752|NCT00546364|560960287|FG000|Overall Study|Administrative reason by sponsor|1|||
155417753|NCT00546364|560960288|FG001|Overall Study|Administrative reason by sponsor|0|||
155417754|NCT00546364|560960289|FG002|Overall Study|Administrative reason by sponsor|0|||
155417755|NCT00546364|560960287|FG000|Overall Study|Poor compliance/noncompliance|0|||
155417756|NCT00546364|560960288|FG001|Overall Study|Poor compliance/noncompliance|0|||
155417757|NCT00546364|560960289|FG002|Overall Study|Poor compliance/noncompliance|1|||
155417758|NCT00546364|560960287|FG000|Overall Study|No longer meets study criteria|1|||
155417759|NCT00546364|560960288|FG001|Overall Study|No longer meets study criteria|1|||
155417760|NCT00546364|560960289|FG002|Overall Study|No longer meets study criteria|0|||
155417761|NCT00546364|560960287|FG000|Overall Study|Withdrawal by Subject|5|||
155417762|NCT00546364|560960288|FG001|Overall Study|Withdrawal by Subject|6|||
155417763|NCT00546364|560960289|FG002|Overall Study|Withdrawal by Subject|3|||
155417764|NCT00546364|560960287|FG000|Overall Study|Prior taxotere|1|||
155417765|NCT00546364|560960288|FG001|Overall Study|Prior taxotere|0|||
155313649|NCT04676022|560581444|FG000|Overall Study|Screen Failure/|1|||
155313650|NCT04676022|560581445|FG001|Overall Study|Screen Failure/|1|||
155313651|NCT04676022|560581446|FG002|Overall Study|Screen Failure/|85|||
155417766|NCT00546364|560960289|FG002|Overall Study|Prior taxotere|0|||
155417767|NCT00546364|560960287|FG000|Overall Study|Mixed response|1|||
155643256|NCT00992836|561783763|FG000|Overall Study|Protocol Violation|2|||
155313652|NCT04676022|560581444|FG000|Overall Study|Lost to Follow-up|1|||
155500172|NCT00450177|561255633|FG001|Overall Study|Withdrawal by Primary Team|1|||
155500173|NCT02923115|561255634|FG000|Overall Study|Lost to Follow-up|0|||
155500174|NCT02923115|561255635|FG001|Overall Study|Lost to Follow-up|0|||
155500175|NCT02923115|561255636|FG002|Overall Study|Lost to Follow-up|0|||
155500176|NCT02923115|561255637|FG003|Overall Study|Lost to Follow-up|1|||
155500177|NCT02923115|561255638|FG004|Overall Study|Lost to Follow-up|0|||
155500178|NCT02923115|561255639|FG005|Overall Study|Lost to Follow-up|0|||
155500179|NCT02923115|561255634|FG000|Overall Study|Withdrawal by Subject|0|||
155500180|NCT02923115|561255635|FG001|Overall Study|Withdrawal by Subject|1|||
155500181|NCT02923115|561255636|FG002|Overall Study|Withdrawal by Subject|0|||
155500182|NCT02923115|561255637|FG003|Overall Study|Withdrawal by Subject|0|||
155500183|NCT02923115|561255638|FG004|Overall Study|Withdrawal by Subject|0|||
155500184|NCT02923115|561255639|FG005|Overall Study|Withdrawal by Subject|0|||
155500185|NCT02923115|561255634|FG000|Overall Study|Randomized, but not dosed|0|||
155500186|NCT02923115|561255635|FG001|Overall Study|Randomized, but not dosed|0|||
155500187|NCT02923115|561255636|FG002|Overall Study|Randomized, but not dosed|3|||
155500188|NCT02923115|561255637|FG003|Overall Study|Randomized, but not dosed|1|||
155500189|NCT02923115|561255638|FG004|Overall Study|Randomized, but not dosed|5|||
155500190|NCT02923115|561255639|FG005|Overall Study|Randomized, but not dosed|0|||
155500191|NCT00835068|561255642|FG000|Overall Study|Death|1|||
155500192|NCT00835068|561255643|FG001|Overall Study|Death|0|||
155500193|NCT00835068|561255642|FG000|Overall Study|Adverse Event|0|||
155500194|NCT00835068|561255643|FG001|Overall Study|Adverse Event|1|||
155500195|NCT00835068|561255642|FG000|Overall Study|Other|8|||
155500196|NCT00835068|561255643|FG001|Overall Study|Other|0|||
155500197|NCT00835068|561255642|FG000|Overall Study|Withdrawal by Subject|1|||
155500198|NCT00835068|561255643|FG001|Overall Study|Withdrawal by Subject|0|||
155500199|NCT04803214|561255646|FG000|Overall Study|Adverse Event|1|||
155500200|NCT04803214|561255647|FG001|Overall Study|Adverse Event|0|||
155500201|NCT04803214|561255646|FG000|Overall Study|Withdrawal by Subject|1|||
155500202|NCT04803214|561255647|FG001|Overall Study|Withdrawal by Subject|2|||
155500203|NCT04803214|561255646|FG000|Overall Study|Lost to Follow-up|2|||
155500204|NCT04803214|561255647|FG001|Overall Study|Lost to Follow-up|4|||
155500205|NCT04803214|561255646|FG000|Overall Study|Physician Decision|1|||
155500206|NCT04803214|561255647|FG001|Overall Study|Physician Decision|1|||
155500207|NCT04803214|561255646|FG000|Overall Study|Missed 12 month visit|0|||
155500208|NCT04803214|561255647|FG001|Overall Study|Missed 12 month visit|3|||
155500209|NCT05631093|561255653|FG000|Overall Study|Death|0|||
155500210|NCT05631093|561255654|FG001|Overall Study|Death|1|||
155500211|NCT05631093|561255653|FG000|Overall Study|Lost to Follow-up|1|||
155500212|NCT05631093|561255654|FG001|Overall Study|Lost to Follow-up|2|||
155500213|NCT05631093|561255653|FG000|Overall Study|Physician Decision|1|||
155500214|NCT05631093|561255654|FG001|Overall Study|Physician Decision|0|||
155500215|NCT05631093|561255653|FG000|Overall Study|Withdrawal by Subject|4|||
155500216|NCT05631093|561255654|FG001|Overall Study|Withdrawal by Subject|1|||
155500217|NCT05631093|561255653|FG000|Overall Study|Ongoing|353|||
155500218|NCT05631093|561255654|FG001|Overall Study|Ongoing|177|||
155500219|NCT05631093|561255653|FG000|Overall Study|Adverse Event|0|||
155500220|NCT05631093|561255654|FG001|Overall Study|Adverse Event|1|||
155500221|NCT03732677|561255655|FG000|Overall Study|Terminated the study|154|||
155500222|NCT03732677|561255656|FG001|Overall Study|Terminated the study|197|||
155500223|NCT03732677|561255655|FG000|Overall Study|Continuing study off treatment|379|||
155500224|NCT03732677|561255656|FG001|Overall Study|Continuing study off treatment|333|||
155500225|NCT03494816|561255658|FG000|Overall Study|Protocol Violation|2|||
155500226|NCT03494816|561255658|FG000|Overall Study|Physician Decision|2|||
155500227|NCT03494816|561255658|FG000|Overall Study|Did not start trial treatment|1|||
155500228|NCT03494816|561255658|FG000|Overall Study|Adverse Event|1|||
155643257|NCT03695094|561783764|FG000|Overall Study|Adverse Event|1|||
155313653|NCT04676022|560581445|FG001|Overall Study|Lost to Follow-up|1|||
155313654|NCT04676022|560581446|FG002|Overall Study|Lost to Follow-up|0|||
155313655|NCT04676022|560581444|FG000|Overall Study|Adverse Event|2|||
155313656|NCT04676022|560581445|FG001|Overall Study|Adverse Event|0|||
155313657|NCT04676022|560581446|FG002|Overall Study|Adverse Event|1|||
155313658|NCT04676022|560581444|FG000|Overall Study|Physician Decision|2|||
155313659|NCT04676022|560581445|FG001|Overall Study|Physician Decision|0|||
155500229|NCT04502862|561255659|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
155500230|NCT04502862|561255660|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
155500231|NCT04502862|561255659|FG000|Overall Study|Withdrawal by Subject|1|||
155500232|NCT04502862|561255660|FG001|Overall Study|Withdrawal by Subject|0|||
155500233|NCT04502862|561255659|FG000|Overall Study|Adverse Event|1|||
155500234|NCT04502862|561255660|FG001|Overall Study|Adverse Event|1|||
155500235|NCT00265239|561256901|FG000|Overall Study|Adverse Event|2|||
155313660|NCT04676022|560581446|FG002|Overall Study|Physician Decision|1|||
155500236|NCT00265239|561256902|FG001|Overall Study|Adverse Event|1|||
155500237|NCT02803138|561256903|FG000|Overall Study|Failure to return|38|||
155500238|NCT02803138|561256903|FG000|Overall Study|Insufficient virological response|2|||
155500239|NCT02803138|561256903|FG000|Overall Study|Withdrawn consent|1|||
155500240|NCT02803138|561256903|FG000|Overall Study|Death|1|||
155313661|NCT04676022|560581444|FG000|Overall Study|Withdrawal by Subject|3|||
155313662|NCT04676022|560581445|FG001|Overall Study|Withdrawal by Subject|1|||
155313663|NCT04676022|560581446|FG002|Overall Study|Withdrawal by Subject|6|||
155313664|NCT04676022|560581444|FG000|Overall Study|Will not move forward with permanent implant|6|||
155313665|NCT04676022|560581445|FG001|Overall Study|Will not move forward with permanent implant|0|||
155313666|NCT04676022|560581446|FG002|Overall Study|Will not move forward with permanent implant|0|||
155313667|NCT04676022|560581444|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
155313668|NCT04676022|560581445|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
155313669|NCT04676022|560581446|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
155313670|NCT02274662|560581464|FG000|Overall Study|Death|1|||
155417768|NCT00546364|560960288|FG001|Overall Study|Mixed response|0|||
155417769|NCT00546364|560960289|FG002|Overall Study|Mixed response|0|||
155417770|NCT00546364|560960287|FG000|Overall Study|Palliative treatment|1|||
155417771|NCT00546364|560960288|FG001|Overall Study|Palliative treatment|0|||
155417772|NCT00546364|560960289|FG002|Overall Study|Palliative treatment|1|||
155417773|NCT00546364|560960287|FG000|Overall Study|Target lesions resected|1|||
155417774|NCT00546364|560960288|FG001|Overall Study|Target lesions resected|0|||
155417775|NCT00546364|560960289|FG002|Overall Study|Target lesions resected|0|||
155417776|NCT00546364|560960287|FG000|Overall Study|Physician Decision|0|||
155417777|NCT00546364|560960288|FG001|Overall Study|Physician Decision|0|||
155417778|NCT00546364|560960289|FG002|Overall Study|Physician Decision|1|||
155417779|NCT00546364|560960287|FG000|Overall Study|Sponsor decision|0|||
155417780|NCT00546364|560960288|FG001|Overall Study|Sponsor decision|0|||
155417781|NCT00546364|560960289|FG002|Overall Study|Sponsor decision|1|||
155417782|NCT03064763|560960290|FG000|Overall Study|Lost to Follow-up|1|||
155417783|NCT03064763|560960290|FG000|Overall Study|Death|8|||
155417784|NCT00619502|560960294|FG000|Overall Study|Lost to Follow-up|8|||
155417785|NCT00619502|560960295|FG001|Overall Study|Lost to Follow-up|10|||
155417786|NCT00223496|560960298|FG000|Overall Study|screen failure|9|||
155417787|NCT00223496|560960298|FG000|Overall Study|Lost to Follow-up|4|||
155417788|NCT00223496|560960298|FG000|Overall Study|Lack of Efficacy|6|||
155417789|NCT00223496|560960298|FG000|Overall Study|Withdrawal by Subject|1|||
155417790|NCT00223496|560960298|FG000|Overall Study|Physician Decision|2|||
155417791|NCT05425563|560960303|FG000|Overall Study|Withdrawal by Subject|17|||
155417792|NCT02624492|560960308|FG000|Overall Study|Adverse Event|2|||
155417793|NCT02624492|560960309|FG001|Overall Study|Adverse Event|2|||
155417794|NCT02624492|560960310|FG002|Overall Study|Adverse Event|2|||
155417795|NCT02624492|560960308|FG000|Overall Study|Progressive disease|0|||
155417796|NCT02624492|560960309|FG001|Overall Study|Progressive disease|2|||
155417797|NCT02624492|560960310|FG002|Overall Study|Progressive disease|3|||
155417798|NCT00343512|560960316|FG000|Overall Study|Withdrawal by Subject|2|||
155417799|NCT02400255|560960317|FG000|Overall Study|Relapse|4|||
155417800|NCT02400255|560960318|FG001|Overall Study|Relapse|1|||
155417801|NCT02400255|560960319|FG002|Overall Study|Relapse|1|||
155417802|NCT02400255|560960320|FG003|Overall Study|Relapse|2|||
155417803|NCT02400255|560960317|FG000|Overall Study|Adverse Event|6|||
155417804|NCT02400255|560960318|FG001|Overall Study|Adverse Event|3|||
155417805|NCT02400255|560960319|FG002|Overall Study|Adverse Event|0|||
155417806|NCT02400255|560960320|FG003|Overall Study|Adverse Event|0|||
155417807|NCT02400255|560960317|FG000|Overall Study|Physician Decision|6|||
155417808|NCT02400255|560960318|FG001|Overall Study|Physician Decision|0|||
155417809|NCT02400255|560960319|FG002|Overall Study|Physician Decision|0|||
155417810|NCT02400255|560960320|FG003|Overall Study|Physician Decision|0|||
155417811|NCT02400255|560960317|FG000|Overall Study|Loss of insurance|1|||
155417812|NCT02400255|560960318|FG001|Overall Study|Loss of insurance|0|||
155417813|NCT02400255|560960319|FG002|Overall Study|Loss of insurance|0|||
155417814|NCT02400255|560960320|FG003|Overall Study|Loss of insurance|0|||
155417815|NCT02568046|560960321|FG000|Overall Study|Adverse Event|0|||
155417816|NCT02568046|560960322|FG001|Overall Study|Adverse Event|1|||
155417817|NCT02568046|560960321|FG000|Overall Study|Death|2|||
155417818|NCT02568046|560960322|FG001|Overall Study|Death|0|||
155417819|NCT02568046|560960321|FG000|Overall Study|Progressive Disease|1|||
155417820|NCT02568046|560960322|FG001|Overall Study|Progressive Disease|0|||
155313671|NCT02274662|560581464|FG000|Overall Study|Lost to Follow-up|3|||
155417821|NCT02568046|560960321|FG000|Overall Study|Withdrawal by Subject|2|||
155417822|NCT02568046|560960322|FG001|Overall Study|Withdrawal by Subject|1|||
155313672|NCT03194217|560581465|FG000|Overall Study|Adverse Event|0|||
155417823|NCT02568046|560960321|FG000|Overall Study|Other Events|0|||
155417824|NCT02568046|560960322|FG001|Overall Study|Other Events|1|||
155417825|NCT00193063|560960323|FG000|Overall Study|Lack of Efficacy|3|||
155417826|NCT00193063|560960323|FG000|Overall Study|Adverse Event|1|||
155417827|NCT01127165|560960325|FG000|Overall Study|Adverse Event|2|||
155417828|NCT01127165|560960326|FG001|Overall Study|Adverse Event|2|||
155417829|NCT01127165|560960325|FG000|Overall Study|Lack of Efficacy|10|||
155417830|NCT01127165|560960326|FG001|Overall Study|Lack of Efficacy|8|||
155417831|NCT01127165|560960325|FG000|Overall Study|Lost to Follow-up|3|||
155417832|NCT01127165|560960326|FG001|Overall Study|Lost to Follow-up|5|||
155643258|NCT03695094|561783765|FG001|Overall Study|Adverse Event|1|||
155313673|NCT03194217|560581466|FG001|Overall Study|Adverse Event|2|||
155313674|NCT03194217|560581467|FG002|Overall Study|Adverse Event|3|||
155313675|NCT03194217|560581468|FG003|Overall Study|Adverse Event|3|||
155313676|NCT03194217|560581465|FG000|Overall Study|Failure to meet randomisation criteria|0|||
155313677|NCT03194217|560581466|FG001|Overall Study|Failure to meet randomisation criteria|0|||
155313678|NCT03194217|560581467|FG002|Overall Study|Failure to meet randomisation criteria|0|||
155313679|NCT03194217|560581468|FG003|Overall Study|Failure to meet randomisation criteria|1|||
155313680|NCT03194217|560581465|FG000|Overall Study|Other|0|||
155313681|NCT03194217|560581466|FG001|Overall Study|Other|1|||
155313682|NCT03194217|560581467|FG002|Overall Study|Other|1|||
155313683|NCT03194217|560581468|FG003|Overall Study|Other|0|||
155313684|NCT03134196|560581479|FG000|Overall Study|Death|2|||
155313685|NCT03134196|560581480|FG001|Overall Study|Death|1|||
155313686|NCT03134196|560581479|FG000|Overall Study|Lost to Follow-up|13|||
155313687|NCT03134196|560581480|FG001|Overall Study|Lost to Follow-up|15|||
155313688|NCT03134196|560581479|FG000|Overall Study|Physician Decision|0|||
155313689|NCT03134196|560581480|FG001|Overall Study|Physician Decision|1|||
155313690|NCT03134196|560581479|FG000|Overall Study|Withdrawal by Subject|19|||
155313691|NCT03134196|560581480|FG001|Overall Study|Withdrawal by Subject|12|||
155313692|NCT03134196|560581479|FG000|Overall Study|Site Unable to Contact Participant|2|||
155313693|NCT03134196|560581480|FG001|Overall Study|Site Unable to Contact Participant|0|||
155313694|NCT03134196|560581479|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
155313695|NCT03134196|560581480|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
155313696|NCT03134196|560581479|FG000|Overall Study|Scheduling Conflict|1|||
155313697|NCT03134196|560581480|FG001|Overall Study|Scheduling Conflict|0|||
155313698|NCT04683744|560581486|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
155313699|NCT04683744|560581487|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
155313700|NCT04683744|560581488|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
155313701|NCT04592549|560581491|FG000|Overall Study|Withdrawal by Subject|0|||
155417833|NCT01127165|560960325|FG000|Overall Study|Withdrawal by Subject|1|||
155417834|NCT01127165|560960326|FG001|Overall Study|Withdrawal by Subject|3|||
155417835|NCT01127165|560960325|FG000|Overall Study|Protocol Violation|0|||
155417836|NCT01127165|560960326|FG001|Overall Study|Protocol Violation|1|||
155417837|NCT02435849|560960327|FG000|Overall Study|Death|23|||
155417838|NCT02435849|560960328|FG001|Overall Study|Death|0|||
155417839|NCT02435849|560960327|FG000|Overall Study|Lack of Efficacy|10|||
155417840|NCT02435849|560960328|FG001|Overall Study|Lack of Efficacy|0|||
155417841|NCT02435849|560960327|FG000|Overall Study|New therapy for study indication|8|||
155417842|NCT02435849|560960328|FG001|Overall Study|New therapy for study indication|0|||
155417843|NCT02435849|560960327|FG000|Overall Study|Subject/guardian decision|5|||
155417844|NCT02435849|560960328|FG001|Overall Study|Subject/guardian decision|1|||
155417845|NCT02435849|560960327|FG000|Overall Study|Lost to Follow-up|1|||
155417846|NCT02435849|560960328|FG001|Overall Study|Lost to Follow-up|0|||
155417847|NCT02435849|560960327|FG000|Overall Study|Physician Decision|1|||
155417848|NCT02435849|560960328|FG001|Overall Study|Physician Decision|0|||
155417849|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
155417850|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155417851|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155417852|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155417853|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155417854|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
155417855|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
155417856|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
155417857|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
155417858|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
155417859|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
155313702|NCT04592549|560581492|FG001|Overall Study|Withdrawal by Subject|1|||
155313703|NCT04592549|560581493|FG002|Overall Study|Withdrawal by Subject|0|||
155313704|NCT04592549|560581494|FG003|Overall Study|Withdrawal by Subject|1|||
155417860|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
155417861|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
155643259|NCT03695094|561783764|FG000|Overall Study|Withdrawal by Subject|1|||
155417862|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
155417863|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
155313705|NCT04592549|560581495|FG004|Overall Study|Withdrawal by Subject|1|||
155313706|NCT04592549|560581496|FG005|Overall Study|Withdrawal by Subject|0|||
155643260|NCT03695094|561783765|FG001|Overall Study|Withdrawal by Subject|0|||
155643261|NCT02323334|561783766|FG000|Period 3|Lost to Follow-up|0|||
155313707|NCT04592549|560581491|FG000|Overall Study|Lost to Follow-up|2|||
155313708|NCT04592549|560581492|FG001|Overall Study|Lost to Follow-up|0|||
155313709|NCT04592549|560581493|FG002|Overall Study|Lost to Follow-up|0|||
155313710|NCT04592549|560581494|FG003|Overall Study|Lost to Follow-up|1|||
155313711|NCT04592549|560581495|FG004|Overall Study|Lost to Follow-up|1|||
155313712|NCT04592549|560581496|FG005|Overall Study|Lost to Follow-up|1|||
155313713|NCT00686335|560581497|FG000|Run-in Period|Adverse Event|1|||
155500241|NCT02803138|561256903|FG000|Overall Study|Other, not specified|28|||
155313714|NCT00686335|560581497|FG000|Run-in Period|asthma exacerbation|1|||
155313715|NCT00686335|560581497|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
155313716|NCT05603143|560581500|FG000|Overall Study|Withdrew consent|6|||
155313717|NCT05603143|560581501|FG001|Overall Study|Withdrew consent|2|||
155313718|NCT05603143|560581500|FG000|Overall Study|Randomized but never treated|0|||
155313719|NCT05603143|560581501|FG001|Overall Study|Randomized but never treated|3|||
155313720|NCT05603143|560581500|FG000|Overall Study|Adverse Event|2|||
155313721|NCT05603143|560581501|FG001|Overall Study|Adverse Event|0|||
155313722|NCT05603143|560581500|FG000|Overall Study|Death|0|||
155313723|NCT05603143|560581501|FG001|Overall Study|Death|1|||
155313724|NCT05603143|560581500|FG000|Overall Study|Investigator's discretion|1|||
155313725|NCT05603143|560581501|FG001|Overall Study|Investigator's discretion|0|||
155313726|NCT05603143|560581500|FG000|Overall Study|Lost to Follow-up|0|||
155313727|NCT05603143|560581501|FG001|Overall Study|Lost to Follow-up|1|||
155313728|NCT05603143|560581500|FG000|Overall Study|Protocol Violation|0|||
155313729|NCT05603143|560581501|FG001|Overall Study|Protocol Violation|1|||
155313730|NCT03524612|560581506|FG000|Overall Study|Lack of Efficacy|10|||
155313731|NCT03524612|560581506|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
155313732|NCT03524612|560581506|FG000|Overall Study|Adverse Event|10|||
155313733|NCT03524612|560581506|FG000|Overall Study|Withdrawal by Subject|7|||
155313734|NCT03524612|560581506|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
155313735|NCT03524612|560581506|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
155313736|NCT03524612|560581506|FG000|Overall Study|New therapy for study indication|6|||
155313737|NCT03524612|560581506|FG000|Overall Study|Death|3|||
155313738|NCT03524612|560581506|FG000|Overall Study|Lost to Follow-up|2|||
155313739|NCT03524612|560581506|FG000|Overall Study|Protocol Violation|1|||
155313740|NCT05609760|560581507|FG000|Overall Study|Lost to Follow-up|0|||
155313741|NCT05609760|560581508|FG001|Overall Study|Lost to Follow-up|1|||
155313742|NCT05609760|560581507|FG000|Overall Study|Withdrawal by Subject|1|||
155313743|NCT05609760|560581508|FG001|Overall Study|Withdrawal by Subject|0|||
155313744|NCT03396588|560581511|FG000|Overall Study|Physician Decision|2|||
155313745|NCT03396588|560581512|FG001|Overall Study|Physician Decision|3|||
155313746|NCT05179395|560581513|FG000|Overall Study|Lack of Efficacy|1|||
155313747|NCT00812461|560581515|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
155313748|NCT00812461|560581516|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
155313749|NCT00812461|560581515|FG000|All Treated Patients|Adverse Event|8|||
155500242|NCT02237118|561256906|FG000|Overall Study|Protocol Violation|0|||
155313750|NCT00812461|560581516|FG001|All Treated Patients|Adverse Event|15|||
155500243|NCT02237118|561256907|FG001|Overall Study|Protocol Violation|1|||
155500244|NCT02237118|561256906|FG000|Overall Study|consent withdrawn|1|||
155500245|NCT02237118|561256907|FG001|Overall Study|consent withdrawn|0|||
155500246|NCT00569231|561256908|FG000|Overall Study|Study unrelated surgery|1|||
155313751|NCT00812461|560581515|FG000|All Treated Patients|Lack of Efficacy|13|||
155313752|NCT00812461|560581516|FG001|All Treated Patients|Lack of Efficacy|7|||
155313753|NCT00812461|560581515|FG000|All Treated Patients|Non-compliance|6|||
155313754|NCT00812461|560581516|FG001|All Treated Patients|Non-compliance|9|||
155313755|NCT00812461|560581515|FG000|All Treated Patients|Protocol Violation|36|||
155313756|NCT00812461|560581516|FG001|All Treated Patients|Protocol Violation|27|||
155313757|NCT00812461|560581515|FG000|All Treated Patients|Withdrawal by Subject|45|||
155313758|NCT00812461|560581516|FG001|All Treated Patients|Withdrawal by Subject|54|||
155313759|NCT00812461|560581515|FG000|All Treated Patients|Lost to Follow-up|11|||
155313760|NCT00812461|560581516|FG001|All Treated Patients|Lost to Follow-up|14|||
155313761|NCT00812461|560581515|FG000|All Treated Patients|Other Reason|13|||
155313762|NCT00812461|560581516|FG001|All Treated Patients|Other Reason|21|||
155313763|NCT03891667|560583136|FG000|Overall Study|Physician Decision|1|||
155313764|NCT03891667|560583137|FG001|Overall Study|Physician Decision|1|||
155313765|NCT03891667|560583136|FG000|Overall Study|COVID related pause|1|||
155313766|NCT03891667|560583137|FG001|Overall Study|COVID related pause|0|||
155313767|NCT03891667|560583136|FG000|Overall Study|Withdrawal by Subject|0|||
155313768|NCT03891667|560583137|FG001|Overall Study|Withdrawal by Subject|1|||
155313769|NCT03891667|560583136|FG000|Overall Study|Adverse Event|0|||
155313770|NCT03891667|560583137|FG001|Overall Study|Adverse Event|1|||
155313771|NCT05659537|560583138|FG000|Overall Study|Adverse Event|5|||
155313772|NCT05659537|560583138|FG000|Overall Study|Lost to Follow-up|4|||
155313773|NCT05659537|560583138|FG000|Overall Study|Withdrawal by Subject|13|||
155313774|NCT05659537|560583138|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
155313775|NCT05659537|560583138|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
155313776|NCT05659537|560583138|FG000|Overall Study|Participant was suffering from anaemia|1|||
155313777|NCT00506519|560583144|FG000|Overall Study|Death|4|||
155313778|NCT00506519|560583145|FG001|Overall Study|Death|6|||
155313779|NCT00506519|560583146|FG002|Overall Study|Death|0|||
155313780|NCT00506519|560583144|FG000|Overall Study|Adverse Event|1|||
155500247|NCT00569231|561256908|FG000|Overall Study|Airfare expense|2|||
155313781|NCT00506519|560583145|FG001|Overall Study|Adverse Event|0|||
155313782|NCT00506519|560583146|FG002|Overall Study|Adverse Event|0|||
155313783|NCT02105766|560583147|FG000|Overall Study|Physician Decision|1|||
155313784|NCT02105766|560583148|FG001|Overall Study|Physician Decision|1|||
155313785|NCT02105766|560583149|FG002|Overall Study|Physician Decision|0|||
155313786|NCT02105766|560583147|FG000|Overall Study|Lost to Follow-up|2|||
155500248|NCT00569231|561256908|FG000|Overall Study|Withdrawal by Subject|1|||
155500249|NCT00569231|561256908|FG000|Overall Study|Car accident injury|1|||
155500250|NCT00569231|561256908|FG000|Overall Study|Non-compliance|2|||
155500251|NCT00399490|561256911|FG000|Overall Study|Adverse Event|19|||
155500252|NCT00399490|561256911|FG000|Overall Study|Lack of Efficacy|31|||
155500253|NCT00399490|561256911|FG000|Overall Study|Lost to Follow-up|5|||
155313787|NCT02105766|560583148|FG001|Overall Study|Lost to Follow-up|0|||
155313788|NCT02105766|560583149|FG002|Overall Study|Lost to Follow-up|0|||
155313789|NCT02105766|560583147|FG000|Overall Study|Death|1|||
155313790|NCT02105766|560583148|FG001|Overall Study|Death|1|||
155313791|NCT02105766|560583149|FG002|Overall Study|Death|0|||
155313792|NCT03867500|560583150|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
155313793|NCT02577835|560583151|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
155313794|NCT04749615|560583152|FG000|Overall Study|Lost to Follow-up|6|||
155313795|NCT04749615|560583153|FG001|Overall Study|Lost to Follow-up|10|||
155313796|NCT03611491|560583154|FG000|Overall Study|Lost to Follow-up|1|||
155313797|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
155313798|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
155313799|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
155313800|NCT05409183|560583158|FG000|Complete Study|Adverse Event|1|||
155417864|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
155417865|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155417866|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155417867|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155417868|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155417869|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
155417870|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
155417871|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
155417872|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
155417873|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
155417874|NCT01017952|560960329|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
155417875|NCT01017952|560960330|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155417876|NCT01017952|560960331|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155417877|NCT01017952|560960332|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155417878|NCT01017952|560960333|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155417879|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
155417880|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
155417881|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
155417882|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
155417883|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
155417884|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155417885|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
155417886|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
155417887|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
155417888|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
155417889|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
155417890|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
155417891|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
155417892|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
155417893|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
155417894|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
155417895|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
155417896|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
155417897|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
155417898|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
155417899|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155500254|NCT00399490|561256911|FG000|Overall Study|Withdrawal by Subject|18|||
155313801|NCT05409183|560583159|FG001|Complete Study|Adverse Event|2|||
155500255|NCT00399490|561256911|FG000|Overall Study|Other|25|||
155313802|NCT05409183|560583158|FG000|Complete Study|Withdrawal by Subject|3|||
155417900|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
155514012|NCT01185288|561308223|FG000|Overall Study|Did not meet inclusion criteria|1|||
155313803|NCT05409183|560583159|FG001|Complete Study|Withdrawal by Subject|0|||
155417901|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
155417902|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
155417903|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
155417904|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155417905|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
155417906|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
155417907|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155417908|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155417909|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155417910|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
155417911|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
155417912|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
155417913|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
155417914|NCT01017952|560960329|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
155417915|NCT01017952|560960330|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
155417916|NCT01017952|560960331|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
155417917|NCT01017952|560960332|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
155417918|NCT01017952|560960333|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
155417919|NCT01064167|560960334|FG000|Overall Study|Protocol Violation|14|||
155417920|NCT01064167|560960335|FG001|Overall Study|Protocol Violation|15|||
155417921|NCT03984305|560960338|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
155417922|NCT03984305|560960339|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
155417923|NCT03984305|560960338|FG000|Overall Study|Withdrawal by Subject|3|||
155417924|NCT03984305|560960339|FG001|Overall Study|Withdrawal by Subject|3|||
155313804|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
155313805|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
155313806|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
155313807|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313808|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313809|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313810|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313811|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313812|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
155313813|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313814|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313815|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313816|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313817|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313818|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313819|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
155313820|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
155313821|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313822|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313823|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313824|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313825|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
155313826|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313827|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313828|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313829|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313830|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313831|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313832|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313833|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
155313834|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313835|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313836|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313837|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313838|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313839|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155417925|NCT03984305|560960338|FG000|Overall Study|Lost to Follow-up|1|||
155313840|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313841|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313842|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
155313843|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313844|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155417926|NCT03984305|560960339|FG001|Overall Study|Lost to Follow-up|0|||
155417927|NCT00352105|560960340|FG000|Overall Study|Death|5|||
155417928|NCT00352105|560960340|FG000|Overall Study|Withdrawal by Subject|5|||
155643262|NCT02323334|561783767|FG001|Period 3|Lost to Follow-up|0|||
155313845|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313846|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313847|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313848|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313849|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313850|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313851|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313852|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
155313853|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313854|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313855|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313856|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313857|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
155313858|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313859|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
155313860|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313861|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313862|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313863|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313864|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313865|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313866|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
155313867|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313868|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
155313869|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313870|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313871|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313872|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313873|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313874|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313875|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313876|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313877|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313878|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
155313879|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313880|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313881|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313882|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313883|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313884|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313885|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
155313886|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313887|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313888|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313889|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
155313890|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
155313891|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
155313892|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313893|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313894|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313895|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
155313896|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
155313897|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
155313898|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
155313899|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
155313900|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
155417929|NCT00352105|560960340|FG000|Overall Study|Lack of Efficacy|9|||
155417930|NCT00352105|560960340|FG000|Overall Study|Adverse Event|19|||
155417931|NCT00352105|560960340|FG000|Overall Study|Protocol Violation|2|||
155417932|NCT02979431|560960343|FG000|Overall Study|Parent/guardian withdrew consent|2|||
155417933|NCT02979431|560960344|FG001|Overall Study|Parent/guardian withdrew consent|1|||
155417934|NCT02979431|560960345|FG002|Overall Study|Parent/guardian withdrew consent|1|||
155417935|NCT02979431|560960346|FG003|Overall Study|Parent/guardian withdrew consent|1|||
155417936|NCT02979431|560960343|FG000|Overall Study|Randomized but received no study drug|1|||
155417937|NCT02979431|560960344|FG001|Overall Study|Randomized but received no study drug|1|||
155417938|NCT02979431|560960345|FG002|Overall Study|Randomized but received no study drug|0|||
155417939|NCT02979431|560960346|FG003|Overall Study|Randomized but received no study drug|0|||
155417940|NCT02979431|560960343|FG000|Overall Study|Adverse Event|0|||
155417941|NCT02979431|560960344|FG001|Overall Study|Adverse Event|0|||
155417942|NCT02979431|560960345|FG002|Overall Study|Adverse Event|1|||
155417943|NCT02979431|560960346|FG003|Overall Study|Adverse Event|0|||
155417944|NCT02979431|560960343|FG000|Overall Study|Subject left country after Day14|1|||
155417945|NCT02979431|560960344|FG001|Overall Study|Subject left country after Day14|0|||
155417946|NCT02979431|560960345|FG002|Overall Study|Subject left country after Day14|0|||
155417947|NCT02979431|560960346|FG003|Overall Study|Subject left country after Day14|0|||
155417948|NCT01656434|560960347|FG000|Overall Study|Adverse Event|199|||
155417949|NCT01656434|560960348|FG001|Overall Study|Adverse Event|63|||
155417950|NCT01656434|560960347|FG000|Overall Study|Enrollment terminated at trial site|2|||
155417951|NCT01656434|560960348|FG001|Overall Study|Enrollment terminated at trial site|0|||
155417952|NCT01656434|560960347|FG000|Overall Study|Lost to Follow-up|309|||
155417953|NCT01656434|560960348|FG001|Overall Study|Lost to Follow-up|76|||
155417954|NCT01656434|560960347|FG000|Overall Study|Site discontinued study participation|24|||
155417955|NCT01656434|560960348|FG001|Overall Study|Site discontinued study participation|9|||
155417956|NCT01656434|560960347|FG000|Overall Study|Screen failure|2|||
155417957|NCT01656434|560960348|FG001|Overall Study|Screen failure|0|||
155417958|NCT01656434|560960347|FG000|Overall Study|Protocol Violation|7|||
155417959|NCT01656434|560960348|FG001|Overall Study|Protocol Violation|0|||
155417960|NCT01656434|560960347|FG000|Overall Study|Pregnancy wish|18|||
155417961|NCT01656434|560960348|FG001|Overall Study|Pregnancy wish|6|||
155417962|NCT01656434|560960347|FG000|Overall Study|Pregnancy|45|||
155417963|NCT01656434|560960348|FG001|Overall Study|Pregnancy|10|||
155417964|NCT01656434|560960347|FG000|Overall Study|Physician Decision|7|||
155417965|NCT01656434|560960348|FG001|Overall Study|Physician Decision|2|||
155417966|NCT01656434|560960347|FG000|Overall Study|Non-compliance with study drug|48|||
155417967|NCT01656434|560960348|FG001|Overall Study|Non-compliance with study drug|9|||
155417968|NCT01656434|560960347|FG000|Overall Study|Study terminated by sponsor|1501|||
155417969|NCT01656434|560960348|FG001|Overall Study|Study terminated by sponsor|348|||
155417970|NCT01656434|560960347|FG000|Overall Study|Participant discontinued; drug related|13|||
155417971|NCT01656434|560960348|FG001|Overall Study|Participant discontinued; drug related|4|||
155417972|NCT01656434|560960347|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
155417973|NCT01656434|560960348|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
155417974|NCT01656434|560960347|FG000|Overall Study|Non-compliance with protocol|39|||
155417975|NCT01656434|560960348|FG001|Overall Study|Non-compliance with protocol|15|||
155417976|NCT01656434|560960347|FG000|Overall Study|Participant moved|40|||
155417977|NCT01656434|560960348|FG001|Overall Study|Participant moved|12|||
155417978|NCT01656434|560960347|FG000|Overall Study|Participant withdrew consent|28|||
155417979|NCT01656434|560960348|FG001|Overall Study|Participant withdrew consent|9|||
155417980|NCT01656434|560960347|FG000|Overall Study|Withdrawal by Subject|64|||
155417981|NCT01656434|560960348|FG001|Overall Study|Withdrawal by Subject|7|||
155417982|NCT01727258|560960349|FG000|Overall Study|Adverse Event|0|||
155417983|NCT01727258|560960350|FG001|Overall Study|Adverse Event|2|||
155417984|NCT01727258|560960351|FG002|Overall Study|Adverse Event|0|||
155417985|NCT01727258|560960349|FG000|Overall Study|Noncompliance with Study Drug|0|||
155417986|NCT01727258|560960350|FG001|Overall Study|Noncompliance with Study Drug|0|||
155417987|NCT01727258|560960351|FG002|Overall Study|Noncompliance with Study Drug|1|||
155417988|NCT01727258|560960349|FG000|Overall Study|Withdrawal by Subject|1|||
155417989|NCT01727258|560960350|FG001|Overall Study|Withdrawal by Subject|1|||
155417990|NCT01727258|560960351|FG002|Overall Study|Withdrawal by Subject|0|||
155417991|NCT01727258|560960349|FG000|Overall Study|Lost to Follow-up|1|||
155417992|NCT01727258|560960350|FG001|Overall Study|Lost to Follow-up|0|||
155417993|NCT01727258|560960351|FG002|Overall Study|Lost to Follow-up|0|||
155417994|NCT01818726|560960362|FG000|Overall Study|Administrative reasons|5|||
155417995|NCT01818726|560960363|FG001|Overall Study|Administrative reasons|1|||
155417996|NCT01818726|560960362|FG000|Overall Study|Withdrawal by Subject|0|||
155417997|NCT01818726|560960363|FG001|Overall Study|Withdrawal by Subject|1|||
155417998|NCT01818726|560960362|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
155417999|NCT01818726|560960363|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
155418000|NCT00993928|560960369|FG000|Overall Study|Withdrawal by Subject|4|||
155418001|NCT00993928|560960370|FG001|Overall Study|Withdrawal by Subject|7|||
155418002|NCT00993928|560960369|FG000|Overall Study|ineligible|1|||
155418003|NCT00993928|560960370|FG001|Overall Study|ineligible|0|||
155643263|NCT02323334|561783768|FG002|Period 3|Lost to Follow-up|1|||
155500256|NCT04723173|561256916|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
155500257|NCT00953927|561256917|FG000|Overall Study|Lost to Follow-up|61|||
155500258|NCT00953927|561256918|FG001|Overall Study|Lost to Follow-up|65|||
155500259|NCT00953927|561256917|FG000|Overall Study|Withdrawal by Subject|36|||
155500260|NCT00953927|561256918|FG001|Overall Study|Withdrawal by Subject|25|||
155500261|NCT00953927|561256917|FG000|Overall Study|Death|7|||
155500262|NCT00953927|561256918|FG001|Overall Study|Death|4|||
155500263|NCT00953927|561256917|FG000|Overall Study|Other study discontinuation|1|||
155500264|NCT00953927|561256918|FG001|Overall Study|Other study discontinuation|1|||
155500265|NCT01396161|561256920|FG000|Overall Study|Withdrawal by Subject|0|||
155500266|NCT01396161|561256921|FG001|Overall Study|Withdrawal by Subject|0|||
155500267|NCT01396161|561256922|FG002|Overall Study|Withdrawal by Subject|0|||
155500268|NCT01396161|561256923|FG003|Overall Study|Withdrawal by Subject|0|||
155500269|NCT01396161|561256924|FG004|Overall Study|Withdrawal by Subject|1|||
155500270|NCT01396161|561256925|FG005|Overall Study|Withdrawal by Subject|0|||
155500271|NCT01396161|561256926|FG006|Overall Study|Withdrawal by Subject|0|||
155500272|NCT01396161|561256920|FG000|Overall Study|Other|0|||
155500273|NCT01396161|561256921|FG001|Overall Study|Other|0|||
155500274|NCT01396161|561256922|FG002|Overall Study|Other|0|||
155500275|NCT01396161|561256923|FG003|Overall Study|Other|0|||
155500276|NCT01396161|561256924|FG004|Overall Study|Other|0|||
155500277|NCT01396161|561256925|FG005|Overall Study|Other|0|||
155500278|NCT01396161|561256926|FG006|Overall Study|Other|1|||
155500279|NCT02962739|561256931|FG000|Overall Study|Withdrawal by Subject|0|||
155500280|NCT02962739|561256932|FG001|Overall Study|Withdrawal by Subject|1|||
155500281|NCT02962739|561256933|FG002|Overall Study|Withdrawal by Subject|0|||
155500282|NCT02962739|561256934|FG003|Overall Study|Withdrawal by Subject|0|||
155500283|NCT02962739|561256935|FG004|Overall Study|Withdrawal by Subject|0|||
155500284|NCT02962739|561256936|FG005|Overall Study|Withdrawal by Subject|0|||
155500285|NCT02962739|561256931|FG000|Overall Study|Protocol Violation|0|||
155500286|NCT02962739|561256932|FG001|Overall Study|Protocol Violation|0|||
155500287|NCT02962739|561256933|FG002|Overall Study|Protocol Violation|1|||
155500288|NCT02962739|561256934|FG003|Overall Study|Protocol Violation|0|||
155500289|NCT02962739|561256935|FG004|Overall Study|Protocol Violation|1|||
155500290|NCT02962739|561256936|FG005|Overall Study|Protocol Violation|0|||
155500291|NCT00414011|561256937|FG000|Overall Study|Physician Decision|3|||
155500292|NCT00414011|561256937|FG000|Overall Study|Withdrawal by Subject|2|||
155500293|NCT00306852|561256938|FG000|Overall Study|Death|14|||
155500294|NCT00306852|561256939|FG001|Overall Study|Death|14|||
155500295|NCT00306852|561256938|FG000|Overall Study|Lost to Follow-up|15|||
155500296|NCT00306852|561256939|FG001|Overall Study|Lost to Follow-up|24|||
155500297|NCT00817778|561256941|FG000|Overall Study|Adverse Event|1|||
155500298|NCT00817778|561256942|FG001|Overall Study|Adverse Event|0|||
155500299|NCT00817778|561256941|FG000|Overall Study|Withdrawal by Subject|1|||
155500300|NCT00817778|561256942|FG001|Overall Study|Withdrawal by Subject|1|||
155500301|NCT00817778|561256941|FG000|Overall Study|Protocol Violation|0|||
155500302|NCT00817778|561256942|FG001|Overall Study|Protocol Violation|1|||
155500303|NCT00817778|561256941|FG000|Overall Study|Study-specific discontinuation criteria|0|||
155500304|NCT00817778|561256942|FG001|Overall Study|Study-specific discontinuation criteria|1|||
155500305|NCT00817778|561256941|FG000|Overall Study|Poor venous access|1|||
155500306|NCT00817778|561256942|FG001|Overall Study|Poor venous access|0|||
155500307|NCT03343054|561256943|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
155500308|NCT03343054|561256944|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
155500309|NCT03343054|561256945|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
155500310|NCT03343054|561256943|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
155500311|NCT03343054|561256944|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
155500312|NCT03343054|561256945|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
155500313|NCT03343054|561256943|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
155500314|NCT03343054|561256944|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
155500315|NCT03343054|561256945|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
155500316|NCT03343054|561256943|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
155500317|NCT03343054|561256944|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
155500318|NCT03343054|561256945|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
155500319|NCT01537549|561256946|FG000|Overall Study|Lost to Follow-up|1|||
155500320|NCT01537549|561256946|FG000|Overall Study|Withdrawal by Subject|2|||
155500321|NCT00883740|561256947|FG000|First Intervention|Lost to Follow-up|1|||
155500322|NCT00883740|561256948|FG001|First Intervention|Lost to Follow-up|0|||
155500323|NCT00883740|561256947|FG000|First Intervention|No longer willing to participate|2|||
155500324|NCT00883740|561256948|FG001|First Intervention|No longer willing to participate|0|||
155500325|NCT00883740|561256947|FG000|First Intervention|Protocol Violation|3|||
155500326|NCT00883740|561256948|FG001|First Intervention|Protocol Violation|6|||
155500327|NCT00883740|561256947|FG000|First Intervention|Adverse Event|1|||
155643264|NCT02323334|561783769|FG003|Period 3|Lost to Follow-up|0|||
155500328|NCT00883740|561256948|FG001|First Intervention|Adverse Event|2|||
155500329|NCT00883740|561256947|FG000|Second Intervention|Protocol Violation|1|||
155500330|NCT00883740|561256948|FG001|Second Intervention|Protocol Violation|0|||
155500331|NCT00883740|561256947|FG000|Second Intervention|No longer willing to participate|0|||
155500332|NCT00883740|561256948|FG001|Second Intervention|No longer willing to participate|1|||
155500333|NCT01286207|561256949|FG000|Overall Study|Adverse Event|27|||
155500334|NCT01286207|561256950|FG001|Overall Study|Adverse Event|41|||
155500335|NCT01286207|561256951|FG002|Overall Study|Adverse Event|8|||
155500336|NCT01286207|561256949|FG000|Overall Study|Lost to Follow-up|49|||
155500337|NCT01286207|561256950|FG001|Overall Study|Lost to Follow-up|43|||
155500338|NCT01286207|561256951|FG002|Overall Study|Lost to Follow-up|20|||
155500339|NCT01286207|561256949|FG000|Overall Study|Withdrawal by Subject|93|||
155500340|NCT01286207|561256950|FG001|Overall Study|Withdrawal by Subject|79|||
155500341|NCT01286207|561256951|FG002|Overall Study|Withdrawal by Subject|41|||
155500342|NCT01286207|561256949|FG000|Overall Study|Lack of Response|92|||
155500343|NCT01286207|561256950|FG001|Overall Study|Lack of Response|38|||
155500344|NCT01286207|561256951|FG002|Overall Study|Lack of Response|8|||
155500345|NCT01286207|561256949|FG000|Overall Study|Other|37|||
155500346|NCT01286207|561256950|FG001|Overall Study|Other|47|||
155500347|NCT01286207|561256951|FG002|Overall Study|Other|13|||
155500348|NCT01875991|561256956|FG000|Overall Study|Withdrawal by Subject|6|||
155500349|NCT01875991|561256957|FG001|Overall Study|Withdrawal by Subject|6|||
155500350|NCT01875991|561256956|FG000|Overall Study|Sponsor Decision|1|||
155500351|NCT01875991|561256957|FG001|Overall Study|Sponsor Decision|0|||
155500352|NCT04840901|561256958|FG000|Overall Study|Lost to Follow-up|3|||
155500353|NCT04840901|561256959|FG001|Overall Study|Lost to Follow-up|1|||
155500354|NCT04840901|561256958|FG000|Overall Study|Moved|1|||
155500355|NCT04840901|561256959|FG001|Overall Study|Moved|0|||
155500356|NCT04840901|561256958|FG000|Overall Study|Unable to comply with study schedule|0|||
155500357|NCT04840901|561256959|FG001|Overall Study|Unable to comply with study schedule|1|||
155500358|NCT04840901|561256958|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
155500359|NCT04840901|561256959|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
155500360|NCT01268683|561256960|FG000|Overall Study|Lost to Follow-up|1|||
155500361|NCT01268683|561256960|FG000|Overall Study|Death|1|||
155500362|NCT00103259|561256966|FG000|Overall Study|Death|3|||
155500363|NCT00103259|561256967|FG001|Overall Study|Death|2|||
155500364|NCT00103259|561256966|FG000|Overall Study|Withdrawal by Subject|2|||
155500365|NCT00103259|561256967|FG001|Overall Study|Withdrawal by Subject|3|||
155500366|NCT00103259|561256966|FG000|Overall Study|alternative therapy|1|||
155500367|NCT00103259|561256967|FG001|Overall Study|alternative therapy|0|||
155500368|NCT00103259|561256966|FG000|Overall Study|other (reasons were not specified)|2|||
155500369|NCT00103259|561256967|FG001|Overall Study|other (reasons were not specified)|1|||
155500370|NCT00103259|561256966|FG000|Overall Study|ineligible/no protocol therapy|4|||
155500371|NCT00103259|561256967|FG001|Overall Study|ineligible/no protocol therapy|6|||
155500372|NCT03224234|561256968|FG000|Main Study|Lost to Follow-up|5|||
155500373|NCT03224234|561256969|FG001|Main Study|Lost to Follow-up|5|||
155500374|NCT02610842|561256970|FG000|Overall Study|Lost to Follow-up|5|||
155500375|NCT02268045|561256977|FG000|Overall Study|Death|4|||
155500376|NCT02268045|561256978|FG001|Overall Study|Death|4|||
155500377|NCT02268045|561256977|FG000|Overall Study|Disease Progression|2|||
155500378|NCT02268045|561256978|FG001|Overall Study|Disease Progression|1|||
155500379|NCT02268045|561256977|FG000|Overall Study|Adverse Event|7|||
155500380|NCT02268045|561256978|FG001|Overall Study|Adverse Event|7|||
155500381|NCT02268045|561256977|FG000|Overall Study|Withdrawal by Subject|2|||
155500382|NCT02268045|561256978|FG001|Overall Study|Withdrawal by Subject|6|||
155500383|NCT02268045|561256977|FG000|Overall Study|Physician Decision|0|||
155500384|NCT02268045|561256978|FG001|Overall Study|Physician Decision|1|||
155500385|NCT02268045|561256977|FG000|Overall Study|Protocol Violation|1|||
155500386|NCT02268045|561256978|FG001|Overall Study|Protocol Violation|1|||
155500387|NCT02125734|561256980|FG000|Period 2|Adverse Event|0|||
155500388|NCT02125734|561256981|FG001|Period 2|Adverse Event|1|||
155500389|NCT01308762|561256982|FG000|Overall Study|Protocol Violation|0|||
155500390|NCT01308762|561256983|FG001|Overall Study|Protocol Violation|1|||
155500391|NCT01308762|561256984|FG002|Overall Study|Protocol Violation|0|||
155500392|NCT02617446|561256985|FG000|Overall Study|Withdrawal by Subject|0|||
155500393|NCT02617446|561256986|FG001|Overall Study|Withdrawal by Subject|2|||
155500394|NCT02617446|561256987|FG002|Overall Study|Withdrawal by Subject|0|||
155500395|NCT02617446|561256985|FG000|Overall Study|Adverse Event|1|||
155500396|NCT02617446|561256986|FG001|Overall Study|Adverse Event|0|||
155500397|NCT02617446|561256987|FG002|Overall Study|Adverse Event|5|||
155500398|NCT02617446|561256985|FG000|Overall Study|Lost to Follow-up|3|||
155500399|NCT02617446|561256986|FG001|Overall Study|Lost to Follow-up|0|||
155500400|NCT02617446|561256987|FG002|Overall Study|Lost to Follow-up|0|||
155500401|NCT02617446|561256985|FG000|Overall Study|Death|0|||
155500402|NCT02617446|561256986|FG001|Overall Study|Death|0|||
155500403|NCT02617446|561256987|FG002|Overall Study|Death|2|||
155500404|NCT01556490|561256996|FG000|Randomized Patients Summary|Protocol Violation|22|||
155500405|NCT01556490|561256997|FG001|Randomized Patients Summary|Protocol Violation|23|||
155643265|NCT02323334|561783770|FG004|Period 3|Lost to Follow-up|0|||
155500406|NCT01556490|561256996|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
155500407|NCT01556490|561256997|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
155500408|NCT06065176|561256998|FG000|Overall Study|Lost to Follow-up|11|||
155500409|NCT06065176|561256999|FG001|Overall Study|Lost to Follow-up|11|||
155313901|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
155313902|NCT04806451|560583167|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
155313903|NCT04806451|560583168|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
155313904|NCT04806451|560583167|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
155313905|NCT04806451|560583168|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
155313906|NCT04806451|560583167|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
155500410|NCT06065176|561257000|FG002|Overall Study|Lost to Follow-up|10|||
155500411|NCT06065176|561256998|FG000|Overall Study|Withdrawal by Subject|1|||
155313907|NCT04806451|560583168|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
155313908|NCT02936752|560583169|FG000|Overall Study|Death|2|||
155313909|NCT02936752|560583170|FG001|Overall Study|Death|1|||
155313910|NCT02936752|560583169|FG000|Overall Study|Physician Decision|4|||
155313911|NCT02936752|560583170|FG001|Overall Study|Physician Decision|0|||
155313912|NCT02936752|560583169|FG000|Overall Study|Withdrawal by Subject|0|||
155313913|NCT02936752|560583170|FG001|Overall Study|Withdrawal by Subject|2|||
155500412|NCT06065176|561256999|FG001|Overall Study|Withdrawal by Subject|1|||
155500413|NCT06065176|561257000|FG002|Overall Study|Withdrawal by Subject|2|||
155500414|NCT06065176|561256998|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
155500415|NCT06065176|561256999|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
155500416|NCT06065176|561257000|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
155500417|NCT02588651|561257001|FG000|Overall Study|Adverse Event|1|||
155500418|NCT02588651|561257001|FG000|Overall Study|Withdrawal by Subject|2|||
155500419|NCT02588651|561257001|FG000|Overall Study|Death|1|||
155500420|NCT02588651|561257001|FG000|Overall Study|Lack of Efficacy|13|||
155500421|NCT02588651|561257001|FG000|Overall Study|Lost to Follow-up|1|||
155500422|NCT02588651|561257001|FG000|Overall Study|Physician Decision|1|||
155500423|NCT02588651|561257001|FG000|Overall Study|Disease progression|2|||
155500424|NCT03107715|561257006|FG000|Overall Study|did not deliver at the home hospital|4|||
155500425|NCT03107715|561257007|FG001|Overall Study|did not deliver at the home hospital|6|||
155500426|NCT03107715|561257006|FG000|Overall Study|infant stillborn|0|||
155500427|NCT03107715|561257007|FG001|Overall Study|infant stillborn|1|||
155500428|NCT03252756|561257010|FG000|Overall Study|Protocol Violation|2|||
155313914|NCT05894577|560583173|FG000|Overall Study|No receipt of study drug|14|||
155313915|NCT05894577|560583174|FG001|Overall Study|No receipt of study drug|13|||
155313916|NCT05894577|560583173|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
155313917|NCT05894577|560583174|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
155313918|NCT05894577|560583173|FG000|Overall Study|Screen Fail|2|||
155313919|NCT05894577|560583174|FG001|Overall Study|Screen Fail|0|||
155313920|NCT05894577|560583173|FG000|Overall Study|Study drug recall|86|||
155500429|NCT03252756|561257011|FG001|Overall Study|Protocol Violation|4|||
155500430|NCT03252756|561257010|FG000|Overall Study|COVID-19 Pandemic|1|||
155500431|NCT03252756|561257011|FG001|Overall Study|COVID-19 Pandemic|1|||
155500432|NCT03252756|561257010|FG000|Overall Study|Study Drug Expiration|0|||
155500433|NCT03252756|561257011|FG001|Overall Study|Study Drug Expiration|1|||
155500434|NCT02706353|561257012|FG000|Dose Level 1|Disease Progression|1|||
155500435|NCT02706353|561257013|FG001|Dose Level 1|Disease Progression|0|||
155500436|NCT02706353|561257014|FG002|Dose Level 1|Disease Progression|0|||
155500437|NCT02706353|561257015|FG003|Dose Level 1|Disease Progression|0|||
155500438|NCT02706353|561257016|FG004|Dose Level 1|Disease Progression|0|||
155500439|NCT02706353|561257017|FG005|Dose Level 1|Disease Progression|0|||
155500440|NCT02706353|561257012|FG000|Dose Level 3|Disease Progression|0|||
155500441|NCT02706353|561257013|FG001|Dose Level 3|Disease Progression|0|||
155500442|NCT02706353|561257014|FG002|Dose Level 3|Disease Progression|2|||
155313921|NCT05894577|560583174|FG001|Overall Study|Study drug recall|63|||
155500443|NCT02706353|561257015|FG003|Dose Level 3|Disease Progression|0|||
155500444|NCT02706353|561257016|FG004|Dose Level 3|Disease Progression|0|||
155500445|NCT02706353|561257017|FG005|Dose Level 3|Disease Progression|0|||
155500446|NCT02706353|561257012|FG000|Dose Level 4|Disease Progression|0|||
155500447|NCT02706353|561257013|FG001|Dose Level 4|Disease Progression|0|||
155643266|NCT02323334|561783771|FG005|Period 3|Lost to Follow-up|0|||
155643267|NCT02323334|561783772|FG006|Period 3|Lost to Follow-up|0|||
155313922|NCT05292365|560583179|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
155500448|NCT02706353|561257014|FG002|Dose Level 4|Disease Progression|0|||
155500449|NCT02706353|561257015|FG003|Dose Level 4|Disease Progression|1|||
155500450|NCT02706353|561257016|FG004|Dose Level 4|Disease Progression|0|||
155500451|NCT02706353|561257017|FG005|Dose Level 4|Disease Progression|0|||
155500452|NCT02706353|561257012|FG000|Dose Level 4|Toxicity|0|||
155500453|NCT02706353|561257013|FG001|Dose Level 4|Toxicity|0|||
155500454|NCT02706353|561257014|FG002|Dose Level 4|Toxicity|0|||
155500455|NCT02706353|561257015|FG003|Dose Level 4|Toxicity|1|||
155500456|NCT02706353|561257016|FG004|Dose Level 4|Toxicity|0|||
155643268|NCT02323334|561783773|FG007|Period 3|Lost to Follow-up|0|||
155313923|NCT05292365|560583180|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
155313924|NCT05292365|560583181|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
155313925|NCT05292365|560583182|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
155313926|NCT05282173|560583183|FG000|Overall Study|Missed|3|||
155313927|NCT05282173|560583184|FG001|Overall Study|Missed|2|||
155313928|NCT05282173|560583185|FG002|Overall Study|Missed|4|||
155313929|NCT02023866|560583195|FG000|Overall Study|Non-compliance|2|||
155313930|NCT02023866|560583195|FG000|Overall Study|Adverse Event|3|||
155313931|NCT02023866|560583195|FG000|Overall Study|Withdrawal by Subject|1|||
155313932|NCT01798498|560583203|FG000|Overall Study|Lost to Follow-up|1|||
155313933|NCT04295798|560583208|FG000|Overall Study|Lost to Follow-up|1|||
155313934|NCT03524118|560583211|FG000|Overall Study|Lost to Follow-up|0|||
155313935|NCT03524118|560583212|FG001|Overall Study|Lost to Follow-up|0|||
155313936|NCT03524118|560583213|FG002|Overall Study|Lost to Follow-up|0|||
155313937|NCT03524118|560583214|FG003|Overall Study|Lost to Follow-up|0|||
155313938|NCT03524118|560583215|FG004|Overall Study|Lost to Follow-up|1|||
155313939|NCT03524118|560583216|FG005|Overall Study|Lost to Follow-up|0|||
155313940|NCT03524118|560583211|FG000|Overall Study|Other|0|||
155313941|NCT03524118|560583212|FG001|Overall Study|Other|1|||
155313942|NCT03524118|560583213|FG002|Overall Study|Other|0|||
155313943|NCT03524118|560583214|FG003|Overall Study|Other|0|||
155313944|NCT03524118|560583215|FG004|Overall Study|Other|1|||
155313945|NCT03524118|560583216|FG005|Overall Study|Other|1|||
155313946|NCT03524118|560583211|FG000|Overall Study|Physician Decision|0|||
155313947|NCT03524118|560583212|FG001|Overall Study|Physician Decision|0|||
155313948|NCT03524118|560583213|FG002|Overall Study|Physician Decision|0|||
155313949|NCT03524118|560583214|FG003|Overall Study|Physician Decision|0|||
155313950|NCT03524118|560583215|FG004|Overall Study|Physician Decision|1|||
155313951|NCT03524118|560583216|FG005|Overall Study|Physician Decision|0|||
155313952|NCT03524118|560583211|FG000|Overall Study|Protocol Violation|0|||
155313953|NCT03524118|560583212|FG001|Overall Study|Protocol Violation|0|||
155313954|NCT03524118|560583213|FG002|Overall Study|Protocol Violation|1|||
155313955|NCT03524118|560583214|FG003|Overall Study|Protocol Violation|0|||
155313956|NCT03524118|560583215|FG004|Overall Study|Protocol Violation|1|||
155313957|NCT03524118|560583216|FG005|Overall Study|Protocol Violation|0|||
155313958|NCT03524118|560583211|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155313959|NCT03524118|560583212|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155313960|NCT03524118|560583213|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155313961|NCT03524118|560583214|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
155313962|NCT03524118|560583215|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
155313963|NCT03524118|560583216|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155500457|NCT02706353|561257017|FG005|Dose Level 4|Toxicity|0|||
155500458|NCT02706353|561257012|FG000|Dose Level 4|Death|0|||
155313966|NCT04650269|560583220|FG000|Overall Study|Death|3|||
155313967|NCT04650269|560583220|FG000|Overall Study|Lost to Follow-up|6|||
155313968|NCT01437709|560583221|FG000|Overall Study|Adverse Event|0|||
155313969|NCT01437709|560583222|FG001|Overall Study|Adverse Event|1|||
155313970|NCT01437709|560583223|FG002|Overall Study|Adverse Event|0|||
155313971|NCT01437709|560583221|FG000|Overall Study|Pt trasnferred care|0|||
155313972|NCT01437709|560583222|FG001|Overall Study|Pt trasnferred care|1|||
155313973|NCT01437709|560583223|FG002|Overall Study|Pt trasnferred care|0|||
155313974|NCT04091750|560583224|FG000|Overall Study|Adverse Event|4|||
155313975|NCT04091750|560583224|FG000|Overall Study|Withdrawal by Subject|1|||
155313976|NCT02319759|560583225|FG000|Week 0 - 16|Lack of Efficacy|1|||
155313977|NCT02319759|560583226|FG001|Week 0 - 16|Lack of Efficacy|0|||
155313978|NCT02319759|560583227|FG002|Week 0 - 16|Lack of Efficacy|0|||
155313979|NCT02319759|560583228|FG003|Week 0 - 16|Lack of Efficacy|0|||
155313980|NCT02319759|560583229|FG004|Week 0 - 16|Lack of Efficacy|0|||
155313981|NCT02319759|560583225|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313982|NCT02319759|560583226|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313983|NCT02319759|560583227|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
155313984|NCT02319759|560583228|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313985|NCT02319759|560583229|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313986|NCT02319759|560583225|FG000|Week 16 - 24|Lack of Efficacy|1|||
155313987|NCT02319759|560583226|FG001|Week 16 - 24|Lack of Efficacy|0|||
155313988|NCT02319759|560583227|FG002|Week 16 - 24|Lack of Efficacy|1|||
155313989|NCT02319759|560583228|FG003|Week 16 - 24|Lack of Efficacy|0|||
155313990|NCT02319759|560583229|FG004|Week 16 - 24|Lack of Efficacy|0|||
155313991|NCT02319759|560583225|FG000|Week 16 - 24|Lost to Follow-up|1|||
155313992|NCT02319759|560583226|FG001|Week 16 - 24|Lost to Follow-up|0|||
155313993|NCT02319759|560583227|FG002|Week 16 - 24|Lost to Follow-up|0|||
155313994|NCT02319759|560583228|FG003|Week 16 - 24|Lost to Follow-up|0|||
155313995|NCT02319759|560583229|FG004|Week 16 - 24|Lost to Follow-up|0|||
155313996|NCT02319759|560583225|FG000|Week 16 - 24|Withdrawal by Subject|0|||
155313997|NCT02319759|560583226|FG001|Week 16 - 24|Withdrawal by Subject|0|||
155313998|NCT02319759|560583227|FG002|Week 16 - 24|Withdrawal by Subject|2|||
155313999|NCT02319759|560583228|FG003|Week 16 - 24|Withdrawal by Subject|0|||
155500459|NCT02706353|561257013|FG001|Dose Level 4|Death|0|||
155500460|NCT02706353|561257014|FG002|Dose Level 4|Death|0|||
155500461|NCT02706353|561257015|FG003|Dose Level 4|Death|1|||
155500462|NCT02706353|561257016|FG004|Dose Level 4|Death|0|||
155500463|NCT02706353|561257017|FG005|Dose Level 4|Death|0|||
155500464|NCT02706353|561257012|FG000|Dose Level 5|Toxicity|0|||
155500465|NCT02706353|561257013|FG001|Dose Level 5|Toxicity|0|||
155500466|NCT02706353|561257014|FG002|Dose Level 5|Toxicity|0|||
155500467|NCT02706353|561257015|FG003|Dose Level 5|Toxicity|0|||
155500468|NCT02706353|561257016|FG004|Dose Level 5|Toxicity|1|||
155500469|NCT02706353|561257017|FG005|Dose Level 5|Toxicity|0|||
155500470|NCT02706353|561257012|FG000|Dose Level 5|Disease Progression|0|||
155500471|NCT02706353|561257013|FG001|Dose Level 5|Disease Progression|0|||
155500472|NCT02706353|561257014|FG002|Dose Level 5|Disease Progression|0|||
155500473|NCT02706353|561257015|FG003|Dose Level 5|Disease Progression|0|||
155500474|NCT02706353|561257016|FG004|Dose Level 5|Disease Progression|3|||
155500475|NCT02706353|561257017|FG005|Dose Level 5|Disease Progression|2|||
155314000|NCT02319759|560583229|FG004|Week 16 - 24|Withdrawal by Subject|0|||
155314001|NCT02319759|560583225|FG000|Week 24 - 56|Adverse Event|0|||
155314002|NCT02319759|560583226|FG001|Week 24 - 56|Adverse Event|0|||
155314003|NCT02319759|560583227|FG002|Week 24 - 56|Adverse Event|2|||
155314004|NCT02319759|560583228|FG003|Week 24 - 56|Adverse Event|0|||
155314005|NCT02319759|560583229|FG004|Week 24 - 56|Adverse Event|0|||
155314006|NCT02319759|560583225|FG000|Week 24 - 56|Lack of Efficacy|0|||
155314007|NCT02319759|560583226|FG001|Week 24 - 56|Lack of Efficacy|0|||
155314008|NCT02319759|560583227|FG002|Week 24 - 56|Lack of Efficacy|0|||
155314009|NCT02319759|560583228|FG003|Week 24 - 56|Lack of Efficacy|2|||
155314010|NCT02319759|560583229|FG004|Week 24 - 56|Lack of Efficacy|1|||
155314011|NCT02319759|560583225|FG000|Week 24 - 56|Withdrawal by Subject|0|||
155314012|NCT02319759|560583226|FG001|Week 24 - 56|Withdrawal by Subject|1|||
155314013|NCT02319759|560583227|FG002|Week 24 - 56|Withdrawal by Subject|0|||
155314014|NCT02319759|560583228|FG003|Week 24 - 56|Withdrawal by Subject|0|||
155314015|NCT02319759|560583229|FG004|Week 24 - 56|Withdrawal by Subject|0|||
155314016|NCT02319759|560583225|FG000|Week 24 - 56|Lost to Follow-up|0|||
155314017|NCT02319759|560583226|FG001|Week 24 - 56|Lost to Follow-up|0|||
155314018|NCT02319759|560583227|FG002|Week 24 - 56|Lost to Follow-up|0|||
155314019|NCT02319759|560583228|FG003|Week 24 - 56|Lost to Follow-up|0|||
155314020|NCT02319759|560583229|FG004|Week 24 - 56|Lost to Follow-up|1|||
155314021|NCT01959425|560583230|FG000|Overall Study|Withdrawal by Subject|5|||
155314022|NCT01959425|560583231|FG001|Overall Study|Withdrawal by Subject|4|||
155314023|NCT01959425|560583230|FG000|Overall Study|Lost to Follow-up|1|||
155314024|NCT01959425|560583231|FG001|Overall Study|Lost to Follow-up|0|||
155314025|NCT01959425|560583230|FG000|Overall Study|Discontinued Subjects|6|||
155314026|NCT01959425|560583231|FG001|Overall Study|Discontinued Subjects|4|||
155314027|NCT04625283|560583237|FG000|Overall Study|post randomization exclusion|28|||
155314028|NCT04625283|560583238|FG001|Overall Study|post randomization exclusion|20|||
155314029|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Death|0|||
155314030|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Death|1|||
155314031|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
155500476|NCT02706353|561257012|FG000|Dose Level 5|Death|0|||
155500477|NCT02706353|561257013|FG001|Dose Level 5|Death|0|||
155500478|NCT02706353|561257014|FG002|Dose Level 5|Death|0|||
155500479|NCT02706353|561257015|FG003|Dose Level 5|Death|0|||
155314032|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
155314033|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
155314034|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
155314035|NCT01824394|560583241|FG000|Overall Study|Early Termination|1|||
155314036|NCT01824394|560583242|FG001|Overall Study|Early Termination|1|||
155314037|NCT01824394|560583243|FG002|Overall Study|Early Termination|3|||
155314038|NCT01824394|560583241|FG000|Overall Study|Withdrawn due to Study Termination|91|||
155314039|NCT01824394|560583242|FG001|Overall Study|Withdrawn due to Study Termination|83|||
155314040|NCT01824394|560583243|FG002|Overall Study|Withdrawn due to Study Termination|41|||
155314041|NCT01824394|560583241|FG000|Overall Study|Lost to Follow-up|0|||
155500480|NCT02706353|561257016|FG004|Dose Level 5|Death|1|||
155500481|NCT02706353|561257017|FG005|Dose Level 5|Death|6|||
155500482|NCT02706353|561257012|FG000|Dose Level 5|Withdrawal by Subject|0|||
155500483|NCT02706353|561257013|FG001|Dose Level 5|Withdrawal by Subject|0|||
155500484|NCT02706353|561257014|FG002|Dose Level 5|Withdrawal by Subject|0|||
155500485|NCT02706353|561257015|FG003|Dose Level 5|Withdrawal by Subject|0|||
155314042|NCT01824394|560583242|FG001|Overall Study|Lost to Follow-up|9|||
155314043|NCT01824394|560583243|FG002|Overall Study|Lost to Follow-up|3|||
155314044|NCT01824394|560583241|FG000|Overall Study|Death|3|||
155314045|NCT01824394|560583242|FG001|Overall Study|Death|2|||
155314046|NCT01824394|560583243|FG002|Overall Study|Death|4|||
155314047|NCT01824394|560583241|FG000|Overall Study|Discontinued Subjects|1|||
155314048|NCT01824394|560583242|FG001|Overall Study|Discontinued Subjects|1|||
155314049|NCT01824394|560583243|FG002|Overall Study|Discontinued Subjects|2|||
155314050|NCT01824394|560583241|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
155500486|NCT02706353|561257016|FG004|Dose Level 5|Withdrawal by Subject|0|||
155500487|NCT02706353|561257017|FG005|Dose Level 5|Withdrawal by Subject|2|||
155500488|NCT00021229|561258484|FG000|Overall Study|Adverse Event|10|||
155314051|NCT01824394|560583242|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
155314052|NCT01824394|560583243|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
155314053|NCT02619838|560583244|FG000|Overall Study|Lost to Follow-up|9|||
155314054|NCT02619838|560583244|FG000|Overall Study|Withdrawal by Subject|15|||
155314055|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
155314056|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
155314057|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
155314058|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
155314059|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
155314060|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
155314061|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
155314062|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
155314063|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
155314064|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
155314065|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
155314066|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
155314067|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
155314068|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
155314069|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
155314070|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
155314071|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
155314072|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
155314073|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
155314074|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
155314075|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
155314076|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
155314077|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
155314078|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
155314079|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
155314080|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
155314081|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
155314082|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
155314083|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
155314084|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
155314085|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
155314086|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
155314087|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
155314088|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
155314089|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
155314090|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
155314091|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
155314092|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
155314093|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
155314094|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
155314095|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
155314096|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
155314097|NCT05020249|560583248|FG000|Overall Study|Protocol Violation|1|||
155314098|NCT05020249|560583249|FG001|Overall Study|Protocol Violation|0|||
155314099|NCT04971681|560583253|FG000|Followup|Lost to Follow-up|1|||
155314100|NCT04971681|560583254|FG001|Followup|Lost to Follow-up|0|||
155314101|NCT06037369|560583257|FG000|Overall Study|Lost to Follow-up|0|||
155314102|NCT06037369|560583258|FG001|Overall Study|Lost to Follow-up|1|||
155314103|NCT05783102|560583259|FG000|Overall Study|Lost to Follow-up|1|||
155500489|NCT00021229|561258485|FG001|Overall Study|Adverse Event|5|||
155500490|NCT00021229|561258486|FG002|Overall Study|Adverse Event|2|||
155500491|NCT00021229|561258484|FG000|Overall Study|Death|0|||
155500492|NCT00021229|561258485|FG001|Overall Study|Death|1|||
155500493|NCT00021229|561258486|FG002|Overall Study|Death|0|||
155314104|NCT05783102|560583259|FG000|Overall Study|Withdrawal by Subject|2|||
155314105|NCT04505904|560583260|FG000|Overall Study|Withdrawal by Subject|1|||
155314106|NCT04505904|560583261|FG001|Overall Study|Withdrawal by Subject|2|||
155314107|NCT04505904|560583262|FG002|Overall Study|Withdrawal by Subject|0|||
155314108|NCT04505904|560583263|FG003|Overall Study|Withdrawal by Subject|0|||
155314109|NCT04505904|560583260|FG000|Overall Study|Physician Decision|1|||
155314110|NCT04505904|560583261|FG001|Overall Study|Physician Decision|0|||
155314111|NCT04505904|560583262|FG002|Overall Study|Physician Decision|0|||
155314112|NCT04505904|560583263|FG003|Overall Study|Physician Decision|0|||
155314113|NCT04505904|560583260|FG000|Overall Study|Adverse Event|0|||
155314114|NCT04505904|560583261|FG001|Overall Study|Adverse Event|1|||
155314115|NCT04505904|560583262|FG002|Overall Study|Adverse Event|0|||
155500494|NCT00021229|561258484|FG000|Overall Study|Withdrawal by Subject|7|||
155643269|NCT02323334|561783774|FG008|Period 3|Lost to Follow-up|0|||
155314116|NCT04505904|560583263|FG003|Overall Study|Adverse Event|0|||
155314117|NCT04277442|560583266|FG000|Overall Study|Death|1|||
155314118|NCT06181760|560583267|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314119|NCT06181760|560583268|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314120|NCT06181760|560583269|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314121|NCT06181760|560583270|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
155314122|NCT04938492|560583272|FG000|Overall Study|Lost to Follow-up|17|||
155314123|NCT04938492|560583273|FG001|Overall Study|Lost to Follow-up|18|||
155314124|NCT05084508|560583274|FG000|Overall Study|Lost to Follow-up|6|||
155314125|NCT05084508|560583275|FG001|Overall Study|Lost to Follow-up|3|||
155314126|NCT05084508|560583276|FG002|Overall Study|Lost to Follow-up|7|||
155314127|NCT05084508|560583277|FG003|Overall Study|Lost to Follow-up|3|||
155314128|NCT05084508|560583274|FG000|Overall Study|Withdrawal by Subject|0|||
155314129|NCT05084508|560583275|FG001|Overall Study|Withdrawal by Subject|2|||
155314130|NCT05084508|560583276|FG002|Overall Study|Withdrawal by Subject|3|||
155314131|NCT05084508|560583277|FG003|Overall Study|Withdrawal by Subject|1|||
155314132|NCT05084508|560583274|FG000|Overall Study|Other|0|||
155314133|NCT05084508|560583275|FG001|Overall Study|Other|0|||
155314134|NCT05084508|560583276|FG002|Overall Study|Other|0|||
155314135|NCT05084508|560583277|FG003|Overall Study|Other|1|||
155314136|NCT04137289|560583278|FG000|Overall Study|Death|0|||
155314137|NCT04137289|560583279|FG001|Overall Study|Death|0|||
155314138|NCT04137289|560583280|FG002|Overall Study|Death|0|||
155314139|NCT04137289|560583281|FG003|Overall Study|Death|0|||
155314140|NCT04137289|560583282|FG004|Overall Study|Death|0|||
155314141|NCT04137289|560583283|FG005|Overall Study|Death|0|||
155314142|NCT04137289|560583284|FG006|Overall Study|Death|1|||
155314143|NCT04137289|560583285|FG007|Overall Study|Death|0|||
155314144|NCT04137289|560583286|FG008|Overall Study|Death|0|||
155314145|NCT04137289|560583278|FG000|Overall Study|Clinical disease progression|0|||
155314146|NCT04137289|560583279|FG001|Overall Study|Clinical disease progression|0|||
155314147|NCT04137289|560583280|FG002|Overall Study|Clinical disease progression|0|||
155500495|NCT00021229|561258485|FG001|Overall Study|Withdrawal by Subject|7|||
155500496|NCT00021229|561258486|FG002|Overall Study|Withdrawal by Subject|1|||
155500497|NCT00021229|561258484|FG000|Overall Study|Progressive Disease|15|||
155314148|NCT04137289|560583281|FG003|Overall Study|Clinical disease progression|4|||
155314149|NCT04137289|560583282|FG004|Overall Study|Clinical disease progression|4|||
155314150|NCT04137289|560583283|FG005|Overall Study|Clinical disease progression|2|||
155314151|NCT04137289|560583284|FG006|Overall Study|Clinical disease progression|5|||
155314152|NCT04137289|560583285|FG007|Overall Study|Clinical disease progression|1|||
155314153|NCT04137289|560583286|FG008|Overall Study|Clinical disease progression|0|||
155314154|NCT04137289|560583278|FG000|Overall Study|Lost to Follow-up|0|||
155314155|NCT04137289|560583279|FG001|Overall Study|Lost to Follow-up|0|||
155314156|NCT04137289|560583280|FG002|Overall Study|Lost to Follow-up|0|||
155314157|NCT04137289|560583281|FG003|Overall Study|Lost to Follow-up|1|||
155314158|NCT04137289|560583282|FG004|Overall Study|Lost to Follow-up|0|||
155314159|NCT04137289|560583283|FG005|Overall Study|Lost to Follow-up|0|||
155314160|NCT04137289|560583284|FG006|Overall Study|Lost to Follow-up|0|||
155314161|NCT04137289|560583285|FG007|Overall Study|Lost to Follow-up|0|||
155314162|NCT04137289|560583286|FG008|Overall Study|Lost to Follow-up|0|||
155314163|NCT04137289|560583278|FG000|Overall Study|Adverse Event|0|||
155314164|NCT04137289|560583279|FG001|Overall Study|Adverse Event|0|||
155314165|NCT04137289|560583280|FG002|Overall Study|Adverse Event|1|||
155314166|NCT04137289|560583281|FG003|Overall Study|Adverse Event|0|||
155314167|NCT04137289|560583282|FG004|Overall Study|Adverse Event|0|||
155314168|NCT04137289|560583283|FG005|Overall Study|Adverse Event|1|||
155314169|NCT04137289|560583284|FG006|Overall Study|Adverse Event|0|||
155314170|NCT04137289|560583285|FG007|Overall Study|Adverse Event|0|||
155314171|NCT04137289|560583286|FG008|Overall Study|Adverse Event|0|||
155314172|NCT04137289|560583278|FG000|Overall Study|Lack of clinical benefit|0|||
155314173|NCT04137289|560583279|FG001|Overall Study|Lack of clinical benefit|0|||
155314174|NCT04137289|560583280|FG002|Overall Study|Lack of clinical benefit|0|||
155314175|NCT04137289|560583281|FG003|Overall Study|Lack of clinical benefit|0|||
155314176|NCT04137289|560583282|FG004|Overall Study|Lack of clinical benefit|0|||
155314177|NCT04137289|560583283|FG005|Overall Study|Lack of clinical benefit|0|||
155314178|NCT04137289|560583284|FG006|Overall Study|Lack of clinical benefit|0|||
155314179|NCT04137289|560583285|FG007|Overall Study|Lack of clinical benefit|0|||
155314180|NCT04137289|560583286|FG008|Overall Study|Lack of clinical benefit|1|||
155314181|NCT04137289|560583278|FG000|Overall Study|Objective disease progression|1|||
155314182|NCT04137289|560583279|FG001|Overall Study|Objective disease progression|1|||
155314183|NCT04137289|560583280|FG002|Overall Study|Objective disease progression|6|||
155314184|NCT04137289|560583281|FG003|Overall Study|Objective disease progression|18|||
155314185|NCT04137289|560583282|FG004|Overall Study|Objective disease progression|12|||
155314186|NCT04137289|560583283|FG005|Overall Study|Objective disease progression|20|||
155314187|NCT04137289|560583284|FG006|Overall Study|Objective disease progression|18|||
155314188|NCT04137289|560583285|FG007|Overall Study|Objective disease progression|7|||
155314189|NCT04137289|560583286|FG008|Overall Study|Objective disease progression|6|||
155314190|NCT03931174|560583291|FG000|Providers|Staff left organization|26|||
155314191|NCT03931174|560583292|FG001|Providers|Staff left organization|25|||
155314192|NCT03931174|560583291|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
155314193|NCT03931174|560583292|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
155314194|NCT03931174|560583291|FG000|Providers|Lost to Follow-up|4|||
155314195|NCT03931174|560583292|FG001|Providers|Lost to Follow-up|4|||
155314196|NCT03931174|560583291|FG000|Patients|Post-consent screening failure|1|||
155314197|NCT03931174|560583292|FG001|Patients|Post-consent screening failure|1|||
155314198|NCT03931174|560583291|FG000|Patients|Death|1|||
155314199|NCT03931174|560583292|FG001|Patients|Death|1|||
155314200|NCT03931174|560583291|FG000|Patients|Lost to Follow-up|60|||
155314201|NCT03931174|560583292|FG001|Patients|Lost to Follow-up|89|||
155314202|NCT05386030|560583293|FG000|Overall Study|Death|1|||
155314203|NCT05386030|560583294|FG001|Overall Study|Death|0|||
155314204|NCT05386030|560583293|FG000|Overall Study|Physician Decision|2|||
155314205|NCT05386030|560583294|FG001|Overall Study|Physician Decision|1|||
155314206|NCT05386030|560583293|FG000|Overall Study|Lost to Follow-up|19|||
155314207|NCT05386030|560583294|FG001|Overall Study|Lost to Follow-up|7|||
155314208|NCT05386030|560583293|FG000|Overall Study|Withdrawal by Subject|20|||
155314209|NCT05386030|560583294|FG001|Overall Study|Withdrawal by Subject|10|||
155314210|NCT05386030|560583293|FG000|Overall Study|Eligibility criteria violation|1|||
155314211|NCT05386030|560583294|FG001|Overall Study|Eligibility criteria violation|1|||
155314212|NCT05386030|560583293|FG000|Overall Study|Personal Reasons|1|||
155314213|NCT05386030|560583294|FG001|Overall Study|Personal Reasons|0|||
155314214|NCT03213691|560583297|FG000|Overall Study|Adverse Event|2|||
155314215|NCT03213691|560583297|FG000|Overall Study|Death|3|||
155314216|NCT03213691|560583297|FG000|Overall Study|Physician Decision|1|||
155314217|NCT03213691|560583297|FG000|Overall Study|Progressive Disease|14|||
155314218|NCT03213691|560583297|FG000|Overall Study|Ineligible|1|||
155314219|NCT05302596|560583298|FG000|Overall Study|Withdrawal by Subject|1|||
155314220|NCT05302596|560583299|FG001|Overall Study|Withdrawal by Subject|1|||
155314221|NCT04977947|560585438|FG000|Overall Study|Lost to Follow-up|1|||
155314222|NCT04977947|560585439|FG001|Overall Study|Lost to Follow-up|1|||
155314223|NCT04029688|560585440|FG000|Overall Study|Death|8|||
155314224|NCT04029688|560585441|FG001|Overall Study|Death|3|||
155314225|NCT04029688|560585442|FG002|Overall Study|Death|6|||
155314226|NCT04029688|560585443|FG003|Overall Study|Death|2|||
155314227|NCT04029688|560585444|FG004|Overall Study|Death|5|||
155314228|NCT04029688|560585445|FG005|Overall Study|Death|0|||
155314229|NCT04029688|560585446|FG006|Overall Study|Death|2|||
155314230|NCT04029688|560585447|FG007|Overall Study|Death|3|||
155314231|NCT04029688|560585440|FG000|Overall Study|Study Terminated by Sponsor|0|||
155314232|NCT04029688|560585441|FG001|Overall Study|Study Terminated by Sponsor|0|||
155314233|NCT04029688|560585442|FG002|Overall Study|Study Terminated by Sponsor|0|||
155314234|NCT04029688|560585443|FG003|Overall Study|Study Terminated by Sponsor|0|||
155314235|NCT04029688|560585444|FG004|Overall Study|Study Terminated by Sponsor|1|||
155314236|NCT04029688|560585445|FG005|Overall Study|Study Terminated by Sponsor|3|||
155314237|NCT04029688|560585446|FG006|Overall Study|Study Terminated by Sponsor|1|||
155418004|NCT04871711|560960371|FG000|Overall Study|Withdrawal by Subject|11|||
155418005|NCT04871711|560960372|FG001|Overall Study|Withdrawal by Subject|5|||
155418006|NCT04871711|560960371|FG000|Overall Study|Lack of Efficacy|5|||
155418007|NCT04871711|560960372|FG001|Overall Study|Lack of Efficacy|7|||
155418008|NCT04871711|560960371|FG000|Overall Study|Adverse Event|2|||
155418009|NCT04871711|560960372|FG001|Overall Study|Adverse Event|6|||
155418010|NCT04871711|560960371|FG000|Overall Study|Various reasons|2|||
155418011|NCT04871711|560960372|FG001|Overall Study|Various reasons|1|||
155418012|NCT04871711|560960371|FG000|Overall Study|Lost to Follow-up|0|||
155418013|NCT04871711|560960372|FG001|Overall Study|Lost to Follow-up|2|||
155418014|NCT01920711|560960373|FG000|Overall Study|Death|347|||
155418015|NCT01920711|560960374|FG001|Overall Study|Death|356|||
155418016|NCT01920711|560960373|FG000|Overall Study|Lost to Follow-up|13|||
155418017|NCT01920711|560960374|FG001|Overall Study|Lost to Follow-up|14|||
155418018|NCT01920711|560960373|FG000|Overall Study|Withdrawal by Subject|4|||
155418019|NCT01920711|560960374|FG001|Overall Study|Withdrawal by Subject|3|||
155314238|NCT04029688|560585447|FG007|Overall Study|Study Terminated by Sponsor|3|||
155314239|NCT04029688|560585440|FG000|Overall Study|Withdrawal by Subject|0|||
155314240|NCT04029688|560585441|FG001|Overall Study|Withdrawal by Subject|0|||
155314241|NCT04029688|560585442|FG002|Overall Study|Withdrawal by Subject|0|||
155314242|NCT04029688|560585443|FG003|Overall Study|Withdrawal by Subject|1|||
155314243|NCT04029688|560585444|FG004|Overall Study|Withdrawal by Subject|0|||
155314244|NCT04029688|560585445|FG005|Overall Study|Withdrawal by Subject|0|||
155314245|NCT04029688|560585446|FG006|Overall Study|Withdrawal by Subject|0|||
155314246|NCT04029688|560585447|FG007|Overall Study|Withdrawal by Subject|0|||
155314247|NCT05875142|560585448|FG000|Overall Study|Lost to Follow-up|0|||
155314248|NCT05875142|560585449|FG001|Overall Study|Lost to Follow-up|1|||
155314249|NCT05875142|560585450|FG002|Overall Study|Lost to Follow-up|1|||
155314250|NCT03436290|560585451|FG000|Overall Study|Post-randomization Exclusion|1|||
155418020|NCT02319044|560960376|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
155418021|NCT02319044|560960377|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
155418022|NCT02319044|560960378|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
155418023|NCT02319044|560960376|FG000|Overall Study|Withdrawal by Subject|3|||
155418024|NCT02319044|560960377|FG001|Overall Study|Withdrawal by Subject|3|||
155418025|NCT02319044|560960378|FG002|Overall Study|Withdrawal by Subject|6|||
155314251|NCT03436290|560585452|FG001|Overall Study|Post-randomization Exclusion|0|||
155314252|NCT03436290|560585451|FG000|Overall Study|Death|6|||
155314253|NCT03436290|560585452|FG001|Overall Study|Death|0|||
155314254|NCT03436290|560585451|FG000|Overall Study|Withdrawal by Subject|4|||
155314255|NCT03436290|560585452|FG001|Overall Study|Withdrawal by Subject|0|||
155314256|NCT03436290|560585451|FG000|Overall Study|Protocol Violation|30|||
155314257|NCT03436290|560585452|FG001|Overall Study|Protocol Violation|0|||
155314258|NCT02677298|560585453|FG000|Double Blind Phase|Adverse Event|2|||
155314259|NCT02677298|560585454|FG001|Double Blind Phase|Adverse Event|1|||
155314260|NCT02677298|560585455|FG002|Double Blind Phase|Adverse Event|0|||
155314261|NCT02677298|560585453|FG000|Double Blind Phase|Physician Decision|5|||
155314262|NCT02677298|560585454|FG001|Double Blind Phase|Physician Decision|0|||
155314263|NCT02677298|560585455|FG002|Double Blind Phase|Physician Decision|0|||
155314264|NCT02677298|560585453|FG000|Double Blind Phase|Lost to Follow-up|11|||
155314265|NCT02677298|560585454|FG001|Double Blind Phase|Lost to Follow-up|7|||
155314266|NCT02677298|560585455|FG002|Double Blind Phase|Lost to Follow-up|0|||
155314267|NCT02677298|560585453|FG000|Double Blind Phase|Withdrawal by Subject|11|||
155314268|NCT02677298|560585454|FG001|Double Blind Phase|Withdrawal by Subject|8|||
155314269|NCT02677298|560585455|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155314270|NCT02677298|560585453|FG000|Double Blind Phase|No study drug available at site|0|||
155314271|NCT02677298|560585454|FG001|Double Blind Phase|No study drug available at site|1|||
155314272|NCT02677298|560585455|FG002|Double Blind Phase|No study drug available at site|0|||
155418026|NCT02319044|560960376|FG000|Overall Study|Condition under investigation worsened|100|||
155418027|NCT02319044|560960377|FG001|Overall Study|Condition under investigation worsened|50|||
155418028|NCT02319044|560960378|FG002|Overall Study|Condition under investigation worsened|46|||
155418029|NCT02319044|560960376|FG000|Overall Study|Adverse Event|17|||
155418030|NCT02319044|560960377|FG001|Overall Study|Adverse Event|2|||
155418031|NCT02319044|560960378|FG002|Overall Study|Adverse Event|8|||
155418032|NCT02319044|560960376|FG000|Overall Study|Study specific discontinuation criteria|2|||
155418033|NCT02319044|560960377|FG001|Overall Study|Study specific discontinuation criteria|2|||
155418034|NCT02319044|560960378|FG002|Overall Study|Study specific discontinuation criteria|1|||
155418035|NCT02319044|560960376|FG000|Overall Study|Not treated|0|||
155418036|NCT02319044|560960377|FG001|Overall Study|Not treated|2|||
155418037|NCT02319044|560960378|FG002|Overall Study|Not treated|2|||
155418038|NCT02026063|560960381|FG000|Overall Study|Physician Decision|0|||
155418039|NCT02026063|560960382|FG001|Overall Study|Physician Decision|10|||
155418040|NCT02026063|560960381|FG000|Overall Study|Noncompliance with Study Drug|1|||
155418041|NCT02026063|560960382|FG001|Overall Study|Noncompliance with Study Drug|1|||
155418042|NCT02026063|560960381|FG000|Overall Study|Withdrawal of Consent|1|||
155418043|NCT02026063|560960382|FG001|Overall Study|Withdrawal of Consent|6|||
155418044|NCT02026063|560960381|FG000|Overall Study|Adverse Event|5|||
155418045|NCT02026063|560960382|FG001|Overall Study|Adverse Event|20|||
155418046|NCT02026063|560960381|FG000|Overall Study|Lack of Efficacy|0|||
155418047|NCT02026063|560960382|FG001|Overall Study|Lack of Efficacy|4|||
155418048|NCT02026063|560960381|FG000|Overall Study|Lost to Follow-up|0|||
155418049|NCT02026063|560960382|FG001|Overall Study|Lost to Follow-up|1|||
155418050|NCT02026063|560960381|FG000|Overall Study|Reason not Specified|2|||
155418051|NCT02026063|560960382|FG001|Overall Study|Reason not Specified|7|||
155418052|NCT02154087|560960384|FG000|Overall Study|Study Termination|1|||
155418053|NCT04556617|560960392|FG000|Overall Study|progressive disease|0|||
155418054|NCT04556617|560960393|FG001|Overall Study|progressive disease|2|||
155418055|NCT04556617|560960394|FG002|Overall Study|progressive disease|2|||
155418056|NCT04556617|560960395|FG003|Overall Study|progressive disease|1|||
155418057|NCT04556617|560960396|FG004|Overall Study|progressive disease|1|||
155418058|NCT04556617|560960392|FG000|Overall Study|Physician Decision|0|||
155418059|NCT04556617|560960393|FG001|Overall Study|Physician Decision|0|||
155418060|NCT04556617|560960394|FG002|Overall Study|Physician Decision|2|||
155418061|NCT04556617|560960395|FG003|Overall Study|Physician Decision|0|||
155418062|NCT04556617|560960396|FG004|Overall Study|Physician Decision|0|||
155418063|NCT04556617|560960392|FG000|Overall Study|Adverse Event|0|||
155418064|NCT04556617|560960393|FG001|Overall Study|Adverse Event|0|||
155418065|NCT04556617|560960394|FG002|Overall Study|Adverse Event|2|||
155418066|NCT04556617|560960395|FG003|Overall Study|Adverse Event|3|||
155314273|NCT02677298|560585453|FG000|Open Label Phase|Adverse Event|0|||
155314274|NCT02677298|560585454|FG001|Open Label Phase|Adverse Event|0|||
155314275|NCT02677298|560585455|FG002|Open Label Phase|Adverse Event|4|||
155418067|NCT04556617|560960396|FG004|Overall Study|Adverse Event|0|||
155418068|NCT04556617|560960392|FG000|Overall Study|Withdrawal by Subject|0|||
155418069|NCT04556617|560960393|FG001|Overall Study|Withdrawal by Subject|2|||
155418070|NCT04556617|560960394|FG002|Overall Study|Withdrawal by Subject|1|||
155418071|NCT04556617|560960395|FG003|Overall Study|Withdrawal by Subject|1|||
155418072|NCT04556617|560960396|FG004|Overall Study|Withdrawal by Subject|0|||
155418073|NCT04556617|560960392|FG000|Overall Study|PSA increase|0|||
155314276|NCT02677298|560585453|FG000|Open Label Phase|Physician Decision|0|||
155314277|NCT02677298|560585454|FG001|Open Label Phase|Physician Decision|0|||
155314278|NCT02677298|560585455|FG002|Open Label Phase|Physician Decision|1|||
155314279|NCT02677298|560585453|FG000|Open Label Phase|Lost to Follow-up|0|||
155314280|NCT02677298|560585454|FG001|Open Label Phase|Lost to Follow-up|0|||
155314281|NCT02677298|560585455|FG002|Open Label Phase|Lost to Follow-up|17|||
155314282|NCT02677298|560585453|FG000|Open Label Phase|Withdrawal by Subject|0|||
155314283|NCT02677298|560585454|FG001|Open Label Phase|Withdrawal by Subject|0|||
155314284|NCT02677298|560585455|FG002|Open Label Phase|Withdrawal by Subject|38|||
155314285|NCT04130438|560585456|FG000|Overall Study|Lost to Follow-up|0|||
155314286|NCT04130438|560585457|FG001|Overall Study|Lost to Follow-up|0|||
155314287|NCT04130438|560585458|FG002|Overall Study|Lost to Follow-up|1|||
155314292|NCT03338933|560585465|FG000|Screening Visit|Lost to Follow-up|1|||
155314293|NCT03338933|560585466|FG001|Screening Visit|Lost to Follow-up|3|||
155314294|NCT03338933|560585467|FG002|Screening Visit|Lost to Follow-up|1|||
155314295|NCT03338933|560585468|FG003|Screening Visit|Lost to Follow-up|4|||
155314296|NCT03338933|560585465|FG000|Screening Visit|Screen fail after consent|2|||
155314297|NCT03338933|560585466|FG001|Screening Visit|Screen fail after consent|7|||
155314298|NCT03338933|560585467|FG002|Screening Visit|Screen fail after consent|1|||
155314299|NCT03338933|560585468|FG003|Screening Visit|Screen fail after consent|4|||
155314300|NCT03338933|560585465|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
155314301|NCT03338933|560585466|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
155314302|NCT03338933|560585467|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
155314303|NCT03338933|560585468|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
155314304|NCT03338933|560585465|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
155314305|NCT03338933|560585466|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
155314306|NCT03338933|560585467|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
155314307|NCT03338933|560585468|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
155314308|NCT03338933|560585465|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
155314309|NCT03338933|560585466|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
155314310|NCT03338933|560585467|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
155314311|NCT03338933|560585468|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
155314312|NCT04515576|560585469|FG000|Overall Study|Withdrawal by Subject|0|||
155314313|NCT04515576|560585470|FG001|Overall Study|Withdrawal by Subject|0|||
155314314|NCT04515576|560585471|FG002|Overall Study|Withdrawal by Subject|0|||
155314315|NCT04515576|560585472|FG003|Overall Study|Withdrawal by Subject|0|||
155314316|NCT04515576|560585473|FG004|Overall Study|Withdrawal by Subject|0|||
155314317|NCT04515576|560585474|FG005|Overall Study|Withdrawal by Subject|1|||
155418074|NCT04556617|560960393|FG001|Overall Study|PSA increase|1|||
155418075|NCT04556617|560960394|FG002|Overall Study|PSA increase|0|||
155418076|NCT04556617|560960395|FG003|Overall Study|PSA increase|0|||
155418077|NCT04556617|560960396|FG004|Overall Study|PSA increase|0|||
155418078|NCT04556617|560960392|FG000|Overall Study|Sponsor study termination|1|||
155418079|NCT04556617|560960393|FG001|Overall Study|Sponsor study termination|0|||
155418080|NCT04556617|560960394|FG002|Overall Study|Sponsor study termination|0|||
155418081|NCT04556617|560960395|FG003|Overall Study|Sponsor study termination|0|||
155418082|NCT04556617|560960396|FG004|Overall Study|Sponsor study termination|0|||
155418083|NCT04949841|560960397|FG000|Overall Study|Adverse Event|7|||
155418084|NCT04949841|560960397|FG000|Overall Study|Death|1|||
155418085|NCT04949841|560960397|FG000|Overall Study|Withdrawal by Subject|52|||
155418086|NCT04949841|560960397|FG000|Overall Study|Pregnancy|4|||
155418087|NCT04949841|560960397|FG000|Overall Study|Lost to Follow-up|9|||
155418088|NCT04949841|560960397|FG000|Overall Study|Lack of Efficacy|55|||
155418089|NCT04949841|560960397|FG000|Overall Study|Various reasons|9|||
155418090|NCT05702736|560960400|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
155418091|NCT05702736|560960401|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
155418092|NCT05702736|560960400|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
155418093|NCT05702736|560960401|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
155418094|NCT04811716|560960404|FG000|Overall Study|Withdrawal by Subject|2|||
155314318|NCT03812679|560585475|FG000|Overall Study|Adverse Event|2|||
155314319|NCT03812679|560585475|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
155314320|NCT03812679|560585475|FG000|Overall Study|Renal transplant|1|||
155314321|NCT03812679|560585475|FG000|Overall Study|Withdrawal by Subject|1|||
155314322|NCT03812679|560585475|FG000|Overall Study|Termination of study|2|||
155418095|NCT04811716|560960405|FG001|Overall Study|Withdrawal by Subject|0|||
155418096|NCT00546052|560960406|FG000|Overall Study|Adverse Event|47|||
155418097|NCT00546052|560960406|FG000|Overall Study|Lost to Follow-up|144|||
155418098|NCT00546052|560960406|FG000|Overall Study|Protocol Violation|9|||
155314323|NCT03812679|560585475|FG000|Overall Study|Water device replacement|1|||
155314324|NCT02140554|560585482|FG000|Overall Study|Withdrawal of consent|1|||
155314325|NCT02140554|560585483|FG001|Overall Study|Withdrawal of consent|0|||
155314326|NCT02140554|560585484|FG002|Overall Study|Withdrawal of consent|4|||
155314327|NCT02140554|560585482|FG000|Overall Study|Physician Decision|1|||
155314328|NCT02140554|560585483|FG001|Overall Study|Physician Decision|0|||
155314329|NCT02140554|560585484|FG002|Overall Study|Physician Decision|2|||
155314330|NCT02140554|560585482|FG000|Overall Study|Death|0|||
155314331|NCT02140554|560585483|FG001|Overall Study|Death|0|||
155314332|NCT02140554|560585484|FG002|Overall Study|Death|1|||
155314333|NCT02140554|560585482|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
155314334|NCT02140554|560585483|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
155314335|NCT02140554|560585484|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
155314336|NCT03953508|560585486|FG000|Baseline|Lost to Follow-up|3|||
155314337|NCT03953508|560585487|FG001|Baseline|Lost to Follow-up|2|||
155314338|NCT03953508|560585486|FG000|6-month Follow-up|Lost to Follow-up|62|||
155314339|NCT03953508|560585487|FG001|6-month Follow-up|Lost to Follow-up|70|||
155314340|NCT03771417|560585488|FG000|Overall Study|Withdrawal by Subject|1|||
155314341|NCT03771417|560585489|FG001|Overall Study|Withdrawal by Subject|0|||
155314342|NCT03771417|560585490|FG002|Overall Study|Withdrawal by Subject|0|||
155314343|NCT03771417|560585488|FG000|Overall Study|Covid-19 Shutdown|0|||
155314344|NCT03771417|560585489|FG001|Overall Study|Covid-19 Shutdown|1|||
155314345|NCT03771417|560585490|FG002|Overall Study|Covid-19 Shutdown|0|||
155314346|NCT04456517|560585491|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
155314347|NCT04456517|560585492|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
155314348|NCT02100813|560585493|FG000|Overall Study|Adverse Event|0|||
155314349|NCT02100813|560585494|FG001|Overall Study|Adverse Event|0|||
155314350|NCT02100813|560585495|FG002|Overall Study|Adverse Event|0|||
155314351|NCT02100813|560585496|FG003|Overall Study|Adverse Event|0|||
155314352|NCT02100813|560585497|FG004|Overall Study|Adverse Event|0|||
155314353|NCT02100813|560585498|FG005|Overall Study|Adverse Event|0|||
155314354|NCT02100813|560585499|FG006|Overall Study|Adverse Event|0|||
155314355|NCT02100813|560585500|FG007|Overall Study|Adverse Event|1|||
155314356|NCT01186367|560585501|FG000|Overall Study|Lost to Follow-up|7|||
155314357|NCT01186367|560585502|FG001|Overall Study|Lost to Follow-up|4|||
155314358|NCT01186367|560585503|FG002|Overall Study|Lost to Follow-up|7|||
155418099|NCT00546052|560960406|FG000|Overall Study|Withdrawal by Subject|20|||
155418100|NCT00546052|560960406|FG000|Overall Study|Non Compliance|7|||
155418101|NCT03048422|560960407|FG000|Overall Study|Death|1|||
155418102|NCT03048422|560960408|FG001|Overall Study|Death|0|||
155418103|NCT03048422|560960409|FG002|Overall Study|Death|0|||
155418104|NCT03048422|560960407|FG000|Overall Study|Lost to Follow-up|5|||
155418105|NCT03048422|560960408|FG001|Overall Study|Lost to Follow-up|0|||
155418106|NCT03048422|560960409|FG002|Overall Study|Lost to Follow-up|1|||
155418107|NCT03048422|560960407|FG000|Overall Study|Withdrawal by Subject|5|||
155418108|NCT03048422|560960408|FG001|Overall Study|Withdrawal by Subject|7|||
155418109|NCT03048422|560960409|FG002|Overall Study|Withdrawal by Subject|4|||
155418110|NCT03048422|560960407|FG000|Overall Study|Moved|3|||
155418111|NCT03048422|560960408|FG001|Overall Study|Moved|2|||
155418112|NCT03048422|560960409|FG002|Overall Study|Moved|2|||
155418113|NCT03048422|560960407|FG000|Overall Study|Noncompliant with Study Requirements|2|||
155418114|NCT03048422|560960408|FG001|Overall Study|Noncompliant with Study Requirements|1|||
155418115|NCT03048422|560960409|FG002|Overall Study|Noncompliant with Study Requirements|2|||
155418116|NCT03048422|560960407|FG000|Overall Study|Not Able to Get to Clinic|1|||
155418117|NCT03048422|560960408|FG001|Overall Study|Not Able to Get to Clinic|0|||
155418118|NCT03048422|560960409|FG002|Overall Study|Not Able to Get to Clinic|0|||
155418119|NCT00500682|560960410|FG000|Overall Study|Adverse Event|37|||
155418120|NCT00500682|560960411|FG001|Overall Study|Adverse Event|29|||
155418121|NCT00500682|560960410|FG000|Overall Study|Death|25|||
155314359|NCT01186367|560585501|FG000|Overall Study|Did not receive study treatment|0|||
155314360|NCT01186367|560585502|FG001|Overall Study|Did not receive study treatment|1|||
155314361|NCT01186367|560585503|FG002|Overall Study|Did not receive study treatment|0|||
155314362|NCT04509674|560585505|FG000|Overall Study|Not treated|33|||
155314363|NCT04509674|560585506|FG001|Overall Study|Not treated|26|||
155314364|NCT04509674|560585505|FG000|Overall Study|Protocol Violation|9|||
155314365|NCT04509674|560585506|FG001|Overall Study|Protocol Violation|10|||
155314366|NCT04509674|560585505|FG000|Overall Study|Lost to Follow-up|31|||
155314367|NCT04509674|560585506|FG001|Overall Study|Lost to Follow-up|39|||
155314368|NCT04509674|560585505|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
155314369|NCT04509674|560585506|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
155418122|NCT00500682|560960411|FG001|Overall Study|Death|16|||
155418123|NCT00500682|560960410|FG000|Overall Study|Lost to Follow-up|11|||
155418124|NCT00500682|560960411|FG001|Overall Study|Lost to Follow-up|11|||
155418125|NCT00500682|560960410|FG000|Overall Study|Physician Decision|6|||
155418126|NCT00500682|560960411|FG001|Overall Study|Physician Decision|10|||
155418127|NCT00500682|560960410|FG000|Overall Study|Pregnancy|2|||
155418128|NCT00500682|560960411|FG001|Overall Study|Pregnancy|0|||
155418129|NCT00500682|560960410|FG000|Overall Study|Protocol Violation|1|||
155314370|NCT04509674|560585505|FG000|Overall Study|Adverse event, serious fatal event|11|||
155314371|NCT04509674|560585506|FG001|Overall Study|Adverse event, serious fatal event|4|||
155314372|NCT04509674|560585505|FG000|Overall Study|Adverse event, non-fatal event|107|||
155314373|NCT04509674|560585506|FG001|Overall Study|Adverse event, non-fatal event|118|||
155314374|NCT04509674|560585505|FG000|Overall Study|Other reason than listed|106|||
155314375|NCT04509674|560585506|FG001|Overall Study|Other reason than listed|95|||
155314376|NCT04064164|560585510|FG000|Overall Study|Withdrawal by Subject|8|||
155314377|NCT04064164|560585511|FG001|Overall Study|Withdrawal by Subject|8|||
155314378|NCT01606215|560585522|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
155314379|NCT01606215|560585523|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
155314380|NCT04316871|560585532|FG000|Overall Study|Protocol Violation|2|||
155314381|NCT04316871|560585533|FG001|Overall Study|Protocol Violation|2|||
155314382|NCT04316871|560585534|FG002|Overall Study|Protocol Violation|2|||
155314383|NCT04316871|560585535|FG003|Overall Study|Protocol Violation|2|||
155314384|NCT05087992|560585536|FG000|Overall Study|Adverse Event|0|||
155314385|NCT05087992|560585537|FG001|Overall Study|Adverse Event|1|||
155314386|NCT05087992|560585538|FG002|Overall Study|Adverse Event|0|||
155314387|NCT05087992|560585536|FG000|Overall Study|Withdrawal by Subject|2|||
155314388|NCT05087992|560585537|FG001|Overall Study|Withdrawal by Subject|0|||
155314389|NCT05087992|560585538|FG002|Overall Study|Withdrawal by Subject|0|||
155314390|NCT05087992|560585536|FG000|Overall Study|clinical disease progression|3|||
155314391|NCT05087992|560585537|FG001|Overall Study|clinical disease progression|1|||
155314392|NCT05087992|560585538|FG002|Overall Study|clinical disease progression|0|||
155314393|NCT05087992|560585536|FG000|Overall Study|objective disease progression|4|||
155314394|NCT05087992|560585537|FG001|Overall Study|objective disease progression|1|||
155314395|NCT05087992|560585538|FG002|Overall Study|objective disease progression|0|||
155314396|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
155314397|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
155314398|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
155314399|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
155314400|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
155314401|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
155314402|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314403|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314404|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314405|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314406|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
155314407|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314408|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314409|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
155314410|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
155314411|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314412|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314413|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314414|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314415|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
155314416|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
155314417|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314418|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314419|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
155418130|NCT00500682|560960411|FG001|Overall Study|Protocol Violation|3|||
155418131|NCT00500682|560960410|FG000|Overall Study|Withdrawal by Subject|80|||
155418132|NCT00500682|560960411|FG001|Overall Study|Withdrawal by Subject|74|||
155418133|NCT00500682|560960410|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
155418134|NCT00500682|560960411|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
155418135|NCT00772668|560960414|FG000|Overall Study|Physician Decision|3|||
155418136|NCT02002975|560961937|FG000|Overall Study|Case Report Forms Uncollected|135|||
155418137|NCT02002975|560961937|FG000|Overall Study|Protocol Deviation|437|||
155418138|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
155418139|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
155314420|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314421|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314422|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314423|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
155314424|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314425|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
155418140|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
155418141|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
155418142|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
155314426|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
155314427|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
155314428|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
155314429|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314430|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314431|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314432|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
155314433|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
155314434|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
155314435|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
155314436|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
155314437|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
155314438|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314439|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314440|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314441|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
155314442|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
155314443|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
155314444|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
155314445|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
155314446|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
155314447|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
155314448|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
155314449|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
155314450|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314451|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314452|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314453|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314454|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314455|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314456|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
155314457|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
155314458|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
155314459|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Death|0|||
155314460|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Death|0|||
155314461|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Death|0|||
155314462|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Death|0|||
155314463|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Death|0|||
155314464|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Death|0|||
155314465|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Death|0|||
155314466|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Death|1|||
155314467|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Death|3|||
155314468|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314469|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314470|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314471|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314472|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314473|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314474|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
155314475|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
155314476|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
155314477|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314478|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314479|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314480|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314481|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314482|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314483|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314484|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
155314485|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
155314486|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314487|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314488|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314489|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314490|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314491|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314492|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
155314493|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
155314494|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
155314495|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314496|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314497|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314498|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314499|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314500|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314501|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
155314502|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
155314503|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
155314504|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314505|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314506|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314507|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314508|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314509|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314510|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
155314511|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
155314512|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
155314513|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Other|0|||
155314514|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Other|0|||
155314515|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Other|0|||
155314516|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Other|0|||
155314517|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Other|0|||
155314518|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Other|0|||
155314519|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Other|110|||
155314520|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Other|9|||
155314521|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Other|17|||
155314522|NCT06424236|560585551|FG000|Overall Study|Adverse Event|0|||
155314523|NCT06424236|560585552|FG001|Overall Study|Adverse Event|1|||
155314524|NCT06424236|560585553|FG002|Overall Study|Adverse Event|0|||
155314525|NCT06424236|560585551|FG000|Overall Study|Withdrawal by Subject|3|||
155314526|NCT06424236|560585552|FG001|Overall Study|Withdrawal by Subject|1|||
155314527|NCT06424236|560585553|FG002|Overall Study|Withdrawal by Subject|2|||
155314528|NCT06424236|560585551|FG000|Overall Study|Physician Decision|0|||
155314529|NCT06424236|560585552|FG001|Overall Study|Physician Decision|1|||
155500498|NCT00021229|561258485|FG001|Overall Study|Progressive Disease|19|||
155500499|NCT00021229|561258486|FG002|Overall Study|Progressive Disease|12|||
155500500|NCT00021229|561258484|FG000|Overall Study|Protocol Violation|1|||
155500501|NCT00021229|561258485|FG001|Overall Study|Protocol Violation|1|||
155500502|NCT00021229|561258486|FG002|Overall Study|Protocol Violation|0|||
155500503|NCT00021229|561258484|FG000|Overall Study|Physician Decision|0|||
155500504|NCT00021229|561258485|FG001|Overall Study|Physician Decision|0|||
155500505|NCT00021229|561258486|FG002|Overall Study|Physician Decision|1|||
155500506|NCT00021229|561258484|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
155500507|NCT00021229|561258485|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
155314530|NCT06424236|560585553|FG002|Overall Study|Physician Decision|0|||
155314531|NCT06424236|560585551|FG000|Overall Study|Study Terminated by Sponsor|11|||
155500508|NCT00021229|561258486|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
155500509|NCT01901146|561258490|FG000|Neoadjuvant Phase|Death|1|||
155500510|NCT01901146|561258491|FG001|Neoadjuvant Phase|Death|2|||
155500511|NCT01901146|561258492|FG002|Neoadjuvant Phase|Death|0|||
155500512|NCT01901146|561258493|FG003|Neoadjuvant Phase|Death|0|||
155500513|NCT01901146|561258494|FG004|Neoadjuvant Phase|Death|0|||
155314532|NCT06424236|560585552|FG001|Overall Study|Study Terminated by Sponsor|20|||
155314533|NCT06424236|560585553|FG002|Overall Study|Study Terminated by Sponsor|16|||
155314534|NCT06424236|560585551|FG000|Overall Study|Lost to Follow-up|0|||
155314535|NCT06424236|560585552|FG001|Overall Study|Lost to Follow-up|1|||
155314536|NCT06424236|560585553|FG002|Overall Study|Lost to Follow-up|0|||
155314537|NCT06424236|560585551|FG000|Overall Study|Disease Progression|0|||
155500514|NCT01901146|561258490|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
155500515|NCT01901146|561258491|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
155500516|NCT01901146|561258492|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
155500517|NCT01901146|561258493|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
155643270|NCT02323334|561783775|FG009|Period 3|Lost to Follow-up|0|||
155314538|NCT06424236|560585552|FG001|Overall Study|Disease Progression|1|||
155314539|NCT06424236|560585553|FG002|Overall Study|Disease Progression|2|||
155314540|NCT06424236|560585551|FG000|Overall Study|Other|0|||
155314541|NCT06424236|560585552|FG001|Overall Study|Other|0|||
155314542|NCT06424236|560585553|FG002|Overall Study|Other|1|||
155314543|NCT00227344|560585555|FG000|Overall Study|study terminated early|12|||
155314544|NCT00227344|560585556|FG001|Overall Study|study terminated early|5|||
155314545|NCT04149704|560585562|FG000|Three Month Follow-up|Death|2|||
155643271|NCT02323334|561783776|FG010|Period 3|Lost to Follow-up|0|||
155643272|NCT02323334|561783777|FG011|Period 3|Lost to Follow-up|0|||
155643273|NCT02323334|561783778|FG012|Period 3|Lost to Follow-up|0|||
155314546|NCT04149704|560585563|FG001|Three Month Follow-up|Death|0|||
155314547|NCT04149704|560585564|FG002|Three Month Follow-up|Death|0|||
155314548|NCT04149704|560585565|FG003|Three Month Follow-up|Death|0|||
155314549|NCT04149704|560585562|FG000|Three Month Follow-up|Lost to Follow-up|1|||
155314550|NCT04149704|560585563|FG001|Three Month Follow-up|Lost to Follow-up|4|||
155314551|NCT04149704|560585564|FG002|Three Month Follow-up|Lost to Follow-up|5|||
155314552|NCT04149704|560585565|FG003|Three Month Follow-up|Lost to Follow-up|5|||
155314553|NCT04149704|560585562|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
155314554|NCT04149704|560585563|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
155314555|NCT04149704|560585564|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
155500518|NCT01901146|561258494|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
155500519|NCT01901146|561258490|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
155500520|NCT01901146|561258491|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
155500521|NCT01901146|561258492|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
155500522|NCT01901146|561258493|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
155500523|NCT01901146|561258494|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
155500524|NCT01901146|561258490|FG000|Neoadjuvant Phase|Physician Decision|1|||
155500525|NCT01901146|561258491|FG001|Neoadjuvant Phase|Physician Decision|2|||
155500526|NCT01901146|561258492|FG002|Neoadjuvant Phase|Physician Decision|0|||
155500527|NCT01901146|561258493|FG003|Neoadjuvant Phase|Physician Decision|0|||
155500528|NCT01901146|561258494|FG004|Neoadjuvant Phase|Physician Decision|0|||
155500529|NCT01901146|561258490|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
155500530|NCT01901146|561258491|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
155500531|NCT01901146|561258492|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
155500532|NCT01901146|561258493|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
155500533|NCT01901146|561258494|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
155500534|NCT01901146|561258490|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
155500535|NCT01901146|561258491|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
155500536|NCT01901146|561258492|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
155500537|NCT01901146|561258493|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
155500538|NCT01901146|561258494|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
155314556|NCT04149704|560585565|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
155418143|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
155418144|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
155418145|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
155418146|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
155418147|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
155418148|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
155418149|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
155418150|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
155418151|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
155418152|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
155418153|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
155418154|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
155418155|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
155418156|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
155418157|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
155418158|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
155418159|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
155418160|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
155418161|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
155418162|NCT04660643|560961938|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
155418163|NCT04660643|560961939|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
155418164|NCT04660643|560961940|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
155418165|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
155418166|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
155418167|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
155418168|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
155418169|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
155418170|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
155418171|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
155418172|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
155418173|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
155418174|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
155418175|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
155418176|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
155314557|NCT04149704|560585562|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
155314558|NCT04149704|560585563|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
155314559|NCT04149704|560585564|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
155314560|NCT04149704|560585565|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
155314561|NCT04376502|560585570|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
155314562|NCT04632992|560585571|FG000|Overall Study|Adverse Event|0|||
155314563|NCT04632992|560585572|FG001|Overall Study|Adverse Event|0|||
155314564|NCT04632992|560585573|FG002|Overall Study|Adverse Event|0|||
155314565|NCT04632992|560585574|FG003|Overall Study|Adverse Event|0|||
155314566|NCT04632992|560585575|FG004|Overall Study|Adverse Event|0|||
155314567|NCT04632992|560585576|FG005|Overall Study|Adverse Event|0|||
155314568|NCT04632992|560585577|FG006|Overall Study|Adverse Event|0|||
155314569|NCT04632992|560585578|FG007|Overall Study|Adverse Event|0|||
155314570|NCT04632992|560585579|FG008|Overall Study|Adverse Event|0|||
155314571|NCT04632992|560585580|FG009|Overall Study|Adverse Event|0|||
155314572|NCT04632992|560585581|FG010|Overall Study|Adverse Event|0|||
155314573|NCT04632992|560585582|FG011|Overall Study|Adverse Event|0|||
155314574|NCT04632992|560585583|FG012|Overall Study|Adverse Event|1|||
155314575|NCT04632992|560585584|FG013|Overall Study|Adverse Event|0|||
155314576|NCT04632992|560585571|FG000|Overall Study|Death|17|||
155314577|NCT04632992|560585572|FG001|Overall Study|Death|1|||
155314578|NCT04632992|560585573|FG002|Overall Study|Death|14|||
155314579|NCT04632992|560585574|FG003|Overall Study|Death|14|||
155314580|NCT04632992|560585575|FG004|Overall Study|Death|13|||
155314581|NCT04632992|560585576|FG005|Overall Study|Death|6|||
155314582|NCT04632992|560585577|FG006|Overall Study|Death|7|||
155314583|NCT04632992|560585578|FG007|Overall Study|Death|12|||
155314584|NCT04632992|560585579|FG008|Overall Study|Death|15|||
155314585|NCT04632992|560585580|FG009|Overall Study|Death|20|||
155314586|NCT04632992|560585581|FG010|Overall Study|Death|8|||
155314587|NCT04632992|560585582|FG011|Overall Study|Death|2|||
155314588|NCT04632992|560585583|FG012|Overall Study|Death|10|||
155314589|NCT04632992|560585584|FG013|Overall Study|Death|1|||
155314590|NCT04632992|560585571|FG000|Overall Study|Lost to Follow-up|1|||
155314591|NCT04632992|560585572|FG001|Overall Study|Lost to Follow-up|0|||
155314592|NCT04632992|560585573|FG002|Overall Study|Lost to Follow-up|1|||
155314593|NCT04632992|560585574|FG003|Overall Study|Lost to Follow-up|0|||
155314594|NCT04632992|560585575|FG004|Overall Study|Lost to Follow-up|2|||
155314595|NCT04632992|560585576|FG005|Overall Study|Lost to Follow-up|0|||
155314596|NCT04632992|560585577|FG006|Overall Study|Lost to Follow-up|1|||
155314597|NCT04632992|560585578|FG007|Overall Study|Lost to Follow-up|1|||
155314598|NCT04632992|560585579|FG008|Overall Study|Lost to Follow-up|1|||
155314599|NCT04632992|560585580|FG009|Overall Study|Lost to Follow-up|1|||
155314600|NCT04632992|560585581|FG010|Overall Study|Lost to Follow-up|2|||
155314601|NCT04632992|560585582|FG011|Overall Study|Lost to Follow-up|0|||
155314602|NCT04632992|560585583|FG012|Overall Study|Lost to Follow-up|0|||
155314603|NCT04632992|560585584|FG013|Overall Study|Lost to Follow-up|0|||
155314604|NCT04632992|560585571|FG000|Overall Study|Reason not Specified|2|||
155314605|NCT04632992|560585572|FG001|Overall Study|Reason not Specified|0|||
155314606|NCT04632992|560585573|FG002|Overall Study|Reason not Specified|1|||
155314607|NCT04632992|560585574|FG003|Overall Study|Reason not Specified|1|||
155314608|NCT04632992|560585575|FG004|Overall Study|Reason not Specified|0|||
155314609|NCT04632992|560585576|FG005|Overall Study|Reason not Specified|0|||
155314610|NCT04632992|560585577|FG006|Overall Study|Reason not Specified|0|||
155314611|NCT04632992|560585578|FG007|Overall Study|Reason not Specified|0|||
155314612|NCT04632992|560585579|FG008|Overall Study|Reason not Specified|0|||
155314613|NCT04632992|560585580|FG009|Overall Study|Reason not Specified|0|||
155314614|NCT04632992|560585581|FG010|Overall Study|Reason not Specified|1|||
155314615|NCT04632992|560585582|FG011|Overall Study|Reason not Specified|0|||
155418177|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
155418178|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
155418179|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
155436206|NCT03700892|561024562|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
155643274|NCT02323334|561783779|FG013|Period 3|Lost to Follow-up|0|||
155314616|NCT04632992|560585583|FG012|Overall Study|Reason not Specified|0|||
155314617|NCT04632992|560585584|FG013|Overall Study|Reason not Specified|0|||
155314618|NCT04632992|560585571|FG000|Overall Study|Physician Decision|0|||
155314619|NCT04632992|560585572|FG001|Overall Study|Physician Decision|0|||
155314620|NCT04632992|560585573|FG002|Overall Study|Physician Decision|0|||
155314621|NCT04632992|560585574|FG003|Overall Study|Physician Decision|2|||
155314622|NCT04632992|560585575|FG004|Overall Study|Physician Decision|1|||
155314623|NCT04632992|560585576|FG005|Overall Study|Physician Decision|0|||
155314624|NCT04632992|560585577|FG006|Overall Study|Physician Decision|0|||
155314625|NCT04632992|560585578|FG007|Overall Study|Physician Decision|0|||
155314626|NCT04632992|560585579|FG008|Overall Study|Physician Decision|0|||
155314627|NCT04632992|560585580|FG009|Overall Study|Physician Decision|0|||
155314628|NCT04632992|560585581|FG010|Overall Study|Physician Decision|0|||
155314629|NCT04632992|560585582|FG011|Overall Study|Physician Decision|0|||
155314630|NCT04632992|560585583|FG012|Overall Study|Physician Decision|3|||
155314631|NCT04632992|560585584|FG013|Overall Study|Physician Decision|0|||
155314632|NCT04632992|560585571|FG000|Overall Study|Progressive Disease|0|||
155314633|NCT04632992|560585572|FG001|Overall Study|Progressive Disease|0|||
155314634|NCT04632992|560585573|FG002|Overall Study|Progressive Disease|0|||
155314635|NCT04632992|560585574|FG003|Overall Study|Progressive Disease|0|||
155314636|NCT04632992|560585575|FG004|Overall Study|Progressive Disease|1|||
155314637|NCT04632992|560585576|FG005|Overall Study|Progressive Disease|0|||
155314638|NCT04632992|560585577|FG006|Overall Study|Progressive Disease|0|||
155314639|NCT04632992|560585578|FG007|Overall Study|Progressive Disease|0|||
155314640|NCT04632992|560585579|FG008|Overall Study|Progressive Disease|0|||
155314641|NCT04632992|560585580|FG009|Overall Study|Progressive Disease|1|||
155314642|NCT04632992|560585581|FG010|Overall Study|Progressive Disease|1|||
155314643|NCT04632992|560585582|FG011|Overall Study|Progressive Disease|0|||
155314644|NCT04632992|560585583|FG012|Overall Study|Progressive Disease|2|||
155314645|NCT04632992|560585584|FG013|Overall Study|Progressive Disease|0|||
155314646|NCT04632992|560585571|FG000|Overall Study|Withdrawal by Subject|4|||
155314647|NCT04632992|560585572|FG001|Overall Study|Withdrawal by Subject|1|||
155314648|NCT04632992|560585573|FG002|Overall Study|Withdrawal by Subject|5|||
155314649|NCT04632992|560585574|FG003|Overall Study|Withdrawal by Subject|4|||
155314650|NCT04632992|560585575|FG004|Overall Study|Withdrawal by Subject|3|||
155314651|NCT04632992|560585576|FG005|Overall Study|Withdrawal by Subject|3|||
155314652|NCT04632992|560585577|FG006|Overall Study|Withdrawal by Subject|0|||
155314653|NCT04632992|560585578|FG007|Overall Study|Withdrawal by Subject|5|||
155314654|NCT04632992|560585579|FG008|Overall Study|Withdrawal by Subject|0|||
155314655|NCT04632992|560585580|FG009|Overall Study|Withdrawal by Subject|2|||
155314656|NCT04632992|560585581|FG010|Overall Study|Withdrawal by Subject|8|||
155314657|NCT04632992|560585582|FG011|Overall Study|Withdrawal by Subject|0|||
155314658|NCT04632992|560585583|FG012|Overall Study|Withdrawal by Subject|1|||
155314659|NCT04632992|560585584|FG013|Overall Study|Withdrawal by Subject|1|||
155314660|NCT02677805|560585585|FG000|Double Blind Phase|Lost to Follow-up|8|||
155418180|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
155418181|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
155418182|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
155314661|NCT02677805|560585586|FG001|Double Blind Phase|Lost to Follow-up|3|||
155314662|NCT02677805|560585587|FG002|Double Blind Phase|Lost to Follow-up|0|||
155314663|NCT02677805|560585585|FG000|Double Blind Phase|Withdrawal by Subject|5|||
155314664|NCT02677805|560585586|FG001|Double Blind Phase|Withdrawal by Subject|2|||
155314665|NCT02677805|560585587|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155314666|NCT02677805|560585585|FG000|Open Label Phase|Lost to Follow-up|0|||
155314667|NCT02677805|560585586|FG001|Open Label Phase|Lost to Follow-up|0|||
155418183|NCT04660643|560961938|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
155418184|NCT04660643|560961939|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
155314668|NCT02677805|560585587|FG002|Open Label Phase|Lost to Follow-up|10|||
155314669|NCT02677805|560585585|FG000|Open Label Phase|Withdrawal by Subject|0|||
155314670|NCT02677805|560585586|FG001|Open Label Phase|Withdrawal by Subject|0|||
155314671|NCT02677805|560585587|FG002|Open Label Phase|Withdrawal by Subject|6|||
155314672|NCT04111536|560585588|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155418185|NCT04660643|560961940|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
155418186|NCT03988907|560961941|FG000|Overall Study|Unable to complete visit|0|||
155418187|NCT03988907|560961942|FG001|Overall Study|Unable to complete visit|1|||
155418188|NCT03609619|560961946|FG000|Overall Study|Adverse Event|1|||
155418189|NCT03609619|560961947|FG001|Overall Study|Adverse Event|0|||
155418190|NCT03609619|560961946|FG000|Overall Study|Lack of Efficacy|1|||
155418191|NCT03609619|560961947|FG001|Overall Study|Lack of Efficacy|2|||
155418192|NCT03609619|560961946|FG000|Overall Study|Protocol Violation|5|||
155418193|NCT03609619|560961947|FG001|Overall Study|Protocol Violation|0|||
155418194|NCT03609619|560961946|FG000|Overall Study|Withdrawal by Subject|2|||
155418195|NCT03609619|560961947|FG001|Overall Study|Withdrawal by Subject|3|||
155418196|NCT03609619|560961946|FG000|Overall Study|Lost to Follow-up|1|||
155314673|NCT04111536|560585589|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155314674|NCT04111536|560585588|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
155314675|NCT04111536|560585589|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
155314676|NCT04111536|560585588|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
155314677|NCT04111536|560585589|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155314678|NCT04111536|560585588|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
155314679|NCT04111536|560585589|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
155314680|NCT04187833|560585590|FG000|Overall Study|Withdrawal by Subject|1|||
155314681|NCT04209465|560585594|FG000|Overall Study|Adverse Event|0|||
155418197|NCT03609619|560961947|FG001|Overall Study|Lost to Follow-up|1|||
155314682|NCT04209465|560585595|FG001|Overall Study|Adverse Event|0|||
155314683|NCT04209465|560585596|FG002|Overall Study|Adverse Event|0|||
155314684|NCT04209465|560585597|FG003|Overall Study|Adverse Event|0|||
155314685|NCT04209465|560585598|FG004|Overall Study|Adverse Event|0|||
155314686|NCT04209465|560585599|FG005|Overall Study|Adverse Event|1|||
155314687|NCT04209465|560585600|FG006|Overall Study|Adverse Event|0|||
155314688|NCT04209465|560585601|FG007|Overall Study|Adverse Event|0|||
155314689|NCT04209465|560585602|FG008|Overall Study|Adverse Event|1|||
155314690|NCT04209465|560585603|FG009|Overall Study|Adverse Event|0|||
155314691|NCT04209465|560585604|FG010|Overall Study|Adverse Event|2|||
155314692|NCT04209465|560585605|FG011|Overall Study|Adverse Event|1|||
155314693|NCT04209465|560585606|FG012|Overall Study|Adverse Event|1|||
155314694|NCT04209465|560585594|FG000|Overall Study|Death|1|||
155314695|NCT04209465|560585595|FG001|Overall Study|Death|0|||
155314696|NCT04209465|560585596|FG002|Overall Study|Death|0|||
155314697|NCT04209465|560585597|FG003|Overall Study|Death|0|||
155314698|NCT04209465|560585598|FG004|Overall Study|Death|2|||
155314699|NCT04209465|560585599|FG005|Overall Study|Death|7|||
155314700|NCT04209465|560585600|FG006|Overall Study|Death|2|||
155314701|NCT04209465|560585601|FG007|Overall Study|Death|2|||
155314702|NCT04209465|560585602|FG008|Overall Study|Death|1|||
155314703|NCT04209465|560585603|FG009|Overall Study|Death|1|||
155314704|NCT04209465|560585604|FG010|Overall Study|Death|1|||
155314705|NCT04209465|560585605|FG011|Overall Study|Death|0|||
155314706|NCT04209465|560585606|FG012|Overall Study|Death|10|||
155314707|NCT04209465|560585594|FG000|Overall Study|Physician Decision|0|||
155314708|NCT04209465|560585595|FG001|Overall Study|Physician Decision|1|||
155418198|NCT05162066|560961948|FG000|Overall Study|Adverse Event|1|||
155418199|NCT05162066|560961949|FG001|Overall Study|Adverse Event|0|||
155418200|NCT05162066|560961950|FG002|Overall Study|Adverse Event|0|||
155418201|NCT05162066|560961948|FG000|Overall Study|Perceived lack of efficacy|1|||
155418202|NCT05162066|560961949|FG001|Overall Study|Perceived lack of efficacy|0|||
155418203|NCT05162066|560961950|FG002|Overall Study|Perceived lack of efficacy|0|||
155418204|NCT00568555|560961951|FG000|Overall Study|Withdrawal by Subject|1|||
155418205|NCT00568555|560961952|FG001|Overall Study|Withdrawal by Subject|1|||
155418206|NCT01220414|560961953|FG000|Overall Study|Withdrawal by Subject|1|||
155418207|NCT01220414|560961954|FG001|Overall Study|Withdrawal by Subject|0|||
155418208|NCT01220414|560961955|FG002|Overall Study|Withdrawal by Subject|0|||
155418209|NCT01220414|560961956|FG003|Overall Study|Withdrawal by Subject|1|||
155418210|NCT00623831|560961959|FG000|Overall Study|Withdrawal by Subject|1|||
155418211|NCT00623831|560961960|FG001|Overall Study|Withdrawal by Subject|0|||
155418212|NCT00623831|560961959|FG000|Overall Study|Progressive Disease|0|||
155418213|NCT00623831|560961960|FG001|Overall Study|Progressive Disease|1|||
155418214|NCT01276821|560961961|FG000|Overall Study|Protocol Violation|0|||
155418215|NCT01276821|560961962|FG001|Overall Study|Protocol Violation|1|||
155418216|NCT03068325|560961963|FG000|Overall Study|Lost to Follow-up|5|||
155418217|NCT00066690|560961964|FG000|Overall Study|Adverse Event|145|||
155418218|NCT00066690|560961965|FG001|Overall Study|Adverse Event|58|||
155418219|NCT00066690|560961966|FG002|Overall Study|Adverse Event|126|||
155418220|NCT00066690|560961964|FG000|Overall Study|Death|3|||
155418221|NCT00066690|560961965|FG001|Overall Study|Death|0|||
155418222|NCT00066690|560961966|FG002|Overall Study|Death|2|||
155418223|NCT00066690|560961964|FG000|Overall Study|Lack of Efficacy|114|||
155418224|NCT00066690|560961965|FG001|Overall Study|Lack of Efficacy|110|||
155418225|NCT00066690|560961966|FG002|Overall Study|Lack of Efficacy|76|||
155418226|NCT00066690|560961964|FG000|Overall Study|Lost to Follow-up|40|||
155418227|NCT00066690|560961965|FG001|Overall Study|Lost to Follow-up|21|||
155418228|NCT00066690|560961966|FG002|Overall Study|Lost to Follow-up|29|||
155418229|NCT00066690|560961964|FG000|Overall Study|Withdrawal by Subject|50|||
155418230|NCT00066690|560961965|FG001|Overall Study|Withdrawal by Subject|55|||
155418231|NCT00066690|560961966|FG002|Overall Study|Withdrawal by Subject|49|||
155418232|NCT00066690|560961964|FG000|Overall Study|Treatment Ongoing|246|||
155418233|NCT00066690|560961965|FG001|Overall Study|Treatment Ongoing|278|||
155418234|NCT00066690|560961966|FG002|Overall Study|Treatment Ongoing|282|||
155500539|NCT01901146|561258490|FG000|Adjuvant Phase|Other|0|||
155314709|NCT04209465|560585596|FG002|Overall Study|Physician Decision|0|||
155418235|NCT02939131|560961967|FG000|Overall Study|Unable to get to clinic|6|||
155418236|NCT02939131|560961968|FG001|Overall Study|Unable to get to clinic|4|||
155418237|NCT02939131|560961967|FG000|Overall Study|Lost to Follow-up|2|||
155314710|NCT04209465|560585597|FG003|Overall Study|Physician Decision|0|||
155314711|NCT04209465|560585598|FG004|Overall Study|Physician Decision|0|||
155314712|NCT04209465|560585599|FG005|Overall Study|Physician Decision|0|||
155314713|NCT04209465|560585600|FG006|Overall Study|Physician Decision|0|||
155314714|NCT04209465|560585601|FG007|Overall Study|Physician Decision|0|||
155314715|NCT04209465|560585602|FG008|Overall Study|Physician Decision|0|||
155418238|NCT02939131|560961968|FG001|Overall Study|Lost to Follow-up|4|||
155418239|NCT02939131|560961967|FG000|Overall Study|severe debilitation|1|||
155418240|NCT02939131|560961968|FG001|Overall Study|severe debilitation|0|||
155418241|NCT02939131|560961967|FG000|Overall Study|Other|0|||
155418242|NCT02939131|560961968|FG001|Overall Study|Other|1|||
155418243|NCT02939131|560961967|FG000|Overall Study|not willing to adhere to protocol|2|||
155418244|NCT02939131|560961968|FG001|Overall Study|not willing to adhere to protocol|0|||
155314716|NCT04209465|560585603|FG009|Overall Study|Physician Decision|0|||
155500540|NCT01901146|561258491|FG001|Adjuvant Phase|Other|0|||
155500541|NCT01901146|561258492|FG002|Adjuvant Phase|Other|1|||
155500542|NCT01901146|561258493|FG003|Adjuvant Phase|Other|0|||
155500543|NCT01901146|561258494|FG004|Adjuvant Phase|Other|0|||
155500544|NCT01901146|561258490|FG000|Adjuvant Phase|Death|0|||
155500545|NCT01901146|561258491|FG001|Adjuvant Phase|Death|0|||
155500546|NCT01901146|561258492|FG002|Adjuvant Phase|Death|0|||
155500547|NCT01901146|561258493|FG003|Adjuvant Phase|Death|0|||
155500548|NCT01901146|561258494|FG004|Adjuvant Phase|Death|3|||
155500549|NCT01901146|561258490|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
155500550|NCT01901146|561258491|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
155500551|NCT01901146|561258492|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
155314717|NCT04209465|560585604|FG010|Overall Study|Physician Decision|0|||
155314718|NCT04209465|560585605|FG011|Overall Study|Physician Decision|0|||
155314719|NCT04209465|560585606|FG012|Overall Study|Physician Decision|0|||
155314720|NCT04209465|560585594|FG000|Overall Study|Progressive Disease|0|||
155314721|NCT04209465|560585595|FG001|Overall Study|Progressive Disease|0|||
155314722|NCT04209465|560585596|FG002|Overall Study|Progressive Disease|1|||
155314723|NCT04209465|560585597|FG003|Overall Study|Progressive Disease|2|||
155314724|NCT04209465|560585598|FG004|Overall Study|Progressive Disease|8|||
155314725|NCT04209465|560585599|FG005|Overall Study|Progressive Disease|5|||
155314726|NCT04209465|560585600|FG006|Overall Study|Progressive Disease|3|||
155314727|NCT04209465|560585601|FG007|Overall Study|Progressive Disease|4|||
155314728|NCT04209465|560585602|FG008|Overall Study|Progressive Disease|1|||
155314729|NCT04209465|560585603|FG009|Overall Study|Progressive Disease|3|||
155314730|NCT04209465|560585604|FG010|Overall Study|Progressive Disease|2|||
155314731|NCT04209465|560585605|FG011|Overall Study|Progressive Disease|1|||
155314732|NCT04209465|560585606|FG012|Overall Study|Progressive Disease|0|||
155314733|NCT04209465|560585594|FG000|Overall Study|Withdrawal by Subject|0|||
155314734|NCT04209465|560585595|FG001|Overall Study|Withdrawal by Subject|0|||
155314735|NCT04209465|560585596|FG002|Overall Study|Withdrawal by Subject|0|||
155314736|NCT04209465|560585597|FG003|Overall Study|Withdrawal by Subject|0|||
155314737|NCT04209465|560585598|FG004|Overall Study|Withdrawal by Subject|0|||
155314738|NCT04209465|560585599|FG005|Overall Study|Withdrawal by Subject|1|||
155314739|NCT04209465|560585600|FG006|Overall Study|Withdrawal by Subject|2|||
155314740|NCT04209465|560585601|FG007|Overall Study|Withdrawal by Subject|0|||
155500552|NCT01901146|561258493|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
155500553|NCT01901146|561258494|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
155500554|NCT01901146|561258490|FG000|Adjuvant Phase|Physician Decision|0|||
155500555|NCT01901146|561258491|FG001|Adjuvant Phase|Physician Decision|0|||
155314741|NCT04209465|560585602|FG008|Overall Study|Withdrawal by Subject|1|||
155314742|NCT04209465|560585603|FG009|Overall Study|Withdrawal by Subject|0|||
155314743|NCT04209465|560585604|FG010|Overall Study|Withdrawal by Subject|0|||
155314744|NCT04209465|560585605|FG011|Overall Study|Withdrawal by Subject|2|||
155314745|NCT04209465|560585606|FG012|Overall Study|Withdrawal by Subject|2|||
155314746|NCT04209465|560585594|FG000|Overall Study|Lost to Follow-up|0|||
155314747|NCT04209465|560585595|FG001|Overall Study|Lost to Follow-up|0|||
155314748|NCT04209465|560585596|FG002|Overall Study|Lost to Follow-up|0|||
155314749|NCT04209465|560585597|FG003|Overall Study|Lost to Follow-up|0|||
155314750|NCT04209465|560585598|FG004|Overall Study|Lost to Follow-up|0|||
155314751|NCT04209465|560585599|FG005|Overall Study|Lost to Follow-up|1|||
155314752|NCT04209465|560585600|FG006|Overall Study|Lost to Follow-up|0|||
155314753|NCT04209465|560585601|FG007|Overall Study|Lost to Follow-up|0|||
155314754|NCT04209465|560585602|FG008|Overall Study|Lost to Follow-up|1|||
155314755|NCT04209465|560585603|FG009|Overall Study|Lost to Follow-up|0|||
155314756|NCT04209465|560585604|FG010|Overall Study|Lost to Follow-up|0|||
155314757|NCT04209465|560585605|FG011|Overall Study|Lost to Follow-up|1|||
155314758|NCT04209465|560585606|FG012|Overall Study|Lost to Follow-up|0|||
155314759|NCT04209465|560585594|FG000|Overall Study|Started new therapy|0|||
155314760|NCT04209465|560585595|FG001|Overall Study|Started new therapy|0|||
155314761|NCT04209465|560585596|FG002|Overall Study|Started new therapy|0|||
155314762|NCT04209465|560585597|FG003|Overall Study|Started new therapy|0|||
155314763|NCT04209465|560585598|FG004|Overall Study|Started new therapy|0|||
155314764|NCT04209465|560585599|FG005|Overall Study|Started new therapy|1|||
155314765|NCT04209465|560585600|FG006|Overall Study|Started new therapy|0|||
155314766|NCT04209465|560585601|FG007|Overall Study|Started new therapy|0|||
155314767|NCT04209465|560585602|FG008|Overall Study|Started new therapy|0|||
155314768|NCT04209465|560585603|FG009|Overall Study|Started new therapy|0|||
155500556|NCT01901146|561258492|FG002|Adjuvant Phase|Physician Decision|9|||
155314769|NCT04209465|560585604|FG010|Overall Study|Started new therapy|0|||
155314770|NCT04209465|560585605|FG011|Overall Study|Started new therapy|0|||
155314771|NCT04209465|560585606|FG012|Overall Study|Started new therapy|0|||
155314772|NCT04209465|560585594|FG000|Overall Study|Study terminated early by sponsor|0|||
155314773|NCT04209465|560585595|FG001|Overall Study|Study terminated early by sponsor|0|||
155314774|NCT04209465|560585596|FG002|Overall Study|Study terminated early by sponsor|0|||
155314775|NCT04209465|560585597|FG003|Overall Study|Study terminated early by sponsor|0|||
155314776|NCT04209465|560585598|FG004|Overall Study|Study terminated early by sponsor|0|||
155500557|NCT01901146|561258493|FG003|Adjuvant Phase|Physician Decision|2|||
155500558|NCT01901146|561258494|FG004|Adjuvant Phase|Physician Decision|4|||
155418245|NCT03569202|560961972|FG000|Part 3|Physician Decision|1|||
155418246|NCT03569202|560961973|FG001|Part 3|Physician Decision|0|||
155418247|NCT03569202|560961972|FG000|Part 3|Other|1|||
155418248|NCT03569202|560961973|FG001|Part 3|Other|1|||
155418249|NCT01668654|560961974|FG000|Overall Study|Study Closed/Terminated|3|||
155418250|NCT01668654|560961974|FG000|Overall Study|Withdrawal by Subject|1|||
155418251|NCT03634800|560961975|FG000|Overall Study|Adverse Event|1|||
155418252|NCT03634800|560961975|FG000|Overall Study|Disease Progression|4|||
155418253|NCT03634800|560961975|FG000|Overall Study|Withdrawal by Subject|1|||
155418254|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
155418255|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
155418256|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
155418257|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
155418258|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
155418259|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
155418260|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
155418261|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
155418262|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
155418263|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
155418264|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
155418265|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
155418266|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
155418267|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
155418268|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
155418269|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
155418270|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
155418271|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
155418272|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
155418273|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
155418274|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
155418275|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
155418276|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
155418277|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
155418278|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Death|2|||
155418279|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Death|1|||
155418280|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Death|2|||
155418281|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Graft loss|0|||
155418282|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Graft loss|2|||
155418283|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Graft loss|0|||
155418284|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
155418285|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
155418286|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
155418287|NCT01114529|560961976|FG000|Completed Study Medication at Month 24|Missing|2|||
155418288|NCT01114529|560961977|FG001|Completed Study Medication at Month 24|Missing|0|||
155418289|NCT01114529|560961978|FG002|Completed Study Medication at Month 24|Missing|0|||
155418290|NCT01114529|560961976|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
155418291|NCT01114529|560961977|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
155418292|NCT01114529|560961978|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
155418293|NCT01114529|560961976|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
155418294|NCT01114529|560961977|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
155418295|NCT01114529|560961978|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
155418296|NCT01114529|560961976|FG000|Completed Study Phase at Month 24|Death|8|||
155418297|NCT01114529|560961977|FG001|Completed Study Phase at Month 24|Death|5|||
155418298|NCT01114529|560961978|FG002|Completed Study Phase at Month 24|Death|4|||
155418299|NCT01114529|560961976|FG000|Completed Study Phase at Month 24|Other|2|||
155418300|NCT01114529|560961977|FG001|Completed Study Phase at Month 24|Other|0|||
155418301|NCT01114529|560961978|FG002|Completed Study Phase at Month 24|Other|0|||
155418302|NCT01114529|560961976|FG000|Completed Study Phase at Month 24|Missing|2|||
155500559|NCT01901146|561258490|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
155500560|NCT01901146|561258491|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
155500561|NCT01901146|561258492|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
155418303|NCT01114529|560961977|FG001|Completed Study Phase at Month 24|Missing|0|||
155418304|NCT01114529|560961978|FG002|Completed Study Phase at Month 24|Missing|0|||
155418305|NCT01235962|560961980|FG000|Overall Study|Withdrawal by Subject|20|||
155418306|NCT01235962|560961981|FG001|Overall Study|Withdrawal by Subject|19|||
155418307|NCT01235962|560961982|FG002|Overall Study|Withdrawal by Subject|62|||
155418308|NCT01235962|560961983|FG003|Overall Study|Withdrawal by Subject|49|||
155418309|NCT01235962|560961980|FG000|Overall Study|Lost to Follow-up|21|||
155500562|NCT01901146|561258493|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
155314777|NCT04209465|560585599|FG005|Overall Study|Study terminated early by sponsor|0|||
155314778|NCT04209465|560585600|FG006|Overall Study|Study terminated early by sponsor|3|||
155314779|NCT04209465|560585601|FG007|Overall Study|Study terminated early by sponsor|0|||
155314780|NCT04209465|560585602|FG008|Overall Study|Study terminated early by sponsor|0|||
155314781|NCT04209465|560585603|FG009|Overall Study|Study terminated early by sponsor|0|||
155314782|NCT04209465|560585604|FG010|Overall Study|Study terminated early by sponsor|0|||
155314783|NCT04209465|560585605|FG011|Overall Study|Study terminated early by sponsor|0|||
155314784|NCT04209465|560585606|FG012|Overall Study|Study terminated early by sponsor|3|||
155314785|NCT04209465|560585594|FG000|Overall Study|Other|0|||
155314786|NCT04209465|560585595|FG001|Overall Study|Other|0|||
155314787|NCT04209465|560585596|FG002|Overall Study|Other|0|||
155314788|NCT04209465|560585597|FG003|Overall Study|Other|0|||
155314789|NCT04209465|560585598|FG004|Overall Study|Other|0|||
155314790|NCT04209465|560585599|FG005|Overall Study|Other|0|||
155314791|NCT04209465|560585600|FG006|Overall Study|Other|0|||
155314792|NCT04209465|560585601|FG007|Overall Study|Other|0|||
155314793|NCT04209465|560585602|FG008|Overall Study|Other|1|||
155314794|NCT04209465|560585603|FG009|Overall Study|Other|0|||
155314795|NCT04209465|560585604|FG010|Overall Study|Other|0|||
155314796|NCT04209465|560585605|FG011|Overall Study|Other|0|||
155314797|NCT04209465|560585606|FG012|Overall Study|Other|0|||
155314798|NCT05647304|560585607|FG000|Overall Study|Withdrawal by Subject|1|||
155643275|NCT02323334|561783780|FG014|Period 3|Lost to Follow-up|0|||
155314799|NCT05647304|560585608|FG001|Overall Study|Withdrawal by Subject|0|||
155314800|NCT04171999|560585609|FG000|Overall Study|deemed ineligible after randomization|2|||
155314801|NCT04171999|560585610|FG001|Overall Study|deemed ineligible after randomization|1|||
155314802|NCT03092518|560585611|FG000|Overall Study|Ineligible|2|||
155314803|NCT02547987|560585612|FG000|Overall Study|Withdrawal by Subject|1|||
155314804|NCT02547987|560585612|FG000|Overall Study|Adverse Event|2|||
155314805|NCT05089019|560585624|FG000|Period 1|Withdrawal by Subject|0|||
155314806|NCT05089019|560585625|FG001|Period 1|Withdrawal by Subject|1|||
155314807|NCT05089019|560585624|FG000|Washout Period|Adverse Event|3|||
155314808|NCT05089019|560585625|FG001|Washout Period|Adverse Event|4|||
155314809|NCT05089019|560585624|FG000|Washout Period|Lost to Follow-up|1|||
155314810|NCT05089019|560585625|FG001|Washout Period|Lost to Follow-up|0|||
155314811|NCT05089019|560585624|FG000|Washout Period|Physician Decision|2|||
155314812|NCT05089019|560585625|FG001|Washout Period|Physician Decision|0|||
155314813|NCT05089019|560585624|FG000|Washout Period|Withdrawal by Subject|6|||
155314814|NCT05089019|560585625|FG001|Washout Period|Withdrawal by Subject|3|||
155314815|NCT05089019|560585624|FG000|Period 2|Adverse Event|4|||
155314816|NCT05089019|560585625|FG001|Period 2|Adverse Event|2|||
155314817|NCT05089019|560585624|FG000|Period 2|Lost to Follow-up|1|||
155314818|NCT05089019|560585625|FG001|Period 2|Lost to Follow-up|0|||
155314819|NCT05089019|560585624|FG000|Period 2|Withdrawal by Subject|0|||
155314820|NCT05089019|560585625|FG001|Period 2|Withdrawal by Subject|1|||
155314821|NCT05170009|560585626|FG000|Overall Study|Physician Decision|0|||
155314822|NCT05170009|560585627|FG001|Overall Study|Physician Decision|1|||
155314823|NCT04925986|560585628|FG000|Overall Study|Death|0|||
155314824|NCT04925986|560585629|FG001|Overall Study|Death|0|||
155314825|NCT04925986|560585630|FG002|Overall Study|Death|2|||
155314826|NCT04925986|560585631|FG003|Overall Study|Death|0|||
155314827|NCT04925986|560585628|FG000|Overall Study|Lack of Efficacy|1|||
155314828|NCT04925986|560585629|FG001|Overall Study|Lack of Efficacy|2|||
155314829|NCT04925986|560585630|FG002|Overall Study|Lack of Efficacy|0|||
155314830|NCT04925986|560585631|FG003|Overall Study|Lack of Efficacy|1|||
155314831|NCT04925986|560585628|FG000|Overall Study|Withdrawal by Subject|0|||
155314832|NCT04925986|560585629|FG001|Overall Study|Withdrawal by Subject|0|||
155314833|NCT04925986|560585630|FG002|Overall Study|Withdrawal by Subject|1|||
155314834|NCT04925986|560585631|FG003|Overall Study|Withdrawal by Subject|2|||
155314835|NCT05457647|560585633|FG000|Overall Study|Lost to Follow-up|3|||
155314836|NCT03115476|560585634|FG000|LP0084-1369|Death|1|||
155314837|NCT03115476|560585635|FG001|LP0084-1369|Death|0|||
155314838|NCT03115476|560585636|FG002|LP0084-1369|Death|2|||
155418310|NCT01235962|560961981|FG001|Overall Study|Lost to Follow-up|16|||
155418311|NCT01235962|560961982|FG002|Overall Study|Lost to Follow-up|47|||
155418312|NCT01235962|560961983|FG003|Overall Study|Lost to Follow-up|32|||
155418313|NCT01235962|560961980|FG000|Overall Study|Physician Decision|5|||
155418314|NCT01235962|560961981|FG001|Overall Study|Physician Decision|0|||
155418315|NCT01235962|560961982|FG002|Overall Study|Physician Decision|9|||
155418316|NCT01235962|560961983|FG003|Overall Study|Physician Decision|5|||
155418317|NCT01580397|560961984|FG000|Overall Study|Lack of Efficacy|14|||
155418318|NCT02883244|560961985|FG000|Overall Study|Lost to Follow-up|0|||
155418319|NCT02883244|560961986|FG001|Overall Study|Lost to Follow-up|1|||
155418320|NCT02435914|560961987|FG000|Overall Study|Ocular Adverse Event|1|||
155418321|NCT02435914|560961988|FG001|Overall Study|Ocular Adverse Event|0|||
155418322|NCT02435914|560961989|FG002|Overall Study|Ocular Adverse Event|0|||
155418323|NCT02435914|560961990|FG003|Overall Study|Ocular Adverse Event|0|||
155418324|NCT02435914|560961987|FG000|Overall Study|Withdrawal by Subject|0|||
155418325|NCT02435914|560961988|FG001|Overall Study|Withdrawal by Subject|1|||
155418326|NCT02435914|560961989|FG002|Overall Study|Withdrawal by Subject|0|||
155314839|NCT03115476|560585634|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
155314840|NCT03115476|560585635|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
155314841|NCT03115476|560585636|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
155314842|NCT03865498|560585637|FG000|Overall Study|Lack of Efficacy|12|||
155314843|NCT03865498|560585638|FG001|Overall Study|Lack of Efficacy|11|||
155314844|NCT03865498|560585637|FG000|Overall Study|Lost to Follow-up|125|||
155314845|NCT03865498|560585638|FG001|Overall Study|Lost to Follow-up|133|||
155314846|NCT03865498|560585637|FG000|Overall Study|Withdrawal by Subject|2|||
155314847|NCT03865498|560585638|FG001|Overall Study|Withdrawal by Subject|4|||
155314848|NCT01648023|560585639|FG000|Overall Study|Screen Fail Post Randomization|1|||
155314849|NCT01648023|560585640|FG001|Overall Study|Screen Fail Post Randomization|2|||
155314850|NCT05296525|560585644|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314851|NCT05296525|560585645|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314852|NCT05296525|560585646|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314853|NCT05296525|560585647|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
155314854|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155314855|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155314856|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
155314857|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
155314858|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155314859|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155314860|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
155314861|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
155314862|NCT02547363|560585650|FG000|12-month Follow-up|Withdrawal by Subject|4|||
155314863|NCT02547363|560585651|FG001|12-month Follow-up|Withdrawal by Subject|3|||
155314864|NCT02547363|560585650|FG000|12-month Follow-up|Lost to Follow-up|4|||
155314865|NCT02547363|560585651|FG001|12-month Follow-up|Lost to Follow-up|1|||
155314866|NCT02547363|560585650|FG000|12-month Follow-up|Lack of Efficacy|1|||
155314867|NCT02547363|560585651|FG001|12-month Follow-up|Lack of Efficacy|1|||
155314868|NCT02547363|560585650|FG000|12-month Follow-up|Other|1|||
155314869|NCT02547363|560585651|FG001|12-month Follow-up|Other|0|||
155314870|NCT05228457|560585652|FG000|Overall Study|Withdrawal by Subject|1|||
155314871|NCT05228457|560585653|FG001|Overall Study|Withdrawal by Subject|1|||
155314872|NCT03161028|560585656|FG000|Overall Study|Withdrawal by Subject|6|||
155314873|NCT03161028|560585657|FG001|Overall Study|Withdrawal by Subject|4|||
155314874|NCT03161028|560585656|FG000|Overall Study|Adverse Event|5|||
155314875|NCT03161028|560585657|FG001|Overall Study|Adverse Event|1|||
155314876|NCT03161028|560585656|FG000|Overall Study|Study drug side effects|2|||
155314877|NCT03161028|560585657|FG001|Overall Study|Study drug side effects|2|||
155314878|NCT03161028|560585656|FG000|Overall Study|Administrative PD/UP|4|||
155314879|NCT03161028|560585657|FG001|Overall Study|Administrative PD/UP|2|||
155314880|NCT03161028|560585656|FG000|Overall Study|Lost to Follow-up|2|||
155314881|NCT03161028|560585657|FG001|Overall Study|Lost to Follow-up|0|||
155314882|NCT03161028|560585656|FG000|Overall Study|Unable to comply with procedures|1|||
155314883|NCT03161028|560585657|FG001|Overall Study|Unable to comply with procedures|1|||
155314884|NCT00736723|560585660|FG000|Overall Study|Withdrawal by Subject|4|||
155314885|NCT00736723|560585661|FG001|Overall Study|Withdrawal by Subject|3|||
155314886|NCT03492216|560585662|FG000|Overall Study|Death|1|||
155314887|NCT03492216|560585663|FG001|Overall Study|Death|0|||
155314888|NCT03492216|560585664|FG002|Overall Study|Death|4|||
155314889|NCT03492216|560585665|FG003|Overall Study|Death|0|||
155314890|NCT03492216|560585662|FG000|Overall Study|Withdrawal by Subject|5|||
155314891|NCT03492216|560585663|FG001|Overall Study|Withdrawal by Subject|3|||
155314892|NCT03492216|560585664|FG002|Overall Study|Withdrawal by Subject|1|||
155314893|NCT03492216|560585665|FG003|Overall Study|Withdrawal by Subject|1|||
155314894|NCT03492216|560585662|FG000|Overall Study|Lost to Follow-up|9|||
155314895|NCT03492216|560585663|FG001|Overall Study|Lost to Follow-up|2|||
155314896|NCT03492216|560585664|FG002|Overall Study|Lost to Follow-up|7|||
155314897|NCT03492216|560585665|FG003|Overall Study|Lost to Follow-up|8|||
155314898|NCT03492216|560585662|FG000|Overall Study|Moved|5|||
155314899|NCT03492216|560585663|FG001|Overall Study|Moved|3|||
155314900|NCT03492216|560585664|FG002|Overall Study|Moved|3|||
155314901|NCT03492216|560585665|FG003|Overall Study|Moved|5|||
155314902|NCT03492216|560585662|FG000|Overall Study|Too ill|0|||
155314903|NCT03492216|560585663|FG001|Overall Study|Too ill|1|||
155314904|NCT03492216|560585664|FG002|Overall Study|Too ill|0|||
155314905|NCT03492216|560585665|FG003|Overall Study|Too ill|0|||
155314906|NCT03492216|560585662|FG000|Overall Study|Incarcerated|0|||
155314907|NCT03492216|560585663|FG001|Overall Study|Incarcerated|0|||
155314908|NCT03492216|560585664|FG002|Overall Study|Incarcerated|2|||
155314909|NCT03492216|560585665|FG003|Overall Study|Incarcerated|0|||
155314910|NCT01799265|560585668|FG000|Overall Study|Lost to Follow-up|1|||
155314911|NCT01799265|560585669|FG001|Overall Study|Lost to Follow-up|0|||
155314912|NCT01799265|560585668|FG000|Overall Study|Protocol Violation|2|||
155314913|NCT01799265|560585669|FG001|Overall Study|Protocol Violation|1|||
155314914|NCT01799265|560585668|FG000|Overall Study|inadequate sleep study|0|||
155314915|NCT01799265|560585669|FG001|Overall Study|inadequate sleep study|2|||
155314916|NCT05351554|560585680|FG000|Overall Study|Study terminated by sponsor|1|||
155314917|NCT05030233|560585681|FG000|Overall Study|withdrawn for transfer|1|||
155314918|NCT05030233|560585682|FG001|Overall Study|withdrawn for transfer|0|||
155314919|NCT04342494|560587677|FG000|Overall Study|Questionnaire partially completed|1|||
155314920|NCT04342494|560587678|FG001|Overall Study|Questionnaire partially completed|0|||
155314921|NCT04342494|560587679|FG002|Overall Study|Questionnaire partially completed|2|||
155314922|NCT04342494|560587680|FG003|Overall Study|Questionnaire partially completed|0|||
155314923|NCT04342494|560587681|FG004|Overall Study|Questionnaire partially completed|1|||
155314924|NCT04342494|560587677|FG000|Overall Study|Lost to Follow-up|49|||
155314925|NCT04342494|560587678|FG001|Overall Study|Lost to Follow-up|38|||
155314926|NCT04342494|560587679|FG002|Overall Study|Lost to Follow-up|34|||
155314927|NCT04342494|560587680|FG003|Overall Study|Lost to Follow-up|34|||
155314928|NCT04342494|560587681|FG004|Overall Study|Lost to Follow-up|35|||
155314929|NCT06190691|560587690|FG000|Overall Study|Adverse Event|2|||
155314930|NCT06190691|560587691|FG001|Overall Study|Adverse Event|0|||
155314931|NCT06190691|560587692|FG002|Overall Study|Adverse Event|0|||
155314932|NCT06190691|560587693|FG003|Overall Study|Adverse Event|0|||
155314933|NCT03016754|560587694|FG000|Overall Study|Death|5|||
155314934|NCT03016754|560587695|FG001|Overall Study|Death|4|||
155314935|NCT03016754|560587696|FG002|Overall Study|Death|5|||
155314936|NCT03016754|560587697|FG003|Overall Study|Death|1|||
155314937|NCT03016754|560587694|FG000|Overall Study|Lost to Follow-up|23|||
155314938|NCT03016754|560587695|FG001|Overall Study|Lost to Follow-up|17|||
155314939|NCT03016754|560587696|FG002|Overall Study|Lost to Follow-up|4|||
155314940|NCT03016754|560587697|FG003|Overall Study|Lost to Follow-up|2|||
155314941|NCT03016754|560587694|FG000|Overall Study|Withdrawal by Subject|6|||
155314942|NCT03016754|560587695|FG001|Overall Study|Withdrawal by Subject|6|||
155314943|NCT03016754|560587696|FG002|Overall Study|Withdrawal by Subject|2|||
155314944|NCT03016754|560587697|FG003|Overall Study|Withdrawal by Subject|2|||
155314945|NCT03016754|560587694|FG000|Overall Study|Other/Unknown|2|||
155314946|NCT03016754|560587695|FG001|Overall Study|Other/Unknown|4|||
155314947|NCT03016754|560587696|FG002|Overall Study|Other/Unknown|2|||
155314948|NCT03016754|560587697|FG003|Overall Study|Other/Unknown|1|||
155314949|NCT03016754|560587694|FG000|Overall Study|Protocol Violation|0|||
155314950|NCT03016754|560587695|FG001|Overall Study|Protocol Violation|0|||
155314951|NCT03016754|560587696|FG002|Overall Study|Protocol Violation|0|||
155314952|NCT03016754|560587697|FG003|Overall Study|Protocol Violation|4|||
155314953|NCT04019873|560587698|FG000|Overall Study|Discontinued from the treatment|1|||
155314954|NCT04019873|560587699|FG001|Overall Study|Discontinued from the treatment|39|||
155314955|NCT04019873|560587700|FG002|Overall Study|Discontinued from the treatment|2|||
155314956|NCT04185298|560587702|FG000|Overall Study|Lost to Follow-up|1|||
155314957|NCT04185298|560587703|FG001|Overall Study|Lost to Follow-up|3|||
155314958|NCT04185298|560587702|FG000|Overall Study|Withdrawal by Subject|0|||
155314959|NCT04185298|560587703|FG001|Overall Study|Withdrawal by Subject|3|||
155314960|NCT03896789|560587704|FG000|Baseline|Lost to Follow-up|1|||
155314961|NCT03896789|560587705|FG001|Baseline|Lost to Follow-up|2|||
155314962|NCT03896789|560587704|FG000|Baseline|Death|3|||
155314963|NCT03896789|560587705|FG001|Baseline|Death|6|||
155314964|NCT03896789|560587704|FG000|Post-Randomization|Lost to Follow-up|12|||
155314965|NCT03896789|560587705|FG001|Post-Randomization|Lost to Follow-up|11|||
155314966|NCT03896789|560587704|FG000|Post-Randomization|Death|12|||
155314967|NCT03896789|560587705|FG001|Post-Randomization|Death|13|||
155314968|NCT01842542|560587706|FG000|Overall Study|Withdrawal by Subject|2|||
155314969|NCT01842542|560587706|FG000|Overall Study|Lack of Efficacy|1|||
155314970|NCT01842542|560587706|FG000|Overall Study|Protocol Non-compliance|2|||
155314971|NCT01842542|560587706|FG000|Overall Study|Lost to Follow-up|1|||
155314972|NCT02919306|560587707|FG000|Overall Study|Withdrawal by Subject|1|||
155314973|NCT02919306|560587708|FG001|Overall Study|Withdrawal by Subject|0|||
155314974|NCT02919306|560587707|FG000|Overall Study|Protocol Violation|1|||
155314975|NCT02919306|560587708|FG001|Overall Study|Protocol Violation|0|||
155314976|NCT04473222|560587709|FG000|Overall Study|Lost to Follow-up|13|||
155314977|NCT04473222|560587710|FG001|Overall Study|Lost to Follow-up|13|||
155314978|NCT04473222|560587709|FG000|Overall Study|Withdrawal by Subject|0|||
155314979|NCT04473222|560587710|FG001|Overall Study|Withdrawal by Subject|1|||
155314980|NCT04473222|560587709|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
155314981|NCT04473222|560587710|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
155314982|NCT04293055|560587711|FG000|Overall Study|Lost to Follow-up|1|||
155314983|NCT04293055|560587712|FG001|Overall Study|Lost to Follow-up|1|||
155314984|NCT04293055|560587711|FG000|Overall Study|Did not trigger randomization|6|||
155314985|NCT04293055|560587712|FG001|Overall Study|Did not trigger randomization|5|||
155314986|NCT03560609|560587713|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
155314987|NCT03560609|560587714|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
155314988|NCT01098812|560587723|FG000|Overall Study|Death|2|||
155314989|NCT01098812|560587724|FG001|Overall Study|Death|0|||
155314990|NCT01098812|560587725|FG002|Overall Study|Death|1|||
155314991|NCT01098812|560587723|FG000|Overall Study|Lost to Follow-up|0|||
155314992|NCT01098812|560587724|FG001|Overall Study|Lost to Follow-up|1|||
155314993|NCT01098812|560587725|FG002|Overall Study|Lost to Follow-up|0|||
155314994|NCT01987895|560587729|FG000|Overall Study|Withdrawal by Subject|12|||
155314995|NCT01987895|560587730|FG001|Overall Study|Withdrawal by Subject|7|||
155314996|NCT01987895|560587729|FG000|Overall Study|Physician Decision|8|||
155314997|NCT01987895|560587730|FG001|Overall Study|Physician Decision|10|||
155314998|NCT01987895|560587729|FG000|Overall Study|Death|7|||
155314999|NCT01987895|560587730|FG001|Overall Study|Death|7|||
155315000|NCT01987895|560587729|FG000|Overall Study|Lost to Follow-up|3|||
155315001|NCT01987895|560587730|FG001|Overall Study|Lost to Follow-up|5|||
155315002|NCT01987895|560587729|FG000|Overall Study|randomized before giving IC|0|||
155315003|NCT01987895|560587730|FG001|Overall Study|randomized before giving IC|1|||
155315004|NCT01073566|560587731|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
155315005|NCT01073566|560587732|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
155315006|NCT03452579|560587743|FG000|Overall Study|Death|0|||
155315007|NCT03452579|560587744|FG001|Overall Study|Death|1|||
155315008|NCT03452579|560587743|FG000|Overall Study|Withdrawal by Subject|2|||
155315009|NCT03452579|560587744|FG001|Overall Study|Withdrawal by Subject|0|||
155315010|NCT03452579|560587743|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
155315011|NCT03452579|560587744|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
155315012|NCT03452579|560587743|FG000|Overall Study|Physician Decision|1|||
155315013|NCT03452579|560587744|FG001|Overall Study|Physician Decision|1|||
155315014|NCT03452579|560587743|FG000|Overall Study|Adverse Event|1|||
155315015|NCT03452579|560587744|FG001|Overall Study|Adverse Event|4|||
155315016|NCT04858321|560587747|FG000|Overall Study|Withdrawal by Subject|3|||
155315017|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
155315018|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
155315019|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
155315020|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
155315021|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
155315022|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
155315023|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Death|6|||
155315024|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Death|0|||
155315025|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Death|0|||
155315026|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
155315027|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
155315028|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
155315029|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
155315030|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
155315031|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
155315032|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
155315033|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
155315034|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
155315035|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Other|5|||
155315036|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Other|0|||
155315037|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Other|0|||
155315038|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
155315039|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
155315040|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
155315041|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Other|0|||
155315042|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Other|1|||
155315043|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Other|1|||
155315044|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
155315045|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
155315046|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
155315047|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
155315048|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
155315049|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
155315050|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
155315051|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
155315052|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
155315053|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
155315054|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
155315055|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
155500563|NCT01901146|561258494|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
155500564|NCT00297492|561258495|FG000|Set Quit Date|Lost to Follow-up|7|||
155315056|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Death|0|||
155315057|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Death|6|||
155315058|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Death|11|||
155315059|NCT05006872|560587759|FG000|Overall Study|Lost to Follow-up|37|||
155315060|NCT05006872|560587760|FG001|Overall Study|Lost to Follow-up|31|||
155315061|NCT05499377|560587766|FG000|Overall Study|Withdrawal by Subject|2|||
155315062|NCT05499377|560587767|FG001|Overall Study|Withdrawal by Subject|0|||
155315063|NCT05499377|560587766|FG000|Overall Study|Physician Decision|1|||
155315064|NCT05499377|560587767|FG001|Overall Study|Physician Decision|0|||
155315065|NCT02573493|560587768|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
155315066|NCT02573493|560587769|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
155315067|NCT02573493|560587770|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
155315068|NCT02573493|560587771|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
155315069|NCT04332926|560587772|FG000|Overall Study|Withdrawal by Subject|6|||
155315070|NCT04332926|560587772|FG000|Overall Study|Physician Decision|6|||
155315071|NCT04350463|560587780|FG000|Overall Study|Other reason|0|||
155315072|NCT04350463|560587781|FG001|Overall Study|Other reason|0|||
155315073|NCT04350463|560587782|FG002|Overall Study|Other reason|0|||
155315074|NCT04350463|560587783|FG003|Overall Study|Other reason|1|||
155315075|NCT04350463|560587780|FG000|Overall Study|Lost to Follow-up|0|||
155315076|NCT04350463|560587781|FG001|Overall Study|Lost to Follow-up|0|||
155315077|NCT04350463|560587782|FG002|Overall Study|Lost to Follow-up|0|||
155315078|NCT04350463|560587783|FG003|Overall Study|Lost to Follow-up|2|||
155315079|NCT04350463|560587780|FG000|Overall Study|Withdrawal by Subject|4|||
155315080|NCT04350463|560587781|FG001|Overall Study|Withdrawal by Subject|0|||
155315081|NCT04350463|560587782|FG002|Overall Study|Withdrawal by Subject|1|||
155315082|NCT04350463|560587783|FG003|Overall Study|Withdrawal by Subject|4|||
155315083|NCT04350463|560587780|FG000|Overall Study|Adverse Event|0|||
155315084|NCT04350463|560587781|FG001|Overall Study|Adverse Event|0|||
155315085|NCT04350463|560587782|FG002|Overall Study|Adverse Event|0|||
155315086|NCT04350463|560587783|FG003|Overall Study|Adverse Event|2|||
155315087|NCT04350463|560587780|FG000|Overall Study|Death|27|||
155315088|NCT04350463|560587781|FG001|Overall Study|Death|2|||
155315089|NCT04350463|560587782|FG002|Overall Study|Death|13|||
155315090|NCT04350463|560587783|FG003|Overall Study|Death|26|||
155315091|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
155315092|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
155315093|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
155315094|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
155315095|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
155315096|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
155315097|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
155315098|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
155315099|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
155315100|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
155315101|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
155315102|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
155315103|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
155500565|NCT00297492|561258496|FG001|Set Quit Date|Lost to Follow-up|13|||
155500566|NCT00297492|561258497|FG002|Set Quit Date|Lost to Follow-up|5|||
155500567|NCT00297492|561258495|FG000|6 Month Follow-up|Lost to Follow-up|63|||
155500568|NCT00297492|561258496|FG001|6 Month Follow-up|Lost to Follow-up|49|||
155500569|NCT00297492|561258497|FG002|6 Month Follow-up|Lost to Follow-up|27|||
155500570|NCT02675426|561258498|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
155500571|NCT02675426|561258499|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
155500572|NCT02675426|561258500|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
155500573|NCT02675426|561258501|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
155500574|NCT02675426|561258498|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
155500575|NCT02675426|561258499|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
155500576|NCT02675426|561258500|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
155500577|NCT02675426|561258501|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
155500578|NCT02675426|561258498|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
155500579|NCT02675426|561258499|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
155500580|NCT02675426|561258500|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
155500581|NCT02675426|561258501|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
155500582|NCT02675426|561258498|FG000|Period 1: Week 1 to Week 12|Other|2|||
155500583|NCT02675426|561258499|FG001|Period 1: Week 1 to Week 12|Other|1|||
155315104|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
155500584|NCT02675426|561258500|FG002|Period 1: Week 1 to Week 12|Other|0|||
155315105|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
155315106|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
155315107|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
155500585|NCT02675426|561258501|FG003|Period 1: Week 1 to Week 12|Other|2|||
155500586|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
155315108|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
155315109|NCT03097549|560587786|FG000|Overall Study|Withdrawal by Subject|1|||
155315110|NCT03097549|560587787|FG001|Overall Study|Withdrawal by Subject|0|||
155315111|NCT03097549|560587786|FG000|Overall Study|Lost to Follow-up|1|||
155315112|NCT03097549|560587787|FG001|Overall Study|Lost to Follow-up|0|||
155315113|NCT01824537|560587790|FG000|Overall Study|Lost to Follow-up|78|||
155315114|NCT01824537|560587791|FG001|Overall Study|Lost to Follow-up|87|||
155315115|NCT04282148|560587792|FG000|Overall Study|Death|7|||
155315116|NCT04282148|560587792|FG000|Overall Study|Withdrawal by Subject|1|||
155315117|NCT04282148|560587792|FG000|Overall Study|Physician Decision|1|||
155315118|NCT02146378|560587793|FG000|Overall Study|No information of administration|2|||
155315119|NCT06215521|560587794|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315120|NCT06215521|560587795|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
155315121|NCT06215521|560587796|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315122|NCT06215521|560587797|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315123|NCT06215521|560587798|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315124|NCT06215521|560587799|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315125|NCT04096040|560587800|FG000|Overall Study|Protocol Violation|12|||
155315126|NCT04096040|560587800|FG000|Overall Study|Non-compliant site|4|||
155315127|NCT04973254|560587801|FG000|Overall Study|Not adherent|0|||
155315128|NCT04973254|560587802|FG001|Overall Study|Not adherent|1|||
155315129|NCT04973254|560587803|FG002|Overall Study|Not adherent|0|||
155315130|NCT04044768|560587804|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
155315131|NCT04044768|560587805|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
155315132|NCT03858634|560587806|FG000|Overall Study|Withdrawal by Subject|1|||
155315133|NCT03858634|560587807|FG001|Overall Study|Withdrawal by Subject|0|||
155315134|NCT03858634|560587806|FG000|Overall Study|Adverse Event|1|||
155315135|NCT03858634|560587807|FG001|Overall Study|Adverse Event|0|||
155315136|NCT03858634|560587806|FG000|Overall Study|Lost to Follow-up|0|||
155315137|NCT03858634|560587807|FG001|Overall Study|Lost to Follow-up|1|||
155315138|NCT03858634|560587806|FG000|Overall Study|Other, Not Specified|1|||
155315139|NCT03858634|560587807|FG001|Overall Study|Other, Not Specified|1|||
155315140|NCT03808818|560587808|FG000|Overall Study|Death|6|||
155315141|NCT03808818|560587809|FG001|Overall Study|Death|6|||
155315142|NCT03808818|560587808|FG000|Overall Study|Withdrawal by Subject|7|||
155315143|NCT03808818|560587809|FG001|Overall Study|Withdrawal by Subject|18|||
155315144|NCT03808818|560587808|FG000|Overall Study|Lost to Follow-up|31|||
155315145|NCT03808818|560587809|FG001|Overall Study|Lost to Follow-up|33|||
155315146|NCT05415722|560587810|FG000|Overall Study|Lost to Follow-up|0|||
155315147|NCT05415722|560587811|FG001|Overall Study|Lost to Follow-up|2|||
155315148|NCT05415722|560587812|FG002|Overall Study|Lost to Follow-up|0|||
155315149|NCT05415722|560587813|FG003|Overall Study|Lost to Follow-up|1|||
155315150|NCT05415722|560587814|FG004|Overall Study|Lost to Follow-up|0|||
155315151|NCT05415722|560587815|FG005|Overall Study|Lost to Follow-up|0|||
155315152|NCT05415722|560587816|FG006|Overall Study|Lost to Follow-up|1|||
155315153|NCT05415722|560587810|FG000|Overall Study|Physician Decision|0|||
155315154|NCT05415722|560587811|FG001|Overall Study|Physician Decision|0|||
155315155|NCT05415722|560587812|FG002|Overall Study|Physician Decision|0|||
155315156|NCT05415722|560587813|FG003|Overall Study|Physician Decision|1|||
155315157|NCT05415722|560587814|FG004|Overall Study|Physician Decision|0|||
155315158|NCT05415722|560587815|FG005|Overall Study|Physician Decision|0|||
155315159|NCT05415722|560587816|FG006|Overall Study|Physician Decision|1|||
155418327|NCT02435914|560961990|FG003|Overall Study|Withdrawal by Subject|0|||
155418328|NCT02435914|560961987|FG000|Overall Study|Other Miscellaneous Reason|0|||
155418329|NCT02435914|560961988|FG001|Overall Study|Other Miscellaneous Reason|0|||
155418330|NCT02435914|560961989|FG002|Overall Study|Other Miscellaneous Reason|1|||
155418331|NCT02435914|560961990|FG003|Overall Study|Other Miscellaneous Reason|0|||
155315160|NCT05415722|560587810|FG000|Overall Study|Protocol Violation|0|||
155315161|NCT05415722|560587811|FG001|Overall Study|Protocol Violation|0|||
155315162|NCT05415722|560587812|FG002|Overall Study|Protocol Violation|0|||
155315163|NCT05415722|560587813|FG003|Overall Study|Protocol Violation|1|||
155418332|NCT01405053|560961991|FG000|Overall Study|Adverse Event|3|||
155418333|NCT01405053|560961992|FG001|Overall Study|Adverse Event|0|||
155418334|NCT01405053|560961991|FG000|Overall Study|Lost to Follow-up|0|||
155315164|NCT05415722|560587814|FG004|Overall Study|Protocol Violation|0|||
155315165|NCT05415722|560587815|FG005|Overall Study|Protocol Violation|0|||
155315166|NCT05415722|560587816|FG006|Overall Study|Protocol Violation|0|||
155315167|NCT05415722|560587810|FG000|Overall Study|Sponsor Discretion|0|||
155315168|NCT05415722|560587811|FG001|Overall Study|Sponsor Discretion|0|||
155315169|NCT05415722|560587812|FG002|Overall Study|Sponsor Discretion|0|||
155315170|NCT05415722|560587813|FG003|Overall Study|Sponsor Discretion|0|||
155418335|NCT01405053|560961992|FG001|Overall Study|Lost to Follow-up|1|||
155418336|NCT01405053|560961991|FG000|Overall Study|Participant choice|2|||
155418337|NCT01405053|560961992|FG001|Overall Study|Participant choice|1|||
155418338|NCT01405053|560961991|FG000|Overall Study|Inadequate therapeutic effect|2|||
155315171|NCT05415722|560587814|FG004|Overall Study|Sponsor Discretion|1|||
155315172|NCT05415722|560587815|FG005|Overall Study|Sponsor Discretion|1|||
155315173|NCT05415722|560587816|FG006|Overall Study|Sponsor Discretion|0|||
155315174|NCT05415722|560587810|FG000|Overall Study|Withdrawal by Subject|0|||
155315175|NCT05415722|560587811|FG001|Overall Study|Withdrawal by Subject|1|||
155315176|NCT05415722|560587812|FG002|Overall Study|Withdrawal by Subject|0|||
155315177|NCT05415722|560587813|FG003|Overall Study|Withdrawal by Subject|1|||
155315178|NCT05415722|560587814|FG004|Overall Study|Withdrawal by Subject|1|||
155500587|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
155500588|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
155315179|NCT05415722|560587815|FG005|Overall Study|Withdrawal by Subject|0|||
155315180|NCT05415722|560587816|FG006|Overall Study|Withdrawal by Subject|1|||
155315181|NCT04629716|560587817|FG000|Overall Study|Lost to Follow-up|7|||
155500589|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
155500590|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
155500591|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
155500592|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
155500593|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
155500594|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
155500595|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
155500596|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
155500597|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
155500598|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
155500599|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
155500600|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
155315182|NCT04629716|560587818|FG001|Overall Study|Lost to Follow-up|3|||
155315183|NCT04537715|560587820|FG000|Overall Study|Death|3|||
155315184|NCT04537715|560587821|FG001|Overall Study|Death|1|||
155315185|NCT04537715|560587820|FG000|Overall Study|Withdrawal by Subject|3|||
155315186|NCT04537715|560587821|FG001|Overall Study|Withdrawal by Subject|1|||
155315187|NCT04537715|560587820|FG000|Overall Study|Other|4|||
155315188|NCT04537715|560587821|FG001|Overall Study|Other|3|||
155315189|NCT04537715|560587820|FG000|Overall Study|Progressive disease|1|||
155315190|NCT04537715|560587821|FG001|Overall Study|Progressive disease|0|||
155315191|NCT03448107|560587822|FG000|Overall Study|Lost to Follow-up|229|||
155315192|NCT03448107|560587823|FG001|Overall Study|Lost to Follow-up|258|||
155315193|NCT04700163|560587824|FG000|Overall Study|Lost to Follow-up|0|||
155315194|NCT04700163|560587825|FG001|Overall Study|Lost to Follow-up|0|||
155315195|NCT04700163|560587826|FG002|Overall Study|Lost to Follow-up|0|||
155315196|NCT04700163|560587827|FG003|Overall Study|Lost to Follow-up|0|||
155500601|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
155500602|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
155500603|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
155500604|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
155500605|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
155500606|NCT02675426|561258498|FG000|Period 2: Week 12 to Week 260|Other|8|||
155500607|NCT02675426|561258499|FG001|Period 2: Week 12 to Week 260|Other|12|||
155500608|NCT02675426|561258500|FG002|Period 2: Week 12 to Week 260|Other|23|||
155500609|NCT02675426|561258501|FG003|Period 2: Week 12 to Week 260|Other|15|||
155500610|NCT03724968|561258502|FG000|Overall Study|Insurance issues|0|||
155315197|NCT04700163|560587828|FG004|Overall Study|Lost to Follow-up|0|||
155315198|NCT04700163|560587829|FG005|Overall Study|Lost to Follow-up|1|||
155315199|NCT05543629|560587836|FG000|Overall Study|Death|1|||
155315200|NCT05543629|560587837|FG001|Overall Study|Death|0|||
155315201|NCT05543629|560587838|FG002|Overall Study|Death|1|||
155315202|NCT05543629|560587839|FG003|Overall Study|Death|0|||
155315203|NCT05543629|560587840|FG004|Overall Study|Death|0|||
155315204|NCT05543629|560587841|FG005|Overall Study|Death|1|||
155315205|NCT05543629|560587842|FG006|Overall Study|Death|2|||
155315206|NCT05543629|560587843|FG007|Overall Study|Death|2|||
155315207|NCT05543629|560587836|FG000|Overall Study|Other Reasons|0|||
155315208|NCT05543629|560587837|FG001|Overall Study|Other Reasons|0|||
155315209|NCT05543629|560587838|FG002|Overall Study|Other Reasons|0|||
155315210|NCT05543629|560587839|FG003|Overall Study|Other Reasons|0|||
155315211|NCT05543629|560587840|FG004|Overall Study|Other Reasons|1|||
155315212|NCT05543629|560587841|FG005|Overall Study|Other Reasons|0|||
155315213|NCT05543629|560587842|FG006|Overall Study|Other Reasons|0|||
155500611|NCT03724968|561258503|FG001|Overall Study|Insurance issues|1|||
155500612|NCT03724968|561258502|FG000|Overall Study|Study closed|0|||
155500613|NCT03724968|561258503|FG001|Overall Study|Study closed|1|||
155500614|NCT01858558|561258504|FG000|Overall Study|Death|1|||
155500615|NCT01858558|561258505|FG001|Overall Study|Death|1|||
155643276|NCT02323334|561783781|FG015|Period 3|Lost to Follow-up|0|||
155315214|NCT05543629|560587843|FG007|Overall Study|Other Reasons|0|||
155315215|NCT05543629|560587836|FG000|Overall Study|Physician Decision|0|||
155315216|NCT05543629|560587837|FG001|Overall Study|Physician Decision|0|||
155315217|NCT05543629|560587838|FG002|Overall Study|Physician Decision|3|||
155315218|NCT05543629|560587839|FG003|Overall Study|Physician Decision|0|||
155315219|NCT05543629|560587840|FG004|Overall Study|Physician Decision|0|||
155315220|NCT05543629|560587841|FG005|Overall Study|Physician Decision|0|||
155315221|NCT05543629|560587842|FG006|Overall Study|Physician Decision|1|||
155315222|NCT05543629|560587843|FG007|Overall Study|Physician Decision|0|||
155315223|NCT05543629|560587836|FG000|Overall Study|Study terminated by Sponsor|1|||
155315224|NCT05543629|560587837|FG001|Overall Study|Study terminated by Sponsor|0|||
155315225|NCT05543629|560587838|FG002|Overall Study|Study terminated by Sponsor|0|||
155315226|NCT05543629|560587839|FG003|Overall Study|Study terminated by Sponsor|1|||
155315227|NCT05543629|560587840|FG004|Overall Study|Study terminated by Sponsor|0|||
155315228|NCT05543629|560587841|FG005|Overall Study|Study terminated by Sponsor|4|||
155315229|NCT05543629|560587842|FG006|Overall Study|Study terminated by Sponsor|1|||
155315230|NCT05543629|560587843|FG007|Overall Study|Study terminated by Sponsor|0|||
155315231|NCT05543629|560587836|FG000|Overall Study|Withdrawal by Subject|1|||
155315232|NCT05543629|560587837|FG001|Overall Study|Withdrawal by Subject|1|||
155315233|NCT05543629|560587838|FG002|Overall Study|Withdrawal by Subject|0|||
155315234|NCT05543629|560587839|FG003|Overall Study|Withdrawal by Subject|2|||
155315235|NCT05543629|560587840|FG004|Overall Study|Withdrawal by Subject|1|||
155315236|NCT05543629|560587841|FG005|Overall Study|Withdrawal by Subject|1|||
155315237|NCT05543629|560587842|FG006|Overall Study|Withdrawal by Subject|1|||
155315238|NCT05543629|560587843|FG007|Overall Study|Withdrawal by Subject|1|||
155315239|NCT05543629|560587836|FG000|Overall Study|Not Reported|2|||
155315240|NCT05543629|560587837|FG001|Overall Study|Not Reported|2|||
155315241|NCT05543629|560587838|FG002|Overall Study|Not Reported|0|||
155315242|NCT05543629|560587839|FG003|Overall Study|Not Reported|0|||
155315243|NCT05543629|560587840|FG004|Overall Study|Not Reported|1|||
155315244|NCT05543629|560587841|FG005|Overall Study|Not Reported|1|||
155315245|NCT05543629|560587842|FG006|Overall Study|Not Reported|3|||
155315246|NCT05543629|560587843|FG007|Overall Study|Not Reported|0|||
155315247|NCT04568603|560587844|FG000|Overall Study|Physician Decision|1|||
155315248|NCT04564742|560587845|FG000|Overall Study|Lost to Follow-up|1|||
155315249|NCT04564742|560587846|FG001|Overall Study|Lost to Follow-up|0|||
155315250|NCT04564742|560587845|FG000|Overall Study|Consent Withdrawal|4|||
155315251|NCT04564742|560587846|FG001|Overall Study|Consent Withdrawal|4|||
155315252|NCT05869383|560587849|FG000|Overall Study|Withdrawal by Subject|2|||
155315253|NCT05869383|560587850|FG001|Overall Study|Withdrawal by Subject|0|||
155315254|NCT03084536|560587857|FG000|Overall Study|Determined to be ineligible|0|||
155315255|NCT03084536|560587858|FG001|Overall Study|Determined to be ineligible|0|||
155315256|NCT03084536|560587859|FG002|Overall Study|Determined to be ineligible|16|||
155315257|NCT03084536|560587857|FG000|Overall Study|Withdrawal by Subject|0|||
155315258|NCT03084536|560587858|FG001|Overall Study|Withdrawal by Subject|0|||
155315259|NCT03084536|560587859|FG002|Overall Study|Withdrawal by Subject|4|||
155315260|NCT03084536|560587857|FG000|Overall Study|Physician Decision|0|||
155315261|NCT03084536|560587858|FG001|Overall Study|Physician Decision|0|||
155315262|NCT03084536|560587859|FG002|Overall Study|Physician Decision|3|||
155315263|NCT03084536|560587857|FG000|Overall Study|Death|0|||
155315264|NCT03084536|560587858|FG001|Overall Study|Death|0|||
155315265|NCT03084536|560587859|FG002|Overall Study|Death|1|||
155315266|NCT03084536|560587857|FG000|Overall Study|Lost to Follow-up|0|||
155315267|NCT03084536|560587858|FG001|Overall Study|Lost to Follow-up|0|||
155315268|NCT03084536|560587859|FG002|Overall Study|Lost to Follow-up|1|||
155315269|NCT03084536|560587857|FG000|Overall Study|Protocol Violation|0|||
155315270|NCT03084536|560587858|FG001|Overall Study|Protocol Violation|0|||
155315271|NCT03084536|560587859|FG002|Overall Study|Protocol Violation|1|||
155315272|NCT03084536|560587857|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
155315273|NCT03084536|560587858|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
155315274|NCT03084536|560587859|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
155315275|NCT04728347|560589884|FG000|Overall Study|Sponsor decision|0|||
155315276|NCT04728347|560589885|FG001|Overall Study|Sponsor decision|0|||
155315277|NCT04728347|560589886|FG002|Overall Study|Sponsor decision|1|||
155315278|NCT04728347|560589887|FG003|Overall Study|Sponsor decision|0|||
155315279|NCT05835336|560589888|FG000|Overall Study|Withdrawal by Subject|5|||
155315280|NCT05835336|560589888|FG000|Overall Study|Did not complete the personalization process|3|||
155315281|NCT04489771|560589889|FG000|Overall Study|Death|27|||
155315282|NCT04489771|560589890|FG001|Overall Study|Death|25|||
155315283|NCT04489771|560589889|FG000|Overall Study|Withdrawal by Subject|1|||
155315284|NCT04489771|560589890|FG001|Overall Study|Withdrawal by Subject|0|||
155315285|NCT04489771|560589889|FG000|Overall Study|Participants Ongoing in Study|50|||
155315286|NCT04489771|560589890|FG001|Overall Study|Participants Ongoing in Study|51|||
155418339|NCT01405053|560961992|FG001|Overall Study|Inadequate therapeutic effect|1|||
155418340|NCT01405053|560961991|FG000|Overall Study|Withdrawal by Subject|3|||
155315287|NCT04059484|560589892|FG000|Overall Study|Adverse Event|2|||
155418341|NCT01405053|560961992|FG001|Overall Study|Withdrawal by Subject|4|||
155315288|NCT04059484|560589893|FG001|Overall Study|Adverse Event|5|||
155315289|NCT04059484|560589892|FG000|Overall Study|Withdrawal by Subject|5|||
155315290|NCT04059484|560589893|FG001|Overall Study|Withdrawal by Subject|3|||
155315291|NCT04059484|560589892|FG000|Overall Study|Progressive disease|112|||
155315292|NCT04059484|560589893|FG001|Overall Study|Progressive disease|112|||
155315293|NCT04059484|560589892|FG000|Overall Study|Other|8|||
155315294|NCT04059484|560589893|FG001|Overall Study|Other|3|||
155315295|NCT04059484|560589892|FG000|Overall Study|Ongoing|20|||
155418342|NCT01405053|560961991|FG000|Overall Study|Other|0|||
155315296|NCT04059484|560589893|FG001|Overall Study|Ongoing|20|||
155315297|NCT04719390|560589894|FG000|Overall Study|Withdrawal by Subject|1|||
155315298|NCT04292223|560589895|FG000|Overall Study|Adverse Event|1|||
155315299|NCT04292223|560589895|FG000|Overall Study|Lost to Follow-up|1|||
155315300|NCT04292223|560589895|FG000|Overall Study|Noncompliance with study drug|2|||
155315301|NCT04292223|560589895|FG000|Overall Study|Patient moved out of the state|1|||
155315302|NCT00753545|560589896|FG000|Overall Study|Death|98|||
155315303|NCT00753545|560589897|FG001|Overall Study|Death|112|||
155315304|NCT00753545|560589896|FG000|Overall Study|Lost to Follow-up|2|||
155315305|NCT00753545|560589897|FG001|Overall Study|Lost to Follow-up|3|||
155315306|NCT00753545|560589896|FG000|Overall Study|Protocol Violation|1|||
155315307|NCT00753545|560589897|FG001|Overall Study|Protocol Violation|0|||
155315308|NCT00753545|560589896|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
155315309|NCT00753545|560589897|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
155315310|NCT05453773|560589898|FG000|Overall Study|Withdrawal by Subject|3|||
155315311|NCT05453773|560589898|FG000|Overall Study|Lost to Follow-up|3|||
155315312|NCT05453773|560589898|FG000|Overall Study|Difficult Blood Draw|3|||
155315313|NCT04633122|560589901|FG000|Overall Study|Remained on treatment|19|||
155315314|NCT04633122|560589902|FG001|Overall Study|Remained on treatment|14|||
155315315|NCT04633122|560589901|FG000|Overall Study|Survival follow-up stopped|22|||
155315316|NCT04633122|560589902|FG001|Overall Study|Survival follow-up stopped|25|||
155315317|NCT03839940|560589903|FG000|Overall Study|Withdrawal by Subject|3|||
155315318|NCT03839940|560589904|FG001|Overall Study|Withdrawal by Subject|0|||
155418343|NCT01405053|560961992|FG001|Overall Study|Other|1|||
155418344|NCT00464178|560962000|FG000|Overall Study|Protocol Violation|1|||
155418345|NCT00464178|560962000|FG000|Overall Study|Withdrawal by Subject|1|||
155418346|NCT01972074|560962007|FG000|Overall Study|Adverse Event|4|||
155418347|NCT01972074|560962008|FG001|Overall Study|Adverse Event|1|||
155418348|NCT01972074|560962009|FG002|Overall Study|Adverse Event|0|||
155418349|NCT01972074|560962007|FG000|Overall Study|Lack of Efficacy|1|||
155418350|NCT01972074|560962008|FG001|Overall Study|Lack of Efficacy|1|||
155418351|NCT01972074|560962009|FG002|Overall Study|Lack of Efficacy|0|||
155418352|NCT01972074|560962007|FG000|Overall Study|Lost to Follow-up|0|||
155315319|NCT03839940|560589903|FG000|Overall Study|Protocol Violation|0|||
155315320|NCT03839940|560589904|FG001|Overall Study|Protocol Violation|1|||
155315321|NCT03839940|560589903|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
155315322|NCT03839940|560589904|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
155315323|NCT04799899|560589905|FG000|Overall Study|Lost to Follow-up|2|||
155315324|NCT04799899|560589906|FG001|Overall Study|Lost to Follow-up|4|||
155315325|NCT02561247|560589907|FG000|Overall Study|Protocol Violation|1|||
155315326|NCT02561247|560589907|FG000|Overall Study|Withdrawal by Subject|1|||
155315327|NCT02561247|560589907|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
155315328|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
155315329|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
155315330|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
155315331|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
155315332|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155418353|NCT01972074|560962008|FG001|Overall Study|Lost to Follow-up|1|||
155418354|NCT01972074|560962009|FG002|Overall Study|Lost to Follow-up|1|||
155418355|NCT01972074|560962007|FG000|Overall Study|Withdrawal by Subject|1|||
155418356|NCT01972074|560962008|FG001|Overall Study|Withdrawal by Subject|1|||
155315333|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
155315334|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155315335|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155315336|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
155315337|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155418357|NCT01972074|560962009|FG002|Overall Study|Withdrawal by Subject|1|||
155500616|NCT01858558|561258504|FG000|Overall Study|Lost to Follow-up|1|||
155500617|NCT01858558|561258505|FG001|Overall Study|Lost to Follow-up|0|||
155500618|NCT01858558|561258504|FG000|Overall Study|Disease progression|3|||
155500619|NCT01858558|561258505|FG001|Overall Study|Disease progression|1|||
155315338|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155315339|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155315340|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
155418358|NCT01972074|560962007|FG000|Overall Study|Scanner Unavailable|0|||
155418359|NCT01972074|560962008|FG001|Overall Study|Scanner Unavailable|0|||
155418360|NCT01972074|560962009|FG002|Overall Study|Scanner Unavailable|1|||
155418361|NCT03687502|560962015|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
155418362|NCT03687502|560962015|FG000|Overall Study|Lumason not available|1|||
155418363|NCT00486278|560962017|FG000|Overall Study|Adverse Event|5|||
155315341|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315342|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315343|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315344|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155500620|NCT01858558|561258504|FG000|Overall Study|Product contamination|2|||
155315345|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
155315346|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155315347|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155315348|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315349|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315350|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315351|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
155315352|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315353|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315354|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
155315355|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315356|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
155315357|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
155315358|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
155315359|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
155315360|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
155315361|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
155315362|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
155315363|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
155315364|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315365|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315366|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
155315367|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315368|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
155315369|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
155315370|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
155315371|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
155315372|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315373|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315374|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315375|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
155315376|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315377|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315378|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315379|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
155315380|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315381|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315382|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315383|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
155315384|NCT04908722|560589916|FG000|Overall Study|Protocol deviation|1|||
155315385|NCT04908722|560589917|FG001|Overall Study|Protocol deviation|0|||
155315386|NCT04908722|560589918|FG002|Overall Study|Protocol deviation|0|||
155315387|NCT04908722|560589919|FG003|Overall Study|Protocol deviation|0|||
155315388|NCT04908722|560589920|FG004|Overall Study|Protocol deviation|0|||
155315389|NCT04908722|560589921|FG005|Overall Study|Protocol deviation|1|||
155315390|NCT04908722|560589916|FG000|Overall Study|Lost to Follow-up|33|||
155315391|NCT04908722|560589917|FG001|Overall Study|Lost to Follow-up|33|||
155315392|NCT04908722|560589918|FG002|Overall Study|Lost to Follow-up|36|||
155315393|NCT04908722|560589919|FG003|Overall Study|Lost to Follow-up|30|||
155315394|NCT04908722|560589920|FG004|Overall Study|Lost to Follow-up|32|||
155315395|NCT04908722|560589921|FG005|Overall Study|Lost to Follow-up|34|||
155315396|NCT04908722|560589916|FG000|Overall Study|Physician Decision|1|||
155315397|NCT04908722|560589917|FG001|Overall Study|Physician Decision|1|||
155315398|NCT04908722|560589918|FG002|Overall Study|Physician Decision|1|||
155315399|NCT04908722|560589919|FG003|Overall Study|Physician Decision|2|||
155315400|NCT04908722|560589920|FG004|Overall Study|Physician Decision|0|||
155315401|NCT04908722|560589921|FG005|Overall Study|Physician Decision|0|||
155315402|NCT04908722|560589916|FG000|Overall Study|Death|1|||
155315403|NCT04908722|560589917|FG001|Overall Study|Death|0|||
155418364|NCT00486278|560962017|FG000|Overall Study|Withdrawal by Subject|2|||
155418365|NCT00486278|560962017|FG000|Overall Study|Physician Decision|2|||
155418366|NCT02183519|560962023|FG000|Overall Study|computer error|3|||
155418367|NCT02183519|560962024|FG001|Overall Study|computer error|0|||
155418368|NCT02183519|560962023|FG000|Overall Study|Did not respond to cough inducter|0|||
155315404|NCT04908722|560589918|FG002|Overall Study|Death|0|||
155315405|NCT04908722|560589919|FG003|Overall Study|Death|0|||
155418369|NCT02183519|560962024|FG001|Overall Study|Did not respond to cough inducter|3|||
155418370|NCT01777581|560962026|FG000|Overall Study|Lost to Follow-up|1|||
155418371|NCT01777581|560962027|FG001|Overall Study|Lost to Follow-up|1|||
155418372|NCT01777581|560962026|FG000|Overall Study|Adverse Event|2|||
155418373|NCT01777581|560962027|FG001|Overall Study|Adverse Event|0|||
155315406|NCT04908722|560589920|FG004|Overall Study|Death|0|||
155315407|NCT04908722|560589921|FG005|Overall Study|Death|1|||
155315408|NCT04908722|560589916|FG000|Overall Study|Withdrawal by Subject|12|||
155315409|NCT04908722|560589917|FG001|Overall Study|Withdrawal by Subject|8|||
155315410|NCT04908722|560589918|FG002|Overall Study|Withdrawal by Subject|7|||
155315411|NCT04908722|560589919|FG003|Overall Study|Withdrawal by Subject|6|||
155315412|NCT04908722|560589920|FG004|Overall Study|Withdrawal by Subject|12|||
155315413|NCT04908722|560589921|FG005|Overall Study|Withdrawal by Subject|14|||
155315414|NCT04908722|560589916|FG000|Overall Study|Other|3|||
155315415|NCT04908722|560589917|FG001|Overall Study|Other|1|||
155315416|NCT04908722|560589918|FG002|Overall Study|Other|3|||
155315417|NCT04908722|560589919|FG003|Overall Study|Other|2|||
155315418|NCT04908722|560589920|FG004|Overall Study|Other|4|||
155315419|NCT04908722|560589921|FG005|Overall Study|Other|1|||
155315420|NCT04908722|560589916|FG000|Overall Study|Initiated prohibited medication|0|||
155315421|NCT04908722|560589917|FG001|Overall Study|Initiated prohibited medication|0|||
155315422|NCT04908722|560589918|FG002|Overall Study|Initiated prohibited medication|0|||
155315423|NCT04908722|560589919|FG003|Overall Study|Initiated prohibited medication|1|||
155315424|NCT04908722|560589920|FG004|Overall Study|Initiated prohibited medication|0|||
155315425|NCT04908722|560589921|FG005|Overall Study|Initiated prohibited medication|1|||
155315426|NCT04908722|560589916|FG000|Overall Study|Randomized but not vaccinated|3|||
155315427|NCT04908722|560589917|FG001|Overall Study|Randomized but not vaccinated|1|||
155315428|NCT04908722|560589918|FG002|Overall Study|Randomized but not vaccinated|2|||
155315429|NCT04908722|560589919|FG003|Overall Study|Randomized but not vaccinated|2|||
155315430|NCT04908722|560589920|FG004|Overall Study|Randomized but not vaccinated|3|||
155315431|NCT04908722|560589921|FG005|Overall Study|Randomized but not vaccinated|4|||
155315432|NCT02979327|560589925|FG000|First Intervention|Protocol Violation|1|||
155315433|NCT02979327|560589926|FG001|First Intervention|Protocol Violation|0|||
155315434|NCT05780437|560589932|FG000|Overall Study|Withdrawal by Subject|22|||
155315435|NCT05780437|560589933|FG001|Overall Study|Withdrawal by Subject|16|||
155315436|NCT03474679|560589937|FG000|Overall Study|Death|7|||
155315437|NCT03474679|560589937|FG000|Overall Study|Withdrawal by Subject|1|||
155315438|NCT04623671|560589946|FG000|Overall Study|Adverse Event|0|||
155315439|NCT04623671|560589947|FG001|Overall Study|Adverse Event|1|||
155315440|NCT04623671|560589946|FG000|Overall Study|Lost to Follow-up|2|||
155315441|NCT04623671|560589947|FG001|Overall Study|Lost to Follow-up|1|||
155315442|NCT04623671|560589946|FG000|Overall Study|Death|5|||
155315443|NCT04623671|560589947|FG001|Overall Study|Death|5|||
155315444|NCT04025554|560589948|FG000|Overall Study|Adverse Event|3|||
155315445|NCT01802788|560589952|FG000|Overall Study|Withdrawal by Subject|102|||
155418374|NCT01777581|560962026|FG000|Overall Study|Lack of Efficacy|0|||
155418375|NCT01777581|560962027|FG001|Overall Study|Lack of Efficacy|1|||
155418376|NCT05168267|560962028|FG000|Overall Study|Withdrawal by Subject|2|||
155418377|NCT05168267|560962029|FG001|Overall Study|Withdrawal by Subject|1|||
155500621|NCT01858558|561258505|FG001|Overall Study|Product contamination|0|||
155500622|NCT01858558|561258504|FG000|Overall Study|Failed expansion of cell product|2|||
155500623|NCT01858558|561258505|FG001|Overall Study|Failed expansion of cell product|0|||
155500624|NCT01336608|561258506|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
155500625|NCT01336608|561258507|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155418378|NCT05168267|560962028|FG000|Overall Study|Withdrawn by Therapist|1|||
155418379|NCT05168267|560962029|FG001|Overall Study|Withdrawn by Therapist|1|||
155418380|NCT05168267|560962028|FG000|Overall Study|Left Facility|1|||
155418381|NCT05168267|560962029|FG001|Overall Study|Left Facility|0|||
155418382|NCT02887521|560962030|FG000|Overall Study|Withdrawal by Subject|0|||
155418383|NCT02887521|560962031|FG001|Overall Study|Withdrawal by Subject|3|||
155418384|NCT00695565|560962032|FG000|Overall Study|Lost to Follow-up|4|||
155418385|NCT00695565|560962033|FG001|Overall Study|Lost to Follow-up|4|||
155418386|NCT00695565|560962032|FG000|Overall Study|Adverse Event|3|||
155418387|NCT00695565|560962033|FG001|Overall Study|Adverse Event|1|||
155418388|NCT00695565|560962032|FG000|Overall Study|Protocol Violation|3|||
155418389|NCT00695565|560962033|FG001|Overall Study|Protocol Violation|1|||
155418390|NCT00695565|560962032|FG000|Overall Study|Withdrawal by Subject|1|||
155315446|NCT01802788|560589953|FG001|Overall Study|Withdrawal by Subject|5|||
155315447|NCT01802788|560589952|FG000|Overall Study|Death|382|||
155418391|NCT00695565|560962033|FG001|Overall Study|Withdrawal by Subject|1|||
155418392|NCT00695565|560962032|FG000|Overall Study|Lack of Efficacy|1|||
155418393|NCT00695565|560962033|FG001|Overall Study|Lack of Efficacy|1|||
155418394|NCT00695565|560962032|FG000|Overall Study|Subject did not follow instructions|1|||
155418395|NCT00695565|560962033|FG001|Overall Study|Subject did not follow instructions|1|||
155418396|NCT02937350|560962034|FG000|Overall Study|Withdrawal by Subject|0|||
155315448|NCT01802788|560589953|FG001|Overall Study|Death|18|||
155315449|NCT01802788|560589952|FG000|Overall Study|Lost to Follow-up|31|||
155315450|NCT01802788|560589953|FG001|Overall Study|Lost to Follow-up|2|||
155315451|NCT01802788|560589952|FG000|Overall Study|Physician Decision|3|||
155514013|NCT01185288|561308224|FG001|Overall Study|Did not meet inclusion criteria|0|||
155315452|NCT01802788|560589953|FG001|Overall Study|Physician Decision|0|||
155315453|NCT01802788|560589952|FG000|Overall Study|Patient Non-Compliance|1|||
155315454|NCT01802788|560589953|FG001|Overall Study|Patient Non-Compliance|0|||
155315455|NCT01802788|560589952|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
155315456|NCT01802788|560589953|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
155315457|NCT01802788|560589952|FG000|Overall Study|Other Reasons|19|||
155315458|NCT01802788|560589953|FG001|Overall Study|Other Reasons|0|||
155315459|NCT05257486|560589954|FG000|Overall Study|Protocol Violation|3|||
155315460|NCT03021096|560589955|FG000|Overall Study|Lost to Follow-up|4|||
155315461|NCT03021096|560589955|FG000|Overall Study|Protocol Violation|2|||
155315462|NCT03848065|560589956|FG000|Overall Study|Death|0|||
155315463|NCT03848065|560589957|FG001|Overall Study|Death|1|||
155315464|NCT03848065|560589958|FG002|Overall Study|Death|0|||
155315465|NCT03848065|560589956|FG000|Overall Study|Lost to Follow-up|0|||
155315466|NCT03848065|560589957|FG001|Overall Study|Lost to Follow-up|0|||
155315467|NCT03848065|560589958|FG002|Overall Study|Lost to Follow-up|1|||
155315468|NCT03848065|560589956|FG000|Overall Study|Physician Decision|0|||
155315469|NCT03848065|560589957|FG001|Overall Study|Physician Decision|0|||
155315470|NCT03848065|560589958|FG002|Overall Study|Physician Decision|1|||
155315471|NCT03313076|560589960|FG000|Overall Study|Withdrawal by Subject|2|||
155315472|NCT03313076|560589961|FG001|Overall Study|Withdrawal by Subject|0|||
155315473|NCT03313076|560589962|FG002|Overall Study|Withdrawal by Subject|0|||
155315474|NCT03313076|560589963|FG003|Overall Study|Withdrawal by Subject|0|||
155315475|NCT03313076|560589960|FG000|Overall Study|Lost to Follow-up|0|||
155315476|NCT03313076|560589961|FG001|Overall Study|Lost to Follow-up|2|||
155315477|NCT03313076|560589962|FG002|Overall Study|Lost to Follow-up|2|||
155315478|NCT03313076|560589963|FG003|Overall Study|Lost to Follow-up|2|||
155315479|NCT05144009|560589966|FG000|Overall Study|Lost to Follow-up|0|||
155315480|NCT05144009|560589967|FG001|Overall Study|Lost to Follow-up|1|||
155315481|NCT05144009|560589966|FG000|Overall Study|Study Termination by the Sponsor|11|||
155315482|NCT05144009|560589967|FG001|Overall Study|Study Termination by the Sponsor|11|||
155315483|NCT05144009|560589966|FG000|Overall Study|Disease Progression|1|||
155315484|NCT05144009|560589967|FG001|Overall Study|Disease Progression|0|||
155315485|NCT05144009|560589966|FG000|Overall Study|Participant Decision|0|||
155315486|NCT05144009|560589967|FG001|Overall Study|Participant Decision|2|||
155315487|NCT05144009|560589966|FG000|Overall Study|Death|5|||
155315488|NCT05144009|560589967|FG001|Overall Study|Death|10|||
155315489|NCT03270501|560589968|FG000|Overall Study|Screen failure|6|||
155315490|NCT03270501|560589968|FG000|Overall Study|Lost to Follow-up|2|||
155315491|NCT03270501|560589968|FG000|Overall Study|Adverse Event|1|||
155315492|NCT00764751|560589971|FG000|Overall Study|Adverse Event|1|||
155315493|NCT00764751|560589972|FG001|Overall Study|Adverse Event|1|||
155315494|NCT00764751|560589971|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
155315495|NCT00764751|560589972|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
155315496|NCT04307355|560589979|FG000|Overall Study|Non-Compliance|3|||
155315497|NCT04307355|560589980|FG001|Overall Study|Non-Compliance|3|||
155315498|NCT04307355|560589981|FG002|Overall Study|Non-Compliance|0|||
155315499|NCT04065841|560589982|FG000|Overall Study|Adverse Event|4|||
155315500|NCT04065841|560589983|FG001|Overall Study|Adverse Event|2|||
155315501|NCT04065841|560589984|FG002|Overall Study|Adverse Event|10|||
155315502|NCT04065841|560589985|FG003|Overall Study|Adverse Event|1|||
155315503|NCT04065841|560589982|FG000|Overall Study|Lost to Follow-up|1|||
155315504|NCT04065841|560589983|FG001|Overall Study|Lost to Follow-up|2|||
155315505|NCT04065841|560589984|FG002|Overall Study|Lost to Follow-up|2|||
155315506|NCT04065841|560589985|FG003|Overall Study|Lost to Follow-up|2|||
155315507|NCT04065841|560589982|FG000|Overall Study|Physician Decision|1|||
155315508|NCT04065841|560589983|FG001|Overall Study|Physician Decision|0|||
155315509|NCT04065841|560589984|FG002|Overall Study|Physician Decision|0|||
155315510|NCT04065841|560589985|FG003|Overall Study|Physician Decision|0|||
155315511|NCT04065841|560589982|FG000|Overall Study|Protocol Violation|0|||
155315512|NCT04065841|560589983|FG001|Overall Study|Protocol Violation|1|||
155418397|NCT02937350|560962035|FG001|Overall Study|Withdrawal by Subject|1|||
155418398|NCT02937350|560962036|FG002|Overall Study|Withdrawal by Subject|0|||
155418399|NCT01462266|560962037|FG000|Overall Study|Adverse Event|7|||
155418400|NCT01462266|560962038|FG001|Overall Study|Adverse Event|6|||
155418401|NCT01462266|560962037|FG000|Overall Study|Death|2|||
155418402|NCT01462266|560962038|FG001|Overall Study|Death|1|||
155514014|NCT01185288|561308223|FG000|Overall Study|Noncompliance|0|||
155315513|NCT04065841|560589984|FG002|Overall Study|Protocol Violation|0|||
155751023|NCT00076024|562188362|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
155315514|NCT04065841|560589985|FG003|Overall Study|Protocol Violation|0|||
155315515|NCT04065841|560589982|FG000|Overall Study|Study terminated by Sponsor|22|||
155315516|NCT04065841|560589983|FG001|Overall Study|Study terminated by Sponsor|16|||
155315517|NCT04065841|560589984|FG002|Overall Study|Study terminated by Sponsor|28|||
155315518|NCT04065841|560589985|FG003|Overall Study|Study terminated by Sponsor|17|||
155315519|NCT04065841|560589982|FG000|Overall Study|Withdrawal by Subject|1|||
155315520|NCT04065841|560589983|FG001|Overall Study|Withdrawal by Subject|1|||
155315521|NCT04065841|560589984|FG002|Overall Study|Withdrawal by Subject|2|||
155418403|NCT01462266|560962037|FG000|Overall Study|Lack of Efficacy|0|||
155418404|NCT01462266|560962038|FG001|Overall Study|Lack of Efficacy|2|||
155418405|NCT01462266|560962037|FG000|Overall Study|Lost to Follow-up|4|||
155751024|NCT00076024|562188363|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
155315522|NCT04065841|560589985|FG003|Overall Study|Withdrawal by Subject|0|||
155315523|NCT01420237|560589988|FG000|Overall Study|Death|13|||
155315524|NCT01420237|560589988|FG000|Overall Study|Withdrawal by Subject|41|||
155315525|NCT01420237|560589988|FG000|Overall Study|Lost to Follow-up|32|||
155315526|NCT01420237|560589988|FG000|Overall Study|Adverse Event|10|||
155315527|NCT01420237|560589988|FG000|Overall Study|Investigative Site Termination|43|||
155315528|NCT01420237|560589988|FG000|Overall Study|Censored because study device not implanted|21|||
155315529|NCT01420237|560589988|FG000|Overall Study|Censored because surgery not performed|2|||
155315530|NCT01420237|560589988|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
155315531|NCT01420237|560589988|FG000|Overall Study|Sponsor terminated study early|127|||
155315532|NCT05269667|560589989|FG000|Overall Study|Study Terminated by Sponsor|4|||
155315533|NCT05270408|560589993|FG000|Started Treatment|Withdrawal by Subject|0|||
155315534|NCT05270408|560589994|FG001|Started Treatment|Withdrawal by Subject|0|||
155315535|NCT05270408|560589995|FG002|Started Treatment|Withdrawal by Subject|3|||
155315536|NCT05270408|560589993|FG000|Started Treatment|Adverse Event|0|||
155315537|NCT05270408|560589994|FG001|Started Treatment|Adverse Event|0|||
155315538|NCT05270408|560589995|FG002|Started Treatment|Adverse Event|1|||
155315539|NCT05270408|560589993|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
155315540|NCT05270408|560589994|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
155315541|NCT05270408|560589995|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
155315542|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
155315543|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
155315544|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
155315545|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
155315546|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
155315547|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
155315548|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
155315549|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
155315550|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
155315551|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
155315552|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
155315553|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
155315554|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
155315555|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
155315556|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
155315557|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
155315558|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
155315559|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
155315560|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
155315561|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
155315562|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
155315563|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
155315564|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
155315565|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
155315566|NCT04492722|560590002|FG000|Overall Study|Adverse Event|7|||
155418406|NCT01462266|560962038|FG001|Overall Study|Lost to Follow-up|3|||
155418407|NCT01462266|560962037|FG000|Overall Study|Non-compliance with study drug|3|||
155418408|NCT01462266|560962038|FG001|Overall Study|Non-compliance with study drug|0|||
155418409|NCT01462266|560962037|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
155418410|NCT01462266|560962038|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
155418411|NCT01462266|560962037|FG000|Overall Study|Physician Decision|2|||
155418412|NCT01462266|560962038|FG001|Overall Study|Physician Decision|5|||
155418413|NCT01462266|560962037|FG000|Overall Study|Protocol Violation|1|||
155418414|NCT01462266|560962038|FG001|Overall Study|Protocol Violation|3|||
155418415|NCT01462266|560962037|FG000|Overall Study|Withdrawal by Subject|7|||
155418416|NCT01462266|560962038|FG001|Overall Study|Withdrawal by Subject|2|||
155418417|NCT01462266|560962037|FG000|Overall Study|Screen failure|1|||
155418418|NCT01462266|560962038|FG001|Overall Study|Screen failure|1|||
155418419|NCT01106846|560962039|FG000|Overall Study|Change in surgical procedure|0|||
155418420|NCT01106846|560962040|FG001|Overall Study|Change in surgical procedure|1|||
155418421|NCT03110900|560962054|FG000|Overall Study|Sponsor withdrew|1|||
155418422|NCT03110900|560962055|FG001|Overall Study|Sponsor withdrew|1|||
155418423|NCT02321436|560962056|FG000|Overall Study|Withdrawal by Subject|1|||
155643277|NCT02323334|561783782|FG016|Period 3|Lost to Follow-up|0|||
155418424|NCT02321436|560962057|FG001|Overall Study|Withdrawal by Subject|0|||
155315567|NCT04492722|560590003|FG001|Overall Study|Adverse Event|2|||
155315568|NCT04492722|560590004|FG002|Overall Study|Adverse Event|3|||
155315569|NCT04492722|560590005|FG003|Overall Study|Adverse Event|0|||
155418425|NCT02321436|560962056|FG000|Overall Study|Lost to Follow-up|0|||
155418426|NCT02321436|560962057|FG001|Overall Study|Lost to Follow-up|1|||
155315570|NCT04492722|560590002|FG000|Overall Study|Death|0|||
155315571|NCT04492722|560590003|FG001|Overall Study|Death|0|||
155315572|NCT04492722|560590004|FG002|Overall Study|Death|0|||
155315573|NCT04492722|560590005|FG003|Overall Study|Death|1|||
155315574|NCT04492722|560590002|FG000|Overall Study|Lost to Follow-up|0|||
155315575|NCT04492722|560590003|FG001|Overall Study|Lost to Follow-up|1|||
155315576|NCT04492722|560590004|FG002|Overall Study|Lost to Follow-up|0|||
155315577|NCT04492722|560590005|FG003|Overall Study|Lost to Follow-up|1|||
155315578|NCT04492722|560590002|FG000|Overall Study|Physician Decision|0|||
155315579|NCT04492722|560590003|FG001|Overall Study|Physician Decision|3|||
155315580|NCT04492722|560590004|FG002|Overall Study|Physician Decision|1|||
155315581|NCT04492722|560590005|FG003|Overall Study|Physician Decision|1|||
155315582|NCT04492722|560590002|FG000|Overall Study|Withdrawal by Subject|6|||
155315583|NCT04492722|560590003|FG001|Overall Study|Withdrawal by Subject|6|||
155315584|NCT04492722|560590004|FG002|Overall Study|Withdrawal by Subject|0|||
155315585|NCT04492722|560590005|FG003|Overall Study|Withdrawal by Subject|3|||
155315586|NCT04492722|560590002|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
155315587|NCT04492722|560590003|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
155315588|NCT04492722|560590004|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
155315589|NCT04492722|560590005|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
155315590|NCT04492722|560590002|FG000|Overall Study|Due to Covid-19 pandemic|7|||
155315591|NCT04492722|560590003|FG001|Overall Study|Due to Covid-19 pandemic|3|||
155315592|NCT04492722|560590004|FG002|Overall Study|Due to Covid-19 pandemic|7|||
155315593|NCT04492722|560590005|FG003|Overall Study|Due to Covid-19 pandemic|6|||
155315594|NCT04492722|560590002|FG000|Overall Study|Failure to meet randomisation criteria|2|||
155315595|NCT04492722|560590003|FG001|Overall Study|Failure to meet randomisation criteria|3|||
155315596|NCT04492722|560590004|FG002|Overall Study|Failure to meet randomisation criteria|4|||
155315597|NCT04492722|560590005|FG003|Overall Study|Failure to meet randomisation criteria|2|||
155315598|NCT04492722|560590002|FG000|Overall Study|Early termination from the study|54|||
155315599|NCT04492722|560590003|FG001|Overall Study|Early termination from the study|51|||
155315600|NCT04492722|560590004|FG002|Overall Study|Early termination from the study|50|||
155315601|NCT04492722|560590005|FG003|Overall Study|Early termination from the study|50|||
155315602|NCT04492722|560590002|FG000|Overall Study|Missing|3|||
155315603|NCT04492722|560590003|FG001|Overall Study|Missing|0|||
155315604|NCT04492722|560590004|FG002|Overall Study|Missing|0|||
155315605|NCT04492722|560590005|FG003|Overall Study|Missing|5|||
155315606|NCT04492722|560590002|FG000|Overall Study|Participants who did not receive treatment|0|||
155315607|NCT04492722|560590003|FG001|Overall Study|Participants who did not receive treatment|1|||
155315608|NCT04492722|560590004|FG002|Overall Study|Participants who did not receive treatment|4|||
155315609|NCT04492722|560590005|FG003|Overall Study|Participants who did not receive treatment|0|||
155315610|NCT04074759|560590006|FG000|Overall Study|Withdrawal by Subject|0|||
155315611|NCT04074759|560590007|FG001|Overall Study|Withdrawal by Subject|0|||
155315612|NCT04074759|560590008|FG002|Overall Study|Withdrawal by Subject|0|||
155315613|NCT04074759|560590009|FG003|Overall Study|Withdrawal by Subject|0|||
155315614|NCT04074759|560590010|FG004|Overall Study|Withdrawal by Subject|0|||
155315615|NCT04074759|560590011|FG005|Overall Study|Withdrawal by Subject|2|||
155315616|NCT04074759|560590012|FG006|Overall Study|Withdrawal by Subject|0|||
155315617|NCT04074759|560590013|FG007|Overall Study|Withdrawal by Subject|2|||
155315618|NCT04074759|560590014|FG008|Overall Study|Withdrawal by Subject|1|||
155315619|NCT04074759|560590015|FG009|Overall Study|Withdrawal by Subject|2|||
155315620|NCT04074759|560590016|FG010|Overall Study|Withdrawal by Subject|9|||
155315621|NCT04074759|560590017|FG011|Overall Study|Withdrawal by Subject|2|||
155315622|NCT04074759|560590018|FG012|Overall Study|Withdrawal by Subject|1|||
155315623|NCT04074759|560590019|FG013|Overall Study|Withdrawal by Subject|3|||
155315624|NCT04074759|560590020|FG014|Overall Study|Withdrawal by Subject|2|||
155315625|NCT04074759|560590021|FG015|Overall Study|Withdrawal by Subject|0|||
155315626|NCT04074759|560590022|FG016|Overall Study|Withdrawal by Subject|0|||
155315627|NCT04074759|560590023|FG017|Overall Study|Withdrawal by Subject|3|||
155315628|NCT04074759|560590024|FG018|Overall Study|Withdrawal by Subject|1|||
155315629|NCT04074759|560590006|FG000|Overall Study|Death|1|||
155315630|NCT04074759|560590007|FG001|Overall Study|Death|0|||
155315631|NCT04074759|560590008|FG002|Overall Study|Death|1|||
155315632|NCT04074759|560590009|FG003|Overall Study|Death|1|||
155315633|NCT04074759|560590010|FG004|Overall Study|Death|2|||
155315634|NCT04074759|560590011|FG005|Overall Study|Death|0|||
155418427|NCT00644787|560962058|FG000|Period 1: Titration Phase|Adverse Event|11|||
155315635|NCT04074759|560590012|FG006|Overall Study|Death|1|||
155315636|NCT04074759|560590013|FG007|Overall Study|Death|0|||
155315637|NCT04074759|560590014|FG008|Overall Study|Death|3|||
155315638|NCT04074759|560590015|FG009|Overall Study|Death|2|||
155315639|NCT04074759|560590016|FG010|Overall Study|Death|4|||
155315640|NCT04074759|560590017|FG011|Overall Study|Death|1|||
155315641|NCT04074759|560590018|FG012|Overall Study|Death|0|||
155315642|NCT04074759|560590019|FG013|Overall Study|Death|2|||
155315643|NCT04074759|560590020|FG014|Overall Study|Death|1|||
155315644|NCT04074759|560590021|FG015|Overall Study|Death|0|||
155315645|NCT04074759|560590022|FG016|Overall Study|Death|1|||
155500626|NCT01336608|561258508|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155500627|NCT01336608|561258509|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155500628|NCT01336608|561258506|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
155500629|NCT01336608|561258507|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155500630|NCT01336608|561258508|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155500631|NCT01336608|561258509|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155500632|NCT01336608|561258506|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
155500633|NCT01336608|561258507|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
155500634|NCT01336608|561258508|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
155500635|NCT01336608|561258509|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
155500636|NCT01336608|561258506|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
155500637|NCT01336608|561258507|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
155500638|NCT01336608|561258508|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
155500639|NCT01336608|561258509|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
155500640|NCT01336608|561258506|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
155500641|NCT01336608|561258507|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155500642|NCT01336608|561258508|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155500643|NCT01336608|561258509|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155500644|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155500645|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
155500646|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
155500647|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
155500648|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155500649|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
155500650|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155500651|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155500652|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155500653|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
155500654|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
155500655|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
155500656|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155500657|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155500658|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155500659|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155500660|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
155500661|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
155500662|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
155500663|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
155500664|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155500665|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
155500666|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155500667|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155500668|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155500669|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
155500670|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
155500671|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
155500672|NCT01336608|561258506|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155500673|NCT01336608|561258507|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
155500674|NCT01336608|561258508|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
155500675|NCT01336608|561258509|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
155500676|NCT02437890|561258516|FG000|Overall Study|Non-compliance to study drug|0|||
155500677|NCT02437890|561258517|FG001|Overall Study|Non-compliance to study drug|1|||
155500678|NCT02437890|561258518|FG002|Overall Study|Non-compliance to study drug|0|||
155500679|NCT02437890|561258519|FG003|Overall Study|Non-compliance to study drug|0|||
155500680|NCT02437890|561258520|FG004|Overall Study|Non-compliance to study drug|1|||
155500681|NCT02437890|561258516|FG000|Overall Study|Sponsor's decision|1|||
155500682|NCT02437890|561258517|FG001|Overall Study|Sponsor's decision|1|||
155500683|NCT02437890|561258518|FG002|Overall Study|Sponsor's decision|4|||
155500684|NCT02437890|561258519|FG003|Overall Study|Sponsor's decision|0|||
155500685|NCT02437890|561258520|FG004|Overall Study|Sponsor's decision|2|||
155500686|NCT02437890|561258516|FG000|Overall Study|Physician Decision|0|||
155500687|NCT02437890|561258517|FG001|Overall Study|Physician Decision|0|||
155500688|NCT02437890|561258518|FG002|Overall Study|Physician Decision|0|||
155500689|NCT02437890|561258519|FG003|Overall Study|Physician Decision|1|||
155315646|NCT04074759|560590023|FG017|Overall Study|Death|0|||
155315647|NCT04074759|560590024|FG018|Overall Study|Death|1|||
155315648|NCT04074759|560590006|FG000|Overall Study|Lost to Follow-up|0|||
155315649|NCT04074759|560590007|FG001|Overall Study|Lost to Follow-up|0|||
155315650|NCT04074759|560590008|FG002|Overall Study|Lost to Follow-up|0|||
155315651|NCT04074759|560590009|FG003|Overall Study|Lost to Follow-up|0|||
155315652|NCT04074759|560590010|FG004|Overall Study|Lost to Follow-up|0|||
155315653|NCT04074759|560590011|FG005|Overall Study|Lost to Follow-up|0|||
155315654|NCT04074759|560590012|FG006|Overall Study|Lost to Follow-up|0|||
155315655|NCT04074759|560590013|FG007|Overall Study|Lost to Follow-up|0|||
155315656|NCT04074759|560590014|FG008|Overall Study|Lost to Follow-up|0|||
155315657|NCT04074759|560590015|FG009|Overall Study|Lost to Follow-up|0|||
155315658|NCT04074759|560590016|FG010|Overall Study|Lost to Follow-up|1|||
155315659|NCT04074759|560590017|FG011|Overall Study|Lost to Follow-up|0|||
155315660|NCT04074759|560590018|FG012|Overall Study|Lost to Follow-up|0|||
155315661|NCT04074759|560590019|FG013|Overall Study|Lost to Follow-up|0|||
155315662|NCT04074759|560590020|FG014|Overall Study|Lost to Follow-up|0|||
155315663|NCT04074759|560590021|FG015|Overall Study|Lost to Follow-up|0|||
155315664|NCT04074759|560590022|FG016|Overall Study|Lost to Follow-up|1|||
155315665|NCT04074759|560590023|FG017|Overall Study|Lost to Follow-up|0|||
155315666|NCT04074759|560590024|FG018|Overall Study|Lost to Follow-up|1|||
155315667|NCT04074759|560590006|FG000|Overall Study|Other|0|||
155315668|NCT04074759|560590007|FG001|Overall Study|Other|1|||
155315669|NCT04074759|560590008|FG002|Overall Study|Other|1|||
155315670|NCT04074759|560590009|FG003|Overall Study|Other|0|||
155315671|NCT04074759|560590010|FG004|Overall Study|Other|2|||
155315672|NCT04074759|560590011|FG005|Overall Study|Other|1|||
155315673|NCT04074759|560590012|FG006|Overall Study|Other|2|||
155315674|NCT04074759|560590013|FG007|Overall Study|Other|1|||
155315675|NCT04074759|560590014|FG008|Overall Study|Other|1|||
155315676|NCT04074759|560590015|FG009|Overall Study|Other|4|||
155315677|NCT04074759|560590016|FG010|Overall Study|Other|4|||
155315678|NCT04074759|560590017|FG011|Overall Study|Other|2|||
155315679|NCT04074759|560590018|FG012|Overall Study|Other|0|||
155315680|NCT04074759|560590019|FG013|Overall Study|Other|0|||
155315681|NCT04074759|560590020|FG014|Overall Study|Other|0|||
155315682|NCT04074759|560590021|FG015|Overall Study|Other|1|||
155315683|NCT04074759|560590022|FG016|Overall Study|Other|0|||
155315684|NCT04074759|560590023|FG017|Overall Study|Other|0|||
155315685|NCT04074759|560590024|FG018|Overall Study|Other|0|||
155315686|NCT04074759|560590006|FG000|Overall Study|Missing end of study status|0|||
155315687|NCT04074759|560590007|FG001|Overall Study|Missing end of study status|0|||
155315688|NCT04074759|560590008|FG002|Overall Study|Missing end of study status|0|||
155315689|NCT04074759|560590009|FG003|Overall Study|Missing end of study status|0|||
155315690|NCT04074759|560590010|FG004|Overall Study|Missing end of study status|0|||
155315691|NCT04074759|560590011|FG005|Overall Study|Missing end of study status|0|||
155315692|NCT04074759|560590012|FG006|Overall Study|Missing end of study status|0|||
155315693|NCT04074759|560590013|FG007|Overall Study|Missing end of study status|0|||
155315694|NCT04074759|560590014|FG008|Overall Study|Missing end of study status|0|||
155315695|NCT04074759|560590015|FG009|Overall Study|Missing end of study status|0|||
155315696|NCT04074759|560590016|FG010|Overall Study|Missing end of study status|2|||
155315697|NCT04074759|560590017|FG011|Overall Study|Missing end of study status|0|||
155315698|NCT04074759|560590018|FG012|Overall Study|Missing end of study status|0|||
155418428|NCT00644787|560962059|FG001|Period 1: Titration Phase|Adverse Event|0|||
155418429|NCT00644787|560962060|FG002|Period 1: Titration Phase|Adverse Event|0|||
155418430|NCT00644787|560962058|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
155418431|NCT00644787|560962059|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
155418432|NCT00644787|560962060|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
155418433|NCT00644787|560962058|FG000|Period 1: Titration Phase|Physician Decision|1|||
155418434|NCT00644787|560962059|FG001|Period 1: Titration Phase|Physician Decision|0|||
155315699|NCT04074759|560590019|FG013|Overall Study|Missing end of study status|0|||
155418435|NCT00644787|560962060|FG002|Period 1: Titration Phase|Physician Decision|0|||
155418436|NCT00644787|560962058|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
155418437|NCT00644787|560962059|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
155418438|NCT00644787|560962060|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
155418439|NCT00644787|560962058|FG000|Period 1: Titration Phase|Worsening of complications|1|||
155418440|NCT00644787|560962059|FG001|Period 1: Titration Phase|Worsening of complications|0|||
155315700|NCT04074759|560590020|FG014|Overall Study|Missing end of study status|0|||
155315701|NCT04074759|560590021|FG015|Overall Study|Missing end of study status|0|||
155315702|NCT04074759|560590022|FG016|Overall Study|Missing end of study status|1|||
155315703|NCT04074759|560590023|FG017|Overall Study|Missing end of study status|0|||
155315704|NCT04074759|560590024|FG018|Overall Study|Missing end of study status|0|||
155315705|NCT03631784|560590026|FG000|Overall Study|Participants Ongoing|1|||
155315706|NCT03631784|560590027|FG001|Overall Study|Participants Ongoing|0|||
155315707|NCT03631784|560590026|FG000|Overall Study|Withdrawal by Subject|3|||
155315708|NCT03631784|560590027|FG001|Overall Study|Withdrawal by Subject|3|||
155315709|NCT03631784|560590026|FG000|Overall Study|Sponsor's Decision|36|||
155315710|NCT03631784|560590027|FG001|Overall Study|Sponsor's Decision|52|||
155315711|NCT03631784|560590026|FG000|Overall Study|Lost to Follow-up|1|||
155315712|NCT03631784|560590027|FG001|Overall Study|Lost to Follow-up|0|||
155315713|NCT03631784|560590026|FG000|Overall Study|Death|71|||
155315714|NCT03631784|560590027|FG001|Overall Study|Death|49|||
155315715|NCT05329220|560590028|FG000|Active Trial Period|Adverse Event|0|||
155315716|NCT05329220|560590029|FG001|Active Trial Period|Adverse Event|0|||
155315717|NCT05329220|560590030|FG002|Active Trial Period|Adverse Event|0|||
155315718|NCT05329220|560590031|FG003|Active Trial Period|Adverse Event|0|||
155315719|NCT05329220|560590032|FG004|Active Trial Period|Adverse Event|1|||
155315720|NCT05329220|560590033|FG005|Active Trial Period|Adverse Event|0|||
155315721|NCT05329220|560590028|FG000|Active Trial Period|Lost to Follow-up|0|||
155315722|NCT05329220|560590029|FG001|Active Trial Period|Lost to Follow-up|0|||
155315723|NCT05329220|560590030|FG002|Active Trial Period|Lost to Follow-up|0|||
155315724|NCT05329220|560590031|FG003|Active Trial Period|Lost to Follow-up|0|||
155315725|NCT05329220|560590032|FG004|Active Trial Period|Lost to Follow-up|32|||
155315726|NCT05329220|560590033|FG005|Active Trial Period|Lost to Follow-up|28|||
155315727|NCT05329220|560590028|FG000|Active Trial Period|Physician Decision|0|||
155315728|NCT05329220|560590029|FG001|Active Trial Period|Physician Decision|0|||
155315729|NCT05329220|560590030|FG002|Active Trial Period|Physician Decision|0|||
155315730|NCT05329220|560590031|FG003|Active Trial Period|Physician Decision|0|||
155315731|NCT05329220|560590032|FG004|Active Trial Period|Physician Decision|2|||
155315732|NCT05329220|560590033|FG005|Active Trial Period|Physician Decision|0|||
155315733|NCT05329220|560590028|FG000|Active Trial Period|Protocol Violation|0|||
155315734|NCT05329220|560590029|FG001|Active Trial Period|Protocol Violation|0|||
155315735|NCT05329220|560590030|FG002|Active Trial Period|Protocol Violation|0|||
155315736|NCT05329220|560590031|FG003|Active Trial Period|Protocol Violation|0|||
155315737|NCT05329220|560590032|FG004|Active Trial Period|Protocol Violation|1|||
155315738|NCT05329220|560590033|FG005|Active Trial Period|Protocol Violation|3|||
155315739|NCT05329220|560590028|FG000|Active Trial Period|Withdrawal by Subject|0|||
155315740|NCT05329220|560590029|FG001|Active Trial Period|Withdrawal by Subject|0|||
155315741|NCT05329220|560590030|FG002|Active Trial Period|Withdrawal by Subject|0|||
155315742|NCT05329220|560590031|FG003|Active Trial Period|Withdrawal by Subject|1|||
155315743|NCT05329220|560590032|FG004|Active Trial Period|Withdrawal by Subject|12|||
155315744|NCT05329220|560590033|FG005|Active Trial Period|Withdrawal by Subject|13|||
155315745|NCT05329220|560590028|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315746|NCT05329220|560590029|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315747|NCT05329220|560590030|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315748|NCT05329220|560590031|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315749|NCT05329220|560590032|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315750|NCT05329220|560590033|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
155315751|NCT05329220|560590028|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315752|NCT05329220|560590029|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315753|NCT05329220|560590030|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315754|NCT05329220|560590031|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315755|NCT05329220|560590032|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315756|NCT05329220|560590033|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
155315757|NCT05329220|560590028|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
155315758|NCT05329220|560590029|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
155315759|NCT05329220|560590030|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
155315760|NCT05329220|560590031|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
155315761|NCT05329220|560590032|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
155315762|NCT05329220|560590033|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
155315763|NCT05329220|560590028|FG000|Follow-up Period|Adverse Event|0|||
155418441|NCT00644787|560962060|FG002|Period 1: Titration Phase|Worsening of complications|0|||
155418442|NCT00644787|560962058|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
155418443|NCT00644787|560962059|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
155418444|NCT00644787|560962060|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
155418445|NCT00644787|560962058|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
155418446|NCT00644787|560962059|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
155418447|NCT00644787|560962060|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
155418448|NCT00644787|560962058|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
155418449|NCT00644787|560962059|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
155418450|NCT00644787|560962060|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
155418451|NCT00644787|560962058|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
155418452|NCT00644787|560962059|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
155500690|NCT02437890|561258520|FG004|Overall Study|Physician Decision|0|||
155514015|NCT01185288|561308224|FG001|Overall Study|Noncompliance|1|||
155315764|NCT05329220|560590029|FG001|Follow-up Period|Adverse Event|0|||
155315765|NCT05329220|560590030|FG002|Follow-up Period|Adverse Event|0|||
155315766|NCT05329220|560590031|FG003|Follow-up Period|Adverse Event|0|||
155315767|NCT05329220|560590032|FG004|Follow-up Period|Adverse Event|2|||
155315768|NCT05329220|560590033|FG005|Follow-up Period|Adverse Event|1|||
155315769|NCT05329220|560590028|FG000|Follow-up Period|Death|0|||
155315770|NCT05329220|560590029|FG001|Follow-up Period|Death|0|||
155315771|NCT05329220|560590030|FG002|Follow-up Period|Death|1|||
155315772|NCT05329220|560590031|FG003|Follow-up Period|Death|1|||
155315773|NCT05329220|560590032|FG004|Follow-up Period|Death|0|||
155315774|NCT05329220|560590033|FG005|Follow-up Period|Death|1|||
155315775|NCT05329220|560590028|FG000|Follow-up Period|Lost to Follow-up|0|||
155315776|NCT05329220|560590029|FG001|Follow-up Period|Lost to Follow-up|1|||
155315777|NCT05329220|560590030|FG002|Follow-up Period|Lost to Follow-up|2|||
155315778|NCT05329220|560590031|FG003|Follow-up Period|Lost to Follow-up|2|||
155315779|NCT05329220|560590032|FG004|Follow-up Period|Lost to Follow-up|113|||
155315780|NCT05329220|560590033|FG005|Follow-up Period|Lost to Follow-up|89|||
155315781|NCT05329220|560590028|FG000|Follow-up Period|Physician Decision|0|||
155418453|NCT00644787|560962060|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
155418454|NCT00644787|560962058|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
155418455|NCT00644787|560962059|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
155418456|NCT00644787|560962060|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
155418457|NCT00644787|560962058|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
155418458|NCT00644787|560962059|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
155418459|NCT00644787|560962060|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
155418460|NCT00644787|560962058|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
155418461|NCT00644787|560962059|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
155418462|NCT00644787|560962060|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
155418463|NCT03355300|560962061|FG000|Overall Study|Physician Decision|0|||
155418464|NCT03355300|560962062|FG001|Overall Study|Physician Decision|1|||
155418465|NCT03355300|560962061|FG000|Overall Study|Lack of Efficacy|2|||
155418466|NCT03355300|560962062|FG001|Overall Study|Lack of Efficacy|1|||
155418467|NCT03355300|560962061|FG000|Overall Study|Other reason|1|||
155418468|NCT03355300|560962062|FG001|Overall Study|Other reason|0|||
155418469|NCT02531646|560962077|FG000|Overall Study|equip. image processing issue|5|||
155418470|NCT02531646|560962078|FG001|Overall Study|equip. image processing issue|1|||
155418471|NCT02531646|560962079|FG002|Overall Study|equip. image processing issue|0|||
155418472|NCT03344003|560962083|FG000|Overall Study|Switched to alternative treatment|1|||
155418473|NCT03344003|560962084|FG001|Overall Study|Switched to alternative treatment|0|||
155418474|NCT03344003|560962083|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
155418475|NCT03344003|560962084|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
155418476|NCT01182428|560962085|FG000|Overall Study|Physician Decision|1|||
155418477|NCT01182428|560962086|FG001|Overall Study|Physician Decision|0|||
155418478|NCT01182428|560962085|FG000|Overall Study|Lost to Follow-up|9|||
155418479|NCT01182428|560962086|FG001|Overall Study|Lost to Follow-up|1|||
155418480|NCT01182428|560962085|FG000|Overall Study|Withdrawal by Subject|1|||
155418481|NCT01182428|560962086|FG001|Overall Study|Withdrawal by Subject|0|||
155418482|NCT05888103|560963426|FG000|Overall Study|Participant decision|3|||
155418483|NCT05888103|560963427|FG001|Overall Study|Participant decision|3|||
155418484|NCT05900115|560963428|FG000|Overall Study|Lost to Follow-up|129|||
155418485|NCT05900115|560963429|FG001|Overall Study|Lost to Follow-up|98|||
155418486|NCT02554929|560963430|FG000|Overall Study|Lost to Follow-up|4|||
155418487|NCT02554929|560963431|FG001|Overall Study|Lost to Follow-up|4|||
155418488|NCT02554929|560963430|FG000|Overall Study|Withdrawal by Subject|2|||
155418489|NCT02554929|560963431|FG001|Overall Study|Withdrawal by Subject|8|||
155418490|NCT01916980|560963432|FG000|Overall Study|Adverse Event|4|||
155418491|NCT01916980|560963433|FG001|Overall Study|Adverse Event|2|||
155418492|NCT01916980|560963432|FG000|Overall Study|Lack of Efficacy|2|||
155418493|NCT01916980|560963433|FG001|Overall Study|Lack of Efficacy|2|||
155418494|NCT01916980|560963432|FG000|Overall Study|Withdrawal by Subject|1|||
155418495|NCT01916980|560963433|FG001|Overall Study|Withdrawal by Subject|0|||
155418496|NCT02324270|560963434|FG000|Overall Study|Withdrawal by Subject|0|||
155418497|NCT02324270|560963435|FG001|Overall Study|Withdrawal by Subject|1|||
155418498|NCT02324270|560963436|FG002|Overall Study|Withdrawal by Subject|0|||
155418499|NCT02324270|560963434|FG000|Overall Study|Lost to Follow-up|4|||
155418500|NCT02324270|560963435|FG001|Overall Study|Lost to Follow-up|3|||
155418501|NCT02324270|560963436|FG002|Overall Study|Lost to Follow-up|4|||
155418502|NCT02324270|560963434|FG000|Overall Study|Protocol Violation|0|||
155643278|NCT02323334|561783766|FG000|Period 3|Withdrawal by Subject|1|||
155643279|NCT02323334|561783767|FG001|Period 3|Withdrawal by Subject|0|||
155418503|NCT02324270|560963435|FG001|Overall Study|Protocol Violation|1|||
155643280|NCT02323334|561783768|FG002|Period 3|Withdrawal by Subject|0|||
155315782|NCT05329220|560590029|FG001|Follow-up Period|Physician Decision|0|||
155315783|NCT05329220|560590030|FG002|Follow-up Period|Physician Decision|0|||
155315784|NCT05329220|560590031|FG003|Follow-up Period|Physician Decision|0|||
155315785|NCT05329220|560590032|FG004|Follow-up Period|Physician Decision|2|||
155315786|NCT05329220|560590033|FG005|Follow-up Period|Physician Decision|2|||
155315787|NCT05329220|560590028|FG000|Follow-up Period|Protocol Violation|0|||
155315788|NCT05329220|560590029|FG001|Follow-up Period|Protocol Violation|0|||
155315789|NCT05329220|560590030|FG002|Follow-up Period|Protocol Violation|0|||
155315790|NCT05329220|560590031|FG003|Follow-up Period|Protocol Violation|0|||
155315791|NCT05329220|560590032|FG004|Follow-up Period|Protocol Violation|0|||
155315792|NCT05329220|560590033|FG005|Follow-up Period|Protocol Violation|1|||
155751025|NCT00076024|562188364|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
155315793|NCT05329220|560590028|FG000|Follow-up Period|Withdrawal by Subject|0|||
155315794|NCT05329220|560590029|FG001|Follow-up Period|Withdrawal by Subject|0|||
155315795|NCT05329220|560590030|FG002|Follow-up Period|Withdrawal by Subject|1|||
155315796|NCT05329220|560590031|FG003|Follow-up Period|Withdrawal by Subject|1|||
155315797|NCT05329220|560590032|FG004|Follow-up Period|Withdrawal by Subject|34|||
155315798|NCT05329220|560590033|FG005|Follow-up Period|Withdrawal by Subject|35|||
155315799|NCT05329220|560590028|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315800|NCT05329220|560590029|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315801|NCT05329220|560590030|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
155315802|NCT05329220|560590031|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315803|NCT05329220|560590032|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315804|NCT05329220|560590033|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315805|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315806|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315807|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315808|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315809|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
155315810|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315811|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315812|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315813|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315814|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315815|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
155315816|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315817|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315818|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315819|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315820|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315821|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315822|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
155315823|NCT05329220|560590028|FG000|Follow-up Period|EARLY TERMINATION|0|||
155315824|NCT05329220|560590029|FG001|Follow-up Period|EARLY TERMINATION|0|||
155315825|NCT05329220|560590030|FG002|Follow-up Period|EARLY TERMINATION|0|||
155315826|NCT05329220|560590031|FG003|Follow-up Period|EARLY TERMINATION|0|||
155315827|NCT05329220|560590032|FG004|Follow-up Period|EARLY TERMINATION|0|||
155315828|NCT05329220|560590033|FG005|Follow-up Period|EARLY TERMINATION|1|||
155315829|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315830|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315831|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315832|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315833|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315834|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
155315835|NCT05329220|560590028|FG000|Follow-up Period|DROPPED|0|||
155315836|NCT05329220|560590029|FG001|Follow-up Period|DROPPED|0|||
155315837|NCT05329220|560590030|FG002|Follow-up Period|DROPPED|0|||
155315838|NCT05329220|560590031|FG003|Follow-up Period|DROPPED|0|||
155315839|NCT05329220|560590032|FG004|Follow-up Period|DROPPED|0|||
155315840|NCT05329220|560590033|FG005|Follow-up Period|DROPPED|1|||
155315841|NCT05329220|560590028|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315842|NCT05329220|560590029|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155418504|NCT02324270|560963436|FG002|Overall Study|Protocol Violation|1|||
155418505|NCT02324270|560963434|FG000|Overall Study|Non Compliance with Study Drug|1|||
155418506|NCT02324270|560963435|FG001|Overall Study|Non Compliance with Study Drug|2|||
155418507|NCT02324270|560963436|FG002|Overall Study|Non Compliance with Study Drug|0|||
155418508|NCT03521791|560963437|FG000|Overall Study|Protocol Violation|7|||
155418509|NCT03521791|560963438|FG001|Overall Study|Protocol Violation|17|||
155418510|NCT00680836|560963440|FG000|Overall Study|Withdrawal by Subject|3|||
155418511|NCT00680836|560963441|FG001|Overall Study|Withdrawal by Subject|0|||
155418512|NCT00680836|560963440|FG000|Overall Study|Lost to Follow-up|3|||
155418513|NCT00680836|560963441|FG001|Overall Study|Lost to Follow-up|1|||
155751026|NCT00076024|562188365|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
155315843|NCT05329220|560590030|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315844|NCT05329220|560590031|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315845|NCT05329220|560590032|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315846|NCT05329220|560590033|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
155315847|NCT02465268|560590035|FG000|Overall Study|Withdrawal by Subject|4|||
155315848|NCT02465268|560590036|FG001|Overall Study|Withdrawal by Subject|3|||
155315849|NCT02465268|560590037|FG002|Overall Study|Withdrawal by Subject|1|||
155315850|NCT02465268|560590035|FG000|Overall Study|Not evaluable per protocol criteria|3|||
155315851|NCT02465268|560590036|FG001|Overall Study|Not evaluable per protocol criteria|2|||
155315852|NCT02465268|560590037|FG002|Overall Study|Not evaluable per protocol criteria|1|||
155315853|NCT02465268|560590035|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
155315854|NCT02465268|560590036|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
155315855|NCT02465268|560590037|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
155315856|NCT02465268|560590035|FG000|Overall Study|Study drug did not pass QA/QC|1|||
155315857|NCT02465268|560590036|FG001|Overall Study|Study drug did not pass QA/QC|0|||
155315858|NCT02465268|560590037|FG002|Overall Study|Study drug did not pass QA/QC|0|||
155315859|NCT02465268|560590035|FG000|Overall Study|Adverse Event|0|||
155315860|NCT02465268|560590036|FG001|Overall Study|Adverse Event|1|||
155315861|NCT02465268|560590037|FG002|Overall Study|Adverse Event|0|||
155315862|NCT02465268|560590035|FG000|Overall Study|Physician Decision|0|||
155315863|NCT02465268|560590036|FG001|Overall Study|Physician Decision|1|||
155315864|NCT02465268|560590037|FG002|Overall Study|Physician Decision|0|||
155315865|NCT03322267|560590039|FG000|Overall Study|Lack of Efficacy|11|||
155315866|NCT03322267|560590039|FG000|Overall Study|Adverse Event|1|||
155315867|NCT03322267|560590039|FG000|Overall Study|Withdrawal by Subject|2|||
155315868|NCT04719832|560590043|FG000|Overall Study|Adverse Event|2|||
155315869|NCT04719832|560590044|FG001|Overall Study|Adverse Event|0|||
155315870|NCT04719832|560590043|FG000|Overall Study|Lack of Efficacy|2|||
155315871|NCT04719832|560590044|FG001|Overall Study|Lack of Efficacy|4|||
155315872|NCT04719832|560590043|FG000|Overall Study|Lost to Follow-up|0|||
155315873|NCT04719832|560590044|FG001|Overall Study|Lost to Follow-up|2|||
155315874|NCT04719832|560590043|FG000|Overall Study|Physician Decision|0|||
155315875|NCT04719832|560590044|FG001|Overall Study|Physician Decision|1|||
155315876|NCT04719832|560590043|FG000|Overall Study|Pregnancy|1|||
155315877|NCT04719832|560590044|FG001|Overall Study|Pregnancy|1|||
155315878|NCT04719832|560590043|FG000|Overall Study|Withdrawal by Subject|5|||
155315879|NCT04719832|560590044|FG001|Overall Study|Withdrawal by Subject|5|||
155315880|NCT04719832|560590043|FG000|Overall Study|Randomized, not treated|0|||
155315881|NCT04719832|560590044|FG001|Overall Study|Randomized, not treated|2|||
155315882|NCT04719832|560590043|FG000|Overall Study|GCP violations|4|||
155315883|NCT04719832|560590044|FG001|Overall Study|GCP violations|7|||
155315884|NCT05704543|560590048|FG000|Overall Study|Withdrawal by Subject|1|||
155315885|NCT05704543|560590049|FG001|Overall Study|Withdrawal by Subject|1|||
155315886|NCT05704543|560590050|FG002|Overall Study|Withdrawal by Subject|0|||
155315887|NCT05704543|560590051|FG003|Overall Study|Withdrawal by Subject|2|||
155315888|NCT05704543|560590048|FG000|Overall Study|Lost to Follow-up|1|||
155315889|NCT05704543|560590049|FG001|Overall Study|Lost to Follow-up|2|||
155315890|NCT05704543|560590050|FG002|Overall Study|Lost to Follow-up|0|||
155315891|NCT05704543|560590051|FG003|Overall Study|Lost to Follow-up|0|||
155315892|NCT04830800|560590056|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
155315893|NCT04830800|560590057|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
155315894|NCT04830800|560590058|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
155315895|NCT04830800|560590059|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
155315896|NCT04830800|560590060|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
155315897|NCT05192109|560590065|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155315898|NCT05192109|560590066|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155315899|NCT05192109|560590067|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315900|NCT05192109|560590068|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315901|NCT05192109|560590065|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155315902|NCT05192109|560590066|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155315903|NCT05192109|560590067|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315904|NCT05192109|560590068|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315905|NCT03287817|560592299|FG000|Overall Study|Progressive disease|4|||
155315906|NCT03287817|560592300|FG001|Overall Study|Progressive disease|2|||
155315907|NCT03287817|560592301|FG002|Overall Study|Progressive disease|3|||
155315908|NCT03287817|560592302|FG003|Overall Study|Progressive disease|10|||
155315909|NCT03287817|560592303|FG004|Overall Study|Progressive disease|8|||
155315910|NCT03287817|560592299|FG000|Overall Study|Death|0|||
155315911|NCT03287817|560592300|FG001|Overall Study|Death|0|||
155315912|NCT03287817|560592301|FG002|Overall Study|Death|2|||
155315913|NCT03287817|560592302|FG003|Overall Study|Death|3|||
155315914|NCT03287817|560592303|FG004|Overall Study|Death|4|||
155315915|NCT03287817|560592299|FG000|Overall Study|Physician Decision|0|||
155315916|NCT03287817|560592300|FG001|Overall Study|Physician Decision|0|||
155315917|NCT03287817|560592301|FG002|Overall Study|Physician Decision|0|||
155315918|NCT03287817|560592302|FG003|Overall Study|Physician Decision|1|||
155315919|NCT03287817|560592303|FG004|Overall Study|Physician Decision|0|||
155315920|NCT03287817|560592299|FG000|Overall Study|Withdrawal by Subject|0|||
155315921|NCT03287817|560592300|FG001|Overall Study|Withdrawal by Subject|0|||
155315922|NCT03287817|560592301|FG002|Overall Study|Withdrawal by Subject|0|||
155315923|NCT03287817|560592302|FG003|Overall Study|Withdrawal by Subject|0|||
155315924|NCT03287817|560592303|FG004|Overall Study|Withdrawal by Subject|4|||
155315925|NCT05251909|560592308|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
155315926|NCT05251909|560592309|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
155315927|NCT03869866|560592315|FG000|Overall Study|Protocol Violation|1|||
155315928|NCT03869866|560592315|FG000|Overall Study|Withdrawal by Subject|3|||
155315929|NCT06181227|560592316|FG000|Overall Study|Study terminated by sponsor|7|||
155315930|NCT06181227|560592317|FG001|Overall Study|Study terminated by sponsor|9|||
155315931|NCT05543915|560592318|FG000|Overall Study|Lost to Follow-up|0|||
155315932|NCT05543915|560592319|FG001|Overall Study|Lost to Follow-up|1|||
155315933|NCT06516705|560592326|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
155315934|NCT06516705|560592327|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
155315935|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
155315936|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
155315937|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|covid-19|1|||
155315938|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|covid-19|2|||
155315939|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
155315940|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
155315941|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
155315942|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
155315943|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|covid-19|3|||
155315944|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|covid-19|2|||
155315945|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
155315946|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
155315947|NCT02485938|560592329|FG000|Overall Study|Withdrawal of consent|2|||
155315948|NCT02485938|560592330|FG001|Overall Study|Withdrawal of consent|0|||
155315949|NCT03241745|560592331|FG000|Overall Study|Adverse Event|7|||
155315950|NCT03241745|560592331|FG000|Overall Study|Death|1|||
155315951|NCT03241745|560592331|FG000|Overall Study|Withdrawal by Subject|5|||
155315952|NCT03241745|560592331|FG000|Overall Study|Treatment delay >28 days|2|||
155315953|NCT03241745|560592331|FG000|Overall Study|Lack of Efficacy|14|||
155315954|NCT00470704|560592332|FG000|Overall Study|Withdrawal by Subject|4|||
155315955|NCT00470704|560592333|FG001|Overall Study|Withdrawal by Subject|3|||
155315956|NCT00470704|560592332|FG000|Overall Study|Relapse/Progression|37|||
155315957|NCT00470704|560592333|FG001|Overall Study|Relapse/Progression|42|||
155315958|NCT00470704|560592332|FG000|Overall Study|toxicity|0|||
155315959|NCT00470704|560592333|FG001|Overall Study|toxicity|1|||
155315960|NCT04802967|560592335|FG000|Part B|Withdrawal by Subject|0|||
155315961|NCT04802967|560592336|FG001|Part B|Withdrawal by Subject|0|||
155315962|NCT04802967|560592337|FG002|Part B|Withdrawal by Subject|0|||
155315963|NCT04802967|560592338|FG003|Part B|Withdrawal by Subject|0|||
155315964|NCT04802967|560592339|FG004|Part B|Withdrawal by Subject|0|||
155315965|NCT04802967|560592340|FG005|Part B|Withdrawal by Subject|1|||
155315966|NCT04802967|560592341|FG006|Part B|Withdrawal by Subject|0|||
155315967|NCT04802967|560592342|FG007|Part B|Withdrawal by Subject|0|||
155315968|NCT04802967|560592343|FG008|Part B|Withdrawal by Subject|0|||
155315969|NCT04802967|560592344|FG009|Part B|Withdrawal by Subject|0|||
155315970|NCT03339713|560592349|FG000|Overall Study|Lost to Follow-up|2|||
155315971|NCT03339713|560592350|FG001|Overall Study|Lost to Follow-up|1|||
155315972|NCT03339713|560592349|FG000|Overall Study|Protocol Violation|1|||
155315973|NCT03339713|560592350|FG001|Overall Study|Protocol Violation|0|||
155315974|NCT03339713|560592349|FG000|Overall Study|Withdrawal by Subject|1|||
155315975|NCT03339713|560592350|FG001|Overall Study|Withdrawal by Subject|1|||
155315976|NCT02268253|560592351|FG000|Stage 1|Withdrawal by Subject|1|||
155315977|NCT02268253|560592352|FG001|Stage 1|Withdrawal by Subject|0|||
155315978|NCT02268253|560592353|FG002|Stage 1|Withdrawal by Subject|0|||
155315979|NCT02268253|560592354|FG003|Stage 1|Withdrawal by Subject|0|||
155315980|NCT02268253|560592355|FG004|Stage 1|Withdrawal by Subject|0|||
155315981|NCT02268253|560592356|FG005|Stage 1|Withdrawal by Subject|0|||
155315982|NCT02268253|560592357|FG006|Stage 1|Withdrawal by Subject|0|||
155315983|NCT02268253|560592351|FG000|Stage 1|Death|0|||
155315984|NCT02268253|560592352|FG001|Stage 1|Death|2|||
155418514|NCT00680836|560963440|FG000|Overall Study|Physician Decision|2|||
155315985|NCT02268253|560592353|FG002|Stage 1|Death|2|||
155315986|NCT02268253|560592354|FG003|Stage 1|Death|2|||
155315987|NCT02268253|560592355|FG004|Stage 1|Death|1|||
155315988|NCT02268253|560592356|FG005|Stage 1|Death|1|||
155315989|NCT02268253|560592357|FG006|Stage 1|Death|0|||
155315990|NCT02268253|560592351|FG000|Stage 2|Disease Recurrence/ Progression|0|||
155315991|NCT02268253|560592352|FG001|Stage 2|Disease Recurrence/ Progression|0|||
155315992|NCT02268253|560592353|FG002|Stage 2|Disease Recurrence/ Progression|1|||
155315993|NCT02268253|560592354|FG003|Stage 2|Disease Recurrence/ Progression|0|||
155315994|NCT02268253|560592355|FG004|Stage 2|Disease Recurrence/ Progression|0|||
155315995|NCT02268253|560592356|FG005|Stage 2|Disease Recurrence/ Progression|0|||
155315996|NCT02268253|560592357|FG006|Stage 2|Disease Recurrence/ Progression|0|||
155315997|NCT02268253|560592351|FG000|Stage 2|Withdrawal by Subject|0|||
155315998|NCT02268253|560592352|FG001|Stage 2|Withdrawal by Subject|0|||
155315999|NCT02268253|560592353|FG002|Stage 2|Withdrawal by Subject|2|||
155316000|NCT02268253|560592354|FG003|Stage 2|Withdrawal by Subject|0|||
155316001|NCT02268253|560592355|FG004|Stage 2|Withdrawal by Subject|0|||
155316002|NCT02268253|560592356|FG005|Stage 2|Withdrawal by Subject|2|||
155316003|NCT02268253|560592357|FG006|Stage 2|Withdrawal by Subject|0|||
155316004|NCT02268253|560592351|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316005|NCT02268253|560592352|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316006|NCT02268253|560592353|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
155316007|NCT02268253|560592354|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316008|NCT02268253|560592355|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316009|NCT02268253|560592356|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
155316010|NCT02268253|560592357|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316011|NCT02268253|560592351|FG000|Stage 2|Death|0|||
155316012|NCT02268253|560592352|FG001|Stage 2|Death|0|||
155316013|NCT02268253|560592353|FG002|Stage 2|Death|19|||
155316014|NCT02268253|560592354|FG003|Stage 2|Death|0|||
155316015|NCT02268253|560592355|FG004|Stage 2|Death|0|||
155316016|NCT02268253|560592356|FG005|Stage 2|Death|20|||
155316017|NCT02268253|560592357|FG006|Stage 2|Death|1|||
155316018|NCT02268253|560592351|FG000|Stage 2|Lost to Follow-up|0|||
155316019|NCT02268253|560592352|FG001|Stage 2|Lost to Follow-up|0|||
155316020|NCT02268253|560592353|FG002|Stage 2|Lost to Follow-up|0|||
155316021|NCT02268253|560592354|FG003|Stage 2|Lost to Follow-up|0|||
155316022|NCT02268253|560592355|FG004|Stage 2|Lost to Follow-up|0|||
155316023|NCT02268253|560592356|FG005|Stage 2|Lost to Follow-up|4|||
155751027|NCT00076024|562188362|FG000|Phase 1, Lead-in|Adverse Event|1|||
155751028|NCT00076024|562188363|FG001|Phase 1, Lead-in|Adverse Event|0|||
155751029|NCT00076024|562188364|FG002|Phase 1, Lead-in|Adverse Event|0|||
155751030|NCT00076024|562188365|FG003|Phase 1, Lead-in|Adverse Event|0|||
155751031|NCT00076024|562188362|FG000|Phase 1, Lead-in|Clinical progression|1|||
155751032|NCT00076024|562188363|FG001|Phase 1, Lead-in|Clinical progression|0|||
155751033|NCT00076024|562188364|FG002|Phase 1, Lead-in|Clinical progression|0|||
155751034|NCT00076024|562188365|FG003|Phase 1, Lead-in|Clinical progression|0|||
155751035|NCT00076024|562188362|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
155316024|NCT02268253|560592357|FG006|Stage 2|Lost to Follow-up|0|||
155316025|NCT02268253|560592351|FG000|Stage 2|Transferred to Hospice|0|||
155316026|NCT02268253|560592352|FG001|Stage 2|Transferred to Hospice|0|||
155316027|NCT02268253|560592353|FG002|Stage 2|Transferred to Hospice|0|||
155751036|NCT00076024|562188363|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
155751037|NCT00076024|562188364|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
155751038|NCT00076024|562188365|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
155751039|NCT00076024|562188362|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
155751040|NCT00076024|562188363|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
155751041|NCT00076024|562188364|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
155751042|NCT00076024|562188365|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
155751043|NCT00076024|562188362|FG000|Phase 2, Double-blind|Adverse Event|0|||
155751044|NCT00076024|562188363|FG001|Phase 2, Double-blind|Adverse Event|25|||
155751045|NCT00076024|562188364|FG002|Phase 2, Double-blind|Adverse Event|6|||
155751046|NCT00076024|562188365|FG003|Phase 2, Double-blind|Adverse Event|0|||
155751047|NCT00076024|562188362|FG000|Phase 2, Double-blind|Un-specified|0|||
155751048|NCT00076024|562188363|FG001|Phase 2, Double-blind|Un-specified|14|||
155751049|NCT00076024|562188364|FG002|Phase 2, Double-blind|Un-specified|6|||
155751050|NCT00076024|562188365|FG003|Phase 2, Double-blind|Un-specified|0|||
155316028|NCT02268253|560592354|FG003|Stage 2|Transferred to Hospice|0|||
155316029|NCT02268253|560592355|FG004|Stage 2|Transferred to Hospice|0|||
155316030|NCT02268253|560592356|FG005|Stage 2|Transferred to Hospice|2|||
155316031|NCT02268253|560592357|FG006|Stage 2|Transferred to Hospice|0|||
155316032|NCT02268253|560592351|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
155316033|NCT02268253|560592352|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
155316034|NCT02268253|560592353|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
155316035|NCT02268253|560592354|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
155751051|NCT00076024|562188362|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
155751052|NCT00076024|562188363|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
155751053|NCT00076024|562188364|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
155751054|NCT00076024|562188365|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
155751055|NCT00076024|562188362|FG000|Phase 2, Open-label|Adverse Event|0|||
155751056|NCT00076024|562188363|FG001|Phase 2, Open-label|Adverse Event|0|||
155316036|NCT02268253|560592355|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
155316037|NCT02268253|560592356|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
155316038|NCT02268253|560592357|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
155316039|NCT02268253|560592351|FG000|Stage 3A|Withdrawal by Subject|0|||
155316040|NCT02268253|560592352|FG001|Stage 3A|Withdrawal by Subject|0|||
155316041|NCT02268253|560592353|FG002|Stage 3A|Withdrawal by Subject|2|||
155316042|NCT02268253|560592354|FG003|Stage 3A|Withdrawal by Subject|0|||
155316043|NCT02268253|560592355|FG004|Stage 3A|Withdrawal by Subject|0|||
155316044|NCT02268253|560592356|FG005|Stage 3A|Withdrawal by Subject|0|||
155316045|NCT02268253|560592357|FG006|Stage 3A|Withdrawal by Subject|0|||
155316046|NCT02268253|560592351|FG000|Stage 3A|Physician Decision|0|||
155316047|NCT02268253|560592352|FG001|Stage 3A|Physician Decision|0|||
155316048|NCT02268253|560592353|FG002|Stage 3A|Physician Decision|2|||
155316049|NCT02268253|560592354|FG003|Stage 3A|Physician Decision|0|||
155316050|NCT02268253|560592355|FG004|Stage 3A|Physician Decision|0|||
155316051|NCT02268253|560592356|FG005|Stage 3A|Physician Decision|0|||
155316052|NCT02268253|560592357|FG006|Stage 3A|Physician Decision|0|||
155316053|NCT02268253|560592351|FG000|Stage 3A|Study Terminated by Sponsor|0|||
155316054|NCT02268253|560592352|FG001|Stage 3A|Study Terminated by Sponsor|0|||
155316055|NCT02268253|560592353|FG002|Stage 3A|Study Terminated by Sponsor|2|||
155316056|NCT02268253|560592354|FG003|Stage 3A|Study Terminated by Sponsor|0|||
155316057|NCT02268253|560592355|FG004|Stage 3A|Study Terminated by Sponsor|0|||
155316058|NCT02268253|560592356|FG005|Stage 3A|Study Terminated by Sponsor|0|||
155316059|NCT02268253|560592357|FG006|Stage 3A|Study Terminated by Sponsor|0|||
155316060|NCT02268253|560592351|FG000|Stage 3A|Lost to Follow-up|0|||
155316061|NCT02268253|560592352|FG001|Stage 3A|Lost to Follow-up|0|||
155316062|NCT02268253|560592353|FG002|Stage 3A|Lost to Follow-up|1|||
155316063|NCT02268253|560592354|FG003|Stage 3A|Lost to Follow-up|0|||
155316064|NCT02268253|560592355|FG004|Stage 3A|Lost to Follow-up|0|||
155316065|NCT02268253|560592356|FG005|Stage 3A|Lost to Follow-up|0|||
155316066|NCT02268253|560592357|FG006|Stage 3A|Lost to Follow-up|0|||
155316067|NCT02268253|560592351|FG000|Stage 3A|Death|0|||
155316068|NCT02268253|560592352|FG001|Stage 3A|Death|0|||
155316069|NCT02268253|560592353|FG002|Stage 3A|Death|5|||
155316070|NCT02268253|560592354|FG003|Stage 3A|Death|0|||
155316071|NCT02268253|560592355|FG004|Stage 3A|Death|0|||
155316072|NCT02268253|560592356|FG005|Stage 3A|Death|0|||
155316073|NCT02268253|560592357|FG006|Stage 3A|Death|0|||
155316074|NCT05714761|560592358|FG000|Overall Study|Lost to Follow-up|3|||
155316075|NCT05714761|560592358|FG000|Overall Study|Withdrawal by Subject|3|||
155316076|NCT05714761|560592358|FG000|Overall Study|unblinding of sensor data|1|||
155316077|NCT05714761|560592358|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
155316078|NCT05714761|560592358|FG000|Overall Study|did not return second CGM sensor|4|||
155316079|NCT05672069|560592359|FG000|Overall Study|Implant removal|1|||
155316080|NCT05672069|560592359|FG000|Overall Study|Lost to Follow-up|2|||
155316081|NCT03544281|560592362|FG000|Main Study Phase|Death|3|||
155316082|NCT03544281|560592363|FG001|Main Study Phase|Death|2|||
155316083|NCT03544281|560592364|FG002|Main Study Phase|Death|6|||
155316084|NCT03544281|560592365|FG003|Main Study Phase|Death|8|||
155316085|NCT03544281|560592366|FG004|Main Study Phase|Death|4|||
155316086|NCT03544281|560592367|FG005|Main Study Phase|Death|2|||
155316087|NCT03544281|560592368|FG006|Main Study Phase|Death|4|||
155316088|NCT03544281|560592369|FG007|Main Study Phase|Death|5|||
155316089|NCT03544281|560592370|FG008|Main Study Phase|Death|5|||
155316090|NCT03544281|560592371|FG009|Main Study Phase|Death|8|||
155316091|NCT03544281|560592372|FG010|Main Study Phase|Death|6|||
155316092|NCT03544281|560592373|FG011|Main Study Phase|Death|4|||
155418515|NCT00680836|560963441|FG001|Overall Study|Physician Decision|1|||
155418516|NCT03786432|560963442|FG000|Overall Study|Screen Failure after consent|1|||
155418517|NCT03786432|560963442|FG000|Overall Study|Lost to Follow-up|4|||
155418518|NCT03786432|560963442|FG000|Overall Study|did not complete 12 month CT scan|1|||
155418519|NCT00388947|560963443|FG000|Overall Study|Protocol Violation|47|||
155418520|NCT03038308|560963444|FG000|Overall Study|Surgical resection|1|||
155418521|NCT03038308|560963444|FG000|Overall Study|Withdrawal by Subject|2|||
155418522|NCT03038308|560963444|FG000|Overall Study|Lost to Follow-up|1|||
155514016|NCT00278512|561308225|FG000|Overall Study|Death|1|||
155643281|NCT02323334|561783769|FG003|Period 3|Withdrawal by Subject|0|||
155316093|NCT03544281|560592374|FG012|Main Study Phase|Death|0|||
155316094|NCT03544281|560592375|FG013|Main Study Phase|Death|0|||
155316095|NCT03544281|560592376|FG014|Main Study Phase|Death|0|||
155643282|NCT02323334|561783770|FG004|Period 3|Withdrawal by Subject|0|||
155316096|NCT03544281|560592377|FG015|Main Study Phase|Death|0|||
155316097|NCT03544281|560592378|FG016|Main Study Phase|Death|0|||
155316098|NCT03544281|560592379|FG017|Main Study Phase|Death|0|||
155316099|NCT03544281|560592380|FG018|Main Study Phase|Death|0|||
155316100|NCT03544281|560592381|FG019|Main Study Phase|Death|0|||
155316101|NCT03544281|560592382|FG020|Main Study Phase|Death|0|||
155316102|NCT03544281|560592383|FG021|Main Study Phase|Death|0|||
155316103|NCT03544281|560592362|FG000|Main Study Phase|Lost to Follow-up|0|||
155316104|NCT03544281|560592363|FG001|Main Study Phase|Lost to Follow-up|0|||
155316105|NCT03544281|560592364|FG002|Main Study Phase|Lost to Follow-up|0|||
155316106|NCT03544281|560592365|FG003|Main Study Phase|Lost to Follow-up|0|||
155316107|NCT03544281|560592366|FG004|Main Study Phase|Lost to Follow-up|0|||
155316108|NCT03544281|560592367|FG005|Main Study Phase|Lost to Follow-up|0|||
155316109|NCT03544281|560592368|FG006|Main Study Phase|Lost to Follow-up|0|||
155316110|NCT03544281|560592369|FG007|Main Study Phase|Lost to Follow-up|0|||
155316111|NCT03544281|560592370|FG008|Main Study Phase|Lost to Follow-up|0|||
155316112|NCT03544281|560592371|FG009|Main Study Phase|Lost to Follow-up|0|||
155316113|NCT03544281|560592372|FG010|Main Study Phase|Lost to Follow-up|1|||
155316114|NCT03544281|560592373|FG011|Main Study Phase|Lost to Follow-up|0|||
155316115|NCT03544281|560592374|FG012|Main Study Phase|Lost to Follow-up|0|||
155316116|NCT03544281|560592375|FG013|Main Study Phase|Lost to Follow-up|0|||
155316117|NCT03544281|560592376|FG014|Main Study Phase|Lost to Follow-up|0|||
155316118|NCT03544281|560592377|FG015|Main Study Phase|Lost to Follow-up|0|||
155316119|NCT03544281|560592378|FG016|Main Study Phase|Lost to Follow-up|0|||
155316120|NCT03544281|560592379|FG017|Main Study Phase|Lost to Follow-up|0|||
155316121|NCT03544281|560592380|FG018|Main Study Phase|Lost to Follow-up|0|||
155316122|NCT03544281|560592381|FG019|Main Study Phase|Lost to Follow-up|0|||
155316123|NCT03544281|560592382|FG020|Main Study Phase|Lost to Follow-up|0|||
155316124|NCT03544281|560592383|FG021|Main Study Phase|Lost to Follow-up|0|||
155316125|NCT03544281|560592362|FG000|Main Study Phase|Physician Decision|0|||
155316126|NCT03544281|560592363|FG001|Main Study Phase|Physician Decision|0|||
155316127|NCT03544281|560592364|FG002|Main Study Phase|Physician Decision|0|||
155316128|NCT03544281|560592365|FG003|Main Study Phase|Physician Decision|0|||
155316129|NCT03544281|560592366|FG004|Main Study Phase|Physician Decision|0|||
155316130|NCT03544281|560592367|FG005|Main Study Phase|Physician Decision|0|||
155316131|NCT03544281|560592368|FG006|Main Study Phase|Physician Decision|0|||
155316132|NCT03544281|560592369|FG007|Main Study Phase|Physician Decision|1|||
155316133|NCT03544281|560592370|FG008|Main Study Phase|Physician Decision|0|||
155316134|NCT03544281|560592371|FG009|Main Study Phase|Physician Decision|0|||
155316135|NCT03544281|560592372|FG010|Main Study Phase|Physician Decision|0|||
155316136|NCT03544281|560592373|FG011|Main Study Phase|Physician Decision|0|||
155316137|NCT03544281|560592374|FG012|Main Study Phase|Physician Decision|0|||
155316138|NCT03544281|560592375|FG013|Main Study Phase|Physician Decision|0|||
155316139|NCT03544281|560592376|FG014|Main Study Phase|Physician Decision|0|||
155316140|NCT03544281|560592377|FG015|Main Study Phase|Physician Decision|0|||
155316141|NCT03544281|560592378|FG016|Main Study Phase|Physician Decision|0|||
155316142|NCT03544281|560592379|FG017|Main Study Phase|Physician Decision|0|||
155316143|NCT03544281|560592380|FG018|Main Study Phase|Physician Decision|0|||
155316144|NCT03544281|560592381|FG019|Main Study Phase|Physician Decision|0|||
155316145|NCT03544281|560592382|FG020|Main Study Phase|Physician Decision|0|||
155316146|NCT03544281|560592383|FG021|Main Study Phase|Physician Decision|0|||
155316147|NCT03544281|560592362|FG000|Main Study Phase|Withdrawal by Subject|2|||
155316148|NCT03544281|560592363|FG001|Main Study Phase|Withdrawal by Subject|0|||
155316149|NCT03544281|560592364|FG002|Main Study Phase|Withdrawal by Subject|1|||
155316150|NCT03544281|560592365|FG003|Main Study Phase|Withdrawal by Subject|2|||
155316151|NCT03544281|560592366|FG004|Main Study Phase|Withdrawal by Subject|0|||
155316152|NCT03544281|560592367|FG005|Main Study Phase|Withdrawal by Subject|0|||
155316153|NCT03544281|560592368|FG006|Main Study Phase|Withdrawal by Subject|0|||
155316154|NCT03544281|560592369|FG007|Main Study Phase|Withdrawal by Subject|0|||
155316155|NCT03544281|560592370|FG008|Main Study Phase|Withdrawal by Subject|2|||
155316156|NCT03544281|560592371|FG009|Main Study Phase|Withdrawal by Subject|3|||
155316157|NCT03544281|560592372|FG010|Main Study Phase|Withdrawal by Subject|0|||
155316158|NCT03544281|560592373|FG011|Main Study Phase|Withdrawal by Subject|4|||
155316159|NCT03544281|560592374|FG012|Main Study Phase|Withdrawal by Subject|0|||
155316160|NCT03544281|560592375|FG013|Main Study Phase|Withdrawal by Subject|0|||
155316161|NCT03544281|560592376|FG014|Main Study Phase|Withdrawal by Subject|0|||
155316162|NCT03544281|560592377|FG015|Main Study Phase|Withdrawal by Subject|0|||
155316163|NCT03544281|560592378|FG016|Main Study Phase|Withdrawal by Subject|0|||
155316164|NCT03544281|560592379|FG017|Main Study Phase|Withdrawal by Subject|0|||
155316165|NCT03544281|560592380|FG018|Main Study Phase|Withdrawal by Subject|0|||
155316166|NCT03544281|560592381|FG019|Main Study Phase|Withdrawal by Subject|0|||
155316167|NCT03544281|560592382|FG020|Main Study Phase|Withdrawal by Subject|0|||
155316168|NCT03544281|560592383|FG021|Main Study Phase|Withdrawal by Subject|0|||
155316169|NCT03544281|560592362|FG000|Main Study Phase|Ongoing|3|||
155316170|NCT03544281|560592363|FG001|Main Study Phase|Ongoing|1|||
155316171|NCT03544281|560592364|FG002|Main Study Phase|Ongoing|2|||
155316172|NCT03544281|560592365|FG003|Main Study Phase|Ongoing|4|||
155316173|NCT03544281|560592366|FG004|Main Study Phase|Ongoing|2|||
155316174|NCT03544281|560592367|FG005|Main Study Phase|Ongoing|4|||
155316175|NCT03544281|560592368|FG006|Main Study Phase|Ongoing|4|||
155316176|NCT03544281|560592369|FG007|Main Study Phase|Ongoing|0|||
155316177|NCT03544281|560592370|FG008|Main Study Phase|Ongoing|2|||
155316178|NCT03544281|560592371|FG009|Main Study Phase|Ongoing|2|||
155316179|NCT03544281|560592372|FG010|Main Study Phase|Ongoing|1|||
155316180|NCT03544281|560592373|FG011|Main Study Phase|Ongoing|0|||
155316181|NCT03544281|560592374|FG012|Main Study Phase|Ongoing|0|||
155316182|NCT03544281|560592375|FG013|Main Study Phase|Ongoing|0|||
155316183|NCT03544281|560592376|FG014|Main Study Phase|Ongoing|0|||
155316184|NCT03544281|560592377|FG015|Main Study Phase|Ongoing|0|||
155316185|NCT03544281|560592378|FG016|Main Study Phase|Ongoing|0|||
155316186|NCT03544281|560592379|FG017|Main Study Phase|Ongoing|0|||
155316187|NCT03544281|560592380|FG018|Main Study Phase|Ongoing|0|||
155316188|NCT03544281|560592381|FG019|Main Study Phase|Ongoing|0|||
155316189|NCT03544281|560592382|FG020|Main Study Phase|Ongoing|0|||
155316190|NCT03544281|560592383|FG021|Main Study Phase|Ongoing|0|||
155316191|NCT03544281|560592362|FG000|Main Study Phase|Investigator Site Closed|0|||
155316192|NCT03544281|560592363|FG001|Main Study Phase|Investigator Site Closed|0|||
155751057|NCT00076024|562188364|FG002|Phase 2, Open-label|Adverse Event|0|||
155316193|NCT03544281|560592364|FG002|Main Study Phase|Investigator Site Closed|0|||
155316194|NCT03544281|560592365|FG003|Main Study Phase|Investigator Site Closed|0|||
155316195|NCT03544281|560592366|FG004|Main Study Phase|Investigator Site Closed|0|||
155316196|NCT03544281|560592367|FG005|Main Study Phase|Investigator Site Closed|0|||
155316197|NCT03544281|560592368|FG006|Main Study Phase|Investigator Site Closed|0|||
155316198|NCT03544281|560592369|FG007|Main Study Phase|Investigator Site Closed|0|||
155316199|NCT03544281|560592370|FG008|Main Study Phase|Investigator Site Closed|0|||
155316200|NCT03544281|560592371|FG009|Main Study Phase|Investigator Site Closed|1|||
155316201|NCT03544281|560592372|FG010|Main Study Phase|Investigator Site Closed|0|||
155316202|NCT03544281|560592373|FG011|Main Study Phase|Investigator Site Closed|0|||
155316203|NCT03544281|560592374|FG012|Main Study Phase|Investigator Site Closed|0|||
155316204|NCT03544281|560592375|FG013|Main Study Phase|Investigator Site Closed|0|||
155316205|NCT03544281|560592376|FG014|Main Study Phase|Investigator Site Closed|0|||
155316206|NCT03544281|560592377|FG015|Main Study Phase|Investigator Site Closed|0|||
155316207|NCT03544281|560592378|FG016|Main Study Phase|Investigator Site Closed|0|||
155316208|NCT03544281|560592379|FG017|Main Study Phase|Investigator Site Closed|0|||
155316209|NCT03544281|560592380|FG018|Main Study Phase|Investigator Site Closed|0|||
155316210|NCT03544281|560592381|FG019|Main Study Phase|Investigator Site Closed|0|||
155316211|NCT03544281|560592382|FG020|Main Study Phase|Investigator Site Closed|0|||
155316212|NCT03544281|560592383|FG021|Main Study Phase|Investigator Site Closed|0|||
155316213|NCT03544281|560592362|FG000|Main Study Phase|Did not receive study treatment|0|||
155316214|NCT03544281|560592363|FG001|Main Study Phase|Did not receive study treatment|0|||
155316215|NCT03544281|560592364|FG002|Main Study Phase|Did not receive study treatment|0|||
155316216|NCT03544281|560592365|FG003|Main Study Phase|Did not receive study treatment|0|||
155316217|NCT03544281|560592366|FG004|Main Study Phase|Did not receive study treatment|0|||
155316218|NCT03544281|560592367|FG005|Main Study Phase|Did not receive study treatment|0|||
155316219|NCT03544281|560592368|FG006|Main Study Phase|Did not receive study treatment|1|||
155316220|NCT03544281|560592369|FG007|Main Study Phase|Did not receive study treatment|0|||
155316221|NCT03544281|560592370|FG008|Main Study Phase|Did not receive study treatment|0|||
155316222|NCT03544281|560592371|FG009|Main Study Phase|Did not receive study treatment|0|||
155316223|NCT03544281|560592372|FG010|Main Study Phase|Did not receive study treatment|0|||
155316224|NCT03544281|560592373|FG011|Main Study Phase|Did not receive study treatment|0|||
155316225|NCT03544281|560592374|FG012|Main Study Phase|Did not receive study treatment|0|||
155316226|NCT03544281|560592375|FG013|Main Study Phase|Did not receive study treatment|0|||
155316227|NCT03544281|560592376|FG014|Main Study Phase|Did not receive study treatment|0|||
155316228|NCT03544281|560592377|FG015|Main Study Phase|Did not receive study treatment|0|||
155316229|NCT03544281|560592378|FG016|Main Study Phase|Did not receive study treatment|0|||
155316230|NCT03544281|560592379|FG017|Main Study Phase|Did not receive study treatment|0|||
155418523|NCT04187092|560963445|FG000|Overall Study|Lost to Follow-up|1|||
155418524|NCT04187092|560963446|FG001|Overall Study|Lost to Follow-up|1|||
155418525|NCT04187092|560963445|FG000|Overall Study|Withdrawal by Subject|1|||
155751058|NCT00076024|562188365|FG003|Phase 2, Open-label|Adverse Event|2|||
155751059|NCT00076024|562188362|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
155751060|NCT00076024|562188363|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
155751061|NCT00076024|562188364|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
155751062|NCT00076024|562188365|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
155751063|NCT00076024|562188362|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
155751064|NCT00076024|562188363|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
155751065|NCT00076024|562188364|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
155751066|NCT00076024|562188365|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
155751067|NCT00076024|562188362|FG000|Phase 2, Open-label|Other|0|||
155751068|NCT00076024|562188363|FG001|Phase 2, Open-label|Other|0|||
155751069|NCT00076024|562188364|FG002|Phase 2, Open-label|Other|0|||
155751070|NCT00076024|562188365|FG003|Phase 2, Open-label|Other|2|||
155751071|NCT01155219|562188372|FG000|Overall Study|Adverse Event|3|||
155751072|NCT01155219|562188373|FG001|Overall Study|Adverse Event|1|||
155418526|NCT04187092|560963446|FG001|Overall Study|Withdrawal by Subject|1|||
155751073|NCT01155219|562188372|FG000|Overall Study|non-medical reason|1|||
155751074|NCT01155219|562188373|FG001|Overall Study|non-medical reason|2|||
155751075|NCT03150485|562188375|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155751076|NCT03150485|562188376|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155751077|NCT03150485|562188377|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
155751078|NCT03150485|562188378|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
155751079|NCT03150485|562188379|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
155751080|NCT03150485|562188380|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
155751081|NCT04533880|562188382|FG000|Overall Study|Lost to Follow-up|0|||
155418527|NCT04187092|560963445|FG000|Overall Study|Adverse Event|0|||
155418528|NCT04187092|560963446|FG001|Overall Study|Adverse Event|1|||
155418529|NCT00771472|560963448|FG000|Overall Study|Physician Decision|2|||
155418530|NCT00771472|560963449|FG001|Overall Study|Physician Decision|3|||
155418531|NCT00771472|560963448|FG000|Overall Study|Progressive Disease|3|||
155418532|NCT00771472|560963449|FG001|Overall Study|Progressive Disease|1|||
155418533|NCT00771472|560963448|FG000|Overall Study|Protocol Violation|1|||
155418534|NCT00771472|560963449|FG001|Overall Study|Protocol Violation|0|||
155418535|NCT00880750|560963453|FG000|First Intervention|Adverse Event|1|||
155418536|NCT00880750|560963454|FG001|First Intervention|Adverse Event|0|||
155418537|NCT00880750|560963453|FG000|First Intervention|Unable to collect urine|4|||
155418538|NCT00880750|560963454|FG001|First Intervention|Unable to collect urine|0|||
155418539|NCT00880750|560963453|FG000|First Intervention|Non-compliance with meals|0|||
155418540|NCT00880750|560963454|FG001|First Intervention|Non-compliance with meals|1|||
155418541|NCT00880750|560963453|FG000|First Intervention|Withdrawal by Subject|2|||
155418542|NCT00880750|560963454|FG001|First Intervention|Withdrawal by Subject|0|||
155418543|NCT00880750|560963453|FG000|First Intervention|Lost to Follow-up|2|||
155418544|NCT00880750|560963454|FG001|First Intervention|Lost to Follow-up|0|||
155418545|NCT00880750|560963453|FG000|Second Intervention|Withdrawal by Subject|2|||
155418546|NCT00880750|560963454|FG001|Second Intervention|Withdrawal by Subject|2|||
155418547|NCT00880750|560963453|FG000|Second Intervention|Protocol Violation|1|||
155418548|NCT00880750|560963454|FG001|Second Intervention|Protocol Violation|0|||
155418549|NCT00880750|560963453|FG000|Second Intervention|Unable to collect urine|1|||
155418550|NCT00880750|560963454|FG001|Second Intervention|Unable to collect urine|0|||
155316231|NCT03544281|560592380|FG018|Main Study Phase|Did not receive study treatment|0|||
155316232|NCT03544281|560592381|FG019|Main Study Phase|Did not receive study treatment|0|||
155316233|NCT03544281|560592382|FG020|Main Study Phase|Did not receive study treatment|0|||
155316234|NCT03544281|560592383|FG021|Main Study Phase|Did not receive study treatment|0|||
155316235|NCT03544281|560592362|FG000|PACT Phase|Adverse Event|0|||
155316236|NCT03544281|560592363|FG001|PACT Phase|Adverse Event|0|||
155316237|NCT03544281|560592364|FG002|PACT Phase|Adverse Event|0|||
155316238|NCT03544281|560592365|FG003|PACT Phase|Adverse Event|0|||
155316239|NCT03544281|560592366|FG004|PACT Phase|Adverse Event|0|||
155316240|NCT03544281|560592367|FG005|PACT Phase|Adverse Event|0|||
155316241|NCT03544281|560592368|FG006|PACT Phase|Adverse Event|0|||
155316242|NCT03544281|560592369|FG007|PACT Phase|Adverse Event|0|||
155316243|NCT03544281|560592370|FG008|PACT Phase|Adverse Event|0|||
155316244|NCT03544281|560592371|FG009|PACT Phase|Adverse Event|0|||
155316245|NCT03544281|560592372|FG010|PACT Phase|Adverse Event|0|||
155316246|NCT03544281|560592373|FG011|PACT Phase|Adverse Event|0|||
155316247|NCT03544281|560592374|FG012|PACT Phase|Adverse Event|1|||
155316248|NCT03544281|560592375|FG013|PACT Phase|Adverse Event|0|||
155316249|NCT03544281|560592376|FG014|PACT Phase|Adverse Event|0|||
155316250|NCT03544281|560592377|FG015|PACT Phase|Adverse Event|0|||
155316251|NCT03544281|560592378|FG016|PACT Phase|Adverse Event|0|||
155316252|NCT03544281|560592379|FG017|PACT Phase|Adverse Event|1|||
155316253|NCT03544281|560592380|FG018|PACT Phase|Adverse Event|1|||
155316254|NCT03544281|560592381|FG019|PACT Phase|Adverse Event|0|||
155316255|NCT03544281|560592382|FG020|PACT Phase|Adverse Event|0|||
155316256|NCT03544281|560592383|FG021|PACT Phase|Adverse Event|0|||
155316257|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155316258|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155316259|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
155316260|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
155316261|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
155418551|NCT01246206|560963455|FG000|Overall Study|Patient did not receive study regiments.|1|||
155418552|NCT01231555|560963458|FG000|Overall Study|Study terminated|8|||
155418553|NCT01231555|560963459|FG001|Overall Study|Study terminated|5|||
155418554|NCT01231555|560963460|FG002|Overall Study|Study terminated|8|||
155418555|NCT01231555|560963458|FG000|Overall Study|Withdrawal by Subject|0|||
155418556|NCT01231555|560963459|FG001|Overall Study|Withdrawal by Subject|2|||
155418557|NCT01231555|560963460|FG002|Overall Study|Withdrawal by Subject|0|||
155418558|NCT00688909|560963461|FG000|Overall Study|Adverse Event|28|||
155418559|NCT00688909|560963461|FG000|Overall Study|Patient withdrew consent|2|||
155500691|NCT02437890|561258516|FG000|Overall Study|Unable to attend visit(s)|1|||
155316262|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
155316263|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
155316264|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155316265|NCT02547233|560592384|FG000|12-month Follow-up|Withdrawal by Subject|10|||
155316266|NCT02547233|560592385|FG001|12-month Follow-up|Withdrawal by Subject|10|||
155316267|NCT02547233|560592384|FG000|12-month Follow-up|Lost to Follow-up|3|||
155418560|NCT00688909|560963461|FG000|Overall Study|Administrative problems|1|||
155418561|NCT00688909|560963461|FG000|Overall Study|Protocol Violation|2|||
155418562|NCT00669617|560963463|FG000|Period 1|Withdrawal by Subject|0|||
155418563|NCT00669617|560963464|FG001|Period 1|Withdrawal by Subject|0|||
155418564|NCT00669617|560963465|FG002|Period 1|Withdrawal by Subject|1|||
155316268|NCT02547233|560592385|FG001|12-month Follow-up|Lost to Follow-up|3|||
155316269|NCT02547233|560592384|FG000|12-month Follow-up|Lack of Efficacy|1|||
155316270|NCT02547233|560592385|FG001|12-month Follow-up|Lack of Efficacy|2|||
155316271|NCT02547233|560592384|FG000|12-month Follow-up|Protocol Violation|0|||
155316272|NCT02547233|560592385|FG001|12-month Follow-up|Protocol Violation|1|||
155316273|NCT02547233|560592384|FG000|12-month Follow-up|Other|0|||
155316274|NCT02547233|560592385|FG001|12-month Follow-up|Other|1|||
155316275|NCT06019559|560592387|FG000|Overall Study|Withdrawal by Subject|7|||
155316276|NCT06019559|560592388|FG001|Overall Study|Withdrawal by Subject|6|||
155316277|NCT06019559|560592389|FG002|Overall Study|Withdrawal by Subject|5|||
155316278|NCT06019559|560592387|FG000|Overall Study|Lost to Follow-up|2|||
155316279|NCT06019559|560592388|FG001|Overall Study|Lost to Follow-up|0|||
155316280|NCT06019559|560592389|FG002|Overall Study|Lost to Follow-up|3|||
155316281|NCT05949788|560592390|FG000|Overall Study|severe birth deformity|2|||
155316282|NCT05949788|560592391|FG001|Overall Study|severe birth deformity|7|||
155316283|NCT05949788|560592390|FG000|Overall Study|twin-twin transfusion syndrome|2|||
155316284|NCT05949788|560592391|FG001|Overall Study|twin-twin transfusion syndrome|7|||
155316285|NCT05949788|560592390|FG000|Overall Study|neonatal hemolytic disease|3|||
155316286|NCT05949788|560592391|FG001|Overall Study|neonatal hemolytic disease|8|||
155316287|NCT05949788|560592390|FG000|Overall Study|death within 14 days after birth|2|||
155316288|NCT05949788|560592391|FG001|Overall Study|death within 14 days after birth|6|||
155316289|NCT05949788|560592390|FG000|Overall Study|transfer to another hospital|2|||
155316290|NCT05949788|560592391|FG001|Overall Study|transfer to another hospital|6|||
155316291|NCT05213390|560592392|FG000|Overall Study|Withdrawal by Subject|2|||
155316292|NCT05213390|560592392|FG000|Overall Study|Lost to Follow-up|12|||
155316293|NCT05213390|560592392|FG000|Overall Study|Protocol Violation|9|||
155316294|NCT05362487|560592393|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
155316295|NCT03603600|560592397|FG000|Overall Study|Withdrawal by Subject|5|||
155316296|NCT03603600|560592398|FG001|Overall Study|Withdrawal by Subject|7|||
155316297|NCT03603600|560592397|FG000|Overall Study|Lost to Follow-up|2|||
155316298|NCT03603600|560592398|FG001|Overall Study|Lost to Follow-up|3|||
155316299|NCT03603600|560592397|FG000|Overall Study|Death|3|||
155316300|NCT03603600|560592398|FG001|Overall Study|Death|1|||
155316301|NCT03603600|560592397|FG000|Overall Study|Physician Decision|2|||
155316302|NCT03603600|560592398|FG001|Overall Study|Physician Decision|1|||
155418565|NCT00669617|560963466|FG003|Period 1|Withdrawal by Subject|0|||
155418566|NCT00669617|560963467|FG004|Period 1|Withdrawal by Subject|0|||
155418567|NCT00669617|560963463|FG000|Period 1|Protocol Deviation|0|||
155418568|NCT00669617|560963464|FG001|Period 1|Protocol Deviation|0|||
155418569|NCT00669617|560963465|FG002|Period 1|Protocol Deviation|0|||
155418570|NCT00669617|560963466|FG003|Period 1|Protocol Deviation|0|||
155418571|NCT00669617|560963467|FG004|Period 1|Protocol Deviation|1|||
155418572|NCT00669617|560963463|FG000|Period 3|Lost to Follow-up|1|||
155316303|NCT03603600|560592397|FG000|Overall Study|Other reason|1|||
155316304|NCT03603600|560592398|FG001|Overall Study|Other reason|0|||
155316305|NCT02191618|560592408|FG000|Overall Study|Withdrawal by Subject|3|||
155316306|NCT02191618|560592408|FG000|Overall Study|Missed Visit|4|||
155418573|NCT00669617|560963464|FG001|Period 3|Lost to Follow-up|0|||
155418574|NCT00669617|560963465|FG002|Period 3|Lost to Follow-up|0|||
155418575|NCT00669617|560963466|FG003|Period 3|Lost to Follow-up|0|||
155418576|NCT00669617|560963467|FG004|Period 3|Lost to Follow-up|0|||
155418577|NCT01748071|560963468|FG000|Overall Study|Adverse Event|2|||
155316307|NCT03031470|560592410|FG000|Overall Study|Adverse Event|3|||
155316308|NCT03031470|560592411|FG001|Overall Study|Adverse Event|0|||
155316309|NCT03031470|560592410|FG000|Overall Study|Death|3|||
155316310|NCT03031470|560592411|FG001|Overall Study|Death|1|||
155316311|NCT03031470|560592410|FG000|Overall Study|Lost to Follow-up|1|||
155316312|NCT03031470|560592411|FG001|Overall Study|Lost to Follow-up|1|||
155316313|NCT03031470|560592410|FG000|Overall Study|Withdrawal by Subject|1|||
155316314|NCT03031470|560592411|FG001|Overall Study|Withdrawal by Subject|0|||
155316315|NCT03031470|560592410|FG000|Overall Study|Protocol entry criteria not met|0|||
155316316|NCT03031470|560592411|FG001|Overall Study|Protocol entry criteria not met|1|||
155316317|NCT03031470|560592410|FG000|Overall Study|Cancel the operation|0|||
155316318|NCT03031470|560592411|FG001|Overall Study|Cancel the operation|1|||
155316319|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
155316320|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
155316321|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
155316322|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
155316323|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
155316324|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
155316325|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
155316326|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
155316327|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
155316328|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
155316329|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
155316330|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
155316331|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
155316332|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
155316333|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
155316334|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
155316335|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
155316336|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
155316337|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
155316338|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
155316339|NCT02683447|560592418|FG000|Overall Study|Lost to Follow-up|2|||
155316340|NCT01943409|560592423|FG000|Overall Study|resumed oral/entral|24|||
155316341|NCT01943409|560592424|FG001|Overall Study|resumed oral/entral|20|||
155316342|NCT01943409|560592423|FG000|Overall Study|Protocol Violation|14|||
155316343|NCT01943409|560592424|FG001|Overall Study|Protocol Violation|24|||
155316344|NCT01943409|560592423|FG000|Overall Study|Death|3|||
155316345|NCT01943409|560592424|FG001|Overall Study|Death|1|||
155316346|NCT01943409|560592423|FG000|Overall Study|Withdrawal by Subject|4|||
155316347|NCT01943409|560592424|FG001|Overall Study|Withdrawal by Subject|3|||
155316348|NCT02489903|560592425|FG000|Screening|Screen Failure|24|||
155316349|NCT02489903|560592426|FG001|Screening|Screen Failure|0|||
155316350|NCT02489903|560592427|FG002|Screening|Screen Failure|0|||
155316351|NCT02489903|560592428|FG003|Screening|Screen Failure|8|||
155316352|NCT02489903|560592425|FG000|Randomized and Received Treatment|Protocol Violation|0|||
155316353|NCT02489903|560592426|FG001|Randomized and Received Treatment|Protocol Violation|1|||
155316354|NCT02489903|560592427|FG002|Randomized and Received Treatment|Protocol Violation|0|||
155316355|NCT02489903|560592428|FG003|Randomized and Received Treatment|Protocol Violation|0|||
155316356|NCT02489903|560592425|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
155316357|NCT02489903|560592426|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
155316358|NCT02489903|560592427|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
155316359|NCT02489903|560592428|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
155316360|NCT02489903|560592425|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
155316361|NCT02489903|560592426|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
155316362|NCT02489903|560592427|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
155316363|NCT02489903|560592428|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
155316364|NCT02489903|560592425|FG000|Randomized and Received Treatment|Death|10|||
155316365|NCT02489903|560592426|FG001|Randomized and Received Treatment|Death|1|||
155316366|NCT02489903|560592427|FG002|Randomized and Received Treatment|Death|0|||
155316367|NCT02489903|560592428|FG003|Randomized and Received Treatment|Death|0|||
155316368|NCT04542317|560592429|FG000|Overall Study|Care recipients passed away|18|||
155316369|NCT04542317|560592430|FG001|Overall Study|Care recipients passed away|13|||
155316370|NCT04542317|560592429|FG000|Overall Study|No longer a primary caregiver|5|||
155316371|NCT04542317|560592430|FG001|Overall Study|No longer a primary caregiver|1|||
155316372|NCT04542317|560592429|FG000|Overall Study|Withdrawal by Subject|4|||
155316373|NCT04542317|560592430|FG001|Overall Study|Withdrawal by Subject|2|||
155316374|NCT04542317|560592429|FG000|Overall Study|Caregivers passed away|0|||
155316375|NCT04542317|560592430|FG001|Overall Study|Caregivers passed away|2|||
155316376|NCT02310646|560592433|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
155418578|NCT01748071|560963469|FG001|Overall Study|Adverse Event|2|||
155418579|NCT01748071|560963470|FG002|Overall Study|Adverse Event|0|||
155316377|NCT02310646|560592434|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
155316378|NCT02310646|560592433|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
155316379|NCT02310646|560592434|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
155316380|NCT00613106|560592441|FG000|Overall Study|Adverse Event|3|||
155316381|NCT00613106|560592442|FG001|Overall Study|Adverse Event|1|||
155316382|NCT00613106|560592441|FG000|Overall Study|Withdrawal by Subject|6|||
155316383|NCT00613106|560592442|FG001|Overall Study|Withdrawal by Subject|3|||
155316384|NCT00613106|560592441|FG000|Overall Study|Lost to Follow-up|7|||
155316385|NCT00613106|560592442|FG001|Overall Study|Lost to Follow-up|2|||
155316386|NCT00613106|560592441|FG000|Overall Study|misc|4|||
155316387|NCT00613106|560592442|FG001|Overall Study|misc|3|||
155316388|NCT03496168|560592443|FG000|Overall Study|Other Reasons|1|||
155316389|NCT03496168|560592443|FG000|Overall Study|Adverse Event|1|||
155316390|NCT02043678|560592448|FG000|Overall Study|Never treated|11|||
155316391|NCT02043678|560592449|FG001|Overall Study|Never treated|9|||
155316392|NCT02043678|560592448|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
155316393|NCT02043678|560592449|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
155316394|NCT02043678|560592448|FG000|Overall Study|AE without clinical PD|54|||
155316395|NCT02043678|560592449|FG001|Overall Study|AE without clinical PD|36|||
155316396|NCT02043678|560592448|FG000|Overall Study|Lost to Follow-up|1|||
155316397|NCT02043678|560592449|FG001|Overall Study|Lost to Follow-up|1|||
155316398|NCT02043678|560592448|FG000|Overall Study|Other|10|||
155316399|NCT02043678|560592449|FG001|Overall Study|Other|14|||
155316400|NCT02043678|560592448|FG000|Overall Study|Clinical PD|114|||
155316401|NCT02043678|560592449|FG001|Overall Study|Clinical PD|148|||
155316402|NCT02043678|560592448|FG000|Overall Study|Radiological PD|100|||
155316403|NCT02043678|560592449|FG001|Overall Study|Radiological PD|90|||
155316404|NCT02043678|560592448|FG000|Overall Study|Protocol-driven decision point|59|||
155316405|NCT02043678|560592449|FG001|Overall Study|Protocol-driven decision point|58|||
155316406|NCT02043678|560592448|FG000|Overall Study|Withdrawal by Subject|16|||
155316407|NCT02043678|560592449|FG001|Overall Study|Withdrawal by Subject|20|||
155316408|NCT02043678|560592448|FG000|Overall Study|Protocol Violation|1|||
155316409|NCT02043678|560592449|FG001|Overall Study|Protocol Violation|0|||
155316410|NCT02043678|560592448|FG000|Overall Study|Deterioration of general conditions|1|||
155316411|NCT02043678|560592449|FG001|Overall Study|Deterioration of general conditions|1|||
155316412|NCT02043678|560592448|FG000|Overall Study|Logistical difficulties|2|||
155316413|NCT02043678|560592449|FG001|Overall Study|Logistical difficulties|0|||
155316414|NCT02043678|560592448|FG000|Overall Study|Non-compliance with study drug|3|||
155316415|NCT02043678|560592449|FG001|Overall Study|Non-compliance with study drug|1|||
155316416|NCT02043678|560592448|FG000|Overall Study|Physician Decision|4|||
155316417|NCT02043678|560592449|FG001|Overall Study|Physician Decision|3|||
155316418|NCT02043678|560592448|FG000|Overall Study|Subject decision|0|||
155316419|NCT02043678|560592449|FG001|Overall Study|Subject decision|1|||
155316420|NCT02043678|560592448|FG000|Overall Study|Switching to other therapy|3|||
155316421|NCT02043678|560592449|FG001|Overall Study|Switching to other therapy|2|||
155316422|NCT02043678|560592448|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
155500692|NCT02437890|561258517|FG001|Overall Study|Unable to attend visit(s)|0|||
155500693|NCT02437890|561258518|FG002|Overall Study|Unable to attend visit(s)|0|||
155500694|NCT02437890|561258519|FG003|Overall Study|Unable to attend visit(s)|0|||
155500695|NCT02437890|561258520|FG004|Overall Study|Unable to attend visit(s)|0|||
155316423|NCT02043678|560592449|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
155316424|NCT02043678|560592448|FG000|Overall Study|Missing|1|||
155316425|NCT02043678|560592449|FG001|Overall Study|Missing|0|||
155316426|NCT02043678|560592448|FG000|Overall Study|Adverse Event|0|||
155316427|NCT02043678|560592449|FG001|Overall Study|Adverse Event|1|||
155316428|NCT04137367|560592452|FG000|Overall Study|Lost to Follow-up|8|||
155316429|NCT04137367|560592453|FG001|Overall Study|Lost to Follow-up|6|||
155316430|NCT04137367|560592454|FG002|Overall Study|Lost to Follow-up|4|||
155316431|NCT01175356|560592455|FG000|Overall Study|Death|1|||
155316432|NCT01175356|560592455|FG000|Overall Study|Lack of Efficacy|12|||
155316433|NCT01175356|560592455|FG000|Overall Study|Lost to Follow-up|1|||
155316434|NCT01175356|560592455|FG000|Overall Study|Physician Decision|23|||
155500696|NCT02437890|561258516|FG000|Overall Study|Lack of Efficacy|1|||
155500697|NCT02437890|561258517|FG001|Overall Study|Lack of Efficacy|3|||
155500698|NCT02437890|561258518|FG002|Overall Study|Lack of Efficacy|0|||
155316435|NCT01175356|560592455|FG000|Overall Study|Ineligible|1|||
155500699|NCT02437890|561258519|FG003|Overall Study|Lack of Efficacy|3|||
155316436|NCT01175356|560592455|FG000|Overall Study|Treatment Slot Not Available|18|||
155500700|NCT02437890|561258520|FG004|Overall Study|Lack of Efficacy|1|||
155500701|NCT02437890|561258516|FG000|Overall Study|Adverse Event|4|||
155500702|NCT02437890|561258517|FG001|Overall Study|Adverse Event|9|||
155500703|NCT02437890|561258518|FG002|Overall Study|Adverse Event|5|||
155316437|NCT01175356|560592455|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
155316438|NCT01175356|560592455|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
155316439|NCT01175356|560592455|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
155316440|NCT01175356|560592455|FG000|Overall Study|Inadequate stem cell for transplant|1|||
155316441|NCT01175356|560592455|FG000|Overall Study|Initiation other tx prior to completion|9|||
155316442|NCT05792085|560592456|FG000|Overall Study|Death|0|||
155316443|NCT05792085|560592457|FG001|Overall Study|Death|0|||
155316444|NCT05792085|560592458|FG002|Overall Study|Death|0|||
155316445|NCT05792085|560592459|FG003|Overall Study|Death|0|||
155316446|NCT05792085|560592460|FG004|Overall Study|Death|1|||
155316447|NCT04898673|560592463|FG000|Overall Study|Screenfail|1|||
155316448|NCT04898673|560592464|FG001|Overall Study|Screenfail|0|||
155316449|NCT04797897|560592465|FG000|Overall Study|Study Termination by Sponsor|1|||
155316450|NCT04797897|560592466|FG001|Overall Study|Study Termination by Sponsor|1|||
155316451|NCT05540665|560593953|FG000|Overall Study|Study terminated by sponsor|6|||
155316452|NCT05540665|560593954|FG001|Overall Study|Study terminated by sponsor|6|||
155643283|NCT02323334|561783771|FG005|Period 3|Withdrawal by Subject|0|||
155643284|NCT02323334|561783772|FG006|Period 3|Withdrawal by Subject|0|||
155316453|NCT05540665|560593955|FG002|Overall Study|Study terminated by sponsor|7|||
155316454|NCT03462030|560593956|FG000|Overall Study|Withdrawal by Subject|1|||
155316455|NCT03462030|560593957|FG001|Overall Study|Withdrawal by Subject|1|||
155316456|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
155316457|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316458|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316459|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316460|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316461|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316462|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316463|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316464|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316465|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
155316466|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316467|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316468|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316469|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316470|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
155316471|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
155316472|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
155316473|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316474|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316475|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316476|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316477|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316478|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
155316479|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316480|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316481|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316482|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316483|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316484|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
155316485|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316486|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
155316487|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316488|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316489|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316490|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316491|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316492|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316493|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316494|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316495|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316496|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
155316497|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316498|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316499|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316500|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316501|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
155316502|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316503|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
155316504|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
155316505|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316506|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316507|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316508|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316509|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316510|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316511|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316512|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316513|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316514|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316515|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
155316516|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
155316517|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
155316518|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
155316519|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316520|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316521|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316522|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316523|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
155316524|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
155316525|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
155316530|NCT03768505|560593975|FG000|Overall Study|sponsor decision|76|||
155316531|NCT03768505|560593975|FG000|Overall Study|Death|35|||
155316532|NCT03768505|560593975|FG000|Overall Study|Other -Various|30|||
155316533|NCT03768505|560593975|FG000|Overall Study|Withdrawal by Subject|22|||
155316534|NCT03768505|560593975|FG000|Overall Study|Lost to Follow-up|6|||
155316535|NCT04948697|560593976|FG000|Overall Study|Progressive disease|27|||
155316536|NCT04948697|560593977|FG001|Overall Study|Progressive disease|18|||
155316537|NCT04948697|560593976|FG000|Overall Study|Adverse Event|14|||
155316538|NCT04948697|560593977|FG001|Overall Study|Adverse Event|4|||
155316539|NCT04948697|560593976|FG000|Overall Study|Participant moved to long term extension study|7|||
155316540|NCT04948697|560593977|FG001|Overall Study|Participant moved to long term extension study|4|||
155316541|NCT04948697|560593976|FG000|Overall Study|Withdrawal by Subject|10|||
155316542|NCT04948697|560593977|FG001|Overall Study|Withdrawal by Subject|0|||
155316543|NCT04948697|560593976|FG000|Overall Study|Closed by Sponsor|3|||
155316544|NCT04948697|560593977|FG001|Overall Study|Closed by Sponsor|2|||
155316545|NCT04948697|560593976|FG000|Overall Study|Physician Decision|0|||
155316546|NCT04948697|560593977|FG001|Overall Study|Physician Decision|2|||
155316547|NCT04948697|560593976|FG000|Overall Study|Lost to Follow-up|0|||
155316548|NCT04948697|560593977|FG001|Overall Study|Lost to Follow-up|1|||
155316549|NCT04948697|560593976|FG000|Overall Study|Other-Miscellaneous|1|||
155316550|NCT04948697|560593977|FG001|Overall Study|Other-Miscellaneous|0|||
155316551|NCT04948697|560593976|FG000|Overall Study|Randomized but not treated|0|||
155316552|NCT04948697|560593977|FG001|Overall Study|Randomized but not treated|1|||
155643285|NCT02323334|561783773|FG007|Period 3|Withdrawal by Subject|0|||
155316553|NCT02815566|560593978|FG000|Overall Study|Adverse Event|1|||
155316554|NCT02815566|560593979|FG001|Overall Study|Adverse Event|1|||
155316555|NCT02815566|560593978|FG000|Overall Study|Withdrawal by Subject|1|||
155316556|NCT02815566|560593979|FG001|Overall Study|Withdrawal by Subject|0|||
155316557|NCT02815566|560593978|FG000|Overall Study|Lost to Follow-up|0|||
155316558|NCT02815566|560593979|FG001|Overall Study|Lost to Follow-up|1|||
155316559|NCT02861300|560593984|FG000|Overall Study|Death|0|||
155316560|NCT02861300|560593985|FG001|Overall Study|Death|0|||
155316561|NCT02861300|560593986|FG002|Overall Study|Death|0|||
155316562|NCT02861300|560593987|FG003|Overall Study|Death|0|||
155316563|NCT02861300|560593988|FG004|Overall Study|Death|0|||
155316564|NCT02861300|560593989|FG005|Overall Study|Death|0|||
155316565|NCT02861300|560593990|FG006|Overall Study|Death|24|||
155316566|NCT02861300|560593984|FG000|Overall Study|Delay in treatment|0|||
155316567|NCT02861300|560593985|FG001|Overall Study|Delay in treatment|0|||
155316568|NCT02861300|560593986|FG002|Overall Study|Delay in treatment|0|||
155316569|NCT02861300|560593987|FG003|Overall Study|Delay in treatment|0|||
155316570|NCT02861300|560593988|FG004|Overall Study|Delay in treatment|0|||
155316571|NCT02861300|560593989|FG005|Overall Study|Delay in treatment|1|||
155316572|NCT02861300|560593990|FG006|Overall Study|Delay in treatment|0|||
155316573|NCT02861300|560593984|FG000|Overall Study|Disease Progression|0|||
155316574|NCT02861300|560593985|FG001|Overall Study|Disease Progression|1|||
155316575|NCT02861300|560593986|FG002|Overall Study|Disease Progression|0|||
155316576|NCT02861300|560593987|FG003|Overall Study|Disease Progression|0|||
155316577|NCT02861300|560593988|FG004|Overall Study|Disease Progression|0|||
155316578|NCT02861300|560593989|FG005|Overall Study|Disease Progression|0|||
155643286|NCT02323334|561783774|FG008|Period 3|Withdrawal by Subject|0|||
155316579|NCT02861300|560593990|FG006|Overall Study|Disease Progression|2|||
155316580|NCT02861300|560593984|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
155316581|NCT02861300|560593985|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
155316582|NCT02861300|560593986|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
155316583|NCT02861300|560593987|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
155316584|NCT02861300|560593988|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
155316585|NCT02861300|560593989|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
155316586|NCT02861300|560593990|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
155316587|NCT02861300|560593984|FG000|Overall Study|Clinical Complications|0|||
155316588|NCT02861300|560593985|FG001|Overall Study|Clinical Complications|0|||
155316589|NCT02861300|560593986|FG002|Overall Study|Clinical Complications|0|||
155316590|NCT02861300|560593987|FG003|Overall Study|Clinical Complications|0|||
155316591|NCT02861300|560593988|FG004|Overall Study|Clinical Complications|0|||
155316592|NCT02861300|560593989|FG005|Overall Study|Clinical Complications|0|||
155316593|NCT02861300|560593990|FG006|Overall Study|Clinical Complications|1|||
155316594|NCT05399459|560594000|FG000|Overall Study|Randomized but not treated|29|||
155316595|NCT05399459|560594001|FG001|Overall Study|Randomized but not treated|30|||
155316596|NCT05399459|560594002|FG002|Overall Study|Randomized but not treated|38|||
155316597|NCT05399459|560594000|FG000|Overall Study|Lost to Follow-up|1|||
155316598|NCT05399459|560594001|FG001|Overall Study|Lost to Follow-up|0|||
155316599|NCT05399459|560594002|FG002|Overall Study|Lost to Follow-up|0|||
155316600|NCT04992520|560594003|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
155316601|NCT04992520|560594004|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
155316602|NCT04992520|560594005|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
155316603|NCT04992520|560594006|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
155316604|NCT04992520|560594007|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
155316605|NCT04992520|560594008|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
155316606|NCT04992520|560594003|FG000|Part A: First Challenge|Non-compliance|0|||
155316607|NCT04992520|560594004|FG001|Part A: First Challenge|Non-compliance|0|||
155316608|NCT04992520|560594005|FG002|Part A: First Challenge|Non-compliance|0|||
155316609|NCT04992520|560594006|FG003|Part A: First Challenge|Non-compliance|1|||
155316610|NCT04992520|560594007|FG004|Part A: First Challenge|Non-compliance|0|||
155316611|NCT04992520|560594008|FG005|Part A: First Challenge|Non-compliance|0|||
155316612|NCT04992520|560594003|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316613|NCT04992520|560594004|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316614|NCT04992520|560594005|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
155316615|NCT04992520|560594006|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316616|NCT04992520|560594007|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316617|NCT04992520|560594008|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
155316618|NCT04992520|560594003|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316619|NCT04992520|560594004|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316620|NCT04992520|560594005|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
155316621|NCT04992520|560594006|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316622|NCT04992520|560594007|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316623|NCT04992520|560594008|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316624|NCT03020199|560594018|FG000|Treatment Period|Adverse Event|0|||
155316625|NCT03020199|560594019|FG001|Treatment Period|Adverse Event|2|||
155316626|NCT03020199|560594018|FG000|Treatment Period|Lack of Efficacy|1|||
155316627|NCT03020199|560594019|FG001|Treatment Period|Lack of Efficacy|6|||
155316628|NCT03020199|560594018|FG000|Treatment Period|Lost to Follow-up|1|||
155316629|NCT03020199|560594019|FG001|Treatment Period|Lost to Follow-up|6|||
155418580|NCT00700180|560963471|FG000|Overall Study|Death|99|||
155418581|NCT00700180|560963472|FG001|Overall Study|Death|114|||
155418582|NCT00700180|560963471|FG000|Overall Study|Alive on treatment|5|||
155418583|NCT00700180|560963472|FG001|Overall Study|Alive on treatment|3|||
155418584|NCT00700180|560963471|FG000|Overall Study|Alive in follow-up|46|||
155418585|NCT00700180|560963472|FG001|Overall Study|Alive in follow-up|27|||
155418586|NCT00700180|560963471|FG000|Overall Study|Lost to Follow-up|4|||
155418587|NCT00700180|560963472|FG001|Overall Study|Lost to Follow-up|5|||
155500704|NCT02437890|561258519|FG003|Overall Study|Adverse Event|11|||
155500705|NCT02437890|561258520|FG004|Overall Study|Adverse Event|7|||
155500706|NCT02437890|561258516|FG000|Overall Study|Withdrawal by Subject|1|||
155751082|NCT04533880|562188383|FG001|Overall Study|Lost to Follow-up|1|||
155316630|NCT03020199|560594018|FG000|Treatment Period|Physician Decision|0|||
155316631|NCT03020199|560594019|FG001|Treatment Period|Physician Decision|1|||
155316632|NCT03020199|560594018|FG000|Treatment Period|Subject/guardian decision|8|||
155316633|NCT03020199|560594019|FG001|Treatment Period|Subject/guardian decision|15|||
155316634|NCT03020199|560594018|FG000|Treatment Period|Subjects not treated|3|||
155316635|NCT03020199|560594019|FG001|Treatment Period|Subjects not treated|4|||
155316636|NCT03020199|560594018|FG000|Follow-up Period|Disease relapse|32|||
155316637|NCT03020199|560594019|FG001|Follow-up Period|Disease relapse|7|||
155418588|NCT01613326|560963473|FG000|Overall Study|Adverse Event|7|||
155418589|NCT01613326|560963474|FG001|Overall Study|Adverse Event|5|||
155500707|NCT02437890|561258517|FG001|Overall Study|Withdrawal by Subject|2|||
155500708|NCT02437890|561258518|FG002|Overall Study|Withdrawal by Subject|6|||
155500709|NCT02437890|561258519|FG003|Overall Study|Withdrawal by Subject|5|||
155500710|NCT02437890|561258520|FG004|Overall Study|Withdrawal by Subject|5|||
155500711|NCT02437890|561258516|FG000|Overall Study|Death|0|||
155500712|NCT02437890|561258517|FG001|Overall Study|Death|0|||
155500713|NCT02437890|561258518|FG002|Overall Study|Death|0|||
155500714|NCT02437890|561258519|FG003|Overall Study|Death|2|||
155500715|NCT02437890|561258520|FG004|Overall Study|Death|0|||
155500716|NCT02328547|561258521|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
155500717|NCT02328547|561258522|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
155500718|NCT02328547|561258521|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155500719|NCT02328547|561258522|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
155500720|NCT01190098|561258523|FG000|Overall Study|Adverse Event|2|||
155500721|NCT01190098|561258524|FG001|Overall Study|Adverse Event|0|||
155500722|NCT01190098|561258523|FG000|Overall Study|Patient coomorbidity|0|||
155500723|NCT01190098|561258524|FG001|Overall Study|Patient coomorbidity|1|||
155500724|NCT01190098|561258523|FG000|Overall Study|Lack of transportation|1|||
155500725|NCT01190098|561258524|FG001|Overall Study|Lack of transportation|0|||
155500726|NCT01190098|561258523|FG000|Overall Study|Other|0|||
155500727|NCT01190098|561258524|FG001|Overall Study|Other|1|||
155500728|NCT00344305|561258525|FG000|Overall Study|Lost to Follow-up|2|||
155500729|NCT00344305|561258526|FG001|Overall Study|Lost to Follow-up|0|||
155500730|NCT00344305|561258525|FG000|Overall Study|Participant was not contacted in window|0|||
155500731|NCT00344305|561258526|FG001|Overall Study|Participant was not contacted in window|1|||
155500732|NCT03978117|561258527|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
155500733|NCT03978117|561258528|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
155500734|NCT03978117|561258527|FG000|Overall Study|Lost to Follow-up|4|||
155500735|NCT03978117|561258528|FG001|Overall Study|Lost to Follow-up|4|||
155500736|NCT01586624|561258533|FG000|Overall Study|Adverse Event|3|||
155500737|NCT01586624|561258534|FG001|Overall Study|Adverse Event|0|||
155500738|NCT01586624|561258535|FG002|Overall Study|Adverse Event|2|||
155500739|NCT01586624|561258536|FG003|Overall Study|Adverse Event|1|||
155500740|NCT01586624|561258537|FG004|Overall Study|Adverse Event|3|||
155500741|NCT01586624|561258538|FG005|Overall Study|Adverse Event|3|||
155500742|NCT01586624|561258539|FG006|Overall Study|Adverse Event|2|||
155500743|NCT01586624|561258540|FG007|Overall Study|Adverse Event|3|||
155500744|NCT01586624|561258533|FG000|Overall Study|Physician Decision|0|||
155500745|NCT01586624|561258534|FG001|Overall Study|Physician Decision|1|||
155500746|NCT01586624|561258535|FG002|Overall Study|Physician Decision|1|||
155500747|NCT01586624|561258536|FG003|Overall Study|Physician Decision|0|||
155500748|NCT01586624|561258537|FG004|Overall Study|Physician Decision|2|||
155500749|NCT01586624|561258538|FG005|Overall Study|Physician Decision|0|||
155500750|NCT01586624|561258539|FG006|Overall Study|Physician Decision|1|||
155500751|NCT01586624|561258540|FG007|Overall Study|Physician Decision|1|||
155500752|NCT01586624|561258533|FG000|Overall Study|Withdrawal by Subject|0|||
155500753|NCT01586624|561258534|FG001|Overall Study|Withdrawal by Subject|0|||
155500754|NCT01586624|561258535|FG002|Overall Study|Withdrawal by Subject|0|||
155500755|NCT01586624|561258536|FG003|Overall Study|Withdrawal by Subject|1|||
155500756|NCT01586624|561258537|FG004|Overall Study|Withdrawal by Subject|0|||
155500757|NCT01586624|561258538|FG005|Overall Study|Withdrawal by Subject|0|||
155500758|NCT01586624|561258539|FG006|Overall Study|Withdrawal by Subject|0|||
155500759|NCT01586624|561258540|FG007|Overall Study|Withdrawal by Subject|0|||
155500760|NCT01586624|561258533|FG000|Overall Study|Evidence of disease progression|1|||
155500761|NCT01586624|561258534|FG001|Overall Study|Evidence of disease progression|3|||
155500762|NCT01586624|561258535|FG002|Overall Study|Evidence of disease progression|2|||
155500763|NCT01586624|561258536|FG003|Overall Study|Evidence of disease progression|5|||
155500764|NCT01586624|561258537|FG004|Overall Study|Evidence of disease progression|3|||
155500765|NCT01586624|561258538|FG005|Overall Study|Evidence of disease progression|5|||
155500766|NCT01586624|561258539|FG006|Overall Study|Evidence of disease progression|4|||
155500767|NCT01586624|561258540|FG007|Overall Study|Evidence of disease progression|6|||
155500768|NCT01586624|561258533|FG000|Overall Study|Screen failure (no treatment received)|0|||
155500769|NCT01586624|561258534|FG001|Overall Study|Screen failure (no treatment received)|0|||
155500770|NCT01586624|561258535|FG002|Overall Study|Screen failure (no treatment received)|0|||
155500771|NCT01586624|561258536|FG003|Overall Study|Screen failure (no treatment received)|0|||
155500772|NCT01586624|561258537|FG004|Overall Study|Screen failure (no treatment received)|0|||
155500773|NCT01586624|561258538|FG005|Overall Study|Screen failure (no treatment received)|0|||
155500774|NCT01586624|561258539|FG006|Overall Study|Screen failure (no treatment received)|1|||
155643287|NCT02323334|561783775|FG009|Period 3|Withdrawal by Subject|0|||
155643288|NCT02323334|561783776|FG010|Period 3|Withdrawal by Subject|0|||
155500775|NCT01586624|561258540|FG007|Overall Study|Screen failure (no treatment received)|0|||
155500776|NCT03578276|561258543|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
155500777|NCT03578276|561258544|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
155500778|NCT02360397|561258547|FG000|Overall Study|Incomplete screening|3|||
155500779|NCT02360397|561258547|FG000|Overall Study|Adverse Event|1|||
155500780|NCT04256759|561258548|FG000|Overall Study|Physician Decision|1|||
155316638|NCT03020199|560594018|FG000|Follow-up Period|Lack of Efficacy|1|||
155316639|NCT03020199|560594019|FG001|Follow-up Period|Lack of Efficacy|2|||
155316640|NCT03020199|560594018|FG000|Follow-up Period|Lost to Follow-up|4|||
155316641|NCT03020199|560594019|FG001|Follow-up Period|Lost to Follow-up|6|||
155316642|NCT03020199|560594018|FG000|Follow-up Period|Physician Decision|2|||
155316643|NCT03020199|560594019|FG001|Follow-up Period|Physician Decision|2|||
155418590|NCT01613326|560963473|FG000|Overall Study|Withdrawal by Subject|3|||
155418591|NCT01613326|560963474|FG001|Overall Study|Withdrawal by Subject|4|||
155418592|NCT01613326|560963473|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155418593|NCT01613326|560963474|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155418594|NCT01613326|560963473|FG000|Overall Study|inability to use device|1|||
155418595|NCT01613326|560963474|FG001|Overall Study|inability to use device|0|||
155418596|NCT01613326|560963473|FG000|Overall Study|Lack of Efficacy|0|||
155418597|NCT01613326|560963474|FG001|Overall Study|Lack of Efficacy|1|||
155418598|NCT01613326|560963473|FG000|Overall Study|Lost to Follow-up|0|||
155643289|NCT02323334|561783777|FG011|Period 3|Withdrawal by Subject|0|||
155316644|NCT03020199|560594018|FG000|Follow-up Period|Protocol Violation|1|||
155316645|NCT03020199|560594019|FG001|Follow-up Period|Protocol Violation|2|||
155316646|NCT03020199|560594018|FG000|Follow-up Period|Study terminated by Sponsor|6|||
155316647|NCT03020199|560594019|FG001|Follow-up Period|Study terminated by Sponsor|3|||
155316648|NCT03020199|560594018|FG000|Follow-up Period|Subject/guardian decision|14|||
155316649|NCT03020199|560594019|FG001|Follow-up Period|Subject/guardian decision|9|||
155316650|NCT04313972|560594020|FG000|Overall Study|Withdrawal by Subject|0|||
155316651|NCT04313972|560594021|FG001|Overall Study|Withdrawal by Subject|1|||
155316652|NCT05201079|560594035|FG000|Overall Study|Adverse Event|7|||
155316653|NCT05201079|560594036|FG001|Overall Study|Adverse Event|11|||
155316654|NCT05201079|560594035|FG000|Overall Study|Death|1|||
155316655|NCT05201079|560594036|FG001|Overall Study|Death|1|||
155316656|NCT05201079|560594035|FG000|Overall Study|Lack of Efficacy|0|||
155316657|NCT05201079|560594036|FG001|Overall Study|Lack of Efficacy|2|||
155316658|NCT05201079|560594035|FG000|Overall Study|Lost to Follow-up|0|||
155418599|NCT01613326|560963474|FG001|Overall Study|Lost to Follow-up|1|||
155418600|NCT01613326|560963473|FG000|Overall Study|Administrative|0|||
155418601|NCT01613326|560963474|FG001|Overall Study|Administrative|2|||
155418602|NCT01613326|560963473|FG000|Overall Study|Protocol Violation|0|||
155418603|NCT01613326|560963474|FG001|Overall Study|Protocol Violation|1|||
155418604|NCT00420511|560963477|FG000|Overall Study|Adverse Event|1|||
155418605|NCT00420511|560963478|FG001|Overall Study|Adverse Event|1|||
155418606|NCT00420511|560963477|FG000|Overall Study|Lost to Follow-up|1|||
155418607|NCT00420511|560963478|FG001|Overall Study|Lost to Follow-up|0|||
155418608|NCT02415712|560963479|FG000|Overall Study|Protocol Violation|16|||
155418609|NCT04557384|560963480|FG000|Overall Study|Study Terminated by Sponsor|1|||
155418610|NCT04557384|560963480|FG000|Overall Study|Death|1|||
155418611|NCT00454779|560963481|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
155418612|NCT00454779|560963482|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
155418613|NCT00454779|560963481|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
155418614|NCT00454779|560963482|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
155418615|NCT00454779|560963481|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
155418616|NCT00454779|560963482|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
155418617|NCT00454779|560963481|FG000|First-line Treatment Phase|Protocol Violation|0|||
155418618|NCT00454779|560963482|FG001|First-line Treatment Phase|Protocol Violation|1|||
155418619|NCT00454779|560963481|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
155418620|NCT00454779|560963482|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
155418621|NCT00454779|560963481|FG000|First-line Treatment Phase|Ongoing|1|||
155418622|NCT00454779|560963482|FG001|First-line Treatment Phase|Ongoing|0|||
155418623|NCT00454779|560963481|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
155418624|NCT00454779|560963482|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
155418625|NCT00454779|560963481|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
155418626|NCT00454779|560963482|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
155418627|NCT00454779|560963481|FG000|Second-line Treatment Phase|Ongoing|0|||
155418628|NCT00454779|560963482|FG001|Second-line Treatment Phase|Ongoing|1|||
155418629|NCT01337973|560963484|FG000|Overall Study|Lost to Follow-up|2|||
155418630|NCT01337973|560963485|FG001|Overall Study|Lost to Follow-up|4|||
155418631|NCT01337973|560963486|FG002|Overall Study|Lost to Follow-up|3|||
155418632|NCT01337973|560963484|FG000|Overall Study|Death|1|||
155418633|NCT01337973|560963485|FG001|Overall Study|Death|2|||
155418634|NCT01337973|560963486|FG002|Overall Study|Death|1|||
155418635|NCT01337973|560963484|FG000|Overall Study|Withdrawal by Subject|10|||
155643290|NCT02323334|561783778|FG012|Period 3|Withdrawal by Subject|0|||
155316659|NCT05201079|560594036|FG001|Overall Study|Lost to Follow-up|1|||
155418636|NCT01337973|560963485|FG001|Overall Study|Withdrawal by Subject|8|||
155316660|NCT05201079|560594035|FG000|Overall Study|Physician Decision|1|||
155316661|NCT05201079|560594036|FG001|Overall Study|Physician Decision|1|||
155316662|NCT05201079|560594035|FG000|Overall Study|Protocol Violation|1|||
155418637|NCT01337973|560963486|FG002|Overall Study|Withdrawal by Subject|4|||
155418638|NCT01337973|560963484|FG000|Overall Study|missing data on primary outcome|3|||
155316663|NCT05201079|560594036|FG001|Overall Study|Protocol Violation|0|||
155316664|NCT05201079|560594035|FG000|Overall Study|Withdrawal by Subject|1|||
155316665|NCT05201079|560594036|FG001|Overall Study|Withdrawal by Subject|0|||
155316666|NCT05201079|560594035|FG000|Overall Study|Forbidden medication|9|||
155316667|NCT05201079|560594036|FG001|Overall Study|Forbidden medication|5|||
155316668|NCT05201079|560594035|FG000|Overall Study|Transfer to another hospital|0|||
155316669|NCT05201079|560594036|FG001|Overall Study|Transfer to another hospital|1|||
155316670|NCT05201079|560594035|FG000|Overall Study|Clinical condition|1|||
155316671|NCT05201079|560594036|FG001|Overall Study|Clinical condition|0|||
155316672|NCT05201079|560594035|FG000|Overall Study|SAE and sepsis|1|||
155316673|NCT05201079|560594036|FG001|Overall Study|SAE and sepsis|0|||
155316674|NCT01210807|560594043|FG000|Overall Study|Lost to Follow-up|1|||
155316675|NCT01210807|560594044|FG001|Overall Study|Lost to Follow-up|2|||
155316676|NCT01210807|560594043|FG000|Overall Study|Not implanted bilaterally|2|||
155316677|NCT01210807|560594044|FG001|Overall Study|Not implanted bilaterally|1|||
155316678|NCT05281562|560594045|FG000|Overall Study|Ineligible patient|1|||
155316679|NCT05281562|560594046|FG001|Overall Study|Ineligible patient|0|||
155316680|NCT00324805|560594047|FG000|Overall Study|Adverse Event|62|||
155316681|NCT00324805|560594048|FG001|Overall Study|Adverse Event|203|||
155316682|NCT00324805|560594047|FG000|Overall Study|Progression|7|||
155316683|NCT00324805|560594048|FG001|Overall Study|Progression|35|||
155316684|NCT00324805|560594047|FG000|Overall Study|Withdrawal by Subject|51|||
155316685|NCT00324805|560594048|FG001|Overall Study|Withdrawal by Subject|174|||
155316686|NCT00324805|560594047|FG000|Overall Study|Death|6|||
155316687|NCT00324805|560594048|FG001|Overall Study|Death|9|||
155316688|NCT00324805|560594047|FG000|Overall Study|Alternative therapy|4|||
155316689|NCT00324805|560594048|FG001|Overall Study|Alternative therapy|8|||
155316690|NCT00324805|560594047|FG000|Overall Study|Other complicating disease|1|||
155316691|NCT00324805|560594048|FG001|Overall Study|Other complicating disease|9|||
155316692|NCT00324805|560594047|FG000|Overall Study|Other reasons|7|||
155316693|NCT00324805|560594048|FG001|Overall Study|Other reasons|26|||
155316694|NCT00324805|560594047|FG000|Overall Study|Other|0|||
155316695|NCT00324805|560594048|FG001|Overall Study|Other|2|||
155316696|NCT00324805|560594047|FG000|Overall Study|Did not start therapy|12|||
155316697|NCT00324805|560594048|FG001|Overall Study|Did not start therapy|17|||
155316698|NCT05526430|560594056|FG000|Overall Study|Withdrawal by Subject|0|||
155316699|NCT05526430|560594057|FG001|Overall Study|Withdrawal by Subject|2|||
155316700|NCT05526430|560594058|FG002|Overall Study|Withdrawal by Subject|0|||
155316701|NCT05526430|560594059|FG003|Overall Study|Withdrawal by Subject|0|||
155316702|NCT03085810|560594060|FG000|Main Study|Withdrawal by Subject|77|||
155316703|NCT03085810|560594061|FG001|Main Study|Withdrawal by Subject|0|||
155316704|NCT03085810|560594062|FG002|Main Study|Withdrawal by Subject|0|||
155316705|NCT03085810|560594060|FG000|Main Study|Terminated By Sponsor|14|||
155316706|NCT03085810|560594061|FG001|Main Study|Terminated By Sponsor|0|||
155316707|NCT03085810|560594062|FG002|Main Study|Terminated By Sponsor|0|||
155316708|NCT03085810|560594060|FG000|Main Study|Protocol Violation|15|||
155316709|NCT03085810|560594061|FG001|Main Study|Protocol Violation|0|||
155316710|NCT03085810|560594062|FG002|Main Study|Protocol Violation|0|||
155316711|NCT03085810|560594060|FG000|Main Study|Physician Decision|13|||
155316712|NCT03085810|560594061|FG001|Main Study|Physician Decision|0|||
155316713|NCT03085810|560594062|FG002|Main Study|Physician Decision|0|||
155316714|NCT03085810|560594060|FG000|Main Study|Lost to Follow-up|17|||
155316715|NCT03085810|560594061|FG001|Main Study|Lost to Follow-up|0|||
155316716|NCT03085810|560594062|FG002|Main Study|Lost to Follow-up|0|||
155316717|NCT03085810|560594060|FG000|Main Study|Adverse Event|25|||
155316718|NCT03085810|560594061|FG001|Main Study|Adverse Event|0|||
155316719|NCT03085810|560594062|FG002|Main Study|Adverse Event|0|||
155316720|NCT03085810|560594060|FG000|Main Study|Pregnancy|7|||
155316721|NCT03085810|560594061|FG001|Main Study|Pregnancy|0|||
155316722|NCT03085810|560594062|FG002|Main Study|Pregnancy|0|||
155316723|NCT03085810|560594060|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
155316724|NCT03085810|560594061|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
155316725|NCT03085810|560594062|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
155418639|NCT01337973|560963485|FG001|Overall Study|missing data on primary outcome|1|||
155418640|NCT01337973|560963486|FG002|Overall Study|missing data on primary outcome|3|||
155316726|NCT03085810|560594060|FG000|Main Study|Lack of Efficacy|10|||
155316727|NCT03085810|560594061|FG001|Main Study|Lack of Efficacy|0|||
155316728|NCT03085810|560594062|FG002|Main Study|Lack of Efficacy|0|||
155316729|NCT03085810|560594060|FG000|Main Study|Death|12|||
155316730|NCT03085810|560594061|FG001|Main Study|Death|0|||
155316731|NCT03085810|560594062|FG002|Main Study|Death|0|||
155316732|NCT03085810|560594060|FG000|Main Study|Disease progression|1|||
155316733|NCT03085810|560594061|FG001|Main Study|Disease progression|0|||
155316734|NCT03085810|560594062|FG002|Main Study|Disease progression|0|||
155316735|NCT03085810|560594060|FG000|Main Study|Site Closure|3|||
155316736|NCT03085810|560594061|FG001|Main Study|Site Closure|0|||
155316737|NCT03085810|560594062|FG002|Main Study|Site Closure|0|||
155316738|NCT03085810|560594060|FG000|Main Study|Planned pregnancy|17|||
155316739|NCT03085810|560594061|FG001|Main Study|Planned pregnancy|0|||
155316740|NCT03085810|560594062|FG002|Main Study|Planned pregnancy|0|||
155316741|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
155316742|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
155316743|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
155316744|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
155316745|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
155316746|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
155316747|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
155316748|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
155316749|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
155316750|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
155316751|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
155316752|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
155316753|NCT02601313|560594063|FG000|Overall Study|Death|2|||
155316754|NCT02601313|560594064|FG001|Overall Study|Death|41|||
155316755|NCT02601313|560594065|FG002|Overall Study|Death|6|||
155316756|NCT02601313|560594063|FG000|Overall Study|Enrolled but never treated|0|||
155316757|NCT02601313|560594064|FG001|Overall Study|Enrolled but never treated|6|||
155316758|NCT02601313|560594065|FG002|Overall Study|Enrolled but never treated|3|||
155316759|NCT02601313|560594063|FG000|Overall Study|Enrolled, did not initiate AC|4|||
155316760|NCT02601313|560594064|FG001|Overall Study|Enrolled, did not initiate AC|0|||
155316761|NCT02601313|560594065|FG002|Overall Study|Enrolled, did not initiate AC|0|||
155316762|NCT02601313|560594063|FG000|Overall Study|Full consent withdrawal|0|||
155316763|NCT02601313|560594064|FG001|Overall Study|Full consent withdrawal|3|||
155316764|NCT02601313|560594065|FG002|Overall Study|Full consent withdrawal|2|||
155316765|NCT02601313|560594063|FG000|Overall Study|Lost to Follow-up|0|||
155316766|NCT02601313|560594064|FG001|Overall Study|Lost to Follow-up|1|||
155316767|NCT02601313|560594065|FG002|Overall Study|Lost to Follow-up|1|||
155316768|NCT03800654|560594066|FG000|Overall Study|Time constraints|3|||
155316769|NCT03800654|560594067|FG001|Overall Study|Time constraints|3|||
155316770|NCT03800654|560594068|FG002|Overall Study|Time constraints|3|||
155316771|NCT03800654|560594066|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
155316772|NCT03800654|560594067|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
155316773|NCT03800654|560594068|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
155316774|NCT03800654|560594066|FG000|Overall Study|Lost to Follow-up|2|||
155316775|NCT03800654|560594067|FG001|Overall Study|Lost to Follow-up|1|||
155316776|NCT03800654|560594068|FG002|Overall Study|Lost to Follow-up|6|||
155316777|NCT03800654|560594066|FG000|Overall Study|Medical Health Issue|0|||
155316778|NCT03800654|560594067|FG001|Overall Study|Medical Health Issue|0|||
155316779|NCT03800654|560594068|FG002|Overall Study|Medical Health Issue|1|||
155316780|NCT03800654|560594066|FG000|Overall Study|Personal Issues|0|||
155316781|NCT03800654|560594067|FG001|Overall Study|Personal Issues|2|||
155316782|NCT03800654|560594068|FG002|Overall Study|Personal Issues|0|||
155316783|NCT03800654|560594066|FG000|Overall Study|Protocol Violation|0|||
155316784|NCT03800654|560594067|FG001|Overall Study|Protocol Violation|1|||
155316785|NCT03800654|560594068|FG002|Overall Study|Protocol Violation|0|||
155316786|NCT03459729|560594069|FG000|Overall Study|Physician Decision|2|||
155316787|NCT02626533|560594071|FG000|Overall Study|Protocol Violation|14|||
155316788|NCT02626533|560594071|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
155316789|NCT02626533|560594071|FG000|Overall Study|Withdrawal by Subject|1|||
155316790|NCT03701763|560594072|FG000|Placebo-controlled Phase|Adverse Event|1|||
155316791|NCT03701763|560594073|FG001|Placebo-controlled Phase|Adverse Event|5|||
155316792|NCT03701763|560594074|FG002|Placebo-controlled Phase|Adverse Event|0|||
155316793|NCT03701763|560594075|FG003|Placebo-controlled Phase|Adverse Event|0|||
155316794|NCT03701763|560594072|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
155316795|NCT03701763|560594073|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
155316796|NCT03701763|560594074|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
155316797|NCT03701763|560594075|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
155316798|NCT03701763|560594072|FG000|Placebo-controlled Phase|Miscellaneous|2|||
155316799|NCT03701763|560594073|FG001|Placebo-controlled Phase|Miscellaneous|0|||
155316800|NCT03701763|560594074|FG002|Placebo-controlled Phase|Miscellaneous|0|||
155316801|NCT03701763|560594075|FG003|Placebo-controlled Phase|Miscellaneous|0|||
155316802|NCT03701763|560594072|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
155316803|NCT03701763|560594073|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
155316804|NCT03701763|560594074|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
155316805|NCT03701763|560594075|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
155418641|NCT02522767|560963489|FG000|Double-blind|Withdrawal by Subject|8|||
155316806|NCT03701763|560594072|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
155316807|NCT03701763|560594073|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
155316808|NCT03701763|560594074|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155316809|NCT03701763|560594075|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
155316810|NCT03701763|560594072|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
155316811|NCT03701763|560594073|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
155418642|NCT02522767|560963490|FG001|Double-blind|Withdrawal by Subject|11|||
155418643|NCT02522767|560963489|FG000|Double-blind|Lost to Follow-up|1|||
155418644|NCT02522767|560963490|FG001|Double-blind|Lost to Follow-up|0|||
155418645|NCT02522767|560963489|FG000|Double-blind|Adverse Event|1|||
155418646|NCT02522767|560963490|FG001|Double-blind|Adverse Event|10|||
155418647|NCT02522767|560963489|FG000|Double-blind|Protocol Violation|0|||
155418648|NCT02522767|560963490|FG001|Double-blind|Protocol Violation|1|||
155418649|NCT02522767|560963489|FG000|Double-blind|Lack of Efficacy|0|||
155418650|NCT02522767|560963490|FG001|Double-blind|Lack of Efficacy|2|||
155418651|NCT02522767|560963489|FG000|Double-blind|Protocol Deviation|1|||
155418652|NCT02522767|560963490|FG001|Double-blind|Protocol Deviation|0|||
155418653|NCT02522767|560963489|FG000|Open-label|Withdrawal by Subject|2|||
155418654|NCT02522767|560963490|FG001|Open-label|Withdrawal by Subject|3|||
155418655|NCT02522767|560963489|FG000|Open-label|Lost to Follow-up|0|||
155418656|NCT02522767|560963490|FG001|Open-label|Lost to Follow-up|1|||
155418657|NCT02522767|560963489|FG000|Open-label|Adverse Event|2|||
155418658|NCT02522767|560963490|FG001|Open-label|Adverse Event|1|||
155418659|NCT02522767|560963489|FG000|Open-label|Lack of Efficacy|1|||
155418660|NCT02522767|560963490|FG001|Open-label|Lack of Efficacy|1|||
155418661|NCT02522767|560963489|FG000|Open-label|Protocol Violation|0|||
155418662|NCT02522767|560963490|FG001|Open-label|Protocol Violation|1|||
155418663|NCT00254566|560963491|FG000|Overall Study|Death|1|||
155418664|NCT00254566|560963492|FG001|Overall Study|Death|0|||
155418665|NCT00254566|560963491|FG000|Overall Study|Adverse Event|5|||
155418666|NCT00254566|560963492|FG001|Overall Study|Adverse Event|4|||
155418667|NCT00254566|560963491|FG000|Overall Study|Lack of Efficacy|12|||
155418668|NCT00254566|560963492|FG001|Overall Study|Lack of Efficacy|9|||
155418669|NCT00254566|560963491|FG000|Overall Study|Other|1|||
155418670|NCT00254566|560963492|FG001|Overall Study|Other|5|||
155418671|NCT00254566|560963491|FG000|Overall Study|Withdrawal by Subject|5|||
155418672|NCT00254566|560963492|FG001|Overall Study|Withdrawal by Subject|6|||
155418673|NCT00254566|560963491|FG000|Overall Study|Lost to Follow-up|7|||
155418674|NCT00254566|560963492|FG001|Overall Study|Lost to Follow-up|2|||
155418675|NCT00548548|560963494|FG000|Overall Study|Death|345|||
155418676|NCT00548548|560963495|FG001|Overall Study|Death|348|||
155418677|NCT00548548|560963494|FG000|Overall Study|Lost to Follow-up|17|||
155418678|NCT00548548|560963495|FG001|Overall Study|Lost to Follow-up|18|||
155418679|NCT01705691|560963498|FG000|Overall Study|Death|1|||
155418680|NCT01705691|560963499|FG001|Overall Study|Death|2|||
155418681|NCT01705691|560963498|FG000|Overall Study|Withdrawal by Subject|1|||
155418682|NCT01705691|560963499|FG001|Overall Study|Withdrawal by Subject|2|||
155418683|NCT01705691|560963498|FG000|Overall Study|Lost to Follow-up|1|||
155418684|NCT01705691|560963499|FG001|Overall Study|Lost to Follow-up|1|||
155418685|NCT01705691|560963498|FG000|Overall Study|Other|0|||
155418686|NCT01705691|560963499|FG001|Overall Study|Other|1|||
155418687|NCT02658448|560963500|FG000|Overall Study|Lost to Follow-up|1|||
155418688|NCT00191451|560963501|FG000|Overall Study|Withdrawal by Subject|2|||
155418689|NCT00191451|560963502|FG001|Overall Study|Withdrawal by Subject|3|||
155418690|NCT00191451|560963503|FG002|Overall Study|Withdrawal by Subject|5|||
155418691|NCT00191451|560963501|FG000|Overall Study|Physician Decision|2|||
155418692|NCT00191451|560963502|FG001|Overall Study|Physician Decision|9|||
155418693|NCT00191451|560963503|FG002|Overall Study|Physician Decision|6|||
155418694|NCT00191451|560963501|FG000|Overall Study|Sponsor Decision|1|||
155418695|NCT00191451|560963502|FG001|Overall Study|Sponsor Decision|0|||
155418696|NCT00191451|560963503|FG002|Overall Study|Sponsor Decision|0|||
155418697|NCT00191451|560963501|FG000|Overall Study|Ineligible|0|||
155418698|NCT00191451|560963502|FG001|Overall Study|Ineligible|1|||
155418699|NCT00191451|560963503|FG002|Overall Study|Ineligible|0|||
155418700|NCT00191451|560963501|FG000|Overall Study|Reason Not Specified|2|||
155418701|NCT00191451|560963502|FG001|Overall Study|Reason Not Specified|1|||
155418702|NCT00191451|560963503|FG002|Overall Study|Reason Not Specified|3|||
155418703|NCT00272987|560963508|FG000|Overall Study|Adverse Event|1|||
155418704|NCT00272987|560963509|FG001|Overall Study|Adverse Event|0|||
155418705|NCT00272987|560963510|FG002|Overall Study|Adverse Event|0|||
155418706|NCT00272987|560963508|FG000|Overall Study|Lost to Follow-up|3|||
155418707|NCT00272987|560963509|FG001|Overall Study|Lost to Follow-up|1|||
155418708|NCT00272987|560963510|FG002|Overall Study|Lost to Follow-up|1|||
155418709|NCT00272987|560963508|FG000|Overall Study|Withdrawal by Subject|1|||
155418710|NCT00272987|560963509|FG001|Overall Study|Withdrawal by Subject|0|||
155418711|NCT00272987|560963510|FG002|Overall Study|Withdrawal by Subject|3|||
155418712|NCT00272987|560963508|FG000|Overall Study|Sponsor Terminated study|0|||
155418713|NCT00272987|560963509|FG001|Overall Study|Sponsor Terminated study|1|||
155418714|NCT00272987|560963510|FG002|Overall Study|Sponsor Terminated study|1|||
155418715|NCT00272987|560963508|FG000|Overall Study|Disease progression|1|||
155418716|NCT00272987|560963509|FG001|Overall Study|Disease progression|1|||
155418717|NCT00272987|560963510|FG002|Overall Study|Disease progression|2|||
155418718|NCT00272987|560963508|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
155418719|NCT00272987|560963509|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
155418720|NCT00272987|560963510|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
155418721|NCT00272987|560963508|FG000|Overall Study|Death|1|||
155316812|NCT03701763|560594074|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155316813|NCT03701763|560594075|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
155316814|NCT03701763|560594072|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155500781|NCT04256759|561258548|FG000|Overall Study|Lack of Efficacy|1|||
155500782|NCT04075292|561258549|FG000|Overall Study|Withdrawal by Subject|1|||
155316815|NCT03701763|560594073|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155500783|NCT04075292|561258550|FG001|Overall Study|Withdrawal by Subject|9|||
155316816|NCT03701763|560594074|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
155316817|NCT03701763|560594075|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
155316818|NCT03701763|560594072|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155316819|NCT03701763|560594073|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155316820|NCT03701763|560594074|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
155316821|NCT03701763|560594075|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
155418722|NCT00272987|560963509|FG001|Overall Study|Death|0|||
155418723|NCT00272987|560963510|FG002|Overall Study|Death|0|||
155418724|NCT02614079|560963511|FG000|Overall Study|Withdrawal by Subject|1|||
155418725|NCT03604445|560963516|FG000|Overall Study|Death|0|||
155418726|NCT03604445|560963517|FG001|Overall Study|Death|0|||
155418727|NCT03604445|560963518|FG002|Overall Study|Death|0|||
155418728|NCT03604445|560963519|FG003|Overall Study|Death|0|||
155418729|NCT03604445|560963520|FG004|Overall Study|Death|0|||
155418730|NCT03604445|560963521|FG005|Overall Study|Death|0|||
155418731|NCT03604445|560963522|FG006|Overall Study|Death|0|||
155418732|NCT03604445|560963523|FG007|Overall Study|Death|0|||
155418733|NCT03604445|560963524|FG008|Overall Study|Death|1|||
155418734|NCT03604445|560963516|FG000|Overall Study|Withdrawal by Subject|0|||
155418735|NCT03604445|560963517|FG001|Overall Study|Withdrawal by Subject|0|||
155418736|NCT03604445|560963518|FG002|Overall Study|Withdrawal by Subject|0|||
155418737|NCT03604445|560963519|FG003|Overall Study|Withdrawal by Subject|0|||
155418738|NCT03604445|560963520|FG004|Overall Study|Withdrawal by Subject|0|||
155418739|NCT03604445|560963521|FG005|Overall Study|Withdrawal by Subject|0|||
155418740|NCT03604445|560963522|FG006|Overall Study|Withdrawal by Subject|1|||
155418741|NCT03604445|560963523|FG007|Overall Study|Withdrawal by Subject|0|||
155418742|NCT03604445|560963524|FG008|Overall Study|Withdrawal by Subject|0|||
155418743|NCT03604445|560963516|FG000|Overall Study|Missing visit|0|||
155418744|NCT03604445|560963517|FG001|Overall Study|Missing visit|0|||
155418745|NCT03604445|560963518|FG002|Overall Study|Missing visit|0|||
155418746|NCT03604445|560963519|FG003|Overall Study|Missing visit|0|||
155418747|NCT03604445|560963520|FG004|Overall Study|Missing visit|0|||
155418748|NCT03604445|560963521|FG005|Overall Study|Missing visit|1|||
155418749|NCT03604445|560963522|FG006|Overall Study|Missing visit|0|||
155418750|NCT03604445|560963523|FG007|Overall Study|Missing visit|1|||
155418751|NCT03604445|560963524|FG008|Overall Study|Missing visit|0|||
155418752|NCT03604445|560963516|FG000|Overall Study|Adverse Event|0|||
155418753|NCT03604445|560963517|FG001|Overall Study|Adverse Event|0|||
155418754|NCT03604445|560963518|FG002|Overall Study|Adverse Event|0|||
155418755|NCT03604445|560963519|FG003|Overall Study|Adverse Event|1|||
155418756|NCT03604445|560963520|FG004|Overall Study|Adverse Event|0|||
155418757|NCT03604445|560963521|FG005|Overall Study|Adverse Event|0|||
155418758|NCT03604445|560963522|FG006|Overall Study|Adverse Event|0|||
155500784|NCT04075292|561258549|FG000|Overall Study|Death|2|||
155500785|NCT04075292|561258550|FG001|Overall Study|Death|5|||
155418759|NCT03604445|560963523|FG007|Overall Study|Adverse Event|0|||
155418760|NCT03604445|560963524|FG008|Overall Study|Adverse Event|1|||
155418761|NCT00130286|560963525|FG000|Overall Study|Withdrawal by Subject|0|||
155418762|NCT00130286|560963526|FG001|Overall Study|Withdrawal by Subject|1|||
155418763|NCT00130286|560963527|FG002|Overall Study|Withdrawal by Subject|2|||
155418764|NCT00130286|560963528|FG003|Overall Study|Withdrawal by Subject|2|||
155418765|NCT00130286|560963525|FG000|Overall Study|Adverse Event|0|||
155418766|NCT00130286|560963526|FG001|Overall Study|Adverse Event|0|||
155418767|NCT00130286|560963527|FG002|Overall Study|Adverse Event|2|||
155500786|NCT04075292|561258549|FG000|Overall Study|Remained on study at time of DCO|74|||
155316822|NCT03701763|560594072|FG000|Apremilast Extension Phase|Adverse Event|0|||
155418768|NCT00130286|560963528|FG003|Overall Study|Adverse Event|0|||
155418769|NCT00130286|560963525|FG000|Overall Study|Missing lab specimens|0|||
155418770|NCT00130286|560963526|FG001|Overall Study|Missing lab specimens|2|||
155418771|NCT00130286|560963527|FG002|Overall Study|Missing lab specimens|0|||
155418772|NCT00130286|560963528|FG003|Overall Study|Missing lab specimens|0|||
155418773|NCT00611247|560963531|FG000|Overall Study|Death|1|||
155418774|NCT00611247|560963532|FG001|Overall Study|Death|5|||
155418775|NCT00611247|560963531|FG000|Overall Study|Lack of Efficacy|1|||
155418776|NCT00611247|560963532|FG001|Overall Study|Lack of Efficacy|16|||
155418777|NCT00243659|560963533|FG000|Overall Study|Withdrawal by Subject|1|||
155418778|NCT00243659|560963534|FG001|Overall Study|Withdrawal by Subject|1|||
155418779|NCT00243659|560963533|FG000|Overall Study|Protocol Violation|1|||
155418780|NCT00243659|560963534|FG001|Overall Study|Protocol Violation|2|||
155418781|NCT01890421|560963535|FG000|Overall Study|Adverse Event|1|||
155418782|NCT01890421|560963535|FG000|Overall Study|Other reason|10|||
155500787|NCT04075292|561258550|FG001|Overall Study|Remained on study at time of DCO|64|||
155316823|NCT03701763|560594073|FG001|Apremilast Extension Phase|Adverse Event|0|||
155316824|NCT03701763|560594074|FG002|Apremilast Extension Phase|Adverse Event|3|||
155316825|NCT03701763|560594075|FG003|Apremilast Extension Phase|Adverse Event|1|||
155316826|NCT03701763|560594072|FG000|Apremilast Extension Phase|Miscellaneous|0|||
155316827|NCT03701763|560594073|FG001|Apremilast Extension Phase|Miscellaneous|0|||
155316828|NCT03701763|560594074|FG002|Apremilast Extension Phase|Miscellaneous|2|||
155316829|NCT03701763|560594075|FG003|Apremilast Extension Phase|Miscellaneous|1|||
155316830|NCT03701763|560594072|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
155316831|NCT03701763|560594073|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
155316832|NCT03701763|560594074|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
155316833|NCT03701763|560594075|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
155316834|NCT03701763|560594072|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155316835|NCT03701763|560594073|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155316836|NCT03701763|560594074|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
155316837|NCT03701763|560594075|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
155316838|NCT03701763|560594072|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
155316839|NCT03701763|560594073|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
155316840|NCT03701763|560594074|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
155316841|NCT03701763|560594075|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
155316842|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316843|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316844|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
155316845|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316846|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
155316847|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
155316848|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
155316849|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
155316850|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Other|0|||
155316851|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Other|0|||
155316852|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Other|1|||
155316853|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Other|0|||
155316854|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316855|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316856|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316857|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
155316858|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316859|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316860|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316861|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
155316862|NCT05576155|560594078|FG000|Overall Study|Withdrawal by Subject|1|||
155316863|NCT05576155|560594079|FG001|Overall Study|Withdrawal by Subject|1|||
155316864|NCT04515849|560594080|FG000|Overall Study|Adverse Event|0|||
155316865|NCT04515849|560594081|FG001|Overall Study|Adverse Event|0|||
155316866|NCT04515849|560594082|FG002|Overall Study|Adverse Event|0|||
155316867|NCT04515849|560594083|FG003|Overall Study|Adverse Event|1|||
155316868|NCT04515849|560594084|FG004|Overall Study|Adverse Event|2|||
155316869|NCT04515849|560594080|FG000|Overall Study|Death|2|||
155316870|NCT04515849|560594081|FG001|Overall Study|Death|0|||
155316871|NCT04515849|560594082|FG002|Overall Study|Death|0|||
155316872|NCT04515849|560594083|FG003|Overall Study|Death|0|||
155316873|NCT04515849|560594084|FG004|Overall Study|Death|0|||
155316874|NCT04515849|560594080|FG000|Overall Study|Other:family emergency|0|||
155316875|NCT04515849|560594081|FG001|Overall Study|Other:family emergency|0|||
155316876|NCT04515849|560594082|FG002|Overall Study|Other:family emergency|0|||
155316877|NCT04515849|560594083|FG003|Overall Study|Other:family emergency|1|||
155316878|NCT04515849|560594084|FG004|Overall Study|Other:family emergency|0|||
155316879|NCT04515849|560594080|FG000|Overall Study|Other:randomised by error|0|||
155316880|NCT04515849|560594081|FG001|Overall Study|Other:randomised by error|1|||
155316881|NCT04515849|560594082|FG002|Overall Study|Other:randomised by error|0|||
155316882|NCT04515849|560594083|FG003|Overall Study|Other:randomised by error|0|||
155316883|NCT04515849|560594084|FG004|Overall Study|Other:randomised by error|0|||
155316884|NCT04515849|560594080|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316885|NCT04515849|560594081|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155418783|NCT00268242|560963536|FG000|Overall Study|Death|1|||
155316886|NCT04515849|560594082|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316887|NCT04515849|560594083|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
155316888|NCT04515849|560594084|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316889|NCT04515849|560594080|FG000|Overall Study|Physician Decision|0|||
155500788|NCT00185731|561258551|FG000|Overall Study|Withdrawal by Subject|1|||
155316890|NCT04515849|560594081|FG001|Overall Study|Physician Decision|1|||
155316891|NCT04515849|560594082|FG002|Overall Study|Physician Decision|0|||
155316892|NCT04515849|560594083|FG003|Overall Study|Physician Decision|0|||
155316893|NCT04515849|560594084|FG004|Overall Study|Physician Decision|0|||
155316894|NCT04515849|560594080|FG000|Overall Study|Withdrawal by Subject|1|||
155316895|NCT04515849|560594081|FG001|Overall Study|Withdrawal by Subject|2|||
155316896|NCT04515849|560594082|FG002|Overall Study|Withdrawal by Subject|1|||
155316897|NCT04515849|560594083|FG003|Overall Study|Withdrawal by Subject|0|||
155316898|NCT04515849|560594084|FG004|Overall Study|Withdrawal by Subject|0|||
155500789|NCT00185731|561258551|FG000|Overall Study|Not Eligible|1|||
155500790|NCT02494583|561258552|FG000|Overall Study|Death|224|||
155316899|NCT04049643|560594092|FG000|Overall Study|Lack of Efficacy|1|||
155316900|NCT04049643|560594093|FG001|Overall Study|Lack of Efficacy|1|||
155316901|NCT04049643|560594094|FG002|Overall Study|Lack of Efficacy|0|||
155316902|NCT04049643|560594092|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155316903|NCT04049643|560594093|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155316904|NCT04049643|560594094|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
155316905|NCT04081103|560594095|FG000|Overall Study|Adverse Event|1|||
155316906|NCT04081103|560594096|FG001|Overall Study|Adverse Event|1|||
155316907|NCT04081103|560594097|FG002|Overall Study|Adverse Event|1|||
155316908|NCT04081103|560594095|FG000|Overall Study|Physician Decision|0|||
155316909|NCT04081103|560594096|FG001|Overall Study|Physician Decision|0|||
155316910|NCT04081103|560594097|FG002|Overall Study|Physician Decision|1|||
155316911|NCT03365882|560594100|FG000|Randomization|Still Receiving Protocol Treatment|2|||
155316912|NCT03365882|560594101|FG001|Randomization|Still Receiving Protocol Treatment|0|||
155316913|NCT03365882|560594100|FG000|Randomization|Adverse Event|1|||
155316914|NCT03365882|560594101|FG001|Randomization|Adverse Event|2|||
155316915|NCT03365882|560594100|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
155316916|NCT03365882|560594101|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
155316917|NCT03365882|560594100|FG000|Randomization|Progression/Relapse|21|||
155316918|NCT03365882|560594101|FG001|Randomization|Progression/Relapse|3|||
155316919|NCT03365882|560594100|FG000|Randomization|Death|1|||
155316920|NCT03365882|560594101|FG001|Randomization|Death|0|||
155316921|NCT03365882|560594100|FG000|Randomization|Other - Not Protocol Specified|1|||
155316922|NCT03365882|560594101|FG001|Randomization|Other - Not Protocol Specified|1|||
155316923|NCT03365882|560594100|FG000|Randomization|Major Protocol Deviation|0|||
155316924|NCT03365882|560594101|FG001|Randomization|Major Protocol Deviation|1|||
155316925|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
155316926|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
155316927|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
155316928|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
155316929|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
155316930|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
155316931|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
155316932|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
155316933|NCT04437615|560594102|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
155316934|NCT04828005|560594103|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
155316935|NCT04828005|560594104|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316936|NCT04828005|560594105|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316937|NCT04828005|560594106|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316938|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
155316939|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
155316940|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
155316941|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
155418784|NCT01665144|560963537|FG000|Core Part|Withdrawal by Subject|96|||
155418785|NCT01665144|560963538|FG001|Core Part|Withdrawal by Subject|77|||
155418786|NCT01665144|560963539|FG002|Core Part|Withdrawal by Subject|0|||
155418787|NCT01665144|560963537|FG000|Core Part|Adverse Event|45|||
155418788|NCT01665144|560963538|FG001|Core Part|Adverse Event|18|||
155418789|NCT01665144|560963539|FG002|Core Part|Adverse Event|0|||
155418790|NCT01665144|560963537|FG000|Core Part|Lack of Efficacy|16|||
155418791|NCT01665144|560963538|FG001|Core Part|Lack of Efficacy|11|||
155418792|NCT01665144|560963539|FG002|Core Part|Lack of Efficacy|0|||
155418793|NCT01665144|560963537|FG000|Core Part|Lost to Follow-up|9|||
155418794|NCT01665144|560963538|FG001|Core Part|Lost to Follow-up|8|||
155418795|NCT01665144|560963539|FG002|Core Part|Lost to Follow-up|0|||
155418796|NCT01665144|560963537|FG000|Core Part|Physician Decision|13|||
155316942|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316943|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316944|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
155418797|NCT01665144|560963538|FG001|Core Part|Physician Decision|1|||
155418798|NCT01665144|560963539|FG002|Core Part|Physician Decision|0|||
155500791|NCT02494583|561258553|FG001|Overall Study|Death|214|||
155316945|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316946|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
155316947|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
155316948|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
155316949|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
155316950|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316951|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316952|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316953|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
155316954|NCT04828005|560594103|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316955|NCT04828005|560594104|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316956|NCT04828005|560594105|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
155316957|NCT04828005|560594106|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316958|NCT04828005|560594103|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
155316959|NCT04828005|560594104|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
155316960|NCT04828005|560594105|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
155316961|NCT04828005|560594106|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
155316962|NCT04828005|560594103|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316963|NCT04828005|560594104|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316964|NCT04828005|560594105|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316965|NCT04828005|560594106|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
155316966|NCT04828005|560594103|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316967|NCT04828005|560594104|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316968|NCT04828005|560594105|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316969|NCT04828005|560594106|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
155316970|NCT05579899|560596106|FG000|Overall Study|Lost to Follow-up|3|||
155316971|NCT05579899|560596107|FG001|Overall Study|Lost to Follow-up|1|||
155316972|NCT05579899|560596106|FG000|Overall Study|Adverse Event|0|||
155316973|NCT05579899|560596107|FG001|Overall Study|Adverse Event|3|||
155316974|NCT05579899|560596106|FG000|Overall Study|Pregnancy|0|||
155316975|NCT05579899|560596107|FG001|Overall Study|Pregnancy|1|||
155316976|NCT05579899|560596106|FG000|Overall Study|Withdrawal by Subject|0|||
155316977|NCT05579899|560596107|FG001|Overall Study|Withdrawal by Subject|3|||
155316978|NCT03023410|560596108|FG000|Overall Study|study termination|0|||
155316979|NCT03023410|560596109|FG001|Overall Study|study termination|1|||
155316980|NCT04987320|560596115|FG000|Overall Study|Withdrawal by Subject|0|||
155316981|NCT04987320|560596116|FG001|Overall Study|Withdrawal by Subject|1|||
155316982|NCT00085735|560596117|FG000|Overall Study|Adverse Event|1|||
155316983|NCT00085735|560596118|FG001|Overall Study|Adverse Event|0|||
155316984|NCT00085735|560596119|FG002|Overall Study|Adverse Event|0|||
155316985|NCT00085735|560596120|FG003|Overall Study|Adverse Event|0|||
155316986|NCT00085735|560596121|FG004|Overall Study|Adverse Event|0|||
155316987|NCT00085735|560596122|FG005|Overall Study|Adverse Event|0|||
155316988|NCT00085735|560596117|FG000|Overall Study|Lack of Efficacy|2|||
155316989|NCT00085735|560596118|FG001|Overall Study|Lack of Efficacy|4|||
155316990|NCT00085735|560596119|FG002|Overall Study|Lack of Efficacy|6|||
155316991|NCT00085735|560596120|FG003|Overall Study|Lack of Efficacy|3|||
155316992|NCT00085735|560596121|FG004|Overall Study|Lack of Efficacy|4|||
155316993|NCT00085735|560596122|FG005|Overall Study|Lack of Efficacy|3|||
155316994|NCT00085735|560596117|FG000|Overall Study|Lost to Follow-up|0|||
155316995|NCT00085735|560596118|FG001|Overall Study|Lost to Follow-up|1|||
155316996|NCT00085735|560596119|FG002|Overall Study|Lost to Follow-up|0|||
155316997|NCT00085735|560596120|FG003|Overall Study|Lost to Follow-up|0|||
155316998|NCT00085735|560596121|FG004|Overall Study|Lost to Follow-up|1|||
155316999|NCT00085735|560596122|FG005|Overall Study|Lost to Follow-up|0|||
155317000|NCT00085735|560596117|FG000|Overall Study|Physician Decision|2|||
155317001|NCT00085735|560596118|FG001|Overall Study|Physician Decision|3|||
155317002|NCT00085735|560596119|FG002|Overall Study|Physician Decision|2|||
155317003|NCT00085735|560596120|FG003|Overall Study|Physician Decision|3|||
155317004|NCT00085735|560596121|FG004|Overall Study|Physician Decision|11|||
155317005|NCT00085735|560596122|FG005|Overall Study|Physician Decision|8|||
155418799|NCT01665144|560963537|FG000|Core Part|Progressive disease|8|||
155418800|NCT01665144|560963538|FG001|Core Part|Progressive disease|4|||
155418801|NCT01665144|560963539|FG002|Core Part|Progressive disease|0|||
155500792|NCT02494583|561258554|FG002|Overall Study|Death|225|||
155317006|NCT00085735|560596117|FG000|Overall Study|Protocol Violation|1|||
155317007|NCT00085735|560596118|FG001|Overall Study|Protocol Violation|0|||
155317008|NCT00085735|560596119|FG002|Overall Study|Protocol Violation|0|||
155317009|NCT00085735|560596120|FG003|Overall Study|Protocol Violation|0|||
155317010|NCT00085735|560596121|FG004|Overall Study|Protocol Violation|0|||
155317011|NCT00085735|560596122|FG005|Overall Study|Protocol Violation|0|||
155317012|NCT00085735|560596117|FG000|Overall Study|Withdrawal by Subject|1|||
155317013|NCT00085735|560596118|FG001|Overall Study|Withdrawal by Subject|0|||
155317014|NCT00085735|560596119|FG002|Overall Study|Withdrawal by Subject|4|||
155317015|NCT00085735|560596120|FG003|Overall Study|Withdrawal by Subject|5|||
155317016|NCT00085735|560596121|FG004|Overall Study|Withdrawal by Subject|7|||
155317017|NCT00085735|560596122|FG005|Overall Study|Withdrawal by Subject|8|||
155317018|NCT00085735|560596117|FG000|Overall Study|Patient ineligible|1|||
155317019|NCT00085735|560596118|FG001|Overall Study|Patient ineligible|0|||
155317020|NCT00085735|560596119|FG002|Overall Study|Patient ineligible|3|||
155317021|NCT00085735|560596120|FG003|Overall Study|Patient ineligible|7|||
155317022|NCT00085735|560596121|FG004|Overall Study|Patient ineligible|17|||
155317023|NCT00085735|560596122|FG005|Overall Study|Patient ineligible|8|||
155317024|NCT00085735|560596117|FG000|Overall Study|Excess residual disease|2|||
155317025|NCT00085735|560596118|FG001|Overall Study|Excess residual disease|2|||
155317026|NCT00085735|560596119|FG002|Overall Study|Excess residual disease|1|||
155317027|NCT00085735|560596120|FG003|Overall Study|Excess residual disease|1|||
155317028|NCT00085735|560596121|FG004|Overall Study|Excess residual disease|1|||
155317029|NCT00085735|560596122|FG005|Overall Study|Excess residual disease|4|||
155500793|NCT02494583|561258552|FG000|Overall Study|Lost to Follow-up|1|||
155500794|NCT02494583|561258553|FG001|Overall Study|Lost to Follow-up|0|||
155418802|NCT01665144|560963537|FG000|Core Part|Non-compliance with study treatment|5|||
155418803|NCT01665144|560963538|FG001|Core Part|Non-compliance with study treatment|0|||
155418804|NCT01665144|560963539|FG002|Core Part|Non-compliance with study treatment|0|||
155418805|NCT01665144|560963537|FG000|Core Part|Death|3|||
155418806|NCT01665144|560963538|FG001|Core Part|Death|1|||
155418807|NCT01665144|560963539|FG002|Core Part|Death|0|||
155418808|NCT01665144|560963537|FG000|Core Part|Protocol deviation|3|||
155418809|NCT01665144|560963538|FG001|Core Part|Protocol deviation|1|||
155418810|NCT01665144|560963539|FG002|Core Part|Protocol deviation|0|||
155418811|NCT01665144|560963537|FG000|Core Part|New therapy for study indication|2|||
155418812|NCT01665144|560963538|FG001|Core Part|New therapy for study indication|1|||
155418813|NCT01665144|560963539|FG002|Core Part|New therapy for study indication|0|||
155418814|NCT01665144|560963537|FG000|Core Part|Technical problems|2|||
155418815|NCT01665144|560963538|FG001|Core Part|Technical problems|0|||
155418816|NCT01665144|560963539|FG002|Core Part|Technical problems|0|||
155418817|NCT01665144|560963537|FG000|Extension Part|Patient/guardian decision|180|||
155418818|NCT01665144|560963538|FG001|Extension Part|Patient/guardian decision|0|||
155418819|NCT01665144|560963539|FG002|Extension Part|Patient/guardian decision|98|||
155418820|NCT01665144|560963537|FG000|Extension Part|Adverse Event|104|||
155418821|NCT01665144|560963538|FG001|Extension Part|Adverse Event|0|||
155418822|NCT01665144|560963539|FG002|Extension Part|Adverse Event|59|||
155418823|NCT01665144|560963537|FG000|Extension Part|Study closed early|42|||
155418824|NCT01665144|560963538|FG001|Extension Part|Study closed early|0|||
155418825|NCT01665144|560963539|FG002|Extension Part|Study closed early|19|||
155418826|NCT01665144|560963537|FG000|Extension Part|Progressive disease|36|||
155418827|NCT01665144|560963538|FG001|Extension Part|Progressive disease|0|||
155418828|NCT01665144|560963539|FG002|Extension Part|Progressive disease|14|||
155418829|NCT01665144|560963537|FG000|Extension Part|Lack of Efficacy|37|||
155418830|NCT01665144|560963538|FG001|Extension Part|Lack of Efficacy|0|||
155418831|NCT01665144|560963539|FG002|Extension Part|Lack of Efficacy|12|||
155418832|NCT01665144|560963537|FG000|Extension Part|Physician Decision|29|||
155418833|NCT01665144|560963538|FG001|Extension Part|Physician Decision|0|||
155418834|NCT01665144|560963539|FG002|Extension Part|Physician Decision|13|||
155418835|NCT01665144|560963537|FG000|Extension Part|Technical problems|20|||
155418836|NCT01665144|560963538|FG001|Extension Part|Technical problems|0|||
155418837|NCT01665144|560963539|FG002|Extension Part|Technical problems|8|||
155418838|NCT01665144|560963537|FG000|Extension Part|Death|20|||
155418839|NCT01665144|560963538|FG001|Extension Part|Death|0|||
155418840|NCT01665144|560963539|FG002|Extension Part|Death|4|||
155418841|NCT01665144|560963537|FG000|Extension Part|Missing|12|||
155418842|NCT01665144|560963538|FG001|Extension Part|Missing|0|||
155418843|NCT01665144|560963539|FG002|Extension Part|Missing|6|||
155418844|NCT01665144|560963537|FG000|Extension Part|Lost to Follow-up|9|||
155418845|NCT01665144|560963538|FG001|Extension Part|Lost to Follow-up|0|||
155418846|NCT01665144|560963539|FG002|Extension Part|Lost to Follow-up|5|||
155418847|NCT01665144|560963537|FG000|Extension Part|New therapy for study indication|3|||
155418848|NCT01665144|560963538|FG001|Extension Part|New therapy for study indication|0|||
155418849|NCT01665144|560963539|FG002|Extension Part|New therapy for study indication|2|||
155418850|NCT01665144|560963537|FG000|Extension Part|Protocol deviation|3|||
155418851|NCT01665144|560963538|FG001|Extension Part|Protocol deviation|0|||
155418852|NCT01665144|560963539|FG002|Extension Part|Protocol deviation|0|||
155418853|NCT01913483|560963540|FG000|Overall Study|Withdrawal by Subject|1|||
155418854|NCT01913483|560963541|FG001|Overall Study|Withdrawal by Subject|2|||
155418855|NCT01913483|560963540|FG000|Overall Study|Lost to Follow-up|6|||
155418856|NCT01913483|560963541|FG001|Overall Study|Lost to Follow-up|3|||
155418857|NCT01913483|560963540|FG000|Overall Study|Death|14|||
155418858|NCT01913483|560963541|FG001|Overall Study|Death|17|||
155418859|NCT03969888|560963542|FG000|Overall Study|Never Received Study Drug|0|||
155418860|NCT03969888|560963543|FG001|Overall Study|Never Received Study Drug|0|||
155418861|NCT03969888|560963544|FG002|Overall Study|Never Received Study Drug|1|||
155317030|NCT00085735|560596117|FG000|Overall Study|Reason not documented|1|||
155418862|NCT03969888|560963545|FG003|Overall Study|Never Received Study Drug|0|||
155418863|NCT03969888|560963546|FG004|Overall Study|Never Received Study Drug|0|||
155418864|NCT03969888|560963547|FG005|Overall Study|Never Received Study Drug|0|||
155418865|NCT03969888|560963548|FG006|Overall Study|Never Received Study Drug|1|||
155317031|NCT00085735|560596118|FG001|Overall Study|Reason not documented|0|||
155317032|NCT00085735|560596119|FG002|Overall Study|Reason not documented|1|||
155317033|NCT00085735|560596120|FG003|Overall Study|Reason not documented|0|||
155317034|NCT00085735|560596121|FG004|Overall Study|Reason not documented|1|||
155317035|NCT00085735|560596122|FG005|Overall Study|Reason not documented|0|||
155317036|NCT00085735|560596117|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
155317037|NCT00085735|560596118|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
155317038|NCT00085735|560596119|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
155317039|NCT00085735|560596120|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
155317040|NCT00085735|560596121|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
155317041|NCT00085735|560596122|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
155317042|NCT01824875|560596123|FG000|Overall Study|Disease progression|22|||
155317043|NCT01824875|560596124|FG001|Overall Study|Disease progression|15|||
155317044|NCT01824875|560596123|FG000|Overall Study|Withdrawal by Subject|5|||
155317045|NCT01824875|560596124|FG001|Overall Study|Withdrawal by Subject|4|||
155317046|NCT01824875|560596123|FG000|Overall Study|Adverse Event|4|||
155317047|NCT01824875|560596124|FG001|Overall Study|Adverse Event|10|||
155317048|NCT01824875|560596123|FG000|Overall Study|Alternative therapy|3|||
155317049|NCT01824875|560596124|FG001|Overall Study|Alternative therapy|0|||
155317050|NCT01824875|560596123|FG000|Overall Study|Complicating disease|1|||
155317051|NCT01824875|560596124|FG001|Overall Study|Complicating disease|0|||
155317052|NCT01824875|560596123|FG000|Overall Study|Physician Decision|0|||
155317053|NCT01824875|560596124|FG001|Overall Study|Physician Decision|1|||
155317054|NCT01824875|560596123|FG000|Overall Study|Non-compliance|1|||
155317055|NCT01824875|560596124|FG001|Overall Study|Non-compliance|1|||
155317056|NCT01824875|560596123|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
155317057|NCT01824875|560596124|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
155317058|NCT01824875|560596123|FG000|Overall Study|Administrative issues|0|||
155317059|NCT01824875|560596124|FG001|Overall Study|Administrative issues|2|||
155317060|NCT01824875|560596123|FG000|Overall Study|Ineligible or never started treatment|9|||
155317061|NCT01824875|560596124|FG001|Overall Study|Ineligible or never started treatment|5|||
155317062|NCT01824875|560596123|FG000|Overall Study|Other|0|||
155317063|NCT01824875|560596124|FG001|Overall Study|Other|2|||
155317064|NCT00433329|560596127|FG000|Overall Study|Adverse Event|9|||
155317065|NCT00433329|560596127|FG000|Overall Study|Death|4|||
155317066|NCT00433329|560596127|FG000|Overall Study|Withdrew consent|3|||
155317067|NCT00433329|560596127|FG000|Overall Study|Discontinued sildenafil|2|||
155317068|NCT00433329|560596127|FG000|Overall Study|Moved out of state|1|||
155317069|NCT00433329|560596127|FG000|Overall Study|Lost to Follow-up|1|||
155317070|NCT00433329|560596127|FG000|Overall Study|Physician Decision|1|||
155317071|NCT04195698|560596128|FG000|Overall Study|Adverse Event|4|||
155317072|NCT04195698|560596129|FG001|Overall Study|Adverse Event|11|||
155317073|NCT04195698|560596128|FG000|Overall Study|Withdrawal by Subject|9|||
155317074|NCT04195698|560596129|FG001|Overall Study|Withdrawal by Subject|10|||
155317075|NCT04195698|560596128|FG000|Overall Study|Lost to Follow-up|5|||
155317076|NCT04195698|560596129|FG001|Overall Study|Lost to Follow-up|4|||
155317077|NCT04195698|560596128|FG000|Overall Study|Lack of Efficacy|2|||
155317078|NCT04195698|560596129|FG001|Overall Study|Lack of Efficacy|10|||
155317079|NCT04195698|560596128|FG000|Overall Study|Other|5|||
155317080|NCT04195698|560596129|FG001|Overall Study|Other|4|||
155317081|NCT05459688|560596130|FG000|Overall Study|Lost to Follow-up|6|||
155317082|NCT05459688|560596130|FG000|Overall Study|Physician Decision|1|||
155317083|NCT05459688|560596130|FG000|Overall Study|Withdrawal by Subject|19|||
155317084|NCT05459688|560596130|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
155317085|NCT02675751|560596131|FG000|Overall Study|Lost to Follow-up|16|||
155317086|NCT03371381|560596132|FG000|Overall Study|Death|5|||
155317087|NCT03371381|560596132|FG000|Overall Study|Study terminated by sponsor|3|||
155317088|NCT03371381|560596132|FG000|Overall Study|Other|4|||
155317089|NCT01593917|560596135|FG000|Overall Study|Death|67|||
155317090|NCT01593917|560596135|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
155317091|NCT01593917|560596135|FG000|Overall Study|Withdrawal by Subject|23|||
155317092|NCT01593917|560596135|FG000|Overall Study|Lost to Follow-up|12|||
155418866|NCT03969888|560963549|FG007|Overall Study|Never Received Study Drug|0|||
155317093|NCT01593917|560596135|FG000|Overall Study|Protocol Violation|5|||
155317094|NCT01593917|560596135|FG000|Overall Study|Physician Decision|3|||
155317095|NCT04663737|560596136|FG000|Overall Study|Withdrawal by Subject|2|||
155317096|NCT04663737|560596137|FG001|Overall Study|Withdrawal by Subject|0|||
155317097|NCT04016662|560596138|FG000|Run-In Phase|Death|1|||
155317098|NCT04016662|560596138|FG000|Run-In Phase|Withdrawal by Subject|11|||
155317099|NCT04016662|560596138|FG000|Run-In Phase|Not meeting screening eligibility|9|||
155317100|NCT04016662|560596138|FG000|Run-In Phase|Physician Decision|3|||
155317101|NCT04016662|560596138|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
155317102|NCT04016662|560596138|FG000|PLGS (12 Weeks)|Death|1|||
155317103|NCT04016662|560596138|FG000|SAP (12 Weeks)|Death|1|||
155317104|NCT03216057|560596139|FG000|Overall Study|Lost to Follow-up|2|||
155500795|NCT02494583|561258554|FG002|Overall Study|Lost to Follow-up|0|||
155500796|NCT02494583|561258552|FG000|Overall Study|Protocol Violation|1|||
155500797|NCT02494583|561258553|FG001|Overall Study|Protocol Violation|2|||
155317105|NCT03216057|560596140|FG001|Overall Study|Lost to Follow-up|2|||
155317106|NCT05126433|560596141|FG000|Overall Study|Withdrawal by Subject|3|||
155317107|NCT05126433|560596142|FG001|Overall Study|Withdrawal by Subject|0|||
155317108|NCT05126433|560596143|FG002|Overall Study|Withdrawal by Subject|4|||
155317109|NCT05126433|560596141|FG000|Overall Study|Death|9|||
155317110|NCT05126433|560596142|FG001|Overall Study|Death|3|||
155317111|NCT05126433|560596143|FG002|Overall Study|Death|5|||
155317112|NCT05126433|560596141|FG000|Overall Study|Study Terminated by sponsor|0|||
155317113|NCT05126433|560596142|FG001|Overall Study|Study Terminated by sponsor|1|||
155317114|NCT05126433|560596143|FG002|Overall Study|Study Terminated by sponsor|2|||
155317115|NCT05126433|560596141|FG000|Overall Study|Progressive Disease|1|||
155317116|NCT05126433|560596142|FG001|Overall Study|Progressive Disease|4|||
155317117|NCT05126433|560596143|FG002|Overall Study|Progressive Disease|3|||
155317118|NCT05126433|560596141|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
155317119|NCT05126433|560596142|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
155317120|NCT05126433|560596143|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
155317121|NCT04599062|560596147|FG000|Overall Study|Physician Decision|1|||
155317122|NCT04599062|560596148|FG001|Overall Study|Physician Decision|0|||
155317123|NCT04032704|560596149|FG000|Part A|Withdrawal by Subject|0|||
155317124|NCT04032704|560596150|FG001|Part A|Withdrawal by Subject|0|||
155317125|NCT04032704|560596151|FG002|Part A|Withdrawal by Subject|3|||
155317126|NCT04032704|560596152|FG003|Part A|Withdrawal by Subject|0|||
155317127|NCT04032704|560596153|FG004|Part A|Withdrawal by Subject|1|||
155317128|NCT04032704|560596154|FG005|Part A|Withdrawal by Subject|7|||
155418867|NCT03969888|560963542|FG000|Overall Study|Reason Not Specified|0|||
155418868|NCT03969888|560963543|FG001|Overall Study|Reason Not Specified|0|||
155418869|NCT03969888|560963544|FG002|Overall Study|Reason Not Specified|0|||
155418870|NCT03969888|560963545|FG003|Overall Study|Reason Not Specified|0|||
155418871|NCT03969888|560963546|FG004|Overall Study|Reason Not Specified|0|||
155500798|NCT02494583|561258554|FG002|Overall Study|Protocol Violation|0|||
155500799|NCT02494583|561258552|FG000|Overall Study|Screen Failure|0|||
155500800|NCT02494583|561258553|FG001|Overall Study|Screen Failure|1|||
155500801|NCT02494583|561258554|FG002|Overall Study|Screen Failure|0|||
155500802|NCT02494583|561258552|FG000|Overall Study|Transferred to Extension Study|15|||
155500803|NCT02494583|561258553|FG001|Overall Study|Transferred to Extension Study|15|||
155500804|NCT02494583|561258554|FG002|Overall Study|Transferred to Extension Study|6|||
155500805|NCT02494583|561258552|FG000|Overall Study|Did Not Continue on Extension Study|8|||
155500806|NCT02494583|561258553|FG001|Overall Study|Did Not Continue on Extension Study|10|||
155500807|NCT02494583|561258554|FG002|Overall Study|Did Not Continue on Extension Study|4|||
155500808|NCT02494583|561258552|FG000|Overall Study|Withdrawal by Subject|7|||
155500809|NCT02494583|561258553|FG001|Overall Study|Withdrawal by Subject|15|||
155500810|NCT02494583|561258554|FG002|Overall Study|Withdrawal by Subject|15|||
155500811|NCT00627458|561258555|FG000|Overall Study|Migrated from study area|1|||
155500812|NCT00627458|561258556|FG001|Overall Study|Migrated from study area|0|||
155500813|NCT00627458|561258557|FG002|Overall Study|Migrated from study area|1|||
155500814|NCT00627458|561258555|FG000|Overall Study|Withdrawal by Subject|2|||
155500815|NCT00627458|561258556|FG001|Overall Study|Withdrawal by Subject|6|||
155500816|NCT00627458|561258557|FG002|Overall Study|Withdrawal by Subject|5|||
155500817|NCT00627458|561258555|FG000|Overall Study|Lost to Follow-up|1|||
155500818|NCT00627458|561258556|FG001|Overall Study|Lost to Follow-up|1|||
155500819|NCT00627458|561258557|FG002|Overall Study|Lost to Follow-up|0|||
155500820|NCT03891875|561258558|FG000|Overall Study|Withdrawal by Subject|20|||
155500821|NCT03891875|561258559|FG001|Overall Study|Withdrawal by Subject|3|||
155500822|NCT03891875|561258558|FG000|Overall Study|Adverse Event|10|||
155418872|NCT03969888|560963547|FG005|Overall Study|Reason Not Specified|0|||
155418873|NCT03969888|560963548|FG006|Overall Study|Reason Not Specified|0|||
155418874|NCT03969888|560963549|FG007|Overall Study|Reason Not Specified|1|||
155418875|NCT04506294|560963550|FG000|Overall Study|Lost to Follow-up|70|||
155317129|NCT04032704|560596155|FG006|Part A|Withdrawal by Subject|0|||
155317130|NCT04032704|560596156|FG007|Part A|Withdrawal by Subject|0|||
155317131|NCT04032704|560596157|FG008|Part A|Withdrawal by Subject|0|||
155418876|NCT04506294|560963551|FG001|Overall Study|Lost to Follow-up|20|||
155418877|NCT04506294|560963550|FG000|Overall Study|Withdrawal by Subject|16|||
155418878|NCT04506294|560963551|FG001|Overall Study|Withdrawal by Subject|2|||
155418879|NCT01469000|560963554|FG000|Overall Study|Withdrawal by Subject|16|||
155418880|NCT01469000|560963555|FG001|Overall Study|Withdrawal by Subject|3|||
155317132|NCT04032704|560596158|FG009|Part A|Withdrawal by Subject|0|||
155317133|NCT04032704|560596159|FG010|Part A|Withdrawal by Subject|0|||
155317134|NCT04032704|560596160|FG011|Part A|Withdrawal by Subject|0|||
155317135|NCT04032704|560596161|FG012|Part A|Withdrawal by Subject|0|||
155317136|NCT04032704|560596162|FG013|Part A|Withdrawal by Subject|0|||
155500823|NCT03891875|561258559|FG001|Overall Study|Adverse Event|4|||
155500824|NCT03891875|561258558|FG000|Overall Study|Physician Decision|1|||
155500825|NCT03891875|561258559|FG001|Overall Study|Physician Decision|1|||
155317137|NCT04032704|560596163|FG014|Part A|Withdrawal by Subject|0|||
155317138|NCT04032704|560596164|FG015|Part A|Withdrawal by Subject|0|||
155317139|NCT04032704|560596165|FG016|Part A|Withdrawal by Subject|0|||
155317140|NCT04032704|560596166|FG017|Part A|Withdrawal by Subject|0|||
155317141|NCT04032704|560596149|FG000|Part A|Lost to Follow-up|1|||
155317142|NCT04032704|560596150|FG001|Part A|Lost to Follow-up|0|||
155317143|NCT04032704|560596151|FG002|Part A|Lost to Follow-up|0|||
155317144|NCT04032704|560596152|FG003|Part A|Lost to Follow-up|0|||
155317145|NCT04032704|560596153|FG004|Part A|Lost to Follow-up|0|||
155317146|NCT04032704|560596154|FG005|Part A|Lost to Follow-up|0|||
155317147|NCT04032704|560596155|FG006|Part A|Lost to Follow-up|0|||
155317148|NCT04032704|560596156|FG007|Part A|Lost to Follow-up|0|||
155317149|NCT04032704|560596157|FG008|Part A|Lost to Follow-up|0|||
155317150|NCT04032704|560596158|FG009|Part A|Lost to Follow-up|0|||
155317151|NCT04032704|560596159|FG010|Part A|Lost to Follow-up|0|||
155317152|NCT04032704|560596160|FG011|Part A|Lost to Follow-up|0|||
155317153|NCT04032704|560596161|FG012|Part A|Lost to Follow-up|0|||
155317154|NCT04032704|560596162|FG013|Part A|Lost to Follow-up|0|||
155317155|NCT04032704|560596163|FG014|Part A|Lost to Follow-up|0|||
155317156|NCT04032704|560596164|FG015|Part A|Lost to Follow-up|0|||
155317157|NCT04032704|560596165|FG016|Part A|Lost to Follow-up|0|||
155317158|NCT04032704|560596166|FG017|Part A|Lost to Follow-up|0|||
155317159|NCT04032704|560596149|FG000|Part A|Death|9|||
155317160|NCT04032704|560596150|FG001|Part A|Death|2|||
155317161|NCT04032704|560596151|FG002|Part A|Death|10|||
155317162|NCT04032704|560596152|FG003|Part A|Death|7|||
155317163|NCT04032704|560596153|FG004|Part A|Death|4|||
155317164|NCT04032704|560596154|FG005|Part A|Death|5|||
155317165|NCT04032704|560596155|FG006|Part A|Death|0|||
155317166|NCT04032704|560596156|FG007|Part A|Death|0|||
155317167|NCT04032704|560596157|FG008|Part A|Death|0|||
155317168|NCT04032704|560596158|FG009|Part A|Death|0|||
155317169|NCT04032704|560596159|FG010|Part A|Death|0|||
155317170|NCT04032704|560596160|FG011|Part A|Death|0|||
155317171|NCT04032704|560596161|FG012|Part A|Death|0|||
155317172|NCT04032704|560596162|FG013|Part A|Death|0|||
155317173|NCT04032704|560596163|FG014|Part A|Death|0|||
155317174|NCT04032704|560596164|FG015|Part A|Death|0|||
155317175|NCT04032704|560596165|FG016|Part A|Death|0|||
155317176|NCT04032704|560596166|FG017|Part A|Death|0|||
155317177|NCT04032704|560596149|FG000|Part B|Other|0|||
155317178|NCT04032704|560596150|FG001|Part B|Other|0|||
155317179|NCT04032704|560596151|FG002|Part B|Other|0|||
155317180|NCT04032704|560596152|FG003|Part B|Other|0|||
155317181|NCT04032704|560596153|FG004|Part B|Other|0|||
155317182|NCT04032704|560596154|FG005|Part B|Other|0|||
155317183|NCT04032704|560596155|FG006|Part B|Other|0|||
155317184|NCT04032704|560596156|FG007|Part B|Other|1|||
155317185|NCT04032704|560596157|FG008|Part B|Other|2|||
155317186|NCT04032704|560596158|FG009|Part B|Other|1|||
155317187|NCT04032704|560596159|FG010|Part B|Other|1|||
155317188|NCT04032704|560596160|FG011|Part B|Other|1|||
155317189|NCT04032704|560596161|FG012|Part B|Other|5|||
155317190|NCT04032704|560596162|FG013|Part B|Other|13|||
155317191|NCT04032704|560596163|FG014|Part B|Other|0|||
155317192|NCT04032704|560596164|FG015|Part B|Other|0|||
155317193|NCT04032704|560596165|FG016|Part B|Other|0|||
155317194|NCT04032704|560596166|FG017|Part B|Other|0|||
155317195|NCT04032704|560596149|FG000|Part B|Study termination by Sponsor|0|||
155317196|NCT04032704|560596150|FG001|Part B|Study termination by Sponsor|0|||
155317197|NCT04032704|560596151|FG002|Part B|Study termination by Sponsor|0|||
155317198|NCT04032704|560596152|FG003|Part B|Study termination by Sponsor|0|||
155317199|NCT04032704|560596153|FG004|Part B|Study termination by Sponsor|0|||
155317200|NCT04032704|560596154|FG005|Part B|Study termination by Sponsor|0|||
155317201|NCT04032704|560596155|FG006|Part B|Study termination by Sponsor|0|||
155317202|NCT04032704|560596156|FG007|Part B|Study termination by Sponsor|0|||
155317203|NCT04032704|560596157|FG008|Part B|Study termination by Sponsor|1|||
155317204|NCT04032704|560596158|FG009|Part B|Study termination by Sponsor|0|||
155317205|NCT04032704|560596159|FG010|Part B|Study termination by Sponsor|0|||
155317206|NCT04032704|560596160|FG011|Part B|Study termination by Sponsor|0|||
155317207|NCT04032704|560596161|FG012|Part B|Study termination by Sponsor|0|||
155317208|NCT04032704|560596162|FG013|Part B|Study termination by Sponsor|0|||
155317209|NCT04032704|560596163|FG014|Part B|Study termination by Sponsor|0|||
155317210|NCT04032704|560596164|FG015|Part B|Study termination by Sponsor|0|||
155317211|NCT04032704|560596165|FG016|Part B|Study termination by Sponsor|0|||
155317212|NCT04032704|560596166|FG017|Part B|Study termination by Sponsor|0|||
155317213|NCT04032704|560596149|FG000|Part B|Withdrawal by Subject|0|||
155317214|NCT04032704|560596150|FG001|Part B|Withdrawal by Subject|0|||
155317215|NCT04032704|560596151|FG002|Part B|Withdrawal by Subject|0|||
155317216|NCT04032704|560596152|FG003|Part B|Withdrawal by Subject|0|||
155317217|NCT04032704|560596153|FG004|Part B|Withdrawal by Subject|0|||
155317218|NCT04032704|560596154|FG005|Part B|Withdrawal by Subject|0|||
155317219|NCT04032704|560596155|FG006|Part B|Withdrawal by Subject|3|||
155317220|NCT04032704|560596156|FG007|Part B|Withdrawal by Subject|2|||
155317221|NCT04032704|560596157|FG008|Part B|Withdrawal by Subject|2|||
155317222|NCT04032704|560596158|FG009|Part B|Withdrawal by Subject|1|||
155317223|NCT04032704|560596159|FG010|Part B|Withdrawal by Subject|4|||
155317224|NCT04032704|560596160|FG011|Part B|Withdrawal by Subject|6|||
155317225|NCT04032704|560596161|FG012|Part B|Withdrawal by Subject|2|||
155317226|NCT04032704|560596162|FG013|Part B|Withdrawal by Subject|1|||
155317227|NCT04032704|560596163|FG014|Part B|Withdrawal by Subject|0|||
155317228|NCT04032704|560596164|FG015|Part B|Withdrawal by Subject|1|||
155317229|NCT04032704|560596165|FG016|Part B|Withdrawal by Subject|0|||
155317230|NCT04032704|560596166|FG017|Part B|Withdrawal by Subject|0|||
155418881|NCT01469000|560963554|FG000|Overall Study|Sponsor Decision|4|||
155418882|NCT01469000|560963555|FG001|Overall Study|Sponsor Decision|1|||
155418883|NCT00769119|560963559|FG000|Overall Study|Voluntary discontinuation|0|||
155418884|NCT00769119|560963560|FG001|Overall Study|Voluntary discontinuation|2|||
155418885|NCT00769119|560963559|FG000|Overall Study|Adverse Event|1|||
155418886|NCT00769119|560963560|FG001|Overall Study|Adverse Event|1|||
155418887|NCT00769119|560963559|FG000|Overall Study|Disallowed medication|1|||
155418888|NCT00769119|560963560|FG001|Overall Study|Disallowed medication|0|||
155418889|NCT06228586|560963568|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
155418890|NCT06228586|560963569|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
155418891|NCT02949128|560965453|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
155418892|NCT02949128|560965453|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
155418893|NCT02949128|560965453|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
155418894|NCT02949128|560965453|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
155418895|NCT02949128|560965453|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
155418896|NCT02949128|560965453|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
155418897|NCT02949128|560965453|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
155418898|NCT02949128|560965453|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
155418899|NCT02949128|560965453|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
155418900|NCT02949128|560965453|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
155418901|NCT01602341|560965454|FG000|Overall Study|Adverse Event|0|||
155418902|NCT01602341|560965455|FG001|Overall Study|Adverse Event|1|||
155418903|NCT02152345|560965456|FG000|Overall Study|Case Cancellations|2|||
155418904|NCT02152345|560965457|FG001|Overall Study|Case Cancellations|4|||
155418905|NCT02152345|560965456|FG000|Overall Study|Withdrawal by Subject|2|||
155418906|NCT02152345|560965457|FG001|Overall Study|Withdrawal by Subject|1|||
155418907|NCT00483327|560965459|FG000|Overall Study|Adverse Event|1|||
155418908|NCT00483327|560965459|FG000|Overall Study|Withdrawal by Subject|3|||
155418909|NCT00483327|560965459|FG000|Overall Study|Lost to Follow-up|4|||
155418910|NCT00483327|560965459|FG000|Overall Study|Patient Non Compliance|2|||
155418911|NCT01390389|560965460|FG000|Overall Study|Withdrawal by Subject|2|||
155418912|NCT01390389|560965461|FG001|Overall Study|Withdrawal by Subject|0|||
155418913|NCT01390389|560965460|FG000|Overall Study|Screen Fail|2|||
155418914|NCT01390389|560965461|FG001|Overall Study|Screen Fail|1|||
155418915|NCT03593915|560965462|FG000|Overall Study|Adverse Event|0|||
155418916|NCT03593915|560965463|FG001|Overall Study|Adverse Event|0|||
155418917|NCT03593915|560965464|FG002|Overall Study|Adverse Event|0|||
155418918|NCT03593915|560965465|FG003|Overall Study|Adverse Event|1|||
155418919|NCT03593915|560965466|FG004|Overall Study|Adverse Event|0|||
155418920|NCT03593915|560965467|FG005|Overall Study|Adverse Event|0|||
155418921|NCT03593915|560965462|FG000|Overall Study|Physician Decision|0|||
155418922|NCT03593915|560965463|FG001|Overall Study|Physician Decision|0|||
155751083|NCT04533880|562188384|FG002|Overall Study|Lost to Follow-up|1|||
155751084|NCT02284178|562188385|FG000|Overall Study|Met exclusion criteria|49|||
155751085|NCT02284178|562188386|FG001|Overall Study|Met exclusion criteria|54|||
155317231|NCT04032704|560596149|FG000|Part B|Lost to Follow-up|0|||
155418923|NCT03593915|560965464|FG002|Overall Study|Physician Decision|0|||
155418924|NCT03593915|560965465|FG003|Overall Study|Physician Decision|0|||
155418925|NCT03593915|560965466|FG004|Overall Study|Physician Decision|0|||
155418926|NCT03593915|560965467|FG005|Overall Study|Physician Decision|1|||
155418927|NCT01583179|560965468|FG000|Overall Study|Screen failure|1|||
155418928|NCT01583179|560965469|FG001|Overall Study|Screen failure|2|||
155418929|NCT00772629|560965471|FG000|Overall Study|Subject was not vaccinated|1|||
155418930|NCT00772629|560965472|FG001|Overall Study|Subject was not vaccinated|0|||
155418931|NCT01171820|560965478|FG000|Overall Study|Death|3|||
155418932|NCT01171820|560965479|FG001|Overall Study|Death|3|||
155418933|NCT01171820|560965478|FG000|Overall Study|Lost to Follow-up|0|||
155418934|NCT01171820|560965479|FG001|Overall Study|Lost to Follow-up|1|||
155418935|NCT01171820|560965478|FG000|Overall Study|Withdrawal by Subject|2|||
155418936|NCT01171820|560965479|FG001|Overall Study|Withdrawal by Subject|0|||
155418937|NCT01171820|560965478|FG000|Overall Study|Physician Decision|0|||
155418938|NCT01171820|560965479|FG001|Overall Study|Physician Decision|1|||
155418939|NCT01171820|560965478|FG000|Overall Study|1-Year Missed Visit|1|||
155418940|NCT01171820|560965479|FG001|Overall Study|1-Year Missed Visit|1|||
155418941|NCT01871090|560965480|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
155418942|NCT01871090|560965481|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
155418943|NCT01871090|560965480|FG000|Overall Study|Interrogation not completed correctly|1|||
155751086|NCT04123665|562188387|FG000|Overall Study|Withdrawal by Subject|7|||
155317232|NCT04032704|560596150|FG001|Part B|Lost to Follow-up|0|||
155317233|NCT04032704|560596151|FG002|Part B|Lost to Follow-up|0|||
155317234|NCT04032704|560596152|FG003|Part B|Lost to Follow-up|0|||
155317235|NCT04032704|560596153|FG004|Part B|Lost to Follow-up|0|||
155317236|NCT04032704|560596154|FG005|Part B|Lost to Follow-up|0|||
155317237|NCT04032704|560596155|FG006|Part B|Lost to Follow-up|0|||
155317238|NCT04032704|560596156|FG007|Part B|Lost to Follow-up|0|||
155317239|NCT04032704|560596157|FG008|Part B|Lost to Follow-up|0|||
155317240|NCT04032704|560596158|FG009|Part B|Lost to Follow-up|0|||
155317241|NCT04032704|560596159|FG010|Part B|Lost to Follow-up|0|||
155317242|NCT04032704|560596160|FG011|Part B|Lost to Follow-up|1|||
155317243|NCT04032704|560596161|FG012|Part B|Lost to Follow-up|0|||
155317244|NCT04032704|560596162|FG013|Part B|Lost to Follow-up|0|||
155317245|NCT04032704|560596163|FG014|Part B|Lost to Follow-up|0|||
155317246|NCT04032704|560596164|FG015|Part B|Lost to Follow-up|0|||
155317247|NCT04032704|560596165|FG016|Part B|Lost to Follow-up|0|||
155317248|NCT04032704|560596166|FG017|Part B|Lost to Follow-up|0|||
155317249|NCT04032704|560596149|FG000|Part B|Death|0|||
155317250|NCT04032704|560596150|FG001|Part B|Death|0|||
155317251|NCT04032704|560596151|FG002|Part B|Death|0|||
155317252|NCT04032704|560596152|FG003|Part B|Death|0|||
155317253|NCT04032704|560596153|FG004|Part B|Death|0|||
155317254|NCT04032704|560596154|FG005|Part B|Death|0|||
155317255|NCT04032704|560596155|FG006|Part B|Death|13|||
155317256|NCT04032704|560596156|FG007|Part B|Death|13|||
155317257|NCT04032704|560596157|FG008|Part B|Death|14|||
155317258|NCT04032704|560596158|FG009|Part B|Death|12|||
155317259|NCT04032704|560596159|FG010|Part B|Death|12|||
155317260|NCT04032704|560596160|FG011|Part B|Death|13|||
155317261|NCT04032704|560596161|FG012|Part B|Death|7|||
155317262|NCT04032704|560596162|FG013|Part B|Death|17|||
155317263|NCT04032704|560596163|FG014|Part B|Death|2|||
155317264|NCT04032704|560596164|FG015|Part B|Death|1|||
155317265|NCT04032704|560596165|FG016|Part B|Death|2|||
155317266|NCT04032704|560596166|FG017|Part B|Death|2|||
155317267|NCT03133546|560596168|FG000|Overall Study|Death|46|||
155317268|NCT03133546|560596169|FG001|Overall Study|Death|43|||
155317269|NCT03133546|560596168|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
155317270|NCT03133546|560596169|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
155317271|NCT05034328|560596170|FG000|Overall Study|Protocol Violation|1|||
155317272|NCT05034328|560596171|FG001|Overall Study|Protocol Violation|0|||
155317273|NCT05034328|560596170|FG000|Overall Study|Lost to Follow-up|0|||
155317274|NCT05034328|560596171|FG001|Overall Study|Lost to Follow-up|10|||
155317275|NCT02993159|560596172|FG000|Overall Study|Withdrawal by Subject|1|||
155317276|NCT02993159|560596173|FG001|Overall Study|Withdrawal by Subject|3|||
155317277|NCT02993159|560596172|FG000|Overall Study|Protocol Violation|1|||
155317278|NCT02993159|560596173|FG001|Overall Study|Protocol Violation|0|||
155317279|NCT02993159|560596172|FG000|Overall Study|Opted out of surgery|2|||
155317280|NCT02993159|560596173|FG001|Overall Study|Opted out of surgery|0|||
155317281|NCT02993159|560596172|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
155317282|NCT02993159|560596173|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
155317283|NCT02993159|560596172|FG000|Overall Study|Physician Decision|0|||
155317284|NCT02993159|560596173|FG001|Overall Study|Physician Decision|1|||
155317285|NCT02231164|560596174|FG000|Overall Study|Adverse Event|1|||
155317286|NCT02231164|560596175|FG001|Overall Study|Adverse Event|1|||
155317287|NCT02231164|560596174|FG000|Overall Study|Lack of Efficacy|4|||
155317288|NCT02231164|560596175|FG001|Overall Study|Lack of Efficacy|3|||
155317289|NCT02231164|560596174|FG000|Overall Study|Withdrawal by Subject|1|||
155317290|NCT02231164|560596175|FG001|Overall Study|Withdrawal by Subject|2|||
155317291|NCT02969707|560596176|FG000|Overall Study|Withdrawal by Subject|6|||
155317292|NCT02969707|560596177|FG001|Overall Study|Withdrawal by Subject|5|||
155317293|NCT02969707|560596176|FG000|Overall Study|Severe anxiety|0|||
155317294|NCT02969707|560596177|FG001|Overall Study|Severe anxiety|1|||
155317295|NCT02969707|560596176|FG000|Overall Study|Positive toxicology screen|0|||
155317296|NCT02969707|560596177|FG001|Overall Study|Positive toxicology screen|2|||
155317297|NCT02969707|560596176|FG000|Overall Study|Claustrophobia|2|||
155317298|NCT02969707|560596177|FG001|Overall Study|Claustrophobia|2|||
155317299|NCT02969707|560596176|FG000|Overall Study|Non-compliance|1|||
155317300|NCT02969707|560596177|FG001|Overall Study|Non-compliance|2|||
155317301|NCT05583578|560596184|FG000|Overall Study|Withdrawal by Subject|2|||
155317302|NCT05583578|560596185|FG001|Overall Study|Withdrawal by Subject|0|||
155317303|NCT00248287|560596186|FG000|Overall Study|Adverse Event|11|||
155317304|NCT00248287|560596187|FG001|Overall Study|Adverse Event|10|||
155317305|NCT00248287|560596186|FG000|Overall Study|Death|1|||
155317306|NCT00248287|560596187|FG001|Overall Study|Death|0|||
155317307|NCT00248287|560596186|FG000|Overall Study|Lost to Follow-up|0|||
155317308|NCT00248287|560596187|FG001|Overall Study|Lost to Follow-up|1|||
155317309|NCT00248287|560596186|FG000|Overall Study|Investigator Request|4|||
155317310|NCT00248287|560596187|FG001|Overall Study|Investigator Request|3|||
155317311|NCT00248287|560596186|FG000|Overall Study|Patient Request|5|||
155317312|NCT00248287|560596187|FG001|Overall Study|Patient Request|3|||
155317313|NCT00248287|560596186|FG000|Overall Study|Other|3|||
155317314|NCT00248287|560596187|FG001|Overall Study|Other|2|||
155317315|NCT02714257|560596188|FG000|Overall Study|Withdrawal by Subject|6|||
155317316|NCT02714257|560596189|FG001|Overall Study|Withdrawal by Subject|11|||
155751087|NCT04123665|562188388|FG001|Overall Study|Withdrawal by Subject|0|||
155317317|NCT02714257|560596188|FG000|Overall Study|Death|3|||
155317318|NCT02714257|560596189|FG001|Overall Study|Death|4|||
155317319|NCT02714257|560596188|FG000|Overall Study|Lost to Follow-up|1|||
155317320|NCT02714257|560596189|FG001|Overall Study|Lost to Follow-up|6|||
155317321|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
155317322|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
155317323|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
155317324|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
155317325|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
155317326|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
155317327|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
155317328|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
155317329|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
155317330|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
155317331|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Other|3|||
155317332|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Other|3|||
155317333|NCT04103580|560596190|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
155317334|NCT04103580|560596191|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
155317335|NCT04103580|560596190|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
155317336|NCT04103580|560596191|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
155317337|NCT04103580|560596190|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
155317338|NCT04103580|560596191|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
155317339|NCT04103580|560596190|FG000|Phase 2 Bereavement|Other|8|||
155317340|NCT04103580|560596191|FG001|Phase 2 Bereavement|Other|6|||
155317341|NCT05808257|560596194|FG000|Overall Study|Lost to Follow-up|8|||
155317342|NCT05808257|560596195|FG001|Overall Study|Lost to Follow-up|8|||
155317343|NCT04568486|560596196|FG000|Overall Study|Withdrawal by Subject|26|||
155317344|NCT04568486|560596196|FG000|Overall Study|Lost to Follow-up|7|||
155317345|NCT04042233|560596197|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
155317346|NCT04042233|560596198|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
155317347|NCT04042233|560596197|FG000|Overall Study|Protocol Violation|0|||
155317348|NCT04042233|560596198|FG001|Overall Study|Protocol Violation|2|||
155317349|NCT04248725|560596212|FG000|Post-Treatment|Lost to Follow-up|6|||
155317350|NCT04248725|560596213|FG001|Post-Treatment|Lost to Follow-up|5|||
155317351|NCT04248725|560596212|FG000|6-Month Follow Up|Lost to Follow-up|9|||
155317352|NCT04248725|560596213|FG001|6-Month Follow Up|Lost to Follow-up|8|||
155317353|NCT04436276|560596216|FG000|Overall Study|Adverse Event|0|||
155317354|NCT04436276|560596217|FG001|Overall Study|Adverse Event|0|||
155317355|NCT04436276|560596218|FG002|Overall Study|Adverse Event|0|||
155317356|NCT04436276|560596219|FG003|Overall Study|Adverse Event|0|||
155317357|NCT04436276|560596220|FG004|Overall Study|Adverse Event|0|||
155317358|NCT04436276|560596221|FG005|Overall Study|Adverse Event|0|||
155317359|NCT04436276|560596222|FG006|Overall Study|Adverse Event|0|||
155317360|NCT04436276|560596223|FG007|Overall Study|Adverse Event|0|||
155317361|NCT04436276|560596224|FG008|Overall Study|Adverse Event|0|||
155317362|NCT04436276|560596225|FG009|Overall Study|Adverse Event|0|||
155317363|NCT04436276|560596226|FG010|Overall Study|Adverse Event|0|||
155317364|NCT04436276|560596227|FG011|Overall Study|Adverse Event|0|||
155317365|NCT04436276|560596228|FG012|Overall Study|Adverse Event|0|||
155317366|NCT04436276|560596229|FG013|Overall Study|Adverse Event|0|||
155317367|NCT04436276|560596230|FG014|Overall Study|Adverse Event|0|||
155317368|NCT04436276|560596231|FG015|Overall Study|Adverse Event|0|||
155317369|NCT04436276|560596232|FG016|Overall Study|Adverse Event|1|||
155418944|NCT01871090|560965481|FG001|Overall Study|Interrogation not completed correctly|0|||
155418945|NCT01871090|560965480|FG000|Overall Study|Subject Non-Compliance|0|||
155418946|NCT01871090|560965481|FG001|Overall Study|Subject Non-Compliance|1|||
155418947|NCT01307033|560965482|FG000|8-week Double-blind Period|Adverse Event|2|||
155418948|NCT01307033|560965483|FG001|8-week Double-blind Period|Adverse Event|0|||
155418949|NCT01307033|560965484|FG002|8-week Double-blind Period|Adverse Event|0|||
155418950|NCT01307033|560965485|FG003|8-week Double-blind Period|Adverse Event|0|||
155418951|NCT01307033|560965482|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
155418952|NCT01307033|560965483|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
155418953|NCT01307033|560965484|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
155500826|NCT03891875|561258558|FG000|Overall Study|Protocol Violation|1|||
155317370|NCT04436276|560596233|FG017|Overall Study|Adverse Event|0|||
155317371|NCT04436276|560596234|FG018|Overall Study|Adverse Event|0|||
155317372|NCT04436276|560596235|FG019|Overall Study|Adverse Event|0|||
155317373|NCT04436276|560596236|FG020|Overall Study|Adverse Event|0|||
155317374|NCT04436276|560596237|FG021|Overall Study|Adverse Event|0|||
155317375|NCT04436276|560596238|FG022|Overall Study|Adverse Event|0|||
155317376|NCT04436276|560596216|FG000|Overall Study|Death|0|||
155317377|NCT04436276|560596217|FG001|Overall Study|Death|0|||
155317378|NCT04436276|560596218|FG002|Overall Study|Death|0|||
155317379|NCT04436276|560596219|FG003|Overall Study|Death|0|||
155317380|NCT04436276|560596220|FG004|Overall Study|Death|0|||
155317381|NCT04436276|560596221|FG005|Overall Study|Death|0|||
155317382|NCT04436276|560596222|FG006|Overall Study|Death|0|||
155317383|NCT04436276|560596223|FG007|Overall Study|Death|0|||
155317384|NCT04436276|560596224|FG008|Overall Study|Death|0|||
155317385|NCT04436276|560596225|FG009|Overall Study|Death|0|||
155317386|NCT04436276|560596226|FG010|Overall Study|Death|0|||
155317387|NCT04436276|560596227|FG011|Overall Study|Death|0|||
155317388|NCT04436276|560596228|FG012|Overall Study|Death|1|||
155317389|NCT04436276|560596229|FG013|Overall Study|Death|0|||
155317390|NCT04436276|560596230|FG014|Overall Study|Death|1|||
155317391|NCT04436276|560596231|FG015|Overall Study|Death|0|||
155317392|NCT04436276|560596232|FG016|Overall Study|Death|0|||
155317393|NCT04436276|560596233|FG017|Overall Study|Death|0|||
155317394|NCT04436276|560596234|FG018|Overall Study|Death|0|||
155317395|NCT04436276|560596235|FG019|Overall Study|Death|2|||
155317396|NCT04436276|560596236|FG020|Overall Study|Death|0|||
155317397|NCT04436276|560596237|FG021|Overall Study|Death|1|||
155317398|NCT04436276|560596238|FG022|Overall Study|Death|0|||
155317399|NCT04436276|560596216|FG000|Overall Study|Lost to Follow-up|0|||
155317400|NCT04436276|560596217|FG001|Overall Study|Lost to Follow-up|2|||
155317401|NCT04436276|560596218|FG002|Overall Study|Lost to Follow-up|2|||
155317402|NCT04436276|560596219|FG003|Overall Study|Lost to Follow-up|1|||
155317403|NCT04436276|560596220|FG004|Overall Study|Lost to Follow-up|4|||
155317404|NCT04436276|560596221|FG005|Overall Study|Lost to Follow-up|1|||
155317405|NCT04436276|560596222|FG006|Overall Study|Lost to Follow-up|0|||
155317406|NCT04436276|560596223|FG007|Overall Study|Lost to Follow-up|0|||
155317407|NCT04436276|560596224|FG008|Overall Study|Lost to Follow-up|1|||
155317408|NCT04436276|560596225|FG009|Overall Study|Lost to Follow-up|0|||
155317409|NCT04436276|560596226|FG010|Overall Study|Lost to Follow-up|5|||
155317410|NCT04436276|560596227|FG011|Overall Study|Lost to Follow-up|5|||
155317411|NCT04436276|560596228|FG012|Overall Study|Lost to Follow-up|4|||
155317412|NCT04436276|560596229|FG013|Overall Study|Lost to Follow-up|1|||
155317413|NCT04436276|560596230|FG014|Overall Study|Lost to Follow-up|7|||
155317414|NCT04436276|560596231|FG015|Overall Study|Lost to Follow-up|7|||
155317415|NCT04436276|560596232|FG016|Overall Study|Lost to Follow-up|1|||
155317416|NCT04436276|560596233|FG017|Overall Study|Lost to Follow-up|0|||
155317417|NCT04436276|560596234|FG018|Overall Study|Lost to Follow-up|1|||
155317418|NCT04436276|560596235|FG019|Overall Study|Lost to Follow-up|1|||
155317419|NCT04436276|560596236|FG020|Overall Study|Lost to Follow-up|2|||
155317420|NCT04436276|560596237|FG021|Overall Study|Lost to Follow-up|1|||
155317421|NCT04436276|560596238|FG022|Overall Study|Lost to Follow-up|1|||
155317422|NCT04436276|560596216|FG000|Overall Study|Physician Decision|1|||
155317423|NCT04436276|560596217|FG001|Overall Study|Physician Decision|0|||
155317424|NCT04436276|560596218|FG002|Overall Study|Physician Decision|2|||
155317425|NCT04436276|560596219|FG003|Overall Study|Physician Decision|1|||
155418954|NCT01307033|560965485|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
155418955|NCT01307033|560965482|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
155418956|NCT01307033|560965483|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
155418957|NCT01307033|560965484|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
155418958|NCT01307033|560965485|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
155418959|NCT01307033|560965482|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
155418960|NCT01307033|560965483|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
155418961|NCT01307033|560965484|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
155418962|NCT01307033|560965485|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
155317426|NCT04436276|560596220|FG004|Overall Study|Physician Decision|0|||
155418963|NCT01307033|560965482|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
155418964|NCT01307033|560965483|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
155418965|NCT01307033|560965484|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
155418966|NCT01307033|560965485|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
155418967|NCT01307033|560965482|FG000|44-week Open-label Extension|Adverse Event|0|||
155418968|NCT01307033|560965483|FG001|44-week Open-label Extension|Adverse Event|0|||
155317427|NCT04436276|560596221|FG005|Overall Study|Physician Decision|0|||
155317428|NCT04436276|560596222|FG006|Overall Study|Physician Decision|0|||
155317429|NCT04436276|560596223|FG007|Overall Study|Physician Decision|0|||
155317430|NCT04436276|560596224|FG008|Overall Study|Physician Decision|0|||
155317431|NCT04436276|560596225|FG009|Overall Study|Physician Decision|0|||
155317432|NCT04436276|560596226|FG010|Overall Study|Physician Decision|0|||
155317433|NCT04436276|560596227|FG011|Overall Study|Physician Decision|1|||
155317434|NCT04436276|560596228|FG012|Overall Study|Physician Decision|2|||
155317435|NCT04436276|560596229|FG013|Overall Study|Physician Decision|0|||
155317436|NCT04436276|560596230|FG014|Overall Study|Physician Decision|0|||
155317437|NCT04436276|560596231|FG015|Overall Study|Physician Decision|0|||
155317438|NCT04436276|560596232|FG016|Overall Study|Physician Decision|0|||
155317439|NCT04436276|560596233|FG017|Overall Study|Physician Decision|0|||
155317440|NCT04436276|560596234|FG018|Overall Study|Physician Decision|0|||
155317441|NCT04436276|560596235|FG019|Overall Study|Physician Decision|0|||
155317442|NCT04436276|560596236|FG020|Overall Study|Physician Decision|1|||
155317443|NCT04436276|560596237|FG021|Overall Study|Physician Decision|2|||
155317444|NCT04436276|560596238|FG022|Overall Study|Physician Decision|0|||
155317445|NCT04436276|560596216|FG000|Overall Study|Protocol Violation|0|||
155317446|NCT04436276|560596217|FG001|Overall Study|Protocol Violation|0|||
155317447|NCT04436276|560596218|FG002|Overall Study|Protocol Violation|0|||
155317448|NCT04436276|560596219|FG003|Overall Study|Protocol Violation|0|||
155317449|NCT04436276|560596220|FG004|Overall Study|Protocol Violation|0|||
155317450|NCT04436276|560596221|FG005|Overall Study|Protocol Violation|0|||
155317451|NCT04436276|560596222|FG006|Overall Study|Protocol Violation|0|||
155317452|NCT04436276|560596223|FG007|Overall Study|Protocol Violation|0|||
155317453|NCT04436276|560596224|FG008|Overall Study|Protocol Violation|0|||
155317454|NCT04436276|560596225|FG009|Overall Study|Protocol Violation|0|||
155317455|NCT04436276|560596226|FG010|Overall Study|Protocol Violation|0|||
155317456|NCT04436276|560596227|FG011|Overall Study|Protocol Violation|0|||
155317457|NCT04436276|560596228|FG012|Overall Study|Protocol Violation|0|||
155317458|NCT04436276|560596229|FG013|Overall Study|Protocol Violation|1|||
155317459|NCT04436276|560596230|FG014|Overall Study|Protocol Violation|0|||
155317460|NCT04436276|560596231|FG015|Overall Study|Protocol Violation|1|||
155317461|NCT04436276|560596232|FG016|Overall Study|Protocol Violation|0|||
155317462|NCT04436276|560596233|FG017|Overall Study|Protocol Violation|0|||
155317463|NCT04436276|560596234|FG018|Overall Study|Protocol Violation|0|||
155317464|NCT04436276|560596235|FG019|Overall Study|Protocol Violation|0|||
155317465|NCT04436276|560596236|FG020|Overall Study|Protocol Violation|0|||
155317466|NCT04436276|560596237|FG021|Overall Study|Protocol Violation|0|||
155317467|NCT04436276|560596238|FG022|Overall Study|Protocol Violation|0|||
155317468|NCT04436276|560596216|FG000|Overall Study|Withdrawal by Subject|25|||
155317469|NCT04436276|560596217|FG001|Overall Study|Withdrawal by Subject|22|||
155317470|NCT04436276|560596218|FG002|Overall Study|Withdrawal by Subject|24|||
155317471|NCT04436276|560596219|FG003|Overall Study|Withdrawal by Subject|23|||
155317472|NCT04436276|560596220|FG004|Overall Study|Withdrawal by Subject|14|||
155317473|NCT04436276|560596221|FG005|Overall Study|Withdrawal by Subject|0|||
155317474|NCT04436276|560596222|FG006|Overall Study|Withdrawal by Subject|0|||
155317475|NCT04436276|560596223|FG007|Overall Study|Withdrawal by Subject|1|||
155317476|NCT04436276|560596224|FG008|Overall Study|Withdrawal by Subject|0|||
155317477|NCT04436276|560596225|FG009|Overall Study|Withdrawal by Subject|1|||
155317478|NCT04436276|560596226|FG010|Overall Study|Withdrawal by Subject|17|||
155317479|NCT04436276|560596227|FG011|Overall Study|Withdrawal by Subject|7|||
155317480|NCT04436276|560596228|FG012|Overall Study|Withdrawal by Subject|10|||
155317481|NCT04436276|560596229|FG013|Overall Study|Withdrawal by Subject|6|||
155317482|NCT04436276|560596230|FG014|Overall Study|Withdrawal by Subject|20|||
155317483|NCT04436276|560596231|FG015|Overall Study|Withdrawal by Subject|6|||
155317484|NCT04436276|560596232|FG016|Overall Study|Withdrawal by Subject|11|||
155317485|NCT04436276|560596233|FG017|Overall Study|Withdrawal by Subject|4|||
155317486|NCT04436276|560596234|FG018|Overall Study|Withdrawal by Subject|14|||
155317487|NCT04436276|560596235|FG019|Overall Study|Withdrawal by Subject|24|||
155317488|NCT04436276|560596236|FG020|Overall Study|Withdrawal by Subject|24|||
155317489|NCT04436276|560596237|FG021|Overall Study|Withdrawal by Subject|16|||
155317490|NCT04436276|560596238|FG022|Overall Study|Withdrawal by Subject|14|||
155317491|NCT04436276|560596216|FG000|Overall Study|Other|3|||
155317492|NCT04436276|560596217|FG001|Overall Study|Other|2|||
155317493|NCT04436276|560596218|FG002|Overall Study|Other|5|||
155317494|NCT04436276|560596219|FG003|Overall Study|Other|9|||
155317495|NCT04436276|560596220|FG004|Overall Study|Other|23|||
155317496|NCT04436276|560596221|FG005|Overall Study|Other|1|||
155317497|NCT04436276|560596222|FG006|Overall Study|Other|0|||
155317498|NCT04436276|560596223|FG007|Overall Study|Other|0|||
155317499|NCT04436276|560596224|FG008|Overall Study|Other|0|||
155317500|NCT04436276|560596225|FG009|Overall Study|Other|0|||
155418969|NCT01307033|560965484|FG002|44-week Open-label Extension|Adverse Event|2|||
155418970|NCT01307033|560965485|FG003|44-week Open-label Extension|Adverse Event|1|||
155418971|NCT01307033|560965482|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
155418972|NCT01307033|560965483|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
155418973|NCT01307033|560965484|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
155418974|NCT01307033|560965485|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
155418975|NCT01307033|560965482|FG000|44-week Open-label Extension|Physician Decision|0|||
155418976|NCT01307033|560965483|FG001|44-week Open-label Extension|Physician Decision|0|||
155418977|NCT01307033|560965484|FG002|44-week Open-label Extension|Physician Decision|1|||
155418978|NCT01307033|560965485|FG003|44-week Open-label Extension|Physician Decision|0|||
155500827|NCT03891875|561258559|FG001|Overall Study|Protocol Violation|0|||
155317501|NCT04436276|560596226|FG010|Overall Study|Other|3|||
155317502|NCT04436276|560596227|FG011|Overall Study|Other|1|||
155317503|NCT04436276|560596228|FG012|Overall Study|Other|1|||
155317504|NCT04436276|560596229|FG013|Overall Study|Other|2|||
155317505|NCT04436276|560596230|FG014|Overall Study|Other|3|||
155317506|NCT04436276|560596231|FG015|Overall Study|Other|0|||
155317507|NCT04436276|560596232|FG016|Overall Study|Other|0|||
155317508|NCT04436276|560596233|FG017|Overall Study|Other|6|||
155317509|NCT04436276|560596234|FG018|Overall Study|Other|1|||
155317510|NCT04436276|560596235|FG019|Overall Study|Other|0|||
155317511|NCT04436276|560596236|FG020|Overall Study|Other|2|||
155317512|NCT04436276|560596237|FG021|Overall Study|Other|2|||
155317513|NCT04436276|560596238|FG022|Overall Study|Other|60|||
155317514|NCT05977530|560596252|FG000|Overall Study|Withdrawal by Subject|1|||
155317515|NCT05977530|560596252|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
155317516|NCT04524442|560596253|FG000|Overall Study|Subject Decision|1|||
155317517|NCT03819153|560596256|FG000|Overall Study|Withdrawal by Subject|20|||
155317518|NCT03819153|560596257|FG001|Overall Study|Withdrawal by Subject|28|||
155317519|NCT03819153|560596256|FG000|Overall Study|Lost to Follow-up|23|||
155317520|NCT03819153|560596257|FG001|Overall Study|Lost to Follow-up|30|||
155317521|NCT03974178|560596263|FG000|Overall Study|Death|0|||
155317522|NCT03974178|560596264|FG001|Overall Study|Death|1|||
155317523|NCT04880863|560596268|FG000|Overall Study|Adverse Event|1|||
155317524|NCT04880863|560596268|FG000|Overall Study|Patient decision|2|||
155317525|NCT04880863|560596268|FG000|Overall Study|Confirmed Disease Progression|15|||
155317526|NCT04880863|560596268|FG000|Overall Study|Death|3|||
155317527|NCT04880863|560596268|FG000|Overall Study|Physician Decision|4|||
155317528|NCT04880863|560596268|FG000|Overall Study|Unconfirmed Disease Progression|4|||
155317529|NCT04880863|560596268|FG000|Overall Study|Withdrawal by Subject|2|||
155317530|NCT04880863|560596268|FG000|Overall Study|Study discontinuation by the sponsor|4|||
155317531|NCT04880863|560596268|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
155317532|NCT04880863|560596268|FG000|Overall Study|Not received study drug NAP|2|||
155317533|NCT03899259|560596269|FG000|Overall Study|Adverse Event|5|||
155317534|NCT03899259|560596270|FG001|Overall Study|Adverse Event|4|||
155317535|NCT03899259|560596271|FG002|Overall Study|Adverse Event|6|||
155317536|NCT03899259|560596269|FG000|Overall Study|Lack of Efficacy|5|||
155317537|NCT03899259|560596270|FG001|Overall Study|Lack of Efficacy|0|||
155317538|NCT03899259|560596271|FG002|Overall Study|Lack of Efficacy|2|||
155317539|NCT03899259|560596269|FG000|Overall Study|Pregnancy|3|||
155317540|NCT03899259|560596270|FG001|Overall Study|Pregnancy|0|||
155317541|NCT03899259|560596271|FG002|Overall Study|Pregnancy|1|||
155317542|NCT03899259|560596269|FG000|Overall Study|Physician Decision|0|||
155317543|NCT03899259|560596270|FG001|Overall Study|Physician Decision|1|||
155317544|NCT03899259|560596271|FG002|Overall Study|Physician Decision|0|||
155317545|NCT03899259|560596269|FG000|Overall Study|Protocol Deviation|1|||
155317546|NCT03899259|560596270|FG001|Overall Study|Protocol Deviation|1|||
155317547|NCT03899259|560596271|FG002|Overall Study|Protocol Deviation|1|||
155317548|NCT03899259|560596269|FG000|Overall Study|Withdrawal by Subject|8|||
155317549|NCT03899259|560596270|FG001|Overall Study|Withdrawal by Subject|10|||
155317550|NCT03899259|560596271|FG002|Overall Study|Withdrawal by Subject|12|||
155317551|NCT03899259|560596269|FG000|Overall Study|Lost to Follow-up|5|||
155317552|NCT03899259|560596270|FG001|Overall Study|Lost to Follow-up|6|||
155317553|NCT03899259|560596271|FG002|Overall Study|Lost to Follow-up|2|||
155317554|NCT03899259|560596269|FG000|Overall Study|Lack of Adherence|1|||
155317555|NCT03899259|560596270|FG001|Overall Study|Lack of Adherence|0|||
155317556|NCT03899259|560596271|FG002|Overall Study|Lack of Adherence|0|||
155317557|NCT03899259|560596269|FG000|Overall Study|Screen Failure|1|||
155317558|NCT03899259|560596270|FG001|Overall Study|Screen Failure|0|||
155317559|NCT03899259|560596271|FG002|Overall Study|Screen Failure|0|||
155317560|NCT03899259|560596269|FG000|Overall Study|Ongoing Study Participation|127|||
155317561|NCT03899259|560596270|FG001|Overall Study|Ongoing Study Participation|134|||
155643291|NCT02323334|561783779|FG013|Period 3|Withdrawal by Subject|0|||
155643292|NCT02323334|561783780|FG014|Period 3|Withdrawal by Subject|0|||
155317562|NCT03899259|560596271|FG002|Overall Study|Ongoing Study Participation|210|||
155317563|NCT04508309|560596272|FG000|Overall Study|Death|0|||
155317564|NCT04508309|560596273|FG001|Overall Study|Death|0|||
155317565|NCT04508309|560596274|FG002|Overall Study|Death|0|||
155317566|NCT04508309|560596275|FG003|Overall Study|Death|0|||
155317567|NCT04508309|560596276|FG004|Overall Study|Death|1|||
155317568|NCT04508309|560596272|FG000|Overall Study|Lost to Follow-up|0|||
155317569|NCT04508309|560596273|FG001|Overall Study|Lost to Follow-up|0|||
155317570|NCT04508309|560596274|FG002|Overall Study|Lost to Follow-up|1|||
155317571|NCT04508309|560596275|FG003|Overall Study|Lost to Follow-up|1|||
155317572|NCT04508309|560596276|FG004|Overall Study|Lost to Follow-up|0|||
155317573|NCT04508309|560596272|FG000|Overall Study|Withdrawal by Subject|0|||
155317574|NCT04508309|560596273|FG001|Overall Study|Withdrawal by Subject|0|||
155317575|NCT04508309|560596274|FG002|Overall Study|Withdrawal by Subject|0|||
155643293|NCT02323334|561783781|FG015|Period 3|Withdrawal by Subject|0|||
155643294|NCT02323334|561783782|FG016|Period 3|Withdrawal by Subject|0|||
155643295|NCT00266812|561783783|FG000|Overall Study|Disease Progression|9|||
155317576|NCT04508309|560596275|FG003|Overall Study|Withdrawal by Subject|0|||
155317577|NCT04508309|560596276|FG004|Overall Study|Withdrawal by Subject|1|||
155317578|NCT03058289|560596277|FG000|Overall Study|Radiographic Deterioration|0|||
155317579|NCT03058289|560596278|FG001|Overall Study|Radiographic Deterioration|3|||
155317580|NCT03058289|560596279|FG002|Overall Study|Radiographic Deterioration|1|||
155317581|NCT03058289|560596280|FG003|Overall Study|Radiographic Deterioration|2|||
155317582|NCT03058289|560596281|FG004|Overall Study|Radiographic Deterioration|6|||
155317583|NCT03058289|560596282|FG005|Overall Study|Radiographic Deterioration|3|||
155317584|NCT03058289|560596283|FG006|Overall Study|Radiographic Deterioration|0|||
155317585|NCT03058289|560596284|FG007|Overall Study|Radiographic Deterioration|4|||
155317586|NCT03058289|560596285|FG008|Overall Study|Radiographic Deterioration|2|||
155317587|NCT03058289|560596277|FG000|Overall Study|Adverse Event|2|||
155317588|NCT03058289|560596278|FG001|Overall Study|Adverse Event|0|||
155317589|NCT03058289|560596279|FG002|Overall Study|Adverse Event|1|||
155317590|NCT03058289|560596280|FG003|Overall Study|Adverse Event|3|||
155317591|NCT03058289|560596281|FG004|Overall Study|Adverse Event|1|||
155317592|NCT03058289|560596282|FG005|Overall Study|Adverse Event|0|||
155317593|NCT03058289|560596283|FG006|Overall Study|Adverse Event|1|||
155317594|NCT03058289|560596284|FG007|Overall Study|Adverse Event|3|||
155317595|NCT03058289|560596285|FG008|Overall Study|Adverse Event|0|||
155317596|NCT03058289|560596277|FG000|Overall Study|Withdrawal by Subject|0|||
155317597|NCT03058289|560596278|FG001|Overall Study|Withdrawal by Subject|0|||
155317598|NCT03058289|560596279|FG002|Overall Study|Withdrawal by Subject|0|||
155317599|NCT03058289|560596280|FG003|Overall Study|Withdrawal by Subject|2|||
155317600|NCT03058289|560596281|FG004|Overall Study|Withdrawal by Subject|0|||
155317601|NCT03058289|560596282|FG005|Overall Study|Withdrawal by Subject|2|||
155317602|NCT03058289|560596283|FG006|Overall Study|Withdrawal by Subject|0|||
155317603|NCT03058289|560596284|FG007|Overall Study|Withdrawal by Subject|4|||
155317604|NCT03058289|560596285|FG008|Overall Study|Withdrawal by Subject|1|||
155317605|NCT03058289|560596277|FG000|Overall Study|Physician Decision|1|||
155317606|NCT03058289|560596278|FG001|Overall Study|Physician Decision|0|||
155317607|NCT03058289|560596279|FG002|Overall Study|Physician Decision|0|||
155317608|NCT03058289|560596280|FG003|Overall Study|Physician Decision|2|||
155317609|NCT03058289|560596281|FG004|Overall Study|Physician Decision|1|||
155317610|NCT03058289|560596282|FG005|Overall Study|Physician Decision|0|||
155317611|NCT03058289|560596283|FG006|Overall Study|Physician Decision|2|||
155317612|NCT03058289|560596284|FG007|Overall Study|Physician Decision|3|||
155317613|NCT03058289|560596285|FG008|Overall Study|Physician Decision|0|||
155317614|NCT03058289|560596277|FG000|Overall Study|Clinical Deterioration|2|||
155317615|NCT03058289|560596278|FG001|Overall Study|Clinical Deterioration|0|||
155317616|NCT03058289|560596279|FG002|Overall Study|Clinical Deterioration|0|||
155317617|NCT03058289|560596280|FG003|Overall Study|Clinical Deterioration|2|||
155317618|NCT03058289|560596281|FG004|Overall Study|Clinical Deterioration|1|||
155317619|NCT03058289|560596282|FG005|Overall Study|Clinical Deterioration|1|||
155317620|NCT03058289|560596283|FG006|Overall Study|Clinical Deterioration|0|||
155317621|NCT03058289|560596284|FG007|Overall Study|Clinical Deterioration|3|||
155317622|NCT03058289|560596285|FG008|Overall Study|Clinical Deterioration|2|||
155317623|NCT03058289|560596277|FG000|Overall Study|Lost to Follow-up|0|||
155317624|NCT03058289|560596278|FG001|Overall Study|Lost to Follow-up|0|||
155317625|NCT03058289|560596279|FG002|Overall Study|Lost to Follow-up|0|||
155317626|NCT03058289|560596280|FG003|Overall Study|Lost to Follow-up|0|||
155317627|NCT03058289|560596281|FG004|Overall Study|Lost to Follow-up|1|||
155317628|NCT03058289|560596282|FG005|Overall Study|Lost to Follow-up|0|||
155317629|NCT03058289|560596283|FG006|Overall Study|Lost to Follow-up|0|||
155317630|NCT03058289|560596284|FG007|Overall Study|Lost to Follow-up|0|||
155317631|NCT03058289|560596285|FG008|Overall Study|Lost to Follow-up|0|||
155317632|NCT03058289|560596277|FG000|Overall Study|Refused Further Treatment|0|||
155317633|NCT03058289|560596278|FG001|Overall Study|Refused Further Treatment|0|||
155317634|NCT03058289|560596279|FG002|Overall Study|Refused Further Treatment|1|||
155317635|NCT03058289|560596280|FG003|Overall Study|Refused Further Treatment|0|||
155317636|NCT03058289|560596281|FG004|Overall Study|Refused Further Treatment|1|||
155317637|NCT03058289|560596282|FG005|Overall Study|Refused Further Treatment|0|||
155317638|NCT03058289|560596283|FG006|Overall Study|Refused Further Treatment|0|||
155317639|NCT03058289|560596284|FG007|Overall Study|Refused Further Treatment|0|||
155317640|NCT03058289|560596285|FG008|Overall Study|Refused Further Treatment|0|||
155317641|NCT03058289|560596277|FG000|Overall Study|Rapid Progression of Disease|0|||
155317642|NCT03058289|560596278|FG001|Overall Study|Rapid Progression of Disease|0|||
155317643|NCT03058289|560596279|FG002|Overall Study|Rapid Progression of Disease|0|||
155317644|NCT03058289|560596280|FG003|Overall Study|Rapid Progression of Disease|1|||
155317645|NCT03058289|560596281|FG004|Overall Study|Rapid Progression of Disease|0|||
155317646|NCT03058289|560596282|FG005|Overall Study|Rapid Progression of Disease|0|||
155317647|NCT03058289|560596283|FG006|Overall Study|Rapid Progression of Disease|0|||
155317648|NCT03058289|560596284|FG007|Overall Study|Rapid Progression of Disease|0|||
155317649|NCT03058289|560596285|FG008|Overall Study|Rapid Progression of Disease|0|||
155317650|NCT05239455|560596291|FG000|Overall Study|Adverse Event|1|||
155317651|NCT05239455|560596291|FG000|Overall Study|Sponsor Decision|5|||
155317652|NCT05239455|560596291|FG000|Overall Study|Incomplete Blood Collection|1|||
155317653|NCT06182033|560596292|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
155317654|NCT06182033|560596293|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
155317655|NCT06182033|560596292|FG000|Overall Study|Target child relocation|1|||
155317656|NCT06182033|560596293|FG001|Overall Study|Target child relocation|1|||
155317657|NCT06182033|560596292|FG000|Overall Study|Withdrawal by Subject|1|||
155317658|NCT06182033|560596293|FG001|Overall Study|Withdrawal by Subject|0|||
155317659|NCT05623228|560596298|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
155317660|NCT05623228|560596299|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317661|NCT05623228|560596300|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317662|NCT05623228|560596301|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317663|NCT05623228|560596302|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317664|NCT05623228|560596303|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317665|NCT05623228|560596304|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317666|NCT05623228|560596305|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317667|NCT05623228|560596298|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317668|NCT05623228|560596299|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317669|NCT05623228|560596300|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317670|NCT05623228|560596301|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317671|NCT05623228|560596302|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317672|NCT05623228|560596303|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317673|NCT05623228|560596304|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317674|NCT05623228|560596305|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317675|NCT01129102|560597770|FG000|Overall Study|No study drug treatment|2|||
155317676|NCT01129102|560597771|FG001|Overall Study|No study drug treatment|3|||
155317677|NCT01129102|560597772|FG002|Overall Study|No study drug treatment|1|||
155317678|NCT01129102|560597770|FG000|Overall Study|Withdrawal by Subject|2|||
155317679|NCT01129102|560597771|FG001|Overall Study|Withdrawal by Subject|0|||
155317680|NCT01129102|560597772|FG002|Overall Study|Withdrawal by Subject|3|||
155317681|NCT01129102|560597770|FG000|Overall Study|Protocol Violation|0|||
155317682|NCT01129102|560597771|FG001|Overall Study|Protocol Violation|1|||
155317683|NCT01129102|560597772|FG002|Overall Study|Protocol Violation|1|||
155317684|NCT01129102|560597770|FG000|Overall Study|Pregnancy|0|||
155317685|NCT01129102|560597771|FG001|Overall Study|Pregnancy|0|||
155317686|NCT01129102|560597772|FG002|Overall Study|Pregnancy|1|||
155317687|NCT01129102|560597770|FG000|Overall Study|Adverse Event|2|||
155317688|NCT01129102|560597771|FG001|Overall Study|Adverse Event|2|||
155317689|NCT01129102|560597772|FG002|Overall Study|Adverse Event|1|||
155317690|NCT01129102|560597770|FG000|Overall Study|Lost to Follow-up|2|||
155317691|NCT01129102|560597771|FG001|Overall Study|Lost to Follow-up|0|||
155317692|NCT01129102|560597772|FG002|Overall Study|Lost to Follow-up|0|||
155317693|NCT03379675|560597775|FG000|Overall Study|Lost to Follow-up|0|||
155317694|NCT03379675|560597776|FG001|Overall Study|Lost to Follow-up|1|||
155317695|NCT03379675|560597777|FG002|Overall Study|Lost to Follow-up|0|||
155317696|NCT03379675|560597775|FG000|Overall Study|Adverse Event|2|||
155317697|NCT03379675|560597776|FG001|Overall Study|Adverse Event|0|||
155317698|NCT03379675|560597777|FG002|Overall Study|Adverse Event|0|||
155317699|NCT03379675|560597775|FG000|Overall Study|Withdrawal by Subject|2|||
155317700|NCT03379675|560597776|FG001|Overall Study|Withdrawal by Subject|1|||
155317701|NCT03379675|560597777|FG002|Overall Study|Withdrawal by Subject|2|||
155317702|NCT02817776|560597778|FG000|Overall Study|Excluded|33|||
155317703|NCT02817776|560597778|FG000|Overall Study|Lost to Follow-up|20|||
155317704|NCT02817776|560597778|FG000|Overall Study|Withdrawal by Subject|33|||
155317705|NCT02817776|560597778|FG000|Overall Study|Death|2|||
155317706|NCT03381196|560597783|FG000|Overall Study|Withdrawal by Subject|7|||
155317707|NCT03381196|560597784|FG001|Overall Study|Withdrawal by Subject|7|||
155317708|NCT03381196|560597783|FG000|Overall Study|Other|0|||
155317709|NCT03381196|560597784|FG001|Overall Study|Other|1|||
155317710|NCT03381196|560597783|FG000|Overall Study|Lost to Follow-up|5|||
155418979|NCT01307033|560965482|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
155418980|NCT01307033|560965483|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
155317711|NCT03381196|560597784|FG001|Overall Study|Lost to Follow-up|4|||
155317712|NCT03381196|560597783|FG000|Overall Study|Death|0|||
155317713|NCT03381196|560597784|FG001|Overall Study|Death|1|||
155317714|NCT03381196|560597783|FG000|Overall Study|Adverse Event|1|||
155418981|NCT01307033|560965484|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
155418982|NCT01307033|560965485|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
155317715|NCT03381196|560597784|FG001|Overall Study|Adverse Event|0|||
155317716|NCT03381196|560597783|FG000|Overall Study|Randomized, not treated|3|||
155317717|NCT03381196|560597784|FG001|Overall Study|Randomized, not treated|6|||
155418983|NCT01307033|560965482|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
155418984|NCT01307033|560965483|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
155418985|NCT01307033|560965484|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
155418986|NCT01307033|560965485|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
155418987|NCT01307033|560965482|FG000|44-week Open-label Extension|Death|0|||
155317718|NCT02359890|560597786|FG000|Overall Study|Not meeting eligibility|4|||
155317719|NCT02359890|560597786|FG000|Overall Study|Never treated with study catheter|6|||
155317720|NCT01574274|560597791|FG000|Overall Study|Ineligible|0|||
155317721|NCT01574274|560597792|FG001|Overall Study|Ineligible|1|||
155317722|NCT01574274|560597791|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
155317723|NCT01574274|560597792|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
155317724|NCT01574274|560597791|FG000|Overall Study|Ph+ B-ALL|3|||
155500828|NCT03891875|561258558|FG000|Overall Study|Lost to Follow-up|1|||
155500829|NCT03891875|561258559|FG001|Overall Study|Lost to Follow-up|0|||
155317725|NCT01574274|560597792|FG001|Overall Study|Ph+ B-ALL|4|||
155317726|NCT01574274|560597791|FG000|Overall Study|Induction Death|2|||
155317727|NCT01574274|560597792|FG001|Overall Study|Induction Death|0|||
155317728|NCT01574274|560597791|FG000|Overall Study|Induction Failure|4|||
155317729|NCT01574274|560597792|FG001|Overall Study|Induction Failure|1|||
155317730|NCT01574274|560597791|FG000|Overall Study|Adverse Event|16|||
155317731|NCT01574274|560597792|FG001|Overall Study|Adverse Event|13|||
155317732|NCT01574274|560597791|FG000|Overall Study|Remission Death|1|||
155317733|NCT01574274|560597792|FG001|Overall Study|Remission Death|0|||
155317734|NCT01574274|560597791|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
155317735|NCT01574274|560597792|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
155317736|NCT01574274|560597791|FG000|Overall Study|Other, unknown|3|||
155317737|NCT01574274|560597792|FG001|Overall Study|Other, unknown|2|||
155317738|NCT03907878|560597803|FG000|Treatment Period|Withdrawal by Subject|5|||
155317739|NCT03907878|560597803|FG000|Treatment Period|Adverse Event|4|||
155317740|NCT03907878|560597803|FG000|Treatment Period|Lack of Efficacy|1|||
155317741|NCT03907878|560597803|FG000|Treatment Period|Protocol Violation|1|||
155317742|NCT03907878|560597803|FG000|Follow-up Period|Adverse Event|3|||
155317743|NCT03907878|560597803|FG000|Follow-up Period|Withdrawal by Subject|3|||
155317744|NCT03904147|560597808|FG000|Overall Study|Death|15|||
155317745|NCT03904147|560597809|FG001|Overall Study|Death|13|||
155500830|NCT03891875|561258558|FG000|Overall Study|COVID-19 infection|1|||
155500831|NCT03891875|561258559|FG001|Overall Study|COVID-19 infection|0|||
155317746|NCT03904147|560597810|FG002|Overall Study|Death|15|||
155317747|NCT03904147|560597808|FG000|Overall Study|Withdrawal by Subject|7|||
155317748|NCT03904147|560597809|FG001|Overall Study|Withdrawal by Subject|12|||
155317749|NCT03904147|560597810|FG002|Overall Study|Withdrawal by Subject|1|||
155317750|NCT03904147|560597808|FG000|Overall Study|1Y visit completed after 365 days|1|||
155317751|NCT03904147|560597809|FG001|Overall Study|1Y visit completed after 365 days|1|||
155317752|NCT03904147|560597810|FG002|Overall Study|1Y visit completed after 365 days|0|||
155317753|NCT03625167|560597812|FG000|Overall Study|Protocol Violation|5|||
155317754|NCT06103188|560597813|FG000|Overall Study|Lost to Follow-up|1|||
155317755|NCT06103188|560597814|FG001|Overall Study|Lost to Follow-up|6|||
155317756|NCT06103188|560597815|FG002|Overall Study|Lost to Follow-up|4|||
155500832|NCT01787188|561258560|FG000|Overall Study|Adverse Event|2|||
155500833|NCT01787188|561258561|FG001|Overall Study|Adverse Event|4|||
155317757|NCT04145440|560597818|FG000|Overall Study|Physician Decision|3|||
155317758|NCT04145440|560597819|FG001|Overall Study|Physician Decision|0|||
155317759|NCT04145440|560597818|FG000|Overall Study|Use of prohibited therapy|2|||
155317760|NCT04145440|560597819|FG001|Overall Study|Use of prohibited therapy|3|||
155317761|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
155317762|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
155317763|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
155317764|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
155317765|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
155317766|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155317767|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
155317768|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
155317769|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155317770|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155500834|NCT01787188|561258562|FG002|Overall Study|Adverse Event|6|||
155500835|NCT01787188|561258560|FG000|Overall Study|Lack of Efficacy|7|||
155500836|NCT01787188|561258561|FG001|Overall Study|Lack of Efficacy|3|||
155500837|NCT01787188|561258562|FG002|Overall Study|Lack of Efficacy|5|||
155751088|NCT04123665|562188387|FG000|Overall Study|Lost to Follow-up|1|||
155751089|NCT04123665|562188388|FG001|Overall Study|Lost to Follow-up|0|||
155317771|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
155317772|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
155317773|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
155317774|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
155317775|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
155317776|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
155317777|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317778|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
155317779|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317780|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317781|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155500838|NCT01787188|561258560|FG000|Overall Study|Non-compliance with Study Drug|0|||
155751090|NCT01282203|562188393|FG000|Overall Study|Adverse Event|1|||
155751091|NCT00930982|562188394|FG000|Overall Study|Adverse Event|19|||
155317782|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
155317783|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317784|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317785|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317786|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
155317787|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
155317788|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
155317789|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
155317790|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
155317791|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
155317792|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
155317793|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
155317794|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
155317795|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
155751092|NCT00930982|562188395|FG001|Overall Study|Adverse Event|23|||
155751093|NCT00930982|562188394|FG000|Overall Study|Protocol Violation|1|||
155751094|NCT00930982|562188395|FG001|Overall Study|Protocol Violation|5|||
155751095|NCT00930982|562188394|FG000|Overall Study|Withdrawal by Subject|1|||
155751096|NCT00930982|562188395|FG001|Overall Study|Withdrawal by Subject|1|||
155751097|NCT00991952|562188396|FG000|Overall Study|Adverse Event|0|||
155751098|NCT00991952|562188397|FG001|Overall Study|Adverse Event|1|||
155751099|NCT00518973|562188398|FG000|Overall Study|Withdrawal by Subject|3|||
155751100|NCT00518973|562188399|FG001|Overall Study|Withdrawal by Subject|2|||
155751101|NCT03452527|562188400|FG000|Overall Study|Withdrawal by Subject|1|||
155751102|NCT03452527|562188401|FG001|Overall Study|Withdrawal by Subject|1|||
155317796|NCT03852472|560597825|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
155317797|NCT03852472|560597826|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
155317798|NCT03852472|560597827|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
155418988|NCT01307033|560965483|FG001|44-week Open-label Extension|Death|0|||
155418989|NCT01307033|560965484|FG002|44-week Open-label Extension|Death|0|||
155418990|NCT01307033|560965485|FG003|44-week Open-label Extension|Death|1|||
155418991|NCT03588741|560965490|FG000|Overall Study|Withdrawal by Subject|1|||
155418992|NCT00605267|560965491|FG000|Overall Study|Adverse Event|0|||
155418993|NCT00605267|560965492|FG001|Overall Study|Adverse Event|1|||
155418994|NCT00605267|560965491|FG000|Overall Study|Lack of Efficacy|1|||
155418995|NCT00605267|560965492|FG001|Overall Study|Lack of Efficacy|5|||
155418996|NCT00605267|560965491|FG000|Overall Study|Withdrawal by Subject|2|||
155418997|NCT00605267|560965492|FG001|Overall Study|Withdrawal by Subject|3|||
155418998|NCT00793793|560965493|FG000|Overall Study|Adverse Event|0|||
155418999|NCT00793793|560965494|FG001|Overall Study|Adverse Event|0|||
155419000|NCT00793793|560965495|FG002|Overall Study|Adverse Event|1|||
155419001|NCT00793793|560965496|FG003|Overall Study|Adverse Event|1|||
155419002|NCT00793793|560965497|FG004|Overall Study|Adverse Event|0|||
155419003|NCT00793793|560965498|FG005|Overall Study|Adverse Event|1|||
155419004|NCT00793793|560965499|FG006|Overall Study|Adverse Event|2|||
155419005|NCT00793793|560965500|FG007|Overall Study|Adverse Event|0|||
155419006|NCT00793793|560965501|FG008|Overall Study|Adverse Event|0|||
155419007|NCT00793793|560965502|FG009|Overall Study|Adverse Event|0|||
155419008|NCT00793793|560965503|FG010|Overall Study|Adverse Event|0|||
155419009|NCT00793793|560965504|FG011|Overall Study|Adverse Event|2|||
155419010|NCT00793793|560965493|FG000|Overall Study|Protocol Violation|0|||
155419011|NCT00793793|560965494|FG001|Overall Study|Protocol Violation|0|||
155419012|NCT00793793|560965495|FG002|Overall Study|Protocol Violation|0|||
155419013|NCT00793793|560965496|FG003|Overall Study|Protocol Violation|1|||
155419014|NCT00793793|560965497|FG004|Overall Study|Protocol Violation|0|||
155419015|NCT00793793|560965498|FG005|Overall Study|Protocol Violation|0|||
155419016|NCT00793793|560965499|FG006|Overall Study|Protocol Violation|0|||
155419017|NCT00793793|560965500|FG007|Overall Study|Protocol Violation|0|||
155419018|NCT00793793|560965501|FG008|Overall Study|Protocol Violation|0|||
155419019|NCT00793793|560965502|FG009|Overall Study|Protocol Violation|0|||
155419020|NCT00793793|560965503|FG010|Overall Study|Protocol Violation|0|||
155419021|NCT00793793|560965504|FG011|Overall Study|Protocol Violation|0|||
155419022|NCT00793793|560965493|FG000|Overall Study|Lost to Follow-up|0|||
155419023|NCT00793793|560965494|FG001|Overall Study|Lost to Follow-up|0|||
155419024|NCT00793793|560965495|FG002|Overall Study|Lost to Follow-up|1|||
155419025|NCT00793793|560965496|FG003|Overall Study|Lost to Follow-up|0|||
155419026|NCT00793793|560965497|FG004|Overall Study|Lost to Follow-up|0|||
155419027|NCT00793793|560965498|FG005|Overall Study|Lost to Follow-up|0|||
155419028|NCT00793793|560965499|FG006|Overall Study|Lost to Follow-up|0|||
155419029|NCT00793793|560965500|FG007|Overall Study|Lost to Follow-up|0|||
155419030|NCT00793793|560965501|FG008|Overall Study|Lost to Follow-up|1|||
155419031|NCT00793793|560965502|FG009|Overall Study|Lost to Follow-up|3|||
155751103|NCT03452527|562188400|FG000|Overall Study|Study Terminated|2|||
155751104|NCT03452527|562188401|FG001|Overall Study|Study Terminated|3|||
155751105|NCT00582816|562188402|FG000|Overall Study|Engraftment Failure|3|||
155751106|NCT01565499|562188405|FG000|Overall Study|Physician Decision|1|||
155751107|NCT01565499|562188405|FG000|Overall Study|Adverse Event|5|||
155317799|NCT03852472|560597828|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
155317800|NCT03852472|560597829|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
155317801|NCT03852472|560597825|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
155317802|NCT03852472|560597826|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
155317803|NCT03852472|560597827|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
155317804|NCT03852472|560597828|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
155317805|NCT03852472|560597829|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
155317806|NCT03852472|560597825|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
155317807|NCT03852472|560597826|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
155317808|NCT03852472|560597827|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
155317809|NCT03852472|560597828|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
155317810|NCT03852472|560597829|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
155317811|NCT03852472|560597825|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317812|NCT03852472|560597826|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
155317813|NCT03852472|560597827|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
155317814|NCT03852472|560597828|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317815|NCT03852472|560597829|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317816|NCT03852472|560597825|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
155317817|NCT03852472|560597826|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
155317818|NCT03852472|560597827|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
155317819|NCT03852472|560597828|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
155317820|NCT03852472|560597829|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
155317821|NCT03852472|560597825|FG000|Period 2 - Week 44|Adverse Event|0|||
155317822|NCT03852472|560597826|FG001|Period 2 - Week 44|Adverse Event|3|||
155317823|NCT03852472|560597827|FG002|Period 2 - Week 44|Adverse Event|1|||
155317824|NCT03852472|560597828|FG003|Period 2 - Week 44|Adverse Event|2|||
155317825|NCT03852472|560597829|FG004|Period 2 - Week 44|Adverse Event|2|||
155317826|NCT03852472|560597825|FG000|Period 2 - Week 44|COVID-19 Related|0|||
155317827|NCT03852472|560597826|FG001|Period 2 - Week 44|COVID-19 Related|0|||
155317828|NCT03852472|560597827|FG002|Period 2 - Week 44|COVID-19 Related|0|||
155317829|NCT03852472|560597828|FG003|Period 2 - Week 44|COVID-19 Related|1|||
155317830|NCT03852472|560597829|FG004|Period 2 - Week 44|COVID-19 Related|0|||
155317831|NCT03852472|560597825|FG000|Period 2 - Week 44|Reason not stated|0|||
155317832|NCT03852472|560597826|FG001|Period 2 - Week 44|Reason not stated|0|||
155317833|NCT03852472|560597827|FG002|Period 2 - Week 44|Reason not stated|0|||
155317834|NCT03852472|560597828|FG003|Period 2 - Week 44|Reason not stated|0|||
155317835|NCT03852472|560597829|FG004|Period 2 - Week 44|Reason not stated|1|||
155317836|NCT01919554|560597830|FG000|Overall Study|Withdrawal by Subject|0|||
155317837|NCT01919554|560597831|FG001|Overall Study|Withdrawal by Subject|0|||
155317838|NCT01919554|560597832|FG002|Overall Study|Withdrawal by Subject|1|||
155317839|NCT01919554|560597833|FG003|Overall Study|Withdrawal by Subject|1|||
155317840|NCT06457802|560597834|FG000|Overall Study|Early termination of study prior to participant completion|2|||
155317841|NCT06457802|560597835|FG001|Overall Study|Early termination of study prior to participant completion|2|||
155317842|NCT05496231|560597836|FG000|Overall Study|Adverse Event|1|||
155317843|NCT05496231|560597837|FG001|Overall Study|Adverse Event|1|||
155317844|NCT05496231|560597838|FG002|Overall Study|Adverse Event|0|||
155500839|NCT01787188|561258561|FG001|Overall Study|Non-compliance with Study Drug|1|||
155500840|NCT01787188|561258562|FG002|Overall Study|Non-compliance with Study Drug|0|||
155500841|NCT01787188|561258560|FG000|Overall Study|Withdrawal by Subject|4|||
155500842|NCT01787188|561258561|FG001|Overall Study|Withdrawal by Subject|3|||
155500843|NCT01787188|561258562|FG002|Overall Study|Withdrawal by Subject|2|||
155500844|NCT01787188|561258560|FG000|Overall Study|Protocol Violation|3|||
155500845|NCT01787188|561258561|FG001|Overall Study|Protocol Violation|2|||
155500846|NCT01787188|561258562|FG002|Overall Study|Protocol Violation|3|||
155500847|NCT01787188|561258560|FG000|Overall Study|Lost to Follow-up|1|||
155500848|NCT01787188|561258561|FG001|Overall Study|Lost to Follow-up|2|||
155500849|NCT01787188|561258562|FG002|Overall Study|Lost to Follow-up|2|||
155500850|NCT01787188|561258560|FG000|Overall Study|Other, including patient moved|0|||
155500851|NCT01787188|561258561|FG001|Overall Study|Other, including patient moved|3|||
155500852|NCT01787188|561258562|FG002|Overall Study|Other, including patient moved|0|||
155500853|NCT00854607|561258563|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
155500854|NCT03151707|561258571|FG000|Overall Study|Lost to Follow-up|6|||
155317845|NCT05496231|560597839|FG003|Overall Study|Adverse Event|4|||
155317846|NCT05496231|560597836|FG000|Overall Study|Withdrawal by Subject|5|||
155317847|NCT05496231|560597837|FG001|Overall Study|Withdrawal by Subject|5|||
155317848|NCT05496231|560597838|FG002|Overall Study|Withdrawal by Subject|4|||
155317849|NCT05496231|560597839|FG003|Overall Study|Withdrawal by Subject|11|||
155317850|NCT05496231|560597836|FG000|Overall Study|Migrated/moved from the study area|3|||
155317851|NCT05496231|560597837|FG001|Overall Study|Migrated/moved from the study area|5|||
155500855|NCT00646282|561258572|FG000|Overall Study|Protocol terminated|4|||
155317852|NCT05496231|560597838|FG002|Overall Study|Migrated/moved from the study area|3|||
155317853|NCT05496231|560597839|FG003|Overall Study|Migrated/moved from the study area|3|||
155317854|NCT05496231|560597836|FG000|Overall Study|Lost to Follow-up|13|||
155317855|NCT05496231|560597837|FG001|Overall Study|Lost to Follow-up|6|||
155317856|NCT05496231|560597838|FG002|Overall Study|Lost to Follow-up|11|||
155317857|NCT05496231|560597839|FG003|Overall Study|Lost to Follow-up|6|||
155317858|NCT05496231|560597836|FG000|Overall Study|Other|9|||
155317859|NCT05496231|560597837|FG001|Overall Study|Other|7|||
155317860|NCT05496231|560597838|FG002|Overall Study|Other|7|||
155317861|NCT05496231|560597839|FG003|Overall Study|Other|8|||
155317862|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
155317863|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
155317864|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
155317865|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
155317866|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
155317867|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
155317868|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
155317869|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
155317870|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
155317871|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
155317872|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
155317873|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
155317874|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317875|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
155317876|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
155317877|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317878|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317879|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317880|NCT05670587|560597848|FG000|Overall Study|Withdrawal by Subject|3|||
155317881|NCT01544114|560597852|FG000|Overall Study|Withdrawal by Subject|0|||
155317882|NCT01544114|560597853|FG001|Overall Study|Withdrawal by Subject|0|||
155317883|NCT01544114|560597854|FG002|Overall Study|Withdrawal by Subject|3|||
155317884|NCT01544114|560597852|FG000|Overall Study|Lost to Follow-up|0|||
155317885|NCT01544114|560597853|FG001|Overall Study|Lost to Follow-up|2|||
155317886|NCT01544114|560597854|FG002|Overall Study|Lost to Follow-up|0|||
155317887|NCT01544114|560597852|FG000|Overall Study|Adverse Event|1|||
155317888|NCT01544114|560597853|FG001|Overall Study|Adverse Event|1|||
155317889|NCT01544114|560597854|FG002|Overall Study|Adverse Event|2|||
155317890|NCT01544114|560597852|FG000|Overall Study|Protocol Violation|0|||
155317891|NCT01544114|560597853|FG001|Overall Study|Protocol Violation|1|||
155317892|NCT01544114|560597854|FG002|Overall Study|Protocol Violation|0|||
155317893|NCT01733316|560597859|FG000|RP103 Phase|Non-compliance|1|||
155317894|NCT01733316|560597859|FG000|Long Term Extension Phase|Adverse Event|1|||
155317895|NCT01733316|560597859|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
155317896|NCT01733316|560597859|FG000|Long Term Extension Phase|Sponsor Decision|2|||
155317897|NCT05940194|560597866|FG000|Overall Study|Adverse Event|0|||
155317898|NCT05940194|560597867|FG001|Overall Study|Adverse Event|1|||
155317899|NCT05940194|560597868|FG002|Overall Study|Adverse Event|0|||
155317900|NCT05940194|560597866|FG000|Overall Study|Migrated/Moved from the study area|2|||
155317901|NCT05940194|560597867|FG001|Overall Study|Migrated/Moved from the study area|2|||
155317902|NCT05940194|560597868|FG002|Overall Study|Migrated/Moved from the study area|4|||
155317903|NCT04625465|560597869|FG000|Overall Study|Lost to Follow-up|2|||
155317904|NCT04625465|560597870|FG001|Overall Study|Lost to Follow-up|2|||
155317905|NCT04625465|560597871|FG002|Overall Study|Lost to Follow-up|1|||
155317906|NCT04625465|560597872|FG003|Overall Study|Lost to Follow-up|0|||
155317907|NCT04625465|560597873|FG004|Overall Study|Lost to Follow-up|0|||
155317908|NCT04625465|560597874|FG005|Overall Study|Lost to Follow-up|2|||
155317909|NCT04625465|560597875|FG006|Overall Study|Lost to Follow-up|0|||
155317910|NCT04625465|560597876|FG007|Overall Study|Lost to Follow-up|0|||
155317911|NCT04625465|560597869|FG000|Overall Study|Death|1|||
155317912|NCT04625465|560597870|FG001|Overall Study|Death|0|||
155317913|NCT04625465|560597871|FG002|Overall Study|Death|0|||
155317914|NCT04625465|560597872|FG003|Overall Study|Death|0|||
155317915|NCT04625465|560597873|FG004|Overall Study|Death|0|||
155317916|NCT04625465|560597874|FG005|Overall Study|Death|0|||
155317917|NCT04625465|560597875|FG006|Overall Study|Death|0|||
155317918|NCT04625465|560597876|FG007|Overall Study|Death|0|||
155317919|NCT04625465|560597869|FG000|Overall Study|Withdrawal by Subject|1|||
155317920|NCT04625465|560597870|FG001|Overall Study|Withdrawal by Subject|0|||
155317921|NCT04625465|560597871|FG002|Overall Study|Withdrawal by Subject|4|||
155317922|NCT04625465|560597872|FG003|Overall Study|Withdrawal by Subject|4|||
155419032|NCT00793793|560965503|FG010|Overall Study|Lost to Follow-up|1|||
155419033|NCT00793793|560965504|FG011|Overall Study|Lost to Follow-up|0|||
155419034|NCT00793793|560965493|FG000|Overall Study|Withdrawal by Subject|0|||
155419035|NCT00793793|560965494|FG001|Overall Study|Withdrawal by Subject|0|||
155419036|NCT00793793|560965495|FG002|Overall Study|Withdrawal by Subject|0|||
155419037|NCT00793793|560965496|FG003|Overall Study|Withdrawal by Subject|0|||
155419038|NCT00793793|560965497|FG004|Overall Study|Withdrawal by Subject|1|||
155317923|NCT04625465|560597873|FG004|Overall Study|Withdrawal by Subject|4|||
155500856|NCT00646282|561258573|FG001|Overall Study|Protocol terminated|4|||
155500857|NCT02181842|561258577|FG000|Overall Study|Case Report Forms Uncollected|2|||
155500858|NCT01652872|561258578|FG000|Overall Study|Death|36|||
155500859|NCT01652872|561258579|FG001|Overall Study|Death|39|||
155500860|NCT01652872|561258578|FG000|Overall Study|Lost to Follow-up|28|||
155500861|NCT01652872|561258579|FG001|Overall Study|Lost to Follow-up|23|||
155500862|NCT01652872|561258578|FG000|Overall Study|Decision by sponsor|5|||
155317924|NCT04625465|560597874|FG005|Overall Study|Withdrawal by Subject|0|||
155317925|NCT04625465|560597875|FG006|Overall Study|Withdrawal by Subject|0|||
155317926|NCT04625465|560597876|FG007|Overall Study|Withdrawal by Subject|0|||
155317927|NCT04753697|560597879|FG000|Induction Phase|Withdrawal by Subject|12|||
155317928|NCT04753697|560597880|FG001|Induction Phase|Withdrawal by Subject|5|||
155317929|NCT04753697|560597881|FG002|Induction Phase|Withdrawal by Subject|6|||
155317930|NCT04753697|560597879|FG000|Induction Phase|Physician Decision|1|||
155317931|NCT04753697|560597880|FG001|Induction Phase|Physician Decision|0|||
155317932|NCT04753697|560597881|FG002|Induction Phase|Physician Decision|0|||
155317933|NCT04753697|560597879|FG000|Induction Phase|Lost to Follow-up|2|||
155317934|NCT04753697|560597880|FG001|Induction Phase|Lost to Follow-up|2|||
155317935|NCT04753697|560597881|FG002|Induction Phase|Lost to Follow-up|1|||
155317936|NCT04753697|560597879|FG000|Induction Phase|Lack of Efficacy|1|||
155317937|NCT04753697|560597880|FG001|Induction Phase|Lack of Efficacy|0|||
155317938|NCT04753697|560597881|FG002|Induction Phase|Lack of Efficacy|0|||
155317939|NCT04753697|560597879|FG000|Maintenance Phase|Physician Decision|0|||
155317940|NCT04753697|560597880|FG001|Maintenance Phase|Physician Decision|0|||
155317941|NCT04753697|560597881|FG002|Maintenance Phase|Physician Decision|1|||
155317942|NCT04753697|560597879|FG000|Maintenance Phase|Withdrawal by Subject|3|||
155317943|NCT04753697|560597880|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155317944|NCT04753697|560597881|FG002|Maintenance Phase|Withdrawal by Subject|6|||
155317945|NCT04753697|560597879|FG000|Maintenance Phase|Lost to Follow-up|2|||
155317946|NCT04753697|560597880|FG001|Maintenance Phase|Lost to Follow-up|2|||
155317947|NCT04753697|560597881|FG002|Maintenance Phase|Lost to Follow-up|0|||
155317948|NCT04753697|560597879|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
155317949|NCT04753697|560597880|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
155317950|NCT04753697|560597881|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
155317951|NCT04753697|560597879|FG000|Maintenance Phase|Adverse Event|0|||
155317952|NCT04753697|560597880|FG001|Maintenance Phase|Adverse Event|1|||
155317953|NCT04753697|560597881|FG002|Maintenance Phase|Adverse Event|1|||
155317954|NCT04753697|560597879|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
155500863|NCT01652872|561258579|FG001|Overall Study|Decision by sponsor|7|||
155500864|NCT01652872|561258578|FG000|Overall Study|Withdrawal by Subject|76|||
155500865|NCT01652872|561258579|FG001|Overall Study|Withdrawal by Subject|84|||
155500866|NCT00758706|561258580|FG000|Overall Study|Adverse Event|4|||
155500867|NCT00758706|561258581|FG001|Overall Study|Adverse Event|4|||
155500868|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
155500869|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
155500870|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
155500871|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
155500872|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
155500873|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
155500874|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
155500875|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
155500876|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
155500877|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
155500878|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
155500879|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
155500880|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
155500881|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
155500882|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
155500883|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
155500884|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
155500885|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
155643296|NCT00266812|561783784|FG001|Overall Study|Disease Progression|3|||
155317955|NCT04753697|560597880|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155317956|NCT04753697|560597881|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155317957|NCT02151981|560597882|FG000|Overall Study|Death|184|||
155317958|NCT02151981|560597883|FG001|Overall Study|Death|88|||
155317959|NCT02151981|560597882|FG000|Overall Study|Lost to Follow-up|7|||
155317960|NCT02151981|560597883|FG001|Overall Study|Lost to Follow-up|1|||
155500886|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
155500887|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
155317961|NCT02151981|560597882|FG000|Overall Study|Withdrawal by Subject|27|||
155317962|NCT02151981|560597883|FG001|Overall Study|Withdrawal by Subject|21|||
155500888|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
155500889|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
155500890|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
155500891|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
155643297|NCT00266812|561783783|FG000|Overall Study|Death|5|||
155317963|NCT02151981|560597882|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155317964|NCT02151981|560597883|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155317965|NCT02151981|560597882|FG000|Overall Study|Other reasons|1|||
155317966|NCT02151981|560597883|FG001|Overall Study|Other reasons|2|||
155317967|NCT05446168|560597884|FG000|Overall Study|Physician Decision|0|||
155317968|NCT05446168|560597885|FG001|Overall Study|Physician Decision|1|||
155317969|NCT03854227|560600526|FG000|Overall Study|Adverse Event|0|||
155317970|NCT03854227|560600527|FG001|Overall Study|Adverse Event|0|||
155317971|NCT03854227|560600528|FG002|Overall Study|Adverse Event|0|||
155317972|NCT03854227|560600529|FG003|Overall Study|Adverse Event|1|||
155317973|NCT03854227|560600530|FG004|Overall Study|Adverse Event|0|||
155317974|NCT03854227|560600531|FG005|Overall Study|Adverse Event|0|||
155317975|NCT03854227|560600532|FG006|Overall Study|Adverse Event|1|||
155317976|NCT03854227|560600533|FG007|Overall Study|Adverse Event|0|||
155317977|NCT03854227|560600534|FG008|Overall Study|Adverse Event|0|||
155317978|NCT03854227|560600535|FG009|Overall Study|Adverse Event|3|||
155317979|NCT03854227|560600536|FG010|Overall Study|Adverse Event|0|||
155317980|NCT03854227|560600537|FG011|Overall Study|Adverse Event|1|||
155317981|NCT03854227|560600526|FG000|Overall Study|Death|0|||
155317982|NCT03854227|560600527|FG001|Overall Study|Death|0|||
155643298|NCT00266812|561783784|FG001|Overall Study|Death|4|||
155643299|NCT00266812|561783783|FG000|Overall Study|Adverse Event|3|||
155643300|NCT00266812|561783784|FG001|Overall Study|Adverse Event|1|||
155643301|NCT00266812|561783783|FG000|Overall Study|Protocol Violation|0|||
155643302|NCT00266812|561783784|FG001|Overall Study|Protocol Violation|1|||
155643303|NCT00266812|561783783|FG000|Overall Study|Withdrawal by Subject|0|||
155643304|NCT00266812|561783784|FG001|Overall Study|Withdrawal by Subject|2|||
155643305|NCT00266812|561783783|FG000|Overall Study|Discontinued before starting study drug|4|||
155643306|NCT00266812|561783784|FG001|Overall Study|Discontinued before starting study drug|0|||
155643307|NCT01617967|561783785|FG000|Overall Study|Protocol Violation|0|||
155643308|NCT01617967|561783786|FG001|Overall Study|Protocol Violation|0|||
155643309|NCT01617967|561783787|FG002|Overall Study|Protocol Violation|0|||
155643310|NCT01617967|561783788|FG003|Overall Study|Protocol Violation|1|||
155643311|NCT01617967|561783789|FG004|Overall Study|Protocol Violation|0|||
155643312|NCT01617967|561783790|FG005|Overall Study|Protocol Violation|0|||
155643313|NCT01617967|561783785|FG000|Overall Study|Withdrawal by Subject|0|||
155643314|NCT01617967|561783786|FG001|Overall Study|Withdrawal by Subject|0|||
155643315|NCT01617967|561783787|FG002|Overall Study|Withdrawal by Subject|0|||
155317983|NCT03854227|560600528|FG002|Overall Study|Death|0|||
155751108|NCT01565499|562188405|FG000|Overall Study|Withdrawal by Subject|2|||
155751109|NCT01923168|562188406|FG000|Overall Study|Protocol Violation|1|||
155751110|NCT01923168|562188407|FG001|Overall Study|Protocol Violation|1|||
155751111|NCT01923168|562188408|FG002|Overall Study|Protocol Violation|0|||
155751112|NCT01923168|562188406|FG000|Overall Study|Subject/guardian decision|14|||
155751113|NCT01923168|562188407|FG001|Overall Study|Subject/guardian decision|14|||
155751114|NCT01923168|562188408|FG002|Overall Study|Subject/guardian decision|4|||
155751115|NCT01923168|562188406|FG000|Overall Study|Adverse Event|12|||
155751116|NCT01923168|562188407|FG001|Overall Study|Adverse Event|12|||
155751117|NCT01923168|562188408|FG002|Overall Study|Adverse Event|0|||
155751118|NCT01923168|562188406|FG000|Overall Study|Physician Decision|6|||
155751119|NCT01923168|562188407|FG001|Overall Study|Physician Decision|9|||
155751120|NCT01923168|562188408|FG002|Overall Study|Physician Decision|5|||
155751121|NCT01923168|562188406|FG000|Overall Study|Progressive disease|4|||
155751122|NCT01923168|562188407|FG001|Overall Study|Progressive disease|3|||
155751123|NCT01923168|562188408|FG002|Overall Study|Progressive disease|7|||
155751124|NCT01923168|562188406|FG000|Overall Study|Death|0|||
155751125|NCT01923168|562188407|FG001|Overall Study|Death|0|||
155751126|NCT01923168|562188408|FG002|Overall Study|Death|1|||
155317984|NCT03854227|560600529|FG003|Overall Study|Death|0|||
155317985|NCT03854227|560600530|FG004|Overall Study|Death|0|||
155317986|NCT03854227|560600531|FG005|Overall Study|Death|1|||
155317987|NCT03854227|560600532|FG006|Overall Study|Death|0|||
155317988|NCT03854227|560600533|FG007|Overall Study|Death|0|||
155317989|NCT03854227|560600534|FG008|Overall Study|Death|0|||
155317990|NCT03854227|560600535|FG009|Overall Study|Death|1|||
155317991|NCT03854227|560600536|FG010|Overall Study|Death|0|||
155317992|NCT03854227|560600537|FG011|Overall Study|Death|1|||
155643316|NCT01617967|561783788|FG003|Overall Study|Withdrawal by Subject|0|||
155643317|NCT01617967|561783789|FG004|Overall Study|Withdrawal by Subject|0|||
155643318|NCT01617967|561783790|FG005|Overall Study|Withdrawal by Subject|1|||
155751127|NCT01255787|562188409|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
155751128|NCT01255787|562188410|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
155751129|NCT01255787|562188411|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
155751130|NCT01255787|562188412|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
155751131|NCT01255787|562188409|FG000|Overall Study|Major Protocol Deviation|1|||
155751132|NCT01255787|562188410|FG001|Overall Study|Major Protocol Deviation|1|||
155751133|NCT01255787|562188411|FG002|Overall Study|Major Protocol Deviation|0|||
155751134|NCT01255787|562188412|FG003|Overall Study|Major Protocol Deviation|4|||
155317993|NCT03854227|560600526|FG000|Overall Study|Physician Decision|0|||
155317994|NCT03854227|560600527|FG001|Overall Study|Physician Decision|0|||
155317995|NCT03854227|560600528|FG002|Overall Study|Physician Decision|0|||
155317996|NCT03854227|560600529|FG003|Overall Study|Physician Decision|0|||
155317997|NCT03854227|560600530|FG004|Overall Study|Physician Decision|0|||
155317998|NCT03854227|560600531|FG005|Overall Study|Physician Decision|1|||
155317999|NCT03854227|560600532|FG006|Overall Study|Physician Decision|0|||
155318000|NCT03854227|560600533|FG007|Overall Study|Physician Decision|0|||
155318001|NCT03854227|560600534|FG008|Overall Study|Physician Decision|1|||
155318002|NCT03854227|560600535|FG009|Overall Study|Physician Decision|1|||
155318003|NCT03854227|560600536|FG010|Overall Study|Physician Decision|0|||
155318004|NCT03854227|560600537|FG011|Overall Study|Physician Decision|1|||
155318005|NCT03854227|560600526|FG000|Overall Study|Progressive disease|1|||
155318006|NCT03854227|560600527|FG001|Overall Study|Progressive disease|1|||
155318007|NCT03854227|560600528|FG002|Overall Study|Progressive disease|1|||
155318008|NCT03854227|560600529|FG003|Overall Study|Progressive disease|2|||
155318009|NCT03854227|560600530|FG004|Overall Study|Progressive disease|3|||
155318010|NCT03854227|560600531|FG005|Overall Study|Progressive disease|1|||
155318011|NCT03854227|560600532|FG006|Overall Study|Progressive disease|2|||
155318012|NCT03854227|560600533|FG007|Overall Study|Progressive disease|5|||
155318013|NCT03854227|560600534|FG008|Overall Study|Progressive disease|2|||
155318014|NCT03854227|560600535|FG009|Overall Study|Progressive disease|5|||
155318015|NCT03854227|560600536|FG010|Overall Study|Progressive disease|1|||
155318016|NCT03854227|560600537|FG011|Overall Study|Progressive disease|6|||
155318017|NCT03854227|560600526|FG000|Overall Study|Study terminated by sponsor|0|||
155318018|NCT03854227|560600527|FG001|Overall Study|Study terminated by sponsor|0|||
155318019|NCT03854227|560600528|FG002|Overall Study|Study terminated by sponsor|0|||
155318020|NCT03854227|560600529|FG003|Overall Study|Study terminated by sponsor|0|||
155318021|NCT03854227|560600530|FG004|Overall Study|Study terminated by sponsor|0|||
155318022|NCT03854227|560600531|FG005|Overall Study|Study terminated by sponsor|0|||
155318023|NCT03854227|560600532|FG006|Overall Study|Study terminated by sponsor|0|||
155318024|NCT03854227|560600533|FG007|Overall Study|Study terminated by sponsor|0|||
155318025|NCT03854227|560600534|FG008|Overall Study|Study terminated by sponsor|0|||
155318026|NCT03854227|560600535|FG009|Overall Study|Study terminated by sponsor|1|||
155318027|NCT03854227|560600536|FG010|Overall Study|Study terminated by sponsor|0|||
155318028|NCT03854227|560600537|FG011|Overall Study|Study terminated by sponsor|0|||
155318029|NCT03854227|560600526|FG000|Overall Study|Withdrawal by Subject|0|||
155318030|NCT03854227|560600527|FG001|Overall Study|Withdrawal by Subject|0|||
155318031|NCT03854227|560600528|FG002|Overall Study|Withdrawal by Subject|1|||
155318032|NCT03854227|560600529|FG003|Overall Study|Withdrawal by Subject|0|||
155318033|NCT03854227|560600530|FG004|Overall Study|Withdrawal by Subject|0|||
155318034|NCT03854227|560600531|FG005|Overall Study|Withdrawal by Subject|0|||
155318035|NCT03854227|560600532|FG006|Overall Study|Withdrawal by Subject|0|||
155318036|NCT03854227|560600533|FG007|Overall Study|Withdrawal by Subject|0|||
155318037|NCT03854227|560600534|FG008|Overall Study|Withdrawal by Subject|0|||
155318038|NCT03854227|560600535|FG009|Overall Study|Withdrawal by Subject|1|||
155318039|NCT03854227|560600536|FG010|Overall Study|Withdrawal by Subject|1|||
155318040|NCT03854227|560600537|FG011|Overall Study|Withdrawal by Subject|0|||
155318041|NCT03854227|560600526|FG000|Overall Study|Disease relapse|0|||
155318042|NCT03854227|560600527|FG001|Overall Study|Disease relapse|0|||
155318043|NCT03854227|560600528|FG002|Overall Study|Disease relapse|0|||
155318044|NCT03854227|560600529|FG003|Overall Study|Disease relapse|0|||
155318045|NCT03854227|560600530|FG004|Overall Study|Disease relapse|0|||
155318046|NCT03854227|560600531|FG005|Overall Study|Disease relapse|0|||
155318047|NCT03854227|560600532|FG006|Overall Study|Disease relapse|0|||
155318048|NCT03854227|560600533|FG007|Overall Study|Disease relapse|0|||
155318049|NCT03854227|560600534|FG008|Overall Study|Disease relapse|1|||
155318050|NCT03854227|560600535|FG009|Overall Study|Disease relapse|0|||
155318051|NCT03854227|560600536|FG010|Overall Study|Disease relapse|0|||
155318052|NCT03854227|560600537|FG011|Overall Study|Disease relapse|0|||
155318053|NCT03854227|560600526|FG000|Overall Study|Global deterioration of health status|0|||
155318054|NCT03854227|560600527|FG001|Overall Study|Global deterioration of health status|0|||
155318055|NCT03854227|560600528|FG002|Overall Study|Global deterioration of health status|0|||
155318056|NCT03854227|560600529|FG003|Overall Study|Global deterioration of health status|0|||
155318057|NCT03854227|560600530|FG004|Overall Study|Global deterioration of health status|0|||
155318058|NCT03854227|560600531|FG005|Overall Study|Global deterioration of health status|1|||
155318059|NCT03854227|560600532|FG006|Overall Study|Global deterioration of health status|0|||
155318060|NCT03854227|560600533|FG007|Overall Study|Global deterioration of health status|1|||
155318061|NCT03854227|560600534|FG008|Overall Study|Global deterioration of health status|0|||
155318062|NCT03854227|560600535|FG009|Overall Study|Global deterioration of health status|0|||
155318063|NCT03854227|560600536|FG010|Overall Study|Global deterioration of health status|0|||
155318064|NCT03854227|560600537|FG011|Overall Study|Global deterioration of health status|0|||
155318065|NCT03854227|560600526|FG000|Overall Study|Refused further treatment|0|||
155318066|NCT03854227|560600527|FG001|Overall Study|Refused further treatment|0|||
155318067|NCT03854227|560600528|FG002|Overall Study|Refused further treatment|0|||
155318068|NCT03854227|560600529|FG003|Overall Study|Refused further treatment|0|||
155318069|NCT03854227|560600530|FG004|Overall Study|Refused further treatment|0|||
155318070|NCT03854227|560600531|FG005|Overall Study|Refused further treatment|0|||
155318071|NCT03854227|560600532|FG006|Overall Study|Refused further treatment|0|||
155318072|NCT03854227|560600533|FG007|Overall Study|Refused further treatment|0|||
155318073|NCT03854227|560600534|FG008|Overall Study|Refused further treatment|0|||
155318074|NCT03854227|560600535|FG009|Overall Study|Refused further treatment|1|||
155318075|NCT03854227|560600536|FG010|Overall Study|Refused further treatment|0|||
155318076|NCT03854227|560600537|FG011|Overall Study|Refused further treatment|1|||
155318077|NCT03854227|560600526|FG000|Overall Study|Other|0|||
155318078|NCT03854227|560600527|FG001|Overall Study|Other|0|||
155318079|NCT03854227|560600528|FG002|Overall Study|Other|0|||
155318080|NCT03854227|560600529|FG003|Overall Study|Other|0|||
155318081|NCT03854227|560600530|FG004|Overall Study|Other|0|||
155318082|NCT03854227|560600531|FG005|Overall Study|Other|0|||
155318083|NCT03854227|560600532|FG006|Overall Study|Other|0|||
155318084|NCT03854227|560600533|FG007|Overall Study|Other|0|||
155318085|NCT03854227|560600534|FG008|Overall Study|Other|1|||
155318086|NCT03854227|560600535|FG009|Overall Study|Other|1|||
155318087|NCT03854227|560600536|FG010|Overall Study|Other|0|||
155318088|NCT03854227|560600537|FG011|Overall Study|Other|0|||
155318089|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
155318090|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
155318091|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
155318092|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
155318093|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
155318094|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
155318095|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
155318096|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
155318097|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
155318098|NCT04119843|560600543|FG000|Overall Study|Adverse Event|3|||
155318099|NCT04119843|560600543|FG000|Overall Study|Death|1|||
155419039|NCT00793793|560965498|FG005|Overall Study|Withdrawal by Subject|0|||
155419040|NCT00793793|560965499|FG006|Overall Study|Withdrawal by Subject|0|||
155419041|NCT00793793|560965500|FG007|Overall Study|Withdrawal by Subject|0|||
155419042|NCT00793793|560965501|FG008|Overall Study|Withdrawal by Subject|1|||
155419043|NCT00793793|560965502|FG009|Overall Study|Withdrawal by Subject|0|||
155419044|NCT00793793|560965503|FG010|Overall Study|Withdrawal by Subject|0|||
155419045|NCT00793793|560965504|FG011|Overall Study|Withdrawal by Subject|0|||
155419046|NCT00793793|560965493|FG000|Overall Study|reason not specified|0|||
155419047|NCT00793793|560965494|FG001|Overall Study|reason not specified|1|||
155419048|NCT00793793|560965495|FG002|Overall Study|reason not specified|0|||
155419049|NCT00793793|560965496|FG003|Overall Study|reason not specified|1|||
155419050|NCT00793793|560965497|FG004|Overall Study|reason not specified|1|||
155419051|NCT00793793|560965498|FG005|Overall Study|reason not specified|1|||
155419052|NCT00793793|560965499|FG006|Overall Study|reason not specified|2|||
155419053|NCT00793793|560965500|FG007|Overall Study|reason not specified|0|||
155419054|NCT00793793|560965501|FG008|Overall Study|reason not specified|7|||
155419055|NCT00793793|560965502|FG009|Overall Study|reason not specified|6|||
155419056|NCT00793793|560965503|FG010|Overall Study|reason not specified|2|||
155419057|NCT00793793|560965504|FG011|Overall Study|reason not specified|4|||
155419058|NCT01445535|560965505|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
155419059|NCT01445535|560965506|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
155419060|NCT01445535|560965507|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
155419061|NCT01445535|560965508|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
155419062|NCT01445535|560965505|FG000|Overall Study|Disease progression|1|||
155419063|NCT01445535|560965506|FG001|Overall Study|Disease progression|0|||
155419064|NCT01445535|560965507|FG002|Overall Study|Disease progression|1|||
155419065|NCT01445535|560965508|FG003|Overall Study|Disease progression|0|||
155419066|NCT01445535|560965505|FG000|Overall Study|PI discretion|0|||
155419067|NCT01445535|560965506|FG001|Overall Study|PI discretion|0|||
155419068|NCT01445535|560965507|FG002|Overall Study|PI discretion|0|||
155419069|NCT01445535|560965508|FG003|Overall Study|PI discretion|1|||
155419070|NCT00883493|560965513|FG000|Overall Study|Adverse Event|11|||
155419071|NCT00883493|560965514|FG001|Overall Study|Adverse Event|12|||
155318100|NCT04499924|560600544|FG000|Overall Study|Study termination by sponsor|4|||
155318101|NCT04499924|560600545|FG001|Overall Study|Study termination by sponsor|6|||
155318102|NCT04499924|560600544|FG000|Overall Study|Withdrawal by Subject|1|||
155419072|NCT00883493|560965513|FG000|Overall Study|Lack of Efficacy|4|||
155419073|NCT00883493|560965514|FG001|Overall Study|Lack of Efficacy|3|||
155419074|NCT00883493|560965513|FG000|Overall Study|Lost to Follow-up|7|||
155318103|NCT04499924|560600545|FG001|Overall Study|Withdrawal by Subject|3|||
155318104|NCT04225273|560600546|FG000|Overall Study|Lost to Follow-up|3|||
155318105|NCT03652389|560600547|FG000|Overall Study|Lost to Follow-up|1|||
155318106|NCT03652389|560600548|FG001|Overall Study|Lost to Follow-up|5|||
155318107|NCT03652389|560600547|FG000|Overall Study|Withdrawal by Subject|5|||
155318108|NCT03652389|560600548|FG001|Overall Study|Withdrawal by Subject|1|||
155318109|NCT03652389|560600547|FG000|Overall Study|New diagnosis|2|||
155318110|NCT03652389|560600548|FG001|Overall Study|New diagnosis|0|||
155318111|NCT04413708|560600549|FG000|Overall Study|Lost to Follow-up|1|||
155318112|NCT04413708|560600550|FG001|Overall Study|Lost to Follow-up|2|||
155318113|NCT04231149|560600551|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318114|NCT04231149|560600552|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
155318115|NCT04231149|560600553|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318116|NCT04231149|560600554|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318117|NCT04231149|560600555|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318118|NCT01501955|560600558|FG000|Overall Study|Withdrawal by Subject|1|||
155318119|NCT01501955|560600559|FG001|Overall Study|Withdrawal by Subject|0|||
155318120|NCT01501955|560600558|FG000|Overall Study|Adverse Event|1|||
155318121|NCT01501955|560600559|FG001|Overall Study|Adverse Event|3|||
155318122|NCT05877976|560600560|FG000|Overall Study|Lost to Follow-up|31|||
155419075|NCT00883493|560965514|FG001|Overall Study|Lost to Follow-up|6|||
155419076|NCT00883493|560965513|FG000|Overall Study|Withdrawal by Subject|11|||
155419077|NCT00883493|560965514|FG001|Overall Study|Withdrawal by Subject|20|||
155318123|NCT04314713|560600561|FG000|Overall Study|Lost to Follow-up|0|||
155318124|NCT04314713|560600562|FG001|Overall Study|Lost to Follow-up|0|||
155318125|NCT04314713|560600563|FG002|Overall Study|Lost to Follow-up|0|||
155318126|NCT04314713|560600564|FG003|Overall Study|Lost to Follow-up|1|||
155318127|NCT04314713|560600565|FG004|Overall Study|Lost to Follow-up|0|||
155318128|NCT04314713|560600566|FG005|Overall Study|Lost to Follow-up|0|||
155318129|NCT04907851|560600567|FG000|Overall Study|Consent withdrawn|1|||
155318130|NCT04907851|560600568|FG001|Overall Study|Consent withdrawn|2|||
155318131|NCT04907851|560600569|FG002|Overall Study|Consent withdrawn|0|||
155318132|NCT04907851|560600567|FG000|Overall Study|Death|5|||
155318133|NCT04907851|560600568|FG001|Overall Study|Death|15|||
155318134|NCT04907851|560600569|FG002|Overall Study|Death|10|||
155318135|NCT03656510|560600580|FG000|Overall Study|Lost to Follow-up|1|||
155318136|NCT03656510|560600581|FG001|Overall Study|Lost to Follow-up|0|||
155318137|NCT03656510|560600582|FG002|Overall Study|Lost to Follow-up|0|||
155318138|NCT03656510|560600583|FG003|Overall Study|Lost to Follow-up|0|||
155318139|NCT03656510|560600584|FG004|Overall Study|Lost to Follow-up|0|||
155318140|NCT03656510|560600585|FG005|Overall Study|Lost to Follow-up|0|||
155318141|NCT03656510|560600580|FG000|Overall Study|Withdrawal by Subject|1|||
155318142|NCT03656510|560600581|FG001|Overall Study|Withdrawal by Subject|1|||
155318143|NCT03656510|560600582|FG002|Overall Study|Withdrawal by Subject|0|||
155318144|NCT03656510|560600583|FG003|Overall Study|Withdrawal by Subject|1|||
155318145|NCT03656510|560600584|FG004|Overall Study|Withdrawal by Subject|0|||
155318146|NCT03656510|560600585|FG005|Overall Study|Withdrawal by Subject|0|||
155318147|NCT05477186|560600588|FG000|Overall Study|Vaccine not administered|0|||
155318148|NCT05477186|560600589|FG001|Overall Study|Vaccine not administered|2|||
155318149|NCT05477186|560600590|FG002|Overall Study|Vaccine not administered|1|||
155318150|NCT05477186|560600591|FG003|Overall Study|Vaccine not administered|0|||
155318151|NCT05477186|560600592|FG004|Overall Study|Vaccine not administered|1|||
155318152|NCT05477186|560600593|FG005|Overall Study|Vaccine not administered|0|||
155318153|NCT05477186|560600594|FG006|Overall Study|Vaccine not administered|0|||
155318154|NCT05477186|560600588|FG000|Overall Study|Withdrawal by Subject|1|||
155318155|NCT05477186|560600589|FG001|Overall Study|Withdrawal by Subject|0|||
155318156|NCT05477186|560600590|FG002|Overall Study|Withdrawal by Subject|0|||
155318157|NCT05477186|560600591|FG003|Overall Study|Withdrawal by Subject|0|||
155318158|NCT05477186|560600592|FG004|Overall Study|Withdrawal by Subject|0|||
155318159|NCT05477186|560600593|FG005|Overall Study|Withdrawal by Subject|1|||
155318160|NCT05477186|560600594|FG006|Overall Study|Withdrawal by Subject|0|||
155318161|NCT05477186|560600588|FG000|Overall Study|Lost to Follow-up|1|||
155318162|NCT05477186|560600589|FG001|Overall Study|Lost to Follow-up|0|||
155318163|NCT05477186|560600590|FG002|Overall Study|Lost to Follow-up|2|||
155318164|NCT05477186|560600591|FG003|Overall Study|Lost to Follow-up|1|||
155318165|NCT05477186|560600592|FG004|Overall Study|Lost to Follow-up|1|||
155318166|NCT05477186|560600593|FG005|Overall Study|Lost to Follow-up|0|||
155318167|NCT05477186|560600594|FG006|Overall Study|Lost to Follow-up|2|||
155318168|NCT02305888|560600600|FG000|Overall Study|Lost to Follow-up|0|||
155318169|NCT02305888|560600601|FG001|Overall Study|Lost to Follow-up|0|||
155419078|NCT00883493|560965513|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
155419079|NCT00883493|560965514|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
155419080|NCT00883493|560965513|FG000|Overall Study|Study specific disc. criteria|2|||
155751135|NCT01255787|562188409|FG000|Overall Study|Lost to Follow-up|1|||
155318170|NCT02305888|560600602|FG002|Overall Study|Lost to Follow-up|1|||
155318171|NCT02305888|560600600|FG000|Overall Study|Adverse Event|0|||
155318172|NCT02305888|560600601|FG001|Overall Study|Adverse Event|1|||
155318173|NCT02305888|560600602|FG002|Overall Study|Adverse Event|0|||
155318174|NCT05139810|560600603|FG000|Overall Study|Voluntary Withdrawal|2|||
155318175|NCT05139810|560600604|FG001|Overall Study|Voluntary Withdrawal|1|||
155318176|NCT05139810|560600605|FG002|Overall Study|Voluntary Withdrawal|0|||
155318177|NCT05139810|560600603|FG000|Overall Study|Pregnancy|1|||
155318178|NCT05139810|560600604|FG001|Overall Study|Pregnancy|0|||
155318179|NCT05139810|560600605|FG002|Overall Study|Pregnancy|0|||
155318180|NCT05139810|560600603|FG000|Overall Study|Roll Over to CS7|19|||
155318181|NCT05139810|560600604|FG001|Overall Study|Roll Over to CS7|44|||
155318182|NCT05139810|560600605|FG002|Overall Study|Roll Over to CS7|20|||
155318183|NCT04914676|560600610|FG000|Overall Study|Study termination|3|||
155318184|NCT04914676|560600611|FG001|Overall Study|Study termination|0|||
155318185|NCT03024437|560600612|FG000|Overall Study|Adverse Event|0|||
155419081|NCT00883493|560965514|FG001|Overall Study|Study specific disc. criteria|0|||
155419082|NCT00883493|560965513|FG000|Overall Study|Other|5|||
155751136|NCT01255787|562188410|FG001|Overall Study|Lost to Follow-up|2|||
155751137|NCT01255787|562188411|FG002|Overall Study|Lost to Follow-up|4|||
155751138|NCT01255787|562188412|FG003|Overall Study|Lost to Follow-up|2|||
155419083|NCT00883493|560965514|FG001|Overall Study|Other|3|||
155419084|NCT01622569|560965515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
155419085|NCT01622569|560965516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
155419086|NCT01622569|560965517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
155419087|NCT01622569|560965518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
155419088|NCT01622569|560965515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
155419089|NCT01622569|560965516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
155419090|NCT01622569|560965517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
155419091|NCT01622569|560965518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
155419092|NCT01622569|560965515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
155419093|NCT01622569|560965516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
155419094|NCT01622569|560965517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
155419095|NCT01622569|560965518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
155419096|NCT01622569|560965515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
155419097|NCT01622569|560965516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
155419098|NCT01622569|560965517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
155419099|NCT01622569|560965518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
155419100|NCT01622569|560965515|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
155419101|NCT01622569|560965516|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
155419102|NCT01622569|560965517|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
155419103|NCT01622569|560965518|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
155419104|NCT01622569|560965515|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
155419105|NCT01622569|560965516|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
155419106|NCT01622569|560965517|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
155419107|NCT01622569|560965518|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
155419108|NCT01622569|560965515|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
155419109|NCT01622569|560965516|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
155419110|NCT01622569|560965517|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
155419111|NCT01622569|560965518|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
155419112|NCT01622569|560965515|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155419113|NCT01622569|560965516|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155419114|NCT01622569|560965517|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
155419115|NCT01622569|560965518|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
155419116|NCT01505894|560965519|FG000|Overall Study|Adverse Event|1|||
155419117|NCT01505894|560965520|FG001|Overall Study|Adverse Event|0|||
155419118|NCT01505894|560965521|FG002|Overall Study|Adverse Event|0|||
155419119|NCT01505894|560965522|FG003|Overall Study|Adverse Event|0|||
155419120|NCT01505894|560965523|FG004|Overall Study|Adverse Event|0|||
155419121|NCT01505894|560965524|FG005|Overall Study|Adverse Event|0|||
155419122|NCT01505894|560965525|FG006|Overall Study|Adverse Event|0|||
155419123|NCT01505894|560965526|FG007|Overall Study|Adverse Event|0|||
155419124|NCT01505894|560965527|FG008|Overall Study|Adverse Event|0|||
155419125|NCT01505894|560965519|FG000|Overall Study|Other than specified|0|||
155419126|NCT01505894|560965520|FG001|Overall Study|Other than specified|0|||
155419127|NCT01505894|560965521|FG002|Overall Study|Other than specified|0|||
155419128|NCT01505894|560965522|FG003|Overall Study|Other than specified|0|||
155419129|NCT01505894|560965523|FG004|Overall Study|Other than specified|1|||
155419130|NCT01505894|560965524|FG005|Overall Study|Other than specified|0|||
155419131|NCT01505894|560965525|FG006|Overall Study|Other than specified|0|||
155419132|NCT01505894|560965526|FG007|Overall Study|Other than specified|0|||
155419133|NCT01505894|560965527|FG008|Overall Study|Other than specified|0|||
155419134|NCT04173741|560965528|FG000|Overall Study|IVC measurement cannot be done|1|||
155751139|NCT01255787|562188409|FG000|Overall Study|Withdrawal of Consent|3|||
155751140|NCT01255787|562188410|FG001|Overall Study|Withdrawal of Consent|9|||
155318186|NCT03024437|560600613|FG001|Overall Study|Adverse Event|1|||
155318187|NCT03024437|560600614|FG002|Overall Study|Adverse Event|3|||
155318188|NCT03024437|560600615|FG003|Overall Study|Adverse Event|5|||
155318189|NCT03024437|560600616|FG004|Overall Study|Adverse Event|0|||
155318190|NCT03024437|560600612|FG000|Overall Study|Physician Decision|1|||
155318191|NCT03024437|560600613|FG001|Overall Study|Physician Decision|0|||
155318192|NCT03024437|560600614|FG002|Overall Study|Physician Decision|0|||
155318193|NCT03024437|560600615|FG003|Overall Study|Physician Decision|1|||
155318194|NCT03024437|560600616|FG004|Overall Study|Physician Decision|0|||
155318195|NCT03024437|560600612|FG000|Overall Study|Disease progression, relapse|1|||
155318196|NCT03024437|560600613|FG001|Overall Study|Disease progression, relapse|0|||
155318197|NCT03024437|560600614|FG002|Overall Study|Disease progression, relapse|0|||
155318198|NCT03024437|560600615|FG003|Overall Study|Disease progression, relapse|3|||
155318199|NCT03024437|560600616|FG004|Overall Study|Disease progression, relapse|0|||
155318200|NCT03024437|560600612|FG000|Overall Study|Disease progression, refractory disease|4|||
155318201|NCT03024437|560600613|FG001|Overall Study|Disease progression, refractory disease|4|||
155318202|NCT03024437|560600614|FG002|Overall Study|Disease progression, refractory disease|2|||
155318203|NCT03024437|560600615|FG003|Overall Study|Disease progression, refractory disease|2|||
155318204|NCT03024437|560600616|FG004|Overall Study|Disease progression, refractory disease|1|||
155318205|NCT03024437|560600612|FG000|Overall Study|Newly diagnosed cancer|0|||
155318206|NCT03024437|560600613|FG001|Overall Study|Newly diagnosed cancer|0|||
155318207|NCT03024437|560600614|FG002|Overall Study|Newly diagnosed cancer|0|||
155318208|NCT03024437|560600615|FG003|Overall Study|Newly diagnosed cancer|1|||
155318209|NCT03024437|560600616|FG004|Overall Study|Newly diagnosed cancer|0|||
155318210|NCT03024437|560600612|FG000|Overall Study|Moved out of state|0|||
155318211|NCT03024437|560600613|FG001|Overall Study|Moved out of state|1|||
155318212|NCT03024437|560600614|FG002|Overall Study|Moved out of state|0|||
155318213|NCT03024437|560600615|FG003|Overall Study|Moved out of state|0|||
155318214|NCT03024437|560600616|FG004|Overall Study|Moved out of state|0|||
155318215|NCT03024437|560600612|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318216|NCT03024437|560600613|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318217|NCT03024437|560600614|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
155318218|NCT03024437|560600615|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318219|NCT03024437|560600616|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318220|NCT03240016|560600619|FG000|Overall Study|Adverse Event|9|||
155318221|NCT03240016|560600619|FG000|Overall Study|Withdrawal by Subject|7|||
155318222|NCT03240016|560600619|FG000|Overall Study|Death|1|||
155318223|NCT03240016|560600619|FG000|Overall Study|Physician Decision|2|||
155318224|NCT05200403|560600620|FG000|Overall Study|Withdrawal by Subject|4|||
155318225|NCT05200403|560600621|FG001|Overall Study|Withdrawal by Subject|2|||
155318226|NCT05200403|560600622|FG002|Overall Study|Withdrawal by Subject|6|||
155318227|NCT05546411|560600623|FG000|Overall Study|Progressive Disease|1|||
155318228|NCT05546411|560600624|FG001|Overall Study|Progressive Disease|0|||
155318229|NCT05546411|560600623|FG000|Overall Study|Adverse Event|0|||
155318230|NCT05546411|560600624|FG001|Overall Study|Adverse Event|1|||
155318231|NCT05546411|560600623|FG000|Overall Study|Metastatic disease|1|||
155318232|NCT05546411|560600624|FG001|Overall Study|Metastatic disease|0|||
155318233|NCT02606422|560600625|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
155419135|NCT04173741|560965529|FG001|Overall Study|IVC measurement cannot be done|1|||
155419136|NCT01940484|560965532|FG000|Overall Study|Withdrawal by Subject|3|||
155419137|NCT01940484|560965532|FG000|Overall Study|Underwent transplantation|4|||
155419138|NCT01940484|560965532|FG000|Overall Study|Death|2|||
155318234|NCT02606422|560600626|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
155318235|NCT02606422|560600625|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
155318236|NCT02606422|560600626|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
155318237|NCT02606422|560600625|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
155318238|NCT02606422|560600626|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
155318239|NCT02606422|560600625|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
155318240|NCT02606422|560600626|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
155318241|NCT05566639|560600628|FG000|Overall Study|Adverse Event|1|||
155318242|NCT05566639|560600629|FG001|Overall Study|Adverse Event|1|||
155318243|NCT05566639|560600628|FG000|Overall Study|Serious Adverse Event|1|||
155318244|NCT05566639|560600629|FG001|Overall Study|Serious Adverse Event|3|||
155318245|NCT05566639|560600628|FG000|Overall Study|Death|44|||
155318246|NCT05566639|560600629|FG001|Overall Study|Death|45|||
155419139|NCT01940484|560965532|FG000|Overall Study|Adverse Event|1|||
155419140|NCT03106779|560965533|FG000|Overall Study|Lack of Efficacy|33|||
155419141|NCT03106779|560965534|FG001|Overall Study|Lack of Efficacy|24|||
155419142|NCT03106779|560965533|FG000|Overall Study|Adverse Event|8|||
155419143|NCT03106779|560965534|FG001|Overall Study|Adverse Event|16|||
155318247|NCT05566639|560600628|FG000|Overall Study|Lost to Follow-up|467|||
155318248|NCT05566639|560600629|FG001|Overall Study|Lost to Follow-up|461|||
155318249|NCT05566639|560600628|FG000|Overall Study|Physician Decision|45|||
155419144|NCT03106779|560965533|FG000|Overall Study|Physician Decision|10|||
155419145|NCT03106779|560965534|FG001|Overall Study|Physician Decision|6|||
155318250|NCT05566639|560600629|FG001|Overall Study|Physician Decision|44|||
155643319|NCT01617967|561783785|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
155643320|NCT01617967|561783786|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
155643321|NCT01617967|561783787|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
155643322|NCT01617967|561783788|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
155643323|NCT01617967|561783789|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
155643324|NCT01617967|561783790|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
155643325|NCT00530075|561783791|FG000|Overall Study|Adverse Event|1|||
155643326|NCT00530075|561783791|FG000|Overall Study|Death|1|||
155643327|NCT00530075|561783791|FG000|Overall Study|Lack of Efficacy|3|||
155643328|NCT00530075|561783791|FG000|Overall Study|Protocol Violation|1|||
155643329|NCT00530075|561783791|FG000|Overall Study|Withdrawal by Subject|1|||
155643330|NCT01166945|561783794|FG000|Randomized|diagnosed with Group A strep|4|||
155643331|NCT01166945|561783795|FG001|Randomized|diagnosed with Group A strep|4|||
155643332|NCT01166945|561783794|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
155643333|NCT01166945|561783795|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
155643334|NCT01166945|561783794|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
155643335|NCT01166945|561783795|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
155643336|NCT01166945|561783794|FG000|Day 30|Lost to Follow-up|4|||
155643337|NCT01166945|561783795|FG001|Day 30|Lost to Follow-up|3|||
155643338|NCT03520569|561783798|FG000|Overall Study|Withdrawal by Subject|1|||
155643339|NCT00784927|561783799|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
155643340|NCT00784927|561783799|FG000|Overall Study|Protocol Violation|1|||
155643341|NCT00784927|561783799|FG000|Overall Study|Ineligible|1|||
155643342|NCT01137812|561783804|FG000|Overall Study|Adverse Event|21|||
155643343|NCT01137812|561783805|FG001|Overall Study|Adverse Event|14|||
155643344|NCT01137812|561783804|FG000|Overall Study|Lost to Follow-up|6|||
155643345|NCT01137812|561783805|FG001|Overall Study|Lost to Follow-up|8|||
155643346|NCT01137812|561783804|FG000|Overall Study|Physician Decision|25|||
155643347|NCT01137812|561783805|FG001|Overall Study|Physician Decision|17|||
155643348|NCT01137812|561783804|FG000|Overall Study|Protocol Violation|5|||
155643349|NCT01137812|561783805|FG001|Overall Study|Protocol Violation|4|||
155643350|NCT01137812|561783804|FG000|Overall Study|Withdrawal by Subject|5|||
155643351|NCT01137812|561783805|FG001|Overall Study|Withdrawal by Subject|13|||
155643352|NCT01137812|561783804|FG000|Overall Study|Death|2|||
155643353|NCT01137812|561783805|FG001|Overall Study|Death|0|||
155643354|NCT01137812|561783804|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
155643355|NCT01137812|561783805|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
155643356|NCT01137812|561783804|FG000|Overall Study|Other|19|||
155643357|NCT01137812|561783805|FG001|Overall Study|Other|27|||
155643358|NCT04425018|561783806|FG000|Overall Study|Withdrawal by Subject|1|||
155643359|NCT04425018|561783807|FG001|Overall Study|Withdrawal by Subject|2|||
155643360|NCT04740567|561783808|FG000|Overall Study|Death|31|||
155643361|NCT04740567|561783809|FG001|Overall Study|Death|43|||
155643362|NCT04740567|561783808|FG000|Overall Study|Lost to Follow-up|2|||
155643363|NCT04740567|561783809|FG001|Overall Study|Lost to Follow-up|11|||
155643364|NCT04740567|561783808|FG000|Overall Study|Patient declined to participate|13|||
155643365|NCT04740567|561783809|FG001|Overall Study|Patient declined to participate|26|||
155643366|NCT04740567|561783808|FG000|Overall Study|Patient was physically incapable|1|||
155643367|NCT04740567|561783809|FG001|Overall Study|Patient was physically incapable|3|||
155643368|NCT04740567|561783808|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
155643369|NCT04740567|561783809|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
155643370|NCT06204887|561783810|FG000|Overall Study|Lost to Follow-up|3|||
155643371|NCT06204887|561783811|FG001|Overall Study|Lost to Follow-up|4|||
155643372|NCT06204887|561783812|FG002|Overall Study|Lost to Follow-up|1|||
155643373|NCT06204887|561783813|FG003|Overall Study|Lost to Follow-up|6|||
155643374|NCT02762604|561783814|FG000|Overall Study|Lost to Follow-up|2|||
155643375|NCT02762604|561783815|FG001|Overall Study|Lost to Follow-up|7|||
155643376|NCT02762604|561783814|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
155643377|NCT02762604|561783815|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
155318251|NCT05566639|560600628|FG000|Overall Study|Protocol Deviation|4|||
155318252|NCT05566639|560600629|FG001|Overall Study|Protocol Deviation|4|||
155643378|NCT05128942|561783816|FG000|Overall Study|Withdrawal by Subject|1|||
155643379|NCT05128942|561783817|FG001|Overall Study|Withdrawal by Subject|0|||
155643380|NCT05128942|561783818|FG002|Overall Study|Withdrawal by Subject|1|||
155643381|NCT05128942|561783819|FG003|Overall Study|Withdrawal by Subject|0|||
155643382|NCT05128942|561783820|FG004|Overall Study|Withdrawal by Subject|0|||
155643383|NCT05128942|561783821|FG005|Overall Study|Withdrawal by Subject|0|||
155643384|NCT05128942|561783822|FG006|Overall Study|Withdrawal by Subject|0|||
155643385|NCT05128942|561783823|FG007|Overall Study|Withdrawal by Subject|0|||
155643386|NCT05128942|561783824|FG008|Overall Study|Withdrawal by Subject|0|||
155643387|NCT05128942|561783816|FG000|Overall Study|Other|2|||
155643388|NCT05128942|561783817|FG001|Overall Study|Other|0|||
155643389|NCT05128942|561783818|FG002|Overall Study|Other|2|||
155643390|NCT05128942|561783819|FG003|Overall Study|Other|0|||
155643391|NCT05128942|561783820|FG004|Overall Study|Other|0|||
155643392|NCT05128942|561783821|FG005|Overall Study|Other|0|||
155643393|NCT05128942|561783822|FG006|Overall Study|Other|0|||
155643394|NCT05128942|561783823|FG007|Overall Study|Other|0|||
155643395|NCT05128942|561783824|FG008|Overall Study|Other|0|||
155643396|NCT05128942|561783816|FG000|Overall Study|Termination by Sponsor|2|||
155643397|NCT05128942|561783817|FG001|Overall Study|Termination by Sponsor|6|||
155643398|NCT05128942|561783818|FG002|Overall Study|Termination by Sponsor|14|||
155643399|NCT05128942|561783819|FG003|Overall Study|Termination by Sponsor|2|||
155643400|NCT05128942|561783820|FG004|Overall Study|Termination by Sponsor|4|||
155643401|NCT05128942|561783821|FG005|Overall Study|Termination by Sponsor|8|||
155643402|NCT05128942|561783822|FG006|Overall Study|Termination by Sponsor|11|||
155643403|NCT05128942|561783823|FG007|Overall Study|Termination by Sponsor|6|||
155643404|NCT05128942|561783824|FG008|Overall Study|Termination by Sponsor|0|||
155643405|NCT05128942|561783816|FG000|Overall Study|Adverse Event|0|||
155643406|NCT05128942|561783817|FG001|Overall Study|Adverse Event|0|||
155643407|NCT05128942|561783818|FG002|Overall Study|Adverse Event|0|||
155643408|NCT05128942|561783819|FG003|Overall Study|Adverse Event|0|||
155643409|NCT05128942|561783820|FG004|Overall Study|Adverse Event|0|||
155643410|NCT05128942|561783821|FG005|Overall Study|Adverse Event|0|||
155643411|NCT05128942|561783822|FG006|Overall Study|Adverse Event|1|||
155643412|NCT05128942|561783823|FG007|Overall Study|Adverse Event|1|||
155643413|NCT05128942|561783824|FG008|Overall Study|Adverse Event|0|||
155643414|NCT05128942|561783816|FG000|Overall Study|Lost to Follow-up|0|||
155643415|NCT05128942|561783817|FG001|Overall Study|Lost to Follow-up|0|||
155643416|NCT05128942|561783818|FG002|Overall Study|Lost to Follow-up|0|||
155643417|NCT05128942|561783819|FG003|Overall Study|Lost to Follow-up|0|||
155643418|NCT05128942|561783820|FG004|Overall Study|Lost to Follow-up|1|||
155643419|NCT05128942|561783821|FG005|Overall Study|Lost to Follow-up|0|||
155643420|NCT05128942|561783822|FG006|Overall Study|Lost to Follow-up|0|||
155318253|NCT05566639|560600628|FG000|Overall Study|Withdrawal by Subject|277|||
155318254|NCT05566639|560600629|FG001|Overall Study|Withdrawal by Subject|271|||
155318255|NCT05566639|560600628|FG000|Overall Study|Other Than Specified|52|||
155318256|NCT05566639|560600629|FG001|Overall Study|Other Than Specified|64|||
155318257|NCT04054193|560600637|FG000|Cycle 1|Physician Decision|1|||
155318258|NCT04054193|560600637|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
155318259|NCT04054193|560600637|FG000|Cycle 1|Allocated but not treated|3|||
155318260|NCT04054193|560600637|FG000|Cycles 2-3|Physician Decision|2|||
155318261|NCT04054193|560600637|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
155318262|NCT04054193|560600637|FG000|Cycles 2-3|Various reasons|17|||
155318263|NCT02966873|560600638|FG000|Overall Study|Lost to Follow-up|16|||
155500892|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
155500893|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
155500894|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
155500895|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
155500896|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
155500897|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
155643421|NCT05128942|561783823|FG007|Overall Study|Lost to Follow-up|0|||
155643422|NCT05128942|561783824|FG008|Overall Study|Lost to Follow-up|0|||
155643423|NCT05182125|561783828|FG000|Overall Study|Withdrawal by Subject|0|||
155643424|NCT05182125|561783829|FG001|Overall Study|Withdrawal by Subject|0|||
155318264|NCT02966873|560600639|FG001|Overall Study|Lost to Follow-up|15|||
155318265|NCT03235544|560600648|FG000|Overall Study|Death|11|||
155318266|NCT03235544|560600649|FG001|Overall Study|Death|31|||
155318267|NCT03235544|560600650|FG002|Overall Study|Death|19|||
155318268|NCT03235544|560600651|FG003|Overall Study|Death|34|||
155318269|NCT03235544|560600648|FG000|Overall Study|Lost to Follow-up|0|||
155318270|NCT03235544|560600649|FG001|Overall Study|Lost to Follow-up|1|||
155318271|NCT03235544|560600650|FG002|Overall Study|Lost to Follow-up|1|||
155318272|NCT03235544|560600651|FG003|Overall Study|Lost to Follow-up|1|||
155643425|NCT05182125|561783830|FG002|Overall Study|Withdrawal by Subject|0|||
155643426|NCT05182125|561783831|FG003|Overall Study|Withdrawal by Subject|0|||
155643427|NCT05182125|561783832|FG004|Overall Study|Withdrawal by Subject|2|||
155318273|NCT03235544|560600648|FG000|Overall Study|Withdrawal by Subject|0|||
155318274|NCT03235544|560600649|FG001|Overall Study|Withdrawal by Subject|3|||
155500898|NCT03985293|561258596|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
155643428|NCT05182125|561783833|FG005|Overall Study|Withdrawal by Subject|0|||
155318275|NCT03235544|560600650|FG002|Overall Study|Withdrawal by Subject|1|||
155318276|NCT03235544|560600651|FG003|Overall Study|Withdrawal by Subject|5|||
155318277|NCT03235544|560600648|FG000|Overall Study|Disease Progression|0|||
155318278|NCT03235544|560600649|FG001|Overall Study|Disease Progression|1|||
155318279|NCT03235544|560600650|FG002|Overall Study|Disease Progression|0|||
155318280|NCT03235544|560600651|FG003|Overall Study|Disease Progression|2|||
155318281|NCT03235544|560600648|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
155500899|NCT03985293|561258597|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
155643429|NCT05182125|561783828|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
155643430|NCT05182125|561783829|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
155643431|NCT05182125|561783830|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
155643432|NCT05182125|561783831|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
155643433|NCT05182125|561783832|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
155643434|NCT05182125|561783833|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
155643435|NCT05182125|561783828|FG000|Overall Study|Death|0|||
155643436|NCT05182125|561783829|FG001|Overall Study|Death|0|||
155318282|NCT03235544|560600649|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
155318283|NCT03235544|560600650|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
155318284|NCT03235544|560600651|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
155318285|NCT03235544|560600648|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318286|NCT03235544|560600649|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318287|NCT03235544|560600650|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318288|NCT03235544|560600651|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
155318289|NCT00950742|560600652|FG000|Overall Study|Other Adverse Event|1|||
155318290|NCT00950742|560600653|FG001|Overall Study|Other Adverse Event|0|||
155318291|NCT00950742|560600652|FG000|Overall Study|Withdrawal by Subject|3|||
155318292|NCT00950742|560600653|FG001|Overall Study|Withdrawal by Subject|0|||
155318293|NCT00950742|560600652|FG000|Overall Study|Progressive Disease|6|||
155318294|NCT00950742|560600653|FG001|Overall Study|Progressive Disease|2|||
155419146|NCT03106779|560965533|FG000|Overall Study|Patient/guardian decision|4|||
155419147|NCT03106779|560965534|FG001|Overall Study|Patient/guardian decision|3|||
155419148|NCT03106779|560965533|FG000|Overall Study|Progressive disease|1|||
155419149|NCT03106779|560965534|FG001|Overall Study|Progressive disease|3|||
155419150|NCT03106779|560965533|FG000|Overall Study|Lost to Follow-up|1|||
155419151|NCT03106779|560965534|FG001|Overall Study|Lost to Follow-up|2|||
155419152|NCT03106779|560965533|FG000|Overall Study|Death|1|||
155419153|NCT03106779|560965534|FG001|Overall Study|Death|0|||
155419154|NCT03106779|560965533|FG000|Overall Study|Protocol Violation|1|||
155419155|NCT03106779|560965534|FG001|Overall Study|Protocol Violation|0|||
155419156|NCT03106779|560965533|FG000|Overall Study|Not treated|1|||
155419157|NCT03106779|560965534|FG001|Overall Study|Not treated|0|||
155419158|NCT04233229|560965535|FG000|Overall Study|Withdrawal by Subject|0|||
155419159|NCT04233229|560965536|FG001|Overall Study|Withdrawal by Subject|1|||
155419160|NCT04233229|560965535|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
155419161|NCT04233229|560965536|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
155419162|NCT04233229|560965535|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
155419163|NCT04233229|560965536|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
155419164|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
155419165|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
155419166|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
155419167|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
155419168|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
155419169|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
155419170|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
155419171|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
155419172|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
155419173|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
155419174|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
155419175|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
155419176|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
155419177|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
155419178|NCT02288247|560965537|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
155419179|NCT02288247|560965538|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
155419180|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
155419181|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
155419182|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
155419183|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
155419184|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
155419185|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
155419186|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
155419187|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
155419188|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
155419189|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
155419190|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
155419191|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
155419192|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
155419193|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
155643437|NCT05182125|561783830|FG002|Overall Study|Death|0|||
155318295|NCT00950742|560600652|FG000|Overall Study|Dose limiting toxicity|6|||
155318296|NCT00950742|560600653|FG001|Overall Study|Dose limiting toxicity|0|||
155318297|NCT05436262|560600655|FG000|Pre-Randomization|Withdrawal by Subject|1|||
155318298|NCT05436262|560600656|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155318299|NCT05436262|560600657|FG002|Pre-Randomization|Withdrawal by Subject|0|||
155318300|NCT05436262|560600655|FG000|Randomization|Withdrawal by Subject|0|||
155318301|NCT05436262|560600656|FG001|Randomization|Withdrawal by Subject|1|||
155318302|NCT05436262|560600657|FG002|Randomization|Withdrawal by Subject|0|||
155318303|NCT01456949|560600658|FG000|Enrollment|PI death- incomplete data|6|||
155318304|NCT01456949|560600658|FG000|Enrollment|Death|1|||
155318305|NCT01456949|560600658|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
155318306|NCT01456949|560600658|FG000|Enrollment|Physician Decision|10|||
155318307|NCT01456949|560600658|FG000|Enrollment|Withdrawal by Subject|7|||
155318308|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
155318309|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
155318310|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
155318311|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
155318312|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
155318313|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
155318314|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
155318315|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
155318316|NCT04200456|560600661|FG000|Overall Study|Physician Decision|0|||
155318317|NCT04200456|560600662|FG001|Overall Study|Physician Decision|1|||
155500900|NCT03985293|561258598|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
155318318|NCT04200456|560600661|FG000|Overall Study|Withdrawal by Subject|2|||
155318319|NCT04200456|560600662|FG001|Overall Study|Withdrawal by Subject|2|||
155318320|NCT04200456|560600661|FG000|Overall Study|Lack of Efficacy|1|||
155318321|NCT04200456|560600662|FG001|Overall Study|Lack of Efficacy|1|||
155318322|NCT04200456|560600661|FG000|Overall Study|Adverse event, non-fatal|0|||
155318323|NCT04200456|560600662|FG001|Overall Study|Adverse event, non-fatal|1|||
155318324|NCT04200456|560600661|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
155318325|NCT04200456|560600662|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
155318326|NCT05002088|560600664|FG000|Overall Study|Withdrawal by Subject|9|||
155318327|NCT05002088|560600665|FG001|Overall Study|Withdrawal by Subject|0|||
155318328|NCT05002088|560600664|FG000|Overall Study|Lost to Follow-up|0|||
155318329|NCT05002088|560600665|FG001|Overall Study|Lost to Follow-up|1|||
155318330|NCT05002088|560600664|FG000|Overall Study|Death|16|||
155318331|NCT05002088|560600665|FG001|Overall Study|Death|2|||
155318332|NCT05002088|560600664|FG000|Overall Study|Protocol Violation|25|||
155318333|NCT05002088|560600665|FG001|Overall Study|Protocol Violation|7|||
155318334|NCT04068181|560600666|FG000|Overall Study|Death|17|||
155318335|NCT04068181|560600667|FG001|Overall Study|Death|12|||
155318336|NCT04068181|560600668|FG002|Overall Study|Death|4|||
155318337|NCT04068181|560600669|FG003|Overall Study|Death|7|||
155318338|NCT04068181|560600666|FG000|Overall Study|Lost to Follow-up|1|||
155318339|NCT04068181|560600667|FG001|Overall Study|Lost to Follow-up|0|||
155318340|NCT04068181|560600668|FG002|Overall Study|Lost to Follow-up|0|||
155318341|NCT04068181|560600669|FG003|Overall Study|Lost to Follow-up|0|||
155318342|NCT04068181|560600666|FG000|Overall Study|Withdrawal of consent from study|3|||
155500901|NCT03985293|561258599|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
155500902|NCT03985293|561258600|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
155500903|NCT03985293|561258601|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
155318343|NCT04068181|560600667|FG001|Overall Study|Withdrawal of consent from study|0|||
155318344|NCT04068181|560600668|FG002|Overall Study|Withdrawal of consent from study|0|||
155318345|NCT04068181|560600669|FG003|Overall Study|Withdrawal of consent from study|0|||
155318346|NCT03785964|560600672|FG000|Overall Study|Adverse Event|14|||
155318347|NCT03785964|560600673|FG001|Overall Study|Adverse Event|1|||
155318348|NCT03785964|560600672|FG000|Overall Study|Unqualified Clinical Progression|1|||
155318349|NCT03785964|560600673|FG001|Overall Study|Unqualified Clinical Progression|1|||
155318350|NCT03785964|560600672|FG000|Overall Study|Participant non-compliance|1|||
155318351|NCT03785964|560600673|FG001|Overall Study|Participant non-compliance|1|||
155318352|NCT03785964|560600672|FG000|Overall Study|Not treated|1|||
155318353|NCT03785964|560600673|FG001|Overall Study|Not treated|0|||
155318354|NCT03785964|560600672|FG000|Overall Study|Other reason|5|||
155318355|NCT03785964|560600673|FG001|Overall Study|Other reason|11|||
155318356|NCT03785964|560600672|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
155318357|NCT03785964|560600673|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
155318358|NCT05070728|560600674|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
155318359|NCT05070728|560600675|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
155318360|NCT03924635|560600692|FG000|Overall Study|Withdrawal by Subject|2|||
155318361|NCT03924635|560600693|FG001|Overall Study|Withdrawal by Subject|4|||
155318362|NCT04568434|560600696|FG000|Overall Study|Voluntary Withdrawal|0|||
155318363|NCT04568434|560600697|FG001|Overall Study|Voluntary Withdrawal|1|||
155318364|NCT04568434|560600698|FG002|Overall Study|Voluntary Withdrawal|1|||
155500904|NCT03985293|561258596|FG000|FOLLOW-UP|Lost to Follow-up|0|||
155318365|NCT04568434|560600696|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
155318366|NCT04568434|560600697|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
155318367|NCT04568434|560600698|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
155318368|NCT04568434|560600696|FG000|Overall Study|Investigator Judgement|1|||
155318369|NCT04568434|560600697|FG001|Overall Study|Investigator Judgement|0|||
155318370|NCT04568434|560600698|FG002|Overall Study|Investigator Judgement|0|||
155318371|NCT05469464|560600699|FG000|Overall Study|Withdrawal by Subject|8|||
155318372|NCT05469464|560600700|FG001|Overall Study|Withdrawal by Subject|7|||
155318373|NCT05469464|560600701|FG002|Overall Study|Withdrawal by Subject|4|||
155318374|NCT05469464|560600702|FG003|Overall Study|Withdrawal by Subject|5|||
155318375|NCT05469464|560600699|FG000|Overall Study|Adverse Event|8|||
155318376|NCT05469464|560600700|FG001|Overall Study|Adverse Event|14|||
155318377|NCT05469464|560600701|FG002|Overall Study|Adverse Event|13|||
155318378|NCT05469464|560600702|FG003|Overall Study|Adverse Event|2|||
155318379|NCT05469464|560600699|FG000|Overall Study|Lost to Follow-up|2|||
155318380|NCT05469464|560600700|FG001|Overall Study|Lost to Follow-up|5|||
155318381|NCT05469464|560600701|FG002|Overall Study|Lost to Follow-up|3|||
155318382|NCT05469464|560600702|FG003|Overall Study|Lost to Follow-up|3|||
155318383|NCT05469464|560600699|FG000|Overall Study|Lack of Efficacy|4|||
155318384|NCT05469464|560600700|FG001|Overall Study|Lack of Efficacy|1|||
155318385|NCT05469464|560600701|FG002|Overall Study|Lack of Efficacy|2|||
155318386|NCT05469464|560600702|FG003|Overall Study|Lack of Efficacy|2|||
155318387|NCT05469464|560600699|FG000|Overall Study|Physician Decision|0|||
155318388|NCT05469464|560600700|FG001|Overall Study|Physician Decision|0|||
155318389|NCT05469464|560600701|FG002|Overall Study|Physician Decision|0|||
155318390|NCT05469464|560600702|FG003|Overall Study|Physician Decision|1|||
155318391|NCT05374798|560600705|FG000|Overall Study|Lost to Follow-up|2|||
155318392|NCT05374798|560600705|FG000|Overall Study|Withdrawal by Subject|2|||
155318393|NCT05374798|560600705|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
155318394|NCT03463044|560600706|FG000|Overall Study|Lost to Follow-up|0|||
155318395|NCT03463044|560600707|FG001|Overall Study|Lost to Follow-up|0|||
155318396|NCT03463044|560600708|FG002|Overall Study|Lost to Follow-up|0|||
155318397|NCT03463044|560600709|FG003|Overall Study|Lost to Follow-up|0|||
155318398|NCT03463044|560600710|FG004|Overall Study|Lost to Follow-up|0|||
155318399|NCT03463044|560600711|FG005|Overall Study|Lost to Follow-up|0|||
155318400|NCT03463044|560600712|FG006|Overall Study|Lost to Follow-up|0|||
155318401|NCT03463044|560600713|FG007|Overall Study|Lost to Follow-up|1|||
155318402|NCT03463044|560600714|FG008|Overall Study|Lost to Follow-up|0|||
155318403|NCT04471246|560600715|FG000|Overall Study|Lost to Follow-up|2|||
155318404|NCT04471246|560600716|FG001|Overall Study|Lost to Follow-up|2|||
155318405|NCT04079218|560600721|FG000|Overall Study|Death|1|||
155318406|NCT04079218|560600722|FG001|Overall Study|Death|0|||
155318407|NCT04079218|560600721|FG000|Overall Study|Withdrawal by Subject|3|||
155318408|NCT04079218|560600722|FG001|Overall Study|Withdrawal by Subject|0|||
155318409|NCT04079218|560600721|FG000|Overall Study|Physician Decision|4|||
155318410|NCT04079218|560600722|FG001|Overall Study|Physician Decision|0|||
155318411|NCT04079218|560600721|FG000|Overall Study|Lost to Follow-up|0|||
155318412|NCT04079218|560600722|FG001|Overall Study|Lost to Follow-up|1|||
155318413|NCT05093842|560600728|FG000|Overall Study|Pregnancy loss|1|||
155318414|NCT05093842|560600729|FG001|Overall Study|Pregnancy loss|1|||
155419194|NCT02288247|560965537|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
155419195|NCT02288247|560965538|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
155419196|NCT04652804|560965539|FG000|Overall Study|Ineligible post randomization|1|||
155419197|NCT04652804|560965540|FG001|Overall Study|Ineligible post randomization|0|||
155419198|NCT04652804|560965541|FG002|Overall Study|Ineligible post randomization|1|||
155419199|NCT04652804|560965542|FG003|Overall Study|Ineligible post randomization|0|||
155419200|NCT04652804|560965543|FG004|Overall Study|Ineligible post randomization|1|||
155419201|NCT04652804|560965544|FG005|Overall Study|Ineligible post randomization|1|||
155419202|NCT04652804|560965539|FG000|Overall Study|Missing SVR lab results|2|||
155419203|NCT04652804|560965540|FG001|Overall Study|Missing SVR lab results|0|||
155419204|NCT04652804|560965541|FG002|Overall Study|Missing SVR lab results|0|||
155419205|NCT04652804|560965542|FG003|Overall Study|Missing SVR lab results|0|||
155419206|NCT04652804|560965543|FG004|Overall Study|Missing SVR lab results|0|||
155419207|NCT04652804|560965544|FG005|Overall Study|Missing SVR lab results|0|||
155419208|NCT00584194|560965545|FG000|Overall Study|Other|135|||
155419209|NCT04093531|560965546|FG000|Overall Study|failed screening|4|||
155419210|NCT00841763|560965547|FG000|Overall Study|Withdrawal by Subject|60|||
155318415|NCT05093842|560600728|FG000|Overall Study|Lost to Follow-up|6|||
155318416|NCT05093842|560600729|FG001|Overall Study|Lost to Follow-up|0|||
155318417|NCT05093842|560600728|FG000|Overall Study|Physician Decision|0|||
155419211|NCT00841763|560965548|FG001|Overall Study|Withdrawal by Subject|17|||
155419212|NCT00841763|560965549|FG002|Overall Study|Withdrawal by Subject|4|||
155419213|NCT00841763|560965550|FG003|Overall Study|Withdrawal by Subject|1|||
155419214|NCT00841763|560965547|FG000|Overall Study|Adverse Event|9|||
155318418|NCT05093842|560600729|FG001|Overall Study|Physician Decision|1|||
155318419|NCT03910478|560600735|FG000|Overall Study|Death|13|||
155318420|NCT03910478|560600736|FG001|Overall Study|Death|6|||
155318421|NCT03910478|560600735|FG000|Overall Study|Withdrawal by Subject|23|||
155318422|NCT03910478|560600736|FG001|Overall Study|Withdrawal by Subject|2|||
155318423|NCT03910478|560600735|FG000|Overall Study|Physician Decision|5|||
155318424|NCT03910478|560600736|FG001|Overall Study|Physician Decision|0|||
155318425|NCT03910478|560600735|FG000|Overall Study|Protocol Violation|1|||
155318426|NCT03910478|560600736|FG001|Overall Study|Protocol Violation|0|||
155318427|NCT03910478|560600735|FG000|Overall Study|Failure to meet continuation criteria|2|||
155318428|NCT03910478|560600736|FG001|Overall Study|Failure to meet continuation criteria|0|||
155318429|NCT03910478|560600735|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
155751141|NCT01255787|562188411|FG002|Overall Study|Withdrawal of Consent|3|||
155751142|NCT01255787|562188412|FG003|Overall Study|Withdrawal of Consent|4|||
155751143|NCT01255787|562188409|FG000|Overall Study|Pregnancy|0|||
155318430|NCT03910478|560600736|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
155318431|NCT03478956|560600738|FG000|Randomized Treatment Period|Adverse Event|1|||
155318432|NCT03478956|560600739|FG001|Randomized Treatment Period|Adverse Event|0|||
155318433|NCT03478956|560600740|FG002|Randomized Treatment Period|Adverse Event|0|||
155318434|NCT03478956|560600741|FG003|Randomized Treatment Period|Adverse Event|0|||
155318435|NCT03478956|560600738|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
155419215|NCT00841763|560965548|FG001|Overall Study|Adverse Event|10|||
155419216|NCT00841763|560965549|FG002|Overall Study|Adverse Event|3|||
155318436|NCT03478956|560600739|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
155419217|NCT00841763|560965550|FG003|Overall Study|Adverse Event|2|||
155419218|NCT00841763|560965547|FG000|Overall Study|Lost to Follow-up|63|||
155419219|NCT00841763|560965548|FG001|Overall Study|Lost to Follow-up|25|||
155419220|NCT00841763|560965549|FG002|Overall Study|Lost to Follow-up|0|||
155419221|NCT00841763|560965550|FG003|Overall Study|Lost to Follow-up|0|||
155419222|NCT00841763|560965547|FG000|Overall Study|Protocol Violation|20|||
155419223|NCT00841763|560965548|FG001|Overall Study|Protocol Violation|3|||
155419224|NCT00841763|560965549|FG002|Overall Study|Protocol Violation|1|||
155419225|NCT00841763|560965550|FG003|Overall Study|Protocol Violation|0|||
155419226|NCT00841763|560965547|FG000|Overall Study|Administrative Reasons|3|||
155419227|NCT00841763|560965548|FG001|Overall Study|Administrative Reasons|1|||
155419228|NCT00841763|560965549|FG002|Overall Study|Administrative Reasons|0|||
155419229|NCT00841763|560965550|FG003|Overall Study|Administrative Reasons|0|||
155419230|NCT00841763|560965547|FG000|Overall Study|Unable to Classify|7|||
155419231|NCT00841763|560965548|FG001|Overall Study|Unable to Classify|1|||
155419232|NCT00841763|560965549|FG002|Overall Study|Unable to Classify|0|||
155419233|NCT00841763|560965550|FG003|Overall Study|Unable to Classify|0|||
155419234|NCT01109940|560965559|FG000|Overall Study|Administrative problems|2|||
155419235|NCT01109940|560965560|FG001|Overall Study|Administrative problems|0|||
155419236|NCT01109940|560965561|FG002|Overall Study|Administrative problems|0|||
155419237|NCT01109940|560965562|FG003|Overall Study|Administrative problems|0|||
155419238|NCT01109940|560965559|FG000|Overall Study|Serious Adverse Event|2|||
155419239|NCT01109940|560965560|FG001|Overall Study|Serious Adverse Event|1|||
155419240|NCT01109940|560965561|FG002|Overall Study|Serious Adverse Event|0|||
155419241|NCT01109940|560965562|FG003|Overall Study|Serious Adverse Event|0|||
155419242|NCT01109940|560965559|FG000|Overall Study|Lost to Follow-up|1|||
155419243|NCT01109940|560965560|FG001|Overall Study|Lost to Follow-up|0|||
155419244|NCT01109940|560965561|FG002|Overall Study|Lost to Follow-up|0|||
155419245|NCT01109940|560965562|FG003|Overall Study|Lost to Follow-up|0|||
155419246|NCT01109940|560965559|FG000|Overall Study|Patient withdrew consent|1|||
155419247|NCT01109940|560965560|FG001|Overall Study|Patient withdrew consent|1|||
155419248|NCT01109940|560965561|FG002|Overall Study|Patient withdrew consent|0|||
155419249|NCT01109940|560965562|FG003|Overall Study|Patient withdrew consent|0|||
155419250|NCT01109940|560965559|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155419251|NCT01109940|560965560|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155419252|NCT01109940|560965561|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
155419253|NCT01109940|560965562|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155419254|NCT02769624|560965563|FG000|Overall Study|Lost to Follow-up|0|||
155318437|NCT03478956|560600740|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
155318438|NCT03478956|560600741|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
155318439|NCT03478956|560600738|FG000|Open Label Extension Period|Adverse Event|0|||
155419255|NCT02769624|560965564|FG001|Overall Study|Lost to Follow-up|1|||
155419256|NCT00179959|560965565|FG000|Overall Study|Lost to Follow-up|3|||
155419257|NCT00179959|560965566|FG001|Overall Study|Lost to Follow-up|1|||
155419258|NCT00179959|560965565|FG000|Overall Study|Withdrawal by Subject|3|||
155419259|NCT00179959|560965566|FG001|Overall Study|Withdrawal by Subject|2|||
155419260|NCT00236080|560965567|FG000|Overall Study|Adverse Event|0|||
155419261|NCT00236080|560965568|FG001|Overall Study|Adverse Event|0|||
155419262|NCT00236080|560965569|FG002|Overall Study|Adverse Event|3|||
155419263|NCT00236080|560965570|FG003|Overall Study|Adverse Event|1|||
155419264|NCT00236080|560965571|FG004|Overall Study|Adverse Event|0|||
155318440|NCT03478956|560600739|FG001|Open Label Extension Period|Adverse Event|0|||
155419265|NCT00236080|560965567|FG000|Overall Study|Lost to Follow-up|0|||
155419266|NCT00236080|560965568|FG001|Overall Study|Lost to Follow-up|1|||
155751144|NCT01255787|562188410|FG001|Overall Study|Pregnancy|0|||
155751145|NCT01255787|562188411|FG002|Overall Study|Pregnancy|0|||
155318441|NCT03478956|560600740|FG002|Open Label Extension Period|Adverse Event|4|||
155318442|NCT03478956|560600741|FG003|Open Label Extension Period|Adverse Event|0|||
155318443|NCT03478956|560600738|FG000|Open Label Extension Period|Lack of Efficacy|0|||
155318444|NCT03478956|560600739|FG001|Open Label Extension Period|Lack of Efficacy|0|||
155318445|NCT03478956|560600740|FG002|Open Label Extension Period|Lack of Efficacy|8|||
155318446|NCT03478956|560600741|FG003|Open Label Extension Period|Lack of Efficacy|0|||
155318447|NCT03478956|560600738|FG000|Open Label Extension Period|Reason Not Provided|0|||
155318448|NCT03478956|560600739|FG001|Open Label Extension Period|Reason Not Provided|0|||
155318449|NCT03478956|560600740|FG002|Open Label Extension Period|Reason Not Provided|1|||
155318450|NCT03478956|560600741|FG003|Open Label Extension Period|Reason Not Provided|0|||
155318451|NCT03478956|560600738|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318452|NCT03478956|560600739|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318453|NCT03478956|560600740|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
155318454|NCT03478956|560600741|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318455|NCT03478956|560600738|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
155318456|NCT03478956|560600739|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
155318457|NCT03478956|560600740|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
155318458|NCT03478956|560600741|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
155318459|NCT03478956|560600738|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318460|NCT03478956|560600739|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318461|NCT03478956|560600740|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318462|NCT03478956|560600741|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
155318463|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
155318464|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
155318465|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
155318466|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
155318467|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
155318468|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
155318469|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
155318470|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
155318471|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
155318472|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
155318473|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
155318474|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
155318475|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
155318476|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
155318477|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
155318478|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
155318479|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
155318480|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
155318481|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
155318482|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
155318483|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
155318484|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
155318485|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
155318486|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
155318487|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
155318488|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
155318489|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
155318490|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
155318491|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
155318492|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
155318493|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
155318494|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
155318495|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
155318496|NCT04032847|560600756|FG000|Overall Study|Study termination by sponsor|8|||
155318497|NCT04032847|560600757|FG001|Overall Study|Study termination by sponsor|0|||
155318498|NCT04032847|560600758|FG002|Overall Study|Study termination by sponsor|4|||
155318499|NCT04032847|560600756|FG000|Overall Study|Death|12|||
155318500|NCT04032847|560600757|FG001|Overall Study|Death|0|||
155318501|NCT04032847|560600758|FG002|Overall Study|Death|0|||
155318502|NCT04032847|560600756|FG000|Overall Study|Progressive disease|2|||
155318503|NCT04032847|560600757|FG001|Overall Study|Progressive disease|0|||
155318504|NCT04032847|560600758|FG002|Overall Study|Progressive disease|1|||
155318505|NCT03056573|560600759|FG000|Overall Study|Death|2|||
155318506|NCT03056573|560600760|FG001|Overall Study|Death|4|||
155318507|NCT03056573|560600759|FG000|Overall Study|Withdrawal by Subject|2|||
155318508|NCT03056573|560600760|FG001|Overall Study|Withdrawal by Subject|0|||
155318509|NCT03056573|560600759|FG000|Overall Study|Lost to Follow-up|1|||
155318510|NCT03056573|560600760|FG001|Overall Study|Lost to Follow-up|1|||
155318511|NCT03668236|560602974|FG000|90-day Follow-up|Withdrawal by Subject|3|||
155318512|NCT03668236|560602975|FG001|90-day Follow-up|Withdrawal by Subject|2|||
155318513|NCT03668236|560602974|FG000|90-day Follow-up|Lost to Follow-up|3|||
155318514|NCT03668236|560602975|FG001|90-day Follow-up|Lost to Follow-up|1|||
155318515|NCT03668236|560602974|FG000|Baseline Characteristics|Lost to Follow-up|9|||
155318516|NCT03668236|560602975|FG001|Baseline Characteristics|Lost to Follow-up|5|||
155318517|NCT03668236|560602974|FG000|1-year Follow-up|Withdrawal by Subject|17|||
155318518|NCT03668236|560602975|FG001|1-year Follow-up|Withdrawal by Subject|15|||
155318519|NCT06132282|560602976|FG000|Overall Study|Lost to Follow-up|31|||
155318520|NCT03748953|560602980|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
155318521|NCT03748953|560602981|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
155318522|NCT03748953|560602980|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
155318523|NCT03748953|560602981|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
155318524|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
155318525|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
155318526|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
155318527|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
155318528|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
155318529|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
155318530|NCT04858451|560602982|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
155318531|NCT04858451|560602983|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318532|NCT04858451|560602984|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318533|NCT04858451|560602985|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318534|NCT04858451|560602986|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318535|NCT04858451|560602987|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318536|NCT04858451|560602988|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318537|NCT04858451|560602989|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318538|NCT04858451|560602990|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318539|NCT04858451|560602982|FG000|Part 2|Discontinued|0|||
155318540|NCT04858451|560602983|FG001|Part 2|Discontinued|0|||
155318541|NCT04858451|560602984|FG002|Part 2|Discontinued|0|||
155318542|NCT04858451|560602985|FG003|Part 2|Discontinued|0|||
155318543|NCT04858451|560602986|FG004|Part 2|Discontinued|0|||
155318544|NCT04858451|560602987|FG005|Part 2|Discontinued|0|||
155318545|NCT04858451|560602988|FG006|Part 2|Discontinued|0|||
155318546|NCT04858451|560602989|FG007|Part 2|Discontinued|0|||
155318547|NCT04858451|560602990|FG008|Part 2|Discontinued|63|||
155318548|NCT03314454|560602991|FG000|Overall Study|Protocol Violation|1|||
155318549|NCT02841579|560603000|FG000|Overall Study|Death|1|||
155318550|NCT02841579|560603000|FG000|Overall Study|Adverse Event|1|||
155318551|NCT02841579|560603000|FG000|Overall Study|Lack of Efficacy|9|||
155318552|NCT03011333|560603003|FG000|Overall Study|Lost to Follow-up|0|||
155318553|NCT03011333|560603004|FG001|Overall Study|Lost to Follow-up|1|||
155318554|NCT03011333|560603005|FG002|Overall Study|Lost to Follow-up|0|||
155318555|NCT03011333|560603006|FG003|Overall Study|Lost to Follow-up|1|||
155318556|NCT03011333|560603007|FG004|Overall Study|Lost to Follow-up|4|||
155318557|NCT03011333|560603008|FG005|Overall Study|Lost to Follow-up|4|||
155318558|NCT03011333|560603009|FG006|Overall Study|Lost to Follow-up|5|||
155318559|NCT04233216|560603010|FG000|Overall Study|Lost to Follow-up|1|||
155318560|NCT04233216|560603011|FG001|Overall Study|Lost to Follow-up|0|||
155318561|NCT04233216|560603012|FG002|Overall Study|Lost to Follow-up|2|||
155318562|NCT04233216|560603013|FG003|Overall Study|Lost to Follow-up|0|||
155318563|NCT04233216|560603010|FG000|Overall Study|Physician Decision|0|||
155419267|NCT00236080|560965569|FG002|Overall Study|Lost to Follow-up|0|||
155419268|NCT00236080|560965570|FG003|Overall Study|Lost to Follow-up|0|||
155419269|NCT00236080|560965571|FG004|Overall Study|Lost to Follow-up|0|||
155419270|NCT00236080|560965567|FG000|Overall Study|Physician Decision|1|||
155419271|NCT00236080|560965568|FG001|Overall Study|Physician Decision|0|||
155419272|NCT00236080|560965569|FG002|Overall Study|Physician Decision|1|||
155419273|NCT00236080|560965570|FG003|Overall Study|Physician Decision|1|||
155318564|NCT04233216|560603011|FG001|Overall Study|Physician Decision|3|||
155318565|NCT04233216|560603012|FG002|Overall Study|Physician Decision|0|||
155318566|NCT04233216|560603013|FG003|Overall Study|Physician Decision|2|||
155318567|NCT04233216|560603010|FG000|Overall Study|Withdrawal by Subject|0|||
155318568|NCT04233216|560603011|FG001|Overall Study|Withdrawal by Subject|2|||
155318569|NCT04233216|560603012|FG002|Overall Study|Withdrawal by Subject|1|||
155318570|NCT04233216|560603013|FG003|Overall Study|Withdrawal by Subject|0|||
155419274|NCT00236080|560965571|FG004|Overall Study|Physician Decision|1|||
155419275|NCT00236080|560965567|FG000|Overall Study|Withdrawal by Subject|1|||
155419276|NCT00236080|560965568|FG001|Overall Study|Withdrawal by Subject|0|||
155318571|NCT02998268|560603014|FG000|Overall Study|Adverse Event|0|||
155318572|NCT02998268|560603015|FG001|Overall Study|Adverse Event|2|||
155318573|NCT02998268|560603014|FG000|Overall Study|Withdrawal by Subject|0|||
155318574|NCT02998268|560603015|FG001|Overall Study|Withdrawal by Subject|1|||
155318575|NCT03252847|560603016|FG000|Overall Study|Withdrawal by Subject|0|||
155318576|NCT03252847|560603017|FG001|Overall Study|Withdrawal by Subject|0|||
155419277|NCT00236080|560965569|FG002|Overall Study|Withdrawal by Subject|0|||
155318577|NCT03252847|560603018|FG002|Overall Study|Withdrawal by Subject|1|||
155318578|NCT03252847|560603019|FG003|Overall Study|Withdrawal by Subject|0|||
155318579|NCT03252847|560603020|FG004|Overall Study|Withdrawal by Subject|0|||
155318580|NCT03252847|560603021|FG005|Overall Study|Withdrawal by Subject|0|||
155318581|NCT03252847|560603022|FG006|Overall Study|Withdrawal by Subject|0|||
155318582|NCT03252847|560603016|FG000|Overall Study|Other: Patient decision|0|||
155318583|NCT03252847|560603017|FG001|Overall Study|Other: Patient decision|0|||
155318584|NCT03252847|560603018|FG002|Overall Study|Other: Patient decision|0|||
155318585|NCT03252847|560603019|FG003|Overall Study|Other: Patient decision|0|||
155318586|NCT03252847|560603020|FG004|Overall Study|Other: Patient decision|1|||
155318587|NCT03252847|560603021|FG005|Overall Study|Other: Patient decision|0|||
155318588|NCT03252847|560603022|FG006|Overall Study|Other: Patient decision|0|||
155318589|NCT04298983|560603025|FG000|Overall Study|Adverse Event|4|||
155318590|NCT04298983|560603025|FG000|Overall Study|Lack of Efficacy|3|||
155318591|NCT02723591|560603028|FG000|Overall Study|Adverse Event|48|||
155318592|NCT02723591|560603029|FG001|Overall Study|Adverse Event|40|||
155318593|NCT02723591|560603028|FG000|Overall Study|Death|2|||
155318594|NCT02723591|560603029|FG001|Overall Study|Death|2|||
155318595|NCT02723591|560603028|FG000|Overall Study|Lack of Efficacy|4|||
155318596|NCT02723591|560603029|FG001|Overall Study|Lack of Efficacy|3|||
155318597|NCT02723591|560603028|FG000|Overall Study|Lost to Follow-up|1|||
155318598|NCT02723591|560603029|FG001|Overall Study|Lost to Follow-up|7|||
155318599|NCT02723591|560603028|FG000|Overall Study|Protocol Violation|20|||
155318600|NCT02723591|560603029|FG001|Overall Study|Protocol Violation|23|||
155318601|NCT02723591|560603028|FG000|Overall Study|Withdrawal by Subject|4|||
155318602|NCT02723591|560603029|FG001|Overall Study|Withdrawal by Subject|8|||
155318603|NCT02723591|560603028|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
155318604|NCT02723591|560603029|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
155318605|NCT02723591|560603028|FG000|Overall Study|Miscellaneous|5|||
155318606|NCT02723591|560603029|FG001|Overall Study|Miscellaneous|6|||
155318607|NCT04770402|560603030|FG000|Overall Study|Lost to Follow-up|1|||
155318608|NCT04770402|560603031|FG001|Overall Study|Lost to Follow-up|2|||
155318609|NCT04770402|560603030|FG000|Overall Study|Non-compliance|1|||
155318610|NCT04770402|560603031|FG001|Overall Study|Non-compliance|0|||
155318611|NCT04770402|560603030|FG000|Overall Study|Withdrawal by Subject|0|||
155318612|NCT04770402|560603031|FG001|Overall Study|Withdrawal by Subject|1|||
155318613|NCT02589795|560603032|FG000|Overall Study|Lost to Follow-up|1|||
155318614|NCT02589795|560603033|FG001|Overall Study|Lost to Follow-up|0|||
155318615|NCT02589795|560603034|FG002|Overall Study|Lost to Follow-up|0|||
155318616|NCT02589795|560603032|FG000|Overall Study|Withdrawal by Subject|0|||
155318617|NCT02589795|560603033|FG001|Overall Study|Withdrawal by Subject|0|||
155318618|NCT02589795|560603034|FG002|Overall Study|Withdrawal by Subject|2|||
155318619|NCT02589795|560603032|FG000|Overall Study|Protocol Violation|0|||
155318620|NCT02589795|560603033|FG001|Overall Study|Protocol Violation|0|||
155318621|NCT02589795|560603034|FG002|Overall Study|Protocol Violation|1|||
155318622|NCT03599661|560603036|FG000|Overall Study|Lost to Follow-up|9|||
155318623|NCT04811040|560603037|FG000|Overall Study|Lost to Follow-up|2|||
155318624|NCT04811040|560603038|FG001|Overall Study|Lost to Follow-up|0|||
155318625|NCT04811040|560603039|FG002|Overall Study|Lost to Follow-up|0|||
155318626|NCT04811040|560603040|FG003|Overall Study|Lost to Follow-up|0|||
155318627|NCT04811040|560603037|FG000|Overall Study|Withdrew consent|1|||
155318628|NCT04811040|560603038|FG001|Overall Study|Withdrew consent|1|||
155318629|NCT04811040|560603039|FG002|Overall Study|Withdrew consent|0|||
155419278|NCT00236080|560965570|FG003|Overall Study|Withdrawal by Subject|0|||
155419279|NCT00236080|560965571|FG004|Overall Study|Withdrawal by Subject|0|||
155419280|NCT00236080|560965567|FG000|Overall Study|Miscellaneous|0|||
155419281|NCT00236080|560965568|FG001|Overall Study|Miscellaneous|0|||
155419282|NCT00236080|560965569|FG002|Overall Study|Miscellaneous|1|||
155419283|NCT00236080|560965570|FG003|Overall Study|Miscellaneous|0|||
155419284|NCT00236080|560965571|FG004|Overall Study|Miscellaneous|0|||
155419285|NCT01214044|560965572|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
155419286|NCT01214044|560965572|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
155318630|NCT04811040|560603040|FG003|Overall Study|Withdrew consent|0|||
155419287|NCT01214044|560965572|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
155318631|NCT01828099|560603041|FG000|Treatment Period|Adverse Event|24|||
155318632|NCT01828099|560603042|FG001|Treatment Period|Adverse Event|23|||
155318633|NCT01828099|560603041|FG000|Treatment Period|Death|10|||
155419288|NCT01214044|560965572|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
155419289|NCT01214044|560965572|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
155318634|NCT01828099|560603042|FG001|Treatment Period|Death|12|||
155318635|NCT01828099|560603041|FG000|Treatment Period|Lost to Follow-up|2|||
155318636|NCT01828099|560603042|FG001|Treatment Period|Lost to Follow-up|1|||
155318637|NCT01828099|560603041|FG000|Treatment Period|Non-compliance with study treatment|1|||
155318638|NCT01828099|560603042|FG001|Treatment Period|Non-compliance with study treatment|0|||
155318639|NCT01828099|560603041|FG000|Treatment Period|Physician Decision|17|||
155318640|NCT01828099|560603042|FG001|Treatment Period|Physician Decision|16|||
155318641|NCT01828099|560603041|FG000|Treatment Period|Progressive disease|99|||
155318642|NCT01828099|560603042|FG001|Treatment Period|Progressive disease|107|||
155318643|NCT01828099|560603041|FG000|Treatment Period|Subject/guardian decision|22|||
155318644|NCT01828099|560603042|FG001|Treatment Period|Subject/guardian decision|26|||
155318645|NCT01828099|560603041|FG000|Treatment Period|Study terminated by Sponsor|13|||
155318646|NCT01828099|560603042|FG001|Treatment Period|Study terminated by Sponsor|1|||
155318647|NCT01828099|560603041|FG000|Treatment Period|Protocol deviation|1|||
155318648|NCT01828099|560603042|FG001|Treatment Period|Protocol deviation|0|||
155318649|NCT01828099|560603041|FG000|Treatment Period|No longer requires treatment|0|||
155318650|NCT01828099|560603042|FG001|Treatment Period|No longer requires treatment|1|||
155318651|NCT01828099|560603041|FG000|Extension-treatment Phase|Adverse Event|0|||
155318652|NCT01828099|560603042|FG001|Extension-treatment Phase|Adverse Event|17|||
155318653|NCT01828099|560603041|FG000|Extension-treatment Phase|Death|0|||
155318654|NCT01828099|560603042|FG001|Extension-treatment Phase|Death|11|||
155318655|NCT01828099|560603041|FG000|Extension-treatment Phase|Physician Decision|0|||
155318656|NCT01828099|560603042|FG001|Extension-treatment Phase|Physician Decision|5|||
155318657|NCT01828099|560603041|FG000|Extension-treatment Phase|Progressive disease|0|||
155318658|NCT01828099|560603042|FG001|Extension-treatment Phase|Progressive disease|54|||
155318659|NCT01828099|560603041|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
155318660|NCT01828099|560603042|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
155318661|NCT01828099|560603041|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
155318662|NCT01828099|560603042|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
155318663|NCT05934942|560603044|FG000|Run-in Period|Not treated|1|||
155318664|NCT05934942|560603044|FG000|Run-in Period|Withdrawal by Subject|1|||
155318665|NCT05645757|560603045|FG000|Overall Study|Enrolled but treatment not administered|0|||
155318666|NCT05645757|560603046|FG001|Overall Study|Enrolled but treatment not administered|0|||
155318667|NCT05645757|560603047|FG002|Overall Study|Enrolled but treatment not administered|0|||
155318668|NCT05645757|560603048|FG003|Overall Study|Enrolled but treatment not administered|0|||
155318669|NCT05645757|560603049|FG004|Overall Study|Enrolled but treatment not administered|1|||
155318670|NCT05645757|560603050|FG005|Overall Study|Enrolled but treatment not administered|1|||
155318671|NCT05645757|560603051|FG006|Overall Study|Enrolled but treatment not administered|0|||
155318672|NCT05645757|560603052|FG007|Overall Study|Enrolled but treatment not administered|0|||
155318673|NCT03905798|560603053|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
155318674|NCT04826471|560603054|FG000|Overall Study|Lost to Follow-up|2|||
155318675|NCT04826471|560603054|FG000|Overall Study|Protocol Violation|3|||
155318676|NCT04826471|560603054|FG000|Overall Study|Withdrawal by Subject|1|||
155318677|NCT05764525|560603055|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
155318678|NCT05764525|560603056|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
155318679|NCT05764525|560603055|FG000|Overall Study|Withdrawal by Subject|4|||
155318680|NCT05764525|560603056|FG001|Overall Study|Withdrawal by Subject|8|||
155318681|NCT05764525|560603055|FG000|Overall Study|Physician Decision|1|||
155318682|NCT05764525|560603056|FG001|Overall Study|Physician Decision|0|||
155318683|NCT03334630|560603057|FG000|Overall Study|Withdrawal by Subject|7|||
155318684|NCT03334630|560603058|FG001|Overall Study|Withdrawal by Subject|7|||
155318685|NCT03334630|560603057|FG000|Overall Study|Lost to Follow-up|3|||
155318686|NCT03334630|560603058|FG001|Overall Study|Lost to Follow-up|1|||
155318687|NCT03334630|560603057|FG000|Overall Study|Adverse Event|0|||
155318688|NCT03334630|560603058|FG001|Overall Study|Adverse Event|1|||
155318689|NCT03334630|560603057|FG000|Overall Study|Physician Decision|1|||
155318690|NCT03334630|560603058|FG001|Overall Study|Physician Decision|1|||
155318691|NCT03334630|560603057|FG000|Overall Study|Enrollment closed|2|||
155419290|NCT01214044|560965572|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
155419291|NCT04698525|560965573|FG000|Overall Study|Lost to Follow-up|1|||
155419292|NCT04698525|560965574|FG001|Overall Study|Lost to Follow-up|2|||
155419293|NCT04698525|560965573|FG000|Overall Study|Three suffered of Covid-19|2|||
155419294|NCT04698525|560965574|FG001|Overall Study|Three suffered of Covid-19|1|||
155419295|NCT01961544|560965575|FG000|Overall Study|Protocol Violation|1|||
155419296|NCT01961544|560965575|FG000|Overall Study|Withdrawal by Subject|7|||
155419297|NCT01961544|560965575|FG000|Overall Study|Adverse Event|1|||
155419298|NCT01961544|560965575|FG000|Overall Study|Physician Decision|2|||
155419299|NCT01961544|560965575|FG000|Overall Study|Poor Tolerance|1|||
155419300|NCT01961544|560965575|FG000|Overall Study|Aggravation of Steral Pain|1|||
155419301|NCT03543410|560965576|FG000|Overall Study|Adverse Event|10|||
155419302|NCT03543410|560965577|FG001|Overall Study|Adverse Event|8|||
155419303|NCT03543410|560965578|FG002|Overall Study|Adverse Event|2|||
155419304|NCT03543410|560965576|FG000|Overall Study|Lack of Efficacy|0|||
155419305|NCT03543410|560965577|FG001|Overall Study|Lack of Efficacy|1|||
155419306|NCT03543410|560965578|FG002|Overall Study|Lack of Efficacy|0|||
155500905|NCT03985293|561258597|FG001|FOLLOW-UP|Lost to Follow-up|0|||
155500906|NCT03985293|561258598|FG002|FOLLOW-UP|Lost to Follow-up|1|||
155500907|NCT03985293|561258599|FG003|FOLLOW-UP|Lost to Follow-up|0|||
155500908|NCT03985293|561258600|FG004|FOLLOW-UP|Lost to Follow-up|0|||
155500909|NCT03985293|561258601|FG005|FOLLOW-UP|Lost to Follow-up|0|||
155500910|NCT03078192|561258605|FG000|Overall Study|Withdrawal by Subject|2|||
155500911|NCT03078192|561258606|FG001|Overall Study|Withdrawal by Subject|1|||
155500912|NCT03078192|561258605|FG000|Overall Study|screen failure|0|||
155500913|NCT03078192|561258606|FG001|Overall Study|screen failure|3|||
155500914|NCT02873195|561258607|FG000|Overall Study|Ineligible|5|||
155500915|NCT02873195|561258608|FG001|Overall Study|Ineligible|0|||
155500916|NCT03594175|561258609|FG000|Overall Study|Not treated|8|||
155500917|NCT03594175|561258610|FG001|Overall Study|Not treated|1|||
155318692|NCT03334630|560603058|FG001|Overall Study|Enrollment closed|1|||
155318693|NCT03334630|560603057|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
155318694|NCT03334630|560603058|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
155318695|NCT03334630|560603057|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
155318696|NCT03334630|560603058|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
155318697|NCT05907174|560603059|FG000|3-Month Assessment|Withdrawal by Subject|0|||
155318698|NCT05907174|560603060|FG001|3-Month Assessment|Withdrawal by Subject|0|||
155318699|NCT05907174|560603061|FG002|3-Month Assessment|Withdrawal by Subject|0|||
155318700|NCT05907174|560603062|FG003|3-Month Assessment|Withdrawal by Subject|1|||
155318701|NCT05907174|560603059|FG000|3-Month Assessment|Lost to Follow-up|1|||
155318702|NCT05907174|560603060|FG001|3-Month Assessment|Lost to Follow-up|1|||
155318703|NCT05907174|560603061|FG002|3-Month Assessment|Lost to Follow-up|1|||
155318704|NCT05907174|560603062|FG003|3-Month Assessment|Lost to Follow-up|1|||
155318705|NCT05907174|560603059|FG000|6-Month Assessment|Death|0|||
155318706|NCT05907174|560603060|FG001|6-Month Assessment|Death|0|||
155318707|NCT05907174|560603061|FG002|6-Month Assessment|Death|3|||
155318708|NCT05907174|560603062|FG003|6-Month Assessment|Death|0|||
155318709|NCT05907174|560603059|FG000|6-Month Assessment|Withdrawal by Subject|0|||
155318710|NCT05907174|560603060|FG001|6-Month Assessment|Withdrawal by Subject|0|||
155318711|NCT05907174|560603061|FG002|6-Month Assessment|Withdrawal by Subject|1|||
155318712|NCT05907174|560603062|FG003|6-Month Assessment|Withdrawal by Subject|1|||
155318713|NCT05907174|560603059|FG000|6-Month Assessment|Lost to Follow-up|0|||
155318714|NCT05907174|560603060|FG001|6-Month Assessment|Lost to Follow-up|1|||
155318715|NCT05907174|560603061|FG002|6-Month Assessment|Lost to Follow-up|1|||
155318716|NCT05907174|560603062|FG003|6-Month Assessment|Lost to Follow-up|1|||
155318717|NCT04498390|560603063|FG000|Overall Study|Adverse Event|0|||
155318718|NCT04498390|560603064|FG001|Overall Study|Adverse Event|0|||
155318719|NCT04498390|560603065|FG002|Overall Study|Adverse Event|1|||
155318720|NCT04498390|560603066|FG003|Overall Study|Adverse Event|0|||
155318721|NCT04498390|560603067|FG004|Overall Study|Adverse Event|0|||
155318722|NCT04498390|560603063|FG000|Overall Study|Withdrawal by Subject|0|||
155318723|NCT04498390|560603064|FG001|Overall Study|Withdrawal by Subject|0|||
155318724|NCT04498390|560603065|FG002|Overall Study|Withdrawal by Subject|0|||
155318725|NCT04498390|560603066|FG003|Overall Study|Withdrawal by Subject|1|||
155318726|NCT04498390|560603067|FG004|Overall Study|Withdrawal by Subject|0|||
155318727|NCT01275677|560603077|FG000|Overall Study|Not at risk for recurrence.|1|||
155318728|NCT01275677|560603078|FG001|Overall Study|Not at risk for recurrence.|1|||
155318729|NCT01275677|560603077|FG000|Overall Study|No follow-up|26|||
155318730|NCT01275677|560603078|FG001|Overall Study|No follow-up|37|||
155318731|NCT01275677|560603077|FG000|Overall Study|No clinical follow up.|1|||
155318732|NCT01275677|560603078|FG001|Overall Study|No clinical follow up.|4|||
155318733|NCT03734679|560603086|FG000|Overall Study|Missed Visit|1|||
155318734|NCT02733159|560603091|FG000|Overall Study|Adverse Event|1|||
155318735|NCT02733159|560603091|FG000|Overall Study|Lack of disease progression|1|||
155318736|NCT03088878|560603101|FG000|Overall Study|Adverse Event|0|||
155318737|NCT03088878|560603102|FG001|Overall Study|Adverse Event|0|||
155318738|NCT03088878|560603103|FG002|Overall Study|Adverse Event|0|||
155318739|NCT03088878|560603104|FG003|Overall Study|Adverse Event|0|||
155318740|NCT03088878|560603105|FG004|Overall Study|Adverse Event|4|||
155318741|NCT03088878|560603106|FG005|Overall Study|Adverse Event|2|||
155500918|NCT03594175|561258611|FG002|Overall Study|Not treated|5|||
155643438|NCT05182125|561783831|FG003|Overall Study|Death|0|||
155643439|NCT05182125|561783832|FG004|Overall Study|Death|1|||
155643440|NCT05182125|561783833|FG005|Overall Study|Death|0|||
155643441|NCT05887401|561783835|FG000|Overall Study|Withdrawal by Subject|0|||
155318742|NCT03088878|560603107|FG006|Overall Study|Adverse Event|1|||
155318743|NCT03088878|560603108|FG007|Overall Study|Adverse Event|0|||
155318744|NCT03088878|560603109|FG008|Overall Study|Adverse Event|0|||
155318745|NCT03088878|560603110|FG009|Overall Study|Adverse Event|0|||
155318746|NCT03088878|560603111|FG010|Overall Study|Adverse Event|0|||
155318747|NCT03088878|560603112|FG011|Overall Study|Adverse Event|0|||
155318748|NCT03088878|560603113|FG012|Overall Study|Adverse Event|5|||
155318749|NCT03088878|560603114|FG013|Overall Study|Adverse Event|3|||
155500919|NCT03594175|561258609|FG000|Overall Study|Adverse Event|3|||
155643442|NCT05887401|561783836|FG001|Overall Study|Withdrawal by Subject|0|||
155643443|NCT05887401|561783837|FG002|Overall Study|Withdrawal by Subject|0|||
155643444|NCT05887401|561783838|FG003|Overall Study|Withdrawal by Subject|0|||
155643445|NCT05887401|561783839|FG004|Overall Study|Withdrawal by Subject|0|||
155643446|NCT05887401|561783840|FG005|Overall Study|Withdrawal by Subject|0|||
155643447|NCT05887401|561783841|FG006|Overall Study|Withdrawal by Subject|0|||
155643448|NCT05887401|561783842|FG007|Overall Study|Withdrawal by Subject|0|||
155318750|NCT03088878|560603101|FG000|Overall Study|Clinical Progression|0|||
155318751|NCT03088878|560603102|FG001|Overall Study|Clinical Progression|0|||
155318752|NCT03088878|560603103|FG002|Overall Study|Clinical Progression|0|||
155318753|NCT03088878|560603104|FG003|Overall Study|Clinical Progression|0|||
155318754|NCT03088878|560603105|FG004|Overall Study|Clinical Progression|2|||
155318755|NCT03088878|560603106|FG005|Overall Study|Clinical Progression|0|||
155318756|NCT03088878|560603107|FG006|Overall Study|Clinical Progression|0|||
155318757|NCT03088878|560603108|FG007|Overall Study|Clinical Progression|0|||
155318758|NCT03088878|560603109|FG008|Overall Study|Clinical Progression|0|||
155318759|NCT03088878|560603110|FG009|Overall Study|Clinical Progression|0|||
155318760|NCT03088878|560603111|FG010|Overall Study|Clinical Progression|0|||
155318761|NCT03088878|560603112|FG011|Overall Study|Clinical Progression|0|||
155318762|NCT03088878|560603113|FG012|Overall Study|Clinical Progression|0|||
155318763|NCT03088878|560603114|FG013|Overall Study|Clinical Progression|0|||
155318764|NCT03088878|560603101|FG000|Overall Study|Death|0|||
155318765|NCT03088878|560603102|FG001|Overall Study|Death|0|||
155318766|NCT03088878|560603103|FG002|Overall Study|Death|0|||
155318767|NCT03088878|560603104|FG003|Overall Study|Death|0|||
155318768|NCT03088878|560603105|FG004|Overall Study|Death|2|||
155318769|NCT03088878|560603106|FG005|Overall Study|Death|0|||
155318770|NCT03088878|560603107|FG006|Overall Study|Death|0|||
155318771|NCT03088878|560603108|FG007|Overall Study|Death|0|||
155318772|NCT03088878|560603109|FG008|Overall Study|Death|0|||
155318773|NCT03088878|560603110|FG009|Overall Study|Death|0|||
155318774|NCT03088878|560603111|FG010|Overall Study|Death|0|||
155318775|NCT03088878|560603112|FG011|Overall Study|Death|1|||
155318776|NCT03088878|560603113|FG012|Overall Study|Death|0|||
155318777|NCT03088878|560603114|FG013|Overall Study|Death|0|||
155318778|NCT03088878|560603101|FG000|Overall Study|Disease Progression|1|||
155318779|NCT03088878|560603102|FG001|Overall Study|Disease Progression|2|||
155318780|NCT03088878|560603103|FG002|Overall Study|Disease Progression|3|||
155318781|NCT03088878|560603104|FG003|Overall Study|Disease Progression|0|||
155318782|NCT03088878|560603105|FG004|Overall Study|Disease Progression|3|||
155318783|NCT03088878|560603106|FG005|Overall Study|Disease Progression|0|||
155318784|NCT03088878|560603107|FG006|Overall Study|Disease Progression|0|||
155318785|NCT03088878|560603108|FG007|Overall Study|Disease Progression|0|||
155318786|NCT03088878|560603109|FG008|Overall Study|Disease Progression|0|||
155318787|NCT03088878|560603110|FG009|Overall Study|Disease Progression|0|||
155318788|NCT03088878|560603111|FG010|Overall Study|Disease Progression|0|||
155318789|NCT03088878|560603112|FG011|Overall Study|Disease Progression|0|||
155318790|NCT03088878|560603113|FG012|Overall Study|Disease Progression|1|||
155318791|NCT03088878|560603114|FG013|Overall Study|Disease Progression|1|||
155318792|NCT03088878|560603101|FG000|Overall Study|Initiation of Alternative Treatment|0|||
155318793|NCT03088878|560603102|FG001|Overall Study|Initiation of Alternative Treatment|0|||
155318794|NCT03088878|560603103|FG002|Overall Study|Initiation of Alternative Treatment|0|||
155318795|NCT03088878|560603104|FG003|Overall Study|Initiation of Alternative Treatment|1|||
155318796|NCT03088878|560603105|FG004|Overall Study|Initiation of Alternative Treatment|0|||
155318797|NCT03088878|560603106|FG005|Overall Study|Initiation of Alternative Treatment|0|||
155318798|NCT03088878|560603107|FG006|Overall Study|Initiation of Alternative Treatment|0|||
155643449|NCT05887401|561783843|FG008|Overall Study|Withdrawal by Subject|0|||
155643450|NCT05887401|561783844|FG009|Overall Study|Withdrawal by Subject|1|||
155643451|NCT05887401|561783845|FG010|Overall Study|Withdrawal by Subject|0|||
155643452|NCT05887401|561783846|FG011|Overall Study|Withdrawal by Subject|0|||
155643453|NCT05887401|561783847|FG012|Overall Study|Withdrawal by Subject|0|||
155643454|NCT05887401|561783848|FG013|Overall Study|Withdrawal by Subject|0|||
155643455|NCT05887401|561783849|FG014|Overall Study|Withdrawal by Subject|0|||
155643456|NCT05887401|561783850|FG015|Overall Study|Withdrawal by Subject|1|||
155318799|NCT03088878|560603108|FG007|Overall Study|Initiation of Alternative Treatment|1|||
155318800|NCT03088878|560603109|FG008|Overall Study|Initiation of Alternative Treatment|1|||
155318801|NCT03088878|560603110|FG009|Overall Study|Initiation of Alternative Treatment|0|||
155500920|NCT03594175|561258610|FG001|Overall Study|Adverse Event|0|||
155500921|NCT03594175|561258611|FG002|Overall Study|Adverse Event|0|||
155500922|NCT03594175|561258609|FG000|Overall Study|Withdrawal by Subject|3|||
155318802|NCT03088878|560603111|FG010|Overall Study|Initiation of Alternative Treatment|0|||
155500923|NCT03594175|561258610|FG001|Overall Study|Withdrawal by Subject|0|||
155643457|NCT05887401|561783835|FG000|Overall Study|Lost to Follow-up|0|||
155643458|NCT05887401|561783836|FG001|Overall Study|Lost to Follow-up|1|||
155643459|NCT05887401|561783837|FG002|Overall Study|Lost to Follow-up|1|||
155643460|NCT05887401|561783838|FG003|Overall Study|Lost to Follow-up|2|||
155318803|NCT03088878|560603112|FG011|Overall Study|Initiation of Alternative Treatment|0|||
155318804|NCT03088878|560603113|FG012|Overall Study|Initiation of Alternative Treatment|0|||
155318805|NCT03088878|560603114|FG013|Overall Study|Initiation of Alternative Treatment|0|||
155318806|NCT03088878|560603101|FG000|Overall Study|Withdrawal by Subject|0|||
155318807|NCT03088878|560603102|FG001|Overall Study|Withdrawal by Subject|0|||
155318808|NCT03088878|560603103|FG002|Overall Study|Withdrawal by Subject|0|||
155318809|NCT03088878|560603104|FG003|Overall Study|Withdrawal by Subject|1|||
155419307|NCT03543410|560965576|FG000|Overall Study|Lost to Follow-up|0|||
155419308|NCT03543410|560965577|FG001|Overall Study|Lost to Follow-up|1|||
155318810|NCT03088878|560603105|FG004|Overall Study|Withdrawal by Subject|4|||
155419309|NCT03543410|560965578|FG002|Overall Study|Lost to Follow-up|0|||
155419310|NCT03543410|560965576|FG000|Overall Study|Withdrawal by Subject|5|||
155419311|NCT03543410|560965577|FG001|Overall Study|Withdrawal by Subject|2|||
155419312|NCT03543410|560965578|FG002|Overall Study|Withdrawal by Subject|8|||
155419313|NCT03543410|560965576|FG000|Overall Study|Protocol Violation|0|||
155419314|NCT03543410|560965577|FG001|Overall Study|Protocol Violation|1|||
155419315|NCT03543410|560965578|FG002|Overall Study|Protocol Violation|0|||
155419316|NCT03543410|560965576|FG000|Overall Study|Due to COVID-19|4|||
155419317|NCT03543410|560965577|FG001|Overall Study|Due to COVID-19|0|||
155419318|NCT03543410|560965578|FG002|Overall Study|Due to COVID-19|2|||
155419319|NCT03543410|560965576|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
155419320|NCT03543410|560965577|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
155419321|NCT03543410|560965578|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
155419322|NCT03543410|560965576|FG000|Overall Study|Not Due to COVID-19|2|||
155419323|NCT03543410|560965577|FG001|Overall Study|Not Due to COVID-19|0|||
155419324|NCT03543410|560965578|FG002|Overall Study|Not Due to COVID-19|1|||
155419325|NCT02211261|560965579|FG000|Overall Study|Withdrawal by Subject|0|||
155419326|NCT02211261|560965580|FG001|Overall Study|Withdrawal by Subject|0|||
155419327|NCT02211261|560965581|FG002|Overall Study|Withdrawal by Subject|1|||
155419328|NCT02211261|560965582|FG003|Overall Study|Withdrawal by Subject|0|||
155419329|NCT02211261|560965583|FG004|Overall Study|Withdrawal by Subject|2|||
155419330|NCT02211261|560965584|FG005|Overall Study|Withdrawal by Subject|0|||
155419331|NCT02211261|560965585|FG006|Overall Study|Withdrawal by Subject|0|||
155419332|NCT02211261|560965586|FG007|Overall Study|Withdrawal by Subject|0|||
155419333|NCT02211261|560965587|FG008|Overall Study|Withdrawal by Subject|0|||
155419334|NCT02211261|560965588|FG009|Overall Study|Withdrawal by Subject|0|||
155419335|NCT02211261|560965589|FG010|Overall Study|Withdrawal by Subject|0|||
155419336|NCT02211261|560965579|FG000|Overall Study|Other|0|||
155419337|NCT02211261|560965580|FG001|Overall Study|Other|0|||
155419338|NCT02211261|560965581|FG002|Overall Study|Other|0|||
155419339|NCT02211261|560965582|FG003|Overall Study|Other|0|||
155419340|NCT02211261|560965583|FG004|Overall Study|Other|0|||
155419341|NCT02211261|560965584|FG005|Overall Study|Other|1|||
155419342|NCT02211261|560965585|FG006|Overall Study|Other|0|||
155419343|NCT02211261|560965586|FG007|Overall Study|Other|0|||
155419344|NCT02211261|560965587|FG008|Overall Study|Other|0|||
155419345|NCT02211261|560965588|FG009|Overall Study|Other|2|||
155419346|NCT02211261|560965589|FG010|Overall Study|Other|0|||
155419347|NCT02211261|560965579|FG000|Overall Study|Lost to Follow-up|0|||
155419348|NCT02211261|560965580|FG001|Overall Study|Lost to Follow-up|0|||
155419349|NCT02211261|560965581|FG002|Overall Study|Lost to Follow-up|0|||
155419350|NCT02211261|560965582|FG003|Overall Study|Lost to Follow-up|0|||
155419351|NCT02211261|560965583|FG004|Overall Study|Lost to Follow-up|0|||
155419352|NCT02211261|560965584|FG005|Overall Study|Lost to Follow-up|0|||
155419353|NCT02211261|560965585|FG006|Overall Study|Lost to Follow-up|0|||
155419354|NCT02211261|560965586|FG007|Overall Study|Lost to Follow-up|1|||
155419355|NCT02211261|560965587|FG008|Overall Study|Lost to Follow-up|0|||
155419356|NCT02211261|560965588|FG009|Overall Study|Lost to Follow-up|0|||
155419357|NCT02211261|560965589|FG010|Overall Study|Lost to Follow-up|0|||
155419358|NCT02817087|560965590|FG000|Overall Study|Withdrawal by Subject|2|||
155419359|NCT02817087|560965591|FG001|Overall Study|Withdrawal by Subject|0|||
155419360|NCT00480857|560965594|FG000|Overall Study|Lack of Efficacy|2|||
155419361|NCT02551159|560965597|FG000|Overall Study|Death|352|||
155419362|NCT02551159|560965598|FG001|Overall Study|Death|174|||
155419363|NCT02551159|560965599|FG002|Overall Study|Death|161|||
155419364|NCT02551159|560965597|FG000|Overall Study|Withdrawal by Subject|8|||
155419365|NCT02551159|560965598|FG001|Overall Study|Withdrawal by Subject|5|||
155419366|NCT02551159|560965599|FG002|Overall Study|Withdrawal by Subject|16|||
155318811|NCT03088878|560603106|FG005|Overall Study|Withdrawal by Subject|1|||
155318812|NCT03088878|560603107|FG006|Overall Study|Withdrawal by Subject|1|||
155318813|NCT03088878|560603108|FG007|Overall Study|Withdrawal by Subject|0|||
155419367|NCT02551159|560965597|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
155419368|NCT02551159|560965598|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
155514017|NCT00278512|561308226|FG001|Overall Study|Death|0|||
155318814|NCT03088878|560603109|FG008|Overall Study|Withdrawal by Subject|1|||
155318815|NCT03088878|560603110|FG009|Overall Study|Withdrawal by Subject|2|||
155318816|NCT03088878|560603111|FG010|Overall Study|Withdrawal by Subject|0|||
155419369|NCT02551159|560965599|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
155419370|NCT06098729|560965600|FG000|Overall Study|Withdrawal by Subject|1|||
155419371|NCT02175680|560965607|FG000|Overall Study|non-compliance|1|||
155419372|NCT02175680|560965607|FG000|Overall Study|other non-medical reason|1|||
155419373|NCT01116544|560965611|FG000|Overall Study|Protocol Violation|1|||
155318817|NCT03088878|560603112|FG011|Overall Study|Withdrawal by Subject|2|||
155318818|NCT03088878|560603113|FG012|Overall Study|Withdrawal by Subject|1|||
155318819|NCT03088878|560603114|FG013|Overall Study|Withdrawal by Subject|0|||
155318820|NCT03088878|560603101|FG000|Overall Study|Terminated by Sponsor|2|||
155318821|NCT03088878|560603102|FG001|Overall Study|Terminated by Sponsor|1|||
155318822|NCT03088878|560603103|FG002|Overall Study|Terminated by Sponsor|0|||
155318823|NCT03088878|560603104|FG003|Overall Study|Terminated by Sponsor|1|||
155318824|NCT03088878|560603105|FG004|Overall Study|Terminated by Sponsor|6|||
155318825|NCT03088878|560603106|FG005|Overall Study|Terminated by Sponsor|0|||
155318826|NCT03088878|560603107|FG006|Overall Study|Terminated by Sponsor|0|||
155318827|NCT03088878|560603108|FG007|Overall Study|Terminated by Sponsor|0|||
155318828|NCT03088878|560603109|FG008|Overall Study|Terminated by Sponsor|0|||
155318829|NCT03088878|560603110|FG009|Overall Study|Terminated by Sponsor|0|||
155318830|NCT03088878|560603111|FG010|Overall Study|Terminated by Sponsor|3|||
155318831|NCT03088878|560603112|FG011|Overall Study|Terminated by Sponsor|13|||
155318832|NCT03088878|560603113|FG012|Overall Study|Terminated by Sponsor|2|||
155318833|NCT03088878|560603114|FG013|Overall Study|Terminated by Sponsor|1|||
155318834|NCT03088878|560603101|FG000|Overall Study|Completed 2 years of Treatment|0|||
155318835|NCT03088878|560603102|FG001|Overall Study|Completed 2 years of Treatment|0|||
155419374|NCT01116544|560965612|FG001|Overall Study|Protocol Violation|0|||
155419375|NCT01116544|560965611|FG000|Overall Study|Withdrawal by Subject|1|||
155419376|NCT01116544|560965612|FG001|Overall Study|Withdrawal by Subject|1|||
155419377|NCT02419508|560965613|FG000|Overall Study|Adverse Event|9|||
155419378|NCT02419508|560965614|FG001|Overall Study|Adverse Event|3|||
155419379|NCT02419508|560965613|FG000|Overall Study|Withdrawal by Subject|1|||
155419380|NCT02419508|560965614|FG001|Overall Study|Withdrawal by Subject|0|||
155419381|NCT02419508|560965613|FG000|Overall Study|Other - Reason not specified|0|||
155419382|NCT02419508|560965614|FG001|Overall Study|Other - Reason not specified|1|||
155419383|NCT01738971|560965623|FG000|Overall Study|Lost to Follow-up|19|||
155419384|NCT01738971|560965624|FG001|Overall Study|Lost to Follow-up|30|||
155419385|NCT01738971|560965625|FG002|Overall Study|Lost to Follow-up|17|||
155419386|NCT04698629|560965628|FG000|Overall Study|Adverse Event|1|||
155419387|NCT02320487|560965629|FG000|Overall Study|Reason not Specified|1|||
155419388|NCT02320487|560965629|FG000|Overall Study|Physician Decision|5|||
155419389|NCT02320487|560965629|FG000|Overall Study|Withdrawal by Subject|1|||
155419390|NCT02320487|560965629|FG000|Overall Study|Death|3|||
155419391|NCT02320487|560965629|FG000|Overall Study|Adverse Event|11|||
155419392|NCT01475734|560968055|FG000|Overall Study|Withdrawal by Subject|1|||
155419393|NCT01475734|560968056|FG001|Overall Study|Withdrawal by Subject|0|||
155419394|NCT01475734|560968055|FG000|Overall Study|Protocol Violation|1|||
155419395|NCT01475734|560968056|FG001|Overall Study|Protocol Violation|0|||
155419396|NCT01475734|560968055|FG000|Overall Study|Physician Decision|0|||
155419397|NCT01475734|560968056|FG001|Overall Study|Physician Decision|1|||
155419398|NCT00667576|560968065|FG000|Overall Study|Withdrawal by Subject|1|||
155419399|NCT00667576|560968066|FG001|Overall Study|Withdrawal by Subject|0|||
155419400|NCT00667576|560968067|FG002|Overall Study|Withdrawal by Subject|1|||
155419401|NCT00667576|560968068|FG003|Overall Study|Withdrawal by Subject|1|||
155419402|NCT00667576|560968069|FG004|Overall Study|Withdrawal by Subject|1|||
155419403|NCT00667576|560968065|FG000|Overall Study|Adverse Event|1|||
155419404|NCT00667576|560968066|FG001|Overall Study|Adverse Event|1|||
155419405|NCT00667576|560968067|FG002|Overall Study|Adverse Event|0|||
155419406|NCT00667576|560968068|FG003|Overall Study|Adverse Event|0|||
155419407|NCT00667576|560968069|FG004|Overall Study|Adverse Event|0|||
155419408|NCT00667576|560968065|FG000|Overall Study|Lost to Follow-up|0|||
155419409|NCT00667576|560968066|FG001|Overall Study|Lost to Follow-up|0|||
155419410|NCT00667576|560968067|FG002|Overall Study|Lost to Follow-up|1|||
155419411|NCT00667576|560968068|FG003|Overall Study|Lost to Follow-up|0|||
155419412|NCT00667576|560968069|FG004|Overall Study|Lost to Follow-up|0|||
155419413|NCT00667576|560968065|FG000|Overall Study|Protocol Violation|0|||
155419414|NCT00667576|560968066|FG001|Overall Study|Protocol Violation|0|||
155419415|NCT00667576|560968067|FG002|Overall Study|Protocol Violation|0|||
155419416|NCT00667576|560968068|FG003|Overall Study|Protocol Violation|1|||
155419417|NCT00667576|560968069|FG004|Overall Study|Protocol Violation|0|||
155419418|NCT00667576|560968065|FG000|Overall Study|Physician Decision|0|||
155419419|NCT00667576|560968066|FG001|Overall Study|Physician Decision|0|||
155419420|NCT00667576|560968067|FG002|Overall Study|Physician Decision|0|||
155419421|NCT00667576|560968068|FG003|Overall Study|Physician Decision|1|||
155419422|NCT00667576|560968069|FG004|Overall Study|Physician Decision|0|||
155419423|NCT00667576|560968065|FG000|Overall Study|Missed Visit|0|||
155419424|NCT00667576|560968066|FG001|Overall Study|Missed Visit|0|||
155318836|NCT03088878|560603103|FG002|Overall Study|Completed 2 years of Treatment|0|||
155318837|NCT03088878|560603104|FG003|Overall Study|Completed 2 years of Treatment|0|||
155318838|NCT03088878|560603105|FG004|Overall Study|Completed 2 years of Treatment|0|||
155419425|NCT00667576|560968067|FG002|Overall Study|Missed Visit|0|||
155419426|NCT00667576|560968068|FG003|Overall Study|Missed Visit|1|||
155419427|NCT00667576|560968069|FG004|Overall Study|Missed Visit|0|||
155419428|NCT00670007|560968073|FG000|Overall Study|Drug abuse|1|||
155419429|NCT00670007|560968073|FG000|Overall Study|Lung transplant|1|||
155318839|NCT03088878|560603106|FG005|Overall Study|Completed 2 years of Treatment|0|||
155318840|NCT03088878|560603107|FG006|Overall Study|Completed 2 years of Treatment|1|||
155318841|NCT03088878|560603108|FG007|Overall Study|Completed 2 years of Treatment|0|||
155318842|NCT03088878|560603109|FG008|Overall Study|Completed 2 years of Treatment|0|||
155318843|NCT03088878|560603110|FG009|Overall Study|Completed 2 years of Treatment|1|||
155318844|NCT03088878|560603111|FG010|Overall Study|Completed 2 years of Treatment|0|||
155318845|NCT03088878|560603112|FG011|Overall Study|Completed 2 years of Treatment|0|||
155318846|NCT03088878|560603113|FG012|Overall Study|Completed 2 years of Treatment|8|||
155318847|NCT03088878|560603114|FG013|Overall Study|Completed 2 years of Treatment|3|||
155318848|NCT03088878|560603101|FG000|Overall Study|Physician Decision|0|||
155318849|NCT03088878|560603102|FG001|Overall Study|Physician Decision|0|||
155318850|NCT03088878|560603103|FG002|Overall Study|Physician Decision|0|||
155318851|NCT03088878|560603104|FG003|Overall Study|Physician Decision|0|||
155318852|NCT03088878|560603105|FG004|Overall Study|Physician Decision|0|||
155318853|NCT03088878|560603106|FG005|Overall Study|Physician Decision|0|||
155318854|NCT03088878|560603107|FG006|Overall Study|Physician Decision|0|||
155318855|NCT03088878|560603108|FG007|Overall Study|Physician Decision|2|||
155318856|NCT03088878|560603109|FG008|Overall Study|Physician Decision|1|||
155318857|NCT03088878|560603110|FG009|Overall Study|Physician Decision|0|||
155500924|NCT03594175|561258611|FG002|Overall Study|Withdrawal by Subject|0|||
155500925|NCT03594175|561258609|FG000|Overall Study|Protocol Violation|2|||
155500926|NCT03594175|561258610|FG001|Overall Study|Protocol Violation|2|||
155500927|NCT03594175|561258611|FG002|Overall Study|Protocol Violation|2|||
155318858|NCT03088878|560603111|FG010|Overall Study|Physician Decision|0|||
155419430|NCT00670007|560968073|FG000|Overall Study|Travel/Vacation|1|||
155419431|NCT00670007|560968073|FG000|Overall Study|Adverse event, serious fatal|1|||
155419432|NCT00670007|560968073|FG000|Overall Study|Adverse Event|1|||
155419433|NCT00670007|560968073|FG000|Overall Study|Withdrawal by Subject|4|||
155419434|NCT00618722|560968074|FG000|Overall Study|Refusal of Treatment|0|||
155419435|NCT00618722|560968075|FG001|Overall Study|Refusal of Treatment|0|||
155419436|NCT00618722|560968076|FG002|Overall Study|Refusal of Treatment|1|||
155419437|NCT00618722|560968077|FG003|Overall Study|Refusal of Treatment|0|||
155419438|NCT00618722|560968074|FG000|Overall Study|Patient Request|1|||
155419439|NCT00618722|560968075|FG001|Overall Study|Patient Request|1|||
155419440|NCT00618722|560968076|FG002|Overall Study|Patient Request|1|||
155419441|NCT00618722|560968077|FG003|Overall Study|Patient Request|1|||
155419442|NCT00618722|560968074|FG000|Overall Study|Inability to Complete Study Procedure|0|||
155419443|NCT00618722|560968075|FG001|Overall Study|Inability to Complete Study Procedure|1|||
155419444|NCT00618722|560968076|FG002|Overall Study|Inability to Complete Study Procedure|0|||
155419445|NCT00618722|560968077|FG003|Overall Study|Inability to Complete Study Procedure|0|||
155419446|NCT00618722|560968074|FG000|Overall Study|Lost to Follow-up|2|||
155419447|NCT00618722|560968075|FG001|Overall Study|Lost to Follow-up|0|||
155419448|NCT00618722|560968076|FG002|Overall Study|Lost to Follow-up|0|||
155419449|NCT00618722|560968077|FG003|Overall Study|Lost to Follow-up|2|||
155419450|NCT00618722|560968074|FG000|Overall Study|Miscellaneous Reasons|0|||
155419451|NCT00618722|560968075|FG001|Overall Study|Miscellaneous Reasons|0|||
155419452|NCT00618722|560968076|FG002|Overall Study|Miscellaneous Reasons|1|||
155419453|NCT00618722|560968077|FG003|Overall Study|Miscellaneous Reasons|1|||
155419454|NCT00925600|560968078|FG000|Overall Study|Withdrawal by Subject|16|||
155419455|NCT00925600|560968079|FG001|Overall Study|Withdrawal by Subject|14|||
155419456|NCT00925600|560968078|FG000|Overall Study|Death|4|||
155419457|NCT00925600|560968079|FG001|Overall Study|Death|3|||
155419458|NCT00925600|560968078|FG000|Overall Study|Lost to Follow-up|2|||
155419459|NCT00925600|560968079|FG001|Overall Study|Lost to Follow-up|2|||
155419460|NCT00925600|560968078|FG000|Overall Study|Disease Progression|1|||
155419461|NCT00925600|560968079|FG001|Overall Study|Disease Progression|3|||
155419462|NCT00925600|560968078|FG000|Overall Study|Administrative Decision|1|||
155419463|NCT00925600|560968079|FG001|Overall Study|Administrative Decision|1|||
155419464|NCT00925600|560968078|FG000|Overall Study|Noncompliance|2|||
155419465|NCT00925600|560968079|FG001|Overall Study|Noncompliance|0|||
155419466|NCT00925600|560968078|FG000|Overall Study|Ineligibility Determined|2|||
155419467|NCT00925600|560968079|FG001|Overall Study|Ineligibility Determined|0|||
155500928|NCT01500434|561258612|FG000|Overall Study|Death|1|||
155318859|NCT03088878|560603112|FG011|Overall Study|Physician Decision|0|||
155318860|NCT03088878|560603113|FG012|Overall Study|Physician Decision|0|||
155419468|NCT00925600|560968078|FG000|Overall Study|Protocol Deviation|0|||
155419469|NCT00925600|560968079|FG001|Overall Study|Protocol Deviation|1|||
155419470|NCT00925600|560968078|FG000|Overall Study|Requirement for Alternative Therapy|0|||
155419471|NCT00925600|560968079|FG001|Overall Study|Requirement for Alternative Therapy|1|||
155318861|NCT03088878|560603114|FG013|Overall Study|Physician Decision|1|||
155318862|NCT03088878|560603101|FG000|Overall Study|COVID Related noncompliance|0|||
155318863|NCT03088878|560603102|FG001|Overall Study|COVID Related noncompliance|0|||
155419472|NCT00925600|560968078|FG000|Overall Study|Other|3|||
155419473|NCT00925600|560968079|FG001|Overall Study|Other|1|||
155419474|NCT00925600|560968078|FG000|Overall Study|Adverse Event|1|||
155419475|NCT00925600|560968079|FG001|Overall Study|Adverse Event|2|||
155419476|NCT00127127|560968084|FG000|Overall Study|Adverse Event|0|||
155318864|NCT03088878|560603103|FG002|Overall Study|COVID Related noncompliance|0|||
155318865|NCT03088878|560603104|FG003|Overall Study|COVID Related noncompliance|0|||
155318866|NCT03088878|560603105|FG004|Overall Study|COVID Related noncompliance|0|||
155318867|NCT03088878|560603106|FG005|Overall Study|COVID Related noncompliance|0|||
155318868|NCT03088878|560603107|FG006|Overall Study|COVID Related noncompliance|0|||
155318869|NCT03088878|560603108|FG007|Overall Study|COVID Related noncompliance|0|||
155318870|NCT03088878|560603109|FG008|Overall Study|COVID Related noncompliance|0|||
155318871|NCT03088878|560603110|FG009|Overall Study|COVID Related noncompliance|0|||
155318872|NCT03088878|560603111|FG010|Overall Study|COVID Related noncompliance|0|||
155318873|NCT03088878|560603112|FG011|Overall Study|COVID Related noncompliance|0|||
155318874|NCT03088878|560603113|FG012|Overall Study|COVID Related noncompliance|0|||
155318875|NCT03088878|560603114|FG013|Overall Study|COVID Related noncompliance|1|||
155318876|NCT03088878|560603101|FG000|Overall Study|Drug or Study Noncompliance|0|||
155318877|NCT03088878|560603102|FG001|Overall Study|Drug or Study Noncompliance|0|||
155318878|NCT03088878|560603103|FG002|Overall Study|Drug or Study Noncompliance|0|||
155318879|NCT03088878|560603104|FG003|Overall Study|Drug or Study Noncompliance|0|||
155318880|NCT03088878|560603105|FG004|Overall Study|Drug or Study Noncompliance|0|||
155318881|NCT03088878|560603106|FG005|Overall Study|Drug or Study Noncompliance|0|||
155318882|NCT03088878|560603107|FG006|Overall Study|Drug or Study Noncompliance|0|||
155318883|NCT03088878|560603108|FG007|Overall Study|Drug or Study Noncompliance|0|||
155318884|NCT03088878|560603109|FG008|Overall Study|Drug or Study Noncompliance|0|||
155419477|NCT00127127|560968085|FG001|Overall Study|Adverse Event|2|||
155419478|NCT00127127|560968086|FG002|Overall Study|Adverse Event|0|||
155419479|NCT00127127|560968087|FG003|Overall Study|Adverse Event|1|||
155419480|NCT00127127|560968084|FG000|Overall Study|Lack of Efficacy|1|||
155419481|NCT00127127|560968085|FG001|Overall Study|Lack of Efficacy|3|||
155419482|NCT00127127|560968086|FG002|Overall Study|Lack of Efficacy|0|||
155419483|NCT00127127|560968087|FG003|Overall Study|Lack of Efficacy|2|||
155419484|NCT00200057|560968088|FG000|Overall Study|Lack of Efficacy|3|||
155419485|NCT00200057|560968088|FG000|Overall Study|Exited due to terminal illness of PI|2|||
155419486|NCT00200057|560968088|FG000|Overall Study|Withdrawal by Subject|1|||
155419487|NCT00200057|560968088|FG000|Overall Study|Change in medical condition|1|||
155419488|NCT00200057|560968088|FG000|Overall Study|Infection|1|||
155419489|NCT00200057|560968088|FG000|Overall Study|Death|1|||
155419490|NCT01059448|560968090|FG000|Overall Study|Adverse Event|1|||
155419491|NCT01059448|560968091|FG001|Overall Study|Adverse Event|3|||
155419492|NCT01059448|560968092|FG002|Overall Study|Adverse Event|0|||
155419493|NCT01059448|560968093|FG003|Overall Study|Adverse Event|1|||
155419494|NCT01059448|560968090|FG000|Overall Study|Withdrawal by Subject|2|||
155419495|NCT01059448|560968091|FG001|Overall Study|Withdrawal by Subject|0|||
155419496|NCT01059448|560968092|FG002|Overall Study|Withdrawal by Subject|2|||
155419497|NCT01059448|560968093|FG003|Overall Study|Withdrawal by Subject|4|||
155419498|NCT01059448|560968090|FG000|Overall Study|Disease Progression|2|||
155419499|NCT01059448|560968091|FG001|Overall Study|Disease Progression|1|||
155419500|NCT01059448|560968092|FG002|Overall Study|Disease Progression|4|||
155419501|NCT01059448|560968093|FG003|Overall Study|Disease Progression|2|||
155419502|NCT01059448|560968090|FG000|Overall Study|Administrative Decision|43|||
155419503|NCT01059448|560968091|FG001|Overall Study|Administrative Decision|49|||
155419504|NCT01059448|560968092|FG002|Overall Study|Administrative Decision|45|||
155419505|NCT01059448|560968093|FG003|Overall Study|Administrative Decision|46|||
155419506|NCT01059448|560968090|FG000|Overall Study|Lost to Follow-up|0|||
155419507|NCT01059448|560968091|FG001|Overall Study|Lost to Follow-up|0|||
155419508|NCT01059448|560968092|FG002|Overall Study|Lost to Follow-up|2|||
155318885|NCT03088878|560603110|FG009|Overall Study|Drug or Study Noncompliance|0|||
155318886|NCT03088878|560603111|FG010|Overall Study|Drug or Study Noncompliance|0|||
155318887|NCT03088878|560603112|FG011|Overall Study|Drug or Study Noncompliance|0|||
155318888|NCT03088878|560603113|FG012|Overall Study|Drug or Study Noncompliance|1|||
155318889|NCT03088878|560603114|FG013|Overall Study|Drug or Study Noncompliance|0|||
155318890|NCT04690582|560603115|FG000|Overall Study|Withdrawal by Subject|6|||
155318891|NCT04690582|560603116|FG001|Overall Study|Withdrawal by Subject|4|||
155318892|NCT05104463|560603117|FG000|Overall Study|Adverse Event|1|||
155318893|NCT05104463|560603118|FG001|Overall Study|Adverse Event|1|||
155318894|NCT05104463|560603117|FG000|Overall Study|Lost to Follow-up|1|||
155419509|NCT01059448|560968093|FG003|Overall Study|Lost to Follow-up|0|||
155318895|NCT05104463|560603118|FG001|Overall Study|Lost to Follow-up|1|||
155318896|NCT05104463|560603117|FG000|Overall Study|Physician Decision|1|||
155318897|NCT05104463|560603118|FG001|Overall Study|Physician Decision|0|||
155419510|NCT01059448|560968090|FG000|Overall Study|Death|0|||
155419511|NCT01059448|560968091|FG001|Overall Study|Death|1|||
155419512|NCT01059448|560968092|FG002|Overall Study|Death|0|||
155419513|NCT01059448|560968093|FG003|Overall Study|Death|0|||
155419514|NCT01059448|560968090|FG000|Overall Study|Other|1|||
155419515|NCT01059448|560968091|FG001|Overall Study|Other|1|||
155419516|NCT01059448|560968092|FG002|Overall Study|Other|0|||
155419517|NCT01059448|560968093|FG003|Overall Study|Other|1|||
155419518|NCT00778830|560968094|FG000|Overall Study|Ongoing at data cut-off|0|||
155419519|NCT00778830|560968095|FG001|Overall Study|Ongoing at data cut-off|1|||
155419520|NCT05512949|560968096|FG000|Overall Study|Lost to Follow-up|4|||
155419521|NCT05512949|560968097|FG001|Overall Study|Lost to Follow-up|6|||
155643461|NCT05887401|561783839|FG004|Overall Study|Lost to Follow-up|0|||
155643462|NCT05887401|561783840|FG005|Overall Study|Lost to Follow-up|0|||
155643463|NCT05887401|561783841|FG006|Overall Study|Lost to Follow-up|0|||
155643464|NCT05887401|561783842|FG007|Overall Study|Lost to Follow-up|0|||
155318898|NCT05104463|560603117|FG000|Overall Study|Protocol Violation|0|||
155318899|NCT05104463|560603118|FG001|Overall Study|Protocol Violation|2|||
155318900|NCT05104463|560603117|FG000|Overall Study|Withdrawal by Subject|1|||
155318901|NCT05104463|560603118|FG001|Overall Study|Withdrawal by Subject|1|||
155318902|NCT05267470|560603119|FG000|Overall Study|Decision by sponsor|0|||
155318903|NCT05267470|560603120|FG001|Overall Study|Decision by sponsor|3|||
155643465|NCT05887401|561783843|FG008|Overall Study|Lost to Follow-up|1|||
155643466|NCT05887401|561783844|FG009|Overall Study|Lost to Follow-up|1|||
155643467|NCT05887401|561783845|FG010|Overall Study|Lost to Follow-up|2|||
155643468|NCT05887401|561783846|FG011|Overall Study|Lost to Follow-up|1|||
155643469|NCT05887401|561783847|FG012|Overall Study|Lost to Follow-up|0|||
155643470|NCT05887401|561783848|FG013|Overall Study|Lost to Follow-up|0|||
155643471|NCT05887401|561783849|FG014|Overall Study|Lost to Follow-up|0|||
155643472|NCT05887401|561783850|FG015|Overall Study|Lost to Follow-up|0|||
155643473|NCT04530526|561783851|FG000|Overall Study|Withdrawal by Subject|6|||
155643474|NCT05179603|561783852|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155643475|NCT05179603|561783852|FG000|Overall Study|Withdrawal by Subject|1|||
155643476|NCT05179603|561783852|FG000|Overall Study|Progressive disease|4|||
155643477|NCT05179603|561783852|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
155643478|NCT05937373|561783853|FG000|Overall Study|Out of Window|2|||
155643479|NCT05937373|561783854|FG001|Overall Study|Out of Window|0|||
155643480|NCT05937373|561783853|FG000|Overall Study|Device fell off prior to date of surgery|0|||
155643481|NCT05937373|561783854|FG001|Overall Study|Device fell off prior to date of surgery|2|||
155643482|NCT05942040|561783855|FG000|Overall Study|No longer employed at study site.|0|||
155643483|NCT05942040|561783856|FG001|Overall Study|No longer employed at study site.|0|||
155643484|NCT05942040|561783857|FG002|Overall Study|No longer employed at study site.|3|||
155643485|NCT06061952|561783858|FG000|Overall Study|Withdrawal by Subject|1|||
155643486|NCT06061952|561783859|FG001|Overall Study|Withdrawal by Subject|2|||
155643487|NCT06061952|561783858|FG000|Overall Study|Lost to Follow-up|2|||
155751146|NCT01255787|562188412|FG003|Overall Study|Pregnancy|1|||
155751147|NCT01255787|562188409|FG000|Overall Study|Lack of Efficacy|2|||
155751148|NCT01255787|562188410|FG001|Overall Study|Lack of Efficacy|2|||
155751149|NCT01255787|562188411|FG002|Overall Study|Lack of Efficacy|2|||
155318904|NCT05267470|560603121|FG002|Overall Study|Decision by sponsor|19|||
155318905|NCT05267470|560603122|FG003|Overall Study|Decision by sponsor|7|||
155318906|NCT05267470|560603123|FG004|Overall Study|Decision by sponsor|3|||
155318907|NCT05267470|560603119|FG000|Overall Study|Withdrawal by Subject|1|||
155318908|NCT05267470|560603120|FG001|Overall Study|Withdrawal by Subject|1|||
155318909|NCT05267470|560603121|FG002|Overall Study|Withdrawal by Subject|2|||
155318910|NCT05267470|560603122|FG003|Overall Study|Withdrawal by Subject|2|||
155318911|NCT05267470|560603123|FG004|Overall Study|Withdrawal by Subject|0|||
155318912|NCT05267470|560603119|FG000|Overall Study|Death|3|||
155419522|NCT05512949|560968098|FG002|Overall Study|Lost to Follow-up|2|||
155419523|NCT05512949|560968096|FG000|Overall Study|Protocol Violation|0|||
155419524|NCT05512949|560968097|FG001|Overall Study|Protocol Violation|0|||
155419525|NCT05512949|560968098|FG002|Overall Study|Protocol Violation|1|||
155419526|NCT05512949|560968096|FG000|Overall Study|Withdrawal by Subject|1|||
155419527|NCT05512949|560968097|FG001|Overall Study|Withdrawal by Subject|1|||
155419528|NCT05512949|560968098|FG002|Overall Study|Withdrawal by Subject|2|||
155419529|NCT05512949|560968096|FG000|Overall Study|Completion status unknown|1|||
155419530|NCT05512949|560968097|FG001|Overall Study|Completion status unknown|3|||
155419531|NCT05512949|560968098|FG002|Overall Study|Completion status unknown|0|||
155419532|NCT01891643|560968099|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155419533|NCT01891643|560968100|FG001|Overall Study|Adverse event unrelated to study drug|5|||
155419534|NCT01891643|560968099|FG000|Overall Study|Disease Progression|4|||
155419535|NCT01891643|560968100|FG001|Overall Study|Disease Progression|3|||
155419536|NCT01891643|560968099|FG000|Overall Study|Study Drug Toxicity|3|||
155419537|NCT01891643|560968100|FG001|Overall Study|Study Drug Toxicity|0|||
155419538|NCT01891643|560968099|FG000|Overall Study|Maximum Clinical Benefit|0|||
155419539|NCT01891643|560968100|FG001|Overall Study|Maximum Clinical Benefit|1|||
155643488|NCT06061952|561783859|FG001|Overall Study|Lost to Follow-up|2|||
155643489|NCT06142383|561783860|FG000|Overall Study|Mis-randomized|0|||
155643490|NCT06142383|561783861|FG001|Overall Study|Mis-randomized|0|||
155643491|NCT06142383|561783862|FG002|Overall Study|Mis-randomized|1|||
155643492|NCT06142383|561783863|FG003|Overall Study|Mis-randomized|0|||
155751150|NCT01255787|562188412|FG003|Overall Study|Lack of Efficacy|2|||
155318913|NCT05267470|560603120|FG001|Overall Study|Death|5|||
155318914|NCT05267470|560603121|FG002|Overall Study|Death|8|||
155318915|NCT05267470|560603122|FG003|Overall Study|Death|18|||
155419540|NCT01891643|560968099|FG000|Overall Study|Poor/Non-compliance|0|||
155419541|NCT01891643|560968100|FG001|Overall Study|Poor/Non-compliance|1|||
155419542|NCT01891643|560968099|FG000|Overall Study|Participant request to discontinue|1|||
155318916|NCT05267470|560603123|FG004|Overall Study|Death|1|||
155318917|NCT05267470|560603119|FG000|Overall Study|Lost to Follow-up|0|||
155318918|NCT05267470|560603120|FG001|Overall Study|Lost to Follow-up|0|||
155318919|NCT05267470|560603121|FG002|Overall Study|Lost to Follow-up|0|||
155318920|NCT05267470|560603122|FG003|Overall Study|Lost to Follow-up|1|||
155318921|NCT05267470|560603123|FG004|Overall Study|Lost to Follow-up|0|||
155318922|NCT04428203|560603124|FG000|Overall Study|Adverse Event|1|||
155318923|NCT04428203|560603125|FG001|Overall Study|Adverse Event|0|||
155318924|NCT04428203|560603126|FG002|Overall Study|Adverse Event|0|||
155318925|NCT04428203|560603124|FG000|Overall Study|Withdrawal by Subject|1|||
155318926|NCT04428203|560603125|FG001|Overall Study|Withdrawal by Subject|0|||
155318927|NCT04428203|560603126|FG002|Overall Study|Withdrawal by Subject|1|||
155318928|NCT02823145|560603127|FG000|Enrollment|Other|1|||
155318929|NCT02823145|560603128|FG001|Enrollment|Other|0|||
155318930|NCT02823145|560603127|FG000|Treatment|Adverse Event|0|||
155318931|NCT02823145|560603128|FG001|Treatment|Adverse Event|11|||
155318932|NCT02823145|560603127|FG000|Treatment|Death|0|||
155318933|NCT02823145|560603128|FG001|Treatment|Death|3|||
155318934|NCT02823145|560603127|FG000|Treatment|Family Decision|0|||
155318935|NCT02823145|560603128|FG001|Treatment|Family Decision|1|||
155318936|NCT02823145|560603127|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
155318937|NCT02823145|560603128|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
155318938|NCT02823145|560603127|FG000|Treatment|Lack of Efficacy|0|||
155318939|NCT02823145|560603128|FG001|Treatment|Lack of Efficacy|48|||
155318940|NCT02823145|560603127|FG000|Treatment|Non-Compliance With E-Diary|0|||
155318941|NCT02823145|560603128|FG001|Treatment|Non-Compliance With E-Diary|1|||
155318942|NCT02823145|560603127|FG000|Treatment|Physician Decision|0|||
155318943|NCT02823145|560603128|FG001|Treatment|Physician Decision|2|||
155318944|NCT02823145|560603127|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
155318945|NCT02823145|560603128|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
155318946|NCT02823145|560603127|FG000|Treatment|Subject needed to take prohibited medication|0|||
155318947|NCT02823145|560603128|FG001|Treatment|Subject needed to take prohibited medication|1|||
155318948|NCT02823145|560603127|FG000|Treatment|Subject transferred to direct access programme|0|||
155318949|NCT02823145|560603128|FG001|Treatment|Subject transferred to direct access programme|1|||
155318950|NCT02823145|560603127|FG000|Treatment|Switching to commercially available drug|0|||
155318951|NCT02823145|560603128|FG001|Treatment|Switching to commercially available drug|11|||
155318952|NCT02823145|560603127|FG000|Treatment|Transitioned to commercial supply of medication|0|||
155318953|NCT02823145|560603128|FG001|Treatment|Transitioned to commercial supply of medication|1|||
155318954|NCT02823145|560603127|FG000|Treatment|Withdrawal By Caregiver|0|||
155318955|NCT02823145|560603128|FG001|Treatment|Withdrawal By Caregiver|1|||
155318956|NCT02823145|560603127|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
155318957|NCT02823145|560603128|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
155318958|NCT02823145|560603127|FG000|Treatment|Withdrawal by Subject|0|||
155318959|NCT02823145|560603128|FG001|Treatment|Withdrawal by Subject|16|||
155318960|NCT02823145|560603127|FG000|Treatment|Reason unknown|0|||
155318961|NCT02823145|560603128|FG001|Treatment|Reason unknown|1|||
155318962|NCT04741776|560603129|FG000|Overall Study|Withdrawal by Subject|7|||
155318963|NCT04741776|560603130|FG001|Overall Study|Withdrawal by Subject|10|||
155318964|NCT04741776|560603131|FG002|Overall Study|Withdrawal by Subject|10|||
155318965|NCT04741776|560603132|FG003|Overall Study|Withdrawal by Subject|17|||
155318966|NCT04741776|560603129|FG000|Overall Study|Death|0|||
155318967|NCT04741776|560603130|FG001|Overall Study|Death|0|||
155318968|NCT04741776|560603131|FG002|Overall Study|Death|1|||
155318969|NCT04741776|560603132|FG003|Overall Study|Death|0|||
155318970|NCT02852655|560603148|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
155318971|NCT02852655|560603149|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
155318972|NCT02852655|560603150|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
155318973|NCT02852655|560603148|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
155318974|NCT02852655|560603149|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
155318975|NCT02852655|560603150|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
155318976|NCT02852655|560603148|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
155318977|NCT02852655|560603149|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
155318978|NCT02852655|560603150|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
155318979|NCT02852655|560603148|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
155318980|NCT02852655|560603149|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
155318981|NCT02852655|560603150|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
155318982|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
155318983|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
155318984|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
155318985|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
155318986|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
155318987|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
155318988|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
155318989|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
155318990|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
155318991|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
155318992|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
155318993|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
155318994|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
155318995|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
155318996|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
155318997|NCT03257410|560605348|FG000|Overall Study|Adverse Event|2|||
155318998|NCT03257410|560605349|FG001|Overall Study|Adverse Event|3|||
155318999|NCT03257410|560605348|FG000|Overall Study|Protocol Violation|1|||
155319000|NCT03257410|560605349|FG001|Overall Study|Protocol Violation|2|||
155319001|NCT03257410|560605348|FG000|Overall Study|Lost to Follow-up|1|||
155319002|NCT03257410|560605349|FG001|Overall Study|Lost to Follow-up|0|||
155319003|NCT03257410|560605348|FG000|Overall Study|Withdrawal by Subject|1|||
155319004|NCT03257410|560605349|FG001|Overall Study|Withdrawal by Subject|2|||
155319005|NCT03257410|560605348|FG000|Overall Study|Physician Decision|1|||
155319006|NCT03257410|560605349|FG001|Overall Study|Physician Decision|1|||
155319007|NCT03257410|560605348|FG000|Overall Study|Renal transplantation|2|||
155319008|NCT03257410|560605349|FG001|Overall Study|Renal transplantation|0|||
155319009|NCT03257410|560605348|FG000|Overall Study|Switch to peritoneal dialysis|1|||
155319010|NCT03257410|560605349|FG001|Overall Study|Switch to peritoneal dialysis|0|||
155319011|NCT03257410|560605348|FG000|Overall Study|Death|3|||
155319012|NCT03257410|560605349|FG001|Overall Study|Death|2|||
155319013|NCT03257410|560605348|FG000|Overall Study|Change to another dialysis center|2|||
155319014|NCT03257410|560605349|FG001|Overall Study|Change to another dialysis center|2|||
155319015|NCT03257410|560605348|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
155319016|NCT03257410|560605349|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
155319017|NCT03257410|560605348|FG000|Overall Study|Miscellaneous|2|||
155319018|NCT03257410|560605349|FG001|Overall Study|Miscellaneous|2|||
155319019|NCT03257410|560605348|FG000|Overall Study|Other|0|||
155319020|NCT03257410|560605349|FG001|Overall Study|Other|1|||
155319021|NCT02598388|560605350|FG000|Overall Study|Lost to Follow-up|1|||
155319022|NCT02598388|560605351|FG001|Overall Study|Lost to Follow-up|0|||
155319023|NCT02598388|560605352|FG002|Overall Study|Lost to Follow-up|1|||
155319024|NCT02598388|560605353|FG003|Overall Study|Lost to Follow-up|0|||
155319025|NCT02598388|560605354|FG004|Overall Study|Lost to Follow-up|5|||
155319026|NCT02598388|560605355|FG005|Overall Study|Lost to Follow-up|1|||
155319027|NCT02598388|560605356|FG006|Overall Study|Lost to Follow-up|2|||
155319028|NCT02598388|560605357|FG007|Overall Study|Lost to Follow-up|1|||
155319029|NCT02598388|560605358|FG008|Overall Study|Lost to Follow-up|0|||
155319030|NCT02598388|560605359|FG009|Overall Study|Lost to Follow-up|0|||
155319031|NCT02598388|560605360|FG010|Overall Study|Lost to Follow-up|1|||
155319032|NCT02598388|560605361|FG011|Overall Study|Lost to Follow-up|0|||
155319033|NCT02598388|560605350|FG000|Overall Study|Withdrawal by Subject|0|||
155319034|NCT02598388|560605351|FG001|Overall Study|Withdrawal by Subject|0|||
155319035|NCT02598388|560605352|FG002|Overall Study|Withdrawal by Subject|0|||
155319036|NCT02598388|560605353|FG003|Overall Study|Withdrawal by Subject|0|||
155643493|NCT06142383|561783864|FG004|Overall Study|Mis-randomized|0|||
155643494|NCT06142383|561783860|FG000|Overall Study|Adverse Event|0|||
155319037|NCT02598388|560605354|FG004|Overall Study|Withdrawal by Subject|2|||
155319038|NCT02598388|560605355|FG005|Overall Study|Withdrawal by Subject|0|||
155319039|NCT02598388|560605356|FG006|Overall Study|Withdrawal by Subject|2|||
155319040|NCT02598388|560605357|FG007|Overall Study|Withdrawal by Subject|0|||
155319041|NCT02598388|560605358|FG008|Overall Study|Withdrawal by Subject|0|||
155319042|NCT02598388|560605359|FG009|Overall Study|Withdrawal by Subject|1|||
155319043|NCT02598388|560605360|FG010|Overall Study|Withdrawal by Subject|0|||
155319044|NCT02598388|560605361|FG011|Overall Study|Withdrawal by Subject|0|||
155319045|NCT02598388|560605350|FG000|Overall Study|Other|0|||
155319046|NCT02598388|560605351|FG001|Overall Study|Other|0|||
155319047|NCT02598388|560605352|FG002|Overall Study|Other|1|||
155319048|NCT02598388|560605353|FG003|Overall Study|Other|0|||
155319049|NCT02598388|560605354|FG004|Overall Study|Other|3|||
155319050|NCT02598388|560605355|FG005|Overall Study|Other|0|||
155319051|NCT02598388|560605356|FG006|Overall Study|Other|1|||
155319052|NCT02598388|560605357|FG007|Overall Study|Other|0|||
155643495|NCT06142383|561783861|FG001|Overall Study|Adverse Event|1|||
155643496|NCT06142383|561783862|FG002|Overall Study|Adverse Event|1|||
155319053|NCT02598388|560605358|FG008|Overall Study|Other|0|||
155319054|NCT02598388|560605359|FG009|Overall Study|Other|0|||
155319055|NCT02598388|560605360|FG010|Overall Study|Other|0|||
155319056|NCT02598388|560605361|FG011|Overall Study|Other|0|||
155319057|NCT05256017|560605364|FG000|Treatment Period|Withdrawal by Subject|1|||
155319058|NCT05256017|560605365|FG001|Treatment Period|Withdrawal by Subject|1|||
155319059|NCT05256017|560605364|FG000|Follow-up|Lost to Follow-up|7|||
155514018|NCT01626859|561308227|FG000|Overall Study|Adverse Event|1|||
155319060|NCT05256017|560605365|FG001|Follow-up|Lost to Follow-up|1|||
155319061|NCT05256017|560605364|FG000|Follow-up|Withdrawal by Subject|1|||
155319062|NCT05256017|560605365|FG001|Follow-up|Withdrawal by Subject|0|||
155319063|NCT05256017|560605364|FG000|Follow-up|Death|0|||
155319064|NCT05256017|560605365|FG001|Follow-up|Death|1|||
155319065|NCT04171141|560605366|FG000|Overall Study|Adverse Event|0|||
155319066|NCT04171141|560605367|FG001|Overall Study|Adverse Event|0|||
155319067|NCT04171141|560605368|FG002|Overall Study|Adverse Event|2|||
155319068|NCT04171141|560605369|FG003|Overall Study|Adverse Event|0|||
155319069|NCT04171141|560605370|FG004|Overall Study|Adverse Event|0|||
155319070|NCT04171141|560605371|FG005|Overall Study|Adverse Event|0|||
155319071|NCT04171141|560605372|FG006|Overall Study|Adverse Event|0|||
155319072|NCT04171141|560605373|FG007|Overall Study|Adverse Event|0|||
155319073|NCT04171141|560605374|FG008|Overall Study|Adverse Event|0|||
155319074|NCT04171141|560605375|FG009|Overall Study|Adverse Event|0|||
155319075|NCT04171141|560605376|FG010|Overall Study|Adverse Event|0|||
155319076|NCT04171141|560605377|FG011|Overall Study|Adverse Event|0|||
155319077|NCT04171141|560605378|FG012|Overall Study|Adverse Event|0|||
155319078|NCT04171141|560605379|FG013|Overall Study|Adverse Event|2|||
155319079|NCT04171141|560605380|FG014|Overall Study|Adverse Event|0|||
155319080|NCT04171141|560605381|FG015|Overall Study|Adverse Event|0|||
155319081|NCT04171141|560605366|FG000|Overall Study|Physician Decision|0|||
155319082|NCT04171141|560605367|FG001|Overall Study|Physician Decision|0|||
155319083|NCT04171141|560605368|FG002|Overall Study|Physician Decision|0|||
155319084|NCT04171141|560605369|FG003|Overall Study|Physician Decision|0|||
155319085|NCT04171141|560605370|FG004|Overall Study|Physician Decision|1|||
155319086|NCT04171141|560605371|FG005|Overall Study|Physician Decision|0|||
155319087|NCT04171141|560605372|FG006|Overall Study|Physician Decision|0|||
155319088|NCT04171141|560605373|FG007|Overall Study|Physician Decision|0|||
155319089|NCT04171141|560605374|FG008|Overall Study|Physician Decision|0|||
155319090|NCT04171141|560605375|FG009|Overall Study|Physician Decision|0|||
155319091|NCT04171141|560605376|FG010|Overall Study|Physician Decision|0|||
155319092|NCT04171141|560605377|FG011|Overall Study|Physician Decision|0|||
155319093|NCT04171141|560605378|FG012|Overall Study|Physician Decision|0|||
155319094|NCT04171141|560605379|FG013|Overall Study|Physician Decision|0|||
155319095|NCT04171141|560605380|FG014|Overall Study|Physician Decision|0|||
155319096|NCT04171141|560605381|FG015|Overall Study|Physician Decision|1|||
155319097|NCT04171141|560605366|FG000|Overall Study|Progressive disease|2|||
155319098|NCT04171141|560605367|FG001|Overall Study|Progressive disease|3|||
155319099|NCT04171141|560605368|FG002|Overall Study|Progressive disease|4|||
155319100|NCT04171141|560605369|FG003|Overall Study|Progressive disease|7|||
155319101|NCT04171141|560605370|FG004|Overall Study|Progressive disease|1|||
155319102|NCT04171141|560605371|FG005|Overall Study|Progressive disease|8|||
155319103|NCT04171141|560605372|FG006|Overall Study|Progressive disease|4|||
155319104|NCT04171141|560605373|FG007|Overall Study|Progressive disease|6|||
155319105|NCT04171141|560605374|FG008|Overall Study|Progressive disease|7|||
155319106|NCT04171141|560605375|FG009|Overall Study|Progressive disease|3|||
155319107|NCT04171141|560605376|FG010|Overall Study|Progressive disease|4|||
155319108|NCT04171141|560605377|FG011|Overall Study|Progressive disease|3|||
155419543|NCT01891643|560968100|FG001|Overall Study|Participant request to discontinue|0|||
155419544|NCT02810964|560968103|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
155419545|NCT02810964|560968104|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
155419546|NCT02810964|560968103|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
155419547|NCT02810964|560968104|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
155419548|NCT02810964|560968103|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
155419549|NCT02810964|560968104|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
155419550|NCT02810964|560968103|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
155419551|NCT02810964|560968104|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
155419552|NCT03523351|560968105|FG000|Overall Study|Death|13|||
155419553|NCT03523351|560968106|FG001|Overall Study|Death|11|||
155419554|NCT03523351|560968105|FG000|Overall Study|Lost to Follow-up|2|||
155419555|NCT03523351|560968106|FG001|Overall Study|Lost to Follow-up|3|||
155419556|NCT03523351|560968105|FG000|Overall Study|Withdrawal by Subject|4|||
155419557|NCT03523351|560968106|FG001|Overall Study|Withdrawal by Subject|0|||
155419558|NCT03523351|560968105|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
155419559|NCT03523351|560968106|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
155419560|NCT01430442|560968108|FG000|Overall Study|Subject Withdrew Consent|3|||
155419561|NCT01430442|560968109|FG001|Overall Study|Subject Withdrew Consent|0|||
155319109|NCT04171141|560605378|FG012|Overall Study|Progressive disease|4|||
155319110|NCT04171141|560605379|FG013|Overall Study|Progressive disease|2|||
155319111|NCT04171141|560605380|FG014|Overall Study|Progressive disease|4|||
155319112|NCT04171141|560605381|FG015|Overall Study|Progressive disease|1|||
155319113|NCT04171141|560605366|FG000|Overall Study|Withdrawal by Subject|0|||
155319114|NCT04171141|560605367|FG001|Overall Study|Withdrawal by Subject|0|||
155319115|NCT04171141|560605368|FG002|Overall Study|Withdrawal by Subject|0|||
155319116|NCT04171141|560605369|FG003|Overall Study|Withdrawal by Subject|1|||
155319117|NCT04171141|560605370|FG004|Overall Study|Withdrawal by Subject|0|||
155319118|NCT04171141|560605371|FG005|Overall Study|Withdrawal by Subject|0|||
155319119|NCT04171141|560605372|FG006|Overall Study|Withdrawal by Subject|1|||
155319120|NCT04171141|560605373|FG007|Overall Study|Withdrawal by Subject|0|||
155319121|NCT04171141|560605374|FG008|Overall Study|Withdrawal by Subject|0|||
155319122|NCT04171141|560605375|FG009|Overall Study|Withdrawal by Subject|1|||
155319123|NCT04171141|560605376|FG010|Overall Study|Withdrawal by Subject|0|||
155319124|NCT04171141|560605377|FG011|Overall Study|Withdrawal by Subject|0|||
155319125|NCT04171141|560605378|FG012|Overall Study|Withdrawal by Subject|0|||
155319126|NCT04171141|560605379|FG013|Overall Study|Withdrawal by Subject|0|||
155319127|NCT04171141|560605380|FG014|Overall Study|Withdrawal by Subject|0|||
155319128|NCT04171141|560605381|FG015|Overall Study|Withdrawal by Subject|0|||
155319129|NCT04171141|560605366|FG000|Overall Study|Global deterioration of health status|0|||
155319130|NCT04171141|560605367|FG001|Overall Study|Global deterioration of health status|0|||
155319131|NCT04171141|560605368|FG002|Overall Study|Global deterioration of health status|0|||
155319132|NCT04171141|560605369|FG003|Overall Study|Global deterioration of health status|1|||
155319133|NCT04171141|560605370|FG004|Overall Study|Global deterioration of health status|0|||
155319134|NCT04171141|560605371|FG005|Overall Study|Global deterioration of health status|2|||
155319135|NCT04171141|560605372|FG006|Overall Study|Global deterioration of health status|1|||
155319136|NCT04171141|560605373|FG007|Overall Study|Global deterioration of health status|0|||
155319137|NCT04171141|560605374|FG008|Overall Study|Global deterioration of health status|1|||
155319138|NCT04171141|560605375|FG009|Overall Study|Global deterioration of health status|0|||
155319139|NCT04171141|560605376|FG010|Overall Study|Global deterioration of health status|0|||
155319140|NCT04171141|560605377|FG011|Overall Study|Global deterioration of health status|0|||
155319141|NCT04171141|560605378|FG012|Overall Study|Global deterioration of health status|0|||
155319142|NCT04171141|560605379|FG013|Overall Study|Global deterioration of health status|0|||
155319143|NCT04171141|560605380|FG014|Overall Study|Global deterioration of health status|1|||
155319144|NCT04171141|560605381|FG015|Overall Study|Global deterioration of health status|1|||
155319145|NCT03663569|560605382|FG000|Overall Study|Discontinuation of study|11|||
155319146|NCT03663569|560605382|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
155319147|NCT03663569|560605382|FG000|Overall Study|Deceased patient|6|||
155319148|NCT03663569|560605382|FG000|Overall Study|Lost to Follow-up|18|||
155319149|NCT03663569|560605382|FG000|Overall Study|Withdrawal of consent|5|||
155319150|NCT03663569|560605382|FG000|Overall Study|Patient's request|11|||
155319151|NCT03663569|560605382|FG000|Overall Study|Adverse Event|4|||
155319152|NCT03663569|560605382|FG000|Overall Study|Not come to second visit|3|||
155319153|NCT03663569|560605382|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
155319154|NCT03663569|560605382|FG000|Overall Study|Serious adverse event|1|||
155319155|NCT04979442|560605383|FG000|Overall Study|Death|43|||
155419562|NCT01430442|560968110|FG002|Overall Study|Subject Withdrew Consent|1|||
155419563|NCT01430442|560968111|FG003|Overall Study|Subject Withdrew Consent|0|||
155419564|NCT01430442|560968112|FG004|Overall Study|Subject Withdrew Consent|2|||
155419565|NCT01430442|560968113|FG005|Overall Study|Subject Withdrew Consent|1|||
155419566|NCT01430442|560968114|FG006|Overall Study|Subject Withdrew Consent|5|||
155419567|NCT01430442|560968115|FG007|Overall Study|Subject Withdrew Consent|2|||
155419568|NCT01430442|560968108|FG000|Overall Study|Lost to Follow-up|2|||
155419569|NCT01430442|560968109|FG001|Overall Study|Lost to Follow-up|0|||
155419570|NCT01430442|560968110|FG002|Overall Study|Lost to Follow-up|1|||
155419571|NCT01430442|560968111|FG003|Overall Study|Lost to Follow-up|2|||
155419572|NCT01430442|560968112|FG004|Overall Study|Lost to Follow-up|2|||
155419573|NCT01430442|560968113|FG005|Overall Study|Lost to Follow-up|1|||
155419574|NCT01430442|560968114|FG006|Overall Study|Lost to Follow-up|5|||
155419575|NCT01430442|560968115|FG007|Overall Study|Lost to Follow-up|1|||
155319156|NCT04979442|560605384|FG001|Overall Study|Death|30|||
155319157|NCT04979442|560605383|FG000|Overall Study|Withdrawal by Subject|8|||
155319158|NCT04979442|560605384|FG001|Overall Study|Withdrawal by Subject|13|||
155319159|NCT04979442|560605383|FG000|Overall Study|Physician Decision|1|||
155319160|NCT04979442|560605384|FG001|Overall Study|Physician Decision|1|||
155319161|NCT04979442|560605383|FG000|Overall Study|Lost to Follow-up|0|||
155319162|NCT04979442|560605384|FG001|Overall Study|Lost to Follow-up|2|||
155319163|NCT04979442|560605383|FG000|Overall Study|do not want to continue|0|||
155319164|NCT04979442|560605384|FG001|Overall Study|do not want to continue|1|||
155319165|NCT04005794|560605386|FG000|Overall Study|Lost to Follow-up|0|||
155319166|NCT04005794|560605387|FG001|Overall Study|Lost to Follow-up|4|||
155319167|NCT04005794|560605388|FG002|Overall Study|Lost to Follow-up|0|||
155319168|NCT00104676|560605392|FG000|Overall Study|Death|3|||
155419576|NCT01430442|560968108|FG000|Overall Study|Pregnancy|1|||
155419577|NCT01430442|560968109|FG001|Overall Study|Pregnancy|0|||
155419578|NCT01430442|560968110|FG002|Overall Study|Pregnancy|0|||
155319169|NCT00104676|560605393|FG001|Overall Study|Death|2|||
155319170|NCT00104676|560605392|FG000|Overall Study|Withdrawal by Subject|0|||
155319171|NCT00104676|560605393|FG001|Overall Study|Withdrawal by Subject|2|||
155419579|NCT01430442|560968111|FG003|Overall Study|Pregnancy|0|||
155419580|NCT01430442|560968112|FG004|Overall Study|Pregnancy|0|||
155419581|NCT01430442|560968113|FG005|Overall Study|Pregnancy|1|||
155419582|NCT01430442|560968114|FG006|Overall Study|Pregnancy|0|||
155419583|NCT01430442|560968115|FG007|Overall Study|Pregnancy|0|||
155419584|NCT01430442|560968108|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
155419585|NCT01430442|560968109|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
155319172|NCT00104676|560605392|FG000|Overall Study|treatment interruption|4|||
155319173|NCT00104676|560605393|FG001|Overall Study|treatment interruption|10|||
155319174|NCT05622812|560605394|FG000|Overall Study|Withdrawal by Subject|1|||
155319175|NCT05622812|560605395|FG001|Overall Study|Withdrawal by Subject|4|||
155319176|NCT05622812|560605394|FG000|Overall Study|Lost to Follow-up|2|||
155319177|NCT05622812|560605395|FG001|Overall Study|Lost to Follow-up|1|||
155319178|NCT02116530|560605396|FG000|Overall Study|Withdrawal by Subject|1|||
155319179|NCT02116530|560605397|FG001|Overall Study|Withdrawal by Subject|2|||
155319180|NCT02116530|560605396|FG000|Overall Study|Adverse Event|4|||
155319181|NCT02116530|560605397|FG001|Overall Study|Adverse Event|0|||
155319182|NCT02116530|560605396|FG000|Overall Study|Physician Decision|1|||
155319183|NCT02116530|560605397|FG001|Overall Study|Physician Decision|0|||
155319184|NCT02116530|560605396|FG000|Overall Study|Lost to Follow-up|1|||
155319185|NCT02116530|560605397|FG001|Overall Study|Lost to Follow-up|0|||
155319186|NCT02116530|560605396|FG000|Overall Study|Other Medical Problems|2|||
155319187|NCT02116530|560605397|FG001|Overall Study|Other Medical Problems|2|||
155319188|NCT02927236|560605398|FG000|Characterization Phase|Physician Decision|0|||
155319189|NCT02927236|560605399|FG001|Characterization Phase|Physician Decision|3|||
155319190|NCT02927236|560605400|FG002|Characterization Phase|Physician Decision|0|||
155319191|NCT02927236|560605401|FG003|Characterization Phase|Physician Decision|2|||
155319192|NCT02927236|560605398|FG000|Characterization Phase|Lost to Follow-up|0|||
155319193|NCT02927236|560605399|FG001|Characterization Phase|Lost to Follow-up|0|||
155319194|NCT02927236|560605400|FG002|Characterization Phase|Lost to Follow-up|0|||
155319195|NCT02927236|560605401|FG003|Characterization Phase|Lost to Follow-up|3|||
155319196|NCT02927236|560605398|FG000|Characterization Phase|Withdrawal by Subject|1|||
155319197|NCT02927236|560605399|FG001|Characterization Phase|Withdrawal by Subject|0|||
155319198|NCT02927236|560605400|FG002|Characterization Phase|Withdrawal by Subject|0|||
155319199|NCT02927236|560605401|FG003|Characterization Phase|Withdrawal by Subject|1|||
155319200|NCT02927236|560605398|FG000|Treatment Phase|Adverse Event|1|||
155319201|NCT02927236|560605399|FG001|Treatment Phase|Adverse Event|0|||
155319202|NCT02927236|560605400|FG002|Treatment Phase|Adverse Event|1|||
155319203|NCT02927236|560605401|FG003|Treatment Phase|Adverse Event|1|||
155319204|NCT02927236|560605398|FG000|Treatment Phase|Protocol Violation|3|||
155319205|NCT02927236|560605399|FG001|Treatment Phase|Protocol Violation|0|||
155319206|NCT02927236|560605400|FG002|Treatment Phase|Protocol Violation|0|||
155319207|NCT02927236|560605401|FG003|Treatment Phase|Protocol Violation|1|||
155319208|NCT02927236|560605398|FG000|Treatment Phase|Lost to Follow-up|1|||
155319209|NCT02927236|560605399|FG001|Treatment Phase|Lost to Follow-up|0|||
155319210|NCT02927236|560605400|FG002|Treatment Phase|Lost to Follow-up|0|||
155319211|NCT02927236|560605401|FG003|Treatment Phase|Lost to Follow-up|0|||
155319212|NCT02927236|560605398|FG000|Follow-up Phase|Lost to Follow-up|1|||
155319213|NCT02927236|560605399|FG001|Follow-up Phase|Lost to Follow-up|0|||
155319214|NCT02927236|560605400|FG002|Follow-up Phase|Lost to Follow-up|1|||
155319215|NCT02927236|560605401|FG003|Follow-up Phase|Lost to Follow-up|0|||
155319216|NCT05297565|560605402|FG000|Overall Study|Other Reasons|0|||
155319217|NCT05297565|560605403|FG001|Overall Study|Other Reasons|1|||
155319218|NCT05297565|560605402|FG000|Overall Study|Physician Decision|0|||
155319219|NCT05297565|560605403|FG001|Overall Study|Physician Decision|1|||
155319220|NCT05297565|560605402|FG000|Overall Study|Disease recurrence|1|||
155319221|NCT05297565|560605403|FG001|Overall Study|Disease recurrence|0|||
155319222|NCT01959607|560605404|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155319223|NCT01959607|560605405|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
155319224|NCT01959607|560605406|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155319225|NCT01959607|560605407|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155319226|NCT03913442|560605408|FG000|Overall Study|Adverse Event|0|||
155500929|NCT01500434|561258612|FG000|Overall Study|Withdrawal by Subject|1|||
155500930|NCT01500434|561258612|FG000|Overall Study|Missed 12-month follow-up|5|||
155500931|NCT00633217|561258613|FG000|Overall Study|Adverse Event|5|||
155500932|NCT00633217|561258614|FG001|Overall Study|Adverse Event|9|||
155500933|NCT00633217|561258613|FG000|Overall Study|Lack of Efficacy|0|||
155319227|NCT03913442|560605409|FG001|Overall Study|Adverse Event|3|||
155643497|NCT06142383|561783863|FG003|Overall Study|Adverse Event|0|||
155319228|NCT03913442|560605408|FG000|Overall Study|Withdrawal by Subject|5|||
155319229|NCT03913442|560605409|FG001|Overall Study|Withdrawal by Subject|5|||
155319230|NCT03913442|560605408|FG000|Overall Study|Terminations|2|||
155319231|NCT03913442|560605409|FG001|Overall Study|Terminations|1|||
155319232|NCT03913442|560605408|FG000|Overall Study|Lost to Follow-up|2|||
155319233|NCT03913442|560605409|FG001|Overall Study|Lost to Follow-up|2|||
155319234|NCT02433379|560605413|FG000|Overall Study|Screen Failures|55|||
155319235|NCT02433379|560605413|FG000|Overall Study|Death|57|||
155319236|NCT02433379|560605413|FG000|Overall Study|Total Withdrawals|209|||
155319237|NCT03952338|560605414|FG000|Overall Study|Lost to Follow-up|11|||
155319238|NCT03952338|560605415|FG001|Overall Study|Lost to Follow-up|17|||
155319239|NCT03952338|560605414|FG000|Overall Study|Withdrawal by Subject|1|||
155319240|NCT03952338|560605415|FG001|Overall Study|Withdrawal by Subject|1|||
155319241|NCT03952338|560605414|FG000|Overall Study|Protocol Violation|1|||
155643498|NCT06142383|561783864|FG004|Overall Study|Adverse Event|0|||
155319242|NCT03952338|560605415|FG001|Overall Study|Protocol Violation|0|||
155419586|NCT01430442|560968110|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
155419587|NCT01430442|560968111|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
155643499|NCT06142383|561783860|FG000|Overall Study|Death|0|||
155643500|NCT06142383|561783861|FG001|Overall Study|Death|1|||
155643501|NCT06142383|561783862|FG002|Overall Study|Death|3|||
155643502|NCT06142383|561783863|FG003|Overall Study|Death|0|||
155643503|NCT06142383|561783864|FG004|Overall Study|Death|1|||
155643504|NCT06142383|561783860|FG000|Overall Study|Study Terminated by Sponsor|20|||
155643505|NCT06142383|561783861|FG001|Overall Study|Study Terminated by Sponsor|17|||
155643506|NCT06142383|561783862|FG002|Overall Study|Study Terminated by Sponsor|33|||
155643507|NCT06142383|561783863|FG003|Overall Study|Study Terminated by Sponsor|0|||
155643508|NCT06142383|561783864|FG004|Overall Study|Study Terminated by Sponsor|21|||
155419588|NCT01430442|560968112|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
155419589|NCT01430442|560968113|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
155419590|NCT01430442|560968114|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
155419591|NCT01430442|560968115|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
155419592|NCT00132041|560968120|FG000|Baseline|Ineligible|6|||
155419593|NCT00132041|560968120|FG000|3 Months Post Ablation|Transplant|1|||
155419594|NCT00132041|560968120|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
155419595|NCT00132041|560968120|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
155419596|NCT00132041|560968120|FG000|6 Months Post Ablation|Death|2|||
155643509|NCT06142383|561783860|FG000|Overall Study|Subject Decision|0|||
155643510|NCT06142383|561783861|FG001|Overall Study|Subject Decision|1|||
155419597|NCT00132041|560968120|FG000|6 Months Post Ablation|Transplant|6|||
155500934|NCT00633217|561258614|FG001|Overall Study|Lack of Efficacy|2|||
155500935|NCT00633217|561258613|FG000|Overall Study|Protocol Violation|3|||
155643511|NCT06142383|561783862|FG002|Overall Study|Subject Decision|2|||
155500936|NCT00633217|561258614|FG001|Overall Study|Protocol Violation|7|||
155500937|NCT00633217|561258613|FG000|Overall Study|Lost to Follow-up|2|||
155500938|NCT00633217|561258614|FG001|Overall Study|Lost to Follow-up|2|||
155643512|NCT06142383|561783863|FG003|Overall Study|Subject Decision|0|||
155643513|NCT06142383|561783864|FG004|Overall Study|Subject Decision|0|||
155643514|NCT01685437|561783868|FG000|Overall Study|Withdrawal by Subject|22|||
155643515|NCT01685437|561783868|FG000|Overall Study|Lost to Follow-up|3|||
155643516|NCT01685437|561783868|FG000|Overall Study|Adverse Event|1|||
155643517|NCT01685437|561783868|FG000|Overall Study|Protocol Violation|4|||
155643518|NCT01685437|561783868|FG000|Overall Study|Unable to make visits due to work|1|||
155643519|NCT03860584|561783877|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
155643520|NCT03860584|561783878|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
155419598|NCT00132041|560968120|FG000|9 Months Post Ablation|Death|1|||
155500939|NCT00633217|561258613|FG000|Overall Study|Investigator Discretion|2|||
155500940|NCT00633217|561258614|FG001|Overall Study|Investigator Discretion|0|||
155500941|NCT00633217|561258613|FG000|Overall Study|Withdrew Consent|3|||
155500942|NCT00633217|561258614|FG001|Overall Study|Withdrew Consent|3|||
155500943|NCT04822701|561258615|FG000|Overall Study|Not treated|2|||
155500944|NCT04822701|561258616|FG001|Overall Study|Not treated|0|||
155500945|NCT04822701|561258615|FG000|Overall Study|Lost to Follow-up|1|||
155500946|NCT04822701|561258616|FG001|Overall Study|Lost to Follow-up|0|||
155500947|NCT04822701|561258615|FG000|Overall Study|Withdrawal by Subject|1|||
155500948|NCT04822701|561258616|FG001|Overall Study|Withdrawal by Subject|0|||
155500949|NCT03560466|561258617|FG000|Overall Study|Adverse Event|1|||
155500950|NCT03560466|561258618|FG001|Overall Study|Adverse Event|2|||
155500951|NCT03560466|561258619|FG002|Overall Study|Adverse Event|0|||
155500952|NCT03560466|561258617|FG000|Overall Study|Poor Compliance to Protocol|0|||
155500953|NCT03560466|561258618|FG001|Overall Study|Poor Compliance to Protocol|2|||
155500954|NCT03560466|561258619|FG002|Overall Study|Poor Compliance to Protocol|0|||
155643521|NCT03860584|561783877|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155643522|NCT03860584|561783878|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155500955|NCT03560466|561258617|FG000|Overall Study|Other|6|||
155500956|NCT03560466|561258618|FG001|Overall Study|Other|8|||
155643523|NCT03860584|561783877|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
155643524|NCT03860584|561783878|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
155643525|NCT03860584|561783877|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
155643526|NCT03860584|561783878|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
155643527|NCT03971422|561785177|FG000|Overall Study|Lost to Follow-up|0|||
155643528|NCT03971422|561785178|FG001|Overall Study|Lost to Follow-up|1|||
155419599|NCT00132041|560968120|FG000|9 Months Post Ablation|Transplant|1|||
155419600|NCT00132041|560968120|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
155419601|NCT00132041|560968120|FG000|12 Months Post Ablation|Death|1|||
155419602|NCT00132041|560968120|FG000|12 Months Post Ablation|Transplant|1|||
155419603|NCT00132041|560968120|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
155643529|NCT03971422|561785179|FG002|Overall Study|Lost to Follow-up|0|||
155500957|NCT03560466|561258619|FG002|Overall Study|Other|1|||
155500958|NCT02996448|561260713|FG000|Overall Study|Study terminated due to adverse effects|3|||
155500959|NCT01160198|561260722|FG000|Overall Study|Withdrawal by Subject|2|||
155500960|NCT01160198|561260723|FG001|Overall Study|Withdrawal by Subject|1|||
155643530|NCT03971422|561785177|FG000|Overall Study|Lack of Efficacy|5|||
155419604|NCT00132041|560968120|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
155419605|NCT00132041|560968120|FG000|15 Months Post Ablation|Death|1|||
155419606|NCT00132041|560968120|FG000|15 Months Post Ablation|Transplant|5|||
155419607|NCT00132041|560968120|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
155419608|NCT00132041|560968120|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
155419609|NCT00132041|560968120|FG000|18 Months Post Ablation|Transplant|1|||
155419610|NCT00132041|560968120|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
155419611|NCT00132041|560968120|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
155419612|NCT03969875|560968121|FG000|Overall Study|did not receive allocated intervention|3|||
155419613|NCT03969875|560968122|FG001|Overall Study|did not receive allocated intervention|3|||
155419614|NCT03969875|560968123|FG002|Overall Study|did not receive allocated intervention|4|||
155419615|NCT03969875|560968121|FG000|Overall Study|Protocol Violation|4|||
155419616|NCT03969875|560968122|FG001|Overall Study|Protocol Violation|2|||
155419617|NCT03969875|560968123|FG002|Overall Study|Protocol Violation|2|||
155419618|NCT00167245|560968124|FG000|Overall Study|Lost to Follow-up|20|||
155419619|NCT00167245|560968125|FG001|Overall Study|Lost to Follow-up|31|||
155419620|NCT00167245|560968124|FG000|Overall Study|Withdrawal by Subject|5|||
155419621|NCT00167245|560968125|FG001|Overall Study|Withdrawal by Subject|8|||
155419622|NCT00167245|560968124|FG000|Overall Study|Incarcerated|3|||
155419623|NCT00167245|560968125|FG001|Overall Study|Incarcerated|2|||
155419624|NCT00167245|560968124|FG000|Overall Study|Drowsy|1|||
155419625|NCT00167245|560968125|FG001|Overall Study|Drowsy|0|||
155419626|NCT02911688|560968129|FG000|Washout|Lost to Follow-up|1|||
155751151|NCT01255787|562188409|FG000|Overall Study|Noncompliance with Study Drug|3|||
155751152|NCT01255787|562188410|FG001|Overall Study|Noncompliance with Study Drug|1|||
155751153|NCT01255787|562188411|FG002|Overall Study|Noncompliance with Study Drug|0|||
155319243|NCT03710603|560605416|FG000|Overall Study|Adverse Event|1|||
155319244|NCT03710603|560605417|FG001|Overall Study|Adverse Event|0|||
155319245|NCT03710603|560605416|FG000|Overall Study|Death|44|||
155319246|NCT03710603|560605417|FG001|Overall Study|Death|34|||
155319247|NCT03710603|560605416|FG000|Overall Study|Lost to Follow-up|3|||
155319248|NCT03710603|560605417|FG001|Overall Study|Lost to Follow-up|5|||
155319249|NCT03710603|560605416|FG000|Overall Study|Withdrawal by Subject|11|||
155319250|NCT03710603|560605417|FG001|Overall Study|Withdrawal by Subject|10|||
155319251|NCT03691935|560605418|FG000|Overall Study|Physician Decision|2|||
155319252|NCT03691935|560605419|FG001|Overall Study|Physician Decision|1|||
155319253|NCT03691935|560605418|FG000|Overall Study|Adverse Event|3|||
155319254|NCT03691935|560605419|FG001|Overall Study|Adverse Event|0|||
155319255|NCT01946789|560605425|FG000|Overall Study|Death|0|||
155319256|NCT01946789|560605426|FG001|Overall Study|Death|2|||
155319257|NCT01946789|560605427|FG002|Overall Study|Death|1|||
155319258|NCT01946789|560605428|FG003|Overall Study|Death|1|||
155319259|NCT01946789|560605429|FG004|Overall Study|Death|1|||
155319260|NCT01946789|560605430|FG005|Overall Study|Death|1|||
155319261|NCT01946789|560605431|FG006|Overall Study|Death|3|||
155319262|NCT01946789|560605432|FG007|Overall Study|Death|1|||
155319263|NCT01946789|560605433|FG008|Overall Study|Death|2|||
155319264|NCT01946789|560605425|FG000|Overall Study|Progressive Disease|0|||
155319265|NCT01946789|560605426|FG001|Overall Study|Progressive Disease|0|||
155319266|NCT01946789|560605427|FG002|Overall Study|Progressive Disease|1|||
155319267|NCT01946789|560605428|FG003|Overall Study|Progressive Disease|0|||
155319268|NCT01946789|560605429|FG004|Overall Study|Progressive Disease|0|||
155319269|NCT01946789|560605430|FG005|Overall Study|Progressive Disease|2|||
155319270|NCT01946789|560605431|FG006|Overall Study|Progressive Disease|0|||
155319271|NCT01946789|560605432|FG007|Overall Study|Progressive Disease|0|||
155319272|NCT01946789|560605433|FG008|Overall Study|Progressive Disease|0|||
155319273|NCT01946789|560605425|FG000|Overall Study|Withdrawal by Subject|0|||
155319274|NCT01946789|560605426|FG001|Overall Study|Withdrawal by Subject|0|||
155319275|NCT01946789|560605427|FG002|Overall Study|Withdrawal by Subject|0|||
155319276|NCT01946789|560605428|FG003|Overall Study|Withdrawal by Subject|2|||
155319277|NCT01946789|560605429|FG004|Overall Study|Withdrawal by Subject|1|||
155319278|NCT01946789|560605430|FG005|Overall Study|Withdrawal by Subject|0|||
155319279|NCT01946789|560605431|FG006|Overall Study|Withdrawal by Subject|1|||
155319280|NCT01946789|560605432|FG007|Overall Study|Withdrawal by Subject|0|||
155319281|NCT01946789|560605433|FG008|Overall Study|Withdrawal by Subject|0|||
155419627|NCT02911688|560968130|FG001|Washout|Lost to Follow-up|1|||
155419628|NCT02911688|560968129|FG000|Washout|Withdrawal by Subject|0|||
155419629|NCT02911688|560968130|FG001|Washout|Withdrawal by Subject|1|||
155419630|NCT00947531|560968137|FG000|Overall Study|Withdrawal by Subject|10|||
155419631|NCT00947531|560968138|FG001|Overall Study|Withdrawal by Subject|7|||
155419632|NCT00947531|560968137|FG000|Overall Study|Administrative Reason|0|||
155319282|NCT04707625|560605434|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
155319283|NCT00321048|560605435|FG000|Overall Study|Withdrawal by Subject|6|||
155419633|NCT00947531|560968138|FG001|Overall Study|Administrative Reason|1|||
155419634|NCT00947531|560968137|FG000|Overall Study|Adverse Event|2|||
155419635|NCT00947531|560968138|FG001|Overall Study|Adverse Event|2|||
155419636|NCT00947531|560968137|FG000|Overall Study|Lack of Efficacy|1|||
155419637|NCT00947531|560968138|FG001|Overall Study|Lack of Efficacy|0|||
155319284|NCT00321048|560605436|FG001|Overall Study|Withdrawal by Subject|8|||
155319285|NCT06473662|560605437|FG000|Overall Study|Withdrawal by Subject|1|||
155319286|NCT06473662|560605438|FG001|Overall Study|Withdrawal by Subject|6|||
155319287|NCT06473662|560605439|FG002|Overall Study|Withdrawal by Subject|5|||
155319288|NCT06473662|560605437|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
155319289|NCT06473662|560605438|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
155319290|NCT06473662|560605439|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
155319291|NCT06473662|560605437|FG000|Overall Study|Starting HbA1c below 7%|0|||
155319292|NCT06473662|560605438|FG001|Overall Study|Starting HbA1c below 7%|1|||
155319293|NCT06473662|560605439|FG002|Overall Study|Starting HbA1c below 7%|1|||
155319294|NCT06473662|560605437|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
155319295|NCT06473662|560605438|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
155319296|NCT06473662|560605439|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
155319297|NCT06473662|560605437|FG000|Overall Study|Did not take medication|2|||
155319298|NCT06473662|560605438|FG001|Overall Study|Did not take medication|3|||
155319299|NCT06473662|560605439|FG002|Overall Study|Did not take medication|2|||
155319300|NCT05485779|560605442|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319301|NCT05485779|560605443|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319302|NCT05485779|560605444|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319303|NCT05485779|560605445|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319304|NCT05485779|560605446|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319305|NCT05485779|560605447|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319306|NCT05485779|560605448|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319307|NCT05485779|560605449|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
155319308|NCT05485779|560605450|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
155319309|NCT05485779|560605451|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319310|NCT05485779|560605452|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319311|NCT05485779|560605442|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319312|NCT05485779|560605443|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319313|NCT05485779|560605444|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319314|NCT05485779|560605445|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319315|NCT05485779|560605446|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319316|NCT05485779|560605447|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319317|NCT05485779|560605448|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319318|NCT05485779|560605449|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319319|NCT05485779|560605450|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319320|NCT05485779|560605451|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319321|NCT05485779|560605452|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
155319322|NCT05485779|560605442|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319323|NCT05485779|560605443|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319324|NCT05485779|560605444|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319325|NCT05485779|560605445|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
155319326|NCT05485779|560605446|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319327|NCT05485779|560605447|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319328|NCT05485779|560605448|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319329|NCT05485779|560605449|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319330|NCT05485779|560605450|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319331|NCT05485779|560605451|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319332|NCT05485779|560605452|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319333|NCT02038777|560605453|FG000|Overall Study|Death|0|||
155319334|NCT02038777|560605454|FG001|Overall Study|Death|2|||
155319335|NCT02038777|560605455|FG002|Overall Study|Death|0|||
155500961|NCT01160198|561260724|FG002|Overall Study|Withdrawal by Subject|0|||
155500962|NCT01160198|561260722|FG000|Overall Study|Adverse Event|0|||
155500963|NCT01160198|561260723|FG001|Overall Study|Adverse Event|1|||
155500964|NCT01160198|561260724|FG002|Overall Study|Adverse Event|0|||
155500965|NCT01160198|561260722|FG000|Overall Study|Lost to Follow-up|0|||
155500966|NCT01160198|561260723|FG001|Overall Study|Lost to Follow-up|1|||
155500967|NCT01160198|561260724|FG002|Overall Study|Lost to Follow-up|0|||
155500968|NCT01160198|561260722|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
155500969|NCT01160198|561260723|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
155500970|NCT01160198|561260724|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
155500971|NCT01796860|561260726|FG000|Overall Study|Withdrawal by Subject|3|||
155643531|NCT03971422|561785178|FG001|Overall Study|Lack of Efficacy|1|||
155643532|NCT03971422|561785179|FG002|Overall Study|Lack of Efficacy|1|||
155643533|NCT03971422|561785177|FG000|Overall Study|Adverse event, not fatal|2|||
155319336|NCT02038777|560605456|FG003|Overall Study|Death|1|||
155319337|NCT02038777|560605457|FG004|Overall Study|Death|2|||
155319338|NCT02038777|560605458|FG005|Overall Study|Death|4|||
155319339|NCT02038777|560605459|FG006|Overall Study|Death|0|||
155319340|NCT02038777|560605460|FG007|Overall Study|Death|11|||
155319341|NCT02038777|560605453|FG000|Overall Study|Lost to Follow-up|0|||
155319342|NCT02038777|560605454|FG001|Overall Study|Lost to Follow-up|0|||
155319343|NCT02038777|560605455|FG002|Overall Study|Lost to Follow-up|0|||
155319344|NCT02038777|560605456|FG003|Overall Study|Lost to Follow-up|1|||
155319345|NCT02038777|560605457|FG004|Overall Study|Lost to Follow-up|0|||
155319346|NCT02038777|560605458|FG005|Overall Study|Lost to Follow-up|0|||
155319347|NCT02038777|560605459|FG006|Overall Study|Lost to Follow-up|0|||
155319348|NCT02038777|560605460|FG007|Overall Study|Lost to Follow-up|0|||
155319349|NCT02038777|560605453|FG000|Overall Study|Other|0|||
155319350|NCT02038777|560605454|FG001|Overall Study|Other|1|||
155319351|NCT02038777|560605455|FG002|Overall Study|Other|0|||
155319352|NCT02038777|560605456|FG003|Overall Study|Other|2|||
155319353|NCT02038777|560605457|FG004|Overall Study|Other|1|||
155319354|NCT02038777|560605458|FG005|Overall Study|Other|0|||
155319355|NCT02038777|560605459|FG006|Overall Study|Other|0|||
155319356|NCT02038777|560605460|FG007|Overall Study|Other|0|||
155319357|NCT02038777|560605453|FG000|Overall Study|Randomized but not treated|0|||
155319358|NCT02038777|560605454|FG001|Overall Study|Randomized but not treated|1|||
155319359|NCT02038777|560605455|FG002|Overall Study|Randomized but not treated|0|||
155319360|NCT02038777|560605456|FG003|Overall Study|Randomized but not treated|0|||
155319361|NCT02038777|560605457|FG004|Overall Study|Randomized but not treated|0|||
155319362|NCT02038777|560605458|FG005|Overall Study|Randomized but not treated|0|||
155319363|NCT02038777|560605459|FG006|Overall Study|Randomized but not treated|0|||
155319364|NCT02038777|560605460|FG007|Overall Study|Randomized but not treated|0|||
155319365|NCT02038777|560605453|FG000|Overall Study|Started Chemotherapy|1|||
155319366|NCT02038777|560605454|FG001|Overall Study|Started Chemotherapy|0|||
155319367|NCT02038777|560605455|FG002|Overall Study|Started Chemotherapy|3|||
155319368|NCT02038777|560605456|FG003|Overall Study|Started Chemotherapy|0|||
155319369|NCT02038777|560605457|FG004|Overall Study|Started Chemotherapy|0|||
155319370|NCT02038777|560605458|FG005|Overall Study|Started Chemotherapy|0|||
155319371|NCT02038777|560605459|FG006|Overall Study|Started Chemotherapy|0|||
155319372|NCT02038777|560605460|FG007|Overall Study|Started Chemotherapy|0|||
155419638|NCT00947531|560968137|FG000|Overall Study|Other|1|||
155419639|NCT00947531|560968138|FG001|Overall Study|Other|1|||
155419640|NCT01773421|560968140|FG000|Treatment Phase|Other|0|||
155419641|NCT01773421|560968141|FG001|Treatment Phase|Other|0|||
155419642|NCT01773421|560968142|FG002|Treatment Phase|Other|2|||
155419643|NCT01773421|560968143|FG003|Treatment Phase|Other|0|||
155419644|NCT01773421|560968144|FG004|Treatment Phase|Other|0|||
155419645|NCT01773421|560968145|FG005|Treatment Phase|Other|0|||
155419646|NCT01773421|560968146|FG006|Treatment Phase|Other|0|||
155419647|NCT01773421|560968140|FG000|Treatment Phase|Adverse Event|0|||
155419648|NCT01773421|560968141|FG001|Treatment Phase|Adverse Event|0|||
155419649|NCT01773421|560968142|FG002|Treatment Phase|Adverse Event|3|||
155419650|NCT01773421|560968143|FG003|Treatment Phase|Adverse Event|1|||
155419651|NCT01773421|560968144|FG004|Treatment Phase|Adverse Event|0|||
155419652|NCT01773421|560968145|FG005|Treatment Phase|Adverse Event|0|||
155419653|NCT01773421|560968146|FG006|Treatment Phase|Adverse Event|0|||
155419654|NCT01773421|560968140|FG000|Treatment Phase|Withdrawal by Subject|0|||
155419655|NCT01773421|560968141|FG001|Treatment Phase|Withdrawal by Subject|0|||
155419656|NCT01773421|560968142|FG002|Treatment Phase|Withdrawal by Subject|1|||
155419657|NCT01773421|560968143|FG003|Treatment Phase|Withdrawal by Subject|1|||
155419658|NCT01773421|560968144|FG004|Treatment Phase|Withdrawal by Subject|0|||
155419659|NCT01773421|560968145|FG005|Treatment Phase|Withdrawal by Subject|0|||
155419660|NCT01773421|560968146|FG006|Treatment Phase|Withdrawal by Subject|0|||
155419661|NCT01773421|560968140|FG000|Extension Phase|Other|0|||
155500972|NCT01408576|561260727|FG000|Overall Study|Lack of Efficacy|17|||
155319373|NCT02038777|560605453|FG000|Overall Study|participation terminated by sponsor|0|||
155319374|NCT02038777|560605454|FG001|Overall Study|participation terminated by sponsor|0|||
155319375|NCT02038777|560605455|FG002|Overall Study|participation terminated by sponsor|0|||
155319376|NCT02038777|560605456|FG003|Overall Study|participation terminated by sponsor|0|||
155319377|NCT02038777|560605457|FG004|Overall Study|participation terminated by sponsor|0|||
155319378|NCT02038777|560605458|FG005|Overall Study|participation terminated by sponsor|0|||
155319379|NCT02038777|560605459|FG006|Overall Study|participation terminated by sponsor|1|||
155319380|NCT02038777|560605460|FG007|Overall Study|participation terminated by sponsor|1|||
155319381|NCT04299464|560605461|FG000|Overall Study|Adverse Event|1|||
155319382|NCT04299464|560605462|FG001|Overall Study|Adverse Event|0|||
155319383|NCT04299464|560605463|FG002|Overall Study|Adverse Event|2|||
155419662|NCT01773421|560968141|FG001|Extension Phase|Other|0|||
155419663|NCT01773421|560968142|FG002|Extension Phase|Other|0|||
155419664|NCT01773421|560968143|FG003|Extension Phase|Other|0|||
155319384|NCT04299464|560605461|FG000|Overall Study|Non-compliance with Study Drug|1|||
155319385|NCT04299464|560605462|FG001|Overall Study|Non-compliance with Study Drug|0|||
155419665|NCT01773421|560968144|FG004|Extension Phase|Other|1|||
155419666|NCT01773421|560968145|FG005|Extension Phase|Other|2|||
155751154|NCT01255787|562188412|FG003|Overall Study|Noncompliance with Study Drug|0|||
155751155|NCT00476047|562188413|FG000|Overall Study|Lost to Follow-up|1|||
155751156|NCT00768469|562188414|FG000|Overall Study|Adverse Event|0|||
155751157|NCT00768469|562188415|FG001|Overall Study|Adverse Event|2|||
155751158|NCT00768469|562188414|FG000|Overall Study|Disease Progression|3|||
155751159|NCT00768469|562188415|FG001|Overall Study|Disease Progression|4|||
155751160|NCT00768469|562188414|FG000|Overall Study|Withdrawal by Subject|0|||
155751161|NCT00768469|562188415|FG001|Overall Study|Withdrawal by Subject|1|||
155751162|NCT04966741|562188416|FG000|Overall Study|Lost to Follow-up|1|||
155751163|NCT04966741|562188417|FG001|Overall Study|Lost to Follow-up|0|||
155751164|NCT00773838|562188420|FG000|Overall Study|Adverse Event|29|||
155751165|NCT00773838|562188420|FG000|Overall Study|Lost to Follow-up|1|||
155751166|NCT00773838|562188420|FG000|Overall Study|Physician Decision|8|||
155751167|NCT00773838|562188420|FG000|Overall Study|Progressive Disease|82|||
155751168|NCT00773838|562188420|FG000|Overall Study|Protocol Violation|2|||
155751169|NCT00773838|562188420|FG000|Overall Study|Withdrawal by Subject|21|||
155751170|NCT00459056|562188422|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
155751171|NCT00459056|562188423|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
155751172|NCT02522871|562188424|FG000|Overall Study|Protocol Violation|1|||
155751173|NCT02522871|562188425|FG001|Overall Study|Protocol Violation|4|||
155751174|NCT02522871|562188424|FG000|Overall Study|Treated without randomization|1|||
155751175|NCT02522871|562188425|FG001|Overall Study|Treated without randomization|0|||
155751176|NCT02522871|562188424|FG000|Overall Study|Death|9|||
155751177|NCT02522871|562188425|FG001|Overall Study|Death|9|||
155751178|NCT02522871|562188424|FG000|Overall Study|Died in operating room prior to transplant|0|||
155751179|NCT02522871|562188425|FG001|Overall Study|Died in operating room prior to transplant|1|||
155751180|NCT00509262|562188426|FG000|Overall Study|Adverse Event|16|||
155751181|NCT00509262|562188427|FG001|Overall Study|Adverse Event|18|||
155751182|NCT00509262|562188426|FG000|Overall Study|Other|2|||
155751183|NCT00509262|562188427|FG001|Overall Study|Other|2|||
155751184|NCT00509262|562188426|FG000|Overall Study|Lack of Efficacy|1|||
155751185|NCT00509262|562188427|FG001|Overall Study|Lack of Efficacy|0|||
155751186|NCT00509262|562188426|FG000|Overall Study|Lost to Follow-up|1|||
155751187|NCT00509262|562188427|FG001|Overall Study|Lost to Follow-up|6|||
155751188|NCT00509262|562188426|FG000|Overall Study|Physician Decision|1|||
155751189|NCT00509262|562188427|FG001|Overall Study|Physician Decision|3|||
155751190|NCT00509262|562188426|FG000|Overall Study|Protocol Violation|2|||
155751191|NCT00509262|562188427|FG001|Overall Study|Protocol Violation|2|||
155751192|NCT00509262|562188426|FG000|Overall Study|Withdrawal by Subject|24|||
155751193|NCT00509262|562188427|FG001|Overall Study|Withdrawal by Subject|11|||
155751194|NCT00725842|562188428|FG000|Overall Study|Lost to Follow-up|19|||
155751195|NCT00725842|562188428|FG000|Overall Study|Death|1|||
155751196|NCT00725842|562188428|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
155751197|NCT00725842|562188428|FG000|Overall Study|Consent date prior to study start date|5|||
155751198|NCT00725842|562188428|FG000|Overall Study|Inclusion criterion not met|1|||
155751199|NCT00725842|562188428|FG000|Overall Study|No Visit 1 data|1|||
155751200|NCT01853618|562188429|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
155751201|NCT01853618|562188430|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
155751202|NCT01853618|562188431|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
155751203|NCT01853618|562188432|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
155751204|NCT01853618|562188433|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
155751205|NCT01853618|562188429|FG000|Overall Study|Progressive disease|1|||
155751206|NCT01853618|562188430|FG001|Overall Study|Progressive disease|1|||
155751207|NCT01853618|562188431|FG002|Overall Study|Progressive disease|1|||
155751208|NCT01853618|562188432|FG003|Overall Study|Progressive disease|1|||
155751209|NCT01853618|562188433|FG004|Overall Study|Progressive disease|2|||
155751210|NCT01853618|562188429|FG000|Overall Study|Physician Decision|0|||
155751211|NCT01853618|562188430|FG001|Overall Study|Physician Decision|1|||
155751212|NCT01853618|562188431|FG002|Overall Study|Physician Decision|1|||
155751213|NCT01853618|562188432|FG003|Overall Study|Physician Decision|0|||
155751214|NCT01853618|562188433|FG004|Overall Study|Physician Decision|0|||
155751215|NCT01853618|562188429|FG000|Overall Study|Refused further treatment|0|||
155751216|NCT01853618|562188430|FG001|Overall Study|Refused further treatment|0|||
155751217|NCT01853618|562188431|FG002|Overall Study|Refused further treatment|0|||
155751218|NCT01853618|562188432|FG003|Overall Study|Refused further treatment|0|||
155751219|NCT01853618|562188433|FG004|Overall Study|Refused further treatment|1|||
155751220|NCT02398227|562188440|FG000|Overall Study|Lost to Follow-up|21|||
155751221|NCT02398227|562188441|FG001|Overall Study|Lost to Follow-up|12|||
155751222|NCT02398227|562188440|FG000|Overall Study|Withdrawal by Subject|5|||
155751223|NCT02398227|562188441|FG001|Overall Study|Withdrawal by Subject|6|||
155751224|NCT02398227|562188440|FG000|Overall Study|Removed from treatment and dropped out|1|||
155751225|NCT02398227|562188441|FG001|Overall Study|Removed from treatment and dropped out|0|||
155419667|NCT01773421|560968146|FG006|Extension Phase|Other|0|||
155419668|NCT01773421|560968140|FG000|Extension Phase|Adverse Event|0|||
155419669|NCT01773421|560968141|FG001|Extension Phase|Adverse Event|0|||
155419670|NCT01773421|560968142|FG002|Extension Phase|Adverse Event|0|||
155419671|NCT01773421|560968143|FG003|Extension Phase|Adverse Event|0|||
155419672|NCT01773421|560968144|FG004|Extension Phase|Adverse Event|2|||
155419673|NCT01773421|560968145|FG005|Extension Phase|Adverse Event|0|||
155419674|NCT01773421|560968146|FG006|Extension Phase|Adverse Event|0|||
155419675|NCT02327260|560968147|FG000|Overall Study|Lost to Follow-up|2|||
155419676|NCT02327260|560968148|FG001|Overall Study|Lost to Follow-up|3|||
155419677|NCT02327260|560968149|FG002|Overall Study|Lost to Follow-up|2|||
155419678|NCT02327260|560968147|FG000|Overall Study|invalid phone number|1|||
155419679|NCT02327260|560968148|FG001|Overall Study|invalid phone number|1|||
155419680|NCT02327260|560968149|FG002|Overall Study|invalid phone number|0|||
155419681|NCT02327260|560968147|FG000|Overall Study|non-adherence to protocol|2|||
155643534|NCT03971422|561785178|FG001|Overall Study|Adverse event, not fatal|2|||
155643535|NCT03971422|561785179|FG002|Overall Study|Adverse event, not fatal|5|||
155643536|NCT03971422|561785177|FG000|Overall Study|Worsening of MG Symptoms|1|||
155643537|NCT03971422|561785178|FG001|Overall Study|Worsening of MG Symptoms|4|||
155643538|NCT03971422|561785179|FG002|Overall Study|Worsening of MG Symptoms|2|||
155643539|NCT03971422|561785177|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
155643540|NCT03971422|561785178|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
155643541|NCT03971422|561785179|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
155643542|NCT03971422|561785177|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
155643543|NCT03971422|561785178|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
155643544|NCT03971422|561785179|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
155643545|NCT03971422|561785177|FG000|Overall Study|Due to COVID-19 pandemic|0|||
155643546|NCT03971422|561785178|FG001|Overall Study|Due to COVID-19 pandemic|1|||
155643547|NCT03971422|561785179|FG002|Overall Study|Due to COVID-19 pandemic|1|||
155643548|NCT01658878|561785180|FG000|Treatment Period|Disease Progression|1|||
155643549|NCT01658878|561785181|FG001|Treatment Period|Disease Progression|3|||
155643550|NCT01658878|561785182|FG002|Treatment Period|Disease Progression|2|||
155643551|NCT01658878|561785183|FG003|Treatment Period|Disease Progression|1|||
155643552|NCT01658878|561785184|FG004|Treatment Period|Disease Progression|13|||
155643553|NCT01658878|561785185|FG005|Treatment Period|Disease Progression|3|||
155643554|NCT01658878|561785186|FG006|Treatment Period|Disease Progression|4|||
155643555|NCT01658878|561785187|FG007|Treatment Period|Disease Progression|3|||
155643556|NCT01658878|561785188|FG008|Treatment Period|Disease Progression|5|||
155643557|NCT01658878|561785189|FG009|Treatment Period|Disease Progression|3|||
155643558|NCT01658878|561785190|FG010|Treatment Period|Disease Progression|3|||
155643559|NCT01658878|561785191|FG011|Treatment Period|Disease Progression|4|||
155643560|NCT01658878|561785192|FG012|Treatment Period|Disease Progression|43|||
155643561|NCT01658878|561785193|FG013|Treatment Period|Disease Progression|48|||
155643562|NCT01658878|561785194|FG014|Treatment Period|Disease Progression|33|||
155643563|NCT01658878|561785195|FG015|Treatment Period|Disease Progression|46|||
155643564|NCT01658878|561785196|FG016|Treatment Period|Disease Progression|41|||
155643565|NCT01658878|561785197|FG017|Treatment Period|Disease Progression|42|||
155643566|NCT01658878|561785198|FG018|Treatment Period|Disease Progression|28|||
155643567|NCT01658878|561785199|FG019|Treatment Period|Disease Progression|37|||
155643568|NCT01658878|561785200|FG020|Treatment Period|Disease Progression|37|||
155643569|NCT01658878|561785201|FG021|Treatment Period|Disease Progression|39|||
155643570|NCT01658878|561785202|FG022|Treatment Period|Disease Progression|27|||
155643571|NCT01658878|561785203|FG023|Treatment Period|Disease Progression|19|||
155643572|NCT01658878|561785180|FG000|Treatment Period|Study Drug Toxicity|0|||
155643573|NCT01658878|561785181|FG001|Treatment Period|Study Drug Toxicity|0|||
155643574|NCT01658878|561785182|FG002|Treatment Period|Study Drug Toxicity|0|||
155643575|NCT01658878|561785183|FG003|Treatment Period|Study Drug Toxicity|1|||
155643576|NCT01658878|561785184|FG004|Treatment Period|Study Drug Toxicity|0|||
155643577|NCT01658878|561785185|FG005|Treatment Period|Study Drug Toxicity|0|||
155643578|NCT01658878|561785186|FG006|Treatment Period|Study Drug Toxicity|0|||
155643579|NCT01658878|561785187|FG007|Treatment Period|Study Drug Toxicity|0|||
155643580|NCT01658878|561785188|FG008|Treatment Period|Study Drug Toxicity|0|||
155643581|NCT01658878|561785189|FG009|Treatment Period|Study Drug Toxicity|0|||
155643582|NCT01658878|561785190|FG010|Treatment Period|Study Drug Toxicity|0|||
155643583|NCT01658878|561785191|FG011|Treatment Period|Study Drug Toxicity|0|||
155419682|NCT02327260|560968148|FG001|Overall Study|non-adherence to protocol|0|||
155419683|NCT02327260|560968149|FG002|Overall Study|non-adherence to protocol|0|||
155643584|NCT01658878|561785192|FG012|Treatment Period|Study Drug Toxicity|7|||
155643585|NCT01658878|561785193|FG013|Treatment Period|Study Drug Toxicity|1|||
155643586|NCT01658878|561785194|FG014|Treatment Period|Study Drug Toxicity|5|||
155643587|NCT01658878|561785195|FG015|Treatment Period|Study Drug Toxicity|0|||
155643588|NCT01658878|561785196|FG016|Treatment Period|Study Drug Toxicity|5|||
155419684|NCT02327260|560968147|FG000|Overall Study|cognitive concerns|1|||
155419685|NCT02327260|560968148|FG001|Overall Study|cognitive concerns|0|||
155419686|NCT02327260|560968149|FG002|Overall Study|cognitive concerns|0|||
155419687|NCT03502330|560968150|FG000|Overall Study|Adverse Event|2|||
155419688|NCT03502330|560968151|FG001|Overall Study|Adverse Event|1|||
155419689|NCT03502330|560968152|FG002|Overall Study|Adverse Event|0|||
155419690|NCT03502330|560968153|FG003|Overall Study|Adverse Event|0|||
155419691|NCT03502330|560968154|FG004|Overall Study|Adverse Event|1|||
155419692|NCT03502330|560968155|FG005|Overall Study|Adverse Event|0|||
155419693|NCT03502330|560968156|FG006|Overall Study|Adverse Event|1|||
155643589|NCT01658878|561785197|FG017|Treatment Period|Study Drug Toxicity|10|||
155419694|NCT03502330|560968157|FG007|Overall Study|Adverse Event|1|||
155419695|NCT03502330|560968158|FG008|Overall Study|Adverse Event|0|||
155419696|NCT03502330|560968150|FG000|Overall Study|Lack of Efficacy|1|||
155419697|NCT03502330|560968151|FG001|Overall Study|Lack of Efficacy|5|||
155419698|NCT03502330|560968152|FG002|Overall Study|Lack of Efficacy|3|||
155419699|NCT03502330|560968153|FG003|Overall Study|Lack of Efficacy|5|||
155419700|NCT03502330|560968154|FG004|Overall Study|Lack of Efficacy|1|||
155419701|NCT03502330|560968155|FG005|Overall Study|Lack of Efficacy|5|||
155419702|NCT03502330|560968156|FG006|Overall Study|Lack of Efficacy|5|||
155419703|NCT03502330|560968157|FG007|Overall Study|Lack of Efficacy|6|||
155419704|NCT03502330|560968158|FG008|Overall Study|Lack of Efficacy|0|||
155419705|NCT03502330|560968150|FG000|Overall Study|Physician Decision|0|||
155419706|NCT03502330|560968151|FG001|Overall Study|Physician Decision|0|||
155643590|NCT01658878|561785198|FG018|Treatment Period|Study Drug Toxicity|12|||
155643591|NCT01658878|561785199|FG019|Treatment Period|Study Drug Toxicity|4|||
155643592|NCT01658878|561785200|FG020|Treatment Period|Study Drug Toxicity|2|||
155643593|NCT01658878|561785201|FG021|Treatment Period|Study Drug Toxicity|3|||
155643594|NCT01658878|561785202|FG022|Treatment Period|Study Drug Toxicity|2|||
155643595|NCT01658878|561785203|FG023|Treatment Period|Study Drug Toxicity|6|||
155643596|NCT01658878|561785180|FG000|Treatment Period|Maximum Clinical Benefit|0|||
155643597|NCT01658878|561785181|FG001|Treatment Period|Maximum Clinical Benefit|0|||
155643598|NCT01658878|561785182|FG002|Treatment Period|Maximum Clinical Benefit|1|||
155643599|NCT01658878|561785183|FG003|Treatment Period|Maximum Clinical Benefit|0|||
155643600|NCT01658878|561785184|FG004|Treatment Period|Maximum Clinical Benefit|0|||
155643601|NCT01658878|561785185|FG005|Treatment Period|Maximum Clinical Benefit|0|||
155643602|NCT01658878|561785186|FG006|Treatment Period|Maximum Clinical Benefit|0|||
155643603|NCT01658878|561785187|FG007|Treatment Period|Maximum Clinical Benefit|0|||
155643604|NCT01658878|561785188|FG008|Treatment Period|Maximum Clinical Benefit|0|||
155643605|NCT01658878|561785189|FG009|Treatment Period|Maximum Clinical Benefit|0|||
155643606|NCT01658878|561785190|FG010|Treatment Period|Maximum Clinical Benefit|0|||
155643607|NCT01658878|561785191|FG011|Treatment Period|Maximum Clinical Benefit|0|||
155643608|NCT01658878|561785192|FG012|Treatment Period|Maximum Clinical Benefit|0|||
155643609|NCT01658878|561785193|FG013|Treatment Period|Maximum Clinical Benefit|0|||
155643610|NCT01658878|561785194|FG014|Treatment Period|Maximum Clinical Benefit|0|||
155643611|NCT01658878|561785195|FG015|Treatment Period|Maximum Clinical Benefit|0|||
155643612|NCT01658878|561785196|FG016|Treatment Period|Maximum Clinical Benefit|0|||
155643613|NCT01658878|561785197|FG017|Treatment Period|Maximum Clinical Benefit|0|||
155643614|NCT01658878|561785198|FG018|Treatment Period|Maximum Clinical Benefit|1|||
155643615|NCT01658878|561785199|FG019|Treatment Period|Maximum Clinical Benefit|1|||
155643616|NCT01658878|561785200|FG020|Treatment Period|Maximum Clinical Benefit|0|||
155643617|NCT01658878|561785201|FG021|Treatment Period|Maximum Clinical Benefit|0|||
155643618|NCT01658878|561785202|FG022|Treatment Period|Maximum Clinical Benefit|0|||
155643619|NCT01658878|561785203|FG023|Treatment Period|Maximum Clinical Benefit|0|||
155643620|NCT01658878|561785180|FG000|Treatment Period|Other Reasons|0|||
155643621|NCT01658878|561785181|FG001|Treatment Period|Other Reasons|0|||
155643622|NCT01658878|561785182|FG002|Treatment Period|Other Reasons|0|||
155643623|NCT01658878|561785183|FG003|Treatment Period|Other Reasons|1|||
155643624|NCT01658878|561785184|FG004|Treatment Period|Other Reasons|0|||
155643625|NCT01658878|561785185|FG005|Treatment Period|Other Reasons|0|||
155643626|NCT01658878|561785186|FG006|Treatment Period|Other Reasons|0|||
155643627|NCT01658878|561785187|FG007|Treatment Period|Other Reasons|0|||
155643628|NCT01658878|561785188|FG008|Treatment Period|Other Reasons|0|||
155643629|NCT01658878|561785189|FG009|Treatment Period|Other Reasons|0|||
155643630|NCT01658878|561785190|FG010|Treatment Period|Other Reasons|0|||
155643631|NCT01658878|561785191|FG011|Treatment Period|Other Reasons|0|||
155419707|NCT03502330|560968152|FG002|Overall Study|Physician Decision|0|||
155419708|NCT03502330|560968153|FG003|Overall Study|Physician Decision|0|||
155419709|NCT03502330|560968154|FG004|Overall Study|Physician Decision|1|||
155419710|NCT03502330|560968155|FG005|Overall Study|Physician Decision|0|||
155419711|NCT03502330|560968156|FG006|Overall Study|Physician Decision|0|||
155419712|NCT03502330|560968157|FG007|Overall Study|Physician Decision|0|||
155643632|NCT01658878|561785192|FG012|Treatment Period|Other Reasons|2|||
155419713|NCT03502330|560968158|FG008|Overall Study|Physician Decision|0|||
155419714|NCT03502330|560968150|FG000|Overall Study|Withdrawal by Subject|0|||
155643633|NCT01658878|561785193|FG013|Treatment Period|Other Reasons|0|||
155643634|NCT01658878|561785194|FG014|Treatment Period|Other Reasons|0|||
155643635|NCT01658878|561785195|FG015|Treatment Period|Other Reasons|2|||
155643636|NCT01658878|561785196|FG016|Treatment Period|Other Reasons|1|||
155643637|NCT01658878|561785197|FG017|Treatment Period|Other Reasons|1|||
155751226|NCT01715129|562188443|FG000|Overall Study|Adverse Event, fatal|1|||
155751227|NCT01715129|562188443|FG000|Overall Study|Lack of Efficacy|3|||
155751228|NCT01715129|562188443|FG000|Overall Study|Protocol Violation|1|||
155751229|NCT01715129|562188443|FG000|Overall Study|Consent Withdrawn|2|||
155751230|NCT01715129|562188443|FG000|Overall Study|Lost to Follow-up|1|||
155751231|NCT01715129|562188443|FG000|Overall Study|Other|1|||
155751232|NCT02009384|562188444|FG000|Overall Study|Death|2|||
155751233|NCT01146860|562188445|FG000|Overall Study|Withdrawal by Subject|0|||
155751234|NCT01146860|562188446|FG001|Overall Study|Withdrawal by Subject|1|||
155751235|NCT00722371|562188447|FG000|Overall Study|Adverse Event|6|||
155751236|NCT00722371|562188448|FG001|Overall Study|Adverse Event|13|||
155751237|NCT00722371|562188449|FG002|Overall Study|Adverse Event|9|||
155751238|NCT00722371|562188450|FG003|Overall Study|Adverse Event|10|||
155751239|NCT00722371|562188451|FG004|Overall Study|Adverse Event|6|||
155751240|NCT00722371|562188452|FG005|Overall Study|Adverse Event|8|||
155751241|NCT00722371|562188453|FG006|Overall Study|Adverse Event|4|||
155751242|NCT00722371|562188447|FG000|Overall Study|Contraindication|0|||
155419715|NCT03502330|560968151|FG001|Overall Study|Withdrawal by Subject|0|||
155419716|NCT03502330|560968152|FG002|Overall Study|Withdrawal by Subject|0|||
155419717|NCT03502330|560968153|FG003|Overall Study|Withdrawal by Subject|0|||
155419718|NCT03502330|560968154|FG004|Overall Study|Withdrawal by Subject|0|||
155419719|NCT03502330|560968155|FG005|Overall Study|Withdrawal by Subject|1|||
155419720|NCT03502330|560968156|FG006|Overall Study|Withdrawal by Subject|0|||
155419721|NCT03502330|560968157|FG007|Overall Study|Withdrawal by Subject|1|||
155419722|NCT03502330|560968158|FG008|Overall Study|Withdrawal by Subject|0|||
155500973|NCT01408576|561260728|FG001|Overall Study|Lack of Efficacy|30|||
155500974|NCT01408576|561260729|FG002|Overall Study|Lack of Efficacy|48|||
155500975|NCT01408576|561260727|FG000|Overall Study|Protocol Violation|1|||
155500976|NCT01408576|561260728|FG001|Overall Study|Protocol Violation|2|||
155500977|NCT01408576|561260729|FG002|Overall Study|Protocol Violation|2|||
155500978|NCT01408576|561260727|FG000|Overall Study|Lost to Follow-up|10|||
155500979|NCT01408576|561260728|FG001|Overall Study|Lost to Follow-up|9|||
155500980|NCT01408576|561260729|FG002|Overall Study|Lost to Follow-up|17|||
155500981|NCT01408576|561260727|FG000|Overall Study|Withdrawal by Subject|34|||
155500982|NCT01408576|561260728|FG001|Overall Study|Withdrawal by Subject|60|||
155500983|NCT01408576|561260729|FG002|Overall Study|Withdrawal by Subject|66|||
155500984|NCT01408576|561260727|FG000|Overall Study|Sponsor terminated study|89|||
155500985|NCT01408576|561260728|FG001|Overall Study|Sponsor terminated study|333|||
155751243|NCT00722371|562188448|FG001|Overall Study|Contraindication|0|||
155751244|NCT00722371|562188449|FG002|Overall Study|Contraindication|1|||
155751245|NCT00722371|562188450|FG003|Overall Study|Contraindication|0|||
155751246|NCT00722371|562188451|FG004|Overall Study|Contraindication|0|||
155751247|NCT00722371|562188452|FG005|Overall Study|Contraindication|0|||
155751248|NCT00722371|562188453|FG006|Overall Study|Contraindication|0|||
155751249|NCT00722371|562188447|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
155751250|NCT00722371|562188448|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
155751251|NCT00722371|562188449|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
155319386|NCT04299464|560605463|FG002|Overall Study|Non-compliance with Study Drug|0|||
155319387|NCT04299464|560605461|FG000|Overall Study|Reason not Specified|0|||
155319388|NCT04299464|560605462|FG001|Overall Study|Reason not Specified|1|||
155319389|NCT04299464|560605463|FG002|Overall Study|Reason not Specified|3|||
155319390|NCT04299464|560605461|FG000|Overall Study|Physician Decision|0|||
155319391|NCT04299464|560605462|FG001|Overall Study|Physician Decision|1|||
155319392|NCT04299464|560605463|FG002|Overall Study|Physician Decision|1|||
155319393|NCT04299464|560605461|FG000|Overall Study|Withdrawal by Subject|0|||
155319394|NCT04299464|560605462|FG001|Overall Study|Withdrawal by Subject|2|||
155319395|NCT04299464|560605463|FG002|Overall Study|Withdrawal by Subject|1|||
155319396|NCT03030261|560605466|FG000|Overall Study|Still receiving continuation therapy|5|||
155319397|NCT05293171|560605473|FG000|Washout 5 to 7 Days|Adverse Event|1|||
155419723|NCT03502330|560968150|FG000|Overall Study|Death|0|||
155419724|NCT03502330|560968151|FG001|Overall Study|Death|0|||
155419725|NCT03502330|560968152|FG002|Overall Study|Death|0|||
155419726|NCT03502330|560968153|FG003|Overall Study|Death|0|||
155419727|NCT03502330|560968154|FG004|Overall Study|Death|0|||
155419728|NCT03502330|560968155|FG005|Overall Study|Death|0|||
155419729|NCT03502330|560968156|FG006|Overall Study|Death|2|||
155500986|NCT01408576|561260729|FG002|Overall Study|Sponsor terminated study|330|||
155500987|NCT01408576|561260727|FG000|Overall Study|AE, serious fatal|4|||
155319398|NCT05293171|560605474|FG001|Washout 5 to 7 Days|Adverse Event|1|||
155319399|NCT05293171|560605475|FG002|Washout 5 to 7 Days|Adverse Event|0|||
155319400|NCT05293171|560605476|FG003|Washout 5 to 7 Days|Adverse Event|0|||
155319401|NCT05293171|560605477|FG004|Washout 5 to 7 Days|Adverse Event|0|||
155419730|NCT03502330|560968157|FG007|Overall Study|Death|0|||
155419731|NCT03502330|560968158|FG008|Overall Study|Death|0|||
155500988|NCT01408576|561260728|FG001|Overall Study|AE, serious fatal|4|||
155751252|NCT00722371|562188450|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
155751253|NCT00722371|562188451|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
155751254|NCT00722371|562188452|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
155751255|NCT00722371|562188453|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
155751256|NCT00722371|562188447|FG000|Overall Study|Excluded medication|0|||
155751257|NCT00722371|562188448|FG001|Overall Study|Excluded medication|1|||
155751258|NCT00722371|562188449|FG002|Overall Study|Excluded medication|1|||
155751259|NCT00722371|562188450|FG003|Overall Study|Excluded medication|0|||
155751260|NCT00722371|562188451|FG004|Overall Study|Excluded medication|0|||
155751261|NCT00722371|562188452|FG005|Overall Study|Excluded medication|0|||
155751262|NCT00722371|562188453|FG006|Overall Study|Excluded medication|1|||
155751263|NCT00722371|562188447|FG000|Overall Study|Hyperglycemia|2|||
155751264|NCT00722371|562188448|FG001|Overall Study|Hyperglycemia|6|||
155751265|NCT00722371|562188449|FG002|Overall Study|Hyperglycemia|4|||
155751266|NCT00722371|562188450|FG003|Overall Study|Hyperglycemia|2|||
155751267|NCT00722371|562188451|FG004|Overall Study|Hyperglycemia|5|||
155751268|NCT00722371|562188452|FG005|Overall Study|Hyperglycemia|1|||
155751269|NCT00722371|562188453|FG006|Overall Study|Hyperglycemia|1|||
155751270|NCT00722371|562188447|FG000|Overall Study|Hypoglycemia|1|||
155751271|NCT00722371|562188448|FG001|Overall Study|Hypoglycemia|0|||
155751272|NCT00722371|562188449|FG002|Overall Study|Hypoglycemia|0|||
155751273|NCT00722371|562188450|FG003|Overall Study|Hypoglycemia|0|||
155751274|NCT00722371|562188451|FG004|Overall Study|Hypoglycemia|0|||
155751275|NCT00722371|562188452|FG005|Overall Study|Hypoglycemia|0|||
155751276|NCT00722371|562188453|FG006|Overall Study|Hypoglycemia|0|||
155751277|NCT00722371|562188447|FG000|Overall Study|Lack of Efficacy|4|||
155751278|NCT00722371|562188448|FG001|Overall Study|Lack of Efficacy|6|||
155751279|NCT00722371|562188449|FG002|Overall Study|Lack of Efficacy|6|||
155751280|NCT00722371|562188450|FG003|Overall Study|Lack of Efficacy|6|||
155751281|NCT00722371|562188451|FG004|Overall Study|Lack of Efficacy|2|||
155751282|NCT00722371|562188452|FG005|Overall Study|Lack of Efficacy|3|||
155751283|NCT00722371|562188453|FG006|Overall Study|Lack of Efficacy|0|||
155751284|NCT00722371|562188447|FG000|Overall Study|Lost to Follow-up|11|||
155751285|NCT00722371|562188448|FG001|Overall Study|Lost to Follow-up|14|||
155751286|NCT00722371|562188449|FG002|Overall Study|Lost to Follow-up|21|||
155751287|NCT00722371|562188450|FG003|Overall Study|Lost to Follow-up|13|||
155751288|NCT00722371|562188451|FG004|Overall Study|Lost to Follow-up|8|||
155751289|NCT00722371|562188452|FG005|Overall Study|Lost to Follow-up|16|||
155751290|NCT00722371|562188453|FG006|Overall Study|Lost to Follow-up|13|||
155751291|NCT00722371|562188447|FG000|Overall Study|Physician Decision|5|||
155751292|NCT00722371|562188448|FG001|Overall Study|Physician Decision|2|||
155751293|NCT00722371|562188449|FG002|Overall Study|Physician Decision|2|||
155751294|NCT00722371|562188450|FG003|Overall Study|Physician Decision|5|||
155751295|NCT00722371|562188451|FG004|Overall Study|Physician Decision|2|||
155751296|NCT00722371|562188452|FG005|Overall Study|Physician Decision|3|||
155751297|NCT00722371|562188453|FG006|Overall Study|Physician Decision|4|||
155751298|NCT00722371|562188447|FG000|Overall Study|Pregnancy|1|||
155751299|NCT00722371|562188448|FG001|Overall Study|Pregnancy|1|||
155751300|NCT00722371|562188449|FG002|Overall Study|Pregnancy|0|||
155751301|NCT00722371|562188450|FG003|Overall Study|Pregnancy|0|||
155751302|NCT00722371|562188451|FG004|Overall Study|Pregnancy|0|||
155751303|NCT00722371|562188452|FG005|Overall Study|Pregnancy|1|||
155751304|NCT00722371|562188453|FG006|Overall Study|Pregnancy|0|||
155500989|NCT01408576|561260729|FG002|Overall Study|AE, serious fatal|1|||
155500990|NCT01408576|561260727|FG000|Overall Study|SAE, non-fatal|11|||
155500991|NCT01408576|561260728|FG001|Overall Study|SAE, non-fatal|23|||
155500992|NCT01408576|561260729|FG002|Overall Study|SAE, non-fatal|14|||
155500993|NCT01408576|561260727|FG000|Overall Study|AE, non-serious non-fatal|12|||
155500994|NCT01408576|561260728|FG001|Overall Study|AE, non-serious non-fatal|19|||
155500995|NCT01408576|561260729|FG002|Overall Study|AE, non-serious non-fatal|11|||
155500996|NCT01408576|561260727|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155500997|NCT01408576|561260728|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155500998|NCT01408576|561260729|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155500999|NCT01408576|561260727|FG000|Overall Study|AE, unknown type|0|||
155501000|NCT01408576|561260728|FG001|Overall Study|AE, unknown type|1|||
155501001|NCT01408576|561260729|FG002|Overall Study|AE, unknown type|0|||
155501002|NCT01408576|561260727|FG000|Overall Study|Other|10|||
155501003|NCT01408576|561260728|FG001|Overall Study|Other|16|||
155751305|NCT00722371|562188447|FG000|Overall Study|Protocol Violation|6|||
155751306|NCT00722371|562188448|FG001|Overall Study|Protocol Violation|1|||
155751307|NCT00722371|562188449|FG002|Overall Study|Protocol Violation|0|||
155751308|NCT00722371|562188450|FG003|Overall Study|Protocol Violation|1|||
155751309|NCT00722371|562188451|FG004|Overall Study|Protocol Violation|4|||
155751310|NCT00722371|562188452|FG005|Overall Study|Protocol Violation|2|||
155751311|NCT00722371|562188453|FG006|Overall Study|Protocol Violation|1|||
155751312|NCT00722371|562188447|FG000|Overall Study|Withdrawal by Subject|18|||
155751313|NCT00722371|562188448|FG001|Overall Study|Withdrawal by Subject|27|||
155751314|NCT00722371|562188449|FG002|Overall Study|Withdrawal by Subject|19|||
155751315|NCT00722371|562188450|FG003|Overall Study|Withdrawal by Subject|23|||
155751316|NCT00722371|562188451|FG004|Overall Study|Withdrawal by Subject|19|||
155751317|NCT00722371|562188452|FG005|Overall Study|Withdrawal by Subject|18|||
155751318|NCT00722371|562188453|FG006|Overall Study|Withdrawal by Subject|26|||
155751319|NCT01092832|562188454|FG000|Overall Study|Other|1|||
155751320|NCT01092832|562188455|FG001|Overall Study|Other|0|||
155751321|NCT01075191|562188456|FG000|Overall Study|Death|1|||
155751322|NCT01075191|562188456|FG000|Overall Study|Intensification|3|||
155751323|NCT01075191|562188456|FG000|Overall Study|Co-morbidities|1|||
155751324|NCT01075191|562188456|FG000|Overall Study|Adverse Event|4|||
155751325|NCT01075191|562188456|FG000|Overall Study|Noncompliance|3|||
155751326|NCT01075191|562188456|FG000|Overall Study|Therapy Break|3|||
155751327|NCT01075191|562188456|FG000|Overall Study|Patient's Wish|2|||
155751328|NCT01075191|562188456|FG000|Overall Study|Unknown Reasons|1|||
155751329|NCT00718237|562188461|FG000|Overall Study|Adverse Event|1|||
155751330|NCT00718237|562188462|FG001|Overall Study|Adverse Event|3|||
155751331|NCT00718237|562188461|FG000|Overall Study|Lost to Follow-up|2|||
155751332|NCT00718237|562188462|FG001|Overall Study|Lost to Follow-up|2|||
155751333|NCT00718237|562188461|FG000|Overall Study|Physician Decision|1|||
155751334|NCT00718237|562188462|FG001|Overall Study|Physician Decision|0|||
155751335|NCT00718237|562188461|FG000|Overall Study|Withdrawal by Subject|9|||
155751336|NCT00718237|562188462|FG001|Overall Study|Withdrawal by Subject|10|||
155751337|NCT02635646|562188463|FG000|Overall Study|Lost to Follow-up|24|||
155751338|NCT02635646|562188464|FG001|Overall Study|Lost to Follow-up|25|||
155751339|NCT02635646|562188463|FG000|Overall Study|Pregnancy|1|||
155751340|NCT02635646|562188464|FG001|Overall Study|Pregnancy|1|||
155751341|NCT03149848|562188467|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
155751342|NCT03149848|562188467|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
155751343|NCT04738318|562188470|FG000|Overall Study|Protocol Violation|1|||
155751344|NCT04738318|562188471|FG001|Overall Study|Protocol Violation|0|||
155751345|NCT01226121|562188472|FG000|Overall Study|Lost to Follow-up|2|||
155751346|NCT01226121|562188473|FG001|Overall Study|Lost to Follow-up|0|||
155751347|NCT01226121|562188474|FG002|Overall Study|Lost to Follow-up|1|||
155751348|NCT00378079|562188475|FG000|Overall Study|Lost to Follow-up|6|||
155751349|NCT00378079|562188476|FG001|Overall Study|Lost to Follow-up|1|||
155751350|NCT00378079|562188477|FG002|Overall Study|Lost to Follow-up|0|||
155751351|NCT00586664|562188485|FG000|Overall Study|Withdrawal by Subject|3|||
155751352|NCT00586664|562188486|FG001|Overall Study|Withdrawal by Subject|7|||
155751353|NCT00586664|562188487|FG002|Overall Study|Withdrawal by Subject|1|||
155751354|NCT00586664|562188485|FG000|Overall Study|Exclusion criteria met|2|||
155751355|NCT00586664|562188486|FG001|Overall Study|Exclusion criteria met|0|||
155751356|NCT00586664|562188487|FG002|Overall Study|Exclusion criteria met|0|||
155751357|NCT00686998|562188491|FG000|Overall Study|Adverse Event|3|||
155751358|NCT00686998|562188492|FG001|Overall Study|Adverse Event|2|||
155751359|NCT00686998|562188493|FG002|Overall Study|Adverse Event|1|||
155751360|NCT00686998|562188491|FG000|Overall Study|Withdrawal by Subject|2|||
155751361|NCT00686998|562188492|FG001|Overall Study|Withdrawal by Subject|1|||
155751362|NCT00686998|562188493|FG002|Overall Study|Withdrawal by Subject|2|||
155751363|NCT00686998|562188491|FG000|Overall Study|Lack of Efficacy|7|||
155751364|NCT00686998|562188492|FG001|Overall Study|Lack of Efficacy|5|||
155751365|NCT00686998|562188493|FG002|Overall Study|Lack of Efficacy|0|||
155751366|NCT00686998|562188491|FG000|Overall Study|Other|0|||
155751367|NCT00686998|562188492|FG001|Overall Study|Other|0|||
155751368|NCT00686998|562188493|FG002|Overall Study|Other|1|||
155751369|NCT00686998|562188491|FG000|Overall Study|Safety Reasons|1|||
155751370|NCT00686998|562188492|FG001|Overall Study|Safety Reasons|0|||
155751371|NCT00686998|562188493|FG002|Overall Study|Safety Reasons|0|||
155751372|NCT02361346|562188494|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751373|NCT02361346|562188495|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751374|NCT02361346|562188496|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751375|NCT02361346|562188497|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
155751376|NCT02361346|562188498|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751377|NCT02361346|562188499|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751378|NCT02361346|562188500|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
155419732|NCT02804763|560968162|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
155419733|NCT02804763|560968163|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
155419734|NCT02804763|560968164|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
155751379|NCT02361346|562188501|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751380|NCT02361346|562188502|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
155751381|NCT02361346|562188494|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751382|NCT02361346|562188495|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751383|NCT02361346|562188496|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751384|NCT02361346|562188497|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751385|NCT02361346|562188498|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
155751386|NCT02361346|562188499|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155419735|NCT02804763|560968165|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
155419736|NCT02804763|560968162|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
155751387|NCT02361346|562188500|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751388|NCT02361346|562188501|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155501004|NCT01408576|561260729|FG002|Overall Study|Other|18|||
155751389|NCT02361346|562188502|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155751390|NCT02361346|562188494|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
155751391|NCT02361346|562188495|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
155751392|NCT02361346|562188496|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
155751393|NCT02361346|562188497|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
155751394|NCT02361346|562188498|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
155751395|NCT02361346|562188499|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
155751396|NCT02361346|562188500|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
155751397|NCT02361346|562188501|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
155751398|NCT02361346|562188502|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
155751399|NCT02361346|562188494|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751400|NCT02361346|562188495|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751401|NCT02361346|562188496|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751402|NCT02361346|562188497|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751403|NCT02361346|562188498|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751404|NCT02361346|562188499|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751405|NCT02361346|562188500|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751406|NCT02361346|562188501|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
155751407|NCT02361346|562188502|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155751408|NCT02361346|562188494|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751409|NCT02361346|562188495|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751410|NCT02361346|562188496|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751411|NCT02361346|562188497|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751412|NCT02361346|562188498|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751413|NCT02361346|562188499|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751414|NCT02361346|562188500|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751415|NCT02361346|562188501|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
155751416|NCT02361346|562188502|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155751417|NCT02361346|562188494|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751418|NCT02361346|562188495|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751419|NCT02361346|562188496|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751420|NCT02361346|562188497|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751421|NCT02361346|562188498|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751422|NCT02361346|562188499|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751423|NCT02361346|562188500|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751424|NCT02361346|562188501|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
155751425|NCT02361346|562188502|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155751426|NCT03052764|562190227|FG000|Double-Blind Treatment Period|Adverse Event|2|||
155751427|NCT03052764|562190228|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155751428|NCT03052764|562190227|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
155751429|NCT03052764|562190228|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155751430|NCT03052764|562190227|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
155751431|NCT03052764|562190228|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
155751432|NCT03052764|562190227|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
155751433|NCT03052764|562190228|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155751434|NCT03052764|562190227|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
155751435|NCT03052764|562190228|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
155751436|NCT01314911|562190229|FG000|Overall Study|Lost to Follow-up|3|||
155751437|NCT01314911|562190230|FG001|Overall Study|Lost to Follow-up|2|||
155751438|NCT01314911|562190229|FG000|Overall Study|Withdrawal by Subject|1|||
155751439|NCT01314911|562190230|FG001|Overall Study|Withdrawal by Subject|3|||
155751440|NCT01314911|562190229|FG000|Overall Study|Received Non-randomized Study Drug|0|||
155751441|NCT01314911|562190230|FG001|Overall Study|Received Non-randomized Study Drug|1|||
155751442|NCT01314911|562190229|FG000|Overall Study|Never Started Treatment|1|||
155751443|NCT01314911|562190230|FG001|Overall Study|Never Started Treatment|0|||
155751444|NCT01394718|562190234|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
155751445|NCT01394718|562190235|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
155751446|NCT00096954|562190238|FG000|Overall Study|Adverse Event|3|||
155751447|NCT00096954|562190239|FG001|Overall Study|Adverse Event|1|||
155419737|NCT02804763|560968163|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
155751448|NCT00096954|562190238|FG000|Overall Study|Withdrawal by Subject|9|||
155751449|NCT00096954|562190239|FG001|Overall Study|Withdrawal by Subject|8|||
155751450|NCT00096954|562190238|FG000|Overall Study|Physician Decision|1|||
155751451|NCT00096954|562190239|FG001|Overall Study|Physician Decision|1|||
155751452|NCT00096954|562190238|FG000|Overall Study|Sponsors Decision|1|||
155751453|NCT00096954|562190239|FG001|Overall Study|Sponsors Decision|1|||
155751454|NCT00096954|562190238|FG000|Overall Study|Pregnancy|1|||
155751455|NCT00096954|562190239|FG001|Overall Study|Pregnancy|1|||
155751456|NCT00096954|562190238|FG000|Overall Study|Initiation of immunotherapy|1|||
155419738|NCT02804763|560968164|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
155751457|NCT00096954|562190239|FG001|Overall Study|Initiation of immunotherapy|0|||
155751458|NCT00096954|562190238|FG000|Overall Study|Non-compliance|0|||
155751459|NCT00096954|562190239|FG001|Overall Study|Non-compliance|3|||
155751460|NCT00096954|562190238|FG000|Overall Study|Lost to Follow-up|8|||
155751461|NCT00096954|562190239|FG001|Overall Study|Lost to Follow-up|5|||
155751462|NCT04478123|562190240|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
155751463|NCT04478123|562190240|FG000|Overall Study|NE|1|||
155751464|NCT02395016|562190241|FG000|Overall Study|Adverse Event|4|||
155751465|NCT02395016|562190242|FG001|Overall Study|Adverse Event|3|||
155751466|NCT02395016|562190241|FG000|Overall Study|Withdrawal by Subject|9|||
155751467|NCT02395016|562190242|FG001|Overall Study|Withdrawal by Subject|6|||
155751468|NCT02395016|562190241|FG000|Overall Study|Protocol Violation|2|||
155751469|NCT02395016|562190242|FG001|Overall Study|Protocol Violation|3|||
155751470|NCT01547780|562190243|FG000|Baseline PET Scan|Physician Decision|1|||
155751471|NCT01547780|562190244|FG001|Baseline PET Scan|Physician Decision|0|||
155751472|NCT01547780|562190245|FG002|Baseline PET Scan|Physician Decision|1|||
155751473|NCT01547780|562190246|FG003|Baseline PET Scan|Physician Decision|0|||
155751474|NCT01547780|562190243|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
155751475|NCT01547780|562190244|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
155751476|NCT01547780|562190245|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
155751477|NCT01547780|562190246|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
155751478|NCT00814879|562190248|FG000|By Week 24|Cancer Diagnosis|1|||
155751479|NCT00814879|562190249|FG001|By Week 24|Cancer Diagnosis|0|||
155751480|NCT00814879|562190248|FG000|By Week 24|Incarceration|0|||
155751481|NCT00814879|562190249|FG001|By Week 24|Incarceration|1|||
155751482|NCT00814879|562190248|FG000|By Week 48|Lost to Follow-up|2|||
155419739|NCT02804763|560968165|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
155419740|NCT02804763|560968162|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
155419741|NCT02804763|560968163|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
155419742|NCT02804763|560968164|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
155419743|NCT02804763|560968165|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
155751483|NCT00814879|562190249|FG001|By Week 48|Lost to Follow-up|2|||
155751484|NCT00814879|562190248|FG000|By Week 48|Death|0|||
155751485|NCT00814879|562190249|FG001|By Week 48|Death|1|||
155751486|NCT00588952|562190250|FG000|Overall Study|Adverse Event|0|||
155751487|NCT00588952|562190251|FG001|Overall Study|Adverse Event|2|||
155319402|NCT05293171|560605478|FG005|Washout 5 to 7 Days|Adverse Event|0|||
155319403|NCT05293171|560605479|FG006|Washout 5 to 7 Days|Adverse Event|0|||
155319404|NCT05293171|560605480|FG007|Washout 5 to 7 Days|Adverse Event|0|||
155319405|NCT05293171|560605481|FG008|Washout 5 to 7 Days|Adverse Event|0|||
155319406|NCT05293171|560605482|FG009|Washout 5 to 7 Days|Adverse Event|0|||
155419744|NCT02804763|560968162|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
155419745|NCT02804763|560968163|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
155419746|NCT02804763|560968164|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
155419747|NCT02804763|560968165|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
155751488|NCT00588952|562190250|FG000|Overall Study|Withdrawal by Subject|3|||
155751489|NCT00588952|562190251|FG001|Overall Study|Withdrawal by Subject|5|||
155751490|NCT01461057|562190252|FG000|Overall Study|Death|10|||
155751491|NCT01461057|562190253|FG001|Overall Study|Death|9|||
155751492|NCT01461057|562190252|FG000|Overall Study|Withdrawal by Subject|2|||
155751493|NCT01461057|562190253|FG001|Overall Study|Withdrawal by Subject|3|||
155751494|NCT01461057|562190252|FG000|Overall Study|Physician Decision|0|||
155751495|NCT01461057|562190253|FG001|Overall Study|Physician Decision|2|||
155751496|NCT01461057|562190252|FG000|Overall Study|Adverse Event|0|||
155751497|NCT01461057|562190253|FG001|Overall Study|Adverse Event|1|||
155751498|NCT01461057|562190252|FG000|Overall Study|Progression of Disease|1|||
155751499|NCT01461057|562190253|FG001|Overall Study|Progression of Disease|0|||
155751500|NCT01461057|562190252|FG000|Overall Study|Study Terminated by Sponsor|2|||
155751501|NCT01461057|562190253|FG001|Overall Study|Study Terminated by Sponsor|0|||
155751502|NCT01288976|562190254|FG000|Overall Study|Withdrawal by Subject|58|||
155751503|NCT01288976|562190255|FG001|Overall Study|Withdrawal by Subject|12|||
155751504|NCT01288976|562190256|FG002|Overall Study|Withdrawal by Subject|9|||
155751505|NCT01288976|562190254|FG000|Overall Study|Death|98|||
155751506|NCT01288976|562190255|FG001|Overall Study|Death|6|||
155419748|NCT02804763|560968162|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
155419749|NCT02804763|560968163|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
155419750|NCT02804763|560968164|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
155419751|NCT02804763|560968165|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
155419752|NCT02804763|560968162|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
155419753|NCT02804763|560968163|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
155419754|NCT02804763|560968164|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
155419755|NCT02804763|560968165|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
155419756|NCT01400932|560968170|FG000|Overall Study|Adverse Event|10|||
155419757|NCT01400932|560968171|FG001|Overall Study|Adverse Event|5|||
155419758|NCT01400932|560968170|FG000|Overall Study|Lack of Efficacy|0|||
155419759|NCT01400932|560968171|FG001|Overall Study|Lack of Efficacy|3|||
155419760|NCT01400932|560968170|FG000|Overall Study|Withdrawal by Subject|2|||
155419761|NCT01400932|560968171|FG001|Overall Study|Withdrawal by Subject|6|||
155419762|NCT01400932|560968170|FG000|Overall Study|Lost to Follow-up|1|||
155419763|NCT01400932|560968171|FG001|Overall Study|Lost to Follow-up|0|||
155419764|NCT01400932|560968170|FG000|Overall Study|Protocol Deviation|0|||
155419765|NCT01400932|560968171|FG001|Overall Study|Protocol Deviation|1|||
155419766|NCT01400932|560968170|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155419767|NCT01400932|560968171|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155419768|NCT00860158|560968172|FG000|Overall Study|Study Terminated|1|||
155419769|NCT02472847|560968173|FG000|Overall Study|Withdrawal by Subject|1|||
155419770|NCT02472847|560968174|FG001|Overall Study|Withdrawal by Subject|5|||
155419771|NCT04656990|560968175|FG000|Baseline|pandemic|20|||
155419772|NCT04656990|560968176|FG001|Baseline|pandemic|24|||
155419773|NCT04656990|560968175|FG000|Follow Up Period|Lost to Follow-up|61|||
155419774|NCT04656990|560968176|FG001|Follow Up Period|Lost to Follow-up|73|||
155751507|NCT01288976|562190256|FG002|Overall Study|Death|4|||
155751508|NCT01288976|562190254|FG000|Overall Study|Data unavailable|22|||
155751509|NCT01288976|562190255|FG001|Overall Study|Data unavailable|9|||
155751510|NCT01288976|562190256|FG002|Overall Study|Data unavailable|7|||
155751511|NCT03560739|562190258|FG000|Overall Study|Adverse Event|0|||
155751512|NCT03560739|562190259|FG001|Overall Study|Adverse Event|1|||
155751513|NCT03560739|562190260|FG002|Overall Study|Adverse Event|0|||
155751514|NCT03560739|562190261|FG003|Overall Study|Adverse Event|0|||
155751515|NCT01362595|562190262|FG000|Overall Study|Screen failure|10|||
155319407|NCT05293171|560605483|FG010|Washout 5 to 7 Days|Adverse Event|0|||
155319408|NCT05293171|560605484|FG011|Washout 5 to 7 Days|Adverse Event|0|||
155319409|NCT05293171|560605473|FG000|Washout 5 to 7 Days|Adverse Event|0|||
155419775|NCT03244059|560968177|FG000|Specific Aim 1|Physician Decision|1|||
155419776|NCT03244059|560968178|FG001|Specific Aim 1|Physician Decision|0|||
155751516|NCT01362595|562190262|FG000|Overall Study|Withdrawal by Subject|2|||
155751517|NCT00959374|562190263|FG000|Overall Study|Withdrawal by Subject|2|||
155751518|NCT00959374|562190263|FG000|Overall Study|Lost to Follow-up|14|||
155751519|NCT00959374|562190263|FG000|Overall Study|Death|1|||
155751520|NCT00959374|562190263|FG000|Overall Study|Protocol Violation|1|||
155751521|NCT00959374|562190263|FG000|Overall Study|Implant Removed/Not Replaced|4|||
155751522|NCT00959374|562190263|FG000|Overall Study|Physician Decision|1|||
155751523|NCT02448680|562190264|FG000|Overall Study|Physician Decision|1|||
155751524|NCT02448680|562190265|FG001|Overall Study|Physician Decision|1|||
155751525|NCT02448680|562190264|FG000|Overall Study|Withdrawal by Subject|0|||
155751526|NCT02448680|562190265|FG001|Overall Study|Withdrawal by Subject|2|||
155751527|NCT01739400|562190266|FG000|Overall Study|Physician Decision|3|||
155751528|NCT01739400|562190267|FG001|Overall Study|Physician Decision|0|||
155751529|NCT01739400|562190266|FG000|Overall Study|Lost to Follow-up|2|||
155751530|NCT01739400|562190267|FG001|Overall Study|Lost to Follow-up|0|||
155751531|NCT01739400|562190266|FG000|Overall Study|Death|5|||
155751532|NCT01739400|562190267|FG001|Overall Study|Death|2|||
155751533|NCT01739400|562190266|FG000|Overall Study|Withdrawal by Subject|7|||
155751534|NCT01739400|562190267|FG001|Overall Study|Withdrawal by Subject|7|||
155751535|NCT01736657|562190268|FG000|Overall Study|insufficient vascular access|1|||
155751536|NCT03350984|562190269|FG000|Overall Study|Death|1|||
155751537|NCT03350984|562190270|FG001|Overall Study|Death|0|||
155751538|NCT03350984|562190269|FG000|Overall Study|Lost to Follow-up|5|||
155751539|NCT03350984|562190270|FG001|Overall Study|Lost to Follow-up|6|||
155751540|NCT03350984|562190269|FG000|Overall Study|Protocol Violation|1|||
155751541|NCT03350984|562190270|FG001|Overall Study|Protocol Violation|2|||
155751542|NCT03350984|562190269|FG000|Overall Study|Physician Decision|1|||
155751543|NCT03350984|562190270|FG001|Overall Study|Physician Decision|0|||
155751544|NCT00642473|562190279|FG000|Overall Study|Withdrawal by Subject|0|||
155751545|NCT00642473|562190280|FG001|Overall Study|Withdrawal by Subject|5|||
155751546|NCT00642473|562190279|FG000|Overall Study|Progression or death|2|||
155751547|NCT00642473|562190280|FG001|Overall Study|Progression or death|4|||
155751548|NCT00642473|562190279|FG000|Overall Study|Other|2|||
155751549|NCT00642473|562190280|FG001|Overall Study|Other|2|||
155751550|NCT01711879|562190283|FG000|Overall Study|Death|1|||
155751551|NCT01711879|562190284|FG001|Overall Study|Death|0|||
155751552|NCT00958789|562190288|FG000|Overall Study|Death|5|||
155751553|NCT00958789|562190288|FG000|Overall Study|Lost to Follow-up|14|||
155751554|NCT00958789|562190288|FG000|Overall Study|Withdrawal by Subject|17|||
155751555|NCT00958789|562190288|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
155751556|NCT00958789|562190288|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
155751557|NCT00958789|562190288|FG000|Overall Study|Subject terminated|2|||
155751558|NCT00958789|562190288|FG000|Overall Study|Revision|7|||
155751559|NCT00478881|562190291|FG000|Overall Study|Adverse Event|31|||
155751560|NCT00478881|562190292|FG001|Overall Study|Adverse Event|12|||
155751561|NCT00478881|562190291|FG000|Overall Study|Lack of Efficacy|0|||
155751562|NCT00478881|562190292|FG001|Overall Study|Lack of Efficacy|3|||
155751563|NCT00478881|562190291|FG000|Overall Study|Lost to Follow-up|0|||
155751564|NCT00478881|562190292|FG001|Overall Study|Lost to Follow-up|1|||
155751565|NCT00478881|562190291|FG000|Overall Study|Protocol Violation|2|||
155751566|NCT00478881|562190292|FG001|Overall Study|Protocol Violation|2|||
155751567|NCT00478881|562190291|FG000|Overall Study|Withdrawal by Subject|6|||
155751568|NCT00478881|562190292|FG001|Overall Study|Withdrawal by Subject|2|||
155751569|NCT00478881|562190291|FG000|Overall Study|Non-Compliance with Study Medication|0|||
155751570|NCT00478881|562190292|FG001|Overall Study|Non-Compliance with Study Medication|2|||
155751571|NCT01466179|562190293|FG000|Overall Study|Ongoing in core study|2|||
155751572|NCT01466179|562190293|FG000|Overall Study|Physician Decision|46|||
155751573|NCT01466179|562190293|FG000|Overall Study|Progressive disease|43|||
155751574|NCT01466179|562190293|FG000|Overall Study|Adverse Event|32|||
155751575|NCT01466179|562190293|FG000|Overall Study|Disease relapse|23|||
155751576|NCT01466179|562190293|FG000|Overall Study|Lack of Efficacy|14|||
155751577|NCT01466179|562190293|FG000|Overall Study|Death|7|||
155751578|NCT01466179|562190293|FG000|Overall Study|Withdrawal by Subject|7|||
155751579|NCT01466179|562190293|FG000|Overall Study|Protocol Violation|2|||
155751580|NCT01466179|562190293|FG000|Overall Study|Other|3|||
155751581|NCT01083173|562190296|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
155751582|NCT01083173|562190297|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
155751583|NCT01083173|562190296|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
155751584|NCT01083173|562190297|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
155751585|NCT01083173|562190296|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
155751586|NCT01083173|562190297|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
155751587|NCT01083173|562190296|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
155751588|NCT01083173|562190297|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
155751589|NCT01083173|562190296|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
155751590|NCT01083173|562190297|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
155751591|NCT01083173|562190296|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
155751592|NCT01083173|562190297|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
155751593|NCT01083173|562190296|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
155319410|NCT05293171|560605474|FG001|Washout 5 to 7 Days|Adverse Event|0|||
155751594|NCT01083173|562190297|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
155319411|NCT05293171|560605475|FG002|Washout 5 to 7 Days|Adverse Event|0|||
155319412|NCT05293171|560605476|FG003|Washout 5 to 7 Days|Adverse Event|0|||
155319413|NCT05293171|560605477|FG004|Washout 5 to 7 Days|Adverse Event|0|||
155319414|NCT05293171|560605478|FG005|Washout 5 to 7 Days|Adverse Event|1|||
155319415|NCT05293171|560605479|FG006|Washout 5 to 7 Days|Adverse Event|0|||
155319416|NCT05293171|560605480|FG007|Washout 5 to 7 Days|Adverse Event|0|||
155319417|NCT05293171|560605481|FG008|Washout 5 to 7 Days|Adverse Event|0|||
155319418|NCT05293171|560605482|FG009|Washout 5 to 7 Days|Adverse Event|0|||
155319419|NCT05293171|560605483|FG010|Washout 5 to 7 Days|Adverse Event|0|||
155319420|NCT05293171|560605484|FG011|Washout 5 to 7 Days|Adverse Event|0|||
155319421|NCT04066205|560605485|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
155319422|NCT04066205|560605486|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
155419777|NCT03244059|560968177|FG000|Specific Aim 2|Physician Decision|1|||
155419778|NCT03244059|560968178|FG001|Specific Aim 2|Physician Decision|0|||
155419779|NCT05499520|560968179|FG000|Overall Study|Lost to Follow-up|0|||
155419780|NCT05499520|560968180|FG001|Overall Study|Lost to Follow-up|0|||
155419781|NCT05499520|560968181|FG002|Overall Study|Lost to Follow-up|38|||
155419782|NCT05499520|560968182|FG003|Overall Study|Lost to Follow-up|41|||
155643638|NCT01658878|561785198|FG018|Treatment Period|Other Reasons|3|||
155643639|NCT01658878|561785199|FG019|Treatment Period|Other Reasons|1|||
155643640|NCT01658878|561785200|FG020|Treatment Period|Other Reasons|4|||
155643641|NCT01658878|561785201|FG021|Treatment Period|Other Reasons|0|||
155643642|NCT01658878|561785202|FG022|Treatment Period|Other Reasons|0|||
155643643|NCT01658878|561785203|FG023|Treatment Period|Other Reasons|4|||
155643644|NCT01658878|561785180|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643645|NCT01658878|561785181|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643646|NCT01658878|561785182|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643647|NCT01658878|561785183|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643648|NCT01658878|561785184|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643649|NCT01658878|561785185|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643650|NCT01658878|561785186|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643651|NCT01658878|561785187|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643652|NCT01658878|561785188|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643653|NCT01658878|561785189|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643654|NCT01658878|561785190|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643655|NCT01658878|561785191|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643656|NCT01658878|561785192|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643657|NCT01658878|561785193|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643658|NCT01658878|561785194|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155643659|NCT01658878|561785195|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643660|NCT01658878|561785196|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643661|NCT01658878|561785197|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155643662|NCT01658878|561785198|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643663|NCT01658878|561785199|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643664|NCT01658878|561785200|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643665|NCT01658878|561785201|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643666|NCT01658878|561785202|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643667|NCT01658878|561785203|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155643668|NCT01658878|561785180|FG000|Treatment Period|Poor/Non-compliance|0|||
155643669|NCT01658878|561785181|FG001|Treatment Period|Poor/Non-compliance|0|||
155643670|NCT01658878|561785182|FG002|Treatment Period|Poor/Non-compliance|0|||
155643671|NCT01658878|561785183|FG003|Treatment Period|Poor/Non-compliance|0|||
155643672|NCT01658878|561785184|FG004|Treatment Period|Poor/Non-compliance|0|||
155643673|NCT01658878|561785185|FG005|Treatment Period|Poor/Non-compliance|0|||
155643674|NCT01658878|561785186|FG006|Treatment Period|Poor/Non-compliance|0|||
155643675|NCT01658878|561785187|FG007|Treatment Period|Poor/Non-compliance|0|||
155643676|NCT01658878|561785188|FG008|Treatment Period|Poor/Non-compliance|0|||
155643677|NCT01658878|561785189|FG009|Treatment Period|Poor/Non-compliance|0|||
155643678|NCT01658878|561785190|FG010|Treatment Period|Poor/Non-compliance|0|||
155319423|NCT04066205|560605485|FG000|T2 Immediate Post-Intervention|did not respond|5|||
155319424|NCT04066205|560605486|FG001|T2 Immediate Post-Intervention|did not respond|3|||
155419783|NCT05499520|560968183|FG004|Overall Study|Lost to Follow-up|46|||
155643679|NCT01658878|561785191|FG011|Treatment Period|Poor/Non-compliance|0|||
155643680|NCT01658878|561785192|FG012|Treatment Period|Poor/Non-compliance|0|||
155643681|NCT01658878|561785193|FG013|Treatment Period|Poor/Non-compliance|0|||
155643682|NCT01658878|561785194|FG014|Treatment Period|Poor/Non-compliance|0|||
155643683|NCT01658878|561785195|FG015|Treatment Period|Poor/Non-compliance|1|||
155643684|NCT01658878|561785196|FG016|Treatment Period|Poor/Non-compliance|0|||
155643685|NCT01658878|561785197|FG017|Treatment Period|Poor/Non-compliance|0|||
155419784|NCT05499520|560968184|FG005|Overall Study|Lost to Follow-up|0|||
155419785|NCT05499520|560968185|FG006|Overall Study|Lost to Follow-up|31|||
155319425|NCT02052882|560605487|FG000|Overall Study|Not treated|11|||
155319426|NCT02052882|560605487|FG000|Overall Study|Protocol Violation|1|||
155319427|NCT02052882|560605487|FG000|Overall Study|Inadequate testing|1|||
155319428|NCT03987022|560605491|FG000|Overall Study|Lost to Follow-up|2|||
155319429|NCT03987022|560605492|FG001|Overall Study|Lost to Follow-up|2|||
155319430|NCT03987022|560605491|FG000|Overall Study|Withdrawal by Subject|1|||
155319431|NCT03987022|560605492|FG001|Overall Study|Withdrawal by Subject|0|||
155319432|NCT05170841|560605494|FG000|Single Dose Phase|Adverse Event|1|||
155319433|NCT05170841|560605495|FG001|Single Dose Phase|Adverse Event|2|||
155319434|NCT05170841|560605496|FG002|Single Dose Phase|Adverse Event|0|||
155319435|NCT05170841|560605497|FG003|Single Dose Phase|Adverse Event|2|||
155319436|NCT05170841|560605494|FG000|Multiple Dose Phase|Adverse Event|1|||
155319437|NCT05170841|560605495|FG001|Multiple Dose Phase|Adverse Event|2|||
155319438|NCT05170841|560605496|FG002|Multiple Dose Phase|Adverse Event|1|||
155643686|NCT01658878|561785198|FG018|Treatment Period|Poor/Non-compliance|0|||
155643687|NCT01658878|561785199|FG019|Treatment Period|Poor/Non-compliance|0|||
155643688|NCT01658878|561785200|FG020|Treatment Period|Poor/Non-compliance|0|||
155643689|NCT01658878|561785201|FG021|Treatment Period|Poor/Non-compliance|0|||
155643690|NCT01658878|561785202|FG022|Treatment Period|Poor/Non-compliance|0|||
155643691|NCT01658878|561785203|FG023|Treatment Period|Poor/Non-compliance|0|||
155643692|NCT01658878|561785180|FG000|Treatment Period|Participant Withdrew Consent|0|||
155643693|NCT01658878|561785181|FG001|Treatment Period|Participant Withdrew Consent|0|||
155643694|NCT01658878|561785182|FG002|Treatment Period|Participant Withdrew Consent|0|||
155643695|NCT01658878|561785183|FG003|Treatment Period|Participant Withdrew Consent|0|||
155643696|NCT01658878|561785184|FG004|Treatment Period|Participant Withdrew Consent|0|||
155643697|NCT01658878|561785185|FG005|Treatment Period|Participant Withdrew Consent|0|||
155643698|NCT01658878|561785186|FG006|Treatment Period|Participant Withdrew Consent|0|||
155643699|NCT01658878|561785187|FG007|Treatment Period|Participant Withdrew Consent|0|||
155643700|NCT01658878|561785188|FG008|Treatment Period|Participant Withdrew Consent|0|||
155643701|NCT01658878|561785189|FG009|Treatment Period|Participant Withdrew Consent|0|||
155643702|NCT01658878|561785190|FG010|Treatment Period|Participant Withdrew Consent|0|||
155643703|NCT01658878|561785191|FG011|Treatment Period|Participant Withdrew Consent|0|||
155643704|NCT01658878|561785192|FG012|Treatment Period|Participant Withdrew Consent|1|||
155643705|NCT01658878|561785193|FG013|Treatment Period|Participant Withdrew Consent|0|||
155643706|NCT01658878|561785194|FG014|Treatment Period|Participant Withdrew Consent|2|||
155643707|NCT01658878|561785195|FG015|Treatment Period|Participant Withdrew Consent|0|||
155643708|NCT01658878|561785196|FG016|Treatment Period|Participant Withdrew Consent|0|||
155643709|NCT01658878|561785197|FG017|Treatment Period|Participant Withdrew Consent|2|||
155643710|NCT01658878|561785198|FG018|Treatment Period|Participant Withdrew Consent|1|||
155643711|NCT01658878|561785199|FG019|Treatment Period|Participant Withdrew Consent|2|||
155643712|NCT01658878|561785200|FG020|Treatment Period|Participant Withdrew Consent|1|||
155643713|NCT01658878|561785201|FG021|Treatment Period|Participant Withdrew Consent|0|||
155643714|NCT01658878|561785202|FG022|Treatment Period|Participant Withdrew Consent|2|||
155643715|NCT01658878|561785203|FG023|Treatment Period|Participant Withdrew Consent|2|||
155643716|NCT01658878|561785180|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643717|NCT01658878|561785181|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643718|NCT01658878|561785182|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643719|NCT01658878|561785183|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643720|NCT01658878|561785184|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643721|NCT01658878|561785185|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643722|NCT01658878|561785186|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643723|NCT01658878|561785187|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643724|NCT01658878|561785188|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643725|NCT01658878|561785189|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643726|NCT01658878|561785190|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643727|NCT01658878|561785191|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643728|NCT01658878|561785192|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155643729|NCT01658878|561785193|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
155643730|NCT01658878|561785194|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
155643731|NCT01658878|561785195|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155643732|NCT01658878|561785196|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155643733|NCT01658878|561785197|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155643734|NCT01658878|561785198|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155419786|NCT05499520|560968186|FG007|Overall Study|Lost to Follow-up|45|||
155319439|NCT05170841|560605497|FG003|Multiple Dose Phase|Adverse Event|4|||
155501005|NCT00802529|561260730|FG000|Overall Study|Lost to Follow-up|0|||
155501006|NCT00802529|561260731|FG001|Overall Study|Lost to Follow-up|1|||
155501007|NCT02476851|561260732|FG000|Overall Study|Protocol Violation|1|||
155501008|NCT02476851|561260733|FG001|Overall Study|Protocol Violation|1|||
155501009|NCT00337129|561260734|FG000|Overall Study|Adverse Event|4|||
155751595|NCT01083173|562190296|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
155751596|NCT01083173|562190297|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
155751597|NCT01083173|562190296|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
155751598|NCT01083173|562190297|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
155751599|NCT01083173|562190296|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
155751600|NCT01083173|562190297|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
155751601|NCT01083173|562190296|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
155751602|NCT01083173|562190297|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
155751603|NCT03410823|562190298|FG000|Overall Study|Death|1|||
155751604|NCT03410823|562190298|FG000|Overall Study|Withdrawal by Subject|2|||
155751605|NCT03410823|562190298|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
155751606|NCT04062123|562190300|FG000|Overall Study|Withdrawal by Subject|0|||
155751607|NCT04062123|562190301|FG001|Overall Study|Withdrawal by Subject|1|||
155751608|NCT04062123|562190302|FG002|Overall Study|Withdrawal by Subject|0|||
155751609|NCT00740246|562190305|FG000|Overall Study|Received Blood Transfusion|0|||
155751610|NCT00740246|562190306|FG001|Overall Study|Received Blood Transfusion|1|||
155751611|NCT00740246|562190305|FG000|Overall Study|Adverse Event|1|||
155751612|NCT00740246|562190306|FG001|Overall Study|Adverse Event|2|||
155751613|NCT00740246|562190305|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
155751614|NCT00740246|562190306|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
155751615|NCT00740246|562190305|FG000|Overall Study|Lost to Follow-up|2|||
155751616|NCT00740246|562190306|FG001|Overall Study|Lost to Follow-up|2|||
155751617|NCT00740246|562190305|FG000|Overall Study|Withdrawal by Subject|4|||
155751618|NCT00740246|562190306|FG001|Overall Study|Withdrawal by Subject|3|||
155501010|NCT00337129|561260734|FG000|Overall Study|Withdrawal by Subject|1|||
155501011|NCT00337129|561260734|FG000|Overall Study|Lack of Efficacy|32|||
155751619|NCT00740246|562190305|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
155751620|NCT00740246|562190306|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
155751621|NCT00740246|562190305|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
155751622|NCT00740246|562190306|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
155751623|NCT00740246|562190305|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
155319440|NCT05170841|560605494|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
155319441|NCT05170841|560605495|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
155319442|NCT05170841|560605496|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
155319443|NCT05170841|560605497|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
155319444|NCT05123586|560605500|FG000|Overall Study|Physician Decision|1|||
155319445|NCT05123586|560605501|FG001|Overall Study|Physician Decision|1|||
155319446|NCT05123586|560605500|FG000|Overall Study|Withdrawal by Subject|0|||
155319447|NCT05123586|560605501|FG001|Overall Study|Withdrawal by Subject|3|||
155319448|NCT06122194|560605517|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319449|NCT06122194|560605518|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319450|NCT06122194|560605519|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
155319451|NCT06122194|560605520|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319452|NCT05218096|560605521|FG000|Primary Evaluation|Withdrawal by Subject|0|||
155319453|NCT05218096|560605522|FG001|Primary Evaluation|Withdrawal by Subject|0|||
155319454|NCT05218096|560605523|FG002|Primary Evaluation|Withdrawal by Subject|2|||
155319455|NCT05218096|560605524|FG003|Primary Evaluation|Withdrawal by Subject|0|||
155319456|NCT05218096|560605525|FG004|Primary Evaluation|Withdrawal by Subject|0|||
155319457|NCT05218096|560605521|FG000|Primary Evaluation|Physician Decision|1|||
155319458|NCT05218096|560605522|FG001|Primary Evaluation|Physician Decision|0|||
155319459|NCT05218096|560605523|FG002|Primary Evaluation|Physician Decision|0|||
155319460|NCT05218096|560605524|FG003|Primary Evaluation|Physician Decision|0|||
155319461|NCT05218096|560605525|FG004|Primary Evaluation|Physician Decision|0|||
155319462|NCT05218096|560605521|FG000|Extended Treatment|Clinical Deterioration|1|||
155319463|NCT05218096|560605522|FG001|Extended Treatment|Clinical Deterioration|1|||
155319464|NCT05218096|560605523|FG002|Extended Treatment|Clinical Deterioration|0|||
155319465|NCT05218096|560605524|FG003|Extended Treatment|Clinical Deterioration|0|||
155319466|NCT05218096|560605525|FG004|Extended Treatment|Clinical Deterioration|0|||
155319467|NCT05218096|560605521|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
155319468|NCT05218096|560605522|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
155319469|NCT05218096|560605523|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
155319470|NCT05218096|560605524|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
155501012|NCT00337129|561260734|FG000|Overall Study|Death|2|||
155751624|NCT00740246|562190306|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
155319471|NCT05218096|560605525|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
155319472|NCT05218096|560605521|FG000|Extended Treatment|Withdrawal by Subject|1|||
155501013|NCT00337129|561260734|FG000|Overall Study|not protocol specified|1|||
155751625|NCT00740246|562190305|FG000|Overall Study|Unable To Comply With Study Visits|2|||
155751626|NCT00740246|562190306|FG001|Overall Study|Unable To Comply With Study Visits|0|||
155751627|NCT00740246|562190305|FG000|Overall Study|Unable to Access Vein|0|||
155751628|NCT00740246|562190306|FG001|Overall Study|Unable to Access Vein|2|||
155751629|NCT00740246|562190305|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
155751630|NCT00740246|562190306|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
155751631|NCT01041495|562190307|FG000|Overall Study|Withdrawal by Subject|2|||
155751632|NCT01041495|562190308|FG001|Overall Study|Withdrawal by Subject|5|||
155751633|NCT01041495|562190307|FG000|Overall Study|Adverse Event|2|||
155751634|NCT01041495|562190308|FG001|Overall Study|Adverse Event|1|||
155751635|NCT01041495|562190307|FG000|Overall Study|Lost to Follow-up|0|||
155419787|NCT05499520|560968187|FG008|Overall Study|Lost to Follow-up|42|||
155419788|NCT05499520|560968188|FG009|Overall Study|Lost to Follow-up|0|||
155419789|NCT05499520|560968189|FG010|Overall Study|Lost to Follow-up|0|||
155751636|NCT01041495|562190308|FG001|Overall Study|Lost to Follow-up|1|||
155751637|NCT03584373|562190309|FG000|Overall Study|Lost to Follow-up|7|||
155751638|NCT03584373|562190310|FG001|Overall Study|Lost to Follow-up|8|||
155751639|NCT03780400|562190312|FG000|Overall Study|Lost to Follow-up|5|||
155751640|NCT03780400|562190312|FG000|Overall Study|Withdrawal by Subject|2|||
155751641|NCT01850602|562190313|FG000|Overall Study|Adverse Event|7|||
155751642|NCT01850602|562190314|FG001|Overall Study|Adverse Event|10|||
155751643|NCT01850602|562190313|FG000|Overall Study|Physician Decision|2|||
155751644|NCT01850602|562190314|FG001|Overall Study|Physician Decision|1|||
155751645|NCT01850602|562190313|FG000|Overall Study|Withdrawal by Subject|2|||
155751646|NCT01850602|562190314|FG001|Overall Study|Withdrawal by Subject|4|||
155751647|NCT01850602|562190313|FG000|Overall Study|Decrease in serum calcium|2|||
155751648|NCT01850602|562190314|FG001|Overall Study|Decrease in serum calcium|3|||
155751649|NCT01850602|562190313|FG000|Overall Study|Increase in serum ferritin|1|||
155751650|NCT01850602|562190314|FG001|Overall Study|Increase in serum ferritin|0|||
155751651|NCT00366340|562190315|FG000|Infant Series|Protocol Violation|3|||
155751652|NCT00366340|562190316|FG001|Infant Series|Protocol Violation|4|||
155751653|NCT00366340|562190315|FG000|Infant Series|Withdrawal by Subject|3|||
155751654|NCT00366340|562190316|FG001|Infant Series|Withdrawal by Subject|3|||
155751655|NCT00366340|562190315|FG000|Infant Series|Adverse Event|0|||
155751656|NCT00366340|562190316|FG001|Infant Series|Adverse Event|2|||
155751657|NCT00366340|562190315|FG000|Infant Series|Lost to Follow-up|1|||
155751658|NCT00366340|562190316|FG001|Infant Series|Lost to Follow-up|1|||
155751659|NCT00366340|562190315|FG000|Infant Series|Failure to return|1|||
155751660|NCT00366340|562190316|FG001|Infant Series|Failure to return|0|||
155751661|NCT00366340|562190315|FG000|After the Infant Series|Parent/legal guardian request|1|||
155751662|NCT00366340|562190316|FG001|After the Infant Series|Parent/legal guardian request|1|||
155751663|NCT00366340|562190315|FG000|After the Infant Series|Failed to return|0|||
155751664|NCT00366340|562190316|FG001|After the Infant Series|Failed to return|1|||
155751665|NCT00366340|562190315|FG000|After the Infant Series|Protocol Violation|2|||
155751666|NCT00366340|562190316|FG001|After the Infant Series|Protocol Violation|2|||
155751667|NCT00366340|562190315|FG000|After the Infant Series|Adverse Event|0|||
155751668|NCT00366340|562190316|FG001|After the Infant Series|Adverse Event|1|||
155751669|NCT00366340|562190315|FG000|After the Infant Series|Lost to Follow-up|0|||
155751670|NCT00366340|562190316|FG001|After the Infant Series|Lost to Follow-up|1|||
155751671|NCT00366340|562190315|FG000|Toddler Dose|Failed to return|1|||
155751672|NCT00366340|562190316|FG001|Toddler Dose|Failed to return|0|||
155751673|NCT00366340|562190315|FG000|Toddler Dose|Parent/legal guardian request|0|||
155751674|NCT00366340|562190316|FG001|Toddler Dose|Parent/legal guardian request|1|||
155751675|NCT00367770|562190317|FG000|Overall Study|Adverse Event|1|||
155751676|NCT00367770|562190317|FG000|Overall Study|Withdrawal by Subject|1|||
155751677|NCT03282565|562190322|FG000|Overall Study|COVID-19 Research Shutdown|0|||
155751678|NCT03282565|562190323|FG001|Overall Study|COVID-19 Research Shutdown|2|||
155751679|NCT03282565|562190324|FG002|Overall Study|COVID-19 Research Shutdown|2|||
155751680|NCT00740051|562190325|FG000|Overall Study|Lack of Efficacy|2|||
155751681|NCT00740051|562190326|FG001|Overall Study|Lack of Efficacy|5|||
155751682|NCT00740051|562190325|FG000|Overall Study|Adverse Event|1|||
155751683|NCT00740051|562190326|FG001|Overall Study|Adverse Event|4|||
155751684|NCT00740051|562190325|FG000|Overall Study|Protocol Violation|2|||
155751685|NCT00740051|562190326|FG001|Overall Study|Protocol Violation|6|||
155751686|NCT00740051|562190325|FG000|Overall Study|Lost to Follow-up|3|||
155419790|NCT05499520|560968190|FG011|Overall Study|Lost to Follow-up|37|||
155419791|NCT05499520|560968191|FG012|Overall Study|Lost to Follow-up|53|||
155751687|NCT00740051|562190326|FG001|Overall Study|Lost to Follow-up|8|||
155751688|NCT00740051|562190325|FG000|Overall Study|Withdrawal by Subject|6|||
155419792|NCT05499520|560968192|FG013|Overall Study|Lost to Follow-up|49|||
155751689|NCT00740051|562190326|FG001|Overall Study|Withdrawal by Subject|8|||
155751690|NCT00740051|562190325|FG000|Overall Study|Other reason (not specified)|4|||
155751691|NCT00740051|562190326|FG001|Overall Study|Other reason (not specified)|1|||
155751692|NCT02011893|562190327|FG000|Enrollment to Randomization|Adverse Event|2|||
155751693|NCT02011893|562190328|FG001|Enrollment to Randomization|Adverse Event|0|||
155751694|NCT02011893|562190329|FG002|Enrollment to Randomization|Adverse Event|0|||
155751695|NCT02011893|562190327|FG000|Enrollment to Randomization|Physician Decision|10|||
155751696|NCT02011893|562190328|FG001|Enrollment to Randomization|Physician Decision|0|||
155751697|NCT02011893|562190329|FG002|Enrollment to Randomization|Physician Decision|0|||
155751698|NCT02011893|562190327|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
155751699|NCT02011893|562190328|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
155751700|NCT02011893|562190329|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
155751701|NCT02011893|562190327|FG000|Enrollment to Randomization|Screening Failure|29|||
155751702|NCT02011893|562190328|FG001|Enrollment to Randomization|Screening Failure|0|||
155751703|NCT02011893|562190329|FG002|Enrollment to Randomization|Screening Failure|0|||
155751704|NCT02011893|562190327|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
155751705|NCT02011893|562190328|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
155751706|NCT02011893|562190329|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
155751707|NCT02011893|562190327|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
155751708|NCT02011893|562190328|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
155751709|NCT02011893|562190329|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
155751710|NCT02011893|562190327|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
155751711|NCT02011893|562190328|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
155751712|NCT02011893|562190329|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
155751713|NCT02011893|562190327|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
155751714|NCT02011893|562190328|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
155751715|NCT02011893|562190329|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
155751716|NCT02011893|562190327|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
155751717|NCT02011893|562190328|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
155751718|NCT02011893|562190329|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
155751719|NCT01001299|562190331|FG000|Overall Study|Insufficient Therapeutic Response|20|||
155751720|NCT01001299|562190331|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
155751721|NCT01001299|562190331|FG000|Overall Study|Death|1|||
155751722|NCT01001299|562190331|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
155751723|NCT01001299|562190331|FG000|Overall Study|Withdrew Consent|1|||
155751724|NCT02793622|562190332|FG000|Overall Study|Lost to Follow-up|31|||
155751725|NCT02793622|562190333|FG001|Overall Study|Lost to Follow-up|19|||
155501014|NCT00647426|561260735|FG000|Overall Study|Withdrawal by Subject|2|||
155501015|NCT01508325|561260739|FG000|Overall Study|Withdrawal by Subject|8|||
155501016|NCT01508325|561260740|FG001|Overall Study|Withdrawal by Subject|9|||
155501017|NCT01508325|561260739|FG000|Overall Study|Protocol Violation|0|||
155501018|NCT01508325|561260740|FG001|Overall Study|Protocol Violation|3|||
155501019|NCT01508325|561260739|FG000|Overall Study|Physician Decision|2|||
155501020|NCT01508325|561260740|FG001|Overall Study|Physician Decision|1|||
155501021|NCT01508325|561260739|FG000|Overall Study|Adverse Event|1|||
155501022|NCT01508325|561260740|FG001|Overall Study|Adverse Event|0|||
155643735|NCT01658878|561785199|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155643736|NCT01658878|561785200|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155643737|NCT01658878|561785201|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155643738|NCT01658878|561785202|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155643739|NCT01658878|561785203|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155643740|NCT01658878|561785180|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
155643741|NCT01658878|561785181|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
155643742|NCT01658878|561785182|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
155643743|NCT01658878|561785183|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
155643744|NCT01658878|561785184|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
155643745|NCT01658878|561785185|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
155643746|NCT01658878|561785186|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
155643747|NCT01658878|561785187|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
155643748|NCT01658878|561785188|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
155643749|NCT01658878|561785189|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
155643750|NCT01658878|561785190|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
155643751|NCT01658878|561785191|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
155643752|NCT01658878|561785192|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
155643753|NCT01658878|561785193|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
155643754|NCT01658878|561785194|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
155643755|NCT01658878|561785195|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
155643756|NCT01658878|561785196|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
155643757|NCT01658878|561785197|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
155643758|NCT01658878|561785198|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
155751726|NCT02793622|562190332|FG000|Overall Study|Withdrawal by Subject|21|||
155751727|NCT02793622|562190333|FG001|Overall Study|Withdrawal by Subject|17|||
155751728|NCT02793622|562190332|FG000|Overall Study|Adverse Event|0|||
155501023|NCT01508325|561260739|FG000|Overall Study|Lost to Follow-up|5|||
155319473|NCT05218096|560605522|FG001|Extended Treatment|Withdrawal by Subject|3|||
155319474|NCT05218096|560605523|FG002|Extended Treatment|Withdrawal by Subject|0|||
155319475|NCT05218096|560605524|FG003|Extended Treatment|Withdrawal by Subject|2|||
155319476|NCT05218096|560605525|FG004|Extended Treatment|Withdrawal by Subject|2|||
155319477|NCT05218096|560605521|FG000|Extended Treatment|Lack of Efficacy|3|||
155319478|NCT05218096|560605522|FG001|Extended Treatment|Lack of Efficacy|0|||
155319479|NCT05218096|560605523|FG002|Extended Treatment|Lack of Efficacy|0|||
155319480|NCT05218096|560605524|FG003|Extended Treatment|Lack of Efficacy|0|||
155319481|NCT05218096|560605525|FG004|Extended Treatment|Lack of Efficacy|0|||
155319482|NCT05218096|560605521|FG000|Extended Treatment|Physician Decision|0|||
155319483|NCT05218096|560605522|FG001|Extended Treatment|Physician Decision|1|||
155319484|NCT05218096|560605523|FG002|Extended Treatment|Physician Decision|0|||
155319485|NCT05218096|560605524|FG003|Extended Treatment|Physician Decision|0|||
155319486|NCT05218096|560605525|FG004|Extended Treatment|Physician Decision|0|||
155319487|NCT05218096|560605521|FG000|Open-label Extension|Adverse Event|1|||
155319488|NCT05218096|560605522|FG001|Open-label Extension|Adverse Event|0|||
155319489|NCT05218096|560605523|FG002|Open-label Extension|Adverse Event|0|||
155319490|NCT05218096|560605524|FG003|Open-label Extension|Adverse Event|0|||
155319491|NCT05218096|560605525|FG004|Open-label Extension|Adverse Event|1|||
155319492|NCT05218096|560605521|FG000|Open-label Extension|Pregnancy|0|||
155319493|NCT05218096|560605522|FG001|Open-label Extension|Pregnancy|0|||
155319494|NCT05218096|560605523|FG002|Open-label Extension|Pregnancy|0|||
155319495|NCT05218096|560605524|FG003|Open-label Extension|Pregnancy|0|||
155319496|NCT05218096|560605525|FG004|Open-label Extension|Pregnancy|1|||
155319497|NCT05218096|560605521|FG000|Open-label Extension|Lack of Efficacy|1|||
155419793|NCT05499520|560968193|FG014|Overall Study|Lost to Follow-up|0|||
155419794|NCT05499520|560968194|FG015|Overall Study|Lost to Follow-up|36|||
155419795|NCT05499520|560968195|FG016|Overall Study|Lost to Follow-up|58|||
155419796|NCT05499520|560968196|FG017|Overall Study|Lost to Follow-up|53|||
155419797|NCT00840827|560968198|FG000|Overall Study|Adverse Event|1|||
155751729|NCT02793622|562190333|FG001|Overall Study|Adverse Event|1|||
155751730|NCT02793622|562190332|FG000|Overall Study|Protocol Violation|1|||
155751731|NCT02793622|562190333|FG001|Overall Study|Protocol Violation|5|||
155751732|NCT01244490|562190334|FG000|Overall Study|Lack of Efficacy|14|||
155751733|NCT01244490|562190335|FG001|Overall Study|Lack of Efficacy|5|||
155751734|NCT01244490|562190336|FG002|Overall Study|Lack of Efficacy|5|||
155751735|NCT01244490|562190334|FG000|Overall Study|Withdrawal by Subject|4|||
155751736|NCT01244490|562190335|FG001|Overall Study|Withdrawal by Subject|4|||
155751737|NCT01244490|562190336|FG002|Overall Study|Withdrawal by Subject|9|||
155751738|NCT01244490|562190334|FG000|Overall Study|Adverse Event|1|||
155751739|NCT01244490|562190335|FG001|Overall Study|Adverse Event|9|||
155751740|NCT01244490|562190336|FG002|Overall Study|Adverse Event|5|||
155751741|NCT01244490|562190334|FG000|Overall Study|Lost to Follow-up|0|||
155751742|NCT01244490|562190335|FG001|Overall Study|Lost to Follow-up|6|||
155751743|NCT01244490|562190336|FG002|Overall Study|Lost to Follow-up|3|||
155751744|NCT01244490|562190334|FG000|Overall Study|Other|0|||
155319498|NCT05218096|560605522|FG001|Open-label Extension|Lack of Efficacy|2|||
155419798|NCT00840827|560968198|FG000|Overall Study|Lack of Efficacy|4|||
155419799|NCT00840827|560968198|FG000|Overall Study|Physician Decision|1|||
155419800|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
155419801|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
155643759|NCT01658878|561785199|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
155643760|NCT01658878|561785200|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
155643761|NCT01658878|561785201|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
155643762|NCT01658878|561785202|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
155643763|NCT01658878|561785203|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
155643764|NCT01658878|561785180|FG000|Treatment Period|Death|0|||
155643765|NCT01658878|561785181|FG001|Treatment Period|Death|0|||
155643766|NCT01658878|561785182|FG002|Treatment Period|Death|0|||
155643767|NCT01658878|561785183|FG003|Treatment Period|Death|0|||
155643768|NCT01658878|561785184|FG004|Treatment Period|Death|0|||
155643769|NCT01658878|561785185|FG005|Treatment Period|Death|0|||
155643770|NCT01658878|561785186|FG006|Treatment Period|Death|0|||
155643771|NCT01658878|561785187|FG007|Treatment Period|Death|0|||
155643772|NCT01658878|561785188|FG008|Treatment Period|Death|0|||
155643773|NCT01658878|561785189|FG009|Treatment Period|Death|0|||
155643774|NCT01658878|561785190|FG010|Treatment Period|Death|0|||
155643775|NCT01658878|561785191|FG011|Treatment Period|Death|0|||
155319499|NCT05218096|560605523|FG002|Open-label Extension|Lack of Efficacy|0|||
155319500|NCT05218096|560605524|FG003|Open-label Extension|Lack of Efficacy|0|||
155319501|NCT05218096|560605525|FG004|Open-label Extension|Lack of Efficacy|0|||
155319502|NCT05218096|560605521|FG000|Open-label Extension|Lost to Follow-up|1|||
155319503|NCT05218096|560605522|FG001|Open-label Extension|Lost to Follow-up|0|||
155643776|NCT01658878|561785192|FG012|Treatment Period|Death|1|||
155643777|NCT01658878|561785193|FG013|Treatment Period|Death|0|||
155751745|NCT01244490|562190335|FG001|Overall Study|Other|0|||
155751746|NCT01244490|562190336|FG002|Overall Study|Other|1|||
155501024|NCT01508325|561260740|FG001|Overall Study|Lost to Follow-up|6|||
155501025|NCT01508325|561260739|FG000|Overall Study|Other|2|||
155501026|NCT01508325|561260740|FG001|Overall Study|Other|2|||
155501027|NCT03543046|561260744|FG000|Overall Study|Adverse Event|1|||
155501028|NCT03543046|561260745|FG001|Overall Study|Adverse Event|1|||
155501029|NCT03543046|561260744|FG000|Overall Study|Physician Decision|1|||
155319504|NCT05218096|560605523|FG002|Open-label Extension|Lost to Follow-up|0|||
155319505|NCT05218096|560605524|FG003|Open-label Extension|Lost to Follow-up|0|||
155319506|NCT05218096|560605525|FG004|Open-label Extension|Lost to Follow-up|0|||
155319507|NCT05218096|560605521|FG000|Open-label Extension|Death|0|||
155319508|NCT05218096|560605522|FG001|Open-label Extension|Death|0|||
155319509|NCT05218096|560605523|FG002|Open-label Extension|Death|0|||
155501030|NCT03543046|561260745|FG001|Overall Study|Physician Decision|1|||
155319510|NCT05218096|560605524|FG003|Open-label Extension|Death|1|||
155319511|NCT05218096|560605525|FG004|Open-label Extension|Death|0|||
155319512|NCT05218096|560605521|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
155319513|NCT05218096|560605522|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
155319514|NCT05218096|560605523|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
155319515|NCT05218096|560605524|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
155319516|NCT05218096|560605525|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
155319517|NCT05863156|560605533|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
155319518|NCT05863156|560605534|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
155419802|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
155419803|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
155419804|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
155419805|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
155419806|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
155419807|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
155419808|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155419809|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155419810|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155419811|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
155501031|NCT03543046|561260744|FG000|Overall Study|Protocol Violation|1|||
155501032|NCT03543046|561260745|FG001|Overall Study|Protocol Violation|0|||
155501033|NCT00520494|561260746|FG000|Overall Study|Withdrawal by Subject|1|||
155501034|NCT02748616|561260749|FG000|Overall Study|Lost to Follow-up|1|||
155501035|NCT02748616|561260749|FG000|Overall Study|Withdrawal by Subject|2|||
155501036|NCT02748616|561260749|FG000|Overall Study|Physician Decision|2|||
155501037|NCT02748616|561260749|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
155501038|NCT00589693|561260750|FG000|Overall Study|randomized in error|12|||
155501039|NCT00589693|561260751|FG001|Overall Study|randomized in error|6|||
155501040|NCT00589693|561260750|FG000|Overall Study|Adverse Event|4|||
155501041|NCT00589693|561260751|FG001|Overall Study|Adverse Event|4|||
155501042|NCT00589693|561260750|FG000|Overall Study|Death|26|||
155501043|NCT00589693|561260751|FG001|Overall Study|Death|16|||
155501044|NCT00589693|561260750|FG000|Overall Study|Lack of Efficacy|0|||
155501045|NCT00589693|561260751|FG001|Overall Study|Lack of Efficacy|1|||
155643778|NCT01658878|561785194|FG014|Treatment Period|Death|0|||
155643779|NCT01658878|561785195|FG015|Treatment Period|Death|0|||
155643780|NCT01658878|561785196|FG016|Treatment Period|Death|1|||
155643781|NCT01658878|561785197|FG017|Treatment Period|Death|1|||
155643782|NCT01658878|561785198|FG018|Treatment Period|Death|0|||
155643783|NCT01658878|561785199|FG019|Treatment Period|Death|0|||
155643784|NCT01658878|561785200|FG020|Treatment Period|Death|0|||
155643785|NCT01658878|561785201|FG021|Treatment Period|Death|2|||
155643786|NCT01658878|561785202|FG022|Treatment Period|Death|0|||
155643787|NCT01658878|561785203|FG023|Treatment Period|Death|0|||
155643788|NCT01658878|561785180|FG000|Treatment Period|Adverse Event|0|||
155643789|NCT01658878|561785181|FG001|Treatment Period|Adverse Event|0|||
155643790|NCT01658878|561785182|FG002|Treatment Period|Adverse Event|0|||
155643791|NCT01658878|561785183|FG003|Treatment Period|Adverse Event|0|||
155643792|NCT01658878|561785184|FG004|Treatment Period|Adverse Event|0|||
155643793|NCT01658878|561785185|FG005|Treatment Period|Adverse Event|0|||
155643794|NCT01658878|561785186|FG006|Treatment Period|Adverse Event|0|||
155643795|NCT01658878|561785187|FG007|Treatment Period|Adverse Event|0|||
155319519|NCT05863156|560605535|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
155319520|NCT03362476|560605536|FG000|Overall Study|Withdrawal by Subject|0|||
155501046|NCT00589693|561260750|FG000|Overall Study|Lost to Follow-up|1|||
155501047|NCT00589693|561260751|FG001|Overall Study|Lost to Follow-up|0|||
155501048|NCT00589693|561260750|FG000|Overall Study|Physician Decision|0|||
155501049|NCT00589693|561260751|FG001|Overall Study|Physician Decision|1|||
155643796|NCT01658878|561785188|FG008|Treatment Period|Adverse Event|0|||
155643797|NCT01658878|561785189|FG009|Treatment Period|Adverse Event|0|||
155643798|NCT01658878|561785190|FG010|Treatment Period|Adverse Event|0|||
155501050|NCT00589693|561260750|FG000|Overall Study|Protocol Violation|1|||
155501051|NCT00589693|561260751|FG001|Overall Study|Protocol Violation|1|||
155501052|NCT01447628|561260754|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
155501053|NCT01447628|561260755|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
155501054|NCT01447628|561260756|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
155501055|NCT01447628|561260757|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
155751747|NCT00400153|562190337|FG000|Overall Study|AE due to study disease worsening|14|||
155751748|NCT00400153|562190338|FG001|Overall Study|AE due to study disease worsening|19|||
155751749|NCT00400153|562190339|FG002|Overall Study|AE due to study disease worsening|20|||
155751750|NCT00400153|562190337|FG000|Overall Study|AE due to other disease worsening|2|||
155751751|NCT00400153|562190338|FG001|Overall Study|AE due to other disease worsening|1|||
155751752|NCT00400153|562190339|FG002|Overall Study|AE due to other disease worsening|0|||
155751753|NCT00400153|562190337|FG000|Overall Study|AE due to other condition|3|||
155751754|NCT00400153|562190338|FG001|Overall Study|AE due to other condition|14|||
155751755|NCT00400153|562190339|FG002|Overall Study|AE due to other condition|15|||
155751756|NCT00400153|562190337|FG000|Overall Study|Protocol Violation|7|||
155751757|NCT00400153|562190338|FG001|Overall Study|Protocol Violation|4|||
155751758|NCT00400153|562190339|FG002|Overall Study|Protocol Violation|9|||
155751759|NCT00400153|562190337|FG000|Overall Study|Lost to Follow-up|2|||
155751760|NCT00400153|562190338|FG001|Overall Study|Lost to Follow-up|1|||
155751761|NCT00400153|562190339|FG002|Overall Study|Lost to Follow-up|4|||
155751762|NCT00400153|562190337|FG000|Overall Study|Withdrawal by Subject|12|||
155751763|NCT00400153|562190338|FG001|Overall Study|Withdrawal by Subject|11|||
155751764|NCT00400153|562190339|FG002|Overall Study|Withdrawal by Subject|10|||
155751765|NCT00400153|562190337|FG000|Overall Study|Other reasons - not mentioned above|8|||
155751766|NCT00400153|562190338|FG001|Overall Study|Other reasons - not mentioned above|5|||
155751767|NCT00400153|562190339|FG002|Overall Study|Other reasons - not mentioned above|3|||
155751768|NCT01423604|562190344|FG000|Safety Run-In|Adverse Event|3|||
155751769|NCT01423604|562190345|FG001|Safety Run-In|Adverse Event|0|||
155751770|NCT01423604|562190344|FG000|Safety Run-In|Death|1|||
155751771|NCT01423604|562190345|FG001|Safety Run-In|Death|0|||
155751772|NCT01423604|562190344|FG000|Safety Run-In|Physician Decision|1|||
155751773|NCT01423604|562190345|FG001|Safety Run-In|Physician Decision|0|||
155751774|NCT01423604|562190344|FG000|Safety Run-In|Disease progression|3|||
155751775|NCT01423604|562190345|FG001|Safety Run-In|Disease progression|0|||
155751776|NCT01423604|562190344|FG000|Safety Run-In|Patient decision|1|||
155751777|NCT01423604|562190345|FG001|Safety Run-In|Patient decision|0|||
155751778|NCT01423604|562190344|FG000|Randomized|Adverse Event|4|||
155751779|NCT01423604|562190345|FG001|Randomized|Adverse Event|10|||
155751780|NCT01423604|562190344|FG000|Randomized|Death|1|||
155751781|NCT01423604|562190345|FG001|Randomized|Death|0|||
155751782|NCT01423604|562190344|FG000|Randomized|Physician Decision|16|||
155751783|NCT01423604|562190345|FG001|Randomized|Physician Decision|13|||
155751784|NCT01423604|562190344|FG000|Randomized|Other - unspecified|37|||
155751785|NCT01423604|562190345|FG001|Randomized|Other - unspecified|31|||
155751786|NCT01423604|562190344|FG000|Randomized|Patient decision|5|||
155751787|NCT01423604|562190345|FG001|Randomized|Patient decision|9|||
155751788|NCT02414139|562190348|FG000|Treatment Period|Adverse Event|11|||
155751789|NCT02414139|562190349|FG001|Treatment Period|Adverse Event|6|||
155751790|NCT02414139|562190350|FG002|Treatment Period|Adverse Event|8|||
155751791|NCT02414139|562190351|FG003|Treatment Period|Adverse Event|5|||
155751792|NCT02414139|562190352|FG004|Treatment Period|Adverse Event|14|||
155751793|NCT02414139|562190353|FG005|Treatment Period|Adverse Event|3|||
155751794|NCT02414139|562190354|FG006|Treatment Period|Adverse Event|6|||
155751795|NCT02414139|562190355|FG007|Treatment Period|Adverse Event|1|||
155751796|NCT02414139|562190356|FG008|Treatment Period|Adverse Event|6|||
155751797|NCT02414139|562190357|FG009|Treatment Period|Adverse Event|8|||
155751798|NCT02414139|562190348|FG000|Treatment Period|Death|0|||
155751799|NCT02414139|562190349|FG001|Treatment Period|Death|0|||
155751800|NCT02414139|562190350|FG002|Treatment Period|Death|1|||
155751801|NCT02414139|562190351|FG003|Treatment Period|Death|1|||
155751802|NCT02414139|562190352|FG004|Treatment Period|Death|0|||
155751803|NCT02414139|562190353|FG005|Treatment Period|Death|0|||
155751804|NCT02414139|562190354|FG006|Treatment Period|Death|0|||
155751805|NCT02414139|562190355|FG007|Treatment Period|Death|0|||
155751806|NCT02414139|562190356|FG008|Treatment Period|Death|0|||
155751807|NCT02414139|562190357|FG009|Treatment Period|Death|1|||
155751808|NCT02414139|562190348|FG000|Treatment Period|Physician Decision|5|||
155751809|NCT02414139|562190349|FG001|Treatment Period|Physician Decision|4|||
155751810|NCT02414139|562190350|FG002|Treatment Period|Physician Decision|6|||
155751811|NCT02414139|562190351|FG003|Treatment Period|Physician Decision|1|||
155751812|NCT02414139|562190352|FG004|Treatment Period|Physician Decision|4|||
155751813|NCT02414139|562190353|FG005|Treatment Period|Physician Decision|0|||
155751814|NCT02414139|562190354|FG006|Treatment Period|Physician Decision|2|||
155751815|NCT02414139|562190355|FG007|Treatment Period|Physician Decision|0|||
155751816|NCT02414139|562190356|FG008|Treatment Period|Physician Decision|1|||
155751817|NCT02414139|562190357|FG009|Treatment Period|Physician Decision|4|||
155751818|NCT02414139|562190348|FG000|Treatment Period|Progressive disease|48|||
155319521|NCT03362476|560605537|FG001|Overall Study|Withdrawal by Subject|1|||
155319522|NCT05216406|560605538|FG000|Overall Study|Lost to Follow-up|8|||
155319523|NCT05216406|560605539|FG001|Overall Study|Lost to Follow-up|9|||
155319524|NCT04270942|560605542|FG000|Overall Study|Death|1|||
155319525|NCT01236781|560605550|FG000|Overall Study|Ineligible|2|||
155319526|NCT01236781|560605551|FG001|Overall Study|Ineligible|1|||
155319527|NCT01236781|560605550|FG000|Overall Study|Did not complete study imaging|5|||
155319528|NCT01236781|560605551|FG001|Overall Study|Did not complete study imaging|0|||
155319529|NCT02709161|560605552|FG000|Overall Study|Withdrawal by Subject|1|||
155319530|NCT02709161|560605553|FG001|Overall Study|Withdrawal by Subject|0|||
155319531|NCT05167864|560605554|FG000|Overall Study|Lost to Follow-up|7|||
155319532|NCT05167864|560605555|FG001|Overall Study|Lost to Follow-up|6|||
155319533|NCT05167864|560605556|FG002|Overall Study|Lost to Follow-up|7|||
155319534|NCT05167864|560605557|FG003|Overall Study|Lost to Follow-up|9|||
155319535|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
155319536|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
155319537|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
155319538|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
155319539|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
155319540|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
155319541|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
155319542|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
155319543|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
155319544|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
155319545|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
155319546|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
155319547|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Death|4|||
155319548|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Death|4|||
155319549|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Death|3|||
155319550|NCT03916185|560607283|FG000|Overall Study|Lost to Follow-up|0|||
155319551|NCT03916185|560607284|FG001|Overall Study|Lost to Follow-up|1|||
155319552|NCT03916185|560607285|FG002|Overall Study|Lost to Follow-up|0|||
155319553|NCT03916185|560607286|FG003|Overall Study|Lost to Follow-up|0|||
155319554|NCT03916185|560607283|FG000|Overall Study|Moved|1|||
155319555|NCT03916185|560607284|FG001|Overall Study|Moved|0|||
155319556|NCT03916185|560607285|FG002|Overall Study|Moved|0|||
155319557|NCT03916185|560607286|FG003|Overall Study|Moved|1|||
155319558|NCT03916185|560607283|FG000|Overall Study|Not Able to Get to Clinic|1|||
155319559|NCT03916185|560607284|FG001|Overall Study|Not Able to Get to Clinic|0|||
155319560|NCT03916185|560607285|FG002|Overall Study|Not Able to Get to Clinic|0|||
155319561|NCT03916185|560607286|FG003|Overall Study|Not Able to Get to Clinic|0|||
155319562|NCT03766685|560607287|FG000|Overall Study|Lost to Follow-up|1|||
155319563|NCT03766685|560607288|FG001|Overall Study|Lost to Follow-up|1|||
155319564|NCT03766685|560607289|FG002|Overall Study|Lost to Follow-up|0|||
155319565|NCT03766685|560607290|FG003|Overall Study|Lost to Follow-up|0|||
155319566|NCT03766685|560607287|FG000|Overall Study|Adverse Event, not fatal|0|||
155319567|NCT03766685|560607288|FG001|Overall Study|Adverse Event, not fatal|1|||
155319568|NCT03766685|560607289|FG002|Overall Study|Adverse Event, not fatal|0|||
155319569|NCT03766685|560607290|FG003|Overall Study|Adverse Event, not fatal|1|||
155319570|NCT03766685|560607287|FG000|Overall Study|Withdrawal by Subject|0|||
155319571|NCT03766685|560607288|FG001|Overall Study|Withdrawal by Subject|2|||
155319572|NCT03766685|560607289|FG002|Overall Study|Withdrawal by Subject|0|||
155319573|NCT03766685|560607290|FG003|Overall Study|Withdrawal by Subject|0|||
155319574|NCT03766685|560607287|FG000|Overall Study|Protocol Violation|0|||
155319575|NCT03766685|560607288|FG001|Overall Study|Protocol Violation|1|||
155319576|NCT03766685|560607289|FG002|Overall Study|Protocol Violation|0|||
155319577|NCT03766685|560607290|FG003|Overall Study|Protocol Violation|0|||
155319578|NCT03766685|560607287|FG000|Overall Study|Non-compliance|0|||
155319579|NCT03766685|560607288|FG001|Overall Study|Non-compliance|2|||
155319580|NCT03766685|560607289|FG002|Overall Study|Non-compliance|0|||
155319581|NCT03766685|560607290|FG003|Overall Study|Non-compliance|0|||
155319582|NCT02844465|560607296|FG000|Overall Study|Screen Failure|36|||
155319583|NCT02844465|560607296|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
155419812|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
155419813|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155419814|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155319584|NCT02844465|560607296|FG000|Overall Study|Withdrawal by Subject|5|||
155319585|NCT02844465|560607296|FG000|Overall Study|Lost to Follow-up|1|||
155319586|NCT02844465|560607296|FG000|Overall Study|Retreatment|1|||
155319587|NCT05029622|560607298|FG000|Overall Study|Lost to Follow-up|1|||
155319588|NCT06232590|560607299|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
155319589|NCT06232590|560607300|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
155319590|NCT05299723|560607301|FG000|Overall Study|Withdrawal by Subject|0|||
155319591|NCT05299723|560607302|FG001|Overall Study|Withdrawal by Subject|2|||
155319592|NCT05299723|560607303|FG002|Overall Study|Withdrawal by Subject|0|||
155319593|NCT02460458|560607304|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
155319594|NCT02460458|560607304|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
155319595|NCT02460458|560607304|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
155319596|NCT02460458|560607304|FG000|First Prospective Phase|Lost to Follow-up|84|||
155319597|NCT02460458|560607304|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
155319598|NCT05299073|560607305|FG000|Overall Study|Withdrawal by Subject|0|||
155319599|NCT05299073|560607306|FG001|Overall Study|Withdrawal by Subject|0|||
155319600|NCT05299073|560607307|FG002|Overall Study|Withdrawal by Subject|1|||
155319601|NCT05299073|560607305|FG000|Overall Study|Adverse Event|0|||
155319602|NCT05299073|560607306|FG001|Overall Study|Adverse Event|1|||
155319603|NCT05299073|560607307|FG002|Overall Study|Adverse Event|0|||
155319604|NCT05299073|560607305|FG000|Overall Study|Lost to Follow-up|0|||
155319605|NCT05299073|560607306|FG001|Overall Study|Lost to Follow-up|1|||
155319606|NCT05299073|560607307|FG002|Overall Study|Lost to Follow-up|0|||
155319607|NCT00592852|560607308|FG000|Overall Study|Non-compliance|1|||
155319608|NCT00592852|560607308|FG000|Overall Study|Adverse Event|3|||
155319609|NCT00592852|560607308|FG000|Overall Study|Found ineligible|1|||
155319610|NCT00592852|560607308|FG000|Overall Study|Withdrawal by Subject|1|||
155319611|NCT02505984|560607312|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
155319612|NCT02505984|560607313|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
155319613|NCT02505984|560607312|FG000|Overall Study|Unreliable self-report data|1|||
155319614|NCT02505984|560607313|FG001|Overall Study|Unreliable self-report data|0|||
155319615|NCT02505984|560607312|FG000|Overall Study|Study blind opened during assessment|0|||
155319616|NCT02505984|560607313|FG001|Overall Study|Study blind opened during assessment|1|||
155319617|NCT02505984|560607312|FG000|Overall Study|Noncompliance with study protocol|0|||
155319618|NCT02505984|560607313|FG001|Overall Study|Noncompliance with study protocol|1|||
155319619|NCT03511664|560607324|FG000|Overall Study|Death|457|||
155319620|NCT03511664|560607325|FG001|Overall Study|Death|201|||
155319621|NCT03511664|560607326|FG002|Overall Study|Death|21|||
155319622|NCT03511664|560607324|FG000|Overall Study|Withdrew consent|40|||
155319623|NCT03511664|560607325|FG001|Overall Study|Withdrew consent|63|||
155319624|NCT03511664|560607326|FG002|Overall Study|Withdrew consent|3|||
155319625|NCT03511664|560607324|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
155319626|NCT03511664|560607325|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
155319627|NCT03511664|560607326|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
155319628|NCT03511664|560607324|FG000|Overall Study|Lost to Follow-up|8|||
155319629|NCT03511664|560607325|FG001|Overall Study|Lost to Follow-up|5|||
155319630|NCT03511664|560607326|FG002|Overall Study|Lost to Follow-up|0|||
155319631|NCT03511664|560607324|FG000|Overall Study|Physician Decision|2|||
155319632|NCT03511664|560607325|FG001|Overall Study|Physician Decision|1|||
155319633|NCT03511664|560607326|FG002|Overall Study|Physician Decision|0|||
155319634|NCT03511664|560607324|FG000|Overall Study|Patient non-compliance|1|||
155319635|NCT03511664|560607325|FG001|Overall Study|Patient non-compliance|0|||
155419815|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
155419816|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
155419817|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
155419818|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
155419819|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
155419820|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
155419821|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
155419822|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
155419823|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
155419824|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
155419825|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
155419826|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
155419827|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
155419828|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
155419829|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
155514019|NCT01626859|561308228|FG001|Overall Study|Adverse Event|3|||
155751819|NCT02414139|562190349|FG001|Treatment Period|Progressive disease|31|||
155751820|NCT02414139|562190350|FG002|Treatment Period|Progressive disease|37|||
155751821|NCT02414139|562190351|FG003|Treatment Period|Progressive disease|21|||
155751822|NCT02414139|562190352|FG004|Treatment Period|Progressive disease|43|||
155751823|NCT02414139|562190353|FG005|Treatment Period|Progressive disease|12|||
155751824|NCT02414139|562190354|FG006|Treatment Period|Progressive disease|16|||
155751825|NCT02414139|562190355|FG007|Treatment Period|Progressive disease|2|||
155319636|NCT03511664|560607326|FG002|Overall Study|Patient non-compliance|0|||
155319637|NCT04362254|560607330|FG000|Overall Study|Adverse Event|1|||
155319638|NCT04362254|560607330|FG000|Overall Study|Protocol Violation|1|||
155319639|NCT04362254|560607330|FG000|Overall Study|Due to early termination of the trial|10|||
155319640|NCT04076618|560607331|FG000|Overall Study|Lost to Follow-up|2|||
155319641|NCT04076618|560607332|FG001|Overall Study|Lost to Follow-up|1|||
155319642|NCT04076618|560607333|FG002|Overall Study|Lost to Follow-up|3|||
155319643|NCT04076618|560607331|FG000|Overall Study|Withdrawal by Subject|3|||
155319644|NCT04076618|560607332|FG001|Overall Study|Withdrawal by Subject|1|||
155319645|NCT04076618|560607333|FG002|Overall Study|Withdrawal by Subject|2|||
155319646|NCT04076618|560607331|FG000|Overall Study|Relocated out of state|0|||
155319647|NCT04076618|560607332|FG001|Overall Study|Relocated out of state|2|||
155319648|NCT04076618|560607333|FG002|Overall Study|Relocated out of state|0|||
155319649|NCT04076618|560607331|FG000|Overall Study|COVID concerns|0|||
155319650|NCT04076618|560607332|FG001|Overall Study|COVID concerns|1|||
155319651|NCT04076618|560607333|FG002|Overall Study|COVID concerns|0|||
155319652|NCT04076618|560607331|FG000|Overall Study|Adverse Event|0|||
155319653|NCT04076618|560607332|FG001|Overall Study|Adverse Event|0|||
155319654|NCT04076618|560607333|FG002|Overall Study|Adverse Event|2|||
155319655|NCT01928394|560607334|FG000|Treatment Period|Disease progression|17|||
155319656|NCT01928394|560607335|FG001|Treatment Period|Disease progression|2|||
155319657|NCT01928394|560607336|FG002|Treatment Period|Disease progression|12|||
155319658|NCT01928394|560607337|FG003|Treatment Period|Disease progression|48|||
155319659|NCT01928394|560607338|FG004|Treatment Period|Disease progression|3|||
155319660|NCT01928394|560607339|FG005|Treatment Period|Disease progression|25|||
155319661|NCT01928394|560607340|FG006|Treatment Period|Disease progression|38|||
155319662|NCT01928394|560607341|FG007|Treatment Period|Disease progression|16|||
155319663|NCT01928394|560607342|FG008|Treatment Period|Disease progression|3|||
155319664|NCT01928394|560607343|FG009|Treatment Period|Disease progression|11|||
155319665|NCT01928394|560607344|FG010|Treatment Period|Disease progression|22|||
155319666|NCT01928394|560607345|FG011|Treatment Period|Disease progression|73|||
155319667|NCT01928394|560607346|FG012|Treatment Period|Disease progression|38|||
155319668|NCT01928394|560607347|FG013|Treatment Period|Disease progression|118|||
155319669|NCT01928394|560607348|FG014|Treatment Period|Disease progression|59|||
155319670|NCT01928394|560607349|FG015|Treatment Period|Disease progression|1|||
155319671|NCT01928394|560607350|FG016|Treatment Period|Disease progression|43|||
155319672|NCT01928394|560607351|FG017|Treatment Period|Disease progression|56|||
155319673|NCT01928394|560607352|FG018|Treatment Period|Disease progression|50|||
155319674|NCT01928394|560607353|FG019|Treatment Period|Disease progression|71|||
155319675|NCT01928394|560607354|FG020|Treatment Period|Disease progression|30|||
155319676|NCT01928394|560607355|FG021|Treatment Period|Disease progression|31|||
155319677|NCT01928394|560607356|FG022|Treatment Period|Disease progression|31|||
155319678|NCT01928394|560607334|FG000|Treatment Period|Study drug toxicity|1|||
155319679|NCT01928394|560607335|FG001|Treatment Period|Study drug toxicity|1|||
155319680|NCT01928394|560607336|FG002|Treatment Period|Study drug toxicity|3|||
155319681|NCT01928394|560607337|FG003|Treatment Period|Study drug toxicity|3|||
155319682|NCT01928394|560607338|FG004|Treatment Period|Study drug toxicity|0|||
155319683|NCT01928394|560607339|FG005|Treatment Period|Study drug toxicity|9|||
155319684|NCT01928394|560607340|FG006|Treatment Period|Study drug toxicity|7|||
155319685|NCT01928394|560607341|FG007|Treatment Period|Study drug toxicity|1|||
155319686|NCT01928394|560607342|FG008|Treatment Period|Study drug toxicity|0|||
155319687|NCT01928394|560607343|FG009|Treatment Period|Study drug toxicity|5|||
155319688|NCT01928394|560607344|FG010|Treatment Period|Study drug toxicity|2|||
155319689|NCT01928394|560607345|FG011|Treatment Period|Study drug toxicity|3|||
155319690|NCT01928394|560607346|FG012|Treatment Period|Study drug toxicity|7|||
155319691|NCT01928394|560607347|FG013|Treatment Period|Study drug toxicity|5|||
155319692|NCT01928394|560607348|FG014|Treatment Period|Study drug toxicity|12|||
155319693|NCT01928394|560607349|FG015|Treatment Period|Study drug toxicity|0|||
155643799|NCT01658878|561785191|FG011|Treatment Period|Adverse Event|0|||
155643800|NCT01658878|561785192|FG012|Treatment Period|Adverse Event|0|||
155643801|NCT01658878|561785193|FG013|Treatment Period|Adverse Event|0|||
155643802|NCT01658878|561785194|FG014|Treatment Period|Adverse Event|0|||
155643803|NCT01658878|561785195|FG015|Treatment Period|Adverse Event|0|||
155643804|NCT01658878|561785196|FG016|Treatment Period|Adverse Event|10|||
155643805|NCT01658878|561785197|FG017|Treatment Period|Adverse Event|3|||
155643806|NCT01658878|561785198|FG018|Treatment Period|Adverse Event|3|||
155643807|NCT01658878|561785199|FG019|Treatment Period|Adverse Event|2|||
155643808|NCT01658878|561785200|FG020|Treatment Period|Adverse Event|3|||
155643809|NCT01658878|561785201|FG021|Treatment Period|Adverse Event|3|||
155643810|NCT01658878|561785202|FG022|Treatment Period|Adverse Event|4|||
155643811|NCT01658878|561785203|FG023|Treatment Period|Adverse Event|3|||
155643812|NCT01658878|561785180|FG000|Treatment Period|Lost to Follow-up|0|||
155643813|NCT01658878|561785181|FG001|Treatment Period|Lost to Follow-up|0|||
155643814|NCT01658878|561785182|FG002|Treatment Period|Lost to Follow-up|0|||
155643815|NCT01658878|561785183|FG003|Treatment Period|Lost to Follow-up|0|||
155643816|NCT01658878|561785184|FG004|Treatment Period|Lost to Follow-up|0|||
155643817|NCT01658878|561785185|FG005|Treatment Period|Lost to Follow-up|0|||
155643818|NCT01658878|561785186|FG006|Treatment Period|Lost to Follow-up|0|||
155643819|NCT01658878|561785187|FG007|Treatment Period|Lost to Follow-up|0|||
155643820|NCT01658878|561785188|FG008|Treatment Period|Lost to Follow-up|0|||
155643821|NCT01658878|561785189|FG009|Treatment Period|Lost to Follow-up|0|||
155643822|NCT01658878|561785190|FG010|Treatment Period|Lost to Follow-up|0|||
155643823|NCT01658878|561785191|FG011|Treatment Period|Lost to Follow-up|0|||
155319694|NCT01928394|560607350|FG016|Treatment Period|Study drug toxicity|3|||
155319695|NCT01928394|560607351|FG017|Treatment Period|Study drug toxicity|3|||
155319696|NCT01928394|560607352|FG018|Treatment Period|Study drug toxicity|12|||
155319697|NCT01928394|560607353|FG019|Treatment Period|Study drug toxicity|15|||
155319698|NCT01928394|560607354|FG020|Treatment Period|Study drug toxicity|4|||
155319699|NCT01928394|560607355|FG021|Treatment Period|Study drug toxicity|7|||
155319700|NCT01928394|560607356|FG022|Treatment Period|Study drug toxicity|4|||
155319701|NCT01928394|560607334|FG000|Treatment Period|AE unrelated to study drug|0|||
155319702|NCT01928394|560607335|FG001|Treatment Period|AE unrelated to study drug|0|||
155319703|NCT01928394|560607336|FG002|Treatment Period|AE unrelated to study drug|2|||
155319704|NCT01928394|560607337|FG003|Treatment Period|AE unrelated to study drug|3|||
155319705|NCT01928394|560607338|FG004|Treatment Period|AE unrelated to study drug|0|||
155319706|NCT01928394|560607339|FG005|Treatment Period|AE unrelated to study drug|5|||
155319707|NCT01928394|560607340|FG006|Treatment Period|AE unrelated to study drug|1|||
155319708|NCT01928394|560607341|FG007|Treatment Period|AE unrelated to study drug|0|||
155319709|NCT01928394|560607342|FG008|Treatment Period|AE unrelated to study drug|0|||
155319710|NCT01928394|560607343|FG009|Treatment Period|AE unrelated to study drug|2|||
155319711|NCT01928394|560607344|FG010|Treatment Period|AE unrelated to study drug|0|||
155319712|NCT01928394|560607345|FG011|Treatment Period|AE unrelated to study drug|12|||
155319713|NCT01928394|560607346|FG012|Treatment Period|AE unrelated to study drug|6|||
155319714|NCT01928394|560607347|FG013|Treatment Period|AE unrelated to study drug|13|||
155319715|NCT01928394|560607348|FG014|Treatment Period|AE unrelated to study drug|6|||
155319716|NCT01928394|560607349|FG015|Treatment Period|AE unrelated to study drug|1|||
155319717|NCT01928394|560607350|FG016|Treatment Period|AE unrelated to study drug|1|||
155319718|NCT01928394|560607351|FG017|Treatment Period|AE unrelated to study drug|6|||
155319719|NCT01928394|560607352|FG018|Treatment Period|AE unrelated to study drug|3|||
155319720|NCT01928394|560607353|FG019|Treatment Period|AE unrelated to study drug|5|||
155319721|NCT01928394|560607354|FG020|Treatment Period|AE unrelated to study drug|1|||
155319722|NCT01928394|560607355|FG021|Treatment Period|AE unrelated to study drug|1|||
155319723|NCT01928394|560607356|FG022|Treatment Period|AE unrelated to study drug|0|||
155319724|NCT01928394|560607334|FG000|Treatment Period|Participant request to stop therapy|0|||
155319725|NCT01928394|560607335|FG001|Treatment Period|Participant request to stop therapy|0|||
155319726|NCT01928394|560607336|FG002|Treatment Period|Participant request to stop therapy|0|||
155319727|NCT01928394|560607337|FG003|Treatment Period|Participant request to stop therapy|0|||
155319728|NCT01928394|560607338|FG004|Treatment Period|Participant request to stop therapy|0|||
155319729|NCT01928394|560607339|FG005|Treatment Period|Participant request to stop therapy|3|||
155319730|NCT01928394|560607340|FG006|Treatment Period|Participant request to stop therapy|3|||
155319731|NCT01928394|560607341|FG007|Treatment Period|Participant request to stop therapy|0|||
155319732|NCT01928394|560607342|FG008|Treatment Period|Participant request to stop therapy|0|||
155319733|NCT01928394|560607343|FG009|Treatment Period|Participant request to stop therapy|0|||
155319734|NCT01928394|560607344|FG010|Treatment Period|Participant request to stop therapy|3|||
155319735|NCT01928394|560607345|FG011|Treatment Period|Participant request to stop therapy|2|||
155643824|NCT01658878|561785192|FG012|Treatment Period|Lost to Follow-up|0|||
155643825|NCT01658878|561785193|FG013|Treatment Period|Lost to Follow-up|0|||
155643826|NCT01658878|561785194|FG014|Treatment Period|Lost to Follow-up|0|||
155643827|NCT01658878|561785195|FG015|Treatment Period|Lost to Follow-up|0|||
155643828|NCT01658878|561785196|FG016|Treatment Period|Lost to Follow-up|1|||
155643829|NCT01658878|561785197|FG017|Treatment Period|Lost to Follow-up|0|||
155643830|NCT01658878|561785198|FG018|Treatment Period|Lost to Follow-up|1|||
155643831|NCT01658878|561785199|FG019|Treatment Period|Lost to Follow-up|1|||
155643832|NCT01658878|561785200|FG020|Treatment Period|Lost to Follow-up|0|||
155643833|NCT01658878|561785201|FG021|Treatment Period|Lost to Follow-up|0|||
155643834|NCT01658878|561785202|FG022|Treatment Period|Lost to Follow-up|1|||
155643835|NCT01658878|561785203|FG023|Treatment Period|Lost to Follow-up|0|||
155643836|NCT03928704|561785209|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155643837|NCT03928704|561785210|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
155643838|NCT03928704|561785211|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155643839|NCT03928704|561785212|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155643840|NCT03928704|561785213|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155643841|NCT03928704|561785214|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155643842|NCT03928704|561785209|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
155643843|NCT03928704|561785210|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155643844|NCT03928704|561785211|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155643845|NCT03928704|561785212|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155643846|NCT03928704|561785213|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155643847|NCT03928704|561785214|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155643848|NCT03928704|561785209|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
155643849|NCT03928704|561785210|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155319736|NCT01928394|560607346|FG012|Treatment Period|Participant request to stop therapy|1|||
155319737|NCT01928394|560607347|FG013|Treatment Period|Participant request to stop therapy|2|||
155319738|NCT01928394|560607348|FG014|Treatment Period|Participant request to stop therapy|4|||
155319739|NCT01928394|560607349|FG015|Treatment Period|Participant request to stop therapy|0|||
155319740|NCT01928394|560607350|FG016|Treatment Period|Participant request to stop therapy|1|||
155319741|NCT01928394|560607351|FG017|Treatment Period|Participant request to stop therapy|3|||
155319742|NCT01928394|560607352|FG018|Treatment Period|Participant request to stop therapy|1|||
155319743|NCT01928394|560607353|FG019|Treatment Period|Participant request to stop therapy|1|||
155319744|NCT01928394|560607354|FG020|Treatment Period|Participant request to stop therapy|3|||
155319745|NCT01928394|560607355|FG021|Treatment Period|Participant request to stop therapy|1|||
155319746|NCT01928394|560607356|FG022|Treatment Period|Participant request to stop therapy|3|||
155319747|NCT01928394|560607334|FG000|Treatment Period|Participant withdrew consent|0|||
155319748|NCT01928394|560607335|FG001|Treatment Period|Participant withdrew consent|0|||
155319749|NCT01928394|560607336|FG002|Treatment Period|Participant withdrew consent|1|||
155319750|NCT01928394|560607337|FG003|Treatment Period|Participant withdrew consent|1|||
155751826|NCT02414139|562190356|FG008|Treatment Period|Progressive disease|20|||
155751827|NCT02414139|562190357|FG009|Treatment Period|Progressive disease|14|||
155751828|NCT02414139|562190348|FG000|Treatment Period|Protocol deviation|0|||
155751829|NCT02414139|562190349|FG001|Treatment Period|Protocol deviation|0|||
155751830|NCT02414139|562190350|FG002|Treatment Period|Protocol deviation|1|||
155751831|NCT02414139|562190351|FG003|Treatment Period|Protocol deviation|0|||
155751832|NCT02414139|562190352|FG004|Treatment Period|Protocol deviation|0|||
155751833|NCT02414139|562190353|FG005|Treatment Period|Protocol deviation|0|||
155751834|NCT02414139|562190354|FG006|Treatment Period|Protocol deviation|0|||
155751835|NCT02414139|562190355|FG007|Treatment Period|Protocol deviation|0|||
155751836|NCT02414139|562190356|FG008|Treatment Period|Protocol deviation|0|||
155751837|NCT02414139|562190357|FG009|Treatment Period|Protocol deviation|0|||
155751838|NCT02414139|562190348|FG000|Treatment Period|Subject/Guardian decision|5|||
155751839|NCT02414139|562190349|FG001|Treatment Period|Subject/Guardian decision|1|||
155751840|NCT02414139|562190350|FG002|Treatment Period|Subject/Guardian decision|1|||
155751841|NCT02414139|562190351|FG003|Treatment Period|Subject/Guardian decision|2|||
155751842|NCT02414139|562190352|FG004|Treatment Period|Subject/Guardian decision|5|||
155751843|NCT02414139|562190353|FG005|Treatment Period|Subject/Guardian decision|0|||
155751844|NCT02414139|562190354|FG006|Treatment Period|Subject/Guardian decision|2|||
155751845|NCT02414139|562190355|FG007|Treatment Period|Subject/Guardian decision|0|||
155751846|NCT02414139|562190356|FG008|Treatment Period|Subject/Guardian decision|1|||
155751847|NCT02414139|562190357|FG009|Treatment Period|Subject/Guardian decision|1|||
155751848|NCT02414139|562190348|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751849|NCT02414139|562190349|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751850|NCT02414139|562190350|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751851|NCT02414139|562190351|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751852|NCT02414139|562190352|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
155751853|NCT02414139|562190353|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751854|NCT02414139|562190354|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
155751855|NCT02414139|562190355|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155751856|NCT02414139|562190356|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
155751857|NCT02414139|562190357|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
155751858|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155751859|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751860|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751861|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751862|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
155751863|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751864|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751865|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751866|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751867|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155751868|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155751869|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155751870|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Death|0|||
155751871|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Death|0|||
155751872|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Death|1|||
155319751|NCT01928394|560607338|FG004|Treatment Period|Participant withdrew consent|0|||
155319752|NCT01928394|560607339|FG005|Treatment Period|Participant withdrew consent|1|||
155319753|NCT01928394|560607340|FG006|Treatment Period|Participant withdrew consent|0|||
155319754|NCT01928394|560607341|FG007|Treatment Period|Participant withdrew consent|1|||
155319755|NCT01928394|560607342|FG008|Treatment Period|Participant withdrew consent|0|||
155319756|NCT01928394|560607343|FG009|Treatment Period|Participant withdrew consent|0|||
155751873|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Death|0|||
155751874|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Death|0|||
155751875|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Death|0|||
155751876|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Death|0|||
155751877|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Death|1|||
155751878|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155751879|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751880|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751881|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751882|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751883|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751884|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751885|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751886|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751887|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155751888|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155751889|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155751890|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155751891|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155751892|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155751893|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155751894|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155751895|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155751896|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155751897|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155319757|NCT01928394|560607344|FG010|Treatment Period|Participant withdrew consent|1|||
155319758|NCT01928394|560607345|FG011|Treatment Period|Participant withdrew consent|1|||
155319759|NCT01928394|560607346|FG012|Treatment Period|Participant withdrew consent|1|||
155319760|NCT01928394|560607347|FG013|Treatment Period|Participant withdrew consent|0|||
155319761|NCT01928394|560607348|FG014|Treatment Period|Participant withdrew consent|2|||
155319762|NCT01928394|560607349|FG015|Treatment Period|Participant withdrew consent|0|||
155319763|NCT01928394|560607350|FG016|Treatment Period|Participant withdrew consent|2|||
155319764|NCT01928394|560607351|FG017|Treatment Period|Participant withdrew consent|1|||
155319765|NCT01928394|560607352|FG018|Treatment Period|Participant withdrew consent|1|||
155319766|NCT01928394|560607353|FG019|Treatment Period|Participant withdrew consent|1|||
155319767|NCT01928394|560607354|FG020|Treatment Period|Participant withdrew consent|0|||
155319768|NCT01928394|560607355|FG021|Treatment Period|Participant withdrew consent|2|||
155319769|NCT01928394|560607356|FG022|Treatment Period|Participant withdrew consent|0|||
155319770|NCT01928394|560607334|FG000|Treatment Period|Poor/non-compliance|0|||
155319771|NCT01928394|560607335|FG001|Treatment Period|Poor/non-compliance|0|||
155319772|NCT01928394|560607336|FG002|Treatment Period|Poor/non-compliance|0|||
155319773|NCT01928394|560607337|FG003|Treatment Period|Poor/non-compliance|1|||
155319774|NCT01928394|560607338|FG004|Treatment Period|Poor/non-compliance|0|||
155319775|NCT01928394|560607339|FG005|Treatment Period|Poor/non-compliance|0|||
155319776|NCT01928394|560607340|FG006|Treatment Period|Poor/non-compliance|0|||
155319777|NCT01928394|560607341|FG007|Treatment Period|Poor/non-compliance|0|||
155319778|NCT01928394|560607342|FG008|Treatment Period|Poor/non-compliance|0|||
155319779|NCT01928394|560607343|FG009|Treatment Period|Poor/non-compliance|0|||
155319780|NCT01928394|560607344|FG010|Treatment Period|Poor/non-compliance|0|||
155319781|NCT01928394|560607345|FG011|Treatment Period|Poor/non-compliance|0|||
155319782|NCT01928394|560607346|FG012|Treatment Period|Poor/non-compliance|1|||
155319783|NCT01928394|560607347|FG013|Treatment Period|Poor/non-compliance|0|||
155319784|NCT01928394|560607348|FG014|Treatment Period|Poor/non-compliance|1|||
155319785|NCT01928394|560607349|FG015|Treatment Period|Poor/non-compliance|0|||
155319786|NCT01928394|560607350|FG016|Treatment Period|Poor/non-compliance|0|||
155319787|NCT01928394|560607351|FG017|Treatment Period|Poor/non-compliance|1|||
155319788|NCT01928394|560607352|FG018|Treatment Period|Poor/non-compliance|0|||
155319789|NCT01928394|560607353|FG019|Treatment Period|Poor/non-compliance|1|||
155319790|NCT01928394|560607354|FG020|Treatment Period|Poor/non-compliance|0|||
155751898|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
155319791|NCT01928394|560607355|FG021|Treatment Period|Poor/non-compliance|0|||
155319792|NCT01928394|560607356|FG022|Treatment Period|Poor/non-compliance|0|||
155319793|NCT01928394|560607334|FG000|Treatment Period|other reason|0|||
155751899|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155751900|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
155751901|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155751902|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
155319794|NCT01928394|560607335|FG001|Treatment Period|other reason|0|||
155419830|NCT05195528|560968199|FG000|Placebo-controlled Treatment Period|Other|0|||
155419831|NCT05195528|560968200|FG001|Placebo-controlled Treatment Period|Other|0|||
155419832|NCT05195528|560968201|FG002|Placebo-controlled Treatment Period|Other|1|||
155319795|NCT01928394|560607336|FG002|Treatment Period|other reason|0|||
155319796|NCT01928394|560607337|FG003|Treatment Period|other reason|0|||
155319797|NCT01928394|560607338|FG004|Treatment Period|other reason|0|||
155319798|NCT01928394|560607339|FG005|Treatment Period|other reason|0|||
155319799|NCT01928394|560607340|FG006|Treatment Period|other reason|0|||
155319800|NCT01928394|560607341|FG007|Treatment Period|other reason|0|||
155319801|NCT01928394|560607342|FG008|Treatment Period|other reason|0|||
155319802|NCT01928394|560607343|FG009|Treatment Period|other reason|0|||
155319803|NCT01928394|560607344|FG010|Treatment Period|other reason|1|||
155319804|NCT01928394|560607345|FG011|Treatment Period|other reason|1|||
155319805|NCT01928394|560607346|FG012|Treatment Period|other reason|1|||
155319806|NCT01928394|560607347|FG013|Treatment Period|other reason|0|||
155319807|NCT01928394|560607348|FG014|Treatment Period|other reason|1|||
155319808|NCT01928394|560607349|FG015|Treatment Period|other reason|0|||
155319809|NCT01928394|560607350|FG016|Treatment Period|other reason|0|||
155319810|NCT01928394|560607351|FG017|Treatment Period|other reason|0|||
155319811|NCT01928394|560607352|FG018|Treatment Period|other reason|2|||
155319812|NCT01928394|560607353|FG019|Treatment Period|other reason|2|||
155319813|NCT01928394|560607354|FG020|Treatment Period|other reason|0|||
155319814|NCT01928394|560607355|FG021|Treatment Period|other reason|0|||
155319815|NCT01928394|560607356|FG022|Treatment Period|other reason|0|||
155319816|NCT01928394|560607334|FG000|Treatment Period|Maximum clinical benefit|0|||
155319817|NCT01928394|560607335|FG001|Treatment Period|Maximum clinical benefit|0|||
155319818|NCT01928394|560607336|FG002|Treatment Period|Maximum clinical benefit|0|||
155319819|NCT01928394|560607337|FG003|Treatment Period|Maximum clinical benefit|0|||
155319820|NCT01928394|560607338|FG004|Treatment Period|Maximum clinical benefit|0|||
155319821|NCT01928394|560607339|FG005|Treatment Period|Maximum clinical benefit|0|||
155319822|NCT01928394|560607340|FG006|Treatment Period|Maximum clinical benefit|0|||
155319823|NCT01928394|560607341|FG007|Treatment Period|Maximum clinical benefit|0|||
155319824|NCT01928394|560607342|FG008|Treatment Period|Maximum clinical benefit|0|||
155319825|NCT01928394|560607343|FG009|Treatment Period|Maximum clinical benefit|0|||
155319826|NCT01928394|560607344|FG010|Treatment Period|Maximum clinical benefit|1|||
155319827|NCT01928394|560607345|FG011|Treatment Period|Maximum clinical benefit|1|||
155319828|NCT01928394|560607346|FG012|Treatment Period|Maximum clinical benefit|0|||
155319829|NCT01928394|560607347|FG013|Treatment Period|Maximum clinical benefit|0|||
155319830|NCT01928394|560607348|FG014|Treatment Period|Maximum clinical benefit|1|||
155319831|NCT01928394|560607349|FG015|Treatment Period|Maximum clinical benefit|0|||
155319832|NCT01928394|560607350|FG016|Treatment Period|Maximum clinical benefit|0|||
155319833|NCT01928394|560607351|FG017|Treatment Period|Maximum clinical benefit|1|||
155319834|NCT01928394|560607352|FG018|Treatment Period|Maximum clinical benefit|1|||
155319835|NCT01928394|560607353|FG019|Treatment Period|Maximum clinical benefit|0|||
155319836|NCT01928394|560607354|FG020|Treatment Period|Maximum clinical benefit|2|||
155319837|NCT01928394|560607355|FG021|Treatment Period|Maximum clinical benefit|0|||
155319838|NCT01928394|560607356|FG022|Treatment Period|Maximum clinical benefit|0|||
155319839|NCT01928394|560607334|FG000|Treatment Period|Lost to Follow-up|0|||
155319840|NCT01928394|560607335|FG001|Treatment Period|Lost to Follow-up|0|||
155319841|NCT01928394|560607336|FG002|Treatment Period|Lost to Follow-up|0|||
155319842|NCT01928394|560607337|FG003|Treatment Period|Lost to Follow-up|0|||
155319843|NCT01928394|560607338|FG004|Treatment Period|Lost to Follow-up|0|||
155419833|NCT05195528|560968202|FG003|Placebo-controlled Treatment Period|Other|0|||
155419834|NCT05195528|560968203|FG004|Placebo-controlled Treatment Period|Other|0|||
155419835|NCT05195528|560968199|FG000|Extension Period|PTE or AE or SAE|0|||
155419836|NCT05195528|560968200|FG001|Extension Period|PTE or AE or SAE|4|||
155419837|NCT05195528|560968201|FG002|Extension Period|PTE or AE or SAE|5|||
155419838|NCT05195528|560968202|FG003|Extension Period|PTE or AE or SAE|4|||
155419839|NCT05195528|560968203|FG004|Extension Period|PTE or AE or SAE|4|||
155419840|NCT05195528|560968199|FG000|Extension Period|Protocol Violation|0|||
155419841|NCT05195528|560968200|FG001|Extension Period|Protocol Violation|2|||
155419842|NCT05195528|560968201|FG002|Extension Period|Protocol Violation|1|||
155419843|NCT05195528|560968202|FG003|Extension Period|Protocol Violation|0|||
155419844|NCT05195528|560968203|FG004|Extension Period|Protocol Violation|1|||
155319844|NCT01928394|560607339|FG005|Treatment Period|Lost to Follow-up|0|||
155319845|NCT01928394|560607340|FG006|Treatment Period|Lost to Follow-up|0|||
155319846|NCT01928394|560607341|FG007|Treatment Period|Lost to Follow-up|0|||
155319847|NCT01928394|560607342|FG008|Treatment Period|Lost to Follow-up|0|||
155319848|NCT01928394|560607343|FG009|Treatment Period|Lost to Follow-up|0|||
155319849|NCT01928394|560607344|FG010|Treatment Period|Lost to Follow-up|0|||
155319850|NCT01928394|560607345|FG011|Treatment Period|Lost to Follow-up|0|||
155419845|NCT05195528|560968199|FG000|Extension Period|Lost to Follow-up|0|||
155319851|NCT01928394|560607346|FG012|Treatment Period|Lost to Follow-up|0|||
155319852|NCT01928394|560607347|FG013|Treatment Period|Lost to Follow-up|0|||
155319853|NCT01928394|560607348|FG014|Treatment Period|Lost to Follow-up|0|||
155319854|NCT01928394|560607349|FG015|Treatment Period|Lost to Follow-up|0|||
155319855|NCT01928394|560607350|FG016|Treatment Period|Lost to Follow-up|0|||
155419846|NCT05195528|560968200|FG001|Extension Period|Lost to Follow-up|6|||
155419847|NCT05195528|560968201|FG002|Extension Period|Lost to Follow-up|13|||
155319856|NCT01928394|560607351|FG017|Treatment Period|Lost to Follow-up|0|||
155319857|NCT01928394|560607352|FG018|Treatment Period|Lost to Follow-up|0|||
155319858|NCT01928394|560607353|FG019|Treatment Period|Lost to Follow-up|0|||
155319859|NCT01928394|560607354|FG020|Treatment Period|Lost to Follow-up|0|||
155319860|NCT01928394|560607355|FG021|Treatment Period|Lost to Follow-up|0|||
155319861|NCT01928394|560607356|FG022|Treatment Period|Lost to Follow-up|1|||
155319862|NCT01928394|560607334|FG000|Treatment Period|Death|0|||
155751903|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
155751904|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155751905|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
155751906|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155751907|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155751908|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751909|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
155751910|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751911|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751912|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751913|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751914|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751915|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751916|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155751917|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
155751918|NCT02414139|562190348|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
155751919|NCT02414139|562190349|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155751920|NCT02414139|562190350|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
155751921|NCT02414139|562190351|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155751922|NCT02414139|562190352|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155751923|NCT02414139|562190353|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155751924|NCT02414139|562190354|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155751925|NCT02414139|562190355|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155751926|NCT02414139|562190356|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155751927|NCT02414139|562190357|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155751928|NCT02290431|562190358|FG000|Overall Study|Adverse Event|20|||
155751929|NCT02290431|562190358|FG000|Overall Study|Progressive disease|4|||
155751930|NCT02290431|562190358|FG000|Overall Study|Study terminated by Sponsor|1|||
155751931|NCT02290431|562190358|FG000|Overall Study|Physician Decision|2|||
155751932|NCT03324581|562190360|FG000|Overall Study|Adverse Event|18|||
155751933|NCT03324581|562190361|FG001|Overall Study|Adverse Event|11|||
155751934|NCT03324581|562190362|FG002|Overall Study|Adverse Event|7|||
155319863|NCT01928394|560607335|FG001|Treatment Period|Death|0|||
155751935|NCT03324581|562190360|FG000|Overall Study|Lack of Efficacy|0|||
155419848|NCT05195528|560968202|FG003|Extension Period|Lost to Follow-up|3|||
155419849|NCT05195528|560968203|FG004|Extension Period|Lost to Follow-up|7|||
155419850|NCT05195528|560968199|FG000|Extension Period|Withdrawal by Subject|0|||
155419851|NCT05195528|560968200|FG001|Extension Period|Withdrawal by Subject|12|||
155419852|NCT05195528|560968201|FG002|Extension Period|Withdrawal by Subject|9|||
155419853|NCT05195528|560968202|FG003|Extension Period|Withdrawal by Subject|6|||
155419854|NCT05195528|560968203|FG004|Extension Period|Withdrawal by Subject|5|||
155419855|NCT05195528|560968199|FG000|Extension Period|Lack of Efficacy|0|||
155419856|NCT05195528|560968200|FG001|Extension Period|Lack of Efficacy|3|||
155419857|NCT05195528|560968201|FG002|Extension Period|Lack of Efficacy|0|||
155419858|NCT05195528|560968202|FG003|Extension Period|Lack of Efficacy|0|||
155419859|NCT05195528|560968203|FG004|Extension Period|Lack of Efficacy|2|||
155419860|NCT05195528|560968199|FG000|Extension Period|Not Treated|0|||
155419861|NCT05195528|560968200|FG001|Extension Period|Not Treated|0|||
155419862|NCT05195528|560968201|FG002|Extension Period|Not Treated|2|||
155419863|NCT05195528|560968202|FG003|Extension Period|Not Treated|3|||
155419864|NCT05195528|560968203|FG004|Extension Period|Not Treated|0|||
155419865|NCT05195528|560968199|FG000|Extension Period|Other|0|||
155419866|NCT05195528|560968200|FG001|Extension Period|Other|1|||
155419867|NCT05195528|560968201|FG002|Extension Period|Other|1|||
155419868|NCT05195528|560968202|FG003|Extension Period|Other|0|||
155419869|NCT05195528|560968203|FG004|Extension Period|Other|0|||
155419870|NCT02487108|560968204|FG000|Overall Study|Adverse Event|1|||
155419871|NCT02487108|560968205|FG001|Overall Study|Adverse Event|6|||
155419872|NCT02487108|560968206|FG002|Overall Study|Adverse Event|12|||
155419873|NCT02487108|560968207|FG003|Overall Study|Adverse Event|6|||
155751936|NCT03324581|562190361|FG001|Overall Study|Lack of Efficacy|1|||
155751937|NCT03324581|562190362|FG002|Overall Study|Lack of Efficacy|0|||
155319864|NCT01928394|560607336|FG002|Treatment Period|Death|0|||
155419874|NCT02487108|560968204|FG000|Overall Study|Withdrawal by Subject|8|||
155419875|NCT02487108|560968205|FG001|Overall Study|Withdrawal by Subject|5|||
155419876|NCT02487108|560968206|FG002|Overall Study|Withdrawal by Subject|5|||
155751938|NCT03324581|562190360|FG000|Overall Study|Lost to Follow-up|5|||
155751939|NCT03324581|562190361|FG001|Overall Study|Lost to Follow-up|3|||
155751940|NCT03324581|562190362|FG002|Overall Study|Lost to Follow-up|6|||
155751941|NCT03324581|562190360|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
155751942|NCT03324581|562190361|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
155751943|NCT03324581|562190362|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
155751944|NCT03324581|562190360|FG000|Overall Study|Physician Decision|0|||
155751945|NCT03324581|562190361|FG001|Overall Study|Physician Decision|1|||
155751946|NCT03324581|562190362|FG002|Overall Study|Physician Decision|2|||
155751947|NCT03324581|562190360|FG000|Overall Study|Protocol Deviation|8|||
155751948|NCT03324581|562190361|FG001|Overall Study|Protocol Deviation|9|||
155751949|NCT03324581|562190362|FG002|Overall Study|Protocol Deviation|4|||
155751950|NCT03324581|562190360|FG000|Overall Study|Withdrawal by Subject|6|||
155751951|NCT03324581|562190361|FG001|Overall Study|Withdrawal by Subject|8|||
155751952|NCT03324581|562190362|FG002|Overall Study|Withdrawal by Subject|6|||
155751953|NCT03324581|562190360|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
155751954|NCT03324581|562190361|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
155751955|NCT03324581|562190362|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
155751956|NCT00321893|562190363|FG000|Overall Study|Non-Compliance/Refusal|16|||
155751957|NCT00321893|562190364|FG001|Overall Study|Non-Compliance/Refusal|10|||
155751958|NCT00321893|562190363|FG000|Overall Study|Lost to Follow-up|2|||
155751959|NCT00321893|562190364|FG001|Overall Study|Lost to Follow-up|1|||
155751960|NCT00321893|562190363|FG000|Overall Study|Adverse Event|6|||
155751961|NCT00321893|562190364|FG001|Overall Study|Adverse Event|3|||
155751962|NCT03455764|562190365|FG000|Overall Study|Adverse Event|1|||
155751963|NCT03455764|562190366|FG001|Overall Study|Adverse Event|0|||
155751964|NCT03455764|562190367|FG002|Overall Study|Adverse Event|0|||
155751965|NCT03455764|562190368|FG003|Overall Study|Adverse Event|0|||
155751966|NCT03455764|562190369|FG004|Overall Study|Adverse Event|0|||
155751967|NCT03455764|562190365|FG000|Overall Study|Disease Progression|4|||
155751968|NCT03455764|562190366|FG001|Overall Study|Disease Progression|0|||
155751969|NCT03455764|562190367|FG002|Overall Study|Disease Progression|0|||
155751970|NCT03455764|562190368|FG003|Overall Study|Disease Progression|0|||
155751971|NCT03455764|562190369|FG004|Overall Study|Disease Progression|0|||
155751972|NCT03455764|562190365|FG000|Overall Study|On Treatment|1|||
155751973|NCT03455764|562190366|FG001|Overall Study|On Treatment|0|||
155751974|NCT03455764|562190367|FG002|Overall Study|On Treatment|0|||
155751975|NCT03455764|562190368|FG003|Overall Study|On Treatment|0|||
155751976|NCT03455764|562190369|FG004|Overall Study|On Treatment|0|||
155751977|NCT01585584|562190370|FG000|Overall Study|Lack of Efficacy|1|||
155751978|NCT01585584|562190370|FG000|Overall Study|Withdrawal by Subject|1|||
155751979|NCT01585584|562190370|FG000|Overall Study|Physician Decision|2|||
155751980|NCT05091567|562191902|FG000|Enrollment Phase|Death|37|||
155751981|NCT05091567|562191903|FG001|Enrollment Phase|Death|0|||
155751982|NCT05091567|562191904|FG002|Enrollment Phase|Death|0|||
155751983|NCT05091567|562191902|FG000|Enrollment Phase|Adverse Event|21|||
155751984|NCT05091567|562191903|FG001|Enrollment Phase|Adverse Event|0|||
155751985|NCT05091567|562191904|FG002|Enrollment Phase|Adverse Event|0|||
155751986|NCT05091567|562191902|FG000|Enrollment Phase|Progressive Disease|10|||
155751987|NCT05091567|562191903|FG001|Enrollment Phase|Progressive Disease|0|||
155751988|NCT05091567|562191904|FG002|Enrollment Phase|Progressive Disease|0|||
155751989|NCT05091567|562191902|FG000|Enrollment Phase|Withdrawal by Subject|8|||
155751990|NCT05091567|562191903|FG001|Enrollment Phase|Withdrawal by Subject|0|||
155419877|NCT02487108|560968207|FG003|Overall Study|Withdrawal by Subject|0|||
155419878|NCT02487108|560968204|FG000|Overall Study|Non-compliance to study medication|3|||
155419879|NCT02487108|560968205|FG001|Overall Study|Non-compliance to study medication|2|||
155419880|NCT02487108|560968206|FG002|Overall Study|Non-compliance to study medication|5|||
155419881|NCT02487108|560968207|FG003|Overall Study|Non-compliance to study medication|4|||
155419882|NCT02487108|560968204|FG000|Overall Study|Protocol Violation|1|||
155419883|NCT02487108|560968205|FG001|Overall Study|Protocol Violation|1|||
155419884|NCT02487108|560968206|FG002|Overall Study|Protocol Violation|2|||
155419885|NCT02487108|560968207|FG003|Overall Study|Protocol Violation|0|||
155419886|NCT02487108|560968204|FG000|Overall Study|Non-compliance to study procedures|0|||
155419887|NCT02487108|560968205|FG001|Overall Study|Non-compliance to study procedures|0|||
155419888|NCT02487108|560968206|FG002|Overall Study|Non-compliance to study procedures|0|||
155419889|NCT02487108|560968207|FG003|Overall Study|Non-compliance to study procedures|1|||
155419890|NCT02487108|560968204|FG000|Overall Study|Other than specified|3|||
155419891|NCT02487108|560968205|FG001|Overall Study|Other than specified|2|||
155419892|NCT02487108|560968206|FG002|Overall Study|Other than specified|2|||
155419893|NCT02487108|560968207|FG003|Overall Study|Other than specified|0|||
155419894|NCT02720757|560968208|FG000|Overall Study|Other reason|5|||
155419895|NCT02720757|560968208|FG000|Overall Study|Loss of contact|4|||
155419896|NCT02720757|560968208|FG000|Overall Study|Informed consent withdrawal|1|||
155419897|NCT02720757|560968208|FG000|Overall Study|Patients wish to withdraw|2|||
155751991|NCT05091567|562191904|FG002|Enrollment Phase|Withdrawal by Subject|0|||
155751992|NCT05091567|562191902|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
155501056|NCT05144477|561260760|FG000|Overall Study|Withdrawal by Subject|1|||
155501057|NCT05144477|561260761|FG001|Overall Study|Withdrawal by Subject|1|||
155501058|NCT00965263|561260764|FG000|Overall Study|Physician Decision|2|||
155501059|NCT00965263|561260765|FG001|Overall Study|Physician Decision|0|||
155501060|NCT00965263|561260764|FG000|Overall Study|Family emergency|0|||
155643850|NCT03928704|561785211|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155643851|NCT03928704|561785212|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155643852|NCT03928704|561785213|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155643853|NCT03928704|561785214|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155643854|NCT03928704|561785209|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
155643855|NCT03928704|561785210|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
155643856|NCT03928704|561785211|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155643857|NCT03928704|561785212|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155643858|NCT03928704|561785213|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155643859|NCT03928704|561785214|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155643860|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155643861|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155643862|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
155643863|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155643864|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155643865|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155643866|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155643867|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155643868|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
155643869|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155643870|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155643871|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155643872|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
155643873|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
155643874|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
155643875|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
155643876|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
155643877|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
155643878|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155643879|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155643880|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
155643881|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155643882|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155643883|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155643884|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155643885|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155643886|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155643887|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155643888|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155643889|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
155643890|NCT03928704|561785209|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
155643891|NCT03928704|561785210|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
155643892|NCT03928704|561785211|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
155643893|NCT03928704|561785212|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
155643894|NCT03928704|561785213|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
155643895|NCT03928704|561785214|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
155643896|NCT05141357|561785216|FG000|Overall Study|Adverse Event|3|||
155643897|NCT05141357|561785216|FG000|Overall Study|Lack of Efficacy|2|||
155643898|NCT05887908|561785217|FG000|Overall Study|Adverse Event|6|||
155643899|NCT05887908|561785218|FG001|Overall Study|Adverse Event|1|||
155643900|NCT05887908|561785219|FG002|Overall Study|Adverse Event|1|||
155643901|NCT05887908|561785217|FG000|Overall Study|Physician Decision|4|||
155643902|NCT05887908|561785218|FG001|Overall Study|Physician Decision|1|||
155643903|NCT05887908|561785219|FG002|Overall Study|Physician Decision|0|||
155643904|NCT05887908|561785217|FG000|Overall Study|Withdrawal by Subject|3|||
155643905|NCT05887908|561785218|FG001|Overall Study|Withdrawal by Subject|2|||
155643906|NCT05887908|561785219|FG002|Overall Study|Withdrawal by Subject|3|||
155643907|NCT05887908|561785217|FG000|Overall Study|Ineligibility after the start of the study|4|||
155643908|NCT05887908|561785218|FG001|Overall Study|Ineligibility after the start of the study|1|||
155643909|NCT05887908|561785219|FG002|Overall Study|Ineligibility after the start of the study|0|||
155643910|NCT05887908|561785217|FG000|Overall Study|Subject non-compliance|4|||
155643911|NCT05887908|561785218|FG001|Overall Study|Subject non-compliance|0|||
155643912|NCT05887908|561785219|FG002|Overall Study|Subject non-compliance|4|||
155501061|NCT00965263|561260765|FG001|Overall Study|Family emergency|1|||
155751993|NCT05091567|562191903|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
155751994|NCT05091567|562191904|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
155751995|NCT05091567|562191902|FG000|Enrollment Phase|Physician Decision|3|||
155751996|NCT05091567|562191903|FG001|Enrollment Phase|Physician Decision|0|||
155751997|NCT05091567|562191904|FG002|Enrollment Phase|Physician Decision|0|||
155751998|NCT05091567|562191902|FG000|Enrollment Phase|Protocol Violation|2|||
155751999|NCT05091567|562191903|FG001|Enrollment Phase|Protocol Violation|0|||
155752000|NCT05091567|562191904|FG002|Enrollment Phase|Protocol Violation|0|||
155752001|NCT05091567|562191902|FG000|Enrollment Phase|Reason not Specified|1|||
155752002|NCT05091567|562191903|FG001|Enrollment Phase|Reason not Specified|0|||
155752003|NCT05091567|562191904|FG002|Enrollment Phase|Reason not Specified|0|||
155752004|NCT05091567|562191902|FG000|Randomized Phase|Death|0|||
155752005|NCT05091567|562191903|FG001|Randomized Phase|Death|135|||
155752006|NCT05091567|562191904|FG002|Randomized Phase|Death|112|||
155752007|NCT05091567|562191902|FG000|Randomized Phase|Progressive Disease|0|||
155752008|NCT05091567|562191903|FG001|Randomized Phase|Progressive Disease|2|||
155752009|NCT05091567|562191904|FG002|Randomized Phase|Progressive Disease|0|||
155752010|NCT05091567|562191902|FG000|Randomized Phase|Withdrawal by Subject|0|||
155752011|NCT05091567|562191903|FG001|Randomized Phase|Withdrawal by Subject|1|||
155752012|NCT05091567|562191904|FG002|Randomized Phase|Withdrawal by Subject|3|||
155752013|NCT05091567|562191902|FG000|Randomized Phase|Lost to Follow-up|0|||
155752014|NCT05091567|562191903|FG001|Randomized Phase|Lost to Follow-up|1|||
155752015|NCT05091567|562191904|FG002|Randomized Phase|Lost to Follow-up|1|||
155752016|NCT05091567|562191902|FG000|Randomized Phase|Ongoing in Study|0|||
155752017|NCT05091567|562191903|FG001|Randomized Phase|Ongoing in Study|102|||
155752018|NCT05091567|562191904|FG002|Randomized Phase|Ongoing in Study|126|||
155752019|NCT05568615|562191905|FG000|Overall Study|Death|1|||
155752020|NCT05568615|562191905|FG000|Overall Study|Physician Decision|1|||
155752021|NCT00565851|562191906|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
155752022|NCT00565851|562191907|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
155752023|NCT00565851|562191908|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
155319865|NCT01928394|560607337|FG003|Treatment Period|Death|0|||
155319866|NCT01928394|560607338|FG004|Treatment Period|Death|0|||
155319867|NCT01928394|560607339|FG005|Treatment Period|Death|0|||
155319868|NCT01928394|560607340|FG006|Treatment Period|Death|0|||
155319869|NCT01928394|560607341|FG007|Treatment Period|Death|0|||
155319870|NCT01928394|560607342|FG008|Treatment Period|Death|0|||
155319871|NCT01928394|560607343|FG009|Treatment Period|Death|0|||
155319872|NCT01928394|560607344|FG010|Treatment Period|Death|0|||
155752024|NCT00565851|562191909|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
155752025|NCT00565851|562191910|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
155752026|NCT00565851|562191911|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
155752027|NCT00565851|562191912|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
155752028|NCT00565851|562191913|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
155752029|NCT00565851|562191906|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
155752030|NCT00565851|562191907|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
155752031|NCT00565851|562191908|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
155752032|NCT00565851|562191909|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
155752033|NCT00565851|562191910|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
155752034|NCT00565851|562191911|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
155752035|NCT00565851|562191912|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
155752036|NCT00565851|562191913|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
155752037|NCT03291067|562191914|FG000|Overall Study|Adverse Event|0|||
155752038|NCT03291067|562191915|FG001|Overall Study|Adverse Event|2|||
155752039|NCT03291067|562191916|FG002|Overall Study|Adverse Event|17|||
155752040|NCT03291067|562191917|FG003|Overall Study|Adverse Event|3|||
155752041|NCT03291067|562191914|FG000|Overall Study|Lost to Follow-up|2|||
155752042|NCT03291067|562191915|FG001|Overall Study|Lost to Follow-up|1|||
155752043|NCT03291067|562191916|FG002|Overall Study|Lost to Follow-up|0|||
155752044|NCT03291067|562191917|FG003|Overall Study|Lost to Follow-up|1|||
155319873|NCT01928394|560607345|FG011|Treatment Period|Death|0|||
155319874|NCT01928394|560607346|FG012|Treatment Period|Death|0|||
155319875|NCT01928394|560607347|FG013|Treatment Period|Death|1|||
155319876|NCT01928394|560607348|FG014|Treatment Period|Death|2|||
155319877|NCT01928394|560607349|FG015|Treatment Period|Death|0|||
155419898|NCT02720757|560968208|FG000|Overall Study|Missing|3|||
155419899|NCT02720757|560968208|FG000|Overall Study|General exclusion|3|||
155752045|NCT03291067|562191914|FG000|Overall Study|Physician Decision|0|||
155319878|NCT01928394|560607350|FG016|Treatment Period|Death|0|||
155319879|NCT01928394|560607351|FG017|Treatment Period|Death|0|||
155319880|NCT01928394|560607352|FG018|Treatment Period|Death|0|||
155319881|NCT01928394|560607353|FG019|Treatment Period|Death|0|||
155319882|NCT01928394|560607354|FG020|Treatment Period|Death|0|||
155419900|NCT00168831|560968210|FG000|Overall Study|Adverse Event|36|||
155752046|NCT03291067|562191915|FG001|Overall Study|Physician Decision|0|||
155752047|NCT03291067|562191916|FG002|Overall Study|Physician Decision|1|||
155752048|NCT03291067|562191917|FG003|Overall Study|Physician Decision|0|||
155752049|NCT03291067|562191914|FG000|Overall Study|Protocol Violation|5|||
155752050|NCT03291067|562191915|FG001|Overall Study|Protocol Violation|3|||
155752051|NCT03291067|562191916|FG002|Overall Study|Protocol Violation|4|||
155752052|NCT03291067|562191917|FG003|Overall Study|Protocol Violation|2|||
155752053|NCT03291067|562191914|FG000|Overall Study|Withdrawal by Subject|3|||
155752054|NCT03291067|562191915|FG001|Overall Study|Withdrawal by Subject|4|||
155752055|NCT03291067|562191916|FG002|Overall Study|Withdrawal by Subject|7|||
155752056|NCT03291067|562191917|FG003|Overall Study|Withdrawal by Subject|5|||
155752057|NCT03291067|562191914|FG000|Overall Study|Other|0|||
155752058|NCT03291067|562191915|FG001|Overall Study|Other|4|||
155752059|NCT03291067|562191916|FG002|Overall Study|Other|4|||
155752060|NCT03291067|562191917|FG003|Overall Study|Other|6|||
155752061|NCT04369053|562191919|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
155752062|NCT04369053|562191919|FG000|Overall Study|Withdrawal by Subject|773|||
155752063|NCT04369053|562191919|FG000|Overall Study|Lost to Follow-up|182|||
155752064|NCT04369053|562191919|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
155752065|NCT01695005|562191924|FG000|Overall Study|Lost to Follow-up|0|||
155752066|NCT01695005|562191925|FG001|Overall Study|Lost to Follow-up|1|||
155752067|NCT01695005|562191926|FG002|Overall Study|Lost to Follow-up|1|||
155752068|NCT01695005|562191927|FG003|Overall Study|Lost to Follow-up|0|||
155752069|NCT01695005|562191928|FG004|Overall Study|Lost to Follow-up|0|||
155752070|NCT01695005|562191929|FG005|Overall Study|Lost to Follow-up|1|||
155752071|NCT01695005|562191930|FG006|Overall Study|Lost to Follow-up|1|||
155752072|NCT01695005|562191931|FG007|Overall Study|Lost to Follow-up|1|||
155752073|NCT01695005|562191932|FG008|Overall Study|Lost to Follow-up|3|||
155752074|NCT01695005|562191933|FG009|Overall Study|Lost to Follow-up|3|||
155752075|NCT01695005|562191934|FG010|Overall Study|Lost to Follow-up|8|||
155752076|NCT01695005|562191935|FG011|Overall Study|Lost to Follow-up|5|||
155752077|NCT01695005|562191936|FG012|Overall Study|Lost to Follow-up|2|||
155752078|NCT01695005|562191937|FG013|Overall Study|Lost to Follow-up|5|||
155752079|NCT01695005|562191938|FG014|Overall Study|Lost to Follow-up|0|||
155752080|NCT01695005|562191939|FG015|Overall Study|Lost to Follow-up|4|||
155752081|NCT01695005|562191940|FG016|Overall Study|Lost to Follow-up|0|||
155752082|NCT01695005|562191941|FG017|Overall Study|Lost to Follow-up|0|||
155752083|NCT01695005|562191942|FG018|Overall Study|Lost to Follow-up|0|||
155752084|NCT01695005|562191943|FG019|Overall Study|Lost to Follow-up|1|||
155752085|NCT01695005|562191944|FG020|Overall Study|Lost to Follow-up|1|||
155752086|NCT01695005|562191945|FG021|Overall Study|Lost to Follow-up|0|||
155752087|NCT01695005|562191946|FG022|Overall Study|Lost to Follow-up|2|||
155752088|NCT01695005|562191947|FG023|Overall Study|Lost to Follow-up|4|||
155752089|NCT01695005|562191948|FG024|Overall Study|Lost to Follow-up|2|||
155752090|NCT01695005|562191949|FG025|Overall Study|Lost to Follow-up|0|||
155752091|NCT01695005|562191950|FG026|Overall Study|Lost to Follow-up|0|||
155752092|NCT01695005|562191951|FG027|Overall Study|Lost to Follow-up|0|||
155752093|NCT01695005|562191952|FG028|Overall Study|Lost to Follow-up|1|||
155752094|NCT01695005|562191924|FG000|Overall Study|Withdrawal by Subject|0|||
155752095|NCT01695005|562191925|FG001|Overall Study|Withdrawal by Subject|0|||
155752096|NCT01695005|562191926|FG002|Overall Study|Withdrawal by Subject|0|||
155752097|NCT01695005|562191927|FG003|Overall Study|Withdrawal by Subject|2|||
155752098|NCT01695005|562191928|FG004|Overall Study|Withdrawal by Subject|0|||
155752099|NCT01695005|562191929|FG005|Overall Study|Withdrawal by Subject|1|||
155752100|NCT01695005|562191930|FG006|Overall Study|Withdrawal by Subject|0|||
155752101|NCT01695005|562191931|FG007|Overall Study|Withdrawal by Subject|1|||
155752102|NCT01695005|562191932|FG008|Overall Study|Withdrawal by Subject|0|||
155752103|NCT01695005|562191933|FG009|Overall Study|Withdrawal by Subject|1|||
155752104|NCT01695005|562191934|FG010|Overall Study|Withdrawal by Subject|2|||
155752105|NCT01695005|562191935|FG011|Overall Study|Withdrawal by Subject|1|||
155752106|NCT01695005|562191936|FG012|Overall Study|Withdrawal by Subject|1|||
155752107|NCT01695005|562191937|FG013|Overall Study|Withdrawal by Subject|0|||
155752108|NCT01695005|562191938|FG014|Overall Study|Withdrawal by Subject|0|||
155752109|NCT01695005|562191939|FG015|Overall Study|Withdrawal by Subject|0|||
155752110|NCT01695005|562191940|FG016|Overall Study|Withdrawal by Subject|0|||
155752111|NCT01695005|562191941|FG017|Overall Study|Withdrawal by Subject|0|||
155752112|NCT01695005|562191942|FG018|Overall Study|Withdrawal by Subject|2|||
155752113|NCT01695005|562191943|FG019|Overall Study|Withdrawal by Subject|0|||
155752114|NCT01695005|562191944|FG020|Overall Study|Withdrawal by Subject|1|||
155752115|NCT01695005|562191945|FG021|Overall Study|Withdrawal by Subject|0|||
155752116|NCT01695005|562191946|FG022|Overall Study|Withdrawal by Subject|0|||
155752117|NCT01695005|562191947|FG023|Overall Study|Withdrawal by Subject|0|||
155752118|NCT01695005|562191948|FG024|Overall Study|Withdrawal by Subject|1|||
155752119|NCT01695005|562191949|FG025|Overall Study|Withdrawal by Subject|0|||
155752120|NCT01695005|562191950|FG026|Overall Study|Withdrawal by Subject|0|||
155752121|NCT01695005|562191951|FG027|Overall Study|Withdrawal by Subject|1|||
155752122|NCT01695005|562191952|FG028|Overall Study|Withdrawal by Subject|0|||
155752123|NCT00255346|562191955|FG000|Overall Study|Adverse Event|1|||
155752124|NCT00255346|562191956|FG001|Overall Study|Adverse Event|0|||
155752125|NCT00255346|562191957|FG002|Overall Study|Adverse Event|0|||
155752126|NCT00255346|562191958|FG003|Overall Study|Adverse Event|0|||
155752127|NCT00255346|562191959|FG004|Overall Study|Adverse Event|0|||
155752128|NCT04402489|562191965|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155752129|NCT04402489|562191966|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
155752130|NCT04402489|562191967|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155752131|NCT04402489|562191968|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155752132|NCT04402489|562191969|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155752133|NCT04402489|562191965|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
155752134|NCT04402489|562191966|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155752135|NCT04402489|562191967|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155752136|NCT04402489|562191968|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155752137|NCT04402489|562191969|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155752138|NCT04402489|562191965|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
155752139|NCT04402489|562191966|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
155752140|NCT04402489|562191967|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
155752141|NCT04402489|562191968|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
155752142|NCT04402489|562191969|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
155752143|NCT04402489|562191965|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155752144|NCT04402489|562191966|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155752145|NCT04402489|562191967|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
155752146|NCT04402489|562191968|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155752147|NCT04402489|562191969|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155752148|NCT04402489|562191965|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155752149|NCT04402489|562191966|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155752150|NCT04402489|562191967|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155752151|NCT04402489|562191968|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
155752152|NCT04402489|562191969|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155752153|NCT04402489|562191965|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155752154|NCT04402489|562191966|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
155752155|NCT04402489|562191967|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
155752156|NCT04402489|562191968|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155752157|NCT04402489|562191969|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155752158|NCT03192891|562191970|FG000|Overall Study|Lost to Follow-up|55|||
155752159|NCT05223868|562191971|FG000|Overall Study|Lost to Follow-up|1|||
155752160|NCT05223868|562191972|FG001|Overall Study|Lost to Follow-up|3|||
155752161|NCT05223868|562191973|FG002|Overall Study|Lost to Follow-up|0|||
155752162|NCT05223868|562191974|FG003|Overall Study|Lost to Follow-up|0|||
155752163|NCT05223868|562191975|FG004|Overall Study|Lost to Follow-up|0|||
155752164|NCT05223868|562191976|FG005|Overall Study|Lost to Follow-up|1|||
155752165|NCT05223868|562191971|FG000|Overall Study|Withdrawal by Subject|6|||
155752166|NCT05223868|562191972|FG001|Overall Study|Withdrawal by Subject|2|||
155752167|NCT05223868|562191973|FG002|Overall Study|Withdrawal by Subject|3|||
155752168|NCT05223868|562191974|FG003|Overall Study|Withdrawal by Subject|1|||
155752169|NCT05223868|562191975|FG004|Overall Study|Withdrawal by Subject|1|||
155752170|NCT05223868|562191976|FG005|Overall Study|Withdrawal by Subject|2|||
155752171|NCT05223868|562191971|FG000|Overall Study|Other|0|||
155752172|NCT05223868|562191972|FG001|Overall Study|Other|2|||
155752173|NCT05223868|562191973|FG002|Overall Study|Other|0|||
155752174|NCT05223868|562191974|FG003|Overall Study|Other|0|||
155752175|NCT05223868|562191975|FG004|Overall Study|Other|1|||
155752176|NCT05223868|562191976|FG005|Overall Study|Other|1|||
155752177|NCT03760731|562191977|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
155752178|NCT03760731|562191978|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
155501062|NCT00965263|561260764|FG000|Overall Study|Protocol Violation|0|||
155752179|NCT03760731|562191977|FG000|Treatment|Attended less than 70% of sessions|10|||
155752180|NCT03760731|562191978|FG001|Treatment|Attended less than 70% of sessions|15|||
155752181|NCT01970358|562191979|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
155752182|NCT01970358|562191979|FG000|Overall Study|Ineligible at time of second consent|4|||
155752183|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
155319883|NCT01928394|560607355|FG021|Treatment Period|Death|0|||
155319884|NCT01928394|560607356|FG022|Treatment Period|Death|0|||
155319885|NCT01928394|560607334|FG000|Follow-up Period|Participant withdrew consent|3|||
155319886|NCT01928394|560607335|FG001|Follow-up Period|Participant withdrew consent|0|||
155319887|NCT01928394|560607336|FG002|Follow-up Period|Participant withdrew consent|1|||
155319888|NCT01928394|560607337|FG003|Follow-up Period|Participant withdrew consent|4|||
155319889|NCT01928394|560607338|FG004|Follow-up Period|Participant withdrew consent|0|||
155319890|NCT01928394|560607339|FG005|Follow-up Period|Participant withdrew consent|2|||
155319891|NCT01928394|560607340|FG006|Follow-up Period|Participant withdrew consent|5|||
155319892|NCT01928394|560607341|FG007|Follow-up Period|Participant withdrew consent|1|||
155319893|NCT01928394|560607342|FG008|Follow-up Period|Participant withdrew consent|0|||
155319894|NCT01928394|560607343|FG009|Follow-up Period|Participant withdrew consent|0|||
155319895|NCT01928394|560607344|FG010|Follow-up Period|Participant withdrew consent|5|||
155501063|NCT00965263|561260765|FG001|Overall Study|Protocol Violation|2|||
155501064|NCT02756078|561260766|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
155501065|NCT02756078|561260767|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
155501066|NCT02756078|561260766|FG000|Period 1|Lost to Follow-up|0|||
155501067|NCT02756078|561260767|FG001|Period 1|Lost to Follow-up|2|||
155501068|NCT02756078|561260766|FG000|Period 1|Protocol Violation|0|||
155501069|NCT02756078|561260767|FG001|Period 1|Protocol Violation|1|||
155501070|NCT02756078|561260766|FG000|Period 1|Adverse Event|1|||
155501071|NCT02756078|561260767|FG001|Period 1|Adverse Event|10|||
155501072|NCT02756078|561260766|FG000|Period 1|Withdrawal by Subject|6|||
155501073|NCT02756078|561260767|FG001|Period 1|Withdrawal by Subject|6|||
155501074|NCT02756078|561260766|FG000|Period 1|Lens Discomfort|2|||
155501075|NCT02756078|561260767|FG001|Period 1|Lens Discomfort|2|||
155501076|NCT02756078|561260766|FG000|Period 2|Adverse Event|3|||
155501077|NCT02756078|561260767|FG001|Period 2|Adverse Event|5|||
155501078|NCT02756078|561260766|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
155501079|NCT02756078|561260767|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
155501080|NCT02756078|561260766|FG000|Period 2|Withdrawal by Subject|3|||
155501081|NCT02756078|561260767|FG001|Period 2|Withdrawal by Subject|1|||
155501082|NCT01783483|561260768|FG000|Overall Study|Death|3|||
155501083|NCT01783483|561260769|FG001|Overall Study|Death|3|||
155501084|NCT01783483|561260768|FG000|Overall Study|Lost to Follow-up|14|||
155501085|NCT01783483|561260769|FG001|Overall Study|Lost to Follow-up|10|||
155501086|NCT01783483|561260768|FG000|Overall Study|Withdrawal by Subject|2|||
155501087|NCT01783483|561260769|FG001|Overall Study|Withdrawal by Subject|1|||
155501088|NCT01783483|561260768|FG000|Overall Study|Physician Decision|1|||
155501089|NCT01783483|561260769|FG001|Overall Study|Physician Decision|1|||
155501090|NCT01591499|561260772|FG000|Baseline Visit|Withdrawal by Subject|0|||
155501091|NCT01591499|561260773|FG001|Baseline Visit|Withdrawal by Subject|2|||
155501092|NCT01591499|561260774|FG002|Baseline Visit|Withdrawal by Subject|0|||
155501093|NCT01591499|561260775|FG003|Baseline Visit|Withdrawal by Subject|2|||
155501094|NCT01591499|561260772|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
155501095|NCT01591499|561260773|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
155501096|NCT01591499|561260774|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
155501097|NCT01591499|561260775|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
155501098|NCT01591499|561260772|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
155501099|NCT01591499|561260773|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
155501100|NCT01591499|561260774|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
155501101|NCT01591499|561260775|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
155501102|NCT00530088|561260776|FG000|Overall Study|Disease Progression|4|||
155501103|NCT00530088|561260776|FG000|Overall Study|Physician Decision|4|||
155501104|NCT00530088|561260776|FG000|Overall Study|Other Not Specified|2|||
155501105|NCT02058368|561260778|FG000|Overall Study|Adverse Event|15|||
155501106|NCT02058368|561260779|FG001|Overall Study|Adverse Event|20|||
155501107|NCT02058368|561260778|FG000|Overall Study|Lack of Efficacy|0|||
155501108|NCT02058368|561260779|FG001|Overall Study|Lack of Efficacy|1|||
155501109|NCT02058368|561260778|FG000|Overall Study|Protocol Violation|0|||
155501110|NCT02058368|561260779|FG001|Overall Study|Protocol Violation|4|||
155501111|NCT02058368|561260778|FG000|Overall Study|Lost to Follow-up|2|||
155501112|NCT02058368|561260779|FG001|Overall Study|Lost to Follow-up|0|||
155752184|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
155752185|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
155752186|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
155752187|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
155752188|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
155752189|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
155752190|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
155752191|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
155752192|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
155752193|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
155752194|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
155752195|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
155501113|NCT02058368|561260778|FG000|Overall Study|Physician Decision|2|||
155501114|NCT02058368|561260779|FG001|Overall Study|Physician Decision|3|||
155501115|NCT02058368|561260778|FG000|Overall Study|Withdrawal by Subject|22|||
155501116|NCT02058368|561260779|FG001|Overall Study|Withdrawal by Subject|26|||
155501117|NCT05899218|561260780|FG000|Overall Study|Lost to Follow-up|2|||
155501118|NCT05899218|561260781|FG001|Overall Study|Lost to Follow-up|2|||
155501119|NCT05899218|561260780|FG000|Overall Study|deemed ineligible out of country|1|||
155501120|NCT05899218|561260781|FG001|Overall Study|deemed ineligible out of country|0|||
155501121|NCT02587325|561260782|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
155501122|NCT02587325|561260783|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
155501123|NCT02587325|561260784|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
155501124|NCT02587325|561260785|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
155501125|NCT02587325|561260786|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
155752196|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
155752197|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
155752198|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
155752199|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
155752200|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
155752201|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
155752202|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
155752203|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
155752204|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
155752205|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
155752206|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
155752207|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
155752208|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
155752209|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
155752210|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
155752211|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
155752212|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
155752213|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
155752214|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
155752215|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
155752216|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
155752217|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
155752218|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
155752219|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
155752220|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
155752221|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
155752222|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
155752223|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
155752224|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
155752225|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
155752226|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
155752227|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
155752228|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
155752229|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
155752230|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
155752231|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
155752232|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
155752233|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
155319896|NCT01928394|560607345|FG011|Follow-up Period|Participant withdrew consent|8|||
155319897|NCT01928394|560607346|FG012|Follow-up Period|Participant withdrew consent|2|||
155319898|NCT01928394|560607347|FG013|Follow-up Period|Participant withdrew consent|12|||
155319899|NCT01928394|560607348|FG014|Follow-up Period|Participant withdrew consent|7|||
155319900|NCT01928394|560607349|FG015|Follow-up Period|Participant withdrew consent|0|||
155319901|NCT01928394|560607350|FG016|Follow-up Period|Participant withdrew consent|5|||
155319902|NCT01928394|560607351|FG017|Follow-up Period|Participant withdrew consent|3|||
155319903|NCT01928394|560607352|FG018|Follow-up Period|Participant withdrew consent|2|||
155319904|NCT01928394|560607353|FG019|Follow-up Period|Participant withdrew consent|7|||
155319905|NCT01928394|560607354|FG020|Follow-up Period|Participant withdrew consent|4|||
155319906|NCT01928394|560607355|FG021|Follow-up Period|Participant withdrew consent|6|||
155319907|NCT01928394|560607356|FG022|Follow-up Period|Participant withdrew consent|2|||
155319908|NCT01928394|560607334|FG000|Follow-up Period|Death|0|||
155319909|NCT01928394|560607335|FG001|Follow-up Period|Death|0|||
155319910|NCT01928394|560607336|FG002|Follow-up Period|Death|2|||
155319911|NCT01928394|560607337|FG003|Follow-up Period|Death|6|||
155419901|NCT00168831|560968211|FG001|Overall Study|Adverse Event|47|||
155419902|NCT00168831|560968212|FG002|Overall Study|Adverse Event|74|||
155419903|NCT00168831|560968210|FG000|Overall Study|Lost to Follow-up|5|||
155419904|NCT00168831|560968211|FG001|Overall Study|Lost to Follow-up|6|||
155419905|NCT00168831|560968212|FG002|Overall Study|Lost to Follow-up|4|||
155419906|NCT00168831|560968210|FG000|Overall Study|Withdrawal by Subject|7|||
155319912|NCT01928394|560607338|FG004|Follow-up Period|Death|0|||
155319913|NCT01928394|560607339|FG005|Follow-up Period|Death|6|||
155319914|NCT01928394|560607340|FG006|Follow-up Period|Death|6|||
155319915|NCT01928394|560607341|FG007|Follow-up Period|Death|2|||
155319916|NCT01928394|560607342|FG008|Follow-up Period|Death|1|||
155319917|NCT01928394|560607343|FG009|Follow-up Period|Death|2|||
155319918|NCT01928394|560607344|FG010|Follow-up Period|Death|4|||
155319919|NCT01928394|560607345|FG011|Follow-up Period|Death|12|||
155319920|NCT01928394|560607346|FG012|Follow-up Period|Death|11|||
155319921|NCT01928394|560607347|FG013|Follow-up Period|Death|25|||
155319922|NCT01928394|560607348|FG014|Follow-up Period|Death|18|||
155319923|NCT01928394|560607349|FG015|Follow-up Period|Death|0|||
155319924|NCT01928394|560607350|FG016|Follow-up Period|Death|6|||
155319925|NCT01928394|560607351|FG017|Follow-up Period|Death|5|||
155319926|NCT01928394|560607352|FG018|Follow-up Period|Death|13|||
155319927|NCT01928394|560607353|FG019|Follow-up Period|Death|13|||
155319928|NCT01928394|560607354|FG020|Follow-up Period|Death|5|||
155319929|NCT01928394|560607355|FG021|Follow-up Period|Death|3|||
155319930|NCT01928394|560607356|FG022|Follow-up Period|Death|2|||
155752234|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
155752235|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
155752236|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
155752237|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
155752238|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
155752239|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
155752240|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
155752241|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
155752242|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
155752243|NCT03395197|562191980|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
155752244|NCT03395197|562191981|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
155752245|NCT03395197|562191982|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
155752246|NCT03395197|562191983|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
155752247|NCT03395197|562191984|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
155752248|NCT03395197|562191985|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
155752249|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Death|0|||
155752250|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Death|0|||
155319931|NCT01928394|560607334|FG000|Follow-up Period|other reason|0|||
155319932|NCT01928394|560607335|FG001|Follow-up Period|other reason|0|||
155319933|NCT01928394|560607336|FG002|Follow-up Period|other reason|0|||
155419907|NCT00168831|560968211|FG001|Overall Study|Withdrawal by Subject|14|||
155319934|NCT01928394|560607337|FG003|Follow-up Period|other reason|0|||
155419908|NCT00168831|560968212|FG002|Overall Study|Withdrawal by Subject|19|||
155419909|NCT00168831|560968210|FG000|Overall Study|Protocol Violation|6|||
155419910|NCT00168831|560968211|FG001|Overall Study|Protocol Violation|11|||
155419911|NCT00168831|560968212|FG002|Overall Study|Protocol Violation|11|||
155419912|NCT00168831|560968210|FG000|Overall Study|Other|6|||
155419913|NCT00168831|560968211|FG001|Overall Study|Other|3|||
155419914|NCT00168831|560968212|FG002|Overall Study|Other|6|||
155419915|NCT00059202|560968213|FG000|Overall Study|Withdrawal by Subject|5|||
155419916|NCT00059202|560968214|FG001|Overall Study|Withdrawal by Subject|9|||
155419917|NCT00059202|560968213|FG000|Overall Study|Protocol Violation|1|||
155419918|NCT00059202|560968214|FG001|Overall Study|Protocol Violation|3|||
155419919|NCT00059202|560968213|FG000|Overall Study|drug toxicity|0|||
155419920|NCT00059202|560968214|FG001|Overall Study|drug toxicity|3|||
155501126|NCT02587325|561260782|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
155501127|NCT02587325|561260783|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
155501128|NCT02587325|561260784|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
155501129|NCT02587325|561260785|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
155501130|NCT02587325|561260786|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
155501131|NCT02587325|561260782|FG000|32-Week Optional Extension Part|Adverse Event|0|||
155501132|NCT02587325|561260783|FG001|32-Week Optional Extension Part|Adverse Event|0|||
155501133|NCT02587325|561260784|FG002|32-Week Optional Extension Part|Adverse Event|1|||
155501134|NCT02587325|561260785|FG003|32-Week Optional Extension Part|Adverse Event|0|||
155501135|NCT02587325|561260786|FG004|32-Week Optional Extension Part|Adverse Event|0|||
155501136|NCT02587325|561260782|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
155501137|NCT02587325|561260783|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
155501138|NCT02587325|561260784|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
155752251|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Death|0|||
155419921|NCT00648167|560968215|FG000|Overall Study|Adverse Event|6|||
155501139|NCT02587325|561260785|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
155319935|NCT01928394|560607338|FG004|Follow-up Period|other reason|0|||
155419922|NCT00648167|560968215|FG000|Overall Study|unable to swallow tablets|1|||
155419923|NCT00927368|560968216|FG000|Overall Study|enrollment in another study|1|||
155319936|NCT01928394|560607339|FG005|Follow-up Period|other reason|0|||
155319937|NCT01928394|560607340|FG006|Follow-up Period|other reason|1|||
155319938|NCT01928394|560607341|FG007|Follow-up Period|other reason|3|||
155319939|NCT01928394|560607342|FG008|Follow-up Period|other reason|0|||
155319940|NCT01928394|560607343|FG009|Follow-up Period|other reason|0|||
155319941|NCT01928394|560607344|FG010|Follow-up Period|other reason|2|||
155419924|NCT00927368|560968217|FG001|Overall Study|enrollment in another study|1|||
155419925|NCT00927368|560968218|FG002|Overall Study|enrollment in another study|2|||
155419926|NCT00927368|560968216|FG000|Overall Study|Lost to Follow-up|4|||
155419927|NCT00927368|560968217|FG001|Overall Study|Lost to Follow-up|0|||
155419928|NCT00927368|560968218|FG002|Overall Study|Lost to Follow-up|0|||
155419929|NCT00927368|560968216|FG000|Overall Study|equipment failure|1|||
155419930|NCT00927368|560968217|FG001|Overall Study|equipment failure|0|||
155419931|NCT00927368|560968218|FG002|Overall Study|equipment failure|0|||
155419932|NCT00927368|560968216|FG000|Overall Study|ineligible post randomization|0|||
155419933|NCT00927368|560968217|FG001|Overall Study|ineligible post randomization|3|||
155419934|NCT00927368|560968218|FG002|Overall Study|ineligible post randomization|1|||
155419935|NCT00927368|560968216|FG000|Overall Study|cancellation of surgery|0|||
155419936|NCT00927368|560968217|FG001|Overall Study|cancellation of surgery|1|||
155419937|NCT00927368|560968218|FG002|Overall Study|cancellation of surgery|2|||
155419938|NCT01482910|560968222|FG000|Overall Study|Adverse Event|6|||
155419939|NCT01482910|560968223|FG001|Overall Study|Adverse Event|5|||
155419940|NCT01482910|560968222|FG000|Overall Study|Lost to Follow-up|0|||
155419941|NCT01482910|560968223|FG001|Overall Study|Lost to Follow-up|1|||
155419942|NCT01482910|560968222|FG000|Overall Study|Protocol Violation|1|||
155419943|NCT01482910|560968223|FG001|Overall Study|Protocol Violation|1|||
155643913|NCT05887908|561785217|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
155643914|NCT05887908|561785218|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
155643915|NCT05887908|561785219|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
155643916|NCT05887908|561785217|FG000|Overall Study|Pregnancy|0|||
155643917|NCT05887908|561785218|FG001|Overall Study|Pregnancy|1|||
155643918|NCT05887908|561785219|FG002|Overall Study|Pregnancy|0|||
155643919|NCT05887908|561785217|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
155643920|NCT05887908|561785218|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
155643921|NCT05887908|561785219|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
155643922|NCT05887908|561785217|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
155643923|NCT05887908|561785218|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
155643924|NCT05887908|561785219|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
155643925|NCT05887908|561785217|FG000|Overall Study|Other Reason|3|||
155643926|NCT05887908|561785218|FG001|Overall Study|Other Reason|3|||
155643927|NCT05887908|561785219|FG002|Overall Study|Other Reason|3|||
155643928|NCT03928743|561785223|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
155643929|NCT03928743|561785224|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
155643930|NCT03928743|561785225|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
155643931|NCT03928743|561785223|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
155643932|NCT03928743|561785224|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
155643933|NCT03928743|561785225|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
155643934|NCT03928743|561785223|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
155643935|NCT03928743|561785224|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
155643936|NCT03928743|561785225|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
155643937|NCT03928743|561785223|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
155643938|NCT03928743|561785224|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
155643939|NCT03928743|561785225|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
155643940|NCT03928743|561785223|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
155643941|NCT03928743|561785224|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
155643942|NCT03928743|561785225|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
155643943|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
155643944|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
155643945|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
155643946|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
155643947|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
155643948|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
155643949|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
155643950|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
155643951|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
155643952|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
155643953|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
155643954|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
155643955|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
155643956|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
155643957|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
155643958|NCT03928743|561785223|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
155643959|NCT03928743|561785224|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
155643960|NCT03928743|561785225|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
155752252|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Death|0|||
155752253|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Death|1|||
155752254|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Death|4|||
155752255|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
155752256|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
155752257|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
155752258|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
155752259|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
155752260|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
155752261|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
155752262|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
155752263|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
155752264|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
155752265|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
155752266|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
155752267|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
155752268|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
155752269|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
155752270|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
155752271|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
155752272|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
155752273|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
155752274|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
155752275|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
155752276|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
155752277|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
155752278|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
155752279|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
155752280|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
155752281|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
155752282|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
155752283|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
155752284|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
155752285|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
155752286|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
155752287|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
155752288|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
155752289|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
155752290|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
155752291|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Other|0|||
155752292|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Other|0|||
155752293|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Other|0|||
155752294|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Other|0|||
155752295|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Other|3|||
155752296|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Other|3|||
155319942|NCT01928394|560607345|FG011|Follow-up Period|other reason|1|||
155319943|NCT01928394|560607346|FG012|Follow-up Period|other reason|0|||
155319944|NCT01928394|560607347|FG013|Follow-up Period|other reason|1|||
155319945|NCT01928394|560607348|FG014|Follow-up Period|other reason|4|||
155319946|NCT01928394|560607349|FG015|Follow-up Period|other reason|0|||
155319947|NCT01928394|560607350|FG016|Follow-up Period|other reason|2|||
155319948|NCT01928394|560607351|FG017|Follow-up Period|other reason|0|||
155319949|NCT01928394|560607352|FG018|Follow-up Period|other reason|1|||
155319950|NCT01928394|560607353|FG019|Follow-up Period|other reason|1|||
155319951|NCT01928394|560607354|FG020|Follow-up Period|other reason|0|||
155319952|NCT01928394|560607355|FG021|Follow-up Period|other reason|0|||
155319953|NCT01928394|560607356|FG022|Follow-up Period|other reason|1|||
155319954|NCT01928394|560607334|FG000|Follow-up Period|Lost to Follow-up|0|||
155319955|NCT01928394|560607335|FG001|Follow-up Period|Lost to Follow-up|0|||
155319956|NCT01928394|560607336|FG002|Follow-up Period|Lost to Follow-up|0|||
155319957|NCT01928394|560607337|FG003|Follow-up Period|Lost to Follow-up|0|||
155319958|NCT01928394|560607338|FG004|Follow-up Period|Lost to Follow-up|0|||
155319959|NCT01928394|560607339|FG005|Follow-up Period|Lost to Follow-up|0|||
155319960|NCT01928394|560607340|FG006|Follow-up Period|Lost to Follow-up|0|||
155319961|NCT01928394|560607341|FG007|Follow-up Period|Lost to Follow-up|0|||
155319962|NCT01928394|560607342|FG008|Follow-up Period|Lost to Follow-up|0|||
155319963|NCT01928394|560607343|FG009|Follow-up Period|Lost to Follow-up|0|||
155319964|NCT01928394|560607344|FG010|Follow-up Period|Lost to Follow-up|0|||
155319965|NCT01928394|560607345|FG011|Follow-up Period|Lost to Follow-up|1|||
155319966|NCT01928394|560607346|FG012|Follow-up Period|Lost to Follow-up|1|||
155319967|NCT01928394|560607347|FG013|Follow-up Period|Lost to Follow-up|0|||
155319968|NCT01928394|560607348|FG014|Follow-up Period|Lost to Follow-up|1|||
155319969|NCT01928394|560607349|FG015|Follow-up Period|Lost to Follow-up|0|||
155319970|NCT01928394|560607350|FG016|Follow-up Period|Lost to Follow-up|1|||
155319971|NCT01928394|560607351|FG017|Follow-up Period|Lost to Follow-up|0|||
155319972|NCT01928394|560607352|FG018|Follow-up Period|Lost to Follow-up|0|||
155319973|NCT01928394|560607353|FG019|Follow-up Period|Lost to Follow-up|0|||
155319974|NCT01928394|560607354|FG020|Follow-up Period|Lost to Follow-up|0|||
155752297|NCT03395197|562191980|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
155752298|NCT03395197|562191981|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
155752299|NCT03395197|562191982|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
155752300|NCT03395197|562191983|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
155752301|NCT03395197|562191984|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
155752302|NCT03395197|562191985|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
155752303|NCT03869216|562191986|FG000|Overall Study|prostate removed during the study|1|||
155752304|NCT03869216|562191987|FG001|Overall Study|prostate removed during the study|1|||
155752305|NCT03869216|562191986|FG000|Overall Study|Withdrawal by Subject|0|||
155752306|NCT03869216|562191987|FG001|Overall Study|Withdrawal by Subject|1|||
155752307|NCT03869216|562191986|FG000|Overall Study|Lost to Follow-up|3|||
155752308|NCT03869216|562191987|FG001|Overall Study|Lost to Follow-up|12|||
155752309|NCT03869216|562191986|FG000|Overall Study|Changed clinical site or moved out of city|5|||
155752310|NCT03869216|562191987|FG001|Overall Study|Changed clinical site or moved out of city|9|||
155752311|NCT03869216|562191986|FG000|Overall Study|No primary care appointment scheduled|10|||
155752312|NCT03869216|562191987|FG001|Overall Study|No primary care appointment scheduled|4|||
155752313|NCT03869216|562191986|FG000|Overall Study|Death|1|||
155752314|NCT03869216|562191987|FG001|Overall Study|Death|1|||
155752315|NCT03609944|562191988|FG000|Overall Study|Lost to Follow-up|1|||
155752316|NCT03609944|562191989|FG001|Overall Study|Lost to Follow-up|5|||
155752317|NCT03609944|562191988|FG000|Overall Study|Withdrawal by Subject|1|||
155752318|NCT03609944|562191989|FG001|Overall Study|Withdrawal by Subject|1|||
155752319|NCT05330975|562191994|FG000|Primary|Lost to Follow-up|12|||
155752320|NCT05330975|562191995|FG001|Primary|Lost to Follow-up|21|||
155752321|NCT05330975|562191996|FG002|Primary|Lost to Follow-up|38|||
155752322|NCT05330975|562191997|FG003|Primary|Lost to Follow-up|30|||
155752323|NCT05330975|562191998|FG004|Primary|Lost to Follow-up|25|||
155752324|NCT05330975|562191999|FG005|Primary|Lost to Follow-up|28|||
155752325|NCT05330975|562192000|FG006|Primary|Lost to Follow-up|0|||
155752326|NCT05330975|562191994|FG000|Primary|Withdrawal by Subject|4|||
155752327|NCT05330975|562191995|FG001|Primary|Withdrawal by Subject|11|||
155752328|NCT05330975|562191996|FG002|Primary|Withdrawal by Subject|8|||
155319975|NCT01928394|560607355|FG021|Follow-up Period|Lost to Follow-up|0|||
155319976|NCT01928394|560607356|FG022|Follow-up Period|Lost to Follow-up|1|||
155319977|NCT03209973|560607360|FG000|Overall Study|Withdrawal by Subject|7|||
155319978|NCT03209973|560607360|FG000|Overall Study|Lost to Follow-up|2|||
155319979|NCT03209973|560607360|FG000|Overall Study|Death|8|||
155752329|NCT05330975|562191997|FG003|Primary|Withdrawal by Subject|23|||
155752330|NCT05330975|562191998|FG004|Primary|Withdrawal by Subject|20|||
155752331|NCT05330975|562191999|FG005|Primary|Withdrawal by Subject|19|||
155752332|NCT05330975|562192000|FG006|Primary|Withdrawal by Subject|0|||
155752333|NCT05330975|562191994|FG000|Primary|Protocol Violation|0|||
155752334|NCT05330975|562191995|FG001|Primary|Protocol Violation|2|||
155752335|NCT05330975|562191996|FG002|Primary|Protocol Violation|0|||
155752336|NCT05330975|562191997|FG003|Primary|Protocol Violation|4|||
155752337|NCT05330975|562191998|FG004|Primary|Protocol Violation|0|||
155752338|NCT05330975|562191999|FG005|Primary|Protocol Violation|3|||
155752339|NCT05330975|562192000|FG006|Primary|Protocol Violation|0|||
155752340|NCT05330975|562191994|FG000|Primary|Death|0|||
155752341|NCT05330975|562191995|FG001|Primary|Death|3|||
155752342|NCT05330975|562191996|FG002|Primary|Death|1|||
155752343|NCT05330975|562191997|FG003|Primary|Death|1|||
155752344|NCT05330975|562191998|FG004|Primary|Death|0|||
155319980|NCT03209973|560607360|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
155319981|NCT03209973|560607360|FG000|Overall Study|Sponsor Decision|18|||
155319982|NCT03209973|560607360|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
155319983|NCT03209973|560607360|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
155752345|NCT05330975|562191999|FG005|Primary|Death|0|||
155752346|NCT05330975|562192000|FG006|Primary|Death|0|||
155752347|NCT05330975|562191994|FG000|Primary|Other Than Specified|0|||
155752348|NCT05330975|562191995|FG001|Primary|Other Than Specified|1|||
155752349|NCT05330975|562191996|FG002|Primary|Other Than Specified|2|||
155752350|NCT05330975|562191997|FG003|Primary|Other Than Specified|1|||
155752351|NCT05330975|562191998|FG004|Primary|Other Than Specified|2|||
155752352|NCT05330975|562191999|FG005|Primary|Other Than Specified|2|||
155319984|NCT02240238|560607372|FG000|Phase 1|Adverse Event|0|||
155319985|NCT02240238|560607373|FG001|Phase 1|Adverse Event|0|||
155319986|NCT02240238|560607374|FG002|Phase 1|Adverse Event|0|||
155319987|NCT02240238|560607375|FG003|Phase 1|Adverse Event|0|||
155319988|NCT02240238|560607376|FG004|Phase 1|Adverse Event|0|||
155319989|NCT02240238|560607377|FG005|Phase 1|Adverse Event|0|||
155319990|NCT02240238|560607378|FG006|Phase 1|Adverse Event|3|||
155319991|NCT02240238|560607379|FG007|Phase 1|Adverse Event|1|||
155319992|NCT02240238|560607380|FG008|Phase 1|Adverse Event|0|||
155319993|NCT02240238|560607381|FG009|Phase 1|Adverse Event|0|||
155319994|NCT02240238|560607382|FG010|Phase 1|Adverse Event|0|||
155319995|NCT02240238|560607383|FG011|Phase 1|Adverse Event|0|||
155319996|NCT02240238|560607372|FG000|Phase 1|Death|0|||
155319997|NCT02240238|560607373|FG001|Phase 1|Death|0|||
155319998|NCT02240238|560607374|FG002|Phase 1|Death|0|||
155319999|NCT02240238|560607375|FG003|Phase 1|Death|0|||
155320000|NCT02240238|560607376|FG004|Phase 1|Death|0|||
155320001|NCT02240238|560607377|FG005|Phase 1|Death|1|||
155320002|NCT02240238|560607378|FG006|Phase 1|Death|0|||
155320003|NCT02240238|560607379|FG007|Phase 1|Death|0|||
155320004|NCT02240238|560607380|FG008|Phase 1|Death|0|||
155320005|NCT02240238|560607381|FG009|Phase 1|Death|0|||
155320006|NCT02240238|560607382|FG010|Phase 1|Death|0|||
155320007|NCT02240238|560607383|FG011|Phase 1|Death|0|||
155320008|NCT02240238|560607372|FG000|Phase 1|Sponsor termination|0|||
155320009|NCT02240238|560607373|FG001|Phase 1|Sponsor termination|0|||
155320010|NCT02240238|560607374|FG002|Phase 1|Sponsor termination|0|||
155320011|NCT02240238|560607375|FG003|Phase 1|Sponsor termination|0|||
155643961|NCT06132386|561785228|FG000|Overall Study|ineligble laboratory|1|||
155643962|NCT06132386|561785229|FG001|Overall Study|ineligble laboratory|0|||
155643963|NCT06132386|561785230|FG002|Overall Study|ineligble laboratory|0|||
155643964|NCT06132386|561785231|FG003|Overall Study|ineligble laboratory|0|||
155643965|NCT06132386|561785232|FG004|Overall Study|ineligble laboratory|1|||
155643966|NCT06132386|561785233|FG005|Overall Study|ineligble laboratory|0|||
155643967|NCT06132386|561785228|FG000|Overall Study|ineligible vital signs|0|||
155643968|NCT06132386|561785229|FG001|Overall Study|ineligible vital signs|1|||
155643969|NCT06132386|561785230|FG002|Overall Study|ineligible vital signs|0|||
155643970|NCT06132386|561785231|FG003|Overall Study|ineligible vital signs|0|||
155643971|NCT06132386|561785232|FG004|Overall Study|ineligible vital signs|0|||
155643972|NCT06132386|561785233|FG005|Overall Study|ineligible vital signs|0|||
155643973|NCT03833167|561785234|FG000|Overall Study|Withdrawal by Subject|4|||
155643974|NCT03833167|561785235|FG001|Overall Study|Withdrawal by Subject|6|||
155643975|NCT03833167|561785234|FG000|Overall Study|Ongoing|186|||
155643976|NCT03833167|561785235|FG001|Overall Study|Ongoing|194|||
155643977|NCT03833167|561785234|FG000|Overall Study|Lost to Follow-up|1|||
155643978|NCT03833167|561785235|FG001|Overall Study|Lost to Follow-up|1|||
155643979|NCT03833167|561785234|FG000|Overall Study|Physician Decision|0|||
155643980|NCT03833167|561785235|FG001|Overall Study|Physician Decision|2|||
155643981|NCT03833167|561785234|FG000|Overall Study|Death|34|||
155643982|NCT03833167|561785235|FG001|Overall Study|Death|22|||
155643983|NCT03003962|561785236|FG000|Overall Study|Withdrawal by Subject|5|||
155643984|NCT03003962|561785237|FG001|Overall Study|Withdrawal by Subject|17|||
155643985|NCT03003962|561785236|FG000|Overall Study|Death|274|||
155643986|NCT03003962|561785237|FG001|Overall Study|Death|277|||
155643987|NCT03003962|561785236|FG000|Overall Study|Participants ongoing at DCO|55|||
155643988|NCT03003962|561785237|FG001|Overall Study|Participants ongoing at DCO|40|||
155643989|NCT06461455|561785238|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
155643990|NCT06461455|561785239|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
155643991|NCT06461455|561785238|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
155643992|NCT06461455|561785239|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
155643993|NCT06461455|561785238|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
155643994|NCT06461455|561785239|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
155643995|NCT06991803|561785242|FG000|Overall Study|Lost to Follow-up|0|||
155643996|NCT06991803|561785243|FG001|Overall Study|Lost to Follow-up|4|||
155643997|NCT06991803|561785244|FG002|Overall Study|Lost to Follow-up|0|||
155643998|NCT06991803|561785245|FG003|Overall Study|Lost to Follow-up|3|||
155643999|NCT06991803|561785246|FG004|Overall Study|Lost to Follow-up|2|||
155644000|NCT06991803|561785247|FG005|Overall Study|Lost to Follow-up|5|||
155644001|NCT03600350|561785597|FG000|Overall Study|Death|1|||
155644002|NCT03600350|561785597|FG000|Overall Study|On Follow Up|18|||
155320012|NCT02240238|560607376|FG004|Phase 1|Sponsor termination|0|||
155320013|NCT02240238|560607377|FG005|Phase 1|Sponsor termination|1|||
155320014|NCT02240238|560607378|FG006|Phase 1|Sponsor termination|0|||
155320015|NCT02240238|560607379|FG007|Phase 1|Sponsor termination|0|||
155320016|NCT02240238|560607380|FG008|Phase 1|Sponsor termination|0|||
155320017|NCT02240238|560607381|FG009|Phase 1|Sponsor termination|0|||
155644003|NCT02400736|561785600|FG000|Overall Study|Lost to Follow-up|6|||
155644004|NCT02400736|561785601|FG001|Overall Study|Lost to Follow-up|6|||
155644005|NCT02400736|561785600|FG000|Overall Study|Withdrawal by Subject|2|||
155644006|NCT02400736|561785601|FG001|Overall Study|Withdrawal by Subject|1|||
155320018|NCT02240238|560607382|FG010|Phase 1|Sponsor termination|0|||
155320019|NCT02240238|560607383|FG011|Phase 1|Sponsor termination|0|||
155320020|NCT02240238|560607372|FG000|Phase 1|Withdrawal by Subject|0|||
155320021|NCT02240238|560607373|FG001|Phase 1|Withdrawal by Subject|0|||
155320022|NCT02240238|560607374|FG002|Phase 1|Withdrawal by Subject|0|||
155320023|NCT02240238|560607375|FG003|Phase 1|Withdrawal by Subject|0|||
155320024|NCT02240238|560607376|FG004|Phase 1|Withdrawal by Subject|0|||
155320025|NCT02240238|560607377|FG005|Phase 1|Withdrawal by Subject|2|||
155320026|NCT02240238|560607378|FG006|Phase 1|Withdrawal by Subject|0|||
155320027|NCT02240238|560607379|FG007|Phase 1|Withdrawal by Subject|0|||
155320028|NCT02240238|560607380|FG008|Phase 1|Withdrawal by Subject|0|||
155320029|NCT02240238|560607381|FG009|Phase 1|Withdrawal by Subject|0|||
155320030|NCT02240238|560607382|FG010|Phase 1|Withdrawal by Subject|0|||
155320031|NCT02240238|560607383|FG011|Phase 1|Withdrawal by Subject|0|||
155320032|NCT02240238|560607372|FG000|Phase 1|Physician Decision|0|||
155320033|NCT02240238|560607373|FG001|Phase 1|Physician Decision|0|||
155320034|NCT02240238|560607374|FG002|Phase 1|Physician Decision|0|||
155320035|NCT02240238|560607375|FG003|Phase 1|Physician Decision|0|||
155320036|NCT02240238|560607376|FG004|Phase 1|Physician Decision|0|||
155320037|NCT02240238|560607377|FG005|Phase 1|Physician Decision|2|||
155320038|NCT02240238|560607378|FG006|Phase 1|Physician Decision|0|||
155320039|NCT02240238|560607379|FG007|Phase 1|Physician Decision|0|||
155320040|NCT02240238|560607380|FG008|Phase 1|Physician Decision|0|||
155320041|NCT02240238|560607381|FG009|Phase 1|Physician Decision|0|||
155320042|NCT02240238|560607382|FG010|Phase 1|Physician Decision|0|||
155752353|NCT05330975|562192000|FG006|Primary|Other Than Specified|0|||
155752354|NCT05330975|562191994|FG000|Primary|Adverse Event|0|||
155752355|NCT05330975|562191995|FG001|Primary|Adverse Event|0|||
155752356|NCT05330975|562191996|FG002|Primary|Adverse Event|0|||
155752357|NCT05330975|562191997|FG003|Primary|Adverse Event|1|||
155752358|NCT05330975|562191998|FG004|Primary|Adverse Event|0|||
155752359|NCT05330975|562191999|FG005|Primary|Adverse Event|0|||
155752360|NCT05330975|562192000|FG006|Primary|Adverse Event|0|||
155752361|NCT05330975|562191994|FG000|Primary|Physician Decision|0|||
155752362|NCT05330975|562191995|FG001|Primary|Physician Decision|0|||
155752363|NCT05330975|562191996|FG002|Primary|Physician Decision|0|||
155752364|NCT05330975|562191997|FG003|Primary|Physician Decision|0|||
155752365|NCT05330975|562191998|FG004|Primary|Physician Decision|1|||
155752366|NCT05330975|562191999|FG005|Primary|Physician Decision|0|||
155752367|NCT05330975|562192000|FG006|Primary|Physician Decision|0|||
155752368|NCT05330975|562191994|FG000|Revaccination|Adverse Event|0|||
155752369|NCT05330975|562191995|FG001|Revaccination|Adverse Event|0|||
155752370|NCT05330975|562191996|FG002|Revaccination|Adverse Event|0|||
155752371|NCT05330975|562191997|FG003|Revaccination|Adverse Event|0|||
155752372|NCT05330975|562191998|FG004|Revaccination|Adverse Event|0|||
155752373|NCT05330975|562191999|FG005|Revaccination|Adverse Event|0|||
155752374|NCT05330975|562192000|FG006|Revaccination|Adverse Event|3|||
155752375|NCT05330975|562191994|FG000|Revaccination|Lost to Follow-up|0|||
155752376|NCT05330975|562191995|FG001|Revaccination|Lost to Follow-up|0|||
155752377|NCT05330975|562191996|FG002|Revaccination|Lost to Follow-up|0|||
155752378|NCT05330975|562191997|FG003|Revaccination|Lost to Follow-up|0|||
155752379|NCT05330975|562191998|FG004|Revaccination|Lost to Follow-up|0|||
155752380|NCT05330975|562191999|FG005|Revaccination|Lost to Follow-up|0|||
155752381|NCT05330975|562192000|FG006|Revaccination|Lost to Follow-up|10|||
155752382|NCT05330975|562191994|FG000|Revaccination|Withdrawal by Subject|0|||
155752383|NCT05330975|562191995|FG001|Revaccination|Withdrawal by Subject|0|||
155752384|NCT05330975|562191996|FG002|Revaccination|Withdrawal by Subject|0|||
155752385|NCT05330975|562191997|FG003|Revaccination|Withdrawal by Subject|0|||
155752386|NCT05330975|562191998|FG004|Revaccination|Withdrawal by Subject|0|||
155752387|NCT05330975|562191999|FG005|Revaccination|Withdrawal by Subject|0|||
155752388|NCT05330975|562192000|FG006|Revaccination|Withdrawal by Subject|2|||
155752389|NCT05330975|562191994|FG000|Revaccination|Death|0|||
155752390|NCT05330975|562191995|FG001|Revaccination|Death|0|||
155752391|NCT05330975|562191996|FG002|Revaccination|Death|0|||
155752392|NCT05330975|562191997|FG003|Revaccination|Death|0|||
155752393|NCT05330975|562191998|FG004|Revaccination|Death|0|||
155320043|NCT02240238|560607383|FG011|Phase 1|Physician Decision|0|||
155752394|NCT05330975|562191999|FG005|Revaccination|Death|0|||
155752395|NCT05330975|562192000|FG006|Revaccination|Death|3|||
155320044|NCT02240238|560607372|FG000|Phase 2|Adverse Event|0|||
155320045|NCT02240238|560607373|FG001|Phase 2|Adverse Event|0|||
155320046|NCT02240238|560607374|FG002|Phase 2|Adverse Event|0|||
155320047|NCT02240238|560607375|FG003|Phase 2|Adverse Event|0|||
155752396|NCT04148911|562192001|FG000|Overall Study|Death|104|||
155752397|NCT04148911|562192001|FG000|Overall Study|Lost to Follow-up|5|||
155752398|NCT04148911|562192001|FG000|Overall Study|Withdrawal by Subject|17|||
155752399|NCT04148911|562192001|FG000|Overall Study|Study Ended by Sponsor|56|||
155752400|NCT05267106|562192007|FG000|Overall Study|Death|50|||
155752401|NCT05267106|562192008|FG001|Overall Study|Death|2|||
155752402|NCT05267106|562192007|FG000|Overall Study|Study terminated by Sponsor|24|||
155320048|NCT02240238|560607376|FG004|Phase 2|Adverse Event|0|||
155320049|NCT02240238|560607377|FG005|Phase 2|Adverse Event|0|||
155320050|NCT02240238|560607378|FG006|Phase 2|Adverse Event|0|||
155320051|NCT02240238|560607379|FG007|Phase 2|Adverse Event|0|||
155320052|NCT02240238|560607380|FG008|Phase 2|Adverse Event|0|||
155320053|NCT02240238|560607381|FG009|Phase 2|Adverse Event|7|||
155320054|NCT02240238|560607382|FG010|Phase 2|Adverse Event|14|||
155320055|NCT02240238|560607383|FG011|Phase 2|Adverse Event|2|||
155320056|NCT02240238|560607372|FG000|Phase 2|Death|0|||
155320057|NCT02240238|560607373|FG001|Phase 2|Death|0|||
155320058|NCT02240238|560607374|FG002|Phase 2|Death|0|||
155320059|NCT02240238|560607375|FG003|Phase 2|Death|0|||
155320060|NCT02240238|560607376|FG004|Phase 2|Death|0|||
155320061|NCT02240238|560607377|FG005|Phase 2|Death|0|||
155320062|NCT02240238|560607378|FG006|Phase 2|Death|0|||
155320063|NCT02240238|560607379|FG007|Phase 2|Death|0|||
155320064|NCT02240238|560607380|FG008|Phase 2|Death|0|||
155320065|NCT02240238|560607381|FG009|Phase 2|Death|3|||
155320066|NCT02240238|560607382|FG010|Phase 2|Death|2|||
155320067|NCT02240238|560607383|FG011|Phase 2|Death|1|||
155320068|NCT02240238|560607372|FG000|Phase 2|Disease progression|0|||
155320069|NCT02240238|560607373|FG001|Phase 2|Disease progression|0|||
155320070|NCT02240238|560607374|FG002|Phase 2|Disease progression|0|||
155320071|NCT02240238|560607375|FG003|Phase 2|Disease progression|0|||
155320072|NCT02240238|560607376|FG004|Phase 2|Disease progression|0|||
155320073|NCT02240238|560607377|FG005|Phase 2|Disease progression|0|||
155320074|NCT02240238|560607378|FG006|Phase 2|Disease progression|0|||
155320075|NCT02240238|560607379|FG007|Phase 2|Disease progression|0|||
155320076|NCT02240238|560607380|FG008|Phase 2|Disease progression|0|||
155320077|NCT02240238|560607381|FG009|Phase 2|Disease progression|5|||
155320078|NCT02240238|560607382|FG010|Phase 2|Disease progression|11|||
155320079|NCT02240238|560607383|FG011|Phase 2|Disease progression|1|||
155320080|NCT02240238|560607372|FG000|Phase 2|Withdrawal by Subject|0|||
155320081|NCT02240238|560607373|FG001|Phase 2|Withdrawal by Subject|0|||
155320082|NCT02240238|560607374|FG002|Phase 2|Withdrawal by Subject|0|||
155320083|NCT02240238|560607375|FG003|Phase 2|Withdrawal by Subject|0|||
155320084|NCT02240238|560607376|FG004|Phase 2|Withdrawal by Subject|0|||
155320085|NCT02240238|560607377|FG005|Phase 2|Withdrawal by Subject|0|||
155320086|NCT02240238|560607378|FG006|Phase 2|Withdrawal by Subject|0|||
155320087|NCT02240238|560607379|FG007|Phase 2|Withdrawal by Subject|0|||
155320088|NCT02240238|560607380|FG008|Phase 2|Withdrawal by Subject|0|||
155320089|NCT02240238|560607381|FG009|Phase 2|Withdrawal by Subject|1|||
155320090|NCT02240238|560607382|FG010|Phase 2|Withdrawal by Subject|1|||
155320091|NCT02240238|560607383|FG011|Phase 2|Withdrawal by Subject|0|||
155320092|NCT02240238|560607372|FG000|Phase 2|Physician Decision|0|||
155320093|NCT02240238|560607373|FG001|Phase 2|Physician Decision|0|||
155320094|NCT02240238|560607374|FG002|Phase 2|Physician Decision|0|||
155320095|NCT02240238|560607375|FG003|Phase 2|Physician Decision|0|||
155320096|NCT02240238|560607376|FG004|Phase 2|Physician Decision|0|||
155320097|NCT02240238|560607377|FG005|Phase 2|Physician Decision|0|||
155320098|NCT02240238|560607378|FG006|Phase 2|Physician Decision|0|||
155320099|NCT02240238|560607379|FG007|Phase 2|Physician Decision|0|||
155320100|NCT02240238|560607380|FG008|Phase 2|Physician Decision|0|||
155320101|NCT02240238|560607381|FG009|Phase 2|Physician Decision|1|||
155320102|NCT02240238|560607382|FG010|Phase 2|Physician Decision|3|||
155320103|NCT02240238|560607383|FG011|Phase 2|Physician Decision|0|||
155320104|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320105|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155419944|NCT01482910|560968222|FG000|Overall Study|Withdrawal by Subject|7|||
155419945|NCT01482910|560968223|FG001|Overall Study|Withdrawal by Subject|2|||
155419946|NCT01482910|560968222|FG000|Overall Study|Death|1|||
155419947|NCT01482910|560968223|FG001|Overall Study|Death|0|||
155419948|NCT00331409|560968224|FG000|Overall Study|Lack of Efficacy|4|||
155320106|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155419949|NCT03222349|560968225|FG000|Overall Study|Treatment B not done|5|||
155419950|NCT03222349|560968226|FG001|Overall Study|Treatment B not done|0|||
155419951|NCT03222349|560968225|FG000|Overall Study|Lost to Follow-up|1|||
155419952|NCT03222349|560968226|FG001|Overall Study|Lost to Follow-up|2|||
155514020|NCT01626859|561308229|FG002|Overall Study|Adverse Event|2|||
155320107|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320108|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320109|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320110|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320111|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320112|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320113|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
155320114|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320115|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320116|NCT02240238|560607372|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320117|NCT02240238|560607373|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320118|NCT02240238|560607374|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320119|NCT02240238|560607375|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320120|NCT02240238|560607376|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320121|NCT02240238|560607377|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320122|NCT02240238|560607378|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320123|NCT02240238|560607379|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320124|NCT02240238|560607380|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320125|NCT02240238|560607381|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
155320126|NCT02240238|560607382|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320127|NCT02240238|560607383|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320128|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320129|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320130|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320131|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320132|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320133|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320134|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320135|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320136|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320137|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320138|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
155320139|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320140|NCT02240238|560607372|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320141|NCT02240238|560607373|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155752403|NCT05267106|562192008|FG001|Overall Study|Study terminated by Sponsor|6|||
155752404|NCT05267106|562192007|FG000|Overall Study|Withdrawal by Subject|0|||
155752405|NCT05267106|562192008|FG001|Overall Study|Withdrawal by Subject|1|||
155752406|NCT04165824|562192009|FG000|Overall Study|Adverse Event|23|||
155320142|NCT02240238|560607374|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320143|NCT02240238|560607375|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320144|NCT02240238|560607376|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320145|NCT02240238|560607377|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320146|NCT02240238|560607378|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320147|NCT02240238|560607379|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320148|NCT02240238|560607380|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320149|NCT02240238|560607381|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320150|NCT02240238|560607382|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
155320151|NCT02240238|560607383|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320152|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320153|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320154|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320155|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320156|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320157|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320158|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320159|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320160|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320161|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320162|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
155320163|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155419953|NCT03222349|560968225|FG000|Overall Study|Withdrawal by Subject|1|||
155419954|NCT03222349|560968226|FG001|Overall Study|Withdrawal by Subject|0|||
155419955|NCT03222349|560968225|FG000|Overall Study|Treatment A not done|0|||
155419956|NCT03222349|560968226|FG001|Overall Study|Treatment A not done|5|||
155419957|NCT03222349|560968225|FG000|Overall Study|Study terminated by sponsor|1|||
155419958|NCT03222349|560968226|FG001|Overall Study|Study terminated by sponsor|0|||
155419959|NCT03739528|560968227|FG000|Overall Study|Not treated|8|||
155419960|NCT03739528|560968228|FG001|Overall Study|Not treated|12|||
155419961|NCT03739528|560968227|FG000|Overall Study|Treatment and study discontinued|6|||
155419962|NCT03739528|560968228|FG001|Overall Study|Treatment and study discontinued|2|||
155419963|NCT03739528|560968227|FG000|Overall Study|Treatment discontinued + study completed|1|||
155419964|NCT03739528|560968228|FG001|Overall Study|Treatment discontinued + study completed|3|||
155419965|NCT05099640|560968231|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
155419966|NCT05099640|560968232|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
155501140|NCT02587325|561260786|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
155501141|NCT00390572|561260787|FG000|Overall Study|Lost to Follow-up|8|||
155501142|NCT00390572|561260788|FG001|Overall Study|Lost to Follow-up|4|||
155501143|NCT00390572|561260787|FG000|Overall Study|health condition|0|||
155501144|NCT00390572|561260788|FG001|Overall Study|health condition|1|||
155501145|NCT02913261|561260795|FG000|Overall Study|Technical problems|0|||
155501146|NCT02913261|561260796|FG001|Overall Study|Technical problems|1|||
155501147|NCT02913261|561260795|FG000|Overall Study|Lack of Efficacy|32|||
155501148|NCT02913261|561260796|FG001|Overall Study|Lack of Efficacy|69|||
155501149|NCT02913261|561260795|FG000|Overall Study|Adverse Event|27|||
155501150|NCT02913261|561260796|FG001|Overall Study|Adverse Event|5|||
155501151|NCT02913261|561260795|FG000|Overall Study|Death|25|||
155501152|NCT02913261|561260796|FG001|Overall Study|Death|22|||
155501153|NCT02913261|561260795|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
155752407|NCT04165824|562192009|FG000|Overall Study|Physician Decision|1|||
155752408|NCT04165824|562192009|FG000|Overall Study|Withdrawal by Subject|17|||
155752409|NCT04165824|562192009|FG000|Overall Study|Other|5|||
155752410|NCT03036930|562192012|FG000|Overall Study|Lost to Follow-up|7|||
155752411|NCT03036930|562192012|FG000|Overall Study|Withdrawal by Subject|3|||
155752412|NCT03036930|562192012|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
155752413|NCT04227899|562192021|FG000|Overall Study|Withdrawal by Subject|6|||
155501154|NCT02913261|561260796|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
155501155|NCT02913261|561260795|FG000|Overall Study|Disease relapse|8|||
155501156|NCT02913261|561260796|FG001|Overall Study|Disease relapse|13|||
155752414|NCT04227899|562192022|FG001|Overall Study|Withdrawal by Subject|3|||
155752415|NCT04227899|562192021|FG000|Overall Study|Death|12|||
155752416|NCT04227899|562192022|FG001|Overall Study|Death|6|||
155752417|NCT04227899|562192021|FG000|Overall Study|Lost to Follow-up|2|||
155752418|NCT04227899|562192022|FG001|Overall Study|Lost to Follow-up|1|||
155752419|NCT05151471|562192023|FG000|Overall Study|Adverse Event|21|||
155752420|NCT05151471|562192024|FG001|Overall Study|Adverse Event|16|||
155752421|NCT05151471|562192023|FG000|Overall Study|Death|1|||
155752422|NCT05151471|562192024|FG001|Overall Study|Death|0|||
155752423|NCT05151471|562192023|FG000|Overall Study|Lost to Follow-up|0|||
155752424|NCT05151471|562192024|FG001|Overall Study|Lost to Follow-up|1|||
155752425|NCT05151471|562192023|FG000|Overall Study|Withdrawal by Subject|7|||
155752426|NCT05151471|562192024|FG001|Overall Study|Withdrawal by Subject|9|||
155752427|NCT05151471|562192023|FG000|Overall Study|Study terminated by sponsor|49|||
155752428|NCT05151471|562192024|FG001|Overall Study|Study terminated by sponsor|47|||
155752429|NCT05151471|562192023|FG000|Overall Study|Other|2|||
155752430|NCT05151471|562192024|FG001|Overall Study|Other|1|||
155752431|NCT03988608|562192025|FG000|Overall Study|Adverse Event|1|||
155752432|NCT03988608|562192025|FG000|Overall Study|Lost to Follow-up|1|||
155752433|NCT03988608|562192025|FG000|Overall Study|Withdrawal by Subject|3|||
155752434|NCT03988608|562192025|FG000|Overall Study|Death|1|||
155752435|NCT03292458|562192035|FG000|Period 1|Adverse Event|2|||
155752436|NCT03292458|562192036|FG001|Period 1|Adverse Event|0|||
155752437|NCT04927364|562192037|FG000|Overall Study|Withdrawal by Subject|3|||
155752438|NCT04927364|562192037|FG000|Overall Study|Unable to complete preassessment MRI|1|||
155752439|NCT02276885|562192040|FG000|Overall Study|Withdrawal by Subject|2|||
155752440|NCT02276885|562192041|FG001|Overall Study|Withdrawal by Subject|0|||
155752441|NCT02276885|562192040|FG000|Overall Study|Lost to Follow-up|5|||
155752442|NCT02276885|562192041|FG001|Overall Study|Lost to Follow-up|2|||
155752443|NCT05101317|562192042|FG000|Week1-13|Adverse Event|0|||
155752444|NCT05101317|562192043|FG001|Week1-13|Adverse Event|1|||
155752445|NCT05101317|562192044|FG002|Week1-13|Adverse Event|0|||
155752446|NCT05101317|562192045|FG003|Week1-13|Adverse Event|0|||
155752447|NCT05101317|562192042|FG000|Week1-13|Withdrawal by Subject|0|||
155752448|NCT05101317|562192043|FG001|Week1-13|Withdrawal by Subject|2|||
155752449|NCT05101317|562192044|FG002|Week1-13|Withdrawal by Subject|0|||
155752450|NCT05101317|562192045|FG003|Week1-13|Withdrawal by Subject|0|||
155752451|NCT05101317|562192042|FG000|Week1-13|Early Withdrawl|0|||
155752452|NCT05101317|562192043|FG001|Week1-13|Early Withdrawl|0|||
155752453|NCT05101317|562192044|FG002|Week1-13|Early Withdrawl|0|||
155752454|NCT05101317|562192045|FG003|Week1-13|Early Withdrawl|1|||
155752455|NCT05101317|562192042|FG000|Week 13-25|Lost to Follow-up|0|||
155752456|NCT05101317|562192043|FG001|Week 13-25|Lost to Follow-up|0|||
155752457|NCT05101317|562192044|FG002|Week 13-25|Lost to Follow-up|1|||
155752458|NCT05101317|562192045|FG003|Week 13-25|Lost to Follow-up|0|||
155752459|NCT05101317|562192042|FG000|Week 13-25|Withdrawal by Subject|1|||
155752460|NCT05101317|562192043|FG001|Week 13-25|Withdrawal by Subject|1|||
155752461|NCT05101317|562192044|FG002|Week 13-25|Withdrawal by Subject|0|||
155752462|NCT05101317|562192045|FG003|Week 13-25|Withdrawal by Subject|0|||
155752463|NCT05101317|562192042|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
155752464|NCT05101317|562192043|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
155752465|NCT05101317|562192044|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
155752466|NCT05101317|562192045|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
155752467|NCT04569032|562192046|FG000|Overall Study|Death|10|||
155752468|NCT04569032|562192047|FG001|Overall Study|Death|13|||
155752469|NCT04569032|562192046|FG000|Overall Study|Withdrawal by Subject|2|||
155419967|NCT05099640|560968233|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
155752470|NCT04569032|562192047|FG001|Overall Study|Withdrawal by Subject|0|||
155752471|NCT04569032|562192046|FG000|Overall Study|Lost to Follow-up|0|||
155752472|NCT04569032|562192047|FG001|Overall Study|Lost to Follow-up|1|||
155320164|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320165|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320166|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320167|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320168|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320169|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320170|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320171|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320172|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320173|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320174|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
155320175|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320176|NCT02240238|560607372|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320177|NCT02240238|560607373|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320178|NCT02240238|560607374|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320179|NCT02240238|560607375|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320180|NCT02240238|560607376|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320181|NCT02240238|560607377|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320182|NCT02240238|560607378|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320183|NCT02240238|560607379|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320184|NCT02240238|560607380|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320185|NCT02240238|560607381|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320186|NCT02240238|560607382|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
155320187|NCT02240238|560607383|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320188|NCT02240238|560607372|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320189|NCT02240238|560607373|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320190|NCT02240238|560607374|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320191|NCT02240238|560607375|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320192|NCT02240238|560607376|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320193|NCT02240238|560607377|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320194|NCT02240238|560607378|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320195|NCT02240238|560607379|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320196|NCT02240238|560607380|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320197|NCT02240238|560607381|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320198|NCT02240238|560607382|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320199|NCT02240238|560607383|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
155320200|NCT02724969|560607395|FG000|Overall Study|Lost to Follow-up|12|||
155320201|NCT02724969|560607396|FG001|Overall Study|Lost to Follow-up|6|||
155320202|NCT02724969|560607395|FG000|Overall Study|Withdrawal by Subject|3|||
155320203|NCT02724969|560607396|FG001|Overall Study|Withdrawal by Subject|3|||
155320204|NCT02724969|560607395|FG000|Overall Study|Infant demise|0|||
155320205|NCT02724969|560607396|FG001|Overall Study|Infant demise|2|||
155320206|NCT01346540|560607397|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
155320207|NCT01346540|560607398|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
155320208|NCT01346540|560607397|FG000|Overall Study|Adverse Event|0|||
155320209|NCT01346540|560607398|FG001|Overall Study|Adverse Event|4|||
155320210|NCT04797195|560607402|FG000|Overall Study|Death|8|||
155320211|NCT04797195|560607403|FG001|Overall Study|Death|15|||
155320212|NCT04797195|560607402|FG000|Overall Study|Change from PD|15|||
155320213|NCT04797195|560607403|FG001|Overall Study|Change from PD|15|||
155320214|NCT04797195|560607402|FG000|Overall Study|Withdrawal by Subject|3|||
155320215|NCT04797195|560607403|FG001|Overall Study|Withdrawal by Subject|2|||
155320216|NCT04577963|560607405|FG000|Part 2|Death|0|||
155320217|NCT04577963|560607406|FG001|Part 2|Death|1|||
155320218|NCT04577963|560607407|FG002|Part 2|Death|8|||
155320219|NCT04577963|560607408|FG003|Part 2|Death|0|||
155320220|NCT04577963|560607409|FG004|Part 2|Death|20|||
155320221|NCT04577963|560607405|FG000|Part 2|Lost to Follow-up|0|||
155320222|NCT04577963|560607406|FG001|Part 2|Lost to Follow-up|0|||
155320223|NCT04577963|560607407|FG002|Part 2|Lost to Follow-up|0|||
155320224|NCT04577963|560607408|FG003|Part 2|Lost to Follow-up|0|||
155320225|NCT04577963|560607409|FG004|Part 2|Lost to Follow-up|2|||
155320226|NCT04577963|560607405|FG000|Part 2|Withdrawal by Subject|0|||
155320227|NCT04577963|560607406|FG001|Part 2|Withdrawal by Subject|0|||
155320228|NCT04577963|560607407|FG002|Part 2|Withdrawal by Subject|0|||
155320229|NCT04577963|560607408|FG003|Part 2|Withdrawal by Subject|0|||
155320230|NCT04577963|560607409|FG004|Part 2|Withdrawal by Subject|10|||
155320231|NCT04577963|560607405|FG000|Part 2|Progressive disease|0|||
155320232|NCT04577963|560607406|FG001|Part 2|Progressive disease|0|||
155320233|NCT04577963|560607407|FG002|Part 2|Progressive disease|0|||
155320234|NCT04577963|560607408|FG003|Part 2|Progressive disease|0|||
155320235|NCT04577963|560607409|FG004|Part 2|Progressive disease|2|||
155320236|NCT04577963|560607405|FG000|Part 2|Investigator decision|0|||
155320237|NCT04577963|560607406|FG001|Part 2|Investigator decision|0|||
155320238|NCT04577963|560607407|FG002|Part 2|Investigator decision|0|||
155320239|NCT04577963|560607408|FG003|Part 2|Investigator decision|0|||
155320240|NCT04577963|560607409|FG004|Part 2|Investigator decision|1|||
155320241|NCT04577963|560607405|FG000|Part 2|Sponsor terminated study|0|||
155320242|NCT04577963|560607406|FG001|Part 2|Sponsor terminated study|0|||
155320243|NCT04577963|560607407|FG002|Part 2|Sponsor terminated study|3|||
155320244|NCT04577963|560607408|FG003|Part 2|Sponsor terminated study|1|||
155320245|NCT04577963|560607409|FG004|Part 2|Sponsor terminated study|4|||
155320246|NCT04862416|560607416|FG000|Overall Study|Withdrawal by Subject|0|||
155320247|NCT04862416|560607417|FG001|Overall Study|Withdrawal by Subject|1|||
155320248|NCT04862416|560607418|FG002|Overall Study|Withdrawal by Subject|0|||
155320249|NCT04862416|560607419|FG003|Overall Study|Withdrawal by Subject|1|||
155320250|NCT04862416|560607420|FG004|Overall Study|Withdrawal by Subject|0|||
155320251|NCT04862416|560607421|FG005|Overall Study|Withdrawal by Subject|0|||
155320252|NCT04862416|560607422|FG006|Overall Study|Withdrawal by Subject|0|||
155320253|NCT04862416|560607423|FG007|Overall Study|Withdrawal by Subject|0|||
155320254|NCT00746096|560607424|FG000|Overall Study|Adverse Event|1|||
155320255|NCT00746096|560607425|FG001|Overall Study|Adverse Event|0|||
155320256|NCT00746096|560607424|FG000|Overall Study|Withdrawal by Subject|5|||
155320257|NCT00746096|560607425|FG001|Overall Study|Withdrawal by Subject|1|||
155320258|NCT00746096|560607424|FG000|Overall Study|Lost to Follow-up|2|||
155320259|NCT00746096|560607425|FG001|Overall Study|Lost to Follow-up|1|||
155320260|NCT00746096|560607424|FG000|Overall Study|Protocol Violation|1|||
155320261|NCT00746096|560607425|FG001|Overall Study|Protocol Violation|0|||
155320262|NCT00746096|560607424|FG000|Overall Study|No study drug treatment|1|||
155320263|NCT00746096|560607425|FG001|Overall Study|No study drug treatment|1|||
155320264|NCT04295512|560607428|FG000|Overall Study|Lack of family response to schedule assessment|0|||
155320265|NCT04295512|560607429|FG001|Overall Study|Lack of family response to schedule assessment|0|||
155752473|NCT04569032|562192046|FG000|Overall Study|In long term follow up|22|||
155752474|NCT04569032|562192047|FG001|Overall Study|In long term follow up|34|||
155320266|NCT04295512|560607430|FG002|Overall Study|Lack of family response to schedule assessment|0|||
155320267|NCT04295512|560607431|FG003|Overall Study|Lack of family response to schedule assessment|2|||
155320268|NCT04295512|560607428|FG000|Overall Study|Therapist did not refer eligible family|7|||
155320269|NCT04295512|560607429|FG001|Overall Study|Therapist did not refer eligible family|7|||
155320270|NCT04295512|560607430|FG002|Overall Study|Therapist did not refer eligible family|0|||
155320271|NCT04295512|560607431|FG003|Overall Study|Therapist did not refer eligible family|0|||
155320272|NCT05207956|560607436|FG000|Overall Study|Lost to follow up|1|||
155320273|NCT05207956|560607437|FG001|Overall Study|Lost to follow up|2|||
155320274|NCT01009788|560607440|FG000|Overall Study|Withdrawal by Subject|1|||
155320275|NCT01009788|560607441|FG001|Overall Study|Withdrawal by Subject|0|||
155320276|NCT04587453|560607442|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
155320277|NCT04587453|560607443|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
155320278|NCT03571581|560607444|FG000|Overall Study|Death|2|||
155320279|NCT03571581|560607444|FG000|Overall Study|Withdrawal by Subject|2|||
155320280|NCT04737330|560607447|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
155320281|NCT04737330|560607448|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
155320282|NCT04737330|560607447|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
155320283|NCT04737330|560607448|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
155320284|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
155320285|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
155320286|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
155320287|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
155320288|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
155320289|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
155320290|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
155320291|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
155320292|NCT03295721|560607452|FG000|Overall Study|Adverse Event|1|||
155320293|NCT03295721|560607453|FG001|Overall Study|Adverse Event|0|||
155320294|NCT03295721|560607454|FG002|Overall Study|Adverse Event|0|||
155320295|NCT03295721|560607452|FG000|Overall Study|Lost to Follow-up|1|||
155320296|NCT03295721|560607453|FG001|Overall Study|Lost to Follow-up|1|||
155320297|NCT03295721|560607454|FG002|Overall Study|Lost to Follow-up|1|||
155320298|NCT03295721|560607452|FG000|Overall Study|Withdrawal by Subject|1|||
155320299|NCT03295721|560607453|FG001|Overall Study|Withdrawal by Subject|0|||
155752475|NCT03837626|562192053|FG000|Overall Study|Adverse Event|3|||
155501157|NCT02913261|561260795|FG000|Overall Study|Physician Decision|8|||
155501158|NCT02913261|561260796|FG001|Overall Study|Physician Decision|9|||
155320300|NCT03295721|560607454|FG002|Overall Study|Withdrawal by Subject|1|||
155320301|NCT03295721|560607452|FG000|Overall Study|Death|0|||
155320302|NCT03295721|560607453|FG001|Overall Study|Death|0|||
155320303|NCT03295721|560607454|FG002|Overall Study|Death|1|||
155320304|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
155320305|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
155320306|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
155320307|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
155320308|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
155320309|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
155320310|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
155320311|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
155320312|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
155320313|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
155320314|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
155320315|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
155320316|NCT05090683|560607458|FG000|Overall Study|Lost to Follow-up|10|||
155320317|NCT05090683|560607459|FG001|Overall Study|Lost to Follow-up|2|||
155320318|NCT05090683|560607458|FG000|Overall Study|Withdrawal by Subject|15|||
155320319|NCT05090683|560607459|FG001|Overall Study|Withdrawal by Subject|0|||
155320320|NCT03325985|560607460|FG000|Overall Study|Lost to Follow-up|122|||
155320321|NCT03325985|560607461|FG001|Overall Study|Lost to Follow-up|26|||
155320322|NCT03325985|560607462|FG002|Overall Study|Lost to Follow-up|141|||
155320323|NCT03325985|560607463|FG003|Overall Study|Lost to Follow-up|28|||
155320324|NCT03325985|560607460|FG000|Overall Study|Death|99|||
155320325|NCT03325985|560607461|FG001|Overall Study|Death|36|||
155320326|NCT03325985|560607462|FG002|Overall Study|Death|94|||
155320327|NCT03325985|560607463|FG003|Overall Study|Death|32|||
155320328|NCT03213665|560607464|FG000|Overall Study|Adverse Event|1|||
155320329|NCT03213665|560607464|FG000|Overall Study|Physician Decision|2|||
155320330|NCT03213665|560607464|FG000|Overall Study|Withdrawal by Subject|3|||
155320331|NCT03213665|560607464|FG000|Overall Study|Progressive Disease|13|||
155320332|NCT03034356|560607465|FG000|Baseline|Lost to Follow-up|2|||
155320333|NCT03034356|560607466|FG001|Baseline|Lost to Follow-up|4|||
155320334|NCT03034356|560607465|FG000|Baseline|Withdrawal by Subject|2|||
155320335|NCT03034356|560607466|FG001|Baseline|Withdrawal by Subject|0|||
155320336|NCT03034356|560607465|FG000|Baseline|Physician Decision|0|||
155320337|NCT03034356|560607466|FG001|Baseline|Physician Decision|1|||
155320338|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
155320339|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
155320340|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
155320341|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
155320342|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
155320343|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
155320344|NCT03034356|560607465|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
155320345|NCT03034356|560607466|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
155320346|NCT02684227|560607467|FG000|Overall Study|Adverse Event|1|||
155320347|NCT02684227|560607468|FG001|Overall Study|Adverse Event|7|||
155320348|NCT02684227|560607467|FG000|Overall Study|Death|0|||
155320349|NCT02684227|560607468|FG001|Overall Study|Death|2|||
155320350|NCT02684227|560607467|FG000|Overall Study|Withdrawal by Subject|0|||
155320351|NCT02684227|560607468|FG001|Overall Study|Withdrawal by Subject|1|||
155320352|NCT02684227|560607467|FG000|Overall Study|Progressive Disease|0|||
155320353|NCT02684227|560607468|FG001|Overall Study|Progressive Disease|2|||
155644007|NCT02400736|561785600|FG000|Overall Study|Moved from the area|3|||
155644008|NCT02400736|561785601|FG001|Overall Study|Moved from the area|1|||
155501159|NCT02913261|561260795|FG000|Overall Study|Subject/guardian decision|4|||
155320354|NCT05292391|560607471|FG000|Overall Study|Lost to Follow-up|0|||
155320355|NCT05292391|560607472|FG001|Overall Study|Lost to Follow-up|0|||
155320356|NCT05292391|560607473|FG002|Overall Study|Lost to Follow-up|0|||
155320357|NCT05292391|560607474|FG003|Overall Study|Lost to Follow-up|1|||
155320358|NCT05292391|560607475|FG004|Overall Study|Lost to Follow-up|0|||
155320359|NCT03221426|560607478|FG000|Overall Study|Ongoing in study|212|||
155320360|NCT03221426|560607479|FG001|Overall Study|Ongoing in study|193|||
155320361|NCT03221426|560607480|FG002|Overall Study|Ongoing in study|61|||
155320362|NCT03221426|560607481|FG003|Overall Study|Ongoing in study|55|||
155320363|NCT03221426|560607478|FG000|Overall Study|Withdrawal by Subject|12|||
155320364|NCT03221426|560607479|FG001|Overall Study|Withdrawal by Subject|4|||
155320365|NCT03221426|560607480|FG002|Overall Study|Withdrawal by Subject|2|||
155320366|NCT03221426|560607481|FG003|Overall Study|Withdrawal by Subject|3|||
155320367|NCT03221426|560607478|FG000|Overall Study|Lost to Follow-up|4|||
155320368|NCT03221426|560607479|FG001|Overall Study|Lost to Follow-up|1|||
155501160|NCT02913261|561260796|FG001|Overall Study|Subject/guardian decision|6|||
155644009|NCT01002105|561785602|FG000|Overall Study|Lost to Follow-up|10|||
155320369|NCT03221426|560607480|FG002|Overall Study|Lost to Follow-up|1|||
155320370|NCT03221426|560607481|FG003|Overall Study|Lost to Follow-up|0|||
155320371|NCT03221426|560607478|FG000|Overall Study|Death|174|||
155320372|NCT03221426|560607479|FG001|Overall Study|Death|204|||
155320373|NCT03221426|560607480|FG002|Overall Study|Death|36|||
155320374|NCT03221426|560607481|FG003|Overall Study|Death|45|||
155320375|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
155320376|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
155320377|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
155320378|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
155320379|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
155320380|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
155320381|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
155320382|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
155320383|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
155320384|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
155320385|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
155320386|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
155320387|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
155320388|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320389|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320390|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320391|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320392|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320393|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
155320394|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320395|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320396|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320397|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320398|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320399|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320400|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320401|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320402|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320403|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320404|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320405|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320406|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
155320407|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320408|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320409|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320410|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155419968|NCT05099640|560968231|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
155419969|NCT05099640|560968232|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
155320411|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155419970|NCT05099640|560968233|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
155419971|NCT05099640|560968231|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
155419972|NCT05099640|560968232|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
155419973|NCT05099640|560968233|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
155419974|NCT05099640|560968231|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
155419975|NCT05099640|560968232|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
155419976|NCT05099640|560968233|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
155419977|NCT05099640|560968231|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
155419978|NCT05099640|560968232|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
155419979|NCT05099640|560968233|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
155419980|NCT05099640|560968231|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
155419981|NCT05099640|560968232|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
155419982|NCT05099640|560968233|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
155644010|NCT01002105|561785603|FG001|Overall Study|Lost to Follow-up|16|||
155644011|NCT01002105|561785602|FG000|Overall Study|non compliance|5|||
155644012|NCT01002105|561785603|FG001|Overall Study|non compliance|3|||
155644013|NCT01002105|561785602|FG000|Overall Study|condition worsened|4|||
155644014|NCT01002105|561785603|FG001|Overall Study|condition worsened|2|||
155644015|NCT03674411|561785606|FG000|Overall Study|Non-treatment|4|||
155320412|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320413|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320414|NCT05671653|560609057|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320415|NCT05671653|560609058|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320416|NCT05671653|560609059|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155644016|NCT02227199|561785607|FG000|Overall Study|Physician Decision|0|||
155644017|NCT02227199|561785608|FG001|Overall Study|Physician Decision|0|||
155320417|NCT05671653|560609060|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320418|NCT05671653|560609061|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320419|NCT05671653|560609062|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320420|NCT05671653|560609063|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320421|NCT05671653|560609064|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320422|NCT05671653|560609065|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
155320423|NCT05671653|560609066|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320424|NCT05671653|560609067|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320425|NCT05671653|560609068|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320426|NCT05671653|560609069|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320427|NCT05671653|560609057|FG000|Cohort 2 Period 2|Adverse Event|0|||
155320428|NCT05671653|560609058|FG001|Cohort 2 Period 2|Adverse Event|0|||
155320429|NCT05671653|560609059|FG002|Cohort 2 Period 2|Adverse Event|0|||
155320430|NCT05671653|560609060|FG003|Cohort 2 Period 2|Adverse Event|0|||
155320431|NCT05671653|560609061|FG004|Cohort 2 Period 2|Adverse Event|0|||
155320432|NCT05671653|560609062|FG005|Cohort 2 Period 2|Adverse Event|0|||
155320433|NCT05671653|560609063|FG006|Cohort 2 Period 2|Adverse Event|0|||
155320434|NCT05671653|560609064|FG007|Cohort 2 Period 2|Adverse Event|0|||
155320435|NCT05671653|560609065|FG008|Cohort 2 Period 2|Adverse Event|0|||
155320436|NCT05671653|560609066|FG009|Cohort 2 Period 2|Adverse Event|0|||
155320437|NCT05671653|560609067|FG010|Cohort 2 Period 2|Adverse Event|1|||
155320438|NCT05671653|560609068|FG011|Cohort 2 Period 2|Adverse Event|0|||
155320439|NCT05671653|560609069|FG012|Cohort 2 Period 2|Adverse Event|0|||
155320440|NCT05671653|560609057|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
155320441|NCT05671653|560609058|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
155320442|NCT05671653|560609059|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
155320443|NCT05671653|560609060|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
155320444|NCT05671653|560609061|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
155320445|NCT05671653|560609062|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
155320446|NCT05671653|560609063|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
155320447|NCT05671653|560609064|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
155320448|NCT05671653|560609065|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
155320449|NCT05671653|560609066|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
155320450|NCT05671653|560609067|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
155320451|NCT05671653|560609068|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
155320452|NCT05671653|560609069|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
155320453|NCT05671653|560609057|FG000|Cohort 2 Period 2|Pregnancy|0|||
155320454|NCT05671653|560609058|FG001|Cohort 2 Period 2|Pregnancy|0|||
155320455|NCT05671653|560609059|FG002|Cohort 2 Period 2|Pregnancy|0|||
155320456|NCT05671653|560609060|FG003|Cohort 2 Period 2|Pregnancy|0|||
155320457|NCT05671653|560609061|FG004|Cohort 2 Period 2|Pregnancy|0|||
155320458|NCT05671653|560609062|FG005|Cohort 2 Period 2|Pregnancy|0|||
155320459|NCT05671653|560609063|FG006|Cohort 2 Period 2|Pregnancy|0|||
155320460|NCT05671653|560609064|FG007|Cohort 2 Period 2|Pregnancy|0|||
155320461|NCT05671653|560609065|FG008|Cohort 2 Period 2|Pregnancy|0|||
155320462|NCT05671653|560609066|FG009|Cohort 2 Period 2|Pregnancy|0|||
155320463|NCT05671653|560609067|FG010|Cohort 2 Period 2|Pregnancy|1|||
155320464|NCT05671653|560609068|FG011|Cohort 2 Period 2|Pregnancy|0|||
155320465|NCT05671653|560609069|FG012|Cohort 2 Period 2|Pregnancy|0|||
155320466|NCT05671653|560609057|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320467|NCT05671653|560609058|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320468|NCT05671653|560609059|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320469|NCT05671653|560609060|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320470|NCT05671653|560609061|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320471|NCT05671653|560609062|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
155752476|NCT03837626|562192054|FG001|Overall Study|Adverse Event|3|||
155752477|NCT03837626|562192053|FG000|Overall Study|Withdrawal by Subject|2|||
155752478|NCT03837626|562192054|FG001|Overall Study|Withdrawal by Subject|4|||
155752479|NCT03837626|562192053|FG000|Overall Study|Physician Decision|2|||
155320472|NCT05671653|560609063|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320473|NCT05671653|560609064|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320474|NCT05671653|560609065|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320475|NCT05671653|560609066|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320476|NCT05671653|560609067|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
155320477|NCT05671653|560609068|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320478|NCT05671653|560609069|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320479|NCT05671653|560609057|FG000|Cohort 2 Period 2|Other|0|||
155320480|NCT05671653|560609058|FG001|Cohort 2 Period 2|Other|0|||
155320481|NCT05671653|560609059|FG002|Cohort 2 Period 2|Other|0|||
155320482|NCT05671653|560609060|FG003|Cohort 2 Period 2|Other|0|||
155320483|NCT05671653|560609061|FG004|Cohort 2 Period 2|Other|0|||
155752480|NCT03837626|562192054|FG001|Overall Study|Physician Decision|3|||
155320484|NCT05671653|560609062|FG005|Cohort 2 Period 2|Other|0|||
155320485|NCT05671653|560609063|FG006|Cohort 2 Period 2|Other|0|||
155320486|NCT05671653|560609064|FG007|Cohort 2 Period 2|Other|0|||
155320487|NCT05671653|560609065|FG008|Cohort 2 Period 2|Other|0|||
155320488|NCT05671653|560609066|FG009|Cohort 2 Period 2|Other|0|||
155320489|NCT05671653|560609067|FG010|Cohort 2 Period 2|Other|1|||
155320490|NCT05671653|560609068|FG011|Cohort 2 Period 2|Other|0|||
155320491|NCT05671653|560609069|FG012|Cohort 2 Period 2|Other|0|||
155320492|NCT05671653|560609057|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320493|NCT05671653|560609058|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320494|NCT05671653|560609059|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320495|NCT05671653|560609060|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320496|NCT05671653|560609061|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320497|NCT05671653|560609062|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320498|NCT05671653|560609063|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320499|NCT05671653|560609064|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320500|NCT05671653|560609065|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320501|NCT05671653|560609066|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320502|NCT05671653|560609067|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320503|NCT05671653|560609068|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
155320504|NCT05671653|560609069|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320505|NCT01197378|560609073|FG000|Overall Study|Adverse Event|3|||
155320506|NCT01197378|560609073|FG000|Overall Study|Withdrawal by Subject|1|||
155320507|NCT01197378|560609073|FG000|Overall Study|Physician Decision|1|||
155320508|NCT01197378|560609073|FG000|Overall Study|Other|2|||
155320509|NCT05274074|560609091|FG000|Overall Study|Lost to Follow-up|2|||
155320510|NCT05274074|560609092|FG001|Overall Study|Lost to Follow-up|3|||
155320511|NCT05274074|560609091|FG000|Overall Study|Withdrawal by Subject|1|||
155320512|NCT05274074|560609092|FG001|Overall Study|Withdrawal by Subject|2|||
155320513|NCT04117347|560609093|FG000|Overall Study|Adverse Event|0|||
155320514|NCT04117347|560609094|FG001|Overall Study|Adverse Event|0|||
155320515|NCT04117347|560609095|FG002|Overall Study|Adverse Event|1|||
155320516|NCT04117347|560609093|FG000|Overall Study|No time for study|0|||
155320517|NCT04117347|560609094|FG001|Overall Study|No time for study|2|||
155320518|NCT04117347|560609095|FG002|Overall Study|No time for study|0|||
155320519|NCT04117347|560609093|FG000|Overall Study|Family emergency|1|||
155320520|NCT04117347|560609094|FG001|Overall Study|Family emergency|0|||
155320521|NCT04117347|560609095|FG002|Overall Study|Family emergency|0|||
155320522|NCT03687086|560609096|FG000|Overall Study|Withdrawal by Subject|3|||
155320523|NCT03687086|560609097|FG001|Overall Study|Withdrawal by Subject|4|||
155320524|NCT03687086|560609096|FG000|Overall Study|Lost to Follow-up|1|||
155320525|NCT03687086|560609097|FG001|Overall Study|Lost to Follow-up|1|||
155320526|NCT03687086|560609096|FG000|Overall Study|Death|1|||
155320527|NCT03687086|560609097|FG001|Overall Study|Death|0|||
155320528|NCT03687086|560609096|FG000|Overall Study|Incomplete assessment|0|||
155320529|NCT03687086|560609097|FG001|Overall Study|Incomplete assessment|2|||
155320530|NCT05194956|560609098|FG000|Washout Period|Withdrawal by Subject|0|||
155320531|NCT05194956|560609099|FG001|Washout Period|Withdrawal by Subject|2|||
155320532|NCT02593773|560609100|FG000|Overall Study|Voluntary Withdrawal|3|||
155320533|NCT02593773|560609100|FG000|Overall Study|Study Terminated by Sponsor|31|||
155320534|NCT02593773|560609100|FG000|Overall Study|Death|1|||
155320535|NCT04294641|560609101|FG000|Overall Study|Screen failure|4|||
155320536|NCT01627574|560609102|FG000|Overall Study|Withdrawal by Subject|8|||
155320537|NCT01627574|560609103|FG001|Overall Study|Withdrawal by Subject|5|||
155320538|NCT01627574|560609102|FG000|Overall Study|Lost to Follow-up|13|||
155320539|NCT01627574|560609103|FG001|Overall Study|Lost to Follow-up|13|||
155320540|NCT03249090|560609111|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
155320541|NCT03249090|560609112|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
155320542|NCT03249090|560609111|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
155320543|NCT03249090|560609112|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
155320544|NCT03249090|560609111|FG000|3 Month Time Point|Voluntary withdrawal|6|||
155320545|NCT03249090|560609112|FG001|3 Month Time Point|Voluntary withdrawal|3|||
155320546|NCT03249090|560609111|FG000|3 Month Time Point|Changed oncology practice|4|||
155320547|NCT03249090|560609112|FG001|3 Month Time Point|Changed oncology practice|2|||
155320548|NCT03249090|560609111|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
155320549|NCT03249090|560609112|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
155419983|NCT01552681|560968234|FG000|Overall Study|Withdrawal by Subject|4|||
155419984|NCT01552681|560968235|FG001|Overall Study|Withdrawal by Subject|0|||
155419985|NCT01552681|560968234|FG000|Overall Study|Physician Decision|1|||
155419986|NCT01552681|560968235|FG001|Overall Study|Physician Decision|0|||
155419987|NCT01552681|560968234|FG000|Overall Study|Subject moved away|0|||
155419988|NCT01552681|560968235|FG001|Overall Study|Subject moved away|1|||
155419989|NCT03075163|560968236|FG000|Overall Study|not eligible for treatment limb|138|||
155320550|NCT03249090|560609111|FG000|12 Month Time Point|Voluntary withdrawal|35|||
155320551|NCT03249090|560609112|FG001|12 Month Time Point|Voluntary withdrawal|4|||
155419990|NCT03075163|560968237|FG001|Overall Study|not eligible for treatment limb|138|||
155320552|NCT03249090|560609111|FG000|12 Month Time Point|Changed oncology practice|20|||
155320553|NCT03249090|560609112|FG001|12 Month Time Point|Changed oncology practice|9|||
155320554|NCT04314778|560609117|FG000|Overall Study|Lost to Follow-up|5|||
155320555|NCT04314778|560609118|FG001|Overall Study|Lost to Follow-up|3|||
155419991|NCT01731678|560968240|FG000|Overall Study|Withdrawal by Subject|3|||
155752481|NCT03837626|562192053|FG000|Overall Study|Lost to Follow-up|3|||
155752482|NCT03837626|562192054|FG001|Overall Study|Lost to Follow-up|1|||
155752483|NCT05764265|562192057|FG000|Overall Study|Adverse Event|1|||
155752484|NCT05764265|562192058|FG001|Overall Study|Adverse Event|0|||
155752485|NCT05764265|562192057|FG000|Overall Study|Physician Decision|1|||
155752486|NCT05764265|562192058|FG001|Overall Study|Physician Decision|8|||
155752487|NCT05764265|562192057|FG000|Overall Study|Study Terminated By Sponsor|20|||
155752488|NCT05764265|562192058|FG001|Overall Study|Study Terminated By Sponsor|0|||
155752489|NCT05764265|562192057|FG000|Overall Study|Participant Decision|1|||
155752490|NCT05764265|562192058|FG001|Overall Study|Participant Decision|0|||
155752491|NCT05422638|562192061|FG000|Overall Study|Withdrawal by Subject|8|||
155752492|NCT05422638|562192062|FG001|Overall Study|Withdrawal by Subject|2|||
155752493|NCT04777331|562192063|FG000|DBT Period|Death|2|||
155752494|NCT04777331|562192064|FG001|DBT Period|Death|1|||
155752495|NCT04777331|562192065|FG002|DBT Period|Death|0|||
155320556|NCT05646355|560609119|FG000|Overall Study|Lost to Follow-up|1|||
155320557|NCT05646355|560609120|FG001|Overall Study|Lost to Follow-up|0|||
155320558|NCT05646355|560609119|FG000|Overall Study|translated materials not available for pilot|2|||
155320559|NCT05646355|560609120|FG001|Overall Study|translated materials not available for pilot|0|||
155320560|NCT05646355|560609119|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
155320561|NCT05646355|560609120|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
155320562|NCT03523572|560609121|FG000|Dose Escalation|Progressive disease|1|||
155320563|NCT03523572|560609122|FG001|Dose Escalation|Progressive disease|0|||
155320564|NCT03523572|560609123|FG002|Dose Escalation|Progressive disease|0|||
155320565|NCT03523572|560609124|FG003|Dose Escalation|Progressive disease|0|||
155320566|NCT03523572|560609125|FG004|Dose Escalation|Progressive disease|0|||
155320567|NCT03523572|560609126|FG005|Dose Escalation|Progressive disease|0|||
155320568|NCT03523572|560609121|FG000|Dose Escalation|Clinical Progression|0|||
155320569|NCT03523572|560609122|FG001|Dose Escalation|Clinical Progression|1|||
155320570|NCT03523572|560609123|FG002|Dose Escalation|Clinical Progression|0|||
155320571|NCT03523572|560609124|FG003|Dose Escalation|Clinical Progression|0|||
155320572|NCT03523572|560609125|FG004|Dose Escalation|Clinical Progression|0|||
155320573|NCT03523572|560609126|FG005|Dose Escalation|Clinical Progression|0|||
155320574|NCT03523572|560609121|FG000|Dose Escalation|Adverse Event|2|||
155320575|NCT03523572|560609122|FG001|Dose Escalation|Adverse Event|0|||
155320576|NCT03523572|560609123|FG002|Dose Escalation|Adverse Event|0|||
155320577|NCT03523572|560609124|FG003|Dose Escalation|Adverse Event|0|||
155320578|NCT03523572|560609125|FG004|Dose Escalation|Adverse Event|0|||
155320579|NCT03523572|560609126|FG005|Dose Escalation|Adverse Event|0|||
155320580|NCT03523572|560609121|FG000|Dose Escalation|Physician Decision|1|||
155320581|NCT03523572|560609122|FG001|Dose Escalation|Physician Decision|1|||
155320582|NCT03523572|560609123|FG002|Dose Escalation|Physician Decision|0|||
155320583|NCT03523572|560609124|FG003|Dose Escalation|Physician Decision|0|||
155320584|NCT03523572|560609125|FG004|Dose Escalation|Physician Decision|0|||
155320585|NCT03523572|560609126|FG005|Dose Escalation|Physician Decision|0|||
155320586|NCT03523572|560609121|FG000|Dose Expansion|Progressive Disease|0|||
155320587|NCT03523572|560609122|FG001|Dose Expansion|Progressive Disease|0|||
155320588|NCT03523572|560609123|FG002|Dose Expansion|Progressive Disease|9|||
155320589|NCT03523572|560609124|FG003|Dose Expansion|Progressive Disease|11|||
155320590|NCT03523572|560609125|FG004|Dose Expansion|Progressive Disease|15|||
155320591|NCT03523572|560609126|FG005|Dose Expansion|Progressive Disease|2|||
155320592|NCT03523572|560609121|FG000|Dose Expansion|Clinical Progression|0|||
155320593|NCT03523572|560609122|FG001|Dose Expansion|Clinical Progression|0|||
155320594|NCT03523572|560609123|FG002|Dose Expansion|Clinical Progression|2|||
155320595|NCT03523572|560609124|FG003|Dose Expansion|Clinical Progression|2|||
155320596|NCT03523572|560609125|FG004|Dose Expansion|Clinical Progression|2|||
155320597|NCT03523572|560609126|FG005|Dose Expansion|Clinical Progression|0|||
155320598|NCT03523572|560609121|FG000|Dose Expansion|Adverse Event|0|||
155320599|NCT03523572|560609122|FG001|Dose Expansion|Adverse Event|0|||
155320600|NCT03523572|560609123|FG002|Dose Expansion|Adverse Event|10|||
155320601|NCT03523572|560609124|FG003|Dose Expansion|Adverse Event|1|||
155320602|NCT03523572|560609125|FG004|Dose Expansion|Adverse Event|5|||
155320603|NCT03523572|560609126|FG005|Dose Expansion|Adverse Event|2|||
155320604|NCT03523572|560609121|FG000|Dose Expansion|Withdrawal by Subject|0|||
155320605|NCT03523572|560609122|FG001|Dose Expansion|Withdrawal by Subject|0|||
155320606|NCT03523572|560609123|FG002|Dose Expansion|Withdrawal by Subject|1|||
155320607|NCT03523572|560609124|FG003|Dose Expansion|Withdrawal by Subject|1|||
155320608|NCT03523572|560609125|FG004|Dose Expansion|Withdrawal by Subject|0|||
155752496|NCT04777331|562192063|FG000|DBT Period|Reason not Specified|1|||
155752497|NCT04777331|562192064|FG001|DBT Period|Reason not Specified|1|||
155752498|NCT04777331|562192065|FG002|DBT Period|Reason not Specified|0|||
155752499|NCT04777331|562192063|FG000|DBT Period|Physician Decision|4|||
155752500|NCT04777331|562192064|FG001|DBT Period|Physician Decision|0|||
155752501|NCT04777331|562192065|FG002|DBT Period|Physician Decision|0|||
155752502|NCT04777331|562192063|FG000|DBT Period|Withdrawal by Subject|12|||
155320609|NCT03523572|560609126|FG005|Dose Expansion|Withdrawal by Subject|0|||
155320610|NCT03523572|560609121|FG000|Dose Expansion|Physician Decision|0|||
155320611|NCT03523572|560609122|FG001|Dose Expansion|Physician Decision|0|||
155320612|NCT03523572|560609123|FG002|Dose Expansion|Physician Decision|1|||
155320613|NCT03523572|560609124|FG003|Dose Expansion|Physician Decision|0|||
155320614|NCT03523572|560609125|FG004|Dose Expansion|Physician Decision|1|||
155320615|NCT03523572|560609126|FG005|Dose Expansion|Physician Decision|0|||
155320616|NCT03523572|560609121|FG000|Dose Expansion|Miscellaneous|0|||
155320617|NCT03523572|560609122|FG001|Dose Expansion|Miscellaneous|0|||
155320618|NCT03523572|560609123|FG002|Dose Expansion|Miscellaneous|0|||
155320619|NCT03523572|560609124|FG003|Dose Expansion|Miscellaneous|0|||
155320620|NCT03523572|560609125|FG004|Dose Expansion|Miscellaneous|3|||
155320621|NCT03523572|560609126|FG005|Dose Expansion|Miscellaneous|0|||
155320622|NCT04685135|560609127|FG000|Overall Study|Death|126|||
155320623|NCT04685135|560609128|FG001|Overall Study|Death|53|||
155320624|NCT04685135|560609127|FG000|Overall Study|Withdrawal by Subject|12|||
155320625|NCT04685135|560609128|FG001|Overall Study|Withdrawal by Subject|16|||
155320626|NCT03672916|560609132|FG000|Overall Study|Death|6|||
155320627|NCT03672916|560609132|FG000|Overall Study|Lost to Follow-up|29|||
155320628|NCT03672916|560609132|FG000|Overall Study|Adverse Event|6|||
155320629|NCT03672916|560609132|FG000|Overall Study|Withdrawal by Subject|11|||
155320630|NCT05868382|560609133|FG000|Overall Study|Lost to Follow-up|5|||
155320631|NCT05868382|560609134|FG001|Overall Study|Lost to Follow-up|0|||
155320632|NCT05868382|560609135|FG002|Overall Study|Lost to Follow-up|6|||
155320633|NCT05868382|560609136|FG003|Overall Study|Lost to Follow-up|4|||
155320634|NCT05868382|560609137|FG004|Overall Study|Lost to Follow-up|2|||
155320635|NCT05868382|560609138|FG005|Overall Study|Lost to Follow-up|6|||
155320636|NCT05868382|560609133|FG000|Overall Study|Withdrawal by Subject|1|||
155320637|NCT05868382|560609134|FG001|Overall Study|Withdrawal by Subject|0|||
155320638|NCT05868382|560609135|FG002|Overall Study|Withdrawal by Subject|0|||
155320639|NCT05868382|560609136|FG003|Overall Study|Withdrawal by Subject|0|||
155320640|NCT05868382|560609137|FG004|Overall Study|Withdrawal by Subject|1|||
155320641|NCT05868382|560609138|FG005|Overall Study|Withdrawal by Subject|0|||
155320642|NCT03513302|560609141|FG000|First Intervention (14 Days)|Screen failure|15|||
155320643|NCT03513302|560609142|FG001|First Intervention (14 Days)|Screen failure|16|||
155320644|NCT05256654|560609143|FG000|Overall Study|Adverse Event|0|||
155320645|NCT05256654|560609144|FG001|Overall Study|Adverse Event|0|||
155320646|NCT05256654|560609145|FG002|Overall Study|Adverse Event|1|||
155320647|NCT05256654|560609146|FG003|Overall Study|Adverse Event|0|||
155320648|NCT05256654|560609143|FG000|Overall Study|Lost to Follow-up|0|||
155320649|NCT05256654|560609144|FG001|Overall Study|Lost to Follow-up|0|||
155320650|NCT05256654|560609145|FG002|Overall Study|Lost to Follow-up|0|||
155320651|NCT05256654|560609146|FG003|Overall Study|Lost to Follow-up|1|||
155320652|NCT05256654|560609143|FG000|Overall Study|Withdrawal by Subject|1|||
155320653|NCT05256654|560609144|FG001|Overall Study|Withdrawal by Subject|2|||
155320654|NCT05256654|560609145|FG002|Overall Study|Withdrawal by Subject|1|||
155320655|NCT05256654|560609146|FG003|Overall Study|Withdrawal by Subject|3|||
155320656|NCT05256654|560609143|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
155320657|NCT05256654|560609144|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
155320658|NCT05256654|560609145|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
155320659|NCT05256654|560609146|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
155320660|NCT05256654|560609143|FG000|Overall Study|Other|0|||
155320661|NCT05256654|560609144|FG001|Overall Study|Other|0|||
155320662|NCT05256654|560609145|FG002|Overall Study|Other|0|||
155320663|NCT05256654|560609146|FG003|Overall Study|Other|1|||
155320664|NCT01309672|560609152|FG000|Overall Study|Lack of Efficacy|20|||
155320665|NCT01309672|560609152|FG000|Overall Study|Other|9|||
155320666|NCT01309672|560609152|FG000|Overall Study|Adverse Event|5|||
155320667|NCT01309672|560609152|FG000|Overall Study|Withdrawal by Subject|3|||
155320668|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
155320669|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
155320670|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
155320671|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
155320672|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
155320673|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
155320674|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
155320675|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
155320676|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
155320677|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
155320678|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
155320679|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
155320680|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
155320681|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
155320682|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
155501161|NCT02913261|561260795|FG000|Overall Study|Graft loss|2|||
155644018|NCT02227199|561785609|FG002|Overall Study|Physician Decision|1|||
155644019|NCT02227199|561785607|FG000|Overall Study|Adverse Event|0|||
155644020|NCT02227199|561785608|FG001|Overall Study|Adverse Event|0|||
155644021|NCT02227199|561785609|FG002|Overall Study|Adverse Event|3|||
155644022|NCT03573882|561785610|FG000|Overall Study|Study Terminated by Sponsor|22|||
155644023|NCT03573882|561785611|FG001|Overall Study|Study Terminated by Sponsor|17|||
155644024|NCT03573882|561785612|FG002|Overall Study|Study Terminated by Sponsor|18|||
155644025|NCT03573882|561785610|FG000|Overall Study|Withdrawal by Subject|6|||
155644026|NCT03573882|561785611|FG001|Overall Study|Withdrawal by Subject|11|||
155644027|NCT03573882|561785612|FG002|Overall Study|Withdrawal by Subject|7|||
155644028|NCT03573882|561785610|FG000|Overall Study|Adverse Event|7|||
155644029|NCT03573882|561785611|FG001|Overall Study|Adverse Event|5|||
155644030|NCT03573882|561785612|FG002|Overall Study|Adverse Event|6|||
155644031|NCT03573882|561785610|FG000|Overall Study|Lost to Follow-up|2|||
155644032|NCT03573882|561785611|FG001|Overall Study|Lost to Follow-up|5|||
155644033|NCT03573882|561785612|FG002|Overall Study|Lost to Follow-up|3|||
155644034|NCT03573882|561785610|FG000|Overall Study|Physician Decision|4|||
155644035|NCT03573882|561785611|FG001|Overall Study|Physician Decision|3|||
155644036|NCT03573882|561785612|FG002|Overall Study|Physician Decision|2|||
155644037|NCT03573882|561785610|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
155644038|NCT03573882|561785611|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
155644039|NCT03573882|561785612|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
155644040|NCT03573882|561785610|FG000|Overall Study|Pregnancy|1|||
155644041|NCT03573882|561785611|FG001|Overall Study|Pregnancy|2|||
155644042|NCT03573882|561785612|FG002|Overall Study|Pregnancy|0|||
155644043|NCT03573882|561785610|FG000|Overall Study|Other|4|||
155644044|NCT03573882|561785611|FG001|Overall Study|Other|2|||
155644045|NCT03573882|561785612|FG002|Overall Study|Other|2|||
155644046|NCT02691572|561785613|FG000|Overall Study|Withdrawal by Subject|1|||
155644047|NCT02691572|561785614|FG001|Overall Study|Withdrawal by Subject|0|||
155644048|NCT02691572|561785613|FG000|Overall Study|Protocol Violation|0|||
155644049|NCT02691572|561785614|FG001|Overall Study|Protocol Violation|1|||
155644050|NCT04337021|561785618|FG000|Overall Study|Lost to Follow-up|54|||
155644051|NCT04337021|561785619|FG001|Overall Study|Lost to Follow-up|66|||
155644052|NCT01405911|561785620|FG000|Overall Study|Pre-treatment lab AE|0|||
155644053|NCT01405911|561785621|FG001|Overall Study|Pre-treatment lab AE|1|||
155644054|NCT01405911|561785622|FG002|Overall Study|Pre-treatment lab AE|0|||
155644055|NCT01405911|561785620|FG000|Overall Study|Lost to Follow-up|0|||
155644056|NCT01405911|561785621|FG001|Overall Study|Lost to Follow-up|1|||
155644057|NCT01405911|561785622|FG002|Overall Study|Lost to Follow-up|0|||
155644058|NCT01405911|561785620|FG000|Overall Study|Protocol Violation|1|||
155644059|NCT01405911|561785621|FG001|Overall Study|Protocol Violation|0|||
155644060|NCT01405911|561785622|FG002|Overall Study|Protocol Violation|0|||
155644061|NCT01405911|561785620|FG000|Overall Study|Withdrawal by Subject|3|||
155644062|NCT01405911|561785621|FG001|Overall Study|Withdrawal by Subject|1|||
155644063|NCT01405911|561785622|FG002|Overall Study|Withdrawal by Subject|1|||
155644064|NCT06375655|561785623|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
155644065|NCT06375655|561785624|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
155644066|NCT02530242|561785628|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
155320683|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
155320684|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
155320685|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
155320686|NCT01254864|560609155|FG000|Randomization Phase|Adverse Event|0|||
155501162|NCT02913261|561260796|FG001|Overall Study|Graft loss|0|||
155501163|NCT02304302|561260819|FG000|Overall Study|Adverse Event|2|||
155501164|NCT02304302|561260820|FG001|Overall Study|Adverse Event|3|||
155501165|NCT02304302|561260819|FG000|Overall Study|Lost to Follow-up|1|||
155501166|NCT02304302|561260820|FG001|Overall Study|Lost to Follow-up|4|||
155501167|NCT02304302|561260819|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
155501168|NCT02304302|561260820|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
155501169|NCT00391118|561260821|FG000|Overall Study|Adverse Event|3|||
155501170|NCT00391118|561260822|FG001|Overall Study|Adverse Event|10|||
155501171|NCT00391118|561260823|FG002|Overall Study|Adverse Event|7|||
155501172|NCT00391118|561260821|FG000|Overall Study|Lost to Follow-up|0|||
155644067|NCT02530242|561785629|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
155644068|NCT00283959|561785630|FG000|Extension Period|Low Compliance|1|||
155644069|NCT03514017|561785636|FG000|Overall Study|Death|1|||
155644070|NCT03514017|561785636|FG000|Overall Study|Adverse Event|1|||
155501173|NCT00391118|561260822|FG001|Overall Study|Lost to Follow-up|2|||
155501174|NCT00391118|561260823|FG002|Overall Study|Lost to Follow-up|3|||
155501175|NCT00391118|561260821|FG000|Overall Study|Withdrawal by Subject|0|||
155644071|NCT06394323|561785637|FG000|Overall Study|Death|0|||
155644072|NCT06394323|561785638|FG001|Overall Study|Death|1|||
155644073|NCT06394323|561785639|FG002|Overall Study|Death|0|||
155644074|NCT06394323|561785640|FG003|Overall Study|Death|0|||
155644075|NCT06394323|561785637|FG000|Overall Study|Physician Decision|0|||
155644076|NCT06394323|561785638|FG001|Overall Study|Physician Decision|2|||
155644077|NCT06394323|561785639|FG002|Overall Study|Physician Decision|0|||
155644078|NCT06394323|561785640|FG003|Overall Study|Physician Decision|0|||
155644079|NCT06394323|561785637|FG000|Overall Study|Withdrawal by Subject|4|||
155644080|NCT06394323|561785638|FG001|Overall Study|Withdrawal by Subject|4|||
155644081|NCT06394323|561785639|FG002|Overall Study|Withdrawal by Subject|0|||
155644082|NCT06394323|561785640|FG003|Overall Study|Withdrawal by Subject|0|||
155644083|NCT00552058|561786896|FG000|Overall Study|Adverse Event|8|||
155644084|NCT00552058|561786897|FG001|Overall Study|Adverse Event|7|||
155644085|NCT00552058|561786896|FG000|Overall Study|Lack of Efficacy|1|||
155644086|NCT00552058|561786897|FG001|Overall Study|Lack of Efficacy|5|||
155644087|NCT00552058|561786896|FG000|Overall Study|Lost to Follow-up|1|||
155644088|NCT00552058|561786897|FG001|Overall Study|Lost to Follow-up|0|||
155644089|NCT00552058|561786896|FG000|Overall Study|Withdrawal by Subject|4|||
155644090|NCT00552058|561786897|FG001|Overall Study|Withdrawal by Subject|4|||
155644091|NCT00552058|561786896|FG000|Overall Study|Other: Protocol Violation|0|||
155644092|NCT00552058|561786897|FG001|Overall Study|Other: Protocol Violation|1|||
155644093|NCT00552058|561786896|FG000|Overall Study|Other: Non Compliance|1|||
155644094|NCT00552058|561786897|FG001|Overall Study|Other: Non Compliance|2|||
155644095|NCT00552058|561786896|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
155644096|NCT00552058|561786897|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
155644097|NCT00552058|561786896|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
155644098|NCT00552058|561786897|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
155644099|NCT00552058|561786896|FG000|Overall Study|Other: Positive Stool Result|0|||
155644100|NCT00552058|561786897|FG001|Overall Study|Other: Positive Stool Result|1|||
155644101|NCT00552058|561786896|FG000|Overall Study|Other: Randomized in error|0|||
155644102|NCT00552058|561786897|FG001|Overall Study|Other: Randomized in error|1|||
155644103|NCT00552058|561786896|FG000|Overall Study|Other: Sponsors Decision|0|||
155644104|NCT00552058|561786897|FG001|Overall Study|Other: Sponsors Decision|1|||
155644105|NCT00552058|561786896|FG000|Overall Study|Other: Early Roll Over|1|||
155644106|NCT00552058|561786897|FG001|Overall Study|Other: Early Roll Over|0|||
155644107|NCT00422461|561786898|FG000|Overall Study|Adverse Event|1|||
155644108|NCT00422461|561786899|FG001|Overall Study|Adverse Event|2|||
155644109|NCT00422461|561786900|FG002|Overall Study|Adverse Event|1|||
155644110|NCT00422461|561786901|FG003|Overall Study|Adverse Event|1|||
155644111|NCT00422461|561786898|FG000|Overall Study|Other|0|||
155644112|NCT00422461|561786899|FG001|Overall Study|Other|0|||
155644113|NCT00422461|561786900|FG002|Overall Study|Other|0|||
155644114|NCT00422461|561786901|FG003|Overall Study|Other|2|||
155644115|NCT00422461|561786898|FG000|Overall Study|Participants no longer willing to participate in study|1|||
155644116|NCT00422461|561786899|FG001|Overall Study|Participants no longer willing to participate in study|0|||
155644117|NCT00422461|561786900|FG002|Overall Study|Participants no longer willing to participate in study|0|||
155644118|NCT00422461|561786901|FG003|Overall Study|Participants no longer willing to participate in study|0|||
155644119|NCT00422461|561786898|FG000|Overall Study|Randomized but not treated|1|||
155644120|NCT00422461|561786899|FG001|Overall Study|Randomized but not treated|1|||
155644121|NCT00422461|561786900|FG002|Overall Study|Randomized but not treated|0|||
155644122|NCT00422461|561786901|FG003|Overall Study|Randomized but not treated|0|||
155644123|NCT01795937|561786903|FG000|Overall Study|Withdrawal by Subject|1|||
155644124|NCT01795937|561786904|FG001|Overall Study|Withdrawal by Subject|0|||
155644125|NCT01795937|561786905|FG002|Overall Study|Withdrawal by Subject|0|||
155644126|NCT01795937|561786903|FG000|Overall Study|Physician Decision|0|||
155644127|NCT01795937|561786904|FG001|Overall Study|Physician Decision|1|||
155644128|NCT01795937|561786905|FG002|Overall Study|Physician Decision|0|||
155644129|NCT01028053|561786906|FG000|Overall Study|Screen Failure|113|||
155644130|NCT01028053|561786906|FG000|Overall Study|Patient Request|11|||
155644131|NCT01028053|561786906|FG000|Overall Study|Protocol Violation|1|||
155644132|NCT01028053|561786906|FG000|Overall Study|Physician Decision|2|||
155644133|NCT01028053|561786906|FG000|Overall Study|Technical Problem|1|||
155644134|NCT01028053|561786906|FG000|Overall Study|Terminated by Sponsor|1|||
155644135|NCT01028053|561786906|FG000|Overall Study|Various reasons|4|||
155644136|NCT00845182|561786907|FG000|Overall Study|Lost to Follow-up|3|||
155644137|NCT00845182|561786908|FG001|Overall Study|Lost to Follow-up|3|||
155644138|NCT00845182|561786909|FG002|Overall Study|Lost to Follow-up|4|||
155644139|NCT00845182|561786907|FG000|Overall Study|Adverse Event|0|||
155644140|NCT00845182|561786908|FG001|Overall Study|Adverse Event|1|||
155644141|NCT00845182|561786909|FG002|Overall Study|Adverse Event|1|||
155320687|NCT01254864|560609156|FG001|Randomization Phase|Adverse Event|5|||
155320688|NCT01254864|560609157|FG002|Randomization Phase|Adverse Event|17|||
155320689|NCT01254864|560609155|FG000|Randomization Phase|Death|0|||
155320690|NCT01254864|560609156|FG001|Randomization Phase|Death|1|||
155320691|NCT01254864|560609157|FG002|Randomization Phase|Death|0|||
155320692|NCT01254864|560609155|FG000|Randomization Phase|Lost to Follow-up|0|||
155320693|NCT01254864|560609156|FG001|Randomization Phase|Lost to Follow-up|0|||
155320694|NCT01254864|560609157|FG002|Randomization Phase|Lost to Follow-up|1|||
155320695|NCT01254864|560609155|FG000|Randomization Phase|Physician Decision|0|||
155320696|NCT01254864|560609156|FG001|Randomization Phase|Physician Decision|20|||
155320697|NCT01254864|560609157|FG002|Randomization Phase|Physician Decision|25|||
155320698|NCT01254864|560609155|FG000|Randomization Phase|Withdrawal by Subject|0|||
155320699|NCT01254864|560609156|FG001|Randomization Phase|Withdrawal by Subject|4|||
155320700|NCT01254864|560609157|FG002|Randomization Phase|Withdrawal by Subject|2|||
155320701|NCT01254864|560609155|FG000|Randomization Phase|Non-Compliance|0|||
155320702|NCT01254864|560609156|FG001|Randomization Phase|Non-Compliance|1|||
155320703|NCT01254864|560609157|FG002|Randomization Phase|Non-Compliance|0|||
155320704|NCT01254864|560609155|FG000|Randomization Phase|Comorbidities|0|||
155320705|NCT01254864|560609156|FG001|Randomization Phase|Comorbidities|2|||
155320706|NCT01254864|560609157|FG002|Randomization Phase|Comorbidities|1|||
155320707|NCT04141891|560609158|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
155320708|NCT04141891|560609159|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
155320709|NCT04141891|560609158|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
155320710|NCT04141891|560609159|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
155752503|NCT04777331|562192064|FG001|DBT Period|Withdrawal by Subject|11|||
155752504|NCT04777331|562192065|FG002|DBT Period|Withdrawal by Subject|0|||
155752505|NCT04777331|562192063|FG000|DBT Period|Randomized but not Treated|1|||
155752506|NCT04777331|562192064|FG001|DBT Period|Randomized but not Treated|3|||
155752507|NCT04777331|562192065|FG002|DBT Period|Randomized but not Treated|0|||
155752508|NCT04777331|562192063|FG000|OLE Period|Ongoing in OLE|0|||
155752509|NCT04777331|562192064|FG001|OLE Period|Ongoing in OLE|0|||
155320711|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
155320712|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
155320713|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
155320714|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
155320715|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
155320716|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
155320717|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
155320718|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
155320719|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
155320720|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
155320721|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
155320722|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
155320723|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
155320724|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
155320725|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
155320726|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
155320727|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
155320728|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
155320729|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
155320730|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
155320731|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
155320732|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
155320733|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
155320734|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
155320735|NCT01828112|560609162|FG000|Treatment Phase|Adverse Event|7|||
155320736|NCT01828112|560609163|FG001|Treatment Phase|Adverse Event|8|||
155320737|NCT01828112|560609164|FG002|Treatment Phase|Adverse Event|0|||
155320738|NCT01828112|560609162|FG000|Treatment Phase|Death|9|||
155320739|NCT01828112|560609163|FG001|Treatment Phase|Death|5|||
155320740|NCT01828112|560609164|FG002|Treatment Phase|Death|0|||
155320741|NCT01828112|560609162|FG000|Treatment Phase|No longer required treatment|0|||
155320742|NCT01828112|560609163|FG001|Treatment Phase|No longer required treatment|1|||
155320743|NCT01828112|560609164|FG002|Treatment Phase|No longer required treatment|0|||
155320744|NCT01828112|560609162|FG000|Treatment Phase|Physician Decision|6|||
155320745|NCT01828112|560609163|FG001|Treatment Phase|Physician Decision|7|||
155419992|NCT01731678|560968240|FG000|Overall Study|Did not meet inclusion criteria|1|||
155419993|NCT01731678|560968240|FG000|Overall Study|RMT too high, making TMS difficult|3|||
155419994|NCT03665285|560968241|FG000|Overall Study|Started New Anticancer Treatment|1|||
155752510|NCT04777331|562192065|FG002|OLE Period|Ongoing in OLE|534|||
155419995|NCT03665285|560968242|FG001|Overall Study|Started New Anticancer Treatment|1|||
155752511|NCT01827956|562192075|FG000|Overall Study|Protocol Violation|3|||
155320746|NCT01828112|560609164|FG002|Treatment Phase|Physician Decision|0|||
155320747|NCT01828112|560609162|FG000|Treatment Phase|Pregnancy|1|||
155320748|NCT01828112|560609163|FG001|Treatment Phase|Pregnancy|0|||
155320749|NCT01828112|560609164|FG002|Treatment Phase|Pregnancy|0|||
155320750|NCT01828112|560609162|FG000|Treatment Phase|Progressive disease|79|||
155320751|NCT01828112|560609163|FG001|Treatment Phase|Progressive disease|87|||
155320752|NCT01828112|560609164|FG002|Treatment Phase|Progressive disease|0|||
155320753|NCT01828112|560609162|FG000|Treatment Phase|Study terminated by sponsor|1|||
155320754|NCT01828112|560609163|FG001|Treatment Phase|Study terminated by sponsor|0|||
155320755|NCT01828112|560609164|FG002|Treatment Phase|Study terminated by sponsor|0|||
155320756|NCT01828112|560609162|FG000|Treatment Phase|Subject/guardian decision|12|||
155320757|NCT01828112|560609163|FG001|Treatment Phase|Subject/guardian decision|8|||
155320758|NCT01828112|560609164|FG002|Treatment Phase|Subject/guardian decision|0|||
155320759|NCT01828112|560609162|FG000|Extension Treatment Phase|Adverse Event|0|||
155320760|NCT01828112|560609163|FG001|Extension Treatment Phase|Adverse Event|0|||
155320761|NCT01828112|560609164|FG002|Extension Treatment Phase|Adverse Event|6|||
155320762|NCT01828112|560609162|FG000|Extension Treatment Phase|Death|0|||
155320763|NCT01828112|560609163|FG001|Extension Treatment Phase|Death|0|||
155320764|NCT01828112|560609164|FG002|Extension Treatment Phase|Death|17|||
155320765|NCT01828112|560609162|FG000|Extension Treatment Phase|Physician Decision|0|||
155320766|NCT01828112|560609163|FG001|Extension Treatment Phase|Physician Decision|0|||
155320767|NCT01828112|560609164|FG002|Extension Treatment Phase|Physician Decision|5|||
155320768|NCT01828112|560609162|FG000|Extension Treatment Phase|Progressive disease|0|||
155320769|NCT01828112|560609163|FG001|Extension Treatment Phase|Progressive disease|0|||
155320770|NCT01828112|560609164|FG002|Extension Treatment Phase|Progressive disease|46|||
155320771|NCT01828112|560609162|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
155320772|NCT01828112|560609163|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
155320773|NCT01828112|560609164|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
155320774|NCT01828112|560609162|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
155320775|NCT01828112|560609163|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
155320776|NCT01828112|560609164|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
155320777|NCT04308681|560609165|FG000|Pre-Treatment|Not reported|1|||
155320778|NCT04308681|560609166|FG001|Pre-Treatment|Not reported|1|||
155320779|NCT04308681|560609167|FG002|Pre-Treatment|Not reported|0|||
155320780|NCT04308681|560609168|FG003|Pre-Treatment|Not reported|0|||
155320781|NCT04308681|560609169|FG004|Pre-Treatment|Not reported|0|||
155320782|NCT04308681|560609170|FG005|Pre-Treatment|Not reported|2|||
155320783|NCT04308681|560609171|FG006|Pre-Treatment|Not reported|0|||
155320784|NCT04308681|560609172|FG007|Pre-Treatment|Not reported|0|||
155320785|NCT04308681|560609165|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
155320786|NCT04308681|560609166|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
155320787|NCT04308681|560609167|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
155320788|NCT04308681|560609168|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
155320789|NCT04308681|560609169|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
155320790|NCT04308681|560609170|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
155320791|NCT04308681|560609171|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
155320792|NCT04308681|560609172|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
155320793|NCT04308681|560609165|FG000|Treatment up to Week 26|Other reasons|2|||
155320794|NCT04308681|560609166|FG001|Treatment up to Week 26|Other reasons|0|||
155320795|NCT04308681|560609167|FG002|Treatment up to Week 26|Other reasons|0|||
155320796|NCT04308681|560609168|FG003|Treatment up to Week 26|Other reasons|0|||
155320797|NCT04308681|560609169|FG004|Treatment up to Week 26|Other reasons|1|||
155320798|NCT04308681|560609170|FG005|Treatment up to Week 26|Other reasons|1|||
155320799|NCT04308681|560609171|FG006|Treatment up to Week 26|Other reasons|0|||
155320800|NCT04308681|560609172|FG007|Treatment up to Week 26|Other reasons|0|||
155320801|NCT04308681|560609165|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320802|NCT04308681|560609166|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320803|NCT04308681|560609167|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
155320804|NCT04308681|560609168|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320805|NCT04308681|560609169|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320806|NCT04308681|560609170|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320807|NCT04308681|560609171|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320808|NCT04308681|560609172|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320809|NCT04308681|560609165|FG000|Treatment up to Week 26|Adverse Event|6|||
155320810|NCT04308681|560609166|FG001|Treatment up to Week 26|Adverse Event|5|||
155320811|NCT04308681|560609167|FG002|Treatment up to Week 26|Adverse Event|5|||
155320812|NCT04308681|560609168|FG003|Treatment up to Week 26|Adverse Event|0|||
155320813|NCT04308681|560609169|FG004|Treatment up to Week 26|Adverse Event|6|||
155320814|NCT04308681|560609170|FG005|Treatment up to Week 26|Adverse Event|1|||
155320815|NCT04308681|560609171|FG006|Treatment up to Week 26|Adverse Event|0|||
155501176|NCT00391118|561260822|FG001|Overall Study|Withdrawal by Subject|9|||
155501177|NCT00391118|561260823|FG002|Overall Study|Withdrawal by Subject|1|||
155644142|NCT00845182|561786907|FG000|Overall Study|Physician Decision|0|||
155644143|NCT00845182|561786908|FG001|Overall Study|Physician Decision|0|||
155644144|NCT00845182|561786909|FG002|Overall Study|Physician Decision|1|||
155644145|NCT04621760|561786910|FG000|Overall Study|Lost to Follow-up|2|||
155644146|NCT04621760|561786911|FG001|Overall Study|Lost to Follow-up|4|||
155644147|NCT04621760|561786910|FG000|Overall Study|Withdrawal by Subject|1|||
155644148|NCT04621760|561786911|FG001|Overall Study|Withdrawal by Subject|0|||
155644149|NCT02965716|561786913|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155644150|NCT02965716|561786914|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
155644151|NCT02965716|561786913|FG000|Overall Study|Progression/Relapse|8|||
155644152|NCT02965716|561786914|FG001|Overall Study|Progression/Relapse|16|||
155644153|NCT02965716|561786913|FG000|Overall Study|Death|1|||
155644154|NCT02965716|561786914|FG001|Overall Study|Death|0|||
155644155|NCT02965716|561786913|FG000|Overall Study|Not Protocol Specified|1|||
155644156|NCT02965716|561786914|FG001|Overall Study|Not Protocol Specified|3|||
155644157|NCT01336972|561786915|FG000|Overall Study|Adverse Event|1|||
155644158|NCT01336972|561786916|FG001|Overall Study|Adverse Event|1|||
155644159|NCT01336972|561786917|FG002|Overall Study|Adverse Event|0|||
155320816|NCT04308681|560609172|FG007|Treatment up to Week 26|Adverse Event|0|||
155320817|NCT04308681|560609165|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320818|NCT04308681|560609166|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
155320819|NCT04308681|560609167|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
155320820|NCT04308681|560609168|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320821|NCT04308681|560609169|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320822|NCT04308681|560609170|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320823|NCT04308681|560609171|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320824|NCT04308681|560609172|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320825|NCT04308681|560609165|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
155320826|NCT04308681|560609166|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
155320827|NCT04308681|560609167|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
155320828|NCT04308681|560609168|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
155320829|NCT04308681|560609169|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
155320830|NCT04308681|560609170|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
155320831|NCT04308681|560609171|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
155320832|NCT04308681|560609172|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
155320833|NCT04308681|560609165|FG000|OTE - 26 Weeks|Death|0|||
155320834|NCT04308681|560609166|FG001|OTE - 26 Weeks|Death|1|||
155320835|NCT04308681|560609167|FG002|OTE - 26 Weeks|Death|0|||
155320836|NCT04308681|560609168|FG003|OTE - 26 Weeks|Death|0|||
155320837|NCT04308681|560609169|FG004|OTE - 26 Weeks|Death|0|||
155320838|NCT04308681|560609170|FG005|OTE - 26 Weeks|Death|0|||
155320839|NCT04308681|560609171|FG006|OTE - 26 Weeks|Death|1|||
155320840|NCT04308681|560609172|FG007|OTE - 26 Weeks|Death|0|||
155320841|NCT04308681|560609165|FG000|OTE - 26 Weeks|Adverse Event|0|||
155320842|NCT04308681|560609166|FG001|OTE - 26 Weeks|Adverse Event|2|||
155320843|NCT04308681|560609167|FG002|OTE - 26 Weeks|Adverse Event|8|||
155320844|NCT04308681|560609168|FG003|OTE - 26 Weeks|Adverse Event|3|||
155320845|NCT04308681|560609169|FG004|OTE - 26 Weeks|Adverse Event|0|||
155320846|NCT04308681|560609170|FG005|OTE - 26 Weeks|Adverse Event|1|||
155320847|NCT04308681|560609171|FG006|OTE - 26 Weeks|Adverse Event|2|||
155320848|NCT04308681|560609172|FG007|OTE - 26 Weeks|Adverse Event|0|||
155320849|NCT04308681|560609165|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320850|NCT04308681|560609166|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320851|NCT04308681|560609167|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320852|NCT04308681|560609168|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320853|NCT04308681|560609169|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320854|NCT04308681|560609170|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320855|NCT04308681|560609171|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320856|NCT04308681|560609172|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320857|NCT04571619|560609177|FG000|Phase 1|Death|22|||
155320858|NCT04571619|560609178|FG001|Phase 1|Death|18|||
155320859|NCT04571619|560609177|FG000|Phase 1|Withdrawal by Subject|7|||
155320860|NCT04571619|560609178|FG001|Phase 1|Withdrawal by Subject|2|||
155501178|NCT00391118|561260821|FG000|Overall Study|Death|0|||
155644160|NCT02441114|561786921|FG000|Washout2|Withdrawal by Subject|4|||
155644161|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
155644162|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
155644163|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
155644164|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
155644165|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
155644166|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
155320861|NCT04571619|560609177|FG000|Phase 2|Death|13|||
155320862|NCT04571619|560609178|FG001|Phase 2|Death|16|||
155320863|NCT04571619|560609177|FG000|Phase 2|Withdrawal by Subject|6|||
155320864|NCT04571619|560609178|FG001|Phase 2|Withdrawal by Subject|4|||
155320865|NCT05309291|560609183|FG000|Overall Study|Adverse Event|0|||
155320866|NCT05309291|560609184|FG001|Overall Study|Adverse Event|1|||
155320867|NCT05209152|560609185|FG000|Overall Study|Sponsor decision|1|||
155320868|NCT05209152|560609186|FG001|Overall Study|Sponsor decision|2|||
155320869|NCT05209152|560609185|FG000|Overall Study|Death|3|||
155320870|NCT05209152|560609186|FG001|Overall Study|Death|1|||
155320871|NCT04857723|560609190|FG000|Overall Study|Withdrawal by Subject|2|||
155501179|NCT00391118|561260822|FG001|Overall Study|Death|1|||
155501180|NCT00391118|561260823|FG002|Overall Study|Death|0|||
155320874|NCT00696111|560610713|FG000|Overall Study|Withdrawal by Subject|17|||
155320875|NCT04850898|560610714|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
155320876|NCT04850898|560610715|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
155320877|NCT04550221|560610716|FG000|Overall Study|Lost to Follow-up|0|||
155320878|NCT04550221|560610717|FG001|Overall Study|Lost to Follow-up|4|||
155320879|NCT04550221|560610716|FG000|Overall Study|Withdrawn|3|||
155320880|NCT04550221|560610717|FG001|Overall Study|Withdrawn|0|||
155320881|NCT04550221|560610716|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
155320882|NCT04550221|560610717|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
155320883|NCT03676192|560610719|FG000|Induction Study Period|Adverse Event|21|||
155320884|NCT03676192|560610720|FG001|Induction Study Period|Adverse Event|20|||
155320885|NCT03676192|560610719|FG000|Induction Study Period|Death|23|||
155320886|NCT03676192|560610720|FG001|Induction Study Period|Death|20|||
155320887|NCT03676192|560610719|FG000|Induction Study Period|Lost to Follow-up|3|||
155320888|NCT03676192|560610720|FG001|Induction Study Period|Lost to Follow-up|3|||
155320889|NCT03676192|560610719|FG000|Induction Study Period|Physician Decision|6|||
155320890|NCT03676192|560610720|FG001|Induction Study Period|Physician Decision|3|||
155752512|NCT03993379|562192076|FG000|Overall Study|The study was terminated early due to business decision.|0|||
155752513|NCT03993379|562192077|FG001|Overall Study|The study was terminated early due to business decision.|2|||
155752514|NCT03993379|562192078|FG002|Overall Study|The study was terminated early due to business decision.|0|||
155752515|NCT03993379|562192079|FG003|Overall Study|The study was terminated early due to business decision.|0|||
155752516|NCT03993379|562192076|FG000|Overall Study|Withdrawal by Subject|0|||
155752517|NCT03993379|562192077|FG001|Overall Study|Withdrawal by Subject|1|||
155752518|NCT03993379|562192078|FG002|Overall Study|Withdrawal by Subject|0|||
155752519|NCT03993379|562192079|FG003|Overall Study|Withdrawal by Subject|0|||
155752520|NCT05029687|562192080|FG000|Overall Study|Withdrawal by Subject|4|||
155752521|NCT05029687|562192081|FG001|Overall Study|Withdrawal by Subject|0|||
155752522|NCT05029687|562192082|FG002|Overall Study|Withdrawal by Subject|2|||
155752523|NCT05029687|562192080|FG000|Overall Study|Lost to Follow-up|4|||
155752524|NCT05029687|562192081|FG001|Overall Study|Lost to Follow-up|0|||
155752525|NCT05029687|562192082|FG002|Overall Study|Lost to Follow-up|2|||
155752526|NCT03345420|562192083|FG000|Overall Study|Withdrawal by Subject|1|||
155752527|NCT05740371|562192086|FG000|Overall Study|Death|1|||
155752528|NCT06374394|562192438|FG000|Overall Study|Adverse Event|0|||
155752529|NCT06374394|562192439|FG001|Overall Study|Adverse Event|2|||
155752530|NCT06374394|562192438|FG000|Overall Study|Lost to Follow-up|6|||
155752531|NCT06374394|562192439|FG001|Overall Study|Lost to Follow-up|9|||
155752532|NCT06374394|562192438|FG000|Overall Study|Withdrawal by Subject|1|||
155752533|NCT06374394|562192439|FG001|Overall Study|Withdrawal by Subject|7|||
155752534|NCT06374394|562192438|FG000|Overall Study|Other|1|||
155752535|NCT06374394|562192439|FG001|Overall Study|Other|0|||
155752536|NCT06475729|562192444|FG000|Overall Study|Withdrawal by Subject|2|||
155752537|NCT06475729|562192445|FG001|Overall Study|Withdrawal by Subject|1|||
155752538|NCT06475729|562192444|FG000|Overall Study|Randomized but did not receive any dose|3|||
155752539|NCT06475729|562192445|FG001|Overall Study|Randomized but did not receive any dose|2|||
155752540|NCT06475729|562192444|FG000|Overall Study|Lost to Follow-up|1|||
155752541|NCT06475729|562192445|FG001|Overall Study|Lost to Follow-up|2|||
155752542|NCT06475729|562192444|FG000|Overall Study|Physician Decision|5|||
155752543|NCT06475729|562192445|FG001|Overall Study|Physician Decision|2|||
155752544|NCT06475729|562192444|FG000|Overall Study|Adverse Event|1|||
155752545|NCT06475729|562192445|FG001|Overall Study|Adverse Event|1|||
155752546|NCT00006436|562192450|FG000|Overall Study|Refused further treatment|2|||
155752547|NCT00006436|562192450|FG000|Overall Study|Declined to participate (before treatment started)|1|||
155752548|NCT04569084|562192868|FG000|Overall Study|Adverse Event|10|||
155752549|NCT04569084|562192869|FG001|Overall Study|Adverse Event|14|||
155752550|NCT04569084|562192868|FG000|Overall Study|Death|2|||
155752551|NCT04569084|562192869|FG001|Overall Study|Death|3|||
155752552|NCT04569084|562192868|FG000|Overall Study|Lost to Follow-up|1|||
155752553|NCT04569084|562192869|FG001|Overall Study|Lost to Follow-up|1|||
155752554|NCT04569084|562192868|FG000|Overall Study|Physician Decision|3|||
155752555|NCT04569084|562192869|FG001|Overall Study|Physician Decision|3|||
155320891|NCT03676192|560610719|FG000|Induction Study Period|Progressive Disease|32|||
155320892|NCT03676192|560610720|FG001|Induction Study Period|Progressive Disease|21|||
155320893|NCT03676192|560610719|FG000|Induction Study Period|Protocol Violation|1|||
155320894|NCT03676192|560610720|FG001|Induction Study Period|Protocol Violation|2|||
155320895|NCT03676192|560610719|FG000|Induction Study Period|Withdrawal by Subject|20|||
155320896|NCT03676192|560610720|FG001|Induction Study Period|Withdrawal by Subject|15|||
155320897|NCT03386578|560610722|FG000|PK Component|Lost to Follow-up|0|||
155320898|NCT03386578|560610723|FG001|PK Component|Lost to Follow-up|1|||
155320899|NCT03386578|560610724|FG002|PK Component|Lost to Follow-up|0|||
155320900|NCT03386578|560610725|FG003|PK Component|Lost to Follow-up|0|||
155320901|NCT03386578|560610726|FG004|PK Component|Lost to Follow-up|0|||
155320902|NCT03386578|560610727|FG005|PK Component|Lost to Follow-up|0|||
155320903|NCT03386578|560610728|FG006|PK Component|Lost to Follow-up|1|||
155320904|NCT03386578|560610729|FG007|PK Component|Lost to Follow-up|0|||
155320905|NCT03386578|560610730|FG008|PK Component|Lost to Follow-up|0|||
155320906|NCT03386578|560610731|FG009|PK Component|Lost to Follow-up|0|||
155320907|NCT03386578|560610722|FG000|PK Component|Stillbirth/Abortion|0|||
155320908|NCT03386578|560610723|FG001|PK Component|Stillbirth/Abortion|0|||
155320909|NCT03386578|560610724|FG002|PK Component|Stillbirth/Abortion|0|||
155320910|NCT03386578|560610725|FG003|PK Component|Stillbirth/Abortion|0|||
155320911|NCT03386578|560610726|FG004|PK Component|Stillbirth/Abortion|0|||
155320912|NCT03386578|560610727|FG005|PK Component|Stillbirth/Abortion|2|||
155320913|NCT03386578|560610728|FG006|PK Component|Stillbirth/Abortion|0|||
155320914|NCT03386578|560610729|FG007|PK Component|Stillbirth/Abortion|0|||
155320915|NCT03386578|560610730|FG008|PK Component|Stillbirth/Abortion|0|||
155320916|NCT03386578|560610731|FG009|PK Component|Stillbirth/Abortion|0|||
155320917|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320918|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320919|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
155320920|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
155320921|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320922|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320923|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320924|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
155320925|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
155320926|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320927|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320928|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320929|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
155320930|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
155320931|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320932|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320933|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320934|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
155320935|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
155320936|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320937|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Death|0|||
155320938|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Death|0|||
155320939|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Death|1|||
155320940|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Death|0|||
155320941|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Death|0|||
155320942|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Death|0|||
155320943|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Death|0|||
155320944|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Death|9|||
155320945|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Death|5|||
155320946|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Death|0|||
155320947|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320948|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320949|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320950|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
155320951|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320952|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320953|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320954|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320955|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
155320956|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155419996|NCT03665285|560968243|FG002|Overall Study|Started New Anticancer Treatment|2|||
155419997|NCT03665285|560968244|FG003|Overall Study|Started New Anticancer Treatment|4|||
155320957|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155419998|NCT03665285|560968245|FG004|Overall Study|Started New Anticancer Treatment|1|||
155320958|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320959|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320960|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320961|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320962|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320963|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320964|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
155320965|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
155320966|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320967|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320968|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320969|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320970|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320971|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320972|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320973|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320974|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
155320975|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
155320976|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320977|NCT02694822|560610734|FG000|Phase 1|Death|2|||
155320978|NCT02694822|560610735|FG001|Phase 1|Death|1|||
155320979|NCT02694822|560610736|FG002|Phase 1|Death|6|||
155320980|NCT02694822|560610737|FG003|Phase 1|Death|6|||
155320981|NCT02694822|560610738|FG004|Phase 1|Death|3|||
155320982|NCT02694822|560610739|FG005|Phase 1|Death|0|||
155320983|NCT02694822|560610734|FG000|Phase 1|Withdrawal by Subject|2|||
155320984|NCT02694822|560610735|FG001|Phase 1|Withdrawal by Subject|2|||
155320985|NCT02694822|560610736|FG002|Phase 1|Withdrawal by Subject|4|||
155320986|NCT02694822|560610737|FG003|Phase 1|Withdrawal by Subject|8|||
155320987|NCT02694822|560610738|FG004|Phase 1|Withdrawal by Subject|1|||
155320988|NCT02694822|560610739|FG005|Phase 1|Withdrawal by Subject|0|||
155320989|NCT02694822|560610734|FG000|Phase 2|Death|0|||
155320990|NCT02694822|560610735|FG001|Phase 2|Death|0|||
155320991|NCT02694822|560610736|FG002|Phase 2|Death|0|||
155320992|NCT02694822|560610737|FG003|Phase 2|Death|0|||
155320993|NCT02694822|560610738|FG004|Phase 2|Death|0|||
155320994|NCT02694822|560610739|FG005|Phase 2|Death|26|||
155320995|NCT02694822|560610734|FG000|Phase 2|Withdrawal by Subject|0|||
155320996|NCT02694822|560610735|FG001|Phase 2|Withdrawal by Subject|0|||
155320997|NCT02694822|560610736|FG002|Phase 2|Withdrawal by Subject|0|||
155320998|NCT02694822|560610737|FG003|Phase 2|Withdrawal by Subject|0|||
155320999|NCT02694822|560610738|FG004|Phase 2|Withdrawal by Subject|0|||
155321000|NCT02694822|560610739|FG005|Phase 2|Withdrawal by Subject|13|||
155321001|NCT02694822|560610734|FG000|Phase 2|Administrative Study Closure|0|||
155321002|NCT02694822|560610735|FG001|Phase 2|Administrative Study Closure|0|||
155321003|NCT02694822|560610736|FG002|Phase 2|Administrative Study Closure|0|||
155321004|NCT02694822|560610737|FG003|Phase 2|Administrative Study Closure|0|||
155321005|NCT02694822|560610738|FG004|Phase 2|Administrative Study Closure|0|||
155321006|NCT02694822|560610739|FG005|Phase 2|Administrative Study Closure|2|||
155321007|NCT02694822|560610734|FG000|Phase 2|Lost to Follow-up|0|||
155321008|NCT02694822|560610735|FG001|Phase 2|Lost to Follow-up|0|||
155321009|NCT02694822|560610736|FG002|Phase 2|Lost to Follow-up|0|||
155321010|NCT02694822|560610737|FG003|Phase 2|Lost to Follow-up|0|||
155321011|NCT02694822|560610738|FG004|Phase 2|Lost to Follow-up|0|||
155321012|NCT02694822|560610739|FG005|Phase 2|Lost to Follow-up|1|||
155321013|NCT02694822|560610734|FG000|Phase 2|Participant Transferred to Another Site|0|||
155321014|NCT02694822|560610735|FG001|Phase 2|Participant Transferred to Another Site|0|||
155321015|NCT02694822|560610736|FG002|Phase 2|Participant Transferred to Another Site|0|||
155321016|NCT02694822|560610737|FG003|Phase 2|Participant Transferred to Another Site|0|||
155321017|NCT02694822|560610738|FG004|Phase 2|Participant Transferred to Another Site|0|||
155321018|NCT02694822|560610739|FG005|Phase 2|Participant Transferred to Another Site|1|||
155321019|NCT01868997|560610740|FG000|Overall Study|Adverse Event|2|||
155321020|NCT01868997|560610741|FG001|Overall Study|Adverse Event|5|||
155321021|NCT01868997|560610740|FG000|Overall Study|Lack of Efficacy|2|||
155321022|NCT01868997|560610741|FG001|Overall Study|Lack of Efficacy|0|||
155321023|NCT01868997|560610740|FG000|Overall Study|Other|3|||
155321024|NCT01868997|560610741|FG001|Overall Study|Other|1|||
155321025|NCT05370040|560610742|FG000|Overall Study|Lost to Follow-up|0|||
155321026|NCT05370040|560610743|FG001|Overall Study|Lost to Follow-up|0|||
155321027|NCT05370040|560610744|FG002|Overall Study|Lost to Follow-up|1|||
155321028|NCT05370040|560610745|FG003|Overall Study|Lost to Follow-up|0|||
155321029|NCT05370040|560610746|FG004|Overall Study|Lost to Follow-up|1|||
155321030|NCT05370040|560610747|FG005|Overall Study|Lost to Follow-up|0|||
155321031|NCT04971109|560610748|FG000|Overall Study|Adverse Event|4|||
155321032|NCT04971109|560610749|FG001|Overall Study|Adverse Event|3|||
155321033|NCT04971109|560610748|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
155321034|NCT04971109|560610749|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
155321035|NCT04971109|560610748|FG000|Overall Study|Lost to Follow-up|8|||
155321036|NCT04971109|560610749|FG001|Overall Study|Lost to Follow-up|2|||
155321037|NCT04971109|560610748|FG000|Overall Study|Physician Decision|5|||
155321038|NCT04971109|560610749|FG001|Overall Study|Physician Decision|0|||
155321039|NCT04971109|560610748|FG000|Overall Study|Protocol Violation|0|||
155752556|NCT04569084|562192868|FG000|Overall Study|Protocol Violation|2|||
155752557|NCT04569084|562192869|FG001|Overall Study|Protocol Violation|1|||
155752558|NCT04569084|562192868|FG000|Overall Study|Withdrawal by Subject|20|||
155752559|NCT04569084|562192869|FG001|Overall Study|Withdrawal by Subject|21|||
155752560|NCT04569084|562192868|FG000|Overall Study|Study terminated by sponsor|26|||
155752561|NCT04569084|562192869|FG001|Overall Study|Study terminated by sponsor|23|||
155752562|NCT04569084|562192868|FG000|Overall Study|Other|3|||
155752563|NCT04569084|562192869|FG001|Overall Study|Other|5|||
155752564|NCT02483429|562192871|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
155752565|NCT02483429|562192872|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
155752566|NCT04577404|562192873|FG000|Overall Study|Adverse Event|31|||
155752567|NCT04577404|562192873|FG000|Overall Study|Death|1|||
155752568|NCT04577404|562192873|FG000|Overall Study|Lack of Efficacy|3|||
155752569|NCT04577404|562192873|FG000|Overall Study|Physician Decision|7|||
155752570|NCT04577404|562192873|FG000|Overall Study|Withdrawal by Subject|21|||
155752571|NCT04577404|562192873|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
155752572|NCT05468320|562192874|FG000|Overall Study|Other|1|||
155752573|NCT05468320|562192874|FG000|Overall Study|Adverse Event|1|||
155752574|NCT03921554|562192875|FG000|Overall Study|Adverse Event|2|||
155752575|NCT03921554|562192875|FG000|Overall Study|Withdrawal by Subject|1|||
155752576|NCT03921554|562192875|FG000|Overall Study|Death|3|||
155752577|NCT04440592|562192876|FG000|Overall Study|Adverse Event|8|||
155752578|NCT04440592|562192877|FG001|Overall Study|Adverse Event|0|||
155752579|NCT04440592|562192876|FG000|Overall Study|Lost to Follow-up|1|||
155752580|NCT04440592|562192877|FG001|Overall Study|Lost to Follow-up|0|||
155752581|NCT04440592|562192876|FG000|Overall Study|Withdrawal by Subject|1|||
155321040|NCT04971109|560610749|FG001|Overall Study|Protocol Violation|1|||
155321041|NCT04971109|560610748|FG000|Overall Study|Withdrawal by Subject|18|||
155321042|NCT04971109|560610749|FG001|Overall Study|Withdrawal by Subject|3|||
155321043|NCT04971109|560610748|FG000|Overall Study|Subject was randomized in error|1|||
155321044|NCT04971109|560610749|FG001|Overall Study|Subject was randomized in error|0|||
155321045|NCT04778397|560610752|FG000|Overall Study|Death|59|||
155321046|NCT04778397|560610753|FG001|Overall Study|Death|54|||
155321047|NCT04778397|560610754|FG002|Overall Study|Death|11|||
155321048|NCT04778397|560610755|FG003|Overall Study|Death|9|||
155321049|NCT04778397|560610752|FG000|Overall Study|Study Terminated by Sponsor|34|||
155321050|NCT04778397|560610753|FG001|Overall Study|Study Terminated by Sponsor|42|||
155321051|NCT04778397|560610754|FG002|Overall Study|Study Terminated by Sponsor|15|||
155321052|NCT04778397|560610755|FG003|Overall Study|Study Terminated by Sponsor|12|||
155321053|NCT04778397|560610752|FG000|Overall Study|Withdrew Consent|5|||
155321054|NCT04778397|560610753|FG001|Overall Study|Withdrew Consent|4|||
155321055|NCT04778397|560610754|FG002|Overall Study|Withdrew Consent|1|||
155419999|NCT03665285|560968246|FG005|Overall Study|Started New Anticancer Treatment|1|||
155420000|NCT03665285|560968247|FG006|Overall Study|Started New Anticancer Treatment|2|||
155420001|NCT03665285|560968248|FG007|Overall Study|Started New Anticancer Treatment|15|||
155420002|NCT03665285|560968249|FG008|Overall Study|Started New Anticancer Treatment|1|||
155420003|NCT03665285|560968241|FG000|Overall Study|Disease Progression|0|||
155420004|NCT03665285|560968242|FG001|Overall Study|Disease Progression|0|||
155420005|NCT03665285|560968243|FG002|Overall Study|Disease Progression|3|||
155420006|NCT03665285|560968244|FG003|Overall Study|Disease Progression|1|||
155420007|NCT03665285|560968245|FG004|Overall Study|Disease Progression|0|||
155420008|NCT03665285|560968246|FG005|Overall Study|Disease Progression|0|||
155420009|NCT03665285|560968247|FG006|Overall Study|Disease Progression|0|||
155420010|NCT03665285|560968248|FG007|Overall Study|Disease Progression|7|||
155420011|NCT03665285|560968249|FG008|Overall Study|Disease Progression|1|||
155420012|NCT03665285|560968241|FG000|Overall Study|Hospice|0|||
155420013|NCT03665285|560968242|FG001|Overall Study|Hospice|0|||
155420014|NCT03665285|560968243|FG002|Overall Study|Hospice|0|||
155752582|NCT04440592|562192877|FG001|Overall Study|Withdrawal by Subject|1|||
155752583|NCT04440592|562192876|FG000|Overall Study|Other therapy needed|0|||
155752584|NCT04440592|562192877|FG001|Overall Study|Other therapy needed|1|||
155752585|NCT04090957|562192878|FG000|Overall Study|Lost to Follow-up|22|||
155752586|NCT04090957|562192879|FG001|Overall Study|Lost to Follow-up|25|||
155321056|NCT04778397|560610755|FG003|Overall Study|Withdrew Consent|1|||
155321057|NCT04778397|560610752|FG000|Overall Study|Reason Not Specified|1|||
155321058|NCT04778397|560610753|FG001|Overall Study|Reason Not Specified|3|||
155321059|NCT04778397|560610754|FG002|Overall Study|Reason Not Specified|0|||
155321060|NCT04778397|560610755|FG003|Overall Study|Reason Not Specified|2|||
155321061|NCT04778397|560610752|FG000|Overall Study|Lost to Follow-up|2|||
155420015|NCT03665285|560968244|FG003|Overall Study|Hospice|0|||
155420016|NCT03665285|560968245|FG004|Overall Study|Hospice|0|||
155420017|NCT03665285|560968246|FG005|Overall Study|Hospice|0|||
155420018|NCT03665285|560968247|FG006|Overall Study|Hospice|0|||
155420019|NCT03665285|560968248|FG007|Overall Study|Hospice|2|||
155752587|NCT04090957|562192880|FG002|Overall Study|Lost to Follow-up|25|||
155752588|NCT04090957|562192881|FG003|Overall Study|Lost to Follow-up|36|||
155321062|NCT04778397|560610753|FG001|Overall Study|Lost to Follow-up|1|||
155321063|NCT04778397|560610754|FG002|Overall Study|Lost to Follow-up|0|||
155321064|NCT04778397|560610755|FG003|Overall Study|Lost to Follow-up|1|||
155321065|NCT05906784|560610757|FG000|Overall Study|Lost to Follow-up|2|||
155321066|NCT05906784|560610758|FG001|Overall Study|Lost to Follow-up|1|||
155321067|NCT05906784|560610759|FG002|Overall Study|Lost to Follow-up|1|||
155321068|NCT05906784|560610760|FG003|Overall Study|Lost to Follow-up|1|||
155321069|NCT04730739|560610764|FG000|Overall Study|Death|1|||
155321070|NCT03308877|560610765|FG000|Overall Study|Lost to Follow-up|32|||
155321071|NCT03308877|560610766|FG001|Overall Study|Lost to Follow-up|28|||
155321072|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321073|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321074|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321075|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321076|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321077|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321078|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321079|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321080|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
155321081|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
155321082|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
155321083|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
155321084|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321085|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
155321086|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321087|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321088|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321089|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321090|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321091|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321092|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321093|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
155321094|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
155321095|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321096|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321097|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321098|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321099|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321100|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321101|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321102|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321103|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
155321104|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321105|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
155321106|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
155321107|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
155321108|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
155321109|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321110|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321111|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
155321112|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
155321113|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
155321114|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
155321115|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
155321116|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
155321117|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
155321118|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
155321119|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
155321120|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
155321121|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
155321122|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321123|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321124|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321125|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321126|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321127|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321128|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321129|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
155321130|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321131|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321132|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321133|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321134|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321135|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321136|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
155321137|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
155321138|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
155321139|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
155321140|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
155321141|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
155321142|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
155321143|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
155321144|NCT03625115|560610781|FG000|Overall Study|Withdrawal by Subject|4|||
155321145|NCT03625115|560610782|FG001|Overall Study|Withdrawal by Subject|7|||
155321146|NCT03625115|560610781|FG000|Overall Study|Lost to Follow-up|17|||
155321147|NCT03625115|560610782|FG001|Overall Study|Lost to Follow-up|24|||
155321148|NCT04197336|560610783|FG000|Overall Study|Withdrawal by Subject|1|||
155321149|NCT03852550|560610793|FG000|Overall Study|Lost to Follow-up|4|||
155321150|NCT03852550|560610794|FG001|Overall Study|Lost to Follow-up|3|||
155321151|NCT03852550|560610793|FG000|Overall Study|Only parent outcomes completed|0|||
155321152|NCT03852550|560610794|FG001|Overall Study|Only parent outcomes completed|1|||
155321153|NCT03852550|560610793|FG000|Overall Study|Withdrawal by Subject|1|||
155321154|NCT03852550|560610794|FG001|Overall Study|Withdrawal by Subject|0|||
155321155|NCT05204654|560610795|FG000|Overall Study|Study terminated due to time restraint|2|||
155321156|NCT05204654|560610796|FG001|Overall Study|Study terminated due to time restraint|2|||
155321157|NCT01221948|560610797|FG000|Overall Study|Physician Decision|5|||
155321158|NCT01221948|560610797|FG000|Overall Study|Withdrawal by Subject|2|||
155321159|NCT01221948|560610797|FG000|Overall Study|not disclosed|2|||
155321160|NCT01221948|560610797|FG000|Overall Study|Death|1|||
155321161|NCT01221948|560610797|FG000|Overall Study|Protocol Violation|4|||
155321162|NCT03756662|560610798|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
155321163|NCT03626220|560610799|FG000|Overall Study|Withdrawal by Subject|2|||
155321164|NCT03626220|560610800|FG001|Overall Study|Withdrawal by Subject|0|||
155321165|NCT05565820|560610807|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
155321166|NCT05565820|560610808|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
155321167|NCT05565820|560610807|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
155321168|NCT05565820|560610808|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
155321169|NCT05828017|560610809|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
155321170|NCT05012163|560610813|FG000|Overall Study|Protocol Violation|0|||
155321171|NCT05012163|560610814|FG001|Overall Study|Protocol Violation|0|||
155321172|NCT05012163|560610815|FG002|Overall Study|Protocol Violation|1|||
155321173|NCT05012163|560610816|FG003|Overall Study|Protocol Violation|1|||
155321174|NCT04132518|560610817|FG000|Overall Study|Prematurely withdrawn from the study|0|||
155321175|NCT04132518|560610818|FG001|Overall Study|Prematurely withdrawn from the study|9|||
155321176|NCT04132518|560610819|FG002|Overall Study|Prematurely withdrawn from the study|1|||
155321177|NCT05425420|560610821|FG000|Overall Study|Physician Decision|1|||
155321178|NCT05425420|560610821|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
155321179|NCT03673501|560610822|FG000|Overall Study|Participants ongoing.|36|||
155321180|NCT03673501|560610823|FG001|Overall Study|Participants ongoing.|24|||
155321181|NCT04599634|560610824|FG000|Overall Study|Dose limiting toxicity|0|||
155321182|NCT04599634|560610825|FG001|Overall Study|Dose limiting toxicity|0|||
155321183|NCT04599634|560610826|FG002|Overall Study|Dose limiting toxicity|2|||
155321184|NCT04599634|560610827|FG003|Overall Study|Dose limiting toxicity|0|||
155321185|NCT03714815|560610828|FG000|Overall Study|Physician Decision|2|||
155321186|NCT03714815|560610828|FG000|Overall Study|Withdrawal by Subject|2|||
155321187|NCT03714815|560610828|FG000|Overall Study|Death|11|||
155321188|NCT03733925|560610831|FG000|Overall Study|Lost to Follow-up|1|||
155321189|NCT03733925|560610831|FG000|Overall Study|Withdrawal by Subject|2|||
155321190|NCT03733925|560610831|FG000|Overall Study|Adverse Event|2|||
155321191|NCT03733925|560610831|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155321192|NCT02631746|560610837|FG000|Overall Study|Lack of Efficacy|3|||
155321193|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
155321194|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
155321195|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
155321196|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
155321197|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
155321198|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
155321199|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
155420020|NCT03665285|560968249|FG008|Overall Study|Hospice|0|||
155321200|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
155321201|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
155321202|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
155321203|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
155321204|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
155321205|NCT00323856|560610840|FG000|Overall Study|Withdrawal by Subject|1|||
155321206|NCT00323856|560610840|FG000|Overall Study|Was uncooperative and noncompliant|1|||
155321207|NCT00323856|560610840|FG000|Overall Study|Reason not specified|1|||
155321208|NCT00323856|560610840|FG000|Overall Study|Missing|2|||
155321209|NCT04086121|560610841|FG000|Overall Study|Other than listed|8|||
155321210|NCT04086121|560610841|FG000|Overall Study|Withdrawal by Subject|3|||
155321211|NCT04086121|560610841|FG000|Overall Study|Lost to Follow-up|2|||
155321212|NCT04086121|560610841|FG000|Overall Study|Adverse Event|1|||
155321213|NCT04167553|560610846|FG000|Overall Study|Withdrawal by Subject|1|||
155420021|NCT03665285|560968241|FG000|Overall Study|Withdrawal by Subject|0|||
155420022|NCT03665285|560968242|FG001|Overall Study|Withdrawal by Subject|0|||
155420023|NCT03665285|560968243|FG002|Overall Study|Withdrawal by Subject|0|||
155420024|NCT03665285|560968244|FG003|Overall Study|Withdrawal by Subject|0|||
155420025|NCT03665285|560968245|FG004|Overall Study|Withdrawal by Subject|1|||
155420026|NCT03665285|560968246|FG005|Overall Study|Withdrawal by Subject|0|||
155420027|NCT03665285|560968247|FG006|Overall Study|Withdrawal by Subject|0|||
155420028|NCT03665285|560968248|FG007|Overall Study|Withdrawal by Subject|2|||
155420029|NCT03665285|560968249|FG008|Overall Study|Withdrawal by Subject|0|||
155420030|NCT03665285|560968241|FG000|Overall Study|Physician Decision|0|||
155420031|NCT03665285|560968242|FG001|Overall Study|Physician Decision|0|||
155420032|NCT03665285|560968243|FG002|Overall Study|Physician Decision|0|||
155420033|NCT03665285|560968244|FG003|Overall Study|Physician Decision|0|||
155420034|NCT03665285|560968245|FG004|Overall Study|Physician Decision|0|||
155420035|NCT03665285|560968246|FG005|Overall Study|Physician Decision|0|||
155420036|NCT03665285|560968247|FG006|Overall Study|Physician Decision|0|||
155420037|NCT03665285|560968248|FG007|Overall Study|Physician Decision|2|||
155420038|NCT03665285|560968249|FG008|Overall Study|Physician Decision|0|||
155420039|NCT00354601|560968250|FG000|Overall Study|Protocol Violation|1|||
155420040|NCT00354601|560968250|FG000|Overall Study|progression|1|||
155420041|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
155420042|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
155420043|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
155420044|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Death|28|||
155420045|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Death|0|||
155420046|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Death|0|||
155420047|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
155420048|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
155420049|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
155420050|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
155420051|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
155420052|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
155420053|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
155420054|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
155420055|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
155420056|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
155420057|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
155420058|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
155420059|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
155420060|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
155420061|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
155420062|NCT00820755|560968253|FG000|Period 1: Combination Therapy Phase|Other|11|||
155420063|NCT00820755|560968254|FG001|Period 1: Combination Therapy Phase|Other|0|||
155420064|NCT00820755|560968255|FG002|Period 1: Combination Therapy Phase|Other|0|||
155420065|NCT00820755|560968253|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
155420066|NCT00820755|560968254|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
155420067|NCT00820755|560968255|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
155420068|NCT02251912|560968256|FG000|Overall Study|Withdrawal by Subject|2|||
155420069|NCT02251912|560968257|FG001|Overall Study|Withdrawal by Subject|3|||
155420070|NCT02251912|560968256|FG000|Overall Study|Adverse Event|0|||
155321214|NCT04167553|560610847|FG001|Overall Study|Withdrawal by Subject|0|||
155420071|NCT02251912|560968257|FG001|Overall Study|Adverse Event|2|||
155420072|NCT03434379|560968259|FG000|Global Period|Lost to Follow-up|3|||
155420073|NCT03434379|560968260|FG001|Global Period|Lost to Follow-up|6|||
155420074|NCT03434379|560968261|FG002|Global Period|Lost to Follow-up|0|||
155420075|NCT03434379|560968262|FG003|Global Period|Lost to Follow-up|0|||
155420076|NCT03434379|560968259|FG000|Global Period|Death|115|||
155420077|NCT03434379|560968260|FG001|Global Period|Death|228|||
155420078|NCT03434379|560968261|FG002|Global Period|Death|0|||
155420079|NCT03434379|560968262|FG003|Global Period|Death|0|||
155420080|NCT03434379|560968259|FG000|Global Period|Withdrawal by Subject|20|||
155420081|NCT03434379|560968260|FG001|Global Period|Withdrawal by Subject|21|||
155420082|NCT03434379|560968261|FG002|Global Period|Withdrawal by Subject|0|||
155420083|NCT03434379|560968262|FG003|Global Period|Withdrawal by Subject|0|||
155420084|NCT03434379|560968259|FG000|Global Period|Reason Unspecified|0|||
155420085|NCT03434379|560968260|FG001|Global Period|Reason Unspecified|1|||
155420086|NCT03434379|560968261|FG002|Global Period|Reason Unspecified|0|||
155420087|NCT03434379|560968262|FG003|Global Period|Reason Unspecified|0|||
155420088|NCT03434379|560968259|FG000|Global Period|Study Ended by Sponsor|26|||
155420089|NCT03434379|560968260|FG001|Global Period|Study Ended by Sponsor|80|||
155420090|NCT03434379|560968261|FG002|Global Period|Study Ended by Sponsor|0|||
155420091|NCT03434379|560968262|FG003|Global Period|Study Ended by Sponsor|0|||
155420092|NCT03434379|560968259|FG000|Global Period|Physician Decision|1|||
155420093|NCT03434379|560968260|FG001|Global Period|Physician Decision|0|||
155420094|NCT03434379|560968261|FG002|Global Period|Physician Decision|0|||
155420095|NCT03434379|560968262|FG003|Global Period|Physician Decision|0|||
155420096|NCT03434379|560968259|FG000|China Extension Period|Lost to Follow-up|0|||
155420097|NCT03434379|560968260|FG001|China Extension Period|Lost to Follow-up|0|||
155420098|NCT03434379|560968261|FG002|China Extension Period|Lost to Follow-up|2|||
155420099|NCT03434379|560968262|FG003|China Extension Period|Lost to Follow-up|3|||
155420100|NCT03434379|560968259|FG000|China Extension Period|Death|0|||
155420101|NCT03434379|560968260|FG001|China Extension Period|Death|0|||
155420102|NCT03434379|560968261|FG002|China Extension Period|Death|46|||
155420103|NCT03434379|560968262|FG003|China Extension Period|Death|88|||
155420104|NCT03434379|560968259|FG000|China Extension Period|Withdrawal by Subject|0|||
155420105|NCT03434379|560968260|FG001|China Extension Period|Withdrawal by Subject|0|||
155420106|NCT03434379|560968261|FG002|China Extension Period|Withdrawal by Subject|8|||
155420107|NCT03434379|560968262|FG003|China Extension Period|Withdrawal by Subject|6|||
155420108|NCT03434379|560968259|FG000|China Extension Period|Study Ended by Sponsor|0|||
155420109|NCT03434379|560968260|FG001|China Extension Period|Study Ended by Sponsor|0|||
155420110|NCT03434379|560968261|FG002|China Extension Period|Study Ended by Sponsor|5|||
155420111|NCT03434379|560968262|FG003|China Extension Period|Study Ended by Sponsor|36|||
155420112|NCT00686647|560968268|FG000|Overall Study|Lost to Follow-up|1|||
155420113|NCT00686647|560968268|FG000|Overall Study|Death|1|||
155420114|NCT03179436|560968270|FG000|Overall Study|Withdrawal by Subject|1|||
155420115|NCT03179436|560968271|FG001|Overall Study|Withdrawal by Subject|0|||
155420116|NCT03179436|560968272|FG002|Overall Study|Withdrawal by Subject|0|||
155420117|NCT03179436|560968273|FG003|Overall Study|Withdrawal by Subject|4|||
155420118|NCT03179436|560968274|FG004|Overall Study|Withdrawal by Subject|2|||
155420119|NCT03179436|560968275|FG005|Overall Study|Withdrawal by Subject|2|||
155420120|NCT03179436|560968276|FG006|Overall Study|Withdrawal by Subject|5|||
155420121|NCT03179436|560968277|FG007|Overall Study|Withdrawal by Subject|0|||
155420122|NCT03179436|560968278|FG008|Overall Study|Withdrawal by Subject|3|||
155420123|NCT03179436|560968279|FG009|Overall Study|Withdrawal by Subject|0|||
155420124|NCT03179436|560968280|FG010|Overall Study|Withdrawal by Subject|0|||
155420125|NCT03179436|560968281|FG011|Overall Study|Withdrawal by Subject|0|||
155420126|NCT03179436|560968270|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155420127|NCT03179436|560968271|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155420128|NCT03179436|560968272|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155420129|NCT03179436|560968273|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155420130|NCT03179436|560968274|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155420131|NCT03179436|560968275|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155420132|NCT03179436|560968276|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
155420133|NCT03179436|560968277|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
155420134|NCT03179436|560968278|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
155420135|NCT03179436|560968279|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
155420136|NCT03179436|560968280|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
155420137|NCT03179436|560968281|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
155420138|NCT03179436|560968270|FG000|Overall Study|Sponsor Decision|0|||
155644167|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
155420139|NCT03179436|560968271|FG001|Overall Study|Sponsor Decision|0|||
155420140|NCT03179436|560968272|FG002|Overall Study|Sponsor Decision|1|||
155420141|NCT03179436|560968273|FG003|Overall Study|Sponsor Decision|3|||
155420142|NCT03179436|560968274|FG004|Overall Study|Sponsor Decision|9|||
155420143|NCT03179436|560968275|FG005|Overall Study|Sponsor Decision|7|||
155420144|NCT03179436|560968276|FG006|Overall Study|Sponsor Decision|2|||
155420145|NCT03179436|560968277|FG007|Overall Study|Sponsor Decision|4|||
155501181|NCT00391118|561260821|FG000|Overall Study|Physician Decision|0|||
155644168|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
155644169|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
155420146|NCT03179436|560968278|FG008|Overall Study|Sponsor Decision|23|||
155420147|NCT03179436|560968279|FG009|Overall Study|Sponsor Decision|6|||
155420148|NCT03179436|560968280|FG010|Overall Study|Sponsor Decision|7|||
155501182|NCT00391118|561260822|FG001|Overall Study|Physician Decision|3|||
155501183|NCT00391118|561260823|FG002|Overall Study|Physician Decision|0|||
155501184|NCT00391118|561260821|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
155501185|NCT00391118|561260822|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
155501186|NCT00391118|561260823|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
155501187|NCT00391118|561260821|FG000|Overall Study|Progressive Disease|7|||
155501188|NCT00391118|561260822|FG001|Overall Study|Progressive Disease|26|||
155501189|NCT00391118|561260823|FG002|Overall Study|Progressive Disease|43|||
155501190|NCT00391118|561260821|FG000|Overall Study|Sponsor Decision|0|||
155501191|NCT00391118|561260822|FG001|Overall Study|Sponsor Decision|1|||
155501192|NCT00391118|561260823|FG002|Overall Study|Sponsor Decision|3|||
155501193|NCT00391118|561260821|FG000|Overall Study|Protocol Violation|1|||
155501194|NCT00391118|561260822|FG001|Overall Study|Protocol Violation|0|||
155501195|NCT00391118|561260823|FG002|Overall Study|Protocol Violation|0|||
155501196|NCT01892020|561260824|FG000|Period 1|Adverse Event|1|||
155501197|NCT01892020|561260825|FG001|Period 1|Adverse Event|1|||
155501198|NCT01892020|561260824|FG000|Period 1|Protocol Violation|2|||
155501199|NCT01892020|561260825|FG001|Period 1|Protocol Violation|4|||
155501200|NCT01892020|561260824|FG000|Period 1|Unclassified|0|||
155501201|NCT01892020|561260825|FG001|Period 1|Unclassified|1|||
155501202|NCT01892020|561260824|FG000|Period 2|Protocol Violation|1|||
155501203|NCT01892020|561260825|FG001|Period 2|Protocol Violation|0|||
155501204|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501205|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501206|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501207|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155501208|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155501209|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501210|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501211|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501212|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501213|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155501214|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501215|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501216|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155501217|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
155501218|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155501219|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
155501220|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
155501221|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
155501222|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155501223|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501224|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501225|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501226|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501227|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501228|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
155501229|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501230|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501231|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501232|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
155501233|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501234|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501235|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501236|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
155501237|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
155501238|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
155501239|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
155501240|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
155501241|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
155501242|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
155501243|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501244|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501245|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501246|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501247|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
155501248|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501249|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155420149|NCT03179436|560968281|FG011|Overall Study|Sponsor Decision|5|||
155420150|NCT03179436|560968270|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420151|NCT03179436|560968271|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
155420152|NCT03179436|560968272|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420153|NCT03179436|560968273|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420154|NCT03179436|560968274|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420155|NCT03179436|560968275|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
155420156|NCT03179436|560968276|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420157|NCT03179436|560968277|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420158|NCT03179436|560968278|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420159|NCT03179436|560968279|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420160|NCT03179436|560968280|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420161|NCT03179436|560968281|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
155420162|NCT03179436|560968270|FG000|Overall Study|Lost to Follow-up|1|||
155420163|NCT03179436|560968271|FG001|Overall Study|Lost to Follow-up|0|||
155420164|NCT03179436|560968272|FG002|Overall Study|Lost to Follow-up|0|||
155420165|NCT03179436|560968273|FG003|Overall Study|Lost to Follow-up|1|||
155420166|NCT03179436|560968274|FG004|Overall Study|Lost to Follow-up|0|||
155420167|NCT03179436|560968275|FG005|Overall Study|Lost to Follow-up|1|||
155420168|NCT03179436|560968276|FG006|Overall Study|Lost to Follow-up|0|||
155420169|NCT03179436|560968277|FG007|Overall Study|Lost to Follow-up|0|||
155420170|NCT03179436|560968278|FG008|Overall Study|Lost to Follow-up|1|||
155420171|NCT03179436|560968279|FG009|Overall Study|Lost to Follow-up|1|||
155420172|NCT03179436|560968280|FG010|Overall Study|Lost to Follow-up|0|||
155420173|NCT03179436|560968281|FG011|Overall Study|Lost to Follow-up|0|||
155420174|NCT03179436|560968270|FG000|Overall Study|Death|12|||
155420175|NCT03179436|560968271|FG001|Overall Study|Death|17|||
155420176|NCT03179436|560968272|FG002|Overall Study|Death|7|||
155420177|NCT03179436|560968273|FG003|Overall Study|Death|32|||
155420178|NCT03179436|560968274|FG004|Overall Study|Death|29|||
155420179|NCT03179436|560968275|FG005|Overall Study|Death|30|||
155420180|NCT03179436|560968276|FG006|Overall Study|Death|33|||
155420181|NCT03179436|560968277|FG007|Overall Study|Death|9|||
155420182|NCT03179436|560968278|FG008|Overall Study|Death|84|||
155420183|NCT03179436|560968279|FG009|Overall Study|Death|33|||
155420184|NCT03179436|560968280|FG010|Overall Study|Death|22|||
155420185|NCT03179436|560968281|FG011|Overall Study|Death|15|||
155420186|NCT01634555|560968282|FG000|Overall Study|Adverse Event|3|||
155420187|NCT01634555|560968282|FG000|Overall Study|Physician Decision|1|||
155420188|NCT00809328|560970430|FG000|Overall Study|Lack of Efficacy|18|||
155420189|NCT00809328|560970430|FG000|Overall Study|Adverse Event|6|||
155420190|NCT00809328|560970430|FG000|Overall Study|Protocol Violation|3|||
155420191|NCT00809328|560970430|FG000|Overall Study|Withdrawal by Subject|2|||
155420192|NCT00282243|560970433|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
155420193|NCT00282243|560970433|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
155420194|NCT00282243|560970433|FG000|Extension Treatment Period|Adverse Event|15|||
155420195|NCT00282243|560970433|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
155420196|NCT00282243|560970433|FG000|Extension Treatment Period|Non-compliance|2|||
155420197|NCT00282243|560970433|FG000|Extension Treatment Period|Physician Decision|1|||
155420198|NCT00270894|560970434|FG000|Overall Study|Adverse Event|1|||
155420199|NCT00270894|560970434|FG000|Overall Study|Withdrawal by Subject|1|||
155420200|NCT00686127|560970435|FG000|Overall Study|Withdrawal by Subject|14|||
155420201|NCT00686127|560970436|FG001|Overall Study|Withdrawal by Subject|6|||
155420202|NCT01552902|560970444|FG000|Overall Study|Adverse Event|1|||
155420203|NCT01552902|560970445|FG001|Overall Study|Adverse Event|15|||
155420204|NCT01552902|560970446|FG002|Overall Study|Adverse Event|14|||
155420205|NCT01552902|560970444|FG000|Overall Study|Protocol Violation|3|||
155420206|NCT01552902|560970445|FG001|Overall Study|Protocol Violation|3|||
155501250|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501251|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501252|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501253|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501254|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501255|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501256|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
155501257|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155420207|NCT01552902|560970446|FG002|Overall Study|Protocol Violation|3|||
155420208|NCT01552902|560970444|FG000|Overall Study|Lack of Efficacy|4|||
155420209|NCT01552902|560970445|FG001|Overall Study|Lack of Efficacy|3|||
155420210|NCT01552902|560970446|FG002|Overall Study|Lack of Efficacy|1|||
155420211|NCT01552902|560970444|FG000|Overall Study|Withdrawal by Subject|1|||
155420212|NCT01552902|560970445|FG001|Overall Study|Withdrawal by Subject|9|||
155420213|NCT01552902|560970446|FG002|Overall Study|Withdrawal by Subject|6|||
155420214|NCT01552902|560970444|FG000|Overall Study|Lost to Follow-up|1|||
155501258|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155752589|NCT04090957|562192878|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
155752590|NCT04090957|562192879|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
155752591|NCT04090957|562192880|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
155752592|NCT04090957|562192881|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
155752593|NCT04090957|562192878|FG000|Overall Study|Adverse Event|19|||
155752594|NCT04090957|562192879|FG001|Overall Study|Adverse Event|25|||
155501259|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
155501260|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155501261|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501262|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155752595|NCT04090957|562192880|FG002|Overall Study|Adverse Event|8|||
155501263|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501264|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501265|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501266|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501267|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501268|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501269|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501270|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501271|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
155501272|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155752596|NCT04090957|562192881|FG003|Overall Study|Adverse Event|104|||
155501273|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501274|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
155501275|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501276|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155752597|NCT04090957|562192878|FG000|Overall Study|Other|10|||
155420215|NCT01552902|560970445|FG001|Overall Study|Lost to Follow-up|3|||
155420216|NCT01552902|560970446|FG002|Overall Study|Lost to Follow-up|6|||
155420217|NCT01552902|560970444|FG000|Overall Study|Other|3|||
155420218|NCT01552902|560970445|FG001|Overall Study|Other|4|||
155420219|NCT01552902|560970446|FG002|Overall Study|Other|3|||
155420220|NCT04088409|560970447|FG000|Part A|Withdrawal by Subject|2|||
155420221|NCT04088409|560970448|FG001|Part A|Withdrawal by Subject|1|||
155420222|NCT04088409|560970447|FG000|Part A|Did Not Meet Randomization Criteria|2|||
155420223|NCT04088409|560970448|FG001|Part A|Did Not Meet Randomization Criteria|0|||
155420224|NCT04088409|560970447|FG000|Part A|Lack of Efficacy|9|||
155420225|NCT04088409|560970448|FG001|Part A|Lack of Efficacy|0|||
155420226|NCT04088409|560970447|FG000|Part A|Lost to Follow-up|1|||
155420227|NCT04088409|560970448|FG001|Part A|Lost to Follow-up|0|||
155420228|NCT04088409|560970447|FG000|Part A|Adverse Event|1|||
155420229|NCT04088409|560970448|FG001|Part A|Adverse Event|0|||
155420230|NCT04088409|560970447|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
155420231|NCT04088409|560970448|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
155420232|NCT04088409|560970447|FG000|Part B|Ongoing Treatment|10|||
155420233|NCT04088409|560970448|FG001|Part B|Ongoing Treatment|0|||
155420234|NCT00400400|560970449|FG000|Overall Study|Adverse Event|9|||
155420235|NCT00400400|560970450|FG001|Overall Study|Adverse Event|8|||
155420236|NCT00400400|560970449|FG000|Overall Study|Protocol Violation|2|||
155420237|NCT00400400|560970450|FG001|Overall Study|Protocol Violation|0|||
155420238|NCT00400400|560970449|FG000|Overall Study|Withdrawal by Subject|1|||
155420239|NCT00400400|560970450|FG001|Overall Study|Withdrawal by Subject|3|||
155420240|NCT00400400|560970449|FG000|Overall Study|Administrative Problem|1|||
155420241|NCT00400400|560970450|FG001|Overall Study|Administrative Problem|0|||
155420242|NCT00400400|560970449|FG000|Overall Study|Lost to Follow-up|0|||
155420243|NCT00400400|560970450|FG001|Overall Study|Lost to Follow-up|1|||
155420244|NCT00400400|560970449|FG000|Overall Study|Did not receive study drug|1|||
155420245|NCT00400400|560970450|FG001|Overall Study|Did not receive study drug|3|||
155420246|NCT00364689|560970451|FG000|Overall Study|Lost to Follow-up|1|||
155420247|NCT03653390|560970461|FG000|Overall Study|Lost to Follow-up|12|||
155420248|NCT03653390|560970462|FG001|Overall Study|Lost to Follow-up|8|||
155420249|NCT03653390|560970463|FG002|Overall Study|Lost to Follow-up|7|||
155420250|NCT03653390|560970461|FG000|Overall Study|Withdrawal by Subject|6|||
155420251|NCT03653390|560970462|FG001|Overall Study|Withdrawal by Subject|1|||
155420252|NCT03653390|560970463|FG002|Overall Study|Withdrawal by Subject|1|||
155420253|NCT03653390|560970461|FG000|Overall Study|Death|1|||
155420254|NCT03653390|560970462|FG001|Overall Study|Death|0|||
155420255|NCT03653390|560970463|FG002|Overall Study|Death|0|||
155420256|NCT03653390|560970461|FG000|Overall Study|Paper Survey Lost|1|||
155420257|NCT03653390|560970462|FG001|Overall Study|Paper Survey Lost|0|||
155420258|NCT03653390|560970463|FG002|Overall Study|Paper Survey Lost|0|||
155420259|NCT03118947|560970464|FG000|Overall Study|Adverse Event|7|||
155420260|NCT03118947|560970464|FG000|Overall Study|Death|3|||
155420261|NCT03118947|560970464|FG000|Overall Study|Lack of Efficacy|4|||
155420262|NCT03118947|560970464|FG000|Overall Study|Non-compliance with study drug|1|||
155420263|NCT03118947|560970464|FG000|Overall Study|Protocol Violation|2|||
155420264|NCT03118947|560970464|FG000|Overall Study|Withdrawal by Subject|3|||
155420265|NCT03118947|560970464|FG000|Overall Study|Withdrawal by caregiver|3|||
155420266|NCT03118947|560970464|FG000|Overall Study|Change in patient's living situation|4|||
155420267|NCT03118947|560970464|FG000|Overall Study|Lost to Follow-up|2|||
155420268|NCT04451330|560970467|FG000|Overall Study|Adverse Event|1|||
155420269|NCT04451330|560970468|FG001|Overall Study|Adverse Event|2|||
155420270|NCT04451330|560970467|FG000|Overall Study|Lost to Follow-up|5|||
155420271|NCT04451330|560970468|FG001|Overall Study|Lost to Follow-up|0|||
155420272|NCT04451330|560970467|FG000|Overall Study|Withdrawal by Subject|3|||
155420273|NCT04451330|560970468|FG001|Overall Study|Withdrawal by Subject|1|||
155420274|NCT04451330|560970467|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155420275|NCT04451330|560970468|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155420276|NCT04451330|560970467|FG000|Overall Study|Other than specified|0|||
155420277|NCT04451330|560970468|FG001|Overall Study|Other than specified|1|||
155420278|NCT01987908|560970479|FG000|Placebo Lead-in Period|Adverse Event|2|||
155420279|NCT01987908|560970480|FG001|Placebo Lead-in Period|Adverse Event|0|||
155420280|NCT01987908|560970481|FG002|Placebo Lead-in Period|Adverse Event|0|||
155420281|NCT01987908|560970479|FG000|Placebo Lead-in Period|Physician Decision|2|||
155420282|NCT01987908|560970480|FG001|Placebo Lead-in Period|Physician Decision|0|||
155420283|NCT01987908|560970481|FG002|Placebo Lead-in Period|Physician Decision|0|||
155420284|NCT01987908|560970479|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
155420285|NCT01987908|560970480|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
155420286|NCT01987908|560970481|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
155420287|NCT01987908|560970479|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
155420288|NCT01987908|560970480|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
155420289|NCT01987908|560970481|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
155420290|NCT01987908|560970479|FG000|Treatment Period|Adverse Event|0|||
155420291|NCT01987908|560970480|FG001|Treatment Period|Adverse Event|1|||
155420292|NCT01987908|560970481|FG002|Treatment Period|Adverse Event|1|||
155420293|NCT01987908|560970479|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
155420294|NCT01987908|560970480|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
155420295|NCT01987908|560970481|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
155420296|NCT01987908|560970479|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
155420297|NCT01987908|560970480|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
155420298|NCT01987908|560970481|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
155420299|NCT00849667|560970482|FG000|Overall Study|Withdrawal by Subject|16|||
155420300|NCT00849667|560970483|FG001|Overall Study|Withdrawal by Subject|33|||
155420301|NCT00849667|560970484|FG002|Overall Study|Withdrawal by Subject|35|||
155420302|NCT00849667|560970482|FG000|Overall Study|Lost to Follow-up|8|||
155420303|NCT00849667|560970483|FG001|Overall Study|Lost to Follow-up|8|||
155420304|NCT00849667|560970484|FG002|Overall Study|Lost to Follow-up|8|||
155420305|NCT00849667|560970482|FG000|Overall Study|Adverse Event|1|||
155420306|NCT00849667|560970483|FG001|Overall Study|Adverse Event|2|||
155420307|NCT00849667|560970484|FG002|Overall Study|Adverse Event|0|||
155420308|NCT00849667|560970482|FG000|Overall Study|Other|18|||
155420309|NCT00849667|560970483|FG001|Overall Study|Other|19|||
155420310|NCT00849667|560970484|FG002|Overall Study|Other|18|||
155420311|NCT00849667|560970482|FG000|Overall Study|Progressive disease|119|||
155420312|NCT00849667|560970483|FG001|Overall Study|Progressive disease|100|||
155420313|NCT00849667|560970484|FG002|Overall Study|Progressive disease|112|||
155420314|NCT00849667|560970482|FG000|Overall Study|Sponsor decision|208|||
155420315|NCT00849667|560970483|FG001|Overall Study|Sponsor decision|204|||
155420316|NCT00849667|560970484|FG002|Overall Study|Sponsor decision|190|||
155420317|NCT00849667|560970482|FG000|Overall Study|Investigator discretion|0|||
155420318|NCT00849667|560970483|FG001|Overall Study|Investigator discretion|0|||
155420319|NCT00849667|560970484|FG002|Overall Study|Investigator discretion|1|||
155420320|NCT00189462|560970485|FG000|Overall Study|Lack of Efficacy|5|||
155501277|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
155514021|NCT01626859|561308227|FG000|Overall Study|Physician Decision|0|||
155644170|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
155420321|NCT00189462|560970486|FG001|Overall Study|Lack of Efficacy|1|||
155420322|NCT00189462|560970485|FG000|Overall Study|Lost to Follow-up|18|||
155420323|NCT00189462|560970486|FG001|Overall Study|Lost to Follow-up|20|||
155420324|NCT01869348|560970487|FG000|Overall Study|Withdrawal by Subject|1|||
155420325|NCT01869348|560970488|FG001|Overall Study|Withdrawal by Subject|1|||
155420326|NCT02789657|560970489|FG000|Overall Study|Withdrawal by Subject|2|||
155420327|NCT02789657|560970490|FG001|Overall Study|Withdrawal by Subject|0|||
155420328|NCT02789657|560970491|FG002|Overall Study|Withdrawal by Subject|0|||
155420329|NCT02789657|560970492|FG003|Overall Study|Withdrawal by Subject|0|||
155420330|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Adverse Event|21|||
155420331|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Adverse Event|6|||
155420332|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
155420333|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
155420334|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
155420335|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
155420336|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
155420337|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
155420338|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Physician Decision|0|||
155420339|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Physician Decision|3|||
155420340|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
155420341|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
155420342|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
155420343|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
155420344|NCT00510276|560970501|FG000|Acute Double-Blind Phase|Subject Decision|26|||
155420345|NCT00510276|560970502|FG001|Acute Double-Blind Phase|Subject Decision|28|||
155420346|NCT00510276|560970501|FG000|Extension Open-Label Phase|Adverse Event|9|||
155420347|NCT00510276|560970502|FG001|Extension Open-Label Phase|Adverse Event|18|||
155420348|NCT00510276|560970501|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
155420349|NCT00510276|560970502|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
155420350|NCT00510276|560970501|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
155420351|NCT00510276|560970502|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
155420352|NCT00510276|560970501|FG000|Extension Open-Label Phase|Physician Decision|2|||
155420353|NCT00510276|560970502|FG001|Extension Open-Label Phase|Physician Decision|3|||
155420354|NCT00510276|560970501|FG000|Extension Open-Label Phase|Protocol Violation|0|||
155420355|NCT00510276|560970502|FG001|Extension Open-Label Phase|Protocol Violation|1|||
155420356|NCT00510276|560970501|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
155420357|NCT00510276|560970502|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
155420358|NCT00510276|560970501|FG000|Extension Open-Label Phase|Subject Decision|7|||
155420359|NCT00510276|560970502|FG001|Extension Open-Label Phase|Subject Decision|9|||
155420360|NCT01500057|560970505|FG000|Overall Study|Lost to Follow-up|6|||
155420361|NCT01500057|560970506|FG001|Overall Study|Lost to Follow-up|4|||
155420362|NCT00888355|560970511|FG000|Overall Study|Adverse Event|10|||
155420363|NCT00888355|560970512|FG001|Overall Study|Adverse Event|0|||
155420364|NCT00888355|560970513|FG002|Overall Study|Adverse Event|3|||
155420365|NCT00888355|560970514|FG003|Overall Study|Adverse Event|3|||
155420366|NCT00888355|560970511|FG000|Overall Study|Lack of Efficacy|9|||
155420367|NCT00888355|560970512|FG001|Overall Study|Lack of Efficacy|2|||
155420368|NCT00888355|560970513|FG002|Overall Study|Lack of Efficacy|5|||
155420369|NCT00888355|560970514|FG003|Overall Study|Lack of Efficacy|2|||
155420370|NCT00888355|560970511|FG000|Overall Study|Lost to Follow-up|0|||
155420371|NCT00888355|560970512|FG001|Overall Study|Lost to Follow-up|2|||
155420372|NCT00888355|560970513|FG002|Overall Study|Lost to Follow-up|2|||
155420373|NCT00888355|560970514|FG003|Overall Study|Lost to Follow-up|0|||
155420374|NCT00888355|560970511|FG000|Overall Study|Protocol Violation|3|||
155420375|NCT00888355|560970512|FG001|Overall Study|Protocol Violation|2|||
155420376|NCT00888355|560970513|FG002|Overall Study|Protocol Violation|1|||
155420377|NCT00888355|560970514|FG003|Overall Study|Protocol Violation|2|||
155420378|NCT00888355|560970511|FG000|Overall Study|Withdrawal by Subject|0|||
155420379|NCT00888355|560970512|FG001|Overall Study|Withdrawal by Subject|3|||
155420380|NCT00888355|560970513|FG002|Overall Study|Withdrawal by Subject|1|||
155420381|NCT00888355|560970514|FG003|Overall Study|Withdrawal by Subject|3|||
155420382|NCT03157531|560970520|FG000|Overall Study|Death|2|||
155420383|NCT03157531|560970520|FG000|Overall Study|Lost to Follow-up|4|||
155420384|NCT03603652|560970521|FG000|Overall Study|Death|2|||
155420385|NCT03213366|560970522|FG000|Overall Study|Lost to Follow-up|9|||
155420386|NCT03213366|560970523|FG001|Overall Study|Lost to Follow-up|4|||
155420387|NCT00666926|560970524|FG000|Overall Study|Adverse Event|0|||
155420388|NCT00666926|560970525|FG001|Overall Study|Adverse Event|0|||
155420389|NCT00666926|560970526|FG002|Overall Study|Adverse Event|0|||
155420390|NCT00666926|560970527|FG003|Overall Study|Adverse Event|0|||
155420391|NCT00666926|560970528|FG004|Overall Study|Adverse Event|0|||
155420392|NCT00666926|560970529|FG005|Overall Study|Adverse Event|0|||
155420393|NCT00666926|560970530|FG006|Overall Study|Adverse Event|0|||
155420394|NCT00666926|560970531|FG007|Overall Study|Adverse Event|0|||
155420395|NCT00666926|560970532|FG008|Overall Study|Adverse Event|0|||
155420396|NCT00666926|560970533|FG009|Overall Study|Adverse Event|2|||
155420397|NCT00666926|560970534|FG010|Overall Study|Adverse Event|2|||
155420398|NCT00666926|560970535|FG011|Overall Study|Adverse Event|2|||
155420399|NCT00666926|560970536|FG012|Overall Study|Adverse Event|0|||
155420400|NCT00666926|560970537|FG013|Overall Study|Adverse Event|1|||
155420401|NCT00666926|560970538|FG014|Overall Study|Adverse Event|0|||
155420402|NCT00666926|560970539|FG015|Overall Study|Adverse Event|0|||
155420403|NCT00666926|560970524|FG000|Overall Study|Laboratory abnormality|0|||
155420404|NCT00666926|560970525|FG001|Overall Study|Laboratory abnormality|0|||
155420405|NCT00666926|560970526|FG002|Overall Study|Laboratory abnormality|0|||
155420406|NCT00666926|560970527|FG003|Overall Study|Laboratory abnormality|0|||
155420407|NCT00666926|560970528|FG004|Overall Study|Laboratory abnormality|0|||
155420408|NCT00666926|560970529|FG005|Overall Study|Laboratory abnormality|0|||
155420409|NCT00666926|560970530|FG006|Overall Study|Laboratory abnormality|0|||
155420410|NCT00666926|560970531|FG007|Overall Study|Laboratory abnormality|0|||
155420411|NCT00666926|560970532|FG008|Overall Study|Laboratory abnormality|0|||
155420412|NCT00666926|560970533|FG009|Overall Study|Laboratory abnormality|0|||
155420413|NCT00666926|560970534|FG010|Overall Study|Laboratory abnormality|1|||
155420414|NCT00666926|560970535|FG011|Overall Study|Laboratory abnormality|0|||
155420415|NCT00666926|560970536|FG012|Overall Study|Laboratory abnormality|0|||
155420416|NCT00666926|560970537|FG013|Overall Study|Laboratory abnormality|0|||
155420417|NCT00666926|560970538|FG014|Overall Study|Laboratory abnormality|0|||
155420418|NCT00666926|560970539|FG015|Overall Study|Laboratory abnormality|1|||
155420419|NCT00666926|560970524|FG000|Overall Study|Lack of Efficacy|0|||
155420420|NCT00666926|560970525|FG001|Overall Study|Lack of Efficacy|0|||
155420421|NCT00666926|560970526|FG002|Overall Study|Lack of Efficacy|0|||
155420422|NCT00666926|560970527|FG003|Overall Study|Lack of Efficacy|0|||
155420423|NCT00666926|560970528|FG004|Overall Study|Lack of Efficacy|0|||
155420424|NCT00666926|560970529|FG005|Overall Study|Lack of Efficacy|1|||
155420425|NCT00666926|560970530|FG006|Overall Study|Lack of Efficacy|0|||
155420426|NCT00666926|560970531|FG007|Overall Study|Lack of Efficacy|0|||
155420427|NCT00666926|560970532|FG008|Overall Study|Lack of Efficacy|0|||
155420428|NCT00666926|560970533|FG009|Overall Study|Lack of Efficacy|0|||
155420429|NCT00666926|560970534|FG010|Overall Study|Lack of Efficacy|0|||
155420430|NCT00666926|560970535|FG011|Overall Study|Lack of Efficacy|1|||
155420431|NCT00666926|560970536|FG012|Overall Study|Lack of Efficacy|0|||
155420432|NCT00666926|560970537|FG013|Overall Study|Lack of Efficacy|0|||
155420433|NCT00666926|560970538|FG014|Overall Study|Lack of Efficacy|0|||
155420434|NCT00666926|560970539|FG015|Overall Study|Lack of Efficacy|0|||
155420435|NCT00666926|560970524|FG000|Overall Study|Lost to Follow-up|0|||
155420436|NCT00666926|560970525|FG001|Overall Study|Lost to Follow-up|0|||
155420437|NCT00666926|560970526|FG002|Overall Study|Lost to Follow-up|0|||
155420438|NCT00666926|560970527|FG003|Overall Study|Lost to Follow-up|1|||
155420439|NCT00666926|560970528|FG004|Overall Study|Lost to Follow-up|0|||
155420440|NCT00666926|560970529|FG005|Overall Study|Lost to Follow-up|0|||
155420441|NCT00666926|560970530|FG006|Overall Study|Lost to Follow-up|0|||
155420442|NCT00666926|560970531|FG007|Overall Study|Lost to Follow-up|0|||
155420443|NCT00666926|560970532|FG008|Overall Study|Lost to Follow-up|0|||
155420444|NCT00666926|560970533|FG009|Overall Study|Lost to Follow-up|0|||
155420445|NCT00666926|560970534|FG010|Overall Study|Lost to Follow-up|0|||
155420446|NCT00666926|560970535|FG011|Overall Study|Lost to Follow-up|0|||
155420447|NCT00666926|560970536|FG012|Overall Study|Lost to Follow-up|0|||
155420448|NCT00666926|560970537|FG013|Overall Study|Lost to Follow-up|0|||
155420449|NCT00666926|560970538|FG014|Overall Study|Lost to Follow-up|0|||
155420450|NCT00666926|560970539|FG015|Overall Study|Lost to Follow-up|0|||
155420451|NCT00666926|560970524|FG000|Overall Study|Other|2|||
155420452|NCT00666926|560970525|FG001|Overall Study|Other|4|||
155420453|NCT00666926|560970526|FG002|Overall Study|Other|3|||
155420454|NCT00666926|560970527|FG003|Overall Study|Other|3|||
155420455|NCT00666926|560970528|FG004|Overall Study|Other|3|||
155420456|NCT00666926|560970529|FG005|Overall Study|Other|3|||
155420457|NCT00666926|560970530|FG006|Overall Study|Other|4|||
155420458|NCT00666926|560970531|FG007|Overall Study|Other|0|||
155420459|NCT00666926|560970532|FG008|Overall Study|Other|3|||
155420460|NCT00666926|560970533|FG009|Overall Study|Other|5|||
155420461|NCT00666926|560970534|FG010|Overall Study|Other|3|||
155420462|NCT00666926|560970535|FG011|Overall Study|Other|26|||
155420463|NCT00666926|560970536|FG012|Overall Study|Other|3|||
155420464|NCT00666926|560970537|FG013|Overall Study|Other|2|||
155420465|NCT00666926|560970538|FG014|Overall Study|Other|4|||
155420466|NCT00666926|560970539|FG015|Overall Study|Other|4|||
155420467|NCT00666926|560970524|FG000|Overall Study|Withdrawal by Subject|0|||
155420468|NCT00666926|560970525|FG001|Overall Study|Withdrawal by Subject|0|||
155420469|NCT00666926|560970526|FG002|Overall Study|Withdrawal by Subject|0|||
155420470|NCT00666926|560970527|FG003|Overall Study|Withdrawal by Subject|0|||
155420471|NCT00666926|560970528|FG004|Overall Study|Withdrawal by Subject|0|||
155420472|NCT00666926|560970529|FG005|Overall Study|Withdrawal by Subject|0|||
155420473|NCT00666926|560970530|FG006|Overall Study|Withdrawal by Subject|0|||
155420474|NCT00666926|560970531|FG007|Overall Study|Withdrawal by Subject|1|||
155420475|NCT00666926|560970532|FG008|Overall Study|Withdrawal by Subject|0|||
155420476|NCT00666926|560970533|FG009|Overall Study|Withdrawal by Subject|3|||
155420477|NCT00666926|560970534|FG010|Overall Study|Withdrawal by Subject|0|||
155420478|NCT00666926|560970535|FG011|Overall Study|Withdrawal by Subject|3|||
155420479|NCT00666926|560970536|FG012|Overall Study|Withdrawal by Subject|0|||
155420480|NCT00666926|560970537|FG013|Overall Study|Withdrawal by Subject|1|||
155420481|NCT00666926|560970538|FG014|Overall Study|Withdrawal by Subject|3|||
155420482|NCT00666926|560970539|FG015|Overall Study|Withdrawal by Subject|3|||
155420483|NCT00666926|560970524|FG000|Overall Study|Death|0|||
155420484|NCT00666926|560970525|FG001|Overall Study|Death|0|||
155420485|NCT00666926|560970526|FG002|Overall Study|Death|0|||
155420486|NCT00666926|560970527|FG003|Overall Study|Death|0|||
155420487|NCT00666926|560970528|FG004|Overall Study|Death|0|||
155420488|NCT00666926|560970529|FG005|Overall Study|Death|0|||
155420489|NCT00666926|560970530|FG006|Overall Study|Death|0|||
155420490|NCT00666926|560970531|FG007|Overall Study|Death|0|||
155420491|NCT00666926|560970532|FG008|Overall Study|Death|0|||
155420492|NCT00666926|560970533|FG009|Overall Study|Death|0|||
155420493|NCT00666926|560970534|FG010|Overall Study|Death|0|||
155420494|NCT00666926|560970535|FG011|Overall Study|Death|1|||
155420495|NCT00666926|560970536|FG012|Overall Study|Death|0|||
155420496|NCT00666926|560970537|FG013|Overall Study|Death|0|||
155420497|NCT00666926|560970538|FG014|Overall Study|Death|0|||
155420498|NCT00666926|560970539|FG015|Overall Study|Death|0|||
155420499|NCT01960855|560970540|FG000|Overall Study|Subject noncompliant|1|||
155420500|NCT01960855|560970541|FG001|Overall Study|Subject noncompliant|0|||
155420501|NCT01960855|560970542|FG002|Overall Study|Subject noncompliant|0|||
155420502|NCT01960855|560970543|FG003|Overall Study|Subject noncompliant|0|||
155420503|NCT01960855|560970544|FG004|Overall Study|Subject noncompliant|0|||
155420504|NCT01960855|560970540|FG000|Overall Study|Adverse Event|2|||
155420505|NCT01960855|560970541|FG001|Overall Study|Adverse Event|0|||
155420506|NCT01960855|560970542|FG002|Overall Study|Adverse Event|6|||
155420507|NCT01960855|560970543|FG003|Overall Study|Adverse Event|2|||
155420508|NCT01960855|560970544|FG004|Overall Study|Adverse Event|2|||
155420509|NCT01960855|560970540|FG000|Overall Study|Lack of Efficacy|1|||
155420510|NCT01960855|560970541|FG001|Overall Study|Lack of Efficacy|1|||
155420511|NCT01960855|560970542|FG002|Overall Study|Lack of Efficacy|0|||
155420512|NCT01960855|560970543|FG003|Overall Study|Lack of Efficacy|0|||
155420513|NCT01960855|560970544|FG004|Overall Study|Lack of Efficacy|0|||
155420514|NCT01960855|560970540|FG000|Overall Study|Other|2|||
155420515|NCT01960855|560970541|FG001|Overall Study|Other|1|||
155420516|NCT01960855|560970542|FG002|Overall Study|Other|1|||
155420517|NCT01960855|560970543|FG003|Overall Study|Other|1|||
155420518|NCT01960855|560970544|FG004|Overall Study|Other|0|||
155420519|NCT01960855|560970540|FG000|Overall Study|Consent withdrawn by subject|3|||
155420520|NCT01960855|560970541|FG001|Overall Study|Consent withdrawn by subject|1|||
155420521|NCT01960855|560970542|FG002|Overall Study|Consent withdrawn by subject|2|||
155420522|NCT01960855|560970543|FG003|Overall Study|Consent withdrawn by subject|1|||
155420523|NCT01960855|560970544|FG004|Overall Study|Consent withdrawn by subject|1|||
155420524|NCT01960855|560970540|FG000|Overall Study|Lost to Follow-up|2|||
155420525|NCT01960855|560970541|FG001|Overall Study|Lost to Follow-up|1|||
155420526|NCT01960855|560970542|FG002|Overall Study|Lost to Follow-up|0|||
155420527|NCT01960855|560970543|FG003|Overall Study|Lost to Follow-up|0|||
155420528|NCT01960855|560970544|FG004|Overall Study|Lost to Follow-up|2|||
155420529|NCT02058147|560970545|FG000|Overall Study|Randomized but not treated|0|||
155420530|NCT02058147|560970546|FG001|Overall Study|Randomized but not treated|0|||
155420531|NCT02058147|560970547|FG002|Overall Study|Randomized but not treated|1|||
155420532|NCT02058147|560970545|FG000|Overall Study|Adverse Event|12|||
155420533|NCT02058147|560970546|FG001|Overall Study|Adverse Event|9|||
155420534|NCT02058147|560970547|FG002|Overall Study|Adverse Event|21|||
155420535|NCT02058147|560970545|FG000|Overall Study|Lack of Efficacy|1|||
155420536|NCT02058147|560970546|FG001|Overall Study|Lack of Efficacy|0|||
155420537|NCT02058147|560970547|FG002|Overall Study|Lack of Efficacy|3|||
155420538|NCT02058147|560970545|FG000|Overall Study|Poor compliance to protocol|8|||
155420539|NCT02058147|560970546|FG001|Overall Study|Poor compliance to protocol|9|||
155420540|NCT02058147|560970547|FG002|Overall Study|Poor compliance to protocol|4|||
155420541|NCT02058147|560970545|FG000|Overall Study|Other than specified|8|||
155420542|NCT02058147|560970546|FG001|Overall Study|Other than specified|9|||
155420543|NCT02058147|560970547|FG002|Overall Study|Other than specified|0|||
155420544|NCT01318122|560970548|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155420545|NCT01318122|560970549|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155420546|NCT01318122|560970550|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
155501278|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
155420547|NCT01318122|560970551|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
155420548|NCT01318122|560970548|FG000|Enrolled - Long-Term Extension Study|Other|1|||
155420549|NCT01318122|560970549|FG001|Enrolled - Long-Term Extension Study|Other|0|||
155420550|NCT01318122|560970550|FG002|Enrolled - Long-Term Extension Study|Other|0|||
155420551|NCT01318122|560970551|FG003|Enrolled - Long-Term Extension Study|Other|0|||
155420552|NCT01318122|560970548|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
155420553|NCT01318122|560970549|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
155644171|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
155644172|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
155644173|NCT03446573|561786923|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
155644174|NCT03446573|561786924|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
155644175|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
155644176|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
155420554|NCT01318122|560970550|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
155420555|NCT01318122|560970551|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
155644177|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
155420556|NCT01318122|560970548|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
155420557|NCT01318122|560970549|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155420558|NCT01318122|560970550|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155420559|NCT01318122|560970551|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155420560|NCT01318122|560970548|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155420561|NCT01318122|560970549|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
155420562|NCT01318122|560970550|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155420563|NCT01318122|560970551|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155420564|NCT01318122|560970548|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155420565|NCT01318122|560970549|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155420566|NCT01318122|560970550|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
155420567|NCT01318122|560970551|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155420568|NCT01486199|560970552|FG000|Two Year Period Between Study Days|Physician Decision|1|||
155420569|NCT01486199|560970553|FG001|Two Year Period Between Study Days|Physician Decision|0|||
155420570|NCT02154425|560970559|FG000|Screening Period|Adverse Event|1|||
155420571|NCT00773279|560970560|FG000|Period 1|Adverse Event|2|||
155420572|NCT00773279|560970561|FG001|Period 1|Adverse Event|1|||
155420573|NCT00773279|560970560|FG000|Period 1|Lack of Efficacy|0|||
155420574|NCT00773279|560970561|FG001|Period 1|Lack of Efficacy|2|||
155420575|NCT00773279|560970560|FG000|Period 1|Unclassified|5|||
155420576|NCT00773279|560970561|FG001|Period 1|Unclassified|1|||
155420577|NCT00773279|560970560|FG000|Period 2|Adverse Event|0|||
155420578|NCT00773279|560970561|FG001|Period 2|Adverse Event|1|||
155420579|NCT00773279|560970560|FG000|Period 2|Lack of Efficacy|1|||
155420580|NCT00773279|560970561|FG001|Period 2|Lack of Efficacy|0|||
155420581|NCT00773279|560970560|FG000|Period 2|Protocol Violation|0|||
155420582|NCT00773279|560970561|FG001|Period 2|Protocol Violation|3|||
155420583|NCT00773279|560970560|FG000|Period 2|Unclassified|2|||
155420584|NCT00773279|560970561|FG001|Period 2|Unclassified|2|||
155420585|NCT01133171|560970568|FG000|Overall Study|Withdrawal by Subject|1|||
155420586|NCT01133171|560970569|FG001|Overall Study|Withdrawal by Subject|2|||
155420587|NCT01133171|560970570|FG002|Overall Study|Withdrawal by Subject|0|||
155420588|NCT02526550|560970571|FG000|Overall Study|Lost to Follow-up|1|||
155420589|NCT04062214|560970575|FG000|Week 12|Death|1|||
155420590|NCT04062214|560970576|FG001|Week 12|Death|1|||
155420591|NCT04062214|560970575|FG000|Week 12|Withdrawal by Subject|14|||
155420592|NCT04062214|560970576|FG001|Week 12|Withdrawal by Subject|13|||
155420593|NCT04062214|560970575|FG000|Week 12|Lost to Follow-up|55|||
155420594|NCT04062214|560970576|FG001|Week 12|Lost to Follow-up|68|||
155420595|NCT04062214|560970575|FG000|Week 12|Intermittent missing|31|||
155420596|NCT04062214|560970576|FG001|Week 12|Intermittent missing|29|||
155420597|NCT04062214|560970575|FG000|Week 36|Withdrawal by Subject|4|||
155420598|NCT04062214|560970576|FG001|Week 36|Withdrawal by Subject|5|||
155420599|NCT04062214|560970575|FG000|Week 36|Lost to Follow-up|50|||
155420600|NCT04062214|560970576|FG001|Week 36|Lost to Follow-up|46|||
155420601|NCT04062214|560970575|FG000|Week 36|Death|0|||
155420602|NCT04062214|560970576|FG001|Week 36|Death|1|||
155420603|NCT00091832|560970577|FG000|Overall Study|Physician Decision|1|||
155420604|NCT00091832|560970578|FG001|Overall Study|Physician Decision|0|||
155420605|NCT00091832|560970579|FG002|Overall Study|Physician Decision|0|||
155420606|NCT00091832|560970580|FG003|Overall Study|Physician Decision|0|||
155420607|NCT00091832|560970581|FG004|Overall Study|Physician Decision|0|||
155420608|NCT00091832|560970582|FG005|Overall Study|Physician Decision|0|||
155420609|NCT00091832|560970577|FG000|Overall Study|Adverse Event|0|||
155420610|NCT00091832|560970578|FG001|Overall Study|Adverse Event|0|||
155420611|NCT00091832|560970579|FG002|Overall Study|Adverse Event|0|||
155420612|NCT00091832|560970580|FG003|Overall Study|Adverse Event|1|||
155420613|NCT00091832|560970581|FG004|Overall Study|Adverse Event|3|||
155420614|NCT00091832|560970582|FG005|Overall Study|Adverse Event|0|||
155420615|NCT00091832|560970577|FG000|Overall Study|Withdrawal by Subject|4|||
155420616|NCT00091832|560970578|FG001|Overall Study|Withdrawal by Subject|5|||
155420617|NCT00091832|560970579|FG002|Overall Study|Withdrawal by Subject|0|||
155420618|NCT00091832|560970580|FG003|Overall Study|Withdrawal by Subject|1|||
155420619|NCT00091832|560970581|FG004|Overall Study|Withdrawal by Subject|3|||
155420620|NCT00091832|560970582|FG005|Overall Study|Withdrawal by Subject|1|||
155420621|NCT00091832|560970577|FG000|Overall Study|Death|6|||
155420622|NCT00091832|560970578|FG001|Overall Study|Death|4|||
155420623|NCT00091832|560970579|FG002|Overall Study|Death|5|||
155420624|NCT00091832|560970580|FG003|Overall Study|Death|8|||
155420625|NCT00091832|560970581|FG004|Overall Study|Death|5|||
155420626|NCT00091832|560970582|FG005|Overall Study|Death|6|||
155420627|NCT00091832|560970577|FG000|Overall Study|Disease Progression|2|||
155420628|NCT00091832|560970578|FG001|Overall Study|Disease Progression|0|||
155420629|NCT00091832|560970579|FG002|Overall Study|Disease Progression|0|||
155420630|NCT00091832|560970580|FG003|Overall Study|Disease Progression|1|||
155420631|NCT00091832|560970581|FG004|Overall Study|Disease Progression|1|||
155420632|NCT00091832|560970582|FG005|Overall Study|Disease Progression|2|||
155420633|NCT00091832|560970577|FG000|Overall Study|Ineligibility Determined|0|||
155420634|NCT00091832|560970578|FG001|Overall Study|Ineligibility Determined|0|||
155420635|NCT00091832|560970579|FG002|Overall Study|Ineligibility Determined|1|||
155420636|NCT00091832|560970580|FG003|Overall Study|Ineligibility Determined|0|||
155420637|NCT00091832|560970581|FG004|Overall Study|Ineligibility Determined|1|||
155420638|NCT00091832|560970582|FG005|Overall Study|Ineligibility Determined|0|||
155420639|NCT00091832|560970577|FG000|Overall Study|Lost to Follow-up|1|||
155420640|NCT00091832|560970578|FG001|Overall Study|Lost to Follow-up|0|||
155420641|NCT00091832|560970579|FG002|Overall Study|Lost to Follow-up|3|||
155420642|NCT00091832|560970580|FG003|Overall Study|Lost to Follow-up|3|||
155420643|NCT00091832|560970581|FG004|Overall Study|Lost to Follow-up|2|||
155420644|NCT00091832|560970582|FG005|Overall Study|Lost to Follow-up|1|||
155420645|NCT00091832|560970577|FG000|Overall Study|Noncompliance|0|||
155420646|NCT00091832|560970578|FG001|Overall Study|Noncompliance|1|||
155321215|NCT04167553|560610848|FG002|Overall Study|Withdrawal by Subject|1|||
155321216|NCT04167553|560610849|FG003|Overall Study|Withdrawal by Subject|2|||
155321217|NCT04167553|560610850|FG004|Overall Study|Withdrawal by Subject|1|||
155321218|NCT04167553|560610851|FG005|Overall Study|Withdrawal by Subject|0|||
155321219|NCT04167553|560610852|FG006|Overall Study|Withdrawal by Subject|0|||
155321220|NCT04167553|560610846|FG000|Overall Study|Physician Decision|0|||
155321221|NCT04167553|560610847|FG001|Overall Study|Physician Decision|0|||
155321222|NCT04167553|560610848|FG002|Overall Study|Physician Decision|0|||
155321223|NCT04167553|560610849|FG003|Overall Study|Physician Decision|0|||
155321224|NCT04167553|560610850|FG004|Overall Study|Physician Decision|2|||
155321225|NCT04167553|560610851|FG005|Overall Study|Physician Decision|2|||
155321226|NCT04167553|560610852|FG006|Overall Study|Physician Decision|0|||
155420647|NCT00091832|560970579|FG002|Overall Study|Noncompliance|0|||
155420648|NCT00091832|560970580|FG003|Overall Study|Noncompliance|0|||
155420649|NCT00091832|560970581|FG004|Overall Study|Noncompliance|0|||
155420650|NCT00091832|560970582|FG005|Overall Study|Noncompliance|0|||
155420651|NCT00091832|560970577|FG000|Overall Study|Other|0|||
155420652|NCT00091832|560970578|FG001|Overall Study|Other|1|||
155420653|NCT00091832|560970579|FG002|Overall Study|Other|2|||
155420654|NCT00091832|560970580|FG003|Overall Study|Other|0|||
155420655|NCT00091832|560970581|FG004|Overall Study|Other|0|||
155321227|NCT04167553|560610846|FG000|Overall Study|Lost to Follow-up|0|||
155321228|NCT04167553|560610847|FG001|Overall Study|Lost to Follow-up|0|||
155321229|NCT04167553|560610848|FG002|Overall Study|Lost to Follow-up|2|||
155420656|NCT00091832|560970582|FG005|Overall Study|Other|0|||
155420657|NCT00091832|560970577|FG000|Overall Study|Protocol Violation|0|||
155420658|NCT00091832|560970578|FG001|Overall Study|Protocol Violation|0|||
155420659|NCT00091832|560970579|FG002|Overall Study|Protocol Violation|1|||
155420660|NCT00091832|560970580|FG003|Overall Study|Protocol Violation|0|||
155420661|NCT00091832|560970581|FG004|Overall Study|Protocol Violation|0|||
155420662|NCT00091832|560970582|FG005|Overall Study|Protocol Violation|1|||
155420663|NCT01557166|560970586|FG000|Overall Study|Adverse Event|20|||
155420664|NCT01557166|560970587|FG001|Overall Study|Adverse Event|6|||
155420665|NCT01557166|560970586|FG000|Overall Study|Lack of Efficacy|2|||
155420666|NCT01557166|560970587|FG001|Overall Study|Lack of Efficacy|1|||
155420667|NCT01557166|560970586|FG000|Overall Study|Protocol Violation|8|||
155420668|NCT01557166|560970587|FG001|Overall Study|Protocol Violation|5|||
155420669|NCT01557166|560970586|FG000|Overall Study|Withdrawn consent|12|||
155420670|NCT01557166|560970587|FG001|Overall Study|Withdrawn consent|20|||
155420671|NCT01557166|560970586|FG000|Overall Study|Target dose not tolerated|1|||
155420672|NCT01557166|560970587|FG001|Overall Study|Target dose not tolerated|0|||
155420673|NCT01557166|560970586|FG000|Overall Study|Psychiatric disorder|1|||
155420674|NCT01557166|560970587|FG001|Overall Study|Psychiatric disorder|0|||
155420675|NCT01557166|560970586|FG000|Overall Study|Unclassified|2|||
155420676|NCT01557166|560970587|FG001|Overall Study|Unclassified|5|||
155420677|NCT00946309|560970588|FG000|Overall Study|Protocol Violation|1|||
155321230|NCT04167553|560610849|FG003|Overall Study|Lost to Follow-up|0|||
155321231|NCT04167553|560610850|FG004|Overall Study|Lost to Follow-up|0|||
155321232|NCT04167553|560610851|FG005|Overall Study|Lost to Follow-up|0|||
155420678|NCT00946309|560970589|FG001|Overall Study|Protocol Violation|0|||
155420679|NCT00946309|560970588|FG000|Overall Study|Lost to Follow-up|0|||
155644178|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
155420680|NCT00946309|560970589|FG001|Overall Study|Lost to Follow-up|1|||
155420681|NCT00946309|560970588|FG000|Overall Study|Procedure cancelled/discontinued|0|||
155420682|NCT00946309|560970589|FG001|Overall Study|Procedure cancelled/discontinued|3|||
155420683|NCT01465659|560970593|FG000|Completed 1 Cycle of Treatment|Death|0|||
155321233|NCT04167553|560610852|FG006|Overall Study|Lost to Follow-up|0|||
155321234|NCT02828358|560610853|FG000|Overall Study|Physician Decision|7|||
155321235|NCT02828358|560610854|FG001|Overall Study|Physician Decision|1|||
155321236|NCT02828358|560610853|FG000|Overall Study|Treatment Failure|6|||
155321237|NCT02828358|560610854|FG001|Overall Study|Treatment Failure|0|||
155321238|NCT02828358|560610853|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
155321239|NCT02828358|560610854|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
155321240|NCT02828358|560610853|FG000|Overall Study|Refusal of further protocol therapy|2|||
155321241|NCT02828358|560610854|FG001|Overall Study|Refusal of further protocol therapy|0|||
155321242|NCT02828358|560610853|FG000|Overall Study|Relapse|25|||
155321243|NCT02828358|560610854|FG001|Overall Study|Relapse|0|||
155321244|NCT02828358|560610853|FG000|Overall Study|Still on therapy|5|||
155321245|NCT02828358|560610854|FG001|Overall Study|Still on therapy|0|||
155321246|NCT05285137|560610867|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
155644179|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
155321247|NCT05285137|560610868|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155321248|NCT05285137|560610869|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
155321249|NCT05285137|560610870|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
155644180|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
155644181|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
155644182|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
155321250|NCT05285137|560610871|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
155321251|NCT05285137|560610872|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
155321252|NCT05285137|560610873|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
155321253|NCT05285137|560610874|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
155321254|NCT05285137|560610875|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
155321255|NCT05285137|560610867|FG000|Overall Study|Lost to Follow-up|0|||
155321256|NCT05285137|560610868|FG001|Overall Study|Lost to Follow-up|0|||
155321257|NCT05285137|560610869|FG002|Overall Study|Lost to Follow-up|1|||
155321258|NCT05285137|560610870|FG003|Overall Study|Lost to Follow-up|3|||
155321259|NCT05285137|560610871|FG004|Overall Study|Lost to Follow-up|0|||
155321260|NCT05285137|560610872|FG005|Overall Study|Lost to Follow-up|0|||
155321261|NCT05285137|560610873|FG006|Overall Study|Lost to Follow-up|1|||
155321262|NCT05285137|560610874|FG007|Overall Study|Lost to Follow-up|0|||
155321263|NCT05285137|560610875|FG008|Overall Study|Lost to Follow-up|0|||
155321264|NCT05285137|560610867|FG000|Overall Study|Physician Decision|0|||
155321265|NCT05285137|560610868|FG001|Overall Study|Physician Decision|1|||
155321266|NCT05285137|560610869|FG002|Overall Study|Physician Decision|0|||
155321267|NCT05285137|560610870|FG003|Overall Study|Physician Decision|0|||
155321268|NCT05285137|560610871|FG004|Overall Study|Physician Decision|0|||
155321269|NCT05285137|560610872|FG005|Overall Study|Physician Decision|0|||
155321270|NCT05285137|560610873|FG006|Overall Study|Physician Decision|0|||
155321271|NCT05285137|560610874|FG007|Overall Study|Physician Decision|0|||
155321272|NCT05285137|560610875|FG008|Overall Study|Physician Decision|0|||
155321273|NCT05285137|560610867|FG000|Overall Study|Pregnancy|0|||
155321274|NCT05285137|560610868|FG001|Overall Study|Pregnancy|0|||
155321275|NCT05285137|560610869|FG002|Overall Study|Pregnancy|0|||
155321276|NCT05285137|560610870|FG003|Overall Study|Pregnancy|0|||
155321277|NCT05285137|560610871|FG004|Overall Study|Pregnancy|0|||
155321278|NCT05285137|560610872|FG005|Overall Study|Pregnancy|0|||
155321279|NCT05285137|560610873|FG006|Overall Study|Pregnancy|1|||
155321280|NCT05285137|560610874|FG007|Overall Study|Pregnancy|0|||
155321281|NCT05285137|560610875|FG008|Overall Study|Pregnancy|0|||
155321282|NCT05285137|560610867|FG000|Overall Study|Withdrawal by Subject|0|||
155420684|NCT01465659|560970594|FG001|Completed 1 Cycle of Treatment|Death|1|||
155420685|NCT01465659|560970595|FG002|Completed 1 Cycle of Treatment|Death|0|||
155420686|NCT01465659|560970596|FG003|Completed 1 Cycle of Treatment|Death|0|||
155420687|NCT01465659|560970593|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
155644183|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
155644184|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
155644185|NCT03446573|561786923|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
155644186|NCT03446573|561786924|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
155644187|NCT02639559|561786930|FG000|Overall Study|Mobilization failure|0|||
155321283|NCT05285137|560610868|FG001|Overall Study|Withdrawal by Subject|1|||
155321284|NCT05285137|560610869|FG002|Overall Study|Withdrawal by Subject|2|||
155321285|NCT05285137|560610870|FG003|Overall Study|Withdrawal by Subject|1|||
155321286|NCT05285137|560610871|FG004|Overall Study|Withdrawal by Subject|0|||
155321287|NCT05285137|560610872|FG005|Overall Study|Withdrawal by Subject|0|||
155321288|NCT05285137|560610873|FG006|Overall Study|Withdrawal by Subject|0|||
155321289|NCT05285137|560610874|FG007|Overall Study|Withdrawal by Subject|0|||
155321290|NCT05285137|560610875|FG008|Overall Study|Withdrawal by Subject|1|||
155420688|NCT01465659|560970594|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
155420689|NCT01465659|560970595|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
155644188|NCT02639559|561786931|FG001|Overall Study|Mobilization failure|3|||
155644189|NCT02639559|561786930|FG000|Overall Study|Issues with vascular acess|1|||
155321291|NCT04479761|560610876|FG000|Overall Study|could not perform the balance tasks|1|||
155321292|NCT04479761|560610877|FG001|Overall Study|could not perform the balance tasks|0|||
155321293|NCT04479761|560610878|FG002|Overall Study|could not perform the balance tasks|0|||
155321294|NCT04479761|560610876|FG000|Overall Study|Adverse Event|1|||
155321295|NCT04479761|560610877|FG001|Overall Study|Adverse Event|0|||
155321296|NCT04479761|560610878|FG002|Overall Study|Adverse Event|0|||
155321297|NCT04479761|560610876|FG000|Overall Study|one control did not meet screening criteria|0|||
155321298|NCT04479761|560610877|FG001|Overall Study|one control did not meet screening criteria|0|||
155321299|NCT04479761|560610878|FG002|Overall Study|one control did not meet screening criteria|1|||
155321300|NCT04479761|560610876|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
155321301|NCT04479761|560610877|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
155321302|NCT04479761|560610878|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
155321303|NCT05809453|560612268|FG000|Overall Study|Withdrawal by Subject|1|||
155321304|NCT05809453|560612269|FG001|Overall Study|Withdrawal by Subject|0|||
155321305|NCT05809453|560612270|FG002|Overall Study|Withdrawal by Subject|0|||
155321306|NCT05809453|560612271|FG003|Overall Study|Withdrawal by Subject|0|||
155321307|NCT04183283|560612273|FG000|Period 1|Withdrawal by Subject|0|||
155321308|NCT04183283|560612274|FG001|Period 1|Withdrawal by Subject|1|||
155321309|NCT04183283|560612275|FG002|Period 1|Withdrawal by Subject|0|||
155321310|NCT04183283|560612276|FG003|Period 1|Withdrawal by Subject|0|||
155321311|NCT04183283|560612273|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
155321312|NCT04183283|560612274|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
155321313|NCT04183283|560612275|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
155321314|NCT04183283|560612276|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
155321315|NCT04909801|560612278|FG000|Overall Study|Lack of Efficacy|2|||
155321316|NCT04909801|560612279|FG001|Overall Study|Lack of Efficacy|1|||
155321317|NCT04909801|560612278|FG000|Overall Study|Adverse Event|1|||
155321318|NCT04909801|560612279|FG001|Overall Study|Adverse Event|2|||
155321319|NCT04909801|560612278|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155321320|NCT04909801|560612279|FG001|Overall Study|Participant request to discontinue study treatment|2|||
155321321|NCT04909801|560612278|FG000|Overall Study|Withdrawal by Subject|2|||
155321322|NCT04909801|560612279|FG001|Overall Study|Withdrawal by Subject|1|||
155321323|NCT04909801|560612278|FG000|Overall Study|other reasons|1|||
155321324|NCT04909801|560612279|FG001|Overall Study|other reasons|1|||
155321325|NCT04447040|560612280|FG000|Overall Study|Lost to Follow-up|2|||
155321326|NCT04447040|560612281|FG001|Overall Study|Lost to Follow-up|1|||
155321327|NCT04447040|560612282|FG002|Overall Study|Lost to Follow-up|3|||
155321328|NCT04447040|560612283|FG003|Overall Study|Lost to Follow-up|3|||
155321329|NCT04447040|560612284|FG004|Overall Study|Lost to Follow-up|1|||
155321330|NCT04447040|560612285|FG005|Overall Study|Lost to Follow-up|3|||
155321331|NCT04447040|560612280|FG000|Overall Study|Withdrawal by Subject|0|||
155321332|NCT04447040|560612281|FG001|Overall Study|Withdrawal by Subject|1|||
155321333|NCT04447040|560612282|FG002|Overall Study|Withdrawal by Subject|1|||
155321334|NCT04447040|560612283|FG003|Overall Study|Withdrawal by Subject|1|||
155321335|NCT04447040|560612284|FG004|Overall Study|Withdrawal by Subject|0|||
155321336|NCT04447040|560612285|FG005|Overall Study|Withdrawal by Subject|0|||
155321337|NCT01208662|560612286|FG000|Induction and Consolidation|Disease Progression|23|||
155321338|NCT01208662|560612287|FG001|Induction and Consolidation|Disease Progression|13|||
155321339|NCT01208662|560612288|FG002|Induction and Consolidation|Disease Progression|0|||
155321340|NCT01208662|560612286|FG000|Induction and Consolidation|Adverse Event|16|||
155321341|NCT01208662|560612287|FG001|Induction and Consolidation|Adverse Event|18|||
155321342|NCT01208662|560612288|FG002|Induction and Consolidation|Adverse Event|2|||
155321343|NCT01208662|560612286|FG000|Induction and Consolidation|MD or Participant Decision|16|||
155321344|NCT01208662|560612287|FG001|Induction and Consolidation|MD or Participant Decision|34|||
155321345|NCT01208662|560612288|FG002|Induction and Consolidation|MD or Participant Decision|4|||
155321346|NCT01208662|560612286|FG000|Induction and Consolidation|Death|1|||
155321347|NCT01208662|560612287|FG001|Induction and Consolidation|Death|3|||
155321348|NCT01208662|560612288|FG002|Induction and Consolidation|Death|1|||
155321349|NCT01208662|560612286|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
155321350|NCT01208662|560612287|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
155321351|NCT01208662|560612288|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
155321352|NCT01208662|560612286|FG000|Maintenance|Disease Progression|156|||
155321353|NCT01208662|560612287|FG001|Maintenance|Disease Progression|102|||
155420690|NCT01465659|560970596|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
155321354|NCT01208662|560612288|FG002|Maintenance|Disease Progression|0|||
155321355|NCT01208662|560612286|FG000|Maintenance|Adverse Event|12|||
155321356|NCT01208662|560612287|FG001|Maintenance|Adverse Event|28|||
155321357|NCT01208662|560612288|FG002|Maintenance|Adverse Event|0|||
155321358|NCT01208662|560612286|FG000|Maintenance|MD or Participant Decision|24|||
155752598|NCT04090957|562192879|FG001|Overall Study|Other|6|||
155321359|NCT01208662|560612287|FG001|Maintenance|MD or Participant Decision|36|||
155420691|NCT01465659|560970593|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
155752599|NCT04090957|562192880|FG002|Overall Study|Other|5|||
155321360|NCT01208662|560612288|FG002|Maintenance|MD or Participant Decision|0|||
155321361|NCT01208662|560612286|FG000|Maintenance|Death|0|||
155321362|NCT01208662|560612287|FG001|Maintenance|Death|3|||
155321363|NCT01208662|560612288|FG002|Maintenance|Death|0|||
155321364|NCT01208662|560612286|FG000|Maintenance|Discontinued for other reasons|21|||
155321365|NCT01208662|560612287|FG001|Maintenance|Discontinued for other reasons|31|||
155321366|NCT01208662|560612288|FG002|Maintenance|Discontinued for other reasons|0|||
155321367|NCT01208662|560612286|FG000|Maintenance|Still on Treatment|78|||
155321368|NCT01208662|560612287|FG001|Maintenance|Still on Treatment|89|||
155321369|NCT01208662|560612288|FG002|Maintenance|Still on Treatment|0|||
155321370|NCT05147116|560612291|FG000|Overall Study|Withdrawal by Subject|0|||
155321371|NCT05147116|560612292|FG001|Overall Study|Withdrawal by Subject|1|||
155321372|NCT04101357|560612293|FG000|Overall Study|Death|1|||
155321373|NCT04101357|560612294|FG001|Overall Study|Death|1|||
155321374|NCT04101357|560612295|FG002|Overall Study|Death|1|||
155321375|NCT04101357|560612296|FG003|Overall Study|Death|2|||
155321376|NCT04101357|560612297|FG004|Overall Study|Death|4|||
155321377|NCT04101357|560612298|FG005|Overall Study|Death|11|||
155321378|NCT04101357|560612299|FG006|Overall Study|Death|4|||
155321379|NCT04101357|560612300|FG007|Overall Study|Death|4|||
155321380|NCT04101357|560612301|FG008|Overall Study|Death|5|||
155321381|NCT04101357|560612302|FG009|Overall Study|Death|2|||
155321382|NCT04101357|560612303|FG010|Overall Study|Death|3|||
155321383|NCT04101357|560612293|FG000|Overall Study|Trial closure|0|||
155321384|NCT04101357|560612294|FG001|Overall Study|Trial closure|0|||
155321385|NCT04101357|560612295|FG002|Overall Study|Trial closure|0|||
155321386|NCT04101357|560612296|FG003|Overall Study|Trial closure|0|||
155321387|NCT04101357|560612297|FG004|Overall Study|Trial closure|0|||
155321388|NCT04101357|560612298|FG005|Overall Study|Trial closure|2|||
155321389|NCT04101357|560612299|FG006|Overall Study|Trial closure|2|||
155321390|NCT04101357|560612300|FG007|Overall Study|Trial closure|0|||
155321391|NCT04101357|560612301|FG008|Overall Study|Trial closure|0|||
155321392|NCT04101357|560612302|FG009|Overall Study|Trial closure|0|||
155321393|NCT04101357|560612303|FG010|Overall Study|Trial closure|1|||
155321394|NCT04101357|560612293|FG000|Overall Study|Lost to Follow-up|0|||
155321395|NCT04101357|560612294|FG001|Overall Study|Lost to Follow-up|0|||
155321396|NCT04101357|560612295|FG002|Overall Study|Lost to Follow-up|0|||
155321397|NCT04101357|560612296|FG003|Overall Study|Lost to Follow-up|1|||
155321398|NCT04101357|560612297|FG004|Overall Study|Lost to Follow-up|0|||
155321399|NCT04101357|560612298|FG005|Overall Study|Lost to Follow-up|0|||
155321400|NCT04101357|560612299|FG006|Overall Study|Lost to Follow-up|0|||
155321401|NCT04101357|560612300|FG007|Overall Study|Lost to Follow-up|1|||
155321402|NCT04101357|560612301|FG008|Overall Study|Lost to Follow-up|0|||
155321403|NCT04101357|560612302|FG009|Overall Study|Lost to Follow-up|0|||
155321404|NCT04101357|560612303|FG010|Overall Study|Lost to Follow-up|0|||
155321405|NCT04101357|560612293|FG000|Overall Study|Withdrawal by Subject|1|||
155321406|NCT04101357|560612294|FG001|Overall Study|Withdrawal by Subject|0|||
155321407|NCT04101357|560612295|FG002|Overall Study|Withdrawal by Subject|0|||
155321408|NCT04101357|560612296|FG003|Overall Study|Withdrawal by Subject|0|||
155321409|NCT04101357|560612297|FG004|Overall Study|Withdrawal by Subject|0|||
155321410|NCT04101357|560612298|FG005|Overall Study|Withdrawal by Subject|0|||
155321411|NCT04101357|560612299|FG006|Overall Study|Withdrawal by Subject|0|||
155321412|NCT04101357|560612300|FG007|Overall Study|Withdrawal by Subject|0|||
155321413|NCT04101357|560612301|FG008|Overall Study|Withdrawal by Subject|1|||
155321414|NCT04101357|560612302|FG009|Overall Study|Withdrawal by Subject|1|||
155321415|NCT04101357|560612303|FG010|Overall Study|Withdrawal by Subject|0|||
155321416|NCT04101357|560612293|FG000|Overall Study|Other|0|||
155321417|NCT04101357|560612294|FG001|Overall Study|Other|0|||
155321418|NCT04101357|560612295|FG002|Overall Study|Other|0|||
155321419|NCT04101357|560612296|FG003|Overall Study|Other|0|||
155321420|NCT04101357|560612297|FG004|Overall Study|Other|0|||
155420692|NCT01465659|560970594|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
155420693|NCT01465659|560970595|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
155321421|NCT04101357|560612298|FG005|Overall Study|Other|1|||
155321422|NCT04101357|560612299|FG006|Overall Study|Other|2|||
155321423|NCT04101357|560612300|FG007|Overall Study|Other|1|||
155321424|NCT04101357|560612301|FG008|Overall Study|Other|0|||
155321425|NCT04101357|560612302|FG009|Overall Study|Other|0|||
155321426|NCT04101357|560612303|FG010|Overall Study|Other|0|||
155321427|NCT04101357|560612293|FG000|Overall Study|Enrolled but not treated|0|||
155321428|NCT04101357|560612294|FG001|Overall Study|Enrolled but not treated|0|||
155321429|NCT04101357|560612295|FG002|Overall Study|Enrolled but not treated|0|||
155321430|NCT04101357|560612296|FG003|Overall Study|Enrolled but not treated|0|||
155321431|NCT04101357|560612297|FG004|Overall Study|Enrolled but not treated|0|||
155321432|NCT04101357|560612298|FG005|Overall Study|Enrolled but not treated|1|||
155321433|NCT04101357|560612299|FG006|Overall Study|Enrolled but not treated|1|||
155321434|NCT04101357|560612300|FG007|Overall Study|Enrolled but not treated|0|||
155321435|NCT04101357|560612301|FG008|Overall Study|Enrolled but not treated|0|||
155321436|NCT04101357|560612302|FG009|Overall Study|Enrolled but not treated|0|||
155321437|NCT04101357|560612303|FG010|Overall Study|Enrolled but not treated|0|||
155321438|NCT03655028|560612304|FG000|12-weeks Follow up|Death|1|||
155321439|NCT03655028|560612305|FG001|12-weeks Follow up|Death|0|||
155321440|NCT03655028|560612304|FG000|12-weeks Follow up|Physician Decision|3|||
155321441|NCT03655028|560612305|FG001|12-weeks Follow up|Physician Decision|3|||
155514022|NCT01626859|561308228|FG001|Overall Study|Physician Decision|1|||
155321442|NCT03655028|560612304|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
155321443|NCT03655028|560612305|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
155321444|NCT03655028|560612304|FG000|12-weeks Follow up|Lost to Follow-up|4|||
155321445|NCT03655028|560612305|FG001|12-weeks Follow up|Lost to Follow-up|4|||
155321446|NCT03655028|560612304|FG000|24-weeks|Lost to Follow-up|1|||
155321447|NCT03655028|560612305|FG001|24-weeks|Lost to Follow-up|1|||
155321448|NCT03655028|560612304|FG000|24-weeks|Death|0|||
155321449|NCT03655028|560612305|FG001|24-weeks|Death|1|||
155321450|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
155321451|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321452|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321453|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321454|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321455|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321456|NCT04625725|560612309|FG000|Provent Main Study|Withdrawal by Subject|242|||
155321457|NCT04625725|560612310|FG001|Provent Main Study|Withdrawal by Subject|144|||
155321458|NCT04625725|560612311|FG002|Provent Main Study|Withdrawal by Subject|0|||
155321459|NCT04625725|560612312|FG003|Provent Main Study|Withdrawal by Subject|0|||
155321460|NCT04625725|560612313|FG004|Provent Main Study|Withdrawal by Subject|0|||
155321461|NCT04625725|560612314|FG005|Provent Main Study|Withdrawal by Subject|0|||
155321462|NCT04625725|560612309|FG000|Provent Main Study|Physician Decision|5|||
155321463|NCT04625725|560612310|FG001|Provent Main Study|Physician Decision|0|||
155321464|NCT04625725|560612311|FG002|Provent Main Study|Physician Decision|0|||
155321465|NCT04625725|560612312|FG003|Provent Main Study|Physician Decision|0|||
155321466|NCT04625725|560612313|FG004|Provent Main Study|Physician Decision|0|||
155321467|NCT04625725|560612314|FG005|Provent Main Study|Physician Decision|0|||
155321468|NCT04625725|560612309|FG000|Provent Main Study|Protocol Violation|1|||
155321469|NCT04625725|560612310|FG001|Provent Main Study|Protocol Violation|0|||
155420694|NCT01465659|560970596|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
155420695|NCT01465659|560970593|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
155501279|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
155501280|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
155501281|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
155501282|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501283|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
155501284|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501285|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501286|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
155501287|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501288|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155420696|NCT01465659|560970594|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
155420697|NCT01465659|560970595|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
155420698|NCT01465659|560970596|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
155420699|NCT01465659|560970593|FG000|Completed Follow for 1 Year|Death|6|||
155420700|NCT01465659|560970594|FG001|Completed Follow for 1 Year|Death|3|||
155420701|NCT01465659|560970595|FG002|Completed Follow for 1 Year|Death|2|||
155420702|NCT01465659|560970596|FG003|Completed Follow for 1 Year|Death|4|||
155420703|NCT02445586|560970602|FG000|Overall Study|Death|14|||
155420704|NCT02445586|560970602|FG000|Overall Study|Withdrawal by Subject|13|||
155420705|NCT02445586|560970602|FG000|Overall Study|Disease Progression|10|||
155420706|NCT02445586|560970602|FG000|Overall Study|Protocol Violation|1|||
155420707|NCT02445586|560970602|FG000|Overall Study|Medical Condition|1|||
155420708|NCT00428597|560970603|FG000|Overall Study|Randomized but not treated|3|||
155420709|NCT00428597|560970604|FG001|Overall Study|Randomized but not treated|3|||
155420710|NCT00428597|560970603|FG000|Overall Study|Objective Progression or Relapse|19|||
155420711|NCT00428597|560970604|FG001|Overall Study|Objective Progression or Relapse|47|||
155420712|NCT00428597|560970603|FG000|Overall Study|Study Terminated by Sponsor|41|||
155420713|NCT00428597|560970604|FG001|Overall Study|Study Terminated by Sponsor|16|||
155420714|NCT00428597|560970603|FG000|Overall Study|Adverse Event|15|||
155420715|NCT00428597|560970604|FG001|Overall Study|Adverse Event|7|||
155420716|NCT00428597|560970603|FG000|Overall Study|Global Deterioration of Health Status|1|||
155420717|NCT00428597|560970604|FG001|Overall Study|Global Deterioration of Health Status|5|||
155501289|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155644190|NCT02639559|561786931|FG001|Overall Study|Issues with vascular acess|0|||
155644191|NCT04999020|561786932|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
155752600|NCT04090957|562192881|FG003|Overall Study|Other|12|||
155321470|NCT04625725|560612311|FG002|Provent Main Study|Protocol Violation|0|||
155420718|NCT00428597|560970603|FG000|Overall Study|Protocol Violation|2|||
155420719|NCT00428597|560970604|FG001|Overall Study|Protocol Violation|1|||
155420720|NCT00428597|560970603|FG000|Overall Study|Withdrawal by Subject|2|||
155420721|NCT00428597|560970604|FG001|Overall Study|Withdrawal by Subject|1|||
155501290|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
155501291|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501292|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
155501293|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
155501294|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
155501295|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
155501296|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
155501297|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
155501298|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155501299|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501300|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501301|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
155501302|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501303|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501304|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501305|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501306|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501307|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501308|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501309|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501310|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501311|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501312|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501313|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501314|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155501315|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
155501316|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
155501317|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155501318|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501319|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501320|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501321|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501322|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
155501323|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501324|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501325|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501326|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501327|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
155501328|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501329|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501330|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155420722|NCT00428597|560970603|FG000|Overall Study|Other|1|||
155420723|NCT00428597|560970604|FG001|Overall Study|Other|1|||
155420724|NCT00428597|560970603|FG000|Overall Study|Lost to Follow-up|0|||
155420725|NCT00428597|560970604|FG001|Overall Study|Lost to Follow-up|1|||
155420726|NCT00428597|560970603|FG000|Overall Study|Pregnancy|1|||
155420727|NCT00428597|560970604|FG001|Overall Study|Pregnancy|0|||
155420728|NCT00428597|560970603|FG000|Overall Study|Death|1|||
155420729|NCT00428597|560970604|FG001|Overall Study|Death|3|||
155420730|NCT00578643|560970605|FG000|Overall Study|Death|1|||
155420731|NCT00578643|560970605|FG000|Overall Study|Lost to Follow-up|1|||
155420732|NCT01725750|560970606|FG000|Overall Study|Adverse Event|1|||
155420733|NCT01725750|560970607|FG001|Overall Study|Adverse Event|0|||
155420734|NCT01725750|560970606|FG000|Overall Study|Lost to Follow-up|1|||
155420735|NCT01725750|560970607|FG001|Overall Study|Lost to Follow-up|1|||
155420736|NCT01725750|560970606|FG000|Overall Study|Withdrawal by Subject|0|||
155420737|NCT01725750|560970607|FG001|Overall Study|Withdrawal by Subject|9|||
155420738|NCT03828487|560970610|FG000|Overall Study|Physician Decision|1|||
155420739|NCT02447848|560970611|FG000|Overall Study|Patient discharged|3|||
155420740|NCT02447848|560970611|FG000|Overall Study|Lack of Efficacy|4|||
155420741|NCT02447848|560970611|FG000|Overall Study|Withdrawal by Subject|4|||
155420742|NCT02307370|560970612|FG000|Overall Study|Death|5|||
155420743|NCT02307370|560970612|FG000|Overall Study|Lost to Follow-up|1|||
155420744|NCT02307370|560970612|FG000|Overall Study|Withdrawal by Subject|1|||
155420745|NCT02307370|560970612|FG000|Overall Study|Declined Addendum ICF|6|||
155420746|NCT02307370|560970612|FG000|Overall Study|No response during telephone contact|5|||
155420747|NCT02307370|560970612|FG000|Overall Study|Protocol Violation|1|||
155420748|NCT01506882|560970613|FG000|Overall Study|Lack of Efficacy|4|||
155321471|NCT04625725|560612312|FG003|Provent Main Study|Protocol Violation|0|||
155321472|NCT04625725|560612313|FG004|Provent Main Study|Protocol Violation|0|||
155321473|NCT04625725|560612314|FG005|Provent Main Study|Protocol Violation|0|||
155321474|NCT04625725|560612309|FG000|Provent Main Study|Lost to Follow-up|357|||
155321475|NCT04625725|560612310|FG001|Provent Main Study|Lost to Follow-up|200|||
155321476|NCT04625725|560612311|FG002|Provent Main Study|Lost to Follow-up|0|||
155321477|NCT04625725|560612312|FG003|Provent Main Study|Lost to Follow-up|0|||
155321478|NCT04625725|560612313|FG004|Provent Main Study|Lost to Follow-up|0|||
155321479|NCT04625725|560612314|FG005|Provent Main Study|Lost to Follow-up|0|||
155321480|NCT04625725|560612309|FG000|Provent Main Study|Death|22|||
155321481|NCT04625725|560612310|FG001|Provent Main Study|Death|10|||
155321482|NCT04625725|560612311|FG002|Provent Main Study|Death|0|||
155321483|NCT04625725|560612312|FG003|Provent Main Study|Death|0|||
155321484|NCT04625725|560612313|FG004|Provent Main Study|Death|0|||
155321485|NCT04625725|560612314|FG005|Provent Main Study|Death|0|||
155321486|NCT04625725|560612309|FG000|Provent Main Study|Adverse Event|2|||
155321487|NCT04625725|560612310|FG001|Provent Main Study|Adverse Event|1|||
155321488|NCT04625725|560612311|FG002|Provent Main Study|Adverse Event|0|||
155321489|NCT04625725|560612312|FG003|Provent Main Study|Adverse Event|0|||
155321490|NCT04625725|560612313|FG004|Provent Main Study|Adverse Event|0|||
155321491|NCT04625725|560612314|FG005|Provent Main Study|Adverse Event|0|||
155321492|NCT04625725|560612309|FG000|Provent Main Study|Participants dosed in sub-study|310|||
155321493|NCT04625725|560612310|FG001|Provent Main Study|Participants dosed in sub-study|193|||
155321494|NCT04625725|560612311|FG002|Provent Main Study|Participants dosed in sub-study|0|||
155321495|NCT04625725|560612312|FG003|Provent Main Study|Participants dosed in sub-study|0|||
155321496|NCT04625725|560612313|FG004|Provent Main Study|Participants dosed in sub-study|0|||
155321497|NCT04625725|560612314|FG005|Provent Main Study|Participants dosed in sub-study|0|||
155321498|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
155321499|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
155321500|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321501|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321502|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321503|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321504|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
155321505|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
155321506|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321507|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321508|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321509|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321510|NCT04625725|560612309|FG000|Provent Main Study|INCARCERATION|3|||
155321511|NCT04625725|560612310|FG001|Provent Main Study|INCARCERATION|0|||
155321512|NCT04625725|560612311|FG002|Provent Main Study|INCARCERATION|0|||
155321513|NCT04625725|560612312|FG003|Provent Main Study|INCARCERATION|0|||
155321514|NCT04625725|560612313|FG004|Provent Main Study|INCARCERATION|0|||
155321515|NCT04625725|560612314|FG005|Provent Main Study|INCARCERATION|0|||
155321516|NCT04625725|560612309|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
155321517|NCT04625725|560612310|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
155321518|NCT04625725|560612311|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321519|NCT04625725|560612312|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321520|NCT04625725|560612313|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321521|NCT04625725|560612314|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321522|NCT04625725|560612309|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
155321523|NCT04625725|560612310|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
155321524|NCT04625725|560612311|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321525|NCT04625725|560612312|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321526|NCT04625725|560612313|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321527|NCT04625725|560612314|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155420749|NCT01506882|560970614|FG001|Overall Study|Lack of Efficacy|3|||
155420750|NCT01506882|560970613|FG000|Overall Study|Lost to Follow-up|1|||
155420751|NCT01506882|560970614|FG001|Overall Study|Lost to Follow-up|0|||
155420752|NCT01506882|560970613|FG000|Overall Study|Withdrawal by Subject|9|||
155420753|NCT01506882|560970614|FG001|Overall Study|Withdrawal by Subject|3|||
155420754|NCT01506882|560970613|FG000|Overall Study|SAE, non-fatal|2|||
155644192|NCT04999020|561786933|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
155644193|NCT04999020|561786934|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
155644194|NCT04999020|561786935|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
155644195|NCT04999020|561786932|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
155644196|NCT04999020|561786933|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
155321528|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
155321529|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
155321530|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321531|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321532|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321533|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321534|NCT04625725|560612309|FG000|Provent Main Study|MISSING REASON|0|||
155321535|NCT04625725|560612310|FG001|Provent Main Study|MISSING REASON|1|||
155321536|NCT04625725|560612311|FG002|Provent Main Study|MISSING REASON|0|||
155321537|NCT04625725|560612312|FG003|Provent Main Study|MISSING REASON|0|||
155321538|NCT04625725|560612313|FG004|Provent Main Study|MISSING REASON|0|||
155321539|NCT04625725|560612314|FG005|Provent Main Study|MISSING REASON|0|||
155321540|NCT04625725|560612309|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321541|NCT04625725|560612310|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321542|NCT04625725|560612311|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321543|NCT04625725|560612312|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
155321544|NCT04625725|560612313|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321545|NCT04625725|560612314|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321546|NCT04625725|560612309|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321547|NCT04625725|560612310|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321548|NCT04625725|560612311|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
155321549|NCT04625725|560612312|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321550|NCT04625725|560612313|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321551|NCT04625725|560612314|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321552|NCT04625725|560612309|FG000|Provent Sub Study|Lost to Follow-up|0|||
155321553|NCT04625725|560612310|FG001|Provent Sub Study|Lost to Follow-up|0|||
155321554|NCT04625725|560612311|FG002|Provent Sub Study|Lost to Follow-up|20|||
155321555|NCT04625725|560612312|FG003|Provent Sub Study|Lost to Follow-up|10|||
155321556|NCT04625725|560612313|FG004|Provent Sub Study|Lost to Follow-up|6|||
155321557|NCT04625725|560612314|FG005|Provent Sub Study|Lost to Follow-up|4|||
155321558|NCT04625725|560612309|FG000|Provent Sub Study|Death|0|||
155321559|NCT04625725|560612310|FG001|Provent Sub Study|Death|0|||
155321560|NCT04625725|560612311|FG002|Provent Sub Study|Death|8|||
155321561|NCT04625725|560612312|FG003|Provent Sub Study|Death|5|||
155321562|NCT04625725|560612313|FG004|Provent Sub Study|Death|0|||
155321563|NCT04625725|560612314|FG005|Provent Sub Study|Death|1|||
155321564|NCT04625725|560612309|FG000|Provent Sub Study|Adverse Event|0|||
155321565|NCT04625725|560612310|FG001|Provent Sub Study|Adverse Event|0|||
155321566|NCT04625725|560612311|FG002|Provent Sub Study|Adverse Event|0|||
155321567|NCT04625725|560612312|FG003|Provent Sub Study|Adverse Event|0|||
155321568|NCT04625725|560612313|FG004|Provent Sub Study|Adverse Event|0|||
155321569|NCT04625725|560612314|FG005|Provent Sub Study|Adverse Event|1|||
155321570|NCT04625725|560612309|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321571|NCT04625725|560612310|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321572|NCT04625725|560612311|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321573|NCT04625725|560612312|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321574|NCT04625725|560612313|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
155321575|NCT04625725|560612314|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321576|NCT04625725|560612309|FG000|Provent Sub Study|Withdrawal by Subject|0|||
155321577|NCT04625725|560612310|FG001|Provent Sub Study|Withdrawal by Subject|0|||
155321578|NCT04625725|560612311|FG002|Provent Sub Study|Withdrawal by Subject|11|||
155321579|NCT04625725|560612312|FG003|Provent Sub Study|Withdrawal by Subject|13|||
155321580|NCT04625725|560612313|FG004|Provent Sub Study|Withdrawal by Subject|5|||
155321581|NCT04625725|560612314|FG005|Provent Sub Study|Withdrawal by Subject|6|||
155321582|NCT04625725|560612309|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321583|NCT04625725|560612310|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321584|NCT04625725|560612311|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321585|NCT04625725|560612312|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321586|NCT04625725|560612313|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321587|NCT04625725|560612314|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
155321588|NCT00429364|560612328|FG000|Overall Study|Withdrawal by Subject|11|||
155321589|NCT00429364|560612329|FG001|Overall Study|Withdrawal by Subject|5|||
155321590|NCT00429364|560612328|FG000|Overall Study|Physician Decision|4|||
155321591|NCT00429364|560612329|FG001|Overall Study|Physician Decision|2|||
155321592|NCT00429364|560612328|FG000|Overall Study|Lost to Follow-up|7|||
155321593|NCT00429364|560612329|FG001|Overall Study|Lost to Follow-up|6|||
155321594|NCT00429364|560612328|FG000|Overall Study|Death|0|||
155321595|NCT00429364|560612329|FG001|Overall Study|Death|1|||
155321596|NCT00429364|560612328|FG000|Overall Study|Underwent aortic root surgery|10|||
155321597|NCT00429364|560612329|FG001|Overall Study|Underwent aortic root surgery|18|||
155321598|NCT00429364|560612328|FG000|Overall Study|Pregnancy|0|||
155321599|NCT00429364|560612329|FG001|Overall Study|Pregnancy|1|||
155321600|NCT04871529|560612330|FG000|Overall Study|Withdrawal by Subject|0|||
155321601|NCT04871529|560612331|FG001|Overall Study|Withdrawal by Subject|1|||
155321602|NCT04871529|560612330|FG000|Overall Study|Death|0|||
155321603|NCT04871529|560612331|FG001|Overall Study|Death|1|||
155752601|NCT04090957|562192878|FG000|Overall Study|Serious Adverse Event|7|||
155321604|NCT04871529|560612330|FG000|Overall Study|Not protocol specified|0|||
155321605|NCT04871529|560612331|FG001|Overall Study|Not protocol specified|1|||
155321606|NCT05184452|560612332|FG000|Overall Study|Lost to Follow-up|0|||
155321607|NCT05184452|560612333|FG001|Overall Study|Lost to Follow-up|0|||
155321608|NCT05184452|560612334|FG002|Overall Study|Lost to Follow-up|0|||
155321609|NCT05184452|560612335|FG003|Overall Study|Lost to Follow-up|0|||
155321610|NCT05184452|560612336|FG004|Overall Study|Lost to Follow-up|0|||
155321611|NCT05184452|560612337|FG005|Overall Study|Lost to Follow-up|2|||
155321612|NCT05184452|560612338|FG006|Overall Study|Lost to Follow-up|0|||
155321613|NCT05184452|560612339|FG007|Overall Study|Lost to Follow-up|0|||
155321614|NCT05184452|560612340|FG008|Overall Study|Lost to Follow-up|0|||
155321615|NCT05184452|560612341|FG009|Overall Study|Lost to Follow-up|1|||
155321616|NCT05184452|560612332|FG000|Overall Study|Withdrawal by Subject|0|||
155321617|NCT05184452|560612333|FG001|Overall Study|Withdrawal by Subject|0|||
155321618|NCT05184452|560612334|FG002|Overall Study|Withdrawal by Subject|0|||
155321619|NCT05184452|560612335|FG003|Overall Study|Withdrawal by Subject|0|||
155321620|NCT05184452|560612336|FG004|Overall Study|Withdrawal by Subject|0|||
155321621|NCT05184452|560612337|FG005|Overall Study|Withdrawal by Subject|1|||
155321622|NCT05184452|560612338|FG006|Overall Study|Withdrawal by Subject|0|||
155321623|NCT05184452|560612339|FG007|Overall Study|Withdrawal by Subject|0|||
155321624|NCT05184452|560612340|FG008|Overall Study|Withdrawal by Subject|0|||
155321625|NCT05184452|560612341|FG009|Overall Study|Withdrawal by Subject|1|||
155321626|NCT05586490|560612342|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321627|NCT05586490|560612343|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321628|NCT05586490|560612344|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
155321629|NCT05586490|560612345|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321630|NCT05586490|560612346|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321631|NCT05586490|560612342|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
155321632|NCT05586490|560612343|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321633|NCT05586490|560612344|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321634|NCT05586490|560612345|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321635|NCT05586490|560612346|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321636|NCT05586490|560612342|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
155321637|NCT05586490|560612343|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321638|NCT05586490|560612344|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321639|NCT05586490|560612345|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321640|NCT05586490|560612346|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321641|NCT05873556|560612347|FG000|Overall Study|Lost to Follow-up|4|||
155321642|NCT05873556|560612348|FG001|Overall Study|Lost to Follow-up|1|||
155321643|NCT03606408|560612350|FG000|Overall Study|Adverse Event|13|||
155321644|NCT03606408|560612350|FG000|Overall Study|Withdrawal by Subject|7|||
155321645|NCT03606408|560612350|FG000|Overall Study|Physician Decision|4|||
155321646|NCT03606408|560612350|FG000|Overall Study|Lack of Efficacy|2|||
155321647|NCT03606408|560612350|FG000|Overall Study|Death|1|||
155321648|NCT03606408|560612350|FG000|Overall Study|new therapy for study indication|1|||
155321649|NCT04689256|560612351|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
155321650|NCT04689256|560612352|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
155321651|NCT03556293|560612353|FG000|Overall Study|Ineligible for analysis|1904|||
155321652|NCT03556293|560612354|FG001|Overall Study|Ineligible for analysis|1471|||
155321653|NCT03556293|560612355|FG002|Overall Study|Ineligible for analysis|1091|||
155321654|NCT03556293|560612356|FG003|Overall Study|Ineligible for analysis|1269|||
155321655|NCT02224144|560612382|FG000|Overall Study|Lost to Follow-up|3|||
155321656|NCT02224144|560612383|FG001|Overall Study|Lost to Follow-up|1|||
155321657|NCT02224144|560612382|FG000|Overall Study|Death|2|||
155321658|NCT02224144|560612383|FG001|Overall Study|Death|0|||
155321659|NCT02224144|560612382|FG000|Overall Study|Withdrawal by Subject|0|||
155321660|NCT02224144|560612383|FG001|Overall Study|Withdrawal by Subject|1|||
155321661|NCT03505008|560612384|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
155752602|NCT04090957|562192879|FG001|Overall Study|Serious Adverse Event|11|||
155752603|NCT04090957|562192880|FG002|Overall Study|Serious Adverse Event|1|||
155752604|NCT04090957|562192881|FG003|Overall Study|Serious Adverse Event|32|||
155752605|NCT04090957|562192878|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
155752606|NCT04090957|562192879|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
155321662|NCT03505008|560612385|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
155321663|NCT03505008|560612386|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
155752607|NCT04090957|562192880|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
155752608|NCT04090957|562192881|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
155321664|NCT03505008|560612387|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
155321665|NCT03505008|560612384|FG000|Before Week 24 Randomization|Adverse Event|10|||
155321666|NCT03505008|560612385|FG001|Before Week 24 Randomization|Adverse Event|0|||
155644197|NCT04999020|561786934|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
155644198|NCT04999020|561786935|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
155321667|NCT03505008|560612386|FG002|Before Week 24 Randomization|Adverse Event|0|||
155321668|NCT03505008|560612387|FG003|Before Week 24 Randomization|Adverse Event|0|||
155321669|NCT03505008|560612384|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
155321670|NCT03505008|560612385|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
155321671|NCT03505008|560612386|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
155321672|NCT03505008|560612387|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
155321673|NCT03505008|560612384|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
155321674|NCT03505008|560612385|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321675|NCT03505008|560612386|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321676|NCT03505008|560612387|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321677|NCT03505008|560612384|FG000|Before Week 24 Randomization|Physician Decision|2|||
155321678|NCT03505008|560612385|FG001|Before Week 24 Randomization|Physician Decision|0|||
155321679|NCT03505008|560612386|FG002|Before Week 24 Randomization|Physician Decision|0|||
155321680|NCT03505008|560612387|FG003|Before Week 24 Randomization|Physician Decision|0|||
155321681|NCT03505008|560612384|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
155321682|NCT03505008|560612385|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
155321683|NCT03505008|560612386|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
155321684|NCT03505008|560612387|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
155321685|NCT03505008|560612384|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
155321686|NCT03505008|560612385|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321687|NCT03505008|560612386|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321688|NCT03505008|560612387|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321689|NCT03505008|560612384|FG000|Before Week 24 Randomization|Complication|1|||
155321690|NCT03505008|560612385|FG001|Before Week 24 Randomization|Complication|0|||
155321691|NCT03505008|560612386|FG002|Before Week 24 Randomization|Complication|0|||
155321692|NCT03505008|560612387|FG003|Before Week 24 Randomization|Complication|0|||
155321693|NCT03505008|560612384|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
155321694|NCT03505008|560612385|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
155321695|NCT03505008|560612386|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
155321696|NCT03505008|560612387|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
155321697|NCT03505008|560612384|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
155321698|NCT03505008|560612385|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
155321699|NCT03505008|560612386|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
155321700|NCT03505008|560612387|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
155321701|NCT03505008|560612384|FG000|After Week 24 Randomization|Adverse Event|0|||
155321702|NCT03505008|560612385|FG001|After Week 24 Randomization|Adverse Event|1|||
155321703|NCT03505008|560612386|FG002|After Week 24 Randomization|Adverse Event|2|||
155321704|NCT03505008|560612387|FG003|After Week 24 Randomization|Adverse Event|2|||
155321705|NCT03505008|560612384|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
155321706|NCT03505008|560612385|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
155321707|NCT03505008|560612386|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
155321708|NCT03505008|560612387|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
155321709|NCT03505008|560612384|FG000|After Week 24 Randomization|Protocol Violation|0|||
155321710|NCT03505008|560612385|FG001|After Week 24 Randomization|Protocol Violation|0|||
155321711|NCT03505008|560612386|FG002|After Week 24 Randomization|Protocol Violation|1|||
155321712|NCT03505008|560612387|FG003|After Week 24 Randomization|Protocol Violation|0|||
155321713|NCT02962076|560612388|FG000|Overall Study|MHED tracer not available|5|||
155321714|NCT02962076|560612388|FG000|Overall Study|Protocol Violation|1|||
155321715|NCT02962076|560612388|FG000|Overall Study|Physician Decision|1|||
155321716|NCT02780700|560612389|FG000|Overall Study|Progressive disease|1|||
155321717|NCT04580914|560612393|FG000|Overall Study|Withdrawal by Subject|6|||
155321718|NCT04580914|560612393|FG000|Overall Study|Lost to Follow-up|2|||
155321719|NCT02998528|560612395|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
155321720|NCT02998528|560612396|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
155321721|NCT02998528|560612397|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
155321722|NCT02998528|560612395|FG000|Randomization Period|Participant withdrew consent|0|||
155321723|NCT02998528|560612396|FG001|Randomization Period|Participant withdrew consent|3|||
155321724|NCT02998528|560612397|FG002|Randomization Period|Participant withdrew consent|0|||
155321725|NCT02998528|560612395|FG000|Randomization Period|Participant no longer meets study criteria|1|||
155321726|NCT02998528|560612396|FG001|Randomization Period|Participant no longer meets study criteria|3|||
155644199|NCT04999020|561786932|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
155644200|NCT04999020|561786933|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
155644201|NCT04999020|561786934|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
155644202|NCT04999020|561786935|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
155644203|NCT04999020|561786932|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155321727|NCT02998528|560612397|FG002|Randomization Period|Participant no longer meets study criteria|2|||
155321728|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
155321729|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
155321730|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
155321731|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
155321732|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
155321733|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
155321734|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
155321735|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
155321736|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
155321737|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
155321738|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
155321739|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
155321740|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
155321741|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
155321742|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
155321743|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Death|1|||
155321744|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Death|0|||
155321745|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Death|0|||
155321746|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
155321747|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
155321748|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
155321749|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
155321750|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
155321751|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
155321752|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
155321753|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
155321754|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
155321755|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
155321756|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
155321757|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
155321758|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
155321759|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
155321760|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
155321761|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
155321762|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
155321763|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
155321764|NCT05035654|560612400|FG000|Overall Study|Physician Decision|0|||
155321765|NCT05035654|560612401|FG001|Overall Study|Physician Decision|1|||
155644204|NCT04999020|561786933|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155644205|NCT04999020|561786934|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155644206|NCT04999020|561786935|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155644207|NCT04999020|561786932|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155644208|NCT04999020|561786933|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155644209|NCT04999020|561786934|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
155752609|NCT04090957|562192878|FG000|Overall Study|Lack of Efficacy|1|||
155752610|NCT04090957|562192879|FG001|Overall Study|Lack of Efficacy|1|||
155752611|NCT04090957|562192880|FG002|Overall Study|Lack of Efficacy|9|||
155321766|NCT05035654|560612402|FG002|Overall Study|Physician Decision|0|||
155321767|NCT05035654|560612400|FG000|Overall Study|Adverse Event|0|||
155321768|NCT05035654|560612401|FG001|Overall Study|Adverse Event|1|||
155321769|NCT05035654|560612402|FG002|Overall Study|Adverse Event|0|||
155321770|NCT05035654|560612400|FG000|Overall Study|Withdrawal by Subject|0|||
155321771|NCT05035654|560612401|FG001|Overall Study|Withdrawal by Subject|0|||
155321772|NCT05035654|560612402|FG002|Overall Study|Withdrawal by Subject|4|||
155321773|NCT05035654|560612400|FG000|Overall Study|Bilateral Dislodgement|1|||
155321774|NCT05035654|560612401|FG001|Overall Study|Bilateral Dislodgement|0|||
155321775|NCT05035654|560612402|FG002|Overall Study|Bilateral Dislodgement|0|||
155321776|NCT01199133|560612413|FG000|Year 1|Adverse Event|16|||
155321777|NCT01199133|560612414|FG001|Year 1|Adverse Event|4|||
155321778|NCT01199133|560612413|FG000|Year 1|Withdrawal by Subject|8|||
155644210|NCT04999020|561786935|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
155752612|NCT04090957|562192881|FG003|Overall Study|Lack of Efficacy|0|||
155752613|NCT04090957|562192878|FG000|Overall Study|Protocol Violation|3|||
155752614|NCT04090957|562192879|FG001|Overall Study|Protocol Violation|5|||
155752615|NCT04090957|562192880|FG002|Overall Study|Protocol Violation|2|||
155321779|NCT01199133|560612414|FG001|Year 1|Withdrawal by Subject|4|||
155321780|NCT01199133|560612413|FG000|Year 1|Any other reason not above-mentioned|6|||
155321781|NCT01199133|560612414|FG001|Year 1|Any other reason not above-mentioned|7|||
155321782|NCT01199133|560612413|FG000|Year 2|Adverse Event|1|||
155321783|NCT01199133|560612414|FG001|Year 2|Adverse Event|0|||
155321784|NCT01199133|560612413|FG000|Year 2|Withdrawal by Subject|1|||
155321785|NCT01199133|560612414|FG001|Year 2|Withdrawal by Subject|1|||
155321786|NCT01199133|560612413|FG000|Year 2|Any other reason not above-mentioned|1|||
155321787|NCT01199133|560612414|FG001|Year 2|Any other reason not above-mentioned|2|||
155321788|NCT02575950|560612415|FG000|Overall Study|Withdrawal by Subject|0|||
155321789|NCT02575950|560612416|FG001|Overall Study|Withdrawal by Subject|0|||
155321790|NCT02575950|560612417|FG002|Overall Study|Withdrawal by Subject|0|||
155321791|NCT02575950|560612418|FG003|Overall Study|Withdrawal by Subject|2|||
155321792|NCT02575950|560612415|FG000|Overall Study|Lost to Follow-up|0|||
155321793|NCT02575950|560612416|FG001|Overall Study|Lost to Follow-up|1|||
155321794|NCT02575950|560612417|FG002|Overall Study|Lost to Follow-up|0|||
155321795|NCT02575950|560612418|FG003|Overall Study|Lost to Follow-up|3|||
155321796|NCT03993392|560612421|FG000|Overall Study|Withdrawal by Subject|3|||
155321797|NCT03993392|560612421|FG000|Overall Study|Lost to Follow-up|2|||
155321798|NCT03993392|560612421|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
155321799|NCT03106740|560614194|FG000|Overall Study|Lost to Follow-up|2|||
155321800|NCT03106740|560614195|FG001|Overall Study|Lost to Follow-up|2|||
155321801|NCT03106740|560614194|FG000|Overall Study|Withdrawal by Subject|2|||
155321802|NCT03106740|560614195|FG001|Overall Study|Withdrawal by Subject|4|||
155321803|NCT03106740|560614194|FG000|Overall Study|Physician Decision|0|||
155321804|NCT03106740|560614195|FG001|Overall Study|Physician Decision|1|||
155321805|NCT03106740|560614194|FG000|Overall Study|Partial data|1|||
155321806|NCT03106740|560614195|FG001|Overall Study|Partial data|0|||
155321807|NCT06262477|560614196|FG000|Overall Study|Withdrawal by Subject|1|||
155321808|NCT06262477|560614197|FG001|Overall Study|Withdrawal by Subject|0|||
155321809|NCT06262477|560614196|FG000|Overall Study|Adverse Event|0|||
155321810|NCT06262477|560614197|FG001|Overall Study|Adverse Event|1|||
155321811|NCT06262477|560614196|FG000|Overall Study|Lost to Follow-up|0|||
155321812|NCT06262477|560614197|FG001|Overall Study|Lost to Follow-up|1|||
155321813|NCT03220035|560614201|FG000|Overall Study|Adverse Event|1|||
155321814|NCT03220035|560614201|FG000|Overall Study|Protocol Violation|1|||
155321815|NCT03220035|560614201|FG000|Overall Study|Progressive Disease|2|||
155321816|NCT05452460|560614202|FG000|Overall Study|Lost to Follow-up|3|||
155321817|NCT05452460|560614203|FG001|Overall Study|Lost to Follow-up|3|||
155321818|NCT05452460|560614202|FG000|Overall Study|Did not receive intervention|1|||
155321819|NCT05452460|560614203|FG001|Overall Study|Did not receive intervention|0|||
155321820|NCT04433208|560614204|FG000|Overall Study|Withdrawal by Subject|0|||
155321821|NCT04433208|560614205|FG001|Overall Study|Withdrawal by Subject|1|||
155321822|NCT04433208|560614206|FG002|Overall Study|Withdrawal by Subject|1|||
155321823|NCT04433208|560614207|FG003|Overall Study|Withdrawal by Subject|0|||
155321824|NCT04433208|560614208|FG004|Overall Study|Withdrawal by Subject|2|||
155321825|NCT04433208|560614209|FG005|Overall Study|Withdrawal by Subject|1|||
155321826|NCT04433208|560614204|FG000|Overall Study|Lost to Follow-up|0|||
155321827|NCT04433208|560614205|FG001|Overall Study|Lost to Follow-up|0|||
155321828|NCT04433208|560614206|FG002|Overall Study|Lost to Follow-up|0|||
155321829|NCT04433208|560614207|FG003|Overall Study|Lost to Follow-up|0|||
155321830|NCT04433208|560614208|FG004|Overall Study|Lost to Follow-up|0|||
155321831|NCT04433208|560614209|FG005|Overall Study|Lost to Follow-up|1|||
155321832|NCT02424617|560614212|FG000|Overall Study|Adverse Event|0|||
155321833|NCT02424617|560614213|FG001|Overall Study|Adverse Event|1|||
155752616|NCT04090957|562192881|FG003|Overall Study|Protocol Violation|1|||
155752617|NCT04090957|562192878|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
155752618|NCT04090957|562192879|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
155752619|NCT04090957|562192880|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
155752620|NCT04090957|562192881|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
155752621|NCT04090957|562192878|FG000|Overall Study|COVID-19|2|||
155321834|NCT02424617|560614214|FG002|Overall Study|Adverse Event|0|||
155321835|NCT02424617|560614215|FG003|Overall Study|Adverse Event|0|||
155321836|NCT02424617|560614212|FG000|Overall Study|Investigator Decision|0|||
155321837|NCT02424617|560614213|FG001|Overall Study|Investigator Decision|0|||
155321838|NCT02424617|560614214|FG002|Overall Study|Investigator Decision|0|||
155501331|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155752622|NCT04090957|562192879|FG001|Overall Study|COVID-19|2|||
155321839|NCT02424617|560614215|FG003|Overall Study|Investigator Decision|1|||
155321840|NCT02424617|560614212|FG000|Overall Study|Withdrawal by Subject|1|||
155321841|NCT02424617|560614213|FG001|Overall Study|Withdrawal by Subject|1|||
155321842|NCT02424617|560614214|FG002|Overall Study|Withdrawal by Subject|0|||
155321843|NCT02424617|560614215|FG003|Overall Study|Withdrawal by Subject|1|||
155321844|NCT02424617|560614212|FG000|Overall Study|Progressive Disease|7|||
155321845|NCT02424617|560614213|FG001|Overall Study|Progressive Disease|6|||
155321846|NCT02424617|560614214|FG002|Overall Study|Progressive Disease|11|||
155321847|NCT02424617|560614215|FG003|Overall Study|Progressive Disease|10|||
155321848|NCT02424617|560614212|FG000|Overall Study|Other|0|||
155321849|NCT02424617|560614213|FG001|Overall Study|Other|0|||
155321850|NCT02424617|560614214|FG002|Overall Study|Other|0|||
155321851|NCT02424617|560614215|FG003|Overall Study|Other|1|||
155321852|NCT04359654|560614217|FG000|Overall Study|Withdrawal by Subject|1|||
155420755|NCT01506882|560970614|FG001|Overall Study|SAE, non-fatal|0|||
155420756|NCT01506882|560970613|FG000|Overall Study|AE, non-serious non-fatal|3|||
155321853|NCT04359654|560614218|FG001|Overall Study|Withdrawal by Subject|0|||
155321854|NCT04359654|560614217|FG000|Overall Study|Adverse Event|0|||
155321855|NCT04359654|560614218|FG001|Overall Study|Adverse Event|1|||
155321856|NCT04024020|560614219|FG000|Overall Study|Withdrawal by Subject|2|||
155321857|NCT04024020|560614220|FG001|Overall Study|Withdrawal by Subject|2|||
155321858|NCT05269966|560614223|FG000|Overall Study|Adverse Event|4|||
155321859|NCT05269966|560614223|FG000|Overall Study|Withdrawal by Subject|1|||
155321860|NCT05269966|560614223|FG000|Overall Study|Lost to Follow-up|4|||
155321861|NCT05269966|560614223|FG000|Overall Study|Physician Decision|1|||
155321862|NCT03476343|560614226|FG000|Overall Study|Clinical exam moved to another scanner|7|||
155321863|NCT03476343|560614226|FG000|Overall Study|Clinical order cancelled|4|||
155321864|NCT03476343|560614226|FG000|Overall Study|Neonate did not settle down for the scan|1|||
155321865|NCT05974501|560614227|FG000|Overall Study|Physician Decision|0|||
155321866|NCT05974501|560614228|FG001|Overall Study|Physician Decision|1|||
155321867|NCT04304144|560614229|FG000|DLT Observation Period|Physician Decision|0|||
155321868|NCT04304144|560614230|FG001|DLT Observation Period|Physician Decision|1|||
155321869|NCT04304144|560614231|FG002|DLT Observation Period|Physician Decision|0|||
155321870|NCT04304144|560614232|FG003|DLT Observation Period|Physician Decision|0|||
155321871|NCT04304144|560614229|FG000|Continued Treatment Period|Adverse Event|0|||
155321872|NCT04304144|560614230|FG001|Continued Treatment Period|Adverse Event|1|||
155321873|NCT04304144|560614231|FG002|Continued Treatment Period|Adverse Event|0|||
155321874|NCT04304144|560614232|FG003|Continued Treatment Period|Adverse Event|0|||
155321875|NCT04304144|560614229|FG000|Continued Treatment Period|Death|0|||
155321876|NCT04304144|560614230|FG001|Continued Treatment Period|Death|0|||
155321877|NCT04304144|560614231|FG002|Continued Treatment Period|Death|1|||
155321878|NCT04304144|560614232|FG003|Continued Treatment Period|Death|2|||
155321879|NCT04304144|560614229|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
155321880|NCT04304144|560614230|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
155321881|NCT04304144|560614231|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
155321882|NCT04304144|560614232|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
155321883|NCT04304144|560614229|FG000|Continued Treatment Period|Other than specified|2|||
155321884|NCT04304144|560614230|FG001|Continued Treatment Period|Other than specified|0|||
155321885|NCT04304144|560614231|FG002|Continued Treatment Period|Other than specified|1|||
155321886|NCT04304144|560614232|FG003|Continued Treatment Period|Other than specified|1|||
155321887|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
155321888|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
155321889|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
155321890|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
155321891|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
155321892|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
155321893|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
155321894|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Death|0|||
155321895|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Death|1|||
155321896|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Death|0|||
155321897|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Death|0|||
155321898|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Death|0|||
155321899|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Death|0|||
155321900|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Death|0|||
155321901|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
155321902|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321903|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321904|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321905|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321906|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321907|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321908|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321909|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
155321910|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321911|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321912|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155752623|NCT04090957|562192880|FG002|Overall Study|COVID-19|3|||
155752624|NCT04090957|562192881|FG003|Overall Study|COVID-19|7|||
155752625|NCT04090957|562192878|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
155321913|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321914|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321915|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Other|1|||
155321916|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Other|0|||
155321917|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Other|0|||
155321918|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Other|0|||
155321919|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Other|0|||
155321920|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Other|0|||
155752626|NCT04090957|562192879|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
155752627|NCT04090957|562192880|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
155752628|NCT04090957|562192881|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
155752629|NCT04090957|562192878|FG000|Overall Study|Physician Decision|2|||
155752630|NCT04090957|562192879|FG001|Overall Study|Physician Decision|1|||
155752631|NCT04090957|562192880|FG002|Overall Study|Physician Decision|1|||
155752632|NCT04090957|562192881|FG003|Overall Study|Physician Decision|5|||
155752633|NCT04090957|562192878|FG000|Overall Study|Sponsor Decision|1|||
155752634|NCT04090957|562192879|FG001|Overall Study|Sponsor Decision|1|||
155752635|NCT04090957|562192880|FG002|Overall Study|Sponsor Decision|1|||
155752636|NCT04090957|562192881|FG003|Overall Study|Sponsor Decision|3|||
155752637|NCT04090957|562192878|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
155752638|NCT04090957|562192879|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
155752639|NCT04090957|562192880|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
155752640|NCT04090957|562192881|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
155752641|NCT04090957|562192878|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
155752642|NCT04090957|562192879|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
155752643|NCT04090957|562192880|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
155752644|NCT04090957|562192881|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
155752645|NCT04090957|562192878|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155752646|NCT04090957|562192879|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155752647|NCT04090957|562192880|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
155752648|NCT04090957|562192881|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155752649|NCT04090957|562192878|FG000|Overall Study|Death|1|||
155752650|NCT04090957|562192879|FG001|Overall Study|Death|0|||
155752651|NCT04090957|562192880|FG002|Overall Study|Death|0|||
155752652|NCT04090957|562192881|FG003|Overall Study|Death|0|||
155752653|NCT04090957|562192878|FG000|Overall Study|No Treatment Administered|2|||
155752654|NCT04090957|562192879|FG001|Overall Study|No Treatment Administered|1|||
155752655|NCT04090957|562192880|FG002|Overall Study|No Treatment Administered|2|||
155752656|NCT04090957|562192881|FG003|Overall Study|No Treatment Administered|1|||
155752657|NCT06173063|562192882|FG000|Overall Study|Withdrawal by Subject|2|||
155752658|NCT03820947|562192883|FG000|Overall Study|Physician Decision|0|||
155752659|NCT03820947|562192884|FG001|Overall Study|Physician Decision|1|||
155752660|NCT03820947|562192885|FG002|Overall Study|Physician Decision|1|||
155752661|NCT03820947|562192886|FG003|Overall Study|Physician Decision|0|||
155752662|NCT03820947|562192887|FG004|Overall Study|Physician Decision|3|||
155752663|NCT03820947|562192883|FG000|Overall Study|Withdrawal by Subject|6|||
155752664|NCT03820947|562192884|FG001|Overall Study|Withdrawal by Subject|10|||
155752665|NCT03820947|562192885|FG002|Overall Study|Withdrawal by Subject|3|||
155752666|NCT03820947|562192886|FG003|Overall Study|Withdrawal by Subject|8|||
155752667|NCT03820947|562192887|FG004|Overall Study|Withdrawal by Subject|5|||
155752668|NCT03820947|562192883|FG000|Overall Study|Procedure Not Attempted|0|||
155752669|NCT03820947|562192884|FG001|Overall Study|Procedure Not Attempted|2|||
155752670|NCT03820947|562192885|FG002|Overall Study|Procedure Not Attempted|1|||
155752671|NCT03820947|562192886|FG003|Overall Study|Procedure Not Attempted|0|||
155752672|NCT03820947|562192887|FG004|Overall Study|Procedure Not Attempted|0|||
155752673|NCT03820947|562192883|FG000|Overall Study|Other Exit|1|||
155752674|NCT03820947|562192884|FG001|Overall Study|Other Exit|3|||
155752675|NCT03820947|562192885|FG002|Overall Study|Other Exit|3|||
155752676|NCT03820947|562192886|FG003|Overall Study|Other Exit|3|||
155752677|NCT03820947|562192887|FG004|Overall Study|Other Exit|0|||
155321921|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Other|0|||
155321922|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
155321923|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
155321924|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321925|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321926|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321927|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321928|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321929|NCT04585815|560614233|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155420757|NCT01506882|560970614|FG001|Overall Study|AE, non-serious non-fatal|1|||
155752678|NCT03820947|562192883|FG000|Overall Study|Follow-up Not Done|10|||
155752679|NCT03820947|562192884|FG001|Overall Study|Follow-up Not Done|13|||
155752680|NCT03820947|562192885|FG002|Overall Study|Follow-up Not Done|2|||
155420758|NCT01506882|560970613|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
155514023|NCT01626859|561308229|FG002|Overall Study|Physician Decision|0|||
155752681|NCT03820947|562192886|FG003|Overall Study|Follow-up Not Done|3|||
155752682|NCT03820947|562192887|FG004|Overall Study|Follow-up Not Done|12|||
155752683|NCT03820947|562192883|FG000|Overall Study|Death|0|||
155752684|NCT03820947|562192884|FG001|Overall Study|Death|0|||
155752685|NCT03820947|562192885|FG002|Overall Study|Death|0|||
155752686|NCT03820947|562192886|FG003|Overall Study|Death|0|||
155321930|NCT04585815|560614234|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
155321931|NCT04585815|560614235|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321932|NCT04585815|560614236|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321933|NCT04585815|560614237|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321934|NCT04585815|560614238|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321935|NCT04585815|560614239|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321936|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
155321937|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
155321938|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
155321939|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
155321940|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
155321941|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
155321942|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
155321943|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Death|0|||
155321944|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Death|0|||
155321945|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Death|0|||
155321946|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Death|1|||
155321947|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Death|0|||
155321948|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Death|0|||
155321949|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Death|0|||
155321950|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321951|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321952|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321953|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
155321954|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321955|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
155321956|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321957|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321958|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321959|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321960|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
155321961|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321962|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321963|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321964|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321965|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321966|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321967|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321968|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321969|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321970|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
155321971|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
155321972|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
155321973|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
155321974|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
155321975|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
155321976|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
155321977|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
155321978|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
155321979|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
155321980|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
155321981|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
155321982|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
155321983|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
155321984|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
155321985|NCT04585815|560614233|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321986|NCT04585815|560614234|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321987|NCT04585815|560614235|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321988|NCT04585815|560614236|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321989|NCT04585815|560614237|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
155321990|NCT04585815|560614238|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
155321991|NCT04585815|560614239|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
155752687|NCT03820947|562192887|FG004|Overall Study|Death|9|||
155321992|NCT04585815|560614233|FG000|Sub-study B- Follow-up Phase|Death|0|||
155321993|NCT04585815|560614234|FG001|Sub-study B- Follow-up Phase|Death|0|||
155321994|NCT04585815|560614235|FG002|Sub-study B- Follow-up Phase|Death|1|||
155321995|NCT04585815|560614236|FG003|Sub-study B- Follow-up Phase|Death|3|||
155321996|NCT04585815|560614237|FG004|Sub-study B- Follow-up Phase|Death|0|||
155321997|NCT04585815|560614238|FG005|Sub-study B- Follow-up Phase|Death|0|||
155321998|NCT04585815|560614239|FG006|Sub-study B- Follow-up Phase|Death|1|||
155321999|NCT02497950|560614242|FG000|Overall Study|Death|209|||
155322000|NCT02497950|560614242|FG000|Overall Study|Transplanted|85|||
155322001|NCT02497950|560614242|FG000|Overall Study|Explanted|8|||
155322002|NCT02497950|560614242|FG000|Overall Study|Device Permanently Deactivated|4|||
155322003|NCT02497950|560614242|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
155322004|NCT02497950|560614242|FG000|Overall Study|Lost to Follow-up|6|||
155322005|NCT02497950|560614242|FG000|Overall Study|Withdrawal by Subject|2|||
155322006|NCT02497950|560614242|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
155322007|NCT02497950|560614242|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
155322008|NCT04660539|560614243|FG000|Overall Study|Adverse Event|10|||
155322009|NCT04660539|560614243|FG000|Overall Study|Lack of Efficacy|4|||
155322010|NCT04660539|560614243|FG000|Overall Study|Lost to Follow-up|5|||
155322011|NCT04660539|560614243|FG000|Overall Study|Non-Compliance With Study Drug|3|||
155322012|NCT04660539|560614243|FG000|Overall Study|Reason not Specified|12|||
155322013|NCT04660539|560614243|FG000|Overall Study|Pregnancy|2|||
155322014|NCT04660539|560614243|FG000|Overall Study|Protocol Violation|2|||
155322015|NCT04660539|560614243|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
155322016|NCT04660539|560614243|FG000|Overall Study|Withdrawal by Subject|21|||
155322017|NCT04862234|560614246|FG000|Overall Study|Surgery cancellation|1|||
155322018|NCT04862234|560614247|FG001|Overall Study|Surgery cancellation|2|||
155322019|NCT04862234|560614246|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
155322020|NCT04862234|560614247|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
155322021|NCT04862234|560614246|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
155322022|NCT04862234|560614247|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
155322023|NCT03292484|560614248|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
155322024|NCT03292484|560614248|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
155322025|NCT03292484|560614248|FG000|Overall Study|Protocol Violation|2|||
155322026|NCT03292484|560614248|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
155322027|NCT03292484|560614248|FG000|Overall Study|Sponsor decision|349|||
155322028|NCT03292484|560614248|FG000|Overall Study|Lost to Follow-up|7|||
155420759|NCT01506882|560970614|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155420760|NCT01506882|560970613|FG000|Overall Study|Other Reason|2|||
155420761|NCT01506882|560970614|FG001|Overall Study|Other Reason|0|||
155420762|NCT02591615|560972432|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
155420763|NCT02591615|560972433|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
155322029|NCT03292484|560614248|FG000|Overall Study|Coronavirus Disease 2019|1|||
155322030|NCT03292484|560614248|FG000|Overall Study|Other|20|||
155322031|NCT05290493|560614251|FG000|Overall Study|Withdrawal by Subject|2|||
155322032|NCT05290493|560614252|FG001|Overall Study|Withdrawal by Subject|2|||
155322033|NCT05290493|560614251|FG000|Overall Study|Adverse Event|1|||
155501332|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501333|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501334|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501335|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501336|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155501337|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
155501338|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501339|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501340|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501341|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501342|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
155501343|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501344|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501345|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501346|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501347|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
155501348|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501349|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501350|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
155501351|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
155501352|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
155501353|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
155501354|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
155501355|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155501356|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501357|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501358|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501359|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501360|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501361|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501362|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501363|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501364|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501365|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501366|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
155501367|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501368|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501369|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501370|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501371|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501372|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501373|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501374|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155501375|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
155322034|NCT05290493|560614252|FG001|Overall Study|Adverse Event|0|||
155322035|NCT05524402|560614253|FG000|Overall Study|Withdrawal by Subject|3|||
155322036|NCT05524402|560614254|FG001|Overall Study|Withdrawal by Subject|1|||
155322037|NCT05524402|560614253|FG000|Overall Study|Lost to Follow-up|2|||
155501376|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
155501377|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155501378|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155501379|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
155501380|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
155501381|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155501382|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
155501383|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155644211|NCT04999020|561786932|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
155644212|NCT04999020|561786933|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
155322038|NCT05524402|560614254|FG001|Overall Study|Lost to Follow-up|1|||
155501384|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
155501385|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155501386|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155501387|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
155501388|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
155501389|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155322039|NCT05976334|560614255|FG000|Part B|Death|0|||
155322040|NCT05976334|560614256|FG001|Part B|Death|1|||
155322041|NCT05976334|560614255|FG000|Part B|Study Terminated by Sponsor|0|||
155322042|NCT05976334|560614256|FG001|Part B|Study Terminated by Sponsor|1|||
155322043|NCT05976334|560614255|FG000|Part B|Reason Not Specified|0|||
155322044|NCT05976334|560614256|FG001|Part B|Reason Not Specified|1|||
155322045|NCT03381586|560614257|FG000|Overall Study|Adverse Event|1|||
155322046|NCT03381586|560614258|FG001|Overall Study|Adverse Event|1|||
155322047|NCT03381586|560614257|FG000|Overall Study|Protocol Violation|1|||
155322048|NCT03381586|560614258|FG001|Overall Study|Protocol Violation|0|||
155322049|NCT03381586|560614257|FG000|Overall Study|Withdrawal by Subject|1|||
155322050|NCT03381586|560614258|FG001|Overall Study|Withdrawal by Subject|2|||
155322051|NCT05280574|560614259|FG000|Overall Study|Withdrawal by Subject|0|||
155322052|NCT05280574|560614260|FG001|Overall Study|Withdrawal by Subject|2|||
155322053|NCT05280574|560614261|FG002|Overall Study|Withdrawal by Subject|0|||
155322054|NCT05363163|560614262|FG000|Overall Study|Withdrawal by Subject|13|||
155322055|NCT05838027|560614266|FG000|Overall Study|Lost to Follow-up|5|||
155322056|NCT05838027|560614267|FG001|Overall Study|Lost to Follow-up|1|||
155322057|NCT05838027|560614266|FG000|Overall Study|Withdrawal by Subject|1|||
155322058|NCT05838027|560614267|FG001|Overall Study|Withdrawal by Subject|0|||
155322059|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322060|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
155322061|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322062|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322063|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
155322064|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
155322065|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
155322066|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
155322067|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322068|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
155322069|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322070|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322071|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
155322072|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
155322073|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
155322074|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
155322075|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322076|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322077|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322078|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
155322079|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
155322080|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
155322081|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
155322082|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
155322083|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
155322084|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
155322085|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
155322086|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
155322087|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322088|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322089|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322090|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
155322091|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
155322092|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
155322093|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
155322094|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
155322095|NCT04999111|560614272|FG000|Overall Study|Lost to Follow-up|21|||
155322096|NCT04999111|560614273|FG001|Overall Study|Lost to Follow-up|16|||
155322097|NCT04999111|560614274|FG002|Overall Study|Lost to Follow-up|2|||
155322098|NCT04999111|560614275|FG003|Overall Study|Lost to Follow-up|26|||
155322099|NCT04999111|560614276|FG004|Overall Study|Lost to Follow-up|30|||
155322100|NCT04999111|560614277|FG005|Overall Study|Lost to Follow-up|6|||
155322101|NCT04999111|560614272|FG000|Overall Study|Physician Decision|1|||
155322102|NCT04999111|560614273|FG001|Overall Study|Physician Decision|3|||
155322103|NCT04999111|560614274|FG002|Overall Study|Physician Decision|0|||
155322104|NCT04999111|560614275|FG003|Overall Study|Physician Decision|1|||
155322105|NCT04999111|560614276|FG004|Overall Study|Physician Decision|2|||
155322106|NCT04999111|560614277|FG005|Overall Study|Physician Decision|0|||
155322107|NCT04999111|560614272|FG000|Overall Study|Withdrawal by Subject|23|||
155752688|NCT03820947|562192883|FG000|Overall Study|Lost to Follow-up|4|||
155322108|NCT04999111|560614273|FG001|Overall Study|Withdrawal by Subject|29|||
155322109|NCT04999111|560614274|FG002|Overall Study|Withdrawal by Subject|15|||
155322110|NCT04999111|560614275|FG003|Overall Study|Withdrawal by Subject|30|||
155322111|NCT04999111|560614276|FG004|Overall Study|Withdrawal by Subject|35|||
155322112|NCT04999111|560614277|FG005|Overall Study|Withdrawal by Subject|10|||
155322113|NCT04999111|560614272|FG000|Overall Study|Other|6|||
155322114|NCT04999111|560614273|FG001|Overall Study|Other|6|||
155322115|NCT04999111|560614274|FG002|Overall Study|Other|3|||
155322116|NCT04999111|560614275|FG003|Overall Study|Other|8|||
155322117|NCT04999111|560614276|FG004|Overall Study|Other|8|||
155322118|NCT04999111|560614277|FG005|Overall Study|Other|5|||
155322119|NCT04999111|560614272|FG000|Overall Study|Non-compliance with study schedule|1|||
155322120|NCT04999111|560614273|FG001|Overall Study|Non-compliance with study schedule|0|||
155322121|NCT04999111|560614274|FG002|Overall Study|Non-compliance with study schedule|0|||
155322122|NCT04999111|560614275|FG003|Overall Study|Non-compliance with study schedule|1|||
155322123|NCT04999111|560614276|FG004|Overall Study|Non-compliance with study schedule|1|||
155322124|NCT04999111|560614277|FG005|Overall Study|Non-compliance with study schedule|1|||
155322125|NCT04999111|560614272|FG000|Overall Study|Randomized but not vaccinated|1|||
155322126|NCT04999111|560614273|FG001|Overall Study|Randomized but not vaccinated|2|||
155322127|NCT04999111|560614274|FG002|Overall Study|Randomized but not vaccinated|0|||
155322128|NCT04999111|560614275|FG003|Overall Study|Randomized but not vaccinated|3|||
155322129|NCT04999111|560614276|FG004|Overall Study|Randomized but not vaccinated|3|||
155322130|NCT04999111|560614277|FG005|Overall Study|Randomized but not vaccinated|0|||
155322131|NCT04999111|560614272|FG000|Overall Study|Adverse Event|1|||
155322132|NCT04999111|560614273|FG001|Overall Study|Adverse Event|1|||
155322133|NCT04999111|560614274|FG002|Overall Study|Adverse Event|0|||
155322134|NCT04999111|560614275|FG003|Overall Study|Adverse Event|0|||
155322135|NCT04999111|560614276|FG004|Overall Study|Adverse Event|0|||
155501390|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
155501391|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
155501392|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
155501393|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
155501394|NCT01915498|561260828|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
155501395|NCT01915498|561260829|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
155501396|NCT01915498|561260830|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
155501397|NCT01915498|561260831|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
155501398|NCT01915498|561260832|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
155501399|NCT01915498|561260833|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
155501400|NCT01915498|561260834|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
155501401|NCT01915498|561260835|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
155501402|NCT01915498|561260836|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
155501403|NCT01915498|561260837|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
155501404|NCT01915498|561260838|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
155501405|NCT01915498|561260839|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
155501406|NCT01915498|561260840|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
155501407|NCT01915498|561260841|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
155501408|NCT01915498|561260842|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
155501409|NCT01915498|561260843|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
155501410|NCT01915498|561260844|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
155501411|NCT01915498|561260845|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
155501412|NCT01915498|561260846|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
155501413|NCT01915498|561260828|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501414|NCT01915498|561260829|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501415|NCT01915498|561260830|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155322136|NCT04999111|560614277|FG005|Overall Study|Adverse Event|0|||
155322137|NCT04999111|560614272|FG000|Overall Study|Initiated prohibited medication|0|||
155322138|NCT04999111|560614273|FG001|Overall Study|Initiated prohibited medication|0|||
155501416|NCT01915498|561260831|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501417|NCT01915498|561260832|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155752689|NCT03820947|562192884|FG001|Overall Study|Lost to Follow-up|6|||
155752690|NCT03820947|562192885|FG002|Overall Study|Lost to Follow-up|0|||
155752691|NCT03820947|562192886|FG003|Overall Study|Lost to Follow-up|0|||
155752692|NCT03820947|562192887|FG004|Overall Study|Lost to Follow-up|9|||
155322139|NCT04999111|560614274|FG002|Overall Study|Initiated prohibited medication|0|||
155322140|NCT04999111|560614275|FG003|Overall Study|Initiated prohibited medication|0|||
155322141|NCT04999111|560614276|FG004|Overall Study|Initiated prohibited medication|1|||
155322142|NCT04999111|560614277|FG005|Overall Study|Initiated prohibited medication|0|||
155322143|NCT04056611|560614284|FG000|Overall Study|Physician Decision|1|||
155322144|NCT03213873|560614285|FG000|Overall Study|Withdrawal by Subject|8|||
155322145|NCT03213873|560614286|FG001|Overall Study|Withdrawal by Subject|9|||
155322146|NCT03213873|560614285|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
155322147|NCT03213873|560614286|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
155322148|NCT03213873|560614285|FG000|Overall Study|Lost to Follow-up|0|||
155322149|NCT03213873|560614286|FG001|Overall Study|Lost to Follow-up|2|||
155322150|NCT04709419|560614288|FG000|Overall Study|Physician Decision|1|||
155322151|NCT04709419|560614289|FG001|Overall Study|Physician Decision|0|||
155322152|NCT05683340|560614290|FG000|Overall Study|Adverse Event|1|||
155322153|NCT05683340|560614291|FG001|Overall Study|Adverse Event|1|||
155322154|NCT05683340|560614290|FG000|Overall Study|Protocol Violation|1|||
155322155|NCT05683340|560614291|FG001|Overall Study|Protocol Violation|0|||
155322156|NCT05683340|560614290|FG000|Overall Study|Withdrawal by Subject|0|||
155322157|NCT05683340|560614291|FG001|Overall Study|Withdrawal by Subject|2|||
155322158|NCT02437136|560614292|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
155322159|NCT02437136|560614293|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322160|NCT02437136|560614294|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322161|NCT02437136|560614295|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322162|NCT02437136|560614296|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322163|NCT02437136|560614297|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322164|NCT02437136|560614298|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322165|NCT02437136|560614292|FG000|Expansion (Phase 2)|Death|0|||
155322166|NCT02437136|560614293|FG001|Expansion (Phase 2)|Death|0|||
155322167|NCT02437136|560614294|FG002|Expansion (Phase 2)|Death|0|||
155322168|NCT02437136|560614295|FG003|Expansion (Phase 2)|Death|6|||
155322169|NCT02437136|560614296|FG004|Expansion (Phase 2)|Death|37|||
155322170|NCT02437136|560614297|FG005|Expansion (Phase 2)|Death|29|||
155322171|NCT02437136|560614298|FG006|Expansion (Phase 2)|Death|24|||
155322172|NCT02437136|560614292|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322173|NCT02437136|560614293|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322174|NCT02437136|560614294|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322175|NCT02437136|560614295|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
155322176|NCT02437136|560614296|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
155322177|NCT02437136|560614297|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
155322178|NCT02437136|560614298|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
155322179|NCT02437136|560614292|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
155322180|NCT02437136|560614293|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
155322181|NCT02437136|560614294|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
155322182|NCT02437136|560614295|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
155322183|NCT02437136|560614296|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
155322184|NCT02437136|560614297|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
155501418|NCT01915498|561260833|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501419|NCT01915498|561260834|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155322185|NCT02437136|560614298|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
155322186|NCT02056834|560614299|FG000|Overall Study|Lost to Follow-up|7|||
155322187|NCT03276676|560614306|FG000|Overall Study|Withdrawal by Subject|2|||
155322188|NCT03276676|560614307|FG001|Overall Study|Withdrawal by Subject|1|||
155322189|NCT03926130|560614316|FG000|Overall Study|Adverse Event|9|||
155322190|NCT03926130|560614317|FG001|Overall Study|Adverse Event|11|||
155322191|NCT03926130|560614318|FG002|Overall Study|Adverse Event|2|||
155322192|NCT03926130|560614319|FG003|Overall Study|Adverse Event|0|||
155322193|NCT03926130|560614316|FG000|Overall Study|Death|2|||
155322194|NCT03926130|560614317|FG001|Overall Study|Death|0|||
155322195|NCT03926130|560614318|FG002|Overall Study|Death|1|||
155322196|NCT03926130|560614319|FG003|Overall Study|Death|0|||
155322197|NCT03926130|560614316|FG000|Overall Study|Lack of Efficacy|14|||
155322198|NCT03926130|560614317|FG001|Overall Study|Lack of Efficacy|11|||
155322199|NCT03926130|560614318|FG002|Overall Study|Lack of Efficacy|7|||
155322200|NCT03926130|560614319|FG003|Overall Study|Lack of Efficacy|1|||
155322201|NCT03926130|560614316|FG000|Overall Study|Lost to Follow-up|0|||
155322202|NCT03926130|560614317|FG001|Overall Study|Lost to Follow-up|7|||
155322203|NCT03926130|560614318|FG002|Overall Study|Lost to Follow-up|1|||
155322204|NCT03926130|560614319|FG003|Overall Study|Lost to Follow-up|0|||
155322205|NCT03926130|560614316|FG000|Overall Study|As Reported by Investigator|2|||
155322206|NCT03926130|560614317|FG001|Overall Study|As Reported by Investigator|6|||
155322207|NCT03926130|560614318|FG002|Overall Study|As Reported by Investigator|6|||
155322208|NCT03926130|560614319|FG003|Overall Study|As Reported by Investigator|0|||
155322209|NCT03926130|560614316|FG000|Overall Study|Physician Decision|3|||
155322210|NCT03926130|560614317|FG001|Overall Study|Physician Decision|2|||
155322211|NCT03926130|560614318|FG002|Overall Study|Physician Decision|1|||
155322212|NCT03926130|560614319|FG003|Overall Study|Physician Decision|0|||
155322213|NCT03926130|560614316|FG000|Overall Study|Pregnancy|2|||
155322214|NCT03926130|560614317|FG001|Overall Study|Pregnancy|2|||
155322215|NCT03926130|560614318|FG002|Overall Study|Pregnancy|1|||
155322216|NCT03926130|560614319|FG003|Overall Study|Pregnancy|0|||
155322217|NCT03926130|560614316|FG000|Overall Study|Withdrawal by Subject|20|||
155322218|NCT03926130|560614317|FG001|Overall Study|Withdrawal by Subject|28|||
155322219|NCT03926130|560614318|FG002|Overall Study|Withdrawal by Subject|18|||
155322220|NCT03926130|560614319|FG003|Overall Study|Withdrawal by Subject|1|||
155322221|NCT03926130|560614316|FG000|Overall Study|Non-Compliance|1|||
155322222|NCT03926130|560614317|FG001|Overall Study|Non-Compliance|1|||
155322223|NCT03926130|560614318|FG002|Overall Study|Non-Compliance|0|||
155322224|NCT03926130|560614319|FG003|Overall Study|Non-Compliance|0|||
155322225|NCT03926130|560614316|FG000|Overall Study|Disposition Not Captured|0|||
155322226|NCT03926130|560614317|FG001|Overall Study|Disposition Not Captured|2|||
155322227|NCT03926130|560614318|FG002|Overall Study|Disposition Not Captured|1|||
155322228|NCT03926130|560614319|FG003|Overall Study|Disposition Not Captured|0|||
155322229|NCT03583333|560614320|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
155322230|NCT03583333|560614321|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
155322231|NCT03583333|560614320|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
155322232|NCT03583333|560614321|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
155322233|NCT03583333|560614320|FG000|Overall Study|Withdrawal by Subject|9|||
155322234|NCT03583333|560614321|FG001|Overall Study|Withdrawal by Subject|5|||
155322235|NCT03583333|560614320|FG000|Overall Study|Physician Decision|3|||
155322236|NCT03583333|560614321|FG001|Overall Study|Physician Decision|2|||
155322237|NCT03583333|560614320|FG000|Overall Study|Death|12|||
155322238|NCT03583333|560614321|FG001|Overall Study|Death|7|||
155322239|NCT03824366|560614337|FG000|Overall Study|Death|1|||
155322240|NCT03824366|560614337|FG000|Overall Study|Previously unidentified metal artifact|1|||
155322241|NCT03824366|560614337|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
155322242|NCT03824366|560614337|FG000|Overall Study|Withdrawal by Subject|1|||
155322243|NCT05069896|560614340|FG000|Overall Study|Adverse Event|0|||
155322244|NCT05069896|560614341|FG001|Overall Study|Adverse Event|1|||
155322245|NCT05069896|560614342|FG002|Overall Study|Adverse Event|1|||
155322246|NCT05069896|560614343|FG003|Overall Study|Adverse Event|0|||
155322247|NCT05069896|560614344|FG004|Overall Study|Adverse Event|0|||
155322248|NCT05069896|560614345|FG005|Overall Study|Adverse Event|0|||
155322249|NCT05069896|560614340|FG000|Overall Study|Lost to Follow-up|0|||
155322250|NCT05069896|560614341|FG001|Overall Study|Lost to Follow-up|0|||
155322251|NCT05069896|560614342|FG002|Overall Study|Lost to Follow-up|1|||
155322252|NCT05069896|560614343|FG003|Overall Study|Lost to Follow-up|0|||
155322253|NCT05069896|560614344|FG004|Overall Study|Lost to Follow-up|1|||
155322254|NCT05069896|560614345|FG005|Overall Study|Lost to Follow-up|2|||
155322255|NCT04068831|560614346|FG000|Overall Study|Disease Progression|10|||
155322256|NCT04068831|560614347|FG001|Overall Study|Disease Progression|8|||
155322257|NCT05715528|560614351|FG000|Overall Study|Randomized but never treated|11|||
155322258|NCT05715528|560614352|FG001|Overall Study|Randomized but never treated|13|||
155322259|NCT05715528|560614351|FG000|Overall Study|Withdrew consent|7|||
155322260|NCT05715528|560614352|FG001|Overall Study|Withdrew consent|15|||
155322261|NCT05715528|560614351|FG000|Overall Study|Lost to Follow-up|5|||
155322262|NCT05715528|560614352|FG001|Overall Study|Lost to Follow-up|13|||
155322263|NCT05715528|560614351|FG000|Overall Study|Investigator's discretion|3|||
155322264|NCT05715528|560614352|FG001|Overall Study|Investigator's discretion|1|||
155322265|NCT05715528|560614351|FG000|Overall Study|Protocol Violation|2|||
155322266|NCT05715528|560614352|FG001|Overall Study|Protocol Violation|0|||
155322267|NCT05715528|560614351|FG000|Overall Study|Non-compliance with study drug|0|||
155322268|NCT05715528|560614352|FG001|Overall Study|Non-compliance with study drug|1|||
155322269|NCT03118518|560614353|FG000|Overall Study|Early Exit after treatment|2|||
155322270|NCT03118518|560614354|FG001|Overall Study|Early Exit after treatment|8|||
155322271|NCT03118518|560614353|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
155322272|NCT03118518|560614354|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
155322273|NCT04565990|560615757|FG000|Overall Study|Death|5|||
155322274|NCT04565990|560615757|FG000|Overall Study|Lost to Follow-up|1|||
155322275|NCT04565990|560615757|FG000|Overall Study|Withdrawal by Subject|1|||
155322276|NCT04797858|560615758|FG000|Overall Study|Withdrawal by Subject|0|||
155322277|NCT04797858|560615759|FG001|Overall Study|Withdrawal by Subject|1|||
155322278|NCT04797858|560615758|FG000|Overall Study|Excluded due to administrative error|7|||
155322279|NCT04797858|560615759|FG001|Overall Study|Excluded due to administrative error|8|||
155322280|NCT01960452|560615763|FG000|Overall Study|Withdrawal by Subject|2|||
155322281|NCT01960452|560615764|FG001|Overall Study|Withdrawal by Subject|1|||
155322282|NCT01960452|560615763|FG000|Overall Study|Sleep apnea in Night 1|1|||
155322283|NCT01960452|560615764|FG001|Overall Study|Sleep apnea in Night 1|0|||
155322284|NCT01960452|560615763|FG000|Overall Study|Poor Sleep in Night 1|0|||
155322285|NCT01960452|560615764|FG001|Overall Study|Poor Sleep in Night 1|2|||
155322286|NCT01960452|560615763|FG000|Overall Study|No Sex/Age Match Night 1|1|||
155322287|NCT01960452|560615764|FG001|Overall Study|No Sex/Age Match Night 1|0|||
155322288|NCT01960452|560615763|FG000|Overall Study|No Sex/Age Match Night 2|0|||
155322289|NCT01960452|560615764|FG001|Overall Study|No Sex/Age Match Night 2|2|||
155322290|NCT01960452|560615763|FG000|Overall Study|Technical Difficulties Night 2|2|||
155322291|NCT01960452|560615764|FG001|Overall Study|Technical Difficulties Night 2|0|||
155322292|NCT04766892|560615765|FG000|Overall Study|Withdrawal by Subject|1|||
155322293|NCT04766892|560615765|FG000|Overall Study|Lost to Follow-up|1|||
155322294|NCT04766892|560615765|FG000|Overall Study|Adverse Event|3|||
155322295|NCT04766892|560615765|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
155322296|NCT02668692|560615766|FG000|Overall Study|Adverse Event|1|||
155322297|NCT02668692|560615767|FG001|Overall Study|Adverse Event|0|||
155322298|NCT03981926|560615768|FG000|Overall Study|Lost to Follow-up|5|||
155322299|NCT03981926|560615769|FG001|Overall Study|Lost to Follow-up|9|||
155322300|NCT06262347|560615772|FG000|Overall Study|Lost to Follow-up|4|||
155322301|NCT06262347|560615773|FG001|Overall Study|Lost to Follow-up|3|||
155322302|NCT06262347|560615772|FG000|Overall Study|Withdrawal by Subject|0|||
155322303|NCT06262347|560615773|FG001|Overall Study|Withdrawal by Subject|1|||
155420764|NCT02591615|560972434|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
155420765|NCT02591615|560972435|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
155420766|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
155420767|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
155420768|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
155420769|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
155420770|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
155420771|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
155420772|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
155322304|NCT03711474|560615787|FG000|Overall Study|Physician Decision|2|||
155322305|NCT03711474|560615788|FG001|Overall Study|Physician Decision|0|||
155322306|NCT05618587|560615789|FG000|Overall Study|Lost to Follow-up|2|||
155322307|NCT05618587|560615790|FG001|Overall Study|Lost to Follow-up|0|||
155322308|NCT03442309|560615791|FG000|Overall Study|Lost to Follow-up|1676|||
155322309|NCT03442309|560615792|FG001|Overall Study|Lost to Follow-up|1642|||
155322310|NCT02446236|560615795|FG000|Overall Study|Screen Failure|1|||
155322311|NCT02446236|560615796|FG001|Overall Study|Screen Failure|0|||
155322312|NCT02446236|560615797|FG002|Overall Study|Screen Failure|1|||
155322313|NCT02446236|560615795|FG000|Overall Study|Actively Receiving Therapy|0|||
155322314|NCT02446236|560615796|FG001|Overall Study|Actively Receiving Therapy|0|||
155322315|NCT02446236|560615797|FG002|Overall Study|Actively Receiving Therapy|1|||
155322316|NCT04136912|560615802|FG000|Overall Study|Operational reasons|0|||
155322317|NCT04136912|560615803|FG001|Overall Study|Operational reasons|0|||
155322318|NCT04136912|560615804|FG002|Overall Study|Operational reasons|2|||
155322319|NCT04003246|560615815|FG000|Overall Study|Death|9|||
155322320|NCT02834390|560615821|FG000|Induction Phase|Progressive disease|0|||
155322321|NCT02834390|560615822|FG001|Induction Phase|Progressive disease|1|||
155322322|NCT02834390|560615821|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
155322323|NCT02834390|560615822|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
155322324|NCT02834390|560615821|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
155322325|NCT02834390|560615822|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
155322326|NCT02834390|560615821|FG000|Consolidation Phase|Physician Decision|1|||
155322327|NCT02834390|560615822|FG001|Consolidation Phase|Physician Decision|1|||
155322328|NCT05533190|560615830|FG000|Overall Study|Lost to Follow-up|19|||
155322329|NCT05533190|560615831|FG001|Overall Study|Lost to Follow-up|7|||
155322330|NCT05533190|560615830|FG000|Overall Study|Failed to download app|1|||
155322331|NCT05533190|560615831|FG001|Overall Study|Failed to download app|0|||
155322332|NCT05533190|560615830|FG000|Overall Study|Thought app was a scam|1|||
155322333|NCT05533190|560615831|FG001|Overall Study|Thought app was a scam|0|||
155322334|NCT05533190|560615830|FG000|Overall Study|Withdrawal by Subject|2|||
155322335|NCT05533190|560615831|FG001|Overall Study|Withdrawal by Subject|0|||
155644213|NCT04999020|561786934|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
155501420|NCT01915498|561260835|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501421|NCT01915498|561260836|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501422|NCT01915498|561260837|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501423|NCT01915498|561260838|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501424|NCT01915498|561260839|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155644214|NCT04999020|561786935|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
155644215|NCT04999020|561786932|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155322336|NCT05856435|560615832|FG000|Overall Study|Lost to Follow-up|6|||
155322337|NCT05660434|560615833|FG000|Overall Study|Never obtained study materials|2|||
155322338|NCT05660434|560615834|FG001|Overall Study|Never obtained study materials|1|||
155420773|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
155420774|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
155420775|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
155420776|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
155420777|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
155420778|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
155420779|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
155420780|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
155420781|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
155420782|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
155420783|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
155420784|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
155420785|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
155420786|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
155420787|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
155420788|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
155420789|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
155420790|NCT02591615|560972432|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
155420791|NCT02591615|560972433|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
155420792|NCT02591615|560972434|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
155420793|NCT02591615|560972435|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
155644216|NCT04999020|561786933|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155644217|NCT04999020|561786934|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155644218|NCT04999020|561786935|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155644219|NCT04999020|561786932|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155644220|NCT04999020|561786933|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155644221|NCT04999020|561786934|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
155644222|NCT04999020|561786935|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
155644223|NCT02609633|561786942|FG000|Overall Study|Consent Withdrawn|0|||
155322339|NCT03213678|560615837|FG000|Overall Study|Death|1|||
155322340|NCT03213678|560615837|FG000|Overall Study|Physician Decision|1|||
155322341|NCT03213678|560615837|FG000|Overall Study|Progressive disease|16|||
155420794|NCT02591615|560972432|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
155322342|NCT02413489|560615840|FG000|Overall Study|Death|11|||
155322343|NCT02413489|560615841|FG001|Overall Study|Death|3|||
155322344|NCT02413489|560615842|FG002|Overall Study|Death|4|||
155322345|NCT02413489|560615840|FG000|Overall Study|Withdrawal by Subject|2|||
155322346|NCT02413489|560615841|FG001|Overall Study|Withdrawal by Subject|0|||
155322347|NCT02413489|560615842|FG002|Overall Study|Withdrawal by Subject|0|||
155322348|NCT02413489|560615840|FG000|Overall Study|Study Terminated By Sponsor|2|||
155322349|NCT02413489|560615841|FG001|Overall Study|Study Terminated By Sponsor|13|||
155322350|NCT02413489|560615842|FG002|Overall Study|Study Terminated By Sponsor|1|||
155322351|NCT04456296|560615843|FG000|Overall Study|Withdrawal by Subject|14|||
155322352|NCT04456296|560615844|FG001|Overall Study|Withdrawal by Subject|21|||
155322353|NCT04456296|560615845|FG002|Overall Study|Withdrawal by Subject|21|||
155322354|NCT04456296|560615843|FG000|Overall Study|Adverse Event|2|||
155322355|NCT04456296|560615844|FG001|Overall Study|Adverse Event|2|||
155322356|NCT04456296|560615845|FG002|Overall Study|Adverse Event|2|||
155322357|NCT04456296|560615843|FG000|Overall Study|Death|1|||
155322358|NCT04456296|560615844|FG001|Overall Study|Death|0|||
155322359|NCT04456296|560615845|FG002|Overall Study|Death|0|||
155322360|NCT04456296|560615843|FG000|Overall Study|Lost to Follow-up|3|||
155322361|NCT04456296|560615844|FG001|Overall Study|Lost to Follow-up|5|||
155322362|NCT04456296|560615845|FG002|Overall Study|Lost to Follow-up|6|||
155322363|NCT04456296|560615843|FG000|Overall Study|Other than specified|0|||
155322364|NCT04456296|560615844|FG001|Overall Study|Other than specified|1|||
155322365|NCT04456296|560615845|FG002|Overall Study|Other than specified|4|||
155322366|NCT04456296|560615843|FG000|Overall Study|Randomized, not treated|2|||
155322367|NCT04456296|560615844|FG001|Overall Study|Randomized, not treated|1|||
155322368|NCT04456296|560615845|FG002|Overall Study|Randomized, not treated|0|||
155322369|NCT05736458|560615846|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
155322370|NCT05736458|560615847|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
155322371|NCT05736458|560615848|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
155322372|NCT05736458|560615846|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
155322373|NCT05736458|560615847|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
155322374|NCT05736458|560615848|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
155322375|NCT05736458|560615846|FG000|TMS/fMRI #1|Physician Decision|0|||
155501425|NCT01915498|561260840|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501426|NCT01915498|561260841|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155322376|NCT05736458|560615847|FG001|TMS/fMRI #1|Physician Decision|0|||
155322377|NCT05736458|560615848|FG002|TMS/fMRI #1|Physician Decision|2|||
155322378|NCT05736458|560615846|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
155322379|NCT05736458|560615847|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155322380|NCT05736458|560615848|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
155501427|NCT01915498|561260842|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501428|NCT01915498|561260843|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501429|NCT01915498|561260844|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155501430|NCT01915498|561260845|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155644224|NCT02609633|561786943|FG001|Overall Study|Consent Withdrawn|1|||
155644225|NCT02609633|561786942|FG000|Overall Study|Protocol Deviation|1|||
155644226|NCT02609633|561786943|FG001|Overall Study|Protocol Deviation|0|||
155644227|NCT02609633|561786942|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
155644228|NCT02609633|561786943|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
155644229|NCT02609633|561786942|FG000|Overall Study|Reason not Specified|2|||
155644230|NCT02609633|561786943|FG001|Overall Study|Reason not Specified|1|||
155644231|NCT02691663|561786948|FG000|Overall Study|Screen failure after baseline|2|||
155644232|NCT02691663|561786949|FG001|Overall Study|Screen failure after baseline|2|||
155644233|NCT02691663|561786948|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
155644234|NCT02691663|561786949|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
155644235|NCT02691663|561786948|FG000|Overall Study|Withdrawn after Follow up 2|1|||
155644236|NCT02691663|561786949|FG001|Overall Study|Withdrawn after Follow up 2|1|||
155644237|NCT02691663|561786948|FG000|Overall Study|Lost to Follow-up|3|||
155644238|NCT02691663|561786949|FG001|Overall Study|Lost to Follow-up|2|||
155322381|NCT05100628|560615853|FG000|Overall Study|Progressive Disease|1|||
155322382|NCT05100628|560615854|FG001|Overall Study|Progressive Disease|0|||
155322383|NCT05100628|560615855|FG002|Overall Study|Progressive Disease|0|||
155322384|NCT05100628|560615856|FG003|Overall Study|Progressive Disease|0|||
155322385|NCT05100628|560615853|FG000|Overall Study|Study Terminated by Sponsor|0|||
155501431|NCT01915498|561260846|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
155501432|NCT01915498|561260828|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501433|NCT01915498|561260829|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501434|NCT01915498|561260830|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501435|NCT01915498|561260831|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501436|NCT01915498|561260832|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501437|NCT01915498|561260833|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501438|NCT01915498|561260834|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155322386|NCT05100628|560615854|FG001|Overall Study|Study Terminated by Sponsor|0|||
155322387|NCT05100628|560615855|FG002|Overall Study|Study Terminated by Sponsor|3|||
155322388|NCT05100628|560615856|FG003|Overall Study|Study Terminated by Sponsor|0|||
155322389|NCT05100628|560615853|FG000|Overall Study|unkown|0|||
155322390|NCT05100628|560615854|FG001|Overall Study|unkown|1|||
155322391|NCT05100628|560615855|FG002|Overall Study|unkown|0|||
155322392|NCT05100628|560615856|FG003|Overall Study|unkown|0|||
155322393|NCT05900154|560615861|FG000|Follow-Up Period|Lost to Follow-up|1|||
155322394|NCT05900154|560615862|FG001|Follow-Up Period|Lost to Follow-up|2|||
155322395|NCT05900154|560615863|FG002|Follow-Up Period|Lost to Follow-up|1|||
155322396|NCT05900154|560615864|FG003|Follow-Up Period|Lost to Follow-up|0|||
155322397|NCT05900154|560615865|FG004|Follow-Up Period|Lost to Follow-up|1|||
155322398|NCT05900154|560615866|FG005|Follow-Up Period|Lost to Follow-up|1|||
155322399|NCT01570361|560615867|FG000|Overall Study|Subject discontinued|1|||
155322400|NCT01570361|560615868|FG001|Overall Study|Subject discontinued|2|||
155322401|NCT01570361|560615867|FG000|Overall Study|Sponsor closing the study|51|||
155322402|NCT01570361|560615868|FG001|Overall Study|Sponsor closing the study|50|||
155322403|NCT01570361|560615867|FG000|Overall Study|Subject excluded|5|||
155322404|NCT01570361|560615868|FG001|Overall Study|Subject excluded|3|||
155322405|NCT01570361|560615867|FG000|Overall Study|Subject withdrew consent|14|||
155322406|NCT01570361|560615868|FG001|Overall Study|Subject withdrew consent|9|||
155322407|NCT01570361|560615867|FG000|Overall Study|Adverse Event|2|||
155322408|NCT01570361|560615868|FG001|Overall Study|Adverse Event|1|||
155322409|NCT01570361|560615867|FG000|Overall Study|Lost to Follow-up|4|||
155322410|NCT01570361|560615868|FG001|Overall Study|Lost to Follow-up|4|||
155322411|NCT01570361|560615867|FG000|Overall Study|Death|5|||
155322412|NCT01570361|560615868|FG001|Overall Study|Death|4|||
155322413|NCT01570361|560615867|FG000|Overall Study|Other|0|||
155322414|NCT01570361|560615868|FG001|Overall Study|Other|2|||
155322415|NCT04129554|560615869|FG000|Overall Study|Withdrawal by Subject|4|||
155322416|NCT04129554|560615870|FG001|Overall Study|Withdrawal by Subject|3|||
155322417|NCT04129554|560615869|FG000|Overall Study|Other|0|||
155322418|NCT04129554|560615870|FG001|Overall Study|Other|2|||
155322419|NCT05158504|560615873|FG000|Overall Study|Lost to Follow-up|2|||
155322420|NCT05158504|560615874|FG001|Overall Study|Lost to Follow-up|3|||
155322421|NCT03606512|560615875|FG000|Overall Study|Lost to Follow-up|0|||
155322422|NCT03606512|560615876|FG001|Overall Study|Lost to Follow-up|1|||
155322423|NCT03606512|560615875|FG000|Overall Study|'moved from study area|0|||
155322424|NCT03606512|560615876|FG001|Overall Study|'moved from study area|1|||
155322425|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322426|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
155322427|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322428|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322429|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
155322430|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
155322431|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
155322432|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
155322433|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
155322434|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155322435|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155322436|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155322437|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
155322438|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322439|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322440|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322441|NCT05513937|560615877|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322442|NCT05513937|560615878|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322443|NCT05513937|560615879|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
155322444|NCT05513937|560615880|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322445|NCT05513937|560615877|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322446|NCT05513937|560615878|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322447|NCT05513937|560615879|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
155322448|NCT05513937|560615880|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322449|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
155322450|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
155322451|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
155322452|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
155322453|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
155322454|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
155322455|NCT02846545|560615881|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
155322456|NCT02846545|560615882|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
155322457|NCT02846545|560615881|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
155322458|NCT02846545|560615882|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
155322459|NCT05654662|560615885|FG000|Overall Study|Withdrawal by Subject|1|||
155322460|NCT05654662|560615886|FG001|Overall Study|Withdrawal by Subject|0|||
155322461|NCT05654662|560615885|FG000|Overall Study|A death in the family|1|||
155322462|NCT05654662|560615886|FG001|Overall Study|A death in the family|0|||
155322463|NCT04230681|560615887|FG000|Overall Study|Physician Decision|2|||
155322464|NCT04230681|560615888|FG001|Overall Study|Physician Decision|3|||
155322465|NCT04230681|560615887|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
155501439|NCT01915498|561260835|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501440|NCT01915498|561260836|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501441|NCT01915498|561260837|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501442|NCT01915498|561260838|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501443|NCT01915498|561260839|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501444|NCT01915498|561260840|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501445|NCT01915498|561260841|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155322466|NCT04230681|560615888|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
155322467|NCT04230681|560615887|FG000|Overall Study|IV inadvertently removed|0|||
155322468|NCT04230681|560615888|FG001|Overall Study|IV inadvertently removed|1|||
155322469|NCT01064440|560617324|FG000|Overall Study|Lost to Follow-up|1|||
155322470|NCT01064440|560617325|FG001|Overall Study|Lost to Follow-up|1|||
155322471|NCT01064440|560617326|FG002|Overall Study|Lost to Follow-up|1|||
155322472|NCT01064440|560617324|FG000|Overall Study|Non-compliance|0|||
155322473|NCT01064440|560617325|FG001|Overall Study|Non-compliance|1|||
155322474|NCT01064440|560617326|FG002|Overall Study|Non-compliance|0|||
155322475|NCT01064440|560617324|FG000|Overall Study|Death|1|||
155322476|NCT01064440|560617325|FG001|Overall Study|Death|0|||
155322477|NCT01064440|560617326|FG002|Overall Study|Death|1|||
155322478|NCT01064440|560617324|FG000|Overall Study|Withdrawal by Subject|0|||
155322479|NCT01064440|560617325|FG001|Overall Study|Withdrawal by Subject|1|||
155322480|NCT01064440|560617326|FG002|Overall Study|Withdrawal by Subject|1|||
155322481|NCT01064440|560617324|FG000|Overall Study|Other: amputation|1|||
155322482|NCT01064440|560617325|FG001|Overall Study|Other: amputation|0|||
155322483|NCT01064440|560617326|FG002|Overall Study|Other: amputation|0|||
155322484|NCT05507333|560617327|FG000|Overall Study|Protocol Violation|1|||
155322485|NCT01880515|560617328|FG000|Overall Study|Lost to Follow-up|3|||
155322486|NCT01880515|560617329|FG001|Overall Study|Lost to Follow-up|2|||
155322487|NCT01880515|560617328|FG000|Overall Study|Disease Progression|5|||
155322488|NCT01880515|560617329|FG001|Overall Study|Disease Progression|7|||
155322489|NCT05247034|560617330|FG000|Overall Study|Lost to Follow-up|3|||
155322490|NCT05247034|560617331|FG001|Overall Study|Lost to Follow-up|2|||
155322491|NCT05247034|560617330|FG000|Overall Study|Organizational problems when attending appointments|1|||
155322492|NCT05247034|560617331|FG001|Overall Study|Organizational problems when attending appointments|0|||
155322493|NCT03505710|560617334|FG000|Overall Study|Progressive Disease|24|||
155322494|NCT03505710|560617335|FG001|Overall Study|Progressive Disease|17|||
155322495|NCT03505710|560617336|FG002|Overall Study|Progressive Disease|43|||
155322496|NCT03505710|560617334|FG000|Overall Study|Clinical Progression|6|||
155322497|NCT03505710|560617335|FG001|Overall Study|Clinical Progression|8|||
155420795|NCT02591615|560972433|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
155420796|NCT02591615|560972434|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
155420797|NCT02591615|560972435|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
155420798|NCT02591615|560972432|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
155420799|NCT02591615|560972433|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
155420800|NCT02591615|560972434|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
155420801|NCT02591615|560972435|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
155420802|NCT02591615|560972432|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
155420803|NCT02591615|560972433|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
155420804|NCT02591615|560972434|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
155420805|NCT02591615|560972435|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
155420806|NCT02591615|560972432|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
155420807|NCT02591615|560972433|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
155420808|NCT02591615|560972434|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
155420809|NCT02591615|560972435|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
155420810|NCT02591615|560972432|FG000|Maintenance MK-3475|Adverse Event|0|||
155322498|NCT03505710|560617336|FG002|Overall Study|Clinical Progression|3|||
155322499|NCT03505710|560617334|FG000|Overall Study|Adverse Event|12|||
155644239|NCT00471107|561786952|FG000|Overall Study|Technical problems/data loss|3|||
155644240|NCT00471107|561786953|FG001|Overall Study|Technical problems/data loss|1|||
155644241|NCT00471107|561786954|FG002|Overall Study|Technical problems/data loss|3|||
155644242|NCT04828486|561786957|FG000|Overall Study|Adverse Event|2|||
155322500|NCT03505710|560617335|FG001|Overall Study|Adverse Event|6|||
155644243|NCT04828486|561786957|FG000|Overall Study|Death|1|||
155322501|NCT03505710|560617336|FG002|Overall Study|Adverse Event|28|||
155322502|NCT03505710|560617334|FG000|Overall Study|Withdrawal by Subject|1|||
155322503|NCT03505710|560617335|FG001|Overall Study|Withdrawal by Subject|3|||
155322504|NCT03505710|560617336|FG002|Overall Study|Withdrawal by Subject|7|||
155322505|NCT03505710|560617334|FG000|Overall Study|Physician Decision|1|||
155322506|NCT03505710|560617335|FG001|Overall Study|Physician Decision|1|||
155322507|NCT03505710|560617336|FG002|Overall Study|Physician Decision|2|||
155322508|NCT03505710|560617334|FG000|Overall Study|Death|4|||
155322509|NCT03505710|560617335|FG001|Overall Study|Death|5|||
155322510|NCT03505710|560617336|FG002|Overall Study|Death|6|||
155644244|NCT04828486|561786957|FG000|Overall Study|Disease Progression|8|||
155644245|NCT04828486|561786957|FG000|Overall Study|Other Complicating Disease|1|||
155644246|NCT04828486|561786957|FG000|Overall Study|Withdrawal by Subject|1|||
155644247|NCT03325439|561786958|FG000|Overall Study|Ineligibility|3|||
155644248|NCT00896233|561786960|FG000|Overall Study|Claustrophobia during MRI|1|||
155644249|NCT00387127|561786961|FG000|Overall Study|Lost to Follow-up|0|||
155644250|NCT00387127|561786962|FG001|Overall Study|Lost to Follow-up|4|||
155644251|NCT00387127|561786961|FG000|Overall Study|Death|16|||
155644252|NCT00387127|561786962|FG001|Overall Study|Death|16|||
155644253|NCT00387127|561786961|FG000|Overall Study|Physician Decision|0|||
155644254|NCT00387127|561786962|FG001|Overall Study|Physician Decision|1|||
155644255|NCT00387127|561786961|FG000|Overall Study|Withdrawal by Subject|3|||
155644256|NCT00387127|561786962|FG001|Overall Study|Withdrawal by Subject|2|||
155644257|NCT00387127|561786961|FG000|Overall Study|Required by Protocol Amendment #4|12|||
155644258|NCT00387127|561786962|FG001|Overall Study|Required by Protocol Amendment #4|10|||
155644259|NCT00387127|561786961|FG000|Overall Study|Serious Adverse Event|1|||
155644260|NCT00387127|561786962|FG001|Overall Study|Serious Adverse Event|1|||
155644261|NCT00387127|561786961|FG000|Overall Study|Sponsor Unblinded|1|||
155322511|NCT03505710|560617334|FG000|Overall Study|Other Reasons|1|||
155322512|NCT03505710|560617335|FG001|Overall Study|Other Reasons|1|||
155322513|NCT03505710|560617336|FG002|Overall Study|Other Reasons|1|||
155322514|NCT03505710|560617334|FG000|Overall Study|Study Terminated by Sponsor|0|||
155322515|NCT03505710|560617335|FG001|Overall Study|Study Terminated by Sponsor|0|||
155322516|NCT03505710|560617336|FG002|Overall Study|Study Terminated by Sponsor|1|||
155322517|NCT04414722|560617339|FG000|Overall Study|Lost to Follow-up|3|||
155322518|NCT04414722|560617340|FG001|Overall Study|Lost to Follow-up|4|||
155322519|NCT04414722|560617341|FG002|Overall Study|Lost to Follow-up|3|||
155644262|NCT00387127|561786962|FG001|Overall Study|Sponsor Unblinded|0|||
155644263|NCT02068599|561786970|FG000|Overall Study|Adverse Event|4|||
155644264|NCT02068599|561786971|FG001|Overall Study|Adverse Event|1|||
155644265|NCT02068599|561786972|FG002|Overall Study|Adverse Event|1|||
155322520|NCT04414722|560617342|FG003|Overall Study|Lost to Follow-up|2|||
155322521|NCT04414722|560617343|FG004|Overall Study|Lost to Follow-up|3|||
155644266|NCT02068599|561786970|FG000|Overall Study|Withdrawal by Subject|2|||
155644267|NCT02068599|561786971|FG001|Overall Study|Withdrawal by Subject|7|||
155644268|NCT02068599|561786972|FG002|Overall Study|Withdrawal by Subject|5|||
155644269|NCT02068599|561786970|FG000|Overall Study|Protocol Violation|4|||
155644270|NCT02068599|561786971|FG001|Overall Study|Protocol Violation|2|||
155644271|NCT02068599|561786972|FG002|Overall Study|Protocol Violation|3|||
155644272|NCT02068599|561786970|FG000|Overall Study|Lost to Follow-up|1|||
155644273|NCT02068599|561786971|FG001|Overall Study|Lost to Follow-up|0|||
155644274|NCT02068599|561786972|FG002|Overall Study|Lost to Follow-up|0|||
155322522|NCT04414722|560617339|FG000|Overall Study|Withdrawal by Subject|6|||
155644275|NCT02068599|561786970|FG000|Overall Study|Lack of Efficacy|0|||
155644276|NCT02068599|561786971|FG001|Overall Study|Lack of Efficacy|0|||
155322523|NCT04414722|560617340|FG001|Overall Study|Withdrawal by Subject|3|||
155644277|NCT02068599|561786972|FG002|Overall Study|Lack of Efficacy|3|||
155322524|NCT04414722|560617341|FG002|Overall Study|Withdrawal by Subject|1|||
155644278|NCT02068599|561786970|FG000|Overall Study|Noncompliance|0|||
155322525|NCT04414722|560617342|FG003|Overall Study|Withdrawal by Subject|5|||
155322526|NCT04414722|560617343|FG004|Overall Study|Withdrawal by Subject|1|||
155322527|NCT04414722|560617339|FG000|Overall Study|Physician Decision|0|||
155322528|NCT04414722|560617340|FG001|Overall Study|Physician Decision|1|||
155644279|NCT02068599|561786971|FG001|Overall Study|Noncompliance|0|||
155644280|NCT02068599|561786972|FG002|Overall Study|Noncompliance|1|||
155644281|NCT01263028|561786973|FG000|Overall Study|Withdrawal by Subject|1|||
155322529|NCT04414722|560617341|FG002|Overall Study|Physician Decision|2|||
155322530|NCT04414722|560617342|FG003|Overall Study|Physician Decision|0|||
155322531|NCT04414722|560617343|FG004|Overall Study|Physician Decision|0|||
155322532|NCT04414722|560617339|FG000|Overall Study|Non-participatory|0|||
155322533|NCT04414722|560617340|FG001|Overall Study|Non-participatory|1|||
155322534|NCT04414722|560617341|FG002|Overall Study|Non-participatory|1|||
155322535|NCT04414722|560617342|FG003|Overall Study|Non-participatory|0|||
155322536|NCT04414722|560617343|FG004|Overall Study|Non-participatory|0|||
155322537|NCT05464069|560617344|FG000|Overall Study|Protocol Violation|3|||
155322538|NCT05464069|560617345|FG001|Overall Study|Protocol Violation|2|||
155322539|NCT04615273|560617349|FG000|Overall Study|Withdrawal by Subject|3|||
155322540|NCT04615273|560617350|FG001|Overall Study|Withdrawal by Subject|1|||
155322541|NCT04615273|560617351|FG002|Overall Study|Withdrawal by Subject|2|||
155322542|NCT04615273|560617349|FG000|Overall Study|Adverse Event|1|||
155322543|NCT04615273|560617350|FG001|Overall Study|Adverse Event|0|||
155322544|NCT04615273|560617351|FG002|Overall Study|Adverse Event|1|||
155322545|NCT04615273|560617349|FG000|Overall Study|Lost to Follow-up|0|||
155322546|NCT04615273|560617350|FG001|Overall Study|Lost to Follow-up|1|||
155322547|NCT04615273|560617351|FG002|Overall Study|Lost to Follow-up|0|||
155322548|NCT04615273|560617349|FG000|Overall Study|Physician Decision|0|||
155322549|NCT04615273|560617350|FG001|Overall Study|Physician Decision|0|||
155322550|NCT04615273|560617351|FG002|Overall Study|Physician Decision|1|||
155322551|NCT04615273|560617349|FG000|Overall Study|Other|0|||
155322552|NCT04615273|560617350|FG001|Overall Study|Other|1|||
155322553|NCT04615273|560617351|FG002|Overall Study|Other|0|||
155322554|NCT04615273|560617349|FG000|Overall Study|Randomized but not treated|1|||
155322555|NCT04615273|560617350|FG001|Overall Study|Randomized but not treated|3|||
155322556|NCT04615273|560617351|FG002|Overall Study|Randomized but not treated|1|||
155322557|NCT03677141|560617352|FG000|Overall Study|Death|2|||
155322558|NCT03677141|560617353|FG001|Overall Study|Death|1|||
155322559|NCT03677141|560617354|FG002|Overall Study|Death|6|||
155322560|NCT03677141|560617355|FG003|Overall Study|Death|9|||
155322561|NCT03677141|560617356|FG004|Overall Study|Death|5|||
155322562|NCT03677141|560617357|FG005|Overall Study|Death|3|||
155322563|NCT03677141|560617352|FG000|Overall Study|Lost to Follow-up|0|||
155322564|NCT03677141|560617353|FG001|Overall Study|Lost to Follow-up|0|||
155322565|NCT03677141|560617354|FG002|Overall Study|Lost to Follow-up|0|||
155322566|NCT03677141|560617355|FG003|Overall Study|Lost to Follow-up|2|||
155322567|NCT03677141|560617356|FG004|Overall Study|Lost to Follow-up|0|||
155322568|NCT03677141|560617357|FG005|Overall Study|Lost to Follow-up|0|||
155322569|NCT03677141|560617352|FG000|Overall Study|Screen failure or enrolled in error|0|||
155322570|NCT03677141|560617353|FG001|Overall Study|Screen failure or enrolled in error|0|||
155322571|NCT03677141|560617354|FG002|Overall Study|Screen failure or enrolled in error|0|||
155322572|NCT03677141|560617355|FG003|Overall Study|Screen failure or enrolled in error|0|||
155322573|NCT03677141|560617356|FG004|Overall Study|Screen failure or enrolled in error|2|||
155322574|NCT03677141|560617357|FG005|Overall Study|Screen failure or enrolled in error|0|||
155322575|NCT03677141|560617352|FG000|Overall Study|Physician Decision|0|||
155322576|NCT03677141|560617353|FG001|Overall Study|Physician Decision|0|||
155322577|NCT03677141|560617354|FG002|Overall Study|Physician Decision|0|||
155322578|NCT03677141|560617355|FG003|Overall Study|Physician Decision|0|||
155322579|NCT03677141|560617356|FG004|Overall Study|Physician Decision|1|||
155322580|NCT03677141|560617357|FG005|Overall Study|Physician Decision|0|||
155322581|NCT03677141|560617352|FG000|Overall Study|Withdrawal by Subject|0|||
155322582|NCT03677141|560617353|FG001|Overall Study|Withdrawal by Subject|0|||
155322583|NCT03677141|560617354|FG002|Overall Study|Withdrawal by Subject|1|||
155322584|NCT03677141|560617355|FG003|Overall Study|Withdrawal by Subject|1|||
155322585|NCT03677141|560617356|FG004|Overall Study|Withdrawal by Subject|1|||
155322586|NCT03677141|560617357|FG005|Overall Study|Withdrawal by Subject|0|||
155322587|NCT01314105|560617361|FG000|Overall Study|Progressive Disease|6|||
155322588|NCT01314105|560617362|FG001|Overall Study|Progressive Disease|10|||
155322589|NCT01314105|560617361|FG000|Overall Study|Refused to continue taking medication|0|||
155322590|NCT01314105|560617362|FG001|Overall Study|Refused to continue taking medication|1|||
155322591|NCT01314105|560617361|FG000|Overall Study|Other Adverse Event|1|||
155322592|NCT01314105|560617362|FG001|Overall Study|Other Adverse Event|1|||
155322593|NCT04526886|560617363|FG000|Overall Study|Physician Decision|4|||
155322594|NCT04820322|560617369|FG000|Overall Study|Adverse Event|1|||
155322595|NCT04820322|560617370|FG001|Overall Study|Adverse Event|0|||
155322596|NCT03156465|560617376|FG000|Overall Study|Withdrawal by Subject|2|||
155322597|NCT03640286|560617377|FG000|Overall Study|Adverse Event|6|||
155322598|NCT03640286|560617378|FG001|Overall Study|Adverse Event|6|||
155322599|NCT03640286|560617377|FG000|Overall Study|Lost to Follow-up|3|||
155322600|NCT03640286|560617378|FG001|Overall Study|Lost to Follow-up|6|||
155322601|NCT03640286|560617377|FG000|Overall Study|Pregnancy|1|||
155322602|NCT03640286|560617378|FG001|Overall Study|Pregnancy|0|||
155322603|NCT03640286|560617377|FG000|Overall Study|Withdrawal by Subject|10|||
155322604|NCT03640286|560617378|FG001|Overall Study|Withdrawal by Subject|10|||
155322605|NCT03640286|560617377|FG000|Overall Study|Non-compliance|4|||
155322606|NCT03640286|560617378|FG001|Overall Study|Non-compliance|10|||
155322607|NCT03640286|560617377|FG000|Overall Study|Medication change|1|||
155322608|NCT03640286|560617378|FG001|Overall Study|Medication change|0|||
155322609|NCT03640286|560617377|FG000|Overall Study|Other|1|||
155322610|NCT03640286|560617378|FG001|Overall Study|Other|2|||
155322611|NCT03640286|560617377|FG000|Overall Study|Joined another lifestyle program|0|||
155322612|NCT03640286|560617378|FG001|Overall Study|Joined another lifestyle program|1|||
155322613|NCT03580356|560617379|FG000|Treatment Period|Withdrawal by Subject|13|||
155322614|NCT03580356|560617380|FG001|Treatment Period|Withdrawal by Subject|0|||
155322615|NCT03580356|560617381|FG002|Treatment Period|Withdrawal by Subject|13|||
155322616|NCT03580356|560617382|FG003|Treatment Period|Withdrawal by Subject|1|||
155322617|NCT03580356|560617383|FG004|Treatment Period|Withdrawal by Subject|17|||
155322618|NCT03580356|560617384|FG005|Treatment Period|Withdrawal by Subject|0|||
155322619|NCT03580356|560617385|FG006|Treatment Period|Withdrawal by Subject|5|||
155322620|NCT03580356|560617386|FG007|Treatment Period|Withdrawal by Subject|0|||
155322621|NCT03580356|560617379|FG000|Treatment Period|Adverse Event|10|||
155322622|NCT03580356|560617380|FG001|Treatment Period|Adverse Event|0|||
155322623|NCT03580356|560617381|FG002|Treatment Period|Adverse Event|13|||
155322624|NCT03580356|560617382|FG003|Treatment Period|Adverse Event|0|||
155322625|NCT03580356|560617383|FG004|Treatment Period|Adverse Event|5|||
155322626|NCT03580356|560617384|FG005|Treatment Period|Adverse Event|0|||
155322627|NCT03580356|560617385|FG006|Treatment Period|Adverse Event|8|||
155322628|NCT03580356|560617386|FG007|Treatment Period|Adverse Event|0|||
155322629|NCT03580356|560617379|FG000|Treatment Period|Protocol Violation|5|||
155322630|NCT03580356|560617380|FG001|Treatment Period|Protocol Violation|0|||
155322631|NCT03580356|560617381|FG002|Treatment Period|Protocol Violation|6|||
155322632|NCT03580356|560617382|FG003|Treatment Period|Protocol Violation|1|||
155322633|NCT03580356|560617383|FG004|Treatment Period|Protocol Violation|9|||
155322634|NCT03580356|560617384|FG005|Treatment Period|Protocol Violation|1|||
155322635|NCT03580356|560617385|FG006|Treatment Period|Protocol Violation|1|||
155322636|NCT03580356|560617386|FG007|Treatment Period|Protocol Violation|0|||
155322637|NCT03580356|560617379|FG000|Treatment Period|Lack of Efficacy|6|||
155322638|NCT03580356|560617380|FG001|Treatment Period|Lack of Efficacy|0|||
155322639|NCT03580356|560617381|FG002|Treatment Period|Lack of Efficacy|2|||
155322640|NCT03580356|560617382|FG003|Treatment Period|Lack of Efficacy|0|||
155322641|NCT03580356|560617383|FG004|Treatment Period|Lack of Efficacy|3|||
155322642|NCT03580356|560617384|FG005|Treatment Period|Lack of Efficacy|0|||
155322643|NCT03580356|560617385|FG006|Treatment Period|Lack of Efficacy|3|||
155322644|NCT03580356|560617386|FG007|Treatment Period|Lack of Efficacy|0|||
155322645|NCT03580356|560617379|FG000|Treatment Period|Pregnancy|1|||
155322646|NCT03580356|560617380|FG001|Treatment Period|Pregnancy|0|||
155322647|NCT03580356|560617381|FG002|Treatment Period|Pregnancy|7|||
155322648|NCT03580356|560617382|FG003|Treatment Period|Pregnancy|0|||
155322649|NCT03580356|560617383|FG004|Treatment Period|Pregnancy|2|||
155322650|NCT03580356|560617384|FG005|Treatment Period|Pregnancy|0|||
155322651|NCT03580356|560617385|FG006|Treatment Period|Pregnancy|1|||
155322652|NCT03580356|560617386|FG007|Treatment Period|Pregnancy|0|||
155322653|NCT03580356|560617379|FG000|Treatment Period|Physician Decision|2|||
155322654|NCT03580356|560617380|FG001|Treatment Period|Physician Decision|0|||
155322655|NCT03580356|560617381|FG002|Treatment Period|Physician Decision|1|||
155322656|NCT03580356|560617382|FG003|Treatment Period|Physician Decision|0|||
155322657|NCT03580356|560617383|FG004|Treatment Period|Physician Decision|4|||
155322658|NCT03580356|560617384|FG005|Treatment Period|Physician Decision|0|||
155322659|NCT03580356|560617385|FG006|Treatment Period|Physician Decision|2|||
155322660|NCT03580356|560617386|FG007|Treatment Period|Physician Decision|0|||
155322661|NCT03580356|560617379|FG000|Treatment Period|Lost to Follow-up|1|||
155322662|NCT03580356|560617380|FG001|Treatment Period|Lost to Follow-up|1|||
155322663|NCT03580356|560617381|FG002|Treatment Period|Lost to Follow-up|1|||
155322664|NCT03580356|560617382|FG003|Treatment Period|Lost to Follow-up|0|||
155322665|NCT03580356|560617383|FG004|Treatment Period|Lost to Follow-up|3|||
155322666|NCT03580356|560617384|FG005|Treatment Period|Lost to Follow-up|0|||
155322667|NCT03580356|560617385|FG006|Treatment Period|Lost to Follow-up|1|||
155322668|NCT03580356|560617386|FG007|Treatment Period|Lost to Follow-up|0|||
155322669|NCT03580356|560617379|FG000|Treatment Period|Death|0|||
155322670|NCT03580356|560617380|FG001|Treatment Period|Death|0|||
155322671|NCT03580356|560617381|FG002|Treatment Period|Death|1|||
155322672|NCT03580356|560617382|FG003|Treatment Period|Death|0|||
155322673|NCT03580356|560617383|FG004|Treatment Period|Death|0|||
155322674|NCT03580356|560617384|FG005|Treatment Period|Death|0|||
155322675|NCT03580356|560617385|FG006|Treatment Period|Death|0|||
155322676|NCT03580356|560617386|FG007|Treatment Period|Death|0|||
155322677|NCT03580356|560617379|FG000|Treatment Period|Technical problems|0|||
155322678|NCT03580356|560617380|FG001|Treatment Period|Technical problems|0|||
155322679|NCT03580356|560617381|FG002|Treatment Period|Technical problems|0|||
155322680|NCT03580356|560617382|FG003|Treatment Period|Technical problems|0|||
155322681|NCT03580356|560617383|FG004|Treatment Period|Technical problems|1|||
155322682|NCT03580356|560617384|FG005|Treatment Period|Technical problems|0|||
155322683|NCT03580356|560617385|FG006|Treatment Period|Technical problems|0|||
155322684|NCT03580356|560617386|FG007|Treatment Period|Technical problems|0|||
155322685|NCT03580356|560617379|FG000|Treatment Period|Misrandomized, no treatment|0|||
155322686|NCT03580356|560617380|FG001|Treatment Period|Misrandomized, no treatment|0|||
155322687|NCT03580356|560617381|FG002|Treatment Period|Misrandomized, no treatment|1|||
155322688|NCT03580356|560617382|FG003|Treatment Period|Misrandomized, no treatment|0|||
155322689|NCT03580356|560617383|FG004|Treatment Period|Misrandomized, no treatment|2|||
155322690|NCT03580356|560617384|FG005|Treatment Period|Misrandomized, no treatment|0|||
155322691|NCT03580356|560617385|FG006|Treatment Period|Misrandomized, no treatment|0|||
155322692|NCT03580356|560617386|FG007|Treatment Period|Misrandomized, no treatment|0|||
155322693|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
155322694|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
155322695|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
155322696|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
155322697|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
155322698|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
155322699|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
155322700|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
155322701|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
155322702|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322703|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
155322704|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322705|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
155322706|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322707|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322708|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322709|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
155322710|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
155322711|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
155322712|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
155322713|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
155322714|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
155420811|NCT02591615|560972433|FG001|Maintenance MK-3475|Adverse Event|3|||
155420812|NCT02591615|560972434|FG002|Maintenance MK-3475|Adverse Event|1|||
155420813|NCT02591615|560972435|FG003|Maintenance MK-3475|Adverse Event|2|||
155322715|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
155322716|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
155322717|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322718|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322719|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
155322720|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155420814|NCT02591615|560972432|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
155420815|NCT02591615|560972433|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
155420816|NCT02591615|560972434|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
155644282|NCT01263028|561786973|FG000|Overall Study|Adverse Event|1|||
155644283|NCT01263028|561786973|FG000|Overall Study|Study terminated due to low enrollment.|4|||
155644284|NCT06042855|561786974|FG000|Overall Study|No Receipt of Study Drug|48|||
155644285|NCT06042855|561786975|FG001|Overall Study|No Receipt of Study Drug|57|||
155644286|NCT06042855|561786974|FG000|Overall Study|Administratively Withdrawn|59|||
155644287|NCT06042855|561786975|FG001|Overall Study|Administratively Withdrawn|59|||
155644288|NCT06038643|561786977|FG000|Overall Study|Withdrawal by Subject|9|||
155644289|NCT06038643|561786978|FG001|Overall Study|Withdrawal by Subject|4|||
155644290|NCT06038643|561786977|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
155644291|NCT06038643|561786978|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
155644292|NCT00294398|561786979|FG000|Overall Study|Lost to Follow-up|21|||
155644293|NCT00294398|561786980|FG001|Overall Study|Lost to Follow-up|26|||
155644294|NCT01428128|561786984|FG000|Overall Study|Withdrawal by Subject|4|||
155644295|NCT01428128|561786984|FG000|Overall Study|Screen failure by p53|10|||
155322721|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
155322722|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322723|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322724|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155420817|NCT02591615|560972435|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
155644296|NCT01428128|561786984|FG000|Overall Study|Received Neulasta in one cycle|2|||
155644297|NCT01428128|561786984|FG000|Overall Study|Adverse Event|1|||
155322725|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
155322726|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
155322727|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
155322728|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
155322729|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
155322730|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
155322731|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
155322732|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
155322733|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
155322734|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
155322735|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
155322736|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
155322737|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
155322738|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
155322739|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
155322740|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
155322741|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
155322742|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
155322743|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
155322744|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
155322745|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
155322746|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
155322747|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
155322748|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
155322749|NCT02839265|560617398|FG000|Overall Study|Screen Failure|2|||
155322750|NCT02839265|560617398|FG000|Overall Study|Death|1|||
155322751|NCT02839265|560617398|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
155322752|NCT05552508|560617399|FG000|Overall Study|Adverse Event|3|||
155322753|NCT04311632|560617401|FG000|Overall Study|Withdrawal by Subject|0|||
155322754|NCT04311632|560617402|FG001|Overall Study|Withdrawal by Subject|0|||
155322755|NCT04311632|560617403|FG002|Overall Study|Withdrawal by Subject|1|||
155322756|NCT04632225|560617404|FG000|Overall Study|Withdrawal by Subject|2|||
155322757|NCT04632225|560617405|FG001|Overall Study|Withdrawal by Subject|2|||
155322758|NCT02323880|560617406|FG000|Overall Study|Adverse Event|2|||
155322759|NCT02323880|560617407|FG001|Overall Study|Adverse Event|0|||
155322760|NCT02323880|560617408|FG002|Overall Study|Adverse Event|1|||
155322761|NCT02323880|560617409|FG003|Overall Study|Adverse Event|1|||
155644298|NCT00250718|561786985|FG000|Overall Study|Death|1|||
155322762|NCT02323880|560617410|FG004|Overall Study|Adverse Event|1|||
155322763|NCT02323880|560617411|FG005|Overall Study|Adverse Event|0|||
155322764|NCT02323880|560617412|FG006|Overall Study|Adverse Event|1|||
155322765|NCT02323880|560617413|FG007|Overall Study|Adverse Event|0|||
155322766|NCT02323880|560617406|FG000|Overall Study|Death|0|||
155322767|NCT02323880|560617407|FG001|Overall Study|Death|0|||
155322768|NCT02323880|560617408|FG002|Overall Study|Death|0|||
155322769|NCT02323880|560617409|FG003|Overall Study|Death|0|||
155322770|NCT02323880|560617410|FG004|Overall Study|Death|0|||
155322771|NCT02323880|560617411|FG005|Overall Study|Death|1|||
155322772|NCT02323880|560617412|FG006|Overall Study|Death|0|||
155322773|NCT02323880|560617413|FG007|Overall Study|Death|0|||
155322774|NCT02323880|560617406|FG000|Overall Study|Lack of Efficacy|4|||
155322775|NCT02323880|560617407|FG001|Overall Study|Lack of Efficacy|11|||
155322776|NCT02323880|560617408|FG002|Overall Study|Lack of Efficacy|5|||
155322777|NCT02323880|560617409|FG003|Overall Study|Lack of Efficacy|5|||
155322778|NCT02323880|560617410|FG004|Overall Study|Lack of Efficacy|4|||
155322779|NCT02323880|560617411|FG005|Overall Study|Lack of Efficacy|8|||
155322780|NCT02323880|560617412|FG006|Overall Study|Lack of Efficacy|4|||
155322781|NCT02323880|560617413|FG007|Overall Study|Lack of Efficacy|6|||
155322782|NCT02323880|560617406|FG000|Overall Study|Physician Decision|0|||
155322783|NCT02323880|560617407|FG001|Overall Study|Physician Decision|0|||
155322784|NCT02323880|560617408|FG002|Overall Study|Physician Decision|0|||
155322785|NCT02323880|560617409|FG003|Overall Study|Physician Decision|0|||
155322786|NCT02323880|560617410|FG004|Overall Study|Physician Decision|1|||
155322787|NCT02323880|560617411|FG005|Overall Study|Physician Decision|1|||
155322788|NCT02323880|560617412|FG006|Overall Study|Physician Decision|1|||
155322789|NCT02323880|560617413|FG007|Overall Study|Physician Decision|0|||
155322790|NCT02323880|560617406|FG000|Overall Study|Withdrawal by Subject|0|||
155322791|NCT02323880|560617407|FG001|Overall Study|Withdrawal by Subject|2|||
155322792|NCT02323880|560617408|FG002|Overall Study|Withdrawal by Subject|0|||
155322793|NCT02323880|560617409|FG003|Overall Study|Withdrawal by Subject|0|||
155322794|NCT02323880|560617410|FG004|Overall Study|Withdrawal by Subject|0|||
155322795|NCT02323880|560617411|FG005|Overall Study|Withdrawal by Subject|0|||
155322796|NCT02323880|560617412|FG006|Overall Study|Withdrawal by Subject|0|||
155322797|NCT02323880|560617413|FG007|Overall Study|Withdrawal by Subject|0|||
155322798|NCT04934072|560617414|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
155322799|NCT04934072|560617415|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
155322800|NCT04934072|560617416|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
155322801|NCT04934072|560617417|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
155322802|NCT04934072|560617418|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
155322803|NCT04934072|560617414|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
155322804|NCT04934072|560617415|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
155322805|NCT04934072|560617416|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322806|NCT04934072|560617417|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322807|NCT04934072|560617418|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322808|NCT04934072|560617414|FG000|Day 0 to Week 52|Other|3|||
155322809|NCT04934072|560617415|FG001|Day 0 to Week 52|Other|1|||
155322810|NCT04934072|560617416|FG002|Day 0 to Week 52|Other|0|||
155322811|NCT04934072|560617417|FG003|Day 0 to Week 52|Other|0|||
155322812|NCT04934072|560617418|FG004|Day 0 to Week 52|Other|0|||
155322813|NCT04934072|560617414|FG000|Day 0 to Week 52|Adverse Event|1|||
155322814|NCT04934072|560617415|FG001|Day 0 to Week 52|Adverse Event|3|||
155322815|NCT04934072|560617416|FG002|Day 0 to Week 52|Adverse Event|0|||
155322816|NCT04934072|560617417|FG003|Day 0 to Week 52|Adverse Event|0|||
155322817|NCT04934072|560617418|FG004|Day 0 to Week 52|Adverse Event|0|||
155322818|NCT04934072|560617414|FG000|Week 52 to Week 78|Adverse Event|0|||
155322819|NCT04934072|560617415|FG001|Week 52 to Week 78|Adverse Event|0|||
155322820|NCT04934072|560617416|FG002|Week 52 to Week 78|Adverse Event|0|||
155322821|NCT04934072|560617417|FG003|Week 52 to Week 78|Adverse Event|1|||
155322822|NCT04934072|560617418|FG004|Week 52 to Week 78|Adverse Event|1|||
155322823|NCT04934072|560617414|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
155322824|NCT04934072|560617415|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
155322825|NCT04934072|560617416|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
155322826|NCT04934072|560617417|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
155322827|NCT04934072|560617418|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
155322828|NCT04934072|560617414|FG000|Week 52 to Week 78|Other|0|||
155322829|NCT04934072|560617415|FG001|Week 52 to Week 78|Other|0|||
155322830|NCT04934072|560617416|FG002|Week 52 to Week 78|Other|1|||
155322831|NCT04934072|560617417|FG003|Week 52 to Week 78|Other|0|||
155322832|NCT04934072|560617418|FG004|Week 52 to Week 78|Other|0|||
155322833|NCT00844415|560617422|FG000|Overall Study|Withdrawal by Subject|1|||
155322834|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
155322835|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
155322836|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
155322837|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
155322838|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Progression|1|||
155322839|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
155322840|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
155322841|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Progression|1|||
155322842|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Adverse Event|3|||
155322843|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
155322844|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Progression|1|||
155322845|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
155322846|NCT03717935|560617424|FG000|Overall Study|Withdrawal by Subject|0|||
155322847|NCT03717935|560617425|FG001|Overall Study|Withdrawal by Subject|2|||
155322848|NCT03015532|560617430|FG000|Overall Study|Adverse Event|0|||
155322849|NCT03015532|560617431|FG001|Overall Study|Adverse Event|0|||
155322850|NCT03015532|560617432|FG002|Overall Study|Adverse Event|0|||
155322851|NCT03015532|560617433|FG003|Overall Study|Adverse Event|0|||
155322852|NCT03015532|560617434|FG004|Overall Study|Adverse Event|0|||
155322853|NCT03015532|560617435|FG005|Overall Study|Adverse Event|2|||
155322854|NCT03015532|560617436|FG006|Overall Study|Adverse Event|1|||
155322855|NCT03015532|560617437|FG007|Overall Study|Adverse Event|0|||
155322856|NCT03015532|560617430|FG000|Overall Study|Withdrawal by Subject|0|||
155322857|NCT03015532|560617431|FG001|Overall Study|Withdrawal by Subject|0|||
155322858|NCT03015532|560617432|FG002|Overall Study|Withdrawal by Subject|0|||
155322859|NCT03015532|560617433|FG003|Overall Study|Withdrawal by Subject|0|||
155322860|NCT03015532|560617434|FG004|Overall Study|Withdrawal by Subject|0|||
155322861|NCT03015532|560617435|FG005|Overall Study|Withdrawal by Subject|0|||
155322862|NCT03015532|560617436|FG006|Overall Study|Withdrawal by Subject|1|||
155322863|NCT03015532|560617437|FG007|Overall Study|Withdrawal by Subject|0|||
155322864|NCT02990338|560617438|FG000|Overall Study|Randomized and not treated|4|||
155322865|NCT02990338|560617439|FG001|Overall Study|Randomized and not treated|2|||
155322866|NCT02990338|560617438|FG000|Overall Study|Adverse Event|23|||
155322867|NCT02990338|560617439|FG001|Overall Study|Adverse Event|22|||
155322868|NCT02990338|560617438|FG000|Overall Study|Progressive disease|118|||
155322869|NCT02990338|560617439|FG001|Overall Study|Progressive disease|107|||
155322870|NCT02990338|560617438|FG000|Overall Study|Poor compliance to protocol|0|||
155322871|NCT02990338|560617439|FG001|Overall Study|Poor compliance to protocol|1|||
155322872|NCT02990338|560617438|FG000|Overall Study|Withdrawal by Subject|6|||
155322873|NCT02990338|560617439|FG001|Overall Study|Withdrawal by Subject|8|||
155322874|NCT02990338|560617438|FG000|Overall Study|Physician's decision|2|||
155322875|NCT02990338|560617439|FG001|Overall Study|Physician's decision|6|||
155322876|NCT02990338|560617438|FG000|Overall Study|Treatment extension study|0|||
155322877|NCT02990338|560617439|FG001|Overall Study|Treatment extension study|6|||
155322878|NCT02990338|560617438|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
155322879|NCT02990338|560617439|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
155322880|NCT02990338|560617438|FG000|Overall Study|Continue with therapy available commercially|0|||
155322881|NCT02990338|560617439|FG001|Overall Study|Continue with therapy available commercially|1|||
155322882|NCT02641730|560617442|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
155322883|NCT02641730|560617443|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155322884|NCT02641730|560617444|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155322885|NCT02641730|560617445|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
155322886|NCT02641730|560617446|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
155322887|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155322888|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155322889|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155322890|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
155322891|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
155322892|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322893|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
155322894|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322895|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
155322896|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322897|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322898|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322899|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322900|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
155322901|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
155322902|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
155322903|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
155322904|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
155322905|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
155322906|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
155322907|NCT02641730|560617442|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
155322908|NCT02641730|560617443|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
155322909|NCT02641730|560617444|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
155322910|NCT02641730|560617445|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
155322911|NCT02641730|560617446|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
155322912|NCT05460871|560617447|FG000|Overall Study|Withdrawal by Subject|1|||
155322913|NCT05460871|560617448|FG001|Overall Study|Withdrawal by Subject|2|||
155322914|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
155322915|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
155322916|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
155322917|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
155322918|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
155322919|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
155322920|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
155322921|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
155322922|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
155322923|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
155322924|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
155322925|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
155322926|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
155322927|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
155322928|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
155322929|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
155322930|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
155322931|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
155322932|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
155322933|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
155322934|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
155322935|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
155322936|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
155322937|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
155322938|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
155322939|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
155322940|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
155322941|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
155322942|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
155322943|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
155322944|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
155322945|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
155322946|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
155322947|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
155322948|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
155322949|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
155322950|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
155322951|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
155322952|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
155322953|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
155322954|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
155420818|NCT02591615|560972432|FG000|Maintenance MK-3475|Death|0|||
155420819|NCT02591615|560972433|FG001|Maintenance MK-3475|Death|1|||
155420820|NCT02591615|560972434|FG002|Maintenance MK-3475|Death|1|||
155420821|NCT02591615|560972435|FG003|Maintenance MK-3475|Death|0|||
155420822|NCT02591615|560972432|FG000|Maintenance MK-3475|Physician discretion|0|||
155322955|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
155322956|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
155322957|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
155322958|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
155420823|NCT02591615|560972433|FG001|Maintenance MK-3475|Physician discretion|0|||
155322959|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
155322960|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
155322961|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
155322962|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
155322963|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
155322964|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
155322965|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
155322966|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
155322967|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
155322968|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
155322969|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
155322970|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
155322971|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
155322972|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
155322973|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
155322974|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
155322975|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
155322976|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
155322977|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
155322978|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
155322979|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
155322980|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
155322981|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
155322982|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
155322983|NCT04271046|560617453|FG000|Overall Study|Death|0|||
155322984|NCT04271046|560617454|FG001|Overall Study|Death|2|||
155322985|NCT04271046|560617455|FG002|Overall Study|Death|0|||
155322986|NCT04271046|560617456|FG003|Overall Study|Death|2|||
155322987|NCT04271046|560617453|FG000|Overall Study|Lost to Follow-up|12|||
155322988|NCT04271046|560617454|FG001|Overall Study|Lost to Follow-up|12|||
155322989|NCT04271046|560617455|FG002|Overall Study|Lost to Follow-up|11|||
155322990|NCT04271046|560617456|FG003|Overall Study|Lost to Follow-up|11|||
155322991|NCT04271046|560617453|FG000|Overall Study|Patient with Dementia Died|2|||
155322992|NCT04271046|560617454|FG001|Overall Study|Patient with Dementia Died|0|||
155322993|NCT04271046|560617455|FG002|Overall Study|Patient with Dementia Died|2|||
155322994|NCT04271046|560617456|FG003|Overall Study|Patient with Dementia Died|0|||
155322995|NCT04271046|560617453|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
155322996|NCT04271046|560617454|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
155322997|NCT04271046|560617455|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
155322998|NCT04271046|560617456|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
155322999|NCT03663205|560617457|FG000|Overall Study|Death|144|||
155323000|NCT03663205|560617458|FG001|Overall Study|Death|69|||
155323001|NCT03663205|560617457|FG000|Overall Study|Sponsor decision|53|||
155323002|NCT03663205|560617458|FG001|Overall Study|Sponsor decision|19|||
155323003|NCT03663205|560617457|FG000|Overall Study|Withdrawal by Subject|8|||
155323004|NCT03663205|560617458|FG001|Overall Study|Withdrawal by Subject|11|||
155323005|NCT03663205|560617457|FG000|Overall Study|Lost to Follow-up|7|||
155323006|NCT03663205|560617458|FG001|Overall Study|Lost to Follow-up|9|||
155323007|NCT03663205|560617457|FG000|Overall Study|Transferred to long term extension study|11|||
155323008|NCT03663205|560617458|FG001|Overall Study|Transferred to long term extension study|3|||
155323009|NCT05962814|560617459|FG000|Overall Study|failed eligibility|1|||
155323010|NCT03057054|560617462|FG000|Overall Study|Death|4|||
155323011|NCT03057054|560617463|FG001|Overall Study|Death|4|||
155323012|NCT03057054|560617462|FG000|Overall Study|Withdrawal by Subject|6|||
155323013|NCT03057054|560617463|FG001|Overall Study|Withdrawal by Subject|3|||
155323014|NCT03057054|560617462|FG000|Overall Study|Ineligible|1|||
155323015|NCT03057054|560617463|FG001|Overall Study|Ineligible|1|||
155323016|NCT03972150|560618571|FG000|Overall Study|Adverse Event|0|||
155323017|NCT03972150|560618572|FG001|Overall Study|Adverse Event|1|||
155323018|NCT03972150|560618573|FG002|Overall Study|Adverse Event|1|||
155323019|NCT03972150|560618574|FG003|Overall Study|Adverse Event|0|||
155323020|NCT03972150|560618575|FG004|Overall Study|Adverse Event|0|||
155323021|NCT03972150|560618571|FG000|Overall Study|Progressive disease|3|||
155323022|NCT03972150|560618572|FG001|Overall Study|Progressive disease|5|||
155323023|NCT03972150|560618573|FG002|Overall Study|Progressive disease|2|||
155323024|NCT03972150|560618574|FG003|Overall Study|Progressive disease|2|||
155323025|NCT03972150|560618575|FG004|Overall Study|Progressive disease|3|||
155323026|NCT03181516|560618577|FG000|Overall Study|Withdrawal by Subject|14|||
155323027|NCT03181516|560618578|FG001|Overall Study|Withdrawal by Subject|7|||
155323028|NCT03181516|560618577|FG000|Overall Study|Lost to Follow-up|2|||
155323029|NCT03181516|560618578|FG001|Overall Study|Lost to Follow-up|2|||
155323030|NCT04544007|560618581|FG000|Overall Study|Withdrawal by Subject|1|||
155323031|NCT04544007|560618581|FG000|Overall Study|Confirmed Progressive Disease|1|||
155323032|NCT03485729|560618582|FG000|Overall Study|Withdrawal by Subject|0|||
155323033|NCT03485729|560618583|FG001|Overall Study|Withdrawal by Subject|0|||
155323034|NCT03485729|560618584|FG002|Overall Study|Withdrawal by Subject|1|||
155323035|NCT03485729|560618582|FG000|Overall Study|Disease progression|8|||
155323036|NCT03485729|560618583|FG001|Overall Study|Disease progression|13|||
155323037|NCT03485729|560618584|FG002|Overall Study|Disease progression|1|||
155323038|NCT03485729|560618582|FG000|Overall Study|Hospice care|1|||
155323039|NCT03485729|560618583|FG001|Overall Study|Hospice care|0|||
155323040|NCT03485729|560618584|FG002|Overall Study|Hospice care|0|||
155323041|NCT03485729|560618582|FG000|Overall Study|Poor performance status|1|||
155323042|NCT03485729|560618583|FG001|Overall Study|Poor performance status|0|||
155323043|NCT03485729|560618584|FG002|Overall Study|Poor performance status|0|||
155323044|NCT03485729|560618582|FG000|Overall Study|Illness|0|||
155323045|NCT03485729|560618583|FG001|Overall Study|Illness|1|||
155323046|NCT03485729|560618584|FG002|Overall Study|Illness|0|||
155323047|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
155323048|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
155323049|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
155323050|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
155323051|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
155323052|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
155323053|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
155323054|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
155323055|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
155323056|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
155323057|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
155323058|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
155323059|NCT04880733|560618585|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
155323060|NCT04880733|560618586|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
155323061|NCT04880733|560618587|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
155323062|NCT04451772|560618602|FG000|Overall Study|Adverse Event|1|||
155323063|NCT04451772|560618603|FG001|Overall Study|Adverse Event|0|||
155323064|NCT04451772|560618604|FG002|Overall Study|Adverse Event|1|||
155323065|NCT04451772|560618605|FG003|Overall Study|Adverse Event|1|||
155323066|NCT04451772|560618606|FG004|Overall Study|Adverse Event|0|||
155323067|NCT04451772|560618607|FG005|Overall Study|Adverse Event|3|||
155323068|NCT04451772|560618602|FG000|Overall Study|Withdrawal by Subject|2|||
155323069|NCT04451772|560618603|FG001|Overall Study|Withdrawal by Subject|7|||
155323070|NCT04451772|560618604|FG002|Overall Study|Withdrawal by Subject|2|||
155323071|NCT04451772|560618605|FG003|Overall Study|Withdrawal by Subject|1|||
155323072|NCT04451772|560618606|FG004|Overall Study|Withdrawal by Subject|1|||
155323073|NCT04451772|560618607|FG005|Overall Study|Withdrawal by Subject|0|||
155323074|NCT04451772|560618602|FG000|Overall Study|Other, not specified|1|||
155323075|NCT04451772|560618603|FG001|Overall Study|Other, not specified|2|||
155323076|NCT04451772|560618604|FG002|Overall Study|Other, not specified|1|||
155323077|NCT04451772|560618605|FG003|Overall Study|Other, not specified|0|||
155323078|NCT04451772|560618606|FG004|Overall Study|Other, not specified|0|||
155323079|NCT04451772|560618607|FG005|Overall Study|Other, not specified|1|||
155323080|NCT04451772|560618602|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323081|NCT04451772|560618603|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323082|NCT04451772|560618604|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323083|NCT04451772|560618605|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
155323084|NCT04451772|560618606|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
155323085|NCT04451772|560618607|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
155323086|NCT04605159|560618608|FG000|Overall Study|Adverse Event|6|||
155501446|NCT01915498|561260842|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501447|NCT01915498|561260843|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501448|NCT01915498|561260844|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501449|NCT01915498|561260845|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155501450|NCT01915498|561260846|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
155501451|NCT01915498|561260828|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501452|NCT01915498|561260829|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501453|NCT01915498|561260830|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501454|NCT01915498|561260831|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155644299|NCT00250718|561786985|FG000|Overall Study|Adverse Event|1|||
155323087|NCT04605159|560618609|FG001|Overall Study|Adverse Event|3|||
155323088|NCT04605159|560618610|FG002|Overall Study|Adverse Event|21|||
155323089|NCT04605159|560618611|FG003|Overall Study|Adverse Event|4|||
155323090|NCT04605159|560618608|FG000|Overall Study|Lost to Follow-up|74|||
155323091|NCT04605159|560618609|FG001|Overall Study|Lost to Follow-up|45|||
155323092|NCT04605159|560618610|FG002|Overall Study|Lost to Follow-up|119|||
155323093|NCT04605159|560618611|FG003|Overall Study|Lost to Follow-up|80|||
155323094|NCT04605159|560618608|FG000|Overall Study|Protocol Violation|4|||
155323095|NCT04605159|560618609|FG001|Overall Study|Protocol Violation|5|||
155323096|NCT04605159|560618610|FG002|Overall Study|Protocol Violation|2|||
155323097|NCT04605159|560618611|FG003|Overall Study|Protocol Violation|0|||
155323098|NCT04605159|560618608|FG000|Overall Study|Withdrawal by Subject|66|||
155323099|NCT04605159|560618609|FG001|Overall Study|Withdrawal by Subject|37|||
155323100|NCT04605159|560618610|FG002|Overall Study|Withdrawal by Subject|68|||
155323101|NCT04605159|560618611|FG003|Overall Study|Withdrawal by Subject|50|||
155323102|NCT04605159|560618608|FG000|Overall Study|Migrated / moved from the study area|32|||
155323103|NCT04605159|560618609|FG001|Overall Study|Migrated / moved from the study area|22|||
155323104|NCT04605159|560618610|FG002|Overall Study|Migrated / moved from the study area|41|||
155323105|NCT04605159|560618611|FG003|Overall Study|Migrated / moved from the study area|21|||
155323106|NCT04605159|560618608|FG000|Overall Study|Other|1|||
155323107|NCT04605159|560618609|FG001|Overall Study|Other|2|||
155323108|NCT04605159|560618610|FG002|Overall Study|Other|7|||
155323109|NCT04605159|560618611|FG003|Overall Study|Other|3|||
155323110|NCT04218851|560618615|FG000|Overall Study|Death|1|||
155323111|NCT04218851|560618616|FG001|Overall Study|Death|3|||
155323112|NCT01820611|560618617|FG000|Overall Study|Death|8|||
155323113|NCT01820611|560618617|FG000|Overall Study|Adverse Event|1|||
155323114|NCT01820611|560618617|FG000|Overall Study|Withdrawal by Subject|9|||
155323115|NCT03484819|560618618|FG000|Overall Study|Death|2|||
155323116|NCT03484819|560618618|FG000|Overall Study|Adverse Event|2|||
155323117|NCT03484819|560618618|FG000|Overall Study|Physician Decision|1|||
155323118|NCT03484819|560618618|FG000|Overall Study|Withdrawal by Subject|2|||
155323119|NCT03484819|560618618|FG000|Overall Study|Disease Progression|4|||
155323120|NCT03484819|560618618|FG000|Overall Study|Complicating Condition|1|||
155323121|NCT05970861|560618619|FG000|Overall Study|Physician Decision|4|||
155323122|NCT05970861|560618620|FG001|Overall Study|Physician Decision|4|||
155323123|NCT05970861|560618619|FG000|Overall Study|Lost to Follow-up|4|||
155323124|NCT05970861|560618620|FG001|Overall Study|Lost to Follow-up|3|||
155323125|NCT04186819|560618622|FG000|Overall Study|Adverse Event|1|||
155323126|NCT04186819|560618622|FG000|Overall Study|Lost to Follow-up|1|||
155323127|NCT04186819|560618622|FG000|Overall Study|Opted for EBRT|1|||
155323128|NCT04186819|560618622|FG000|Overall Study|Opted SBRT|1|||
155323129|NCT04186819|560618622|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
155323130|NCT04186819|560618622|FG000|Overall Study|Physician Decision|1|||
155323131|NCT04186819|560618622|FG000|Overall Study|RP Delayed|1|||
155323132|NCT04186819|560618622|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
155323133|NCT04186819|560618622|FG000|Overall Study|Subject declined for financial reasons|1|||
155323134|NCT04186819|560618622|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
155323135|NCT04186819|560618622|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
155323136|NCT04186819|560618622|FG000|Overall Study|The subject opted for other treatment option|2|||
155323137|NCT04186819|560618622|FG000|Overall Study|The subject opted for other treatment options|1|||
155323138|NCT04186819|560618622|FG000|Overall Study|Withdrawal by Subject|3|||
155323139|NCT04186819|560618622|FG000|Overall Study|Reason not specified|1|||
155323140|NCT03988621|560618627|FG000|Overall Study|Lost to Follow-up|16|||
155323141|NCT03988621|560618628|FG001|Overall Study|Lost to Follow-up|17|||
155323142|NCT03988621|560618627|FG000|Overall Study|Withdrawal by Subject|14|||
155323143|NCT03988621|560618628|FG001|Overall Study|Withdrawal by Subject|7|||
155323144|NCT03988621|560618627|FG000|Overall Study|Patient Lost to Follow Up|15|||
155323145|NCT03988621|560618628|FG001|Overall Study|Patient Lost to Follow Up|15|||
155323146|NCT03988621|560618627|FG000|Overall Study|Patient death|1|||
155323147|NCT03988621|560618628|FG001|Overall Study|Patient death|5|||
155323148|NCT05013385|560618629|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
155323149|NCT01447719|560618634|FG000|Overall Study|Image acquisition failure|2|||
155323150|NCT01447719|560618634|FG000|Overall Study|Invalid image or not imaged|3|||
155323151|NCT01447719|560618634|FG000|Overall Study|Subject still living at end of study|79|||
155323152|NCT01447719|560618634|FG000|Overall Study|Withdrawal by Subject|2|||
155323153|NCT01447719|560618634|FG000|Overall Study|Family withdrew autopsy consent|7|||
155323154|NCT03914469|560618635|FG000|Overall Study|Lost to Follow-up|1|||
155323155|NCT03914469|560618636|FG001|Overall Study|Lost to Follow-up|4|||
155323156|NCT03252288|560618637|FG000|Overall Study|Death|1|||
155323157|NCT03252288|560618638|FG001|Overall Study|Death|0|||
155323158|NCT03252288|560618639|FG002|Overall Study|Death|0|||
155323159|NCT03252288|560618637|FG000|Overall Study|Death|11|||
155323160|NCT03252288|560618638|FG001|Overall Study|Death|0|||
155323161|NCT03252288|560618639|FG002|Overall Study|Death|0|||
155323162|NCT03252288|560618637|FG000|Overall Study|Withdrawal by Subject|2|||
155323163|NCT03252288|560618638|FG001|Overall Study|Withdrawal by Subject|0|||
155323164|NCT03252288|560618639|FG002|Overall Study|Withdrawal by Subject|0|||
155323165|NCT03252288|560618637|FG000|Overall Study|Lost to Follow-up|79|||
155323166|NCT03252288|560618638|FG001|Overall Study|Lost to Follow-up|0|||
155323167|NCT03252288|560618639|FG002|Overall Study|Lost to Follow-up|0|||
155323168|NCT03252288|560618637|FG000|Overall Study|Loss of baseline data on tablets|6|||
155323169|NCT03252288|560618638|FG001|Overall Study|Loss of baseline data on tablets|0|||
155323170|NCT03252288|560618639|FG002|Overall Study|Loss of baseline data on tablets|0|||
155323171|NCT00677365|560618640|FG000|Overall Study|Adverse Event|2|||
155323172|NCT00677365|560618641|FG001|Overall Study|Adverse Event|1|||
155323173|NCT00677365|560618642|FG002|Overall Study|Adverse Event|1|||
155323174|NCT00677365|560618643|FG003|Overall Study|Adverse Event|2|||
155323175|NCT00677365|560618640|FG000|Overall Study|Withdrawal by Subject|0|||
155323176|NCT00677365|560618641|FG001|Overall Study|Withdrawal by Subject|0|||
155323177|NCT00677365|560618642|FG002|Overall Study|Withdrawal by Subject|1|||
155323178|NCT00677365|560618643|FG003|Overall Study|Withdrawal by Subject|0|||
155323179|NCT00677365|560618640|FG000|Overall Study|Other reason|0|||
155323180|NCT00677365|560618641|FG001|Overall Study|Other reason|0|||
155323181|NCT00677365|560618642|FG002|Overall Study|Other reason|0|||
155323182|NCT00677365|560618643|FG003|Overall Study|Other reason|1|||
155644300|NCT00250718|561786985|FG000|Overall Study|Withdrawal by Subject|1|||
155644301|NCT06100250|561786988|FG000|Overall Study|Lost to Follow-up|5|||
155644302|NCT00424008|561786990|FG000|Overall Study|Adverse Event|8|||
155644303|NCT00424008|561786991|FG001|Overall Study|Adverse Event|6|||
155323183|NCT02944968|560618644|FG000|Overall Study|Subject excluded before study procedure|1|||
155323184|NCT02944968|560618644|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
155323185|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
155323186|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
155644304|NCT00424008|561786990|FG000|Overall Study|Lack of Efficacy|40|||
155644305|NCT00424008|561786991|FG001|Overall Study|Lack of Efficacy|34|||
155644306|NCT00424008|561786990|FG000|Overall Study|Lost to Follow-up|1|||
155644307|NCT00424008|561786991|FG001|Overall Study|Lost to Follow-up|2|||
155644308|NCT00424008|561786990|FG000|Overall Study|Withdrawal by Subject|5|||
155644309|NCT00424008|561786991|FG001|Overall Study|Withdrawal by Subject|8|||
155644310|NCT00424008|561786990|FG000|Overall Study|Noncompliance with protocol|13|||
155644311|NCT00424008|561786991|FG001|Overall Study|Noncompliance with protocol|7|||
155644312|NCT00424008|561786990|FG000|Overall Study|Did not meet protocol eligibility|16|||
155644313|NCT00424008|561786991|FG001|Overall Study|Did not meet protocol eligibility|21|||
155644314|NCT00424008|561786990|FG000|Overall Study|Administrative|266|||
155644315|NCT00424008|561786991|FG001|Overall Study|Administrative|257|||
155644316|NCT02114684|561787000|FG000|Overall Study|Death|6|||
155644317|NCT02114684|561787001|FG001|Overall Study|Death|4|||
155644318|NCT02114684|561787000|FG000|Overall Study|Lost to Follow-up|1|||
155644319|NCT02114684|561787001|FG001|Overall Study|Lost to Follow-up|2|||
155644320|NCT02114684|561787000|FG000|Overall Study|Withdrawal by Subject|1|||
155644321|NCT02114684|561787001|FG001|Overall Study|Withdrawal by Subject|2|||
155644322|NCT02114684|561787000|FG000|Overall Study|Relocation|3|||
155644323|NCT02114684|561787001|FG001|Overall Study|Relocation|1|||
155644324|NCT02114684|561787000|FG000|Overall Study|Rifampicin resistant on culture|0|||
155644325|NCT02114684|561787001|FG001|Overall Study|Rifampicin resistant on culture|1|||
155644326|NCT02114684|561787000|FG000|Overall Study|Patient Incarcerated|1|||
155644327|NCT02114684|561787001|FG001|Overall Study|Patient Incarcerated|0|||
155644328|NCT01397747|561787008|FG000|Overall Study|Multitarget DNA test excluded|689|||
155644329|NCT01397747|561787008|FG000|Overall Study|Colonoscopy excluded|304|||
155644330|NCT01397747|561787008|FG000|Overall Study|FIT excluded|34|||
155644331|NCT03828383|561787009|FG000|Overall Study|Lost to Follow-up|3|||
155644332|NCT03828383|561787010|FG001|Overall Study|Lost to Follow-up|2|||
155644333|NCT03828383|561787009|FG000|Overall Study|Withdrawal by Subject|4|||
155644334|NCT03828383|561787010|FG001|Overall Study|Withdrawal by Subject|5|||
155644335|NCT00504309|561787012|FG000|Overall Study|Death|0|||
155644336|NCT00504309|561787013|FG001|Overall Study|Death|0|||
155644337|NCT00504309|561787014|FG002|Overall Study|Death|0|||
155644338|NCT00504309|561787015|FG003|Overall Study|Death|0|||
155644339|NCT00504309|561787016|FG004|Overall Study|Death|1|||
155644340|NCT00504309|561787017|FG005|Overall Study|Death|0|||
155323187|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
155323188|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
155323189|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
155323190|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
155323191|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
155644341|NCT00504309|561787012|FG000|Overall Study|Withdrawal by Subject|0|||
155644342|NCT00504309|561787013|FG001|Overall Study|Withdrawal by Subject|0|||
155644343|NCT00504309|561787014|FG002|Overall Study|Withdrawal by Subject|1|||
155644344|NCT00504309|561787015|FG003|Overall Study|Withdrawal by Subject|0|||
155644345|NCT00504309|561787016|FG004|Overall Study|Withdrawal by Subject|0|||
155644346|NCT00504309|561787017|FG005|Overall Study|Withdrawal by Subject|0|||
155644347|NCT02665455|561787018|FG000|Overall Study|Withdrawal by Subject|6|||
155323192|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
155323193|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
155323194|NCT02905331|560618645|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
155323195|NCT02905331|560618646|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
155323196|NCT02905331|560618647|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
155323197|NCT02905331|560618645|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
155323198|NCT02905331|560618646|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
155323199|NCT02905331|560618647|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
155323200|NCT04102111|560618655|FG000|Overall Study|Withdrawal by Subject|2|||
155323201|NCT04102111|560618656|FG001|Overall Study|Withdrawal by Subject|3|||
155323202|NCT04102111|560618655|FG000|Overall Study|Adverse Event|1|||
155323203|NCT04102111|560618656|FG001|Overall Study|Adverse Event|1|||
155323204|NCT04102111|560618655|FG000|Overall Study|Study terminated by sponsor|1|||
155323205|NCT04102111|560618656|FG001|Overall Study|Study terminated by sponsor|3|||
155323206|NCT03334695|560618657|FG000|Overall Study|Lost to Follow-up|3|||
155323207|NCT03334695|560618658|FG001|Overall Study|Lost to Follow-up|3|||
155323208|NCT03334695|560618657|FG000|Overall Study|Physician Decision|1|||
155323209|NCT03334695|560618658|FG001|Overall Study|Physician Decision|2|||
155323210|NCT03334695|560618657|FG000|Overall Study|Protocol Violation|0|||
155323211|NCT03334695|560618658|FG001|Overall Study|Protocol Violation|1|||
155323212|NCT02542631|560618659|FG000|Overall Study|Adverse Event|1|||
155323213|NCT02542631|560618660|FG001|Overall Study|Adverse Event|1|||
155323214|NCT02542631|560618659|FG000|Overall Study|Sponsor Termination|1|||
155323215|NCT02542631|560618660|FG001|Overall Study|Sponsor Termination|0|||
155323216|NCT02542631|560618659|FG000|Overall Study|Withdrawal by Subject|11|||
155323217|NCT02542631|560618660|FG001|Overall Study|Withdrawal by Subject|16|||
155323218|NCT02542631|560618659|FG000|Overall Study|Protocol Violation|1|||
155323219|NCT02542631|560618660|FG001|Overall Study|Protocol Violation|1|||
155323220|NCT02542631|560618659|FG000|Overall Study|Physician Decision|6|||
155323221|NCT02542631|560618660|FG001|Overall Study|Physician Decision|4|||
155420824|NCT02591615|560972434|FG002|Maintenance MK-3475|Physician discretion|1|||
155420825|NCT02591615|560972435|FG003|Maintenance MK-3475|Physician discretion|0|||
155420826|NCT02591615|560972432|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
155420827|NCT02591615|560972433|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
155420828|NCT02591615|560972434|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
155420829|NCT02591615|560972435|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
155420830|NCT02591615|560972432|FG000|Maintenance MK-3475|In active treatment|2|||
155420831|NCT02591615|560972433|FG001|Maintenance MK-3475|In active treatment|0|||
155420832|NCT02591615|560972434|FG002|Maintenance MK-3475|In active treatment|0|||
155420833|NCT02591615|560972435|FG003|Maintenance MK-3475|In active treatment|1|||
155420834|NCT04047797|560972438|FG000|Overall Study|Progressive Disease|1|||
155420835|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
155420836|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
155420837|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
155420838|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155420839|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155420840|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155420841|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155420842|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155420843|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
155420844|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
155420845|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
155420846|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155420847|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155420848|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155420849|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155420850|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155420851|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
155420852|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
155420853|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
155420854|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155420855|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155420856|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155420857|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155644348|NCT02665455|561787018|FG000|Overall Study|Lost to Follow-up|1|||
155644349|NCT02665455|561787018|FG000|Overall Study|Adverse Event|1|||
155644350|NCT02665455|561787018|FG000|Overall Study|Protocol Violation|1|||
155644351|NCT01039675|561787022|FG000|Overall Study|Adverse Event|0|||
155644352|NCT01039675|561787023|FG001|Overall Study|Adverse Event|2|||
155644353|NCT01039675|561787022|FG000|Overall Study|Lack of Efficacy|0|||
155644354|NCT01039675|561787023|FG001|Overall Study|Lack of Efficacy|2|||
155644355|NCT01039675|561787022|FG000|Overall Study|Withdrawal by Subject|0|||
155644356|NCT01039675|561787023|FG001|Overall Study|Withdrawal by Subject|1|||
155644357|NCT01039675|561787022|FG000|Overall Study|Lost to Follow-up|0|||
155323222|NCT02542631|560618659|FG000|Overall Study|Lost to Follow-up|6|||
155323223|NCT02542631|560618660|FG001|Overall Study|Lost to Follow-up|5|||
155323224|NCT02542631|560618659|FG000|Overall Study|Death|1|||
155323225|NCT02542631|560618660|FG001|Overall Study|Death|2|||
155323226|NCT02542631|560618659|FG000|Overall Study|Other|2|||
155323227|NCT02542631|560618660|FG001|Overall Study|Other|1|||
155323228|NCT02542631|560618659|FG000|Overall Study|Used Prohibited Medication|2|||
155323229|NCT02542631|560618660|FG001|Overall Study|Used Prohibited Medication|1|||
155323230|NCT02938923|560618661|FG000|Overall Study|Death|1|||
155323231|NCT02938923|560618662|FG001|Overall Study|Death|0|||
155323232|NCT02938923|560618663|FG002|Overall Study|Death|0|||
155323233|NCT02938923|560618661|FG000|Overall Study|Physician Decision|0|||
155323234|NCT02938923|560618662|FG001|Overall Study|Physician Decision|2|||
155323235|NCT02938923|560618663|FG002|Overall Study|Physician Decision|0|||
155323236|NCT02938923|560618661|FG000|Overall Study|Withdrawal by Subject|0|||
155323237|NCT02938923|560618662|FG001|Overall Study|Withdrawal by Subject|1|||
155323238|NCT02938923|560618663|FG002|Overall Study|Withdrawal by Subject|1|||
155323239|NCT00721149|560618664|FG000|Overall Study|Physician Decision|1|||
155323240|NCT06010836|560618672|FG000|Overall Study|Lost to Follow-up|2|||
155323241|NCT06010836|560618673|FG001|Overall Study|Lost to Follow-up|2|||
155323242|NCT06010836|560618672|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
155323243|NCT06010836|560618673|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
155323244|NCT06010836|560618672|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
155323245|NCT06010836|560618673|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
155323246|NCT06010836|560618672|FG000|Overall Study|Did not receive intervention discussion|0|||
155323247|NCT06010836|560618673|FG001|Overall Study|Did not receive intervention discussion|4|||
155323248|NCT05890105|560618677|FG000|Overall Study|Adverse Event|1|||
155323249|NCT05890105|560618678|FG001|Overall Study|Adverse Event|0|||
155323250|NCT05890105|560618679|FG002|Overall Study|Adverse Event|0|||
155323251|NCT05890105|560618677|FG000|Overall Study|Other|1|||
155323252|NCT05890105|560618678|FG001|Overall Study|Other|2|||
155323253|NCT05890105|560618679|FG002|Overall Study|Other|0|||
155323254|NCT04206787|560618680|FG000|Overall Study|Other than listed|2|||
155323255|NCT04206787|560618680|FG000|Overall Study|Investigator decision|1|||
155323256|NCT04206787|560618680|FG000|Overall Study|Death|25|||
155323257|NCT04206787|560618680|FG000|Overall Study|Lost to Follow-up|9|||
155323258|NCT04206787|560618680|FG000|Overall Study|Withdrawal of consent|9|||
155323259|NCT04505410|560618682|FG000|Overall Study|Adverse Event|2|||
155323260|NCT04505410|560618683|FG001|Overall Study|Adverse Event|0|||
155323261|NCT04505410|560618682|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
155323262|NCT04505410|560618683|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
155323263|NCT04505410|560618682|FG000|Overall Study|did not want to follow diet|1|||
155323264|NCT04505410|560618683|FG001|Overall Study|did not want to follow diet|0|||
155323265|NCT04505410|560618682|FG000|Overall Study|flare up of ulcerative colitis|0|||
155323266|NCT04505410|560618683|FG001|Overall Study|flare up of ulcerative colitis|1|||
155323267|NCT04505410|560618682|FG000|Overall Study|Lost to Follow-up|0|||
155323268|NCT04505410|560618683|FG001|Overall Study|Lost to Follow-up|2|||
155323269|NCT04505410|560618682|FG000|Overall Study|Lost to Follow-up|1|||
155323270|NCT04505410|560618683|FG001|Overall Study|Lost to Follow-up|0|||
155644358|NCT01039675|561787023|FG001|Overall Study|Lost to Follow-up|1|||
155323271|NCT04505410|560618682|FG000|Overall Study|initiated another diet on their own|0|||
155323272|NCT04505410|560618683|FG001|Overall Study|initiated another diet on their own|2|||
155323273|NCT03533257|560618692|FG000|Overall Study|Adverse Event|4|||
155323274|NCT03533257|560618693|FG001|Overall Study|Adverse Event|2|||
155323275|NCT03533257|560618692|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
155323276|NCT03533257|560618693|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
155323277|NCT04108130|560619875|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
155644359|NCT01039675|561787022|FG000|Overall Study|Physician Decision|0|||
155644360|NCT01039675|561787023|FG001|Overall Study|Physician Decision|1|||
155323278|NCT04108130|560619876|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
155323279|NCT04108130|560619875|FG000|Overall Study|Consent Withdrawn|9|||
155323280|NCT04108130|560619876|FG001|Overall Study|Consent Withdrawn|6|||
155323281|NCT04108130|560619875|FG000|Overall Study|Surgery Cancelled|4|||
155323282|NCT04108130|560619876|FG001|Overall Study|Surgery Cancelled|4|||
155323283|NCT04108130|560619875|FG000|Overall Study|Found Ineligible for Study|4|||
155323284|NCT04108130|560619876|FG001|Overall Study|Found Ineligible for Study|3|||
155323285|NCT04108130|560619875|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
155323286|NCT04108130|560619876|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
155323287|NCT04108130|560619875|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
155323288|NCT04108130|560619876|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
155323289|NCT01130883|560619877|FG000|Overall Study|Patient Noncompliance|6|||
155323290|NCT01130883|560619877|FG000|Overall Study|Reason Unknown|1|||
155323291|NCT01130883|560619877|FG000|Overall Study|Adverse Event|3|||
155323292|NCT05311176|560619880|FG000|Overall Study|Death|6|||
155323293|NCT05311176|560619880|FG000|Overall Study|Sponsor discontinued the study|1|||
155323294|NCT06106022|560619885|FG000|Overall Study|Lost to Follow-up|1|||
155323295|NCT06106022|560619886|FG001|Overall Study|Lost to Follow-up|0|||
155323296|NCT06106022|560619885|FG000|Overall Study|Voluntary Withdrawal|0|||
155323297|NCT06106022|560619886|FG001|Overall Study|Voluntary Withdrawal|2|||
155323298|NCT05405985|560619887|FG000|Overall Study|Withdrawal by Subject|1|||
155323299|NCT05405985|560619888|FG001|Overall Study|Withdrawal by Subject|0|||
155323300|NCT05424380|560619891|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
155323301|NCT05424380|560619892|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323302|NCT05424380|560619893|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323303|NCT05424380|560619894|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323304|NCT05424380|560619895|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323305|NCT05424380|560619896|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323306|NCT05424380|560619891|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
155323307|NCT05424380|560619892|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323308|NCT05424380|560619893|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323309|NCT05424380|560619894|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323310|NCT05424380|560619895|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323311|NCT05424380|560619896|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323312|NCT05424380|560619891|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
155323313|NCT05424380|560619892|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323314|NCT05424380|560619893|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323315|NCT05424380|560619894|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323316|NCT05424380|560619895|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323317|NCT05424380|560619896|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323318|NCT05424380|560619891|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323319|NCT05424380|560619892|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
155323320|NCT05424380|560619893|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323321|NCT05424380|560619894|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323322|NCT05424380|560619895|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323323|NCT05424380|560619896|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323324|NCT05424380|560619891|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323325|NCT05424380|560619892|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
155323326|NCT05424380|560619893|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323327|NCT05424380|560619894|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323328|NCT05424380|560619895|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323329|NCT05424380|560619896|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323330|NCT05424380|560619891|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155323331|NCT05424380|560619892|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155323332|NCT05424380|560619893|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
155323333|NCT05424380|560619894|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155420858|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155644361|NCT02564978|561787024|FG000|Overall Study|Adverse Event|8|||
155323334|NCT05424380|560619895|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155323335|NCT05424380|560619896|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155644362|NCT02564978|561787024|FG000|Overall Study|Death|1|||
155644363|NCT02564978|561787024|FG000|Overall Study|Lost to Follow-up|1|||
155644364|NCT02564978|561787024|FG000|Overall Study|Withdrawal by Subject|15|||
155644365|NCT02564978|561787024|FG000|Overall Study|Early Study Closure|2|||
155644366|NCT02564978|561787024|FG000|Overall Study|Other Reason|5|||
155644367|NCT03554473|561788257|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
155644368|NCT03554473|561788258|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
155644369|NCT03554473|561788259|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
155644370|NCT03554473|561788257|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
155644371|NCT03554473|561788258|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
155323336|NCT05424380|560619891|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323337|NCT05424380|560619892|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323338|NCT05424380|560619893|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
155323339|NCT05424380|560619894|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323340|NCT05424380|560619895|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323341|NCT05424380|560619896|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323342|NCT05424380|560619891|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323343|NCT05424380|560619892|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323344|NCT05424380|560619893|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
155323345|NCT05424380|560619894|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323346|NCT05424380|560619895|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323347|NCT05424380|560619896|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323348|NCT05424380|560619891|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323349|NCT05424380|560619892|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323350|NCT05424380|560619893|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323351|NCT05424380|560619894|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
155323352|NCT05424380|560619895|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323353|NCT05424380|560619896|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323354|NCT05424380|560619891|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323355|NCT05424380|560619892|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323356|NCT05424380|560619893|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323357|NCT05424380|560619894|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
155501455|NCT01915498|561260832|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501456|NCT01915498|561260833|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501457|NCT01915498|561260834|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501458|NCT01915498|561260835|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501459|NCT01915498|561260836|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501460|NCT01915498|561260837|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501461|NCT01915498|561260838|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501462|NCT01915498|561260839|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501463|NCT01915498|561260840|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501464|NCT01915498|561260841|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501465|NCT01915498|561260842|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501466|NCT01915498|561260843|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501467|NCT01915498|561260844|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501468|NCT01915498|561260845|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
155501469|NCT01915498|561260846|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
155501470|NCT00314262|561260853|FG000|Overall Study|Adverse Event|2|||
155501471|NCT00314262|561260853|FG000|Overall Study|Withdrawal by Subject|2|||
155501472|NCT00314262|561260853|FG000|Overall Study|Physician Decision|1|||
155501473|NCT00883129|561260854|FG000|Overall Study|Adverse Event|7|||
155501474|NCT00883129|561260855|FG001|Overall Study|Adverse Event|15|||
155501475|NCT00883129|561260854|FG000|Overall Study|Withdrawal by Subject|8|||
155501476|NCT00883129|561260855|FG001|Overall Study|Withdrawal by Subject|9|||
155501477|NCT00883129|561260854|FG000|Overall Study|Non-compliance|3|||
155501478|NCT00883129|561260855|FG001|Overall Study|Non-compliance|6|||
155501479|NCT00883129|561260854|FG000|Overall Study|Lost to Follow-up|1|||
155501480|NCT00883129|561260855|FG001|Overall Study|Lost to Follow-up|2|||
155501481|NCT00883129|561260854|FG000|Overall Study|Death|1|||
155501482|NCT00883129|561260855|FG001|Overall Study|Death|2|||
155323358|NCT05424380|560619895|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323359|NCT05424380|560619896|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323360|NCT05424380|560619891|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155420859|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
155420860|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
155420861|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
155420862|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155420863|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155420864|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155420865|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155420866|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155420867|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
155420868|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
155420869|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
155420870|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155420871|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155420872|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155420873|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155420874|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155420875|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
155501483|NCT00883129|561260854|FG000|Overall Study|Defined Treatment Failure|0|||
155501484|NCT00883129|561260855|FG001|Overall Study|Defined Treatment Failure|2|||
155501485|NCT01966107|561260857|FG000|Overall Study|excluded from FAS|21|||
155501486|NCT01966107|561260858|FG001|Overall Study|excluded from FAS|20|||
155501487|NCT01966107|561260857|FG000|Overall Study|discontinued treatment|345|||
155501488|NCT01966107|561260858|FG001|Overall Study|discontinued treatment|372|||
155501489|NCT01966107|561260857|FG000|Overall Study|due to study closure|164|||
155501490|NCT01966107|561260858|FG001|Overall Study|due to study closure|186|||
155501491|NCT01966107|561260857|FG000|Overall Study|withdrew from the study|272|||
155420876|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
155420877|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155420878|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155420879|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155420880|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155420881|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155420882|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155501492|NCT01966107|561260858|FG001|Overall Study|withdrew from the study|303|||
155501493|NCT01185639|561260859|FG000|Overall Study|Progressed and didn't receive therapy|2|||
155501494|NCT02200614|561260860|FG000|Double Blind Treatment|Adverse Event|86|||
155501495|NCT02200614|561260861|FG001|Double Blind Treatment|Adverse Event|48|||
155501496|NCT02200614|561260860|FG000|Double Blind Treatment|Confirmed metastasis|120|||
155501497|NCT02200614|561260861|FG001|Double Blind Treatment|Confirmed metastasis|140|||
155501498|NCT02200614|561260860|FG000|Double Blind Treatment|Judgment of the investigator|59|||
155501499|NCT02200614|561260861|FG001|Double Blind Treatment|Judgment of the investigator|99|||
155501500|NCT02200614|561260860|FG000|Double Blind Treatment|Metastasis by local reading|1|||
155323361|NCT05424380|560619892|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323362|NCT05424380|560619893|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323363|NCT05424380|560619894|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
155323364|NCT05424380|560619895|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323365|NCT05424380|560619896|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323366|NCT05424380|560619891|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323367|NCT05424380|560619892|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323368|NCT05424380|560619893|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323369|NCT05424380|560619894|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323370|NCT05424380|560619895|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
155501501|NCT02200614|561260861|FG001|Double Blind Treatment|Metastasis by local reading|3|||
155501502|NCT02200614|561260860|FG000|Double Blind Treatment|Other reason|6|||
155501503|NCT02200614|561260861|FG001|Double Blind Treatment|Other reason|2|||
155501504|NCT02200614|561260860|FG000|Double Blind Treatment|Personal reason|77|||
155501505|NCT02200614|561260861|FG001|Double Blind Treatment|Personal reason|85|||
155501506|NCT02200614|561260860|FG000|Double Blind Treatment|Protocol deviation|14|||
155501507|NCT02200614|561260861|FG001|Double Blind Treatment|Protocol deviation|7|||
155501508|NCT02200614|561260860|FG000|Double Blind Treatment|Not treated|1|||
155501509|NCT02200614|561260861|FG001|Double Blind Treatment|Not treated|0|||
155501510|NCT02200614|561260860|FG000|Open Label|Adverse Event|41|||
155501511|NCT02200614|561260861|FG001|Open Label|Adverse Event|11|||
155501512|NCT02200614|561260860|FG000|Open Label|Confirmed metastasis|1|||
155501513|NCT02200614|561260861|FG001|Open Label|Confirmed metastasis|0|||
155501514|NCT02200614|561260860|FG000|Open Label|Judgment of the investigator|29|||
155501515|NCT02200614|561260861|FG001|Open Label|Judgment of the investigator|2|||
155501516|NCT02200614|561260860|FG000|Open Label|Metastasis by local reading|138|||
155501517|NCT02200614|561260861|FG001|Open Label|Metastasis by local reading|27|||
155644372|NCT03554473|561788259|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
155644373|NCT03554473|561788257|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
155644374|NCT03554473|561788258|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
155501518|NCT02200614|561260860|FG000|Open Label|Other reason|22|||
155501519|NCT02200614|561260861|FG001|Open Label|Other reason|4|||
155501520|NCT02200614|561260860|FG000|Open Label|Personal reason|60|||
155501521|NCT02200614|561260861|FG001|Open Label|Personal reason|8|||
155501522|NCT02200614|561260860|FG000|Open Label|Protocol deviation|3|||
155501523|NCT02200614|561260861|FG001|Open Label|Protocol deviation|2|||
155501524|NCT02200614|561260860|FG000|Open Label|Missing|2|||
155501525|NCT02200614|561260861|FG001|Open Label|Missing|2|||
155501526|NCT00532779|561260862|FG000|Overall Study|Adverse Event|122|||
155501527|NCT00532779|561260863|FG001|Overall Study|Adverse Event|112|||
155501528|NCT00532779|561260864|FG002|Overall Study|Adverse Event|56|||
155501529|NCT00532779|561260862|FG000|Overall Study|Lost to Follow-up|76|||
155501530|NCT00532779|561260863|FG001|Overall Study|Lost to Follow-up|65|||
155501531|NCT00532779|561260864|FG002|Overall Study|Lost to Follow-up|66|||
155501532|NCT00532779|561260862|FG000|Overall Study|Withdrawal by Subject|63|||
155501533|NCT00532779|561260863|FG001|Overall Study|Withdrawal by Subject|60|||
155644375|NCT03554473|561788259|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
155644376|NCT05206604|561788260|FG000|Overall Study|Non-compliance with study drug|0|||
155644377|NCT05206604|561788261|FG001|Overall Study|Non-compliance with study drug|0|||
155323371|NCT05424380|560619896|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323372|NCT05424380|560619891|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323373|NCT05424380|560619892|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155501534|NCT00532779|561260864|FG002|Overall Study|Withdrawal by Subject|90|||
155501535|NCT00532779|561260862|FG000|Overall Study|Lack of Efficacy|12|||
155501536|NCT00532779|561260863|FG001|Overall Study|Lack of Efficacy|12|||
155644378|NCT05206604|561788262|FG002|Overall Study|Non-compliance with study drug|0|||
155644379|NCT05206604|561788263|FG003|Overall Study|Non-compliance with study drug|0|||
155644380|NCT05206604|561788264|FG004|Overall Study|Non-compliance with study drug|0|||
155644381|NCT05206604|561788265|FG005|Overall Study|Non-compliance with study drug|1|||
155644382|NCT05206604|561788266|FG006|Overall Study|Non-compliance with study drug|0|||
155644383|NCT05206604|561788267|FG007|Overall Study|Non-compliance with study drug|0|||
155644384|NCT00567580|561788268|FG000|Overall Study|Protocol Violation|28|||
155644385|NCT00567580|561788269|FG001|Overall Study|Protocol Violation|24|||
155644386|NCT00567580|561788270|FG002|Overall Study|Protocol Violation|24|||
155644387|NCT04289298|561788273|FG000|Overall Study|Lost to Follow-up|5|||
155644388|NCT04289298|561788274|FG001|Overall Study|Lost to Follow-up|0|||
155501537|NCT00532779|561260864|FG002|Overall Study|Lack of Efficacy|40|||
155501538|NCT00532779|561260862|FG000|Overall Study|Protocol Violation|5|||
155501539|NCT00532779|561260863|FG001|Overall Study|Protocol Violation|9|||
155501540|NCT00532779|561260864|FG002|Overall Study|Protocol Violation|7|||
155323374|NCT05424380|560619893|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323375|NCT05424380|560619894|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323376|NCT05424380|560619895|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
155323377|NCT05424380|560619896|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323378|NCT05424380|560619891|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323379|NCT05424380|560619892|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155420883|NCT01097629|560972444|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
155420884|NCT01097629|560972445|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
155420885|NCT01097629|560972446|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
155420886|NCT01097629|560972447|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155420887|NCT01097629|560972448|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155420888|NCT01097629|560972449|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155420889|NCT01097629|560972450|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155420890|NCT01097629|560972451|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155420891|NCT01097629|560972444|FG000|DB RO Phase|Withdrawal by Subject|0|||
155420892|NCT01097629|560972445|FG001|DB RO Phase|Withdrawal by Subject|0|||
155420893|NCT01097629|560972446|FG002|DB RO Phase|Withdrawal by Subject|0|||
155420894|NCT01097629|560972447|FG003|DB RO Phase|Withdrawal by Subject|0|||
155420895|NCT01097629|560972448|FG004|DB RO Phase|Withdrawal by Subject|0|||
155420896|NCT01097629|560972449|FG005|DB RO Phase|Withdrawal by Subject|0|||
155420897|NCT01097629|560972450|FG006|DB RO Phase|Withdrawal by Subject|0|||
155420898|NCT01097629|560972451|FG007|DB RO Phase|Withdrawal by Subject|1|||
155420899|NCT01097629|560972444|FG000|DB RO Phase|Protocol Violation|0|||
155420900|NCT01097629|560972445|FG001|DB RO Phase|Protocol Violation|0|||
155420901|NCT01097629|560972446|FG002|DB RO Phase|Protocol Violation|0|||
155420902|NCT01097629|560972447|FG003|DB RO Phase|Protocol Violation|1|||
155420903|NCT01097629|560972448|FG004|DB RO Phase|Protocol Violation|0|||
155420904|NCT01097629|560972449|FG005|DB RO Phase|Protocol Violation|1|||
155420905|NCT01097629|560972450|FG006|DB RO Phase|Protocol Violation|1|||
155420906|NCT01097629|560972451|FG007|DB RO Phase|Protocol Violation|0|||
155420907|NCT01097629|560972444|FG000|DB RO Phase|Lost to Follow-up|0|||
155420908|NCT01097629|560972445|FG001|DB RO Phase|Lost to Follow-up|0|||
155420909|NCT01097629|560972446|FG002|DB RO Phase|Lost to Follow-up|0|||
155420910|NCT01097629|560972447|FG003|DB RO Phase|Lost to Follow-up|0|||
155420911|NCT01097629|560972448|FG004|DB RO Phase|Lost to Follow-up|0|||
155420912|NCT01097629|560972449|FG005|DB RO Phase|Lost to Follow-up|0|||
155420913|NCT01097629|560972450|FG006|DB RO Phase|Lost to Follow-up|2|||
155420914|NCT01097629|560972451|FG007|DB RO Phase|Lost to Follow-up|0|||
155420915|NCT00956943|560972452|FG000|Overall Study|Lost to Follow-up|9|||
155420916|NCT00956943|560972453|FG001|Overall Study|Lost to Follow-up|10|||
155420917|NCT02663895|560972454|FG000|Overall Study|Adverse Event|3|||
155420918|NCT02663895|560972454|FG000|Overall Study|Physician Decision|2|||
155420919|NCT02663895|560972454|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
155420920|NCT02663895|560972454|FG000|Overall Study|Withdrawal by Subject|1|||
155420921|NCT01793792|560972455|FG000|Overall Study|Death|5|||
155420922|NCT01793792|560972455|FG000|Overall Study|Lost to Follow-up|5|||
155420923|NCT01793792|560972455|FG000|Overall Study|Withdrawal by Subject|1|||
155420924|NCT01793792|560972455|FG000|Overall Study|Device Not Implanted|1|||
155420925|NCT00851903|560972458|FG000|Overall Study|Withdrawal by Subject|2|||
155420926|NCT01070329|560972459|FG000|Overall Study|Adverse Event|13|||
155420927|NCT01070329|560972460|FG001|Overall Study|Adverse Event|10|||
155420928|NCT01070329|560972459|FG000|Overall Study|Lost to Follow-up|22|||
155420929|NCT01070329|560972460|FG001|Overall Study|Lost to Follow-up|12|||
155420930|NCT01070329|560972459|FG000|Overall Study|Withdrawal by Subject|9|||
155420931|NCT01070329|560972460|FG001|Overall Study|Withdrawal by Subject|11|||
155420932|NCT01070329|560972459|FG000|Overall Study|Protocol Violation|3|||
155420933|NCT01070329|560972460|FG001|Overall Study|Protocol Violation|8|||
155420934|NCT01070329|560972459|FG000|Overall Study|Lack of Efficacy|2|||
155420935|NCT01070329|560972460|FG001|Overall Study|Lack of Efficacy|6|||
155420936|NCT01070329|560972459|FG000|Overall Study|Physician Decision|2|||
155420937|NCT01070329|560972460|FG001|Overall Study|Physician Decision|1|||
155420938|NCT01070329|560972459|FG000|Overall Study|Entry Criteria Not Met|1|||
155420939|NCT01070329|560972460|FG001|Overall Study|Entry Criteria Not Met|0|||
155323380|NCT05424380|560619893|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155420940|NCT01070329|560972459|FG000|Overall Study|Sponsor Decision|0|||
155420941|NCT01070329|560972460|FG001|Overall Study|Sponsor Decision|1|||
155420942|NCT02863848|560972461|FG000|Overall Study|Lost to Follow-up|1|||
155420943|NCT02863848|560972462|FG001|Overall Study|Lost to Follow-up|1|||
155420944|NCT02863848|560972461|FG000|Overall Study|Protocol Violation|1|||
155420945|NCT02863848|560972462|FG001|Overall Study|Protocol Violation|2|||
155420946|NCT06441877|560972463|FG000|Overall Study|Withdrawal by Subject|0|||
155323381|NCT05424380|560619894|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323382|NCT05424380|560619895|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
155420947|NCT06441877|560972464|FG001|Overall Study|Withdrawal by Subject|2|||
155420948|NCT06441877|560972465|FG002|Overall Study|Withdrawal by Subject|0|||
155323383|NCT05424380|560619896|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323384|NCT02473445|560619901|FG000|Overall Study|Withdrawal by Subject|2|||
155323385|NCT02473445|560619901|FG000|Overall Study|Sponsor Decision|20|||
155323386|NCT04247802|560619902|FG000|Overall Study|Withdrawal by Subject|1|||
155323387|NCT04247802|560619903|FG001|Overall Study|Withdrawal by Subject|3|||
155323388|NCT04247802|560619902|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
155323389|NCT04247802|560619903|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
155323390|NCT04778410|560619908|FG000|Safety Run-in Period|Death|5|||
155420949|NCT06441877|560972466|FG003|Overall Study|Withdrawal by Subject|0|||
155420950|NCT03980938|560972467|FG000|Treatment Period 1|Study Terminated|1|||
155420951|NCT03980938|560972468|FG001|Treatment Period 1|Study Terminated|1|||
155323391|NCT04778410|560619909|FG001|Safety Run-in Period|Death|6|||
155323392|NCT04778410|560619910|FG002|Safety Run-in Period|Death|0|||
155323393|NCT04778410|560619911|FG003|Safety Run-in Period|Death|0|||
155323394|NCT04778410|560619912|FG004|Safety Run-in Period|Death|0|||
155323395|NCT04778410|560619913|FG005|Safety Run-in Period|Death|0|||
155323396|NCT04778410|560619908|FG000|Phase 2 Period|Death|0|||
155323397|NCT04778410|560619909|FG001|Phase 2 Period|Death|0|||
155323398|NCT04778410|560619910|FG002|Phase 2 Period|Death|0|||
155323399|NCT04778410|560619911|FG003|Phase 2 Period|Death|5|||
155323400|NCT04778410|560619912|FG004|Phase 2 Period|Death|18|||
155323401|NCT04778410|560619913|FG005|Phase 2 Period|Death|0|||
155323402|NCT04778410|560619908|FG000|Phase 2 Period|Lost to Follow-up|0|||
155323403|NCT04778410|560619909|FG001|Phase 2 Period|Lost to Follow-up|0|||
155323404|NCT04778410|560619910|FG002|Phase 2 Period|Lost to Follow-up|0|||
155323405|NCT04778410|560619911|FG003|Phase 2 Period|Lost to Follow-up|1|||
155323406|NCT04778410|560619912|FG004|Phase 2 Period|Lost to Follow-up|1|||
155323407|NCT04778410|560619913|FG005|Phase 2 Period|Lost to Follow-up|0|||
155323408|NCT04778410|560619908|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
155323409|NCT04778410|560619909|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
155323410|NCT04778410|560619910|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
155323411|NCT04778410|560619911|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
155323412|NCT04778410|560619912|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
155323413|NCT04778410|560619913|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
155323414|NCT04778410|560619908|FG000|Phase 2 Period|Withdrew Consent|0|||
155323415|NCT04778410|560619909|FG001|Phase 2 Period|Withdrew Consent|0|||
155323416|NCT04778410|560619910|FG002|Phase 2 Period|Withdrew Consent|0|||
155323417|NCT04778410|560619911|FG003|Phase 2 Period|Withdrew Consent|0|||
155323418|NCT04778410|560619912|FG004|Phase 2 Period|Withdrew Consent|2|||
155323419|NCT04778410|560619913|FG005|Phase 2 Period|Withdrew Consent|0|||
155323420|NCT05422885|560619918|FG000|Overall Study|Lost to Follow-up|1|||
155323421|NCT05422885|560619918|FG000|Overall Study|Withdrawal by Subject|2|||
155323422|NCT03691298|560619921|FG000|Overall Study|Lost to Follow-up|8|||
155323423|NCT03691298|560619921|FG000|Overall Study|Sponsor terminated study|2|||
155323424|NCT04214834|560619928|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
155323425|NCT04214834|560619929|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
155323426|NCT04924400|560619930|FG000|Overall Study|Lost to Follow-up|3|||
155323427|NCT04924400|560619931|FG001|Overall Study|Lost to Follow-up|0|||
155323428|NCT04424316|560619932|FG000|Overall Study|Adverse Event|0|||
155323429|NCT04424316|560619933|FG001|Overall Study|Adverse Event|1|||
155323430|NCT04424316|560619934|FG002|Overall Study|Adverse Event|0|||
155323431|NCT04424316|560619935|FG003|Overall Study|Adverse Event|0|||
155323432|NCT04424316|560619932|FG000|Overall Study|Death|1|||
155323433|NCT04424316|560619933|FG001|Overall Study|Death|0|||
155323434|NCT04424316|560619934|FG002|Overall Study|Death|8|||
155323435|NCT04424316|560619935|FG003|Overall Study|Death|14|||
155323436|NCT04424316|560619932|FG000|Overall Study|Lost to Follow-up|93|||
155323437|NCT04424316|560619933|FG001|Overall Study|Lost to Follow-up|88|||
155323438|NCT04424316|560619934|FG002|Overall Study|Lost to Follow-up|224|||
155323439|NCT04424316|560619935|FG003|Overall Study|Lost to Follow-up|211|||
155323440|NCT04424316|560619932|FG000|Overall Study|No longer met eligibility criteria|1|||
155323441|NCT04424316|560619933|FG001|Overall Study|No longer met eligibility criteria|0|||
155323442|NCT04424316|560619934|FG002|Overall Study|No longer met eligibility criteria|0|||
155323443|NCT04424316|560619935|FG003|Overall Study|No longer met eligibility criteria|0|||
155323444|NCT04424316|560619932|FG000|Overall Study|Other|15|||
155323445|NCT04424316|560619933|FG001|Overall Study|Other|11|||
155323446|NCT04424316|560619934|FG002|Overall Study|Other|34|||
155323447|NCT04424316|560619935|FG003|Overall Study|Other|45|||
155323448|NCT04424316|560619932|FG000|Overall Study|Physician Decision|1|||
155323449|NCT04424316|560619933|FG001|Overall Study|Physician Decision|0|||
155323450|NCT04424316|560619934|FG002|Overall Study|Physician Decision|1|||
155323451|NCT04424316|560619935|FG003|Overall Study|Physician Decision|1|||
155323452|NCT04424316|560619932|FG000|Overall Study|Protocol Violation|0|||
155323453|NCT04424316|560619933|FG001|Overall Study|Protocol Violation|1|||
155323454|NCT04424316|560619934|FG002|Overall Study|Protocol Violation|0|||
155323455|NCT04424316|560619935|FG003|Overall Study|Protocol Violation|0|||
155323456|NCT04424316|560619932|FG000|Overall Study|Withdrawal by Subject|71|||
155323457|NCT04424316|560619933|FG001|Overall Study|Withdrawal by Subject|77|||
155323458|NCT04424316|560619934|FG002|Overall Study|Withdrawal by Subject|0|||
155323459|NCT04424316|560619935|FG003|Overall Study|Withdrawal by Subject|0|||
155323460|NCT04424316|560619932|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155323461|NCT04424316|560619933|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155323462|NCT04424316|560619934|FG002|Overall Study|Withdrawal by parent/guardian|74|||
155323463|NCT04424316|560619935|FG003|Overall Study|Withdrawal by parent/guardian|81|||
155323464|NCT04424316|560619932|FG000|Overall Study|Randomized but not vaccinated|13|||
155501541|NCT00532779|561260862|FG000|Overall Study|Pregnancy|2|||
155323465|NCT04424316|560619933|FG001|Overall Study|Randomized but not vaccinated|21|||
155323466|NCT04424316|560619934|FG002|Overall Study|Randomized but not vaccinated|0|||
155323467|NCT04424316|560619935|FG003|Overall Study|Randomized but not vaccinated|0|||
155323468|NCT04424316|560619932|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
155323469|NCT04424316|560619933|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
155323470|NCT04424316|560619934|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
155323471|NCT04424316|560619935|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
155501542|NCT00532779|561260863|FG001|Overall Study|Pregnancy|5|||
155501543|NCT00532779|561260864|FG002|Overall Study|Pregnancy|3|||
155501544|NCT00532779|561260862|FG000|Overall Study|Death|0|||
155501545|NCT00532779|561260863|FG001|Overall Study|Death|1|||
155501546|NCT00532779|561260864|FG002|Overall Study|Death|0|||
155501547|NCT00532779|561260862|FG000|Overall Study|Drug noncompliance, moved, other|14|||
155501548|NCT00532779|561260863|FG001|Overall Study|Drug noncompliance, moved, other|23|||
155501549|NCT00532779|561260864|FG002|Overall Study|Drug noncompliance, moved, other|29|||
155501550|NCT02662556|561260865|FG000|Overall Study|Adverse Event|4|||
155501551|NCT02662556|561260865|FG000|Overall Study|Lack of Efficacy|4|||
155501552|NCT00828516|561260874|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
155501553|NCT00689273|561260875|FG000|Overall Study|Adverse Event|3|||
155501554|NCT00689273|561260876|FG001|Overall Study|Adverse Event|1|||
155501555|NCT00689273|561260875|FG000|Overall Study|Lack of Efficacy|3|||
155501556|NCT00689273|561260876|FG001|Overall Study|Lack of Efficacy|0|||
155501557|NCT00689273|561260875|FG000|Overall Study|Lost to Follow-up|0|||
155501558|NCT00689273|561260876|FG001|Overall Study|Lost to Follow-up|2|||
155501559|NCT00689273|561260875|FG000|Overall Study|Other|6|||
155501560|NCT00689273|561260876|FG001|Overall Study|Other|2|||
155501561|NCT00689273|561260875|FG000|Overall Study|Randomized but not Treated|1|||
155501562|NCT00689273|561260876|FG001|Overall Study|Randomized but not Treated|0|||
155501563|NCT02787746|561260881|FG000|Overall Study|Adverse Event|42|||
155501564|NCT02787746|561260881|FG000|Overall Study|Withdrawal by Subject|65|||
155501565|NCT02787746|561260881|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
155501566|NCT03703297|561260886|FG000|Overall Study|Death|115|||
155501567|NCT03703297|561260887|FG001|Overall Study|Death|0|||
155323472|NCT04633538|560619936|FG000|Overall Study|Death|1|||
155323473|NCT04633538|560619936|FG000|Overall Study|Lost to Follow-up|3|||
155323474|NCT04633538|560619936|FG000|Overall Study|Withdrawal by Subject|1|||
155501568|NCT03703297|561260888|FG002|Overall Study|Death|144|||
155501569|NCT03703297|561260886|FG000|Overall Study|Withdrawal by Subject|9|||
155501570|NCT03703297|561260887|FG001|Overall Study|Withdrawal by Subject|0|||
155501571|NCT03703297|561260888|FG002|Overall Study|Withdrawal by Subject|11|||
155501572|NCT03703297|561260886|FG000|Overall Study|Ongoing at the time of DCO|140|||
155501573|NCT03703297|561260887|FG001|Overall Study|Ongoing at the time of DCO|200|||
155501574|NCT03703297|561260888|FG002|Overall Study|Ongoing at the time of DCO|111|||
155501575|NCT01142466|561263291|FG000|Overall Study|Adverse Event|2|||
155501576|NCT01142466|561263292|FG001|Overall Study|Adverse Event|1|||
155501577|NCT01142466|561263291|FG000|Overall Study|Withdrawal by Subject|1|||
155501578|NCT01142466|561263292|FG001|Overall Study|Withdrawal by Subject|1|||
155420952|NCT03980938|560972467|FG000|Treatment Period 2|Study Terminated|2|||
155420953|NCT03980938|560972468|FG001|Treatment Period 2|Study Terminated|2|||
155420954|NCT03706365|560972469|FG000|Overall Study|Lost to Follow-up|7|||
155420955|NCT03706365|560972470|FG001|Overall Study|Lost to Follow-up|0|||
155420956|NCT03706365|560972469|FG000|Overall Study|Withdrawal by Subject|17|||
155420957|NCT03706365|560972470|FG001|Overall Study|Withdrawal by Subject|15|||
155420958|NCT03706365|560972469|FG000|Overall Study|On Study Treatment|51|||
155420959|NCT03706365|560972470|FG001|Overall Study|On Study Treatment|51|||
155420960|NCT03116113|560972471|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420961|NCT03116113|560972472|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420962|NCT03116113|560972473|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420963|NCT03116113|560972474|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420964|NCT03116113|560972475|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420965|NCT03116113|560972476|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420966|NCT03116113|560972477|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
155420967|NCT03116113|560972478|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
155420968|NCT03116113|560972479|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
155420969|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155420970|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
155420971|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155420972|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155420973|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155420974|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
155420975|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
155420976|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
155420977|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
155420978|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
155420979|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
155420980|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
155420981|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155420982|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
155420983|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
155420984|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
155420985|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
155420986|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
155420987|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
155420988|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
155420989|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155420990|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155420991|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155420992|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
155420993|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155420994|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
155420995|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
155420996|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
155420997|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
155420998|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
155420999|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
155421000|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
155421001|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
155421002|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
155421003|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
155421004|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
155421005|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
155421006|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
155421007|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
155421008|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
155421009|NCT00289913|560972482|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
155421010|NCT00289913|560972483|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421011|NCT00289913|560972484|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
155421012|NCT00289913|560972485|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155323475|NCT05070741|560619937|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
155323476|NCT03245840|560619938|FG000|Overall Study|Adverse Event|6|||
155323477|NCT03245840|560619939|FG001|Overall Study|Adverse Event|0|||
155323478|NCT03245840|560619938|FG000|Overall Study|Death|2|||
155323479|NCT03245840|560619939|FG001|Overall Study|Death|0|||
155323480|NCT03245840|560619938|FG000|Overall Study|Withdrawal by Subject|31|||
155323481|NCT03245840|560619939|FG001|Overall Study|Withdrawal by Subject|1|||
155323482|NCT03245840|560619938|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155323483|NCT03245840|560619939|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155323484|NCT03245840|560619938|FG000|Overall Study|Physician Decision|4|||
155323485|NCT03245840|560619939|FG001|Overall Study|Physician Decision|1|||
155323486|NCT03245840|560619938|FG000|Overall Study|Study Terminated by Sponsor|56|||
155323487|NCT03245840|560619939|FG001|Overall Study|Study Terminated by Sponsor|6|||
155323488|NCT03245840|560619938|FG000|Overall Study|Site Terminated by Sponsor|4|||
155323489|NCT03245840|560619939|FG001|Overall Study|Site Terminated by Sponsor|0|||
155323490|NCT03245840|560619938|FG000|Overall Study|Lost to Follow-up|12|||
155323491|NCT03245840|560619939|FG001|Overall Study|Lost to Follow-up|2|||
155323492|NCT03245840|560619938|FG000|Overall Study|Pregnancy|2|||
155323493|NCT03245840|560619939|FG001|Overall Study|Pregnancy|0|||
155323494|NCT03245840|560619938|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155323495|NCT03245840|560619939|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155323496|NCT03245840|560619938|FG000|Overall Study|Not treated|1|||
155323497|NCT03245840|560619939|FG001|Overall Study|Not treated|1|||
155323498|NCT03582033|560619946|FG000|Part A|Other|0|||
155323499|NCT03582033|560619947|FG001|Part A|Other|0|||
155323500|NCT03582033|560619948|FG002|Part A|Other|0|||
155323501|NCT03582033|560619949|FG003|Part A|Other|0|||
155323502|NCT03582033|560619950|FG004|Part A|Other|2|||
155323503|NCT03582033|560619951|FG005|Part A|Other|0|||
155323504|NCT03582033|560619952|FG006|Part A|Other|0|||
155323505|NCT03582033|560619953|FG007|Part A|Other|0|||
155323506|NCT03582033|560619954|FG008|Part A|Other|0|||
155323507|NCT03582033|560619955|FG009|Part A|Other|0|||
155323508|NCT03582033|560619946|FG000|Part A|Death|1|||
155323509|NCT03582033|560619947|FG001|Part A|Death|1|||
155323510|NCT03582033|560619948|FG002|Part A|Death|2|||
155323511|NCT03582033|560619949|FG003|Part A|Death|4|||
155323512|NCT03582033|560619950|FG004|Part A|Death|11|||
155323513|NCT03582033|560619951|FG005|Part A|Death|0|||
155323514|NCT03582033|560619952|FG006|Part A|Death|0|||
155323515|NCT03582033|560619953|FG007|Part A|Death|0|||
155323516|NCT03582033|560619954|FG008|Part A|Death|0|||
155323517|NCT03582033|560619955|FG009|Part A|Death|0|||
155323518|NCT03582033|560619946|FG000|Part A|Lost to Follow-up|0|||
155323519|NCT03582033|560619947|FG001|Part A|Lost to Follow-up|0|||
155323520|NCT03582033|560619948|FG002|Part A|Lost to Follow-up|0|||
155323521|NCT03582033|560619949|FG003|Part A|Lost to Follow-up|0|||
155323522|NCT03582033|560619950|FG004|Part A|Lost to Follow-up|1|||
155323523|NCT03582033|560619951|FG005|Part A|Lost to Follow-up|0|||
155323524|NCT03582033|560619952|FG006|Part A|Lost to Follow-up|0|||
155323525|NCT03582033|560619953|FG007|Part A|Lost to Follow-up|0|||
155323526|NCT03582033|560619954|FG008|Part A|Lost to Follow-up|0|||
155323527|NCT03582033|560619955|FG009|Part A|Lost to Follow-up|0|||
155323528|NCT03582033|560619946|FG000|Part A|Study terminated by sponsor|0|||
155323529|NCT03582033|560619947|FG001|Part A|Study terminated by sponsor|0|||
155323530|NCT03582033|560619948|FG002|Part A|Study terminated by sponsor|0|||
155323531|NCT03582033|560619949|FG003|Part A|Study terminated by sponsor|2|||
155323532|NCT03582033|560619950|FG004|Part A|Study terminated by sponsor|1|||
155323533|NCT03582033|560619951|FG005|Part A|Study terminated by sponsor|0|||
155323534|NCT03582033|560619952|FG006|Part A|Study terminated by sponsor|0|||
155323535|NCT03582033|560619953|FG007|Part A|Study terminated by sponsor|0|||
155323536|NCT03582033|560619954|FG008|Part A|Study terminated by sponsor|0|||
155323537|NCT03582033|560619955|FG009|Part A|Study terminated by sponsor|0|||
155323538|NCT03582033|560619946|FG000|Part A|Withdrawal by Subject|1|||
155323539|NCT03582033|560619947|FG001|Part A|Withdrawal by Subject|1|||
155323540|NCT03582033|560619948|FG002|Part A|Withdrawal by Subject|0|||
155323541|NCT03582033|560619949|FG003|Part A|Withdrawal by Subject|1|||
155323542|NCT03582033|560619950|FG004|Part A|Withdrawal by Subject|7|||
155323543|NCT03582033|560619951|FG005|Part A|Withdrawal by Subject|0|||
155323544|NCT03582033|560619952|FG006|Part A|Withdrawal by Subject|0|||
155323545|NCT03582033|560619953|FG007|Part A|Withdrawal by Subject|0|||
155323546|NCT03582033|560619954|FG008|Part A|Withdrawal by Subject|0|||
155323547|NCT03582033|560619955|FG009|Part A|Withdrawal by Subject|0|||
155323548|NCT03582033|560619946|FG000|Part B|Death|0|||
155323549|NCT03582033|560619947|FG001|Part B|Death|0|||
155323550|NCT03582033|560619948|FG002|Part B|Death|0|||
155323551|NCT03582033|560619949|FG003|Part B|Death|0|||
155323552|NCT03582033|560619950|FG004|Part B|Death|0|||
155323553|NCT03582033|560619951|FG005|Part B|Death|2|||
155323554|NCT03582033|560619952|FG006|Part B|Death|0|||
155323555|NCT03582033|560619953|FG007|Part B|Death|0|||
155323556|NCT03582033|560619954|FG008|Part B|Death|0|||
155323557|NCT03582033|560619955|FG009|Part B|Death|0|||
155501579|NCT00700310|561263297|FG000|Overall Study|Adverse Event|6|||
155501580|NCT00700310|561263298|FG001|Overall Study|Adverse Event|10|||
155501581|NCT00700310|561263299|FG002|Overall Study|Adverse Event|5|||
155501582|NCT00700310|561263300|FG003|Overall Study|Adverse Event|11|||
155501583|NCT00700310|561263297|FG000|Overall Study|Lost to Follow-up|4|||
155501584|NCT00700310|561263298|FG001|Overall Study|Lost to Follow-up|1|||
155501585|NCT00700310|561263299|FG002|Overall Study|Lost to Follow-up|0|||
155501586|NCT00700310|561263300|FG003|Overall Study|Lost to Follow-up|1|||
155501587|NCT00700310|561263297|FG000|Overall Study|Withdrawal by Subject|8|||
155501588|NCT00700310|561263298|FG001|Overall Study|Withdrawal by Subject|9|||
155501589|NCT00700310|561263299|FG002|Overall Study|Withdrawal by Subject|8|||
155501590|NCT00700310|561263300|FG003|Overall Study|Withdrawal by Subject|8|||
155501591|NCT00700310|561263297|FG000|Overall Study|Lack of Efficacy|0|||
155323558|NCT03582033|560619946|FG000|Part B|Study terminated by sponsor|0|||
155323559|NCT03582033|560619947|FG001|Part B|Study terminated by sponsor|0|||
155323560|NCT03582033|560619948|FG002|Part B|Study terminated by sponsor|0|||
155323561|NCT03582033|560619949|FG003|Part B|Study terminated by sponsor|0|||
155323562|NCT03582033|560619950|FG004|Part B|Study terminated by sponsor|0|||
155323563|NCT03582033|560619951|FG005|Part B|Study terminated by sponsor|12|||
155323564|NCT03582033|560619952|FG006|Part B|Study terminated by sponsor|0|||
155323565|NCT03582033|560619953|FG007|Part B|Study terminated by sponsor|0|||
155323566|NCT03582033|560619954|FG008|Part B|Study terminated by sponsor|0|||
155323567|NCT03582033|560619955|FG009|Part B|Study terminated by sponsor|0|||
155323568|NCT03582033|560619946|FG000|Part B|Withdrawal by Subject|0|||
155323569|NCT03582033|560619947|FG001|Part B|Withdrawal by Subject|0|||
155323570|NCT03582033|560619948|FG002|Part B|Withdrawal by Subject|0|||
155323571|NCT03582033|560619949|FG003|Part B|Withdrawal by Subject|0|||
155323572|NCT03582033|560619950|FG004|Part B|Withdrawal by Subject|0|||
155323573|NCT03582033|560619951|FG005|Part B|Withdrawal by Subject|6|||
155323574|NCT03582033|560619952|FG006|Part B|Withdrawal by Subject|0|||
155323575|NCT03582033|560619953|FG007|Part B|Withdrawal by Subject|0|||
155323576|NCT03582033|560619954|FG008|Part B|Withdrawal by Subject|0|||
155323577|NCT03582033|560619955|FG009|Part B|Withdrawal by Subject|0|||
155323578|NCT03582033|560619946|FG000|Part C|Other|0|||
155323579|NCT03582033|560619947|FG001|Part C|Other|0|||
155323580|NCT03582033|560619948|FG002|Part C|Other|0|||
155323581|NCT03582033|560619949|FG003|Part C|Other|0|||
155323582|NCT03582033|560619950|FG004|Part C|Other|0|||
155323583|NCT03582033|560619951|FG005|Part C|Other|0|||
155323584|NCT03582033|560619952|FG006|Part C|Other|2|||
155323585|NCT03582033|560619953|FG007|Part C|Other|0|||
155323586|NCT03582033|560619954|FG008|Part C|Other|0|||
155323587|NCT03582033|560619955|FG009|Part C|Other|0|||
155323588|NCT03582033|560619946|FG000|Part C|Death|0|||
155323589|NCT03582033|560619947|FG001|Part C|Death|0|||
155421013|NCT00289913|560972486|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421014|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421015|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421016|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
155421017|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421018|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421019|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
155421020|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
155421021|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
155421022|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
155421023|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
155421024|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
155421025|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
155501592|NCT00700310|561263298|FG001|Overall Study|Lack of Efficacy|3|||
155501593|NCT00700310|561263299|FG002|Overall Study|Lack of Efficacy|0|||
155501594|NCT00700310|561263300|FG003|Overall Study|Lack of Efficacy|1|||
155501595|NCT00700310|561263297|FG000|Overall Study|Administrative/Other|1|||
155501596|NCT00700310|561263298|FG001|Overall Study|Administrative/Other|3|||
155501597|NCT00700310|561263299|FG002|Overall Study|Administrative/Other|1|||
155501598|NCT00700310|561263300|FG003|Overall Study|Administrative/Other|3|||
155501599|NCT00700310|561263297|FG000|Overall Study|Randomized, Not Treated|2|||
155323590|NCT03582033|560619948|FG002|Part C|Death|0|||
155323591|NCT03582033|560619949|FG003|Part C|Death|0|||
155323592|NCT03582033|560619950|FG004|Part C|Death|0|||
155501600|NCT00700310|561263298|FG001|Overall Study|Randomized, Not Treated|0|||
155323593|NCT03582033|560619951|FG005|Part C|Death|0|||
155323594|NCT03582033|560619952|FG006|Part C|Death|6|||
155323595|NCT03582033|560619953|FG007|Part C|Death|1|||
155323596|NCT03582033|560619954|FG008|Part C|Death|2|||
155323597|NCT03582033|560619955|FG009|Part C|Death|0|||
155323598|NCT03582033|560619946|FG000|Part C|Study terminated by sponsor|0|||
155323599|NCT03582033|560619947|FG001|Part C|Study terminated by sponsor|0|||
155323600|NCT03582033|560619948|FG002|Part C|Study terminated by sponsor|0|||
155644389|NCT04289298|561788273|FG000|Overall Study|Withdrawal by Subject|2|||
155644390|NCT04289298|561788274|FG001|Overall Study|Withdrawal by Subject|0|||
155644391|NCT01778985|561788275|FG000|Overall Study|Lost to Follow-up|1|||
155644392|NCT01778985|561788276|FG001|Overall Study|Lost to Follow-up|0|||
155644393|NCT01778985|561788275|FG000|Overall Study|Physician Decision|2|||
155644394|NCT01778985|561788276|FG001|Overall Study|Physician Decision|2|||
155644395|NCT01778985|561788275|FG000|Overall Study|Protocol Violation|4|||
155644396|NCT01778985|561788276|FG001|Overall Study|Protocol Violation|1|||
155644397|NCT00504231|561788278|FG000|Overall Study|Discrepant chart documentation re route|0|||
155644398|NCT00504231|561788279|FG001|Overall Study|Discrepant chart documentation re route|0|||
155644399|NCT00504231|561788280|FG002|Overall Study|Discrepant chart documentation re route|1|||
155644400|NCT00504231|561788281|FG003|Overall Study|Discrepant chart documentation re route|0|||
155644401|NCT01629563|561788282|FG000|Overall Study|Adverse Event|16|||
155644402|NCT01629563|561788283|FG001|Overall Study|Adverse Event|16|||
155323601|NCT03582033|560619949|FG003|Part C|Study terminated by sponsor|0|||
155323602|NCT03582033|560619950|FG004|Part C|Study terminated by sponsor|0|||
155323603|NCT03582033|560619951|FG005|Part C|Study terminated by sponsor|0|||
155323604|NCT03582033|560619952|FG006|Part C|Study terminated by sponsor|3|||
155323605|NCT03582033|560619953|FG007|Part C|Study terminated by sponsor|3|||
155323606|NCT03582033|560619954|FG008|Part C|Study terminated by sponsor|2|||
155323607|NCT03582033|560619955|FG009|Part C|Study terminated by sponsor|0|||
155323608|NCT03582033|560619946|FG000|Part C|Withdrawal by Subject|0|||
155323609|NCT03582033|560619947|FG001|Part C|Withdrawal by Subject|0|||
155323610|NCT03582033|560619948|FG002|Part C|Withdrawal by Subject|0|||
155323611|NCT03582033|560619949|FG003|Part C|Withdrawal by Subject|0|||
155323612|NCT03582033|560619950|FG004|Part C|Withdrawal by Subject|0|||
155323613|NCT03582033|560619951|FG005|Part C|Withdrawal by Subject|0|||
155323614|NCT03582033|560619952|FG006|Part C|Withdrawal by Subject|1|||
155323615|NCT03582033|560619953|FG007|Part C|Withdrawal by Subject|2|||
155323616|NCT03582033|560619954|FG008|Part C|Withdrawal by Subject|1|||
155323617|NCT03582033|560619955|FG009|Part C|Withdrawal by Subject|0|||
155323618|NCT03582033|560619946|FG000|Part D|Death|0|||
155323619|NCT03582033|560619947|FG001|Part D|Death|0|||
155323620|NCT03582033|560619948|FG002|Part D|Death|0|||
155323621|NCT03582033|560619949|FG003|Part D|Death|0|||
155323622|NCT03582033|560619950|FG004|Part D|Death|0|||
155323623|NCT03582033|560619951|FG005|Part D|Death|0|||
155323624|NCT03582033|560619952|FG006|Part D|Death|0|||
155323625|NCT03582033|560619953|FG007|Part D|Death|0|||
155323626|NCT03582033|560619954|FG008|Part D|Death|0|||
155323627|NCT03582033|560619955|FG009|Part D|Death|1|||
155323628|NCT03582033|560619946|FG000|Part D|Study terminated by sponsor|0|||
155323629|NCT03582033|560619947|FG001|Part D|Study terminated by sponsor|0|||
155323630|NCT03582033|560619948|FG002|Part D|Study terminated by sponsor|0|||
155323631|NCT03582033|560619949|FG003|Part D|Study terminated by sponsor|0|||
155323632|NCT03582033|560619950|FG004|Part D|Study terminated by sponsor|0|||
155323633|NCT03582033|560619951|FG005|Part D|Study terminated by sponsor|0|||
155323634|NCT03582033|560619952|FG006|Part D|Study terminated by sponsor|0|||
155323635|NCT03582033|560619953|FG007|Part D|Study terminated by sponsor|0|||
155323636|NCT03582033|560619954|FG008|Part D|Study terminated by sponsor|0|||
155323637|NCT03582033|560619955|FG009|Part D|Study terminated by sponsor|4|||
155323638|NCT05741294|560619956|FG000|Overall Study|Lost to Follow-up|3|||
155323639|NCT05741294|560619956|FG000|Overall Study|Protocol deviation|3|||
155323640|NCT05741294|560619956|FG000|Overall Study|Withdrawal by Subject|1|||
155323641|NCT04707768|560619967|FG000|Overall Study|Adverse Event|9|||
155323642|NCT04707768|560619968|FG001|Overall Study|Adverse Event|18|||
155323643|NCT04707768|560619969|FG002|Overall Study|Adverse Event|3|||
155323644|NCT04707768|560619967|FG000|Overall Study|Investigator's Discretion|8|||
155323645|NCT04707768|560619968|FG001|Overall Study|Investigator's Discretion|4|||
155323646|NCT04707768|560619969|FG002|Overall Study|Investigator's Discretion|3|||
155323647|NCT04707768|560619967|FG000|Overall Study|Withdrawal by Subject|6|||
155323648|NCT04707768|560619968|FG001|Overall Study|Withdrawal by Subject|8|||
155323649|NCT04707768|560619969|FG002|Overall Study|Withdrawal by Subject|2|||
155323650|NCT04707768|560619967|FG000|Overall Study|Lack of Efficacy|1|||
155323651|NCT04707768|560619968|FG001|Overall Study|Lack of Efficacy|3|||
155323652|NCT04707768|560619969|FG002|Overall Study|Lack of Efficacy|0|||
155323653|NCT04707768|560619967|FG000|Overall Study|Lost to Follow-up|0|||
155323654|NCT04707768|560619968|FG001|Overall Study|Lost to Follow-up|0|||
155323655|NCT04707768|560619969|FG002|Overall Study|Lost to Follow-up|3|||
155323656|NCT04707768|560619967|FG000|Overall Study|Death|13|||
155323657|NCT04707768|560619968|FG001|Overall Study|Death|11|||
155323658|NCT04707768|560619969|FG002|Overall Study|Death|13|||
155323659|NCT04707768|560619967|FG000|Overall Study|Protocol Violation|2|||
155323660|NCT04707768|560619968|FG001|Overall Study|Protocol Violation|1|||
155644403|NCT01629563|561788282|FG000|Overall Study|Death|2|||
155644404|NCT01629563|561788283|FG001|Overall Study|Death|0|||
155323661|NCT04707768|560619969|FG002|Overall Study|Protocol Violation|0|||
155644405|NCT01629563|561788282|FG000|Overall Study|Lack of Efficacy|2|||
155501601|NCT00700310|561263299|FG002|Overall Study|Randomized, Not Treated|2|||
155501602|NCT00700310|561263300|FG003|Overall Study|Randomized, Not Treated|2|||
155501603|NCT02414854|561263301|FG000|Overall Study|Adverse Event|9|||
155501604|NCT02414854|561263302|FG001|Overall Study|Adverse Event|7|||
155501605|NCT02414854|561263303|FG002|Overall Study|Adverse Event|1|||
155501606|NCT02414854|561263304|FG003|Overall Study|Adverse Event|12|||
155501607|NCT02414854|561263301|FG000|Overall Study|Poor compliance to protocol|1|||
155501608|NCT02414854|561263302|FG001|Overall Study|Poor compliance to protocol|1|||
155501609|NCT02414854|561263303|FG002|Overall Study|Poor compliance to protocol|2|||
155323662|NCT04707768|560619967|FG000|Overall Study|Non Compliance with Study Drug|1|||
155501610|NCT02414854|561263304|FG003|Overall Study|Poor compliance to protocol|2|||
155501611|NCT02414854|561263301|FG000|Overall Study|Other than specified above|12|||
155501612|NCT02414854|561263302|FG001|Overall Study|Other than specified above|37|||
155501613|NCT02414854|561263303|FG002|Overall Study|Other than specified above|17|||
155501614|NCT02414854|561263304|FG003|Overall Study|Other than specified above|37|||
155501615|NCT01422720|561263305|FG000|Overall Study|Adverse Event|16|||
155501616|NCT01422720|561263305|FG000|Overall Study|Lack of Efficacy|1|||
155501617|NCT01422720|561263305|FG000|Overall Study|Withdrawal by Subject|4|||
155501618|NCT01422720|561263305|FG000|Overall Study|Ineligibility|1|||
155501619|NCT00606801|561263306|FG000|Intervention|Protocol Violation|3|||
155501620|NCT00606801|561263307|FG001|Intervention|Protocol Violation|3|||
155501621|NCT02082262|561263308|FG000|Overall Study|Withdrawal by Subject|3|||
155501622|NCT02082262|561263308|FG000|Overall Study|Adverse Event|48|||
155501623|NCT01726335|561263309|FG000|Overall Study|Lost to Follow-up|2|||
155501624|NCT01726335|561263309|FG000|Overall Study|Withdrawal by Subject|15|||
155501625|NCT01726335|561263309|FG000|Overall Study|Adverse Event|4|||
155501626|NCT01726335|561263309|FG000|Overall Study|Lost to Follow-up|2|||
155501627|NCT01726335|561263309|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
155501628|NCT02162511|561263316|FG000|Overall Study|Lack of Efficacy|0|||
155501629|NCT02162511|561263317|FG001|Overall Study|Lack of Efficacy|0|||
155501630|NCT02162511|561263318|FG002|Overall Study|Lack of Efficacy|2|||
155501631|NCT02016755|561263322|FG000|Overall Study|Major amputation of index limb|2|||
155501632|NCT02016755|561263322|FG000|Overall Study|Adverse Event|2|||
155501633|NCT02016755|561263322|FG000|Overall Study|Physician Decision|1|||
155501634|NCT02016755|561263322|FG000|Overall Study|Death|2|||
155501635|NCT01084603|561263332|FG000|Baseline|Withdrawal by Subject|2|||
155501636|NCT01084603|561263332|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
155501637|NCT01084603|561263332|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
155501638|NCT01084603|561263332|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
155501639|NCT01084603|561263332|FG000|Washout Period 4|Adverse Event|1|||
155501640|NCT01392170|561263334|FG000|Overall Study|Withdrawal by Subject|1|||
155501641|NCT01392170|561263334|FG000|Overall Study|Ineligible|1|||
155501642|NCT02018042|561263346|FG000|Overall Study|Withdrawal by Subject|1|||
155501643|NCT02419469|561263347|FG000|Overall Study|Withdrawal by Subject|1|||
155501644|NCT01414062|561263348|FG000|Overall Study|Lost to Follow-up|3|||
155501645|NCT01414062|561263349|FG001|Overall Study|Lost to Follow-up|2|||
155323663|NCT04707768|560619968|FG001|Overall Study|Non Compliance with Study Drug|0|||
155323664|NCT04707768|560619969|FG002|Overall Study|Non Compliance with Study Drug|0|||
155323665|NCT04707768|560619967|FG000|Overall Study|Transplant|4|||
155323666|NCT04707768|560619968|FG001|Overall Study|Transplant|4|||
155323667|NCT04707768|560619969|FG002|Overall Study|Transplant|8|||
155323668|NCT04707768|560619967|FG000|Overall Study|Other|9|||
155323669|NCT04707768|560619968|FG001|Overall Study|Other|5|||
155323670|NCT04707768|560619969|FG002|Overall Study|Other|2|||
155323671|NCT02518048|560619970|FG000|Overall Study|Withdrawal by Subject|1|||
155323672|NCT05123027|560619975|FG000|Overall Study|Lost to Follow-up|17|||
155501646|NCT01414062|561263348|FG000|Overall Study|Left Country|1|||
155323673|NCT05123027|560619976|FG001|Overall Study|Lost to Follow-up|22|||
155323674|NCT05123027|560619975|FG000|Overall Study|Incarceration|3|||
155501647|NCT01414062|561263349|FG001|Overall Study|Left Country|1|||
155501648|NCT01414062|561263348|FG000|Overall Study|Family Disapproval|1|||
155501649|NCT01414062|561263349|FG001|Overall Study|Family Disapproval|0|||
155501650|NCT01414062|561263348|FG000|Overall Study|Withdrawal by Subject|0|||
155501651|NCT01414062|561263349|FG001|Overall Study|Withdrawal by Subject|1|||
155501652|NCT04285983|561263350|FG000|Overall Study|Protocol Violation|6|||
155501653|NCT00902265|561263353|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
155501654|NCT00902265|561263353|FG000|Overall Study|Adverse Event|2|||
155501655|NCT00902265|561263353|FG000|Overall Study|Lack of Efficacy|2|||
155501656|NCT00902265|561263353|FG000|Overall Study|Protocol Violation|1|||
155501657|NCT02866695|561263354|FG000|Overall Study|Adverse Event|1|||
155501658|NCT02866695|561263354|FG000|Overall Study|Lost to Follow-up|1|||
155501659|NCT05016765|561263355|FG000|Overall Study|Lost to Follow-up|4|||
155323675|NCT05123027|560619976|FG001|Overall Study|Incarceration|4|||
155323676|NCT05123027|560619975|FG000|Overall Study|Death|2|||
155501660|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
155501661|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
155501662|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
155501663|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
155501664|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
155501665|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
155501666|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
155501667|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
155501668|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
155501669|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
155501670|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
155501671|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
155501672|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
155501673|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
155501674|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
155501675|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
155501676|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
155501677|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
155501678|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
155501679|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
155501680|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
155501681|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
155501682|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
155501683|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
155501684|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
155501685|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
155501686|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
155501687|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
155501688|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
155501689|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
155501690|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
155501691|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
155501692|NCT03747939|561263356|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
155323677|NCT05123027|560619976|FG001|Overall Study|Death|2|||
155323678|NCT05123027|560619975|FG000|Overall Study|Other|2|||
155323679|NCT05123027|560619976|FG001|Overall Study|Other|0|||
155323680|NCT03735979|560619977|FG000|Overall Study|Lost to Follow-up|1|||
155323681|NCT03735979|560619978|FG001|Overall Study|Lost to Follow-up|12|||
155323682|NCT03735979|560619979|FG002|Overall Study|Lost to Follow-up|14|||
155323683|NCT03735979|560619977|FG000|Overall Study|Withdrawal by Subject|1|||
155323684|NCT03735979|560619978|FG001|Overall Study|Withdrawal by Subject|5|||
155323685|NCT03735979|560619979|FG002|Overall Study|Withdrawal by Subject|2|||
155323686|NCT03735979|560619977|FG000|Overall Study|Not due to the above reasons|1|||
155323687|NCT03735979|560619978|FG001|Overall Study|Not due to the above reasons|0|||
155323688|NCT03735979|560619979|FG002|Overall Study|Not due to the above reasons|0|||
155323689|NCT00319111|560619982|FG000|Overall Study|Adverse Event|20|||
155323690|NCT00319111|560619982|FG000|Overall Study|Withdrawal of consent|11|||
155323691|NCT00319111|560619982|FG000|Overall Study|Death|9|||
155323692|NCT00319111|560619982|FG000|Overall Study|Lack of clinical improvement|4|||
155323693|NCT00319111|560619982|FG000|Overall Study|Administrative|2|||
155501693|NCT03747939|561263357|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
155501694|NCT03747939|561263358|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
155501695|NCT03747939|561263359|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
155501696|NCT03747939|561263356|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
155501697|NCT03747939|561263357|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
155501698|NCT03747939|561263358|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
155501699|NCT03747939|561263359|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
155501700|NCT03747939|561263356|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
155501701|NCT03747939|561263357|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
155501702|NCT03747939|561263358|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
155501703|NCT03747939|561263359|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
155501704|NCT03747939|561263356|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
155501705|NCT03747939|561263357|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
155501706|NCT03747939|561263358|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
155323694|NCT00319111|560619982|FG000|Overall Study|Treatment failure|1|||
155644406|NCT01629563|561788283|FG001|Overall Study|Lack of Efficacy|3|||
155323695|NCT04330040|560619983|FG000|Overall Study|Other: Adverse event|5|||
155323696|NCT04330040|560619984|FG001|Overall Study|Other: Adverse event|0|||
155323697|NCT04330040|560619985|FG002|Overall Study|Other: Adverse event|0|||
155323698|NCT04330040|560619983|FG000|Overall Study|Disease progression|38|||
155323699|NCT04330040|560619984|FG001|Overall Study|Disease progression|10|||
155323700|NCT04330040|560619985|FG002|Overall Study|Disease progression|0|||
155323701|NCT04330040|560619983|FG000|Overall Study|Physician Decision|5|||
155323702|NCT04330040|560619984|FG001|Overall Study|Physician Decision|3|||
155323703|NCT04330040|560619985|FG002|Overall Study|Physician Decision|0|||
155323704|NCT04330040|560619983|FG000|Overall Study|Lost to Follow-up|1|||
155323705|NCT04330040|560619984|FG001|Overall Study|Lost to Follow-up|1|||
155323706|NCT04330040|560619985|FG002|Overall Study|Lost to Follow-up|0|||
155323707|NCT04330040|560619983|FG000|Overall Study|Death|2|||
155323708|NCT04330040|560619984|FG001|Overall Study|Death|1|||
155323709|NCT04330040|560619985|FG002|Overall Study|Death|0|||
155323710|NCT04330040|560619983|FG000|Overall Study|Withdrawal by Subject|3|||
155323711|NCT04330040|560619984|FG001|Overall Study|Withdrawal by Subject|3|||
155323712|NCT04330040|560619985|FG002|Overall Study|Withdrawal by Subject|0|||
155323713|NCT04330040|560619983|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
155323714|NCT04330040|560619984|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
155323715|NCT04330040|560619985|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
155323716|NCT04330040|560619983|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
155323717|NCT04330040|560619984|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
155323718|NCT04330040|560619985|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
155323719|NCT04330040|560619983|FG000|Overall Study|Other: Disease progression|1|||
155323720|NCT04330040|560619984|FG001|Overall Study|Other: Disease progression|0|||
155323721|NCT04330040|560619985|FG002|Overall Study|Other: Disease progression|0|||
155323722|NCT04330040|560619983|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
155323723|NCT04330040|560619984|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
155323724|NCT04330040|560619985|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
155323725|NCT04330040|560619983|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
155323726|NCT04330040|560619984|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
155323727|NCT04330040|560619985|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
155323728|NCT04330040|560619983|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
155323729|NCT04330040|560619984|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
155323730|NCT04330040|560619985|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
155323731|NCT05525104|560619986|FG000|Overall Study|Failed caudal analgesia|1|||
155323732|NCT05525104|560619987|FG001|Overall Study|Failed caudal analgesia|3|||
155323733|NCT05525104|560619986|FG000|Overall Study|Premedication needed|0|||
155323734|NCT05525104|560619987|FG001|Overall Study|Premedication needed|1|||
155323735|NCT05525104|560619986|FG000|Overall Study|Protocol Violation|10|||
155323736|NCT05525104|560619987|FG001|Overall Study|Protocol Violation|0|||
155323737|NCT05525104|560619986|FG000|Overall Study|Cancelled operation|1|||
155323738|NCT05525104|560619987|FG001|Overall Study|Cancelled operation|0|||
155323739|NCT02039401|560619988|FG000|Overall Study|Adverse Event|0|||
155323740|NCT02039401|560619989|FG001|Overall Study|Adverse Event|1|||
155323741|NCT02585323|560621884|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
155323742|NCT02585323|560621885|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
155323743|NCT02585323|560621884|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
155323744|NCT02585323|560621885|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
155323745|NCT02585323|560621884|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
155323746|NCT02585323|560621885|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
155323747|NCT02585323|560621884|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
155323748|NCT02585323|560621885|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
155323749|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
155323750|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
155323751|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
155323752|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
155323753|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
155323754|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
155323755|NCT05524116|560621901|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
155323756|NCT05524116|560621902|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
155323757|NCT05524116|560621901|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
155323758|NCT05524116|560621902|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
155323759|NCT04389957|560621903|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
155323760|NCT04389957|560621904|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
155421026|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
155421027|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
155421028|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
155421029|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
155421030|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
155421031|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
155421032|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155323761|NCT04389957|560621905|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
155323762|NCT04389957|560621906|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
155323763|NCT04389957|560621907|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
155323764|NCT04084574|560621914|FG000|Overall Study|Lost to Follow-up|1|||
155501707|NCT03747939|561263359|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
155501708|NCT03747939|561263356|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
155501709|NCT03747939|561263357|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
155501710|NCT03747939|561263358|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
155501711|NCT03747939|561263359|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
155501712|NCT03747939|561263356|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
155501713|NCT03747939|561263357|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
155501714|NCT03747939|561263358|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
155323765|NCT04084574|560621915|FG001|Overall Study|Lost to Follow-up|0|||
155323766|NCT04084574|560621914|FG000|Overall Study|Physician Decision|1|||
155323767|NCT04084574|560621915|FG001|Overall Study|Physician Decision|0|||
155323768|NCT04084574|560621914|FG000|Overall Study|Relocated out of state|1|||
155323769|NCT04084574|560621915|FG001|Overall Study|Relocated out of state|0|||
155323770|NCT01121588|560621916|FG000|Overall Study|Death|5|||
155323771|NCT01121588|560621917|FG001|Overall Study|Death|3|||
155323772|NCT01121588|560621918|FG002|Overall Study|Death|13|||
155323773|NCT01121588|560621916|FG000|Overall Study|Study Terminated by Sponsor|1|||
155323774|NCT01121588|560621917|FG001|Overall Study|Study Terminated by Sponsor|1|||
155323775|NCT01121588|560621918|FG002|Overall Study|Study Terminated by Sponsor|0|||
155323776|NCT01121588|560621916|FG000|Overall Study|Participant Refused Further Followup|2|||
155323777|NCT01121588|560621917|FG001|Overall Study|Participant Refused Further Followup|0|||
155323778|NCT01121588|560621918|FG002|Overall Study|Participant Refused Further Followup|2|||
155323779|NCT01121588|560621916|FG000|Overall Study|Lost to Follow-up|0|||
155323780|NCT01121588|560621917|FG001|Overall Study|Lost to Follow-up|1|||
155323781|NCT01121588|560621918|FG002|Overall Study|Lost to Follow-up|1|||
155323782|NCT01121588|560621916|FG000|Overall Study|Non-Specified Reasons|9|||
155323783|NCT01121588|560621917|FG001|Overall Study|Non-Specified Reasons|4|||
155323784|NCT01121588|560621918|FG002|Overall Study|Non-Specified Reasons|2|||
155323785|NCT00942877|560621919|FG000|Overall Study|Refused further treatment|1|||
155323786|NCT00942877|560621920|FG001|Overall Study|Refused further treatment|1|||
155323787|NCT00942877|560621919|FG000|Overall Study|Patient was not treated|1|||
155323788|NCT00942877|560621920|FG001|Overall Study|Patient was not treated|0|||
155323789|NCT00942877|560621919|FG000|Overall Study|Adverse Event|1|||
155323790|NCT00942877|560621920|FG001|Overall Study|Adverse Event|0|||
155323791|NCT00942877|560621919|FG000|Overall Study|Progressive disease|42|||
155323792|NCT00942877|560621920|FG001|Overall Study|Progressive disease|3|||
155323793|NCT01385202|560621923|FG000|Overall Study|Lost to Follow-up|6|||
155323794|NCT01385202|560621923|FG000|Overall Study|Not Eligible|11|||
155323795|NCT01385202|560621923|FG000|Overall Study|Withdrawn|1|||
155323796|NCT03681262|560621924|FG000|Overall Study|Continuing on study|3|||
155323797|NCT03681262|560621925|FG001|Overall Study|Continuing on study|3|||
155323798|NCT03681262|560621924|FG000|Overall Study|Lost to Follow-up|1|||
155421033|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155421034|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
155421035|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421036|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
155421037|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421038|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421039|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
155421040|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
155421041|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
155501715|NCT03747939|561263359|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
155501716|NCT01988493|561263360|FG000|Overall Study|Randomized but not treated|0|||
155501717|NCT01988493|561263361|FG001|Overall Study|Randomized but not treated|0|||
155501718|NCT01988493|561263362|FG002|Overall Study|Randomized but not treated|0|||
155501719|NCT01988493|561263363|FG003|Overall Study|Randomized but not treated|0|||
155501720|NCT01988493|561263364|FG004|Overall Study|Randomized but not treated|1|||
155323799|NCT03681262|560621925|FG001|Overall Study|Lost to Follow-up|0|||
155323800|NCT02095691|560621926|FG000|Overall Study|Physician Decision|1|||
155501721|NCT03087773|561263365|FG000|Overall Study|Withdrawal by Subject|8|||
155323801|NCT04583280|560621927|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
155323802|NCT04583280|560621928|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
155323803|NCT00964392|560621929|FG000|Overall Study|Withdrawal by Subject|4|||
155323804|NCT00964392|560621930|FG001|Overall Study|Withdrawal by Subject|6|||
155323805|NCT00964392|560621929|FG000|Overall Study|Lost to Follow-up|4|||
155323806|NCT00964392|560621930|FG001|Overall Study|Lost to Follow-up|10|||
155323807|NCT00964392|560621929|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
155323808|NCT00964392|560621930|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
155501722|NCT03087773|561263366|FG001|Overall Study|Withdrawal by Subject|4|||
155501723|NCT03087773|561263365|FG000|Overall Study|Lost to Follow-up|12|||
155501724|NCT03087773|561263366|FG001|Overall Study|Lost to Follow-up|8|||
155644407|NCT01629563|561788282|FG000|Overall Study|Lost to Follow-up|1|||
155644408|NCT01629563|561788283|FG001|Overall Study|Lost to Follow-up|0|||
155644409|NCT01629563|561788282|FG000|Overall Study|Pregnancy|1|||
155644410|NCT01629563|561788283|FG001|Overall Study|Pregnancy|2|||
155644411|NCT01629563|561788282|FG000|Overall Study|Protocol Violation|0|||
155644412|NCT01629563|561788283|FG001|Overall Study|Protocol Violation|1|||
155644413|NCT01629563|561788282|FG000|Overall Study|Withdrawal by Subject|27|||
155644414|NCT01629563|561788283|FG001|Overall Study|Withdrawal by Subject|20|||
155644415|NCT01629563|561788282|FG000|Overall Study|surgery|0|||
155644416|NCT01629563|561788283|FG001|Overall Study|surgery|3|||
155644417|NCT01629563|561788282|FG000|Overall Study|Lack of return of menses|12|||
155644418|NCT01629563|561788283|FG001|Overall Study|Lack of return of menses|7|||
155644419|NCT01629563|561788282|FG000|Overall Study|Protocol Violation|0|||
155644420|NCT01629563|561788283|FG001|Overall Study|Protocol Violation|1|||
155644421|NCT00088881|561788285|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
155644422|NCT00088881|561788285|FG000|Step 1 - R-CHOP|Adverse Event|1|||
155644423|NCT00088881|561788285|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
155644424|NCT00088881|561788285|FG000|Step 1 - R-CHOP|Physician Decision|1|||
155644425|NCT00088881|561788285|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
155644426|NCT00088881|561788285|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
155644427|NCT00088881|561788285|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
155644428|NCT01129284|561788286|FG000|Overall Study|Adverse Event|2|||
155501725|NCT03496207|561263369|FG000|Base Study|Adverse Event|0|||
155501726|NCT03496207|561263370|FG001|Base Study|Adverse Event|0|||
155501727|NCT03496207|561263371|FG002|Base Study|Adverse Event|1|||
155501728|NCT03496207|561263372|FG003|Base Study|Adverse Event|1|||
155501729|NCT03496207|561263373|FG004|Base Study|Adverse Event|4|||
155501730|NCT03496207|561263369|FG000|Base Study|Death|0|||
155501731|NCT03496207|561263370|FG001|Base Study|Death|0|||
155501732|NCT03496207|561263371|FG002|Base Study|Death|0|||
155501733|NCT03496207|561263372|FG003|Base Study|Death|0|||
155501734|NCT03496207|561263373|FG004|Base Study|Death|1|||
155501735|NCT03496207|561263369|FG000|Base Study|Withdrawal by Subject|0|||
155501736|NCT03496207|561263370|FG001|Base Study|Withdrawal by Subject|0|||
155501737|NCT03496207|561263371|FG002|Base Study|Withdrawal by Subject|1|||
155501738|NCT03496207|561263372|FG003|Base Study|Withdrawal by Subject|0|||
155501739|NCT03496207|561263373|FG004|Base Study|Withdrawal by Subject|1|||
155501740|NCT03496207|561263369|FG000|Extension Period|Adverse Event|0|||
155501741|NCT03496207|561263370|FG001|Extension Period|Adverse Event|0|||
155501742|NCT03496207|561263371|FG002|Extension Period|Adverse Event|0|||
155501743|NCT03496207|561263372|FG003|Extension Period|Adverse Event|1|||
155501744|NCT03496207|561263373|FG004|Extension Period|Adverse Event|1|||
155501745|NCT03496207|561263369|FG000|Extension Period|Death|1|||
155501746|NCT03496207|561263370|FG001|Extension Period|Death|0|||
155501747|NCT03496207|561263371|FG002|Extension Period|Death|0|||
155501748|NCT03496207|561263372|FG003|Extension Period|Death|1|||
155501749|NCT03496207|561263373|FG004|Extension Period|Death|2|||
155501750|NCT03496207|561263369|FG000|Extension Period|Withdrawal by Subject|1|||
155501751|NCT03496207|561263370|FG001|Extension Period|Withdrawal by Subject|0|||
155501752|NCT03496207|561263371|FG002|Extension Period|Withdrawal by Subject|0|||
155501753|NCT03496207|561263372|FG003|Extension Period|Withdrawal by Subject|1|||
155501754|NCT03496207|561263373|FG004|Extension Period|Withdrawal by Subject|1|||
155501755|NCT03496207|561263369|FG000|Extension Period|Elevated hemoglobin levels|0|||
155501756|NCT03496207|561263370|FG001|Extension Period|Elevated hemoglobin levels|0|||
155501757|NCT03496207|561263371|FG002|Extension Period|Elevated hemoglobin levels|0|||
155501758|NCT03496207|561263372|FG003|Extension Period|Elevated hemoglobin levels|0|||
155501759|NCT03496207|561263373|FG004|Extension Period|Elevated hemoglobin levels|1|||
155501760|NCT00902278|561263375|FG000|Overall Study|Physician Decision|1|||
155501761|NCT00902278|561263376|FG001|Overall Study|Physician Decision|0|||
155501762|NCT00902278|561263377|FG002|Overall Study|Physician Decision|2|||
155501763|NCT00902278|561263378|FG003|Overall Study|Physician Decision|0|||
155501764|NCT00902278|561263379|FG004|Overall Study|Physician Decision|1|||
155501765|NCT00902278|561263375|FG000|Overall Study|Lost to Follow-up|3|||
155501766|NCT00902278|561263376|FG001|Overall Study|Lost to Follow-up|2|||
155501767|NCT00902278|561263377|FG002|Overall Study|Lost to Follow-up|3|||
155501768|NCT00902278|561263378|FG003|Overall Study|Lost to Follow-up|0|||
155501769|NCT00902278|561263379|FG004|Overall Study|Lost to Follow-up|1|||
155501770|NCT01289990|561263382|FG000|Overall Study|Death|0|||
155501771|NCT01289990|561263383|FG001|Overall Study|Death|0|||
155644429|NCT01129284|561788287|FG001|Overall Study|Adverse Event|0|||
155644430|NCT01129284|561788288|FG002|Overall Study|Adverse Event|1|||
155323809|NCT00964392|560621929|FG000|Overall Study|Not completed|44|||
155644431|NCT02082483|561788289|FG000|Overall Study|Lost to Follow-up|1|||
155644432|NCT02082483|561788290|FG001|Overall Study|Lost to Follow-up|1|||
155501772|NCT01289990|561263384|FG002|Overall Study|Death|0|||
155501773|NCT01289990|561263385|FG003|Overall Study|Death|1|||
155501774|NCT01289990|561263386|FG004|Overall Study|Death|2|||
155644433|NCT02082483|561788289|FG000|Overall Study|Withdrawal by Subject|2|||
155501775|NCT01289990|561263387|FG005|Overall Study|Death|1|||
155323810|NCT00964392|560621930|FG001|Overall Study|Not completed|168|||
155323811|NCT03652272|560621935|FG000|3 Month|Withdrawal by Subject|1|||
155323812|NCT03652272|560621936|FG001|3 Month|Withdrawal by Subject|1|||
155323813|NCT03652272|560621935|FG000|3 Month|Lost to Follow-up|16|||
155323814|NCT03652272|560621936|FG001|3 Month|Lost to Follow-up|14|||
155323815|NCT02326974|560621937|FG000|Overall Study|Withdrawal by Subject|2|||
155323816|NCT02326974|560621937|FG000|Overall Study|failed heterogenity evaluation|5|||
155323817|NCT02577354|560621938|FG000|Overall Study|Lack of Efficacy|4|||
155323818|NCT02577354|560621939|FG001|Overall Study|Lack of Efficacy|4|||
155323819|NCT02577354|560621938|FG000|Overall Study|Lost to Follow-up|3|||
155323820|NCT02577354|560621939|FG001|Overall Study|Lost to Follow-up|1|||
155323821|NCT02577354|560621938|FG000|Overall Study|Missed Visit|4|||
155323822|NCT02577354|560621939|FG001|Overall Study|Missed Visit|3|||
155323823|NCT02577354|560621938|FG000|Overall Study|Adverse Event|4|||
155323824|NCT02577354|560621939|FG001|Overall Study|Adverse Event|5|||
155323825|NCT02938520|560621942|FG000|Overall Study|On-going at the time of analysis|258|||
155323826|NCT02938520|560621943|FG001|Overall Study|On-going at the time of analysis|261|||
155323827|NCT02938520|560621942|FG000|Overall Study|Physician Decision|2|||
155323828|NCT02938520|560621943|FG001|Overall Study|Physician Decision|5|||
155323829|NCT02938520|560621942|FG000|Overall Study|Lost to Follow-up|2|||
155323830|NCT02938520|560621943|FG001|Overall Study|Lost to Follow-up|2|||
155323831|NCT02938520|560621942|FG000|Overall Study|Withdrawal by Subject|7|||
155323832|NCT02938520|560621943|FG001|Overall Study|Withdrawal by Subject|7|||
155323833|NCT02938520|560621942|FG000|Overall Study|Protocol Violation|0|||
155323834|NCT02938520|560621943|FG001|Overall Study|Protocol Violation|1|||
155323835|NCT02938520|560621942|FG000|Overall Study|Lack of Efficacy|5|||
155323836|NCT02938520|560621943|FG001|Overall Study|Lack of Efficacy|3|||
155323837|NCT02938520|560621942|FG000|Overall Study|Adverse Event|9|||
155323838|NCT02938520|560621943|FG001|Overall Study|Adverse Event|4|||
155323839|NCT03812614|560621946|FG000|Intervention|Withdrawal by Subject|7|||
155323840|NCT03812614|560621947|FG001|Intervention|Withdrawal by Subject|2|||
155323841|NCT03812614|560621948|FG002|Intervention|Withdrawal by Subject|7|||
155323842|NCT03812614|560621949|FG003|Intervention|Withdrawal by Subject|2|||
155323843|NCT03812614|560621946|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
155323844|NCT03812614|560621947|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
155323845|NCT03812614|560621948|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
155323846|NCT03812614|560621949|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
155421042|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
155421043|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
155421044|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
155421045|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
155421046|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
155421047|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
155421048|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
155421049|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
155421050|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
155421051|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
155421052|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
155421053|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
155421054|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
155421055|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
155421056|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
155421057|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
155421058|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
155421059|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
155421060|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
155421061|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
155421062|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
155421063|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
155421064|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
155421065|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
155421066|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
155421067|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
155421068|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
155501776|NCT01289990|561263388|FG006|Overall Study|Death|0|||
155501777|NCT01289990|561263389|FG007|Overall Study|Death|0|||
155323847|NCT03812614|560621946|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
155323848|NCT03812614|560621947|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
155323849|NCT03812614|560621948|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
155323850|NCT03812614|560621949|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
155323851|NCT03812614|560621946|FG000|6-month Follow-up|Lost to Follow-up|0|||
155323852|NCT03812614|560621947|FG001|6-month Follow-up|Lost to Follow-up|0|||
155323853|NCT03812614|560621948|FG002|6-month Follow-up|Lost to Follow-up|12|||
155323854|NCT03812614|560621949|FG003|6-month Follow-up|Lost to Follow-up|8|||
155421069|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
155421070|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
155421071|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
155421072|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
155421073|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
155421074|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
155421075|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
155421076|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
155421077|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
155421078|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
155421079|NCT00289913|560972482|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
155421080|NCT00289913|560972483|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
155421081|NCT00289913|560972484|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
155421082|NCT00289913|560972485|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
155421083|NCT00289913|560972486|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
155421084|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421085|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
155421086|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421087|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421088|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
155421089|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
155421090|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
155421091|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
155421092|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
155421093|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
155421094|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155501778|NCT01289990|561263390|FG008|Overall Study|Death|0|||
155501779|NCT01289990|561263391|FG009|Overall Study|Death|0|||
155501780|NCT01289990|561263392|FG010|Overall Study|Death|0|||
155501781|NCT01289990|561263393|FG011|Overall Study|Death|1|||
155501782|NCT01289990|561263394|FG012|Overall Study|Death|0|||
155501783|NCT01289990|561263382|FG000|Overall Study|Lost to Follow-up|3|||
155501784|NCT01289990|561263383|FG001|Overall Study|Lost to Follow-up|2|||
155501785|NCT01289990|561263384|FG002|Overall Study|Lost to Follow-up|5|||
155501786|NCT01289990|561263385|FG003|Overall Study|Lost to Follow-up|5|||
155501787|NCT01289990|561263386|FG004|Overall Study|Lost to Follow-up|3|||
155501788|NCT01289990|561263387|FG005|Overall Study|Lost to Follow-up|4|||
155501789|NCT01289990|561263388|FG006|Overall Study|Lost to Follow-up|2|||
155501790|NCT01289990|561263389|FG007|Overall Study|Lost to Follow-up|2|||
155501791|NCT01289990|561263390|FG008|Overall Study|Lost to Follow-up|1|||
155501792|NCT01289990|561263391|FG009|Overall Study|Lost to Follow-up|4|||
155501793|NCT01289990|561263392|FG010|Overall Study|Lost to Follow-up|2|||
155501794|NCT01289990|561263393|FG011|Overall Study|Lost to Follow-up|1|||
155501795|NCT01289990|561263394|FG012|Overall Study|Lost to Follow-up|2|||
155501796|NCT01289990|561263382|FG000|Overall Study|Withdrawal by Subject|15|||
155501797|NCT01289990|561263383|FG001|Overall Study|Withdrawal by Subject|14|||
155501798|NCT01289990|561263384|FG002|Overall Study|Withdrawal by Subject|12|||
155501799|NCT01289990|561263385|FG003|Overall Study|Withdrawal by Subject|13|||
155501800|NCT01289990|561263386|FG004|Overall Study|Withdrawal by Subject|8|||
155323855|NCT03812614|560621946|FG000|12-month Follow-up|Lost to Follow-up|18|||
155323856|NCT03812614|560621947|FG001|12-month Follow-up|Lost to Follow-up|17|||
155323857|NCT03812614|560621948|FG002|12-month Follow-up|Lost to Follow-up|5|||
155323858|NCT03812614|560621949|FG003|12-month Follow-up|Lost to Follow-up|2|||
155323859|NCT05652010|560621950|FG000|First Intervention|Withdrawal by Subject|0|||
155323860|NCT05652010|560621951|FG001|First Intervention|Withdrawal by Subject|1|||
155323861|NCT05652010|560621950|FG000|Second Intervention|Withdrawal by Subject|1|||
155323862|NCT05652010|560621951|FG001|Second Intervention|Withdrawal by Subject|0|||
155323863|NCT05451693|560621952|FG000|Overall Study|Withdrawal by Subject|1|||
155323864|NCT05451693|560621953|FG001|Overall Study|Withdrawal by Subject|1|||
155323865|NCT04490109|560621960|FG000|Overall Study|Lost to Follow-up|3|||
155323866|NCT04490109|560621961|FG001|Overall Study|Lost to Follow-up|10|||
155323867|NCT04490109|560621962|FG002|Overall Study|Lost to Follow-up|4|||
155323868|NCT04490109|560621960|FG000|Overall Study|Withdrawal by Subject|8|||
155323869|NCT04490109|560621961|FG001|Overall Study|Withdrawal by Subject|6|||
155323870|NCT04490109|560621962|FG002|Overall Study|Withdrawal by Subject|9|||
155323871|NCT04490109|560621960|FG000|Overall Study|Physician Decision|0|||
155323872|NCT04490109|560621961|FG001|Overall Study|Physician Decision|2|||
155323873|NCT04490109|560621962|FG002|Overall Study|Physician Decision|3|||
155323874|NCT04490109|560621960|FG000|Overall Study|Adverse Event|2|||
155323875|NCT04490109|560621961|FG001|Overall Study|Adverse Event|1|||
155323876|NCT04490109|560621962|FG002|Overall Study|Adverse Event|0|||
155501801|NCT01289990|561263387|FG005|Overall Study|Withdrawal by Subject|7|||
155501802|NCT01289990|561263388|FG006|Overall Study|Withdrawal by Subject|13|||
155501803|NCT01289990|561263389|FG007|Overall Study|Withdrawal by Subject|9|||
155501804|NCT01289990|561263390|FG008|Overall Study|Withdrawal by Subject|12|||
155501805|NCT01289990|561263391|FG009|Overall Study|Withdrawal by Subject|13|||
155501806|NCT01289990|561263392|FG010|Overall Study|Withdrawal by Subject|11|||
155501807|NCT01289990|561263393|FG011|Overall Study|Withdrawal by Subject|13|||
155501808|NCT01289990|561263394|FG012|Overall Study|Withdrawal by Subject|16|||
155501809|NCT01289990|561263382|FG000|Overall Study|discontinued in preceding trial|18|||
155501810|NCT01289990|561263383|FG001|Overall Study|discontinued in preceding trial|20|||
155501811|NCT01289990|561263384|FG002|Overall Study|discontinued in preceding trial|41|||
155501812|NCT01289990|561263385|FG003|Overall Study|discontinued in preceding trial|17|||
155501813|NCT01289990|561263386|FG004|Overall Study|discontinued in preceding trial|11|||
155501814|NCT01289990|561263387|FG005|Overall Study|discontinued in preceding trial|12|||
155501815|NCT01289990|561263388|FG006|Overall Study|discontinued in preceding trial|18|||
155501816|NCT01289990|561263389|FG007|Overall Study|discontinued in preceding trial|8|||
155323877|NCT04490109|560621960|FG000|Overall Study|Significant Non-Compliance|2|||
155323878|NCT04490109|560621961|FG001|Overall Study|Significant Non-Compliance|4|||
155323879|NCT04490109|560621962|FG002|Overall Study|Significant Non-Compliance|4|||
155323880|NCT04490109|560621960|FG000|Overall Study|Significant Clinical Event|0|||
155323881|NCT04490109|560621961|FG001|Overall Study|Significant Clinical Event|1|||
155323882|NCT04490109|560621962|FG002|Overall Study|Significant Clinical Event|0|||
155323883|NCT04490109|560621960|FG000|Overall Study|Other Reason|4|||
155323884|NCT04490109|560621961|FG001|Overall Study|Other Reason|1|||
155323885|NCT04490109|560621962|FG002|Overall Study|Other Reason|1|||
155323886|NCT03372057|560621963|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
155323887|NCT03372057|560621964|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
155323888|NCT03372057|560621965|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
155421095|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155421096|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155421097|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
155421098|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
155323889|NCT03372057|560621963|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
155421099|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421100|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421101|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155323890|NCT03372057|560621964|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
155323891|NCT03372057|560621965|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
155323892|NCT03372057|560621963|FG000|Dose Optimization Phase|Death|16|||
155323893|NCT03372057|560621964|FG001|Dose Optimization Phase|Death|11|||
155323894|NCT03372057|560621965|FG002|Dose Optimization Phase|Death|0|||
155323895|NCT03372057|560621963|FG000|Expansion Phase|Withdrawal by Subject|0|||
155323896|NCT03372057|560621964|FG001|Expansion Phase|Withdrawal by Subject|0|||
155323897|NCT03372057|560621965|FG002|Expansion Phase|Withdrawal by Subject|4|||
155323898|NCT03372057|560621963|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
155323899|NCT03372057|560621964|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
155323900|NCT03372057|560621965|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
155323901|NCT03372057|560621963|FG000|Expansion Phase|Death|0|||
155323902|NCT03372057|560621964|FG001|Expansion Phase|Death|0|||
155323903|NCT03372057|560621965|FG002|Expansion Phase|Death|78|||
155323904|NCT03372057|560621963|FG000|Expansion Phase|Progressive Disease|0|||
155323905|NCT03372057|560621964|FG001|Expansion Phase|Progressive Disease|0|||
155323906|NCT03372057|560621965|FG002|Expansion Phase|Progressive Disease|1|||
155501817|NCT01289990|561263390|FG008|Overall Study|discontinued in preceding trial|17|||
155501818|NCT01289990|561263391|FG009|Overall Study|discontinued in preceding trial|21|||
155501819|NCT01289990|561263392|FG010|Overall Study|discontinued in preceding trial|17|||
155501820|NCT01289990|561263393|FG011|Overall Study|discontinued in preceding trial|17|||
155501821|NCT01289990|561263394|FG012|Overall Study|discontinued in preceding trial|24|||
155501822|NCT01289990|561263382|FG000|Overall Study|did not continue in extension|41|||
155501823|NCT01289990|561263383|FG001|Overall Study|did not continue in extension|45|||
155501824|NCT01289990|561263384|FG002|Overall Study|did not continue in extension|51|||
155501825|NCT01289990|561263385|FG003|Overall Study|did not continue in extension|51|||
155501826|NCT01289990|561263386|FG004|Overall Study|did not continue in extension|48|||
155501827|NCT01289990|561263387|FG005|Overall Study|did not continue in extension|50|||
155501828|NCT01289990|561263388|FG006|Overall Study|did not continue in extension|54|||
155501829|NCT01289990|561263389|FG007|Overall Study|did not continue in extension|36|||
155501830|NCT01289990|561263390|FG008|Overall Study|did not continue in extension|44|||
155501831|NCT01289990|561263391|FG009|Overall Study|did not continue in extension|48|||
155501832|NCT01289990|561263392|FG010|Overall Study|did not continue in extension|45|||
155501833|NCT01289990|561263393|FG011|Overall Study|did not continue in extension|34|||
155501834|NCT01289990|561263394|FG012|Overall Study|did not continue in extension|56|||
155501835|NCT01289990|561263382|FG000|Overall Study|Not treated|0|||
155501836|NCT01289990|561263383|FG001|Overall Study|Not treated|0|||
155501837|NCT01289990|561263384|FG002|Overall Study|Not treated|0|||
155501838|NCT01289990|561263385|FG003|Overall Study|Not treated|0|||
155501839|NCT01289990|561263386|FG004|Overall Study|Not treated|0|||
155501840|NCT01289990|561263387|FG005|Overall Study|Not treated|0|||
155501841|NCT01289990|561263388|FG006|Overall Study|Not treated|1|||
155501842|NCT01289990|561263389|FG007|Overall Study|Not treated|0|||
155501843|NCT01289990|561263390|FG008|Overall Study|Not treated|1|||
155501844|NCT01289990|561263391|FG009|Overall Study|Not treated|0|||
155501845|NCT01289990|561263392|FG010|Overall Study|Not treated|1|||
155501846|NCT01289990|561263393|FG011|Overall Study|Not treated|2|||
155501847|NCT01289990|561263394|FG012|Overall Study|Not treated|0|||
155501848|NCT02441179|561263396|FG000|Overall Study|Withdrawal by Subject|1|||
155501849|NCT02441179|561263397|FG001|Overall Study|Withdrawal by Subject|1|||
155501850|NCT03454672|561263398|FG000|Overall Study|Adverse Event|1|||
155501851|NCT03454672|561263399|FG001|Overall Study|Adverse Event|1|||
155501852|NCT03454672|561263398|FG000|Overall Study|Lost to Follow-up|1|||
155501853|NCT03454672|561263399|FG001|Overall Study|Lost to Follow-up|3|||
155501854|NCT03454672|561263398|FG000|Overall Study|painful|1|||
155501855|NCT03454672|561263399|FG001|Overall Study|painful|2|||
155501856|NCT03454672|561263398|FG000|Overall Study|Non-compliance|2|||
155323907|NCT03372057|560621963|FG000|Expansion Phase|Adverse Event|0|||
155323908|NCT03372057|560621964|FG001|Expansion Phase|Adverse Event|0|||
155323909|NCT03372057|560621965|FG002|Expansion Phase|Adverse Event|1|||
155323910|NCT05953740|560621966|FG000|Period 1|Physician Decision|0|||
155323911|NCT05953740|560621967|FG001|Period 1|Physician Decision|1|||
155323912|NCT05953740|560621968|FG002|Period 1|Physician Decision|0|||
155323913|NCT05953740|560621969|FG003|Period 1|Physician Decision|0|||
155323914|NCT05953740|560621970|FG004|Period 1|Physician Decision|0|||
155323915|NCT05953740|560621971|FG005|Period 1|Physician Decision|0|||
155323916|NCT05953740|560621972|FG006|Period 1|Physician Decision|0|||
155323917|NCT05953740|560621973|FG007|Period 1|Physician Decision|0|||
155323918|NCT05953740|560621966|FG000|Period 2|Withdrawal by Subject|0|||
155323919|NCT05953740|560621967|FG001|Period 2|Withdrawal by Subject|1|||
155323920|NCT05953740|560621968|FG002|Period 2|Withdrawal by Subject|1|||
155323921|NCT05953740|560621969|FG003|Period 2|Withdrawal by Subject|0|||
155323922|NCT05953740|560621970|FG004|Period 2|Withdrawal by Subject|0|||
155323923|NCT05953740|560621971|FG005|Period 2|Withdrawal by Subject|0|||
155323924|NCT05953740|560621972|FG006|Period 2|Withdrawal by Subject|0|||
155323925|NCT05953740|560621973|FG007|Period 2|Withdrawal by Subject|0|||
155323926|NCT03880955|560621974|FG000|Overall Study|Adverse Event|1|||
155323927|NCT03880955|560621974|FG000|Overall Study|Death|1|||
155323928|NCT03880955|560621974|FG000|Overall Study|Lost to Follow-up|12|||
155323929|NCT03880955|560621974|FG000|Overall Study|Withdrawal by Subject|4|||
155323930|NCT03880955|560621974|FG000|Overall Study|Missing- Study Site Closed|27|||
155323931|NCT05112900|560621975|FG000|Overall Study|Withdrawal by Subject|960|||
155323932|NCT05112900|560621976|FG001|Overall Study|Withdrawal by Subject|921|||
155323933|NCT05112900|560621977|FG002|Overall Study|Withdrawal by Subject|968|||
155323934|NCT04761198|560621980|FG000|Overall Study|Progressive Disease|1|||
155323935|NCT04761198|560621981|FG001|Overall Study|Progressive Disease|0|||
155323936|NCT04761198|560621982|FG002|Overall Study|Progressive Disease|0|||
155323937|NCT04761198|560621983|FG003|Overall Study|Progressive Disease|1|||
155323938|NCT04761198|560621984|FG004|Overall Study|Progressive Disease|4|||
155323939|NCT04761198|560621985|FG005|Overall Study|Progressive Disease|1|||
155323940|NCT04761198|560621986|FG006|Overall Study|Progressive Disease|2|||
155323941|NCT04761198|560621980|FG000|Overall Study|Protocol Violation|0|||
155323942|NCT04761198|560621981|FG001|Overall Study|Protocol Violation|0|||
155323943|NCT04761198|560621982|FG002|Overall Study|Protocol Violation|0|||
155323944|NCT04761198|560621983|FG003|Overall Study|Protocol Violation|0|||
155323945|NCT04761198|560621984|FG004|Overall Study|Protocol Violation|1|||
155323946|NCT04761198|560621985|FG005|Overall Study|Protocol Violation|0|||
155323947|NCT04761198|560621986|FG006|Overall Study|Protocol Violation|0|||
155323948|NCT04761198|560621980|FG000|Overall Study|Death|2|||
155323949|NCT04761198|560621981|FG001|Overall Study|Death|1|||
155323950|NCT04761198|560621982|FG002|Overall Study|Death|2|||
155323951|NCT04761198|560621983|FG003|Overall Study|Death|5|||
155323952|NCT04761198|560621984|FG004|Overall Study|Death|14|||
155323953|NCT04761198|560621985|FG005|Overall Study|Death|2|||
155323954|NCT04761198|560621986|FG006|Overall Study|Death|5|||
155323955|NCT04761198|560621980|FG000|Overall Study|Lost to Follow-up|0|||
155323956|NCT04761198|560621981|FG001|Overall Study|Lost to Follow-up|0|||
155323957|NCT04761198|560621982|FG002|Overall Study|Lost to Follow-up|0|||
155323958|NCT04761198|560621983|FG003|Overall Study|Lost to Follow-up|0|||
155323959|NCT04761198|560621984|FG004|Overall Study|Lost to Follow-up|1|||
155323960|NCT04761198|560621985|FG005|Overall Study|Lost to Follow-up|0|||
155323961|NCT04761198|560621986|FG006|Overall Study|Lost to Follow-up|0|||
155323962|NCT04761198|560621980|FG000|Overall Study|Withdrawal by Subject|2|||
155323963|NCT04761198|560621981|FG001|Overall Study|Withdrawal by Subject|0|||
155323964|NCT04761198|560621982|FG002|Overall Study|Withdrawal by Subject|1|||
155323965|NCT04761198|560621983|FG003|Overall Study|Withdrawal by Subject|0|||
155323966|NCT04761198|560621984|FG004|Overall Study|Withdrawal by Subject|2|||
155323967|NCT04761198|560621985|FG005|Overall Study|Withdrawal by Subject|0|||
155323968|NCT04761198|560621986|FG006|Overall Study|Withdrawal by Subject|1|||
155323969|NCT04761198|560621980|FG000|Overall Study|Study Terminated by Sponsor|6|||
155323970|NCT04761198|560621981|FG001|Overall Study|Study Terminated by Sponsor|0|||
155323971|NCT04761198|560621982|FG002|Overall Study|Study Terminated by Sponsor|5|||
155323972|NCT04761198|560621983|FG003|Overall Study|Study Terminated by Sponsor|3|||
155323973|NCT04761198|560621984|FG004|Overall Study|Study Terminated by Sponsor|10|||
155323974|NCT04761198|560621985|FG005|Overall Study|Study Terminated by Sponsor|1|||
155323975|NCT04761198|560621986|FG006|Overall Study|Study Terminated by Sponsor|2|||
155323976|NCT02994927|560621987|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155323977|NCT02994927|560621988|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155323978|NCT02994927|560621987|FG000|Overall Study|Did not meet eligibility criteria|0|||
155323979|NCT02994927|560621988|FG001|Overall Study|Did not meet eligibility criteria|1|||
155323980|NCT02994927|560621987|FG000|Overall Study|Physician Decision|4|||
155323981|NCT02994927|560621988|FG001|Overall Study|Physician Decision|3|||
155323982|NCT02994927|560621987|FG000|Overall Study|Death|4|||
155323983|NCT02994927|560621988|FG001|Overall Study|Death|2|||
155323984|NCT02994927|560621987|FG000|Overall Study|Adverse Event|2|||
155323985|NCT02994927|560621988|FG001|Overall Study|Adverse Event|1|||
155323986|NCT02994927|560621987|FG000|Overall Study|Withdrawal by Subject|3|||
155323987|NCT02994927|560621988|FG001|Overall Study|Withdrawal by Subject|6|||
155323988|NCT02994927|560621987|FG000|Overall Study|Lost to Follow-up|2|||
155323989|NCT02994927|560621988|FG001|Overall Study|Lost to Follow-up|1|||
155323990|NCT02865538|560621990|FG000|Overall Study|Withdrawal by Subject|0|||
155323991|NCT02865538|560621991|FG001|Overall Study|Withdrawal by Subject|0|||
155323992|NCT02865538|560621992|FG002|Overall Study|Withdrawal by Subject|1|||
155323993|NCT02865538|560621993|FG003|Overall Study|Withdrawal by Subject|0|||
155323994|NCT02865538|560621994|FG004|Overall Study|Withdrawal by Subject|0|||
155323995|NCT02865538|560621990|FG000|Overall Study|Lost to Follow-up|1|||
155323996|NCT02865538|560621991|FG001|Overall Study|Lost to Follow-up|0|||
155323997|NCT02865538|560621992|FG002|Overall Study|Lost to Follow-up|0|||
155323998|NCT02865538|560621993|FG003|Overall Study|Lost to Follow-up|0|||
155644434|NCT02082483|561788290|FG001|Overall Study|Withdrawal by Subject|1|||
155644435|NCT02082483|561788289|FG000|Overall Study|Physician Decision|1|||
155323999|NCT02865538|560621994|FG004|Overall Study|Lost to Follow-up|0|||
155324000|NCT04427007|560623514|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
155324001|NCT04427007|560623515|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
155324002|NCT04165213|560623524|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
155324003|NCT04165213|560623525|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
155324004|NCT04165213|560623524|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
155324005|NCT04165213|560623525|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
155324006|NCT04165213|560623524|FG000|Clinician Enrollment|Termination from site|0|||
155324007|NCT04165213|560623525|FG001|Clinician Enrollment|Termination from site|1|||
155324008|NCT04165213|560623524|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
155324009|NCT04165213|560623525|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
155324010|NCT04165213|560623524|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
155324011|NCT04165213|560623525|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
155324012|NCT04165213|560623524|FG000|Caregiver Enrollment|Physician Decision|1|||
155324013|NCT04165213|560623525|FG001|Caregiver Enrollment|Physician Decision|0|||
155324014|NCT04165213|560623524|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
155324015|NCT04165213|560623525|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
155324016|NCT04165213|560623524|FG000|Caregiver Enrollment|PLWD death|2|||
155324017|NCT04165213|560623525|FG001|Caregiver Enrollment|PLWD death|0|||
155324018|NCT04165213|560623524|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
155324019|NCT04165213|560623525|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
155324020|NCT04165213|560623524|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
155324021|NCT04165213|560623525|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
155324022|NCT04165213|560623524|FG000|PLWD Enrollment|Lost to Follow-up|1|||
155324023|NCT04165213|560623525|FG001|PLWD Enrollment|Lost to Follow-up|1|||
155324024|NCT04165213|560623524|FG000|PLWD Enrollment|Physician Decision|1|||
155324025|NCT04165213|560623525|FG001|PLWD Enrollment|Physician Decision|0|||
155324026|NCT04165213|560623524|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
155324027|NCT04165213|560623525|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
155324028|NCT04165213|560623524|FG000|PLWD Enrollment|Death|2|||
155324029|NCT04165213|560623525|FG001|PLWD Enrollment|Death|0|||
155324030|NCT04165213|560623524|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
155324031|NCT04165213|560623525|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
155324032|NCT04464564|560623526|FG000|Period A (Placebo lead-in)|Other|5|||
155324033|NCT04464564|560623527|FG001|Period A (Placebo lead-in)|Other|0|||
155324034|NCT04464564|560623528|FG002|Period A (Placebo lead-in)|Other|0|||
155324035|NCT04464564|560623529|FG003|Period A (Placebo lead-in)|Other|0|||
155324036|NCT04464564|560623526|FG000|Period B (Randomization Period)|Adverse Event|0|||
155324037|NCT04464564|560623527|FG001|Period B (Randomization Period)|Adverse Event|1|||
155324038|NCT04464564|560623528|FG002|Period B (Randomization Period)|Adverse Event|2|||
155324039|NCT04464564|560623529|FG003|Period B (Randomization Period)|Adverse Event|8|||
155324040|NCT04464564|560623526|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
155324041|NCT04464564|560623527|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
155324042|NCT04464564|560623528|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
155324043|NCT04464564|560623529|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
155324044|NCT04464564|560623526|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
155324045|NCT04464564|560623527|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
155324046|NCT04464564|560623528|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
155324047|NCT04464564|560623529|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
155324048|NCT04464564|560623526|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
155324049|NCT04464564|560623527|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
155324050|NCT04464564|560623528|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
155324051|NCT04464564|560623529|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
155324052|NCT04464564|560623526|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
155324053|NCT04464564|560623527|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
155324054|NCT04464564|560623528|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
155324055|NCT04464564|560623529|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
155324056|NCT04464564|560623526|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
155324057|NCT04464564|560623527|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
155324058|NCT04464564|560623528|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
155324059|NCT04464564|560623529|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
155324060|NCT04464564|560623526|FG000|Period B (Randomization Period)|Reason not Specified|0|||
155324061|NCT04464564|560623527|FG001|Period B (Randomization Period)|Reason not Specified|3|||
155324062|NCT04464564|560623528|FG002|Period B (Randomization Period)|Reason not Specified|3|||
155324063|NCT04464564|560623529|FG003|Period B (Randomization Period)|Reason not Specified|3|||
155324064|NCT04089865|560623538|FG000|Overall Study|Withdrawal by Subject|2|||
155324065|NCT04089865|560623539|FG001|Overall Study|Withdrawal by Subject|2|||
155421102|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
155421103|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
155421104|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
155421105|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
155421106|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
155421107|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
155421108|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
155421109|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
155421110|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
155421111|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
155421112|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
155421113|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
155421114|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
155421115|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
155421116|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
155421117|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
155421118|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
155421119|NCT00289913|560972482|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421120|NCT00289913|560972483|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
155421121|NCT00289913|560972484|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421122|NCT00289913|560972485|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421123|NCT00289913|560972486|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
155421124|NCT03822884|560972487|FG000|Overall Study|Withdrawal by Subject|0|||
155421125|NCT03822884|560972488|FG001|Overall Study|Withdrawal by Subject|0|||
155421126|NCT03822884|560972489|FG002|Overall Study|Withdrawal by Subject|0|||
155421127|NCT03822884|560972490|FG003|Overall Study|Withdrawal by Subject|0|||
155421128|NCT03822884|560972491|FG004|Overall Study|Withdrawal by Subject|1|||
155421129|NCT03822884|560972492|FG005|Overall Study|Withdrawal by Subject|0|||
155421130|NCT02411448|560972497|FG000|Overall Study|Withdrawal by Subject|1|||
155421131|NCT02411448|560972498|FG001|Overall Study|Withdrawal by Subject|14|||
155421132|NCT02411448|560972499|FG002|Overall Study|Withdrawal by Subject|9|||
155421133|NCT02411448|560972497|FG000|Overall Study|Other|0|||
155421134|NCT02411448|560972498|FG001|Overall Study|Other|2|||
155421135|NCT02411448|560972499|FG002|Overall Study|Other|0|||
155421136|NCT02411448|560972497|FG000|Overall Study|Did not receive study treatment|0|||
155421137|NCT02411448|560972498|FG001|Overall Study|Did not receive study treatment|3|||
155421138|NCT02411448|560972499|FG002|Overall Study|Did not receive study treatment|0|||
155421139|NCT02411448|560972497|FG000|Overall Study|Alive on study treatment|3|||
155501857|NCT03454672|561263399|FG001|Overall Study|Non-compliance|4|||
155501858|NCT03454672|561263398|FG000|Overall Study|personal reasons|3|||
155501859|NCT03454672|561263399|FG001|Overall Study|personal reasons|2|||
155501860|NCT03454672|561263398|FG000|Overall Study|Withdrawal by Subject|1|||
155501861|NCT03454672|561263399|FG001|Overall Study|Withdrawal by Subject|0|||
155501862|NCT01488071|561263400|FG000|Overall Study|Adverse Event|15|||
155501863|NCT01488071|561263401|FG001|Overall Study|Adverse Event|23|||
155501864|NCT01488071|561263400|FG000|Overall Study|Lack of Efficacy|11|||
155501865|NCT01488071|561263401|FG001|Overall Study|Lack of Efficacy|17|||
155501866|NCT01488071|561263400|FG000|Overall Study|Non-compliance with study drug|2|||
155501867|NCT01488071|561263401|FG001|Overall Study|Non-compliance with study drug|0|||
155501868|NCT01488071|561263400|FG000|Overall Study|Protocol Violation|5|||
155421140|NCT02411448|560972498|FG001|Overall Study|Alive on study treatment|64|||
155501869|NCT01488071|561263401|FG001|Overall Study|Protocol Violation|7|||
155501870|NCT01488071|561263400|FG000|Overall Study|Withdrawal of Consent|14|||
155421141|NCT02411448|560972499|FG002|Overall Study|Alive on study treatment|43|||
155421142|NCT02631538|560972500|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
155501871|NCT01488071|561263401|FG001|Overall Study|Withdrawal of Consent|12|||
155501872|NCT01488071|561263400|FG000|Overall Study|Lost to Follow-up|1|||
155501873|NCT01488071|561263401|FG001|Overall Study|Lost to Follow-up|0|||
155501874|NCT01488071|561263400|FG000|Overall Study|Administrative or Other Reason(s)|5|||
155644436|NCT02082483|561788290|FG001|Overall Study|Physician Decision|1|||
155644437|NCT02082483|561788289|FG000|Overall Study|Death|2|||
155324066|NCT04089865|560623540|FG002|Overall Study|Withdrawal by Subject|7|||
155324067|NCT04089865|560623541|FG003|Overall Study|Withdrawal by Subject|2|||
155324068|NCT04282980|560623544|FG000|Overall Study|Remained on treatment|6|||
155324069|NCT04282980|560623544|FG000|Overall Study|Survival follow-up|11|||
155324070|NCT04282980|560623544|FG000|Overall Study|Withdrawal of informed consent|1|||
155324071|NCT04282980|560623544|FG000|Overall Study|Lost to Follow-up|1|||
155324072|NCT01917084|560623546|FG000|Overall Study|Withdrawal by Subject|1|||
155324073|NCT03571386|560623547|FG000|Overall Study|scheduling conflict|4|||
155324074|NCT03571386|560623548|FG001|Overall Study|scheduling conflict|0|||
155324075|NCT03571386|560623547|FG000|Overall Study|Withdrawal by Subject|15|||
155324076|NCT03571386|560623548|FG001|Overall Study|Withdrawal by Subject|5|||
155324077|NCT02909686|560623556|FG000|Overall Study|Physician Decision|3|||
155324078|NCT02909686|560623556|FG000|Overall Study|Withdrawal by Subject|2|||
155324079|NCT03858517|560623557|FG000|Overall Study|Adverse Event|1|||
155324080|NCT03858517|560623557|FG000|Overall Study|Lost to Follow-up|1|||
155324081|NCT03858517|560623557|FG000|Overall Study|removed for being incarcerated|1|||
155324082|NCT03858517|560623557|FG000|Overall Study|Sponsor Closure|48|||
155324083|NCT00887198|560623559|FG000|Randomized Period|Ongoing|42|||
155324084|NCT00887198|560623560|FG001|Randomized Period|Ongoing|0|||
155324085|NCT00887198|560623561|FG002|Randomized Period|Ongoing|0|||
155324086|NCT00887198|560623559|FG000|Randomized Period|Adverse Event|50|||
155324087|NCT00887198|560623560|FG001|Randomized Period|Adverse Event|33|||
155324088|NCT00887198|560623561|FG002|Randomized Period|Adverse Event|0|||
155324089|NCT00887198|560623559|FG000|Randomized Period|Lost to Follow-up|1|||
155324090|NCT00887198|560623560|FG001|Randomized Period|Lost to Follow-up|0|||
155324091|NCT00887198|560623561|FG002|Randomized Period|Lost to Follow-up|0|||
155324092|NCT00887198|560623559|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
155324093|NCT00887198|560623560|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
155324094|NCT00887198|560623561|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
155324095|NCT00887198|560623559|FG000|Randomized Period|Withdrawal by Subject|41|||
155324096|NCT00887198|560623560|FG001|Randomized Period|Withdrawal by Subject|56|||
155324097|NCT00887198|560623561|FG002|Randomized Period|Withdrawal by Subject|0|||
155324098|NCT00887198|560623559|FG000|Randomized Period|Progressive disease|366|||
155324099|NCT00887198|560623560|FG001|Randomized Period|Progressive disease|370|||
155324100|NCT00887198|560623561|FG002|Randomized Period|Progressive disease|0|||
155324101|NCT00887198|560623559|FG000|Randomized Period|Other|42|||
155324102|NCT00887198|560623560|FG001|Randomized Period|Other|30|||
155324103|NCT00887198|560623561|FG002|Randomized Period|Other|0|||
155324104|NCT00887198|560623559|FG000|Randomized Period|Randomized, Not treated|4|||
155324105|NCT00887198|560623560|FG001|Randomized Period|Randomized, Not treated|2|||
155324106|NCT00887198|560623561|FG002|Randomized Period|Randomized, Not treated|0|||
155324107|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
155324108|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
155324109|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
155324110|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
155324111|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
155324112|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
155324113|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
155324114|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
155324115|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
155501875|NCT01488071|561263401|FG001|Overall Study|Administrative or Other Reason(s)|4|||
155501876|NCT02139306|561263402|FG000|Overall Study|Withdrawal by Subject|4|||
155501877|NCT02139306|561263403|FG001|Overall Study|Withdrawal by Subject|6|||
155501878|NCT02139306|561263402|FG000|Overall Study|Adverse Event|3|||
155324116|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
155501879|NCT02139306|561263403|FG001|Overall Study|Adverse Event|4|||
155501880|NCT02139306|561263402|FG000|Overall Study|Physician Decision|0|||
155501881|NCT02139306|561263403|FG001|Overall Study|Physician Decision|1|||
155501882|NCT02139306|561263402|FG000|Overall Study|Other Unspecified|2|||
155501883|NCT02139306|561263403|FG001|Overall Study|Other Unspecified|3|||
155501884|NCT02139306|561263402|FG000|Overall Study|Protocol Violation|4|||
155501885|NCT02139306|561263403|FG001|Overall Study|Protocol Violation|0|||
155501886|NCT04449354|561263404|FG000|Overall Study|Withdrawal by Subject|1|||
155501887|NCT01220128|561263405|FG000|Overall Study|Progressive disease|0|||
155501888|NCT01220128|561263406|FG001|Overall Study|Progressive disease|0|||
155501889|NCT01220128|561263407|FG002|Overall Study|Progressive disease|2|||
155501890|NCT01220128|561263408|FG003|Overall Study|Progressive disease|0|||
155501891|NCT01220128|561263409|FG004|Overall Study|Progressive disease|0|||
155501892|NCT01220128|561263410|FG005|Overall Study|Progressive disease|0|||
155501893|NCT01220128|561263411|FG006|Overall Study|Progressive disease|0|||
155501894|NCT01220128|561263405|FG000|Overall Study|Sponsor study termination|0|||
155324117|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
155324118|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
155324119|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
155501895|NCT01220128|561263406|FG001|Overall Study|Sponsor study termination|1|||
155501896|NCT01220128|561263407|FG002|Overall Study|Sponsor study termination|0|||
155324120|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
155324121|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
155324122|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Other|0|||
155324123|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Other|0|||
155324124|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Other|19|||
155324125|NCT02782676|560623562|FG000|Overall Study|Lost to Follow-up|0|||
155324126|NCT02782676|560623563|FG001|Overall Study|Lost to Follow-up|1|||
155324127|NCT05007080|560623564|FG000|Overall Study|Lost to Follow-up|0|||
155324128|NCT05007080|560623565|FG001|Overall Study|Lost to Follow-up|1|||
155324129|NCT05007080|560623566|FG002|Overall Study|Lost to Follow-up|0|||
155324130|NCT05007080|560623567|FG003|Overall Study|Lost to Follow-up|1|||
155324131|NCT05007080|560623568|FG004|Overall Study|Lost to Follow-up|1|||
155324132|NCT05007080|560623569|FG005|Overall Study|Lost to Follow-up|1|||
155324133|NCT05007080|560623564|FG000|Overall Study|Death|0|||
155324134|NCT05007080|560623565|FG001|Overall Study|Death|1|||
155324135|NCT05007080|560623566|FG002|Overall Study|Death|0|||
155324136|NCT05007080|560623567|FG003|Overall Study|Death|0|||
155324137|NCT05007080|560623568|FG004|Overall Study|Death|0|||
155324138|NCT05007080|560623569|FG005|Overall Study|Death|0|||
155324139|NCT05007080|560623564|FG000|Overall Study|Withdrawal by Subject|1|||
155324140|NCT05007080|560623565|FG001|Overall Study|Withdrawal by Subject|2|||
155324141|NCT05007080|560623566|FG002|Overall Study|Withdrawal by Subject|0|||
155324142|NCT05007080|560623567|FG003|Overall Study|Withdrawal by Subject|2|||
155324143|NCT05007080|560623568|FG004|Overall Study|Withdrawal by Subject|1|||
155324144|NCT05007080|560623569|FG005|Overall Study|Withdrawal by Subject|1|||
155324145|NCT05007080|560623564|FG000|Overall Study|Other|1|||
155324146|NCT05007080|560623565|FG001|Overall Study|Other|0|||
155324147|NCT05007080|560623566|FG002|Overall Study|Other|1|||
155324148|NCT05007080|560623567|FG003|Overall Study|Other|1|||
155324149|NCT05007080|560623568|FG004|Overall Study|Other|0|||
155324150|NCT05007080|560623569|FG005|Overall Study|Other|2|||
155324151|NCT05007080|560623564|FG000|Overall Study|Randomized not vaccinated|0|||
155324152|NCT05007080|560623565|FG001|Overall Study|Randomized not vaccinated|0|||
155324153|NCT05007080|560623566|FG002|Overall Study|Randomized not vaccinated|0|||
155324154|NCT05007080|560623567|FG003|Overall Study|Randomized not vaccinated|0|||
155324155|NCT05007080|560623568|FG004|Overall Study|Randomized not vaccinated|0|||
155324156|NCT05007080|560623569|FG005|Overall Study|Randomized not vaccinated|1|||
155324157|NCT02874742|560623571|FG000|Overall Study|Death|0|||
155324158|NCT02874742|560623572|FG001|Overall Study|Death|1|||
155324159|NCT02874742|560623573|FG002|Overall Study|Death|0|||
155324160|NCT02874742|560623571|FG000|Overall Study|Lost to Follow-up|5|||
155324161|NCT02874742|560623572|FG001|Overall Study|Lost to Follow-up|4|||
155324162|NCT02874742|560623573|FG002|Overall Study|Lost to Follow-up|1|||
155324163|NCT02874742|560623571|FG000|Overall Study|Withdrawal by Subject|17|||
155501897|NCT01220128|561263408|FG003|Overall Study|Sponsor study termination|0|||
155501898|NCT01220128|561263409|FG004|Overall Study|Sponsor study termination|0|||
155501899|NCT01220128|561263410|FG005|Overall Study|Sponsor study termination|0|||
155501900|NCT01220128|561263411|FG006|Overall Study|Sponsor study termination|1|||
155501901|NCT01220128|561263405|FG000|Overall Study|Adverse event, serious fatal|2|||
155501902|NCT01220128|561263406|FG001|Overall Study|Adverse event, serious fatal|0|||
155501903|NCT01220128|561263407|FG002|Overall Study|Adverse event, serious fatal|0|||
155501904|NCT01220128|561263408|FG003|Overall Study|Adverse event, serious fatal|0|||
155501905|NCT01220128|561263409|FG004|Overall Study|Adverse event, serious fatal|0|||
155501906|NCT01220128|561263410|FG005|Overall Study|Adverse event, serious fatal|0|||
155501907|NCT01220128|561263411|FG006|Overall Study|Adverse event, serious fatal|1|||
155501908|NCT01220128|561263405|FG000|Overall Study|Adverse event, non-fatal|1|||
155501909|NCT01220128|561263406|FG001|Overall Study|Adverse event, non-fatal|0|||
155501910|NCT01220128|561263407|FG002|Overall Study|Adverse event, non-fatal|0|||
155501911|NCT01220128|561263408|FG003|Overall Study|Adverse event, non-fatal|0|||
155501912|NCT01220128|561263409|FG004|Overall Study|Adverse event, non-fatal|0|||
155501913|NCT01220128|561263410|FG005|Overall Study|Adverse event, non-fatal|0|||
155501914|NCT01220128|561263411|FG006|Overall Study|Adverse event, non-fatal|3|||
155501915|NCT01220128|561263405|FG000|Overall Study|Other|0|||
155501916|NCT01220128|561263406|FG001|Overall Study|Other|0|||
155501917|NCT01220128|561263407|FG002|Overall Study|Other|1|||
155501918|NCT01220128|561263408|FG003|Overall Study|Other|0|||
155501919|NCT01220128|561263409|FG004|Overall Study|Other|0|||
155324164|NCT02874742|560623572|FG001|Overall Study|Withdrawal by Subject|8|||
155324165|NCT02874742|560623573|FG002|Overall Study|Withdrawal by Subject|0|||
155324166|NCT02874742|560623571|FG000|Overall Study|Other|4|||
155324167|NCT02874742|560623572|FG001|Overall Study|Other|1|||
155324168|NCT02874742|560623573|FG002|Overall Study|Other|0|||
155324169|NCT02874742|560623571|FG000|Overall Study|Progressive Disease|1|||
155324170|NCT02874742|560623572|FG001|Overall Study|Progressive Disease|0|||
155324171|NCT02874742|560623573|FG002|Overall Study|Progressive Disease|0|||
155324172|NCT02874742|560623571|FG000|Overall Study|Screen Failure|0|||
155324173|NCT02874742|560623572|FG001|Overall Study|Screen Failure|2|||
155324174|NCT02874742|560623573|FG002|Overall Study|Screen Failure|0|||
155501920|NCT01220128|561263410|FG005|Overall Study|Other|0|||
155501921|NCT01220128|561263411|FG006|Overall Study|Other|0|||
155324175|NCT00631475|560623579|FG000|Overall Study|Death|18|||
155324176|NCT00631475|560623579|FG000|Overall Study|Adverse Event|14|||
155324177|NCT00631475|560623579|FG000|Overall Study|Withdrew consent|5|||
155324178|NCT00631475|560623579|FG000|Overall Study|Preparation for lung transplant|8|||
155324179|NCT00303459|560623580|FG000|Overall Study|Death|33|||
155324180|NCT00303459|560623581|FG001|Overall Study|Death|44|||
155324181|NCT00303459|560623580|FG000|Overall Study|Withdrawal of consent|32|||
155324182|NCT00303459|560623581|FG001|Overall Study|Withdrawal of consent|26|||
155324183|NCT00303459|560623580|FG000|Overall Study|Lost to Follow-up|5|||
155324184|NCT00303459|560623581|FG001|Overall Study|Lost to Follow-up|4|||
155324185|NCT00303459|560623580|FG000|Overall Study|Administrative reason|7|||
155324186|NCT00303459|560623581|FG001|Overall Study|Administrative reason|7|||
155324187|NCT00303459|560623580|FG000|Overall Study|Decision by the investigator|5|||
155324188|NCT00303459|560623581|FG001|Overall Study|Decision by the investigator|7|||
155324189|NCT00303459|560623580|FG000|Overall Study|Lung transplantation|1|||
155324190|NCT00303459|560623581|FG001|Overall Study|Lung transplantation|1|||
155324191|NCT02492711|560623584|FG000|Overall Study|Adverse Event|9|||
155324192|NCT02492711|560623585|FG001|Overall Study|Adverse Event|9|||
155324193|NCT02492711|560623586|FG002|Overall Study|Adverse Event|2|||
155324194|NCT02492711|560623584|FG000|Overall Study|Death|3|||
155324195|NCT02492711|560623585|FG001|Overall Study|Death|3|||
155324196|NCT02492711|560623586|FG002|Overall Study|Death|0|||
155324197|NCT02492711|560623584|FG000|Overall Study|Withdrawal by Subject|10|||
155324198|NCT02492711|560623585|FG001|Overall Study|Withdrawal by Subject|16|||
155324199|NCT02492711|560623586|FG002|Overall Study|Withdrawal by Subject|5|||
155324200|NCT02492711|560623584|FG000|Overall Study|Physician Decision|10|||
155324201|NCT02492711|560623585|FG001|Overall Study|Physician Decision|6|||
155324202|NCT02492711|560623586|FG002|Overall Study|Physician Decision|4|||
155324203|NCT02492711|560623584|FG000|Overall Study|Lost to Follow-up|0|||
155324204|NCT02492711|560623585|FG001|Overall Study|Lost to Follow-up|0|||
155324205|NCT02492711|560623586|FG002|Overall Study|Lost to Follow-up|1|||
155421143|NCT02631538|560972501|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
155421144|NCT02631538|560972502|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
155421145|NCT02631538|560972503|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
155421146|NCT02631538|560972500|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
155421147|NCT02631538|560972501|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
155421148|NCT02631538|560972502|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
155421149|NCT02631538|560972503|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
155421150|NCT02631538|560972500|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
155421151|NCT02631538|560972501|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
155421152|NCT02631538|560972502|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
155421153|NCT02631538|560972503|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
155421154|NCT02631538|560972500|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
155421155|NCT02631538|560972501|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
155421156|NCT02631538|560972502|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
155421157|NCT02631538|560972503|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
155421158|NCT02631538|560972500|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
155421159|NCT02631538|560972501|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
155421160|NCT02631538|560972502|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
155421161|NCT02631538|560972503|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
155421162|NCT02631538|560972500|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
155421163|NCT02631538|560972501|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
155421164|NCT02631538|560972502|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
155421165|NCT02631538|560972503|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
155421166|NCT01688050|560972504|FG000|Overall Study|Death|7|||
155421167|NCT01688050|560972504|FG000|Overall Study|Conversion to open repair|1|||
155421168|NCT01688050|560972504|FG000|Overall Study|Lost to Follow-up|13|||
155421169|NCT01688050|560972504|FG000|Overall Study|Withdrawal by Subject|10|||
155421170|NCT01848145|560972505|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
155421171|NCT01848145|560972505|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
155421172|NCT01848145|560972505|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
155421173|NCT01848145|560972505|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
155421174|NCT01848145|560972505|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
155421175|NCT01848145|560972505|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
155421176|NCT01848145|560972505|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
155421177|NCT01554579|560972506|FG000|Overall Study|Adverse Event|6|||
155324206|NCT02492711|560623584|FG000|Overall Study|study treatment delay|2|||
155324207|NCT02492711|560623585|FG001|Overall Study|study treatment delay|1|||
155324208|NCT02492711|560623586|FG002|Overall Study|study treatment delay|0|||
155324209|NCT02492711|560623584|FG000|Overall Study|change in chemotherapy|0|||
155324210|NCT02492711|560623585|FG001|Overall Study|change in chemotherapy|1|||
155324211|NCT02492711|560623586|FG002|Overall Study|change in chemotherapy|0|||
155324212|NCT02492711|560623584|FG000|Overall Study|never treated|2|||
155324213|NCT02492711|560623585|FG001|Overall Study|never treated|4|||
155324214|NCT02492711|560623586|FG002|Overall Study|never treated|0|||
155324215|NCT02492711|560623584|FG000|Overall Study|Other|0|||
155324216|NCT02492711|560623585|FG001|Overall Study|Other|0|||
155324217|NCT02492711|560623586|FG002|Overall Study|Other|1|||
155324218|NCT05830799|560623591|FG000|Overall Study|Withdrawal by Subject|1|||
155324219|NCT04109066|560623603|FG000|Pre-treatment|Participant withdrew consent|2|||
155324220|NCT04109066|560623604|FG001|Pre-treatment|Participant withdrew consent|0|||
155324221|NCT04109066|560623603|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
155421178|NCT01554579|560972507|FG001|Overall Study|Adverse Event|25|||
155324222|NCT04109066|560623604|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
155421179|NCT01554579|560972506|FG000|Overall Study|Lack of Efficacy|2|||
155421180|NCT01554579|560972507|FG001|Overall Study|Lack of Efficacy|1|||
155421181|NCT01554579|560972506|FG000|Overall Study|Withdrawal by Subject|2|||
155421182|NCT01554579|560972507|FG001|Overall Study|Withdrawal by Subject|1|||
155421183|NCT00234039|560972508|FG000|Overall Study|Adverse Event|2|||
155421184|NCT00234039|560972508|FG000|Overall Study|Progression/relapse|34|||
155421185|NCT00234039|560972508|FG000|Overall Study|Other - Not Protocol Specified|3|||
155421186|NCT00234039|560972508|FG000|Overall Study|Ineligible|9|||
155421187|NCT00234039|560972508|FG000|Overall Study|No Protocol Treatment Received|2|||
155421188|NCT03683394|560972509|FG000|Overall Study|Withdrawal by Subject|4|||
155421189|NCT03683394|560972510|FG001|Overall Study|Withdrawal by Subject|8|||
155421190|NCT03683394|560972509|FG000|Overall Study|Lost to Follow-up|7|||
155421191|NCT03683394|560972510|FG001|Overall Study|Lost to Follow-up|0|||
155421192|NCT03683394|560972509|FG000|Overall Study|Death|3|||
155421193|NCT03683394|560972510|FG001|Overall Study|Death|1|||
155421194|NCT03072160|560972513|FG000|Overall Study|Adverse Event|3|||
155421195|NCT03072160|560972514|FG001|Overall Study|Adverse Event|1|||
155421196|NCT03072160|560972513|FG000|Overall Study|Refused further treatment|6|||
155421197|NCT03072160|560972514|FG001|Overall Study|Refused further treatment|1|||
155421198|NCT03072160|560972513|FG000|Overall Study|Physician Decision|1|||
155421199|NCT03072160|560972514|FG001|Overall Study|Physician Decision|0|||
155421200|NCT03072160|560972513|FG000|Overall Study|Disease progression on study|1|||
155421201|NCT03072160|560972514|FG001|Overall Study|Disease progression on study|1|||
155421202|NCT03072160|560972513|FG000|Overall Study|No contact|0|||
155421203|NCT03072160|560972514|FG001|Overall Study|No contact|1|||
155421204|NCT04426695|560972515|FG000|Overall Study|Death|2|||
155421205|NCT04426695|560972516|FG001|Overall Study|Death|0|||
155421206|NCT04426695|560972517|FG002|Overall Study|Death|1|||
155421207|NCT04426695|560972518|FG003|Overall Study|Death|27|||
155421208|NCT04426695|560972519|FG004|Overall Study|Death|25|||
155421209|NCT04426695|560972520|FG005|Overall Study|Death|21|||
155421210|NCT04426695|560972521|FG006|Overall Study|Death|42|||
155421211|NCT04426695|560972522|FG007|Overall Study|Death|23|||
155421212|NCT04426695|560972523|FG008|Overall Study|Death|37|||
155421213|NCT04426695|560972524|FG009|Overall Study|Death|14|||
155421214|NCT04426695|560972525|FG010|Overall Study|Death|8|||
155421215|NCT04426695|560972526|FG011|Overall Study|Death|7|||
155421216|NCT04426695|560972527|FG012|Overall Study|Death|13|||
155421217|NCT04426695|560972528|FG013|Overall Study|Death|25|||
155421218|NCT04426695|560972529|FG014|Overall Study|Death|19|||
155421219|NCT04426695|560972530|FG015|Overall Study|Death|7|||
155421220|NCT04426695|560972531|FG016|Overall Study|Death|8|||
155421221|NCT04426695|560972532|FG017|Overall Study|Death|4|||
155421222|NCT04426695|560972515|FG000|Overall Study|Lost to Follow-up|2|||
155421223|NCT04426695|560972516|FG001|Overall Study|Lost to Follow-up|4|||
155421224|NCT04426695|560972517|FG002|Overall Study|Lost to Follow-up|1|||
155421225|NCT04426695|560972518|FG003|Overall Study|Lost to Follow-up|19|||
155421226|NCT04426695|560972519|FG004|Overall Study|Lost to Follow-up|10|||
155421227|NCT04426695|560972520|FG005|Overall Study|Lost to Follow-up|14|||
155421228|NCT04426695|560972521|FG006|Overall Study|Lost to Follow-up|5|||
155324223|NCT04109066|560623603|FG000|Treatment|Lack of Efficacy|2|||
155421229|NCT04426695|560972522|FG007|Overall Study|Lost to Follow-up|14|||
155421230|NCT04426695|560972523|FG008|Overall Study|Lost to Follow-up|10|||
155421231|NCT04426695|560972524|FG009|Overall Study|Lost to Follow-up|11|||
155421232|NCT04426695|560972525|FG010|Overall Study|Lost to Follow-up|12|||
155421233|NCT04426695|560972526|FG011|Overall Study|Lost to Follow-up|6|||
155421234|NCT04426695|560972527|FG012|Overall Study|Lost to Follow-up|2|||
155421235|NCT04426695|560972528|FG013|Overall Study|Lost to Follow-up|2|||
155421236|NCT04426695|560972529|FG014|Overall Study|Lost to Follow-up|2|||
155324224|NCT04109066|560623604|FG001|Treatment|Lack of Efficacy|4|||
155324225|NCT04109066|560623603|FG000|Treatment|Adverse Event|23|||
155324226|NCT04109066|560623604|FG001|Treatment|Adverse Event|7|||
155421237|NCT04426695|560972530|FG015|Overall Study|Lost to Follow-up|0|||
155421238|NCT04426695|560972531|FG016|Overall Study|Lost to Follow-up|0|||
155421239|NCT04426695|560972532|FG017|Overall Study|Lost to Follow-up|0|||
155421240|NCT04426695|560972515|FG000|Overall Study|Participant Decision|1|||
155421241|NCT04426695|560972516|FG001|Overall Study|Participant Decision|2|||
155421242|NCT04426695|560972517|FG002|Overall Study|Participant Decision|2|||
155421243|NCT04426695|560972518|FG003|Overall Study|Participant Decision|12|||
155421244|NCT04426695|560972519|FG004|Overall Study|Participant Decision|18|||
155324227|NCT04109066|560623603|FG000|Treatment|Participant request to discontinue Study treatment|15|||
155324228|NCT04109066|560623604|FG001|Treatment|Participant request to discontinue Study treatment|14|||
155324229|NCT04109066|560623603|FG000|Treatment|Withdrawal by Subject|8|||
155324230|NCT04109066|560623604|FG001|Treatment|Withdrawal by Subject|8|||
155324231|NCT04109066|560623603|FG000|Treatment|Death|3|||
155324232|NCT04109066|560623604|FG001|Treatment|Death|0|||
155324233|NCT04109066|560623603|FG000|Treatment|Participant no longer meets study criteria|2|||
155324234|NCT04109066|560623604|FG001|Treatment|Participant no longer meets study criteria|2|||
155324235|NCT04109066|560623603|FG000|Treatment|Administrative reasons by sponsor|2|||
155324236|NCT04109066|560623604|FG001|Treatment|Administrative reasons by sponsor|3|||
155324237|NCT04109066|560623603|FG000|Treatment|Other reasons|17|||
155324238|NCT04109066|560623604|FG001|Treatment|Other reasons|23|||
155324239|NCT04109066|560623603|FG000|Treatment|Disease Progression|4|||
155324240|NCT04109066|560623604|FG001|Treatment|Disease Progression|7|||
155324241|NCT04109066|560623603|FG000|Treatment|Study drug toxicity|12|||
155324242|NCT04109066|560623604|FG001|Treatment|Study drug toxicity|5|||
155324243|NCT04109066|560623603|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
155324244|NCT04109066|560623604|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
155324245|NCT04109066|560623603|FG000|Treatment|Disease Recurrence|0|||
155324246|NCT04109066|560623604|FG001|Treatment|Disease Recurrence|2|||
155324247|NCT04109066|560623603|FG000|Treatment|Not reported|4|||
155324248|NCT04109066|560623604|FG001|Treatment|Not reported|8|||
155324249|NCT05205161|560623605|FG000|Overall Study|Study terminated by sponsor|3|||
155324250|NCT05205161|560623606|FG001|Overall Study|Study terminated by sponsor|3|||
155421245|NCT04426695|560972520|FG005|Overall Study|Participant Decision|22|||
155421246|NCT04426695|560972521|FG006|Overall Study|Participant Decision|13|||
155644438|NCT02082483|561788290|FG001|Overall Study|Death|3|||
155644439|NCT01028560|561788293|FG000|Overall Study|Lack of Efficacy|3|||
155644440|NCT01028560|561788294|FG001|Overall Study|Lack of Efficacy|6|||
155644441|NCT01028560|561788293|FG000|Overall Study|Withdrawal by Subject|7|||
155644442|NCT01028560|561788294|FG001|Overall Study|Withdrawal by Subject|12|||
155644443|NCT01060111|561788295|FG000|Overall Study|Adverse Event|9|||
155644444|NCT01060111|561788296|FG001|Overall Study|Adverse Event|5|||
155644445|NCT01060111|561788297|FG002|Overall Study|Adverse Event|18|||
155644446|NCT01060111|561788295|FG000|Overall Study|Lack of Efficacy|2|||
155644447|NCT01060111|561788296|FG001|Overall Study|Lack of Efficacy|1|||
155644448|NCT01060111|561788297|FG002|Overall Study|Lack of Efficacy|0|||
155644449|NCT01060111|561788295|FG000|Overall Study|Inappropriate participant|5|||
155644450|NCT01060111|561788296|FG001|Overall Study|Inappropriate participant|4|||
155644451|NCT01060111|561788297|FG002|Overall Study|Inappropriate participant|5|||
155644452|NCT01060111|561788295|FG000|Overall Study|Participants' evasion for hospital visit|0|||
155644453|NCT01060111|561788296|FG001|Overall Study|Participants' evasion for hospital visit|3|||
155644454|NCT01060111|561788297|FG002|Overall Study|Participants' evasion for hospital visit|2|||
155644455|NCT01060111|561788295|FG000|Overall Study|Participants' non-cooperation|8|||
155644456|NCT01060111|561788296|FG001|Overall Study|Participants' non-cooperation|6|||
155324251|NCT05205161|560623607|FG002|Overall Study|Study terminated by sponsor|1|||
155421247|NCT04426695|560972522|FG007|Overall Study|Participant Decision|13|||
155324252|NCT04369911|560623609|FG000|Overall Study|Lost to Follow-up|3|||
155324253|NCT04369911|560623610|FG001|Overall Study|Lost to Follow-up|3|||
155324254|NCT04369911|560623609|FG000|Overall Study|Withdrawal by Subject|1|||
155421248|NCT04426695|560972523|FG008|Overall Study|Participant Decision|10|||
155421249|NCT04426695|560972524|FG009|Overall Study|Participant Decision|15|||
155421250|NCT04426695|560972525|FG010|Overall Study|Participant Decision|16|||
155421251|NCT04426695|560972526|FG011|Overall Study|Participant Decision|17|||
155421252|NCT04426695|560972527|FG012|Overall Study|Participant Decision|2|||
155421253|NCT04426695|560972528|FG013|Overall Study|Participant Decision|1|||
155644457|NCT01060111|561788297|FG002|Overall Study|Participants' non-cooperation|6|||
155644458|NCT01060111|561788295|FG000|Overall Study|Adverse event and insufficient effect|0|||
155644459|NCT01060111|561788296|FG001|Overall Study|Adverse event and insufficient effect|1|||
155644460|NCT01060111|561788297|FG002|Overall Study|Adverse event and insufficient effect|0|||
155644461|NCT01060111|561788295|FG000|Overall Study|Participants' non-cooperation|1|||
155644462|NCT01060111|561788296|FG001|Overall Study|Participants' non-cooperation|0|||
155644463|NCT01060111|561788297|FG002|Overall Study|Participants' non-cooperation|0|||
155644464|NCT01060111|561788295|FG000|Overall Study|Other|2|||
155644465|NCT01060111|561788296|FG001|Overall Study|Other|3|||
155644466|NCT01060111|561788297|FG002|Overall Study|Other|4|||
155644467|NCT05278065|561788298|FG000|Overall Study|Withdrawal by Subject|1|||
155644468|NCT05278065|561788299|FG001|Overall Study|Withdrawal by Subject|0|||
155644469|NCT04149353|561788300|FG000|Overall Study|Study terminated|1|||
155644470|NCT01871727|561788301|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
155644471|NCT01871727|561788302|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
155644472|NCT01871727|561788303|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
155644473|NCT01871727|561788304|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
155644474|NCT01871727|561788305|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
155644475|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
155324255|NCT04369911|560623610|FG001|Overall Study|Withdrawal by Subject|2|||
155324256|NCT04163991|560623613|FG000|Overall Study|Adverse Event|0|||
155324257|NCT04163991|560623614|FG001|Overall Study|Adverse Event|0|||
155324258|NCT04163991|560623615|FG002|Overall Study|Adverse Event|0|||
155324259|NCT04163991|560623616|FG003|Overall Study|Adverse Event|1|||
155324260|NCT04163991|560623617|FG004|Overall Study|Adverse Event|0|||
155324261|NCT04163991|560623613|FG000|Overall Study|Death|0|||
155324262|NCT04163991|560623614|FG001|Overall Study|Death|0|||
155324263|NCT04163991|560623615|FG002|Overall Study|Death|1|||
155324264|NCT04163991|560623616|FG003|Overall Study|Death|0|||
155324265|NCT04163991|560623617|FG004|Overall Study|Death|0|||
155324266|NCT04163991|560623613|FG000|Overall Study|Lost to Follow-up|0|||
155324267|NCT04163991|560623614|FG001|Overall Study|Lost to Follow-up|1|||
155324268|NCT04163991|560623615|FG002|Overall Study|Lost to Follow-up|0|||
155324269|NCT04163991|560623616|FG003|Overall Study|Lost to Follow-up|0|||
155324270|NCT04163991|560623617|FG004|Overall Study|Lost to Follow-up|0|||
155324271|NCT04163991|560623613|FG000|Overall Study|Withdrawal by Subject|1|||
155324272|NCT04163991|560623614|FG001|Overall Study|Withdrawal by Subject|1|||
155324273|NCT04163991|560623615|FG002|Overall Study|Withdrawal by Subject|3|||
155324274|NCT04163991|560623616|FG003|Overall Study|Withdrawal by Subject|1|||
155324275|NCT04163991|560623617|FG004|Overall Study|Withdrawal by Subject|1|||
155324276|NCT04163991|560623613|FG000|Overall Study|Other, Not Specified|0|||
155324277|NCT04163991|560623614|FG001|Overall Study|Other, Not Specified|1|||
155324278|NCT04163991|560623615|FG002|Overall Study|Other, Not Specified|1|||
155324279|NCT04163991|560623616|FG003|Overall Study|Other, Not Specified|1|||
155324280|NCT04163991|560623617|FG004|Overall Study|Other, Not Specified|0|||
155324281|NCT02510235|560623619|FG000|Overall Study|Withdrawal by Subject|1|||
155324282|NCT02510235|560623620|FG001|Overall Study|Withdrawal by Subject|0|||
155324283|NCT00450216|560623621|FG000|Overall Study|Adverse Event|38|||
155324284|NCT00450216|560623622|FG001|Overall Study|Adverse Event|23|||
155324285|NCT00450216|560623621|FG000|Overall Study|Withdrawal by Subject|48|||
155324286|NCT00450216|560623622|FG001|Overall Study|Withdrawal by Subject|26|||
155324287|NCT00450216|560623621|FG000|Overall Study|Lost to Follow-up|16|||
155324288|NCT00450216|560623622|FG001|Overall Study|Lost to Follow-up|9|||
155324289|NCT00450216|560623621|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
155324290|NCT00450216|560623622|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
155324291|NCT00450216|560623621|FG000|Overall Study|misc|21|||
155324292|NCT00450216|560623622|FG001|Overall Study|misc|20|||
155324293|NCT05008055|560623623|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
155324294|NCT05008055|560623624|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
155324295|NCT05008055|560623625|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
155501922|NCT01220128|561263405|FG000|Overall Study|Consent withdrawn by subject|1|||
155501923|NCT01220128|561263406|FG001|Overall Study|Consent withdrawn by subject|0|||
155501924|NCT01220128|561263407|FG002|Overall Study|Consent withdrawn by subject|0|||
155501925|NCT01220128|561263408|FG003|Overall Study|Consent withdrawn by subject|0|||
155501926|NCT01220128|561263409|FG004|Overall Study|Consent withdrawn by subject|0|||
155501927|NCT01220128|561263410|FG005|Overall Study|Consent withdrawn by subject|0|||
155501928|NCT01220128|561263411|FG006|Overall Study|Consent withdrawn by subject|0|||
155501929|NCT02508649|561263415|FG000|Overall Study|Withdrawal by Subject|4|||
155324296|NCT03011034|560623633|FG000|Overall Study|Adverse Event|1|||
155324297|NCT03011034|560623634|FG001|Overall Study|Adverse Event|0|||
155324298|NCT02461134|560623640|FG000|Overall Study|Adverse Event|1|||
155324299|NCT03165955|560623641|FG000|Treatment|Withdrawal by Subject|3|||
155324300|NCT03165955|560623641|FG000|Treatment|Death|1|||
155324301|NCT03165955|560623641|FG000|Treatment|Adverse Event|1|||
155324302|NCT03165955|560623641|FG000|Treatment|Progressive disease|3|||
155324303|NCT00626795|560623642|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
155324304|NCT00626795|560623643|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
155324305|NCT00626795|560623644|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
155324306|NCT00626795|560623642|FG000|Blinded Treatment|Lack of Efficacy|2|||
155324307|NCT00626795|560623643|FG001|Blinded Treatment|Lack of Efficacy|0|||
155324308|NCT00626795|560623644|FG002|Blinded Treatment|Lack of Efficacy|0|||
155324309|NCT00626795|560623642|FG000|Blinded Treatment|Unacceptable adverse event|0|||
155324310|NCT00626795|560623643|FG001|Blinded Treatment|Unacceptable adverse event|0|||
155501930|NCT02508649|561263416|FG001|Overall Study|Withdrawal by Subject|6|||
155324311|NCT00626795|560623644|FG002|Blinded Treatment|Unacceptable adverse event|1|||
155324312|NCT00626795|560623642|FG000|Blinded Treatment|Protocol Violation|0|||
155324313|NCT00626795|560623643|FG001|Blinded Treatment|Protocol Violation|1|||
155324314|NCT00626795|560623644|FG002|Blinded Treatment|Protocol Violation|1|||
155324315|NCT00626795|560623642|FG000|Blinded Treatment|Withdrawal by Subject|1|||
155324316|NCT00626795|560623643|FG001|Blinded Treatment|Withdrawal by Subject|1|||
155324317|NCT00626795|560623644|FG002|Blinded Treatment|Withdrawal by Subject|0|||
155324318|NCT00626795|560623642|FG000|Blinded Treatment|Other reasons|2|||
155324319|NCT00626795|560623643|FG001|Blinded Treatment|Other reasons|0|||
155501931|NCT02508649|561263417|FG002|Overall Study|Withdrawal by Subject|5|||
155501932|NCT02508649|561263418|FG003|Overall Study|Withdrawal by Subject|6|||
155644476|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
155644477|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
155644478|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
155644479|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
155644480|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155324320|NCT00626795|560623644|FG002|Blinded Treatment|Other reasons|2|||
155324321|NCT00626795|560623642|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
155324322|NCT00626795|560623643|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
155324323|NCT00626795|560623644|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
155324324|NCT03493542|560623645|FG000|Base Study|Withdrawal by Subject|0|||
155324325|NCT03493542|560623646|FG001|Base Study|Withdrawal by Subject|4|||
155324326|NCT03493542|560623647|FG002|Base Study|Withdrawal by Subject|0|||
155324327|NCT03493542|560623645|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
155324328|NCT03493542|560623646|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
155324329|NCT03493542|560623647|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
155324330|NCT03493542|560623645|FG000|Extension Study|Withdrawal by Subject|0|||
155644481|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155644482|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155324331|NCT03493542|560623646|FG001|Extension Study|Withdrawal by Subject|0|||
155324332|NCT03493542|560623647|FG002|Extension Study|Withdrawal by Subject|25|||
155324333|NCT04499521|560623648|FG000|Overall Study|Disease Progression|1|||
155324334|NCT04499521|560623649|FG001|Overall Study|Disease Progression|0|||
155324335|NCT04244175|560624368|FG000|Overall Study|Adverse Event|3|||
155324336|NCT04244175|560624369|FG001|Overall Study|Adverse Event|2|||
155324337|NCT04244175|560624370|FG002|Overall Study|Adverse Event|5|||
155324338|NCT04244175|560624368|FG000|Overall Study|Lack of Efficacy|1|||
155324339|NCT04244175|560624369|FG001|Overall Study|Lack of Efficacy|0|||
155324340|NCT04244175|560624370|FG002|Overall Study|Lack of Efficacy|1|||
155324341|NCT04244175|560624368|FG000|Overall Study|Lost to Follow-up|1|||
155324342|NCT04244175|560624369|FG001|Overall Study|Lost to Follow-up|0|||
155324343|NCT04244175|560624370|FG002|Overall Study|Lost to Follow-up|0|||
155324344|NCT04244175|560624368|FG000|Overall Study|Non-compliance with study drug|1|||
155324345|NCT04244175|560624369|FG001|Overall Study|Non-compliance with study drug|0|||
155324346|NCT04244175|560624370|FG002|Overall Study|Non-compliance with study drug|1|||
155324347|NCT04244175|560624368|FG000|Overall Study|Protocol deviation|0|||
155324348|NCT04244175|560624369|FG001|Overall Study|Protocol deviation|1|||
155324349|NCT04244175|560624370|FG002|Overall Study|Protocol deviation|0|||
155324350|NCT04244175|560624368|FG000|Overall Study|Withdrawal by Subject|1|||
155324351|NCT04244175|560624369|FG001|Overall Study|Withdrawal by Subject|3|||
155324352|NCT04244175|560624370|FG002|Overall Study|Withdrawal by Subject|1|||
155324353|NCT04244175|560624368|FG000|Overall Study|Other, not specified|0|||
155324354|NCT04244175|560624369|FG001|Overall Study|Other, not specified|1|||
155324355|NCT04244175|560624370|FG002|Overall Study|Other, not specified|2|||
155324356|NCT03417284|560624371|FG000|Overall Study|Inadequate supply on study drug|1|||
155324357|NCT03417284|560624372|FG001|Overall Study|Inadequate supply on study drug|0|||
155324358|NCT03417284|560624373|FG002|Overall Study|Inadequate supply on study drug|0|||
155324359|NCT03417284|560624374|FG003|Overall Study|Inadequate supply on study drug|0|||
155324360|NCT03417284|560624371|FG000|Overall Study|Disease Progression|0|||
155421254|NCT04426695|560972529|FG014|Overall Study|Participant Decision|2|||
155421255|NCT04426695|560972530|FG015|Overall Study|Participant Decision|0|||
155421256|NCT04426695|560972531|FG016|Overall Study|Participant Decision|0|||
155421257|NCT04426695|560972532|FG017|Overall Study|Participant Decision|0|||
155421258|NCT04426695|560972515|FG000|Overall Study|Adverse Event|0|||
155421259|NCT04426695|560972516|FG001|Overall Study|Adverse Event|0|||
155421260|NCT04426695|560972517|FG002|Overall Study|Adverse Event|0|||
155421261|NCT04426695|560972518|FG003|Overall Study|Adverse Event|0|||
155421262|NCT04426695|560972519|FG004|Overall Study|Adverse Event|0|||
155644483|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155324361|NCT03417284|560624372|FG001|Overall Study|Disease Progression|0|||
155324362|NCT03417284|560624373|FG002|Overall Study|Disease Progression|1|||
155324363|NCT03417284|560624374|FG003|Overall Study|Disease Progression|0|||
155421263|NCT04426695|560972520|FG005|Overall Study|Adverse Event|0|||
155421264|NCT04426695|560972521|FG006|Overall Study|Adverse Event|0|||
155421265|NCT04426695|560972522|FG007|Overall Study|Adverse Event|1|||
155421266|NCT04426695|560972523|FG008|Overall Study|Adverse Event|0|||
155421267|NCT04426695|560972524|FG009|Overall Study|Adverse Event|0|||
155421268|NCT04426695|560972525|FG010|Overall Study|Adverse Event|1|||
155421269|NCT04426695|560972526|FG011|Overall Study|Adverse Event|1|||
155324364|NCT03636490|560624375|FG000|Overall Study|Dropped out or incomplete data|141|||
155324365|NCT02278211|560624378|FG000|Overall Study|Unable to analyse PET scan|2|||
155324366|NCT06037668|560624381|FG000|Overall Study|Lost to Follow-up|1|||
155421270|NCT04426695|560972527|FG012|Overall Study|Adverse Event|0|||
155421271|NCT04426695|560972528|FG013|Overall Study|Adverse Event|0|||
155421272|NCT04426695|560972529|FG014|Overall Study|Adverse Event|0|||
155324367|NCT06037668|560624382|FG001|Overall Study|Lost to Follow-up|1|||
155324368|NCT06037668|560624381|FG000|Overall Study|Protocol Violation|1|||
155324369|NCT06037668|560624382|FG001|Overall Study|Protocol Violation|0|||
155324370|NCT06037668|560624381|FG000|Overall Study|Withdrawal by Subject|1|||
155324371|NCT06037668|560624382|FG001|Overall Study|Withdrawal by Subject|0|||
155324372|NCT06037668|560624381|FG000|Overall Study|Other Study Discontinuation Reason|1|||
155324373|NCT06037668|560624382|FG001|Overall Study|Other Study Discontinuation Reason|0|||
155324374|NCT04804540|560624383|FG000|Overall Study|Adverse Event|26|||
155324375|NCT04804540|560624384|FG001|Overall Study|Adverse Event|13|||
155324376|NCT05172232|560624385|FG000|Overall Study|Lost to Follow-up|3|||
155324377|NCT04881461|560624386|FG000|Overall Study|Adverse Event|2|||
155324378|NCT04881461|560624387|FG001|Overall Study|Adverse Event|4|||
155324379|NCT04881461|560624386|FG000|Overall Study|Withdrawal by Subject|19|||
155324380|NCT04881461|560624387|FG001|Overall Study|Withdrawal by Subject|19|||
155324381|NCT04881461|560624386|FG000|Overall Study|Lost to Follow-up|4|||
155324382|NCT04881461|560624387|FG001|Overall Study|Lost to Follow-up|4|||
155324383|NCT04881461|560624386|FG000|Overall Study|Lack of Efficacy|1|||
155324384|NCT04881461|560624387|FG001|Overall Study|Lack of Efficacy|0|||
155324385|NCT04881461|560624386|FG000|Overall Study|"Reason stated as other in CRF"|1|||
155324386|NCT04881461|560624387|FG001|Overall Study|"Reason stated as other in CRF"|2|||
155324387|NCT02997202|560624388|FG000|Overall Study|Miscellaneous|2|||
155324388|NCT02997202|560624389|FG001|Overall Study|Miscellaneous|2|||
155324389|NCT02997202|560624388|FG000|Overall Study|Withdrawal by Subject|8|||
155324390|NCT02997202|560624389|FG001|Overall Study|Withdrawal by Subject|12|||
155324391|NCT02997202|560624388|FG000|Overall Study|Lost to Follow-up|5|||
155324392|NCT02997202|560624389|FG001|Overall Study|Lost to Follow-up|3|||
155324393|NCT02997202|560624388|FG000|Overall Study|Death|41|||
155324394|NCT02997202|560624389|FG001|Overall Study|Death|45|||
155324395|NCT04629339|560624393|FG000|Overall Study|Death|1|||
155324396|NCT04629339|560624394|FG001|Overall Study|Death|0|||
155324397|NCT04629339|560624395|FG002|Overall Study|Death|2|||
155324398|NCT04629339|560624396|FG003|Overall Study|Death|2|||
155324399|NCT04629339|560624397|FG004|Overall Study|Death|0|||
155324400|NCT04629339|560624393|FG000|Overall Study|Disease Progression|0|||
155324401|NCT04629339|560624394|FG001|Overall Study|Disease Progression|0|||
155324402|NCT04629339|560624395|FG002|Overall Study|Disease Progression|1|||
155324403|NCT04629339|560624396|FG003|Overall Study|Disease Progression|1|||
155324404|NCT04629339|560624397|FG004|Overall Study|Disease Progression|0|||
155324405|NCT04629339|560624393|FG000|Overall Study|Lost to Follow-up|0|||
155644484|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
155644485|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155644486|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155644487|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155644488|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155324406|NCT04629339|560624394|FG001|Overall Study|Lost to Follow-up|0|||
155324407|NCT04629339|560624395|FG002|Overall Study|Lost to Follow-up|0|||
155324408|NCT04629339|560624396|FG003|Overall Study|Lost to Follow-up|1|||
155324409|NCT04629339|560624397|FG004|Overall Study|Lost to Follow-up|0|||
155324410|NCT04629339|560624393|FG000|Overall Study|Physician Decision|0|||
155324411|NCT04629339|560624394|FG001|Overall Study|Physician Decision|1|||
155324412|NCT04629339|560624395|FG002|Overall Study|Physician Decision|0|||
155324413|NCT04629339|560624396|FG003|Overall Study|Physician Decision|0|||
155324414|NCT04629339|560624397|FG004|Overall Study|Physician Decision|0|||
155324415|NCT04629339|560624393|FG000|Overall Study|Study Terminated by Sponsor|0|||
155324416|NCT04629339|560624394|FG001|Overall Study|Study Terminated by Sponsor|0|||
155324417|NCT04629339|560624395|FG002|Overall Study|Study Terminated by Sponsor|0|||
155324418|NCT04629339|560624396|FG003|Overall Study|Study Terminated by Sponsor|1|||
155644489|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
155644490|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155644491|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155324419|NCT04629339|560624397|FG004|Overall Study|Study Terminated by Sponsor|0|||
155324420|NCT04629339|560624393|FG000|Overall Study|Withdrawal by Subject|0|||
155324421|NCT04629339|560624394|FG001|Overall Study|Withdrawal by Subject|0|||
155644492|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155644493|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155324422|NCT04629339|560624395|FG002|Overall Study|Withdrawal by Subject|2|||
155324423|NCT04629339|560624396|FG003|Overall Study|Withdrawal by Subject|2|||
155324424|NCT04629339|560624397|FG004|Overall Study|Withdrawal by Subject|0|||
155324425|NCT04158739|560624398|FG000|Overall Study|Adverse Event|1|||
155324426|NCT04158739|560624399|FG001|Overall Study|Adverse Event|0|||
155324427|NCT04158739|560624398|FG000|Overall Study|Death|0|||
155324428|NCT04158739|560624399|FG001|Overall Study|Death|1|||
155324429|NCT04158739|560624398|FG000|Overall Study|Lack of Efficacy|3|||
155324430|NCT04158739|560624399|FG001|Overall Study|Lack of Efficacy|7|||
155324431|NCT04158739|560624398|FG000|Overall Study|Physician Decision|0|||
155324432|NCT04158739|560624399|FG001|Overall Study|Physician Decision|1|||
155324433|NCT04158739|560624398|FG000|Overall Study|Withdrawal by Subject|3|||
155324434|NCT04158739|560624399|FG001|Overall Study|Withdrawal by Subject|0|||
155324435|NCT04055012|560624406|FG000|Overall Study|Withdrawal by Subject|1|||
155324436|NCT04055012|560624407|FG001|Overall Study|Withdrawal by Subject|3|||
155324437|NCT04055012|560624408|FG002|Overall Study|Withdrawal by Subject|1|||
155324438|NCT04055012|560624409|FG003|Overall Study|Withdrawal by Subject|0|||
155324439|NCT04055012|560624406|FG000|Overall Study|Metformin Recall|1|||
155324440|NCT04055012|560624407|FG001|Overall Study|Metformin Recall|1|||
155324441|NCT04055012|560624408|FG002|Overall Study|Metformin Recall|1|||
155324442|NCT04055012|560624409|FG003|Overall Study|Metformin Recall|0|||
155324443|NCT04173247|560624410|FG000|Overall Study|Withdrawal by Subject|0|||
155324444|NCT04173247|560624411|FG001|Overall Study|Withdrawal by Subject|2|||
155324445|NCT04173247|560624410|FG000|Overall Study|Death|1|||
155324446|NCT04173247|560624411|FG001|Overall Study|Death|0|||
155324447|NCT04173247|560624410|FG000|Overall Study|Physician Decision|1|||
155324448|NCT04173247|560624411|FG001|Overall Study|Physician Decision|0|||
155324449|NCT03418740|560624417|FG000|Overall Study|Lost to Follow-up|13|||
155324450|NCT03418740|560624417|FG000|Overall Study|Scheduling Issues|7|||
155324451|NCT03418740|560624417|FG000|Overall Study|Withdrawal by Subject|2|||
155324452|NCT03418740|560624417|FG000|Overall Study|Unable to Continue Consent|1|||
155324453|NCT01475786|560624418|FG000|Overall Study|Adverse Event|0|||
155324454|NCT01475786|560624419|FG001|Overall Study|Adverse Event|1|||
155324455|NCT01475786|560624420|FG002|Overall Study|Adverse Event|0|||
155324456|NCT01475786|560624418|FG000|Overall Study|Lost to Follow-up|1|||
155324457|NCT01475786|560624419|FG001|Overall Study|Lost to Follow-up|2|||
155324458|NCT01475786|560624420|FG002|Overall Study|Lost to Follow-up|1|||
155324459|NCT01475786|560624418|FG000|Overall Study|Withdrawal by Subject|0|||
155324460|NCT01475786|560624419|FG001|Overall Study|Withdrawal by Subject|1|||
155324461|NCT01475786|560624420|FG002|Overall Study|Withdrawal by Subject|1|||
155324462|NCT01475786|560624418|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
155324463|NCT01475786|560624419|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
155324464|NCT01475786|560624420|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
155324465|NCT04678856|560624429|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
155324466|NCT04678856|560624430|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
155324467|NCT04678856|560624429|FG000|Overall Study|Withdrawal by Subject|5|||
155324468|NCT04678856|560624430|FG001|Overall Study|Withdrawal by Subject|1|||
155324469|NCT01828021|560624871|FG000|Overall Study|Adverse Event|5|||
155324470|NCT01828021|560624871|FG000|Overall Study|Lack of Efficacy|17|||
155324471|NCT01828021|560624871|FG000|Overall Study|Withdrawal by Subject|2|||
155324472|NCT01828021|560624871|FG000|Overall Study|Ileal obstruction, unrelated|1|||
155324473|NCT02163694|560624881|FG000|Overall Study|Adverse event- related to progression|4|||
155324474|NCT02163694|560624882|FG001|Overall Study|Adverse event- related to progression|10|||
155501933|NCT02508649|561263415|FG000|Overall Study|Investigator withdrew the subject|1|||
155501934|NCT02508649|561263416|FG001|Overall Study|Investigator withdrew the subject|2|||
155501935|NCT02508649|561263417|FG002|Overall Study|Investigator withdrew the subject|1|||
155501936|NCT02508649|561263418|FG003|Overall Study|Investigator withdrew the subject|0|||
155501937|NCT02508649|561263415|FG000|Overall Study|Post randomization screening failure|12|||
155324475|NCT02163694|560624881|FG000|Overall Study|Adverse event- not related to progression|7|||
155324476|NCT02163694|560624882|FG001|Overall Study|Adverse event- not related to progression|22|||
155324477|NCT02163694|560624881|FG000|Overall Study|Withdrew consent|13|||
155324478|NCT02163694|560624882|FG001|Overall Study|Withdrew consent|28|||
155324479|NCT02163694|560624881|FG000|Overall Study|Lost to Follow-up|2|||
155324480|NCT02163694|560624882|FG001|Overall Study|Lost to Follow-up|2|||
155324481|NCT02163694|560624881|FG000|Overall Study|Sponsor discontinued study|3|||
155324482|NCT02163694|560624882|FG001|Overall Study|Sponsor discontinued study|29|||
155324483|NCT02163694|560624881|FG000|Overall Study|Progressive disease per protocol|125|||
155324484|NCT02163694|560624882|FG001|Overall Study|Progressive disease per protocol|224|||
155324485|NCT02163694|560624881|FG000|Overall Study|Other, not specified|17|||
155324486|NCT02163694|560624882|FG001|Overall Study|Other, not specified|22|||
155324487|NCT02163694|560624881|FG000|Overall Study|Randomized but Not Treated|1|||
155324488|NCT02163694|560624882|FG001|Overall Study|Randomized but Not Treated|0|||
155324489|NCT02163694|560624881|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
155324490|NCT02163694|560624882|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
155324491|NCT04967599|560624889|FG000|Overall Study|Lost to Follow-up|35|||
155324492|NCT04967599|560624890|FG001|Overall Study|Lost to Follow-up|19|||
155501938|NCT02508649|561263416|FG001|Overall Study|Post randomization screening failure|4|||
155644494|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
155644495|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155644496|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155644497|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155324493|NCT04967599|560624891|FG002|Overall Study|Lost to Follow-up|23|||
155324494|NCT03817983|560624892|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
155324495|NCT03817983|560624893|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
155644498|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155644499|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
155644500|NCT01871727|561788301|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
155644501|NCT01871727|561788302|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
155644502|NCT01871727|561788303|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
155644503|NCT01871727|561788304|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
155644504|NCT01871727|561788305|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
155644505|NCT03019588|561788306|FG000|Overall Study|Death|44|||
155644506|NCT03019588|561788307|FG001|Overall Study|Death|46|||
155644507|NCT03019588|561788306|FG000|Overall Study|Study terminated by Sponsor|3|||
155644508|NCT03019588|561788307|FG001|Overall Study|Study terminated by Sponsor|1|||
155644509|NCT00366535|561788310|FG000|First Phase: 12 Weeks|Adverse Event|1|||
155644510|NCT00366535|561788311|FG001|First Phase: 12 Weeks|Adverse Event|3|||
155644511|NCT00366535|561788310|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
155644512|NCT00366535|561788311|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
155324496|NCT03817983|560624894|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
155324497|NCT03744676|560624895|FG000|Pre-Treatment Phase|Disease related complications|2|||
155324498|NCT03744676|560624895|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
155324499|NCT03744676|560624895|FG000|Pre-Treatment Phase|Death|7|||
155324500|NCT03744676|560624895|FG000|Pre-Treatment Phase|Other Reasons|7|||
155324501|NCT03744676|560624895|FG000|Treatment Phase|Participant withdrew consent|8|||
155644513|NCT00366535|561788310|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
155644514|NCT00366535|561788311|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
155644515|NCT00366535|561788310|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
155644516|NCT00366535|561788311|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
155644517|NCT02958527|561788316|FG000|Overall Study|Not collected CRFs|12|||
155644518|NCT00699751|561788318|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
155644519|NCT00699751|561788319|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
155644520|NCT00699751|561788318|FG000|Period 1: Without/Before Drug Switch|Death|28|||
155644521|NCT00699751|561788319|FG001|Period 1: Without/Before Drug Switch|Death|29|||
155644522|NCT00699751|561788318|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
155644523|NCT00699751|561788319|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
155644524|NCT00699751|561788318|FG000|Period 1: Without/Before Drug Switch|Other|30|||
155644525|NCT00699751|561788319|FG001|Period 1: Without/Before Drug Switch|Other|20|||
155644526|NCT00699751|561788318|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
155644527|NCT00699751|561788319|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
155644528|NCT00699751|561788318|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
155644529|NCT00699751|561788319|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
155644530|NCT00699751|561788318|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
155644531|NCT00699751|561788319|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
155644532|NCT00699751|561788318|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
155644533|NCT00699751|561788319|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
155644534|NCT01947933|561788320|FG000|Overall Study|Withdrawal by Subject|0|||
155644535|NCT01947933|561788321|FG001|Overall Study|Withdrawal by Subject|0|||
155644536|NCT01947933|561788322|FG002|Overall Study|Withdrawal by Subject|1|||
155644537|NCT01947933|561788323|FG003|Overall Study|Withdrawal by Subject|0|||
155644538|NCT01947933|561788324|FG004|Overall Study|Withdrawal by Subject|0|||
155644539|NCT01947933|561788325|FG005|Overall Study|Withdrawal by Subject|0|||
155644540|NCT01947933|561788326|FG006|Overall Study|Withdrawal by Subject|0|||
155644541|NCT01947933|561788327|FG007|Overall Study|Withdrawal by Subject|0|||
155644542|NCT01947933|561788328|FG008|Overall Study|Withdrawal by Subject|0|||
155644543|NCT01947933|561788320|FG000|Overall Study|Lost to Follow-up|0|||
155644544|NCT01947933|561788321|FG001|Overall Study|Lost to Follow-up|0|||
155644545|NCT01947933|561788322|FG002|Overall Study|Lost to Follow-up|0|||
155644546|NCT01947933|561788323|FG003|Overall Study|Lost to Follow-up|0|||
155644547|NCT01947933|561788324|FG004|Overall Study|Lost to Follow-up|0|||
155644548|NCT01947933|561788325|FG005|Overall Study|Lost to Follow-up|0|||
155644549|NCT01947933|561788326|FG006|Overall Study|Lost to Follow-up|0|||
155644550|NCT01947933|561788327|FG007|Overall Study|Lost to Follow-up|0|||
155644551|NCT01947933|561788328|FG008|Overall Study|Lost to Follow-up|1|||
155644552|NCT05259033|561788332|FG000|Overall Study|Withdrawal by Subject|10|||
155644553|NCT05259033|561788333|FG001|Overall Study|Withdrawal by Subject|5|||
155644554|NCT05259033|561788332|FG000|Overall Study|Lost to Follow-up|1|||
155644555|NCT05259033|561788333|FG001|Overall Study|Lost to Follow-up|0|||
155644556|NCT05259033|561788332|FG000|Overall Study|Death|2|||
155644557|NCT05259033|561788333|FG001|Overall Study|Death|0|||
155324502|NCT03744676|560624895|FG000|Treatment Phase|Death|33|||
155324503|NCT03744676|560624895|FG000|Treatment Phase|other reasons|6|||
155324504|NCT05541484|560624898|FG000|Overall Study|Withdrawal by Subject|1|||
155324505|NCT05541484|560624899|FG001|Overall Study|Withdrawal by Subject|0|||
155324506|NCT01438853|560624900|FG000|Overall Study|Death|0|||
155501939|NCT02508649|561263417|FG002|Overall Study|Post randomization screening failure|9|||
155501940|NCT02508649|561263418|FG003|Overall Study|Post randomization screening failure|3|||
155501941|NCT02508649|561263415|FG000|Overall Study|Lost to Follow-up|1|||
155501942|NCT02508649|561263416|FG001|Overall Study|Lost to Follow-up|1|||
155501943|NCT02508649|561263417|FG002|Overall Study|Lost to Follow-up|0|||
155501944|NCT02508649|561263418|FG003|Overall Study|Lost to Follow-up|1|||
155501945|NCT01311505|561263419|FG000|First Intervention Period|Protocol Violation|0|||
155501946|NCT01311505|561263420|FG001|First Intervention Period|Protocol Violation|1|||
155501947|NCT00567996|561263427|FG000|Overall Study|Adverse Event|18|||
155501948|NCT00567996|561263428|FG001|Overall Study|Adverse Event|16|||
155501949|NCT00567996|561263429|FG002|Overall Study|Adverse Event|13|||
155501950|NCT00567996|561263427|FG000|Overall Study|Protocol Deviation|9|||
155501951|NCT00567996|561263428|FG001|Overall Study|Protocol Deviation|11|||
155501952|NCT00567996|561263429|FG002|Overall Study|Protocol Deviation|13|||
155501953|NCT00567996|561263427|FG000|Overall Study|Withdrawal by Subject|8|||
155501954|NCT00567996|561263428|FG001|Overall Study|Withdrawal by Subject|12|||
155501955|NCT00567996|561263429|FG002|Overall Study|Withdrawal by Subject|22|||
155501956|NCT00567996|561263427|FG000|Overall Study|Abnormal Lab value(s)|2|||
155501957|NCT00567996|561263428|FG001|Overall Study|Abnormal Lab value(s)|1|||
155501958|NCT00567996|561263429|FG002|Overall Study|Abnormal Lab value(s)|2|||
155501959|NCT00567996|561263427|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155501960|NCT00567996|561263428|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155501961|NCT00567996|561263429|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155501962|NCT00567996|561263427|FG000|Overall Study|Lost to Follow-up|2|||
155501963|NCT00567996|561263428|FG001|Overall Study|Lost to Follow-up|5|||
155501964|NCT00567996|561263429|FG002|Overall Study|Lost to Follow-up|2|||
155501965|NCT00567996|561263427|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155501966|NCT00567996|561263428|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155501967|NCT00567996|561263429|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
155501968|NCT00567996|561263427|FG000|Overall Study|Administrative problems|1|||
155501969|NCT00567996|561263428|FG001|Overall Study|Administrative problems|1|||
155501970|NCT00567996|561263429|FG002|Overall Study|Administrative problems|0|||
155501971|NCT00567996|561263427|FG000|Overall Study|Death|1|||
155324507|NCT01438853|560624901|FG001|Overall Study|Death|0|||
155324508|NCT01438853|560624902|FG002|Overall Study|Death|0|||
155501972|NCT00567996|561263428|FG001|Overall Study|Death|0|||
155501973|NCT00567996|561263429|FG002|Overall Study|Death|2|||
155501974|NCT00567996|561263427|FG000|Overall Study|Patient's inability to use the device|0|||
155324509|NCT01438853|560624903|FG003|Overall Study|Death|1|||
155324510|NCT01438853|560624900|FG000|Overall Study|Withdrawal by Subject|0|||
155501975|NCT00567996|561263428|FG001|Overall Study|Patient's inability to use the device|1|||
155324511|NCT01438853|560624901|FG001|Overall Study|Withdrawal by Subject|0|||
155324512|NCT01438853|560624902|FG002|Overall Study|Withdrawal by Subject|1|||
155324513|NCT01438853|560624903|FG003|Overall Study|Withdrawal by Subject|0|||
155324514|NCT02919917|560624904|FG000|Overall Study|Withdrawal by Subject|4|||
155324515|NCT02919917|560624905|FG001|Overall Study|Withdrawal by Subject|8|||
155324516|NCT04743973|560624909|FG000|Overall Study|Withdrawal by Subject|5|||
155324517|NCT04159519|560624910|FG000|Overall Study|Adverse Event|1|||
155324518|NCT04159519|560624911|FG001|Overall Study|Adverse Event|1|||
155324519|NCT04159519|560624910|FG000|Overall Study|Lack of Efficacy|1|||
155644558|NCT02593864|561788337|FG000|Overall Study|Withdrawal by Subject|3|||
155644559|NCT02593864|561788337|FG000|Overall Study|Lost to Follow-up|3|||
155644560|NCT03345095|561788345|FG000|Overall Study|Lack of Efficacy|184|||
155644561|NCT03345095|561788346|FG001|Overall Study|Lack of Efficacy|156|||
155324520|NCT04159519|560624911|FG001|Overall Study|Lack of Efficacy|0|||
155324521|NCT04159519|560624910|FG000|Overall Study|Discontinued from study|1|||
155324522|NCT04159519|560624911|FG001|Overall Study|Discontinued from study|0|||
155324523|NCT04159519|560624910|FG000|Overall Study|Protocol Violation|1|||
155324524|NCT04159519|560624911|FG001|Overall Study|Protocol Violation|1|||
155324525|NCT04159519|560624910|FG000|Overall Study|Withdrawal by Subject|4|||
155324526|NCT04159519|560624911|FG001|Overall Study|Withdrawal by Subject|4|||
155324527|NCT04780581|560624915|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
155644562|NCT03345095|561788345|FG000|Overall Study|Adverse Event|36|||
155644563|NCT03345095|561788346|FG001|Overall Study|Adverse Event|118|||
155644564|NCT03345095|561788345|FG000|Overall Study|Withdrawal by Subject|22|||
155644565|NCT03345095|561788346|FG001|Overall Study|Withdrawal by Subject|59|||
155324528|NCT04780581|560624916|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
155324529|NCT04780581|560624915|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
155324530|NCT04780581|560624916|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
155324531|NCT01756300|560624917|FG000|Overall Study|Death|1|||
155324532|NCT01756300|560624917|FG000|Overall Study|Withdrawal by Subject|1|||
155421273|NCT04426695|560972530|FG015|Overall Study|Adverse Event|0|||
155421274|NCT04426695|560972531|FG016|Overall Study|Adverse Event|0|||
155421275|NCT04426695|560972532|FG017|Overall Study|Adverse Event|0|||
155421276|NCT04426695|560972515|FG000|Overall Study|Sponsor Request|0|||
155421277|NCT04426695|560972516|FG001|Overall Study|Sponsor Request|0|||
155421278|NCT04426695|560972517|FG002|Overall Study|Sponsor Request|0|||
155421279|NCT04426695|560972518|FG003|Overall Study|Sponsor Request|0|||
155421280|NCT04426695|560972519|FG004|Overall Study|Sponsor Request|0|||
155421281|NCT04426695|560972520|FG005|Overall Study|Sponsor Request|0|||
155421282|NCT04426695|560972521|FG006|Overall Study|Sponsor Request|1|||
155644566|NCT03345095|561788345|FG000|Overall Study|Physician Decision|3|||
155421283|NCT04426695|560972522|FG007|Overall Study|Sponsor Request|0|||
155421284|NCT04426695|560972523|FG008|Overall Study|Sponsor Request|0|||
155421285|NCT04426695|560972524|FG009|Overall Study|Sponsor Request|0|||
155421286|NCT04426695|560972525|FG010|Overall Study|Sponsor Request|0|||
155421287|NCT04426695|560972526|FG011|Overall Study|Sponsor Request|0|||
155421288|NCT04426695|560972527|FG012|Overall Study|Sponsor Request|0|||
155421289|NCT04426695|560972528|FG013|Overall Study|Sponsor Request|0|||
155421290|NCT04426695|560972529|FG014|Overall Study|Sponsor Request|0|||
155421291|NCT04426695|560972530|FG015|Overall Study|Sponsor Request|0|||
155421292|NCT04426695|560972531|FG016|Overall Study|Sponsor Request|0|||
155421293|NCT04426695|560972532|FG017|Overall Study|Sponsor Request|0|||
155421294|NCT04426695|560972515|FG000|Overall Study|Physician Decision|0|||
155421295|NCT04426695|560972516|FG001|Overall Study|Physician Decision|0|||
155421296|NCT04426695|560972517|FG002|Overall Study|Physician Decision|0|||
155421297|NCT04426695|560972518|FG003|Overall Study|Physician Decision|0|||
155421298|NCT04426695|560972519|FG004|Overall Study|Physician Decision|0|||
155421299|NCT04426695|560972520|FG005|Overall Study|Physician Decision|0|||
155421300|NCT04426695|560972521|FG006|Overall Study|Physician Decision|0|||
155421301|NCT04426695|560972522|FG007|Overall Study|Physician Decision|0|||
155644567|NCT03345095|561788346|FG001|Overall Study|Physician Decision|18|||
155421302|NCT04426695|560972523|FG008|Overall Study|Physician Decision|0|||
155421303|NCT04426695|560972524|FG009|Overall Study|Physician Decision|1|||
155421304|NCT04426695|560972525|FG010|Overall Study|Physician Decision|0|||
155421305|NCT04426695|560972526|FG011|Overall Study|Physician Decision|0|||
155421306|NCT04426695|560972527|FG012|Overall Study|Physician Decision|1|||
155421307|NCT04426695|560972528|FG013|Overall Study|Physician Decision|0|||
155644568|NCT03345095|561788345|FG000|Overall Study|Death|2|||
155644569|NCT03345095|561788346|FG001|Overall Study|Death|4|||
155324533|NCT04595331|560625504|FG000|Overall Study|Withdrawal by Subject|0|||
155324534|NCT04595331|560625505|FG001|Overall Study|Withdrawal by Subject|1|||
155324535|NCT04595331|560625504|FG000|Overall Study|Lost to Follow-up|0|||
155324536|NCT04595331|560625505|FG001|Overall Study|Lost to Follow-up|5|||
155324537|NCT04595331|560625504|FG000|Overall Study|Medical reason|0|||
155324538|NCT04595331|560625505|FG001|Overall Study|Medical reason|1|||
155324539|NCT02246127|560625506|FG000|First Course Treatment|Adverse Event|9|||
155501976|NCT00567996|561263429|FG002|Overall Study|Patient's inability to use the device|0|||
155501977|NCT02149199|561263430|FG000|Overall Study|Study specific withdrawal criteria|4|||
155501978|NCT02149199|561263431|FG001|Overall Study|Study specific withdrawal criteria|21|||
155501979|NCT02149199|561263432|FG002|Overall Study|Study specific withdrawal criteria|6|||
155501980|NCT02149199|561263430|FG000|Overall Study|Other|20|||
155501981|NCT02149199|561263431|FG001|Overall Study|Other|25|||
155501982|NCT02149199|561263432|FG002|Overall Study|Other|20|||
155501983|NCT02149199|561263430|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
155501984|NCT02149199|561263431|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
155501985|NCT02149199|561263432|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
155501986|NCT02149199|561263430|FG000|Overall Study|Withdrawal by Subject|75|||
155501987|NCT02149199|561263431|FG001|Overall Study|Withdrawal by Subject|93|||
155501988|NCT02149199|561263432|FG002|Overall Study|Withdrawal by Subject|77|||
155501989|NCT02149199|561263430|FG000|Overall Study|Protocol Violation|16|||
155501990|NCT02149199|561263431|FG001|Overall Study|Protocol Violation|13|||
155501991|NCT02149199|561263432|FG002|Overall Study|Protocol Violation|15|||
155501992|NCT02149199|561263430|FG000|Overall Study|Lost to Follow-up|3|||
155501993|NCT02149199|561263431|FG001|Overall Study|Lost to Follow-up|12|||
155501994|NCT02149199|561263432|FG002|Overall Study|Lost to Follow-up|11|||
155501995|NCT02149199|561263430|FG000|Overall Study|Death|0|||
155501996|NCT02149199|561263431|FG001|Overall Study|Death|0|||
155501997|NCT02149199|561263432|FG002|Overall Study|Death|1|||
155501998|NCT02149199|561263430|FG000|Overall Study|Adverse Event|6|||
155501999|NCT02149199|561263431|FG001|Overall Study|Adverse Event|15|||
155502000|NCT02149199|561263432|FG002|Overall Study|Adverse Event|9|||
155502001|NCT02956005|561263433|FG000|Overall Study|Not eligible|1|||
155502002|NCT02956005|561263433|FG000|Overall Study|Withdrawal by Subject|3|||
155324540|NCT02246127|560625507|FG001|First Course Treatment|Adverse Event|7|||
155502003|NCT02956005|561263433|FG000|Overall Study|Physician Decision|12|||
155502004|NCT02524665|561263438|FG000|Overall Study|Lost to Follow-up|1|||
155502005|NCT01066039|561263441|FG000|Overall Study|Adverse Event|6|||
155324541|NCT02246127|560625506|FG000|First Course Treatment|Withdrawal by Subject|6|||
155502006|NCT01066039|561263441|FG000|Overall Study|Withdrawal by Subject|17|||
155502007|NCT01066039|561263441|FG000|Overall Study|Protocol Violation|2|||
155502008|NCT01066039|561263441|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
155502009|NCT01066039|561263441|FG000|Overall Study|Investigator's Request|1|||
155502010|NCT01066039|561263441|FG000|Overall Study|Dropout due to Insulin Administration|1|||
155502011|NCT01066039|561263441|FG000|Overall Study|Additional Antihypertensive Required|4|||
155324542|NCT02246127|560625507|FG001|First Course Treatment|Withdrawal by Subject|7|||
155324543|NCT02246127|560625506|FG000|First Course Treatment|Physician Decision|9|||
155324544|NCT02246127|560625507|FG001|First Course Treatment|Physician Decision|9|||
155324545|NCT02246127|560625506|FG000|First Course Treatment|Death|3|||
155324546|NCT02246127|560625507|FG001|First Course Treatment|Death|3|||
155324547|NCT02246127|560625506|FG000|First Course Treatment|Not reported reasons|6|||
155324548|NCT02246127|560625507|FG001|First Course Treatment|Not reported reasons|7|||
155324549|NCT02246127|560625506|FG000|First Course Treatment|Not treated|3|||
155324550|NCT02246127|560625507|FG001|First Course Treatment|Not treated|3|||
155324551|NCT03635567|560625508|FG000|Overall Study|Lost to Follow-up|4|||
155324552|NCT03635567|560625509|FG001|Overall Study|Lost to Follow-up|1|||
155324553|NCT03635567|560625508|FG000|Overall Study|Withdrawal by Subject|11|||
155421308|NCT04426695|560972529|FG014|Overall Study|Physician Decision|0|||
155421309|NCT04426695|560972530|FG015|Overall Study|Physician Decision|0|||
155421310|NCT04426695|560972531|FG016|Overall Study|Physician Decision|0|||
155421311|NCT04426695|560972532|FG017|Overall Study|Physician Decision|0|||
155421312|NCT04426695|560972515|FG000|Overall Study|Randomized but Never Treated|3|||
155421313|NCT04426695|560972516|FG001|Overall Study|Randomized but Never Treated|1|||
155421314|NCT04426695|560972517|FG002|Overall Study|Randomized but Never Treated|0|||
155421315|NCT04426695|560972518|FG003|Overall Study|Randomized but Never Treated|4|||
155421316|NCT04426695|560972519|FG004|Overall Study|Randomized but Never Treated|5|||
155421317|NCT04426695|560972520|FG005|Overall Study|Randomized but Never Treated|5|||
155421318|NCT04426695|560972521|FG006|Overall Study|Randomized but Never Treated|4|||
155421319|NCT04426695|560972522|FG007|Overall Study|Randomized but Never Treated|6|||
155421320|NCT04426695|560972523|FG008|Overall Study|Randomized but Never Treated|6|||
155421321|NCT04426695|560972524|FG009|Overall Study|Randomized but Never Treated|3|||
155421322|NCT04426695|560972525|FG010|Overall Study|Randomized but Never Treated|3|||
155421323|NCT04426695|560972526|FG011|Overall Study|Randomized but Never Treated|6|||
155421324|NCT04426695|560972527|FG012|Overall Study|Randomized but Never Treated|1|||
155421325|NCT04426695|560972528|FG013|Overall Study|Randomized but Never Treated|2|||
155421326|NCT04426695|560972529|FG014|Overall Study|Randomized but Never Treated|0|||
155421327|NCT04426695|560972530|FG015|Overall Study|Randomized but Never Treated|0|||
155421328|NCT04426695|560972531|FG016|Overall Study|Randomized but Never Treated|0|||
155421329|NCT04426695|560972532|FG017|Overall Study|Randomized but Never Treated|0|||
155421330|NCT04303000|560972533|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
155421331|NCT04303000|560972534|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
155421332|NCT04303000|560972535|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
155421333|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Adverse Event|11|||
155421334|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Adverse Event|15|||
155502012|NCT01066039|561263441|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
155502013|NCT01066039|561263441|FG000|Overall Study|Failure to Control Blood Pressure|1|||
155502014|NCT01066039|561263441|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
155502015|NCT03022799|561263442|FG000|Overall Study|Adverse Event|0|||
155502016|NCT03022799|561263443|FG001|Overall Study|Adverse Event|0|||
155502017|NCT03022799|561263444|FG002|Overall Study|Adverse Event|0|||
155502018|NCT03022799|561263445|FG003|Overall Study|Adverse Event|0|||
155502019|NCT03022799|561263446|FG004|Overall Study|Adverse Event|0|||
155502020|NCT03022799|561263447|FG005|Overall Study|Adverse Event|0|||
155502021|NCT03022799|561263448|FG006|Overall Study|Adverse Event|0|||
155502022|NCT03022799|561263449|FG007|Overall Study|Adverse Event|0|||
155502023|NCT03022799|561263450|FG008|Overall Study|Adverse Event|0|||
155502024|NCT03022799|561263451|FG009|Overall Study|Adverse Event|1|||
155502025|NCT03022799|561263452|FG010|Overall Study|Adverse Event|1|||
155502026|NCT03022799|561263453|FG011|Overall Study|Adverse Event|0|||
155421335|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
155421336|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
155421337|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
155502027|NCT03022799|561263454|FG012|Overall Study|Adverse Event|0|||
155502028|NCT04881448|561263457|FG000|Overall Study|Study cancelled by sponsor|220|||
155502029|NCT04881448|561263457|FG000|Overall Study|Withdrawal by Subject|2|||
155502030|NCT04881448|561263457|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
155324554|NCT03635567|560625509|FG001|Overall Study|Withdrawal by Subject|16|||
155324555|NCT03635567|560625508|FG000|Overall Study|Sponsor Decision|99|||
155502031|NCT01898884|561263459|FG000|Multiple Dose Period|Adverse Event|0|||
155324556|NCT03635567|560625509|FG001|Overall Study|Sponsor Decision|57|||
155502032|NCT01898884|561263460|FG001|Multiple Dose Period|Adverse Event|0|||
155502033|NCT01898884|561263461|FG002|Multiple Dose Period|Adverse Event|0|||
155502034|NCT01898884|561263462|FG003|Multiple Dose Period|Adverse Event|0|||
155502035|NCT01898884|561263463|FG004|Multiple Dose Period|Adverse Event|0|||
155502036|NCT01898884|561263464|FG005|Multiple Dose Period|Adverse Event|0|||
155502037|NCT01898884|561263465|FG006|Multiple Dose Period|Adverse Event|1|||
155502038|NCT01898884|561263466|FG007|Multiple Dose Period|Adverse Event|0|||
155502039|NCT01898884|561263467|FG008|Multiple Dose Period|Adverse Event|0|||
155502040|NCT01898884|561263459|FG000|Multiple Dose Period|Randomized Not Treated|0|||
155502041|NCT01898884|561263460|FG001|Multiple Dose Period|Randomized Not Treated|0|||
155502042|NCT01898884|561263461|FG002|Multiple Dose Period|Randomized Not Treated|0|||
155502043|NCT01898884|561263462|FG003|Multiple Dose Period|Randomized Not Treated|0|||
155502044|NCT01898884|561263463|FG004|Multiple Dose Period|Randomized Not Treated|0|||
155502045|NCT01898884|561263464|FG005|Multiple Dose Period|Randomized Not Treated|0|||
155502046|NCT01898884|561263465|FG006|Multiple Dose Period|Randomized Not Treated|0|||
155502047|NCT01898884|561263466|FG007|Multiple Dose Period|Randomized Not Treated|0|||
155502048|NCT01898884|561263467|FG008|Multiple Dose Period|Randomized Not Treated|1|||
155502049|NCT01355523|561265363|FG000|Overall Study|Withdrawal by Subject|1|||
155502050|NCT01355523|561265364|FG001|Overall Study|Withdrawal by Subject|4|||
155502051|NCT01355523|561265363|FG000|Overall Study|Lost to Follow-up|0|||
155502052|NCT01355523|561265364|FG001|Overall Study|Lost to Follow-up|2|||
155502053|NCT01355523|561265363|FG000|Overall Study|Protocol Violation|0|||
155502054|NCT01355523|561265364|FG001|Overall Study|Protocol Violation|2|||
155502055|NCT01355523|561265363|FG000|Overall Study|Adverse Event|0|||
155324557|NCT03635567|560625508|FG000|Overall Study|Death|194|||
155324558|NCT03635567|560625509|FG001|Overall Study|Death|235|||
155324559|NCT00739908|560625510|FG000|Overall Study|Adverse Event|5|||
155324560|NCT00739908|560625511|FG001|Overall Study|Adverse Event|6|||
155324561|NCT00739908|560625510|FG000|Overall Study|Withdrawal by Subject|4|||
155324562|NCT00739908|560625511|FG001|Overall Study|Withdrawal by Subject|2|||
155324563|NCT00739908|560625510|FG000|Overall Study|Lost to Follow-up|14|||
155324564|NCT00739908|560625511|FG001|Overall Study|Lost to Follow-up|9|||
155324565|NCT00739908|560625510|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
155324566|NCT00739908|560625511|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
155324567|NCT00739908|560625510|FG000|Overall Study|Non-Compliance With Study Medication|0|||
155324568|NCT00739908|560625511|FG001|Overall Study|Non-Compliance With Study Medication|3|||
155324569|NCT00739908|560625510|FG000|Overall Study|Lack of Efficacy|0|||
155324570|NCT00739908|560625511|FG001|Overall Study|Lack of Efficacy|1|||
155324571|NCT00739908|560625510|FG000|Overall Study|Relocation|0|||
155324572|NCT00739908|560625511|FG001|Overall Study|Relocation|1|||
155324573|NCT05157841|560625512|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
155324574|NCT05157841|560625513|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
155324575|NCT05157841|560625514|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
155324576|NCT05157841|560625512|FG000|Part A (14 Days)|Adverse Event|1|||
155324577|NCT05157841|560625513|FG001|Part A (14 Days)|Adverse Event|0|||
155324578|NCT05157841|560625514|FG002|Part A (14 Days)|Adverse Event|0|||
155421338|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
155421339|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
155421340|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
155421341|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155421342|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
155421343|NCT01058096|560972536|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
155502056|NCT01355523|561265364|FG001|Overall Study|Adverse Event|2|||
155502057|NCT00303316|561265365|FG000|Overall Study|Protocol Violation|1|||
155502058|NCT00303316|561265366|FG001|Overall Study|Protocol Violation|0|||
155502059|NCT00303316|561265365|FG000|Overall Study|Lost to Follow-up|0|||
155421344|NCT01058096|560972537|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
155421345|NCT05655377|560972538|FG000|Overall Study|Withdrawal by Subject|2|||
155421346|NCT00553462|560972544|FG000|Overall Study|Adverse Event|4|||
155421347|NCT00553462|560972544|FG000|Overall Study|Progression|4|||
155421348|NCT00553462|560972544|FG000|Overall Study|Withdrawal by Subject|5|||
155324579|NCT05157841|560625512|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
155324580|NCT05157841|560625513|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
155324581|NCT05157841|560625514|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
155324582|NCT03884101|560625517|FG000|Overall Study|Participant Ongoing in Study|202|||
155324583|NCT03884101|560625518|FG001|Overall Study|Participant Ongoing in Study|186|||
155421349|NCT00553462|560972544|FG000|Overall Study|Physician Decision|1|||
155502060|NCT00303316|561265366|FG001|Overall Study|Lost to Follow-up|1|||
155502061|NCT00303316|561265365|FG000|Overall Study|Withdrawal by Subject|1|||
155324584|NCT03884101|560625517|FG000|Overall Study|Death|212|||
155502062|NCT00303316|561265366|FG001|Overall Study|Withdrawal by Subject|2|||
155502063|NCT01074307|561265368|FG000|Overall Study|No primary endpoint evaluation|14|||
155502064|NCT01074307|561265369|FG001|Overall Study|No primary endpoint evaluation|6|||
155502065|NCT01074307|561265368|FG000|Overall Study|Exclusion criterion|0|||
155502066|NCT01074307|561265369|FG001|Overall Study|Exclusion criterion|1|||
155502067|NCT01074307|561265368|FG000|Overall Study|Protocol Violation|8|||
155502068|NCT01074307|561265369|FG001|Overall Study|Protocol Violation|5|||
155502069|NCT02703454|561265371|FG000|Overall Study|Not treated|1|||
155502070|NCT02703454|561265372|FG001|Overall Study|Not treated|3|||
155502071|NCT02703454|561265371|FG000|Overall Study|Withdrawal by Subject|4|||
155502072|NCT02703454|561265372|FG001|Overall Study|Withdrawal by Subject|3|||
155502073|NCT02703454|561265371|FG000|Overall Study|Lost to Follow-up|1|||
155502074|NCT02703454|561265372|FG001|Overall Study|Lost to Follow-up|2|||
155502075|NCT02703454|561265371|FG000|Overall Study|Study discontinuation|5|||
155502076|NCT02703454|561265372|FG001|Overall Study|Study discontinuation|8|||
155502077|NCT02284373|561265373|FG000|Overall Study|Withdrawal by Subject|0|||
155502078|NCT02284373|561265374|FG001|Overall Study|Withdrawal by Subject|1|||
155502079|NCT02284373|561265375|FG002|Overall Study|Withdrawal by Subject|0|||
155502080|NCT02284373|561265373|FG000|Overall Study|Other|0|||
155502081|NCT02284373|561265374|FG001|Overall Study|Other|1|||
155502082|NCT02284373|561265375|FG002|Overall Study|Other|0|||
155502083|NCT02284373|561265373|FG000|Overall Study|Lost to Follow-up|0|||
155502084|NCT02284373|561265374|FG001|Overall Study|Lost to Follow-up|1|||
155502085|NCT02284373|561265375|FG002|Overall Study|Lost to Follow-up|0|||
155502086|NCT00552617|561265377|FG000|Overall Study|Not Treated|0|||
155502087|NCT00552617|561265378|FG001|Overall Study|Not Treated|0|||
155502088|NCT00552617|561265379|FG002|Overall Study|Not Treated|1|||
155502089|NCT00552617|561265380|FG003|Overall Study|Not Treated|0|||
155502090|NCT00552617|561265381|FG004|Overall Study|Not Treated|0|||
155502091|NCT00552617|561265382|FG005|Overall Study|Not Treated|0|||
155502092|NCT00552617|561265383|FG006|Overall Study|Not Treated|0|||
155502093|NCT00552617|561265384|FG007|Overall Study|Not Treated|0|||
155502094|NCT00552617|561265385|FG008|Overall Study|Not Treated|0|||
155502095|NCT00552617|561265386|FG009|Overall Study|Not Treated|1|||
155502096|NCT00552617|561265377|FG000|Overall Study|Lost to Follow-up|0|||
155502097|NCT00552617|561265378|FG001|Overall Study|Lost to Follow-up|0|||
155502098|NCT00552617|561265379|FG002|Overall Study|Lost to Follow-up|0|||
155502099|NCT00552617|561265380|FG003|Overall Study|Lost to Follow-up|1|||
155502100|NCT00552617|561265381|FG004|Overall Study|Lost to Follow-up|0|||
155502101|NCT00552617|561265382|FG005|Overall Study|Lost to Follow-up|2|||
155502102|NCT00552617|561265383|FG006|Overall Study|Lost to Follow-up|0|||
155502103|NCT00552617|561265384|FG007|Overall Study|Lost to Follow-up|0|||
155502104|NCT00552617|561265385|FG008|Overall Study|Lost to Follow-up|2|||
155502105|NCT00552617|561265386|FG009|Overall Study|Lost to Follow-up|0|||
155502106|NCT04651218|561265387|FG000|Overall Study|Withdrawal by Subject|0|||
155502107|NCT04651218|561265388|FG001|Overall Study|Withdrawal by Subject|2|||
155502108|NCT01399125|561265393|FG000|Overall Study|Adverse Event|32|||
155502109|NCT01399125|561265394|FG001|Overall Study|Adverse Event|30|||
155502110|NCT01399125|561265393|FG000|Overall Study|Abnormal Lab values|0|||
155502111|NCT01399125|561265394|FG001|Overall Study|Abnormal Lab values|1|||
155502112|NCT01399125|561265393|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155502113|NCT01399125|561265394|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155502114|NCT01399125|561265393|FG000|Overall Study|Withdrawal by Subject|5|||
155502115|NCT01399125|561265394|FG001|Overall Study|Withdrawal by Subject|8|||
155502116|NCT01399125|561265393|FG000|Overall Study|Lost to Follow-up|2|||
155502117|NCT01399125|561265394|FG001|Overall Study|Lost to Follow-up|3|||
155502118|NCT01399125|561265393|FG000|Overall Study|Administrative Problems|7|||
155502119|NCT01399125|561265394|FG001|Overall Study|Administrative Problems|11|||
155502120|NCT01399125|561265393|FG000|Overall Study|Death|0|||
155502121|NCT01399125|561265394|FG001|Overall Study|Death|1|||
155502122|NCT01399125|561265393|FG000|Overall Study|Protocol Deviation|5|||
155502123|NCT01399125|561265394|FG001|Overall Study|Protocol Deviation|2|||
155502124|NCT00563524|561265395|FG000|Overall Study|Adverse Event|0|||
155502125|NCT00563524|561265396|FG001|Overall Study|Adverse Event|1|||
155421350|NCT01262625|560972545|FG000|Overall Study|Administrative Error|1|||
155421351|NCT01262625|560972546|FG001|Overall Study|Administrative Error|1|||
155421352|NCT01262625|560972545|FG000|Overall Study|Site Closed|1|||
155421353|NCT01262625|560972546|FG001|Overall Study|Site Closed|0|||
155421354|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
155421355|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
155421356|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|Death|1|||
155421357|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|Death|0|||
155421358|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
155421359|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
155421360|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
155421361|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
155502126|NCT00563524|561265397|FG002|Overall Study|Adverse Event|0|||
155502127|NCT00563524|561265398|FG003|Overall Study|Adverse Event|0|||
155502128|NCT00563524|561265399|FG004|Overall Study|Adverse Event|2|||
155502129|NCT00563524|561265400|FG005|Overall Study|Adverse Event|0|||
155324585|NCT03884101|560625518|FG001|Overall Study|Death|224|||
155324586|NCT03884101|560625517|FG000|Overall Study|Lost to Follow-up|0|||
155324587|NCT03884101|560625518|FG001|Overall Study|Lost to Follow-up|1|||
155324588|NCT03884101|560625517|FG000|Overall Study|Withdrawal by Subject|6|||
155324589|NCT03884101|560625518|FG001|Overall Study|Withdrawal by Subject|11|||
155324590|NCT04560179|560625519|FG000|Overall Study|Physician Decision|1|||
155502130|NCT00563524|561265395|FG000|Overall Study|Lost to Follow-up|1|||
155502131|NCT00563524|561265396|FG001|Overall Study|Lost to Follow-up|0|||
155502132|NCT00563524|561265397|FG002|Overall Study|Lost to Follow-up|0|||
155502133|NCT00563524|561265398|FG003|Overall Study|Lost to Follow-up|0|||
155502134|NCT00563524|561265399|FG004|Overall Study|Lost to Follow-up|0|||
155502135|NCT00563524|561265400|FG005|Overall Study|Lost to Follow-up|0|||
155502136|NCT00563524|561265395|FG000|Overall Study|Protocol Violation|0|||
155502137|NCT00563524|561265396|FG001|Overall Study|Protocol Violation|1|||
155502138|NCT00563524|561265397|FG002|Overall Study|Protocol Violation|0|||
155502139|NCT00563524|561265398|FG003|Overall Study|Protocol Violation|0|||
155502140|NCT00563524|561265399|FG004|Overall Study|Protocol Violation|0|||
155502141|NCT00563524|561265400|FG005|Overall Study|Protocol Violation|0|||
155502142|NCT00563524|561265395|FG000|Overall Study|Withdrawal by Subject|1|||
155502143|NCT00563524|561265396|FG001|Overall Study|Withdrawal by Subject|1|||
155502144|NCT00563524|561265397|FG002|Overall Study|Withdrawal by Subject|3|||
155502145|NCT00563524|561265398|FG003|Overall Study|Withdrawal by Subject|0|||
155502146|NCT00563524|561265399|FG004|Overall Study|Withdrawal by Subject|0|||
155502147|NCT00563524|561265400|FG005|Overall Study|Withdrawal by Subject|1|||
155502148|NCT01467570|561265402|FG000|Overall Study|Lost to Follow-up|8|||
155502149|NCT01467570|561265403|FG001|Overall Study|Lost to Follow-up|9|||
155502150|NCT02626182|561265406|FG000|Overall Study|Adverse Event|2|||
155502151|NCT02626182|561265407|FG001|Overall Study|Adverse Event|0|||
155502152|NCT02766088|561265419|FG000|Overall Study|Sponsor study termination|498|||
155502153|NCT02766088|561265419|FG000|Overall Study|Migrated/moved from the study area|1|||
155502154|NCT02766088|561265419|FG000|Overall Study|Lost to Follow-up|5|||
155502155|NCT02766088|561265419|FG000|Overall Study|Other|1|||
155502156|NCT02766088|561265419|FG000|Overall Study|Death|1|||
155502157|NCT01222715|561265420|FG000|Overall Study|Adverse Event|0|||
155502158|NCT01222715|561265421|FG001|Overall Study|Adverse Event|4|||
155502159|NCT01222715|561265420|FG000|Overall Study|Death|0|||
155502160|NCT01222715|561265421|FG001|Overall Study|Death|1|||
155502161|NCT01222715|561265420|FG000|Overall Study|Lack of Efficacy|22|||
155502162|NCT01222715|561265421|FG001|Overall Study|Lack of Efficacy|14|||
155502163|NCT01222715|561265420|FG000|Overall Study|Physician Decision|12|||
155502164|NCT01222715|561265421|FG001|Overall Study|Physician Decision|2|||
155502165|NCT01222715|561265420|FG000|Overall Study|Refusal of further protocol therapy|0|||
155502166|NCT01222715|561265421|FG001|Overall Study|Refusal of further protocol therapy|4|||
155502167|NCT01222715|561265420|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
155502168|NCT01222715|561265421|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
155502169|NCT01222715|561265420|FG000|Overall Study|Ineligible|0|||
155502170|NCT01222715|561265421|FG001|Overall Study|Ineligible|1|||
155502171|NCT01222715|561265420|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
155502172|NCT01222715|561265421|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
155502173|NCT03836729|561265422|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
155502174|NCT00948025|561265423|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
155502175|NCT00948025|561265424|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
155324591|NCT04560179|560625520|FG001|Overall Study|Physician Decision|0|||
155324592|NCT04560179|560625521|FG002|Overall Study|Physician Decision|0|||
155324593|NCT04560179|560625522|FG003|Overall Study|Physician Decision|0|||
155324594|NCT04560179|560625523|FG004|Overall Study|Physician Decision|0|||
155502176|NCT00948025|561265423|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
155502177|NCT00948025|561265424|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
155502178|NCT00948025|561265423|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
155502179|NCT00948025|561265424|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
155502180|NCT03174925|561265427|FG000|Overall Study|Elastographic images not retrievable|2|||
155502181|NCT03174925|561265427|FG000|Overall Study|Elastography image not interpretable|1|||
155324595|NCT04560179|560625519|FG000|Overall Study|Adverse Event|0|||
155324596|NCT04560179|560625520|FG001|Overall Study|Adverse Event|0|||
155324597|NCT04560179|560625521|FG002|Overall Study|Adverse Event|0|||
155324598|NCT04560179|560625522|FG003|Overall Study|Adverse Event|1|||
155502182|NCT04247594|561265432|FG000|Overall Study|Withdrawal by Subject|4|||
155502183|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
155502184|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
155502185|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
155502186|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
155502187|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
155502188|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
155502189|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
155324599|NCT04560179|560625523|FG004|Overall Study|Adverse Event|0|||
155324600|NCT04631016|560625524|FG000|Overall Study|Adverse Event|3|||
155324601|NCT04631016|560625525|FG001|Overall Study|Adverse Event|0|||
155324602|NCT04631016|560625524|FG000|Overall Study|Withdrawal by Subject|5|||
155324603|NCT04631016|560625525|FG001|Overall Study|Withdrawal by Subject|4|||
155324604|NCT04631016|560625524|FG000|Overall Study|Reason unspecified|1|||
155324605|NCT04631016|560625525|FG001|Overall Study|Reason unspecified|0|||
155324606|NCT04631016|560625524|FG000|Overall Study|Failure to meet randomization criteria|2|||
155324607|NCT04631016|560625525|FG001|Overall Study|Failure to meet randomization criteria|1|||
155324608|NCT05454514|560625531|FG000|Overall Study|Withdrawal by Subject|4|||
155324609|NCT02624050|560625537|FG000|Overall Study|Physician Decision|4|||
155324610|NCT02624050|560625538|FG001|Overall Study|Physician Decision|0|||
155324611|NCT02624050|560625537|FG000|Overall Study|Protocol Violation|2|||
155502190|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
155502191|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502192|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502193|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502194|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
155502195|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
155502196|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502197|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502198|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
155502199|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
155502200|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
155502201|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
155502202|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
155502203|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
155502204|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
155502205|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
155324612|NCT02624050|560625538|FG001|Overall Study|Protocol Violation|0|||
155324613|NCT04795245|560625539|FG000|Overall Study|Unkown reason|7|||
155324614|NCT04795245|560625539|FG000|Overall Study|Death|17|||
155324615|NCT04795245|560625539|FG000|Overall Study|Other than listed|19|||
155324616|NCT04795245|560625539|FG000|Overall Study|Adverse Event|143|||
155324617|NCT04795245|560625539|FG000|Overall Study|Progressive disease|512|||
155324618|NCT04795245|560625539|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
155324619|NCT03904576|560625540|FG000|Washout Period|Protocol Violation|1|||
155324620|NCT03904576|560625541|FG001|Washout Period|Protocol Violation|1|||
155324621|NCT01897441|560625544|FG000|Overall Study|Lost to Follow-up|0|||
155324622|NCT01897441|560625545|FG001|Overall Study|Lost to Follow-up|0|||
155324623|NCT01897441|560625546|FG002|Overall Study|Lost to Follow-up|1|||
155324624|NCT01897441|560625547|FG003|Overall Study|Lost to Follow-up|0|||
155324625|NCT01897441|560625548|FG004|Overall Study|Lost to Follow-up|0|||
155324626|NCT01897441|560625549|FG005|Overall Study|Lost to Follow-up|0|||
155324627|NCT01897441|560625544|FG000|Overall Study|Withdrawal by Subject|0|||
155324628|NCT01897441|560625545|FG001|Overall Study|Withdrawal by Subject|0|||
155324629|NCT01897441|560625546|FG002|Overall Study|Withdrawal by Subject|0|||
155324630|NCT01897441|560625547|FG003|Overall Study|Withdrawal by Subject|0|||
155324631|NCT01897441|560625548|FG004|Overall Study|Withdrawal by Subject|1|||
155324632|NCT01897441|560625549|FG005|Overall Study|Withdrawal by Subject|0|||
155324633|NCT01897441|560625544|FG000|Overall Study|Withdrawn by Provider|0|||
155324634|NCT01897441|560625545|FG001|Overall Study|Withdrawn by Provider|2|||
155324635|NCT01897441|560625546|FG002|Overall Study|Withdrawn by Provider|0|||
155324636|NCT01897441|560625547|FG003|Overall Study|Withdrawn by Provider|0|||
155324637|NCT01897441|560625548|FG004|Overall Study|Withdrawn by Provider|0|||
155324638|NCT01897441|560625549|FG005|Overall Study|Withdrawn by Provider|0|||
155324639|NCT03279978|560625550|FG000|Overall Study|Withdrawal by Subject|0|||
155324640|NCT03279978|560625551|FG001|Overall Study|Withdrawal by Subject|1|||
155324641|NCT03279978|560625552|FG002|Overall Study|Withdrawal by Subject|0|||
155324642|NCT03279978|560625553|FG003|Overall Study|Withdrawal by Subject|0|||
155324643|NCT03279978|560625554|FG004|Overall Study|Withdrawal by Subject|0|||
155324644|NCT03279978|560625555|FG005|Overall Study|Withdrawal by Subject|0|||
155324645|NCT03279978|560625556|FG006|Overall Study|Withdrawal by Subject|0|||
155324646|NCT03279978|560625557|FG007|Overall Study|Withdrawal by Subject|0|||
155324647|NCT03279978|560625558|FG008|Overall Study|Withdrawal by Subject|0|||
155324648|NCT03279978|560625559|FG009|Overall Study|Withdrawal by Subject|1|||
155324649|NCT03279978|560625550|FG000|Overall Study|Lost to Follow-up|1|||
155324650|NCT03279978|560625551|FG001|Overall Study|Lost to Follow-up|0|||
155324651|NCT03279978|560625552|FG002|Overall Study|Lost to Follow-up|1|||
155324652|NCT03279978|560625553|FG003|Overall Study|Lost to Follow-up|0|||
155324653|NCT03279978|560625554|FG004|Overall Study|Lost to Follow-up|0|||
155324654|NCT03279978|560625555|FG005|Overall Study|Lost to Follow-up|0|||
155324655|NCT03279978|560625556|FG006|Overall Study|Lost to Follow-up|0|||
155324656|NCT03279978|560625557|FG007|Overall Study|Lost to Follow-up|0|||
155324657|NCT03279978|560625558|FG008|Overall Study|Lost to Follow-up|0|||
155324658|NCT03279978|560625559|FG009|Overall Study|Lost to Follow-up|0|||
155324659|NCT03279978|560625550|FG000|Overall Study|Other than stated above|0|||
155324660|NCT03279978|560625551|FG001|Overall Study|Other than stated above|0|||
155324661|NCT03279978|560625552|FG002|Overall Study|Other than stated above|0|||
155324662|NCT03279978|560625553|FG003|Overall Study|Other than stated above|0|||
155324663|NCT03279978|560625554|FG004|Overall Study|Other than stated above|0|||
155324664|NCT03279978|560625555|FG005|Overall Study|Other than stated above|0|||
155324665|NCT03279978|560625556|FG006|Overall Study|Other than stated above|1|||
155324666|NCT03279978|560625557|FG007|Overall Study|Other than stated above|0|||
155324667|NCT03279978|560625558|FG008|Overall Study|Other than stated above|0|||
155324668|NCT03279978|560625559|FG009|Overall Study|Other than stated above|0|||
155324669|NCT01651000|560625560|FG000|Overall Study|Adverse Event|2|||
155324670|NCT01651000|560625561|FG001|Overall Study|Adverse Event|8|||
155324671|NCT01651000|560625560|FG000|Overall Study|Lost to Follow-up|3|||
155324672|NCT01651000|560625561|FG001|Overall Study|Lost to Follow-up|2|||
155324673|NCT01651000|560625560|FG000|Overall Study|Protocol Violation|0|||
155324674|NCT01651000|560625561|FG001|Overall Study|Protocol Violation|3|||
155324675|NCT01651000|560625560|FG000|Overall Study|Withdrawal by Subject|2|||
155324676|NCT01651000|560625561|FG001|Overall Study|Withdrawal by Subject|10|||
155324677|NCT01651000|560625560|FG000|Overall Study|Subject noncompliance|0|||
155324678|NCT01651000|560625561|FG001|Overall Study|Subject noncompliance|3|||
155324679|NCT01651000|560625560|FG000|Overall Study|Lack of Efficacy|1|||
155324680|NCT01651000|560625561|FG001|Overall Study|Lack of Efficacy|1|||
155324681|NCT01651000|560625560|FG000|Overall Study|Physician Decision|1|||
155324682|NCT01651000|560625561|FG001|Overall Study|Physician Decision|0|||
155324683|NCT01651000|560625560|FG000|Overall Study|Administrative reason|1|||
155324684|NCT01651000|560625561|FG001|Overall Study|Administrative reason|0|||
155324685|NCT01651000|560625560|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
155324686|NCT01651000|560625561|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
155324687|NCT02765412|560625562|FG000|Overall Study|Death|482|||
155324688|NCT02765412|560625563|FG001|Overall Study|Death|855|||
155324689|NCT03990883|560625564|FG000|Blinded Treatment Phase|Adverse Event|1|||
155324690|NCT03990883|560625565|FG001|Blinded Treatment Phase|Adverse Event|1|||
155324691|NCT03990883|560625566|FG002|Blinded Treatment Phase|Adverse Event|0|||
155324692|NCT03990883|560625564|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
155324693|NCT03990883|560625565|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
155324694|NCT03990883|560625566|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
155324695|NCT03990883|560625564|FG000|Blinded Treatment Phase|Physician Decision|1|||
155324696|NCT03990883|560625565|FG001|Blinded Treatment Phase|Physician Decision|0|||
155324697|NCT03990883|560625566|FG002|Blinded Treatment Phase|Physician Decision|0|||
155324698|NCT03990883|560625564|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
155324699|NCT03990883|560625565|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
155324700|NCT03990883|560625566|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
155324701|NCT03990883|560625564|FG000|Blinded Treatment Phase|COVID-19|3|||
155324702|NCT03990883|560625565|FG001|Blinded Treatment Phase|COVID-19|2|||
155324703|NCT03990883|560625566|FG002|Blinded Treatment Phase|COVID-19|0|||
155324704|NCT03990883|560625564|FG000|Blinded Treatment Phase|Personal Reasons|6|||
155324705|NCT03990883|560625565|FG001|Blinded Treatment Phase|Personal Reasons|3|||
155324706|NCT03990883|560625566|FG002|Blinded Treatment Phase|Personal Reasons|0|||
155324707|NCT03990883|560625564|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
155324708|NCT03990883|560625565|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
155324709|NCT03990883|560625566|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
155324710|NCT03990883|560625564|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
155324711|NCT03990883|560625565|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
155324712|NCT03990883|560625566|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
155324713|NCT03990883|560625564|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
155324714|NCT03990883|560625565|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155324715|NCT03990883|560625566|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
155324716|NCT03734029|560625567|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
155324717|NCT03734029|560625568|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
155324718|NCT03734029|560625567|FG000|Overall Study|Adverse Event|60|||
155324719|NCT03734029|560625568|FG001|Overall Study|Adverse Event|14|||
155324720|NCT03734029|560625567|FG000|Overall Study|Withdrawal by Subject|12|||
155421362|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
155644570|NCT03345095|561788345|FG000|Overall Study|Other reasons|2|||
155324721|NCT03734029|560625568|FG001|Overall Study|Withdrawal by Subject|11|||
155324722|NCT03734029|560625567|FG000|Overall Study|Clinical progression by investigator|10|||
155324723|NCT03734029|560625568|FG001|Overall Study|Clinical progression by investigator|8|||
155324724|NCT03734029|560625567|FG000|Overall Study|Death|5|||
155502206|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
155502207|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
155502208|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
155502209|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
155502210|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
155502211|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
155502212|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
155502213|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
155502214|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
155502215|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
155502216|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
155502217|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
155644571|NCT03345095|561788346|FG001|Overall Study|Other reasons|11|||
155324725|NCT03734029|560625568|FG001|Overall Study|Death|2|||
155324726|NCT03734029|560625567|FG000|Overall Study|Physician Decision|4|||
155324727|NCT03734029|560625568|FG001|Overall Study|Physician Decision|3|||
155324728|NCT03734029|560625567|FG000|Overall Study|Other|2|||
155324729|NCT03734029|560625568|FG001|Overall Study|Other|0|||
155324730|NCT03734029|560625567|FG000|Overall Study|Lost to Follow-up|0|||
155324731|NCT03734029|560625568|FG001|Overall Study|Lost to Follow-up|1|||
155324732|NCT03734029|560625567|FG000|Overall Study|Randomized, but not treated|2|||
155324733|NCT03734029|560625568|FG001|Overall Study|Randomized, but not treated|12|||
155324734|NCT05412004|560626551|FG000|Overall Study|Adverse Event|0|||
155324735|NCT05412004|560626552|FG001|Overall Study|Adverse Event|2|||
155324736|NCT05412004|560626553|FG002|Overall Study|Adverse Event|1|||
155324737|NCT05412004|560626554|FG003|Overall Study|Adverse Event|5|||
155324738|NCT05412004|560626551|FG000|Overall Study|Assigned Treatment by Mistake|5|||
155324739|NCT05412004|560626552|FG001|Overall Study|Assigned Treatment by Mistake|10|||
155324740|NCT05412004|560626553|FG002|Overall Study|Assigned Treatment by Mistake|2|||
155324741|NCT05412004|560626554|FG003|Overall Study|Assigned Treatment by Mistake|5|||
155324742|NCT05412004|560626551|FG000|Overall Study|Lost to Follow-up|3|||
155324743|NCT05412004|560626552|FG001|Overall Study|Lost to Follow-up|0|||
155324744|NCT05412004|560626553|FG002|Overall Study|Lost to Follow-up|0|||
155324745|NCT05412004|560626554|FG003|Overall Study|Lost to Follow-up|0|||
155324746|NCT05412004|560626551|FG000|Overall Study|Patient could not travel to site|0|||
155324747|NCT05412004|560626552|FG001|Overall Study|Patient could not travel to site|1|||
155324748|NCT05412004|560626553|FG002|Overall Study|Patient could not travel to site|0|||
155421363|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
155421364|NCT00110994|560972548|FG000|Double-blind (DB) Treatment|other reasons|2|||
155421365|NCT00110994|560972549|FG001|Double-blind (DB) Treatment|other reasons|3|||
155421366|NCT00110994|560972548|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
155421367|NCT00110994|560972549|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
155421368|NCT00110994|560972548|FG000|Active Follow-up|Other reasons|0|||
155421369|NCT00110994|560972549|FG001|Active Follow-up|Other reasons|2|||
155421370|NCT00110994|560972548|FG000|Long Term Follow-up|Death|19|||
155421371|NCT00110994|560972549|FG001|Long Term Follow-up|Death|17|||
155421372|NCT02772757|560972551|FG000|Overall Study|Withdrawal by Subject|1|||
155421373|NCT02772757|560972552|FG001|Overall Study|Withdrawal by Subject|0|||
155421374|NCT02772757|560972553|FG002|Overall Study|Withdrawal by Subject|1|||
155421375|NCT02772757|560972551|FG000|Overall Study|Protocol Violation|0|||
155421376|NCT02772757|560972552|FG001|Overall Study|Protocol Violation|0|||
155421377|NCT02772757|560972553|FG002|Overall Study|Protocol Violation|1|||
155421378|NCT02772757|560972551|FG000|Overall Study|Physician Decision|0|||
155421379|NCT02772757|560972552|FG001|Overall Study|Physician Decision|3|||
155421380|NCT02772757|560972553|FG002|Overall Study|Physician Decision|3|||
155421381|NCT00531960|560972554|FG000|Overall Study|Adverse Event|5|||
155421382|NCT00531960|560972555|FG001|Overall Study|Adverse Event|4|||
155421383|NCT00531960|560972554|FG000|Overall Study|Death|3|||
155421384|NCT00531960|560972555|FG001|Overall Study|Death|2|||
155421385|NCT00531960|560972554|FG000|Overall Study|Lack of Efficacy|42|||
155421386|NCT00531960|560972555|FG001|Overall Study|Lack of Efficacy|41|||
155421387|NCT00531960|560972554|FG000|Overall Study|Violation of Selection Criteria|2|||
155421388|NCT00531960|560972555|FG001|Overall Study|Violation of Selection Criteria|0|||
155421389|NCT00531960|560972554|FG000|Overall Study|Refused Treatment|5|||
155324749|NCT05412004|560626554|FG003|Overall Study|Patient could not travel to site|0|||
155324750|NCT05412004|560626551|FG000|Overall Study|Physician Decision|0|||
155324751|NCT05412004|560626552|FG001|Overall Study|Physician Decision|1|||
155324752|NCT05412004|560626553|FG002|Overall Study|Physician Decision|0|||
155324753|NCT05412004|560626554|FG003|Overall Study|Physician Decision|0|||
155421390|NCT00531960|560972555|FG001|Overall Study|Refused Treatment|6|||
155421391|NCT00531960|560972554|FG000|Overall Study|Other|4|||
155502218|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
155502219|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
155502220|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
155324754|NCT05412004|560626551|FG000|Overall Study|Pregnancy|0|||
155324755|NCT05412004|560626552|FG001|Overall Study|Pregnancy|1|||
155324756|NCT05412004|560626553|FG002|Overall Study|Pregnancy|0|||
155324757|NCT05412004|560626554|FG003|Overall Study|Pregnancy|0|||
155324758|NCT05412004|560626551|FG000|Overall Study|Protocol Violation|1|||
155324759|NCT05412004|560626552|FG001|Overall Study|Protocol Violation|0|||
155324760|NCT05412004|560626553|FG002|Overall Study|Protocol Violation|0|||
155324761|NCT05412004|560626554|FG003|Overall Study|Protocol Violation|0|||
155324762|NCT05412004|560626551|FG000|Overall Study|Withdrawal by Subject|4|||
155324763|NCT05412004|560626552|FG001|Overall Study|Withdrawal by Subject|19|||
155324764|NCT05412004|560626553|FG002|Overall Study|Withdrawal by Subject|4|||
155324765|NCT05412004|560626554|FG003|Overall Study|Withdrawal by Subject|14|||
155324766|NCT05412004|560626551|FG000|Overall Study|Screen Failure|0|||
155324767|NCT05412004|560626552|FG001|Overall Study|Screen Failure|0|||
155324768|NCT05412004|560626553|FG002|Overall Study|Screen Failure|0|||
155502221|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
155324769|NCT05412004|560626554|FG003|Overall Study|Screen Failure|1|||
155324770|NCT05412004|560626551|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324771|NCT05412004|560626552|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324772|NCT05412004|560626553|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324773|NCT05412004|560626554|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
155324774|NCT03781089|560626555|FG000|Overall Study|Constipation|1|||
155324775|NCT03781089|560626556|FG001|Overall Study|Constipation|0|||
155324776|NCT03781089|560626555|FG000|Overall Study|Positive pregnancy test|0|||
155324777|NCT03781089|560626556|FG001|Overall Study|Positive pregnancy test|1|||
155324778|NCT04644029|560626557|FG000|Overall Study|Death|1|||
155324779|NCT04644029|560626558|FG001|Overall Study|Death|0|||
155324780|NCT04644029|560626557|FG000|Overall Study|Physician Decision|1|||
155324781|NCT04644029|560626558|FG001|Overall Study|Physician Decision|2|||
155324782|NCT04644029|560626557|FG000|Overall Study|Withdrawal by Subject|21|||
155324783|NCT04644029|560626558|FG001|Overall Study|Withdrawal by Subject|19|||
155324784|NCT04644029|560626557|FG000|Overall Study|Lost to Follow-up|31|||
155324785|NCT04644029|560626558|FG001|Overall Study|Lost to Follow-up|34|||
155324786|NCT04644029|560626557|FG000|Overall Study|Study Terminated by Sponsor|308|||
155324787|NCT04644029|560626558|FG001|Overall Study|Study Terminated by Sponsor|309|||
155324788|NCT04644029|560626557|FG000|Overall Study|Randomized in Error|2|||
155324789|NCT04644029|560626558|FG001|Overall Study|Randomized in Error|1|||
155324790|NCT04644029|560626557|FG000|Overall Study|Other|0|||
155324791|NCT04644029|560626558|FG001|Overall Study|Other|1|||
155502222|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
155502223|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
155502224|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
155502225|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
155502226|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
155502227|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
155502228|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
155502229|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
155502230|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
155502231|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
155502232|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
155502233|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
155502234|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
155502235|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
155502236|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
155324792|NCT05132400|560626559|FG000|Overall Study|Withdrawal by Subject|14|||
155502237|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
155502238|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
155502239|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
155502240|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
155502241|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
155324793|NCT05132400|560626560|FG001|Overall Study|Withdrawal by Subject|8|||
155324794|NCT05132400|560626559|FG000|Overall Study|Lost to Follow-up|132|||
155324795|NCT05132400|560626560|FG001|Overall Study|Lost to Follow-up|121|||
155324796|NCT03934931|560626561|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
155324797|NCT03934931|560626562|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
155324798|NCT03934931|560626563|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
155324799|NCT02076009|560626566|FG000|Overall Study|Death|172|||
155324800|NCT02076009|560626567|FG001|Overall Study|Death|153|||
155324801|NCT02076009|560626566|FG000|Overall Study|Withdrawal by Subject|16|||
155502242|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
155502243|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
155502244|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
155502245|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
155502246|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
155502247|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
155502248|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
155502249|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
155502250|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
155502251|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
155324802|NCT02076009|560626567|FG001|Overall Study|Withdrawal by Subject|12|||
155324803|NCT02076009|560626566|FG000|Overall Study|Lost to Follow-up|4|||
155324804|NCT02076009|560626567|FG001|Overall Study|Lost to Follow-up|2|||
155324805|NCT02076009|560626566|FG000|Overall Study|Progressive Disease|1|||
155324806|NCT02076009|560626567|FG001|Overall Study|Progressive Disease|0|||
155324807|NCT02076009|560626566|FG000|Overall Study|Physician Decision|0|||
155324808|NCT02076009|560626567|FG001|Overall Study|Physician Decision|1|||
155324809|NCT02076009|560626566|FG000|Overall Study|End of data collection|90|||
155324810|NCT02076009|560626567|FG001|Overall Study|End of data collection|118|||
155324811|NCT03786926|560626570|FG000|Overall Study|Adverse Event|0|||
155324812|NCT03786926|560626571|FG001|Overall Study|Adverse Event|0|||
155324813|NCT03786926|560626572|FG002|Overall Study|Adverse Event|0|||
155324814|NCT03786926|560626573|FG003|Overall Study|Adverse Event|0|||
155324815|NCT03786926|560626574|FG004|Overall Study|Adverse Event|0|||
155324816|NCT03786926|560626575|FG005|Overall Study|Adverse Event|0|||
155324817|NCT03786926|560626576|FG006|Overall Study|Adverse Event|0|||
155324818|NCT03786926|560626577|FG007|Overall Study|Adverse Event|1|||
155324819|NCT03786926|560626578|FG008|Overall Study|Adverse Event|1|||
155324820|NCT03786926|560626579|FG009|Overall Study|Adverse Event|0|||
155324821|NCT03786926|560626580|FG010|Overall Study|Adverse Event|1|||
155324822|NCT03786926|560626570|FG000|Overall Study|Progressive disease|3|||
155324823|NCT03786926|560626571|FG001|Overall Study|Progressive disease|0|||
155324824|NCT03786926|560626572|FG002|Overall Study|Progressive disease|3|||
155324825|NCT03786926|560626573|FG003|Overall Study|Progressive disease|1|||
155324826|NCT03786926|560626574|FG004|Overall Study|Progressive disease|2|||
155324827|NCT03786926|560626575|FG005|Overall Study|Progressive disease|2|||
155324828|NCT03786926|560626576|FG006|Overall Study|Progressive disease|1|||
155324829|NCT03786926|560626577|FG007|Overall Study|Progressive disease|6|||
155324830|NCT03786926|560626578|FG008|Overall Study|Progressive disease|1|||
155324831|NCT03786926|560626579|FG009|Overall Study|Progressive disease|1|||
155324832|NCT03786926|560626580|FG010|Overall Study|Progressive disease|1|||
155324833|NCT03786926|560626570|FG000|Overall Study|Death|0|||
155324834|NCT03786926|560626571|FG001|Overall Study|Death|1|||
155324835|NCT03786926|560626572|FG002|Overall Study|Death|1|||
155324836|NCT03786926|560626573|FG003|Overall Study|Death|0|||
155502252|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
155324837|NCT03786926|560626574|FG004|Overall Study|Death|0|||
155324838|NCT03786926|560626575|FG005|Overall Study|Death|0|||
155324839|NCT03786926|560626576|FG006|Overall Study|Death|0|||
155324840|NCT03786926|560626577|FG007|Overall Study|Death|0|||
155324841|NCT03786926|560626578|FG008|Overall Study|Death|0|||
155324842|NCT03786926|560626579|FG009|Overall Study|Death|1|||
155324843|NCT03786926|560626580|FG010|Overall Study|Death|2|||
155324844|NCT03786926|560626570|FG000|Overall Study|Physician Decision|0|||
155324845|NCT03786926|560626571|FG001|Overall Study|Physician Decision|1|||
155324846|NCT03786926|560626572|FG002|Overall Study|Physician Decision|0|||
155324847|NCT03786926|560626573|FG003|Overall Study|Physician Decision|1|||
155324848|NCT03786926|560626574|FG004|Overall Study|Physician Decision|2|||
155324849|NCT03786926|560626575|FG005|Overall Study|Physician Decision|0|||
155324850|NCT03786926|560626576|FG006|Overall Study|Physician Decision|0|||
155324851|NCT03786926|560626577|FG007|Overall Study|Physician Decision|2|||
155324852|NCT03786926|560626578|FG008|Overall Study|Physician Decision|1|||
155324853|NCT03786926|560626579|FG009|Overall Study|Physician Decision|1|||
155324854|NCT03786926|560626580|FG010|Overall Study|Physician Decision|0|||
155324855|NCT03786926|560626570|FG000|Overall Study|Withdrawal by Subject|0|||
155324856|NCT03786926|560626571|FG001|Overall Study|Withdrawal by Subject|1|||
155502253|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
155644572|NCT03345095|561788345|FG000|Overall Study|Protocol Violation|0|||
155324857|NCT03786926|560626572|FG002|Overall Study|Withdrawal by Subject|1|||
155324858|NCT03786926|560626573|FG003|Overall Study|Withdrawal by Subject|0|||
155324859|NCT03786926|560626574|FG004|Overall Study|Withdrawal by Subject|0|||
155324860|NCT03786926|560626575|FG005|Overall Study|Withdrawal by Subject|0|||
155324861|NCT03786926|560626576|FG006|Overall Study|Withdrawal by Subject|1|||
155324862|NCT03786926|560626577|FG007|Overall Study|Withdrawal by Subject|0|||
155324863|NCT03786926|560626578|FG008|Overall Study|Withdrawal by Subject|1|||
155324864|NCT03786926|560626579|FG009|Overall Study|Withdrawal by Subject|0|||
155324865|NCT03786926|560626580|FG010|Overall Study|Withdrawal by Subject|1|||
155324866|NCT03786926|560626570|FG000|Overall Study|Study terminated by Sponsor|0|||
155324867|NCT03786926|560626571|FG001|Overall Study|Study terminated by Sponsor|0|||
155324868|NCT03786926|560626572|FG002|Overall Study|Study terminated by Sponsor|0|||
155324869|NCT03786926|560626573|FG003|Overall Study|Study terminated by Sponsor|0|||
155324870|NCT03786926|560626574|FG004|Overall Study|Study terminated by Sponsor|1|||
155324871|NCT03786926|560626575|FG005|Overall Study|Study terminated by Sponsor|0|||
155324872|NCT03786926|560626576|FG006|Overall Study|Study terminated by Sponsor|0|||
155324873|NCT03786926|560626577|FG007|Overall Study|Study terminated by Sponsor|4|||
155324874|NCT03786926|560626578|FG008|Overall Study|Study terminated by Sponsor|0|||
155324875|NCT03786926|560626579|FG009|Overall Study|Study terminated by Sponsor|0|||
155324876|NCT03786926|560626580|FG010|Overall Study|Study terminated by Sponsor|0|||
155324877|NCT03786926|560626570|FG000|Overall Study|Anti-neoplasm treatment|0|||
155324878|NCT03786926|560626571|FG001|Overall Study|Anti-neoplasm treatment|0|||
155324879|NCT03786926|560626572|FG002|Overall Study|Anti-neoplasm treatment|0|||
155324880|NCT03786926|560626573|FG003|Overall Study|Anti-neoplasm treatment|0|||
155324881|NCT03786926|560626574|FG004|Overall Study|Anti-neoplasm treatment|1|||
155324882|NCT03786926|560626575|FG005|Overall Study|Anti-neoplasm treatment|0|||
155324883|NCT03786926|560626576|FG006|Overall Study|Anti-neoplasm treatment|1|||
155324884|NCT03786926|560626577|FG007|Overall Study|Anti-neoplasm treatment|0|||
155324885|NCT03786926|560626578|FG008|Overall Study|Anti-neoplasm treatment|0|||
155324886|NCT03786926|560626579|FG009|Overall Study|Anti-neoplasm treatment|0|||
155324887|NCT03786926|560626580|FG010|Overall Study|Anti-neoplasm treatment|0|||
155324888|NCT03786926|560626570|FG000|Overall Study|Other|0|||
155324889|NCT03786926|560626571|FG001|Overall Study|Other|0|||
155324890|NCT03786926|560626572|FG002|Overall Study|Other|0|||
155324891|NCT03786926|560626573|FG003|Overall Study|Other|1|||
155324892|NCT03786926|560626574|FG004|Overall Study|Other|0|||
155324893|NCT03786926|560626575|FG005|Overall Study|Other|1|||
155324894|NCT03786926|560626576|FG006|Overall Study|Other|0|||
155324895|NCT03786926|560626577|FG007|Overall Study|Other|0|||
155324896|NCT03786926|560626578|FG008|Overall Study|Other|2|||
155324897|NCT03786926|560626579|FG009|Overall Study|Other|0|||
155324898|NCT03786926|560626580|FG010|Overall Study|Other|0|||
155324899|NCT05988398|560626586|FG000|Overall Study|Lack of time|21|||
155324900|NCT05988398|560626587|FG001|Overall Study|Lack of time|0|||
155324901|NCT05988398|560626586|FG000|Overall Study|Absent from school|0|||
155324902|NCT05988398|560626587|FG001|Overall Study|Absent from school|38|||
155324903|NCT05988398|560626586|FG000|Overall Study|Chose not to participate|0|||
155324904|NCT05988398|560626587|FG001|Overall Study|Chose not to participate|42|||
155324905|NCT05988398|560626586|FG000|Overall Study|Other commitments (e.g., sports)|0|||
155324906|NCT05988398|560626587|FG001|Overall Study|Other commitments (e.g., sports)|25|||
155324907|NCT00942734|560626589|FG000|Overall Study|Adverse Event|2|||
155324908|NCT00942734|560626589|FG000|Overall Study|Protocol Violation|3|||
155324909|NCT00942734|560626589|FG000|Overall Study|Disease Progression|2|||
155324910|NCT00942734|560626589|FG000|Overall Study|Physician Decision|1|||
155324911|NCT00319046|560626590|FG000|Overall Study|withdrawal of subject's consent|7|||
155324912|NCT00319046|560626590|FG000|Overall Study|administrative reason|1|||
155324913|NCT05147584|560626591|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
155324914|NCT03370913|560626597|FG000|Overall Study|Death|1|||
155324915|NCT03370913|560626597|FG000|Overall Study|Lost to Follow-up|1|||
155324916|NCT04496752|560626602|FG000|Second Assessment|Lost to Follow-up|3|||
155324917|NCT04496752|560626603|FG001|Second Assessment|Lost to Follow-up|3|||
155324918|NCT04496752|560626602|FG000|Second Assessment|Adverse Event|2|||
155324919|NCT04496752|560626603|FG001|Second Assessment|Adverse Event|0|||
155324920|NCT04078152|560626604|FG000|Overall Study|Other|83|||
155324921|NCT04078152|560626605|FG001|Overall Study|Other|22|||
155324922|NCT04078152|560626606|FG002|Overall Study|Other|25|||
155324923|NCT04078152|560626604|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
155324924|NCT04078152|560626605|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
155324925|NCT04078152|560626606|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
155324926|NCT04078152|560626604|FG000|Overall Study|Withdrawal by Subject|5|||
155324927|NCT04078152|560626605|FG001|Overall Study|Withdrawal by Subject|0|||
155324928|NCT04078152|560626606|FG002|Overall Study|Withdrawal by Subject|1|||
155324929|NCT04078152|560626604|FG000|Overall Study|Death|10|||
155324930|NCT04078152|560626605|FG001|Overall Study|Death|2|||
155324931|NCT04078152|560626606|FG002|Overall Study|Death|12|||
155324932|NCT04078152|560626604|FG000|Overall Study|Adverse Event|1|||
155324933|NCT04078152|560626605|FG001|Overall Study|Adverse Event|0|||
155324934|NCT04078152|560626606|FG002|Overall Study|Adverse Event|0|||
155324935|NCT04679389|560626607|FG000|Overall Study|Adverse Event|1|||
155324936|NCT04679389|560626608|FG001|Overall Study|Adverse Event|0|||
155324937|NCT04679389|560626607|FG000|Overall Study|Protocol Violation|2|||
155324938|NCT04679389|560626608|FG001|Overall Study|Protocol Violation|0|||
155324939|NCT04679389|560626607|FG000|Overall Study|Physician Decision|3|||
155324940|NCT04679389|560626608|FG001|Overall Study|Physician Decision|5|||
155502254|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
155324941|NCT04679389|560626607|FG000|Overall Study|Withdrawal by Subject|5|||
155502255|NCT04440163|561265434|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
155502256|NCT04440163|561265435|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
155502257|NCT04440163|561265436|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
155502258|NCT04440163|561265437|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
155502259|NCT04440163|561265438|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
155502260|NCT04440163|561265439|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
155502261|NCT04440163|561265440|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
155502262|NCT04440163|561265441|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
155502263|NCT04440163|561265434|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
155502264|NCT04440163|561265435|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
155502265|NCT04440163|561265436|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
155502266|NCT04440163|561265437|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
155502267|NCT04440163|561265438|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
155502268|NCT04440163|561265439|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
155502269|NCT04440163|561265440|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
155502270|NCT04440163|561265441|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
155324942|NCT04679389|560626608|FG001|Overall Study|Withdrawal by Subject|7|||
155324943|NCT03522298|560626620|FG000|Overall Study|Adverse Event|1|||
155324944|NCT03522298|560626621|FG001|Overall Study|Adverse Event|0|||
155324945|NCT03522298|560626622|FG002|Overall Study|Adverse Event|0|||
155324946|NCT03522298|560626623|FG003|Overall Study|Adverse Event|1|||
155324947|NCT03522298|560626620|FG000|Overall Study|Death|2|||
155324948|NCT03522298|560626621|FG001|Overall Study|Death|4|||
155324949|NCT03522298|560626622|FG002|Overall Study|Death|8|||
155324950|NCT03522298|560626623|FG003|Overall Study|Death|8|||
155324951|NCT03522298|560626620|FG000|Overall Study|Patient decision|0|||
155324952|NCT03522298|560626621|FG001|Overall Study|Patient decision|2|||
155324953|NCT03522298|560626622|FG002|Overall Study|Patient decision|2|||
155324954|NCT03522298|560626623|FG003|Overall Study|Patient decision|2|||
155324955|NCT05718687|560626626|FG000|Overall Study|Withdrawal by Subject|3|||
155324956|NCT03250676|560626631|FG000|Overall Study|Adverse Event|0|||
155324957|NCT03250676|560626632|FG001|Overall Study|Adverse Event|0|||
155324958|NCT03250676|560626633|FG002|Overall Study|Adverse Event|0|||
155324959|NCT03250676|560626634|FG003|Overall Study|Adverse Event|1|||
155324960|NCT03250676|560626635|FG004|Overall Study|Adverse Event|2|||
155324961|NCT03250676|560626636|FG005|Overall Study|Adverse Event|9|||
155324962|NCT03250676|560626631|FG000|Overall Study|Withdrawal by Subject|1|||
155324963|NCT03250676|560626632|FG001|Overall Study|Withdrawal by Subject|0|||
155324964|NCT03250676|560626633|FG002|Overall Study|Withdrawal by Subject|0|||
155324965|NCT03250676|560626634|FG003|Overall Study|Withdrawal by Subject|1|||
155324966|NCT03250676|560626635|FG004|Overall Study|Withdrawal by Subject|1|||
155324967|NCT03250676|560626636|FG005|Overall Study|Withdrawal by Subject|2|||
155324968|NCT03250676|560626631|FG000|Overall Study|Physician Decision|0|||
155324969|NCT03250676|560626632|FG001|Overall Study|Physician Decision|0|||
155324970|NCT03250676|560626633|FG002|Overall Study|Physician Decision|0|||
155324971|NCT03250676|560626634|FG003|Overall Study|Physician Decision|2|||
155324972|NCT03250676|560626635|FG004|Overall Study|Physician Decision|0|||
155324973|NCT03250676|560626636|FG005|Overall Study|Physician Decision|3|||
155502271|NCT04440163|561265434|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502272|NCT04440163|561265435|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502273|NCT04440163|561265436|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502274|NCT04440163|561265437|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
155324974|NCT03250676|560626631|FG000|Overall Study|Withdrawal of consent|0|||
155324975|NCT03250676|560626632|FG001|Overall Study|Withdrawal of consent|0|||
155324976|NCT03250676|560626633|FG002|Overall Study|Withdrawal of consent|2|||
155324977|NCT03250676|560626634|FG003|Overall Study|Withdrawal of consent|0|||
155324978|NCT03250676|560626635|FG004|Overall Study|Withdrawal of consent|0|||
155502275|NCT04440163|561265438|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502276|NCT04440163|561265439|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502277|NCT04440163|561265440|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155324979|NCT03250676|560626636|FG005|Overall Study|Withdrawal of consent|2|||
155324980|NCT03250676|560626631|FG000|Overall Study|Other|1|||
155324981|NCT03250676|560626632|FG001|Overall Study|Other|0|||
155324982|NCT03250676|560626633|FG002|Overall Study|Other|0|||
155324983|NCT03250676|560626634|FG003|Overall Study|Other|0|||
155324984|NCT03250676|560626635|FG004|Overall Study|Other|0|||
155324985|NCT03250676|560626636|FG005|Overall Study|Other|0|||
155324986|NCT03250676|560626631|FG000|Overall Study|Disease progression|4|||
155324987|NCT03250676|560626632|FG001|Overall Study|Disease progression|12|||
155324988|NCT03250676|560626633|FG002|Overall Study|Disease progression|9|||
155324989|NCT03250676|560626634|FG003|Overall Study|Disease progression|7|||
155324990|NCT03250676|560626635|FG004|Overall Study|Disease progression|4|||
155324991|NCT03250676|560626636|FG005|Overall Study|Disease progression|88|||
155324992|NCT05020353|560627738|FG000|Overall Study|Protocol Violation|7|||
155324993|NCT05020353|560627738|FG000|Overall Study|Withdrawal by Subject|33|||
155324994|NCT04633278|560627742|FG000|Overall Study|Adverse Event|1|||
155324995|NCT04633278|560627743|FG001|Overall Study|Adverse Event|0|||
155324996|NCT04633278|560627742|FG000|Overall Study|Withdrawal by Subject|1|||
155324997|NCT04633278|560627743|FG001|Overall Study|Withdrawal by Subject|0|||
155324998|NCT04633278|560627742|FG000|Overall Study|Death|11|||
155324999|NCT04633278|560627743|FG001|Overall Study|Death|7|||
155325000|NCT04633278|560627742|FG000|Overall Study|Sponsor Decision|3|||
155325001|NCT04633278|560627743|FG001|Overall Study|Sponsor Decision|0|||
155325002|NCT04633278|560627742|FG000|Overall Study|Not Listed|1|||
155325003|NCT04633278|560627743|FG001|Overall Study|Not Listed|0|||
155325004|NCT02611687|560627744|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
155325005|NCT02611687|560627745|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
155325006|NCT02075554|560627749|FG000|Overall Study|Lost to Follow-up|7|||
155325007|NCT02075554|560627749|FG000|Overall Study|Withdrawal by Subject|5|||
155325008|NCT02075554|560627749|FG000|Overall Study|Physician Decision|3|||
155325009|NCT04933474|560627755|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
155325010|NCT04933474|560627756|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
155325011|NCT04933474|560627755|FG000|Overall Study|Lost to Follow-up|19|||
155325012|NCT04933474|560627756|FG001|Overall Study|Lost to Follow-up|9|||
155325013|NCT04933474|560627755|FG000|Overall Study|Life Burden - unable to participate|6|||
155325014|NCT04933474|560627756|FG001|Overall Study|Life Burden - unable to participate|2|||
155325015|NCT04933474|560627755|FG000|Overall Study|Disease Burden - unable to participate|4|||
155325016|NCT04933474|560627756|FG001|Overall Study|Disease Burden - unable to participate|1|||
155325017|NCT04933474|560627755|FG000|Overall Study|Surgery/Hospitalization|1|||
155325018|NCT04933474|560627756|FG001|Overall Study|Surgery/Hospitalization|2|||
155325019|NCT04933474|560627755|FG000|Overall Study|Dissatisfied with Intervention|1|||
155325020|NCT04933474|560627756|FG001|Overall Study|Dissatisfied with Intervention|1|||
155325021|NCT04933474|560627755|FG000|Overall Study|Withdrew interest in participation|1|||
155325022|NCT04933474|560627756|FG001|Overall Study|Withdrew interest in participation|0|||
155325023|NCT04933474|560627755|FG000|Overall Study|Had previously enrolled in the study|0|||
155325024|NCT04933474|560627756|FG001|Overall Study|Had previously enrolled in the study|1|||
155325025|NCT04757753|560627761|FG000|Overall Study|Lost to Follow-up|7|||
155325026|NCT04757753|560627762|FG001|Overall Study|Lost to Follow-up|7|||
155644573|NCT03345095|561788346|FG001|Overall Study|Protocol Violation|1|||
155644574|NCT05865886|561788347|FG000|Overall Study|Serious adverse event|0|||
155502278|NCT04440163|561265441|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
155502279|NCT00068406|561265445|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
155325027|NCT04757753|560627761|FG000|Overall Study|Withdrawal by Subject|0|||
155325028|NCT04757753|560627762|FG001|Overall Study|Withdrawal by Subject|3|||
155325029|NCT04757753|560627761|FG000|Overall Study|Endodontic treatment failure|1|||
155325030|NCT04757753|560627762|FG001|Overall Study|Endodontic treatment failure|2|||
155325031|NCT04757753|560627761|FG000|Overall Study|Tooth fracture/extraction|3|||
155325032|NCT04757753|560627762|FG001|Overall Study|Tooth fracture/extraction|0|||
155325033|NCT06655818|560627767|FG000|Overall Study|Withdrawal by Subject|1|||
155325034|NCT03816397|560627772|FG000|Overall Study|Censored at interim analysis date.|13|||
155325035|NCT03816397|560627773|FG001|Overall Study|Censored at interim analysis date.|6|||
155325036|NCT03816397|560627772|FG000|Overall Study|Withdrawal by Subject|1|||
155325037|NCT03816397|560627773|FG001|Overall Study|Withdrawal by Subject|1|||
155325038|NCT04908930|560627776|FG000|Overall Study|Lost to Follow-up|1|||
155325039|NCT04908930|560627777|FG001|Overall Study|Lost to Follow-up|1|||
155325040|NCT04908930|560627778|FG002|Overall Study|Lost to Follow-up|0|||
155325041|NCT04908930|560627779|FG003|Overall Study|Lost to Follow-up|0|||
155325042|NCT04908930|560627780|FG004|Overall Study|Lost to Follow-up|0|||
155325043|NCT04908930|560627776|FG000|Overall Study|hardware in mouth|1|||
155325044|NCT04908930|560627777|FG001|Overall Study|hardware in mouth|1|||
155325045|NCT04908930|560627778|FG002|Overall Study|hardware in mouth|0|||
155325046|NCT04908930|560627779|FG003|Overall Study|hardware in mouth|0|||
155325047|NCT04908930|560627780|FG004|Overall Study|hardware in mouth|0|||
155325048|NCT04908930|560627776|FG000|Overall Study|wrong team|1|||
155325049|NCT04908930|560627777|FG001|Overall Study|wrong team|0|||
155325050|NCT04908930|560627778|FG002|Overall Study|wrong team|0|||
155325051|NCT04908930|560627779|FG003|Overall Study|wrong team|0|||
155325052|NCT04908930|560627780|FG004|Overall Study|wrong team|0|||
155325053|NCT04908930|560627776|FG000|Overall Study|quit team|2|||
155502280|NCT00068406|561265445|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
155325054|NCT04908930|560627777|FG001|Overall Study|quit team|4|||
155325055|NCT04908930|560627778|FG002|Overall Study|quit team|0|||
155325056|NCT04908930|560627779|FG003|Overall Study|quit team|0|||
155325057|NCT04908930|560627780|FG004|Overall Study|quit team|0|||
155644575|NCT05865886|561788348|FG001|Overall Study|Serious adverse event|1|||
155325058|NCT04908930|560627776|FG000|Overall Study|Withdrawal by Subject|1|||
155325059|NCT04908930|560627777|FG001|Overall Study|Withdrawal by Subject|2|||
155325060|NCT04908930|560627778|FG002|Overall Study|Withdrawal by Subject|0|||
155325061|NCT04908930|560627779|FG003|Overall Study|Withdrawal by Subject|0|||
155325062|NCT04908930|560627780|FG004|Overall Study|Withdrawal by Subject|0|||
155325063|NCT04908930|560627776|FG000|Overall Study|parent not liking program|0|||
155325064|NCT04908930|560627777|FG001|Overall Study|parent not liking program|1|||
155325065|NCT04908930|560627778|FG002|Overall Study|parent not liking program|0|||
155325066|NCT04908930|560627779|FG003|Overall Study|parent not liking program|0|||
155325067|NCT04908930|560627780|FG004|Overall Study|parent not liking program|0|||
155325068|NCT03248479|560627781|FG000|Overall Study|Death|12|||
155325069|NCT03248479|560627782|FG001|Overall Study|Death|44|||
155325070|NCT03248479|560627783|FG002|Overall Study|Death|1|||
155325071|NCT03248479|560627784|FG003|Overall Study|Death|72|||
155325072|NCT03248479|560627785|FG004|Overall Study|Death|17|||
155325073|NCT03248479|560627786|FG005|Overall Study|Death|6|||
155325074|NCT03248479|560627787|FG006|Overall Study|Death|1|||
155325075|NCT03248479|560627788|FG007|Overall Study|Death|14|||
155325076|NCT03248479|560627789|FG008|Overall Study|Death|3|||
155325077|NCT03248479|560627790|FG009|Overall Study|Death|7|||
155325078|NCT03248479|560627791|FG010|Overall Study|Death|3|||
155325079|NCT03248479|560627792|FG011|Overall Study|Death|1|||
155325080|NCT03248479|560627793|FG012|Overall Study|Death|1|||
155325081|NCT03248479|560627781|FG000|Overall Study|Study terminated by sponsor|12|||
155325082|NCT03248479|560627782|FG001|Overall Study|Study terminated by sponsor|15|||
155325083|NCT03248479|560627783|FG002|Overall Study|Study terminated by sponsor|0|||
155325084|NCT03248479|560627784|FG003|Overall Study|Study terminated by sponsor|5|||
155325085|NCT03248479|560627785|FG004|Overall Study|Study terminated by sponsor|0|||
155325086|NCT03248479|560627786|FG005|Overall Study|Study terminated by sponsor|0|||
155325087|NCT03248479|560627787|FG006|Overall Study|Study terminated by sponsor|0|||
155325088|NCT03248479|560627788|FG007|Overall Study|Study terminated by sponsor|1|||
155325089|NCT03248479|560627789|FG008|Overall Study|Study terminated by sponsor|1|||
155325090|NCT03248479|560627790|FG009|Overall Study|Study terminated by sponsor|0|||
155325091|NCT03248479|560627791|FG010|Overall Study|Study terminated by sponsor|5|||
155325092|NCT03248479|560627792|FG011|Overall Study|Study terminated by sponsor|4|||
155325093|NCT03248479|560627793|FG012|Overall Study|Study terminated by sponsor|0|||
155325094|NCT03248479|560627781|FG000|Overall Study|Consent withdrawn|6|||
155325095|NCT03248479|560627782|FG001|Overall Study|Consent withdrawn|3|||
155325096|NCT03248479|560627783|FG002|Overall Study|Consent withdrawn|0|||
155325097|NCT03248479|560627784|FG003|Overall Study|Consent withdrawn|9|||
155325098|NCT03248479|560627785|FG004|Overall Study|Consent withdrawn|1|||
155325099|NCT03248479|560627786|FG005|Overall Study|Consent withdrawn|0|||
155325100|NCT03248479|560627787|FG006|Overall Study|Consent withdrawn|0|||
155325101|NCT03248479|560627788|FG007|Overall Study|Consent withdrawn|1|||
155325102|NCT03248479|560627789|FG008|Overall Study|Consent withdrawn|0|||
155325103|NCT03248479|560627790|FG009|Overall Study|Consent withdrawn|3|||
155325104|NCT03248479|560627791|FG010|Overall Study|Consent withdrawn|1|||
155325105|NCT03248479|560627792|FG011|Overall Study|Consent withdrawn|0|||
155325106|NCT03248479|560627793|FG012|Overall Study|Consent withdrawn|1|||
155325107|NCT03248479|560627781|FG000|Overall Study|Lost to Follow-up|2|||
155325108|NCT03248479|560627782|FG001|Overall Study|Lost to Follow-up|1|||
155325109|NCT03248479|560627783|FG002|Overall Study|Lost to Follow-up|0|||
155325110|NCT03248479|560627784|FG003|Overall Study|Lost to Follow-up|0|||
155325111|NCT03248479|560627785|FG004|Overall Study|Lost to Follow-up|0|||
155325112|NCT03248479|560627786|FG005|Overall Study|Lost to Follow-up|0|||
155325113|NCT03248479|560627787|FG006|Overall Study|Lost to Follow-up|0|||
155325114|NCT03248479|560627788|FG007|Overall Study|Lost to Follow-up|0|||
155325115|NCT03248479|560627789|FG008|Overall Study|Lost to Follow-up|0|||
155325116|NCT03248479|560627790|FG009|Overall Study|Lost to Follow-up|0|||
155325117|NCT03248479|560627791|FG010|Overall Study|Lost to Follow-up|0|||
155325118|NCT03248479|560627792|FG011|Overall Study|Lost to Follow-up|0|||
155325119|NCT03248479|560627793|FG012|Overall Study|Lost to Follow-up|1|||
155325120|NCT03248479|560627781|FG000|Overall Study|Not reported|0|||
155325121|NCT03248479|560627782|FG001|Overall Study|Not reported|0|||
155325122|NCT03248479|560627783|FG002|Overall Study|Not reported|0|||
155325123|NCT03248479|560627784|FG003|Overall Study|Not reported|1|||
155325124|NCT03248479|560627785|FG004|Overall Study|Not reported|1|||
155325125|NCT03248479|560627786|FG005|Overall Study|Not reported|0|||
155325126|NCT03248479|560627787|FG006|Overall Study|Not reported|0|||
155325127|NCT03248479|560627788|FG007|Overall Study|Not reported|1|||
155325128|NCT03248479|560627789|FG008|Overall Study|Not reported|1|||
155325129|NCT03248479|560627790|FG009|Overall Study|Not reported|0|||
155325130|NCT03248479|560627791|FG010|Overall Study|Not reported|0|||
155325131|NCT03248479|560627792|FG011|Overall Study|Not reported|0|||
155325132|NCT03248479|560627793|FG012|Overall Study|Not reported|0|||
155325133|NCT02777593|560627794|FG000|Overall Study|Still in study|1|||
155325134|NCT02777593|560627795|FG001|Overall Study|Still in study|32|||
155325135|NCT02777593|560627796|FG002|Overall Study|Still in study|3|||
155325136|NCT02777593|560627797|FG003|Overall Study|Still in study|6|||
155325137|NCT02777593|560627798|FG004|Overall Study|Still in study|5|||
155325138|NCT02777593|560627794|FG000|Overall Study|Death|21|||
155325139|NCT02777593|560627795|FG001|Overall Study|Death|28|||
155325140|NCT02777593|560627796|FG002|Overall Study|Death|0|||
155325141|NCT02777593|560627797|FG003|Overall Study|Death|5|||
155325142|NCT02777593|560627798|FG004|Overall Study|Death|0|||
155325143|NCT02777593|560627794|FG000|Overall Study|Withdrawal by Subject|8|||
155325144|NCT02777593|560627795|FG001|Overall Study|Withdrawal by Subject|4|||
155325145|NCT02777593|560627796|FG002|Overall Study|Withdrawal by Subject|1|||
155325146|NCT02777593|560627797|FG003|Overall Study|Withdrawal by Subject|1|||
155325147|NCT02777593|560627798|FG004|Overall Study|Withdrawal by Subject|0|||
155325148|NCT02777593|560627794|FG000|Overall Study|Lost to Follow-up|8|||
155325149|NCT02777593|560627795|FG001|Overall Study|Lost to Follow-up|16|||
155325150|NCT02777593|560627796|FG002|Overall Study|Lost to Follow-up|5|||
155325151|NCT02777593|560627797|FG003|Overall Study|Lost to Follow-up|0|||
155325152|NCT02777593|560627798|FG004|Overall Study|Lost to Follow-up|1|||
155325153|NCT02777593|560627794|FG000|Overall Study|Physician Decision|2|||
155325154|NCT02777593|560627795|FG001|Overall Study|Physician Decision|2|||
155325155|NCT02777593|560627796|FG002|Overall Study|Physician Decision|0|||
155325156|NCT02777593|560627797|FG003|Overall Study|Physician Decision|0|||
155325157|NCT02777593|560627798|FG004|Overall Study|Physician Decision|0|||
155325158|NCT02777593|560627794|FG000|Overall Study|Discontinued due to Other|1|||
155325159|NCT02777593|560627795|FG001|Overall Study|Discontinued due to Other|0|||
155325160|NCT02777593|560627796|FG002|Overall Study|Discontinued due to Other|0|||
155325161|NCT02777593|560627797|FG003|Overall Study|Discontinued due to Other|0|||
155325162|NCT02777593|560627798|FG004|Overall Study|Discontinued due to Other|0|||
155325163|NCT05785130|560627802|FG000|Overall Study|Withdrawal by Subject|1|||
155325164|NCT05785130|560627803|FG001|Overall Study|Withdrawal by Subject|0|||
155325165|NCT05785130|560627802|FG000|Overall Study|Lack of Efficacy|0|||
155325166|NCT05785130|560627803|FG001|Overall Study|Lack of Efficacy|1|||
155325167|NCT03547271|560627804|FG000|Overall Study|Adverse Event|1|||
155325168|NCT03547271|560627805|FG001|Overall Study|Adverse Event|1|||
155325169|NCT03547271|560627806|FG002|Overall Study|Adverse Event|0|||
155325170|NCT03547271|560627807|FG003|Overall Study|Adverse Event|0|||
155325171|NCT03547271|560627804|FG000|Overall Study|Protocol deviation|5|||
155325172|NCT03547271|560627805|FG001|Overall Study|Protocol deviation|7|||
155325173|NCT03547271|560627806|FG002|Overall Study|Protocol deviation|3|||
155325174|NCT03547271|560627807|FG003|Overall Study|Protocol deviation|0|||
155325175|NCT03547271|560627804|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
155325176|NCT03547271|560627805|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
155325177|NCT03547271|560627806|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155325178|NCT03547271|560627807|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
155325179|NCT03547271|560627804|FG000|Overall Study|Lost to Follow-up|3|||
155325180|NCT03547271|560627805|FG001|Overall Study|Lost to Follow-up|3|||
155325181|NCT03547271|560627806|FG002|Overall Study|Lost to Follow-up|1|||
155325182|NCT03547271|560627807|FG003|Overall Study|Lost to Follow-up|0|||
155325183|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
155325184|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
155325185|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
155325186|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
155325187|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
155325188|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
155325189|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
155325190|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
155325191|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
155325192|NCT06065735|560627808|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
155325193|NCT06065735|560627809|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
155325194|NCT06065735|560627810|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
155325195|NCT06065735|560627808|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
155325196|NCT06065735|560627809|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
155502281|NCT03231709|561265449|FG000|Treatment Period 1|Reason not Specified|0|||
155502282|NCT03231709|561265450|FG001|Treatment Period 1|Reason not Specified|1|||
155502283|NCT03231709|561265449|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
155502284|NCT03231709|561265450|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
155502285|NCT02609178|561265451|FG000|First Crown|Withdrawal by Subject|0|||
155325197|NCT06065735|560627810|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
155325198|NCT03982186|560627811|FG000|Overall Study|Lost to Follow-up|0|||
155325199|NCT03982186|560627812|FG001|Overall Study|Lost to Follow-up|1|||
155502286|NCT02609178|561265452|FG001|First Crown|Withdrawal by Subject|0|||
155325200|NCT03982186|560627813|FG002|Overall Study|Lost to Follow-up|2|||
155325201|NCT03982186|560627814|FG003|Overall Study|Lost to Follow-up|1|||
155325202|NCT03982186|560627815|FG004|Overall Study|Lost to Follow-up|1|||
155325203|NCT03982186|560627816|FG005|Overall Study|Lost to Follow-up|0|||
155325204|NCT03982186|560627811|FG000|Overall Study|Physician Decision|0|||
155502287|NCT02609178|561265453|FG002|First Crown|Withdrawal by Subject|1|||
155325205|NCT03982186|560627812|FG001|Overall Study|Physician Decision|1|||
155325206|NCT03982186|560627813|FG002|Overall Study|Physician Decision|0|||
155325207|NCT03982186|560627814|FG003|Overall Study|Physician Decision|0|||
155325208|NCT03982186|560627815|FG004|Overall Study|Physician Decision|0|||
155325209|NCT03982186|560627816|FG005|Overall Study|Physician Decision|0|||
155325210|NCT03982186|560627811|FG000|Overall Study|Withdrawal by Subject|3|||
155325211|NCT03982186|560627812|FG001|Overall Study|Withdrawal by Subject|4|||
155325212|NCT03982186|560627813|FG002|Overall Study|Withdrawal by Subject|1|||
155325213|NCT03982186|560627814|FG003|Overall Study|Withdrawal by Subject|7|||
155325214|NCT03982186|560627815|FG004|Overall Study|Withdrawal by Subject|2|||
155325215|NCT03982186|560627816|FG005|Overall Study|Withdrawal by Subject|0|||
155325216|NCT03982186|560627811|FG000|Overall Study|Randomized and not treated|0|||
155325217|NCT03982186|560627812|FG001|Overall Study|Randomized and not treated|0|||
155325218|NCT03982186|560627813|FG002|Overall Study|Randomized and not treated|0|||
155325219|NCT03982186|560627814|FG003|Overall Study|Randomized and not treated|1|||
155325220|NCT03982186|560627815|FG004|Overall Study|Randomized and not treated|0|||
155325221|NCT03982186|560627816|FG005|Overall Study|Randomized and not treated|0|||
155325222|NCT02325154|560627817|FG000|Overall Study|Physician Decision|1|||
155325223|NCT01265537|560627818|FG000|Overall Study|Adverse Event|2|||
155325224|NCT01265537|560627819|FG001|Overall Study|Adverse Event|1|||
155325225|NCT01265537|560627818|FG000|Overall Study|Physician Decision|0|||
155325226|NCT01265537|560627819|FG001|Overall Study|Physician Decision|1|||
155325227|NCT03512301|560628507|FG000|Overall Study|Protocol Violation|2|||
155325228|NCT03512301|560628507|FG000|Overall Study|Did Not Qualify|3|||
155325229|NCT03512301|560628507|FG000|Overall Study|Age-ineligible|1|||
155325230|NCT03512301|560628507|FG000|Overall Study|Inadequate fluency with the English language|3|||
155325231|NCT02720068|560628511|FG000|Overall Study|Adverse Event|0|||
155325232|NCT02720068|560628512|FG001|Overall Study|Adverse Event|0|||
155325233|NCT02720068|560628513|FG002|Overall Study|Adverse Event|0|||
155325234|NCT02720068|560628514|FG003|Overall Study|Adverse Event|0|||
155325235|NCT02720068|560628515|FG004|Overall Study|Adverse Event|0|||
155325236|NCT02720068|560628516|FG005|Overall Study|Adverse Event|0|||
155325237|NCT02720068|560628517|FG006|Overall Study|Adverse Event|0|||
155325238|NCT02720068|560628518|FG007|Overall Study|Adverse Event|0|||
155421392|NCT00531960|560972555|FG001|Overall Study|Other|10|||
155421393|NCT02471716|560972561|FG000|Overall Study|Withdrawal by Subject|0|||
155421394|NCT02471716|560972562|FG001|Overall Study|Withdrawal by Subject|1|||
155421395|NCT02471716|560972563|FG002|Overall Study|Withdrawal by Subject|0|||
155421396|NCT02471716|560972564|FG003|Overall Study|Withdrawal by Subject|2|||
155421397|NCT02471716|560972565|FG004|Overall Study|Withdrawal by Subject|5|||
155421398|NCT02471716|560972561|FG000|Overall Study|Study Terminiated by sponsor|0|||
155421399|NCT02471716|560972562|FG001|Overall Study|Study Terminiated by sponsor|0|||
155421400|NCT02471716|560972563|FG002|Overall Study|Study Terminiated by sponsor|0|||
155421401|NCT02471716|560972564|FG003|Overall Study|Study Terminiated by sponsor|1|||
155421402|NCT02471716|560972565|FG004|Overall Study|Study Terminiated by sponsor|0|||
155421403|NCT02471716|560972561|FG000|Overall Study|Lost to Follow-up|0|||
155421404|NCT02471716|560972562|FG001|Overall Study|Lost to Follow-up|0|||
155421405|NCT02471716|560972563|FG002|Overall Study|Lost to Follow-up|0|||
155421406|NCT02471716|560972564|FG003|Overall Study|Lost to Follow-up|3|||
155421407|NCT02471716|560972565|FG004|Overall Study|Lost to Follow-up|2|||
155421408|NCT02471716|560972561|FG000|Overall Study|Death|0|||
155421409|NCT02471716|560972562|FG001|Overall Study|Death|0|||
155421410|NCT02471716|560972563|FG002|Overall Study|Death|0|||
155421411|NCT02471716|560972564|FG003|Overall Study|Death|1|||
155421412|NCT02471716|560972565|FG004|Overall Study|Death|0|||
155421413|NCT02471716|560972561|FG000|Overall Study|Other|0|||
155421414|NCT02471716|560972562|FG001|Overall Study|Other|0|||
155421415|NCT02471716|560972563|FG002|Overall Study|Other|0|||
155421416|NCT02471716|560972564|FG003|Overall Study|Other|8|||
155325239|NCT02720068|560628519|FG008|Overall Study|Adverse Event|0|||
155421417|NCT02471716|560972565|FG004|Overall Study|Other|9|||
155325240|NCT02720068|560628520|FG009|Overall Study|Adverse Event|0|||
155325241|NCT02720068|560628521|FG010|Overall Study|Adverse Event|0|||
155325242|NCT02720068|560628522|FG011|Overall Study|Adverse Event|1|||
155325243|NCT02720068|560628523|FG012|Overall Study|Adverse Event|0|||
155421418|NCT04178772|560972580|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
155644576|NCT01671059|561788349|FG000|Overall Study|Adverse Event|4|||
155644577|NCT01671059|561788349|FG000|Overall Study|Lack of Efficacy|1|||
155644578|NCT04971837|561789809|FG000|Overall Study|Long Term Illness|1|||
155644579|NCT04971837|561789809|FG000|Overall Study|BMI too low|9|||
155644580|NCT04971837|561789809|FG000|Overall Study|geographic location|1|||
155644581|NCT04971837|561789809|FG000|Overall Study|Discontinued scheduling conflict|1|||
155644582|NCT03787212|561789813|FG000|Period 1|Study Termination|2|||
155644583|NCT03787212|561789814|FG001|Period 1|Study Termination|2|||
155644584|NCT00884949|561789818|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
155644585|NCT00884949|561789818|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
155644586|NCT03022630|561789819|FG000|Overall Study|Death|9|||
155644587|NCT03022630|561789820|FG001|Overall Study|Death|7|||
155644588|NCT03022630|561789819|FG000|Overall Study|Withdrawal by Subject|0|||
155644589|NCT03022630|561789820|FG001|Overall Study|Withdrawal by Subject|5|||
155644590|NCT00382070|561789821|FG000|Overall Study|No follow up data mapped to Other|17|||
155644591|NCT00382070|561789822|FG001|Overall Study|No follow up data mapped to Other|19|||
155644592|NCT00382070|561789821|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
155644593|NCT00382070|561789822|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
155644594|NCT00382070|561789821|FG000|Overall Study|No clinical assessment|9|||
155644595|NCT00382070|561789822|FG001|Overall Study|No clinical assessment|11|||
155644596|NCT01734928|561789823|FG000|Randomization|Physician Decision|0|||
155644597|NCT01734928|561789824|FG001|Randomization|Physician Decision|1|||
155644598|NCT01734928|561789823|FG000|Randomization|clinical progression|0|||
155644599|NCT01734928|561789824|FG001|Randomization|clinical progression|1|||
155644600|NCT01734928|561789823|FG000|Randomization|progressive disease|0|||
155644601|NCT01734928|561789824|FG001|Randomization|progressive disease|2|||
155644602|NCT01734928|561789823|FG000|Randomization|Withdrew informed consent|0|||
155644603|NCT01734928|561789824|FG001|Randomization|Withdrew informed consent|4|||
155644604|NCT01734928|561789823|FG000|Randomization|Death|1|||
155644605|NCT01734928|561789824|FG001|Randomization|Death|0|||
155644606|NCT01734928|561789823|FG000|Randomization|Randomization error|1|||
155644607|NCT01734928|561789824|FG001|Randomization|Randomization error|0|||
155644608|NCT01734928|561789823|FG000|Randomization|Lost to Follow-up|1|||
155644609|NCT01734928|561789824|FG001|Randomization|Lost to Follow-up|0|||
155644610|NCT01734928|561789823|FG000|Treatment Period|Lost to Follow-up|0|||
155644611|NCT01734928|561789824|FG001|Treatment Period|Lost to Follow-up|2|||
155644612|NCT01734928|561789823|FG000|Treatment Period|Progressive Disease|167|||
155644613|NCT01734928|561789824|FG001|Treatment Period|Progressive Disease|165|||
155644614|NCT01734928|561789823|FG000|Treatment Period|Adverse Event|39|||
155644615|NCT01734928|561789824|FG001|Treatment Period|Adverse Event|52|||
155644616|NCT01734928|561789823|FG000|Treatment Period|Withdrawal of Consent|25|||
155644617|NCT01734928|561789824|FG001|Treatment Period|Withdrawal of Consent|22|||
155644618|NCT01734928|561789823|FG000|Treatment Period|Death|20|||
155644619|NCT01734928|561789824|FG001|Treatment Period|Death|9|||
155644620|NCT01734928|561789823|FG000|Treatment Period|Other Reasons|27|||
155644621|NCT01734928|561789824|FG001|Treatment Period|Other Reasons|19|||
155644622|NCT01734928|561789823|FG000|Treatment Period|Pregnancy|0|||
155644623|NCT01734928|561789824|FG001|Treatment Period|Pregnancy|1|||
155644624|NCT00620035|561789825|FG000|Overall Study|Adverse Event|106|||
155644625|NCT00620035|561789825|FG000|Overall Study|Withdrawal of Informed Consent|1|||
155644626|NCT00620035|561789825|FG000|Overall Study|Other Reason|38|||
155644627|NCT03684057|561789827|FG000|Overall Study|Withdrawal by Subject|4|||
155644628|NCT03684057|561789828|FG001|Overall Study|Withdrawal by Subject|5|||
155644629|NCT00456612|561789830|FG000|Overall Study|Withdrawal by Subject|3|||
155644630|NCT02316613|561789831|FG000|Overall Study|Death|63|||
155644631|NCT02316613|561789831|FG000|Overall Study|Lost to Follow-up|9|||
155421419|NCT04178772|560972580|FG000|Overall Study|study terminated early due to COVID-19|7|||
155421420|NCT01481896|560972585|FG000|Overall Study|Lost to Follow-up|12|||
155421421|NCT01162421|560972588|FG000|Overall Study|Did not receive study drug|2|||
155421422|NCT01162421|560972589|FG001|Overall Study|Did not receive study drug|1|||
155421423|NCT01162421|560972588|FG000|Overall Study|Adverse Event|2|||
155421424|NCT01162421|560972589|FG001|Overall Study|Adverse Event|5|||
155421425|NCT01162421|560972588|FG000|Overall Study|Lost to Follow-up|0|||
155421426|NCT01162421|560972589|FG001|Overall Study|Lost to Follow-up|2|||
155644632|NCT02316613|561789831|FG000|Overall Study|Lymphoma transformation|2|||
155421427|NCT01162421|560972588|FG000|Overall Study|Lack of Efficacy|2|||
155421428|NCT01162421|560972589|FG001|Overall Study|Lack of Efficacy|2|||
155421429|NCT01162421|560972588|FG000|Overall Study|Other|2|||
155644633|NCT02316613|561789831|FG000|Overall Study|Participant moved/changed medical team|11|||
155644634|NCT02316613|561789831|FG000|Overall Study|No data and duplicate cases|5|||
155644635|NCT02316613|561789831|FG000|Overall Study|Did not met selection criteria|14|||
155644636|NCT03422718|561789841|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
155644637|NCT03422718|561789842|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
155644638|NCT03422718|561789843|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
155644639|NCT03422718|561789844|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
155421430|NCT01162421|560972589|FG001|Overall Study|Other|3|||
155644640|NCT03422718|561789845|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
155325244|NCT02720068|560628524|FG013|Overall Study|Adverse Event|0|||
155325245|NCT02720068|560628525|FG014|Overall Study|Adverse Event|0|||
155325246|NCT02720068|560628526|FG015|Overall Study|Adverse Event|0|||
155325247|NCT02720068|560628527|FG016|Overall Study|Adverse Event|0|||
155325248|NCT02720068|560628528|FG017|Overall Study|Adverse Event|0|||
155325249|NCT02720068|560628511|FG000|Overall Study|Death|1|||
155325250|NCT02720068|560628512|FG001|Overall Study|Death|3|||
155325251|NCT02720068|560628513|FG002|Overall Study|Death|2|||
155325252|NCT02720068|560628514|FG003|Overall Study|Death|1|||
155325253|NCT02720068|560628515|FG004|Overall Study|Death|2|||
155325254|NCT02720068|560628516|FG005|Overall Study|Death|1|||
155421431|NCT03336502|560972590|FG000|Overall Study|Physician Decision|0|||
155421432|NCT03336502|560972591|FG001|Overall Study|Physician Decision|1|||
155421433|NCT03336502|560972590|FG000|Overall Study|Prohibited Drugs|1|||
155421434|NCT03336502|560972591|FG001|Overall Study|Prohibited Drugs|1|||
155421435|NCT03336502|560972590|FG000|Overall Study|Death|1|||
155421436|NCT03336502|560972591|FG001|Overall Study|Death|2|||
155421437|NCT03336502|560972590|FG000|Overall Study|Adverse Event|2|||
155421438|NCT03336502|560972591|FG001|Overall Study|Adverse Event|5|||
155421439|NCT01107444|560972596|FG000|Overall Study|Withdrawal by Subject|8|||
155421440|NCT01107444|560972597|FG001|Overall Study|Withdrawal by Subject|12|||
155421441|NCT01107444|560972596|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
155421442|NCT01107444|560972597|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
155421443|NCT03310970|560972601|FG000|Overall Study|Withdrawal by Subject|0|||
155421444|NCT03310970|560972602|FG001|Overall Study|Withdrawal by Subject|1|||
155421445|NCT01446419|560972603|FG000|Overall Study|Death|1|||
155421446|NCT01446419|560972604|FG001|Overall Study|Death|0|||
155421447|NCT01446419|560972603|FG000|Overall Study|Withdrawal by Subject|1|||
155421448|NCT01446419|560972604|FG001|Overall Study|Withdrawal by Subject|1|||
155421449|NCT01446419|560972603|FG000|Overall Study|Terminated per protocol|3|||
155421450|NCT01446419|560972604|FG001|Overall Study|Terminated per protocol|0|||
155421451|NCT04025632|560974259|FG000|Overall Study|Adverse Event|1|||
155421452|NCT04025632|560974260|FG001|Overall Study|Adverse Event|1|||
155421453|NCT04025632|560974259|FG000|Overall Study|Withdrawal by Subject|1|||
155421454|NCT04025632|560974260|FG001|Overall Study|Withdrawal by Subject|1|||
155421455|NCT04025632|560974259|FG000|Overall Study|Study Terminated by Sponsor|10|||
155421456|NCT04025632|560974260|FG001|Overall Study|Study Terminated by Sponsor|9|||
155421457|NCT04025632|560974259|FG000|Overall Study|Physician Decision|3|||
155421458|NCT04025632|560974260|FG001|Overall Study|Physician Decision|1|||
155421459|NCT02159807|560974263|FG000|Overall Study|Adverse Event|0|||
155421460|NCT02159807|560974264|FG001|Overall Study|Adverse Event|0|||
155421461|NCT02159807|560974265|FG002|Overall Study|Adverse Event|1|||
155421462|NCT02159807|560974263|FG000|Overall Study|No CSF|1|||
155421463|NCT02159807|560974264|FG001|Overall Study|No CSF|1|||
155421464|NCT02159807|560974265|FG002|Overall Study|No CSF|1|||
155421465|NCT02159807|560974263|FG000|Overall Study|elevated blood pressure|0|||
155421466|NCT02159807|560974264|FG001|Overall Study|elevated blood pressure|0|||
155421467|NCT02159807|560974265|FG002|Overall Study|elevated blood pressure|1|||
155421468|NCT00950170|560974266|FG000|Overall Study|Parent/Legal Guardian Request|1|||
155421469|NCT00950170|560974266|FG000|Overall Study|Adverse Event|2|||
155421470|NCT00950170|560974266|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
155421471|NCT02367521|560974269|FG000|Overall Study|severe headache after intervention|2|||
155421472|NCT02367521|560974270|FG001|Overall Study|severe headache after intervention|0|||
155421473|NCT02367521|560974269|FG000|Overall Study|unable to find transportation|2|||
155421474|NCT02367521|560974270|FG001|Overall Study|unable to find transportation|0|||
155421475|NCT00600171|560974271|FG000|Overall Study|Adverse Event|0|||
155502288|NCT02609178|561265454|FG003|First Crown|Withdrawal by Subject|1|||
155502289|NCT02609178|561265455|FG004|First Crown|Withdrawal by Subject|0|||
155502290|NCT02609178|561265456|FG005|First Crown|Withdrawal by Subject|0|||
155502291|NCT01128153|561265457|FG000|Overall Study|Adverse Event|1|||
155502292|NCT01128153|561265458|FG001|Overall Study|Adverse Event|3|||
155502293|NCT01128153|561265457|FG000|Overall Study|Condition under investigation worsened|8|||
155502294|NCT01128153|561265458|FG001|Overall Study|Condition under investigation worsened|7|||
155421476|NCT00600171|560974272|FG001|Overall Study|Adverse Event|1|||
155421477|NCT00600171|560974273|FG002|Overall Study|Adverse Event|0|||
155421478|NCT00600171|560974274|FG003|Overall Study|Adverse Event|0|||
155421479|NCT00600171|560974275|FG004|Overall Study|Adverse Event|1|||
155421480|NCT00600171|560974276|FG005|Overall Study|Adverse Event|0|||
155421481|NCT00600171|560974271|FG000|Overall Study|Lack of Efficacy|9|||
155421482|NCT00600171|560974272|FG001|Overall Study|Lack of Efficacy|12|||
155421483|NCT00600171|560974273|FG002|Overall Study|Lack of Efficacy|3|||
155421484|NCT00600171|560974274|FG003|Overall Study|Lack of Efficacy|5|||
155502295|NCT01128153|561265457|FG000|Overall Study|Withdrawal by Subject|2|||
155502296|NCT01128153|561265458|FG001|Overall Study|Withdrawal by Subject|3|||
155325255|NCT02720068|560628517|FG006|Overall Study|Death|2|||
155325256|NCT02720068|560628518|FG007|Overall Study|Death|2|||
155325257|NCT02720068|560628519|FG008|Overall Study|Death|3|||
155502297|NCT01128153|561265457|FG000|Overall Study|Incorrect enrolment to study|2|||
155325258|NCT02720068|560628520|FG009|Overall Study|Death|1|||
155502298|NCT01128153|561265458|FG001|Overall Study|Incorrect enrolment to study|1|||
155325259|NCT02720068|560628521|FG010|Overall Study|Death|20|||
155325260|NCT02720068|560628522|FG011|Overall Study|Death|166|||
155502299|NCT01128153|561265457|FG000|Overall Study|Protocol Violation|2|||
155502300|NCT01128153|561265458|FG001|Overall Study|Protocol Violation|0|||
155502301|NCT01128153|561265457|FG000|Overall Study|Developed discontinuation criteria|1|||
155325261|NCT02720068|560628523|FG012|Overall Study|Death|34|||
155325262|NCT02720068|560628524|FG013|Overall Study|Death|30|||
155325263|NCT02720068|560628525|FG014|Overall Study|Death|45|||
155325264|NCT02720068|560628526|FG015|Overall Study|Death|16|||
155325265|NCT02720068|560628527|FG016|Overall Study|Death|20|||
155325266|NCT02720068|560628528|FG017|Overall Study|Death|28|||
155325267|NCT02720068|560628511|FG000|Overall Study|Lost to Follow-up|0|||
155325268|NCT02720068|560628512|FG001|Overall Study|Lost to Follow-up|0|||
155325269|NCT02720068|560628513|FG002|Overall Study|Lost to Follow-up|0|||
155644641|NCT03422718|561789846|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
155644642|NCT03422718|561789847|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
155644643|NCT03422718|561789848|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
155644644|NCT03422718|561789841|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
155644645|NCT03422718|561789842|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
155644646|NCT03422718|561789843|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
155644647|NCT03422718|561789844|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
155644648|NCT03422718|561789845|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
155644649|NCT03422718|561789846|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
155644650|NCT03422718|561789847|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
155644651|NCT03422718|561789848|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
155644652|NCT03422718|561789841|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
155644653|NCT03422718|561789842|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
155644654|NCT03422718|561789843|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
155644655|NCT03422718|561789844|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155644656|NCT03422718|561789845|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
155644657|NCT03422718|561789846|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155644658|NCT03422718|561789847|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155644659|NCT03422718|561789848|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
155644660|NCT03422718|561789841|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155644661|NCT03422718|561789842|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
155644662|NCT03422718|561789843|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155644663|NCT03422718|561789844|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155644664|NCT03422718|561789845|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
155644665|NCT03422718|561789846|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
155644666|NCT03422718|561789847|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155644667|NCT03422718|561789848|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155644668|NCT03422718|561789841|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
155502302|NCT01128153|561265458|FG001|Overall Study|Developed discontinuation criteria|1|||
155502303|NCT01954082|561265459|FG000|Overall Study|Study Suspension|42|||
155325270|NCT02720068|560628514|FG003|Overall Study|Lost to Follow-up|0|||
155325271|NCT02720068|560628515|FG004|Overall Study|Lost to Follow-up|0|||
155325272|NCT02720068|560628516|FG005|Overall Study|Lost to Follow-up|0|||
155325273|NCT02720068|560628517|FG006|Overall Study|Lost to Follow-up|0|||
155502304|NCT01954082|561265460|FG001|Overall Study|Study Suspension|36|||
155325274|NCT02720068|560628518|FG007|Overall Study|Lost to Follow-up|0|||
155502305|NCT01954082|561265459|FG000|Overall Study|Adverse Event|10|||
155325275|NCT02720068|560628519|FG008|Overall Study|Lost to Follow-up|0|||
155325276|NCT02720068|560628520|FG009|Overall Study|Lost to Follow-up|0|||
155325277|NCT02720068|560628521|FG010|Overall Study|Lost to Follow-up|0|||
155502306|NCT01954082|561265460|FG001|Overall Study|Adverse Event|4|||
155502307|NCT01954082|561265459|FG000|Overall Study|Intolerance|0|||
155502308|NCT01954082|561265460|FG001|Overall Study|Intolerance|1|||
155325278|NCT02720068|560628522|FG011|Overall Study|Lost to Follow-up|1|||
155325279|NCT02720068|560628523|FG012|Overall Study|Lost to Follow-up|0|||
155325280|NCT02720068|560628524|FG013|Overall Study|Lost to Follow-up|1|||
155325281|NCT02720068|560628525|FG014|Overall Study|Lost to Follow-up|2|||
155325282|NCT02720068|560628526|FG015|Overall Study|Lost to Follow-up|0|||
155325283|NCT02720068|560628527|FG016|Overall Study|Lost to Follow-up|0|||
155325284|NCT02720068|560628528|FG017|Overall Study|Lost to Follow-up|1|||
155325285|NCT02720068|560628511|FG000|Overall Study|Physician Decision|0|||
155325286|NCT02720068|560628512|FG001|Overall Study|Physician Decision|0|||
155325287|NCT02720068|560628513|FG002|Overall Study|Physician Decision|0|||
155325288|NCT02720068|560628514|FG003|Overall Study|Physician Decision|1|||
155325289|NCT02720068|560628515|FG004|Overall Study|Physician Decision|0|||
155325290|NCT02720068|560628516|FG005|Overall Study|Physician Decision|0|||
155325291|NCT02720068|560628517|FG006|Overall Study|Physician Decision|0|||
155325292|NCT02720068|560628518|FG007|Overall Study|Physician Decision|0|||
155325293|NCT02720068|560628519|FG008|Overall Study|Physician Decision|0|||
155325294|NCT02720068|560628520|FG009|Overall Study|Physician Decision|0|||
155325295|NCT02720068|560628521|FG010|Overall Study|Physician Decision|0|||
155325296|NCT02720068|560628522|FG011|Overall Study|Physician Decision|1|||
155325297|NCT02720068|560628523|FG012|Overall Study|Physician Decision|0|||
155502309|NCT01954082|561265459|FG000|Overall Study|Non-compliance|6|||
155502310|NCT01954082|561265460|FG001|Overall Study|Non-compliance|4|||
155502311|NCT01954082|561265459|FG000|Overall Study|Physician Decision|2|||
155502312|NCT01954082|561265460|FG001|Overall Study|Physician Decision|0|||
155502313|NCT01954082|561265459|FG000|Overall Study|Parent Decision|1|||
155502314|NCT01954082|561265460|FG001|Overall Study|Parent Decision|0|||
155502315|NCT01954082|561265459|FG000|Overall Study|Withdrawal by Subject|0|||
155502316|NCT01954082|561265460|FG001|Overall Study|Withdrawal by Subject|1|||
155502317|NCT01954082|561265459|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
155502318|NCT01954082|561265460|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
155502319|NCT01954082|561265459|FG000|Overall Study|Redirection of Care|0|||
155502320|NCT01954082|561265460|FG001|Overall Study|Redirection of Care|2|||
155502321|NCT01954082|561265459|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
155502322|NCT01954082|561265460|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
155502323|NCT01954082|561265459|FG000|Overall Study|Comfort Care|0|||
155502324|NCT01954082|561265460|FG001|Overall Study|Comfort Care|1|||
155502325|NCT01954082|561265459|FG000|Overall Study|Infant Moved|0|||
155502326|NCT01954082|561265460|FG001|Overall Study|Infant Moved|1|||
155502327|NCT01954082|561265459|FG000|Overall Study|Randomized not Treated|4|||
155502328|NCT01954082|561265460|FG001|Overall Study|Randomized not Treated|2|||
155502329|NCT01682512|561265461|FG000|Overall Study|Adverse Event|6|||
155502330|NCT01682512|561265462|FG001|Overall Study|Adverse Event|5|||
155502331|NCT01682512|561265463|FG002|Overall Study|Adverse Event|2|||
155325298|NCT02720068|560628524|FG013|Overall Study|Physician Decision|0|||
155325299|NCT02720068|560628525|FG014|Overall Study|Physician Decision|0|||
155325300|NCT02720068|560628526|FG015|Overall Study|Physician Decision|0|||
155325301|NCT02720068|560628527|FG016|Overall Study|Physician Decision|0|||
155325302|NCT02720068|560628528|FG017|Overall Study|Physician Decision|1|||
155325303|NCT02720068|560628511|FG000|Overall Study|Progressive Disease|2|||
155325304|NCT02720068|560628512|FG001|Overall Study|Progressive Disease|3|||
155325305|NCT02720068|560628513|FG002|Overall Study|Progressive Disease|1|||
155325306|NCT02720068|560628514|FG003|Overall Study|Progressive Disease|1|||
155325307|NCT02720068|560628515|FG004|Overall Study|Progressive Disease|1|||
155325308|NCT02720068|560628516|FG005|Overall Study|Progressive Disease|2|||
155325309|NCT02720068|560628517|FG006|Overall Study|Progressive Disease|1|||
155325310|NCT02720068|560628518|FG007|Overall Study|Progressive Disease|1|||
155325311|NCT02720068|560628519|FG008|Overall Study|Progressive Disease|0|||
155325312|NCT02720068|560628520|FG009|Overall Study|Progressive Disease|1|||
155325313|NCT02720068|560628521|FG010|Overall Study|Progressive Disease|0|||
155325314|NCT02720068|560628522|FG011|Overall Study|Progressive Disease|4|||
155325315|NCT02720068|560628523|FG012|Overall Study|Progressive Disease|1|||
155325316|NCT02720068|560628524|FG013|Overall Study|Progressive Disease|0|||
155325317|NCT02720068|560628525|FG014|Overall Study|Progressive Disease|0|||
155325318|NCT02720068|560628526|FG015|Overall Study|Progressive Disease|0|||
155325319|NCT02720068|560628527|FG016|Overall Study|Progressive Disease|0|||
155325320|NCT02720068|560628528|FG017|Overall Study|Progressive Disease|0|||
155325321|NCT02720068|560628511|FG000|Overall Study|Sponsor Decision|0|||
155325322|NCT02720068|560628512|FG001|Overall Study|Sponsor Decision|0|||
155325323|NCT02720068|560628513|FG002|Overall Study|Sponsor Decision|0|||
155325324|NCT02720068|560628514|FG003|Overall Study|Sponsor Decision|0|||
155325325|NCT02720068|560628515|FG004|Overall Study|Sponsor Decision|0|||
155325326|NCT02720068|560628516|FG005|Overall Study|Sponsor Decision|0|||
155325327|NCT02720068|560628517|FG006|Overall Study|Sponsor Decision|0|||
155325328|NCT02720068|560628518|FG007|Overall Study|Sponsor Decision|0|||
155502332|NCT01682512|561265461|FG000|Overall Study|Withdrawal by Subject|2|||
155502333|NCT01682512|561265462|FG001|Overall Study|Withdrawal by Subject|6|||
155502334|NCT01682512|561265463|FG002|Overall Study|Withdrawal by Subject|3|||
155502335|NCT01682512|561265461|FG000|Overall Study|Physician Decision|0|||
155502336|NCT01682512|561265462|FG001|Overall Study|Physician Decision|2|||
155502337|NCT01682512|561265463|FG002|Overall Study|Physician Decision|0|||
155325329|NCT02720068|560628519|FG008|Overall Study|Sponsor Decision|0|||
155325330|NCT02720068|560628520|FG009|Overall Study|Sponsor Decision|0|||
155325331|NCT02720068|560628521|FG010|Overall Study|Sponsor Decision|0|||
155325332|NCT02720068|560628522|FG011|Overall Study|Sponsor Decision|6|||
155325333|NCT02720068|560628523|FG012|Overall Study|Sponsor Decision|3|||
155325334|NCT02720068|560628524|FG013|Overall Study|Sponsor Decision|2|||
155325335|NCT02720068|560628525|FG014|Overall Study|Sponsor Decision|4|||
155325336|NCT02720068|560628526|FG015|Overall Study|Sponsor Decision|4|||
155325337|NCT02720068|560628527|FG016|Overall Study|Sponsor Decision|0|||
155325338|NCT02720068|560628528|FG017|Overall Study|Sponsor Decision|8|||
155325339|NCT02720068|560628511|FG000|Overall Study|Withdrawal by Subject|0|||
155325340|NCT02720068|560628512|FG001|Overall Study|Withdrawal by Subject|0|||
155325341|NCT02720068|560628513|FG002|Overall Study|Withdrawal by Subject|0|||
155325342|NCT02720068|560628514|FG003|Overall Study|Withdrawal by Subject|0|||
155325343|NCT02720068|560628515|FG004|Overall Study|Withdrawal by Subject|0|||
155325344|NCT02720068|560628516|FG005|Overall Study|Withdrawal by Subject|0|||
155325345|NCT02720068|560628517|FG006|Overall Study|Withdrawal by Subject|0|||
155325346|NCT02720068|560628518|FG007|Overall Study|Withdrawal by Subject|0|||
155325347|NCT02720068|560628519|FG008|Overall Study|Withdrawal by Subject|0|||
155325348|NCT02720068|560628520|FG009|Overall Study|Withdrawal by Subject|1|||
155325349|NCT02720068|560628521|FG010|Overall Study|Withdrawal by Subject|0|||
155325350|NCT02720068|560628522|FG011|Overall Study|Withdrawal by Subject|27|||
155325351|NCT02720068|560628523|FG012|Overall Study|Withdrawal by Subject|2|||
155325352|NCT02720068|560628524|FG013|Overall Study|Withdrawal by Subject|8|||
155325353|NCT02720068|560628525|FG014|Overall Study|Withdrawal by Subject|7|||
155325354|NCT02720068|560628526|FG015|Overall Study|Withdrawal by Subject|0|||
155325355|NCT02720068|560628527|FG016|Overall Study|Withdrawal by Subject|0|||
155325356|NCT02720068|560628528|FG017|Overall Study|Withdrawal by Subject|2|||
155325357|NCT02720068|560628511|FG000|Overall Study|Protocol Violation|0|||
155325358|NCT02720068|560628512|FG001|Overall Study|Protocol Violation|0|||
155325359|NCT02720068|560628513|FG002|Overall Study|Protocol Violation|0|||
155325360|NCT02720068|560628514|FG003|Overall Study|Protocol Violation|0|||
155325361|NCT02720068|560628515|FG004|Overall Study|Protocol Violation|0|||
155325362|NCT02720068|560628516|FG005|Overall Study|Protocol Violation|0|||
155325363|NCT02720068|560628517|FG006|Overall Study|Protocol Violation|0|||
155325364|NCT02720068|560628518|FG007|Overall Study|Protocol Violation|0|||
155325365|NCT02720068|560628519|FG008|Overall Study|Protocol Violation|0|||
155325366|NCT02720068|560628520|FG009|Overall Study|Protocol Violation|0|||
155325367|NCT02720068|560628521|FG010|Overall Study|Protocol Violation|1|||
155325368|NCT02720068|560628522|FG011|Overall Study|Protocol Violation|0|||
155325369|NCT02720068|560628523|FG012|Overall Study|Protocol Violation|0|||
155325370|NCT02720068|560628524|FG013|Overall Study|Protocol Violation|0|||
155325371|NCT02720068|560628525|FG014|Overall Study|Protocol Violation|1|||
155325372|NCT02720068|560628526|FG015|Overall Study|Protocol Violation|0|||
155325373|NCT02720068|560628527|FG016|Overall Study|Protocol Violation|1|||
155325374|NCT02720068|560628528|FG017|Overall Study|Protocol Violation|0|||
155325375|NCT01773993|560628532|FG000|Overall Study|No Visit After Treatment|35|||
155325376|NCT04993677|560628536|FG000|Overall Study|Lost to Follow-up|1|||
155325377|NCT04993677|560628537|FG001|Overall Study|Lost to Follow-up|0|||
155325378|NCT04993677|560628538|FG002|Overall Study|Lost to Follow-up|0|||
155325379|NCT04993677|560628539|FG003|Overall Study|Lost to Follow-up|0|||
155325380|NCT04993677|560628536|FG000|Overall Study|Death|11|||
155325381|NCT04993677|560628537|FG001|Overall Study|Death|8|||
155325382|NCT04993677|560628538|FG002|Overall Study|Death|3|||
155325383|NCT04993677|560628539|FG003|Overall Study|Death|1|||
155325384|NCT04993677|560628536|FG000|Overall Study|Subject withdrawal of consent|4|||
155325385|NCT04993677|560628537|FG001|Overall Study|Subject withdrawal of consent|3|||
155325386|NCT04993677|560628538|FG002|Overall Study|Subject withdrawal of consent|0|||
155325387|NCT04993677|560628539|FG003|Overall Study|Subject withdrawal of consent|2|||
155325388|NCT04993677|560628536|FG000|Overall Study|Study termination by sponsor|3|||
155325389|NCT04993677|560628537|FG001|Overall Study|Study termination by sponsor|25|||
155325390|NCT04993677|560628538|FG002|Overall Study|Study termination by sponsor|3|||
155325391|NCT04993677|560628539|FG003|Overall Study|Study termination by sponsor|3|||
155325392|NCT04993677|560628536|FG000|Overall Study|Other|2|||
155325393|NCT04993677|560628537|FG001|Overall Study|Other|3|||
155325394|NCT04993677|560628538|FG002|Overall Study|Other|3|||
155325395|NCT04993677|560628539|FG003|Overall Study|Other|2|||
155325396|NCT04408755|560628552|FG000|Period A (Placebo lead-in)|Other|11|||
155325397|NCT04408755|560628553|FG001|Period A (Placebo lead-in)|Other|0|||
155325398|NCT04408755|560628554|FG002|Period A (Placebo lead-in)|Other|0|||
155325399|NCT04408755|560628555|FG003|Period A (Placebo lead-in)|Other|0|||
155325400|NCT04408755|560628552|FG000|Period B (Randomization Period)|Adverse Event|0|||
155325401|NCT04408755|560628553|FG001|Period B (Randomization Period)|Adverse Event|3|||
155325402|NCT04408755|560628554|FG002|Period B (Randomization Period)|Adverse Event|0|||
155325403|NCT04408755|560628555|FG003|Period B (Randomization Period)|Adverse Event|1|||
155325404|NCT04408755|560628552|FG000|Period B (Randomization Period)|Death|0|||
155325405|NCT04408755|560628553|FG001|Period B (Randomization Period)|Death|0|||
155325406|NCT04408755|560628554|FG002|Period B (Randomization Period)|Death|1|||
155325407|NCT04408755|560628555|FG003|Period B (Randomization Period)|Death|0|||
155325408|NCT04408755|560628552|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
155325409|NCT04408755|560628553|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
155325410|NCT04408755|560628554|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
155325411|NCT04408755|560628555|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
155325412|NCT04408755|560628552|FG000|Period B (Randomization Period)|Physician Decision|0|||
155325413|NCT04408755|560628553|FG001|Period B (Randomization Period)|Physician Decision|0|||
155325414|NCT04408755|560628554|FG002|Period B (Randomization Period)|Physician Decision|1|||
155325415|NCT04408755|560628555|FG003|Period B (Randomization Period)|Physician Decision|0|||
155325416|NCT04408755|560628552|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
155325417|NCT04408755|560628553|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
155325418|NCT04408755|560628554|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
155325419|NCT04408755|560628555|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
155325420|NCT04408755|560628552|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
155325421|NCT04408755|560628553|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325422|NCT04408755|560628554|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325423|NCT04408755|560628555|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325424|NCT04408755|560628552|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
155325425|NCT04408755|560628553|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
155325426|NCT04408755|560628554|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
155325427|NCT04408755|560628555|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
155325428|NCT04408755|560628552|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
155325429|NCT04408755|560628553|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
155325430|NCT04408755|560628554|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
155325431|NCT04408755|560628555|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
155325432|NCT04408755|560628552|FG000|Period B (Randomization Period)|Reason not Specified|0|||
155325433|NCT04408755|560628553|FG001|Period B (Randomization Period)|Reason not Specified|1|||
155325434|NCT04408755|560628554|FG002|Period B (Randomization Period)|Reason not Specified|0|||
155325435|NCT04408755|560628555|FG003|Period B (Randomization Period)|Reason not Specified|2|||
155325436|NCT03733626|560628556|FG000|Overall Study|Physician Decision|4|||
155325437|NCT03733626|560628557|FG001|Overall Study|Physician Decision|4|||
155325438|NCT00412607|560628560|FG000|Overall Study|Withdrawal by Subject|9|||
155325439|NCT00412607|560628560|FG000|Overall Study|Lost to Follow-up|19|||
155325440|NCT00412607|560628560|FG000|Overall Study|Death|61|||
155325441|NCT00412607|560628560|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
155325442|NCT03662022|560628561|FG000|Year 1 2019|prevalent case|83|||
155325443|NCT03662022|560628562|FG001|Year 1 2019|prevalent case|116|||
155325444|NCT03662022|560628563|FG002|Year 1 2019|prevalent case|158|||
155325445|NCT03662022|560628564|FG003|Year 1 2019|prevalent case|99|||
155325446|NCT03662022|560628561|FG000|Year 2 2020|incident case|18|||
155325447|NCT03662022|560628562|FG001|Year 2 2020|incident case|18|||
155325448|NCT03662022|560628563|FG002|Year 2 2020|incident case|16|||
155325449|NCT03662022|560628564|FG003|Year 2 2020|incident case|26|||
155325450|NCT03662022|560628561|FG000|Year 2 2020|other case|18|||
155325451|NCT03662022|560628562|FG001|Year 2 2020|other case|16|||
155325452|NCT03662022|560628563|FG002|Year 2 2020|other case|16|||
155325453|NCT03662022|560628564|FG003|Year 2 2020|other case|24|||
155325454|NCT03662022|560628561|FG000|Year 2 2020|Lost to Follow-up|1633|||
155325455|NCT03662022|560628562|FG001|Year 2 2020|Lost to Follow-up|1183|||
155325456|NCT03662022|560628563|FG002|Year 2 2020|Lost to Follow-up|1381|||
155325457|NCT03662022|560628564|FG003|Year 2 2020|Lost to Follow-up|2858|||
155325458|NCT03662022|560628561|FG000|Year 3 2021|incident case|24|||
155325459|NCT03662022|560628562|FG001|Year 3 2021|incident case|27|||
155325460|NCT03662022|560628563|FG002|Year 3 2021|incident case|24|||
155421485|NCT00600171|560974275|FG004|Overall Study|Lack of Efficacy|4|||
155421486|NCT00600171|560974276|FG005|Overall Study|Lack of Efficacy|0|||
155421487|NCT00600171|560974271|FG000|Overall Study|Protocol Violation|1|||
155421488|NCT00600171|560974272|FG001|Overall Study|Protocol Violation|2|||
155421489|NCT00600171|560974273|FG002|Overall Study|Protocol Violation|0|||
155421490|NCT00600171|560974274|FG003|Overall Study|Protocol Violation|1|||
155421491|NCT00600171|560974275|FG004|Overall Study|Protocol Violation|0|||
155421492|NCT00600171|560974276|FG005|Overall Study|Protocol Violation|0|||
155421493|NCT00600171|560974271|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
155421494|NCT00600171|560974272|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155421495|NCT00600171|560974273|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
155421496|NCT00600171|560974274|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
155421497|NCT00600171|560974275|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155421498|NCT00600171|560974276|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155421499|NCT00600171|560974271|FG000|Overall Study|Withdrawal by Subject|3|||
155421500|NCT00600171|560974272|FG001|Overall Study|Withdrawal by Subject|0|||
155421501|NCT00600171|560974273|FG002|Overall Study|Withdrawal by Subject|0|||
155325461|NCT03662022|560628564|FG003|Year 3 2021|incident case|11|||
155325462|NCT03662022|560628561|FG000|Year 3 2021|other case|4|||
155325463|NCT03662022|560628562|FG001|Year 3 2021|other case|15|||
155325464|NCT03662022|560628563|FG002|Year 3 2021|other case|10|||
155325465|NCT03662022|560628564|FG003|Year 3 2021|other case|14|||
155325466|NCT03662022|560628561|FG000|Year 3 2021|Lost to Follow-up|179|||
155325467|NCT03662022|560628562|FG001|Year 3 2021|Lost to Follow-up|244|||
155325468|NCT03662022|560628563|FG002|Year 3 2021|Lost to Follow-up|480|||
155325469|NCT03662022|560628564|FG003|Year 3 2021|Lost to Follow-up|477|||
155325470|NCT03662022|560628561|FG000|Year 4 2022|incident case|25|||
155325471|NCT03662022|560628562|FG001|Year 4 2022|incident case|41|||
155325472|NCT03662022|560628563|FG002|Year 4 2022|incident case|28|||
155325473|NCT03662022|560628564|FG003|Year 4 2022|incident case|7|||
155325474|NCT03662022|560628561|FG000|Year 4 2022|other case|8|||
155325475|NCT03662022|560628562|FG001|Year 4 2022|other case|19|||
155325476|NCT03662022|560628563|FG002|Year 4 2022|other case|13|||
155325477|NCT03662022|560628564|FG003|Year 4 2022|other case|7|||
155325478|NCT03662022|560628561|FG000|Year 4 2022|Lost to Follow-up|986|||
155325479|NCT03662022|560628562|FG001|Year 4 2022|Lost to Follow-up|1079|||
155325480|NCT03662022|560628563|FG002|Year 4 2022|Lost to Follow-up|1236|||
155325481|NCT03662022|560628564|FG003|Year 4 2022|Lost to Follow-up|1826|||
155325482|NCT03884439|560628574|FG000|Overall Study|No informed consent for publication of study results|38|||
155325483|NCT03884439|560628574|FG000|Overall Study|Contract violation/deficiency|7|||
155325484|NCT05215054|560628575|FG000|Overall Study|Lost to Follow-up|1|||
155325485|NCT05215054|560628576|FG001|Overall Study|Lost to Follow-up|1|||
155325486|NCT05215054|560628575|FG000|Overall Study|Protocol Violation|1|||
155325487|NCT05215054|560628576|FG001|Overall Study|Protocol Violation|1|||
155325488|NCT05215054|560628575|FG000|Overall Study|Withdrawal by Subject|4|||
155325489|NCT05215054|560628576|FG001|Overall Study|Withdrawal by Subject|4|||
155325490|NCT02933489|560628577|FG000|Overall Study|Ineligible|3|||
155325491|NCT02933489|560628578|FG001|Overall Study|Ineligible|3|||
155325492|NCT02933489|560628577|FG000|Overall Study|Withdrawal by Subject|27|||
155325493|NCT02933489|560628578|FG001|Overall Study|Withdrawal by Subject|18|||
155325494|NCT02933489|560628577|FG000|Overall Study|Unable to complete exams (other)|14|||
155325495|NCT02933489|560628578|FG001|Overall Study|Unable to complete exams (other)|7|||
155325496|NCT05485935|560628579|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
155325497|NCT05485935|560628580|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
155325498|NCT05485935|560628579|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
155325499|NCT05485935|560628580|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
155325500|NCT05485935|560628579|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
155325501|NCT05485935|560628580|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
155325502|NCT05485935|560628579|FG000|Period 2 (T2 and V3)|loss of contact|0|||
155325503|NCT05485935|560628580|FG001|Period 2 (T2 and V3)|loss of contact|1|||
155325504|NCT02806726|560628581|FG000|Overall Study|Lost to Follow-up|1|||
155325505|NCT01499368|560628582|FG000|Overall Study|Did not meet I/E criteria|8|||
155325506|NCT01499368|560628583|FG001|Overall Study|Did not meet I/E criteria|4|||
155325507|NCT01499368|560628584|FG002|Overall Study|Did not meet I/E criteria|4|||
155325508|NCT01499368|560628582|FG000|Overall Study|Prohibited Concomitant medication|1|||
155325509|NCT01499368|560628583|FG001|Overall Study|Prohibited Concomitant medication|1|||
155325510|NCT01499368|560628584|FG002|Overall Study|Prohibited Concomitant medication|0|||
155325511|NCT01499368|560628582|FG000|Overall Study|Withdrawal by Subject|11|||
155325512|NCT01499368|560628583|FG001|Overall Study|Withdrawal by Subject|10|||
155325513|NCT01499368|560628584|FG002|Overall Study|Withdrawal by Subject|8|||
155421502|NCT00600171|560974274|FG003|Overall Study|Withdrawal by Subject|1|||
155421503|NCT00600171|560974275|FG004|Overall Study|Withdrawal by Subject|1|||
155421504|NCT00600171|560974276|FG005|Overall Study|Withdrawal by Subject|1|||
155421505|NCT00600171|560974271|FG000|Overall Study|Physician Decision|0|||
155421506|NCT00600171|560974272|FG001|Overall Study|Physician Decision|1|||
155421507|NCT00600171|560974273|FG002|Overall Study|Physician Decision|0|||
155421508|NCT00600171|560974274|FG003|Overall Study|Physician Decision|1|||
155421509|NCT00600171|560974275|FG004|Overall Study|Physician Decision|0|||
155421510|NCT00600171|560974276|FG005|Overall Study|Physician Decision|2|||
155325514|NCT01499368|560628582|FG000|Overall Study|Lost to Follow-up|3|||
155325515|NCT01499368|560628583|FG001|Overall Study|Lost to Follow-up|2|||
155325516|NCT01499368|560628584|FG002|Overall Study|Lost to Follow-up|5|||
155421511|NCT00600171|560974271|FG000|Overall Study|Lost to Follow-up|0|||
155325517|NCT01499368|560628582|FG000|Overall Study|Adverse Event|4|||
155325518|NCT01499368|560628583|FG001|Overall Study|Adverse Event|0|||
155325519|NCT01499368|560628584|FG002|Overall Study|Adverse Event|2|||
155421512|NCT00600171|560974272|FG001|Overall Study|Lost to Follow-up|0|||
155325520|NCT01499368|560628582|FG000|Overall Study|Physician Decision|0|||
155325521|NCT01499368|560628583|FG001|Overall Study|Physician Decision|1|||
155325522|NCT01499368|560628584|FG002|Overall Study|Physician Decision|0|||
155325523|NCT01499368|560628582|FG000|Overall Study|Deviation from visit window|0|||
155325524|NCT01499368|560628583|FG001|Overall Study|Deviation from visit window|0|||
155325525|NCT01499368|560628584|FG002|Overall Study|Deviation from visit window|1|||
155325526|NCT01499368|560628582|FG000|Overall Study|Error of Prescriptions|0|||
155325527|NCT01499368|560628583|FG001|Overall Study|Error of Prescriptions|0|||
155502338|NCT01682512|561265461|FG000|Overall Study|Study terminated by sponsor|46|||
155502339|NCT01682512|561265462|FG001|Overall Study|Study terminated by sponsor|43|||
155502340|NCT01682512|561265463|FG002|Overall Study|Study terminated by sponsor|0|||
155502341|NCT01682512|561265461|FG000|Overall Study|Lost to Follow-up|3|||
155502342|NCT01682512|561265462|FG001|Overall Study|Lost to Follow-up|0|||
155502343|NCT01682512|561265463|FG002|Overall Study|Lost to Follow-up|2|||
155502344|NCT01682512|561265461|FG000|Overall Study|Protocol Violation|2|||
155502345|NCT01682512|561265462|FG001|Overall Study|Protocol Violation|3|||
155502346|NCT01682512|561265463|FG002|Overall Study|Protocol Violation|2|||
155502347|NCT01682512|561265461|FG000|Overall Study|Primary lack of efficacy|10|||
155502348|NCT01682512|561265462|FG001|Overall Study|Primary lack of efficacy|7|||
155502349|NCT01682512|561265463|FG002|Overall Study|Primary lack of efficacy|7|||
155502350|NCT01682512|561265461|FG000|Overall Study|Secondary lack of efficacy|1|||
155502351|NCT01682512|561265462|FG001|Overall Study|Secondary lack of efficacy|1|||
155502352|NCT01682512|561265463|FG002|Overall Study|Secondary lack of efficacy|0|||
155502353|NCT01682512|561265461|FG000|Overall Study|Other than stated above|2|||
155325528|NCT01499368|560628584|FG002|Overall Study|Error of Prescriptions|1|||
155325529|NCT03092674|560628585|FG000|Overall Study|Adverse Event or Side Effects|1|||
155325530|NCT03092674|560628586|FG001|Overall Study|Adverse Event or Side Effects|4|||
155325531|NCT03092674|560628587|FG002|Overall Study|Adverse Event or Side Effects|4|||
155325532|NCT03092674|560628585|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
155325533|NCT03092674|560628586|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
155325534|NCT03092674|560628587|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
155325535|NCT03092674|560628585|FG000|Overall Study|Progression/Relapse|5|||
155325536|NCT03092674|560628586|FG001|Overall Study|Progression/Relapse|4|||
155325537|NCT03092674|560628587|FG002|Overall Study|Progression/Relapse|8|||
155325538|NCT03092674|560628585|FG000|Overall Study|Death|4|||
155325539|NCT03092674|560628586|FG001|Overall Study|Death|8|||
155325540|NCT03092674|560628587|FG002|Overall Study|Death|2|||
155325541|NCT03092674|560628585|FG000|Overall Study|Other - Not Protocol Specified|11|||
155325542|NCT03092674|560628586|FG001|Overall Study|Other - Not Protocol Specified|8|||
155325543|NCT03092674|560628587|FG002|Overall Study|Other - Not Protocol Specified|8|||
155325544|NCT04626427|560628588|FG000|Overall Study|Death|1|||
155325545|NCT04626427|560628588|FG000|Overall Study|Withdrawal by Subject|1|||
155325546|NCT04626427|560628588|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
155325547|NCT04626427|560628588|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
155325548|NCT04518943|560629355|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
155325549|NCT04518943|560629356|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
155502354|NCT01682512|561265462|FG001|Overall Study|Other than stated above|4|||
155502355|NCT01682512|561265463|FG002|Overall Study|Other than stated above|2|||
155502356|NCT01377233|561265464|FG000|Open-label|Adverse Event|1|||
155325550|NCT04518943|560629357|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
155325551|NCT04518943|560629358|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
155325552|NCT04518943|560629359|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
155325553|NCT04518943|560629360|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
155502357|NCT01377233|561265465|FG001|Open-label|Adverse Event|0|||
155325554|NCT04518943|560629361|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
155502358|NCT01377233|561265466|FG002|Open-label|Adverse Event|0|||
155502359|NCT01377233|561265467|FG003|Open-label|Adverse Event|0|||
155502360|NCT01377233|561265468|FG004|Open-label|Adverse Event|0|||
155502361|NCT01377233|561265464|FG000|Open-label|Withdrawal by Subject|3|||
155502362|NCT01377233|561265465|FG001|Open-label|Withdrawal by Subject|0|||
155325555|NCT04518943|560629362|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
155325556|NCT04518943|560629363|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
155644669|NCT03422718|561789842|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
155644670|NCT03422718|561789843|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
155644671|NCT03422718|561789844|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
155325557|NCT04518943|560629364|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
155325558|NCT04518943|560629365|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
155325559|NCT04518943|560629366|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
155325560|NCT04518943|560629367|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
155325561|NCT04518943|560629368|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
155325562|NCT04518943|560629369|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
155325563|NCT04518943|560629370|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
155325564|NCT03705793|560629374|FG000|Overall Study|Lost to Follow-up|3|||
155325565|NCT03705793|560629375|FG001|Overall Study|Lost to Follow-up|4|||
155325566|NCT03705793|560629374|FG000|Overall Study|Withdrawal by Subject|2|||
155325567|NCT03705793|560629375|FG001|Overall Study|Withdrawal by Subject|1|||
155325568|NCT04174170|560629376|FG000|Placebo Run-in Period|Not Randomized|38|||
155325569|NCT04174170|560629377|FG001|Placebo Run-in Period|Not Randomized|0|||
155325570|NCT04174170|560629378|FG002|Placebo Run-in Period|Not Randomized|0|||
155325571|NCT04174170|560629379|FG003|Placebo Run-in Period|Not Randomized|0|||
155325572|NCT04174170|560629376|FG000|Double Blind Treatment Period|Adverse Event|0|||
155325573|NCT04174170|560629377|FG001|Double Blind Treatment Period|Adverse Event|9|||
155644672|NCT03422718|561789845|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
155644673|NCT03422718|561789846|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
155644674|NCT03422718|561789847|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
155325574|NCT04174170|560629378|FG002|Double Blind Treatment Period|Adverse Event|9|||
155325575|NCT04174170|560629379|FG003|Double Blind Treatment Period|Adverse Event|8|||
155325576|NCT04174170|560629376|FG000|Double Blind Treatment Period|Death|0|||
155325577|NCT04174170|560629377|FG001|Double Blind Treatment Period|Death|1|||
155325578|NCT04174170|560629378|FG002|Double Blind Treatment Period|Death|0|||
155325579|NCT04174170|560629379|FG003|Double Blind Treatment Period|Death|0|||
155325580|NCT04174170|560629376|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155325581|NCT04174170|560629377|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
155325582|NCT04174170|560629378|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
155325583|NCT04174170|560629379|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
155325584|NCT04174170|560629376|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
155325585|NCT04174170|560629377|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
155325586|NCT04174170|560629378|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
155325587|NCT04174170|560629379|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
155325588|NCT04174170|560629376|FG000|Double Blind Treatment Period|Physician Decision|0|||
155325589|NCT04174170|560629377|FG001|Double Blind Treatment Period|Physician Decision|1|||
155325590|NCT04174170|560629378|FG002|Double Blind Treatment Period|Physician Decision|0|||
155325591|NCT04174170|560629379|FG003|Double Blind Treatment Period|Physician Decision|1|||
155325592|NCT04174170|560629376|FG000|Double Blind Treatment Period|Pregnancy|0|||
155325593|NCT04174170|560629377|FG001|Double Blind Treatment Period|Pregnancy|1|||
155325594|NCT04174170|560629378|FG002|Double Blind Treatment Period|Pregnancy|0|||
155325595|NCT04174170|560629379|FG003|Double Blind Treatment Period|Pregnancy|1|||
155325596|NCT04174170|560629376|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
155325597|NCT04174170|560629377|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
155325598|NCT04174170|560629378|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
155325599|NCT04174170|560629379|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
155325600|NCT04174170|560629376|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155325601|NCT04174170|560629377|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
155325602|NCT04174170|560629378|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
155325603|NCT04174170|560629379|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
155325604|NCT04174170|560629376|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
155325605|NCT04174170|560629377|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
155325606|NCT04174170|560629378|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
155325607|NCT04174170|560629379|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
155421513|NCT00600171|560974273|FG002|Overall Study|Lost to Follow-up|0|||
155421514|NCT00600171|560974274|FG003|Overall Study|Lost to Follow-up|1|||
155644675|NCT03422718|561789848|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
155421515|NCT00600171|560974275|FG004|Overall Study|Lost to Follow-up|0|||
155421516|NCT00600171|560974276|FG005|Overall Study|Lost to Follow-up|0|||
155421517|NCT00469612|560974277|FG000|Overall Study|Study terminated before data collected|2|||
155421518|NCT00469612|560974278|FG001|Overall Study|Study terminated before data collected|0|||
155421519|NCT00542191|560974279|FG000|Overall Study|Death|3|||
155421520|NCT02357420|560974282|FG000|Overall Study|Adverse Event|3|||
155644676|NCT03422718|561789841|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
155325608|NCT04664881|560629380|FG000|Overall Study|Withdrawal by Subject|1|||
155325609|NCT04664881|560629381|FG001|Overall Study|Withdrawal by Subject|8|||
155325610|NCT04664881|560629380|FG000|Overall Study|Physician Decision|0|||
155325611|NCT04664881|560629381|FG001|Overall Study|Physician Decision|5|||
155325612|NCT04664881|560629380|FG000|Overall Study|Lost to Follow-up|1|||
155325613|NCT04664881|560629381|FG001|Overall Study|Lost to Follow-up|0|||
155325614|NCT04772534|560629390|FG000|Overall Study|Physician Decision|1|||
155325615|NCT04772534|560629391|FG001|Overall Study|Physician Decision|0|||
155325616|NCT04772534|560629392|FG002|Overall Study|Physician Decision|0|||
155325617|NCT04772534|560629390|FG000|Overall Study|Withdrawal by Subject|3|||
155325618|NCT04772534|560629391|FG001|Overall Study|Withdrawal by Subject|0|||
155325619|NCT04772534|560629392|FG002|Overall Study|Withdrawal by Subject|1|||
155325620|NCT04194450|560629393|FG000|Overall Study|not eligible|1|||
155325621|NCT04194450|560629394|FG001|Overall Study|not eligible|0|||
155325622|NCT05875701|560629401|FG000|Overall Study|Lost to Follow-up|2|||
155325623|NCT05875701|560629402|FG001|Overall Study|Lost to Follow-up|0|||
155325624|NCT05875701|560629401|FG000|Overall Study|Withdrawal by Subject|1|||
155325625|NCT05875701|560629402|FG001|Overall Study|Withdrawal by Subject|1|||
155325626|NCT00308997|560629410|FG000|Overall Study|Subject feigned clinical data|0|||
155325627|NCT00308997|560629411|FG001|Overall Study|Subject feigned clinical data|1|||
155325628|NCT00308997|560629410|FG000|Overall Study|Unable to tolerate intervention|1|||
155325629|NCT00308997|560629411|FG001|Overall Study|Unable to tolerate intervention|0|||
155325630|NCT04490356|560629413|FG000|Overall Study|Lost to Follow-up|1|||
155325631|NCT04214418|560629427|FG000|Overall Study|Withdrawal by Subject|1|||
155325632|NCT04214418|560629428|FG001|Overall Study|Withdrawal by Subject|0|||
155325633|NCT04214418|560629429|FG002|Overall Study|Withdrawal by Subject|0|||
155325634|NCT04214418|560629430|FG003|Overall Study|Withdrawal by Subject|0|||
155325635|NCT04214418|560629431|FG004|Overall Study|Withdrawal by Subject|0|||
155325636|NCT04214418|560629432|FG005|Overall Study|Withdrawal by Subject|0|||
155325637|NCT04214418|560629427|FG000|Overall Study|Adverse Event|0|||
155325638|NCT04214418|560629428|FG001|Overall Study|Adverse Event|2|||
155325639|NCT04214418|560629429|FG002|Overall Study|Adverse Event|0|||
155325640|NCT04214418|560629430|FG003|Overall Study|Adverse Event|0|||
155325641|NCT04214418|560629431|FG004|Overall Study|Adverse Event|0|||
155325642|NCT04214418|560629432|FG005|Overall Study|Adverse Event|0|||
155325643|NCT04214418|560629427|FG000|Overall Study|Death|1|||
155325644|NCT04214418|560629428|FG001|Overall Study|Death|0|||
155325645|NCT04214418|560629429|FG002|Overall Study|Death|0|||
155325646|NCT04214418|560629430|FG003|Overall Study|Death|0|||
155325647|NCT04214418|560629431|FG004|Overall Study|Death|0|||
155325648|NCT04214418|560629432|FG005|Overall Study|Death|0|||
155325649|NCT05836012|560629435|FG000|Overall Study|Lost to Follow-up|1|||
155325650|NCT05836012|560629436|FG001|Overall Study|Lost to Follow-up|0|||
155421521|NCT02357420|560974283|FG001|Overall Study|Adverse Event|3|||
155421522|NCT02357420|560974284|FG002|Overall Study|Adverse Event|8|||
155421523|NCT02357420|560974285|FG003|Overall Study|Adverse Event|9|||
155421524|NCT02357420|560974282|FG000|Overall Study|Investigator Decision|1|||
155421525|NCT02357420|560974283|FG001|Overall Study|Investigator Decision|0|||
155421526|NCT02357420|560974284|FG002|Overall Study|Investigator Decision|0|||
155421527|NCT02357420|560974285|FG003|Overall Study|Investigator Decision|0|||
155421528|NCT02357420|560974282|FG000|Overall Study|Prohibited Medication|1|||
155421529|NCT02357420|560974283|FG001|Overall Study|Prohibited Medication|1|||
155421530|NCT02357420|560974284|FG002|Overall Study|Prohibited Medication|0|||
155421531|NCT02357420|560974285|FG003|Overall Study|Prohibited Medication|0|||
155421532|NCT02357420|560974282|FG000|Overall Study|Protocol Non-compliance|0|||
155421533|NCT02357420|560974283|FG001|Overall Study|Protocol Non-compliance|0|||
155421534|NCT02357420|560974284|FG002|Overall Study|Protocol Non-compliance|0|||
155421535|NCT02357420|560974285|FG003|Overall Study|Protocol Non-compliance|1|||
155421536|NCT02357420|560974282|FG000|Overall Study|Withdrawn Consent|4|||
155421537|NCT02357420|560974283|FG001|Overall Study|Withdrawn Consent|8|||
155421538|NCT02357420|560974284|FG002|Overall Study|Withdrawn Consent|6|||
155421539|NCT02357420|560974285|FG003|Overall Study|Withdrawn Consent|6|||
155421540|NCT02357420|560974282|FG000|Overall Study|Lost to Follow-up|3|||
155421541|NCT02357420|560974283|FG001|Overall Study|Lost to Follow-up|0|||
155421542|NCT02357420|560974284|FG002|Overall Study|Lost to Follow-up|2|||
155421543|NCT02357420|560974285|FG003|Overall Study|Lost to Follow-up|3|||
155421544|NCT00440726|560974289|FG000|Phase 1|Dose-Limiting Toxicity|0|||
155421545|NCT00440726|560974290|FG001|Phase 1|Dose-Limiting Toxicity|1|||
155644677|NCT03422718|561789842|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
155325651|NCT05836012|560629435|FG000|Overall Study|Withdrawal by Subject|1|||
155325652|NCT05836012|560629436|FG001|Overall Study|Withdrawal by Subject|3|||
155325653|NCT05836012|560629435|FG000|Overall Study|Reason not included in pre-specified categories|2|||
155325654|NCT05836012|560629436|FG001|Overall Study|Reason not included in pre-specified categories|1|||
155325655|NCT04093869|560629440|FG000|Overall Study|Death|0|||
155325656|NCT04093869|560629441|FG001|Overall Study|Death|1|||
155421546|NCT00440726|560974291|FG002|Phase 1|Dose-Limiting Toxicity|0|||
155421547|NCT00440726|560974289|FG000|Phase 1|Physician Decision|1|||
155325657|NCT04093869|560629440|FG000|Overall Study|Withdrawal by Subject|1|||
155325658|NCT04093869|560629441|FG001|Overall Study|Withdrawal by Subject|0|||
155325659|NCT05129501|560629442|FG000|Overall Study|Lost to Follow-up|54|||
155325660|NCT05129501|560629443|FG001|Overall Study|Lost to Follow-up|41|||
155325661|NCT01527188|560629446|FG000|Overall Study|Adverse Event|5|||
155325662|NCT01527188|560629447|FG001|Overall Study|Adverse Event|5|||
155325663|NCT01527188|560629448|FG002|Overall Study|Adverse Event|11|||
155325664|NCT01527188|560629449|FG003|Overall Study|Adverse Event|0|||
155325665|NCT01527188|560629446|FG000|Overall Study|Withdrawal by Subject|3|||
155325666|NCT01527188|560629447|FG001|Overall Study|Withdrawal by Subject|6|||
155325667|NCT01527188|560629448|FG002|Overall Study|Withdrawal by Subject|4|||
155325668|NCT01527188|560629449|FG003|Overall Study|Withdrawal by Subject|4|||
155325669|NCT01527188|560629446|FG000|Overall Study|Any other reason not above-mentioned|6|||
155325670|NCT01527188|560629447|FG001|Overall Study|Any other reason not above-mentioned|7|||
155325671|NCT01527188|560629448|FG002|Overall Study|Any other reason not above-mentioned|8|||
155325672|NCT01527188|560629449|FG003|Overall Study|Any other reason not above-mentioned|8|||
155325673|NCT05162586|560630069|FG000|Overall Study|Other|0|||
155325674|NCT05162586|560630070|FG001|Overall Study|Other|0|||
155325675|NCT05162586|560630071|FG002|Overall Study|Other|0|||
155325676|NCT05162586|560630072|FG003|Overall Study|Other|0|||
155325677|NCT05162586|560630073|FG004|Overall Study|Other|1|||
155325678|NCT05162586|560630074|FG005|Overall Study|Other|0|||
155325679|NCT05162586|560630075|FG006|Overall Study|Other|2|||
155325680|NCT05162586|560630076|FG007|Overall Study|Other|2|||
155325681|NCT05162586|560630069|FG000|Overall Study|Lack of Efficacy|0|||
155325682|NCT05162586|560630070|FG001|Overall Study|Lack of Efficacy|0|||
155325683|NCT05162586|560630071|FG002|Overall Study|Lack of Efficacy|0|||
155325684|NCT05162586|560630072|FG003|Overall Study|Lack of Efficacy|0|||
155325685|NCT05162586|560630073|FG004|Overall Study|Lack of Efficacy|1|||
155325686|NCT05162586|560630074|FG005|Overall Study|Lack of Efficacy|0|||
155325687|NCT05162586|560630075|FG006|Overall Study|Lack of Efficacy|0|||
155325688|NCT05162586|560630076|FG007|Overall Study|Lack of Efficacy|1|||
155325689|NCT05162586|560630069|FG000|Overall Study|Lost to Follow-up|0|||
155325690|NCT05162586|560630070|FG001|Overall Study|Lost to Follow-up|0|||
155325691|NCT05162586|560630071|FG002|Overall Study|Lost to Follow-up|0|||
155325692|NCT05162586|560630072|FG003|Overall Study|Lost to Follow-up|0|||
155325693|NCT05162586|560630073|FG004|Overall Study|Lost to Follow-up|2|||
155325694|NCT05162586|560630074|FG005|Overall Study|Lost to Follow-up|0|||
155325695|NCT05162586|560630075|FG006|Overall Study|Lost to Follow-up|0|||
155325696|NCT05162586|560630076|FG007|Overall Study|Lost to Follow-up|2|||
155325697|NCT05162586|560630069|FG000|Overall Study|Non-Compliance|0|||
155325698|NCT05162586|560630070|FG001|Overall Study|Non-Compliance|1|||
155325699|NCT05162586|560630071|FG002|Overall Study|Non-Compliance|0|||
155325700|NCT05162586|560630072|FG003|Overall Study|Non-Compliance|0|||
155325701|NCT05162586|560630073|FG004|Overall Study|Non-Compliance|1|||
155325702|NCT05162586|560630074|FG005|Overall Study|Non-Compliance|0|||
155325703|NCT05162586|560630075|FG006|Overall Study|Non-Compliance|0|||
155325704|NCT05162586|560630076|FG007|Overall Study|Non-Compliance|1|||
155325705|NCT05162586|560630069|FG000|Overall Study|Withdrawal by Subject|2|||
155325706|NCT05162586|560630070|FG001|Overall Study|Withdrawal by Subject|0|||
155325707|NCT05162586|560630071|FG002|Overall Study|Withdrawal by Subject|0|||
155325708|NCT05162586|560630072|FG003|Overall Study|Withdrawal by Subject|0|||
155325709|NCT05162586|560630073|FG004|Overall Study|Withdrawal by Subject|7|||
155325710|NCT05162586|560630074|FG005|Overall Study|Withdrawal by Subject|6|||
155325711|NCT05162586|560630075|FG006|Overall Study|Withdrawal by Subject|2|||
155325712|NCT05162586|560630076|FG007|Overall Study|Withdrawal by Subject|2|||
155325713|NCT05162586|560630069|FG000|Overall Study|Adverse Event|2|||
155325714|NCT05162586|560630070|FG001|Overall Study|Adverse Event|0|||
155325715|NCT05162586|560630071|FG002|Overall Study|Adverse Event|1|||
155325716|NCT05162586|560630072|FG003|Overall Study|Adverse Event|2|||
155325717|NCT05162586|560630073|FG004|Overall Study|Adverse Event|4|||
155325718|NCT05162586|560630074|FG005|Overall Study|Adverse Event|1|||
155325719|NCT05162586|560630075|FG006|Overall Study|Adverse Event|5|||
155325720|NCT05162586|560630076|FG007|Overall Study|Adverse Event|2|||
155325721|NCT02656706|560630078|FG000|Overall Study|Insurance Denial|1|||
155502363|NCT01377233|561265466|FG002|Open-label|Withdrawal by Subject|0|||
155325722|NCT04675034|560630081|FG000|Overall Study|Lost to Follow-up|1|||
155325723|NCT04675034|560630082|FG001|Overall Study|Lost to Follow-up|1|||
155325724|NCT04675034|560630083|FG002|Overall Study|Lost to Follow-up|0|||
155325725|NCT04675034|560630084|FG003|Overall Study|Lost to Follow-up|2|||
155325726|NCT04675034|560630085|FG004|Overall Study|Lost to Follow-up|0|||
155502364|NCT01377233|561265467|FG003|Open-label|Withdrawal by Subject|0|||
155325727|NCT04675034|560630081|FG000|Overall Study|Protocol Violation|1|||
155325728|NCT04675034|560630082|FG001|Overall Study|Protocol Violation|0|||
155325729|NCT04675034|560630083|FG002|Overall Study|Protocol Violation|0|||
155325730|NCT04675034|560630084|FG003|Overall Study|Protocol Violation|1|||
155325731|NCT04675034|560630085|FG004|Overall Study|Protocol Violation|3|||
155325732|NCT04675034|560630081|FG000|Overall Study|Withdrawal by Subject|9|||
155325733|NCT04675034|560630082|FG001|Overall Study|Withdrawal by Subject|3|||
155502365|NCT01377233|561265468|FG004|Open-label|Withdrawal by Subject|0|||
155325734|NCT04675034|560630083|FG002|Overall Study|Withdrawal by Subject|4|||
155325735|NCT04675034|560630084|FG003|Overall Study|Withdrawal by Subject|8|||
155325736|NCT04675034|560630085|FG004|Overall Study|Withdrawal by Subject|6|||
155325737|NCT03201939|560630086|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
155325738|NCT03201939|560630087|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
155325739|NCT02532621|560630090|FG000|Overall Study|Death|3|||
155325740|NCT02532621|560630090|FG000|Overall Study|Lost to Follow-up|3|||
155325741|NCT02532621|560630090|FG000|Overall Study|Withdrawal by Subject|6|||
155502366|NCT01377233|561265464|FG000|Double-blind|Adverse Event|0|||
155502367|NCT01377233|561265465|FG001|Double-blind|Adverse Event|1|||
155502368|NCT01377233|561265466|FG002|Double-blind|Adverse Event|2|||
155502369|NCT01377233|561265467|FG003|Double-blind|Adverse Event|2|||
155502370|NCT01377233|561265468|FG004|Double-blind|Adverse Event|0|||
155502371|NCT01377233|561265464|FG000|Double-blind|Protocol Violation|0|||
155502372|NCT01377233|561265465|FG001|Double-blind|Protocol Violation|0|||
155502373|NCT01377233|561265466|FG002|Double-blind|Protocol Violation|0|||
155502374|NCT01377233|561265467|FG003|Double-blind|Protocol Violation|0|||
155502375|NCT01377233|561265468|FG004|Double-blind|Protocol Violation|1|||
155502376|NCT01377233|561265464|FG000|Double-blind|Withdrawal by Subject|0|||
155502377|NCT01377233|561265465|FG001|Double-blind|Withdrawal by Subject|0|||
155502378|NCT01377233|561265466|FG002|Double-blind|Withdrawal by Subject|0|||
155502379|NCT01377233|561265467|FG003|Double-blind|Withdrawal by Subject|1|||
155502380|NCT01377233|561265468|FG004|Double-blind|Withdrawal by Subject|0|||
155502381|NCT01377233|561265464|FG000|Double-blind|Administrative or other|0|||
155502382|NCT01377233|561265465|FG001|Double-blind|Administrative or other|0|||
155502383|NCT01377233|561265466|FG002|Double-blind|Administrative or other|0|||
155502384|NCT01377233|561265467|FG003|Double-blind|Administrative or other|1|||
155502385|NCT01377233|561265468|FG004|Double-blind|Administrative or other|1|||
155502386|NCT01785875|561265469|FG000|Overall Study|Withdrawal by Subject|41|||
155502387|NCT01785875|561265470|FG001|Overall Study|Withdrawal by Subject|34|||
155502388|NCT01785875|561265471|FG002|Overall Study|Withdrawal by Subject|36|||
155502389|NCT01785875|561265469|FG000|Overall Study|Lost to Follow-up|19|||
155502390|NCT01785875|561265470|FG001|Overall Study|Lost to Follow-up|22|||
155502391|NCT01785875|561265471|FG002|Overall Study|Lost to Follow-up|6|||
155502392|NCT01785875|561265469|FG000|Overall Study|Death|27|||
155502393|NCT01785875|561265470|FG001|Overall Study|Death|16|||
155502394|NCT01785875|561265471|FG002|Overall Study|Death|7|||
155502395|NCT01785875|561265469|FG000|Overall Study|Sponsor Decision|0|||
155325742|NCT02532621|560630090|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
155325743|NCT02532621|560630090|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
155325744|NCT04281498|560630097|FG000|Overall Study|Progression of disease|1|||
155325745|NCT04281498|560630097|FG000|Overall Study|Planned SCT|1|||
155325746|NCT04281498|560630097|FG000|Overall Study|Alternative Treatment|1|||
155325747|NCT03142009|560630098|FG000|Overall Study|Lost to Follow-up|45|||
155502396|NCT01785875|561265470|FG001|Overall Study|Sponsor Decision|2|||
155502397|NCT01785875|561265471|FG002|Overall Study|Sponsor Decision|0|||
155502398|NCT01785875|561265469|FG000|Overall Study|Protocol Specified Criteria|207|||
155502399|NCT01785875|561265470|FG001|Overall Study|Protocol Specified Criteria|214|||
155502400|NCT01785875|561265471|FG002|Overall Study|Protocol Specified Criteria|55|||
155325748|NCT03142009|560630099|FG001|Overall Study|Lost to Follow-up|30|||
155325749|NCT03587805|560630100|FG000|Overall Study|Adverse Event|72|||
155325750|NCT03587805|560630100|FG000|Overall Study|Death|1|||
155325751|NCT03587805|560630100|FG000|Overall Study|Lost to Follow-up|78|||
155325752|NCT03587805|560630100|FG000|Overall Study|Withdrawal by Subject|105|||
155325753|NCT03587805|560630100|FG000|Overall Study|Lack of Efficacy|119|||
155325754|NCT03587805|560630100|FG000|Overall Study|Reason unknown|26|||
155325755|NCT03587805|560630100|FG000|Overall Study|COVID_19 pandemic|4|||
155325756|NCT03587805|560630100|FG000|Overall Study|Various reasons|121|||
155325757|NCT03587805|560630100|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155325758|NCT01553149|560630101|FG000|Overall Study|Adverse Event|0|||
155325759|NCT01553149|560630102|FG001|Overall Study|Adverse Event|9|||
155325760|NCT01553149|560630101|FG000|Overall Study|Physician Decision|5|||
155325761|NCT01553149|560630102|FG001|Overall Study|Physician Decision|10|||
155325762|NCT01553149|560630101|FG000|Overall Study|Ineligible|0|||
155325763|NCT01553149|560630102|FG001|Overall Study|Ineligible|1|||
155325764|NCT03008382|560630103|FG000|Overall Study|Withdrawal by Subject|2|||
155325765|NCT03008382|560630104|FG001|Overall Study|Withdrawal by Subject|5|||
155325766|NCT03008382|560630105|FG002|Overall Study|Withdrawal by Subject|2|||
155325767|NCT03008382|560630106|FG003|Overall Study|Withdrawal by Subject|0|||
155325768|NCT03008382|560630103|FG000|Overall Study|Protocol Violation|1|||
155325769|NCT03008382|560630104|FG001|Overall Study|Protocol Violation|0|||
155325770|NCT03008382|560630105|FG002|Overall Study|Protocol Violation|0|||
155325771|NCT03008382|560630106|FG003|Overall Study|Protocol Violation|0|||
155325772|NCT03008382|560630103|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325773|NCT03008382|560630104|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
155325774|NCT03008382|560630105|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325775|NCT03008382|560630106|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325776|NCT03008382|560630103|FG000|Overall Study|Lost to Follow-up|0|||
155325777|NCT03008382|560630104|FG001|Overall Study|Lost to Follow-up|0|||
155325778|NCT03008382|560630105|FG002|Overall Study|Lost to Follow-up|1|||
155325779|NCT03008382|560630106|FG003|Overall Study|Lost to Follow-up|0|||
155325780|NCT03008382|560630103|FG000|Overall Study|Screenfail|0|||
155325781|NCT03008382|560630104|FG001|Overall Study|Screenfail|0|||
155325782|NCT03008382|560630105|FG002|Overall Study|Screenfail|2|||
155325783|NCT03008382|560630106|FG003|Overall Study|Screenfail|0|||
155325784|NCT05267639|560630794|FG000|Overall Study|Withdrawal by Subject|1|||
155325785|NCT05267639|560630795|FG001|Overall Study|Withdrawal by Subject|0|||
155325786|NCT04732871|560630796|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
155325787|NCT04732871|560630797|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
155325788|NCT04732871|560630798|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
155325789|NCT04732871|560630796|FG000|Overall Study|Lost to Follow-up|7|||
155325790|NCT04732871|560630797|FG001|Overall Study|Lost to Follow-up|4|||
155325791|NCT04732871|560630798|FG002|Overall Study|Lost to Follow-up|3|||
155325792|NCT04732871|560630796|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
155325793|NCT04732871|560630797|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
155325794|NCT04732871|560630798|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
155325795|NCT04732871|560630796|FG000|Overall Study|Migrated / moved from the study area|5|||
155325796|NCT04732871|560630797|FG001|Overall Study|Migrated / moved from the study area|0|||
155325797|NCT04732871|560630798|FG002|Overall Study|Migrated / moved from the study area|0|||
155325798|NCT04732871|560630796|FG000|Overall Study|Other|1|||
155421548|NCT00440726|560974290|FG001|Phase 1|Physician Decision|0|||
155421549|NCT00440726|560974291|FG002|Phase 1|Physician Decision|0|||
155421550|NCT00440726|560974289|FG000|Phase 2|Death|0|||
155421551|NCT00440726|560974290|FG001|Phase 2|Death|0|||
155421552|NCT00440726|560974291|FG002|Phase 2|Death|1|||
155421553|NCT00440726|560974289|FG000|Phase 2|Adverse Event|0|||
155421554|NCT00440726|560974290|FG001|Phase 2|Adverse Event|0|||
155421555|NCT00440726|560974291|FG002|Phase 2|Adverse Event|1|||
155421556|NCT01808612|560974292|FG000|Treatment Period|Adverse Event|8|||
155325799|NCT04732871|560630797|FG001|Overall Study|Other|0|||
155325800|NCT04732871|560630798|FG002|Overall Study|Other|1|||
155325801|NCT04732871|560630796|FG000|Overall Study|Ongoing|6|||
155325802|NCT04732871|560630797|FG001|Overall Study|Ongoing|0|||
155325803|NCT04732871|560630798|FG002|Overall Study|Ongoing|1|||
155325804|NCT04732871|560630796|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
155325805|NCT04732871|560630797|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
155325806|NCT04732871|560630798|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
155325807|NCT05180539|560630808|FG000|Overall Study|Lost to Follow-up|27|||
155325808|NCT05180539|560630809|FG001|Overall Study|Lost to Follow-up|30|||
155325809|NCT00968149|560630813|FG000|Overall Study|Adverse Event|5|||
155325810|NCT00968149|560630814|FG001|Overall Study|Adverse Event|1|||
155325811|NCT00968149|560630813|FG000|Overall Study|Lack of Efficacy|0|||
155325812|NCT00968149|560630814|FG001|Overall Study|Lack of Efficacy|4|||
155325813|NCT00968149|560630813|FG000|Overall Study|Lost to Follow-up|0|||
155325814|NCT00968149|560630814|FG001|Overall Study|Lost to Follow-up|1|||
155325815|NCT00968149|560630813|FG000|Overall Study|Protocol Violation|4|||
155325816|NCT00968149|560630814|FG001|Overall Study|Protocol Violation|0|||
155325817|NCT00968149|560630813|FG000|Overall Study|Withdrawal by Subject|2|||
155325818|NCT00968149|560630814|FG001|Overall Study|Withdrawal by Subject|0|||
155325819|NCT00447980|560630815|FG000|Overall Study|Withdrawal by Subject|1|||
155325820|NCT00447980|560630816|FG001|Overall Study|Withdrawal by Subject|1|||
155325821|NCT00447980|560630817|FG002|Overall Study|Withdrawal by Subject|4|||
155325822|NCT00447980|560630818|FG003|Overall Study|Withdrawal by Subject|4|||
155325823|NCT00447980|560630815|FG000|Overall Study|Lost to Follow-up|1|||
155325824|NCT00447980|560630816|FG001|Overall Study|Lost to Follow-up|1|||
155325825|NCT00447980|560630817|FG002|Overall Study|Lost to Follow-up|0|||
155325826|NCT00447980|560630818|FG003|Overall Study|Lost to Follow-up|0|||
155325827|NCT00447980|560630815|FG000|Overall Study|Did not proceed with surgery|3|||
155325828|NCT00447980|560630816|FG001|Overall Study|Did not proceed with surgery|3|||
155325829|NCT00447980|560630817|FG002|Overall Study|Did not proceed with surgery|2|||
155325830|NCT00447980|560630818|FG003|Overall Study|Did not proceed with surgery|2|||
155325831|NCT02467270|560630819|FG000|Overall Study|Participants Never Treated|0|||
155325832|NCT02467270|560630820|FG001|Overall Study|Participants Never Treated|1|||
155325833|NCT02467270|560630821|FG002|Overall Study|Participants Never Treated|0|||
155325834|NCT02467270|560630819|FG000|Overall Study|Ongoing|50|||
155325835|NCT02467270|560630820|FG001|Overall Study|Ongoing|41|||
155325836|NCT02467270|560630821|FG002|Overall Study|Ongoing|43|||
155325837|NCT02467270|560630819|FG000|Overall Study|Adverse Event|16|||
155325838|NCT02467270|560630820|FG001|Overall Study|Adverse Event|15|||
155325839|NCT02467270|560630821|FG002|Overall Study|Adverse Event|14|||
155325840|NCT02467270|560630819|FG000|Overall Study|Progressive Disease|7|||
155325841|NCT02467270|560630820|FG001|Overall Study|Progressive Disease|7|||
155325842|NCT02467270|560630821|FG002|Overall Study|Progressive Disease|4|||
155325843|NCT02467270|560630819|FG000|Overall Study|Death|2|||
155325844|NCT02467270|560630820|FG001|Overall Study|Death|0|||
155325845|NCT02467270|560630821|FG002|Overall Study|Death|2|||
155325846|NCT02467270|560630819|FG000|Overall Study|Lack of Efficacy|12|||
155325847|NCT02467270|560630820|FG001|Overall Study|Lack of Efficacy|18|||
155325848|NCT02467270|560630821|FG002|Overall Study|Lack of Efficacy|23|||
155325849|NCT02467270|560630819|FG000|Overall Study|Non-compliance With Study Drug|0|||
155325850|NCT02467270|560630820|FG001|Overall Study|Non-compliance With Study Drug|2|||
155325851|NCT02467270|560630821|FG002|Overall Study|Non-compliance With Study Drug|1|||
155325852|NCT02467270|560630819|FG000|Overall Study|Lost to Follow-up|2|||
155325853|NCT02467270|560630820|FG001|Overall Study|Lost to Follow-up|1|||
155325854|NCT02467270|560630821|FG002|Overall Study|Lost to Follow-up|0|||
155325855|NCT02467270|560630819|FG000|Overall Study|Pregnancy|0|||
155325856|NCT02467270|560630820|FG001|Overall Study|Pregnancy|1|||
155325857|NCT02467270|560630821|FG002|Overall Study|Pregnancy|0|||
155325858|NCT02467270|560630819|FG000|Overall Study|Physician Decision|0|||
155325859|NCT02467270|560630820|FG001|Overall Study|Physician Decision|4|||
155325860|NCT02467270|560630821|FG002|Overall Study|Physician Decision|1|||
155325861|NCT02467270|560630819|FG000|Overall Study|Withdrawal by Subject|4|||
155325862|NCT02467270|560630820|FG001|Overall Study|Withdrawal by Subject|3|||
155325863|NCT02467270|560630821|FG002|Overall Study|Withdrawal by Subject|5|||
155325864|NCT02467270|560630819|FG000|Overall Study|Reason not Specified|1|||
155325865|NCT02467270|560630820|FG001|Overall Study|Reason not Specified|2|||
155325866|NCT02467270|560630821|FG002|Overall Study|Reason not Specified|1|||
155325867|NCT06408870|560630822|FG000|Washout period|Withdrawal by Subject|1|||
155325868|NCT06408870|560630823|FG001|Washout period|Withdrawal by Subject|0|||
155325869|NCT06408870|560630822|FG000|Washout period|Adverse Event|2|||
155325870|NCT06408870|560630823|FG001|Washout period|Adverse Event|0|||
155325871|NCT00495677|560630824|FG000|Stage 1 (25 Days)|Adverse Event|0|||
155325872|NCT00495677|560630825|FG001|Stage 1 (25 Days)|Adverse Event|0|||
155325873|NCT00495677|560630826|FG002|Stage 1 (25 Days)|Adverse Event|1|||
155325874|NCT00495677|560630827|FG003|Stage 1 (25 Days)|Adverse Event|0|||
155325875|NCT00495677|560630828|FG004|Stage 1 (25 Days)|Adverse Event|0|||
155325876|NCT00495677|560630829|FG005|Stage 1 (25 Days)|Adverse Event|0|||
155325877|NCT00495677|560630830|FG006|Stage 1 (25 Days)|Adverse Event|0|||
155325878|NCT02567435|560630834|FG000|Overall Study|Death|1|||
155325879|NCT02567435|560630835|FG001|Overall Study|Death|1|||
155325880|NCT02567435|560630836|FG002|Overall Study|Death|0|||
155325881|NCT02567435|560630837|FG003|Overall Study|Death|0|||
155325882|NCT02567435|560630834|FG000|Overall Study|Ineligible|1|||
155325883|NCT02567435|560630835|FG001|Overall Study|Ineligible|3|||
155325884|NCT02567435|560630836|FG002|Overall Study|Ineligible|0|||
155325885|NCT02567435|560630837|FG003|Overall Study|Ineligible|0|||
155325886|NCT02567435|560630834|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
155325887|NCT02567435|560630835|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
155325888|NCT02567435|560630836|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
155325889|NCT02567435|560630837|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
155325890|NCT05771467|560630838|FG000|Overall Study|Lost to Follow-up|6|||
155325891|NCT05771467|560630839|FG001|Overall Study|Lost to Follow-up|3|||
155325892|NCT01220531|560630842|FG000|Overall Study|Death|7|||
155325893|NCT01220531|560630842|FG000|Overall Study|Lost to Follow-up|1|||
155325894|NCT05866926|560630846|FG000|Overall Study|Death|16|||
155325895|NCT05866926|560630847|FG001|Overall Study|Death|9|||
155325896|NCT05866926|560630846|FG000|Overall Study|Lost to Follow-up|0|||
155325897|NCT05866926|560630847|FG001|Overall Study|Lost to Follow-up|1|||
155325898|NCT05866926|560630846|FG000|Overall Study|Adverse Event|1|||
155325899|NCT05866926|560630847|FG001|Overall Study|Adverse Event|0|||
155325900|NCT05866926|560630846|FG000|Overall Study|Withdrawal by Subject|5|||
155325901|NCT05866926|560630847|FG001|Overall Study|Withdrawal by Subject|1|||
155644678|NCT03422718|561789843|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
155644679|NCT03422718|561789844|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
155644680|NCT03422718|561789845|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
155644681|NCT03422718|561789846|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
155644682|NCT03422718|561789847|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
155644683|NCT03422718|561789848|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
155644684|NCT03309605|561789849|FG000|Overall Study|Adverse Event|0|||
155644685|NCT03309605|561789850|FG001|Overall Study|Adverse Event|0|||
155644686|NCT03309605|561789851|FG002|Overall Study|Adverse Event|0|||
155644687|NCT03309605|561789852|FG003|Overall Study|Adverse Event|1|||
155644688|NCT03309605|561789853|FG004|Overall Study|Adverse Event|0|||
155644689|NCT03309605|561789854|FG005|Overall Study|Adverse Event|0|||
155325902|NCT05866926|560630846|FG000|Overall Study|Disease progression|1|||
155325903|NCT05866926|560630847|FG001|Overall Study|Disease progression|0|||
155325904|NCT05866926|560630846|FG000|Overall Study|other causes|2|||
155325905|NCT05866926|560630847|FG001|Overall Study|other causes|1|||
155325906|NCT00709956|560630848|FG000|Overall Study|Withdrawal by Subject|1|||
155325907|NCT00709956|560630849|FG001|Overall Study|Withdrawal by Subject|1|||
155325908|NCT00709956|560630848|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
155325909|NCT00709956|560630849|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
155325910|NCT01105091|560630850|FG000|Overall Study|Death|2|||
155325911|NCT01105091|560630851|FG001|Overall Study|Death|0|||
155325912|NCT02206828|560630854|FG000|Overall Study|Lost to Follow-up|7|||
155325913|NCT04039113|560630859|FG000|Overall Study|Withdrawal by Subject|8|||
155325914|NCT04039113|560630860|FG001|Overall Study|Withdrawal by Subject|11|||
155325915|NCT04039113|560630859|FG000|Overall Study|Lost to Follow-up|1|||
155325916|NCT04039113|560630860|FG001|Overall Study|Lost to Follow-up|1|||
155325917|NCT04039113|560630859|FG000|Overall Study|Adverse Event|2|||
155325918|NCT04039113|560630860|FG001|Overall Study|Adverse Event|2|||
155325919|NCT04039113|560630859|FG000|Overall Study|Death|2|||
155325920|NCT04039113|560630860|FG001|Overall Study|Death|4|||
155325921|NCT04039113|560630859|FG000|Overall Study|Site Closure|6|||
155325922|NCT04039113|560630860|FG001|Overall Study|Site Closure|0|||
155325923|NCT04039113|560630859|FG000|Overall Study|Failure to meet randomisation criteria|4|||
155325924|NCT04039113|560630860|FG001|Overall Study|Failure to meet randomisation criteria|0|||
155325925|NCT00353496|560630861|FG000|Overall Study|Adverse Event|1|||
155325926|NCT00353496|560630862|FG001|Overall Study|Adverse Event|0|||
155325927|NCT00353496|560630861|FG000|Overall Study|Protocol Violation|2|||
155325928|NCT00353496|560630862|FG001|Overall Study|Protocol Violation|2|||
155325929|NCT00353496|560630861|FG000|Overall Study|Withdrawal by Subject|3|||
155325930|NCT00353496|560630862|FG001|Overall Study|Withdrawal by Subject|4|||
155325931|NCT00353496|560630861|FG000|Overall Study|Physician Decision|6|||
155325932|NCT00353496|560630862|FG001|Overall Study|Physician Decision|9|||
155325933|NCT00353496|560630861|FG000|Overall Study|Not otherwise specified|4|||
155325934|NCT00353496|560630862|FG001|Overall Study|Not otherwise specified|2|||
155502401|NCT01785875|561265469|FG000|Overall Study|Missing|0|||
155644690|NCT03309605|561789855|FG006|Overall Study|Adverse Event|2|||
155325935|NCT00945724|560630863|FG000|Overall Study|Withdrawal by Subject|2|||
155644691|NCT03309605|561789856|FG007|Overall Study|Adverse Event|1|||
155644692|NCT03309605|561789849|FG000|Overall Study|Withdrawal by Subject|0|||
155644693|NCT03309605|561789850|FG001|Overall Study|Withdrawal by Subject|0|||
155644694|NCT03309605|561789851|FG002|Overall Study|Withdrawal by Subject|0|||
155644695|NCT03309605|561789852|FG003|Overall Study|Withdrawal by Subject|0|||
155644696|NCT03309605|561789853|FG004|Overall Study|Withdrawal by Subject|1|||
155644697|NCT03309605|561789854|FG005|Overall Study|Withdrawal by Subject|0|||
155644698|NCT03309605|561789855|FG006|Overall Study|Withdrawal by Subject|1|||
155325936|NCT00945724|560630863|FG000|Overall Study|Physician Decision|1|||
155325937|NCT00945724|560630863|FG000|Overall Study|Adverse Event|5|||
155644699|NCT03309605|561789856|FG007|Overall Study|Withdrawal by Subject|1|||
155421557|NCT01808612|560974293|FG001|Treatment Period|Adverse Event|4|||
155325938|NCT00945724|560630863|FG000|Overall Study|Second malignancy|1|||
155325939|NCT02502266|560631485|FG000|Overall Study|Adverse Event|0|||
155325940|NCT02502266|560631486|FG001|Overall Study|Adverse Event|0|||
155325941|NCT02502266|560631487|FG002|Overall Study|Adverse Event|0|||
155325942|NCT02502266|560631488|FG003|Overall Study|Adverse Event|0|||
155325943|NCT02502266|560631489|FG004|Overall Study|Adverse Event|1|||
155325944|NCT02502266|560631490|FG005|Overall Study|Adverse Event|1|||
155325945|NCT02502266|560631491|FG006|Overall Study|Adverse Event|1|||
155325946|NCT02502266|560631485|FG000|Overall Study|Withdrawal by Subject|30|||
155325947|NCT02502266|560631486|FG001|Overall Study|Withdrawal by Subject|15|||
155325948|NCT02502266|560631487|FG002|Overall Study|Withdrawal by Subject|16|||
155325949|NCT02502266|560631488|FG003|Overall Study|Withdrawal by Subject|0|||
155325950|NCT02502266|560631489|FG004|Overall Study|Withdrawal by Subject|0|||
155325951|NCT02502266|560631490|FG005|Overall Study|Withdrawal by Subject|0|||
155325952|NCT02502266|560631491|FG006|Overall Study|Withdrawal by Subject|0|||
155325953|NCT02502266|560631485|FG000|Overall Study|Still on Treatment|0|||
155325954|NCT02502266|560631486|FG001|Overall Study|Still on Treatment|0|||
155325955|NCT02502266|560631487|FG002|Overall Study|Still on Treatment|1|||
155325956|NCT02502266|560631488|FG003|Overall Study|Still on Treatment|0|||
155325957|NCT02502266|560631489|FG004|Overall Study|Still on Treatment|0|||
155325958|NCT02502266|560631490|FG005|Overall Study|Still on Treatment|0|||
155325959|NCT02502266|560631491|FG006|Overall Study|Still on Treatment|0|||
155325960|NCT02502266|560631485|FG000|Overall Study|Other Reasons|19|||
155325961|NCT02502266|560631486|FG001|Overall Study|Other Reasons|6|||
155325962|NCT02502266|560631487|FG002|Overall Study|Other Reasons|14|||
155325963|NCT02502266|560631488|FG003|Overall Study|Other Reasons|0|||
155325964|NCT02502266|560631489|FG004|Overall Study|Other Reasons|1|||
155325965|NCT02502266|560631490|FG005|Overall Study|Other Reasons|1|||
155325966|NCT02502266|560631491|FG006|Overall Study|Other Reasons|0|||
155325967|NCT02502266|560631485|FG000|Overall Study|Arm 4 Discontinued|0|||
155325968|NCT02502266|560631486|FG001|Overall Study|Arm 4 Discontinued|0|||
155325969|NCT02502266|560631487|FG002|Overall Study|Arm 4 Discontinued|0|||
155325970|NCT02502266|560631488|FG003|Overall Study|Arm 4 Discontinued|52|||
155325971|NCT02502266|560631489|FG004|Overall Study|Arm 4 Discontinued|0|||
155325972|NCT02502266|560631490|FG005|Overall Study|Arm 4 Discontinued|0|||
155325973|NCT02502266|560631491|FG006|Overall Study|Arm 4 Discontinued|0|||
155325974|NCT02502266|560631485|FG000|Overall Study|Never treated|0|||
155325975|NCT02502266|560631486|FG001|Overall Study|Never treated|0|||
155325976|NCT02502266|560631487|FG002|Overall Study|Never treated|0|||
155325977|NCT02502266|560631488|FG003|Overall Study|Never treated|0|||
155325978|NCT02502266|560631489|FG004|Overall Study|Never treated|0|||
155325979|NCT02502266|560631490|FG005|Overall Study|Never treated|1|||
155325980|NCT02502266|560631491|FG006|Overall Study|Never treated|0|||
155421558|NCT01808612|560974294|FG002|Treatment Period|Adverse Event|3|||
155421559|NCT01808612|560974292|FG000|Treatment Period|Lost to Follow-up|2|||
155421560|NCT01808612|560974293|FG001|Treatment Period|Lost to Follow-up|2|||
155325981|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Other|0|||
155325982|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Other|2|||
155325983|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Other|1|||
155325984|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Other|2|||
155325985|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Other|2|||
155325986|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Other|0|||
155325987|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Other|0|||
155325988|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Other|0|||
155325989|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Other|0|||
155325990|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Other|0|||
155325991|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Other|0|||
155325992|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Other|0|||
155325993|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Other|0|||
155325994|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Other|0|||
155325995|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Other|0|||
155325996|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Other|0|||
155325997|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Other|0|||
155325998|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
155325999|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
155326000|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
155326001|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
155326002|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
155326003|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
155326004|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326005|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155502402|NCT01785875|561265470|FG001|Overall Study|Missing|1|||
155502403|NCT01785875|561265471|FG002|Overall Study|Missing|3|||
155326006|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326007|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326008|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326009|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326010|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326011|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326012|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326013|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326014|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326015|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326016|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
155326017|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326018|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326019|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326020|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326021|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326022|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326023|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326024|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326025|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326026|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326027|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326028|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326029|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326030|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326031|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326032|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Death|2|||
155326033|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Death|1|||
155326034|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Death|1|||
155326035|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Death|0|||
155326036|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Death|0|||
155326037|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Death|0|||
155326038|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Death|0|||
155326039|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Death|0|||
155326040|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Death|0|||
155326041|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Death|0|||
155326042|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Death|0|||
155326043|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Death|0|||
155326044|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Death|0|||
155326045|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Death|0|||
155644700|NCT05788328|561789857|FG000|Treatment Period 4 (5 Days)|Other|1|||
155644701|NCT05788328|561789857|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
155326046|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Death|0|||
155326047|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Death|0|||
155326048|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Death|0|||
155326049|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326050|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326051|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326052|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326053|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326054|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326055|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326056|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326057|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326058|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326059|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326060|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326061|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326062|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326063|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326064|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326065|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326066|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326067|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326068|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
155644702|NCT02181621|561789858|FG000|Overall Study|Adverse Event|1|||
155644703|NCT02181621|561789859|FG001|Overall Study|Adverse Event|0|||
155326069|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326070|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
155326071|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
155326072|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
155644704|NCT02181621|561789858|FG000|Overall Study|Previously Enrolled|0|||
155326073|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326074|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326075|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326076|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326077|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326078|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326079|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326080|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326081|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326082|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326083|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326084|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326085|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
155326086|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326087|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326088|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326089|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326090|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326091|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326092|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326093|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326094|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326095|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326096|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326097|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326098|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326099|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326100|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326101|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326102|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326103|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326104|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326105|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326106|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
155326107|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
155326108|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
155326109|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326110|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326111|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326112|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326113|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155421561|NCT01808612|560974294|FG002|Treatment Period|Lost to Follow-up|1|||
155421562|NCT01808612|560974292|FG000|Treatment Period|Protocol Violation|1|||
155421563|NCT01808612|560974293|FG001|Treatment Period|Protocol Violation|0|||
155421564|NCT01808612|560974294|FG002|Treatment Period|Protocol Violation|0|||
155421565|NCT01808612|560974292|FG000|Treatment Period|Withdrawal by Subject|1|||
155421566|NCT01808612|560974293|FG001|Treatment Period|Withdrawal by Subject|0|||
155421567|NCT01808612|560974294|FG002|Treatment Period|Withdrawal by Subject|4|||
155421568|NCT01808612|560974292|FG000|Treatment Period|Physician Decision|1|||
155421569|NCT01808612|560974293|FG001|Treatment Period|Physician Decision|0|||
155421570|NCT01808612|560974294|FG002|Treatment Period|Physician Decision|4|||
155421571|NCT01808612|560974292|FG000|Treatment Period|Sponsor Decision|1|||
155421572|NCT01808612|560974293|FG001|Treatment Period|Sponsor Decision|0|||
155421573|NCT01808612|560974294|FG002|Treatment Period|Sponsor Decision|0|||
155421574|NCT01808612|560974292|FG000|Treatment Period|Lack of Efficacy|1|||
155421575|NCT01808612|560974293|FG001|Treatment Period|Lack of Efficacy|1|||
155421576|NCT01808612|560974294|FG002|Treatment Period|Lack of Efficacy|2|||
155421577|NCT01808612|560974292|FG000|Discontinuation Period|Adverse Event|1|||
155421578|NCT01808612|560974293|FG001|Discontinuation Period|Adverse Event|0|||
155421579|NCT01808612|560974294|FG002|Discontinuation Period|Adverse Event|0|||
155421580|NCT01808612|560974292|FG000|Discontinuation Period|Physician Decision|1|||
155421581|NCT01808612|560974293|FG001|Discontinuation Period|Physician Decision|0|||
155421582|NCT01808612|560974294|FG002|Discontinuation Period|Physician Decision|0|||
155326114|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326115|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326116|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326117|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326118|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155421583|NCT01808612|560974292|FG000|Discontinuation Period|Lost to Follow-up|0|||
155421584|NCT01808612|560974293|FG001|Discontinuation Period|Lost to Follow-up|1|||
155421585|NCT01808612|560974294|FG002|Discontinuation Period|Lost to Follow-up|0|||
155421586|NCT00110019|560974295|FG000|Overall Study|Lack of Efficacy|253|||
155421587|NCT00110019|560974296|FG001|Overall Study|Lack of Efficacy|285|||
155421588|NCT00110019|560974295|FG000|Overall Study|Adverse Event|61|||
155502404|NCT03137082|561265474|FG000|Overall Study|Withdrawal by Subject|1|||
155502405|NCT03137082|561265475|FG001|Overall Study|Withdrawal by Subject|1|||
155502406|NCT03137082|561265474|FG000|Overall Study|Lost to Follow-up|1|||
155502407|NCT03137082|561265475|FG001|Overall Study|Lost to Follow-up|0|||
155644705|NCT02181621|561789859|FG001|Overall Study|Previously Enrolled|1|||
155644706|NCT02181621|561789858|FG000|Overall Study|Enrollment Hold|1|||
155644707|NCT02181621|561789859|FG001|Overall Study|Enrollment Hold|1|||
155644708|NCT00145327|561789860|FG000|Overall Study|Withdrawal by Subject|77|||
155644709|NCT00145327|561789861|FG001|Overall Study|Withdrawal by Subject|72|||
155644710|NCT00145327|561789862|FG002|Overall Study|Withdrawal by Subject|164|||
155644711|NCT00145327|561789860|FG000|Overall Study|Death|26|||
155644712|NCT00145327|561789861|FG001|Overall Study|Death|18|||
155644713|NCT00145327|561789862|FG002|Overall Study|Death|30|||
155644714|NCT00145327|561789860|FG000|Overall Study|Adverse Event|14|||
155644715|NCT00145327|561789861|FG001|Overall Study|Adverse Event|11|||
155644716|NCT00145327|561789862|FG002|Overall Study|Adverse Event|22|||
155644717|NCT00145327|561789860|FG000|Overall Study|Lost to Follow-up|9|||
155644718|NCT00145327|561789861|FG001|Overall Study|Lost to Follow-up|14|||
155644719|NCT00145327|561789862|FG002|Overall Study|Lost to Follow-up|14|||
155644720|NCT00145327|561789860|FG000|Overall Study|Administrative problems|12|||
155644721|NCT00145327|561789861|FG001|Overall Study|Administrative problems|9|||
155644722|NCT00145327|561789862|FG002|Overall Study|Administrative problems|13|||
155644723|NCT00145327|561789860|FG000|Overall Study|Protocol Violation|2|||
155644724|NCT00145327|561789861|FG001|Overall Study|Protocol Violation|0|||
155644725|NCT00145327|561789862|FG002|Overall Study|Protocol Violation|2|||
155644726|NCT00145327|561789860|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155644727|NCT00145327|561789861|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155644728|NCT00145327|561789862|FG002|Overall Study|Abnormal laboratory value(s)|2|||
155644729|NCT00145327|561789860|FG000|Overall Study|Missing - not stated|1|||
155644730|NCT00145327|561789861|FG001|Overall Study|Missing - not stated|0|||
155644731|NCT00145327|561789862|FG002|Overall Study|Missing - not stated|1|||
155644732|NCT00864513|561789864|FG000|Overall Study|Withdrawal by Subject|3|||
155644733|NCT00762788|561789865|FG000|Overall Study|Lost to Follow-up|26|||
155644734|NCT00762788|561789866|FG001|Overall Study|Lost to Follow-up|37|||
155644735|NCT00762788|561789867|FG002|Overall Study|Lost to Follow-up|21|||
155644736|NCT00762788|561789868|FG003|Overall Study|Lost to Follow-up|26|||
155644737|NCT00762788|561789869|FG004|Overall Study|Lost to Follow-up|13|||
155644738|NCT00762788|561789870|FG005|Overall Study|Lost to Follow-up|21|||
155644739|NCT03073109|561789872|FG000|Overall Study|Adverse Event|0|||
155644740|NCT03073109|561789873|FG001|Overall Study|Adverse Event|1|||
155644741|NCT03073109|561789872|FG000|Overall Study|Other|2|||
155644742|NCT03073109|561789873|FG001|Overall Study|Other|0|||
155644743|NCT03073109|561789872|FG000|Overall Study|Lost to Follow-up|8|||
155644744|NCT03073109|561789873|FG001|Overall Study|Lost to Follow-up|1|||
155644745|NCT05938010|561789874|FG000|Overall Study|Lost to Follow-up|2|||
155644746|NCT01158404|561789883|FG000|Overall Study|Withdrawal by Subject|0|||
155644747|NCT01158404|561789884|FG001|Overall Study|Withdrawal by Subject|1|||
155644748|NCT01158404|561789885|FG002|Overall Study|Withdrawal by Subject|0|||
155644749|NCT01158404|561789886|FG003|Overall Study|Withdrawal by Subject|0|||
155644750|NCT01158404|561789887|FG004|Overall Study|Withdrawal by Subject|3|||
155644751|NCT01158404|561789888|FG005|Overall Study|Withdrawal by Subject|1|||
155644752|NCT01158404|561789889|FG006|Overall Study|Withdrawal by Subject|0|||
155644753|NCT01158404|561789890|FG007|Overall Study|Withdrawal by Subject|1|||
155644754|NCT01158404|561789883|FG000|Overall Study|Physician Decision|0|||
155644755|NCT01158404|561789884|FG001|Overall Study|Physician Decision|0|||
155644756|NCT01158404|561789885|FG002|Overall Study|Physician Decision|0|||
155644757|NCT01158404|561789886|FG003|Overall Study|Physician Decision|0|||
155644758|NCT01158404|561789887|FG004|Overall Study|Physician Decision|0|||
155644759|NCT01158404|561789888|FG005|Overall Study|Physician Decision|0|||
155644760|NCT01158404|561789889|FG006|Overall Study|Physician Decision|0|||
155644761|NCT01158404|561789890|FG007|Overall Study|Physician Decision|1|||
155644762|NCT01158404|561789883|FG000|Overall Study|Progressive Disease|0|||
155644763|NCT01158404|561789884|FG001|Overall Study|Progressive Disease|0|||
155644764|NCT01158404|561789885|FG002|Overall Study|Progressive Disease|0|||
155644765|NCT01158404|561789886|FG003|Overall Study|Progressive Disease|0|||
155644766|NCT01158404|561789887|FG004|Overall Study|Progressive Disease|0|||
155644767|NCT01158404|561789888|FG005|Overall Study|Progressive Disease|0|||
155644768|NCT01158404|561789889|FG006|Overall Study|Progressive Disease|1|||
155644769|NCT01158404|561789890|FG007|Overall Study|Progressive Disease|0|||
155644770|NCT02029443|561789893|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
155644771|NCT02029443|561789894|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
155644772|NCT02029443|561789895|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
155644773|NCT02029443|561789896|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
155644774|NCT02029443|561789897|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
155644775|NCT02029443|561789893|FG000|Overall Study|Death|13|||
155644776|NCT02029443|561789894|FG001|Overall Study|Death|2|||
155644777|NCT02029443|561789895|FG002|Overall Study|Death|2|||
155644778|NCT02029443|561789896|FG003|Overall Study|Death|11|||
155644779|NCT02029443|561789897|FG004|Overall Study|Death|2|||
155326119|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326120|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326121|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326122|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326123|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
155326124|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
155326125|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326126|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326127|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326128|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326129|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326130|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326131|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326132|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326133|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326134|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Death|0|||
155326135|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Death|0|||
155326136|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Death|0|||
155326137|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Death|0|||
155326138|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Death|0|||
155326139|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Death|0|||
155326140|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Death|1|||
155326141|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Death|6|||
155326142|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Death|0|||
155326143|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Death|0|||
155326144|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Death|0|||
155326145|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Death|0|||
155326146|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Death|0|||
155326147|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Death|0|||
155326148|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Death|0|||
155326149|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Death|0|||
155326150|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Death|0|||
155326151|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326152|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326153|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326154|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326155|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326156|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326157|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
155644780|NCT02029443|561789893|FG000|Overall Study|Lost to Follow-up|1|||
155644781|NCT02029443|561789894|FG001|Overall Study|Lost to Follow-up|0|||
155326158|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
155326159|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326160|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326161|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326162|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326163|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326164|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326165|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326166|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326167|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326168|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326169|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326170|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
155644782|NCT02029443|561789895|FG002|Overall Study|Lost to Follow-up|1|||
155644783|NCT02029443|561789896|FG003|Overall Study|Lost to Follow-up|1|||
155644784|NCT02029443|561789897|FG004|Overall Study|Lost to Follow-up|0|||
155644785|NCT02029443|561789893|FG000|Overall Study|Started other anti-cancer therapy|17|||
155644786|NCT02029443|561789894|FG001|Overall Study|Started other anti-cancer therapy|4|||
155644787|NCT02029443|561789895|FG002|Overall Study|Started other anti-cancer therapy|7|||
155644788|NCT02029443|561789896|FG003|Overall Study|Started other anti-cancer therapy|9|||
155644789|NCT02029443|561789897|FG004|Overall Study|Started other anti-cancer therapy|3|||
155644790|NCT02029443|561789893|FG000|Overall Study|Withdrawal by Subject|3|||
155644791|NCT02029443|561789894|FG001|Overall Study|Withdrawal by Subject|1|||
155644792|NCT02029443|561789895|FG002|Overall Study|Withdrawal by Subject|1|||
155644793|NCT02029443|561789896|FG003|Overall Study|Withdrawal by Subject|1|||
155326171|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326172|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326173|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326174|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
155326175|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
155326176|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326177|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326178|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326179|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326180|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326181|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326182|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326183|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326184|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326185|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Other|0|||
155326186|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Other|0|||
155326187|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Other|0|||
155326188|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Other|0|||
155326189|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Other|0|||
155326190|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Other|0|||
155326191|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Other|1|||
155326192|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Other|7|||
155326193|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Other|0|||
155326194|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Other|0|||
155326195|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Other|0|||
155326196|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Other|0|||
155326197|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Other|0|||
155326198|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Other|0|||
155326199|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Other|0|||
155326200|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Other|0|||
155326201|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Other|0|||
155326202|NCT02719574|560631492|FG000|Phase 2|Protocol Defined Disease Progression|0|||
155326203|NCT02719574|560631493|FG001|Phase 2|Protocol Defined Disease Progression|0|||
155326204|NCT02719574|560631494|FG002|Phase 2|Protocol Defined Disease Progression|0|||
155326205|NCT02719574|560631495|FG003|Phase 2|Protocol Defined Disease Progression|0|||
155326206|NCT02719574|560631496|FG004|Phase 2|Protocol Defined Disease Progression|0|||
155326207|NCT02719574|560631497|FG005|Phase 2|Protocol Defined Disease Progression|0|||
155326208|NCT02719574|560631498|FG006|Phase 2|Protocol Defined Disease Progression|0|||
155326209|NCT02719574|560631499|FG007|Phase 2|Protocol Defined Disease Progression|0|||
155326210|NCT02719574|560631500|FG008|Phase 2|Protocol Defined Disease Progression|0|||
155326211|NCT02719574|560631501|FG009|Phase 2|Protocol Defined Disease Progression|65|||
155326212|NCT02719574|560631502|FG010|Phase 2|Protocol Defined Disease Progression|8|||
155326213|NCT02719574|560631503|FG011|Phase 2|Protocol Defined Disease Progression|2|||
155326214|NCT02719574|560631504|FG012|Phase 2|Protocol Defined Disease Progression|4|||
155326215|NCT02719574|560631505|FG013|Phase 2|Protocol Defined Disease Progression|9|||
155326216|NCT02719574|560631506|FG014|Phase 2|Protocol Defined Disease Progression|11|||
155326217|NCT02719574|560631507|FG015|Phase 2|Protocol Defined Disease Progression|3|||
155326218|NCT02719574|560631508|FG016|Phase 2|Protocol Defined Disease Progression|4|||
155326219|NCT02719574|560631492|FG000|Phase 2|Adverse Event|0|||
155326220|NCT02719574|560631493|FG001|Phase 2|Adverse Event|0|||
155326221|NCT02719574|560631494|FG002|Phase 2|Adverse Event|0|||
155326222|NCT02719574|560631495|FG003|Phase 2|Adverse Event|0|||
155326223|NCT02719574|560631496|FG004|Phase 2|Adverse Event|0|||
155326224|NCT02719574|560631497|FG005|Phase 2|Adverse Event|0|||
155326225|NCT02719574|560631498|FG006|Phase 2|Adverse Event|0|||
155326226|NCT02719574|560631499|FG007|Phase 2|Adverse Event|0|||
155326227|NCT02719574|560631500|FG008|Phase 2|Adverse Event|0|||
155326228|NCT02719574|560631501|FG009|Phase 2|Adverse Event|27|||
155326229|NCT02719574|560631502|FG010|Phase 2|Adverse Event|0|||
155326230|NCT02719574|560631503|FG011|Phase 2|Adverse Event|1|||
155326231|NCT02719574|560631504|FG012|Phase 2|Adverse Event|1|||
155326232|NCT02719574|560631505|FG013|Phase 2|Adverse Event|1|||
155326233|NCT02719574|560631506|FG014|Phase 2|Adverse Event|2|||
155326234|NCT02719574|560631507|FG015|Phase 2|Adverse Event|2|||
155326235|NCT02719574|560631508|FG016|Phase 2|Adverse Event|3|||
155326236|NCT02719574|560631492|FG000|Phase 2|Other|0|||
155326237|NCT02719574|560631493|FG001|Phase 2|Other|0|||
155326238|NCT02719574|560631494|FG002|Phase 2|Other|0|||
155326239|NCT02719574|560631495|FG003|Phase 2|Other|0|||
155326240|NCT02719574|560631496|FG004|Phase 2|Other|0|||
155326241|NCT02719574|560631497|FG005|Phase 2|Other|0|||
155326242|NCT02719574|560631498|FG006|Phase 2|Other|0|||
155326243|NCT02719574|560631499|FG007|Phase 2|Other|0|||
155326244|NCT02719574|560631500|FG008|Phase 2|Other|0|||
155326245|NCT02719574|560631501|FG009|Phase 2|Other|20|||
155326246|NCT02719574|560631502|FG010|Phase 2|Other|7|||
155326247|NCT02719574|560631503|FG011|Phase 2|Other|0|||
155326248|NCT02719574|560631504|FG012|Phase 2|Other|5|||
155326249|NCT02719574|560631505|FG013|Phase 2|Other|7|||
155326250|NCT02719574|560631506|FG014|Phase 2|Other|0|||
155326251|NCT02719574|560631507|FG015|Phase 2|Other|1|||
155326252|NCT02719574|560631508|FG016|Phase 2|Other|4|||
155326253|NCT02719574|560631492|FG000|Phase 2|Transplant|0|||
155326254|NCT02719574|560631493|FG001|Phase 2|Transplant|0|||
155326255|NCT02719574|560631494|FG002|Phase 2|Transplant|0|||
155326256|NCT02719574|560631495|FG003|Phase 2|Transplant|0|||
155326257|NCT02719574|560631496|FG004|Phase 2|Transplant|0|||
155326258|NCT02719574|560631497|FG005|Phase 2|Transplant|0|||
155326259|NCT02719574|560631498|FG006|Phase 2|Transplant|0|||
155326260|NCT02719574|560631499|FG007|Phase 2|Transplant|0|||
155326261|NCT02719574|560631500|FG008|Phase 2|Transplant|0|||
155326262|NCT02719574|560631501|FG009|Phase 2|Transplant|15|||
155326263|NCT02719574|560631502|FG010|Phase 2|Transplant|2|||
155326264|NCT02719574|560631503|FG011|Phase 2|Transplant|0|||
155326265|NCT02719574|560631504|FG012|Phase 2|Transplant|6|||
155326266|NCT02719574|560631505|FG013|Phase 2|Transplant|1|||
155326267|NCT02719574|560631506|FG014|Phase 2|Transplant|1|||
155326268|NCT02719574|560631507|FG015|Phase 2|Transplant|0|||
155326269|NCT02719574|560631508|FG016|Phase 2|Transplant|0|||
155326270|NCT02719574|560631492|FG000|Phase 2|Death|0|||
155326271|NCT02719574|560631493|FG001|Phase 2|Death|0|||
155326272|NCT02719574|560631494|FG002|Phase 2|Death|0|||
155326273|NCT02719574|560631495|FG003|Phase 2|Death|0|||
155326274|NCT02719574|560631496|FG004|Phase 2|Death|0|||
155326275|NCT02719574|560631497|FG005|Phase 2|Death|0|||
155326276|NCT02719574|560631498|FG006|Phase 2|Death|0|||
155326277|NCT02719574|560631499|FG007|Phase 2|Death|0|||
155326278|NCT02719574|560631500|FG008|Phase 2|Death|0|||
155326279|NCT02719574|560631501|FG009|Phase 2|Death|14|||
155326280|NCT02719574|560631502|FG010|Phase 2|Death|0|||
155326281|NCT02719574|560631503|FG011|Phase 2|Death|0|||
155326282|NCT02719574|560631504|FG012|Phase 2|Death|1|||
155326283|NCT02719574|560631505|FG013|Phase 2|Death|1|||
155326284|NCT02719574|560631506|FG014|Phase 2|Death|2|||
155326285|NCT02719574|560631507|FG015|Phase 2|Death|0|||
155326286|NCT02719574|560631508|FG016|Phase 2|Death|0|||
155326287|NCT02719574|560631492|FG000|Phase 2|Investigator Decision|0|||
155326288|NCT02719574|560631493|FG001|Phase 2|Investigator Decision|0|||
155326289|NCT02719574|560631494|FG002|Phase 2|Investigator Decision|0|||
155326290|NCT02719574|560631495|FG003|Phase 2|Investigator Decision|0|||
155326291|NCT02719574|560631496|FG004|Phase 2|Investigator Decision|0|||
155326292|NCT02719574|560631497|FG005|Phase 2|Investigator Decision|0|||
155326293|NCT02719574|560631498|FG006|Phase 2|Investigator Decision|0|||
155326294|NCT02719574|560631499|FG007|Phase 2|Investigator Decision|0|||
155326295|NCT02719574|560631500|FG008|Phase 2|Investigator Decision|0|||
155326296|NCT02719574|560631501|FG009|Phase 2|Investigator Decision|6|||
155326297|NCT02719574|560631502|FG010|Phase 2|Investigator Decision|1|||
155326298|NCT02719574|560631503|FG011|Phase 2|Investigator Decision|2|||
155326299|NCT02719574|560631504|FG012|Phase 2|Investigator Decision|3|||
155326300|NCT02719574|560631505|FG013|Phase 2|Investigator Decision|1|||
155421589|NCT00110019|560974296|FG001|Overall Study|Adverse Event|40|||
155421590|NCT00110019|560974295|FG000|Overall Study|Death|13|||
155421591|NCT00110019|560974296|FG001|Overall Study|Death|15|||
155421592|NCT00110019|560974295|FG000|Overall Study|Withdrawal by Subject|21|||
155421593|NCT00110019|560974296|FG001|Overall Study|Withdrawal by Subject|9|||
155421594|NCT00110019|560974295|FG000|Overall Study|alternative therapy|5|||
155421595|NCT00110019|560974296|FG001|Overall Study|alternative therapy|1|||
155421596|NCT00110019|560974295|FG000|Overall Study|complicating disease|1|||
155326301|NCT02719574|560631506|FG014|Phase 2|Investigator Decision|3|||
155326302|NCT02719574|560631507|FG015|Phase 2|Investigator Decision|2|||
155326303|NCT02719574|560631508|FG016|Phase 2|Investigator Decision|0|||
155326304|NCT02719574|560631492|FG000|Phase 2|Withdrawal by Subject|0|||
155326305|NCT02719574|560631493|FG001|Phase 2|Withdrawal by Subject|0|||
155326306|NCT02719574|560631494|FG002|Phase 2|Withdrawal by Subject|0|||
155326307|NCT02719574|560631495|FG003|Phase 2|Withdrawal by Subject|0|||
155326308|NCT02719574|560631496|FG004|Phase 2|Withdrawal by Subject|0|||
155326309|NCT02719574|560631497|FG005|Phase 2|Withdrawal by Subject|0|||
155326310|NCT02719574|560631498|FG006|Phase 2|Withdrawal by Subject|0|||
155326311|NCT02719574|560631499|FG007|Phase 2|Withdrawal by Subject|0|||
155326312|NCT02719574|560631500|FG008|Phase 2|Withdrawal by Subject|0|||
155326313|NCT02719574|560631501|FG009|Phase 2|Withdrawal by Subject|5|||
155326314|NCT02719574|560631502|FG010|Phase 2|Withdrawal by Subject|0|||
155326315|NCT02719574|560631503|FG011|Phase 2|Withdrawal by Subject|0|||
155326316|NCT02719574|560631504|FG012|Phase 2|Withdrawal by Subject|0|||
155326317|NCT02719574|560631505|FG013|Phase 2|Withdrawal by Subject|1|||
155421597|NCT00110019|560974296|FG001|Overall Study|complicating disease|1|||
155421598|NCT00110019|560974295|FG000|Overall Study|symptom deterioration|13|||
155421599|NCT00110019|560974296|FG001|Overall Study|symptom deterioration|16|||
155326318|NCT02719574|560631506|FG014|Phase 2|Withdrawal by Subject|1|||
155326319|NCT02719574|560631507|FG015|Phase 2|Withdrawal by Subject|2|||
155326320|NCT02719574|560631508|FG016|Phase 2|Withdrawal by Subject|0|||
155326321|NCT02719574|560631492|FG000|Phase 2|Protocol Violation|0|||
155326322|NCT02719574|560631493|FG001|Phase 2|Protocol Violation|0|||
155326323|NCT02719574|560631494|FG002|Phase 2|Protocol Violation|0|||
155326324|NCT02719574|560631495|FG003|Phase 2|Protocol Violation|0|||
155326325|NCT02719574|560631496|FG004|Phase 2|Protocol Violation|0|||
155326326|NCT02719574|560631497|FG005|Phase 2|Protocol Violation|0|||
155326327|NCT02719574|560631498|FG006|Phase 2|Protocol Violation|0|||
155326328|NCT02719574|560631499|FG007|Phase 2|Protocol Violation|0|||
155326329|NCT02719574|560631500|FG008|Phase 2|Protocol Violation|0|||
155326330|NCT02719574|560631501|FG009|Phase 2|Protocol Violation|1|||
155326331|NCT02719574|560631502|FG010|Phase 2|Protocol Violation|0|||
155326332|NCT02719574|560631503|FG011|Phase 2|Protocol Violation|0|||
155326333|NCT02719574|560631504|FG012|Phase 2|Protocol Violation|0|||
155326334|NCT02719574|560631505|FG013|Phase 2|Protocol Violation|0|||
155326335|NCT02719574|560631506|FG014|Phase 2|Protocol Violation|0|||
155326336|NCT02719574|560631507|FG015|Phase 2|Protocol Violation|0|||
155326337|NCT02719574|560631508|FG016|Phase 2|Protocol Violation|0|||
155326338|NCT00113360|560631510|FG000|Overall Study|Adverse Event|3|||
155326339|NCT00113360|560631510|FG000|Overall Study|Subject required surgery|1|||
155326340|NCT00113360|560631510|FG000|Overall Study|Did not meet eligibility criteria|3|||
155326341|NCT01976936|560631523|FG000|Overall Study|Did not receive at least 9 doses|9|||
155326342|NCT01976936|560631524|FG001|Overall Study|Did not receive at least 9 doses|4|||
155326343|NCT02231749|560631528|FG000|Overall Study|Disease progression|229|||
155326344|NCT02231749|560631529|FG001|Overall Study|Disease progression|297|||
155326345|NCT02231749|560631528|FG000|Overall Study|Study Drug Toxicity|134|||
155326346|NCT02231749|560631529|FG001|Overall Study|Study Drug Toxicity|63|||
155326347|NCT02231749|560631528|FG000|Overall Study|Death|1|||
155326348|NCT02231749|560631529|FG001|Overall Study|Death|1|||
155326349|NCT02231749|560631528|FG000|Overall Study|AE unrelated to Study drug|32|||
155326350|NCT02231749|560631529|FG001|Overall Study|AE unrelated to Study drug|31|||
155326351|NCT02231749|560631528|FG000|Overall Study|Participant's request to discontinue|10|||
155326352|NCT02231749|560631529|FG001|Overall Study|Participant's request to discontinue|21|||
155326353|NCT02231749|560631528|FG000|Overall Study|Participant withdrew Consent|8|||
155326354|NCT02231749|560631529|FG001|Overall Study|Participant withdrew Consent|15|||
155326355|NCT02231749|560631528|FG000|Overall Study|Lost to Follow-up|1|||
155326356|NCT02231749|560631529|FG001|Overall Study|Lost to Follow-up|2|||
155326357|NCT02231749|560631528|FG000|Overall Study|Maximum Clinical Benefit|5|||
155326358|NCT02231749|560631529|FG001|Overall Study|Maximum Clinical Benefit|8|||
155326359|NCT02231749|560631528|FG000|Overall Study|Poor/Non-Compliance|0|||
155421600|NCT00110019|560974295|FG000|Overall Study|Not start protocol therapy|17|||
155421601|NCT00110019|560974296|FG001|Overall Study|Not start protocol therapy|16|||
155421602|NCT00110019|560974295|FG000|Overall Study|other reasons|22|||
155421603|NCT00110019|560974296|FG001|Overall Study|other reasons|30|||
155421604|NCT02239263|560974297|FG000|Overall Study|Protocol Violation|6|||
155421605|NCT01046695|560974298|FG000|Overall Study|Subject had a pacemaker|0|||
155421606|NCT01046695|560974299|FG001|Overall Study|Subject had a pacemaker|1|||
155421607|NCT01046695|560974298|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
155421608|NCT01046695|560974299|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
155421609|NCT00559273|560974303|FG000|Correction Period (20 Weeks)|Death|3|||
155421610|NCT00559273|560974304|FG001|Correction Period (20 Weeks)|Death|4|||
155421611|NCT00559273|560974303|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
155421612|NCT00559273|560974304|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
155421613|NCT00559273|560974303|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
155421614|NCT00559273|560974304|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
155421615|NCT00559273|560974303|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
155421616|NCT00559273|560974304|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
155421617|NCT00559273|560974303|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
155421618|NCT00559273|560974304|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
155421619|NCT00559273|560974303|FG000|Evaluation Period (8 Weeks)|Death|1|||
155421620|NCT00559273|560974304|FG001|Evaluation Period (8 Weeks)|Death|3|||
155421621|NCT00559273|560974303|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
155421622|NCT00559273|560974304|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
155326360|NCT02231749|560631529|FG001|Overall Study|Poor/Non-Compliance|3|||
155326361|NCT02231749|560631528|FG000|Overall Study|Pregnancy|1|||
155326362|NCT02231749|560631529|FG001|Overall Study|Pregnancy|0|||
155326363|NCT02231749|560631528|FG000|Overall Study|other|0|||
155326364|NCT02231749|560631529|FG001|Overall Study|other|8|||
155326365|NCT02231749|560631528|FG000|Overall Study|No longer meets Study Criteria|1|||
155421623|NCT00559273|560974303|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
155502408|NCT00417027|561265476|FG000|Overall Study|Protocol Violation|0|||
155502409|NCT00417027|561265477|FG001|Overall Study|Protocol Violation|5|||
155502410|NCT00417027|561265478|FG002|Overall Study|Protocol Violation|5|||
155502411|NCT01017029|561265479|FG000|Overall Study|Lost to Follow-up|1|||
155502412|NCT01017029|561265480|FG001|Overall Study|Lost to Follow-up|0|||
155502413|NCT01017029|561265479|FG000|Overall Study|Administrative problem|0|||
155502414|NCT01017029|561265480|FG001|Overall Study|Administrative problem|1|||
155502415|NCT01017029|561265479|FG000|Overall Study|Death|3|||
155502416|NCT01017029|561265480|FG001|Overall Study|Death|1|||
155502417|NCT02216214|561265481|FG000|Overall Study|Randomized Never Received Study Drug|1|||
155502418|NCT02216214|561265482|FG001|Overall Study|Randomized Never Received Study Drug|0|||
155502419|NCT02216214|561265481|FG000|Overall Study|Adverse Event|10|||
155502420|NCT02216214|561265482|FG001|Overall Study|Adverse Event|8|||
155502421|NCT02216214|561265481|FG000|Overall Study|Lack of Efficacy|2|||
155502422|NCT02216214|561265482|FG001|Overall Study|Lack of Efficacy|2|||
155502423|NCT02216214|561265481|FG000|Overall Study|Lost to Follow-up|3|||
155502424|NCT02216214|561265482|FG001|Overall Study|Lost to Follow-up|2|||
155502425|NCT02216214|561265481|FG000|Overall Study|Protocol Violation|4|||
155502426|NCT02216214|561265482|FG001|Overall Study|Protocol Violation|2|||
155502427|NCT02216214|561265481|FG000|Overall Study|Withdrawal by Subject|22|||
155421624|NCT00559273|560974304|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
155421625|NCT00559273|560974303|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
155421626|NCT00559273|560974304|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
155421627|NCT01256177|560974305|FG000|Overall Study|Withdrawal by Subject|23|||
155421628|NCT01256177|560974306|FG001|Overall Study|Withdrawal by Subject|22|||
155421629|NCT01256177|560974305|FG000|Overall Study|Lost to Follow-up|2|||
155421630|NCT01256177|560974306|FG001|Overall Study|Lost to Follow-up|2|||
155421631|NCT01256177|560974305|FG000|Overall Study|Adverse Event|8|||
155421632|NCT01256177|560974306|FG001|Overall Study|Adverse Event|9|||
155421633|NCT01256177|560974305|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
155421634|NCT01256177|560974306|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155421635|NCT01256177|560974305|FG000|Overall Study|Condition under Investigation Worsened|1|||
155421636|NCT01256177|560974306|FG001|Overall Study|Condition under Investigation Worsened|0|||
155421637|NCT01256177|560974305|FG000|Overall Study|Lack of Efficacy|11|||
155421638|NCT01256177|560974306|FG001|Overall Study|Lack of Efficacy|2|||
155421639|NCT01256177|560974305|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
155421640|NCT01256177|560974306|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
155421641|NCT01728779|560974310|FG000|Overall Study|Withdrawal by Subject|1|||
155421642|NCT00448708|560974311|FG000|Overall Study|Death|21|||
155421643|NCT00448708|560974312|FG001|Overall Study|Death|17|||
155421644|NCT00448708|560974311|FG000|Overall Study|Withdrawal by Subject|8|||
155421645|NCT00448708|560974312|FG001|Overall Study|Withdrawal by Subject|4|||
155421646|NCT00448708|560974311|FG000|Overall Study|Lost to Follow-up|6|||
155421647|NCT00448708|560974312|FG001|Overall Study|Lost to Follow-up|8|||
155421648|NCT00448708|560974311|FG000|Overall Study|not listed|0|||
155421649|NCT00448708|560974312|FG001|Overall Study|not listed|2|||
155421650|NCT01925209|560974313|FG000|Treatment Epoch|Physician Decision|1|||
155421651|NCT01925209|560974314|FG001|Treatment Epoch|Physician Decision|0|||
155421652|NCT01925209|560974315|FG002|Treatment Epoch|Physician Decision|0|||
155421653|NCT01925209|560974316|FG003|Treatment Epoch|Physician Decision|0|||
155421654|NCT01925209|560974313|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
155421655|NCT01925209|560974314|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
155421656|NCT01925209|560974315|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
155421657|NCT01925209|560974316|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
155502428|NCT02216214|561265482|FG001|Overall Study|Withdrawal by Subject|20|||
155502429|NCT02216214|561265481|FG000|Overall Study|Study Terminated By Sponsor|0|||
155502430|NCT02216214|561265482|FG001|Overall Study|Study Terminated By Sponsor|1|||
155421658|NCT01925209|560974313|FG000|Treatment Epoch|Death|1|||
155421659|NCT01925209|560974314|FG001|Treatment Epoch|Death|0|||
155421660|NCT01925209|560974315|FG002|Treatment Epoch|Death|0|||
155421661|NCT01925209|560974316|FG003|Treatment Epoch|Death|0|||
155421662|NCT01925209|560974313|FG000|Treatment Epoch|Protocol deviation|0|||
155502431|NCT02216214|561265481|FG000|Overall Study|Miscellaneous|1|||
155502432|NCT02216214|561265482|FG001|Overall Study|Miscellaneous|1|||
155502433|NCT05354206|561265483|FG000|Overall Study|Withdrawal by Subject|1|||
155502434|NCT05354206|561265484|FG001|Overall Study|Withdrawal by Subject|0|||
155502435|NCT00713830|561265485|FG000|Overall Study|Adverse Event|23|||
155502436|NCT00713830|561265486|FG001|Overall Study|Adverse Event|71|||
155502437|NCT00713830|561265485|FG000|Overall Study|Lack of Efficacy|24|||
155502438|NCT00713830|561265486|FG001|Overall Study|Lack of Efficacy|16|||
155502439|NCT00713830|561265485|FG000|Overall Study|Lost to Follow-up|2|||
155502440|NCT00713830|561265486|FG001|Overall Study|Lost to Follow-up|9|||
155502441|NCT00713830|561265485|FG000|Overall Study|Withdrawal by Subject|13|||
155502442|NCT00713830|561265486|FG001|Overall Study|Withdrawal by Subject|23|||
155502443|NCT00713830|561265485|FG000|Overall Study|Poor Compliance to Protocol|7|||
155502444|NCT00713830|561265486|FG001|Overall Study|Poor Compliance to Protocol|14|||
155502445|NCT00713830|561265485|FG000|Overall Study|Familial and Personal Reasons|9|||
155502446|NCT00713830|561265486|FG001|Overall Study|Familial and Personal Reasons|34|||
155502447|NCT00713830|561265485|FG000|Overall Study|Sponsor Decision|4|||
155502448|NCT00713830|561265486|FG001|Overall Study|Sponsor Decision|10|||
155502449|NCT00422058|561265487|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
155502450|NCT00422058|561265488|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
155502451|NCT00422058|561265489|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
155502452|NCT00422058|561265490|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
155502453|NCT00422058|561265491|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
155502454|NCT00422058|561265492|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
155502455|NCT00422058|561265487|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
155502456|NCT00422058|561265488|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
155502457|NCT00422058|561265489|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
155502458|NCT00422058|561265490|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
155502459|NCT00422058|561265491|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
155502460|NCT00422058|561265492|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
155502461|NCT00422058|561265487|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
155502462|NCT00422058|561265488|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
155502463|NCT00422058|561265489|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
155502464|NCT00422058|561265490|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
155502465|NCT00422058|561265491|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
155502466|NCT00422058|561265492|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
155502467|NCT00422058|561265487|FG000|Double-Blind, Week 0-20|Other|11|||
155502468|NCT00422058|561265488|FG001|Double-Blind, Week 0-20|Other|3|||
155502469|NCT00422058|561265489|FG002|Double-Blind, Week 0-20|Other|8|||
155502470|NCT00422058|561265490|FG003|Double-Blind, Week 0-20|Other|8|||
155502471|NCT00422058|561265491|FG004|Double-Blind, Week 0-20|Other|4|||
155502472|NCT00422058|561265492|FG005|Double-Blind, Week 0-20|Other|10|||
155502473|NCT00422058|561265487|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
155502474|NCT00422058|561265488|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
155502475|NCT00422058|561265489|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
155502476|NCT00422058|561265490|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
155502477|NCT00422058|561265491|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
155502478|NCT00422058|561265492|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
155502479|NCT00422058|561265487|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
155502480|NCT00422058|561265488|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
155502481|NCT00422058|561265489|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
155502482|NCT00422058|561265490|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
155502483|NCT00422058|561265491|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
155502484|NCT00422058|561265492|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
155502485|NCT00422058|561265487|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
155502486|NCT00422058|561265488|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
155502487|NCT00422058|561265489|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
155502488|NCT00422058|561265490|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
155502489|NCT00422058|561265491|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
155502490|NCT00422058|561265492|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
155502491|NCT00422058|561265487|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
155502492|NCT00422058|561265488|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
155644794|NCT02029443|561789897|FG004|Overall Study|Withdrawal by Subject|0|||
155502493|NCT00422058|561265489|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
155644795|NCT02029443|561789893|FG000|Overall Study|Other|6|||
155644796|NCT02029443|561789894|FG001|Overall Study|Other|6|||
155644797|NCT02029443|561789895|FG002|Overall Study|Other|4|||
155644798|NCT02029443|561789896|FG003|Overall Study|Other|2|||
155644799|NCT02029443|561789897|FG004|Overall Study|Other|0|||
155644800|NCT02070991|561789899|FG000|Overall Study|Death|2|||
155644801|NCT02070991|561789900|FG001|Overall Study|Death|0|||
155644802|NCT02070991|561789899|FG000|Overall Study|Withdrawal by Subject|1|||
155644803|NCT02070991|561789900|FG001|Overall Study|Withdrawal by Subject|0|||
155326366|NCT02231749|560631529|FG001|Overall Study|No longer meets Study Criteria|0|||
155326367|NCT02989662|560631536|FG000|Overall Study|Lost to Follow-up|0|||
155326368|NCT02989662|560631537|FG001|Overall Study|Lost to Follow-up|0|||
155326369|NCT02989662|560631538|FG002|Overall Study|Lost to Follow-up|0|||
155326370|NCT02989662|560631539|FG003|Overall Study|Lost to Follow-up|2|||
155326371|NCT02989662|560631536|FG000|Overall Study|Physician Decision|3|||
155502494|NCT00422058|561265490|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
155502495|NCT00422058|561265491|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
155502496|NCT00422058|561265492|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
155502497|NCT00422058|561265487|FG000|Open-Label Extension, Week 20-104|Other|13|||
155502498|NCT00422058|561265488|FG001|Open-Label Extension, Week 20-104|Other|14|||
155502499|NCT00422058|561265489|FG002|Open-Label Extension, Week 20-104|Other|6|||
155502500|NCT00422058|561265490|FG003|Open-Label Extension, Week 20-104|Other|13|||
155644804|NCT03670628|561789903|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
155326372|NCT02989662|560631537|FG001|Overall Study|Physician Decision|0|||
155326373|NCT02989662|560631538|FG002|Overall Study|Physician Decision|0|||
155326374|NCT02989662|560631539|FG003|Overall Study|Physician Decision|0|||
155326375|NCT02989662|560631536|FG000|Overall Study|Withdrawal by Subject|1|||
155326376|NCT02989662|560631537|FG001|Overall Study|Withdrawal by Subject|0|||
155326377|NCT02989662|560631538|FG002|Overall Study|Withdrawal by Subject|0|||
155326378|NCT02989662|560631539|FG003|Overall Study|Withdrawal by Subject|0|||
155326379|NCT00328783|560631540|FG000|Overall Study|Could not tolerate ABC|21|||
155326380|NCT00328783|560631540|FG000|Overall Study|No heart in RT field|4|||
155326381|NCT00328783|560631540|FG000|Overall Study|Withdrawal by Subject|1|||
155326382|NCT00357682|560631541|FG000|Overall Study|Did not receive allocated Treatment|10|||
155326383|NCT00357682|560631542|FG001|Overall Study|Did not receive allocated Treatment|9|||
155326384|NCT00357682|560631543|FG002|Overall Study|Did not receive allocated Treatment|9|||
155326385|NCT00357682|560631544|FG003|Overall Study|Did not receive allocated Treatment|10|||
155326386|NCT00357682|560631541|FG000|Overall Study|Withdrew consent|6|||
155326387|NCT00357682|560631542|FG001|Overall Study|Withdrew consent|6|||
155326388|NCT00357682|560631543|FG002|Overall Study|Withdrew consent|5|||
155326389|NCT00357682|560631544|FG003|Overall Study|Withdrew consent|5|||
155326390|NCT00357682|560631541|FG000|Overall Study|Lost to Follow-up|39|||
155326391|NCT00357682|560631542|FG001|Overall Study|Lost to Follow-up|33|||
155326392|NCT00357682|560631543|FG002|Overall Study|Lost to Follow-up|26|||
155421663|NCT01925209|560974314|FG001|Treatment Epoch|Protocol deviation|0|||
155421664|NCT01925209|560974315|FG002|Treatment Epoch|Protocol deviation|1|||
155421665|NCT01925209|560974316|FG003|Treatment Epoch|Protocol deviation|1|||
155421666|NCT01925209|560974313|FG000|Treatment Epoch|Withdrawal by Subject|4|||
155421667|NCT01925209|560974314|FG001|Treatment Epoch|Withdrawal by Subject|3|||
155421668|NCT01925209|560974315|FG002|Treatment Epoch|Withdrawal by Subject|3|||
155421669|NCT01925209|560974316|FG003|Treatment Epoch|Withdrawal by Subject|2|||
155421670|NCT01925209|560974313|FG000|Treatment Epoch|Adverse Event|3|||
155421671|NCT01925209|560974314|FG001|Treatment Epoch|Adverse Event|5|||
155421672|NCT01925209|560974315|FG002|Treatment Epoch|Adverse Event|3|||
155421673|NCT01925209|560974316|FG003|Treatment Epoch|Adverse Event|1|||
155421674|NCT01925209|560974313|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
155421675|NCT01925209|560974314|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
155421676|NCT01925209|560974315|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
155421677|NCT01925209|560974316|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
155421678|NCT01925209|560974313|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
155421679|NCT01925209|560974314|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
155421680|NCT01925209|560974315|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
155421681|NCT01925209|560974316|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
155421682|NCT01925209|560974313|FG000|Follow-up|Adverse Event|1|||
155421683|NCT01925209|560974314|FG001|Follow-up|Adverse Event|4|||
155421684|NCT01925209|560974315|FG002|Follow-up|Adverse Event|0|||
155421685|NCT01925209|560974316|FG003|Follow-up|Adverse Event|1|||
155421686|NCT01925209|560974313|FG000|Follow-up|Physician Decision|0|||
155421687|NCT01925209|560974314|FG001|Follow-up|Physician Decision|0|||
155421688|NCT01925209|560974315|FG002|Follow-up|Physician Decision|1|||
155421689|NCT01925209|560974316|FG003|Follow-up|Physician Decision|0|||
155326393|NCT00357682|560631544|FG003|Overall Study|Lost to Follow-up|35|||
155326394|NCT00357682|560631541|FG000|Overall Study|Adverse Event|24|||
155326395|NCT00357682|560631542|FG001|Overall Study|Adverse Event|32|||
155326396|NCT00357682|560631543|FG002|Overall Study|Adverse Event|22|||
155326397|NCT00357682|560631544|FG003|Overall Study|Adverse Event|27|||
155326398|NCT00357682|560631541|FG000|Overall Study|Physician Decision|32|||
155326399|NCT00357682|560631542|FG001|Overall Study|Physician Decision|20|||
155326400|NCT00357682|560631543|FG002|Overall Study|Physician Decision|24|||
155421690|NCT01925209|560974313|FG000|Follow-up|Non-compliance with study treatment|0|||
155421691|NCT01925209|560974314|FG001|Follow-up|Non-compliance with study treatment|0|||
155326401|NCT00357682|560631544|FG003|Overall Study|Physician Decision|30|||
155326402|NCT00357682|560631541|FG000|Overall Study|Patient decision|73|||
155421692|NCT01925209|560974315|FG002|Follow-up|Non-compliance with study treatment|0|||
155502501|NCT00422058|561265491|FG004|Open-Label Extension, Week 20-104|Other|16|||
155326403|NCT00357682|560631542|FG001|Overall Study|Patient decision|80|||
155326404|NCT00357682|560631543|FG002|Overall Study|Patient decision|51|||
155326405|NCT00357682|560631544|FG003|Overall Study|Patient decision|59|||
155326406|NCT00357682|560631541|FG000|Overall Study|Other reason|157|||
155326407|NCT00357682|560631542|FG001|Overall Study|Other reason|130|||
155326408|NCT00357682|560631543|FG002|Overall Study|Other reason|114|||
155326409|NCT00357682|560631544|FG003|Overall Study|Other reason|99|||
155326410|NCT05424718|560631551|FG000|Overall Study|Lost to Follow-up|5|||
155326411|NCT05424718|560631552|FG001|Overall Study|Lost to Follow-up|4|||
155326412|NCT04046549|560631553|FG000|Overall Study|Adverse Event|1|||
155326413|NCT04046549|560631553|FG000|Overall Study|Physician Decision|1|||
155326414|NCT04046549|560631553|FG000|Overall Study|Withdrawal by Subject|3|||
155326415|NCT04046549|560631553|FG000|Overall Study|Other, Not Specified|5|||
155326416|NCT06059443|560631554|FG000|Overall Study|Withdrawal by Subject|2|||
155326417|NCT06059443|560631555|FG001|Overall Study|Withdrawal by Subject|0|||
155326418|NCT06059443|560631554|FG000|Overall Study|Lost to Follow-up|2|||
155326419|NCT06059443|560631555|FG001|Overall Study|Lost to Follow-up|2|||
155326420|NCT04479787|560631560|FG000|Through 6 Months|Withdrawal by Subject|16|||
155326421|NCT04479787|560631561|FG001|Through 6 Months|Withdrawal by Subject|14|||
155326422|NCT04479787|560631560|FG000|Through 6 Months|Unsuccessful Trial|17|||
155326423|NCT04479787|560631561|FG001|Through 6 Months|Unsuccessful Trial|0|||
155326424|NCT04479787|560631560|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
155326425|NCT04479787|560631561|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
155326426|NCT04479787|560631560|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
155326427|NCT04479787|560631561|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
155326428|NCT04479787|560631560|FG000|Through 6 Months|Lost to Follow-up|3|||
155326429|NCT04479787|560631561|FG001|Through 6 Months|Lost to Follow-up|2|||
155326430|NCT04479787|560631560|FG000|Through 6 Months|Death|3|||
155326431|NCT04479787|560631561|FG001|Through 6 Months|Death|0|||
155326432|NCT04479787|560631560|FG000|Through 6 Months|Inclusion/Exclusion|2|||
155326433|NCT04479787|560631561|FG001|Through 6 Months|Inclusion/Exclusion|1|||
155326434|NCT04479787|560631560|FG000|Through 6 Months|Subject Became Pregnant|1|||
155326435|NCT04479787|560631561|FG001|Through 6 Months|Subject Became Pregnant|1|||
155326436|NCT04479787|560631560|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
155326437|NCT04479787|560631561|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
155326438|NCT04479787|560631560|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
155326439|NCT04479787|560631561|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
155326440|NCT04479787|560631560|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
155326441|NCT04479787|560631561|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
155326442|NCT04479787|560631560|FG000|After 6 Months|Withdrawal by Subject|3|||
155326443|NCT04479787|560631561|FG001|After 6 Months|Withdrawal by Subject|13|||
155326444|NCT04479787|560631560|FG000|After 6 Months|Unsuccessful Trial|0|||
155326445|NCT04479787|560631561|FG001|After 6 Months|Unsuccessful Trial|7|||
155326446|NCT04479787|560631560|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
155326447|NCT04479787|560631561|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
155326448|NCT04479787|560631560|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
155326449|NCT04479787|560631561|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
155326450|NCT04479787|560631560|FG000|After 6 Months|Death|2|||
155326451|NCT04479787|560631561|FG001|After 6 Months|Death|0|||
155326452|NCT04479787|560631560|FG000|After 6 Months|Lost to Follow-up|1|||
155326453|NCT04479787|560631561|FG001|After 6 Months|Lost to Follow-up|1|||
155326454|NCT04479787|560631560|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
155326455|NCT04479787|560631561|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
155326456|NCT04479787|560631560|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
155326457|NCT04479787|560631561|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
155326458|NCT04479787|560631560|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
155326459|NCT04479787|560631561|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
155326460|NCT04479787|560631560|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
155326461|NCT04479787|560631561|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
155326462|NCT03983382|560632216|FG000|Overall Study|Death|1|||
155326463|NCT03983382|560632216|FG000|Overall Study|Lost to Follow-up|3|||
155326464|NCT03983382|560632216|FG000|Overall Study|Physician Decision|2|||
155326465|NCT03983382|560632216|FG000|Overall Study|Withdrawal by Subject|10|||
155326466|NCT03983382|560632216|FG000|Overall Study|Change in cancer treatment|2|||
155326467|NCT02166463|560632223|FG000|Overall Study|Lost to Follow-up|0|||
155326468|NCT02166463|560632224|FG001|Overall Study|Lost to Follow-up|1|||
155326469|NCT02166463|560632223|FG000|Overall Study|Physician Decision|10|||
155326470|NCT02166463|560632224|FG001|Overall Study|Physician Decision|10|||
155326471|NCT02166463|560632223|FG000|Overall Study|Ineligible|11|||
155326472|NCT02166463|560632224|FG001|Overall Study|Ineligible|2|||
155326473|NCT02166463|560632223|FG000|Overall Study|Progressive Disease|9|||
155326474|NCT02166463|560632224|FG001|Overall Study|Progressive Disease|6|||
155326475|NCT02166463|560632223|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
155326476|NCT02166463|560632224|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
155326477|NCT02166463|560632223|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
155326478|NCT02166463|560632224|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
155326479|NCT02166463|560632223|FG000|Overall Study|Refusal of further protocol therapy|5|||
155326480|NCT02166463|560632224|FG001|Overall Study|Refusal of further protocol therapy|6|||
155326481|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
155326482|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
155326483|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
155326484|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
155326485|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
155326486|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
155326487|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
155326488|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
155326489|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
155326490|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
155326491|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
155326492|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
155326493|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
155326494|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
155326495|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
155326496|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
155326497|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
155326498|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
155326499|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
155326500|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
155326501|NCT03767335|560632227|FG000|Overall Study|Physician Decision|1|||
155326502|NCT03767335|560632228|FG001|Overall Study|Physician Decision|1|||
155326503|NCT03767335|560632229|FG002|Overall Study|Physician Decision|0|||
155326504|NCT03767335|560632227|FG000|Overall Study|Withdrawal by Subject|0|||
155326505|NCT03767335|560632228|FG001|Overall Study|Withdrawal by Subject|0|||
155326506|NCT03767335|560632229|FG002|Overall Study|Withdrawal by Subject|6|||
155326507|NCT03767335|560632227|FG000|Overall Study|Participant excluded from efficacy population|0|||
155326508|NCT03767335|560632228|FG001|Overall Study|Participant excluded from efficacy population|0|||
155326509|NCT03767335|560632229|FG002|Overall Study|Participant excluded from efficacy population|1|||
155326510|NCT03767335|560632227|FG000|Overall Study|Death|0|||
155326511|NCT03767335|560632228|FG001|Overall Study|Death|0|||
155326512|NCT03767335|560632229|FG002|Overall Study|Death|2|||
155326513|NCT03767335|560632227|FG000|Overall Study|Progressive Disease|2|||
155326514|NCT03767335|560632228|FG001|Overall Study|Progressive Disease|2|||
155326515|NCT03767335|560632229|FG002|Overall Study|Progressive Disease|2|||
155326516|NCT03767335|560632227|FG000|Overall Study|Disease progression needing additional medication|0|||
155326517|NCT03767335|560632228|FG001|Overall Study|Disease progression needing additional medication|0|||
155326518|NCT03767335|560632229|FG002|Overall Study|Disease progression needing additional medication|17|||
155326519|NCT03767335|560632227|FG000|Overall Study|Sponsor decision|0|||
155326520|NCT03767335|560632228|FG001|Overall Study|Sponsor decision|0|||
155326521|NCT03767335|560632229|FG002|Overall Study|Sponsor decision|2|||
155326522|NCT03767335|560632227|FG000|Overall Study|Other Medical Reasons|0|||
155326523|NCT03767335|560632228|FG001|Overall Study|Other Medical Reasons|0|||
155326524|NCT03767335|560632229|FG002|Overall Study|Other Medical Reasons|3|||
155326525|NCT03660930|560632230|FG000|Overall Study|Adverse Event|0|||
155326526|NCT03660930|560632231|FG001|Overall Study|Adverse Event|0|||
155326527|NCT03660930|560632232|FG002|Overall Study|Adverse Event|0|||
155326528|NCT03660930|560632233|FG003|Overall Study|Adverse Event|2|||
155326529|NCT03660930|560632234|FG004|Overall Study|Adverse Event|0|||
155326530|NCT03660930|560632235|FG005|Overall Study|Adverse Event|1|||
155326531|NCT03660930|560632236|FG006|Overall Study|Adverse Event|0|||
155326532|NCT03660930|560632237|FG007|Overall Study|Adverse Event|0|||
155326533|NCT03660930|560632230|FG000|Overall Study|Withdrawal by Subject|0|||
155326534|NCT03660930|560632231|FG001|Overall Study|Withdrawal by Subject|0|||
155326535|NCT03660930|560632232|FG002|Overall Study|Withdrawal by Subject|0|||
155326536|NCT03660930|560632233|FG003|Overall Study|Withdrawal by Subject|0|||
155326537|NCT03660930|560632234|FG004|Overall Study|Withdrawal by Subject|0|||
155326538|NCT03660930|560632235|FG005|Overall Study|Withdrawal by Subject|1|||
155326539|NCT03660930|560632236|FG006|Overall Study|Withdrawal by Subject|0|||
155326540|NCT03660930|560632237|FG007|Overall Study|Withdrawal by Subject|0|||
155326541|NCT02726386|560632242|FG000|Overall Study|Adverse Event|17|||
155326542|NCT02726386|560632243|FG001|Overall Study|Adverse Event|20|||
155326543|NCT02726386|560632242|FG000|Overall Study|Withdrawal by Subject|14|||
155326544|NCT02726386|560632243|FG001|Overall Study|Withdrawal by Subject|28|||
155326545|NCT02726386|560632242|FG000|Overall Study|Other reasons|7|||
155326546|NCT02726386|560632243|FG001|Overall Study|Other reasons|8|||
155326547|NCT02112916|560632248|FG000|Overall Study|Adverse Event|6|||
155326548|NCT02112916|560632249|FG001|Overall Study|Adverse Event|9|||
155326549|NCT02112916|560632250|FG002|Overall Study|Adverse Event|3|||
155326550|NCT02112916|560632251|FG003|Overall Study|Adverse Event|2|||
155326551|NCT02112916|560632248|FG000|Overall Study|Death|9|||
155326552|NCT02112916|560632249|FG001|Overall Study|Death|9|||
155326553|NCT02112916|560632250|FG002|Overall Study|Death|3|||
155326554|NCT02112916|560632251|FG003|Overall Study|Death|4|||
155326555|NCT02112916|560632248|FG000|Overall Study|Lost to Follow-up|1|||
155326556|NCT02112916|560632249|FG001|Overall Study|Lost to Follow-up|0|||
155326557|NCT02112916|560632250|FG002|Overall Study|Lost to Follow-up|0|||
155326558|NCT02112916|560632251|FG003|Overall Study|Lost to Follow-up|0|||
155326559|NCT02112916|560632248|FG000|Overall Study|Physician Decision|94|||
155326560|NCT02112916|560632249|FG001|Overall Study|Physician Decision|72|||
155326561|NCT02112916|560632250|FG002|Overall Study|Physician Decision|24|||
155326562|NCT02112916|560632251|FG003|Overall Study|Physician Decision|15|||
155326563|NCT02112916|560632248|FG000|Overall Study|Withdrawal by Subject|5|||
155326564|NCT02112916|560632249|FG001|Overall Study|Withdrawal by Subject|3|||
155326565|NCT02112916|560632250|FG002|Overall Study|Withdrawal by Subject|1|||
155326566|NCT02112916|560632251|FG003|Overall Study|Withdrawal by Subject|1|||
155326567|NCT02112916|560632248|FG000|Overall Study|Ineligible|4|||
155326568|NCT02112916|560632249|FG001|Overall Study|Ineligible|8|||
155326569|NCT02112916|560632250|FG002|Overall Study|Ineligible|3|||
155326570|NCT02112916|560632251|FG003|Overall Study|Ineligible|8|||
155326571|NCT02112916|560632248|FG000|Overall Study|Inevaluable|6|||
155326572|NCT02112916|560632249|FG001|Overall Study|Inevaluable|4|||
155326573|NCT02112916|560632250|FG002|Overall Study|Inevaluable|5|||
155326574|NCT02112916|560632251|FG003|Overall Study|Inevaluable|5|||
155326575|NCT02112916|560632248|FG000|Overall Study|Refusal of further protocol therapy|19|||
155326576|NCT02112916|560632249|FG001|Overall Study|Refusal of further protocol therapy|16|||
155326577|NCT02112916|560632250|FG002|Overall Study|Refusal of further protocol therapy|1|||
155326578|NCT02112916|560632251|FG003|Overall Study|Refusal of further protocol therapy|7|||
155326579|NCT02112916|560632248|FG000|Overall Study|Development of SMN|1|||
155326580|NCT02112916|560632249|FG001|Overall Study|Development of SMN|0|||
155326581|NCT02112916|560632250|FG002|Overall Study|Development of SMN|0|||
155326582|NCT02112916|560632251|FG003|Overall Study|Development of SMN|1|||
155326583|NCT02112916|560632248|FG000|Overall Study|Relapse/Progression|10|||
155326584|NCT02112916|560632249|FG001|Overall Study|Relapse/Progression|18|||
155326585|NCT02112916|560632250|FG002|Overall Study|Relapse/Progression|15|||
155326586|NCT02112916|560632251|FG003|Overall Study|Relapse/Progression|2|||
155326587|NCT02112916|560632248|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
155326588|NCT02112916|560632249|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
155326589|NCT02112916|560632250|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
155326590|NCT02112916|560632251|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
155326591|NCT02112916|560632248|FG000|Overall Study|Still on Therapy|44|||
155326592|NCT02112916|560632249|FG001|Overall Study|Still on Therapy|47|||
155326593|NCT02112916|560632250|FG002|Overall Study|Still on Therapy|3|||
155326594|NCT02112916|560632251|FG003|Overall Study|Still on Therapy|2|||
155326595|NCT02112916|560632248|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
155326596|NCT02112916|560632249|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
155326597|NCT02112916|560632250|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
155326598|NCT02112916|560632251|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
155326599|NCT02112916|560632248|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
155326600|NCT02112916|560632249|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
155326601|NCT02112916|560632250|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
155326602|NCT02112916|560632251|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
155326603|NCT03333915|560632253|FG000|Overall Study|Lost to Follow-up|0|||
155326604|NCT03333915|560632254|FG001|Overall Study|Lost to Follow-up|0|||
155326605|NCT03333915|560632255|FG002|Overall Study|Lost to Follow-up|1|||
155326606|NCT03333915|560632256|FG003|Overall Study|Lost to Follow-up|0|||
155326607|NCT03333915|560632257|FG004|Overall Study|Lost to Follow-up|0|||
155326608|NCT03333915|560632253|FG000|Overall Study|Disease Progression|0|||
155326609|NCT03333915|560632254|FG001|Overall Study|Disease Progression|1|||
155326610|NCT03333915|560632255|FG002|Overall Study|Disease Progression|0|||
155326611|NCT03333915|560632256|FG003|Overall Study|Disease Progression|0|||
155326612|NCT03333915|560632257|FG004|Overall Study|Disease Progression|0|||
155326613|NCT03333915|560632253|FG000|Overall Study|Death|0|||
155326614|NCT03333915|560632254|FG001|Overall Study|Death|0|||
155326615|NCT03333915|560632255|FG002|Overall Study|Death|0|||
155326616|NCT03333915|560632256|FG003|Overall Study|Death|37|||
155326617|NCT03333915|560632257|FG004|Overall Study|Death|18|||
155326618|NCT03333915|560632253|FG000|Overall Study|Sponsor's Decision|0|||
155326619|NCT03333915|560632254|FG001|Overall Study|Sponsor's Decision|0|||
155326620|NCT03333915|560632255|FG002|Overall Study|Sponsor's Decision|0|||
155326621|NCT03333915|560632256|FG003|Overall Study|Sponsor's Decision|48|||
155326622|NCT03333915|560632257|FG004|Overall Study|Sponsor's Decision|4|||
155326623|NCT03333915|560632253|FG000|Overall Study|Withdrawal by Subject|0|||
155326624|NCT03333915|560632254|FG001|Overall Study|Withdrawal by Subject|0|||
155326625|NCT03333915|560632255|FG002|Overall Study|Withdrawal by Subject|0|||
155326626|NCT03333915|560632256|FG003|Overall Study|Withdrawal by Subject|5|||
155326627|NCT03333915|560632257|FG004|Overall Study|Withdrawal by Subject|1|||
155326628|NCT04174560|560632275|FG000|Overall Study|Lost to Follow-up|1|||
155326629|NCT04174560|560632276|FG001|Overall Study|Lost to Follow-up|0|||
155326630|NCT04174560|560632277|FG002|Overall Study|Lost to Follow-up|0|||
155326631|NCT04174560|560632278|FG003|Overall Study|Lost to Follow-up|0|||
155326632|NCT04174560|560632275|FG000|Overall Study|Withdrawal by Subject|0|||
155326633|NCT04174560|560632276|FG001|Overall Study|Withdrawal by Subject|0|||
155326634|NCT04174560|560632277|FG002|Overall Study|Withdrawal by Subject|2|||
155326635|NCT04174560|560632278|FG003|Overall Study|Withdrawal by Subject|0|||
155326636|NCT04940624|560632281|FG000|Overall Study|Adverse Event|4|||
155326637|NCT04940624|560632282|FG001|Overall Study|Adverse Event|11|||
155326638|NCT04940624|560632281|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155326639|NCT04940624|560632282|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155326640|NCT04940624|560632281|FG000|Overall Study|Physician Decision|1|||
155326641|NCT04940624|560632282|FG001|Overall Study|Physician Decision|0|||
155326642|NCT04940624|560632281|FG000|Overall Study|Lost to Follow-up|1|||
155326643|NCT04940624|560632282|FG001|Overall Study|Lost to Follow-up|0|||
155326644|NCT04940624|560632281|FG000|Overall Study|Reason Not Specified|1|||
155326645|NCT04940624|560632282|FG001|Overall Study|Reason Not Specified|0|||
155326646|NCT02890355|560632285|FG000|Overall Study|Adverse Event|5|||
155326647|NCT02890355|560632286|FG001|Overall Study|Adverse Event|5|||
155326648|NCT02890355|560632285|FG000|Overall Study|Refusal unrelated to adverse event|5|||
155326649|NCT02890355|560632286|FG001|Overall Study|Refusal unrelated to adverse event|10|||
155326650|NCT02890355|560632285|FG000|Overall Study|Progression/relapse|46|||
155326651|NCT02890355|560632286|FG001|Overall Study|Progression/relapse|39|||
155326652|NCT02890355|560632285|FG000|Overall Study|Not protocol specified|3|||
155326653|NCT02890355|560632286|FG001|Overall Study|Not protocol specified|4|||
155326654|NCT02180867|560632288|FG000|Overall Study|Adverse Event|3|||
155326655|NCT02180867|560632289|FG001|Overall Study|Adverse Event|4|||
155326656|NCT02180867|560632290|FG002|Overall Study|Adverse Event|1|||
155326657|NCT02180867|560632291|FG003|Overall Study|Adverse Event|5|||
155326658|NCT02180867|560632292|FG004|Overall Study|Adverse Event|0|||
155326659|NCT02180867|560632293|FG005|Overall Study|Adverse Event|0|||
155326660|NCT02180867|560632294|FG006|Overall Study|Adverse Event|0|||
155326661|NCT02180867|560632288|FG000|Overall Study|Death|0|||
155326662|NCT02180867|560632289|FG001|Overall Study|Death|0|||
155326663|NCT02180867|560632290|FG002|Overall Study|Death|0|||
155326664|NCT02180867|560632291|FG003|Overall Study|Death|0|||
155326665|NCT02180867|560632292|FG004|Overall Study|Death|1|||
155326666|NCT02180867|560632293|FG005|Overall Study|Death|0|||
155421693|NCT01925209|560974316|FG003|Follow-up|Non-compliance with study treatment|1|||
155421694|NCT01925209|560974313|FG000|Follow-up|Withdrawal by Subject|0|||
155421695|NCT01925209|560974314|FG001|Follow-up|Withdrawal by Subject|2|||
155326667|NCT02180867|560632294|FG006|Overall Study|Death|0|||
155326668|NCT02180867|560632288|FG000|Overall Study|Lack of Efficacy|0|||
155326669|NCT02180867|560632289|FG001|Overall Study|Lack of Efficacy|2|||
155326670|NCT02180867|560632290|FG002|Overall Study|Lack of Efficacy|0|||
155326671|NCT02180867|560632291|FG003|Overall Study|Lack of Efficacy|1|||
155326672|NCT02180867|560632292|FG004|Overall Study|Lack of Efficacy|6|||
155326673|NCT02180867|560632293|FG005|Overall Study|Lack of Efficacy|0|||
155326674|NCT02180867|560632294|FG006|Overall Study|Lack of Efficacy|1|||
155326675|NCT02180867|560632288|FG000|Overall Study|Physician Decision|1|||
155326676|NCT02180867|560632289|FG001|Overall Study|Physician Decision|3|||
155326677|NCT02180867|560632290|FG002|Overall Study|Physician Decision|1|||
155326678|NCT02180867|560632291|FG003|Overall Study|Physician Decision|10|||
155326679|NCT02180867|560632292|FG004|Overall Study|Physician Decision|9|||
155326680|NCT02180867|560632293|FG005|Overall Study|Physician Decision|3|||
155326681|NCT02180867|560632294|FG006|Overall Study|Physician Decision|4|||
155326682|NCT02180867|560632288|FG000|Overall Study|Withdrawal by Subject|0|||
155326683|NCT02180867|560632289|FG001|Overall Study|Withdrawal by Subject|0|||
155326684|NCT02180867|560632290|FG002|Overall Study|Withdrawal by Subject|0|||
155326685|NCT02180867|560632291|FG003|Overall Study|Withdrawal by Subject|1|||
155326686|NCT02180867|560632292|FG004|Overall Study|Withdrawal by Subject|1|||
155326687|NCT02180867|560632293|FG005|Overall Study|Withdrawal by Subject|0|||
155326688|NCT02180867|560632294|FG006|Overall Study|Withdrawal by Subject|0|||
155326689|NCT02180867|560632288|FG000|Overall Study|Ineligible|1|||
155326690|NCT02180867|560632289|FG001|Overall Study|Ineligible|2|||
155326691|NCT02180867|560632290|FG002|Overall Study|Ineligible|0|||
155326692|NCT02180867|560632291|FG003|Overall Study|Ineligible|3|||
155326693|NCT02180867|560632292|FG004|Overall Study|Ineligible|5|||
155326694|NCT02180867|560632293|FG005|Overall Study|Ineligible|0|||
155326695|NCT02180867|560632294|FG006|Overall Study|Ineligible|0|||
155326696|NCT02180867|560632288|FG000|Overall Study|Repeat Eligibility Studies|0|||
155326697|NCT02180867|560632289|FG001|Overall Study|Repeat Eligibility Studies|0|||
155326698|NCT02180867|560632290|FG002|Overall Study|Repeat Eligibility Studies|0|||
155326699|NCT02180867|560632291|FG003|Overall Study|Repeat Eligibility Studies|0|||
155326700|NCT02180867|560632292|FG004|Overall Study|Repeat Eligibility Studies|1|||
155326701|NCT02180867|560632293|FG005|Overall Study|Repeat Eligibility Studies|0|||
155326702|NCT02180867|560632294|FG006|Overall Study|Repeat Eligibility Studies|0|||
155326703|NCT02180867|560632288|FG000|Overall Study|Refusal of further protocol therapy|1|||
155326704|NCT02180867|560632289|FG001|Overall Study|Refusal of further protocol therapy|0|||
155326705|NCT02180867|560632290|FG002|Overall Study|Refusal of further protocol therapy|2|||
155326706|NCT02180867|560632291|FG003|Overall Study|Refusal of further protocol therapy|6|||
155326707|NCT02180867|560632292|FG004|Overall Study|Refusal of further protocol therapy|4|||
155326708|NCT02180867|560632293|FG005|Overall Study|Refusal of further protocol therapy|0|||
155326709|NCT02180867|560632294|FG006|Overall Study|Refusal of further protocol therapy|0|||
155326710|NCT00994643|560632655|FG000|Overall Study|Withdrawal by Subject|1|||
155326711|NCT03653364|560632656|FG000|Overall Study|Withdrawal by Subject|1|||
155326712|NCT03653364|560632656|FG000|Overall Study|Enrolled in Error|1|||
155326713|NCT03653364|560632656|FG000|Overall Study|Death|1|||
155326714|NCT02306161|560632659|FG000|Overall Study|Death|1|||
155326715|NCT02306161|560632660|FG001|Overall Study|Death|3|||
155326716|NCT02306161|560632659|FG000|Overall Study|Lack of Efficacy|20|||
155326717|NCT02306161|560632660|FG001|Overall Study|Lack of Efficacy|43|||
155326718|NCT02306161|560632659|FG000|Overall Study|Physician Decision|30|||
155326719|NCT02306161|560632660|FG001|Overall Study|Physician Decision|18|||
155326720|NCT02306161|560632659|FG000|Overall Study|Withdrawal by Subject|4|||
155326721|NCT02306161|560632660|FG001|Overall Study|Withdrawal by Subject|0|||
155326722|NCT02306161|560632659|FG000|Overall Study|Ineligible|9|||
155326723|NCT02306161|560632660|FG001|Overall Study|Ineligible|5|||
155326724|NCT03705390|560632665|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
155326725|NCT03705390|560632665|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
155326726|NCT03047213|560632666|FG000|Overall Study|Withdrawal by Subject|2|||
155326727|NCT03047213|560632667|FG001|Overall Study|Withdrawal by Subject|0|||
155326728|NCT03047213|560632666|FG000|Overall Study|Adverse Event|2|||
155326729|NCT03047213|560632667|FG001|Overall Study|Adverse Event|0|||
155326730|NCT03725332|560632669|FG000|Overall Study|Adverse Event|5|||
155326731|NCT03725332|560632670|FG001|Overall Study|Adverse Event|10|||
155326732|NCT03725332|560632669|FG000|Overall Study|Death|1|||
155326733|NCT03725332|560632670|FG001|Overall Study|Death|3|||
155326734|NCT03725332|560632669|FG000|Overall Study|Lost to Follow-up|43|||
155326735|NCT03725332|560632670|FG001|Overall Study|Lost to Follow-up|122|||
155326736|NCT03725332|560632669|FG000|Overall Study|Withdrawal by Subject|0|||
155326737|NCT03725332|560632670|FG001|Overall Study|Withdrawal by Subject|1|||
155326738|NCT03725332|560632669|FG000|Overall Study|Duplicate enrollment|0|||
155326739|NCT03725332|560632670|FG001|Overall Study|Duplicate enrollment|1|||
155326740|NCT03725332|560632669|FG000|Overall Study|Did not consent|0|||
155326741|NCT03725332|560632670|FG001|Overall Study|Did not consent|1|||
155326742|NCT03242915|560632673|FG000|Overall Study|Adverse Event|5|||
155326743|NCT03242915|560632674|FG001|Overall Study|Adverse Event|1|||
155326744|NCT03242915|560632673|FG000|Overall Study|Withdrawal by Subject|0|||
155326745|NCT03242915|560632674|FG001|Overall Study|Withdrawal by Subject|2|||
155326746|NCT03242915|560632673|FG000|Overall Study|Physician Decision|4|||
155326747|NCT03242915|560632674|FG001|Overall Study|Physician Decision|1|||
155326748|NCT02754596|560632675|FG000|Overall Study|Withdrawal by Subject|3|||
155326749|NCT02754596|560632676|FG001|Overall Study|Withdrawal by Subject|4|||
155326750|NCT02754596|560632677|FG002|Overall Study|Withdrawal by Subject|0|||
155326751|NCT02754596|560632675|FG000|Overall Study|Physician Decision|1|||
155326752|NCT02754596|560632676|FG001|Overall Study|Physician Decision|1|||
155326753|NCT02754596|560632677|FG002|Overall Study|Physician Decision|1|||
155326754|NCT02754596|560632675|FG000|Overall Study|Lost to Follow-up|1|||
155326755|NCT02754596|560632676|FG001|Overall Study|Lost to Follow-up|1|||
155326756|NCT02754596|560632677|FG002|Overall Study|Lost to Follow-up|2|||
155326757|NCT02754596|560632675|FG000|Overall Study|Death|0|||
155326758|NCT02754596|560632676|FG001|Overall Study|Death|2|||
155326759|NCT02754596|560632677|FG002|Overall Study|Death|0|||
155326760|NCT02754596|560632675|FG000|Overall Study|Adverse Event|1|||
155326761|NCT02754596|560632676|FG001|Overall Study|Adverse Event|0|||
155326762|NCT02754596|560632677|FG002|Overall Study|Adverse Event|1|||
155326763|NCT02754596|560632675|FG000|Overall Study|Other|1|||
155326764|NCT02754596|560632676|FG001|Overall Study|Other|0|||
155326765|NCT02754596|560632677|FG002|Overall Study|Other|0|||
155326766|NCT03872466|560632678|FG000|Overall Study|Withdrawal by Subject|1|||
155326767|NCT03872466|560632679|FG001|Overall Study|Withdrawal by Subject|0|||
155326768|NCT03872466|560632678|FG000|Overall Study|Physician Decision|2|||
155326769|NCT03872466|560632679|FG001|Overall Study|Physician Decision|0|||
155326770|NCT01778686|560632680|FG000|Overall Study|Adverse Event|0|||
155326771|NCT01778686|560632681|FG001|Overall Study|Adverse Event|0|||
155326772|NCT01778686|560632682|FG002|Overall Study|Adverse Event|1|||
155326773|NCT04012567|560632683|FG000|Overall Study|Lost to Follow-up|0|||
155326774|NCT04012567|560632684|FG001|Overall Study|Lost to Follow-up|1|||
155326775|NCT04012567|560632683|FG000|Overall Study|Withdrawal by Subject|1|||
155326776|NCT04012567|560632684|FG001|Overall Study|Withdrawal by Subject|0|||
155326777|NCT03782116|560632687|FG000|Completed Intervetion|Lost to Follow-up|11|||
155326778|NCT03782116|560632688|FG001|Completed Intervetion|Lost to Follow-up|7|||
155326779|NCT03782116|560632687|FG000|Completed Intervetion|Withdrawal by Subject|6|||
155326780|NCT03782116|560632688|FG001|Completed Intervetion|Withdrawal by Subject|5|||
155326781|NCT03782116|560632687|FG000|Included in Analysis|Protocol Violation|5|||
155326782|NCT03782116|560632688|FG001|Included in Analysis|Protocol Violation|5|||
155326783|NCT05714059|560632691|FG000|Overall Study|Withdrawal by Subject|2|||
155326784|NCT05714059|560632692|FG001|Overall Study|Withdrawal by Subject|2|||
155326785|NCT05714059|560632691|FG000|Overall Study|Adverse Event|0|||
155326786|NCT05714059|560632692|FG001|Overall Study|Adverse Event|1|||
155326787|NCT05714059|560632691|FG000|Overall Study|Lost to Follow-up|0|||
155326788|NCT05714059|560632692|FG001|Overall Study|Lost to Follow-up|1|||
155326789|NCT05714059|560632691|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
155326790|NCT05714059|560632692|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155326791|NCT05714059|560632691|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
155326792|NCT05714059|560632692|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
155326793|NCT04899674|560632693|FG000|Test|Adverse Event|1|||
155326794|NCT04129450|560632694|FG000|Overall Study|Lost to Follow-up|20|||
155326795|NCT04129450|560632695|FG001|Overall Study|Lost to Follow-up|10|||
155326796|NCT04129450|560632694|FG000|Overall Study|Withdrawal by Subject|9|||
155326797|NCT04129450|560632695|FG001|Overall Study|Withdrawal by Subject|5|||
155326798|NCT04129450|560632694|FG000|Overall Study|Work Family Obligations|2|||
155326799|NCT04129450|560632695|FG001|Overall Study|Work Family Obligations|0|||
155326800|NCT04129450|560632694|FG000|Overall Study|Other|3|||
155326801|NCT04129450|560632695|FG001|Overall Study|Other|0|||
155326802|NCT05039021|560633367|FG000|Overall Study|Death|1|||
155326803|NCT05039021|560633367|FG000|Overall Study|Lost to Follow-up|3|||
155326804|NCT02566889|560633368|FG000|Overall Study|Withdrawal by Subject|3|||
155326805|NCT02566889|560633369|FG001|Overall Study|Withdrawal by Subject|1|||
155326806|NCT02566889|560633368|FG000|Overall Study|Adverse Event|4|||
155326807|NCT02566889|560633369|FG001|Overall Study|Adverse Event|2|||
155326808|NCT02566889|560633368|FG000|Overall Study|Other|6|||
155326809|NCT02566889|560633369|FG001|Overall Study|Other|2|||
155326810|NCT04974047|560633371|FG000|Overall Study|Sponsor Ended Study|20|||
155326811|NCT04974047|560633372|FG001|Overall Study|Sponsor Ended Study|22|||
155326812|NCT04974047|560633371|FG000|Overall Study|Death|8|||
155326813|NCT04974047|560633372|FG001|Overall Study|Death|17|||
155326814|NCT04974047|560633371|FG000|Overall Study|Lost to Follow-up|2|||
155326815|NCT04974047|560633372|FG001|Overall Study|Lost to Follow-up|0|||
155326816|NCT04974047|560633371|FG000|Overall Study|Withdrawal by Subject|0|||
155326817|NCT04974047|560633372|FG001|Overall Study|Withdrawal by Subject|1|||
155326818|NCT00655499|560633373|FG000|Overall Study|not eligible|4|||
155326819|NCT03391466|560633374|FG000|Overall Study|Death|84|||
155326820|NCT03391466|560633375|FG001|Overall Study|Death|91|||
155326821|NCT03391466|560633374|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
155326822|NCT03391466|560633375|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
155326823|NCT03391466|560633374|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
155502502|NCT00422058|561265492|FG005|Open-Label Extension, Week 20-104|Other|18|||
155326824|NCT03391466|560633375|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
155326825|NCT03391466|560633374|FG000|Overall Study|Lost to Follow-up|9|||
155326826|NCT03391466|560633375|FG001|Overall Study|Lost to Follow-up|5|||
155326827|NCT03391466|560633374|FG000|Overall Study|Reason Not Specified|2|||
155326828|NCT03391466|560633375|FG001|Overall Study|Reason Not Specified|2|||
155326829|NCT03391466|560633374|FG000|Overall Study|Investigator Decision|0|||
155326830|NCT03391466|560633375|FG001|Overall Study|Investigator Decision|1|||
155326831|NCT03140670|560633376|FG000|Overall Study|Withdrawal by Subject|2|||
155326832|NCT03140670|560633376|FG000|Overall Study|Lost to Follow-up|1|||
155326833|NCT03140670|560633376|FG000|Overall Study|Physician Decision|1|||
155326834|NCT00220805|560633377|FG000|Overall Study|Adverse Event|1|||
155326835|NCT00220805|560633378|FG001|Overall Study|Adverse Event|3|||
155326836|NCT00220805|560633377|FG000|Overall Study|Withdrawal by Subject|3|||
155326837|NCT00220805|560633378|FG001|Overall Study|Withdrawal by Subject|0|||
155326838|NCT00220805|560633377|FG000|Overall Study|Lack of Efficacy|1|||
155326839|NCT00220805|560633378|FG001|Overall Study|Lack of Efficacy|0|||
155326840|NCT00220805|560633377|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
155326841|NCT00220805|560633378|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
155326842|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
155326843|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
155326844|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
155326845|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
155326846|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
155326847|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
155326848|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
155326849|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
155326850|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
155326851|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
155326852|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
155326853|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
155326854|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
155326855|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
155326856|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
155326857|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
155326858|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
155326859|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
155326860|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
155326861|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
155326862|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
155326863|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
155326864|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
155326865|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
155326866|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
155326867|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
155326868|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
155326869|NCT03699163|560633382|FG000|Overall Study|Physician Decision|12|||
155326870|NCT03699163|560633383|FG001|Overall Study|Physician Decision|0|||
155326871|NCT03699163|560633382|FG000|Overall Study|failed QC measures|205|||
155326872|NCT03699163|560633383|FG001|Overall Study|failed QC measures|206|||
155326873|NCT01596972|560633384|FG000|Overall Study|Physician Decision|1|||
155326874|NCT01596972|560633385|FG001|Overall Study|Physician Decision|9|||
155326875|NCT01596972|560633384|FG000|Overall Study|Lost to Follow-up|0|||
155326876|NCT01596972|560633385|FG001|Overall Study|Lost to Follow-up|4|||
155326877|NCT01596972|560633384|FG000|Overall Study|Withdrawal by Subject|0|||
155326878|NCT01596972|560633385|FG001|Overall Study|Withdrawal by Subject|1|||
155326879|NCT01964300|560633387|FG000|Overall Study|Ineligible after enrollment|0|||
155326880|NCT01964300|560633388|FG001|Overall Study|Ineligible after enrollment|1|||
155326881|NCT01964300|560633387|FG000|Overall Study|Adverse Event|1|||
155326882|NCT01964300|560633388|FG001|Overall Study|Adverse Event|1|||
155326883|NCT01964300|560633387|FG000|Overall Study|Lack of Efficacy|3|||
155326884|NCT01964300|560633388|FG001|Overall Study|Lack of Efficacy|5|||
155502503|NCT04333199|561265502|FG000|Evaluated Patients|Lost to Follow-up|0|||
155502504|NCT04333199|561265503|FG001|Evaluated Patients|Lost to Follow-up|1|||
155502505|NCT04333199|561265504|FG002|Evaluated Patients|Lost to Follow-up|2|||
155502506|NCT03959137|561265506|FG000|Overall Study|Protocol Violation|6|||
155502507|NCT00190684|561265513|FG000|Overall Study|Adverse Event|86|||
155502508|NCT00190684|561265513|FG000|Overall Study|Satisfactory response|80|||
155502509|NCT00190684|561265513|FG000|Overall Study|Lack of efficacy|204|||
155326885|NCT01964300|560633387|FG000|Overall Study|Withdrawal by Subject|0|||
155326886|NCT01964300|560633388|FG001|Overall Study|Withdrawal by Subject|1|||
155326887|NCT01964300|560633387|FG000|Overall Study|To receive alternative therapy|1|||
155326888|NCT01964300|560633388|FG001|Overall Study|To receive alternative therapy|2|||
155502510|NCT00190684|561265513|FG000|Overall Study|Lost to Follow-up|232|||
155421696|NCT01925209|560974315|FG002|Follow-up|Withdrawal by Subject|0|||
155421697|NCT01925209|560974316|FG003|Follow-up|Withdrawal by Subject|2|||
155326889|NCT01964300|560633387|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
155326890|NCT01964300|560633388|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
155326891|NCT01964300|560633387|FG000|Overall Study|Weight criteria not met|0|||
155326892|NCT01964300|560633388|FG001|Overall Study|Weight criteria not met|1|||
155326893|NCT00557492|560633389|FG000|Overall Study|Change in health insurance|1|||
155326894|NCT04129164|560633391|FG000|Overall Study|Non-compliance with procedures|0|||
155326895|NCT04129164|560633392|FG001|Overall Study|Non-compliance with procedures|0|||
155326896|NCT04129164|560633393|FG002|Overall Study|Non-compliance with procedures|2|||
155326897|NCT04129164|560633394|FG003|Overall Study|Non-compliance with procedures|0|||
155326898|NCT04129164|560633391|FG000|Overall Study|Adverse Event|0|||
155326899|NCT04129164|560633392|FG001|Overall Study|Adverse Event|0|||
155326900|NCT04129164|560633393|FG002|Overall Study|Adverse Event|2|||
155326901|NCT04129164|560633394|FG003|Overall Study|Adverse Event|0|||
155326902|NCT04129164|560633391|FG000|Overall Study|Pregnancy|0|||
155326903|NCT04129164|560633392|FG001|Overall Study|Pregnancy|0|||
155326904|NCT04129164|560633393|FG002|Overall Study|Pregnancy|0|||
155326905|NCT04129164|560633394|FG003|Overall Study|Pregnancy|1|||
155326906|NCT04129164|560633391|FG000|Overall Study|Withdrawal by Subject|3|||
155326907|NCT04129164|560633392|FG001|Overall Study|Withdrawal by Subject|2|||
155326908|NCT04129164|560633393|FG002|Overall Study|Withdrawal by Subject|4|||
155326909|NCT04129164|560633394|FG003|Overall Study|Withdrawal by Subject|6|||
155326910|NCT04129164|560633391|FG000|Overall Study|Death|0|||
155326911|NCT04129164|560633392|FG001|Overall Study|Death|1|||
155326912|NCT04129164|560633393|FG002|Overall Study|Death|0|||
155326913|NCT04129164|560633394|FG003|Overall Study|Death|0|||
155326914|NCT04129164|560633391|FG000|Overall Study|Lost to Follow-up|0|||
155326915|NCT04129164|560633392|FG001|Overall Study|Lost to Follow-up|1|||
155326916|NCT04129164|560633393|FG002|Overall Study|Lost to Follow-up|0|||
155326917|NCT04129164|560633394|FG003|Overall Study|Lost to Follow-up|0|||
155326918|NCT01260896|560633401|FG000|First Intervention|Withdrawn Due to Emesis|2|||
155326919|NCT01260896|560633402|FG001|First Intervention|Withdrawn Due to Emesis|0|||
155326920|NCT00003222|560633412|FG000|Overall Study|Physician Decision|0|||
155326921|NCT00003222|560633413|FG001|Overall Study|Physician Decision|1|||
155326922|NCT05030584|560633414|FG000|Overall Study|Adverse Event|17|||
155326923|NCT05030584|560633415|FG001|Overall Study|Adverse Event|2|||
155326924|NCT05030584|560633414|FG000|Overall Study|Lack of Efficacy|0|||
155326925|NCT05030584|560633415|FG001|Overall Study|Lack of Efficacy|6|||
155326926|NCT05030584|560633414|FG000|Overall Study|Lost to Follow-up|5|||
155326927|NCT05030584|560633415|FG001|Overall Study|Lost to Follow-up|2|||
155326928|NCT05030584|560633414|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155326929|NCT05030584|560633415|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155326930|NCT05030584|560633414|FG000|Overall Study|Other reason|4|||
155326931|NCT05030584|560633415|FG001|Overall Study|Other reason|3|||
155326932|NCT05030584|560633414|FG000|Overall Study|Physician Decision|1|||
155326933|NCT05030584|560633415|FG001|Overall Study|Physician Decision|4|||
155326934|NCT05030584|560633414|FG000|Overall Study|Protocol Violation|0|||
155326935|NCT05030584|560633415|FG001|Overall Study|Protocol Violation|2|||
155326936|NCT05030584|560633414|FG000|Overall Study|Randomized by Mistake|0|||
155326937|NCT05030584|560633415|FG001|Overall Study|Randomized by Mistake|2|||
155326938|NCT05030584|560633414|FG000|Overall Study|Withdrawal by Subject|21|||
155326939|NCT05030584|560633415|FG001|Overall Study|Withdrawal by Subject|28|||
155326940|NCT05030584|560633414|FG000|Overall Study|Technical Problems|0|||
155326941|NCT05030584|560633415|FG001|Overall Study|Technical Problems|1|||
155326942|NCT05030584|560633414|FG000|Overall Study|Completed post-treatment/FU visits|41|||
155326943|NCT05030584|560633415|FG001|Overall Study|Completed post-treatment/FU visits|31|||
155326944|NCT01313559|560633422|FG000|Overall Study|Withdrawal by Subject|1|||
155326945|NCT01313559|560633423|FG001|Overall Study|Withdrawal by Subject|2|||
155326946|NCT01313559|560633422|FG000|Overall Study|Disease progression|1|||
155326947|NCT01313559|560633423|FG001|Overall Study|Disease progression|0|||
155326948|NCT01313559|560633422|FG000|Overall Study|Rising PSA|2|||
155326949|NCT01313559|560633423|FG001|Overall Study|Rising PSA|0|||
155326950|NCT06393127|560633424|FG000|Washout period|Withdrawal by Subject|1|||
155326951|NCT06393127|560633425|FG001|Washout period|Withdrawal by Subject|0|||
155326952|NCT06393127|560633424|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
155326953|NCT06393127|560633425|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
155326954|NCT02446600|560633426|FG000|Overall Study|Never treated|20|||
155326955|NCT02446600|560633427|FG001|Overall Study|Never treated|2|||
155326956|NCT02446600|560633428|FG002|Overall Study|Never treated|6|||
155326957|NCT02446600|560633429|FG003|Overall Study|Never treated|0|||
155326958|NCT02446600|560633426|FG000|Overall Study|Withdrawal by Subject|19|||
155326959|NCT02446600|560633427|FG001|Overall Study|Withdrawal by Subject|5|||
155326960|NCT02446600|560633428|FG002|Overall Study|Withdrawal by Subject|17|||
155326961|NCT02446600|560633429|FG003|Overall Study|Withdrawal by Subject|0|||
155326962|NCT02446600|560633426|FG000|Overall Study|Ineligible|1|||
155326963|NCT02446600|560633427|FG001|Overall Study|Ineligible|4|||
155326964|NCT02446600|560633428|FG002|Overall Study|Ineligible|4|||
155326965|NCT02446600|560633429|FG003|Overall Study|Ineligible|1|||
155326966|NCT02446600|560633426|FG000|Overall Study|Duplicate Enrollment|0|||
155326967|NCT02446600|560633427|FG001|Overall Study|Duplicate Enrollment|1|||
155326968|NCT02446600|560633428|FG002|Overall Study|Duplicate Enrollment|0|||
155326969|NCT02446600|560633429|FG003|Overall Study|Duplicate Enrollment|0|||
155326970|NCT02466971|560633432|FG000|Overall Study|eligible and never treated|14|||
155326971|NCT02466971|560633433|FG001|Overall Study|eligible and never treated|20|||
155326972|NCT02466971|560633432|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
155326973|NCT02466971|560633433|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
155326974|NCT02466971|560633432|FG000|Overall Study|ineligible and treated|1|||
155326975|NCT02466971|560633433|FG001|Overall Study|ineligible and treated|0|||
155326976|NCT02466971|560633432|FG000|Overall Study|ineligible and never treated|0|||
155326977|NCT02466971|560633433|FG001|Overall Study|ineligible and never treated|1|||
155326978|NCT02101853|560633434|FG000|Block 1 Induction|Adverse Event|11|||
155326979|NCT02101853|560633435|FG001|Block 1 Induction|Adverse Event|0|||
155326980|NCT02101853|560633436|FG002|Block 1 Induction|Adverse Event|0|||
155326981|NCT02101853|560633437|FG003|Block 1 Induction|Adverse Event|0|||
155326982|NCT02101853|560633438|FG004|Block 1 Induction|Adverse Event|0|||
155326983|NCT02101853|560633439|FG005|Block 1 Induction|Adverse Event|0|||
155326984|NCT02101853|560633434|FG000|Block 1 Induction|Death|20|||
155326985|NCT02101853|560633435|FG001|Block 1 Induction|Death|0|||
155326986|NCT02101853|560633436|FG002|Block 1 Induction|Death|0|||
155326987|NCT02101853|560633437|FG003|Block 1 Induction|Death|0|||
155326988|NCT02101853|560633438|FG004|Block 1 Induction|Death|0|||
155326989|NCT02101853|560633439|FG005|Block 1 Induction|Death|0|||
155326990|NCT02101853|560633434|FG000|Block 1 Induction|Lack of Efficacy|6|||
155421698|NCT04398732|560974317|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
155421699|NCT01299727|560974318|FG000|Overall Study|Withdrawal by Subject|1|||
155421700|NCT01299727|560974319|FG001|Overall Study|Withdrawal by Subject|0|||
155421701|NCT01299727|560974320|FG002|Overall Study|Withdrawal by Subject|0|||
155421702|NCT01299727|560974318|FG000|Overall Study|Adverse Event|0|||
155421703|NCT01299727|560974319|FG001|Overall Study|Adverse Event|0|||
155421704|NCT01299727|560974320|FG002|Overall Study|Adverse Event|1|||
155421705|NCT01299727|560974318|FG000|Overall Study|Completed the Treatment Period|3|||
155421706|NCT01299727|560974319|FG001|Overall Study|Completed the Treatment Period|4|||
155421707|NCT01299727|560974320|FG002|Overall Study|Completed the Treatment Period|3|||
155421708|NCT03882424|560974322|FG000|Overall Study|Lost to Follow-up|3|||
155421709|NCT03882424|560974323|FG001|Overall Study|Lost to Follow-up|0|||
155421710|NCT03882424|560974324|FG002|Overall Study|Lost to Follow-up|0|||
155421711|NCT03882424|560974322|FG000|Overall Study|schedule conflict|1|||
155421712|NCT03882424|560974323|FG001|Overall Study|schedule conflict|0|||
155421713|NCT03882424|560974324|FG002|Overall Study|schedule conflict|0|||
155421714|NCT01596257|560974329|FG000|Overall Study|Inadequate Collection|23|||
155421715|NCT01596257|560974330|FG001|Overall Study|Inadequate Collection|19|||
155421716|NCT01570244|560974334|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
155421717|NCT03486392|560974337|FG000|Overall Study|Lost to Follow-up|0|||
155421718|NCT03486392|560974338|FG001|Overall Study|Lost to Follow-up|0|||
155421719|NCT03486392|560974339|FG002|Overall Study|Lost to Follow-up|8|||
155421720|NCT03486392|560974340|FG003|Overall Study|Lost to Follow-up|5|||
155644805|NCT03670628|561789904|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
155644806|NCT03670628|561789903|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
155644807|NCT03670628|561789904|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
155644808|NCT03123588|561789905|FG000|Overall Study|Study Terminated by Sponsor|2|||
155644809|NCT03123588|561789906|FG001|Overall Study|Study Terminated by Sponsor|5|||
155644810|NCT03123588|561789905|FG000|Overall Study|Withdrawal by Subject|1|||
155644811|NCT03123588|561789906|FG001|Overall Study|Withdrawal by Subject|0|||
155644812|NCT03123588|561789905|FG000|Overall Study|Adverse Event|1|||
155644813|NCT03123588|561789906|FG001|Overall Study|Adverse Event|0|||
155644814|NCT03123588|561789905|FG000|Overall Study|Physician Decision|2|||
155644815|NCT03123588|561789906|FG001|Overall Study|Physician Decision|1|||
155644816|NCT00997126|561789908|FG000|Overall Study|Physician Decision|7|||
155644817|NCT00997126|561789909|FG001|Overall Study|Physician Decision|11|||
155644818|NCT01769443|561789911|FG000|Overall Study|Study closure|1|||
155644819|NCT01769443|561789912|FG001|Overall Study|Study closure|0|||
155644820|NCT00866320|561789915|FG000|Overall Study|Withdrawal by Subject|4|||
155644821|NCT00866320|561789915|FG000|Overall Study|Death|2|||
155644822|NCT02063724|561789916|FG000|Overall Study|Disease progression|1|||
155644823|NCT02315625|561789917|FG000|First Intervention|Disease Progression|1|||
155644824|NCT02315625|561789918|FG001|First Intervention|Disease Progression|0|||
155644825|NCT02315625|561789917|FG000|Second Intervention|Physician Decision|2|||
155644826|NCT02315625|561789918|FG001|Second Intervention|Physician Decision|1|||
155644827|NCT02315625|561789917|FG000|Second Intervention|Study closure|1|||
155644828|NCT02315625|561789918|FG001|Second Intervention|Study closure|0|||
155644829|NCT02315625|561789917|FG000|Second Intervention|Disease Progression|1|||
155644830|NCT02315625|561789918|FG001|Second Intervention|Disease Progression|0|||
155644831|NCT02697422|561789919|FG000|Overall Study|Declined exit survey|9|||
155644832|NCT02697422|561789920|FG001|Overall Study|Declined exit survey|2|||
155644833|NCT02697422|561789919|FG000|Overall Study|Lost to Follow-up|13|||
155644834|NCT02697422|561789920|FG001|Overall Study|Lost to Follow-up|8|||
155644835|NCT02697422|561789919|FG000|Overall Study|Death|2|||
155644836|NCT02697422|561789920|FG001|Overall Study|Death|1|||
155644837|NCT02697422|561789919|FG000|Overall Study|Withdrawal by Subject|0|||
155326991|NCT02101853|560633435|FG001|Block 1 Induction|Lack of Efficacy|0|||
155326992|NCT02101853|560633436|FG002|Block 1 Induction|Lack of Efficacy|0|||
155421721|NCT03486392|560974341|FG004|Overall Study|Lost to Follow-up|2|||
155421722|NCT03486392|560974337|FG000|Overall Study|Withdrawal by Subject|3|||
155326993|NCT02101853|560633437|FG003|Block 1 Induction|Lack of Efficacy|0|||
155326994|NCT02101853|560633438|FG004|Block 1 Induction|Lack of Efficacy|0|||
155326995|NCT02101853|560633439|FG005|Block 1 Induction|Lack of Efficacy|0|||
155326996|NCT02101853|560633434|FG000|Block 1 Induction|Physician Decision|61|||
155326997|NCT02101853|560633435|FG001|Block 1 Induction|Physician Decision|0|||
155326998|NCT02101853|560633436|FG002|Block 1 Induction|Physician Decision|0|||
155326999|NCT02101853|560633437|FG003|Block 1 Induction|Physician Decision|0|||
155327000|NCT02101853|560633438|FG004|Block 1 Induction|Physician Decision|0|||
155327001|NCT02101853|560633439|FG005|Block 1 Induction|Physician Decision|0|||
155327002|NCT02101853|560633434|FG000|Block 1 Induction|Protocol Violation|2|||
155327003|NCT02101853|560633435|FG001|Block 1 Induction|Protocol Violation|0|||
155644838|NCT02697422|561789920|FG001|Overall Study|Withdrawal by Subject|1|||
155644839|NCT02697422|561789919|FG000|Overall Study|Physician Decision|1|||
155644840|NCT02697422|561789920|FG001|Overall Study|Physician Decision|1|||
155644841|NCT02697422|561789919|FG000|Overall Study|Exit survey data lost|1|||
155644842|NCT02697422|561789920|FG001|Overall Study|Exit survey data lost|0|||
155644843|NCT02939781|561789921|FG000|Overall Study|Protocol Violation|8|||
155644844|NCT02939781|561789921|FG000|Overall Study|Withdrawal by Subject|1|||
155644845|NCT03753542|561789922|FG000|Overall Study|Lost to Follow-up|9|||
155644846|NCT03753542|561789923|FG001|Overall Study|Lost to Follow-up|14|||
155644847|NCT01068249|561789924|FG000|Overall Study|Death|1|||
155644848|NCT01068249|561789924|FG000|Overall Study|Withdrawal by Subject|3|||
155644849|NCT05537571|561789925|FG000|Overall Study|Withdrawal by Subject|1|||
155644850|NCT05537571|561789926|FG001|Overall Study|Withdrawal by Subject|1|||
155327004|NCT02101853|560633436|FG002|Block 1 Induction|Protocol Violation|0|||
155327005|NCT02101853|560633437|FG003|Block 1 Induction|Protocol Violation|0|||
155327006|NCT02101853|560633438|FG004|Block 1 Induction|Protocol Violation|0|||
155327007|NCT02101853|560633439|FG005|Block 1 Induction|Protocol Violation|0|||
155327008|NCT02101853|560633434|FG000|Block 1 Induction|Withdrawal by Subject|65|||
155327009|NCT02101853|560633435|FG001|Block 1 Induction|Withdrawal by Subject|0|||
155327010|NCT02101853|560633436|FG002|Block 1 Induction|Withdrawal by Subject|0|||
155327011|NCT02101853|560633437|FG003|Block 1 Induction|Withdrawal by Subject|0|||
155327012|NCT02101853|560633438|FG004|Block 1 Induction|Withdrawal by Subject|0|||
155327013|NCT02101853|560633439|FG005|Block 1 Induction|Withdrawal by Subject|0|||
155327014|NCT02101853|560633434|FG000|Block 1 Induction|Ineligible|8|||
155327015|NCT02101853|560633435|FG001|Block 1 Induction|Ineligible|0|||
155327016|NCT02101853|560633436|FG002|Block 1 Induction|Ineligible|0|||
155327017|NCT02101853|560633437|FG003|Block 1 Induction|Ineligible|0|||
155327018|NCT02101853|560633438|FG004|Block 1 Induction|Ineligible|0|||
155327019|NCT02101853|560633439|FG005|Block 1 Induction|Ineligible|0|||
155327020|NCT02101853|560633434|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
155327021|NCT02101853|560633435|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327022|NCT02101853|560633436|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327023|NCT02101853|560633437|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327024|NCT02101853|560633438|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327025|NCT02101853|560633439|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327026|NCT02101853|560633434|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
155327027|NCT02101853|560633435|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327028|NCT02101853|560633436|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327029|NCT02101853|560633437|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327030|NCT02101853|560633438|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327031|NCT02101853|560633439|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327032|NCT02101853|560633434|FG000|Post Induction Randomization|Adverse Event|0|||
155327033|NCT02101853|560633435|FG001|Post Induction Randomization|Adverse Event|3|||
155327034|NCT02101853|560633436|FG002|Post Induction Randomization|Adverse Event|8|||
155327035|NCT02101853|560633437|FG003|Post Induction Randomization|Adverse Event|4|||
155327036|NCT02101853|560633438|FG004|Post Induction Randomization|Adverse Event|4|||
155327037|NCT02101853|560633439|FG005|Post Induction Randomization|Adverse Event|0|||
155327038|NCT02101853|560633434|FG000|Post Induction Randomization|Death|0|||
155327039|NCT02101853|560633435|FG001|Post Induction Randomization|Death|9|||
155327040|NCT02101853|560633436|FG002|Post Induction Randomization|Death|2|||
155327041|NCT02101853|560633437|FG003|Post Induction Randomization|Death|2|||
155327042|NCT02101853|560633438|FG004|Post Induction Randomization|Death|0|||
155327043|NCT02101853|560633439|FG005|Post Induction Randomization|Death|0|||
155327044|NCT02101853|560633434|FG000|Post Induction Randomization|Lack of Efficacy|0|||
155327045|NCT02101853|560633435|FG001|Post Induction Randomization|Lack of Efficacy|14|||
155327046|NCT02101853|560633436|FG002|Post Induction Randomization|Lack of Efficacy|23|||
155327047|NCT02101853|560633437|FG003|Post Induction Randomization|Lack of Efficacy|18|||
155327048|NCT02101853|560633438|FG004|Post Induction Randomization|Lack of Efficacy|21|||
155327049|NCT02101853|560633439|FG005|Post Induction Randomization|Lack of Efficacy|0|||
155327050|NCT02101853|560633434|FG000|Post Induction Randomization|Physician Decision|0|||
155327051|NCT02101853|560633435|FG001|Post Induction Randomization|Physician Decision|43|||
155327052|NCT02101853|560633436|FG002|Post Induction Randomization|Physician Decision|23|||
155327053|NCT02101853|560633437|FG003|Post Induction Randomization|Physician Decision|14|||
155327054|NCT02101853|560633438|FG004|Post Induction Randomization|Physician Decision|14|||
155327055|NCT02101853|560633439|FG005|Post Induction Randomization|Physician Decision|0|||
155327056|NCT02101853|560633434|FG000|Post Induction Randomization|Protocol Violation|0|||
155327057|NCT02101853|560633435|FG001|Post Induction Randomization|Protocol Violation|3|||
155327058|NCT02101853|560633436|FG002|Post Induction Randomization|Protocol Violation|0|||
155327059|NCT02101853|560633437|FG003|Post Induction Randomization|Protocol Violation|0|||
155327060|NCT02101853|560633438|FG004|Post Induction Randomization|Protocol Violation|0|||
155327061|NCT02101853|560633439|FG005|Post Induction Randomization|Protocol Violation|0|||
155327062|NCT02101853|560633434|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
155327063|NCT02101853|560633435|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
155327064|NCT02101853|560633436|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
155327065|NCT02101853|560633437|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
155327066|NCT02101853|560633438|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
155327067|NCT02101853|560633439|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
155327068|NCT02101853|560633434|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327069|NCT02101853|560633435|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327070|NCT02101853|560633436|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327071|NCT02101853|560633437|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
155327072|NCT02101853|560633438|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327073|NCT02101853|560633439|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327074|NCT02101853|560633434|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327075|NCT02101853|560633435|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
155327076|NCT02101853|560633436|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
155327077|NCT02101853|560633437|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327078|NCT02101853|560633438|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327079|NCT02101853|560633439|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327080|NCT02101853|560633434|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327081|NCT02101853|560633435|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
155327082|NCT02101853|560633436|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327083|NCT02101853|560633437|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327084|NCT02101853|560633438|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327085|NCT02101853|560633439|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327086|NCT02101853|560633434|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327087|NCT02101853|560633435|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327088|NCT02101853|560633436|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327089|NCT02101853|560633437|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
155327090|NCT02101853|560633438|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
155327091|NCT02101853|560633439|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327092|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Death|0|||
155327093|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Death|0|||
155327094|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Death|0|||
155327095|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Death|0|||
155327096|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Death|0|||
155327097|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Death|2|||
155327098|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327099|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327100|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327101|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327102|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327103|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
155327104|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327105|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327106|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327107|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327108|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327109|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
155502511|NCT00190684|561265513|FG000|Overall Study|Patient moved|60|||
155327110|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327111|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327112|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327113|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327114|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327115|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
155327116|NCT05707351|560633443|FG000|Overall Study|Withdrawal by Subject|2|||
155327117|NCT05707351|560633443|FG000|Overall Study|Reason Not Specified|1|||
155327118|NCT05934292|560633449|FG000|Overall Study|Lost to Follow-up|0|||
155327119|NCT05934292|560633450|FG001|Overall Study|Lost to Follow-up|0|||
155327120|NCT05934292|560633451|FG002|Overall Study|Lost to Follow-up|1|||
155327121|NCT05934292|560633452|FG003|Overall Study|Lost to Follow-up|0|||
155327122|NCT01639131|560634382|FG000|Overall Study|Disease Progression|6|||
155327123|NCT01637402|560634383|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
155327124|NCT01637402|560634384|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
155327125|NCT01637402|560634383|FG000|Standard Dose Regimen|Adverse Event|1|||
155327126|NCT01637402|560634384|FG001|Standard Dose Regimen|Adverse Event|0|||
155327127|NCT01637402|560634383|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
155327128|NCT01637402|560634384|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
155327129|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
155327130|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
155327131|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
155327132|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
155327133|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
155327134|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
155327135|NCT02285270|560634385|FG000|Overall Study|Lost to Follow-up|1|||
155327136|NCT02285270|560634385|FG000|Overall Study|Physician Decision|3|||
155327137|NCT02285270|560634385|FG000|Overall Study|Determined to be ineligible|1|||
155327138|NCT00439270|560634386|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
155327139|NCT00439270|560634387|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
155327140|NCT00439270|560634388|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
155327141|NCT00439270|560634389|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
155327142|NCT00439270|560634390|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
155327143|NCT00439270|560634386|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327144|NCT00439270|560634387|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
155327145|NCT00439270|560634388|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327146|NCT00439270|560634389|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327147|NCT00439270|560634390|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327148|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
155327149|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
155327150|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
155327151|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
155327152|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
155327153|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327154|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327155|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327156|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
155327157|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327158|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327159|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327160|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327161|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
155327162|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327163|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327164|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327165|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327166|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
155327167|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327168|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327169|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327170|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327171|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
155327172|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327173|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327174|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327175|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327176|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
155327177|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327178|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327179|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155502512|NCT00190684|561265513|FG000|Overall Study|Patient Decision|432|||
155327180|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327181|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
155327182|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327183|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327184|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327185|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327186|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
155327187|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327188|NCT01268306|560634391|FG000|Overall Study|Lost to Follow-up|1|||
155327189|NCT04334317|560634392|FG000|Overall Study|Adverse Event|1|||
155327190|NCT04334317|560634393|FG001|Overall Study|Adverse Event|2|||
155327191|NCT04334317|560634394|FG002|Overall Study|Adverse Event|0|||
155327192|NCT04334317|560634395|FG003|Overall Study|Adverse Event|0|||
155327193|NCT04334317|560634392|FG000|Overall Study|Protocol Deviation|0|||
155327194|NCT04334317|560634393|FG001|Overall Study|Protocol Deviation|1|||
155327195|NCT04334317|560634394|FG002|Overall Study|Protocol Deviation|0|||
155327196|NCT04334317|560634395|FG003|Overall Study|Protocol Deviation|0|||
155327197|NCT04334317|560634392|FG000|Overall Study|Withdrawal by Subject|2|||
155327198|NCT04334317|560634393|FG001|Overall Study|Withdrawal by Subject|2|||
155327199|NCT04334317|560634394|FG002|Overall Study|Withdrawal by Subject|0|||
155327200|NCT04334317|560634395|FG003|Overall Study|Withdrawal by Subject|0|||
155327201|NCT04121546|560634400|FG000|Overall Study|Lost to Follow-up|1|||
155327202|NCT04121546|560634401|FG001|Overall Study|Lost to Follow-up|3|||
155327203|NCT03286114|560634405|FG000|Overall Study|Adverse Event|6|||
155327204|NCT03286114|560634405|FG000|Overall Study|Death|3|||
155327205|NCT00943917|560634414|FG000|Stage I|Adverse Event|1|||
155327206|NCT00943917|560634415|FG001|Stage I|Adverse Event|2|||
155327207|NCT00943917|560634416|FG002|Stage I|Adverse Event|2|||
155327208|NCT00943917|560634417|FG003|Stage I|Adverse Event|0|||
155327209|NCT00943917|560634418|FG004|Stage I|Adverse Event|0|||
155327210|NCT00943917|560634419|FG005|Stage I|Adverse Event|0|||
155327211|NCT00943917|560634420|FG006|Stage I|Adverse Event|0|||
155327212|NCT00943917|560634421|FG007|Stage I|Adverse Event|0|||
155327213|NCT00943917|560634422|FG008|Stage I|Adverse Event|0|||
155327214|NCT00943917|560634423|FG009|Stage I|Adverse Event|0|||
155327215|NCT00943917|560634424|FG010|Stage I|Adverse Event|0|||
155327216|NCT00943917|560634425|FG011|Stage I|Adverse Event|0|||
155327217|NCT00943917|560634426|FG012|Stage I|Adverse Event|0|||
155327218|NCT00943917|560634427|FG013|Stage I|Adverse Event|0|||
155327219|NCT00943917|560634428|FG014|Stage I|Adverse Event|0|||
155327220|NCT00943917|560634414|FG000|Stage I|Lost to Follow-up|0|||
155327221|NCT00943917|560634415|FG001|Stage I|Lost to Follow-up|0|||
155327222|NCT00943917|560634416|FG002|Stage I|Lost to Follow-up|1|||
155327223|NCT00943917|560634417|FG003|Stage I|Lost to Follow-up|0|||
155327224|NCT00943917|560634418|FG004|Stage I|Lost to Follow-up|0|||
155327225|NCT00943917|560634419|FG005|Stage I|Lost to Follow-up|0|||
155327226|NCT00943917|560634420|FG006|Stage I|Lost to Follow-up|0|||
155327227|NCT00943917|560634421|FG007|Stage I|Lost to Follow-up|0|||
155327228|NCT00943917|560634422|FG008|Stage I|Lost to Follow-up|0|||
155327229|NCT00943917|560634423|FG009|Stage I|Lost to Follow-up|0|||
155327230|NCT00943917|560634424|FG010|Stage I|Lost to Follow-up|0|||
155327231|NCT00943917|560634425|FG011|Stage I|Lost to Follow-up|0|||
155327232|NCT00943917|560634426|FG012|Stage I|Lost to Follow-up|0|||
155327233|NCT00943917|560634427|FG013|Stage I|Lost to Follow-up|0|||
155327234|NCT00943917|560634428|FG014|Stage I|Lost to Follow-up|0|||
155327235|NCT00943917|560634414|FG000|Stage I|hyperglycemia|0|||
155327236|NCT00943917|560634415|FG001|Stage I|hyperglycemia|0|||
155327237|NCT00943917|560634416|FG002|Stage I|hyperglycemia|1|||
155327238|NCT00943917|560634417|FG003|Stage I|hyperglycemia|0|||
155327239|NCT00943917|560634418|FG004|Stage I|hyperglycemia|0|||
155327240|NCT00943917|560634419|FG005|Stage I|hyperglycemia|0|||
155327241|NCT00943917|560634420|FG006|Stage I|hyperglycemia|0|||
155327242|NCT00943917|560634421|FG007|Stage I|hyperglycemia|0|||
155327243|NCT00943917|560634422|FG008|Stage I|hyperglycemia|0|||
155421723|NCT03486392|560974338|FG001|Overall Study|Withdrawal by Subject|0|||
155327244|NCT00943917|560634423|FG009|Stage I|hyperglycemia|0|||
155644851|NCT05537571|561789927|FG002|Overall Study|Withdrawal by Subject|0|||
155644852|NCT05537571|561789928|FG003|Overall Study|Withdrawal by Subject|0|||
155327245|NCT00943917|560634424|FG010|Stage I|hyperglycemia|0|||
155327246|NCT00943917|560634425|FG011|Stage I|hyperglycemia|0|||
155327247|NCT00943917|560634426|FG012|Stage I|hyperglycemia|0|||
155327248|NCT00943917|560634427|FG013|Stage I|hyperglycemia|0|||
155327249|NCT00943917|560634428|FG014|Stage I|hyperglycemia|0|||
155327250|NCT00943917|560634414|FG000|Stage I|A1C elevation|1|||
155327251|NCT00943917|560634415|FG001|Stage I|A1C elevation|0|||
155327252|NCT00943917|560634416|FG002|Stage I|A1C elevation|0|||
155327253|NCT00943917|560634417|FG003|Stage I|A1C elevation|0|||
155327254|NCT00943917|560634418|FG004|Stage I|A1C elevation|0|||
155327255|NCT00943917|560634419|FG005|Stage I|A1C elevation|0|||
155327256|NCT00943917|560634420|FG006|Stage I|A1C elevation|0|||
155327257|NCT00943917|560634421|FG007|Stage I|A1C elevation|0|||
155502513|NCT00190684|561265513|FG000|Overall Study|Clinical relapse|67|||
155327258|NCT00943917|560634422|FG008|Stage I|A1C elevation|0|||
155327259|NCT00943917|560634423|FG009|Stage I|A1C elevation|0|||
155327260|NCT00943917|560634424|FG010|Stage I|A1C elevation|0|||
155327261|NCT00943917|560634425|FG011|Stage I|A1C elevation|0|||
155327262|NCT00943917|560634426|FG012|Stage I|A1C elevation|0|||
155327263|NCT00943917|560634427|FG013|Stage I|A1C elevation|0|||
155327264|NCT00943917|560634428|FG014|Stage I|A1C elevation|0|||
155327265|NCT00943917|560634414|FG000|Stage I|Withdrawal by Subject|2|||
155327266|NCT00943917|560634415|FG001|Stage I|Withdrawal by Subject|1|||
155327267|NCT00943917|560634416|FG002|Stage I|Withdrawal by Subject|2|||
155327268|NCT00943917|560634417|FG003|Stage I|Withdrawal by Subject|0|||
155644853|NCT05537571|561789929|FG004|Overall Study|Withdrawal by Subject|0|||
155644854|NCT05537571|561789925|FG000|Overall Study|Adverse Event|2|||
155644855|NCT05537571|561789926|FG001|Overall Study|Adverse Event|0|||
155644856|NCT05537571|561789927|FG002|Overall Study|Adverse Event|0|||
155327269|NCT00943917|560634418|FG004|Stage I|Withdrawal by Subject|0|||
155327270|NCT00943917|560634419|FG005|Stage I|Withdrawal by Subject|0|||
155327271|NCT00943917|560634420|FG006|Stage I|Withdrawal by Subject|0|||
155327272|NCT00943917|560634421|FG007|Stage I|Withdrawal by Subject|0|||
155327273|NCT00943917|560634422|FG008|Stage I|Withdrawal by Subject|0|||
155327274|NCT00943917|560634423|FG009|Stage I|Withdrawal by Subject|0|||
155327275|NCT00943917|560634424|FG010|Stage I|Withdrawal by Subject|0|||
155327276|NCT00943917|560634425|FG011|Stage I|Withdrawal by Subject|0|||
155327277|NCT00943917|560634426|FG012|Stage I|Withdrawal by Subject|0|||
155327278|NCT00943917|560634427|FG013|Stage I|Withdrawal by Subject|0|||
155644857|NCT05537571|561789928|FG003|Overall Study|Adverse Event|0|||
155644858|NCT05537571|561789929|FG004|Overall Study|Adverse Event|0|||
155644859|NCT05537571|561789925|FG000|Overall Study|Hepatitis A screening result|2|||
155327279|NCT00943917|560634428|FG014|Stage I|Withdrawal by Subject|0|||
155327280|NCT00943917|560634414|FG000|Stage II|Adverse Event|0|||
155502514|NCT00190684|561265513|FG000|Overall Study|Sponsor's decision|17|||
155644860|NCT05537571|561789926|FG001|Overall Study|Hepatitis A screening result|0|||
155644861|NCT05537571|561789927|FG002|Overall Study|Hepatitis A screening result|0|||
155327281|NCT00943917|560634415|FG001|Stage II|Adverse Event|0|||
155644862|NCT05537571|561789928|FG003|Overall Study|Hepatitis A screening result|0|||
155327282|NCT00943917|560634416|FG002|Stage II|Adverse Event|0|||
155327283|NCT00943917|560634417|FG003|Stage II|Adverse Event|0|||
155327284|NCT00943917|560634418|FG004|Stage II|Adverse Event|0|||
155327285|NCT00943917|560634419|FG005|Stage II|Adverse Event|1|||
155327286|NCT00943917|560634420|FG006|Stage II|Adverse Event|3|||
155327287|NCT00943917|560634421|FG007|Stage II|Adverse Event|0|||
155327288|NCT00943917|560634422|FG008|Stage II|Adverse Event|1|||
155327289|NCT00943917|560634423|FG009|Stage II|Adverse Event|0|||
155327290|NCT00943917|560634424|FG010|Stage II|Adverse Event|0|||
155327291|NCT00943917|560634425|FG011|Stage II|Adverse Event|0|||
155327292|NCT00943917|560634426|FG012|Stage II|Adverse Event|0|||
155327293|NCT00943917|560634427|FG013|Stage II|Adverse Event|0|||
155327294|NCT00943917|560634428|FG014|Stage II|Adverse Event|0|||
155327295|NCT00943917|560634414|FG000|Stage II|Withdrawal by Subject|0|||
155327296|NCT00943917|560634415|FG001|Stage II|Withdrawal by Subject|0|||
155327297|NCT00943917|560634416|FG002|Stage II|Withdrawal by Subject|0|||
155327298|NCT00943917|560634417|FG003|Stage II|Withdrawal by Subject|0|||
155327299|NCT00943917|560634418|FG004|Stage II|Withdrawal by Subject|0|||
155327300|NCT00943917|560634419|FG005|Stage II|Withdrawal by Subject|1|||
155327301|NCT00943917|560634420|FG006|Stage II|Withdrawal by Subject|0|||
155327302|NCT00943917|560634421|FG007|Stage II|Withdrawal by Subject|0|||
155327303|NCT00943917|560634422|FG008|Stage II|Withdrawal by Subject|0|||
155327304|NCT00943917|560634423|FG009|Stage II|Withdrawal by Subject|0|||
155327305|NCT00943917|560634424|FG010|Stage II|Withdrawal by Subject|0|||
155327306|NCT00943917|560634425|FG011|Stage II|Withdrawal by Subject|0|||
155327307|NCT00943917|560634426|FG012|Stage II|Withdrawal by Subject|0|||
155327308|NCT00943917|560634427|FG013|Stage II|Withdrawal by Subject|0|||
155327309|NCT00943917|560634428|FG014|Stage II|Withdrawal by Subject|0|||
155327310|NCT00943917|560634414|FG000|Stage II|Pregnancy|0|||
155327311|NCT00943917|560634415|FG001|Stage II|Pregnancy|0|||
155327312|NCT00943917|560634416|FG002|Stage II|Pregnancy|0|||
155327313|NCT00943917|560634417|FG003|Stage II|Pregnancy|0|||
155327314|NCT00943917|560634418|FG004|Stage II|Pregnancy|0|||
155327315|NCT00943917|560634419|FG005|Stage II|Pregnancy|1|||
155327316|NCT00943917|560634420|FG006|Stage II|Pregnancy|0|||
155327317|NCT00943917|560634421|FG007|Stage II|Pregnancy|0|||
155327318|NCT00943917|560634422|FG008|Stage II|Pregnancy|0|||
155327319|NCT00943917|560634423|FG009|Stage II|Pregnancy|0|||
155327320|NCT00943917|560634424|FG010|Stage II|Pregnancy|0|||
155327321|NCT00943917|560634425|FG011|Stage II|Pregnancy|0|||
155327322|NCT00943917|560634426|FG012|Stage II|Pregnancy|0|||
155327323|NCT00943917|560634427|FG013|Stage II|Pregnancy|0|||
155327324|NCT00943917|560634428|FG014|Stage II|Pregnancy|0|||
155327325|NCT00943917|560634414|FG000|Stage II Continuation|Adverse Event|0|||
155327326|NCT00943917|560634415|FG001|Stage II Continuation|Adverse Event|0|||
155327327|NCT00943917|560634416|FG002|Stage II Continuation|Adverse Event|0|||
155327328|NCT00943917|560634417|FG003|Stage II Continuation|Adverse Event|0|||
155327329|NCT00943917|560634418|FG004|Stage II Continuation|Adverse Event|0|||
155327330|NCT00943917|560634419|FG005|Stage II Continuation|Adverse Event|0|||
155327331|NCT00943917|560634420|FG006|Stage II Continuation|Adverse Event|0|||
155327332|NCT00943917|560634421|FG007|Stage II Continuation|Adverse Event|0|||
155327333|NCT00943917|560634422|FG008|Stage II Continuation|Adverse Event|0|||
155327334|NCT00943917|560634423|FG009|Stage II Continuation|Adverse Event|0|||
155327335|NCT00943917|560634424|FG010|Stage II Continuation|Adverse Event|0|||
155327336|NCT00943917|560634425|FG011|Stage II Continuation|Adverse Event|1|||
155327337|NCT00943917|560634426|FG012|Stage II Continuation|Adverse Event|2|||
155327338|NCT00943917|560634427|FG013|Stage II Continuation|Adverse Event|1|||
155327339|NCT00943917|560634428|FG014|Stage II Continuation|Adverse Event|1|||
155327340|NCT00943917|560634414|FG000|Stage II Continuation|Withdrawal by Subject|0|||
155327341|NCT00943917|560634415|FG001|Stage II Continuation|Withdrawal by Subject|0|||
155327342|NCT00943917|560634416|FG002|Stage II Continuation|Withdrawal by Subject|0|||
155327343|NCT00943917|560634417|FG003|Stage II Continuation|Withdrawal by Subject|0|||
155327344|NCT00943917|560634418|FG004|Stage II Continuation|Withdrawal by Subject|0|||
155327345|NCT00943917|560634419|FG005|Stage II Continuation|Withdrawal by Subject|0|||
155327346|NCT00943917|560634420|FG006|Stage II Continuation|Withdrawal by Subject|0|||
155327347|NCT00943917|560634421|FG007|Stage II Continuation|Withdrawal by Subject|0|||
155327348|NCT00943917|560634422|FG008|Stage II Continuation|Withdrawal by Subject|0|||
155327349|NCT00943917|560634423|FG009|Stage II Continuation|Withdrawal by Subject|0|||
155327350|NCT00943917|560634424|FG010|Stage II Continuation|Withdrawal by Subject|0|||
155327351|NCT00943917|560634425|FG011|Stage II Continuation|Withdrawal by Subject|0|||
155327352|NCT00943917|560634426|FG012|Stage II Continuation|Withdrawal by Subject|0|||
155502515|NCT00190684|561265513|FG000|Overall Study|Physician Decision|84|||
155327353|NCT00943917|560634427|FG013|Stage II Continuation|Withdrawal by Subject|1|||
155327354|NCT00943917|560634428|FG014|Stage II Continuation|Withdrawal by Subject|3|||
155327355|NCT00943917|560634414|FG000|Stage II Continuation|Protocol Violation|0|||
155327356|NCT00943917|560634415|FG001|Stage II Continuation|Protocol Violation|0|||
155327357|NCT00943917|560634416|FG002|Stage II Continuation|Protocol Violation|0|||
155327358|NCT00943917|560634417|FG003|Stage II Continuation|Protocol Violation|0|||
155327359|NCT00943917|560634418|FG004|Stage II Continuation|Protocol Violation|0|||
155327360|NCT00943917|560634419|FG005|Stage II Continuation|Protocol Violation|0|||
155327361|NCT00943917|560634420|FG006|Stage II Continuation|Protocol Violation|0|||
155327362|NCT00943917|560634421|FG007|Stage II Continuation|Protocol Violation|0|||
155327363|NCT00943917|560634422|FG008|Stage II Continuation|Protocol Violation|0|||
155327364|NCT00943917|560634423|FG009|Stage II Continuation|Protocol Violation|1|||
155327365|NCT00943917|560634424|FG010|Stage II Continuation|Protocol Violation|0|||
155327366|NCT00943917|560634425|FG011|Stage II Continuation|Protocol Violation|1|||
155327367|NCT00943917|560634426|FG012|Stage II Continuation|Protocol Violation|0|||
155327368|NCT00943917|560634427|FG013|Stage II Continuation|Protocol Violation|0|||
155327369|NCT00943917|560634428|FG014|Stage II Continuation|Protocol Violation|0|||
155327370|NCT00943917|560634414|FG000|Stage II Continuation|hypoglycemia|0|||
155327371|NCT00943917|560634415|FG001|Stage II Continuation|hypoglycemia|0|||
155327372|NCT00943917|560634416|FG002|Stage II Continuation|hypoglycemia|0|||
155327373|NCT00943917|560634417|FG003|Stage II Continuation|hypoglycemia|0|||
155327374|NCT00943917|560634418|FG004|Stage II Continuation|hypoglycemia|0|||
155327375|NCT00943917|560634419|FG005|Stage II Continuation|hypoglycemia|0|||
155327376|NCT00943917|560634420|FG006|Stage II Continuation|hypoglycemia|0|||
155327377|NCT00943917|560634421|FG007|Stage II Continuation|hypoglycemia|0|||
155327378|NCT00943917|560634422|FG008|Stage II Continuation|hypoglycemia|0|||
155327379|NCT00943917|560634423|FG009|Stage II Continuation|hypoglycemia|0|||
155327380|NCT00943917|560634424|FG010|Stage II Continuation|hypoglycemia|0|||
155327381|NCT00943917|560634425|FG011|Stage II Continuation|hypoglycemia|0|||
155327382|NCT00943917|560634426|FG012|Stage II Continuation|hypoglycemia|1|||
155327383|NCT00943917|560634427|FG013|Stage II Continuation|hypoglycemia|0|||
155327384|NCT00943917|560634428|FG014|Stage II Continuation|hypoglycemia|0|||
155327385|NCT00943917|560634414|FG000|Stage II Continuation|A1C elevation|0|||
155327386|NCT00943917|560634415|FG001|Stage II Continuation|A1C elevation|0|||
155327387|NCT00943917|560634416|FG002|Stage II Continuation|A1C elevation|0|||
155327388|NCT00943917|560634417|FG003|Stage II Continuation|A1C elevation|0|||
155327389|NCT00943917|560634418|FG004|Stage II Continuation|A1C elevation|0|||
155327390|NCT00943917|560634419|FG005|Stage II Continuation|A1C elevation|0|||
155327391|NCT00943917|560634420|FG006|Stage II Continuation|A1C elevation|0|||
155327392|NCT00943917|560634421|FG007|Stage II Continuation|A1C elevation|0|||
155327393|NCT00943917|560634422|FG008|Stage II Continuation|A1C elevation|0|||
155327394|NCT00943917|560634423|FG009|Stage II Continuation|A1C elevation|0|||
155327395|NCT00943917|560634424|FG010|Stage II Continuation|A1C elevation|0|||
155327396|NCT00943917|560634425|FG011|Stage II Continuation|A1C elevation|0|||
155327397|NCT00943917|560634426|FG012|Stage II Continuation|A1C elevation|0|||
155327398|NCT00943917|560634427|FG013|Stage II Continuation|A1C elevation|1|||
155327399|NCT00943917|560634428|FG014|Stage II Continuation|A1C elevation|0|||
155327400|NCT01171976|560634429|FG000|Overall Study|Protocol Violation|0|||
155327401|NCT01171976|560634430|FG001|Overall Study|Protocol Violation|0|||
155327402|NCT01171976|560634431|FG002|Overall Study|Protocol Violation|1|||
155327403|NCT01171976|560634429|FG000|Overall Study|Death|2|||
155327404|NCT01171976|560634430|FG001|Overall Study|Death|4|||
155327405|NCT01171976|560634431|FG002|Overall Study|Death|1|||
155327406|NCT01171976|560634429|FG000|Overall Study|Lost to Follow-up|4|||
155327407|NCT01171976|560634430|FG001|Overall Study|Lost to Follow-up|0|||
155327408|NCT01171976|560634431|FG002|Overall Study|Lost to Follow-up|2|||
155327409|NCT01171976|560634429|FG000|Overall Study|Withdrawal by Subject|1|||
155327410|NCT01171976|560634430|FG001|Overall Study|Withdrawal by Subject|5|||
155327411|NCT01171976|560634431|FG002|Overall Study|Withdrawal by Subject|6|||
155327412|NCT01171976|560634429|FG000|Overall Study|Abnormal test result|1|||
155327413|NCT01171976|560634430|FG001|Overall Study|Abnormal test result|0|||
155327414|NCT01171976|560634431|FG002|Overall Study|Abnormal test result|0|||
155327415|NCT01171976|560634429|FG000|Overall Study|Adverse Event|6|||
155327416|NCT01171976|560634430|FG001|Overall Study|Adverse Event|2|||
155327417|NCT01171976|560634431|FG002|Overall Study|Adverse Event|5|||
155327418|NCT03248492|560634432|FG000|Overall Study|Progressive Disease|24|||
155327419|NCT03248492|560634433|FG001|Overall Study|Progressive Disease|23|||
155327420|NCT03248492|560634434|FG002|Overall Study|Progressive Disease|11|||
155327421|NCT03248492|560634435|FG003|Overall Study|Progressive Disease|66|||
155327422|NCT03248492|560634436|FG004|Overall Study|Progressive Disease|1|||
155327423|NCT03248492|560634432|FG000|Overall Study|Adverse Event|14|||
155327424|NCT03248492|560634433|FG001|Overall Study|Adverse Event|13|||
155327425|NCT03248492|560634434|FG002|Overall Study|Adverse Event|9|||
155644863|NCT05537571|561789929|FG004|Overall Study|Hepatitis A screening result|0|||
155644864|NCT05537571|561789925|FG000|Overall Study|Lost to Follow-up|0|||
155644865|NCT05537571|561789926|FG001|Overall Study|Lost to Follow-up|0|||
155644866|NCT05537571|561789927|FG002|Overall Study|Lost to Follow-up|1|||
155644867|NCT05537571|561789928|FG003|Overall Study|Lost to Follow-up|0|||
155644868|NCT05537571|561789929|FG004|Overall Study|Lost to Follow-up|1|||
155644869|NCT04439123|561789932|FG000|Overall Study|Adverse Event|11|||
155644870|NCT04439123|561789932|FG000|Overall Study|Death|1|||
155644871|NCT04439123|561789932|FG000|Overall Study|Disease progression|19|||
155644872|NCT04439123|561789932|FG000|Overall Study|Withdrawal by Subject|2|||
155327426|NCT03248492|560634435|FG003|Overall Study|Adverse Event|22|||
155644873|NCT04439123|561789932|FG000|Overall Study|Still on treatment|2|||
155327427|NCT03248492|560634436|FG004|Overall Study|Adverse Event|2|||
155327428|NCT03248492|560634432|FG000|Overall Study|Withdrawal by Subject|5|||
155327429|NCT03248492|560634433|FG001|Overall Study|Withdrawal by Subject|4|||
155327430|NCT03248492|560634434|FG002|Overall Study|Withdrawal by Subject|0|||
155327431|NCT03248492|560634435|FG003|Overall Study|Withdrawal by Subject|8|||
155327432|NCT03248492|560634436|FG004|Overall Study|Withdrawal by Subject|1|||
155327433|NCT03248492|560634432|FG000|Overall Study|Physician Decision|1|||
155327434|NCT03248492|560634433|FG001|Overall Study|Physician Decision|1|||
155327435|NCT03248492|560634434|FG002|Overall Study|Physician Decision|1|||
155327436|NCT03248492|560634435|FG003|Overall Study|Physician Decision|7|||
155327437|NCT03248492|560634436|FG004|Overall Study|Physician Decision|0|||
155327438|NCT03248492|560634432|FG000|Overall Study|Death|1|||
155327439|NCT03248492|560634433|FG001|Overall Study|Death|1|||
155327440|NCT03248492|560634434|FG002|Overall Study|Death|0|||
155327441|NCT03248492|560634435|FG003|Overall Study|Death|6|||
155327442|NCT03248492|560634436|FG004|Overall Study|Death|0|||
155327443|NCT03248492|560634432|FG000|Overall Study|Study Terminated by Sponsor|3|||
155327444|NCT03248492|560634433|FG001|Overall Study|Study Terminated by Sponsor|1|||
155327445|NCT03248492|560634434|FG002|Overall Study|Study Terminated by Sponsor|0|||
155327446|NCT03248492|560634435|FG003|Overall Study|Study Terminated by Sponsor|7|||
155327447|NCT03248492|560634436|FG004|Overall Study|Study Terminated by Sponsor|0|||
155327448|NCT03248492|560634432|FG000|Overall Study|Other|2|||
155327449|NCT03248492|560634433|FG001|Overall Study|Other|5|||
155327450|NCT03248492|560634434|FG002|Overall Study|Other|0|||
155327451|NCT03248492|560634435|FG003|Overall Study|Other|14|||
155327452|NCT03248492|560634436|FG004|Overall Study|Other|0|||
155327453|NCT04495621|560634439|FG000|Overall Study|Withdrawal by Subject|0|||
155327454|NCT04495621|560634440|FG001|Overall Study|Withdrawal by Subject|3|||
155327455|NCT04495621|560634439|FG000|Overall Study|Death|7|||
155327456|NCT04495621|560634440|FG001|Overall Study|Death|11|||
155327457|NCT04495621|560634439|FG000|Overall Study|Investigator Decision|0|||
155327458|NCT04495621|560634440|FG001|Overall Study|Investigator Decision|7|||
155327459|NCT04495621|560634439|FG000|Overall Study|Lost to Follow-up|0|||
155327460|NCT04495621|560634440|FG001|Overall Study|Lost to Follow-up|1|||
155327461|NCT04908514|560634447|FG000|Overall Study|Lost to Follow-up|2|||
155327462|NCT04908514|560634447|FG000|Overall Study|Withdrawal by Subject|1|||
155327463|NCT03774472|560634448|FG000|Overall Study|Physician Decision|1|||
155327464|NCT03774472|560634449|FG001|Overall Study|Physician Decision|0|||
155327465|NCT03774472|560634450|FG002|Overall Study|Physician Decision|0|||
155327466|NCT03774472|560634448|FG000|Overall Study|Progression prior to 4 weeks|0|||
155327467|NCT03774472|560634449|FG001|Overall Study|Progression prior to 4 weeks|1|||
155327468|NCT03774472|560634450|FG002|Overall Study|Progression prior to 4 weeks|0|||
155327469|NCT03774472|560634448|FG000|Overall Study|Withdrawal by Subject|0|||
155327470|NCT03774472|560634449|FG001|Overall Study|Withdrawal by Subject|1|||
155327471|NCT03774472|560634450|FG002|Overall Study|Withdrawal by Subject|0|||
155327472|NCT05155306|560634455|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
155327473|NCT05155306|560634456|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
155327474|NCT05155306|560634457|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
155327475|NCT05155306|560634458|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
155327476|NCT05155306|560634455|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
155327477|NCT05155306|560634456|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
155327478|NCT05155306|560634457|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
155327479|NCT05155306|560634458|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
155327480|NCT03150862|560634459|FG000|Overall Study|Death|2|||
155327481|NCT03150862|560634460|FG001|Overall Study|Death|7|||
155327482|NCT03150862|560634461|FG002|Overall Study|Death|8|||
155327483|NCT03150862|560634462|FG003|Overall Study|Death|27|||
155327484|NCT03150862|560634463|FG004|Overall Study|Death|4|||
155327485|NCT03150862|560634464|FG005|Overall Study|Death|8|||
155327486|NCT03150862|560634465|FG006|Overall Study|Death|6|||
155327487|NCT03150862|560634466|FG007|Overall Study|Death|21|||
155327488|NCT03150862|560634459|FG000|Overall Study|Withdrawal by Subject|1|||
155327489|NCT03150862|560634460|FG001|Overall Study|Withdrawal by Subject|1|||
155502516|NCT00190684|561265513|FG000|Overall Study|Protocol Violation|123|||
155644874|NCT00002874|561789933|FG000|Overall Study|Withdrawal by Subject|1|||
155327490|NCT03150862|560634461|FG002|Overall Study|Withdrawal by Subject|0|||
155327491|NCT03150862|560634462|FG003|Overall Study|Withdrawal by Subject|3|||
155327492|NCT03150862|560634463|FG004|Overall Study|Withdrawal by Subject|1|||
155327493|NCT03150862|560634464|FG005|Overall Study|Withdrawal by Subject|1|||
155327494|NCT03150862|560634465|FG006|Overall Study|Withdrawal by Subject|1|||
155327495|NCT03150862|560634466|FG007|Overall Study|Withdrawal by Subject|3|||
155327496|NCT03150862|560634459|FG000|Overall Study|Lost to Follow-up|0|||
155327497|NCT03150862|560634460|FG001|Overall Study|Lost to Follow-up|0|||
155327498|NCT03150862|560634461|FG002|Overall Study|Lost to Follow-up|1|||
155327499|NCT03150862|560634462|FG003|Overall Study|Lost to Follow-up|0|||
155327500|NCT03150862|560634463|FG004|Overall Study|Lost to Follow-up|0|||
155327501|NCT03150862|560634464|FG005|Overall Study|Lost to Follow-up|0|||
155327502|NCT03150862|560634465|FG006|Overall Study|Lost to Follow-up|0|||
155327503|NCT03150862|560634466|FG007|Overall Study|Lost to Follow-up|2|||
155327504|NCT03150862|560634459|FG000|Overall Study|Sponsor's decision|0|||
155327505|NCT03150862|560634460|FG001|Overall Study|Sponsor's decision|0|||
155327506|NCT03150862|560634461|FG002|Overall Study|Sponsor's decision|0|||
155327507|NCT03150862|560634462|FG003|Overall Study|Sponsor's decision|10|||
155327508|NCT03150862|560634463|FG004|Overall Study|Sponsor's decision|3|||
155327509|NCT03150862|560634464|FG005|Overall Study|Sponsor's decision|0|||
155327510|NCT03150862|560634465|FG006|Overall Study|Sponsor's decision|1|||
155327511|NCT03150862|560634466|FG007|Overall Study|Sponsor's decision|1|||
155327512|NCT03150862|560634459|FG000|Overall Study|Change in Methylation status|0|||
155327513|NCT03150862|560634460|FG001|Overall Study|Change in Methylation status|0|||
155327514|NCT03150862|560634461|FG002|Overall Study|Change in Methylation status|0|||
155327515|NCT03150862|560634462|FG003|Overall Study|Change in Methylation status|0|||
155327516|NCT03150862|560634463|FG004|Overall Study|Change in Methylation status|1|||
155327517|NCT03150862|560634464|FG005|Overall Study|Change in Methylation status|0|||
155327518|NCT03150862|560634465|FG006|Overall Study|Change in Methylation status|0|||
155327519|NCT03150862|560634466|FG007|Overall Study|Change in Methylation status|0|||
155327520|NCT03150862|560634459|FG000|Overall Study|Roll over in to Long Term Extension|0|||
155327521|NCT03150862|560634460|FG001|Overall Study|Roll over in to Long Term Extension|0|||
155327522|NCT03150862|560634461|FG002|Overall Study|Roll over in to Long Term Extension|0|||
155327523|NCT03150862|560634462|FG003|Overall Study|Roll over in to Long Term Extension|0|||
155327524|NCT03150862|560634463|FG004|Overall Study|Roll over in to Long Term Extension|0|||
155327525|NCT03150862|560634464|FG005|Overall Study|Roll over in to Long Term Extension|0|||
155327526|NCT03150862|560634465|FG006|Overall Study|Roll over in to Long Term Extension|0|||
155327527|NCT03150862|560634466|FG007|Overall Study|Roll over in to Long Term Extension|1|||
155327528|NCT03150862|560634459|FG000|Overall Study|Progressive Disease|0|||
155327529|NCT03150862|560634460|FG001|Overall Study|Progressive Disease|0|||
155327530|NCT03150862|560634461|FG002|Overall Study|Progressive Disease|0|||
155327531|NCT03150862|560634462|FG003|Overall Study|Progressive Disease|0|||
155327532|NCT03150862|560634463|FG004|Overall Study|Progressive Disease|0|||
155327533|NCT03150862|560634464|FG005|Overall Study|Progressive Disease|0|||
155327534|NCT03150862|560634465|FG006|Overall Study|Progressive Disease|0|||
155327535|NCT03150862|560634466|FG007|Overall Study|Progressive Disease|2|||
155327536|NCT04158141|560634467|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
155327537|NCT04158141|560634468|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
155327538|NCT04158141|560634469|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
155327539|NCT04158141|560634467|FG000|Step 1: Registration|Adverse Event|1|||
155327540|NCT04158141|560634468|FG001|Step 1: Registration|Adverse Event|0|||
155327541|NCT04158141|560634469|FG002|Step 1: Registration|Adverse Event|0|||
155327542|NCT04158141|560634467|FG000|Step 1: Registration|Withdrawal by Subject|1|||
155327543|NCT04158141|560634468|FG001|Step 1: Registration|Withdrawal by Subject|0|||
155327544|NCT04158141|560634469|FG002|Step 1: Registration|Withdrawal by Subject|0|||
155327545|NCT04158141|560634467|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
155327546|NCT04158141|560634468|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
155327547|NCT04158141|560634469|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
155327548|NCT04121741|560634473|FG000|Overall Study|Protocol Violation|1|||
155327549|NCT04121741|560634474|FG001|Overall Study|Protocol Violation|0|||
155327550|NCT04121741|560634475|FG002|Overall Study|Protocol Violation|0|||
155327551|NCT04121741|560634476|FG003|Overall Study|Protocol Violation|0|||
155327552|NCT04121741|560634477|FG004|Overall Study|Protocol Violation|0|||
155327553|NCT04121741|560634478|FG005|Overall Study|Protocol Violation|0|||
155327554|NCT01084863|560634479|FG000|Main Study Treatment Period|Disease progression|11|||
155327555|NCT01084863|560634480|FG001|Main Study Treatment Period|Disease progression|7|||
155327556|NCT01084863|560634479|FG000|Main Study Treatment Period|Adverse Event|5|||
155327557|NCT01084863|560634480|FG001|Main Study Treatment Period|Adverse Event|3|||
155327558|NCT01084863|560634479|FG000|Main Study Treatment Period|Other Reason|0|||
155327559|NCT01084863|560634480|FG001|Main Study Treatment Period|Other Reason|1|||
155327560|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
155327561|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
155327562|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
155327563|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
155327564|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
155327565|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
155327566|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
155327567|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
155327568|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Other|0|||
155327569|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Other|1|||
155327570|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
155327571|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
155327572|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
155327573|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
155327574|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
155327575|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
155327576|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
155327577|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
155327578|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
155327579|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
155327580|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
155327581|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
155327582|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
155327583|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
155327584|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
155327585|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
155327586|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
155327587|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
155327588|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
155327589|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
155327590|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
155327591|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
155502517|NCT00190684|561265513|FG000|Overall Study|Study Period III Completed|103|||
155644875|NCT00002874|561789934|FG001|Overall Study|Withdrawal by Subject|1|||
155644876|NCT00002874|561789933|FG000|Overall Study|Protocol Violation|44|||
155644877|NCT00002874|561789934|FG001|Overall Study|Protocol Violation|34|||
155644878|NCT03166631|561792059|FG000|Overall Study|Progressive disease|2|||
155644879|NCT03166631|561792060|FG001|Overall Study|Progressive disease|1|||
155644880|NCT03166631|561792061|FG002|Overall Study|Progressive disease|3|||
155644881|NCT03166631|561792062|FG003|Overall Study|Progressive disease|4|||
155644882|NCT03166631|561792063|FG004|Overall Study|Progressive disease|2|||
155644883|NCT03166631|561792064|FG005|Overall Study|Progressive disease|2|||
155644884|NCT03166631|561792065|FG006|Overall Study|Progressive disease|5|||
155644885|NCT03166631|561792066|FG007|Overall Study|Progressive disease|6|||
155644886|NCT03166631|561792067|FG008|Overall Study|Progressive disease|11|||
155644887|NCT03166631|561792068|FG009|Overall Study|Progressive disease|5|||
155644888|NCT03166631|561792069|FG010|Overall Study|Progressive disease|7|||
155644889|NCT03166631|561792059|FG000|Overall Study|Physician Decision|0|||
155644890|NCT03166631|561792060|FG001|Overall Study|Physician Decision|0|||
155327592|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
155327593|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
155327594|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
155327595|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
155327596|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
155327597|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
155327598|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
155327599|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
155327600|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
155327601|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
155327602|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
155327603|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
155327604|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
155327605|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
155327606|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
155327607|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
155327608|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
155327609|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
155327610|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
155327611|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
155327612|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
155327613|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
155327614|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
155327615|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
155327616|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
155327617|NCT03473223|560634485|FG000|Overall Study|Lost to Follow-up|1|||
155327618|NCT03473223|560634486|FG001|Overall Study|Lost to Follow-up|1|||
155327619|NCT03473223|560634485|FG000|Overall Study|Withdrawal by Subject|47|||
155327620|NCT03473223|560634486|FG001|Overall Study|Withdrawal by Subject|42|||
155327621|NCT03473223|560634485|FG000|Overall Study|Indirect contact|32|||
155327622|NCT03473223|560634486|FG001|Overall Study|Indirect contact|29|||
155327623|NCT03473223|560634485|FG000|Overall Study|Other (Not specified)|32|||
155327624|NCT03473223|560634486|FG001|Overall Study|Other (Not specified)|20|||
155327625|NCT04755595|560634487|FG000|Overall Study|Lost to Follow-up|1|||
155327626|NCT00319696|560634488|FG000|Overall Study|Adverse Event|36|||
155327627|NCT00319696|560634488|FG000|Overall Study|withdrawal of consent|14|||
155327628|NCT00319696|560634488|FG000|Overall Study|administrative|7|||
155644891|NCT03166631|561792061|FG002|Overall Study|Physician Decision|0|||
155327629|NCT00319696|560634488|FG000|Overall Study|Lost to Follow-up|3|||
155327630|NCT04530487|560635214|FG000|Overall Study|Death|1|||
155327631|NCT00210106|560635215|FG000|Overall Study|Death|1|||
155327632|NCT00210106|560635215|FG000|Overall Study|Protocol Violation|13|||
155327633|NCT01288443|560635218|FG000|Overall Study|Adverse Event|0|||
155327634|NCT01288443|560635219|FG001|Overall Study|Adverse Event|0|||
155327635|NCT01288443|560635220|FG002|Overall Study|Adverse Event|1|||
155644892|NCT03166631|561792062|FG003|Overall Study|Physician Decision|0|||
155644893|NCT03166631|561792063|FG004|Overall Study|Physician Decision|0|||
155644894|NCT03166631|561792064|FG005|Overall Study|Physician Decision|0|||
155644895|NCT03166631|561792065|FG006|Overall Study|Physician Decision|1|||
155644896|NCT03166631|561792066|FG007|Overall Study|Physician Decision|0|||
155644897|NCT03166631|561792067|FG008|Overall Study|Physician Decision|1|||
155644898|NCT03166631|561792068|FG009|Overall Study|Physician Decision|0|||
155644899|NCT03166631|561792069|FG010|Overall Study|Physician Decision|1|||
155644900|NCT03166631|561792059|FG000|Overall Study|Death|0|||
155644901|NCT03166631|561792060|FG001|Overall Study|Death|0|||
155644902|NCT03166631|561792061|FG002|Overall Study|Death|0|||
155644903|NCT03166631|561792062|FG003|Overall Study|Death|0|||
155644904|NCT03166631|561792063|FG004|Overall Study|Death|1|||
155644905|NCT03166631|561792064|FG005|Overall Study|Death|0|||
155644906|NCT03166631|561792065|FG006|Overall Study|Death|1|||
155644907|NCT03166631|561792066|FG007|Overall Study|Death|0|||
155644908|NCT03166631|561792067|FG008|Overall Study|Death|0|||
155644909|NCT03166631|561792068|FG009|Overall Study|Death|0|||
155644910|NCT03166631|561792069|FG010|Overall Study|Death|0|||
155644911|NCT03166631|561792059|FG000|Overall Study|Adverse Event|1|||
155644912|NCT03166631|561792060|FG001|Overall Study|Adverse Event|0|||
155644913|NCT03166631|561792061|FG002|Overall Study|Adverse Event|0|||
155644914|NCT03166631|561792062|FG003|Overall Study|Adverse Event|0|||
155644915|NCT03166631|561792063|FG004|Overall Study|Adverse Event|0|||
155644916|NCT03166631|561792064|FG005|Overall Study|Adverse Event|1|||
155644917|NCT03166631|561792065|FG006|Overall Study|Adverse Event|1|||
155644918|NCT03166631|561792066|FG007|Overall Study|Adverse Event|0|||
155644919|NCT03166631|561792067|FG008|Overall Study|Adverse Event|1|||
155644920|NCT03166631|561792068|FG009|Overall Study|Adverse Event|2|||
155644921|NCT03166631|561792069|FG010|Overall Study|Adverse Event|1|||
155644922|NCT03166631|561792059|FG000|Overall Study|Withdrawal by Subject|0|||
155327636|NCT01288443|560635221|FG003|Overall Study|Adverse Event|1|||
155327637|NCT01288443|560635222|FG004|Overall Study|Adverse Event|3|||
155327638|NCT01288443|560635223|FG005|Overall Study|Adverse Event|1|||
155327639|NCT01288443|560635218|FG000|Overall Study|Poor compliance to protocol|0|||
155327640|NCT01288443|560635219|FG001|Overall Study|Poor compliance to protocol|0|||
155327641|NCT01288443|560635220|FG002|Overall Study|Poor compliance to protocol|0|||
155327642|NCT01288443|560635221|FG003|Overall Study|Poor compliance to protocol|0|||
155327643|NCT01288443|560635222|FG004|Overall Study|Poor compliance to protocol|0|||
155327644|NCT01288443|560635223|FG005|Overall Study|Poor compliance to protocol|1|||
155327645|NCT01288443|560635218|FG000|Overall Study|Participant Moved|0|||
155327646|NCT01288443|560635219|FG001|Overall Study|Participant Moved|0|||
155327647|NCT01288443|560635220|FG002|Overall Study|Participant Moved|0|||
155327648|NCT01288443|560635221|FG003|Overall Study|Participant Moved|1|||
155327649|NCT01288443|560635222|FG004|Overall Study|Participant Moved|2|||
155327650|NCT01288443|560635223|FG005|Overall Study|Participant Moved|1|||
155327651|NCT01288443|560635218|FG000|Overall Study|Consent withdrawn by Participant|0|||
155327652|NCT01288443|560635219|FG001|Overall Study|Consent withdrawn by Participant|0|||
155327653|NCT01288443|560635220|FG002|Overall Study|Consent withdrawn by Participant|0|||
155327654|NCT01288443|560635221|FG003|Overall Study|Consent withdrawn by Participant|0|||
155327655|NCT01288443|560635222|FG004|Overall Study|Consent withdrawn by Participant|0|||
155327656|NCT01288443|560635223|FG005|Overall Study|Consent withdrawn by Participant|1|||
155327657|NCT01288443|560635218|FG000|Overall Study|Lost to Follow-up|0|||
155327658|NCT01288443|560635219|FG001|Overall Study|Lost to Follow-up|1|||
155327659|NCT01288443|560635220|FG002|Overall Study|Lost to Follow-up|0|||
155327660|NCT01288443|560635221|FG003|Overall Study|Lost to Follow-up|0|||
155327661|NCT01288443|560635222|FG004|Overall Study|Lost to Follow-up|0|||
155327662|NCT01288443|560635223|FG005|Overall Study|Lost to Follow-up|0|||
155644923|NCT03166631|561792060|FG001|Overall Study|Withdrawal by Subject|0|||
155644924|NCT03166631|561792061|FG002|Overall Study|Withdrawal by Subject|0|||
155644925|NCT03166631|561792062|FG003|Overall Study|Withdrawal by Subject|0|||
155644926|NCT03166631|561792063|FG004|Overall Study|Withdrawal by Subject|0|||
155644927|NCT03166631|561792064|FG005|Overall Study|Withdrawal by Subject|0|||
155644928|NCT03166631|561792065|FG006|Overall Study|Withdrawal by Subject|0|||
155644929|NCT03166631|561792066|FG007|Overall Study|Withdrawal by Subject|0|||
155644930|NCT03166631|561792067|FG008|Overall Study|Withdrawal by Subject|1|||
155644931|NCT03166631|561792068|FG009|Overall Study|Withdrawal by Subject|1|||
155644932|NCT03166631|561792069|FG010|Overall Study|Withdrawal by Subject|0|||
155644933|NCT02370394|561792079|FG000|Overall Study|Lost to Follow-up|2|||
155644934|NCT02370394|561792080|FG001|Overall Study|Lost to Follow-up|1|||
155644935|NCT02370394|561792079|FG000|Overall Study|Withdrawal by Subject|0|||
155644936|NCT02370394|561792080|FG001|Overall Study|Withdrawal by Subject|1|||
155644937|NCT01108796|561792083|FG000|Overall Study|Adverse Event|0|||
155644938|NCT01108796|561792084|FG001|Overall Study|Adverse Event|1|||
155644939|NCT01108796|561792083|FG000|Overall Study|Lost to Follow-up|7|||
155644940|NCT01108796|561792084|FG001|Overall Study|Lost to Follow-up|6|||
155644941|NCT00758043|561792085|FG000|Overall Study|Adverse Event|1|||
155644942|NCT00758043|561792086|FG001|Overall Study|Adverse Event|20|||
155644943|NCT00758043|561792087|FG002|Overall Study|Adverse Event|12|||
155644944|NCT00758043|561792088|FG003|Overall Study|Adverse Event|62|||
155644945|NCT00758043|561792085|FG000|Overall Study|Lack of Efficacy|0|||
155644946|NCT00758043|561792086|FG001|Overall Study|Lack of Efficacy|6|||
155644947|NCT00758043|561792087|FG002|Overall Study|Lack of Efficacy|18|||
155644948|NCT00758043|561792088|FG003|Overall Study|Lack of Efficacy|12|||
155644949|NCT00758043|561792085|FG000|Overall Study|Refused Further Treatment|0|||
155644950|NCT00758043|561792086|FG001|Overall Study|Refused Further Treatment|11|||
155644951|NCT00758043|561792087|FG002|Overall Study|Refused Further Treatment|5|||
155644952|NCT00758043|561792088|FG003|Overall Study|Refused Further Treatment|8|||
155644953|NCT00758043|561792085|FG000|Overall Study|Lost to Follow-up|0|||
155644954|NCT00758043|561792086|FG001|Overall Study|Lost to Follow-up|2|||
155644955|NCT00758043|561792087|FG002|Overall Study|Lost to Follow-up|2|||
155644956|NCT00758043|561792088|FG003|Overall Study|Lost to Follow-up|5|||
155644957|NCT00758043|561792085|FG000|Overall Study|Withdrawal by Subject|0|||
155644958|NCT00758043|561792086|FG001|Overall Study|Withdrawal by Subject|1|||
155644959|NCT00758043|561792087|FG002|Overall Study|Withdrawal by Subject|1|||
155644960|NCT00758043|561792088|FG003|Overall Study|Withdrawal by Subject|4|||
155644961|NCT00758043|561792085|FG000|Overall Study|Required Prohibited Medication|0|||
155327663|NCT01288443|560635218|FG000|Overall Study|Study drug auto-injector administration|0|||
155327664|NCT01288443|560635219|FG001|Overall Study|Study drug auto-injector administration|0|||
155327665|NCT01288443|560635220|FG002|Overall Study|Study drug auto-injector administration|0|||
155644962|NCT00758043|561792086|FG001|Overall Study|Required Prohibited Medication|0|||
155644963|NCT00758043|561792087|FG002|Overall Study|Required Prohibited Medication|1|||
155327666|NCT01288443|560635221|FG003|Overall Study|Study drug auto-injector administration|0|||
155327667|NCT01288443|560635222|FG004|Overall Study|Study drug auto-injector administration|1|||
155327668|NCT01288443|560635223|FG005|Overall Study|Study drug auto-injector administration|1|||
155327669|NCT01288443|560635218|FG000|Overall Study|Other than above|0|||
155327670|NCT01288443|560635219|FG001|Overall Study|Other than above|0|||
155327671|NCT01288443|560635220|FG002|Overall Study|Other than above|0|||
155327672|NCT01288443|560635221|FG003|Overall Study|Other than above|2|||
155327673|NCT01288443|560635222|FG004|Overall Study|Other than above|1|||
155327674|NCT01288443|560635223|FG005|Overall Study|Other than above|0|||
155327675|NCT04876417|560635226|FG000|Overall Study|Lost to Follow-up|5|||
155327676|NCT04876417|560635227|FG001|Overall Study|Lost to Follow-up|8|||
155327677|NCT04876417|560635228|FG002|Overall Study|Lost to Follow-up|0|||
155327678|NCT04876417|560635229|FG003|Overall Study|Lost to Follow-up|0|||
155327679|NCT02111096|560635230|FG000|Overall Study|Adverse Event|4|||
155327680|NCT02111096|560635231|FG001|Overall Study|Adverse Event|1|||
155327681|NCT02111096|560635232|FG002|Overall Study|Adverse Event|2|||
155327682|NCT02111096|560635230|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155327683|NCT02111096|560635231|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155327684|NCT02111096|560635232|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155327685|NCT02111096|560635230|FG000|Overall Study|Lost to Follow Up|1|||
155327686|NCT02111096|560635231|FG001|Overall Study|Lost to Follow Up|1|||
155327687|NCT02111096|560635232|FG002|Overall Study|Lost to Follow Up|1|||
155327688|NCT02111096|560635230|FG000|Overall Study|Physician Decision|0|||
155327689|NCT02111096|560635231|FG001|Overall Study|Physician Decision|1|||
155327690|NCT02111096|560635232|FG002|Overall Study|Physician Decision|0|||
155327691|NCT02111096|560635230|FG000|Overall Study|Protocol Violation|1|||
155327692|NCT02111096|560635231|FG001|Overall Study|Protocol Violation|0|||
155327693|NCT02111096|560635232|FG002|Overall Study|Protocol Violation|1|||
155327694|NCT02111096|560635230|FG000|Overall Study|Terminated by Sponsor|53|||
155327695|NCT02111096|560635231|FG001|Overall Study|Terminated by Sponsor|35|||
155327696|NCT02111096|560635232|FG002|Overall Study|Terminated by Sponsor|54|||
155327697|NCT02111096|560635230|FG000|Overall Study|Withdrawal by Subject|4|||
155327698|NCT02111096|560635231|FG001|Overall Study|Withdrawal by Subject|2|||
155327699|NCT02111096|560635232|FG002|Overall Study|Withdrawal by Subject|8|||
155327700|NCT03875313|560635237|FG000|Overall Study|Withdrawal by Subject|1|||
155327701|NCT03875313|560635238|FG001|Overall Study|Withdrawal by Subject|3|||
155327702|NCT03875313|560635239|FG002|Overall Study|Withdrawal by Subject|0|||
155327703|NCT03875313|560635240|FG003|Overall Study|Withdrawal by Subject|0|||
155327704|NCT03875313|560635241|FG004|Overall Study|Withdrawal by Subject|0|||
155327705|NCT03875313|560635237|FG000|Overall Study|Death|0|||
155327706|NCT03875313|560635238|FG001|Overall Study|Death|0|||
155327707|NCT03875313|560635239|FG002|Overall Study|Death|0|||
155327708|NCT03875313|560635240|FG003|Overall Study|Death|0|||
155327709|NCT03875313|560635241|FG004|Overall Study|Death|1|||
155421724|NCT03486392|560974339|FG002|Overall Study|Withdrawal by Subject|6|||
155327710|NCT03875313|560635237|FG000|Overall Study|Lost to Follow-up|0|||
155327711|NCT03875313|560635238|FG001|Overall Study|Lost to Follow-up|0|||
155327712|NCT03875313|560635239|FG002|Overall Study|Lost to Follow-up|0|||
155327713|NCT03875313|560635240|FG003|Overall Study|Lost to Follow-up|0|||
155327714|NCT03875313|560635241|FG004|Overall Study|Lost to Follow-up|1|||
155327715|NCT03875313|560635237|FG000|Overall Study|Study Termination by Sponsor|0|||
155327716|NCT03875313|560635238|FG001|Overall Study|Study Termination by Sponsor|1|||
155327717|NCT03875313|560635239|FG002|Overall Study|Study Termination by Sponsor|1|||
155327718|NCT03875313|560635240|FG003|Overall Study|Study Termination by Sponsor|0|||
155327719|NCT03875313|560635241|FG004|Overall Study|Study Termination by Sponsor|1|||
155327720|NCT03875313|560635237|FG000|Overall Study|New Anticancer Treatment|0|||
155327721|NCT03875313|560635238|FG001|Overall Study|New Anticancer Treatment|1|||
155327722|NCT03875313|560635239|FG002|Overall Study|New Anticancer Treatment|2|||
155327723|NCT03875313|560635240|FG003|Overall Study|New Anticancer Treatment|1|||
155327724|NCT03875313|560635241|FG004|Overall Study|New Anticancer Treatment|0|||
155327725|NCT03875313|560635237|FG000|Overall Study|Other, Not Specified|2|||
155327726|NCT03875313|560635238|FG001|Overall Study|Other, Not Specified|11|||
155327727|NCT03875313|560635239|FG002|Overall Study|Other, Not Specified|3|||
155327728|NCT03875313|560635240|FG003|Overall Study|Other, Not Specified|3|||
155327729|NCT03875313|560635241|FG004|Overall Study|Other, Not Specified|1|||
155327730|NCT03213457|560635243|FG000|Screening Period|Withdrawal by Subject|0|||
155327731|NCT03213457|560635244|FG001|Screening Period|Withdrawal by Subject|1|||
155327732|NCT03213457|560635245|FG002|Screening Period|Withdrawal by Subject|0|||
155327733|NCT03213457|560635243|FG000|Screening Period|Other|1|||
155327734|NCT03213457|560635244|FG001|Screening Period|Other|0|||
155327735|NCT03213457|560635245|FG002|Screening Period|Other|0|||
155421725|NCT03486392|560974340|FG003|Overall Study|Withdrawal by Subject|4|||
155421726|NCT03486392|560974341|FG004|Overall Study|Withdrawal by Subject|1|||
155327736|NCT03213457|560635243|FG000|Double-Blind Period|Adverse Event|3|||
155327737|NCT03213457|560635244|FG001|Double-Blind Period|Adverse Event|2|||
155327738|NCT03213457|560635245|FG002|Double-Blind Period|Adverse Event|7|||
155327739|NCT03213457|560635243|FG000|Double-Blind Period|Withdrawal by Subject|14|||
155327740|NCT03213457|560635244|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155327741|NCT03213457|560635245|FG002|Double-Blind Period|Withdrawal by Subject|14|||
155327742|NCT03213457|560635243|FG000|Double-Blind Period|Lost to Follow-up|2|||
155327743|NCT03213457|560635244|FG001|Double-Blind Period|Lost to Follow-up|3|||
155327744|NCT03213457|560635245|FG002|Double-Blind Period|Lost to Follow-up|9|||
155327745|NCT03213457|560635243|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327746|NCT03213457|560635244|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327747|NCT03213457|560635245|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
155327748|NCT03213457|560635243|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
155327749|NCT03213457|560635244|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
155327750|NCT03213457|560635245|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
155327751|NCT03213457|560635243|FG000|Double-Blind Period|Pregnancy|5|||
155327752|NCT03213457|560635244|FG001|Double-Blind Period|Pregnancy|0|||
155327753|NCT03213457|560635245|FG002|Double-Blind Period|Pregnancy|0|||
155327754|NCT03213457|560635243|FG000|Double-Blind Period|Other|10|||
155327755|NCT03213457|560635244|FG001|Double-Blind Period|Other|3|||
155327756|NCT03213457|560635245|FG002|Double-Blind Period|Other|17|||
155327757|NCT03213457|560635243|FG000|Open-Label Period|Adverse Event|1|||
155327758|NCT03213457|560635244|FG001|Open-Label Period|Adverse Event|2|||
155327759|NCT03213457|560635245|FG002|Open-Label Period|Adverse Event|2|||
155327760|NCT03213457|560635243|FG000|Open-Label Period|Withdrawal by Subject|12|||
155327761|NCT03213457|560635244|FG001|Open-Label Period|Withdrawal by Subject|5|||
155327762|NCT03213457|560635245|FG002|Open-Label Period|Withdrawal by Subject|24|||
155327763|NCT03213457|560635243|FG000|Open-Label Period|Lost to Follow-up|1|||
155327764|NCT03213457|560635244|FG001|Open-Label Period|Lost to Follow-up|2|||
155327765|NCT03213457|560635245|FG002|Open-Label Period|Lost to Follow-up|8|||
155327766|NCT03213457|560635243|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327767|NCT03213457|560635244|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327768|NCT03213457|560635245|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327769|NCT03213457|560635243|FG000|Open-Label Period|Non-compliance with study procedures|1|||
155327770|NCT03213457|560635244|FG001|Open-Label Period|Non-compliance with study procedures|1|||
155327771|NCT03213457|560635245|FG002|Open-Label Period|Non-compliance with study procedures|2|||
155327772|NCT03213457|560635243|FG000|Open-Label Period|Exclusionary medications|0|||
155327773|NCT03213457|560635244|FG001|Open-Label Period|Exclusionary medications|0|||
155327774|NCT03213457|560635245|FG002|Open-Label Period|Exclusionary medications|1|||
155327775|NCT03213457|560635243|FG000|Open-Label Period|Other|1|||
155327776|NCT03213457|560635244|FG001|Open-Label Period|Other|1|||
155327777|NCT03213457|560635245|FG002|Open-Label Period|Other|6|||
155327778|NCT03213457|560635243|FG000|Follow-Up Period|Adverse Event|16|||
155327779|NCT03213457|560635244|FG001|Follow-Up Period|Adverse Event|8|||
155327780|NCT03213457|560635245|FG002|Follow-Up Period|Adverse Event|37|||
155327781|NCT03213457|560635243|FG000|Follow-Up Period|Withdrawal by Subject|18|||
155327782|NCT03213457|560635244|FG001|Follow-Up Period|Withdrawal by Subject|11|||
155327783|NCT03213457|560635245|FG002|Follow-Up Period|Withdrawal by Subject|55|||
155327784|NCT03213457|560635243|FG000|Follow-Up Period|Lost to Follow-up|28|||
155327785|NCT03213457|560635244|FG001|Follow-Up Period|Lost to Follow-up|15|||
155327786|NCT03213457|560635245|FG002|Follow-Up Period|Lost to Follow-up|50|||
155327787|NCT03213457|560635243|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
155327788|NCT03213457|560635244|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
155327789|NCT03213457|560635245|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327790|NCT03213457|560635243|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
155327791|NCT03213457|560635244|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
155327792|NCT03213457|560635245|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
155327793|NCT03213457|560635243|FG000|Follow-Up Period|Pregnancy|7|||
155327794|NCT03213457|560635244|FG001|Follow-Up Period|Pregnancy|0|||
155327795|NCT03213457|560635245|FG002|Follow-Up Period|Pregnancy|18|||
155327796|NCT03213457|560635243|FG000|Follow-Up Period|Exclusionary medications|1|||
155327797|NCT03213457|560635244|FG001|Follow-Up Period|Exclusionary medications|1|||
155327798|NCT03213457|560635245|FG002|Follow-Up Period|Exclusionary medications|5|||
155327799|NCT03213457|560635243|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
155327800|NCT03213457|560635244|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
155327801|NCT03213457|560635245|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
155327802|NCT03213457|560635243|FG000|Follow-Up Period|Other|14|||
155327803|NCT03213457|560635244|FG001|Follow-Up Period|Other|10|||
155327804|NCT03213457|560635245|FG002|Follow-Up Period|Other|31|||
155327805|NCT02951052|560635246|FG000|Overall Study|Adverse Event|13|||
155327806|NCT02951052|560635247|FG001|Overall Study|Adverse Event|5|||
155327807|NCT02951052|560635246|FG000|Overall Study|Withdrawal by Subject|1|||
155327808|NCT02951052|560635247|FG001|Overall Study|Withdrawal by Subject|5|||
155327809|NCT02951052|560635246|FG000|Overall Study|Physician Decision|2|||
155327810|NCT02951052|560635247|FG001|Overall Study|Physician Decision|0|||
155327811|NCT02951052|560635246|FG000|Overall Study|Lost to Follow-up|1|||
155327812|NCT02951052|560635247|FG001|Overall Study|Lost to Follow-up|1|||
155327813|NCT02951052|560635246|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
155327814|NCT02951052|560635247|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
155327815|NCT02951052|560635246|FG000|Overall Study|Protocol Violation|5|||
155327816|NCT02951052|560635247|FG001|Overall Study|Protocol Violation|3|||
155327817|NCT02951052|560635246|FG000|Overall Study|Lack of Efficacy|3|||
155327818|NCT02951052|560635247|FG001|Overall Study|Lack of Efficacy|4|||
155327819|NCT02951052|560635246|FG000|Overall Study|Ongoing|1|||
155327820|NCT02951052|560635247|FG001|Overall Study|Ongoing|0|||
155327821|NCT04018495|560635252|FG000|Overall Study|Physician Decision|1|||
155327822|NCT04059406|560635261|FG000|Overall Study|Early Treatment Termination|5|||
155327823|NCT04059406|560635262|FG001|Overall Study|Early Treatment Termination|5|||
155327824|NCT04059406|560635263|FG002|Overall Study|Early Treatment Termination|15|||
155327825|NCT04305327|560635269|FG000|Overall Study|Study early termination|2|||
155327826|NCT04305327|560635270|FG001|Overall Study|Study early termination|5|||
155327827|NCT04305327|560635271|FG002|Overall Study|Study early termination|2|||
155327828|NCT04305327|560635272|FG003|Overall Study|Study early termination|2|||
155327829|NCT04305327|560635269|FG000|Overall Study|Withdrawal by Subject|0|||
155327830|NCT04305327|560635270|FG001|Overall Study|Withdrawal by Subject|1|||
155327831|NCT04305327|560635271|FG002|Overall Study|Withdrawal by Subject|0|||
155327832|NCT04305327|560635272|FG003|Overall Study|Withdrawal by Subject|0|||
155644964|NCT00758043|561792088|FG003|Overall Study|Required Prohibited Medication|3|||
155644965|NCT00758043|561792085|FG000|Overall Study|Non-Compliant With study Drug|0|||
155644966|NCT00758043|561792086|FG001|Overall Study|Non-Compliant With study Drug|0|||
155644967|NCT00758043|561792087|FG002|Overall Study|Non-Compliant With study Drug|0|||
155644968|NCT00758043|561792088|FG003|Overall Study|Non-Compliant With study Drug|1|||
155644969|NCT00758043|561792085|FG000|Overall Study|Other Reasons|0|||
155327833|NCT04977583|560636332|FG000|Overall Study|Lost to Follow-up|8|||
155327834|NCT04977583|560636333|FG001|Overall Study|Lost to Follow-up|4|||
155327835|NCT04977583|560636334|FG002|Overall Study|Lost to Follow-up|13|||
155327836|NCT04977583|560636332|FG000|Overall Study|Withdrawal by Subject|3|||
155327837|NCT04977583|560636333|FG001|Overall Study|Withdrawal by Subject|2|||
155327838|NCT04977583|560636334|FG002|Overall Study|Withdrawal by Subject|1|||
155327839|NCT00786864|560636358|FG000|Overall Study|Lost to Follow-up|0|||
155327840|NCT00786864|560636359|FG001|Overall Study|Lost to Follow-up|1|||
155327841|NCT00786864|560636358|FG000|Overall Study|Sustained serious back injury|1|||
155327842|NCT00786864|560636359|FG001|Overall Study|Sustained serious back injury|0|||
155327843|NCT02422615|560636362|FG000|Treatment Period|Progressive disease|314|||
155421727|NCT03486392|560974337|FG000|Overall Study|Death|0|||
155421728|NCT03486392|560974338|FG001|Overall Study|Death|0|||
155644970|NCT00758043|561792086|FG001|Overall Study|Other Reasons|1|||
155644971|NCT00758043|561792087|FG002|Overall Study|Other Reasons|0|||
155327844|NCT02422615|560636363|FG001|Treatment Period|Progressive disease|200|||
155327845|NCT02422615|560636362|FG000|Treatment Period|Adverse Event|51|||
155327846|NCT02422615|560636363|FG001|Treatment Period|Adverse Event|9|||
155327847|NCT02422615|560636362|FG000|Treatment Period|Physician Decision|32|||
155327848|NCT02422615|560636363|FG001|Treatment Period|Physician Decision|8|||
155327849|NCT02422615|560636362|FG000|Treatment Period|Subject/guardian decision|38|||
155327850|NCT02422615|560636363|FG001|Treatment Period|Subject/guardian decision|8|||
155327851|NCT02422615|560636362|FG000|Treatment Period|Death|2|||
155327852|NCT02422615|560636363|FG001|Treatment Period|Death|1|||
155327853|NCT02422615|560636362|FG000|Treatment Period|Technical problems|0|||
155327854|NCT02422615|560636363|FG001|Treatment Period|Technical problems|1|||
155327855|NCT02422615|560636362|FG000|Treatment Period|Protocol deviation|1|||
155327856|NCT02422615|560636363|FG001|Treatment Period|Protocol deviation|1|||
155327857|NCT02422615|560636362|FG000|Treatment Period|Study terminated as per protocol|46|||
155327858|NCT02422615|560636363|FG001|Treatment Period|Study terminated as per protocol|14|||
155327859|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155327860|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155327861|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Death|2|||
155327862|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155327863|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155327864|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155327865|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
155327866|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
155327867|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
155327868|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
155327869|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
155327870|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
155327871|NCT01036724|560636364|FG000|Overall Study|Adverse Event|1|||
155327872|NCT01036724|560636365|FG001|Overall Study|Adverse Event|2|||
155327873|NCT01036724|560636364|FG000|Overall Study|Lack of Efficacy|1|||
155327874|NCT01036724|560636365|FG001|Overall Study|Lack of Efficacy|1|||
155327875|NCT01036724|560636364|FG000|Overall Study|Protocol Violation|4|||
155327876|NCT01036724|560636365|FG001|Overall Study|Protocol Violation|5|||
155327877|NCT02291913|560636370|FG000|Overall Study|Progressive Disease|32|||
155327878|NCT02291913|560636370|FG000|Overall Study|Adverse Event|11|||
155327879|NCT02291913|560636370|FG000|Overall Study|Death|2|||
155327880|NCT02291913|560636370|FG000|Overall Study|Physician Decision|1|||
155327881|NCT02291913|560636370|FG000|Overall Study|Withdrawal by Subject|1|||
155327882|NCT02291913|560636370|FG000|Overall Study|Protocol Violation|1|||
155327883|NCT03709706|560636371|FG000|Overall Study|Adverse Event|0|||
155327884|NCT03709706|560636372|FG001|Overall Study|Adverse Event|1|||
155327885|NCT03709706|560636371|FG000|Overall Study|Physician Decision|14|||
155327886|NCT03709706|560636372|FG001|Overall Study|Physician Decision|8|||
155327887|NCT03709706|560636371|FG000|Overall Study|Withdrawal by Subject|2|||
155327888|NCT03709706|560636372|FG001|Overall Study|Withdrawal by Subject|1|||
155327889|NCT03709706|560636371|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
155327890|NCT03709706|560636372|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
155644972|NCT00758043|561792088|FG003|Overall Study|Other Reasons|5|||
155644973|NCT02545127|561792095|FG000|Overall Study|Lost to Follow-up|1|||
155327891|NCT01105975|560636373|FG000|Overall Study|Adverse Event|2|||
155644974|NCT02545127|561792096|FG001|Overall Study|Lost to Follow-up|0|||
155644975|NCT03197935|561792097|FG000|Overall Study|Death due to any cause|26|||
155644976|NCT03197935|561792098|FG001|Overall Study|Death due to any cause|15|||
155644977|NCT03197935|561792097|FG000|Overall Study|Lost to Follow-up|3|||
155644978|NCT03197935|561792098|FG001|Overall Study|Lost to Follow-up|5|||
155644979|NCT03197935|561792097|FG000|Overall Study|Physician Decision|2|||
155644980|NCT03197935|561792098|FG001|Overall Study|Physician Decision|1|||
155644981|NCT03197935|561792097|FG000|Overall Study|Withdrawal by Subject|16|||
155644982|NCT03197935|561792098|FG001|Overall Study|Withdrawal by Subject|8|||
155644983|NCT04027946|561792099|FG000|Overall Study|Screen failures|3|||
155644984|NCT00985192|561792100|FG000|Overall Study|Withdrawal by Subject|1|||
155644985|NCT00985192|561792100|FG000|Overall Study|Disease Progression|1|||
155644986|NCT00985192|561792100|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
155644987|NCT01875237|561792109|FG000|Overall Study|GVDH before DLI|1|||
155644988|NCT01875237|561792110|FG001|Overall Study|GVDH before DLI|0|||
155644989|NCT01875237|561792109|FG000|Overall Study|DLI cells could not be produced|1|||
155644990|NCT01875237|561792110|FG001|Overall Study|DLI cells could not be produced|0|||
155644991|NCT00983957|561792111|FG000|Overall Study|Adverse Event|1|||
155644992|NCT00983957|561792111|FG000|Overall Study|Personal Reasons|1|||
155644993|NCT03055195|561792112|FG000|Overall Study|Lack of Efficacy|1|||
155644994|NCT03055195|561792113|FG001|Overall Study|Lack of Efficacy|0|||
155644995|NCT03055195|561792112|FG000|Overall Study|Withdrawal by Subject|6|||
155644996|NCT03055195|561792113|FG001|Overall Study|Withdrawal by Subject|7|||
155644997|NCT03055195|561792112|FG000|Overall Study|Study Terminated by Sponsor|2|||
155327892|NCT01105975|560636374|FG001|Overall Study|Adverse Event|1|||
155327893|NCT01105975|560636375|FG002|Overall Study|Adverse Event|5|||
155327894|NCT01105975|560636376|FG003|Overall Study|Adverse Event|1|||
155327895|NCT01105975|560636377|FG004|Overall Study|Adverse Event|0|||
155327896|NCT01105975|560636378|FG005|Overall Study|Adverse Event|1|||
155327897|NCT01105975|560636379|FG006|Overall Study|Adverse Event|2|||
155327898|NCT01105975|560636380|FG007|Overall Study|Adverse Event|4|||
155327899|NCT01105975|560636381|FG008|Overall Study|Adverse Event|1|||
155327900|NCT01105975|560636382|FG009|Overall Study|Adverse Event|4|||
155327901|NCT01105975|560636373|FG000|Overall Study|Withdrawal by Subject|2|||
155327902|NCT01105975|560636374|FG001|Overall Study|Withdrawal by Subject|2|||
155327903|NCT01105975|560636375|FG002|Overall Study|Withdrawal by Subject|2|||
155327904|NCT01105975|560636376|FG003|Overall Study|Withdrawal by Subject|0|||
155327905|NCT01105975|560636377|FG004|Overall Study|Withdrawal by Subject|4|||
155327906|NCT01105975|560636378|FG005|Overall Study|Withdrawal by Subject|1|||
155327907|NCT01105975|560636379|FG006|Overall Study|Withdrawal by Subject|2|||
155327908|NCT01105975|560636380|FG007|Overall Study|Withdrawal by Subject|1|||
155327909|NCT01105975|560636381|FG008|Overall Study|Withdrawal by Subject|0|||
155327910|NCT01105975|560636382|FG009|Overall Study|Withdrawal by Subject|3|||
155327911|NCT01105975|560636373|FG000|Overall Study|Lost to Follow-up|1|||
155327912|NCT01105975|560636374|FG001|Overall Study|Lost to Follow-up|0|||
155327913|NCT01105975|560636375|FG002|Overall Study|Lost to Follow-up|0|||
155327914|NCT01105975|560636376|FG003|Overall Study|Lost to Follow-up|1|||
155327915|NCT01105975|560636377|FG004|Overall Study|Lost to Follow-up|1|||
155327916|NCT01105975|560636378|FG005|Overall Study|Lost to Follow-up|0|||
155327917|NCT01105975|560636379|FG006|Overall Study|Lost to Follow-up|0|||
155327918|NCT01105975|560636380|FG007|Overall Study|Lost to Follow-up|0|||
155327919|NCT01105975|560636381|FG008|Overall Study|Lost to Follow-up|1|||
155327920|NCT01105975|560636382|FG009|Overall Study|Lost to Follow-up|0|||
155327921|NCT01105975|560636373|FG000|Overall Study|Physician Decision|0|||
155327922|NCT01105975|560636374|FG001|Overall Study|Physician Decision|0|||
155327923|NCT01105975|560636375|FG002|Overall Study|Physician Decision|0|||
155327924|NCT01105975|560636376|FG003|Overall Study|Physician Decision|0|||
155327925|NCT01105975|560636377|FG004|Overall Study|Physician Decision|0|||
155327926|NCT01105975|560636378|FG005|Overall Study|Physician Decision|0|||
155327927|NCT01105975|560636379|FG006|Overall Study|Physician Decision|2|||
155327928|NCT01105975|560636380|FG007|Overall Study|Physician Decision|0|||
155327929|NCT01105975|560636381|FG008|Overall Study|Physician Decision|0|||
155327930|NCT01105975|560636382|FG009|Overall Study|Physician Decision|0|||
155327931|NCT01105975|560636373|FG000|Overall Study|Protocol Violation|0|||
155327932|NCT01105975|560636374|FG001|Overall Study|Protocol Violation|2|||
155327933|NCT01105975|560636375|FG002|Overall Study|Protocol Violation|2|||
155327934|NCT01105975|560636376|FG003|Overall Study|Protocol Violation|0|||
155327935|NCT01105975|560636377|FG004|Overall Study|Protocol Violation|1|||
155327936|NCT01105975|560636378|FG005|Overall Study|Protocol Violation|1|||
155327937|NCT01105975|560636379|FG006|Overall Study|Protocol Violation|1|||
155327938|NCT01105975|560636380|FG007|Overall Study|Protocol Violation|1|||
155327939|NCT01105975|560636381|FG008|Overall Study|Protocol Violation|2|||
155327940|NCT01105975|560636382|FG009|Overall Study|Protocol Violation|2|||
155327941|NCT01105975|560636373|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327942|NCT01105975|560636374|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327943|NCT01105975|560636375|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327944|NCT01105975|560636376|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327945|NCT01105975|560636377|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327946|NCT01105975|560636378|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
155327947|NCT01105975|560636379|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327948|NCT01105975|560636380|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327949|NCT01105975|560636381|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
155327950|NCT01105975|560636382|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327951|NCT04868617|560636383|FG000|Overall Study|Death|1|||
155327952|NCT04868617|560636384|FG001|Overall Study|Death|0|||
155327953|NCT04868617|560636383|FG000|Overall Study|Adverse Event|1|||
155327954|NCT04868617|560636384|FG001|Overall Study|Adverse Event|0|||
155327955|NCT04868617|560636383|FG000|Overall Study|Withdrawal by Subject|1|||
155327956|NCT04868617|560636384|FG001|Overall Study|Withdrawal by Subject|0|||
155327957|NCT04868617|560636383|FG000|Overall Study|Device deficiency|1|||
155327958|NCT04868617|560636384|FG001|Overall Study|Device deficiency|0|||
155327959|NCT02502526|560636385|FG000|Overall Study|Lost to Follow-up|2|||
155327960|NCT02502526|560636386|FG001|Overall Study|Lost to Follow-up|2|||
155327961|NCT02502526|560636387|FG002|Overall Study|Lost to Follow-up|3|||
155327962|NCT02502526|560636385|FG000|Overall Study|Withdrawal by Subject|0|||
155327963|NCT02502526|560636386|FG001|Overall Study|Withdrawal by Subject|1|||
155327964|NCT02502526|560636387|FG002|Overall Study|Withdrawal by Subject|1|||
155327965|NCT02502526|560636385|FG000|Overall Study|Disqualified due to cataract grading|0|||
155327966|NCT02502526|560636386|FG001|Overall Study|Disqualified due to cataract grading|0|||
155327967|NCT02502526|560636387|FG002|Overall Study|Disqualified due to cataract grading|1|||
155327968|NCT02502526|560636385|FG000|Overall Study|Enrollment suspension|4|||
155327969|NCT02502526|560636386|FG001|Overall Study|Enrollment suspension|1|||
155327970|NCT02502526|560636387|FG002|Overall Study|Enrollment suspension|1|||
155327971|NCT02964741|560636388|FG000|Overall Study|Protocol Violation|1|||
155327972|NCT02964741|560636389|FG001|Overall Study|Protocol Violation|0|||
155327973|NCT02964741|560636390|FG002|Overall Study|Protocol Violation|0|||
155327974|NCT02964741|560636388|FG000|Overall Study|Withdrawal by Subject|0|||
155327975|NCT02964741|560636389|FG001|Overall Study|Withdrawal by Subject|1|||
155327976|NCT02964741|560636390|FG002|Overall Study|Withdrawal by Subject|0|||
155327977|NCT02964741|560636388|FG000|Overall Study|claustrophobia|1|||
155327978|NCT02964741|560636389|FG001|Overall Study|claustrophobia|0|||
155327979|NCT02964741|560636390|FG002|Overall Study|claustrophobia|0|||
155327980|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
155327981|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155327982|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155327983|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155327984|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
155327985|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327986|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327987|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327988|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
155327989|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327990|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327991|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327992|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
155327993|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155421729|NCT03486392|560974339|FG002|Overall Study|Death|0|||
155421730|NCT03486392|560974340|FG003|Overall Study|Death|0|||
155421731|NCT03486392|560974341|FG004|Overall Study|Death|1|||
155421732|NCT00441792|560974342|FG000|Overall Study|Lost to Follow-up|0|||
155421733|NCT00441792|560974343|FG001|Overall Study|Lost to Follow-up|2|||
155421734|NCT02532855|560974347|FG000|Overall Study|Lost to Follow-up|4|||
155421735|NCT02532855|560974348|FG001|Overall Study|Lost to Follow-up|3|||
155421736|NCT02532855|560974347|FG000|Overall Study|Withdrawal by Subject|4|||
155421737|NCT02532855|560974348|FG001|Overall Study|Withdrawal by Subject|8|||
155421738|NCT01879410|560974351|FG000|Overall Study|Adverse Event|9|||
155421739|NCT01879410|560974352|FG001|Overall Study|Adverse Event|14|||
155421740|NCT01879410|560974351|FG000|Overall Study|Lack of Efficacy|4|||
155327994|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155327995|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155327996|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
155327997|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155327998|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155327999|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155328000|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
155328001|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328002|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328003|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328004|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
155328005|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328006|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328007|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328008|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
155328009|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
155328010|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
155328011|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
155328012|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
155328013|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
155328014|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
155328015|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
155328016|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328017|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
155328018|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328019|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328020|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
155328021|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
155328022|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
155328023|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
155328024|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
155328025|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
155328026|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
155328027|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
155328028|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155328029|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
155328030|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155328031|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155328032|NCT00640159|560636398|FG000|Overall Study|Lost to Follow-up|2|||
155328033|NCT00112359|560636399|FG000|Overall Study|Unrelated adverse event|16|||
155328034|NCT00112359|560636400|FG001|Overall Study|Unrelated adverse event|8|||
155328035|NCT00112359|560636399|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
155328036|NCT00112359|560636400|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
155328037|NCT00112359|560636399|FG000|Overall Study|Related adverse event|5|||
155328038|NCT00112359|560636400|FG001|Overall Study|Related adverse event|3|||
155328039|NCT00112359|560636399|FG000|Overall Study|Lost to Follow-up|0|||
155328040|NCT00112359|560636400|FG001|Overall Study|Lost to Follow-up|1|||
155328041|NCT00112359|560636399|FG000|Overall Study|Personal/administrative|1|||
155328042|NCT00112359|560636400|FG001|Overall Study|Personal/administrative|1|||
155328043|NCT00112359|560636399|FG000|Overall Study|Other|3|||
155328044|NCT00112359|560636400|FG001|Overall Study|Other|0|||
155328045|NCT00312208|560636401|FG000|Overall Study|Adverse Event|97|||
155328046|NCT00312208|560636402|FG001|Overall Study|Adverse Event|61|||
155328047|NCT00312208|560636401|FG000|Overall Study|Protocol Violation|5|||
155328048|NCT00312208|560636402|FG001|Overall Study|Protocol Violation|3|||
155328049|NCT00312208|560636401|FG000|Overall Study|Death|2|||
155328050|NCT00312208|560636402|FG001|Overall Study|Death|1|||
155328051|NCT00312208|560636401|FG000|Overall Study|Lack of Efficacy|7|||
155328052|NCT00312208|560636402|FG001|Overall Study|Lack of Efficacy|4|||
155328053|NCT00312208|560636401|FG000|Overall Study|Lost to Follow-up|3|||
155328054|NCT00312208|560636402|FG001|Overall Study|Lost to Follow-up|5|||
155328055|NCT00312208|560636401|FG000|Overall Study|Withdrawal by Subject|53|||
155328056|NCT00312208|560636402|FG001|Overall Study|Withdrawal by Subject|42|||
155328057|NCT00312208|560636401|FG000|Overall Study|Other|5|||
155328058|NCT00312208|560636402|FG001|Overall Study|Other|7|||
155328059|NCT01315132|560636403|FG000|Overall Study|not treated due to disease progression|1|||
155328060|NCT03275285|560636411|FG000|Overall Study|Ongoing|45|||
155328061|NCT03275285|560636412|FG001|Overall Study|Ongoing|69|||
155328062|NCT00115934|560636413|FG000|Overall Study|Lost to Follow-up|1|||
155328063|NCT00115934|560636414|FG001|Overall Study|Lost to Follow-up|0|||
155328064|NCT00115934|560636413|FG000|Overall Study|Did not receive intervention|3|||
155328065|NCT00115934|560636414|FG001|Overall Study|Did not receive intervention|2|||
155328066|NCT00747565|560636415|FG000|Overall Study|Withdrawal by Subject|10|||
155328067|NCT00747565|560636416|FG001|Overall Study|Withdrawal by Subject|6|||
155328068|NCT00747565|560636415|FG000|Overall Study|Lost to Follow-up|4|||
155328069|NCT00747565|560636416|FG001|Overall Study|Lost to Follow-up|1|||
155328070|NCT03777657|560636417|FG000|Overall Study|Death|397|||
155328071|NCT03777657|560636418|FG001|Overall Study|Death|431|||
155328072|NCT03777657|560636417|FG000|Overall Study|Study Closed by Sponsor|77|||
155328073|NCT03777657|560636418|FG001|Overall Study|Study Closed by Sponsor|38|||
155328074|NCT03777657|560636417|FG000|Overall Study|Withdrawal by Subject|20|||
155328075|NCT03777657|560636418|FG001|Overall Study|Withdrawal by Subject|17|||
155328076|NCT03777657|560636417|FG000|Overall Study|Lost to Follow-up|6|||
155328077|NCT03777657|560636418|FG001|Overall Study|Lost to Follow-up|10|||
155502518|NCT00190684|561265513|FG000|Overall Study|Study Period V Completed|1|||
155328079|NCT00319020|560636426|FG000|Overall Study|Death|2|||
155328080|NCT00319020|560636427|FG001|Overall Study|Death|2|||
155328081|NCT00319020|560636426|FG000|Overall Study|Withdrawal by Subject|4|||
155328082|NCT00319020|560636427|FG001|Overall Study|Withdrawal by Subject|1|||
155328083|NCT00319020|560636426|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
155328084|NCT00319020|560636427|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
155328085|NCT00319020|560636426|FG000|Overall Study|Administrative reason|0|||
155328086|NCT00319020|560636427|FG001|Overall Study|Administrative reason|5|||
155328087|NCT00319020|560636426|FG000|Overall Study|Disease progression|0|||
155328088|NCT00319020|560636427|FG001|Overall Study|Disease progression|2|||
155328089|NCT00319020|560636426|FG000|Overall Study|Transplant|0|||
155328090|NCT00319020|560636427|FG001|Overall Study|Transplant|1|||
155328091|NCT00319020|560636426|FG000|Overall Study|Treatment failure|0|||
155328092|NCT00319020|560636427|FG001|Overall Study|Treatment failure|1|||
155328093|NCT00319020|560636426|FG000|Overall Study|Adverse Event|0|||
155328094|NCT00319020|560636427|FG001|Overall Study|Adverse Event|1|||
155328095|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155328096|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155328097|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
155328098|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
155328099|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
155328100|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
155328101|NCT02549352|560636430|FG000|12-month Follow-up|Withdrawal by Subject|4|||
155328102|NCT02549352|560636431|FG001|12-month Follow-up|Withdrawal by Subject|5|||
155328103|NCT02549352|560636430|FG000|12-month Follow-up|Lost to Follow-up|3|||
155328104|NCT02549352|560636431|FG001|12-month Follow-up|Lost to Follow-up|2|||
155328105|NCT02549352|560636430|FG000|12-month Follow-up|Death|0|||
155328106|NCT02549352|560636431|FG001|12-month Follow-up|Death|1|||
155328107|NCT02549352|560636430|FG000|12-month Follow-up|Protocol Violation|0|||
155328108|NCT02549352|560636431|FG001|12-month Follow-up|Protocol Violation|1|||
155328109|NCT02549352|560636430|FG000|12-month Follow-up|Other|1|||
155328110|NCT02549352|560636431|FG001|12-month Follow-up|Other|3|||
155328111|NCT04980300|560636432|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
155328112|NCT04980300|560636433|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
155328113|NCT04980300|560636432|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
155328114|NCT04980300|560636433|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
155328115|NCT04980300|560636432|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
155328116|NCT04980300|560636433|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
155328117|NCT04980300|560636432|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
155328118|NCT04980300|560636433|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
155328119|NCT05864209|560637455|FG000|Overall Study|Lost to Follow-up|2|||
155328120|NCT05864209|560637456|FG001|Overall Study|Lost to Follow-up|3|||
155328121|NCT02722434|560637459|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
155328122|NCT02722434|560637460|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
155328123|NCT02722434|560637459|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
155328124|NCT02722434|560637460|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
155328125|NCT04559698|560637461|FG000|Overall Study|Lost to Follow-up|14|||
155328126|NCT04559698|560637462|FG001|Overall Study|Lost to Follow-up|15|||
155328127|NCT04559698|560637461|FG000|Overall Study|Withdrawal by Subject|0|||
155328128|NCT04559698|560637462|FG001|Overall Study|Withdrawal by Subject|1|||
155328129|NCT03437733|560637463|FG000|Overall Study|Eligibility criteria not met|0|||
155328130|NCT03437733|560637464|FG001|Overall Study|Eligibility criteria not met|3|||
155328131|NCT01982682|560637465|FG000|Overall Study|Physician Decision|1|||
155328132|NCT02760654|560637466|FG000|Overall Study|Lost to Follow-up|3|||
155328133|NCT02760654|560637467|FG001|Overall Study|Lost to Follow-up|3|||
155328134|NCT02760654|560637466|FG000|Overall Study|Withdrawal by Subject|4|||
155328135|NCT02760654|560637467|FG001|Overall Study|Withdrawal by Subject|3|||
155328136|NCT00146172|560637468|FG000|Overall Study|Adverse Event|0|||
155328137|NCT00146172|560637469|FG001|Overall Study|Adverse Event|0|||
155328138|NCT00146172|560637470|FG002|Overall Study|Adverse Event|1|||
155328139|NCT00146172|560637471|FG003|Overall Study|Adverse Event|1|||
155328140|NCT00146172|560637472|FG004|Overall Study|Adverse Event|0|||
155328141|NCT00146172|560637473|FG005|Overall Study|Adverse Event|2|||
155328142|NCT00146172|560637474|FG006|Overall Study|Adverse Event|3|||
155328143|NCT00146172|560637475|FG007|Overall Study|Adverse Event|10|||
155328144|NCT00146172|560637468|FG000|Overall Study|Lost to Follow-up|0|||
155328145|NCT00146172|560637469|FG001|Overall Study|Lost to Follow-up|0|||
155328146|NCT00146172|560637470|FG002|Overall Study|Lost to Follow-up|0|||
155328147|NCT00146172|560637471|FG003|Overall Study|Lost to Follow-up|0|||
155328148|NCT00146172|560637472|FG004|Overall Study|Lost to Follow-up|0|||
155328149|NCT00146172|560637473|FG005|Overall Study|Lost to Follow-up|0|||
155328150|NCT00146172|560637474|FG006|Overall Study|Lost to Follow-up|0|||
155328151|NCT00146172|560637475|FG007|Overall Study|Lost to Follow-up|1|||
155328152|NCT00146172|560637468|FG000|Overall Study|Disease Progression|2|||
155328153|NCT00146172|560637469|FG001|Overall Study|Disease Progression|4|||
155644998|NCT03055195|561792113|FG001|Overall Study|Study Terminated by Sponsor|6|||
155328154|NCT00146172|560637470|FG002|Overall Study|Disease Progression|2|||
155328155|NCT00146172|560637471|FG003|Overall Study|Disease Progression|5|||
155328156|NCT00146172|560637472|FG004|Overall Study|Disease Progression|2|||
155328157|NCT00146172|560637473|FG005|Overall Study|Disease Progression|2|||
155328158|NCT00146172|560637474|FG006|Overall Study|Disease Progression|1|||
155328159|NCT00146172|560637475|FG007|Overall Study|Disease Progression|22|||
155328160|NCT00146172|560637468|FG000|Overall Study|Death|0|||
155328161|NCT00146172|560637469|FG001|Overall Study|Death|0|||
155328162|NCT00146172|560637470|FG002|Overall Study|Death|0|||
155328163|NCT00146172|560637471|FG003|Overall Study|Death|0|||
155328164|NCT00146172|560637472|FG004|Overall Study|Death|0|||
155421741|NCT01879410|560974352|FG001|Overall Study|Lack of Efficacy|6|||
155421742|NCT01879410|560974351|FG000|Overall Study|Protocol Violation|1|||
155421743|NCT01879410|560974352|FG001|Overall Study|Protocol Violation|7|||
155421744|NCT01879410|560974351|FG000|Overall Study|Lost to Follow-up|2|||
155421745|NCT01879410|560974352|FG001|Overall Study|Lost to Follow-up|1|||
155421746|NCT01879410|560974351|FG000|Overall Study|Withdrawal by Subject|7|||
155421747|NCT01879410|560974352|FG001|Overall Study|Withdrawal by Subject|8|||
155421748|NCT01879410|560974351|FG000|Overall Study|Randomised in Error|1|||
155421749|NCT01879410|560974352|FG001|Overall Study|Randomised in Error|2|||
155421750|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
155421751|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
155421752|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
155421753|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
155421754|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
155421755|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
155421756|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
155421757|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
155421758|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
155644999|NCT03055195|561792112|FG000|Overall Study|Protocol Violation|2|||
155645000|NCT03055195|561792113|FG001|Overall Study|Protocol Violation|1|||
155645001|NCT03055195|561792112|FG000|Overall Study|Physician Decision|1|||
155645002|NCT03055195|561792113|FG001|Overall Study|Physician Decision|0|||
155645003|NCT00986232|561792114|FG000|Overall Study|Adverse Event|1|||
155645004|NCT00986232|561792115|FG001|Overall Study|Adverse Event|2|||
155645005|NCT00986232|561792116|FG002|Overall Study|Adverse Event|3|||
155645006|NCT00986232|561792117|FG003|Overall Study|Adverse Event|0|||
155645007|NCT00986232|561792114|FG000|Overall Study|Lost to Follow-up|19|||
155645008|NCT00986232|561792115|FG001|Overall Study|Lost to Follow-up|12|||
155645009|NCT00986232|561792116|FG002|Overall Study|Lost to Follow-up|12|||
155645010|NCT00986232|561792117|FG003|Overall Study|Lost to Follow-up|7|||
155645011|NCT00986232|561792114|FG000|Overall Study|Protocol Violation|2|||
155645012|NCT00986232|561792115|FG001|Overall Study|Protocol Violation|3|||
155645013|NCT00986232|561792116|FG002|Overall Study|Protocol Violation|0|||
155645014|NCT00986232|561792117|FG003|Overall Study|Protocol Violation|1|||
155645015|NCT00986232|561792114|FG000|Overall Study|Withdrawal by Subject|13|||
155645016|NCT00986232|561792115|FG001|Overall Study|Withdrawal by Subject|16|||
155645017|NCT00986232|561792116|FG002|Overall Study|Withdrawal by Subject|12|||
155645018|NCT00986232|561792117|FG003|Overall Study|Withdrawal by Subject|3|||
155645019|NCT00986232|561792114|FG000|Overall Study|Missed one or more bleeds|13|||
155645020|NCT00986232|561792115|FG001|Overall Study|Missed one or more bleeds|10|||
155645021|NCT00986232|561792116|FG002|Overall Study|Missed one or more bleeds|6|||
155645022|NCT00986232|561792117|FG003|Overall Study|Missed one or more bleeds|7|||
155645023|NCT00986232|561792114|FG000|Overall Study|Incomplete safety follow-up|3|||
155645024|NCT00986232|561792115|FG001|Overall Study|Incomplete safety follow-up|7|||
155645025|NCT00986232|561792116|FG002|Overall Study|Incomplete safety follow-up|2|||
155645026|NCT00986232|561792117|FG003|Overall Study|Incomplete safety follow-up|2|||
155645027|NCT02568423|561792118|FG000|Overall Study|Lost to Follow-up|0|||
155645028|NCT02568423|561792119|FG001|Overall Study|Lost to Follow-up|2|||
155645029|NCT02568423|561792120|FG002|Overall Study|Lost to Follow-up|0|||
155645030|NCT02568423|561792121|FG003|Overall Study|Lost to Follow-up|0|||
155328165|NCT00146172|560637473|FG005|Overall Study|Death|0|||
155328166|NCT00146172|560637474|FG006|Overall Study|Death|1|||
155328167|NCT00146172|560637475|FG007|Overall Study|Death|0|||
155328168|NCT00146172|560637468|FG000|Overall Study|Physician Decision|0|||
155328169|NCT00146172|560637469|FG001|Overall Study|Physician Decision|0|||
155421759|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
155645031|NCT02568423|561792122|FG004|Overall Study|Lost to Follow-up|0|||
155645032|NCT02568423|561792123|FG005|Overall Study|Lost to Follow-up|0|||
155645033|NCT02568423|561792124|FG006|Overall Study|Lost to Follow-up|0|||
155645034|NCT02568423|561792125|FG007|Overall Study|Lost to Follow-up|0|||
155645035|NCT02568423|561792118|FG000|Overall Study|Physician Decision|0|||
155328170|NCT00146172|560637470|FG002|Overall Study|Physician Decision|0|||
155328171|NCT00146172|560637471|FG003|Overall Study|Physician Decision|0|||
155328172|NCT00146172|560637472|FG004|Overall Study|Physician Decision|0|||
155328173|NCT00146172|560637473|FG005|Overall Study|Physician Decision|0|||
155328174|NCT00146172|560637474|FG006|Overall Study|Physician Decision|0|||
155328175|NCT00146172|560637475|FG007|Overall Study|Physician Decision|1|||
155328176|NCT00146172|560637468|FG000|Overall Study|Withdrawal by Subject|0|||
155328177|NCT00146172|560637469|FG001|Overall Study|Withdrawal by Subject|0|||
155328178|NCT00146172|560637470|FG002|Overall Study|Withdrawal by Subject|0|||
155328179|NCT00146172|560637471|FG003|Overall Study|Withdrawal by Subject|0|||
155328180|NCT00146172|560637472|FG004|Overall Study|Withdrawal by Subject|0|||
155328181|NCT00146172|560637473|FG005|Overall Study|Withdrawal by Subject|1|||
155328182|NCT00146172|560637474|FG006|Overall Study|Withdrawal by Subject|1|||
155328183|NCT00146172|560637475|FG007|Overall Study|Withdrawal by Subject|4|||
155328184|NCT00146172|560637468|FG000|Overall Study|Symptomatic Deterioration|1|||
155328185|NCT00146172|560637469|FG001|Overall Study|Symptomatic Deterioration|0|||
155328186|NCT00146172|560637470|FG002|Overall Study|Symptomatic Deterioration|1|||
155328187|NCT00146172|560637471|FG003|Overall Study|Symptomatic Deterioration|0|||
155328188|NCT00146172|560637472|FG004|Overall Study|Symptomatic Deterioration|1|||
155328189|NCT00146172|560637473|FG005|Overall Study|Symptomatic Deterioration|2|||
155328190|NCT00146172|560637474|FG006|Overall Study|Symptomatic Deterioration|0|||
155645036|NCT02568423|561792119|FG001|Overall Study|Physician Decision|0|||
155645037|NCT02568423|561792120|FG002|Overall Study|Physician Decision|0|||
155645038|NCT02568423|561792121|FG003|Overall Study|Physician Decision|0|||
155645039|NCT02568423|561792122|FG004|Overall Study|Physician Decision|0|||
155645040|NCT02568423|561792123|FG005|Overall Study|Physician Decision|1|||
155645041|NCT02568423|561792124|FG006|Overall Study|Physician Decision|0|||
155645042|NCT02568423|561792125|FG007|Overall Study|Physician Decision|0|||
155645043|NCT00790933|561792126|FG000|Overall Study|Adverse Event|94|||
155645044|NCT00790933|561792127|FG001|Overall Study|Adverse Event|119|||
155645045|NCT00790933|561792128|FG002|Overall Study|Adverse Event|65|||
155645046|NCT00790933|561792129|FG003|Overall Study|Adverse Event|5|||
155645047|NCT00790933|561792130|FG004|Overall Study|Adverse Event|69|||
155645048|NCT00790933|561792126|FG000|Overall Study|Protocol Violation(s)|8|||
155645049|NCT00790933|561792127|FG001|Overall Study|Protocol Violation(s)|18|||
155645050|NCT00790933|561792128|FG002|Overall Study|Protocol Violation(s)|7|||
155645051|NCT00790933|561792129|FG003|Overall Study|Protocol Violation(s)|0|||
155645052|NCT00790933|561792130|FG004|Overall Study|Protocol Violation(s)|12|||
155645053|NCT00790933|561792126|FG000|Overall Study|Lack of Efficacy|192|||
155645054|NCT00790933|561792127|FG001|Overall Study|Lack of Efficacy|176|||
155645055|NCT00790933|561792128|FG002|Overall Study|Lack of Efficacy|130|||
155328191|NCT00146172|560637475|FG007|Overall Study|Symptomatic Deterioration|2|||
155328192|NCT03876457|560637477|FG000|Overall Study|Lost to Follow-up|1|||
155328193|NCT03876457|560637478|FG001|Overall Study|Lost to Follow-up|3|||
155328194|NCT01574716|560637480|FG000|Part 1|Death|3|||
155328195|NCT01574716|560637481|FG001|Part 1|Death|1|||
155328196|NCT01574716|560637482|FG002|Part 1|Death|8|||
155328197|NCT01574716|560637483|FG003|Part 1|Death|0|||
155328198|NCT01574716|560637484|FG004|Part 1|Death|0|||
155328199|NCT01574716|560637480|FG000|Part 1|Discontinuation of study by sponsor|0|||
155328200|NCT01574716|560637481|FG001|Part 1|Discontinuation of study by sponsor|0|||
155328201|NCT01574716|560637482|FG002|Part 1|Discontinuation of study by sponsor|1|||
155328202|NCT01574716|560637483|FG003|Part 1|Discontinuation of study by sponsor|0|||
155328203|NCT01574716|560637484|FG004|Part 1|Discontinuation of study by sponsor|0|||
155328204|NCT01574716|560637480|FG000|Part 1|Withdrawal by Subject|0|||
155328205|NCT01574716|560637481|FG001|Part 1|Withdrawal by Subject|2|||
155328206|NCT01574716|560637482|FG002|Part 1|Withdrawal by Subject|0|||
155328207|NCT01574716|560637483|FG003|Part 1|Withdrawal by Subject|0|||
155328208|NCT01574716|560637484|FG004|Part 1|Withdrawal by Subject|0|||
155328209|NCT01574716|560637480|FG000|Part 1|Lost to Follow-up|0|||
155328210|NCT01574716|560637481|FG001|Part 1|Lost to Follow-up|1|||
155328211|NCT01574716|560637482|FG002|Part 1|Lost to Follow-up|0|||
155328212|NCT01574716|560637483|FG003|Part 1|Lost to Follow-up|0|||
155328213|NCT01574716|560637484|FG004|Part 1|Lost to Follow-up|0|||
155645056|NCT00790933|561792129|FG003|Overall Study|Lack of Efficacy|1|||
155645057|NCT00790933|561792130|FG004|Overall Study|Lack of Efficacy|121|||
155645058|NCT00790933|561792126|FG000|Overall Study|Study Terminated by Sponsor|0|||
155645059|NCT00790933|561792127|FG001|Overall Study|Study Terminated by Sponsor|0|||
155645060|NCT00790933|561792128|FG002|Overall Study|Study Terminated by Sponsor|1|||
155328214|NCT01574716|560637480|FG000|Part 2|Progressive disease|0|||
155328215|NCT01574716|560637481|FG001|Part 2|Progressive disease|0|||
155328216|NCT01574716|560637482|FG002|Part 2|Progressive disease|0|||
155328217|NCT01574716|560637483|FG003|Part 2|Progressive disease|1|||
155328218|NCT01574716|560637484|FG004|Part 2|Progressive disease|0|||
155328219|NCT01574716|560637480|FG000|Part 2|Death|0|||
155328220|NCT01574716|560637481|FG001|Part 2|Death|0|||
155328221|NCT01574716|560637482|FG002|Part 2|Death|0|||
155328222|NCT01574716|560637483|FG003|Part 2|Death|76|||
155328223|NCT01574716|560637484|FG004|Part 2|Death|35|||
155328224|NCT01574716|560637480|FG000|Part 2|Discontinuation of study by sponsor|0|||
155328225|NCT01574716|560637481|FG001|Part 2|Discontinuation of study by sponsor|0|||
155328226|NCT01574716|560637482|FG002|Part 2|Discontinuation of study by sponsor|0|||
155328227|NCT01574716|560637483|FG003|Part 2|Discontinuation of study by sponsor|51|||
155328228|NCT01574716|560637484|FG004|Part 2|Discontinuation of study by sponsor|31|||
155328229|NCT01574716|560637480|FG000|Part 2|Withdrawal by Subject|0|||
155328230|NCT01574716|560637481|FG001|Part 2|Withdrawal by Subject|0|||
155328231|NCT01574716|560637482|FG002|Part 2|Withdrawal by Subject|0|||
155328232|NCT01574716|560637483|FG003|Part 2|Withdrawal by Subject|5|||
155328233|NCT01574716|560637484|FG004|Part 2|Withdrawal by Subject|4|||
155328234|NCT01574716|560637480|FG000|Part 2|Brain metastases|0|||
155328235|NCT01574716|560637481|FG001|Part 2|Brain metastases|0|||
155328236|NCT01574716|560637482|FG002|Part 2|Brain metastases|0|||
155328237|NCT01574716|560637483|FG003|Part 2|Brain metastases|1|||
155328238|NCT01574716|560637484|FG004|Part 2|Brain metastases|0|||
155328239|NCT01574716|560637480|FG000|Part 2|Lost to Follow-up|0|||
155328240|NCT01574716|560637481|FG001|Part 2|Lost to Follow-up|0|||
155328241|NCT01574716|560637482|FG002|Part 2|Lost to Follow-up|0|||
155328242|NCT01574716|560637483|FG003|Part 2|Lost to Follow-up|3|||
155328243|NCT01574716|560637484|FG004|Part 2|Lost to Follow-up|0|||
155328244|NCT02438137|560637485|FG000|Overall Study|Lost to Follow-up|3|||
155328245|NCT02438137|560637486|FG001|Overall Study|Lost to Follow-up|2|||
155328246|NCT02438137|560637485|FG000|Overall Study|Adverse Event|1|||
155328247|NCT02438137|560637486|FG001|Overall Study|Adverse Event|0|||
155328248|NCT02438137|560637485|FG000|Overall Study|Withdrawal by Subject|4|||
155328249|NCT02438137|560637486|FG001|Overall Study|Withdrawal by Subject|3|||
155328250|NCT02438137|560637485|FG000|Overall Study|Physician Decision|0|||
155328251|NCT02438137|560637486|FG001|Overall Study|Physician Decision|1|||
155328252|NCT00945321|560637487|FG000|Period 1|Adverse Event|0|||
155328253|NCT00945321|560637488|FG001|Period 1|Adverse Event|0|||
155328254|NCT00945321|560637489|FG002|Period 1|Adverse Event|0|||
155328255|NCT00945321|560637490|FG003|Period 1|Adverse Event|0|||
155328256|NCT00945321|560637491|FG004|Period 1|Adverse Event|1|||
155328257|NCT00945321|560637492|FG005|Period 1|Adverse Event|0|||
155328258|NCT00945321|560637487|FG000|Period 4|Lost to Follow-up|0|||
155328259|NCT00945321|560637488|FG001|Period 4|Lost to Follow-up|0|||
155328260|NCT00945321|560637489|FG002|Period 4|Lost to Follow-up|0|||
155328261|NCT00945321|560637490|FG003|Period 4|Lost to Follow-up|0|||
155328262|NCT00945321|560637491|FG004|Period 4|Lost to Follow-up|0|||
155328263|NCT00945321|560637492|FG005|Period 4|Lost to Follow-up|1|||
155328264|NCT00692913|560637494|FG000|Overall Study|Adverse Event|8|||
155328265|NCT00692913|560637495|FG001|Overall Study|Adverse Event|4|||
155328266|NCT00692913|560637494|FG000|Overall Study|Lost to Follow-up|3|||
155328267|NCT00692913|560637495|FG001|Overall Study|Lost to Follow-up|5|||
155328268|NCT00692913|560637494|FG000|Overall Study|Physician Decision|2|||
155328269|NCT00692913|560637495|FG001|Overall Study|Physician Decision|0|||
155421760|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
155421761|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
155421762|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
155328270|NCT00692913|560637494|FG000|Overall Study|Protocol Violation|1|||
155328271|NCT00692913|560637495|FG001|Overall Study|Protocol Violation|1|||
155328272|NCT00692913|560637494|FG000|Overall Study|Withdrawal by Subject|15|||
155328273|NCT00692913|560637495|FG001|Overall Study|Withdrawal by Subject|20|||
155328274|NCT03621735|560637496|FG000|Overall Study|Withdrawal by Subject|13|||
155328275|NCT03621735|560637497|FG001|Overall Study|Withdrawal by Subject|13|||
155328276|NCT00605306|560637500|FG000|Overall Study|Adverse Event|0|||
155328277|NCT00605306|560637501|FG001|Overall Study|Adverse Event|1|||
155328278|NCT01750684|560637502|FG000|Overall Study|Death|1|||
155328279|NCT01750684|560637503|FG001|Overall Study|Death|0|||
155328280|NCT01750684|560637502|FG000|Overall Study|Non-compliance with Study Drug|0|||
155328281|NCT01750684|560637503|FG001|Overall Study|Non-compliance with Study Drug|1|||
155328282|NCT01750684|560637502|FG000|Overall Study|Withdrawn by Sponsor|0|||
155328283|NCT01750684|560637503|FG001|Overall Study|Withdrawn by Sponsor|1|||
155328284|NCT01750684|560637502|FG000|Overall Study|Protocol Violation|1|||
155328285|NCT01750684|560637503|FG001|Overall Study|Protocol Violation|0|||
155328286|NCT02185794|560637505|FG000|Overall Study|Enrolled but Never Dosed|1|||
155328287|NCT02185794|560637506|FG001|Overall Study|Enrolled but Never Dosed|6|||
155328288|NCT02185794|560637507|FG002|Overall Study|Enrolled but Never Dosed|3|||
155328289|NCT02185794|560637508|FG003|Overall Study|Enrolled but Never Dosed|1|||
155328290|NCT02185794|560637509|FG004|Overall Study|Enrolled but Never Dosed|1|||
155328291|NCT02185794|560637510|FG005|Overall Study|Enrolled but Never Dosed|0|||
155328292|NCT02185794|560637505|FG000|Overall Study|Investigator's Discretion|1|||
155328293|NCT02185794|560637506|FG001|Overall Study|Investigator's Discretion|0|||
155328294|NCT02185794|560637507|FG002|Overall Study|Investigator's Discretion|1|||
155328295|NCT02185794|560637508|FG003|Overall Study|Investigator's Discretion|2|||
155328296|NCT02185794|560637509|FG004|Overall Study|Investigator's Discretion|2|||
155328297|NCT02185794|560637510|FG005|Overall Study|Investigator's Discretion|15|||
155328298|NCT02185794|560637505|FG000|Overall Study|Withdrew Consent|2|||
155328299|NCT02185794|560637506|FG001|Overall Study|Withdrew Consent|5|||
155328300|NCT02185794|560637507|FG002|Overall Study|Withdrew Consent|10|||
155328301|NCT02185794|560637508|FG003|Overall Study|Withdrew Consent|2|||
155328302|NCT02185794|560637509|FG004|Overall Study|Withdrew Consent|0|||
155328303|NCT02185794|560637510|FG005|Overall Study|Withdrew Consent|0|||
155328304|NCT02185794|560637505|FG000|Overall Study|Lost to Follow-up|1|||
155328305|NCT02185794|560637506|FG001|Overall Study|Lost to Follow-up|2|||
155328306|NCT02185794|560637507|FG002|Overall Study|Lost to Follow-up|2|||
155328307|NCT02185794|560637508|FG003|Overall Study|Lost to Follow-up|3|||
155328308|NCT02185794|560637509|FG004|Overall Study|Lost to Follow-up|0|||
155328309|NCT02185794|560637510|FG005|Overall Study|Lost to Follow-up|1|||
155328310|NCT00336505|560637511|FG000|Overall Study|Adverse Event|10|||
155328311|NCT00336505|560637512|FG001|Overall Study|Adverse Event|9|||
155502519|NCT00810615|561265519|FG000|Overall Study|Withdrawal by Subject|1|||
155502520|NCT00810615|561265520|FG001|Overall Study|Withdrawal by Subject|1|||
155328312|NCT00336505|560637511|FG000|Overall Study|Lack of Efficacy|8|||
155328313|NCT00336505|560637512|FG001|Overall Study|Lack of Efficacy|4|||
155328314|NCT00336505|560637511|FG000|Overall Study|Lost to Follow-up|7|||
155328315|NCT00336505|560637512|FG001|Overall Study|Lost to Follow-up|4|||
155328316|NCT00336505|560637511|FG000|Overall Study|Withdrawal by Subject|5|||
155328317|NCT00336505|560637512|FG001|Overall Study|Withdrawal by Subject|3|||
155328318|NCT00336505|560637511|FG000|Overall Study|Other|7|||
155328319|NCT00336505|560637512|FG001|Overall Study|Other|7|||
155328320|NCT01092416|560637513|FG000|Enrollment|Atherectomy device not inserted|3|||
155328321|NCT01092416|560637513|FG000|30-Day Follow-up|Death|2|||
155328322|NCT01092416|560637513|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
155328323|NCT01092416|560637513|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
155328324|NCT01092416|560637513|FG000|12-Month Follow-up|Death|16|||
155328325|NCT01092416|560637513|FG000|12-Month Follow-up|Lost to Follow-up|4|||
155328326|NCT01092416|560637513|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
155328327|NCT01092416|560637513|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
155328328|NCT01092416|560637513|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
155328329|NCT00366249|560637514|FG000|Overall Study|Adverse Event|53|||
155328330|NCT00366249|560637515|FG001|Overall Study|Adverse Event|28|||
155328331|NCT00366249|560637514|FG000|Overall Study|Death|0|||
155328332|NCT00366249|560637515|FG001|Overall Study|Death|1|||
155328333|NCT00366249|560637514|FG000|Overall Study|Physician Decision|5|||
155328334|NCT00366249|560637515|FG001|Overall Study|Physician Decision|2|||
155328335|NCT00366249|560637514|FG000|Overall Study|Lost to Follow-up|2|||
155328336|NCT00366249|560637515|FG001|Overall Study|Lost to Follow-up|0|||
155328337|NCT00366249|560637514|FG000|Overall Study|Protocol Violation|1|||
155328338|NCT00366249|560637515|FG001|Overall Study|Protocol Violation|2|||
155328339|NCT00366249|560637514|FG000|Overall Study|Withdrawal by Subject|18|||
155328340|NCT00366249|560637515|FG001|Overall Study|Withdrawal by Subject|4|||
155328341|NCT00366249|560637514|FG000|Overall Study|Lack of Efficacy|21|||
155328342|NCT00366249|560637515|FG001|Overall Study|Lack of Efficacy|21|||
155328343|NCT00366249|560637514|FG000|Overall Study|Most due to osteomylitis status|31|||
155328344|NCT00366249|560637515|FG001|Overall Study|Most due to osteomylitis status|20|||
155328345|NCT00246805|560637516|FG000|Phase 1|Lost to Follow-up|1|||
155328346|NCT00246805|560637517|FG001|Phase 1|Lost to Follow-up|0|||
155328347|NCT03183050|560637518|FG000|Overall Study|Lost to Follow-up|23|||
155328348|NCT00686595|560637522|FG000|Overall Study|Adverse Event|3|||
155328349|NCT00686595|560637522|FG000|Overall Study|Protocol Violation|1|||
155328350|NCT00686595|560637522|FG000|Overall Study|Lost to Follow-up|1|||
155328351|NCT00686595|560637522|FG000|Overall Study|Lack of Efficacy|1|||
155328352|NCT00686595|560637522|FG000|Overall Study|Poor Compliance|1|||
155328353|NCT02797132|560637523|FG000|Part A (15 Days)|Adverse Event|1|||
155328354|NCT02797132|560637523|FG000|Part B (24 Weeks)|Adverse Event|3|||
155328355|NCT01342367|560637525|FG000|Overall Study|Death|1|||
155328356|NCT01342367|560637526|FG001|Overall Study|Death|0|||
155328357|NCT01342367|560637525|FG000|Overall Study|Withdrawal by Subject|1|||
155328358|NCT01342367|560637526|FG001|Overall Study|Withdrawal by Subject|2|||
155328359|NCT01961609|560637527|FG000|Initiation|Missing|3|||
155328360|NCT01961609|560637528|FG001|Initiation|Missing|2|||
155328361|NCT01961609|560637529|FG002|Initiation|Missing|0|||
155328362|NCT01961609|560637530|FG003|Initiation|Missing|0|||
155328363|NCT01961609|560637527|FG000|Initiation|Protocol deviation|1|||
155328364|NCT01961609|560637528|FG001|Initiation|Protocol deviation|0|||
155328365|NCT01961609|560637529|FG002|Initiation|Protocol deviation|0|||
155328366|NCT01961609|560637530|FG003|Initiation|Protocol deviation|0|||
155328367|NCT01961609|560637527|FG000|Initiation|Death|0|||
155328368|NCT01961609|560637528|FG001|Initiation|Death|1|||
155421763|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
155421764|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
155421765|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
155421766|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
155421767|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
155421768|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
155421769|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
155421770|NCT01360645|560974354|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
155421771|NCT01360645|560974355|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
155421772|NCT01360645|560974356|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
155421773|NCT01360645|560974357|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
155421774|NCT01360645|560974354|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
155421775|NCT01360645|560974355|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
155328369|NCT01961609|560637529|FG002|Initiation|Death|0|||
155328370|NCT01961609|560637530|FG003|Initiation|Death|0|||
155328371|NCT01961609|560637527|FG000|Initiation|Administrative problems|1|||
155328372|NCT01961609|560637528|FG001|Initiation|Administrative problems|0|||
155328373|NCT01961609|560637529|FG002|Initiation|Administrative problems|0|||
155328374|NCT01961609|560637530|FG003|Initiation|Administrative problems|0|||
155328375|NCT01961609|560637527|FG000|Initiation|Withdrawal by Subject|1|||
155328376|NCT01961609|560637528|FG001|Initiation|Withdrawal by Subject|2|||
155328377|NCT01961609|560637529|FG002|Initiation|Withdrawal by Subject|0|||
155328378|NCT01961609|560637530|FG003|Initiation|Withdrawal by Subject|0|||
155328379|NCT01961609|560637527|FG000|Initiation|Lack of Efficacy|2|||
155328380|NCT01961609|560637528|FG001|Initiation|Lack of Efficacy|1|||
155328381|NCT01961609|560637529|FG002|Initiation|Lack of Efficacy|0|||
155328382|NCT01961609|560637530|FG003|Initiation|Lack of Efficacy|0|||
155328383|NCT01961609|560637527|FG000|Initiation|Abnormal lab values|0|||
155328384|NCT01961609|560637528|FG001|Initiation|Abnormal lab values|1|||
155328385|NCT01961609|560637529|FG002|Initiation|Abnormal lab values|0|||
155328386|NCT01961609|560637530|FG003|Initiation|Abnormal lab values|0|||
155328387|NCT01961609|560637527|FG000|Initiation|Adverse Event|3|||
155328388|NCT01961609|560637528|FG001|Initiation|Adverse Event|5|||
155328389|NCT01961609|560637529|FG002|Initiation|Adverse Event|0|||
155328390|NCT01961609|560637530|FG003|Initiation|Adverse Event|0|||
155328391|NCT01961609|560637527|FG000|Initiation|Randomized but not treated|1|||
155328392|NCT01961609|560637528|FG001|Initiation|Randomized but not treated|1|||
155328393|NCT01961609|560637529|FG002|Initiation|Randomized but not treated|0|||
155328394|NCT01961609|560637530|FG003|Initiation|Randomized but not treated|0|||
155328395|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
155328396|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
155328397|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
155328398|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
155328399|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
155645061|NCT00790933|561792129|FG003|Overall Study|Study Terminated by Sponsor|0|||
155645062|NCT00790933|561792130|FG004|Overall Study|Study Terminated by Sponsor|0|||
155328400|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
155328401|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
155328402|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
155328403|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
155328404|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
155328405|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
155328406|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
155328407|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
155328408|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
155328409|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
155328410|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
155328411|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
155328412|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
155328413|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
155328414|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
155328415|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328416|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328417|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
155328418|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328419|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
155328420|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
155328421|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
155421776|NCT01360645|560974356|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
155421777|NCT01360645|560974357|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
155421778|NCT01360645|560974354|FG000|Phase B (6 Weeks)|Adverse Event|0|||
155421779|NCT01360645|560974355|FG001|Phase B (6 Weeks)|Adverse Event|6|||
155421780|NCT01360645|560974356|FG002|Phase B (6 Weeks)|Adverse Event|0|||
155328422|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
155328423|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
155328424|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
155421781|NCT01360645|560974357|FG003|Phase B (6 Weeks)|Adverse Event|0|||
155421782|NCT01360645|560974354|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155421783|NCT01360645|560974355|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
155421784|NCT01360645|560974356|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
155421785|NCT01360645|560974357|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155421786|NCT01360645|560974354|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
155421787|NCT01360645|560974355|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
155421788|NCT01360645|560974356|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
155421789|NCT01360645|560974357|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
155421790|NCT01360645|560974354|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
155421791|NCT01360645|560974355|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
155421792|NCT01360645|560974356|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
155421793|NCT01360645|560974357|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
155421794|NCT01360645|560974354|FG000|Phase A+|Lost to Follow-up|0|||
155421795|NCT01360645|560974355|FG001|Phase A+|Lost to Follow-up|0|||
155421796|NCT01360645|560974356|FG002|Phase A+|Lost to Follow-up|0|||
155421797|NCT01360645|560974357|FG003|Phase A+|Lost to Follow-up|7|||
155645063|NCT00790933|561792126|FG000|Overall Study|Withdrawal by Subject|123|||
155645064|NCT00790933|561792127|FG001|Overall Study|Withdrawal by Subject|120|||
155645065|NCT00790933|561792128|FG002|Overall Study|Withdrawal by Subject|52|||
155645066|NCT00790933|561792129|FG003|Overall Study|Withdrawal by Subject|6|||
155328425|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
155328426|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
155328427|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
155328428|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328429|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328430|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328431|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328432|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
155328433|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328434|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328435|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
155328436|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
155328437|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
155328438|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
155328439|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
155328440|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
155328441|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
155328442|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
155328443|NCT02284113|560637531|FG000|Overall Study|Adverse Event|1|||
155328444|NCT02284113|560637532|FG001|Overall Study|Adverse Event|0|||
155328445|NCT02284113|560637531|FG000|Overall Study|non-compliance|0|||
155328446|NCT02284113|560637532|FG001|Overall Study|non-compliance|1|||
155328447|NCT02284113|560637531|FG000|Overall Study|Withdrawal by Subject|0|||
155328448|NCT02284113|560637532|FG001|Overall Study|Withdrawal by Subject|1|||
155328449|NCT02284113|560637531|FG000|Overall Study|not provided|0|||
155328450|NCT02284113|560637532|FG001|Overall Study|not provided|1|||
155328451|NCT02284113|560637531|FG000|Overall Study|surgery cancelled|2|||
155328452|NCT02284113|560637532|FG001|Overall Study|surgery cancelled|0|||
155328453|NCT04191824|560637533|FG000|Overall Study|Death|13|||
155328454|NCT04191824|560637534|FG001|Overall Study|Death|12|||
155328455|NCT04191824|560637533|FG000|Overall Study|Lost to Follow-up|456|||
155502521|NCT02567266|561265521|FG000|Overall Study|Withdrawal by Subject|10|||
155328456|NCT04191824|560637534|FG001|Overall Study|Lost to Follow-up|435|||
155328457|NCT04191824|560637533|FG000|Overall Study|Physician Decision|2|||
155328458|NCT04191824|560637534|FG001|Overall Study|Physician Decision|1|||
155328459|NCT04191824|560637533|FG000|Overall Study|Protocol Violation|0|||
155328460|NCT04191824|560637534|FG001|Overall Study|Protocol Violation|2|||
155328461|NCT04191824|560637533|FG000|Overall Study|Withdrawal by Subject|16|||
155328462|NCT04191824|560637534|FG001|Overall Study|Withdrawal by Subject|18|||
155328463|NCT04191824|560637533|FG000|Overall Study|Early site closure|24|||
155328464|NCT04191824|560637534|FG001|Overall Study|Early site closure|22|||
155328465|NCT01218009|560637537|FG000|Overall Study|Protocol Violation|2|||
155328466|NCT01218009|560637538|FG001|Overall Study|Protocol Violation|1|||
155328467|NCT01218009|560637537|FG000|Overall Study|Withdrawal by Subject|3|||
155328468|NCT01218009|560637538|FG001|Overall Study|Withdrawal by Subject|1|||
155328469|NCT01218009|560637537|FG000|Overall Study|Sponsor terminated study|161|||
155328470|NCT01218009|560637538|FG001|Overall Study|Sponsor terminated study|163|||
155328471|NCT01324310|560637539|FG000|Overall Study|Adverse Event|1|||
155328472|NCT01324310|560637539|FG000|Overall Study|Disease Progression|1|||
155328473|NCT03170882|560637540|FG000|Overall Study|Death|17|||
155328474|NCT03170882|560637541|FG001|Overall Study|Death|29|||
155328475|NCT03170882|560637540|FG000|Overall Study|Lost to Follow-up|0|||
155328476|NCT03170882|560637541|FG001|Overall Study|Lost to Follow-up|1|||
155328477|NCT03170882|560637540|FG000|Overall Study|Withdrawal by Subject|4|||
155328478|NCT03170882|560637541|FG001|Overall Study|Withdrawal by Subject|7|||
155328479|NCT03170882|560637540|FG000|Overall Study|Reason not Specified|28|||
155328480|NCT03170882|560637541|FG001|Overall Study|Reason not Specified|36|||
155328481|NCT01371994|560637545|FG000|Overall Study|Adverse Event|3|||
155328482|NCT01371994|560637546|FG001|Overall Study|Adverse Event|6|||
155328483|NCT01371994|560637545|FG000|Overall Study|Lack of Efficacy|3|||
155328484|NCT01371994|560637546|FG001|Overall Study|Lack of Efficacy|0|||
155328485|NCT01371994|560637545|FG000|Overall Study|Withdrawal by Subject|13|||
155328486|NCT01371994|560637546|FG001|Overall Study|Withdrawal by Subject|7|||
155328487|NCT01371994|560637545|FG000|Overall Study|Lost to Follow-up|1|||
155328488|NCT01371994|560637546|FG001|Overall Study|Lost to Follow-up|1|||
155328489|NCT01371994|560637545|FG000|Overall Study|Protocol Violation|24|||
155328490|NCT01371994|560637546|FG001|Overall Study|Protocol Violation|17|||
155328491|NCT01371994|560637545|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
155328492|NCT01371994|560637546|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
155328493|NCT01371994|560637545|FG000|Overall Study|Physician Decision|1|||
155328494|NCT01371994|560637546|FG001|Overall Study|Physician Decision|1|||
155328495|NCT01371994|560637545|FG000|Overall Study|Miscellaneous Reasons|6|||
155328496|NCT01371994|560637546|FG001|Overall Study|Miscellaneous Reasons|4|||
155328497|NCT00087685|560637547|FG000|Overall Study|Adverse Event|5|||
155328498|NCT00087685|560637547|FG000|Overall Study|Non-Compliance|1|||
155328499|NCT00087685|560637547|FG000|Overall Study|Progressive Disease|5|||
155328500|NCT00087685|560637547|FG000|Overall Study|Withdrawal by Subject|3|||
155328501|NCT03891758|560637549|FG000|Overall Study|Adverse Event|2|||
155328502|NCT03891758|560637550|FG001|Overall Study|Adverse Event|0|||
155328503|NCT03891758|560637549|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155328504|NCT03891758|560637550|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155328505|NCT01983683|560637551|FG000|Overall Study|Withdrawal by Subject|14|||
155328506|NCT01983683|560637552|FG001|Overall Study|Withdrawal by Subject|18|||
155328507|NCT01983683|560637551|FG000|Overall Study|Death|11|||
155328508|NCT01983683|560637552|FG001|Overall Study|Death|15|||
155328509|NCT01983683|560637551|FG000|Overall Study|Physician Decision|8|||
155328510|NCT01983683|560637552|FG001|Overall Study|Physician Decision|9|||
155328511|NCT01983683|560637551|FG000|Overall Study|Lost to Follow-up|4|||
155328512|NCT01983683|560637552|FG001|Overall Study|Lost to Follow-up|8|||
155328513|NCT01983683|560637551|FG000|Overall Study|Sponsor Decision|1|||
155328514|NCT01983683|560637552|FG001|Overall Study|Sponsor Decision|1|||
155328515|NCT00536120|560638186|FG000|Overall Study|Lost to Follow-up|1|||
155328516|NCT00536120|560638187|FG001|Overall Study|Lost to Follow-up|0|||
155328517|NCT00536120|560638186|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
155328518|NCT00536120|560638187|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
155328519|NCT00536120|560638186|FG000|Overall Study|Non-compliance|1|||
155328520|NCT00536120|560638187|FG001|Overall Study|Non-compliance|0|||
155328521|NCT00536120|560638186|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
155328522|NCT00536120|560638187|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
155328523|NCT00536120|560638186|FG000|Overall Study|Steroid Use|0|||
155328524|NCT00536120|560638187|FG001|Overall Study|Steroid Use|2|||
155328525|NCT00536120|560638186|FG000|Overall Study|Missed Study Visit|0|||
155328526|NCT00536120|560638187|FG001|Overall Study|Missed Study Visit|1|||
155328527|NCT04989816|560638188|FG000|Overall Study|Death|77|||
155328528|NCT04989816|560638188|FG000|Overall Study|Lost to Follow-up|3|||
155421798|NCT01360645|560974354|FG000|Phase A+|Adverse Event|0|||
155328529|NCT01184326|560638192|FG000|Overall Study|Adverse Event|1|||
155328530|NCT01184326|560638193|FG001|Overall Study|Adverse Event|2|||
155328531|NCT01184326|560638194|FG002|Overall Study|Adverse Event|0|||
155328532|NCT01184326|560638192|FG000|Overall Study|Death|0|||
155328533|NCT01184326|560638193|FG001|Overall Study|Death|0|||
155328534|NCT01184326|560638194|FG002|Overall Study|Death|1|||
155328535|NCT01184326|560638192|FG000|Overall Study|Withdrawal by Subject|0|||
155328536|NCT01184326|560638193|FG001|Overall Study|Withdrawal by Subject|0|||
155328537|NCT01184326|560638194|FG002|Overall Study|Withdrawal by Subject|1|||
155328538|NCT01184326|560638192|FG000|Overall Study|Physician Decision|1|||
155328539|NCT01184326|560638193|FG001|Overall Study|Physician Decision|1|||
155328540|NCT01184326|560638194|FG002|Overall Study|Physician Decision|0|||
155328541|NCT01184326|560638192|FG000|Overall Study|Disease Progression|1|||
155328542|NCT01184326|560638193|FG001|Overall Study|Disease Progression|3|||
155328543|NCT01184326|560638194|FG002|Overall Study|Disease Progression|12|||
155328544|NCT01084694|560638195|FG000|Overall Study|Withdrawal by Subject|2|||
155328545|NCT01084694|560638196|FG001|Overall Study|Withdrawal by Subject|1|||
155328546|NCT01084694|560638195|FG000|Overall Study|Death|2|||
155328547|NCT01084694|560638196|FG001|Overall Study|Death|12|||
155328548|NCT01084694|560638195|FG000|Overall Study|eligibility not maintained|2|||
155328549|NCT01084694|560638196|FG001|Overall Study|eligibility not maintained|7|||
155328550|NCT04017611|560638202|FG000|Overall Study|Withdrawn prior to completion|1|||
155328551|NCT00777049|560638213|FG000|Overall Study|Withdrawal by Subject|1|||
155328552|NCT00777049|560638214|FG001|Overall Study|Withdrawal by Subject|0|||
155328553|NCT00777049|560638213|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
155328554|NCT00777049|560638214|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
155328555|NCT00609869|560638215|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
155328556|NCT00609869|560638215|FG000|Overall Study|Severe hematologic toxicity|1|||
155328557|NCT00609869|560638215|FG000|Overall Study|Withdrawal by Subject|1|||
155328558|NCT00609869|560638215|FG000|Overall Study|Seizures|1|||
155328559|NCT00609869|560638215|FG000|Overall Study|Severe tumor flare reaction|1|||
155328560|NCT00609869|560638215|FG000|Overall Study|Hepatitis B infection|1|||
155328561|NCT00609869|560638215|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
155328562|NCT00609869|560638215|FG000|Overall Study|Mantle cell: not evaluable|4|||
155328563|NCT03478969|560638216|FG000|Overall Study|Withdrawal by Subject|4|||
155328564|NCT03478969|560638217|FG001|Overall Study|Withdrawal by Subject|7|||
155328565|NCT03478969|560638218|FG002|Overall Study|Withdrawal by Subject|6|||
155328566|NCT03478969|560638216|FG000|Overall Study|Adverse Event|2|||
155328567|NCT03478969|560638217|FG001|Overall Study|Adverse Event|0|||
155328568|NCT03478969|560638218|FG002|Overall Study|Adverse Event|1|||
155328569|NCT03478969|560638216|FG000|Overall Study|Pregnancy|1|||
155328570|NCT03478969|560638217|FG001|Overall Study|Pregnancy|0|||
155328571|NCT03478969|560638218|FG002|Overall Study|Pregnancy|0|||
155328572|NCT03478969|560638216|FG000|Overall Study|Personal Reasons|1|||
155328573|NCT03478969|560638217|FG001|Overall Study|Personal Reasons|0|||
155328574|NCT03478969|560638218|FG002|Overall Study|Personal Reasons|1|||
155328575|NCT03478969|560638216|FG000|Overall Study|Covid-19|1|||
155328576|NCT03478969|560638217|FG001|Overall Study|Covid-19|4|||
155328577|NCT03478969|560638218|FG002|Overall Study|Covid-19|3|||
155328578|NCT03478969|560638216|FG000|Overall Study|Multiple Reasons|0|||
155328579|NCT03478969|560638217|FG001|Overall Study|Multiple Reasons|1|||
155328580|NCT03478969|560638218|FG002|Overall Study|Multiple Reasons|1|||
155328581|NCT03478969|560638216|FG000|Overall Study|Eligibility Criteria|0|||
155328582|NCT03478969|560638217|FG001|Overall Study|Eligibility Criteria|0|||
155328583|NCT03478969|560638218|FG002|Overall Study|Eligibility Criteria|5|||
155328584|NCT03478969|560638216|FG000|Overall Study|Lost to Follow-up|0|||
155328585|NCT03478969|560638217|FG001|Overall Study|Lost to Follow-up|0|||
155328586|NCT03478969|560638218|FG002|Overall Study|Lost to Follow-up|1|||
155328587|NCT03885232|560638221|FG000|Overall Study|Lost to Follow-up|74|||
155328588|NCT03885232|560638222|FG001|Overall Study|Lost to Follow-up|32|||
155328589|NCT03885232|560638221|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
155328590|NCT03885232|560638222|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
155328591|NCT05139992|560638223|FG000|Overall Study|Withdrawal by Subject|12|||
155328592|NCT05139992|560638223|FG000|Overall Study|Lost to Follow-up|6|||
155328593|NCT05521516|560638224|FG000|Overall Study|Withdrawal by Subject|1|||
155328594|NCT05521516|560638225|FG001|Overall Study|Withdrawal by Subject|1|||
155328595|NCT02500576|560638227|FG000|Overall Study|Adverse Event|0|||
155328596|NCT02500576|560638228|FG001|Overall Study|Adverse Event|1|||
155328597|NCT02500576|560638227|FG000|Overall Study|Death|2|||
155328598|NCT02500576|560638228|FG001|Overall Study|Death|1|||
155328599|NCT02500576|560638227|FG000|Overall Study|Lack of Efficacy|5|||
155328600|NCT02500576|560638228|FG001|Overall Study|Lack of Efficacy|5|||
155328601|NCT02500576|560638227|FG000|Overall Study|Withdrawal by Subject|1|||
155328602|NCT02500576|560638228|FG001|Overall Study|Withdrawal by Subject|1|||
155328603|NCT04882917|560638237|FG000|Overall Study|Adverse Event|0|||
155328604|NCT04882917|560638238|FG001|Overall Study|Adverse Event|1|||
155328605|NCT04882917|560638239|FG002|Overall Study|Adverse Event|2|||
155328606|NCT04882917|560638240|FG003|Overall Study|Adverse Event|2|||
155328607|NCT04882917|560638237|FG000|Overall Study|Withdrawal by Subject|1|||
155328608|NCT04882917|560638238|FG001|Overall Study|Withdrawal by Subject|0|||
155328609|NCT04882917|560638239|FG002|Overall Study|Withdrawal by Subject|2|||
155328610|NCT04882917|560638240|FG003|Overall Study|Withdrawal by Subject|1|||
155328611|NCT04882917|560638237|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
155328612|NCT04882917|560638238|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328613|NCT04882917|560638239|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328614|NCT04882917|560638240|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328615|NCT00227266|560638241|FG000|Overall Study|Withdrawal by Subject|0|||
155328616|NCT00227266|560638242|FG001|Overall Study|Withdrawal by Subject|0|||
155328617|NCT00227266|560638243|FG002|Overall Study|Withdrawal by Subject|1|||
155328618|NCT00227266|560638241|FG000|Overall Study|Protocol Violation|1|||
155328619|NCT00227266|560638242|FG001|Overall Study|Protocol Violation|0|||
155328620|NCT00227266|560638243|FG002|Overall Study|Protocol Violation|1|||
155328621|NCT00227266|560638241|FG000|Overall Study|Excessive weight gain|0|||
155328622|NCT00227266|560638242|FG001|Overall Study|Excessive weight gain|0|||
155328623|NCT00227266|560638243|FG002|Overall Study|Excessive weight gain|2|||
155328624|NCT03959423|560638247|FG000|Overall Study|Withdrawal by Subject|2|||
155328625|NCT03959423|560638248|FG001|Overall Study|Withdrawal by Subject|3|||
155328626|NCT03959423|560638247|FG000|Overall Study|Physician Decision|0|||
155328627|NCT03959423|560638248|FG001|Overall Study|Physician Decision|1|||
155328628|NCT03959423|560638247|FG000|Overall Study|Lost to Follow-up|1|||
155328629|NCT03959423|560638248|FG001|Overall Study|Lost to Follow-up|0|||
155328630|NCT03959423|560638247|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
155328631|NCT03959423|560638248|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155328632|NCT04926740|560638249|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
155328633|NCT04926740|560638250|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
155328634|NCT04926740|560638249|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
155328635|NCT04926740|560638250|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
155328636|NCT01470144|560638253|FG000|Overall Study|Adverse Event|2|||
155328637|NCT01470144|560638253|FG000|Overall Study|Death|1|||
155328638|NCT01470144|560638253|FG000|Overall Study|Lung transplant|6|||
155328639|NCT01470144|560638253|FG000|Overall Study|Patient's and investigator's decision|1|||
155328640|NCT00593840|560638254|FG000|Overall Study|Withdrawal by Subject|1|||
155328641|NCT01128595|560639252|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155328642|NCT01128595|560639253|FG001|Treatment Period 3|Withdrawal by Subject|1|||
155328643|NCT01128595|560639254|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155328644|NCT01128595|560639255|FG003|Treatment Period 3|Withdrawal by Subject|0|||
155328645|NCT01561300|560639257|FG000|Run in on Placebo|Adverse Event|1|||
155328646|NCT01561300|560639258|FG001|Run in on Placebo|Adverse Event|0|||
155328647|NCT01185600|560639259|FG000|Overall Study|Adverse Event|1|||
155328648|NCT01185600|560639260|FG001|Overall Study|Adverse Event|1|||
155328649|NCT01185600|560639259|FG000|Overall Study|Death|0|||
155328650|NCT01185600|560639260|FG001|Overall Study|Death|1|||
155328651|NCT01185600|560639259|FG000|Overall Study|Lost to Follow-up|0|||
155328652|NCT01185600|560639260|FG001|Overall Study|Lost to Follow-up|5|||
155328653|NCT01185600|560639259|FG000|Overall Study|Physician Decision|29|||
155328654|NCT01185600|560639260|FG001|Overall Study|Physician Decision|35|||
155328655|NCT01185600|560639259|FG000|Overall Study|Withdrawal by Subject|1|||
155328656|NCT01185600|560639260|FG001|Overall Study|Withdrawal by Subject|1|||
155328657|NCT01185600|560639259|FG000|Overall Study|Hold by DSMB|1|||
155328658|NCT01185600|560639260|FG001|Overall Study|Hold by DSMB|2|||
155328659|NCT01436175|560639261|FG000|Overall Study|Adverse Event|111|||
155328660|NCT01436175|560639261|FG000|Overall Study|Protocol Violation|49|||
155328661|NCT01436175|560639261|FG000|Overall Study|Withdrawal by Subject|108|||
155328662|NCT01436175|560639261|FG000|Overall Study|Lost to Follow-up|89|||
155328663|NCT01436175|560639261|FG000|Overall Study|Lack of Efficacy|24|||
155328664|NCT01436175|560639261|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
155328665|NCT01436175|560639261|FG000|Overall Study|Other|826|||
155328666|NCT05405244|560639262|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
155328667|NCT05405244|560639263|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
155328668|NCT05405244|560639262|FG000|Washout (2 Weeks)|Adverse Event|2|||
155328669|NCT05405244|560639263|FG001|Washout (2 Weeks)|Adverse Event|0|||
155328670|NCT05405244|560639262|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
155328671|NCT05405244|560639263|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
155328672|NCT00739934|560639264|FG000|Voriconazole IV|Adverse Event|6|||
155328673|NCT00739934|560639264|FG000|Voriconazole Oral|Other|3|||
155328674|NCT04353492|560639270|FG000|Overall Study|Subject decision|24|||
155328675|NCT04353492|560639270|FG000|Overall Study|Physician Decision|5|||
155328676|NCT04353492|560639270|FG000|Overall Study|Adverse Event|3|||
155328677|NCT04353492|560639270|FG000|Overall Study|Pregnancy|3|||
155328678|NCT04353492|560639270|FG000|Overall Study|Lost to Follow-up|2|||
155328679|NCT04353492|560639270|FG000|Overall Study|Protocol deviation|1|||
155328680|NCT04353492|560639270|FG000|Overall Study|Technical problems|1|||
155328681|NCT04250194|560639271|FG000|Overall Study|Declined to schedule biopsy|6|||
155328682|NCT04250194|560639272|FG001|Overall Study|Declined to schedule biopsy|10|||
155328683|NCT04250194|560639271|FG000|Overall Study|Medically Unfit for Biopsy|2|||
155328684|NCT04250194|560639272|FG001|Overall Study|Medically Unfit for Biopsy|1|||
155328685|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
155328686|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
155328687|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
155328688|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
155328689|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
155421799|NCT01360645|560974355|FG001|Phase A+|Adverse Event|0|||
155328690|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
155328691|NCT00857766|560639273|FG000|Overall Study|Adverse Event|13|||
155328692|NCT00857766|560639274|FG001|Overall Study|Adverse Event|12|||
155328693|NCT00857766|560639273|FG000|Overall Study|Protocol Violation|11|||
155328694|NCT00857766|560639274|FG001|Overall Study|Protocol Violation|11|||
155328695|NCT00857766|560639273|FG000|Overall Study|Lost to Follow-up|1|||
155328696|NCT00857766|560639274|FG001|Overall Study|Lost to Follow-up|0|||
155328697|NCT00857766|560639273|FG000|Overall Study|Investigator Discretion|2|||
155328698|NCT00857766|560639274|FG001|Overall Study|Investigator Discretion|3|||
155328699|NCT00857766|560639273|FG000|Overall Study|Participant Withdrew Consent|4|||
155328700|NCT00857766|560639274|FG001|Overall Study|Participant Withdrew Consent|4|||
155328701|NCT01212744|560639277|FG000|Overall Study|Withdrawal by Subject|1|||
155328702|NCT02167451|560639279|FG000|Overall Study|Withdrawal by Subject|1|||
155328703|NCT00571649|560639280|FG000|Treatment Period|Adverse Event|438|||
155328704|NCT00571649|560639281|FG001|Treatment Period|Adverse Event|385|||
155328705|NCT00571649|560639280|FG000|Treatment Period|Clinical endpoint reached|50|||
155328706|NCT00571649|560639281|FG001|Treatment Period|Clinical endpoint reached|56|||
155328707|NCT00571649|560639280|FG000|Treatment Period|Withdrawal by Subject|285|||
155328708|NCT00571649|560639281|FG001|Treatment Period|Withdrawal by Subject|255|||
155328709|NCT00571649|560639280|FG000|Treatment Period|Death|76|||
155328710|NCT00571649|560639281|FG001|Treatment Period|Death|59|||
155328711|NCT00571649|560639280|FG000|Treatment Period|Physician Decision|8|||
155328712|NCT00571649|560639281|FG001|Treatment Period|Physician Decision|9|||
155328713|NCT00571649|560639280|FG000|Treatment Period|Lost to Follow-up|43|||
155328714|NCT00571649|560639281|FG001|Treatment Period|Lost to Follow-up|41|||
155328715|NCT00571649|560639280|FG000|Treatment Period|Non-compliant with study medication|88|||
155328716|NCT00571649|560639281|FG001|Treatment Period|Non-compliant with study medication|89|||
155328717|NCT00571649|560639280|FG000|Treatment Period|Patient convenience|11|||
155328718|NCT00571649|560639281|FG001|Treatment Period|Patient convenience|13|||
155328719|NCT00571649|560639280|FG000|Treatment Period|Protocol Violation|90|||
155328720|NCT00571649|560639281|FG001|Treatment Period|Protocol Violation|92|||
155328721|NCT00571649|560639280|FG000|Treatment Period|Technical problems|3|||
155328722|NCT00571649|560639281|FG001|Treatment Period|Technical problems|5|||
155328723|NCT00571649|560639280|FG000|Follow-up Period|Adverse Event|46|||
155328724|NCT00571649|560639281|FG001|Follow-up Period|Adverse Event|40|||
155328725|NCT00571649|560639280|FG000|Follow-up Period|Clinical endpoint reached|5|||
155328726|NCT00571649|560639281|FG001|Follow-up Period|Clinical endpoint reached|2|||
155328727|NCT00571649|560639280|FG000|Follow-up Period|Withdrawal by Subject|119|||
155328728|NCT00571649|560639281|FG001|Follow-up Period|Withdrawal by Subject|115|||
155328729|NCT00571649|560639280|FG000|Follow-up Period|Death|132|||
155328730|NCT00571649|560639281|FG001|Follow-up Period|Death|133|||
155328731|NCT00571649|560639280|FG000|Follow-up Period|Physician Decision|7|||
155328732|NCT00571649|560639281|FG001|Follow-up Period|Physician Decision|13|||
155328733|NCT00571649|560639280|FG000|Follow-up Period|Lost to Follow-up|95|||
155328734|NCT00571649|560639281|FG001|Follow-up Period|Lost to Follow-up|92|||
155421800|NCT01360645|560974356|FG002|Phase A+|Adverse Event|0|||
155421801|NCT01360645|560974357|FG003|Phase A+|Adverse Event|2|||
155421802|NCT01360645|560974354|FG000|Phase A+|Met Withdrawal Criteria|0|||
155328735|NCT00571649|560639280|FG000|Follow-up Period|Patient convenience|136|||
155328736|NCT00571649|560639281|FG001|Follow-up Period|Patient convenience|121|||
155328737|NCT00571649|560639280|FG000|Follow-up Period|Protocol Violation|5|||
155328738|NCT00571649|560639281|FG001|Follow-up Period|Protocol Violation|12|||
155328739|NCT01218659|560639282|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
155328740|NCT01218659|560639283|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
155328741|NCT01218659|560639284|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
155328742|NCT01218659|560639282|FG000|18-Month Randomized Period|Did not receive study drug|0|||
155328743|NCT01218659|560639283|FG001|18-Month Randomized Period|Did not receive study drug|3|||
155328744|NCT01218659|560639284|FG002|18-Month Randomized Period|Did not receive study drug|0|||
155328745|NCT01218659|560639282|FG000|12-Month OLE|Withdrawal by Subject|0|||
155328746|NCT01218659|560639283|FG001|12-Month OLE|Withdrawal by Subject|0|||
155645067|NCT00790933|561792130|FG004|Overall Study|Withdrawal by Subject|50|||
155645068|NCT00790933|561792126|FG000|Overall Study|Lost to Follow-up|13|||
155645069|NCT00790933|561792127|FG001|Overall Study|Lost to Follow-up|31|||
155645070|NCT00790933|561792128|FG002|Overall Study|Lost to Follow-up|10|||
155645071|NCT00790933|561792129|FG003|Overall Study|Lost to Follow-up|1|||
155645072|NCT00790933|561792130|FG004|Overall Study|Lost to Follow-up|15|||
155645073|NCT00790933|561792126|FG000|Overall Study|Reason Not Specified|8|||
155645074|NCT00790933|561792127|FG001|Overall Study|Reason Not Specified|16|||
155645075|NCT00790933|561792128|FG002|Overall Study|Reason Not Specified|4|||
155645076|NCT00790933|561792129|FG003|Overall Study|Reason Not Specified|1|||
155645077|NCT00790933|561792130|FG004|Overall Study|Reason Not Specified|9|||
155645078|NCT00720083|561792133|FG000|Overall Study|Ineligible|1|||
155645079|NCT00720083|561792134|FG001|Overall Study|Ineligible|2|||
155645080|NCT01913470|561792136|FG000|Overall Study|Lost to Follow-up|0|||
155645081|NCT01913470|561792137|FG001|Overall Study|Lost to Follow-up|1|||
155645082|NCT01913470|561792136|FG000|Overall Study|Physician Decision|0|||
155645083|NCT01913470|561792137|FG001|Overall Study|Physician Decision|1|||
155645084|NCT01913470|561792136|FG000|Overall Study|Withdrawal by Subject|0|||
155328747|NCT01218659|560639284|FG002|12-Month OLE|Withdrawal by Subject|2|||
155328748|NCT01218659|560639282|FG000|12-Month OLE|Physician Decision|0|||
155328749|NCT01218659|560639283|FG001|12-Month OLE|Physician Decision|0|||
155328750|NCT01218659|560639284|FG002|12-Month OLE|Physician Decision|1|||
155328751|NCT01218659|560639282|FG000|12-Month OLE|Lost to Follow-up|0|||
155328752|NCT01218659|560639283|FG001|12-Month OLE|Lost to Follow-up|0|||
155645085|NCT01913470|561792137|FG001|Overall Study|Withdrawal by Subject|1|||
155645086|NCT00245570|561792140|FG000|Washout Between Periods III and IV|Adverse Event|0|||
155645087|NCT00245570|561792141|FG001|Washout Between Periods III and IV|Adverse Event|1|||
155645088|NCT00245570|561792142|FG002|Washout Between Periods III and IV|Adverse Event|0|||
155645089|NCT00245570|561792143|FG003|Washout Between Periods III and IV|Adverse Event|0|||
155645090|NCT00245570|561792144|FG004|Washout Between Periods III and IV|Adverse Event|0|||
155645091|NCT00245570|561792145|FG005|Washout Between Periods III and IV|Adverse Event|0|||
155645092|NCT01829165|561792150|FG000|Overall Study|Did not complete intervention|2|||
155645093|NCT01829165|561792151|FG001|Overall Study|Did not complete intervention|0|||
155645094|NCT02573467|561792152|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155645095|NCT02573467|561792153|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155645096|NCT02573467|561792154|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
155645097|NCT02573467|561792155|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155645098|NCT02573467|561792152|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
155645099|NCT02573467|561792153|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
155645100|NCT02573467|561792154|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
155645101|NCT02573467|561792155|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
155645102|NCT02573467|561792152|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
155645103|NCT02573467|561792153|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
155645104|NCT02573467|561792154|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
155645105|NCT02573467|561792155|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
155645106|NCT02573467|561792152|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
155645107|NCT02573467|561792153|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
155645108|NCT02573467|561792154|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
155645109|NCT02573467|561792155|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
155645110|NCT02573467|561792152|FG000|Post-treatment Follow up Epoch|Death|1|||
155645111|NCT02573467|561792153|FG001|Post-treatment Follow up Epoch|Death|1|||
155645112|NCT02573467|561792154|FG002|Post-treatment Follow up Epoch|Death|0|||
155645113|NCT02573467|561792155|FG003|Post-treatment Follow up Epoch|Death|1|||
155645114|NCT02573467|561792152|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
155645115|NCT02573467|561792153|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
155645116|NCT02573467|561792154|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
155645117|NCT02573467|561792155|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
155645118|NCT02573467|561792152|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
155645119|NCT02573467|561792153|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
155645120|NCT02573467|561792154|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
155645121|NCT02573467|561792155|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
155645122|NCT00710970|561792157|FG000|Overall Study|Never took drug|3|||
155645123|NCT01960842|561792160|FG000|Overall Study|Adverse Event|1|||
155645124|NCT01960842|561792160|FG000|Overall Study|Withdrawal by Subject|2|||
155645125|NCT02056288|561792165|FG000|In-Hospital Data|Surgery cancelled|1|||
155645126|NCT02056288|561792166|FG001|In-Hospital Data|Surgery cancelled|0|||
155645127|NCT02056288|561792165|FG000|In-Hospital Data|Protocol Violation|3|||
155645128|NCT02056288|561792166|FG001|In-Hospital Data|Protocol Violation|0|||
155645129|NCT02056288|561792165|FG000|In-Hospital Data|Physician Decision|1|||
155645130|NCT02056288|561792166|FG001|In-Hospital Data|Physician Decision|0|||
155645131|NCT02056288|561792165|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
155328753|NCT01218659|560639284|FG002|12-Month OLE|Lost to Follow-up|1|||
155328754|NCT01218659|560639282|FG000|12-Month OLE|Pregnancy|0|||
155328755|NCT01218659|560639283|FG001|12-Month OLE|Pregnancy|0|||
155328756|NCT01218659|560639284|FG002|12-Month OLE|Pregnancy|1|||
155328757|NCT01218659|560639282|FG000|12-Month OLE|Lack of Efficacy|0|||
155328758|NCT01218659|560639283|FG001|12-Month OLE|Lack of Efficacy|0|||
155328759|NCT01218659|560639284|FG002|12-Month OLE|Lack of Efficacy|1|||
155328760|NCT01218659|560639282|FG000|12-Month OLE|Declined to participate in the OLE|0|||
155328761|NCT01218659|560639283|FG001|12-Month OLE|Declined to participate in the OLE|0|||
155328762|NCT01218659|560639284|FG002|12-Month OLE|Declined to participate in the OLE|4|||
155328763|NCT03066609|560639291|FG000|INDUCTION|Pregnancy|0|||
155328764|NCT03066609|560639292|FG001|INDUCTION|Pregnancy|0|||
155328765|NCT03066609|560639293|FG002|INDUCTION|Pregnancy|1|||
155328766|NCT03066609|560639294|FG003|INDUCTION|Pregnancy|0|||
155328767|NCT03066609|560639291|FG000|INDUCTION|Lack of Efficacy|0|||
155328768|NCT03066609|560639292|FG001|INDUCTION|Lack of Efficacy|0|||
155328769|NCT03066609|560639293|FG002|INDUCTION|Lack of Efficacy|1|||
155328770|NCT03066609|560639294|FG003|INDUCTION|Lack of Efficacy|0|||
155328771|NCT03066609|560639291|FG000|INDUCTION|Adverse Event|2|||
155328772|NCT03066609|560639292|FG001|INDUCTION|Adverse Event|2|||
155328773|NCT03066609|560639293|FG002|INDUCTION|Adverse Event|0|||
155328774|NCT03066609|560639294|FG003|INDUCTION|Adverse Event|0|||
155421803|NCT01360645|560974355|FG001|Phase A+|Met Withdrawal Criteria|0|||
155421804|NCT01360645|560974356|FG002|Phase A+|Met Withdrawal Criteria|0|||
155328775|NCT03066609|560639291|FG000|MAINTENANCE|Adverse Event|0|||
155328776|NCT03066609|560639292|FG001|MAINTENANCE|Adverse Event|0|||
155421805|NCT01360645|560974357|FG003|Phase A+|Met Withdrawal Criteria|4|||
155328777|NCT03066609|560639293|FG002|MAINTENANCE|Adverse Event|0|||
155328778|NCT03066609|560639294|FG003|MAINTENANCE|Adverse Event|1|||
155328779|NCT03066609|560639291|FG000|MAINTENANCE|Withdrawal by Subject|4|||
155328780|NCT03066609|560639292|FG001|MAINTENANCE|Withdrawal by Subject|2|||
155328781|NCT03066609|560639293|FG002|MAINTENANCE|Withdrawal by Subject|1|||
155328782|NCT03066609|560639294|FG003|MAINTENANCE|Withdrawal by Subject|1|||
155328783|NCT03066609|560639291|FG000|MAINTENANCE|Lost to Follow-up|0|||
155328784|NCT03066609|560639292|FG001|MAINTENANCE|Lost to Follow-up|1|||
155328785|NCT03066609|560639293|FG002|MAINTENANCE|Lost to Follow-up|1|||
155328786|NCT03066609|560639294|FG003|MAINTENANCE|Lost to Follow-up|0|||
155328787|NCT03066609|560639291|FG000|MAINTENANCE|Pregnancy|1|||
155328788|NCT03066609|560639292|FG001|MAINTENANCE|Pregnancy|0|||
155328789|NCT03066609|560639293|FG002|MAINTENANCE|Pregnancy|0|||
155328790|NCT03066609|560639294|FG003|MAINTENANCE|Pregnancy|0|||
155328791|NCT03066609|560639291|FG000|MAINTENANCE|Lack of Efficacy|2|||
155328792|NCT03066609|560639292|FG001|MAINTENANCE|Lack of Efficacy|1|||
155328793|NCT03066609|560639293|FG002|MAINTENANCE|Lack of Efficacy|0|||
155328794|NCT03066609|560639294|FG003|MAINTENANCE|Lack of Efficacy|1|||
155328795|NCT03066609|560639291|FG000|OVERALL STUDY|Adverse Event|2|||
155328796|NCT03066609|560639292|FG001|OVERALL STUDY|Adverse Event|2|||
155328797|NCT03066609|560639293|FG002|OVERALL STUDY|Adverse Event|0|||
155328798|NCT03066609|560639294|FG003|OVERALL STUDY|Adverse Event|1|||
155328799|NCT03066609|560639291|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
155328800|NCT03066609|560639292|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
155328801|NCT03066609|560639293|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
155328802|NCT03066609|560639294|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
155328803|NCT03066609|560639291|FG000|OVERALL STUDY|Lost to Follow-up|1|||
155328804|NCT03066609|560639292|FG001|OVERALL STUDY|Lost to Follow-up|1|||
155328805|NCT03066609|560639293|FG002|OVERALL STUDY|Lost to Follow-up|1|||
155328806|NCT03066609|560639294|FG003|OVERALL STUDY|Lost to Follow-up|1|||
155328807|NCT03066609|560639291|FG000|OVERALL STUDY|Pregnancy|1|||
155328808|NCT03066609|560639292|FG001|OVERALL STUDY|Pregnancy|0|||
155328809|NCT03066609|560639293|FG002|OVERALL STUDY|Pregnancy|1|||
155328810|NCT03066609|560639294|FG003|OVERALL STUDY|Pregnancy|0|||
155328811|NCT03066609|560639291|FG000|OVERALL STUDY|Lack of Efficacy|2|||
155328812|NCT03066609|560639292|FG001|OVERALL STUDY|Lack of Efficacy|1|||
155328813|NCT03066609|560639293|FG002|OVERALL STUDY|Lack of Efficacy|1|||
155328814|NCT03066609|560639294|FG003|OVERALL STUDY|Lack of Efficacy|1|||
155328815|NCT03066609|560639291|FG000|OVERALL STUDY|discontinued follow up|0|||
155328816|NCT03066609|560639292|FG001|OVERALL STUDY|discontinued follow up|2|||
155328817|NCT03066609|560639293|FG002|OVERALL STUDY|discontinued follow up|0|||
155328818|NCT03066609|560639294|FG003|OVERALL STUDY|discontinued follow up|0|||
155328819|NCT03355573|560639295|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
155328820|NCT03355573|560639295|FG000|Overall Study|Sponsor's decision|1|||
155328821|NCT03355573|560639295|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
155328822|NCT03355573|560639295|FG000|Overall Study|PI's decision|2|||
155328823|NCT03355573|560639295|FG000|Overall Study|Withdrawal by Subject|23|||
155328824|NCT03355573|560639295|FG000|Overall Study|Lost to Follow-up|4|||
155328825|NCT03355573|560639295|FG000|Overall Study|Lack of Efficacy|2|||
155328826|NCT03355573|560639295|FG000|Overall Study|Adverse Event, non-fatal|17|||
155328827|NCT03355573|560639295|FG000|Overall Study|Adverse Event, serious fatal|2|||
155328828|NCT01566890|560639296|FG000|Overall Study|Adverse Event|1|||
155328829|NCT01566890|560639297|FG001|Overall Study|Adverse Event|0|||
155328830|NCT01566890|560639298|FG002|Overall Study|Adverse Event|0|||
155328831|NCT01566890|560639299|FG003|Overall Study|Adverse Event|0|||
155328832|NCT01566890|560639300|FG004|Overall Study|Adverse Event|0|||
155328833|NCT01566890|560639296|FG000|Overall Study|Withdrawal by Subject|3|||
155328834|NCT01566890|560639297|FG001|Overall Study|Withdrawal by Subject|1|||
155328835|NCT01566890|560639298|FG002|Overall Study|Withdrawal by Subject|1|||
155328836|NCT01566890|560639299|FG003|Overall Study|Withdrawal by Subject|1|||
155328837|NCT01566890|560639300|FG004|Overall Study|Withdrawal by Subject|0|||
155328838|NCT01566890|560639296|FG000|Overall Study|Screen failure|6|||
155328839|NCT01566890|560639297|FG001|Overall Study|Screen failure|0|||
155328840|NCT01566890|560639298|FG002|Overall Study|Screen failure|1|||
155328841|NCT01566890|560639299|FG003|Overall Study|Screen failure|1|||
155328842|NCT01566890|560639300|FG004|Overall Study|Screen failure|0|||
155328843|NCT01566890|560639296|FG000|Overall Study|Incomplete CEU data|1|||
155328844|NCT01566890|560639297|FG001|Overall Study|Incomplete CEU data|3|||
155328845|NCT01566890|560639298|FG002|Overall Study|Incomplete CEU data|5|||
155328846|NCT01566890|560639299|FG003|Overall Study|Incomplete CEU data|8|||
155328847|NCT01566890|560639300|FG004|Overall Study|Incomplete CEU data|0|||
155328848|NCT01566890|560639296|FG000|Overall Study|Lost to Follow-up|0|||
155328849|NCT01566890|560639297|FG001|Overall Study|Lost to Follow-up|0|||
155328850|NCT01566890|560639298|FG002|Overall Study|Lost to Follow-up|4|||
155328851|NCT01566890|560639299|FG003|Overall Study|Lost to Follow-up|4|||
155328852|NCT01566890|560639300|FG004|Overall Study|Lost to Follow-up|0|||
155328853|NCT01566890|560639296|FG000|Overall Study|Other|0|||
155328854|NCT01566890|560639297|FG001|Overall Study|Other|0|||
155328855|NCT01566890|560639298|FG002|Overall Study|Other|0|||
155328856|NCT01566890|560639299|FG003|Overall Study|Other|0|||
155328857|NCT01566890|560639300|FG004|Overall Study|Other|7|||
155328858|NCT00523419|560639306|FG000|Overall Study|Adverse Event|1|||
155328859|NCT00523419|560639306|FG000|Overall Study|Withdrawal by Subject|1|||
155328860|NCT00523419|560639306|FG000|Overall Study|Physician Decision|2|||
155328861|NCT00523419|560639306|FG000|Overall Study|Progressive Disease|22|||
155328862|NCT00523419|560639306|FG000|Overall Study|Death due to Study Disease|4|||
155328863|NCT00523419|560639306|FG000|Overall Study|Death due to Adverse Event|2|||
155328864|NCT00822120|560639307|FG000|Initial Registration|Adverse Event|1|||
155328865|NCT00822120|560639308|FG001|Initial Registration|Adverse Event|0|||
155328866|NCT00822120|560639309|FG002|Initial Registration|Adverse Event|0|||
155328867|NCT00822120|560639310|FG003|Initial Registration|Adverse Event|0|||
155328868|NCT00822120|560639311|FG004|Initial Registration|Adverse Event|0|||
155328869|NCT00822120|560639312|FG005|Initial Registration|Adverse Event|0|||
155328870|NCT00822120|560639307|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
155328871|NCT00822120|560639308|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328872|NCT00822120|560639309|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328873|NCT00822120|560639310|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328874|NCT00822120|560639311|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328875|NCT00822120|560639312|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328876|NCT00822120|560639307|FG000|Initial Registration|Reasons not Protocol Specified|2|||
155328877|NCT00822120|560639308|FG001|Initial Registration|Reasons not Protocol Specified|0|||
155328878|NCT00822120|560639309|FG002|Initial Registration|Reasons not Protocol Specified|0|||
155328879|NCT00822120|560639310|FG003|Initial Registration|Reasons not Protocol Specified|0|||
155328880|NCT00822120|560639311|FG004|Initial Registration|Reasons not Protocol Specified|0|||
155328881|NCT00822120|560639312|FG005|Initial Registration|Reasons not Protocol Specified|0|||
155328882|NCT00822120|560639307|FG000|Initial Registration|Ineligible|22|||
155328883|NCT00822120|560639308|FG001|Initial Registration|Ineligible|1|||
155328884|NCT00822120|560639309|FG002|Initial Registration|Ineligible|0|||
155328885|NCT00822120|560639310|FG003|Initial Registration|Ineligible|0|||
155328886|NCT00822120|560639311|FG004|Initial Registration|Ineligible|0|||
155328887|NCT00822120|560639312|FG005|Initial Registration|Ineligible|0|||
155328888|NCT00822120|560639307|FG000|PET-directed Therapy|Adverse Event|0|||
155328889|NCT00822120|560639308|FG001|PET-directed Therapy|Adverse Event|0|||
155328890|NCT00822120|560639309|FG002|PET-directed Therapy|Adverse Event|0|||
155328891|NCT00822120|560639310|FG003|PET-directed Therapy|Adverse Event|1|||
155328892|NCT00822120|560639311|FG004|PET-directed Therapy|Adverse Event|0|||
155328893|NCT00822120|560639312|FG005|PET-directed Therapy|Adverse Event|0|||
155328894|NCT00822120|560639307|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155502522|NCT02567266|561265522|FG001|Overall Study|Withdrawal by Subject|7|||
155502523|NCT02567266|561265523|FG002|Overall Study|Withdrawal by Subject|6|||
155328895|NCT00822120|560639308|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328896|NCT00822120|560639309|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328897|NCT00822120|560639310|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
155328898|NCT00822120|560639311|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328899|NCT00822120|560639312|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328900|NCT00822120|560639307|FG000|PET-directed Therapy|Death|0|||
155328901|NCT00822120|560639308|FG001|PET-directed Therapy|Death|0|||
155328902|NCT00822120|560639309|FG002|PET-directed Therapy|Death|0|||
155328903|NCT00822120|560639310|FG003|PET-directed Therapy|Death|2|||
155328904|NCT00822120|560639311|FG004|PET-directed Therapy|Death|0|||
155328905|NCT00822120|560639312|FG005|PET-directed Therapy|Death|0|||
155328906|NCT00822120|560639307|FG000|PET-directed Therapy|Protocol Violation|0|||
155328907|NCT00822120|560639308|FG001|PET-directed Therapy|Protocol Violation|0|||
155328908|NCT00822120|560639309|FG002|PET-directed Therapy|Protocol Violation|0|||
155328909|NCT00822120|560639310|FG003|PET-directed Therapy|Protocol Violation|6|||
155328910|NCT00822120|560639311|FG004|PET-directed Therapy|Protocol Violation|0|||
155328911|NCT00822120|560639312|FG005|PET-directed Therapy|Protocol Violation|0|||
155328912|NCT01437319|560639314|FG000|Phase I|Lost to Follow-up|2|||
155421806|NCT01360645|560974354|FG000|Phase A+|Physician Decision|0|||
155328913|NCT01437319|560639315|FG001|Phase I|Lost to Follow-up|0|||
155328914|NCT01437319|560639316|FG002|Phase I|Lost to Follow-up|0|||
155328915|NCT01437319|560639314|FG000|Phase I|Protocol Violation|1|||
155328916|NCT01437319|560639315|FG001|Phase I|Protocol Violation|0|||
155328917|NCT01437319|560639316|FG002|Phase I|Protocol Violation|0|||
155328918|NCT01437319|560639314|FG000|Phase I|Study related symptoms/complaints|27|||
155328919|NCT01437319|560639315|FG001|Phase I|Study related symptoms/complaints|0|||
155328920|NCT01437319|560639316|FG002|Phase I|Study related symptoms/complaints|0|||
155328921|NCT01437319|560639314|FG000|Phase I|Withdrawal by Subject|25|||
155328922|NCT01437319|560639315|FG001|Phase I|Withdrawal by Subject|0|||
155328923|NCT01437319|560639316|FG002|Phase I|Withdrawal by Subject|0|||
155328924|NCT01437319|560639314|FG000|Phase II|Withdrawal by Subject|0|||
155328925|NCT01437319|560639315|FG001|Phase II|Withdrawal by Subject|8|||
155421807|NCT01360645|560974355|FG001|Phase A+|Physician Decision|0|||
155421808|NCT01360645|560974356|FG002|Phase A+|Physician Decision|0|||
155421809|NCT01360645|560974357|FG003|Phase A+|Physician Decision|2|||
155328926|NCT01437319|560639316|FG002|Phase II|Withdrawal by Subject|16|||
155328927|NCT01437319|560639314|FG000|Phase II|Lost to Follow-up|0|||
155328928|NCT01437319|560639315|FG001|Phase II|Lost to Follow-up|7|||
155328929|NCT01437319|560639316|FG002|Phase II|Lost to Follow-up|2|||
155328930|NCT01437319|560639314|FG000|Phase II|Study related symptoms/complaints|0|||
155328931|NCT01437319|560639315|FG001|Phase II|Study related symptoms/complaints|28|||
155328932|NCT01437319|560639316|FG002|Phase II|Study related symptoms/complaints|19|||
155328933|NCT01437319|560639314|FG000|Phase II|Protocol Violation|0|||
155328934|NCT01437319|560639315|FG001|Phase II|Protocol Violation|1|||
155328935|NCT01437319|560639316|FG002|Phase II|Protocol Violation|0|||
155328936|NCT00811941|560639317|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
155328937|NCT00811941|560639318|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
155328938|NCT00811941|560639317|FG000|All Treated Patients|Adverse Event|2|||
155328939|NCT00811941|560639318|FG001|All Treated Patients|Adverse Event|43|||
155328940|NCT00811941|560639317|FG000|All Treated Patients|Lack of Efficacy|2|||
155328941|NCT00811941|560639318|FG001|All Treated Patients|Lack of Efficacy|3|||
155328942|NCT00811941|560639317|FG000|All Treated Patients|Non-compliance|1|||
155328943|NCT00811941|560639318|FG001|All Treated Patients|Non-compliance|8|||
155328944|NCT00811941|560639317|FG000|All Treated Patients|Protocol Violation|5|||
155328945|NCT00811941|560639318|FG001|All Treated Patients|Protocol Violation|17|||
155328946|NCT00811941|560639317|FG000|All Treated Patients|Withdrawal by Subject|35|||
155328947|NCT00811941|560639318|FG001|All Treated Patients|Withdrawal by Subject|94|||
155328948|NCT00811941|560639317|FG000|All Treated Patients|Lost to Follow-up|3|||
155328949|NCT00811941|560639318|FG001|All Treated Patients|Lost to Follow-up|12|||
155328950|NCT00811941|560639317|FG000|All Treated Patients|Other Reason|4|||
155328951|NCT00811941|560639318|FG001|All Treated Patients|Other Reason|14|||
155328952|NCT00942266|560639326|FG000|Overall Study|Withdrawal by Subject|1|||
155328953|NCT00942266|560639327|FG001|Overall Study|Withdrawal by Subject|0|||
155328954|NCT00942266|560639326|FG000|Overall Study|Adverse Event|2|||
155328955|NCT00942266|560639327|FG001|Overall Study|Adverse Event|1|||
155328956|NCT00942266|560639326|FG000|Overall Study|Disease Progression|38|||
155328957|NCT00942266|560639327|FG001|Overall Study|Disease Progression|11|||
155328958|NCT00942266|560639326|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
155328959|NCT00942266|560639327|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
155328960|NCT00942266|560639326|FG000|Overall Study|Intercurrent illness|0|||
155328961|NCT00942266|560639327|FG001|Overall Study|Intercurrent illness|1|||
155328962|NCT00942266|560639326|FG000|Overall Study|Physician Decision|2|||
155328963|NCT00942266|560639327|FG001|Overall Study|Physician Decision|0|||
155328964|NCT00942266|560639326|FG000|Overall Study|medical deterioration (pneumonia)|0|||
155328965|NCT00942266|560639327|FG001|Overall Study|medical deterioration (pneumonia)|1|||
155328966|NCT02397096|560639344|FG000|Day 1 to Week 24|Adverse Event|7|||
155328967|NCT02397096|560639345|FG001|Day 1 to Week 24|Adverse Event|1|||
155328968|NCT02397096|560639344|FG000|Day 1 to Week 24|Death|1|||
155328969|NCT02397096|560639345|FG001|Day 1 to Week 24|Death|0|||
155328970|NCT02397096|560639344|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
155328971|NCT02397096|560639345|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
155328972|NCT02397096|560639344|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
155328973|NCT02397096|560639345|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
155328974|NCT02397096|560639344|FG000|Day 1 to Week 24|Physician Decision|2|||
155328975|NCT02397096|560639345|FG001|Day 1 to Week 24|Physician Decision|3|||
155328976|NCT02397096|560639344|FG000|Day 1 to Week 24|Protocol Violation|1|||
155328977|NCT02397096|560639345|FG001|Day 1 to Week 24|Protocol Violation|4|||
155328978|NCT02397096|560639344|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
155328979|NCT02397096|560639345|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
155328980|NCT02397096|560639344|FG000|Day 1 to Week 24|Randomized, not treated|3|||
155328981|NCT02397096|560639345|FG001|Day 1 to Week 24|Randomized, not treated|0|||
155328982|NCT02397096|560639344|FG000|Week 24 to Week 48|Adverse Event|6|||
155328983|NCT02397096|560639345|FG001|Week 24 to Week 48|Adverse Event|2|||
155328984|NCT02397096|560639344|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
155328985|NCT02397096|560639345|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
155328986|NCT02397096|560639344|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
155328987|NCT02397096|560639345|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
155328988|NCT02397096|560639344|FG000|Week 24 to Week 48|Physician Decision|2|||
155328989|NCT02397096|560639345|FG001|Week 24 to Week 48|Physician Decision|1|||
155328990|NCT02397096|560639344|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
155328991|NCT02397096|560639345|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
155328992|NCT02397096|560639344|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
155328993|NCT02397096|560639345|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
155328994|NCT02397096|560639344|FG000|Study Extension 1|Adverse Event|7|||
155328995|NCT02397096|560639345|FG001|Study Extension 1|Adverse Event|5|||
155328996|NCT02397096|560639344|FG000|Study Extension 1|Death|1|||
155328997|NCT02397096|560639345|FG001|Study Extension 1|Death|0|||
155328998|NCT02397096|560639344|FG000|Study Extension 1|Lack of Efficacy|2|||
155328999|NCT02397096|560639345|FG001|Study Extension 1|Lack of Efficacy|5|||
155329000|NCT02397096|560639344|FG000|Study Extension 1|Lost to Follow-up|2|||
155329001|NCT02397096|560639345|FG001|Study Extension 1|Lost to Follow-up|3|||
155329002|NCT02397096|560639344|FG000|Study Extension 1|Non-compliance with study drug|3|||
155329003|NCT02397096|560639345|FG001|Study Extension 1|Non-compliance with study drug|0|||
155329004|NCT02397096|560639344|FG000|Study Extension 1|Physician Decision|4|||
155329005|NCT02397096|560639345|FG001|Study Extension 1|Physician Decision|2|||
155329006|NCT02397096|560639344|FG000|Study Extension 1|Pregnancy|1|||
155329007|NCT02397096|560639345|FG001|Study Extension 1|Pregnancy|0|||
155329008|NCT02397096|560639344|FG000|Study Extension 1|Protocol Violation|0|||
155329009|NCT02397096|560639345|FG001|Study Extension 1|Protocol Violation|1|||
155329010|NCT02397096|560639344|FG000|Study Extension 1|Withdrawal by Subject|21|||
155329011|NCT02397096|560639345|FG001|Study Extension 1|Withdrawal by Subject|7|||
155329012|NCT02397096|560639344|FG000|Study Extension 2|Adverse Event|3|||
155329013|NCT02397096|560639345|FG001|Study Extension 2|Adverse Event|3|||
155329014|NCT02397096|560639344|FG000|Study Extension 2|Availability of study medication locally|152|||
155329015|NCT02397096|560639345|FG001|Study Extension 2|Availability of study medication locally|64|||
155329016|NCT02397096|560639344|FG000|Study Extension 2|Death|2|||
155329017|NCT02397096|560639345|FG001|Study Extension 2|Death|0|||
155329018|NCT02397096|560639344|FG000|Study Extension 2|Lack of Efficacy|1|||
155329019|NCT02397096|560639345|FG001|Study Extension 2|Lack of Efficacy|0|||
155329020|NCT02397096|560639344|FG000|Study Extension 2|Lost to Follow-up|2|||
155329021|NCT02397096|560639345|FG001|Study Extension 2|Lost to Follow-up|1|||
155329022|NCT02397096|560639344|FG000|Study Extension 2|Non-compliance with study drug|1|||
155329023|NCT02397096|560639345|FG001|Study Extension 2|Non-compliance with study drug|0|||
155329024|NCT02397096|560639344|FG000|Study Extension 2|Physician Decision|2|||
155329025|NCT02397096|560639345|FG001|Study Extension 2|Physician Decision|5|||
155502524|NCT02567266|561265521|FG000|Overall Study|Lost to Follow-up|13|||
155329026|NCT02397096|560639344|FG000|Study Extension 2|Pregnancy|1|||
155329027|NCT02397096|560639345|FG001|Study Extension 2|Pregnancy|0|||
155329028|NCT02397096|560639344|FG000|Study Extension 2|Withdrawal by Subject|10|||
155329029|NCT02397096|560639345|FG001|Study Extension 2|Withdrawal by Subject|3|||
155329030|NCT02397096|560639344|FG000|Study Extension 3|Adverse Event|1|||
155329031|NCT02397096|560639345|FG001|Study Extension 3|Adverse Event|0|||
155329032|NCT02397096|560639344|FG000|Study Extension 3|Availability of study medication locally|11|||
155329033|NCT02397096|560639345|FG001|Study Extension 3|Availability of study medication locally|3|||
155329034|NCT02397096|560639344|FG000|Study Extension 3|Lost to Follow-up|1|||
155329035|NCT02397096|560639345|FG001|Study Extension 3|Lost to Follow-up|0|||
155502525|NCT02567266|561265522|FG001|Overall Study|Lost to Follow-up|8|||
155502526|NCT02567266|561265523|FG002|Overall Study|Lost to Follow-up|10|||
155645132|NCT02056288|561792166|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
155329036|NCT02397096|560639344|FG000|Study Extension 3|Withdrawal by Subject|2|||
155329037|NCT02397096|560639345|FG001|Study Extension 3|Withdrawal by Subject|1|||
155329038|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
155329039|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
155329040|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
155329041|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
155329042|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
155329043|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
155329044|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
155329045|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
155329046|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
155329047|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
155329048|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
155329049|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
155329050|NCT03357952|560639351|FG000|Overall Study|Withdrawal by Subject|0|||
155329051|NCT03357952|560639352|FG001|Overall Study|Withdrawal by Subject|1|||
155329052|NCT03357952|560639351|FG000|Overall Study|Sponsor Decision|9|||
155329053|NCT03357952|560639352|FG001|Overall Study|Sponsor Decision|0|||
155329054|NCT05018143|560639353|FG000|Overall Study|Lost to Follow-up|5|||
155329055|NCT05018143|560639354|FG001|Overall Study|Lost to Follow-up|4|||
155329056|NCT05018143|560639353|FG000|Overall Study|Withdrawal by Subject|0|||
155329057|NCT05018143|560639354|FG001|Overall Study|Withdrawal by Subject|1|||
155329058|NCT01830595|560639355|FG000|First Period|Withdrawal by Subject|1|||
155329059|NCT01830595|560639356|FG001|First Period|Withdrawal by Subject|3|||
155329060|NCT01830595|560639355|FG000|Washout|Withdrawal by Subject|2|||
155329061|NCT01830595|560639356|FG001|Washout|Withdrawal by Subject|2|||
155329062|NCT06688357|560639357|FG000|Overall Study|Adverse Event|0|||
155329063|NCT06688357|560639358|FG001|Overall Study|Adverse Event|1|||
155329064|NCT05116774|560639359|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
155329065|NCT05116774|560639360|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
155329066|NCT05116774|560639359|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
155329067|NCT05116774|560639360|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
155329068|NCT05116774|560639359|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
155329069|NCT05116774|560639360|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
155329070|NCT05116774|560639359|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
155329071|NCT05116774|560639360|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
155329072|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
155329073|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
155329074|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
155329075|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
155329076|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
155329077|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
155329078|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
155329079|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
155329080|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
155329081|NCT03280030|560639361|FG000|Part 2 - Efficacy|Adverse Event|0|||
155329082|NCT03280030|560639362|FG001|Part 2 - Efficacy|Adverse Event|4|||
155329083|NCT03280030|560639363|FG002|Part 2 - Efficacy|Adverse Event|6|||
155329084|NCT03280030|560639361|FG000|Part 2 - Efficacy|Death|0|||
155329085|NCT03280030|560639362|FG001|Part 2 - Efficacy|Death|3|||
155329086|NCT03280030|560639363|FG002|Part 2 - Efficacy|Death|0|||
155329087|NCT03280030|560639361|FG000|Part 2 - Efficacy|Physician Decision|0|||
155329088|NCT03280030|560639362|FG001|Part 2 - Efficacy|Physician Decision|10|||
155329089|NCT03280030|560639363|FG002|Part 2 - Efficacy|Physician Decision|16|||
155329090|NCT03280030|560639361|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
155329091|NCT03280030|560639362|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
155329092|NCT03280030|560639363|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
155329093|NCT03280030|560639361|FG000|Part 2 - Efficacy|Progressive disease|0|||
155329094|NCT03280030|560639362|FG001|Part 2 - Efficacy|Progressive disease|7|||
155329095|NCT03280030|560639363|FG002|Part 2 - Efficacy|Progressive disease|5|||
155329096|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
155329097|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
155329098|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
155645133|NCT02384460|561792169|FG000|Overall Study|Protocol Violation|0|||
155329099|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
155329100|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
155329101|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
155329102|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
155329103|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
155329104|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
155329105|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
155645134|NCT02384460|561792170|FG001|Overall Study|Protocol Violation|1|||
155421810|NCT01360645|560974354|FG000|Phase A+|Withdrawal by Subject|0|||
155421811|NCT01360645|560974355|FG001|Phase A+|Withdrawal by Subject|0|||
155421812|NCT01360645|560974356|FG002|Phase A+|Withdrawal by Subject|0|||
155421813|NCT01360645|560974357|FG003|Phase A+|Withdrawal by Subject|5|||
155421814|NCT01360645|560974354|FG000|Phase A+|Protocol Deviation|0|||
155421815|NCT01360645|560974355|FG001|Phase A+|Protocol Deviation|0|||
155421816|NCT01360645|560974356|FG002|Phase A+|Protocol Deviation|0|||
155421817|NCT01360645|560974357|FG003|Phase A+|Protocol Deviation|4|||
155421818|NCT01737931|560974364|FG000|Overall Study|Withdrawal by Subject|0|||
155421819|NCT01737931|560974365|FG001|Overall Study|Withdrawal by Subject|1|||
155421820|NCT01737931|560974366|FG002|Overall Study|Withdrawal by Subject|1|||
155421821|NCT01737931|560974364|FG000|Overall Study|Physician Decision|0|||
155421822|NCT01737931|560974365|FG001|Overall Study|Physician Decision|1|||
155421823|NCT01737931|560974366|FG002|Overall Study|Physician Decision|0|||
155421824|NCT02041962|560974367|FG000|Overall Study|Lost Aetna Coverage|43|||
155421825|NCT02041962|560974368|FG001|Overall Study|Lost Aetna Coverage|40|||
155421826|NCT02041962|560974367|FG000|Overall Study|Death|1|||
155421827|NCT02041962|560974368|FG001|Overall Study|Death|1|||
155421828|NCT02041962|560974367|FG000|Overall Study|Lost to Follow-up|37|||
155421829|NCT02041962|560974368|FG001|Overall Study|Lost to Follow-up|32|||
155421830|NCT02041962|560974367|FG000|Overall Study|Withdrawal by Subject|0|||
155421831|NCT02041962|560974368|FG001|Overall Study|Withdrawal by Subject|11|||
155421832|NCT00330187|560974369|FG000|Overall Study|Lost to Follow-up|12|||
155421833|NCT00330187|560974370|FG001|Overall Study|Lost to Follow-up|13|||
155421834|NCT00330187|560974371|FG002|Overall Study|Lost to Follow-up|14|||
155502527|NCT01542736|561265524|FG000|Overall Study|Death|1|||
155502528|NCT01766310|561265525|FG000|Overall Study|Lost to Follow-up|1|||
155502529|NCT01766310|561265526|FG001|Overall Study|Lost to Follow-up|3|||
155502530|NCT02602080|561265530|FG000|Overall Study|Protocol Violation|6|||
155502531|NCT02602080|561265531|FG001|Overall Study|Protocol Violation|1|||
155645135|NCT02384460|561792169|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
155645136|NCT02384460|561792170|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
155421835|NCT00330187|560974372|FG003|Overall Study|Lost to Follow-up|10|||
155421836|NCT00330187|560974369|FG000|Overall Study|Withdrawal by Subject|8|||
155421837|NCT00330187|560974370|FG001|Overall Study|Withdrawal by Subject|5|||
155502532|NCT02602080|561265532|FG002|Overall Study|Protocol Violation|3|||
155502533|NCT02574260|561265535|FG000|Overall Study|Disease Progression|1|||
155645137|NCT02384460|561792169|FG000|Overall Study|Adverse Event|5|||
155645138|NCT02384460|561792170|FG001|Overall Study|Adverse Event|2|||
155645139|NCT02384460|561792169|FG000|Overall Study|Withdrawal by Subject|0|||
155645140|NCT02384460|561792170|FG001|Overall Study|Withdrawal by Subject|3|||
155645141|NCT02384460|561792169|FG000|Overall Study|Elective medical treatment|1|||
155645142|NCT02384460|561792170|FG001|Overall Study|Elective medical treatment|0|||
155645143|NCT02384460|561792169|FG000|Overall Study|Non-compliance|1|||
155645144|NCT02384460|561792170|FG001|Overall Study|Non-compliance|0|||
155645145|NCT02400580|561792171|FG000|Overall Study|Withdrawal by Subject|1|||
155645146|NCT02400580|561792172|FG001|Overall Study|Withdrawal by Subject|1|||
155645147|NCT02400580|561792171|FG000|Overall Study|Adverse Event|1|||
155645148|NCT02400580|561792172|FG001|Overall Study|Adverse Event|0|||
155645149|NCT04233580|561792173|FG000|Overall Study|Adverse Event|3|||
155645150|NCT04233580|561792174|FG001|Overall Study|Adverse Event|3|||
155645151|NCT04233580|561792173|FG000|Overall Study|Withdrawal by Subject|2|||
155645152|NCT04233580|561792174|FG001|Overall Study|Withdrawal by Subject|1|||
155645153|NCT00625378|561792175|FG000|Overall Study|Adverse Event|22|||
155645154|NCT00625378|561792176|FG001|Overall Study|Adverse Event|0|||
155645155|NCT00625378|561792175|FG000|Overall Study|Withdrawal by Subject|16|||
155645156|NCT00625378|561792176|FG001|Overall Study|Withdrawal by Subject|0|||
155645157|NCT00625378|561792175|FG000|Overall Study|Death|38|||
155645158|NCT00625378|561792176|FG001|Overall Study|Death|0|||
155645159|NCT00625378|561792175|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
155645160|NCT00625378|561792176|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
155645161|NCT00625378|561792175|FG000|Overall Study|Lost to Follow-up|17|||
155645162|NCT00625378|561792176|FG001|Overall Study|Lost to Follow-up|0|||
155645163|NCT00625378|561792175|FG000|Overall Study|Non-compliant with study medication|3|||
155645164|NCT00625378|561792176|FG001|Overall Study|Non-compliant with study medication|0|||
155645165|NCT00625378|561792175|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
155645166|NCT00625378|561792176|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
155645167|NCT00625378|561792175|FG000|Overall Study|Medical decision|1|||
155645168|NCT00625378|561792176|FG001|Overall Study|Medical decision|0|||
155645169|NCT00625378|561792175|FG000|Overall Study|Multiple toxicities|1|||
155645170|NCT00625378|561792176|FG001|Overall Study|Multiple toxicities|0|||
155645171|NCT00625378|561792175|FG000|Overall Study|New cancer|1|||
155645172|NCT00625378|561792176|FG001|Overall Study|New cancer|0|||
155645173|NCT00625378|561792175|FG000|Overall Study|PTA program|2|||
155645174|NCT00625378|561792176|FG001|Overall Study|PTA program|0|||
155645175|NCT00625378|561792175|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
155645176|NCT00625378|561792176|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
155645177|NCT00625378|561792175|FG000|Overall Study|Sponsor decision|1|||
155329106|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
155329107|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
155329108|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
155329109|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
155329110|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
155329111|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
155329112|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
155329113|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
155329114|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
155329115|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
155329116|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
155329117|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
155329118|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
155329119|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
155329120|NCT03834740|560639368|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
155329121|NCT03834740|560639369|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
155329122|NCT03834740|560639370|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
155329123|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
155329124|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329125|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329126|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329127|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
155329128|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329129|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329130|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329131|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
155329132|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329133|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329134|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329135|NCT03691493|560639375|FG000|Overall Study|Withdrawal by Subject|1|||
155329136|NCT04213807|560640778|FG000|Overall Study|Physician Decision|0|||
155329137|NCT04213807|560640779|FG001|Overall Study|Physician Decision|0|||
155329138|NCT04213807|560640780|FG002|Overall Study|Physician Decision|1|||
155329139|NCT03442777|560640781|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
155329140|NCT03442777|560640782|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
155645178|NCT00625378|561792176|FG001|Overall Study|Sponsor decision|0|||
155329141|NCT03442777|560640783|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
155329142|NCT02866942|560640784|FG000|Overall Study|Invalid consent|1|||
155329143|NCT03418922|560640786|FG000|Overall Study|Withdrawal by Subject|0|||
155329144|NCT03418922|560640787|FG001|Overall Study|Withdrawal by Subject|2|||
155329145|NCT03418922|560640786|FG000|Overall Study|Adverse Event|2|||
155329146|NCT03418922|560640787|FG001|Overall Study|Adverse Event|2|||
155329147|NCT03418922|560640786|FG000|Overall Study|Death|0|||
155329148|NCT03418922|560640787|FG001|Overall Study|Death|1|||
155329149|NCT03418922|560640786|FG000|Overall Study|Physician Decision|0|||
155329150|NCT03418922|560640787|FG001|Overall Study|Physician Decision|1|||
155329151|NCT03577106|560640788|FG000|Overall Study|Withdrawal by Subject|3|||
155329152|NCT00754065|560640791|FG000|Overall Study|Never received treatment|12|||
155329153|NCT00754065|560640792|FG001|Overall Study|Never received treatment|2|||
155329154|NCT00754065|560640791|FG000|Overall Study|Adverse Event|19|||
155329155|NCT00754065|560640792|FG001|Overall Study|Adverse Event|25|||
155329156|NCT00754065|560640791|FG000|Overall Study|Lost to Follow-up|7|||
155329157|NCT00754065|560640792|FG001|Overall Study|Lost to Follow-up|11|||
155329158|NCT00754065|560640791|FG000|Overall Study|Protocol Violation|12|||
155329159|NCT00754065|560640792|FG001|Overall Study|Protocol Violation|10|||
155329160|NCT00754065|560640791|FG000|Overall Study|Withdrawal by Subject|4|||
155329161|NCT00754065|560640792|FG001|Overall Study|Withdrawal by Subject|5|||
155329162|NCT00754065|560640791|FG000|Overall Study|Pregnancy|6|||
155329163|NCT00754065|560640792|FG001|Overall Study|Pregnancy|0|||
155329164|NCT00754065|560640791|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
155329165|NCT00754065|560640792|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
155329166|NCT01500200|560640795|FG000|Stage 1|Adverse Event|1|||
155329167|NCT01500200|560640796|FG001|Stage 1|Adverse Event|4|||
155329168|NCT01500200|560640797|FG002|Stage 1|Adverse Event|5|||
155329169|NCT01500200|560640798|FG003|Stage 1|Adverse Event|0|||
155329170|NCT01500200|560640799|FG004|Stage 1|Adverse Event|0|||
155329171|NCT01500200|560640800|FG005|Stage 1|Adverse Event|0|||
155329172|NCT01500200|560640795|FG000|Stage 1|Lost to Follow-up|2|||
155329173|NCT01500200|560640796|FG001|Stage 1|Lost to Follow-up|2|||
155329174|NCT01500200|560640797|FG002|Stage 1|Lost to Follow-up|1|||
155329175|NCT01500200|560640798|FG003|Stage 1|Lost to Follow-up|0|||
155329176|NCT01500200|560640799|FG004|Stage 1|Lost to Follow-up|0|||
155329177|NCT01500200|560640800|FG005|Stage 1|Lost to Follow-up|0|||
155329178|NCT01500200|560640795|FG000|Stage 1|Withdrawal by Subject|3|||
155329179|NCT01500200|560640796|FG001|Stage 1|Withdrawal by Subject|0|||
155329180|NCT01500200|560640797|FG002|Stage 1|Withdrawal by Subject|0|||
155329181|NCT01500200|560640798|FG003|Stage 1|Withdrawal by Subject|0|||
155329182|NCT01500200|560640799|FG004|Stage 1|Withdrawal by Subject|0|||
155329183|NCT01500200|560640800|FG005|Stage 1|Withdrawal by Subject|0|||
155329184|NCT01500200|560640795|FG000|Stage 1|Noncompliance with Study Drug|1|||
155329185|NCT01500200|560640796|FG001|Stage 1|Noncompliance with Study Drug|0|||
155329186|NCT01500200|560640797|FG002|Stage 1|Noncompliance with Study Drug|0|||
155329187|NCT01500200|560640798|FG003|Stage 1|Noncompliance with Study Drug|0|||
155329188|NCT01500200|560640799|FG004|Stage 1|Noncompliance with Study Drug|0|||
155329189|NCT01500200|560640800|FG005|Stage 1|Noncompliance with Study Drug|0|||
155329190|NCT01500200|560640795|FG000|Stage 1|Physician Decision|1|||
155329191|NCT01500200|560640796|FG001|Stage 1|Physician Decision|0|||
155329192|NCT01500200|560640797|FG002|Stage 1|Physician Decision|0|||
155329193|NCT01500200|560640798|FG003|Stage 1|Physician Decision|0|||
155329194|NCT01500200|560640799|FG004|Stage 1|Physician Decision|0|||
155329195|NCT01500200|560640800|FG005|Stage 1|Physician Decision|0|||
155329196|NCT01500200|560640795|FG000|Stage 2|Adverse Event|0|||
155329197|NCT01500200|560640796|FG001|Stage 2|Adverse Event|0|||
155329198|NCT01500200|560640797|FG002|Stage 2|Adverse Event|0|||
155329199|NCT01500200|560640798|FG003|Stage 2|Adverse Event|0|||
155329200|NCT01500200|560640799|FG004|Stage 2|Adverse Event|5|||
155329201|NCT01500200|560640800|FG005|Stage 2|Adverse Event|4|||
155329202|NCT00623194|560640801|FG000|Overall Study|Lack of Efficacy|1|||
155329203|NCT00623194|560640801|FG000|Overall Study|Protocol Violation|3|||
155329204|NCT00623194|560640801|FG000|Overall Study|Unclassified|1|||
155329205|NCT01952366|560640802|FG000|Overall Study|Death|22|||
155329206|NCT01952366|560640802|FG000|Overall Study|Withdrawal by Subject|9|||
155329207|NCT04860505|560640803|FG000|Overall Study|Lost to Follow-up|2|||
155329208|NCT01988402|560640804|FG000|Overall Study|Adverse Event|1|||
155329209|NCT01988402|560640805|FG001|Overall Study|Adverse Event|2|||
155329210|NCT01988402|560640804|FG000|Overall Study|Withdrawal by Subject|1|||
155329211|NCT01988402|560640805|FG001|Overall Study|Withdrawal by Subject|0|||
155329212|NCT01759862|560640809|FG000|Overall Study|Physician Decision|3|||
155329213|NCT01759862|560640810|FG001|Overall Study|Physician Decision|1|||
155329214|NCT01759862|560640809|FG000|Overall Study|Adverse Event|0|||
155329215|NCT01759862|560640810|FG001|Overall Study|Adverse Event|1|||
155329216|NCT04060212|560640811|FG000|Overall Study|Withdrawal by Subject|7|||
155329217|NCT01499849|560640812|FG000|Overall Study|Adverse Event|28|||
155329218|NCT01499849|560640813|FG001|Overall Study|Adverse Event|32|||
155329219|NCT01499849|560640812|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
155329220|NCT01499849|560640813|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
155329221|NCT01499849|560640812|FG000|Overall Study|Withdrawal by Subject|43|||
155329222|NCT01499849|560640813|FG001|Overall Study|Withdrawal by Subject|43|||
155329223|NCT01499849|560640812|FG000|Overall Study|Death|5|||
155329224|NCT01499849|560640813|FG001|Overall Study|Death|7|||
155329225|NCT01499849|560640812|FG000|Overall Study|Disease Progression|11|||
155329226|NCT01499849|560640813|FG001|Overall Study|Disease Progression|10|||
155329227|NCT01499849|560640812|FG000|Overall Study|Protocol Violation|11|||
155329228|NCT01499849|560640813|FG001|Overall Study|Protocol Violation|11|||
155329229|NCT01499849|560640812|FG000|Overall Study|Physician Decision|20|||
155329230|NCT01499849|560640813|FG001|Overall Study|Physician Decision|19|||
155329231|NCT01499849|560640812|FG000|Overall Study|Lack of Efficacy|3|||
155329232|NCT01499849|560640813|FG001|Overall Study|Lack of Efficacy|4|||
155329233|NCT01499849|560640812|FG000|Overall Study|Lost to Follow-up|6|||
155329234|NCT01499849|560640813|FG001|Overall Study|Lost to Follow-up|3|||
155329235|NCT01499849|560640812|FG000|Overall Study|Other Reasons|27|||
155329236|NCT01499849|560640813|FG001|Overall Study|Other Reasons|30|||
155329237|NCT00622700|560640814|FG000|Core Treatment Period|Randomized but Not Treated|0|||
155329238|NCT00622700|560640815|FG001|Core Treatment Period|Randomized but Not Treated|2|||
155329239|NCT00622700|560640816|FG002|Core Treatment Period|Randomized but Not Treated|2|||
155329240|NCT00622700|560640817|FG003|Core Treatment Period|Randomized but Not Treated|0|||
155329241|NCT00622700|560640818|FG004|Core Treatment Period|Randomized but Not Treated|0|||
155329242|NCT00622700|560640819|FG005|Core Treatment Period|Randomized but Not Treated|0|||
155329243|NCT00622700|560640820|FG006|Core Treatment Period|Randomized but Not Treated|0|||
155329244|NCT00622700|560640814|FG000|Core Treatment Period|Adverse Event|18|||
155329245|NCT00622700|560640815|FG001|Core Treatment Period|Adverse Event|25|||
155329246|NCT00622700|560640816|FG002|Core Treatment Period|Adverse Event|18|||
155329247|NCT00622700|560640817|FG003|Core Treatment Period|Adverse Event|0|||
155329248|NCT00622700|560640818|FG004|Core Treatment Period|Adverse Event|0|||
155329249|NCT00622700|560640819|FG005|Core Treatment Period|Adverse Event|0|||
155329250|NCT00622700|560640820|FG006|Core Treatment Period|Adverse Event|0|||
155329251|NCT00622700|560640814|FG000|Core Treatment Period|Lack of Efficacy|19|||
155329252|NCT00622700|560640815|FG001|Core Treatment Period|Lack of Efficacy|6|||
155329253|NCT00622700|560640816|FG002|Core Treatment Period|Lack of Efficacy|12|||
155329254|NCT00622700|560640817|FG003|Core Treatment Period|Lack of Efficacy|0|||
155329255|NCT00622700|560640818|FG004|Core Treatment Period|Lack of Efficacy|0|||
155329256|NCT00622700|560640819|FG005|Core Treatment Period|Lack of Efficacy|0|||
155329257|NCT00622700|560640820|FG006|Core Treatment Period|Lack of Efficacy|0|||
155329258|NCT00622700|560640814|FG000|Core Treatment Period|Lost to Follow-up|1|||
155329259|NCT00622700|560640815|FG001|Core Treatment Period|Lost to Follow-up|1|||
155329260|NCT00622700|560640816|FG002|Core Treatment Period|Lost to Follow-up|1|||
155329261|NCT00622700|560640817|FG003|Core Treatment Period|Lost to Follow-up|0|||
155329262|NCT00622700|560640818|FG004|Core Treatment Period|Lost to Follow-up|0|||
155329263|NCT00622700|560640819|FG005|Core Treatment Period|Lost to Follow-up|0|||
155329264|NCT00622700|560640820|FG006|Core Treatment Period|Lost to Follow-up|0|||
155329265|NCT00622700|560640814|FG000|Core Treatment Period|Death|1|||
155329266|NCT00622700|560640815|FG001|Core Treatment Period|Death|0|||
155329267|NCT00622700|560640816|FG002|Core Treatment Period|Death|0|||
155329268|NCT00622700|560640817|FG003|Core Treatment Period|Death|0|||
155329269|NCT00622700|560640818|FG004|Core Treatment Period|Death|0|||
155329270|NCT00622700|560640819|FG005|Core Treatment Period|Death|0|||
155329271|NCT00622700|560640820|FG006|Core Treatment Period|Death|0|||
155329272|NCT00622700|560640814|FG000|Core Treatment Period|Progressive Disease|3|||
155329273|NCT00622700|560640815|FG001|Core Treatment Period|Progressive Disease|1|||
155329274|NCT00622700|560640816|FG002|Core Treatment Period|Progressive Disease|0|||
155329275|NCT00622700|560640817|FG003|Core Treatment Period|Progressive Disease|0|||
155329276|NCT00622700|560640818|FG004|Core Treatment Period|Progressive Disease|0|||
155329277|NCT00622700|560640819|FG005|Core Treatment Period|Progressive Disease|0|||
155329278|NCT00622700|560640820|FG006|Core Treatment Period|Progressive Disease|0|||
155329279|NCT00622700|560640814|FG000|Core Treatment Period|Withdrawal by Subject|12|||
155329280|NCT00622700|560640815|FG001|Core Treatment Period|Withdrawal by Subject|18|||
155329281|NCT00622700|560640816|FG002|Core Treatment Period|Withdrawal by Subject|15|||
155329282|NCT00622700|560640817|FG003|Core Treatment Period|Withdrawal by Subject|0|||
155329283|NCT00622700|560640818|FG004|Core Treatment Period|Withdrawal by Subject|0|||
155329284|NCT00622700|560640819|FG005|Core Treatment Period|Withdrawal by Subject|0|||
155329285|NCT00622700|560640820|FG006|Core Treatment Period|Withdrawal by Subject|0|||
155329286|NCT00622700|560640814|FG000|Core Treatment Period|Other than specified above|2|||
155329287|NCT00622700|560640815|FG001|Core Treatment Period|Other than specified above|2|||
155329288|NCT00622700|560640816|FG002|Core Treatment Period|Other than specified above|5|||
155329289|NCT00622700|560640817|FG003|Core Treatment Period|Other than specified above|0|||
155329290|NCT00622700|560640818|FG004|Core Treatment Period|Other than specified above|0|||
155329291|NCT00622700|560640819|FG005|Core Treatment Period|Other than specified above|0|||
155329292|NCT00622700|560640820|FG006|Core Treatment Period|Other than specified above|0|||
155329293|NCT00622700|560640814|FG000|Extension Treatment Period|Adverse Event|0|||
155329294|NCT00622700|560640815|FG001|Extension Treatment Period|Adverse Event|0|||
155329295|NCT00622700|560640816|FG002|Extension Treatment Period|Adverse Event|0|||
155329296|NCT00622700|560640817|FG003|Extension Treatment Period|Adverse Event|5|||
155329297|NCT00622700|560640818|FG004|Extension Treatment Period|Adverse Event|9|||
155329298|NCT00622700|560640819|FG005|Extension Treatment Period|Adverse Event|6|||
155329299|NCT00622700|560640820|FG006|Extension Treatment Period|Adverse Event|8|||
155329300|NCT00622700|560640814|FG000|Extension Treatment Period|Lack of Efficacy|0|||
155329301|NCT00622700|560640815|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155421838|NCT00330187|560974371|FG002|Overall Study|Withdrawal by Subject|4|||
155421839|NCT00330187|560974372|FG003|Overall Study|Withdrawal by Subject|4|||
155329302|NCT00622700|560640816|FG002|Extension Treatment Period|Lack of Efficacy|0|||
155329303|NCT00622700|560640817|FG003|Extension Treatment Period|Lack of Efficacy|2|||
155329304|NCT00622700|560640818|FG004|Extension Treatment Period|Lack of Efficacy|8|||
155329305|NCT00622700|560640819|FG005|Extension Treatment Period|Lack of Efficacy|1|||
155329306|NCT00622700|560640820|FG006|Extension Treatment Period|Lack of Efficacy|9|||
155329307|NCT00622700|560640814|FG000|Extension Treatment Period|Protocol Violation|0|||
155329308|NCT00622700|560640815|FG001|Extension Treatment Period|Protocol Violation|0|||
155329309|NCT00622700|560640816|FG002|Extension Treatment Period|Protocol Violation|0|||
155329310|NCT00622700|560640817|FG003|Extension Treatment Period|Protocol Violation|0|||
155329311|NCT00622700|560640818|FG004|Extension Treatment Period|Protocol Violation|0|||
155329312|NCT00622700|560640819|FG005|Extension Treatment Period|Protocol Violation|2|||
155329313|NCT00622700|560640820|FG006|Extension Treatment Period|Protocol Violation|0|||
155421840|NCT01573910|560974373|FG000|Overall Study|Adverse Event|4|||
155421841|NCT01573910|560974374|FG001|Overall Study|Adverse Event|4|||
155421842|NCT01573910|560974373|FG000|Overall Study|Lost to Follow-up|2|||
155421843|NCT01573910|560974374|FG001|Overall Study|Lost to Follow-up|1|||
155421844|NCT01573910|560974373|FG000|Overall Study|Withdrawal by Subject|0|||
155421845|NCT01573910|560974374|FG001|Overall Study|Withdrawal by Subject|1|||
155421846|NCT01573910|560974373|FG000|Overall Study|Protocol Violation|3|||
155329314|NCT00622700|560640814|FG000|Extension Treatment Period|Lost to Follow-up|0|||
155329315|NCT00622700|560640815|FG001|Extension Treatment Period|Lost to Follow-up|0|||
155329316|NCT00622700|560640816|FG002|Extension Treatment Period|Lost to Follow-up|0|||
155329317|NCT00622700|560640817|FG003|Extension Treatment Period|Lost to Follow-up|0|||
155329318|NCT00622700|560640818|FG004|Extension Treatment Period|Lost to Follow-up|1|||
155329319|NCT00622700|560640819|FG005|Extension Treatment Period|Lost to Follow-up|0|||
155329320|NCT00622700|560640820|FG006|Extension Treatment Period|Lost to Follow-up|0|||
155329321|NCT00622700|560640814|FG000|Extension Treatment Period|Progressive Disease|0|||
155329322|NCT00622700|560640815|FG001|Extension Treatment Period|Progressive Disease|0|||
155329323|NCT00622700|560640816|FG002|Extension Treatment Period|Progressive Disease|0|||
155329324|NCT00622700|560640817|FG003|Extension Treatment Period|Progressive Disease|1|||
155329325|NCT00622700|560640818|FG004|Extension Treatment Period|Progressive Disease|2|||
155329326|NCT00622700|560640819|FG005|Extension Treatment Period|Progressive Disease|0|||
155329327|NCT00622700|560640820|FG006|Extension Treatment Period|Progressive Disease|2|||
155329328|NCT00622700|560640814|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155329329|NCT00622700|560640815|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155329330|NCT00622700|560640816|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155329331|NCT00622700|560640817|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
155329332|NCT00622700|560640818|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
155329333|NCT00622700|560640819|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
155329334|NCT00622700|560640820|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
155329335|NCT00622700|560640814|FG000|Extension Treatment Period|Missing|0|||
155329336|NCT00622700|560640815|FG001|Extension Treatment Period|Missing|0|||
155329337|NCT00622700|560640816|FG002|Extension Treatment Period|Missing|0|||
155329338|NCT00622700|560640817|FG003|Extension Treatment Period|Missing|2|||
155329339|NCT00622700|560640818|FG004|Extension Treatment Period|Missing|3|||
155329340|NCT00622700|560640819|FG005|Extension Treatment Period|Missing|1|||
155329341|NCT00622700|560640820|FG006|Extension Treatment Period|Missing|0|||
155329342|NCT00622700|560640814|FG000|Extension Treatment Period|Other than specified above|0|||
155329343|NCT00622700|560640815|FG001|Extension Treatment Period|Other than specified above|0|||
155329344|NCT00622700|560640816|FG002|Extension Treatment Period|Other than specified above|0|||
155329345|NCT00622700|560640817|FG003|Extension Treatment Period|Other than specified above|0|||
155329346|NCT00622700|560640818|FG004|Extension Treatment Period|Other than specified above|0|||
155329347|NCT00622700|560640819|FG005|Extension Treatment Period|Other than specified above|1|||
155329348|NCT00622700|560640820|FG006|Extension Treatment Period|Other than specified above|1|||
155329349|NCT02646618|560640823|FG000|Overall Study|Lost to Follow-up|10|||
155329350|NCT02646618|560640824|FG001|Overall Study|Lost to Follow-up|14|||
155329351|NCT04035447|560640825|FG000|Treatment Period|Lost to Follow-up|6|||
155329352|NCT04035447|560640826|FG001|Treatment Period|Lost to Follow-up|5|||
155329353|NCT04035447|560640825|FG000|Treatment Period|Physician Decision|0|||
155329354|NCT04035447|560640826|FG001|Treatment Period|Physician Decision|2|||
155329355|NCT00274261|560640827|FG000|Overall Study|Adverse Event|19|||
155329356|NCT00274261|560640828|FG001|Overall Study|Adverse Event|11|||
155329357|NCT00274261|560640827|FG000|Overall Study|Pregnancy|114|||
155329358|NCT00274261|560640828|FG001|Overall Study|Pregnancy|83|||
155329359|NCT00274261|560640827|FG000|Overall Study|Withdrawal by Subject|179|||
155329360|NCT00274261|560640828|FG001|Overall Study|Withdrawal by Subject|126|||
155329361|NCT00274261|560640827|FG000|Overall Study|Protocol Violation|71|||
155329362|NCT00274261|560640828|FG001|Overall Study|Protocol Violation|42|||
155329363|NCT00274261|560640827|FG000|Overall Study|Lost to Follow-up|106|||
155329364|NCT00274261|560640828|FG001|Overall Study|Lost to Follow-up|75|||
155329365|NCT03500549|560640829|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
155329366|NCT03500549|560640830|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
155329367|NCT03500549|560640829|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
155329368|NCT03500549|560640830|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
155329369|NCT05509816|560640831|FG000|Overall Study|Lost to Follow-up|1|||
155329370|NCT00589875|560640835|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
155329371|NCT00589875|560640835|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
155421847|NCT01573910|560974374|FG001|Overall Study|Protocol Violation|0|||
155421848|NCT01573910|560974373|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
155421849|NCT01573910|560974374|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
155421850|NCT00364182|560974375|FG000|First Intervention|Secondary prophylaxis|1|||
155421851|NCT00364182|560974376|FG001|First Intervention|Secondary prophylaxis|0|||
155421852|NCT00364182|560974377|FG002|First Intervention|Secondary prophylaxis|0|||
155421853|NCT00364182|560974375|FG000|First Intervention|Withdrawal by Subject|2|||
155329372|NCT02016872|560640838|FG000|Overall Study|Withdrawal by Subject|10|||
155329373|NCT02016872|560640838|FG000|Overall Study|Death Progression|2|||
155329374|NCT02016872|560640838|FG000|Overall Study|No FMISO scan|1|||
155421854|NCT00364182|560974376|FG001|First Intervention|Withdrawal by Subject|0|||
155421855|NCT00364182|560974377|FG002|First Intervention|Withdrawal by Subject|0|||
155421856|NCT00364182|560974375|FG000|Second Intervention|non-compliance|0|||
155421857|NCT00364182|560974376|FG001|Second Intervention|non-compliance|1|||
155329375|NCT02016872|560640838|FG000|Overall Study|Ineligible|2|||
155329376|NCT03222609|560640841|FG000|Overall Study|Withdrew consent|2|||
155329377|NCT03222609|560640842|FG001|Overall Study|Withdrew consent|3|||
155329378|NCT03222609|560640843|FG002|Overall Study|Withdrew consent|4|||
155329379|NCT03222609|560640844|FG003|Overall Study|Withdrew consent|2|||
155329380|NCT03222609|560640841|FG000|Overall Study|Lost to Follow-up|1|||
155329381|NCT03222609|560640842|FG001|Overall Study|Lost to Follow-up|0|||
155329382|NCT03222609|560640843|FG002|Overall Study|Lost to Follow-up|0|||
155329383|NCT03222609|560640844|FG003|Overall Study|Lost to Follow-up|0|||
155329384|NCT03222609|560640841|FG000|Overall Study|Death|16|||
155329385|NCT03222609|560640842|FG001|Overall Study|Death|13|||
155329386|NCT03222609|560640843|FG002|Overall Study|Death|9|||
155329387|NCT03222609|560640844|FG003|Overall Study|Death|6|||
155329388|NCT03222609|560640841|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
155329389|NCT03222609|560640842|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
155329390|NCT03222609|560640843|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
155329391|NCT03222609|560640844|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
155329392|NCT03789110|560640845|FG000|Overall Study|Adverse Event|2|||
155329393|NCT03789110|560640845|FG000|Overall Study|Physician Decision|1|||
155329394|NCT03789110|560640845|FG000|Overall Study|Withdrawal by Subject|2|||
155329395|NCT03789110|560640845|FG000|Overall Study|Lack of Efficacy|22|||
155329396|NCT03789110|560640845|FG000|Overall Study|still on treatment|3|||
155329397|NCT00545545|560640846|FG000|Overall Study|Progressive Neoplastic Disease|1|||
155329398|NCT00545545|560640847|FG001|Overall Study|Progressive Neoplastic Disease|5|||
155329399|NCT00545545|560640848|FG002|Overall Study|Progressive Neoplastic Disease|0|||
155329400|NCT00545545|560640849|FG003|Overall Study|Progressive Neoplastic Disease|4|||
155329401|NCT00545545|560640850|FG004|Overall Study|Progressive Neoplastic Disease|8|||
155329402|NCT00545545|560640851|FG005|Overall Study|Progressive Neoplastic Disease|7|||
155329403|NCT00545545|560640846|FG000|Overall Study|Withdrawal by Subject|0|||
155329404|NCT00545545|560640847|FG001|Overall Study|Withdrawal by Subject|1|||
155329405|NCT00545545|560640848|FG002|Overall Study|Withdrawal by Subject|0|||
155329406|NCT00545545|560640849|FG003|Overall Study|Withdrawal by Subject|0|||
155329407|NCT00545545|560640850|FG004|Overall Study|Withdrawal by Subject|0|||
155329408|NCT00545545|560640851|FG005|Overall Study|Withdrawal by Subject|0|||
155329409|NCT00545545|560640846|FG000|Overall Study|Physician Decision|1|||
155329410|NCT00545545|560640847|FG001|Overall Study|Physician Decision|0|||
155329411|NCT00545545|560640848|FG002|Overall Study|Physician Decision|0|||
155329412|NCT00545545|560640849|FG003|Overall Study|Physician Decision|0|||
155329413|NCT00545545|560640850|FG004|Overall Study|Physician Decision|0|||
155329414|NCT00545545|560640851|FG005|Overall Study|Physician Decision|1|||
155329415|NCT00545545|560640846|FG000|Overall Study|Irinotecan intolerance|1|||
155329416|NCT00545545|560640847|FG001|Overall Study|Irinotecan intolerance|1|||
155329417|NCT00545545|560640848|FG002|Overall Study|Irinotecan intolerance|0|||
155329418|NCT00545545|560640849|FG003|Overall Study|Irinotecan intolerance|0|||
155329419|NCT00545545|560640850|FG004|Overall Study|Irinotecan intolerance|0|||
155329420|NCT00545545|560640851|FG005|Overall Study|Irinotecan intolerance|0|||
155329421|NCT00545545|560640846|FG000|Overall Study|No target lesions to track post surgery|0|||
155329422|NCT00545545|560640847|FG001|Overall Study|No target lesions to track post surgery|0|||
155329423|NCT00545545|560640848|FG002|Overall Study|No target lesions to track post surgery|0|||
155329424|NCT00545545|560640849|FG003|Overall Study|No target lesions to track post surgery|0|||
155329425|NCT00545545|560640850|FG004|Overall Study|No target lesions to track post surgery|1|||
155329426|NCT00545545|560640851|FG005|Overall Study|No target lesions to track post surgery|1|||
155329427|NCT05827068|560640861|FG000|Overall Study|Lost to Follow-up|1|||
155329428|NCT05827068|560640862|FG001|Overall Study|Lost to Follow-up|4|||
155329429|NCT05827068|560640863|FG002|Overall Study|Lost to Follow-up|1|||
155329430|NCT05827068|560640864|FG003|Overall Study|Lost to Follow-up|1|||
155329431|NCT05827068|560640865|FG004|Overall Study|Lost to Follow-up|2|||
155329432|NCT05827068|560640866|FG005|Overall Study|Lost to Follow-up|4|||
155329433|NCT05827068|560640867|FG006|Overall Study|Lost to Follow-up|1|||
155329434|NCT05827068|560640861|FG000|Overall Study|Withdrawal by Subject|4|||
155329435|NCT05827068|560640862|FG001|Overall Study|Withdrawal by Subject|0|||
155329436|NCT05827068|560640863|FG002|Overall Study|Withdrawal by Subject|1|||
155329437|NCT05827068|560640864|FG003|Overall Study|Withdrawal by Subject|2|||
155329438|NCT05827068|560640865|FG004|Overall Study|Withdrawal by Subject|3|||
155329439|NCT05827068|560640866|FG005|Overall Study|Withdrawal by Subject|0|||
155421858|NCT00364182|560974377|FG002|Second Intervention|non-compliance|1|||
155421859|NCT00364182|560974375|FG000|Second Intervention|Protocol Violation|0|||
155421860|NCT00364182|560974376|FG001|Second Intervention|Protocol Violation|1|||
155329440|NCT05827068|560640867|FG006|Overall Study|Withdrawal by Subject|1|||
155329441|NCT05827068|560640861|FG000|Overall Study|Physician Decision|0|||
155329442|NCT05827068|560640862|FG001|Overall Study|Physician Decision|0|||
155329443|NCT05827068|560640863|FG002|Overall Study|Physician Decision|0|||
155329444|NCT05827068|560640864|FG003|Overall Study|Physician Decision|0|||
155329445|NCT05827068|560640865|FG004|Overall Study|Physician Decision|1|||
155329446|NCT05827068|560640866|FG005|Overall Study|Physician Decision|0|||
155329447|NCT05827068|560640867|FG006|Overall Study|Physician Decision|1|||
155329448|NCT05827068|560640861|FG000|Overall Study|Other Than Specified|0|||
155329449|NCT05827068|560640862|FG001|Overall Study|Other Than Specified|1|||
155329450|NCT05827068|560640863|FG002|Overall Study|Other Than Specified|0|||
155329451|NCT05827068|560640864|FG003|Overall Study|Other Than Specified|0|||
155329452|NCT05827068|560640865|FG004|Overall Study|Other Than Specified|0|||
155329453|NCT05827068|560640866|FG005|Overall Study|Other Than Specified|0|||
155329454|NCT05827068|560640867|FG006|Overall Study|Other Than Specified|0|||
155329455|NCT05704725|560640874|FG000|Overall Study|Lost to Follow-up|0|||
155329456|NCT05704725|560640875|FG001|Overall Study|Lost to Follow-up|1|||
155329457|NCT05704725|560640874|FG000|Overall Study|Withdrawal by Subject|1|||
155329458|NCT05704725|560640875|FG001|Overall Study|Withdrawal by Subject|0|||
155329459|NCT00490139|560640876|FG000|Overall Study|Lost to Follow-up|249|||
155329460|NCT00490139|560640877|FG001|Overall Study|Lost to Follow-up|216|||
155329461|NCT00490139|560640878|FG002|Overall Study|Lost to Follow-up|205|||
155329462|NCT00490139|560640879|FG003|Overall Study|Lost to Follow-up|229|||
155329463|NCT00490139|560640876|FG000|Overall Study|Withdrawal by Subject|333|||
155329464|NCT00490139|560640877|FG001|Overall Study|Withdrawal by Subject|322|||
155329465|NCT00490139|560640878|FG002|Overall Study|Withdrawal by Subject|396|||
155329466|NCT00490139|560640879|FG003|Overall Study|Withdrawal by Subject|295|||
155329467|NCT00490139|560640876|FG000|Overall Study|Patient did not sign ICF 12|169|||
155329468|NCT00490139|560640877|FG001|Overall Study|Patient did not sign ICF 12|176|||
155329469|NCT00490139|560640878|FG002|Overall Study|Patient did not sign ICF 12|139|||
155329470|NCT00490139|560640879|FG003|Overall Study|Patient did not sign ICF 12|167|||
155329471|NCT00490139|560640876|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
155329472|NCT00490139|560640877|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
155329473|NCT00490139|560640878|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
155329474|NCT00490139|560640879|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
155329475|NCT00490139|560640876|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329476|NCT00490139|560640877|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
155329477|NCT00490139|560640878|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329478|NCT00490139|560640879|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329479|NCT00490139|560640876|FG000|Overall Study|Other reasons as defined per protocol|98|||
155329480|NCT00490139|560640877|FG001|Overall Study|Other reasons as defined per protocol|84|||
155329481|NCT00490139|560640878|FG002|Overall Study|Other reasons as defined per protocol|82|||
155329482|NCT00490139|560640879|FG003|Overall Study|Other reasons as defined per protocol|105|||
155329483|NCT03664804|560640881|FG000|Overall Study|Withdrawal by Subject|7|||
155329484|NCT05529992|560640882|FG000|Overall Study|Withdrawal by Subject|1|||
155329485|NCT06140290|560640883|FG000|Period 1|Adverse Event|1|||
155329486|NCT06140290|560640884|FG001|Period 1|Adverse Event|0|||
155329487|NCT06140290|560640883|FG000|Period 2|Assigned but not treated|0|||
155329488|NCT06140290|560640884|FG001|Period 2|Assigned but not treated|1|||
155329489|NCT06140290|560640883|FG000|Period 2|Withdrawal by Subject|0|||
155329490|NCT06140290|560640884|FG001|Period 2|Withdrawal by Subject|1|||
155329491|NCT02798471|560640887|FG000|Overall Study|Adverse Event|7|||
155329492|NCT02798471|560640888|FG001|Overall Study|Adverse Event|2|||
155329493|NCT02798471|560640887|FG000|Overall Study|Physician Decision|3|||
155329494|NCT02798471|560640888|FG001|Overall Study|Physician Decision|7|||
155329495|NCT02798471|560640887|FG000|Overall Study|Death|2|||
155329496|NCT02798471|560640888|FG001|Overall Study|Death|3|||
155329497|NCT02798471|560640887|FG000|Overall Study|Lost to Follow-up|0|||
155329498|NCT02798471|560640888|FG001|Overall Study|Lost to Follow-up|1|||
155329499|NCT02798471|560640887|FG000|Overall Study|Other|5|||
155329500|NCT02798471|560640888|FG001|Overall Study|Other|3|||
155329501|NCT02798471|560640887|FG000|Overall Study|Subject withdrew consent|0|||
155329502|NCT02798471|560640888|FG001|Overall Study|Subject withdrew consent|6|||
155329503|NCT02798471|560640887|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
155329504|NCT02798471|560640888|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
155329505|NCT02798471|560640887|FG000|Overall Study|Randomized, but not treated|0|||
155329506|NCT02798471|560640888|FG001|Overall Study|Randomized, but not treated|2|||
155329507|NCT04503681|560642177|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
155329508|NCT04503681|560642178|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
155329509|NCT03352713|560642181|FG000|Overall Study|Lost to Follow-up|8|||
155329510|NCT03352713|560642181|FG000|Overall Study|Withdrawn by investigator|5|||
155329511|NCT03352713|560642181|FG000|Overall Study|Completed 0 EMAs|8|||
155329512|NCT03352713|560642181|FG000|Overall Study|Device incompatible/stolen|5|||
155329513|NCT01812759|560642182|FG000|Overall Study|Physician Decision|0|||
155329514|NCT01812759|560642183|FG001|Overall Study|Physician Decision|0|||
155329515|NCT01812759|560642184|FG002|Overall Study|Physician Decision|1|||
155329516|NCT03758638|560642185|FG000|Overall Study|Pregnancy|17|||
155329517|NCT03758638|560642186|FG001|Overall Study|Pregnancy|25|||
155329518|NCT03758638|560642185|FG000|Overall Study|Lost to Follow-up|60|||
155329519|NCT03758638|560642186|FG001|Overall Study|Lost to Follow-up|54|||
155329520|NCT03758638|560642185|FG000|Overall Study|Protocol Violation|2|||
155329521|NCT03758638|560642186|FG001|Overall Study|Protocol Violation|0|||
155329522|NCT03758638|560642185|FG000|Overall Study|Withdrawal by Subject|8|||
155329523|NCT03758638|560642186|FG001|Overall Study|Withdrawal by Subject|2|||
155329524|NCT03758638|560642185|FG000|Overall Study|Providers not included in the primary outcome.|183|||
155329525|NCT03758638|560642186|FG001|Overall Study|Providers not included in the primary outcome.|128|||
155329526|NCT00372775|560642188|FG000|Overall Study|Adverse Event|8|||
155329527|NCT00372775|560642188|FG000|Overall Study|Death|15|||
155329528|NCT00372775|560642188|FG000|Overall Study|Objective progression or relapse|30|||
155329529|NCT00372775|560642188|FG000|Overall Study|Global deterioration of health status|6|||
155329530|NCT00372775|560642188|FG000|Overall Study|Withdrawal by Subject|1|||
155329531|NCT00372775|560642188|FG000|Overall Study|Other|1|||
155329532|NCT00372775|560642188|FG000|Overall Study|Not Treated|2|||
155329533|NCT00724126|560642189|FG000|Overall Study|Adverse Event|2|||
155329534|NCT00724126|560642190|FG001|Overall Study|Adverse Event|0|||
155329535|NCT00724126|560642189|FG000|Overall Study|Withdrawal by Subject|8|||
155329536|NCT00724126|560642190|FG001|Overall Study|Withdrawal by Subject|6|||
155329537|NCT00724126|560642189|FG000|Overall Study|Lost to Follow-up|6|||
155329538|NCT00724126|560642190|FG001|Overall Study|Lost to Follow-up|6|||
155329539|NCT00724126|560642189|FG000|Overall Study|Noncompliance|2|||
155329540|NCT00724126|560642190|FG001|Overall Study|Noncompliance|1|||
155329541|NCT00724126|560642189|FG000|Overall Study|Subject randomized although ineligible|1|||
155329542|NCT00724126|560642190|FG001|Overall Study|Subject randomized although ineligible|1|||
155329543|NCT00724126|560642189|FG000|Overall Study|Subject had to leave vicinity of site|0|||
155329544|NCT00724126|560642190|FG001|Overall Study|Subject had to leave vicinity of site|1|||
155329545|NCT01579318|560642191|FG000|Overall Study|Disease Progression|1|||
155329546|NCT03601715|560642194|FG000|Second Intervention|Lost to Follow-up|1|||
155329547|NCT03601715|560642195|FG001|Second Intervention|Lost to Follow-up|1|||
155329548|NCT03601715|560642196|FG002|Second Intervention|Lost to Follow-up|0|||
155329549|NCT02347332|560642197|FG000|Overall Study|Not treated|5|||
155329550|NCT02347332|560642198|FG001|Overall Study|Not treated|2|||
155329551|NCT02347332|560642197|FG000|Overall Study|Progressive disease|141|||
155329552|NCT02347332|560642198|FG001|Overall Study|Progressive disease|159|||
155329553|NCT02347332|560642197|FG000|Overall Study|Adverse Event|50|||
155329554|NCT02347332|560642198|FG001|Overall Study|Adverse Event|41|||
155329555|NCT02347332|560642197|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
155329556|NCT02347332|560642198|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
155329557|NCT02347332|560642197|FG000|Overall Study|Protocol Violation|1|||
155329558|NCT02347332|560642198|FG001|Overall Study|Protocol Violation|1|||
155329559|NCT02347332|560642197|FG000|Overall Study|Lost to Follow-up|2|||
155329560|NCT02347332|560642198|FG001|Overall Study|Lost to Follow-up|1|||
155329561|NCT02347332|560642197|FG000|Overall Study|Physician Decision|4|||
155329562|NCT02347332|560642198|FG001|Overall Study|Physician Decision|3|||
155329563|NCT02347332|560642197|FG000|Overall Study|Withdrawal by Subject|20|||
155329564|NCT02347332|560642198|FG001|Overall Study|Withdrawal by Subject|14|||
155329565|NCT02347332|560642197|FG000|Overall Study|Protocol requirement|1|||
155329566|NCT02347332|560642198|FG001|Overall Study|Protocol requirement|1|||
155329567|NCT02347332|560642197|FG000|Overall Study|Switch Post-Trial program|0|||
155421861|NCT00364182|560974377|FG002|Second Intervention|Protocol Violation|0|||
155421862|NCT00364182|560974375|FG000|Second Intervention|Adverse Event|0|||
155421863|NCT00364182|560974376|FG001|Second Intervention|Adverse Event|0|||
155421864|NCT00364182|560974377|FG002|Second Intervention|Adverse Event|1|||
155421865|NCT00364182|560974375|FG000|Third Intervention|non-compliance|0|||
155421866|NCT00364182|560974376|FG001|Third Intervention|non-compliance|1|||
155645179|NCT00625378|561792175|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
155645180|NCT00625378|561792176|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
155645181|NCT00625378|561792175|FG000|Overall Study|Switch to commercial drug|6|||
155329568|NCT02347332|560642198|FG001|Overall Study|Switch Post-Trial program|1|||
155329569|NCT01478594|560642199|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
155329570|NCT01478594|560642200|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
155329571|NCT01478594|560642199|FG000|Overall Study|Death|45|||
155329572|NCT01478594|560642200|FG001|Overall Study|Death|18|||
155329573|NCT01478594|560642199|FG000|Overall Study|Lost to Follow-up|3|||
155329574|NCT01478594|560642200|FG001|Overall Study|Lost to Follow-up|1|||
155421867|NCT00364182|560974377|FG002|Third Intervention|non-compliance|0|||
155329575|NCT01478594|560642199|FG000|Overall Study|Withdrawal by Subject|9|||
155329576|NCT01478594|560642200|FG001|Overall Study|Withdrawal by Subject|3|||
155421868|NCT00364182|560974375|FG000|Third Intervention|Lost to Follow-up|0|||
155645182|NCT00625378|561792176|FG001|Overall Study|Switch to commercial drug|1|||
155645183|NCT00625378|561792175|FG000|Overall Study|Missing|2|||
155645184|NCT00625378|561792176|FG001|Overall Study|Missing|0|||
155645185|NCT00625378|561792175|FG000|Overall Study|End of treatment not available|2|||
155329577|NCT01478594|560642199|FG000|Overall Study|Study Closed by Sponsor|8|||
155329578|NCT01478594|560642200|FG001|Overall Study|Study Closed by Sponsor|5|||
155645186|NCT00625378|561792176|FG001|Overall Study|End of treatment not available|0|||
155645187|NCT00625378|561792175|FG000|Overall Study|Never treated|2|||
155645188|NCT00625378|561792176|FG001|Overall Study|Never treated|0|||
155645189|NCT04676646|561792177|FG000|Open-label Run-in Phase|Adverse Event|3|||
155645190|NCT04676646|561792178|FG001|Open-label Run-in Phase|Adverse Event|0|||
155645191|NCT04676646|561792179|FG002|Open-label Run-in Phase|Adverse Event|0|||
155645192|NCT04676646|561792177|FG000|Open-label Run-in Phase|Death|3|||
155645193|NCT04676646|561792178|FG001|Open-label Run-in Phase|Death|0|||
155645194|NCT04676646|561792179|FG002|Open-label Run-in Phase|Death|0|||
155645195|NCT04676646|561792177|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
155645196|NCT04676646|561792178|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
155645197|NCT04676646|561792179|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
155645198|NCT04676646|561792177|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
155645199|NCT04676646|561792178|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
155329579|NCT01313884|560642201|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
155329580|NCT01970007|560642202|FG000|Overall Study|Death|5|||
155329581|NCT01970007|560642202|FG000|Overall Study|Withdrawal by Subject|23|||
155329582|NCT01970007|560642202|FG000|Overall Study|Lost to Follow-up|24|||
155329583|NCT01970007|560642202|FG000|Overall Study|"Other endpoint"|3|||
155329584|NCT00776009|560642203|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
155329585|NCT00776009|560642204|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
155329586|NCT00776009|560642205|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
155329587|NCT00776009|560642206|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
155329588|NCT00776009|560642207|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
155329589|NCT00776009|560642208|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
155329590|NCT00776009|560642203|FG000|Period 1: First Intervention|Protocol Violation|0|||
155329591|NCT00776009|560642204|FG001|Period 1: First Intervention|Protocol Violation|1|||
155329592|NCT00776009|560642205|FG002|Period 1: First Intervention|Protocol Violation|0|||
155329593|NCT00776009|560642206|FG003|Period 1: First Intervention|Protocol Violation|0|||
155329594|NCT00776009|560642207|FG004|Period 1: First Intervention|Protocol Violation|1|||
155329595|NCT00776009|560642208|FG005|Period 1: First Intervention|Protocol Violation|0|||
155329596|NCT00776009|560642203|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329597|NCT00776009|560642204|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329598|NCT00776009|560642205|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329599|NCT00776009|560642206|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329600|NCT00776009|560642207|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329601|NCT00776009|560642208|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
155329602|NCT00776009|560642203|FG000|Period 2: Second Intervention|Protocol Violation|1|||
155329603|NCT00776009|560642204|FG001|Period 2: Second Intervention|Protocol Violation|0|||
155329604|NCT00776009|560642205|FG002|Period 2: Second Intervention|Protocol Violation|1|||
155329605|NCT00776009|560642206|FG003|Period 2: Second Intervention|Protocol Violation|0|||
155329606|NCT00776009|560642207|FG004|Period 2: Second Intervention|Protocol Violation|0|||
155329607|NCT00776009|560642208|FG005|Period 2: Second Intervention|Protocol Violation|0|||
155329608|NCT00776009|560642203|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
155329609|NCT00776009|560642204|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329610|NCT00776009|560642205|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329611|NCT00776009|560642206|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329612|NCT00776009|560642207|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329613|NCT00776009|560642208|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329614|NCT01640951|560642209|FG000|Overall Study|Adverse Event|8|||
155329615|NCT01640951|560642210|FG001|Overall Study|Adverse Event|3|||
155329616|NCT01640951|560642211|FG002|Overall Study|Adverse Event|10|||
155329617|NCT01640951|560642212|FG003|Overall Study|Adverse Event|6|||
155329618|NCT01640951|560642213|FG004|Overall Study|Adverse Event|1|||
155329619|NCT01640951|560642214|FG005|Overall Study|Adverse Event|11|||
155329620|NCT01640951|560642215|FG006|Overall Study|Adverse Event|1|||
155329621|NCT01640951|560642216|FG007|Overall Study|Adverse Event|3|||
155329622|NCT01640951|560642209|FG000|Overall Study|Lack of Efficacy|20|||
155329623|NCT01640951|560642210|FG001|Overall Study|Lack of Efficacy|1|||
155329624|NCT01640951|560642211|FG002|Overall Study|Lack of Efficacy|7|||
155329625|NCT01640951|560642212|FG003|Overall Study|Lack of Efficacy|14|||
155329626|NCT01640951|560642213|FG004|Overall Study|Lack of Efficacy|0|||
155329627|NCT01640951|560642214|FG005|Overall Study|Lack of Efficacy|6|||
155329628|NCT01640951|560642215|FG006|Overall Study|Lack of Efficacy|5|||
155329629|NCT01640951|560642216|FG007|Overall Study|Lack of Efficacy|6|||
155329630|NCT01640951|560642209|FG000|Overall Study|Lost to Follow-up|1|||
155329631|NCT01640951|560642210|FG001|Overall Study|Lost to Follow-up|0|||
155329632|NCT01640951|560642211|FG002|Overall Study|Lost to Follow-up|6|||
155329633|NCT01640951|560642212|FG003|Overall Study|Lost to Follow-up|2|||
155329634|NCT01640951|560642213|FG004|Overall Study|Lost to Follow-up|2|||
155329635|NCT01640951|560642214|FG005|Overall Study|Lost to Follow-up|3|||
155329636|NCT01640951|560642215|FG006|Overall Study|Lost to Follow-up|1|||
155421869|NCT00364182|560974376|FG001|Third Intervention|Lost to Follow-up|0|||
155421870|NCT00364182|560974377|FG002|Third Intervention|Lost to Follow-up|1|||
155329637|NCT01640951|560642216|FG007|Overall Study|Lost to Follow-up|1|||
155329638|NCT01640951|560642209|FG000|Overall Study|Non-compliance with study treatment|0|||
155329639|NCT01640951|560642210|FG001|Overall Study|Non-compliance with study treatment|0|||
155329640|NCT01640951|560642211|FG002|Overall Study|Non-compliance with study treatment|1|||
155329641|NCT01640951|560642212|FG003|Overall Study|Non-compliance with study treatment|1|||
155329642|NCT01640951|560642213|FG004|Overall Study|Non-compliance with study treatment|1|||
155421871|NCT02601573|560974378|FG000|Overall Study|Lost to Follow-up|0|||
155329643|NCT01640951|560642214|FG005|Overall Study|Non-compliance with study treatment|4|||
155329644|NCT01640951|560642215|FG006|Overall Study|Non-compliance with study treatment|1|||
155329645|NCT01640951|560642216|FG007|Overall Study|Non-compliance with study treatment|0|||
155329646|NCT01640951|560642209|FG000|Overall Study|Physician Decision|2|||
155329647|NCT01640951|560642210|FG001|Overall Study|Physician Decision|5|||
155329648|NCT01640951|560642211|FG002|Overall Study|Physician Decision|2|||
155329649|NCT01640951|560642212|FG003|Overall Study|Physician Decision|2|||
155329650|NCT01640951|560642213|FG004|Overall Study|Physician Decision|2|||
155329651|NCT01640951|560642214|FG005|Overall Study|Physician Decision|3|||
155329652|NCT01640951|560642215|FG006|Overall Study|Physician Decision|3|||
155329653|NCT01640951|560642216|FG007|Overall Study|Physician Decision|0|||
155329654|NCT01640951|560642209|FG000|Overall Study|Pregnancy|3|||
155329655|NCT01640951|560642210|FG001|Overall Study|Pregnancy|0|||
155329656|NCT01640951|560642211|FG002|Overall Study|Pregnancy|0|||
155329657|NCT01640951|560642212|FG003|Overall Study|Pregnancy|4|||
155329658|NCT01640951|560642213|FG004|Overall Study|Pregnancy|0|||
155329659|NCT01640951|560642214|FG005|Overall Study|Pregnancy|0|||
155329660|NCT01640951|560642215|FG006|Overall Study|Pregnancy|2|||
155329661|NCT01640951|560642216|FG007|Overall Study|Pregnancy|0|||
155329662|NCT01640951|560642209|FG000|Overall Study|Protocol Deviation|0|||
155329663|NCT01640951|560642210|FG001|Overall Study|Protocol Deviation|1|||
155329664|NCT01640951|560642211|FG002|Overall Study|Protocol Deviation|2|||
155329665|NCT01640951|560642212|FG003|Overall Study|Protocol Deviation|1|||
155329666|NCT01640951|560642213|FG004|Overall Study|Protocol Deviation|0|||
155329667|NCT01640951|560642214|FG005|Overall Study|Protocol Deviation|1|||
155329668|NCT01640951|560642215|FG006|Overall Study|Protocol Deviation|0|||
155329669|NCT01640951|560642216|FG007|Overall Study|Protocol Deviation|0|||
155329670|NCT01640951|560642209|FG000|Overall Study|Subject/Guardian decision|12|||
155329671|NCT01640951|560642210|FG001|Overall Study|Subject/Guardian decision|4|||
155329672|NCT01640951|560642211|FG002|Overall Study|Subject/Guardian decision|13|||
155329673|NCT01640951|560642212|FG003|Overall Study|Subject/Guardian decision|15|||
155329674|NCT01640951|560642213|FG004|Overall Study|Subject/Guardian decision|7|||
155329675|NCT01640951|560642214|FG005|Overall Study|Subject/Guardian decision|19|||
155329676|NCT01640951|560642215|FG006|Overall Study|Subject/Guardian decision|5|||
155329677|NCT01640951|560642216|FG007|Overall Study|Subject/Guardian decision|4|||
155329678|NCT01640951|560642209|FG000|Overall Study|Death|0|||
155329679|NCT01640951|560642210|FG001|Overall Study|Death|1|||
155329680|NCT01640951|560642211|FG002|Overall Study|Death|1|||
155329681|NCT01640951|560642212|FG003|Overall Study|Death|0|||
155329682|NCT01640951|560642213|FG004|Overall Study|Death|0|||
155329683|NCT01640951|560642214|FG005|Overall Study|Death|0|||
155329684|NCT01640951|560642215|FG006|Overall Study|Death|0|||
155329685|NCT01640951|560642216|FG007|Overall Study|Death|2|||
155329686|NCT00582972|560642217|FG000|Overall Study|Protocol Violation|2|||
155329687|NCT00293397|560642221|FG000|Overall Study|Death|2|||
155329688|NCT03304587|560642230|FG000|Overall Study|Headache after intervention|0|||
155329689|NCT03304587|560642231|FG001|Overall Study|Headache after intervention|1|||
155329690|NCT03304587|560642230|FG000|Overall Study|Withdrawal by Subject|1|||
155329691|NCT03304587|560642231|FG001|Overall Study|Withdrawal by Subject|0|||
155329692|NCT01458366|560642233|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
155329693|NCT01458366|560642234|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
155329694|NCT01458366|560642235|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
155329695|NCT01458366|560642236|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
155329696|NCT01458366|560642237|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
155329697|NCT01458366|560642233|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329698|NCT01458366|560642234|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329699|NCT01458366|560642235|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329700|NCT01458366|560642236|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329701|NCT01458366|560642237|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
155329702|NCT04647487|560642238|FG000|Overall Study|Protocol Deviation|0|||
155329703|NCT04647487|560642239|FG001|Overall Study|Protocol Deviation|0|||
155329704|NCT04647487|560642240|FG002|Overall Study|Protocol Deviation|1|||
155329705|NCT04647487|560642238|FG000|Overall Study|Withdrawal by Subject|1|||
155329706|NCT04647487|560642239|FG001|Overall Study|Withdrawal by Subject|0|||
155329707|NCT04647487|560642240|FG002|Overall Study|Withdrawal by Subject|2|||
155329708|NCT03840902|560642241|FG000|Overall Study|Randomized but not treated|1|||
155329709|NCT03840902|560642242|FG001|Overall Study|Randomized but not treated|1|||
155329710|NCT00174252|560642243|FG000|Overall Study|Protocol Violation|2|||
155329711|NCT02107261|560642250|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
155329712|NCT02107261|560642251|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
155329713|NCT02107261|560642250|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
155329714|NCT02107261|560642251|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
155329715|NCT04337931|560642253|FG000|Overall Study|Death|4|||
155329716|NCT04337931|560642254|FG001|Overall Study|Death|1|||
155329717|NCT04337931|560642255|FG002|Overall Study|Death|7|||
155329718|NCT04337931|560642253|FG000|Overall Study|Withdrawal by Subject|0|||
155329719|NCT04337931|560642254|FG001|Overall Study|Withdrawal by Subject|1|||
155329720|NCT04337931|560642255|FG002|Overall Study|Withdrawal by Subject|0|||
155329721|NCT04337931|560642253|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
155329722|NCT04337931|560642254|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
155329723|NCT04337931|560642255|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
155329724|NCT04337931|560642253|FG000|Overall Study|Study terminated by sponsor|3|||
155329725|NCT04337931|560642254|FG001|Overall Study|Study terminated by sponsor|6|||
155329726|NCT04337931|560642255|FG002|Overall Study|Study terminated by sponsor|2|||
155329727|NCT04337931|560642253|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
155329728|NCT04337931|560642254|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
155329729|NCT04337931|560642255|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
155329730|NCT04337931|560642253|FG000|Overall Study|Colorectal cancer treatment|1|||
155329731|NCT04337931|560642254|FG001|Overall Study|Colorectal cancer treatment|0|||
155329732|NCT04337931|560642255|FG002|Overall Study|Colorectal cancer treatment|0|||
155329733|NCT04337931|560642253|FG000|Overall Study|Participant decision|0|||
155329734|NCT04337931|560642254|FG001|Overall Study|Participant decision|1|||
155329735|NCT04337931|560642255|FG002|Overall Study|Participant decision|0|||
155329736|NCT01738438|560642256|FG000|Overall Study|Disease Progression|32|||
155329737|NCT01738438|560642256|FG000|Overall Study|Adverse Event|3|||
155329738|NCT02130557|560642258|FG000|Overall Study|Withdrawal by Subject|12|||
155329739|NCT02130557|560642259|FG001|Overall Study|Withdrawal by Subject|12|||
155329740|NCT02130557|560642258|FG000|Overall Study|Investigator Request|0|||
155329741|NCT02130557|560642259|FG001|Overall Study|Investigator Request|2|||
155329742|NCT02130557|560642258|FG000|Overall Study|Deceased|14|||
155329743|NCT02130557|560642259|FG001|Overall Study|Deceased|14|||
155329744|NCT02130557|560642258|FG000|Overall Study|Lost to Follow-up|6|||
155329745|NCT02130557|560642259|FG001|Overall Study|Lost to Follow-up|7|||
155329746|NCT02130557|560642258|FG000|Overall Study|Other|2|||
155329747|NCT02130557|560642259|FG001|Overall Study|Other|1|||
155329748|NCT02130557|560642258|FG000|Overall Study|Missing|2|||
155329749|NCT02130557|560642259|FG001|Overall Study|Missing|1|||
155329750|NCT01532999|560642260|FG000|Overall Study|Lost to Follow-up|14|||
155329751|NCT01532999|560642261|FG001|Overall Study|Lost to Follow-up|8|||
155329752|NCT01532999|560642260|FG000|Overall Study|Physician Decision|1|||
155329753|NCT01532999|560642261|FG001|Overall Study|Physician Decision|2|||
155329754|NCT01532999|560642260|FG000|Overall Study|Withdrawal by Subject|5|||
155329755|NCT01532999|560642261|FG001|Overall Study|Withdrawal by Subject|0|||
155329756|NCT01532999|560642260|FG000|Overall Study|Relocated|2|||
155329757|NCT01532999|560642261|FG001|Overall Study|Relocated|0|||
155329758|NCT01532999|560642260|FG000|Overall Study|should not have been randomized|1|||
155329759|NCT01532999|560642261|FG001|Overall Study|should not have been randomized|0|||
155329760|NCT01532999|560642260|FG000|Overall Study|substantial noncompliance|2|||
155329761|NCT01532999|560642261|FG001|Overall Study|substantial noncompliance|0|||
155329762|NCT01532999|560642260|FG000|Overall Study|no show for week 9 assessments|6|||
155329763|NCT01532999|560642261|FG001|Overall Study|no show for week 9 assessments|4|||
155329764|NCT01532999|560642260|FG000|Overall Study|Adverse Event|0|||
155329765|NCT01532999|560642261|FG001|Overall Study|Adverse Event|1|||
155329766|NCT01532999|560642260|FG000|Overall Study|incarcerated|0|||
155329767|NCT01532999|560642261|FG001|Overall Study|incarcerated|1|||
155329768|NCT01532999|560642260|FG000|Overall Study|New job|0|||
155329769|NCT01532999|560642261|FG001|Overall Study|New job|2|||
155329770|NCT02928172|560642262|FG000|Overall Study|Device did not record data|1|||
155329771|NCT02408887|560642263|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
155329772|NCT02408887|560642264|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
155329773|NCT02408887|560642263|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
155329774|NCT02408887|560642264|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
155329775|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155329776|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155329777|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155421872|NCT02601573|560974379|FG001|Overall Study|Lost to Follow-up|3|||
155645200|NCT04676646|561792179|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
155421873|NCT02601573|560974380|FG002|Overall Study|Lost to Follow-up|1|||
155421874|NCT02601573|560974381|FG003|Overall Study|Lost to Follow-up|0|||
155329778|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155329779|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155329780|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155329781|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
155329782|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155329783|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
155329784|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
155329785|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
155421875|NCT02601573|560974382|FG004|Overall Study|Lost to Follow-up|2|||
155329786|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
155329787|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
155329788|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
155329789|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
155329790|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
155329791|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
155329792|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
155329793|NCT03333109|560642266|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
155329794|NCT03333109|560642267|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
155329795|NCT03333109|560642268|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
155329796|NCT03333109|560642266|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
155329797|NCT03333109|560642267|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
155329798|NCT03333109|560642268|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
155329799|NCT04066075|560642269|FG000|Overall Study|Lost to Follow-up|3|||
155329800|NCT04066075|560642270|FG001|Overall Study|Lost to Follow-up|3|||
155329801|NCT04066075|560642269|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
155329802|NCT04066075|560642270|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
155329803|NCT04066075|560642269|FG000|Overall Study|Withdrawal by Subject|2|||
155329804|NCT04066075|560642270|FG001|Overall Study|Withdrawal by Subject|2|||
155329805|NCT00309166|560642271|FG000|Overall Study|Adverse event, non-fatal|1|||
155329806|NCT00309166|560642272|FG001|Overall Study|Adverse event, non-fatal|0|||
155329807|NCT00309166|560642271|FG000|Overall Study|Withdrawal by Subject|4|||
155329808|NCT00309166|560642272|FG001|Overall Study|Withdrawal by Subject|3|||
155329809|NCT00701701|560642273|FG000|Overall Study|Withdrawal by Subject|0|||
155329810|NCT00701701|560642274|FG001|Overall Study|Withdrawal by Subject|1|||
155329811|NCT00701701|560642273|FG000|Overall Study|Adverse Event|0|||
155329812|NCT00701701|560642274|FG001|Overall Study|Adverse Event|1|||
155329813|NCT03593226|560642277|FG000|Overall Study|Disease progression|6|||
155329814|NCT03593226|560642278|FG001|Overall Study|Disease progression|13|||
155329815|NCT03593226|560642279|FG002|Overall Study|Disease progression|5|||
155329816|NCT03593226|560642280|FG003|Overall Study|Disease progression|6|||
155329817|NCT03593226|560642277|FG000|Overall Study|Adverse Event|0|||
155329818|NCT03593226|560642278|FG001|Overall Study|Adverse Event|1|||
155329819|NCT03593226|560642279|FG002|Overall Study|Adverse Event|0|||
155329820|NCT03593226|560642280|FG003|Overall Study|Adverse Event|0|||
155329821|NCT03593226|560642277|FG000|Overall Study|Withdrawal by Subject|0|||
155329822|NCT03593226|560642278|FG001|Overall Study|Withdrawal by Subject|4|||
155329823|NCT03593226|560642279|FG002|Overall Study|Withdrawal by Subject|1|||
155329824|NCT03593226|560642280|FG003|Overall Study|Withdrawal by Subject|0|||
155329825|NCT03593226|560642277|FG000|Overall Study|Physician Decision|0|||
155329826|NCT03593226|560642278|FG001|Overall Study|Physician Decision|1|||
155329827|NCT03593226|560642279|FG002|Overall Study|Physician Decision|0|||
155329828|NCT03593226|560642280|FG003|Overall Study|Physician Decision|0|||
155329829|NCT03593226|560642277|FG000|Overall Study|Clinical disease progression|0|||
155329830|NCT03593226|560642278|FG001|Overall Study|Clinical disease progression|0|||
155329831|NCT03593226|560642279|FG002|Overall Study|Clinical disease progression|1|||
155329832|NCT03593226|560642280|FG003|Overall Study|Clinical disease progression|0|||
155329833|NCT04517435|560642297|FG000|Overall Study|Withdrawal by Subject|0|||
155329834|NCT04517435|560642298|FG001|Overall Study|Withdrawal by Subject|0|||
155329835|NCT04517435|560642299|FG002|Overall Study|Withdrawal by Subject|1|||
155329836|NCT04517435|560642297|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
155329837|NCT04517435|560642298|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
155329838|NCT04517435|560642299|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
155329839|NCT06191679|560642300|FG000|Baseline|Lost to Follow-up|1|||
155329840|NCT06191679|560642301|FG001|Baseline|Lost to Follow-up|0|||
155329841|NCT06191679|560642302|FG002|Baseline|Lost to Follow-up|1|||
155329842|NCT06191679|560642303|FG003|Baseline|Lost to Follow-up|0|||
155329843|NCT06191679|560642300|FG000|Allocation to Group|Withdrawal by Subject|0|||
155329844|NCT06191679|560642301|FG001|Allocation to Group|Withdrawal by Subject|1|||
155329845|NCT06191679|560642302|FG002|Allocation to Group|Withdrawal by Subject|2|||
155329846|NCT06191679|560642303|FG003|Allocation to Group|Withdrawal by Subject|0|||
155329847|NCT06191679|560642300|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
155329848|NCT06191679|560642301|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
155329849|NCT06191679|560642302|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
155329850|NCT06191679|560642303|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
155329851|NCT06191679|560642300|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
155329852|NCT06191679|560642301|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
155329853|NCT06191679|560642302|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
155329854|NCT06191679|560642303|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
155329855|NCT06191679|560642300|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155329856|NCT06191679|560642301|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155329857|NCT06191679|560642302|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155329858|NCT06191679|560642303|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
155329859|NCT05464732|560642304|FG000|Overall Study|Lost to Follow-up|0|||
155329860|NCT05464732|560642305|FG001|Overall Study|Lost to Follow-up|1|||
155329861|NCT05464732|560642304|FG000|Overall Study|Adverse Event|1|||
155329862|NCT05464732|560642305|FG001|Overall Study|Adverse Event|0|||
155329863|NCT02678689|560642307|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
155329864|NCT02678689|560642308|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
155329865|NCT02761187|560642309|FG000|Overall Study|Too ill to Participate|13|||
155329866|NCT02761187|560642310|FG001|Overall Study|Too ill to Participate|8|||
155329867|NCT02761187|560642309|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
155329868|NCT02761187|560642310|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
155329869|NCT02761187|560642309|FG000|Overall Study|Patient withdrew consent|64|||
155329870|NCT02761187|560642310|FG001|Overall Study|Patient withdrew consent|58|||
155329871|NCT02761187|560642309|FG000|Overall Study|Physician discretion|4|||
155329872|NCT02761187|560642310|FG001|Overall Study|Physician discretion|8|||
155329873|NCT02761187|560642309|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
155329874|NCT02761187|560642310|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
155329875|NCT02761187|560642309|FG000|Overall Study|On Hospice|20|||
155329876|NCT02761187|560642310|FG001|Overall Study|On Hospice|26|||
155329877|NCT02761187|560642309|FG000|Overall Study|Deceased|474|||
155329878|NCT02761187|560642310|FG001|Overall Study|Deceased|642|||
155329879|NCT02761187|560642309|FG000|Overall Study|Lost to Follow-up|73|||
155329880|NCT02761187|560642310|FG001|Overall Study|Lost to Follow-up|63|||
155329881|NCT02761187|560642309|FG000|Overall Study|Due to study discontinued at site|100|||
155329882|NCT02761187|560642310|FG001|Overall Study|Due to study discontinued at site|85|||
155329883|NCT02761187|560642309|FG000|Overall Study|Reason not Specified|1484|||
155329884|NCT02761187|560642310|FG001|Overall Study|Reason not Specified|937|||
155329885|NCT05786612|560642311|FG000|Overall Study|Adverse Event|1|||
155329886|NCT05786612|560642312|FG001|Overall Study|Adverse Event|2|||
155329887|NCT05786612|560642311|FG000|Overall Study|one screening failure|0|||
155329888|NCT05786612|560642312|FG001|Overall Study|one screening failure|2|||
155329889|NCT05630833|560642317|FG000|Overall Study|Adverse Event|3|||
155329890|NCT05630833|560642318|FG001|Overall Study|Adverse Event|0|||
155329891|NCT05630833|560642317|FG000|Overall Study|Lack of Efficacy|0|||
155329892|NCT05630833|560642318|FG001|Overall Study|Lack of Efficacy|1|||
155329893|NCT05630833|560642317|FG000|Overall Study|Lost to Follow-up|1|||
155329894|NCT05630833|560642318|FG001|Overall Study|Lost to Follow-up|0|||
155329895|NCT05630833|560642317|FG000|Overall Study|Withdrawal by Subject|3|||
155329896|NCT05630833|560642318|FG001|Overall Study|Withdrawal by Subject|1|||
155329897|NCT03459196|560643539|FG000|Overall Study|Subject didn't receive study catheter|2|||
155329898|NCT00092534|560643542|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
155329899|NCT00092534|560643543|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
155329900|NCT00092534|560643544|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329901|NCT00092534|560643545|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329902|NCT00092534|560643546|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329903|NCT00092534|560643542|FG000|Base Study Vaccination Period|Adverse Event|3|||
155329904|NCT00092534|560643543|FG001|Base Study Vaccination Period|Adverse Event|1|||
155329905|NCT00092534|560643544|FG002|Base Study Vaccination Period|Adverse Event|0|||
155329906|NCT00092534|560643545|FG003|Base Study Vaccination Period|Adverse Event|0|||
155329907|NCT00092534|560643546|FG004|Base Study Vaccination Period|Adverse Event|0|||
155329908|NCT00092534|560643542|FG000|Base Study Vaccination Period|Death|5|||
155329909|NCT00092534|560643543|FG001|Base Study Vaccination Period|Death|4|||
155329910|NCT00092534|560643544|FG002|Base Study Vaccination Period|Death|0|||
155329911|NCT00092534|560643545|FG003|Base Study Vaccination Period|Death|0|||
155329912|NCT00092534|560643546|FG004|Base Study Vaccination Period|Death|0|||
155329913|NCT00092534|560643542|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
155329914|NCT00092534|560643543|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
155329915|NCT00092534|560643544|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
155329916|NCT00092534|560643545|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
155329917|NCT00092534|560643546|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155329918|NCT00092534|560643542|FG000|Base Study Vaccination Period|Physician Decision|1|||
155329919|NCT00092534|560643543|FG001|Base Study Vaccination Period|Physician Decision|0|||
155329920|NCT00092534|560643544|FG002|Base Study Vaccination Period|Physician Decision|0|||
155329921|NCT00092534|560643545|FG003|Base Study Vaccination Period|Physician Decision|0|||
155329922|NCT00092534|560643546|FG004|Base Study Vaccination Period|Physician Decision|0|||
155329923|NCT00092534|560643542|FG000|Base Study Vaccination Period|Pregnancy|9|||
155329924|NCT00092534|560643543|FG001|Base Study Vaccination Period|Pregnancy|7|||
155329925|NCT00092534|560643544|FG002|Base Study Vaccination Period|Pregnancy|0|||
155329926|NCT00092534|560643545|FG003|Base Study Vaccination Period|Pregnancy|0|||
155329927|NCT00092534|560643546|FG004|Base Study Vaccination Period|Pregnancy|0|||
155329928|NCT00092534|560643542|FG000|Base Study Vaccination Period|Protocol Violation|2|||
155329929|NCT00092534|560643543|FG001|Base Study Vaccination Period|Protocol Violation|1|||
155329930|NCT00092534|560643544|FG002|Base Study Vaccination Period|Protocol Violation|0|||
155329931|NCT00092534|560643545|FG003|Base Study Vaccination Period|Protocol Violation|0|||
155329932|NCT00092534|560643546|FG004|Base Study Vaccination Period|Protocol Violation|0|||
155329933|NCT00092534|560643542|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
155329934|NCT00092534|560643543|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
155329935|NCT00092534|560643544|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329936|NCT00092534|560643545|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329937|NCT00092534|560643546|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329938|NCT00092534|560643542|FG000|Base Study Vaccination Period|Moved|14|||
155329939|NCT00092534|560643543|FG001|Base Study Vaccination Period|Moved|12|||
155329940|NCT00092534|560643544|FG002|Base Study Vaccination Period|Moved|0|||
155329941|NCT00092534|560643545|FG003|Base Study Vaccination Period|Moved|0|||
155329942|NCT00092534|560643546|FG004|Base Study Vaccination Period|Moved|0|||
155329943|NCT00092534|560643542|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
155329944|NCT00092534|560643543|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329945|NCT00092534|560643544|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329946|NCT00092534|560643545|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329947|NCT00092534|560643546|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329948|NCT00092534|560643542|FG000|Base Study Vaccination Period|Travel|1|||
155329949|NCT00092534|560643543|FG001|Base Study Vaccination Period|Travel|0|||
155329950|NCT00092534|560643544|FG002|Base Study Vaccination Period|Travel|0|||
155329951|NCT00092534|560643545|FG003|Base Study Vaccination Period|Travel|0|||
155329952|NCT00092534|560643546|FG004|Base Study Vaccination Period|Travel|0|||
155329953|NCT00092534|560643542|FG000|Base Study Vaccination Period|Site Closed|0|||
155329954|NCT00092534|560643543|FG001|Base Study Vaccination Period|Site Closed|1|||
155329955|NCT00092534|560643544|FG002|Base Study Vaccination Period|Site Closed|0|||
155329956|NCT00092534|560643545|FG003|Base Study Vaccination Period|Site Closed|0|||
155329957|NCT00092534|560643546|FG004|Base Study Vaccination Period|Site Closed|0|||
155329958|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Adverse Event|2|||
155329959|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Adverse Event|4|||
155329960|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Adverse Event|0|||
155329961|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Adverse Event|0|||
155329962|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Adverse Event|0|||
155329963|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Death|2|||
155329964|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Death|1|||
155329965|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Death|0|||
155329966|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Death|0|||
155329967|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Death|0|||
155329968|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
155329969|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
155329970|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329971|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329972|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329973|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Pregnancy|6|||
155329974|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Pregnancy|10|||
155329975|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Pregnancy|0|||
155329976|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Pregnancy|0|||
155329977|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Pregnancy|0|||
155329978|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
155329979|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
155329980|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
155329981|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
155329982|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
155329983|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
155329984|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
155329985|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329986|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329987|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329988|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Moved|62|||
155329989|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Moved|58|||
155329990|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Moved|0|||
155329991|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Moved|0|||
155329992|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Moved|0|||
155329993|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Travel|10|||
155329994|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Travel|7|||
155329995|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Travel|0|||
155329996|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Travel|0|||
155329997|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Travel|0|||
155329998|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Site Closed|0|||
155329999|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Site Closed|2|||
155330000|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Site Closed|0|||
155330001|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Site Closed|0|||
155330002|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Site Closed|0|||
155330003|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
155330004|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
155330005|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
155330006|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
155330007|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
155330008|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
155330009|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
155330010|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
155330011|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
155330012|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
155330013|NCT00092534|560643542|FG000|Base Study EXT|Lost to Follow-up|0|||
155330014|NCT00092534|560643543|FG001|Base Study EXT|Lost to Follow-up|0|||
155330015|NCT00092534|560643544|FG002|Base Study EXT|Lost to Follow-up|41|||
155330016|NCT00092534|560643545|FG003|Base Study EXT|Lost to Follow-up|0|||
155330017|NCT00092534|560643546|FG004|Base Study EXT|Lost to Follow-up|0|||
155330018|NCT00092534|560643542|FG000|Base Study EXT|Physician Decision|0|||
155330019|NCT00092534|560643543|FG001|Base Study EXT|Physician Decision|0|||
155330020|NCT00092534|560643544|FG002|Base Study EXT|Physician Decision|1|||
155330021|NCT00092534|560643545|FG003|Base Study EXT|Physician Decision|0|||
155330022|NCT00092534|560643546|FG004|Base Study EXT|Physician Decision|0|||
155330023|NCT00092534|560643542|FG000|Base Study EXT|Pregnancy|0|||
155330024|NCT00092534|560643543|FG001|Base Study EXT|Pregnancy|0|||
155330025|NCT00092534|560643544|FG002|Base Study EXT|Pregnancy|12|||
155330026|NCT00092534|560643545|FG003|Base Study EXT|Pregnancy|0|||
155330027|NCT00092534|560643546|FG004|Base Study EXT|Pregnancy|0|||
155330028|NCT00092534|560643542|FG000|Base Study EXT|Withdrawal by Subject|0|||
155330029|NCT00092534|560643543|FG001|Base Study EXT|Withdrawal by Subject|0|||
155330030|NCT00092534|560643544|FG002|Base Study EXT|Withdrawal by Subject|18|||
155330031|NCT00092534|560643545|FG003|Base Study EXT|Withdrawal by Subject|0|||
155330032|NCT00092534|560643546|FG004|Base Study EXT|Withdrawal by Subject|0|||
155330033|NCT00092534|560643542|FG000|Base Study EXT|Participant moved|0|||
155330034|NCT00092534|560643543|FG001|Base Study EXT|Participant moved|0|||
155330035|NCT00092534|560643544|FG002|Base Study EXT|Participant moved|6|||
155330036|NCT00092534|560643545|FG003|Base Study EXT|Participant moved|0|||
155330037|NCT00092534|560643546|FG004|Base Study EXT|Participant moved|0|||
155330038|NCT00092534|560643542|FG000|Base Study EXT|Travel|0|||
155330039|NCT00092534|560643543|FG001|Base Study EXT|Travel|0|||
155330040|NCT00092534|560643544|FG002|Base Study EXT|Travel|2|||
155330041|NCT00092534|560643545|FG003|Base Study EXT|Travel|0|||
155330042|NCT00092534|560643546|FG004|Base Study EXT|Travel|0|||
155330043|NCT00092534|560643542|FG000|Base Study EXT|Site closed|0|||
155330044|NCT00092534|560643543|FG001|Base Study EXT|Site closed|0|||
155330045|NCT00092534|560643544|FG002|Base Study EXT|Site closed|21|||
155330046|NCT00092534|560643545|FG003|Base Study EXT|Site closed|0|||
155330047|NCT00092534|560643546|FG004|Base Study EXT|Site closed|0|||
155645201|NCT04676646|561792177|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
155645202|NCT04676646|561792178|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
155330048|NCT00092534|560643542|FG000|Base Study EXT|Study ended|0|||
155330049|NCT00092534|560643543|FG001|Base Study EXT|Study ended|0|||
155330050|NCT00092534|560643544|FG002|Base Study EXT|Study ended|29|||
155330051|NCT00092534|560643545|FG003|Base Study EXT|Study ended|0|||
155330052|NCT00092534|560643546|FG004|Base Study EXT|Study ended|0|||
155330053|NCT00092534|560643542|FG000|Base Study EXT|Protocol Violation|0|||
155330054|NCT00092534|560643543|FG001|Base Study EXT|Protocol Violation|0|||
155330055|NCT00092534|560643544|FG002|Base Study EXT|Protocol Violation|15|||
155330056|NCT00092534|560643545|FG003|Base Study EXT|Protocol Violation|0|||
155330057|NCT00092534|560643546|FG004|Base Study EXT|Protocol Violation|0|||
155330058|NCT00092534|560643542|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330059|NCT00092534|560643543|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330060|NCT00092534|560643544|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330061|NCT00092534|560643545|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
155330062|NCT00092534|560643546|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330063|NCT03083366|560643547|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
155330064|NCT03083366|560643548|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
155330065|NCT03083366|560643547|FG000|Enrollment Period|Lack of Efficacy|1|||
155330066|NCT03083366|560643548|FG001|Enrollment Period|Lack of Efficacy|0|||
155330067|NCT06056310|560643553|FG000|Overall Study|Other Reasons|2|||
155330068|NCT06056310|560643553|FG000|Overall Study|Sponsor Request|16|||
155330069|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330070|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330071|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
155330072|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
155330073|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330074|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330075|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330076|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330077|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
155330078|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330079|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Death|0|||
155330080|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Death|0|||
155330081|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Death|0|||
155330082|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Death|0|||
155330083|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Death|0|||
155330084|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Death|0|||
155330085|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Death|0|||
155330086|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Death|0|||
155330087|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Death|1|||
155330088|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Death|0|||
155330089|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
155330090|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330091|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
155421876|NCT02601573|560974378|FG000|Overall Study|Withdrawal by Subject|0|||
155421877|NCT02601573|560974379|FG001|Overall Study|Withdrawal by Subject|1|||
155421878|NCT02601573|560974380|FG002|Overall Study|Withdrawal by Subject|0|||
155421879|NCT02601573|560974381|FG003|Overall Study|Withdrawal by Subject|1|||
155421880|NCT02601573|560974382|FG004|Overall Study|Withdrawal by Subject|0|||
155421881|NCT00974220|560974383|FG000|Treatment Period 1|Adverse Event|2|||
155421882|NCT00974220|560974384|FG001|Treatment Period 1|Adverse Event|1|||
155421883|NCT00974220|560974383|FG000|Treatment Period 1|noncompliant subjects|0|||
155421884|NCT00974220|560974384|FG001|Treatment Period 1|noncompliant subjects|1|||
155421885|NCT01850615|560974385|FG000|Overall Study|Protocol Violation|4|||
155421886|NCT01850615|560974386|FG001|Overall Study|Protocol Violation|1|||
155421887|NCT01850615|560974385|FG000|Overall Study|Adverse Event|2|||
155421888|NCT01850615|560974386|FG001|Overall Study|Adverse Event|1|||
155421889|NCT01850615|560974385|FG000|Overall Study|Withdrawal by Subject|3|||
155421890|NCT01850615|560974386|FG001|Overall Study|Withdrawal by Subject|1|||
155421891|NCT01850615|560974385|FG000|Overall Study|Lost to Follow-up|0|||
155330092|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330093|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330094|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330095|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330096|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155421892|NCT01850615|560974386|FG001|Overall Study|Lost to Follow-up|1|||
155421893|NCT01850615|560974385|FG000|Overall Study|Unclassified|0|||
155330097|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
155421894|NCT01850615|560974386|FG001|Overall Study|Unclassified|1|||
155421895|NCT00706628|560974387|FG000|Overall Study|Other Adverse Event|16|||
155502534|NCT00752895|561265536|FG000|Overall Study|Withdrawal by Subject|8|||
155502535|NCT00752895|561265537|FG001|Overall Study|Withdrawal by Subject|3|||
155502536|NCT03273257|561265538|FG000|Overall Study|Death|0|||
155502537|NCT03273257|561265539|FG001|Overall Study|Death|1|||
155502538|NCT03273257|561265538|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
155502539|NCT03273257|561265539|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
155502540|NCT03273257|561265538|FG000|Overall Study|Study terminated|3|||
155502541|NCT03273257|561265539|FG001|Overall Study|Study terminated|2|||
155502542|NCT00434148|561265540|FG000|Overall Study|Adverse Event|18|||
155502543|NCT00434148|561265541|FG001|Overall Study|Adverse Event|18|||
155502544|NCT00434148|561265540|FG000|Overall Study|Lack of Efficacy|25|||
155330098|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330099|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330100|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330101|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330102|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330103|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
155330104|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330105|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330106|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330107|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
155330108|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
155330109|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330110|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330111|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330112|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
155330113|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330114|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330115|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330116|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330117|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330118|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330119|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
155330120|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
155330121|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
155330122|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
155330123|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
155330124|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
155330125|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
155330126|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
155330127|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
155330128|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
155330129|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330130|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330131|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330132|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330133|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330134|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330135|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330136|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
155330137|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330138|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330139|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330140|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
155330141|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
155330142|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330143|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330144|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155502545|NCT00434148|561265541|FG001|Overall Study|Lack of Efficacy|28|||
155330145|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330146|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330147|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
155330148|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330149|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330150|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
155330151|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
155330152|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
155330153|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
155502546|NCT00434148|561265540|FG000|Overall Study|Withdrawal by Subject|15|||
155502547|NCT00434148|561265541|FG001|Overall Study|Withdrawal by Subject|15|||
155502548|NCT00434148|561265540|FG000|Overall Study|Protocol Violation|4|||
155330154|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330155|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330156|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330157|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330158|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
155330159|NCT02702843|560643565|FG000|Overall Study|Insufficient data to analyze|15|||
155330160|NCT02702843|560643566|FG001|Overall Study|Insufficient data to analyze|23|||
155330161|NCT05802173|560643567|FG000|Overall Study|Withdrawal by Subject|2|||
155330162|NCT05802173|560643568|FG001|Overall Study|Withdrawal by Subject|0|||
155330163|NCT05802173|560643569|FG002|Overall Study|Withdrawal by Subject|0|||
155330164|NCT05802173|560643567|FG000|Overall Study|Protocol Violation|1|||
155330165|NCT05802173|560643568|FG001|Overall Study|Protocol Violation|0|||
155330166|NCT05802173|560643569|FG002|Overall Study|Protocol Violation|0|||
155330167|NCT05802173|560643567|FG000|Overall Study|Lost to Follow-up|0|||
155330168|NCT05802173|560643568|FG001|Overall Study|Lost to Follow-up|6|||
155330169|NCT05802173|560643569|FG002|Overall Study|Lost to Follow-up|4|||
155330170|NCT05802173|560643567|FG000|Overall Study|non-compliance|0|||
155330171|NCT05802173|560643568|FG001|Overall Study|non-compliance|1|||
155330172|NCT05802173|560643569|FG002|Overall Study|non-compliance|0|||
155330173|NCT03752684|560643571|FG000|Overall Study|Lost to Follow-up|4|||
155330174|NCT00360269|560643574|FG000|Overall Study|Lost to Follow-up|7|||
155330175|NCT00360269|560643575|FG001|Overall Study|Lost to Follow-up|9|||
155330176|NCT00360269|560643574|FG000|Overall Study|Physician Decision|1|||
155330177|NCT00360269|560643575|FG001|Overall Study|Physician Decision|2|||
155330178|NCT00360269|560643574|FG000|Overall Study|Adverse Event|1|||
155330179|NCT00360269|560643575|FG001|Overall Study|Adverse Event|0|||
155330180|NCT00360269|560643574|FG000|Overall Study|Withdrawal by Subject|1|||
155330181|NCT00360269|560643575|FG001|Overall Study|Withdrawal by Subject|1|||
155330182|NCT00048932|560643578|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
155330183|NCT00048932|560643579|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
155330184|NCT00048932|560643580|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
155330185|NCT00048932|560643578|FG000|Double Blind Period (DB)|Adverse Event|51|||
155330186|NCT00048932|560643579|FG001|Double Blind Period (DB)|Adverse Event|19|||
155330187|NCT00048932|560643580|FG002|Double Blind Period (DB)|Adverse Event|0|||
155330188|NCT00048932|560643578|FG000|Double Blind Period (DB)|Death|5|||
155330189|NCT00048932|560643579|FG001|Double Blind Period (DB)|Death|3|||
155330190|NCT00048932|560643580|FG002|Double Blind Period (DB)|Death|0|||
155330191|NCT00048932|560643578|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
155330192|NCT00048932|560643579|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
155330193|NCT00048932|560643580|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
155330194|NCT00048932|560643578|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
155330195|NCT00048932|560643579|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
155330196|NCT00048932|560643580|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
155330197|NCT00048932|560643578|FG000|Double Blind Period (DB)|Relocation|1|||
155330198|NCT00048932|560643579|FG001|Double Blind Period (DB)|Relocation|0|||
155330199|NCT00048932|560643580|FG002|Double Blind Period (DB)|Relocation|0|||
155330200|NCT00048932|560643578|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
155330201|NCT00048932|560643579|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
155330202|NCT00048932|560643580|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
155330203|NCT00048932|560643578|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
155330204|NCT00048932|560643579|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
155502549|NCT00434148|561265541|FG001|Overall Study|Protocol Violation|0|||
155502550|NCT00434148|561265540|FG000|Overall Study|Administrative problems|6|||
155645203|NCT04676646|561792179|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
155645204|NCT04676646|561792177|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
155645205|NCT04676646|561792178|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
155645206|NCT04676646|561792179|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
155645207|NCT04676646|561792177|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
155330205|NCT00048932|560643580|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
155330206|NCT00048932|560643578|FG000|Double Blind Period (DB)|Pregnancy|1|||
155330207|NCT00048932|560643579|FG001|Double Blind Period (DB)|Pregnancy|0|||
155330208|NCT00048932|560643580|FG002|Double Blind Period (DB)|Pregnancy|0|||
155330209|NCT00048932|560643578|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
155330210|NCT00048932|560643579|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
155330211|NCT00048932|560643580|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
155330212|NCT00048932|560643578|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
155330213|NCT00048932|560643579|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
155330214|NCT00048932|560643580|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
155330215|NCT00048932|560643578|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
155330216|NCT00048932|560643579|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
155330217|NCT00048932|560643580|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
155502551|NCT00434148|561265541|FG001|Overall Study|Administrative problems|10|||
155650638|NCT00468546|561812520|FG001|Week 24 to Week 104 Analysis|Other|14|||
155330218|NCT00048932|560643578|FG000|Open Label Period (OL)|Death|0|||
155330219|NCT00048932|560643579|FG001|Open Label Period (OL)|Death|0|||
155330220|NCT00048932|560643580|FG002|Open Label Period (OL)|Death|25|||
155330221|NCT00048932|560643578|FG000|Open Label Period (OL)|Adverse Event|0|||
155330222|NCT00048932|560643579|FG001|Open Label Period (OL)|Adverse Event|0|||
155330223|NCT00048932|560643580|FG002|Open Label Period (OL)|Adverse Event|103|||
155330224|NCT00048932|560643578|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
155330225|NCT00048932|560643579|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
155330226|NCT00048932|560643580|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
155330227|NCT00048932|560643578|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
155330228|NCT00048932|560643579|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
155330229|NCT00048932|560643580|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
155330230|NCT00048932|560643578|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
155330231|NCT00048932|560643579|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
155330232|NCT00048932|560643580|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
155330233|NCT00048932|560643578|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
155330234|NCT00048932|560643579|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
155330235|NCT00048932|560643580|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
155330236|NCT00048932|560643578|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
155330237|NCT00048932|560643579|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
155330238|NCT00048932|560643580|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
155330239|NCT00048932|560643578|FG000|Open Label Period (OL)|Pregnancy|0|||
155330240|NCT00048932|560643579|FG001|Open Label Period (OL)|Pregnancy|0|||
155330241|NCT00048932|560643580|FG002|Open Label Period (OL)|Pregnancy|6|||
155330242|NCT00048932|560643578|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
155330243|NCT00048932|560643579|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
155330244|NCT00048932|560643580|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
155330245|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Retiring|0|||
155330246|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Retiring|0|||
155330247|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Retiring|2|||
155330248|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
155330249|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
155330250|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
155330251|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Relocated|0|||
155330252|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Relocated|0|||
155330253|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Relocated|6|||
155330254|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
155330255|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
155330256|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
155330257|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Closure|0|||
155330258|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Closure|0|||
155330259|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Closure|3|||
155330260|NCT00048932|560643578|FG000|Open Label Period (OL)|Trial Terminated|0|||
155330261|NCT00048932|560643579|FG001|Open Label Period (OL)|Trial Terminated|0|||
155330262|NCT00048932|560643580|FG002|Open Label Period (OL)|Trial Terminated|1|||
155330263|NCT00048932|560643578|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
155330264|NCT00048932|560643579|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
155330265|NCT00048932|560643580|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
155330266|NCT00048932|560643578|FG000|Open Label Period (OL)|Patient Decision|0|||
155330267|NCT00048932|560643579|FG001|Open Label Period (OL)|Patient Decision|0|||
155330268|NCT00048932|560643580|FG002|Open Label Period (OL)|Patient Decision|4|||
155330269|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
155330270|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
155330271|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
155330272|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
155330273|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
155330274|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
155330275|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
155330276|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
155330277|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
155330278|NCT00048932|560643578|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
155330279|NCT00048932|560643579|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
155330280|NCT00048932|560643580|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
155330281|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Decision|0|||
155330282|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Decision|0|||
155330283|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Decision|4|||
155330284|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Staff Issues|0|||
155330285|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Staff Issues|0|||
155330286|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Staff Issues|2|||
155330287|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
155330288|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
155330289|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
155330290|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Surgery|0|||
155330291|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Surgery|0|||
155330292|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Surgery|1|||
155330293|NCT02568215|560643585|FG000|Overall Study|Death|1|||
155330294|NCT02568215|560643586|FG001|Overall Study|Death|2|||
155330295|NCT02568215|560643587|FG002|Overall Study|Death|0|||
155330296|NCT02568215|560643585|FG000|Overall Study|Physician Decision|2|||
155330297|NCT02568215|560643586|FG001|Overall Study|Physician Decision|2|||
155330298|NCT02568215|560643587|FG002|Overall Study|Physician Decision|2|||
155330299|NCT02568215|560643585|FG000|Overall Study|Lost to Follow-up|29|||
155330300|NCT02568215|560643586|FG001|Overall Study|Lost to Follow-up|32|||
155330301|NCT02568215|560643587|FG002|Overall Study|Lost to Follow-up|41|||
155330302|NCT02568215|560643585|FG000|Overall Study|Withdrawal by Subject|21|||
155330303|NCT02568215|560643586|FG001|Overall Study|Withdrawal by Subject|19|||
155330304|NCT02568215|560643587|FG002|Overall Study|Withdrawal by Subject|22|||
155330305|NCT02568215|560643585|FG000|Overall Study|Protocol Violation|1|||
155330306|NCT02568215|560643586|FG001|Overall Study|Protocol Violation|1|||
155330307|NCT02568215|560643587|FG002|Overall Study|Protocol Violation|0|||
155330308|NCT02568215|560643585|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
155330309|NCT02568215|560643586|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
155330310|NCT02568215|560643587|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
155330311|NCT02568215|560643585|FG000|Overall Study|Other|0|||
155330312|NCT02568215|560643586|FG001|Overall Study|Other|1|||
155330313|NCT02568215|560643587|FG002|Overall Study|Other|4|||
155330314|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
155330315|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
155330316|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
155330317|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Death|0|||
155330318|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Death|2|||
155330319|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Death|1|||
155330320|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
155330321|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
155330322|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
155330323|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
155330324|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
155330325|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
155330326|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
155330327|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
155330328|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
155330329|NCT00790569|560643588|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
155330330|NCT00790569|560643589|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
155330331|NCT00790569|560643590|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
155330332|NCT01627561|560643591|FG000|Overall Study|Lost to Follow-up|1|||
155330333|NCT01627561|560643592|FG001|Overall Study|Lost to Follow-up|0|||
155330334|NCT01627561|560643591|FG000|Overall Study|Withdrawal by Subject|0|||
155330335|NCT01627561|560643592|FG001|Overall Study|Withdrawal by Subject|1|||
155330336|NCT01627561|560643591|FG000|Overall Study|Migrated/moved from study area|0|||
155330337|NCT01627561|560643592|FG001|Overall Study|Migrated/moved from study area|2|||
155330338|NCT03244800|560643593|FG000|Overall Study|Adverse Event|0|||
155330339|NCT03244800|560643594|FG001|Overall Study|Adverse Event|1|||
155330340|NCT03244800|560643595|FG002|Overall Study|Adverse Event|0|||
155330341|NCT03244800|560643596|FG003|Overall Study|Adverse Event|1|||
155330342|NCT03244800|560643593|FG000|Overall Study|Withdrew treatment|0|||
155330343|NCT03244800|560643594|FG001|Overall Study|Withdrew treatment|0|||
155330344|NCT03244800|560643595|FG002|Overall Study|Withdrew treatment|0|||
155330345|NCT03244800|560643596|FG003|Overall Study|Withdrew treatment|1|||
155330346|NCT00890591|560643604|FG000|Overall Study|Lack of Efficacy|20|||
155330347|NCT02941549|560643605|FG000|Overall Study|Adverse Event|1|||
155330348|NCT02941549|560643606|FG001|Overall Study|Adverse Event|0|||
155330349|NCT02941549|560643607|FG002|Overall Study|Adverse Event|0|||
155330350|NCT02941549|560643605|FG000|Overall Study|Withdrawal by Subject|2|||
155330351|NCT02941549|560643606|FG001|Overall Study|Withdrawal by Subject|1|||
155330352|NCT02941549|560643607|FG002|Overall Study|Withdrawal by Subject|2|||
155330353|NCT03451422|560643614|FG000|Overall Study|Lost to Follow-up|0|||
155330354|NCT03451422|560643615|FG001|Overall Study|Lost to Follow-up|0|||
155330355|NCT03451422|560643616|FG002|Overall Study|Lost to Follow-up|0|||
155330356|NCT03451422|560643617|FG003|Overall Study|Lost to Follow-up|0|||
155330357|NCT03451422|560643618|FG004|Overall Study|Lost to Follow-up|0|||
155330358|NCT03451422|560643619|FG005|Overall Study|Lost to Follow-up|1|||
155330359|NCT03451422|560643614|FG000|Overall Study|Decision by sponsor|1|||
155330360|NCT03451422|560643615|FG001|Overall Study|Decision by sponsor|0|||
155330361|NCT03451422|560643616|FG002|Overall Study|Decision by sponsor|1|||
155330362|NCT03451422|560643617|FG003|Overall Study|Decision by sponsor|0|||
155330363|NCT03451422|560643618|FG004|Overall Study|Decision by sponsor|0|||
155330364|NCT03451422|560643619|FG005|Overall Study|Decision by sponsor|0|||
155330365|NCT03451422|560643614|FG000|Overall Study|Withdrawal by Subject|0|||
155330366|NCT03451422|560643615|FG001|Overall Study|Withdrawal by Subject|0|||
155330367|NCT03451422|560643616|FG002|Overall Study|Withdrawal by Subject|2|||
155330368|NCT03451422|560643617|FG003|Overall Study|Withdrawal by Subject|3|||
155330369|NCT03451422|560643618|FG004|Overall Study|Withdrawal by Subject|2|||
155330370|NCT03451422|560643619|FG005|Overall Study|Withdrawal by Subject|1|||
155330371|NCT04545619|560643620|FG000|Overall Study|due to equipment challenges|1|||
155330372|NCT04384172|560643623|FG000|Overall Study|Lost to Follow-up|0|||
155330373|NCT04384172|560643624|FG001|Overall Study|Lost to Follow-up|2|||
155330374|NCT04384172|560643623|FG000|Overall Study|Pregnancy|1|||
155330375|NCT04384172|560643624|FG001|Overall Study|Pregnancy|0|||
155330376|NCT04384172|560643623|FG000|Overall Study|Withdrawal by Subject|0|||
155330377|NCT04384172|560643624|FG001|Overall Study|Withdrawal by Subject|1|||
155330378|NCT04949542|560643625|FG000|Overall Study|Lost to Follow-up|4|||
155330379|NCT04949542|560643626|FG001|Overall Study|Lost to Follow-up|1|||
155330380|NCT01536093|560643629|FG000|Overall Study|Death|1|||
155330381|NCT01536093|560643630|FG001|Overall Study|Death|2|||
155330382|NCT01536093|560643629|FG000|Overall Study|absence of maternal colostrum|2|||
155330383|NCT01536093|560643630|FG001|Overall Study|absence of maternal colostrum|0|||
155330384|NCT01536093|560643629|FG000|Overall Study|Withdrawal by Subject|0|||
155330385|NCT01536093|560643630|FG001|Overall Study|Withdrawal by Subject|1|||
155330386|NCT01211184|560643631|FG000|Overall Study|Withdrawal by Subject|0|||
155330387|NCT01211184|560643632|FG001|Overall Study|Withdrawal by Subject|2|||
155330388|NCT01211184|560643633|FG002|Overall Study|Withdrawal by Subject|1|||
155330389|NCT01421667|560643634|FG000|Overall Study|Withdrawal by Subject|0|||
155330390|NCT01421667|560643635|FG001|Overall Study|Withdrawal by Subject|1|||
155330391|NCT01421667|560643636|FG002|Overall Study|Withdrawal by Subject|2|||
155330392|NCT01421667|560643637|FG003|Overall Study|Withdrawal by Subject|1|||
155330393|NCT01421667|560643634|FG000|Overall Study|Lost to Follow-up|0|||
155330394|NCT01421667|560643635|FG001|Overall Study|Lost to Follow-up|1|||
155330395|NCT01421667|560643636|FG002|Overall Study|Lost to Follow-up|0|||
155330396|NCT01421667|560643637|FG003|Overall Study|Lost to Follow-up|0|||
155330397|NCT00503906|560643638|FG000|Overall Study|Withdrawal by Subject|1|||
155330398|NCT03631407|560643639|FG000|Overall Study|Withdrawal by Subject|3|||
155330399|NCT03631407|560643640|FG001|Overall Study|Withdrawal by Subject|2|||
155330400|NCT03631407|560643639|FG000|Overall Study|Sponsor Decision|0|||
155330401|NCT03631407|560643640|FG001|Overall Study|Sponsor Decision|2|||
155330402|NCT03631407|560643639|FG000|Overall Study|Death|16|||
155330403|NCT03631407|560643640|FG001|Overall Study|Death|16|||
155330404|NCT03631407|560643639|FG000|Overall Study|Randomized by mistake without study treatment|1|||
155330405|NCT03631407|560643640|FG001|Overall Study|Randomized by mistake without study treatment|0|||
155330406|NCT03802994|560643642|FG000|Overall Study|Lost to Follow-up|0|||
155330407|NCT03802994|560643643|FG001|Overall Study|Lost to Follow-up|2|||
155330408|NCT03802994|560643644|FG002|Overall Study|Lost to Follow-up|3|||
155330409|NCT03802994|560643645|FG003|Overall Study|Lost to Follow-up|2|||
155330410|NCT03802994|560643646|FG004|Overall Study|Lost to Follow-up|2|||
155330411|NCT00983294|560643647|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
155330412|NCT00983294|560643647|FG000|Colchicine With Azithromycin|Adverse Event|1|||
155330413|NCT00980954|560643648|FG000|Overall Study|Protocol Violation|9|||
155330414|NCT00980954|560643649|FG001|Overall Study|Protocol Violation|15|||
155330415|NCT02744066|560643653|FG000|Overall Study|Withdrawal by parent|0|||
155330416|NCT02744066|560643654|FG001|Overall Study|Withdrawal by parent|1|||
155330417|NCT02744066|560643653|FG000|Overall Study|Discharged from NICU prior to completion|0|||
155330418|NCT02744066|560643654|FG001|Overall Study|Discharged from NICU prior to completion|4|||
155330419|NCT02415127|560643655|FG000|Overall Study|Adverse Event|1|||
155330420|NCT02415127|560643656|FG001|Overall Study|Adverse Event|0|||
155330421|NCT04153890|560643659|FG000|Overall Study|Lost to Follow-up|9|||
155330422|NCT04153890|560643660|FG001|Overall Study|Lost to Follow-up|0|||
155330423|NCT04153890|560643661|FG002|Overall Study|Lost to Follow-up|9|||
155330424|NCT04153890|560643662|FG003|Overall Study|Lost to Follow-up|0|||
155330425|NCT04153890|560643659|FG000|Overall Study|Death|0|||
155330426|NCT04153890|560643660|FG001|Overall Study|Death|2|||
155330427|NCT04153890|560643661|FG002|Overall Study|Death|0|||
155330428|NCT04153890|560643662|FG003|Overall Study|Death|0|||
155330429|NCT04153890|560643659|FG000|Overall Study|Withdrawal by Subject|0|||
155330430|NCT04153890|560643660|FG001|Overall Study|Withdrawal by Subject|0|||
155330431|NCT04153890|560643661|FG002|Overall Study|Withdrawal by Subject|0|||
155330432|NCT04153890|560643662|FG003|Overall Study|Withdrawal by Subject|2|||
155330433|NCT03997474|560643665|FG000|Overall Study|Death|6|||
155330434|NCT03997474|560643666|FG001|Overall Study|Death|2|||
155330435|NCT03997474|560643667|FG002|Overall Study|Death|1|||
155330436|NCT03997474|560643665|FG000|Overall Study|Physician Decision|2|||
155330437|NCT03997474|560643666|FG001|Overall Study|Physician Decision|0|||
155330438|NCT03997474|560643667|FG002|Overall Study|Physician Decision|0|||
155330439|NCT03997474|560643665|FG000|Overall Study|study terminated by sponsor|1|||
155330440|NCT03997474|560643666|FG001|Overall Study|study terminated by sponsor|0|||
155330441|NCT03997474|560643667|FG002|Overall Study|study terminated by sponsor|1|||
155330442|NCT03277989|560643669|FG000|Overall Study|Lost to Follow-up|6|||
155330443|NCT03277989|560643669|FG000|Overall Study|Adverse Event|6|||
155330444|NCT03277989|560643669|FG000|Overall Study|Withdrawal by Subject|3|||
155330445|NCT03277989|560643669|FG000|Overall Study|Didn't Receive Study Device|7|||
155330446|NCT03277989|560643669|FG000|Overall Study|Site Closure|26|||
155330447|NCT03277989|560643669|FG000|Overall Study|Sponsor Closure|107|||
155330448|NCT05037513|560643673|FG000|Intervention Period|Lost to Follow-up|1|||
155330449|NCT05037513|560643674|FG001|Intervention Period|Lost to Follow-up|2|||
155330450|NCT05037513|560643673|FG000|Follow Up Period|Lost to Follow-up|16|||
155330451|NCT05037513|560643674|FG001|Follow Up Period|Lost to Follow-up|21|||
155330452|NCT05037513|560643673|FG000|Follow Up Period|Death|0|||
155330453|NCT05037513|560643674|FG001|Follow Up Period|Death|1|||
155330454|NCT05037513|560643673|FG000|Follow Up Period|Incarcerated|4|||
155330455|NCT05037513|560643674|FG001|Follow Up Period|Incarcerated|2|||
155330456|NCT02232737|560645452|FG000|Overall Study|Lost to Follow-up|18|||
155330457|NCT02232737|560645453|FG001|Overall Study|Lost to Follow-up|28|||
155330458|NCT02232737|560645454|FG002|Overall Study|Lost to Follow-up|33|||
155330459|NCT02232737|560645452|FG000|Overall Study|Personal reasons|7|||
155330460|NCT02232737|560645453|FG001|Overall Study|Personal reasons|8|||
155330461|NCT02232737|560645454|FG002|Overall Study|Personal reasons|14|||
155330462|NCT02232737|560645452|FG000|Overall Study|Adverse Event|6|||
155330463|NCT02232737|560645453|FG001|Overall Study|Adverse Event|3|||
155330464|NCT02232737|560645454|FG002|Overall Study|Adverse Event|8|||
155330465|NCT02232737|560645452|FG000|Overall Study|Incarcerated|2|||
155330466|NCT02232737|560645453|FG001|Overall Study|Incarcerated|1|||
155330467|NCT02232737|560645454|FG002|Overall Study|Incarcerated|2|||
155330468|NCT02232737|560645452|FG000|Overall Study|Withdrawal by Subject|0|||
155330469|NCT02232737|560645453|FG001|Overall Study|Withdrawal by Subject|1|||
155330470|NCT02232737|560645454|FG002|Overall Study|Withdrawal by Subject|2|||
155330471|NCT02232737|560645452|FG000|Overall Study|Death|0|||
155330472|NCT02232737|560645453|FG001|Overall Study|Death|1|||
155330473|NCT02232737|560645454|FG002|Overall Study|Death|1|||
155330474|NCT02232737|560645452|FG000|Overall Study|Physician Decision|1|||
155330475|NCT02232737|560645453|FG001|Overall Study|Physician Decision|3|||
155330476|NCT02232737|560645454|FG002|Overall Study|Physician Decision|1|||
155330477|NCT02232737|560645452|FG000|Overall Study|Protocol Violation|1|||
155330478|NCT02232737|560645453|FG001|Overall Study|Protocol Violation|0|||
155330479|NCT02232737|560645454|FG002|Overall Study|Protocol Violation|1|||
155330480|NCT02232737|560645452|FG000|Overall Study|Reason unknown|1|||
155330481|NCT02232737|560645453|FG001|Overall Study|Reason unknown|0|||
155330482|NCT02232737|560645454|FG002|Overall Study|Reason unknown|0|||
155330483|NCT00065182|560645463|FG000|Overall Study|Adverse Event|24|||
155330484|NCT00065182|560645464|FG001|Overall Study|Adverse Event|17|||
155330485|NCT00065182|560645463|FG000|Overall Study|Lost to Follow-up|0|||
155330486|NCT00065182|560645464|FG001|Overall Study|Lost to Follow-up|4|||
155330487|NCT00065182|560645463|FG000|Overall Study|Protocol Violation|3|||
155330488|NCT00065182|560645464|FG001|Overall Study|Protocol Violation|4|||
155330489|NCT00065182|560645463|FG000|Overall Study|Serious adverse events (SAE)|1|||
155330490|NCT00065182|560645464|FG001|Overall Study|Serious adverse events (SAE)|0|||
155330491|NCT00065182|560645463|FG000|Overall Study|Sponsor Decision|11|||
155330492|NCT00065182|560645464|FG001|Overall Study|Sponsor Decision|7|||
155330493|NCT00065182|560645463|FG000|Overall Study|Withdrawal by Subject|8|||
155330494|NCT00065182|560645464|FG001|Overall Study|Withdrawal by Subject|3|||
155330495|NCT00065182|560645463|FG000|Overall Study|No clinical benefit|1|||
155330496|NCT00065182|560645464|FG001|Overall Study|No clinical benefit|0|||
155330497|NCT00065182|560645463|FG000|Overall Study|Death|0|||
155330498|NCT00065182|560645464|FG001|Overall Study|Death|1|||
155330499|NCT00065182|560645463|FG000|Overall Study|Decline in Status|0|||
155330500|NCT00065182|560645464|FG001|Overall Study|Decline in Status|1|||
155330501|NCT03738228|560645465|FG000|Overall Study|Never received study treatment|2|||
155330502|NCT03738228|560645466|FG001|Overall Study|Never received study treatment|2|||
155330503|NCT01641900|560645467|FG000|Overall Study|Withdrawal by Subject|2|||
155330504|NCT01641900|560645468|FG001|Overall Study|Withdrawal by Subject|2|||
155330505|NCT02275611|560645472|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
155330506|NCT02275611|560645473|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330507|NCT02275611|560645474|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330508|NCT02275611|560645475|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330509|NCT02101775|560645476|FG000|Overall Study|Adverse Event|4|||
155330510|NCT02101775|560645477|FG001|Overall Study|Adverse Event|0|||
155330511|NCT02101775|560645478|FG002|Overall Study|Adverse Event|0|||
155330512|NCT02101775|560645476|FG000|Overall Study|Admission to Hospital|0|||
155330513|NCT02101775|560645477|FG001|Overall Study|Admission to Hospital|1|||
155330514|NCT02101775|560645478|FG002|Overall Study|Admission to Hospital|0|||
155330515|NCT03611556|560645479|FG000|Overall Study|Death|7|||
155330516|NCT03611556|560645480|FG001|Overall Study|Death|7|||
155330517|NCT03611556|560645481|FG002|Overall Study|Death|3|||
155330518|NCT03611556|560645482|FG003|Overall Study|Death|8|||
155330519|NCT03611556|560645483|FG004|Overall Study|Death|47|||
155330520|NCT03611556|560645484|FG005|Overall Study|Death|32|||
155330521|NCT03611556|560645485|FG006|Overall Study|Death|53|||
155330522|NCT03611556|560645479|FG000|Overall Study|Withdrawal by Subject|0|||
155330523|NCT03611556|560645480|FG001|Overall Study|Withdrawal by Subject|0|||
155330524|NCT03611556|560645481|FG002|Overall Study|Withdrawal by Subject|0|||
155330525|NCT03611556|560645482|FG003|Overall Study|Withdrawal by Subject|0|||
155330526|NCT03611556|560645483|FG004|Overall Study|Withdrawal by Subject|4|||
155330527|NCT03611556|560645484|FG005|Overall Study|Withdrawal by Subject|2|||
155330528|NCT03611556|560645485|FG006|Overall Study|Withdrawal by Subject|4|||
155330529|NCT03611556|560645479|FG000|Overall Study|Sponsor decision|0|||
155330530|NCT03611556|560645480|FG001|Overall Study|Sponsor decision|0|||
155330531|NCT03611556|560645481|FG002|Overall Study|Sponsor decision|0|||
155330532|NCT03611556|560645482|FG003|Overall Study|Sponsor decision|0|||
155330533|NCT03611556|560645483|FG004|Overall Study|Sponsor decision|9|||
155330534|NCT03611556|560645484|FG005|Overall Study|Sponsor decision|4|||
155330535|NCT03611556|560645485|FG006|Overall Study|Sponsor decision|12|||
155330536|NCT03611556|560645479|FG000|Overall Study|Reasons|0|||
155330537|NCT03611556|560645480|FG001|Overall Study|Reasons|0|||
155330538|NCT03611556|560645481|FG002|Overall Study|Reasons|0|||
155330539|NCT03611556|560645482|FG003|Overall Study|Reasons|0|||
155330540|NCT03611556|560645483|FG004|Overall Study|Reasons|2|||
155330541|NCT03611556|560645484|FG005|Overall Study|Reasons|0|||
155330542|NCT03611556|560645485|FG006|Overall Study|Reasons|1|||
155330543|NCT02844439|560645486|FG000|Overall Study|Withdrawal by Subject|1|||
155330544|NCT02844439|560645486|FG000|Overall Study|Lost to Follow-up|2|||
155330545|NCT02844439|560645486|FG000|Overall Study|Termination by Sponsor|4|||
155330546|NCT02844439|560645486|FG000|Overall Study|Death|28|||
155330547|NCT02844439|560645486|FG000|Overall Study|Other|5|||
155330548|NCT00390884|560645489|FG000|Overall Study|Withdrawal by Subject|2|||
155330549|NCT00390884|560645490|FG001|Overall Study|Withdrawal by Subject|2|||
155502552|NCT00434148|561265540|FG000|Overall Study|Lost to Follow-up|0|||
155502553|NCT00434148|561265541|FG001|Overall Study|Lost to Follow-up|1|||
155502554|NCT00434148|561265540|FG000|Overall Study|Condition no longer requires study drug|1|||
155502555|NCT00434148|561265541|FG001|Overall Study|Condition no longer requires study drug|0|||
155502556|NCT00434148|561265540|FG000|Overall Study|Abnormal test procedure result|0|||
155502557|NCT00434148|561265541|FG001|Overall Study|Abnormal test procedure result|1|||
155502558|NCT01640964|561265547|FG000|Overall Study|Lost to Follow-up|0|||
155502559|NCT01640964|561265548|FG001|Overall Study|Lost to Follow-up|0|||
155330550|NCT00756574|560645491|FG000|Overall Study|Withdrawal by Subject|9|||
155330551|NCT00756574|560645492|FG001|Overall Study|Withdrawal by Subject|7|||
155330552|NCT00756574|560645491|FG000|Overall Study|Lost to Follow-up|4|||
155330553|NCT00756574|560645492|FG001|Overall Study|Lost to Follow-up|4|||
155502560|NCT01640964|561265549|FG002|Overall Study|Lost to Follow-up|1|||
155330554|NCT04622332|560645493|FG000|Overall Study|Withdrawal by Subject|4|||
155330555|NCT04622332|560645494|FG001|Overall Study|Withdrawal by Subject|2|||
155330556|NCT04622332|560645493|FG000|Overall Study|Physician Decision|1|||
155330557|NCT04622332|560645494|FG001|Overall Study|Physician Decision|1|||
155330558|NCT04622332|560645493|FG000|Overall Study|Adverse Event|0|||
155330559|NCT04622332|560645494|FG001|Overall Study|Adverse Event|2|||
155330560|NCT04622332|560645493|FG000|Overall Study|Protocol Violation|0|||
155330561|NCT04622332|560645494|FG001|Overall Study|Protocol Violation|1|||
155330562|NCT05966155|560645495|FG000|Overall Study|Death|1|||
155330563|NCT05966155|560645496|FG001|Overall Study|Death|2|||
155502561|NCT01640964|561265547|FG000|Overall Study|Protocol Deviation|1|||
155330564|NCT05966155|560645495|FG000|Overall Study|Lost to Follow-up|63|||
155330565|NCT05966155|560645496|FG001|Overall Study|Lost to Follow-up|67|||
155330566|NCT05966155|560645495|FG000|Overall Study|Protocol Violation|1|||
155330567|NCT05966155|560645496|FG001|Overall Study|Protocol Violation|0|||
155330568|NCT05966155|560645495|FG000|Overall Study|Withdrawal by Subject|8|||
155330569|NCT05966155|560645496|FG001|Overall Study|Withdrawal by Subject|9|||
155330570|NCT05966155|560645495|FG000|Overall Study|Enrolled Erroneously|0|||
155330571|NCT05966155|560645496|FG001|Overall Study|Enrolled Erroneously|1|||
155330572|NCT05966155|560645495|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
155330573|NCT05966155|560645496|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
155330574|NCT05036278|560645499|FG000|Overall Study|Withdrawal by Subject|1|||
155330575|NCT05036278|560645499|FG000|Overall Study|Adverse Event|1|||
155330576|NCT02787005|560645502|FG000|Overall Study|Adverse Event|24|||
155330577|NCT02787005|560645503|FG001|Overall Study|Adverse Event|9|||
155330578|NCT02787005|560645504|FG002|Overall Study|Adverse Event|9|||
155330579|NCT02787005|560645505|FG003|Overall Study|Adverse Event|7|||
155330580|NCT02787005|560645506|FG004|Overall Study|Adverse Event|2|||
155330581|NCT02787005|560645502|FG000|Overall Study|Death|100|||
155330582|NCT02787005|560645503|FG001|Overall Study|Death|53|||
155330583|NCT02787005|560645504|FG002|Overall Study|Death|48|||
155330584|NCT02787005|560645505|FG003|Overall Study|Death|69|||
155330585|NCT02787005|560645506|FG004|Overall Study|Death|38|||
155330586|NCT02787005|560645502|FG000|Overall Study|Sponsor Decision|7|||
155330587|NCT02787005|560645503|FG001|Overall Study|Sponsor Decision|4|||
155330588|NCT02787005|560645504|FG002|Overall Study|Sponsor Decision|0|||
155330589|NCT02787005|560645505|FG003|Overall Study|Sponsor Decision|4|||
155330590|NCT02787005|560645506|FG004|Overall Study|Sponsor Decision|5|||
155330591|NCT02787005|560645502|FG000|Overall Study|Withdrawal by Subject|2|||
155330592|NCT02787005|560645503|FG001|Overall Study|Withdrawal by Subject|1|||
155330593|NCT02787005|560645504|FG002|Overall Study|Withdrawal by Subject|1|||
155330594|NCT02787005|560645505|FG003|Overall Study|Withdrawal by Subject|0|||
155330595|NCT02787005|560645506|FG004|Overall Study|Withdrawal by Subject|1|||
155330596|NCT02787005|560645502|FG000|Overall Study|Screen Failure|0|||
155330597|NCT02787005|560645503|FG001|Overall Study|Screen Failure|2|||
155330598|NCT02787005|560645504|FG002|Overall Study|Screen Failure|0|||
155330599|NCT02787005|560645505|FG003|Overall Study|Screen Failure|0|||
155330600|NCT02787005|560645506|FG004|Overall Study|Screen Failure|1|||
155330601|NCT02787005|560645502|FG000|Overall Study|Lost to Follow-up|0|||
155330602|NCT02787005|560645503|FG001|Overall Study|Lost to Follow-up|0|||
155330603|NCT02787005|560645504|FG002|Overall Study|Lost to Follow-up|0|||
155330604|NCT02787005|560645505|FG003|Overall Study|Lost to Follow-up|1|||
155330605|NCT02787005|560645506|FG004|Overall Study|Lost to Follow-up|0|||
155330606|NCT05580003|560645512|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330607|NCT05580003|560645513|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330608|NCT05580003|560645514|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330609|NCT05580003|560645515|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330610|NCT05580003|560645516|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330611|NCT05580003|560645517|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330612|NCT05580003|560645518|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
155330613|NCT05580003|560645519|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330614|NCT05580003|560645520|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330615|NCT05580003|560645521|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330616|NCT05580003|560645522|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330617|NCT05580003|560645523|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330618|NCT05580003|560645524|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330619|NCT05580003|560645525|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330620|NCT05580003|560645526|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330621|NCT05580003|560645527|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330622|NCT05580003|560645528|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330623|NCT05580003|560645529|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330624|NCT05580003|560645530|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330625|NCT05580003|560645531|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330626|NCT05580003|560645532|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330627|NCT05580003|560645533|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330628|NCT05580003|560645534|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330629|NCT05580003|560645535|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330630|NCT05580003|560645536|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155421896|NCT00706628|560974388|FG001|Overall Study|Other Adverse Event|5|||
155645208|NCT04676646|561792178|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
155330631|NCT05580003|560645537|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330632|NCT05580003|560645538|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330633|NCT05580003|560645539|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330634|NCT05580003|560645512|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155421897|NCT00706628|560974389|FG002|Overall Study|Other Adverse Event|5|||
155330635|NCT05580003|560645513|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330636|NCT05580003|560645514|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330637|NCT05580003|560645515|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330638|NCT05580003|560645516|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330639|NCT05580003|560645517|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
155330640|NCT05580003|560645518|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330641|NCT05580003|560645519|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330642|NCT05580003|560645520|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330643|NCT05580003|560645521|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330644|NCT05580003|560645522|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330645|NCT05580003|560645523|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330646|NCT05580003|560645524|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330647|NCT05580003|560645525|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330648|NCT05580003|560645526|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330649|NCT05580003|560645527|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330650|NCT05580003|560645528|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330651|NCT05580003|560645529|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330652|NCT05580003|560645530|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330653|NCT05580003|560645531|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330654|NCT05580003|560645532|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330655|NCT05580003|560645533|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330656|NCT05580003|560645534|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330657|NCT05580003|560645535|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330658|NCT05580003|560645536|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330659|NCT05580003|560645537|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330660|NCT05580003|560645538|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330661|NCT05580003|560645539|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330662|NCT05580003|560645512|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330663|NCT05580003|560645513|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330664|NCT05580003|560645514|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330665|NCT05580003|560645515|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
155330666|NCT05580003|560645516|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330667|NCT05580003|560645517|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330668|NCT05580003|560645518|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330669|NCT05580003|560645519|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330670|NCT05580003|560645520|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330671|NCT05580003|560645521|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330672|NCT05580003|560645522|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330673|NCT05580003|560645523|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330674|NCT05580003|560645524|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330675|NCT05580003|560645525|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330676|NCT05580003|560645526|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330677|NCT05580003|560645527|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330678|NCT05580003|560645528|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330679|NCT05580003|560645529|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330680|NCT05580003|560645530|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330681|NCT05580003|560645531|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330682|NCT05580003|560645532|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330683|NCT05580003|560645533|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330684|NCT05580003|560645534|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330685|NCT05580003|560645535|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155421898|NCT00706628|560974390|FG003|Overall Study|Other Adverse Event|2|||
155421899|NCT00706628|560974387|FG000|Overall Study|Non compliant with protocol|0|||
155421900|NCT00706628|560974388|FG001|Overall Study|Non compliant with protocol|1|||
155421901|NCT00706628|560974389|FG002|Overall Study|Non compliant with protocol|0|||
155330686|NCT05580003|560645536|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330687|NCT05580003|560645537|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330688|NCT05580003|560645538|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330689|NCT05580003|560645539|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330690|NCT05580003|560645512|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330691|NCT05580003|560645513|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
155421902|NCT00706628|560974390|FG003|Overall Study|Non compliant with protocol|0|||
155330692|NCT05580003|560645514|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330693|NCT05580003|560645515|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155421903|NCT00706628|560974387|FG000|Overall Study|Consent withdrawn|6|||
155421904|NCT00706628|560974388|FG001|Overall Study|Consent withdrawn|1|||
155330694|NCT05580003|560645516|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330695|NCT05580003|560645517|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330696|NCT05580003|560645518|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330697|NCT05580003|560645519|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330698|NCT05580003|560645520|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330699|NCT05580003|560645521|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330700|NCT05580003|560645522|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330701|NCT05580003|560645523|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330702|NCT05580003|560645524|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330703|NCT05580003|560645525|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330704|NCT05580003|560645526|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330705|NCT05580003|560645527|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330706|NCT05580003|560645528|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330707|NCT05580003|560645529|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330708|NCT05580003|560645530|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330709|NCT05580003|560645531|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330710|NCT05580003|560645532|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330711|NCT05580003|560645533|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330712|NCT05580003|560645534|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330713|NCT05580003|560645535|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330714|NCT05580003|560645536|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330715|NCT05580003|560645537|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330716|NCT05580003|560645538|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330717|NCT05580003|560645539|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330718|NCT05580003|560645512|FG000|Part 2 (up to 10 Days)|Other|0|||
155330719|NCT05580003|560645513|FG001|Part 2 (up to 10 Days)|Other|0|||
155330720|NCT05580003|560645514|FG002|Part 2 (up to 10 Days)|Other|0|||
155330721|NCT05580003|560645515|FG003|Part 2 (up to 10 Days)|Other|0|||
155330722|NCT05580003|560645516|FG004|Part 2 (up to 10 Days)|Other|0|||
155330723|NCT05580003|560645517|FG005|Part 2 (up to 10 Days)|Other|0|||
155330724|NCT05580003|560645518|FG006|Part 2 (up to 10 Days)|Other|0|||
155330725|NCT05580003|560645519|FG007|Part 2 (up to 10 Days)|Other|0|||
155330726|NCT05580003|560645520|FG008|Part 2 (up to 10 Days)|Other|0|||
155330727|NCT05580003|560645521|FG009|Part 2 (up to 10 Days)|Other|1|||
155330728|NCT05580003|560645522|FG010|Part 2 (up to 10 Days)|Other|0|||
155330729|NCT05580003|560645523|FG011|Part 2 (up to 10 Days)|Other|0|||
155330730|NCT05580003|560645524|FG012|Part 2 (up to 10 Days)|Other|0|||
155330731|NCT05580003|560645525|FG013|Part 2 (up to 10 Days)|Other|0|||
155330732|NCT05580003|560645526|FG014|Part 2 (up to 10 Days)|Other|0|||
155330733|NCT05580003|560645527|FG015|Part 2 (up to 10 Days)|Other|0|||
155330734|NCT05580003|560645528|FG016|Part 2 (up to 10 Days)|Other|0|||
155330735|NCT05580003|560645529|FG017|Part 2 (up to 10 Days)|Other|0|||
155330736|NCT05580003|560645530|FG018|Part 2 (up to 10 Days)|Other|0|||
155330737|NCT05580003|560645531|FG019|Part 2 (up to 10 Days)|Other|0|||
155330738|NCT05580003|560645532|FG020|Part 2 (up to 10 Days)|Other|0|||
155330739|NCT05580003|560645533|FG021|Part 2 (up to 10 Days)|Other|0|||
155330740|NCT05580003|560645534|FG022|Part 2 (up to 10 Days)|Other|0|||
155330741|NCT05580003|560645535|FG023|Part 2 (up to 10 Days)|Other|0|||
155330742|NCT05580003|560645536|FG024|Part 2 (up to 10 Days)|Other|0|||
155330743|NCT05580003|560645537|FG025|Part 2 (up to 10 Days)|Other|0|||
155330744|NCT05580003|560645538|FG026|Part 2 (up to 10 Days)|Other|0|||
155330745|NCT05580003|560645539|FG027|Part 2 (up to 10 Days)|Other|0|||
155330746|NCT05580003|560645512|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330747|NCT05580003|560645513|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330748|NCT05580003|560645514|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330749|NCT05580003|560645515|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330750|NCT05580003|560645516|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330751|NCT05580003|560645517|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330752|NCT05580003|560645518|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330753|NCT05580003|560645519|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330754|NCT05580003|560645520|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330755|NCT05580003|560645521|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330756|NCT05580003|560645522|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330757|NCT05580003|560645523|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330758|NCT05580003|560645524|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330759|NCT05580003|560645525|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330760|NCT05580003|560645526|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330761|NCT05580003|560645527|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330762|NCT05580003|560645528|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330763|NCT05580003|560645529|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330764|NCT05580003|560645530|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330765|NCT05580003|560645531|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
155330766|NCT05580003|560645532|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330767|NCT05580003|560645533|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330768|NCT05580003|560645534|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330769|NCT05580003|560645535|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330770|NCT05580003|560645536|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330771|NCT05580003|560645537|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330772|NCT05580003|560645538|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330773|NCT05580003|560645539|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330774|NCT05580003|560645512|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330775|NCT05580003|560645513|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330776|NCT05580003|560645514|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330777|NCT05580003|560645515|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330778|NCT05580003|560645516|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330779|NCT05580003|560645517|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330780|NCT05580003|560645518|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330781|NCT05580003|560645519|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330782|NCT05580003|560645520|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330783|NCT05580003|560645521|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330784|NCT05580003|560645522|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330785|NCT05580003|560645523|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330786|NCT05580003|560645524|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330787|NCT05580003|560645525|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330788|NCT05580003|560645526|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330789|NCT05580003|560645527|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330790|NCT05580003|560645528|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330791|NCT05580003|560645529|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330792|NCT05580003|560645530|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330793|NCT05580003|560645531|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330794|NCT05580003|560645532|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
155330795|NCT05580003|560645533|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330796|NCT05580003|560645534|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330797|NCT05580003|560645535|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330798|NCT05580003|560645536|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330799|NCT05580003|560645537|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330800|NCT05580003|560645538|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330801|NCT05580003|560645539|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330802|NCT05580003|560645512|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330803|NCT05580003|560645513|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330804|NCT05580003|560645514|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330805|NCT05580003|560645515|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330806|NCT05580003|560645516|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330807|NCT05580003|560645517|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330808|NCT05580003|560645518|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330809|NCT05580003|560645519|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330810|NCT05580003|560645520|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330811|NCT05580003|560645521|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330812|NCT05580003|560645522|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330813|NCT05580003|560645523|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330814|NCT05580003|560645524|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330815|NCT05580003|560645525|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330816|NCT05580003|560645526|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330817|NCT05580003|560645527|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330818|NCT05580003|560645528|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330819|NCT05580003|560645529|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330820|NCT05580003|560645530|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330821|NCT05580003|560645531|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330822|NCT05580003|560645532|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330823|NCT05580003|560645533|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
155330824|NCT05580003|560645534|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330825|NCT05580003|560645535|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330826|NCT05580003|560645536|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330827|NCT05580003|560645537|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330828|NCT05580003|560645538|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330829|NCT05580003|560645539|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330830|NCT05580003|560645512|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330831|NCT05580003|560645513|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330832|NCT05580003|560645514|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330833|NCT05580003|560645515|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330834|NCT05580003|560645516|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330835|NCT05580003|560645517|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330836|NCT05580003|560645518|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330837|NCT05580003|560645519|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330838|NCT05580003|560645520|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330839|NCT05580003|560645521|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330840|NCT05580003|560645522|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330841|NCT05580003|560645523|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330842|NCT05580003|560645524|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330843|NCT05580003|560645525|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330844|NCT05580003|560645526|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330845|NCT05580003|560645527|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330846|NCT05580003|560645528|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330847|NCT05580003|560645529|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330848|NCT05580003|560645530|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330849|NCT05580003|560645531|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330850|NCT05580003|560645532|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330851|NCT05580003|560645533|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330852|NCT05580003|560645534|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330853|NCT05580003|560645535|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330854|NCT05580003|560645536|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330855|NCT05580003|560645537|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330856|NCT05580003|560645538|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330857|NCT05580003|560645539|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
155330858|NCT05580003|560645512|FG000|Part 6 Period 2 (Day 1)|Other|0|||
155330859|NCT05580003|560645513|FG001|Part 6 Period 2 (Day 1)|Other|0|||
155330860|NCT05580003|560645514|FG002|Part 6 Period 2 (Day 1)|Other|0|||
155330861|NCT05580003|560645515|FG003|Part 6 Period 2 (Day 1)|Other|0|||
155330862|NCT05580003|560645516|FG004|Part 6 Period 2 (Day 1)|Other|0|||
155330863|NCT05580003|560645517|FG005|Part 6 Period 2 (Day 1)|Other|0|||
155330864|NCT05580003|560645518|FG006|Part 6 Period 2 (Day 1)|Other|0|||
155330865|NCT05580003|560645519|FG007|Part 6 Period 2 (Day 1)|Other|0|||
155330866|NCT05580003|560645520|FG008|Part 6 Period 2 (Day 1)|Other|0|||
155330867|NCT05580003|560645521|FG009|Part 6 Period 2 (Day 1)|Other|0|||
155330868|NCT05580003|560645522|FG010|Part 6 Period 2 (Day 1)|Other|0|||
155330869|NCT05580003|560645523|FG011|Part 6 Period 2 (Day 1)|Other|0|||
155330870|NCT05580003|560645524|FG012|Part 6 Period 2 (Day 1)|Other|0|||
155330871|NCT05580003|560645525|FG013|Part 6 Period 2 (Day 1)|Other|0|||
155330872|NCT05580003|560645526|FG014|Part 6 Period 2 (Day 1)|Other|0|||
155330873|NCT05580003|560645527|FG015|Part 6 Period 2 (Day 1)|Other|0|||
155330874|NCT05580003|560645528|FG016|Part 6 Period 2 (Day 1)|Other|0|||
155330875|NCT05580003|560645529|FG017|Part 6 Period 2 (Day 1)|Other|0|||
155330876|NCT05580003|560645530|FG018|Part 6 Period 2 (Day 1)|Other|0|||
155330877|NCT05580003|560645531|FG019|Part 6 Period 2 (Day 1)|Other|0|||
155330878|NCT05580003|560645532|FG020|Part 6 Period 2 (Day 1)|Other|0|||
155330879|NCT05580003|560645533|FG021|Part 6 Period 2 (Day 1)|Other|0|||
155330880|NCT05580003|560645534|FG022|Part 6 Period 2 (Day 1)|Other|0|||
155330881|NCT05580003|560645535|FG023|Part 6 Period 2 (Day 1)|Other|0|||
155330882|NCT05580003|560645536|FG024|Part 6 Period 2 (Day 1)|Other|1|||
155330883|NCT05580003|560645537|FG025|Part 6 Period 2 (Day 1)|Other|0|||
155330884|NCT05580003|560645538|FG026|Part 6 Period 2 (Day 1)|Other|0|||
155330885|NCT05580003|560645539|FG027|Part 6 Period 2 (Day 1)|Other|0|||
155330886|NCT03516812|560645540|FG000|Overall Study|Adverse Event|4|||
155330887|NCT03516812|560645540|FG000|Overall Study|Lack of Efficacy|2|||
155330888|NCT04795167|560645541|FG000|Overall Study|Death|1|||
155330889|NCT04795167|560645542|FG001|Overall Study|Death|18|||
155330890|NCT04795167|560645543|FG002|Overall Study|Death|1|||
155330891|NCT04795167|560645541|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
155330892|NCT04795167|560645542|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
155330893|NCT04795167|560645543|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
155330894|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
155330895|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
155330896|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
155330897|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
155330898|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
155330899|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
155330900|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
155330901|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
155330902|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
155330903|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
155330904|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
155330905|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
155330906|NCT03890289|560645546|FG000|Overall Study|Adverse Event|1|||
155330907|NCT03890289|560645546|FG000|Overall Study|Physician Decision|1|||
155330908|NCT03890289|560645546|FG000|Overall Study|Lack of Efficacy|2|||
155330909|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330910|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
155330911|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330912|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
155330913|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330914|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330915|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330916|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330917|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330918|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330919|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
155330920|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330921|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330922|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330923|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330924|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330925|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330926|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
155330927|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
155330928|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330929|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330930|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
155330931|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330932|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330933|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330934|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330935|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330936|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330937|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330938|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
155330939|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
155330940|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
155330941|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
155330942|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
155330943|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
155330944|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
155330945|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330946|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330947|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
155330948|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330949|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
155330950|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330951|NCT02392234|560645553|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
155330952|NCT02392234|560645554|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330953|NCT02392234|560645555|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330954|NCT02392234|560645556|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330955|NCT02392234|560645557|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155645209|NCT04676646|561792179|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
155645210|NCT04676646|561792177|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
155330956|NCT02392234|560645558|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330957|NCT02029235|560645563|FG000|Overall Study|Non-compliance with study meds or diary|4|||
155330958|NCT02029235|560645564|FG001|Overall Study|Non-compliance with study meds or diary|1|||
155330959|NCT01387516|560645565|FG000|Overall Study|Lost to Follow-up|4|||
155330960|NCT01387516|560645566|FG001|Overall Study|Lost to Follow-up|4|||
155645211|NCT04676646|561792178|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
155645212|NCT04676646|561792179|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
155645213|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
155645214|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
155645215|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
155645216|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Death|0|||
155645217|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Death|1|||
155645218|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Death|2|||
155645219|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
155645220|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
155645221|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
155645222|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
155645223|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
155645224|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
155645225|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
155645226|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
155645227|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
155645228|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
155645229|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
155645230|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
155645231|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
155330961|NCT01387516|560645567|FG002|Overall Study|Lost to Follow-up|2|||
155330962|NCT01387516|560645568|FG003|Overall Study|Lost to Follow-up|3|||
155330963|NCT01387516|560645565|FG000|Overall Study|Withdrawal by Subject|1|||
155330964|NCT01387516|560645566|FG001|Overall Study|Withdrawal by Subject|1|||
155330965|NCT01387516|560645567|FG002|Overall Study|Withdrawal by Subject|2|||
155330966|NCT01387516|560645568|FG003|Overall Study|Withdrawal by Subject|0|||
155330967|NCT01387516|560645565|FG000|Overall Study|Death|0|||
155330968|NCT01387516|560645566|FG001|Overall Study|Death|0|||
155330969|NCT01387516|560645567|FG002|Overall Study|Death|0|||
155330970|NCT01387516|560645568|FG003|Overall Study|Death|1|||
155330971|NCT03582475|560645569|FG000|Treatment Period|Withdrawal by Subject|0|||
155330972|NCT03582475|560645570|FG001|Treatment Period|Withdrawal by Subject|1|||
155330973|NCT03582475|560645569|FG000|Follow-up Period|Withdrawal by Subject|0|||
155330974|NCT03582475|560645570|FG001|Follow-up Period|Withdrawal by Subject|1|||
155330975|NCT03170648|560645572|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
155330976|NCT03170648|560645572|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
155330977|NCT02052440|560645573|FG000|Overall Study|Withdrawal by Subject|0|||
155330978|NCT02052440|560645574|FG001|Overall Study|Withdrawal by Subject|1|||
155330979|NCT03509909|560645575|FG000|Overall Study|Withdrawal by Subject|16|||
155330980|NCT03509909|560645576|FG001|Overall Study|Withdrawal by Subject|9|||
155330981|NCT03509909|560645575|FG000|Overall Study|Lost to Follow-up|3|||
155330982|NCT03509909|560645576|FG001|Overall Study|Lost to Follow-up|4|||
155330983|NCT03509909|560645575|FG000|Overall Study|Adverse Event|2|||
155330984|NCT03509909|560645576|FG001|Overall Study|Adverse Event|0|||
155330985|NCT01400958|560645577|FG000|Overall Study|Physician Decision|0|||
155330986|NCT01400958|560645578|FG001|Overall Study|Physician Decision|1|||
155330987|NCT01400958|560645577|FG000|Overall Study|Withdrawal by Subject|0|||
155330988|NCT01400958|560645578|FG001|Overall Study|Withdrawal by Subject|1|||
155330989|NCT01400958|560645577|FG000|Overall Study|Adverse Event|1|||
155330990|NCT01400958|560645578|FG001|Overall Study|Adverse Event|0|||
155330991|NCT04436289|560645579|FG000|Overall Study|Death prior to hospital discharge|8|||
155330992|NCT04436289|560645580|FG001|Overall Study|Death prior to hospital discharge|5|||
155330993|NCT04436289|560645581|FG002|Overall Study|Death prior to hospital discharge|0|||
155330994|NCT04436289|560645582|FG003|Overall Study|Death prior to hospital discharge|1|||
155330995|NCT04436289|560645579|FG000|Overall Study|Withdrawal by Subject|0|||
155330996|NCT04436289|560645580|FG001|Overall Study|Withdrawal by Subject|1|||
155330997|NCT04436289|560645581|FG002|Overall Study|Withdrawal by Subject|4|||
155330998|NCT04436289|560645582|FG003|Overall Study|Withdrawal by Subject|0|||
155330999|NCT04436289|560645579|FG000|Overall Study|Extended hospital stay|0|||
155331000|NCT04436289|560645580|FG001|Overall Study|Extended hospital stay|1|||
155331001|NCT04436289|560645581|FG002|Overall Study|Extended hospital stay|0|||
155331002|NCT04436289|560645582|FG003|Overall Study|Extended hospital stay|0|||
155331003|NCT04436289|560645579|FG000|Overall Study|Lost to Follow-up|0|||
155331004|NCT04436289|560645580|FG001|Overall Study|Lost to Follow-up|4|||
155331005|NCT04436289|560645581|FG002|Overall Study|Lost to Follow-up|1|||
155331006|NCT04436289|560645582|FG003|Overall Study|Lost to Follow-up|3|||
155331007|NCT04801420|560645589|FG000|Overall Study|Other|1|||
155331008|NCT04801420|560645590|FG001|Overall Study|Other|2|||
155331009|NCT04801420|560645591|FG002|Overall Study|Other|1|||
155331010|NCT04801420|560645589|FG000|Overall Study|Lost to Follow-up|7|||
155331011|NCT04801420|560645590|FG001|Overall Study|Lost to Follow-up|9|||
155331012|NCT04801420|560645591|FG002|Overall Study|Lost to Follow-up|10|||
155331013|NCT04801420|560645589|FG000|Overall Study|Moved from study area|0|||
155331014|NCT04801420|560645590|FG001|Overall Study|Moved from study area|1|||
155331015|NCT04801420|560645591|FG002|Overall Study|Moved from study area|1|||
155331016|NCT04801420|560645589|FG000|Overall Study|Withdrawal by Subject|5|||
155331017|NCT04801420|560645590|FG001|Overall Study|Withdrawal by Subject|1|||
155331018|NCT04801420|560645591|FG002|Overall Study|Withdrawal by Subject|4|||
155331019|NCT04801420|560645589|FG000|Overall Study|Individual stopping criteria reached|0|||
155331020|NCT04801420|560645590|FG001|Overall Study|Individual stopping criteria reached|1|||
155331021|NCT04801420|560645591|FG002|Overall Study|Individual stopping criteria reached|0|||
155331022|NCT04801420|560645589|FG000|Overall Study|Ongoing in the study|195|||
155331023|NCT04801420|560645590|FG001|Overall Study|Ongoing in the study|195|||
155331024|NCT04801420|560645591|FG002|Overall Study|Ongoing in the study|192|||
155331025|NCT03598907|560645592|FG000|Overall Study|Physician Decision|14|||
155331026|NCT03598907|560645593|FG001|Overall Study|Physician Decision|19|||
155331027|NCT02078648|560645596|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
155331028|NCT02078648|560645597|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
155331029|NCT02078648|560645596|FG000|Overall Study|Adverse Event|0|||
155331030|NCT02078648|560645597|FG001|Overall Study|Adverse Event|1|||
155331031|NCT02078648|560645596|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
155331032|NCT02078648|560645597|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
155331033|NCT02078648|560645596|FG000|Overall Study|Withdrawal by Subject|3|||
155331034|NCT02078648|560645597|FG001|Overall Study|Withdrawal by Subject|1|||
155331035|NCT02078648|560645596|FG000|Overall Study|Investigator Decision|5|||
155331036|NCT02078648|560645597|FG001|Overall Study|Investigator Decision|7|||
155331037|NCT02078648|560645596|FG000|Overall Study|Death|1|||
155331038|NCT02078648|560645597|FG001|Overall Study|Death|1|||
155331039|NCT02078648|560645596|FG000|Overall Study|Undefined|0|||
155331040|NCT02078648|560645597|FG001|Overall Study|Undefined|1|||
155331041|NCT04088227|560645598|FG000|Overall Study|Withdrawal by Subject|1|||
155331042|NCT04088227|560645599|FG001|Overall Study|Withdrawal by Subject|0|||
155331043|NCT04088227|560645598|FG000|Overall Study|Surgery postponed >5weeks|1|||
155331044|NCT04088227|560645599|FG001|Overall Study|Surgery postponed >5weeks|0|||
155331045|NCT01675492|560645600|FG000|Overall Study|study completed early - product approval|42|||
155331046|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
155331047|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
155331048|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
155331049|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
155331050|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
155331051|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
155331052|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
155331053|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
155331054|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331055|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331056|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
155331057|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
155331058|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
155331059|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331060|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
155331061|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
155331062|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
155331063|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
155331064|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
155331065|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
155331066|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
155331067|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155421905|NCT00706628|560974389|FG002|Overall Study|Consent withdrawn|3|||
155331068|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331069|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331070|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331071|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331072|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
155331073|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
155331074|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
155331075|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331076|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331077|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331078|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331079|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331080|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
155331081|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331082|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331083|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331084|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331085|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331086|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
155331087|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
155331088|NCT03656718|560645601|FG000|Treatment Period Part C|Disease progression|0|||
155331089|NCT03656718|560645602|FG001|Treatment Period Part C|Disease progression|0|||
155331090|NCT03656718|560645603|FG002|Treatment Period Part C|Disease progression|0|||
155331091|NCT03656718|560645604|FG003|Treatment Period Part C|Disease progression|0|||
155331092|NCT03656718|560645605|FG004|Treatment Period Part C|Disease progression|12|||
155331093|NCT03656718|560645606|FG005|Treatment Period Part C|Disease progression|0|||
155331094|NCT03656718|560645607|FG006|Treatment Period Part C|Disease progression|0|||
155331095|NCT03656718|560645601|FG000|Treatment Period Part C|Death|0|||
155331096|NCT03656718|560645602|FG001|Treatment Period Part C|Death|0|||
155331097|NCT03656718|560645603|FG002|Treatment Period Part C|Death|0|||
155331098|NCT03656718|560645604|FG003|Treatment Period Part C|Death|0|||
155331099|NCT03656718|560645605|FG004|Treatment Period Part C|Death|1|||
155331100|NCT03656718|560645606|FG005|Treatment Period Part C|Death|0|||
155331101|NCT03656718|560645607|FG006|Treatment Period Part C|Death|0|||
155331102|NCT03656718|560645601|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331103|NCT03656718|560645602|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331104|NCT03656718|560645603|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331105|NCT03656718|560645604|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331106|NCT03656718|560645605|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
155331107|NCT03656718|560645606|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331108|NCT03656718|560645607|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331109|NCT03656718|560645601|FG000|Treatment Period Part C|Other reasons|0|||
155331110|NCT03656718|560645602|FG001|Treatment Period Part C|Other reasons|0|||
155331111|NCT03656718|560645603|FG002|Treatment Period Part C|Other reasons|0|||
155331112|NCT03656718|560645604|FG003|Treatment Period Part C|Other reasons|0|||
155331113|NCT03656718|560645605|FG004|Treatment Period Part C|Other reasons|1|||
155331114|NCT03656718|560645606|FG005|Treatment Period Part C|Other reasons|0|||
155331115|NCT03656718|560645607|FG006|Treatment Period Part C|Other reasons|0|||
155331116|NCT03656718|560645601|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
155331117|NCT03656718|560645602|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
155331118|NCT03656718|560645603|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
155331119|NCT03656718|560645604|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
155331120|NCT03656718|560645605|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
155331121|NCT03656718|560645606|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
155331122|NCT03656718|560645607|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
155331123|NCT03211247|560645608|FG000|Overall Study|Adverse Event|8|||
155331124|NCT03211247|560645609|FG001|Overall Study|Adverse Event|0|||
155331125|NCT03211247|560645610|FG002|Overall Study|Adverse Event|1|||
155502562|NCT01640964|561265548|FG001|Overall Study|Protocol Deviation|1|||
155502563|NCT01640964|561265549|FG002|Overall Study|Protocol Deviation|2|||
155331126|NCT03211247|560645611|FG003|Overall Study|Adverse Event|0|||
155331127|NCT03211247|560645612|FG004|Overall Study|Adverse Event|0|||
155331128|NCT03211247|560645608|FG000|Overall Study|Lost to Follow-up|2|||
155331129|NCT03211247|560645609|FG001|Overall Study|Lost to Follow-up|1|||
155502564|NCT02464059|561267233|FG000|Overall Study|Lost to Follow-up|6|||
155331130|NCT03211247|560645610|FG002|Overall Study|Lost to Follow-up|0|||
155502565|NCT02499406|561267236|FG000|Overall Study|missed 3 treatment sessions|4|||
155331131|NCT03211247|560645611|FG003|Overall Study|Lost to Follow-up|0|||
155331132|NCT03211247|560645612|FG004|Overall Study|Lost to Follow-up|0|||
155331133|NCT03211247|560645608|FG000|Overall Study|Physician Decision|1|||
155331134|NCT03211247|560645609|FG001|Overall Study|Physician Decision|2|||
155331135|NCT03211247|560645610|FG002|Overall Study|Physician Decision|0|||
155331136|NCT03211247|560645611|FG003|Overall Study|Physician Decision|0|||
155331137|NCT03211247|560645612|FG004|Overall Study|Physician Decision|0|||
155331138|NCT03211247|560645608|FG000|Overall Study|Non-compliance with study drug|2|||
155331139|NCT03211247|560645609|FG001|Overall Study|Non-compliance with study drug|0|||
155331140|NCT03211247|560645610|FG002|Overall Study|Non-compliance with study drug|0|||
155331141|NCT03211247|560645611|FG003|Overall Study|Non-compliance with study drug|0|||
155331142|NCT03211247|560645612|FG004|Overall Study|Non-compliance with study drug|0|||
155331143|NCT03211247|560645608|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
155331144|NCT03211247|560645609|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
155331145|NCT03211247|560645610|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
155331146|NCT03211247|560645611|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
155331147|NCT03211247|560645612|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
155331148|NCT03211247|560645608|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
155331149|NCT03211247|560645609|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
155331150|NCT03211247|560645610|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
155331151|NCT03211247|560645611|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
155331152|NCT03211247|560645612|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
155331153|NCT03211247|560645608|FG000|Overall Study|Protocol Violation|0|||
155331154|NCT03211247|560645609|FG001|Overall Study|Protocol Violation|1|||
155331155|NCT03211247|560645610|FG002|Overall Study|Protocol Violation|0|||
155331156|NCT03211247|560645611|FG003|Overall Study|Protocol Violation|0|||
155331157|NCT03211247|560645612|FG004|Overall Study|Protocol Violation|0|||
155331158|NCT01855750|560645613|FG000|Overall Study|Death|78|||
155331159|NCT01855750|560645614|FG001|Overall Study|Death|78|||
155331160|NCT01855750|560645613|FG000|Overall Study|Lost to Follow-up|9|||
155331161|NCT01855750|560645614|FG001|Overall Study|Lost to Follow-up|23|||
155331162|NCT01855750|560645613|FG000|Overall Study|Withdrawal by Subject|35|||
155331163|NCT01855750|560645614|FG001|Overall Study|Withdrawal by Subject|28|||
155331164|NCT01855750|560645613|FG000|Overall Study|Sponsor ends the study|297|||
155331165|NCT01855750|560645614|FG001|Overall Study|Sponsor ends the study|290|||
155331166|NCT05379270|560645615|FG000|Overall Study|Withdrawal by Subject|1|||
155331167|NCT05379270|560645616|FG001|Overall Study|Withdrawal by Subject|1|||
155331168|NCT03160885|560645617|FG000|Initial Treatment Period|Not dosed|2|||
155331169|NCT03160885|560645618|FG001|Initial Treatment Period|Not dosed|0|||
155331170|NCT03160885|560645619|FG002|Initial Treatment Period|Not dosed|0|||
155331171|NCT03160885|560645620|FG003|Initial Treatment Period|Not dosed|0|||
155331172|NCT03160885|560645621|FG004|Initial Treatment Period|Not dosed|0|||
155331173|NCT03160885|560645622|FG005|Initial Treatment Period|Not dosed|0|||
155331174|NCT03160885|560645623|FG006|Initial Treatment Period|Not dosed|0|||
155331175|NCT03160885|560645617|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
155331176|NCT03160885|560645618|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
155331177|NCT03160885|560645619|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331178|NCT03160885|560645620|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331179|NCT03160885|560645621|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331180|NCT03160885|560645622|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331181|NCT03160885|560645623|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331182|NCT03160885|560645617|FG000|Open-label Treatment|Not dosed|0|||
155331183|NCT03160885|560645618|FG001|Open-label Treatment|Not dosed|0|||
155331184|NCT03160885|560645619|FG002|Open-label Treatment|Not dosed|0|||
155331185|NCT03160885|560645620|FG003|Open-label Treatment|Not dosed|0|||
155331186|NCT03160885|560645621|FG004|Open-label Treatment|Not dosed|0|||
155331187|NCT03160885|560645622|FG005|Open-label Treatment|Not dosed|0|||
155331188|NCT03160885|560645623|FG006|Open-label Treatment|Not dosed|2|||
155331189|NCT03160885|560645617|FG000|Open-label Treatment|Discontinued IMP|0|||
155331190|NCT03160885|560645618|FG001|Open-label Treatment|Discontinued IMP|0|||
155331191|NCT03160885|560645619|FG002|Open-label Treatment|Discontinued IMP|0|||
155331192|NCT03160885|560645620|FG003|Open-label Treatment|Discontinued IMP|0|||
155331193|NCT03160885|560645621|FG004|Open-label Treatment|Discontinued IMP|0|||
155331194|NCT03160885|560645622|FG005|Open-label Treatment|Discontinued IMP|0|||
155331195|NCT03160885|560645623|FG006|Open-label Treatment|Discontinued IMP|131|||
155331196|NCT03160885|560645617|FG000|Open-label Treatment|Completed Week 50|0|||
155331197|NCT03160885|560645618|FG001|Open-label Treatment|Completed Week 50|0|||
155331198|NCT03160885|560645619|FG002|Open-label Treatment|Completed Week 50|0|||
155331199|NCT03160885|560645620|FG003|Open-label Treatment|Completed Week 50|0|||
155331200|NCT03160885|560645621|FG004|Open-label Treatment|Completed Week 50|0|||
155331201|NCT03160885|560645622|FG005|Open-label Treatment|Completed Week 50|0|||
155331202|NCT03160885|560645623|FG006|Open-label Treatment|Completed Week 50|4|||
155331203|NCT03160885|560645617|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331204|NCT03160885|560645618|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331205|NCT03160885|560645619|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331206|NCT03160885|560645620|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
155331207|NCT03160885|560645621|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331208|NCT03160885|560645622|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331209|NCT03160885|560645623|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331210|NCT03160885|560645617|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
155331211|NCT03160885|560645618|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
155331212|NCT03160885|560645619|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
155331213|NCT03160885|560645620|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
155331214|NCT03160885|560645621|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
155331215|NCT03160885|560645622|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
155331216|NCT03160885|560645623|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
155331217|NCT03160885|560645617|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331218|NCT03160885|560645618|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331219|NCT03160885|560645619|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
155331220|NCT03160885|560645620|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
155331221|NCT03160885|560645621|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
155331222|NCT03160885|560645622|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
155331223|NCT03160885|560645623|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331224|NCT03160885|560645617|FG000|Maintenance Treatment Period|Completed Week 50|0|||
155331225|NCT03160885|560645618|FG001|Maintenance Treatment Period|Completed Week 50|0|||
155331226|NCT03160885|560645619|FG002|Maintenance Treatment Period|Completed Week 50|1|||
155331227|NCT03160885|560645620|FG003|Maintenance Treatment Period|Completed Week 50|0|||
155331228|NCT03160885|560645621|FG004|Maintenance Treatment Period|Completed Week 50|0|||
155331229|NCT03160885|560645622|FG005|Maintenance Treatment Period|Completed Week 50|0|||
155331230|NCT03160885|560645623|FG006|Maintenance Treatment Period|Completed Week 50|0|||
155331231|NCT03610581|560645624|FG000|Overall Study|Study terminated by sponsor|2|||
155331232|NCT03610581|560645625|FG001|Overall Study|Study terminated by sponsor|0|||
155331233|NCT03610581|560645624|FG000|Overall Study|Other|0|||
155331234|NCT03610581|560645625|FG001|Overall Study|Other|1|||
155331235|NCT03610581|560645624|FG000|Overall Study|Withdrawal by Subject|1|||
155331236|NCT03610581|560645625|FG001|Overall Study|Withdrawal by Subject|0|||
155331237|NCT02307682|560645626|FG000|Overall Study|Adverse Event|9|||
155331238|NCT02307682|560645627|FG001|Overall Study|Adverse Event|8|||
155331239|NCT02307682|560645628|FG002|Overall Study|Adverse Event|12|||
155331240|NCT02307682|560645626|FG000|Overall Study|Lack of Efficacy|1|||
155331241|NCT02307682|560645627|FG001|Overall Study|Lack of Efficacy|0|||
155331242|NCT02307682|560645628|FG002|Overall Study|Lack of Efficacy|1|||
155331243|NCT02307682|560645626|FG000|Overall Study|Physician Decision|2|||
155331244|NCT02307682|560645627|FG001|Overall Study|Physician Decision|2|||
155331245|NCT02307682|560645628|FG002|Overall Study|Physician Decision|8|||
155331246|NCT02307682|560645626|FG000|Overall Study|Progressive Disease|1|||
155331247|NCT02307682|560645627|FG001|Overall Study|Progressive Disease|0|||
155331248|NCT02307682|560645628|FG002|Overall Study|Progressive Disease|0|||
155331249|NCT02307682|560645626|FG000|Overall Study|Withdrawal by Subject|26|||
155331250|NCT02307682|560645627|FG001|Overall Study|Withdrawal by Subject|34|||
155331251|NCT02307682|560645628|FG002|Overall Study|Withdrawal by Subject|23|||
155331252|NCT02307682|560645626|FG000|Overall Study|Death|9|||
155331253|NCT02307682|560645627|FG001|Overall Study|Death|7|||
155331254|NCT02307682|560645628|FG002|Overall Study|Death|12|||
155331255|NCT02307682|560645626|FG000|Overall Study|Lost to Follow-up|1|||
155331256|NCT02307682|560645627|FG001|Overall Study|Lost to Follow-up|5|||
155645232|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
155331257|NCT02307682|560645628|FG002|Overall Study|Lost to Follow-up|6|||
155331258|NCT02307682|560645626|FG000|Overall Study|Protocol Deviation|0|||
155331259|NCT02307682|560645627|FG001|Overall Study|Protocol Deviation|0|||
155331260|NCT02307682|560645628|FG002|Overall Study|Protocol Deviation|2|||
155331261|NCT02307682|560645626|FG000|Overall Study|Other|1|||
155331262|NCT02307682|560645627|FG001|Overall Study|Other|1|||
155331263|NCT02307682|560645628|FG002|Overall Study|Other|0|||
155331264|NCT03367156|560646919|FG000|Overall Study|Lack of interest|3|||
155331265|NCT03367156|560646920|FG001|Overall Study|Lack of interest|1|||
155331266|NCT03367156|560646919|FG000|Overall Study|Death|2|||
155331267|NCT03367156|560646920|FG001|Overall Study|Death|0|||
155331268|NCT03367156|560646919|FG000|Overall Study|Lost to Follow-up|2|||
155331269|NCT03367156|560646920|FG001|Overall Study|Lost to Follow-up|1|||
155331270|NCT03367156|560646919|FG000|Overall Study|Became ineligible|1|||
155331271|NCT03367156|560646920|FG001|Overall Study|Became ineligible|2|||
155331272|NCT03367156|560646919|FG000|Overall Study|Hospitalization|1|||
155331273|NCT03367156|560646920|FG001|Overall Study|Hospitalization|0|||
155331274|NCT03367156|560646919|FG000|Overall Study|Concerned about Treatment|11|||
155331275|NCT03367156|560646920|FG001|Overall Study|Concerned about Treatment|3|||
155331276|NCT03367156|560646919|FG000|Overall Study|Started new treatment|4|||
155331277|NCT03367156|560646920|FG001|Overall Study|Started new treatment|1|||
155331278|NCT03762850|560646921|FG000|Overall Study|Death|0|||
155331279|NCT03762850|560646922|FG001|Overall Study|Death|1|||
155331280|NCT03762850|560646921|FG000|Overall Study|Lost to Follow-up|0|||
155331281|NCT03762850|560646922|FG001|Overall Study|Lost to Follow-up|1|||
155331282|NCT03762850|560646921|FG000|Overall Study|Physician Decision|0|||
155331283|NCT03762850|560646922|FG001|Overall Study|Physician Decision|1|||
155331284|NCT03762850|560646921|FG000|Overall Study|Withdrawal by Subject|4|||
155331285|NCT03762850|560646922|FG001|Overall Study|Withdrawal by Subject|9|||
155331286|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
155331287|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
155331288|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331289|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331290|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331291|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
155331292|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
155331293|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
155331294|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
155331295|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
155331296|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
155331297|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
155331298|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331299|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331300|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331301|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331302|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
155331303|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331304|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331305|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155421906|NCT00706628|560974390|FG003|Overall Study|Consent withdrawn|0|||
155421907|NCT00706628|560974387|FG000|Overall Study|Progressive disease|20|||
155645233|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
155650639|NCT02006654|561812521|FG000|Overall Study|Withdrawal before treatment|4|||
155331306|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
155331307|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
155331308|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331309|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331310|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331311|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other|1|||
155331312|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other|0|||
155331313|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other|0|||
155331314|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other|0|||
155331315|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other|0|||
155331316|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
155331317|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
155421908|NCT00706628|560974388|FG001|Overall Study|Progressive disease|13|||
155331318|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331319|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331320|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331321|NCT03002194|560646932|FG000|Overall Study|Lost to Follow-up|6|||
155331322|NCT03002194|560646932|FG000|Overall Study|Adverse Event|1|||
155331323|NCT03002194|560646932|FG000|Overall Study|Lack of Efficacy|1|||
155331324|NCT03002194|560646932|FG000|Overall Study|Withdrawal by Subject|2|||
155331325|NCT02200705|560646933|FG000|Overall Study|Excluded|12|||
155331326|NCT02200705|560646933|FG000|Overall Study|Death|21|||
155331327|NCT02200705|560646933|FG000|Overall Study|Withdrawal by Subject|22|||
155331328|NCT02200705|560646933|FG000|Overall Study|Lost to Follow-up|13|||
155331329|NCT02200705|560646933|FG000|Overall Study|Physician Decision|5|||
155331330|NCT02200705|560646933|FG000|Overall Study|Adverse Event|2|||
155331331|NCT05250115|560646934|FG000|Overall Study|Premature study end|40|||
155331332|NCT05250115|560646934|FG000|Overall Study|Adverse Event|8|||
155331333|NCT05250115|560646934|FG000|Overall Study|Lost to Follow-up|7|||
155331334|NCT05250115|560646934|FG000|Overall Study|Withdrawal by Subject|6|||
155331335|NCT05250115|560646934|FG000|Overall Study|Withdrawal of informed consent|1|||
155331336|NCT05250115|560646934|FG000|Overall Study|Other|7|||
155331337|NCT02633215|560646938|FG000|Overall Study|Lost to Follow-up|2|||
155331338|NCT02633215|560646939|FG001|Overall Study|Lost to Follow-up|3|||
155331339|NCT00754325|560646940|FG000|Initial Treatment|Continuing Active Treatment|4|||
155331340|NCT00754325|560646941|FG001|Initial Treatment|Continuing Active Treatment|5|||
155331341|NCT00754325|560646940|FG000|Initial Treatment|Adverse Event|7|||
155331342|NCT00754325|560646941|FG001|Initial Treatment|Adverse Event|6|||
155331343|NCT00754325|560646940|FG000|Initial Treatment|Withdrawal by Subject|2|||
155331344|NCT00754325|560646941|FG001|Initial Treatment|Withdrawal by Subject|2|||
155331345|NCT00754325|560646940|FG000|Initial Treatment|Physician Decision|2|||
155331346|NCT00754325|560646941|FG001|Initial Treatment|Physician Decision|0|||
155331347|NCT00754325|560646940|FG000|Initial Treatment|Sponsor Request|0|||
155331348|NCT00754325|560646941|FG001|Initial Treatment|Sponsor Request|1|||
155331349|NCT00754325|560646940|FG000|Initial Treatment|Disease Progression|35|||
155331350|NCT00754325|560646941|FG001|Initial Treatment|Disease Progression|35|||
155331351|NCT03801148|560646942|FG000|Period 1 (2 Days)|Adverse Event|1|||
155331352|NCT03801148|560646943|FG001|Period 1 (2 Days)|Adverse Event|1|||
155331353|NCT03801148|560646944|FG002|Period 1 (2 Days)|Adverse Event|0|||
155331354|NCT03801148|560646945|FG003|Period 1 (2 Days)|Adverse Event|0|||
155331355|NCT03801148|560646942|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331356|NCT03801148|560646943|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331357|NCT03801148|560646944|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331358|NCT03801148|560646945|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
155331359|NCT03801148|560646942|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331360|NCT03801148|560646943|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331361|NCT03801148|560646944|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
155331362|NCT03801148|560646945|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331363|NCT03801148|560646942|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
155331364|NCT03801148|560646943|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
155331365|NCT03801148|560646944|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
155331366|NCT03801148|560646945|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
155331367|NCT06212752|560646946|FG000|Overall Study|Death|5|||
155331368|NCT06212752|560646947|FG001|Overall Study|Death|3|||
155331369|NCT06212752|560646946|FG000|Overall Study|Participants ongoing|23|||
155331370|NCT06212752|560646947|FG001|Overall Study|Participants ongoing|8|||
155331371|NCT04162210|560646948|FG000|Overall Study|Lost to Follow-up|4|||
155331372|NCT04162210|560646949|FG001|Overall Study|Lost to Follow-up|1|||
155331373|NCT04162210|560646948|FG000|Overall Study|Withdrawal by Subject|17|||
155331374|NCT04162210|560646949|FG001|Overall Study|Withdrawal by Subject|9|||
155331375|NCT04162210|560646948|FG000|Overall Study|Ongoing|113|||
155331376|NCT04162210|560646949|FG001|Overall Study|Ongoing|59|||
155331377|NCT00371345|560646950|FG000|Overall Study|Disease Progression|21|||
155331378|NCT00371345|560646951|FG001|Overall Study|Disease Progression|35|||
155331379|NCT00371345|560646950|FG000|Overall Study|Study Drug Toxicity|1|||
155331380|NCT00371345|560646951|FG001|Overall Study|Study Drug Toxicity|7|||
155331381|NCT00371345|560646950|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
155331382|NCT00371345|560646951|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
155331383|NCT00371345|560646950|FG000|Overall Study|Participant Request|1|||
155331384|NCT00371345|560646951|FG001|Overall Study|Participant Request|1|||
155331385|NCT00371345|560646950|FG000|Overall Study|Participant Withdrew Consent|0|||
155331386|NCT00371345|560646951|FG001|Overall Study|Participant Withdrew Consent|1|||
155331387|NCT00705406|560646952|FG000|Overall Study|Lost to Follow-up|3|||
155331388|NCT00705406|560646953|FG001|Overall Study|Lost to Follow-up|3|||
155331389|NCT00705406|560646952|FG000|Overall Study|Did not receive study drug|1|||
155331390|NCT00705406|560646953|FG001|Overall Study|Did not receive study drug|2|||
155331391|NCT01779700|560646954|FG000|Overall Study|Adverse Event|4|||
155331392|NCT01779700|560646955|FG001|Overall Study|Adverse Event|3|||
155331393|NCT01779700|560646954|FG000|Overall Study|Withdrawal by Subject|0|||
155331394|NCT01779700|560646955|FG001|Overall Study|Withdrawal by Subject|2|||
155331395|NCT00442104|560646956|FG000|Overall Study|Adverse Event|5|||
155331396|NCT00442104|560646956|FG000|Overall Study|Death|2|||
155331397|NCT00442104|560646956|FG000|Overall Study|Lost to Follow-up|3|||
155331398|NCT00442104|560646956|FG000|Overall Study|Withdrawal by Subject|5|||
155331399|NCT00442104|560646956|FG000|Overall Study|Insufficient Clinical Response|10|||
155331400|NCT00442104|560646956|FG000|Overall Study|Other|21|||
155331401|NCT00442104|560646956|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
155331402|NCT00918333|560646959|FG000|Overall Study|Drug not taken per protocol|1|||
155331403|NCT00918333|560646960|FG001|Overall Study|Drug not taken per protocol|0|||
155331404|NCT00918333|560646959|FG000|Overall Study|Inadequate amount of drugs provided|1|||
155331405|NCT00918333|560646960|FG001|Overall Study|Inadequate amount of drugs provided|4|||
155331406|NCT00918333|560646959|FG000|Overall Study|Ineligible|1|||
155331407|NCT00918333|560646960|FG001|Overall Study|Ineligible|0|||
155331408|NCT00918333|560646959|FG000|Overall Study|Withdrawal by Subject|0|||
155331409|NCT00918333|560646960|FG001|Overall Study|Withdrawal by Subject|1|||
155331410|NCT04497415|560646961|FG000|Overall Study|Lost to Follow-up|43|||
155331411|NCT04497415|560646962|FG001|Overall Study|Lost to Follow-up|27|||
155331412|NCT00263757|560646963|FG000|Overall Study|Withdrawal by Subject|5|||
155331413|NCT00263757|560646964|FG001|Overall Study|Withdrawal by Subject|4|||
155331414|NCT00263757|560646963|FG000|Overall Study|Screen failure|0|||
155331415|NCT00263757|560646964|FG001|Overall Study|Screen failure|1|||
155331416|NCT00263757|560646963|FG000|Overall Study|Adverse Event|3|||
155331417|NCT00263757|560646964|FG001|Overall Study|Adverse Event|3|||
155331418|NCT00713596|560646965|FG000|Overall Study|Study was terminated|2|||
155331419|NCT00713596|560646966|FG001|Overall Study|Study was terminated|3|||
155331420|NCT00713596|560646967|FG002|Overall Study|Study was terminated|2|||
155331421|NCT03712371|560646968|FG000|Overall Study|Lack of Efficacy|0|||
155331422|NCT03712371|560646969|FG001|Overall Study|Lack of Efficacy|0|||
155331423|NCT03712371|560646970|FG002|Overall Study|Lack of Efficacy|0|||
155331424|NCT03712371|560646971|FG003|Overall Study|Lack of Efficacy|1|||
155331425|NCT02463448|560646976|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
155331426|NCT02463448|560646976|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
155331427|NCT02463448|560646976|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
155331428|NCT02463448|560646976|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
155331429|NCT03021993|560646982|FG000|Overall Study|Withdrawal by Subject|4|||
155331430|NCT03021993|560646982|FG000|Overall Study|Physician Decision|1|||
155331431|NCT03021993|560646982|FG000|Overall Study|enrolled but were not treated|1|||
155331432|NCT03021993|560646982|FG000|Overall Study|Death|3|||
155331433|NCT02816398|560646995|FG000|Overall Study|Death|5|||
155331434|NCT02816398|560646995|FG000|Overall Study|Lack of Efficacy|8|||
155331435|NCT02816398|560646995|FG000|Overall Study|Lost to Follow-up|1|||
155331436|NCT02499328|560647001|FG000|Overall Study|Withdrawal by Subject|1|||
155331437|NCT02499328|560647002|FG001|Overall Study|Withdrawal by Subject|1|||
155331438|NCT02499328|560647003|FG002|Overall Study|Withdrawal by Subject|5|||
155331439|NCT02499328|560647004|FG003|Overall Study|Withdrawal by Subject|3|||
155331440|NCT02499328|560647005|FG004|Overall Study|Withdrawal by Subject|5|||
155331441|NCT02499328|560647006|FG005|Overall Study|Withdrawal by Subject|0|||
155331442|NCT02499328|560647007|FG006|Overall Study|Withdrawal by Subject|0|||
155331443|NCT02499328|560647008|FG007|Overall Study|Withdrawal by Subject|0|||
155331444|NCT02499328|560647009|FG008|Overall Study|Withdrawal by Subject|2|||
155331445|NCT02499328|560647010|FG009|Overall Study|Withdrawal by Subject|2|||
155331446|NCT02499328|560647011|FG010|Overall Study|Withdrawal by Subject|0|||
155331447|NCT02499328|560647012|FG011|Overall Study|Withdrawal by Subject|3|||
155331448|NCT02499328|560647013|FG012|Overall Study|Withdrawal by Subject|7|||
155331449|NCT02499328|560647014|FG013|Overall Study|Withdrawal by Subject|3|||
155331450|NCT02499328|560647015|FG014|Overall Study|Withdrawal by Subject|1|||
155331451|NCT02499328|560647016|FG015|Overall Study|Withdrawal by Subject|0|||
155331452|NCT02499328|560647017|FG016|Overall Study|Withdrawal by Subject|0|||
155331453|NCT02499328|560647018|FG017|Overall Study|Withdrawal by Subject|3|||
155331454|NCT02499328|560647019|FG018|Overall Study|Withdrawal by Subject|0|||
155331455|NCT02499328|560647001|FG000|Overall Study|Lost to Follow-up|0|||
155331456|NCT02499328|560647002|FG001|Overall Study|Lost to Follow-up|1|||
155331457|NCT02499328|560647003|FG002|Overall Study|Lost to Follow-up|1|||
155331458|NCT02499328|560647004|FG003|Overall Study|Lost to Follow-up|2|||
155331459|NCT02499328|560647005|FG004|Overall Study|Lost to Follow-up|0|||
155331460|NCT02499328|560647006|FG005|Overall Study|Lost to Follow-up|0|||
155331461|NCT02499328|560647007|FG006|Overall Study|Lost to Follow-up|0|||
155331462|NCT02499328|560647008|FG007|Overall Study|Lost to Follow-up|2|||
155331463|NCT02499328|560647009|FG008|Overall Study|Lost to Follow-up|3|||
155331464|NCT02499328|560647010|FG009|Overall Study|Lost to Follow-up|0|||
155331465|NCT02499328|560647011|FG010|Overall Study|Lost to Follow-up|0|||
155331466|NCT02499328|560647012|FG011|Overall Study|Lost to Follow-up|0|||
155331467|NCT02499328|560647013|FG012|Overall Study|Lost to Follow-up|0|||
155331468|NCT02499328|560647014|FG013|Overall Study|Lost to Follow-up|0|||
155331469|NCT02499328|560647015|FG014|Overall Study|Lost to Follow-up|0|||
155331470|NCT02499328|560647016|FG015|Overall Study|Lost to Follow-up|0|||
155331471|NCT02499328|560647017|FG016|Overall Study|Lost to Follow-up|0|||
155331472|NCT02499328|560647018|FG017|Overall Study|Lost to Follow-up|0|||
155331473|NCT02499328|560647019|FG018|Overall Study|Lost to Follow-up|1|||
155331474|NCT02499328|560647001|FG000|Overall Study|Death|0|||
155331475|NCT02499328|560647002|FG001|Overall Study|Death|3|||
155331476|NCT02499328|560647003|FG002|Overall Study|Death|3|||
155331477|NCT02499328|560647004|FG003|Overall Study|Death|2|||
155331478|NCT02499328|560647005|FG004|Overall Study|Death|4|||
155331479|NCT02499328|560647006|FG005|Overall Study|Death|7|||
155331480|NCT02499328|560647007|FG006|Overall Study|Death|3|||
155331481|NCT02499328|560647008|FG007|Overall Study|Death|0|||
155331482|NCT02499328|560647009|FG008|Overall Study|Death|2|||
155331483|NCT02499328|560647010|FG009|Overall Study|Death|6|||
155331484|NCT02499328|560647011|FG010|Overall Study|Death|6|||
155331485|NCT02499328|560647012|FG011|Overall Study|Death|20|||
155331486|NCT02499328|560647013|FG012|Overall Study|Death|9|||
155331487|NCT02499328|560647014|FG013|Overall Study|Death|7|||
155331488|NCT02499328|560647015|FG014|Overall Study|Death|3|||
155331489|NCT02499328|560647016|FG015|Overall Study|Death|1|||
155331490|NCT02499328|560647017|FG016|Overall Study|Death|1|||
155331491|NCT02499328|560647018|FG017|Overall Study|Death|16|||
155331492|NCT02499328|560647019|FG018|Overall Study|Death|5|||
155331493|NCT02499328|560647001|FG000|Overall Study|"Other"|2|||
155331494|NCT02499328|560647002|FG001|Overall Study|"Other"|2|||
155331495|NCT02499328|560647003|FG002|Overall Study|"Other"|1|||
155331496|NCT02499328|560647004|FG003|Overall Study|"Other"|3|||
155331497|NCT02499328|560647005|FG004|Overall Study|"Other"|6|||
155331498|NCT02499328|560647006|FG005|Overall Study|"Other"|2|||
155331499|NCT02499328|560647007|FG006|Overall Study|"Other"|3|||
155331500|NCT02499328|560647008|FG007|Overall Study|"Other"|4|||
155331501|NCT02499328|560647009|FG008|Overall Study|"Other"|6|||
155331502|NCT02499328|560647010|FG009|Overall Study|"Other"|16|||
155331503|NCT02499328|560647011|FG010|Overall Study|"Other"|13|||
155331504|NCT02499328|560647012|FG011|Overall Study|"Other"|31|||
155331505|NCT02499328|560647013|FG012|Overall Study|"Other"|8|||
155331506|NCT02499328|560647014|FG013|Overall Study|"Other"|7|||
155331507|NCT02499328|560647015|FG014|Overall Study|"Other"|6|||
155331508|NCT02499328|560647016|FG015|Overall Study|"Other"|0|||
155331509|NCT02499328|560647017|FG016|Overall Study|"Other"|0|||
155331510|NCT02499328|560647018|FG017|Overall Study|"Other"|34|||
155331511|NCT02499328|560647019|FG018|Overall Study|"Other"|43|||
155331512|NCT02499328|560647001|FG000|Overall Study|Disease Progression|0|||
155331513|NCT02499328|560647002|FG001|Overall Study|Disease Progression|0|||
155331514|NCT02499328|560647003|FG002|Overall Study|Disease Progression|0|||
155331515|NCT02499328|560647004|FG003|Overall Study|Disease Progression|0|||
155331516|NCT02499328|560647005|FG004|Overall Study|Disease Progression|0|||
155331517|NCT02499328|560647006|FG005|Overall Study|Disease Progression|0|||
155331518|NCT02499328|560647007|FG006|Overall Study|Disease Progression|1|||
155331519|NCT02499328|560647008|FG007|Overall Study|Disease Progression|0|||
155331520|NCT02499328|560647009|FG008|Overall Study|Disease Progression|1|||
155331521|NCT02499328|560647010|FG009|Overall Study|Disease Progression|0|||
155331522|NCT02499328|560647011|FG010|Overall Study|Disease Progression|1|||
155331523|NCT02499328|560647012|FG011|Overall Study|Disease Progression|0|||
155331524|NCT02499328|560647013|FG012|Overall Study|Disease Progression|0|||
155331525|NCT02499328|560647014|FG013|Overall Study|Disease Progression|0|||
155331526|NCT02499328|560647015|FG014|Overall Study|Disease Progression|0|||
155331527|NCT02499328|560647016|FG015|Overall Study|Disease Progression|0|||
155331528|NCT02499328|560647017|FG016|Overall Study|Disease Progression|0|||
155331529|NCT02499328|560647018|FG017|Overall Study|Disease Progression|2|||
155331530|NCT02499328|560647019|FG018|Overall Study|Disease Progression|0|||
155331531|NCT02499328|560647001|FG000|Overall Study|Adverse Event|1|||
155331532|NCT02499328|560647002|FG001|Overall Study|Adverse Event|0|||
155331533|NCT02499328|560647003|FG002|Overall Study|Adverse Event|0|||
155331534|NCT02499328|560647004|FG003|Overall Study|Adverse Event|1|||
155331535|NCT02499328|560647005|FG004|Overall Study|Adverse Event|0|||
155331536|NCT02499328|560647006|FG005|Overall Study|Adverse Event|0|||
155331537|NCT02499328|560647007|FG006|Overall Study|Adverse Event|0|||
155331538|NCT02499328|560647008|FG007|Overall Study|Adverse Event|0|||
155331539|NCT02499328|560647009|FG008|Overall Study|Adverse Event|0|||
155502566|NCT03591107|561267240|FG000|Overall Study|Same patient in both arms|1|||
155331540|NCT02499328|560647010|FG009|Overall Study|Adverse Event|0|||
155502567|NCT03591107|561267241|FG001|Overall Study|Same patient in both arms|1|||
155331541|NCT02499328|560647011|FG010|Overall Study|Adverse Event|0|||
155331542|NCT02499328|560647012|FG011|Overall Study|Adverse Event|0|||
155331543|NCT02499328|560647013|FG012|Overall Study|Adverse Event|1|||
155331544|NCT02499328|560647014|FG013|Overall Study|Adverse Event|0|||
155331545|NCT02499328|560647015|FG014|Overall Study|Adverse Event|0|||
155331546|NCT02499328|560647016|FG015|Overall Study|Adverse Event|0|||
155331547|NCT02499328|560647017|FG016|Overall Study|Adverse Event|0|||
155331548|NCT02499328|560647018|FG017|Overall Study|Adverse Event|0|||
155331549|NCT02499328|560647019|FG018|Overall Study|Adverse Event|0|||
155331550|NCT03414684|560647020|FG000|First-course Treatment|Complete response|0|||
155331551|NCT03414684|560647021|FG001|First-course Treatment|Complete response|1|||
155502568|NCT03591107|561267240|FG000|Overall Study|Sought care at other clinics|0|||
155331552|NCT03414684|560647020|FG000|First-course Treatment|Intercurrent illness|1|||
155645234|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
155331553|NCT03414684|560647021|FG001|First-course Treatment|Intercurrent illness|0|||
155331554|NCT03414684|560647020|FG000|First-course Treatment|Progressive Disease|31|||
155331555|NCT03414684|560647021|FG001|First-course Treatment|Progressive Disease|32|||
155331556|NCT03414684|560647020|FG000|First-course Treatment|Adverse Event|1|||
155645235|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
155645236|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
155331557|NCT03414684|560647021|FG001|First-course Treatment|Adverse Event|2|||
155331558|NCT03414684|560647020|FG000|First-course Treatment|Physician Decision|0|||
155331559|NCT03414684|560647021|FG001|First-course Treatment|Physician Decision|1|||
155331560|NCT03414684|560647020|FG000|First-course Treatment|Withdrawal by Subject|0|||
155331561|NCT03414684|560647021|FG001|First-course Treatment|Withdrawal by Subject|1|||
155331562|NCT03414684|560647020|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
155331563|NCT03414684|560647021|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
155331564|NCT03414684|560647020|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
155331565|NCT03414684|560647021|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
155331566|NCT03414684|560647020|FG000|First-course Treatment|Still on treatment|3|||
155331567|NCT03414684|560647021|FG001|First-course Treatment|Still on treatment|0|||
155331568|NCT03414684|560647020|FG000|First-course Treatment|Never started protocol therapy|2|||
155331569|NCT03414684|560647021|FG001|First-course Treatment|Never started protocol therapy|1|||
155331570|NCT03414684|560647020|FG000|Crossover Treatment|Progressive disease|0|||
155331571|NCT03414684|560647021|FG001|Crossover Treatment|Progressive disease|12|||
155331572|NCT03414684|560647020|FG000|Crossover Treatment|Adverse Event|0|||
155331573|NCT03414684|560647021|FG001|Crossover Treatment|Adverse Event|3|||
155331574|NCT03414684|560647020|FG000|Crossover Treatment|Physician Decision|0|||
155331575|NCT03414684|560647021|FG001|Crossover Treatment|Physician Decision|1|||
155331576|NCT03414684|560647020|FG000|Crossover Treatment|Still on treatment|0|||
155331577|NCT03414684|560647021|FG001|Crossover Treatment|Still on treatment|2|||
155331578|NCT05525572|560647022|FG000|Overall Study|Lost to Follow-up|2|||
155331579|NCT05251363|560647023|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
155331580|NCT05251363|560647023|FG000|Overall Study After Implant Period|Death|9|||
155331581|NCT05251363|560647023|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
155331582|NCT05251363|560647023|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
155331583|NCT05251363|560647023|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
155331584|NCT05251363|560647023|FG000|Overall Study After Implant Period|Physician Decision|1|||
155331585|NCT05251363|560647023|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
155331586|NCT03425682|560647024|FG000|Overall Study|Lost to Follow-up|2|||
155331587|NCT03425682|560647025|FG001|Overall Study|Lost to Follow-up|4|||
155331588|NCT03425682|560647024|FG000|Overall Study|Withdrawal by Subject|0|||
155331589|NCT03425682|560647025|FG001|Overall Study|Withdrawal by Subject|3|||
155331590|NCT03425682|560647024|FG000|Overall Study|Subject did not meet I/E|4|||
155331591|NCT03425682|560647025|FG001|Overall Study|Subject did not meet I/E|10|||
155331592|NCT04306367|560647026|FG000|Overall Study|Progression of Disease|9|||
155645237|NCT04676646|561792177|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
155331593|NCT04306367|560647026|FG000|Overall Study|Adverse Event|3|||
155331594|NCT04306367|560647026|FG000|Overall Study|Withdrawal by Subject|1|||
155331595|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
155331596|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
155331597|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
155331598|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
155331599|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
155331600|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
155331601|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
155331602|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
155331603|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
155331604|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
155331605|NCT02157116|560648489|FG000|Overall Study|Withdrawal by Subject|4|||
155331606|NCT02157116|560648489|FG000|Overall Study|Physician Decision|3|||
155645238|NCT04676646|561792178|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
155331607|NCT02157116|560648489|FG000|Overall Study|Failed Screening|2|||
155331608|NCT00975585|560648490|FG000|Overall Study|Adverse Event|0|||
155331609|NCT00975585|560648491|FG001|Overall Study|Adverse Event|4|||
155331610|NCT00975585|560648490|FG000|Overall Study|Lost to Follow-up|3|||
155331611|NCT00975585|560648491|FG001|Overall Study|Lost to Follow-up|5|||
155331612|NCT00975585|560648490|FG000|Overall Study|Withdrawal by Subject|2|||
155331613|NCT00975585|560648491|FG001|Overall Study|Withdrawal by Subject|1|||
155331614|NCT00975585|560648490|FG000|Overall Study|Lens issue|2|||
155331615|NCT00975585|560648491|FG001|Overall Study|Lens issue|2|||
155331616|NCT01953224|560648492|FG000|Overall Study|Lost to Follow-up|1|||
155331617|NCT01953224|560648493|FG001|Overall Study|Lost to Follow-up|1|||
155331618|NCT01953224|560648492|FG000|Overall Study|Withdrawal by Subject|1|||
155331619|NCT01953224|560648493|FG001|Overall Study|Withdrawal by Subject|2|||
155331620|NCT00683800|560648494|FG000|Overall Study|Adverse Event|195|||
155331621|NCT00683800|560648495|FG001|Overall Study|Adverse Event|102|||
155331622|NCT00683800|560648494|FG000|Overall Study|Death|0|||
155331623|NCT00683800|560648495|FG001|Overall Study|Death|1|||
155331624|NCT00683800|560648494|FG000|Overall Study|Lost to Follow-up|57|||
155331625|NCT00683800|560648495|FG001|Overall Study|Lost to Follow-up|44|||
155331626|NCT00683800|560648494|FG000|Overall Study|Other|5|||
155331627|NCT00683800|560648495|FG001|Overall Study|Other|2|||
155331628|NCT00683800|560648494|FG000|Overall Study|Protocol Violation|13|||
155331629|NCT00683800|560648495|FG001|Overall Study|Protocol Violation|16|||
155331630|NCT00683800|560648494|FG000|Overall Study|Withdrawal by Subject|66|||
155331631|NCT00683800|560648495|FG001|Overall Study|Withdrawal by Subject|64|||
155331632|NCT00683800|560648494|FG000|Overall Study|Lack of Efficacy|61|||
155331633|NCT00683800|560648495|FG001|Overall Study|Lack of Efficacy|104|||
155331634|NCT00683800|560648494|FG000|Overall Study|Randomized, not treated|35|||
155331635|NCT00683800|560648495|FG001|Overall Study|Randomized, not treated|33|||
155331636|NCT01359150|560648496|FG000|Overall Study|Lack of Efficacy|1|||
155331637|NCT01359150|560648497|FG001|Overall Study|Lack of Efficacy|1|||
155331638|NCT01359150|560648496|FG000|Overall Study|Withdrawal by Subject|1|||
155331639|NCT01359150|560648497|FG001|Overall Study|Withdrawal by Subject|1|||
155331640|NCT01359150|560648496|FG000|Overall Study|Adverse Event|4|||
155331641|NCT01359150|560648497|FG001|Overall Study|Adverse Event|3|||
155331642|NCT01359150|560648496|FG000|Overall Study|Other|1|||
155331643|NCT01359150|560648497|FG001|Overall Study|Other|0|||
155331644|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
155331645|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
155331646|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
155331647|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
155331648|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
155331649|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
155331650|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
155331651|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
155331652|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
155331653|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
155331654|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
155331655|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
155331656|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
155331657|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
155331658|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Death|1|||
155331659|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Death|0|||
155331660|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
155331661|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
155331662|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
155331663|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
155331664|NCT02406092|560648502|FG000|Overall Study|Screen failure|10|||
155331665|NCT02406092|560648503|FG001|Overall Study|Screen failure|7|||
155331666|NCT02406092|560648502|FG000|Overall Study|Death|22|||
155331667|NCT02406092|560648503|FG001|Overall Study|Death|5|||
155331668|NCT02406092|560648502|FG000|Overall Study|Lost to Follow-up|4|||
155331669|NCT02406092|560648503|FG001|Overall Study|Lost to Follow-up|1|||
155331670|NCT02406092|560648502|FG000|Overall Study|Adverse Event|1|||
155331671|NCT02406092|560648503|FG001|Overall Study|Adverse Event|0|||
155331672|NCT02406092|560648502|FG000|Overall Study|Withdrawal by Subject|1|||
155331673|NCT02406092|560648503|FG001|Overall Study|Withdrawal by Subject|0|||
155331674|NCT03041233|560648504|FG000|Overall Study|Death|5|||
155331675|NCT03041233|560648504|FG000|Overall Study|Physician Decision|1|||
155331676|NCT03041233|560648504|FG000|Overall Study|Lost to Follow-up|16|||
155331677|NCT03041233|560648504|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
155331678|NCT03041233|560648504|FG000|Overall Study|Sponsor Request|1|||
155331679|NCT03041233|560648504|FG000|Overall Study|Duplicate subject|1|||
155331680|NCT03041233|560648504|FG000|Overall Study|Re-ablation|1|||
155331681|NCT00853593|560648508|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
155331682|NCT00853593|560648508|FG000|Overall Study|Model 4396 lead not attempted|29|||
155331683|NCT00853593|560648508|FG000|Overall Study|Implant not attempted|4|||
155331684|NCT03362190|560648511|FG000|Overall Study|Adverse Event|0|||
155331685|NCT03362190|560648512|FG001|Overall Study|Adverse Event|0|||
155331686|NCT03362190|560648513|FG002|Overall Study|Adverse Event|0|||
155331687|NCT03362190|560648514|FG003|Overall Study|Adverse Event|1|||
155331688|NCT03362190|560648511|FG000|Overall Study|Withdrawal by Subject|0|||
155331689|NCT03362190|560648512|FG001|Overall Study|Withdrawal by Subject|0|||
155331690|NCT03362190|560648513|FG002|Overall Study|Withdrawal by Subject|0|||
155331691|NCT03362190|560648514|FG003|Overall Study|Withdrawal by Subject|1|||
155331692|NCT01588951|560648516|FG000|Overall Study|Ineligible in retrospect|0|||
155331693|NCT01588951|560648517|FG001|Overall Study|Ineligible in retrospect|0|||
155331694|NCT01588951|560648518|FG002|Overall Study|Ineligible in retrospect|1|||
155331695|NCT03683576|560648519|FG000|Overall Study|Withdrawal by Subject|2|||
155331696|NCT03683576|560648520|FG001|Overall Study|Withdrawal by Subject|0|||
155331697|NCT03683576|560648521|FG002|Overall Study|Withdrawal by Subject|8|||
155331698|NCT03683576|560648522|FG003|Overall Study|Withdrawal by Subject|3|||
155331699|NCT03683576|560648519|FG000|Overall Study|Adverse Event|3|||
155331700|NCT03683576|560648520|FG001|Overall Study|Adverse Event|0|||
155331701|NCT03683576|560648521|FG002|Overall Study|Adverse Event|0|||
155331702|NCT03683576|560648522|FG003|Overall Study|Adverse Event|4|||
155331703|NCT03683576|560648519|FG000|Overall Study|Lack of Efficacy|1|||
155421909|NCT00706628|560974389|FG002|Overall Study|Progressive disease|8|||
155421910|NCT00706628|560974390|FG003|Overall Study|Progressive disease|1|||
155421911|NCT00706628|560974387|FG000|Overall Study|Other than those stated above|4|||
155421912|NCT00706628|560974388|FG001|Overall Study|Other than those stated above|0|||
155421913|NCT00706628|560974389|FG002|Overall Study|Other than those stated above|0|||
155645239|NCT04676646|561792179|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
155331704|NCT03683576|560648520|FG001|Overall Study|Lack of Efficacy|0|||
155331705|NCT03683576|560648521|FG002|Overall Study|Lack of Efficacy|1|||
155645240|NCT04270760|561792180|FG000|Overall Study|Withdrawal by Subject|0|||
155331706|NCT03683576|560648522|FG003|Overall Study|Lack of Efficacy|1|||
155331707|NCT03683576|560648519|FG000|Overall Study|Lost to Follow-up|0|||
155331708|NCT03683576|560648520|FG001|Overall Study|Lost to Follow-up|1|||
155331709|NCT03683576|560648521|FG002|Overall Study|Lost to Follow-up|2|||
155331710|NCT03683576|560648522|FG003|Overall Study|Lost to Follow-up|0|||
155331711|NCT03683576|560648519|FG000|Overall Study|Other, Not Specified|0|||
155331712|NCT03683576|560648520|FG001|Overall Study|Other, Not Specified|2|||
155331713|NCT03683576|560648521|FG002|Overall Study|Other, Not Specified|0|||
155331714|NCT03683576|560648522|FG003|Overall Study|Other, Not Specified|0|||
155331715|NCT03683576|560648519|FG000|Overall Study|Protocol Violation|0|||
155502569|NCT03591107|561267241|FG001|Overall Study|Sought care at other clinics|2|||
155502570|NCT03591107|561267240|FG000|Overall Study|Discharged from clinic|0|||
155502571|NCT03591107|561267241|FG001|Overall Study|Discharged from clinic|1|||
155502572|NCT03591107|561267240|FG000|Overall Study|Withdrawal by Subject|0|||
155502573|NCT03591107|561267241|FG001|Overall Study|Withdrawal by Subject|1|||
155502574|NCT01902134|561267242|FG000|Overall Study|Adverse Event|3|||
155502575|NCT01902134|561267243|FG001|Overall Study|Adverse Event|1|||
155502576|NCT01902134|561267244|FG002|Overall Study|Adverse Event|2|||
155502577|NCT01902134|561267245|FG003|Overall Study|Adverse Event|1|||
155502578|NCT01902134|561267246|FG004|Overall Study|Adverse Event|1|||
155502579|NCT01902134|561267247|FG005|Overall Study|Adverse Event|3|||
155645241|NCT04270760|561792181|FG001|Overall Study|Withdrawal by Subject|1|||
155331716|NCT03683576|560648520|FG001|Overall Study|Protocol Violation|1|||
155331717|NCT03683576|560648521|FG002|Overall Study|Protocol Violation|1|||
155331718|NCT03683576|560648522|FG003|Overall Study|Protocol Violation|0|||
155331719|NCT03488719|560648523|FG000|Overall Study|Adverse Event|0|||
155331720|NCT03488719|560648524|FG001|Overall Study|Adverse Event|4|||
155331721|NCT03488719|560648525|FG002|Overall Study|Adverse Event|2|||
155331722|NCT03488719|560648523|FG000|Overall Study|Other|0|||
155331723|NCT03488719|560648524|FG001|Overall Study|Other|0|||
155331724|NCT03488719|560648525|FG002|Overall Study|Other|5|||
155331725|NCT04038580|560648529|FG000|Washout 1|Death|0|||
155331726|NCT04038580|560648530|FG001|Washout 1|Death|0|||
155331727|NCT04038580|560648531|FG002|Washout 1|Death|0|||
155331728|NCT04038580|560648532|FG003|Washout 1|Death|1|||
155331729|NCT04038580|560648533|FG004|Washout 1|Death|0|||
155331730|NCT04038580|560648534|FG005|Washout 1|Death|0|||
155331731|NCT04038580|560648529|FG000|Washout 1|Withdrawal by Subject|0|||
155331732|NCT04038580|560648530|FG001|Washout 1|Withdrawal by Subject|0|||
155331733|NCT04038580|560648531|FG002|Washout 1|Withdrawal by Subject|0|||
155331734|NCT04038580|560648532|FG003|Washout 1|Withdrawal by Subject|0|||
155331735|NCT04038580|560648533|FG004|Washout 1|Withdrawal by Subject|1|||
155331736|NCT04038580|560648534|FG005|Washout 1|Withdrawal by Subject|0|||
155331737|NCT04038580|560648529|FG000|Wash-out 2|Withdrawal by Subject|1|||
155331738|NCT04038580|560648530|FG001|Wash-out 2|Withdrawal by Subject|0|||
155331739|NCT04038580|560648531|FG002|Wash-out 2|Withdrawal by Subject|0|||
155331740|NCT04038580|560648532|FG003|Wash-out 2|Withdrawal by Subject|2|||
155331741|NCT04038580|560648533|FG004|Wash-out 2|Withdrawal by Subject|0|||
155331742|NCT04038580|560648534|FG005|Wash-out 2|Withdrawal by Subject|1|||
155331743|NCT04038580|560648529|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
155331744|NCT04038580|560648530|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
155331745|NCT04038580|560648531|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
155331746|NCT04038580|560648532|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
155331747|NCT04038580|560648533|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
155331748|NCT04038580|560648534|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
155331749|NCT04038580|560648529|FG000|Wash-out 3|Withdrawal by Subject|1|||
155331750|NCT04038580|560648530|FG001|Wash-out 3|Withdrawal by Subject|0|||
155331751|NCT04038580|560648531|FG002|Wash-out 3|Withdrawal by Subject|2|||
155331752|NCT04038580|560648532|FG003|Wash-out 3|Withdrawal by Subject|0|||
155331753|NCT04038580|560648533|FG004|Wash-out 3|Withdrawal by Subject|0|||
155331754|NCT04038580|560648534|FG005|Wash-out 3|Withdrawal by Subject|0|||
155331755|NCT03477175|560648535|FG000|Overall Study|Unable to travel due to COVID-19|0|||
155331756|NCT03477175|560648536|FG001|Overall Study|Unable to travel due to COVID-19|1|||
155331757|NCT03477175|560648535|FG000|Overall Study|Physician Decision|1|||
155331758|NCT03477175|560648536|FG001|Overall Study|Physician Decision|0|||
155331759|NCT03477175|560648535|FG000|Overall Study|Transitioned to commercial drug|6|||
155331760|NCT03477175|560648536|FG001|Overall Study|Transitioned to commercial drug|6|||
155331761|NCT03477175|560648535|FG000|Overall Study|Lost to Follow-up|1|||
155331762|NCT03477175|560648536|FG001|Overall Study|Lost to Follow-up|1|||
155331763|NCT03477175|560648535|FG000|Overall Study|Withdrawal by Subject|3|||
155331764|NCT03477175|560648536|FG001|Overall Study|Withdrawal by Subject|1|||
155502580|NCT01902134|561267242|FG000|Overall Study|Lack of Efficacy|0|||
155645242|NCT04270760|561792182|FG002|Overall Study|Withdrawal by Subject|3|||
155645243|NCT04270760|561792183|FG003|Overall Study|Withdrawal by Subject|0|||
155331765|NCT03477175|560648535|FG000|Overall Study|Adverse Event|1|||
155331766|NCT03477175|560648536|FG001|Overall Study|Adverse Event|5|||
155331767|NCT03477175|560648535|FG000|Overall Study|Disease Progression|7|||
155331768|NCT03477175|560648536|FG001|Overall Study|Disease Progression|7|||
155331769|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331770|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
155331771|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331772|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331773|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331774|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331775|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
155331776|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331777|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331778|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331779|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331780|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331781|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331782|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331783|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
155331784|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331785|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331786|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331787|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
155331788|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
155331789|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
155331790|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
155331791|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
155331792|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
155331793|NCT04021862|560648537|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331794|NCT04021862|560648538|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331795|NCT04021862|560648539|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331796|NCT04021862|560648540|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
155331797|NCT04021862|560648541|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331798|NCT04021862|560648542|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331799|NCT03371017|560648543|FG000|Overall Study|Physician Decision|0|||
155331800|NCT03371017|560648544|FG001|Overall Study|Physician Decision|1|||
155331801|NCT03371017|560648543|FG000|Overall Study|Reason not Specified|0|||
155331802|NCT03371017|560648544|FG001|Overall Study|Reason not Specified|1|||
155331803|NCT03371017|560648543|FG000|Overall Study|Lost to Follow-up|13|||
155331804|NCT03371017|560648544|FG001|Overall Study|Lost to Follow-up|16|||
155331805|NCT03371017|560648543|FG000|Overall Study|Death|228|||
155331806|NCT03371017|560648544|FG001|Overall Study|Death|215|||
155331807|NCT03371017|560648543|FG000|Overall Study|Withdrawal by Subject|20|||
155331808|NCT03371017|560648544|FG001|Overall Study|Withdrawal by Subject|25|||
155331809|NCT03371017|560648543|FG000|Overall Study|Study Ended by Sponsor|37|||
155331810|NCT03371017|560648544|FG001|Overall Study|Study Ended by Sponsor|38|||
155331811|NCT03371017|560648543|FG000|Overall Study|Protocol Deviation|0|||
155331812|NCT03371017|560648544|FG001|Overall Study|Protocol Deviation|1|||
155331813|NCT00489307|560648547|FG000|Overall Study|Death|1|||
155331814|NCT00489307|560648548|FG001|Overall Study|Death|1|||
155331815|NCT00489307|560648547|FG000|Overall Study|Lost to Follow-up|2|||
155331816|NCT00489307|560648548|FG001|Overall Study|Lost to Follow-up|2|||
155331817|NCT00489307|560648547|FG000|Overall Study|Physician Decision|1|||
155331818|NCT00489307|560648548|FG001|Overall Study|Physician Decision|0|||
155331819|NCT00489307|560648547|FG000|Overall Study|Withdrawal by Subject|2|||
155331820|NCT00489307|560648548|FG001|Overall Study|Withdrawal by Subject|4|||
155331821|NCT00489307|560648547|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
155331822|NCT00489307|560648548|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
155421914|NCT00706628|560974390|FG003|Overall Study|Other than those stated above|0|||
155421915|NCT00706628|560974387|FG000|Overall Study|Not treated|1|||
155421916|NCT00706628|560974388|FG001|Overall Study|Not treated|1|||
155421917|NCT00706628|560974389|FG002|Overall Study|Not treated|0|||
155421918|NCT00706628|560974390|FG003|Overall Study|Not treated|0|||
155421919|NCT02921425|560974391|FG000|Overall Study|Protocol Violation|9|||
155421920|NCT01227967|560974392|FG000|Overall Study|Protocol Violation|3|||
155421921|NCT01227967|560974393|FG001|Overall Study|Protocol Violation|1|||
155421922|NCT01227967|560974392|FG000|Overall Study|Death|0|||
155421923|NCT01227967|560974393|FG001|Overall Study|Death|1|||
155421924|NCT01227967|560974392|FG000|Overall Study|Lost to Follow-up|8|||
155421925|NCT01227967|560974393|FG001|Overall Study|Lost to Follow-up|3|||
155645244|NCT04270760|561792184|FG004|Overall Study|Withdrawal by Subject|0|||
155645245|NCT04270760|561792180|FG000|Overall Study|Lost to Follow-up|1|||
155331823|NCT00489307|560648547|FG000|Overall Study|Surgery after assignment|1|||
155331824|NCT00489307|560648548|FG001|Overall Study|Surgery after assignment|0|||
155331825|NCT00489307|560648547|FG000|Overall Study|Did not fill up the forms|2|||
155421926|NCT01227967|560974392|FG000|Overall Study|Withdrawal by Subject|4|||
155421927|NCT01227967|560974393|FG001|Overall Study|Withdrawal by Subject|3|||
155421928|NCT01227967|560974392|FG000|Overall Study|Physician Decision|0|||
155645246|NCT04270760|561792181|FG001|Overall Study|Lost to Follow-up|2|||
155645247|NCT04270760|561792182|FG002|Overall Study|Lost to Follow-up|1|||
155645248|NCT04270760|561792183|FG003|Overall Study|Lost to Follow-up|0|||
155645249|NCT04270760|561792184|FG004|Overall Study|Lost to Follow-up|0|||
155645250|NCT04270760|561792180|FG000|Overall Study|Death|0|||
155645251|NCT04270760|561792181|FG001|Overall Study|Death|0|||
155645252|NCT04270760|561792182|FG002|Overall Study|Death|0|||
155645253|NCT04270760|561792183|FG003|Overall Study|Death|0|||
155645254|NCT04270760|561792184|FG004|Overall Study|Death|1|||
155645255|NCT01814332|561792185|FG000|Overall Study|Adverse Event|8|||
155645256|NCT01814332|561792186|FG001|Overall Study|Adverse Event|3|||
155645257|NCT01814332|561792185|FG000|Overall Study|Withdrawal by Subject|3|||
155645258|NCT01814332|561792186|FG001|Overall Study|Withdrawal by Subject|8|||
155645259|NCT01814332|561792185|FG000|Overall Study|Protocol Violation|0|||
155645260|NCT01814332|561792186|FG001|Overall Study|Protocol Violation|4|||
155645261|NCT01814332|561792185|FG000|Overall Study|Lost to Follow-up|5|||
155645262|NCT01814332|561792186|FG001|Overall Study|Lost to Follow-up|1|||
155645263|NCT04996264|561792188|FG000|Overall Study|Lost to Follow-up|0|||
155645264|NCT04996264|561792189|FG001|Overall Study|Lost to Follow-up|1|||
155645265|NCT04996264|561792188|FG000|Overall Study|Withdrawal by Subject|4|||
155645266|NCT04996264|561792189|FG001|Overall Study|Withdrawal by Subject|3|||
155645267|NCT04996264|561792188|FG000|Overall Study|1 left AMA|0|||
155645268|NCT04996264|561792189|FG001|Overall Study|1 left AMA|1|||
155645269|NCT04996264|561792188|FG000|Overall Study|Subject changed hospitals|0|||
155645270|NCT04996264|561792189|FG001|Overall Study|Subject changed hospitals|1|||
155645271|NCT04996264|561792188|FG000|Overall Study|unable to complete due to work|0|||
155645272|NCT04996264|561792189|FG001|Overall Study|unable to complete due to work|1|||
155645273|NCT00685698|561792190|FG000|Overall Study|Withdrawal by Subject|1|||
155645274|NCT00685698|561792190|FG000|Overall Study|Protocol Violation|6|||
155645275|NCT00685698|561792190|FG000|Overall Study|Adverse Event|3|||
155645276|NCT00685698|561792190|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
155645277|NCT00685698|561792190|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
155645278|NCT00685698|561792190|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
155645279|NCT02030418|561792191|FG000|Overall Study|Death|78|||
155645280|NCT02030418|561792191|FG000|Overall Study|Missed 12-Month Visit|9|||
155645281|NCT02030418|561792191|FG000|Overall Study|Withdrawn|57|||
155645282|NCT03983109|561792203|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
155645283|NCT03983109|561792204|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
155645284|NCT00887588|561792205|FG000|Core Period|Death|1|||
155645285|NCT00887588|561792206|FG001|Core Period|Death|1|||
155645286|NCT00887588|561792205|FG000|Core Period|Lost to Follow-up|3|||
155645287|NCT00887588|561792206|FG001|Core Period|Lost to Follow-up|1|||
155645288|NCT00887588|561792205|FG000|Core Period|Withdrawal by Subject|6|||
155645289|NCT00887588|561792206|FG001|Core Period|Withdrawal by Subject|8|||
155645290|NCT00887588|561792205|FG000|Core Period|Adverse Event|9|||
155645291|NCT00887588|561792206|FG001|Core Period|Adverse Event|11|||
155645292|NCT00887588|561792205|FG000|Extension Period|Adverse Event|4|||
155645293|NCT00887588|561792206|FG001|Extension Period|Adverse Event|4|||
155645294|NCT00887588|561792205|FG000|Extension Period|Death|0|||
155645295|NCT00887588|561792206|FG001|Extension Period|Death|1|||
155645296|NCT00887588|561792205|FG000|Extension Period|Protocol deviation|1|||
155645297|NCT00887588|561792206|FG001|Extension Period|Protocol deviation|0|||
155645298|NCT00887588|561792205|FG000|Extension Period|Lost to Follow-up|1|||
155645299|NCT00887588|561792206|FG001|Extension Period|Lost to Follow-up|0|||
155645300|NCT04210375|561792211|FG000|Overall Study|Death|0|||
155645301|NCT04210375|561792212|FG001|Overall Study|Death|1|||
155645302|NCT04210375|561792213|FG002|Overall Study|Death|0|||
155645303|NCT04210375|561792214|FG003|Overall Study|Death|0|||
155645304|NCT05752487|561792215|FG000|Overall Study|Enrolled, not treated|9|||
155645305|NCT05752487|561792215|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
155645306|NCT05752487|561792215|FG000|Overall Study|Withdrawal by Subject|2|||
155645307|NCT04124965|561792217|FG000|Overall Study|Adverse event, non-fatal|3|||
155645308|NCT04124965|561792218|FG001|Overall Study|Adverse event, non-fatal|1|||
155645309|NCT04124965|561792217|FG000|Overall Study|Withdrawal by Subject|1|||
155645310|NCT04124965|561792218|FG001|Overall Study|Withdrawal by Subject|1|||
155645311|NCT04124965|561792217|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
155645312|NCT04124965|561792218|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
155645313|NCT04124965|561792217|FG000|Overall Study|Pregnancy|1|||
155645314|NCT04124965|561792218|FG001|Overall Study|Pregnancy|0|||
155331826|NCT00489307|560648548|FG001|Overall Study|Did not fill up the forms|1|||
155331827|NCT00489307|560648547|FG000|Overall Study|Patient or family refusal|5|||
155331828|NCT00489307|560648548|FG001|Overall Study|Patient or family refusal|9|||
155331829|NCT03835754|560648549|FG000|Overall Study|Death|4|||
155331830|NCT02751528|560648554|FG000|Overall Study|Withdrawal by Subject|1|||
155645315|NCT04124965|561792217|FG000|Overall Study|Sponsor and participant decision|0|||
155645316|NCT04124965|561792218|FG001|Overall Study|Sponsor and participant decision|1|||
155645317|NCT04124965|561792217|FG000|Overall Study|Personal surgery|0|||
155645318|NCT04124965|561792218|FG001|Overall Study|Personal surgery|1|||
155645319|NCT04124965|561792217|FG000|Overall Study|Physician Decision|0|||
155331831|NCT02751528|560648554|FG000|Overall Study|Adverse Event|1|||
155331832|NCT05485805|560648555|FG000|Overall Study|Withdrawal by Subject|1|||
155331833|NCT05485805|560648556|FG001|Overall Study|Withdrawal by Subject|2|||
155331834|NCT05485805|560648557|FG002|Overall Study|Withdrawal by Subject|2|||
155331835|NCT05485805|560648558|FG003|Overall Study|Withdrawal by Subject|0|||
155331836|NCT05485805|560648559|FG004|Overall Study|Withdrawal by Subject|2|||
155331837|NCT05485805|560648555|FG000|Overall Study|Adverse Event|0|||
155331838|NCT05485805|560648556|FG001|Overall Study|Adverse Event|1|||
155331839|NCT05485805|560648557|FG002|Overall Study|Adverse Event|0|||
155331840|NCT05485805|560648558|FG003|Overall Study|Adverse Event|0|||
155331841|NCT05485805|560648559|FG004|Overall Study|Adverse Event|0|||
155331842|NCT05485805|560648555|FG000|Overall Study|Lost to Follow-up|1|||
155331843|NCT05485805|560648556|FG001|Overall Study|Lost to Follow-up|1|||
155331844|NCT05485805|560648557|FG002|Overall Study|Lost to Follow-up|3|||
155331845|NCT05485805|560648558|FG003|Overall Study|Lost to Follow-up|1|||
155331846|NCT05485805|560648559|FG004|Overall Study|Lost to Follow-up|0|||
155331847|NCT04218357|560648560|FG000|1st Allocation|Withdrawal by Subject|1|||
155331848|NCT04218357|560648561|FG001|1st Allocation|Withdrawal by Subject|0|||
155331849|NCT05349838|560648562|FG000|Overall Study|Virological Failure|1|||
155331850|NCT05349838|560648563|FG001|Overall Study|Virological Failure|2|||
155331851|NCT05349838|560648562|FG000|Overall Study|Withdrawal by Subject|2|||
155331852|NCT05349838|560648563|FG001|Overall Study|Withdrawal by Subject|3|||
155331853|NCT05349838|560648562|FG000|Overall Study|Adverse Event|3|||
155331854|NCT05349838|560648563|FG001|Overall Study|Adverse Event|1|||
155331855|NCT05349838|560648562|FG000|Overall Study|Lost to Follow-up|1|||
155331856|NCT05349838|560648563|FG001|Overall Study|Lost to Follow-up|2|||
155331857|NCT05349838|560648562|FG000|Overall Study|Other reasons|5|||
155331858|NCT05349838|560648563|FG001|Overall Study|Other reasons|1|||
155331859|NCT05071430|560648565|FG000|Overall Study|Adverse Event|1|||
155331860|NCT05071430|560648566|FG001|Overall Study|Adverse Event|2|||
155331861|NCT05071430|560648565|FG000|Overall Study|Lost to Follow-up|4|||
155331862|NCT05071430|560648566|FG001|Overall Study|Lost to Follow-up|4|||
155331863|NCT05071430|560648565|FG000|Overall Study|Protocol Violation|1|||
155331864|NCT05071430|560648566|FG001|Overall Study|Protocol Violation|0|||
155331865|NCT05071430|560648565|FG000|Overall Study|Withdrawal by Subject|3|||
155331866|NCT05071430|560648566|FG001|Overall Study|Withdrawal by Subject|2|||
155331867|NCT05071430|560648565|FG000|Overall Study|Other|1|||
155331868|NCT05071430|560648566|FG001|Overall Study|Other|1|||
155331869|NCT01958021|560648567|FG000|Treatment|Progressive disease|206|||
155331870|NCT01958021|560648568|FG001|Treatment|Progressive disease|265|||
155331871|NCT01958021|560648567|FG000|Treatment|Adverse Event|38|||
155331872|NCT01958021|560648568|FG001|Treatment|Adverse Event|10|||
155331873|NCT01958021|560648567|FG000|Treatment|Subject/guardian decision|29|||
155331874|NCT01958021|560648568|FG001|Treatment|Subject/guardian decision|25|||
155331875|NCT01958021|560648567|FG000|Treatment|Physician Decision|28|||
155331876|NCT01958021|560648568|FG001|Treatment|Physician Decision|21|||
155331877|NCT01958021|560648567|FG000|Treatment|Death|6|||
155331878|NCT01958021|560648568|FG001|Treatment|Death|1|||
155331879|NCT01958021|560648567|FG000|Treatment|Protocol deviation|3|||
155331880|NCT01958021|560648568|FG001|Treatment|Protocol deviation|1|||
155331881|NCT01958021|560648567|FG000|Treatment|Sponsor decision|24|||
155331882|NCT01958021|560648568|FG001|Treatment|Sponsor decision|11|||
155331883|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155331884|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155331885|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Death|1|||
155331886|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Death|0|||
155331887|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155331888|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155331889|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155331890|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155331891|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
155331892|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155331893|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
155331894|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
155331895|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
155331896|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
155331897|NCT05810285|560648572|FG000|Overall Study|Death|4|||
155331898|NCT05810285|560648573|FG001|Overall Study|Death|21|||
155331899|NCT05810285|560648572|FG000|Overall Study|Adverse Event|18|||
155331900|NCT05810285|560648573|FG001|Overall Study|Adverse Event|16|||
155331901|NCT04484623|560648574|FG000|Overall Study|Lost to Follow-up|0|||
155331902|NCT04484623|560648575|FG001|Overall Study|Lost to Follow-up|1|||
155331903|NCT04484623|560648574|FG000|Overall Study|Protocol Deviation|1|||
155331904|NCT04484623|560648575|FG001|Overall Study|Protocol Deviation|0|||
155331905|NCT04484623|560648574|FG000|Overall Study|Physician Decision|1|||
155331906|NCT04484623|560648575|FG001|Overall Study|Physician Decision|0|||
155331907|NCT04484623|560648574|FG000|Overall Study|Withdrawal by Subject|11|||
155331908|NCT04484623|560648575|FG001|Overall Study|Withdrawal by Subject|8|||
155331909|NCT04484623|560648574|FG000|Overall Study|Ongoing|94|||
155331910|NCT04484623|560648575|FG001|Overall Study|Ongoing|84|||
155331911|NCT05470114|560648576|FG000|Overall Study|Withdrawal by Subject|1|||
155331912|NCT05470114|560648577|FG001|Overall Study|Withdrawal by Subject|0|||
155331913|NCT05470114|560648576|FG000|Overall Study|Lost to Follow-up|1|||
155331914|NCT05470114|560648577|FG001|Overall Study|Lost to Follow-up|0|||
155331915|NCT04649047|560648582|FG000|Overall Study|Withdrawal by Subject|3|||
155331916|NCT02488408|560648583|FG000|Part A|Adverse Event|2|||
155331917|NCT02488408|560648584|FG001|Part A|Adverse Event|0|||
155331918|NCT02488408|560648585|FG002|Part A|Adverse Event|0|||
155331919|NCT02488408|560648586|FG003|Part A|Adverse Event|0|||
155331920|NCT02488408|560648587|FG004|Part A|Adverse Event|0|||
155331921|NCT02488408|560648588|FG005|Part A|Adverse Event|0|||
155331922|NCT02488408|560648589|FG006|Part A|Adverse Event|0|||
155331923|NCT02488408|560648590|FG007|Part A|Adverse Event|0|||
155331924|NCT02488408|560648591|FG008|Part A|Adverse Event|0|||
155331925|NCT02488408|560648592|FG009|Part A|Adverse Event|0|||
155331926|NCT02488408|560648583|FG000|Part A|Death|1|||
155331927|NCT02488408|560648584|FG001|Part A|Death|5|||
155331928|NCT02488408|560648585|FG002|Part A|Death|0|||
155331929|NCT02488408|560648586|FG003|Part A|Death|0|||
155331930|NCT02488408|560648587|FG004|Part A|Death|3|||
155331931|NCT02488408|560648588|FG005|Part A|Death|0|||
155331932|NCT02488408|560648589|FG006|Part A|Death|0|||
155331933|NCT02488408|560648590|FG007|Part A|Death|0|||
155331934|NCT02488408|560648591|FG008|Part A|Death|0|||
155331935|NCT02488408|560648592|FG009|Part A|Death|0|||
155331936|NCT02488408|560648583|FG000|Part A|Disease Progression|2|||
155331937|NCT02488408|560648584|FG001|Part A|Disease Progression|8|||
155331938|NCT02488408|560648585|FG002|Part A|Disease Progression|2|||
155331939|NCT02488408|560648586|FG003|Part A|Disease Progression|3|||
155331940|NCT02488408|560648587|FG004|Part A|Disease Progression|4|||
155331941|NCT02488408|560648588|FG005|Part A|Disease Progression|0|||
155331942|NCT02488408|560648589|FG006|Part A|Disease Progression|0|||
155331943|NCT02488408|560648590|FG007|Part A|Disease Progression|0|||
155331944|NCT02488408|560648591|FG008|Part A|Disease Progression|0|||
155331945|NCT02488408|560648592|FG009|Part A|Disease Progression|0|||
155331946|NCT02488408|560648583|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
155331947|NCT02488408|560648584|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
155331948|NCT02488408|560648585|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
155331949|NCT02488408|560648586|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
155331950|NCT02488408|560648587|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
155331951|NCT02488408|560648588|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
155331952|NCT02488408|560648589|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
155331953|NCT02488408|560648590|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
155331954|NCT02488408|560648591|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
155331955|NCT02488408|560648592|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
155331956|NCT02488408|560648583|FG000|Part A|Investigator Decision|0|||
155331957|NCT02488408|560648584|FG001|Part A|Investigator Decision|1|||
155331958|NCT02488408|560648585|FG002|Part A|Investigator Decision|1|||
155331959|NCT02488408|560648586|FG003|Part A|Investigator Decision|0|||
155331960|NCT02488408|560648587|FG004|Part A|Investigator Decision|0|||
155331961|NCT02488408|560648588|FG005|Part A|Investigator Decision|0|||
155331962|NCT02488408|560648589|FG006|Part A|Investigator Decision|0|||
155331963|NCT02488408|560648590|FG007|Part A|Investigator Decision|0|||
155331964|NCT02488408|560648591|FG008|Part A|Investigator Decision|0|||
155331965|NCT02488408|560648592|FG009|Part A|Investigator Decision|0|||
155331966|NCT02488408|560648583|FG000|Part A|Withdrawal by Subject|0|||
155331967|NCT02488408|560648584|FG001|Part A|Withdrawal by Subject|0|||
155331968|NCT02488408|560648585|FG002|Part A|Withdrawal by Subject|2|||
155331969|NCT02488408|560648586|FG003|Part A|Withdrawal by Subject|0|||
155331970|NCT02488408|560648587|FG004|Part A|Withdrawal by Subject|0|||
155331971|NCT02488408|560648588|FG005|Part A|Withdrawal by Subject|0|||
155331972|NCT02488408|560648589|FG006|Part A|Withdrawal by Subject|0|||
155331973|NCT02488408|560648590|FG007|Part A|Withdrawal by Subject|0|||
155331974|NCT02488408|560648591|FG008|Part A|Withdrawal by Subject|0|||
155331975|NCT02488408|560648592|FG009|Part A|Withdrawal by Subject|0|||
155331976|NCT02488408|560648583|FG000|Part A|Other|1|||
155331977|NCT02488408|560648584|FG001|Part A|Other|0|||
155331978|NCT02488408|560648585|FG002|Part A|Other|0|||
155331979|NCT02488408|560648586|FG003|Part A|Other|0|||
155331980|NCT02488408|560648587|FG004|Part A|Other|0|||
155331981|NCT02488408|560648588|FG005|Part A|Other|0|||
155331982|NCT02488408|560648589|FG006|Part A|Other|0|||
155331983|NCT02488408|560648590|FG007|Part A|Other|0|||
155331984|NCT02488408|560648591|FG008|Part A|Other|0|||
155331985|NCT02488408|560648592|FG009|Part A|Other|0|||
155331986|NCT02488408|560648583|FG000|Part B|Adverse Event|0|||
155331987|NCT02488408|560648584|FG001|Part B|Adverse Event|0|||
155331988|NCT02488408|560648585|FG002|Part B|Adverse Event|0|||
155331989|NCT02488408|560648586|FG003|Part B|Adverse Event|0|||
155331990|NCT02488408|560648587|FG004|Part B|Adverse Event|0|||
155331991|NCT02488408|560648588|FG005|Part B|Adverse Event|2|||
155331992|NCT02488408|560648589|FG006|Part B|Adverse Event|2|||
155331993|NCT02488408|560648590|FG007|Part B|Adverse Event|7|||
155331994|NCT02488408|560648591|FG008|Part B|Adverse Event|2|||
155331995|NCT02488408|560648592|FG009|Part B|Adverse Event|2|||
155331996|NCT02488408|560648583|FG000|Part B|Death|0|||
155331997|NCT02488408|560648584|FG001|Part B|Death|0|||
155331998|NCT02488408|560648585|FG002|Part B|Death|0|||
155331999|NCT02488408|560648586|FG003|Part B|Death|0|||
155332000|NCT02488408|560648587|FG004|Part B|Death|0|||
155332001|NCT02488408|560648588|FG005|Part B|Death|3|||
155332002|NCT02488408|560648589|FG006|Part B|Death|1|||
155332003|NCT02488408|560648590|FG007|Part B|Death|2|||
155332004|NCT02488408|560648591|FG008|Part B|Death|2|||
155332005|NCT02488408|560648592|FG009|Part B|Death|2|||
155332006|NCT02488408|560648583|FG000|Part B|Death due to Disease Progression|0|||
155332007|NCT02488408|560648584|FG001|Part B|Death due to Disease Progression|0|||
155332008|NCT02488408|560648585|FG002|Part B|Death due to Disease Progression|0|||
155332009|NCT02488408|560648586|FG003|Part B|Death due to Disease Progression|0|||
155332010|NCT02488408|560648587|FG004|Part B|Death due to Disease Progression|0|||
155332011|NCT02488408|560648588|FG005|Part B|Death due to Disease Progression|2|||
155332012|NCT02488408|560648589|FG006|Part B|Death due to Disease Progression|2|||
155332013|NCT02488408|560648590|FG007|Part B|Death due to Disease Progression|1|||
155332014|NCT02488408|560648591|FG008|Part B|Death due to Disease Progression|1|||
155332015|NCT02488408|560648592|FG009|Part B|Death due to Disease Progression|1|||
155332016|NCT02488408|560648583|FG000|Part B|Disease Progression|0|||
155332017|NCT02488408|560648584|FG001|Part B|Disease Progression|0|||
155332018|NCT02488408|560648585|FG002|Part B|Disease Progression|0|||
155332019|NCT02488408|560648586|FG003|Part B|Disease Progression|0|||
155332020|NCT02488408|560648587|FG004|Part B|Disease Progression|0|||
155332021|NCT02488408|560648588|FG005|Part B|Disease Progression|6|||
155332022|NCT02488408|560648589|FG006|Part B|Disease Progression|9|||
155332023|NCT02488408|560648590|FG007|Part B|Disease Progression|7|||
155332024|NCT02488408|560648591|FG008|Part B|Disease Progression|9|||
155332025|NCT02488408|560648592|FG009|Part B|Disease Progression|11|||
155332026|NCT02488408|560648583|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
155332027|NCT02488408|560648584|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
155332028|NCT02488408|560648585|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
155332029|NCT02488408|560648586|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
155332030|NCT02488408|560648587|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
155332031|NCT02488408|560648588|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
155332032|NCT02488408|560648589|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
155332033|NCT02488408|560648590|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
155332034|NCT02488408|560648591|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
155332035|NCT02488408|560648592|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
155332036|NCT02488408|560648583|FG000|Part B|Investigator Decision|0|||
155332037|NCT02488408|560648584|FG001|Part B|Investigator Decision|0|||
155332038|NCT02488408|560648585|FG002|Part B|Investigator Decision|0|||
155332039|NCT02488408|560648586|FG003|Part B|Investigator Decision|0|||
155332040|NCT02488408|560648587|FG004|Part B|Investigator Decision|0|||
155332041|NCT02488408|560648588|FG005|Part B|Investigator Decision|0|||
155332042|NCT02488408|560648589|FG006|Part B|Investigator Decision|1|||
155332043|NCT02488408|560648590|FG007|Part B|Investigator Decision|0|||
155332044|NCT02488408|560648591|FG008|Part B|Investigator Decision|2|||
155332045|NCT02488408|560648592|FG009|Part B|Investigator Decision|1|||
155332046|NCT00719888|560648593|FG000|Overall Study|Death|24|||
155332047|NCT00719888|560648594|FG001|Overall Study|Death|9|||
155332048|NCT00719888|560648593|FG000|Overall Study|Relapse|8|||
155332049|NCT00719888|560648594|FG001|Overall Study|Relapse|3|||
155332050|NCT00719888|560648593|FG000|Overall Study|Physician Decision|1|||
155332051|NCT00719888|560648594|FG001|Overall Study|Physician Decision|0|||
155332052|NCT00719888|560648593|FG000|Overall Study|Withdrawal by Subject|1|||
155421929|NCT01227967|560974393|FG001|Overall Study|Physician Decision|1|||
155645320|NCT04124965|561792218|FG001|Overall Study|Physician Decision|1|||
155332053|NCT00719888|560648594|FG001|Overall Study|Withdrawal by Subject|0|||
155332054|NCT05886777|560648595|FG000|Overall Study|Lost to Follow-up|1|||
155332055|NCT05886777|560648596|FG001|Overall Study|Lost to Follow-up|0|||
155332056|NCT05886777|560648597|FG002|Overall Study|Lost to Follow-up|2|||
155332057|NCT05886777|560648598|FG003|Overall Study|Lost to Follow-up|1|||
155332058|NCT05886777|560648599|FG004|Overall Study|Lost to Follow-up|0|||
155332059|NCT05886777|560648600|FG005|Overall Study|Lost to Follow-up|2|||
155332060|NCT05886777|560648601|FG006|Overall Study|Lost to Follow-up|0|||
155332061|NCT05886777|560648595|FG000|Overall Study|Other|0|||
155332062|NCT05886777|560648596|FG001|Overall Study|Other|2|||
155332063|NCT05886777|560648597|FG002|Overall Study|Other|1|||
155332064|NCT05886777|560648598|FG003|Overall Study|Other|0|||
155332065|NCT05886777|560648599|FG004|Overall Study|Other|0|||
155332066|NCT05886777|560648600|FG005|Overall Study|Other|0|||
155332067|NCT05886777|560648601|FG006|Overall Study|Other|0|||
155332068|NCT05886777|560648595|FG000|Overall Study|Withdrawal by Subject|1|||
155332069|NCT05886777|560648596|FG001|Overall Study|Withdrawal by Subject|0|||
155332070|NCT05886777|560648597|FG002|Overall Study|Withdrawal by Subject|1|||
155332071|NCT05886777|560648598|FG003|Overall Study|Withdrawal by Subject|4|||
155332072|NCT05886777|560648599|FG004|Overall Study|Withdrawal by Subject|3|||
155332073|NCT05886777|560648600|FG005|Overall Study|Withdrawal by Subject|1|||
155332074|NCT05886777|560648601|FG006|Overall Study|Withdrawal by Subject|1|||
155332075|NCT05886777|560648595|FG000|Overall Study|Protocol Violation|0|||
155332076|NCT05886777|560648596|FG001|Overall Study|Protocol Violation|0|||
155332077|NCT05886777|560648597|FG002|Overall Study|Protocol Violation|1|||
155332078|NCT05886777|560648598|FG003|Overall Study|Protocol Violation|0|||
155332079|NCT05886777|560648599|FG004|Overall Study|Protocol Violation|0|||
155332080|NCT05886777|560648600|FG005|Overall Study|Protocol Violation|0|||
155332081|NCT05886777|560648601|FG006|Overall Study|Protocol Violation|0|||
155332082|NCT05886777|560648595|FG000|Overall Study|No longer met eligibility criteria|0|||
155332083|NCT05886777|560648596|FG001|Overall Study|No longer met eligibility criteria|1|||
155645321|NCT02184156|561792219|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
155645322|NCT02184156|561792220|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
155645323|NCT02184156|561792219|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
155332084|NCT05886777|560648597|FG002|Overall Study|No longer met eligibility criteria|0|||
155332085|NCT05886777|560648598|FG003|Overall Study|No longer met eligibility criteria|0|||
155332086|NCT05886777|560648599|FG004|Overall Study|No longer met eligibility criteria|0|||
155332087|NCT05886777|560648600|FG005|Overall Study|No longer met eligibility criteria|0|||
155332088|NCT05886777|560648601|FG006|Overall Study|No longer met eligibility criteria|0|||
155332089|NCT03773107|560648602|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
155332090|NCT03773107|560648603|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
155332091|NCT03773107|560648604|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
155332092|NCT03773107|560648605|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
155332093|NCT07204444|560648607|FG000|Overall Study|Medical/Hospitalization|6|||
155332094|NCT07204444|560648608|FG001|Overall Study|Medical/Hospitalization|9|||
155332095|NCT07204444|560648609|FG002|Overall Study|Medical/Hospitalization|6|||
155332096|NCT07204444|560648607|FG000|Overall Study|Treatment Provider Issue|1|||
155332097|NCT07204444|560648608|FG001|Overall Study|Treatment Provider Issue|3|||
155332098|NCT07204444|560648609|FG002|Overall Study|Treatment Provider Issue|0|||
155332099|NCT07204444|560648607|FG000|Overall Study|Withdrawal by Subject|11|||
155332100|NCT07204444|560648608|FG001|Overall Study|Withdrawal by Subject|5|||
155332101|NCT07204444|560648609|FG002|Overall Study|Withdrawal by Subject|5|||
155332102|NCT07204444|560648607|FG000|Overall Study|Death|3|||
155332103|NCT07204444|560648608|FG001|Overall Study|Death|6|||
155332104|NCT07204444|560648609|FG002|Overall Study|Death|1|||
155332105|NCT07204444|560648607|FG000|Overall Study|Unable To Reach|29|||
155332106|NCT07204444|560648608|FG001|Overall Study|Unable To Reach|26|||
155332107|NCT07204444|560648609|FG002|Overall Study|Unable To Reach|17|||
155332108|NCT07204444|560648607|FG000|Overall Study|Protocol Deviation|3|||
155332109|NCT07204444|560648608|FG001|Overall Study|Protocol Deviation|2|||
155332110|NCT07204444|560648609|FG002|Overall Study|Protocol Deviation|0|||
155332111|NCT05199571|560650131|FG000|Treatment Period|Participant decision|3|||
155332112|NCT05199571|560650131|FG000|Treatment Period|Physician Decision|1|||
155332113|NCT05199571|560650131|FG000|Post-treatment Follow up Period|Participant decision|3|||
155332114|NCT05029284|560650132|FG000|Overall Study|Lost to Follow-up|1|||
155332115|NCT02972034|560650133|FG000|Overall Study|Death|11|||
155332116|NCT02972034|560650134|FG001|Overall Study|Death|1|||
155332117|NCT02972034|560650135|FG002|Overall Study|Death|3|||
155332118|NCT02972034|560650136|FG003|Overall Study|Death|3|||
155332119|NCT02972034|560650137|FG004|Overall Study|Death|2|||
155332120|NCT02972034|560650138|FG005|Overall Study|Death|2|||
155332121|NCT02972034|560650139|FG006|Overall Study|Death|3|||
155332122|NCT02972034|560650140|FG007|Overall Study|Death|4|||
155332123|NCT02972034|560650141|FG008|Overall Study|Death|8|||
155332124|NCT02972034|560650142|FG009|Overall Study|Death|11|||
155332125|NCT02972034|560650143|FG010|Overall Study|Death|3|||
155332126|NCT02972034|560650144|FG011|Overall Study|Death|2|||
155332127|NCT02972034|560650145|FG012|Overall Study|Death|11|||
155332128|NCT02972034|560650146|FG013|Overall Study|Death|10|||
155332129|NCT02972034|560650147|FG014|Overall Study|Death|9|||
155332130|NCT02972034|560650133|FG000|Overall Study|Lost to Follow-up|0|||
155332131|NCT02972034|560650134|FG001|Overall Study|Lost to Follow-up|0|||
155332132|NCT02972034|560650135|FG002|Overall Study|Lost to Follow-up|0|||
155332133|NCT02972034|560650136|FG003|Overall Study|Lost to Follow-up|0|||
155332134|NCT02972034|560650137|FG004|Overall Study|Lost to Follow-up|1|||
155332135|NCT02972034|560650138|FG005|Overall Study|Lost to Follow-up|0|||
155332136|NCT02972034|560650139|FG006|Overall Study|Lost to Follow-up|0|||
155332137|NCT02972034|560650140|FG007|Overall Study|Lost to Follow-up|1|||
155332138|NCT02972034|560650141|FG008|Overall Study|Lost to Follow-up|0|||
155332139|NCT02972034|560650142|FG009|Overall Study|Lost to Follow-up|0|||
155332140|NCT02972034|560650143|FG010|Overall Study|Lost to Follow-up|0|||
155332141|NCT02972034|560650144|FG011|Overall Study|Lost to Follow-up|0|||
155332142|NCT02972034|560650145|FG012|Overall Study|Lost to Follow-up|0|||
155332143|NCT02972034|560650146|FG013|Overall Study|Lost to Follow-up|0|||
155332144|NCT02972034|560650147|FG014|Overall Study|Lost to Follow-up|1|||
155332145|NCT02972034|560650133|FG000|Overall Study|Physician Decision|0|||
155332146|NCT02972034|560650134|FG001|Overall Study|Physician Decision|0|||
155332147|NCT02972034|560650135|FG002|Overall Study|Physician Decision|0|||
155332148|NCT02972034|560650136|FG003|Overall Study|Physician Decision|0|||
155332149|NCT02972034|560650137|FG004|Overall Study|Physician Decision|0|||
155332150|NCT02972034|560650138|FG005|Overall Study|Physician Decision|0|||
155332151|NCT02972034|560650139|FG006|Overall Study|Physician Decision|0|||
155332152|NCT02972034|560650140|FG007|Overall Study|Physician Decision|1|||
155332153|NCT02972034|560650141|FG008|Overall Study|Physician Decision|0|||
155332154|NCT02972034|560650142|FG009|Overall Study|Physician Decision|0|||
155332155|NCT02972034|560650143|FG010|Overall Study|Physician Decision|1|||
155332156|NCT02972034|560650144|FG011|Overall Study|Physician Decision|0|||
155332157|NCT02972034|560650145|FG012|Overall Study|Physician Decision|0|||
155332158|NCT02972034|560650146|FG013|Overall Study|Physician Decision|0|||
155332159|NCT02972034|560650147|FG014|Overall Study|Physician Decision|0|||
155332160|NCT02972034|560650133|FG000|Overall Study|Sponsor Decision|0|||
155332161|NCT02972034|560650134|FG001|Overall Study|Sponsor Decision|0|||
155332162|NCT02972034|560650135|FG002|Overall Study|Sponsor Decision|0|||
155332163|NCT02972034|560650136|FG003|Overall Study|Sponsor Decision|1|||
155332164|NCT02972034|560650137|FG004|Overall Study|Sponsor Decision|0|||
155332165|NCT02972034|560650138|FG005|Overall Study|Sponsor Decision|0|||
155332166|NCT02972034|560650139|FG006|Overall Study|Sponsor Decision|1|||
155332167|NCT02972034|560650140|FG007|Overall Study|Sponsor Decision|1|||
155332168|NCT02972034|560650141|FG008|Overall Study|Sponsor Decision|1|||
155332169|NCT02972034|560650142|FG009|Overall Study|Sponsor Decision|2|||
155332170|NCT02972034|560650143|FG010|Overall Study|Sponsor Decision|2|||
155332171|NCT02972034|560650144|FG011|Overall Study|Sponsor Decision|0|||
155332172|NCT02972034|560650145|FG012|Overall Study|Sponsor Decision|1|||
155332173|NCT02972034|560650146|FG013|Overall Study|Sponsor Decision|0|||
155332174|NCT02972034|560650147|FG014|Overall Study|Sponsor Decision|1|||
155332175|NCT02972034|560650133|FG000|Overall Study|Withdrawal by Subject|3|||
155332176|NCT02972034|560650134|FG001|Overall Study|Withdrawal by Subject|0|||
155332177|NCT02972034|560650135|FG002|Overall Study|Withdrawal by Subject|0|||
155332178|NCT02972034|560650136|FG003|Overall Study|Withdrawal by Subject|0|||
155332179|NCT02972034|560650137|FG004|Overall Study|Withdrawal by Subject|1|||
155332180|NCT02972034|560650138|FG005|Overall Study|Withdrawal by Subject|1|||
155332181|NCT02972034|560650139|FG006|Overall Study|Withdrawal by Subject|0|||
155332182|NCT02972034|560650140|FG007|Overall Study|Withdrawal by Subject|0|||
155332183|NCT02972034|560650141|FG008|Overall Study|Withdrawal by Subject|1|||
155332184|NCT02972034|560650142|FG009|Overall Study|Withdrawal by Subject|1|||
155332185|NCT02972034|560650143|FG010|Overall Study|Withdrawal by Subject|2|||
155332186|NCT02972034|560650144|FG011|Overall Study|Withdrawal by Subject|1|||
155332187|NCT02972034|560650145|FG012|Overall Study|Withdrawal by Subject|1|||
155332188|NCT02972034|560650146|FG013|Overall Study|Withdrawal by Subject|1|||
155332189|NCT02972034|560650147|FG014|Overall Study|Withdrawal by Subject|0|||
155332190|NCT02972034|560650133|FG000|Overall Study|Screen Failure|0|||
155332191|NCT02972034|560650134|FG001|Overall Study|Screen Failure|0|||
155332192|NCT02972034|560650135|FG002|Overall Study|Screen Failure|0|||
155332193|NCT02972034|560650136|FG003|Overall Study|Screen Failure|0|||
155332194|NCT02972034|560650137|FG004|Overall Study|Screen Failure|0|||
155332195|NCT02972034|560650138|FG005|Overall Study|Screen Failure|0|||
155332196|NCT02972034|560650139|FG006|Overall Study|Screen Failure|0|||
155332197|NCT02972034|560650140|FG007|Overall Study|Screen Failure|0|||
155332198|NCT02972034|560650141|FG008|Overall Study|Screen Failure|0|||
155332199|NCT02972034|560650142|FG009|Overall Study|Screen Failure|0|||
155332200|NCT02972034|560650143|FG010|Overall Study|Screen Failure|0|||
155421930|NCT01227967|560974392|FG000|Overall Study|Never Started Treatment|0|||
155421931|NCT01227967|560974393|FG001|Overall Study|Never Started Treatment|4|||
155421932|NCT01227967|560974392|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
155332201|NCT02972034|560650144|FG011|Overall Study|Screen Failure|0|||
155421933|NCT01227967|560974393|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
155421934|NCT01948830|560974394|FG000|Overall Study|Physician Decision|1|||
155332202|NCT02972034|560650145|FG012|Overall Study|Screen Failure|1|||
155332203|NCT02972034|560650146|FG013|Overall Study|Screen Failure|0|||
155332204|NCT02972034|560650147|FG014|Overall Study|Screen Failure|0|||
155332205|NCT03861052|560650148|FG000|Overall Study|Adverse Event|1|||
155421935|NCT01948830|560974395|FG001|Overall Study|Physician Decision|3|||
155332206|NCT03861052|560650149|FG001|Overall Study|Adverse Event|1|||
155332207|NCT03861052|560650150|FG002|Overall Study|Adverse Event|2|||
155332208|NCT03861052|560650151|FG003|Overall Study|Adverse Event|4|||
155332209|NCT03861052|560650148|FG000|Overall Study|Lost to Follow-up|0|||
155332210|NCT03861052|560650149|FG001|Overall Study|Lost to Follow-up|0|||
155332211|NCT03861052|560650150|FG002|Overall Study|Lost to Follow-up|0|||
155332212|NCT03861052|560650151|FG003|Overall Study|Lost to Follow-up|1|||
155332213|NCT03861052|560650148|FG000|Overall Study|Physician Decision|0|||
155332214|NCT03861052|560650149|FG001|Overall Study|Physician Decision|1|||
155332215|NCT03861052|560650150|FG002|Overall Study|Physician Decision|0|||
155332216|NCT03861052|560650151|FG003|Overall Study|Physician Decision|0|||
155332217|NCT03861052|560650148|FG000|Overall Study|Withdrawal by Subject|2|||
155332218|NCT03861052|560650149|FG001|Overall Study|Withdrawal by Subject|5|||
155332219|NCT03861052|560650150|FG002|Overall Study|Withdrawal by Subject|3|||
155332220|NCT03861052|560650151|FG003|Overall Study|Withdrawal by Subject|0|||
155332221|NCT03861052|560650148|FG000|Overall Study|Relocation to other city|1|||
155332222|NCT03861052|560650149|FG001|Overall Study|Relocation to other city|0|||
155332223|NCT03861052|560650150|FG002|Overall Study|Relocation to other city|0|||
155332224|NCT03861052|560650151|FG003|Overall Study|Relocation to other city|0|||
155332225|NCT03009344|560650152|FG000|Overall Study|Lack of Efficacy|5|||
155332226|NCT03009344|560650152|FG000|Overall Study|Withdrawal by Subject|1|||
155332227|NCT03009344|560650152|FG000|Overall Study|Adverse Event|1|||
155332228|NCT00454194|560650163|FG000|Overall Study|Adverse Event|7|||
155332229|NCT00454194|560650164|FG001|Overall Study|Adverse Event|2|||
155332230|NCT00454194|560650163|FG000|Overall Study|Withdrawal by Subject|12|||
155332231|NCT00454194|560650164|FG001|Overall Study|Withdrawal by Subject|8|||
155332232|NCT00454194|560650163|FG000|Overall Study|Other Medical Problems|1|||
155332233|NCT00454194|560650164|FG001|Overall Study|Other Medical Problems|2|||
155332234|NCT00454194|560650163|FG000|Overall Study|Other Unspecified Reason|2|||
155421936|NCT01948830|560974394|FG000|Overall Study|Protocol deviation|1|||
155421937|NCT01948830|560974395|FG001|Overall Study|Protocol deviation|2|||
155421938|NCT01948830|560974394|FG000|Overall Study|Lost to Follow-up|5|||
155421939|NCT01948830|560974395|FG001|Overall Study|Lost to Follow-up|4|||
155421940|NCT01948830|560974394|FG000|Overall Study|Withdrawal by Subject|14|||
155421941|NCT01948830|560974395|FG001|Overall Study|Withdrawal by Subject|17|||
155421942|NCT01948830|560974394|FG000|Overall Study|Adverse Event|9|||
155421943|NCT01948830|560974395|FG001|Overall Study|Adverse Event|2|||
155421944|NCT01948830|560974394|FG000|Overall Study|Death|3|||
155332235|NCT00454194|560650164|FG001|Overall Study|Other Unspecified Reason|2|||
155332236|NCT00229658|560650182|FG000|Overall Study|Administrative|2|||
155332237|NCT00229658|560650183|FG001|Overall Study|Administrative|1|||
155332238|NCT00229658|560650182|FG000|Overall Study|Investigator decision|13|||
155332239|NCT00229658|560650183|FG001|Overall Study|Investigator decision|10|||
155332240|NCT00229658|560650182|FG000|Overall Study|Other|80|||
155421945|NCT01948830|560974395|FG001|Overall Study|Death|4|||
155421946|NCT01145560|560974396|FG000|Overall Study|Withdrawal by Subject|2|||
155421947|NCT01145560|560974397|FG001|Overall Study|Withdrawal by Subject|1|||
155421948|NCT01145560|560974398|FG002|Overall Study|Withdrawal by Subject|0|||
155421949|NCT01145560|560974396|FG000|Overall Study|Lost to Follow-up|1|||
155421950|NCT01145560|560974397|FG001|Overall Study|Lost to Follow-up|1|||
155421951|NCT01145560|560974398|FG002|Overall Study|Lost to Follow-up|1|||
155421952|NCT01145560|560974396|FG000|Overall Study|No study drug by 24h after organ failure|1|||
155421953|NCT01145560|560974397|FG001|Overall Study|No study drug by 24h after organ failure|0|||
155421954|NCT01145560|560974398|FG002|Overall Study|No study drug by 24h after organ failure|0|||
155421955|NCT01145560|560974396|FG000|Overall Study|Accidental unblinding of study treatment|0|||
155645324|NCT02184156|561792220|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
155645325|NCT01214720|561792222|FG000|Overall Study|Alive and still on treatment|34|||
155645326|NCT01214720|561792223|FG001|Overall Study|Alive and still on treatment|18|||
155645327|NCT01214720|561792222|FG000|Overall Study|Alive and in follow-up|45|||
155645328|NCT01214720|561792223|FG001|Overall Study|Alive and in follow-up|48|||
155645329|NCT01214720|561792222|FG000|Overall Study|Lost to Follow-up|6|||
155645330|NCT01214720|561792223|FG001|Overall Study|Lost to Follow-up|2|||
155645331|NCT05591755|561792224|FG000|Overall Study|Screen Failure|1|||
155645332|NCT05591755|561792225|FG001|Overall Study|Screen Failure|0|||
155645333|NCT05591755|561792226|FG002|Overall Study|Screen Failure|0|||
155645334|NCT05591755|561792227|FG003|Overall Study|Screen Failure|0|||
155645335|NCT05591755|561792224|FG000|Overall Study|Protocol Violation|0|||
155645336|NCT05591755|561792225|FG001|Overall Study|Protocol Violation|0|||
155645337|NCT05591755|561792226|FG002|Overall Study|Protocol Violation|2|||
155645338|NCT05591755|561792227|FG003|Overall Study|Protocol Violation|0|||
155645339|NCT05591755|561792224|FG000|Overall Study|Withdrawal by Subject|0|||
155645340|NCT05591755|561792225|FG001|Overall Study|Withdrawal by Subject|1|||
155645341|NCT05591755|561792226|FG002|Overall Study|Withdrawal by Subject|0|||
155645342|NCT05591755|561792227|FG003|Overall Study|Withdrawal by Subject|0|||
155645343|NCT03158311|561792230|FG000|Overall Study|Subject/Guardian Decision|10|||
155645344|NCT03158311|561792231|FG001|Overall Study|Subject/Guardian Decision|6|||
155645345|NCT03158311|561792232|FG002|Overall Study|Subject/Guardian Decision|11|||
155645346|NCT03158311|561792230|FG000|Overall Study|Adverse Event|5|||
155645347|NCT03158311|561792231|FG001|Overall Study|Adverse Event|3|||
155332241|NCT00229658|560650183|FG001|Overall Study|Other|60|||
155645348|NCT03158311|561792232|FG002|Overall Study|Adverse Event|3|||
155332242|NCT00229658|560650182|FG000|Overall Study|Lost to Follow-up|82|||
155332243|NCT00229658|560650183|FG001|Overall Study|Lost to Follow-up|55|||
155332244|NCT00229658|560650182|FG000|Overall Study|Serious Adverse Event|2|||
155332245|NCT00229658|560650183|FG001|Overall Study|Serious Adverse Event|2|||
155332246|NCT00229658|560650182|FG000|Overall Study|Withdrawal of consent|46|||
155332247|NCT00229658|560650183|FG001|Overall Study|Withdrawal of consent|39|||
155332248|NCT00205179|560650184|FG000|Overall Study|Death|0|||
155332249|NCT00205179|560650185|FG001|Overall Study|Death|2|||
155332250|NCT00205179|560650184|FG000|Overall Study|Physician Decision|1|||
155332251|NCT00205179|560650185|FG001|Overall Study|Physician Decision|1|||
155332252|NCT00205179|560650184|FG000|Overall Study|Adverse Event|1|||
155332253|NCT00205179|560650185|FG001|Overall Study|Adverse Event|1|||
155332254|NCT00463229|560650186|FG000|Overall Study|Lost to Follow-up|5|||
155332255|NCT00463229|560650187|FG001|Overall Study|Lost to Follow-up|7|||
155332256|NCT00463229|560650186|FG000|Overall Study|Death|4|||
155332257|NCT00463229|560650187|FG001|Overall Study|Death|3|||
155332258|NCT01700205|560650194|FG000|Overall Study|Withdrawal by Subject|13|||
155332259|NCT01700205|560650195|FG001|Overall Study|Withdrawal by Subject|13|||
155332260|NCT01700205|560650194|FG000|Overall Study|Protocol Violation|2|||
155332261|NCT01700205|560650195|FG001|Overall Study|Protocol Violation|2|||
155332262|NCT01728324|560650200|FG000|Termination of DBV|Adverse Event|14|||
155332263|NCT01728324|560650201|FG001|Termination of DBV|Adverse Event|13|||
155332264|NCT01728324|560650202|FG002|Termination of DBV|Adverse Event|4|||
155332265|NCT01728324|560650200|FG000|Termination of DBV|Lack of Efficacy|14|||
155332266|NCT01728324|560650201|FG001|Termination of DBV|Lack of Efficacy|12|||
155332267|NCT01728324|560650202|FG002|Termination of DBV|Lack of Efficacy|8|||
155332268|NCT01728324|560650200|FG000|Termination of DBV|Withdrawal by Subject|9|||
155332269|NCT01728324|560650201|FG001|Termination of DBV|Withdrawal by Subject|6|||
155332270|NCT01728324|560650202|FG002|Termination of DBV|Withdrawal by Subject|2|||
155332271|NCT01728324|560650200|FG000|Termination of DBV|Other than stated|1|||
155332272|NCT01728324|560650201|FG001|Termination of DBV|Other than stated|3|||
155332273|NCT01728324|560650202|FG002|Termination of DBV|Other than stated|0|||
155332274|NCT01728324|560650200|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
155332275|NCT01728324|560650201|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
155332276|NCT01728324|560650202|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
155332277|NCT01728324|560650200|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
155332278|NCT01728324|560650201|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
155332279|NCT01728324|560650202|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
155332280|NCT01728324|560650200|FG000|Termination of FDV|Adverse Event|14|||
155332281|NCT01728324|560650201|FG001|Termination of FDV|Adverse Event|13|||
155332282|NCT01728324|560650202|FG002|Termination of FDV|Adverse Event|4|||
155332283|NCT01728324|560650200|FG000|Termination of FDV|Lack of Efficacy|14|||
155332284|NCT01728324|560650201|FG001|Termination of FDV|Lack of Efficacy|12|||
155332285|NCT01728324|560650202|FG002|Termination of FDV|Lack of Efficacy|8|||
155332286|NCT01728324|560650200|FG000|Termination of FDV|Withdrawal by Subject|9|||
155332287|NCT01728324|560650201|FG001|Termination of FDV|Withdrawal by Subject|6|||
155332288|NCT01728324|560650202|FG002|Termination of FDV|Withdrawal by Subject|2|||
155332289|NCT01728324|560650200|FG000|Termination of FDV|Other than stated|1|||
155332290|NCT01728324|560650201|FG001|Termination of FDV|Other than stated|3|||
155332291|NCT01728324|560650202|FG002|Termination of FDV|Other than stated|0|||
155332292|NCT01728324|560650200|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
155332293|NCT01728324|560650201|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
155332294|NCT01728324|560650202|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
155332295|NCT01728324|560650200|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
155332296|NCT01728324|560650201|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
155332297|NCT01728324|560650202|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
155332298|NCT01728324|560650200|FG000|Termination of RBV|Adverse Event|15|||
155332299|NCT01728324|560650201|FG001|Termination of RBV|Adverse Event|16|||
155332300|NCT01728324|560650202|FG002|Termination of RBV|Adverse Event|5|||
155332301|NCT01728324|560650200|FG000|Termination of RBV|Lack of Efficacy|14|||
155332302|NCT01728324|560650201|FG001|Termination of RBV|Lack of Efficacy|11|||
155332303|NCT01728324|560650202|FG002|Termination of RBV|Lack of Efficacy|7|||
155332304|NCT01728324|560650200|FG000|Termination of RBV|Withdrawal by Subject|9|||
155332305|NCT01728324|560650201|FG001|Termination of RBV|Withdrawal by Subject|5|||
155332306|NCT01728324|560650202|FG002|Termination of RBV|Withdrawal by Subject|2|||
155332307|NCT01728324|560650200|FG000|Termination of RBV|Other than stated|1|||
155332308|NCT01728324|560650201|FG001|Termination of RBV|Other than stated|3|||
155332309|NCT01728324|560650202|FG002|Termination of RBV|Other than stated|1|||
155332310|NCT01728324|560650200|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
155332311|NCT01728324|560650201|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
155332312|NCT01728324|560650202|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
155645349|NCT03158311|561792230|FG000|Overall Study|Techinical Problems|3|||
155332313|NCT01728324|560650200|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
155332314|NCT01728324|560650201|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
155332315|NCT01728324|560650202|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
155332316|NCT01170208|560650203|FG000|Overall Study|Withdrawal by Subject|5|||
155332317|NCT01170208|560650204|FG001|Overall Study|Withdrawal by Subject|0|||
155332318|NCT01170208|560650205|FG002|Overall Study|Withdrawal by Subject|1|||
155332319|NCT01170208|560650203|FG000|Overall Study|Protocol Violation|1|||
155332320|NCT01170208|560650204|FG001|Overall Study|Protocol Violation|0|||
155332321|NCT01170208|560650205|FG002|Overall Study|Protocol Violation|1|||
155332322|NCT03113409|560650208|FG000|Overall Study|Withdrawal by Subject|5|||
155332323|NCT03113409|560650209|FG001|Overall Study|Withdrawal by Subject|0|||
155332324|NCT03113409|560650210|FG002|Overall Study|Withdrawal by Subject|0|||
155332325|NCT00388726|560650211|FG000|Overall Study|Adverse Event|50|||
155332326|NCT00388726|560650212|FG001|Overall Study|Adverse Event|24|||
155332327|NCT00388726|560650211|FG000|Overall Study|Progressive Disease|336|||
155332328|NCT00388726|560650212|FG001|Overall Study|Progressive Disease|153|||
155332329|NCT00388726|560650211|FG000|Overall Study|Clinical Progression|61|||
155332330|NCT00388726|560650212|FG001|Overall Study|Clinical Progression|36|||
155332331|NCT00388726|560650211|FG000|Overall Study|Withdrawal by Subject|10|||
155332332|NCT00388726|560650212|FG001|Overall Study|Withdrawal by Subject|7|||
155332333|NCT00388726|560650211|FG000|Overall Study|Administrative|6|||
155332334|NCT00388726|560650212|FG001|Overall Study|Administrative|9|||
155332335|NCT00388726|560650211|FG000|Overall Study|Physician Decision|18|||
155332336|NCT00388726|560650212|FG001|Overall Study|Physician Decision|13|||
155332337|NCT00388726|560650211|FG000|Overall Study|Death|3|||
155332338|NCT00388726|560650212|FG001|Overall Study|Death|2|||
155332339|NCT00641537|560650215|FG000|96-week Period|Adverse Event|0|||
155332340|NCT00641537|560650216|FG001|96-week Period|Adverse Event|1|||
155332341|NCT00641537|560650217|FG002|96-week Period|Adverse Event|3|||
155332342|NCT00641537|560650218|FG003|96-week Period|Adverse Event|0|||
155332343|NCT00641537|560650219|FG004|96-week Period|Adverse Event|2|||
155332344|NCT00641537|560650220|FG005|96-week Period|Adverse Event|0|||
155332345|NCT00641537|560650221|FG006|96-week Period|Adverse Event|0|||
155332346|NCT00641537|560650222|FG007|96-week Period|Adverse Event|0|||
155332347|NCT00641537|560650215|FG000|96-week Period|Lost to Follow-up|3|||
155332348|NCT00641537|560650216|FG001|96-week Period|Lost to Follow-up|1|||
155332349|NCT00641537|560650217|FG002|96-week Period|Lost to Follow-up|2|||
155332350|NCT00641537|560650218|FG003|96-week Period|Lost to Follow-up|2|||
155332351|NCT00641537|560650219|FG004|96-week Period|Lost to Follow-up|4|||
155332352|NCT00641537|560650220|FG005|96-week Period|Lost to Follow-up|0|||
155332353|NCT00641537|560650221|FG006|96-week Period|Lost to Follow-up|1|||
155332354|NCT00641537|560650222|FG007|96-week Period|Lost to Follow-up|0|||
155332355|NCT00641537|560650215|FG000|96-week Period|Protocol Violation|0|||
155332356|NCT00641537|560650216|FG001|96-week Period|Protocol Violation|1|||
155332357|NCT00641537|560650217|FG002|96-week Period|Protocol Violation|0|||
155332358|NCT00641537|560650218|FG003|96-week Period|Protocol Violation|1|||
155332359|NCT00641537|560650219|FG004|96-week Period|Protocol Violation|0|||
155332360|NCT00641537|560650220|FG005|96-week Period|Protocol Violation|1|||
155332361|NCT00641537|560650221|FG006|96-week Period|Protocol Violation|0|||
155332362|NCT00641537|560650222|FG007|96-week Period|Protocol Violation|0|||
155332363|NCT00641537|560650215|FG000|96-week Period|Death|2|||
155332364|NCT00641537|560650216|FG001|96-week Period|Death|0|||
155332365|NCT00641537|560650217|FG002|96-week Period|Death|1|||
155332366|NCT00641537|560650218|FG003|96-week Period|Death|0|||
155332367|NCT00641537|560650219|FG004|96-week Period|Death|0|||
155332368|NCT00641537|560650220|FG005|96-week Period|Death|0|||
155332369|NCT00641537|560650221|FG006|96-week Period|Death|0|||
155332370|NCT00641537|560650222|FG007|96-week Period|Death|0|||
155332371|NCT00641537|560650215|FG000|96-week Period|Other|4|||
155332372|NCT00641537|560650216|FG001|96-week Period|Other|7|||
155332373|NCT00641537|560650217|FG002|96-week Period|Other|14|||
155332374|NCT00641537|560650218|FG003|96-week Period|Other|9|||
155332375|NCT00641537|560650219|FG004|96-week Period|Other|11|||
155332376|NCT00641537|560650220|FG005|96-week Period|Other|6|||
155332377|NCT00641537|560650221|FG006|96-week Period|Other|4|||
155332378|NCT00641537|560650222|FG007|96-week Period|Other|6|||
155332379|NCT00641537|560650215|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332380|NCT00641537|560650216|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332381|NCT00641537|560650217|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332382|NCT00641537|560650218|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
155332383|NCT00641537|560650219|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
155332384|NCT00641537|560650220|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332385|NCT00641537|560650221|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332386|NCT00641537|560650222|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332387|NCT00641537|560650215|FG000|24-Week Supplemental Follow-up Period|Other|0|||
155332388|NCT00641537|560650216|FG001|24-Week Supplemental Follow-up Period|Other|2|||
155332389|NCT00641537|560650217|FG002|24-Week Supplemental Follow-up Period|Other|2|||
155332390|NCT00641537|560650218|FG003|24-Week Supplemental Follow-up Period|Other|1|||
155332391|NCT00641537|560650219|FG004|24-Week Supplemental Follow-up Period|Other|3|||
155332392|NCT00641537|560650220|FG005|24-Week Supplemental Follow-up Period|Other|0|||
155332393|NCT00641537|560650221|FG006|24-Week Supplemental Follow-up Period|Other|1|||
155332394|NCT00641537|560650222|FG007|24-Week Supplemental Follow-up Period|Other|1|||
155421956|NCT01145560|560974397|FG001|Overall Study|Accidental unblinding of study treatment|1|||
155421957|NCT01145560|560974398|FG002|Overall Study|Accidental unblinding of study treatment|0|||
155421958|NCT01145560|560974396|FG000|Overall Study|False insurance information|0|||
155332395|NCT03229408|560650223|FG000|Overall Study|Withdrawal by Subject|4|||
155332396|NCT03229408|560650224|FG001|Overall Study|Withdrawal by Subject|1|||
155332397|NCT03229408|560650223|FG000|Overall Study|Adverse Event|2|||
155332398|NCT03229408|560650224|FG001|Overall Study|Adverse Event|0|||
155332399|NCT03229408|560650223|FG000|Overall Study|Pregnancy|0|||
155332400|NCT03229408|560650224|FG001|Overall Study|Pregnancy|1|||
155332401|NCT03229408|560650223|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
155332402|NCT03229408|560650224|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
155332403|NCT03745313|560650229|FG000|At 30 Days Follow-up|Death|2|||
155332404|NCT03745313|560650229|FG000|At 6 Months Follow-up|Death|1|||
155332405|NCT03745313|560650229|FG000|At 6 Months Follow-up|Missed Visit|1|||
155332406|NCT03745313|560650229|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
155332407|NCT03745313|560650229|FG000|At 1 Year Follow-up|Death|2|||
155332408|NCT03745313|560650229|FG000|At 1 Year Follow-up|Missed Visit|2|||
155332409|NCT03745313|560650229|FG000|At 2 Year Follow-up|Missed Visit|1|||
155332410|NCT01706159|560650230|FG000|Overall Study|Withdrawal Criteria|2|||
155332411|NCT01706159|560650231|FG001|Overall Study|Withdrawal Criteria|1|||
155332412|NCT01706159|560650230|FG000|Overall Study|Unclassified|6|||
155332413|NCT01706159|560650231|FG001|Overall Study|Unclassified|1|||
155332414|NCT02235298|560650239|FG000|Overall Study|Lost to Follow-up|6|||
155332415|NCT02235298|560650240|FG001|Overall Study|Lost to Follow-up|5|||
155332416|NCT02235298|560650239|FG000|Overall Study|Adverse Event|2|||
155332417|NCT02235298|560650240|FG001|Overall Study|Adverse Event|2|||
155332418|NCT02235298|560650239|FG000|Overall Study|Withdrawal by Subject|0|||
155332419|NCT02235298|560650240|FG001|Overall Study|Withdrawal by Subject|1|||
155332420|NCT02628626|560650245|FG000|Overall Study|Withdrawal by Subject|2|||
155332421|NCT02628626|560650246|FG001|Overall Study|Withdrawal by Subject|2|||
155332422|NCT01593020|560650247|FG000|Overall Study|Adverse Event|1|||
155332423|NCT01593020|560650248|FG001|Overall Study|Adverse Event|1|||
155332424|NCT01593020|560650247|FG000|Overall Study|Death|0|||
155332425|NCT01593020|560650248|FG001|Overall Study|Death|1|||
155332426|NCT01593020|560650247|FG000|Overall Study|Ineligible|1|||
155332427|NCT01593020|560650248|FG001|Overall Study|Ineligible|0|||
155332428|NCT02454959|560650249|FG000|Overall Study|Protocol-Specified Criteria|3|||
155332429|NCT02454959|560650249|FG000|Overall Study|Physician Decision|1|||
155332430|NCT02454959|560650249|FG000|Overall Study|Withdrawal by Subject|3|||
155332431|NCT02454959|560650249|FG000|Overall Study|Adverse Event|2|||
155332432|NCT02350634|560650250|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
155421959|NCT01145560|560974397|FG001|Overall Study|False insurance information|1|||
155421960|NCT01145560|560974398|FG002|Overall Study|False insurance information|0|||
155645350|NCT03158311|561792231|FG001|Overall Study|Techinical Problems|1|||
155421961|NCT01145560|560974396|FG000|Overall Study|Withdrawal of therapy|0|||
155421962|NCT01145560|560974397|FG001|Overall Study|Withdrawal of therapy|0|||
155332433|NCT03102034|560650261|FG000|Overall Study|Withdrawal by Subject|1|||
155332434|NCT03102034|560650262|FG001|Overall Study|Withdrawal by Subject|0|||
155332435|NCT03611075|560650266|FG000|Overall Study|Physician Decision|0|||
155332436|NCT03611075|560650267|FG001|Overall Study|Physician Decision|1|||
155332437|NCT03611075|560650268|FG002|Overall Study|Physician Decision|1|||
155332438|NCT03611075|560650269|FG003|Overall Study|Physician Decision|0|||
155332439|NCT03611075|560650270|FG004|Overall Study|Physician Decision|0|||
155332440|NCT03611075|560650271|FG005|Overall Study|Physician Decision|0|||
155332441|NCT03611075|560650272|FG006|Overall Study|Physician Decision|0|||
155332442|NCT03611075|560650273|FG007|Overall Study|Physician Decision|0|||
155332443|NCT03611075|560650274|FG008|Overall Study|Physician Decision|0|||
155332444|NCT03611075|560650266|FG000|Overall Study|Lost to Follow-up|1|||
155332445|NCT03611075|560650267|FG001|Overall Study|Lost to Follow-up|0|||
155332446|NCT03611075|560650268|FG002|Overall Study|Lost to Follow-up|0|||
155332447|NCT03611075|560650269|FG003|Overall Study|Lost to Follow-up|2|||
155332448|NCT03611075|560650270|FG004|Overall Study|Lost to Follow-up|0|||
155332449|NCT03611075|560650271|FG005|Overall Study|Lost to Follow-up|0|||
155332450|NCT03611075|560650272|FG006|Overall Study|Lost to Follow-up|0|||
155332451|NCT03611075|560650273|FG007|Overall Study|Lost to Follow-up|0|||
155332452|NCT03611075|560650274|FG008|Overall Study|Lost to Follow-up|0|||
155332453|NCT03611075|560650266|FG000|Overall Study|Withdrawal by Subject|0|||
155332454|NCT03611075|560650267|FG001|Overall Study|Withdrawal by Subject|1|||
155332455|NCT03611075|560650268|FG002|Overall Study|Withdrawal by Subject|1|||
155332456|NCT03611075|560650269|FG003|Overall Study|Withdrawal by Subject|1|||
155332457|NCT03611075|560650270|FG004|Overall Study|Withdrawal by Subject|0|||
155332458|NCT03611075|560650271|FG005|Overall Study|Withdrawal by Subject|0|||
155332459|NCT03611075|560650272|FG006|Overall Study|Withdrawal by Subject|1|||
155332460|NCT03611075|560650273|FG007|Overall Study|Withdrawal by Subject|0|||
155332461|NCT03611075|560650274|FG008|Overall Study|Withdrawal by Subject|0|||
155332462|NCT03611075|560650266|FG000|Overall Study|Reason unknown|0|||
155421963|NCT01145560|560974398|FG002|Overall Study|Withdrawal of therapy|1|||
155421964|NCT02149810|560974400|FG000|Overall Study|Physician Decision|1|||
155421965|NCT02149810|560974401|FG001|Overall Study|Physician Decision|2|||
155421966|NCT02149810|560974400|FG000|Overall Study|Lost to Follow-up|2|||
155421967|NCT02149810|560974401|FG001|Overall Study|Lost to Follow-up|1|||
155332463|NCT03611075|560650267|FG001|Overall Study|Reason unknown|0|||
155332464|NCT03611075|560650268|FG002|Overall Study|Reason unknown|0|||
155332465|NCT03611075|560650269|FG003|Overall Study|Reason unknown|1|||
155332466|NCT03611075|560650270|FG004|Overall Study|Reason unknown|0|||
155332467|NCT03611075|560650271|FG005|Overall Study|Reason unknown|0|||
155332468|NCT03611075|560650272|FG006|Overall Study|Reason unknown|1|||
155421968|NCT02149810|560974400|FG000|Overall Study|Withdrawal by Subject|5|||
155332469|NCT03611075|560650273|FG007|Overall Study|Reason unknown|0|||
155332470|NCT03611075|560650274|FG008|Overall Study|Reason unknown|0|||
155421969|NCT02149810|560974401|FG001|Overall Study|Withdrawal by Subject|1|||
155332471|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Adverse Event|1|||
155332472|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155332473|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155332474|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155332475|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Physician Decision|1|||
155332476|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Physician Decision|0|||
155332477|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Physician Decision|0|||
155332478|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Physician Decision|0|||
155332479|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
155332480|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
155332481|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
155332482|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
155332483|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332484|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332485|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332486|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
155332487|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332488|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332489|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332490|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
155332491|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332492|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332493|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332494|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
155332495|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332496|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332497|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332498|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
155332499|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332500|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332501|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332502|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
155332503|NCT02972359|560650279|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
155332504|NCT02972359|560650279|FG000|Overall Study|Lack of Efficacy|1|||
155332505|NCT02972359|560650279|FG000|Overall Study|Adverse Event|4|||
155332506|NCT02972359|560650279|FG000|Overall Study|Death|1|||
155332507|NCT02972359|560650279|FG000|Overall Study|Withdrawal by Subject|30|||
155332508|NCT02972359|560650279|FG000|Overall Study|Protocol Violation|1|||
155332509|NCT02972359|560650279|FG000|Overall Study|Lost to Follow-up|26|||
155332510|NCT02972359|560650279|FG000|Overall Study|Other reasons|5|||
155332511|NCT02972359|560650279|FG000|Overall Study|Missing|1|||
155332512|NCT02830204|560650282|FG000|Overall Study|Death|9|||
155332513|NCT02830204|560650282|FG000|Overall Study|Withdrawal by Subject|1|||
155332514|NCT02517268|560650285|FG000|Overall Study|Withdrawal by Subject|1|||
155332515|NCT02517268|560650286|FG001|Overall Study|Withdrawal by Subject|0|||
155332516|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332517|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332518|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332519|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
155332520|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332521|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332522|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332523|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332524|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332525|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332526|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
155332527|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332528|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155421970|NCT04082663|560974419|FG000|Overall Study|Adverse Event|6|||
155421971|NCT04082663|560974419|FG000|Overall Study|Lost to Follow-up|1|||
155421972|NCT02542072|560974420|FG000|First Intervention (1 Month)|Adverse Event|1|||
155421973|NCT02542072|560974421|FG001|First Intervention (1 Month)|Adverse Event|1|||
155421974|NCT02542072|560974420|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
155421975|NCT02542072|560974421|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
155421976|NCT02542072|560974420|FG000|First Intervention (1 Month)|Lens discomfort|1|||
155421977|NCT02542072|560974421|FG001|First Intervention (1 Month)|Lens discomfort|2|||
155421978|NCT02542072|560974420|FG000|First Intervention (1 Month)|Protocol Violation|1|||
155421979|NCT02542072|560974421|FG001|First Intervention (1 Month)|Protocol Violation|0|||
155421980|NCT02542072|560974420|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
155421981|NCT02542072|560974421|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
155421982|NCT02542072|560974420|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
155421983|NCT02542072|560974421|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
155332529|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
155332530|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332531|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332532|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332533|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332534|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332535|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332536|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Death|1|||
155332537|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Death|2|||
155332538|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Death|3|||
155332539|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Death|5|||
155332540|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Death|4|||
155332541|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Death|0|||
155332542|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Death|0|||
155332543|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Death|0|||
155332544|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Death|0|||
155332545|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Death|0|||
155332546|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332547|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
155332548|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332549|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332550|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
155332551|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332552|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332553|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332554|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332555|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332556|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
155332557|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332558|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332559|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332560|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
155332561|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332562|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332563|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332564|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332565|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332566|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332567|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332568|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332569|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332570|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332571|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
155332572|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332573|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332574|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332575|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332576|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332577|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332578|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332579|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332580|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332581|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332582|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
155332583|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155421984|NCT05032950|560974423|FG000|Overall Study|Adverse Event|0|||
155332584|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332585|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332586|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332587|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332588|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332589|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332590|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332591|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
155332592|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
155332593|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332594|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332595|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332596|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332597|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332598|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332599|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332600|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332601|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
155332602|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332603|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332604|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332605|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332606|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332607|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332608|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332609|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332610|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332611|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332612|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332613|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
155332614|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
155332615|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
155332616|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332617|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332618|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332619|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332620|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332621|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332622|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332623|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332624|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
155332625|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
155332626|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332627|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332628|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332629|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332630|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332631|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332632|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332633|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332634|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332635|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
155332636|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332637|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332638|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332639|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332640|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332641|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155421985|NCT05032950|560974424|FG001|Overall Study|Adverse Event|0|||
155421986|NCT05032950|560974425|FG002|Overall Study|Adverse Event|1|||
155421987|NCT05032950|560974426|FG003|Overall Study|Adverse Event|1|||
155332642|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332643|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332644|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
155332645|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332646|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332647|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332648|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332649|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332650|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332651|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332652|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332653|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
155332654|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332655|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
155332656|NCT00378898|560651308|FG000|Overall Study|Withdrawal by Subject|10|||
155332657|NCT00378898|560651309|FG001|Overall Study|Withdrawal by Subject|5|||
155332658|NCT00378898|560651308|FG000|Overall Study|Protocol Violation|1|||
155332659|NCT00378898|560651309|FG001|Overall Study|Protocol Violation|1|||
155332660|NCT03116464|560651311|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
155332661|NCT00345046|560651314|FG000|Overall Study|Protocol Violation|1|||
155332662|NCT00345046|560651315|FG001|Overall Study|Protocol Violation|1|||
155332663|NCT00345046|560651316|FG002|Overall Study|Protocol Violation|2|||
155332664|NCT03689946|560651317|FG000|Overall Study|Withdrawal by Subject|3|||
155332665|NCT03689946|560651317|FG000|Overall Study|Lost to Follow-up|3|||
155332666|NCT03689946|560651317|FG000|Overall Study|Data corruption|2|||
155332667|NCT04608409|560651322|FG000|Overall Study|Physician Decision|1|||
155332668|NCT04608409|560651323|FG001|Overall Study|Physician Decision|1|||
155332669|NCT04608409|560651324|FG002|Overall Study|Physician Decision|2|||
155332670|NCT01787032|560651325|FG000|Overall Study|Protocol Violation|0|||
155332671|NCT01787032|560651326|FG001|Overall Study|Protocol Violation|0|||
155332672|NCT01787032|560651327|FG002|Overall Study|Protocol Violation|0|||
155332673|NCT01787032|560651328|FG003|Overall Study|Protocol Violation|0|||
155332674|NCT01787032|560651329|FG004|Overall Study|Protocol Violation|1|||
155332675|NCT01787032|560651330|FG005|Overall Study|Protocol Violation|1|||
155332676|NCT00687219|560651336|FG000|Overall Study|Adverse Event|8|||
155332677|NCT00687219|560651336|FG000|Overall Study|Discontinuance criteria met|7|||
155332678|NCT00687219|560651336|FG000|Overall Study|HCV-RNA positive conversion|34|||
155332679|NCT00687219|560651336|FG000|Overall Study|Withdrawal by Subject|1|||
155332680|NCT00687219|560651336|FG000|Overall Study|Lack of Efficacy|1|||
155332681|NCT04827732|560651348|FG000|Overall Study|Did not start treatment|0|||
155332682|NCT04827732|560651349|FG001|Overall Study|Did not start treatment|1|||
155332683|NCT04827732|560651350|FG002|Overall Study|Did not start treatment|0|||
155332684|NCT04827732|560651351|FG003|Overall Study|Did not start treatment|1|||
155332685|NCT04300023|560651354|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
155332686|NCT04300023|560651355|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
155332687|NCT05025384|560651362|FG000|Overall Study|Physician Decision|5|||
155332688|NCT05025384|560651363|FG001|Overall Study|Physician Decision|6|||
155332689|NCT04057131|560651364|FG000|Overall Study|Protocol Violation|24|||
155332690|NCT04686266|560651367|FG000|Overall Study|Withdrawal by Subject|0|||
155332691|NCT04686266|560651368|FG001|Overall Study|Withdrawal by Subject|1|||
155332692|NCT05613907|560651373|FG000|Overall Study|Lost to Follow-up|5|||
155332693|NCT05613907|560651373|FG000|Overall Study|Death|3|||
155332694|NCT05613907|560651373|FG000|Overall Study|Withdrawal by Subject|2|||
155332695|NCT00748709|560651383|FG000|Overall Study|Progressive disease|15|||
155332696|NCT00748709|560651383|FG000|Overall Study|Drug reducing Toxity|2|||
155421988|NCT05032950|560974427|FG004|Overall Study|Adverse Event|0|||
155421989|NCT05032950|560974428|FG005|Overall Study|Adverse Event|0|||
155421990|NCT01990261|560974429|FG000|Overall Study|Death Before Treatment Start|2|||
155421991|NCT01990261|560974429|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
155421992|NCT01990261|560974429|FG000|Overall Study|Death From other Causes|1|||
155332697|NCT00748709|560651383|FG000|Overall Study|Other Adverse Event|1|||
155421993|NCT01990261|560974429|FG000|Overall Study|Disease Progression (PD)|8|||
155332698|NCT00748709|560651383|FG000|Overall Study|Withdrawal by Subject|1|||
155332699|NCT00748709|560651383|FG000|Overall Study|Other Reasons|1|||
155332700|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
155332701|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332702|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332703|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
155332704|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332705|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332706|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332707|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
155332708|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332709|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332710|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
155502581|NCT01902134|561267243|FG001|Overall Study|Lack of Efficacy|0|||
155502582|NCT01902134|561267244|FG002|Overall Study|Lack of Efficacy|2|||
155502583|NCT01902134|561267245|FG003|Overall Study|Lack of Efficacy|0|||
155502584|NCT01902134|561267246|FG004|Overall Study|Lack of Efficacy|0|||
155502585|NCT01902134|561267247|FG005|Overall Study|Lack of Efficacy|1|||
155502586|NCT01902134|561267242|FG000|Overall Study|Physician Decision|0|||
155502587|NCT01902134|561267243|FG001|Overall Study|Physician Decision|1|||
155502588|NCT01902134|561267244|FG002|Overall Study|Physician Decision|0|||
155332711|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332712|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332713|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332714|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332715|NCT03789656|560651384|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
155332716|NCT03789656|560651385|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332717|NCT03789656|560651386|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332718|NCT03789656|560651387|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332719|NCT03789656|560651388|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332720|NCT05325294|560651394|FG000|Overall Study|Adverse Event|3|||
155332721|NCT05325294|560651395|FG001|Overall Study|Adverse Event|3|||
155332722|NCT05325294|560651394|FG000|Overall Study|Physician Decision|0|||
155332723|NCT05325294|560651395|FG001|Overall Study|Physician Decision|1|||
155332724|NCT05325294|560651394|FG000|Overall Study|Withdrawal by Subject|0|||
155332725|NCT05325294|560651395|FG001|Overall Study|Withdrawal by Subject|3|||
155332726|NCT05325294|560651394|FG000|Overall Study|Lost to Follow-up|1|||
155332727|NCT05325294|560651395|FG001|Overall Study|Lost to Follow-up|0|||
155332728|NCT05325294|560651394|FG000|Overall Study|Sponsor Request|0|||
155332729|NCT05325294|560651395|FG001|Overall Study|Sponsor Request|2|||
155332730|NCT00491894|560651396|FG000|Overall Study|Adverse Event|14|||
155332731|NCT00491894|560651396|FG000|Overall Study|Withdrawal by Subject|5|||
155332732|NCT00491894|560651396|FG000|Overall Study|Death|3|||
155332733|NCT00491894|560651396|FG000|Overall Study|Lost to Follow-up|3|||
155332734|NCT00491894|560651396|FG000|Overall Study|Lack of Efficacy|2|||
155332735|NCT00491894|560651396|FG000|Overall Study|Other-Failed to meet any criteria|2|||
155332736|NCT00491894|560651396|FG000|Overall Study|Physician Decision|2|||
155332737|NCT00491894|560651396|FG000|Overall Study|Protocol Violation|2|||
155332738|NCT00491894|560651396|FG000|Overall Study|Other-Intake of prohibited medication|1|||
155332739|NCT01563185|560651397|FG000|Overall Study|Withdrawal by Subject|1|||
155332740|NCT01563185|560651397|FG000|Overall Study|Non-Compliance with study drug|1|||
155332741|NCT04577651|560651398|FG000|Overall Study|Screen Failure|7|||
155332742|NCT04577651|560651398|FG000|Overall Study|Adverse Event|1|||
155332743|NCT04577651|560651398|FG000|Overall Study|Death|1|||
155332744|NCT04577651|560651398|FG000|Overall Study|Physician Decision|1|||
155332745|NCT04577651|560651398|FG000|Overall Study|Withdrawal by Subject|3|||
155332746|NCT05422339|560652642|FG000|Overall Study|Withdrawal by Subject|17|||
155332747|NCT05422339|560652643|FG001|Overall Study|Withdrawal by Subject|15|||
155332748|NCT04172675|560652644|FG000|Overall Study|Withdrawal by Subject|7|||
155502589|NCT01902134|561267245|FG003|Overall Study|Physician Decision|0|||
155502590|NCT01902134|561267246|FG004|Overall Study|Physician Decision|0|||
155502591|NCT01902134|561267247|FG005|Overall Study|Physician Decision|0|||
155332749|NCT04172675|560652645|FG001|Overall Study|Withdrawal by Subject|5|||
155332750|NCT04172675|560652646|FG002|Overall Study|Withdrawal by Subject|1|||
155332751|NCT04172675|560652647|FG003|Overall Study|Withdrawal by Subject|4|||
155332752|NCT03070392|560652648|FG000|Overall Study|Not Treated|7|||
155332753|NCT03070392|560652649|FG001|Overall Study|Not Treated|0|||
155332754|NCT03070392|560652650|FG002|Overall Study|Not Treated|3|||
155332755|NCT03070392|560652651|FG003|Overall Study|Not Treated|12|||
155332756|NCT03070392|560652648|FG000|Overall Study|Death|3|||
155332757|NCT03070392|560652649|FG001|Overall Study|Death|0|||
155332758|NCT03070392|560652650|FG002|Overall Study|Death|0|||
155332759|NCT03070392|560652651|FG003|Overall Study|Death|1|||
155332760|NCT03070392|560652648|FG000|Overall Study|Withdrawal by Subject|7|||
155332761|NCT03070392|560652649|FG001|Overall Study|Withdrawal by Subject|0|||
155332762|NCT03070392|560652650|FG002|Overall Study|Withdrawal by Subject|0|||
155332763|NCT03070392|560652651|FG003|Overall Study|Withdrawal by Subject|3|||
155332764|NCT03070392|560652648|FG000|Overall Study|Physician Decision|1|||
155332765|NCT03070392|560652649|FG001|Overall Study|Physician Decision|0|||
155332766|NCT03070392|560652650|FG002|Overall Study|Physician Decision|0|||
155332767|NCT03070392|560652651|FG003|Overall Study|Physician Decision|2|||
155332768|NCT03070392|560652648|FG000|Overall Study|Progressive Disease|154|||
155332769|NCT03070392|560652649|FG001|Overall Study|Progressive Disease|6|||
155332770|NCT03070392|560652650|FG002|Overall Study|Progressive Disease|2|||
155332771|NCT03070392|560652651|FG003|Overall Study|Progressive Disease|70|||
155332772|NCT03070392|560652648|FG000|Overall Study|Adverse Event|6|||
155332773|NCT03070392|560652649|FG001|Overall Study|Adverse Event|1|||
155332774|NCT03070392|560652650|FG002|Overall Study|Adverse Event|1|||
155332775|NCT03070392|560652651|FG003|Overall Study|Adverse Event|3|||
155332776|NCT03070392|560652648|FG000|Overall Study|Alternate anticancer treatment|1|||
155332777|NCT03070392|560652649|FG001|Overall Study|Alternate anticancer treatment|0|||
155332778|NCT03070392|560652650|FG002|Overall Study|Alternate anticancer treatment|0|||
155332779|NCT03070392|560652651|FG003|Overall Study|Alternate anticancer treatment|1|||
155332780|NCT03070392|560652648|FG000|Overall Study|Ongoing|73|||
155332781|NCT03070392|560652649|FG001|Overall Study|Ongoing|0|||
155421994|NCT01990261|560974429|FG000|Overall Study|PD Before Treatment Start|1|||
155421995|NCT01990261|560974429|FG000|Overall Study|Dossier not Approved|1|||
155332782|NCT03070392|560652650|FG002|Overall Study|Ongoing|0|||
155421996|NCT01990261|560974429|FG000|Overall Study|Lost to Follow-up|2|||
155332783|NCT03070392|560652651|FG003|Overall Study|Ongoing|11|||
155332784|NCT02534233|560652657|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
155332785|NCT00925548|560652658|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
155332786|NCT00925548|560652659|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
155332787|NCT01278030|560652660|FG000|Overall Study|Withdrawal by Subject|8|||
155332788|NCT01278030|560652661|FG001|Overall Study|Withdrawal by Subject|4|||
155332789|NCT00458783|560652663|FG000|Overall Study|Protocol Violation|1228|||
155332790|NCT00458783|560652664|FG001|Overall Study|Protocol Violation|1220|||
155332791|NCT01737398|560652665|FG000|Overall Study|Adverse event or SAE|16|||
155332792|NCT01737398|560652666|FG001|Overall Study|Adverse event or SAE|1|||
155332793|NCT01737398|560652665|FG000|Overall Study|Stopping rule met|2|||
155332794|NCT01737398|560652666|FG001|Overall Study|Stopping rule met|1|||
155332795|NCT01737398|560652665|FG000|Overall Study|Voluntary withdrawal|2|||
155332796|NCT01737398|560652666|FG001|Overall Study|Voluntary withdrawal|3|||
155332797|NCT01737398|560652665|FG000|Overall Study|Ineligibility|1|||
155332798|NCT01737398|560652666|FG001|Overall Study|Ineligibility|0|||
155332799|NCT01737398|560652665|FG000|Overall Study|Liver transplant|1|||
155332800|NCT01737398|560652666|FG001|Overall Study|Liver transplant|0|||
155332801|NCT01737398|560652665|FG000|Overall Study|Disease progression|2|||
155332802|NCT01737398|560652666|FG001|Overall Study|Disease progression|3|||
155332803|NCT01737398|560652665|FG000|Overall Study|Sponsor's decision|2|||
155332804|NCT01737398|560652666|FG001|Overall Study|Sponsor's decision|0|||
155332805|NCT02372799|560652669|FG000|Treatment Period|Adverse Event|3|||
155332806|NCT02372799|560652670|FG001|Treatment Period|Adverse Event|10|||
155332807|NCT02372799|560652671|FG002|Treatment Period|Adverse Event|6|||
155332808|NCT02372799|560652669|FG000|Treatment Period|Insufficient therapeutic response|2|||
155332809|NCT02372799|560652670|FG001|Treatment Period|Insufficient therapeutic response|2|||
155332810|NCT02372799|560652671|FG002|Treatment Period|Insufficient therapeutic response|0|||
155332811|NCT02372799|560652669|FG000|Treatment Period|Withdrawal by Subject|10|||
155332812|NCT02372799|560652670|FG001|Treatment Period|Withdrawal by Subject|10|||
155332813|NCT02372799|560652671|FG002|Treatment Period|Withdrawal by Subject|2|||
155332814|NCT02372799|560652669|FG000|Treatment Period|Lost to Follow-up|11|||
155332815|NCT02372799|560652670|FG001|Treatment Period|Lost to Follow-up|5|||
155332816|NCT02372799|560652671|FG002|Treatment Period|Lost to Follow-up|3|||
155332817|NCT02372799|560652669|FG000|Treatment Period|Protocol Violation|3|||
155332818|NCT02372799|560652670|FG001|Treatment Period|Protocol Violation|0|||
155332819|NCT02372799|560652671|FG002|Treatment Period|Protocol Violation|0|||
155332820|NCT02372799|560652669|FG000|Treatment Period|Non-compliance with study drug|4|||
155332821|NCT02372799|560652670|FG001|Treatment Period|Non-compliance with study drug|4|||
155332822|NCT02372799|560652671|FG002|Treatment Period|Non-compliance with study drug|4|||
155332823|NCT02372799|560652669|FG000|Treatment Period|Miscellaneous Reasons|1|||
155332824|NCT02372799|560652670|FG001|Treatment Period|Miscellaneous Reasons|1|||
155332825|NCT02372799|560652671|FG002|Treatment Period|Miscellaneous Reasons|0|||
155332826|NCT02372799|560652669|FG000|Down-taper Period|Lost to Follow-up|1|||
155332827|NCT02372799|560652670|FG001|Down-taper Period|Lost to Follow-up|2|||
155332828|NCT02372799|560652671|FG002|Down-taper Period|Lost to Follow-up|2|||
155332829|NCT00089609|560652672|FG000|Overall Study|Withdrawal by Subject|3|||
155332830|NCT00089609|560652673|FG001|Overall Study|Withdrawal by Subject|1|||
155332831|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
155332832|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
155332833|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
155332834|NCT05815342|560652675|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
155332835|NCT05815342|560652675|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
155332836|NCT01555138|560652680|FG000|Overall Study|Death|0|||
155332837|NCT01555138|560652681|FG001|Overall Study|Death|1|||
155332838|NCT01555138|560652680|FG000|Overall Study|Lost to Follow-up|1|||
155332839|NCT01555138|560652681|FG001|Overall Study|Lost to Follow-up|0|||
155332840|NCT01555138|560652680|FG000|Overall Study|Abnormal Lab reults|1|||
155332841|NCT01555138|560652681|FG001|Overall Study|Abnormal Lab reults|3|||
155332842|NCT01555138|560652680|FG000|Overall Study|Lack of Efficacy|2|||
155332843|NCT01555138|560652681|FG001|Overall Study|Lack of Efficacy|2|||
155332844|NCT01555138|560652680|FG000|Overall Study|Protocol Violation|5|||
155332845|NCT01555138|560652681|FG001|Overall Study|Protocol Violation|3|||
155332846|NCT01555138|560652680|FG000|Overall Study|Administrative problems|8|||
155332847|NCT01555138|560652681|FG001|Overall Study|Administrative problems|0|||
155332848|NCT01555138|560652680|FG000|Overall Study|Withdrawal by Subject|16|||
155645351|NCT03158311|561792232|FG002|Overall Study|Techinical Problems|5|||
155645352|NCT03158311|561792230|FG000|Overall Study|Physician Decision|2|||
155332849|NCT01555138|560652681|FG001|Overall Study|Withdrawal by Subject|15|||
155332850|NCT01555138|560652680|FG000|Overall Study|Adverse Event|14|||
155332851|NCT01555138|560652681|FG001|Overall Study|Adverse Event|14|||
155332852|NCT03220724|560652683|FG000|Overall Study|Lost to Follow-up|2|||
155645353|NCT03158311|561792231|FG001|Overall Study|Physician Decision|3|||
155645354|NCT03158311|561792232|FG002|Overall Study|Physician Decision|7|||
155645355|NCT03158311|561792230|FG000|Overall Study|Lost to Follow-up|1|||
155645356|NCT03158311|561792231|FG001|Overall Study|Lost to Follow-up|1|||
155645357|NCT03158311|561792232|FG002|Overall Study|Lost to Follow-up|1|||
155645358|NCT03158311|561792230|FG000|Overall Study|Sponsor decision|1|||
155645359|NCT03158311|561792231|FG001|Overall Study|Sponsor decision|0|||
155645360|NCT03158311|561792232|FG002|Overall Study|Sponsor decision|0|||
155645361|NCT03158311|561792230|FG000|Overall Study|Pregnancy|0|||
155332853|NCT03220724|560652684|FG001|Overall Study|Lost to Follow-up|2|||
155332854|NCT03220724|560652685|FG002|Overall Study|Lost to Follow-up|0|||
155332855|NCT03220724|560652686|FG003|Overall Study|Lost to Follow-up|3|||
155332856|NCT03220724|560652687|FG004|Overall Study|Lost to Follow-up|1|||
155332857|NCT03220724|560652688|FG005|Overall Study|Lost to Follow-up|0|||
155332858|NCT03220724|560652689|FG006|Overall Study|Lost to Follow-up|2|||
155332859|NCT03220724|560652690|FG007|Overall Study|Lost to Follow-up|1|||
155332860|NCT03220724|560652691|FG008|Overall Study|Lost to Follow-up|0|||
155332861|NCT03220724|560652683|FG000|Overall Study|Withdrawal by Subject|1|||
155332862|NCT03220724|560652684|FG001|Overall Study|Withdrawal by Subject|0|||
155332863|NCT03220724|560652685|FG002|Overall Study|Withdrawal by Subject|1|||
155332864|NCT03220724|560652686|FG003|Overall Study|Withdrawal by Subject|0|||
155332865|NCT03220724|560652687|FG004|Overall Study|Withdrawal by Subject|0|||
155332866|NCT03220724|560652688|FG005|Overall Study|Withdrawal by Subject|0|||
155332867|NCT03220724|560652689|FG006|Overall Study|Withdrawal by Subject|0|||
155332868|NCT03220724|560652690|FG007|Overall Study|Withdrawal by Subject|0|||
155332869|NCT03220724|560652691|FG008|Overall Study|Withdrawal by Subject|0|||
155332870|NCT01613417|560652692|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
155332871|NCT01613417|560652693|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
155332872|NCT00512252|560652694|FG000|Overall Study|Lost to Follow-up|0|||
155332873|NCT00512252|560652695|FG001|Overall Study|Lost to Follow-up|0|||
155332874|NCT00512252|560652696|FG002|Overall Study|Lost to Follow-up|1|||
155332875|NCT00512252|560652694|FG000|Overall Study|Protocol Violation|0|||
155332876|NCT00512252|560652695|FG001|Overall Study|Protocol Violation|0|||
155332877|NCT00512252|560652696|FG002|Overall Study|Protocol Violation|1|||
155332878|NCT00512252|560652694|FG000|Overall Study|Death|0|||
155332879|NCT00512252|560652695|FG001|Overall Study|Death|0|||
155332880|NCT00512252|560652696|FG002|Overall Study|Death|1|||
155332881|NCT02357966|560652697|FG000|Overall Study|Death|0|||
155332882|NCT02357966|560652698|FG001|Overall Study|Death|0|||
155332883|NCT02357966|560652699|FG002|Overall Study|Death|1|||
155332884|NCT02357966|560652700|FG003|Overall Study|Death|0|||
155332885|NCT02357966|560652701|FG004|Overall Study|Death|2|||
155332886|NCT02357966|560652702|FG005|Overall Study|Death|0|||
155332887|NCT02357966|560652697|FG000|Overall Study|Physician Decision|1|||
155332888|NCT02357966|560652698|FG001|Overall Study|Physician Decision|0|||
155332889|NCT02357966|560652699|FG002|Overall Study|Physician Decision|0|||
155332890|NCT02357966|560652700|FG003|Overall Study|Physician Decision|0|||
155332891|NCT02357966|560652701|FG004|Overall Study|Physician Decision|1|||
155332892|NCT02357966|560652702|FG005|Overall Study|Physician Decision|0|||
155332893|NCT00047385|560652704|FG000|Overall Study|Death before any screening|2|||
155332894|NCT00047385|560652705|FG001|Overall Study|Death before any screening|5|||
155332895|NCT00047385|560652704|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
155332896|NCT00047385|560652705|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
155332897|NCT00047385|560652704|FG000|Overall Study|Eligible for screening but had no screen|260|||
155332898|NCT00047385|560652705|FG001|Overall Study|Eligible for screening but had no screen|492|||
155332899|NCT03392194|560652706|FG000|Overall Study|Withdrawal by Subject|1|||
155332900|NCT03392194|560652707|FG001|Overall Study|Withdrawal by Subject|2|||
155332901|NCT03392194|560652706|FG000|Overall Study|Conflicts with personal schedule|1|||
155332902|NCT03392194|560652707|FG001|Overall Study|Conflicts with personal schedule|0|||
155332903|NCT03865732|560652708|FG000|Overall Study|Adverse Event|0|||
155332904|NCT03865732|560652709|FG001|Overall Study|Adverse Event|1|||
155332905|NCT00620854|560652712|FG000|Washout 1|Withdrawal by Subject|0|||
155332906|NCT00620854|560652713|FG001|Washout 1|Withdrawal by Subject|0|||
155332907|NCT00620854|560652714|FG002|Washout 1|Withdrawal by Subject|1|||
155332908|NCT00620854|560652715|FG003|Washout 1|Withdrawal by Subject|1|||
155332909|NCT00620854|560652716|FG004|Washout 1|Withdrawal by Subject|0|||
155332910|NCT00620854|560652717|FG005|Washout 1|Withdrawal by Subject|0|||
155332911|NCT03345979|560652718|FG000|Overall Study|Withdrawal by Subject|20|||
155332912|NCT03345979|560652719|FG001|Overall Study|Withdrawal by Subject|31|||
155332913|NCT03345979|560652718|FG000|Overall Study|Adverse Event|10|||
155332914|NCT03345979|560652719|FG001|Overall Study|Adverse Event|11|||
155332915|NCT03345979|560652718|FG000|Overall Study|Lost to Follow-up|8|||
155332916|NCT03345979|560652719|FG001|Overall Study|Lost to Follow-up|9|||
155332917|NCT03345979|560652718|FG000|Overall Study|Lack of Efficacy|4|||
155332918|NCT03345979|560652719|FG001|Overall Study|Lack of Efficacy|2|||
155332919|NCT03345979|560652718|FG000|Overall Study|Protocol Violation|1|||
155332920|NCT03345979|560652719|FG001|Overall Study|Protocol Violation|3|||
155332921|NCT03345979|560652718|FG000|Overall Study|Physician Decision|0|||
155332922|NCT03345979|560652719|FG001|Overall Study|Physician Decision|2|||
155332923|NCT00734578|560652723|FG000|Overall Study|Adverse Event|4|||
155332924|NCT00734578|560652724|FG001|Overall Study|Adverse Event|6|||
155332925|NCT00734578|560652725|FG002|Overall Study|Adverse Event|1|||
155332926|NCT00734578|560652723|FG000|Overall Study|Protocol Violation|8|||
155332927|NCT00734578|560652724|FG001|Overall Study|Protocol Violation|6|||
155332928|NCT00734578|560652725|FG002|Overall Study|Protocol Violation|3|||
155332929|NCT00734578|560652723|FG000|Overall Study|Withdrawal by Subject|7|||
155332930|NCT00734578|560652724|FG001|Overall Study|Withdrawal by Subject|8|||
155332931|NCT00734578|560652725|FG002|Overall Study|Withdrawal by Subject|11|||
155332932|NCT00734578|560652723|FG000|Overall Study|Lost to Follow-up|9|||
155332933|NCT00734578|560652724|FG001|Overall Study|Lost to Follow-up|3|||
155332934|NCT00734578|560652725|FG002|Overall Study|Lost to Follow-up|5|||
155332935|NCT00734578|560652723|FG000|Overall Study|Lack of Efficacy|3|||
155332936|NCT00734578|560652724|FG001|Overall Study|Lack of Efficacy|2|||
155332937|NCT00734578|560652725|FG002|Overall Study|Lack of Efficacy|5|||
155332938|NCT00734578|560652723|FG000|Overall Study|Randomized in error|1|||
155332939|NCT00734578|560652724|FG001|Overall Study|Randomized in error|0|||
155332940|NCT00734578|560652725|FG002|Overall Study|Randomized in error|0|||
155332941|NCT00734578|560652723|FG000|Overall Study|Exclusion criteria|1|||
155332942|NCT00734578|560652724|FG001|Overall Study|Exclusion criteria|0|||
155332943|NCT00734578|560652725|FG002|Overall Study|Exclusion criteria|0|||
155332944|NCT00999596|560652726|FG000|Overall Study|Statistical population not required|101|||
155332945|NCT02095145|560652727|FG000|Overall Study|Withdrawal by Subject|1|||
155332946|NCT02095145|560652728|FG001|Overall Study|Withdrawal by Subject|0|||
155332947|NCT02085941|560652730|FG000|Overall Study|Lack of Efficacy|1|||
155332948|NCT02085941|560652731|FG001|Overall Study|Lack of Efficacy|0|||
155332949|NCT02085941|560652730|FG000|Overall Study|Death|6|||
155332950|NCT02085941|560652731|FG001|Overall Study|Death|1|||
155332951|NCT02085941|560652730|FG000|Overall Study|Lost to Follow-up|1|||
155332952|NCT02085941|560652731|FG001|Overall Study|Lost to Follow-up|0|||
155332953|NCT02085941|560652730|FG000|Overall Study|Physician Decision|0|||
155332954|NCT02085941|560652731|FG001|Overall Study|Physician Decision|2|||
155332955|NCT00093496|560652735|FG000|Overall Study|Protocol Violation|1|||
155332956|NCT00093496|560652736|FG001|Overall Study|Protocol Violation|3|||
155332957|NCT00586313|560652737|FG000|Overall Study|Lack of Efficacy|2|||
155332958|NCT01932970|560652741|FG000|Overall Study|Withdrawal by Subject|5|||
155332959|NCT01932970|560652741|FG000|Overall Study|Death|1|||
155332960|NCT01932970|560652741|FG000|Overall Study|Lost to Follow-up|2|||
155332961|NCT01932970|560652741|FG000|Overall Study|Protocol Specified Criteria|10|||
155332962|NCT03205566|560652743|FG000|Phase 1|Protocol Violation|1|||
155332963|NCT03205566|560652744|FG001|Phase 1|Protocol Violation|1|||
155332964|NCT03184987|560652745|FG000|Overall Study|Withdrawal by Subject|0|||
155332965|NCT03184987|560652746|FG001|Overall Study|Withdrawal by Subject|1|||
155332966|NCT03184987|560652747|FG002|Overall Study|Withdrawal by Subject|2|||
155332967|NCT03184987|560652745|FG000|Overall Study|Physician Decision|0|||
155332968|NCT03184987|560652746|FG001|Overall Study|Physician Decision|0|||
155332969|NCT03184987|560652747|FG002|Overall Study|Physician Decision|1|||
155332970|NCT03184987|560652745|FG000|Overall Study|Adverse Event|1|||
155332971|NCT03184987|560652746|FG001|Overall Study|Adverse Event|0|||
155332972|NCT03184987|560652747|FG002|Overall Study|Adverse Event|1|||
155332973|NCT00853580|560652748|FG000|Overall Study|Lost to Follow-up|3|||
155332974|NCT00853580|560652749|FG001|Overall Study|Lost to Follow-up|5|||
155332975|NCT00853580|560652748|FG000|Overall Study|Protocol Violation|2|||
155332976|NCT00853580|560652749|FG001|Overall Study|Protocol Violation|1|||
155332977|NCT00853580|560652748|FG000|Overall Study|Withdrawal by Subject|2|||
155332978|NCT00853580|560652749|FG001|Overall Study|Withdrawal by Subject|8|||
155332979|NCT00853580|560652748|FG000|Overall Study|Commenced contraindicated therapy|0|||
155332980|NCT00853580|560652749|FG001|Overall Study|Commenced contraindicated therapy|2|||
155332981|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
155332982|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
155332983|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
155332984|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
155332985|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
155332986|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
155332987|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
155332988|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
155332989|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
155332990|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
155332991|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
155332992|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
155332993|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
155332994|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
155332995|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
155332996|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
155332997|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
155332998|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
155502592|NCT01902134|561267242|FG000|Overall Study|Protocol Violation|0|||
155332999|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
155333000|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
155333001|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
155333002|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
155333003|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
155333004|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
155333005|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
155333006|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
155333007|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
155333008|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
155333009|NCT02040870|560652754|FG000|Overall Study|Completed treatment phase|6|||
155333010|NCT02040870|560652754|FG000|Overall Study|Adverse Event|7|||
155333011|NCT02040870|560652754|FG000|Overall Study|Progressive disease|58|||
155333012|NCT02040870|560652754|FG000|Overall Study|Physician Decision|6|||
155333013|NCT02040870|560652754|FG000|Overall Study|Subject/guardian decision|10|||
155333014|NCT02040870|560652754|FG000|Overall Study|Lost to Follow-up|3|||
155333015|NCT02040870|560652754|FG000|Overall Study|Death|13|||
155333016|NCT04971733|560652757|FG000|Overall Study|Adverse Event|1|||
155333017|NCT04971733|560652758|FG001|Overall Study|Adverse Event|1|||
155333018|NCT04971733|560652757|FG000|Overall Study|Subject choice|2|||
155333019|NCT04971733|560652758|FG001|Overall Study|Subject choice|0|||
155333020|NCT04971733|560652757|FG000|Overall Study|Withdrawal by Subject|1|||
155333021|NCT04971733|560652758|FG001|Overall Study|Withdrawal by Subject|0|||
155333022|NCT04971733|560652757|FG000|Overall Study|Other|1|||
155333023|NCT04971733|560652758|FG001|Overall Study|Other|0|||
155333024|NCT00600353|560652759|FG000|Overall Study|history of malignancy within 5 years|1|||
155333025|NCT00600353|560652760|FG001|Overall Study|history of malignancy within 5 years|0|||
155333026|NCT00600353|560652759|FG000|Overall Study|History of prepartive regimen|0|||
155333027|NCT00600353|560652760|FG001|Overall Study|History of prepartive regimen|1|||
155333028|NCT04941482|560652761|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
155333029|NCT04941482|560652762|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
155333030|NCT04200664|560652763|FG000|Overall Study|Withdrawal by Subject|1|||
155333031|NCT04200664|560652764|FG001|Overall Study|Withdrawal by Subject|0|||
155333032|NCT04200664|560652765|FG002|Overall Study|Withdrawal by Subject|0|||
155333033|NCT01367236|560652769|FG000|Overall Study|Withdrawal by Subject|3|||
155333034|NCT01367236|560652770|FG001|Overall Study|Withdrawal by Subject|1|||
155333035|NCT05293717|560652776|FG000|Overall Study|Physician Decision|1|||
155333036|NCT00357994|560653793|FG000|Overall Study|Adverse Event|1|||
155333037|NCT00357994|560653794|FG001|Overall Study|Adverse Event|2|||
155333038|NCT00357994|560653793|FG000|Overall Study|Lack of Efficacy|0|||
155333039|NCT00357994|560653794|FG001|Overall Study|Lack of Efficacy|1|||
155333040|NCT00357994|560653793|FG000|Overall Study|Protocol Violation|1|||
155333041|NCT00357994|560653794|FG001|Overall Study|Protocol Violation|0|||
155333042|NCT00019604|560653798|FG000|Overall Study|Death|1|||
155333043|NCT00019604|560653798|FG000|Overall Study|Progressive disease|23|||
155333044|NCT00019604|560653798|FG000|Overall Study|Refused treatment|1|||
155333045|NCT00019604|560653798|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
155333046|NCT00019604|560653798|FG000|Overall Study|Going to have liver transplant|1|||
155421997|NCT02474329|560974433|FG000|Overall Study|Withdraw or did not contribute data.|13|||
155421998|NCT01356589|560974434|FG000|Overall Study|Enrolled, but not treated|3|||
155333047|NCT00019604|560653798|FG000|Overall Study|Move to a different study|1|||
155333048|NCT00019604|560653798|FG000|Overall Study|Non compliant on systemic CH|1|||
155333049|NCT00019604|560653798|FG000|Overall Study|Non compliant|1|||
155333050|NCT00019604|560653798|FG000|Overall Study|Resectable disease|1|||
155502593|NCT01902134|561267243|FG001|Overall Study|Protocol Violation|0|||
155333051|NCT00019604|560653798|FG000|Overall Study|Started new chemo regimen|1|||
155333052|NCT00019604|560653798|FG000|Overall Study|Pt going to immunotherapy study|1|||
155333053|NCT00019604|560653798|FG000|Overall Study|Too much disease|1|||
155333054|NCT00019604|560653798|FG000|Overall Study|Unable to evaluate|1|||
155333055|NCT00019604|560653798|FG000|Overall Study|Details for other not available|4|||
155333056|NCT02203799|560653822|FG000|Overall Study|Withdrawal by Subject|3|||
155421999|NCT01356589|560974434|FG000|Overall Study|Dose data not recorded|2|||
155645362|NCT03158311|561792231|FG001|Overall Study|Pregnancy|2|||
155333057|NCT03335488|560653823|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
155333058|NCT03335488|560653824|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
155333059|NCT03335488|560653823|FG000|Safety Extension Period|Adverse Event|1|||
155333060|NCT03335488|560653824|FG001|Safety Extension Period|Adverse Event|0|||
155333061|NCT03335488|560653823|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
155333062|NCT03335488|560653824|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
155333063|NCT01953692|560653825|FG000|Overall Study|Adverse Event|5|||
155333064|NCT01953692|560653826|FG001|Overall Study|Adverse Event|2|||
155333065|NCT01953692|560653827|FG002|Overall Study|Adverse Event|4|||
155333066|NCT01953692|560653828|FG003|Overall Study|Adverse Event|2|||
155333067|NCT01953692|560653829|FG004|Overall Study|Adverse Event|1|||
155333068|NCT01953692|560653830|FG005|Overall Study|Adverse Event|2|||
155333069|NCT01953692|560653831|FG006|Overall Study|Adverse Event|0|||
155333070|NCT01953692|560653832|FG007|Overall Study|Adverse Event|0|||
155333071|NCT01953692|560653833|FG008|Overall Study|Adverse Event|0|||
155333072|NCT01953692|560653825|FG000|Overall Study|Clinical Progression|0|||
155333073|NCT01953692|560653826|FG001|Overall Study|Clinical Progression|15|||
155333074|NCT01953692|560653827|FG002|Overall Study|Clinical Progression|7|||
155333075|NCT01953692|560653828|FG003|Overall Study|Clinical Progression|5|||
155333076|NCT01953692|560653829|FG004|Overall Study|Clinical Progression|0|||
155333077|NCT01953692|560653830|FG005|Overall Study|Clinical Progression|7|||
155333078|NCT01953692|560653831|FG006|Overall Study|Clinical Progression|20|||
155333079|NCT01953692|560653832|FG007|Overall Study|Clinical Progression|3|||
155333080|NCT01953692|560653833|FG008|Overall Study|Clinical Progression|3|||
155333081|NCT01953692|560653825|FG000|Overall Study|Death|5|||
155333082|NCT01953692|560653826|FG001|Overall Study|Death|0|||
155333083|NCT01953692|560653827|FG002|Overall Study|Death|2|||
155333084|NCT01953692|560653828|FG003|Overall Study|Death|2|||
155333085|NCT01953692|560653829|FG004|Overall Study|Death|1|||
155333086|NCT01953692|560653830|FG005|Overall Study|Death|3|||
155333087|NCT01953692|560653831|FG006|Overall Study|Death|6|||
155333088|NCT01953692|560653832|FG007|Overall Study|Death|2|||
155333089|NCT01953692|560653833|FG008|Overall Study|Death|1|||
155333090|NCT01953692|560653825|FG000|Overall Study|Excluded Medication|1|||
155333091|NCT01953692|560653826|FG001|Overall Study|Excluded Medication|0|||
155333092|NCT01953692|560653827|FG002|Overall Study|Excluded Medication|0|||
155333093|NCT01953692|560653828|FG003|Overall Study|Excluded Medication|0|||
155333094|NCT01953692|560653829|FG004|Overall Study|Excluded Medication|0|||
155333095|NCT01953692|560653830|FG005|Overall Study|Excluded Medication|0|||
155333096|NCT01953692|560653831|FG006|Overall Study|Excluded Medication|0|||
155333097|NCT01953692|560653832|FG007|Overall Study|Excluded Medication|0|||
155333098|NCT01953692|560653833|FG008|Overall Study|Excluded Medication|0|||
155333099|NCT01953692|560653825|FG000|Overall Study|Lost to Follow-up|1|||
155333100|NCT01953692|560653826|FG001|Overall Study|Lost to Follow-up|0|||
155333101|NCT01953692|560653827|FG002|Overall Study|Lost to Follow-up|3|||
155333102|NCT01953692|560653828|FG003|Overall Study|Lost to Follow-up|1|||
155333103|NCT01953692|560653829|FG004|Overall Study|Lost to Follow-up|0|||
155333104|NCT01953692|560653830|FG005|Overall Study|Lost to Follow-up|1|||
155333105|NCT01953692|560653831|FG006|Overall Study|Lost to Follow-up|0|||
155333106|NCT01953692|560653832|FG007|Overall Study|Lost to Follow-up|0|||
155333107|NCT01953692|560653833|FG008|Overall Study|Lost to Follow-up|0|||
155333108|NCT01953692|560653825|FG000|Overall Study|Physician Decision|11|||
155333109|NCT01953692|560653826|FG001|Overall Study|Physician Decision|4|||
155333110|NCT01953692|560653827|FG002|Overall Study|Physician Decision|2|||
155333111|NCT01953692|560653828|FG003|Overall Study|Physician Decision|2|||
155333112|NCT01953692|560653829|FG004|Overall Study|Physician Decision|1|||
155333113|NCT01953692|560653830|FG005|Overall Study|Physician Decision|2|||
155333114|NCT01953692|560653831|FG006|Overall Study|Physician Decision|4|||
155333115|NCT01953692|560653832|FG007|Overall Study|Physician Decision|1|||
155333116|NCT01953692|560653833|FG008|Overall Study|Physician Decision|0|||
155645363|NCT03158311|561792232|FG002|Overall Study|Pregnancy|0|||
155645364|NCT03158311|561792230|FG000|Overall Study|Randomized in error|0|||
155645365|NCT03158311|561792231|FG001|Overall Study|Randomized in error|0|||
155645366|NCT03158311|561792232|FG002|Overall Study|Randomized in error|1|||
155645367|NCT01033071|561792235|FG000|Overall Study|Adverse Event|28|||
155645368|NCT01033071|561792236|FG001|Overall Study|Adverse Event|51|||
155333117|NCT01953692|560653825|FG000|Overall Study|Protocol Violation|0|||
155333118|NCT01953692|560653826|FG001|Overall Study|Protocol Violation|2|||
155333119|NCT01953692|560653827|FG002|Overall Study|Protocol Violation|1|||
155333120|NCT01953692|560653828|FG003|Overall Study|Protocol Violation|0|||
155333121|NCT01953692|560653829|FG004|Overall Study|Protocol Violation|0|||
155333122|NCT01953692|560653830|FG005|Overall Study|Protocol Violation|0|||
155422000|NCT04343651|560974435|FG000|Overall Study|Physician Decision|2|||
155333123|NCT01953692|560653831|FG006|Overall Study|Protocol Violation|0|||
155333124|NCT01953692|560653832|FG007|Overall Study|Protocol Violation|1|||
155333125|NCT01953692|560653833|FG008|Overall Study|Protocol Violation|0|||
155333126|NCT01953692|560653825|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155422001|NCT04343651|560974436|FG001|Overall Study|Physician Decision|1|||
155333127|NCT01953692|560653826|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333128|NCT01953692|560653827|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333129|NCT01953692|560653828|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333130|NCT01953692|560653829|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333131|NCT01953692|560653830|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333132|NCT01953692|560653831|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333133|NCT01953692|560653832|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
155333134|NCT01953692|560653833|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333135|NCT01953692|560653825|FG000|Overall Study|Withdrawal by Subject|4|||
155333136|NCT01953692|560653826|FG001|Overall Study|Withdrawal by Subject|2|||
155333137|NCT01953692|560653827|FG002|Overall Study|Withdrawal by Subject|1|||
155333138|NCT01953692|560653828|FG003|Overall Study|Withdrawal by Subject|2|||
155333139|NCT01953692|560653829|FG004|Overall Study|Withdrawal by Subject|0|||
155333140|NCT01953692|560653830|FG005|Overall Study|Withdrawal by Subject|3|||
155333141|NCT01953692|560653831|FG006|Overall Study|Withdrawal by Subject|2|||
155333142|NCT01953692|560653832|FG007|Overall Study|Withdrawal by Subject|1|||
155333143|NCT01953692|560653833|FG008|Overall Study|Withdrawal by Subject|1|||
155333144|NCT01160354|560653838|FG000|Overall Study|Death|0|||
155333145|NCT01160354|560653839|FG001|Overall Study|Death|1|||
155333146|NCT01160354|560653840|FG002|Overall Study|Death|1|||
155333147|NCT01801007|560653844|FG000|Overall Study|Adverse Event|2|||
155333148|NCT01801007|560653844|FG000|Overall Study|Lost to Follow-up|4|||
155333149|NCT01801007|560653844|FG000|Overall Study|Withdrawal by Subject|5|||
155333150|NCT02743819|560653845|FG000|Overall Study|Lack of Efficacy|5|||
155333151|NCT02743819|560653845|FG000|Overall Study|Death|2|||
155333152|NCT02743819|560653845|FG000|Overall Study|Adverse Event|1|||
155333153|NCT00145470|560653846|FG000|Overall Study|Adverse Event|19|||
155333154|NCT00145470|560653847|FG001|Overall Study|Adverse Event|25|||
155333155|NCT00145470|560653846|FG000|Overall Study|Lack of Efficacy|27|||
155333156|NCT00145470|560653847|FG001|Overall Study|Lack of Efficacy|13|||
155333157|NCT00145470|560653846|FG000|Overall Study|Withdrawal by Subject|36|||
155333158|NCT00145470|560653847|FG001|Overall Study|Withdrawal by Subject|34|||
155333159|NCT00145470|560653846|FG000|Overall Study|Lost to Follow-up|21|||
155333160|NCT00145470|560653847|FG001|Overall Study|Lost to Follow-up|17|||
155333161|NCT00145470|560653846|FG000|Overall Study|Reason Not Reported|9|||
155333162|NCT00145470|560653847|FG001|Overall Study|Reason Not Reported|9|||
155333163|NCT00914966|560653854|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
155333164|NCT00914966|560653854|FG000|Step 1: 1500 Units|Physician Decision|1|||
155333165|NCT00914966|560653854|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
155333166|NCT01701401|560653855|FG000|Overall Study|Randomized But Not Treated|3|||
155333167|NCT01701401|560653856|FG001|Overall Study|Randomized But Not Treated|1|||
155333168|NCT01701401|560653857|FG002|Overall Study|Randomized But Not Treated|0|||
155333169|NCT01701401|560653858|FG003|Overall Study|Randomized But Not Treated|1|||
155333170|NCT01701401|560653855|FG000|Overall Study|Lost to Follow-up|5|||
155333171|NCT01701401|560653856|FG001|Overall Study|Lost to Follow-up|5|||
155333172|NCT01701401|560653857|FG002|Overall Study|Lost to Follow-up|1|||
155333173|NCT01701401|560653858|FG003|Overall Study|Lost to Follow-up|3|||
155333174|NCT01701401|560653855|FG000|Overall Study|Withdrew Consent|0|||
155333175|NCT01701401|560653856|FG001|Overall Study|Withdrew Consent|3|||
155333176|NCT01701401|560653857|FG002|Overall Study|Withdrew Consent|1|||
155333177|NCT01701401|560653858|FG003|Overall Study|Withdrew Consent|2|||
155333178|NCT01701401|560653855|FG000|Overall Study|Lack of Efficacy|1|||
155333179|NCT01701401|560653856|FG001|Overall Study|Lack of Efficacy|0|||
155333180|NCT01701401|560653857|FG002|Overall Study|Lack of Efficacy|2|||
155333181|NCT01701401|560653858|FG003|Overall Study|Lack of Efficacy|0|||
155333182|NCT01701401|560653855|FG000|Overall Study|Adverse Event|1|||
155333183|NCT01701401|560653856|FG001|Overall Study|Adverse Event|0|||
155333184|NCT01701401|560653857|FG002|Overall Study|Adverse Event|0|||
155333185|NCT01701401|560653858|FG003|Overall Study|Adverse Event|0|||
155333186|NCT01701401|560653855|FG000|Overall Study|Protocol Violation|0|||
155333187|NCT01701401|560653856|FG001|Overall Study|Protocol Violation|0|||
155333188|NCT01701401|560653857|FG002|Overall Study|Protocol Violation|1|||
155333189|NCT01701401|560653858|FG003|Overall Study|Protocol Violation|0|||
155333190|NCT04762277|560653862|FG000|Overall Study|Withdrawal by Subject|0|||
155333191|NCT04762277|560653863|FG001|Overall Study|Withdrawal by Subject|2|||
155333192|NCT04762277|560653862|FG000|Overall Study|Protocol Violation|0|||
155333193|NCT04762277|560653863|FG001|Overall Study|Protocol Violation|1|||
155333194|NCT04762277|560653862|FG000|Overall Study|Adverse Event|1|||
155333195|NCT04762277|560653863|FG001|Overall Study|Adverse Event|0|||
155333196|NCT05824559|560653864|FG000|Overall Study|Adverse Event|2|||
155333197|NCT05824559|560653864|FG000|Overall Study|Physician Decision|2|||
155333198|NCT05824559|560653864|FG000|Overall Study|Progressive Disease|16|||
155333199|NCT05824559|560653864|FG000|Overall Study|Study Terminated by Sponsor|1|||
155333200|NCT05824559|560653864|FG000|Overall Study|Withdrawal by Subject|2|||
155333201|NCT01690624|560653865|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
155333202|NCT01690624|560653866|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
155333203|NCT01690624|560653867|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
155333204|NCT01690624|560653868|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
155333205|NCT01690624|560653865|FG000|Overall Study|Adverse event (other than DLT)|3|||
155333206|NCT01690624|560653866|FG001|Overall Study|Adverse event (other than DLT)|1|||
155333207|NCT01690624|560653867|FG002|Overall Study|Adverse event (other than DLT)|1|||
155333208|NCT01690624|560653868|FG003|Overall Study|Adverse event (other than DLT)|1|||
155333209|NCT01690624|560653865|FG000|Overall Study|Withdrawal by Subject|0|||
155333210|NCT01690624|560653866|FG001|Overall Study|Withdrawal by Subject|0|||
155333211|NCT01690624|560653867|FG002|Overall Study|Withdrawal by Subject|1|||
155333212|NCT01690624|560653868|FG003|Overall Study|Withdrawal by Subject|0|||
155333213|NCT01690624|560653865|FG000|Overall Study|Sponsor is ending trial|0|||
155333214|NCT01690624|560653866|FG001|Overall Study|Sponsor is ending trial|0|||
155333215|NCT01690624|560653867|FG002|Overall Study|Sponsor is ending trial|0|||
155333216|NCT01690624|560653868|FG003|Overall Study|Sponsor is ending trial|1|||
155333217|NCT01690624|560653865|FG000|Overall Study|Physician Decision|0|||
155333218|NCT01690624|560653866|FG001|Overall Study|Physician Decision|0|||
155333219|NCT01690624|560653867|FG002|Overall Study|Physician Decision|0|||
155333220|NCT01690624|560653868|FG003|Overall Study|Physician Decision|1|||
155333221|NCT01690624|560653865|FG000|Overall Study|Withdrawal by Subject|0|||
155333222|NCT01690624|560653866|FG001|Overall Study|Withdrawal by Subject|1|||
155333223|NCT01690624|560653867|FG002|Overall Study|Withdrawal by Subject|0|||
155333224|NCT01690624|560653868|FG003|Overall Study|Withdrawal by Subject|0|||
155333225|NCT01690624|560653865|FG000|Overall Study|Lack of Efficacy|1|||
155333226|NCT01690624|560653866|FG001|Overall Study|Lack of Efficacy|1|||
155333227|NCT01690624|560653867|FG002|Overall Study|Lack of Efficacy|3|||
155333228|NCT01690624|560653868|FG003|Overall Study|Lack of Efficacy|0|||
155333229|NCT04445831|560653869|FG000|Overall Study|Withdrawal by Subject|2|||
155333230|NCT04445831|560653870|FG001|Overall Study|Withdrawal by Subject|1|||
155333231|NCT04445831|560653871|FG002|Overall Study|Withdrawal by Subject|1|||
155333232|NCT04445831|560653872|FG003|Overall Study|Withdrawal by Subject|0|||
155333233|NCT04445831|560653873|FG004|Overall Study|Withdrawal by Subject|0|||
155333234|NCT04445831|560653874|FG005|Overall Study|Withdrawal by Subject|0|||
155333235|NCT04445831|560653875|FG006|Overall Study|Withdrawal by Subject|0|||
155333236|NCT04445831|560653869|FG000|Overall Study|Subject withdrawal by caregiver|0|||
155333237|NCT04445831|560653870|FG001|Overall Study|Subject withdrawal by caregiver|1|||
155333238|NCT04445831|560653871|FG002|Overall Study|Subject withdrawal by caregiver|0|||
155333239|NCT04445831|560653872|FG003|Overall Study|Subject withdrawal by caregiver|0|||
155333240|NCT04445831|560653873|FG004|Overall Study|Subject withdrawal by caregiver|0|||
155333241|NCT04445831|560653874|FG005|Overall Study|Subject withdrawal by caregiver|0|||
155333242|NCT04445831|560653875|FG006|Overall Study|Subject withdrawal by caregiver|0|||
155333243|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
155333244|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
155333245|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
155333246|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
155333247|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
155333248|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
155333249|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
155333250|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
155333251|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
155333252|NCT04701203|560653878|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
155333253|NCT04701203|560653879|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
155333254|NCT04701203|560653880|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
155333255|NCT02434328|560653883|FG000|Overall Study|Adverse Event|9|||
155333256|NCT02434328|560653884|FG001|Overall Study|Adverse Event|4|||
155333257|NCT02434328|560653883|FG000|Overall Study|Lack of Efficacy|0|||
155333258|NCT02434328|560653884|FG001|Overall Study|Lack of Efficacy|2|||
155333259|NCT02434328|560653883|FG000|Overall Study|Physician Decision|0|||
155333260|NCT02434328|560653884|FG001|Overall Study|Physician Decision|1|||
155333261|NCT02434328|560653883|FG000|Overall Study|Withdrawal by Subject|12|||
155333262|NCT02434328|560653884|FG001|Overall Study|Withdrawal by Subject|21|||
155333263|NCT02434328|560653883|FG000|Overall Study|Death|4|||
155333264|NCT02434328|560653884|FG001|Overall Study|Death|7|||
155333265|NCT02434328|560653883|FG000|Overall Study|Lost to Follow-up|1|||
155333266|NCT02434328|560653884|FG001|Overall Study|Lost to Follow-up|6|||
155333267|NCT02434328|560653883|FG000|Overall Study|Other|4|||
155333268|NCT02434328|560653884|FG001|Overall Study|Other|1|||
155333269|NCT03147287|560653885|FG000|Overall Study|Randomized Not Treated|2|||
155333270|NCT03147287|560653886|FG001|Overall Study|Randomized Not Treated|1|||
155333271|NCT03147287|560653887|FG002|Overall Study|Randomized Not Treated|1|||
155333272|NCT03147287|560653885|FG000|Overall Study|Progressive Disease RECIST|31|||
155333273|NCT03147287|560653886|FG001|Overall Study|Progressive Disease RECIST|72|||
155333274|NCT03147287|560653887|FG002|Overall Study|Progressive Disease RECIST|32|||
155333275|NCT03147287|560653885|FG000|Overall Study|Progressive Disease not RECIST|13|||
155333276|NCT03147287|560653886|FG001|Overall Study|Progressive Disease not RECIST|21|||
155333277|NCT03147287|560653887|FG002|Overall Study|Progressive Disease not RECIST|13|||
155333278|NCT03147287|560653885|FG000|Overall Study|Physician Decision|1|||
155333279|NCT03147287|560653886|FG001|Overall Study|Physician Decision|2|||
155333280|NCT03147287|560653887|FG002|Overall Study|Physician Decision|1|||
155333281|NCT03147287|560653885|FG000|Overall Study|Intercurrent illness|0|||
155333282|NCT03147287|560653886|FG001|Overall Study|Intercurrent illness|1|||
155333283|NCT03147287|560653887|FG002|Overall Study|Intercurrent illness|0|||
155333284|NCT03147287|560653885|FG000|Overall Study|Withdrawal by Subject|2|||
155333285|NCT03147287|560653886|FG001|Overall Study|Withdrawal by Subject|3|||
155333286|NCT03147287|560653887|FG002|Overall Study|Withdrawal by Subject|2|||
155333287|NCT03147287|560653885|FG000|Overall Study|Patient Non-Compliance|0|||
155333288|NCT03147287|560653886|FG001|Overall Study|Patient Non-Compliance|2|||
155333289|NCT03147287|560653887|FG002|Overall Study|Patient Non-Compliance|0|||
155333290|NCT03147287|560653885|FG000|Overall Study|Patient moved|0|||
155333291|NCT03147287|560653886|FG001|Overall Study|Patient moved|1|||
155333292|NCT03147287|560653887|FG002|Overall Study|Patient moved|0|||
155333293|NCT03147287|560653885|FG000|Overall Study|Arm A crossover without PD|1|||
155333294|NCT03147287|560653886|FG001|Overall Study|Arm A crossover without PD|0|||
155333295|NCT03147287|560653887|FG002|Overall Study|Arm A crossover without PD|0|||
155333296|NCT03147287|560653885|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
155333297|NCT03147287|560653886|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
155333298|NCT03147287|560653887|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
155333299|NCT03678688|560655953|FG000|Overall Study|Reason not Specified|0|||
155333300|NCT03678688|560655954|FG001|Overall Study|Reason not Specified|0|||
155333301|NCT03678688|560655955|FG002|Overall Study|Reason not Specified|3|||
155333302|NCT03678688|560655956|FG003|Overall Study|Reason not Specified|0|||
155333303|NCT03678688|560655957|FG004|Overall Study|Reason not Specified|1|||
155333304|NCT03678688|560655958|FG005|Overall Study|Reason not Specified|0|||
155333305|NCT03678688|560655959|FG006|Overall Study|Reason not Specified|0|||
155333306|NCT03678688|560655960|FG007|Overall Study|Reason not Specified|0|||
155333307|NCT03678688|560655961|FG008|Overall Study|Reason not Specified|0|||
155333308|NCT03678688|560655953|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
155333309|NCT03678688|560655954|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
155333310|NCT03678688|560655955|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
155333311|NCT03678688|560655956|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
155333312|NCT03678688|560655957|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
155333313|NCT03678688|560655958|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
155333314|NCT03678688|560655959|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
155333315|NCT03678688|560655960|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
155333316|NCT03678688|560655961|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
155333317|NCT03678688|560655953|FG000|Overall Study|Covid Related Adverse Event|0|||
155333318|NCT03678688|560655954|FG001|Overall Study|Covid Related Adverse Event|0|||
155333319|NCT03678688|560655955|FG002|Overall Study|Covid Related Adverse Event|0|||
155333320|NCT03678688|560655956|FG003|Overall Study|Covid Related Adverse Event|0|||
155333321|NCT03678688|560655957|FG004|Overall Study|Covid Related Adverse Event|0|||
155333322|NCT03678688|560655958|FG005|Overall Study|Covid Related Adverse Event|3|||
155333323|NCT03678688|560655959|FG006|Overall Study|Covid Related Adverse Event|1|||
155333324|NCT03678688|560655960|FG007|Overall Study|Covid Related Adverse Event|1|||
155333325|NCT03678688|560655961|FG008|Overall Study|Covid Related Adverse Event|0|||
155333326|NCT03678688|560655953|FG000|Overall Study|Physician Decision|0|||
155333327|NCT03678688|560655954|FG001|Overall Study|Physician Decision|0|||
155333328|NCT03678688|560655955|FG002|Overall Study|Physician Decision|0|||
155333329|NCT03678688|560655956|FG003|Overall Study|Physician Decision|0|||
155333330|NCT03678688|560655957|FG004|Overall Study|Physician Decision|0|||
155333331|NCT03678688|560655958|FG005|Overall Study|Physician Decision|1|||
155333332|NCT03678688|560655959|FG006|Overall Study|Physician Decision|0|||
155333333|NCT03678688|560655960|FG007|Overall Study|Physician Decision|0|||
155333334|NCT03678688|560655961|FG008|Overall Study|Physician Decision|0|||
155333335|NCT03678688|560655953|FG000|Overall Study|Withdrawal by Subject|0|||
155333336|NCT03678688|560655954|FG001|Overall Study|Withdrawal by Subject|0|||
155333337|NCT03678688|560655955|FG002|Overall Study|Withdrawal by Subject|0|||
155333338|NCT03678688|560655956|FG003|Overall Study|Withdrawal by Subject|0|||
155333339|NCT03678688|560655957|FG004|Overall Study|Withdrawal by Subject|0|||
155333340|NCT03678688|560655958|FG005|Overall Study|Withdrawal by Subject|0|||
155333341|NCT03678688|560655959|FG006|Overall Study|Withdrawal by Subject|2|||
155333342|NCT03678688|560655960|FG007|Overall Study|Withdrawal by Subject|1|||
155333343|NCT03678688|560655961|FG008|Overall Study|Withdrawal by Subject|0|||
155333344|NCT00551421|560655962|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
155333345|NCT03136159|560655963|FG000|Overall Study|chorioamnionitis|2|||
155333346|NCT03136159|560655964|FG001|Overall Study|chorioamnionitis|0|||
155333347|NCT03136159|560655963|FG000|Overall Study|vertical skin incision|1|||
155333348|NCT03136159|560655964|FG001|Overall Study|vertical skin incision|0|||
155333349|NCT03136159|560655963|FG000|Overall Study|additional dressing|1|||
155333350|NCT03136159|560655964|FG001|Overall Study|additional dressing|0|||
155333351|NCT03136159|560655963|FG000|Overall Study|never got dressing placed|1|||
155333352|NCT03136159|560655964|FG001|Overall Study|never got dressing placed|0|||
155333353|NCT03823703|560655965|FG000|Overall Study|Sponsor request|0|||
155333354|NCT03823703|560655966|FG001|Overall Study|Sponsor request|3|||
155333355|NCT03823703|560655967|FG002|Overall Study|Sponsor request|4|||
155333356|NCT03823703|560655965|FG000|Overall Study|Adverse Event|3|||
155333357|NCT03823703|560655966|FG001|Overall Study|Adverse Event|1|||
155333358|NCT03823703|560655967|FG002|Overall Study|Adverse Event|0|||
155333359|NCT03823703|560655965|FG000|Overall Study|Withdrawal by Subject|0|||
155333360|NCT03823703|560655966|FG001|Overall Study|Withdrawal by Subject|1|||
155333361|NCT03823703|560655967|FG002|Overall Study|Withdrawal by Subject|0|||
155333362|NCT04323800|560655968|FG000|Overall Study|Withdrawal by Subject|4|||
155333363|NCT04323800|560655969|FG001|Overall Study|Withdrawal by Subject|4|||
155333364|NCT04323800|560655968|FG000|Overall Study|Incomplete transfusion|1|||
155333365|NCT04323800|560655969|FG001|Overall Study|Incomplete transfusion|0|||
155333366|NCT04323800|560655968|FG000|Overall Study|Other|0|||
155333367|NCT04323800|560655969|FG001|Overall Study|Other|1|||
155333368|NCT04323800|560655968|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
155333369|NCT04323800|560655969|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
155333370|NCT00489554|560655970|FG000|Overall Study|Adverse Event|2|||
155333371|NCT00489554|560655970|FG000|Overall Study|Withdrawal by Subject|1|||
155333372|NCT00489554|560655970|FG000|Overall Study|Lost to Follow-up|1|||
155333373|NCT01732757|560655971|FG000|Overall Study|Lost to Follow-up|1|||
155333374|NCT01732757|560655972|FG001|Overall Study|Lost to Follow-up|0|||
155333375|NCT01732757|560655973|FG002|Overall Study|Lost to Follow-up|0|||
155333376|NCT00731692|560655974|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
155333377|NCT00731692|560655975|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
155333378|NCT00731692|560655976|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
155333379|NCT00731692|560655974|FG000|Core Study (36 Months)|Physician Decision|1|||
155333380|NCT00731692|560655975|FG001|Core Study (36 Months)|Physician Decision|0|||
155333381|NCT00731692|560655976|FG002|Core Study (36 Months)|Physician Decision|2|||
155333382|NCT00731692|560655974|FG000|Core Study (36 Months)|Death|2|||
155333383|NCT00731692|560655975|FG001|Core Study (36 Months)|Death|1|||
155333384|NCT00731692|560655976|FG002|Core Study (36 Months)|Death|2|||
155333385|NCT00731692|560655974|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
155333386|NCT00731692|560655975|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
155333387|NCT00731692|560655976|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
155333388|NCT00731692|560655974|FG000|Core Study (36 Months)|Administrative|2|||
155333389|NCT00731692|560655975|FG001|Core Study (36 Months)|Administrative|2|||
155333390|NCT00731692|560655976|FG002|Core Study (36 Months)|Administrative|6|||
155333391|NCT00731692|560655974|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
155333392|NCT00731692|560655975|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
155333393|NCT00731692|560655976|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
155333394|NCT00731692|560655974|FG000|Core Study (36 Months)|Protocol Violation|4|||
155333395|NCT00731692|560655975|FG001|Core Study (36 Months)|Protocol Violation|5|||
155333396|NCT00731692|560655976|FG002|Core Study (36 Months)|Protocol Violation|8|||
155333397|NCT00731692|560655974|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
155333398|NCT00731692|560655975|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
155333399|NCT00731692|560655976|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
155333400|NCT00731692|560655974|FG000|Core Study (36 Months)|Adverse Event|25|||
155333401|NCT00731692|560655975|FG001|Core Study (36 Months)|Adverse Event|28|||
155333402|NCT00731692|560655976|FG002|Core Study (36 Months)|Adverse Event|29|||
155333403|NCT00731692|560655974|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
155333404|NCT00731692|560655975|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
155333405|NCT00731692|560655976|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
155333406|NCT00731692|560655974|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
155333407|NCT00731692|560655975|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
155333408|NCT00731692|560655976|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
155333409|NCT00731692|560655974|FG000|Extension Phase|Abnormal test procedure|0|||
155333410|NCT00731692|560655975|FG001|Extension Phase|Abnormal test procedure|0|||
155333411|NCT00731692|560655976|FG002|Extension Phase|Abnormal test procedure|1|||
155333412|NCT00731692|560655974|FG000|Extension Phase|Abnormal lab values|0|||
155333413|NCT00731692|560655975|FG001|Extension Phase|Abnormal lab values|0|||
155333414|NCT00731692|560655976|FG002|Extension Phase|Abnormal lab values|1|||
155333415|NCT00731692|560655974|FG000|Extension Phase|Lost to Follow-up|0|||
155333416|NCT00731692|560655975|FG001|Extension Phase|Lost to Follow-up|1|||
155333417|NCT00731692|560655976|FG002|Extension Phase|Lost to Follow-up|4|||
155333418|NCT00731692|560655974|FG000|Extension Phase|Withdrawal by Subject|4|||
155333419|NCT00731692|560655975|FG001|Extension Phase|Withdrawal by Subject|5|||
155333420|NCT00731692|560655976|FG002|Extension Phase|Withdrawal by Subject|3|||
155333421|NCT00731692|560655974|FG000|Extension Phase|Adverse Event|1|||
155333422|NCT00731692|560655975|FG001|Extension Phase|Adverse Event|1|||
155333423|NCT00731692|560655976|FG002|Extension Phase|Adverse Event|15|||
155333424|NCT00747006|560655977|FG000|Overall Study|Adverse Event|1|||
155333425|NCT00747006|560655978|FG001|Overall Study|Adverse Event|0|||
155333426|NCT00747006|560655979|FG002|Overall Study|Adverse Event|0|||
155333427|NCT00747006|560655977|FG000|Overall Study|Lost to Follow-up|0|||
155333428|NCT00747006|560655978|FG001|Overall Study|Lost to Follow-up|1|||
155333429|NCT00747006|560655979|FG002|Overall Study|Lost to Follow-up|0|||
155333430|NCT00747006|560655977|FG000|Overall Study|Physician Decision|2|||
155333431|NCT00747006|560655978|FG001|Overall Study|Physician Decision|0|||
155333432|NCT00747006|560655979|FG002|Overall Study|Physician Decision|1|||
155333433|NCT02132949|560655984|FG000|Overall Study|Death|7|||
155333434|NCT02132949|560655985|FG001|Overall Study|Death|13|||
155333435|NCT02132949|560655984|FG000|Overall Study|Lost to Follow-up|14|||
155333436|NCT02132949|560655985|FG001|Overall Study|Lost to Follow-up|4|||
155333437|NCT02132949|560655984|FG000|Overall Study|Withdrawal by Subject|6|||
155333438|NCT02132949|560655985|FG001|Overall Study|Withdrawal by Subject|5|||
155333439|NCT02132949|560655984|FG000|Overall Study|Noncompliance|5|||
155333440|NCT02132949|560655985|FG001|Overall Study|Noncompliance|1|||
155333441|NCT02132949|560655984|FG000|Overall Study|Physician Decision|3|||
155333442|NCT02132949|560655985|FG001|Overall Study|Physician Decision|1|||
155333443|NCT02132949|560655984|FG000|Overall Study|Disease Progression|3|||
155333444|NCT02132949|560655985|FG001|Overall Study|Disease Progression|0|||
155333445|NCT02132949|560655984|FG000|Overall Study|Adverse Event|2|||
155333446|NCT02132949|560655985|FG001|Overall Study|Adverse Event|1|||
155333447|NCT02132949|560655984|FG000|Overall Study|Withdrew Prior to Treatment|1|||
155333448|NCT02132949|560655985|FG001|Overall Study|Withdrew Prior to Treatment|2|||
155333449|NCT02132949|560655984|FG000|Overall Study|Reason Unspecified|0|||
155333450|NCT02132949|560655985|FG001|Overall Study|Reason Unspecified|1|||
155333451|NCT00745875|560655990|FG000|Overall Study|Continuing study treatment|4|||
155333452|NCT00745875|560655991|FG001|Overall Study|Continuing study treatment|4|||
155333453|NCT01583166|560655992|FG000|Overall Study|Withdrawal by Subject|4|||
155333454|NCT01583166|560655993|FG001|Overall Study|Withdrawal by Subject|6|||
155333455|NCT04652869|560655994|FG000|Overall Study|Withdrawal by Subject|0|||
155333456|NCT04652869|560655995|FG001|Overall Study|Withdrawal by Subject|2|||
155333457|NCT04652869|560655996|FG002|Overall Study|Withdrawal by Subject|0|||
155333458|NCT01372085|560655997|FG000|Washout Period 2|Physician Decision|0|||
155333459|NCT01372085|560655998|FG001|Washout Period 2|Physician Decision|0|||
155333460|NCT01372085|560655999|FG002|Washout Period 2|Physician Decision|0|||
155333461|NCT01372085|560656000|FG003|Washout Period 2|Physician Decision|0|||
155333462|NCT01372085|560656001|FG004|Washout Period 2|Physician Decision|1|||
155333463|NCT01372085|560656002|FG005|Washout Period 2|Physician Decision|0|||
155333464|NCT01372085|560656003|FG006|Washout Period 2|Physician Decision|0|||
155333465|NCT01372085|560656004|FG007|Washout Period 2|Physician Decision|0|||
155333466|NCT01372085|560656005|FG008|Washout Period 2|Physician Decision|0|||
155333467|NCT01372085|560656006|FG009|Washout Period 2|Physician Decision|0|||
155333468|NCT01372085|560655997|FG000|Washout Period 3|Withdrawal by Subject|0|||
155333469|NCT01372085|560655998|FG001|Washout Period 3|Withdrawal by Subject|0|||
155333470|NCT01372085|560655999|FG002|Washout Period 3|Withdrawal by Subject|0|||
155333471|NCT01372085|560656000|FG003|Washout Period 3|Withdrawal by Subject|0|||
155333472|NCT01372085|560656001|FG004|Washout Period 3|Withdrawal by Subject|0|||
155333473|NCT01372085|560656002|FG005|Washout Period 3|Withdrawal by Subject|2|||
155333474|NCT01372085|560656003|FG006|Washout Period 3|Withdrawal by Subject|0|||
155333475|NCT01372085|560656004|FG007|Washout Period 3|Withdrawal by Subject|0|||
155333476|NCT01372085|560656005|FG008|Washout Period 3|Withdrawal by Subject|0|||
155333477|NCT01372085|560656006|FG009|Washout Period 3|Withdrawal by Subject|0|||
155333478|NCT01833455|560656007|FG000|Overall Study|Withdrawal by Subject|1|||
155333479|NCT01833455|560656008|FG001|Overall Study|Withdrawal by Subject|0|||
155333480|NCT00562094|560656009|FG000|Overall Study|Lost to Follow-up|62|||
155333481|NCT02000752|560656014|FG000|Overall Study|Dystocic delivery|19|||
155333482|NCT02000752|560656015|FG001|Overall Study|Dystocic delivery|8|||
155333483|NCT02000752|560656014|FG000|Overall Study|Shift Changes|12|||
155333484|NCT02000752|560656015|FG001|Overall Study|Shift Changes|5|||
155333485|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
155333486|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
155333487|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
155333488|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
155333489|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
155333490|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
155333491|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
155333492|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333493|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333494|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333495|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
155333496|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333497|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333498|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333499|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
155333500|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
155333501|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
155333502|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
155333503|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
155333504|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
155333505|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
155333506|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
155333507|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
155333508|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
155333509|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
155333510|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
155333511|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
155333512|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
155333513|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
155333514|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
155333515|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333516|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333517|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333518|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333519|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333520|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333521|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333522|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333523|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333524|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155333525|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155333526|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
155333527|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333528|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333529|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333530|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333531|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333532|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
155333533|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333534|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333535|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333536|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333537|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
155333538|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333539|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333540|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333541|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
155333542|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
155333543|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
155333544|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
155333545|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
155333546|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
155333547|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
155333548|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
155333549|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
155645369|NCT01033071|561792237|FG002|Overall Study|Adverse Event|26|||
155333550|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
155333551|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
155333552|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
155333553|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
155645370|NCT01033071|561792235|FG000|Overall Study|Protocol Violation|0|||
155645371|NCT01033071|561792236|FG001|Overall Study|Protocol Violation|2|||
155333554|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
155333555|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333556|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
155333557|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333558|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333559|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333560|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333561|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333562|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333563|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333564|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333565|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333566|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333567|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333568|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333569|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
155333570|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
155333571|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333572|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333573|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
155333574|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333575|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333576|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
155333577|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
155333578|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
155333579|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
155333580|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
155333581|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
155333582|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
155333583|NCT00599196|560656031|FG000|Overall Study|Lack of Efficacy|22|||
155333584|NCT00599196|560656031|FG000|Overall Study|Adverse Event|93|||
155333585|NCT00599196|560656031|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
155333586|NCT00599196|560656031|FG000|Overall Study|Subject withdrew consent|43|||
155333587|NCT00599196|560656031|FG000|Overall Study|Study ended per sponsor|197|||
155333588|NCT00599196|560656031|FG000|Overall Study|Lost to Follow-up|17|||
155333589|NCT00599196|560656031|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
155333590|NCT00599196|560656031|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
155333591|NCT00599196|560656031|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
155333592|NCT00599196|560656031|FG000|Overall Study|Other: Pt Moved To Australia|1|||
155333593|NCT00599196|560656031|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
155333594|NCT00599196|560656031|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
155333595|NCT01009645|560656032|FG000|Overall Study|Lost to Follow-up|2|||
155333596|NCT01009645|560656033|FG001|Overall Study|Lost to Follow-up|8|||
155333597|NCT01009645|560656034|FG002|Overall Study|Lost to Follow-up|4|||
155333598|NCT01009645|560656035|FG003|Overall Study|Lost to Follow-up|5|||
155333599|NCT01079806|560656036|FG000|Day 1 to Week 96|Adverse Event|0|||
155333600|NCT01079806|560656037|FG001|Day 1 to Week 96|Adverse Event|3|||
155333601|NCT01079806|560656036|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
155333602|NCT01079806|560656037|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
155333603|NCT01079806|560656036|FG000|Day 1 to Week 96|Pregnancy|0|||
155333604|NCT01079806|560656037|FG001|Day 1 to Week 96|Pregnancy|1|||
155333605|NCT01079806|560656036|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
155333606|NCT01079806|560656037|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
155333607|NCT01079806|560656036|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
155333608|NCT01079806|560656037|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
155333609|NCT01079806|560656036|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
155333610|NCT01079806|560656037|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
155333611|NCT01079806|560656036|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
155333612|NCT01079806|560656037|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
155333613|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
155333614|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
155333615|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
155333616|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
155333617|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
155333618|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
155333619|NCT02788981|560656038|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
155333620|NCT02788981|560656039|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
155333621|NCT00795184|560656041|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
155333622|NCT00795184|560656042|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
155333623|NCT03781375|560656043|FG000|Double-blind Phase|Adverse Event|0|||
155333624|NCT03781375|560656044|FG001|Double-blind Phase|Adverse Event|1|||
155333625|NCT03781375|560656043|FG000|Double-blind Phase|Lack of Response|6|||
155333626|NCT03781375|560656044|FG001|Double-blind Phase|Lack of Response|2|||
155333627|NCT03781375|560656043|FG000|Double-blind Phase|Other|1|||
155333628|NCT03781375|560656044|FG001|Double-blind Phase|Other|3|||
155333629|NCT03781375|560656043|FG000|Open-label Phase|Protocol Issues|0|||
155333630|NCT03781375|560656044|FG001|Open-label Phase|Protocol Issues|1|||
155333631|NCT03781375|560656043|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
155333632|NCT03781375|560656044|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
155333633|NCT03781375|560656043|FG000|Open-label Phase|Other|2|||
155333634|NCT03781375|560656044|FG001|Open-label Phase|Other|2|||
155333635|NCT03489369|560656067|FG000|Overall Study|Documented Progressive Disease|3|||
155333636|NCT03489369|560656068|FG001|Overall Study|Documented Progressive Disease|2|||
155333637|NCT03489369|560656069|FG002|Overall Study|Documented Progressive Disease|3|||
155333638|NCT03489369|560656070|FG003|Overall Study|Documented Progressive Disease|6|||
155333639|NCT03489369|560656067|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333640|NCT03489369|560656068|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
155333641|NCT03489369|560656069|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333642|NCT03489369|560656070|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333643|NCT02106884|560656073|FG000|Overall Study|Change of diagnosis/exclusion|0|||
155333644|NCT02106884|560656074|FG001|Overall Study|Change of diagnosis/exclusion|1|||
155333645|NCT02384382|560656075|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
155333646|NCT02384382|560656075|FG000|Overall Study|Death|1|||
155333647|NCT02384382|560656075|FG000|Overall Study|Adverse Event|1|||
155333648|NCT02384382|560656075|FG000|Overall Study|Disease progression|16|||
155333649|NCT01822756|560656078|FG000|Overall Study|Adverse Event|0|||
155333650|NCT01822756|560656079|FG001|Overall Study|Adverse Event|0|||
155333651|NCT01822756|560656080|FG002|Overall Study|Adverse Event|0|||
155333652|NCT01822756|560656081|FG003|Overall Study|Adverse Event|2|||
155333653|NCT01822756|560656082|FG004|Overall Study|Adverse Event|0|||
155333654|NCT01822756|560656078|FG000|Overall Study|Disease progression|11|||
155333655|NCT01822756|560656079|FG001|Overall Study|Disease progression|1|||
155333656|NCT01822756|560656080|FG002|Overall Study|Disease progression|7|||
155333657|NCT01822756|560656081|FG003|Overall Study|Disease progression|2|||
155333658|NCT01822756|560656082|FG004|Overall Study|Disease progression|6|||
155333659|NCT01822756|560656078|FG000|Overall Study|Death|2|||
155333660|NCT01822756|560656079|FG001|Overall Study|Death|2|||
155333661|NCT01822756|560656080|FG002|Overall Study|Death|1|||
155333662|NCT01822756|560656081|FG003|Overall Study|Death|0|||
155333663|NCT01822756|560656082|FG004|Overall Study|Death|0|||
155333664|NCT01822756|560656078|FG000|Overall Study|Lost to Follow-up|1|||
155333665|NCT01822756|560656079|FG001|Overall Study|Lost to Follow-up|0|||
155333666|NCT01822756|560656080|FG002|Overall Study|Lost to Follow-up|1|||
155333667|NCT01822756|560656081|FG003|Overall Study|Lost to Follow-up|0|||
155333668|NCT01822756|560656082|FG004|Overall Study|Lost to Follow-up|1|||
155333669|NCT01822756|560656078|FG000|Overall Study|Physician Decision|0|||
155333670|NCT01822756|560656079|FG001|Overall Study|Physician Decision|1|||
155333671|NCT01822756|560656080|FG002|Overall Study|Physician Decision|0|||
155333672|NCT01822756|560656081|FG003|Overall Study|Physician Decision|0|||
155333673|NCT01822756|560656082|FG004|Overall Study|Physician Decision|0|||
155333674|NCT01822756|560656078|FG000|Overall Study|disease progression & patient preference|2|||
155333675|NCT01822756|560656079|FG001|Overall Study|disease progression & patient preference|0|||
155333676|NCT01822756|560656080|FG002|Overall Study|disease progression & patient preference|1|||
155333677|NCT01822756|560656081|FG003|Overall Study|disease progression & patient preference|0|||
155333678|NCT01822756|560656082|FG004|Overall Study|disease progression & patient preference|0|||
155333679|NCT02091752|560656083|FG000|Overall Study|Study terminated by Sponsor|2|||
155333680|NCT02091752|560656083|FG000|Overall Study|Adverse Event|1|||
155422002|NCT04343651|560974435|FG000|Overall Study|Lost to Follow-up|2|||
155422003|NCT04343651|560974436|FG001|Overall Study|Lost to Follow-up|1|||
155422004|NCT04343651|560974435|FG000|Overall Study|Protocol Violation|4|||
155422005|NCT04343651|560974436|FG001|Overall Study|Protocol Violation|6|||
155422006|NCT04343651|560974435|FG000|Overall Study|Missing|3|||
155422007|NCT04343651|560974436|FG001|Overall Study|Missing|9|||
155333681|NCT00665392|560656090|FG000|Overall Study|not treated|1|||
155333682|NCT03389802|560656100|FG000|Overall Study|Lack of Efficacy|3|||
155333683|NCT03389802|560656101|FG001|Overall Study|Lack of Efficacy|3|||
155333684|NCT03389802|560656102|FG002|Overall Study|Lack of Efficacy|13|||
155333685|NCT03389802|560656103|FG003|Overall Study|Lack of Efficacy|6|||
155422008|NCT04343651|560974435|FG000|Overall Study|Withdrawal by Subject|0|||
155422009|NCT04343651|560974436|FG001|Overall Study|Withdrawal by Subject|4|||
155422010|NCT04343651|560974435|FG000|Overall Study|Death|0|||
155422011|NCT04343651|560974436|FG001|Overall Study|Death|1|||
155333686|NCT03389802|560656104|FG004|Overall Study|Lack of Efficacy|1|||
155333687|NCT03389802|560656100|FG000|Overall Study|Adverse Event|0|||
155333688|NCT03389802|560656101|FG001|Overall Study|Adverse Event|0|||
155333689|NCT03389802|560656102|FG002|Overall Study|Adverse Event|1|||
155333690|NCT03389802|560656103|FG003|Overall Study|Adverse Event|0|||
155333691|NCT03389802|560656104|FG004|Overall Study|Adverse Event|4|||
155333692|NCT03389802|560656100|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
155333693|NCT03389802|560656101|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
155333694|NCT03389802|560656102|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
155333695|NCT03389802|560656103|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
155333696|NCT03389802|560656104|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
155333697|NCT02426138|560656105|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155333698|NCT02426138|560656106|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155333699|NCT04677738|560656107|FG000|Overall Study|Withdrawal by Subject|4|||
155333700|NCT04677738|560656108|FG001|Overall Study|Withdrawal by Subject|2|||
155333701|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333702|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333703|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
155333704|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333705|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333706|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
155333707|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
155333708|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
155333709|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
155333710|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
155333711|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333712|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
155333713|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333714|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333715|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333716|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333717|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333718|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333719|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
155333720|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
155333721|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333722|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333723|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
155333724|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333725|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333726|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
155333727|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333728|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333729|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
155333730|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333731|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
155333732|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333733|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333734|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333735|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
155333736|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
155333737|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333738|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333739|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333740|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333741|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
155333742|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
155333743|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
155333744|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
155333745|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
155333746|NCT01683409|560656113|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333747|NCT01683409|560656114|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333748|NCT01683409|560656115|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155422012|NCT04343651|560974435|FG000|Overall Study|Did not start treatment|1|||
155333749|NCT01683409|560656116|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333750|NCT01683409|560656117|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
155333751|NCT01683409|560656113|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333752|NCT01683409|560656114|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333753|NCT01683409|560656115|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
155422013|NCT04343651|560974436|FG001|Overall Study|Did not start treatment|1|||
155333754|NCT01683409|560656116|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333755|NCT01683409|560656117|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333756|NCT00553332|560656119|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
155333757|NCT03520036|560656123|FG000|Overall Study|Adverse Event|1|||
155333758|NCT03520036|560656124|FG001|Overall Study|Adverse Event|2|||
155333759|NCT03520036|560656125|FG002|Overall Study|Adverse Event|0|||
155333760|NCT03520036|560656123|FG000|Overall Study|Protocol Violation|1|||
155333761|NCT03520036|560656124|FG001|Overall Study|Protocol Violation|0|||
155333762|NCT03520036|560656125|FG002|Overall Study|Protocol Violation|0|||
155333763|NCT03520036|560656123|FG000|Overall Study|Withdrawal by Subject|0|||
155333764|NCT03520036|560656124|FG001|Overall Study|Withdrawal by Subject|1|||
155333765|NCT03520036|560656125|FG002|Overall Study|Withdrawal by Subject|4|||
155333766|NCT03520036|560656123|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
155333767|NCT03520036|560656124|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
155333768|NCT03520036|560656125|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
155333769|NCT00467272|560656129|FG000|Overall Study|Pneumonia|2|||
155333770|NCT00467272|560656129|FG000|Overall Study|Thrombophlebitis|1|||
155333771|NCT04745676|560656132|FG000|Overall Study|Death|1|||
155333772|NCT04745676|560656133|FG001|Overall Study|Death|0|||
155333773|NCT04745676|560656134|FG002|Overall Study|Death|0|||
155333774|NCT00676091|560656135|FG000|Infant Series|Parent or legal guardian request|10|||
155333775|NCT00676091|560656136|FG001|Infant Series|Parent or legal guardian request|8|||
155333776|NCT00676091|560656135|FG000|Infant Series|Protocol Violation|6|||
155333777|NCT00676091|560656136|FG001|Infant Series|Protocol Violation|3|||
155333778|NCT00676091|560656135|FG000|Infant Series|Adverse Event|2|||
155333779|NCT00676091|560656136|FG001|Infant Series|Adverse Event|3|||
155333780|NCT00676091|560656135|FG000|Infant Series|Failed to return|1|||
155333781|NCT00676091|560656136|FG001|Infant Series|Failed to return|3|||
155333782|NCT00676091|560656135|FG000|Infant Series|Lost to Follow-up|1|||
155333783|NCT00676091|560656136|FG001|Infant Series|Lost to Follow-up|0|||
155333784|NCT00676091|560656135|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
155333785|NCT00676091|560656136|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
155333786|NCT00676091|560656135|FG000|After Infant Series|Adverse Event|0|||
155333787|NCT00676091|560656136|FG001|After Infant Series|Adverse Event|1|||
155333788|NCT00676091|560656135|FG000|After Infant Series|Protocol Violation|0|||
155333789|NCT00676091|560656136|FG001|After Infant Series|Protocol Violation|1|||
155333790|NCT00676091|560656135|FG000|After Infant Series|Failed to return|1|||
155333791|NCT00676091|560656136|FG001|After Infant Series|Failed to return|1|||
155333792|NCT00676091|560656135|FG000|Toddler Dose|Failed to return|2|||
155333793|NCT00676091|560656136|FG001|Toddler Dose|Failed to return|0|||
155333794|NCT00676091|560656135|FG000|Toddler Dose|Parent or legal guardian request|1|||
155333795|NCT00676091|560656136|FG001|Toddler Dose|Parent or legal guardian request|0|||
155333796|NCT00989196|560656137|FG000|Treatment Period|Lost to Follow-up|1|||
155333797|NCT00989196|560656138|FG001|Treatment Period|Lost to Follow-up|0|||
155333798|NCT04912856|560656144|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
155333799|NCT04912856|560656145|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
155333800|NCT04912856|560656144|FG000|Overall Study|Not reported in synoptic CSR.|0|||
155333801|NCT04912856|560656145|FG001|Overall Study|Not reported in synoptic CSR.|1|||
155333802|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
155422014|NCT04343651|560974435|FG000|Overall Study|Patient did not complete visits 3-6|0|||
155422015|NCT04343651|560974436|FG001|Overall Study|Patient did not complete visits 3-6|1|||
155422016|NCT04188197|560976166|FG000|Overall Study|Lost to Follow-up|4|||
155422017|NCT04188197|560976167|FG001|Overall Study|Lost to Follow-up|1|||
155422018|NCT04188197|560976166|FG000|Overall Study|Withdrawal by Subject|1|||
155422019|NCT04188197|560976167|FG001|Overall Study|Withdrawal by Subject|1|||
155422020|NCT04188197|560976166|FG000|Overall Study|Pregnancy|0|||
155422021|NCT04188197|560976167|FG001|Overall Study|Pregnancy|1|||
155422022|NCT02613208|560976168|FG000|Overall Study|Withdrawal by Subject|1|||
155422023|NCT02613208|560976168|FG000|Overall Study|Change of address|2|||
155422024|NCT02613208|560976168|FG000|Overall Study|Physician Decision|2|||
155422025|NCT02613208|560976168|FG000|Overall Study|Lost to Follow-up|5|||
155422026|NCT02613208|560976168|FG000|Overall Study|Death|37|||
155422027|NCT05742984|560976171|FG000|Overall Study|Adverse Event|0|||
155333803|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
155333804|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333805|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333806|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333807|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
155333808|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
155422028|NCT05742984|560976172|FG001|Overall Study|Adverse Event|0|||
155422029|NCT05742984|560976173|FG002|Overall Study|Adverse Event|1|||
155422030|NCT05742984|560976174|FG003|Overall Study|Adverse Event|0|||
155422031|NCT05742984|560976175|FG004|Overall Study|Adverse Event|1|||
155645372|NCT01033071|561792237|FG002|Overall Study|Protocol Violation|1|||
155645373|NCT01033071|561792235|FG000|Overall Study|Lost to Follow-up|4|||
155645374|NCT01033071|561792236|FG001|Overall Study|Lost to Follow-up|5|||
155645375|NCT01033071|561792237|FG002|Overall Study|Lost to Follow-up|5|||
155645376|NCT01033071|561792235|FG000|Overall Study|Withdrawal by Subject|17|||
155645377|NCT01033071|561792236|FG001|Overall Study|Withdrawal by Subject|14|||
155645378|NCT01033071|561792237|FG002|Overall Study|Withdrawal by Subject|11|||
155645379|NCT01033071|561792235|FG000|Overall Study|Lack of Efficacy|0|||
155645380|NCT01033071|561792236|FG001|Overall Study|Lack of Efficacy|1|||
155645381|NCT01033071|561792237|FG002|Overall Study|Lack of Efficacy|1|||
155645382|NCT01033071|561792235|FG000|Overall Study|Other|6|||
155645383|NCT01033071|561792236|FG001|Overall Study|Other|4|||
155645384|NCT01033071|561792237|FG002|Overall Study|Other|3|||
155645385|NCT03315689|561793991|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
155645386|NCT03315689|561793992|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
155645387|NCT03315689|561793991|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
155645388|NCT03315689|561793992|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
155645389|NCT03315689|561793991|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
155645390|NCT03315689|561793992|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
155645391|NCT01348698|561793993|FG000|Overall Study|Does not meet lesion size criteria|1|||
155645392|NCT01348698|561793993|FG000|Overall Study|Death|3|||
155645393|NCT01348698|561793993|FG000|Overall Study|PI decision to close study|68|||
155645394|NCT01297244|561793994|FG000|Overall Study|Progressive disease|22|||
155645395|NCT01297244|561793995|FG001|Overall Study|Progressive disease|3|||
155645396|NCT01297244|561793994|FG000|Overall Study|Adverse Event|9|||
155422032|NCT05742984|560976176|FG005|Overall Study|Adverse Event|1|||
155422033|NCT05742984|560976171|FG000|Overall Study|Withdrawal by Subject|0|||
155422034|NCT05742984|560976172|FG001|Overall Study|Withdrawal by Subject|1|||
155422035|NCT05742984|560976173|FG002|Overall Study|Withdrawal by Subject|0|||
155422036|NCT05742984|560976174|FG003|Overall Study|Withdrawal by Subject|0|||
155422037|NCT05742984|560976175|FG004|Overall Study|Withdrawal by Subject|0|||
155422038|NCT05742984|560976176|FG005|Overall Study|Withdrawal by Subject|2|||
155422039|NCT02162862|560976177|FG000|Overall Study|Lost to Follow-up|0|||
155645397|NCT01297244|561793995|FG001|Overall Study|Adverse Event|1|||
155645398|NCT01297244|561793994|FG000|Overall Study|Death|1|||
155645399|NCT01297244|561793995|FG001|Overall Study|Death|1|||
155645400|NCT01297244|561793994|FG000|Overall Study|Clinical progression|1|||
155645401|NCT01297244|561793995|FG001|Overall Study|Clinical progression|1|||
155645402|NCT01297244|561793994|FG000|Overall Study|Withdrawal by Subject|2|||
155645403|NCT01297244|561793995|FG001|Overall Study|Withdrawal by Subject|0|||
155645404|NCT02595749|561793996|FG000|Overall Study|Withdrawal by Subject|12|||
155645405|NCT02595749|561793997|FG001|Overall Study|Withdrawal by Subject|7|||
155645406|NCT00669331|561793998|FG000|Randomisation to First Dose|Adverse Event|1|||
155645407|NCT00669331|561793999|FG001|Randomisation to First Dose|Adverse Event|0|||
155645408|NCT00669331|561793998|FG000|Randomisation to First Dose|Protocol Violation|1|||
155645409|NCT00669331|561793999|FG001|Randomisation to First Dose|Protocol Violation|0|||
155645410|NCT00669331|561793998|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
155645411|NCT00669331|561793999|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
155645412|NCT00669331|561793998|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
155645413|NCT00669331|561793999|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
155645414|NCT00669331|561793998|FG000|Randomisation to First Dose|Death|1|||
155645415|NCT00669331|561793999|FG001|Randomisation to First Dose|Death|0|||
155645416|NCT00669331|561793998|FG000|Randomisation to First Dose|Sponsor decision|0|||
155645417|NCT00669331|561793999|FG001|Randomisation to First Dose|Sponsor decision|1|||
155645418|NCT00669331|561793998|FG000|Randomisation to First Dose|Randomised in error|3|||
155645419|NCT00669331|561793999|FG001|Randomisation to First Dose|Randomised in error|10|||
155645420|NCT00669331|561793998|FG000|Blinded Treatment Period|Adverse Event|16|||
155645421|NCT00669331|561793999|FG001|Blinded Treatment Period|Adverse Event|10|||
155645422|NCT00669331|561793998|FG000|Blinded Treatment Period|Protocol Violation|1|||
155333809|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
155333810|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
155333811|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
155333812|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
155333813|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333814|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333815|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333816|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333817|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Disease progression|0|||
155333818|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Disease progression|1|||
155333819|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Disease progression|1|||
155333820|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Disease progression|0|||
155333821|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Disease progression|0|||
155333822|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333823|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333824|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333825|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
155333826|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
155333827|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333828|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333829|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333830|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
155333831|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333832|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333833|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333834|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333835|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
155333836|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333837|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
155333838|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
155333839|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
155333840|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
155333841|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
155333842|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Death|0|||
155333843|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Death|0|||
155333844|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Death|0|||
155333845|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Death|1|||
155333846|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Death|1|||
155333847|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333848|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333849|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333850|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333851|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
155333852|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333853|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333854|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333855|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333856|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
155333857|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333858|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333859|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333860|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
155333861|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333862|NCT02556918|560657803|FG000|Overall Study|Protocol Violation|5|||
155333863|NCT02556918|560657804|FG001|Overall Study|Protocol Violation|6|||
155333864|NCT02556918|560657803|FG000|Overall Study|Withdrawal by Subject|4|||
155333865|NCT02556918|560657804|FG001|Overall Study|Withdrawal by Subject|4|||
155333866|NCT04511702|560657814|FG000|Overall Study|Lost to Follow-up|3|||
155333867|NCT04511702|560657815|FG001|Overall Study|Lost to Follow-up|0|||
155333868|NCT04511702|560657816|FG002|Overall Study|Lost to Follow-up|4|||
155333869|NCT04511702|560657814|FG000|Overall Study|Withdrawal by Subject|17|||
155333870|NCT04511702|560657815|FG001|Overall Study|Withdrawal by Subject|1|||
155333871|NCT04511702|560657816|FG002|Overall Study|Withdrawal by Subject|8|||
155333872|NCT05349721|560657817|FG000|Part A (24 Weeks)|Adverse Event|9|||
155333873|NCT05349721|560657818|FG001|Part A (24 Weeks)|Adverse Event|2|||
155333874|NCT05349721|560657817|FG000|Part A (24 Weeks)|Death|8|||
155333875|NCT05349721|560657818|FG001|Part A (24 Weeks)|Death|3|||
155333876|NCT05349721|560657817|FG000|Part A (24 Weeks)|Disease Progression|1|||
155333877|NCT05349721|560657818|FG001|Part A (24 Weeks)|Disease Progression|1|||
155333878|NCT05349721|560657817|FG000|Part A (24 Weeks)|Screen Failure|2|||
155333879|NCT05349721|560657818|FG001|Part A (24 Weeks)|Screen Failure|0|||
155333880|NCT05349721|560657817|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
155333881|NCT05349721|560657818|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
155333882|NCT05349721|560657817|FG000|Part A (24 Weeks)|Other Than Specified|5|||
155333883|NCT05349721|560657818|FG001|Part A (24 Weeks)|Other Than Specified|1|||
155333884|NCT05349721|560657817|FG000|Part B (28 Weeks)|Adverse Event|3|||
155333885|NCT05349721|560657818|FG001|Part B (28 Weeks)|Adverse Event|0|||
155333886|NCT05349721|560657817|FG000|Part B (28 Weeks)|Death|21|||
155333887|NCT05349721|560657818|FG001|Part B (28 Weeks)|Death|11|||
155333888|NCT05349721|560657817|FG000|Part B (28 Weeks)|Disease Progression|2|||
155333889|NCT05349721|560657818|FG001|Part B (28 Weeks)|Disease Progression|1|||
155333890|NCT05349721|560657817|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
155333891|NCT05349721|560657818|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
155333892|NCT05349721|560657817|FG000|Part B (28 Weeks)|Physician Decision|1|||
155333893|NCT05349721|560657818|FG001|Part B (28 Weeks)|Physician Decision|0|||
155333894|NCT05349721|560657817|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
155333895|NCT05349721|560657818|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
155333896|NCT05349721|560657817|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
155333897|NCT05349721|560657818|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
155333898|NCT05349721|560657817|FG000|Part B (28 Weeks)|Other Than Specified|4|||
155333899|NCT05349721|560657818|FG001|Part B (28 Weeks)|Other Than Specified|2|||
155333900|NCT05349721|560657817|FG000|Part C (108 Weeks)|Death|0|||
155333901|NCT05349721|560657818|FG001|Part C (108 Weeks)|Death|1|||
155333902|NCT05349721|560657817|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
155333903|NCT05349721|560657818|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
155333904|NCT05349721|560657817|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
155333905|NCT05349721|560657818|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
155333906|NCT05349721|560657817|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
155333907|NCT05349721|560657818|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
155333908|NCT00799409|560657821|FG000|Overall Study|Withdrawal by Subject|1|||
155333909|NCT00799409|560657822|FG001|Overall Study|Withdrawal by Subject|0|||
155333910|NCT00799409|560657823|FG002|Overall Study|Withdrawal by Subject|0|||
155333911|NCT00799409|560657821|FG000|Overall Study|Lost to Follow-up|1|||
155333912|NCT00799409|560657822|FG001|Overall Study|Lost to Follow-up|0|||
155333913|NCT00799409|560657823|FG002|Overall Study|Lost to Follow-up|0|||
155333914|NCT00799409|560657821|FG000|Overall Study|Optimal Dose Not Achieved|2|||
155333915|NCT00799409|560657822|FG001|Overall Study|Optimal Dose Not Achieved|0|||
155333916|NCT00799409|560657823|FG002|Overall Study|Optimal Dose Not Achieved|0|||
155333917|NCT00799409|560657821|FG000|Overall Study|Failure to follow study protocol)|1|||
155333918|NCT00799409|560657822|FG001|Overall Study|Failure to follow study protocol)|0|||
155333919|NCT00799409|560657823|FG002|Overall Study|Failure to follow study protocol)|0|||
155333920|NCT00799409|560657821|FG000|Overall Study|Did not attend lab school day 1|1|||
155333921|NCT00799409|560657822|FG001|Overall Study|Did not attend lab school day 1|0|||
155333922|NCT00799409|560657823|FG002|Overall Study|Did not attend lab school day 1|0|||
155333923|NCT00799409|560657821|FG000|Overall Study|medication compliance|1|||
155333924|NCT00799409|560657822|FG001|Overall Study|medication compliance|0|||
155333925|NCT00799409|560657823|FG002|Overall Study|medication compliance|0|||
155333926|NCT03137459|560657824|FG000|2-month Assessment|Withdrawal by Subject|13|||
155333927|NCT03137459|560657825|FG001|2-month Assessment|Withdrawal by Subject|3|||
155333928|NCT03137459|560657824|FG000|2-month Assessment|Unable to reach|42|||
155333929|NCT03137459|560657825|FG001|2-month Assessment|Unable to reach|32|||
155333930|NCT03137459|560657824|FG000|2-month Assessment|Refused assessment|7|||
155333931|NCT03137459|560657825|FG001|2-month Assessment|Refused assessment|5|||
155333932|NCT03137459|560657824|FG000|2-month Assessment|Acutely ill|6|||
155333933|NCT03137459|560657825|FG001|2-month Assessment|Acutely ill|2|||
155333934|NCT03137459|560657824|FG000|4-month Assessment|Death|4|||
155333935|NCT03137459|560657825|FG001|4-month Assessment|Death|2|||
155333936|NCT03137459|560657824|FG000|4-month Assessment|Withdrawal by Subject|4|||
155333937|NCT03137459|560657825|FG001|4-month Assessment|Withdrawal by Subject|2|||
155333938|NCT03137459|560657824|FG000|4-month Assessment|Unable to reach|44|||
155333939|NCT03137459|560657825|FG001|4-month Assessment|Unable to reach|29|||
155333940|NCT03137459|560657824|FG000|4-month Assessment|Refused assessment|24|||
155333941|NCT03137459|560657825|FG001|4-month Assessment|Refused assessment|10|||
155333942|NCT03137459|560657824|FG000|4-month Assessment|Acutely ill|2|||
155333943|NCT03137459|560657825|FG001|4-month Assessment|Acutely ill|3|||
155333944|NCT03137459|560657824|FG000|6-months|Lost to Follow-up|14|||
155333945|NCT03137459|560657825|FG001|6-months|Lost to Follow-up|11|||
155333946|NCT03137459|560657824|FG000|6-months|Death|0|||
155333947|NCT03137459|560657825|FG001|6-months|Death|2|||
155333948|NCT03137459|560657824|FG000|6-months|Refused assessment|6|||
155333949|NCT03137459|560657825|FG001|6-months|Refused assessment|3|||
155333950|NCT03137459|560657824|FG000|6-months|Acutely ill|1|||
155333951|NCT03137459|560657825|FG001|6-months|Acutely ill|1|||
155333952|NCT04921358|560657827|FG000|Overall Study|Withdrawal by Subject|6|||
155333953|NCT04921358|560657828|FG001|Overall Study|Withdrawal by Subject|13|||
155333954|NCT04921358|560657827|FG000|Overall Study|Lost to Follow-up|3|||
155333955|NCT04921358|560657828|FG001|Overall Study|Lost to Follow-up|6|||
155333956|NCT04921358|560657827|FG000|Overall Study|Study Terminated by Sponsor|86|||
155333957|NCT04921358|560657828|FG001|Overall Study|Study Terminated by Sponsor|89|||
155333958|NCT04921358|560657827|FG000|Overall Study|Death|92|||
155333959|NCT04921358|560657828|FG001|Overall Study|Death|82|||
155333960|NCT02278796|560657829|FG000|Overall Study|Death|2|||
155333961|NCT02278796|560657830|FG001|Overall Study|Death|3|||
155333962|NCT04926857|560657831|FG000|Overall Study|Withdrawal by Subject|40|||
155333963|NCT04926857|560657831|FG000|Overall Study|Death|9|||
155333964|NCT04926857|560657831|FG000|Overall Study|Study product no longer in use|44|||
155333965|NCT04926857|560657831|FG000|Overall Study|Inadequate data to address primary objective|16|||
155333966|NCT02310581|560657832|FG000|Overall Study|Adverse Event|1|||
155333967|NCT02310581|560657833|FG001|Overall Study|Adverse Event|1|||
155333968|NCT02310581|560657834|FG002|Overall Study|Adverse Event|1|||
155333969|NCT02310581|560657835|FG003|Overall Study|Adverse Event|0|||
155333970|NCT02310581|560657832|FG000|Overall Study|Withdrawal by Subject|2|||
155333971|NCT02310581|560657833|FG001|Overall Study|Withdrawal by Subject|1|||
155333972|NCT02310581|560657834|FG002|Overall Study|Withdrawal by Subject|0|||
155333973|NCT02310581|560657835|FG003|Overall Study|Withdrawal by Subject|1|||
155333974|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
155333975|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
155333976|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
155333977|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
155333978|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
155333979|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
155333980|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
155333981|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
155333982|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
155333983|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
155333984|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
155333985|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
155333986|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Other|1|||
155333987|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Other|0|||
155333988|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Other|0|||
155333989|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
155333990|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
155333991|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
155333992|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
155333993|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
155333994|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
155333995|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
155333996|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
155333997|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
155422040|NCT02162862|560976178|FG001|Overall Study|Lost to Follow-up|11|||
155333998|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
155333999|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
155334000|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
155334001|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
155334002|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
155334003|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
155334004|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
155334005|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
155334006|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
155334007|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Other|1|||
155334008|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Other|0|||
155334009|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Other|0|||
155334010|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
155334011|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
155334012|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
155334013|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
155334014|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
155334015|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
155334016|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
155334017|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
155422041|NCT02162862|560976179|FG002|Overall Study|Lost to Follow-up|0|||
155422042|NCT02162862|560976177|FG000|Overall Study|Subject did not feel the med was needed|0|||
155422043|NCT02162862|560976178|FG001|Overall Study|Subject did not feel the med was needed|0|||
155422044|NCT02162862|560976179|FG002|Overall Study|Subject did not feel the med was needed|4|||
155422045|NCT01279057|560976183|FG000|Overall Study|Adverse Event|1|||
155422046|NCT01279057|560976184|FG001|Overall Study|Adverse Event|0|||
155422047|NCT01279057|560976185|FG002|Overall Study|Adverse Event|1|||
155422048|NCT01279057|560976183|FG000|Overall Study|Insufficient therapeutic response|0|||
155422049|NCT01279057|560976184|FG001|Overall Study|Insufficient therapeutic response|0|||
155422050|NCT01279057|560976185|FG002|Overall Study|Insufficient therapeutic response|1|||
155422051|NCT01279057|560976183|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155422052|NCT01279057|560976184|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
155422053|NCT01279057|560976185|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155422054|NCT01279057|560976183|FG000|Overall Study|Withdrew consent|2|||
155422055|NCT01279057|560976184|FG001|Overall Study|Withdrew consent|0|||
155422056|NCT01279057|560976185|FG002|Overall Study|Withdrew consent|1|||
155422057|NCT01279057|560976183|FG000|Overall Study|Pregnancy|0|||
155422058|NCT01279057|560976184|FG001|Overall Study|Pregnancy|1|||
155422059|NCT01279057|560976185|FG002|Overall Study|Pregnancy|0|||
155422060|NCT01279057|560976183|FG000|Overall Study|Other|3|||
155422061|NCT01279057|560976184|FG001|Overall Study|Other|3|||
155422062|NCT01279057|560976185|FG002|Overall Study|Other|0|||
155422063|NCT01427309|560976187|FG000|Overall Study|Lost to Follow-up|130|||
155422064|NCT01427309|560976188|FG001|Overall Study|Lost to Follow-up|145|||
155422065|NCT01427309|560976189|FG002|Overall Study|Lost to Follow-up|122|||
155422066|NCT01427309|560976190|FG003|Overall Study|Lost to Follow-up|135|||
155422067|NCT01427309|560976187|FG000|Overall Study|Protocol Violation|42|||
155422068|NCT01427309|560976188|FG001|Overall Study|Protocol Violation|69|||
155422069|NCT01427309|560976189|FG002|Overall Study|Protocol Violation|125|||
155422070|NCT01427309|560976190|FG003|Overall Study|Protocol Violation|124|||
155422071|NCT01427309|560976187|FG000|Overall Study|Adverse Event|0|||
155422072|NCT01427309|560976188|FG001|Overall Study|Adverse Event|0|||
155422073|NCT01427309|560976189|FG002|Overall Study|Adverse Event|3|||
155422074|NCT01427309|560976190|FG003|Overall Study|Adverse Event|1|||
155422075|NCT01427309|560976187|FG000|Overall Study|Serious adverse event|52|||
155422076|NCT01427309|560976188|FG001|Overall Study|Serious adverse event|45|||
155422077|NCT01427309|560976189|FG002|Overall Study|Serious adverse event|50|||
155422078|NCT01427309|560976190|FG003|Overall Study|Serious adverse event|61|||
155422079|NCT01427309|560976187|FG000|Overall Study|Withdrawal by Subject|148|||
155422080|NCT01427309|560976188|FG001|Overall Study|Withdrawal by Subject|148|||
155422081|NCT01427309|560976189|FG002|Overall Study|Withdrawal by Subject|61|||
155422082|NCT01427309|560976190|FG003|Overall Study|Withdrawal by Subject|55|||
155422083|NCT03617705|560976193|FG000|Overall Study|Withdrawal by Subject|2|||
155422084|NCT03617705|560976193|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
155422085|NCT03617705|560976193|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
155422086|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
155422087|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
155422088|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
155422089|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
155422090|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
155422091|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
155422092|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
155422093|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
155422094|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
155422095|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
155334018|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
155422096|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
155422097|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
155422098|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
155334019|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
155334020|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
155334021|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
155334022|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
155334023|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
155334024|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
155334025|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
155334026|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
155334027|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
155334028|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Other|30|||
155334029|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Other|0|||
155334030|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Other|0|||
155334031|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
155334032|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
155334033|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
155334034|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
155334035|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
155334036|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
155334037|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Adverse Event|0|||
155334038|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Adverse Event|7|||
155334039|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Adverse Event|2|||
155334040|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Failed to return|0|||
155334041|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Failed to return|2|||
155645423|NCT00669331|561793999|FG001|Blinded Treatment Period|Protocol Violation|1|||
155645424|NCT00669331|561793998|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
155645425|NCT00669331|561793999|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
155645426|NCT00669331|561793998|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
155645427|NCT00669331|561793999|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
155645428|NCT00669331|561793998|FG000|Blinded Treatment Period|Death|0|||
155645429|NCT00669331|561793999|FG001|Blinded Treatment Period|Death|2|||
155334042|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Failed to return|2|||
155334043|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
155334044|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
155334045|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
155334046|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
155334047|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
155334048|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
155334049|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Other|0|||
155334050|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Other|2|||
155334051|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Other|0|||
155334052|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
155334053|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
155334054|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
155334055|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
155334056|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
155334057|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
155334058|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
155334059|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
155334060|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
155334061|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
155334062|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
155334063|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
155334064|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
155334065|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
155334066|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
155334067|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
155334068|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
155334069|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
155334070|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
155334071|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
155334072|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
155334073|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
155334074|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
155334075|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
155334076|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
155334077|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
155334078|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
155334079|NCT03883828|560657839|FG000|Overall Study|Did not start radiotherapy|1|||
155334080|NCT03883828|560657840|FG001|Overall Study|Did not start radiotherapy|2|||
155334081|NCT03960645|560657841|FG000|Overall Study|Protocol Violation|1|||
155334082|NCT03960645|560657842|FG001|Overall Study|Protocol Violation|0|||
155334083|NCT04938453|560657843|FG000|Washout Period 1|Adverse Event|1|||
155334084|NCT04938453|560657844|FG001|Washout Period 1|Adverse Event|0|||
155334085|NCT04938453|560657843|FG000|Washout Period 1|Physician Decision|0|||
155334086|NCT04938453|560657844|FG001|Washout Period 1|Physician Decision|1|||
155334087|NCT03737110|560657845|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
155334088|NCT03737110|560657846|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
155334089|NCT03737110|560657847|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
155334090|NCT03737110|560657848|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
155334091|NCT03737110|560657849|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
155334092|NCT03737110|560657850|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
155334093|NCT03737110|560657845|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
155334094|NCT03737110|560657846|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334095|NCT03737110|560657847|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334096|NCT03737110|560657848|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334097|NCT03737110|560657849|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334098|NCT03737110|560657850|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334099|NCT03737110|560657845|FG000|Run-in (RI) Period|Adverse Event|4|||
155334100|NCT03737110|560657846|FG001|Run-in (RI) Period|Adverse Event|0|||
155334101|NCT03737110|560657847|FG002|Run-in (RI) Period|Adverse Event|0|||
155334102|NCT03737110|560657848|FG003|Run-in (RI) Period|Adverse Event|0|||
155334103|NCT03737110|560657849|FG004|Run-in (RI) Period|Adverse Event|0|||
155334104|NCT03737110|560657850|FG005|Run-in (RI) Period|Adverse Event|0|||
155334105|NCT03737110|560657845|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334106|NCT03737110|560657846|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
155334107|NCT03737110|560657847|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334108|NCT03737110|560657848|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334109|NCT03737110|560657849|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334110|NCT03737110|560657850|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334111|NCT03737110|560657845|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334112|NCT03737110|560657846|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334113|NCT03737110|560657847|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
155334114|NCT03737110|560657848|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334115|NCT03737110|560657849|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334116|NCT03737110|560657850|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334117|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334118|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334119|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334120|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
155334121|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334122|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334123|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334124|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334125|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334126|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
155334127|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334128|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
155334129|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334130|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334131|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334132|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334133|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
155334134|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334135|NCT05553366|560657859|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
155334136|NCT05553366|560657860|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
155334137|NCT05553366|560657861|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
155334138|NCT05553366|560657859|FG000|Overall Study|Lost to Follow-up|3|||
155334139|NCT05553366|560657860|FG001|Overall Study|Lost to Follow-up|3|||
155334140|NCT05553366|560657861|FG002|Overall Study|Lost to Follow-up|3|||
155334141|NCT05553366|560657859|FG000|Overall Study|Other non-compliance|1|||
155334142|NCT05553366|560657860|FG001|Overall Study|Other non-compliance|1|||
155422099|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
155422100|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
155422101|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
155422102|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
155422103|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
155334143|NCT05553366|560657861|FG002|Overall Study|Other non-compliance|0|||
155334144|NCT05553366|560657859|FG000|Overall Study|Randomized but not dosed|0|||
155334145|NCT05553366|560657860|FG001|Overall Study|Randomized but not dosed|0|||
155334146|NCT05553366|560657861|FG002|Overall Study|Randomized but not dosed|2|||
155334147|NCT00249769|560657862|FG000|Overall Study|Withdrawal by Subject|1|||
155334148|NCT00249769|560657863|FG001|Overall Study|Withdrawal by Subject|10|||
155334149|NCT00249769|560657864|FG002|Overall Study|Withdrawal by Subject|6|||
155334150|NCT00249769|560657862|FG000|Overall Study|Migration from Study Area|1|||
155334151|NCT00249769|560657863|FG001|Overall Study|Migration from Study Area|3|||
155334152|NCT00249769|560657864|FG002|Overall Study|Migration from Study Area|14|||
155334153|NCT00249769|560657862|FG000|Overall Study|Miscellaneous|0|||
155334154|NCT00249769|560657863|FG001|Overall Study|Miscellaneous|2|||
155334155|NCT00249769|560657864|FG002|Overall Study|Miscellaneous|2|||
155334156|NCT00249769|560657862|FG000|Overall Study|Adverse Event|0|||
155334157|NCT00249769|560657863|FG001|Overall Study|Adverse Event|0|||
155334158|NCT00249769|560657864|FG002|Overall Study|Adverse Event|1|||
155334159|NCT00249769|560657862|FG000|Overall Study|Physician Decision|0|||
155334160|NCT00249769|560657863|FG001|Overall Study|Physician Decision|0|||
155334161|NCT00249769|560657864|FG002|Overall Study|Physician Decision|2|||
155334162|NCT00249769|560657862|FG000|Overall Study|Lost to Follow-up|0|||
155334163|NCT00249769|560657863|FG001|Overall Study|Lost to Follow-up|0|||
155334164|NCT00249769|560657864|FG002|Overall Study|Lost to Follow-up|3|||
155334165|NCT02022657|560657869|FG000|Overall Study|Withdrawal by Subject|2|||
155334166|NCT02022657|560657870|FG001|Overall Study|Withdrawal by Subject|0|||
155334167|NCT02022657|560657871|FG002|Overall Study|Withdrawal by Subject|1|||
155334168|NCT02022657|560657872|FG003|Overall Study|Withdrawal by Subject|0|||
155334169|NCT02022657|560657873|FG004|Overall Study|Withdrawal by Subject|0|||
155334170|NCT02022657|560657874|FG005|Overall Study|Withdrawal by Subject|0|||
155334171|NCT02022657|560657869|FG000|Overall Study|Physician Decision|0|||
155334172|NCT02022657|560657870|FG001|Overall Study|Physician Decision|0|||
155422104|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
155422105|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
155422106|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
155422107|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
155334173|NCT02022657|560657871|FG002|Overall Study|Physician Decision|0|||
155422108|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
155334174|NCT02022657|560657872|FG003|Overall Study|Physician Decision|0|||
155334175|NCT02022657|560657873|FG004|Overall Study|Physician Decision|0|||
155334176|NCT02022657|560657874|FG005|Overall Study|Physician Decision|1|||
155334177|NCT03274076|560657875|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334178|NCT03274076|560657876|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
155334179|NCT03274076|560657877|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334180|NCT03274076|560657878|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334181|NCT03274076|560657875|FG000|24 Weeks Open Label|Adverse Event|0|||
155334182|NCT03274076|560657876|FG001|24 Weeks Open Label|Adverse Event|0|||
155334183|NCT03274076|560657877|FG002|24 Weeks Open Label|Adverse Event|2|||
155334184|NCT03274076|560657878|FG003|24 Weeks Open Label|Adverse Event|0|||
155334185|NCT03274076|560657875|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
155334186|NCT03274076|560657876|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
155334187|NCT03274076|560657877|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
155334188|NCT03274076|560657878|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
155334189|NCT01629589|560657879|FG000|Overall Study|Protocol Violation|4|||
155334190|NCT01629589|560657880|FG001|Overall Study|Protocol Violation|2|||
155334191|NCT01629589|560657879|FG000|Overall Study|Lost to Follow-up|2|||
155334192|NCT01629589|560657880|FG001|Overall Study|Lost to Follow-up|1|||
155334193|NCT01629589|560657879|FG000|Overall Study|Withdrawal by Subject|2|||
155334194|NCT01629589|560657880|FG001|Overall Study|Withdrawal by Subject|3|||
155334195|NCT01629589|560657879|FG000|Overall Study|Did not receive study vaccine|0|||
155334196|NCT01629589|560657880|FG001|Overall Study|Did not receive study vaccine|1|||
155334197|NCT01530334|560657881|FG000|Overall Study|Adverse Event|3|||
155334198|NCT01530334|560657881|FG000|Overall Study|unknown reason|1|||
155334199|NCT01530334|560657881|FG000|Overall Study|Progressive disease|47|||
155334200|NCT02079649|560657883|FG000|Overall Study|Lost to Follow-up|0|||
155334201|NCT02079649|560657884|FG001|Overall Study|Lost to Follow-up|0|||
155334202|NCT02079649|560657885|FG002|Overall Study|Lost to Follow-up|0|||
155334203|NCT02079649|560657886|FG003|Overall Study|Lost to Follow-up|1|||
155334204|NCT02079649|560657883|FG000|Overall Study|Withdrawal by Subject|0|||
155334205|NCT02079649|560657884|FG001|Overall Study|Withdrawal by Subject|0|||
155334206|NCT02079649|560657885|FG002|Overall Study|Withdrawal by Subject|0|||
155334207|NCT02079649|560657886|FG003|Overall Study|Withdrawal by Subject|1|||
155334208|NCT02079649|560657883|FG000|Overall Study|Randomization error (prior to treatment)|1|||
155334209|NCT02079649|560657884|FG001|Overall Study|Randomization error (prior to treatment)|0|||
155334210|NCT02079649|560657885|FG002|Overall Study|Randomization error (prior to treatment)|1|||
155334211|NCT02079649|560657886|FG003|Overall Study|Randomization error (prior to treatment)|0|||
155334212|NCT03739866|560657889|FG000|Overall Study|Lost to Follow-up|0|||
155334213|NCT03739866|560657890|FG001|Overall Study|Lost to Follow-up|0|||
155334214|NCT03739866|560657891|FG002|Overall Study|Lost to Follow-up|0|||
155436207|NCT03700892|561024563|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
155334215|NCT03739866|560657892|FG003|Overall Study|Lost to Follow-up|1|||
155334216|NCT03739866|560657893|FG004|Overall Study|Lost to Follow-up|0|||
155334217|NCT03739866|560657894|FG005|Overall Study|Lost to Follow-up|0|||
155334218|NCT03739866|560657895|FG006|Overall Study|Lost to Follow-up|0|||
155334219|NCT03739866|560657896|FG007|Overall Study|Lost to Follow-up|0|||
155334220|NCT03739866|560657889|FG000|Overall Study|Enrolled but not treated|0|||
155334221|NCT03739866|560657890|FG001|Overall Study|Enrolled but not treated|0|||
155334222|NCT03739866|560657891|FG002|Overall Study|Enrolled but not treated|1|||
155334223|NCT03739866|560657892|FG003|Overall Study|Enrolled but not treated|0|||
155334224|NCT03739866|560657893|FG004|Overall Study|Enrolled but not treated|1|||
155334225|NCT03739866|560657894|FG005|Overall Study|Enrolled but not treated|0|||
155334226|NCT03739866|560657895|FG006|Overall Study|Enrolled but not treated|0|||
155334227|NCT03739866|560657896|FG007|Overall Study|Enrolled but not treated|0|||
155334228|NCT01034306|560657897|FG000|Overall Study|Adverse Event|1|||
155334229|NCT01034306|560657898|FG001|Overall Study|Adverse Event|0|||
155334230|NCT01034306|560657897|FG000|Overall Study|Lost to Follow-up|0|||
155334231|NCT01034306|560657898|FG001|Overall Study|Lost to Follow-up|1|||
155334232|NCT01034306|560657897|FG000|Overall Study|Withdrawal by Subject|2|||
155334233|NCT01034306|560657898|FG001|Overall Study|Withdrawal by Subject|2|||
155334234|NCT01034306|560657897|FG000|Overall Study|hospitalized and decided to stop|1|||
155334235|NCT01034306|560657898|FG001|Overall Study|hospitalized and decided to stop|0|||
155334236|NCT01034306|560657897|FG000|Overall Study|Noncomplience|1|||
155334237|NCT01034306|560657898|FG001|Overall Study|Noncomplience|0|||
155334238|NCT00836498|560657899|FG000|Overall Study|Adverse Event|1|||
155334239|NCT00836498|560657900|FG001|Overall Study|Adverse Event|0|||
155334240|NCT00836498|560657899|FG000|Overall Study|Lost to Follow-up|1|||
155334241|NCT00836498|560657900|FG001|Overall Study|Lost to Follow-up|0|||
155334242|NCT00836498|560657899|FG000|Overall Study|Withdrawal by Subject|2|||
155334243|NCT00836498|560657900|FG001|Overall Study|Withdrawal by Subject|1|||
155334244|NCT01968967|560657901|FG000|Treatment Period|Other|22|||
155334245|NCT01968967|560657902|FG001|Treatment Period|Other|22|||
155334246|NCT01968967|560657903|FG002|Treatment Period|Other|0|||
155334247|NCT01968967|560657904|FG003|Treatment Period|Other|0|||
155334248|NCT01968967|560657905|FG004|Treatment Period|Other|0|||
155334249|NCT01968967|560657901|FG000|Treatment Period|Withdrawal by Subject|71|||
155334250|NCT01968967|560657902|FG001|Treatment Period|Withdrawal by Subject|61|||
155334251|NCT01968967|560657903|FG002|Treatment Period|Withdrawal by Subject|0|||
155334252|NCT01968967|560657904|FG003|Treatment Period|Withdrawal by Subject|0|||
155334253|NCT01968967|560657905|FG004|Treatment Period|Withdrawal by Subject|0|||
155422109|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
155422110|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
155422111|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
155422112|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
155422113|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
155422114|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
155422115|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
155422116|NCT00849017|560976194|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
155422117|NCT00849017|560976195|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
155422118|NCT00849017|560976196|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
155422119|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
155422120|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
155422121|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
155422122|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
155422123|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
155422124|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
155422125|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
155422126|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
155422127|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
155422128|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
155422129|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
155422130|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
155422131|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
155422132|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
155422133|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
155422134|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
155422135|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
155422136|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
155422137|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
155422138|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
155422139|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
155422140|NCT00849017|560976194|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
155422141|NCT00849017|560976195|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
155334254|NCT01968967|560657901|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
155334255|NCT01968967|560657902|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
155334256|NCT01968967|560657903|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334257|NCT01968967|560657904|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334258|NCT01968967|560657905|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334259|NCT01968967|560657901|FG000|Treatment Period|Lost to Follow-up|26|||
155334260|NCT01968967|560657902|FG001|Treatment Period|Lost to Follow-up|31|||
155334261|NCT01968967|560657903|FG002|Treatment Period|Lost to Follow-up|0|||
155334262|NCT01968967|560657904|FG003|Treatment Period|Lost to Follow-up|0|||
155334263|NCT01968967|560657905|FG004|Treatment Period|Lost to Follow-up|0|||
155334264|NCT01968967|560657901|FG000|Treatment Period|Protocol Violation|1|||
155334265|NCT01968967|560657902|FG001|Treatment Period|Protocol Violation|2|||
155334266|NCT01968967|560657903|FG002|Treatment Period|Protocol Violation|0|||
155334267|NCT01968967|560657904|FG003|Treatment Period|Protocol Violation|0|||
155334268|NCT01968967|560657905|FG004|Treatment Period|Protocol Violation|0|||
155334269|NCT01968967|560657901|FG000|Treatment Period|Adverse Event|9|||
155334270|NCT01968967|560657902|FG001|Treatment Period|Adverse Event|8|||
155334271|NCT01968967|560657903|FG002|Treatment Period|Adverse Event|0|||
155334272|NCT01968967|560657904|FG003|Treatment Period|Adverse Event|0|||
155334273|NCT01968967|560657905|FG004|Treatment Period|Adverse Event|0|||
155334274|NCT01968967|560657901|FG000|Treatment Period|Death|9|||
155334275|NCT01968967|560657902|FG001|Treatment Period|Death|2|||
155334276|NCT01968967|560657903|FG002|Treatment Period|Death|0|||
155334277|NCT01968967|560657904|FG003|Treatment Period|Death|0|||
155334278|NCT01968967|560657905|FG004|Treatment Period|Death|0|||
155334279|NCT01968967|560657901|FG000|Treatment Period|Randomized Not Treated|6|||
155334280|NCT01968967|560657902|FG001|Treatment Period|Randomized Not Treated|5|||
155334281|NCT01968967|560657903|FG002|Treatment Period|Randomized Not Treated|0|||
155334282|NCT01968967|560657904|FG003|Treatment Period|Randomized Not Treated|0|||
155334283|NCT01968967|560657905|FG004|Treatment Period|Randomized Not Treated|0|||
155334284|NCT01968967|560657901|FG000|Extension Period|Withdrew Consent|0|||
155334285|NCT01968967|560657902|FG001|Extension Period|Withdrew Consent|0|||
155334286|NCT01968967|560657903|FG002|Extension Period|Withdrew Consent|2|||
155334287|NCT01968967|560657904|FG003|Extension Period|Withdrew Consent|0|||
155334288|NCT01968967|560657905|FG004|Extension Period|Withdrew Consent|5|||
155334289|NCT00701415|560657910|FG000|Overall Study|Adverse Event|0|||
155334290|NCT00701415|560657911|FG001|Overall Study|Adverse Event|1|||
155334291|NCT00701415|560657910|FG000|Overall Study|Social/family issues and needle phobia|1|||
155334292|NCT00701415|560657911|FG001|Overall Study|Social/family issues and needle phobia|0|||
155334293|NCT00109031|560657912|FG000|Overall Study|Adverse Event|0|||
155334294|NCT00109031|560657913|FG001|Overall Study|Adverse Event|0|||
155334295|NCT00109031|560657914|FG002|Overall Study|Adverse Event|1|||
155334296|NCT00109031|560657915|FG003|Overall Study|Adverse Event|0|||
155334297|NCT00109031|560657912|FG000|Overall Study|Withdrawal by Subject|0|||
155334298|NCT00109031|560657913|FG001|Overall Study|Withdrawal by Subject|1|||
155334299|NCT00109031|560657914|FG002|Overall Study|Withdrawal by Subject|0|||
155334300|NCT00109031|560657915|FG003|Overall Study|Withdrawal by Subject|0|||
155334301|NCT00109031|560657912|FG000|Overall Study|Physician Decision|0|||
155334302|NCT00109031|560657913|FG001|Overall Study|Physician Decision|1|||
155334303|NCT00109031|560657914|FG002|Overall Study|Physician Decision|0|||
155334304|NCT00109031|560657915|FG003|Overall Study|Physician Decision|0|||
155334305|NCT00109031|560657912|FG000|Overall Study|Protocol Violation|0|||
155334306|NCT00109031|560657913|FG001|Overall Study|Protocol Violation|0|||
155334307|NCT00109031|560657914|FG002|Overall Study|Protocol Violation|1|||
155334308|NCT00109031|560657915|FG003|Overall Study|Protocol Violation|0|||
155334309|NCT04029090|560657916|FG000|Overall Study|Protocol Violation|1|||
155334310|NCT04029090|560657917|FG001|Overall Study|Protocol Violation|0|||
155334311|NCT04029090|560657918|FG002|Overall Study|Protocol Violation|0|||
155334312|NCT04029090|560657916|FG000|Overall Study|Withdrawal by Subject|0|||
155334313|NCT04029090|560657917|FG001|Overall Study|Withdrawal by Subject|1|||
155334314|NCT04029090|560657918|FG002|Overall Study|Withdrawal by Subject|0|||
155334315|NCT01065779|560657919|FG000|Overall Study|Duplicate Investigation|1|||
155334316|NCT01065779|560657919|FG000|Overall Study|Investigation Before Contract Date|37|||
155334317|NCT01065779|560657919|FG000|Overall Study|Non-enrollment Period Administration|10|||
155334318|NCT01065779|560657919|FG000|Overall Study|Not Administered With Study Drug|17|||
155334319|NCT01065779|560657919|FG000|Overall Study|Failed to Follow-up|10|||
155334320|NCT01065779|560657919|FG000|Overall Study|Inclusion Criteria Violation|7|||
155334321|NCT02157948|560657920|FG000|Overall Study|Withdrawal by Subject|4|||
155334322|NCT02157948|560657921|FG001|Overall Study|Withdrawal by Subject|5|||
155334323|NCT02157948|560657920|FG000|Overall Study|Lost to Follow-up|3|||
155334324|NCT02157948|560657921|FG001|Overall Study|Lost to Follow-up|2|||
155502594|NCT01902134|561267244|FG002|Overall Study|Protocol Violation|0|||
155334325|NCT02157948|560657920|FG000|Overall Study|Protocol Specified Criteria|2|||
155334326|NCT02157948|560657921|FG001|Overall Study|Protocol Specified Criteria|1|||
155334327|NCT02157948|560657920|FG000|Overall Study|Decision by Sponsor|0|||
155334328|NCT02157948|560657921|FG001|Overall Study|Decision by Sponsor|1|||
155334329|NCT01604824|560657923|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334330|NCT01604824|560657924|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334331|NCT01604824|560657925|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334332|NCT01604824|560657926|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334333|NCT01604824|560657927|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
155334334|NCT01604824|560657928|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334335|NCT01604824|560657923|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334336|NCT01604824|560657924|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334337|NCT01604824|560657925|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334338|NCT01604824|560657926|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334339|NCT01604824|560657927|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
155334340|NCT01604824|560657928|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334341|NCT02630966|560657929|FG000|Overall Study|Adverse Event|1|||
155334342|NCT02630966|560657930|FG001|Overall Study|Adverse Event|3|||
155334343|NCT02630966|560657929|FG000|Overall Study|Significant Protocol Deviation|0|||
155334344|NCT02630966|560657930|FG001|Overall Study|Significant Protocol Deviation|2|||
155334345|NCT02630966|560657929|FG000|Overall Study|Voluntary Withdrawal|1|||
155334346|NCT02630966|560657930|FG001|Overall Study|Voluntary Withdrawal|1|||
155334347|NCT02630966|560657929|FG000|Overall Study|Lack of Efficacy|0|||
155334348|NCT02630966|560657930|FG001|Overall Study|Lack of Efficacy|2|||
155334349|NCT04218864|560657945|FG000|Overall Study|Lost to Follow-up|8|||
155334350|NCT04218864|560657946|FG001|Overall Study|Lost to Follow-up|4|||
155334351|NCT04218864|560657945|FG000|Overall Study|Withdrawal by Subject|1|||
155334352|NCT04218864|560657946|FG001|Overall Study|Withdrawal by Subject|3|||
155334353|NCT00933270|560657947|FG000|Overall Study|Withdrawal by Subject|26|||
155334354|NCT00933270|560657947|FG000|Overall Study|Insufficient Follow-up|10|||
155334355|NCT00933270|560657947|FG000|Overall Study|Lost to Follow-up|14|||
155334356|NCT00933270|560657947|FG000|Overall Study|Adverse Event|1|||
155334357|NCT00933270|560657947|FG000|Overall Study|Missed Visit|2|||
155334358|NCT00933270|560657947|FG000|Overall Study|Death|24|||
155334359|NCT00933270|560657947|FG000|Overall Study|Moved or would not return|10|||
155334360|NCT02409680|560657948|FG000|Overall Study|Lost to Follow-up|15|||
155334361|NCT02409680|560657949|FG001|Overall Study|Lost to Follow-up|30|||
155334362|NCT05366751|560657950|FG000|Overall Study|Adverse Event|25|||
155334363|NCT05366751|560657950|FG000|Overall Study|Physician Decision|3|||
155334364|NCT05366751|560657950|FG000|Overall Study|Lost to Follow-up|2|||
155334365|NCT05366751|560657950|FG000|Overall Study|Withdrawal by Subject|14|||
155334366|NCT05366751|560657950|FG000|Overall Study|Study Terminated by Sponsor|50|||
155334367|NCT05366751|560657950|FG000|Overall Study|Site Terminated by Sponsor|3|||
155334368|NCT00108355|560660071|FG000|Overall Study|Peritonitis at index paracentesis|1|||
155334369|NCT00108355|560660072|FG001|Overall Study|Peritonitis at index paracentesis|1|||
155334370|NCT00108355|560660071|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
155334371|NCT00108355|560660072|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
155334372|NCT03214081|560660073|FG000|Overall Study|Case Report Forms Uncollected|9|||
155334373|NCT03214081|560660073|FG000|Overall Study|Protocol Deviation|54|||
155334374|NCT02962284|560660074|FG000|Overall Study|Death|2|||
155334375|NCT02962284|560660075|FG001|Overall Study|Death|0|||
155334376|NCT02962284|560660074|FG000|Overall Study|Progressive disease|2|||
155334377|NCT02962284|560660075|FG001|Overall Study|Progressive disease|3|||
155334378|NCT02962284|560660074|FG000|Overall Study|Withdrawal by Subject|1|||
155422142|NCT00849017|560976196|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
155422143|NCT00214461|560976197|FG000|Overall Study|Adverse Event|0|||
155422144|NCT00214461|560976198|FG001|Overall Study|Adverse Event|0|||
155422145|NCT00214461|560976199|FG002|Overall Study|Adverse Event|1|||
155422146|NCT00214461|560976200|FG003|Overall Study|Adverse Event|1|||
155422147|NCT00214461|560976197|FG000|Overall Study|Withdrawal by Subject|0|||
155422148|NCT00214461|560976198|FG001|Overall Study|Withdrawal by Subject|0|||
155422149|NCT00214461|560976199|FG002|Overall Study|Withdrawal by Subject|1|||
155422150|NCT00214461|560976200|FG003|Overall Study|Withdrawal by Subject|0|||
155422151|NCT02908100|560976202|FG000|Overall Study|Adverse Event|7|||
155422152|NCT02908100|560976203|FG001|Overall Study|Adverse Event|6|||
155422153|NCT02908100|560976204|FG002|Overall Study|Adverse Event|9|||
155422154|NCT02908100|560976202|FG000|Overall Study|Death|2|||
155422155|NCT02908100|560976203|FG001|Overall Study|Death|0|||
155422156|NCT02908100|560976204|FG002|Overall Study|Death|0|||
155422157|NCT02908100|560976202|FG000|Overall Study|Lack of Efficacy|2|||
155422158|NCT02908100|560976203|FG001|Overall Study|Lack of Efficacy|3|||
155334379|NCT02962284|560660075|FG001|Overall Study|Withdrawal by Subject|0|||
155334380|NCT02637063|560660076|FG000|Overall Study|Lost to Follow-up|3|||
155334381|NCT02637063|560660077|FG001|Overall Study|Lost to Follow-up|2|||
155334382|NCT02637063|560660078|FG002|Overall Study|Lost to Follow-up|3|||
155334383|NCT02637063|560660076|FG000|Overall Study|Withdrawal by Subject|2|||
155334384|NCT02637063|560660077|FG001|Overall Study|Withdrawal by Subject|2|||
155422159|NCT02908100|560976204|FG002|Overall Study|Lack of Efficacy|3|||
155422160|NCT02908100|560976202|FG000|Overall Study|Lost to Follow-up|0|||
155334385|NCT02637063|560660078|FG002|Overall Study|Withdrawal by Subject|3|||
155334386|NCT02634307|560660079|FG000|Overall Study|Adverse Event|50|||
155334387|NCT02634307|560660080|FG001|Overall Study|Adverse Event|24|||
155334388|NCT02634307|560660081|FG002|Overall Study|Adverse Event|14|||
155334389|NCT02634307|560660079|FG000|Overall Study|Lost to Follow-up|21|||
155334390|NCT02634307|560660080|FG001|Overall Study|Lost to Follow-up|5|||
155334391|NCT02634307|560660081|FG002|Overall Study|Lost to Follow-up|6|||
155334392|NCT02634307|560660079|FG000|Overall Study|Pregnancy|5|||
155334393|NCT02634307|560660080|FG001|Overall Study|Pregnancy|1|||
155334394|NCT02634307|560660081|FG002|Overall Study|Pregnancy|3|||
155334395|NCT02634307|560660079|FG000|Overall Study|Withdrawal by Subject|38|||
155334396|NCT02634307|560660080|FG001|Overall Study|Withdrawal by Subject|24|||
155334397|NCT02634307|560660081|FG002|Overall Study|Withdrawal by Subject|18|||
155334398|NCT02634307|560660079|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155334399|NCT02634307|560660080|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155334400|NCT02634307|560660081|FG002|Overall Study|Non-Compliance with Study Drug|2|||
155334401|NCT02634307|560660079|FG000|Overall Study|Lack of Efficacy|1|||
155334402|NCT02634307|560660080|FG001|Overall Study|Lack of Efficacy|5|||
155334403|NCT02634307|560660081|FG002|Overall Study|Lack of Efficacy|3|||
155334404|NCT02634307|560660079|FG000|Overall Study|Physician Decision|7|||
155334405|NCT02634307|560660080|FG001|Overall Study|Physician Decision|5|||
155334406|NCT02634307|560660081|FG002|Overall Study|Physician Decision|5|||
155334407|NCT02634307|560660079|FG000|Overall Study|Reason not Specified|3|||
155334408|NCT02634307|560660080|FG001|Overall Study|Reason not Specified|5|||
155334409|NCT02634307|560660081|FG002|Overall Study|Reason not Specified|10|||
155334410|NCT01532648|560660087|FG000|Overall Study|Lost to Follow-up|3|||
155334411|NCT01532648|560660088|FG001|Overall Study|Lost to Follow-up|4|||
155334412|NCT01532648|560660087|FG000|Overall Study|Lack of Efficacy|4|||
155334413|NCT01532648|560660088|FG001|Overall Study|Lack of Efficacy|1|||
155334414|NCT01532648|560660087|FG000|Overall Study|Protocol Violation|1|||
155334415|NCT01532648|560660088|FG001|Overall Study|Protocol Violation|1|||
155334416|NCT01532648|560660087|FG000|Overall Study|Adverse Event|12|||
155334417|NCT01532648|560660088|FG001|Overall Study|Adverse Event|9|||
155334418|NCT01532648|560660087|FG000|Overall Study|Withdrawal by Subject|16|||
155334419|NCT01532648|560660088|FG001|Overall Study|Withdrawal by Subject|2|||
155334420|NCT02824198|560660089|FG000|Overall Study|Non-compliance with the protocol|5|||
155334421|NCT02824198|560660090|FG001|Overall Study|Non-compliance with the protocol|1|||
155334422|NCT02824198|560660089|FG000|Overall Study|Lost to Follow-up|5|||
155334423|NCT02824198|560660090|FG001|Overall Study|Lost to Follow-up|2|||
155334424|NCT02824198|560660089|FG000|Overall Study|Withdrawal by Subject|5|||
155334425|NCT02824198|560660090|FG001|Overall Study|Withdrawal by Subject|0|||
155334426|NCT01256359|560660091|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
155334427|NCT01256359|560660092|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
155334428|NCT01256359|560660091|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
155334429|NCT01256359|560660092|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
155334430|NCT03292406|560660093|FG000|Overall Study|Progressive Disease|6|||
155334431|NCT03292406|560660094|FG001|Overall Study|Progressive Disease|3|||
155334432|NCT03292406|560660095|FG002|Overall Study|Progressive Disease|4|||
155334433|NCT03292406|560660093|FG000|Overall Study|Adverse Event|7|||
155334434|NCT03292406|560660094|FG001|Overall Study|Adverse Event|1|||
155334435|NCT03292406|560660095|FG002|Overall Study|Adverse Event|4|||
155334436|NCT03292406|560660093|FG000|Overall Study|Withdrawal by Subject|0|||
155334437|NCT03292406|560660094|FG001|Overall Study|Withdrawal by Subject|7|||
155334438|NCT03292406|560660095|FG002|Overall Study|Withdrawal by Subject|2|||
155334439|NCT03292406|560660093|FG000|Overall Study|Protocol Violation|0|||
155334440|NCT03292406|560660094|FG001|Overall Study|Protocol Violation|1|||
155334441|NCT03292406|560660095|FG002|Overall Study|Protocol Violation|1|||
155334442|NCT03292406|560660093|FG000|Overall Study|Other|0|||
155334443|NCT03292406|560660094|FG001|Overall Study|Other|1|||
155334444|NCT03292406|560660095|FG002|Overall Study|Other|2|||
155334445|NCT02575365|560660096|FG000|Overall Study|Lost to Follow-up|4|||
155334446|NCT00487240|560660098|FG000|Overall Study|Withdrawal by Subject|12|||
155334447|NCT00487240|560660099|FG001|Overall Study|Withdrawal by Subject|6|||
155334448|NCT00487240|560660098|FG000|Overall Study|Lost to Follow-up|7|||
155334449|NCT00487240|560660099|FG001|Overall Study|Lost to Follow-up|6|||
155334450|NCT00487240|560660098|FG000|Overall Study|Adverse Event|0|||
155334451|NCT00487240|560660099|FG001|Overall Study|Adverse Event|4|||
155334452|NCT00487240|560660098|FG000|Overall Study|Protocol Violation|5|||
155334453|NCT00487240|560660099|FG001|Overall Study|Protocol Violation|5|||
155334454|NCT00487240|560660098|FG000|Overall Study|Entry Criteria Not Met|3|||
155334455|NCT00487240|560660099|FG001|Overall Study|Entry Criteria Not Met|4|||
155334456|NCT00487240|560660098|FG000|Overall Study|Sponsor Decision|2|||
155334457|NCT00487240|560660099|FG001|Overall Study|Sponsor Decision|1|||
155334458|NCT00487240|560660098|FG000|Overall Study|Physician Decision|2|||
155334459|NCT00487240|560660099|FG001|Overall Study|Physician Decision|0|||
155334460|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
155334461|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
155502595|NCT01902134|561267245|FG003|Overall Study|Protocol Violation|0|||
155502596|NCT01902134|561267246|FG004|Overall Study|Protocol Violation|0|||
155502597|NCT01902134|561267247|FG005|Overall Study|Protocol Violation|1|||
155502598|NCT01902134|561267242|FG000|Overall Study|Withdrawal by Subject|4|||
155502599|NCT01902134|561267243|FG001|Overall Study|Withdrawal by Subject|8|||
155502600|NCT01902134|561267244|FG002|Overall Study|Withdrawal by Subject|9|||
155502601|NCT01902134|561267245|FG003|Overall Study|Withdrawal by Subject|1|||
155502602|NCT01902134|561267246|FG004|Overall Study|Withdrawal by Subject|5|||
155502603|NCT01902134|561267247|FG005|Overall Study|Withdrawal by Subject|4|||
155502604|NCT01902134|561267242|FG000|Overall Study|no compliance|1|||
155502605|NCT01902134|561267243|FG001|Overall Study|no compliance|0|||
155502606|NCT01902134|561267244|FG002|Overall Study|no compliance|0|||
155502607|NCT01902134|561267245|FG003|Overall Study|no compliance|0|||
155502608|NCT01902134|561267246|FG004|Overall Study|no compliance|0|||
155502609|NCT01902134|561267247|FG005|Overall Study|no compliance|0|||
155502610|NCT01902134|561267242|FG000|Overall Study|Other|0|||
155502611|NCT01902134|561267243|FG001|Overall Study|Other|1|||
155502612|NCT01902134|561267244|FG002|Overall Study|Other|2|||
155502613|NCT01902134|561267245|FG003|Overall Study|Other|0|||
155502614|NCT01902134|561267246|FG004|Overall Study|Other|1|||
155502615|NCT01902134|561267247|FG005|Overall Study|Other|0|||
155502616|NCT00305110|561267248|FG000|Overall Study|Missing data|29|||
155502617|NCT01272193|561267251|FG000|Overall Study|Adverse Event|1|||
155502618|NCT01272193|561267252|FG001|Overall Study|Adverse Event|1|||
155502619|NCT01272193|561267251|FG000|Overall Study|Lack of Efficacy|0|||
155502620|NCT01272193|561267252|FG001|Overall Study|Lack of Efficacy|3|||
155502621|NCT01272193|561267251|FG000|Overall Study|Withdrawal Criteria|1|||
155502622|NCT01272193|561267252|FG001|Overall Study|Withdrawal Criteria|1|||
155502623|NCT01272193|561267251|FG000|Overall Study|Unclassified|8|||
155502624|NCT01272193|561267252|FG001|Overall Study|Unclassified|7|||
155502625|NCT00350519|561267261|FG000|Overall Study|Death|0|||
155334462|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Death|2|||
155334463|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
155334464|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
155334465|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
155334466|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
155334467|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Death|1|||
155334468|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
155334469|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
155334470|NCT03176407|560660101|FG000|Overall Study|Protocol Violation|1|||
155334471|NCT03176407|560660101|FG000|Overall Study|human failure|1|||
155334472|NCT03176407|560660101|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
155334473|NCT01428583|560660104|FG000|Overall Study|Adverse Event|75|||
155334474|NCT01428583|560660104|FG000|Overall Study|Withdrawal by Subject|51|||
155334475|NCT01428583|560660104|FG000|Overall Study|Lack of Efficacy|37|||
155334476|NCT01428583|560660104|FG000|Overall Study|Lost to Follow-up|17|||
155334477|NCT01428583|560660104|FG000|Overall Study|Death|1|||
155334478|NCT01428583|560660104|FG000|Overall Study|Pregnancy|1|||
155334479|NCT01428583|560660104|FG000|Overall Study|Protocol Violation|1|||
155334480|NCT01428583|560660104|FG000|Overall Study|Physician Decision|12|||
155334481|NCT01428583|560660104|FG000|Overall Study|Non-compliant|25|||
155334482|NCT01428583|560660104|FG000|Overall Study|Confirmed positive urine drug test|8|||
155334483|NCT01428583|560660104|FG000|Overall Study|Sponsor's request|3|||
155334484|NCT01428583|560660104|FG000|Overall Study|Other|6|||
155334485|NCT00768755|560660107|FG000|Phase 1|Death|6|||
155334486|NCT00768755|560660108|FG001|Phase 1|Death|0|||
155334487|NCT00768755|560660109|FG002|Phase 1|Death|0|||
155334488|NCT00768755|560660110|FG003|Phase 1|Death|0|||
155334489|NCT00768755|560660107|FG000|Phase 1|Other|4|||
155334490|NCT00768755|560660108|FG001|Phase 1|Other|0|||
155334491|NCT00768755|560660109|FG002|Phase 1|Other|0|||
155334492|NCT00768755|560660110|FG003|Phase 1|Other|0|||
155334493|NCT00768755|560660107|FG000|Phase 2|Death|0|||
155334494|NCT00768755|560660108|FG001|Phase 2|Death|37|||
155334495|NCT00768755|560660109|FG002|Phase 2|Death|48|||
155334496|NCT00768755|560660110|FG003|Phase 2|Death|31|||
155334497|NCT00768755|560660107|FG000|Phase 2|Protocol Violation|0|||
155334498|NCT00768755|560660108|FG001|Phase 2|Protocol Violation|2|||
155334499|NCT00768755|560660109|FG002|Phase 2|Protocol Violation|0|||
155334500|NCT00768755|560660110|FG003|Phase 2|Protocol Violation|1|||
155502626|NCT00350519|561267262|FG001|Overall Study|Death|1|||
155502627|NCT00350519|561267261|FG000|Overall Study|Physician Decision|0|||
155334501|NCT00768755|560660107|FG000|Phase 2|Lost to Follow-up|0|||
155334502|NCT00768755|560660108|FG001|Phase 2|Lost to Follow-up|1|||
155334503|NCT00768755|560660109|FG002|Phase 2|Lost to Follow-up|1|||
155334504|NCT00768755|560660110|FG003|Phase 2|Lost to Follow-up|4|||
155334505|NCT00768755|560660107|FG000|Phase 2|Withdrawal by Subject|0|||
155334506|NCT00768755|560660108|FG001|Phase 2|Withdrawal by Subject|1|||
155334507|NCT00768755|560660109|FG002|Phase 2|Withdrawal by Subject|0|||
155334508|NCT00768755|560660110|FG003|Phase 2|Withdrawal by Subject|1|||
155502628|NCT00350519|561267262|FG001|Overall Study|Physician Decision|1|||
155334509|NCT00768755|560660107|FG000|Phase 2|Other|0|||
155334510|NCT00768755|560660108|FG001|Phase 2|Other|1|||
155334511|NCT00768755|560660109|FG002|Phase 2|Other|2|||
155334512|NCT00768755|560660110|FG003|Phase 2|Other|4|||
155334513|NCT00768755|560660107|FG000|Phase 2|Study Terminated by Sponsor|0|||
155334514|NCT00768755|560660108|FG001|Phase 2|Study Terminated by Sponsor|13|||
155334515|NCT00768755|560660109|FG002|Phase 2|Study Terminated by Sponsor|7|||
155334516|NCT00768755|560660110|FG003|Phase 2|Study Terminated by Sponsor|14|||
155334517|NCT00768755|560660107|FG000|Phase 2|Randomized but not treated|0|||
155334518|NCT00768755|560660108|FG001|Phase 2|Randomized but not treated|0|||
155334519|NCT00768755|560660109|FG002|Phase 2|Randomized but not treated|0|||
155334520|NCT00768755|560660110|FG003|Phase 2|Randomized but not treated|2|||
155334521|NCT00670488|560660111|FG000|Overall Study|Adverse Event|0|||
155334522|NCT00670488|560660112|FG001|Overall Study|Adverse Event|7|||
155334523|NCT00670488|560660113|FG002|Overall Study|Adverse Event|0|||
155334524|NCT00670488|560660114|FG003|Overall Study|Adverse Event|3|||
155334525|NCT00670488|560660115|FG004|Overall Study|Adverse Event|1|||
155334526|NCT00670488|560660116|FG005|Overall Study|Adverse Event|1|||
155334527|NCT00670488|560660117|FG006|Overall Study|Adverse Event|5|||
155334528|NCT00670488|560660118|FG007|Overall Study|Adverse Event|1|||
155334529|NCT00670488|560660119|FG008|Overall Study|Adverse Event|0|||
155334530|NCT00670488|560660120|FG009|Overall Study|Adverse Event|1|||
155334531|NCT00670488|560660111|FG000|Overall Study|Physician Decision|1|||
155334532|NCT00670488|560660112|FG001|Overall Study|Physician Decision|9|||
155334533|NCT00670488|560660113|FG002|Overall Study|Physician Decision|0|||
155334534|NCT00670488|560660114|FG003|Overall Study|Physician Decision|1|||
155334535|NCT00670488|560660115|FG004|Overall Study|Physician Decision|0|||
155334536|NCT00670488|560660116|FG005|Overall Study|Physician Decision|0|||
155334537|NCT00670488|560660117|FG006|Overall Study|Physician Decision|0|||
155334538|NCT00670488|560660118|FG007|Overall Study|Physician Decision|0|||
155334539|NCT00670488|560660119|FG008|Overall Study|Physician Decision|0|||
155334540|NCT00670488|560660120|FG009|Overall Study|Physician Decision|0|||
155334541|NCT00670488|560660111|FG000|Overall Study|Progressive Disease|2|||
155334542|NCT00670488|560660112|FG001|Overall Study|Progressive Disease|41|||
155334543|NCT00670488|560660113|FG002|Overall Study|Progressive Disease|3|||
155334544|NCT00670488|560660114|FG003|Overall Study|Progressive Disease|2|||
155334545|NCT00670488|560660115|FG004|Overall Study|Progressive Disease|2|||
155334546|NCT00670488|560660116|FG005|Overall Study|Progressive Disease|4|||
155334547|NCT00670488|560660117|FG006|Overall Study|Progressive Disease|11|||
155334548|NCT00670488|560660118|FG007|Overall Study|Progressive Disease|2|||
155334549|NCT00670488|560660119|FG008|Overall Study|Progressive Disease|2|||
155645430|NCT00669331|561793998|FG000|Blinded Treatment Period|Physician Decision|3|||
155645431|NCT00669331|561793999|FG001|Blinded Treatment Period|Physician Decision|3|||
155645432|NCT00669331|561793998|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
155334550|NCT00670488|560660120|FG009|Overall Study|Progressive Disease|1|||
155334551|NCT00670488|560660111|FG000|Overall Study|Withdrawal by Subject|0|||
155334552|NCT00670488|560660112|FG001|Overall Study|Withdrawal by Subject|1|||
155334553|NCT00670488|560660113|FG002|Overall Study|Withdrawal by Subject|0|||
155334554|NCT00670488|560660114|FG003|Overall Study|Withdrawal by Subject|1|||
155334555|NCT00670488|560660115|FG004|Overall Study|Withdrawal by Subject|0|||
155334556|NCT00670488|560660116|FG005|Overall Study|Withdrawal by Subject|0|||
155334557|NCT00670488|560660117|FG006|Overall Study|Withdrawal by Subject|1|||
155334558|NCT00670488|560660118|FG007|Overall Study|Withdrawal by Subject|0|||
155334559|NCT00670488|560660119|FG008|Overall Study|Withdrawal by Subject|1|||
155334560|NCT00670488|560660120|FG009|Overall Study|Withdrawal by Subject|0|||
155334561|NCT00878189|560660121|FG000|Overall Study|Death|0|||
155334562|NCT00878189|560660122|FG001|Overall Study|Death|1|||
155334563|NCT00878189|560660123|FG002|Overall Study|Death|0|||
155334564|NCT00878189|560660124|FG003|Overall Study|Death|1|||
155334565|NCT00878189|560660125|FG004|Overall Study|Death|0|||
155334566|NCT00878189|560660126|FG005|Overall Study|Death|0|||
155334567|NCT00878189|560660127|FG006|Overall Study|Death|0|||
155334568|NCT00878189|560660128|FG007|Overall Study|Death|0|||
155334569|NCT00878189|560660129|FG008|Overall Study|Death|1|||
155334570|NCT00878189|560660121|FG000|Overall Study|Participant Refused to Follow-up|0|||
155334571|NCT00878189|560660122|FG001|Overall Study|Participant Refused to Follow-up|0|||
155334572|NCT00878189|560660123|FG002|Overall Study|Participant Refused to Follow-up|0|||
155334573|NCT00878189|560660124|FG003|Overall Study|Participant Refused to Follow-up|0|||
155334574|NCT00878189|560660125|FG004|Overall Study|Participant Refused to Follow-up|0|||
155334575|NCT00878189|560660126|FG005|Overall Study|Participant Refused to Follow-up|4|||
155334576|NCT00878189|560660127|FG006|Overall Study|Participant Refused to Follow-up|0|||
155334577|NCT00878189|560660128|FG007|Overall Study|Participant Refused to Follow-up|0|||
155334578|NCT00878189|560660129|FG008|Overall Study|Participant Refused to Follow-up|0|||
155334579|NCT00878189|560660121|FG000|Overall Study|Other|3|||
155334580|NCT00878189|560660122|FG001|Overall Study|Other|2|||
155334581|NCT00878189|560660123|FG002|Overall Study|Other|4|||
155334582|NCT00878189|560660124|FG003|Overall Study|Other|7|||
155334583|NCT00878189|560660125|FG004|Overall Study|Other|4|||
155645433|NCT00669331|561793999|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
155334584|NCT00878189|560660126|FG005|Overall Study|Other|18|||
155334585|NCT00878189|560660127|FG006|Overall Study|Other|15|||
155334586|NCT00878189|560660128|FG007|Overall Study|Other|3|||
155334587|NCT00878189|560660129|FG008|Overall Study|Other|4|||
155334588|NCT00878189|560660121|FG000|Overall Study|Lost to Follow-up|0|||
155334589|NCT00878189|560660122|FG001|Overall Study|Lost to Follow-up|0|||
155334590|NCT00878189|560660123|FG002|Overall Study|Lost to Follow-up|0|||
155334591|NCT00878189|560660124|FG003|Overall Study|Lost to Follow-up|0|||
155334592|NCT00878189|560660125|FG004|Overall Study|Lost to Follow-up|0|||
155334593|NCT00878189|560660126|FG005|Overall Study|Lost to Follow-up|1|||
155334594|NCT00878189|560660127|FG006|Overall Study|Lost to Follow-up|1|||
155334595|NCT00878189|560660128|FG007|Overall Study|Lost to Follow-up|0|||
155334596|NCT00878189|560660129|FG008|Overall Study|Lost to Follow-up|0|||
155334597|NCT00878189|560660121|FG000|Overall Study|Objection Progression or Relapse|0|||
155334598|NCT00878189|560660122|FG001|Overall Study|Objection Progression or Relapse|0|||
155334599|NCT00878189|560660123|FG002|Overall Study|Objection Progression or Relapse|0|||
155334600|NCT00878189|560660124|FG003|Overall Study|Objection Progression or Relapse|0|||
155334601|NCT00878189|560660125|FG004|Overall Study|Objection Progression or Relapse|0|||
155334602|NCT00878189|560660126|FG005|Overall Study|Objection Progression or Relapse|0|||
155334603|NCT00878189|560660127|FG006|Overall Study|Objection Progression or Relapse|0|||
155334604|NCT00878189|560660128|FG007|Overall Study|Objection Progression or Relapse|0|||
155334605|NCT00878189|560660129|FG008|Overall Study|Objection Progression or Relapse|3|||
155334606|NCT04693637|560660130|FG000|Overall Study|Death|4|||
155334607|NCT04693637|560660130|FG000|Overall Study|Withdrawal by Subject|3|||
155334608|NCT04693637|560660130|FG000|Overall Study|Physician Decision|2|||
155334609|NCT04693637|560660130|FG000|Overall Study|Lost to Follow-up|1|||
155334610|NCT04237792|560660131|FG000|Treatment (Day 1)|Adverse Event|1|||
155334611|NCT04237792|560660132|FG001|Treatment (Day 1)|Adverse Event|0|||
155334612|NCT04237792|560660133|FG002|Treatment (Day 1)|Adverse Event|0|||
155334613|NCT04237792|560660134|FG003|Treatment (Day 1)|Adverse Event|0|||
155334614|NCT04237792|560660135|FG004|Treatment (Day 1)|Adverse Event|1|||
155334615|NCT04237792|560660136|FG005|Treatment (Day 1)|Adverse Event|1|||
155334616|NCT04237792|560660131|FG000|Treatment (Day 1)|Other|0|||
155334617|NCT04237792|560660132|FG001|Treatment (Day 1)|Other|0|||
155334618|NCT04237792|560660133|FG002|Treatment (Day 1)|Other|1|||
155334619|NCT04237792|560660134|FG003|Treatment (Day 1)|Other|0|||
155334620|NCT04237792|560660135|FG004|Treatment (Day 1)|Other|0|||
155334621|NCT04237792|560660136|FG005|Treatment (Day 1)|Other|1|||
155334622|NCT04237792|560660131|FG000|Treatment (Day 1)|Not treated|1|||
155334623|NCT04237792|560660132|FG001|Treatment (Day 1)|Not treated|1|||
155334624|NCT04237792|560660133|FG002|Treatment (Day 1)|Not treated|2|||
155334625|NCT04237792|560660134|FG003|Treatment (Day 1)|Not treated|1|||
155334626|NCT04237792|560660135|FG004|Treatment (Day 1)|Not treated|0|||
155334627|NCT04237792|560660136|FG005|Treatment (Day 1)|Not treated|1|||
155334628|NCT04885998|560660137|FG000|Overall Study|Withdrawal by Subject|0|||
155334629|NCT04885998|560660138|FG001|Overall Study|Withdrawal by Subject|2|||
155334630|NCT04885998|560660139|FG002|Overall Study|Withdrawal by Subject|0|||
155334631|NCT04885998|560660140|FG003|Overall Study|Withdrawal by Subject|3|||
155334632|NCT04885998|560660137|FG000|Overall Study|Lost to Follow-up|1|||
155334633|NCT04885998|560660138|FG001|Overall Study|Lost to Follow-up|1|||
155334634|NCT04885998|560660139|FG002|Overall Study|Lost to Follow-up|0|||
155334635|NCT04885998|560660140|FG003|Overall Study|Lost to Follow-up|0|||
155334636|NCT04885998|560660137|FG000|Overall Study|Death|2|||
155334637|NCT04885998|560660138|FG001|Overall Study|Death|1|||
155334638|NCT04885998|560660139|FG002|Overall Study|Death|2|||
155334639|NCT04885998|560660140|FG003|Overall Study|Death|2|||
155334640|NCT04885998|560660137|FG000|Overall Study|Decision by sponsor|1|||
155334641|NCT04885998|560660138|FG001|Overall Study|Decision by sponsor|1|||
155334642|NCT04885998|560660139|FG002|Overall Study|Decision by sponsor|0|||
155502629|NCT00350519|561267261|FG000|Overall Study|Protocol Violation|1|||
155502630|NCT00350519|561267262|FG001|Overall Study|Protocol Violation|2|||
155645434|NCT01454063|561794000|FG000|Randomized|Adverse Event|1|||
155334643|NCT04885998|560660140|FG003|Overall Study|Decision by sponsor|0|||
155334644|NCT05260437|560660141|FG000|Overall Study|Lost to Follow-up|5|||
155334645|NCT05260437|560660142|FG001|Overall Study|Lost to Follow-up|2|||
155334646|NCT05260437|560660143|FG002|Overall Study|Lost to Follow-up|1|||
155334647|NCT05260437|560660144|FG003|Overall Study|Lost to Follow-up|2|||
155334648|NCT05260437|560660145|FG004|Overall Study|Lost to Follow-up|2|||
155334649|NCT05260437|560660141|FG000|Overall Study|Withdrawal by Subject|3|||
155334650|NCT05260437|560660142|FG001|Overall Study|Withdrawal by Subject|0|||
155334651|NCT05260437|560660143|FG002|Overall Study|Withdrawal by Subject|4|||
155334652|NCT05260437|560660144|FG003|Overall Study|Withdrawal by Subject|5|||
155334653|NCT05260437|560660145|FG004|Overall Study|Withdrawal by Subject|0|||
155334654|NCT05260437|560660141|FG000|Overall Study|Vaccine Not Administered|0|||
155334655|NCT05260437|560660142|FG001|Overall Study|Vaccine Not Administered|1|||
155334656|NCT05260437|560660143|FG002|Overall Study|Vaccine Not Administered|0|||
155334657|NCT05260437|560660144|FG003|Overall Study|Vaccine Not Administered|0|||
155334658|NCT05260437|560660145|FG004|Overall Study|Vaccine Not Administered|0|||
155334659|NCT00910962|560660146|FG000|Overall Study|Adverse Event|5|||
155334660|NCT00910962|560660147|FG001|Overall Study|Adverse Event|20|||
155334661|NCT00910962|560660148|FG002|Overall Study|Adverse Event|17|||
155334662|NCT00910962|560660146|FG000|Overall Study|Protocol Violation|1|||
155334663|NCT00910962|560660147|FG001|Overall Study|Protocol Violation|3|||
155334664|NCT00910962|560660148|FG002|Overall Study|Protocol Violation|3|||
155334665|NCT00910962|560660146|FG000|Overall Study|Lost to Follow-up|0|||
155334666|NCT00910962|560660147|FG001|Overall Study|Lost to Follow-up|3|||
155334667|NCT00910962|560660148|FG002|Overall Study|Lost to Follow-up|1|||
155334668|NCT00910962|560660146|FG000|Overall Study|Physician Decision|0|||
155334669|NCT00910962|560660147|FG001|Overall Study|Physician Decision|6|||
155334670|NCT00910962|560660148|FG002|Overall Study|Physician Decision|6|||
155422161|NCT02908100|560976203|FG001|Overall Study|Lost to Follow-up|1|||
155422162|NCT02908100|560976204|FG002|Overall Study|Lost to Follow-up|2|||
155422163|NCT02908100|560976202|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155422164|NCT02908100|560976203|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155334671|NCT00910962|560660146|FG000|Overall Study|Withdrawal by Subject|25|||
155334672|NCT00910962|560660147|FG001|Overall Study|Withdrawal by Subject|32|||
155334673|NCT00910962|560660148|FG002|Overall Study|Withdrawal by Subject|32|||
155334674|NCT00910962|560660146|FG000|Overall Study|Reached defined stopping criteria|12|||
155334675|NCT00910962|560660147|FG001|Overall Study|Reached defined stopping criteria|14|||
155334676|NCT00910962|560660148|FG002|Overall Study|Reached defined stopping criteria|17|||
155334677|NCT00195819|560660149|FG000|Double-Blind|Withdrawal by Subject|1|||
155334678|NCT00195819|560660150|FG001|Double-Blind|Withdrawal by Subject|0|||
155334679|NCT00195819|560660149|FG000|Double-Blind|Moved|1|||
155334680|NCT00195819|560660150|FG001|Double-Blind|Moved|0|||
155334681|NCT00195819|560660149|FG000|Open-label|Adverse Event|0|||
155422165|NCT02908100|560976204|FG002|Overall Study|Non-Compliance With Study Drug|2|||
155422166|NCT02908100|560976202|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
155422167|NCT02908100|560976203|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
155422168|NCT02908100|560976204|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
155422169|NCT02908100|560976202|FG000|Overall Study|Physician Decision|0|||
155422170|NCT02908100|560976203|FG001|Overall Study|Physician Decision|1|||
155422171|NCT02908100|560976204|FG002|Overall Study|Physician Decision|0|||
155422172|NCT02908100|560976202|FG000|Overall Study|Pregnancy|1|||
155422173|NCT02908100|560976203|FG001|Overall Study|Pregnancy|2|||
155422174|NCT02908100|560976204|FG002|Overall Study|Pregnancy|0|||
155422175|NCT02908100|560976202|FG000|Overall Study|Withdrawal by Subject|8|||
155422176|NCT02908100|560976203|FG001|Overall Study|Withdrawal by Subject|7|||
155422177|NCT02908100|560976204|FG002|Overall Study|Withdrawal by Subject|5|||
155422178|NCT02908100|560976202|FG000|Overall Study|Randomised in Error|1|||
155422179|NCT02908100|560976203|FG001|Overall Study|Randomised in Error|0|||
155422180|NCT02908100|560976204|FG002|Overall Study|Randomised in Error|0|||
155422181|NCT02024971|560976205|FG000|Overall Study|Data Not Available|30|||
155422182|NCT02024971|560976205|FG000|Overall Study|Lost to Follow-up|6|||
155422183|NCT05254418|560976206|FG000|Overall Study|Adverse Event|2|||
155422184|NCT06118385|560976208|FG000|Overall Study|Protocol Violation|0|||
155422185|NCT06118385|560976209|FG001|Overall Study|Protocol Violation|0|||
155422186|NCT06118385|560976210|FG002|Overall Study|Protocol Violation|0|||
155422187|NCT06118385|560976211|FG003|Overall Study|Protocol Violation|0|||
155422188|NCT06118385|560976212|FG004|Overall Study|Protocol Violation|0|||
155422189|NCT06118385|560976213|FG005|Overall Study|Protocol Violation|0|||
155422190|NCT06118385|560976214|FG006|Overall Study|Protocol Violation|0|||
155422191|NCT06118385|560976215|FG007|Overall Study|Protocol Violation|0|||
155422192|NCT06118385|560976216|FG008|Overall Study|Protocol Violation|1|||
155422193|NCT06118385|560976217|FG009|Overall Study|Protocol Violation|0|||
155422194|NCT06118385|560976218|FG010|Overall Study|Protocol Violation|0|||
155422195|NCT06118385|560976219|FG011|Overall Study|Protocol Violation|0|||
155422196|NCT06118385|560976208|FG000|Overall Study|Out-of-range blood tests|0|||
155422197|NCT06118385|560976209|FG001|Overall Study|Out-of-range blood tests|0|||
155422198|NCT06118385|560976210|FG002|Overall Study|Out-of-range blood tests|0|||
155422199|NCT06118385|560976211|FG003|Overall Study|Out-of-range blood tests|0|||
155422200|NCT06118385|560976212|FG004|Overall Study|Out-of-range blood tests|0|||
155422201|NCT06118385|560976213|FG005|Overall Study|Out-of-range blood tests|0|||
155422202|NCT06118385|560976214|FG006|Overall Study|Out-of-range blood tests|0|||
155422203|NCT06118385|560976215|FG007|Overall Study|Out-of-range blood tests|0|||
155422204|NCT06118385|560976216|FG008|Overall Study|Out-of-range blood tests|1|||
155334682|NCT00195819|560660150|FG001|Open-label|Adverse Event|9|||
155334683|NCT00195819|560660149|FG000|Open-label|Lack of Efficacy|0|||
155334684|NCT00195819|560660150|FG001|Open-label|Lack of Efficacy|2|||
155334685|NCT00195819|560660149|FG000|Open-label|Pregnancy|0|||
155422205|NCT06118385|560976217|FG009|Overall Study|Out-of-range blood tests|0|||
155422206|NCT06118385|560976218|FG010|Overall Study|Out-of-range blood tests|0|||
155422207|NCT06118385|560976219|FG011|Overall Study|Out-of-range blood tests|0|||
155422208|NCT02318784|560976220|FG000|Overall Study|Adverse Event|13|||
155422209|NCT02318784|560976220|FG000|Overall Study|Death|2|||
155422210|NCT02318784|560976220|FG000|Overall Study|Progressive Disease|37|||
155422211|NCT02318784|560976220|FG000|Overall Study|Withdrawal by Subject|10|||
155422212|NCT00331006|560976221|FG000|Screening Phase|Withdrawal by Subject|1|||
155422213|NCT00331006|560976221|FG000|Screening Phase|enrollment halted|1|||
155422214|NCT00331006|560976221|FG000|Screening Phase|Lost to Follow-up|1|||
155422215|NCT00331006|560976221|FG000|Screening Phase|Ineligible for treatment phase|4|||
155422216|NCT00331006|560976221|FG000|Treatment Phase|Withdrawal by Subject|1|||
155422217|NCT00331006|560976221|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
155334686|NCT00195819|560660150|FG001|Open-label|Pregnancy|1|||
155334687|NCT00195819|560660149|FG000|Open-label|Protocol Violation|0|||
155334688|NCT00195819|560660150|FG001|Open-label|Protocol Violation|2|||
155334689|NCT00195819|560660149|FG000|Open-label|Moved|0|||
155334690|NCT00195819|560660150|FG001|Open-label|Moved|1|||
155334691|NCT00195819|560660149|FG000|Open-label|Withdrawal by Subject|0|||
155334692|NCT00195819|560660150|FG001|Open-label|Withdrawal by Subject|5|||
155334693|NCT00787176|560660151|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
155334694|NCT00787176|560660152|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
155334695|NCT00787176|560660153|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
155334696|NCT00787176|560660154|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
155334697|NCT01124045|560660155|FG000|Overall Study|Lost to Follow-up|0|||
155334698|NCT01124045|560660156|FG001|Overall Study|Lost to Follow-up|1|||
155334699|NCT01124045|560660155|FG000|Overall Study|Physician Decision|0|||
155334700|NCT01124045|560660156|FG001|Overall Study|Physician Decision|2|||
155334701|NCT03057600|560660160|FG000|Overall Study|Adverse Event|0|||
155334702|NCT03057600|560660161|FG001|Overall Study|Adverse Event|0|||
155334703|NCT03057600|560660162|FG002|Overall Study|Adverse Event|4|||
155334704|NCT03057600|560660163|FG003|Overall Study|Adverse Event|0|||
155334705|NCT03057600|560660160|FG000|Overall Study|Radiologic Disease Progression|8|||
155334706|NCT03057600|560660161|FG001|Overall Study|Radiologic Disease Progression|7|||
155334707|NCT03057600|560660162|FG002|Overall Study|Radiologic Disease Progression|13|||
155334708|NCT03057600|560660163|FG003|Overall Study|Radiologic Disease Progression|10|||
155334709|NCT03057600|560660160|FG000|Overall Study|Symptomatic Deterioration|0|||
155334710|NCT03057600|560660161|FG001|Overall Study|Symptomatic Deterioration|1|||
155334711|NCT03057600|560660162|FG002|Overall Study|Symptomatic Deterioration|1|||
155334712|NCT03057600|560660163|FG003|Overall Study|Symptomatic Deterioration|0|||
155334713|NCT03057600|560660160|FG000|Overall Study|Investigator Decision|0|||
155334714|NCT03057600|560660161|FG001|Overall Study|Investigator Decision|0|||
155334715|NCT03057600|560660162|FG002|Overall Study|Investigator Decision|1|||
155334716|NCT03057600|560660163|FG003|Overall Study|Investigator Decision|0|||
155334717|NCT03057600|560660160|FG000|Overall Study|Study Termination by Sponsor|0|||
155334718|NCT03057600|560660161|FG001|Overall Study|Study Termination by Sponsor|0|||
155334719|NCT03057600|560660162|FG002|Overall Study|Study Termination by Sponsor|0|||
155334720|NCT03057600|560660163|FG003|Overall Study|Study Termination by Sponsor|2|||
155334721|NCT03057600|560660160|FG000|Overall Study|Withdrawal by Subject|0|||
155334722|NCT03057600|560660161|FG001|Overall Study|Withdrawal by Subject|1|||
155334723|NCT03057600|560660162|FG002|Overall Study|Withdrawal by Subject|0|||
155334724|NCT03057600|560660163|FG003|Overall Study|Withdrawal by Subject|0|||
155334725|NCT03057600|560660160|FG000|Overall Study|Other, Not Specified|1|||
155334726|NCT03057600|560660161|FG001|Overall Study|Other, Not Specified|1|||
155334727|NCT03057600|560660162|FG002|Overall Study|Other, Not Specified|1|||
155334728|NCT03057600|560660163|FG003|Overall Study|Other, Not Specified|1|||
155334729|NCT02022670|560660168|FG000|Overall Study|Adverse Event|1|||
155334730|NCT02022670|560660169|FG001|Overall Study|Adverse Event|0|||
155334731|NCT02022670|560660170|FG002|Overall Study|Adverse Event|1|||
155334732|NCT02113449|560660171|FG000|Overall Study|Adverse Event|4|||
155334733|NCT04638816|560660172|FG000|Overall Study|Withdrawal by Subject|0|||
155334734|NCT04638816|560660173|FG001|Overall Study|Withdrawal by Subject|1|||
155334735|NCT04638816|560660172|FG000|Overall Study|Lost to Follow-up|0|||
155334736|NCT04638816|560660173|FG001|Overall Study|Lost to Follow-up|1|||
155334737|NCT01328496|560660176|FG000|Overall Study|Significant Change in Health Status|1|||
155334738|NCT01328496|560660177|FG001|Overall Study|Significant Change in Health Status|0|||
155334739|NCT02208843|560660180|FG000|Overall Study|Clinical symptoms of progression|2|||
155334740|NCT02208843|560660180|FG000|Overall Study|Progression disease according to RECIST|24|||
155334741|NCT02208843|560660180|FG000|Overall Study|Adverse Event|12|||
155334742|NCT02208843|560660180|FG000|Overall Study|Protocol Violation|1|||
155334743|NCT02208843|560660180|FG000|Overall Study|Withdrawal by Subject|1|||
155334744|NCT02208843|560660180|FG000|Overall Study|Switched to commercial afatinib|20|||
155334745|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
155334746|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
155334747|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
155334748|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
155334749|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
155334750|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
155334751|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
155334752|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
155436208|NCT00849212|561024564|FG000|Overall Study|Lack of Efficacy|1|||
155334753|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
155334754|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
155334755|NCT03822832|560660185|FG000|Re-allocation|Not re-allocated to open label period|2|||
155334756|NCT03822832|560660186|FG001|Re-allocation|Not re-allocated to open label period|6|||
155334757|NCT03822832|560660185|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
155334758|NCT03822832|560660186|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
155334759|NCT03822832|560660185|FG000|Period 2 - Open Label Period|Adverse Event|0|||
155334760|NCT03822832|560660186|FG001|Period 2 - Open Label Period|Adverse Event|3|||
155334761|NCT00243867|560660187|FG000|Overall Study|Adverse Event|24|||
155502631|NCT00350519|561267261|FG000|Overall Study|Withdrawal by Subject|3|||
155502632|NCT00350519|561267262|FG001|Overall Study|Withdrawal by Subject|2|||
155502633|NCT00736099|561267264|FG000|Overall Study|Adverse Event|61|||
155502634|NCT00736099|561267265|FG001|Overall Study|Adverse Event|18|||
155502635|NCT00736099|561267264|FG000|Overall Study|Protocol Violation|10|||
155502636|NCT00736099|561267265|FG001|Overall Study|Protocol Violation|4|||
155502637|NCT00736099|561267264|FG000|Overall Study|Lost to Follow-up|12|||
155502638|NCT00736099|561267265|FG001|Overall Study|Lost to Follow-up|5|||
155502639|NCT00736099|561267264|FG000|Overall Study|Withdrawal by Subject|42|||
155502640|NCT00736099|561267265|FG001|Overall Study|Withdrawal by Subject|13|||
155502641|NCT00736099|561267264|FG000|Overall Study|Lack of Efficacy|15|||
155502642|NCT00736099|561267265|FG001|Overall Study|Lack of Efficacy|8|||
155502643|NCT00736099|561267264|FG000|Overall Study|Other reason|43|||
155502644|NCT00736099|561267265|FG001|Overall Study|Other reason|10|||
155502645|NCT02239601|561267270|FG000|Overall Study|Withdrawal by Subject|3|||
155502646|NCT02239601|561267271|FG001|Overall Study|Withdrawal by Subject|4|||
155502647|NCT02239601|561267270|FG000|Overall Study|Protocol Violation|4|||
155502648|NCT02239601|561267271|FG001|Overall Study|Protocol Violation|2|||
155502649|NCT01791127|561267275|FG000|Overall Study|Death|356|||
155334762|NCT00243867|560660188|FG001|Overall Study|Adverse Event|34|||
155422218|NCT00331006|560976221|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
155422219|NCT01950819|560976224|FG000|Overall Study|Graft Loss|35|||
155422220|NCT01950819|560976225|FG001|Overall Study|Graft Loss|30|||
155422221|NCT01950819|560976224|FG000|Overall Study|Death|29|||
155422222|NCT01950819|560976225|FG001|Overall Study|Death|34|||
155422223|NCT01950819|560976224|FG000|Overall Study|Subject / Gardian decision|54|||
155422224|NCT01950819|560976225|FG001|Overall Study|Subject / Gardian decision|51|||
155422225|NCT01950819|560976224|FG000|Overall Study|technical problems|2|||
155422226|NCT01950819|560976225|FG001|Overall Study|technical problems|0|||
155422227|NCT01950819|560976224|FG000|Overall Study|Pregnancy|0|||
155422228|NCT01950819|560976225|FG001|Overall Study|Pregnancy|2|||
155422229|NCT01950819|560976224|FG000|Overall Study|Lost to Follow-up|9|||
155422230|NCT01950819|560976225|FG001|Overall Study|Lost to Follow-up|17|||
155422231|NCT01014585|560976230|FG000|Overall Study|Adverse Event|0|||
155422232|NCT01014585|560976231|FG001|Overall Study|Adverse Event|2|||
155422233|NCT01014585|560976232|FG002|Overall Study|Adverse Event|0|||
155422234|NCT01014585|560976233|FG003|Overall Study|Adverse Event|3|||
155422235|NCT01014585|560976230|FG000|Overall Study|Withdrawal by Subject|2|||
155422236|NCT01014585|560976231|FG001|Overall Study|Withdrawal by Subject|0|||
155422237|NCT01014585|560976232|FG002|Overall Study|Withdrawal by Subject|1|||
155422238|NCT01014585|560976233|FG003|Overall Study|Withdrawal by Subject|3|||
155422239|NCT01014585|560976230|FG000|Overall Study|Lost to Follow-up|0|||
155422240|NCT01014585|560976231|FG001|Overall Study|Lost to Follow-up|0|||
155422241|NCT01014585|560976232|FG002|Overall Study|Lost to Follow-up|0|||
155422242|NCT01014585|560976233|FG003|Overall Study|Lost to Follow-up|2|||
155422243|NCT01014585|560976230|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
155422244|NCT01014585|560976231|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
155422245|NCT01014585|560976232|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
155422246|NCT01014585|560976233|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
155422247|NCT04897867|560976234|FG000|Overall Study|Withdrawal of Consent|1|||
155422248|NCT04897867|560976234|FG000|Overall Study|Pregnancy|1|||
155422249|NCT04897867|560976234|FG000|Overall Study|Lost to Follow-up|7|||
155422250|NCT04897867|560976234|FG000|Overall Study|Reason not Specified|2|||
155422251|NCT00508391|560976235|FG000|First Treatment|Withdrawal by Subject|6|||
155422252|NCT00508391|560976236|FG001|First Treatment|Withdrawal by Subject|3|||
155422253|NCT00508391|560976235|FG000|Second Treatment|Withdrawal by Subject|2|||
155422254|NCT00508391|560976236|FG001|Second Treatment|Withdrawal by Subject|0|||
155422255|NCT00880256|560976240|FG000|Overall Study|Lost to Follow-up|28|||
155422256|NCT01686568|560976241|FG000|Main Study|Withdrawal by Subject|1|||
155422257|NCT01686568|560976242|FG001|Main Study|Withdrawal by Subject|3|||
155422258|NCT01686568|560976241|FG000|Main Study|Noncompliance with protocol|0|||
155422259|NCT01686568|560976242|FG001|Main Study|Noncompliance with protocol|1|||
155422260|NCT01686568|560976241|FG000|Main Study|Liver enzymes above range of exclusion|1|||
155502650|NCT01791127|561267275|FG000|Overall Study|Patient has withdrawn from study|293|||
155422261|NCT01686568|560976242|FG001|Main Study|Liver enzymes above range of exclusion|0|||
155422262|NCT01686568|560976241|FG000|Sub-Study|Not consented for sub-study|2|||
155422263|NCT01686568|560976242|FG001|Sub-Study|Not consented for sub-study|2|||
155422264|NCT01838044|560976243|FG000|Overall Study|Adverse Event|4|||
155422265|NCT01838044|560976244|FG001|Overall Study|Adverse Event|6|||
155422266|NCT01838044|560976243|FG000|Overall Study|Protocol Violation|3|||
155422267|NCT01838044|560976244|FG001|Overall Study|Protocol Violation|3|||
155422268|NCT01838044|560976243|FG000|Overall Study|Withdrawal by Subject|0|||
155422269|NCT01838044|560976244|FG001|Overall Study|Withdrawal by Subject|2|||
155422270|NCT01838044|560976243|FG000|Overall Study|Insufficient clinical response|1|||
155422271|NCT01838044|560976244|FG001|Overall Study|Insufficient clinical response|2|||
155422272|NCT01838044|560976243|FG000|Overall Study|Medication error without associated AE|0|||
155422273|NCT01838044|560976244|FG001|Overall Study|Medication error without associated AE|1|||
155422274|NCT01838044|560976243|FG000|Overall Study|Lost to Follow-up|0|||
155422275|NCT01838044|560976244|FG001|Overall Study|Lost to Follow-up|2|||
155422276|NCT01413958|560976245|FG000|Overall Study|Lost to Follow-up|0|||
155422277|NCT01413958|560976246|FG001|Overall Study|Lost to Follow-up|1|||
155422278|NCT02908516|560976247|FG000|Overall Study|Study Terminated|3|||
155422279|NCT02908516|560976248|FG001|Overall Study|Study Terminated|3|||
155422280|NCT01225562|560976249|FG000|Overall Study|Withdrawal by Subject|52|||
155422281|NCT01225562|560976250|FG001|Overall Study|Withdrawal by Subject|50|||
155422282|NCT01225562|560976251|FG002|Overall Study|Withdrawal by Subject|52|||
155422283|NCT01225562|560976249|FG000|Overall Study|Lost to Follow-up|3|||
155422284|NCT01225562|560976250|FG001|Overall Study|Lost to Follow-up|6|||
155422285|NCT01225562|560976251|FG002|Overall Study|Lost to Follow-up|1|||
155422286|NCT03403400|560976253|FG000|Overall Study|Lost to Follow-up|1|||
155422287|NCT03403400|560976254|FG001|Overall Study|Lost to Follow-up|0|||
155422288|NCT03403400|560976255|FG002|Overall Study|Lost to Follow-up|1|||
155422289|NCT03403400|560976253|FG000|Overall Study|Hospitalization|1|||
155422290|NCT03403400|560976254|FG001|Overall Study|Hospitalization|0|||
155422291|NCT03403400|560976255|FG002|Overall Study|Hospitalization|0|||
155422292|NCT03403400|560976253|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
155422293|NCT03403400|560976254|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
155422294|NCT03403400|560976255|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
155422295|NCT00712348|560976259|FG000|Overall Study|Withdrawal by Subject|1|||
155422296|NCT01273064|560976262|FG000|Overall Study|Adverse Event|5|||
155422297|NCT01273064|560976263|FG001|Overall Study|Adverse Event|1|||
155422298|NCT01273064|560976264|FG002|Overall Study|Adverse Event|3|||
155422299|NCT01273064|560976265|FG003|Overall Study|Adverse Event|2|||
155422300|NCT01273064|560976266|FG004|Overall Study|Adverse Event|1|||
155422301|NCT01273064|560976262|FG000|Overall Study|Withdrawal by Subject|4|||
155422302|NCT01273064|560976263|FG001|Overall Study|Withdrawal by Subject|2|||
155422303|NCT01273064|560976264|FG002|Overall Study|Withdrawal by Subject|2|||
155422304|NCT01273064|560976265|FG003|Overall Study|Withdrawal by Subject|2|||
155422305|NCT01273064|560976266|FG004|Overall Study|Withdrawal by Subject|0|||
155422306|NCT01273064|560976262|FG000|Overall Study|Study Termination|13|||
155422307|NCT01273064|560976263|FG001|Overall Study|Study Termination|27|||
155422308|NCT01273064|560976264|FG002|Overall Study|Study Termination|26|||
155422309|NCT01273064|560976265|FG003|Overall Study|Study Termination|16|||
155422310|NCT01273064|560976266|FG004|Overall Study|Study Termination|8|||
155422311|NCT01273064|560976262|FG000|Overall Study|Lost to Follow-up|1|||
155422312|NCT01273064|560976263|FG001|Overall Study|Lost to Follow-up|0|||
155422313|NCT01273064|560976264|FG002|Overall Study|Lost to Follow-up|0|||
155422314|NCT01273064|560976265|FG003|Overall Study|Lost to Follow-up|0|||
155422315|NCT01273064|560976266|FG004|Overall Study|Lost to Follow-up|0|||
155422316|NCT01273064|560976262|FG000|Overall Study|Physician Decision|0|||
155422317|NCT01273064|560976263|FG001|Overall Study|Physician Decision|0|||
155422318|NCT01273064|560976264|FG002|Overall Study|Physician Decision|0|||
155422319|NCT01273064|560976265|FG003|Overall Study|Physician Decision|0|||
155422320|NCT01273064|560976266|FG004|Overall Study|Physician Decision|1|||
155422321|NCT04666038|560976267|FG000|Overall Study|Progressive Disease|2|||
155422322|NCT04666038|560976268|FG001|Overall Study|Progressive Disease|0|||
155422323|NCT04666038|560976267|FG000|Overall Study|Death|38|||
155422324|NCT04666038|560976268|FG001|Overall Study|Death|32|||
155422325|NCT04666038|560976267|FG000|Overall Study|Withdrawal by Subject|10|||
155422326|NCT04666038|560976268|FG001|Overall Study|Withdrawal by Subject|19|||
155422327|NCT04666038|560976267|FG000|Overall Study|Lost to Follow-up|0|||
155422328|NCT04666038|560976268|FG001|Overall Study|Lost to Follow-up|2|||
155422329|NCT04666038|560976267|FG000|Overall Study|On Study Treatment|46|||
155422330|NCT04666038|560976268|FG001|Overall Study|On Study Treatment|5|||
155422331|NCT04666038|560976267|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
155422332|NCT04666038|560976268|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
155422333|NCT01375764|560976273|FG000|Overall Study|Lost to Follow-up|0|||
155422334|NCT01375764|560976274|FG001|Overall Study|Lost to Follow-up|1|||
155422335|NCT01375764|560976275|FG002|Overall Study|Lost to Follow-up|0|||
155422336|NCT01375764|560976276|FG003|Overall Study|Lost to Follow-up|0|||
155422337|NCT01375764|560976277|FG004|Overall Study|Lost to Follow-up|0|||
155422338|NCT01375764|560976273|FG000|Overall Study|Withdrawal by Subject|2|||
155422339|NCT01375764|560976274|FG001|Overall Study|Withdrawal by Subject|0|||
155422340|NCT01375764|560976275|FG002|Overall Study|Withdrawal by Subject|0|||
155422341|NCT01375764|560976276|FG003|Overall Study|Withdrawal by Subject|0|||
155422342|NCT01375764|560976277|FG004|Overall Study|Withdrawal by Subject|1|||
155422343|NCT01375764|560976273|FG000|Overall Study|Other|0|||
155422344|NCT01375764|560976274|FG001|Overall Study|Other|0|||
155422345|NCT01375764|560976275|FG002|Overall Study|Other|0|||
155422346|NCT01375764|560976276|FG003|Overall Study|Other|1|||
155422347|NCT01375764|560976277|FG004|Overall Study|Other|0|||
155422348|NCT02867761|560976280|FG000|Overall Study|Participant withdrawn by investigator|0|||
155422349|NCT02867761|560976281|FG001|Overall Study|Participant withdrawn by investigator|1|||
155422350|NCT02867761|560976280|FG000|Overall Study|Lost to Follow-up|25|||
155422351|NCT02867761|560976281|FG001|Overall Study|Lost to Follow-up|18|||
155422352|NCT02867761|560976280|FG000|Overall Study|Unable to complete protocol|3|||
155422353|NCT02867761|560976281|FG001|Overall Study|Unable to complete protocol|7|||
155645435|NCT01454063|561794001|FG001|Randomized|Adverse Event|1|||
155645436|NCT01454063|561794000|FG000|Randomized|Protocol Violation|0|||
155645437|NCT01454063|561794001|FG001|Randomized|Protocol Violation|1|||
155645438|NCT01562444|561794002|FG000|Overall Study|Did not meet entry criteria|2|||
155645439|NCT01562444|561794003|FG001|Overall Study|Did not meet entry criteria|0|||
155645440|NCT01562444|561794004|FG002|Overall Study|Did not meet entry criteria|3|||
155645441|NCT01562444|561794002|FG000|Overall Study|Did not comply with blood draw schedule|1|||
155645442|NCT01562444|561794003|FG001|Overall Study|Did not comply with blood draw schedule|0|||
155645443|NCT01562444|561794004|FG002|Overall Study|Did not comply with blood draw schedule|1|||
155645444|NCT01562444|561794002|FG000|Overall Study|Unavailable serological results|0|||
155645445|NCT01562444|561794003|FG001|Overall Study|Unavailable serological results|2|||
155645446|NCT01562444|561794004|FG002|Overall Study|Unavailable serological results|2|||
155645447|NCT01562444|561794002|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
155645448|NCT01562444|561794003|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
155645449|NCT01562444|561794004|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
155645450|NCT01562444|561794002|FG000|Overall Study|Protocol forbidden medication|1|||
155645451|NCT01562444|561794003|FG001|Overall Study|Protocol forbidden medication|0|||
155645452|NCT01562444|561794004|FG002|Overall Study|Protocol forbidden medication|0|||
155645453|NCT03387046|561794010|FG000|Overall Study|Adverse Event|1|||
155645454|NCT03387046|561794011|FG001|Overall Study|Adverse Event|1|||
155645455|NCT03558672|561794012|FG000|Overall Study|Study Early Termination|10|||
155645456|NCT00509600|561794013|FG000|Overall Study|Adverse Event|1|||
155645457|NCT03794544|561794018|FG000|Overall Study|Withdrawal by Subject|1|||
155645458|NCT03794544|561794019|FG001|Overall Study|Withdrawal by Subject|1|||
155645459|NCT03794544|561794020|FG002|Overall Study|Withdrawal by Subject|0|||
155645460|NCT03794544|561794021|FG003|Overall Study|Withdrawal by Subject|0|||
155645461|NCT03794544|561794018|FG000|Overall Study|Death|0|||
155645462|NCT03794544|561794019|FG001|Overall Study|Death|0|||
155645463|NCT03794544|561794020|FG002|Overall Study|Death|0|||
155645464|NCT03794544|561794021|FG003|Overall Study|Death|1|||
155645465|NCT03794544|561794018|FG000|Overall Study|Lost to Follow-up|0|||
155645466|NCT03794544|561794019|FG001|Overall Study|Lost to Follow-up|1|||
155645467|NCT03794544|561794020|FG002|Overall Study|Lost to Follow-up|1|||
155645468|NCT03794544|561794021|FG003|Overall Study|Lost to Follow-up|0|||
155645469|NCT03794544|561794018|FG000|Overall Study|Other|0|||
155645470|NCT03794544|561794019|FG001|Overall Study|Other|1|||
155645471|NCT03794544|561794020|FG002|Overall Study|Other|0|||
155645472|NCT03794544|561794021|FG003|Overall Study|Other|0|||
155645473|NCT01027416|561794022|FG000|Overall Study|Withdrawal by Subject|0|||
155645474|NCT01027416|561794023|FG001|Overall Study|Withdrawal by Subject|1|||
155645475|NCT01027416|561794022|FG000|Overall Study|Physician Decision|1|||
155645476|NCT01027416|561794023|FG001|Overall Study|Physician Decision|4|||
155334763|NCT00243867|560660187|FG000|Overall Study|Lack of Efficacy|115|||
155334764|NCT00243867|560660188|FG001|Overall Study|Lack of Efficacy|78|||
155334765|NCT00243867|560660187|FG000|Overall Study|Withdrawal by Subject|11|||
155334766|NCT00243867|560660188|FG001|Overall Study|Withdrawal by Subject|23|||
155334767|NCT00243867|560660187|FG000|Overall Study|Lost to Follow-up|2|||
155334768|NCT00243867|560660188|FG001|Overall Study|Lost to Follow-up|1|||
155334769|NCT00243867|560660187|FG000|Overall Study|Physician Decision|2|||
155334770|NCT00243867|560660188|FG001|Overall Study|Physician Decision|7|||
155334771|NCT00243867|560660187|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
155334772|NCT00243867|560660188|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
155422354|NCT03595280|560976282|FG000|Overall Study|Lost to Follow-up|6|||
155422355|NCT03595280|560976283|FG001|Overall Study|Lost to Follow-up|9|||
155645477|NCT00421733|561794024|FG000|Overall Study|Adverse Event|4|||
155645478|NCT00421733|561794025|FG001|Overall Study|Adverse Event|9|||
155645479|NCT00421733|561794026|FG002|Overall Study|Adverse Event|2|||
155645480|NCT00421733|561794024|FG000|Overall Study|Lost to Follow-up|1|||
155645481|NCT00421733|561794025|FG001|Overall Study|Lost to Follow-up|2|||
155645482|NCT00421733|561794026|FG002|Overall Study|Lost to Follow-up|4|||
155645483|NCT00421733|561794024|FG000|Overall Study|Withdrawal by Subject|1|||
155645484|NCT00421733|561794025|FG001|Overall Study|Withdrawal by Subject|2|||
155645485|NCT00421733|561794026|FG002|Overall Study|Withdrawal by Subject|7|||
155645486|NCT00421733|561794024|FG000|Overall Study|Death|0|||
155334773|NCT04248803|560660199|FG000|Overall Study|Lost to Follow-up|7|||
155334774|NCT04248803|560660200|FG001|Overall Study|Lost to Follow-up|7|||
155334775|NCT04248803|560660201|FG002|Overall Study|Lost to Follow-up|7|||
155334776|NCT04248803|560660202|FG003|Overall Study|Lost to Follow-up|7|||
155334777|NCT04248803|560660203|FG004|Overall Study|Lost to Follow-up|7|||
155334778|NCT04248803|560660204|FG005|Overall Study|Lost to Follow-up|7|||
155334779|NCT05352230|560660205|FG000|First Intervention (3 Months)|study terminated|2|||
155334780|NCT05352230|560660206|FG001|First Intervention (3 Months)|study terminated|2|||
155334781|NCT04399837|560660207|FG000|Overall Study|Other than listed|0|||
155334782|NCT04399837|560660208|FG001|Overall Study|Other than listed|2|||
155334783|NCT04399837|560660209|FG002|Overall Study|Other than listed|2|||
155334784|NCT04399837|560660210|FG003|Overall Study|Other than listed|3|||
155334785|NCT04399837|560660207|FG000|Overall Study|Withdrawal by Subject|1|||
155334786|NCT04399837|560660208|FG001|Overall Study|Withdrawal by Subject|2|||
155334787|NCT04399837|560660209|FG002|Overall Study|Withdrawal by Subject|1|||
155334788|NCT04399837|560660210|FG003|Overall Study|Withdrawal by Subject|1|||
155334789|NCT02060487|560660211|FG000|Overall Study|Other|1|||
155334790|NCT02060487|560660212|FG001|Overall Study|Other|2|||
155334791|NCT02060487|560660213|FG002|Overall Study|Other|1|||
155334792|NCT02060487|560660211|FG000|Overall Study|Lack of Efficacy|0|||
155334793|NCT02060487|560660212|FG001|Overall Study|Lack of Efficacy|1|||
155334794|NCT02060487|560660213|FG002|Overall Study|Lack of Efficacy|0|||
155334795|NCT02060487|560660211|FG000|Overall Study|Withdrawal by Subject|3|||
155334796|NCT02060487|560660212|FG001|Overall Study|Withdrawal by Subject|10|||
155334797|NCT02060487|560660213|FG002|Overall Study|Withdrawal by Subject|4|||
155334798|NCT02060487|560660211|FG000|Overall Study|Study Terminated By Sponsor|87|||
155334799|NCT02060487|560660212|FG001|Overall Study|Study Terminated By Sponsor|89|||
155334800|NCT02060487|560660213|FG002|Overall Study|Study Terminated By Sponsor|100|||
155334801|NCT02060487|560660211|FG000|Overall Study|Randomized in error|1|||
155334802|NCT02060487|560660212|FG001|Overall Study|Randomized in error|0|||
155334803|NCT02060487|560660213|FG002|Overall Study|Randomized in error|0|||
155334804|NCT02060487|560660211|FG000|Overall Study|Protocol Violation|0|||
155334805|NCT02060487|560660212|FG001|Overall Study|Protocol Violation|1|||
155334806|NCT02060487|560660213|FG002|Overall Study|Protocol Violation|1|||
155334807|NCT02060487|560660211|FG000|Overall Study|Lost to Follow-up|3|||
155334808|NCT02060487|560660212|FG001|Overall Study|Lost to Follow-up|0|||
155334809|NCT02060487|560660213|FG002|Overall Study|Lost to Follow-up|2|||
155334810|NCT02060487|560660211|FG000|Overall Study|Death|34|||
155334811|NCT02060487|560660212|FG001|Overall Study|Death|25|||
155334812|NCT02060487|560660213|FG002|Overall Study|Death|19|||
155334813|NCT02060487|560660211|FG000|Overall Study|Adverse Event|0|||
155334814|NCT02060487|560660212|FG001|Overall Study|Adverse Event|0|||
155334815|NCT02060487|560660213|FG002|Overall Study|Adverse Event|1|||
155334816|NCT03697603|560660214|FG000|Overall Study|Adverse Event|3|||
155334817|NCT03697603|560660215|FG001|Overall Study|Adverse Event|18|||
155334818|NCT03697603|560660216|FG002|Overall Study|Adverse Event|3|||
155334819|NCT03697603|560660214|FG000|Overall Study|Physician Decision|1|||
155334820|NCT03697603|560660215|FG001|Overall Study|Physician Decision|0|||
155334821|NCT03697603|560660216|FG002|Overall Study|Physician Decision|2|||
155334822|NCT03697603|560660214|FG000|Overall Study|Protocol Violation|3|||
155334823|NCT03697603|560660215|FG001|Overall Study|Protocol Violation|8|||
155334824|NCT03697603|560660216|FG002|Overall Study|Protocol Violation|5|||
155334825|NCT03697603|560660214|FG000|Overall Study|Withdrawal by Subject|5|||
155334826|NCT03697603|560660215|FG001|Overall Study|Withdrawal by Subject|1|||
155334827|NCT03697603|560660216|FG002|Overall Study|Withdrawal by Subject|1|||
155334828|NCT03697603|560660214|FG000|Overall Study|Protocol Violation|0|||
155334829|NCT03697603|560660215|FG001|Overall Study|Protocol Violation|0|||
155334830|NCT03697603|560660216|FG002|Overall Study|Protocol Violation|1|||
155334831|NCT05182606|560660217|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
155334832|NCT02309294|560660218|FG000|Overall Study|Withdrawal by Subject|2|||
155334833|NCT03683030|560660221|FG000|Overall Study|Enrolled but screen failures|12|||
155334834|NCT03683030|560660222|FG001|Overall Study|Enrolled but screen failures|7|||
155334835|NCT03683030|560660221|FG000|Overall Study|Enrolled but no catheter inserted|11|||
155334836|NCT03683030|560660222|FG001|Overall Study|Enrolled but no catheter inserted|13|||
155334837|NCT03683030|560660221|FG000|Overall Study|Withdrawal by Subject|0|||
155334838|NCT03683030|560660222|FG001|Overall Study|Withdrawal by Subject|2|||
155334839|NCT03683030|560660221|FG000|Overall Study|Early termination by subject|1|||
155334840|NCT03683030|560660222|FG001|Overall Study|Early termination by subject|0|||
155334841|NCT03683030|560660221|FG000|Overall Study|Lost to Follow-up|0|||
155334842|NCT03683030|560660222|FG001|Overall Study|Lost to Follow-up|6|||
155334843|NCT03683030|560660221|FG000|Overall Study|Death|0|||
155334844|NCT03683030|560660222|FG001|Overall Study|Death|2|||
155334845|NCT03683030|560660221|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
155334846|NCT03683030|560660222|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
155334847|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
155334848|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
155334849|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
155334850|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
155334851|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
155334852|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
155334853|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
155334854|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
155334855|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
155334856|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
155334857|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
155334858|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
155334859|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
155334860|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
155334861|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
155334862|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
155334863|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
155334864|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
155334865|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
155334866|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
155334867|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
155334868|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
155334869|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
155334870|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
155422356|NCT03595280|560976284|FG002|Overall Study|Lost to Follow-up|15|||
155422357|NCT02411747|560976285|FG000|Overall Study|Withdrawal by Subject|1|||
155422358|NCT02411747|560976286|FG001|Overall Study|Withdrawal by Subject|0|||
155422359|NCT02411747|560976285|FG000|Overall Study|Protocol Violation|2|||
155422360|NCT02411747|560976286|FG001|Overall Study|Protocol Violation|4|||
155422361|NCT01176916|560976287|FG000|Overall Study|Adverse Event|61|||
155422362|NCT01176916|560976287|FG000|Overall Study|Death|1|||
155422363|NCT01176916|560976287|FG000|Overall Study|Lost to Follow-up|15|||
155422364|NCT01176916|560976287|FG000|Overall Study|Objective progression or relapse|17|||
155422365|NCT01176916|560976287|FG000|Overall Study|Protocol Violation|24|||
155422366|NCT01176916|560976287|FG000|Overall Study|Withdrawal by Subject|37|||
155422367|NCT01176916|560976287|FG000|Overall Study|Other|6|||
155422368|NCT01176916|560976287|FG000|Overall Study|Withdrawal prior to Treatment|6|||
155422369|NCT00675597|560976288|FG000|Overall Study|Withdrawal by Subject|3|||
155422370|NCT03158220|560976291|FG000|Overall Study|Screen Failure|0|||
155422371|NCT03158220|560976292|FG001|Overall Study|Screen Failure|1|||
155422372|NCT03158220|560976291|FG000|Overall Study|Withdrawal by Subject|8|||
155422373|NCT03158220|560976292|FG001|Overall Study|Withdrawal by Subject|9|||
155422374|NCT03158220|560976291|FG000|Overall Study|Status unknown|0|||
155422375|NCT03158220|560976292|FG001|Overall Study|Status unknown|1|||
155422376|NCT03158220|560976291|FG000|Overall Study|Lost to Follow-up|8|||
155422377|NCT03158220|560976292|FG001|Overall Study|Lost to Follow-up|5|||
155422378|NCT03158220|560976291|FG000|Overall Study|Physician Decision|1|||
155422379|NCT03158220|560976292|FG001|Overall Study|Physician Decision|0|||
155422380|NCT00560755|560976293|FG000|Overall Study|Protocol Violation|15|||
155422381|NCT00560755|560976293|FG000|Overall Study|Withdrawal by Subject|26|||
155422382|NCT00560755|560976293|FG000|Overall Study|Lost to Follow-up|9|||
155422383|NCT00560755|560976293|FG000|Overall Study|Adverse Event|8|||
155422384|NCT00560755|560976293|FG000|Overall Study|Physician Decision|2|||
155422385|NCT01439945|560976294|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
155422386|NCT01439945|560976295|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
155422387|NCT01439945|560976296|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
155422388|NCT01439945|560976297|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
155422389|NCT01439945|560976294|FG000|Double-Blind Treatment Phase|Ineligible|1|||
155422390|NCT01439945|560976295|FG001|Double-Blind Treatment Phase|Ineligible|2|||
155422391|NCT01439945|560976296|FG002|Double-Blind Treatment Phase|Ineligible|0|||
155422392|NCT01439945|560976297|FG003|Double-Blind Treatment Phase|Ineligible|1|||
155422393|NCT02959814|560976300|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
155422394|NCT02959814|560976300|FG000|Overall Study|Excluded based on anatomical criteria|2|||
155422395|NCT02959814|560976300|FG000|Overall Study|Protocol Violation|7|||
155422396|NCT02959814|560976300|FG000|Overall Study|FFR not measured|2|||
155422397|NCT02959814|560976300|FG000|Overall Study|In-procedure QFR not computed|6|||
155422398|NCT02959814|560976300|FG000|Overall Study|Excluded by FFR core-lab|24|||
155645487|NCT00421733|561794025|FG001|Overall Study|Death|3|||
155645488|NCT00421733|561794026|FG002|Overall Study|Death|0|||
155334871|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
155334872|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
155334873|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
155334874|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
155334875|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
155334876|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
155334877|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
155334878|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
155334879|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
155334880|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
155334881|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
155334882|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
155334883|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
155334884|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
155334885|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
155334886|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
155334887|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
155334888|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
155334889|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
155334890|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
155334891|NCT02542943|560660229|FG000|Overall Study|Lost to Follow-up|1|||
155334892|NCT02542943|560660230|FG001|Overall Study|Lost to Follow-up|0|||
155334893|NCT02542943|560660231|FG002|Overall Study|Lost to Follow-up|0|||
155334894|NCT02542943|560660229|FG000|Overall Study|Withdrawal by Subject|0|||
155334895|NCT02542943|560660230|FG001|Overall Study|Withdrawal by Subject|1|||
155334896|NCT02542943|560660231|FG002|Overall Study|Withdrawal by Subject|0|||
155334897|NCT03476798|560660235|FG000|Overall Study|Death|1|||
155334898|NCT03476798|560660235|FG000|Overall Study|Withdrawal by Subject|2|||
155334899|NCT03476798|560660235|FG000|Overall Study|Protocol Violation|2|||
155334900|NCT06269003|560660236|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334901|NCT06269003|560660237|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334902|NCT06269003|560660238|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
155334903|NCT06269003|560660239|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334904|NCT00647387|560660243|FG000|Overall Study|Lost to Follow-up|6|||
155334905|NCT00647387|560660243|FG000|Overall Study|Unsuccessful implant|5|||
155334906|NCT00647387|560660243|FG000|Overall Study|Device explanted|3|||
155334907|NCT00647387|560660243|FG000|Overall Study|Other Reason|3|||
155334908|NCT00647387|560660243|FG000|Overall Study|Death|2|||
155502651|NCT01791127|561267275|FG000|Overall Study|Lost to Follow-up|42|||
155502652|NCT01791127|561267275|FG000|Overall Study|All Siello leads are explanted|31|||
155502653|NCT01791127|561267275|FG000|Overall Study|Completion of 30 day safety registry|1|||
155502654|NCT01791127|561267275|FG000|Overall Study|Study terminated for EP Passion|749|||
155502655|NCT00707174|561267280|FG000|Overall Study|Adverse Event|1|||
155502656|NCT00707174|561267281|FG001|Overall Study|Adverse Event|6|||
155502657|NCT00707174|561267280|FG000|Overall Study|Withdrawal by Subject|4|||
155502658|NCT00707174|561267281|FG001|Overall Study|Withdrawal by Subject|1|||
155502659|NCT00544557|561267282|FG000|Overall Study|Adverse Event|140|||
155502660|NCT00544557|561267282|FG000|Overall Study|Lack of Efficacy|196|||
155502661|NCT00544557|561267282|FG000|Overall Study|Other|98|||
155502662|NCT01020305|561267285|FG000|Overall Study|Adverse Event|2|||
155502663|NCT00467818|561267286|FG000|Overall Study|Adverse Event|1|||
155502664|NCT00467818|561267287|FG001|Overall Study|Adverse Event|0|||
155502665|NCT00467818|561267286|FG000|Overall Study|Lost to Follow-up|2|||
155502666|NCT00467818|561267287|FG001|Overall Study|Lost to Follow-up|2|||
155502667|NCT04936334|561267288|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
155502668|NCT04057118|561267291|FG000|Overall Study|Adverse Event|1|||
155502669|NCT04057118|561267292|FG001|Overall Study|Adverse Event|0|||
155502670|NCT04057118|561267293|FG002|Overall Study|Adverse Event|1|||
155502671|NCT04057118|561267294|FG003|Overall Study|Adverse Event|1|||
155502672|NCT04057118|561267291|FG000|Overall Study|Physician Decision|0|||
155502673|NCT04057118|561267292|FG001|Overall Study|Physician Decision|0|||
155502674|NCT04057118|561267293|FG002|Overall Study|Physician Decision|1|||
155502675|NCT04057118|561267294|FG003|Overall Study|Physician Decision|1|||
155502676|NCT04057118|561267291|FG000|Overall Study|Withdrawal by Subject|2|||
155502677|NCT04057118|561267292|FG001|Overall Study|Withdrawal by Subject|2|||
155502678|NCT04057118|561267293|FG002|Overall Study|Withdrawal by Subject|0|||
155502679|NCT04057118|561267294|FG003|Overall Study|Withdrawal by Subject|2|||
155502680|NCT04057118|561267291|FG000|Overall Study|Not Specific|0|||
155502681|NCT04057118|561267292|FG001|Overall Study|Not Specific|0|||
155645489|NCT00421733|561794024|FG000|Overall Study|Required dialysis|1|||
155645490|NCT00421733|561794025|FG001|Overall Study|Required dialysis|0|||
155422399|NCT01609842|560976304|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
155422400|NCT01609842|560976305|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
155422401|NCT03186989|560976306|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422402|NCT03186989|560976307|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422403|NCT03186989|560976308|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
155422404|NCT03186989|560976309|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
155422405|NCT03186989|560976310|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
155422406|NCT03186989|560976311|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422407|NCT03186989|560976312|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422408|NCT03186989|560976313|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422409|NCT03186989|560976314|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422410|NCT03186989|560976315|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422411|NCT03186989|560976316|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
155422412|NCT03186989|560976306|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422413|NCT03186989|560976307|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422414|NCT03186989|560976308|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422415|NCT03186989|560976309|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422416|NCT03186989|560976310|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422417|NCT03186989|560976311|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
155422418|NCT03186989|560976312|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422419|NCT03186989|560976313|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422420|NCT03186989|560976314|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422421|NCT03186989|560976315|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155422422|NCT03186989|560976316|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
155502682|NCT04057118|561267293|FG002|Overall Study|Not Specific|1|||
155502683|NCT04057118|561267294|FG003|Overall Study|Not Specific|1|||
155502684|NCT02787785|561267295|FG000|Overall Study|Death|3|||
155502685|NCT02787785|561267296|FG001|Overall Study|Death|4|||
155502686|NCT02787785|561267295|FG000|Overall Study|Lost to Follow-up|1|||
155502687|NCT02787785|561267296|FG001|Overall Study|Lost to Follow-up|1|||
155502688|NCT02787785|561267295|FG000|Overall Study|Withdrawal by Subject|0|||
155502689|NCT02787785|561267296|FG001|Overall Study|Withdrawal by Subject|5|||
155502690|NCT02030834|561267299|FG000|Overall Study|Death|4|||
155502691|NCT02030834|561267300|FG001|Overall Study|Death|0|||
155502692|NCT02030834|561267301|FG002|Overall Study|Death|0|||
155502693|NCT02030834|561267299|FG000|Overall Study|Manufacturing failure|2|||
155502694|NCT02030834|561267300|FG001|Overall Study|Manufacturing failure|0|||
155502695|NCT02030834|561267301|FG002|Overall Study|Manufacturing failure|1|||
155502696|NCT02030834|561267299|FG000|Overall Study|Disease progression|2|||
155502697|NCT02030834|561267300|FG001|Overall Study|Disease progression|0|||
155502698|NCT02030834|561267301|FG002|Overall Study|Disease progression|2|||
155502699|NCT02030834|561267299|FG000|Overall Study|Lost to Follow-up|1|||
155502700|NCT02030834|561267300|FG001|Overall Study|Lost to Follow-up|0|||
155502701|NCT02030834|561267301|FG002|Overall Study|Lost to Follow-up|0|||
155502702|NCT02030834|561267299|FG000|Overall Study|Withdrawal by Subject|1|||
155502703|NCT02030834|561267300|FG001|Overall Study|Withdrawal by Subject|0|||
155502704|NCT02030834|561267301|FG002|Overall Study|Withdrawal by Subject|0|||
155502705|NCT02030834|561267299|FG000|Overall Study|Lack of funding|1|||
155502706|NCT02030834|561267300|FG001|Overall Study|Lack of funding|0|||
155502707|NCT02030834|561267301|FG002|Overall Study|Lack of funding|0|||
155502708|NCT01347879|561267302|FG000|Overall Study|Adverse Event|0|||
155502709|NCT01347879|561267303|FG001|Overall Study|Adverse Event|12|||
155502710|NCT01347879|561267302|FG000|Overall Study|Lost to Follow-up|2|||
155502711|NCT01347879|561267303|FG001|Overall Study|Lost to Follow-up|0|||
155502712|NCT01347879|561267302|FG000|Overall Study|Withdrawal by Subject|3|||
155502713|NCT01347879|561267303|FG001|Overall Study|Withdrawal by Subject|2|||
155502714|NCT01347879|561267302|FG000|Overall Study|Other|2|||
155502715|NCT01347879|561267303|FG001|Overall Study|Other|3|||
155502716|NCT01850108|561267306|FG000|Overall Study|Lost to Follow-up|4|||
155502717|NCT01850108|561267306|FG000|Overall Study|Not eligible|1|||
155422423|NCT03186989|560976306|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155502718|NCT01850108|561267306|FG000|Overall Study|Failed engraftment|2|||
155502719|NCT01850108|561267306|FG000|Overall Study|Physician Decision|1|||
155502720|NCT03273712|561267315|FG000|Overall Study|Death|5|||
155502721|NCT03273712|561267315|FG000|Overall Study|Adverse Event|1|||
155502722|NCT03273712|561267315|FG000|Overall Study|Disease Progression|1|||
155502723|NCT00666718|561267317|FG000|Overall Study|Adverse Event|0|||
155502724|NCT00666718|561267318|FG001|Overall Study|Adverse Event|1|||
155502725|NCT00666718|561267317|FG000|Overall Study|Death|1|||
155502726|NCT00666718|561267318|FG001|Overall Study|Death|0|||
155502727|NCT00666718|561267317|FG000|Overall Study|Lost to Follow-up|1|||
155502728|NCT00666718|561267318|FG001|Overall Study|Lost to Follow-up|0|||
155502729|NCT00666718|561267317|FG000|Overall Study|Entry Criteria Not Met|2|||
155502730|NCT00666718|561267318|FG001|Overall Study|Entry Criteria Not Met|0|||
155502731|NCT00666718|561267317|FG000|Overall Study|Protocol Violation|1|||
155502732|NCT00666718|561267318|FG001|Overall Study|Protocol Violation|3|||
155502733|NCT00666718|561267317|FG000|Overall Study|Withdrawal by Subject|7|||
155645491|NCT00421733|561794026|FG002|Overall Study|Required dialysis|0|||
155645492|NCT00421733|561794024|FG000|Overall Study|Administrative|2|||
155645493|NCT00421733|561794025|FG001|Overall Study|Administrative|0|||
155645494|NCT00421733|561794026|FG002|Overall Study|Administrative|0|||
155645495|NCT00421733|561794024|FG000|Overall Study|Did not satisfy entry criteria|1|||
155645496|NCT00421733|561794025|FG001|Overall Study|Did not satisfy entry criteria|3|||
155645497|NCT00421733|561794026|FG002|Overall Study|Did not satisfy entry criteria|2|||
155645498|NCT00421733|561794024|FG000|Overall Study|Sponsor request|1|||
155645499|NCT00421733|561794025|FG001|Overall Study|Sponsor request|0|||
155645500|NCT00421733|561794026|FG002|Overall Study|Sponsor request|3|||
155645501|NCT00421733|561794024|FG000|Overall Study|Protocol deviation|4|||
155645502|NCT00421733|561794025|FG001|Overall Study|Protocol deviation|7|||
155645503|NCT00421733|561794026|FG002|Overall Study|Protocol deviation|2|||
155645504|NCT00875667|561794027|FG000|Overall Study|Adverse Event|29|||
155645505|NCT00875667|561794028|FG001|Overall Study|Adverse Event|10|||
155645506|NCT00875667|561794027|FG000|Overall Study|Withdrawal by Subject|17|||
155645507|NCT00875667|561794028|FG001|Overall Study|Withdrawal by Subject|5|||
155645508|NCT00875667|561794027|FG000|Overall Study|Death|7|||
155645509|NCT00875667|561794028|FG001|Overall Study|Death|2|||
155645510|NCT00875667|561794027|FG000|Overall Study|Protocol Violation|2|||
155645511|NCT00875667|561794028|FG001|Overall Study|Protocol Violation|0|||
155645512|NCT00875667|561794027|FG000|Overall Study|Disease Progression|100|||
155645513|NCT00875667|561794028|FG001|Overall Study|Disease Progression|49|||
155645514|NCT00875667|561794027|FG000|Overall Study|Miscellaneous|12|||
155645515|NCT00875667|561794028|FG001|Overall Study|Miscellaneous|6|||
155645516|NCT00875667|561794027|FG000|Overall Study|Randomized but no Study Drug Given|3|||
155645517|NCT00875667|561794028|FG001|Overall Study|Randomized but no Study Drug Given|1|||
155645518|NCT00894647|561794029|FG000|Overall Study|Adverse Event|5|||
155645519|NCT00894647|561794030|FG001|Overall Study|Adverse Event|4|||
155645520|NCT00894647|561794029|FG000|Overall Study|Withdrawal by Subject|4|||
155645521|NCT00894647|561794030|FG001|Overall Study|Withdrawal by Subject|4|||
155645522|NCT00894647|561794029|FG000|Overall Study|Lost to Follow-up|0|||
155645523|NCT00894647|561794030|FG001|Overall Study|Lost to Follow-up|2|||
155645524|NCT00894647|561794029|FG000|Overall Study|Non-compliance with study procedures|0|||
155334909|NCT00985088|560661668|FG000|Overall Study|Serious Adverse Event|1|||
155334910|NCT00985088|560661669|FG001|Overall Study|Serious Adverse Event|1|||
155334911|NCT00985088|560661670|FG002|Overall Study|Serious Adverse Event|0|||
155334912|NCT00985088|560661671|FG003|Overall Study|Serious Adverse Event|0|||
155502734|NCT00666718|561267318|FG001|Overall Study|Withdrawal by Subject|12|||
155502735|NCT00666718|561267317|FG000|Overall Study|Physician Decision|0|||
155502736|NCT00666718|561267318|FG001|Overall Study|Physician Decision|2|||
155502737|NCT04529096|561267320|FG000|Overall Study|Adverse Event|6|||
155502738|NCT04529096|561267321|FG001|Overall Study|Adverse Event|1|||
155502739|NCT04529096|561267320|FG000|Overall Study|Lack of Efficacy|1|||
155502740|NCT04529096|561267321|FG001|Overall Study|Lack of Efficacy|0|||
155502741|NCT04529096|561267320|FG000|Overall Study|Lost to Follow-up|1|||
155502742|NCT04529096|561267321|FG001|Overall Study|Lost to Follow-up|1|||
155502743|NCT04529096|561267320|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155502744|NCT04529096|561267321|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155502745|NCT04529096|561267320|FG000|Overall Study|Physician Decision|1|||
155502746|NCT04529096|561267321|FG001|Overall Study|Physician Decision|3|||
155502747|NCT04529096|561267320|FG000|Overall Study|Withdrawal by Subject|5|||
155645525|NCT00894647|561794030|FG001|Overall Study|Non-compliance with study procedures|2|||
155334913|NCT00985088|560661672|FG004|Overall Study|Serious Adverse Event|0|||
155502748|NCT04529096|561267321|FG001|Overall Study|Withdrawal by Subject|0|||
155645526|NCT00894647|561794029|FG000|Overall Study|Other, not due to AE|1|||
155645527|NCT00894647|561794030|FG001|Overall Study|Other, not due to AE|2|||
155645528|NCT01967277|561794031|FG000|Overall Study|Lost to Follow-up|1|||
155645529|NCT01967277|561794032|FG001|Overall Study|Lost to Follow-up|2|||
155502749|NCT04529499|561267322|FG000|Overall Study|Withdrawal by Subject|9|||
155502750|NCT04529499|561267323|FG001|Overall Study|Withdrawal by Subject|11|||
155502751|NCT04529499|561267322|FG000|Overall Study|Physician Decision|1|||
155502752|NCT04529499|561267323|FG001|Overall Study|Physician Decision|2|||
155334914|NCT00985088|560661673|FG005|Overall Study|Serious Adverse Event|0|||
155502753|NCT04529499|561267322|FG000|Overall Study|Adverse Event|4|||
155502754|NCT04529499|561267323|FG001|Overall Study|Adverse Event|4|||
155502755|NCT04529499|561267322|FG000|Overall Study|Death|14|||
155502756|NCT04529499|561267323|FG001|Overall Study|Death|11|||
155645530|NCT01967277|561794031|FG000|Overall Study|Unrelated illness|0|||
155645531|NCT01967277|561794032|FG001|Overall Study|Unrelated illness|1|||
155645532|NCT01524705|561794038|FG000|Overall Study|Adverse Event|2|||
155645533|NCT01524705|561794039|FG001|Overall Study|Adverse Event|0|||
155645534|NCT01524705|561794038|FG000|Overall Study|Death|1|||
155334915|NCT00985088|560661674|FG006|Overall Study|Serious Adverse Event|0|||
155334916|NCT00985088|560661675|FG007|Overall Study|Serious Adverse Event|1|||
155334917|NCT00985088|560661668|FG000|Overall Study|Adverse Event|0|||
155334918|NCT00985088|560661669|FG001|Overall Study|Adverse Event|0|||
155502757|NCT04529499|561267322|FG000|Overall Study|Lost to Follow-up|1|||
155502758|NCT04529499|561267323|FG001|Overall Study|Lost to Follow-up|1|||
155502759|NCT04529499|561267322|FG000|Overall Study|Others|7|||
155502760|NCT04529499|561267323|FG001|Overall Study|Others|11|||
155502761|NCT00683904|561267324|FG000|Dose Level 1|Disease progression|2|||
155502762|NCT00683904|561267325|FG001|Dose Level 1|Disease progression|0|||
155502763|NCT00683904|561267324|FG000|Dose Level 1|Adverse Event|1|||
155502764|NCT00683904|561267325|FG001|Dose Level 1|Adverse Event|0|||
155502765|NCT00683904|561267324|FG000|Dose Level 2|Adverse Event|0|||
155502766|NCT00683904|561267325|FG001|Dose Level 2|Adverse Event|2|||
155502767|NCT03091400|561267326|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
155502768|NCT03091400|561267327|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
155502769|NCT00975884|561267328|FG000|Overall Study|Adverse Event|1|||
155502770|NCT00975884|561267329|FG001|Overall Study|Adverse Event|0|||
155502771|NCT00975884|561267328|FG000|Overall Study|Lost to Follow-up|5|||
155502772|NCT00975884|561267329|FG001|Overall Study|Lost to Follow-up|3|||
155502773|NCT00975884|561267328|FG000|Overall Study|Withdrawal by Subject|9|||
155502774|NCT00975884|561267329|FG001|Overall Study|Withdrawal by Subject|9|||
155502775|NCT00975884|561267328|FG000|Overall Study|Other|1|||
155502776|NCT00975884|561267329|FG001|Overall Study|Other|3|||
155502777|NCT00363129|561267330|FG000|Overall Study|Withdrawal by Subject|11|||
155502778|NCT00363129|561267331|FG001|Overall Study|Withdrawal by Subject|18|||
155502779|NCT00363129|561267330|FG000|Overall Study|Adverse Event|8|||
155502780|NCT00363129|561267331|FG001|Overall Study|Adverse Event|3|||
155502781|NCT00363129|561267330|FG000|Overall Study|Alternate Treatment|2|||
155502782|NCT00363129|561267331|FG001|Overall Study|Alternate Treatment|4|||
155502783|NCT00363129|561267330|FG000|Overall Study|Other Medical Problems|2|||
155502784|NCT00363129|561267331|FG001|Overall Study|Other Medical Problems|4|||
155502785|NCT00363129|561267330|FG000|Overall Study|Death|0|||
155502786|NCT00363129|561267331|FG001|Overall Study|Death|1|||
155502787|NCT00363129|561267330|FG000|Overall Study|Other Reasons|6|||
155502788|NCT00363129|561267331|FG001|Overall Study|Other Reasons|3|||
155502789|NCT05166512|561267332|FG000|Randomized|Lost to Follow-up|2|||
155502790|NCT05166512|561267333|FG001|Randomized|Lost to Follow-up|0|||
155502791|NCT05166512|561267332|FG000|Randomized|Withdrawal by Subject|1|||
155502792|NCT05166512|561267333|FG001|Randomized|Withdrawal by Subject|0|||
155502793|NCT05166512|561267332|FG000|Baseline Data Collection|Lost to Follow-up|0|||
155502794|NCT05166512|561267333|FG001|Baseline Data Collection|Lost to Follow-up|3|||
155502795|NCT05166512|561267332|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
155502796|NCT05166512|561267333|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
155502797|NCT05166512|561267332|FG000|Baseline Data Collection|Protocol Violation|2|||
155502798|NCT05166512|561267333|FG001|Baseline Data Collection|Protocol Violation|0|||
155502799|NCT05166512|561267332|FG000|4 Month Data Collection|Lost to Follow-up|1|||
155645535|NCT01524705|561794039|FG001|Overall Study|Death|0|||
155645536|NCT01524705|561794038|FG000|Overall Study|Lost to Follow-up|0|||
155645537|NCT01524705|561794039|FG001|Overall Study|Lost to Follow-up|1|||
155645538|NCT01524705|561794038|FG000|Overall Study|Withdrawal by Subject|0|||
155645539|NCT01524705|561794039|FG001|Overall Study|Withdrawal by Subject|1|||
155645540|NCT01524705|561794038|FG000|Overall Study|Pancreatic Cancer|0|||
155645541|NCT01524705|561794039|FG001|Overall Study|Pancreatic Cancer|1|||
155645542|NCT00103506|561794040|FG000|Overall Study|Study closed by sponsor|34|||
155645543|NCT00103506|561794041|FG001|Overall Study|Study closed by sponsor|37|||
155645544|NCT00103506|561794040|FG000|Overall Study|Death|257|||
155645545|NCT00103506|561794041|FG001|Overall Study|Death|253|||
155645546|NCT00103506|561794040|FG000|Overall Study|Lost to Follow-up|13|||
155645547|NCT00103506|561794041|FG001|Overall Study|Lost to Follow-up|13|||
155645548|NCT00103506|561794040|FG000|Overall Study|Withdrawal by Subject|18|||
155645549|NCT00103506|561794041|FG001|Overall Study|Withdrawal by Subject|21|||
155645550|NCT00585585|561794042|FG000|Overall Study|Adverse Event|1|||
155645551|NCT02153827|561794045|FG000|Overall Study|Lost to Follow-up|3|||
155645552|NCT02153827|561794046|FG001|Overall Study|Lost to Follow-up|9|||
155645553|NCT00397930|561794051|FG000|Overall Study|Personal reasons|14|||
155645554|NCT00397930|561794052|FG001|Overall Study|Personal reasons|8|||
155645555|NCT00397930|561794051|FG000|Overall Study|Other medical|9|||
155645556|NCT00397930|561794052|FG001|Overall Study|Other medical|4|||
155645557|NCT00397930|561794051|FG000|Overall Study|Unknown reasons|9|||
155645558|NCT00397930|561794052|FG001|Overall Study|Unknown reasons|14|||
155645559|NCT00397930|561794051|FG000|Overall Study|Noncompliant|3|||
155645560|NCT00397930|561794052|FG001|Overall Study|Noncompliant|2|||
155645561|NCT00397930|561794051|FG000|Overall Study|Too time-consuming|2|||
155334919|NCT00985088|560661670|FG002|Overall Study|Adverse Event|1|||
155645562|NCT00397930|561794052|FG001|Overall Study|Too time-consuming|9|||
155645563|NCT00397930|561794051|FG000|Overall Study|Started own yoga program|1|||
155645564|NCT00397930|561794052|FG001|Overall Study|Started own yoga program|1|||
155645565|NCT00397930|561794051|FG000|Overall Study|Did not want to be in control group|0|||
155334920|NCT00985088|560661671|FG003|Overall Study|Adverse Event|0|||
155334921|NCT00985088|560661672|FG004|Overall Study|Adverse Event|0|||
155334922|NCT00985088|560661673|FG005|Overall Study|Adverse Event|0|||
155334923|NCT00985088|560661674|FG006|Overall Study|Adverse Event|0|||
155334924|NCT00985088|560661675|FG007|Overall Study|Adverse Event|0|||
155334925|NCT00985088|560661668|FG000|Overall Study|Withdrawal by Subject|4|||
155334926|NCT00985088|560661669|FG001|Overall Study|Withdrawal by Subject|0|||
155334927|NCT00985088|560661670|FG002|Overall Study|Withdrawal by Subject|0|||
155334928|NCT00985088|560661671|FG003|Overall Study|Withdrawal by Subject|1|||
155334929|NCT00985088|560661672|FG004|Overall Study|Withdrawal by Subject|3|||
155334930|NCT00985088|560661673|FG005|Overall Study|Withdrawal by Subject|2|||
155334931|NCT00985088|560661674|FG006|Overall Study|Withdrawal by Subject|1|||
155334932|NCT00985088|560661675|FG007|Overall Study|Withdrawal by Subject|2|||
155334933|NCT00985088|560661668|FG000|Overall Study|Migrated/moved from study area|0|||
155334934|NCT00985088|560661669|FG001|Overall Study|Migrated/moved from study area|0|||
155334935|NCT00985088|560661670|FG002|Overall Study|Migrated/moved from study area|1|||
155334936|NCT00985088|560661671|FG003|Overall Study|Migrated/moved from study area|0|||
155334937|NCT00985088|560661672|FG004|Overall Study|Migrated/moved from study area|0|||
155334938|NCT00985088|560661673|FG005|Overall Study|Migrated/moved from study area|0|||
155334939|NCT00985088|560661674|FG006|Overall Study|Migrated/moved from study area|0|||
155334940|NCT00985088|560661675|FG007|Overall Study|Migrated/moved from study area|1|||
155334941|NCT00985088|560661668|FG000|Overall Study|Lost to Follow-up|6|||
155334942|NCT00985088|560661669|FG001|Overall Study|Lost to Follow-up|1|||
155334943|NCT00985088|560661670|FG002|Overall Study|Lost to Follow-up|2|||
155334944|NCT00985088|560661671|FG003|Overall Study|Lost to Follow-up|6|||
155334945|NCT00985088|560661672|FG004|Overall Study|Lost to Follow-up|6|||
155334946|NCT00985088|560661673|FG005|Overall Study|Lost to Follow-up|5|||
155334947|NCT00985088|560661674|FG006|Overall Study|Lost to Follow-up|3|||
155334948|NCT00985088|560661675|FG007|Overall Study|Lost to Follow-up|2|||
155334949|NCT01970878|560661676|FG000|Overall Study|Withdrawal by Subject|11|||
155334950|NCT01970878|560661677|FG001|Overall Study|Withdrawal by Subject|10|||
155334951|NCT01970878|560661678|FG002|Overall Study|Withdrawal by Subject|14|||
155334952|NCT01970878|560661679|FG003|Overall Study|Withdrawal by Subject|7|||
155334953|NCT01970878|560661676|FG000|Overall Study|Lost to Follow-up|1|||
155334954|NCT01970878|560661677|FG001|Overall Study|Lost to Follow-up|3|||
155334955|NCT01970878|560661678|FG002|Overall Study|Lost to Follow-up|2|||
155334956|NCT01970878|560661679|FG003|Overall Study|Lost to Follow-up|4|||
155334957|NCT01970878|560661676|FG000|Overall Study|Administrative Reasons|1|||
155334958|NCT01970878|560661677|FG001|Overall Study|Administrative Reasons|0|||
155334959|NCT01970878|560661678|FG002|Overall Study|Administrative Reasons|0|||
155334960|NCT01970878|560661679|FG003|Overall Study|Administrative Reasons|4|||
155334961|NCT01970878|560661676|FG000|Overall Study|Lack of Efficacy|2|||
155334962|NCT01970878|560661677|FG001|Overall Study|Lack of Efficacy|1|||
155334963|NCT01970878|560661678|FG002|Overall Study|Lack of Efficacy|2|||
155334964|NCT01970878|560661679|FG003|Overall Study|Lack of Efficacy|0|||
155334965|NCT01970878|560661676|FG000|Overall Study|Adverse Event|12|||
155334966|NCT01970878|560661677|FG001|Overall Study|Adverse Event|7|||
155334967|NCT01970878|560661678|FG002|Overall Study|Adverse Event|4|||
155334968|NCT01970878|560661679|FG003|Overall Study|Adverse Event|3|||
155334969|NCT01970878|560661676|FG000|Overall Study|Protocol Specified Criteria|10|||
155334970|NCT01970878|560661677|FG001|Overall Study|Protocol Specified Criteria|4|||
155334971|NCT01970878|560661678|FG002|Overall Study|Protocol Specified Criteria|3|||
155334972|NCT01970878|560661679|FG003|Overall Study|Protocol Specified Criteria|6|||
155334973|NCT01970878|560661676|FG000|Overall Study|Physician Decision|0|||
155334974|NCT01970878|560661677|FG001|Overall Study|Physician Decision|1|||
155334975|NCT01970878|560661678|FG002|Overall Study|Physician Decision|1|||
155334976|NCT01970878|560661679|FG003|Overall Study|Physician Decision|0|||
155334977|NCT01970878|560661676|FG000|Overall Study|No Completion Status|0|||
155334978|NCT01970878|560661677|FG001|Overall Study|No Completion Status|1|||
155334979|NCT01970878|560661678|FG002|Overall Study|No Completion Status|0|||
155334980|NCT01970878|560661679|FG003|Overall Study|No Completion Status|0|||
155334981|NCT06571695|560661684|FG000|Overall Study|Lost to Follow-up|1|||
155334982|NCT06571695|560661685|FG001|Overall Study|Lost to Follow-up|6|||
155334983|NCT00491400|560661686|FG000|Overall Study|Withdrawal by Subject|5|||
155334984|NCT00491400|560661687|FG001|Overall Study|Withdrawal by Subject|4|||
155334985|NCT00597376|560661688|FG000|Overall Study|Withdrawal by Subject|4|||
155334986|NCT00597376|560661689|FG001|Overall Study|Withdrawal by Subject|3|||
155334987|NCT00597376|560661688|FG000|Overall Study|Adverse Event|4|||
155334988|NCT00597376|560661689|FG001|Overall Study|Adverse Event|1|||
155334989|NCT02698475|560661690|FG000|Main Study Period|Lack of Efficacy|1|||
155334990|NCT02698475|560661690|FG000|Main Study Period|Protocol Violation|2|||
155334991|NCT02698475|560661690|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
155334992|NCT02698475|560661690|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
155334993|NCT02698475|560661690|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
155334994|NCT02698475|560661690|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
155334995|NCT02698475|560661690|FG000|Long-Term Extension Period|Other|1|||
155334996|NCT01214200|560661695|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
155334997|NCT01214200|560661695|FG000|Overall Study|Withdrawal by Subject|2|||
155334998|NCT02736188|560661700|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
155334999|NCT02736188|560661700|FG000|Overall Study|Adverse Event|1|||
155335000|NCT02736188|560661700|FG000|Overall Study|Withdrawal by Subject|1|||
155335001|NCT02736188|560661700|FG000|Overall Study|Other|6|||
155335002|NCT02708498|560661701|FG000|Overall Study|Death|20|||
155335003|NCT02708498|560661702|FG001|Overall Study|Death|19|||
155335004|NCT02708498|560661703|FG002|Overall Study|Death|0|||
155335005|NCT02708498|560661704|FG003|Overall Study|Death|0|||
155335006|NCT02708498|560661705|FG004|Overall Study|Death|1|||
155335007|NCT02708498|560661706|FG005|Overall Study|Death|0|||
155335008|NCT02708498|560661707|FG006|Overall Study|Death|0|||
155335009|NCT02708498|560661708|FG007|Overall Study|Death|0|||
155335010|NCT02708498|560661701|FG000|Overall Study|Unknown reason, missing data|0|||
155335011|NCT02708498|560661702|FG001|Overall Study|Unknown reason, missing data|0|||
155335012|NCT02708498|560661703|FG002|Overall Study|Unknown reason, missing data|62|||
155335013|NCT02708498|560661704|FG003|Overall Study|Unknown reason, missing data|51|||
155335014|NCT02708498|560661705|FG004|Overall Study|Unknown reason, missing data|195|||
155335015|NCT02708498|560661706|FG005|Overall Study|Unknown reason, missing data|132|||
155335016|NCT02708498|560661707|FG006|Overall Study|Unknown reason, missing data|0|||
155335017|NCT02708498|560661708|FG007|Overall Study|Unknown reason, missing data|0|||
155335018|NCT03052517|560661709|FG000|Overall Study|Study Terminated By Sponsor|928|||
155335019|NCT03052517|560661710|FG001|Overall Study|Study Terminated By Sponsor|938|||
155335020|NCT03052517|560661711|FG002|Overall Study|Study Terminated By Sponsor|296|||
155335021|NCT03052517|560661709|FG000|Overall Study|Subject/Guardian Decision|50|||
155335022|NCT03052517|560661710|FG001|Overall Study|Subject/Guardian Decision|45|||
155335023|NCT03052517|560661711|FG002|Overall Study|Subject/Guardian Decision|22|||
155335024|NCT03052517|560661709|FG000|Overall Study|Lack of Efficacy|23|||
155335025|NCT03052517|560661710|FG001|Overall Study|Lack of Efficacy|14|||
155335026|NCT03052517|560661711|FG002|Overall Study|Lack of Efficacy|7|||
155335027|NCT03052517|560661709|FG000|Overall Study|Adverse Event|6|||
155335028|NCT03052517|560661710|FG001|Overall Study|Adverse Event|5|||
155335029|NCT03052517|560661711|FG002|Overall Study|Adverse Event|0|||
155335030|NCT03052517|560661709|FG000|Overall Study|Physician Decision|4|||
155335031|NCT03052517|560661710|FG001|Overall Study|Physician Decision|5|||
155335032|NCT03052517|560661711|FG002|Overall Study|Physician Decision|1|||
155335033|NCT03052517|560661709|FG000|Overall Study|Death|3|||
155335034|NCT03052517|560661710|FG001|Overall Study|Death|0|||
155335035|NCT03052517|560661711|FG002|Overall Study|Death|1|||
155335036|NCT03052517|560661709|FG000|Overall Study|Lost to Follow-up|2|||
155335037|NCT03052517|560661710|FG001|Overall Study|Lost to Follow-up|4|||
155335038|NCT03052517|560661711|FG002|Overall Study|Lost to Follow-up|0|||
155335039|NCT03052517|560661709|FG000|Overall Study|Pregnancy|1|||
155335040|NCT03052517|560661710|FG001|Overall Study|Pregnancy|0|||
155335041|NCT03052517|560661711|FG002|Overall Study|Pregnancy|1|||
155335042|NCT03052517|560661709|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
155335043|NCT03052517|560661710|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
155335044|NCT03052517|560661711|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
155335045|NCT03052517|560661709|FG000|Overall Study|Technical Problems|0|||
155335046|NCT03052517|560661710|FG001|Overall Study|Technical Problems|1|||
155335047|NCT03052517|560661711|FG002|Overall Study|Technical Problems|0|||
155335048|NCT01858688|560661712|FG000|Overall Study|Withdrawal by Subject|8|||
155502800|NCT05166512|561267333|FG001|4 Month Data Collection|Lost to Follow-up|0|||
155335049|NCT01858688|560661712|FG000|Overall Study|Participant began another therapy|3|||
155335050|NCT01858688|560661712|FG000|Overall Study|Physician Decision|2|||
155502801|NCT05166512|561267332|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
155502802|NCT05166512|561267333|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
155502803|NCT05166512|561267332|FG000|12 Month Data Collection|Lost to Follow-up|3|||
155502804|NCT05166512|561267333|FG001|12 Month Data Collection|Lost to Follow-up|1|||
155502805|NCT05166512|561267332|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
155502806|NCT05166512|561267333|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
155502807|NCT00420849|561267334|FG000|Overall Study|Lack of Efficacy|154|||
155502808|NCT00420849|561267334|FG000|Overall Study|Adverse Event|107|||
155502809|NCT00420849|561267334|FG000|Overall Study|Withdrawal by Subject|28|||
155502810|NCT00420849|561267334|FG000|Overall Study|Death|18|||
155502811|NCT00420849|561267334|FG000|Overall Study|Other|14|||
155502812|NCT00420849|561267334|FG000|Overall Study|Transplant|8|||
155502813|NCT00420849|561267334|FG000|Overall Study|Protocol Violation|1|||
155502814|NCT00420849|561267334|FG000|Overall Study|Lost to Follow-up|1|||
155502815|NCT05789420|561267335|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
155502816|NCT05789420|561267335|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
155502817|NCT02278952|561267336|FG000|Overall Study|Insufficient Sample|6|||
155502818|NCT00659581|561267337|FG000|Overall Study|Adverse Event|1006|||
155502819|NCT00659581|561267337|FG000|Overall Study|Lack of Efficacy|1183|||
155502820|NCT00659581|561267337|FG000|Overall Study|Other|6393|||
155502821|NCT05473247|561267338|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
155502822|NCT01831596|561267339|FG000|Overall Study|Other|8|||
155502823|NCT00446134|561267340|FG000|Overall Study|Adverse Event|7|||
155502824|NCT00446134|561267341|FG001|Overall Study|Adverse Event|17|||
155502825|NCT00446134|561267342|FG002|Overall Study|Adverse Event|13|||
155502826|NCT00446134|561267343|FG003|Overall Study|Adverse Event|18|||
155502827|NCT00446134|561267340|FG000|Overall Study|Lack of Efficacy|19|||
155502828|NCT00446134|561267341|FG001|Overall Study|Lack of Efficacy|19|||
155502829|NCT00446134|561267342|FG002|Overall Study|Lack of Efficacy|24|||
155502830|NCT00446134|561267343|FG003|Overall Study|Lack of Efficacy|19|||
155502831|NCT00446134|561267340|FG000|Overall Study|Protocol Violation|0|||
155502832|NCT00446134|561267341|FG001|Overall Study|Protocol Violation|2|||
155502833|NCT00446134|561267342|FG002|Overall Study|Protocol Violation|1|||
155502834|NCT00446134|561267343|FG003|Overall Study|Protocol Violation|0|||
155502835|NCT00446134|561267340|FG000|Overall Study|Lost to Follow-up|1|||
155502836|NCT00446134|561267341|FG001|Overall Study|Lost to Follow-up|3|||
155502837|NCT00446134|561267342|FG002|Overall Study|Lost to Follow-up|1|||
155502838|NCT00446134|561267343|FG003|Overall Study|Lost to Follow-up|1|||
155502839|NCT00446134|561267340|FG000|Overall Study|Withdrawal by Subject|3|||
155502840|NCT00446134|561267341|FG001|Overall Study|Withdrawal by Subject|3|||
155502841|NCT00446134|561267342|FG002|Overall Study|Withdrawal by Subject|1|||
155502842|NCT00446134|561267343|FG003|Overall Study|Withdrawal by Subject|3|||
155502843|NCT00446134|561267340|FG000|Overall Study|Physician Decision|0|||
155502844|NCT00446134|561267341|FG001|Overall Study|Physician Decision|0|||
155502845|NCT00446134|561267342|FG002|Overall Study|Physician Decision|0|||
155502846|NCT00446134|561267343|FG003|Overall Study|Physician Decision|2|||
155502847|NCT00446134|561267340|FG000|Overall Study|Adverse Event-Diarrhea|1|||
155502848|NCT00446134|561267341|FG001|Overall Study|Adverse Event-Diarrhea|1|||
155502849|NCT00446134|561267342|FG002|Overall Study|Adverse Event-Diarrhea|2|||
155502850|NCT00446134|561267343|FG003|Overall Study|Adverse Event-Diarrhea|0|||
155502851|NCT00446134|561267340|FG000|Overall Study|Reason Not Completed|3|||
155502852|NCT00446134|561267341|FG001|Overall Study|Reason Not Completed|0|||
155502853|NCT00446134|561267342|FG002|Overall Study|Reason Not Completed|1|||
155502854|NCT00446134|561267343|FG003|Overall Study|Reason Not Completed|2|||
155502855|NCT03125629|561267344|FG000|Overall Study|Withdrawal by Subject|2|||
155502856|NCT03125629|561267344|FG000|Overall Study|Equipment malfunction|1|||
155502857|NCT00743119|561267345|FG000|Overall Study|unreliable|3|||
155502858|NCT00743119|561267345|FG000|Overall Study|Withdrawal by Subject|1|||
155335051|NCT01858688|560661712|FG000|Overall Study|Progressive Disease|2|||
155335052|NCT01858688|560661712|FG000|Overall Study|Reason not reproted|5|||
155502859|NCT02989610|561267346|FG000|Overall Study|Withdrawal by Subject|20|||
155502860|NCT02989610|561267346|FG000|Overall Study|Departure of PI from Site|8|||
155502861|NCT02989610|561267346|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
155502862|NCT02989610|561267346|FG000|Overall Study|Lost to Follow-up|3|||
155502863|NCT02989610|561267346|FG000|Overall Study|Death|3|||
155502864|NCT02989610|561267346|FG000|Overall Study|System Explant|3|||
155502865|NCT02989610|561267346|FG000|Overall Study|Subject Non-Compliance|2|||
155502866|NCT02989610|561267346|FG000|Overall Study|System Revision|2|||
155335053|NCT03298087|560661715|FG000|Overall Study|Withdrawal by Subject|4|||
155335054|NCT01303510|560661716|FG000|Overall Study|Lost to Follow-up|1|||
155335055|NCT01303510|560661717|FG001|Overall Study|Lost to Follow-up|0|||
155335056|NCT00822900|560661721|FG000|Overall Study|Withdrawal by Subject|14|||
155335057|NCT00822900|560661722|FG001|Overall Study|Withdrawal by Subject|14|||
155335058|NCT00822900|560661721|FG000|Overall Study|Lost to Follow-up|9|||
155335059|NCT00822900|560661722|FG001|Overall Study|Lost to Follow-up|9|||
155335060|NCT00822900|560661721|FG000|Overall Study|Death|83|||
155335061|NCT00822900|560661722|FG001|Overall Study|Death|69|||
155335062|NCT00822900|560661721|FG000|Overall Study|Became a ward of the state|2|||
155335063|NCT00822900|560661722|FG001|Overall Study|Became a ward of the state|1|||
155335064|NCT00659373|560661734|FG000|Overall Study|Withdrawal by Subject|3|||
155335065|NCT00659373|560661735|FG001|Overall Study|Withdrawal by Subject|5|||
155335066|NCT00659373|560661734|FG000|Overall Study|Assessment Missed|2|||
155335067|NCT00659373|560661735|FG001|Overall Study|Assessment Missed|2|||
155335068|NCT03042767|560661738|FG000|Overall Study|Lost to Follow-up|1|||
155335069|NCT03042767|560661739|FG001|Overall Study|Lost to Follow-up|2|||
155645566|NCT00397930|561794052|FG001|Overall Study|Did not want to be in control group|1|||
155645567|NCT00397930|561794051|FG000|Overall Study|Withdrawal by Subject|0|||
155645568|NCT00397930|561794052|FG001|Overall Study|Withdrawal by Subject|8|||
155645569|NCT00397930|561794051|FG000|Overall Study|Missing data|0|||
155645570|NCT00397930|561794052|FG001|Overall Study|Missing data|4|||
155645571|NCT00965094|561794061|FG000|Overall Study|Adverse Event|5|||
155645572|NCT00965094|561794062|FG001|Overall Study|Adverse Event|0|||
155645573|NCT00965094|561794061|FG000|Overall Study|Lost to Follow-up|0|||
155645574|NCT00965094|561794062|FG001|Overall Study|Lost to Follow-up|1|||
155645575|NCT01433978|561794063|FG000|Core Study|Adverse Event, Non-Fatal|0|||
155645576|NCT01433978|561794064|FG001|Core Study|Adverse Event, Non-Fatal|1|||
155645577|NCT01433978|561794065|FG002|Core Study|Adverse Event, Non-Fatal|0|||
155645578|NCT01433978|561794063|FG000|Core Study|Lack of Efficacy|5|||
155645579|NCT01433978|561794064|FG001|Core Study|Lack of Efficacy|1|||
155645580|NCT01433978|561794065|FG002|Core Study|Lack of Efficacy|0|||
155645581|NCT01433978|561794063|FG000|Core Study|Study Terminated by Sponsor|6|||
155335070|NCT02686658|560661746|FG000|Overall Study|Adverse Event|0|||
155502867|NCT02989610|561267346|FG000|Overall Study|PI Left, Study Closing|1|||
155502868|NCT02989610|561267346|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
155502869|NCT02989610|561267346|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
155502870|NCT04508621|561267347|FG000|Overall Study|Adverse Event|39|||
155502871|NCT04508621|561267348|FG001|Overall Study|Adverse Event|16|||
155502872|NCT04508621|561267347|FG000|Overall Study|Lack of Efficacy|2|||
155502873|NCT04508621|561267348|FG001|Overall Study|Lack of Efficacy|8|||
155502874|NCT04508621|561267347|FG000|Overall Study|Physician Decision|0|||
155502875|NCT04508621|561267348|FG001|Overall Study|Physician Decision|1|||
155502876|NCT04508621|561267347|FG000|Overall Study|Withdrawal by Subject|10|||
155502877|NCT04508621|561267348|FG001|Overall Study|Withdrawal by Subject|14|||
155502878|NCT04508621|561267347|FG000|Overall Study|Lost to Follow-up|12|||
155502879|NCT04508621|561267348|FG001|Overall Study|Lost to Follow-up|9|||
155502880|NCT04508621|561267347|FG000|Overall Study|COVID-19 related crisis|3|||
155502881|NCT04508621|561267348|FG001|Overall Study|COVID-19 related crisis|0|||
155502882|NCT04508621|561267347|FG000|Overall Study|Subject non-compliance|1|||
155502883|NCT04508621|561267348|FG001|Overall Study|Subject non-compliance|0|||
155502884|NCT00759759|561267349|FG000|Overall Study|didn't return for period 2|1|||
155502885|NCT00759759|561267350|FG001|Overall Study|didn't return for period 2|0|||
155502886|NCT00759759|561267349|FG000|Overall Study|Didn't receive drug in period 2|1|||
155502887|NCT00759759|561267350|FG001|Overall Study|Didn't receive drug in period 2|0|||
155502888|NCT00759759|561267349|FG000|Overall Study|Withdrawal by Subject|2|||
155502889|NCT00759759|561267350|FG001|Overall Study|Withdrawal by Subject|1|||
155502890|NCT01556165|561267352|FG000|Overall Study|Adverse Event|5|||
155502891|NCT01556165|561267353|FG001|Overall Study|Adverse Event|3|||
155502892|NCT01556165|561267352|FG000|Overall Study|Protocol Violation|0|||
155502893|NCT01556165|561267353|FG001|Overall Study|Protocol Violation|3|||
155502894|NCT01556165|561267352|FG000|Overall Study|Withdrawal of Consent|7|||
155502895|NCT01556165|561267353|FG001|Overall Study|Withdrawal of Consent|1|||
155502896|NCT02531698|561267356|FG000|Overall Study|Adverse Event|2|||
155502897|NCT02531698|561267357|FG001|Overall Study|Adverse Event|1|||
155502898|NCT02531698|561267356|FG000|Overall Study|Withdrawal by Subject|6|||
155502899|NCT02531698|561267357|FG001|Overall Study|Withdrawal by Subject|1|||
155502900|NCT02531698|561267356|FG000|Overall Study|Protocol Violation|2|||
155502901|NCT02531698|561267357|FG001|Overall Study|Protocol Violation|0|||
155502902|NCT02531698|561267356|FG000|Overall Study|Lost to Follow-up|1|||
155502903|NCT02531698|561267357|FG001|Overall Study|Lost to Follow-up|0|||
155502904|NCT01861717|561267358|FG000|Overall Study|Lost to Follow-up|1|||
155502905|NCT01861717|561267358|FG000|Overall Study|Withdrawal by Subject|1|||
155502906|NCT02395536|561267359|FG000|Overall Study|Lost to Follow-up|4|||
155502907|NCT02395536|561267360|FG001|Overall Study|Lost to Follow-up|4|||
155502908|NCT02395536|561267359|FG000|Overall Study|Death|2|||
155502909|NCT02395536|561267360|FG001|Overall Study|Death|0|||
155502910|NCT02395536|561267359|FG000|Overall Study|Physician Decision|4|||
155502911|NCT02395536|561267360|FG001|Overall Study|Physician Decision|6|||
155502912|NCT02395536|561267359|FG000|Overall Study|Withdrawal by Subject|9|||
155502913|NCT02395536|561267360|FG001|Overall Study|Withdrawal by Subject|17|||
155502914|NCT02395536|561267359|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
155502915|NCT02395536|561267360|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
155502916|NCT02395536|561267359|FG000|Overall Study|Insurance issue|0|||
155502917|NCT02395536|561267360|FG001|Overall Study|Insurance issue|1|||
155502918|NCT00701558|561267361|FG000|Overall Study|Death|7|||
155502919|NCT00701558|561267361|FG000|Overall Study|Lost to Follow-up|8|||
155502920|NCT01637961|561269305|FG000|Overall Study|Ineligible: wrong primary|1|||
155502921|NCT01637961|561269305|FG000|Overall Study|Ineligible: inadequate pathology|1|||
155502922|NCT04006847|561269306|FG000|Overall Study|Product issue|1|||
155502923|NCT03555890|561269316|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155502924|NCT03555890|561269317|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155502925|NCT03555890|561269318|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155502926|NCT03555890|561269319|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
155502927|NCT03372369|561269320|FG000|Qualification Period|Withdrawal by Subject|16|||
155502928|NCT03372369|561269321|FG001|Qualification Period|Withdrawal by Subject|13|||
155502929|NCT03372369|561269320|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
155645582|NCT01433978|561794064|FG001|Core Study|Study Terminated by Sponsor|9|||
155335071|NCT02686658|560661747|FG001|Overall Study|Adverse Event|0|||
155335072|NCT02686658|560661748|FG002|Overall Study|Adverse Event|1|||
155502930|NCT03372369|561269321|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
155502931|NCT03372369|561269320|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
155502932|NCT03372369|561269321|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
155502933|NCT01383954|561269322|FG000|Overall Study|Lack of Efficacy|2|||
155502934|NCT01383954|561269322|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
155502935|NCT01383954|561269322|FG000|Overall Study|Adverse Event|1|||
155502936|NCT01383954|561269322|FG000|Overall Study|Reason Not Specified|9|||
155502937|NCT04388527|561269324|FG000|Overall Study|Death|14|||
155335073|NCT02686658|560661749|FG003|Overall Study|Adverse Event|1|||
155335074|NCT02686658|560661750|FG004|Overall Study|Adverse Event|2|||
155335075|NCT02686658|560661751|FG005|Overall Study|Adverse Event|1|||
155335076|NCT02686658|560661746|FG000|Overall Study|Investigator decision|0|||
155335077|NCT02686658|560661747|FG001|Overall Study|Investigator decision|0|||
155335078|NCT02686658|560661748|FG002|Overall Study|Investigator decision|0|||
155335079|NCT02686658|560661749|FG003|Overall Study|Investigator decision|1|||
155335080|NCT02686658|560661750|FG004|Overall Study|Investigator decision|2|||
155335081|NCT02686658|560661751|FG005|Overall Study|Investigator decision|1|||
155335082|NCT02686658|560661746|FG000|Overall Study|Sponsor decision|1|||
155335083|NCT02686658|560661747|FG001|Overall Study|Sponsor decision|2|||
155335084|NCT02686658|560661748|FG002|Overall Study|Sponsor decision|1|||
155335085|NCT02686658|560661749|FG003|Overall Study|Sponsor decision|5|||
155335086|NCT02686658|560661750|FG004|Overall Study|Sponsor decision|13|||
155335087|NCT02686658|560661751|FG005|Overall Study|Sponsor decision|2|||
155335088|NCT02686658|560661746|FG000|Overall Study|Lost to Follow-up|0|||
155335089|NCT02686658|560661747|FG001|Overall Study|Lost to Follow-up|0|||
155335090|NCT02686658|560661748|FG002|Overall Study|Lost to Follow-up|2|||
155335091|NCT02686658|560661749|FG003|Overall Study|Lost to Follow-up|0|||
155335092|NCT02686658|560661750|FG004|Overall Study|Lost to Follow-up|0|||
155335093|NCT02686658|560661751|FG005|Overall Study|Lost to Follow-up|1|||
155335094|NCT02686658|560661746|FG000|Overall Study|Death|1|||
155335095|NCT02686658|560661747|FG001|Overall Study|Death|0|||
155335096|NCT02686658|560661748|FG002|Overall Study|Death|0|||
155335097|NCT02686658|560661749|FG003|Overall Study|Death|1|||
155335098|NCT02686658|560661750|FG004|Overall Study|Death|1|||
155422424|NCT03186989|560976307|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422425|NCT03186989|560976308|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422426|NCT03186989|560976309|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422427|NCT03186989|560976310|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422428|NCT03186989|560976311|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422429|NCT03186989|560976312|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
155422430|NCT03186989|560976313|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422431|NCT03186989|560976314|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422432|NCT03186989|560976315|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422433|NCT03186989|560976316|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
155422434|NCT03186989|560976306|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422435|NCT03186989|560976307|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422436|NCT03186989|560976308|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422437|NCT03186989|560976309|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422438|NCT03186989|560976310|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422439|NCT03186989|560976311|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
155422440|NCT03186989|560976312|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
155422441|NCT03186989|560976313|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422442|NCT03186989|560976314|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
155422443|NCT03186989|560976315|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422444|NCT03186989|560976316|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
155422445|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
155422446|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
155422447|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
155422448|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422449|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422450|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422451|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422452|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422453|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155422454|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
155422455|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
155502938|NCT04388527|561269324|FG000|Overall Study|Withdrawal by Subject|2|||
155502939|NCT04388527|561269324|FG000|Overall Study|Lost to Follow-up|1|||
155502940|NCT03471182|561269325|FG000|Overall Study|Withdrawal by Subject|1|||
155502941|NCT03471182|561269326|FG001|Overall Study|Withdrawal by Subject|1|||
155502942|NCT03471182|561269327|FG002|Overall Study|Withdrawal by Subject|0|||
155335099|NCT02686658|560661751|FG005|Overall Study|Death|1|||
155335100|NCT02686658|560661746|FG000|Overall Study|Withdrawal by Subject|2|||
155335101|NCT02686658|560661747|FG001|Overall Study|Withdrawal by Subject|5|||
155335102|NCT02686658|560661748|FG002|Overall Study|Withdrawal by Subject|4|||
155335103|NCT02686658|560661749|FG003|Overall Study|Withdrawal by Subject|4|||
155335104|NCT02686658|560661750|FG004|Overall Study|Withdrawal by Subject|17|||
155335105|NCT02686658|560661751|FG005|Overall Study|Withdrawal by Subject|8|||
155335106|NCT02686658|560661746|FG000|Overall Study|Placed in hospice care|0|||
155422456|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
155422457|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422458|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422459|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422460|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422461|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422462|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155422463|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
155422464|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
155422465|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155502943|NCT03471182|561269325|FG000|Overall Study|Technical failure|2|||
155502944|NCT03471182|561269326|FG001|Overall Study|Technical failure|0|||
155502945|NCT03471182|561269327|FG002|Overall Study|Technical failure|0|||
155335107|NCT02686658|560661747|FG001|Overall Study|Placed in hospice care|0|||
155335108|NCT02686658|560661748|FG002|Overall Study|Placed in hospice care|1|||
155335109|NCT02686658|560661749|FG003|Overall Study|Placed in hospice care|0|||
155335110|NCT02686658|560661750|FG004|Overall Study|Placed in hospice care|0|||
155335111|NCT02686658|560661751|FG005|Overall Study|Placed in hospice care|0|||
155335112|NCT02686658|560661746|FG000|Overall Study|Participant non-compliance|0|||
155335113|NCT02686658|560661747|FG001|Overall Study|Participant non-compliance|0|||
155335114|NCT02686658|560661748|FG002|Overall Study|Participant non-compliance|0|||
155335115|NCT02686658|560661749|FG003|Overall Study|Participant non-compliance|0|||
155335116|NCT02686658|560661750|FG004|Overall Study|Participant non-compliance|0|||
155335117|NCT02686658|560661751|FG005|Overall Study|Participant non-compliance|1|||
155335118|NCT02686658|560661746|FG000|Overall Study|Concern over coronavirus disease care|0|||
155335119|NCT02686658|560661747|FG001|Overall Study|Concern over coronavirus disease care|0|||
155335120|NCT02686658|560661748|FG002|Overall Study|Concern over coronavirus disease care|0|||
155335121|NCT02686658|560661749|FG003|Overall Study|Concern over coronavirus disease care|0|||
155335122|NCT02686658|560661750|FG004|Overall Study|Concern over coronavirus disease care|2|||
155335123|NCT02686658|560661751|FG005|Overall Study|Concern over coronavirus disease care|1|||
155335124|NCT01227421|560661754|FG000|Overall Study|Lost to Follow-up|6|||
155335125|NCT01227421|560661755|FG001|Overall Study|Lost to Follow-up|7|||
155335126|NCT01227421|560661756|FG002|Overall Study|Lost to Follow-up|5|||
155335127|NCT01227421|560661754|FG000|Overall Study|Adverse Event|2|||
155335128|NCT01227421|560661755|FG001|Overall Study|Adverse Event|7|||
155335129|NCT01227421|560661756|FG002|Overall Study|Adverse Event|2|||
155335130|NCT01227421|560661754|FG000|Overall Study|Withdrawal by Subject|1|||
155335131|NCT01227421|560661755|FG001|Overall Study|Withdrawal by Subject|2|||
155335132|NCT01227421|560661756|FG002|Overall Study|Withdrawal by Subject|1|||
155335133|NCT01227421|560661754|FG000|Overall Study|Protocol Violation|1|||
155335134|NCT01227421|560661755|FG001|Overall Study|Protocol Violation|1|||
155335135|NCT01227421|560661756|FG002|Overall Study|Protocol Violation|2|||
155335136|NCT01227421|560661754|FG000|Overall Study|Randomized in error|1|||
155335137|NCT01227421|560661755|FG001|Overall Study|Randomized in error|1|||
155335138|NCT01227421|560661756|FG002|Overall Study|Randomized in error|0|||
155335139|NCT01827839|560661759|FG000|Overall Study|Adverse Event|1|||
155502946|NCT02773446|561269336|FG000|First Admission|Withdrawal by Subject|0|||
155502947|NCT02773446|561269337|FG001|First Admission|Withdrawal by Subject|0|||
155502948|NCT02773446|561269338|FG002|First Admission|Withdrawal by Subject|0|||
155502949|NCT02773446|561269339|FG003|First Admission|Withdrawal by Subject|1|||
155502950|NCT02773446|561269340|FG004|First Admission|Withdrawal by Subject|0|||
155502951|NCT02773446|561269341|FG005|First Admission|Withdrawal by Subject|0|||
155502952|NCT02773446|561269336|FG000|First Admission|Lost to Follow-up|1|||
155502953|NCT02773446|561269337|FG001|First Admission|Lost to Follow-up|0|||
155502954|NCT02773446|561269338|FG002|First Admission|Lost to Follow-up|0|||
155502955|NCT02773446|561269339|FG003|First Admission|Lost to Follow-up|0|||
155502956|NCT02773446|561269340|FG004|First Admission|Lost to Follow-up|0|||
155502957|NCT02773446|561269341|FG005|First Admission|Lost to Follow-up|0|||
155502958|NCT00289731|561269342|FG000|Overall Study|Adverse Event|1|||
155502959|NCT00289731|561269343|FG001|Overall Study|Adverse Event|2|||
155502960|NCT00289731|561269344|FG002|Overall Study|Adverse Event|2|||
155502961|NCT00289731|561269342|FG000|Overall Study|Other|1|||
155502962|NCT00289731|561269343|FG001|Overall Study|Other|0|||
155502963|NCT00289731|561269344|FG002|Overall Study|Other|0|||
155502964|NCT04023994|561269345|FG000|Overall Study|Lost to Follow-up|0|||
155502965|NCT04023994|561269346|FG001|Overall Study|Lost to Follow-up|1|||
155335140|NCT01827839|560661759|FG000|Overall Study|Consent Withdrawal|2|||
155502966|NCT04023994|561269347|FG002|Overall Study|Lost to Follow-up|2|||
155335141|NCT00614614|560661760|FG000|Primary Vaccination Phase|Adverse Event|6|||
155335142|NCT00614614|560661761|FG001|Primary Vaccination Phase|Adverse Event|0|||
155502967|NCT04023994|561269348|FG003|Overall Study|Lost to Follow-up|0|||
155502968|NCT04023994|561269349|FG004|Overall Study|Lost to Follow-up|0|||
155502969|NCT04023994|561269350|FG005|Overall Study|Lost to Follow-up|0|||
155502970|NCT04023994|561269345|FG000|Overall Study|Withdrawal by Subject|0|||
155335143|NCT00614614|560661762|FG002|Primary Vaccination Phase|Adverse Event|0|||
155335144|NCT00614614|560661763|FG003|Primary Vaccination Phase|Adverse Event|0|||
155335145|NCT00614614|560661764|FG004|Primary Vaccination Phase|Adverse Event|0|||
155335146|NCT00614614|560661760|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
155335147|NCT00614614|560661761|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
155335148|NCT00614614|560661762|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335149|NCT00614614|560661763|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335150|NCT00614614|560661764|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335151|NCT00614614|560661760|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
155335152|NCT00614614|560661761|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
155335153|NCT00614614|560661762|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
155335154|NCT00614614|560661763|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
155335155|NCT00614614|560661764|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
155335156|NCT00614614|560661760|FG000|Primary Vaccination Phase|Protocol Violation|9|||
155335157|NCT00614614|560661761|FG001|Primary Vaccination Phase|Protocol Violation|3|||
155335158|NCT00614614|560661762|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155335159|NCT00614614|560661763|FG003|Primary Vaccination Phase|Protocol Violation|0|||
155335160|NCT00614614|560661764|FG004|Primary Vaccination Phase|Protocol Violation|0|||
155335161|NCT00614614|560661760|FG000|Primary Vaccination Phase|Other|4|||
155335162|NCT00614614|560661761|FG001|Primary Vaccination Phase|Other|0|||
155335163|NCT00614614|560661762|FG002|Primary Vaccination Phase|Other|0|||
155335164|NCT00614614|560661763|FG003|Primary Vaccination Phase|Other|0|||
155335165|NCT00614614|560661764|FG004|Primary Vaccination Phase|Other|0|||
155335166|NCT00614614|560661760|FG000|Booster Vaccination Phase|Adverse Event|0|||
155335167|NCT00614614|560661761|FG001|Booster Vaccination Phase|Adverse Event|0|||
155335168|NCT00614614|560661762|FG002|Booster Vaccination Phase|Adverse Event|1|||
155335169|NCT00614614|560661763|FG003|Booster Vaccination Phase|Adverse Event|1|||
155335170|NCT00614614|560661764|FG004|Booster Vaccination Phase|Adverse Event|0|||
155335171|NCT00614614|560661760|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
155335172|NCT00614614|560661761|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155335173|NCT00614614|560661762|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
155335174|NCT00614614|560661763|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
155335175|NCT00614614|560661764|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
155335176|NCT00614614|560661760|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
155335177|NCT00614614|560661761|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
155335178|NCT00614614|560661762|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
155335179|NCT00614614|560661763|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
155335180|NCT00614614|560661764|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
155335181|NCT00614614|560661760|FG000|Booster Vaccination Phase|Protocol Violation|0|||
155422466|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422467|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422468|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422469|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422470|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422471|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155422472|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
155422473|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
155422474|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
155422475|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422476|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422477|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422478|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422479|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422480|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155422481|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
155422482|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
155422483|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155422484|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155422485|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155422486|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155422487|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155422488|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155335182|NCT00614614|560661761|FG001|Booster Vaccination Phase|Protocol Violation|0|||
155335183|NCT00614614|560661762|FG002|Booster Vaccination Phase|Protocol Violation|2|||
155335184|NCT00614614|560661763|FG003|Booster Vaccination Phase|Protocol Violation|3|||
155422489|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155335185|NCT00614614|560661764|FG004|Booster Vaccination Phase|Protocol Violation|0|||
155335186|NCT00614614|560661760|FG000|Booster Vaccination Phase|Other|0|||
155645583|NCT01433978|561794065|FG002|Core Study|Study Terminated by Sponsor|0|||
155645584|NCT01433978|561794063|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
155645585|NCT01433978|561794064|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
155645586|NCT01433978|561794065|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
155645587|NCT01433978|561794063|FG000|Extension Phase|Lack of Efficacy|0|||
155645588|NCT01433978|561794064|FG001|Extension Phase|Lack of Efficacy|0|||
155645589|NCT01433978|561794065|FG002|Extension Phase|Lack of Efficacy|1|||
155645590|NCT01433978|561794063|FG000|Extension Phase|Study Terminated by Sponsor|0|||
155645591|NCT01433978|561794064|FG001|Extension Phase|Study Terminated by Sponsor|0|||
155645592|NCT01433978|561794065|FG002|Extension Phase|Study Terminated by Sponsor|4|||
155645593|NCT01773889|561794066|FG000|Overall Study|lack of funding|2|||
155645594|NCT03954938|561794067|FG000|Overall Study|Withdrawal by Subject|2|||
155645595|NCT03954938|561794067|FG000|Overall Study|Adverse Event|1|||
155645596|NCT02565186|561794068|FG000|Overall Study|Adverse Event|113|||
155645597|NCT02565186|561794069|FG001|Overall Study|Adverse Event|148|||
155645598|NCT02565186|561794068|FG000|Overall Study|Lost to Follow-up|102|||
155645599|NCT02565186|561794069|FG001|Overall Study|Lost to Follow-up|93|||
155645600|NCT02565186|561794068|FG000|Overall Study|Non-Compliance|57|||
155645601|NCT02565186|561794069|FG001|Overall Study|Non-Compliance|55|||
155645602|NCT02565186|561794068|FG000|Overall Study|Withdrawal by Subject|229|||
155645603|NCT02565186|561794069|FG001|Overall Study|Withdrawal by Subject|214|||
155645604|NCT02565186|561794068|FG000|Overall Study|Physician Decision|18|||
155645605|NCT02565186|561794069|FG001|Overall Study|Physician Decision|16|||
155645606|NCT02565186|561794068|FG000|Overall Study|Sponsor Request|5|||
155645607|NCT02565186|561794069|FG001|Overall Study|Sponsor Request|9|||
155335187|NCT00614614|560661761|FG001|Booster Vaccination Phase|Other|1|||
155335188|NCT00614614|560661762|FG002|Booster Vaccination Phase|Other|3|||
155335189|NCT00614614|560661763|FG003|Booster Vaccination Phase|Other|2|||
155335190|NCT00614614|560661764|FG004|Booster Vaccination Phase|Other|1|||
155335191|NCT05426109|560661765|FG000|Overall Study|Withdrawal by Subject|0|||
155335192|NCT05426109|560661766|FG001|Overall Study|Withdrawal by Subject|1|||
155335193|NCT05212285|560661767|FG000|Overall Study|Lack of Efficacy|12|||
155335194|NCT05212285|560661768|FG001|Overall Study|Lack of Efficacy|8|||
155335195|NCT05212285|560661767|FG000|Overall Study|Withdrawal by Subject|8|||
155335196|NCT05212285|560661768|FG001|Overall Study|Withdrawal by Subject|1|||
155335197|NCT05212285|560661767|FG000|Overall Study|Lost to Follow-up|13|||
155335198|NCT05212285|560661768|FG001|Overall Study|Lost to Follow-up|1|||
155335199|NCT05212285|560661767|FG000|Overall Study|miss data|21|||
155335200|NCT05212285|560661768|FG001|Overall Study|miss data|2|||
155335201|NCT01000805|560661770|FG000|Overall Study|Adverse Event|21|||
155335202|NCT01000805|560661771|FG001|Overall Study|Adverse Event|9|||
155335203|NCT01000805|560661770|FG000|Overall Study|Lack of Efficacy|5|||
155335204|NCT01000805|560661771|FG001|Overall Study|Lack of Efficacy|16|||
155335205|NCT01000805|560661770|FG000|Overall Study|Lost to Follow-up|16|||
155335206|NCT01000805|560661771|FG001|Overall Study|Lost to Follow-up|21|||
155335207|NCT01000805|560661770|FG000|Overall Study|Physician Decision|0|||
155335208|NCT01000805|560661771|FG001|Overall Study|Physician Decision|1|||
155335209|NCT01000805|560661770|FG000|Overall Study|Protocol Violation|12|||
155335210|NCT01000805|560661771|FG001|Overall Study|Protocol Violation|8|||
155335211|NCT01000805|560661770|FG000|Overall Study|Withdrawal by Subject|16|||
155335212|NCT01000805|560661771|FG001|Overall Study|Withdrawal by Subject|6|||
155335213|NCT01000805|560661770|FG000|Overall Study|Sponsor Decision|0|||
155335214|NCT01000805|560661771|FG001|Overall Study|Sponsor Decision|1|||
155335215|NCT03343704|560661774|FG000|Overall Study|Refused to complete follow up|0|||
155335216|NCT03343704|560661775|FG001|Overall Study|Refused to complete follow up|1|||
155335217|NCT03343704|560661774|FG000|Overall Study|Death|0|||
155335218|NCT03343704|560661775|FG001|Overall Study|Death|1|||
155335219|NCT03343704|560661774|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
155335220|NCT03343704|560661775|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
155645608|NCT02565186|561794068|FG000|Overall Study|Missing|1|||
155645609|NCT02565186|561794069|FG001|Overall Study|Missing|0|||
155335221|NCT05432986|560661780|FG000|Overall Study|Withdrawal by Subject|2|||
155335222|NCT05432986|560661780|FG000|Overall Study|incomplete measurement|7|||
155335223|NCT00949117|560663034|FG000|Overall Study|Lack of Efficacy|2|||
155335224|NCT00949117|560663035|FG001|Overall Study|Lack of Efficacy|3|||
155335225|NCT00949117|560663034|FG000|Overall Study|Protocol Violation|1|||
155335226|NCT00949117|560663035|FG001|Overall Study|Protocol Violation|1|||
155335227|NCT00949117|560663034|FG000|Overall Study|Adverse Event|0|||
155335228|NCT00949117|560663035|FG001|Overall Study|Adverse Event|1|||
155335229|NCT03964974|560663036|FG000|Overall Study|Lost to Follow-up|3|||
155335230|NCT03964974|560663037|FG001|Overall Study|Lost to Follow-up|2|||
155645610|NCT02565186|561794068|FG000|Overall Study|Did Not Receive Study Drug|55|||
155645611|NCT02565186|561794069|FG001|Overall Study|Did Not Receive Study Drug|86|||
155422490|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422491|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422492|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
155422493|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422494|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422495|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422496|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422497|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422498|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155422499|NCT01583374|560976317|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422500|NCT01583374|560976318|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
155422501|NCT01583374|560976319|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422502|NCT01583374|560976320|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422503|NCT01583374|560976321|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422504|NCT01583374|560976322|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422505|NCT01583374|560976323|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422506|NCT01583374|560976324|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422507|NCT01583374|560976325|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
155422508|NCT01583374|560976317|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422509|NCT01583374|560976318|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422510|NCT01583374|560976319|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422511|NCT01583374|560976320|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422512|NCT01583374|560976321|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422513|NCT01583374|560976322|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422514|NCT01583374|560976323|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422515|NCT01583374|560976324|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
155422516|NCT01583374|560976325|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155422517|NCT01583374|560976317|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
155422518|NCT01583374|560976318|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155422519|NCT01583374|560976319|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
155422520|NCT01583374|560976320|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
155422521|NCT01583374|560976321|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155422522|NCT01583374|560976322|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155422523|NCT01583374|560976323|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
155422524|NCT01583374|560976324|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155422525|NCT01583374|560976325|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
155422526|NCT01583374|560976317|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
155422527|NCT01583374|560976318|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
155422528|NCT01583374|560976319|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
155422529|NCT01583374|560976320|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
155422530|NCT01583374|560976321|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
155422531|NCT01583374|560976322|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
155422532|NCT01583374|560976323|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
155422533|NCT01583374|560976324|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
155422534|NCT01583374|560976325|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
155422535|NCT01583374|560976317|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422536|NCT01583374|560976318|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
155422537|NCT01583374|560976319|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
155422538|NCT01583374|560976320|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422539|NCT01583374|560976321|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
155422540|NCT01583374|560976322|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422541|NCT01583374|560976323|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422542|NCT01583374|560976324|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422543|NCT01583374|560976325|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
155422544|NCT01583374|560976317|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422545|NCT01583374|560976318|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422546|NCT01583374|560976319|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
155422547|NCT01583374|560976320|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422548|NCT01583374|560976321|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
155422549|NCT01583374|560976322|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
155422550|NCT01583374|560976323|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422551|NCT01583374|560976324|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422552|NCT01583374|560976325|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155422553|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
155422554|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
155422555|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
155422556|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
155502971|NCT04023994|561269346|FG001|Overall Study|Withdrawal by Subject|0|||
155502972|NCT04023994|561269347|FG002|Overall Study|Withdrawal by Subject|0|||
155335231|NCT03964974|560663036|FG000|Overall Study|Withdrawal by Subject|0|||
155335232|NCT03964974|560663037|FG001|Overall Study|Withdrawal by Subject|3|||
155335233|NCT02014402|560663038|FG000|Overall Study|Adverse Event|1|||
155335234|NCT02014402|560663039|FG001|Overall Study|Adverse Event|0|||
155335235|NCT02014402|560663040|FG002|Overall Study|Adverse Event|0|||
155335236|NCT02014402|560663041|FG003|Overall Study|Adverse Event|0|||
155335237|NCT02014402|560663038|FG000|Overall Study|Withdrawal by Subject|1|||
155335238|NCT02014402|560663039|FG001|Overall Study|Withdrawal by Subject|2|||
155335239|NCT02014402|560663040|FG002|Overall Study|Withdrawal by Subject|2|||
155335240|NCT02014402|560663041|FG003|Overall Study|Withdrawal by Subject|1|||
155335241|NCT02014402|560663038|FG000|Overall Study|Subject did not have transportation|0|||
155335242|NCT02014402|560663039|FG001|Overall Study|Subject did not have transportation|1|||
155335243|NCT02014402|560663040|FG002|Overall Study|Subject did not have transportation|0|||
155335244|NCT02014402|560663041|FG003|Overall Study|Subject did not have transportation|0|||
155335245|NCT02014402|560663038|FG000|Overall Study|Lost to Follow-up|0|||
155335246|NCT02014402|560663039|FG001|Overall Study|Lost to Follow-up|0|||
155335247|NCT02014402|560663040|FG002|Overall Study|Lost to Follow-up|1|||
155335248|NCT02014402|560663041|FG003|Overall Study|Lost to Follow-up|2|||
155335249|NCT01364597|560663043|FG000|Overall Study|Adverse Event|4|||
155335250|NCT01364597|560663044|FG001|Overall Study|Adverse Event|5|||
155335251|NCT01364597|560663045|FG002|Overall Study|Adverse Event|16|||
155335252|NCT01364597|560663046|FG003|Overall Study|Adverse Event|7|||
155335253|NCT01364597|560663043|FG000|Overall Study|Lack of Efficacy|4|||
155335254|NCT01364597|560663044|FG001|Overall Study|Lack of Efficacy|4|||
155335255|NCT01364597|560663045|FG002|Overall Study|Lack of Efficacy|23|||
155335256|NCT01364597|560663046|FG003|Overall Study|Lack of Efficacy|8|||
155335257|NCT01364597|560663043|FG000|Overall Study|Protocol Violation|0|||
155335258|NCT01364597|560663044|FG001|Overall Study|Protocol Violation|0|||
155335259|NCT01364597|560663045|FG002|Overall Study|Protocol Violation|2|||
155335260|NCT01364597|560663046|FG003|Overall Study|Protocol Violation|0|||
155335261|NCT01364597|560663043|FG000|Overall Study|Lost to Follow-up|0|||
155335262|NCT01364597|560663044|FG001|Overall Study|Lost to Follow-up|0|||
155335263|NCT01364597|560663045|FG002|Overall Study|Lost to Follow-up|5|||
155335264|NCT01364597|560663046|FG003|Overall Study|Lost to Follow-up|3|||
155335265|NCT01364597|560663043|FG000|Overall Study|Withdrawal by Subject|4|||
155502973|NCT04023994|561269348|FG003|Overall Study|Withdrawal by Subject|1|||
155335266|NCT01364597|560663044|FG001|Overall Study|Withdrawal by Subject|1|||
155335267|NCT01364597|560663045|FG002|Overall Study|Withdrawal by Subject|18|||
155335268|NCT01364597|560663046|FG003|Overall Study|Withdrawal by Subject|6|||
155335269|NCT01364597|560663043|FG000|Overall Study|Non compliance|1|||
155335270|NCT01364597|560663044|FG001|Overall Study|Non compliance|0|||
155335271|NCT01364597|560663045|FG002|Overall Study|Non compliance|1|||
155335272|NCT01364597|560663046|FG003|Overall Study|Non compliance|0|||
155335273|NCT01364597|560663043|FG000|Overall Study|Lack of compliance|1|||
155335274|NCT01364597|560663044|FG001|Overall Study|Lack of compliance|0|||
155335275|NCT01364597|560663045|FG002|Overall Study|Lack of compliance|0|||
155335276|NCT01364597|560663046|FG003|Overall Study|Lack of compliance|0|||
155335277|NCT01364597|560663043|FG000|Overall Study|End of treatment epilepsy|1|||
155335278|NCT01364597|560663044|FG001|Overall Study|End of treatment epilepsy|0|||
155335279|NCT01364597|560663045|FG002|Overall Study|End of treatment epilepsy|0|||
155335280|NCT01364597|560663046|FG003|Overall Study|End of treatment epilepsy|0|||
155335281|NCT01364597|560663043|FG000|Overall Study|No Seizures|1|||
155335282|NCT01364597|560663044|FG001|Overall Study|No Seizures|0|||
155335283|NCT01364597|560663045|FG002|Overall Study|No Seizures|0|||
155335284|NCT01364597|560663046|FG003|Overall Study|No Seizures|0|||
155335285|NCT01364597|560663043|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
155335286|NCT01364597|560663044|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335287|NCT01364597|560663045|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335288|NCT01364597|560663046|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335289|NCT01364597|560663043|FG000|Overall Study|Cure|1|||
155335290|NCT01364597|560663044|FG001|Overall Study|Cure|0|||
155335291|NCT01364597|560663045|FG002|Overall Study|Cure|0|||
155335292|NCT01364597|560663046|FG003|Overall Study|Cure|0|||
155335293|NCT01364597|560663043|FG000|Overall Study|Patient was moving|0|||
155335294|NCT01364597|560663044|FG001|Overall Study|Patient was moving|1|||
155335295|NCT01364597|560663045|FG002|Overall Study|Patient was moving|0|||
155335296|NCT01364597|560663046|FG003|Overall Study|Patient was moving|0|||
155335297|NCT01364597|560663043|FG000|Overall Study|Seizures resolved|0|||
155335298|NCT01364597|560663044|FG001|Overall Study|Seizures resolved|0|||
155335299|NCT01364597|560663045|FG002|Overall Study|Seizures resolved|1|||
155335300|NCT01364597|560663046|FG003|Overall Study|Seizures resolved|0|||
155335301|NCT01364597|560663043|FG000|Overall Study|Patient became seizure-free after surgery|0|||
155335302|NCT01364597|560663044|FG001|Overall Study|Patient became seizure-free after surgery|0|||
155502974|NCT04023994|561269349|FG004|Overall Study|Withdrawal by Subject|0|||
155502975|NCT04023994|561269350|FG005|Overall Study|Withdrawal by Subject|0|||
155502976|NCT01613131|561269351|FG000|Overall Study|Withdrawal by Subject|3|||
155502977|NCT01613131|561269352|FG001|Overall Study|Withdrawal by Subject|5|||
155502978|NCT02454972|561269353|FG000|Overall Study|Progressive disease|17|||
155502979|NCT02454972|561269354|FG001|Overall Study|Progressive disease|16|||
155502980|NCT02454972|561269355|FG002|Overall Study|Progressive disease|59|||
155502981|NCT02454972|561269356|FG003|Overall Study|Progressive disease|23|||
155335303|NCT01364597|560663045|FG002|Overall Study|Patient became seizure-free after surgery|1|||
155335304|NCT01364597|560663046|FG003|Overall Study|Patient became seizure-free after surgery|0|||
155335305|NCT01364597|560663043|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
155335306|NCT01364597|560663044|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
155335307|NCT01364597|560663045|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
155335308|NCT01364597|560663046|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
155335309|NCT01364597|560663043|FG000|Overall Study|Patient cured from Epilepsy|0|||
155335310|NCT01364597|560663044|FG001|Overall Study|Patient cured from Epilepsy|0|||
155502982|NCT02454972|561269357|FG004|Overall Study|Progressive disease|16|||
155502983|NCT02454972|561269358|FG005|Overall Study|Progressive disease|12|||
155502984|NCT02454972|561269359|FG006|Overall Study|Progressive disease|19|||
155502985|NCT02454972|561269360|FG007|Overall Study|Progressive disease|27|||
155335311|NCT01364597|560663045|FG002|Overall Study|Patient cured from Epilepsy|1|||
155335312|NCT01364597|560663046|FG003|Overall Study|Patient cured from Epilepsy|0|||
155335313|NCT01364597|560663043|FG000|Overall Study|Investigator decision|0|||
155335314|NCT01364597|560663044|FG001|Overall Study|Investigator decision|0|||
155335315|NCT01364597|560663045|FG002|Overall Study|Investigator decision|1|||
155335316|NCT01364597|560663046|FG003|Overall Study|Investigator decision|0|||
155335317|NCT01364597|560663043|FG000|Overall Study|Sponsor recommended discontinuation|0|||
155335318|NCT01364597|560663044|FG001|Overall Study|Sponsor recommended discontinuation|0|||
155335319|NCT01364597|560663045|FG002|Overall Study|Sponsor recommended discontinuation|0|||
155502986|NCT02454972|561269361|FG008|Overall Study|Progressive disease|0|||
155502987|NCT02454972|561269353|FG000|Overall Study|Death|0|||
155502988|NCT02454972|561269354|FG001|Overall Study|Death|0|||
155335320|NCT01364597|560663046|FG003|Overall Study|Sponsor recommended discontinuation|1|||
155335321|NCT01364597|560663043|FG000|Overall Study|Parents went abroad with the patient|0|||
155335322|NCT01364597|560663044|FG001|Overall Study|Parents went abroad with the patient|0|||
155335323|NCT01364597|560663045|FG002|Overall Study|Parents went abroad with the patient|1|||
155335324|NCT01364597|560663046|FG003|Overall Study|Parents went abroad with the patient|0|||
155335325|NCT01364597|560663043|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335326|NCT01364597|560663044|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335327|NCT01364597|560663045|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
155335328|NCT01364597|560663046|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335329|NCT01364597|560663043|FG000|Overall Study|BRV administration dropout|0|||
155335330|NCT01364597|560663044|FG001|Overall Study|BRV administration dropout|0|||
155335331|NCT01364597|560663045|FG002|Overall Study|BRV administration dropout|1|||
155335332|NCT01364597|560663046|FG003|Overall Study|BRV administration dropout|0|||
155335333|NCT01364597|560663043|FG000|Overall Study|Dropout|0|||
155335334|NCT01364597|560663044|FG001|Overall Study|Dropout|0|||
155335335|NCT01364597|560663045|FG002|Overall Study|Dropout|3|||
155335336|NCT01364597|560663046|FG003|Overall Study|Dropout|1|||
155335337|NCT01364597|560663043|FG000|Overall Study|Unreliable subject|0|||
155335338|NCT01364597|560663044|FG001|Overall Study|Unreliable subject|0|||
155335339|NCT01364597|560663045|FG002|Overall Study|Unreliable subject|0|||
155335340|NCT01364597|560663046|FG003|Overall Study|Unreliable subject|1|||
155335341|NCT01364597|560663043|FG000|Overall Study|Other|0|||
155335342|NCT01364597|560663044|FG001|Overall Study|Other|0|||
155335343|NCT01364597|560663045|FG002|Overall Study|Other|0|||
155335344|NCT01364597|560663046|FG003|Overall Study|Other|1|||
155335345|NCT03493282|560663050|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
155335346|NCT03493282|560663051|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
155335347|NCT03493282|560663052|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
155335348|NCT03493282|560663050|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
155335349|NCT03493282|560663051|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
155335350|NCT03493282|560663052|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
155335351|NCT01380145|560663053|FG000|Overall Study|Progressive disease|4|||
155335352|NCT02038049|560663054|FG000|Overall Study|Lost to Follow-up|1|||
155335353|NCT02038049|560663055|FG001|Overall Study|Lost to Follow-up|0|||
155335354|NCT02660086|560663057|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
155335355|NCT02660086|560663058|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
155335356|NCT02660086|560663057|FG000|Overall Study- 12-month|Left full-time employment|12|||
155335357|NCT02660086|560663058|FG001|Overall Study- 12-month|Left full-time employment|20|||
155335358|NCT02660086|560663057|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
155335359|NCT02660086|560663058|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
155335360|NCT02660086|560663057|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
155335361|NCT02660086|560663058|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
155335362|NCT02660086|560663057|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
155335363|NCT02660086|560663058|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
155335364|NCT02660086|560663057|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
155335365|NCT02660086|560663058|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
155335366|NCT00587171|560663061|FG000|Overall Study|Lost to Follow-up|1|||
155335367|NCT00587171|560663062|FG001|Overall Study|Lost to Follow-up|1|||
155335368|NCT02148705|560663066|FG000|Overall Study|Death|2|||
155335369|NCT02148705|560663067|FG001|Overall Study|Death|0|||
155335370|NCT02148705|560663068|FG002|Overall Study|Death|0|||
155335371|NCT02148705|560663066|FG000|Overall Study|Lost to Follow-up|13|||
155335372|NCT02148705|560663067|FG001|Overall Study|Lost to Follow-up|4|||
155335373|NCT02148705|560663068|FG002|Overall Study|Lost to Follow-up|10|||
155335374|NCT02148705|560663066|FG000|Overall Study|Withdrawal by Subject|3|||
155335375|NCT02148705|560663067|FG001|Overall Study|Withdrawal by Subject|0|||
155335376|NCT02148705|560663068|FG002|Overall Study|Withdrawal by Subject|2|||
155502989|NCT02454972|561269355|FG002|Overall Study|Death|5|||
155502990|NCT02454972|561269356|FG003|Overall Study|Death|1|||
155502991|NCT02454972|561269357|FG004|Overall Study|Death|0|||
155335377|NCT02148705|560663066|FG000|Overall Study|Not Treated|0|||
155335378|NCT02148705|560663067|FG001|Overall Study|Not Treated|1|||
155335379|NCT02148705|560663068|FG002|Overall Study|Not Treated|5|||
155335380|NCT01737021|560663069|FG000|Overall Study|Lost to Follow-up|5|||
155335381|NCT01737021|560663070|FG001|Overall Study|Lost to Follow-up|3|||
155335382|NCT01673594|560663071|FG000|Overall Study|Adverse Event|3|||
155335383|NCT01673594|560663072|FG001|Overall Study|Adverse Event|1|||
155335384|NCT01673594|560663071|FG000|Overall Study|Lost to Follow-up|1|||
155335385|NCT01673594|560663072|FG001|Overall Study|Lost to Follow-up|0|||
155335386|NCT01673594|560663071|FG000|Overall Study|Physician Decision|2|||
155335387|NCT01673594|560663072|FG001|Overall Study|Physician Decision|4|||
155502992|NCT02454972|561269358|FG005|Overall Study|Death|0|||
155335388|NCT01673594|560663071|FG000|Overall Study|Withdrawal by Subject|0|||
155335389|NCT01673594|560663072|FG001|Overall Study|Withdrawal by Subject|1|||
155335390|NCT02605174|560663076|FG000|Overall Study|Adverse Event|0|||
155335391|NCT02605174|560663077|FG001|Overall Study|Adverse Event|0|||
155335392|NCT02605174|560663078|FG002|Overall Study|Adverse Event|1|||
155335393|NCT02605174|560663079|FG003|Overall Study|Adverse Event|0|||
155335394|NCT02605174|560663080|FG004|Overall Study|Adverse Event|4|||
155335395|NCT02605174|560663081|FG005|Overall Study|Adverse Event|0|||
155335396|NCT02605174|560663082|FG006|Overall Study|Adverse Event|0|||
155335397|NCT02605174|560663076|FG000|Overall Study|Lost to Follow-up|20|||
155335398|NCT02605174|560663077|FG001|Overall Study|Lost to Follow-up|7|||
155335399|NCT02605174|560663078|FG002|Overall Study|Lost to Follow-up|27|||
155335400|NCT02605174|560663079|FG003|Overall Study|Lost to Follow-up|10|||
155335401|NCT02605174|560663080|FG004|Overall Study|Lost to Follow-up|20|||
155335402|NCT02605174|560663081|FG005|Overall Study|Lost to Follow-up|10|||
155335403|NCT02605174|560663082|FG006|Overall Study|Lost to Follow-up|29|||
155335404|NCT02605174|560663076|FG000|Overall Study|Protocol Violation|10|||
155335405|NCT02605174|560663077|FG001|Overall Study|Protocol Violation|4|||
155335406|NCT02605174|560663078|FG002|Overall Study|Protocol Violation|14|||
155335407|NCT02605174|560663079|FG003|Overall Study|Protocol Violation|6|||
155335408|NCT02605174|560663080|FG004|Overall Study|Protocol Violation|7|||
155335409|NCT02605174|560663081|FG005|Overall Study|Protocol Violation|7|||
155335410|NCT02605174|560663082|FG006|Overall Study|Protocol Violation|12|||
155335411|NCT02605174|560663076|FG000|Overall Study|Pregnancy|1|||
155335412|NCT02605174|560663077|FG001|Overall Study|Pregnancy|0|||
155335413|NCT02605174|560663078|FG002|Overall Study|Pregnancy|0|||
155335414|NCT02605174|560663079|FG003|Overall Study|Pregnancy|2|||
155335415|NCT02605174|560663080|FG004|Overall Study|Pregnancy|0|||
155335416|NCT02605174|560663081|FG005|Overall Study|Pregnancy|0|||
155335417|NCT02605174|560663082|FG006|Overall Study|Pregnancy|0|||
155335418|NCT02605174|560663076|FG000|Overall Study|Withdrawal by Subject|9|||
155335419|NCT02605174|560663077|FG001|Overall Study|Withdrawal by Subject|6|||
155335420|NCT02605174|560663078|FG002|Overall Study|Withdrawal by Subject|14|||
155335421|NCT02605174|560663079|FG003|Overall Study|Withdrawal by Subject|11|||
155335422|NCT02605174|560663080|FG004|Overall Study|Withdrawal by Subject|6|||
155335423|NCT02605174|560663081|FG005|Overall Study|Withdrawal by Subject|4|||
155335424|NCT02605174|560663082|FG006|Overall Study|Withdrawal by Subject|15|||
155335425|NCT02605174|560663076|FG000|Overall Study|Physician Decision|2|||
155335426|NCT02605174|560663077|FG001|Overall Study|Physician Decision|0|||
155335427|NCT02605174|560663078|FG002|Overall Study|Physician Decision|0|||
155335428|NCT02605174|560663079|FG003|Overall Study|Physician Decision|0|||
155335429|NCT02605174|560663080|FG004|Overall Study|Physician Decision|0|||
155335430|NCT02605174|560663081|FG005|Overall Study|Physician Decision|0|||
155335431|NCT02605174|560663082|FG006|Overall Study|Physician Decision|3|||
155335432|NCT02605174|560663076|FG000|Overall Study|Randomization Failure|22|||
155335433|NCT02605174|560663077|FG001|Overall Study|Randomization Failure|6|||
155335434|NCT02605174|560663078|FG002|Overall Study|Randomization Failure|20|||
155335435|NCT02605174|560663079|FG003|Overall Study|Randomization Failure|7|||
155335436|NCT02605174|560663080|FG004|Overall Study|Randomization Failure|16|||
155335437|NCT02605174|560663081|FG005|Overall Study|Randomization Failure|11|||
155335438|NCT02605174|560663082|FG006|Overall Study|Randomization Failure|30|||
155335439|NCT04250636|560663083|FG000|Overall Study|Lost to Follow-up|2|||
155335440|NCT05005247|560663088|FG000|Overall Study|Withdrawal by Subject|0|||
155335441|NCT05005247|560663089|FG001|Overall Study|Withdrawal by Subject|1|||
155335442|NCT05005247|560663090|FG002|Overall Study|Withdrawal by Subject|0|||
155335443|NCT02827201|560663097|FG000|Overall Study|Death|1|||
155335444|NCT02827201|560663098|FG001|Overall Study|Death|2|||
155335445|NCT02827201|560663097|FG000|Overall Study|Patients not treated|1|||
155335446|NCT02827201|560663098|FG001|Overall Study|Patients not treated|1|||
155335447|NCT02630186|560663099|FG000|Overall Study|Withdrawal by Subject|1|||
155335448|NCT00439218|560663100|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
155335449|NCT02128269|560663103|FG000|Treatment Period|Adverse Event|1|||
155335450|NCT02128269|560663103|FG000|Treatment Period|Physician Decision|1|||
155335451|NCT01021748|560663104|FG000|Overall Study|Adverse Event|2|||
155335452|NCT01021748|560663105|FG001|Overall Study|Adverse Event|1|||
155335453|NCT01021748|560663106|FG002|Overall Study|Adverse Event|2|||
155335454|NCT01021748|560663107|FG003|Overall Study|Adverse Event|0|||
155335455|NCT01021748|560663108|FG004|Overall Study|Adverse Event|2|||
155335456|NCT01021748|560663109|FG005|Overall Study|Adverse Event|0|||
155422557|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
155422558|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
155335457|NCT01021748|560663110|FG006|Overall Study|Adverse Event|1|||
155335458|NCT01021748|560663111|FG007|Overall Study|Adverse Event|0|||
155335459|NCT01021748|560663112|FG008|Overall Study|Adverse Event|7|||
155335460|NCT01021748|560663104|FG000|Overall Study|Physician Decision|1|||
155335461|NCT01021748|560663105|FG001|Overall Study|Physician Decision|0|||
155335462|NCT01021748|560663106|FG002|Overall Study|Physician Decision|1|||
155335463|NCT01021748|560663107|FG003|Overall Study|Physician Decision|1|||
155335464|NCT01021748|560663108|FG004|Overall Study|Physician Decision|0|||
155502993|NCT02454972|561269359|FG006|Overall Study|Death|0|||
155502994|NCT02454972|561269360|FG007|Overall Study|Death|0|||
155502995|NCT02454972|561269361|FG008|Overall Study|Death|95|||
155502996|NCT02454972|561269353|FG000|Overall Study|Physician Decision|0|||
155502997|NCT02454972|561269354|FG001|Overall Study|Physician Decision|1|||
155502998|NCT02454972|561269355|FG002|Overall Study|Physician Decision|2|||
155502999|NCT02454972|561269356|FG003|Overall Study|Physician Decision|1|||
155503000|NCT02454972|561269357|FG004|Overall Study|Physician Decision|2|||
155503001|NCT02454972|561269358|FG005|Overall Study|Physician Decision|0|||
155503002|NCT02454972|561269359|FG006|Overall Study|Physician Decision|0|||
155503003|NCT02454972|561269360|FG007|Overall Study|Physician Decision|1|||
155503004|NCT02454972|561269361|FG008|Overall Study|Physician Decision|0|||
155503005|NCT02454972|561269353|FG000|Overall Study|Non treatment-related adverse event|2|||
155503006|NCT02454972|561269354|FG001|Overall Study|Non treatment-related adverse event|0|||
155503007|NCT02454972|561269355|FG002|Overall Study|Non treatment-related adverse event|1|||
155503008|NCT02454972|561269356|FG003|Overall Study|Non treatment-related adverse event|0|||
155503009|NCT02454972|561269357|FG004|Overall Study|Non treatment-related adverse event|0|||
155503010|NCT02454972|561269358|FG005|Overall Study|Non treatment-related adverse event|1|||
155503011|NCT02454972|561269359|FG006|Overall Study|Non treatment-related adverse event|0|||
155503012|NCT02454972|561269360|FG007|Overall Study|Non treatment-related adverse event|1|||
155503013|NCT02454972|561269361|FG008|Overall Study|Non treatment-related adverse event|0|||
155503014|NCT02454972|561269353|FG000|Overall Study|Treatment-related adverse events|0|||
155503015|NCT02454972|561269354|FG001|Overall Study|Treatment-related adverse events|1|||
155503016|NCT02454972|561269355|FG002|Overall Study|Treatment-related adverse events|1|||
155503017|NCT02454972|561269356|FG003|Overall Study|Treatment-related adverse events|0|||
155503018|NCT02454972|561269357|FG004|Overall Study|Treatment-related adverse events|2|||
155503019|NCT02454972|561269358|FG005|Overall Study|Treatment-related adverse events|0|||
155503020|NCT02454972|561269359|FG006|Overall Study|Treatment-related adverse events|0|||
155503021|NCT02454972|561269360|FG007|Overall Study|Treatment-related adverse events|2|||
155503022|NCT02454972|561269361|FG008|Overall Study|Treatment-related adverse events|0|||
155335465|NCT01021748|560663109|FG005|Overall Study|Physician Decision|0|||
155335466|NCT01021748|560663110|FG006|Overall Study|Physician Decision|1|||
155335467|NCT01021748|560663111|FG007|Overall Study|Physician Decision|1|||
155335468|NCT01021748|560663112|FG008|Overall Study|Physician Decision|2|||
155335469|NCT01021748|560663104|FG000|Overall Study|Progressive Disease|3|||
155335470|NCT01021748|560663105|FG001|Overall Study|Progressive Disease|3|||
155335471|NCT01021748|560663106|FG002|Overall Study|Progressive Disease|4|||
155335472|NCT01021748|560663107|FG003|Overall Study|Progressive Disease|6|||
155335473|NCT01021748|560663108|FG004|Overall Study|Progressive Disease|7|||
155335474|NCT01021748|560663109|FG005|Overall Study|Progressive Disease|3|||
155335475|NCT01021748|560663110|FG006|Overall Study|Progressive Disease|0|||
155335476|NCT01021748|560663111|FG007|Overall Study|Progressive Disease|5|||
155335477|NCT01021748|560663112|FG008|Overall Study|Progressive Disease|6|||
155335478|NCT01021748|560663104|FG000|Overall Study|Withdrawal by Subject|0|||
155335479|NCT01021748|560663105|FG001|Overall Study|Withdrawal by Subject|0|||
155335480|NCT01021748|560663106|FG002|Overall Study|Withdrawal by Subject|0|||
155335481|NCT01021748|560663107|FG003|Overall Study|Withdrawal by Subject|0|||
155335482|NCT01021748|560663108|FG004|Overall Study|Withdrawal by Subject|0|||
155335483|NCT01021748|560663109|FG005|Overall Study|Withdrawal by Subject|0|||
155335484|NCT01021748|560663110|FG006|Overall Study|Withdrawal by Subject|1|||
155335485|NCT01021748|560663111|FG007|Overall Study|Withdrawal by Subject|0|||
155335486|NCT01021748|560663112|FG008|Overall Study|Withdrawal by Subject|1|||
155335487|NCT01021748|560663104|FG000|Overall Study|Not Treated|0|||
155503023|NCT02454972|561269353|FG000|Overall Study|Patient moves to compassionate use|0|||
155335488|NCT01021748|560663105|FG001|Overall Study|Not Treated|1|||
155335489|NCT01021748|560663106|FG002|Overall Study|Not Treated|0|||
155503024|NCT02454972|561269354|FG001|Overall Study|Patient moves to compassionate use|0|||
155335490|NCT01021748|560663107|FG003|Overall Study|Not Treated|0|||
155335491|NCT01021748|560663108|FG004|Overall Study|Not Treated|0|||
155335492|NCT01021748|560663109|FG005|Overall Study|Not Treated|0|||
155335493|NCT01021748|560663110|FG006|Overall Study|Not Treated|0|||
155335494|NCT01021748|560663111|FG007|Overall Study|Not Treated|0|||
155503025|NCT02454972|561269355|FG002|Overall Study|Patient moves to compassionate use|0|||
155335495|NCT01021748|560663112|FG008|Overall Study|Not Treated|0|||
155335496|NCT01829711|560663113|FG000|Overall Study|Lost to Follow-up|2|||
155335497|NCT01829711|560663113|FG000|Overall Study|Withdrawal by Subject|3|||
155335498|NCT01829711|560663113|FG000|Overall Study|Death|4|||
155335499|NCT01829711|560663113|FG000|Overall Study|Started new therapies|17|||
155335500|NCT01829711|560663113|FG000|Overall Study|Adverse Event|3|||
155335501|NCT01829711|560663113|FG000|Overall Study|Due to progression of disease|13|||
155503026|NCT02454972|561269356|FG003|Overall Study|Patient moves to compassionate use|0|||
155503027|NCT02454972|561269357|FG004|Overall Study|Patient moves to compassionate use|0|||
155503028|NCT02454972|561269358|FG005|Overall Study|Patient moves to compassionate use|0|||
155503029|NCT02454972|561269359|FG006|Overall Study|Patient moves to compassionate use|2|||
155503030|NCT02454972|561269360|FG007|Overall Study|Patient moves to compassionate use|0|||
155503031|NCT02454972|561269361|FG008|Overall Study|Patient moves to compassionate use|0|||
155503032|NCT02454972|561269353|FG000|Overall Study|Withdrawal by Subject|0|||
155503033|NCT02454972|561269354|FG001|Overall Study|Withdrawal by Subject|1|||
155503034|NCT02454972|561269355|FG002|Overall Study|Withdrawal by Subject|5|||
155503035|NCT02454972|561269356|FG003|Overall Study|Withdrawal by Subject|2|||
155503036|NCT02454972|561269357|FG004|Overall Study|Withdrawal by Subject|3|||
155503037|NCT02454972|561269358|FG005|Overall Study|Withdrawal by Subject|2|||
155503038|NCT02454972|561269359|FG006|Overall Study|Withdrawal by Subject|0|||
155503039|NCT02454972|561269360|FG007|Overall Study|Withdrawal by Subject|1|||
155503040|NCT02454972|561269361|FG008|Overall Study|Withdrawal by Subject|2|||
155503041|NCT02454972|561269353|FG000|Overall Study|Multiple delay/holds on treatment|0|||
155503042|NCT02454972|561269354|FG001|Overall Study|Multiple delay/holds on treatment|0|||
155503043|NCT02454972|561269355|FG002|Overall Study|Multiple delay/holds on treatment|0|||
155503044|NCT02454972|561269356|FG003|Overall Study|Multiple delay/holds on treatment|1|||
155503045|NCT02454972|561269357|FG004|Overall Study|Multiple delay/holds on treatment|0|||
155503046|NCT02454972|561269358|FG005|Overall Study|Multiple delay/holds on treatment|0|||
155503047|NCT02454972|561269359|FG006|Overall Study|Multiple delay/holds on treatment|0|||
155503048|NCT02454972|561269360|FG007|Overall Study|Multiple delay/holds on treatment|0|||
155503049|NCT02454972|561269361|FG008|Overall Study|Multiple delay/holds on treatment|0|||
155503050|NCT02454972|561269353|FG000|Overall Study|Never treated|0|||
155503051|NCT02454972|561269354|FG001|Overall Study|Never treated|0|||
155503052|NCT02454972|561269355|FG002|Overall Study|Never treated|3|||
155503053|NCT02454972|561269356|FG003|Overall Study|Never treated|1|||
155503054|NCT02454972|561269357|FG004|Overall Study|Never treated|1|||
155503055|NCT02454972|561269358|FG005|Overall Study|Never treated|0|||
155503056|NCT02454972|561269359|FG006|Overall Study|Never treated|0|||
155503057|NCT02454972|561269360|FG007|Overall Study|Never treated|0|||
155503058|NCT02454972|561269361|FG008|Overall Study|Never treated|5|||
155503059|NCT02454972|561269353|FG000|Overall Study|Lost to Follow-up|0|||
155503060|NCT02454972|561269354|FG001|Overall Study|Lost to Follow-up|0|||
155503061|NCT02454972|561269355|FG002|Overall Study|Lost to Follow-up|0|||
155503062|NCT02454972|561269356|FG003|Overall Study|Lost to Follow-up|0|||
155503063|NCT02454972|561269357|FG004|Overall Study|Lost to Follow-up|0|||
155503064|NCT02454972|561269358|FG005|Overall Study|Lost to Follow-up|0|||
155503065|NCT02454972|561269359|FG006|Overall Study|Lost to Follow-up|0|||
155503066|NCT02454972|561269360|FG007|Overall Study|Lost to Follow-up|0|||
155503067|NCT02454972|561269361|FG008|Overall Study|Lost to Follow-up|2|||
155503068|NCT02454972|561269353|FG000|Overall Study|Study termination|0|||
155503069|NCT02454972|561269354|FG001|Overall Study|Study termination|0|||
155503070|NCT02454972|561269355|FG002|Overall Study|Study termination|0|||
155503071|NCT02454972|561269356|FG003|Overall Study|Study termination|0|||
155503072|NCT02454972|561269357|FG004|Overall Study|Study termination|0|||
155503073|NCT02454972|561269358|FG005|Overall Study|Study termination|0|||
155503074|NCT02454972|561269359|FG006|Overall Study|Study termination|0|||
155503075|NCT02454972|561269360|FG007|Overall Study|Study termination|0|||
155503076|NCT02454972|561269361|FG008|Overall Study|Study termination|6|||
155645612|NCT00617903|561794070|FG000|Overall Study|Withdrawal by Subject|2|||
155335502|NCT01829711|560663113|FG000|Overall Study|Due to lack of response|1|||
155335503|NCT01480258|560663114|FG000|Infant Series|Protocol Violation|2|||
155335504|NCT01480258|560663115|FG001|Infant Series|Protocol Violation|0|||
155645613|NCT00617903|561794071|FG001|Overall Study|Withdrawal by Subject|3|||
155645614|NCT00617903|561794070|FG000|Overall Study|Lost to Follow-up|1|||
155645615|NCT00617903|561794071|FG001|Overall Study|Lost to Follow-up|1|||
155645616|NCT00617903|561794070|FG000|Overall Study|Lack of Efficacy|0|||
155645617|NCT00617903|561794071|FG001|Overall Study|Lack of Efficacy|1|||
155645618|NCT00617903|561794070|FG000|Overall Study|Adverse Event|0|||
155645619|NCT00617903|561794071|FG001|Overall Study|Adverse Event|1|||
155645620|NCT00617903|561794070|FG000|Overall Study|noncompliance|0|||
155645621|NCT00617903|561794071|FG001|Overall Study|noncompliance|1|||
155645622|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
155503077|NCT01070966|561269366|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
155503078|NCT01070966|561269366|FG000|Participants for Safety Evaluation|Off-label use|9|||
155503079|NCT01070966|561269366|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
155645623|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
155645624|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
155503080|NCT01070966|561269366|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
155503081|NCT01070966|561269366|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
155503082|NCT01070966|561269366|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
155503083|NCT01070966|561269366|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
155503084|NCT01070966|561269366|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
155503085|NCT02770716|561269367|FG000|Overall Study|Death|101|||
155503086|NCT02770716|561269368|FG001|Overall Study|Death|45|||
155503087|NCT02770716|561269367|FG000|Overall Study|Withdrawal by Subject|4|||
155503088|NCT02770716|561269368|FG001|Overall Study|Withdrawal by Subject|2|||
155503089|NCT02770716|561269367|FG000|Overall Study|Lost to Follow-up|1|||
155503090|NCT02770716|561269368|FG001|Overall Study|Lost to Follow-up|0|||
155503091|NCT02770716|561269367|FG000|Overall Study|Various reasons|6|||
155503092|NCT02770716|561269368|FG001|Overall Study|Various reasons|2|||
155503093|NCT01725113|561269369|FG000|Overall Study|Kidney Transplant|1|||
155503094|NCT01725113|561269370|FG001|Overall Study|Kidney Transplant|1|||
155503095|NCT01725113|561269369|FG000|Overall Study|Withdrawal by Subject|0|||
155503096|NCT01725113|561269370|FG001|Overall Study|Withdrawal by Subject|1|||
155503097|NCT01415921|561269373|FG000|Overall Study|Adverse Event|0|||
155503098|NCT01415921|561269374|FG001|Overall Study|Adverse Event|1|||
155503099|NCT01415921|561269373|FG000|Overall Study|Physician Decision|1|||
155503100|NCT01415921|561269374|FG001|Overall Study|Physician Decision|1|||
155503101|NCT01415921|561269373|FG000|Overall Study|Withdrawal by Subject|0|||
155503102|NCT01415921|561269374|FG001|Overall Study|Withdrawal by Subject|1|||
155503103|NCT01415921|561269373|FG000|Overall Study|Other|2|||
155503104|NCT01415921|561269374|FG001|Overall Study|Other|0|||
155503105|NCT01830920|561269377|FG000|Overall Study|Adverse Event|1|||
155503106|NCT01830920|561269378|FG001|Overall Study|Adverse Event|0|||
155503107|NCT01830920|561269379|FG002|Overall Study|Adverse Event|1|||
155503108|NCT01830920|561269380|FG003|Overall Study|Adverse Event|0|||
155503109|NCT01830920|561269381|FG004|Overall Study|Adverse Event|0|||
155503110|NCT01830920|561269377|FG000|Overall Study|Withdrawal by Subject|2|||
155503111|NCT01830920|561269378|FG001|Overall Study|Withdrawal by Subject|2|||
155503112|NCT01830920|561269379|FG002|Overall Study|Withdrawal by Subject|1|||
155503113|NCT01830920|561269380|FG003|Overall Study|Withdrawal by Subject|7|||
155503114|NCT01830920|561269381|FG004|Overall Study|Withdrawal by Subject|1|||
155503115|NCT01830920|561269377|FG000|Overall Study|Death|3|||
155503116|NCT01830920|561269378|FG001|Overall Study|Death|3|||
155503117|NCT01830920|561269379|FG002|Overall Study|Death|5|||
155503118|NCT01830920|561269380|FG003|Overall Study|Death|4|||
155503119|NCT01830920|561269381|FG004|Overall Study|Death|4|||
155503120|NCT01830920|561269377|FG000|Overall Study|Other|15|||
155503121|NCT01830920|561269378|FG001|Overall Study|Other|1|||
155335505|NCT01480258|560663114|FG000|Infant Series|Physician Decision|0|||
155335506|NCT01480258|560663115|FG001|Infant Series|Physician Decision|1|||
155335507|NCT01480258|560663114|FG000|Infant Series|Not Vaccinated|3|||
155335508|NCT01480258|560663115|FG001|Infant Series|Not Vaccinated|0|||
155335509|NCT01480258|560663114|FG000|Infant Series|Adverse Event|1|||
155335510|NCT01480258|560663115|FG001|Infant Series|Adverse Event|1|||
155503122|NCT01830920|561269379|FG002|Overall Study|Other|1|||
155335511|NCT01480258|560663114|FG000|Infant Series|Withdrawal by Subject|1|||
155335512|NCT01480258|560663115|FG001|Infant Series|Withdrawal by Subject|6|||
155335513|NCT01480258|560663114|FG000|Interim Period|Lost to Follow-up|0|||
155335514|NCT01480258|560663115|FG001|Interim Period|Lost to Follow-up|2|||
155335515|NCT01480258|560663114|FG000|Interim Period|Physician Decision|1|||
155335516|NCT01480258|560663115|FG001|Interim Period|Physician Decision|0|||
155335517|NCT01480258|560663114|FG000|Interim Period|Protocol Violation|0|||
155335518|NCT01480258|560663115|FG001|Interim Period|Protocol Violation|1|||
155335519|NCT01480258|560663114|FG000|Interim Period|Withdrawal by Subject|9|||
155335520|NCT01480258|560663115|FG001|Interim Period|Withdrawal by Subject|6|||
155335521|NCT01640288|560663118|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
155335522|NCT01640288|560663119|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
155335523|NCT01640288|560663118|FG000|Overall Study|Screen Failure|20|||
155503123|NCT01830920|561269380|FG003|Overall Study|Other|5|||
155503124|NCT01830920|561269381|FG004|Overall Study|Other|3|||
155335524|NCT01640288|560663119|FG001|Overall Study|Screen Failure|18|||
155335525|NCT01640288|560663118|FG000|Overall Study|Withdrawn by PI|5|||
155335526|NCT01640288|560663119|FG001|Overall Study|Withdrawn by PI|0|||
155335527|NCT01640288|560663118|FG000|Overall Study|Withdrawal by Subject|1|||
155335528|NCT01640288|560663119|FG001|Overall Study|Withdrawal by Subject|0|||
155335529|NCT01485887|560663123|FG000|Overall Study|Withdrawal by Subject|2|||
155335530|NCT01485887|560663123|FG000|Overall Study|Adverse Event|8|||
155503125|NCT01313728|561269382|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
155503126|NCT00572156|561269391|FG000|Overall Study|Adverse Event|3|||
155503127|NCT00572156|561269392|FG001|Overall Study|Adverse Event|1|||
155503128|NCT00572156|561269393|FG002|Overall Study|Adverse Event|5|||
155503129|NCT00572156|561269394|FG003|Overall Study|Adverse Event|1|||
155503130|NCT00572156|561269391|FG000|Overall Study|Lost to Follow-up|1|||
155503131|NCT00572156|561269392|FG001|Overall Study|Lost to Follow-up|1|||
155503132|NCT00572156|561269393|FG002|Overall Study|Lost to Follow-up|1|||
155503133|NCT00572156|561269394|FG003|Overall Study|Lost to Follow-up|0|||
155503134|NCT00572156|561269391|FG000|Overall Study|Protocol Violation|1|||
155503135|NCT00572156|561269392|FG001|Overall Study|Protocol Violation|2|||
155503136|NCT00572156|561269393|FG002|Overall Study|Protocol Violation|0|||
155335531|NCT01485887|560663123|FG000|Overall Study|Deterioration of primary disease|1|||
155335532|NCT01485887|560663123|FG000|Overall Study|Primary disease markedly improved|1|||
155335533|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335534|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
155503137|NCT00572156|561269394|FG003|Overall Study|Protocol Violation|2|||
155503138|NCT00572156|561269391|FG000|Overall Study|Patient/Parent Decision|1|||
155335535|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335536|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
155503139|NCT00572156|561269392|FG001|Overall Study|Patient/Parent Decision|6|||
155503140|NCT00572156|561269393|FG002|Overall Study|Patient/Parent Decision|4|||
155335537|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335538|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335539|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335540|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335541|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
155335542|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335543|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335544|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335545|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335546|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335547|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Death|1|||
155335548|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Death|2|||
155335549|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Death|0|||
155335550|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Death|1|||
155335551|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Death|0|||
155335552|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Death|0|||
155335553|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Death|0|||
155335554|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
155335555|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
155335556|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
155335557|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
155335558|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
155335559|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
155335560|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
155503141|NCT00572156|561269394|FG003|Overall Study|Patient/Parent Decision|3|||
155503142|NCT00572156|561269391|FG000|Overall Study|Sponsor Decision|20|||
155335561|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335562|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
155335563|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335564|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335565|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335566|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335567|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335568|NCT02234141|560663124|FG000|Long-Term Treatment Period|Death|0|||
155335569|NCT02234141|560663125|FG001|Long-Term Treatment Period|Death|0|||
155335570|NCT02234141|560663126|FG002|Long-Term Treatment Period|Death|0|||
155335571|NCT02234141|560663127|FG003|Long-Term Treatment Period|Death|0|||
155335572|NCT02234141|560663128|FG004|Long-Term Treatment Period|Death|0|||
155335573|NCT02234141|560663129|FG005|Long-Term Treatment Period|Death|1|||
155335574|NCT02234141|560663130|FG006|Long-Term Treatment Period|Death|0|||
155335575|NCT02234141|560663124|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
155335576|NCT02234141|560663125|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
155335577|NCT02234141|560663126|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
155335578|NCT02234141|560663127|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
155335579|NCT02234141|560663128|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
155335580|NCT02234141|560663129|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
155335581|NCT02234141|560663130|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
155335582|NCT02234141|560663124|FG000|Long-Term Treatment Period|Adverse Event|4|||
155335583|NCT02234141|560663125|FG001|Long-Term Treatment Period|Adverse Event|0|||
155335584|NCT02234141|560663126|FG002|Long-Term Treatment Period|Adverse Event|5|||
155335585|NCT02234141|560663127|FG003|Long-Term Treatment Period|Adverse Event|0|||
155335586|NCT02234141|560663128|FG004|Long-Term Treatment Period|Adverse Event|1|||
155335587|NCT02234141|560663129|FG005|Long-Term Treatment Period|Adverse Event|1|||
155335588|NCT02234141|560663130|FG006|Long-Term Treatment Period|Adverse Event|1|||
155335589|NCT02234141|560663124|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
155335590|NCT02234141|560663125|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
155335591|NCT02234141|560663126|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
155335592|NCT02234141|560663127|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
155335593|NCT02234141|560663128|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
155335594|NCT02234141|560663129|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
155335595|NCT02234141|560663130|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
155335596|NCT02234141|560663124|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
155335597|NCT02234141|560663125|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
155335598|NCT02234141|560663126|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
155335599|NCT02234141|560663127|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
155335600|NCT02234141|560663128|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
155335601|NCT02234141|560663129|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
155422559|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
155422560|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
155422561|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
155422562|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
155422563|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
155422564|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
155422565|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
155422566|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
155422567|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
155422568|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
155422569|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
155422570|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
155422571|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422572|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422573|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422574|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422575|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
155422576|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422577|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
155422578|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
155422579|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
155422580|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
155422581|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
155422582|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
155422583|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
155422584|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
155422585|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
155422586|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
155422587|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
155422588|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
155422589|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422590|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422591|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422592|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422593|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
155422594|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422595|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
155422596|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422597|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
155422598|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
155422599|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
155422600|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
155422601|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
155422602|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
155422603|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
155422604|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
155422605|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
155422606|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
155422607|NCT01583374|560976317|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
155422608|NCT01583374|560976318|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
155503143|NCT00572156|561269392|FG001|Overall Study|Sponsor Decision|16|||
155645625|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
155645626|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
155645627|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
155645628|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
155645629|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
155645630|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
155645631|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
155645632|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
155335602|NCT02234141|560663130|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
155335603|NCT00895245|560663131|FG000|Overall Study|Lack of Efficacy|6|||
155335604|NCT02095678|560663132|FG000|Overall Study|Withdrawal by Subject|0|||
155335605|NCT02095678|560663133|FG001|Overall Study|Withdrawal by Subject|1|||
155335606|NCT02095678|560663132|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
155645633|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
155645634|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
155645635|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
155645636|NCT00976391|561794072|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
155645637|NCT00976391|561794073|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
155645638|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
155645639|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
155645640|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
155645641|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
155645642|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
155335607|NCT02095678|560663133|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
155335608|NCT02095678|560663132|FG000|Overall Study|lesion impacted by previous treatment|1|||
155335609|NCT02095678|560663133|FG001|Overall Study|lesion impacted by previous treatment|1|||
155335610|NCT02095678|560663132|FG000|Overall Study|No Confirmed Diagnosis|0|||
155335611|NCT02095678|560663133|FG001|Overall Study|No Confirmed Diagnosis|3|||
155335612|NCT02095678|560663132|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
155335613|NCT02095678|560663133|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
155335614|NCT02095678|560663132|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
155335615|NCT02095678|560663133|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
155335616|NCT03418545|560663134|FG000|Overall Study|Withdrawal by Participant|2|||
155335617|NCT03418545|560663135|FG001|Overall Study|Withdrawal by Participant|4|||
155335618|NCT03418545|560663134|FG000|Overall Study|Lost to Follow-up|3|||
155335619|NCT03418545|560663135|FG001|Overall Study|Lost to Follow-up|5|||
155335620|NCT03418545|560663134|FG000|Overall Study|Reason Not Specified|0|||
155335621|NCT03418545|560663135|FG001|Overall Study|Reason Not Specified|1|||
155335622|NCT03418545|560663134|FG000|Overall Study|Missing Completion Status|0|||
155335623|NCT03418545|560663135|FG001|Overall Study|Missing Completion Status|1|||
155422609|NCT01583374|560976319|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
155422610|NCT01583374|560976320|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
155422611|NCT01583374|560976321|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
155422612|NCT01583374|560976322|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
155422613|NCT01583374|560976323|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
155422614|NCT01583374|560976324|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
155422615|NCT01583374|560976325|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
155422616|NCT00821678|560976328|FG000|Overall Study|Withdrawal by Subject|8|||
155422617|NCT00821678|560976329|FG001|Overall Study|Withdrawal by Subject|0|||
155422618|NCT00821678|560976328|FG000|Overall Study|Lost to Follow-up|13|||
155422619|NCT00821678|560976329|FG001|Overall Study|Lost to Follow-up|12|||
155422620|NCT00821678|560976328|FG000|Overall Study|Death|0|||
155422621|NCT00821678|560976329|FG001|Overall Study|Death|2|||
155422622|NCT03219164|560978538|FG000|Overall Study|Study Terminated by Sponsor|16|||
155422623|NCT03219164|560978539|FG001|Overall Study|Study Terminated by Sponsor|12|||
155422624|NCT03219164|560978538|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
155422625|NCT03219164|560978539|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
155422626|NCT03219164|560978538|FG000|Overall Study|Lost to Follow-up|1|||
155422627|NCT03219164|560978539|FG001|Overall Study|Lost to Follow-up|1|||
155422628|NCT03219164|560978538|FG000|Overall Study|Adverse Event|1|||
155422629|NCT03219164|560978539|FG001|Overall Study|Adverse Event|0|||
155422630|NCT03219164|560978538|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155422631|NCT03219164|560978539|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155422632|NCT03219164|560978538|FG000|Overall Study|Protocol Violation|0|||
155422633|NCT03219164|560978539|FG001|Overall Study|Protocol Violation|1|||
155422634|NCT03219164|560978538|FG000|Overall Study|Withdrew Assent|1|||
155422635|NCT03219164|560978539|FG001|Overall Study|Withdrew Assent|0|||
155422636|NCT00376961|560978540|FG000|Initial Registration|Adverse Event|1|||
155422637|NCT00376961|560978541|FG001|Initial Registration|Adverse Event|0|||
155422638|NCT00376961|560978540|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
155422639|NCT00376961|560978541|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155422640|NCT00376961|560978540|FG000|Initial Registration|Progression/relapse|1|||
155422641|NCT00376961|560978541|FG001|Initial Registration|Progression/relapse|0|||
155422642|NCT00376961|560978540|FG000|Initial Registration|Ineligible|3|||
155422643|NCT00376961|560978541|FG001|Initial Registration|Ineligible|0|||
155422644|NCT00376961|560978540|FG000|Maintenance|Adverse Event|0|||
155422645|NCT00376961|560978541|FG001|Maintenance|Adverse Event|1|||
155422646|NCT00376961|560978540|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
155422647|NCT00376961|560978541|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
155503144|NCT00572156|561269393|FG002|Overall Study|Sponsor Decision|17|||
155503145|NCT00572156|561269394|FG003|Overall Study|Sponsor Decision|19|||
155503146|NCT01440595|561269395|FG000|Overall Study|Lost to Follow-up|0|||
155503147|NCT01440595|561269396|FG001|Overall Study|Lost to Follow-up|1|||
155503148|NCT01440595|561269397|FG002|Overall Study|Lost to Follow-up|0|||
155503149|NCT01440595|561269395|FG000|Overall Study|Study terminated by sponsor.|1|||
155503150|NCT01440595|561269396|FG001|Overall Study|Study terminated by sponsor.|2|||
155645643|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
155645644|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
155645645|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
155645646|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
155645647|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
155645648|NCT00976391|561794072|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
155645649|NCT00976391|561794073|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155645650|NCT01371565|561794074|FG000|Overall Study|Withdrawal by Subject|1|||
155645651|NCT01371565|561794074|FG000|Overall Study|Death|1|||
155645652|NCT01371565|561794074|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
155645653|NCT02217982|561794075|FG000|Overall Study|Trial discontinued|1|||
155645654|NCT02217982|561794076|FG001|Overall Study|Trial discontinued|0|||
155645655|NCT02217982|561794075|FG000|Overall Study|Adverse Event|0|||
155645656|NCT02217982|561794076|FG001|Overall Study|Adverse Event|1|||
155645657|NCT05156125|561794077|FG000|Overall Study|Lack of Efficacy|1|||
155645658|NCT05156125|561794078|FG001|Overall Study|Lack of Efficacy|1|||
155503151|NCT01440595|561269397|FG002|Overall Study|Study terminated by sponsor.|1|||
155503152|NCT03216954|561269398|FG000|Overall Study|Adverse Event|0|||
155645659|NCT05156125|561794079|FG002|Overall Study|Lack of Efficacy|1|||
155645660|NCT05156125|561794077|FG000|Overall Study|Physician Decision|0|||
155503153|NCT03216954|561269399|FG001|Overall Study|Adverse Event|0|||
155645661|NCT05156125|561794078|FG001|Overall Study|Physician Decision|0|||
155422648|NCT00376961|560978540|FG000|Maintenance|Progression/relapse|0|||
155422649|NCT00376961|560978541|FG001|Maintenance|Progression/relapse|18|||
155422650|NCT00376961|560978540|FG000|Maintenance|Ineligible|0|||
155422651|NCT00376961|560978541|FG001|Maintenance|Ineligible|3|||
155422652|NCT04574999|560978543|FG000|Overall Study|Adverse Event|1|||
155422653|NCT04574999|560978544|FG001|Overall Study|Adverse Event|0|||
155422654|NCT04574999|560978543|FG000|Overall Study|Lack of Efficacy|2|||
155422655|NCT04574999|560978544|FG001|Overall Study|Lack of Efficacy|3|||
155422656|NCT04574999|560978543|FG000|Overall Study|Protocol Violation|1|||
155422657|NCT04574999|560978544|FG001|Overall Study|Protocol Violation|0|||
155422658|NCT04574999|560978543|FG000|Overall Study|Withdrawal by Subject|2|||
155422659|NCT04574999|560978544|FG001|Overall Study|Withdrawal by Subject|2|||
155422660|NCT04574999|560978543|FG000|Overall Study|Lost to Follow-up|1|||
155422661|NCT04574999|560978544|FG001|Overall Study|Lost to Follow-up|0|||
155422662|NCT04574999|560978543|FG000|Overall Study|Personal problems|1|||
155422663|NCT04574999|560978544|FG001|Overall Study|Personal problems|0|||
155422664|NCT04574999|560978543|FG000|Overall Study|Previous planned surgery|1|||
155422665|NCT04574999|560978544|FG001|Overall Study|Previous planned surgery|0|||
155422666|NCT00008385|560978546|FG000|Overall Study|Off treatment reasons not reported|79|||
155422667|NCT00008385|560978547|FG001|Overall Study|Off treatment reasons not reported|70|||
155422668|NCT00008385|560978546|FG000|Overall Study|Progressive disease|52|||
155422669|NCT00008385|560978547|FG001|Overall Study|Progressive disease|117|||
155422670|NCT00008385|560978546|FG000|Overall Study|Adverse Event|8|||
155422671|NCT00008385|560978547|FG001|Overall Study|Adverse Event|20|||
155422672|NCT00008385|560978546|FG000|Overall Study|Death|12|||
155503154|NCT03216954|561269400|FG002|Overall Study|Adverse Event|1|||
155503155|NCT03216954|561269401|FG003|Overall Study|Adverse Event|0|||
155503156|NCT03216954|561269402|FG004|Overall Study|Adverse Event|1|||
155503157|NCT03216954|561269398|FG000|Overall Study|Withdrawal by Subject|2|||
155503158|NCT03216954|561269399|FG001|Overall Study|Withdrawal by Subject|0|||
155503159|NCT03216954|561269400|FG002|Overall Study|Withdrawal by Subject|0|||
155503160|NCT03216954|561269401|FG003|Overall Study|Withdrawal by Subject|0|||
155503161|NCT03216954|561269402|FG004|Overall Study|Withdrawal by Subject|0|||
155503162|NCT03216954|561269398|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
155503163|NCT03216954|561269399|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
155503164|NCT03216954|561269400|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
155503165|NCT03216954|561269401|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
155503166|NCT03216954|561269402|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
155503167|NCT02981602|561269405|FG000|Overall Study|Adverse Event|0|||
155503168|NCT02981602|561269406|FG001|Overall Study|Adverse Event|0|||
155503169|NCT02981602|561269407|FG002|Overall Study|Adverse Event|0|||
155503170|NCT02981602|561269408|FG003|Overall Study|Adverse Event|1|||
155503171|NCT02981602|561269409|FG004|Overall Study|Adverse Event|0|||
155503172|NCT00963599|561269410|FG000|Overall Study|Adverse Event|2|||
155503173|NCT00963599|561269411|FG001|Overall Study|Adverse Event|0|||
155503174|NCT00963599|561269412|FG002|Overall Study|Adverse Event|1|||
155503175|NCT00963599|561269413|FG003|Overall Study|Adverse Event|2|||
155503176|NCT00963599|561269410|FG000|Overall Study|Lack of Efficacy|0|||
155503177|NCT00963599|561269411|FG001|Overall Study|Lack of Efficacy|2|||
155503178|NCT00963599|561269412|FG002|Overall Study|Lack of Efficacy|1|||
155503179|NCT00963599|561269413|FG003|Overall Study|Lack of Efficacy|4|||
155503180|NCT00963599|561269410|FG000|Overall Study|Lost to Follow-up|0|||
155503181|NCT00963599|561269411|FG001|Overall Study|Lost to Follow-up|1|||
155503182|NCT00963599|561269412|FG002|Overall Study|Lost to Follow-up|1|||
155503183|NCT00963599|561269413|FG003|Overall Study|Lost to Follow-up|1|||
155503184|NCT00963599|561269410|FG000|Overall Study|Protocol Violation|2|||
155503185|NCT00963599|561269411|FG001|Overall Study|Protocol Violation|2|||
155503186|NCT00963599|561269412|FG002|Overall Study|Protocol Violation|3|||
155503187|NCT00963599|561269413|FG003|Overall Study|Protocol Violation|4|||
155503188|NCT00963599|561269410|FG000|Overall Study|Withdrawal by Subject|2|||
155503189|NCT00963599|561269411|FG001|Overall Study|Withdrawal by Subject|1|||
155503190|NCT00963599|561269412|FG002|Overall Study|Withdrawal by Subject|3|||
155503191|NCT00963599|561269413|FG003|Overall Study|Withdrawal by Subject|3|||
155503192|NCT02983227|561269415|FG000|Overall Study|Adverse Event|21|||
155503193|NCT02983227|561269416|FG001|Overall Study|Adverse Event|3|||
155503194|NCT02983227|561269415|FG000|Overall Study|Death|3|||
155503195|NCT02983227|561269416|FG001|Overall Study|Death|0|||
155503196|NCT02983227|561269415|FG000|Overall Study|Lack of Efficacy|8|||
155503197|NCT02983227|561269416|FG001|Overall Study|Lack of Efficacy|1|||
155503198|NCT02983227|561269415|FG000|Overall Study|Lost to Follow-up|3|||
155503199|NCT02983227|561269416|FG001|Overall Study|Lost to Follow-up|0|||
155503200|NCT02983227|561269415|FG000|Overall Study|Multiple Reasons|2|||
155503201|NCT02983227|561269416|FG001|Overall Study|Multiple Reasons|1|||
155503202|NCT02983227|561269415|FG000|Overall Study|Physician Decision|3|||
155503203|NCT02983227|561269416|FG001|Overall Study|Physician Decision|1|||
155503204|NCT02983227|561269415|FG000|Overall Study|Withdrawal by Subject|19|||
155503205|NCT02983227|561269416|FG001|Overall Study|Withdrawal by Subject|8|||
155503206|NCT02354976|561269417|FG000|Overall Study|Other - reason not specified|1|||
155503207|NCT02354976|561269418|FG001|Overall Study|Other - reason not specified|0|||
155503208|NCT02354976|561269419|FG002|Overall Study|Other - reason not specified|1|||
155503209|NCT02354976|561269417|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
155503210|NCT02354976|561269418|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
155503211|NCT02354976|561269419|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
155503212|NCT02354976|561269417|FG000|Overall Study|Adverse Event|1|||
155503213|NCT02354976|561269418|FG001|Overall Study|Adverse Event|0|||
155503214|NCT02354976|561269419|FG002|Overall Study|Adverse Event|2|||
155503215|NCT01706770|561269420|FG000|Overall Study|Lost to Follow-up|1|||
155503216|NCT01706770|561269421|FG001|Overall Study|Lost to Follow-up|0|||
155503217|NCT01706770|561269420|FG000|Overall Study|Physician Decision|1|||
155503218|NCT01706770|561269421|FG001|Overall Study|Physician Decision|0|||
155503219|NCT00068445|561269424|FG000|Randomization|Cancel|1|||
155503220|NCT00068445|561269425|FG001|Randomization|Cancel|3|||
155503221|NCT00068445|561269424|FG000|Randomization|Ineligible|1|||
155503222|NCT00068445|561269425|FG001|Randomization|Ineligible|1|||
155422673|NCT00008385|560978547|FG001|Overall Study|Death|18|||
155422674|NCT00008385|560978546|FG000|Overall Study|Withdrawal by Subject|67|||
155422675|NCT00008385|560978547|FG001|Overall Study|Withdrawal by Subject|157|||
155422676|NCT00008385|560978546|FG000|Overall Study|Start non-protocol therapy|3|||
155422677|NCT00008385|560978547|FG001|Overall Study|Start non-protocol therapy|1|||
155422678|NCT00008385|560978546|FG000|Overall Study|Other complicating disease|17|||
155422679|NCT00008385|560978547|FG001|Overall Study|Other complicating disease|30|||
155422680|NCT00008385|560978546|FG000|Overall Study|Maximum dose reached|0|||
155422681|NCT00008385|560978547|FG001|Overall Study|Maximum dose reached|2|||
155422682|NCT00008385|560978546|FG000|Overall Study|Other|105|||
155422683|NCT00008385|560978547|FG001|Overall Study|Other|212|||
155422684|NCT00008385|560978546|FG000|Overall Study|Not start protocol therapy|44|||
155422685|NCT00008385|560978547|FG001|Overall Study|Not start protocol therapy|175|||
155422686|NCT05148884|560978548|FG000|Overall Study|Withdrawal by Subject|3|||
155422687|NCT05148884|560978549|FG001|Overall Study|Withdrawal by Subject|0|||
155422688|NCT05148884|560978548|FG000|Overall Study|Deep brain stimulation operation|0|||
155422689|NCT05148884|560978549|FG001|Overall Study|Deep brain stimulation operation|1|||
155422690|NCT00317044|560978552|FG000|Overall Study|Protocol Violation|28|||
155422691|NCT00317044|560978553|FG001|Overall Study|Protocol Violation|22|||
155422692|NCT00317044|560978554|FG002|Overall Study|Protocol Violation|20|||
155422693|NCT00317044|560978552|FG000|Overall Study|Adverse Event|4|||
155422694|NCT00317044|560978553|FG001|Overall Study|Adverse Event|7|||
155422695|NCT00317044|560978554|FG002|Overall Study|Adverse Event|4|||
155422696|NCT00317044|560978552|FG000|Overall Study|Withdrawal by Subject|10|||
155422697|NCT00317044|560978553|FG001|Overall Study|Withdrawal by Subject|7|||
155422698|NCT00317044|560978554|FG002|Overall Study|Withdrawal by Subject|12|||
155422699|NCT00317044|560978552|FG000|Overall Study|Lost to Follow-up|0|||
155422700|NCT00317044|560978553|FG001|Overall Study|Lost to Follow-up|2|||
155503223|NCT00068445|561269424|FG000|Treatment|Refused Further Treatment|13|||
155422701|NCT00317044|560978554|FG002|Overall Study|Lost to Follow-up|3|||
155422702|NCT00317044|560978552|FG000|Overall Study|Multiple Reasons|6|||
155503224|NCT00068445|561269425|FG001|Treatment|Refused Further Treatment|10|||
155422703|NCT00317044|560978553|FG001|Overall Study|Multiple Reasons|2|||
155422704|NCT00317044|560978554|FG002|Overall Study|Multiple Reasons|6|||
155422705|NCT04317690|560978557|FG000|Overall Study|did not have complete information for primary outcome|0|||
155422706|NCT04317690|560978558|FG001|Overall Study|did not have complete information for primary outcome|4|||
155422707|NCT04317690|560978559|FG002|Overall Study|did not have complete information for primary outcome|0|||
155422708|NCT04317690|560978560|FG003|Overall Study|did not have complete information for primary outcome|2|||
155422709|NCT04317690|560978561|FG004|Overall Study|did not have complete information for primary outcome|0|||
155422710|NCT01719757|560978562|FG000|Overall Study|Adverse Event|38|||
155422711|NCT01719757|560978562|FG000|Overall Study|Withdrawal by Subject|15|||
155335624|NCT04447027|560663136|FG000|Dose Escalation|Withdrawal by Subject|1|||
155335625|NCT04447027|560663137|FG001|Dose Escalation|Withdrawal by Subject|4|||
155335626|NCT04447027|560663138|FG002|Dose Escalation|Withdrawal by Subject|3|||
155335627|NCT04447027|560663139|FG003|Dose Escalation|Withdrawal by Subject|3|||
155335628|NCT04447027|560663140|FG004|Dose Escalation|Withdrawal by Subject|1|||
155335629|NCT04447027|560663141|FG005|Dose Escalation|Withdrawal by Subject|0|||
155335630|NCT04447027|560663142|FG006|Dose Escalation|Withdrawal by Subject|0|||
155335631|NCT04447027|560663143|FG007|Dose Escalation|Withdrawal by Subject|0|||
155335632|NCT04447027|560663144|FG008|Dose Escalation|Withdrawal by Subject|0|||
155335633|NCT04447027|560663136|FG000|Dose Escalation|Refused further treatment|0|||
155335634|NCT04447027|560663137|FG001|Dose Escalation|Refused further treatment|1|||
155335635|NCT04447027|560663138|FG002|Dose Escalation|Refused further treatment|1|||
155335636|NCT04447027|560663139|FG003|Dose Escalation|Refused further treatment|0|||
155335637|NCT04447027|560663140|FG004|Dose Escalation|Refused further treatment|0|||
155335638|NCT04447027|560663141|FG005|Dose Escalation|Refused further treatment|0|||
155335639|NCT04447027|560663142|FG006|Dose Escalation|Refused further treatment|0|||
155335640|NCT04447027|560663143|FG007|Dose Escalation|Refused further treatment|0|||
155335641|NCT04447027|560663144|FG008|Dose Escalation|Refused further treatment|0|||
155335642|NCT04447027|560663136|FG000|Dose Expansion|Withdrawal by Subject|0|||
155335643|NCT04447027|560663137|FG001|Dose Expansion|Withdrawal by Subject|0|||
155335644|NCT04447027|560663138|FG002|Dose Expansion|Withdrawal by Subject|0|||
155335645|NCT04447027|560663139|FG003|Dose Expansion|Withdrawal by Subject|0|||
155335646|NCT04447027|560663140|FG004|Dose Expansion|Withdrawal by Subject|0|||
155335647|NCT04447027|560663141|FG005|Dose Expansion|Withdrawal by Subject|2|||
155335648|NCT04447027|560663142|FG006|Dose Expansion|Withdrawal by Subject|0|||
155335649|NCT04447027|560663143|FG007|Dose Expansion|Withdrawal by Subject|2|||
155335650|NCT04447027|560663144|FG008|Dose Expansion|Withdrawal by Subject|0|||
155335651|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Death|4|||
155335652|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
155422712|NCT01719757|560978562|FG000|Overall Study|Lost to Follow-up|20|||
155422713|NCT01719757|560978562|FG000|Overall Study|Protocol Violation|1|||
155422714|NCT01719757|560978562|FG000|Overall Study|well controlled pain|27|||
155422715|NCT02626338|560978563|FG000|Overall Study|Lack of Efficacy|3|||
155422716|NCT02626338|560978564|FG001|Overall Study|Lack of Efficacy|2|||
155422717|NCT02626338|560978565|FG002|Overall Study|Lack of Efficacy|0|||
155422718|NCT03312218|560978571|FG000|Overall Study|Never signed in to access the app|54|||
155422719|NCT03312218|560978572|FG001|Overall Study|Never signed in to access the app|58|||
155422720|NCT01901224|560978573|FG000|Overall Study|study was not funded and terminated|2|||
155422721|NCT01254669|560978577|FG000|Overall Study|Withdrawal by Subject|0|||
155422722|NCT01254669|560978578|FG001|Overall Study|Withdrawal by Subject|1|||
155422723|NCT01254669|560978577|FG000|Overall Study|time constraint|2|||
155422724|NCT01254669|560978578|FG001|Overall Study|time constraint|2|||
155422725|NCT01254669|560978577|FG000|Overall Study|called to clinic during intervention|1|||
155422726|NCT01254669|560978578|FG001|Overall Study|called to clinic during intervention|1|||
155422727|NCT00103012|560978579|FG000|Overall Study|Withdrawal by Subject|2|||
155422728|NCT00103012|560978580|FG001|Overall Study|Withdrawal by Subject|1|||
155422729|NCT00103012|560978581|FG002|Overall Study|Withdrawal by Subject|2|||
155422730|NCT00103012|560978579|FG000|Overall Study|Pregnancy|1|||
155422731|NCT00103012|560978580|FG001|Overall Study|Pregnancy|0|||
155422732|NCT00103012|560978581|FG002|Overall Study|Pregnancy|0|||
155422733|NCT00103012|560978579|FG000|Overall Study|Adverse Event|0|||
155422734|NCT00103012|560978580|FG001|Overall Study|Adverse Event|0|||
155645662|NCT05156125|561794079|FG002|Overall Study|Physician Decision|1|||
155645663|NCT05156125|561794077|FG000|Overall Study|Non-compliance|0|||
155645664|NCT05156125|561794078|FG001|Overall Study|Non-compliance|1|||
155645665|NCT05156125|561794079|FG002|Overall Study|Non-compliance|1|||
155645666|NCT05156125|561794077|FG000|Overall Study|Withdrawal by Subject|0|||
155645667|NCT05156125|561794078|FG001|Overall Study|Withdrawal by Subject|0|||
155645668|NCT05156125|561794079|FG002|Overall Study|Withdrawal by Subject|1|||
155645669|NCT05156125|561794077|FG000|Overall Study|Adverse Event|2|||
155645670|NCT05156125|561794078|FG001|Overall Study|Adverse Event|1|||
155645671|NCT05156125|561794079|FG002|Overall Study|Adverse Event|0|||
155645672|NCT01623752|561794082|FG000|Phase 1 (78 Weeks)|No Data|249|||
155645673|NCT01623752|561794083|FG001|Phase 1 (78 Weeks)|No Data|66|||
155645674|NCT01623752|561794084|FG002|Phase 1 (78 Weeks)|No Data|2|||
155645675|NCT01623752|561794082|FG000|Phase 1 (78 Weeks)|Other|33|||
155645676|NCT01623752|561794083|FG001|Phase 1 (78 Weeks)|Other|20|||
155645677|NCT01623752|561794084|FG002|Phase 1 (78 Weeks)|Other|0|||
155645678|NCT01623752|561794082|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
155645679|NCT01623752|561794083|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
155645680|NCT01623752|561794084|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
155335653|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
155422735|NCT00103012|560978581|FG002|Overall Study|Adverse Event|1|||
155422736|NCT00103012|560978579|FG000|Overall Study|Subject non-compliant with medications|0|||
155335654|NCT04224272|560663145|FG000|Part 2 - Dose Expansion|Death|10|||
155335655|NCT04224272|560663145|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
155335656|NCT02609048|560663146|FG000|Overall Study|Adverse Event|3|||
155335657|NCT02609048|560663147|FG001|Overall Study|Adverse Event|0|||
155335658|NCT02609048|560663148|FG002|Overall Study|Adverse Event|0|||
155335659|NCT02609048|560663146|FG000|Overall Study|Randomized but never treated|1|||
155335660|NCT02609048|560663147|FG001|Overall Study|Randomized but never treated|1|||
155335661|NCT02609048|560663148|FG002|Overall Study|Randomized but never treated|1|||
155335662|NCT02609048|560663146|FG000|Overall Study|Withdrawal of informed consent|1|||
155335663|NCT02609048|560663147|FG001|Overall Study|Withdrawal of informed consent|0|||
155335664|NCT02609048|560663148|FG002|Overall Study|Withdrawal of informed consent|0|||
155503225|NCT00068445|561269424|FG000|Treatment|Adverse Event|7|||
155503226|NCT00068445|561269425|FG001|Treatment|Adverse Event|1|||
155503227|NCT00068445|561269424|FG000|Treatment|Other (Specifics not available)|9|||
155503228|NCT00068445|561269425|FG001|Treatment|Other (Specifics not available)|5|||
155503229|NCT01896700|561269426|FG000|Overall Study|Adverse Event|4|||
155503230|NCT01896700|561269427|FG001|Overall Study|Adverse Event|5|||
155503231|NCT01896700|561269426|FG000|Overall Study|Withdrawal by Subject|0|||
155503232|NCT01896700|561269427|FG001|Overall Study|Withdrawal by Subject|1|||
155503233|NCT00423488|561269428|FG000|Overall Study|No evidence of study drug intake|2|||
155503234|NCT00423488|561269429|FG001|Overall Study|No evidence of study drug intake|1|||
155503235|NCT00423488|561269428|FG000|Overall Study|No post baseline data|3|||
155503236|NCT00423488|561269429|FG001|Overall Study|No post baseline data|0|||
155503237|NCT03835975|561269430|FG000|Overall Study|Lost to Follow-up|1|||
155503238|NCT03835975|561269431|FG001|Overall Study|Lost to Follow-up|1|||
155503239|NCT03835975|561269432|FG002|Overall Study|Lost to Follow-up|0|||
155503240|NCT03835975|561269433|FG003|Overall Study|Lost to Follow-up|0|||
155503241|NCT03835975|561269434|FG004|Overall Study|Lost to Follow-up|0|||
155503242|NCT03835975|561269430|FG000|Overall Study|No longer met eligibility criteria|0|||
155503243|NCT03835975|561269431|FG001|Overall Study|No longer met eligibility criteria|1|||
155503244|NCT03835975|561269432|FG002|Overall Study|No longer met eligibility criteria|0|||
155503245|NCT03835975|561269433|FG003|Overall Study|No longer met eligibility criteria|0|||
155503246|NCT03835975|561269434|FG004|Overall Study|No longer met eligibility criteria|0|||
155503247|NCT03835975|561269430|FG000|Overall Study|Protocol Violation|1|||
155503248|NCT03835975|561269431|FG001|Overall Study|Protocol Violation|1|||
155503249|NCT03835975|561269432|FG002|Overall Study|Protocol Violation|2|||
155503250|NCT03835975|561269433|FG003|Overall Study|Protocol Violation|0|||
155503251|NCT03835975|561269434|FG004|Overall Study|Protocol Violation|0|||
155503252|NCT03835975|561269430|FG000|Overall Study|Withdrawal by Subject|1|||
155503253|NCT03835975|561269431|FG001|Overall Study|Withdrawal by Subject|0|||
155503254|NCT03835975|561269432|FG002|Overall Study|Withdrawal by Subject|1|||
155335665|NCT02609048|560663146|FG000|Overall Study|Reason not specified|6|||
155335666|NCT02609048|560663147|FG001|Overall Study|Reason not specified|9|||
155503255|NCT03835975|561269433|FG003|Overall Study|Withdrawal by Subject|1|||
155503256|NCT03835975|561269434|FG004|Overall Study|Withdrawal by Subject|0|||
155503257|NCT01612702|561269437|FG000|Overall Study|Protocol Violation|11|||
155503258|NCT01612702|561269438|FG001|Overall Study|Protocol Violation|11|||
155503259|NCT03070431|561269439|FG000|Overall Study|Withdrawal by Subject|2|||
155503260|NCT03070431|561269439|FG000|Overall Study|Lost to Follow-up|2|||
155503261|NCT03674827|561269442|FG000|Treatment Phase|Adverse Event|0|||
155503262|NCT03674827|561269443|FG001|Treatment Phase|Adverse Event|0|||
155503263|NCT03674827|561269444|FG002|Treatment Phase|Adverse Event|0|||
155503264|NCT03674827|561269445|FG003|Treatment Phase|Adverse Event|0|||
155503265|NCT03674827|561269446|FG004|Treatment Phase|Adverse Event|0|||
155503266|NCT03674827|561269447|FG005|Treatment Phase|Adverse Event|2|||
155503267|NCT03674827|561269442|FG000|Treatment Phase|Death|2|||
155503268|NCT03674827|561269443|FG001|Treatment Phase|Death|0|||
155503269|NCT03674827|561269444|FG002|Treatment Phase|Death|0|||
155503270|NCT03674827|561269445|FG003|Treatment Phase|Death|0|||
155503271|NCT03674827|561269446|FG004|Treatment Phase|Death|1|||
155503272|NCT03674827|561269447|FG005|Treatment Phase|Death|0|||
155503273|NCT03674827|561269442|FG000|Treatment Phase|Progressive Disease|0|||
155503274|NCT03674827|561269443|FG001|Treatment Phase|Progressive Disease|4|||
155503275|NCT03674827|561269444|FG002|Treatment Phase|Progressive Disease|3|||
155503276|NCT03674827|561269445|FG003|Treatment Phase|Progressive Disease|4|||
155503277|NCT03674827|561269446|FG004|Treatment Phase|Progressive Disease|4|||
155503278|NCT03674827|561269447|FG005|Treatment Phase|Progressive Disease|9|||
155503279|NCT03674827|561269442|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
155503280|NCT03674827|561269443|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
155503281|NCT03674827|561269444|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
155503282|NCT03674827|561269445|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
155503283|NCT03674827|561269446|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
155503284|NCT03674827|561269447|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
155503285|NCT03674827|561269442|FG000|Treatment Phase|Withdrawal by Subject|0|||
155503286|NCT03674827|561269443|FG001|Treatment Phase|Withdrawal by Subject|0|||
155503287|NCT03674827|561269444|FG002|Treatment Phase|Withdrawal by Subject|0|||
155503288|NCT03674827|561269445|FG003|Treatment Phase|Withdrawal by Subject|0|||
155503289|NCT03674827|561269446|FG004|Treatment Phase|Withdrawal by Subject|0|||
155503290|NCT03674827|561269447|FG005|Treatment Phase|Withdrawal by Subject|1|||
155503291|NCT03674827|561269442|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
155503292|NCT03674827|561269443|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
155503293|NCT03674827|561269444|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
155503294|NCT03674827|561269445|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
155503295|NCT03674827|561269446|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
155503296|NCT03674827|561269447|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
155503297|NCT03674827|561269442|FG000|Treatment Phase|Other|0|||
155503298|NCT03674827|561269443|FG001|Treatment Phase|Other|1|||
155503299|NCT03674827|561269444|FG002|Treatment Phase|Other|0|||
155503300|NCT03674827|561269445|FG003|Treatment Phase|Other|0|||
155503301|NCT03674827|561269446|FG004|Treatment Phase|Other|0|||
155503302|NCT03674827|561269447|FG005|Treatment Phase|Other|1|||
155503303|NCT03674827|561269442|FG000|Long-Term Follow-up Phase|Death|2|||
155503304|NCT03674827|561269443|FG001|Long-Term Follow-up Phase|Death|4|||
155503305|NCT03674827|561269444|FG002|Long-Term Follow-up Phase|Death|2|||
155503306|NCT03674827|561269445|FG003|Long-Term Follow-up Phase|Death|3|||
155503307|NCT03674827|561269446|FG004|Long-Term Follow-up Phase|Death|2|||
155503308|NCT03674827|561269447|FG005|Long-Term Follow-up Phase|Death|6|||
155503309|NCT03674827|561269442|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
155503310|NCT03674827|561269443|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
155503311|NCT03674827|561269444|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
155503312|NCT03674827|561269445|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
155503313|NCT03674827|561269446|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
155503314|NCT03674827|561269447|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
155503315|NCT03674827|561269442|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
155503316|NCT03674827|561269443|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
155503317|NCT03674827|561269444|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
155503318|NCT03674827|561269445|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
155503319|NCT03674827|561269446|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
155503320|NCT03674827|561269447|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
155503321|NCT00527397|561269448|FG000|Overall Study|Adverse Event|3|||
155503322|NCT00527397|561269448|FG000|Overall Study|Lack of Efficacy|1|||
155645681|NCT01623752|561794082|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
155645682|NCT01623752|561794083|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
155645683|NCT01623752|561794084|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
155503323|NCT00527397|561269448|FG000|Overall Study|Protocol Violation|1|||
155503324|NCT00527397|561269448|FG000|Overall Study|Withdrawal by Subject|6|||
155503325|NCT00527397|561269448|FG000|Overall Study|Study terminated by sponsor|13|||
155503326|NCT00370396|561269456|FG000|Overall Study|Withdrawal by Subject|0|||
155503327|NCT00370396|561269457|FG001|Overall Study|Withdrawal by Subject|0|||
155503328|NCT00370396|561269458|FG002|Overall Study|Withdrawal by Subject|1|||
155503329|NCT00370396|561269456|FG000|Overall Study|Lost to Follow-up|11|||
155503330|NCT00370396|561269457|FG001|Overall Study|Lost to Follow-up|1|||
155503331|NCT00370396|561269458|FG002|Overall Study|Lost to Follow-up|0|||
155503332|NCT02065791|561269459|FG000|Overall Study|Closed Site|1|||
155503333|NCT02065791|561269460|FG001|Overall Study|Closed Site|1|||
155503334|NCT02065791|561269459|FG000|Overall Study|Withdrawal by Subject|11|||
155503335|NCT02065791|561269460|FG001|Overall Study|Withdrawal by Subject|5|||
155503336|NCT02065791|561269459|FG000|Overall Study|Lost to Follow-up|13|||
155503337|NCT02065791|561269460|FG001|Overall Study|Lost to Follow-up|9|||
155503338|NCT02702271|561269463|FG000|Overall Study|Death|36|||
155503339|NCT02702271|561269464|FG001|Overall Study|Death|7|||
155503340|NCT02702271|561269463|FG000|Overall Study|Lost to Follow-up|12|||
155503341|NCT02702271|561269464|FG001|Overall Study|Lost to Follow-up|0|||
155503342|NCT02702271|561269463|FG000|Overall Study|Withdrawal by Subject|8|||
155503343|NCT02702271|561269464|FG001|Overall Study|Withdrawal by Subject|1|||
155503344|NCT02702271|561269463|FG000|Overall Study|Physician Decision|2|||
155503345|NCT02702271|561269464|FG001|Overall Study|Physician Decision|0|||
155503346|NCT02702271|561269463|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
155503347|NCT02702271|561269464|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
155503348|NCT01494649|561269465|FG000|Overall Study|Lost to Follow-up|0|||
155503349|NCT01494649|561269466|FG001|Overall Study|Lost to Follow-up|1|||
155503350|NCT03467971|561269467|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155503351|NCT03467971|561269468|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155503352|NCT03707522|561269471|FG000|Overall Study|Lost to Follow-up|24|||
155503353|NCT03707522|561269472|FG001|Overall Study|Lost to Follow-up|27|||
155503354|NCT03707522|561269473|FG002|Overall Study|Lost to Follow-up|41|||
155503355|NCT03707522|561269474|FG003|Overall Study|Lost to Follow-up|36|||
155503356|NCT00383019|561269475|FG000|Overall Study|Adverse Event|5|||
155503357|NCT00383019|561269476|FG001|Overall Study|Adverse Event|1|||
155503358|NCT00383019|561269475|FG000|Overall Study|Withdrawal by Subject|0|||
155503359|NCT00383019|561269476|FG001|Overall Study|Withdrawal by Subject|1|||
155503360|NCT01619085|561269480|FG000|Overall Study|Adverse Event|231|||
155503361|NCT01619085|561269480|FG000|Overall Study|Protocol Violation|4|||
155503362|NCT01619085|561269480|FG000|Overall Study|Lost to Follow-up|3|||
155503363|NCT01619085|561269480|FG000|Overall Study|Withdrawal by Subject|45|||
155503364|NCT01619085|561269480|FG000|Overall Study|Other than specified|96|||
155503365|NCT01619085|561269480|FG000|Overall Study|Not treated|1|||
155503366|NCT01619085|561269480|FG000|Overall Study|Death|145|||
155503367|NCT01345058|561269481|FG000|Overall Study|Withdrawal by Subject|1|||
155503368|NCT01345058|561269482|FG001|Overall Study|Withdrawal by Subject|0|||
155503369|NCT01345058|561269481|FG000|Overall Study|Participant Reported Increase in Events|1|||
155503370|NCT01345058|561269482|FG001|Overall Study|Participant Reported Increase in Events|0|||
155503371|NCT01345058|561269481|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
155503372|NCT01345058|561269482|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
155503373|NCT01345058|561269481|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
155335667|NCT02609048|560663148|FG002|Overall Study|Reason not specified|9|||
155335668|NCT04118894|560663154|FG000|Overall Study|Lost to Follow-up|21|||
155335669|NCT04118894|560663154|FG000|Overall Study|Withdrawal by Subject|10|||
155335670|NCT04118894|560663154|FG000|Overall Study|Adverse Event|4|||
155335671|NCT04992273|560664737|FG000|Overall Study|Lost to Follow-up|0|||
155335672|NCT04992273|560664738|FG001|Overall Study|Lost to Follow-up|1|||
155335673|NCT00670449|560664739|FG000|Overall Study|Adverse Event|6|||
155335674|NCT00670449|560664740|FG001|Overall Study|Adverse Event|2|||
155335675|NCT00670449|560664741|FG002|Overall Study|Adverse Event|8|||
155335676|NCT00670449|560664742|FG003|Overall Study|Adverse Event|5|||
155335677|NCT00670449|560664739|FG000|Overall Study|Protocol Deviation|1|||
155335678|NCT00670449|560664740|FG001|Overall Study|Protocol Deviation|2|||
155335679|NCT00670449|560664741|FG002|Overall Study|Protocol Deviation|0|||
155335680|NCT00670449|560664742|FG003|Overall Study|Protocol Deviation|1|||
155335681|NCT00670449|560664739|FG000|Overall Study|Administrative Problems|0|||
155335682|NCT00670449|560664740|FG001|Overall Study|Administrative Problems|2|||
155335683|NCT00670449|560664741|FG002|Overall Study|Administrative Problems|0|||
155335684|NCT00670449|560664742|FG003|Overall Study|Administrative Problems|1|||
155335685|NCT00670449|560664739|FG000|Overall Study|Subject Withdrew Consent|0|||
155335686|NCT00670449|560664740|FG001|Overall Study|Subject Withdrew Consent|2|||
155335687|NCT00670449|560664741|FG002|Overall Study|Subject Withdrew Consent|0|||
155335688|NCT00670449|560664742|FG003|Overall Study|Subject Withdrew Consent|1|||
155335689|NCT00670449|560664739|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
155335690|NCT00670449|560664740|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155335691|NCT00670449|560664741|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155335692|NCT00670449|560664742|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155335693|NCT00670449|560664739|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155422737|NCT00103012|560978580|FG001|Overall Study|Subject non-compliant with medications|0|||
155422738|NCT00103012|560978581|FG002|Overall Study|Subject non-compliant with medications|1|||
155422739|NCT05211336|560978584|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
155422740|NCT05211336|560978585|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
155422741|NCT05211336|560978584|FG000|Overall Study|Progressive disease|0|||
155422742|NCT05211336|560978585|FG001|Overall Study|Progressive disease|4|||
155422743|NCT05211336|560978584|FG000|Overall Study|Death due to myocardial infarction|0|||
155422744|NCT05211336|560978585|FG001|Overall Study|Death due to myocardial infarction|1|||
155422745|NCT05211336|560978584|FG000|Overall Study|Death due to unknown cause|0|||
155422746|NCT05211336|560978585|FG001|Overall Study|Death due to unknown cause|1|||
155503374|NCT01345058|561269482|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
155503375|NCT01345058|561269481|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
155503376|NCT01345058|561269482|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
155503377|NCT00000135|561269483|FG000|Overall Study|Death|27|||
155503378|NCT00000135|561269484|FG001|Overall Study|Death|14|||
155503379|NCT00833976|561270721|FG000|Overall Study|Withdrawal by Subject|5|||
155503380|NCT00833976|561270721|FG000|Overall Study|Lost to Follow-up|4|||
155422747|NCT05211336|560978584|FG000|Overall Study|Worsening kidney function and quality of response|0|||
155503381|NCT00833976|561270721|FG000|Overall Study|Did not meet eligibility criteria|41|||
155503382|NCT00833976|561270721|FG000|Overall Study|Physician Decision|1|||
155503383|NCT00681824|561270724|FG000|Overall Study|withdrawn by investigator|0|||
155503384|NCT00681824|561270725|FG001|Overall Study|withdrawn by investigator|0|||
155503385|NCT00681824|561270726|FG002|Overall Study|withdrawn by investigator|1|||
155503386|NCT00681824|561270724|FG000|Overall Study|scheduling conflict|1|||
155503387|NCT00681824|561270725|FG001|Overall Study|scheduling conflict|0|||
155503388|NCT00681824|561270726|FG002|Overall Study|scheduling conflict|0|||
155503389|NCT00681824|561270724|FG000|Overall Study|Death|0|||
155503390|NCT00681824|561270725|FG001|Overall Study|Death|1|||
155503391|NCT00681824|561270726|FG002|Overall Study|Death|0|||
155503392|NCT03101293|561270730|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
155503393|NCT03101293|561270731|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
155503394|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
155503395|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
155503396|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
155503397|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
155503398|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
155503399|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
155503400|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
155503401|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
155503402|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155503403|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155503404|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
155503405|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155503406|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155503407|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155503408|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155503409|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
155503410|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
155503411|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
155503412|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
155503413|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
155503414|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
155503415|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
155503416|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
155503417|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
155503418|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
155503419|NCT04682639|561270732|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
155503420|NCT04682639|561270733|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
155503421|NCT04682639|561270734|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
155503422|NCT04682639|561270735|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155503423|NCT04682639|561270736|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155503424|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
155503425|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
155503426|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
155503427|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
155503428|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
155503429|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Other|1|||
155503430|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Other|2|||
155503431|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Other|0|||
155503432|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Other|0|||
155503433|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Other|1|||
155503434|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
155503435|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
155503436|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
155503437|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
155335694|NCT00670449|560664740|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
155335695|NCT00670449|560664741|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155335696|NCT00670449|560664742|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155335697|NCT02771366|560664743|FG000|Period 1|Withdrawal by Subject|0|||
155335698|NCT02771366|560664744|FG001|Period 1|Withdrawal by Subject|2|||
155335699|NCT02771366|560664743|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
155503438|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
155503439|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
155503440|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
155503441|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155335700|NCT02771366|560664744|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
155335701|NCT01823224|560664745|FG000|Overall Study|Lost to Follow-up|5|||
155503442|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155503443|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155503444|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
155503445|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
155503446|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155503447|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155503448|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155503449|NCT04682639|561270732|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
155503450|NCT04682639|561270733|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
155503451|NCT04682639|561270734|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
155503452|NCT04682639|561270735|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
155503453|NCT04682639|561270736|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
155503454|NCT00763269|561270737|FG000|Overall Study|Lost to Follow-up|12|||
155503455|NCT00763269|561270738|FG001|Overall Study|Lost to Follow-up|13|||
155503456|NCT03333382|561270739|FG000|Overall Study|Lost to Follow-up|1|||
155503457|NCT03333382|561270740|FG001|Overall Study|Lost to Follow-up|0|||
155503458|NCT03451331|561270741|FG000|Overall Study|Withdrawal by Subject|1|||
155503459|NCT03451331|561270742|FG001|Overall Study|Withdrawal by Subject|0|||
155503460|NCT03451331|561270741|FG000|Overall Study|Unable to start treatment.|1|||
155503461|NCT03451331|561270742|FG001|Overall Study|Unable to start treatment.|1|||
155503462|NCT04736576|561270747|FG000|Overall Study|Progressive disease|3|||
155503463|NCT04736576|561270748|FG001|Overall Study|Progressive disease|1|||
155503464|NCT04736576|561270747|FG000|Overall Study|Death|1|||
155503465|NCT04736576|561270748|FG001|Overall Study|Death|0|||
155503466|NCT00720304|561270752|FG000|Overall Study|Withdrawal by Subject|14|||
155503467|NCT00720304|561270753|FG001|Overall Study|Withdrawal by Subject|1|||
155503468|NCT00720304|561270752|FG000|Overall Study|Death|1|||
155503469|NCT00720304|561270753|FG001|Overall Study|Death|0|||
155503470|NCT00720304|561270752|FG000|Overall Study|Physician Decision|5|||
155503471|NCT00720304|561270753|FG001|Overall Study|Physician Decision|2|||
155503472|NCT00720304|561270752|FG000|Overall Study|Adverse Event|3|||
155503473|NCT00720304|561270753|FG001|Overall Study|Adverse Event|1|||
155503474|NCT00720304|561270752|FG000|Overall Study|Disease progression|6|||
155503475|NCT00720304|561270753|FG001|Overall Study|Disease progression|1|||
155335702|NCT01823224|560664746|FG001|Overall Study|Lost to Follow-up|6|||
155335703|NCT01823224|560664745|FG000|Overall Study|didn't qualify|1|||
155335704|NCT01823224|560664746|FG001|Overall Study|didn't qualify|2|||
155335705|NCT01823224|560664745|FG000|Overall Study|pharmacy error|0|||
155335706|NCT01823224|560664746|FG001|Overall Study|pharmacy error|1|||
155335707|NCT01823224|560664745|FG000|Overall Study|missed med dose|0|||
155335708|NCT01823224|560664746|FG001|Overall Study|missed med dose|1|||
155335709|NCT01823224|560664745|FG000|Overall Study|Withdrawal by Subject|0|||
155335710|NCT01823224|560664746|FG001|Overall Study|Withdrawal by Subject|1|||
155503476|NCT04330482|561270756|FG000|Overall Study|Lost to Follow-up|2|||
155503477|NCT04330482|561270757|FG001|Overall Study|Lost to Follow-up|1|||
155503478|NCT04330482|561270756|FG000|Overall Study|Withdrawal by Subject|0|||
155503479|NCT04330482|561270757|FG001|Overall Study|Withdrawal by Subject|3|||
155503480|NCT05180630|561270758|FG000|First Intervention|Physician Decision|0|||
155503481|NCT05180630|561270759|FG001|First Intervention|Physician Decision|0|||
155335711|NCT01779050|560664749|FG000|Overall Study|Withdrawal by Subject|1|||
155335712|NCT01779050|560664750|FG001|Overall Study|Withdrawal by Subject|0|||
155335713|NCT00022672|560664751|FG000|Main Phase: 24 Months|Adverse Event|6|||
155335714|NCT00022672|560664752|FG001|Main Phase: 24 Months|Adverse Event|0|||
155335715|NCT00022672|560664751|FG000|Main Phase: 24 Months|Death|0|||
155335716|NCT00022672|560664752|FG001|Main Phase: 24 Months|Death|3|||
155335717|NCT00022672|560664751|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
155335718|NCT00022672|560664752|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
155335719|NCT00022672|560664751|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
155335720|NCT00022672|560664752|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
155335721|NCT00022672|560664751|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
155335722|NCT00022672|560664752|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
155335723|NCT00022672|560664751|FG000|Main Phase: 24 Months|Refused Treatment|3|||
155335724|NCT00022672|560664752|FG001|Main Phase: 24 Months|Refused Treatment|4|||
155335725|NCT00022672|560664751|FG000|Main Phase: 24 Months|Failure to Return|1|||
155335726|NCT00022672|560664752|FG001|Main Phase: 24 Months|Failure to Return|1|||
155335727|NCT00022672|560664751|FG000|Main Phase: 24 Months|Other|1|||
155335728|NCT00022672|560664752|FG001|Main Phase: 24 Months|Other|0|||
155335729|NCT00022672|560664751|FG000|Extension Phase|Adverse Event|1|||
155335730|NCT00022672|560664752|FG001|Extension Phase|Adverse Event|3|||
155335731|NCT00022672|560664751|FG000|Extension Phase|Death|0|||
155645684|NCT01623752|561794082|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
155645685|NCT01623752|561794083|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
155335732|NCT00022672|560664752|FG001|Extension Phase|Death|1|||
155335733|NCT00022672|560664751|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
155335734|NCT00022672|560664752|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
155335735|NCT00022672|560664751|FG000|Extension Phase|Refused Treatment|0|||
155335736|NCT00022672|560664752|FG001|Extension Phase|Refused Treatment|2|||
155335737|NCT00022672|560664751|FG000|Extension Phase|Other|1|||
155335738|NCT00022672|560664752|FG001|Extension Phase|Other|1|||
155335739|NCT03648541|560664753|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
155335740|NCT03648541|560664754|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
155335741|NCT03648541|560664753|FG000|Re-induction Period Only|Lack of Efficacy|7|||
155335742|NCT03648541|560664754|FG001|Re-induction Period Only|Lack of Efficacy|0|||
155335743|NCT03648541|560664753|FG000|Maintenance Period Only|Missing|0|||
155335744|NCT03648541|560664754|FG001|Maintenance Period Only|Missing|1|||
155335745|NCT03648541|560664753|FG000|Maintenance Period Only|Other not listed below|0|||
155335746|NCT03648541|560664754|FG001|Maintenance Period Only|Other not listed below|4|||
155335747|NCT03648541|560664753|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
155335748|NCT03648541|560664754|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
155335749|NCT03648541|560664753|FG000|Maintenance Period Only|Protocol Violation|0|||
155335750|NCT03648541|560664754|FG001|Maintenance Period Only|Protocol Violation|1|||
155335751|NCT03648541|560664753|FG000|Maintenance Period Only|Lack of Efficacy|0|||
155335752|NCT03648541|560664754|FG001|Maintenance Period Only|Lack of Efficacy|18|||
155335753|NCT03648541|560664753|FG000|Maintenance Period Only|Adverse Event|0|||
155335754|NCT03648541|560664754|FG001|Maintenance Period Only|Adverse Event|4|||
155335755|NCT03648541|560664753|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
155422748|NCT05211336|560978585|FG001|Overall Study|Worsening kidney function and quality of response|1|||
155422749|NCT00393718|560978593|FG000|Overall Study|Adverse Event|20|||
155422750|NCT00393718|560978594|FG001|Overall Study|Adverse Event|8|||
155422751|NCT00393718|560978593|FG000|Overall Study|Protocol Violation|1|||
155422752|NCT00393718|560978594|FG001|Overall Study|Protocol Violation|2|||
155422753|NCT00393718|560978593|FG000|Overall Study|Lack of Efficacy|10|||
155422754|NCT00393718|560978594|FG001|Overall Study|Lack of Efficacy|9|||
155422755|NCT00393718|560978593|FG000|Overall Study|Hypoglycaemia|3|||
155422756|NCT00393718|560978594|FG001|Overall Study|Hypoglycaemia|2|||
155422757|NCT00393718|560978593|FG000|Overall Study|Subject decision|5|||
155422758|NCT00393718|560978594|FG001|Overall Study|Subject decision|0|||
155422759|NCT00393718|560978593|FG000|Overall Study|Withdrawal of consent|2|||
155422760|NCT00393718|560978594|FG001|Overall Study|Withdrawal of consent|1|||
155422761|NCT00393718|560978593|FG000|Overall Study|Missed measurement|1|||
155422762|NCT00393718|560978594|FG001|Overall Study|Missed measurement|0|||
155422763|NCT00393718|560978593|FG000|Overall Study|Move|1|||
155422764|NCT00393718|560978594|FG001|Overall Study|Move|0|||
155422765|NCT01084551|560978596|FG000|Overall Study|Adverse Event|2|||
155422766|NCT01084551|560978597|FG001|Overall Study|Adverse Event|9|||
155422767|NCT01084551|560978598|FG002|Overall Study|Adverse Event|4|||
155422768|NCT01084551|560978596|FG000|Overall Study|Lack of Efficacy|2|||
155422769|NCT01084551|560978597|FG001|Overall Study|Lack of Efficacy|0|||
155422770|NCT01084551|560978598|FG002|Overall Study|Lack of Efficacy|1|||
155422771|NCT01084551|560978596|FG000|Overall Study|Withdrawal by Subject|2|||
155645686|NCT01623752|561794084|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
155645687|NCT01623752|561794082|FG000|Phase 2 (78 Weeks)|Other|5|||
155645688|NCT01623752|561794083|FG001|Phase 2 (78 Weeks)|Other|1|||
155645689|NCT01623752|561794084|FG002|Phase 2 (78 Weeks)|Other|0|||
155645690|NCT01623752|561794082|FG000|Phase 2 (78 Weeks)|No Data|43|||
155645691|NCT01623752|561794083|FG001|Phase 2 (78 Weeks)|No Data|11|||
155645692|NCT01623752|561794084|FG002|Phase 2 (78 Weeks)|No Data|0|||
155645693|NCT01623752|561794082|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
155645694|NCT01623752|561794083|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
155645695|NCT01623752|561794084|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
155645696|NCT01755637|561794085|FG000|Period 1|Adverse Event|0|||
155645697|NCT01755637|561794086|FG001|Period 1|Adverse Event|1|||
155645698|NCT04389671|561794087|FG000|Overall Study|Death|7|||
155645699|NCT03338023|561794088|FG000|Overall Study|Withdrawal by Subject|3|||
155645700|NCT03338023|561794089|FG001|Overall Study|Withdrawal by Subject|4|||
155645701|NCT03338023|561794088|FG000|Overall Study|Protocol Violation|3|||
155645702|NCT03338023|561794089|FG001|Overall Study|Protocol Violation|3|||
155645703|NCT03338023|561794088|FG000|Overall Study|Lost to Follow-up|2|||
155645704|NCT03338023|561794089|FG001|Overall Study|Lost to Follow-up|1|||
155645705|NCT03338023|561794088|FG000|Overall Study|Physician Decision|1|||
155645706|NCT03338023|561794089|FG001|Overall Study|Physician Decision|2|||
155645707|NCT03412890|561794090|FG000|Overall Study|Adverse Event|5|||
155645708|NCT03412890|561794091|FG001|Overall Study|Adverse Event|5|||
155645709|NCT03412890|561794092|FG002|Overall Study|Adverse Event|9|||
155645710|NCT03412890|561794090|FG000|Overall Study|Protocol deviation|2|||
155645711|NCT03412890|561794091|FG001|Overall Study|Protocol deviation|1|||
155645712|NCT03412890|561794092|FG002|Overall Study|Protocol deviation|2|||
155645713|NCT03412890|561794090|FG000|Overall Study|Lost to Follow-up|7|||
155645714|NCT03412890|561794091|FG001|Overall Study|Lost to Follow-up|10|||
155645715|NCT03412890|561794092|FG002|Overall Study|Lost to Follow-up|10|||
155645716|NCT03412890|561794090|FG000|Overall Study|Withdrawal by Subject|9|||
155645717|NCT03412890|561794091|FG001|Overall Study|Withdrawal by Subject|12|||
155645718|NCT03412890|561794092|FG002|Overall Study|Withdrawal by Subject|11|||
155645719|NCT03412890|561794090|FG000|Overall Study|Lack of Efficacy|2|||
155645720|NCT03412890|561794091|FG001|Overall Study|Lack of Efficacy|7|||
155645721|NCT03412890|561794092|FG002|Overall Study|Lack of Efficacy|5|||
155645722|NCT03412890|561794090|FG000|Overall Study|Other|5|||
155645723|NCT03412890|561794091|FG001|Overall Study|Other|6|||
155335756|NCT03648541|560664754|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
155335757|NCT00273052|560664755|FG000|Overall Study|Withdrawal by Subject|16|||
155335758|NCT00273052|560664756|FG001|Overall Study|Withdrawal by Subject|19|||
155335759|NCT00273052|560664755|FG000|Overall Study|Adverse Event|21|||
155335760|NCT00273052|560664756|FG001|Overall Study|Adverse Event|19|||
155335761|NCT00273052|560664755|FG000|Overall Study|Protocol Violation|14|||
155335762|NCT00273052|560664756|FG001|Overall Study|Protocol Violation|18|||
155335763|NCT00273052|560664755|FG000|Overall Study|Lost to Follow-up|7|||
155335764|NCT00273052|560664756|FG001|Overall Study|Lost to Follow-up|25|||
155335765|NCT00273052|560664755|FG000|Overall Study|Lack of Efficacy|6|||
155335766|NCT00273052|560664756|FG001|Overall Study|Lack of Efficacy|4|||
155335767|NCT00273052|560664755|FG000|Overall Study|Non-Compliance|3|||
155335768|NCT00273052|560664756|FG001|Overall Study|Non-Compliance|1|||
155422772|NCT01084551|560978597|FG001|Overall Study|Withdrawal by Subject|1|||
155422773|NCT01084551|560978598|FG002|Overall Study|Withdrawal by Subject|0|||
155422774|NCT01084551|560978596|FG000|Overall Study|Protocol Violation|2|||
155422775|NCT01084551|560978597|FG001|Overall Study|Protocol Violation|4|||
155422776|NCT01084551|560978598|FG002|Overall Study|Protocol Violation|0|||
155422777|NCT01084551|560978596|FG000|Overall Study|Lost to Follow-up|0|||
155422778|NCT01084551|560978597|FG001|Overall Study|Lost to Follow-up|0|||
155422779|NCT01084551|560978598|FG002|Overall Study|Lost to Follow-up|3|||
155422780|NCT01084551|560978596|FG000|Overall Study|Physician Decision|1|||
155422781|NCT01084551|560978597|FG001|Overall Study|Physician Decision|0|||
155422782|NCT01084551|560978598|FG002|Overall Study|Physician Decision|0|||
155422783|NCT03902080|560978599|FG000|Overall Study|Adverse Event|17|||
155422784|NCT03902080|560978600|FG001|Overall Study|Adverse Event|15|||
155335769|NCT00273052|560664755|FG000|Overall Study|Other|2|||
155422785|NCT03902080|560978599|FG000|Overall Study|Withdrawal by Subject|28|||
155422786|NCT03902080|560978600|FG001|Overall Study|Withdrawal by Subject|35|||
155422787|NCT03902080|560978599|FG000|Overall Study|Lost to Follow-up|6|||
155503482|NCT05180630|561270760|FG002|First Intervention|Physician Decision|3|||
155503483|NCT00996918|561270761|FG000|Overall Study|Lack of Efficacy|1|||
155503484|NCT00996918|561270762|FG001|Overall Study|Lack of Efficacy|1|||
155503485|NCT00996918|561270763|FG002|Overall Study|Lack of Efficacy|2|||
155503486|NCT00996918|561270764|FG003|Overall Study|Lack of Efficacy|2|||
155503487|NCT00996918|561270765|FG004|Overall Study|Lack of Efficacy|0|||
155503488|NCT00996918|561270761|FG000|Overall Study|Adverse Event|2|||
155503489|NCT00996918|561270762|FG001|Overall Study|Adverse Event|5|||
155503490|NCT00996918|561270763|FG002|Overall Study|Adverse Event|2|||
155503491|NCT00996918|561270764|FG003|Overall Study|Adverse Event|6|||
155503492|NCT00996918|561270765|FG004|Overall Study|Adverse Event|0|||
155503493|NCT00996918|561270761|FG000|Overall Study|Withdrawal by Subject|1|||
155503494|NCT00996918|561270762|FG001|Overall Study|Withdrawal by Subject|4|||
155503495|NCT00996918|561270763|FG002|Overall Study|Withdrawal by Subject|3|||
155503496|NCT00996918|561270764|FG003|Overall Study|Withdrawal by Subject|3|||
155503497|NCT00996918|561270765|FG004|Overall Study|Withdrawal by Subject|2|||
155503498|NCT00996918|561270761|FG000|Overall Study|Physician Decision|1|||
155503499|NCT00996918|561270762|FG001|Overall Study|Physician Decision|0|||
155503500|NCT00996918|561270763|FG002|Overall Study|Physician Decision|0|||
155503501|NCT00996918|561270764|FG003|Overall Study|Physician Decision|0|||
155503502|NCT00996918|561270765|FG004|Overall Study|Physician Decision|0|||
155503503|NCT00996918|561270761|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
155503504|NCT00996918|561270762|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
155503505|NCT00996918|561270763|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
155503506|NCT00996918|561270764|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
155503507|NCT00996918|561270765|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
155503508|NCT00996918|561270761|FG000|Overall Study|Loss of Caregiver|0|||
155503509|NCT00996918|561270762|FG001|Overall Study|Loss of Caregiver|1|||
155503510|NCT00996918|561270763|FG002|Overall Study|Loss of Caregiver|0|||
155503511|NCT00996918|561270764|FG003|Overall Study|Loss of Caregiver|0|||
155503512|NCT00996918|561270765|FG004|Overall Study|Loss of Caregiver|0|||
155503513|NCT00996918|561270761|FG000|Overall Study|Other|3|||
155503514|NCT00996918|561270762|FG001|Overall Study|Other|1|||
155503515|NCT00996918|561270763|FG002|Overall Study|Other|0|||
155503516|NCT00996918|561270764|FG003|Overall Study|Other|0|||
155503517|NCT00996918|561270765|FG004|Overall Study|Other|0|||
155503518|NCT01333475|561270768|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
155503519|NCT01333475|561270769|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
155503520|NCT01333475|561270768|FG000|Overall Study|Toxicity|1|||
155503521|NCT01333475|561270769|FG001|Overall Study|Toxicity|3|||
155503522|NCT04440007|561270770|FG000|Overall Study|Adverse Event|0|||
155503523|NCT04440007|561270771|FG001|Overall Study|Adverse Event|1|||
155503524|NCT04440007|561270770|FG000|Overall Study|Lost to Follow-up|1|||
155503525|NCT04440007|561270771|FG001|Overall Study|Lost to Follow-up|3|||
155503526|NCT04440007|561270770|FG000|Overall Study|Death|7|||
155503527|NCT04440007|561270771|FG001|Overall Study|Death|2|||
155503528|NCT04440007|561270770|FG000|Overall Study|Physician Decision|1|||
155503529|NCT04440007|561270771|FG001|Overall Study|Physician Decision|1|||
155503530|NCT04440007|561270770|FG000|Overall Study|Withdrawal by Subject|2|||
155503531|NCT04440007|561270771|FG001|Overall Study|Withdrawal by Subject|1|||
155503532|NCT04440007|561270770|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
155503533|NCT04440007|561270771|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
155503534|NCT04440007|561270770|FG000|Overall Study|Discontinued prior to dosing|0|||
155503535|NCT04440007|561270771|FG001|Overall Study|Discontinued prior to dosing|2|||
155503536|NCT01466673|561270772|FG000|Overall Study|Non-compliance with study treatment|2|||
155503537|NCT01466673|561270773|FG001|Overall Study|Non-compliance with study treatment|0|||
155503538|NCT01466673|561270772|FG000|Overall Study|Lost to Follow-up|3|||
155503539|NCT01466673|561270773|FG001|Overall Study|Lost to Follow-up|5|||
155503540|NCT01466673|561270772|FG000|Overall Study|Adverse Event|2|||
155503541|NCT01466673|561270773|FG001|Overall Study|Adverse Event|1|||
155503542|NCT02725671|561270774|FG000|Overall Study|Lost to Follow-up|1|||
155503543|NCT01155284|561270781|FG000|Overall Study|Withdrawal by Subject|4|||
155503544|NCT01155284|561270782|FG001|Overall Study|Withdrawal by Subject|3|||
155503545|NCT01155284|561270781|FG000|Overall Study|Lost to Follow-up|1|||
155503546|NCT01155284|561270782|FG001|Overall Study|Lost to Follow-up|2|||
155503547|NCT01155284|561270781|FG000|Overall Study|Physician Decision|1|||
155503548|NCT01155284|561270782|FG001|Overall Study|Physician Decision|0|||
155503549|NCT01155284|561270781|FG000|Overall Study|Adverse Event|1|||
155503550|NCT01155284|561270782|FG001|Overall Study|Adverse Event|0|||
155503551|NCT00123487|561270783|FG000|Randomized|Death prior to starting treatment|0|||
155503552|NCT00123487|561270784|FG001|Randomized|Death prior to starting treatment|1|||
155503553|NCT00123487|561270783|FG000|Randomized|SAE prior to starting treatment|1|||
155503554|NCT00123487|561270784|FG001|Randomized|SAE prior to starting treatment|0|||
155503555|NCT00123487|561270783|FG000|Treated With Study Drug|Adverse Event|23|||
155503556|NCT00123487|561270784|FG001|Treated With Study Drug|Adverse Event|22|||
155503557|NCT00123487|561270783|FG000|Treated With Study Drug|Disease Progression|141|||
155645724|NCT03412890|561794092|FG002|Overall Study|Other|5|||
155503558|NCT00123487|561270784|FG001|Treated With Study Drug|Disease Progression|122|||
155503559|NCT00123487|561270783|FG000|Treated With Study Drug|Physician Decision|8|||
155503560|NCT00123487|561270784|FG001|Treated With Study Drug|Physician Decision|9|||
155503561|NCT00123487|561270783|FG000|Treated With Study Drug|Other|59|||
155503562|NCT00123487|561270784|FG001|Treated With Study Drug|Other|58|||
155503563|NCT00123487|561270783|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
155503564|NCT00123487|561270784|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
155503565|NCT00123487|561270783|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
155503566|NCT00123487|561270784|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
155503567|NCT00123487|561270783|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
155503568|NCT00123487|561270784|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
155503569|NCT03118765|561270785|FG000|Overall Study|Withdrawal by Subject|0|||
155503570|NCT03118765|561270786|FG001|Overall Study|Withdrawal by Subject|0|||
155503571|NCT03118765|561270787|FG002|Overall Study|Withdrawal by Subject|1|||
155503572|NCT03118765|561270788|FG003|Overall Study|Withdrawal by Subject|0|||
155503573|NCT03118765|561270789|FG004|Overall Study|Withdrawal by Subject|0|||
155503574|NCT03118765|561270785|FG000|Overall Study|Adverse Event|1|||
155503575|NCT03118765|561270786|FG001|Overall Study|Adverse Event|1|||
155503576|NCT03118765|561270787|FG002|Overall Study|Adverse Event|1|||
155503577|NCT03118765|561270788|FG003|Overall Study|Adverse Event|1|||
155503578|NCT03118765|561270789|FG004|Overall Study|Adverse Event|1|||
155503579|NCT03118765|561270785|FG000|Overall Study|Non compliance with Study Procedures|0|||
155503580|NCT03118765|561270786|FG001|Overall Study|Non compliance with Study Procedures|0|||
155503581|NCT03118765|561270787|FG002|Overall Study|Non compliance with Study Procedures|0|||
155503582|NCT03118765|561270788|FG003|Overall Study|Non compliance with Study Procedures|1|||
155503583|NCT03118765|561270789|FG004|Overall Study|Non compliance with Study Procedures|0|||
155503584|NCT03118765|561270785|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
155503585|NCT03118765|561270786|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
155503586|NCT03118765|561270787|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
155503587|NCT03118765|561270788|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
155503588|NCT03118765|561270789|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
155503589|NCT03118765|561270785|FG000|Overall Study|COPD Exacerbation|1|||
155503590|NCT03118765|561270786|FG001|Overall Study|COPD Exacerbation|0|||
155503591|NCT03118765|561270787|FG002|Overall Study|COPD Exacerbation|0|||
155503592|NCT03118765|561270788|FG003|Overall Study|COPD Exacerbation|1|||
155503593|NCT03118765|561270789|FG004|Overall Study|COPD Exacerbation|0|||
155503594|NCT03118765|561270785|FG000|Overall Study|Lost to Follow-up|1|||
155503595|NCT03118765|561270786|FG001|Overall Study|Lost to Follow-up|0|||
155503596|NCT03118765|561270787|FG002|Overall Study|Lost to Follow-up|1|||
155503597|NCT03118765|561270788|FG003|Overall Study|Lost to Follow-up|0|||
155503598|NCT03118765|561270789|FG004|Overall Study|Lost to Follow-up|0|||
155503599|NCT03118765|561270785|FG000|Overall Study|Sponsor Decision|1|||
155503600|NCT03118765|561270786|FG001|Overall Study|Sponsor Decision|0|||
155503601|NCT03118765|561270787|FG002|Overall Study|Sponsor Decision|1|||
155503602|NCT03118765|561270788|FG003|Overall Study|Sponsor Decision|0|||
155503603|NCT03118765|561270789|FG004|Overall Study|Sponsor Decision|1|||
155503604|NCT01255722|561270792|FG000|Overall Study|Adverse Event|0|||
155503605|NCT01255722|561270793|FG001|Overall Study|Adverse Event|1|||
155503606|NCT01255722|561270794|FG002|Overall Study|Adverse Event|1|||
155503607|NCT01255722|561270792|FG000|Overall Study|asymptomatic patient|1|||
155503608|NCT01255722|561270793|FG001|Overall Study|asymptomatic patient|0|||
155503609|NCT01255722|561270794|FG002|Overall Study|asymptomatic patient|0|||
155503610|NCT01255722|561270792|FG000|Overall Study|beta-blocker contraindicated|2|||
155503611|NCT01255722|561270793|FG001|Overall Study|beta-blocker contraindicated|0|||
155503612|NCT01255722|561270794|FG002|Overall Study|beta-blocker contraindicated|0|||
155503613|NCT02164539|561270795|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
155503614|NCT02164539|561270796|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
155503615|NCT02164539|561270797|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
155503616|NCT02164539|561270798|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
155503617|NCT02164539|561270799|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
155503618|NCT02164539|561270800|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
155503619|NCT02164539|561270801|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
155645725|NCT03412890|561794090|FG000|Overall Study|Participants who did not receive any study drug|0|||
155645726|NCT03412890|561794091|FG001|Overall Study|Participants who did not receive any study drug|1|||
155645727|NCT03412890|561794092|FG002|Overall Study|Participants who did not receive any study drug|0|||
155645728|NCT02583477|561794094|FG000|Overall Study|Adverse Event|0|||
155645729|NCT02583477|561794095|FG001|Overall Study|Adverse Event|2|||
155645730|NCT02583477|561794094|FG000|Overall Study|Death|1|||
155645731|NCT02583477|561794095|FG001|Overall Study|Death|16|||
155645732|NCT02583477|561794094|FG000|Overall Study|Study terminated|2|||
155645733|NCT02583477|561794095|FG001|Overall Study|Study terminated|2|||
155422788|NCT03902080|560978600|FG001|Overall Study|Lost to Follow-up|7|||
155503620|NCT02164539|561270795|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
155503621|NCT02164539|561270796|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
155503622|NCT02164539|561270797|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
155503623|NCT02164539|561270798|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
155503624|NCT02164539|561270799|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
155503625|NCT02164539|561270800|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
155503626|NCT02164539|561270801|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
155503627|NCT02164539|561270795|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
155503628|NCT02164539|561270796|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
155503629|NCT02164539|561270797|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
155503630|NCT02164539|561270798|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
155503631|NCT02164539|561270799|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
155503632|NCT02164539|561270800|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
155503633|NCT02164539|561270801|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
155503634|NCT02164539|561270795|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
155503635|NCT02164539|561270796|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503636|NCT02164539|561270797|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503637|NCT02164539|561270798|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503638|NCT02164539|561270799|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503639|NCT02164539|561270800|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503640|NCT02164539|561270801|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
155503641|NCT02164539|561270795|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
155503642|NCT02164539|561270796|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
155503643|NCT02164539|561270797|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
155422789|NCT03902080|560978599|FG000|Overall Study|Other|3|||
155422790|NCT03902080|560978600|FG001|Overall Study|Other|5|||
155422791|NCT03902080|560978599|FG000|Overall Study|Non compliance|4|||
155422792|NCT03902080|560978600|FG001|Overall Study|Non compliance|3|||
155422793|NCT03902080|560978599|FG000|Overall Study|Physician Decision|5|||
155503644|NCT02164539|561270798|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
155503645|NCT02164539|561270799|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
155503646|NCT02164539|561270800|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
155503647|NCT02164539|561270801|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
155503648|NCT02164539|561270795|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
155503649|NCT02164539|561270796|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
155503650|NCT02164539|561270797|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
155503651|NCT02164539|561270798|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
155422794|NCT03902080|560978600|FG001|Overall Study|Physician Decision|1|||
155422795|NCT03902080|560978599|FG000|Overall Study|Protocol Violation|3|||
155422796|NCT03902080|560978600|FG001|Overall Study|Protocol Violation|3|||
155422797|NCT03902080|560978599|FG000|Overall Study|Lack of Efficacy|1|||
155422798|NCT03902080|560978600|FG001|Overall Study|Lack of Efficacy|3|||
155422799|NCT03902080|560978599|FG000|Overall Study|Withdrawn prior to dosing|0|||
155422800|NCT03902080|560978600|FG001|Overall Study|Withdrawn prior to dosing|1|||
155422801|NCT04684420|560978601|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155422802|NCT04684420|560978602|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155422803|NCT04684420|560978603|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
155422804|NCT04684420|560978604|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
155422805|NCT04684420|560978601|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
155422806|NCT04684420|560978602|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
155422807|NCT04684420|560978603|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
155422808|NCT04684420|560978604|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
155422809|NCT00463476|560978605|FG000|Overall Study|Withdrawal by Subject|1|||
155422810|NCT00463476|560978606|FG001|Overall Study|Withdrawal by Subject|2|||
155422811|NCT00463476|560978605|FG000|Overall Study|Lost to Follow-up|1|||
155422812|NCT00463476|560978606|FG001|Overall Study|Lost to Follow-up|1|||
155422813|NCT01703000|560978608|FG000|Overall Study|Death|1|||
155422814|NCT00434967|560978609|FG000|Overall Study|Adverse Event|2|||
155422815|NCT00434967|560978610|FG001|Overall Study|Adverse Event|4|||
155422816|NCT00434967|560978611|FG002|Overall Study|Adverse Event|3|||
155422817|NCT00434967|560978612|FG003|Overall Study|Adverse Event|3|||
155422818|NCT00434967|560978609|FG000|Overall Study|Lost to Follow-up|0|||
155503652|NCT02164539|561270799|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
155503653|NCT02164539|561270800|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
155503654|NCT02164539|561270801|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
155503655|NCT02643966|561270802|FG000|First Screening Round|ineligible|1|||
155503656|NCT02643966|561270802|FG000|First Screening Round|excluded from analysis|2|||
155645734|NCT05507450|561794096|FG000|Overall Study|Death|0|||
155645735|NCT05507450|561794097|FG001|Overall Study|Death|0|||
155645736|NCT05507450|561794098|FG002|Overall Study|Death|1|||
155645737|NCT05507450|561794099|FG003|Overall Study|Death|0|||
155645738|NCT05507450|561794096|FG000|Overall Study|Lost to Follow-up|22|||
155645739|NCT05507450|561794097|FG001|Overall Study|Lost to Follow-up|20|||
155645740|NCT05507450|561794098|FG002|Overall Study|Lost to Follow-up|20|||
155645741|NCT05507450|561794099|FG003|Overall Study|Lost to Follow-up|7|||
155503657|NCT02643966|561270802|FG000|First Screening Round|Lost to Follow-up|56|||
155503658|NCT02643966|561270802|FG000|First Screening Round|Withdrawal by Subject|28|||
155335770|NCT00273052|560664756|FG001|Overall Study|Other|0|||
155335771|NCT00273052|560664755|FG000|Overall Study|Worsening serum lipid levels|0|||
155335772|NCT00273052|560664756|FG001|Overall Study|Worsening serum lipid levels|2|||
155335773|NCT01852045|560664757|FG000|Overall Study|Adverse Event|1|||
155335774|NCT01852045|560664758|FG001|Overall Study|Adverse Event|0|||
155335775|NCT01852045|560664759|FG002|Overall Study|Adverse Event|0|||
155335776|NCT01852045|560664757|FG000|Overall Study|Lack of Efficacy|3|||
155335777|NCT01852045|560664758|FG001|Overall Study|Lack of Efficacy|0|||
155335778|NCT01852045|560664759|FG002|Overall Study|Lack of Efficacy|0|||
155335779|NCT01852045|560664757|FG000|Overall Study|Lost to Follow-up|0|||
155335780|NCT01852045|560664758|FG001|Overall Study|Lost to Follow-up|1|||
155335781|NCT01852045|560664759|FG002|Overall Study|Lost to Follow-up|1|||
155335782|NCT01852045|560664757|FG000|Overall Study|Withdrawal by Subject|1|||
155422819|NCT00434967|560978610|FG001|Overall Study|Lost to Follow-up|0|||
155422820|NCT00434967|560978611|FG002|Overall Study|Lost to Follow-up|1|||
155422821|NCT00434967|560978612|FG003|Overall Study|Lost to Follow-up|0|||
155422822|NCT00434967|560978609|FG000|Overall Study|Withdrawal by Subject|2|||
155422823|NCT00434967|560978610|FG001|Overall Study|Withdrawal by Subject|2|||
155422824|NCT00434967|560978611|FG002|Overall Study|Withdrawal by Subject|4|||
155422825|NCT00434967|560978612|FG003|Overall Study|Withdrawal by Subject|6|||
155422826|NCT00434967|560978609|FG000|Overall Study|Randomized in error|0|||
155422827|NCT00434967|560978610|FG001|Overall Study|Randomized in error|0|||
155422828|NCT00434967|560978611|FG002|Overall Study|Randomized in error|0|||
155422829|NCT00434967|560978612|FG003|Overall Study|Randomized in error|1|||
155422830|NCT00434967|560978609|FG000|Overall Study|Protocol Violation|0|||
155422831|NCT00434967|560978610|FG001|Overall Study|Protocol Violation|1|||
155422832|NCT00434967|560978611|FG002|Overall Study|Protocol Violation|0|||
155422833|NCT00434967|560978612|FG003|Overall Study|Protocol Violation|1|||
155422834|NCT00434967|560978609|FG000|Overall Study|Physician Decision|1|||
155422835|NCT00434967|560978610|FG001|Overall Study|Physician Decision|1|||
155422836|NCT00434967|560978611|FG002|Overall Study|Physician Decision|1|||
155422837|NCT00434967|560978612|FG003|Overall Study|Physician Decision|0|||
155422838|NCT00434967|560978609|FG000|Overall Study|Patient Disposition Challenges|2|||
155422839|NCT00434967|560978610|FG001|Overall Study|Patient Disposition Challenges|0|||
155335783|NCT01852045|560664758|FG001|Overall Study|Withdrawal by Subject|0|||
155335784|NCT01852045|560664759|FG002|Overall Study|Withdrawal by Subject|1|||
155335785|NCT01852045|560664757|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155335786|NCT01852045|560664758|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155335787|NCT01852045|560664759|FG002|Overall Study|Other Miscellaneous Reasons|2|||
155335788|NCT03142932|560664760|FG000|Overall Study|Lost to Follow-up|2|||
155335789|NCT03142932|560664761|FG001|Overall Study|Lost to Follow-up|11|||
155335790|NCT00703092|560664762|FG000|Overall Study|Withdrawal by Subject|2|||
155335791|NCT00681109|560664763|FG000|Overall Study|Lost to Follow-up|2|||
155335792|NCT00681109|560664764|FG001|Overall Study|Lost to Follow-up|6|||
155335793|NCT00681109|560664765|FG002|Overall Study|Lost to Follow-up|0|||
155335794|NCT04660799|560664766|FG000|Overall Study|Progressive Disease|1|||
155335795|NCT04660799|560664767|FG001|Overall Study|Progressive Disease|1|||
155335796|NCT04660799|560664766|FG000|Overall Study|Death|2|||
155335797|NCT04660799|560664767|FG001|Overall Study|Death|1|||
155335798|NCT04660799|560664766|FG000|Overall Study|Adverse Event|2|||
155335799|NCT04660799|560664767|FG001|Overall Study|Adverse Event|1|||
155335800|NCT04660799|560664766|FG000|Overall Study|Withdrawal by Subject|2|||
155335801|NCT04660799|560664767|FG001|Overall Study|Withdrawal by Subject|5|||
155335802|NCT02706483|560664768|FG000|Overall Study|Adverse Event|97|||
155335803|NCT02706483|560664768|FG000|Overall Study|Death|1|||
155335804|NCT02706483|560664768|FG000|Overall Study|Lack of Efficacy|39|||
155335805|NCT02706483|560664768|FG000|Overall Study|Lost to Follow-up|101|||
155335806|NCT02706483|560664768|FG000|Overall Study|Non-compliance with study drug|15|||
155335807|NCT02706483|560664768|FG000|Overall Study|Physician Decision|6|||
155335808|NCT02706483|560664768|FG000|Overall Study|Pregnancy|6|||
155335809|NCT02706483|560664768|FG000|Overall Study|Protocol Violation|18|||
155335810|NCT02706483|560664768|FG000|Overall Study|Withdrawal by Subject|136|||
155335811|NCT02706483|560664768|FG000|Overall Study|Non-compliance with visits|6|||
155335812|NCT02706483|560664768|FG000|Overall Study|Site closure|4|||
155335813|NCT02706483|560664768|FG000|Overall Study|Subject moved|1|||
155335814|NCT04248868|560664769|FG000|Overall Study|Death|1|||
155335815|NCT04248868|560664769|FG000|Overall Study|Lost to Follow-up|3|||
155335816|NCT04248868|560664769|FG000|Overall Study|Protocol Violation|2|||
155335817|NCT03131713|560664772|FG000|Overall Study|Lost to Follow-up|5|||
155335818|NCT03131713|560664773|FG001|Overall Study|Lost to Follow-up|0|||
155335819|NCT01972776|560664774|FG000|Part 1|Withdrawal by Subject|0|||
155335820|NCT01972776|560664775|FG001|Part 1|Withdrawal by Subject|0|||
155335821|NCT01972776|560664776|FG002|Part 1|Withdrawal by Subject|1|||
155335822|NCT01972776|560664777|FG003|Part 1|Withdrawal by Subject|0|||
155335823|NCT01972776|560664778|FG004|Part 1|Withdrawal by Subject|0|||
155335824|NCT01972776|560664779|FG005|Part 1|Withdrawal by Subject|0|||
155335825|NCT01972776|560664774|FG000|Part 1|Adverse Event|0|||
155645742|NCT05507450|561794096|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155645743|NCT05507450|561794097|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155422840|NCT00434967|560978611|FG002|Overall Study|Patient Disposition Challenges|0|||
155422841|NCT00434967|560978612|FG003|Overall Study|Patient Disposition Challenges|3|||
155422842|NCT03502187|560978613|FG000|Overall Study|Withdrawal by Subject|4|||
155422843|NCT03502187|560978614|FG001|Overall Study|Withdrawal by Subject|3|||
155422844|NCT03502187|560978615|FG002|Overall Study|Withdrawal by Subject|3|||
155422845|NCT03502187|560978613|FG000|Overall Study|Lost to Follow-up|5|||
155422846|NCT03502187|560978614|FG001|Overall Study|Lost to Follow-up|4|||
155422847|NCT03502187|560978615|FG002|Overall Study|Lost to Follow-up|5|||
155645744|NCT05507450|561794098|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155335826|NCT01972776|560664775|FG001|Part 1|Adverse Event|0|||
155335827|NCT01972776|560664776|FG002|Part 1|Adverse Event|1|||
155335828|NCT01972776|560664777|FG003|Part 1|Adverse Event|1|||
155335829|NCT01972776|560664778|FG004|Part 1|Adverse Event|0|||
155335830|NCT01972776|560664779|FG005|Part 1|Adverse Event|0|||
155335831|NCT01972776|560664774|FG000|Part 2|Adverse Event|0|||
155335832|NCT01972776|560664775|FG001|Part 2|Adverse Event|0|||
155335833|NCT01972776|560664776|FG002|Part 2|Adverse Event|0|||
155335834|NCT01972776|560664777|FG003|Part 2|Adverse Event|0|||
155335835|NCT01972776|560664778|FG004|Part 2|Adverse Event|3|||
155335836|NCT01972776|560664779|FG005|Part 2|Adverse Event|0|||
155335837|NCT01972776|560664774|FG000|Part 2|Administrative problems|0|||
155335838|NCT01972776|560664775|FG001|Part 2|Administrative problems|0|||
155335839|NCT01972776|560664776|FG002|Part 2|Administrative problems|0|||
155335840|NCT01972776|560664777|FG003|Part 2|Administrative problems|0|||
155335841|NCT01972776|560664778|FG004|Part 2|Administrative problems|10|||
155335842|NCT01972776|560664779|FG005|Part 2|Administrative problems|7|||
155335843|NCT01228734|560664783|FG000|Overall Study|Randomized, but not treated|0|||
155335844|NCT01228734|560664784|FG001|Overall Study|Randomized, but not treated|4|||
155335845|NCT02382640|560664792|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
155335846|NCT02382640|560664793|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335847|NCT02382640|560664794|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335848|NCT02382640|560664795|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335849|NCT01543204|560664796|FG000|Overall Study|Non-compliance|1|||
155335850|NCT01543204|560664796|FG000|Overall Study|Adverse Event|1|||
155335851|NCT01543204|560664796|FG000|Overall Study|Withdrawal by Subject|4|||
155335852|NCT01543204|560664796|FG000|Overall Study|Requirement for Alternative Therapy|1|||
155335853|NCT01543204|560664796|FG000|Overall Study|Lost to Follow-up|1|||
155335854|NCT01220999|560664797|FG000|Overall Study|Progressive disease|0|||
155335855|NCT01220999|560664798|FG001|Overall Study|Progressive disease|0|||
155335856|NCT01220999|560664799|FG002|Overall Study|Progressive disease|1|||
155335857|NCT01220999|560664800|FG003|Overall Study|Progressive disease|0|||
155335858|NCT01220999|560664801|FG004|Overall Study|Progressive disease|0|||
155335859|NCT01560429|560664805|FG000|Overall Study|Protocol Violation|3|||
155335860|NCT01560429|560664806|FG001|Overall Study|Protocol Violation|6|||
155335861|NCT02449902|560664807|FG000|Overall Study|Adverse Event|0|||
155335862|NCT02449902|560664808|FG001|Overall Study|Adverse Event|1|||
155335863|NCT02449902|560664807|FG000|Overall Study|Withdrawal by Subject|0|||
155335864|NCT02449902|560664808|FG001|Overall Study|Withdrawal by Subject|1|||
155335865|NCT01365546|560664809|FG000|Overall Study|Withdrawal by Subject|1|||
155335866|NCT01365546|560664809|FG000|Overall Study|Screen failure|9|||
155335867|NCT01365546|560664809|FG000|Overall Study|Study termination|1|||
155335868|NCT03326856|560664810|FG000|Overall Study|Lost to Follow-up|1|||
155335869|NCT03326856|560664811|FG001|Overall Study|Lost to Follow-up|1|||
155335870|NCT03326856|560664812|FG002|Overall Study|Lost to Follow-up|0|||
155335871|NCT03326856|560664813|FG003|Overall Study|Lost to Follow-up|0|||
155335872|NCT03326856|560664814|FG004|Overall Study|Lost to Follow-up|0|||
155335873|NCT02037568|560664815|FG000|Overall Study|Withdrawal by Subject|17|||
155335874|NCT02037568|560664816|FG001|Overall Study|Withdrawal by Subject|24|||
155335875|NCT02037568|560664815|FG000|Overall Study|Lost to Follow-up|16|||
155335876|NCT02037568|560664816|FG001|Overall Study|Lost to Follow-up|13|||
155335877|NCT02037568|560664815|FG000|Overall Study|Screen Failure|3|||
155335878|NCT02037568|560664816|FG001|Overall Study|Screen Failure|1|||
155335879|NCT02037568|560664815|FG000|Overall Study|Patient did not receive transplant|0|||
155335880|NCT02037568|560664816|FG001|Overall Study|Patient did not receive transplant|1|||
155335881|NCT00721734|560664819|FG000|Overall Study|Progressive Disease|3|||
155335882|NCT00721734|560664820|FG001|Overall Study|Progressive Disease|10|||
155335883|NCT00721734|560664821|FG002|Overall Study|Progressive Disease|4|||
155335884|NCT00721734|560664822|FG003|Overall Study|Progressive Disease|5|||
155335885|NCT00721734|560664823|FG004|Overall Study|Progressive Disease|2|||
155335886|NCT00721734|560664819|FG000|Overall Study|Adverse Event|3|||
155335887|NCT00721734|560664820|FG001|Overall Study|Adverse Event|1|||
155335888|NCT00721734|560664821|FG002|Overall Study|Adverse Event|4|||
155335889|NCT00721734|560664822|FG003|Overall Study|Adverse Event|0|||
155335890|NCT00721734|560664823|FG004|Overall Study|Adverse Event|3|||
155335891|NCT00721734|560664819|FG000|Overall Study|Withdrawal by Subject|2|||
155335892|NCT00721734|560664820|FG001|Overall Study|Withdrawal by Subject|1|||
155503659|NCT02643966|561270802|FG000|First Screening Round|Death|1|||
155503660|NCT02643966|561270802|FG000|Between First and Second Screening|Lost to Follow-up|65|||
155503661|NCT02643966|561270802|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
155503662|NCT02643966|561270802|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
155335893|NCT00721734|560664821|FG002|Overall Study|Withdrawal by Subject|0|||
155335894|NCT00721734|560664822|FG003|Overall Study|Withdrawal by Subject|0|||
155503663|NCT02643966|561270802|FG000|Second Screening Round|Withdrawal by Subject|20|||
155503664|NCT02643966|561270802|FG000|Second Screening Round|Lost to Follow-up|57|||
155503665|NCT02643966|561270802|FG000|Second Screening Round|Physician Decision|2|||
155503666|NCT02643966|561270802|FG000|Second Screening Round|Death|4|||
155645745|NCT05507450|561794099|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155645746|NCT05507450|561794096|FG000|Overall Study|Withdrawal by Subject|4|||
155645747|NCT05507450|561794097|FG001|Overall Study|Withdrawal by Subject|11|||
155645748|NCT05507450|561794098|FG002|Overall Study|Withdrawal by Subject|7|||
155645749|NCT05507450|561794099|FG003|Overall Study|Withdrawal by Subject|3|||
155335895|NCT00721734|560664823|FG004|Overall Study|Withdrawal by Subject|1|||
155335896|NCT00721734|560664819|FG000|Overall Study|Other|0|||
155335897|NCT00721734|560664820|FG001|Overall Study|Other|0|||
155335898|NCT00721734|560664821|FG002|Overall Study|Other|0|||
155335899|NCT00721734|560664822|FG003|Overall Study|Other|1|||
155335900|NCT00721734|560664823|FG004|Overall Study|Other|0|||
155335901|NCT03162614|560664824|FG000|Overall Study|Lost to Follow-up|2|||
155335902|NCT03162614|560664825|FG001|Overall Study|Lost to Follow-up|1|||
155335903|NCT03162614|560664826|FG002|Overall Study|Lost to Follow-up|1|||
155335904|NCT03162614|560664827|FG003|Overall Study|Lost to Follow-up|1|||
155335905|NCT03162614|560664828|FG004|Overall Study|Lost to Follow-up|2|||
155335906|NCT03162614|560664829|FG005|Overall Study|Lost to Follow-up|0|||
155335907|NCT03162614|560664824|FG000|Overall Study|Protocol Violation|0|||
155335908|NCT03162614|560664825|FG001|Overall Study|Protocol Violation|1|||
155335909|NCT03162614|560664826|FG002|Overall Study|Protocol Violation|0|||
155335910|NCT03162614|560664827|FG003|Overall Study|Protocol Violation|1|||
155335911|NCT03162614|560664828|FG004|Overall Study|Protocol Violation|0|||
155335912|NCT03162614|560664829|FG005|Overall Study|Protocol Violation|0|||
155335913|NCT03162614|560664824|FG000|Overall Study|Withdrawal by Subject|2|||
155335914|NCT03162614|560664825|FG001|Overall Study|Withdrawal by Subject|1|||
155335915|NCT03162614|560664826|FG002|Overall Study|Withdrawal by Subject|1|||
155335916|NCT03162614|560664827|FG003|Overall Study|Withdrawal by Subject|1|||
155335917|NCT03162614|560664828|FG004|Overall Study|Withdrawal by Subject|0|||
155335918|NCT03162614|560664829|FG005|Overall Study|Withdrawal by Subject|0|||
155335919|NCT03162614|560664824|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
155335920|NCT03162614|560664825|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
155335921|NCT03162614|560664826|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
155335922|NCT03162614|560664827|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
155335923|NCT03162614|560664828|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
155645750|NCT05507450|561794096|FG000|Overall Study|Participant left the country|0|||
155645751|NCT05507450|561794097|FG001|Overall Study|Participant left the country|0|||
155645752|NCT05507450|561794098|FG002|Overall Study|Participant left the country|1|||
155645753|NCT05507450|561794099|FG003|Overall Study|Participant left the country|0|||
155645754|NCT05436288|561794101|FG000|Overall Study|Lost to Follow-up|1|||
155645755|NCT05436288|561794101|FG000|Overall Study|Adverse Event|1|||
155645756|NCT03767894|561794107|FG000|Overall Study|Withdrawal by Subject|1|||
155645757|NCT01436500|561794109|FG000|Overall Study|Death|1|||
155645758|NCT01436500|561794110|FG001|Overall Study|Death|0|||
155645759|NCT01436500|561794111|FG002|Overall Study|Death|0|||
155645760|NCT01436500|561794112|FG003|Overall Study|Death|0|||
155645761|NCT01436500|561794113|FG004|Overall Study|Death|0|||
155645762|NCT01436500|561794109|FG000|Overall Study|Adverse Event|0|||
155645763|NCT01436500|561794110|FG001|Overall Study|Adverse Event|2|||
155645764|NCT01436500|561794111|FG002|Overall Study|Adverse Event|2|||
155645765|NCT01436500|561794112|FG003|Overall Study|Adverse Event|0|||
155645766|NCT01436500|561794113|FG004|Overall Study|Adverse Event|1|||
155645767|NCT01436500|561794109|FG000|Overall Study|Withdrawal by Subject|0|||
155335924|NCT03162614|560664829|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
155335925|NCT03861234|560664830|FG000|Overall Study|Not treated|0|||
155335926|NCT03861234|560664831|FG001|Overall Study|Not treated|0|||
155335927|NCT03861234|560664832|FG002|Overall Study|Not treated|0|||
155335928|NCT03861234|560664833|FG003|Overall Study|Not treated|0|||
155335929|NCT03861234|560664834|FG004|Overall Study|Not treated|0|||
155335930|NCT03861234|560664835|FG005|Overall Study|Not treated|1|||
155503667|NCT02643966|561270802|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
155503668|NCT02643966|561270802|FG000|Between Second and Third Screening|Death|1|||
155503669|NCT02643966|561270802|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
155503670|NCT02643966|561270802|FG000|Third Screening Round|PI excluded|2|||
155503671|NCT02643966|561270802|FG000|Third Screening Round|Lost to Follow-up|241|||
155503672|NCT01946282|561270803|FG000|Year 1|Did not return FIT kit|4186|||
155503673|NCT01946282|561270804|FG001|Year 1|Did not return FIT kit|608|||
155503674|NCT01946282|561270805|FG002|Year 1|Did not return FIT kit|654|||
155503675|NCT01946282|561270803|FG000|Year 2|Did not return FIT kit|803|||
155503676|NCT01946282|561270804|FG001|Year 2|Did not return FIT kit|131|||
155503677|NCT01946282|561270805|FG002|Year 2|Did not return FIT kit|115|||
155503678|NCT01946282|561270803|FG000|Year 3|Did not return FIT kit|288|||
155503679|NCT01946282|561270804|FG001|Year 3|Did not return FIT kit|43|||
155503680|NCT01946282|561270805|FG002|Year 3|Did not return FIT kit|30|||
155503681|NCT01493531|561270806|FG000|Overall Study|Adverse Event|4|||
155503682|NCT01493531|561270807|FG001|Overall Study|Adverse Event|12|||
155503683|NCT01493531|561270808|FG002|Overall Study|Adverse Event|9|||
155503684|NCT01493531|561270806|FG000|Overall Study|Gout flare|3|||
155503685|NCT01493531|561270807|FG001|Overall Study|Gout flare|0|||
155503686|NCT01493531|561270808|FG002|Overall Study|Gout flare|2|||
155503687|NCT01493531|561270806|FG000|Overall Study|Protocol Violation|8|||
155503688|NCT01493531|561270807|FG001|Overall Study|Protocol Violation|15|||
155503689|NCT01493531|561270808|FG002|Overall Study|Protocol Violation|12|||
155503690|NCT01493531|561270806|FG000|Overall Study|Sponsor terminated study|5|||
155503691|NCT01493531|561270807|FG001|Overall Study|Sponsor terminated study|2|||
155503692|NCT01493531|561270808|FG002|Overall Study|Sponsor terminated study|3|||
155503693|NCT01493531|561270806|FG000|Overall Study|Lost to Follow-up|5|||
155503694|NCT01493531|561270807|FG001|Overall Study|Lost to Follow-up|7|||
155503695|NCT01493531|561270808|FG002|Overall Study|Lost to Follow-up|11|||
155503696|NCT01493531|561270806|FG000|Overall Study|Withdrawal by Subject|16|||
155503697|NCT01493531|561270807|FG001|Overall Study|Withdrawal by Subject|13|||
155503698|NCT01493531|561270808|FG002|Overall Study|Withdrawal by Subject|11|||
155503699|NCT01493531|561270806|FG000|Overall Study|Death|0|||
155503700|NCT01493531|561270807|FG001|Overall Study|Death|1|||
155503701|NCT01493531|561270808|FG002|Overall Study|Death|0|||
155503702|NCT03031431|561270811|FG000|Overall Study|Infant removed by maternal request|1|||
155503703|NCT01462695|561270812|FG000|Overall Study|Adverse Event|1|||
155503704|NCT01462695|561270813|FG001|Overall Study|Adverse Event|1|||
155503705|NCT01462695|561270812|FG000|Overall Study|Death|2|||
155503706|NCT01462695|561270813|FG001|Overall Study|Death|0|||
155503707|NCT01462695|561270812|FG000|Overall Study|Lack of Efficacy|6|||
155503708|NCT01462695|561270813|FG001|Overall Study|Lack of Efficacy|12|||
155503709|NCT01462695|561270812|FG000|Overall Study|Physician Decision|5|||
155503710|NCT01462695|561270813|FG001|Overall Study|Physician Decision|0|||
155503711|NCT01462695|561270812|FG000|Overall Study|Withdrawal by Subject|2|||
155503712|NCT01462695|561270813|FG001|Overall Study|Withdrawal by Subject|0|||
155503713|NCT01462695|561270812|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
155645768|NCT01436500|561794110|FG001|Overall Study|Withdrawal by Subject|0|||
155335931|NCT03861234|560664836|FG006|Overall Study|Not treated|0|||
155335932|NCT03861234|560664837|FG007|Overall Study|Not treated|0|||
155335933|NCT03861234|560664830|FG000|Overall Study|Adverse Event|0|||
155335934|NCT03861234|560664831|FG001|Overall Study|Adverse Event|0|||
155335935|NCT03861234|560664832|FG002|Overall Study|Adverse Event|0|||
155335936|NCT03861234|560664833|FG003|Overall Study|Adverse Event|0|||
155335937|NCT03861234|560664834|FG004|Overall Study|Adverse Event|0|||
155335938|NCT03861234|560664835|FG005|Overall Study|Adverse Event|1|||
155335939|NCT03861234|560664836|FG006|Overall Study|Adverse Event|0|||
155335940|NCT03861234|560664837|FG007|Overall Study|Adverse Event|0|||
155335941|NCT03861234|560664830|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
155335942|NCT03861234|560664831|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
155335943|NCT03861234|560664832|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
155335944|NCT03861234|560664833|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
155335945|NCT03861234|560664834|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
155335946|NCT03861234|560664835|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
155335947|NCT03861234|560664836|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
155335948|NCT03861234|560664837|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
155503714|NCT01462695|561270813|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
155503715|NCT00995488|561270814|FG000|Overall Study|Withdrawal by Subject|1|||
155503716|NCT00051636|561270815|FG000|Period 1 - Core|Adverse Event|2|||
155503717|NCT00051636|561270816|FG001|Period 1 - Core|Adverse Event|2|||
155503718|NCT00051636|561270815|FG000|Period 1 - Core|Protocol Violation|1|||
155503719|NCT00051636|561270816|FG001|Period 1 - Core|Protocol Violation|0|||
155503720|NCT00051636|561270815|FG000|Period 1 - Core|Withdrawal by Subject|1|||
155503721|NCT00051636|561270816|FG001|Period 1 - Core|Withdrawal by Subject|2|||
155503722|NCT00051636|561270815|FG000|Period 1 - Core|Lost to Follow-up|0|||
155503723|NCT00051636|561270816|FG001|Period 1 - Core|Lost to Follow-up|2|||
155503724|NCT00051636|561270815|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
155503725|NCT00051636|561270816|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
155503726|NCT00051636|561270815|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
155503727|NCT00051636|561270816|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
155503728|NCT00051636|561270815|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
155503729|NCT00051636|561270816|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
155503730|NCT00051636|561270815|FG000|Period 2- Extended Observation Period|Death|4|||
155503731|NCT00051636|561270816|FG001|Period 2- Extended Observation Period|Death|5|||
155503732|NCT00051636|561270815|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
155503733|NCT00051636|561270816|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
155503734|NCT01656967|561270817|FG000|Overall Study|faulty monitor|1|||
155503735|NCT01656967|561270818|FG001|Overall Study|faulty monitor|0|||
155503736|NCT01656967|561270817|FG000|Overall Study|unsuccessful ETT insertion|3|||
155503737|NCT01656967|561270818|FG001|Overall Study|unsuccessful ETT insertion|2|||
155503738|NCT01174368|561270819|FG000|Overall Study|Withdrawal by Subject|1|||
155503739|NCT00479765|561270820|FG000|Overall Study|study terminated|4|||
155503740|NCT00725725|561270823|FG000|Overall Study|Adverse Event|1|||
155503741|NCT00725725|561270824|FG001|Overall Study|Adverse Event|3|||
155503742|NCT00725725|561270825|FG002|Overall Study|Adverse Event|2|||
155503743|NCT00725725|561270823|FG000|Overall Study|Lost to Follow-up|2|||
155503744|NCT00725725|561270824|FG001|Overall Study|Lost to Follow-up|0|||
155503745|NCT00725725|561270825|FG002|Overall Study|Lost to Follow-up|2|||
155503746|NCT00725725|561270823|FG000|Overall Study|Withdrawal by Subject|1|||
155503747|NCT00725725|561270824|FG001|Overall Study|Withdrawal by Subject|0|||
155503748|NCT00725725|561270825|FG002|Overall Study|Withdrawal by Subject|1|||
155503749|NCT00725725|561270823|FG000|Overall Study|Protocol Violation|0|||
155503750|NCT00725725|561270824|FG001|Overall Study|Protocol Violation|1|||
155503751|NCT00725725|561270825|FG002|Overall Study|Protocol Violation|0|||
155503752|NCT02392559|561270826|FG000|Overall Study|Withdrawal by Subject|0|||
155503753|NCT02392559|561270827|FG001|Overall Study|Withdrawal by Subject|1|||
155503754|NCT02340078|561270833|FG000|Overall Study|Protocol Violation|1|||
155503755|NCT00944125|561270834|FG000|3 to 6 Months|Withdrawal by Subject|0|||
155503756|NCT00944125|561270835|FG001|3 to 6 Months|Withdrawal by Subject|2|||
155503757|NCT00944125|561270834|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
155503758|NCT00944125|561270835|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
155503759|NCT04816877|561270836|FG000|Overall Study|Withdrawal by Subject|1|||
155503760|NCT04816877|561270837|FG001|Overall Study|Withdrawal by Subject|0|||
155503761|NCT00995930|561270838|FG000|Overall Study|Protocol deviation|2|||
155503762|NCT00995930|561270839|FG001|Overall Study|Protocol deviation|5|||
155503763|NCT00995930|561270838|FG000|Overall Study|Death|0|||
155503764|NCT00995930|561270839|FG001|Overall Study|Death|1|||
155503765|NCT00995930|561270838|FG000|Overall Study|Administrative problems|4|||
155503766|NCT00995930|561270839|FG001|Overall Study|Administrative problems|2|||
155503767|NCT00995930|561270838|FG000|Overall Study|Lost to Follow-up|1|||
155503768|NCT00995930|561270839|FG001|Overall Study|Lost to Follow-up|2|||
155503769|NCT00995930|561270838|FG000|Overall Study|Withdrawal by Subject|3|||
155503770|NCT00995930|561270839|FG001|Overall Study|Withdrawal by Subject|4|||
155503771|NCT00995930|561270838|FG000|Overall Study|Adverse Event|11|||
155503772|NCT00995930|561270839|FG001|Overall Study|Adverse Event|14|||
155503773|NCT01246973|561271964|FG000|Overall Study|Other|38|||
155503774|NCT01246973|561271965|FG001|Overall Study|Other|25|||
155503775|NCT01246973|561271964|FG000|Overall Study|Adverse Event|16|||
155503776|NCT01246973|561271965|FG001|Overall Study|Adverse Event|9|||
155335949|NCT03861234|560664830|FG000|Overall Study|As per sponsor decision|0|||
155335950|NCT03861234|560664831|FG001|Overall Study|As per sponsor decision|0|||
155335951|NCT03861234|560664832|FG002|Overall Study|As per sponsor decision|0|||
155503777|NCT01246973|561271964|FG000|Overall Study|Withdrawal by Subject|7|||
155503778|NCT01246973|561271965|FG001|Overall Study|Withdrawal by Subject|13|||
155335952|NCT03861234|560664833|FG003|Overall Study|As per sponsor decision|0|||
155335953|NCT03861234|560664834|FG004|Overall Study|As per sponsor decision|0|||
155335954|NCT03861234|560664835|FG005|Overall Study|As per sponsor decision|0|||
155335955|NCT03861234|560664836|FG006|Overall Study|As per sponsor decision|1|||
155503779|NCT02598622|561271966|FG000|Overall Study|Withdrawal by Subject|3|||
155503780|NCT02598622|561271967|FG001|Overall Study|Withdrawal by Subject|0|||
155503781|NCT02598622|561271966|FG000|Overall Study|Physician Decision|3|||
155503782|NCT02598622|561271967|FG001|Overall Study|Physician Decision|0|||
155503783|NCT03724916|561271971|FG000|Overall Study|Withdrawal by Subject|0|||
155503784|NCT03724916|561271972|FG001|Overall Study|Withdrawal by Subject|1|||
155335956|NCT03861234|560664837|FG007|Overall Study|As per sponsor decision|0|||
155335957|NCT03861234|560664830|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
155335958|NCT03861234|560664831|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
155335959|NCT03861234|560664832|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
155335960|NCT03861234|560664833|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
155335961|NCT03861234|560664834|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
155335962|NCT03861234|560664835|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
155335963|NCT03861234|560664836|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
155335964|NCT03861234|560664837|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
155335965|NCT00621842|560664838|FG000|Overall Study|Adverse Event|6|||
155335966|NCT00621842|560664838|FG000|Overall Study|Withdrawal by Subject|7|||
155335967|NCT00621842|560664838|FG000|Overall Study|Protocol Violation|4|||
155335968|NCT00621842|560664838|FG000|Overall Study|Lack of Efficacy|2|||
155335969|NCT02251652|560664841|FG000|Overall Study|Withdrawal by Subject|1|||
155335970|NCT01074242|560664844|FG000|Overall Study|Case report before date of contract|40|||
155335971|NCT01074242|560664844|FG000|Overall Study|Lost to Follow-up|1|||
155335972|NCT01074242|560664844|FG000|Overall Study|Case report unclear|6|||
155335973|NCT01074242|560664844|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
155335974|NCT01074242|560664844|FG000|Overall Study|Duplicate Case Report Form|5|||
155335975|NCT01957163|560664845|FG000|Overall Study|Adverse Event|5|||
155335976|NCT01957163|560664846|FG001|Overall Study|Adverse Event|2|||
155335977|NCT01957163|560664847|FG002|Overall Study|Adverse Event|4|||
155335978|NCT01957163|560664845|FG000|Overall Study|Lack of Efficacy|5|||
155335979|NCT01957163|560664846|FG001|Overall Study|Lack of Efficacy|4|||
155335980|NCT01957163|560664847|FG002|Overall Study|Lack of Efficacy|9|||
155335981|NCT01957163|560664845|FG000|Overall Study|Protocol Violation|1|||
155335982|NCT01957163|560664846|FG001|Overall Study|Protocol Violation|2|||
155335983|NCT01957163|560664847|FG002|Overall Study|Protocol Violation|0|||
155335984|NCT01957163|560664845|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
155335985|NCT01957163|560664846|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
155335986|NCT01957163|560664847|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
155335987|NCT01957163|560664845|FG000|Overall Study|Lost to Follow-up|0|||
155335988|NCT01957163|560664846|FG001|Overall Study|Lost to Follow-up|1|||
155335989|NCT01957163|560664847|FG002|Overall Study|Lost to Follow-up|0|||
155335990|NCT01957163|560664845|FG000|Overall Study|Withdrawal by Subject|4|||
155335991|NCT01957163|560664846|FG001|Overall Study|Withdrawal by Subject|2|||
155335992|NCT01957163|560664847|FG002|Overall Study|Withdrawal by Subject|4|||
155335993|NCT05169684|560664848|FG000|Overall Study|Adverse Event|1|||
155335994|NCT05169684|560664849|FG001|Overall Study|Adverse Event|3|||
155335995|NCT05169684|560664848|FG000|Overall Study|Physician Decision|0|||
155335996|NCT05169684|560664849|FG001|Overall Study|Physician Decision|1|||
155335997|NCT05169684|560664848|FG000|Overall Study|Progressive Disease|1|||
155335998|NCT05169684|560664849|FG001|Overall Study|Progressive Disease|1|||
155335999|NCT05169684|560664848|FG000|Overall Study|Participant request to discontinue treatment|0|||
155336000|NCT05169684|560664849|FG001|Overall Study|Participant request to discontinue treatment|1|||
155336001|NCT05169684|560664848|FG000|Overall Study|Other Reason|0|||
155336002|NCT05169684|560664849|FG001|Overall Study|Other Reason|1|||
155336003|NCT01668719|560664850|FG000|Phase I|On treatment|1|||
155336004|NCT01668719|560664851|FG001|Phase I|On treatment|0|||
155336005|NCT01668719|560664852|FG002|Phase I|On treatment|0|||
155336006|NCT01668719|560664850|FG000|Phase I|Adverse Event|2|||
155336007|NCT01668719|560664851|FG001|Phase I|Adverse Event|0|||
155336008|NCT01668719|560664852|FG002|Phase I|Adverse Event|0|||
155336009|NCT01668719|560664850|FG000|Phase I|Progression/relapse|1|||
155336010|NCT01668719|560664851|FG001|Phase I|Progression/relapse|0|||
155336011|NCT01668719|560664852|FG002|Phase I|Progression/relapse|0|||
155336012|NCT01668719|560664850|FG000|Phase I|not protocol specified|2|||
155336013|NCT01668719|560664851|FG001|Phase I|not protocol specified|0|||
155336014|NCT01668719|560664852|FG002|Phase I|not protocol specified|0|||
155336015|NCT01668719|560664850|FG000|Phase II|On treatment|0|||
155336016|NCT01668719|560664851|FG001|Phase II|On treatment|4|||
155336017|NCT01668719|560664852|FG002|Phase II|On treatment|3|||
155336018|NCT01668719|560664850|FG000|Phase II|Adverse Event|0|||
155336019|NCT01668719|560664851|FG001|Phase II|Adverse Event|18|||
155336020|NCT01668719|560664852|FG002|Phase II|Adverse Event|18|||
155336021|NCT01668719|560664850|FG000|Phase II|Refusal unrelated to adverse event|0|||
155336022|NCT01668719|560664851|FG001|Phase II|Refusal unrelated to adverse event|4|||
155336023|NCT01668719|560664852|FG002|Phase II|Refusal unrelated to adverse event|1|||
155336024|NCT01668719|560664850|FG000|Phase II|Progression/relapse|0|||
155336025|NCT01668719|560664851|FG001|Phase II|Progression/relapse|13|||
155336026|NCT01668719|560664852|FG002|Phase II|Progression/relapse|17|||
155336027|NCT01668719|560664850|FG000|Phase II|Death|0|||
155336028|NCT01668719|560664851|FG001|Phase II|Death|0|||
155336029|NCT01668719|560664852|FG002|Phase II|Death|2|||
155336030|NCT01668719|560664850|FG000|Phase II|not protocol specified|0|||
155336031|NCT01668719|560664851|FG001|Phase II|not protocol specified|13|||
155336032|NCT01668719|560664852|FG002|Phase II|not protocol specified|7|||
155336033|NCT03539055|560664853|FG000|Overall Study|Death|4|||
155503785|NCT03724916|561271973|FG002|Overall Study|Withdrawal by Subject|1|||
155503786|NCT03724916|561271974|FG003|Overall Study|Withdrawal by Subject|2|||
155503787|NCT03724916|561271971|FG000|Overall Study|Randomized but not Treated|1|||
155503788|NCT03724916|561271972|FG001|Overall Study|Randomized but not Treated|0|||
155503789|NCT03724916|561271973|FG002|Overall Study|Randomized but not Treated|0|||
155503790|NCT03724916|561271974|FG003|Overall Study|Randomized but not Treated|0|||
155503791|NCT04575038|561271975|FG000|Overall Study|Withdrawal by Subject|1|||
155503792|NCT04575038|561271976|FG001|Overall Study|Withdrawal by Subject|1|||
155503793|NCT01416142|561271981|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
155503794|NCT01416142|561271982|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
155503795|NCT01416142|561271983|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
155503796|NCT00678379|561271984|FG000|Overall Study|Injection performed after tonsillectomy|2|||
155503797|NCT00678379|561271985|FG001|Overall Study|Injection performed after tonsillectomy|0|||
155503798|NCT00678379|561271986|FG002|Overall Study|Injection performed after tonsillectomy|1|||
155503799|NCT00678379|561271984|FG000|Overall Study|Incomplete Data|4|||
155503800|NCT00678379|561271985|FG001|Overall Study|Incomplete Data|3|||
155503801|NCT00678379|561271986|FG002|Overall Study|Incomplete Data|3|||
155503802|NCT04335110|561271987|FG000|Overall Study|Withdrawal by Subject|1|||
155503803|NCT04335110|561271988|FG001|Overall Study|Withdrawal by Subject|1|||
155503804|NCT04335110|561271987|FG000|Overall Study|Death|0|||
155503805|NCT04335110|561271988|FG001|Overall Study|Death|1|||
155503806|NCT02513459|561271990|FG000|Overall Study|Adverse Event|7|||
155503807|NCT02513459|561271990|FG000|Overall Study|Withdrew consent|5|||
155503808|NCT02513459|561271990|FG000|Overall Study|Loss of efficacy|2|||
155503809|NCT02513459|561271990|FG000|Overall Study|Pregnancy|2|||
155503810|NCT02513459|561271990|FG000|Overall Study|Subject decision|2|||
155336034|NCT03539055|560664853|FG000|Overall Study|Lost to Follow-up|1|||
155336035|NCT03539055|560664853|FG000|Overall Study|Withdrawal by Subject|2|||
155336036|NCT03539055|560664853|FG000|Overall Study|Screen Fail|7|||
155336037|NCT03539055|560664853|FG000|Overall Study|Drug Intolerance|2|||
155336038|NCT01321073|560664854|FG000|Overall Study|Did not attempt implant|4|||
155336039|NCT01321073|560664854|FG000|Overall Study|Death|3|||
155336040|NCT01638000|560664855|FG000|Overall Study|Randomized but Never Received Drug|7|||
155336041|NCT01638000|560664856|FG001|Overall Study|Randomized but Never Received Drug|10|||
155336042|NCT01638000|560664855|FG000|Overall Study|Adverse Event|14|||
155336043|NCT01638000|560664856|FG001|Overall Study|Adverse Event|16|||
155336044|NCT01638000|560664855|FG000|Overall Study|Lack of Efficacy|5|||
155336045|NCT01638000|560664856|FG001|Overall Study|Lack of Efficacy|6|||
155336046|NCT01638000|560664855|FG000|Overall Study|Protocol Violation|11|||
155336047|NCT01638000|560664856|FG001|Overall Study|Protocol Violation|13|||
155336048|NCT01638000|560664855|FG000|Overall Study|Withdrawal by Subject|21|||
155336049|NCT01638000|560664856|FG001|Overall Study|Withdrawal by Subject|24|||
155336050|NCT01638000|560664855|FG000|Overall Study|Miscellaneous|2|||
155336051|NCT01638000|560664856|FG001|Overall Study|Miscellaneous|2|||
155336052|NCT05484661|560664857|FG000|Overall Study|Withdrawal by Subject|1|||
155336053|NCT05484661|560664858|FG001|Overall Study|Withdrawal by Subject|0|||
155336054|NCT00875706|560664859|FG000|Overall Study|Withdrawal by Subject|1|||
155336055|NCT00875706|560664860|FG001|Overall Study|Withdrawal by Subject|0|||
155336056|NCT00875706|560664861|FG002|Overall Study|Withdrawal by Subject|0|||
155336057|NCT03775213|560664862|FG000|Overall Study|Withdrawal by Subject|51|||
155336058|NCT03775213|560664863|FG001|Overall Study|Withdrawal by Subject|53|||
155336059|NCT03775213|560664862|FG000|Overall Study|Incomplete Survey|7|||
155336060|NCT03775213|560664863|FG001|Overall Study|Incomplete Survey|7|||
155336061|NCT00786188|560664864|FG000|Overall Study|Adverse Event|3|||
155336062|NCT00786188|560664865|FG001|Overall Study|Adverse Event|1|||
155336063|NCT00786188|560664864|FG000|Overall Study|Withdrawal by Subject|2|||
155336064|NCT00786188|560664865|FG001|Overall Study|Withdrawal by Subject|0|||
155336065|NCT00326183|560664866|FG000|Overall Study|Lost to Follow-up|104|||
155336066|NCT00326183|560664867|FG001|Overall Study|Lost to Follow-up|56|||
155336067|NCT00326183|560664866|FG000|Overall Study|Protocol Violation|6|||
155336068|NCT00326183|560664867|FG001|Overall Study|Protocol Violation|3|||
155503811|NCT02513459|561271990|FG000|Overall Study|Lack of response|1|||
155503812|NCT02513459|561271990|FG000|Overall Study|Reproductive plans|1|||
155336069|NCT00326183|560664866|FG000|Overall Study|Withdrawal by Subject|35|||
155336070|NCT00326183|560664867|FG001|Overall Study|Withdrawal by Subject|7|||
155336071|NCT00326183|560664866|FG000|Overall Study|Subject Moved|7|||
155336072|NCT00326183|560664867|FG001|Overall Study|Subject Moved|4|||
155336073|NCT00326183|560664866|FG000|Overall Study|Other|47|||
155336074|NCT00326183|560664867|FG001|Overall Study|Other|13|||
155336075|NCT00326183|560664866|FG000|Overall Study|Adverse Event|1|||
155503813|NCT02513459|561271990|FG000|Overall Study|Surgery planned-- not done|1|||
155503814|NCT00787566|561271993|FG000|Overall Study|AE related to chemotherapy|0|||
155336076|NCT00326183|560664867|FG001|Overall Study|Adverse Event|0|||
155336077|NCT00570505|560664872|FG000|Overall Study|Adverse Event|7|||
155503815|NCT00787566|561271994|FG001|Overall Study|AE related to chemotherapy|1|||
155503816|NCT00787566|561271995|FG002|Overall Study|AE related to chemotherapy|0|||
155336078|NCT00570505|560664872|FG000|Overall Study|Withdrawal by Subject|7|||
155336079|NCT00570505|560664872|FG000|Overall Study|Lost to Follow-up|23|||
155336080|NCT00570505|560664872|FG000|Overall Study|Other loss to follow-up|4|||
155336081|NCT05865392|560664877|FG000|Overall Study|Withdrawal by Subject|4|||
155336082|NCT05865392|560664878|FG001|Overall Study|Withdrawal by Subject|0|||
155336083|NCT05865392|560664877|FG000|Overall Study|Didn't meet inclusion criteria|4|||
155336084|NCT05865392|560664878|FG001|Overall Study|Didn't meet inclusion criteria|0|||
155336085|NCT02159989|560664879|FG000|Overall Study|Adverse Event|1|||
155336086|NCT02159989|560664880|FG001|Overall Study|Adverse Event|0|||
155336087|NCT02159989|560664881|FG002|Overall Study|Adverse Event|0|||
155336088|NCT02159989|560664882|FG003|Overall Study|Adverse Event|0|||
155336089|NCT02159989|560664883|FG004|Overall Study|Adverse Event|1|||
155336090|NCT02159989|560664884|FG005|Overall Study|Adverse Event|0|||
155336091|NCT02159989|560664885|FG006|Overall Study|Adverse Event|1|||
155336092|NCT02159989|560664886|FG007|Overall Study|Adverse Event|2|||
155336093|NCT02159989|560664887|FG008|Overall Study|Adverse Event|0|||
155336094|NCT02159989|560664888|FG009|Overall Study|Adverse Event|2|||
155336095|NCT02159989|560664889|FG010|Overall Study|Adverse Event|1|||
155336096|NCT02159989|560664879|FG000|Overall Study|Death|0|||
155336097|NCT02159989|560664880|FG001|Overall Study|Death|0|||
155336098|NCT02159989|560664881|FG002|Overall Study|Death|0|||
155336099|NCT02159989|560664882|FG003|Overall Study|Death|0|||
155336100|NCT02159989|560664883|FG004|Overall Study|Death|0|||
155336101|NCT02159989|560664884|FG005|Overall Study|Death|0|||
155336102|NCT02159989|560664885|FG006|Overall Study|Death|0|||
155336103|NCT02159989|560664886|FG007|Overall Study|Death|0|||
155336104|NCT02159989|560664887|FG008|Overall Study|Death|0|||
155336105|NCT02159989|560664888|FG009|Overall Study|Death|0|||
155336106|NCT02159989|560664889|FG010|Overall Study|Death|1|||
155336107|NCT02159989|560664879|FG000|Overall Study|Lack of Efficacy|2|||
155336108|NCT02159989|560664880|FG001|Overall Study|Lack of Efficacy|3|||
155336109|NCT02159989|560664881|FG002|Overall Study|Lack of Efficacy|3|||
155336110|NCT02159989|560664882|FG003|Overall Study|Lack of Efficacy|0|||
155336111|NCT02159989|560664883|FG004|Overall Study|Lack of Efficacy|2|||
155336112|NCT02159989|560664884|FG005|Overall Study|Lack of Efficacy|3|||
155336113|NCT02159989|560664885|FG006|Overall Study|Lack of Efficacy|3|||
155336114|NCT02159989|560664886|FG007|Overall Study|Lack of Efficacy|1|||
155336115|NCT02159989|560664887|FG008|Overall Study|Lack of Efficacy|3|||
155336116|NCT02159989|560664888|FG009|Overall Study|Lack of Efficacy|6|||
155336117|NCT02159989|560664889|FG010|Overall Study|Lack of Efficacy|7|||
155336118|NCT02159989|560664879|FG000|Overall Study|Lost to Follow-up|0|||
155336119|NCT02159989|560664880|FG001|Overall Study|Lost to Follow-up|0|||
155336120|NCT02159989|560664881|FG002|Overall Study|Lost to Follow-up|0|||
155336121|NCT02159989|560664882|FG003|Overall Study|Lost to Follow-up|1|||
155336122|NCT02159989|560664883|FG004|Overall Study|Lost to Follow-up|0|||
155336123|NCT02159989|560664884|FG005|Overall Study|Lost to Follow-up|0|||
155336124|NCT02159989|560664885|FG006|Overall Study|Lost to Follow-up|0|||
155336125|NCT02159989|560664886|FG007|Overall Study|Lost to Follow-up|0|||
155336126|NCT02159989|560664887|FG008|Overall Study|Lost to Follow-up|0|||
155336127|NCT02159989|560664888|FG009|Overall Study|Lost to Follow-up|0|||
155336128|NCT02159989|560664889|FG010|Overall Study|Lost to Follow-up|1|||
155336129|NCT02159989|560664879|FG000|Overall Study|Withdrawal by Subject|2|||
155336130|NCT02159989|560664880|FG001|Overall Study|Withdrawal by Subject|0|||
155336131|NCT02159989|560664881|FG002|Overall Study|Withdrawal by Subject|0|||
155336132|NCT02159989|560664882|FG003|Overall Study|Withdrawal by Subject|2|||
155336133|NCT02159989|560664883|FG004|Overall Study|Withdrawal by Subject|1|||
155336134|NCT02159989|560664884|FG005|Overall Study|Withdrawal by Subject|0|||
155336135|NCT02159989|560664885|FG006|Overall Study|Withdrawal by Subject|3|||
155336136|NCT02159989|560664886|FG007|Overall Study|Withdrawal by Subject|1|||
155336137|NCT02159989|560664887|FG008|Overall Study|Withdrawal by Subject|0|||
155336138|NCT02159989|560664888|FG009|Overall Study|Withdrawal by Subject|0|||
155336139|NCT02159989|560664889|FG010|Overall Study|Withdrawal by Subject|0|||
155336140|NCT02159989|560664879|FG000|Overall Study|New treatment|0|||
155336141|NCT02159989|560664880|FG001|Overall Study|New treatment|1|||
155336142|NCT02159989|560664881|FG002|Overall Study|New treatment|0|||
155336143|NCT02159989|560664882|FG003|Overall Study|New treatment|0|||
155422848|NCT02913313|560978616|FG000|Overall Study|DISEASE PROGRESSION|1|||
155336144|NCT02159989|560664883|FG004|Overall Study|New treatment|0|||
155336145|NCT02159989|560664884|FG005|Overall Study|New treatment|0|||
155336146|NCT02159989|560664885|FG006|Overall Study|New treatment|0|||
155336147|NCT02159989|560664886|FG007|Overall Study|New treatment|0|||
155336148|NCT02159989|560664887|FG008|Overall Study|New treatment|0|||
155336149|NCT02159989|560664888|FG009|Overall Study|New treatment|0|||
155336150|NCT02159989|560664889|FG010|Overall Study|New treatment|0|||
155336151|NCT02159989|560664879|FG000|Overall Study|Insurance Issues|0|||
155336152|NCT02159989|560664880|FG001|Overall Study|Insurance Issues|0|||
155336153|NCT02159989|560664881|FG002|Overall Study|Insurance Issues|0|||
155336154|NCT02159989|560664882|FG003|Overall Study|Insurance Issues|0|||
155336155|NCT02159989|560664883|FG004|Overall Study|Insurance Issues|0|||
155336156|NCT02159989|560664884|FG005|Overall Study|Insurance Issues|0|||
155336157|NCT02159989|560664885|FG006|Overall Study|Insurance Issues|0|||
155422849|NCT02913313|560978617|FG001|Overall Study|DISEASE PROGRESSION|2|||
155422850|NCT02913313|560978618|FG002|Overall Study|DISEASE PROGRESSION|2|||
155336158|NCT02159989|560664886|FG007|Overall Study|Insurance Issues|0|||
155336159|NCT02159989|560664887|FG008|Overall Study|Insurance Issues|0|||
155336160|NCT02159989|560664888|FG009|Overall Study|Insurance Issues|1|||
155336161|NCT02159989|560664889|FG010|Overall Study|Insurance Issues|0|||
155336162|NCT02485925|560664897|FG000|Overall Study|Withdrawal by Subject|3|||
155336163|NCT02485925|560664897|FG000|Overall Study|Death|1|||
155336164|NCT02485925|560664897|FG000|Overall Study|Lost to Follow-up|11|||
155336165|NCT02969356|560664898|FG000|Overall Study|Adverse Event|7|||
155336166|NCT02969356|560664898|FG000|Overall Study|Consent withdrawn|2|||
155336167|NCT02969356|560664898|FG000|Overall Study|Lost to Follow-up|3|||
155336168|NCT02969356|560664898|FG000|Overall Study|Did not need to be reinjected|6|||
155336169|NCT02969356|560664898|FG000|Overall Study|Personal reasons|5|||
155336170|NCT04924608|560666186|FG000|Overall Study|Adverse Event|10|||
155336171|NCT04924608|560666187|FG001|Overall Study|Adverse Event|6|||
155336172|NCT04924608|560666186|FG000|Overall Study|Lost to Follow-up|1|||
155336173|NCT04924608|560666187|FG001|Overall Study|Lost to Follow-up|1|||
155336174|NCT04924608|560666186|FG000|Overall Study|Ongoing at the data cut-off date|54|||
155336175|NCT04924608|560666187|FG001|Overall Study|Ongoing at the data cut-off date|60|||
155336176|NCT04924608|560666186|FG000|Overall Study|Progressive Disease|2|||
155336177|NCT04924608|560666187|FG001|Overall Study|Progressive Disease|0|||
155336178|NCT04924608|560666186|FG000|Overall Study|Withdrawal by Subject|3|||
155336179|NCT04924608|560666187|FG001|Overall Study|Withdrawal by Subject|6|||
155336180|NCT04924608|560666186|FG000|Overall Study|Other reason|1|||
155336181|NCT04924608|560666187|FG001|Overall Study|Other reason|1|||
155336182|NCT04493424|560666188|FG000|Overall Study|Termination of the trial by the sponsor|89|||
155336183|NCT04493424|560666188|FG000|Overall Study|Withdrawal by Subject|9|||
155336184|NCT04493424|560666188|FG000|Overall Study|Lost to Follow-up|2|||
155336185|NCT04493424|560666188|FG000|Overall Study|Lack of Efficacy|3|||
155336186|NCT04493424|560666188|FG000|Overall Study|Adverse Event|5|||
155336187|NCT03769090|560666189|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
155336188|NCT03769090|560666190|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
155336189|NCT03769090|560666191|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
155336190|NCT03769090|560666189|FG000|Overall Study|Withdrawal by Subject|52|||
155336191|NCT03769090|560666190|FG001|Overall Study|Withdrawal by Subject|62|||
155336192|NCT03769090|560666191|FG002|Overall Study|Withdrawal by Subject|74|||
155336193|NCT03769090|560666189|FG000|Overall Study|Death|4|||
155336194|NCT03769090|560666190|FG001|Overall Study|Death|2|||
155336195|NCT03769090|560666191|FG002|Overall Study|Death|2|||
155336196|NCT03769090|560666189|FG000|Overall Study|Adverse Event|7|||
155336197|NCT03769090|560666190|FG001|Overall Study|Adverse Event|7|||
155336198|NCT03769090|560666191|FG002|Overall Study|Adverse Event|8|||
155336199|NCT03769090|560666189|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
155336200|NCT03769090|560666190|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
155336201|NCT03769090|560666191|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
155336202|NCT03769090|560666189|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
155336203|NCT03769090|560666190|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
155336204|NCT03769090|560666191|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
155336205|NCT03769090|560666189|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
155336206|NCT03769090|560666190|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
155336207|NCT03769090|560666191|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
155336208|NCT03769090|560666189|FG000|Overall Study|Protocol Violation|5|||
155336209|NCT03769090|560666190|FG001|Overall Study|Protocol Violation|6|||
155336210|NCT03769090|560666191|FG002|Overall Study|Protocol Violation|8|||
155336211|NCT03769090|560666189|FG000|Overall Study|Pregnancy|1|||
155336212|NCT03769090|560666190|FG001|Overall Study|Pregnancy|0|||
155336213|NCT03769090|560666191|FG002|Overall Study|Pregnancy|3|||
155336214|NCT03769090|560666189|FG000|Overall Study|Lost to Follow-up|19|||
155336215|NCT03769090|560666190|FG001|Overall Study|Lost to Follow-up|25|||
155336216|NCT03769090|560666191|FG002|Overall Study|Lost to Follow-up|21|||
155336217|NCT03769090|560666189|FG000|Overall Study|Condition under investigation worsened|2|||
155336218|NCT03769090|560666190|FG001|Overall Study|Condition under investigation worsened|0|||
155336219|NCT03769090|560666191|FG002|Overall Study|Condition under investigation worsened|1|||
155422851|NCT02913313|560978619|FG003|Overall Study|DISEASE PROGRESSION|4|||
155422852|NCT02913313|560978620|FG004|Overall Study|DISEASE PROGRESSION|6|||
155422853|NCT02913313|560978621|FG005|Overall Study|DISEASE PROGRESSION|4|||
155422854|NCT02913313|560978622|FG006|Overall Study|DISEASE PROGRESSION|19|||
155422855|NCT02913313|560978623|FG007|Overall Study|DISEASE PROGRESSION|3|||
155336220|NCT03769090|560666189|FG000|Overall Study|Lack of Efficacy|1|||
155336221|NCT03769090|560666190|FG001|Overall Study|Lack of Efficacy|2|||
155336222|NCT03769090|560666191|FG002|Overall Study|Lack of Efficacy|2|||
155336223|NCT03769090|560666189|FG000|Overall Study|Other reasons|8|||
155336224|NCT03769090|560666190|FG001|Overall Study|Other reasons|12|||
155336225|NCT03769090|560666191|FG002|Overall Study|Other reasons|15|||
155336226|NCT01190124|560666196|FG000|Overall Study|Death|3|||
155422856|NCT02913313|560978624|FG008|Overall Study|DISEASE PROGRESSION|4|||
155422857|NCT02913313|560978625|FG009|Overall Study|DISEASE PROGRESSION|4|||
155336227|NCT01190124|560666197|FG001|Overall Study|Death|0|||
155336228|NCT01190124|560666198|FG002|Overall Study|Death|0|||
155336229|NCT01190124|560666196|FG000|Overall Study|Therapeutic Failure|12|||
155336230|NCT01190124|560666197|FG001|Overall Study|Therapeutic Failure|0|||
155336231|NCT01190124|560666198|FG002|Overall Study|Therapeutic Failure|1|||
155336232|NCT01190124|560666196|FG000|Overall Study|Lost to Follow-up|2|||
155336233|NCT01190124|560666197|FG001|Overall Study|Lost to Follow-up|0|||
155336234|NCT01190124|560666198|FG002|Overall Study|Lost to Follow-up|0|||
155336235|NCT02713594|560666199|FG000|Overall Study|Withdrawal by Subject|32|||
155336236|NCT02713594|560666200|FG001|Overall Study|Withdrawal by Subject|22|||
155336237|NCT02713594|560666199|FG000|Overall Study|Lost to Follow-up|358|||
155336238|NCT02713594|560666200|FG001|Overall Study|Lost to Follow-up|374|||
155336239|NCT00413283|560666201|FG000|Overall Study|Withdrawal by Subject|1|||
155336240|NCT00413283|560666202|FG001|Overall Study|Withdrawal by Subject|0|||
155336241|NCT00413283|560666203|FG002|Overall Study|Withdrawal by Subject|0|||
155336242|NCT00413283|560666204|FG003|Overall Study|Withdrawal by Subject|1|||
155336243|NCT00413283|560666201|FG000|Overall Study|Death|0|||
155336244|NCT00413283|560666202|FG001|Overall Study|Death|0|||
155336245|NCT00413283|560666203|FG002|Overall Study|Death|1|||
155336246|NCT00413283|560666204|FG003|Overall Study|Death|1|||
155336247|NCT00413283|560666201|FG000|Overall Study|Adverse Event|0|||
155336248|NCT00413283|560666202|FG001|Overall Study|Adverse Event|0|||
155422858|NCT02913313|560978626|FG010|Overall Study|DISEASE PROGRESSION|11|||
155422859|NCT02913313|560978627|FG011|Overall Study|DISEASE PROGRESSION|5|||
155422860|NCT02913313|560978628|FG012|Overall Study|DISEASE PROGRESSION|14|||
155422861|NCT02913313|560978629|FG013|Overall Study|DISEASE PROGRESSION|3|||
155422862|NCT02913313|560978616|FG000|Overall Study|Not Reported|0|||
155422863|NCT02913313|560978617|FG001|Overall Study|Not Reported|0|||
155422864|NCT02913313|560978618|FG002|Overall Study|Not Reported|0|||
155422865|NCT02913313|560978619|FG003|Overall Study|Not Reported|0|||
155422866|NCT02913313|560978620|FG004|Overall Study|Not Reported|1|||
155422867|NCT02913313|560978621|FG005|Overall Study|Not Reported|0|||
155422868|NCT02913313|560978622|FG006|Overall Study|Not Reported|0|||
155422869|NCT02913313|560978623|FG007|Overall Study|Not Reported|0|||
155422870|NCT02913313|560978624|FG008|Overall Study|Not Reported|0|||
155422871|NCT02913313|560978625|FG009|Overall Study|Not Reported|0|||
155422872|NCT02913313|560978626|FG010|Overall Study|Not Reported|4|||
155422873|NCT02913313|560978627|FG011|Overall Study|Not Reported|0|||
155422874|NCT02913313|560978628|FG012|Overall Study|Not Reported|0|||
155422875|NCT02913313|560978629|FG013|Overall Study|Not Reported|0|||
155422876|NCT02913313|560978616|FG000|Overall Study|Other reasons|0|||
155422877|NCT02913313|560978617|FG001|Overall Study|Other reasons|0|||
155422878|NCT02913313|560978618|FG002|Overall Study|Other reasons|0|||
155422879|NCT02913313|560978619|FG003|Overall Study|Other reasons|0|||
155422880|NCT02913313|560978620|FG004|Overall Study|Other reasons|1|||
155422881|NCT02913313|560978621|FG005|Overall Study|Other reasons|0|||
155422882|NCT02913313|560978622|FG006|Overall Study|Other reasons|0|||
155422883|NCT02913313|560978623|FG007|Overall Study|Other reasons|0|||
155422884|NCT02913313|560978624|FG008|Overall Study|Other reasons|0|||
155422885|NCT02913313|560978625|FG009|Overall Study|Other reasons|0|||
155422886|NCT02913313|560978626|FG010|Overall Study|Other reasons|1|||
155422887|NCT02913313|560978627|FG011|Overall Study|Other reasons|0|||
155422888|NCT02913313|560978628|FG012|Overall Study|Other reasons|0|||
155422889|NCT02913313|560978629|FG013|Overall Study|Other reasons|0|||
155422890|NCT02913313|560978616|FG000|Overall Study|Withdrawal by Subject|0|||
155422891|NCT02913313|560978617|FG001|Overall Study|Withdrawal by Subject|0|||
155422892|NCT02913313|560978618|FG002|Overall Study|Withdrawal by Subject|1|||
155422893|NCT02913313|560978619|FG003|Overall Study|Withdrawal by Subject|0|||
155422894|NCT02913313|560978620|FG004|Overall Study|Withdrawal by Subject|0|||
155422895|NCT02913313|560978621|FG005|Overall Study|Withdrawal by Subject|0|||
155422896|NCT02913313|560978622|FG006|Overall Study|Withdrawal by Subject|1|||
155422897|NCT02913313|560978623|FG007|Overall Study|Withdrawal by Subject|1|||
155422898|NCT02913313|560978624|FG008|Overall Study|Withdrawal by Subject|0|||
155422899|NCT02913313|560978625|FG009|Overall Study|Withdrawal by Subject|0|||
155422900|NCT02913313|560978626|FG010|Overall Study|Withdrawal by Subject|1|||
155422901|NCT02913313|560978627|FG011|Overall Study|Withdrawal by Subject|0|||
155422902|NCT02913313|560978628|FG012|Overall Study|Withdrawal by Subject|0|||
155422903|NCT02913313|560978629|FG013|Overall Study|Withdrawal by Subject|0|||
155422904|NCT02913313|560978616|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155336249|NCT00413283|560666203|FG002|Overall Study|Adverse Event|0|||
155336250|NCT00413283|560666204|FG003|Overall Study|Adverse Event|1|||
155336251|NCT00413283|560666201|FG000|Overall Study|Ineligibility determined|0|||
155336252|NCT00413283|560666202|FG001|Overall Study|Ineligibility determined|0|||
155336253|NCT00413283|560666203|FG002|Overall Study|Ineligibility determined|0|||
155336254|NCT00413283|560666204|FG003|Overall Study|Ineligibility determined|1|||
155336255|NCT00413283|560666201|FG000|Overall Study|Protocol deviation|0|||
155422905|NCT02913313|560978617|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422906|NCT02913313|560978618|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155336256|NCT00413283|560666202|FG001|Overall Study|Protocol deviation|1|||
155336257|NCT00413283|560666203|FG002|Overall Study|Protocol deviation|0|||
155336258|NCT00413283|560666204|FG003|Overall Study|Protocol deviation|0|||
155336259|NCT00413283|560666201|FG000|Overall Study|Requirement for alternative therapy|0|||
155336260|NCT00413283|560666202|FG001|Overall Study|Requirement for alternative therapy|2|||
155336261|NCT00413283|560666203|FG002|Overall Study|Requirement for alternative therapy|0|||
155336262|NCT00413283|560666204|FG003|Overall Study|Requirement for alternative therapy|0|||
155336263|NCT00413283|560666201|FG000|Overall Study|Other|0|||
155336264|NCT00413283|560666202|FG001|Overall Study|Other|0|||
155336265|NCT00413283|560666203|FG002|Overall Study|Other|1|||
155336266|NCT00413283|560666204|FG003|Overall Study|Other|0|||
155336267|NCT00671853|560666206|FG000|Overall Study|Lack of Efficacy|3|||
155336268|NCT00671853|560666207|FG001|Overall Study|Lack of Efficacy|7|||
155336269|NCT00671853|560666206|FG000|Overall Study|Adverse Event|7|||
155336270|NCT00671853|560666207|FG001|Overall Study|Adverse Event|1|||
155422907|NCT02913313|560978619|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422908|NCT02913313|560978620|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422909|NCT02913313|560978621|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422910|NCT02913313|560978622|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422911|NCT02913313|560978623|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422912|NCT02913313|560978624|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422913|NCT02913313|560978625|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422914|NCT02913313|560978626|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
155422915|NCT02913313|560978627|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
155422916|NCT02913313|560978628|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
155422917|NCT02913313|560978629|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
155422918|NCT02913313|560978616|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
155422919|NCT02913313|560978617|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
155422920|NCT02913313|560978618|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
155422921|NCT02913313|560978619|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
155422922|NCT02913313|560978620|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
155422923|NCT02913313|560978621|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
155422924|NCT02913313|560978622|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
155422925|NCT02913313|560978623|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
155422926|NCT02913313|560978624|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
155422927|NCT02913313|560978625|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
155422928|NCT02913313|560978626|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
155422929|NCT02913313|560978627|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
155422930|NCT02913313|560978628|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
155422931|NCT02913313|560978629|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
155422932|NCT04276207|560978631|FG000|Period 1|Withdrawal by Subject|0|||
155422933|NCT04276207|560978632|FG001|Period 1|Withdrawal by Subject|1|||
155422934|NCT02690194|560978633|FG000|Overall Study|Withdrawal by Subject|1|||
155422935|NCT02690194|560978634|FG001|Overall Study|Withdrawal by Subject|4|||
155422936|NCT02690194|560978635|FG002|Overall Study|Withdrawal by Subject|0|||
155422937|NCT03624946|560978636|FG000|Overall Study|Lost to Follow-up|0|||
155422938|NCT03624946|560978637|FG001|Overall Study|Lost to Follow-up|1|||
155422939|NCT00624520|560978638|FG000|Overall Study|Withdrawal by Subject|12|||
155422940|NCT00624520|560978639|FG001|Overall Study|Withdrawal by Subject|7|||
155422941|NCT00624520|560978638|FG000|Overall Study|Death|0|||
155422942|NCT00624520|560978639|FG001|Overall Study|Death|1|||
155422943|NCT00675025|560978640|FG000|Overall Study|Study Terminated by Sponsor|38|||
155422944|NCT00675025|560978641|FG001|Overall Study|Study Terminated by Sponsor|42|||
155422945|NCT00675025|560978640|FG000|Overall Study|Adverse Event|6|||
155422946|NCT00675025|560978641|FG001|Overall Study|Adverse Event|11|||
155422947|NCT00675025|560978640|FG000|Overall Study|Lost to Follow-up|6|||
155422948|NCT00675025|560978641|FG001|Overall Study|Lost to Follow-up|4|||
155422949|NCT00675025|560978640|FG000|Overall Study|Withdrawal by Subject|4|||
155422950|NCT00675025|560978641|FG001|Overall Study|Withdrawal by Subject|6|||
155422951|NCT00556426|560978645|FG000|Overall Study|Withdrawal by Subject|3|||
155422952|NCT00556426|560978645|FG000|Overall Study|Death|6|||
155422953|NCT00944034|560978647|FG000|Overall Study|Inappropriate enrollment|0|||
155422954|NCT00944034|560978648|FG001|Overall Study|Inappropriate enrollment|1|||
155422955|NCT00944034|560978649|FG002|Overall Study|Inappropriate enrollment|0|||
155422956|NCT00944034|560978650|FG003|Overall Study|Inappropriate enrollment|1|||
155422957|NCT00944034|560978651|FG004|Overall Study|Inappropriate enrollment|2|||
155422958|NCT00944034|560978652|FG005|Overall Study|Inappropriate enrollment|1|||
155503817|NCT00660790|561272004|FG000|Baseline to 3 Months|Death|1|||
155336271|NCT00671853|560666206|FG000|Overall Study|Withdrawal by Subject|1|||
155336272|NCT00671853|560666207|FG001|Overall Study|Withdrawal by Subject|5|||
155336273|NCT00671853|560666206|FG000|Overall Study|Lost to Follow-up|8|||
155336274|NCT00671853|560666207|FG001|Overall Study|Lost to Follow-up|8|||
155336275|NCT00671853|560666206|FG000|Overall Study|Physician Decision|0|||
155336276|NCT00671853|560666207|FG001|Overall Study|Physician Decision|2|||
155422959|NCT00944034|560978653|FG006|Overall Study|Inappropriate enrollment|0|||
155422960|NCT00944034|560978654|FG007|Overall Study|Inappropriate enrollment|0|||
155422961|NCT00944034|560978655|FG008|Overall Study|Inappropriate enrollment|1|||
155336277|NCT00671853|560666206|FG000|Overall Study|Non-adherence with study procedures|1|||
155336278|NCT00671853|560666207|FG001|Overall Study|Non-adherence with study procedures|4|||
155336279|NCT01377844|560666208|FG000|Overall Study|Withdrawal by Subject|25|||
155336280|NCT01377844|560666209|FG001|Overall Study|Withdrawal by Subject|28|||
155336281|NCT01377844|560666208|FG000|Overall Study|Protocol Violation|2|||
155336282|NCT01377844|560666209|FG001|Overall Study|Protocol Violation|3|||
155336283|NCT01377844|560666208|FG000|Overall Study|Adverse Event|3|||
155336284|NCT01377844|560666209|FG001|Overall Study|Adverse Event|0|||
155336285|NCT01377844|560666208|FG000|Overall Study|Physician Decision|6|||
155336286|NCT01377844|560666209|FG001|Overall Study|Physician Decision|3|||
155336287|NCT01377844|560666208|FG000|Overall Study|Study terminated by Sponsor|0|||
155336288|NCT01377844|560666209|FG001|Overall Study|Study terminated by Sponsor|1|||
155336289|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
155336290|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336291|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336292|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336293|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
155336294|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336295|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336296|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336297|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
155336298|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336299|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336300|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336301|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
155336302|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336303|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336304|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336305|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
155336306|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336307|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336308|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336309|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
155336310|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336311|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336312|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336313|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
155336314|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336315|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336316|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336317|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155336318|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155336319|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
155336320|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155336321|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155336322|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
155336323|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
155336324|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
155336325|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155336326|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
155336327|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
155336328|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
155336329|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155336330|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155336331|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155336332|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155336333|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155336334|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155645769|NCT01436500|561794111|FG002|Overall Study|Withdrawal by Subject|2|||
155645770|NCT01436500|561794112|FG003|Overall Study|Withdrawal by Subject|0|||
155645771|NCT01436500|561794113|FG004|Overall Study|Withdrawal by Subject|2|||
155645772|NCT01436500|561794109|FG000|Overall Study|Physician Decision|0|||
155645773|NCT01436500|561794110|FG001|Overall Study|Physician Decision|0|||
155336335|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
155336336|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155336337|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155336338|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
155645774|NCT01436500|561794111|FG002|Overall Study|Physician Decision|1|||
155336339|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
155336340|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
155336341|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155336342|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155336343|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
155336344|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
155336345|NCT00667017|560666217|FG000|Overall Study|Withdrawal by Subject|1|||
155336346|NCT01848483|560666218|FG000|Overall Study|Death|2|||
155336347|NCT01848483|560666219|FG001|Overall Study|Death|1|||
155336348|NCT01848483|560666218|FG000|Overall Study|Lost to Follow-up|6|||
155336349|NCT01848483|560666219|FG001|Overall Study|Lost to Follow-up|8|||
155336350|NCT01848483|560666218|FG000|Overall Study|Withdrawal by Subject|1|||
155422962|NCT00944034|560978656|FG009|Overall Study|Inappropriate enrollment|1|||
155422963|NCT00944034|560978657|FG010|Overall Study|Inappropriate enrollment|0|||
155422964|NCT00944034|560978658|FG011|Overall Study|Inappropriate enrollment|0|||
155422965|NCT00944034|560978647|FG000|Overall Study|Withdrawal by Subject|3|||
155422966|NCT00944034|560978648|FG001|Overall Study|Withdrawal by Subject|2|||
155422967|NCT00944034|560978649|FG002|Overall Study|Withdrawal by Subject|6|||
155422968|NCT00944034|560978650|FG003|Overall Study|Withdrawal by Subject|2|||
155422969|NCT00944034|560978651|FG004|Overall Study|Withdrawal by Subject|5|||
155422970|NCT00944034|560978652|FG005|Overall Study|Withdrawal by Subject|8|||
155422971|NCT00944034|560978653|FG006|Overall Study|Withdrawal by Subject|2|||
155422972|NCT00944034|560978654|FG007|Overall Study|Withdrawal by Subject|2|||
155422973|NCT00944034|560978655|FG008|Overall Study|Withdrawal by Subject|3|||
155422974|NCT00944034|560978656|FG009|Overall Study|Withdrawal by Subject|4|||
155422975|NCT00944034|560978657|FG010|Overall Study|Withdrawal by Subject|0|||
155422976|NCT00944034|560978658|FG011|Overall Study|Withdrawal by Subject|4|||
155422977|NCT00944034|560978647|FG000|Overall Study|Lost to Follow-up|0|||
155422978|NCT00944034|560978648|FG001|Overall Study|Lost to Follow-up|4|||
155422979|NCT00944034|560978649|FG002|Overall Study|Lost to Follow-up|2|||
155422980|NCT00944034|560978650|FG003|Overall Study|Lost to Follow-up|0|||
155422981|NCT00944034|560978651|FG004|Overall Study|Lost to Follow-up|5|||
155422982|NCT00944034|560978652|FG005|Overall Study|Lost to Follow-up|7|||
155422983|NCT00944034|560978653|FG006|Overall Study|Lost to Follow-up|0|||
155422984|NCT00944034|560978654|FG007|Overall Study|Lost to Follow-up|1|||
155422985|NCT00944034|560978655|FG008|Overall Study|Lost to Follow-up|5|||
155422986|NCT00944034|560978656|FG009|Overall Study|Lost to Follow-up|1|||
155422987|NCT00944034|560978657|FG010|Overall Study|Lost to Follow-up|1|||
155422988|NCT00944034|560978658|FG011|Overall Study|Lost to Follow-up|0|||
155422989|NCT00944034|560978647|FG000|Overall Study|Death|0|||
155422990|NCT00944034|560978648|FG001|Overall Study|Death|0|||
155422991|NCT00944034|560978649|FG002|Overall Study|Death|1|||
155422992|NCT00944034|560978650|FG003|Overall Study|Death|0|||
155422993|NCT00944034|560978651|FG004|Overall Study|Death|0|||
155422994|NCT00944034|560978652|FG005|Overall Study|Death|0|||
155422995|NCT00944034|560978653|FG006|Overall Study|Death|0|||
155422996|NCT00944034|560978654|FG007|Overall Study|Death|0|||
155422997|NCT00944034|560978655|FG008|Overall Study|Death|0|||
155422998|NCT00944034|560978656|FG009|Overall Study|Death|0|||
155422999|NCT00944034|560978657|FG010|Overall Study|Death|0|||
155423000|NCT00944034|560978658|FG011|Overall Study|Death|0|||
155423001|NCT00944034|560978647|FG000|Overall Study|Protocol Violation|2|||
155423002|NCT00944034|560978648|FG001|Overall Study|Protocol Violation|0|||
155423003|NCT00944034|560978649|FG002|Overall Study|Protocol Violation|0|||
155423004|NCT00944034|560978650|FG003|Overall Study|Protocol Violation|1|||
155423005|NCT00944034|560978651|FG004|Overall Study|Protocol Violation|2|||
155423006|NCT00944034|560978652|FG005|Overall Study|Protocol Violation|3|||
155423007|NCT00944034|560978653|FG006|Overall Study|Protocol Violation|0|||
155423008|NCT00944034|560978654|FG007|Overall Study|Protocol Violation|1|||
155336351|NCT01848483|560666219|FG001|Overall Study|Withdrawal by Subject|0|||
155336352|NCT01848483|560666218|FG000|Overall Study|Incarceration|2|||
155423009|NCT00944034|560978655|FG008|Overall Study|Protocol Violation|1|||
155423010|NCT00944034|560978656|FG009|Overall Study|Protocol Violation|4|||
155503818|NCT00660790|561272004|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
155423011|NCT00944034|560978657|FG010|Overall Study|Protocol Violation|0|||
155503819|NCT00660790|561272004|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
155423012|NCT00944034|560978658|FG011|Overall Study|Protocol Violation|0|||
155503820|NCT00686374|561272010|FG000|Overall Study|Lack of Efficacy|10|||
155336353|NCT01848483|560666219|FG001|Overall Study|Incarceration|2|||
155336354|NCT00246129|560666222|FG000|Overall Study|Lost to Follow-up|1|||
155423013|NCT00944034|560978647|FG000|Overall Study|Unable to classify|0|||
155423014|NCT00944034|560978648|FG001|Overall Study|Unable to classify|0|||
155423015|NCT00944034|560978649|FG002|Overall Study|Unable to classify|0|||
155423016|NCT00944034|560978650|FG003|Overall Study|Unable to classify|0|||
155423017|NCT00944034|560978651|FG004|Overall Study|Unable to classify|0|||
155423018|NCT00944034|560978652|FG005|Overall Study|Unable to classify|1|||
155423019|NCT00944034|560978653|FG006|Overall Study|Unable to classify|1|||
155336355|NCT00246129|560666223|FG001|Overall Study|Lost to Follow-up|0|||
155336356|NCT00246129|560666222|FG000|Overall Study|Death|2|||
155336357|NCT00246129|560666223|FG001|Overall Study|Death|1|||
155336358|NCT00246129|560666222|FG000|Overall Study|suffered primary non-function|1|||
155336359|NCT00246129|560666223|FG001|Overall Study|suffered primary non-function|0|||
155336360|NCT00246129|560666222|FG000|Overall Study|grafts failed|3|||
155503821|NCT00686374|561272010|FG000|Overall Study|Adverse Event|8|||
155503822|NCT00686374|561272010|FG000|Overall Study|Withdrew consent|5|||
155503823|NCT00686374|561272010|FG000|Overall Study|Lost to Follow-up|1|||
155503824|NCT00686374|561272010|FG000|Overall Study|Missing reason|33|||
155503825|NCT00686374|561272010|FG000|Overall Study|Other, not specified|4|||
155503826|NCT00618774|561272011|FG000|Overall Study|Adverse Event|5|||
155503827|NCT00618774|561272012|FG001|Overall Study|Adverse Event|3|||
155503828|NCT00618774|561272011|FG000|Overall Study|Withdrawal by Subject|1|||
155503829|NCT00618774|561272012|FG001|Overall Study|Withdrawal by Subject|0|||
155503830|NCT02753400|561272014|FG000|Overall Study|Adverse Event|3|||
155503831|NCT02753400|561272015|FG001|Overall Study|Adverse Event|0|||
155503832|NCT02753400|561272014|FG000|Overall Study|Withdrawal by Subject|2|||
155336361|NCT00246129|560666223|FG001|Overall Study|grafts failed|1|||
155336362|NCT03469258|560666224|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
155336363|NCT03041090|560666230|FG000|Overall Study|technical error|0|||
155336364|NCT03041090|560666231|FG001|Overall Study|technical error|3|||
155336365|NCT02202317|560666232|FG000|Overall Study|Lost to Follow-up|1|||
155336366|NCT01353274|560666233|FG000|Overall Study|No case report form (CRF) collected|28|||
155336367|NCT02701296|560666234|FG000|Overall Study|Incomplete Data|0|||
155336368|NCT02701296|560666235|FG001|Overall Study|Incomplete Data|2|||
155336369|NCT01409837|560666238|FG000|Overall Study|Withdrawal by Subject|2|||
155336370|NCT01409837|560666239|FG001|Overall Study|Withdrawal by Subject|1|||
155336371|NCT01409837|560666238|FG000|Overall Study|Lost to Follow-up|1|||
155336372|NCT01409837|560666239|FG001|Overall Study|Lost to Follow-up|0|||
155336373|NCT01409837|560666238|FG000|Overall Study|Physician Decision|0|||
155336374|NCT01409837|560666239|FG001|Overall Study|Physician Decision|1|||
155336375|NCT00403494|560666241|FG000|Overall Study|Adverse Event|10|||
155336376|NCT00403494|560666242|FG001|Overall Study|Adverse Event|8|||
155336377|NCT00403494|560666241|FG000|Overall Study|Withdrew Consent|3|||
155336378|NCT00403494|560666242|FG001|Overall Study|Withdrew Consent|2|||
155336379|NCT00403494|560666241|FG000|Overall Study|Inappropriately enrolled|0|||
155336380|NCT00403494|560666242|FG001|Overall Study|Inappropriately enrolled|1|||
155336381|NCT00403494|560666241|FG000|Overall Study|Lost to Follow-up|0|||
155336382|NCT00403494|560666242|FG001|Overall Study|Lost to Follow-up|2|||
155336383|NCT00403494|560666241|FG000|Overall Study|Protocol noncompliance|0|||
155336384|NCT00403494|560666242|FG001|Overall Study|Protocol noncompliance|1|||
155336385|NCT00403494|560666241|FG000|Overall Study|Death|1|||
155336386|NCT00403494|560666242|FG001|Overall Study|Death|0|||
155336387|NCT00403494|560666241|FG000|Overall Study|Sponsor Request|1|||
155336388|NCT00403494|560666242|FG001|Overall Study|Sponsor Request|0|||
155336389|NCT03851094|560666244|FG000|Overall Study|Withdrawal by Subject|0|||
155336390|NCT03851094|560666245|FG001|Overall Study|Withdrawal by Subject|1|||
155336391|NCT03851094|560666244|FG000|Overall Study|Participant lost device|0|||
155336392|NCT03851094|560666245|FG001|Overall Study|Participant lost device|1|||
155336393|NCT03851094|560666244|FG000|Overall Study|Participant returned device|0|||
155336394|NCT03851094|560666245|FG001|Overall Study|Participant returned device|2|||
155336395|NCT04658784|560666246|FG000|6-month Follow-up|Lost to Follow-up|2|||
155336396|NCT04658784|560666247|FG001|6-month Follow-up|Lost to Follow-up|5|||
155336397|NCT03490032|560666248|FG000|Overall Study|family issue (child custody)|1|||
155336398|NCT03490032|560666249|FG001|Overall Study|family issue (child custody)|0|||
155336399|NCT03490032|560666250|FG002|Overall Study|family issue (child custody)|0|||
155336400|NCT02958553|560666251|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
155336401|NCT02958553|560666251|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
155336402|NCT00308308|560666253|FG000|Overall Study|Adverse Event|17|||
155336403|NCT00308308|560666254|FG001|Overall Study|Adverse Event|2|||
155336404|NCT00308308|560666253|FG000|Overall Study|Lost to Follow-up|5|||
155336405|NCT00308308|560666254|FG001|Overall Study|Lost to Follow-up|5|||
155336406|NCT00308308|560666253|FG000|Overall Study|Physician Decision|15|||
155336407|NCT00308308|560666254|FG001|Overall Study|Physician Decision|7|||
155336408|NCT00308308|560666253|FG000|Overall Study|Protocol Violation|3|||
155336409|NCT00308308|560666254|FG001|Overall Study|Protocol Violation|14|||
155336410|NCT00308308|560666253|FG000|Overall Study|Withdrawal by Subject|47|||
155336411|NCT00308308|560666254|FG001|Overall Study|Withdrawal by Subject|19|||
155336412|NCT00308308|560666253|FG000|Overall Study|Various|7|||
155336413|NCT00308308|560666254|FG001|Overall Study|Various|5|||
155336414|NCT00308308|560666253|FG000|Overall Study|Randomized but not dosed|8|||
155336415|NCT00308308|560666254|FG001|Overall Study|Randomized but not dosed|16|||
155336416|NCT00308308|560666253|FG000|Overall Study|Other|1|||
155336417|NCT00308308|560666254|FG001|Overall Study|Other|0|||
155503833|NCT02753400|561272015|FG001|Overall Study|Withdrawal by Subject|1|||
155336418|NCT02392507|560666261|FG000|Induction Regimen|Death|3|||
155503834|NCT03989115|561272016|FG000|Overall Study|Withdrawal by Subject|2|||
155336419|NCT02392507|560666261|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
155336420|NCT02392507|560666261|FG000|Induction Regimen|Physician Decision|1|||
155336421|NCT02392507|560666261|FG000|Induction Regimen|Withdrawal by Subject|2|||
155336422|NCT02392507|560666261|FG000|Maintenance Regimen|Death|1|||
155336423|NCT02392507|560666261|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
155336424|NCT01802333|560666266|FG000|Overall Study|Ineligible|2|||
155336425|NCT01802333|560666267|FG001|Overall Study|Ineligible|6|||
155336426|NCT01802333|560666268|FG002|Overall Study|Ineligible|8|||
155336427|NCT01802333|560666266|FG000|Overall Study|Adverse Event|1|||
155336428|NCT01802333|560666267|FG001|Overall Study|Adverse Event|8|||
155336429|NCT01802333|560666268|FG002|Overall Study|Adverse Event|8|||
155336430|NCT01802333|560666266|FG000|Overall Study|Withdrawal by Subject|6|||
155336431|NCT01802333|560666267|FG001|Overall Study|Withdrawal by Subject|6|||
155336432|NCT01802333|560666268|FG002|Overall Study|Withdrawal by Subject|5|||
155336433|NCT01802333|560666266|FG000|Overall Study|Progression/relapse|1|||
155336434|NCT01802333|560666267|FG001|Overall Study|Progression/relapse|3|||
155336435|NCT01802333|560666268|FG002|Overall Study|Progression/relapse|0|||
155336436|NCT01802333|560666266|FG000|Overall Study|Death|7|||
155336437|NCT01802333|560666267|FG001|Overall Study|Death|14|||
155336438|NCT01802333|560666268|FG002|Overall Study|Death|13|||
155336439|NCT01802333|560666266|FG000|Overall Study|Other - not protocol specified|32|||
155336440|NCT01802333|560666267|FG001|Overall Study|Other - not protocol specified|22|||
155336441|NCT01802333|560666268|FG002|Overall Study|Other - not protocol specified|24|||
155336442|NCT01802333|560666266|FG000|Overall Study|Did not start treatment|0|||
155336443|NCT01802333|560666267|FG001|Overall Study|Did not start treatment|2|||
155336444|NCT01802333|560666268|FG002|Overall Study|Did not start treatment|5|||
155336445|NCT02224755|560666269|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
155336446|NCT02224755|560666270|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
155336447|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Death|103|||
155336448|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Death|98|||
155336449|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
155336450|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
155336451|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
155336452|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
155336453|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
155336454|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
155336455|NCT01951703|560666271|FG000|First Intervention|Withdrawal by Subject|1|||
155336456|NCT01951703|560666272|FG001|First Intervention|Withdrawal by Subject|0|||
155336457|NCT01951703|560666271|FG000|First Intervention|Subject was not compliant|1|||
155336458|NCT01951703|560666272|FG001|First Intervention|Subject was not compliant|1|||
155336459|NCT01951703|560666271|FG000|First Intervention|Physician Decision|1|||
155336460|NCT01951703|560666272|FG001|First Intervention|Physician Decision|0|||
155336461|NCT01951703|560666271|FG000|Second Intervention|Protocol Violation|0|||
155336462|NCT01951703|560666272|FG001|Second Intervention|Protocol Violation|1|||
155336463|NCT01951703|560666271|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
155336464|NCT01951703|560666272|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
155336465|NCT00240994|560666275|FG000|Overall Study|Lost to Follow-up|1|||
155336466|NCT00240994|560666275|FG000|Overall Study|Protocol Violation|1|||
155336467|NCT00240994|560666275|FG000|Overall Study|Graft failure|1|||
155336468|NCT01019135|560666280|FG000|Overall Study|Did not receive allocated intervention|12|||
155336469|NCT01019135|560666281|FG001|Overall Study|Did not receive allocated intervention|6|||
155336470|NCT01019135|560666282|FG002|Overall Study|Did not receive allocated intervention|25|||
155336471|NCT01019135|560666280|FG000|Overall Study|Did not attend CR|8|||
155336472|NCT01019135|560666281|FG001|Overall Study|Did not attend CR|13|||
155336473|NCT01019135|560666282|FG002|Overall Study|Did not attend CR|6|||
155336474|NCT05124210|560666283|FG000|Overall Study|Lost to Follow-up|1|||
155336475|NCT05124210|560666284|FG001|Overall Study|Lost to Follow-up|0|||
155336476|NCT05124210|560666283|FG000|Overall Study|Withdrawal by Subject|1|||
155336477|NCT05124210|560666284|FG001|Overall Study|Withdrawal by Subject|0|||
155336478|NCT00638456|560666285|FG000|Overall Study|Withdrawal by Subject|6|||
155336479|NCT00638456|560666286|FG001|Overall Study|Withdrawal by Subject|2|||
155336480|NCT02007070|560666287|FG000|Overall Study|Adverse Event|4|||
155336481|NCT02007070|560666287|FG000|Overall Study|Clinical Progression|4|||
155336482|NCT02007070|560666287|FG000|Overall Study|Death|1|||
155423020|NCT00944034|560978654|FG007|Overall Study|Unable to classify|1|||
155423021|NCT00944034|560978655|FG008|Overall Study|Unable to classify|0|||
155423022|NCT00944034|560978656|FG009|Overall Study|Unable to classify|0|||
155423023|NCT00944034|560978657|FG010|Overall Study|Unable to classify|0|||
155336483|NCT02007070|560666287|FG000|Overall Study|Protocol Violation|2|||
155336484|NCT02007070|560666287|FG000|Overall Study|Physician Decision|1|||
155336485|NCT02007070|560666287|FG000|Overall Study|Progressive Disease|21|||
155336486|NCT03128099|560666288|FG000|Overall Study|High dose task was too long|0|||
155336487|NCT03128099|560666289|FG001|Overall Study|High dose task was too long|4|||
155336488|NCT03128099|560666290|FG002|Overall Study|High dose task was too long|0|||
155645775|NCT01436500|561794112|FG003|Overall Study|Physician Decision|0|||
155336489|NCT03128099|560666288|FG000|Overall Study|Participant got a full time job.|1|||
155645776|NCT01436500|561794113|FG004|Overall Study|Physician Decision|0|||
155336490|NCT03128099|560666289|FG001|Overall Study|Participant got a full time job.|0|||
155336491|NCT03128099|560666290|FG002|Overall Study|Participant got a full time job.|0|||
155336492|NCT03128099|560666288|FG000|Overall Study|Became homeless and lost contact|1|||
155336493|NCT03128099|560666289|FG001|Overall Study|Became homeless and lost contact|0|||
155336494|NCT03128099|560666290|FG002|Overall Study|Became homeless and lost contact|0|||
155336495|NCT03128099|560666288|FG000|Overall Study|Did not complete all the assessments|0|||
155336496|NCT03128099|560666289|FG001|Overall Study|Did not complete all the assessments|0|||
155336497|NCT03128099|560666290|FG002|Overall Study|Did not complete all the assessments|1|||
155336498|NCT02362789|560666296|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
155336499|NCT02362789|560666297|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
155336500|NCT02362789|560666298|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
155336501|NCT02362789|560666296|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
155336502|NCT02362789|560666297|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
155336503|NCT02362789|560666298|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
155336504|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
155336505|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
155336506|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
155336507|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
155336508|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
155336509|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
155336510|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
155336511|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
155336512|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
155336513|NCT05270460|560666301|FG000|Overall Study|Adverse Event|0|||
155336514|NCT05270460|560666302|FG001|Overall Study|Adverse Event|1|||
155336515|NCT05270460|560666303|FG002|Overall Study|Adverse Event|0|||
155336516|NCT05270460|560666301|FG000|Overall Study|Early Termination|0|||
155336517|NCT05270460|560666302|FG001|Overall Study|Early Termination|1|||
155336518|NCT05270460|560666303|FG002|Overall Study|Early Termination|0|||
155336519|NCT00680771|560666306|FG000|Overall Study|Withdrawal by Subject|1|||
155336520|NCT00680771|560666307|FG001|Overall Study|Withdrawal by Subject|0|||
155336521|NCT00680771|560666306|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
155336522|NCT00680771|560666307|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
155336523|NCT00680771|560666306|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
155336524|NCT00680771|560666307|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
155336525|NCT03205488|560666319|FG000|Overall Study|Adverse Event|1|||
155336526|NCT03205488|560666320|FG001|Overall Study|Adverse Event|2|||
155336527|NCT03205488|560666321|FG002|Overall Study|Adverse Event|4|||
155336528|NCT03205488|560666319|FG000|Overall Study|Protocol Violation|0|||
155336529|NCT03205488|560666320|FG001|Overall Study|Protocol Violation|0|||
155336530|NCT03205488|560666321|FG002|Overall Study|Protocol Violation|1|||
155336531|NCT03652610|560666322|FG000|Overall Study|Lost to Follow-up|1|||
155336532|NCT03652610|560666323|FG001|Overall Study|Lost to Follow-up|0|||
155336533|NCT03652610|560666322|FG000|Overall Study|Withdrawal by Subject|3|||
155336534|NCT03652610|560666323|FG001|Overall Study|Withdrawal by Subject|5|||
155336535|NCT04748341|560666325|FG000|Overall Study|Lost to Follow-up|1|||
155336536|NCT04748341|560666326|FG001|Overall Study|Lost to Follow-up|1|||
155336537|NCT02334215|560666327|FG000|Overall Study|Death|1|||
155336538|NCT02334215|560666328|FG001|Overall Study|Death|1|||
155336539|NCT02334215|560666329|FG002|Overall Study|Death|0|||
155503835|NCT03989115|561272017|FG001|Overall Study|Withdrawal by Subject|1|||
155645777|NCT01436500|561794109|FG000|Overall Study|liver transplant|1|||
155336540|NCT02334215|560666327|FG000|Overall Study|Lost to Follow-up|1|||
155336541|NCT02334215|560666328|FG001|Overall Study|Lost to Follow-up|0|||
155336542|NCT02334215|560666329|FG002|Overall Study|Lost to Follow-up|4|||
155336543|NCT02334215|560666327|FG000|Overall Study|Withdrawal by Subject|2|||
155336544|NCT02334215|560666328|FG001|Overall Study|Withdrawal by Subject|2|||
155336545|NCT02334215|560666329|FG002|Overall Study|Withdrawal by Subject|1|||
155336546|NCT02334215|560666327|FG000|Overall Study|Not released from incarceration on time|3|||
155336547|NCT02334215|560666328|FG001|Overall Study|Not released from incarceration on time|3|||
155336548|NCT02334215|560666329|FG002|Overall Study|Not released from incarceration on time|3|||
155336549|NCT02334215|560666327|FG000|Overall Study|Incarcerated|0|||
155336550|NCT02334215|560666328|FG001|Overall Study|Incarcerated|0|||
155336551|NCT02334215|560666329|FG002|Overall Study|Incarcerated|7|||
155336552|NCT05615363|560666330|FG000|Overall Study|Adverse Event|0|||
155336553|NCT05615363|560666331|FG001|Overall Study|Adverse Event|4|||
155645778|NCT01436500|561794110|FG001|Overall Study|liver transplant|0|||
155336554|NCT05615363|560666332|FG002|Overall Study|Adverse Event|4|||
155336555|NCT05615363|560666333|FG003|Overall Study|Adverse Event|3|||
155336556|NCT05615363|560666334|FG004|Overall Study|Adverse Event|1|||
155336557|NCT05615363|560666330|FG000|Overall Study|Physician Decision|2|||
155336558|NCT05615363|560666331|FG001|Overall Study|Physician Decision|0|||
155503836|NCT03989115|561272018|FG002|Overall Study|Withdrawal by Subject|3|||
155503837|NCT03989115|561272019|FG003|Overall Study|Withdrawal by Subject|0|||
155503838|NCT03989115|561272020|FG004|Overall Study|Withdrawal by Subject|17|||
155503839|NCT03989115|561272021|FG005|Overall Study|Withdrawal by Subject|1|||
155503840|NCT03989115|561272022|FG006|Overall Study|Withdrawal by Subject|0|||
155503841|NCT03989115|561272023|FG007|Overall Study|Withdrawal by Subject|0|||
155503842|NCT03989115|561272016|FG000|Overall Study|Sponsor decision to terminate the study|1|||
155503843|NCT03989115|561272017|FG001|Overall Study|Sponsor decision to terminate the study|1|||
155503844|NCT03989115|561272018|FG002|Overall Study|Sponsor decision to terminate the study|0|||
155503845|NCT03989115|561272019|FG003|Overall Study|Sponsor decision to terminate the study|1|||
155503846|NCT03989115|561272020|FG004|Overall Study|Sponsor decision to terminate the study|11|||
155503847|NCT03989115|561272021|FG005|Overall Study|Sponsor decision to terminate the study|0|||
155503848|NCT03989115|561272022|FG006|Overall Study|Sponsor decision to terminate the study|2|||
155503849|NCT03989115|561272023|FG007|Overall Study|Sponsor decision to terminate the study|1|||
155503850|NCT03989115|561272016|FG000|Overall Study|Lost to Follow-up|2|||
155503851|NCT03989115|561272017|FG001|Overall Study|Lost to Follow-up|0|||
155503852|NCT03989115|561272018|FG002|Overall Study|Lost to Follow-up|0|||
155503853|NCT03989115|561272019|FG003|Overall Study|Lost to Follow-up|0|||
155336559|NCT05615363|560666332|FG002|Overall Study|Physician Decision|4|||
155503854|NCT03989115|561272020|FG004|Overall Study|Lost to Follow-up|1|||
155503855|NCT03989115|561272021|FG005|Overall Study|Lost to Follow-up|0|||
155503856|NCT03989115|561272022|FG006|Overall Study|Lost to Follow-up|0|||
155503857|NCT03989115|561272023|FG007|Overall Study|Lost to Follow-up|0|||
155503858|NCT03989115|561272016|FG000|Overall Study|Death|2|||
155503859|NCT03989115|561272017|FG001|Overall Study|Death|2|||
155503860|NCT03989115|561272018|FG002|Overall Study|Death|9|||
155503861|NCT03989115|561272019|FG003|Overall Study|Death|6|||
155503862|NCT03989115|561272020|FG004|Overall Study|Death|31|||
155503863|NCT03989115|561272021|FG005|Overall Study|Death|6|||
155503864|NCT03989115|561272022|FG006|Overall Study|Death|2|||
155503865|NCT03989115|561272023|FG007|Overall Study|Death|3|||
155503866|NCT03989115|561272016|FG000|Overall Study|Other|1|||
155503867|NCT03989115|561272017|FG001|Overall Study|Other|2|||
155503868|NCT03989115|561272018|FG002|Overall Study|Other|0|||
155503869|NCT03989115|561272019|FG003|Overall Study|Other|0|||
155503870|NCT03989115|561272020|FG004|Overall Study|Other|5|||
155503871|NCT03989115|561272021|FG005|Overall Study|Other|0|||
155503872|NCT03989115|561272022|FG006|Overall Study|Other|0|||
155503873|NCT03989115|561272023|FG007|Overall Study|Other|0|||
155336560|NCT05615363|560666333|FG003|Overall Study|Physician Decision|1|||
155336561|NCT05615363|560666334|FG004|Overall Study|Physician Decision|3|||
155336562|NCT05615363|560666330|FG000|Overall Study|Protocol Violation|2|||
155336563|NCT05615363|560666331|FG001|Overall Study|Protocol Violation|0|||
155336564|NCT05615363|560666332|FG002|Overall Study|Protocol Violation|0|||
155336565|NCT05615363|560666333|FG003|Overall Study|Protocol Violation|0|||
155336566|NCT05615363|560666334|FG004|Overall Study|Protocol Violation|1|||
155336567|NCT05615363|560666330|FG000|Overall Study|Withdrawal by Subject|0|||
155503874|NCT02143947|561272024|FG000|Overall Study|Lost to Follow-up|4|||
155503875|NCT02143947|561272025|FG001|Overall Study|Lost to Follow-up|2|||
155503876|NCT01244815|561272028|FG000|Overall Study|Not Treated|0|||
155503877|NCT01244815|561272029|FG001|Overall Study|Not Treated|1|||
155503878|NCT01244815|561272030|FG002|Overall Study|Not Treated|0|||
155503879|NCT01244815|561272031|FG003|Overall Study|Not Treated|0|||
155336568|NCT05615363|560666331|FG001|Overall Study|Withdrawal by Subject|0|||
155503880|NCT01244815|561272028|FG000|Overall Study|Adverse Event|4|||
155503881|NCT01244815|561272029|FG001|Overall Study|Adverse Event|7|||
155503882|NCT01244815|561272030|FG002|Overall Study|Adverse Event|5|||
155503883|NCT01244815|561272031|FG003|Overall Study|Adverse Event|5|||
155503884|NCT01244815|561272028|FG000|Overall Study|Treatment Failure|0|||
155503885|NCT01244815|561272029|FG001|Overall Study|Treatment Failure|0|||
155503886|NCT01244815|561272030|FG002|Overall Study|Treatment Failure|0|||
155336569|NCT05615363|560666332|FG002|Overall Study|Withdrawal by Subject|1|||
155336570|NCT05615363|560666333|FG003|Overall Study|Withdrawal by Subject|0|||
155336571|NCT05615363|560666334|FG004|Overall Study|Withdrawal by Subject|0|||
155336572|NCT01276509|560668171|FG000|Overall Study|Adverse Event|9|||
155503887|NCT01244815|561272031|FG003|Overall Study|Treatment Failure|1|||
155503888|NCT01244815|561272028|FG000|Overall Study|Lost to Follow-up|3|||
155503889|NCT01244815|561272029|FG001|Overall Study|Lost to Follow-up|2|||
155503890|NCT01244815|561272030|FG002|Overall Study|Lost to Follow-up|3|||
155503891|NCT01244815|561272031|FG003|Overall Study|Lost to Follow-up|2|||
155503892|NCT01244815|561272028|FG000|Overall Study|Withdrawal by Subject|0|||
155503893|NCT01244815|561272029|FG001|Overall Study|Withdrawal by Subject|2|||
155336573|NCT01276509|560668172|FG001|Overall Study|Adverse Event|8|||
155336574|NCT01276509|560668173|FG002|Overall Study|Adverse Event|4|||
155423024|NCT00944034|560978658|FG011|Overall Study|Unable to classify|0|||
155423025|NCT00944034|560978647|FG000|Overall Study|Administrative reason|0|||
155423026|NCT00944034|560978648|FG001|Overall Study|Administrative reason|0|||
155423027|NCT00944034|560978649|FG002|Overall Study|Administrative reason|0|||
155423028|NCT00944034|560978650|FG003|Overall Study|Administrative reason|0|||
155423029|NCT00944034|560978651|FG004|Overall Study|Administrative reason|0|||
155423030|NCT00944034|560978652|FG005|Overall Study|Administrative reason|0|||
155423031|NCT00944034|560978653|FG006|Overall Study|Administrative reason|1|||
155423032|NCT00944034|560978654|FG007|Overall Study|Administrative reason|0|||
155423033|NCT00944034|560978655|FG008|Overall Study|Administrative reason|0|||
155423034|NCT00944034|560978656|FG009|Overall Study|Administrative reason|0|||
155423035|NCT00944034|560978657|FG010|Overall Study|Administrative reason|0|||
155423036|NCT00944034|560978658|FG011|Overall Study|Administrative reason|0|||
155423037|NCT02347631|560978667|FG000|First Intervention (2 Months)|Adverse Event|1|||
155423038|NCT02347631|560978668|FG001|First Intervention (2 Months)|Adverse Event|1|||
155423039|NCT02347631|560978667|FG000|First Intervention (2 Months)|Pregnancy|1|||
155336575|NCT01276509|560668174|FG003|Overall Study|Adverse Event|3|||
155336576|NCT01276509|560668171|FG000|Overall Study|Lack of Efficacy|2|||
155336577|NCT01276509|560668172|FG001|Overall Study|Lack of Efficacy|1|||
155336578|NCT01276509|560668173|FG002|Overall Study|Lack of Efficacy|1|||
155336579|NCT01276509|560668174|FG003|Overall Study|Lack of Efficacy|2|||
155336580|NCT01276509|560668171|FG000|Overall Study|Pregnancy|1|||
155336581|NCT01276509|560668172|FG001|Overall Study|Pregnancy|0|||
155336582|NCT01276509|560668173|FG002|Overall Study|Pregnancy|0|||
155336583|NCT01276509|560668174|FG003|Overall Study|Pregnancy|0|||
155336584|NCT01276509|560668171|FG000|Overall Study|Withdrawal by Subject|1|||
155336585|NCT01276509|560668172|FG001|Overall Study|Withdrawal by Subject|2|||
155336586|NCT01276509|560668173|FG002|Overall Study|Withdrawal by Subject|0|||
155336587|NCT01276509|560668174|FG003|Overall Study|Withdrawal by Subject|0|||
155336588|NCT01276509|560668171|FG000|Overall Study|Other|0|||
155336589|NCT01276509|560668172|FG001|Overall Study|Other|1|||
155336590|NCT01276509|560668173|FG002|Overall Study|Other|0|||
155336591|NCT01276509|560668174|FG003|Overall Study|Other|0|||
155336592|NCT03403036|560668178|FG000|Overall Study|Lack of Efficacy|5|||
155336593|NCT01128959|560668179|FG000|Lead in Period|Adverse Event|3|||
155336594|NCT01128959|560668179|FG000|Treatment Period|Adverse Event|3|||
155336595|NCT01128959|560668179|FG000|Treatment Period|Withdrawal by Subject|1|||
155336596|NCT02338999|560668180|FG000|First Intervention|Withdrawal by Subject|3|||
155336597|NCT02338999|560668181|FG001|First Intervention|Withdrawal by Subject|1|||
155336598|NCT02338999|560668180|FG000|Washout Period|Withdrawal by Subject|0|||
155336599|NCT02338999|560668181|FG001|Washout Period|Withdrawal by Subject|2|||
155336600|NCT02338999|560668180|FG000|Second Intervention|Withdrawal by Subject|0|||
155336601|NCT02338999|560668181|FG001|Second Intervention|Withdrawal by Subject|2|||
155423040|NCT02347631|560978668|FG001|First Intervention (2 Months)|Pregnancy|0|||
155423041|NCT02347631|560978667|FG000|First Intervention (2 Months)|Moved out of area|0|||
155336602|NCT01450007|560668183|FG000|Overall Study|Late exclusion before treatment|2|||
155336603|NCT01450007|560668184|FG001|Overall Study|Late exclusion before treatment|3|||
155503894|NCT01244815|561272030|FG002|Overall Study|Withdrawal by Subject|0|||
155336604|NCT01450007|560668185|FG002|Overall Study|Late exclusion before treatment|2|||
155503895|NCT01244815|561272031|FG003|Overall Study|Withdrawal by Subject|3|||
155503896|NCT01244815|561272028|FG000|Overall Study|Protocol Violation|7|||
155503897|NCT01244815|561272029|FG001|Overall Study|Protocol Violation|4|||
155503898|NCT01244815|561272030|FG002|Overall Study|Protocol Violation|3|||
155503899|NCT01244815|561272031|FG003|Overall Study|Protocol Violation|1|||
155503900|NCT01244815|561272028|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
155503901|NCT01244815|561272029|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
155503902|NCT01244815|561272030|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
155503903|NCT01244815|561272031|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
155503904|NCT00697112|561272032|FG000|Overall Study|Adverse Event|8|||
155503905|NCT00697112|561272032|FG000|Overall Study|Lost to Follow-up|1|||
155503906|NCT00697112|561272032|FG000|Overall Study|Did not meet inclusion criteria|1|||
155503907|NCT03402126|561272037|FG000|Overall Study|Lost to Follow-up|6|||
155503908|NCT03402126|561272037|FG000|Overall Study|Protocol Violation|10|||
155503909|NCT03402126|561272037|FG000|Overall Study|Sponsor request/Study termination|29|||
155503910|NCT03402126|561272037|FG000|Overall Study|Study product no longer in use|1|||
155503911|NCT03402126|561272037|FG000|Overall Study|Technical problems|1|||
155503912|NCT03402126|561272037|FG000|Overall Study|Withdrawal by Subject|6|||
155503913|NCT03402126|561272037|FG000|Overall Study|Physician Decision|2|||
155503914|NCT03402126|561272037|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
155503915|NCT03402126|561272037|FG000|Overall Study|Death|4|||
155503916|NCT02261974|561272038|FG000|Overall Study|Withdrawal by Subject|3|||
155503917|NCT02261974|561272039|FG001|Overall Study|Withdrawal by Subject|2|||
155503918|NCT02261974|561272038|FG000|Overall Study|Pregnancy|0|||
155503919|NCT02261974|561272039|FG001|Overall Study|Pregnancy|1|||
155503920|NCT02261974|561272038|FG000|Overall Study|Missed treatment cut-off date|6|||
155503921|NCT02261974|561272039|FG001|Overall Study|Missed treatment cut-off date|3|||
155503922|NCT02261974|561272038|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
155503923|NCT02261974|561272039|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
155503924|NCT02261974|561272038|FG000|Overall Study|Lost to Follow-up|2|||
155503925|NCT02261974|561272039|FG001|Overall Study|Lost to Follow-up|0|||
155503926|NCT02261974|561272038|FG000|Overall Study|Adverse Event|1|||
155503927|NCT02261974|561272039|FG001|Overall Study|Adverse Event|0|||
155503928|NCT00709735|561272042|FG000|Overall Study|Lost to Follow-up|1|||
155503929|NCT00709735|561272043|FG001|Overall Study|Lost to Follow-up|1|||
155503930|NCT00709735|561272042|FG000|Overall Study|Relapse into Opioid Abuse|0|||
155503931|NCT00709735|561272043|FG001|Overall Study|Relapse into Opioid Abuse|1|||
155503932|NCT00709735|561272042|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
155503933|NCT00709735|561272043|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
155503934|NCT02555618|561272046|FG000|Overall Study|Sponsor's Circumstances|1|||
155503935|NCT02555618|561272047|FG001|Overall Study|Sponsor's Circumstances|0|||
155503936|NCT01021137|561272055|FG000|Overall Study|Lost to Follow-up|9|||
155503937|NCT01021137|561272056|FG001|Overall Study|Lost to Follow-up|4|||
155503938|NCT01021137|561272057|FG002|Overall Study|Lost to Follow-up|2|||
155503939|NCT01021137|561272058|FG003|Overall Study|Lost to Follow-up|6|||
155503940|NCT01021137|561272055|FG000|Overall Study|Withdrawal by Subject|1|||
155336605|NCT01450007|560668183|FG000|Overall Study|Protocol Violation|0|||
155336606|NCT01450007|560668184|FG001|Overall Study|Protocol Violation|1|||
155336607|NCT01450007|560668185|FG002|Overall Study|Protocol Violation|1|||
155336608|NCT01450007|560668183|FG000|Overall Study|Adverse Event|0|||
155336609|NCT01450007|560668184|FG001|Overall Study|Adverse Event|1|||
155336610|NCT01450007|560668185|FG002|Overall Study|Adverse Event|0|||
155336611|NCT00484198|560668186|FG000|Overall Study|Participant Withdrew Consent|12|||
155503941|NCT01021137|561272056|FG001|Overall Study|Withdrawal by Subject|0|||
155503942|NCT01021137|561272057|FG002|Overall Study|Withdrawal by Subject|0|||
155503943|NCT01021137|561272058|FG003|Overall Study|Withdrawal by Subject|3|||
155503944|NCT02176642|561272068|FG000|Overall Study|Withdrawal by Subject|0|||
155503945|NCT02176642|561272069|FG001|Overall Study|Withdrawal by Subject|1|||
155503946|NCT03338673|561272071|FG000|Overall Study|Lost to Follow-up|1|||
155503947|NCT03338673|561272072|FG001|Overall Study|Lost to Follow-up|1|||
155336612|NCT00484198|560668187|FG001|Overall Study|Participant Withdrew Consent|21|||
155503948|NCT04523831|561272082|FG000|Overall Study|Lost to Follow-up|15|||
155503949|NCT04523831|561272083|FG001|Overall Study|Lost to Follow-up|17|||
155503950|NCT04523831|561272082|FG000|Overall Study|Death|0|||
155503951|NCT04523831|561272083|FG001|Overall Study|Death|3|||
155503952|NCT04523831|561272082|FG000|Overall Study|Adverse Event|2|||
155503953|NCT04523831|561272083|FG001|Overall Study|Adverse Event|0|||
155503954|NCT04556838|561272084|FG000|Overall Study|Withdrawal by Subject|3|||
155503955|NCT04556838|561272085|FG001|Overall Study|Withdrawal by Subject|1|||
155503956|NCT04556838|561272086|FG002|Overall Study|Withdrawal by Subject|2|||
155503957|NCT04556838|561272084|FG000|Overall Study|Adverse Event|0|||
155503958|NCT04556838|561272085|FG001|Overall Study|Adverse Event|1|||
155503959|NCT04556838|561272086|FG002|Overall Study|Adverse Event|1|||
155503960|NCT04556838|561272084|FG000|Overall Study|Lost to Follow-up|0|||
155336613|NCT00484198|560668188|FG002|Overall Study|Participant Withdrew Consent|47|||
155336614|NCT00484198|560668189|FG003|Overall Study|Participant Withdrew Consent|59|||
155336615|NCT00484198|560668186|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
155336616|NCT00484198|560668187|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
155336617|NCT00484198|560668188|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
155336618|NCT00484198|560668189|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
155336619|NCT00484198|560668186|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
155336620|NCT00484198|560668187|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
155503961|NCT04556838|561272085|FG001|Overall Study|Lost to Follow-up|0|||
155503962|NCT04556838|561272086|FG002|Overall Study|Lost to Follow-up|2|||
155503963|NCT04556838|561272084|FG000|Overall Study|Subject travel|0|||
155503964|NCT04556838|561272085|FG001|Overall Study|Subject travel|1|||
155336621|NCT00484198|560668188|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
155336622|NCT00484198|560668189|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
155336623|NCT00484198|560668186|FG000|Overall Study|Adverse Event|3|||
155336624|NCT00484198|560668187|FG001|Overall Study|Adverse Event|11|||
155336625|NCT00484198|560668188|FG002|Overall Study|Adverse Event|32|||
155503965|NCT04556838|561272086|FG002|Overall Study|Subject travel|0|||
155503966|NCT04556838|561272084|FG000|Overall Study|Physician Decision|1|||
155503967|NCT04556838|561272085|FG001|Overall Study|Physician Decision|0|||
155503968|NCT04556838|561272086|FG002|Overall Study|Physician Decision|0|||
155503969|NCT05788237|561272091|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
155645779|NCT01436500|561794111|FG002|Overall Study|liver transplant|0|||
155645780|NCT01436500|561794112|FG003|Overall Study|liver transplant|0|||
155645781|NCT01436500|561794113|FG004|Overall Study|liver transplant|0|||
155336626|NCT00484198|560668189|FG003|Overall Study|Adverse Event|31|||
155336627|NCT00484198|560668186|FG000|Overall Study|Protocol Violation|0|||
155645782|NCT01436500|561794109|FG000|Overall Study|initiation of dialysis|0|||
155645783|NCT01436500|561794110|FG001|Overall Study|initiation of dialysis|0|||
155336628|NCT00484198|560668187|FG001|Overall Study|Protocol Violation|5|||
155336629|NCT00484198|560668188|FG002|Overall Study|Protocol Violation|6|||
155336630|NCT00484198|560668189|FG003|Overall Study|Protocol Violation|8|||
155336631|NCT00484198|560668186|FG000|Overall Study|Other|7|||
155336632|NCT00484198|560668187|FG001|Overall Study|Other|10|||
155336633|NCT00484198|560668188|FG002|Overall Study|Other|31|||
155336634|NCT00484198|560668189|FG003|Overall Study|Other|28|||
155336635|NCT01536704|560668190|FG000|Washout Period 1|Withdrawal by Subject|1|||
155336636|NCT01536704|560668191|FG001|Washout Period 1|Withdrawal by Subject|2|||
155336637|NCT01536704|560668192|FG002|Washout Period 1|Withdrawal by Subject|0|||
155336638|NCT01536704|560668193|FG003|Washout Period 1|Withdrawal by Subject|0|||
155336639|NCT01536704|560668190|FG000|Washout Period 2|Adverse Event|1|||
155336640|NCT01536704|560668191|FG001|Washout Period 2|Adverse Event|0|||
155503970|NCT05788237|561272092|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
155503971|NCT05788237|561272093|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
155503972|NCT05788237|561272094|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
155503973|NCT05788237|561272091|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
155503974|NCT05788237|561272092|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
155645784|NCT01436500|561794111|FG002|Overall Study|initiation of dialysis|0|||
155645785|NCT01436500|561794112|FG003|Overall Study|initiation of dialysis|0|||
155645786|NCT01436500|561794113|FG004|Overall Study|initiation of dialysis|1|||
155645787|NCT01436500|561794109|FG000|Overall Study|discontinued study drug|1|||
155645788|NCT01436500|561794110|FG001|Overall Study|discontinued study drug|0|||
155645789|NCT01436500|561794111|FG002|Overall Study|discontinued study drug|0|||
155645790|NCT01436500|561794112|FG003|Overall Study|discontinued study drug|0|||
155645791|NCT01436500|561794113|FG004|Overall Study|discontinued study drug|0|||
155645792|NCT01436500|561794109|FG000|Overall Study|Other|0|||
155645793|NCT01436500|561794110|FG001|Overall Study|Other|1|||
155645794|NCT01436500|561794111|FG002|Overall Study|Other|0|||
155645795|NCT01436500|561794112|FG003|Overall Study|Other|1|||
155645796|NCT01436500|561794113|FG004|Overall Study|Other|0|||
155645797|NCT04625972|561794117|FG000|Overall Study|Death|3|||
155645798|NCT04625972|561794118|FG001|Overall Study|Death|2|||
155645799|NCT04625972|561794117|FG000|Overall Study|Lost to Follow-up|82|||
155645800|NCT04625972|561794118|FG001|Overall Study|Lost to Follow-up|38|||
155645801|NCT04625972|561794117|FG000|Overall Study|Physician Decision|2|||
155645802|NCT04625972|561794118|FG001|Overall Study|Physician Decision|0|||
155503975|NCT05788237|561272093|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
155503976|NCT05788237|561272094|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
155503977|NCT05788237|561272091|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
155503978|NCT05788237|561272092|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
155503979|NCT05788237|561272093|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
155503980|NCT05788237|561272094|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
155503981|NCT05788237|561272091|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
155503982|NCT05788237|561272092|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
155503983|NCT05788237|561272093|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
155503984|NCT05788237|561272094|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
155503985|NCT05788237|561272091|FG000|SSA (Approximately 2 Months)|Death|0|||
155503986|NCT05788237|561272092|FG001|SSA (Approximately 2 Months)|Death|1|||
155503987|NCT05788237|561272093|FG002|SSA (Approximately 2 Months)|Death|0|||
155503988|NCT05788237|561272094|FG003|SSA (Approximately 2 Months)|Death|0|||
155503989|NCT05788237|561272091|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
155503990|NCT05788237|561272092|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
155503991|NCT05788237|561272093|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
155503992|NCT05788237|561272094|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
155503993|NCT05788237|561272091|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
155503994|NCT05788237|561272092|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
155503995|NCT05788237|561272093|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
155503996|NCT05788237|561272094|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
155503997|NCT05788237|561272091|FG000|SSB (Approximately 1 Month)|Other|0|||
155503998|NCT05788237|561272092|FG001|SSB (Approximately 1 Month)|Other|0|||
155336641|NCT01536704|560668192|FG002|Washout Period 2|Adverse Event|0|||
155336642|NCT01536704|560668193|FG003|Washout Period 2|Adverse Event|0|||
155336643|NCT01536704|560668190|FG000|Washout Period 2|Withdrawal by Subject|0|||
155503999|NCT05788237|561272093|FG002|SSB (Approximately 1 Month)|Other|0|||
155504000|NCT05788237|561272094|FG003|SSB (Approximately 1 Month)|Other|1|||
155504001|NCT01835470|561273883|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
155504002|NCT01835470|561273883|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
155504003|NCT01011907|561273884|FG000|Overall Study|Withdrawal by Subject|13|||
155504004|NCT01011907|561273885|FG001|Overall Study|Withdrawal by Subject|11|||
155336644|NCT01536704|560668191|FG001|Washout Period 2|Withdrawal by Subject|0|||
155336645|NCT01536704|560668192|FG002|Washout Period 2|Withdrawal by Subject|0|||
155336646|NCT01536704|560668193|FG003|Washout Period 2|Withdrawal by Subject|1|||
155504005|NCT01011907|561273884|FG000|Overall Study|Adverse Event|1|||
155504006|NCT01011907|561273885|FG001|Overall Study|Adverse Event|4|||
155504007|NCT00304954|561273888|FG000|Overall Study|Withdrawal by Subject|0|||
155504008|NCT00304954|561273889|FG001|Overall Study|Withdrawal by Subject|0|||
155504009|NCT00304954|561273890|FG002|Overall Study|Withdrawal by Subject|1|||
155504010|NCT00304954|561273891|FG003|Overall Study|Withdrawal by Subject|0|||
155504011|NCT00304954|561273888|FG000|Overall Study|Adverse Event|1|||
155504012|NCT00304954|561273889|FG001|Overall Study|Adverse Event|0|||
155504013|NCT00304954|561273890|FG002|Overall Study|Adverse Event|0|||
155504014|NCT00304954|561273891|FG003|Overall Study|Adverse Event|0|||
155504015|NCT00923195|561273894|FG000|Overall Study|Death|0|||
155504016|NCT00923195|561273895|FG001|Overall Study|Death|1|||
155504017|NCT00525031|561273896|FG000|Overall Study|Disease Progression|1|||
155504018|NCT00525031|561273897|FG001|Overall Study|Disease Progression|1|||
155504019|NCT02140164|561273900|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
155645803|NCT04625972|561794117|FG000|Overall Study|Protocol Violation|0|||
155645804|NCT04625972|561794118|FG001|Overall Study|Protocol Violation|1|||
155336647|NCT01536704|560668190|FG000|Period 3|Adverse Event|0|||
155336648|NCT01536704|560668191|FG001|Period 3|Adverse Event|0|||
155336649|NCT01536704|560668192|FG002|Period 3|Adverse Event|0|||
155336650|NCT01536704|560668193|FG003|Period 3|Adverse Event|1|||
155336651|NCT01536704|560668190|FG000|Washout Period 3|Adverse Event|0|||
155336652|NCT01536704|560668191|FG001|Washout Period 3|Adverse Event|0|||
155336653|NCT01536704|560668192|FG002|Washout Period 3|Adverse Event|1|||
155336654|NCT01536704|560668193|FG003|Washout Period 3|Adverse Event|0|||
155336655|NCT01947491|560668194|FG000|Overall Study|Lost to Follow-up|5|||
155504020|NCT00775983|561273901|FG000|Overall Study|Protocol Violation|1|||
155504021|NCT00775983|561273902|FG001|Overall Study|Protocol Violation|2|||
155504022|NCT02424565|561273903|FG000|Period 1 (D0)|Protocol Violation|0|||
155336656|NCT01947491|560668195|FG001|Overall Study|Lost to Follow-up|3|||
155336657|NCT01947491|560668196|FG002|Overall Study|Lost to Follow-up|1|||
155504023|NCT02424565|561273904|FG001|Period 1 (D0)|Protocol Violation|1|||
155645805|NCT04625972|561794117|FG000|Overall Study|Withdrawal by Subject|37|||
155504024|NCT01427920|561273912|FG000|Overall Study|Adverse Event|1|||
155504025|NCT01427920|561273913|FG001|Overall Study|Adverse Event|2|||
155504026|NCT01427920|561273912|FG000|Overall Study|Lack of Efficacy|1|||
155504027|NCT01427920|561273913|FG001|Overall Study|Lack of Efficacy|0|||
155504028|NCT01427920|561273912|FG000|Overall Study|Protocol Violation|1|||
155645806|NCT04625972|561794118|FG001|Overall Study|Withdrawal by Subject|24|||
155336658|NCT01947491|560668197|FG003|Overall Study|Lost to Follow-up|2|||
155336659|NCT01947491|560668194|FG000|Overall Study|Lack of Efficacy|1|||
155336660|NCT01947491|560668195|FG001|Overall Study|Lack of Efficacy|0|||
155336661|NCT01947491|560668196|FG002|Overall Study|Lack of Efficacy|0|||
155336662|NCT01947491|560668197|FG003|Overall Study|Lack of Efficacy|1|||
155336663|NCT01947491|560668194|FG000|Overall Study|Protocol Violation|1|||
155336664|NCT01947491|560668195|FG001|Overall Study|Protocol Violation|0|||
155336665|NCT01947491|560668196|FG002|Overall Study|Protocol Violation|0|||
155336666|NCT01947491|560668197|FG003|Overall Study|Protocol Violation|0|||
155336667|NCT01947491|560668194|FG000|Overall Study|Withdrawal by Subject|1|||
155336668|NCT01947491|560668195|FG001|Overall Study|Withdrawal by Subject|1|||
155336669|NCT01947491|560668196|FG002|Overall Study|Withdrawal by Subject|1|||
155336670|NCT01947491|560668197|FG003|Overall Study|Withdrawal by Subject|0|||
155336671|NCT01947491|560668194|FG000|Overall Study|Worsening of condition|0|||
155336672|NCT01947491|560668195|FG001|Overall Study|Worsening of condition|1|||
155336673|NCT01947491|560668196|FG002|Overall Study|Worsening of condition|0|||
155336674|NCT01947491|560668197|FG003|Overall Study|Worsening of condition|0|||
155336675|NCT01947491|560668194|FG000|Overall Study|Adverse Event|0|||
155336676|NCT01947491|560668195|FG001|Overall Study|Adverse Event|1|||
155336677|NCT01947491|560668196|FG002|Overall Study|Adverse Event|0|||
155336678|NCT01947491|560668197|FG003|Overall Study|Adverse Event|2|||
155336679|NCT02067663|560668199|FG000|Overall Study|Lost to Follow-up|13|||
155336680|NCT02067663|560668200|FG001|Overall Study|Lost to Follow-up|14|||
155336681|NCT00704340|560668201|FG000|Overall Study|Lost to Follow-up|2|||
155336682|NCT00704340|560668202|FG001|Overall Study|Lost to Follow-up|1|||
155336683|NCT00704340|560668201|FG000|Overall Study|Death|0|||
155336684|NCT00704340|560668202|FG001|Overall Study|Death|1|||
155336685|NCT03236779|560668204|FG000|Overall Study|Lost to Follow-up|13|||
155336686|NCT03236779|560668205|FG001|Overall Study|Lost to Follow-up|21|||
155336687|NCT00403845|560668210|FG000|Treatment Period 1|Subject withdrew consent|1|||
155336688|NCT00403845|560668211|FG001|Treatment Period 1|Subject withdrew consent|0|||
155336689|NCT00403845|560668212|FG002|Treatment Period 1|Subject withdrew consent|0|||
155336690|NCT00403845|560668213|FG003|Treatment Period 1|Subject withdrew consent|0|||
155336691|NCT00403845|560668210|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
155336692|NCT00403845|560668211|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
155336693|NCT00403845|560668212|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
155336694|NCT00403845|560668213|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
155336695|NCT00403845|560668210|FG000|Treatment Period 2|Subject withdrew consent|1|||
155336696|NCT00403845|560668211|FG001|Treatment Period 2|Subject withdrew consent|0|||
155336697|NCT00403845|560668212|FG002|Treatment Period 2|Subject withdrew consent|0|||
155336698|NCT00403845|560668213|FG003|Treatment Period 2|Subject withdrew consent|0|||
155336699|NCT00403845|560668210|FG000|Treatment Period 3|Subject withdrew consent|0|||
155336700|NCT00403845|560668211|FG001|Treatment Period 3|Subject withdrew consent|0|||
155336701|NCT00403845|560668212|FG002|Treatment Period 3|Subject withdrew consent|0|||
155336702|NCT00403845|560668213|FG003|Treatment Period 3|Subject withdrew consent|1|||
155336703|NCT00403845|560668210|FG000|Treatment Period 3|Adverse Event|0|||
155336704|NCT00403845|560668211|FG001|Treatment Period 3|Adverse Event|0|||
155336705|NCT00403845|560668212|FG002|Treatment Period 3|Adverse Event|0|||
155336706|NCT00403845|560668213|FG003|Treatment Period 3|Adverse Event|1|||
155336707|NCT01836523|560668214|FG000|Overall Study|Adverse Event|15|||
155336708|NCT01836523|560668215|FG001|Overall Study|Adverse Event|41|||
155336709|NCT01836523|560668216|FG002|Overall Study|Adverse Event|49|||
155336710|NCT01836523|560668217|FG003|Overall Study|Adverse Event|14|||
155336711|NCT01836523|560668214|FG000|Overall Study|Protocol Violation|6|||
155336712|NCT01836523|560668215|FG001|Overall Study|Protocol Violation|3|||
155336713|NCT01836523|560668216|FG002|Overall Study|Protocol Violation|2|||
155336714|NCT01836523|560668217|FG003|Overall Study|Protocol Violation|4|||
155336715|NCT01836523|560668214|FG000|Overall Study|Met Withdrawal Criteria|13|||
155336716|NCT01836523|560668215|FG001|Overall Study|Met Withdrawal Criteria|13|||
155336717|NCT01836523|560668216|FG002|Overall Study|Met Withdrawal Criteria|21|||
155336718|NCT01836523|560668217|FG003|Overall Study|Met Withdrawal Criteria|27|||
155336719|NCT01836523|560668214|FG000|Overall Study|Unclassified|17|||
155423042|NCT02347631|560978668|FG001|First Intervention (2 Months)|Moved out of area|2|||
155336720|NCT01836523|560668215|FG001|Overall Study|Unclassified|28|||
155336721|NCT01836523|560668216|FG002|Overall Study|Unclassified|19|||
155336722|NCT01836523|560668217|FG003|Overall Study|Unclassified|29|||
155336723|NCT00624377|560668220|FG000|Overall Study|Lost to Follow-up|355|||
155336724|NCT00624377|560668220|FG000|Overall Study|Withdrawal by Subject|100|||
155336725|NCT00624377|560668220|FG000|Overall Study|Adverse Event|14|||
155336726|NCT00624377|560668220|FG000|Overall Study|Other|91|||
155336727|NCT00624377|560668220|FG000|Overall Study|Non-evaluable population|84|||
155423043|NCT02347631|560978667|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
155336728|NCT00089791|560668224|FG000|Overall Study|Physician Decision|6|||
155336729|NCT00089791|560668225|FG001|Overall Study|Physician Decision|3|||
155336730|NCT00089791|560668224|FG000|Overall Study|Adverse Event|81|||
155336731|NCT00089791|560668225|FG001|Overall Study|Adverse Event|93|||
155504029|NCT01427920|561273913|FG001|Overall Study|Protocol Violation|3|||
155504030|NCT01427920|561273912|FG000|Overall Study|Withdrawal Criteria|4|||
155504031|NCT01427920|561273913|FG001|Overall Study|Withdrawal Criteria|4|||
155504032|NCT01427920|561273912|FG000|Overall Study|Unclassified|2|||
155504033|NCT01427920|561273913|FG001|Overall Study|Unclassified|8|||
155504034|NCT04228302|561273914|FG000|Overall Study|Adverse Event|0|||
155504035|NCT04228302|561273915|FG001|Overall Study|Adverse Event|0|||
155504036|NCT04228302|561273916|FG002|Overall Study|Adverse Event|0|||
155504037|NCT04228302|561273917|FG003|Overall Study|Adverse Event|0|||
155504038|NCT04228302|561273918|FG004|Overall Study|Adverse Event|1|||
155504039|NCT04228302|561273919|FG005|Overall Study|Adverse Event|0|||
155504040|NCT03066440|561273922|FG000|Overall Study|Physician Decision|1|||
155504041|NCT03066440|561273923|FG001|Overall Study|Physician Decision|1|||
155504042|NCT03066440|561273922|FG000|Overall Study|Protocol Violation|0|||
155504043|NCT03066440|561273923|FG001|Overall Study|Protocol Violation|2|||
155504044|NCT00736333|561273924|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
155504045|NCT00736333|561273924|FG000|Overall Study|Data Missing|2|||
155504046|NCT00736333|561273924|FG000|Overall Study|Tumor Progression|75|||
155504047|NCT00736333|561273924|FG000|Overall Study|Toxicity|6|||
155504048|NCT00736333|561273924|FG000|Overall Study|Withdrawal by Subject|10|||
155504049|NCT00736333|561273924|FG000|Overall Study|Death|7|||
155504050|NCT00736333|561273924|FG000|Overall Study|Other|4|||
155504051|NCT04991311|561273926|FG000|Overall Study|Adverse Event|1|||
155504052|NCT00054275|561273928|FG000|Overall Study|Withdrawal by Subject|4|||
155504053|NCT00054275|561273928|FG000|Overall Study|Adverse Event|5|||
155504054|NCT00054275|561273928|FG000|Overall Study|Progressive disease in cycle 1|1|||
155504055|NCT00054275|561273928|FG000|Overall Study|Physician Decision|1|||
155504056|NCT00755937|561273929|FG000|Recruitment|Unknown if infliximab received|164|||
155504057|NCT00755937|561273929|FG000|Observational Follow-up|Lost to Follow-up|148|||
155504058|NCT01106352|561273930|FG000|Overall Study|Subjects untreated|0|||
155504059|NCT01106352|561273931|FG001|Overall Study|Subjects untreated|0|||
155504060|NCT01106352|561273932|FG002|Overall Study|Subjects untreated|0|||
155504061|NCT01106352|561273933|FG003|Overall Study|Subjects untreated|3|||
155504062|NCT01106352|561273934|FG004|Overall Study|Subjects untreated|4|||
155504063|NCT01106352|561273930|FG000|Overall Study|Sponsor Decision|1|||
155504064|NCT01106352|561273931|FG001|Overall Study|Sponsor Decision|0|||
155504065|NCT01106352|561273932|FG002|Overall Study|Sponsor Decision|0|||
155504066|NCT01106352|561273933|FG003|Overall Study|Sponsor Decision|0|||
155504067|NCT01106352|561273934|FG004|Overall Study|Sponsor Decision|0|||
155504068|NCT01106352|561273930|FG000|Overall Study|Too ill to come in for the visit|0|||
155504069|NCT01106352|561273931|FG001|Overall Study|Too ill to come in for the visit|0|||
155504070|NCT01106352|561273932|FG002|Overall Study|Too ill to come in for the visit|1|||
155336732|NCT00089791|560668224|FG000|Overall Study|Withdrawal by Subject|403|||
155336733|NCT00089791|560668225|FG001|Overall Study|Withdrawal by Subject|344|||
155336734|NCT00089791|560668224|FG000|Overall Study|Death|78|||
155336735|NCT00089791|560668225|FG001|Overall Study|Death|62|||
155645807|NCT04625972|561794117|FG000|Overall Study|Not specified elsewhere|8|||
155645808|NCT04625972|561794118|FG001|Overall Study|Not specified elsewhere|6|||
155645809|NCT00433290|561794119|FG000|Overall Study|Adverse Event|24|||
155645810|NCT00433290|561794120|FG001|Overall Study|Adverse Event|7|||
155645811|NCT00433290|561794119|FG000|Overall Study|Lack of Efficacy|1|||
155336736|NCT00089791|560668224|FG000|Overall Study|Disease progression|7|||
155336737|NCT00089791|560668225|FG001|Overall Study|Disease progression|3|||
155336738|NCT00089791|560668224|FG000|Overall Study|Ineligibility determined|12|||
155336739|NCT00089791|560668225|FG001|Overall Study|Ineligibility determined|9|||
155336740|NCT00089791|560668224|FG000|Overall Study|Lost to Follow-up|57|||
155504071|NCT01106352|561273933|FG003|Overall Study|Too ill to come in for the visit|0|||
155504072|NCT01106352|561273934|FG004|Overall Study|Too ill to come in for the visit|0|||
155504073|NCT01106352|561273930|FG000|Overall Study|Lost to Follow-up|0|||
155645812|NCT00433290|561794120|FG001|Overall Study|Lack of Efficacy|5|||
155645813|NCT00433290|561794119|FG000|Overall Study|Withdrawal by Subject|4|||
155336741|NCT00089791|560668225|FG001|Overall Study|Lost to Follow-up|57|||
155336742|NCT00089791|560668224|FG000|Overall Study|Noncompliance|17|||
155504074|NCT01106352|561273931|FG001|Overall Study|Lost to Follow-up|0|||
155504075|NCT01106352|561273932|FG002|Overall Study|Lost to Follow-up|0|||
155504076|NCT01106352|561273933|FG003|Overall Study|Lost to Follow-up|0|||
155336743|NCT00089791|560668225|FG001|Overall Study|Noncompliance|13|||
155336744|NCT00089791|560668224|FG000|Overall Study|Other|20|||
155504077|NCT01106352|561273934|FG004|Overall Study|Lost to Follow-up|1|||
155504078|NCT01106352|561273930|FG000|Overall Study|Death|0|||
155504079|NCT01106352|561273931|FG001|Overall Study|Death|0|||
155504080|NCT01106352|561273932|FG002|Overall Study|Death|1|||
155504081|NCT01106352|561273933|FG003|Overall Study|Death|3|||
155504082|NCT01106352|561273934|FG004|Overall Study|Death|1|||
155504083|NCT01106352|561273930|FG000|Overall Study|Disease progression|0|||
155504084|NCT01106352|561273931|FG001|Overall Study|Disease progression|0|||
155504085|NCT01106352|561273932|FG002|Overall Study|Disease progression|0|||
155336745|NCT00089791|560668225|FG001|Overall Study|Other|32|||
155645814|NCT00433290|561794120|FG001|Overall Study|Withdrawal by Subject|2|||
155645815|NCT00433290|561794119|FG000|Overall Study|Protocol Violation|3|||
155504086|NCT01106352|561273933|FG003|Overall Study|Disease progression|1|||
155504087|NCT01106352|561273934|FG004|Overall Study|Disease progression|0|||
155504088|NCT01106352|561273930|FG000|Overall Study|Withdrawal by Subject|0|||
155336746|NCT00089791|560668224|FG000|Overall Study|Protocol deviation|12|||
155336747|NCT00089791|560668225|FG001|Overall Study|Protocol deviation|10|||
155336748|NCT00089791|560668224|FG000|Overall Study|Requirement for alternative therapy|7|||
155336749|NCT00089791|560668225|FG001|Overall Study|Requirement for alternative therapy|4|||
155336750|NCT00148122|560668226|FG000|Overall Study|Withdrawal by Subject|2|||
155336751|NCT05074433|560668229|FG000|Overall Study|Adverse Event|0|||
155336752|NCT05074433|560668230|FG001|Overall Study|Adverse Event|2|||
155336753|NCT05074433|560668231|FG002|Overall Study|Adverse Event|0|||
155336754|NCT05074433|560668232|FG003|Overall Study|Adverse Event|1|||
155336755|NCT05074433|560668229|FG000|Overall Study|Sponsor Request|0|||
155336756|NCT05074433|560668230|FG001|Overall Study|Sponsor Request|1|||
155336757|NCT05074433|560668231|FG002|Overall Study|Sponsor Request|1|||
155336758|NCT05074433|560668232|FG003|Overall Study|Sponsor Request|0|||
155336759|NCT05074433|560668229|FG000|Overall Study|Death|1|||
155336760|NCT05074433|560668230|FG001|Overall Study|Death|0|||
155336761|NCT05074433|560668231|FG002|Overall Study|Death|0|||
155336762|NCT05074433|560668232|FG003|Overall Study|Death|0|||
155336763|NCT05074433|560668229|FG000|Overall Study|Lost to Follow-up|0|||
155336764|NCT05074433|560668230|FG001|Overall Study|Lost to Follow-up|0|||
155336765|NCT05074433|560668231|FG002|Overall Study|Lost to Follow-up|2|||
155504089|NCT01106352|561273931|FG001|Overall Study|Withdrawal by Subject|0|||
155504090|NCT01106352|561273932|FG002|Overall Study|Withdrawal by Subject|0|||
155645816|NCT00433290|561794120|FG001|Overall Study|Protocol Violation|2|||
155645817|NCT00433290|561794119|FG000|Overall Study|Physician Decision|2|||
155336766|NCT05074433|560668232|FG003|Overall Study|Lost to Follow-up|0|||
155336767|NCT05074433|560668229|FG000|Overall Study|Subject Decision|8|||
155336768|NCT05074433|560668230|FG001|Overall Study|Subject Decision|6|||
155336769|NCT05074433|560668231|FG002|Overall Study|Subject Decision|4|||
155336770|NCT05074433|560668232|FG003|Overall Study|Subject Decision|5|||
155336771|NCT04397263|560668233|FG000|Overall Study|Withdrawal by Subject|2|||
155336772|NCT01989689|560668234|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
155336773|NCT01989689|560668235|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
155336774|NCT01989689|560668234|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
155336775|NCT01989689|560668235|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
155336776|NCT04492475|560668236|FG000|Overall Study|Enrolled but not treated|8|||
155336777|NCT04492475|560668237|FG001|Overall Study|Enrolled but not treated|8|||
155336778|NCT04492475|560668236|FG000|Overall Study|Withdrawal by Subject|4|||
155336779|NCT04492475|560668237|FG001|Overall Study|Withdrawal by Subject|0|||
155336780|NCT04492475|560668236|FG000|Overall Study|Became ineligible after enrollment|2|||
155336781|NCT04492475|560668237|FG001|Overall Study|Became ineligible after enrollment|0|||
155336782|NCT02066636|560668238|FG000|Overall Study|Disease progression|51|||
155336783|NCT02066636|560668239|FG001|Overall Study|Disease progression|60|||
155336784|NCT02066636|560668240|FG002|Overall Study|Disease progression|700|||
155336785|NCT02066636|560668238|FG000|Overall Study|Study drug toxicity|13|||
155336786|NCT02066636|560668239|FG001|Overall Study|Study drug toxicity|2|||
155336787|NCT02066636|560668240|FG002|Overall Study|Study drug toxicity|58|||
155336788|NCT02066636|560668238|FG000|Overall Study|Death|4|||
155336789|NCT02066636|560668239|FG001|Overall Study|Death|2|||
155336790|NCT02066636|560668240|FG002|Overall Study|Death|158|||
155336791|NCT02066636|560668238|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155336792|NCT02066636|560668239|FG001|Overall Study|Adverse event unrelated to study drug|4|||
155336793|NCT02066636|560668240|FG002|Overall Study|Adverse event unrelated to study drug|45|||
155336794|NCT02066636|560668238|FG000|Overall Study|Participant request to discontinue treatment|12|||
155336795|NCT02066636|560668239|FG001|Overall Study|Participant request to discontinue treatment|12|||
155336796|NCT02066636|560668240|FG002|Overall Study|Participant request to discontinue treatment|70|||
155336797|NCT02066636|560668238|FG000|Overall Study|Participant withdrew consent|10|||
155336798|NCT02066636|560668239|FG001|Overall Study|Participant withdrew consent|18|||
155336799|NCT02066636|560668240|FG002|Overall Study|Participant withdrew consent|61|||
155336800|NCT02066636|560668238|FG000|Overall Study|Lost to Follow-up|0|||
155336801|NCT02066636|560668239|FG001|Overall Study|Lost to Follow-up|2|||
155336802|NCT02066636|560668240|FG002|Overall Study|Lost to Follow-up|2|||
155336803|NCT02066636|560668238|FG000|Overall Study|Maximum clinical benefit|2|||
155336804|NCT02066636|560668239|FG001|Overall Study|Maximum clinical benefit|2|||
155336805|NCT02066636|560668240|FG002|Overall Study|Maximum clinical benefit|3|||
155336806|NCT02066636|560668238|FG000|Overall Study|Poor/non-compliance|2|||
155336807|NCT02066636|560668239|FG001|Overall Study|Poor/non-compliance|1|||
155336808|NCT02066636|560668240|FG002|Overall Study|Poor/non-compliance|1|||
155336809|NCT02066636|560668238|FG000|Overall Study|Participant no loner meets study criteria|3|||
155645818|NCT00433290|561794120|FG001|Overall Study|Physician Decision|0|||
155336810|NCT02066636|560668239|FG001|Overall Study|Participant no loner meets study criteria|2|||
155336811|NCT02066636|560668240|FG002|Overall Study|Participant no loner meets study criteria|28|||
155336812|NCT02066636|560668238|FG000|Overall Study|Administrative reasons by sponsor|8|||
155336813|NCT02066636|560668239|FG001|Overall Study|Administrative reasons by sponsor|5|||
155336814|NCT02066636|560668240|FG002|Overall Study|Administrative reasons by sponsor|0|||
155336815|NCT02066636|560668238|FG000|Overall Study|Other reasons|16|||
155336816|NCT02066636|560668239|FG001|Overall Study|Other reasons|15|||
155336817|NCT02066636|560668240|FG002|Overall Study|Other reasons|50|||
155336818|NCT00391170|560668241|FG000|Overall Study|Withdrawal by Subject|1|||
155336819|NCT00391170|560668242|FG001|Overall Study|Withdrawal by Subject|0|||
155336820|NCT00391170|560668241|FG000|Overall Study|Adverse Event|3|||
155336821|NCT00391170|560668242|FG001|Overall Study|Adverse Event|2|||
155336822|NCT00391170|560668241|FG000|Overall Study|Physician Decision|2|||
155336823|NCT00391170|560668242|FG001|Overall Study|Physician Decision|2|||
155336824|NCT03567616|560668247|FG000|Overall Study|Disease progression|4|||
155336825|NCT03567616|560668247|FG000|Overall Study|Withdrawal by Subject|1|||
155336826|NCT03567616|560668247|FG000|Overall Study|Physician Decision|1|||
155336827|NCT03567616|560668247|FG000|Overall Study|Death|1|||
155336828|NCT03567616|560668247|FG000|Overall Study|Adverse Event|1|||
155336829|NCT03200574|560668260|FG000|Overall Study|Death|4|||
155336830|NCT03200574|560668260|FG000|Overall Study|Withdrawal by Subject|8|||
155336831|NCT03200574|560668260|FG000|Overall Study|Long-Term need for anticoagulation|1|||
155336832|NCT03200574|560668260|FG000|Overall Study|Relocation|2|||
155336833|NCT03200574|560668260|FG000|Overall Study|Lost to Follow-up|2|||
155336834|NCT00705159|560668261|FG000|Overall Study|Withdrawal by Subject|0|||
155336835|NCT00705159|560668262|FG001|Overall Study|Withdrawal by Subject|1|||
155336836|NCT00705159|560668263|FG002|Overall Study|Withdrawal by Subject|1|||
155336837|NCT00705159|560668264|FG003|Overall Study|Withdrawal by Subject|1|||
155336838|NCT00705159|560668261|FG000|Overall Study|Protocol Violation|0|||
155336839|NCT00705159|560668262|FG001|Overall Study|Protocol Violation|1|||
155336840|NCT00705159|560668263|FG002|Overall Study|Protocol Violation|0|||
155336841|NCT00705159|560668264|FG003|Overall Study|Protocol Violation|0|||
155336842|NCT00705159|560668261|FG000|Overall Study|Adverse Event|0|||
155336843|NCT00705159|560668262|FG001|Overall Study|Adverse Event|0|||
155336844|NCT00705159|560668263|FG002|Overall Study|Adverse Event|1|||
155336845|NCT00705159|560668264|FG003|Overall Study|Adverse Event|0|||
155336846|NCT00705159|560668261|FG000|Overall Study|Lost to Follow-up|0|||
155336847|NCT00705159|560668262|FG001|Overall Study|Lost to Follow-up|0|||
155336848|NCT00705159|560668263|FG002|Overall Study|Lost to Follow-up|3|||
155336849|NCT00705159|560668264|FG003|Overall Study|Lost to Follow-up|2|||
155336850|NCT00705159|560668261|FG000|Overall Study|Screen Failure|0|||
155336851|NCT00705159|560668262|FG001|Overall Study|Screen Failure|0|||
155336852|NCT00705159|560668263|FG002|Overall Study|Screen Failure|0|||
155336853|NCT00705159|560668264|FG003|Overall Study|Screen Failure|1|||
155336854|NCT00526994|560668265|FG000|Overall Study|Lost to Follow-up|98|||
155336855|NCT00526994|560668266|FG001|Overall Study|Lost to Follow-up|108|||
155336856|NCT00526994|560668267|FG002|Overall Study|Lost to Follow-up|96|||
155336857|NCT00526994|560668265|FG000|Overall Study|Death|4|||
155336858|NCT00526994|560668266|FG001|Overall Study|Death|3|||
155336859|NCT00526994|560668267|FG002|Overall Study|Death|3|||
155336860|NCT00526994|560668265|FG000|Overall Study|Withdrawal by Subject|2|||
155336861|NCT00526994|560668266|FG001|Overall Study|Withdrawal by Subject|7|||
155336862|NCT00526994|560668267|FG002|Overall Study|Withdrawal by Subject|5|||
155336863|NCT00526994|560668265|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
155336864|NCT00526994|560668266|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
155336865|NCT00526994|560668267|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
155336866|NCT03026166|560668268|FG000|Overall Study|Death|22|||
155336867|NCT03026166|560668269|FG001|Overall Study|Death|7|||
155336868|NCT03026166|560668268|FG000|Overall Study|Physician Decision|2|||
155336869|NCT03026166|560668269|FG001|Overall Study|Physician Decision|0|||
155336870|NCT03026166|560668268|FG000|Overall Study|Withdrawal by Subject|1|||
155336871|NCT03026166|560668269|FG001|Overall Study|Withdrawal by Subject|2|||
155336872|NCT03026166|560668268|FG000|Overall Study|Lost to Follow-up|1|||
155336873|NCT03026166|560668269|FG001|Overall Study|Lost to Follow-up|0|||
155423044|NCT02347631|560978668|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
155336874|NCT03026166|560668268|FG000|Overall Study|Study Terminated by Sponsor|3|||
155336875|NCT03026166|560668269|FG001|Overall Study|Study Terminated by Sponsor|3|||
155336876|NCT03026166|560668268|FG000|Overall Study|Other|1|||
155336877|NCT03026166|560668269|FG001|Overall Study|Other|0|||
155336878|NCT03035942|560668270|FG000|Overall Study|Adverse Event|8|||
155336879|NCT03035942|560668271|FG001|Overall Study|Adverse Event|4|||
155336880|NCT03035942|560668272|FG002|Overall Study|Adverse Event|5|||
155336881|NCT00380250|560668273|FG000|Overall Study|Withdrawal by Subject|39|||
155336882|NCT00380250|560668274|FG001|Overall Study|Withdrawal by Subject|28|||
155336883|NCT00380250|560668273|FG000|Overall Study|Adverse Event|20|||
155336884|NCT00380250|560668274|FG001|Overall Study|Adverse Event|9|||
155336885|NCT00380250|560668273|FG000|Overall Study|Lack of Efficacy|10|||
155336886|NCT00380250|560668274|FG001|Overall Study|Lack of Efficacy|8|||
155336887|NCT00380250|560668273|FG000|Overall Study|Protocol Violation|15|||
155336888|NCT00380250|560668274|FG001|Overall Study|Protocol Violation|5|||
155336889|NCT00380250|560668273|FG000|Overall Study|Lost to Follow-up|14|||
155336890|NCT00380250|560668274|FG001|Overall Study|Lost to Follow-up|5|||
155336891|NCT00380250|560668273|FG000|Overall Study|Physician Decision|1|||
155336892|NCT00380250|560668274|FG001|Overall Study|Physician Decision|0|||
155336893|NCT01989104|560668275|FG000|Overall Study|Withdrawal by Subject|3|||
155336894|NCT01989104|560668276|FG001|Overall Study|Withdrawal by Subject|0|||
155336895|NCT01989104|560668277|FG002|Overall Study|Withdrawal by Subject|0|||
155336896|NCT01989104|560668278|FG003|Overall Study|Withdrawal by Subject|0|||
155336897|NCT01989104|560668279|FG004|Overall Study|Withdrawal by Subject|0|||
155336898|NCT02833948|560668280|FG000|Overall Study|Death|2|||
155336899|NCT02833948|560668281|FG001|Overall Study|Death|3|||
155336900|NCT02833948|560668280|FG000|Overall Study|were not scanned|8|||
155336901|NCT02833948|560668281|FG001|Overall Study|were not scanned|13|||
155336902|NCT02833948|560668280|FG000|Overall Study|scans could not be evaluated|5|||
155336903|NCT02833948|560668281|FG001|Overall Study|scans could not be evaluated|2|||
155336904|NCT02691702|560668285|FG000|Overall Study|Adverse Event|1|||
155336905|NCT02691702|560668286|FG001|Overall Study|Adverse Event|0|||
155336906|NCT02691702|560668287|FG002|Overall Study|Adverse Event|0|||
155336907|NCT02691702|560668288|FG003|Overall Study|Adverse Event|0|||
155336908|NCT02691702|560668289|FG004|Overall Study|Adverse Event|0|||
155336909|NCT02691702|560668290|FG005|Overall Study|Adverse Event|0|||
155336910|NCT02691702|560668291|FG006|Overall Study|Adverse Event|0|||
155336911|NCT02691702|560668292|FG007|Overall Study|Adverse Event|0|||
155336912|NCT02691702|560668293|FG008|Overall Study|Adverse Event|1|||
155336913|NCT02691702|560668294|FG009|Overall Study|Adverse Event|0|||
155336914|NCT02691702|560668295|FG010|Overall Study|Adverse Event|1|||
155336915|NCT02691702|560668285|FG000|Overall Study|Lost to Follow-up|0|||
155336916|NCT02691702|560668286|FG001|Overall Study|Lost to Follow-up|0|||
155336917|NCT02691702|560668287|FG002|Overall Study|Lost to Follow-up|1|||
155336918|NCT02691702|560668288|FG003|Overall Study|Lost to Follow-up|0|||
155336919|NCT02691702|560668289|FG004|Overall Study|Lost to Follow-up|0|||
155336920|NCT02691702|560668290|FG005|Overall Study|Lost to Follow-up|2|||
155336921|NCT02691702|560668291|FG006|Overall Study|Lost to Follow-up|0|||
155336922|NCT02691702|560668292|FG007|Overall Study|Lost to Follow-up|0|||
155336923|NCT02691702|560668293|FG008|Overall Study|Lost to Follow-up|0|||
155336924|NCT02691702|560668294|FG009|Overall Study|Lost to Follow-up|0|||
155336925|NCT02691702|560668295|FG010|Overall Study|Lost to Follow-up|1|||
155336926|NCT02691702|560668285|FG000|Overall Study|Withdrawal by Subject|1|||
155336927|NCT02691702|560668286|FG001|Overall Study|Withdrawal by Subject|1|||
155336928|NCT02691702|560668287|FG002|Overall Study|Withdrawal by Subject|0|||
155336929|NCT02691702|560668288|FG003|Overall Study|Withdrawal by Subject|0|||
155336930|NCT02691702|560668289|FG004|Overall Study|Withdrawal by Subject|0|||
155336931|NCT02691702|560668290|FG005|Overall Study|Withdrawal by Subject|1|||
155336932|NCT02691702|560668291|FG006|Overall Study|Withdrawal by Subject|2|||
155336933|NCT02691702|560668292|FG007|Overall Study|Withdrawal by Subject|0|||
155336934|NCT02691702|560668293|FG008|Overall Study|Withdrawal by Subject|0|||
155336935|NCT02691702|560668294|FG009|Overall Study|Withdrawal by Subject|0|||
155336936|NCT02691702|560668295|FG010|Overall Study|Withdrawal by Subject|0|||
155336937|NCT02691702|560668285|FG000|Overall Study|Other|0|||
155336938|NCT02691702|560668286|FG001|Overall Study|Other|0|||
155336939|NCT02691702|560668287|FG002|Overall Study|Other|0|||
155336940|NCT02691702|560668288|FG003|Overall Study|Other|0|||
155336941|NCT02691702|560668289|FG004|Overall Study|Other|0|||
155336942|NCT02691702|560668290|FG005|Overall Study|Other|0|||
155336943|NCT02691702|560668291|FG006|Overall Study|Other|1|||
155336944|NCT02691702|560668292|FG007|Overall Study|Other|0|||
155336945|NCT02691702|560668293|FG008|Overall Study|Other|1|||
155336946|NCT02691702|560668294|FG009|Overall Study|Other|0|||
155336947|NCT02691702|560668295|FG010|Overall Study|Other|0|||
155336948|NCT02691702|560668285|FG000|Overall Study|Protocol Violation|0|||
155336949|NCT02691702|560668286|FG001|Overall Study|Protocol Violation|0|||
155336950|NCT02691702|560668287|FG002|Overall Study|Protocol Violation|0|||
155336951|NCT02691702|560668288|FG003|Overall Study|Protocol Violation|0|||
155336952|NCT02691702|560668289|FG004|Overall Study|Protocol Violation|0|||
155336953|NCT02691702|560668290|FG005|Overall Study|Protocol Violation|0|||
155336954|NCT02691702|560668291|FG006|Overall Study|Protocol Violation|0|||
155423045|NCT02347631|560978667|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
155336955|NCT02691702|560668292|FG007|Overall Study|Protocol Violation|0|||
155336956|NCT02691702|560668293|FG008|Overall Study|Protocol Violation|0|||
155336957|NCT02691702|560668294|FG009|Overall Study|Protocol Violation|2|||
155336958|NCT02691702|560668295|FG010|Overall Study|Protocol Violation|0|||
155336959|NCT05613088|560668296|FG000|Treatment|Ongoing Study Treatment|9|||
155336960|NCT05613088|560668297|FG001|Treatment|Ongoing Study Treatment|2|||
155336961|NCT05613088|560668296|FG000|Treatment|Adverse Event|3|||
155336962|NCT05613088|560668297|FG001|Treatment|Adverse Event|1|||
155336963|NCT05613088|560668296|FG000|Treatment|Other Reasons|0|||
155336964|NCT05613088|560668297|FG001|Treatment|Other Reasons|1|||
155336965|NCT05613088|560668296|FG000|Treatment|Progressive Disease|58|||
155336966|NCT05613088|560668297|FG001|Treatment|Progressive Disease|26|||
155336967|NCT05613088|560668296|FG000|Treatment|Withdrawal by Subject|0|||
155336968|NCT05613088|560668297|FG001|Treatment|Withdrawal by Subject|4|||
155336969|NCT05163353|560668300|FG000|Overall Study|Adverse Event|1|||
155336970|NCT05163353|560668301|FG001|Overall Study|Adverse Event|0|||
155336971|NCT05163353|560668300|FG000|Overall Study|Withdrawal by Subject|21|||
155336972|NCT05163353|560668301|FG001|Overall Study|Withdrawal by Subject|6|||
155336973|NCT05163353|560668300|FG000|Overall Study|Protocol Violation|0|||
155336974|NCT05163353|560668301|FG001|Overall Study|Protocol Violation|1|||
155336975|NCT05163353|560668300|FG000|Overall Study|Lost to Follow-up|13|||
155336976|NCT05163353|560668301|FG001|Overall Study|Lost to Follow-up|2|||
155336977|NCT06086028|560668303|FG000|Overall Study|Withdrawal by Subject|1|||
155336978|NCT06086028|560668304|FG001|Overall Study|Withdrawal by Subject|1|||
155336979|NCT06086028|560668303|FG000|Overall Study|Lost to Follow-up|2|||
155336980|NCT06086028|560668304|FG001|Overall Study|Lost to Follow-up|3|||
155336981|NCT00824408|560668305|FG000|Run-in Phase|Progressive disease|4|||
155336982|NCT00824408|560668306|FG001|Run-in Phase|Progressive disease|4|||
155336983|NCT00824408|560668307|FG002|Run-in Phase|Progressive disease|0|||
155336984|NCT00824408|560668308|FG003|Run-in Phase|Progressive disease|0|||
155336985|NCT00824408|560668309|FG004|Run-in Phase|Progressive disease|0|||
155336986|NCT00824408|560668305|FG000|Run-in Phase|Adverse Event|1|||
155336987|NCT00824408|560668306|FG001|Run-in Phase|Adverse Event|1|||
155336988|NCT00824408|560668307|FG002|Run-in Phase|Adverse Event|0|||
155336989|NCT00824408|560668308|FG003|Run-in Phase|Adverse Event|0|||
155336990|NCT00824408|560668309|FG004|Run-in Phase|Adverse Event|0|||
155336991|NCT00824408|560668305|FG000|Run-in Phase|Refused to continue medication|1|||
155336992|NCT00824408|560668306|FG001|Run-in Phase|Refused to continue medication|0|||
155336993|NCT00824408|560668307|FG002|Run-in Phase|Refused to continue medication|0|||
155336994|NCT00824408|560668308|FG003|Run-in Phase|Refused to continue medication|0|||
155336995|NCT00824408|560668309|FG004|Run-in Phase|Refused to continue medication|0|||
155504091|NCT01106352|561273933|FG003|Overall Study|Withdrawal by Subject|3|||
155504092|NCT01106352|561273934|FG004|Overall Study|Withdrawal by Subject|2|||
155504093|NCT01106352|561273930|FG000|Overall Study|Went on hospice|0|||
155504094|NCT01106352|561273931|FG001|Overall Study|Went on hospice|0|||
155504095|NCT01106352|561273932|FG002|Overall Study|Went on hospice|0|||
155504096|NCT01106352|561273933|FG003|Overall Study|Went on hospice|1|||
155504097|NCT01106352|561273934|FG004|Overall Study|Went on hospice|0|||
155504098|NCT01106352|561273930|FG000|Overall Study|Subject entered hospice|0|||
155504099|NCT01106352|561273931|FG001|Overall Study|Subject entered hospice|0|||
155504100|NCT01106352|561273932|FG002|Overall Study|Subject entered hospice|0|||
155504101|NCT01106352|561273933|FG003|Overall Study|Subject entered hospice|1|||
155504102|NCT01106352|561273934|FG004|Overall Study|Subject entered hospice|0|||
155504103|NCT01106352|561273930|FG000|Overall Study|Home hospice since July 2013|0|||
155504104|NCT01106352|561273931|FG001|Overall Study|Home hospice since July 2013|0|||
155504105|NCT01106352|561273932|FG002|Overall Study|Home hospice since July 2013|0|||
155504106|NCT01106352|561273933|FG003|Overall Study|Home hospice since July 2013|1|||
155504107|NCT01106352|561273934|FG004|Overall Study|Home hospice since July 2013|0|||
155504108|NCT03876873|561273935|FG000|Overall Study|Physician Decision|0|||
155504109|NCT03876873|561273936|FG001|Overall Study|Physician Decision|1|||
155504110|NCT03547531|561273937|FG000|Overall Study|not coming in data collection : sick|2|||
155504111|NCT03547531|561273938|FG001|Overall Study|not coming in data collection : sick|2|||
155336996|NCT00824408|560668305|FG000|Run-in Phase|Other reason not defined above|0|||
155336997|NCT00824408|560668306|FG001|Run-in Phase|Other reason not defined above|1|||
155336998|NCT00824408|560668307|FG002|Run-in Phase|Other reason not defined above|0|||
155336999|NCT00824408|560668308|FG003|Run-in Phase|Other reason not defined above|0|||
155504112|NCT03547531|561273937|FG000|Overall Study|having family occasion|0|||
155504113|NCT03547531|561273938|FG001|Overall Study|having family occasion|2|||
155504114|NCT03944707|561273939|FG000|Overall Study|Adverse Event|0|||
155504115|NCT03944707|561273940|FG001|Overall Study|Adverse Event|2|||
155645819|NCT00433290|561794119|FG000|Overall Study|Entry Criteria Not Met|0|||
155645820|NCT00433290|561794120|FG001|Overall Study|Entry Criteria Not Met|1|||
155645821|NCT00433290|561794119|FG000|Overall Study|Lost to Follow-up|1|||
155645822|NCT00433290|561794120|FG001|Overall Study|Lost to Follow-up|0|||
155645823|NCT02547935|561794121|FG000|Overall Study|Other|0|||
155645824|NCT02547935|561794122|FG001|Overall Study|Other|1|||
155645825|NCT02547935|561794123|FG002|Overall Study|Other|0|||
155645826|NCT02547935|561794121|FG000|Overall Study|Withdrawal by Subject|2|||
155645827|NCT02547935|561794122|FG001|Overall Study|Withdrawal by Subject|3|||
155645828|NCT02547935|561794123|FG002|Overall Study|Withdrawal by Subject|4|||
155645829|NCT02547935|561794121|FG000|Overall Study|Screen Failure|2|||
155645830|NCT02547935|561794122|FG001|Overall Study|Screen Failure|0|||
155645831|NCT02547935|561794123|FG002|Overall Study|Screen Failure|0|||
155645832|NCT02547935|561794121|FG000|Overall Study|Physician Decision|0|||
155645833|NCT02547935|561794122|FG001|Overall Study|Physician Decision|1|||
155645834|NCT02547935|561794123|FG002|Overall Study|Physician Decision|0|||
155645835|NCT02547935|561794121|FG000|Overall Study|Lost to Follow-up|0|||
155645836|NCT02547935|561794122|FG001|Overall Study|Lost to Follow-up|2|||
155645837|NCT02547935|561794123|FG002|Overall Study|Lost to Follow-up|1|||
155645838|NCT02547935|561794121|FG000|Overall Study|Death|1|||
155645839|NCT02547935|561794122|FG001|Overall Study|Death|1|||
155645840|NCT02547935|561794123|FG002|Overall Study|Death|0|||
155645841|NCT00086307|561794124|FG000|Overall Study|Lack of Efficacy|1|||
155504116|NCT03944707|561273939|FG000|Overall Study|Study terminated by sponsor|12|||
155504117|NCT03944707|561273940|FG001|Overall Study|Study terminated by sponsor|7|||
155504118|NCT03944707|561273939|FG000|Overall Study|Subject decision|0|||
155504119|NCT03944707|561273940|FG001|Overall Study|Subject decision|1|||
155504120|NCT02117479|561273949|FG000|Overall Study|Death|13|||
155504121|NCT02117479|561273950|FG001|Overall Study|Death|8|||
155504122|NCT02117479|561273949|FG000|Overall Study|Adverse Event|8|||
155504123|NCT02117479|561273950|FG001|Overall Study|Adverse Event|16|||
155504124|NCT02117479|561273949|FG000|Overall Study|Subject decision|8|||
155504125|NCT02117479|561273950|FG001|Overall Study|Subject decision|9|||
155504126|NCT02117479|561273949|FG000|Overall Study|Disease progression|104|||
155504127|NCT02117479|561273950|FG001|Overall Study|Disease progression|108|||
155504128|NCT02117479|561273949|FG000|Overall Study|Noncompliance with study treatment|1|||
155504129|NCT02117479|561273950|FG001|Overall Study|Noncompliance with study treatment|0|||
155504130|NCT02117479|561273949|FG000|Overall Study|Study terminated by the sponsor|4|||
155504131|NCT02117479|561273950|FG001|Overall Study|Study terminated by the sponsor|6|||
155504132|NCT02117479|561273949|FG000|Overall Study|Physician Decision|7|||
155504133|NCT02117479|561273950|FG001|Overall Study|Physician Decision|2|||
155504134|NCT02117479|561273949|FG000|Overall Study|Other unspecified|11|||
155504135|NCT02117479|561273950|FG001|Overall Study|Other unspecified|7|||
155504136|NCT02444182|561273951|FG000|Overall Study|non-compliance|2|||
155504137|NCT02444182|561273952|FG001|Overall Study|non-compliance|1|||
155504138|NCT02444182|561273951|FG000|Overall Study|Lost to Follow-up|0|||
155504139|NCT02444182|561273952|FG001|Overall Study|Lost to Follow-up|4|||
155645842|NCT00086307|561794125|FG001|Overall Study|Lack of Efficacy|1|||
155645843|NCT00086307|561794126|FG002|Overall Study|Lack of Efficacy|2|||
155645844|NCT00086307|561794124|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
155645845|NCT00086307|561794125|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
155645846|NCT00086307|561794126|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
155645847|NCT00086307|561794124|FG000|Overall Study|Nausea and headaches|0|||
155645848|NCT00086307|561794125|FG001|Overall Study|Nausea and headaches|0|||
155504140|NCT01959230|561273953|FG000|Overall Study|Failure to follow study procedures|0|||
155504141|NCT01959230|561273954|FG001|Overall Study|Failure to follow study procedures|1|||
155504142|NCT01959230|561273953|FG000|Overall Study|Administrative reasons|2|||
155504143|NCT01959230|561273954|FG001|Overall Study|Administrative reasons|0|||
155504144|NCT01959230|561273953|FG000|Overall Study|Withdrawal by Subject|2|||
155504145|NCT01959230|561273954|FG001|Overall Study|Withdrawal by Subject|0|||
155504146|NCT01453374|561273955|FG000|Overall Study|Adverse Event|7|||
155645849|NCT00086307|561794126|FG002|Overall Study|Nausea and headaches|1|||
155645850|NCT00086307|561794124|FG000|Overall Study|Constipation and sleepiness|0|||
155645851|NCT00086307|561794125|FG001|Overall Study|Constipation and sleepiness|0|||
155645852|NCT00086307|561794126|FG002|Overall Study|Constipation and sleepiness|1|||
155645853|NCT00086307|561794124|FG000|Overall Study|Suicidal ideation|0|||
155645854|NCT00086307|561794125|FG001|Overall Study|Suicidal ideation|0|||
155645855|NCT00086307|561794126|FG002|Overall Study|Suicidal ideation|1|||
155645856|NCT00086307|561794124|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
155645857|NCT00086307|561794125|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
155645858|NCT00086307|561794126|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
155337000|NCT00824408|560668309|FG004|Run-in Phase|Other reason not defined above|0|||
155337001|NCT00824408|560668305|FG000|Randomized Phase|Not treated|0|||
155337002|NCT00824408|560668306|FG001|Randomized Phase|Not treated|0|||
155337003|NCT00824408|560668307|FG002|Randomized Phase|Not treated|1|||
155337004|NCT00824408|560668308|FG003|Randomized Phase|Not treated|1|||
155337005|NCT00824408|560668309|FG004|Randomized Phase|Not treated|1|||
155337006|NCT00824408|560668305|FG000|Randomized Phase|Progressive disease|0|||
155337007|NCT00824408|560668306|FG001|Randomized Phase|Progressive disease|0|||
155337008|NCT00824408|560668307|FG002|Randomized Phase|Progressive disease|25|||
155337009|NCT00824408|560668308|FG003|Randomized Phase|Progressive disease|36|||
155337010|NCT00824408|560668309|FG004|Randomized Phase|Progressive disease|34|||
155337011|NCT00824408|560668305|FG000|Randomized Phase|Adverse Event|0|||
155337012|NCT00824408|560668306|FG001|Randomized Phase|Adverse Event|0|||
155337013|NCT00824408|560668307|FG002|Randomized Phase|Adverse Event|4|||
155337014|NCT00824408|560668308|FG003|Randomized Phase|Adverse Event|5|||
155337015|NCT00824408|560668309|FG004|Randomized Phase|Adverse Event|5|||
155337016|NCT00824408|560668305|FG000|Randomized Phase|Refused to continue medication|0|||
155337017|NCT00824408|560668306|FG001|Randomized Phase|Refused to continue medication|0|||
155337018|NCT00824408|560668307|FG002|Randomized Phase|Refused to continue medication|2|||
155337019|NCT00824408|560668308|FG003|Randomized Phase|Refused to continue medication|2|||
155337020|NCT00824408|560668309|FG004|Randomized Phase|Refused to continue medication|2|||
155337021|NCT00824408|560668305|FG000|Randomized Phase|Other reason not defined above|0|||
155337022|NCT00824408|560668306|FG001|Randomized Phase|Other reason not defined above|0|||
155337023|NCT00824408|560668307|FG002|Randomized Phase|Other reason not defined above|4|||
155337024|NCT00824408|560668308|FG003|Randomized Phase|Other reason not defined above|2|||
155337025|NCT00824408|560668309|FG004|Randomized Phase|Other reason not defined above|4|||
155337026|NCT01218594|560668312|FG000|Overall Study|Death|1|||
155337027|NCT01218594|560668312|FG000|Overall Study|Withdrawal by Subject|3|||
155337028|NCT01218594|560668312|FG000|Overall Study|Adverse Event|2|||
155337029|NCT01218594|560668312|FG000|Overall Study|Physician Decision|6|||
155337030|NCT04602728|560668315|FG000|Overall Study|Lost to Follow-up|4|||
155337031|NCT04602728|560668316|FG001|Overall Study|Lost to Follow-up|4|||
155337032|NCT04181788|560668317|FG000|TREATMENT|Adverse Event|0|||
155337033|NCT04181788|560668318|FG001|TREATMENT|Adverse Event|2|||
155337034|NCT04181788|560668319|FG002|TREATMENT|Adverse Event|1|||
155337035|NCT04181788|560668320|FG003|TREATMENT|Adverse Event|0|||
155337036|NCT04181788|560668321|FG004|TREATMENT|Adverse Event|1|||
155337037|NCT04181788|560668322|FG005|TREATMENT|Adverse Event|3|||
155337038|NCT04181788|560668317|FG000|TREATMENT|Death|0|||
155337039|NCT04181788|560668318|FG001|TREATMENT|Death|0|||
155337040|NCT04181788|560668319|FG002|TREATMENT|Death|0|||
155337041|NCT04181788|560668320|FG003|TREATMENT|Death|0|||
155337042|NCT04181788|560668321|FG004|TREATMENT|Death|8|||
155337043|NCT04181788|560668322|FG005|TREATMENT|Death|8|||
155337044|NCT04181788|560668317|FG000|TREATMENT|Physician Decision|0|||
155337045|NCT04181788|560668318|FG001|TREATMENT|Physician Decision|0|||
155337046|NCT04181788|560668319|FG002|TREATMENT|Physician Decision|0|||
155337047|NCT04181788|560668320|FG003|TREATMENT|Physician Decision|0|||
155337048|NCT04181788|560668321|FG004|TREATMENT|Physician Decision|0|||
155423046|NCT02347631|560978668|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
155423047|NCT02347631|560978667|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
155423048|NCT02347631|560978668|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
155337049|NCT04181788|560668322|FG005|TREATMENT|Physician Decision|1|||
155337050|NCT04181788|560668317|FG000|TREATMENT|Progressive disease|3|||
155337051|NCT04181788|560668318|FG001|TREATMENT|Progressive disease|3|||
155337052|NCT04181788|560668319|FG002|TREATMENT|Progressive disease|5|||
155337053|NCT04181788|560668320|FG003|TREATMENT|Progressive disease|7|||
155337054|NCT04181788|560668321|FG004|TREATMENT|Progressive disease|20|||
155337055|NCT04181788|560668322|FG005|TREATMENT|Progressive disease|38|||
155645859|NCT00086307|561794124|FG000|Overall Study|Withdrawal by Subject|0|||
155645860|NCT00086307|561794125|FG001|Overall Study|Withdrawal by Subject|0|||
155645861|NCT00086307|561794126|FG002|Overall Study|Withdrawal by Subject|2|||
155337056|NCT04181788|560668317|FG000|TREATMENT|Global deterioration of health status|0|||
155337057|NCT04181788|560668318|FG001|TREATMENT|Global deterioration of health status|2|||
155337058|NCT04181788|560668319|FG002|TREATMENT|Global deterioration of health status|0|||
155337059|NCT04181788|560668320|FG003|TREATMENT|Global deterioration of health status|0|||
155337060|NCT04181788|560668321|FG004|TREATMENT|Global deterioration of health status|2|||
155337061|NCT04181788|560668322|FG005|TREATMENT|Global deterioration of health status|8|||
155645862|NCT01018953|561794127|FG000|Overall Study|Adverse Event|2|||
155645863|NCT01018953|561794127|FG000|Overall Study|Withdrawal by Subject|1|||
155645864|NCT01018953|561794127|FG000|Overall Study|Study termination by sponsor|5|||
155645865|NCT00724503|561794128|FG000|Overall Study|Lost to Follow-up|4|||
155645866|NCT00724503|561794129|FG001|Overall Study|Lost to Follow-up|8|||
155645867|NCT00724503|561794128|FG000|Overall Study|Withdrawal by Subject|11|||
155645868|NCT00724503|561794129|FG001|Overall Study|Withdrawal by Subject|23|||
155337062|NCT04181788|560668317|FG000|TREATMENT|Withdrawal by Subject|1|||
155337063|NCT04181788|560668318|FG001|TREATMENT|Withdrawal by Subject|2|||
155337064|NCT04181788|560668319|FG002|TREATMENT|Withdrawal by Subject|0|||
155337065|NCT04181788|560668320|FG003|TREATMENT|Withdrawal by Subject|0|||
155337066|NCT04181788|560668321|FG004|TREATMENT|Withdrawal by Subject|3|||
155337067|NCT04181788|560668322|FG005|TREATMENT|Withdrawal by Subject|5|||
155337068|NCT04181788|560668317|FG000|TREATMENT|Other unspecified|0|||
155337069|NCT04181788|560668318|FG001|TREATMENT|Other unspecified|0|||
155337070|NCT04181788|560668319|FG002|TREATMENT|Other unspecified|0|||
155337071|NCT04181788|560668320|FG003|TREATMENT|Other unspecified|0|||
155337072|NCT04181788|560668321|FG004|TREATMENT|Other unspecified|0|||
155337073|NCT04181788|560668322|FG005|TREATMENT|Other unspecified|2|||
155337074|NCT04181788|560668317|FG000|TREATMENT|Ongoing|0|||
155337075|NCT04181788|560668318|FG001|TREATMENT|Ongoing|3|||
155337076|NCT04181788|560668319|FG002|TREATMENT|Ongoing|0|||
155337077|NCT04181788|560668320|FG003|TREATMENT|Ongoing|5|||
155337078|NCT04181788|560668321|FG004|TREATMENT|Ongoing|7|||
155337079|NCT04181788|560668322|FG005|TREATMENT|Ongoing|15|||
155337080|NCT04181788|560668317|FG000|FOLLOW-UP|Death|0|||
155337081|NCT04181788|560668318|FG001|FOLLOW-UP|Death|0|||
155337082|NCT04181788|560668319|FG002|FOLLOW-UP|Death|1|||
155337083|NCT04181788|560668320|FG003|FOLLOW-UP|Death|2|||
155337084|NCT04181788|560668321|FG004|FOLLOW-UP|Death|8|||
155337085|NCT04181788|560668322|FG005|FOLLOW-UP|Death|20|||
155337086|NCT04181788|560668317|FG000|FOLLOW-UP|Lost to Follow-up|0|||
155337087|NCT04181788|560668318|FG001|FOLLOW-UP|Lost to Follow-up|0|||
155337088|NCT04181788|560668319|FG002|FOLLOW-UP|Lost to Follow-up|0|||
155337089|NCT04181788|560668320|FG003|FOLLOW-UP|Lost to Follow-up|0|||
155337090|NCT04181788|560668321|FG004|FOLLOW-UP|Lost to Follow-up|0|||
155337091|NCT04181788|560668322|FG005|FOLLOW-UP|Lost to Follow-up|2|||
155337092|NCT04181788|560668317|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
155337093|NCT04181788|560668318|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
155337094|NCT04181788|560668319|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
155337095|NCT04181788|560668320|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
155337096|NCT04181788|560668321|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
155337097|NCT04181788|560668322|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
155337098|NCT04181788|560668317|FG000|FOLLOW-UP|Other unspecified|0|||
155337099|NCT04181788|560668318|FG001|FOLLOW-UP|Other unspecified|1|||
155337100|NCT04181788|560668319|FG002|FOLLOW-UP|Other unspecified|0|||
155337101|NCT04181788|560668320|FG003|FOLLOW-UP|Other unspecified|0|||
155337102|NCT04181788|560668321|FG004|FOLLOW-UP|Other unspecified|0|||
155337103|NCT04181788|560668322|FG005|FOLLOW-UP|Other unspecified|3|||
155337104|NCT04181788|560668317|FG000|FOLLOW-UP|Ongoing|0|||
155337105|NCT04181788|560668318|FG001|FOLLOW-UP|Ongoing|0|||
155337106|NCT04181788|560668319|FG002|FOLLOW-UP|Ongoing|1|||
155337107|NCT04181788|560668320|FG003|FOLLOW-UP|Ongoing|3|||
155337108|NCT04181788|560668321|FG004|FOLLOW-UP|Ongoing|2|||
155337109|NCT04181788|560668322|FG005|FOLLOW-UP|Ongoing|2|||
155337110|NCT04535414|560668323|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
155337111|NCT04535414|560668324|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
155337112|NCT04535414|560668323|FG000|Overall Study|Cancelled appointment|1|||
155337113|NCT04535414|560668324|FG001|Overall Study|Cancelled appointment|0|||
155337114|NCT04535414|560668323|FG000|Overall Study|cancelled - food in stomach|2|||
155337115|NCT04535414|560668324|FG001|Overall Study|cancelled - food in stomach|0|||
155337116|NCT04535414|560668323|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
155337117|NCT04535414|560668324|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
155337118|NCT04535414|560668323|FG000|Overall Study|Withdrawal by Subject|0|||
155337119|NCT04535414|560668324|FG001|Overall Study|Withdrawal by Subject|1|||
155337120|NCT04186247|560668325|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
155337121|NCT04186247|560668326|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337122|NCT04186247|560668327|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337123|NCT04186247|560668328|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337124|NCT04186247|560668329|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337125|NCT03662659|560668330|FG000|Pre-treatment|Participant no longer met study criteria|1|||
155337126|NCT03662659|560668331|FG001|Pre-treatment|Participant no longer met study criteria|1|||
155337127|NCT03662659|560668330|FG000|Pre-treatment|Other reasons|1|||
155337128|NCT03662659|560668331|FG001|Pre-treatment|Other reasons|0|||
155337129|NCT03662659|560668330|FG000|Treatment|Completed Treatment|0|||
155337130|NCT03662659|560668331|FG001|Treatment|Completed Treatment|2|||
155337131|NCT03662659|560668330|FG000|Treatment|Disease Progression|85|||
155337132|NCT03662659|560668331|FG001|Treatment|Disease Progression|97|||
155337133|NCT03662659|560668330|FG000|Treatment|Study Drug Toxicity|19|||
155337134|NCT03662659|560668331|FG001|Treatment|Study Drug Toxicity|9|||
155337135|NCT03662659|560668330|FG000|Treatment|Death|11|||
155337136|NCT03662659|560668331|FG001|Treatment|Death|9|||
155337137|NCT03662659|560668330|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
155337138|NCT03662659|560668331|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
155337139|NCT03662659|560668330|FG000|Treatment|Withdrawal by Subject|1|||
155337140|NCT03662659|560668331|FG001|Treatment|Withdrawal by Subject|1|||
155337141|NCT03662659|560668330|FG000|Treatment|Poor/Non-compliance|1|||
155504147|NCT01453374|561273955|FG000|Overall Study|Lack of Efficacy|1|||
155504148|NCT01453374|561273955|FG000|Overall Study|Lost to Follow-up|3|||
155504149|NCT01453374|561273955|FG000|Overall Study|Withdrawal by Subject|5|||
155504150|NCT01453374|561273955|FG000|Overall Study|Incarcerated|2|||
155504151|NCT02629133|561273958|FG000|Overall Study|Lost to Follow-up|3|||
155504152|NCT02629133|561273959|FG001|Overall Study|Lost to Follow-up|1|||
155504153|NCT02629133|561273958|FG000|Overall Study|Withdrawal by Subject|1|||
155504154|NCT02629133|561273959|FG001|Overall Study|Withdrawal by Subject|1|||
155504155|NCT01223196|561273960|FG000|Overall Study|Lost to Follow-up|2|||
155504156|NCT01223196|561273961|FG001|Overall Study|Lost to Follow-up|0|||
155504157|NCT01223196|561273960|FG000|Overall Study|Physician Decision|1|||
155504158|NCT01223196|561273961|FG001|Overall Study|Physician Decision|0|||
155504159|NCT01223196|561273960|FG000|Overall Study|Withdrawal by Subject|1|||
155504160|NCT01223196|561273961|FG001|Overall Study|Withdrawal by Subject|0|||
155504161|NCT02487979|561273962|FG000|Overall Study|Physician Decision|2|||
155504162|NCT02487979|561273962|FG000|Overall Study|Withdrawal by Subject|2|||
155504163|NCT02487979|561273962|FG000|Overall Study|Progressive Disease|17|||
155504164|NCT00447694|561273963|FG000|Overall Study|Adverse Event|2|||
155504165|NCT00447694|561273963|FG000|Overall Study|Abnormal laboratory value|1|||
155337142|NCT03662659|560668331|FG001|Treatment|Poor/Non-compliance|0|||
155337143|NCT03662659|560668330|FG000|Treatment|Participant no longer meets study criteria|1|||
155337144|NCT03662659|560668331|FG001|Treatment|Participant no longer meets study criteria|0|||
155337145|NCT03662659|560668330|FG000|Treatment|Other reasons|10|||
155337146|NCT03662659|560668331|FG001|Treatment|Other reasons|8|||
155337147|NCT03662659|560668330|FG000|Treatment|Administrative reasons by sponsor|1|||
155337148|NCT03662659|560668331|FG001|Treatment|Administrative reasons by sponsor|0|||
155337149|NCT03662659|560668330|FG000|Treatment|maximum clinical benefit|0|||
155337150|NCT03662659|560668331|FG001|Treatment|maximum clinical benefit|2|||
155337151|NCT04369664|560670642|FG000|Overall Study|Physician Decision|1|||
155337152|NCT04369664|560670643|FG001|Overall Study|Physician Decision|0|||
155337153|NCT01668355|560670646|FG000|Overall Study|Death|3|||
155337154|NCT01668355|560670647|FG001|Overall Study|Death|1|||
155337155|NCT01668355|560670646|FG000|Overall Study|Withdrawal by Subject|6|||
155337156|NCT01668355|560670647|FG001|Overall Study|Withdrawal by Subject|1|||
155337157|NCT00535626|560670648|FG000|Overall Study|Death|15|||
155337158|NCT00535626|560670648|FG000|Overall Study|Lost to Follow-up|29|||
155337159|NCT00535626|560670648|FG000|Overall Study|Withdrawal by Subject|20|||
155337160|NCT00535626|560670648|FG000|Overall Study|Removal/revision of study component|8|||
155337161|NCT00535626|560670648|FG000|Overall Study|Subject terminated|31|||
155337162|NCT00535626|560670648|FG000|Overall Study|Unable to return|2|||
155337163|NCT02830893|560670649|FG000|Overall Study|Relocation to out of the country|1|||
155337164|NCT02830893|560670650|FG001|Overall Study|Relocation to out of the country|0|||
155337165|NCT02830893|560670649|FG000|Overall Study|Lost to Follow-up|0|||
155337166|NCT02830893|560670650|FG001|Overall Study|Lost to Follow-up|2|||
155337167|NCT02830893|560670649|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
155337168|NCT02830893|560670650|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
155337169|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
155337170|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
155337171|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
155337172|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
155337173|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
155337174|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
155337175|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
155337176|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
155337177|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
155337178|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
155337179|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
155504166|NCT00447694|561273963|FG000|Overall Study|Abnormal test procedure result|1|||
155504167|NCT00447694|561273963|FG000|Overall Study|Withdrawal by Subject|2|||
155504168|NCT01965535|561273964|FG000|Overall Study|Lack of Efficacy|2|||
155504169|NCT01965535|561273965|FG001|Overall Study|Lack of Efficacy|1|||
155504170|NCT01169987|561273966|FG000|Overall Study|Withdrawal by Subject|3|||
155504171|NCT01169987|561273966|FG000|Overall Study|Lost to Follow-up|24|||
155337180|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
155337181|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
155504172|NCT01169987|561273966|FG000|Overall Study|Other|4|||
155337182|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
155337183|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
155337184|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
155504173|NCT00829439|561273967|FG000|Overall Study|Adverse Event|0|||
155504174|NCT00829439|561273968|FG001|Overall Study|Adverse Event|0|||
155504175|NCT00829439|561273969|FG002|Overall Study|Adverse Event|1|||
155504176|NCT00829439|561273970|FG003|Overall Study|Adverse Event|0|||
155504177|NCT00386100|561273971|FG000|Overall Study|Did not receive study medication|6|||
155504178|NCT00386100|561273972|FG001|Overall Study|Did not receive study medication|4|||
155504179|NCT00386100|561273971|FG000|Overall Study|Adverse Event|15|||
155504180|NCT00386100|561273972|FG001|Overall Study|Adverse Event|25|||
155504181|NCT00386100|561273971|FG000|Overall Study|Death|0|||
155504182|NCT00386100|561273972|FG001|Overall Study|Death|1|||
155504183|NCT00386100|561273971|FG000|Overall Study|Insufficient therapeutic effect|30|||
155504184|NCT00386100|561273972|FG001|Overall Study|Insufficient therapeutic effect|6|||
155504185|NCT00386100|561273971|FG000|Overall Study|Lost to Follow-up|29|||
155504186|NCT00386100|561273972|FG001|Overall Study|Lost to Follow-up|29|||
155504187|NCT00386100|561273971|FG000|Overall Study|Non-compliance|18|||
155504188|NCT00386100|561273972|FG001|Overall Study|Non-compliance|19|||
155504189|NCT00386100|561273971|FG000|Overall Study|Protocol Violation|5|||
155504190|NCT00386100|561273972|FG001|Overall Study|Protocol Violation|3|||
155504191|NCT00386100|561273971|FG000|Overall Study|Withdrawal by Subject|32|||
155504192|NCT00386100|561273972|FG001|Overall Study|Withdrawal by Subject|31|||
155504193|NCT00386100|561273971|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
155504194|NCT00386100|561273972|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
155504195|NCT00386100|561273971|FG000|Overall Study|BMD <2.5|1|||
155504196|NCT00386100|561273972|FG001|Overall Study|BMD <2.5|0|||
155337185|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
155337186|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
155337187|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
155337188|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
155337189|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
155337190|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
155337191|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
155337192|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
155337193|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
155504197|NCT00386100|561273971|FG000|Overall Study|Consecutive elevated Hba1C|1|||
155504198|NCT00386100|561273972|FG001|Overall Study|Consecutive elevated Hba1C|0|||
155504199|NCT00386100|561273971|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
155504200|NCT00386100|561273972|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
155504201|NCT00386100|561273971|FG000|Overall Study|Laboratory findings|1|||
155504202|NCT00386100|561273972|FG001|Overall Study|Laboratory findings|0|||
155504203|NCT00386100|561273971|FG000|Overall Study|Participant's concern due to CPK levels|1|||
155504204|NCT00386100|561273972|FG001|Overall Study|Participant's concern due to CPK levels|0|||
155504205|NCT00386100|561273971|FG000|Overall Study|Participant moving out of state|2|||
155504206|NCT00386100|561273972|FG001|Overall Study|Participant moving out of state|0|||
155504207|NCT00386100|561273971|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
155504208|NCT00386100|561273972|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
155504209|NCT00386100|561273971|FG000|Overall Study|Didn't meet entry criteria|1|||
155504210|NCT00386100|561273972|FG001|Overall Study|Didn't meet entry criteria|1|||
155504211|NCT00386100|561273971|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
155504212|NCT00386100|561273972|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
155504213|NCT00386100|561273971|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
155504214|NCT00386100|561273972|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
155504215|NCT00386100|561273971|FG000|Overall Study|Bad metabolic control & patient security|1|||
155504216|NCT00386100|561273972|FG001|Overall Study|Bad metabolic control & patient security|0|||
155504217|NCT00386100|561273971|FG000|Overall Study|Bone loss by DXA bone scan|1|||
155504218|NCT00386100|561273972|FG001|Overall Study|Bone loss by DXA bone scan|0|||
155337194|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
155337195|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
155337196|NCT02710669|560670654|FG000|Overall Study|Physician Decision|2|||
155504219|NCT00386100|561273971|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
155337197|NCT02710669|560670655|FG001|Overall Study|Physician Decision|1|||
155337198|NCT02710669|560670656|FG002|Overall Study|Physician Decision|0|||
155337199|NCT02710669|560670654|FG000|Overall Study|Institutional delays (including COVID)|2|||
155337200|NCT02710669|560670655|FG001|Overall Study|Institutional delays (including COVID)|2|||
155337201|NCT02710669|560670656|FG002|Overall Study|Institutional delays (including COVID)|0|||
155337202|NCT02710669|560670654|FG000|Overall Study|arrived in afib/aflutter|10|||
155337203|NCT02710669|560670655|FG001|Overall Study|arrived in afib/aflutter|8|||
155337204|NCT02710669|560670656|FG002|Overall Study|arrived in afib/aflutter|2|||
155504220|NCT00386100|561273972|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
155504221|NCT00386100|561273971|FG000|Overall Study|7.6% bone loss|1|||
155504222|NCT00386100|561273972|FG001|Overall Study|7.6% bone loss|0|||
155504223|NCT00386100|561273971|FG000|Overall Study|Osteoporosis|0|||
155504224|NCT00386100|561273972|FG001|Overall Study|Osteoporosis|1|||
155504225|NCT00386100|561273971|FG000|Overall Study|Positive pregnancy test|1|||
155504226|NCT00386100|561273972|FG001|Overall Study|Positive pregnancy test|3|||
155504227|NCT00386100|561273971|FG000|Overall Study|Out of country for 5 months|1|||
155337205|NCT01567852|560670659|FG000|Overall Study|Withdrawal by Subject|3|||
155504228|NCT00386100|561273972|FG001|Overall Study|Out of country for 5 months|0|||
155504229|NCT00386100|561273971|FG000|Overall Study|Hb1Ac >8%|0|||
155504230|NCT00386100|561273972|FG001|Overall Study|Hb1Ac >8%|1|||
155504231|NCT00386100|561273971|FG000|Overall Study|Participant randomized in error|1|||
155504232|NCT00386100|561273972|FG001|Overall Study|Participant randomized in error|0|||
155504233|NCT02525562|561273973|FG000|Overall Study|Death|9|||
155504234|NCT02525562|561273974|FG001|Overall Study|Death|0|||
155504235|NCT02525562|561273975|FG002|Overall Study|Death|0|||
155504236|NCT02525562|561273973|FG000|Overall Study|Lost to Follow-up|19|||
155504237|NCT02525562|561273974|FG001|Overall Study|Lost to Follow-up|0|||
155504238|NCT02525562|561273975|FG002|Overall Study|Lost to Follow-up|0|||
155504239|NCT02525562|561273973|FG000|Overall Study|Withdrawal by Subject|37|||
155504240|NCT02525562|561273974|FG001|Overall Study|Withdrawal by Subject|0|||
155504241|NCT02525562|561273975|FG002|Overall Study|Withdrawal by Subject|0|||
155504242|NCT02525562|561273973|FG000|Overall Study|Revision/Removal of Study Device|4|||
155504243|NCT02525562|561273974|FG001|Overall Study|Revision/Removal of Study Device|0|||
155504244|NCT02525562|561273975|FG002|Overall Study|Revision/Removal of Study Device|0|||
155504245|NCT02525562|561273973|FG000|Overall Study|Study Closed by Sponsor|154|||
155504246|NCT02525562|561273974|FG001|Overall Study|Study Closed by Sponsor|0|||
155504247|NCT02525562|561273975|FG002|Overall Study|Study Closed by Sponsor|0|||
155504248|NCT00886782|561273978|FG000|Overall Study|Disease progression|3|||
155504249|NCT00886782|561273979|FG001|Overall Study|Disease progression|3|||
155504250|NCT00886782|561273980|FG002|Overall Study|Disease progression|3|||
155504251|NCT00886782|561273978|FG000|Overall Study|Study drug toxicity|0|||
155504252|NCT00886782|561273979|FG001|Overall Study|Study drug toxicity|0|||
155504253|NCT00886782|561273980|FG002|Overall Study|Study drug toxicity|1|||
155504254|NCT00886782|561273978|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
155504255|NCT00886782|561273979|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
155504256|NCT00886782|561273980|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
155504257|NCT00849524|561273981|FG000|Overall Study|Lack of Efficacy|3|||
155504258|NCT02624518|561273982|FG000|Overall Study|Physician Decision|1|||
155504259|NCT03012815|561273983|FG000|Overall Study|Lost to Follow-up|1|||
155504260|NCT03012815|561273984|FG001|Overall Study|Lost to Follow-up|0|||
155504261|NCT03012815|561273983|FG000|Overall Study|Physician Decision|3|||
155504262|NCT03012815|561273984|FG001|Overall Study|Physician Decision|2|||
155504263|NCT03012815|561273983|FG000|Overall Study|Adverse Event|1|||
155504264|NCT03012815|561273984|FG001|Overall Study|Adverse Event|0|||
155504265|NCT00272961|561273985|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
155504266|NCT00272961|561273986|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
155504267|NCT00272961|561273987|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
155504268|NCT00272961|561273988|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
155504269|NCT00272961|561273989|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
155504270|NCT00272961|561273985|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
155504271|NCT00272961|561273986|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
155504272|NCT00272961|561273987|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
155504273|NCT00272961|561273988|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
155504274|NCT00272961|561273989|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
155504275|NCT00272961|561273985|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
155504276|NCT00272961|561273986|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
155504277|NCT00272961|561273987|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
155504278|NCT00272961|561273988|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
155504279|NCT00272961|561273989|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
155337206|NCT01567852|560670660|FG001|Overall Study|Withdrawal by Subject|6|||
155337207|NCT01567852|560670659|FG000|Overall Study|ECT discontinued|1|||
155337208|NCT01567852|560670660|FG001|Overall Study|ECT discontinued|1|||
155337209|NCT03332589|560670661|FG000|Overall Study|Lack of Efficacy|2|||
155337210|NCT03332589|560670662|FG001|Overall Study|Lack of Efficacy|0|||
155337211|NCT03332589|560670663|FG002|Overall Study|Lack of Efficacy|0|||
155337212|NCT03332589|560670661|FG000|Overall Study|Adverse Event|1|||
155337213|NCT03332589|560670662|FG001|Overall Study|Adverse Event|0|||
155337214|NCT03332589|560670663|FG002|Overall Study|Adverse Event|0|||
155337215|NCT03332589|560670661|FG000|Overall Study|Death|1|||
155337216|NCT03332589|560670662|FG001|Overall Study|Death|0|||
155645869|NCT00724503|561794128|FG000|Overall Study|Death|190|||
155337217|NCT03332589|560670663|FG002|Overall Study|Death|0|||
155504280|NCT00272961|561273985|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
155504281|NCT00272961|561273986|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
155504282|NCT00272961|561273987|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
155504283|NCT00272961|561273988|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
155504284|NCT00272961|561273989|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
155504285|NCT00272961|561273985|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
155645870|NCT00724503|561794129|FG001|Overall Study|Death|182|||
155337218|NCT04633200|560670664|FG000|Overall Study|Lost to Follow-up|3|||
155337219|NCT04633200|560670665|FG001|Overall Study|Lost to Follow-up|5|||
155645871|NCT00724503|561794128|FG000|Overall Study|Adverse Event|1|||
155337220|NCT03690219|560670666|FG000|Overall Study|no injuries|9|||
155337221|NCT03690219|560670667|FG001|Overall Study|no injuries|20|||
155337222|NCT03690219|560670666|FG000|Overall Study|missing information|7|||
155337223|NCT03690219|560670667|FG001|Overall Study|missing information|7|||
155337224|NCT01523392|560670668|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155337225|NCT01523392|560670669|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155337226|NCT01523392|560670668|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
155337227|NCT01523392|560670669|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
155337228|NCT01523392|560670668|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
155337229|NCT01523392|560670669|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
155337230|NCT04809623|560670670|FG000|Overall Study|Study Terminated by Sponsor|1|||
155337231|NCT04809623|560670671|FG001|Overall Study|Study Terminated by Sponsor|0|||
155337232|NCT02002689|560670672|FG000|Overall Study|Disease Progression|7|||
155337233|NCT02002689|560670672|FG000|Overall Study|Adverse Event|3|||
155337234|NCT02354417|560670673|FG000|Overall Study|Physician Decision|1|||
155337235|NCT02092285|560670674|FG000|Induction Phase|Adverse Event|7|||
155337236|NCT02092285|560670674|FG000|Induction Phase|Physician Decision|4|||
155337237|NCT02092285|560670674|FG000|Induction Phase|Pregnancy|1|||
155337238|NCT02092285|560670674|FG000|Induction Phase|Relapse/Recurrence|7|||
155337239|NCT02092285|560670674|FG000|Induction Phase|Withdrawal by Subject|2|||
155337240|NCT02092285|560670674|FG000|Induction Phase|Lack of Efficacy|14|||
155337241|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
155337242|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
155337243|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
155337244|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
155337245|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
155337246|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
155337247|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
155337248|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
155337249|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
155337250|NCT00087516|560670675|FG000|Overall Study|Adverse Event|10|||
155337251|NCT00087516|560670676|FG001|Overall Study|Adverse Event|10|||
155337252|NCT00087516|560670677|FG002|Overall Study|Adverse Event|3|||
155337253|NCT00087516|560670678|FG003|Overall Study|Adverse Event|6|||
155337254|NCT00087516|560670675|FG000|Overall Study|Lack of Efficacy|82|||
155337255|NCT00087516|560670676|FG001|Overall Study|Lack of Efficacy|80|||
155337256|NCT00087516|560670677|FG002|Overall Study|Lack of Efficacy|39|||
155337257|NCT00087516|560670678|FG003|Overall Study|Lack of Efficacy|29|||
155337258|NCT00087516|560670675|FG000|Overall Study|Lost to Follow-up|8|||
155337259|NCT00087516|560670676|FG001|Overall Study|Lost to Follow-up|6|||
155337260|NCT00087516|560670677|FG002|Overall Study|Lost to Follow-up|5|||
155337261|NCT00087516|560670678|FG003|Overall Study|Lost to Follow-up|5|||
155337262|NCT00087516|560670675|FG000|Overall Study|Protocol Violation|4|||
155337263|NCT00087516|560670676|FG001|Overall Study|Protocol Violation|8|||
155337264|NCT00087516|560670677|FG002|Overall Study|Protocol Violation|3|||
155337265|NCT00087516|560670678|FG003|Overall Study|Protocol Violation|6|||
155337266|NCT00087516|560670675|FG000|Overall Study|Withdrawal by Subject|16|||
155337267|NCT00087516|560670676|FG001|Overall Study|Withdrawal by Subject|27|||
155337268|NCT00087516|560670677|FG002|Overall Study|Withdrawal by Subject|11|||
155337269|NCT00087516|560670678|FG003|Overall Study|Withdrawal by Subject|12|||
155337270|NCT00087516|560670675|FG000|Overall Study|Site terminated|0|||
155337271|NCT00087516|560670676|FG001|Overall Study|Site terminated|2|||
155337272|NCT00087516|560670677|FG002|Overall Study|Site terminated|1|||
155504286|NCT00272961|561273986|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
155504287|NCT00272961|561273987|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
155504288|NCT00272961|561273988|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
155337273|NCT00087516|560670678|FG003|Overall Study|Site terminated|0|||
155337274|NCT00087516|560670675|FG000|Overall Study|Protocol specified discontinuation|35|||
155337275|NCT00087516|560670676|FG001|Overall Study|Protocol specified discontinuation|33|||
155504289|NCT00272961|561273989|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
155504290|NCT00272961|561273985|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
155337276|NCT00087516|560670677|FG002|Overall Study|Protocol specified discontinuation|33|||
155337277|NCT00087516|560670678|FG003|Overall Study|Protocol specified discontinuation|26|||
155337278|NCT00087516|560670675|FG000|Overall Study|Patient moved|3|||
155337279|NCT00087516|560670676|FG001|Overall Study|Patient moved|2|||
155337280|NCT00087516|560670677|FG002|Overall Study|Patient moved|1|||
155337281|NCT00087516|560670678|FG003|Overall Study|Patient moved|0|||
155504291|NCT00272961|561273986|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
155337282|NCT00087516|560670675|FG000|Overall Study|Patient was non-compliant|3|||
155337283|NCT00087516|560670676|FG001|Overall Study|Patient was non-compliant|1|||
155337284|NCT00087516|560670677|FG002|Overall Study|Patient was non-compliant|0|||
155337285|NCT00087516|560670678|FG003|Overall Study|Patient was non-compliant|0|||
155337286|NCT00087516|560670675|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
155337287|NCT00087516|560670676|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
155337288|NCT00087516|560670677|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
155645872|NCT00724503|561794129|FG001|Overall Study|Adverse Event|0|||
155645873|NCT00724503|561794128|FG000|Overall Study|Not otherwise specified|4|||
155645874|NCT00724503|561794129|FG001|Overall Study|Not otherwise specified|7|||
155645875|NCT01560416|561794138|FG000|Randomized Phase|Crossover Participants|7|||
155337289|NCT00087516|560670678|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
155337290|NCT00087516|560670675|FG000|Overall Study|Other|0|||
155337291|NCT00087516|560670676|FG001|Overall Study|Other|0|||
155337292|NCT00087516|560670677|FG002|Overall Study|Other|1|||
155337293|NCT00087516|560670678|FG003|Overall Study|Other|0|||
155337294|NCT01719172|560670679|FG000|Overall Study|Lost to Follow-up|1|||
155337295|NCT01719172|560670679|FG000|Overall Study|Death|1|||
155337296|NCT02236611|560670682|FG000|Overall Study|Adverse Event|10|||
155337297|NCT02236611|560670683|FG001|Overall Study|Adverse Event|16|||
155337298|NCT02236611|560670682|FG000|Overall Study|Lack of Efficacy|4|||
155337299|NCT02236611|560670683|FG001|Overall Study|Lack of Efficacy|7|||
155337300|NCT02236611|560670682|FG000|Overall Study|Lost to Follow-up|0|||
155337301|NCT02236611|560670683|FG001|Overall Study|Lost to Follow-up|2|||
155337302|NCT02236611|560670682|FG000|Overall Study|Protocol deviation|3|||
155337303|NCT02236611|560670683|FG001|Overall Study|Protocol deviation|5|||
155337304|NCT02236611|560670682|FG000|Overall Study|Withdrew consent|9|||
155337305|NCT02236611|560670683|FG001|Overall Study|Withdrew consent|4|||
155337306|NCT01332266|560670684|FG000|Phase 1b|Death|3|||
155337307|NCT01332266|560670685|FG001|Phase 1b|Death|3|||
155337308|NCT01332266|560670686|FG002|Phase 1b|Death|2|||
155337309|NCT01332266|560670687|FG003|Phase 1b|Death|0|||
155337310|NCT01332266|560670688|FG004|Phase 1b|Death|0|||
155337311|NCT01332266|560670684|FG000|Phase 1b|Lost to Follow-up|0|||
155337312|NCT01332266|560670685|FG001|Phase 1b|Lost to Follow-up|1|||
155337313|NCT01332266|560670686|FG002|Phase 1b|Lost to Follow-up|0|||
155337314|NCT01332266|560670687|FG003|Phase 1b|Lost to Follow-up|0|||
155337315|NCT01332266|560670688|FG004|Phase 1b|Lost to Follow-up|0|||
155337316|NCT01332266|560670684|FG000|Phase 1b|Withdrawal by Subject|1|||
155337317|NCT01332266|560670685|FG001|Phase 1b|Withdrawal by Subject|1|||
155337318|NCT01332266|560670686|FG002|Phase 1b|Withdrawal by Subject|1|||
155337319|NCT01332266|560670687|FG003|Phase 1b|Withdrawal by Subject|0|||
155337320|NCT01332266|560670688|FG004|Phase 1b|Withdrawal by Subject|0|||
155337321|NCT01332266|560670684|FG000|Phase 2|Death|0|||
155337322|NCT01332266|560670685|FG001|Phase 2|Death|0|||
155337323|NCT01332266|560670686|FG002|Phase 2|Death|0|||
155337324|NCT01332266|560670687|FG003|Phase 2|Death|33|||
155337325|NCT01332266|560670688|FG004|Phase 2|Death|36|||
155337326|NCT01332266|560670684|FG000|Phase 2|Lost to Follow-up|0|||
155337327|NCT01332266|560670685|FG001|Phase 2|Lost to Follow-up|0|||
155337328|NCT01332266|560670686|FG002|Phase 2|Lost to Follow-up|0|||
155337329|NCT01332266|560670687|FG003|Phase 2|Lost to Follow-up|2|||
155645876|NCT01560416|561794139|FG001|Randomized Phase|Crossover Participants|0|||
155645877|NCT01695772|561794140|FG000|Overall Study|Withdrawal by Subject|18|||
155645878|NCT01695772|561794140|FG000|Overall Study|Progressive Disease|8|||
155645879|NCT01695772|561794140|FG000|Overall Study|Investigator Decision|5|||
155337330|NCT01332266|560670688|FG004|Phase 2|Lost to Follow-up|0|||
155337331|NCT01332266|560670684|FG000|Phase 2|Physician Decision|0|||
155337332|NCT01332266|560670685|FG001|Phase 2|Physician Decision|0|||
155337333|NCT01332266|560670686|FG002|Phase 2|Physician Decision|0|||
155337334|NCT01332266|560670687|FG003|Phase 2|Physician Decision|3|||
155337335|NCT01332266|560670688|FG004|Phase 2|Physician Decision|1|||
155337336|NCT01332266|560670684|FG000|Phase 2|Symptomatic deterioration|0|||
155337337|NCT01332266|560670685|FG001|Phase 2|Symptomatic deterioration|0|||
155337338|NCT01332266|560670686|FG002|Phase 2|Symptomatic deterioration|0|||
155337339|NCT01332266|560670687|FG003|Phase 2|Symptomatic deterioration|0|||
155337340|NCT01332266|560670688|FG004|Phase 2|Symptomatic deterioration|1|||
155337341|NCT01332266|560670684|FG000|Phase 2|Progression Disease|0|||
155337342|NCT01332266|560670685|FG001|Phase 2|Progression Disease|0|||
155337343|NCT01332266|560670686|FG002|Phase 2|Progression Disease|0|||
155337344|NCT01332266|560670687|FG003|Phase 2|Progression Disease|2|||
155423049|NCT02347631|560978667|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
155423050|NCT02347631|560978668|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
155423051|NCT02347631|560978667|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
155423052|NCT02347631|560978668|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
155423053|NCT00238264|560978670|FG000|Overall Study|Death|7|||
155423054|NCT00238264|560978670|FG000|Overall Study|Lost to Follow-up|18|||
155423055|NCT00238264|560978670|FG000|Overall Study|Withdrawal by Subject|4|||
155423056|NCT00238264|560978670|FG000|Overall Study|Ineligible|7|||
155337345|NCT01332266|560670688|FG004|Phase 2|Progression Disease|1|||
155423057|NCT00713219|560978671|FG000|Overall Study|Death|1|||
155423058|NCT00713219|560978671|FG000|Overall Study|Protocol Violation|1|||
155337346|NCT01332266|560670684|FG000|Phase 2|Withdrawal by Subject|0|||
155423059|NCT00802360|560978674|FG000|Overall Study|Stimulation failure|4|||
155337347|NCT01332266|560670685|FG001|Phase 2|Withdrawal by Subject|0|||
155423060|NCT00802360|560978675|FG001|Overall Study|Stimulation failure|0|||
155645880|NCT01695772|561794140|FG000|Overall Study|Lost to Follow-up|4|||
155337348|NCT01332266|560670686|FG002|Phase 2|Withdrawal by Subject|0|||
155337349|NCT01332266|560670687|FG003|Phase 2|Withdrawal by Subject|2|||
155504292|NCT00272961|561273987|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
155337350|NCT01332266|560670688|FG004|Phase 2|Withdrawal by Subject|2|||
155337351|NCT00486954|560670691|FG000|Pilot Part|Adverse Event|4|||
155337352|NCT00486954|560670692|FG001|Pilot Part|Adverse Event|0|||
155337353|NCT00486954|560670693|FG002|Pilot Part|Adverse Event|5|||
155337354|NCT00486954|560670694|FG003|Pilot Part|Adverse Event|0|||
155337355|NCT00486954|560670695|FG004|Pilot Part|Adverse Event|0|||
155337356|NCT00486954|560670691|FG000|Pilot Part|Disease Progression|2|||
155337357|NCT00486954|560670692|FG001|Pilot Part|Disease Progression|0|||
155337358|NCT00486954|560670693|FG002|Pilot Part|Disease Progression|1|||
155337359|NCT00486954|560670694|FG003|Pilot Part|Disease Progression|0|||
155337360|NCT00486954|560670695|FG004|Pilot Part|Disease Progression|0|||
155337361|NCT00486954|560670691|FG000|Randomized Part|Lost to Follow-up|0|||
155337362|NCT00486954|560670692|FG001|Randomized Part|Lost to Follow-up|0|||
155337363|NCT00486954|560670693|FG002|Randomized Part|Lost to Follow-up|0|||
155337364|NCT00486954|560670694|FG003|Randomized Part|Lost to Follow-up|0|||
155337365|NCT00486954|560670695|FG004|Randomized Part|Lost to Follow-up|1|||
155337366|NCT00486954|560670691|FG000|Randomized Part|Withdrawal by Subject|0|||
155337367|NCT00486954|560670692|FG001|Randomized Part|Withdrawal by Subject|0|||
155337368|NCT00486954|560670693|FG002|Randomized Part|Withdrawal by Subject|0|||
155337369|NCT00486954|560670694|FG003|Randomized Part|Withdrawal by Subject|1|||
155337370|NCT00486954|560670695|FG004|Randomized Part|Withdrawal by Subject|0|||
155337371|NCT00486954|560670691|FG000|Randomized Part|Sponsor Terminated Study|0|||
155337372|NCT00486954|560670692|FG001|Randomized Part|Sponsor Terminated Study|0|||
155337373|NCT00486954|560670693|FG002|Randomized Part|Sponsor Terminated Study|0|||
155337374|NCT00486954|560670694|FG003|Randomized Part|Sponsor Terminated Study|19|||
155337375|NCT00486954|560670695|FG004|Randomized Part|Sponsor Terminated Study|13|||
155337376|NCT03316170|560670698|FG000|Overall Study|Death|1|||
155337377|NCT03316170|560670699|FG001|Overall Study|Death|0|||
155337378|NCT03316170|560670698|FG000|Overall Study|Lost to Follow-up|6|||
155337379|NCT03316170|560670699|FG001|Overall Study|Lost to Follow-up|7|||
155337380|NCT02935673|560670700|FG000|Overall Study|Adverse Event|0|||
155337381|NCT02935673|560670701|FG001|Overall Study|Adverse Event|1|||
155337382|NCT02935673|560670702|FG002|Overall Study|Adverse Event|0|||
155337383|NCT02935673|560670700|FG000|Overall Study|Withdrawal by Subject|1|||
155337384|NCT02935673|560670701|FG001|Overall Study|Withdrawal by Subject|2|||
155337385|NCT02935673|560670702|FG002|Overall Study|Withdrawal by Subject|0|||
155337386|NCT01102426|560670706|FG000|Overall Study|Randomized but not treated|4|||
155337387|NCT01102426|560670707|FG001|Overall Study|Randomized but not treated|1|||
155337388|NCT01102426|560670706|FG000|Overall Study|Adverse Events (treatment-related)|15|||
155337389|NCT01102426|560670707|FG001|Overall Study|Adverse Events (treatment-related)|8|||
155337390|NCT01102426|560670706|FG000|Overall Study|Physician Decision|9|||
155337391|NCT01102426|560670707|FG001|Overall Study|Physician Decision|6|||
155337392|NCT01102426|560670706|FG000|Overall Study|Progressive Disease|85|||
155337393|NCT01102426|560670707|FG001|Overall Study|Progressive Disease|44|||
155337394|NCT01102426|560670706|FG000|Overall Study|Adverse Events (unrelated to|9|||
155337395|NCT01102426|560670707|FG001|Overall Study|Adverse Events (unrelated to|1|||
155337396|NCT01102426|560670706|FG000|Overall Study|Patient Refusal|24|||
155337397|NCT01102426|560670707|FG001|Overall Study|Patient Refusal|12|||
155337398|NCT01102426|560670706|FG000|Overall Study|Death (due to adverse events|0|||
155337399|NCT01102426|560670707|FG001|Overall Study|Death (due to adverse events|1|||
155337400|NCT01102426|560670706|FG000|Overall Study|Death (non-related to the study|19|||
155337401|NCT01102426|560670707|FG001|Overall Study|Death (non-related to the study|8|||
155337402|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
155337403|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
155337404|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
155337405|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
155337406|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
155337407|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
155504293|NCT00272961|561273988|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
155504294|NCT00272961|561273989|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
155504295|NCT00272961|561273985|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
155504296|NCT00272961|561273986|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
155504297|NCT00272961|561273987|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
155504298|NCT00272961|561273988|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
155337408|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Adverse Event|6|||
155337409|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Adverse Event|4|||
155337410|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Adverse Event|8|||
155337411|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
155645881|NCT01695772|561794140|FG000|Overall Study|Protocol Violation|2|||
155337412|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
155337413|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
155337414|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155337415|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155337416|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155504299|NCT00272961|561273989|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
155504300|NCT00272961|561273985|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
155504301|NCT00272961|561273986|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
155504302|NCT00272961|561273987|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
155504303|NCT00272961|561273988|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
155504304|NCT00272961|561273989|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
155504305|NCT02400905|561273990|FG000|Overall Study|Death|24|||
155504306|NCT02400905|561273990|FG000|Overall Study|Lost to Follow-up|18|||
155504307|NCT02400905|561273990|FG000|Overall Study|Withdrawal by Subject|16|||
155504308|NCT02400905|561273990|FG000|Overall Study|Physician Decision|4|||
155504309|NCT02400905|561273990|FG000|Overall Study|Other|1|||
155504310|NCT00879970|561273993|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
155504311|NCT00879970|561273994|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
155504312|NCT00879970|561273995|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
155504313|NCT00879970|561273996|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
155504314|NCT00879970|561273997|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
155504315|NCT00879970|561273993|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
155504316|NCT00879970|561273994|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
155504317|NCT00879970|561273995|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
155504318|NCT00879970|561273996|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
155504319|NCT00879970|561273997|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
155504320|NCT00879970|561273993|FG000|Period 1 TZD Randomization|Death|2|||
155504321|NCT00879970|561273994|FG001|Period 1 TZD Randomization|Death|1|||
155504322|NCT00879970|561273995|FG002|Period 1 TZD Randomization|Death|0|||
155504323|NCT00879970|561273996|FG003|Period 1 TZD Randomization|Death|0|||
155504324|NCT00879970|561273997|FG004|Period 1 TZD Randomization|Death|0|||
155504325|NCT00879970|561273993|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
155504326|NCT00879970|561273994|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
155504327|NCT00879970|561273995|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
155504328|NCT00879970|561273996|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
155504329|NCT00879970|561273997|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
155337417|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
155337418|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
155337419|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
155337420|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
155337421|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
155337422|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
155337423|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
155337424|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
155337425|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
155337426|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
155337427|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
155337428|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
155337429|NCT03938272|560670722|FG000|Overall Study|Withdrawal by Subject|1|||
155337430|NCT03938272|560670723|FG001|Overall Study|Withdrawal by Subject|0|||
155337431|NCT03938272|560670722|FG000|Overall Study|Physician Decision|0|||
155337432|NCT03938272|560670723|FG001|Overall Study|Physician Decision|2|||
155337433|NCT03938272|560670722|FG000|Overall Study|Study termination by sponsor|10|||
155337434|NCT03938272|560670723|FG001|Overall Study|Study termination by sponsor|8|||
155337435|NCT04821271|560670731|FG000|Period 1|Withdrawal by Subject|2|||
155337436|NCT04821271|560670732|FG001|Period 1|Withdrawal by Subject|0|||
155337437|NCT02521493|560670736|FG000|Overall Study|Death|3|||
155337438|NCT02521493|560670737|FG001|Overall Study|Death|4|||
155337439|NCT02521493|560670738|FG002|Overall Study|Death|1|||
155337440|NCT02521493|560670736|FG000|Overall Study|Physician Decision|19|||
155504330|NCT00879970|561273993|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
155504331|NCT00879970|561273994|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
155504332|NCT00879970|561273995|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
155504333|NCT00879970|561273996|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
155504334|NCT00879970|561273997|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
155504335|NCT00879970|561273993|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
155504336|NCT00879970|561273994|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
155337441|NCT02521493|560670737|FG001|Overall Study|Physician Decision|1|||
155337442|NCT02521493|560670738|FG002|Overall Study|Physician Decision|2|||
155337443|NCT02521493|560670736|FG000|Overall Study|Withdrawal by Subject|3|||
155337444|NCT02521493|560670737|FG001|Overall Study|Withdrawal by Subject|0|||
155504337|NCT00879970|561273995|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
155504338|NCT00879970|561273996|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
155337445|NCT02521493|560670738|FG002|Overall Study|Withdrawal by Subject|0|||
155337446|NCT02521493|560670736|FG000|Overall Study|Ineligible|0|||
155337447|NCT02521493|560670737|FG001|Overall Study|Ineligible|1|||
155504339|NCT00879970|561273997|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
155504340|NCT00879970|561273993|FG000|Period 2 Vitamin D Randomization|Death|0|||
155504341|NCT00879970|561273994|FG001|Period 2 Vitamin D Randomization|Death|0|||
155337448|NCT02521493|560670738|FG002|Overall Study|Ineligible|0|||
155337449|NCT02521493|560670736|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
155337450|NCT02521493|560670737|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
155337451|NCT02521493|560670738|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
155337452|NCT02521493|560670736|FG000|Overall Study|No MRD result|0|||
155337453|NCT02521493|560670737|FG001|Overall Study|No MRD result|0|||
155337454|NCT02521493|560670738|FG002|Overall Study|No MRD result|4|||
155337455|NCT04083781|560670739|FG000|Main Part|Physician Decision|0|||
155337456|NCT04083781|560670740|FG001|Main Part|Physician Decision|1|||
155337457|NCT04083781|560670741|FG002|Main Part|Physician Decision|2|||
155337458|NCT04083781|560670742|FG003|Main Part|Physician Decision|0|||
155337459|NCT04083781|560670739|FG000|Main Part|Death|1|||
155337460|NCT04083781|560670740|FG001|Main Part|Death|3|||
155337461|NCT04083781|560670741|FG002|Main Part|Death|1|||
155337462|NCT04083781|560670742|FG003|Main Part|Death|0|||
155337463|NCT04083781|560670739|FG000|Main Part|Withdrawal by Subject|5|||
155337464|NCT04083781|560670740|FG001|Main Part|Withdrawal by Subject|2|||
155337465|NCT04083781|560670741|FG002|Main Part|Withdrawal by Subject|3|||
155337466|NCT04083781|560670742|FG003|Main Part|Withdrawal by Subject|7|||
155504342|NCT00879970|561273995|FG002|Period 2 Vitamin D Randomization|Death|0|||
155504343|NCT00879970|561273996|FG003|Period 2 Vitamin D Randomization|Death|2|||
155504344|NCT00879970|561273997|FG004|Period 2 Vitamin D Randomization|Death|0|||
155504345|NCT01749033|561273999|FG000|Overall Study|Did not receive allocated intervention|3|||
155504346|NCT01749033|561274000|FG001|Overall Study|Did not receive allocated intervention|3|||
155504347|NCT01749033|561274001|FG002|Overall Study|Did not receive allocated intervention|0|||
155504348|NCT01749033|561273999|FG000|Overall Study|Lost to Follow-up|0|||
155504349|NCT01749033|561274000|FG001|Overall Study|Lost to Follow-up|2|||
155504350|NCT01749033|561274001|FG002|Overall Study|Lost to Follow-up|1|||
155504351|NCT01256398|561274002|FG000|Overall Study|Withdrawal by Subject|1|||
155504352|NCT00061945|561274003|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
155504353|NCT00061945|561274004|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
155504354|NCT00061945|561274003|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
155337467|NCT04083781|560670739|FG000|Extension Part|Physician Decision|0|||
155337468|NCT04083781|560670740|FG001|Extension Part|Physician Decision|0|||
155337469|NCT04083781|560670741|FG002|Extension Part|Physician Decision|0|||
155337470|NCT04083781|560670742|FG003|Extension Part|Physician Decision|1|||
155337471|NCT04083781|560670739|FG000|Extension Part|Death|0|||
155337472|NCT04083781|560670740|FG001|Extension Part|Death|1|||
155337473|NCT04083781|560670741|FG002|Extension Part|Death|0|||
155337474|NCT04083781|560670742|FG003|Extension Part|Death|1|||
155337475|NCT04083781|560670739|FG000|Extension Part|Withdrawal by Subject|0|||
155337476|NCT04083781|560670740|FG001|Extension Part|Withdrawal by Subject|1|||
155337477|NCT04083781|560670741|FG002|Extension Part|Withdrawal by Subject|0|||
155337478|NCT04083781|560670742|FG003|Extension Part|Withdrawal by Subject|0|||
155337479|NCT04083781|560670739|FG000|Extension Part|Ongoing|13|||
155337480|NCT04083781|560670740|FG001|Extension Part|Ongoing|25|||
155337481|NCT04083781|560670741|FG002|Extension Part|Ongoing|15|||
155337482|NCT04083781|560670742|FG003|Extension Part|Ongoing|51|||
155337483|NCT01263496|560670743|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
155337484|NCT01263496|560670744|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337485|NCT01263496|560670745|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155504355|NCT00061945|561274004|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
155504356|NCT00061945|561274003|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
155504357|NCT00061945|561274004|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
155645882|NCT01695772|561794140|FG000|Overall Study|Unspecified Reason|1|||
155337486|NCT01263496|560670746|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337487|NCT01263496|560670747|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337488|NCT01263496|560670748|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337489|NCT01263496|560670749|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337490|NCT01263496|560670750|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337491|NCT01263496|560670751|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337492|NCT01263496|560670743|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337493|NCT01263496|560670744|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337494|NCT01263496|560670745|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337495|NCT01263496|560670746|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
155337496|NCT01263496|560670747|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
155337497|NCT01263496|560670748|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155504358|NCT00061945|561274003|FG000|Course IV: Alemtuzumab|Early exits|6|||
155504359|NCT00061945|561274004|FG001|Course IV: Alemtuzumab|Early exits|15|||
155504360|NCT01039584|561274005|FG000|Overall Study|Withdrawal by Subject|4|||
155504361|NCT01039584|561274006|FG001|Overall Study|Withdrawal by Subject|2|||
155337498|NCT01263496|560670749|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337499|NCT01263496|560670750|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337500|NCT01263496|560670751|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337501|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
155337502|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
155337503|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
155337504|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
155337505|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
155337506|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
155337507|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
155504362|NCT01039584|561274007|FG002|Overall Study|Withdrawal by Subject|1|||
155504363|NCT01039584|561274005|FG000|Overall Study|Protocol Violation|10|||
155504364|NCT01039584|561274006|FG001|Overall Study|Protocol Violation|4|||
155504365|NCT01039584|561274007|FG002|Overall Study|Protocol Violation|6|||
155504366|NCT01039584|561274005|FG000|Overall Study|Lost to Follow-up|5|||
155504367|NCT01039584|561274006|FG001|Overall Study|Lost to Follow-up|3|||
155504368|NCT01039584|561274007|FG002|Overall Study|Lost to Follow-up|4|||
155504369|NCT01039584|561274005|FG000|Overall Study|Negative Baseline culture for Candida|59|||
155504370|NCT01039584|561274006|FG001|Overall Study|Negative Baseline culture for Candida|59|||
155504371|NCT01039584|561274007|FG002|Overall Study|Negative Baseline culture for Candida|24|||
155337508|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
155337509|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
155337510|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337511|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
155337512|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337513|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337514|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337515|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337516|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337517|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337518|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337519|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337520|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155337521|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155337522|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155337523|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
155337524|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337525|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337526|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155337527|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337528|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
155337529|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155337530|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155504372|NCT01039584|561274005|FG000|Overall Study|Lack of Efficacy|7|||
155504373|NCT01039584|561274006|FG001|Overall Study|Lack of Efficacy|6|||
155504374|NCT01039584|561274007|FG002|Overall Study|Lack of Efficacy|10|||
155504375|NCT01039584|561274005|FG000|Overall Study|other|1|||
155504376|NCT01039584|561274006|FG001|Overall Study|other|3|||
155504377|NCT01039584|561274007|FG002|Overall Study|other|1|||
155504378|NCT01039584|561274005|FG000|Overall Study|Pap smear with significant pathology|10|||
155504379|NCT01039584|561274006|FG001|Overall Study|Pap smear with significant pathology|10|||
155504380|NCT01039584|561274007|FG002|Overall Study|Pap smear with significant pathology|3|||
155504381|NCT01039584|561274005|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
155504382|NCT01039584|561274006|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
155504383|NCT01039584|561274007|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
155504384|NCT04380701|561274012|FG000|Overall Study|Pregnancy|0|||
155504385|NCT04380701|561274013|FG001|Overall Study|Pregnancy|0|||
155504386|NCT04380701|561274014|FG002|Overall Study|Pregnancy|0|||
155504387|NCT04380701|561274015|FG003|Overall Study|Pregnancy|0|||
155337531|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155504388|NCT04380701|561274016|FG004|Overall Study|Pregnancy|0|||
155337532|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
155337533|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155337534|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155504389|NCT04380701|561274017|FG005|Overall Study|Pregnancy|0|||
155645883|NCT04073407|561794145|FG000|Part 1|Withdrawal by Subject|1|||
155504390|NCT04380701|561274018|FG006|Overall Study|Pregnancy|0|||
155504391|NCT04380701|561274019|FG007|Overall Study|Pregnancy|0|||
155504392|NCT04380701|561274020|FG008|Overall Study|Pregnancy|0|||
155504393|NCT04380701|561274021|FG009|Overall Study|Pregnancy|0|||
155337535|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155337536|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155337537|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337538|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337539|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337540|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337541|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337542|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337543|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337544|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155337545|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337546|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
155337547|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337548|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337549|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337550|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
155337551|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337552|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337553|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337554|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
155337555|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337556|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337557|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337558|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
155337559|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337560|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337561|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337562|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
155337563|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337564|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337565|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337566|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
155337567|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337568|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337569|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337570|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
155337571|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337572|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337573|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337574|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
155337575|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
155337576|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
155337577|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
155337578|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
155337579|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
155337580|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
155337581|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
155337582|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
155337583|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
155337584|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
155337585|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
155337586|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337587|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337588|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337589|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
155337590|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
155337591|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
155337592|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
155337593|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
155504394|NCT04380701|561274022|FG010|Overall Study|Pregnancy|0|||
155504395|NCT04380701|561274023|FG011|Overall Study|Pregnancy|0|||
155504396|NCT04380701|561274024|FG012|Overall Study|Pregnancy|0|||
155504397|NCT04380701|561274025|FG013|Overall Study|Pregnancy|0|||
155504398|NCT04380701|561274026|FG014|Overall Study|Pregnancy|0|||
155504399|NCT04380701|561274027|FG015|Overall Study|Pregnancy|0|||
155504400|NCT04380701|561274028|FG016|Overall Study|Pregnancy|0|||
155504401|NCT04380701|561274029|FG017|Overall Study|Pregnancy|0|||
155504402|NCT04380701|561274030|FG018|Overall Study|Pregnancy|0|||
155504403|NCT04380701|561274031|FG019|Overall Study|Pregnancy|0|||
155337594|NCT02241785|560670757|FG000|Overall Study|Sponsor Termination|43|||
155337595|NCT02241785|560670757|FG000|Overall Study|Withdrawal by Subject|1|||
155337596|NCT02241785|560670757|FG000|Overall Study|Lost to Follow-up|2|||
155337597|NCT02241785|560670757|FG000|Overall Study|Adverse Event|1|||
155337598|NCT03905642|560670760|FG000|Overall Study|Withdrawal by Subject|3|||
155337599|NCT03905642|560670760|FG000|Overall Study|Pregnancy|1|||
155337600|NCT03905642|560670760|FG000|Overall Study|Adverse Event|1|||
155337601|NCT03905642|560670760|FG000|Overall Study|Lack of Efficacy|1|||
155337602|NCT03905642|560670760|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
155337603|NCT05289037|560670763|FG000|Overall Study|Withdrawal by Subject|7|||
155423061|NCT00802360|560978676|FG002|Overall Study|Stimulation failure|3|||
155423062|NCT00802360|560978677|FG003|Overall Study|Stimulation failure|3|||
155423063|NCT00802360|560978674|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
155423064|NCT00802360|560978675|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
155423065|NCT00802360|560978676|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
155423066|NCT00802360|560978677|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
155423067|NCT00802360|560978674|FG000|Overall Study|Cycle cancelled|0|||
155423068|NCT00802360|560978675|FG001|Overall Study|Cycle cancelled|1|||
155423069|NCT00802360|560978676|FG002|Overall Study|Cycle cancelled|1|||
155423070|NCT00802360|560978677|FG003|Overall Study|Cycle cancelled|1|||
155423071|NCT00802360|560978674|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
155423072|NCT00802360|560978675|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
155337604|NCT05289037|560670764|FG001|Overall Study|Withdrawal by Subject|0|||
155337605|NCT05289037|560670765|FG002|Overall Study|Withdrawal by Subject|3|||
155337606|NCT05289037|560670766|FG003|Overall Study|Withdrawal by Subject|3|||
155337607|NCT05289037|560670767|FG004|Overall Study|Withdrawal by Subject|1|||
155337608|NCT05289037|560670768|FG005|Overall Study|Withdrawal by Subject|5|||
155337609|NCT05289037|560670769|FG006|Overall Study|Withdrawal by Subject|2|||
155337610|NCT05289037|560670770|FG007|Overall Study|Withdrawal by Subject|1|||
155337611|NCT05289037|560670771|FG008|Overall Study|Withdrawal by Subject|2|||
155337612|NCT05289037|560670772|FG009|Overall Study|Withdrawal by Subject|2|||
155337613|NCT05289037|560670773|FG010|Overall Study|Withdrawal by Subject|1|||
155337614|NCT05289037|560670774|FG011|Overall Study|Withdrawal by Subject|0|||
155337615|NCT05289037|560670775|FG012|Overall Study|Withdrawal by Subject|1|||
155337616|NCT05289037|560670776|FG013|Overall Study|Withdrawal by Subject|2|||
155337617|NCT05289037|560670777|FG014|Overall Study|Withdrawal by Subject|0|||
155337618|NCT05289037|560670778|FG015|Overall Study|Withdrawal by Subject|3|||
155337619|NCT05289037|560670779|FG016|Overall Study|Withdrawal by Subject|3|||
155337620|NCT05289037|560670763|FG000|Overall Study|Lost to Follow-up|1|||
155337621|NCT05289037|560670764|FG001|Overall Study|Lost to Follow-up|4|||
155337622|NCT05289037|560670765|FG002|Overall Study|Lost to Follow-up|3|||
155337623|NCT05289037|560670766|FG003|Overall Study|Lost to Follow-up|3|||
155337624|NCT05289037|560670767|FG004|Overall Study|Lost to Follow-up|3|||
155337625|NCT05289037|560670768|FG005|Overall Study|Lost to Follow-up|2|||
155337626|NCT05289037|560670769|FG006|Overall Study|Lost to Follow-up|3|||
155337627|NCT05289037|560670770|FG007|Overall Study|Lost to Follow-up|2|||
155337628|NCT05289037|560670771|FG008|Overall Study|Lost to Follow-up|2|||
155337629|NCT05289037|560670772|FG009|Overall Study|Lost to Follow-up|1|||
155337630|NCT05289037|560670773|FG010|Overall Study|Lost to Follow-up|3|||
155337631|NCT05289037|560670774|FG011|Overall Study|Lost to Follow-up|4|||
155337632|NCT05289037|560670775|FG012|Overall Study|Lost to Follow-up|2|||
155337633|NCT05289037|560670776|FG013|Overall Study|Lost to Follow-up|7|||
155337634|NCT05289037|560670777|FG014|Overall Study|Lost to Follow-up|4|||
155337635|NCT05289037|560670778|FG015|Overall Study|Lost to Follow-up|6|||
155337636|NCT05289037|560670779|FG016|Overall Study|Lost to Follow-up|4|||
155337637|NCT05289037|560670763|FG000|Overall Study|Death|0|||
155337638|NCT05289037|560670764|FG001|Overall Study|Death|0|||
155337639|NCT05289037|560670765|FG002|Overall Study|Death|0|||
155337640|NCT05289037|560670766|FG003|Overall Study|Death|0|||
155337641|NCT05289037|560670767|FG004|Overall Study|Death|0|||
155337642|NCT05289037|560670768|FG005|Overall Study|Death|1|||
155337643|NCT05289037|560670769|FG006|Overall Study|Death|0|||
155337644|NCT05289037|560670770|FG007|Overall Study|Death|0|||
155337645|NCT05289037|560670771|FG008|Overall Study|Death|0|||
155337646|NCT05289037|560670772|FG009|Overall Study|Death|0|||
155337647|NCT05289037|560670773|FG010|Overall Study|Death|0|||
155337648|NCT05289037|560670774|FG011|Overall Study|Death|0|||
155337649|NCT05289037|560670775|FG012|Overall Study|Death|0|||
155337650|NCT05289037|560670776|FG013|Overall Study|Death|0|||
155337651|NCT05289037|560670777|FG014|Overall Study|Death|1|||
155337652|NCT05289037|560670778|FG015|Overall Study|Death|0|||
155337653|NCT05289037|560670779|FG016|Overall Study|Death|0|||
155337654|NCT05289037|560670763|FG000|Overall Study|Did not receive vaccine|0|||
155337655|NCT05289037|560670764|FG001|Overall Study|Did not receive vaccine|3|||
155337656|NCT05289037|560670765|FG002|Overall Study|Did not receive vaccine|0|||
155337657|NCT05289037|560670766|FG003|Overall Study|Did not receive vaccine|0|||
155337658|NCT05289037|560670767|FG004|Overall Study|Did not receive vaccine|1|||
155337659|NCT05289037|560670768|FG005|Overall Study|Did not receive vaccine|1|||
155337660|NCT05289037|560670769|FG006|Overall Study|Did not receive vaccine|1|||
155337661|NCT05289037|560670770|FG007|Overall Study|Did not receive vaccine|0|||
155337662|NCT05289037|560670771|FG008|Overall Study|Did not receive vaccine|0|||
155337663|NCT05289037|560670772|FG009|Overall Study|Did not receive vaccine|0|||
155337664|NCT05289037|560670773|FG010|Overall Study|Did not receive vaccine|0|||
155337665|NCT05289037|560670774|FG011|Overall Study|Did not receive vaccine|0|||
155337666|NCT05289037|560670775|FG012|Overall Study|Did not receive vaccine|0|||
155337667|NCT05289037|560670776|FG013|Overall Study|Did not receive vaccine|0|||
155337668|NCT05289037|560670777|FG014|Overall Study|Did not receive vaccine|1|||
155337669|NCT05289037|560670778|FG015|Overall Study|Did not receive vaccine|0|||
155337670|NCT05289037|560670779|FG016|Overall Study|Did not receive vaccine|0|||
155337671|NCT05289037|560670763|FG000|Overall Study|Unable to make last visit|0|||
155337672|NCT05289037|560670764|FG001|Overall Study|Unable to make last visit|0|||
155337673|NCT05289037|560670765|FG002|Overall Study|Unable to make last visit|1|||
155337674|NCT05289037|560670766|FG003|Overall Study|Unable to make last visit|0|||
155337675|NCT05289037|560670767|FG004|Overall Study|Unable to make last visit|0|||
155337676|NCT05289037|560670768|FG005|Overall Study|Unable to make last visit|0|||
155337677|NCT05289037|560670769|FG006|Overall Study|Unable to make last visit|0|||
155337678|NCT05289037|560670770|FG007|Overall Study|Unable to make last visit|0|||
155337679|NCT05289037|560670771|FG008|Overall Study|Unable to make last visit|0|||
155337680|NCT05289037|560670772|FG009|Overall Study|Unable to make last visit|0|||
155337681|NCT05289037|560670773|FG010|Overall Study|Unable to make last visit|0|||
155337682|NCT05289037|560670774|FG011|Overall Study|Unable to make last visit|0|||
155337683|NCT05289037|560670775|FG012|Overall Study|Unable to make last visit|0|||
155337684|NCT05289037|560670776|FG013|Overall Study|Unable to make last visit|0|||
155337685|NCT05289037|560670777|FG014|Overall Study|Unable to make last visit|0|||
155337686|NCT05289037|560670778|FG015|Overall Study|Unable to make last visit|0|||
155337687|NCT05289037|560670779|FG016|Overall Study|Unable to make last visit|0|||
155337688|NCT05289037|560670763|FG000|Overall Study|Protocol deviation|0|||
155337689|NCT05289037|560670764|FG001|Overall Study|Protocol deviation|0|||
155337690|NCT05289037|560670765|FG002|Overall Study|Protocol deviation|0|||
155504404|NCT04380701|561274032|FG020|Overall Study|Pregnancy|0|||
155504405|NCT04380701|561274033|FG021|Overall Study|Pregnancy|0|||
155337691|NCT05289037|560670766|FG003|Overall Study|Protocol deviation|0|||
155337692|NCT05289037|560670767|FG004|Overall Study|Protocol deviation|0|||
155337693|NCT05289037|560670768|FG005|Overall Study|Protocol deviation|0|||
155337694|NCT05289037|560670769|FG006|Overall Study|Protocol deviation|0|||
155504406|NCT04380701|561274034|FG022|Overall Study|Pregnancy|0|||
155337695|NCT05289037|560670770|FG007|Overall Study|Protocol deviation|0|||
155337696|NCT05289037|560670771|FG008|Overall Study|Protocol deviation|0|||
155337697|NCT05289037|560670772|FG009|Overall Study|Protocol deviation|0|||
155337698|NCT05289037|560670773|FG010|Overall Study|Protocol deviation|0|||
155337699|NCT05289037|560670774|FG011|Overall Study|Protocol deviation|0|||
155504407|NCT04380701|561274035|FG023|Overall Study|Pregnancy|0|||
155504408|NCT04380701|561274036|FG024|Overall Study|Pregnancy|0|||
155504409|NCT04380701|561274037|FG025|Overall Study|Pregnancy|0|||
155504410|NCT04380701|561274038|FG026|Overall Study|Pregnancy|0|||
155337700|NCT05289037|560670775|FG012|Overall Study|Protocol deviation|0|||
155337701|NCT05289037|560670776|FG013|Overall Study|Protocol deviation|0|||
155337702|NCT05289037|560670777|FG014|Overall Study|Protocol deviation|0|||
155337703|NCT05289037|560670778|FG015|Overall Study|Protocol deviation|1|||
155337704|NCT05289037|560670779|FG016|Overall Study|Protocol deviation|0|||
155337705|NCT05995977|560670780|FG000|Overall Study|Withdrawal by Subject|1|||
155337706|NCT05995977|560670781|FG001|Overall Study|Withdrawal by Subject|4|||
155337707|NCT05995977|560670780|FG000|Overall Study|Lost to Follow-up|2|||
155337708|NCT05995977|560670781|FG001|Overall Study|Lost to Follow-up|0|||
155337709|NCT04937504|560670782|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
155337710|NCT04937504|560670783|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
155337711|NCT04937504|560670782|FG000|9 Months Assessment|Lost to Follow-up|3|||
155337712|NCT04937504|560670783|FG001|9 Months Assessment|Lost to Follow-up|2|||
155337713|NCT04852978|560670787|FG000|Overall Study|Physician Decision|0|||
155337714|NCT04852978|560670788|FG001|Overall Study|Physician Decision|1|||
155337715|NCT04852978|560670789|FG002|Overall Study|Physician Decision|0|||
155337716|NCT04852978|560670790|FG003|Overall Study|Physician Decision|0|||
155337717|NCT04852978|560670791|FG004|Overall Study|Physician Decision|0|||
155337718|NCT04852978|560670792|FG005|Overall Study|Physician Decision|0|||
155337719|NCT04852978|560670793|FG006|Overall Study|Physician Decision|0|||
155337720|NCT04852978|560670794|FG007|Overall Study|Physician Decision|2|||
155337721|NCT04852978|560670795|FG008|Overall Study|Physician Decision|0|||
155337722|NCT04852978|560670787|FG000|Overall Study|Sponsor request|0|||
155337723|NCT04852978|560670788|FG001|Overall Study|Sponsor request|0|||
155337724|NCT04852978|560670789|FG002|Overall Study|Sponsor request|1|||
155337725|NCT04852978|560670790|FG003|Overall Study|Sponsor request|0|||
155337726|NCT04852978|560670791|FG004|Overall Study|Sponsor request|0|||
155337727|NCT04852978|560670792|FG005|Overall Study|Sponsor request|0|||
155337728|NCT04852978|560670793|FG006|Overall Study|Sponsor request|0|||
155337729|NCT04852978|560670794|FG007|Overall Study|Sponsor request|0|||
155337730|NCT04852978|560670795|FG008|Overall Study|Sponsor request|0|||
155337731|NCT04852978|560670787|FG000|Overall Study|Death|0|||
155337732|NCT04852978|560670788|FG001|Overall Study|Death|0|||
155337733|NCT04852978|560670789|FG002|Overall Study|Death|0|||
155337734|NCT04852978|560670790|FG003|Overall Study|Death|0|||
155337735|NCT04852978|560670791|FG004|Overall Study|Death|0|||
155337736|NCT04852978|560670792|FG005|Overall Study|Death|0|||
155337737|NCT04852978|560670793|FG006|Overall Study|Death|1|||
155337738|NCT04852978|560670794|FG007|Overall Study|Death|0|||
155504411|NCT04380701|561274039|FG027|Overall Study|Pregnancy|0|||
155504412|NCT04380701|561274040|FG028|Overall Study|Pregnancy|0|||
155504413|NCT04380701|561274041|FG029|Overall Study|Pregnancy|0|||
155504414|NCT04380701|561274042|FG030|Overall Study|Pregnancy|0|||
155504415|NCT04380701|561274043|FG031|Overall Study|Pregnancy|0|||
155504416|NCT04380701|561274044|FG032|Overall Study|Pregnancy|1|||
155504417|NCT04380701|561274045|FG033|Overall Study|Pregnancy|0|||
155504418|NCT04380701|561274012|FG000|Overall Study|Lost to Follow-up|0|||
155504419|NCT04380701|561274013|FG001|Overall Study|Lost to Follow-up|0|||
155504420|NCT04380701|561274014|FG002|Overall Study|Lost to Follow-up|0|||
155504421|NCT04380701|561274015|FG003|Overall Study|Lost to Follow-up|0|||
155504422|NCT04380701|561274016|FG004|Overall Study|Lost to Follow-up|0|||
155504423|NCT04380701|561274017|FG005|Overall Study|Lost to Follow-up|0|||
155504424|NCT04380701|561274018|FG006|Overall Study|Lost to Follow-up|0|||
155504425|NCT04380701|561274019|FG007|Overall Study|Lost to Follow-up|0|||
155504426|NCT04380701|561274020|FG008|Overall Study|Lost to Follow-up|0|||
155504427|NCT04380701|561274021|FG009|Overall Study|Lost to Follow-up|0|||
155504428|NCT04380701|561274022|FG010|Overall Study|Lost to Follow-up|0|||
155504429|NCT04380701|561274023|FG011|Overall Study|Lost to Follow-up|0|||
155337739|NCT04852978|560670795|FG008|Overall Study|Death|0|||
155337740|NCT04852978|560670787|FG000|Overall Study|Lost to Follow-up|3|||
155337741|NCT04852978|560670788|FG001|Overall Study|Lost to Follow-up|2|||
155337742|NCT04852978|560670789|FG002|Overall Study|Lost to Follow-up|2|||
155337743|NCT04852978|560670790|FG003|Overall Study|Lost to Follow-up|0|||
155337744|NCT04852978|560670791|FG004|Overall Study|Lost to Follow-up|2|||
155337745|NCT04852978|560670792|FG005|Overall Study|Lost to Follow-up|4|||
155337746|NCT04852978|560670793|FG006|Overall Study|Lost to Follow-up|1|||
155337747|NCT04852978|560670794|FG007|Overall Study|Lost to Follow-up|2|||
155337748|NCT04852978|560670795|FG008|Overall Study|Lost to Follow-up|2|||
155337749|NCT04852978|560670787|FG000|Overall Study|Withdrawal by Subject|4|||
155337750|NCT04852978|560670788|FG001|Overall Study|Withdrawal by Subject|2|||
155337751|NCT04852978|560670789|FG002|Overall Study|Withdrawal by Subject|2|||
155337752|NCT04852978|560670790|FG003|Overall Study|Withdrawal by Subject|1|||
155337753|NCT04852978|560670791|FG004|Overall Study|Withdrawal by Subject|5|||
155504430|NCT04380701|561274024|FG012|Overall Study|Lost to Follow-up|0|||
155504431|NCT04380701|561274025|FG013|Overall Study|Lost to Follow-up|0|||
155504432|NCT04380701|561274026|FG014|Overall Study|Lost to Follow-up|0|||
155504433|NCT04380701|561274027|FG015|Overall Study|Lost to Follow-up|0|||
155504434|NCT04380701|561274028|FG016|Overall Study|Lost to Follow-up|0|||
155504435|NCT04380701|561274029|FG017|Overall Study|Lost to Follow-up|0|||
155423073|NCT00802360|560978676|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
155423074|NCT00802360|560978677|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
155423075|NCT00802360|560978674|FG000|Overall Study|No positive serum pregnancy|17|||
155423076|NCT00802360|560978675|FG001|Overall Study|No positive serum pregnancy|20|||
155423077|NCT00802360|560978676|FG002|Overall Study|No positive serum pregnancy|14|||
155423078|NCT00802360|560978677|FG003|Overall Study|No positive serum pregnancy|10|||
155423079|NCT00802360|560978674|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
155423080|NCT00802360|560978675|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155423081|NCT00802360|560978676|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
155423082|NCT00802360|560978677|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155423083|NCT00802360|560978674|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
155423084|NCT00802360|560978675|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
155423085|NCT00802360|560978676|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
155423086|NCT00802360|560978677|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
155423087|NCT00802360|560978674|FG000|Overall Study|Other|2|||
155423088|NCT00802360|560978675|FG001|Overall Study|Other|3|||
155423089|NCT00802360|560978676|FG002|Overall Study|Other|6|||
155423090|NCT00802360|560978677|FG003|Overall Study|Other|3|||
155423091|NCT02978222|560978680|FG000|Overall Study|Withdrawal by Subject|2|||
155423092|NCT02978222|560978681|FG001|Overall Study|Withdrawal by Subject|2|||
155423093|NCT02978222|560978680|FG000|Overall Study|Physician Decision|2|||
155423094|NCT02978222|560978681|FG001|Overall Study|Physician Decision|0|||
155423095|NCT02978222|560978680|FG000|Overall Study|Adverse Event|0|||
155423096|NCT02978222|560978681|FG001|Overall Study|Adverse Event|1|||
155423097|NCT02978222|560978680|FG000|Overall Study|Death|1|||
155423098|NCT02978222|560978681|FG001|Overall Study|Death|0|||
155423099|NCT02978222|560978680|FG000|Overall Study|Disease Progression|32|||
155423100|NCT02978222|560978681|FG001|Overall Study|Disease Progression|32|||
155423101|NCT02978222|560978680|FG000|Overall Study|Early Study Termination|24|||
155337754|NCT04852978|560670792|FG005|Overall Study|Withdrawal by Subject|3|||
155337755|NCT04852978|560670793|FG006|Overall Study|Withdrawal by Subject|2|||
155337756|NCT04852978|560670794|FG007|Overall Study|Withdrawal by Subject|2|||
155337757|NCT04852978|560670795|FG008|Overall Study|Withdrawal by Subject|1|||
155337758|NCT00070707|560672463|FG000|Overall Study|Adverse Event|1|||
155337759|NCT00070707|560672464|FG001|Overall Study|Adverse Event|2|||
155337760|NCT00070707|560672463|FG000|Overall Study|Lack of Efficacy|4|||
155337761|NCT00070707|560672464|FG001|Overall Study|Lack of Efficacy|1|||
155337762|NCT00070707|560672463|FG000|Overall Study|Protocol Violation|8|||
155337763|NCT00070707|560672464|FG001|Overall Study|Protocol Violation|4|||
155337764|NCT00070707|560672463|FG000|Overall Study|Unrelated to Study Medication|1|||
155337765|NCT00070707|560672464|FG001|Overall Study|Unrelated to Study Medication|0|||
155337766|NCT01808534|560672465|FG000|Overall Study|Disease progression|3|||
155337767|NCT01808534|560672465|FG000|Overall Study|Physician Decision|1|||
155337768|NCT00278395|560672468|FG000|Overall Study|Adverse Event|2|||
155337769|NCT00278395|560672468|FG000|Overall Study|Nonevaluable|1|||
155337770|NCT01148017|560672469|FG000|Overall Study|Withdrawal by Subject|31|||
155337771|NCT01148017|560672470|FG001|Overall Study|Withdrawal by Subject|14|||
155337772|NCT01148017|560672471|FG002|Overall Study|Withdrawal by Subject|0|||
155337773|NCT01148017|560672472|FG003|Overall Study|Withdrawal by Subject|0|||
155337774|NCT01148017|560672469|FG000|Overall Study|Lost to Follow-up|23|||
155337775|NCT01148017|560672470|FG001|Overall Study|Lost to Follow-up|10|||
155337776|NCT01148017|560672471|FG002|Overall Study|Lost to Follow-up|0|||
155337777|NCT01148017|560672472|FG003|Overall Study|Lost to Follow-up|0|||
155337778|NCT01148017|560672469|FG000|Overall Study|Inappropriate enrollment|1|||
155337779|NCT01148017|560672470|FG001|Overall Study|Inappropriate enrollment|0|||
155337780|NCT01148017|560672471|FG002|Overall Study|Inappropriate enrollment|0|||
155337781|NCT01148017|560672472|FG003|Overall Study|Inappropriate enrollment|0|||
155337782|NCT01148017|560672469|FG000|Overall Study|Administrative reason|22|||
155337783|NCT01148017|560672470|FG001|Overall Study|Administrative reason|9|||
155337784|NCT01148017|560672471|FG002|Overall Study|Administrative reason|0|||
155337785|NCT01148017|560672472|FG003|Overall Study|Administrative reason|0|||
155337786|NCT01148017|560672469|FG000|Overall Study|Unable to classify|3|||
155337787|NCT01148017|560672470|FG001|Overall Study|Unable to classify|1|||
155337788|NCT01148017|560672471|FG002|Overall Study|Unable to classify|0|||
155337789|NCT01148017|560672472|FG003|Overall Study|Unable to classify|0|||
155337790|NCT03740737|560672473|FG000|Overall Study|Protocol deviation|13|||
155337791|NCT03740737|560672474|FG001|Overall Study|Protocol deviation|0|||
155337792|NCT03740737|560672473|FG000|Overall Study|Adverse Event|2|||
155337793|NCT03740737|560672474|FG001|Overall Study|Adverse Event|0|||
155337794|NCT03740737|560672473|FG000|Overall Study|Lost to Follow-up|1|||
155337795|NCT03740737|560672474|FG001|Overall Study|Lost to Follow-up|0|||
155423102|NCT02978222|560978681|FG001|Overall Study|Early Study Termination|21|||
155423103|NCT03258814|560978684|FG000|Overall Study|Early Termination|4|||
155423104|NCT03258814|560978685|FG001|Overall Study|Early Termination|3|||
155645884|NCT04073407|561794146|FG001|Part 1|Withdrawal by Subject|0|||
155645885|NCT04073407|561794145|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
155645886|NCT04073407|561794146|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
155645887|NCT04073407|561794145|FG000|Part 2|Withdrawal by Subject|0|||
155645888|NCT04073407|561794146|FG001|Part 2|Withdrawal by Subject|1|||
155645889|NCT00960856|561795591|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155645890|NCT00960856|561795592|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
155645891|NCT00960856|561795593|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
155645892|NCT00960856|561795594|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
155645893|NCT00960856|561795591|FG000|Washout Period of 7 Days|Adverse Event|0|||
155645894|NCT00960856|561795592|FG001|Washout Period of 7 Days|Adverse Event|0|||
155645895|NCT00960856|561795593|FG002|Washout Period of 7 Days|Adverse Event|1|||
155337796|NCT03740737|560672473|FG000|Overall Study|Randomization failure|1|||
155645896|NCT00960856|561795594|FG003|Washout Period of 7 Days|Adverse Event|0|||
155337797|NCT03740737|560672474|FG001|Overall Study|Randomization failure|0|||
155337798|NCT03740737|560672473|FG000|Overall Study|Participant withdrew consent|1|||
155337799|NCT03740737|560672474|FG001|Overall Study|Participant withdrew consent|0|||
155337800|NCT03740737|560672473|FG000|Overall Study|Participant withdrew from trial|2|||
155337801|NCT03740737|560672474|FG001|Overall Study|Participant withdrew from trial|1|||
155337802|NCT00569166|560672476|FG000|Overall Study|Withdrawal by Subject|7|||
155337803|NCT00569166|560672477|FG001|Overall Study|Withdrawal by Subject|5|||
155337804|NCT00569166|560672478|FG002|Overall Study|Withdrawal by Subject|3|||
155337805|NCT00569166|560672476|FG000|Overall Study|Lost to Follow-up|2|||
155337806|NCT00569166|560672477|FG001|Overall Study|Lost to Follow-up|1|||
155337807|NCT00569166|560672478|FG002|Overall Study|Lost to Follow-up|1|||
155337808|NCT01686152|560672479|FG000|Overall Study|Withdrawal by Subject|11|||
155337809|NCT01686152|560672480|FG001|Overall Study|Withdrawal by Subject|11|||
155337810|NCT01686152|560672481|FG002|Overall Study|Withdrawal by Subject|3|||
155337811|NCT01686152|560672479|FG000|Overall Study|Drug Code Unblinded|0|||
155337812|NCT01686152|560672480|FG001|Overall Study|Drug Code Unblinded|1|||
155337813|NCT01686152|560672481|FG002|Overall Study|Drug Code Unblinded|0|||
155337814|NCT01686152|560672479|FG000|Overall Study|Protocol Violation|6|||
155337815|NCT01686152|560672480|FG001|Overall Study|Protocol Violation|1|||
155337816|NCT01686152|560672481|FG002|Overall Study|Protocol Violation|0|||
155337817|NCT01686152|560672479|FG000|Overall Study|Adverse Event|12|||
155337818|NCT01686152|560672480|FG001|Overall Study|Adverse Event|11|||
155337819|NCT01686152|560672481|FG002|Overall Study|Adverse Event|0|||
155337820|NCT01686152|560672479|FG000|Overall Study|Lack of Efficacy|0|||
155337821|NCT01686152|560672480|FG001|Overall Study|Lack of Efficacy|0|||
155337822|NCT01686152|560672481|FG002|Overall Study|Lack of Efficacy|1|||
155337823|NCT01686152|560672479|FG000|Overall Study|IP Non-compliance|5|||
155337824|NCT01686152|560672480|FG001|Overall Study|IP Non-compliance|5|||
155337825|NCT01686152|560672481|FG002|Overall Study|IP Non-compliance|0|||
155337826|NCT01686152|560672479|FG000|Overall Study|Lost to Follow-up|7|||
155337827|NCT01686152|560672480|FG001|Overall Study|Lost to Follow-up|6|||
155337828|NCT01686152|560672481|FG002|Overall Study|Lost to Follow-up|5|||
155337829|NCT01853384|560672482|FG000|Randomized|Adverse Event|5|||
155337830|NCT01853384|560672483|FG001|Randomized|Adverse Event|3|||
155337831|NCT01853384|560672482|FG000|Randomized|Death|1|||
155337832|NCT01853384|560672483|FG001|Randomized|Death|2|||
155337833|NCT01853384|560672482|FG000|Randomized|Lost to Follow-up|1|||
155337834|NCT01853384|560672483|FG001|Randomized|Lost to Follow-up|1|||
155337835|NCT01853384|560672482|FG000|Randomized|Withdrawal by Subject|5|||
155337836|NCT01853384|560672483|FG001|Randomized|Withdrawal by Subject|3|||
155337837|NCT01853384|560672482|FG000|Randomized|Sponsor Decision|47|||
155337838|NCT01853384|560672483|FG001|Randomized|Sponsor Decision|34|||
155337839|NCT01853384|560672482|FG000|Randomized|Other|3|||
155337840|NCT01853384|560672483|FG001|Randomized|Other|3|||
155337841|NCT01853384|560672482|FG000|Completed Follow up Visit 1|Early Termination|13|||
155337842|NCT01853384|560672483|FG001|Completed Follow up Visit 1|Early Termination|9|||
155423105|NCT03258814|560978686|FG002|Overall Study|Early Termination|10|||
155423106|NCT01900002|560978687|FG000|Overall Study|Withdrawal by Subject|2|||
155423107|NCT01900002|560978687|FG000|Overall Study|ineligible for Y-90|4|||
155423108|NCT01662648|560978692|FG000|Overall Study|Death|1|||
155423109|NCT01662648|560978693|FG001|Overall Study|Death|3|||
155423110|NCT01662648|560978692|FG000|Overall Study|Adverse Event|40|||
155423111|NCT01662648|560978693|FG001|Overall Study|Adverse Event|37|||
155423112|NCT01662648|560978692|FG000|Overall Study|Lack of Efficacy|17|||
155423113|NCT01662648|560978693|FG001|Overall Study|Lack of Efficacy|16|||
155423114|NCT01662648|560978692|FG000|Overall Study|Participant ineligible to continue trial|1|||
155423115|NCT01662648|560978693|FG001|Overall Study|Participant ineligible to continue trial|1|||
155423116|NCT01662648|560978692|FG000|Overall Study|Lost to Follow-up|24|||
155423117|NCT01662648|560978693|FG001|Overall Study|Lost to Follow-up|36|||
155423118|NCT01662648|560978692|FG000|Overall Study|Withdrawal by Subject|36|||
155423119|NCT01662648|560978693|FG001|Overall Study|Withdrawal by Subject|53|||
155423120|NCT01662648|560978692|FG000|Overall Study|Participant non-compliant|16|||
155423121|NCT01662648|560978693|FG001|Overall Study|Participant non-compliant|20|||
155423122|NCT01662648|560978692|FG000|Overall Study|Other|8|||
155423123|NCT01662648|560978693|FG001|Overall Study|Other|11|||
155423124|NCT01662648|560978692|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
155423125|NCT01662648|560978693|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
155423126|NCT01662648|560978692|FG000|Overall Study|LOE and other reason unspecified|1|||
155423127|NCT01662648|560978693|FG001|Overall Study|LOE and other reason unspecified|0|||
155423128|NCT01662648|560978692|FG000|Overall Study|LOE and Participant non-compliant|0|||
155423129|NCT01662648|560978693|FG001|Overall Study|LOE and Participant non-compliant|1|||
155423130|NCT02928952|560978696|FG000|Overall Study|Lost to Follow-up|5|||
155423131|NCT02928952|560978697|FG001|Overall Study|Lost to Follow-up|5|||
155337843|NCT01853384|560672482|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
155337844|NCT01853384|560672483|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
155337845|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Adverse Event|1|||
155337846|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Adverse Event|0|||
155337847|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
155337848|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
155337849|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Death|1|||
155645897|NCT01428713|561795599|FG000|Overall Study|Non-compliance|2|||
155645898|NCT01428713|561795600|FG001|Overall Study|Non-compliance|2|||
155337850|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Death|0|||
155337851|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
155337852|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
155337853|NCT00929526|560672484|FG000|Overall Study|Withdrawal by Subject|1|||
155337854|NCT00929526|560672485|FG001|Overall Study|Withdrawal by Subject|11|||
155337855|NCT00929526|560672484|FG000|Overall Study|Lost to Follow-up|8|||
155337856|NCT00929526|560672485|FG001|Overall Study|Lost to Follow-up|12|||
155337857|NCT00929526|560672484|FG000|Overall Study|Other|8|||
155337858|NCT00929526|560672485|FG001|Overall Study|Other|6|||
155337859|NCT02169414|560672488|FG000|Overall Study|Withdrawal by Subject|1|||
155337860|NCT02169414|560672489|FG001|Overall Study|Withdrawal by Subject|0|||
155337861|NCT02169414|560672490|FG002|Overall Study|Withdrawal by Subject|0|||
155337862|NCT02169414|560672491|FG003|Overall Study|Withdrawal by Subject|0|||
155337863|NCT02169414|560672488|FG000|Overall Study|Adverse Event|0|||
155337864|NCT02169414|560672489|FG001|Overall Study|Adverse Event|1|||
155337865|NCT02169414|560672490|FG002|Overall Study|Adverse Event|0|||
155337866|NCT02169414|560672491|FG003|Overall Study|Adverse Event|0|||
155337867|NCT03374254|560672494|FG000|Overall Study|Death|5|||
155337868|NCT03374254|560672495|FG001|Overall Study|Death|16|||
155337869|NCT03374254|560672496|FG002|Overall Study|Death|13|||
155337870|NCT03374254|560672497|FG003|Overall Study|Death|11|||
155337871|NCT03374254|560672498|FG004|Overall Study|Death|9|||
155337872|NCT03374254|560672499|FG005|Overall Study|Death|12|||
155337873|NCT03374254|560672500|FG006|Overall Study|Death|11|||
155337874|NCT03374254|560672501|FG007|Overall Study|Death|6|||
155337875|NCT03374254|560672502|FG008|Overall Study|Death|7|||
155337876|NCT03374254|560672494|FG000|Overall Study|Lost to Follow-up|0|||
155337877|NCT03374254|560672495|FG001|Overall Study|Lost to Follow-up|0|||
155337878|NCT03374254|560672496|FG002|Overall Study|Lost to Follow-up|0|||
155337879|NCT03374254|560672497|FG003|Overall Study|Lost to Follow-up|0|||
155337880|NCT03374254|560672498|FG004|Overall Study|Lost to Follow-up|0|||
155337881|NCT03374254|560672499|FG005|Overall Study|Lost to Follow-up|0|||
155337882|NCT03374254|560672500|FG006|Overall Study|Lost to Follow-up|2|||
155337883|NCT03374254|560672501|FG007|Overall Study|Lost to Follow-up|0|||
155337884|NCT03374254|560672502|FG008|Overall Study|Lost to Follow-up|0|||
155337885|NCT03374254|560672494|FG000|Overall Study|Sponsor Decision|1|||
155337886|NCT03374254|560672495|FG001|Overall Study|Sponsor Decision|0|||
155337887|NCT03374254|560672496|FG002|Overall Study|Sponsor Decision|2|||
155337888|NCT03374254|560672497|FG003|Overall Study|Sponsor Decision|3|||
155337889|NCT03374254|560672498|FG004|Overall Study|Sponsor Decision|2|||
155337890|NCT03374254|560672499|FG005|Overall Study|Sponsor Decision|3|||
155337891|NCT03374254|560672500|FG006|Overall Study|Sponsor Decision|3|||
155337892|NCT03374254|560672501|FG007|Overall Study|Sponsor Decision|3|||
155337893|NCT03374254|560672502|FG008|Overall Study|Sponsor Decision|4|||
155337894|NCT03374254|560672494|FG000|Overall Study|Withdrawal by Subject|0|||
155337895|NCT03374254|560672495|FG001|Overall Study|Withdrawal by Subject|0|||
155337896|NCT03374254|560672496|FG002|Overall Study|Withdrawal by Subject|0|||
155337897|NCT03374254|560672497|FG003|Overall Study|Withdrawal by Subject|2|||
155337898|NCT03374254|560672498|FG004|Overall Study|Withdrawal by Subject|0|||
155337899|NCT03374254|560672499|FG005|Overall Study|Withdrawal by Subject|1|||
155337900|NCT03374254|560672500|FG006|Overall Study|Withdrawal by Subject|0|||
155337901|NCT03374254|560672501|FG007|Overall Study|Withdrawal by Subject|0|||
155337902|NCT03374254|560672502|FG008|Overall Study|Withdrawal by Subject|0|||
155337903|NCT04070105|560672503|FG000|Overall Study|Lost to Follow-up|0|||
155337904|NCT04070105|560672504|FG001|Overall Study|Lost to Follow-up|0|||
155337905|NCT04070105|560672505|FG002|Overall Study|Lost to Follow-up|0|||
155337906|NCT04070105|560672506|FG003|Overall Study|Lost to Follow-up|0|||
155337907|NCT04070105|560672507|FG004|Overall Study|Lost to Follow-up|0|||
155337908|NCT04070105|560672508|FG005|Overall Study|Lost to Follow-up|1|||
155337909|NCT00749944|560672511|FG000|Overall Study|Lost to Follow-up|2|||
155337910|NCT00749944|560672512|FG001|Overall Study|Lost to Follow-up|1|||
155337911|NCT00749944|560672511|FG000|Overall Study|Other|1|||
155337912|NCT00749944|560672512|FG001|Overall Study|Other|0|||
155337913|NCT00749944|560672511|FG000|Overall Study|Withdrawal by Subject|2|||
155337914|NCT00749944|560672512|FG001|Overall Study|Withdrawal by Subject|0|||
155337915|NCT02547974|560672513|FG000|Overall Study|Withdrawal by Subject|1|||
155337916|NCT02547974|560672514|FG001|Overall Study|Withdrawal by Subject|0|||
155337917|NCT02547974|560672515|FG002|Overall Study|Withdrawal by Subject|0|||
155337918|NCT02547974|560672516|FG003|Overall Study|Withdrawal by Subject|0|||
155337919|NCT00923078|560672517|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
155337920|NCT00923078|560672518|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
155337921|NCT00923078|560672519|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
155337922|NCT00923078|560672517|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
155337923|NCT00923078|560672518|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
155337924|NCT00923078|560672519|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
155337925|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337926|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337927|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155337928|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337929|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337930|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337931|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337932|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337933|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337934|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337935|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337936|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337937|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337938|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337939|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337940|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337941|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337942|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337943|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337944|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337945|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337946|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337947|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337948|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337949|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337950|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337951|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337952|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337953|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337954|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337955|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337956|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337957|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337958|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337959|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337960|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
155337961|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337962|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337963|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337964|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337965|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337966|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337967|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337968|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337969|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337970|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337971|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
155337972|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337973|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337974|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337975|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337976|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337977|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337978|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337979|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337980|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
155337981|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337982|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337983|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155645899|NCT01428713|561795599|FG000|Overall Study|Withdrawal by Subject|1|||
155337984|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337985|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337986|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337987|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337988|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337989|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337990|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337991|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337992|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337993|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337994|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337995|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337996|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337997|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155337998|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155337999|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155338000|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338001|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338002|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338003|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338004|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338005|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338006|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338007|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338008|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338009|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338010|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338011|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338012|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338013|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338014|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338015|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338016|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338017|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338018|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338019|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338020|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338021|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338022|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
155338023|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338024|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338025|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338026|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338027|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338028|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338029|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338030|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338031|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338032|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338033|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
155338034|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
155338035|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
155338036|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
155338037|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
155338038|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
155338039|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
155338040|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
155338041|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
155338042|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
155338043|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
155338044|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
155338045|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
155338046|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
155338047|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
155338048|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
155338049|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
155338050|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
155338051|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338052|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338053|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338054|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338055|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338056|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338057|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338058|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338059|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338060|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338061|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338062|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338063|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338064|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338065|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338066|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
155338067|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338068|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338069|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
155338070|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
155338071|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
155338072|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
155338073|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
155338074|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
155338075|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
155338076|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
155338077|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
155338078|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
155338079|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
155423132|NCT02928952|560978696|FG000|Overall Study|Withdrawal by Subject|5|||
155423133|NCT02928952|560978697|FG001|Overall Study|Withdrawal by Subject|1|||
155423134|NCT02928952|560978696|FG000|Overall Study|Physician Decision|0|||
155423135|NCT02928952|560978697|FG001|Overall Study|Physician Decision|1|||
155338080|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
155338081|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
155423136|NCT02292212|560978698|FG000|ViE Phase|Withdrawal by Subject|1|||
155338082|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
155338083|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
155338084|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
155338085|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
155338086|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
155338087|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338088|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338089|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338090|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338091|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338092|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338093|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338094|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338095|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338096|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338097|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338098|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338099|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
155338100|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338101|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338102|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338103|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338104|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338105|NCT01072149|560672523|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338106|NCT01072149|560672524|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338107|NCT01072149|560672525|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
155338108|NCT01072149|560672526|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338109|NCT01072149|560672527|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338110|NCT01072149|560672528|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338111|NCT01072149|560672529|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338112|NCT01072149|560672530|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338113|NCT01072149|560672531|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338114|NCT01072149|560672532|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338115|NCT01072149|560672533|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338116|NCT01072149|560672534|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338117|NCT01072149|560672535|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338118|NCT01072149|560672536|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
155338119|NCT01072149|560672537|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338120|NCT01072149|560672538|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338121|NCT01072149|560672539|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338122|NCT01072149|560672540|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338123|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
155338124|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
155338125|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
155338126|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
155338127|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Adverse Event|7|||
155338128|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Adverse Event|8|||
155338129|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Adverse Event|8|||
155338130|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Adverse Event|9|||
155338131|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
155338132|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
155338133|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
155338134|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
155338135|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
155338136|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
155338137|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
155338138|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
155338139|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Pregnancy|0|||
155338140|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Pregnancy|2|||
155338141|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Pregnancy|2|||
155338142|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Pregnancy|0|||
155338143|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Non-compliance|1|||
155338144|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Non-compliance|0|||
155338145|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Non-compliance|0|||
155338146|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Non-compliance|3|||
155338147|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Other|3|||
155338148|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Other|0|||
155338149|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Other|3|||
155338150|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Other|2|||
155338151|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155338152|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155338153|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155338154|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
155338155|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
155338156|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338157|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338158|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338159|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
155338160|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
155338161|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
155338162|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
155338163|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
155338164|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
155338165|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155338166|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
155338167|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338168|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338169|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
155338170|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338171|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
155338172|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
155338173|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
155338174|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
155338175|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
155338176|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
155338177|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
155338178|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
155338179|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
155338180|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
155338181|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
155338182|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
155338183|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
155338184|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
155338185|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
155338186|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
155338187|NCT01768572|560672545|FG000|Overall Study|Adverse Event|7|||
155338188|NCT01768572|560672546|FG001|Overall Study|Adverse Event|8|||
155338189|NCT01768572|560672547|FG002|Overall Study|Adverse Event|4|||
155338190|NCT01768572|560672545|FG000|Overall Study|Lack of Efficacy|1|||
155338191|NCT01768572|560672546|FG001|Overall Study|Lack of Efficacy|3|||
155338192|NCT01768572|560672547|FG002|Overall Study|Lack of Efficacy|1|||
155338193|NCT01768572|560672545|FG000|Overall Study|Other, Not due to an adverse event|1|||
155338194|NCT01768572|560672546|FG001|Overall Study|Other, Not due to an adverse event|1|||
155338195|NCT01768572|560672547|FG002|Overall Study|Other, Not due to an adverse event|1|||
155338196|NCT02245620|560672550|FG000|Overall Study|Physician Decision|1|||
155338197|NCT02245620|560672551|FG001|Overall Study|Physician Decision|1|||
155338198|NCT01999335|560672552|FG000|Overall Study|Discontinued before receiving treatment|0|||
155338199|NCT01999335|560672553|FG001|Overall Study|Discontinued before receiving treatment|0|||
155645900|NCT01428713|561795600|FG001|Overall Study|Withdrawal by Subject|1|||
155338200|NCT01999335|560672554|FG002|Overall Study|Discontinued before receiving treatment|0|||
155338201|NCT01999335|560672555|FG003|Overall Study|Discontinued before receiving treatment|0|||
155338202|NCT01999335|560672556|FG004|Overall Study|Discontinued before receiving treatment|2|||
155338203|NCT04766996|560672557|FG000|Overall Study|Withdrawal by Subject|1|||
155338204|NCT04766996|560672558|FG001|Overall Study|Withdrawal by Subject|0|||
155338205|NCT04766996|560672559|FG002|Overall Study|Withdrawal by Subject|13|||
155338206|NCT00080119|560672560|FG000|Overall Study|Discontinued because of study closure|0|||
155338207|NCT00080119|560672561|FG001|Overall Study|Discontinued because of study closure|0|||
155338208|NCT00080119|560672562|FG002|Overall Study|Discontinued because of study closure|130|||
155338209|NCT00080119|560672563|FG003|Overall Study|Discontinued because of study closure|141|||
155645901|NCT01428713|561795599|FG000|Overall Study|Adverse Event|0|||
155645902|NCT01428713|561795600|FG001|Overall Study|Adverse Event|2|||
155645903|NCT00120250|561795603|FG000|Overall Study|Lost to Follow-up|1|||
155338210|NCT00080119|560672560|FG000|Overall Study|Unable to get to clinic|24|||
155338211|NCT00080119|560672561|FG001|Overall Study|Unable to get to clinic|24|||
155338212|NCT00080119|560672562|FG002|Overall Study|Unable to get to clinic|7|||
155338213|NCT00080119|560672563|FG003|Overall Study|Unable to get to clinic|1|||
155338214|NCT00080119|560672560|FG000|Overall Study|Consent withdrawn|13|||
155338215|NCT00080119|560672561|FG001|Overall Study|Consent withdrawn|17|||
155338216|NCT00080119|560672562|FG002|Overall Study|Consent withdrawn|4|||
155338217|NCT00080119|560672563|FG003|Overall Study|Consent withdrawn|6|||
155645904|NCT00120250|561795604|FG001|Overall Study|Lost to Follow-up|1|||
155645905|NCT00120250|561795603|FG000|Overall Study|Protocol Violation|0|||
155645906|NCT00120250|561795604|FG001|Overall Study|Protocol Violation|1|||
155645907|NCT00585169|561795605|FG000|Overall Study|Withdrawal by Subject|1|||
155645908|NCT03055221|561795606|FG000|Overall Study|Adverse Event|2|||
155338218|NCT00080119|560672560|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
155338219|NCT00080119|560672561|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
155338220|NCT00080119|560672562|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
155338221|NCT00080119|560672563|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
155338222|NCT00080119|560672560|FG000|Overall Study|Lost to Follow-up|16|||
155338223|NCT00080119|560672561|FG001|Overall Study|Lost to Follow-up|19|||
155338224|NCT00080119|560672562|FG002|Overall Study|Lost to Follow-up|19|||
155338225|NCT00080119|560672563|FG003|Overall Study|Lost to Follow-up|14|||
155338226|NCT01322386|560672564|FG000|Overall Study|Protocol Violation|0|||
155338227|NCT01322386|560672565|FG001|Overall Study|Protocol Violation|1|||
155338228|NCT01322386|560672564|FG000|Overall Study|Physician Decision|0|||
155338229|NCT01322386|560672565|FG001|Overall Study|Physician Decision|1|||
155338230|NCT00871494|560672576|FG000|Overall Study|Protocol Violation|5|||
155338231|NCT00871494|560672576|FG000|Overall Study|Lack of Efficacy|4|||
155338232|NCT00871494|560672576|FG000|Overall Study|Adverse Event|4|||
155338233|NCT00871494|560672576|FG000|Overall Study|Lost to Follow-up|1|||
155338234|NCT00889863|560672580|FG000|Part I: Open Label|Death|1|||
155338235|NCT00889863|560672581|FG001|Part I: Open Label|Death|0|||
155338236|NCT00889863|560672580|FG000|Part I: Open Label|Adverse Event|4|||
155338237|NCT00889863|560672581|FG001|Part I: Open Label|Adverse Event|0|||
155338238|NCT00889863|560672580|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
155338239|NCT00889863|560672581|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
155338240|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
155338241|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
155338242|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
155338243|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
155338244|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
155338245|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
155338246|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
155338247|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
155338248|NCT04410445|560672590|FG000|Overall Study|Lost to Follow-up|3|||
155338249|NCT04410445|560672591|FG001|Overall Study|Lost to Follow-up|9|||
155338250|NCT04410445|560672590|FG000|Overall Study|Withdrawal by Subject|27|||
155338251|NCT04410445|560672591|FG001|Overall Study|Withdrawal by Subject|15|||
155338252|NCT03547154|560672597|FG000|Overall Study|Disease Progression/Recurrence|6|||
155338253|NCT03547154|560672598|FG001|Overall Study|Disease Progression/Recurrence|14|||
155338254|NCT03547154|560672597|FG000|Overall Study|Adverse Event|26|||
155423137|NCT02292212|560978698|FG000|ViE Phase|Protocol Violation|2|||
155423138|NCT04957290|560978699|FG000|Overall Study|Progressive disease|3|||
155423139|NCT04957290|560978700|FG001|Overall Study|Progressive disease|3|||
155423140|NCT04957290|560978701|FG002|Overall Study|Progressive disease|2|||
155423141|NCT04957290|560978702|FG003|Overall Study|Progressive disease|0|||
155423142|NCT04957290|560978703|FG004|Overall Study|Progressive disease|0|||
155423143|NCT04957290|560978704|FG005|Overall Study|Progressive disease|0|||
155423144|NCT04957290|560978699|FG000|Overall Study|Withdrawal by Subject|1|||
155423145|NCT04957290|560978700|FG001|Overall Study|Withdrawal by Subject|0|||
155423146|NCT04957290|560978701|FG002|Overall Study|Withdrawal by Subject|1|||
155423147|NCT04957290|560978702|FG003|Overall Study|Withdrawal by Subject|0|||
155423148|NCT04957290|560978703|FG004|Overall Study|Withdrawal by Subject|0|||
155423149|NCT04957290|560978704|FG005|Overall Study|Withdrawal by Subject|0|||
155423150|NCT04957290|560978699|FG000|Overall Study|Death|0|||
155338255|NCT03547154|560672598|FG001|Overall Study|Adverse Event|31|||
155338256|NCT03547154|560672597|FG000|Overall Study|Protocol Violation|6|||
155338257|NCT03547154|560672598|FG001|Overall Study|Protocol Violation|1|||
155338258|NCT03547154|560672597|FG000|Overall Study|Physician Decision|4|||
155338259|NCT03547154|560672598|FG001|Overall Study|Physician Decision|3|||
155338260|NCT03547154|560672597|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155338261|NCT03547154|560672598|FG001|Overall Study|Insufficient Therapeutic Response|10|||
155338262|NCT03547154|560672597|FG000|Overall Study|Withdrawal by Subject|10|||
155338263|NCT03547154|560672598|FG001|Overall Study|Withdrawal by Subject|6|||
155338264|NCT03547154|560672597|FG000|Overall Study|Not Selected|0|||
155338265|NCT03547154|560672598|FG001|Overall Study|Not Selected|1|||
155338266|NCT03547154|560672597|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
155338267|NCT03547154|560672598|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
155338268|NCT02988713|560672599|FG000|Overall Study|Withdrawal by Subject|1|||
155338269|NCT02988713|560672599|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
155338270|NCT03265132|560672600|FG000|Overall Study|Adverse Event|0|||
155338271|NCT03265132|560672601|FG001|Overall Study|Adverse Event|1|||
155338272|NCT03265132|560672600|FG000|Overall Study|Lack of Efficacy|0|||
155338273|NCT03265132|560672601|FG001|Overall Study|Lack of Efficacy|2|||
155338274|NCT03265132|560672600|FG000|Overall Study|Progressive disease|0|||
155338275|NCT03265132|560672601|FG001|Overall Study|Progressive disease|2|||
155338276|NCT03265132|560672600|FG000|Overall Study|Withdrawal by Subject|0|||
155338277|NCT03265132|560672601|FG001|Overall Study|Withdrawal by Subject|1|||
155338278|NCT00666705|560672607|FG000|Overall Study|Withdrawal by Subject|1|||
155338279|NCT03259568|560672610|FG000|Overall Study|Participant performance was low|3|||
155338280|NCT01976507|560672611|FG000|Overall Study|Adverse Event|6|||
155338281|NCT01976507|560672611|FG000|Overall Study|ablation not done, drug not given|1|||
155338282|NCT01029704|560672613|FG000|Overall Study|Adverse Event|0|||
155338283|NCT01029704|560672614|FG001|Overall Study|Adverse Event|0|||
155338284|NCT01029704|560672615|FG002|Overall Study|Adverse Event|0|||
155338285|NCT01029704|560672616|FG003|Overall Study|Adverse Event|0|||
155338286|NCT01029704|560672617|FG004|Overall Study|Adverse Event|0|||
155338287|NCT01029704|560672618|FG005|Overall Study|Adverse Event|0|||
155338288|NCT01029704|560672619|FG006|Overall Study|Adverse Event|1|||
155338289|NCT01029704|560672620|FG007|Overall Study|Adverse Event|1|||
155338290|NCT01029704|560672621|FG008|Overall Study|Adverse Event|0|||
155338291|NCT01029704|560672613|FG000|Overall Study|Withdrawal by Subject|0|||
155338292|NCT01029704|560672614|FG001|Overall Study|Withdrawal by Subject|0|||
155338293|NCT01029704|560672615|FG002|Overall Study|Withdrawal by Subject|0|||
155338294|NCT01029704|560672616|FG003|Overall Study|Withdrawal by Subject|0|||
155338295|NCT01029704|560672617|FG004|Overall Study|Withdrawal by Subject|2|||
155338296|NCT01029704|560672618|FG005|Overall Study|Withdrawal by Subject|1|||
155338297|NCT01029704|560672619|FG006|Overall Study|Withdrawal by Subject|1|||
155338298|NCT01029704|560672620|FG007|Overall Study|Withdrawal by Subject|1|||
155338299|NCT01029704|560672621|FG008|Overall Study|Withdrawal by Subject|0|||
155338300|NCT01029704|560672613|FG000|Overall Study|Lost to Follow-up|0|||
155338301|NCT01029704|560672614|FG001|Overall Study|Lost to Follow-up|0|||
155338302|NCT01029704|560672615|FG002|Overall Study|Lost to Follow-up|0|||
155338303|NCT01029704|560672616|FG003|Overall Study|Lost to Follow-up|0|||
155338304|NCT01029704|560672617|FG004|Overall Study|Lost to Follow-up|0|||
155338305|NCT01029704|560672618|FG005|Overall Study|Lost to Follow-up|0|||
155338306|NCT01029704|560672619|FG006|Overall Study|Lost to Follow-up|1|||
155338307|NCT01029704|560672620|FG007|Overall Study|Lost to Follow-up|1|||
155338308|NCT01029704|560672621|FG008|Overall Study|Lost to Follow-up|1|||
155338309|NCT01029704|560672613|FG000|Overall Study|Lack of Efficacy|0|||
155338310|NCT01029704|560672614|FG001|Overall Study|Lack of Efficacy|0|||
155338311|NCT01029704|560672615|FG002|Overall Study|Lack of Efficacy|0|||
155338312|NCT01029704|560672616|FG003|Overall Study|Lack of Efficacy|0|||
155338313|NCT01029704|560672617|FG004|Overall Study|Lack of Efficacy|2|||
155338314|NCT01029704|560672618|FG005|Overall Study|Lack of Efficacy|3|||
155338315|NCT01029704|560672619|FG006|Overall Study|Lack of Efficacy|1|||
155338316|NCT01029704|560672620|FG007|Overall Study|Lack of Efficacy|2|||
155338317|NCT01029704|560672621|FG008|Overall Study|Lack of Efficacy|0|||
155338318|NCT01029704|560672613|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
155338319|NCT01029704|560672614|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
155338320|NCT01029704|560672615|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
155338321|NCT01029704|560672616|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
155338322|NCT01029704|560672617|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
155338323|NCT01029704|560672618|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
155338324|NCT01029704|560672619|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
155338325|NCT01029704|560672620|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
155338326|NCT01029704|560672621|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
155338327|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
155338328|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
155338329|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
155338330|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
155338331|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Death|0|||
155504436|NCT04380701|561274030|FG018|Overall Study|Lost to Follow-up|0|||
155338332|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Death|0|||
155338333|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Death|1|||
155338334|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Death|0|||
155338335|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
155338336|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
155338337|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
155338338|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
155338339|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155338340|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155338341|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155338342|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155338343|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
155338344|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338345|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338346|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338347|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
155338348|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
155338349|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
155338350|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
155338351|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
155338352|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338353|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338354|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338355|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Other|2|||
155338356|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Other|0|||
155338357|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Other|0|||
155338358|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Other|0|||
155338359|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
155338360|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
155338361|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
155338362|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
155338363|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
155338364|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
155338365|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
155338366|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
155338367|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
155338368|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
155338369|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
155338370|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155338371|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
155338372|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
155338373|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
155338374|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
155338375|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Death|0|||
155338376|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Death|0|||
155338377|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Death|1|||
155338378|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Death|1|||
155338379|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
155338380|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
155338381|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
155338382|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
155338383|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
155338384|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
155338385|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
155338386|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
155338387|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338388|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338389|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338390|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
155338391|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Other|1|||
155338392|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Other|0|||
155338393|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Other|1|||
155338394|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Other|0|||
155338395|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
155338396|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
155338397|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
155338398|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
155338399|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155338400|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155338401|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155423151|NCT04957290|560978700|FG001|Overall Study|Death|2|||
155338402|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
155338403|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
155338404|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
155338405|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
155338406|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
155338407|NCT01109979|560672626|FG000|Overall Study|Physician Decision|2|||
155338408|NCT01109979|560672627|FG001|Overall Study|Physician Decision|0|||
155338409|NCT01109979|560672626|FG000|Overall Study|Withdrawal by Subject|0|||
155338410|NCT01109979|560672627|FG001|Overall Study|Withdrawal by Subject|1|||
155338411|NCT02161458|560672628|FG000|Overall Study|Withdrawal by Subject|0|||
155338412|NCT02161458|560672629|FG001|Overall Study|Withdrawal by Subject|4|||
155338413|NCT02161458|560672630|FG002|Overall Study|Withdrawal by Subject|4|||
155338414|NCT02161458|560672631|FG003|Overall Study|Withdrawal by Subject|0|||
155338415|NCT02161458|560672628|FG000|Overall Study|Lost to Follow-up|0|||
155338416|NCT02161458|560672629|FG001|Overall Study|Lost to Follow-up|2|||
155338417|NCT02161458|560672630|FG002|Overall Study|Lost to Follow-up|1|||
155338418|NCT02161458|560672631|FG003|Overall Study|Lost to Follow-up|0|||
155338419|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
155338420|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
155338421|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338422|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338423|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338424|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338425|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338426|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
155338427|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
155338428|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338429|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338430|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338431|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338432|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338433|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
155338434|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
155338435|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338436|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338437|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338438|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338439|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338440|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338441|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
155338442|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338443|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338444|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338445|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338446|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338447|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
155338448|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
155338449|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338450|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338451|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338452|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338453|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338454|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338455|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338456|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338457|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
155338458|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
155338459|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338460|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
155338461|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155423152|NCT04957290|560978701|FG002|Overall Study|Death|1|||
155423153|NCT04957290|560978702|FG003|Overall Study|Death|0|||
155423154|NCT04957290|560978703|FG004|Overall Study|Death|0|||
155338462|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155423155|NCT04957290|560978704|FG005|Overall Study|Death|0|||
155338463|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
155338464|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338465|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338466|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338467|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338468|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338469|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338470|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
155338471|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338472|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338473|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338474|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338475|NCT03390166|560672640|FG000|Overall Study|Death|0|||
155338476|NCT03390166|560672641|FG001|Overall Study|Death|1|||
155338477|NCT03390166|560672640|FG000|Overall Study|Lost to Follow-up|6|||
155338478|NCT03390166|560672641|FG001|Overall Study|Lost to Follow-up|4|||
155338479|NCT03390166|560672640|FG000|Overall Study|Physician Decision|2|||
155338480|NCT03390166|560672641|FG001|Overall Study|Physician Decision|1|||
155338481|NCT03390166|560672640|FG000|Overall Study|Move from study area|3|||
155338482|NCT03390166|560672641|FG001|Overall Study|Move from study area|2|||
155338483|NCT03390166|560672640|FG000|Overall Study|To militarycamp for conscript|1|||
155338484|NCT03390166|560672641|FG001|Overall Study|To militarycamp for conscript|0|||
155338485|NCT03390166|560672640|FG000|Overall Study|To drug therapy course|0|||
155338486|NCT03390166|560672641|FG001|Overall Study|To drug therapy course|1|||
155338487|NCT03390166|560672640|FG000|Overall Study|Move to work oversea|0|||
155338488|NCT03390166|560672641|FG001|Overall Study|Move to work oversea|1|||
155338489|NCT00274287|560672644|FG000|Overall Study|Withdrawal by Subject|1|||
155338490|NCT00274287|560672644|FG000|Overall Study|subject non-compliance|1|||
155338491|NCT01880736|560672648|FG000|Overall Study|Adverse Event|0|||
155338492|NCT01880736|560672649|FG001|Overall Study|Adverse Event|0|||
155338493|NCT01880736|560672650|FG002|Overall Study|Adverse Event|0|||
155338494|NCT01880736|560672651|FG003|Overall Study|Adverse Event|1|||
155338495|NCT01880736|560672648|FG000|Overall Study|Withdrawal Criteria|1|||
155338496|NCT01880736|560672649|FG001|Overall Study|Withdrawal Criteria|2|||
155338497|NCT01880736|560672650|FG002|Overall Study|Withdrawal Criteria|1|||
155338498|NCT01880736|560672651|FG003|Overall Study|Withdrawal Criteria|5|||
155338499|NCT00747149|560674019|FG000|Overall Study|Adverse Event|0|||
155338500|NCT00747149|560674020|FG001|Overall Study|Adverse Event|15|||
155338501|NCT00747149|560674019|FG000|Overall Study|Lost to Follow-up|0|||
155338502|NCT00747149|560674020|FG001|Overall Study|Lost to Follow-up|10|||
155338503|NCT00747149|560674019|FG000|Overall Study|Withdrawal by Subject|0|||
155338504|NCT00747149|560674020|FG001|Overall Study|Withdrawal by Subject|6|||
155338505|NCT00747149|560674019|FG000|Overall Study|Did not receive treatment|0|||
155338506|NCT00747149|560674020|FG001|Overall Study|Did not receive treatment|1|||
155338507|NCT00747149|560674019|FG000|Overall Study|Incorrect enrollment|0|||
155338508|NCT00747149|560674020|FG001|Overall Study|Incorrect enrollment|6|||
155338509|NCT00747149|560674019|FG000|Overall Study|Severe non-compliance to protocol|0|||
155338510|NCT00747149|560674020|FG001|Overall Study|Severe non-compliance to protocol|1|||
155338511|NCT00747149|560674019|FG000|Overall Study|Not reported|1|||
155338512|NCT00747149|560674020|FG001|Overall Study|Not reported|4|||
155338513|NCT03840200|560674021|FG000|Overall Study|Death|6|||
155338514|NCT03840200|560674022|FG001|Overall Study|Death|3|||
155338515|NCT03840200|560674023|FG002|Overall Study|Death|6|||
155338516|NCT03840200|560674024|FG003|Overall Study|Death|10|||
155338517|NCT03840200|560674021|FG000|Overall Study|Reason Not Specified|2|||
155338518|NCT03840200|560674022|FG001|Overall Study|Reason Not Specified|2|||
155338519|NCT03840200|560674023|FG002|Overall Study|Reason Not Specified|1|||
155338520|NCT03840200|560674024|FG003|Overall Study|Reason Not Specified|15|||
155423156|NCT04957290|560978699|FG000|Overall Study|non compliance with study drug|0|||
155423157|NCT04957290|560978700|FG001|Overall Study|non compliance with study drug|1|||
155423158|NCT04957290|560978701|FG002|Overall Study|non compliance with study drug|0|||
155423159|NCT04957290|560978702|FG003|Overall Study|non compliance with study drug|0|||
155423160|NCT04957290|560978703|FG004|Overall Study|non compliance with study drug|0|||
155504437|NCT04380701|561274031|FG019|Overall Study|Lost to Follow-up|0|||
155338521|NCT03840200|560674021|FG000|Overall Study|Physician Decision|0|||
155338522|NCT03840200|560674022|FG001|Overall Study|Physician Decision|0|||
155338523|NCT03840200|560674023|FG002|Overall Study|Physician Decision|0|||
155338524|NCT03840200|560674024|FG003|Overall Study|Physician Decision|2|||
155338525|NCT03840200|560674021|FG000|Overall Study|Progressive Disease|0|||
155338526|NCT03840200|560674022|FG001|Overall Study|Progressive Disease|0|||
155338527|NCT03840200|560674023|FG002|Overall Study|Progressive Disease|0|||
155338528|NCT03840200|560674024|FG003|Overall Study|Progressive Disease|1|||
155338529|NCT03840200|560674021|FG000|Overall Study|Withdrawal by Subject|0|||
155338530|NCT03840200|560674022|FG001|Overall Study|Withdrawal by Subject|1|||
155338531|NCT03840200|560674023|FG002|Overall Study|Withdrawal by Subject|0|||
155338532|NCT03840200|560674024|FG003|Overall Study|Withdrawal by Subject|2|||
155338533|NCT02196259|560674027|FG000|Overall Study|Researcher choice|0|||
155338534|NCT02196259|560674028|FG001|Overall Study|Researcher choice|0|||
155338535|NCT02196259|560674029|FG002|Overall Study|Researcher choice|1|||
155504438|NCT04380701|561274032|FG020|Overall Study|Lost to Follow-up|1|||
155338536|NCT02196259|560674027|FG000|Overall Study|Partial data analysis|0|||
155338537|NCT02196259|560674028|FG001|Overall Study|Partial data analysis|3|||
155338538|NCT02196259|560674029|FG002|Overall Study|Partial data analysis|0|||
155338539|NCT00443820|560674030|FG000|Overall Study|Adverse Event|1|||
155338540|NCT00443820|560674031|FG001|Overall Study|Adverse Event|1|||
155338541|NCT00443820|560674032|FG002|Overall Study|Adverse Event|0|||
155338542|NCT00443820|560674033|FG003|Overall Study|Adverse Event|0|||
155338543|NCT00443820|560674030|FG000|Overall Study|Lack of Efficacy|3|||
155338544|NCT00443820|560674031|FG001|Overall Study|Lack of Efficacy|2|||
155338545|NCT00443820|560674032|FG002|Overall Study|Lack of Efficacy|1|||
155338546|NCT00443820|560674033|FG003|Overall Study|Lack of Efficacy|1|||
155338547|NCT00443820|560674030|FG000|Overall Study|Protocol Violation|2|||
155338548|NCT00443820|560674031|FG001|Overall Study|Protocol Violation|1|||
155338549|NCT00443820|560674032|FG002|Overall Study|Protocol Violation|2|||
155338550|NCT00443820|560674033|FG003|Overall Study|Protocol Violation|1|||
155338551|NCT00443820|560674030|FG000|Overall Study|Withdrawal by Subject|6|||
155338552|NCT00443820|560674031|FG001|Overall Study|Withdrawal by Subject|7|||
155338553|NCT00443820|560674032|FG002|Overall Study|Withdrawal by Subject|8|||
155338554|NCT00443820|560674033|FG003|Overall Study|Withdrawal by Subject|9|||
155338555|NCT00443820|560674030|FG000|Overall Study|Lost to Follow-up|9|||
155338556|NCT00443820|560674031|FG001|Overall Study|Lost to Follow-up|8|||
155338557|NCT00443820|560674032|FG002|Overall Study|Lost to Follow-up|6|||
155338558|NCT00443820|560674033|FG003|Overall Study|Lost to Follow-up|5|||
155338559|NCT00443820|560674030|FG000|Overall Study|Administrative problems|0|||
155338560|NCT00443820|560674031|FG001|Overall Study|Administrative problems|0|||
155338561|NCT00443820|560674032|FG002|Overall Study|Administrative problems|0|||
155338562|NCT00443820|560674033|FG003|Overall Study|Administrative problems|1|||
155338563|NCT00443820|560674030|FG000|Overall Study|Death|0|||
155338564|NCT00443820|560674031|FG001|Overall Study|Death|0|||
155338565|NCT00443820|560674032|FG002|Overall Study|Death|1|||
155338566|NCT00443820|560674033|FG003|Overall Study|Death|0|||
155338567|NCT02507297|560674034|FG000|Overall Study|Withdrawal by Subject|1|||
155338568|NCT02507297|560674035|FG001|Overall Study|Withdrawal by Subject|0|||
155338569|NCT02507297|560674034|FG000|Overall Study|Lost to Follow-up|0|||
155338570|NCT02507297|560674035|FG001|Overall Study|Lost to Follow-up|1|||
155338571|NCT02489799|560674036|FG000|Overall Study|Lost to Follow-up|4|||
155338572|NCT02489799|560674037|FG001|Overall Study|Lost to Follow-up|1|||
155338573|NCT02489799|560674036|FG000|Overall Study|Failure to Maintain Eligibility|4|||
155338574|NCT02489799|560674037|FG001|Overall Study|Failure to Maintain Eligibility|6|||
155338575|NCT02489799|560674036|FG000|Overall Study|Withdrawal by Subject|1|||
155338576|NCT02489799|560674037|FG001|Overall Study|Withdrawal by Subject|1|||
155338577|NCT02489799|560674036|FG000|Overall Study|Death|0|||
155338578|NCT02489799|560674037|FG001|Overall Study|Death|1|||
155338579|NCT01304940|560674047|FG000|Overall Study|not meet symptom severity requirement|3|||
155338580|NCT01304940|560674048|FG001|Overall Study|not meet symptom severity requirement|0|||
155338581|NCT04311983|560674052|FG000|Overall Study|Lost to Follow-up|421|||
155338582|NCT04311983|560674053|FG001|Overall Study|Lost to Follow-up|456|||
155338583|NCT04311983|560674052|FG000|Overall Study|Incomplete survey|7|||
155338584|NCT04311983|560674053|FG001|Overall Study|Incomplete survey|9|||
155338585|NCT04311983|560674052|FG000|Overall Study|Death|1|||
155338586|NCT04311983|560674053|FG001|Overall Study|Death|0|||
155338587|NCT01205126|560674054|FG000|Titration Phase|Adverse Event|5|||
155338588|NCT01205126|560674055|FG001|Titration Phase|Adverse Event|3|||
155338589|NCT01205126|560674054|FG000|Titration Phase|Withdrawal by Subject|5|||
155338590|NCT01205126|560674055|FG001|Titration Phase|Withdrawal by Subject|5|||
155338591|NCT01205126|560674054|FG000|Titration Phase|Lost to Follow-up|2|||
155338592|NCT01205126|560674055|FG001|Titration Phase|Lost to Follow-up|2|||
155338593|NCT01205126|560674054|FG000|Titration Phase|No stable titration dose|1|||
155338594|NCT01205126|560674055|FG001|Titration Phase|No stable titration dose|0|||
155338595|NCT01205126|560674054|FG000|Titration Phase|More than maximum dosage required|2|||
155338596|NCT01205126|560674055|FG001|Titration Phase|More than maximum dosage required|3|||
155338597|NCT01205126|560674054|FG000|Titration Phase|Other|8|||
155338598|NCT01205126|560674055|FG001|Titration Phase|Other|6|||
155338599|NCT01205126|560674054|FG000|Between Titration & Maintenance Phase|Other|0|||
155338600|NCT01205126|560674055|FG001|Between Titration & Maintenance Phase|Other|4|||
155338601|NCT01205126|560674054|FG000|Maintenance Phase|Adverse Event|3|||
155338602|NCT01205126|560674055|FG001|Maintenance Phase|Adverse Event|7|||
155338603|NCT01205126|560674054|FG000|Maintenance Phase|Death|4|||
155338604|NCT01205126|560674055|FG001|Maintenance Phase|Death|4|||
155338605|NCT01205126|560674054|FG000|Maintenance Phase|More than the maximum dosage required|5|||
155338606|NCT01205126|560674055|FG001|Maintenance Phase|More than the maximum dosage required|5|||
155338607|NCT01205126|560674054|FG000|Maintenance Phase|Prohibited drugs used|1|||
155338608|NCT01205126|560674055|FG001|Maintenance Phase|Prohibited drugs used|0|||
155338609|NCT01205126|560674054|FG000|Maintenance Phase|Other|11|||
155338610|NCT01205126|560674055|FG001|Maintenance Phase|Other|8|||
155338611|NCT01205126|560674054|FG000|Maintenance Phase|Lost to Follow-up|5|||
155338612|NCT01205126|560674055|FG001|Maintenance Phase|Lost to Follow-up|5|||
155338613|NCT01205126|560674054|FG000|Maintenance Phase|Withdrawal by Subject|8|||
155338614|NCT01205126|560674055|FG001|Maintenance Phase|Withdrawal by Subject|11|||
155423161|NCT04957290|560978704|FG005|Overall Study|non compliance with study drug|0|||
155423162|NCT04957290|560978699|FG000|Overall Study|none specified.|0|||
155423163|NCT04957290|560978700|FG001|Overall Study|none specified.|1|||
155423164|NCT04957290|560978701|FG002|Overall Study|none specified.|2|||
155423165|NCT04957290|560978702|FG003|Overall Study|none specified.|0|||
155423166|NCT04957290|560978703|FG004|Overall Study|none specified.|0|||
155338615|NCT00578344|560674056|FG000|Overall Study|Insurance problems|1|||
155338616|NCT00578344|560674056|FG000|Overall Study|Graft failure|1|||
155338617|NCT04803734|560674057|FG000|Overall Study|Withdrawal by Subject|0|||
155338618|NCT04803734|560674058|FG001|Overall Study|Withdrawal by Subject|1|||
155338619|NCT04803734|560674057|FG000|Overall Study|Protocol Violation|0|||
155338620|NCT04803734|560674058|FG001|Overall Study|Protocol Violation|1|||
155338621|NCT02309515|560674060|FG000|Overall Study|Withdrawal by Subject|0|||
155423167|NCT04957290|560978704|FG005|Overall Study|none specified.|0|||
155423168|NCT04957290|560978699|FG000|Overall Study|unacceptable toxicity|0|||
155423169|NCT04957290|560978700|FG001|Overall Study|unacceptable toxicity|0|||
155423170|NCT04957290|560978701|FG002|Overall Study|unacceptable toxicity|1|||
155423171|NCT04957290|560978702|FG003|Overall Study|unacceptable toxicity|0|||
155645909|NCT03055221|561795606|FG000|Overall Study|Withdrawal by Subject|4|||
155645910|NCT03055221|561795606|FG000|Overall Study|Death|6|||
155645911|NCT03055221|561795606|FG000|Overall Study|Physician Decision|1|||
155645912|NCT03055221|561795606|FG000|Overall Study|Study terminated by Sponsor|3|||
155645913|NCT03055221|561795606|FG000|Overall Study|Lost to Follow-up|4|||
155645914|NCT01964560|561795607|FG000|Overall Study|Adverse Event|23|||
155645915|NCT01964560|561795607|FG000|Overall Study|Lack of Efficacy|46|||
155645916|NCT01964560|561795607|FG000|Overall Study|Protocol deviation|2|||
155645917|NCT01964560|561795607|FG000|Overall Study|Lost to Follow-up|4|||
155645918|NCT01964560|561795607|FG000|Overall Study|Withdrawal by Subject|64|||
155645919|NCT01964560|561795607|FG000|Overall Study|Surgery-hemispherotomy|1|||
155645920|NCT01964560|561795607|FG000|Overall Study|Surgery|1|||
155338622|NCT02309515|560674061|FG001|Overall Study|Withdrawal by Subject|1|||
155645921|NCT01964560|561795607|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
155645922|NCT01964560|561795607|FG000|Overall Study|Patient and Investigator choice|1|||
155645923|NCT01964560|561795607|FG000|Overall Study|Patient was prescribed CBD|1|||
155338623|NCT02784834|560674073|FG000|Overall Study|Lack of Efficacy|1|||
155338624|NCT01090739|560674078|FG000|Enrollment|Withdrawal by Subject|24|||
155338625|NCT01090739|560674078|FG000|Enrollment|Protocol Violation|14|||
155338626|NCT01090739|560674078|FG000|Enrollment|Lost to Follow-up|5|||
155338627|NCT01090739|560674078|FG000|Enrollment|Physician Decision|5|||
155338628|NCT01090739|560674078|FG000|Enrollment|Sponsor termination of site|4|||
155338629|NCT01090739|560674078|FG000|Enrollment|Study implant limit reached|2|||
155338630|NCT01090739|560674078|FG000|Enrollment|Adverse Event|1|||
155338631|NCT01090739|560674078|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
155338632|NCT01090739|560674078|FG000|12 Month Follow-up|Lost to Follow-up|1|||
155338633|NCT01090739|560674078|FG000|12 Month Follow-up|Physician Decision|1|||
155338634|NCT01090739|560674078|FG000|12 Month Follow-up|Death|1|||
155338635|NCT01090739|560674078|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
155338636|NCT01090739|560674078|FG000|24 Month Follow-up|Lost to Follow-up|1|||
155338637|NCT01090739|560674078|FG000|24 Month Follow-up|Death|1|||
155338638|NCT01090739|560674078|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
155338639|NCT01090739|560674078|FG000|36 Month Follow-up|Visit still pending|17|||
155338640|NCT00441168|560674079|FG000|Treatment Period|Death|3|||
155338641|NCT00441168|560674080|FG001|Treatment Period|Death|0|||
155338642|NCT00441168|560674079|FG000|Treatment Period|Adverse Event|1|||
155338643|NCT00441168|560674080|FG001|Treatment Period|Adverse Event|2|||
155338644|NCT00441168|560674079|FG000|Treatment Period|Progressive Disease|0|||
155338645|NCT00441168|560674080|FG001|Treatment Period|Progressive Disease|2|||
155338646|NCT00441168|560674079|FG000|Treatment Period|Protocol Violation|0|||
155338647|NCT00441168|560674080|FG001|Treatment Period|Protocol Violation|1|||
155338648|NCT00441168|560674079|FG000|Treatment Period|Lost to Follow-up|0|||
155338649|NCT00441168|560674080|FG001|Treatment Period|Lost to Follow-up|1|||
155338650|NCT00441168|560674079|FG000|Treatment Period|Withdrawal by Subject|3|||
155338651|NCT00441168|560674080|FG001|Treatment Period|Withdrawal by Subject|0|||
155338652|NCT00441168|560674079|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
155338653|NCT00441168|560674080|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
155338654|NCT00441168|560674079|FG000|Treatment Period|refractory disease|1|||
155338655|NCT00441168|560674080|FG001|Treatment Period|refractory disease|0|||
155338656|NCT00441168|560674079|FG000|Follow-up Period|Death|3|||
155338657|NCT00441168|560674080|FG001|Follow-up Period|Death|0|||
155338658|NCT00441168|560674079|FG000|Follow-up Period|Lost to Follow-up|5|||
155338659|NCT00441168|560674080|FG001|Follow-up Period|Lost to Follow-up|6|||
155338660|NCT00441168|560674079|FG000|Follow-up Period|Withdrawal by Subject|3|||
155338661|NCT00441168|560674080|FG001|Follow-up Period|Withdrawal by Subject|0|||
155338662|NCT00441168|560674079|FG000|Follow-up Period|Other|1|||
155338663|NCT00441168|560674080|FG001|Follow-up Period|Other|3|||
155338664|NCT02404441|560674082|FG000|Phase 1 Part|Adverse Event|1|||
155338665|NCT02404441|560674083|FG001|Phase 1 Part|Adverse Event|0|||
155338666|NCT02404441|560674084|FG002|Phase 1 Part|Adverse Event|0|||
155338667|NCT02404441|560674085|FG003|Phase 1 Part|Adverse Event|0|||
155338668|NCT02404441|560674086|FG004|Phase 1 Part|Adverse Event|0|||
155338669|NCT02404441|560674087|FG005|Phase 1 Part|Adverse Event|0|||
155338670|NCT02404441|560674088|FG006|Phase 1 Part|Adverse Event|0|||
155338671|NCT02404441|560674089|FG007|Phase 1 Part|Adverse Event|0|||
155338672|NCT02404441|560674090|FG008|Phase 1 Part|Adverse Event|0|||
155338673|NCT02404441|560674091|FG009|Phase 1 Part|Adverse Event|0|||
155338674|NCT02404441|560674082|FG000|Phase 1 Part|Physician Decision|0|||
155338675|NCT02404441|560674083|FG001|Phase 1 Part|Physician Decision|1|||
155338676|NCT02404441|560674084|FG002|Phase 1 Part|Physician Decision|0|||
155338677|NCT02404441|560674085|FG003|Phase 1 Part|Physician Decision|0|||
155338678|NCT02404441|560674086|FG004|Phase 1 Part|Physician Decision|0|||
155338679|NCT02404441|560674087|FG005|Phase 1 Part|Physician Decision|0|||
155338680|NCT02404441|560674088|FG006|Phase 1 Part|Physician Decision|0|||
155338681|NCT02404441|560674089|FG007|Phase 1 Part|Physician Decision|0|||
155338682|NCT02404441|560674090|FG008|Phase 1 Part|Physician Decision|0|||
155338683|NCT02404441|560674091|FG009|Phase 1 Part|Physician Decision|0|||
155338684|NCT02404441|560674082|FG000|Phase 1 Part|Progressive Disease|14|||
155423172|NCT04957290|560978703|FG004|Overall Study|unacceptable toxicity|0|||
155423173|NCT04957290|560978704|FG005|Overall Study|unacceptable toxicity|0|||
155423174|NCT04957290|560978699|FG000|Overall Study|Adverse Event|0|||
155423175|NCT04957290|560978700|FG001|Overall Study|Adverse Event|0|||
155338685|NCT02404441|560674083|FG001|Phase 1 Part|Progressive Disease|11|||
155338686|NCT02404441|560674084|FG002|Phase 1 Part|Progressive Disease|7|||
155338687|NCT02404441|560674085|FG003|Phase 1 Part|Progressive Disease|6|||
155338688|NCT02404441|560674086|FG004|Phase 1 Part|Progressive Disease|9|||
155338689|NCT02404441|560674087|FG005|Phase 1 Part|Progressive Disease|0|||
155338690|NCT02404441|560674088|FG006|Phase 1 Part|Progressive Disease|0|||
155338691|NCT02404441|560674089|FG007|Phase 1 Part|Progressive Disease|0|||
155338692|NCT02404441|560674090|FG008|Phase 1 Part|Progressive Disease|0|||
155338693|NCT02404441|560674091|FG009|Phase 1 Part|Progressive Disease|0|||
155338694|NCT02404441|560674082|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
155338695|NCT02404441|560674083|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
155338696|NCT02404441|560674084|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
155338697|NCT02404441|560674085|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
155338698|NCT02404441|560674086|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
155338699|NCT02404441|560674087|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
155338700|NCT02404441|560674088|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
155338701|NCT02404441|560674089|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
155338702|NCT02404441|560674090|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
155338703|NCT02404441|560674091|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
155338704|NCT02404441|560674082|FG000|Phase 1 Part|Death|1|||
155338705|NCT02404441|560674083|FG001|Phase 1 Part|Death|1|||
155338706|NCT02404441|560674084|FG002|Phase 1 Part|Death|1|||
155338707|NCT02404441|560674085|FG003|Phase 1 Part|Death|0|||
155338708|NCT02404441|560674086|FG004|Phase 1 Part|Death|1|||
155338709|NCT02404441|560674087|FG005|Phase 1 Part|Death|0|||
155338710|NCT02404441|560674088|FG006|Phase 1 Part|Death|0|||
155338711|NCT02404441|560674089|FG007|Phase 1 Part|Death|0|||
155338712|NCT02404441|560674090|FG008|Phase 1 Part|Death|0|||
155338713|NCT02404441|560674091|FG009|Phase 1 Part|Death|0|||
155338714|NCT02404441|560674082|FG000|Phase 2 Part|Adverse Event|0|||
155338715|NCT02404441|560674083|FG001|Phase 2 Part|Adverse Event|0|||
155338716|NCT02404441|560674084|FG002|Phase 2 Part|Adverse Event|0|||
155338717|NCT02404441|560674085|FG003|Phase 2 Part|Adverse Event|0|||
155338718|NCT02404441|560674086|FG004|Phase 2 Part|Adverse Event|0|||
155338719|NCT02404441|560674087|FG005|Phase 2 Part|Adverse Event|2|||
155338720|NCT02404441|560674088|FG006|Phase 2 Part|Adverse Event|3|||
155338721|NCT02404441|560674089|FG007|Phase 2 Part|Adverse Event|3|||
155338722|NCT02404441|560674090|FG008|Phase 2 Part|Adverse Event|6|||
155338723|NCT02404441|560674091|FG009|Phase 2 Part|Adverse Event|1|||
155338724|NCT02404441|560674082|FG000|Phase 2 Part|Physician Decision|0|||
155338725|NCT02404441|560674083|FG001|Phase 2 Part|Physician Decision|0|||
155338726|NCT02404441|560674084|FG002|Phase 2 Part|Physician Decision|0|||
155338727|NCT02404441|560674085|FG003|Phase 2 Part|Physician Decision|0|||
155338728|NCT02404441|560674086|FG004|Phase 2 Part|Physician Decision|0|||
155338729|NCT02404441|560674087|FG005|Phase 2 Part|Physician Decision|7|||
155338730|NCT02404441|560674088|FG006|Phase 2 Part|Physician Decision|9|||
155338731|NCT02404441|560674089|FG007|Phase 2 Part|Physician Decision|2|||
155338732|NCT02404441|560674090|FG008|Phase 2 Part|Physician Decision|1|||
155338733|NCT02404441|560674091|FG009|Phase 2 Part|Physician Decision|3|||
155338734|NCT02404441|560674082|FG000|Phase 2 Part|Progressive disease|0|||
155338735|NCT02404441|560674083|FG001|Phase 2 Part|Progressive disease|0|||
155338736|NCT02404441|560674084|FG002|Phase 2 Part|Progressive disease|0|||
155338737|NCT02404441|560674085|FG003|Phase 2 Part|Progressive disease|0|||
155338738|NCT02404441|560674086|FG004|Phase 2 Part|Progressive disease|0|||
155338739|NCT02404441|560674087|FG005|Phase 2 Part|Progressive disease|43|||
155338740|NCT02404441|560674088|FG006|Phase 2 Part|Progressive disease|32|||
155338741|NCT02404441|560674089|FG007|Phase 2 Part|Progressive disease|31|||
155338742|NCT02404441|560674090|FG008|Phase 2 Part|Progressive disease|39|||
155338743|NCT02404441|560674091|FG009|Phase 2 Part|Progressive disease|27|||
155338744|NCT02404441|560674082|FG000|Phase 2 Part|Subject/guardian decision|0|||
155338745|NCT02404441|560674083|FG001|Phase 2 Part|Subject/guardian decision|0|||
155338746|NCT02404441|560674084|FG002|Phase 2 Part|Subject/guardian decision|0|||
155338747|NCT02404441|560674085|FG003|Phase 2 Part|Subject/guardian decision|0|||
155338748|NCT02404441|560674086|FG004|Phase 2 Part|Subject/guardian decision|0|||
155338749|NCT02404441|560674087|FG005|Phase 2 Part|Subject/guardian decision|3|||
155423176|NCT04957290|560978701|FG002|Overall Study|Adverse Event|1|||
155423177|NCT04957290|560978702|FG003|Overall Study|Adverse Event|0|||
155423178|NCT04957290|560978703|FG004|Overall Study|Adverse Event|0|||
155423179|NCT04957290|560978704|FG005|Overall Study|Adverse Event|0|||
155423180|NCT04957290|560978699|FG000|Overall Study|study terminated by sponsor|0|||
155423181|NCT04957290|560978700|FG001|Overall Study|study terminated by sponsor|0|||
155504439|NCT04380701|561274033|FG021|Overall Study|Lost to Follow-up|0|||
155504440|NCT04380701|561274034|FG022|Overall Study|Lost to Follow-up|0|||
155504441|NCT04380701|561274035|FG023|Overall Study|Lost to Follow-up|1|||
155338750|NCT02404441|560674088|FG006|Phase 2 Part|Subject/guardian decision|9|||
155338751|NCT02404441|560674089|FG007|Phase 2 Part|Subject/guardian decision|0|||
155423182|NCT04957290|560978701|FG002|Overall Study|study terminated by sponsor|2|||
155504442|NCT04380701|561274036|FG024|Overall Study|Lost to Follow-up|0|||
155338752|NCT02404441|560674090|FG008|Phase 2 Part|Subject/guardian decision|3|||
155338753|NCT02404441|560674091|FG009|Phase 2 Part|Subject/guardian decision|2|||
155338754|NCT02404441|560674082|FG000|Phase 2 Part|Death|0|||
155423183|NCT04957290|560978702|FG003|Overall Study|study terminated by sponsor|0|||
155423184|NCT04957290|560978703|FG004|Overall Study|study terminated by sponsor|0|||
155423185|NCT04957290|560978704|FG005|Overall Study|study terminated by sponsor|0|||
155504443|NCT04380701|561274037|FG025|Overall Study|Lost to Follow-up|0|||
155338755|NCT02404441|560674083|FG001|Phase 2 Part|Death|0|||
155338756|NCT02404441|560674084|FG002|Phase 2 Part|Death|0|||
155338757|NCT02404441|560674085|FG003|Phase 2 Part|Death|0|||
155338758|NCT02404441|560674086|FG004|Phase 2 Part|Death|0|||
155338759|NCT02404441|560674087|FG005|Phase 2 Part|Death|4|||
155338760|NCT02404441|560674088|FG006|Phase 2 Part|Death|8|||
155504444|NCT04380701|561274038|FG026|Overall Study|Lost to Follow-up|0|||
155338761|NCT02404441|560674089|FG007|Phase 2 Part|Death|4|||
155338762|NCT02404441|560674090|FG008|Phase 2 Part|Death|10|||
155338763|NCT02404441|560674091|FG009|Phase 2 Part|Death|9|||
155338764|NCT01918033|560674092|FG000|Overall Study|Adverse Event|1|||
155338765|NCT01918033|560674093|FG001|Overall Study|Adverse Event|0|||
155338766|NCT01918033|560674094|FG002|Overall Study|Adverse Event|2|||
155338767|NCT01918033|560674092|FG000|Overall Study|Lost to Follow-up|0|||
155338768|NCT01918033|560674093|FG001|Overall Study|Lost to Follow-up|1|||
155338769|NCT01918033|560674094|FG002|Overall Study|Lost to Follow-up|0|||
155338770|NCT01918033|560674092|FG000|Overall Study|Protocol Violation|2|||
155338771|NCT01918033|560674093|FG001|Overall Study|Protocol Violation|0|||
155338772|NCT01918033|560674094|FG002|Overall Study|Protocol Violation|1|||
155338773|NCT01918033|560674092|FG000|Overall Study|Withdrawal by Subject|2|||
155338774|NCT01918033|560674093|FG001|Overall Study|Withdrawal by Subject|1|||
155338775|NCT01918033|560674094|FG002|Overall Study|Withdrawal by Subject|0|||
155338776|NCT03909100|560674100|FG000|Overall Study|Protocol Deviation|2|||
155338777|NCT03909100|560674100|FG000|Overall Study|Technical Problems|4|||
155338778|NCT03909100|560674100|FG000|Overall Study|Withdrawal by Subject|4|||
155338779|NCT03909100|560674100|FG000|Overall Study|Lost to Follow-up|1|||
155338780|NCT03909100|560674100|FG000|Overall Study|Reason not Specified|4|||
155338781|NCT00088166|560674101|FG000|Overall Study|Adverse Event|11|||
155338782|NCT00088166|560674102|FG001|Overall Study|Adverse Event|9|||
155338783|NCT00088166|560674101|FG000|Overall Study|Death|3|||
155338784|NCT00088166|560674102|FG001|Overall Study|Death|1|||
155338785|NCT00088166|560674101|FG000|Overall Study|Lost to Follow-up|0|||
155338786|NCT00088166|560674102|FG001|Overall Study|Lost to Follow-up|1|||
155338787|NCT00088166|560674101|FG000|Overall Study|Physician Decision|4|||
155338788|NCT00088166|560674102|FG001|Overall Study|Physician Decision|1|||
155338789|NCT00088166|560674101|FG000|Overall Study|Protocol Violation|1|||
155338790|NCT00088166|560674102|FG001|Overall Study|Protocol Violation|5|||
155338791|NCT00088166|560674101|FG000|Overall Study|Patient deterioration|29|||
155338792|NCT00088166|560674102|FG001|Overall Study|Patient deterioration|39|||
155338793|NCT00088166|560674101|FG000|Overall Study|Withdrawal by Subject|5|||
155504445|NCT04380701|561274039|FG027|Overall Study|Lost to Follow-up|0|||
155338794|NCT00088166|560674102|FG001|Overall Study|Withdrawal by Subject|5|||
155338795|NCT02671266|560674103|FG000|Overall Study|Withdrawal by Subject|1|||
155338796|NCT02671266|560674104|FG001|Overall Study|Withdrawal by Subject|1|||
155338797|NCT02538094|560674105|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
155338798|NCT02538094|560674106|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
155338799|NCT02538094|560674105|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
155338800|NCT02538094|560674106|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
155338801|NCT03803475|560674107|FG000|Overall Study|Physician Decision|1|||
155338802|NCT02807857|560674110|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
155338803|NCT02807857|560674110|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
155338804|NCT02807857|560674110|FG000|Follow-Up Set|Withdrawal by Subject|8|||
155338805|NCT02807857|560674110|FG000|Follow-Up Set|Lost to Follow-up|7|||
155338806|NCT02807857|560674110|FG000|Follow-Up Set|Physician Decision|6|||
155338807|NCT02807857|560674110|FG000|Follow-Up Set|Adverse Event|3|||
155338808|NCT02807857|560674110|FG000|Follow-Up Set|Death|27|||
155338809|NCT02807857|560674110|FG000|Follow-Up Set|Relocation|2|||
155338810|NCT00513071|560674112|FG000|Overall Study|Adverse Event|1|||
155338811|NCT00513071|560674112|FG000|Overall Study|Withdrawal by Subject|1|||
155338812|NCT00513071|560674112|FG000|Overall Study|Physician Decision|3|||
155338813|NCT00667732|560674114|FG000|Run -In (8 Weeks)|Adverse Event|4|||
155338814|NCT00667732|560674115|FG001|Run -In (8 Weeks)|Adverse Event|0|||
155338815|NCT00667732|560674116|FG002|Run -In (8 Weeks)|Adverse Event|0|||
155338816|NCT00667732|560674114|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
155338817|NCT00667732|560674115|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
155338818|NCT00667732|560674116|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
155338819|NCT00667732|560674114|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
155338820|NCT00667732|560674115|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
155338821|NCT00667732|560674116|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
155338822|NCT02106325|560674119|FG000|Phase 1|Lost to Follow-up|2|||
155338823|NCT02106325|560674120|FG001|Phase 1|Lost to Follow-up|2|||
155338824|NCT02106325|560674119|FG000|Phase 2|Lost to Follow-up|2|||
155338825|NCT02106325|560674120|FG001|Phase 2|Lost to Follow-up|3|||
155338826|NCT02106325|560674119|FG000|Phase 3|Lost to Follow-up|2|||
155338827|NCT02106325|560674120|FG001|Phase 3|Lost to Follow-up|1|||
155338828|NCT00452114|560674122|FG000|Overall Study|Physician Decision|3|||
155338829|NCT00452114|560674123|FG001|Overall Study|Physician Decision|3|||
155338830|NCT04197713|560674124|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
155338831|NCT04197713|560674125|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
155338832|NCT03242863|560674126|FG000|Study Week 1|Withdrawal by Subject|0|||
155338833|NCT03242863|560674127|FG001|Study Week 1|Withdrawal by Subject|1|||
155338834|NCT03242863|560674128|FG002|Study Week 1|Withdrawal by Subject|0|||
155338835|NCT03242863|560674129|FG003|Study Week 1|Withdrawal by Subject|0|||
155338836|NCT03242863|560674130|FG004|Study Week 1|Withdrawal by Subject|3|||
155338837|NCT03242863|560674131|FG005|Study Week 1|Withdrawal by Subject|0|||
155338838|NCT05338476|560674144|FG000|Period 2|Adverse Event|0|||
155338839|NCT05338476|560674145|FG001|Period 2|Adverse Event|1|||
155338840|NCT02831049|560674148|FG000|Overall Study|Lost to Follow-up|0|||
155338841|NCT02831049|560674149|FG001|Overall Study|Lost to Follow-up|0|||
155338842|NCT02831049|560674150|FG002|Overall Study|Lost to Follow-up|1|||
155338843|NCT02831049|560674148|FG000|Overall Study|Withdrawal by Subject|0|||
155338844|NCT02831049|560674149|FG001|Overall Study|Withdrawal by Subject|1|||
155338845|NCT02831049|560674150|FG002|Overall Study|Withdrawal by Subject|1|||
155338846|NCT02831049|560674148|FG000|Overall Study|Pandemic shutdown|1|||
155338847|NCT02831049|560674149|FG001|Overall Study|Pandemic shutdown|0|||
155338848|NCT02831049|560674150|FG002|Overall Study|Pandemic shutdown|0|||
155338849|NCT03786471|560674151|FG000|Overall Study|Death|254|||
155338850|NCT03786471|560674152|FG001|Overall Study|Death|223|||
155504446|NCT04380701|561274040|FG028|Overall Study|Lost to Follow-up|0|||
155338851|NCT03786471|560674153|FG002|Overall Study|Death|37|||
155338852|NCT03786471|560674151|FG000|Overall Study|Lost to Follow-up|63|||
155338853|NCT03786471|560674152|FG001|Overall Study|Lost to Follow-up|50|||
155338854|NCT03786471|560674153|FG002|Overall Study|Lost to Follow-up|15|||
155338855|NCT03786471|560674151|FG000|Overall Study|Withdrawal by Subject|99|||
155338856|NCT03786471|560674152|FG001|Overall Study|Withdrawal by Subject|81|||
155338857|NCT03786471|560674153|FG002|Overall Study|Withdrawal by Subject|11|||
155338858|NCT00215943|560675625|FG000|Overall Study|Disease Progression|3|||
155338859|NCT00215943|560675626|FG001|Overall Study|Disease Progression|5|||
155338860|NCT00215943|560675625|FG000|Overall Study|Alternate therapy|0|||
155338861|NCT00215943|560675626|FG001|Overall Study|Alternate therapy|1|||
155338862|NCT00215943|560675625|FG000|Overall Study|Adverse Event|3|||
155423186|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423187|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423188|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423189|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
155423190|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423191|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
155423192|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423193|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423194|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423195|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423196|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423197|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423198|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423199|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423200|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155338863|NCT00215943|560675626|FG001|Overall Study|Adverse Event|6|||
155338864|NCT00215943|560675625|FG000|Overall Study|Other disease|0|||
155338865|NCT00215943|560675626|FG001|Overall Study|Other disease|1|||
155338866|NCT00215943|560675625|FG000|Overall Study|Other complications|3|||
155338867|NCT00215943|560675626|FG001|Overall Study|Other complications|1|||
155338868|NCT03137784|560675629|FG000|Overall Study|Adverse Event|1|||
155338869|NCT03137784|560675630|FG001|Overall Study|Adverse Event|1|||
155338870|NCT03137784|560675631|FG002|Overall Study|Adverse Event|0|||
155338871|NCT03137784|560675632|FG003|Overall Study|Adverse Event|0|||
155338872|NCT03137784|560675633|FG004|Overall Study|Adverse Event|0|||
155338873|NCT03137784|560675634|FG005|Overall Study|Adverse Event|0|||
155338874|NCT03137784|560675629|FG000|Overall Study|Subject/guardian decision|1|||
155338875|NCT03137784|560675630|FG001|Overall Study|Subject/guardian decision|0|||
155338876|NCT03137784|560675631|FG002|Overall Study|Subject/guardian decision|0|||
155338877|NCT03137784|560675632|FG003|Overall Study|Subject/guardian decision|0|||
155338878|NCT03137784|560675633|FG004|Overall Study|Subject/guardian decision|0|||
155338879|NCT03137784|560675634|FG005|Overall Study|Subject/guardian decision|0|||
155338880|NCT03137784|560675629|FG000|Overall Study|Non-compliance with study treatment|0|||
155338881|NCT03137784|560675630|FG001|Overall Study|Non-compliance with study treatment|0|||
155338882|NCT03137784|560675631|FG002|Overall Study|Non-compliance with study treatment|0|||
155338883|NCT03137784|560675632|FG003|Overall Study|Non-compliance with study treatment|0|||
155338884|NCT03137784|560675633|FG004|Overall Study|Non-compliance with study treatment|1|||
155338885|NCT03137784|560675634|FG005|Overall Study|Non-compliance with study treatment|0|||
155338886|NCT00805792|560675635|FG000|Overall Study|Death|3|||
155338887|NCT00805792|560675635|FG000|Overall Study|Lost to Follow-up|2|||
155338888|NCT02165202|560675637|FG000|Oral Phase|Refused further participation|5|||
155338889|NCT02165202|560675638|FG001|Oral Phase|Refused further participation|1|||
155338890|NCT02165202|560675637|FG000|Oral Phase|Study product Related Toxicity|1|||
155338891|NCT02165202|560675638|FG001|Oral Phase|Study product Related Toxicity|0|||
155338892|NCT02165202|560675637|FG000|Oral Phase|Unable to contact Participant|1|||
155338893|NCT02165202|560675638|FG001|Oral Phase|Unable to contact Participant|1|||
155338894|NCT02165202|560675637|FG000|Oral Phase|Clinical reasons|1|||
155338895|NCT02165202|560675638|FG001|Oral Phase|Clinical reasons|0|||
155338896|NCT02165202|560675637|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
155338897|NCT02165202|560675638|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
155338898|NCT02165202|560675637|FG000|Oral Phase|CMC advised termination|1|||
155338899|NCT02165202|560675638|FG001|Oral Phase|CMC advised termination|0|||
155338900|NCT02165202|560675637|FG000|Oral Phase|Relocated, no follow-up planned|1|||
155338901|NCT02165202|560675638|FG001|Oral Phase|Relocated, no follow-up planned|0|||
155338902|NCT02165202|560675637|FG000|Oral Phase|Abnormal EKG|0|||
155423201|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423202|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423203|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155338903|NCT02165202|560675638|FG001|Oral Phase|Abnormal EKG|1|||
155338904|NCT02165202|560675637|FG000|Injection Phase|Abnormal Lab Value|5|||
155338905|NCT02165202|560675638|FG001|Injection Phase|Abnormal Lab Value|1|||
155338906|NCT02165202|560675637|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
155338907|NCT02165202|560675638|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
155338908|NCT02165202|560675637|FG000|Injection Phase|Unable to attend within Visit Window|1|||
155338909|NCT02165202|560675638|FG001|Injection Phase|Unable to attend within Visit Window|0|||
155338910|NCT02165202|560675637|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
155423204|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155504447|NCT04380701|561274041|FG029|Overall Study|Lost to Follow-up|1|||
155338911|NCT02165202|560675638|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
155338912|NCT02165202|560675637|FG000|Injection Phase|End of Study|2|||
155338913|NCT02165202|560675638|FG001|Injection Phase|End of Study|1|||
155338914|NCT02165202|560675637|FG000|Injection Phase|Study Product related Toxicity|1|||
155338915|NCT02165202|560675638|FG001|Injection Phase|Study Product related Toxicity|0|||
155338916|NCT02165202|560675637|FG000|Injection Phase|No longer interested|0|||
155338917|NCT02165202|560675638|FG001|Injection Phase|No longer interested|1|||
155338918|NCT02165202|560675637|FG000|Injection Phase|Participant unwilling to comply|1|||
155338919|NCT02165202|560675638|FG001|Injection Phase|Participant unwilling to comply|0|||
155504448|NCT04380701|561274042|FG030|Overall Study|Lost to Follow-up|0|||
155504449|NCT04380701|561274043|FG031|Overall Study|Lost to Follow-up|0|||
155504450|NCT04380701|561274044|FG032|Overall Study|Lost to Follow-up|0|||
155504451|NCT04380701|561274045|FG033|Overall Study|Lost to Follow-up|1|||
155504452|NCT04380701|561274012|FG000|Overall Study|Private reason(s)|0|||
155504453|NCT04380701|561274013|FG001|Overall Study|Private reason(s)|0|||
155504454|NCT04380701|561274014|FG002|Overall Study|Private reason(s)|0|||
155338920|NCT00990184|560675646|FG000|Overall Study|Physician Decision|1|||
155338921|NCT02753075|560675649|FG000|Overall Study|Adverse Event|2|||
155338922|NCT02753075|560675650|FG001|Overall Study|Adverse Event|1|||
155338923|NCT02753075|560675651|FG002|Overall Study|Adverse Event|0|||
155338924|NCT02753075|560675649|FG000|Overall Study|Lost to Follow-up|2|||
155338925|NCT02753075|560675650|FG001|Overall Study|Lost to Follow-up|0|||
155338926|NCT02753075|560675651|FG002|Overall Study|Lost to Follow-up|0|||
155338927|NCT02753075|560675649|FG000|Overall Study|Withdrawal of Consent|1|||
155338928|NCT02753075|560675650|FG001|Overall Study|Withdrawal of Consent|1|||
155338929|NCT02753075|560675651|FG002|Overall Study|Withdrawal of Consent|3|||
155338930|NCT02753075|560675649|FG000|Overall Study|Physician Decision|3|||
155338931|NCT02753075|560675650|FG001|Overall Study|Physician Decision|1|||
155338932|NCT02753075|560675651|FG002|Overall Study|Physician Decision|0|||
155338933|NCT02152384|560675652|FG000|Period 1|Withdrawal by Subject|0|||
155338934|NCT02152384|560675653|FG001|Period 1|Withdrawal by Subject|1|||
155423205|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423206|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423207|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423208|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
155423209|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
155423210|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
155423211|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
155423212|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
155423213|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
155423214|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
155423215|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
155423216|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423217|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423218|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423219|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423220|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423221|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423222|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423223|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155504455|NCT04380701|561274015|FG003|Overall Study|Private reason(s)|0|||
155504456|NCT04380701|561274016|FG004|Overall Study|Private reason(s)|0|||
155504457|NCT04380701|561274017|FG005|Overall Study|Private reason(s)|0|||
155504458|NCT04380701|561274018|FG006|Overall Study|Private reason(s)|1|||
155338935|NCT02152384|560675652|FG000|Period 1|Adverse Event|1|||
155338936|NCT02152384|560675653|FG001|Period 1|Adverse Event|1|||
155423224|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423225|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423226|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423227|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155338937|NCT01215253|560675656|FG000|Overall Study|Withdrawal by Subject|57|||
155338938|NCT01215253|560675657|FG001|Overall Study|Withdrawal by Subject|35|||
155338939|NCT01215253|560675656|FG000|Overall Study|Physician Decision|9|||
155504459|NCT04380701|561274019|FG007|Overall Study|Private reason(s)|0|||
155338940|NCT01215253|560675657|FG001|Overall Study|Physician Decision|12|||
155338941|NCT01215253|560675656|FG000|Overall Study|Lost to Follow-up|6|||
155338942|NCT01215253|560675657|FG001|Overall Study|Lost to Follow-up|4|||
155338943|NCT01215253|560675656|FG000|Overall Study|Other|14|||
155338944|NCT01215253|560675657|FG001|Overall Study|Other|12|||
155338945|NCT01320683|560675658|FG000|Overall Study|Positive antibody response|1|||
155338946|NCT02291861|560675659|FG000|Overall Study|Adverse Event|2|||
155338947|NCT02291861|560675660|FG001|Overall Study|Adverse Event|4|||
155338948|NCT02291861|560675661|FG002|Overall Study|Adverse Event|1|||
155338949|NCT02291861|560675662|FG003|Overall Study|Adverse Event|2|||
155338950|NCT02291861|560675659|FG000|Overall Study|Death|0|||
155338951|NCT02291861|560675660|FG001|Overall Study|Death|0|||
155338952|NCT02291861|560675661|FG002|Overall Study|Death|1|||
155338953|NCT02291861|560675662|FG003|Overall Study|Death|1|||
155338954|NCT02291861|560675659|FG000|Overall Study|Protocol Violation|1|||
155338955|NCT02291861|560675660|FG001|Overall Study|Protocol Violation|0|||
155338956|NCT02291861|560675661|FG002|Overall Study|Protocol Violation|0|||
155338957|NCT02291861|560675662|FG003|Overall Study|Protocol Violation|1|||
155338958|NCT02291861|560675659|FG000|Overall Study|Withdrawal by Subject|1|||
155338959|NCT02291861|560675660|FG001|Overall Study|Withdrawal by Subject|2|||
155338960|NCT02291861|560675661|FG002|Overall Study|Withdrawal by Subject|1|||
155338961|NCT02291861|560675662|FG003|Overall Study|Withdrawal by Subject|4|||
155338962|NCT02291861|560675659|FG000|Overall Study|Noncompliance|1|||
155338963|NCT02291861|560675660|FG001|Overall Study|Noncompliance|1|||
155338964|NCT02291861|560675661|FG002|Overall Study|Noncompliance|2|||
155338965|NCT02291861|560675662|FG003|Overall Study|Noncompliance|1|||
155338966|NCT02291861|560675659|FG000|Overall Study|Lost to Follow-up|2|||
155338967|NCT02291861|560675660|FG001|Overall Study|Lost to Follow-up|1|||
155338968|NCT02291861|560675661|FG002|Overall Study|Lost to Follow-up|4|||
155338969|NCT02291861|560675662|FG003|Overall Study|Lost to Follow-up|0|||
155338970|NCT02291861|560675659|FG000|Overall Study|Other|0|||
155338971|NCT02291861|560675660|FG001|Overall Study|Other|0|||
155338972|NCT02291861|560675661|FG002|Overall Study|Other|0|||
155338973|NCT02291861|560675662|FG003|Overall Study|Other|1|||
155338974|NCT00267956|560675665|FG000|Controlled Period|Adverse Event|4|||
155338975|NCT00267956|560675666|FG001|Controlled Period|Adverse Event|1|||
155338976|NCT00267956|560675667|FG002|Controlled Period|Adverse Event|0|||
155338977|NCT00267956|560675668|FG003|Controlled Period|Adverse Event|0|||
155338978|NCT00267956|560675665|FG000|Controlled Period|Lack of Efficacy|4|||
155338979|NCT00267956|560675666|FG001|Controlled Period|Lack of Efficacy|2|||
155338980|NCT00267956|560675667|FG002|Controlled Period|Lack of Efficacy|0|||
155338981|NCT00267956|560675668|FG003|Controlled Period|Lack of Efficacy|0|||
155338982|NCT00267956|560675665|FG000|Controlled Period|Lost to Follow-up|2|||
155338983|NCT00267956|560675666|FG001|Controlled Period|Lost to Follow-up|0|||
155338984|NCT00267956|560675667|FG002|Controlled Period|Lost to Follow-up|0|||
155338985|NCT00267956|560675668|FG003|Controlled Period|Lost to Follow-up|0|||
155504460|NCT04380701|561274020|FG008|Overall Study|Private reason(s)|1|||
155504461|NCT04380701|561274021|FG009|Overall Study|Private reason(s)|1|||
155504462|NCT04380701|561274022|FG010|Overall Study|Private reason(s)|0|||
155504463|NCT04380701|561274023|FG011|Overall Study|Private reason(s)|0|||
155504464|NCT04380701|561274024|FG012|Overall Study|Private reason(s)|0|||
155504465|NCT04380701|561274025|FG013|Overall Study|Private reason(s)|0|||
155504466|NCT04380701|561274026|FG014|Overall Study|Private reason(s)|0|||
155504467|NCT04380701|561274027|FG015|Overall Study|Private reason(s)|0|||
155504468|NCT04380701|561274028|FG016|Overall Study|Private reason(s)|0|||
155504469|NCT04380701|561274029|FG017|Overall Study|Private reason(s)|0|||
155504470|NCT04380701|561274030|FG018|Overall Study|Private reason(s)|0|||
155338986|NCT00267956|560675665|FG000|Controlled Period|Withdrew consent|3|||
155338987|NCT00267956|560675666|FG001|Controlled Period|Withdrew consent|1|||
155338988|NCT00267956|560675667|FG002|Controlled Period|Withdrew consent|0|||
155338989|NCT00267956|560675668|FG003|Controlled Period|Withdrew consent|0|||
155338990|NCT00267956|560675665|FG000|After Controlled Period|Adverse Event|0|||
155338991|NCT00267956|560675666|FG001|After Controlled Period|Adverse Event|0|||
155338992|NCT00267956|560675667|FG002|After Controlled Period|Adverse Event|2|||
155338993|NCT00267956|560675668|FG003|After Controlled Period|Adverse Event|1|||
155338994|NCT00267956|560675665|FG000|After Controlled Period|Lack of Efficacy|0|||
155338995|NCT00267956|560675666|FG001|After Controlled Period|Lack of Efficacy|0|||
155338996|NCT00267956|560675667|FG002|After Controlled Period|Lack of Efficacy|1|||
155338997|NCT00267956|560675668|FG003|After Controlled Period|Lack of Efficacy|1|||
155338998|NCT00267956|560675665|FG000|After Controlled Period|Lost to Follow-up|0|||
155338999|NCT00267956|560675666|FG001|After Controlled Period|Lost to Follow-up|0|||
155339000|NCT00267956|560675667|FG002|After Controlled Period|Lost to Follow-up|1|||
155339001|NCT00267956|560675668|FG003|After Controlled Period|Lost to Follow-up|0|||
155339002|NCT00267956|560675665|FG000|After Controlled Period|Withdrew consent|0|||
155339003|NCT00267956|560675666|FG001|After Controlled Period|Withdrew consent|0|||
155339004|NCT00267956|560675667|FG002|After Controlled Period|Withdrew consent|1|||
155339005|NCT00267956|560675668|FG003|After Controlled Period|Withdrew consent|0|||
155339006|NCT01263223|560675669|FG000|Period 2|Withdrawal by Subject|0|||
155339007|NCT01263223|560675670|FG001|Period 2|Withdrawal by Subject|1|||
155339008|NCT01263223|560675669|FG000|7-day Follow-up|Withdrawal by Subject|0|||
155339009|NCT01263223|560675670|FG001|7-day Follow-up|Withdrawal by Subject|1|||
155339010|NCT01263223|560675669|FG000|7-day Follow-up|Lost to Follow-up|1|||
155339011|NCT01263223|560675670|FG001|7-day Follow-up|Lost to Follow-up|0|||
155339012|NCT02005484|560675673|FG000|Overall Study|Death|1|||
155339013|NCT02005484|560675673|FG000|Overall Study|Disease progression|1|||
155339014|NCT02005484|560675673|FG000|Overall Study|Changed to a Different Study|1|||
155339015|NCT02005484|560675673|FG000|Overall Study|Sponsor decision|1|||
155339016|NCT02246647|560675674|FG000|Overall Study|Withdrawal by Subject|1|||
155339017|NCT02246647|560675675|FG001|Overall Study|Withdrawal by Subject|1|||
155339018|NCT01393964|560675676|FG000|Overall Study|Disease Progression|4|||
155339019|NCT01393964|560675677|FG001|Overall Study|Disease Progression|3|||
155339020|NCT01393964|560675678|FG002|Overall Study|Disease Progression|5|||
155339021|NCT01393964|560675676|FG000|Overall Study|Study drug toxicity|1|||
155339022|NCT01393964|560675677|FG001|Overall Study|Study drug toxicity|0|||
155339023|NCT01393964|560675678|FG002|Overall Study|Study drug toxicity|0|||
155339024|NCT01393964|560675676|FG000|Overall Study|Withdrawal by Subject|0|||
155339025|NCT01393964|560675677|FG001|Overall Study|Withdrawal by Subject|0|||
155339026|NCT01393964|560675678|FG002|Overall Study|Withdrawal by Subject|1|||
155339027|NCT01393964|560675676|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155504471|NCT04380701|561274031|FG019|Overall Study|Private reason(s)|0|||
155504472|NCT04380701|561274032|FG020|Overall Study|Private reason(s)|0|||
155504473|NCT04380701|561274033|FG021|Overall Study|Private reason(s)|0|||
155504474|NCT04380701|561274034|FG022|Overall Study|Private reason(s)|0|||
155504475|NCT04380701|561274035|FG023|Overall Study|Private reason(s)|1|||
155504476|NCT04380701|561274036|FG024|Overall Study|Private reason(s)|0|||
155504477|NCT04380701|561274037|FG025|Overall Study|Private reason(s)|0|||
155504478|NCT04380701|561274038|FG026|Overall Study|Private reason(s)|0|||
155504479|NCT04380701|561274039|FG027|Overall Study|Private reason(s)|0|||
155504480|NCT04380701|561274040|FG028|Overall Study|Private reason(s)|0|||
155339028|NCT01393964|560675677|FG001|Overall Study|Adverse event unrelated to study drug|3|||
155339029|NCT01393964|560675678|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155339030|NCT01393964|560675676|FG000|Overall Study|Subject request stop study treatment|0|||
155339031|NCT01393964|560675677|FG001|Overall Study|Subject request stop study treatment|1|||
155504481|NCT04380701|561274041|FG029|Overall Study|Private reason(s)|1|||
155339032|NCT01393964|560675678|FG002|Overall Study|Subject request stop study treatment|0|||
155339033|NCT01393964|560675676|FG000|Overall Study|Subject decided to move to transplant|1|||
155339034|NCT01393964|560675677|FG001|Overall Study|Subject decided to move to transplant|0|||
155339035|NCT01393964|560675678|FG002|Overall Study|Subject decided to move to transplant|0|||
155504482|NCT04380701|561274042|FG030|Overall Study|Private reason(s)|0|||
155504483|NCT04380701|561274043|FG031|Overall Study|Private reason(s)|0|||
155504484|NCT04380701|561274044|FG032|Overall Study|Private reason(s)|0|||
155339036|NCT01393964|560675676|FG000|Overall Study|Subject switched to commercial supply|1|||
155339037|NCT01393964|560675677|FG001|Overall Study|Subject switched to commercial supply|0|||
155339038|NCT01393964|560675678|FG002|Overall Study|Subject switched to commercial supply|2|||
155339039|NCT01393964|560675676|FG000|Overall Study|Subject plateaued in terms of effect|1|||
155339040|NCT01393964|560675677|FG001|Overall Study|Subject plateaued in terms of effect|0|||
155339041|NCT01393964|560675678|FG002|Overall Study|Subject plateaued in terms of effect|0|||
155339042|NCT01393964|560675676|FG000|Overall Study|Investigator removed subject from study|0|||
155339043|NCT01393964|560675677|FG001|Overall Study|Investigator removed subject from study|1|||
155339044|NCT01393964|560675678|FG002|Overall Study|Investigator removed subject from study|0|||
155339045|NCT01393964|560675676|FG000|Overall Study|Subject converted to roll-over study|0|||
155339046|NCT01393964|560675677|FG001|Overall Study|Subject converted to roll-over study|1|||
155339047|NCT01393964|560675678|FG002|Overall Study|Subject converted to roll-over study|0|||
155339048|NCT01393964|560675676|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
155339049|NCT01393964|560675677|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
155339050|NCT01393964|560675678|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
155339051|NCT01113541|560675679|FG000|Overall Study|Withdrawal by Subject|1|||
155339052|NCT01113541|560675679|FG000|Overall Study|Protocol Violation|1|||
155339053|NCT01113541|560675679|FG000|Overall Study|Study Terminated by Sponsor|7|||
155339054|NCT01113541|560675679|FG000|Overall Study|Adverse Event|4|||
155339055|NCT04679675|560675682|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
155339056|NCT04679675|560675683|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
155339057|NCT04679675|560675684|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
155339058|NCT04679675|560675685|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
155339059|NCT04679675|560675682|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
155339060|NCT04679675|560675683|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
155339061|NCT04679675|560675684|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
155339062|NCT04679675|560675685|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
155339063|NCT01794299|560675690|FG000|Overall Study|ATIR manufacturing not possible|1|||
155339064|NCT01794299|560675690|FG000|Overall Study|Death|14|||
155339065|NCT01794299|560675690|FG000|Overall Study|Graft failure|1|||
155339066|NCT01794299|560675690|FG000|Overall Study|ATIR batch rejected|2|||
155339067|NCT01794299|560675690|FG000|Overall Study|Relapse|2|||
155339068|NCT01794299|560675690|FG000|Overall Study|Discontinued from active follow-up|1|||
155339069|NCT01794299|560675690|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
155339070|NCT03006393|560675691|FG000|Overall Study|Withdrawal by Subject|1|||
155339071|NCT03006393|560675692|FG001|Overall Study|Withdrawal by Subject|1|||
155339072|NCT03006393|560675691|FG000|Overall Study|Pregnancy|0|||
155339073|NCT03006393|560675692|FG001|Overall Study|Pregnancy|1|||
155339074|NCT03006393|560675691|FG000|Overall Study|Lost to Follow-up|0|||
155339075|NCT03006393|560675692|FG001|Overall Study|Lost to Follow-up|1|||
155339076|NCT00807599|560675695|FG000|Overall Study|Not treated on protocol study|0|||
155339077|NCT00807599|560675696|FG001|Overall Study|Not treated on protocol study|0|||
155339078|NCT00807599|560675697|FG002|Overall Study|Not treated on protocol study|2|||
155339079|NCT00807599|560675695|FG000|Overall Study|Adverse Event|0|||
155339080|NCT00807599|560675696|FG001|Overall Study|Adverse Event|0|||
155339081|NCT00807599|560675697|FG002|Overall Study|Adverse Event|5|||
155339082|NCT00807599|560675695|FG000|Overall Study|Inadequate response to induction|0|||
155339083|NCT00807599|560675696|FG001|Overall Study|Inadequate response to induction|0|||
155423228|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423229|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423230|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423231|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
155423232|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
155423233|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
155423234|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
155423235|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
155423236|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
155423237|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
155423238|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
155423239|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
155423240|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423241|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423242|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423243|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423244|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423245|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155645924|NCT01964560|561795607|FG000|Overall Study|Participant moved to another country|1|||
155339084|NCT00807599|560675697|FG002|Overall Study|Inadequate response to induction|9|||
155339085|NCT00807599|560675695|FG000|Overall Study|Withdrawal by Subject|0|||
155645925|NCT02391584|561795608|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
155645926|NCT02391584|561795609|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
155339086|NCT00807599|560675696|FG001|Overall Study|Withdrawal by Subject|0|||
155339087|NCT00807599|560675697|FG002|Overall Study|Withdrawal by Subject|1|||
155339088|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
155339089|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
155339090|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
155339091|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
155339092|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
155339093|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
155339094|NCT01328756|560675702|FG000|Overall Study|Protocol Violation|4|||
155339095|NCT01328756|560675702|FG000|Overall Study|Adverse Event|39|||
155339096|NCT01328756|560675702|FG000|Overall Study|Lack of Efficacy|5|||
155339097|NCT01328756|560675702|FG000|Overall Study|Withdrawal by Subject|41|||
155339098|NCT01328756|560675702|FG000|Overall Study|Lost to Follow-up|5|||
155339099|NCT01328756|560675702|FG000|Overall Study|Other|29|||
155339100|NCT04183491|560675708|FG000|Overall Study|Withdrawal by Subject|0|||
155339101|NCT04183491|560675709|FG001|Overall Study|Withdrawal by Subject|0|||
155339102|NCT04183491|560675710|FG002|Overall Study|Withdrawal by Subject|1|||
155339103|NCT04183491|560675711|FG003|Overall Study|Withdrawal by Subject|0|||
155339104|NCT04183491|560675712|FG004|Overall Study|Withdrawal by Subject|0|||
155339105|NCT04183491|560675713|FG005|Overall Study|Withdrawal by Subject|1|||
155339106|NCT04183491|560675714|FG006|Overall Study|Withdrawal by Subject|0|||
155339107|NCT03288506|560675715|FG000|Overall Study|Withdrawal by Subject|52|||
155339108|NCT03692871|560675716|FG000|Overall Study|Death|1|||
155339109|NCT03692871|560675717|FG001|Overall Study|Death|1|||
155339110|NCT03692871|560675716|FG000|Overall Study|Lost to Follow-up|24|||
155339111|NCT03692871|560675717|FG001|Overall Study|Lost to Follow-up|9|||
155339112|NCT03692871|560675716|FG000|Overall Study|Physician Decision|22|||
155339113|NCT03692871|560675717|FG001|Overall Study|Physician Decision|7|||
155339114|NCT03692871|560675716|FG000|Overall Study|Protocol Deviation|1|||
155339115|NCT03692871|560675717|FG001|Overall Study|Protocol Deviation|0|||
155339116|NCT03692871|560675716|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
155339117|NCT03692871|560675717|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
155339118|NCT02852824|560675720|FG000|Overall Study|Withdrawal by Subject|1|||
155339119|NCT02852824|560675721|FG001|Overall Study|Withdrawal by Subject|0|||
155339120|NCT02852824|560675722|FG002|Overall Study|Withdrawal by Subject|0|||
155339121|NCT02852824|560675723|FG003|Overall Study|Withdrawal by Subject|0|||
155339122|NCT02852824|560675724|FG004|Overall Study|Withdrawal by Subject|0|||
155339123|NCT02852824|560675725|FG005|Overall Study|Withdrawal by Subject|0|||
155339124|NCT02852824|560675726|FG006|Overall Study|Withdrawal by Subject|0|||
155339125|NCT02852824|560675720|FG000|Overall Study|Adverse Event|0|||
155339126|NCT02852824|560675721|FG001|Overall Study|Adverse Event|0|||
155339127|NCT02852824|560675722|FG002|Overall Study|Adverse Event|0|||
155339128|NCT02852824|560675723|FG003|Overall Study|Adverse Event|0|||
155339129|NCT02852824|560675724|FG004|Overall Study|Adverse Event|2|||
155339130|NCT02852824|560675725|FG005|Overall Study|Adverse Event|0|||
155339131|NCT02852824|560675726|FG006|Overall Study|Adverse Event|0|||
155339132|NCT01316913|560675727|FG000|Overall Study|Adverse Event|17|||
155339133|NCT01316913|560675728|FG001|Overall Study|Adverse Event|20|||
155339134|NCT01316913|560675729|FG002|Overall Study|Adverse Event|15|||
155339135|NCT01316913|560675730|FG003|Overall Study|Adverse Event|11|||
155339136|NCT01316913|560675727|FG000|Overall Study|Lack of Efficacy|22|||
155339137|NCT01316913|560675728|FG001|Overall Study|Lack of Efficacy|12|||
155339138|NCT01316913|560675729|FG002|Overall Study|Lack of Efficacy|9|||
155339139|NCT01316913|560675730|FG003|Overall Study|Lack of Efficacy|13|||
155339140|NCT01316913|560675727|FG000|Overall Study|Protocol Violation|1|||
155339141|NCT01316913|560675728|FG001|Overall Study|Protocol Violation|4|||
155339142|NCT01316913|560675729|FG002|Overall Study|Protocol Violation|4|||
155339143|NCT01316913|560675730|FG003|Overall Study|Protocol Violation|1|||
155339144|NCT01316913|560675727|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
155339145|NCT01316913|560675728|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
155423246|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155504485|NCT04380701|561274045|FG033|Overall Study|Private reason(s)|0|||
155339146|NCT01316913|560675729|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
155339147|NCT01316913|560675730|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
155339148|NCT01316913|560675727|FG000|Overall Study|Lost to Follow-up|0|||
155339149|NCT01316913|560675728|FG001|Overall Study|Lost to Follow-up|1|||
155339150|NCT01316913|560675729|FG002|Overall Study|Lost to Follow-up|0|||
155339151|NCT01316913|560675730|FG003|Overall Study|Lost to Follow-up|2|||
155339152|NCT01316913|560675727|FG000|Overall Study|Withdrawal by Subject|10|||
155339153|NCT01316913|560675728|FG001|Overall Study|Withdrawal by Subject|9|||
155339154|NCT01316913|560675729|FG002|Overall Study|Withdrawal by Subject|10|||
155339155|NCT01316913|560675730|FG003|Overall Study|Withdrawal by Subject|6|||
155339156|NCT01860079|560675731|FG000|Overall Study|Physician Decision|14|||
155339157|NCT01860079|560675732|FG001|Overall Study|Physician Decision|22|||
155339158|NCT04867382|560675733|FG000|Overall Study|Did not complete the survey|2|||
155339159|NCT04867382|560675734|FG001|Overall Study|Did not complete the survey|1|||
155339160|NCT02102724|560675735|FG000|Overall Study|Lost to Follow-up|1|||
155339161|NCT02102724|560675736|FG001|Overall Study|Lost to Follow-up|0|||
155339162|NCT02102724|560675735|FG000|Overall Study|surgery for brain aneurysm|1|||
155339163|NCT02102724|560675736|FG001|Overall Study|surgery for brain aneurysm|1|||
155339164|NCT05445557|560675737|FG000|Double Blind Part|Lost to Follow-up|1|||
155339165|NCT02008916|560675738|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
155339166|NCT02008916|560675739|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
155339167|NCT02008916|560675740|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
155339168|NCT02008916|560675738|FG000|Week 16 - 156|Adverse Event|4|||
155339169|NCT02008916|560675739|FG001|Week 16 - 156|Adverse Event|2|||
155339170|NCT02008916|560675740|FG002|Week 16 - 156|Adverse Event|3|||
155339171|NCT02008916|560675738|FG000|Week 16 - 156|Withdrawal by Subject|7|||
155339172|NCT02008916|560675739|FG001|Week 16 - 156|Withdrawal by Subject|3|||
155339173|NCT02008916|560675740|FG002|Week 16 - 156|Withdrawal by Subject|5|||
155339174|NCT02008916|560675738|FG000|Week 16 - 156|No longer requires treatment|0|||
155339175|NCT02008916|560675739|FG001|Week 16 - 156|No longer requires treatment|1|||
155339176|NCT02008916|560675740|FG002|Week 16 - 156|No longer requires treatment|0|||
155339177|NCT02008916|560675738|FG000|Week 16 - 156|Lost to Follow-up|5|||
155339178|NCT02008916|560675739|FG001|Week 16 - 156|Lost to Follow-up|0|||
155339179|NCT02008916|560675740|FG002|Week 16 - 156|Lost to Follow-up|0|||
155339180|NCT02008916|560675738|FG000|Week 16 - 156|Lack of Efficacy|3|||
155339181|NCT02008916|560675739|FG001|Week 16 - 156|Lack of Efficacy|5|||
155339182|NCT02008916|560675740|FG002|Week 16 - 156|Lack of Efficacy|2|||
155339183|NCT02008916|560675738|FG000|Week 16 - 156|Pregnancy|0|||
155339184|NCT02008916|560675739|FG001|Week 16 - 156|Pregnancy|1|||
155504486|NCT04380701|561274012|FG000|Overall Study|Withdrawal by Subject|0|||
155504487|NCT04380701|561274013|FG001|Overall Study|Withdrawal by Subject|0|||
155504488|NCT04380701|561274014|FG002|Overall Study|Withdrawal by Subject|0|||
155504489|NCT04380701|561274015|FG003|Overall Study|Withdrawal by Subject|0|||
155504490|NCT04380701|561274016|FG004|Overall Study|Withdrawal by Subject|0|||
155339185|NCT02008916|560675740|FG002|Week 16 - 156|Pregnancy|0|||
155339186|NCT02008916|560675738|FG000|Week 16 - 156|Physician Decision|0|||
155339187|NCT02008916|560675739|FG001|Week 16 - 156|Physician Decision|1|||
155339188|NCT02008916|560675740|FG002|Week 16 - 156|Physician Decision|0|||
155339189|NCT01323790|560675741|FG000|Overall Study|Other|3|||
155339190|NCT01323790|560675742|FG001|Overall Study|Other|2|||
155339191|NCT01323790|560675743|FG002|Overall Study|Other|1|||
155339192|NCT01323790|560675741|FG000|Overall Study|Lost to Follow-up|11|||
155339193|NCT01323790|560675742|FG001|Overall Study|Lost to Follow-up|9|||
155339194|NCT01323790|560675743|FG002|Overall Study|Lost to Follow-up|9|||
155339195|NCT01323790|560675741|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155339196|NCT01323790|560675742|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
155339197|NCT01323790|560675743|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
155339198|NCT01323790|560675741|FG000|Overall Study|Lack of Efficacy|3|||
155339199|NCT01323790|560675742|FG001|Overall Study|Lack of Efficacy|0|||
155339200|NCT01323790|560675743|FG002|Overall Study|Lack of Efficacy|3|||
155339201|NCT01323790|560675741|FG000|Overall Study|Adverse Event|11|||
155339202|NCT01323790|560675742|FG001|Overall Study|Adverse Event|24|||
155339203|NCT01323790|560675743|FG002|Overall Study|Adverse Event|12|||
155339204|NCT01323790|560675741|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155339205|NCT01323790|560675742|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155339206|NCT01323790|560675743|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
155339207|NCT01323790|560675741|FG000|Overall Study|Withdrawal by Subject|23|||
155339208|NCT01323790|560675742|FG001|Overall Study|Withdrawal by Subject|20|||
155339209|NCT01323790|560675743|FG002|Overall Study|Withdrawal by Subject|13|||
155339210|NCT01323790|560675741|FG000|Overall Study|Did Not Receive Treatment|2|||
155339211|NCT01323790|560675742|FG001|Overall Study|Did Not Receive Treatment|0|||
155339212|NCT01323790|560675743|FG002|Overall Study|Did Not Receive Treatment|1|||
155339213|NCT01323790|560675741|FG000|Overall Study|Severe non-compliance with protocol|2|||
155339214|NCT01323790|560675742|FG001|Overall Study|Severe non-compliance with protocol|2|||
155504491|NCT04380701|561274017|FG005|Overall Study|Withdrawal by Subject|0|||
155339215|NCT01323790|560675743|FG002|Overall Study|Severe non-compliance with protocol|2|||
155339216|NCT00266656|560675750|FG000|Overall Study|Death|1|||
155339217|NCT00266656|560675751|FG001|Overall Study|Death|0|||
155339218|NCT00266656|560675750|FG000|Overall Study|Lost to Follow-up|4|||
155339219|NCT00266656|560675751|FG001|Overall Study|Lost to Follow-up|1|||
155339220|NCT00266656|560675750|FG000|Overall Study|Withdrawal by Subject|4|||
155339221|NCT00266656|560675751|FG001|Overall Study|Withdrawal by Subject|2|||
155339222|NCT00266656|560675750|FG000|Overall Study|Did Not Reach Final Height|4|||
155339223|NCT00266656|560675751|FG001|Overall Study|Did Not Reach Final Height|8|||
155504492|NCT04380701|561274018|FG006|Overall Study|Withdrawal by Subject|1|||
155339224|NCT00266656|560675750|FG000|Overall Study|Parent/Caregiver Decision|1|||
155339225|NCT00266656|560675751|FG001|Overall Study|Parent/Caregiver Decision|2|||
155339226|NCT02915783|560675753|FG000|Overall Study|Death|21|||
155339227|NCT02915783|560675753|FG000|Overall Study|Lost to Follow-up|1|||
155339228|NCT02915783|560675753|FG000|Overall Study|Withdrawal by Subject|2|||
155504493|NCT04380701|561274019|FG007|Overall Study|Withdrawal by Subject|1|||
155339229|NCT02950961|560675754|FG000|Overall Study|Study had to stop due to COVID.|7|||
155339230|NCT01915914|560675757|FG000|Acute Phase|Withdrawal by Subject|4|||
155339231|NCT01915914|560675758|FG001|Acute Phase|Withdrawal by Subject|0|||
155339232|NCT01915914|560675759|FG002|Acute Phase|Withdrawal by Subject|0|||
155339233|NCT01915914|560675760|FG003|Acute Phase|Withdrawal by Subject|0|||
155339234|NCT01915914|560675757|FG000|Acute Phase|Lost to Follow-up|4|||
155339235|NCT01915914|560675758|FG001|Acute Phase|Lost to Follow-up|0|||
155339236|NCT01915914|560675759|FG002|Acute Phase|Lost to Follow-up|0|||
155339237|NCT01915914|560675760|FG003|Acute Phase|Lost to Follow-up|0|||
155339238|NCT01915914|560675757|FG000|Acute Phase|Physician Decision|1|||
155339239|NCT01915914|560675758|FG001|Acute Phase|Physician Decision|0|||
155339240|NCT01915914|560675759|FG002|Acute Phase|Physician Decision|0|||
155339241|NCT01915914|560675760|FG003|Acute Phase|Physician Decision|0|||
155339242|NCT01915914|560675757|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
155339243|NCT01915914|560675758|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
155339244|NCT01915914|560675759|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
155339245|NCT01915914|560675760|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
155339246|NCT01915914|560675757|FG000|Acute Phase|"Not Achieved treatment success"|1|||
155339247|NCT01915914|560675758|FG001|Acute Phase|"Not Achieved treatment success"|0|||
155339248|NCT01915914|560675759|FG002|Acute Phase|"Not Achieved treatment success"|0|||
155339249|NCT01915914|560675760|FG003|Acute Phase|"Not Achieved treatment success"|0|||
155339250|NCT01915914|560675757|FG000|Acute Phase|Missing|1|||
155339251|NCT01915914|560675758|FG001|Acute Phase|Missing|0|||
155339252|NCT01915914|560675759|FG002|Acute Phase|Missing|0|||
155339253|NCT01915914|560675760|FG003|Acute Phase|Missing|0|||
155339254|NCT01915914|560675757|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155339255|NCT01915914|560675758|FG001|Maintenance Phase|Withdrawal by Subject|1|||
155339256|NCT01915914|560675759|FG002|Maintenance Phase|Withdrawal by Subject|1|||
155339257|NCT01915914|560675760|FG003|Maintenance Phase|Withdrawal by Subject|0|||
155339258|NCT01915914|560675757|FG000|Maintenance Phase|Lost to Follow-up|0|||
155339259|NCT01915914|560675758|FG001|Maintenance Phase|Lost to Follow-up|4|||
155339260|NCT01915914|560675759|FG002|Maintenance Phase|Lost to Follow-up|1|||
155339261|NCT01915914|560675760|FG003|Maintenance Phase|Lost to Follow-up|0|||
155339262|NCT01915914|560675757|FG000|Maintenance Phase|Missing|0|||
155339263|NCT01915914|560675758|FG001|Maintenance Phase|Missing|1|||
155339264|NCT01915914|560675759|FG002|Maintenance Phase|Missing|0|||
155339265|NCT01915914|560675760|FG003|Maintenance Phase|Missing|0|||
155339266|NCT01915914|560675757|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155339267|NCT01915914|560675758|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155339268|NCT01915914|560675759|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155339269|NCT01915914|560675760|FG003|Follow-up Phase|Withdrawal by Subject|1|||
155339270|NCT01915914|560675757|FG000|Follow-up Phase|Physician Decision|0|||
155339271|NCT01915914|560675758|FG001|Follow-up Phase|Physician Decision|0|||
155339272|NCT01915914|560675759|FG002|Follow-up Phase|Physician Decision|0|||
155339273|NCT01915914|560675760|FG003|Follow-up Phase|Physician Decision|1|||
155339274|NCT00428714|560675762|FG000|Overall Study|Progressive Disease|28|||
155339275|NCT00428714|560675763|FG001|Overall Study|Progressive Disease|36|||
155339276|NCT00428714|560675762|FG000|Overall Study|Withdrawal by Subject|0|||
155339277|NCT00428714|560675763|FG001|Overall Study|Withdrawal by Subject|3|||
155339278|NCT00428714|560675762|FG000|Overall Study|Adverse Event|0|||
155339279|NCT00428714|560675763|FG001|Overall Study|Adverse Event|2|||
155339280|NCT00428714|560675762|FG000|Overall Study|Physician Decision|1|||
155339281|NCT00428714|560675763|FG001|Overall Study|Physician Decision|1|||
155339282|NCT00428714|560675762|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
155339283|NCT00428714|560675763|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
155339284|NCT00428714|560675762|FG000|Overall Study|Death due to other then PD|1|||
155339285|NCT00428714|560675763|FG001|Overall Study|Death due to other then PD|0|||
155339286|NCT02432274|560675764|FG000|Overall Study|Death|2|||
155339287|NCT02432274|560675765|FG001|Overall Study|Death|6|||
155339288|NCT02432274|560675766|FG002|Overall Study|Death|7|||
155339289|NCT02432274|560675767|FG003|Overall Study|Death|0|||
155339290|NCT02432274|560675768|FG004|Overall Study|Death|27|||
155339291|NCT02432274|560675769|FG005|Overall Study|Death|7|||
155339292|NCT02432274|560675770|FG006|Overall Study|Death|9|||
155339293|NCT02432274|560675771|FG007|Overall Study|Death|14|||
155339294|NCT02432274|560675764|FG000|Overall Study|Withdrawal of Consent|0|||
155339295|NCT02432274|560675765|FG001|Overall Study|Withdrawal of Consent|0|||
155339296|NCT02432274|560675766|FG002|Overall Study|Withdrawal of Consent|0|||
155339297|NCT02432274|560675767|FG003|Overall Study|Withdrawal of Consent|0|||
155339298|NCT02432274|560675768|FG004|Overall Study|Withdrawal of Consent|2|||
155339299|NCT02432274|560675769|FG005|Overall Study|Withdrawal of Consent|0|||
155339300|NCT02432274|560675770|FG006|Overall Study|Withdrawal of Consent|1|||
155339301|NCT02432274|560675771|FG007|Overall Study|Withdrawal of Consent|2|||
155339302|NCT01736475|560675772|FG000|Overall Study|Adverse Event|4|||
155339303|NCT01736475|560675773|FG001|Overall Study|Adverse Event|0|||
155339304|NCT01736475|560675772|FG000|Overall Study|Withdrawal by Subject|2|||
155645927|NCT02391584|561795608|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
155645928|NCT02391584|561795609|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
155504494|NCT04380701|561274020|FG008|Overall Study|Withdrawal by Subject|0|||
155504495|NCT04380701|561274021|FG009|Overall Study|Withdrawal by Subject|0|||
155504496|NCT04380701|561274022|FG010|Overall Study|Withdrawal by Subject|0|||
155504497|NCT04380701|561274023|FG011|Overall Study|Withdrawal by Subject|1|||
155504498|NCT04380701|561274024|FG012|Overall Study|Withdrawal by Subject|0|||
155504499|NCT04380701|561274025|FG013|Overall Study|Withdrawal by Subject|1|||
155504500|NCT04380701|561274026|FG014|Overall Study|Withdrawal by Subject|0|||
155504501|NCT04380701|561274027|FG015|Overall Study|Withdrawal by Subject|0|||
155504502|NCT04380701|561274028|FG016|Overall Study|Withdrawal by Subject|1|||
155504503|NCT04380701|561274029|FG017|Overall Study|Withdrawal by Subject|0|||
155645929|NCT02391584|561795608|FG000|3 Month|Lost to Follow-up|1|||
155645930|NCT02391584|561795609|FG001|3 Month|Lost to Follow-up|0|||
155645931|NCT02391584|561795608|FG000|6 Month|Withdrawal by Subject|1|||
155339305|NCT01736475|560675773|FG001|Overall Study|Withdrawal by Subject|0|||
155339306|NCT01736475|560675772|FG000|Overall Study|Protocol Violation|4|||
155339307|NCT01736475|560675773|FG001|Overall Study|Protocol Violation|0|||
155339308|NCT01736475|560675772|FG000|Overall Study|Other - Screen failure|1|||
155339309|NCT01736475|560675773|FG001|Overall Study|Other - Screen failure|0|||
155339310|NCT01736475|560675772|FG000|Overall Study|Other - Surgical procedure|1|||
155339311|NCT01736475|560675773|FG001|Overall Study|Other - Surgical procedure|0|||
155339312|NCT02114515|560675775|FG000|Overall Study|Lost to Follow-up|52|||
155339313|NCT02114515|560675776|FG001|Overall Study|Lost to Follow-up|55|||
155339314|NCT02114515|560675775|FG000|Overall Study|Death|12|||
155339315|NCT02114515|560675776|FG001|Overall Study|Death|12|||
155339316|NCT02114515|560675775|FG000|Overall Study|Withdrawal by Subject|4|||
155339317|NCT02114515|560675776|FG001|Overall Study|Withdrawal by Subject|22|||
155339318|NCT02114515|560675775|FG000|Overall Study|Other|65|||
155339319|NCT02114515|560675776|FG001|Overall Study|Other|61|||
155339320|NCT05522777|560677169|FG000|Overall Study|Lack of Efficacy|1|||
155339321|NCT05522777|560677169|FG000|Overall Study|Withdrawal by Subject|1|||
155339322|NCT05487300|560677172|FG000|Overall Study|Withdrawal by Subject|1|||
155339323|NCT05487300|560677173|FG001|Overall Study|Withdrawal by Subject|0|||
155339324|NCT03141177|560677174|FG000|Overall Study|Death|62|||
155339325|NCT03141177|560677175|FG001|Overall Study|Death|13|||
155504504|NCT04380701|561274030|FG018|Overall Study|Withdrawal by Subject|0|||
155504505|NCT04380701|561274031|FG019|Overall Study|Withdrawal by Subject|0|||
155645932|NCT02391584|561795609|FG001|6 Month|Withdrawal by Subject|0|||
155645933|NCT02391584|561795608|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
155339326|NCT03141177|560677176|FG002|Overall Study|Death|84|||
155339327|NCT03141177|560677174|FG000|Overall Study|Participant withdrew consent|9|||
155339328|NCT03141177|560677175|FG001|Overall Study|Participant withdrew consent|2|||
155339329|NCT03141177|560677176|FG002|Overall Study|Participant withdrew consent|13|||
155339330|NCT03141177|560677174|FG000|Overall Study|Not reported|1|||
155339331|NCT03141177|560677175|FG001|Overall Study|Not reported|0|||
155339332|NCT03141177|560677176|FG002|Overall Study|Not reported|1|||
155339333|NCT03141177|560677174|FG000|Overall Study|Lost to Follow-up|2|||
155339334|NCT03141177|560677175|FG001|Overall Study|Lost to Follow-up|1|||
155339335|NCT03141177|560677176|FG002|Overall Study|Lost to Follow-up|1|||
155339336|NCT03141177|560677174|FG000|Overall Study|Other reasons|4|||
155339337|NCT03141177|560677175|FG001|Overall Study|Other reasons|0|||
155339338|NCT03141177|560677176|FG002|Overall Study|Other reasons|11|||
155339339|NCT03141177|560677174|FG000|Overall Study|Participants did not start treatment period|3|||
155339340|NCT03141177|560677175|FG001|Overall Study|Participants did not start treatment period|0|||
155339341|NCT03141177|560677176|FG002|Overall Study|Participants did not start treatment period|8|||
155339342|NCT05006703|560677177|FG000|Overall Study|Withdrawal by Subject|1|||
155339343|NCT05006703|560677178|FG001|Overall Study|Withdrawal by Subject|0|||
155339344|NCT05006703|560677177|FG000|Overall Study|Lost to Follow-up|13|||
155339345|NCT05006703|560677178|FG001|Overall Study|Lost to Follow-up|5|||
155339346|NCT00264576|560677183|FG000|Overall Study|Lost to Follow-up|1|||
155339347|NCT00264576|560677184|FG001|Overall Study|Lost to Follow-up|1|||
155339348|NCT02659059|560677185|FG000|Overall Study|Other reasons|6|||
155339349|NCT02659059|560677186|FG001|Overall Study|Other reasons|1|||
155339350|NCT02659059|560677185|FG000|Overall Study|Disease Progression|143|||
155339351|NCT02659059|560677186|FG001|Overall Study|Disease Progression|16|||
155339352|NCT02659059|560677185|FG000|Overall Study|Study Drug toxicity|56|||
155339353|NCT02659059|560677186|FG001|Overall Study|Study Drug toxicity|9|||
155339354|NCT02659059|560677185|FG000|Overall Study|Death|3|||
155339355|NCT02659059|560677186|FG001|Overall Study|Death|1|||
155339356|NCT02659059|560677185|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
155339357|NCT02659059|560677186|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
155339358|NCT02659059|560677185|FG000|Overall Study|Participant request to discontinue study treatment|5|||
155339359|NCT02659059|560677186|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155339360|NCT02659059|560677185|FG000|Overall Study|Participant withdrew consent|6|||
155339361|NCT02659059|560677186|FG001|Overall Study|Participant withdrew consent|1|||
155339362|NCT00092456|560677187|FG000|Overall Study|Adverse Event|0|||
155339363|NCT00092456|560677188|FG001|Overall Study|Adverse Event|0|||
155339364|NCT00092456|560677189|FG002|Overall Study|Adverse Event|1|||
155339365|NCT00092456|560677190|FG003|Overall Study|Adverse Event|1|||
155339366|NCT00092456|560677187|FG000|Overall Study|Lost to Follow-up|2|||
155339367|NCT00092456|560677188|FG001|Overall Study|Lost to Follow-up|2|||
155339368|NCT00092456|560677189|FG002|Overall Study|Lost to Follow-up|1|||
155339369|NCT00092456|560677190|FG003|Overall Study|Lost to Follow-up|2|||
155339370|NCT00092456|560677187|FG000|Overall Study|Protocol Violation|5|||
155339371|NCT00092456|560677188|FG001|Overall Study|Protocol Violation|7|||
155339372|NCT00092456|560677189|FG002|Overall Study|Protocol Violation|8|||
155339373|NCT00092456|560677190|FG003|Overall Study|Protocol Violation|6|||
155339374|NCT00092456|560677187|FG000|Overall Study|Withdrawal by Subject|13|||
155339375|NCT00092456|560677188|FG001|Overall Study|Withdrawal by Subject|5|||
155339376|NCT00092456|560677189|FG002|Overall Study|Withdrawal by Subject|16|||
155339377|NCT00092456|560677190|FG003|Overall Study|Withdrawal by Subject|6|||
155339378|NCT00092456|560677187|FG000|Overall Study|Moved|1|||
155339379|NCT00092456|560677188|FG001|Overall Study|Moved|1|||
155339380|NCT00092456|560677189|FG002|Overall Study|Moved|0|||
155423247|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155339381|NCT00092456|560677190|FG003|Overall Study|Moved|1|||
155423248|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155339382|NCT00092456|560677187|FG000|Overall Study|Other|4|||
155339383|NCT00092456|560677188|FG001|Overall Study|Other|2|||
155339384|NCT00092456|560677189|FG002|Overall Study|Other|3|||
155339385|NCT00092456|560677190|FG003|Overall Study|Other|0|||
155339386|NCT04783389|560677191|FG000|Overall Study|Withdrawal by Subject|2|||
155339387|NCT04783389|560677192|FG001|Overall Study|Withdrawal by Subject|0|||
155339388|NCT04783389|560677193|FG002|Overall Study|Withdrawal by Subject|0|||
155339389|NCT04783389|560677191|FG000|Overall Study|Termination of Study by Sponsor|10|||
155339390|NCT04783389|560677192|FG001|Overall Study|Termination of Study by Sponsor|12|||
155339391|NCT04783389|560677193|FG002|Overall Study|Termination of Study by Sponsor|14|||
155339392|NCT02121808|560677194|FG000|Overall Study|Technical problem|3|||
155339393|NCT00647699|560677195|FG000|Overall Study|Lost to Follow-up|5|||
155423249|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423250|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423251|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423252|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423253|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423254|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
155423255|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423256|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423257|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
155423258|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423259|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
155423260|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423261|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423262|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423263|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423264|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423265|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423266|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423267|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423268|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423269|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423270|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423271|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423272|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423273|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155504506|NCT04380701|561274032|FG020|Overall Study|Withdrawal by Subject|0|||
155423274|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155645934|NCT02391584|561795609|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
155645935|NCT01441414|561795622|FG000|Overall Study|Participant died|9|||
155645936|NCT01441414|561795622|FG000|Overall Study|Other reasons|3|||
155645937|NCT01441414|561795622|FG000|Overall Study|Study terminated by sponsor|2|||
155645938|NCT01441414|561795622|FG000|Overall Study|Subject refused further follow-up|1|||
155645939|NCT01058005|561795634|FG000|Overall Study|Adverse Event|0|||
155645940|NCT01058005|561795635|FG001|Overall Study|Adverse Event|2|||
155645941|NCT01058005|561795636|FG002|Overall Study|Adverse Event|1|||
155645942|NCT01058005|561795634|FG000|Overall Study|Physician Decision|2|||
155645943|NCT01058005|561795635|FG001|Overall Study|Physician Decision|2|||
155645944|NCT01058005|561795636|FG002|Overall Study|Physician Decision|0|||
155645945|NCT01058005|561795634|FG000|Overall Study|Withdrawal by Subject|4|||
155645946|NCT01058005|561795635|FG001|Overall Study|Withdrawal by Subject|5|||
155645947|NCT01058005|561795636|FG002|Overall Study|Withdrawal by Subject|11|||
155645948|NCT01058005|561795634|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
155645949|NCT01058005|561795635|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
155645950|NCT01058005|561795636|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
155645951|NCT01058005|561795634|FG000|Overall Study|Reason Missing|5|||
155645952|NCT01058005|561795635|FG001|Overall Study|Reason Missing|3|||
155645953|NCT01058005|561795636|FG002|Overall Study|Reason Missing|1|||
155645954|NCT01717859|561795637|FG000|Overall Study|Adverse Event|5|||
155645955|NCT01717859|561795637|FG000|Overall Study|Moved out of state|1|||
155645956|NCT01717859|561795637|FG000|Overall Study|Patient concerned about mental health|1|||
155645957|NCT01717859|561795637|FG000|Overall Study|Lost to Follow-up|1|||
155645958|NCT01717859|561795637|FG000|Overall Study|Withdrawal by Subject|2|||
155645959|NCT02287025|561795639|FG000|Overall Study|Not treated|2|||
155645960|NCT02287025|561795640|FG001|Overall Study|Not treated|0|||
155645961|NCT02287025|561795639|FG000|Overall Study|Progression of disease|3|||
155645962|NCT02287025|561795640|FG001|Overall Study|Progression of disease|2|||
155645963|NCT02287025|561795639|FG000|Overall Study|Adverse Event|2|||
155645964|NCT02287025|561795640|FG001|Overall Study|Adverse Event|4|||
155645965|NCT02287025|561795639|FG000|Overall Study|Withdrawal by Subject|2|||
155645966|NCT02287025|561795640|FG001|Overall Study|Withdrawal by Subject|2|||
155645967|NCT02287025|561795639|FG000|Overall Study|Screening failed|1|||
155645968|NCT02287025|561795640|FG001|Overall Study|Screening failed|1|||
155645969|NCT00899847|561795641|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
155645970|NCT05987540|561795642|FG000|Overall Study|Withdrawal by Subject|2|||
155645971|NCT05987540|561795642|FG000|Overall Study|Death|1|||
155339394|NCT00647699|560677196|FG001|Overall Study|Lost to Follow-up|4|||
155339395|NCT00647699|560677195|FG000|Overall Study|Withdrawal by Subject|3|||
155339396|NCT00647699|560677196|FG001|Overall Study|Withdrawal by Subject|8|||
155339397|NCT04909593|560677197|FG000|Overall Study|Withdrawal by Subject|1|||
155339398|NCT01018992|560677198|FG000|Overall Study|Adverse Event|8|||
155339399|NCT01018992|560677199|FG001|Overall Study|Adverse Event|3|||
155339400|NCT01018992|560677198|FG000|Overall Study|Withdrawal by Subject|3|||
155339401|NCT01018992|560677199|FG001|Overall Study|Withdrawal by Subject|8|||
155339402|NCT01018992|560677198|FG000|Overall Study|Protocol Violation|0|||
155339403|NCT01018992|560677199|FG001|Overall Study|Protocol Violation|4|||
155339404|NCT01018992|560677198|FG000|Overall Study|Lost to Follow-up|5|||
155339405|NCT01018992|560677199|FG001|Overall Study|Lost to Follow-up|1|||
155339406|NCT01241448|560677200|FG000|Overall Study|Adverse Event|1|||
155339407|NCT01241448|560677201|FG001|Overall Study|Adverse Event|0|||
155645972|NCT05987540|561795642|FG000|Overall Study|Study Termination|1|||
155645973|NCT05987540|561795642|FG000|Overall Study|Adverse Event|2|||
155339408|NCT01241448|560677202|FG002|Overall Study|Adverse Event|2|||
155339409|NCT01241448|560677203|FG003|Overall Study|Adverse Event|2|||
155339410|NCT01241448|560677200|FG000|Overall Study|Lost to Follow-up|2|||
155339411|NCT01241448|560677201|FG001|Overall Study|Lost to Follow-up|1|||
155339412|NCT01241448|560677202|FG002|Overall Study|Lost to Follow-up|1|||
155645974|NCT01421134|561795643|FG000|Overall Study|Adverse Event|3|||
155645975|NCT01421134|561795644|FG001|Overall Study|Adverse Event|5|||
155645976|NCT01421134|561795643|FG000|Overall Study|Lack of Efficacy|2|||
155645977|NCT01421134|561795644|FG001|Overall Study|Lack of Efficacy|4|||
155645978|NCT01421134|561795643|FG000|Overall Study|Protocol Violation|0|||
155645979|NCT01421134|561795644|FG001|Overall Study|Protocol Violation|3|||
155645980|NCT01421134|561795643|FG000|Overall Study|Withdrawal by Subject|1|||
155645981|NCT01421134|561795644|FG001|Overall Study|Withdrawal by Subject|1|||
155645982|NCT01421134|561795643|FG000|Overall Study|Administrative|0|||
155645983|NCT01421134|561795644|FG001|Overall Study|Administrative|1|||
155339413|NCT01241448|560677203|FG003|Overall Study|Lost to Follow-up|1|||
155339414|NCT01241448|560677200|FG000|Overall Study|Physician Decision|0|||
155339415|NCT01241448|560677201|FG001|Overall Study|Physician Decision|2|||
155339416|NCT01241448|560677202|FG002|Overall Study|Physician Decision|0|||
155339417|NCT01241448|560677203|FG003|Overall Study|Physician Decision|0|||
155339418|NCT01241448|560677200|FG000|Overall Study|Protocol Violation|10|||
155339419|NCT01241448|560677201|FG001|Overall Study|Protocol Violation|5|||
155339420|NCT01241448|560677202|FG002|Overall Study|Protocol Violation|3|||
155339421|NCT01241448|560677203|FG003|Overall Study|Protocol Violation|6|||
155339422|NCT01241448|560677200|FG000|Overall Study|Sponsor Decision|17|||
155339423|NCT01241448|560677201|FG001|Overall Study|Sponsor Decision|14|||
155339424|NCT01241448|560677202|FG002|Overall Study|Sponsor Decision|12|||
155339425|NCT01241448|560677203|FG003|Overall Study|Sponsor Decision|6|||
155339426|NCT01241448|560677200|FG000|Overall Study|Withdrawal by Subject|4|||
155339427|NCT01241448|560677201|FG001|Overall Study|Withdrawal by Subject|5|||
155339428|NCT01241448|560677202|FG002|Overall Study|Withdrawal by Subject|3|||
155339429|NCT01241448|560677203|FG003|Overall Study|Withdrawal by Subject|6|||
155339430|NCT01241448|560677200|FG000|Overall Study|Excluded due to data integrity issues|3|||
155339431|NCT01241448|560677201|FG001|Overall Study|Excluded due to data integrity issues|2|||
155339432|NCT01241448|560677202|FG002|Overall Study|Excluded due to data integrity issues|2|||
155339433|NCT01241448|560677203|FG003|Overall Study|Excluded due to data integrity issues|2|||
155339434|NCT04425252|560677204|FG000|Overall Study|Withdrawal by Subject|2|||
155339435|NCT04425252|560677205|FG001|Overall Study|Withdrawal by Subject|1|||
155339436|NCT04425252|560677204|FG000|Overall Study|Lost to Follow-up|1|||
155339437|NCT04425252|560677205|FG001|Overall Study|Lost to Follow-up|0|||
155339438|NCT04425252|560677204|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
155339439|NCT04425252|560677205|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
155339440|NCT00307489|560677206|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
155339441|NCT00307489|560677207|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
155339442|NCT00307489|560677206|FG000|Baseline Through Week 48|Physician Decision|1|||
155339443|NCT00307489|560677207|FG001|Baseline Through Week 48|Physician Decision|0|||
155339444|NCT00307489|560677206|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
155339445|NCT00307489|560677207|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
155339446|NCT00307489|560677206|FG000|Week 48 Through Week 168|Adverse Event|1|||
155339447|NCT00307489|560677207|FG001|Week 48 Through Week 168|Adverse Event|0|||
155339448|NCT00307489|560677206|FG000|Week 48 Through Week 168|Physician Decision|1|||
155339449|NCT00307489|560677207|FG001|Week 48 Through Week 168|Physician Decision|0|||
155339450|NCT00307489|560677206|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
155339451|NCT00307489|560677207|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
155339452|NCT00307489|560677206|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
155339453|NCT00307489|560677207|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
155339454|NCT00307489|560677206|FG000|Week 48 Through Week 168|Death|0|||
155339455|NCT00307489|560677207|FG001|Week 48 Through Week 168|Death|1|||
155339456|NCT00307489|560677206|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
155339457|NCT00307489|560677207|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
155339458|NCT00307489|560677206|FG000|Week 48 Through Week 168|Seroconversion|1|||
155339459|NCT00307489|560677207|FG001|Week 48 Through Week 168|Seroconversion|0|||
155339460|NCT01825785|560677208|FG000|Overall Study|Adverse Event|0|||
155339461|NCT01825785|560677209|FG001|Overall Study|Adverse Event|0|||
155339462|NCT01825785|560677210|FG002|Overall Study|Adverse Event|0|||
155339463|NCT01825785|560677211|FG003|Overall Study|Adverse Event|0|||
155339464|NCT01825785|560677212|FG004|Overall Study|Adverse Event|1|||
155339465|NCT01825785|560677213|FG005|Overall Study|Adverse Event|0|||
155339466|NCT01825785|560677214|FG006|Overall Study|Adverse Event|0|||
155339467|NCT01825785|560677208|FG000|Overall Study|Withdrawal by Subject|0|||
155339468|NCT01825785|560677209|FG001|Overall Study|Withdrawal by Subject|0|||
155339469|NCT01825785|560677210|FG002|Overall Study|Withdrawal by Subject|0|||
155339470|NCT01825785|560677211|FG003|Overall Study|Withdrawal by Subject|0|||
155339471|NCT01825785|560677212|FG004|Overall Study|Withdrawal by Subject|1|||
155339472|NCT01825785|560677213|FG005|Overall Study|Withdrawal by Subject|1|||
155339473|NCT01825785|560677214|FG006|Overall Study|Withdrawal by Subject|0|||
155339474|NCT00304278|560677217|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
155339475|NCT00304278|560677217|FG000|Overall Study|PT had medical condition preventing TX|1|||
155339476|NCT02065895|560677218|FG000|Overall Study|Protocol Violation|1|||
155339477|NCT02065895|560677219|FG001|Overall Study|Protocol Violation|0|||
155339478|NCT02065895|560677220|FG002|Overall Study|Protocol Violation|0|||
155339479|NCT02065895|560677221|FG003|Overall Study|Protocol Violation|1|||
155339480|NCT02065895|560677222|FG004|Overall Study|Protocol Violation|0|||
155339481|NCT02065895|560677223|FG005|Overall Study|Protocol Violation|0|||
155339482|NCT02065895|560677218|FG000|Overall Study|Scheduling conflicts|0|||
155339483|NCT02065895|560677219|FG001|Overall Study|Scheduling conflicts|1|||
155339484|NCT02065895|560677220|FG002|Overall Study|Scheduling conflicts|0|||
155339485|NCT02065895|560677221|FG003|Overall Study|Scheduling conflicts|0|||
155339486|NCT02065895|560677222|FG004|Overall Study|Scheduling conflicts|0|||
155339487|NCT02065895|560677223|FG005|Overall Study|Scheduling conflicts|0|||
155339488|NCT01381549|560677229|FG000|Overall Study|Ineligible: No organisms isolated|0|||
155339489|NCT01381549|560677230|FG001|Overall Study|Ineligible: No organisms isolated|0|||
155339490|NCT01381549|560677231|FG002|Overall Study|Ineligible: No organisms isolated|1|||
155339491|NCT02981953|560677232|FG000|Overall Study|Death|9|||
155339492|NCT02981953|560677232|FG000|Overall Study|Withdrawal by Subject|1|||
155339493|NCT02981953|560677232|FG000|Overall Study|Withdrawal to non-compliance|1|||
155339494|NCT01655498|560677241|FG000|Overall Study|Unrelated health issue|2|||
155423275|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423276|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423277|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
155423278|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
155423279|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423280|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423281|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
155423282|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155339495|NCT01655498|560677241|FG000|Overall Study|Protocol Violation|2|||
155339496|NCT01655498|560677241|FG000|Overall Study|Withdrawal by Subject|1|||
155339497|NCT00603798|560677242|FG000|Overall Study|Adverse Event|4|||
155339498|NCT00603798|560677243|FG001|Overall Study|Adverse Event|2|||
155339499|NCT00603798|560677244|FG002|Overall Study|Adverse Event|1|||
155339500|NCT00603798|560677242|FG000|Overall Study|Withdrawal by Subject|4|||
155339501|NCT00603798|560677243|FG001|Overall Study|Withdrawal by Subject|3|||
155339502|NCT00603798|560677244|FG002|Overall Study|Withdrawal by Subject|4|||
155339503|NCT00603798|560677242|FG000|Overall Study|Lost to Follow-up|1|||
155339504|NCT00603798|560677243|FG001|Overall Study|Lost to Follow-up|0|||
155339505|NCT00603798|560677244|FG002|Overall Study|Lost to Follow-up|1|||
155339506|NCT00603798|560677242|FG000|Overall Study|Non-compliance with study procedures|0|||
155339507|NCT00603798|560677243|FG001|Overall Study|Non-compliance with study procedures|1|||
155339508|NCT00603798|560677244|FG002|Overall Study|Non-compliance with study procedures|0|||
155339509|NCT00603798|560677242|FG000|Overall Study|Not due to AE|1|||
155339510|NCT00603798|560677243|FG001|Overall Study|Not due to AE|1|||
155339511|NCT00603798|560677244|FG002|Overall Study|Not due to AE|4|||
155339512|NCT00988429|560677247|FG000|Overall Study|Adverse Event|9|||
155339513|NCT00988429|560677248|FG001|Overall Study|Adverse Event|21|||
155339514|NCT00988429|560677249|FG002|Overall Study|Adverse Event|45|||
155339515|NCT00988429|560677247|FG000|Overall Study|Lack of Efficacy|0|||
155339516|NCT00988429|560677248|FG001|Overall Study|Lack of Efficacy|0|||
155339517|NCT00988429|560677249|FG002|Overall Study|Lack of Efficacy|1|||
155339518|NCT00988429|560677247|FG000|Overall Study|Non-Compliance with Study Drug|5|||
155339519|NCT00988429|560677248|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155339520|NCT00988429|560677249|FG002|Overall Study|Non-Compliance with Study Drug|3|||
155339521|NCT00988429|560677247|FG000|Overall Study|Physician Decision|1|||
155339522|NCT00988429|560677248|FG001|Overall Study|Physician Decision|0|||
155339523|NCT00988429|560677249|FG002|Overall Study|Physician Decision|3|||
155339524|NCT00988429|560677247|FG000|Overall Study|Pregnancy|2|||
155339525|NCT00988429|560677248|FG001|Overall Study|Pregnancy|1|||
155339526|NCT00988429|560677249|FG002|Overall Study|Pregnancy|0|||
155339527|NCT00988429|560677247|FG000|Overall Study|Protocol Violation|4|||
155339528|NCT00988429|560677248|FG001|Overall Study|Protocol Violation|3|||
155339529|NCT00988429|560677249|FG002|Overall Study|Protocol Violation|3|||
155339530|NCT00988429|560677247|FG000|Overall Study|Withdrawal by Subject|7|||
155339531|NCT00988429|560677248|FG001|Overall Study|Withdrawal by Subject|7|||
155339532|NCT00988429|560677249|FG002|Overall Study|Withdrawal by Subject|12|||
155339533|NCT00988429|560677247|FG000|Overall Study|Administrative Reasons|1|||
155339534|NCT00988429|560677248|FG001|Overall Study|Administrative Reasons|2|||
155339535|NCT00988429|560677249|FG002|Overall Study|Administrative Reasons|1|||
155339536|NCT00988429|560677247|FG000|Overall Study|other reasons|8|||
155339537|NCT00988429|560677248|FG001|Overall Study|other reasons|8|||
155339538|NCT00988429|560677249|FG002|Overall Study|other reasons|1|||
155339539|NCT02964234|560677250|FG000|Overall Study|Lost to Follow-up|22|||
155339540|NCT02964234|560677251|FG001|Overall Study|Lost to Follow-up|13|||
155339541|NCT01799993|560677252|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
155339542|NCT01799993|560677253|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
155339543|NCT01799993|560677252|FG000|Overall Study|Death|61|||
155339544|NCT01799993|560677253|FG001|Overall Study|Death|45|||
155339545|NCT01799993|560677252|FG000|Overall Study|Withdrawal by Subject|23|||
155339546|NCT01799993|560677253|FG001|Overall Study|Withdrawal by Subject|24|||
155339547|NCT01799993|560677252|FG000|Overall Study|Lost to Follow-up|5|||
155339548|NCT01799993|560677253|FG001|Overall Study|Lost to Follow-up|8|||
155339549|NCT01799993|560677252|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
155339550|NCT01799993|560677253|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
155339551|NCT01799993|560677252|FG000|Overall Study|Protocol driven decision point|0|||
155339552|NCT01799993|560677253|FG001|Overall Study|Protocol driven decision point|3|||
155339553|NCT01799993|560677252|FG000|Overall Study|Protocol Violation|1|||
155339554|NCT01799993|560677253|FG001|Overall Study|Protocol Violation|1|||
155339555|NCT01799993|560677252|FG000|Overall Study|Deterioration of general conditions|2|||
155339556|NCT01799993|560677253|FG001|Overall Study|Deterioration of general conditions|0|||
155339557|NCT01799993|560677252|FG000|Overall Study|Screen failure|0|||
155339558|NCT01799993|560677253|FG001|Overall Study|Screen failure|1|||
155339559|NCT01799993|560677252|FG000|Overall Study|Adverse Event|1|||
155339560|NCT01799993|560677253|FG001|Overall Study|Adverse Event|0|||
155339561|NCT01799993|560677252|FG000|Overall Study|Lack of Efficacy|1|||
155339562|NCT01799993|560677253|FG001|Overall Study|Lack of Efficacy|0|||
155339563|NCT01799993|560677252|FG000|Overall Study|Recovery|0|||
155339564|NCT01799993|560677253|FG001|Overall Study|Recovery|1|||
155339565|NCT01799993|560677252|FG000|Overall Study|Logistical difficulties|1|||
155339566|NCT01799993|560677253|FG001|Overall Study|Logistical difficulties|0|||
155339567|NCT01799993|560677252|FG000|Overall Study|Protocol deviation|1|||
155339568|NCT01799993|560677253|FG001|Overall Study|Protocol deviation|0|||
155339569|NCT01799993|560677252|FG000|Overall Study|Non-compliance with medical device|1|||
155339570|NCT01799993|560677253|FG001|Overall Study|Non-compliance with medical device|0|||
155339571|NCT01799993|560677252|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155339572|NCT01799993|560677253|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155339573|NCT01799993|560677252|FG000|Overall Study|Other|1|||
155339574|NCT01799993|560677253|FG001|Overall Study|Other|0|||
155339575|NCT01799993|560677252|FG000|Overall Study|Subject didn't return for follow-up|0|||
155339576|NCT01799993|560677253|FG001|Overall Study|Subject didn't return for follow-up|1|||
155339577|NCT04361617|560677254|FG000|Overall Study|Withdrawal by Subject|0|||
155339578|NCT04361617|560677255|FG001|Overall Study|Withdrawal by Subject|1|||
155339579|NCT00687297|560677261|FG000|Randomization|Withdrawal by Subject|2|||
155339580|NCT00687297|560677262|FG001|Randomization|Withdrawal by Subject|0|||
155339581|NCT00687297|560677261|FG000|Randomization|Withdrew before treatment, ineligible|1|||
155339582|NCT00687297|560677262|FG001|Randomization|Withdrew before treatment, ineligible|1|||
155339583|NCT00687297|560677261|FG000|Induction|Withdrawal by Subject|4|||
155339584|NCT00687297|560677262|FG001|Induction|Withdrawal by Subject|4|||
155339585|NCT00687297|560677261|FG000|Induction|Adverse Event|16|||
155339586|NCT00687297|560677262|FG001|Induction|Adverse Event|15|||
155339587|NCT00687297|560677261|FG000|Induction|Death|7|||
155339588|NCT00687297|560677262|FG001|Induction|Death|11|||
155339589|NCT00687297|560677261|FG000|Induction|Lack of Efficacy|17|||
155339590|NCT00687297|560677262|FG001|Induction|Lack of Efficacy|21|||
155423283|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423284|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423285|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423286|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423287|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423288|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423289|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423290|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423291|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423292|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423293|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423294|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423295|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423296|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423297|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423298|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423299|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155423300|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
155504507|NCT04380701|561274033|FG021|Overall Study|Withdrawal by Subject|0|||
155504508|NCT04380701|561274034|FG022|Overall Study|Withdrawal by Subject|2|||
155339591|NCT00687297|560677261|FG000|Induction|Ineligible|0|||
155339592|NCT00687297|560677262|FG001|Induction|Ineligible|1|||
155339593|NCT00687297|560677261|FG000|Induction|Patient Noncompliance|1|||
155339594|NCT00687297|560677262|FG001|Induction|Patient Noncompliance|0|||
155339595|NCT00687297|560677261|FG000|Induction|Physician Decision|0|||
155339596|NCT00687297|560677262|FG001|Induction|Physician Decision|2|||
155339597|NCT00687297|560677261|FG000|Induction|Other|0|||
155339598|NCT00687297|560677262|FG001|Induction|Other|1|||
155339599|NCT04617847|560677267|FG000|Overall Study|Withdrawal by Subject|1|||
155504509|NCT04380701|561274035|FG023|Overall Study|Withdrawal by Subject|2|||
155504510|NCT04380701|561274036|FG024|Overall Study|Withdrawal by Subject|1|||
155339600|NCT04617847|560677268|FG001|Overall Study|Withdrawal by Subject|0|||
155339601|NCT04617847|560677267|FG000|Overall Study|Adverse Event|0|||
155339602|NCT04617847|560677268|FG001|Overall Study|Adverse Event|2|||
155339603|NCT04617847|560677267|FG000|Overall Study|Death|0|||
155339604|NCT04617847|560677268|FG001|Overall Study|Death|1|||
155339605|NCT04617847|560677267|FG000|Overall Study|Termination of Study by Sponsor|2|||
155339606|NCT04617847|560677268|FG001|Overall Study|Termination of Study by Sponsor|21|||
155339607|NCT00700999|560677269|FG000|Overall Study|Lost to Follow-up|7|||
155339608|NCT00700999|560677270|FG001|Overall Study|Lost to Follow-up|7|||
155339609|NCT00700999|560677269|FG000|Overall Study|Excluded - did not meet study criteria|0|||
155339610|NCT00700999|560677270|FG001|Overall Study|Excluded - did not meet study criteria|1|||
155339611|NCT00700999|560677269|FG000|Overall Study|Withdrawal by Subject|8|||
155339612|NCT00700999|560677270|FG001|Overall Study|Withdrawal by Subject|1|||
155339613|NCT00244751|560677271|FG000|Overall Study|Adverse Event|7|||
155339614|NCT00244751|560677272|FG001|Overall Study|Adverse Event|7|||
155339615|NCT00244751|560677273|FG002|Overall Study|Adverse Event|5|||
155339616|NCT00244751|560677271|FG000|Overall Study|Lost to Follow-up|0|||
155339617|NCT00244751|560677272|FG001|Overall Study|Lost to Follow-up|1|||
155339618|NCT00244751|560677273|FG002|Overall Study|Lost to Follow-up|0|||
155339619|NCT00244751|560677271|FG000|Overall Study|Protocol Violation|1|||
155339620|NCT00244751|560677272|FG001|Overall Study|Protocol Violation|0|||
155339621|NCT00244751|560677273|FG002|Overall Study|Protocol Violation|1|||
155339622|NCT00244751|560677271|FG000|Overall Study|Withdrawal by Subject|7|||
155339623|NCT00244751|560677272|FG001|Overall Study|Withdrawal by Subject|5|||
155339624|NCT00244751|560677273|FG002|Overall Study|Withdrawal by Subject|3|||
155339625|NCT00244751|560677271|FG000|Overall Study|Elevated liver enzymes|1|||
155339626|NCT00244751|560677272|FG001|Overall Study|Elevated liver enzymes|0|||
155339627|NCT00244751|560677273|FG002|Overall Study|Elevated liver enzymes|0|||
155339628|NCT00244751|560677271|FG000|Overall Study|Lack of compliance with protocol|0|||
155339629|NCT00244751|560677272|FG001|Overall Study|Lack of compliance with protocol|1|||
155339630|NCT00244751|560677273|FG002|Overall Study|Lack of compliance with protocol|0|||
155339631|NCT00244751|560677271|FG000|Overall Study|Safety reasons|0|||
155339632|NCT00244751|560677272|FG001|Overall Study|Safety reasons|1|||
155339633|NCT00244751|560677273|FG002|Overall Study|Safety reasons|0|||
155339634|NCT00244751|560677271|FG000|Overall Study|Participant randomized by mistake|0|||
155339635|NCT00244751|560677272|FG001|Overall Study|Participant randomized by mistake|0|||
155339636|NCT00244751|560677273|FG002|Overall Study|Participant randomized by mistake|1|||
155339637|NCT03031782|560677276|FG000|Treatment Period 1|Lack of Efficacy|3|||
155339638|NCT03031782|560677277|FG001|Treatment Period 1|Lack of Efficacy|0|||
155339639|NCT03031782|560677278|FG002|Treatment Period 1|Lack of Efficacy|0|||
155339640|NCT03031782|560677279|FG003|Treatment Period 1|Lack of Efficacy|0|||
155339641|NCT03031782|560677280|FG004|Treatment Period 1|Lack of Efficacy|0|||
155339642|NCT03031782|560677276|FG000|Treatment Period 2|Physician Decision|0|||
155339643|NCT03031782|560677277|FG001|Treatment Period 2|Physician Decision|1|||
155339644|NCT03031782|560677278|FG002|Treatment Period 2|Physician Decision|0|||
155339645|NCT03031782|560677279|FG003|Treatment Period 2|Physician Decision|0|||
155339646|NCT03031782|560677280|FG004|Treatment Period 2|Physician Decision|3|||
155339647|NCT03031782|560677276|FG000|Treatment Period 2|Lack of Efficacy|0|||
155339648|NCT03031782|560677277|FG001|Treatment Period 2|Lack of Efficacy|1|||
155339649|NCT03031782|560677278|FG002|Treatment Period 2|Lack of Efficacy|0|||
155339650|NCT03031782|560677279|FG003|Treatment Period 2|Lack of Efficacy|0|||
155339651|NCT03031782|560677280|FG004|Treatment Period 2|Lack of Efficacy|1|||
155339652|NCT03031782|560677276|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155339653|NCT03031782|560677277|FG001|Treatment Period 2|Withdrawal by Subject|3|||
155339654|NCT03031782|560677278|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155339655|NCT03031782|560677279|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155339656|NCT03031782|560677280|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155339657|NCT03031782|560677276|FG000|Treatment Period 2|Adverse Event|0|||
155339658|NCT03031782|560677277|FG001|Treatment Period 2|Adverse Event|1|||
155339659|NCT03031782|560677278|FG002|Treatment Period 2|Adverse Event|2|||
155339660|NCT03031782|560677279|FG003|Treatment Period 2|Adverse Event|0|||
155339661|NCT03031782|560677280|FG004|Treatment Period 2|Adverse Event|0|||
155339662|NCT03031782|560677276|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155339663|NCT03031782|560677277|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155339664|NCT03031782|560677278|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155339665|NCT03031782|560677279|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155339666|NCT03031782|560677280|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155339667|NCT02699099|560677281|FG000|Overall Study|Adverse Event|1|||
155339668|NCT02699099|560677282|FG001|Overall Study|Adverse Event|0|||
155339669|NCT02699099|560677283|FG002|Overall Study|Adverse Event|2|||
155339670|NCT02699099|560677281|FG000|Overall Study|Lost to Follow-up|0|||
155339671|NCT02699099|560677282|FG001|Overall Study|Lost to Follow-up|1|||
155504511|NCT04380701|561274037|FG025|Overall Study|Withdrawal by Subject|1|||
155504512|NCT04380701|561274038|FG026|Overall Study|Withdrawal by Subject|0|||
155423301|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423302|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423303|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
155423304|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423305|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423306|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423307|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423308|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423309|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423310|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423311|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423312|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155645984|NCT01421134|561795643|FG000|Overall Study|Lost to Follow-up|1|||
155645985|NCT01421134|561795644|FG001|Overall Study|Lost to Follow-up|1|||
155645986|NCT02959892|561795645|FG000|Overall Study|PET tracer synthesis failure|1|||
155645987|NCT02959892|561795646|FG001|Overall Study|PET tracer synthesis failure|0|||
155645988|NCT02959892|561795645|FG000|Overall Study|Study termination|0|||
155645989|NCT02959892|561795646|FG001|Overall Study|Study termination|1|||
155645990|NCT04433975|561795647|FG000|1-month Follow Up|Withdrawal by Subject|1|||
155645991|NCT04433975|561795648|FG001|1-month Follow Up|Withdrawal by Subject|1|||
155645992|NCT04433975|561795647|FG000|1-month Follow Up|Lost to Follow-up|21|||
155645993|NCT04433975|561795648|FG001|1-month Follow Up|Lost to Follow-up|25|||
155645994|NCT04433975|561795647|FG000|3-month Follow Up|Lost to Follow-up|20|||
155645995|NCT04433975|561795648|FG001|3-month Follow Up|Lost to Follow-up|24|||
155645996|NCT04433975|561795647|FG000|3-month Follow Up|Death|1|||
155645997|NCT04433975|561795648|FG001|3-month Follow Up|Death|0|||
155645998|NCT04433975|561795647|FG000|3-month Follow Up|Withdrawal by Subject|2|||
155645999|NCT04433975|561795648|FG001|3-month Follow Up|Withdrawal by Subject|0|||
155646000|NCT04433975|561795647|FG000|6-month Follow Up|Lost to Follow-up|23|||
155646001|NCT04433975|561795648|FG001|6-month Follow Up|Lost to Follow-up|28|||
155646002|NCT04433975|561795647|FG000|6-month Follow Up|Withdrawal by Subject|1|||
155646003|NCT04433975|561795648|FG001|6-month Follow Up|Withdrawal by Subject|1|||
155646004|NCT04433975|561795647|FG000|9-month Follow Up|Lost to Follow-up|27|||
155646005|NCT04433975|561795648|FG001|9-month Follow Up|Lost to Follow-up|36|||
155646006|NCT04433975|561795647|FG000|9-month Follow Up|Death|0|||
155646007|NCT04433975|561795648|FG001|9-month Follow Up|Death|1|||
155646008|NCT04433975|561795647|FG000|12-month Follow Up|Lost to Follow-up|27|||
155339672|NCT02699099|560677283|FG002|Overall Study|Lost to Follow-up|0|||
155339673|NCT02699099|560677281|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
155339674|NCT02699099|560677282|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155339675|NCT02699099|560677283|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
155339676|NCT01240590|560677286|FG000|Phase I|Refused further treatment|0|||
155339677|NCT01240590|560677287|FG001|Phase I|Refused further treatment|0|||
155339678|NCT01240590|560677288|FG002|Phase I|Refused further treatment|3|||
155339679|NCT01240590|560677289|FG003|Phase I|Refused further treatment|0|||
155339680|NCT01240590|560677290|FG004|Phase I|Refused further treatment|0|||
155339681|NCT01240590|560677286|FG000|Phase II|Refused further treatment|0|||
155339682|NCT01240590|560677287|FG001|Phase II|Refused further treatment|0|||
155339683|NCT01240590|560677288|FG002|Phase II|Refused further treatment|0|||
155339684|NCT01240590|560677289|FG003|Phase II|Refused further treatment|2|||
155339685|NCT01240590|560677290|FG004|Phase II|Refused further treatment|1|||
155339686|NCT05184062|560677295|FG000|Overall Study|Lost to Follow-up|5|||
155339687|NCT05184062|560677296|FG001|Overall Study|Lost to Follow-up|1|||
155339688|NCT05184062|560677295|FG000|Overall Study|Withdrawal by Subject|1|||
155339689|NCT05184062|560677296|FG001|Overall Study|Withdrawal by Subject|0|||
155339690|NCT04620733|560678930|FG000|Overall Study|Adverse Event|4|||
155339691|NCT04620733|560678931|FG001|Overall Study|Adverse Event|3|||
155339692|NCT04620733|560678930|FG000|Overall Study|Withdrawal by Subject|2|||
155339693|NCT04620733|560678931|FG001|Overall Study|Withdrawal by Subject|5|||
155339694|NCT04620733|560678930|FG000|Overall Study|Lost to Follow-up|1|||
155339695|NCT04620733|560678931|FG001|Overall Study|Lost to Follow-up|1|||
155339696|NCT04620733|560678930|FG000|Overall Study|Protocol Deviation|1|||
155339697|NCT04620733|560678931|FG001|Overall Study|Protocol Deviation|1|||
155339698|NCT04620733|560678930|FG000|Overall Study|Reason Not Specified|0|||
155339699|NCT04620733|560678931|FG001|Overall Study|Reason Not Specified|1|||
155339700|NCT03976102|560678932|FG000|Overall Study|Withdrawal by Subject|4|||
155339701|NCT03976102|560678933|FG001|Overall Study|Withdrawal by Subject|4|||
155339702|NCT03976102|560678932|FG000|Overall Study|Adverse Event|2|||
155339703|NCT03976102|560678933|FG001|Overall Study|Adverse Event|4|||
155339704|NCT03976102|560678932|FG000|Overall Study|Not related to Covid-19|9|||
155339705|NCT03976102|560678933|FG001|Overall Study|Not related to Covid-19|13|||
155339706|NCT03976102|560678932|FG000|Overall Study|Lost to Follow-up|0|||
155339707|NCT03976102|560678933|FG001|Overall Study|Lost to Follow-up|2|||
155339708|NCT03976102|560678932|FG000|Overall Study|Death|3|||
155339709|NCT03976102|560678933|FG001|Overall Study|Death|2|||
155339710|NCT03976102|560678932|FG000|Overall Study|Physician Decision|1|||
155339711|NCT03976102|560678933|FG001|Overall Study|Physician Decision|1|||
155339712|NCT02164578|560678945|FG000|Treatment Period|Withdrawal by Subject|3|||
155339713|NCT02164578|560678946|FG001|Treatment Period|Withdrawal by Subject|3|||
155339714|NCT02164578|560678945|FG000|Treatment Period|Adverse Event|13|||
155339715|NCT02164578|560678946|FG001|Treatment Period|Adverse Event|6|||
155339716|NCT02164578|560678945|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
155339717|NCT02164578|560678946|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
155339718|NCT02164578|560678945|FG000|Treatment Period|Protocol Violation|0|||
155339719|NCT02164578|560678946|FG001|Treatment Period|Protocol Violation|2|||
155339720|NCT02164578|560678945|FG000|Extension Period|Withdrawal by Subject|2|||
155339721|NCT02164578|560678946|FG001|Extension Period|Withdrawal by Subject|0|||
155339722|NCT02164578|560678945|FG000|Extension Period|Adverse Event|4|||
155339723|NCT02164578|560678946|FG001|Extension Period|Adverse Event|0|||
155339724|NCT02164578|560678945|FG000|Extension Period|Expiry of study medication|1|||
155339725|NCT02164578|560678946|FG001|Extension Period|Expiry of study medication|0|||
155339726|NCT02164578|560678945|FG000|Extension Period|Protocol Violation|0|||
155339727|NCT02164578|560678946|FG001|Extension Period|Protocol Violation|1|||
155339728|NCT03924193|560678952|FG000|Overall Study|Adverse Event|10|||
155339729|NCT03924193|560678953|FG001|Overall Study|Adverse Event|0|||
155339730|NCT03924193|560678954|FG002|Overall Study|Adverse Event|10|||
155339731|NCT03924193|560678952|FG000|Overall Study|Withdrawal by Subject|5|||
155339732|NCT03924193|560678953|FG001|Overall Study|Withdrawal by Subject|10|||
155339733|NCT03924193|560678954|FG002|Overall Study|Withdrawal by Subject|2|||
155339734|NCT01562275|560678955|FG000|Stage 1|Adverse Event|0|||
155339735|NCT01562275|560678956|FG001|Stage 1|Adverse Event|0|||
155339736|NCT01562275|560678957|FG002|Stage 1|Adverse Event|0|||
155339737|NCT01562275|560678958|FG003|Stage 1|Adverse Event|1|||
155339738|NCT01562275|560678959|FG004|Stage 1|Adverse Event|1|||
155339739|NCT01562275|560678960|FG005|Stage 1|Adverse Event|0|||
155339740|NCT01562275|560678961|FG006|Stage 1|Adverse Event|0|||
155339741|NCT01562275|560678962|FG007|Stage 1|Adverse Event|0|||
155339742|NCT01562275|560678963|FG008|Stage 1|Adverse Event|0|||
155339743|NCT01562275|560678964|FG009|Stage 1|Adverse Event|1|||
155339744|NCT01562275|560678965|FG010|Stage 1|Adverse Event|0|||
155339745|NCT01562275|560678966|FG011|Stage 1|Adverse Event|0|||
155339746|NCT01562275|560678967|FG012|Stage 1|Adverse Event|0|||
155339747|NCT01562275|560678955|FG000|Stage 1|Death|1|||
155339748|NCT01562275|560678956|FG001|Stage 1|Death|0|||
155646009|NCT04433975|561795648|FG001|12-month Follow Up|Lost to Follow-up|31|||
155646010|NCT04392635|561795653|FG000|Overall Study|Lost to Follow-up|0|||
155339749|NCT01562275|560678957|FG002|Stage 1|Death|0|||
155339750|NCT01562275|560678958|FG003|Stage 1|Death|0|||
155339751|NCT01562275|560678959|FG004|Stage 1|Death|0|||
155339752|NCT01562275|560678960|FG005|Stage 1|Death|0|||
155339753|NCT01562275|560678961|FG006|Stage 1|Death|0|||
155339754|NCT01562275|560678962|FG007|Stage 1|Death|0|||
155339755|NCT01562275|560678963|FG008|Stage 1|Death|0|||
155339756|NCT01562275|560678964|FG009|Stage 1|Death|0|||
155339757|NCT01562275|560678965|FG010|Stage 1|Death|0|||
155339758|NCT01562275|560678966|FG011|Stage 1|Death|0|||
155339759|NCT01562275|560678967|FG012|Stage 1|Death|0|||
155339760|NCT01562275|560678955|FG000|Stage 1|Non Compliance|0|||
155339761|NCT01562275|560678956|FG001|Stage 1|Non Compliance|0|||
155339762|NCT01562275|560678957|FG002|Stage 1|Non Compliance|1|||
155339763|NCT01562275|560678958|FG003|Stage 1|Non Compliance|0|||
155339764|NCT01562275|560678959|FG004|Stage 1|Non Compliance|0|||
155339765|NCT01562275|560678960|FG005|Stage 1|Non Compliance|0|||
155339766|NCT01562275|560678961|FG006|Stage 1|Non Compliance|0|||
155339767|NCT01562275|560678962|FG007|Stage 1|Non Compliance|0|||
155339768|NCT01562275|560678963|FG008|Stage 1|Non Compliance|0|||
155339769|NCT01562275|560678964|FG009|Stage 1|Non Compliance|0|||
155339770|NCT01562275|560678965|FG010|Stage 1|Non Compliance|0|||
155339771|NCT01562275|560678966|FG011|Stage 1|Non Compliance|0|||
155339772|NCT01562275|560678967|FG012|Stage 1|Non Compliance|0|||
155339773|NCT01562275|560678955|FG000|Stage 1|Physician Decision|0|||
155339774|NCT01562275|560678956|FG001|Stage 1|Physician Decision|0|||
155339775|NCT01562275|560678957|FG002|Stage 1|Physician Decision|0|||
155339776|NCT01562275|560678958|FG003|Stage 1|Physician Decision|0|||
155339777|NCT01562275|560678959|FG004|Stage 1|Physician Decision|1|||
155339778|NCT01562275|560678960|FG005|Stage 1|Physician Decision|0|||
155339779|NCT01562275|560678961|FG006|Stage 1|Physician Decision|1|||
155339780|NCT01562275|560678962|FG007|Stage 1|Physician Decision|0|||
155339781|NCT01562275|560678963|FG008|Stage 1|Physician Decision|1|||
155339782|NCT01562275|560678964|FG009|Stage 1|Physician Decision|0|||
155339783|NCT01562275|560678965|FG010|Stage 1|Physician Decision|0|||
155504513|NCT04380701|561274039|FG027|Overall Study|Withdrawal by Subject|0|||
155339784|NCT01562275|560678966|FG011|Stage 1|Physician Decision|0|||
155339785|NCT01562275|560678967|FG012|Stage 1|Physician Decision|0|||
155339786|NCT01562275|560678955|FG000|Stage 1|Progression of Disease|2|||
155339787|NCT01562275|560678956|FG001|Stage 1|Progression of Disease|6|||
155339788|NCT01562275|560678957|FG002|Stage 1|Progression of Disease|2|||
155339789|NCT01562275|560678958|FG003|Stage 1|Progression of Disease|1|||
155339790|NCT01562275|560678959|FG004|Stage 1|Progression of Disease|2|||
155339791|NCT01562275|560678960|FG005|Stage 1|Progression of Disease|4|||
155339792|NCT01562275|560678961|FG006|Stage 1|Progression of Disease|1|||
155339793|NCT01562275|560678962|FG007|Stage 1|Progression of Disease|7|||
155339794|NCT01562275|560678963|FG008|Stage 1|Progression of Disease|2|||
155339795|NCT01562275|560678964|FG009|Stage 1|Progression of Disease|5|||
155339796|NCT01562275|560678965|FG010|Stage 1|Progression of Disease|3|||
155339797|NCT01562275|560678966|FG011|Stage 1|Progression of Disease|0|||
155339798|NCT01562275|560678967|FG012|Stage 1|Progression of Disease|0|||
155339799|NCT01562275|560678955|FG000|Stage 1|Withdrawal by Subject|0|||
155339800|NCT01562275|560678956|FG001|Stage 1|Withdrawal by Subject|1|||
155339801|NCT01562275|560678957|FG002|Stage 1|Withdrawal by Subject|0|||
155339802|NCT01562275|560678958|FG003|Stage 1|Withdrawal by Subject|2|||
155339803|NCT01562275|560678959|FG004|Stage 1|Withdrawal by Subject|0|||
155339804|NCT01562275|560678960|FG005|Stage 1|Withdrawal by Subject|0|||
155339805|NCT01562275|560678961|FG006|Stage 1|Withdrawal by Subject|1|||
155339806|NCT01562275|560678962|FG007|Stage 1|Withdrawal by Subject|0|||
155339807|NCT01562275|560678963|FG008|Stage 1|Withdrawal by Subject|0|||
155339808|NCT01562275|560678964|FG009|Stage 1|Withdrawal by Subject|1|||
155339809|NCT01562275|560678965|FG010|Stage 1|Withdrawal by Subject|0|||
155339810|NCT01562275|560678966|FG011|Stage 1|Withdrawal by Subject|0|||
155339811|NCT01562275|560678967|FG012|Stage 1|Withdrawal by Subject|0|||
155339812|NCT01562275|560678955|FG000|Stage 2|Death|0|||
155339813|NCT01562275|560678956|FG001|Stage 2|Death|0|||
155339814|NCT01562275|560678957|FG002|Stage 2|Death|0|||
155339815|NCT01562275|560678958|FG003|Stage 2|Death|0|||
155423313|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423314|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423315|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423316|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423317|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423318|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423319|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423320|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423321|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423322|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423323|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
155423324|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423325|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423326|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
155423327|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423328|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423329|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423330|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423331|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423332|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423333|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423334|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423335|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423336|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423337|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423338|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155339816|NCT01562275|560678959|FG004|Stage 2|Death|0|||
155339817|NCT01562275|560678960|FG005|Stage 2|Death|0|||
155339818|NCT01562275|560678961|FG006|Stage 2|Death|0|||
155339819|NCT01562275|560678962|FG007|Stage 2|Death|0|||
155339820|NCT01562275|560678963|FG008|Stage 2|Death|0|||
155339821|NCT01562275|560678964|FG009|Stage 2|Death|0|||
155339822|NCT01562275|560678965|FG010|Stage 2|Death|0|||
155339823|NCT01562275|560678966|FG011|Stage 2|Death|2|||
155339824|NCT01562275|560678967|FG012|Stage 2|Death|1|||
155339825|NCT01562275|560678955|FG000|Stage 2|Progression of Disease|0|||
155339826|NCT01562275|560678956|FG001|Stage 2|Progression of Disease|0|||
155339827|NCT01562275|560678957|FG002|Stage 2|Progression of Disease|0|||
155339828|NCT01562275|560678958|FG003|Stage 2|Progression of Disease|0|||
155339829|NCT01562275|560678959|FG004|Stage 2|Progression of Disease|0|||
155339830|NCT01562275|560678960|FG005|Stage 2|Progression of Disease|0|||
155339831|NCT01562275|560678961|FG006|Stage 2|Progression of Disease|0|||
155339832|NCT01562275|560678962|FG007|Stage 2|Progression of Disease|0|||
155339833|NCT01562275|560678963|FG008|Stage 2|Progression of Disease|0|||
155339834|NCT01562275|560678964|FG009|Stage 2|Progression of Disease|0|||
155339835|NCT01562275|560678965|FG010|Stage 2|Progression of Disease|0|||
155339836|NCT01562275|560678966|FG011|Stage 2|Progression of Disease|12|||
155339837|NCT01562275|560678967|FG012|Stage 2|Progression of Disease|4|||
155339838|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
155339839|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
155339840|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
155339841|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
155339842|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
155339843|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
155339844|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
155339845|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
155339846|NCT01863368|560678968|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
155339847|NCT01863368|560678969|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
155339848|NCT01863368|560678968|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
155339849|NCT01863368|560678969|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
155339850|NCT00515112|560678971|FG000|Overall Study|Death|0|||
155339851|NCT00515112|560678972|FG001|Overall Study|Death|1|||
155339852|NCT00515112|560678971|FG000|Overall Study|The study was terminated|3|||
155339853|NCT00515112|560678972|FG001|Overall Study|The study was terminated|2|||
155339854|NCT03029585|560678975|FG000|Overall Study|Death|1|||
155339855|NCT03029585|560678976|FG001|Overall Study|Death|1|||
155339856|NCT03029585|560678975|FG000|Overall Study|Withdrawal by Subject|1|||
155339857|NCT03029585|560678976|FG001|Overall Study|Withdrawal by Subject|0|||
155339858|NCT04025762|560678979|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
155339859|NCT04025762|560678980|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
155339860|NCT03340961|560678982|FG000|Overall Study|Adverse Event|1|||
155339861|NCT03340961|560678983|FG001|Overall Study|Adverse Event|3|||
155339862|NCT03340961|560678984|FG002|Overall Study|Adverse Event|2|||
155339863|NCT03340961|560678985|FG003|Overall Study|Adverse Event|4|||
155339864|NCT03340961|560678982|FG000|Overall Study|Lost to Follow-up|0|||
155339865|NCT03340961|560678983|FG001|Overall Study|Lost to Follow-up|1|||
155339866|NCT03340961|560678984|FG002|Overall Study|Lost to Follow-up|0|||
155339867|NCT03340961|560678985|FG003|Overall Study|Lost to Follow-up|1|||
155339868|NCT03340961|560678982|FG000|Overall Study|Withdrawal by Subject|3|||
155339869|NCT03340961|560678983|FG001|Overall Study|Withdrawal by Subject|2|||
155339870|NCT03340961|560678984|FG002|Overall Study|Withdrawal by Subject|4|||
155339871|NCT03340961|560678985|FG003|Overall Study|Withdrawal by Subject|7|||
155339872|NCT03340961|560678982|FG000|Overall Study|Use of prohibited treatment|0|||
155339873|NCT03340961|560678983|FG001|Overall Study|Use of prohibited treatment|3|||
155339874|NCT03340961|560678984|FG002|Overall Study|Use of prohibited treatment|2|||
155339875|NCT03340961|560678985|FG003|Overall Study|Use of prohibited treatment|4|||
155339876|NCT03340961|560678982|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
155423339|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423340|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423341|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423342|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423343|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423344|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423345|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423346|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
155423347|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155646011|NCT04392635|561795654|FG001|Overall Study|Lost to Follow-up|1|||
155339877|NCT03340961|560678983|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
155339878|NCT03340961|560678984|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
155339879|NCT03340961|560678985|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
155339880|NCT03340961|560678982|FG000|Overall Study|Subject developed an exclusion criterion|0|||
155339881|NCT03340961|560678983|FG001|Overall Study|Subject developed an exclusion criterion|1|||
155339882|NCT03340961|560678984|FG002|Overall Study|Subject developed an exclusion criterion|0|||
155339883|NCT03340961|560678985|FG003|Overall Study|Subject developed an exclusion criterion|0|||
155339884|NCT03340961|560678982|FG000|Overall Study|Protocol Violation|1|||
155339885|NCT03340961|560678983|FG001|Overall Study|Protocol Violation|0|||
155339886|NCT03340961|560678984|FG002|Overall Study|Protocol Violation|1|||
155646012|NCT00724893|561795656|FG000|Overall Study|Adverse Event|76|||
155646013|NCT00724893|561795657|FG001|Overall Study|Adverse Event|142|||
155339887|NCT03340961|560678985|FG003|Overall Study|Protocol Violation|0|||
155339888|NCT03340961|560678982|FG000|Overall Study|Adverse Event|1|||
155339889|NCT03340961|560678983|FG001|Overall Study|Adverse Event|1|||
155339890|NCT03340961|560678984|FG002|Overall Study|Adverse Event|0|||
155339891|NCT03340961|560678985|FG003|Overall Study|Adverse Event|0|||
155339892|NCT03340961|560678982|FG000|Overall Study|Lack of Efficacy|0|||
155339893|NCT03340961|560678983|FG001|Overall Study|Lack of Efficacy|0|||
155339894|NCT03340961|560678984|FG002|Overall Study|Lack of Efficacy|0|||
155339895|NCT03340961|560678985|FG003|Overall Study|Lack of Efficacy|1|||
155339896|NCT01286311|560678986|FG000|Overall Study|Physician did not want outreach sent|14|||
155339897|NCT01286311|560678987|FG001|Overall Study|Physician did not want outreach sent|0|||
155339898|NCT01437540|560678988|FG000|Overall Study|Not listed below|7|||
155339899|NCT01437540|560678989|FG001|Overall Study|Not listed below|6|||
155339900|NCT01437540|560678988|FG000|Overall Study|COPD exacerbation|13|||
155339901|NCT01437540|560678989|FG001|Overall Study|COPD exacerbation|3|||
155339902|NCT01437540|560678988|FG000|Overall Study|Lost to Follow-up|3|||
155339903|NCT01437540|560678989|FG001|Overall Study|Lost to Follow-up|5|||
155339904|NCT01437540|560678988|FG000|Overall Study|Lack of Efficacy|23|||
155339905|NCT01437540|560678989|FG001|Overall Study|Lack of Efficacy|11|||
155339906|NCT01437540|560678988|FG000|Overall Study|Protocol Violation|24|||
155339907|NCT01437540|560678989|FG001|Overall Study|Protocol Violation|12|||
155339908|NCT01437540|560678988|FG000|Overall Study|Adverse Event|26|||
155339909|NCT01437540|560678989|FG001|Overall Study|Adverse Event|13|||
155339910|NCT01437540|560678988|FG000|Overall Study|Withdrawal by Subject|31|||
155339911|NCT01437540|560678989|FG001|Overall Study|Withdrawal by Subject|15|||
155339912|NCT04328467|560678994|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
155339913|NCT04328467|560678995|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
155339914|NCT04328467|560678996|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
155339915|NCT01975701|560678997|FG000|Overall Study|Lost to Follow-up|1|||
155339916|NCT01975701|560678997|FG000|Overall Study|Death|23|||
155339917|NCT01975701|560678997|FG000|Overall Study|Physician Decision|1|||
155339918|NCT02446015|560679000|FG000|Overall Study|Adverse Event|0|||
155339919|NCT02446015|560679001|FG001|Overall Study|Adverse Event|1|||
155339920|NCT02446015|560679000|FG000|Overall Study|Withdrawal by Subject|1|||
155339921|NCT02446015|560679001|FG001|Overall Study|Withdrawal by Subject|0|||
155339922|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155339923|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
155339924|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155339925|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155423348|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423349|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423350|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
155423351|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423352|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423353|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423354|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423355|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423356|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423357|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423358|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423359|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155436209|NCT00849212|561024564|FG000|Overall Study|Withdrawal by Subject|3|||
155339926|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339927|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339928|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
155339929|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339930|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339931|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339932|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339933|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
155339934|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339935|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339936|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339937|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
155339938|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339939|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339940|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
155339941|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339942|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339943|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339944|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
155339945|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339946|NCT01393600|560679002|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339947|NCT01393600|560679003|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339948|NCT01393600|560679004|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
155339949|NCT01393600|560679005|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339950|NCT01670877|560679006|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339951|NCT01670877|560679007|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
155339952|NCT01670877|560679008|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339953|NCT01670877|560679009|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339954|NCT01670877|560679010|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339955|NCT01670877|560679011|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339956|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339957|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339958|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
155339959|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339960|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339961|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339962|NCT01670877|560679006|FG000|Part I and Part 2|Grade 2 vomiting|0|||
155339963|NCT01670877|560679007|FG001|Part I and Part 2|Grade 2 vomiting|0|||
155339964|NCT01670877|560679008|FG002|Part I and Part 2|Grade 2 vomiting|0|||
155339965|NCT01670877|560679009|FG003|Part I and Part 2|Grade 2 vomiting|1|||
155339966|NCT01670877|560679010|FG004|Part I and Part 2|Grade 2 vomiting|0|||
155339967|NCT01670877|560679011|FG005|Part I and Part 2|Grade 2 vomiting|0|||
155339968|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339969|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339970|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339971|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
155339972|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339973|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339974|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339975|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339976|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339977|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
155339978|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339979|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339980|NCT02525744|560679012|FG000|Period 1|Physician Decision|0|||
155339981|NCT02525744|560679013|FG001|Period 1|Physician Decision|0|||
155339982|NCT02525744|560679014|FG002|Period 1|Physician Decision|1|||
155339983|NCT02525744|560679015|FG003|Period 1|Physician Decision|0|||
155339984|NCT02525744|560679012|FG000|Period 3|Adverse Event|0|||
155339985|NCT02525744|560679013|FG001|Period 3|Adverse Event|1|||
155339986|NCT02525744|560679014|FG002|Period 3|Adverse Event|0|||
155339987|NCT02525744|560679015|FG003|Period 3|Adverse Event|0|||
155339988|NCT02525744|560679012|FG000|Period 4|Withdrawal by Subject|1|||
155339989|NCT02525744|560679013|FG001|Period 4|Withdrawal by Subject|0|||
155339990|NCT02525744|560679014|FG002|Period 4|Withdrawal by Subject|0|||
155339991|NCT02525744|560679015|FG003|Period 4|Withdrawal by Subject|0|||
155339992|NCT02525744|560679012|FG000|Period 5|Physician Decision|1|||
155339993|NCT02525744|560679013|FG001|Period 5|Physician Decision|0|||
155339994|NCT02525744|560679014|FG002|Period 5|Physician Decision|0|||
155339995|NCT02525744|560679015|FG003|Period 5|Physician Decision|0|||
155339996|NCT01182285|560679016|FG000|First Intervention Week 1-10|Disease progression|1|||
155339997|NCT01182285|560679017|FG001|First Intervention Week 1-10|Disease progression|0|||
155339998|NCT01182285|560679018|FG002|First Intervention Week 1-10|Disease progression|0|||
155339999|NCT01182285|560679016|FG000|First Intervention Week 1-10|Adverse Event|1|||
155340000|NCT01182285|560679017|FG001|First Intervention Week 1-10|Adverse Event|0|||
155340001|NCT01182285|560679018|FG002|First Intervention Week 1-10|Adverse Event|0|||
155340002|NCT01182285|560679016|FG000|First Intervention Week 1-10|Non-compliance|1|||
155340003|NCT01182285|560679017|FG001|First Intervention Week 1-10|Non-compliance|0|||
155340004|NCT01182285|560679018|FG002|First Intervention Week 1-10|Non-compliance|0|||
155340005|NCT01182285|560679016|FG000|Third Intervention Week 11-52|Disease Progression|0|||
155340006|NCT01182285|560679017|FG001|Third Intervention Week 11-52|Disease Progression|0|||
155340007|NCT01182285|560679018|FG002|Third Intervention Week 11-52|Disease Progression|6|||
155340008|NCT01182285|560679016|FG000|Third Intervention Week 11-52|Other|0|||
155340009|NCT01182285|560679017|FG001|Third Intervention Week 11-52|Other|0|||
155340010|NCT01182285|560679018|FG002|Third Intervention Week 11-52|Other|2|||
155340011|NCT00472082|560679019|FG000|Overall Study|Study prematurely terminated|5|||
155340012|NCT03449979|560679020|FG000|Overall Study|Technical difficulty|0|||
155340013|NCT03449979|560679021|FG001|Overall Study|Technical difficulty|0|||
155340014|NCT03449979|560679022|FG002|Overall Study|Technical difficulty|0|||
155340015|NCT03449979|560679023|FG003|Overall Study|Technical difficulty|1|||
155340016|NCT02069379|560679024|FG000|Baseline Measurements|Lost to Follow-up|1|||
155340017|NCT02069379|560679025|FG001|Baseline Measurements|Lost to Follow-up|0|||
155340018|NCT02069379|560679026|FG002|Baseline Measurements|Lost to Follow-up|0|||
155340019|NCT02069379|560679027|FG003|Baseline Measurements|Lost to Follow-up|0|||
155340020|NCT02069379|560679024|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
155340021|NCT02069379|560679025|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
155340022|NCT02069379|560679026|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
155340023|NCT02069379|560679027|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
155340024|NCT02069379|560679024|FG000|First Treatment Arm|Lost to Follow-up|0|||
155340025|NCT02069379|560679025|FG001|First Treatment Arm|Lost to Follow-up|1|||
155340026|NCT02069379|560679026|FG002|First Treatment Arm|Lost to Follow-up|1|||
155340027|NCT02069379|560679027|FG003|First Treatment Arm|Lost to Follow-up|0|||
155340028|NCT02069379|560679024|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340029|NCT02069379|560679025|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155340030|NCT02069379|560679026|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340031|NCT02069379|560679027|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340032|NCT02069379|560679024|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
155340033|NCT02069379|560679025|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
155340034|NCT02069379|560679026|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
155340035|NCT02069379|560679027|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
155340036|NCT02069379|560679024|FG000|Second Treatment Arm|Lost to Follow-up|0|||
155340037|NCT02069379|560679025|FG001|Second Treatment Arm|Lost to Follow-up|0|||
155340038|NCT02069379|560679026|FG002|Second Treatment Arm|Lost to Follow-up|1|||
155340039|NCT02069379|560679027|FG003|Second Treatment Arm|Lost to Follow-up|0|||
155340040|NCT01762345|560679028|FG000|Overall Study|Adverse Event|5|||
155340041|NCT01762345|560679028|FG000|Overall Study|Protocol Violation|2|||
155340042|NCT01525875|560679029|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155340043|NCT01525875|560679030|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
155340044|NCT01525875|560679029|FG000|Open-label Period|Lost to Follow-up|0|||
155340045|NCT01525875|560679030|FG001|Open-label Period|Lost to Follow-up|2|||
155340046|NCT02379078|560679031|FG000|Overall Study|Lost to Follow-up|33|||
155340047|NCT02379078|560679032|FG001|Overall Study|Lost to Follow-up|30|||
155340048|NCT02379078|560679031|FG000|Overall Study|Withdrawal by Subject|6|||
155340049|NCT02379078|560679032|FG001|Overall Study|Withdrawal by Subject|5|||
155340050|NCT02206607|560679033|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
155340051|NCT02206607|560679034|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
155340052|NCT02206607|560679035|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
155340053|NCT02206607|560679036|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
155340054|NCT02206607|560679037|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
155340055|NCT02206607|560679033|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
155340056|NCT02206607|560679034|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
155340057|NCT02206607|560679035|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
155340058|NCT02206607|560679036|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
155340059|NCT02206607|560679037|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
155340060|NCT00761267|560679038|FG000|Overall Study|Death|1|||
155340061|NCT00761267|560679039|FG001|Overall Study|Death|2|||
155340062|NCT00761267|560679040|FG002|Overall Study|Death|5|||
155504514|NCT04380701|561274040|FG028|Overall Study|Withdrawal by Subject|0|||
155504515|NCT04380701|561274041|FG029|Overall Study|Withdrawal by Subject|0|||
155504516|NCT04380701|561274042|FG030|Overall Study|Withdrawal by Subject|0|||
155504517|NCT04380701|561274043|FG031|Overall Study|Withdrawal by Subject|0|||
155504518|NCT04380701|561274044|FG032|Overall Study|Withdrawal by Subject|0|||
155504519|NCT04380701|561274045|FG033|Overall Study|Withdrawal by Subject|0|||
155340063|NCT00761267|560679038|FG000|Overall Study|Lost to Follow-up|0|||
155340064|NCT00761267|560679039|FG001|Overall Study|Lost to Follow-up|0|||
155340065|NCT00761267|560679040|FG002|Overall Study|Lost to Follow-up|1|||
155340066|NCT00761267|560679038|FG000|Overall Study|Randomized but not treated|1|||
155504520|NCT04380701|561274012|FG000|Overall Study|Adverse Event|0|||
155504521|NCT04380701|561274013|FG001|Overall Study|Adverse Event|0|||
155340067|NCT00761267|560679039|FG001|Overall Study|Randomized but not treated|1|||
155340068|NCT00761267|560679040|FG002|Overall Study|Randomized but not treated|0|||
155340069|NCT00761267|560679038|FG000|Overall Study|Withdrawal by Subject|0|||
155340070|NCT00761267|560679039|FG001|Overall Study|Withdrawal by Subject|1|||
155340071|NCT00761267|560679040|FG002|Overall Study|Withdrawal by Subject|0|||
155340072|NCT01777932|560679045|FG000|Overall Study|Disease progression|136|||
155340073|NCT01777932|560679045|FG000|Overall Study|Death|3|||
155340074|NCT01777932|560679045|FG000|Overall Study|Adverse Event|34|||
155340075|NCT01777932|560679045|FG000|Overall Study|Lost to Follow-up|3|||
155340076|NCT01777932|560679045|FG000|Overall Study|Investigator decision|10|||
155340077|NCT01777932|560679045|FG000|Overall Study|Reimbursement limit|9|||
155340078|NCT01777932|560679045|FG000|Overall Study|Patient refused further treatment|10|||
155340079|NCT03989232|560679055|FG000|Overall Study|Lost to Follow-up|3|||
155340080|NCT03989232|560679056|FG001|Overall Study|Lost to Follow-up|10|||
155340081|NCT03989232|560679055|FG000|Overall Study|Withdrawal by Subject|6|||
155340082|NCT03989232|560679056|FG001|Overall Study|Withdrawal by Subject|6|||
155340083|NCT03989232|560679055|FG000|Overall Study|Death|1|||
155340084|NCT03989232|560679056|FG001|Overall Study|Death|2|||
155340085|NCT02644122|560679060|FG000|Overall Study|Withdrawal by Subject|1|||
155340086|NCT01930188|560679063|FG000|Overall Study|unclassified|4|||
155340087|NCT01930188|560679064|FG001|Overall Study|unclassified|5|||
155340088|NCT01930188|560679065|FG002|Overall Study|unclassified|3|||
155340089|NCT01930188|560679063|FG000|Overall Study|Missing follow-up information|2|||
155340090|NCT01930188|560679064|FG001|Overall Study|Missing follow-up information|2|||
155340091|NCT01930188|560679065|FG002|Overall Study|Missing follow-up information|3|||
155340092|NCT01930188|560679063|FG000|Overall Study|Lost to Follow-up|5|||
155340093|NCT01930188|560679064|FG001|Overall Study|Lost to Follow-up|2|||
155340094|NCT01930188|560679065|FG002|Overall Study|Lost to Follow-up|2|||
155340095|NCT01930188|560679063|FG000|Overall Study|Death|2|||
155340096|NCT01930188|560679064|FG001|Overall Study|Death|1|||
155340097|NCT01930188|560679065|FG002|Overall Study|Death|3|||
155340098|NCT01930188|560679063|FG000|Overall Study|Withdrawal by Subject|9|||
155340099|NCT01930188|560679064|FG001|Overall Study|Withdrawal by Subject|11|||
155340100|NCT01930188|560679065|FG002|Overall Study|Withdrawal by Subject|8|||
155340101|NCT02514824|560679066|FG000|Overall Study|Withdrawal by Subject|1|||
155340102|NCT02514824|560679067|FG001|Overall Study|Withdrawal by Subject|0|||
155340103|NCT02514824|560679068|FG002|Overall Study|Withdrawal by Subject|0|||
155340104|NCT02514824|560679069|FG003|Overall Study|Withdrawal by Subject|0|||
155340105|NCT02514824|560679066|FG000|Overall Study|Dose-Limiting Toxicity|0|||
155340106|NCT02514824|560679067|FG001|Overall Study|Dose-Limiting Toxicity|1|||
155340107|NCT02514824|560679068|FG002|Overall Study|Dose-Limiting Toxicity|0|||
155340108|NCT02514824|560679069|FG003|Overall Study|Dose-Limiting Toxicity|0|||
155340109|NCT02170207|560679072|FG000|Overall Study|Case report forms unavailable|5|||
155340110|NCT03122860|560679073|FG000|Overall Study|Discontinued Before Treatment|1|||
155340111|NCT03122860|560679074|FG001|Overall Study|Discontinued Before Treatment|1|||
155340112|NCT03122860|560679075|FG002|Overall Study|Discontinued Before Treatment|2|||
155340113|NCT03122860|560679076|FG003|Overall Study|Discontinued Before Treatment|0|||
155340114|NCT03122860|560679077|FG004|Overall Study|Discontinued Before Treatment|1|||
155340115|NCT03122860|560679078|FG005|Overall Study|Discontinued Before Treatment|0|||
155340116|NCT03122860|560679073|FG000|Overall Study|Adverse Event|1|||
155340117|NCT03122860|560679074|FG001|Overall Study|Adverse Event|0|||
155340118|NCT03122860|560679075|FG002|Overall Study|Adverse Event|1|||
155340119|NCT03122860|560679076|FG003|Overall Study|Adverse Event|1|||
155504522|NCT04380701|561274014|FG002|Overall Study|Adverse Event|0|||
155504523|NCT04380701|561274015|FG003|Overall Study|Adverse Event|0|||
155504524|NCT04380701|561274016|FG004|Overall Study|Adverse Event|0|||
155504525|NCT04380701|561274017|FG005|Overall Study|Adverse Event|1|||
155340120|NCT03122860|560679077|FG004|Overall Study|Adverse Event|0|||
155340121|NCT03122860|560679078|FG005|Overall Study|Adverse Event|0|||
155340122|NCT03122860|560679073|FG000|Overall Study|Lost to Follow-up|5|||
155340123|NCT03122860|560679074|FG001|Overall Study|Lost to Follow-up|2|||
155340124|NCT03122860|560679075|FG002|Overall Study|Lost to Follow-up|3|||
155340125|NCT03122860|560679076|FG003|Overall Study|Lost to Follow-up|3|||
155340126|NCT03122860|560679077|FG004|Overall Study|Lost to Follow-up|5|||
155340127|NCT03122860|560679078|FG005|Overall Study|Lost to Follow-up|4|||
155340128|NCT03122860|560679073|FG000|Overall Study|Subject Non-Compliance|0|||
155340129|NCT03122860|560679074|FG001|Overall Study|Subject Non-Compliance|0|||
155340130|NCT03122860|560679075|FG002|Overall Study|Subject Non-Compliance|1|||
155504526|NCT04380701|561274018|FG006|Overall Study|Adverse Event|0|||
155504527|NCT04380701|561274019|FG007|Overall Study|Adverse Event|0|||
155340131|NCT03122860|560679076|FG003|Overall Study|Subject Non-Compliance|0|||
155340132|NCT03122860|560679077|FG004|Overall Study|Subject Non-Compliance|0|||
155340133|NCT03122860|560679078|FG005|Overall Study|Subject Non-Compliance|0|||
155340134|NCT03122860|560679073|FG000|Overall Study|Withdrawal by Subject|3|||
155340135|NCT03122860|560679074|FG001|Overall Study|Withdrawal by Subject|2|||
155340136|NCT03122860|560679075|FG002|Overall Study|Withdrawal by Subject|5|||
155504528|NCT04380701|561274020|FG008|Overall Study|Adverse Event|0|||
155504529|NCT04380701|561274021|FG009|Overall Study|Adverse Event|0|||
155340137|NCT03122860|560679076|FG003|Overall Study|Withdrawal by Subject|7|||
155340138|NCT03122860|560679077|FG004|Overall Study|Withdrawal by Subject|9|||
155340139|NCT03122860|560679078|FG005|Overall Study|Withdrawal by Subject|8|||
155340140|NCT01138657|560679079|FG000|Overall Study|Adverse Event|3|||
155340141|NCT01138657|560679080|FG001|Overall Study|Adverse Event|10|||
155340142|NCT01138657|560679079|FG000|Overall Study|Lack of Efficacy|2|||
155340143|NCT01138657|560679080|FG001|Overall Study|Lack of Efficacy|1|||
155340144|NCT01138657|560679079|FG000|Overall Study|Lost to Follow-up|0|||
155340145|NCT01138657|560679080|FG001|Overall Study|Lost to Follow-up|3|||
155340146|NCT01138657|560679079|FG000|Overall Study|Miscellaneous Reasons|3|||
155340147|NCT01138657|560679080|FG001|Overall Study|Miscellaneous Reasons|4|||
155340148|NCT02399449|560679083|FG000|Overall Study|Withdrawal by Subject|3|||
155340149|NCT02399449|560679084|FG001|Overall Study|Withdrawal by Subject|9|||
155340150|NCT02399449|560679083|FG000|Overall Study|Physician Decision|0|||
155340151|NCT02399449|560679084|FG001|Overall Study|Physician Decision|1|||
155340152|NCT01020435|560679085|FG000|Overall Study|Lost to Follow-up|0|||
155340153|NCT01020435|560679086|FG001|Overall Study|Lost to Follow-up|1|||
155340154|NCT00337610|560679087|FG000|Overall Study|Adverse Event|2|||
155340155|NCT00337610|560679088|FG001|Overall Study|Adverse Event|2|||
155340156|NCT00337610|560679087|FG000|Overall Study|Death|0|||
155340157|NCT00337610|560679088|FG001|Overall Study|Death|1|||
155340158|NCT00337610|560679087|FG000|Overall Study|Lack of Efficacy|6|||
155340159|NCT00337610|560679088|FG001|Overall Study|Lack of Efficacy|3|||
155340160|NCT00337610|560679087|FG000|Overall Study|Lost to Follow-up|3|||
155340161|NCT00337610|560679088|FG001|Overall Study|Lost to Follow-up|3|||
155340162|NCT00337610|560679087|FG000|Overall Study|Withdrawal by Subject|6|||
155340163|NCT00337610|560679088|FG001|Overall Study|Withdrawal by Subject|5|||
155340164|NCT00346398|560679089|FG000|Overall Study|Lost to Follow-up|3|||
155340165|NCT00346398|560679090|FG001|Overall Study|Lost to Follow-up|0|||
155340166|NCT00346398|560679089|FG000|Overall Study|Withdrawal by Subject|0|||
155340167|NCT00346398|560679090|FG001|Overall Study|Withdrawal by Subject|2|||
155340168|NCT03979040|560679091|FG000|Overall Study|Withdrawal by Subject|24|||
155340169|NCT03979040|560679092|FG001|Overall Study|Withdrawal by Subject|32|||
155340170|NCT03979040|560679091|FG000|Overall Study|randomized but never started treatment|32|||
155340171|NCT03979040|560679092|FG001|Overall Study|randomized but never started treatment|39|||
155340172|NCT03979040|560679091|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
155340173|NCT03979040|560679092|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
155340174|NCT02607956|560679093|FG000|Double-Blinded Phase|Withdrew Consent|17|||
155340175|NCT02607956|560679094|FG001|Double-Blinded Phase|Withdrew Consent|19|||
155340176|NCT02607956|560679095|FG002|Double-Blinded Phase|Withdrew Consent|0|||
155340177|NCT02607956|560679096|FG003|Double-Blinded Phase|Withdrew Consent|0|||
155340178|NCT02607956|560679093|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
155340179|NCT02607956|560679094|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
155340180|NCT02607956|560679095|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
155340181|NCT02607956|560679096|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
155340182|NCT02607956|560679093|FG000|Double-Blinded Phase|Randomized but never treated|7|||
155340183|NCT02607956|560679094|FG001|Double-Blinded Phase|Randomized but never treated|5|||
155340184|NCT02607956|560679095|FG002|Double-Blinded Phase|Randomized but never treated|0|||
155340185|NCT02607956|560679096|FG003|Double-Blinded Phase|Randomized but never treated|0|||
155340186|NCT02607956|560679093|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
155340187|NCT02607956|560679094|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
155340188|NCT02607956|560679095|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
155340189|NCT02607956|560679096|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
155340190|NCT02607956|560679093|FG000|Double-Blinded Phase|Death|4|||
155340191|NCT02607956|560679094|FG001|Double-Blinded Phase|Death|4|||
155340192|NCT02607956|560679095|FG002|Double-Blinded Phase|Death|0|||
155423360|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423361|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423362|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155646014|NCT00724893|561795656|FG000|Overall Study|Withdrawal by Subject|0|||
155646015|NCT00724893|561795657|FG001|Overall Study|Withdrawal by Subject|1|||
155646016|NCT00724893|561795656|FG000|Overall Study|Lack of virologic response|94|||
155646017|NCT00724893|561795657|FG001|Overall Study|Lack of virologic response|202|||
155646018|NCT00724893|561795656|FG000|Overall Study|Reason not specified|193|||
155340193|NCT02607956|560679096|FG003|Double-Blinded Phase|Death|0|||
155340194|NCT02607956|560679093|FG000|Double-Blinded Phase|Adverse Event|4|||
155340195|NCT02607956|560679094|FG001|Double-Blinded Phase|Adverse Event|3|||
155340196|NCT02607956|560679095|FG002|Double-Blinded Phase|Adverse Event|0|||
155340197|NCT02607956|560679096|FG003|Double-Blinded Phase|Adverse Event|0|||
155340198|NCT02607956|560679093|FG000|Double-Blinded Phase|Protocol Violation|3|||
155340199|NCT02607956|560679094|FG001|Double-Blinded Phase|Protocol Violation|1|||
155646019|NCT00724893|561795657|FG001|Overall Study|Reason not specified|7|||
155646020|NCT00724893|561795656|FG000|Overall Study|Patient choice|0|||
155646021|NCT00724893|561795657|FG001|Overall Study|Patient choice|26|||
155646022|NCT00724893|561795656|FG000|Overall Study|Geographic reasons|0|||
155340200|NCT02607956|560679095|FG002|Double-Blinded Phase|Protocol Violation|0|||
155340201|NCT02607956|560679096|FG003|Double-Blinded Phase|Protocol Violation|0|||
155340202|NCT02607956|560679093|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340203|NCT02607956|560679094|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
155340204|NCT02607956|560679095|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340205|NCT02607956|560679096|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340206|NCT02607956|560679093|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
155340207|NCT02607956|560679094|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
155340208|NCT02607956|560679095|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
155340209|NCT02607956|560679096|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
155340210|NCT02607956|560679093|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155340211|NCT02607956|560679094|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155340212|NCT02607956|560679095|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
155340213|NCT02607956|560679096|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
155340214|NCT02607956|560679093|FG000|Open-Label Extension Phase|Death|0|||
155340215|NCT02607956|560679094|FG001|Open-Label Extension Phase|Death|0|||
155340216|NCT02607956|560679095|FG002|Open-Label Extension Phase|Death|1|||
155340217|NCT02607956|560679096|FG003|Open-Label Extension Phase|Death|3|||
155340218|NCT02607956|560679093|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
155340219|NCT02607956|560679094|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
155340220|NCT02607956|560679095|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
155340221|NCT02607956|560679096|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
155340222|NCT02607956|560679093|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340223|NCT02607956|560679094|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340224|NCT02607956|560679095|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
155340225|NCT02607956|560679096|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340226|NCT02607956|560679093|FG000|Open-Label Extension Phase|Protocol Violation|0|||
155340227|NCT02607956|560679094|FG001|Open-Label Extension Phase|Protocol Violation|0|||
155340228|NCT02607956|560679095|FG002|Open-Label Extension Phase|Protocol Violation|0|||
155340229|NCT02607956|560679096|FG003|Open-Label Extension Phase|Protocol Violation|2|||
155340230|NCT02607956|560679093|FG000|Open-Label Extension Phase|Pregnancy|0|||
155340231|NCT02607956|560679094|FG001|Open-Label Extension Phase|Pregnancy|0|||
155340232|NCT02607956|560679095|FG002|Open-Label Extension Phase|Pregnancy|0|||
155340233|NCT02607956|560679096|FG003|Open-Label Extension Phase|Pregnancy|1|||
155340234|NCT02326220|560679102|FG000|Double-blind Treatment Period|Adverse Event|1|||
155340235|NCT02326220|560679103|FG001|Double-blind Treatment Period|Adverse Event|2|||
155340236|NCT02326220|560679104|FG002|Double-blind Treatment Period|Adverse Event|0|||
155340237|NCT02326220|560679102|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155340238|NCT02326220|560679103|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155340239|NCT02326220|560679104|FG002|Double-blind Treatment Period|Protocol Violation|0|||
155340240|NCT02326220|560679102|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155340241|NCT02326220|560679103|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155340242|NCT02326220|560679104|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155340243|NCT02326220|560679102|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155340244|NCT02326220|560679103|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155340245|NCT02326220|560679104|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
155340246|NCT02326220|560679102|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155340247|NCT02326220|560679103|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155340248|NCT02326220|560679104|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
155340249|NCT00824850|560679105|FG000|Overall Study|Withdrawal by Subject|0|||
155340250|NCT00824850|560679106|FG001|Overall Study|Withdrawal by Subject|1|||
155340251|NCT01075152|560679108|FG000|Overall Study|Withdrawal by Subject|1|||
155340252|NCT01075152|560679109|FG001|Overall Study|Withdrawal by Subject|0|||
155340253|NCT04820491|560679110|FG000|Overall Study|Withdrawal by Subject|1|||
155340254|NCT04820491|560679111|FG001|Overall Study|Withdrawal by Subject|0|||
155340255|NCT01079949|560679114|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
155340256|NCT01079949|560679115|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
155340257|NCT01079949|560679114|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
155340258|NCT01079949|560679115|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
155340259|NCT01079949|560679114|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
155340260|NCT01079949|560679115|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
155423363|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423364|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155340261|NCT01079949|560679114|FG000|Overall Study|Randomized but not treated|1|||
155340262|NCT01079949|560679115|FG001|Overall Study|Randomized but not treated|0|||
155340263|NCT02144285|560679116|FG000|Overall Study|Withdrawal by Subject|0|||
155340264|NCT02144285|560679117|FG001|Overall Study|Withdrawal by Subject|0|||
155340265|NCT02144285|560679118|FG002|Overall Study|Withdrawal by Subject|0|||
155423365|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155340266|NCT02144285|560679119|FG003|Overall Study|Withdrawal by Subject|0|||
155340267|NCT02144285|560679120|FG004|Overall Study|Withdrawal by Subject|1|||
155340268|NCT02144285|560679121|FG005|Overall Study|Withdrawal by Subject|0|||
155340269|NCT02144285|560679122|FG006|Overall Study|Withdrawal by Subject|0|||
155340270|NCT02144285|560679123|FG007|Overall Study|Withdrawal by Subject|0|||
155340271|NCT02144285|560679124|FG008|Overall Study|Withdrawal by Subject|0|||
155340272|NCT02144285|560679125|FG009|Overall Study|Withdrawal by Subject|0|||
155340273|NCT01529632|560679126|FG000|Overall Study|Administrative problem|2|||
155340274|NCT01529632|560679127|FG001|Overall Study|Administrative problem|1|||
155340275|NCT01529632|560679126|FG000|Overall Study|Protocol Violation|0|||
155340276|NCT01529632|560679127|FG001|Overall Study|Protocol Violation|1|||
155340277|NCT01529632|560679126|FG000|Overall Study|Adverse Event|1|||
155340278|NCT01529632|560679127|FG001|Overall Study|Adverse Event|1|||
155340279|NCT03659136|560679133|FG000|Overall Study|Not treated|2|||
155340280|NCT03659136|560679134|FG001|Overall Study|Not treated|0|||
155340281|NCT03659136|560679133|FG000|Overall Study|Covid-19 related|1|||
155340282|NCT03659136|560679134|FG001|Overall Study|Covid-19 related|1|||
155340283|NCT03659136|560679133|FG000|Overall Study|Withdrawal by Subject|1|||
155340284|NCT03659136|560679134|FG001|Overall Study|Withdrawal by Subject|6|||
155340285|NCT03659136|560679133|FG000|Overall Study|Adverse Event|4|||
155340286|NCT03659136|560679134|FG001|Overall Study|Adverse Event|6|||
155340287|NCT03659136|560679133|FG000|Overall Study|Progressive disease|37|||
155340288|NCT03659136|560679134|FG001|Overall Study|Progressive disease|31|||
155340289|NCT03659136|560679133|FG000|Overall Study|Study closure|2|||
155340290|NCT03659136|560679134|FG001|Overall Study|Study closure|2|||
155340291|NCT03659136|560679133|FG000|Overall Study|Sponsor decision/recommendation|3|||
155340292|NCT03659136|560679134|FG001|Overall Study|Sponsor decision/recommendation|2|||
155340293|NCT03659136|560679133|FG000|Overall Study|Switched to other drug/therapy|2|||
155340294|NCT03659136|560679134|FG001|Overall Study|Switched to other drug/therapy|2|||
155340295|NCT03659136|560679133|FG000|Overall Study|Lack of clinical benefit|0|||
155340296|NCT03659136|560679134|FG001|Overall Study|Lack of clinical benefit|1|||
155340297|NCT04914897|560681211|FG000|Overall Study|Withdrawal by Subject|3|||
155340298|NCT04914897|560681212|FG001|Overall Study|Withdrawal by Subject|1|||
155340299|NCT04914897|560681213|FG002|Overall Study|Withdrawal by Subject|1|||
155340300|NCT04914897|560681214|FG003|Overall Study|Withdrawal by Subject|1|||
155340301|NCT04914897|560681211|FG000|Overall Study|Poor compliance to protocol|0|||
155340302|NCT04914897|560681212|FG001|Overall Study|Poor compliance to protocol|0|||
155340303|NCT04914897|560681213|FG002|Overall Study|Poor compliance to protocol|1|||
155340304|NCT04914897|560681214|FG003|Overall Study|Poor compliance to protocol|0|||
155340305|NCT04914897|560681211|FG000|Overall Study|Progressive disease|5|||
155340306|NCT04914897|560681212|FG001|Overall Study|Progressive disease|14|||
155340307|NCT04914897|560681213|FG002|Overall Study|Progressive disease|30|||
155340308|NCT04914897|560681214|FG003|Overall Study|Progressive disease|21|||
155340309|NCT04914897|560681211|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155340310|NCT04914897|560681212|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
155340311|NCT04914897|560681213|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
155340312|NCT04914897|560681214|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
155340313|NCT04914897|560681211|FG000|Overall Study|Other|1|||
155340314|NCT04914897|560681212|FG001|Overall Study|Other|0|||
155340315|NCT04914897|560681213|FG002|Overall Study|Other|0|||
155340316|NCT04914897|560681214|FG003|Overall Study|Other|1|||
155340317|NCT03020914|560681215|FG000|Overall Study|Surgery Cancelled|1|||
155340318|NCT03020914|560681216|FG001|Overall Study|Surgery Cancelled|0|||
155340319|NCT00451906|560681225|FG000|Overall Study|Adverse Event|515|||
155340320|NCT00451906|560681225|FG000|Overall Study|Lost to Follow-up|31|||
155340321|NCT00451906|560681225|FG000|Overall Study|Withdrawal by Subject|111|||
155340322|NCT00451906|560681225|FG000|Overall Study|Protocol Violation|21|||
155340323|NCT00451906|560681225|FG000|Overall Study|Progressive disease|1328|||
155340324|NCT00451906|560681225|FG000|Overall Study|Termination of the study|108|||
155340325|NCT00451906|560681225|FG000|Overall Study|Other Reasons|121|||
155340326|NCT00451906|560681225|FG000|Overall Study|Did not complete final visit|4|||
155340327|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
155340328|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
155340329|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
155340330|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
155340331|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
155340332|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
155340333|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
155340334|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
155340335|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
155340336|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
155340337|NCT05066230|560681227|FG000|After Week 48|Adverse Event|1|||
155340338|NCT05066230|560681228|FG001|After Week 48|Adverse Event|0|||
155340339|NCT05066230|560681227|FG000|After Week 48|Non-compliance with study schedule|1|||
155340340|NCT05066230|560681228|FG001|After Week 48|Non-compliance with study schedule|0|||
155340341|NCT05066230|560681227|FG000|After Week 48|Withdrawal by Subject|0|||
155340342|NCT05066230|560681228|FG001|After Week 48|Withdrawal by Subject|1|||
155340343|NCT05066230|560681227|FG000|After Week 48|Lost to Follow-up|3|||
155340344|NCT05066230|560681228|FG001|After Week 48|Lost to Follow-up|3|||
155340345|NCT05066230|560681227|FG000|After Week 48|Sponsor Request|115|||
155340346|NCT05066230|560681228|FG001|After Week 48|Sponsor Request|111|||
155340347|NCT03072238|560681229|FG000|Overall Study|Withdrawal by Subject|44|||
155340348|NCT03072238|560681230|FG001|Overall Study|Withdrawal by Subject|64|||
155340349|NCT03072238|560681229|FG000|Overall Study|Lost to Follow-up|14|||
155340350|NCT03072238|560681230|FG001|Overall Study|Lost to Follow-up|5|||
155340351|NCT03072238|560681229|FG000|Overall Study|Physician Decision|4|||
155340352|NCT03072238|560681230|FG001|Overall Study|Physician Decision|6|||
155340353|NCT03072238|560681229|FG000|Overall Study|Death|351|||
155340354|NCT03072238|560681230|FG001|Overall Study|Death|318|||
155340355|NCT03072238|560681229|FG000|Overall Study|Progressive Disease|3|||
155340356|NCT03072238|560681230|FG001|Overall Study|Progressive Disease|4|||
155340357|NCT03072238|560681229|FG000|Overall Study|Reason Not Specified|138|||
155340358|NCT03072238|560681230|FG001|Overall Study|Reason Not Specified|150|||
155340359|NCT02400749|560681231|FG000|Week 0 -16|Withdrawal by Subject|5|||
155340360|NCT02400749|560681232|FG001|Week 0 -16|Withdrawal by Subject|5|||
155340361|NCT02400749|560681231|FG000|Week 0 -16|Adverse Event|3|||
155340362|NCT02400749|560681232|FG001|Week 0 -16|Adverse Event|1|||
155340363|NCT02400749|560681231|FG000|Week 0 -16|Lost to Follow-up|2|||
155340364|NCT02400749|560681232|FG001|Week 0 -16|Lost to Follow-up|0|||
155340365|NCT02400749|560681231|FG000|Week 0 -16|Protocol Violation|1|||
155340366|NCT02400749|560681232|FG001|Week 0 -16|Protocol Violation|0|||
155340367|NCT02400749|560681231|FG000|Week 17 - 32|Withdrawal by Subject|3|||
155340368|NCT02400749|560681232|FG001|Week 17 - 32|Withdrawal by Subject|2|||
155340369|NCT02400749|560681231|FG000|Week 17 - 32|Adverse Event|2|||
155340370|NCT02400749|560681232|FG001|Week 17 - 32|Adverse Event|1|||
155340371|NCT00507429|560681233|FG000|Treatment Phase|Disease Progression|12|||
155340372|NCT00507429|560681234|FG001|Treatment Phase|Disease Progression|5|||
155340373|NCT00507429|560681233|FG000|Treatment Phase|Adverse Event|12|||
155340374|NCT00507429|560681234|FG001|Treatment Phase|Adverse Event|5|||
155340375|NCT00507429|560681233|FG000|Treatment Phase|Withdrawal by Subject|3|||
155340376|NCT00507429|560681234|FG001|Treatment Phase|Withdrawal by Subject|3|||
155340377|NCT00507429|560681233|FG000|Treatment Phase|Physician Decision|4|||
155340378|NCT00507429|560681234|FG001|Treatment Phase|Physician Decision|2|||
155340379|NCT00507429|560681233|FG000|Treatment Phase|Other|6|||
155340380|NCT00507429|560681234|FG001|Treatment Phase|Other|3|||
155340381|NCT00507429|560681233|FG000|Maintenance Phase|Progressive Disease|14|||
155340382|NCT00507429|560681234|FG001|Maintenance Phase|Progressive Disease|0|||
155340383|NCT02889900|560681235|FG000|Overall Study|Adverse Event|11|||
155340384|NCT02889900|560681235|FG000|Overall Study|Condition under investigation worsened|32|||
155340385|NCT02889900|560681235|FG000|Overall Study|Other|5|||
155340386|NCT02889900|560681235|FG000|Overall Study|Withdrawal by Subject|7|||
155340387|NCT02889900|560681235|FG000|Overall Study|Not treated|2|||
155340388|NCT00813709|560681236|FG000|Double Blind Period|Adverse Event|4|||
155340389|NCT00813709|560681237|FG001|Double Blind Period|Adverse Event|1|||
155340390|NCT00813709|560681238|FG002|Double Blind Period|Adverse Event|4|||
155340391|NCT00813709|560681239|FG003|Double Blind Period|Adverse Event|0|||
155340392|NCT00813709|560681240|FG004|Double Blind Period|Adverse Event|0|||
155340393|NCT00813709|560681241|FG005|Double Blind Period|Adverse Event|0|||
155340394|NCT00813709|560681236|FG000|Double Blind Period|Lost to Follow-up|3|||
155340395|NCT00813709|560681237|FG001|Double Blind Period|Lost to Follow-up|2|||
155340396|NCT00813709|560681238|FG002|Double Blind Period|Lost to Follow-up|2|||
155340397|NCT00813709|560681239|FG003|Double Blind Period|Lost to Follow-up|0|||
155340398|NCT00813709|560681240|FG004|Double Blind Period|Lost to Follow-up|0|||
155340399|NCT00813709|560681241|FG005|Double Blind Period|Lost to Follow-up|0|||
155340400|NCT00813709|560681236|FG000|Double Blind Period|Switched to open label phase|9|||
155340401|NCT00813709|560681237|FG001|Double Blind Period|Switched to open label phase|26|||
155340402|NCT00813709|560681238|FG002|Double Blind Period|Switched to open label phase|18|||
155340403|NCT00813709|560681239|FG003|Double Blind Period|Switched to open label phase|0|||
155340404|NCT00813709|560681240|FG004|Double Blind Period|Switched to open label phase|0|||
155340405|NCT00813709|560681241|FG005|Double Blind Period|Switched to open label phase|0|||
155340406|NCT00813709|560681236|FG000|Double Blind Period|Randomized but not treated|1|||
155340407|NCT00813709|560681237|FG001|Double Blind Period|Randomized but not treated|3|||
155340408|NCT00813709|560681238|FG002|Double Blind Period|Randomized but not treated|1|||
155340409|NCT00813709|560681239|FG003|Double Blind Period|Randomized but not treated|0|||
155340410|NCT00813709|560681240|FG004|Double Blind Period|Randomized but not treated|0|||
155340411|NCT00813709|560681241|FG005|Double Blind Period|Randomized but not treated|0|||
155340412|NCT00813709|560681236|FG000|Double Blind Period|Other|14|||
155340413|NCT00813709|560681237|FG001|Double Blind Period|Other|9|||
155340414|NCT00813709|560681238|FG002|Double Blind Period|Other|6|||
155340415|NCT00813709|560681239|FG003|Double Blind Period|Other|0|||
155340416|NCT00813709|560681240|FG004|Double Blind Period|Other|0|||
155340417|NCT00813709|560681241|FG005|Double Blind Period|Other|0|||
155340418|NCT00813709|560681236|FG000|Open Label Period|Adverse Event|0|||
155340419|NCT00813709|560681237|FG001|Open Label Period|Adverse Event|0|||
155340420|NCT00813709|560681238|FG002|Open Label Period|Adverse Event|0|||
155340421|NCT00813709|560681239|FG003|Open Label Period|Adverse Event|5|||
155340422|NCT00813709|560681240|FG004|Open Label Period|Adverse Event|4|||
155340423|NCT00813709|560681241|FG005|Open Label Period|Adverse Event|3|||
155340424|NCT00813709|560681236|FG000|Open Label Period|Lack of Efficacy|0|||
155340425|NCT00813709|560681237|FG001|Open Label Period|Lack of Efficacy|0|||
155340426|NCT00813709|560681238|FG002|Open Label Period|Lack of Efficacy|0|||
155340427|NCT00813709|560681239|FG003|Open Label Period|Lack of Efficacy|3|||
155340428|NCT00813709|560681240|FG004|Open Label Period|Lack of Efficacy|1|||
155340429|NCT00813709|560681241|FG005|Open Label Period|Lack of Efficacy|1|||
155340430|NCT00813709|560681236|FG000|Open Label Period|Randomized but not treated|0|||
155340431|NCT00813709|560681237|FG001|Open Label Period|Randomized but not treated|0|||
155340432|NCT00813709|560681238|FG002|Open Label Period|Randomized but not treated|0|||
155340433|NCT00813709|560681239|FG003|Open Label Period|Randomized but not treated|1|||
155340434|NCT00813709|560681240|FG004|Open Label Period|Randomized but not treated|0|||
155340435|NCT00813709|560681241|FG005|Open Label Period|Randomized but not treated|1|||
155340436|NCT00813709|560681236|FG000|Open Label Period|Other|0|||
155340437|NCT00813709|560681237|FG001|Open Label Period|Other|0|||
155340438|NCT00813709|560681238|FG002|Open Label Period|Other|0|||
155340439|NCT00813709|560681239|FG003|Open Label Period|Other|11|||
155340440|NCT00813709|560681240|FG004|Open Label Period|Other|5|||
155340441|NCT00813709|560681241|FG005|Open Label Period|Other|6|||
155340442|NCT03761849|560681244|FG000|Overall Study|transferred to OpenLabelExtension|35|||
155340443|NCT03761849|560681245|FG001|Overall Study|transferred to OpenLabelExtension|34|||
155340444|NCT03761849|560681246|FG002|Overall Study|transferred to OpenLabelExtension|36|||
155340445|NCT03761849|560681247|FG003|Overall Study|transferred to OpenLabelExtension|0|||
155340446|NCT03761849|560681248|FG004|Overall Study|transferred to OpenLabelExtension|0|||
155340447|NCT03761849|560681249|FG005|Overall Study|transferred to OpenLabelExtension|0|||
155340448|NCT03761849|560681244|FG000|Overall Study|Adverse Event|1|||
155340449|NCT03761849|560681245|FG001|Overall Study|Adverse Event|0|||
155340450|NCT03761849|560681246|FG002|Overall Study|Adverse Event|0|||
155340451|NCT03761849|560681247|FG003|Overall Study|Adverse Event|0|||
155340452|NCT03761849|560681248|FG004|Overall Study|Adverse Event|2|||
155340453|NCT03761849|560681249|FG005|Overall Study|Adverse Event|3|||
155340454|NCT03761849|560681244|FG000|Overall Study|Withdrawal by Subject|0|||
155340455|NCT03761849|560681245|FG001|Overall Study|Withdrawal by Subject|0|||
155340456|NCT03761849|560681246|FG002|Overall Study|Withdrawal by Subject|0|||
155340457|NCT03761849|560681247|FG003|Overall Study|Withdrawal by Subject|41|||
155340458|NCT03761849|560681248|FG004|Overall Study|Withdrawal by Subject|43|||
155340459|NCT03761849|560681249|FG005|Overall Study|Withdrawal by Subject|35|||
155340460|NCT03761849|560681244|FG000|Overall Study|Lost to Follow-up|0|||
155340461|NCT03761849|560681245|FG001|Overall Study|Lost to Follow-up|1|||
155340462|NCT03761849|560681246|FG002|Overall Study|Lost to Follow-up|0|||
155340463|NCT03761849|560681247|FG003|Overall Study|Lost to Follow-up|2|||
155504530|NCT04380701|561274022|FG010|Overall Study|Adverse Event|0|||
155504531|NCT04380701|561274023|FG011|Overall Study|Adverse Event|0|||
155504532|NCT04380701|561274024|FG012|Overall Study|Adverse Event|0|||
155504533|NCT04380701|561274025|FG013|Overall Study|Adverse Event|0|||
155504534|NCT04380701|561274026|FG014|Overall Study|Adverse Event|0|||
155504535|NCT04380701|561274027|FG015|Overall Study|Adverse Event|1|||
155504536|NCT04380701|561274028|FG016|Overall Study|Adverse Event|0|||
155504537|NCT04380701|561274029|FG017|Overall Study|Adverse Event|0|||
155504538|NCT04380701|561274030|FG018|Overall Study|Adverse Event|0|||
155504539|NCT04380701|561274031|FG019|Overall Study|Adverse Event|1|||
155504540|NCT04380701|561274032|FG020|Overall Study|Adverse Event|0|||
155504541|NCT04380701|561274033|FG021|Overall Study|Adverse Event|0|||
155504542|NCT04380701|561274034|FG022|Overall Study|Adverse Event|0|||
155504543|NCT04380701|561274035|FG023|Overall Study|Adverse Event|0|||
155504544|NCT04380701|561274036|FG024|Overall Study|Adverse Event|0|||
155504545|NCT04380701|561274037|FG025|Overall Study|Adverse Event|0|||
155504546|NCT04380701|561274038|FG026|Overall Study|Adverse Event|0|||
155504547|NCT04380701|561274039|FG027|Overall Study|Adverse Event|0|||
155504548|NCT04380701|561274040|FG028|Overall Study|Adverse Event|0|||
155504549|NCT04380701|561274041|FG029|Overall Study|Adverse Event|0|||
155504550|NCT04380701|561274042|FG030|Overall Study|Adverse Event|0|||
155504551|NCT04380701|561274043|FG031|Overall Study|Adverse Event|0|||
155504552|NCT04380701|561274044|FG032|Overall Study|Adverse Event|0|||
155504553|NCT04380701|561274045|FG033|Overall Study|Adverse Event|0|||
155504554|NCT04380701|561274012|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
155504555|NCT04380701|561274013|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
155504556|NCT04380701|561274014|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
155504557|NCT04380701|561274015|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
155504558|NCT04380701|561274016|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
155504559|NCT04380701|561274017|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
155504560|NCT04380701|561274018|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
155504561|NCT04380701|561274019|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
155504562|NCT04380701|561274020|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
155504563|NCT04380701|561274021|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
155504564|NCT04380701|561274022|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
155504565|NCT04380701|561274023|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
155504566|NCT04380701|561274024|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
155504567|NCT04380701|561274025|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
155504568|NCT04380701|561274026|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
155504569|NCT04380701|561274027|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
155504570|NCT04380701|561274028|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
155504571|NCT04380701|561274029|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
155504572|NCT04380701|561274030|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
155504573|NCT04380701|561274031|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
155504574|NCT04380701|561274032|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
155504575|NCT04380701|561274033|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
155504576|NCT04380701|561274034|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
155504577|NCT04380701|561274035|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
155504578|NCT04380701|561274036|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
155504579|NCT04380701|561274037|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
155504580|NCT04380701|561274038|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
155504581|NCT04380701|561274039|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
155504582|NCT04380701|561274040|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
155504583|NCT04380701|561274041|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
155504584|NCT04380701|561274042|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
155504585|NCT04380701|561274043|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
155504586|NCT04380701|561274044|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
155504587|NCT04380701|561274045|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
155504588|NCT04380701|561274012|FG000|Overall Study|Physician Decision|0|||
155504589|NCT04380701|561274013|FG001|Overall Study|Physician Decision|0|||
155504590|NCT04380701|561274014|FG002|Overall Study|Physician Decision|0|||
155504591|NCT04380701|561274015|FG003|Overall Study|Physician Decision|0|||
155340464|NCT03761849|560681248|FG004|Overall Study|Lost to Follow-up|4|||
155504592|NCT04380701|561274016|FG004|Overall Study|Physician Decision|0|||
155504593|NCT04380701|561274017|FG005|Overall Study|Physician Decision|0|||
155504594|NCT04380701|561274018|FG006|Overall Study|Physician Decision|0|||
155504595|NCT04380701|561274019|FG007|Overall Study|Physician Decision|0|||
155504596|NCT04380701|561274020|FG008|Overall Study|Physician Decision|0|||
155504597|NCT04380701|561274021|FG009|Overall Study|Physician Decision|0|||
155504598|NCT04380701|561274022|FG010|Overall Study|Physician Decision|0|||
155504599|NCT04380701|561274023|FG011|Overall Study|Physician Decision|0|||
155504600|NCT04380701|561274024|FG012|Overall Study|Physician Decision|0|||
155504601|NCT04380701|561274025|FG013|Overall Study|Physician Decision|0|||
155504602|NCT04380701|561274026|FG014|Overall Study|Physician Decision|0|||
155504603|NCT04380701|561274027|FG015|Overall Study|Physician Decision|0|||
155504604|NCT04380701|561274028|FG016|Overall Study|Physician Decision|0|||
155504605|NCT04380701|561274029|FG017|Overall Study|Physician Decision|0|||
155504606|NCT04380701|561274030|FG018|Overall Study|Physician Decision|0|||
155504607|NCT04380701|561274031|FG019|Overall Study|Physician Decision|0|||
155504608|NCT04380701|561274032|FG020|Overall Study|Physician Decision|0|||
155504609|NCT04380701|561274033|FG021|Overall Study|Physician Decision|0|||
155504610|NCT04380701|561274034|FG022|Overall Study|Physician Decision|0|||
155504611|NCT04380701|561274035|FG023|Overall Study|Physician Decision|0|||
155504612|NCT04380701|561274036|FG024|Overall Study|Physician Decision|2|||
155340465|NCT03761849|560681249|FG005|Overall Study|Lost to Follow-up|5|||
155340466|NCT03761849|560681244|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
155340467|NCT03761849|560681245|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
155340468|NCT03761849|560681246|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
155340469|NCT03761849|560681247|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
155340470|NCT03761849|560681248|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
155340471|NCT03761849|560681249|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
155340472|NCT03761849|560681244|FG000|Overall Study|Physician Decision|0|||
155340473|NCT03761849|560681245|FG001|Overall Study|Physician Decision|0|||
155340474|NCT03761849|560681246|FG002|Overall Study|Physician Decision|0|||
155340475|NCT03761849|560681247|FG003|Overall Study|Physician Decision|1|||
155340476|NCT03761849|560681248|FG004|Overall Study|Physician Decision|4|||
155340477|NCT03761849|560681249|FG005|Overall Study|Physician Decision|4|||
155340478|NCT03761849|560681244|FG000|Overall Study|Death|0|||
155340479|NCT03761849|560681245|FG001|Overall Study|Death|0|||
155340480|NCT03761849|560681246|FG002|Overall Study|Death|0|||
155340481|NCT03761849|560681247|FG003|Overall Study|Death|1|||
155340482|NCT03761849|560681248|FG004|Overall Study|Death|1|||
155340483|NCT03761849|560681249|FG005|Overall Study|Death|3|||
155340484|NCT03761849|560681244|FG000|Overall Study|Protocol Violation|0|||
155340485|NCT03761849|560681245|FG001|Overall Study|Protocol Violation|0|||
155340486|NCT03761849|560681246|FG002|Overall Study|Protocol Violation|0|||
155340487|NCT03761849|560681247|FG003|Overall Study|Protocol Violation|2|||
155340488|NCT03761849|560681248|FG004|Overall Study|Protocol Violation|2|||
155340489|NCT03761849|560681249|FG005|Overall Study|Protocol Violation|1|||
155340490|NCT03761849|560681244|FG000|Overall Study|Participant could not come to site|0|||
155340491|NCT03761849|560681245|FG001|Overall Study|Participant could not come to site|0|||
155340492|NCT03761849|560681246|FG002|Overall Study|Participant could not come to site|0|||
155340493|NCT03761849|560681247|FG003|Overall Study|Participant could not come to site|0|||
155340494|NCT03761849|560681248|FG004|Overall Study|Participant could not come to site|1|||
155340495|NCT03761849|560681249|FG005|Overall Study|Participant could not come to site|0|||
155340496|NCT03761849|560681244|FG000|Overall Study|SF- safety Finding|0|||
155340497|NCT03761849|560681245|FG001|Overall Study|SF- safety Finding|0|||
155340498|NCT03761849|560681246|FG002|Overall Study|SF- safety Finding|0|||
155340499|NCT03761849|560681247|FG003|Overall Study|SF- safety Finding|0|||
155340500|NCT03761849|560681248|FG004|Overall Study|SF- safety Finding|0|||
155340501|NCT03761849|560681249|FG005|Overall Study|SF- safety Finding|1|||
155340502|NCT03761849|560681244|FG000|Overall Study|Patient did not attend visit|0|||
155340503|NCT03761849|560681245|FG001|Overall Study|Patient did not attend visit|0|||
155340504|NCT03761849|560681246|FG002|Overall Study|Patient did not attend visit|0|||
155340505|NCT03761849|560681247|FG003|Overall Study|Patient did not attend visit|0|||
155340506|NCT03761849|560681248|FG004|Overall Study|Patient did not attend visit|0|||
155340507|NCT03761849|560681249|FG005|Overall Study|Patient did not attend visit|1|||
155340508|NCT03840993|560681250|FG000|Overall Study|Adverse Event|1|||
155340509|NCT03840993|560681251|FG001|Overall Study|Adverse Event|0|||
155340510|NCT03840993|560681250|FG000|Overall Study|Lost to Follow-up|4|||
155340511|NCT03840993|560681251|FG001|Overall Study|Lost to Follow-up|0|||
155340512|NCT03840993|560681250|FG000|Overall Study|Physician Decision|0|||
155340513|NCT03840993|560681251|FG001|Overall Study|Physician Decision|1|||
155340514|NCT03840993|560681250|FG000|Overall Study|Pregnancy|0|||
155340515|NCT03840993|560681251|FG001|Overall Study|Pregnancy|1|||
155340516|NCT03840993|560681250|FG000|Overall Study|Withdrawal by Subject|1|||
155340517|NCT03840993|560681251|FG001|Overall Study|Withdrawal by Subject|3|||
155340518|NCT03840993|560681250|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
155340519|NCT03840993|560681251|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
155340520|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
155340521|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340522|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340523|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340524|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340525|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340526|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340527|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340528|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340529|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340530|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340531|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340532|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340533|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340534|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340535|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340536|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340537|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340538|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340539|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340540|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340541|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340542|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340543|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340544|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
155340545|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340546|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
155340547|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340548|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340549|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340550|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340551|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340552|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340553|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340554|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340555|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340556|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340557|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340558|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340559|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340560|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340561|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340562|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155423366|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423367|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423368|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423369|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
155423370|NCT00896532|560978705|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423371|NCT00896532|560978706|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
155423372|NCT00896532|560978707|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155340563|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340564|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
155340565|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340566|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340567|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340568|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340569|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340570|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340571|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340572|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340573|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340574|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340575|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340576|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340577|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
155340578|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
155340579|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
155340580|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
155340581|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
155340582|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
155340583|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
155340584|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
155340585|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340586|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340587|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340588|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340589|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340590|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340591|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340592|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340593|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340594|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340595|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340596|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340597|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340598|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340599|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340600|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340601|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340602|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340603|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340604|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
155340605|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
155340606|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
155340607|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340608|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340609|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340610|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340611|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340612|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340613|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155423373|NCT00896532|560978708|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
155423374|NCT00896532|560978709|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
155423375|NCT00896532|560978710|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423376|NCT00896532|560978711|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423377|NCT00896532|560978712|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423378|NCT00896532|560978713|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423379|NCT00896532|560978714|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423380|NCT00896532|560978715|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423381|NCT00896532|560978716|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423382|NCT00896532|560978717|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423383|NCT00896532|560978718|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155504613|NCT04380701|561274037|FG025|Overall Study|Physician Decision|0|||
155340614|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340615|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340616|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340617|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340618|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340619|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340620|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340621|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340622|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340623|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
155340624|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340625|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
155340626|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340627|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340628|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340629|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340630|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340631|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340632|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340633|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340634|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340635|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340636|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340637|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340638|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340639|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340640|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340641|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340642|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340643|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
155340644|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
155340645|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340646|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340647|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340648|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340649|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340650|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340651|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340652|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340653|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340654|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340655|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340656|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340657|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340658|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340659|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340660|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340661|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
155340662|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340663|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340664|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340665|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340666|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340667|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340668|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340669|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340670|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340671|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340672|NCT01587703|560681252|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340673|NCT01587703|560681253|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340674|NCT01587703|560681254|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340675|NCT01587703|560681255|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340676|NCT01587703|560681256|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340677|NCT01587703|560681257|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340678|NCT01587703|560681258|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340679|NCT01587703|560681259|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340680|NCT01587703|560681260|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340681|NCT01587703|560681261|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340682|NCT01587703|560681262|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340683|NCT01587703|560681263|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340684|NCT01587703|560681264|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340685|NCT01587703|560681265|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340686|NCT01587703|560681266|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340687|NCT01587703|560681267|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340688|NCT01587703|560681268|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340689|NCT01587703|560681269|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340690|NCT01587703|560681270|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
155340691|NCT01587703|560681252|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340692|NCT01587703|560681253|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340693|NCT01587703|560681254|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340694|NCT01587703|560681255|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340695|NCT01587703|560681256|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340696|NCT01587703|560681257|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340697|NCT01587703|560681258|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340698|NCT01587703|560681259|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340699|NCT01587703|560681260|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340700|NCT01587703|560681261|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340701|NCT01587703|560681262|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340702|NCT01587703|560681263|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340703|NCT01587703|560681264|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340704|NCT01587703|560681265|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340705|NCT01587703|560681266|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340706|NCT01587703|560681267|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340707|NCT01587703|560681268|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340708|NCT01587703|560681269|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
155340709|NCT01587703|560681270|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
155340710|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340711|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340712|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340713|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340714|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340715|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340716|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340717|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340718|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340719|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340720|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340721|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340722|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340723|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340724|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340725|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
155340726|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340727|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155423384|NCT00896532|560978719|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423385|NCT00896532|560978720|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423386|NCT00896532|560978721|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423387|NCT00896532|560978722|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423388|NCT00896532|560978723|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423389|NCT00896532|560978724|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423390|NCT00896532|560978725|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423391|NCT00896532|560978726|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423392|NCT00896532|560978727|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
155423393|NCT00896532|560978705|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423394|NCT00896532|560978706|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155340728|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155423395|NCT00896532|560978707|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423396|NCT00896532|560978708|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155340729|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340730|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340731|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340732|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340733|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340734|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340735|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340736|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340737|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340738|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340739|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340740|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
155340741|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340742|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340743|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
155340744|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340745|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340746|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340747|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340748|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340749|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340750|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340751|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340752|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340753|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340754|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340755|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340756|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340757|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340758|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340759|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
155340760|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
155340761|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
155340762|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
155340763|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
155340764|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
155340765|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340766|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340767|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340768|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340769|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340770|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340771|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340772|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340773|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340774|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340775|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340776|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340777|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340778|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
155340779|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
155340780|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
155340781|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
155340782|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
155340783|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
155340784|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340785|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340786|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340787|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340788|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340789|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340790|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155646023|NCT00724893|561795657|FG001|Overall Study|Geographic reasons|11|||
155340791|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340792|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340793|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155646024|NCT00724893|561795656|FG000|Overall Study|Incarceration|0|||
155646025|NCT00724893|561795657|FG001|Overall Study|Incarceration|9|||
155646026|NCT00724893|561795656|FG000|Overall Study|Substance abuse|0|||
155340794|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340795|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340796|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340797|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
155340798|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340799|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340800|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340801|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340802|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340803|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340804|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340805|NCT04751929|560681271|FG000|Overall Study|Withdrawal by Subject|2|||
155340806|NCT04751929|560681272|FG001|Overall Study|Withdrawal by Subject|0|||
155340807|NCT04751929|560681273|FG002|Overall Study|Withdrawal by Subject|0|||
155340808|NCT04751929|560681274|FG003|Overall Study|Withdrawal by Subject|0|||
155340809|NCT04751929|560681271|FG000|Overall Study|Rising PSA|0|||
155340810|NCT04751929|560681272|FG001|Overall Study|Rising PSA|1|||
155340811|NCT04751929|560681273|FG002|Overall Study|Rising PSA|0|||
155340812|NCT04751929|560681274|FG003|Overall Study|Rising PSA|0|||
155340813|NCT04751929|560681271|FG000|Overall Study|Adverse Event|1|||
155340814|NCT04751929|560681272|FG001|Overall Study|Adverse Event|2|||
155340815|NCT04751929|560681273|FG002|Overall Study|Adverse Event|0|||
155340816|NCT04751929|560681274|FG003|Overall Study|Adverse Event|0|||
155340817|NCT04751929|560681271|FG000|Overall Study|Progressive Disease|3|||
155340818|NCT04751929|560681272|FG001|Overall Study|Progressive Disease|4|||
155340819|NCT04751929|560681273|FG002|Overall Study|Progressive Disease|4|||
155340820|NCT04751929|560681274|FG003|Overall Study|Progressive Disease|0|||
155340821|NCT04751929|560681271|FG000|Overall Study|Death|1|||
155340822|NCT04751929|560681272|FG001|Overall Study|Death|1|||
155340823|NCT04751929|560681273|FG002|Overall Study|Death|0|||
155340824|NCT04751929|560681274|FG003|Overall Study|Death|0|||
155340825|NCT01123356|560681275|FG000|Overall Study|Adverse Event|2|||
155340826|NCT01123356|560681275|FG000|Overall Study|Lack of Efficacy|4|||
155340827|NCT01123356|560681275|FG000|Overall Study|Withdrawal by Subject|1|||
155340828|NCT00376259|560681278|FG000|Overall Study|Sponsor request - study termination|21|||
155340829|NCT00376259|560681279|FG001|Overall Study|Sponsor request - study termination|21|||
155340830|NCT00376259|560681278|FG000|Overall Study|Patient request|1|||
155340831|NCT00376259|560681279|FG001|Overall Study|Patient request|0|||
155340832|NCT00759681|560681281|FG000|Overall Study|Death|2|||
155340833|NCT00759681|560681282|FG001|Overall Study|Death|5|||
155340834|NCT00759681|560681281|FG000|Overall Study|Lost to Follow-up|8|||
155340835|NCT00759681|560681282|FG001|Overall Study|Lost to Follow-up|5|||
155340836|NCT00930644|560681283|FG000|Overall Study|Withdrawal by Subject|4|||
155340837|NCT00930644|560681283|FG000|Overall Study|Physician Decision|2|||
155340838|NCT00930644|560681283|FG000|Overall Study|Death|1|||
155340839|NCT00930644|560681283|FG000|Overall Study|Adverse Event|16|||
155340840|NCT01877720|560681284|FG000|Overall Study|Adverse Event|1|||
155340841|NCT01877720|560681285|FG001|Overall Study|Adverse Event|0|||
155340842|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Adverse Event|0|||
155340843|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Adverse Event|0|||
155340844|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Adverse Event|0|||
155340845|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Adverse Event|5|||
155340846|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Adverse Event|0|||
155340847|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Death|0|||
155340848|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Death|0|||
155340849|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Death|0|||
155340850|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Death|1|||
155340851|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Death|0|||
155340852|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Disease Progression|1|||
155340853|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Disease Progression|1|||
155340854|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Disease Progression|0|||
155423397|NCT00896532|560978709|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155340855|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Disease Progression|10|||
155340856|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Disease Progression|1|||
155340857|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Other|0|||
155340858|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Other|0|||
155340859|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Other|0|||
155340860|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Other|1|||
155340861|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Other|0|||
155340862|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Adverse Event|0|||
155340863|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Adverse Event|0|||
155340864|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Adverse Event|0|||
155340865|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Adverse Event|1|||
155340866|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Adverse Event|0|||
155340867|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Death|0|||
155340868|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Death|0|||
155340869|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Death|0|||
155340870|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Death|1|||
155340871|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Death|1|||
155340872|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Disease Progression|0|||
155340873|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Disease Progression|2|||
155340874|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Disease Progression|2|||
155340875|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Disease Progression|17|||
155340876|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Disease Progression|1|||
155340877|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340878|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340879|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340880|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
155340881|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340882|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Other|1|||
155340883|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Other|0|||
155340884|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Other|0|||
155340885|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Other|3|||
155340886|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Other|0|||
155340887|NCT01129011|560681293|FG000|Overall Study|Adverse Event|20|||
155340888|NCT01129011|560681294|FG001|Overall Study|Adverse Event|30|||
155340889|NCT01129011|560681293|FG000|Overall Study|Withdrawal by Subject|24|||
155340890|NCT01129011|560681294|FG001|Overall Study|Withdrawal by Subject|8|||
155340891|NCT01129011|560681293|FG000|Overall Study|Lost to Follow-up|6|||
155340892|NCT01129011|560681294|FG001|Overall Study|Lost to Follow-up|7|||
155340893|NCT01129011|560681293|FG000|Overall Study|Duodenal Ulcer|2|||
155340894|NCT01129011|560681294|FG001|Overall Study|Duodenal Ulcer|8|||
155340895|NCT01129011|560681293|FG000|Overall Study|misc|7|||
155340896|NCT01129011|560681294|FG001|Overall Study|misc|4|||
155340897|NCT01012999|560681298|FG000|Overall Study|Protocol Violation|1|||
155340898|NCT01369147|560681299|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
155340899|NCT01369147|560681300|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
155340900|NCT01369147|560681301|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
155340901|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
155340902|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
155340903|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
155340904|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
155340905|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
155340906|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
155340907|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
155340908|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
155340909|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155340910|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155340911|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
155340912|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
155340913|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
155340914|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
155340915|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
155340916|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
155340917|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
155340918|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
155340919|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
155340920|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
155340921|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
155340922|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
155340923|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
155340924|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
155340925|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
155340926|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
155340927|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
155340928|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
155340929|NCT02410278|560681310|FG000|Run-in Period|Adverse Event|5|||
155340930|NCT02410278|560681311|FG001|Run-in Period|Adverse Event|0|||
155340931|NCT02410278|560681312|FG002|Run-in Period|Adverse Event|0|||
155340932|NCT02410278|560681310|FG000|Run-in Period|GSRS Threshold Not Met|30|||
155340933|NCT02410278|560681311|FG001|Run-in Period|GSRS Threshold Not Met|0|||
155340934|NCT02410278|560681312|FG002|Run-in Period|GSRS Threshold Not Met|0|||
155340935|NCT02410278|560681310|FG000|Run-in Period|Lost to Follow-up|1|||
155340936|NCT02410278|560681311|FG001|Run-in Period|Lost to Follow-up|0|||
155340937|NCT02410278|560681312|FG002|Run-in Period|Lost to Follow-up|0|||
155340938|NCT02410278|560681310|FG000|Run-in Period|Withdrawal by Subject|1|||
155340939|NCT02410278|560681311|FG001|Run-in Period|Withdrawal by Subject|0|||
155340940|NCT02410278|560681312|FG002|Run-in Period|Withdrawal by Subject|0|||
155340941|NCT02410278|560681310|FG000|Run-in Period|Pregnancy|1|||
155340942|NCT02410278|560681311|FG001|Run-in Period|Pregnancy|0|||
155340943|NCT02410278|560681312|FG002|Run-in Period|Pregnancy|0|||
155340944|NCT02410278|560681310|FG000|Study Treatment Period|Adverse Event|0|||
155340945|NCT02410278|560681311|FG001|Study Treatment Period|Adverse Event|6|||
155340946|NCT02410278|560681312|FG002|Study Treatment Period|Adverse Event|3|||
155340947|NCT02410278|560681310|FG000|Study Treatment Period|Physician Decision|0|||
155340948|NCT02410278|560681311|FG001|Study Treatment Period|Physician Decision|0|||
155340949|NCT02410278|560681312|FG002|Study Treatment Period|Physician Decision|1|||
155340950|NCT02410278|560681310|FG000|Study Treatment Period|Withdrawal by Subject|0|||
155340951|NCT02410278|560681311|FG001|Study Treatment Period|Withdrawal by Subject|1|||
155340952|NCT02410278|560681312|FG002|Study Treatment Period|Withdrawal by Subject|0|||
155340953|NCT02410278|560681310|FG000|Study Treatment Period|Other|0|||
155340954|NCT02410278|560681311|FG001|Study Treatment Period|Other|3|||
155340955|NCT02410278|560681312|FG002|Study Treatment Period|Other|0|||
155340956|NCT02410278|560681310|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
155340957|NCT02410278|560681311|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
155340958|NCT02410278|560681312|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
155340959|NCT02584257|560681313|FG000|Period 1|Withdrawal by Subject|0|||
155340960|NCT02584257|560681314|FG001|Period 1|Withdrawal by Subject|0|||
155340961|NCT02584257|560681315|FG002|Period 1|Withdrawal by Subject|0|||
155340962|NCT02584257|560681316|FG003|Period 1|Withdrawal by Subject|0|||
155340963|NCT02584257|560681317|FG004|Period 1|Withdrawal by Subject|0|||
155340964|NCT02584257|560681318|FG005|Period 1|Withdrawal by Subject|0|||
155340965|NCT02584257|560681319|FG006|Period 1|Withdrawal by Subject|1|||
155340966|NCT02584257|560681320|FG007|Period 1|Withdrawal by Subject|0|||
155340967|NCT02584257|560681321|FG008|Period 1|Withdrawal by Subject|0|||
155340968|NCT02584257|560681313|FG000|Period 2|Physician Decision|1|||
155340969|NCT02584257|560681314|FG001|Period 2|Physician Decision|0|||
155340970|NCT02584257|560681315|FG002|Period 2|Physician Decision|0|||
155340971|NCT02584257|560681316|FG003|Period 2|Physician Decision|0|||
155340972|NCT02584257|560681317|FG004|Period 2|Physician Decision|0|||
155340973|NCT02584257|560681318|FG005|Period 2|Physician Decision|0|||
155340974|NCT02584257|560681319|FG006|Period 2|Physician Decision|0|||
155340975|NCT02584257|560681320|FG007|Period 2|Physician Decision|0|||
155340976|NCT02584257|560681321|FG008|Period 2|Physician Decision|0|||
155340977|NCT02584257|560681313|FG000|Period 2|Adverse Event|0|||
155340978|NCT02584257|560681314|FG001|Period 2|Adverse Event|1|||
155340979|NCT02584257|560681315|FG002|Period 2|Adverse Event|0|||
155340980|NCT02584257|560681316|FG003|Period 2|Adverse Event|0|||
155340981|NCT02584257|560681317|FG004|Period 2|Adverse Event|0|||
155340982|NCT02584257|560681318|FG005|Period 2|Adverse Event|0|||
155340983|NCT02584257|560681319|FG006|Period 2|Adverse Event|0|||
155340984|NCT02584257|560681320|FG007|Period 2|Adverse Event|0|||
155340985|NCT02584257|560681321|FG008|Period 2|Adverse Event|0|||
155340986|NCT05376397|560681324|FG000|Overall Study|Lost to Follow-up|1|||
155340987|NCT02721147|560681325|FG000|Overall Study|Lost to Follow-up|2|||
155340988|NCT02721147|560681326|FG001|Overall Study|Lost to Follow-up|0|||
155340989|NCT02721147|560681327|FG002|Overall Study|Lost to Follow-up|0|||
155340990|NCT01722097|560681328|FG000|Overall Study|Patient sheets not returned|6|||
155340991|NCT01722097|560681329|FG001|Overall Study|Patient sheets not returned|5|||
155340992|NCT01535261|560681331|FG000|Overall Study|Physician Decision|8|||
155340993|NCT01535261|560681331|FG000|Overall Study|Protocol Violation|3|||
155340994|NCT01535261|560681331|FG000|Overall Study|Death|5|||
155340995|NCT01535261|560681331|FG000|Overall Study|Lost to Follow-up|8|||
155340996|NCT01535261|560681331|FG000|Overall Study|Withdrawal by Subject|14|||
155340997|NCT01535261|560681331|FG000|Overall Study|Adverse Event|12|||
155423398|NCT00896532|560978710|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423399|NCT00896532|560978711|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423400|NCT00896532|560978712|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423401|NCT00896532|560978713|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
155423402|NCT00896532|560978714|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155436210|NCT00849212|561024564|FG000|Overall Study|Adverse Event|2|||
155340998|NCT01137682|560681332|FG000|Overall Study|Adverse Event-CORE|2|||
155340999|NCT01137682|560681333|FG001|Overall Study|Adverse Event-CORE|4|||
155341000|NCT01137682|560681334|FG002|Overall Study|Adverse Event-CORE|0|||
155341001|NCT01137682|560681332|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
155341002|NCT01137682|560681333|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
155341003|NCT01137682|560681334|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
155341004|NCT01137682|560681332|FG000|Overall Study|Administrative problems-CORE|2|||
155341005|NCT01137682|560681333|FG001|Overall Study|Administrative problems-CORE|1|||
155341006|NCT01137682|560681334|FG002|Overall Study|Administrative problems-CORE|0|||
155341007|NCT01137682|560681332|FG000|Overall Study|Protocol Violation-CORE|0|||
155341008|NCT01137682|560681333|FG001|Overall Study|Protocol Violation-CORE|1|||
155341009|NCT01137682|560681334|FG002|Overall Study|Protocol Violation-CORE|1|||
155341010|NCT01137682|560681332|FG000|Overall Study|Adverse Event-Extension|4|||
155341011|NCT01137682|560681333|FG001|Overall Study|Adverse Event-Extension|8|||
155341012|NCT01137682|560681334|FG002|Overall Study|Adverse Event-Extension|7|||
155341013|NCT01137682|560681332|FG000|Overall Study|Lack of Efficacy-Extension|15|||
155341014|NCT01137682|560681333|FG001|Overall Study|Lack of Efficacy-Extension|9|||
155341015|NCT01137682|560681334|FG002|Overall Study|Lack of Efficacy-Extension|13|||
155341016|NCT01137682|560681332|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
155341017|NCT01137682|560681333|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
155341018|NCT01137682|560681334|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
155341019|NCT01137682|560681332|FG000|Overall Study|Lost to Follow Up-Extension|0|||
155341020|NCT01137682|560681333|FG001|Overall Study|Lost to Follow Up-Extension|1|||
155341021|NCT01137682|560681334|FG002|Overall Study|Lost to Follow Up-Extension|0|||
155341022|NCT01137682|560681332|FG000|Overall Study|Administrative problems-Extension|0|||
155341023|NCT01137682|560681333|FG001|Overall Study|Administrative problems-Extension|2|||
155341024|NCT01137682|560681334|FG002|Overall Study|Administrative problems-Extension|0|||
155341025|NCT01137682|560681332|FG000|Overall Study|Death-Extension|2|||
155341026|NCT01137682|560681333|FG001|Overall Study|Death-Extension|0|||
155341027|NCT01137682|560681334|FG002|Overall Study|Death-Extension|0|||
155341028|NCT01137682|560681332|FG000|Overall Study|Protocol Violation-Extension|2|||
155341029|NCT01137682|560681333|FG001|Overall Study|Protocol Violation-Extension|1|||
155341030|NCT01137682|560681334|FG002|Overall Study|Protocol Violation-Extension|0|||
155341031|NCT01137682|560681332|FG000|Overall Study|Did not enter extension|2|||
155341032|NCT01137682|560681333|FG001|Overall Study|Did not enter extension|3|||
155341033|NCT01137682|560681334|FG002|Overall Study|Did not enter extension|2|||
155341034|NCT01137682|560681332|FG000|Overall Study|Did not receive treatment in extension|0|||
155341035|NCT01137682|560681333|FG001|Overall Study|Did not receive treatment in extension|0|||
155341036|NCT01137682|560681334|FG002|Overall Study|Did not receive treatment in extension|1|||
155341037|NCT02009332|560681337|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341038|NCT02009332|560681338|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
155341039|NCT02009332|560681339|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341040|NCT02009332|560681340|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341041|NCT02009332|560681341|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341042|NCT02009332|560681342|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341043|NCT02009332|560681337|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341044|NCT02009332|560681338|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341045|NCT02009332|560681339|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341046|NCT02009332|560681340|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341047|NCT02009332|560681341|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
155341048|NCT02009332|560681342|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341049|NCT02009332|560681337|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341050|NCT02009332|560681338|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341051|NCT02009332|560681339|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341052|NCT02009332|560681340|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341053|NCT02009332|560681341|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341054|NCT02009332|560681342|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
155341055|NCT01912599|560681343|FG000|Overall Study|Withdrawal by Subject|0|||
155341056|NCT01912599|560681344|FG001|Overall Study|Withdrawal by Subject|1|||
155341057|NCT01280721|560681348|FG000|Overall Study|Adverse Event|4|||
155341058|NCT01280721|560681348|FG000|Overall Study|Physician Decision|3|||
155341059|NCT01280721|560681348|FG000|Overall Study|Withdrawal by Subject|6|||
155341060|NCT01280721|560681348|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
155341061|NCT01280721|560681348|FG000|Overall Study|No tolerability for the lowest dose|2|||
155341062|NCT01180400|560681349|FG000|Overall Study|Withdrawal by Subject|5|||
155341063|NCT01180400|560681350|FG001|Overall Study|Withdrawal by Subject|6|||
155341064|NCT01180400|560681349|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155341065|NCT01180400|560681350|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155341066|NCT01180400|560681349|FG000|Overall Study|Adverse Event|12|||
155341067|NCT01180400|560681350|FG001|Overall Study|Adverse Event|10|||
155341068|NCT01180400|560681349|FG000|Overall Study|Severe non-compliance to protocol|1|||
155341069|NCT01180400|560681350|FG001|Overall Study|Severe non-compliance to protocol|2|||
155341070|NCT01180400|560681349|FG000|Overall Study|Condition under investigation worsened|2|||
155341071|NCT01180400|560681350|FG001|Overall Study|Condition under investigation worsened|1|||
155341072|NCT01180400|560681349|FG000|Overall Study|Lack of Efficacy|2|||
155341073|NCT01180400|560681350|FG001|Overall Study|Lack of Efficacy|0|||
155341074|NCT01180400|560681349|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155341075|NCT01180400|560681350|FG001|Overall Study|Study-specific withdrawal criteria|2|||
155341076|NCT01180400|560681349|FG000|Overall Study|Lost to Follow-up|2|||
155341077|NCT01180400|560681350|FG001|Overall Study|Lost to Follow-up|3|||
155423403|NCT00896532|560978715|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155341078|NCT01180400|560681349|FG000|Overall Study|Other|0|||
155341079|NCT01180400|560681350|FG001|Overall Study|Other|1|||
155341080|NCT00042939|560681352|FG000|Overall Study|Adverse Event|6|||
155341081|NCT00042939|560681353|FG001|Overall Study|Adverse Event|7|||
155341082|NCT00042939|560681352|FG000|Overall Study|Death|3|||
155341083|NCT00042939|560681353|FG001|Overall Study|Death|2|||
155341084|NCT00042939|560681352|FG000|Overall Study|Withdrawal by Subject|3|||
155341085|NCT00042939|560681353|FG001|Overall Study|Withdrawal by Subject|4|||
155341086|NCT00042939|560681352|FG000|Overall Study|Other disease|1|||
155341087|NCT00042939|560681353|FG001|Overall Study|Other disease|0|||
155341088|NCT00042939|560681352|FG000|Overall Study|Ineligible|2|||
155341089|NCT00042939|560681353|FG001|Overall Study|Ineligible|2|||
155341090|NCT00042939|560681352|FG000|Overall Study|Deterioration of health|3|||
155341091|NCT00042939|560681353|FG001|Overall Study|Deterioration of health|4|||
155341092|NCT00042939|560681352|FG000|Overall Study|QOL diminished|1|||
155341093|NCT00042939|560681353|FG001|Overall Study|QOL diminished|0|||
155341094|NCT00042939|560681352|FG000|Overall Study|Rising ca 19-9|1|||
155341095|NCT00042939|560681353|FG001|Overall Study|Rising ca 19-9|0|||
155341096|NCT00042939|560681352|FG000|Overall Study|Patient non-compliance|1|||
155341097|NCT00042939|560681353|FG001|Overall Study|Patient non-compliance|0|||
155341098|NCT00042939|560681352|FG000|Overall Study|Still on treatment|1|||
155423404|NCT00896532|560978716|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423405|NCT00896532|560978717|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423406|NCT00896532|560978718|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423407|NCT00896532|560978719|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423408|NCT00896532|560978720|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423409|NCT00896532|560978721|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423410|NCT00896532|560978722|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155341099|NCT00042939|560681353|FG001|Overall Study|Still on treatment|0|||
155341100|NCT00042939|560681352|FG000|Overall Study|Treatment break > 4 weeks|0|||
155341101|NCT00042939|560681353|FG001|Overall Study|Treatment break > 4 weeks|1|||
155341102|NCT00042939|560681352|FG000|Overall Study|Did not start treatment|2|||
155341103|NCT00042939|560681353|FG001|Overall Study|Did not start treatment|1|||
155423411|NCT00896532|560978723|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423412|NCT00896532|560978724|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155646027|NCT00724893|561795657|FG001|Overall Study|Substance abuse|3|||
155646028|NCT00724893|561795656|FG000|Overall Study|Financial reasons|0|||
155646029|NCT00724893|561795657|FG001|Overall Study|Financial reasons|2|||
155646030|NCT00724893|561795656|FG000|Overall Study|Assigned shorter treatment|0|||
155646031|NCT00724893|561795657|FG001|Overall Study|Assigned shorter treatment|2|||
155646032|NCT00724893|561795656|FG000|Overall Study|Lost to Follow-up|0|||
155646033|NCT00724893|561795657|FG001|Overall Study|Lost to Follow-up|52|||
155646034|NCT00724893|561795656|FG000|Overall Study|Unknown, missing data|1|||
155646035|NCT00724893|561795657|FG001|Overall Study|Unknown, missing data|1|||
155646036|NCT01290731|561795660|FG000|Overall Study|Withdrawal by Subject|1|||
155646037|NCT01179516|561795662|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
155646038|NCT01179516|561795663|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
155646039|NCT01179516|561795664|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
155646040|NCT01179516|561795662|FG000|Overall Study|Lack of Efficacy|4|||
155646041|NCT01179516|561795663|FG001|Overall Study|Lack of Efficacy|2|||
155646042|NCT01179516|561795664|FG002|Overall Study|Lack of Efficacy|0|||
155646043|NCT01179516|561795662|FG000|Overall Study|Noncompliance with Study Drug|2|||
155646044|NCT01179516|561795663|FG001|Overall Study|Noncompliance with Study Drug|0|||
155646045|NCT01179516|561795664|FG002|Overall Study|Noncompliance with Study Drug|1|||
155646046|NCT01179516|561795662|FG000|Overall Study|Protocol Deviations|4|||
155646047|NCT01179516|561795663|FG001|Overall Study|Protocol Deviations|3|||
155646048|NCT01179516|561795664|FG002|Overall Study|Protocol Deviations|3|||
155646049|NCT01179516|561795662|FG000|Overall Study|Withdrawal of Consent|2|||
155646050|NCT01179516|561795663|FG001|Overall Study|Withdrawal of Consent|6|||
155646051|NCT01179516|561795664|FG002|Overall Study|Withdrawal of Consent|10|||
155646052|NCT01179516|561795662|FG000|Overall Study|Lost to Follow-up|7|||
155646053|NCT01179516|561795663|FG001|Overall Study|Lost to Follow-up|7|||
155646054|NCT01179516|561795664|FG002|Overall Study|Lost to Follow-up|3|||
155646055|NCT01179516|561795662|FG000|Overall Study|Other|2|||
155646056|NCT01179516|561795663|FG001|Overall Study|Other|0|||
155646057|NCT01179516|561795664|FG002|Overall Study|Other|2|||
155646058|NCT00888849|561795669|FG000|Overall Study|Death|4|||
155646059|NCT00888849|561795670|FG001|Overall Study|Death|7|||
155646060|NCT00888849|561795669|FG000|Overall Study|Lost to Follow-up|1|||
155646061|NCT00888849|561795670|FG001|Overall Study|Lost to Follow-up|2|||
155646062|NCT05064800|561795671|FG000|Period 3|Withdrawal by Subject|0|||
155646063|NCT05064800|561795672|FG001|Period 3|Withdrawal by Subject|0|||
155646064|NCT05064800|561795673|FG002|Period 3|Withdrawal by Subject|0|||
155646065|NCT05064800|561795674|FG003|Period 3|Withdrawal by Subject|0|||
155646066|NCT05064800|561795675|FG004|Period 3|Withdrawal by Subject|1|||
155646067|NCT05064800|561795676|FG005|Period 3|Withdrawal by Subject|0|||
155504614|NCT04380701|561274038|FG026|Overall Study|Physician Decision|0|||
155504615|NCT04380701|561274039|FG027|Overall Study|Physician Decision|0|||
155504616|NCT04380701|561274040|FG028|Overall Study|Physician Decision|0|||
155504617|NCT04380701|561274041|FG029|Overall Study|Physician Decision|0|||
155504618|NCT04380701|561274042|FG030|Overall Study|Physician Decision|0|||
155341104|NCT03349476|560681354|FG000|Overall Study|Physician Decision|3|||
155341105|NCT00795639|560681355|FG000|Overall Study|Death|1|||
155341106|NCT00795639|560681356|FG001|Overall Study|Death|6|||
155341107|NCT00795639|560681355|FG000|Overall Study|Withdrawal by Subject|1|||
155341108|NCT00795639|560681356|FG001|Overall Study|Withdrawal by Subject|3|||
155341109|NCT00795639|560681355|FG000|Overall Study|Pregnancy|1|||
155341110|NCT00795639|560681356|FG001|Overall Study|Pregnancy|0|||
155341111|NCT00795639|560681355|FG000|Overall Study|Adverse Event|5|||
155341112|NCT00795639|560681356|FG001|Overall Study|Adverse Event|2|||
155341113|NCT00795639|560681355|FG000|Overall Study|Other|0|||
155646068|NCT00629239|561795677|FG000|Overall Study|Adverse Event|7|||
155646069|NCT00629239|561795678|FG001|Overall Study|Adverse Event|4|||
155646070|NCT00629239|561795677|FG000|Overall Study|Physician Decision|1|||
155646071|NCT00629239|561795678|FG001|Overall Study|Physician Decision|0|||
155646072|NCT01851369|561795679|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646073|NCT01851369|561795680|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646074|NCT01851369|561795681|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646075|NCT01851369|561795682|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646076|NCT01851369|561795683|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646077|NCT01851369|561795684|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
155646078|NCT01851369|561795685|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646079|NCT01851369|561795686|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646080|NCT01851369|561795687|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155341114|NCT00795639|560681356|FG001|Overall Study|Other|2|||
155341115|NCT00795639|560681355|FG000|Overall Study|Terminated by sponsor|13|||
155341116|NCT00795639|560681356|FG001|Overall Study|Terminated by sponsor|12|||
155341117|NCT00795639|560681355|FG000|Overall Study|Randomized and not treated|0|||
155341118|NCT00795639|560681356|FG001|Overall Study|Randomized and not treated|1|||
155341119|NCT00068107|560681357|FG000|Overall Study|end-stage renal disease|6|||
155341120|NCT00068107|560681357|FG000|Overall Study|Death|2|||
155341121|NCT00068107|560681357|FG000|Overall Study|Withdrawal by Subject|1|||
155341122|NCT01419184|560681358|FG000|Overall Study|Site data not available|3|||
155504619|NCT04380701|561274043|FG031|Overall Study|Physician Decision|0|||
155341123|NCT01419184|560681359|FG001|Overall Study|Site data not available|2|||
155341124|NCT01419184|560681358|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
155341125|NCT01419184|560681359|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
155341126|NCT01419184|560681358|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
155436211|NCT00849212|561024564|FG000|Overall Study|Miscellaneous|1|||
155436212|NCT04407507|561024565|FG000|Overall Study|Withdrawal by Subject|0|||
155436213|NCT04407507|561024566|FG001|Overall Study|Withdrawal by Subject|1|||
155436214|NCT01499576|561024567|FG000|Overall Study|Physician Decision|12|||
155436215|NCT01499576|561024567|FG000|Overall Study|Withdrawal by Subject|9|||
155436216|NCT03396471|561024570|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
155436217|NCT03396471|561024570|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
155436218|NCT03396471|561024570|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
155436219|NCT03396471|561024570|FG000|Study Treatment - Up to 22 Months|Death|2|||
155436220|NCT03396471|561024570|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
155436221|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|Death|9|||
155436222|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
155436223|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
155436224|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|study terminated|1|||
155436225|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
155436226|NCT03396471|561024570|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
155436227|NCT00923091|561024571|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
155436228|NCT00923091|561024572|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
155436229|NCT00923091|561024573|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
155436230|NCT00923091|561024574|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
155436231|NCT00923091|561024575|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
155436232|NCT00923091|561024576|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
155436233|NCT00923091|561024577|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
155436234|NCT00923091|561024578|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
155436235|NCT00923091|561024579|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
155436236|NCT00923091|561024580|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
155436237|NCT00923091|561024581|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
155436238|NCT00923091|561024582|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
155436239|NCT00923091|561024583|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
155436240|NCT00923091|561024571|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
155436241|NCT00923091|561024572|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
155436242|NCT00923091|561024573|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
155436243|NCT00923091|561024574|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
155436244|NCT00923091|561024575|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
155436245|NCT00923091|561024576|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
155436246|NCT00923091|561024577|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
155436247|NCT00923091|561024578|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
155436248|NCT00923091|561024579|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
155436249|NCT00923091|561024580|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
155436250|NCT00923091|561024581|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
155436251|NCT00923091|561024582|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
155436252|NCT00923091|561024583|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
155436253|NCT00923091|561024571|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
155436254|NCT00923091|561024572|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
155436255|NCT00923091|561024573|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
155504620|NCT04380701|561274044|FG032|Overall Study|Physician Decision|0|||
155504621|NCT04380701|561274045|FG033|Overall Study|Physician Decision|0|||
155504622|NCT04380701|561274012|FG000|Overall Study|Death|0|||
155504623|NCT04380701|561274013|FG001|Overall Study|Death|0|||
155504624|NCT04380701|561274014|FG002|Overall Study|Death|0|||
155341127|NCT01419184|560681359|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
155341128|NCT01419184|560681358|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
155341129|NCT01419184|560681359|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
155341130|NCT01419184|560681358|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
155341131|NCT01419184|560681359|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
155341132|NCT01419184|560681358|FG000|Overall Study|Participant randomized, not treated|1|||
155341133|NCT01419184|560681359|FG001|Overall Study|Participant randomized, not treated|0|||
155341134|NCT01441596|560681368|FG000|Overall Study|Other reason not defined below|0|||
155341135|NCT01441596|560681369|FG001|Overall Study|Other reason not defined below|2|||
155341136|NCT01441596|560681370|FG002|Overall Study|Other reason not defined below|1|||
155341137|NCT01441596|560681368|FG000|Overall Study|Withdrawal by Subject|4|||
155341138|NCT01441596|560681369|FG001|Overall Study|Withdrawal by Subject|0|||
155341139|NCT01441596|560681370|FG002|Overall Study|Withdrawal by Subject|2|||
155341140|NCT01441596|560681368|FG000|Overall Study|Not treated|0|||
155341141|NCT01441596|560681369|FG001|Overall Study|Not treated|1|||
155341142|NCT01441596|560681370|FG002|Overall Study|Not treated|1|||
155341143|NCT03055988|560681371|FG000|Period 1|Adverse Event|0|||
155341144|NCT03055988|560681372|FG001|Period 1|Adverse Event|1|||
155341145|NCT03055988|560681371|FG000|Period 1|Lost to Follow-up|1|||
155341146|NCT03055988|560681372|FG001|Period 1|Lost to Follow-up|0|||
155341147|NCT03055988|560681371|FG000|Period 1|Withdrawal by Subject|0|||
155341148|NCT03055988|560681372|FG001|Period 1|Withdrawal by Subject|4|||
155341149|NCT03055988|560681371|FG000|Period 2|Adverse Event|0|||
155341150|NCT03055988|560681372|FG001|Period 2|Adverse Event|1|||
155341151|NCT03055988|560681371|FG000|Period 2|Other than listed|1|||
155341152|NCT03055988|560681372|FG001|Period 2|Other than listed|1|||
155341153|NCT01528605|560681373|FG000|Overall Study|Lost to Follow-up|1|||
155341154|NCT01528605|560681374|FG001|Overall Study|Lost to Follow-up|0|||
155341155|NCT01528605|560681375|FG002|Overall Study|Lost to Follow-up|1|||
155341156|NCT01528605|560681376|FG003|Overall Study|Lost to Follow-up|1|||
155341157|NCT01528605|560681377|FG004|Overall Study|Lost to Follow-up|0|||
155341158|NCT01528605|560681378|FG005|Overall Study|Lost to Follow-up|0|||
155341159|NCT01528605|560681373|FG000|Overall Study|Death|1|||
155341160|NCT01528605|560681374|FG001|Overall Study|Death|0|||
155341161|NCT01528605|560681375|FG002|Overall Study|Death|0|||
155341162|NCT01528605|560681376|FG003|Overall Study|Death|0|||
155341163|NCT01528605|560681377|FG004|Overall Study|Death|0|||
155341164|NCT01528605|560681378|FG005|Overall Study|Death|0|||
155341165|NCT01681511|560681379|FG000|Overall Study|No Treatment Received|1|||
155341166|NCT01681511|560681380|FG001|Overall Study|No Treatment Received|3|||
155341167|NCT01681511|560681379|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
155504625|NCT04380701|561274015|FG003|Overall Study|Death|0|||
155504626|NCT04380701|561274016|FG004|Overall Study|Death|0|||
155504627|NCT04380701|561274017|FG005|Overall Study|Death|0|||
155504628|NCT04380701|561274018|FG006|Overall Study|Death|0|||
155504629|NCT04380701|561274019|FG007|Overall Study|Death|0|||
155504630|NCT04380701|561274020|FG008|Overall Study|Death|0|||
155504631|NCT04380701|561274021|FG009|Overall Study|Death|0|||
155504632|NCT04380701|561274022|FG010|Overall Study|Death|0|||
155504633|NCT04380701|561274023|FG011|Overall Study|Death|0|||
155504634|NCT04380701|561274024|FG012|Overall Study|Death|0|||
155504635|NCT04380701|561274025|FG013|Overall Study|Death|0|||
155504636|NCT04380701|561274026|FG014|Overall Study|Death|0|||
155504637|NCT04380701|561274027|FG015|Overall Study|Death|0|||
155504638|NCT04380701|561274028|FG016|Overall Study|Death|0|||
155504639|NCT04380701|561274029|FG017|Overall Study|Death|0|||
155504640|NCT04380701|561274030|FG018|Overall Study|Death|0|||
155504641|NCT04380701|561274031|FG019|Overall Study|Death|0|||
155504642|NCT04380701|561274032|FG020|Overall Study|Death|0|||
155504643|NCT04380701|561274033|FG021|Overall Study|Death|0|||
155504644|NCT04380701|561274034|FG022|Overall Study|Death|0|||
155504645|NCT04380701|561274035|FG023|Overall Study|Death|0|||
155646081|NCT01851369|561795688|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646082|NCT01851369|561795689|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646083|NCT01851369|561795690|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646084|NCT01851369|561795691|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155646085|NCT00183391|561795692|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
155646086|NCT00183391|561795693|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
155646087|NCT00183391|561795692|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
155646088|NCT00183391|561795693|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
155646089|NCT00395512|561795694|FG000|Overall Study|Adverse Event|3|||
155646090|NCT00395512|561795695|FG001|Overall Study|Adverse Event|8|||
155646091|NCT00395512|561795696|FG002|Overall Study|Adverse Event|6|||
155646092|NCT00395512|561795697|FG003|Overall Study|Adverse Event|6|||
155646093|NCT00395512|561795694|FG000|Overall Study|Protocol Violation|2|||
155646094|NCT00395512|561795695|FG001|Overall Study|Protocol Violation|3|||
155646095|NCT00395512|561795696|FG002|Overall Study|Protocol Violation|6|||
155646096|NCT00395512|561795697|FG003|Overall Study|Protocol Violation|7|||
155646097|NCT00395512|561795694|FG000|Overall Study|Lost to Follow-up|2|||
155646098|NCT00395512|561795695|FG001|Overall Study|Lost to Follow-up|6|||
155646099|NCT00395512|561795696|FG002|Overall Study|Lost to Follow-up|5|||
155646100|NCT00395512|561795697|FG003|Overall Study|Lost to Follow-up|5|||
155646101|NCT00395512|561795694|FG000|Overall Study|Withdrawal by Subject|6|||
155646102|NCT00395512|561795695|FG001|Overall Study|Withdrawal by Subject|5|||
155646103|NCT00395512|561795696|FG002|Overall Study|Withdrawal by Subject|5|||
155646104|NCT00395512|561795697|FG003|Overall Study|Withdrawal by Subject|12|||
155646105|NCT00395512|561795694|FG000|Overall Study|Physician Decision|6|||
155646106|NCT00395512|561795695|FG001|Overall Study|Physician Decision|4|||
155646107|NCT00395512|561795696|FG002|Overall Study|Physician Decision|2|||
155646108|NCT00395512|561795697|FG003|Overall Study|Physician Decision|2|||
155646109|NCT00395512|561795694|FG000|Overall Study|Other|1|||
155646110|NCT00395512|561795695|FG001|Overall Study|Other|1|||
155646111|NCT00395512|561795696|FG002|Overall Study|Other|0|||
155646112|NCT00395512|561795697|FG003|Overall Study|Other|0|||
155646113|NCT00395512|561795694|FG000|Overall Study|Hyperglycemic Rescue|18|||
155646114|NCT00395512|561795695|FG001|Overall Study|Hyperglycemic Rescue|10|||
155646115|NCT00395512|561795696|FG002|Overall Study|Hyperglycemic Rescue|4|||
155646116|NCT00395512|561795697|FG003|Overall Study|Hyperglycemic Rescue|6|||
155646117|NCT04584554|561795704|FG000|Overall Study|Withdrawal by Subject|2|||
155646118|NCT04584554|561795705|FG001|Overall Study|Withdrawal by Subject|2|||
155646119|NCT01483651|561795709|FG000|Overall Study|Withdrawal by Subject|0|||
155646120|NCT01483651|561795710|FG001|Overall Study|Withdrawal by Subject|1|||
155646121|NCT01483651|561795711|FG002|Overall Study|Withdrawal by Subject|1|||
155646122|NCT01483651|561795712|FG003|Overall Study|Withdrawal by Subject|0|||
155646123|NCT01483651|561795713|FG004|Overall Study|Withdrawal by Subject|0|||
155646124|NCT01483651|561795714|FG005|Overall Study|Withdrawal by Subject|1|||
155646125|NCT01184118|561795716|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
155646126|NCT01184118|561795716|FG000|Overall Study|No physiologic confirmation of asthma|8|||
155646127|NCT01184118|561795716|FG000|Overall Study|FEV1 <60% predicted|2|||
155646128|NCT01184118|561795716|FG000|Overall Study|Exclusionary medical condition|2|||
155646129|NCT01184118|561795716|FG000|Overall Study|Withdrawal by Subject|5|||
155646130|NCT01186419|561795717|FG000|Overall Study|Withdrawal by Subject|5|||
155646131|NCT01186419|561795718|FG001|Overall Study|Withdrawal by Subject|3|||
155646132|NCT01186419|561795717|FG000|Overall Study|Adverse Event|1|||
155646133|NCT01186419|561795718|FG001|Overall Study|Adverse Event|2|||
155646134|NCT01186419|561795717|FG000|Overall Study|Physician Decision|0|||
155341168|NCT01681511|560681380|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
155341169|NCT01681511|560681379|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
155341170|NCT01681511|560681380|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
155341171|NCT01681511|560681379|FG000|Overall Study|No Daily Urine Sample Collected|0|||
155341172|NCT01681511|560681380|FG001|Overall Study|No Daily Urine Sample Collected|1|||
155423413|NCT00896532|560978725|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423414|NCT00896532|560978726|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423415|NCT00896532|560978727|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
155423416|NCT00896532|560978705|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423417|NCT00896532|560978706|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423418|NCT00896532|560978707|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423419|NCT00896532|560978708|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423420|NCT00896532|560978709|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423421|NCT00896532|560978710|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423422|NCT00896532|560978711|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423423|NCT00896532|560978712|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423424|NCT00896532|560978713|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423425|NCT00896532|560978714|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423426|NCT00896532|560978715|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423427|NCT00896532|560978716|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423428|NCT00896532|560978717|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
155423429|NCT00896532|560978718|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423430|NCT00896532|560978719|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423431|NCT00896532|560978720|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423432|NCT00896532|560978721|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155504646|NCT04380701|561274036|FG024|Overall Study|Death|1|||
155504647|NCT04380701|561274037|FG025|Overall Study|Death|0|||
155504648|NCT04380701|561274038|FG026|Overall Study|Death|0|||
155504649|NCT04380701|561274039|FG027|Overall Study|Death|0|||
155423433|NCT00896532|560978722|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155504650|NCT04380701|561274040|FG028|Overall Study|Death|0|||
155504651|NCT04380701|561274041|FG029|Overall Study|Death|0|||
155646135|NCT01186419|561795718|FG001|Overall Study|Physician Decision|3|||
155646136|NCT01186419|561795717|FG000|Overall Study|Other|1|||
155646137|NCT01186419|561795718|FG001|Overall Study|Other|1|||
155646138|NCT01928771|561795720|FG000|Overall Study|Adverse Event|6|||
155646139|NCT01928771|561795721|FG001|Overall Study|Adverse Event|5|||
155646140|NCT01928771|561795722|FG002|Overall Study|Adverse Event|1|||
155646141|NCT01928771|561795720|FG000|Overall Study|Death|2|||
155646142|NCT01928771|561795721|FG001|Overall Study|Death|2|||
155646143|NCT01928771|561795722|FG002|Overall Study|Death|2|||
155646144|NCT01928771|561795720|FG000|Overall Study|Lost to Follow-up|5|||
155646145|NCT01928771|561795721|FG001|Overall Study|Lost to Follow-up|6|||
155646146|NCT01928771|561795722|FG002|Overall Study|Lost to Follow-up|3|||
155646147|NCT01928771|561795720|FG000|Overall Study|Withdrawal by Subject|20|||
155646148|NCT01928771|561795721|FG001|Overall Study|Withdrawal by Subject|15|||
155646149|NCT01928771|561795722|FG002|Overall Study|Withdrawal by Subject|17|||
155646150|NCT01928771|561795720|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155646151|NCT01928771|561795721|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155646152|NCT01928771|561795722|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
155646153|NCT01928771|561795720|FG000|Overall Study|Other Reasons|9|||
155646154|NCT01928771|561795721|FG001|Overall Study|Other Reasons|9|||
155646155|NCT01928771|561795722|FG002|Overall Study|Other Reasons|14|||
155646156|NCT01928771|561795720|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
155646157|NCT01928771|561795721|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155646158|NCT01928771|561795722|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
155646159|NCT01937117|561795723|FG000|Overall Study|Disease Progression|7|||
155646160|NCT01937117|561795723|FG000|Overall Study|Physician Decision|4|||
155423434|NCT00896532|560978723|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423435|NCT00896532|560978724|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423436|NCT00896532|560978725|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423437|NCT00896532|560978726|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423438|NCT00896532|560978727|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
155423439|NCT00896532|560978705|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423440|NCT00896532|560978706|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423441|NCT00896532|560978707|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423442|NCT00896532|560978708|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423443|NCT00896532|560978709|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423444|NCT00896532|560978710|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423445|NCT00896532|560978711|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423446|NCT00896532|560978712|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423447|NCT00896532|560978713|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423448|NCT00896532|560978714|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423449|NCT00896532|560978715|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
155423450|NCT00896532|560978716|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423451|NCT00896532|560978717|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
155423452|NCT00896532|560978718|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423453|NCT00896532|560978719|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423454|NCT00896532|560978720|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423455|NCT00896532|560978721|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423456|NCT00896532|560978722|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423457|NCT00896532|560978723|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423458|NCT00896532|560978724|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423459|NCT00896532|560978725|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423460|NCT00896532|560978726|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423461|NCT00896532|560978727|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
155423462|NCT00896532|560978705|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423463|NCT00896532|560978706|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423464|NCT00896532|560978707|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423465|NCT00896532|560978708|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423466|NCT00896532|560978709|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423467|NCT00896532|560978710|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423468|NCT00896532|560978711|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423469|NCT00896532|560978712|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423470|NCT00896532|560978713|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423471|NCT00896532|560978714|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423472|NCT00896532|560978715|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423473|NCT00896532|560978716|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423474|NCT00896532|560978717|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
155423475|NCT00896532|560978718|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
155423476|NCT00896532|560978719|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423477|NCT00896532|560978720|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423478|NCT00896532|560978721|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423479|NCT00896532|560978722|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423480|NCT00896532|560978723|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423481|NCT00896532|560978724|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155646161|NCT01937117|561795723|FG000|Overall Study|Adverse Event|2|||
155646162|NCT01407367|561795726|FG000|Overall Study|Death|24|||
155646163|NCT01407367|561795727|FG001|Overall Study|Death|32|||
155646164|NCT01407367|561795726|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
155646165|NCT01407367|561795727|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
155646166|NCT01407367|561795726|FG000|Overall Study|Withdrawal by Subject|4|||
155646167|NCT01407367|561795727|FG001|Overall Study|Withdrawal by Subject|15|||
155646168|NCT01407367|561795726|FG000|Overall Study|Lost to Follow-up|0|||
155646169|NCT01407367|561795727|FG001|Overall Study|Lost to Follow-up|2|||
155646170|NCT02186171|561795731|FG000|Overall Study|Withdrawal by Subject|1|||
155646171|NCT02186171|561795732|FG001|Overall Study|Withdrawal by Subject|9|||
155646172|NCT02186171|561795731|FG000|Overall Study|Lost to Follow-up|2|||
155646173|NCT02186171|561795732|FG001|Overall Study|Lost to Follow-up|2|||
155646174|NCT02186171|561795731|FG000|Overall Study|Death|1|||
155646175|NCT02186171|561795732|FG001|Overall Study|Death|2|||
155646176|NCT02186171|561795731|FG000|Overall Study|Protocol-specified Criteria|0|||
155646177|NCT02186171|561795732|FG001|Overall Study|Protocol-specified Criteria|2|||
155646178|NCT01245062|561795733|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
155646179|NCT01245062|561795734|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
155646180|NCT01245062|561795735|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
155646181|NCT01245062|561795733|FG000|Randomization and Crossover Phase|Physician Decision|2|||
155646182|NCT01245062|561795734|FG001|Randomization and Crossover Phase|Physician Decision|4|||
155646183|NCT01245062|561795735|FG002|Randomization and Crossover Phase|Physician Decision|0|||
155646184|NCT01245062|561795733|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
155646185|NCT01245062|561795734|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
155646186|NCT01245062|561795735|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
155646187|NCT01245062|561795733|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
155646188|NCT01245062|561795734|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
155646189|NCT01245062|561795735|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
155646190|NCT01245062|561795733|FG000|Cross-over Phase|Lost to Follow-up|0|||
155646191|NCT01245062|561795734|FG001|Cross-over Phase|Lost to Follow-up|0|||
155646192|NCT01245062|561795735|FG002|Cross-over Phase|Lost to Follow-up|1|||
155646193|NCT01245062|561795733|FG000|Cross-over Phase|Physician Decision|0|||
155646194|NCT01245062|561795734|FG001|Cross-over Phase|Physician Decision|0|||
155646195|NCT01245062|561795735|FG002|Cross-over Phase|Physician Decision|1|||
155341173|NCT01681511|560681379|FG000|Overall Study|No post-catheter sample collected|11|||
155504652|NCT04380701|561274042|FG030|Overall Study|Death|0|||
155504653|NCT04380701|561274043|FG031|Overall Study|Death|0|||
155504654|NCT04380701|561274044|FG032|Overall Study|Death|0|||
155504655|NCT04380701|561274045|FG033|Overall Study|Death|0|||
155504656|NCT04380701|561274012|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155341174|NCT01681511|560681380|FG001|Overall Study|No post-catheter sample collected|4|||
155341175|NCT01156675|560681381|FG000|Overall Study|Death|5|||
155341176|NCT01156675|560681382|FG001|Overall Study|Death|3|||
155504657|NCT04380701|561274013|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504658|NCT04380701|561274014|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504659|NCT04380701|561274015|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504660|NCT04380701|561274016|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504661|NCT04380701|561274017|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504662|NCT04380701|561274018|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504663|NCT04380701|561274019|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504664|NCT04380701|561274020|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504665|NCT04380701|561274021|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504666|NCT04380701|561274022|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504667|NCT04380701|561274023|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504668|NCT04380701|561274024|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504669|NCT04380701|561274025|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504670|NCT04380701|561274026|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504671|NCT04380701|561274027|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504672|NCT04380701|561274028|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504673|NCT04380701|561274029|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504674|NCT04380701|561274030|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504675|NCT04380701|561274031|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504676|NCT04380701|561274032|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504677|NCT04380701|561274033|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
155504678|NCT04380701|561274034|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
155504679|NCT04380701|561274035|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
155504680|NCT04380701|561274036|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
155504681|NCT04380701|561274037|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504682|NCT04380701|561274038|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504683|NCT04380701|561274039|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504684|NCT04380701|561274040|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504685|NCT04380701|561274041|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504686|NCT04380701|561274042|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504687|NCT04380701|561274043|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504688|NCT04380701|561274044|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504689|NCT04380701|561274045|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155504690|NCT03550794|561274046|FG000|Overall Study|No longer met inclusion criteria|1|||
155504691|NCT03550794|561274047|FG001|Overall Study|No longer met inclusion criteria|2|||
155504692|NCT03550794|561274046|FG000|Overall Study|Goals of care changed|1|||
155504693|NCT03550794|561274047|FG001|Overall Study|Goals of care changed|0|||
155504694|NCT03550794|561274046|FG000|Overall Study|Withdrawal by Subject|2|||
155504695|NCT03550794|561274047|FG001|Overall Study|Withdrawal by Subject|0|||
155504696|NCT03550794|561274046|FG000|Overall Study|Death|0|||
155504697|NCT03550794|561274047|FG001|Overall Study|Death|1|||
155504698|NCT01864525|561274048|FG000|Overall Study|Adverse Event|1|||
155504699|NCT01864525|561274049|FG001|Overall Study|Adverse Event|0|||
155504700|NCT01890785|561274050|FG000|Third Intervention|Withdrawal by Subject|0|||
155504701|NCT01890785|561274051|FG001|Third Intervention|Withdrawal by Subject|1|||
155341177|NCT01156675|560681383|FG002|Overall Study|Death|0|||
155341178|NCT01156675|560681381|FG000|Overall Study|No data|29|||
155504702|NCT01890785|561274052|FG002|Third Intervention|Withdrawal by Subject|0|||
155504703|NCT01890785|561274053|FG003|Third Intervention|Withdrawal by Subject|0|||
155341179|NCT01156675|560681382|FG001|Overall Study|No data|22|||
155341180|NCT01156675|560681383|FG002|Overall Study|No data|2|||
155504704|NCT01890785|561274054|FG004|Third Intervention|Withdrawal by Subject|0|||
155504705|NCT01890785|561274055|FG005|Third Intervention|Withdrawal by Subject|0|||
155341181|NCT00090519|560681397|FG000|Overall Study|Adverse Event|5|||
155341182|NCT00090519|560681398|FG001|Overall Study|Adverse Event|4|||
155341183|NCT00090519|560681397|FG000|Overall Study|Death|9|||
155646196|NCT01245062|561795733|FG000|Cross-over Phase|Withdrew Consent|0|||
155646197|NCT01245062|561795734|FG001|Cross-over Phase|Withdrew Consent|0|||
155646198|NCT01245062|561795735|FG002|Cross-over Phase|Withdrew Consent|4|||
155646199|NCT01245062|561795733|FG000|Cross-over Phase|Study closed/ terminated|0|||
155646200|NCT01245062|561795734|FG001|Cross-over Phase|Study closed/ terminated|0|||
155646201|NCT01245062|561795735|FG002|Cross-over Phase|Study closed/ terminated|11|||
155646202|NCT05762744|561795737|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
155646203|NCT05762744|561795738|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
155646204|NCT05762744|561795737|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
155646205|NCT05762744|561795738|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
155646206|NCT00004859|561795740|FG000|Overall Study|Lack of Efficacy|43|||
155646207|NCT00004859|561795741|FG001|Overall Study|Lack of Efficacy|113|||
155646208|NCT00004859|561795740|FG000|Overall Study|Adverse Event|31|||
155646209|NCT00004859|561795741|FG001|Overall Study|Adverse Event|93|||
155646210|NCT00004859|561795740|FG000|Overall Study|Death|5|||
155646211|NCT00004859|561795741|FG001|Overall Study|Death|5|||
155646212|NCT00004859|561795740|FG000|Overall Study|Withdrawal by Subject|7|||
155646213|NCT00004859|561795741|FG001|Overall Study|Withdrawal by Subject|33|||
155646214|NCT00004859|561795740|FG000|Overall Study|Protocol Violation|2|||
155646215|NCT00004859|561795741|FG001|Overall Study|Protocol Violation|2|||
155646216|NCT00004859|561795740|FG000|Overall Study|other disease|0|||
155646217|NCT00004859|561795741|FG001|Overall Study|other disease|3|||
155646218|NCT00004859|561795740|FG000|Overall Study|error|3|||
155646219|NCT00004859|561795741|FG001|Overall Study|error|1|||
155646220|NCT00004859|561795740|FG000|Overall Study|missing data|14|||
155646221|NCT00004859|561795741|FG001|Overall Study|missing data|11|||
155646222|NCT00004859|561795740|FG000|Overall Study|Other|13|||
155646223|NCT00004859|561795741|FG001|Overall Study|Other|21|||
155646224|NCT03882801|561797427|FG000|Period 1|Adverse Event|0|||
155646225|NCT03882801|561797428|FG001|Period 1|Adverse Event|1|||
155646226|NCT03882801|561797427|FG000|Period 1|Non-compliance with study drug|1|||
155646227|NCT03882801|561797428|FG001|Period 1|Non-compliance with study drug|1|||
155646228|NCT03882801|561797427|FG000|Period 1|Never treated with study drug|1|||
155646229|NCT03882801|561797428|FG001|Period 1|Never treated with study drug|0|||
155646230|NCT03882801|561797427|FG000|Washout Period|Physician Decision|0|||
155646231|NCT03882801|561797428|FG001|Washout Period|Physician Decision|1|||
155646232|NCT03882801|561797427|FG000|Period 2|Non-compliance with study drug|0|||
155646233|NCT03882801|561797428|FG001|Period 2|Non-compliance with study drug|1|||
155646234|NCT01793129|561797429|FG000|Overall Study|Lost to Follow-up|3|||
155646235|NCT01793129|561797430|FG001|Overall Study|Lost to Follow-up|7|||
155646236|NCT01793129|561797429|FG000|Overall Study|Withdrawal by Subject|0|||
155646237|NCT01793129|561797430|FG001|Overall Study|Withdrawal by Subject|2|||
155646238|NCT04193176|561797433|FG000|Overall Study|Withdrawal by Subject|6|||
155646239|NCT04193176|561797434|FG001|Overall Study|Withdrawal by Subject|10|||
155646240|NCT00944645|561797435|FG000|Period 2|Adverse Event|1|||
155646241|NCT00944645|561797436|FG001|Period 2|Adverse Event|0|||
155646242|NCT00944645|561797435|FG000|Period 2|Lost to Follow-up|0|||
155646243|NCT00944645|561797436|FG001|Period 2|Lost to Follow-up|3|||
155646244|NCT00944645|561797435|FG000|Period 2|Withdrawal by Subject|7|||
155646245|NCT00944645|561797436|FG001|Period 2|Withdrawal by Subject|6|||
155646246|NCT04535362|561797439|FG000|Overall Study|Lost to Follow-up|3|||
155646247|NCT04535362|561797440|FG001|Overall Study|Lost to Follow-up|1|||
155646248|NCT03791060|561797441|FG000|Overall Study|Withdrawal by Subject|1|||
155646249|NCT02018887|561797442|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
155646250|NCT02018887|561797443|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646251|NCT02018887|561797444|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646252|NCT02018887|561797445|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646253|NCT02018887|561797446|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646254|NCT02018887|561797447|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646255|NCT02018887|561797448|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646256|NCT02018887|561797449|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646257|NCT02018887|561797450|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646258|NCT02018887|561797451|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646259|NCT02018887|561797452|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155646260|NCT02018887|561797442|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646261|NCT02018887|561797443|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646262|NCT02018887|561797444|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646263|NCT02018887|561797445|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646264|NCT02018887|561797446|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
155646265|NCT02018887|561797447|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646266|NCT02018887|561797448|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
155646267|NCT02018887|561797449|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
155646268|NCT02018887|561797450|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646269|NCT02018887|561797451|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155504706|NCT03296553|561274056|FG000|Overall Study|Withdrawal by Subject|1|||
155504707|NCT03296553|561274057|FG001|Overall Study|Withdrawal by Subject|1|||
155504708|NCT03296553|561274056|FG000|Overall Study|Death|1|||
155504709|NCT03296553|561274057|FG001|Overall Study|Death|0|||
155504710|NCT00558519|561274058|FG000|Overall Study|Ph+|20|||
155504711|NCT00558519|561274058|FG000|Overall Study|Ineligible|1|||
155504712|NCT00558519|561274058|FG000|Overall Study|Insufficient data|1|||
155504713|NCT00558519|561274058|FG000|Overall Study|Never received treatment|1|||
155504714|NCT03001011|561274059|FG000|Overall Study|Adverse Event|9|||
155504715|NCT03001011|561274060|FG001|Overall Study|Adverse Event|3|||
155504716|NCT03001011|561274059|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
155504717|NCT03001011|561274060|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
155504718|NCT03001011|561274059|FG000|Overall Study|Other than specified above|3|||
155504719|NCT03001011|561274060|FG001|Overall Study|Other than specified above|8|||
155504720|NCT00065065|561274061|FG000|Overall Study|Adverse Event|3|||
155504721|NCT00065065|561274062|FG001|Overall Study|Adverse Event|2|||
155504722|NCT00065065|561274061|FG000|Overall Study|Withdrawal by Subject|1|||
155504723|NCT00065065|561274062|FG001|Overall Study|Withdrawal by Subject|5|||
155504724|NCT00065065|561274061|FG000|Overall Study|Lack of Efficacy|4|||
155504725|NCT00065065|561274062|FG001|Overall Study|Lack of Efficacy|11|||
155504726|NCT00065065|561274061|FG000|Overall Study|Other|2|||
155504727|NCT00065065|561274062|FG001|Overall Study|Other|2|||
155504728|NCT01050673|561274063|FG000|Overall Study|Physician Decision|4|||
155504729|NCT01050673|561274064|FG001|Overall Study|Physician Decision|5|||
155504730|NCT04363736|561274065|FG000|Overall Study|Withdrawal by Subject|1|||
155504731|NCT04363736|561274066|FG001|Overall Study|Withdrawal by Subject|0|||
155504732|NCT04363736|561274065|FG000|Overall Study|Lost to Follow-up|10|||
155504733|NCT04363736|561274066|FG001|Overall Study|Lost to Follow-up|7|||
155504734|NCT04363736|561274065|FG000|Overall Study|Death|8|||
155504735|NCT04363736|561274066|FG001|Overall Study|Death|6|||
155504736|NCT03125915|561274071|FG000|1 Month Follow up|Lost to Follow-up|3|||
155504737|NCT03125915|561274072|FG001|1 Month Follow up|Lost to Follow-up|3|||
155504738|NCT03125915|561274073|FG002|1 Month Follow up|Lost to Follow-up|2|||
155504739|NCT03125915|561274074|FG003|1 Month Follow up|Lost to Follow-up|3|||
155504740|NCT03125915|561274071|FG000|3 Month Follow-up|Lost to Follow-up|6|||
155504741|NCT03125915|561274072|FG001|3 Month Follow-up|Lost to Follow-up|4|||
155504742|NCT03125915|561274073|FG002|3 Month Follow-up|Lost to Follow-up|4|||
155504743|NCT03125915|561274074|FG003|3 Month Follow-up|Lost to Follow-up|2|||
155504744|NCT03125915|561274071|FG000|6 Month Follow-up|Lost to Follow-up|7|||
155504745|NCT03125915|561274072|FG001|6 Month Follow-up|Lost to Follow-up|3|||
155504746|NCT03125915|561274073|FG002|6 Month Follow-up|Lost to Follow-up|6|||
155504747|NCT03125915|561274074|FG003|6 Month Follow-up|Lost to Follow-up|3|||
155504748|NCT04355767|561274075|FG000|Overall Study|Withdrawal by Subject|2|||
155504749|NCT04355767|561274076|FG001|Overall Study|Withdrawal by Subject|2|||
155504750|NCT04355767|561274075|FG000|Overall Study|Death|5|||
155504751|NCT04355767|561274076|FG001|Overall Study|Death|1|||
155504752|NCT01999322|561274077|FG000|Overall Study|Adverse Event|1|||
155504753|NCT01999322|561274078|FG001|Overall Study|Adverse Event|0|||
155504754|NCT01440647|561275965|FG000|Overall Study|Death|2|||
155341184|NCT00090519|560681398|FG001|Overall Study|Death|9|||
155341185|NCT00090519|560681397|FG000|Overall Study|Lost to Follow-up|26|||
155341186|NCT00090519|560681398|FG001|Overall Study|Lost to Follow-up|29|||
155341187|NCT00090519|560681397|FG000|Overall Study|Withdrawal by Subject|28|||
155341188|NCT00090519|560681398|FG001|Overall Study|Withdrawal by Subject|29|||
155341189|NCT00090519|560681397|FG000|Overall Study|Physician Decision|2|||
155341190|NCT00090519|560681398|FG001|Overall Study|Physician Decision|3|||
155341191|NCT00090519|560681397|FG000|Overall Study|Sponsor Decision|3|||
155341192|NCT00090519|560681398|FG001|Overall Study|Sponsor Decision|1|||
155341193|NCT00116649|560681399|FG000|Overall Study|Adverse Event|20|||
155341194|NCT00116649|560681399|FG000|Overall Study|Lack of Efficacy|1|||
155341195|NCT00116649|560681399|FG000|Overall Study|Lost to Follow-up|32|||
155341196|NCT00116649|560681399|FG000|Overall Study|Withdrawal by Subject|68|||
155504755|NCT01440647|561275966|FG001|Overall Study|Death|3|||
155504756|NCT00207714|561275980|FG000|Overall Study|Adverse Event|6|||
155504757|NCT00207714|561275981|FG001|Overall Study|Adverse Event|2|||
155341197|NCT00116649|560681399|FG000|Overall Study|Local Skin Reaction|9|||
155504758|NCT00207714|561275982|FG002|Overall Study|Adverse Event|4|||
155504759|NCT00207714|561275983|FG003|Overall Study|Adverse Event|3|||
155504760|NCT00207714|561275984|FG004|Overall Study|Adverse Event|1|||
155504761|NCT00207714|561275980|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155504762|NCT00207714|561275981|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155504763|NCT00207714|561275982|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
155504764|NCT00207714|561275983|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
155504765|NCT00207714|561275984|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
155504766|NCT00207714|561275980|FG000|Overall Study|Other|3|||
155504767|NCT00207714|561275981|FG001|Overall Study|Other|2|||
155504768|NCT00207714|561275982|FG002|Overall Study|Other|5|||
155504769|NCT00207714|561275983|FG003|Overall Study|Other|1|||
155504770|NCT00207714|561275984|FG004|Overall Study|Other|0|||
155504771|NCT03627195|561275985|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
155504772|NCT03627195|561275986|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
155504773|NCT03627195|561275987|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
155504774|NCT03627195|561275988|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
155504775|NCT03627195|561275989|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
155504776|NCT03627195|561275990|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
155504777|NCT04242186|561276001|FG000|Overall Study|Death|5|||
155504778|NCT00550420|561276004|FG000|Overall Study|Adverse Event|28|||
155504779|NCT00550420|561276004|FG000|Overall Study|Lost to Follow-up|8|||
155504780|NCT00550420|561276004|FG000|Overall Study|Protocol Violation|11|||
155504781|NCT00550420|561276004|FG000|Overall Study|Withdrawal by Subject|30|||
155504782|NCT00550420|561276004|FG000|Overall Study|Still in study at termination|206|||
155504783|NCT00550420|561276004|FG000|Overall Study|Missing|2|||
155504784|NCT00550420|561276004|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
155504785|NCT00550420|561276004|FG000|Overall Study|Investigators opinion|1|||
155504786|NCT00550420|561276004|FG000|Overall Study|Lack of curative effect|1|||
155504787|NCT00550420|561276004|FG000|Overall Study|Unethical stop of enrollment|2|||
155504788|NCT00550420|561276004|FG000|Overall Study|Caregiver's decision to withdraw|1|||
155504789|NCT00550420|561276004|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
155504790|NCT00550420|561276004|FG000|Overall Study|Exclusion criteria|1|||
155504791|NCT00550420|561276004|FG000|Overall Study|Prohibited medicine|1|||
155504792|NCT00782275|561276005|FG000|Overall Study|Adverse Event|11|||
155504793|NCT00782275|561276005|FG000|Overall Study|Withdrawal by Subject|1|||
155504794|NCT00782275|561276005|FG000|Overall Study|Progressive Disease|21|||
155504795|NCT00782275|561276005|FG000|Overall Study|Physician Decision|4|||
155504796|NCT00782275|561276005|FG000|Overall Study|Not started treatment|1|||
155646270|NCT02018887|561797452|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155646271|NCT02018887|561797442|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
155646272|NCT02018887|561797443|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
155646273|NCT02018887|561797444|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
155646274|NCT02018887|561797445|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
155646275|NCT02018887|561797446|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
155646276|NCT02018887|561797447|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
155646277|NCT02018887|561797448|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
155646278|NCT02018887|561797449|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
155646279|NCT02018887|561797450|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
155646280|NCT02018887|561797451|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
155646281|NCT02018887|561797452|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
155646282|NCT02018887|561797442|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
155646283|NCT02018887|561797443|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
155646284|NCT02018887|561797444|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
155646285|NCT02018887|561797445|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
155646286|NCT02018887|561797446|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
155646287|NCT02018887|561797447|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
155646288|NCT02018887|561797448|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
155646289|NCT02018887|561797449|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
155646290|NCT02018887|561797450|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
155646291|NCT02018887|561797451|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
155646292|NCT02018887|561797452|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
155646293|NCT04053452|561797453|FG000|Overall Study|Withdrawal by Subject|1|||
155646294|NCT04053452|561797454|FG001|Overall Study|Withdrawal by Subject|0|||
155646295|NCT04053452|561797453|FG000|Overall Study|Time restraint due to inpatient needs|1|||
155646296|NCT04053452|561797454|FG001|Overall Study|Time restraint due to inpatient needs|2|||
155646297|NCT00122187|561797455|FG000|Overall Study|Withdrew because of resource limitations|2|||
155646298|NCT00122187|561797456|FG001|Overall Study|Withdrew because of resource limitations|2|||
155646299|NCT02061592|561797460|FG000|Period 1|Withdrawal by Subject|1|||
155646300|NCT02061592|561797461|FG001|Period 1|Withdrawal by Subject|0|||
155646301|NCT02061592|561797460|FG000|Period 1|Protocol Violation|1|||
155646302|NCT02061592|561797461|FG001|Period 1|Protocol Violation|0|||
155646303|NCT02061592|561797460|FG000|Period 2|Lost to Follow-up|0|||
155646304|NCT02061592|561797461|FG001|Period 2|Lost to Follow-up|1|||
155646305|NCT01279200|561797469|FG000|Overall Study|Withdrawal by Subject|1|||
155646306|NCT01279200|561797470|FG001|Overall Study|Withdrawal by Subject|3|||
155646307|NCT01279200|561797469|FG000|Overall Study|Patient withdrawal due to high cost|0|||
155646308|NCT01279200|561797470|FG001|Overall Study|Patient withdrawal due to high cost|1|||
155646309|NCT01279200|561797469|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
155646310|NCT01279200|561797470|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
155646311|NCT01279200|561797469|FG000|Overall Study|ultrasound screening failure|0|||
155646312|NCT01279200|561797470|FG001|Overall Study|ultrasound screening failure|1|||
155646313|NCT01279200|561797469|FG000|Overall Study|Lost to Follow-up|0|||
155646314|NCT01279200|561797470|FG001|Overall Study|Lost to Follow-up|1|||
155646315|NCT01279200|561797469|FG000|Overall Study|Adverse Event|1|||
155646316|NCT01279200|561797470|FG001|Overall Study|Adverse Event|0|||
155646317|NCT01399099|561797471|FG000|Overall Study|Lost to Follow-up|14|||
155646318|NCT01399099|561797471|FG000|Overall Study|Physician Decision|1|||
155646319|NCT01399099|561797471|FG000|Overall Study|Protocol Violation|1|||
155646320|NCT01399099|561797471|FG000|Overall Study|Skin Irritation|13|||
155646321|NCT01399099|561797471|FG000|Overall Study|Infection|1|||
155646322|NCT01399099|561797471|FG000|Overall Study|Miscellaneous|4|||
155646323|NCT02181738|561797472|FG000|Overall Study|Participant Withdrew Consent|2|||
155646324|NCT02181738|561797473|FG001|Overall Study|Participant Withdrew Consent|1|||
155646325|NCT02181738|561797474|FG002|Overall Study|Participant Withdrew Consent|1|||
155646326|NCT02181738|561797475|FG003|Overall Study|Participant Withdrew Consent|1|||
155646327|NCT02181738|561797472|FG000|Overall Study|Lost to Follow-up|1|||
155646328|NCT02181738|561797473|FG001|Overall Study|Lost to Follow-up|2|||
155646329|NCT02181738|561797474|FG002|Overall Study|Lost to Follow-up|1|||
155646330|NCT02181738|561797475|FG003|Overall Study|Lost to Follow-up|1|||
155646331|NCT02181738|561797472|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
155646332|NCT02181738|561797473|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
155646333|NCT02181738|561797474|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
155646334|NCT02181738|561797475|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
155646335|NCT02181738|561797472|FG000|Overall Study|Poor/Non-Compliance|1|||
155646336|NCT02181738|561797473|FG001|Overall Study|Poor/Non-Compliance|0|||
155646337|NCT02181738|561797474|FG002|Overall Study|Poor/Non-Compliance|2|||
155646338|NCT02181738|561797475|FG003|Overall Study|Poor/Non-Compliance|1|||
155646339|NCT02181738|561797472|FG000|Overall Study|Disease Progression|28|||
155646340|NCT02181738|561797473|FG001|Overall Study|Disease Progression|35|||
155646341|NCT02181738|561797474|FG002|Overall Study|Disease Progression|40|||
155646342|NCT02181738|561797475|FG003|Overall Study|Disease Progression|0|||
155646343|NCT02181738|561797472|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
155646344|NCT02181738|561797473|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
155646345|NCT02181738|561797474|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
155646346|NCT02181738|561797475|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
155646347|NCT02181738|561797472|FG000|Overall Study|Study Drug Toxicity|6|||
155646348|NCT02181738|561797473|FG001|Overall Study|Study Drug Toxicity|11|||
155646349|NCT02181738|561797474|FG002|Overall Study|Study Drug Toxicity|8|||
155646350|NCT02181738|561797475|FG003|Overall Study|Study Drug Toxicity|1|||
155646351|NCT02181738|561797472|FG000|Overall Study|Other Reasons|14|||
155646352|NCT02181738|561797473|FG001|Overall Study|Other Reasons|16|||
155646353|NCT02181738|561797474|FG002|Overall Study|Other Reasons|28|||
155646354|NCT02181738|561797475|FG003|Overall Study|Other Reasons|0|||
155646355|NCT02181738|561797472|FG000|Overall Study|Maximum Clinical Benefit|3|||
155646356|NCT02181738|561797473|FG001|Overall Study|Maximum Clinical Benefit|0|||
155646357|NCT02181738|561797474|FG002|Overall Study|Maximum Clinical Benefit|1|||
155646358|NCT02181738|561797475|FG003|Overall Study|Maximum Clinical Benefit|0|||
155646359|NCT02181738|561797472|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155646360|NCT02181738|561797473|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155646361|NCT02181738|561797474|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155646362|NCT02181738|561797475|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155646363|NCT01668537|561797476|FG000|Overall Study|Request to Discontinue Prematurely|1|||
155646364|NCT01668537|561797477|FG001|Overall Study|Request to Discontinue Prematurely|1|||
155646365|NCT01668537|561797476|FG000|Overall Study|Subject unwilling/unable to comply|5|||
155646366|NCT01668537|561797477|FG001|Overall Study|Subject unwilling/unable to comply|0|||
155646367|NCT01668537|561797476|FG000|Overall Study|Reason Precludes Participation|1|||
155646368|NCT01668537|561797477|FG001|Overall Study|Reason Precludes Participation|0|||
155646369|NCT01668537|561797476|FG000|Overall Study|Lost to Follow-up|13|||
155646370|NCT01668537|561797477|FG001|Overall Study|Lost to Follow-up|6|||
155646371|NCT01668537|561797476|FG000|Overall Study|Other|2|||
155646372|NCT01668537|561797477|FG001|Overall Study|Other|3|||
155646373|NCT01149538|561797478|FG000|Overall Study|Lost to Follow-up|0|||
155646374|NCT01149538|561797479|FG001|Overall Study|Lost to Follow-up|1|||
155646375|NCT01149538|561797478|FG000|Overall Study|Withdrawal by Subject|5|||
155646376|NCT01149538|561797479|FG001|Overall Study|Withdrawal by Subject|3|||
155646377|NCT00567112|561797482|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
155646378|NCT00567112|561797483|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
155646379|NCT00567112|561797484|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
155646380|NCT00567112|561797482|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
155646381|NCT00567112|561797483|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
155646382|NCT00567112|561797484|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
155341198|NCT00116649|560681399|FG000|Overall Study|Various Reasons|18|||
155646383|NCT00567112|561797482|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
155646384|NCT00567112|561797483|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
155646385|NCT00567112|561797484|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
155646386|NCT04689009|561797485|FG000|Overall Study|Adverse Event|1|||
155646387|NCT04689009|561797486|FG001|Overall Study|Adverse Event|0|||
155646388|NCT04689009|561797485|FG000|Overall Study|Lost to Follow-up|1|||
155646389|NCT04689009|561797486|FG001|Overall Study|Lost to Follow-up|2|||
155646390|NCT04689009|561797485|FG000|Overall Study|Withdrawal by Subject|4|||
155646391|NCT04689009|561797486|FG001|Overall Study|Withdrawal by Subject|3|||
155646392|NCT04689009|561797485|FG000|Overall Study|Protocol Violation|1|||
155504797|NCT00782275|561276005|FG000|Overall Study|Other|3|||
155504798|NCT00331773|561276006|FG000|Overall Study|Withdrawal by Subject|6|||
155504799|NCT00331773|561276007|FG001|Overall Study|Withdrawal by Subject|4|||
155504800|NCT00331773|561276006|FG000|Overall Study|Protocol Violation|10|||
155504801|NCT00331773|561276007|FG001|Overall Study|Protocol Violation|3|||
155504802|NCT04378010|561276008|FG000|Overall Study|Adverse Event|8|||
155504803|NCT04378010|561276009|FG001|Overall Study|Adverse Event|14|||
155504804|NCT04378010|561276010|FG002|Overall Study|Adverse Event|4|||
155504805|NCT04378010|561276008|FG000|Overall Study|Withdrawal by Subject|0|||
155504806|NCT04378010|561276009|FG001|Overall Study|Withdrawal by Subject|2|||
155504807|NCT04378010|561276010|FG002|Overall Study|Withdrawal by Subject|1|||
155504808|NCT04378010|561276008|FG000|Overall Study|Protocol Violation|2|||
155504809|NCT04378010|561276009|FG001|Overall Study|Protocol Violation|1|||
155504810|NCT04378010|561276010|FG002|Overall Study|Protocol Violation|4|||
155504811|NCT04378010|561276008|FG000|Overall Study|Study terminated by Sponsor|22|||
155504812|NCT04378010|561276009|FG001|Overall Study|Study terminated by Sponsor|16|||
155646393|NCT04689009|561797486|FG001|Overall Study|Protocol Violation|0|||
155646394|NCT00985790|561797487|FG000|Overall Study|Withdrawal by Subject|1|||
155646395|NCT00985790|561797488|FG001|Overall Study|Withdrawal by Subject|1|||
155646396|NCT00985790|561797487|FG000|Overall Study|Lost to Follow-up|6|||
155646397|NCT00985790|561797488|FG001|Overall Study|Lost to Follow-up|7|||
155646398|NCT01666314|561797489|FG000|Overall Study|Adverse Event|3|||
155646399|NCT01666314|561797490|FG001|Overall Study|Adverse Event|13|||
155646400|NCT01666314|561797491|FG002|Overall Study|Adverse Event|7|||
155646401|NCT01666314|561797492|FG003|Overall Study|Adverse Event|7|||
155646402|NCT01666314|561797489|FG000|Overall Study|Progressive Disease|11|||
155646403|NCT01666314|561797490|FG001|Overall Study|Progressive Disease|9|||
155646404|NCT01666314|561797491|FG002|Overall Study|Progressive Disease|19|||
155646405|NCT01666314|561797492|FG003|Overall Study|Progressive Disease|20|||
155646406|NCT01666314|561797489|FG000|Overall Study|Symptomatic Deterioration|1|||
155646407|NCT01666314|561797490|FG001|Overall Study|Symptomatic Deterioration|0|||
155646408|NCT01666314|561797491|FG002|Overall Study|Symptomatic Deterioration|2|||
155646409|NCT01666314|561797492|FG003|Overall Study|Symptomatic Deterioration|0|||
155646410|NCT01666314|561797489|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
155646411|NCT01666314|561797490|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
155646412|NCT01666314|561797491|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
155646413|NCT01666314|561797492|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
155646414|NCT01666314|561797489|FG000|Overall Study|Withdrawal by Subject|1|||
155646415|NCT01666314|561797490|FG001|Overall Study|Withdrawal by Subject|1|||
155646416|NCT01666314|561797491|FG002|Overall Study|Withdrawal by Subject|2|||
155646417|NCT01666314|561797492|FG003|Overall Study|Withdrawal by Subject|3|||
155646418|NCT01666314|561797489|FG000|Overall Study|Reason not Specified|10|||
155646419|NCT01666314|561797490|FG001|Overall Study|Reason not Specified|7|||
155646420|NCT01666314|561797491|FG002|Overall Study|Reason not Specified|5|||
155646421|NCT01666314|561797492|FG003|Overall Study|Reason not Specified|5|||
155646422|NCT05089357|561797499|FG000|Overall Study|Withdrawal by Subject|23|||
155646423|NCT05089357|561797499|FG000|Overall Study|Lost to Follow-up|6|||
155646424|NCT05089357|561797499|FG000|Overall Study|Medical reason|1|||
155646425|NCT05089357|561797499|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
155646426|NCT05089357|561797499|FG000|Overall Study|Pregnancy|2|||
155646427|NCT02021318|561797500|FG000|Overall Study|Adverse Event|2|||
155646428|NCT02021318|561797501|FG001|Overall Study|Adverse Event|1|||
155646429|NCT02021318|561797500|FG000|Overall Study|Death|33|||
155646430|NCT02021318|561797501|FG001|Overall Study|Death|34|||
155646431|NCT02021318|561797500|FG000|Overall Study|Lost to Follow-up|3|||
155646432|NCT02021318|561797501|FG001|Overall Study|Lost to Follow-up|3|||
155646433|NCT02021318|561797500|FG000|Overall Study|Progressive Disease|0|||
155646434|NCT02021318|561797501|FG001|Overall Study|Progressive Disease|1|||
155646435|NCT02021318|561797500|FG000|Overall Study|Withdrawal by Subject|30|||
155646436|NCT02021318|561797501|FG001|Overall Study|Withdrawal by Subject|18|||
155646437|NCT02021318|561797500|FG000|Overall Study|Physician Decision|3|||
155646438|NCT02021318|561797501|FG001|Overall Study|Physician Decision|3|||
155646439|NCT02021318|561797500|FG000|Overall Study|Miscellaneous|2|||
155646440|NCT02021318|561797501|FG001|Overall Study|Miscellaneous|3|||
155646441|NCT00689052|561797502|FG000|Overall Study|Adverse Event|4|||
155646442|NCT00689052|561797503|FG001|Overall Study|Adverse Event|6|||
155646443|NCT00689052|561797502|FG000|Overall Study|Protocol Violation|1|||
155646444|NCT00689052|561797503|FG001|Overall Study|Protocol Violation|0|||
155646445|NCT00689052|561797502|FG000|Overall Study|Lost to Follow-up|2|||
155646446|NCT00689052|561797503|FG001|Overall Study|Lost to Follow-up|0|||
155646447|NCT00689052|561797502|FG000|Overall Study|Withdrawal by Subject|2|||
155646448|NCT00689052|561797503|FG001|Overall Study|Withdrawal by Subject|0|||
155646449|NCT00689052|561797502|FG000|Overall Study|Early termination of the trial|22|||
155646450|NCT00689052|561797503|FG001|Overall Study|Early termination of the trial|24|||
155646451|NCT04180696|561797504|FG000|Overall Study|Death|5|||
155646452|NCT04180696|561797505|FG001|Overall Study|Death|6|||
155646453|NCT04180696|561797504|FG000|Overall Study|Lost to Follow-up|1|||
155646454|NCT04180696|561797505|FG001|Overall Study|Lost to Follow-up|0|||
155646455|NCT04180696|561797504|FG000|Overall Study|Withdrawal by Subject|0|||
155646456|NCT04180696|561797505|FG001|Overall Study|Withdrawal by Subject|1|||
155646457|NCT01740427|561797506|FG000|Overall Study|Objective Progression or Relapse|286|||
155646458|NCT01740427|561797507|FG001|Overall Study|Objective Progression or Relapse|172|||
155646459|NCT01740427|561797506|FG000|Overall Study|Adverse Event|32|||
155646460|NCT01740427|561797507|FG001|Overall Study|Adverse Event|9|||
155646461|NCT01740427|561797506|FG000|Overall Study|Global Deterioration of Health Status|28|||
155646462|NCT01740427|561797507|FG001|Overall Study|Global Deterioration of Health Status|12|||
155646463|NCT01740427|561797506|FG000|Overall Study|Participant Refused Continued Treatment|27|||
155646464|NCT01740427|561797507|FG001|Overall Study|Participant Refused Continued Treatment|15|||
155646465|NCT01740427|561797506|FG000|Overall Study|Unspecified reasons|52|||
155646466|NCT01740427|561797507|FG001|Overall Study|Unspecified reasons|8|||
155646467|NCT01740427|561797506|FG000|Overall Study|Death|10|||
155646468|NCT01740427|561797507|FG001|Overall Study|Death|3|||
155646469|NCT01740427|561797506|FG000|Overall Study|Protocol Violation|5|||
155646470|NCT01740427|561797507|FG001|Overall Study|Protocol Violation|3|||
155646471|NCT01740427|561797506|FG000|Overall Study|Lost to Follow-up|3|||
155646472|NCT01740427|561797507|FG001|Overall Study|Lost to Follow-up|0|||
155646473|NCT01740427|561797506|FG000|Overall Study|Site Terminated by Sponsor|1|||
155646474|NCT01740427|561797507|FG001|Overall Study|Site Terminated by Sponsor|0|||
155646475|NCT04796207|561797510|FG000|Overall Study|Lost to Follow-up|7|||
155646476|NCT04796207|561797511|FG001|Overall Study|Lost to Follow-up|2|||
155646477|NCT01860989|561797514|FG000|Overall Study|Unsatisfactory therapeutic|5|||
155646478|NCT04739709|561797517|FG000|Overall Study|Physician Decision|1|||
155646479|NCT04739709|561797518|FG001|Overall Study|Physician Decision|0|||
155646480|NCT03003468|561797519|FG000|Overall Study|Withdrawal by Subject|0|||
155646481|NCT03003468|561797520|FG001|Overall Study|Withdrawal by Subject|0|||
155646482|NCT03003468|561797521|FG002|Overall Study|Withdrawal by Subject|1|||
155646483|NCT03003468|561797519|FG000|Overall Study|No measurable lesions|0|||
155646484|NCT03003468|561797520|FG001|Overall Study|No measurable lesions|0|||
155646485|NCT03003468|561797521|FG002|Overall Study|No measurable lesions|1|||
155646486|NCT00421993|561797522|FG000|Overall Study|Withdrawal by Subject|22|||
155646487|NCT00421993|561797523|FG001|Overall Study|Withdrawal by Subject|23|||
155646488|NCT00421993|561797524|FG002|Overall Study|Withdrawal by Subject|23|||
155646489|NCT00421993|561797525|FG003|Overall Study|Withdrawal by Subject|24|||
155646490|NCT00421993|561797522|FG000|Overall Study|Lost to Follow-up|18|||
155646491|NCT00421993|561797523|FG001|Overall Study|Lost to Follow-up|19|||
155646492|NCT00421993|561797524|FG002|Overall Study|Lost to Follow-up|22|||
155646493|NCT00421993|561797525|FG003|Overall Study|Lost to Follow-up|20|||
155646494|NCT00421993|561797522|FG000|Overall Study|Adverse Event|11|||
155646495|NCT00421993|561797523|FG001|Overall Study|Adverse Event|1|||
155646496|NCT00421993|561797524|FG002|Overall Study|Adverse Event|6|||
155646497|NCT00421993|561797525|FG003|Overall Study|Adverse Event|4|||
155646498|NCT00421993|561797522|FG000|Overall Study|Protocol Violation|2|||
155646499|NCT00421993|561797523|FG001|Overall Study|Protocol Violation|2|||
155646500|NCT00421993|561797524|FG002|Overall Study|Protocol Violation|0|||
155646501|NCT00421993|561797525|FG003|Overall Study|Protocol Violation|1|||
155646502|NCT00421993|561797522|FG000|Overall Study|Lack of Efficacy|0|||
155646503|NCT00421993|561797523|FG001|Overall Study|Lack of Efficacy|3|||
155646504|NCT00421993|561797524|FG002|Overall Study|Lack of Efficacy|0|||
155646505|NCT00421993|561797525|FG003|Overall Study|Lack of Efficacy|5|||
155646506|NCT00421993|561797522|FG000|Overall Study|Pregnancy|0|||
155646507|NCT00421993|561797523|FG001|Overall Study|Pregnancy|1|||
155646508|NCT00421993|561797524|FG002|Overall Study|Pregnancy|1|||
155646509|NCT00421993|561797525|FG003|Overall Study|Pregnancy|2|||
155646510|NCT00421993|561797522|FG000|Overall Study|Subject transportation issues|0|||
155646511|NCT00421993|561797523|FG001|Overall Study|Subject transportation issues|0|||
155646512|NCT00421993|561797524|FG002|Overall Study|Subject transportation issues|0|||
155646513|NCT00421993|561797525|FG003|Overall Study|Subject transportation issues|1|||
155646514|NCT02405962|561797526|FG000|Overall Study|Lost to Follow-up|1|||
155646515|NCT02405962|561797527|FG001|Overall Study|Lost to Follow-up|4|||
155646516|NCT02405962|561797526|FG000|Overall Study|A participant has moved to another place|0|||
155646517|NCT02405962|561797527|FG001|Overall Study|A participant has moved to another place|1|||
155646518|NCT01980888|561797528|FG000|Overall Study|Study Terminated by Sponsor|116|||
155646519|NCT01980888|561797529|FG001|Overall Study|Study Terminated by Sponsor|122|||
155646520|NCT01980888|561797528|FG000|Overall Study|Withdrew Consent|17|||
155646521|NCT01980888|561797529|FG001|Overall Study|Withdrew Consent|6|||
155504813|NCT04378010|561276010|FG002|Overall Study|Study terminated by Sponsor|22|||
155504814|NCT04378010|561276008|FG000|Overall Study|Subject inability to complete study visit|0|||
155504815|NCT04378010|561276009|FG001|Overall Study|Subject inability to complete study visit|0|||
155504816|NCT04378010|561276010|FG002|Overall Study|Subject inability to complete study visit|1|||
155504817|NCT04378010|561276008|FG000|Overall Study|Subject never dosed|0|||
155504818|NCT04378010|561276009|FG001|Overall Study|Subject never dosed|1|||
155504819|NCT04378010|561276010|FG002|Overall Study|Subject never dosed|0|||
155504820|NCT01792284|561276011|FG000|Lead-in Period|Adverse Event|15|||
155504821|NCT01792284|561276012|FG001|Lead-in Period|Adverse Event|0|||
155504822|NCT01792284|561276013|FG002|Lead-in Period|Adverse Event|0|||
155504823|NCT01792284|561276011|FG000|Lead-in Period|Lost to Follow-up|2|||
155504824|NCT01792284|561276012|FG001|Lead-in Period|Lost to Follow-up|0|||
155504825|NCT01792284|561276013|FG002|Lead-in Period|Lost to Follow-up|0|||
155504826|NCT01792284|561276011|FG000|Lead-in Period|Protocol Violation|1|||
155504827|NCT01792284|561276012|FG001|Lead-in Period|Protocol Violation|0|||
155504828|NCT01792284|561276013|FG002|Lead-in Period|Protocol Violation|0|||
155504829|NCT01792284|561276011|FG000|Lead-in Period|Withdrawal by Subject|10|||
155504830|NCT01792284|561276012|FG001|Lead-in Period|Withdrawal by Subject|0|||
155504831|NCT01792284|561276013|FG002|Lead-in Period|Withdrawal by Subject|0|||
155504832|NCT01792284|561276011|FG000|Lead-in Period|Physician Decision|1|||
155504833|NCT01792284|561276012|FG001|Lead-in Period|Physician Decision|0|||
155504834|NCT01792284|561276013|FG002|Lead-in Period|Physician Decision|0|||
155504835|NCT01792284|561276011|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
155341199|NCT00116649|560681399|FG000|Overall Study|Protocol Specified|7|||
155341200|NCT02161146|560681400|FG000|Overall Study|Adverse Event|1|||
155341201|NCT02161146|560681401|FG001|Overall Study|Adverse Event|1|||
155504836|NCT01792284|561276012|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
155504837|NCT01792284|561276013|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
155504838|NCT01792284|561276011|FG000|Randomization Period 1|Withdrawal by Subject|0|||
155504839|NCT01792284|561276012|FG001|Randomization Period 1|Withdrawal by Subject|1|||
155504840|NCT01792284|561276013|FG002|Randomization Period 1|Withdrawal by Subject|1|||
155504841|NCT01792284|561276011|FG000|Randomization Period 1|Physician Decision|0|||
155504842|NCT01792284|561276012|FG001|Randomization Period 1|Physician Decision|1|||
155504843|NCT01792284|561276013|FG002|Randomization Period 1|Physician Decision|1|||
155504844|NCT01792284|561276011|FG000|Randomization Period 1|Adverse Event|0|||
155504845|NCT01792284|561276012|FG001|Randomization Period 1|Adverse Event|0|||
155504846|NCT01792284|561276013|FG002|Randomization Period 1|Adverse Event|2|||
155504847|NCT01792284|561276011|FG000|Randomization Period 1|Lost to Follow-up|0|||
155504848|NCT01792284|561276012|FG001|Randomization Period 1|Lost to Follow-up|0|||
155504849|NCT01792284|561276013|FG002|Randomization Period 1|Lost to Follow-up|1|||
155504850|NCT01792284|561276011|FG000|Randomization Period 2|Protocol Violation|0|||
155504851|NCT01792284|561276012|FG001|Randomization Period 2|Protocol Violation|1|||
155504852|NCT01792284|561276013|FG002|Randomization Period 2|Protocol Violation|0|||
155504853|NCT01792284|561276011|FG000|Randomization Period 2|Withdrawal by Subject|0|||
155504854|NCT01792284|561276012|FG001|Randomization Period 2|Withdrawal by Subject|2|||
155504855|NCT01792284|561276013|FG002|Randomization Period 2|Withdrawal by Subject|0|||
155504856|NCT02019979|561276014|FG000|Overall Study|study terminated|14|||
155504857|NCT00379587|561276020|FG000|Overall Study|Lost to Follow-up|2|||
155504858|NCT01169649|561276024|FG000|Overall Study|Patient Not Treated|3|||
155504859|NCT02919475|561276025|FG000|Overall Study|Adverse Event|3|||
155504860|NCT02919475|561276026|FG001|Overall Study|Adverse Event|3|||
155504861|NCT02919475|561276027|FG002|Overall Study|Adverse Event|3|||
155504862|NCT02919475|561276028|FG003|Overall Study|Adverse Event|9|||
155504863|NCT02919475|561276029|FG004|Overall Study|Adverse Event|2|||
155504864|NCT02919475|561276025|FG000|Overall Study|Death|0|||
155504865|NCT02919475|561276026|FG001|Overall Study|Death|1|||
155504866|NCT02919475|561276027|FG002|Overall Study|Death|0|||
155504867|NCT02919475|561276028|FG003|Overall Study|Death|0|||
155504868|NCT02919475|561276029|FG004|Overall Study|Death|0|||
155504869|NCT02919475|561276025|FG000|Overall Study|Lost to Follow-up|0|||
155504870|NCT02919475|561276026|FG001|Overall Study|Lost to Follow-up|0|||
155504871|NCT02919475|561276027|FG002|Overall Study|Lost to Follow-up|0|||
155504872|NCT02919475|561276028|FG003|Overall Study|Lost to Follow-up|1|||
155504873|NCT02919475|561276029|FG004|Overall Study|Lost to Follow-up|0|||
155504874|NCT02919475|561276025|FG000|Overall Study|Withdrawal by Subject|2|||
155504875|NCT02919475|561276026|FG001|Overall Study|Withdrawal by Subject|3|||
155504876|NCT02919475|561276027|FG002|Overall Study|Withdrawal by Subject|1|||
155504877|NCT02919475|561276028|FG003|Overall Study|Withdrawal by Subject|2|||
155504878|NCT02919475|561276029|FG004|Overall Study|Withdrawal by Subject|2|||
155504879|NCT02919475|561276025|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155504880|NCT02919475|561276026|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155504881|NCT02919475|561276027|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155504882|NCT02919475|561276028|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155504883|NCT02919475|561276029|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155504884|NCT02323295|561276030|FG000|Overall Study|Adverse Event|0|||
155504885|NCT02323295|561276031|FG001|Overall Study|Adverse Event|1|||
155504886|NCT02323295|561276030|FG000|Overall Study|Withdrawal by Subject|0|||
155504887|NCT02323295|561276031|FG001|Overall Study|Withdrawal by Subject|1|||
155504888|NCT02323295|561276030|FG000|Overall Study|Patient did not have surgery as planned.|0|||
155504889|NCT02323295|561276031|FG001|Overall Study|Patient did not have surgery as planned.|1|||
155504890|NCT02370784|561276032|FG000|Overall Study|Patient started prohibited medication|0|||
155504891|NCT02370784|561276033|FG001|Overall Study|Patient started prohibited medication|1|||
155504892|NCT01155063|561276037|FG000|Overall Study|Adverse Event|1|||
155504893|NCT01155063|561276037|FG000|Overall Study|Withdrawal by Subject|1|||
155504894|NCT01155063|561276037|FG000|Overall Study|Study terminated by sponsor|87|||
155504895|NCT01663714|561276038|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
155504896|NCT01663714|561276038|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
155504897|NCT01663714|561276038|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
155504898|NCT01663714|561276038|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
155504899|NCT01663714|561276038|FG000|Long-Term Follow-Up|Death|4|||
155504900|NCT01663714|561276038|FG000|Long-Term Follow-Up|Non-compliance|1|||
155504901|NCT02280421|561276039|FG000|Washout (2 Weeks)|Adverse Event|0|||
155504902|NCT02280421|561276040|FG001|Washout (2 Weeks)|Adverse Event|1|||
155504903|NCT02280421|561276039|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155504904|NCT02280421|561276040|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
155504905|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
155504906|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
155504907|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
155504908|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
155504909|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
155504910|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
155504911|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
155504912|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
155504913|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
155504914|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
155504915|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
155504916|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
155504917|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
155504918|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
155504919|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
155504920|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
155646522|NCT01980888|561797528|FG000|Overall Study|Investigator's Discretion|8|||
155646523|NCT01980888|561797529|FG001|Overall Study|Investigator's Discretion|3|||
155646524|NCT01980888|561797528|FG000|Overall Study|Non-Compliance with Study Drug|3|||
155646525|NCT01980888|561797529|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155646526|NCT00165698|561797531|FG000|Overall Study|Adverse Event|2|||
155646527|NCT00165698|561797532|FG001|Overall Study|Adverse Event|10|||
155504921|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
155504922|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
155504923|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
155504924|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
155504925|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
155504926|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
155504927|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
155504928|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
155646528|NCT00165698|561797531|FG000|Overall Study|Lost to Follow-up|2|||
155646529|NCT00165698|561797532|FG001|Overall Study|Lost to Follow-up|2|||
155646530|NCT00165698|561797531|FG000|Overall Study|Withdrawal by Subject|2|||
155646531|NCT00165698|561797532|FG001|Overall Study|Withdrawal by Subject|1|||
155423482|NCT00896532|560978725|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423483|NCT00896532|560978726|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423484|NCT00896532|560978727|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
155423485|NCT00896532|560978705|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
155646532|NCT00165698|561797531|FG000|Overall Study|Protocol Violation|1|||
155646533|NCT00165698|561797532|FG001|Overall Study|Protocol Violation|0|||
155646534|NCT00165698|561797531|FG000|Overall Study|Not Taken/Lost the medicine|1|||
155646535|NCT00165698|561797532|FG001|Overall Study|Not Taken/Lost the medicine|2|||
155646536|NCT01727154|561797546|FG000|Overall Study|Death|17|||
155646537|NCT01727154|561797546|FG000|Overall Study|Withdrawal by Subject|14|||
155646538|NCT01727154|561797546|FG000|Overall Study|Subject Withdrew Consent|18|||
155646539|NCT01727154|561797546|FG000|Overall Study|Study Terminated|6|||
155646540|NCT01727154|561797546|FG000|Overall Study|No Discontinuation Documentation|4|||
155646541|NCT00003474|561797547|FG000|Overall Study|Not Evaluable|14|||
155646542|NCT03020888|561797548|FG000|Overall Study|Physician Decision|4|||
155646543|NCT03020888|561797548|FG000|Overall Study|Withdrawal by Subject|6|||
155646544|NCT03020888|561797548|FG000|Overall Study|Insurance coverage|2|||
155646545|NCT03020888|561797548|FG000|Overall Study|Lost to Follow-up|1|||
155646546|NCT01198548|561797553|FG000|Overall Study|Disease Progression|9|||
155646547|NCT01198548|561797553|FG000|Overall Study|Administrative Decision|1|||
155646548|NCT02015104|561797554|FG000|Overall Study|Withdrew consent after first dose drug|1|||
155646549|NCT02015104|561797555|FG001|Overall Study|Withdrew consent after first dose drug|0|||
155646550|NCT02015104|561797554|FG000|Overall Study|Withdrew consent prior to treatment|0|||
155646551|NCT02015104|561797555|FG001|Overall Study|Withdrew consent prior to treatment|1|||
155646552|NCT06025695|561797556|FG000|Overall Study|Adverse Event|5|||
155646553|NCT06025695|561797557|FG001|Overall Study|Adverse Event|6|||
155646554|NCT06025695|561797556|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
155646555|NCT06025695|561797557|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
155646556|NCT06025695|561797556|FG000|Overall Study|Other|23|||
155646557|NCT06025695|561797557|FG001|Overall Study|Other|19|||
155646558|NCT06025695|561797556|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
155646559|NCT06025695|561797557|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
155646560|NCT01452347|561797558|FG000|Overall Study|Adverse Event|2|||
155646561|NCT01452347|561797559|FG001|Overall Study|Adverse Event|1|||
155646562|NCT01452347|561797558|FG000|Overall Study|Non compliance protocol|2|||
155646563|NCT01452347|561797559|FG001|Overall Study|Non compliance protocol|0|||
155646564|NCT01452347|561797558|FG000|Overall Study|Lost to Follow-up|2|||
155646565|NCT01452347|561797559|FG001|Overall Study|Lost to Follow-up|0|||
155646566|NCT01452347|561797558|FG000|Overall Study|Withdrawal by Subject|3|||
155646567|NCT01452347|561797559|FG001|Overall Study|Withdrawal by Subject|3|||
155646568|NCT01452347|561797558|FG000|Overall Study|Not treated|6|||
155646569|NCT01452347|561797559|FG001|Overall Study|Not treated|3|||
155646570|NCT01452347|561797558|FG000|Overall Study|Other reason not defined above|2|||
155646571|NCT01452347|561797559|FG001|Overall Study|Other reason not defined above|0|||
155646572|NCT01030900|561797560|FG000|Overall Study|Not treated due to congestive heart failure|1|||
155646573|NCT01030900|561797560|FG000|Overall Study|Not treated due to rapid disease|1|||
155646574|NCT00441896|561797561|FG000|Overall Study|Withdrawal by Subject|0|||
155646575|NCT00441896|561797562|FG001|Overall Study|Withdrawal by Subject|0|||
155646576|NCT00441896|561797563|FG002|Overall Study|Withdrawal by Subject|0|||
155646577|NCT00441896|561797564|FG003|Overall Study|Withdrawal by Subject|1|||
155646578|NCT00441896|561797565|FG004|Overall Study|Withdrawal by Subject|0|||
155646579|NCT00441896|561797566|FG005|Overall Study|Withdrawal by Subject|0|||
155646580|NCT00441896|561797567|FG006|Overall Study|Withdrawal by Subject|0|||
155646581|NCT00441896|561797568|FG007|Overall Study|Withdrawal by Subject|0|||
155646582|NCT00441896|561797569|FG008|Overall Study|Withdrawal by Subject|0|||
155646583|NCT00441896|561797570|FG009|Overall Study|Withdrawal by Subject|0|||
155646584|NCT00441896|561797561|FG000|Overall Study|Other|0|||
155646585|NCT00441896|561797562|FG001|Overall Study|Other|0|||
155646586|NCT00441896|561797563|FG002|Overall Study|Other|0|||
155646587|NCT00441896|561797564|FG003|Overall Study|Other|0|||
155646588|NCT00441896|561797565|FG004|Overall Study|Other|1|||
155646589|NCT00441896|561797566|FG005|Overall Study|Other|0|||
155646590|NCT00441896|561797567|FG006|Overall Study|Other|0|||
155646591|NCT00441896|561797568|FG007|Overall Study|Other|0|||
155646592|NCT00441896|561797569|FG008|Overall Study|Other|0|||
155646593|NCT00441896|561797570|FG009|Overall Study|Other|0|||
155646594|NCT01301092|561797571|FG000|Overall Study|Lost to Follow-up|0|||
155646595|NCT01301092|561797572|FG001|Overall Study|Lost to Follow-up|0|||
155646596|NCT01301092|561797573|FG002|Overall Study|Lost to Follow-up|1|||
155646597|NCT03334175|561797574|FG000|Overall Study|Lost to Follow-up|0|||
155646598|NCT03334175|561797575|FG001|Overall Study|Lost to Follow-up|1|||
155646599|NCT01350973|561797576|FG000|Overall Study|Adverse Event|4|||
155646600|NCT01350973|561797577|FG001|Overall Study|Adverse Event|7|||
155646601|NCT01350973|561797578|FG002|Overall Study|Adverse Event|7|||
155646602|NCT01350973|561797576|FG000|Overall Study|Voluntary Withdrawal|2|||
155646603|NCT01350973|561797577|FG001|Overall Study|Voluntary Withdrawal|1|||
155646604|NCT01350973|561797578|FG002|Overall Study|Voluntary Withdrawal|1|||
155646605|NCT00853047|561797582|FG000|Core Phase|Participant Request|0|||
155646606|NCT00853047|561797583|FG001|Core Phase|Participant Request|0|||
155646607|NCT00853047|561797584|FG002|Core Phase|Participant Request|0|||
155646608|NCT00853047|561797585|FG003|Core Phase|Participant Request|1|||
155646609|NCT00853047|561797586|FG004|Core Phase|Participant Request|0|||
155646610|NCT00853047|561797587|FG005|Core Phase|Participant Request|0|||
155646611|NCT00853047|561797582|FG000|Open-Label Extension Phase|Participant Request|0|||
155646612|NCT00853047|561797583|FG001|Open-Label Extension Phase|Participant Request|0|||
155646613|NCT00853047|561797584|FG002|Open-Label Extension Phase|Participant Request|0|||
155646614|NCT00853047|561797585|FG003|Open-Label Extension Phase|Participant Request|0|||
155646615|NCT00853047|561797586|FG004|Open-Label Extension Phase|Participant Request|0|||
155646616|NCT00853047|561797587|FG005|Open-Label Extension Phase|Participant Request|7|||
155646617|NCT00853047|561797582|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155646618|NCT00853047|561797583|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155646619|NCT00853047|561797584|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155646620|NCT00853047|561797585|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
155646621|NCT00853047|561797586|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
155646622|NCT00853047|561797587|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
155646623|NCT00853047|561797582|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155646624|NCT00853047|561797583|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155646625|NCT00853047|561797584|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155646626|NCT00853047|561797585|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155646627|NCT00853047|561797586|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155646628|NCT00853047|561797587|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
155646629|NCT00853047|561797582|FG000|Open-Label Extension Phase|Investigator Decision|0|||
155646630|NCT00853047|561797583|FG001|Open-Label Extension Phase|Investigator Decision|0|||
155646631|NCT00853047|561797584|FG002|Open-Label Extension Phase|Investigator Decision|0|||
155646632|NCT00853047|561797585|FG003|Open-Label Extension Phase|Investigator Decision|0|||
155646633|NCT00853047|561797586|FG004|Open-Label Extension Phase|Investigator Decision|0|||
155646634|NCT00853047|561797587|FG005|Open-Label Extension Phase|Investigator Decision|1|||
155646635|NCT00853047|561797582|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
155646636|NCT00853047|561797583|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
155504929|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
155504930|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
155504931|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
155504932|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
155504933|NCT01872689|561276044|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
155504934|NCT01872689|561276045|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
155504935|NCT01872689|561276046|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
155504936|NCT01872689|561276047|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
155504937|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
155504938|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
155504939|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
155504940|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
155504941|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
155504942|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
155504943|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
155504944|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
155504945|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
155504946|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
155504947|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
155504948|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
155504949|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
155646637|NCT00853047|561797584|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
155646638|NCT00853047|561797585|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
155646639|NCT00853047|561797586|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
155646640|NCT00853047|561797587|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
155646641|NCT02638493|561797588|FG000|Overall Study|Inability to provide semen samples|2|||
155646642|NCT02638493|561797589|FG001|Overall Study|Inability to provide semen samples|0|||
155504950|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
155504951|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
155504952|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
155504953|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
155504954|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
155504955|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
155504956|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
155504957|NCT01872689|561276044|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
155504958|NCT01872689|561276045|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
155504959|NCT01872689|561276046|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
155504960|NCT01872689|561276047|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
155504961|NCT00751998|561276054|FG000|Overall Study|Lost to Follow-up|7|||
155504962|NCT00751998|561276054|FG000|Overall Study|Death|11|||
155504963|NCT00751998|561276054|FG000|Overall Study|Withdrawal by Subject|2|||
155504964|NCT01238822|561276056|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
155504965|NCT02598193|561276057|FG000|Overall Study|Adverse Event|13|||
155504966|NCT02598193|561276057|FG000|Overall Study|Withdrawal by Subject|1|||
155504967|NCT02598193|561276057|FG000|Overall Study|Listed in active lung transplant list|1|||
155504968|NCT02598193|561276057|FG000|Overall Study|Does not want to take Nintedanib|1|||
155504969|NCT02410837|561276058|FG000|Overall Study|Death|387|||
155504970|NCT02410837|561276058|FG000|Overall Study|Lost to Follow-up|50|||
155504971|NCT02410837|561276058|FG000|Overall Study|Withdrawal by Subject|44|||
155504972|NCT02410837|561276058|FG000|Overall Study|Physician Decision|6|||
155341202|NCT02161146|560681402|FG002|Overall Study|Adverse Event|0|||
155504973|NCT02410837|561276058|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
155504974|NCT00837577|561276059|FG000|Double-blind Period|Clinical Adverse Event|1|||
155504975|NCT00837577|561276060|FG001|Double-blind Period|Clinical Adverse Event|0|||
155504976|NCT00837577|561276059|FG000|Double-blind Period|Withdrawal by Subject|1|||
155504977|NCT00837577|561276060|FG001|Double-blind Period|Withdrawal by Subject|0|||
155504978|NCT00837577|561276059|FG000|Open-label Period|Clinical Adverse Event|2|||
155504979|NCT00837577|561276060|FG001|Open-label Period|Clinical Adverse Event|2|||
155504980|NCT00837577|561276059|FG000|Open-label Period|Laboratory Adverse Event|0|||
155504981|NCT00837577|561276060|FG001|Open-label Period|Laboratory Adverse Event|1|||
155504982|NCT00837577|561276059|FG000|Open-label Period|Lack of Efficacy|4|||
155504983|NCT00837577|561276060|FG001|Open-label Period|Lack of Efficacy|3|||
155504984|NCT00837577|561276059|FG000|Open-label Period|Withdrawal by Subject|1|||
155504985|NCT00837577|561276060|FG001|Open-label Period|Withdrawal by Subject|2|||
155504986|NCT00837577|561276059|FG000|Open-label Period|Other Reason|1|||
155504987|NCT00837577|561276060|FG001|Open-label Period|Other Reason|1|||
155504988|NCT01825876|561276064|FG000|Period 2|Withdrawal by Subject|0|||
155504989|NCT01825876|561276065|FG001|Period 2|Withdrawal by Subject|1|||
155504990|NCT01027884|561276070|FG000|Overall Study|Adverse Event|2|||
155504991|NCT01027884|561276071|FG001|Overall Study|Adverse Event|1|||
155504992|NCT01027884|561276070|FG000|Overall Study|Protocol Violation|1|||
155504993|NCT01027884|561276071|FG001|Overall Study|Protocol Violation|0|||
155504994|NCT01027884|561276070|FG000|Overall Study|Non-compliance|1|||
155504995|NCT01027884|561276071|FG001|Overall Study|Non-compliance|1|||
155504996|NCT01027884|561276070|FG000|Overall Study|Withdrawal by Subject|0|||
155504997|NCT01027884|561276071|FG001|Overall Study|Withdrawal by Subject|1|||
155504998|NCT01027884|561276070|FG000|Overall Study|Lost to Follow-up|0|||
155504999|NCT01027884|561276071|FG001|Overall Study|Lost to Follow-up|1|||
155505000|NCT01027884|561276070|FG000|Overall Study|Spinal fixation surgery|0|||
155505001|NCT01027884|561276071|FG001|Overall Study|Spinal fixation surgery|3|||
155505002|NCT03636542|561276074|FG000|Overall Study|Lost to Follow-up|1|||
155505003|NCT03636542|561276075|FG001|Overall Study|Lost to Follow-up|1|||
155505004|NCT03636542|561276074|FG000|Overall Study|Physician Decision|0|||
155505005|NCT03636542|561276075|FG001|Overall Study|Physician Decision|1|||
155505006|NCT03636542|561276074|FG000|Overall Study|Withdrawal by Subject|1|||
155505007|NCT03636542|561276075|FG001|Overall Study|Withdrawal by Subject|0|||
155505008|NCT03670537|561276076|FG000|Overall Study|Protocol Violation|1|||
155505009|NCT02059187|561276077|FG000|Overall Study|Adverse Event|0|||
155505010|NCT02059187|561276078|FG001|Overall Study|Adverse Event|3|||
155505011|NCT02059187|561276077|FG000|Overall Study|Death|1|||
155505012|NCT02059187|561276078|FG001|Overall Study|Death|1|||
155505013|NCT02059187|561276077|FG000|Overall Study|Lost to Follow-up|9|||
155505014|NCT02059187|561276078|FG001|Overall Study|Lost to Follow-up|8|||
155505015|NCT02059187|561276077|FG000|Overall Study|Non-compliance with study drug|1|||
155505016|NCT02059187|561276078|FG001|Overall Study|Non-compliance with study drug|0|||
155505017|NCT02059187|561276077|FG000|Overall Study|Physician Decision|1|||
155505018|NCT02059187|561276078|FG001|Overall Study|Physician Decision|2|||
155505019|NCT02059187|561276077|FG000|Overall Study|Protocol Violation|1|||
155505020|NCT02059187|561276078|FG001|Overall Study|Protocol Violation|0|||
155505021|NCT02059187|561276077|FG000|Overall Study|Withdrawal by Subject|12|||
155505022|NCT02059187|561276078|FG001|Overall Study|Withdrawal by Subject|8|||
155505023|NCT03751020|561276079|FG000|Overall Study|Withdrawal by Subject|2|||
155505024|NCT03751020|561276080|FG001|Overall Study|Withdrawal by Subject|0|||
155505025|NCT03751020|561276081|FG002|Overall Study|Withdrawal by Subject|0|||
155505026|NCT03751020|561276079|FG000|Overall Study|Lost to Follow-up|7|||
155505027|NCT03751020|561276080|FG001|Overall Study|Lost to Follow-up|4|||
155505028|NCT03751020|561276081|FG002|Overall Study|Lost to Follow-up|10|||
155505029|NCT01889862|561276082|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
155505030|NCT01889862|561276083|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
155505031|NCT01889862|561276084|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
155505032|NCT01889862|561276085|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
155505033|NCT01889862|561276086|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
155505034|NCT01889862|561276082|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
155505035|NCT01889862|561276083|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
155646643|NCT02638493|561797590|FG002|Overall Study|Inability to provide semen samples|0|||
155646644|NCT01567085|561799498|FG000|Overall Study|Death|6|||
155646645|NCT01567085|561799498|FG000|Overall Study|Adverse Event|6|||
155646646|NCT01567085|561799498|FG000|Overall Study|Lost to Follow-up|3|||
155505036|NCT01889862|561276084|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
155505037|NCT01889862|561276085|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
155505038|NCT01889862|561276086|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
155505039|NCT01889862|561276082|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
155505040|NCT01889862|561276083|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
155505041|NCT01889862|561276084|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
155505042|NCT01889862|561276085|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
155505043|NCT01889862|561276086|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
155505044|NCT01889862|561276082|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
155646647|NCT01567085|561799498|FG000|Overall Study|Graft loss|2|||
155341203|NCT02161146|560681403|FG003|Overall Study|Adverse Event|1|||
155505045|NCT01889862|561276083|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
155505046|NCT01889862|561276084|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
155505047|NCT01889862|561276085|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
155505048|NCT01889862|561276086|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
155505049|NCT01889862|561276082|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
155505050|NCT01889862|561276083|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
155505051|NCT01889862|561276084|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
155505052|NCT01889862|561276085|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
155505053|NCT01889862|561276086|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
155505054|NCT01889862|561276082|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
155505055|NCT01889862|561276083|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
155505056|NCT01889862|561276084|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
155505057|NCT01889862|561276085|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
155505058|NCT01889862|561276086|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
155505059|NCT01889862|561276082|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
155505060|NCT01889862|561276083|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
155505061|NCT01889862|561276084|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
155505062|NCT01889862|561276085|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
155505063|NCT01889862|561276086|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
155505064|NCT01889862|561276082|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
155505065|NCT01889862|561276083|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
155505066|NCT01889862|561276084|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
155505067|NCT01889862|561276085|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
155505068|NCT01889862|561276086|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
155505069|NCT01889862|561276082|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
155505070|NCT01889862|561276083|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
155505071|NCT01889862|561276084|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
155505072|NCT01889862|561276085|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
155505073|NCT01889862|561276086|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
155505074|NCT01889862|561276082|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
155505075|NCT01889862|561276083|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
155505076|NCT01889862|561276084|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
155505077|NCT01889862|561276085|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
155505078|NCT01889862|561276086|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
155505079|NCT00033631|561276087|FG000|Overall Study|Protocol Violation|14|||
155505080|NCT00033631|561276088|FG001|Overall Study|Protocol Violation|11|||
155505081|NCT00033631|561276087|FG000|Overall Study|Withdrawal by Subject|4|||
155505082|NCT00033631|561276088|FG001|Overall Study|Withdrawal by Subject|4|||
155505083|NCT00078819|561276089|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
155505084|NCT00078819|561276090|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
155505085|NCT00078819|561276091|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
155505086|NCT00078819|561276092|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
155505087|NCT00078819|561276089|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
155505088|NCT00078819|561276090|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
155505089|NCT00078819|561276091|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
155505090|NCT00078819|561276092|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
155505091|NCT00078819|561276089|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
155505092|NCT00078819|561276090|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
155505093|NCT00078819|561276091|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
155505094|NCT00078819|561276092|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
155505095|NCT00078819|561276089|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
155505096|NCT00078819|561276090|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
155505097|NCT00078819|561276091|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
155505098|NCT00078819|561276092|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
155505099|NCT00078819|561276089|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
155505100|NCT00078819|561276090|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
155505101|NCT00078819|561276091|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
155646648|NCT01567085|561799498|FG000|Overall Study|Renal transplantectomy|1|||
155505102|NCT00078819|561276092|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
155505103|NCT00078819|561276089|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
155505104|NCT00078819|561276090|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
155646649|NCT01567085|561799498|FG000|Overall Study|Returned to chronic dialysis|1|||
155646650|NCT01567085|561799498|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
155646651|NCT03537729|561799509|FG000|Overall Study|Death|2|||
155646652|NCT03537729|561799510|FG001|Overall Study|Death|2|||
155646653|NCT03537729|561799511|FG002|Overall Study|Death|7|||
155646654|NCT03537729|561799509|FG000|Overall Study|Withdrawal by Subject|3|||
155646655|NCT03537729|561799510|FG001|Overall Study|Withdrawal by Subject|3|||
155646656|NCT03537729|561799511|FG002|Overall Study|Withdrawal by Subject|0|||
155341204|NCT02161146|560681404|FG004|Overall Study|Adverse Event|0|||
155341205|NCT02161146|560681400|FG000|Overall Study|Lost to Follow-up|0|||
155646657|NCT03537729|561799509|FG000|Overall Study|Subject Moved|8|||
155646658|NCT03537729|561799510|FG001|Overall Study|Subject Moved|5|||
155646659|NCT03537729|561799511|FG002|Overall Study|Subject Moved|4|||
155646660|NCT03537729|561799509|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
155646661|NCT03537729|561799510|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
155646662|NCT03537729|561799511|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
155646663|NCT03537729|561799509|FG000|Overall Study|COVID-19 Site Restrictions|11|||
155646664|NCT03537729|561799510|FG001|Overall Study|COVID-19 Site Restrictions|15|||
155646665|NCT03537729|561799511|FG002|Overall Study|COVID-19 Site Restrictions|18|||
155646666|NCT03537729|561799509|FG000|Overall Study|Decline in Health|5|||
155646667|NCT03537729|561799510|FG001|Overall Study|Decline in Health|9|||
155646668|NCT03537729|561799511|FG002|Overall Study|Decline in Health|4|||
155646669|NCT03537729|561799509|FG000|Overall Study|Determined Ineligible|0|||
155646670|NCT03537729|561799510|FG001|Overall Study|Determined Ineligible|0|||
155646671|NCT03537729|561799511|FG002|Overall Study|Determined Ineligible|1|||
155341206|NCT02161146|560681401|FG001|Overall Study|Lost to Follow-up|1|||
155341207|NCT02161146|560681402|FG002|Overall Study|Lost to Follow-up|0|||
155341208|NCT02161146|560681403|FG003|Overall Study|Lost to Follow-up|0|||
155341209|NCT02161146|560681404|FG004|Overall Study|Lost to Follow-up|0|||
155341210|NCT02161146|560681400|FG000|Overall Study|Personal Reasons|0|||
155341211|NCT02161146|560681401|FG001|Overall Study|Personal Reasons|1|||
155341212|NCT02161146|560681402|FG002|Overall Study|Personal Reasons|0|||
155341213|NCT02161146|560681403|FG003|Overall Study|Personal Reasons|2|||
155341214|NCT02161146|560681404|FG004|Overall Study|Personal Reasons|1|||
155341215|NCT02161146|560681400|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155341216|NCT02161146|560681401|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155341217|NCT02161146|560681402|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155646672|NCT00284934|561799516|FG000|Overall Study|Adverse Event|1|||
155646673|NCT00284934|561799517|FG001|Overall Study|Adverse Event|2|||
155646674|NCT00284934|561799516|FG000|Overall Study|Other reasons|3|||
155646675|NCT00284934|561799517|FG001|Overall Study|Other reasons|1|||
155646676|NCT00454142|561799518|FG000|Overall Study|Withdrawal by Subject|1|||
155646677|NCT01245751|561799522|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
155646678|NCT01245751|561799523|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
155646679|NCT01245751|561799524|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
155646680|NCT01245751|561799525|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
155646681|NCT01245751|561799522|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155646682|NCT01245751|561799523|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155646683|NCT01245751|561799524|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155646684|NCT01245751|561799525|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
155646685|NCT01245751|561799522|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155646686|NCT01245751|561799523|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
155646687|NCT01245751|561799524|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155646688|NCT01245751|561799525|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155646689|NCT01783015|561799528|FG000|Blinded Treatment|Adverse Event|0|||
155646690|NCT01783015|561799529|FG001|Blinded Treatment|Adverse Event|1|||
155646691|NCT01783015|561799530|FG002|Blinded Treatment|Adverse Event|0|||
155646692|NCT01783015|561799528|FG000|Blinded Treatment|Protocol Violation|0|||
155646693|NCT01783015|561799529|FG001|Blinded Treatment|Protocol Violation|1|||
155646694|NCT01783015|561799530|FG002|Blinded Treatment|Protocol Violation|0|||
155646695|NCT01783015|561799528|FG000|Blinded Treatment|Withdrawal by Subject|0|||
155646696|NCT01783015|561799529|FG001|Blinded Treatment|Withdrawal by Subject|1|||
155646697|NCT01783015|561799530|FG002|Blinded Treatment|Withdrawal by Subject|0|||
155646698|NCT01783015|561799528|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
155646699|NCT01783015|561799529|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
155646700|NCT01783015|561799530|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
155646701|NCT01783015|561799528|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
155646702|NCT01783015|561799529|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
155646703|NCT01783015|561799530|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
155646704|NCT00504556|561799531|FG000|Overall Study|Adverse Event|11|||
155646705|NCT00504556|561799532|FG001|Overall Study|Adverse Event|11|||
155646706|NCT00504556|561799533|FG002|Overall Study|Adverse Event|14|||
155646707|NCT00504556|561799534|FG003|Overall Study|Adverse Event|13|||
155646708|NCT00504556|561799535|FG004|Overall Study|Adverse Event|5|||
155646709|NCT00504556|561799531|FG000|Overall Study|Death|3|||
155646710|NCT00504556|561799532|FG001|Overall Study|Death|3|||
155646711|NCT00504556|561799533|FG002|Overall Study|Death|1|||
155646712|NCT00504556|561799534|FG003|Overall Study|Death|0|||
155646713|NCT00504556|561799535|FG004|Overall Study|Death|2|||
155646714|NCT00504556|561799531|FG000|Overall Study|Protocol Violation|1|||
155646715|NCT00504556|561799532|FG001|Overall Study|Protocol Violation|3|||
155646716|NCT00504556|561799533|FG002|Overall Study|Protocol Violation|2|||
155646717|NCT00504556|561799534|FG003|Overall Study|Protocol Violation|1|||
155646718|NCT00504556|561799535|FG004|Overall Study|Protocol Violation|2|||
155646719|NCT00504556|561799531|FG000|Overall Study|Lost to Follow-up|0|||
155646720|NCT00504556|561799532|FG001|Overall Study|Lost to Follow-up|0|||
155646721|NCT00504556|561799533|FG002|Overall Study|Lost to Follow-up|1|||
155646722|NCT00504556|561799534|FG003|Overall Study|Lost to Follow-up|1|||
155646723|NCT00504556|561799535|FG004|Overall Study|Lost to Follow-up|1|||
155646724|NCT00504556|561799531|FG000|Overall Study|Withdrawal by Subject|16|||
155646725|NCT00504556|561799532|FG001|Overall Study|Withdrawal by Subject|16|||
155646726|NCT00504556|561799533|FG002|Overall Study|Withdrawal by Subject|7|||
155646727|NCT00504556|561799534|FG003|Overall Study|Withdrawal by Subject|8|||
155646728|NCT00504556|561799535|FG004|Overall Study|Withdrawal by Subject|12|||
155646729|NCT00504556|561799531|FG000|Overall Study|administrative reasons|0|||
155646730|NCT00504556|561799532|FG001|Overall Study|administrative reasons|2|||
155646731|NCT00504556|561799533|FG002|Overall Study|administrative reasons|2|||
155646732|NCT00504556|561799534|FG003|Overall Study|administrative reasons|1|||
155646733|NCT00504556|561799535|FG004|Overall Study|administrative reasons|2|||
155646734|NCT00504556|561799531|FG000|Overall Study|did not meet entry criteria|2|||
155646735|NCT00504556|561799532|FG001|Overall Study|did not meet entry criteria|0|||
155646736|NCT00504556|561799533|FG002|Overall Study|did not meet entry criteria|1|||
155646737|NCT00504556|561799534|FG003|Overall Study|did not meet entry criteria|1|||
155646738|NCT00504556|561799535|FG004|Overall Study|did not meet entry criteria|0|||
155646739|NCT00504556|561799531|FG000|Overall Study|data monitor committee decision|0|||
155646740|NCT00504556|561799532|FG001|Overall Study|data monitor committee decision|0|||
155646741|NCT00504556|561799533|FG002|Overall Study|data monitor committee decision|0|||
155646742|NCT00504556|561799534|FG003|Overall Study|data monitor committee decision|100|||
155646743|NCT00504556|561799535|FG004|Overall Study|data monitor committee decision|0|||
155341218|NCT02161146|560681403|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155341219|NCT02161146|560681404|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155505105|NCT00078819|561276091|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
155646744|NCT00504556|561799531|FG000|Overall Study|Other|2|||
155341220|NCT00845520|560681405|FG000|Overall Study|Death|1|||
155646745|NCT00504556|561799532|FG001|Overall Study|Other|2|||
155646746|NCT00504556|561799533|FG002|Overall Study|Other|2|||
155646747|NCT00504556|561799534|FG003|Overall Study|Other|3|||
155646748|NCT00504556|561799535|FG004|Overall Study|Other|0|||
155646749|NCT00504556|561799531|FG000|Overall Study|not in safety analysis set|0|||
155646750|NCT00504556|561799532|FG001|Overall Study|not in safety analysis set|1|||
155646751|NCT00504556|561799533|FG002|Overall Study|not in safety analysis set|1|||
155646752|NCT00504556|561799534|FG003|Overall Study|not in safety analysis set|0|||
155646753|NCT00504556|561799535|FG004|Overall Study|not in safety analysis set|1|||
155646754|NCT03607695|561799536|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
155646755|NCT03607695|561799536|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
155646756|NCT02741193|561799537|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
155646757|NCT02741193|561799537|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
155646758|NCT02502383|561799540|FG000|Overall Study|Lost to Follow-up|130|||
155646759|NCT02502383|561799541|FG001|Overall Study|Lost to Follow-up|131|||
155646760|NCT02502383|561799540|FG000|Overall Study|Withdrawal by Subject|31|||
155341221|NCT00845520|560681406|FG001|Overall Study|Death|2|||
155341222|NCT00845520|560681407|FG002|Overall Study|Death|0|||
155341223|NCT00845520|560681405|FG000|Overall Study|Lost to Follow-up|1|||
155646761|NCT02502383|561799541|FG001|Overall Study|Withdrawal by Subject|24|||
155646762|NCT00289978|561799542|FG000|Overall Study|Withdrawal by Subject|31|||
155646763|NCT00289978|561799543|FG001|Overall Study|Withdrawal by Subject|17|||
155341224|NCT00845520|560681406|FG001|Overall Study|Lost to Follow-up|0|||
155341225|NCT00845520|560681407|FG002|Overall Study|Lost to Follow-up|0|||
155341226|NCT00845520|560681405|FG000|Overall Study|Adverse Event|0|||
155341227|NCT00845520|560681406|FG001|Overall Study|Adverse Event|0|||
155341228|NCT00845520|560681407|FG002|Overall Study|Adverse Event|1|||
155341229|NCT02613403|560681408|FG000|Overall Study|Lost to Follow-up|0|||
155341230|NCT02613403|560681409|FG001|Overall Study|Lost to Follow-up|1|||
155341231|NCT02613403|560681410|FG002|Overall Study|Lost to Follow-up|0|||
155341232|NCT02613403|560681411|FG003|Overall Study|Lost to Follow-up|0|||
155341233|NCT02613403|560681412|FG004|Overall Study|Lost to Follow-up|0|||
155341234|NCT02613403|560681408|FG000|Overall Study|Withdrawal by Subject|2|||
155341235|NCT02613403|560681409|FG001|Overall Study|Withdrawal by Subject|0|||
155341236|NCT02613403|560681410|FG002|Overall Study|Withdrawal by Subject|0|||
155341237|NCT02613403|560681411|FG003|Overall Study|Withdrawal by Subject|0|||
155341238|NCT02613403|560681412|FG004|Overall Study|Withdrawal by Subject|0|||
155341239|NCT00800176|560681413|FG000|Overall Study|Adverse Event|2|||
155341240|NCT00800176|560681414|FG001|Overall Study|Adverse Event|1|||
155341241|NCT00800176|560681415|FG002|Overall Study|Adverse Event|0|||
155341242|NCT00800176|560681416|FG003|Overall Study|Adverse Event|2|||
155423486|NCT00896532|560978706|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
155341243|NCT00800176|560681417|FG004|Overall Study|Adverse Event|1|||
155341244|NCT00800176|560681418|FG005|Overall Study|Adverse Event|1|||
155341245|NCT00800176|560681413|FG000|Overall Study|Refused treatment|3|||
155423487|NCT00896532|560978707|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
155423488|NCT00896532|560978708|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
155423489|NCT00896532|560978709|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
155423490|NCT00896532|560978710|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
155423491|NCT00896532|560978711|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
155341246|NCT00800176|560681414|FG001|Overall Study|Refused treatment|2|||
155341247|NCT00800176|560681415|FG002|Overall Study|Refused treatment|0|||
155341248|NCT00800176|560681416|FG003|Overall Study|Refused treatment|0|||
155341249|NCT00800176|560681417|FG004|Overall Study|Refused treatment|1|||
155341250|NCT00800176|560681418|FG005|Overall Study|Refused treatment|4|||
155341251|NCT00800176|560681413|FG000|Overall Study|Failure to return|3|||
155341252|NCT00800176|560681414|FG001|Overall Study|Failure to return|3|||
155505106|NCT00078819|561276092|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
155505107|NCT00078819|561276089|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
155505108|NCT00078819|561276090|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
155505109|NCT00078819|561276091|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
155341253|NCT00800176|560681415|FG002|Overall Study|Failure to return|0|||
155341254|NCT00800176|560681416|FG003|Overall Study|Failure to return|2|||
155505110|NCT00078819|561276092|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
155505111|NCT00078819|561276089|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
155341255|NCT00800176|560681417|FG004|Overall Study|Failure to return|0|||
155341256|NCT00800176|560681418|FG005|Overall Study|Failure to return|0|||
155341257|NCT00800176|560681413|FG000|Overall Study|Other|1|||
155341258|NCT00800176|560681414|FG001|Overall Study|Other|0|||
155341259|NCT00800176|560681415|FG002|Overall Study|Other|0|||
155341260|NCT00800176|560681416|FG003|Overall Study|Other|0|||
155341261|NCT00800176|560681417|FG004|Overall Study|Other|2|||
155341262|NCT00800176|560681418|FG005|Overall Study|Other|0|||
155341263|NCT02659540|560681421|FG000|Overall Study|Adverse Event|3|||
155341264|NCT02659540|560681422|FG001|Overall Study|Adverse Event|2|||
155341265|NCT02659540|560681421|FG000|Overall Study|Death|1|||
155341266|NCT02659540|560681422|FG001|Overall Study|Death|0|||
155341267|NCT02659540|560681421|FG000|Overall Study|Progressive disease|2|||
155341268|NCT02659540|560681422|FG001|Overall Study|Progressive disease|6|||
155341269|NCT00608959|560683134|FG000|Part 1|Did not meet eligibility criteria|1|||
155341270|NCT01416285|560683135|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
155341271|NCT01416285|560683136|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
155341272|NCT01005602|560683137|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
155341273|NCT01005602|560683138|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
155341274|NCT01248715|560683139|FG000|Overall Study|Not influenza positive|501|||
155341275|NCT01248715|560683140|FG001|Overall Study|Not influenza positive|510|||
155341276|NCT01919489|560683141|FG000|Overall Study|Rejected the need of injections|4|||
155341277|NCT01919489|560683142|FG001|Overall Study|Rejected the need of injections|7|||
155341278|NCT01919489|560683141|FG000|Overall Study|Adverse Event|10|||
155341279|NCT01919489|560683142|FG001|Overall Study|Adverse Event|0|||
155341280|NCT01919489|560683141|FG000|Overall Study|Hospital readmission|2|||
155341281|NCT01919489|560683142|FG001|Overall Study|Hospital readmission|9|||
155341282|NCT01919489|560683141|FG000|Overall Study|Death|2|||
155341283|NCT01919489|560683142|FG001|Overall Study|Death|1|||
155341284|NCT01919489|560683141|FG000|Overall Study|Lost to Follow-up|38|||
155341285|NCT01919489|560683142|FG001|Overall Study|Lost to Follow-up|27|||
155341286|NCT01131325|560683143|FG000|Overall Study|Adverse Event|1|||
155341287|NCT01131325|560683143|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
155341288|NCT03884478|560683144|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
155341289|NCT03884478|560683145|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
155341290|NCT03884478|560683146|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
155341291|NCT03884478|560683144|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
155341292|NCT03884478|560683145|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
155341293|NCT03884478|560683146|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
155341294|NCT03884478|560683144|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
155341295|NCT03884478|560683145|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
155341296|NCT03884478|560683146|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
155341297|NCT03884478|560683144|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
155341298|NCT03884478|560683145|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
155341299|NCT03884478|560683146|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
155341300|NCT01807234|560683147|FG000|Overall Study|Lost to Follow-up|2|||
155341301|NCT01807234|560683148|FG001|Overall Study|Lost to Follow-up|5|||
155505112|NCT00078819|561276090|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
155505113|NCT00078819|561276091|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
155505114|NCT00078819|561276092|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
155341302|NCT01807234|560683149|FG002|Overall Study|Lost to Follow-up|1|||
155341303|NCT01807234|560683150|FG003|Overall Study|Lost to Follow-up|1|||
155341304|NCT01807234|560683151|FG004|Overall Study|Lost to Follow-up|1|||
155341305|NCT01807234|560683152|FG005|Overall Study|Lost to Follow-up|2|||
155341306|NCT01807234|560683147|FG000|Overall Study|Withdrawal by Subject|3|||
155341307|NCT01807234|560683148|FG001|Overall Study|Withdrawal by Subject|1|||
155341308|NCT01807234|560683149|FG002|Overall Study|Withdrawal by Subject|1|||
155341309|NCT01807234|560683150|FG003|Overall Study|Withdrawal by Subject|1|||
155341310|NCT01807234|560683151|FG004|Overall Study|Withdrawal by Subject|2|||
155341311|NCT01807234|560683152|FG005|Overall Study|Withdrawal by Subject|1|||
155341312|NCT01807234|560683147|FG000|Overall Study|Lack of Efficacy|0|||
155341313|NCT01807234|560683148|FG001|Overall Study|Lack of Efficacy|0|||
155341314|NCT01807234|560683149|FG002|Overall Study|Lack of Efficacy|0|||
155341315|NCT01807234|560683150|FG003|Overall Study|Lack of Efficacy|0|||
155341316|NCT01807234|560683151|FG004|Overall Study|Lack of Efficacy|1|||
155341317|NCT01807234|560683152|FG005|Overall Study|Lack of Efficacy|1|||
155341318|NCT01540474|560683153|FG000|Vaccination Period|Lost to Follow-up|0|||
155341319|NCT01540474|560683154|FG001|Vaccination Period|Lost to Follow-up|1|||
155341320|NCT01540474|560683155|FG002|Vaccination Period|Lost to Follow-up|0|||
155341321|NCT01540474|560683156|FG003|Vaccination Period|Lost to Follow-up|0|||
155341322|NCT00857311|560683157|FG000|Overall Study|Lost to Follow-up|1|||
155341323|NCT00857311|560683158|FG001|Overall Study|Lost to Follow-up|0|||
155341324|NCT00857311|560683159|FG002|Overall Study|Lost to Follow-up|0|||
155341325|NCT00857311|560683160|FG003|Overall Study|Lost to Follow-up|0|||
155341326|NCT00828139|560683161|FG000|Overall Study|Adverse Event|8|||
155341327|NCT00828139|560683162|FG001|Overall Study|Adverse Event|1|||
155341328|NCT00828139|560683163|FG002|Overall Study|Adverse Event|10|||
155341329|NCT00828139|560683164|FG003|Overall Study|Adverse Event|5|||
155341330|NCT00828139|560683161|FG000|Overall Study|Death|2|||
155341331|NCT00828139|560683162|FG001|Overall Study|Death|1|||
155341332|NCT00828139|560683163|FG002|Overall Study|Death|0|||
155341333|NCT00828139|560683164|FG003|Overall Study|Death|2|||
155341334|NCT00828139|560683161|FG000|Overall Study|Refusal unrelated to toxicity|3|||
155341335|NCT00828139|560683162|FG001|Overall Study|Refusal unrelated to toxicity|4|||
155341336|NCT00828139|560683163|FG002|Overall Study|Refusal unrelated to toxicity|5|||
155341337|NCT00828139|560683164|FG003|Overall Study|Refusal unrelated to toxicity|3|||
155341338|NCT00828139|560683161|FG000|Overall Study|Disease Progression|24|||
155341339|NCT00828139|560683162|FG001|Overall Study|Disease Progression|33|||
155341340|NCT00828139|560683163|FG002|Overall Study|Disease Progression|35|||
155341341|NCT00828139|560683164|FG003|Overall Study|Disease Progression|39|||
155341342|NCT00828139|560683161|FG000|Overall Study|Other|4|||
155341343|NCT00828139|560683162|FG001|Overall Study|Other|2|||
155341344|NCT00828139|560683163|FG002|Overall Study|Other|5|||
155341345|NCT00828139|560683164|FG003|Overall Study|Other|2|||
155341346|NCT01714947|560683165|FG000|Part B|Progressive Disease|3|||
155341347|NCT04271254|560683169|FG000|Overall Study|Withdrawal by Subject|3|||
155341348|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
155341349|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
155341350|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
155341351|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
155341352|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
155341353|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
155341354|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
155341355|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155341356|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
155341357|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
155341358|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
155341359|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
155341360|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
155341361|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
155341362|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
155341363|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
155341364|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
155341365|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
155341366|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
155423492|NCT00896532|560978712|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
155423493|NCT00896532|560978713|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
155423494|NCT00896532|560978714|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
155423495|NCT00896532|560978715|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
155423496|NCT00896532|560978716|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
155423497|NCT00896532|560978717|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
155423498|NCT00896532|560978718|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
155423499|NCT00896532|560978719|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
155341367|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
155341368|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
155423500|NCT00896532|560978720|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
155423501|NCT00896532|560978721|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
155341369|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
155341370|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
155341371|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
155341372|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
155341373|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
155341374|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
155341375|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
155341376|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
155341377|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
155341378|NCT02137785|560683176|FG000|Overall Study|Lost to Follow-up|1|||
155341379|NCT02137785|560683177|FG001|Overall Study|Lost to Follow-up|0|||
155341380|NCT02137785|560683176|FG000|Overall Study|Withdrawal by Subject|1|||
155341381|NCT02137785|560683177|FG001|Overall Study|Withdrawal by Subject|4|||
155341382|NCT02137785|560683176|FG000|Overall Study|subject moved out of state|1|||
155341383|NCT02137785|560683177|FG001|Overall Study|subject moved out of state|0|||
155341384|NCT00417885|560683178|FG000|Overall Study|Adverse Event|1|||
155341385|NCT00417885|560683178|FG000|Overall Study|Objective Progression or Relapse|3|||
155341386|NCT00417885|560683178|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
155341387|NCT02309892|560683179|FG000|Overall Study|Physician Decision|1|||
155341388|NCT02309892|560683180|FG001|Overall Study|Physician Decision|0|||
155341389|NCT02309892|560683181|FG002|Overall Study|Physician Decision|0|||
155341390|NCT02309892|560683182|FG003|Overall Study|Physician Decision|0|||
155341391|NCT02309892|560683183|FG004|Overall Study|Physician Decision|0|||
155341392|NCT02309892|560683184|FG005|Overall Study|Physician Decision|0|||
155341393|NCT02309892|560683185|FG006|Overall Study|Physician Decision|0|||
155341394|NCT02309892|560683179|FG000|Overall Study|Adverse Event|1|||
155341395|NCT02309892|560683180|FG001|Overall Study|Adverse Event|0|||
155341396|NCT02309892|560683181|FG002|Overall Study|Adverse Event|1|||
155341397|NCT02309892|560683182|FG003|Overall Study|Adverse Event|0|||
155341398|NCT02309892|560683183|FG004|Overall Study|Adverse Event|0|||
155341399|NCT02309892|560683184|FG005|Overall Study|Adverse Event|0|||
155341400|NCT02309892|560683185|FG006|Overall Study|Adverse Event|0|||
155341401|NCT02309892|560683179|FG000|Overall Study|Progressive Disease|0|||
155341402|NCT02309892|560683180|FG001|Overall Study|Progressive Disease|1|||
155341403|NCT02309892|560683181|FG002|Overall Study|Progressive Disease|0|||
155341404|NCT02309892|560683182|FG003|Overall Study|Progressive Disease|0|||
155341405|NCT02309892|560683183|FG004|Overall Study|Progressive Disease|1|||
155341406|NCT02309892|560683184|FG005|Overall Study|Progressive Disease|0|||
155341407|NCT02309892|560683185|FG006|Overall Study|Progressive Disease|0|||
155341408|NCT02309892|560683179|FG000|Overall Study|Death|0|||
155341409|NCT02309892|560683180|FG001|Overall Study|Death|0|||
155341410|NCT02309892|560683181|FG002|Overall Study|Death|0|||
155341411|NCT02309892|560683182|FG003|Overall Study|Death|0|||
155341412|NCT02309892|560683183|FG004|Overall Study|Death|0|||
155341413|NCT02309892|560683184|FG005|Overall Study|Death|1|||
155341414|NCT02309892|560683185|FG006|Overall Study|Death|0|||
155341415|NCT01584648|560683186|FG000|Overall Study|Death|136|||
155341416|NCT01584648|560683187|FG001|Overall Study|Death|146|||
155341417|NCT01584648|560683186|FG000|Overall Study|Lost to Follow-up|9|||
155341418|NCT01584648|560683187|FG001|Overall Study|Lost to Follow-up|9|||
155341419|NCT01584648|560683186|FG000|Overall Study|Investigator discretion|3|||
155341420|NCT01584648|560683187|FG001|Overall Study|Investigator discretion|2|||
155341421|NCT01584648|560683186|FG000|Overall Study|Withdrew consent|13|||
155341422|NCT01584648|560683187|FG001|Overall Study|Withdrew consent|4|||
155341423|NCT01584648|560683186|FG000|Overall Study|Study closed/terminated|50|||
155341424|NCT01584648|560683187|FG001|Overall Study|Study closed/terminated|23|||
155341425|NCT01584648|560683186|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
155341426|NCT01584648|560683187|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
155341427|NCT03146845|560683188|FG000|Overall Study|Reference ulcer healed|1|||
155341428|NCT03146845|560683189|FG001|Overall Study|Reference ulcer healed|0|||
155341429|NCT03146845|560683188|FG000|Overall Study|Physician Decision|1|||
155341430|NCT03146845|560683189|FG001|Overall Study|Physician Decision|0|||
155341431|NCT03146845|560683188|FG000|Overall Study|Adverse Event|1|||
155341432|NCT03146845|560683189|FG001|Overall Study|Adverse Event|0|||
155341433|NCT03146845|560683188|FG000|Overall Study|Withdrawal by Subject|2|||
155341434|NCT03146845|560683189|FG001|Overall Study|Withdrawal by Subject|0|||
155341435|NCT03146845|560683188|FG000|Overall Study|Noncompliance|0|||
155341436|NCT03146845|560683189|FG001|Overall Study|Noncompliance|1|||
155341437|NCT03146845|560683188|FG000|Overall Study|Protocol Violation|0|||
155341438|NCT03146845|560683189|FG001|Overall Study|Protocol Violation|2|||
155341439|NCT03146845|560683188|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
155341440|NCT03146845|560683189|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
155341441|NCT01757288|560683198|FG000|Overall Study|Consent withdrawal|0|||
155341442|NCT01757288|560683199|FG001|Overall Study|Consent withdrawal|4|||
155341443|NCT01757288|560683200|FG002|Overall Study|Consent withdrawal|4|||
155341444|NCT01757288|560683198|FG000|Overall Study|Patient off study, IRB hold.|0|||
155341445|NCT01757288|560683199|FG001|Overall Study|Patient off study, IRB hold.|0|||
155341446|NCT01757288|560683200|FG002|Overall Study|Patient off study, IRB hold.|1|||
155341447|NCT01757288|560683198|FG000|Overall Study|Patient death prior to starting treatment|0|||
155341448|NCT01757288|560683199|FG001|Overall Study|Patient death prior to starting treatment|0|||
155341449|NCT01757288|560683200|FG002|Overall Study|Patient death prior to starting treatment|1|||
155341450|NCT01757288|560683198|FG000|Overall Study|Wrong medication administered|0|||
155341451|NCT01757288|560683199|FG001|Overall Study|Wrong medication administered|1|||
155341452|NCT01757288|560683200|FG002|Overall Study|Wrong medication administered|0|||
155341453|NCT01757288|560683198|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
155341454|NCT01757288|560683199|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
155341455|NCT01757288|560683200|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
155341456|NCT01757288|560683198|FG000|Overall Study|Not meeting protocol constraints|0|||
155341457|NCT01757288|560683199|FG001|Overall Study|Not meeting protocol constraints|1|||
155341458|NCT01757288|560683200|FG002|Overall Study|Not meeting protocol constraints|1|||
155341459|NCT01757288|560683198|FG000|Overall Study|Multiple missed appointments|0|||
155341460|NCT01757288|560683199|FG001|Overall Study|Multiple missed appointments|1|||
155341461|NCT01757288|560683200|FG002|Overall Study|Multiple missed appointments|0|||
155341462|NCT01757288|560683198|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
155341463|NCT01757288|560683199|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
155341464|NCT01757288|560683200|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
155341465|NCT01757288|560683198|FG000|Overall Study|>2 weeks treatment break|0|||
155341466|NCT01757288|560683199|FG001|Overall Study|>2 weeks treatment break|0|||
155341467|NCT01757288|560683200|FG002|Overall Study|>2 weeks treatment break|1|||
155341468|NCT02825550|560683202|FG000|Overall Study|Physician Decision|1|||
155341469|NCT03386344|560683203|FG000|Overall Study|Adverse Event|6|||
155341470|NCT03386344|560683204|FG001|Overall Study|Adverse Event|3|||
155341471|NCT03386344|560683205|FG002|Overall Study|Adverse Event|1|||
155341472|NCT03386344|560683203|FG000|Overall Study|Poor Compliance to Protocol|0|||
155341473|NCT03386344|560683204|FG001|Overall Study|Poor Compliance to Protocol|1|||
155341474|NCT03386344|560683205|FG002|Overall Study|Poor Compliance to Protocol|0|||
155341475|NCT03386344|560683203|FG000|Overall Study|Study Terminated by Sponsor|101|||
155341476|NCT03386344|560683204|FG001|Overall Study|Study Terminated by Sponsor|102|||
155341477|NCT03386344|560683205|FG002|Overall Study|Study Terminated by Sponsor|106|||
155341478|NCT03386344|560683203|FG000|Overall Study|Lost to Follow-up|3|||
155341479|NCT03386344|560683204|FG001|Overall Study|Lost to Follow-up|2|||
155341480|NCT03386344|560683205|FG002|Overall Study|Lost to Follow-up|1|||
155505115|NCT02217345|561276093|FG000|Overall Study|Lost to Follow-up|2|||
155505116|NCT02217345|561276094|FG001|Overall Study|Lost to Follow-up|1|||
155505117|NCT02217345|561276093|FG000|Overall Study|Withdrawal by Subject|3|||
155505118|NCT02217345|561276094|FG001|Overall Study|Withdrawal by Subject|2|||
155646764|NCT00289978|561799544|FG002|Overall Study|Withdrawal by Subject|28|||
155341481|NCT03386344|560683203|FG000|Overall Study|At the Participant's own Request|7|||
155341482|NCT03386344|560683204|FG001|Overall Study|At the Participant's own Request|7|||
155341483|NCT03386344|560683205|FG002|Overall Study|At the Participant's own Request|8|||
155341484|NCT03386344|560683203|FG000|Overall Study|Reason not Specified|0|||
155341485|NCT03386344|560683204|FG001|Overall Study|Reason not Specified|1|||
155341486|NCT03386344|560683205|FG002|Overall Study|Reason not Specified|0|||
155341487|NCT00248794|560683214|FG000|Overall Study|Lost to Follow-up|6|||
155341488|NCT00248794|560683215|FG001|Overall Study|Lost to Follow-up|8|||
155341489|NCT00248794|560683216|FG002|Overall Study|Lost to Follow-up|3|||
155341490|NCT04421456|560683217|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
155341491|NCT04421456|560683218|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
155341492|NCT04421456|560683219|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
155341493|NCT04421456|560683217|FG000|Randomized Treatment Period|Adverse Event|0|||
155341494|NCT04421456|560683218|FG001|Randomized Treatment Period|Adverse Event|1|||
155341495|NCT04421456|560683219|FG002|Randomized Treatment Period|Adverse Event|0|||
155341496|NCT04421456|560683217|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
155341497|NCT04421456|560683218|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
155341498|NCT04421456|560683219|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
155341499|NCT04421456|560683217|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
155341500|NCT04421456|560683218|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
155341501|NCT04421456|560683219|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
155341502|NCT04421456|560683217|FG000|Randomized Treatment Period|Participant non-compliance|1|||
155341503|NCT04421456|560683218|FG001|Randomized Treatment Period|Participant non-compliance|1|||
155341504|NCT04421456|560683219|FG002|Randomized Treatment Period|Participant non-compliance|2|||
155341505|NCT04421456|560683217|FG000|Randomized Treatment Period|Other|0|||
155341506|NCT04421456|560683218|FG001|Randomized Treatment Period|Other|1|||
155341507|NCT04421456|560683219|FG002|Randomized Treatment Period|Other|3|||
155341508|NCT03209492|560683220|FG000|Overall Study|Case Report Forms Uncollected|5|||
155341509|NCT03481725|560683221|FG000|Overall Study|Withdrawal by Subject|1|||
155341510|NCT03481725|560683222|FG001|Overall Study|Withdrawal by Subject|0|||
155341511|NCT01894620|560683227|FG000|Overall Study|Withdrawal by Subject|0|||
155341512|NCT01894620|560683228|FG001|Overall Study|Withdrawal by Subject|1|||
155341513|NCT02877680|560683229|FG000|Overall Study|Lost to Follow-up|1|||
155341514|NCT02877680|560683230|FG001|Overall Study|Lost to Follow-up|1|||
155341515|NCT01133678|560683231|FG000|Overall Study|Death|1|||
155341516|NCT01133678|560683232|FG001|Overall Study|Death|1|||
155341517|NCT00879710|560683239|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
155341518|NCT00879710|560683240|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
155341519|NCT00879710|560683241|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
155341520|NCT00879710|560683242|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
155341521|NCT00879710|560683239|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
155341522|NCT00879710|560683240|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
155423502|NCT00896532|560978722|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
155423503|NCT00896532|560978723|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
155423504|NCT00896532|560978724|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
155423505|NCT00896532|560978725|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
155423506|NCT00896532|560978726|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
155423507|NCT00896532|560978727|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
155423508|NCT00896532|560978705|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423509|NCT00896532|560978706|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423510|NCT00896532|560978707|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423511|NCT00896532|560978708|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423512|NCT00896532|560978709|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423513|NCT00896532|560978710|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423514|NCT00896532|560978711|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423515|NCT00896532|560978712|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423516|NCT00896532|560978713|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423517|NCT00896532|560978714|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423518|NCT00896532|560978715|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423519|NCT00896532|560978716|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423520|NCT00896532|560978717|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423521|NCT00896532|560978718|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423522|NCT00896532|560978719|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155505119|NCT02217345|561276093|FG000|Overall Study|Adverse Event|2|||
155505120|NCT02217345|561276094|FG001|Overall Study|Adverse Event|1|||
155341523|NCT00879710|560683241|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
155341524|NCT00879710|560683242|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
155341525|NCT01864200|560683243|FG000|Overall Study|Lost to Follow-up|1|||
155341526|NCT01864200|560683244|FG001|Overall Study|Lost to Follow-up|3|||
155341527|NCT01864200|560683243|FG000|Overall Study|Protocol Violation|1|||
155423523|NCT00896532|560978720|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
155423524|NCT00896532|560978721|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
155423525|NCT00896532|560978722|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423526|NCT00896532|560978723|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423527|NCT00896532|560978724|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423528|NCT00896532|560978725|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423529|NCT00896532|560978726|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423530|NCT00896532|560978727|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
155423531|NCT00896532|560978705|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423532|NCT00896532|560978706|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423533|NCT00896532|560978707|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423534|NCT00896532|560978708|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423535|NCT00896532|560978709|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423536|NCT00896532|560978710|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423537|NCT00896532|560978711|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423538|NCT00896532|560978712|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423539|NCT00896532|560978713|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423540|NCT00896532|560978714|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423541|NCT00896532|560978715|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423542|NCT00896532|560978716|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423543|NCT00896532|560978717|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423544|NCT00896532|560978718|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423545|NCT00896532|560978719|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423546|NCT00896532|560978720|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
155423547|NCT00896532|560978721|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
155423548|NCT00896532|560978722|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
155423549|NCT00896532|560978723|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423550|NCT00896532|560978724|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423551|NCT00896532|560978725|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423552|NCT00896532|560978726|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423553|NCT00896532|560978727|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155423554|NCT00896532|560978705|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423555|NCT00896532|560978706|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155341528|NCT01864200|560683244|FG001|Overall Study|Protocol Violation|0|||
155341529|NCT02077374|560683245|FG000|Overall Study|Withdrawal by Subject|0|||
155341530|NCT02077374|560683246|FG001|Overall Study|Withdrawal by Subject|1|||
155341531|NCT02077374|560683245|FG000|Overall Study|Protocol Violation|0|||
155341532|NCT02077374|560683246|FG001|Overall Study|Protocol Violation|1|||
155341533|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
155341534|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341535|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341536|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341537|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341538|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Adverse Event|0|||
155341539|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Adverse Event|1|||
155341540|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Adverse Event|1|||
155341541|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Adverse Event|0|||
155341542|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Adverse Event|0|||
155341543|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
155341544|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341545|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341546|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341547|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341548|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Physician Decision|1|||
155341549|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Physician Decision|0|||
155341550|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Physician Decision|0|||
155341551|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Physician Decision|0|||
155341552|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Physician Decision|0|||
155341553|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
155341554|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
155341555|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
155341556|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
155341557|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
155341558|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Ongoing|0|||
155341559|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Ongoing|0|||
155341560|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Ongoing|1|||
155341561|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Ongoing|0|||
155341562|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Ongoing|0|||
155341563|NCT00446095|560683247|FG000|Phase I (28 Days)|Adverse Event|0|||
155341564|NCT00446095|560683248|FG001|Phase I (28 Days)|Adverse Event|0|||
155341565|NCT00446095|560683249|FG002|Phase I (28 Days)|Adverse Event|0|||
155341566|NCT00446095|560683250|FG003|Phase I (28 Days)|Adverse Event|1|||
155341567|NCT00446095|560683251|FG004|Phase I (28 Days)|Adverse Event|0|||
155341568|NCT00446095|560683247|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
155341569|NCT00446095|560683248|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
155341570|NCT00446095|560683249|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
155341571|NCT00446095|560683250|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
155341572|NCT00446095|560683251|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
155341573|NCT00424476|560683252|FG000|Overall Study|Withdrawal by Subject|7|||
155341574|NCT00424476|560683253|FG001|Overall Study|Withdrawal by Subject|6|||
155341575|NCT00424476|560683254|FG002|Overall Study|Withdrawal by Subject|3|||
155341576|NCT00424476|560683252|FG000|Overall Study|Adverse Event|19|||
155341577|NCT00424476|560683253|FG001|Overall Study|Adverse Event|16|||
155341578|NCT00424476|560683254|FG002|Overall Study|Adverse Event|15|||
155341579|NCT00424476|560683252|FG000|Overall Study|Lack of Efficacy|16|||
155341580|NCT00424476|560683253|FG001|Overall Study|Lack of Efficacy|12|||
155341581|NCT00424476|560683254|FG002|Overall Study|Lack of Efficacy|12|||
155341582|NCT00424476|560683252|FG000|Overall Study|Lack of Compliance|1|||
155341583|NCT00424476|560683253|FG001|Overall Study|Lack of Compliance|1|||
155341584|NCT00424476|560683254|FG002|Overall Study|Lack of Compliance|1|||
155341585|NCT00424476|560683252|FG000|Overall Study|Lost to Follow-up|4|||
155341586|NCT00424476|560683253|FG001|Overall Study|Lost to Follow-up|6|||
155341587|NCT00424476|560683254|FG002|Overall Study|Lost to Follow-up|3|||
155341588|NCT00424476|560683252|FG000|Overall Study|Protocol Violation|7|||
155341589|NCT00424476|560683253|FG001|Overall Study|Protocol Violation|2|||
155341590|NCT00424476|560683254|FG002|Overall Study|Protocol Violation|3|||
155341591|NCT00424476|560683252|FG000|Overall Study|Physician Decision|3|||
155341592|NCT00424476|560683253|FG001|Overall Study|Physician Decision|2|||
155341593|NCT00424476|560683254|FG002|Overall Study|Physician Decision|3|||
155341594|NCT00424476|560683252|FG000|Overall Study|Other|4|||
155341595|NCT00424476|560683253|FG001|Overall Study|Other|3|||
155341596|NCT00424476|560683254|FG002|Overall Study|Other|9|||
155341597|NCT00886834|560683255|FG000|Overall Study|Protocol Violation|0|||
155341598|NCT00886834|560683256|FG001|Overall Study|Protocol Violation|3|||
155646765|NCT00289978|561799542|FG000|Overall Study|Adverse Event|22|||
155646766|NCT00289978|561799543|FG001|Overall Study|Adverse Event|13|||
155646767|NCT00289978|561799544|FG002|Overall Study|Adverse Event|18|||
155646768|NCT00289978|561799542|FG000|Overall Study|Lack of Efficacy|13|||
155646769|NCT00289978|561799543|FG001|Overall Study|Lack of Efficacy|6|||
155341599|NCT00657709|560683257|FG000|Overall Study|AE or Death|7|||
155341600|NCT00657709|560683258|FG001|Overall Study|AE or Death|7|||
155341601|NCT00657709|560683259|FG002|Overall Study|AE or Death|6|||
155341602|NCT00657709|560683260|FG003|Overall Study|AE or Death|7|||
155341603|NCT00657709|560683261|FG004|Overall Study|AE or Death|1|||
155341604|NCT00657709|560683257|FG000|Overall Study|Withdrawal by Subject|7|||
155341605|NCT00657709|560683258|FG001|Overall Study|Withdrawal by Subject|15|||
155341606|NCT00657709|560683259|FG002|Overall Study|Withdrawal by Subject|15|||
155341607|NCT00657709|560683260|FG003|Overall Study|Withdrawal by Subject|5|||
155341608|NCT00657709|560683261|FG004|Overall Study|Withdrawal by Subject|9|||
155341609|NCT00657709|560683257|FG000|Overall Study|Lost to Follow-up|9|||
155341610|NCT00657709|560683258|FG001|Overall Study|Lost to Follow-up|9|||
155341611|NCT00657709|560683259|FG002|Overall Study|Lost to Follow-up|7|||
155341612|NCT00657709|560683260|FG003|Overall Study|Lost to Follow-up|1|||
155341613|NCT00657709|560683261|FG004|Overall Study|Lost to Follow-up|21|||
155341614|NCT00657709|560683257|FG000|Overall Study|Protocol Violation|0|||
155341615|NCT00657709|560683258|FG001|Overall Study|Protocol Violation|2|||
155341616|NCT00657709|560683259|FG002|Overall Study|Protocol Violation|0|||
155341617|NCT00657709|560683260|FG003|Overall Study|Protocol Violation|1|||
155341618|NCT00657709|560683261|FG004|Overall Study|Protocol Violation|2|||
155341619|NCT02574286|560683262|FG000|Overall Study|Adverse Event|3|||
155341620|NCT02574286|560683262|FG000|Overall Study|Withdrawal by Subject|2|||
155341621|NCT01029925|560683265|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
155341622|NCT01029925|560683265|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
155341623|NCT01029925|560683265|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
155341624|NCT02279732|560683266|FG000|Overall Study|Death|23|||
155341625|NCT02279732|560683267|FG001|Overall Study|Death|20|||
155341626|NCT02279732|560683266|FG000|Overall Study|Disease Progression|13|||
155341627|NCT02279732|560683267|FG001|Overall Study|Disease Progression|3|||
155341628|NCT02279732|560683266|FG000|Overall Study|Withdrawal by Subject|2|||
155341629|NCT02279732|560683267|FG001|Overall Study|Withdrawal by Subject|7|||
155341630|NCT02279732|560683266|FG000|Overall Study|Adverse Event|1|||
155341631|NCT02279732|560683267|FG001|Overall Study|Adverse Event|2|||
155341632|NCT02279732|560683266|FG000|Overall Study|Administrative Reason By Sponsor|0|||
155341633|NCT02279732|560683267|FG001|Overall Study|Administrative Reason By Sponsor|2|||
155341634|NCT02279732|560683266|FG000|Overall Study|Study Drug Toxicity|2|||
155341635|NCT02279732|560683267|FG001|Overall Study|Study Drug Toxicity|0|||
155341636|NCT02279732|560683266|FG000|Overall Study|Lost to Follow-up|0|||
155341637|NCT02279732|560683267|FG001|Overall Study|Lost to Follow-up|1|||
155341638|NCT02279732|560683266|FG000|Overall Study|Maximum Clinical Benefit|1|||
155341639|NCT02279732|560683267|FG001|Overall Study|Maximum Clinical Benefit|0|||
155341640|NCT02279732|560683266|FG000|Overall Study|Subject Requested to Discontinue|0|||
155341641|NCT02279732|560683267|FG001|Overall Study|Subject Requested to Discontinue|1|||
155341642|NCT02279732|560683266|FG000|Overall Study|Other|53|||
155341643|NCT02279732|560683267|FG001|Overall Study|Other|67|||
155505121|NCT02217345|561276093|FG000|Overall Study|Physician Decision|0|||
155505122|NCT02217345|561276094|FG001|Overall Study|Physician Decision|1|||
155505123|NCT00971204|561276095|FG000|Overall Study|Did not meet all criteria-not treated|14|||
155505124|NCT00971204|561276095|FG000|Overall Study|Lost to Follow-up|10|||
155505125|NCT04130919|561276096|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
155505126|NCT04130919|561276097|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
155505127|NCT04130919|561276098|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
155505128|NCT04130919|561276099|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
155505129|NCT04130919|561276100|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
155505130|NCT04130919|561276101|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
155505131|NCT04130919|561276096|FG000|Blinded Treatment Phase|Adverse Event|0|||
155505132|NCT04130919|561276097|FG001|Blinded Treatment Phase|Adverse Event|0|||
155505133|NCT04130919|561276098|FG002|Blinded Treatment Phase|Adverse Event|1|||
155505134|NCT04130919|561276099|FG003|Blinded Treatment Phase|Adverse Event|0|||
155505135|NCT04130919|561276100|FG004|Blinded Treatment Phase|Adverse Event|0|||
155341644|NCT02279732|560683266|FG000|Overall Study|Other|3|||
155341645|NCT02279732|560683267|FG001|Overall Study|Other|3|||
155341646|NCT02203513|560683268|FG000|Overall Study|Refused further treatment|2|||
155341647|NCT02203513|560683269|FG001|Overall Study|Refused further treatment|0|||
155341648|NCT02203513|560683270|FG002|Overall Study|Refused further treatment|1|||
155341649|NCT02203513|560683271|FG003|Overall Study|Refused further treatment|0|||
155341650|NCT02203513|560683272|FG004|Overall Study|Refused further treatment|0|||
155341651|NCT02203513|560683268|FG000|Overall Study|Switched to alternative treatment|3|||
155341652|NCT02203513|560683269|FG001|Overall Study|Switched to alternative treatment|4|||
155341653|NCT02203513|560683270|FG002|Overall Study|Switched to alternative treatment|0|||
155505136|NCT04130919|561276101|FG005|Blinded Treatment Phase|Adverse Event|0|||
155505137|NCT04130919|561276096|FG000|Blinded Treatment Phase|Disease worsening|0|||
155505138|NCT04130919|561276097|FG001|Blinded Treatment Phase|Disease worsening|0|||
155341654|NCT02203513|560683271|FG003|Overall Study|Switched to alternative treatment|0|||
155341655|NCT02203513|560683272|FG004|Overall Study|Switched to alternative treatment|4|||
155341656|NCT02203513|560683268|FG000|Overall Study|Did not receive investigational product (IP)|0|||
155341657|NCT02203513|560683269|FG001|Overall Study|Did not receive investigational product (IP)|1|||
155341658|NCT02203513|560683270|FG002|Overall Study|Did not receive investigational product (IP)|0|||
155341659|NCT02203513|560683271|FG003|Overall Study|Did not receive investigational product (IP)|0|||
155341660|NCT02203513|560683272|FG004|Overall Study|Did not receive investigational product (IP)|0|||
155341661|NCT02203513|560683268|FG000|Overall Study|Death (unrelated to study therapy)|1|||
155341662|NCT02203513|560683269|FG001|Overall Study|Death (unrelated to study therapy)|3|||
155341663|NCT02203513|560683270|FG002|Overall Study|Death (unrelated to study therapy)|1|||
155341664|NCT02203513|560683271|FG003|Overall Study|Death (unrelated to study therapy)|0|||
155341665|NCT02203513|560683272|FG004|Overall Study|Death (unrelated to study therapy)|2|||
155341666|NCT02203513|560683268|FG000|Overall Study|Lost to Follow-up|0|||
155341667|NCT02203513|560683269|FG001|Overall Study|Lost to Follow-up|0|||
155341668|NCT02203513|560683270|FG002|Overall Study|Lost to Follow-up|1|||
155341669|NCT02203513|560683271|FG003|Overall Study|Lost to Follow-up|1|||
155341670|NCT02203513|560683272|FG004|Overall Study|Lost to Follow-up|0|||
155341671|NCT03060525|560683274|FG000|Overall Study|moved out of state|1|||
155341672|NCT03060525|560683275|FG001|Overall Study|moved out of state|1|||
155341673|NCT03060525|560683276|FG002|Overall Study|moved out of state|1|||
155341674|NCT03060525|560683277|FG003|Overall Study|moved out of state|1|||
155341675|NCT03060525|560683274|FG000|Overall Study|unable to meet time commitment required of study|2|||
155341676|NCT03060525|560683275|FG001|Overall Study|unable to meet time commitment required of study|3|||
155341677|NCT03060525|560683276|FG002|Overall Study|unable to meet time commitment required of study|3|||
155341678|NCT03060525|560683277|FG003|Overall Study|unable to meet time commitment required of study|1|||
155341679|NCT03060525|560683274|FG000|Overall Study|no longer interested in doing intervention|0|||
155341680|NCT03060525|560683275|FG001|Overall Study|no longer interested in doing intervention|0|||
155341681|NCT03060525|560683276|FG002|Overall Study|no longer interested in doing intervention|0|||
155341682|NCT03060525|560683277|FG003|Overall Study|no longer interested in doing intervention|1|||
155341683|NCT02978716|560683278|FG000|Overall Study|Death|25|||
155341684|NCT02978716|560683279|FG001|Overall Study|Death|13|||
155341685|NCT02978716|560683280|FG002|Overall Study|Death|20|||
155341686|NCT02978716|560683278|FG000|Overall Study|Lost to Follow-up|0|||
155341687|NCT02978716|560683279|FG001|Overall Study|Lost to Follow-up|0|||
155341688|NCT02978716|560683280|FG002|Overall Study|Lost to Follow-up|1|||
155341689|NCT02978716|560683278|FG000|Overall Study|Withdrawal by Subject|6|||
155341690|NCT02978716|560683279|FG001|Overall Study|Withdrawal by Subject|4|||
155341691|NCT02978716|560683280|FG002|Overall Study|Withdrawal by Subject|5|||
155341692|NCT02978716|560683278|FG000|Overall Study|Sponsor terminated|2|||
155341693|NCT02978716|560683279|FG001|Overall Study|Sponsor terminated|13|||
155341694|NCT02978716|560683280|FG002|Overall Study|Sponsor terminated|9|||
155341695|NCT02978716|560683278|FG000|Overall Study|Other|1|||
155341696|NCT02978716|560683279|FG001|Overall Study|Other|3|||
155341697|NCT02978716|560683280|FG002|Overall Study|Other|0|||
155341698|NCT00960206|560683281|FG000|Overall Study|Death|7|||
155341699|NCT00960206|560683282|FG001|Overall Study|Death|4|||
155341700|NCT00960206|560683283|FG002|Overall Study|Death|1|||
155341701|NCT00960206|560683281|FG000|Overall Study|Unwilling/Unable to return|1|||
155341702|NCT00960206|560683282|FG001|Overall Study|Unwilling/Unable to return|2|||
155341703|NCT00960206|560683283|FG002|Overall Study|Unwilling/Unable to return|0|||
155341704|NCT00960206|560683281|FG000|Overall Study|Lost to Follow-up|8|||
155341705|NCT00960206|560683282|FG001|Overall Study|Lost to Follow-up|14|||
155341706|NCT00960206|560683283|FG002|Overall Study|Lost to Follow-up|8|||
155341707|NCT00960206|560683281|FG000|Overall Study|Withdrawal by Subject|2|||
155341708|NCT00960206|560683282|FG001|Overall Study|Withdrawal by Subject|4|||
155341709|NCT00960206|560683283|FG002|Overall Study|Withdrawal by Subject|0|||
155341710|NCT00960206|560683281|FG000|Overall Study|Revision of study component|2|||
155341711|NCT00960206|560683282|FG001|Overall Study|Revision of study component|2|||
155423556|NCT00896532|560978707|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423557|NCT00896532|560978708|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423558|NCT00896532|560978709|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423559|NCT00896532|560978710|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423560|NCT00896532|560978711|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423561|NCT00896532|560978712|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423562|NCT00896532|560978713|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423563|NCT00896532|560978714|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423564|NCT00896532|560978715|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155341712|NCT00960206|560683283|FG002|Overall Study|Revision of study component|2|||
155341713|NCT00960206|560683281|FG000|Overall Study|Missing 10 year data|20|||
155341714|NCT00960206|560683282|FG001|Overall Study|Missing 10 year data|1|||
155341715|NCT00960206|560683283|FG002|Overall Study|Missing 10 year data|1|||
155341716|NCT02612285|560683286|FG000|Overall Study|Withdrawal by Subject|1|||
155341717|NCT02548585|560683287|FG000|Overall Study|Withdrawal by Subject|0|||
155341718|NCT02548585|560683288|FG001|Overall Study|Withdrawal by Subject|0|||
155341719|NCT02548585|560683289|FG002|Overall Study|Withdrawal by Subject|0|||
155341720|NCT02548585|560683290|FG003|Overall Study|Withdrawal by Subject|0|||
155341721|NCT02548585|560683291|FG004|Overall Study|Withdrawal by Subject|0|||
155341722|NCT02548585|560683292|FG005|Overall Study|Withdrawal by Subject|1|||
155341723|NCT02548585|560683293|FG006|Overall Study|Withdrawal by Subject|0|||
155341724|NCT02548585|560683287|FG000|Overall Study|Lost to Follow-up|1|||
155341725|NCT02548585|560683288|FG001|Overall Study|Lost to Follow-up|0|||
155341726|NCT02548585|560683289|FG002|Overall Study|Lost to Follow-up|0|||
155341727|NCT02548585|560683290|FG003|Overall Study|Lost to Follow-up|0|||
155341728|NCT02548585|560683291|FG004|Overall Study|Lost to Follow-up|0|||
155341729|NCT02548585|560683292|FG005|Overall Study|Lost to Follow-up|0|||
155341730|NCT02548585|560683293|FG006|Overall Study|Lost to Follow-up|0|||
155341731|NCT02548585|560683287|FG000|Overall Study|Other|1|||
155341732|NCT02548585|560683288|FG001|Overall Study|Other|0|||
155341733|NCT02548585|560683289|FG002|Overall Study|Other|0|||
155341734|NCT02548585|560683290|FG003|Overall Study|Other|2|||
155341735|NCT02548585|560683291|FG004|Overall Study|Other|3|||
155341736|NCT02548585|560683292|FG005|Overall Study|Other|0|||
155341737|NCT02548585|560683293|FG006|Overall Study|Other|1|||
155341738|NCT02548585|560683287|FG000|Overall Study|Randomized but not treated|0|||
155341739|NCT02548585|560683288|FG001|Overall Study|Randomized but not treated|0|||
155341740|NCT02548585|560683289|FG002|Overall Study|Randomized but not treated|0|||
155341741|NCT02548585|560683290|FG003|Overall Study|Randomized but not treated|0|||
155341742|NCT02548585|560683291|FG004|Overall Study|Randomized but not treated|0|||
155341743|NCT02548585|560683292|FG005|Overall Study|Randomized but not treated|1|||
155341744|NCT02548585|560683293|FG006|Overall Study|Randomized but not treated|0|||
155341745|NCT00452452|560683296|FG000|Overall Study|Protocol Violation|0|||
155341746|NCT00452452|560683297|FG001|Overall Study|Protocol Violation|0|||
155341747|NCT00452452|560683298|FG002|Overall Study|Protocol Violation|1|||
155341748|NCT00452452|560683296|FG000|Overall Study|Withdrawal by Subject|1|||
155341749|NCT00452452|560683297|FG001|Overall Study|Withdrawal by Subject|0|||
155341750|NCT00452452|560683298|FG002|Overall Study|Withdrawal by Subject|0|||
155341751|NCT00452452|560683296|FG000|Overall Study|Lost to Follow-up|1|||
155341752|NCT00452452|560683297|FG001|Overall Study|Lost to Follow-up|0|||
155341753|NCT00452452|560683298|FG002|Overall Study|Lost to Follow-up|0|||
155341754|NCT00711555|560684994|FG000|Overall Study|Adverse Event|3|||
155341755|NCT02068352|560685000|FG000|Overall Study|Lost to Follow-up|0|||
155341756|NCT02068352|560685001|FG001|Overall Study|Lost to Follow-up|2|||
155341757|NCT02068352|560685002|FG002|Overall Study|Lost to Follow-up|0|||
155341758|NCT02068352|560685000|FG000|Overall Study|Adverse Event|4|||
155341759|NCT02068352|560685001|FG001|Overall Study|Adverse Event|2|||
155341760|NCT02068352|560685002|FG002|Overall Study|Adverse Event|7|||
155341761|NCT02068352|560685000|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
155341762|NCT02068352|560685001|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
155341763|NCT02068352|560685002|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
155341764|NCT02068352|560685000|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
155341765|NCT02068352|560685001|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
155341766|NCT02068352|560685002|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
155341767|NCT02068352|560685000|FG000|Overall Study|Protocol Deviation|0|||
155341768|NCT02068352|560685001|FG001|Overall Study|Protocol Deviation|0|||
155341769|NCT02068352|560685002|FG002|Overall Study|Protocol Deviation|1|||
155341770|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
155341771|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
155341772|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
155341773|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
155341774|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
155341775|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
155341776|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
155341777|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
155341778|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Death|3|||
155341779|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
155341780|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
155341781|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
155341782|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
155341783|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|other|3|||
155646770|NCT00289978|561799544|FG002|Overall Study|Lack of Efficacy|25|||
155646771|NCT00289978|561799542|FG000|Overall Study|Abnormal laboratory value(s)|20|||
155646772|NCT00289978|561799543|FG001|Overall Study|Abnormal laboratory value(s)|9|||
155646773|NCT00289978|561799544|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155646774|NCT00289978|561799542|FG000|Overall Study|Lost to Follow-up|3|||
155646775|NCT00289978|561799543|FG001|Overall Study|Lost to Follow-up|5|||
155646776|NCT00289978|561799544|FG002|Overall Study|Lost to Follow-up|7|||
155646777|NCT00289978|561799542|FG000|Overall Study|Protocol Violation|5|||
155646778|NCT00289978|561799543|FG001|Overall Study|Protocol Violation|5|||
155646779|NCT00289978|561799544|FG002|Overall Study|Protocol Violation|4|||
155646780|NCT00289978|561799542|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155341784|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155341785|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155341786|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341787|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341788|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341789|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341790|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341791|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
155341792|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
155341793|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
155341794|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341795|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341796|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341797|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341798|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
155341799|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341800|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155341801|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341802|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341803|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341804|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341805|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341806|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
155341807|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341808|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341809|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341810|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341811|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341812|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
155341813|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
155341814|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
155341815|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341816|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341817|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341818|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341819|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
155341820|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
155341821|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
155341822|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341823|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341824|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341825|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341826|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341827|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341828|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341829|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341830|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341831|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
155341832|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341833|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341834|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341835|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341836|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155341837|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341838|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
155341839|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
155341840|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341841|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341842|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341843|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
155341844|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
155341845|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
155341846|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
155341847|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341848|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341849|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341850|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
155341851|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341852|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
155341853|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
155341854|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341855|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341856|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341857|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
155341858|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341859|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341860|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
155341861|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341862|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341863|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341864|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341865|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341866|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
155341867|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341868|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341869|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341870|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341871|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
155341872|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
155341873|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
155341874|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
155341875|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341876|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341877|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341878|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341879|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341880|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341881|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341882|NCT03456856|560685016|FG000|Overall Study|Lost to Follow-up|2|||
155341883|NCT03456856|560685016|FG000|Overall Study|Withdrawal by Subject|1|||
155341884|NCT01190436|560685017|FG000|Overall Study|Lost to Follow-up|35|||
155341885|NCT01190436|560685017|FG000|Overall Study|Other|4|||
155341886|NCT00113529|560685018|FG000|Overall Study|Adverse Event|4|||
155341887|NCT00113529|560685018|FG000|Overall Study|Lack of Efficacy|20|||
155341888|NCT00113529|560685018|FG000|Overall Study|Decision of sponsor|6|||
155341889|NCT00113529|560685018|FG000|Overall Study|Withdrawal by Subject|4|||
155341890|NCT01077284|560685019|FG000|Overall Study|Adverse Event|2|||
155423565|NCT00896532|560978716|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423566|NCT00896532|560978717|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423567|NCT00896532|560978718|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423568|NCT00896532|560978719|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423569|NCT00896532|560978720|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423570|NCT00896532|560978721|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
155341891|NCT01077284|560685020|FG001|Overall Study|Adverse Event|0|||
155341892|NCT01077284|560685021|FG002|Overall Study|Adverse Event|1|||
155341893|NCT01077284|560685019|FG000|Overall Study|Lost to Follow-up|1|||
155423571|NCT00896532|560978722|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155341894|NCT01077284|560685020|FG001|Overall Study|Lost to Follow-up|2|||
155341895|NCT01077284|560685021|FG002|Overall Study|Lost to Follow-up|0|||
155341896|NCT01077284|560685019|FG000|Overall Study|Withdrawal by Subject|2|||
155341897|NCT01077284|560685020|FG001|Overall Study|Withdrawal by Subject|3|||
155341898|NCT01077284|560685021|FG002|Overall Study|Withdrawal by Subject|1|||
155341899|NCT01077284|560685019|FG000|Overall Study|Other|0|||
155341900|NCT01077284|560685020|FG001|Overall Study|Other|0|||
155341901|NCT01077284|560685021|FG002|Overall Study|Other|1|||
155341902|NCT04626128|560685022|FG000|Overall Study|Withdrawal by Subject|0|||
155341903|NCT04626128|560685023|FG001|Overall Study|Withdrawal by Subject|1|||
155341904|NCT04626128|560685024|FG002|Overall Study|Withdrawal by Subject|0|||
155341905|NCT04626128|560685025|FG003|Overall Study|Withdrawal by Subject|0|||
155341906|NCT00841321|560685026|FG000|Overall Study|Lost to Follow-up|1|||
155341907|NCT00841321|560685027|FG001|Overall Study|Lost to Follow-up|1|||
155341908|NCT00841321|560685026|FG000|Overall Study|Adverse Event|0|||
155423572|NCT00896532|560978723|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423573|NCT00896532|560978724|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423574|NCT00896532|560978725|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423575|NCT00896532|560978726|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423576|NCT00896532|560978727|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
155423577|NCT00896532|560978705|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
155341909|NCT00841321|560685027|FG001|Overall Study|Adverse Event|2|||
155341910|NCT02632747|560685028|FG000|Wash-out Period|Adverse Event|1|||
155341911|NCT02632747|560685029|FG001|Wash-out Period|Adverse Event|0|||
155341912|NCT04908488|560685030|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
155341913|NCT04908488|560685031|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
155341914|NCT04908488|560685030|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
155341915|NCT04908488|560685031|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
155341916|NCT03444155|560685032|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
155341917|NCT03444155|560685033|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
155341918|NCT01107912|560685034|FG000|Period 1|Adverse Event|0|||
155341919|NCT01107912|560685035|FG001|Period 1|Adverse Event|0|||
155341920|NCT01107912|560685036|FG002|Period 1|Adverse Event|0|||
155341921|NCT01107912|560685037|FG003|Period 1|Adverse Event|0|||
155341922|NCT01107912|560685038|FG004|Period 1|Adverse Event|2|||
155341923|NCT01107912|560685039|FG005|Period 1|Adverse Event|0|||
155341924|NCT01107912|560685034|FG000|Period 1|Physician Decision|0|||
155341925|NCT01107912|560685035|FG001|Period 1|Physician Decision|0|||
155341926|NCT01107912|560685036|FG002|Period 1|Physician Decision|0|||
155341927|NCT01107912|560685037|FG003|Period 1|Physician Decision|0|||
155341928|NCT01107912|560685038|FG004|Period 1|Physician Decision|1|||
155341929|NCT01107912|560685039|FG005|Period 1|Physician Decision|0|||
155341930|NCT01107912|560685034|FG000|Period 1|Withdrawal by Subject|1|||
155341931|NCT01107912|560685035|FG001|Period 1|Withdrawal by Subject|0|||
155341932|NCT01107912|560685036|FG002|Period 1|Withdrawal by Subject|0|||
155341933|NCT01107912|560685037|FG003|Period 1|Withdrawal by Subject|0|||
155341934|NCT01107912|560685038|FG004|Period 1|Withdrawal by Subject|0|||
155341935|NCT01107912|560685039|FG005|Period 1|Withdrawal by Subject|0|||
155341936|NCT01107912|560685034|FG000|Period 2|Physician Decision|0|||
155341937|NCT01107912|560685035|FG001|Period 2|Physician Decision|0|||
155341938|NCT01107912|560685036|FG002|Period 2|Physician Decision|1|||
155341939|NCT01107912|560685037|FG003|Period 2|Physician Decision|0|||
155341940|NCT01107912|560685038|FG004|Period 2|Physician Decision|0|||
155341941|NCT01107912|560685039|FG005|Period 2|Physician Decision|0|||
155341942|NCT01107912|560685034|FG000|Period 3|Adverse Event|0|||
155341943|NCT01107912|560685035|FG001|Period 3|Adverse Event|1|||
155341944|NCT01107912|560685036|FG002|Period 3|Adverse Event|1|||
155341945|NCT01107912|560685037|FG003|Period 3|Adverse Event|0|||
155341946|NCT01107912|560685038|FG004|Period 3|Adverse Event|0|||
155341947|NCT01107912|560685039|FG005|Period 3|Adverse Event|0|||
155341948|NCT01107912|560685034|FG000|Period 3|Withdrawal by Subject|0|||
155341949|NCT01107912|560685035|FG001|Period 3|Withdrawal by Subject|0|||
155341950|NCT01107912|560685036|FG002|Period 3|Withdrawal by Subject|0|||
155341951|NCT01107912|560685037|FG003|Period 3|Withdrawal by Subject|1|||
155341952|NCT01107912|560685038|FG004|Period 3|Withdrawal by Subject|0|||
155341953|NCT01107912|560685039|FG005|Period 3|Withdrawal by Subject|0|||
155341954|NCT01124916|560685044|FG000|Overall Study|Lost to Follow-up|3|||
155341955|NCT01124916|560685045|FG001|Overall Study|Lost to Follow-up|2|||
155341956|NCT00595959|560685046|FG000|Overall Study|Withdrawal by Subject|1|||
155341957|NCT00595959|560685046|FG000|Overall Study|Lost to Follow-up|1|||
155341958|NCT00963924|560685049|FG000|Overall Study|Adverse Event|1|||
155341959|NCT00963924|560685050|FG001|Overall Study|Adverse Event|0|||
155505139|NCT04130919|561276098|FG002|Blinded Treatment Phase|Disease worsening|1|||
155505140|NCT04130919|561276099|FG003|Blinded Treatment Phase|Disease worsening|0|||
155341960|NCT00963924|560685049|FG000|Overall Study|Withdrawal by Subject|0|||
155341961|NCT00963924|560685050|FG001|Overall Study|Withdrawal by Subject|1|||
155341962|NCT00963924|560685049|FG000|Overall Study|Changed antipsychotic|0|||
155341963|NCT00963924|560685050|FG001|Overall Study|Changed antipsychotic|1|||
155341964|NCT00963924|560685049|FG000|Overall Study|Lost to Follow-up|0|||
155341965|NCT00963924|560685050|FG001|Overall Study|Lost to Follow-up|1|||
155341966|NCT03875729|560685052|FG000|Overall Study|Adverse Event|0|||
155341967|NCT03875729|560685053|FG001|Overall Study|Adverse Event|5|||
155341968|NCT03875729|560685052|FG000|Overall Study|Withdrawal by Subject|8|||
155341969|NCT03875729|560685053|FG001|Overall Study|Withdrawal by Subject|11|||
155341970|NCT03875729|560685052|FG000|Overall Study|Pregnancy|0|||
155341971|NCT03875729|560685053|FG001|Overall Study|Pregnancy|1|||
155341972|NCT03875729|560685052|FG000|Overall Study|Lost to Follow-up|0|||
155341973|NCT03875729|560685053|FG001|Overall Study|Lost to Follow-up|5|||
155341974|NCT03875729|560685052|FG000|Overall Study|Personal reasons|2|||
155341975|NCT03875729|560685053|FG001|Overall Study|Personal reasons|0|||
155341976|NCT00753896|560685054|FG000|Overall Study|Adverse Event|4|||
155341977|NCT00753896|560685054|FG000|Overall Study|Death|1|||
155341978|NCT00753896|560685054|FG000|Overall Study|Lost to Follow-up|2|||
155341979|NCT00753896|560685054|FG000|Overall Study|Protocol Violation|1|||
155341980|NCT00753896|560685054|FG000|Overall Study|Withdrawal by Subject|4|||
155341981|NCT00753896|560685054|FG000|Overall Study|Entry Criteria Not Met|4|||
155341982|NCT01280656|560685055|FG000|Overall Study|Adverse Event|1|||
155341983|NCT01280656|560685056|FG001|Overall Study|Adverse Event|14|||
155341984|NCT01280656|560685057|FG002|Overall Study|Adverse Event|13|||
155341985|NCT01280656|560685055|FG000|Overall Study|Lack of Efficacy|1|||
155341986|NCT01280656|560685056|FG001|Overall Study|Lack of Efficacy|22|||
155341987|NCT01280656|560685057|FG002|Overall Study|Lack of Efficacy|38|||
155505141|NCT04130919|561276100|FG004|Blinded Treatment Phase|Disease worsening|0|||
155505142|NCT04130919|561276101|FG005|Blinded Treatment Phase|Disease worsening|0|||
155341988|NCT01280656|560685055|FG000|Overall Study|Treatment shortening (RGT)|0|||
155341989|NCT01280656|560685056|FG001|Overall Study|Treatment shortening (RGT)|4|||
155341990|NCT01280656|560685057|FG002|Overall Study|Treatment shortening (RGT)|5|||
155341991|NCT01280656|560685055|FG000|Overall Study|Other|1|||
155341992|NCT01280656|560685056|FG001|Overall Study|Other|7|||
155341993|NCT01280656|560685057|FG002|Overall Study|Other|7|||
155341994|NCT00952523|560685058|FG000|Overall Study|Withdrawal by Subject|7|||
155341995|NCT05265247|560685059|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
155341996|NCT05265247|560685060|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
155341997|NCT05265247|560685059|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
155341998|NCT05265247|560685060|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
155341999|NCT05265247|560685059|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
155342000|NCT05265247|560685060|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
155342001|NCT02159352|560685063|FG000|Overall Study|Adverse Event|3|||
155342002|NCT02159352|560685064|FG001|Overall Study|Adverse Event|1|||
155342003|NCT02159352|560685063|FG000|Overall Study|Withdrawal by Subject|0|||
155342004|NCT02159352|560685064|FG001|Overall Study|Withdrawal by Subject|1|||
155342005|NCT00529529|560685065|FG000|Overall Study|Adverse Event|12|||
155342006|NCT00529529|560685066|FG001|Overall Study|Adverse Event|17|||
155342007|NCT00529529|560685067|FG002|Overall Study|Adverse Event|8|||
155505143|NCT04130919|561276096|FG000|Blinded Treatment Phase|Investigator's decision|0|||
155342008|NCT00529529|560685065|FG000|Overall Study|Subject withdrew consent|12|||
155505144|NCT04130919|561276097|FG001|Blinded Treatment Phase|Investigator's decision|1|||
155505145|NCT04130919|561276098|FG002|Blinded Treatment Phase|Investigator's decision|0|||
155505146|NCT04130919|561276099|FG003|Blinded Treatment Phase|Investigator's decision|0|||
155505147|NCT04130919|561276100|FG004|Blinded Treatment Phase|Investigator's decision|0|||
155505148|NCT04130919|561276101|FG005|Blinded Treatment Phase|Investigator's decision|0|||
155342009|NCT00529529|560685066|FG001|Overall Study|Subject withdrew consent|9|||
155342010|NCT00529529|560685067|FG002|Overall Study|Subject withdrew consent|12|||
155342011|NCT00529529|560685065|FG000|Overall Study|Protocol deviation|8|||
155342012|NCT00529529|560685066|FG001|Overall Study|Protocol deviation|12|||
155342013|NCT00529529|560685067|FG002|Overall Study|Protocol deviation|5|||
155342014|NCT00529529|560685065|FG000|Overall Study|Lost to Follow-up|5|||
155342015|NCT00529529|560685066|FG001|Overall Study|Lost to Follow-up|3|||
155342016|NCT00529529|560685067|FG002|Overall Study|Lost to Follow-up|1|||
155342017|NCT00529529|560685065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155342018|NCT00529529|560685066|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155342019|NCT00529529|560685067|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155342020|NCT00529529|560685065|FG000|Overall Study|Death|2|||
155342021|NCT00529529|560685066|FG001|Overall Study|Death|0|||
155342022|NCT00529529|560685067|FG002|Overall Study|Death|0|||
155342023|NCT00529529|560685065|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155342024|NCT00529529|560685066|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155342025|NCT00529529|560685067|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155505149|NCT04130919|561276096|FG000|Blinded Treatment Phase|Withdrew consent|1|||
155505150|NCT04130919|561276097|FG001|Blinded Treatment Phase|Withdrew consent|0|||
155505151|NCT04130919|561276098|FG002|Blinded Treatment Phase|Withdrew consent|0|||
155505152|NCT04130919|561276099|FG003|Blinded Treatment Phase|Withdrew consent|0|||
155505153|NCT04130919|561276100|FG004|Blinded Treatment Phase|Withdrew consent|0|||
155505154|NCT04130919|561276101|FG005|Blinded Treatment Phase|Withdrew consent|0|||
155505155|NCT04130919|561276096|FG000|Open-label Treatment Phase|Withdrew consent|0|||
155505156|NCT04130919|561276097|FG001|Open-label Treatment Phase|Withdrew consent|0|||
155505157|NCT04130919|561276098|FG002|Open-label Treatment Phase|Withdrew consent|0|||
155505158|NCT04130919|561276099|FG003|Open-label Treatment Phase|Withdrew consent|1|||
155505159|NCT04130919|561276100|FG004|Open-label Treatment Phase|Withdrew consent|1|||
155505160|NCT04130919|561276101|FG005|Open-label Treatment Phase|Withdrew consent|1|||
155505161|NCT04130919|561276096|FG000|Open-label Treatment Phase|Disease worsening|0|||
155505162|NCT04130919|561276097|FG001|Open-label Treatment Phase|Disease worsening|0|||
155505163|NCT04130919|561276098|FG002|Open-label Treatment Phase|Disease worsening|0|||
155505164|NCT04130919|561276099|FG003|Open-label Treatment Phase|Disease worsening|1|||
155505165|NCT04130919|561276100|FG004|Open-label Treatment Phase|Disease worsening|0|||
155505166|NCT04130919|561276101|FG005|Open-label Treatment Phase|Disease worsening|1|||
155505167|NCT04130919|561276096|FG000|Open-label Treatment Phase|Investigator's decision|0|||
155505168|NCT04130919|561276097|FG001|Open-label Treatment Phase|Investigator's decision|0|||
155505169|NCT04130919|561276098|FG002|Open-label Treatment Phase|Investigator's decision|0|||
155505170|NCT04130919|561276099|FG003|Open-label Treatment Phase|Investigator's decision|1|||
155505171|NCT04130919|561276100|FG004|Open-label Treatment Phase|Investigator's decision|0|||
155505172|NCT04130919|561276101|FG005|Open-label Treatment Phase|Investigator's decision|0|||
155505173|NCT04130919|561276096|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
155505174|NCT04130919|561276097|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
155505175|NCT04130919|561276098|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
155505176|NCT04130919|561276099|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
155505177|NCT04130919|561276100|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
155342026|NCT00529529|560685065|FG000|Overall Study|Administrative problems|1|||
155342027|NCT00529529|560685066|FG001|Overall Study|Administrative problems|0|||
155342028|NCT00529529|560685067|FG002|Overall Study|Administrative problems|3|||
155342029|NCT04749797|560685072|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
155342030|NCT04749797|560685073|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
155342031|NCT04749797|560685074|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
155342032|NCT03072862|560685075|FG000|Overall Study|Withdrawal by Subject|4|||
155342033|NCT03072862|560685075|FG000|Overall Study|Lost to Follow-up|6|||
155342034|NCT03072862|560685075|FG000|Overall Study|Protocol Violation|4|||
155342035|NCT03072862|560685075|FG000|Overall Study|Physician Decision|2|||
155342036|NCT03072862|560685075|FG000|Overall Study|Death|1|||
155342037|NCT03072862|560685075|FG000|Overall Study|Adverse Event|1|||
155342038|NCT00632736|560685076|FG000|Overall Study|Adverse Event|104|||
155342039|NCT00632736|560685076|FG000|Overall Study|Lost to Follow-up|15|||
155342040|NCT00632736|560685076|FG000|Overall Study|Protocol Violation|14|||
155342041|NCT00632736|560685076|FG000|Overall Study|Withdrawal by Subject|99|||
155342042|NCT00632736|560685076|FG000|Overall Study|Lack of Efficacy|5|||
155342043|NCT00632736|560685076|FG000|Overall Study|Sponsor terminated study|5|||
155342044|NCT00632736|560685076|FG000|Overall Study|Non-compliance|10|||
155342045|NCT00632736|560685076|FG000|Overall Study|Other|16|||
155342046|NCT03347396|560685077|FG000|Part A (26 Weeks)|Adverse Event|1|||
155342047|NCT03347396|560685078|FG001|Part A (26 Weeks)|Adverse Event|0|||
155342048|NCT03347396|560685077|FG000|Part A (26 Weeks)|Death|0|||
155342049|NCT03347396|560685078|FG001|Part A (26 Weeks)|Death|1|||
155342050|NCT03347396|560685077|FG000|Part B (149 Weeks)|Adverse Event|1|||
155342051|NCT03347396|560685078|FG001|Part B (149 Weeks)|Adverse Event|1|||
155505178|NCT04130919|561276101|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
155342052|NCT03347396|560685077|FG000|Part B (149 Weeks)|Death|1|||
155342053|NCT03347396|560685078|FG001|Part B (149 Weeks)|Death|0|||
155342054|NCT00871715|560685079|FG000|Overall Study|Withdrawal by Subject|6|||
155342055|NCT00871715|560685080|FG001|Overall Study|Withdrawal by Subject|10|||
155342056|NCT00871715|560685081|FG002|Overall Study|Withdrawal by Subject|15|||
155342057|NCT00871715|560685079|FG000|Overall Study|Physician Decision|6|||
155505179|NCT04130919|561276096|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
155342058|NCT00871715|560685080|FG001|Overall Study|Physician Decision|0|||
155342059|NCT00871715|560685081|FG002|Overall Study|Physician Decision|2|||
155505180|NCT04130919|561276097|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
155505181|NCT04130919|561276098|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
155505182|NCT04130919|561276099|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
155342060|NCT00871715|560685079|FG000|Overall Study|Lost to Follow-up|3|||
155342061|NCT00871715|560685080|FG001|Overall Study|Lost to Follow-up|6|||
155342062|NCT00871715|560685081|FG002|Overall Study|Lost to Follow-up|9|||
155342063|NCT03015220|560685085|FG000|Overall Study|Withdrawal by Subject|3|||
155342064|NCT03015220|560685086|FG001|Overall Study|Withdrawal by Subject|2|||
155342065|NCT03015220|560685087|FG002|Overall Study|Withdrawal by Subject|2|||
155342066|NCT03015220|560685088|FG003|Overall Study|Withdrawal by Subject|2|||
155342067|NCT03015220|560685085|FG000|Overall Study|Lost to Follow-up|0|||
155342068|NCT03015220|560685086|FG001|Overall Study|Lost to Follow-up|0|||
155342069|NCT03015220|560685087|FG002|Overall Study|Lost to Follow-up|1|||
155342070|NCT03015220|560685088|FG003|Overall Study|Lost to Follow-up|0|||
155342071|NCT01670526|560685090|FG000|Overall Study|Withdrawal by Subject|3|||
155342072|NCT01670526|560685091|FG001|Overall Study|Withdrawal by Subject|1|||
155342073|NCT01670526|560685090|FG000|Overall Study|Lost to Follow-up|9|||
155342074|NCT01670526|560685091|FG001|Overall Study|Lost to Follow-up|5|||
155342075|NCT00392197|560685092|FG000|Overall Study|Adverse Event|4|||
155342076|NCT00392197|560685093|FG001|Overall Study|Adverse Event|12|||
155342077|NCT00392197|560685092|FG000|Overall Study|Lack of Efficacy|3|||
155342078|NCT00392197|560685093|FG001|Overall Study|Lack of Efficacy|4|||
155342079|NCT00392197|560685092|FG000|Overall Study|Lost to Follow-up|0|||
155342080|NCT00392197|560685093|FG001|Overall Study|Lost to Follow-up|1|||
155342081|NCT00392197|560685092|FG000|Overall Study|Physician Decision|3|||
155342082|NCT00392197|560685093|FG001|Overall Study|Physician Decision|2|||
155342083|NCT00392197|560685092|FG000|Overall Study|Protocol Violation|7|||
155342084|NCT00392197|560685093|FG001|Overall Study|Protocol Violation|5|||
155342085|NCT00392197|560685092|FG000|Overall Study|Withdrawal by Subject|4|||
155342086|NCT00392197|560685093|FG001|Overall Study|Withdrawal by Subject|6|||
155342087|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
155342088|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
155505183|NCT04130919|561276100|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
155505184|NCT04130919|561276101|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
155505185|NCT02729194|561276102|FG000|Overall Study|Withdrawal by Subject|3|||
155505186|NCT00845026|561276103|FG000|Study Period III|Adverse Event|23|||
155505187|NCT00845026|561276104|FG001|Study Period III|Adverse Event|19|||
155505188|NCT00845026|561276103|FG000|Study Period III|Perceived lack of efficacy|27|||
155505189|NCT00845026|561276104|FG001|Study Period III|Perceived lack of efficacy|15|||
155342089|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
155342090|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
155342091|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
155342092|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
155342093|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
155342094|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
155342095|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
155342096|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
155342097|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
155342098|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
155342099|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
155342100|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
155342101|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
155342102|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
155342103|NCT02312258|560685098|FG000|Overall Study|Lost to Follow-up|8|||
155342104|NCT02312258|560685099|FG001|Overall Study|Lost to Follow-up|8|||
155342105|NCT02312258|560685098|FG000|Overall Study|Withdrawal by Patient|49|||
155342106|NCT02312258|560685099|FG001|Overall Study|Withdrawal by Patient|76|||
155342107|NCT02312258|560685098|FG000|Overall Study|Reason not Specified|107|||
155342108|NCT02312258|560685099|FG001|Overall Study|Reason not Specified|159|||
155342109|NCT02312258|560685098|FG000|Overall Study|Missing|2|||
155342110|NCT02312258|560685099|FG001|Overall Study|Missing|1|||
155342111|NCT02312258|560685098|FG000|Overall Study|Death|115|||
155342112|NCT02312258|560685099|FG001|Overall Study|Death|181|||
155505190|NCT00845026|561276103|FG000|Study Period III|Withdrawal by Subject|19|||
155505191|NCT00845026|561276104|FG001|Study Period III|Withdrawal by Subject|15|||
155342113|NCT01970527|560685100|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
155342114|NCT01970527|560685101|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
155342115|NCT01970527|560685100|FG000|Treatment|Disease progression|0|||
155342116|NCT01970527|560685101|FG001|Treatment|Disease progression|1|||
155342117|NCT01970527|560685100|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
155342118|NCT01970527|560685101|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
155423578|NCT00896532|560978706|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
155423579|NCT00896532|560978707|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
155423580|NCT00896532|560978708|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
155423581|NCT00896532|560978709|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
155423582|NCT00896532|560978710|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
155423583|NCT00896532|560978711|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
155423584|NCT00896532|560978712|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
155423585|NCT00896532|560978713|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
155423586|NCT00896532|560978714|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
155423587|NCT00896532|560978715|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
155423588|NCT00896532|560978716|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
155423589|NCT00896532|560978717|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
155342119|NCT01970527|560685100|FG000|Treatment|Death|0|||
155342120|NCT01970527|560685101|FG001|Treatment|Death|1|||
155342121|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Disease progression|1|||
155342122|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Disease progression|1|||
155342123|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
155342124|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
155342125|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
155342126|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
155342127|NCT01964547|560685102|FG000|Overall Study|Adverse Event|8|||
155342128|NCT01964547|560685103|FG001|Overall Study|Adverse Event|2|||
155423590|NCT00896532|560978718|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
155423591|NCT00896532|560978719|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
155505192|NCT00845026|561276103|FG000|Study Period III|Entry Criteria not met|8|||
155646781|NCT00289978|561799543|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155646782|NCT00289978|561799544|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155646783|NCT00289978|561799542|FG000|Overall Study|Death|1|||
155646784|NCT00289978|561799543|FG001|Overall Study|Death|0|||
155646785|NCT00289978|561799544|FG002|Overall Study|Death|2|||
155646786|NCT00903344|561799545|FG000|Overall Study|Pregnancy|2|||
155646787|NCT00903344|561799546|FG001|Overall Study|Pregnancy|3|||
155646788|NCT00903344|561799545|FG000|Overall Study|Lost to Follow-up|3|||
155646789|NCT00903344|561799546|FG001|Overall Study|Lost to Follow-up|0|||
155646790|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
155646791|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
155646792|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
155646793|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
155646794|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
155646795|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
155646796|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
155646797|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
155646798|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
155646799|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
155646800|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
155646801|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
155646802|NCT01243424|561799549|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
155646803|NCT01243424|561799550|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
155646804|NCT01243424|561799549|FG000|Discontinuation From Treatment|Not treated|5|||
155646805|NCT01243424|561799550|FG001|Discontinuation From Treatment|Not treated|4|||
155646806|NCT01243424|561799549|FG000|Discontinuation From Treatment|Adverse Event|457|||
155646807|NCT01243424|561799550|FG001|Discontinuation From Treatment|Adverse Event|523|||
155646808|NCT01243424|561799549|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
155646809|NCT01243424|561799550|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
155646810|NCT01243424|561799549|FG000|Discontinuation From Treatment|Protocol Violation|46|||
155646811|NCT01243424|561799550|FG001|Discontinuation From Treatment|Protocol Violation|47|||
155646812|NCT01243424|561799549|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
155646813|NCT01243424|561799550|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
155646814|NCT01243424|561799549|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
155646815|NCT01243424|561799550|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
155646816|NCT01243424|561799549|FG000|Discontinuation From Treatment|Other than listed above|230|||
155646817|NCT01243424|561799550|FG001|Discontinuation From Treatment|Other than listed above|211|||
155646818|NCT01093885|561799568|FG000|Overall Study|Adverse Event|4|||
155342129|NCT01964547|560685102|FG000|Overall Study|Withdrawal by Subject|4|||
155342130|NCT01964547|560685103|FG001|Overall Study|Withdrawal by Subject|7|||
155342131|NCT01964547|560685102|FG000|Overall Study|Lost to Follow-up|0|||
155423592|NCT00896532|560978720|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
155342132|NCT01964547|560685103|FG001|Overall Study|Lost to Follow-up|1|||
155342133|NCT01964547|560685102|FG000|Overall Study|Withdrawal by Investigator|0|||
155342134|NCT01964547|560685103|FG001|Overall Study|Withdrawal by Investigator|1|||
155342135|NCT04447287|560685104|FG000|Period 1: Run-in Period|Adverse Event|3|||
155342136|NCT04447287|560685105|FG001|Period 1: Run-in Period|Adverse Event|0|||
155342137|NCT04447287|560685106|FG002|Period 1: Run-in Period|Adverse Event|0|||
155342138|NCT04447287|560685104|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
155342139|NCT04447287|560685105|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
155342140|NCT04447287|560685106|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
155342141|NCT04447287|560685104|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
155342142|NCT04447287|560685105|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
155342143|NCT04447287|560685106|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
155342144|NCT02147093|560685109|FG000|Period 1|Lost to Follow-up|0|||
155342145|NCT02147093|560685110|FG001|Period 1|Lost to Follow-up|1|||
155342146|NCT02147093|560685109|FG000|Period 2|Protocol Violation|2|||
155342147|NCT02147093|560685110|FG001|Period 2|Protocol Violation|0|||
155342148|NCT01229176|560685123|FG000|Overall Study|Withdrawal by Subject|0|||
155342149|NCT01229176|560685124|FG001|Overall Study|Withdrawal by Subject|0|||
155423593|NCT00896532|560978721|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
155423594|NCT00896532|560978722|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
155423595|NCT00896532|560978723|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
155423596|NCT00896532|560978724|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
155423597|NCT00896532|560978725|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
155423598|NCT00896532|560978726|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
155423599|NCT00896532|560978727|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
155423600|NCT00896532|560978705|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423601|NCT00896532|560978706|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423602|NCT00896532|560978707|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423603|NCT00896532|560978708|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423604|NCT00896532|560978709|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423605|NCT00896532|560978710|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423606|NCT00896532|560978711|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423607|NCT00896532|560978712|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423608|NCT00896532|560978713|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423609|NCT00896532|560978714|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423610|NCT00896532|560978715|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423611|NCT00896532|560978716|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423612|NCT00896532|560978717|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423613|NCT00896532|560978718|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423614|NCT00896532|560978719|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155505193|NCT00845026|561276104|FG001|Study Period III|Entry Criteria not met|11|||
155342150|NCT01229176|560685125|FG002|Overall Study|Withdrawal by Subject|0|||
155342151|NCT01229176|560685126|FG003|Overall Study|Withdrawal by Subject|1|||
155342152|NCT01229176|560685127|FG004|Overall Study|Withdrawal by Subject|1|||
155342153|NCT01229176|560685128|FG005|Overall Study|Withdrawal by Subject|1|||
155342154|NCT01229176|560685129|FG006|Overall Study|Withdrawal by Subject|0|||
155342155|NCT01229176|560685130|FG007|Overall Study|Withdrawal by Subject|1|||
155342156|NCT01229176|560685123|FG000|Overall Study|Lost to Follow-up|0|||
155342157|NCT01229176|560685124|FG001|Overall Study|Lost to Follow-up|3|||
155342158|NCT01229176|560685125|FG002|Overall Study|Lost to Follow-up|0|||
155342159|NCT01229176|560685126|FG003|Overall Study|Lost to Follow-up|0|||
155342160|NCT01229176|560685127|FG004|Overall Study|Lost to Follow-up|1|||
155342161|NCT01229176|560685128|FG005|Overall Study|Lost to Follow-up|1|||
155342162|NCT01229176|560685129|FG006|Overall Study|Lost to Follow-up|0|||
155342163|NCT01229176|560685130|FG007|Overall Study|Lost to Follow-up|2|||
155342164|NCT03890484|560685131|FG000|Overall Study|Lost to Follow-up|1|||
155342165|NCT03890484|560685132|FG001|Overall Study|Lost to Follow-up|1|||
155342166|NCT00518206|560685133|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
155342167|NCT00518206|560685134|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
155342168|NCT00518206|560685133|FG000|Overall Study|Withdrawal by Subject|2|||
155342169|NCT00518206|560685134|FG001|Overall Study|Withdrawal by Subject|0|||
155342170|NCT00518206|560685133|FG000|Overall Study|Drug Supply Issue|1|||
155342171|NCT00518206|560685134|FG001|Overall Study|Drug Supply Issue|0|||
155342172|NCT00518206|560685133|FG000|Overall Study|Reason Unknown|1|||
155342173|NCT00518206|560685134|FG001|Overall Study|Reason Unknown|0|||
155342174|NCT00518206|560685133|FG000|Overall Study|Completion Status Unknown|1|||
155342175|NCT00518206|560685134|FG001|Overall Study|Completion Status Unknown|0|||
155342176|NCT03075878|560685135|FG000|Overall Study|Physician Decision|1|||
155342177|NCT02188459|560685136|FG000|Overall Study|Lost to Follow-up|3|||
155342178|NCT02188459|560685137|FG001|Overall Study|Lost to Follow-up|4|||
155342179|NCT02188459|560685136|FG000|Overall Study|Early Termination|0|||
155342180|NCT02188459|560685137|FG001|Overall Study|Early Termination|3|||
155342181|NCT00882050|560685142|FG000|Overall Study|Physician Decision|1|||
155342182|NCT00882050|560685143|FG001|Overall Study|Physician Decision|0|||
155423615|NCT00896532|560978720|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423616|NCT00896532|560978721|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
155646819|NCT01093885|561799568|FG000|Overall Study|Lost to Follow-up|1|||
155646820|NCT01301001|561799569|FG000|First Intervention|Lost to Follow-up|4|||
155646821|NCT01301001|561799570|FG001|First Intervention|Lost to Follow-up|4|||
155646822|NCT01301001|561799569|FG000|First Intervention|Withdrawal by Subject|1|||
155646823|NCT01301001|561799570|FG001|First Intervention|Withdrawal by Subject|4|||
155646824|NCT01301001|561799569|FG000|First Intervention|Adverse Event|5|||
155646825|NCT01301001|561799570|FG001|First Intervention|Adverse Event|0|||
155646826|NCT01301001|561799569|FG000|First Intervention|Protocol Violation|0|||
155646827|NCT01301001|561799570|FG001|First Intervention|Protocol Violation|1|||
155646828|NCT01301001|561799569|FG000|Second Intervention|Adverse Event|2|||
155646829|NCT01301001|561799570|FG001|Second Intervention|Adverse Event|0|||
155646830|NCT01301001|561799569|FG000|Second Intervention|Withdrawal by Subject|2|||
155646831|NCT01301001|561799570|FG001|Second Intervention|Withdrawal by Subject|0|||
155646832|NCT01560988|561799571|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
155646833|NCT01560988|561799572|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
155646834|NCT01560988|561799571|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
155646835|NCT01560988|561799572|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
155646836|NCT01560988|561799571|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
155646837|NCT01560988|561799572|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
155646838|NCT01160744|561799573|FG000|Overall Study|Withdrawal by Subject|11|||
155646839|NCT01160744|561799574|FG001|Overall Study|Withdrawal by Subject|5|||
155646840|NCT01160744|561799575|FG002|Overall Study|Withdrawal by Subject|6|||
155646841|NCT01160744|561799576|FG003|Overall Study|Withdrawal by Subject|4|||
155646842|NCT01160744|561799573|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
155646843|NCT01160744|561799574|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
155646844|NCT01160744|561799575|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
155646845|NCT01160744|561799576|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
155646846|NCT02301429|561799581|FG000|Overall Study|not acceptable vascular anatomy|3|||
155646847|NCT01502072|561799582|FG000|Overall Study|Withdrawal by Subject|1|||
155646848|NCT01502072|561799583|FG001|Overall Study|Withdrawal by Subject|0|||
155646849|NCT01502072|561799584|FG002|Overall Study|Withdrawal by Subject|0|||
155646850|NCT01502072|561799582|FG000|Overall Study|Death|0|||
155646851|NCT01502072|561799583|FG001|Overall Study|Death|1|||
155646852|NCT01502072|561799584|FG002|Overall Study|Death|0|||
155646853|NCT00500110|561799585|FG000|Overall Study|Withdrawal by Subject|3|||
155646854|NCT00605657|561799586|FG000|Overall Study|Adverse Event|1|||
155646855|NCT00605657|561799586|FG000|Overall Study|Protocol Violation|1|||
155646856|NCT04821245|561799587|FG000|Overall Study|Withdrawal by Subject|3|||
155646857|NCT04821245|561799587|FG000|Overall Study|Physician Decision|1|||
155342183|NCT00882050|560685144|FG002|Overall Study|Physician Decision|0|||
155342184|NCT00805441|560685145|FG000|Overall Study|Adverse Event|5|||
155505194|NCT00845026|561276103|FG000|Study Period III|Lost to Follow-up|4|||
155505195|NCT00845026|561276104|FG001|Study Period III|Lost to Follow-up|5|||
155646858|NCT04821245|561799587|FG000|Overall Study|Protocol Violation|5|||
155646859|NCT00397046|561799595|FG000|Overall Study|Disease Progression|3|||
155646860|NCT00397046|561799596|FG001|Overall Study|Disease Progression|3|||
155646861|NCT00397046|561799597|FG002|Overall Study|Disease Progression|10|||
155646862|NCT00397046|561799598|FG003|Overall Study|Disease Progression|5|||
155646863|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
155646864|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
155646865|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
155646866|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155646867|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155646868|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155646869|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
155646870|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
155646871|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
155646872|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
155646873|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
155646874|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
155646875|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Other|6|||
155646876|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Other|3|||
155646877|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Other|0|||
155646878|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
155646879|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155646880|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155646881|NCT03636269|561799599|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
155646882|NCT03636269|561799600|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
155646883|NCT03636269|561799601|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
155646884|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Adverse Event|0|||
155646885|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Adverse Event|0|||
155646886|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Adverse Event|21|||
155646887|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
155646888|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
155646889|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
155646890|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
155646891|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
155646892|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
155646893|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
155646894|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
155646895|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
155646896|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Administrative|0|||
155646897|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Administrative|0|||
155646898|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Administrative|36|||
155646899|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Other|0|||
155646900|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Other|0|||
155646901|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Other|9|||
155646902|NCT03636269|561799599|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
155342185|NCT00805441|560685146|FG001|Overall Study|Adverse Event|2|||
155342186|NCT00805441|560685145|FG000|Overall Study|Lack of Efficacy|0|||
155342187|NCT00805441|560685146|FG001|Overall Study|Lack of Efficacy|2|||
155342188|NCT00805441|560685145|FG000|Overall Study|Protocol Violation|4|||
155342189|NCT00805441|560685146|FG001|Overall Study|Protocol Violation|8|||
155342190|NCT00805441|560685145|FG000|Overall Study|Lost to Follow-up|10|||
155342191|NCT00805441|560685146|FG001|Overall Study|Lost to Follow-up|13|||
155342192|NCT00805441|560685145|FG000|Overall Study|Withdrawal by Subject|15|||
155342193|NCT00805441|560685146|FG001|Overall Study|Withdrawal by Subject|9|||
155342194|NCT00805441|560685145|FG000|Overall Study|Physician Decision|0|||
155423617|NCT00896532|560978722|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423618|NCT00896532|560978723|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423619|NCT00896532|560978724|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423620|NCT00896532|560978725|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155646903|NCT03636269|561799600|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
155646904|NCT03636269|561799601|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
155646905|NCT01975285|561799614|FG000|Overall Study|Failed Block and follow up|2|||
155423621|NCT00896532|560978726|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155646906|NCT01975285|561799615|FG001|Overall Study|Failed Block and follow up|2|||
155646907|NCT02852434|561799616|FG000|Overall Study|Withdrawal by Subject|0|||
155646908|NCT02852434|561799617|FG001|Overall Study|Withdrawal by Subject|1|||
155646909|NCT02852434|561799616|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
155646910|NCT02852434|561799617|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
155646911|NCT01145222|561799622|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
155646912|NCT01145222|561799623|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
155646913|NCT01145222|561799624|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
155646914|NCT01145222|561799625|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
155646915|NCT01145222|561799622|FG000|Overall Study|Poor bowel preparation|0|||
155342195|NCT00805441|560685146|FG001|Overall Study|Physician Decision|1|||
155342196|NCT00805441|560685145|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
155342197|NCT00805441|560685146|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
155342198|NCT02935894|560685151|FG000|Overall Study|Subject dismissed|1|||
155342199|NCT00853957|560685152|FG000|Overall Study|Adverse Event|9|||
155342200|NCT00853957|560685153|FG001|Overall Study|Adverse Event|3|||
155342201|NCT00853957|560685152|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155342202|NCT00853957|560685153|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155342203|NCT00853957|560685152|FG000|Overall Study|Subject withdrew consent|4|||
155342204|NCT00853957|560685153|FG001|Overall Study|Subject withdrew consent|5|||
155342205|NCT00853957|560685152|FG000|Overall Study|Lost to Follow-up|1|||
155342206|NCT00853957|560685153|FG001|Overall Study|Lost to Follow-up|6|||
155342207|NCT00853957|560685152|FG000|Overall Study|Protocol deviation|0|||
155342208|NCT00853957|560685153|FG001|Overall Study|Protocol deviation|3|||
155342209|NCT02942771|560685154|FG000|Overall Study|Adverse Event|1|||
155342210|NCT02942771|560685155|FG001|Overall Study|Adverse Event|0|||
155342211|NCT02942771|560685156|FG002|Overall Study|Adverse Event|0|||
155342212|NCT02942771|560685157|FG003|Overall Study|Adverse Event|0|||
155342213|NCT02942771|560685158|FG004|Overall Study|Adverse Event|2|||
155342214|NCT02942771|560685154|FG000|Overall Study|Lost to Follow-up|1|||
155342215|NCT02942771|560685155|FG001|Overall Study|Lost to Follow-up|0|||
155342216|NCT02942771|560685156|FG002|Overall Study|Lost to Follow-up|0|||
155342217|NCT02942771|560685157|FG003|Overall Study|Lost to Follow-up|0|||
155342218|NCT02942771|560685158|FG004|Overall Study|Lost to Follow-up|0|||
155342219|NCT02942771|560685154|FG000|Overall Study|Withdrawal by Subject|1|||
155342220|NCT02942771|560685155|FG001|Overall Study|Withdrawal by Subject|0|||
155342221|NCT02942771|560685156|FG002|Overall Study|Withdrawal by Subject|0|||
155342222|NCT02942771|560685157|FG003|Overall Study|Withdrawal by Subject|0|||
155342223|NCT02942771|560685158|FG004|Overall Study|Withdrawal by Subject|2|||
155342224|NCT01186809|560685159|FG000|Overall Study|Death|30|||
155342225|NCT04895085|560685160|FG000|Overall Study|Death|1|||
155342226|NCT04895085|560685160|FG000|Overall Study|Withdrawal by Subject|1|||
155342227|NCT04895085|560685160|FG000|Overall Study|No longer eligible: Moved from area|1|||
155342228|NCT04919499|560685165|FG000|Overall Study|Adverse Event|0|||
155342229|NCT04919499|560685166|FG001|Overall Study|Adverse Event|0|||
155505196|NCT00845026|561276103|FG000|Study Period III|Protocol Violation|8|||
155505197|NCT00845026|561276104|FG001|Study Period III|Protocol Violation|1|||
155505198|NCT00845026|561276103|FG000|Study Period III|Scheduled conflict|3|||
155505199|NCT00845026|561276104|FG001|Study Period III|Scheduled conflict|1|||
155646916|NCT01145222|561799623|FG001|Overall Study|Poor bowel preparation|0|||
155646917|NCT01145222|561799624|FG002|Overall Study|Poor bowel preparation|0|||
155342230|NCT04919499|560685167|FG002|Overall Study|Adverse Event|0|||
155342231|NCT04919499|560685168|FG003|Overall Study|Adverse Event|0|||
155342232|NCT04919499|560685169|FG004|Overall Study|Adverse Event|2|||
155342233|NCT04919499|560685165|FG000|Overall Study|Not treated|0|||
155342234|NCT04919499|560685166|FG001|Overall Study|Not treated|0|||
155342235|NCT04919499|560685167|FG002|Overall Study|Not treated|0|||
155646918|NCT01145222|561799625|FG003|Overall Study|Poor bowel preparation|1|||
155646919|NCT00604383|561799626|FG000|Overall Study|Withdrawal by Subject|33|||
155646920|NCT00604383|561799627|FG001|Overall Study|Withdrawal by Subject|31|||
155646921|NCT00604383|561799626|FG000|Overall Study|Lost to Follow-up|24|||
155646922|NCT00604383|561799627|FG001|Overall Study|Lost to Follow-up|19|||
155646923|NCT00604383|561799626|FG000|Overall Study|Death|14|||
155646924|NCT00604383|561799627|FG001|Overall Study|Death|22|||
155646925|NCT00604383|561799626|FG000|Overall Study|Adverse Event|16|||
155646926|NCT00604383|561799627|FG001|Overall Study|Adverse Event|9|||
155646927|NCT00604383|561799626|FG000|Overall Study|Physician Decision|0|||
155646928|NCT00604383|561799627|FG001|Overall Study|Physician Decision|3|||
155646929|NCT01698008|561799628|FG000|Overall Study|Withdrawal by Subject|1|||
155646930|NCT01698008|561799629|FG001|Overall Study|Withdrawal by Subject|2|||
155646931|NCT01011283|561799632|FG000|Overall Study|Adverse Event|4|||
155646932|NCT01011283|561799633|FG001|Overall Study|Adverse Event|2|||
155646933|NCT01011283|561799632|FG000|Overall Study|Progressive Disease|0|||
155646934|NCT01011283|561799633|FG001|Overall Study|Progressive Disease|2|||
155646935|NCT01011283|561799632|FG000|Overall Study|Terminated by Sponsor|5|||
155646936|NCT01011283|561799633|FG001|Overall Study|Terminated by Sponsor|5|||
155646937|NCT01011283|561799632|FG000|Overall Study|Other|2|||
155646938|NCT01011283|561799633|FG001|Overall Study|Other|2|||
155646939|NCT02619812|561799638|FG000|Overall Study|Withdrawal by Subject|0|||
155646940|NCT02619812|561799639|FG001|Overall Study|Withdrawal by Subject|0|||
155646941|NCT02619812|561799640|FG002|Overall Study|Withdrawal by Subject|1|||
155646942|NCT02619812|561799641|FG003|Overall Study|Withdrawal by Subject|2|||
155646943|NCT00191152|561799642|FG000|Initial Treatment|Adverse Event|43|||
155646944|NCT00191152|561799643|FG001|Initial Treatment|Adverse Event|67|||
155646945|NCT00191152|561799642|FG000|Initial Treatment|Physician Decision|40|||
155646946|NCT00191152|561799643|FG001|Initial Treatment|Physician Decision|31|||
155646947|NCT00191152|561799642|FG000|Initial Treatment|Withdrawal by Subject|40|||
155646948|NCT00191152|561799643|FG001|Initial Treatment|Withdrawal by Subject|28|||
155646949|NCT00191152|561799642|FG000|Initial Treatment|Lost to Follow-up|0|||
155646950|NCT00191152|561799643|FG001|Initial Treatment|Lost to Follow-up|6|||
155646951|NCT00191152|561799642|FG000|Initial Treatment|Other|18|||
155423622|NCT00896532|560978727|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
155423623|NCT00896532|560978705|FG000|Months 48-72: Follow-on Phase|Death|0|||
155423624|NCT00896532|560978706|FG001|Months 48-72: Follow-on Phase|Death|0|||
155423625|NCT00896532|560978707|FG002|Months 48-72: Follow-on Phase|Death|0|||
155423626|NCT00896532|560978708|FG003|Months 48-72: Follow-on Phase|Death|0|||
155423627|NCT00896532|560978709|FG004|Months 48-72: Follow-on Phase|Death|0|||
155423628|NCT00896532|560978710|FG005|Months 48-72: Follow-on Phase|Death|0|||
155505200|NCT00845026|561276103|FG000|Study Period III|Subject is moving or has moved|2|||
155505201|NCT00845026|561276104|FG001|Study Period III|Subject is moving or has moved|4|||
155505202|NCT00845026|561276103|FG000|Study Period III|Transportation issues|1|||
155505203|NCT00845026|561276104|FG001|Study Period III|Transportation issues|1|||
155505204|NCT00845026|561276103|FG000|Study Period IV|Adverse Event|4|||
155505205|NCT00845026|561276104|FG001|Study Period IV|Adverse Event|0|||
155505206|NCT00845026|561276103|FG000|Study Period IV|Perceived lack of efficacy|2|||
155505207|NCT00845026|561276104|FG001|Study Period IV|Perceived lack of efficacy|1|||
155505208|NCT00845026|561276103|FG000|Study Period IV|Protocol Violation|3|||
155505209|NCT00845026|561276104|FG001|Study Period IV|Protocol Violation|1|||
155505210|NCT00845026|561276103|FG000|Study Period IV|Lost to Follow-up|1|||
155505211|NCT00845026|561276104|FG001|Study Period IV|Lost to Follow-up|0|||
155505212|NCT00845026|561276103|FG000|Study Period IV|Withdrawal by Subject|4|||
155423629|NCT00896532|560978711|FG006|Months 48-72: Follow-on Phase|Death|0|||
155505213|NCT00845026|561276104|FG001|Study Period IV|Withdrawal by Subject|1|||
155646952|NCT00191152|561799643|FG001|Initial Treatment|Other|21|||
155342236|NCT04919499|560685168|FG003|Overall Study|Not treated|1|||
155342237|NCT04919499|560685169|FG004|Overall Study|Not treated|0|||
155342238|NCT00476151|560686998|FG000|Overall Study|Adverse Event|0|||
155342239|NCT00476151|560686999|FG001|Overall Study|Adverse Event|2|||
155342240|NCT00476151|560686998|FG000|Overall Study|Protocol Violation|1|||
155342241|NCT00476151|560686999|FG001|Overall Study|Protocol Violation|3|||
155342242|NCT00476151|560686998|FG000|Overall Study|Withdrawal by Subject|2|||
155342243|NCT00476151|560686999|FG001|Overall Study|Withdrawal by Subject|0|||
155342244|NCT00476151|560686998|FG000|Overall Study|Physician Decision|0|||
155342245|NCT00476151|560686999|FG001|Overall Study|Physician Decision|2|||
155342246|NCT01767376|560687000|FG000|Overall Study|Lost to Follow-up|3|||
155342247|NCT01767376|560687001|FG001|Overall Study|Lost to Follow-up|2|||
155342248|NCT01767376|560687002|FG002|Overall Study|Lost to Follow-up|0|||
155342249|NCT01767376|560687000|FG000|Overall Study|Withdrawal by Subject|1|||
155342250|NCT01767376|560687001|FG001|Overall Study|Withdrawal by Subject|1|||
155342251|NCT01767376|560687002|FG002|Overall Study|Withdrawal by Subject|0|||
155342252|NCT04175834|560687003|FG000|Overall Study|Withdrawal by Subject|1|||
155342253|NCT04175834|560687004|FG001|Overall Study|Withdrawal by Subject|0|||
155342254|NCT00946088|560687005|FG000|Overall Study|Withdrawal by Subject|0|||
155342255|NCT00946088|560687006|FG001|Overall Study|Withdrawal by Subject|1|||
155342256|NCT04239911|560687010|FG000|Overall Study|Lost to Follow-up|2|||
155342257|NCT04239911|560687011|FG001|Overall Study|Lost to Follow-up|1|||
155342258|NCT03693989|560687013|FG000|Overall Study|Protocol Violation|3|||
155342259|NCT03693989|560687014|FG001|Overall Study|Protocol Violation|4|||
155342260|NCT01052272|560687015|FG000|Overall Study|Death|0|||
155342261|NCT01052272|560687016|FG001|Overall Study|Death|0|||
155342262|NCT01052272|560687017|FG002|Overall Study|Death|1|||
155342263|NCT01052272|560687018|FG003|Overall Study|Death|1|||
155342264|NCT01052272|560687015|FG000|Overall Study|Physician Decision|0|||
155342265|NCT01052272|560687016|FG001|Overall Study|Physician Decision|1|||
155342266|NCT01052272|560687017|FG002|Overall Study|Physician Decision|0|||
155342267|NCT01052272|560687018|FG003|Overall Study|Physician Decision|0|||
155342268|NCT01052272|560687015|FG000|Overall Study|patient refuses follow-up|5|||
155342269|NCT01052272|560687016|FG001|Overall Study|patient refuses follow-up|4|||
155342270|NCT01052272|560687017|FG002|Overall Study|patient refuses follow-up|2|||
155342271|NCT01052272|560687018|FG003|Overall Study|patient refuses follow-up|4|||
155342272|NCT01052272|560687015|FG000|Overall Study|Withdrawal by Subject|0|||
155342273|NCT01052272|560687016|FG001|Overall Study|Withdrawal by Subject|2|||
155342274|NCT01052272|560687017|FG002|Overall Study|Withdrawal by Subject|3|||
155342275|NCT01052272|560687018|FG003|Overall Study|Withdrawal by Subject|2|||
155423630|NCT00896532|560978712|FG007|Months 48-72: Follow-on Phase|Death|0|||
155423631|NCT00896532|560978713|FG008|Months 48-72: Follow-on Phase|Death|0|||
155423632|NCT00896532|560978714|FG009|Months 48-72: Follow-on Phase|Death|0|||
155423633|NCT00896532|560978715|FG010|Months 48-72: Follow-on Phase|Death|0|||
155423634|NCT00896532|560978716|FG011|Months 48-72: Follow-on Phase|Death|0|||
155423635|NCT00896532|560978717|FG012|Months 48-72: Follow-on Phase|Death|0|||
155423636|NCT00896532|560978718|FG013|Months 48-72: Follow-on Phase|Death|0|||
155423637|NCT00896532|560978719|FG014|Months 48-72: Follow-on Phase|Death|0|||
155423638|NCT00896532|560978720|FG015|Months 48-72: Follow-on Phase|Death|0|||
155423639|NCT00896532|560978721|FG016|Months 48-72: Follow-on Phase|Death|0|||
155423640|NCT00896532|560978722|FG017|Months 48-72: Follow-on Phase|Death|0|||
155423641|NCT00896532|560978723|FG018|Months 48-72: Follow-on Phase|Death|1|||
155423642|NCT00896532|560978724|FG019|Months 48-72: Follow-on Phase|Death|0|||
155423643|NCT00896532|560978725|FG020|Months 48-72: Follow-on Phase|Death|0|||
155423644|NCT00896532|560978726|FG021|Months 48-72: Follow-on Phase|Death|0|||
155423645|NCT00896532|560978727|FG022|Months 48-72: Follow-on Phase|Death|0|||
155423646|NCT00896532|560978705|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423647|NCT00896532|560978706|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423648|NCT00896532|560978707|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423649|NCT00896532|560978708|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423650|NCT00896532|560978709|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423651|NCT00896532|560978710|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423652|NCT00896532|560978711|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423653|NCT00896532|560978712|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155505214|NCT00845026|561276103|FG000|Study Period IV|Entry Criteria Not Met|1|||
155505215|NCT00845026|561276104|FG001|Study Period IV|Entry Criteria Not Met|0|||
155342276|NCT01052272|560687015|FG000|Overall Study|placed in long-term care|0|||
155342277|NCT01052272|560687016|FG001|Overall Study|placed in long-term care|0|||
155342278|NCT01052272|560687017|FG002|Overall Study|placed in long-term care|1|||
155342279|NCT01052272|560687018|FG003|Overall Study|placed in long-term care|0|||
155342280|NCT01052272|560687015|FG000|Overall Study|decline in health|0|||
155342281|NCT01052272|560687016|FG001|Overall Study|decline in health|0|||
155342282|NCT01052272|560687017|FG002|Overall Study|decline in health|1|||
155342283|NCT01052272|560687018|FG003|Overall Study|decline in health|0|||
155342284|NCT00648895|560687019|FG000|Overall Study|Lack of Efficacy|0|||
155342285|NCT00648895|560687020|FG001|Overall Study|Lack of Efficacy|1|||
155342286|NCT00096278|560687023|FG000|Overall Study|No follow-up data|15|||
155342287|NCT00096278|560687024|FG001|Overall Study|No follow-up data|18|||
155342288|NCT00096278|560687023|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
155342289|NCT00096278|560687024|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
155342290|NCT00379210|560687027|FG000|Overall Study|Withdrawal by Subject|10|||
155342291|NCT00379210|560687028|FG001|Overall Study|Withdrawal by Subject|7|||
155342292|NCT01358175|560687029|FG000|Overall Study|Death|1|||
155342293|NCT01358175|560687030|FG001|Overall Study|Death|0|||
155342294|NCT01358175|560687031|FG002|Overall Study|Death|1|||
155342295|NCT01358175|560687029|FG000|Overall Study|Withdrawal by Subject|9|||
155342296|NCT01358175|560687030|FG001|Overall Study|Withdrawal by Subject|5|||
155342297|NCT01358175|560687031|FG002|Overall Study|Withdrawal by Subject|10|||
155342298|NCT01358175|560687029|FG000|Overall Study|Technical issues|0|||
155342299|NCT01358175|560687030|FG001|Overall Study|Technical issues|1|||
155342300|NCT01358175|560687031|FG002|Overall Study|Technical issues|0|||
155342301|NCT01358175|560687029|FG000|Overall Study|Pregnancy|0|||
155342302|NCT01358175|560687030|FG001|Overall Study|Pregnancy|1|||
155342303|NCT01358175|560687031|FG002|Overall Study|Pregnancy|0|||
155342304|NCT01358175|560687029|FG000|Overall Study|Physician Decision|1|||
155342305|NCT01358175|560687030|FG001|Overall Study|Physician Decision|0|||
155342306|NCT01358175|560687031|FG002|Overall Study|Physician Decision|0|||
155342307|NCT01358175|560687029|FG000|Overall Study|Non Compliance with Study Treatment|0|||
155342308|NCT01358175|560687030|FG001|Overall Study|Non Compliance with Study Treatment|1|||
155342309|NCT01358175|560687031|FG002|Overall Study|Non Compliance with Study Treatment|1|||
155342310|NCT01358175|560687029|FG000|Overall Study|Lost to Follow-up|1|||
155342311|NCT01358175|560687030|FG001|Overall Study|Lost to Follow-up|1|||
155342312|NCT01358175|560687031|FG002|Overall Study|Lost to Follow-up|3|||
155342313|NCT01358175|560687029|FG000|Overall Study|Lack of Efficacy|3|||
155342314|NCT01358175|560687030|FG001|Overall Study|Lack of Efficacy|8|||
155342315|NCT01358175|560687031|FG002|Overall Study|Lack of Efficacy|6|||
155342316|NCT01358175|560687029|FG000|Overall Study|Adverse Event|6|||
155342317|NCT01358175|560687030|FG001|Overall Study|Adverse Event|11|||
155342318|NCT01358175|560687031|FG002|Overall Study|Adverse Event|11|||
155342319|NCT02991118|560687034|FG000|Overall Study|Death|3|||
155342320|NCT02991118|560687035|FG001|Overall Study|Death|8|||
155342321|NCT02991118|560687034|FG000|Overall Study|Protocol Violation|0|||
155342322|NCT02991118|560687035|FG001|Overall Study|Protocol Violation|3|||
155342323|NCT02991118|560687034|FG000|Overall Study|Physician Decision|0|||
155342324|NCT02991118|560687035|FG001|Overall Study|Physician Decision|1|||
155342325|NCT02991118|560687034|FG000|Overall Study|Moved out of the country|0|||
155342326|NCT02991118|560687035|FG001|Overall Study|Moved out of the country|1|||
155342327|NCT02991118|560687034|FG000|Overall Study|Adverse Event|2|||
155342328|NCT02991118|560687035|FG001|Overall Study|Adverse Event|2|||
155342329|NCT02991118|560687034|FG000|Overall Study|Withdrawal by Subject|1|||
155342330|NCT02991118|560687035|FG001|Overall Study|Withdrawal by Subject|7|||
155342331|NCT02991118|560687034|FG000|Overall Study|Could not attend study visits|0|||
155342332|NCT02991118|560687035|FG001|Overall Study|Could not attend study visits|1|||
155342333|NCT02991118|560687034|FG000|Overall Study|Lost to Follow-up|1|||
155342334|NCT02991118|560687035|FG001|Overall Study|Lost to Follow-up|9|||
155342335|NCT02764320|560687042|FG000|Overall Study|Withdrawal by Subject|35|||
155342336|NCT02764320|560687043|FG001|Overall Study|Withdrawal by Subject|38|||
155342337|NCT02764320|560687042|FG000|Overall Study|Protocol Violation|11|||
155342338|NCT02764320|560687043|FG001|Overall Study|Protocol Violation|6|||
155342339|NCT02764320|560687042|FG000|Overall Study|Adverse Event|2|||
155342340|NCT02764320|560687043|FG001|Overall Study|Adverse Event|0|||
155342341|NCT02764320|560687042|FG000|Overall Study|Health Issues unable to continue|2|||
155342342|NCT02764320|560687043|FG001|Overall Study|Health Issues unable to continue|0|||
155342343|NCT02764320|560687042|FG000|Overall Study|Did not meet inclusion criteria|1|||
155342344|NCT02764320|560687043|FG001|Overall Study|Did not meet inclusion criteria|0|||
155342345|NCT02764320|560687042|FG000|Overall Study|Subject moved|0|||
155342346|NCT02764320|560687043|FG001|Overall Study|Subject moved|2|||
155342347|NCT02764320|560687042|FG000|Overall Study|Overused medication unavailable|0|||
155342348|NCT02764320|560687043|FG001|Overall Study|Overused medication unavailable|1|||
155342349|NCT02764320|560687042|FG000|Overall Study|Seeking care outside site|0|||
155342350|NCT02764320|560687043|FG001|Overall Study|Seeking care outside site|1|||
155342351|NCT02764320|560687042|FG000|Overall Study|Technology barriers|0|||
155342352|NCT02764320|560687043|FG001|Overall Study|Technology barriers|1|||
155342353|NCT04085614|560687044|FG000|Overall Study|Protocol Violation|9|||
155342354|NCT04085614|560687045|FG001|Overall Study|Protocol Violation|6|||
155342355|NCT03529942|560687046|FG000|Overall Study|Withdrawal by Subject|13|||
155342356|NCT03529942|560687046|FG000|Overall Study|Physician Decision|1|||
155342357|NCT03529942|560687046|FG000|Overall Study|Lost to Follow-up|7|||
155342358|NCT03529942|560687046|FG000|Overall Study|Needle inserted but no drug administered|1|||
155342359|NCT03529942|560687046|FG000|Overall Study|Personal reasons|1|||
155342360|NCT00476957|560687047|FG000|Overall Study|Lost to Follow-up|176|||
155342361|NCT00476957|560687048|FG001|Overall Study|Lost to Follow-up|193|||
155342362|NCT02516202|560687053|FG000|Overall Study|Withdrawal by Subject|1|||
155342363|NCT02516202|560687054|FG001|Overall Study|Withdrawal by Subject|0|||
155342364|NCT02516202|560687055|FG002|Overall Study|Withdrawal by Subject|1|||
155342365|NCT02516202|560687053|FG000|Overall Study|Lost to Follow-up|1|||
155342366|NCT02516202|560687054|FG001|Overall Study|Lost to Follow-up|1|||
155342367|NCT02516202|560687055|FG002|Overall Study|Lost to Follow-up|1|||
155342368|NCT02516202|560687053|FG000|Overall Study|Stopped Follow-up|0|||
155342369|NCT02516202|560687054|FG001|Overall Study|Stopped Follow-up|0|||
155342370|NCT02516202|560687055|FG002|Overall Study|Stopped Follow-up|1|||
155342371|NCT00409747|560687060|FG000|Overall Study|Withdrawal by Subject|1|||
155342372|NCT01000649|560687063|FG000|Overall Study|Adverse Event|5|||
155342373|NCT01000649|560687064|FG001|Overall Study|Adverse Event|1|||
155342374|NCT01000649|560687065|FG002|Overall Study|Adverse Event|2|||
155342375|NCT01000649|560687066|FG003|Overall Study|Adverse Event|4|||
155342376|NCT01000649|560687063|FG000|Overall Study|Lost to Follow-up|0|||
155342377|NCT01000649|560687064|FG001|Overall Study|Lost to Follow-up|2|||
155342378|NCT01000649|560687065|FG002|Overall Study|Lost to Follow-up|0|||
155342379|NCT01000649|560687066|FG003|Overall Study|Lost to Follow-up|2|||
155342380|NCT01916109|560687067|FG000|Overall Study|Withdrawal by Subject|1|||
155342381|NCT00103857|560687068|FG000|54-Week Base Study|Adverse Event|12|||
155342382|NCT00103857|560687069|FG001|54-Week Base Study|Adverse Event|9|||
155342383|NCT00103857|560687070|FG002|54-Week Base Study|Adverse Event|11|||
155342384|NCT00103857|560687071|FG003|54-Week Base Study|Adverse Event|6|||
155342385|NCT00103857|560687072|FG004|54-Week Base Study|Adverse Event|5|||
155342386|NCT00103857|560687073|FG005|54-Week Base Study|Adverse Event|11|||
155342387|NCT00103857|560687074|FG006|54-Week Base Study|Adverse Event|3|||
155505216|NCT00845026|561276103|FG000|Study Period IV|Subject is moving or has moved|0|||
155505217|NCT00845026|561276104|FG001|Study Period IV|Subject is moving or has moved|1|||
155505218|NCT00845026|561276103|FG000|Study Period IV|Scheduling conflict|1|||
155505219|NCT00845026|561276104|FG001|Study Period IV|Scheduling conflict|0|||
155646953|NCT00191152|561799642|FG000|Crossover Treatment|Adverse Event|8|||
155342388|NCT00103857|560687068|FG000|54-Week Base Study|Death|0|||
155342389|NCT00103857|560687069|FG001|54-Week Base Study|Death|0|||
155342390|NCT00103857|560687070|FG002|54-Week Base Study|Death|0|||
155342391|NCT00103857|560687071|FG003|54-Week Base Study|Death|0|||
155342392|NCT00103857|560687072|FG004|54-Week Base Study|Death|1|||
155342393|NCT00103857|560687073|FG005|54-Week Base Study|Death|1|||
155342394|NCT00103857|560687074|FG006|54-Week Base Study|Death|0|||
155342395|NCT00103857|560687068|FG000|54-Week Base Study|Lack of Efficacy|11|||
155342396|NCT00103857|560687069|FG001|54-Week Base Study|Lack of Efficacy|14|||
155342397|NCT00103857|560687070|FG002|54-Week Base Study|Lack of Efficacy|8|||
155342398|NCT00103857|560687071|FG003|54-Week Base Study|Lack of Efficacy|4|||
155342399|NCT00103857|560687072|FG004|54-Week Base Study|Lack of Efficacy|3|||
155342400|NCT00103857|560687073|FG005|54-Week Base Study|Lack of Efficacy|14|||
155342401|NCT00103857|560687074|FG006|54-Week Base Study|Lack of Efficacy|19|||
155342402|NCT00103857|560687068|FG000|54-Week Base Study|Lost to Follow-up|5|||
155342403|NCT00103857|560687069|FG001|54-Week Base Study|Lost to Follow-up|4|||
155423654|NCT00896532|560978713|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423655|NCT00896532|560978714|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423656|NCT00896532|560978715|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423657|NCT00896532|560978716|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423658|NCT00896532|560978717|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423659|NCT00896532|560978718|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423660|NCT00896532|560978719|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423661|NCT00896532|560978720|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423662|NCT00896532|560978721|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423663|NCT00896532|560978722|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423664|NCT00896532|560978723|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423665|NCT00896532|560978724|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423666|NCT00896532|560978725|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423667|NCT00896532|560978726|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
155423668|NCT00896532|560978727|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
155423669|NCT00896532|560978705|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423670|NCT00896532|560978706|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423671|NCT00896532|560978707|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423672|NCT00896532|560978708|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423673|NCT00896532|560978709|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423674|NCT00896532|560978710|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423675|NCT00896532|560978711|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423676|NCT00896532|560978712|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423677|NCT00896532|560978713|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423678|NCT00896532|560978714|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423679|NCT00896532|560978715|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423680|NCT00896532|560978716|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423681|NCT00896532|560978717|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423682|NCT00896532|560978718|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423683|NCT00896532|560978719|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423684|NCT00896532|560978720|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423685|NCT00896532|560978721|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155342404|NCT00103857|560687070|FG002|54-Week Base Study|Lost to Follow-up|7|||
155342405|NCT00103857|560687071|FG003|54-Week Base Study|Lost to Follow-up|5|||
155342406|NCT00103857|560687072|FG004|54-Week Base Study|Lost to Follow-up|10|||
155342407|NCT00103857|560687073|FG005|54-Week Base Study|Lost to Follow-up|9|||
155342408|NCT00103857|560687074|FG006|54-Week Base Study|Lost to Follow-up|3|||
155342409|NCT00103857|560687068|FG000|54-Week Base Study|Physician Decision|1|||
155342410|NCT00103857|560687069|FG001|54-Week Base Study|Physician Decision|1|||
155505220|NCT01325532|561276105|FG000|Overall Study|Withdrawal by Subject|2|||
155505221|NCT01325532|561276106|FG001|Overall Study|Withdrawal by Subject|0|||
155342411|NCT00103857|560687070|FG002|54-Week Base Study|Physician Decision|0|||
155342412|NCT00103857|560687071|FG003|54-Week Base Study|Physician Decision|0|||
155505222|NCT03196791|561276108|FG000|Overall Study|Protocol Violation|7|||
155505223|NCT03196791|561276109|FG001|Overall Study|Protocol Violation|3|||
155342413|NCT00103857|560687072|FG004|54-Week Base Study|Physician Decision|1|||
155342414|NCT00103857|560687073|FG005|54-Week Base Study|Physician Decision|0|||
155342415|NCT00103857|560687074|FG006|54-Week Base Study|Physician Decision|0|||
155505224|NCT03196791|561276108|FG000|Overall Study|Withdrawal by Subject|3|||
155505225|NCT03196791|561276109|FG001|Overall Study|Withdrawal by Subject|2|||
155505226|NCT03672396|561276116|FG000|Overall Study|Withdrawal by Subject|4|||
155646954|NCT00191152|561799643|FG001|Crossover Treatment|Adverse Event|8|||
155646955|NCT00191152|561799642|FG000|Crossover Treatment|Physician Decision|7|||
155646956|NCT00191152|561799643|FG001|Crossover Treatment|Physician Decision|7|||
155646957|NCT00191152|561799642|FG000|Crossover Treatment|Withdrawal by Subject|6|||
155646958|NCT00191152|561799643|FG001|Crossover Treatment|Withdrawal by Subject|9|||
155646959|NCT00191152|561799642|FG000|Crossover Treatment|Lost to Follow-up|2|||
155646960|NCT00191152|561799643|FG001|Crossover Treatment|Lost to Follow-up|1|||
155646961|NCT00191152|561799642|FG000|Crossover Treatment|Other|4|||
155646962|NCT00191152|561799643|FG001|Crossover Treatment|Other|3|||
155646963|NCT00114777|561799647|FG000|Randomization to Month 36|Death|10|||
155646964|NCT00114777|561799648|FG001|Randomization to Month 36|Death|4|||
155646965|NCT00114777|561799649|FG002|Randomization to Month 36|Death|3|||
155646966|NCT00114777|561799647|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
155646967|NCT00114777|561799648|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
155646968|NCT00114777|561799649|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
155646969|NCT00114777|561799647|FG000|Randomization to Month 36|Lack of Efficacy|19|||
155646970|NCT00114777|561799648|FG001|Randomization to Month 36|Lack of Efficacy|15|||
155646971|NCT00114777|561799649|FG002|Randomization to Month 36|Lack of Efficacy|17|||
155646972|NCT00114777|561799647|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
155646973|NCT00114777|561799648|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
155646974|NCT00114777|561799649|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
155646975|NCT00114777|561799647|FG000|Randomization to Month 36|Adverse Event|34|||
155646976|NCT00114777|561799648|FG001|Randomization to Month 36|Adverse Event|35|||
155646977|NCT00114777|561799649|FG002|Randomization to Month 36|Adverse Event|44|||
155646978|NCT00114777|561799647|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
155646979|NCT00114777|561799648|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
155646980|NCT00114777|561799649|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
155646981|NCT00114777|561799647|FG000|Randomization to Month 36|Other|9|||
155646982|NCT00114777|561799648|FG001|Randomization to Month 36|Other|3|||
155646983|NCT00114777|561799649|FG002|Randomization to Month 36|Other|12|||
155646984|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Death|8|||
155646985|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Death|13|||
155646986|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Death|7|||
155646987|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
155646988|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
155646989|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
155646990|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
155646991|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
155646992|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
155646993|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
155646994|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
155646995|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
155423686|NCT00896532|560978722|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423687|NCT00896532|560978723|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423688|NCT00896532|560978724|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423689|NCT00896532|560978725|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423690|NCT00896532|560978726|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
155423691|NCT00896532|560978727|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
155423692|NCT00848120|560978728|FG000|Overall Study|Adverse Event|1|||
155423693|NCT01961115|560978736|FG000|Overall Study|Disease Progression|1|||
155423694|NCT01961115|560978737|FG001|Overall Study|Disease Progression|0|||
155423695|NCT01961115|560978738|FG002|Overall Study|Disease Progression|3|||
155423696|NCT01961115|560978736|FG000|Overall Study|Adverse Event|1|||
155423697|NCT01961115|560978737|FG001|Overall Study|Adverse Event|0|||
155423698|NCT01961115|560978738|FG002|Overall Study|Adverse Event|1|||
155423699|NCT00705263|560978744|FG000|Overall Study|Withdrawal by Subject|2|||
155423700|NCT05501119|560978745|FG000|Overall Study|Withdrawal by Subject|2|||
155423701|NCT05501119|560978745|FG000|Overall Study|Lost to Follow-up|5|||
155646996|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
155646997|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
155646998|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
155646999|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
155647000|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
155647001|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
155647002|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
155647003|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
155647004|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
155647005|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
155647006|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
155647007|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
155647008|NCT00114777|561799647|FG000|Long-Term Extension to Month 84|Other|2|||
155647009|NCT00114777|561799648|FG001|Long-Term Extension to Month 84|Other|0|||
155647010|NCT00114777|561799649|FG002|Long-Term Extension to Month 84|Other|2|||
155647011|NCT02280499|561799653|FG000|Overall Study|Death|14|||
155647012|NCT02280499|561799653|FG000|Overall Study|Lost to Follow-up|42|||
155647013|NCT02280499|561799653|FG000|Overall Study|Adverse Event|5|||
155647014|NCT03511066|561799661|FG000|Overall Study|Withdrawal by Subject|1|||
155647015|NCT03511066|561799662|FG001|Overall Study|Withdrawal by Subject|2|||
155647016|NCT03511066|561799663|FG002|Overall Study|Withdrawal by Subject|3|||
155647017|NCT03511066|561799661|FG000|Overall Study|Lost to Follow-up|2|||
155647018|NCT03511066|561799662|FG001|Overall Study|Lost to Follow-up|3|||
155647019|NCT03511066|561799663|FG002|Overall Study|Lost to Follow-up|0|||
155647020|NCT04560309|561799666|FG000|Overall Study|Meet drop out criteria|1|||
155647021|NCT04560309|561799667|FG001|Overall Study|Meet drop out criteria|1|||
155647022|NCT05085405|561799668|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155647023|NCT05085405|561799669|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155647024|NCT05085405|561799670|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
155647025|NCT05085405|561799671|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
155647026|NCT05085405|561799672|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155647027|NCT05085405|561799673|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155647028|NCT05085405|561799668|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155647029|NCT05085405|561799669|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155647030|NCT05085405|561799670|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155647031|NCT05085405|561799671|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
155647032|NCT05085405|561799672|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155647033|NCT05085405|561799673|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155647034|NCT04146909|561799674|FG000|Overall Study|Withdrawal by Subject|3|||
155647035|NCT04146909|561799674|FG000|Overall Study|Did not qualify after consented|1|||
155647036|NCT01860404|561799675|FG000|Overall Study|Lost to Follow-up|3|||
155647037|NCT01860404|561799676|FG001|Overall Study|Lost to Follow-up|4|||
155647038|NCT01860404|561799677|FG002|Overall Study|Lost to Follow-up|1|||
155647039|NCT01860404|561799678|FG003|Overall Study|Lost to Follow-up|6|||
155647040|NCT01860404|561799679|FG004|Overall Study|Lost to Follow-up|4|||
155647041|NCT01860404|561799675|FG000|Overall Study|Withdrawal by Subject|0|||
155647042|NCT01860404|561799676|FG001|Overall Study|Withdrawal by Subject|0|||
155647043|NCT01860404|561799677|FG002|Overall Study|Withdrawal by Subject|4|||
155647044|NCT01860404|561799678|FG003|Overall Study|Withdrawal by Subject|0|||
155647045|NCT01860404|561799679|FG004|Overall Study|Withdrawal by Subject|0|||
155647046|NCT00356421|561799681|FG000|Overall Study|Lack of Efficacy|3|||
155647047|NCT00356421|561799682|FG001|Overall Study|Lack of Efficacy|0|||
155647048|NCT00356421|561799681|FG000|Overall Study|Withdrawal by Subject|9|||
155647049|NCT00356421|561799682|FG001|Overall Study|Withdrawal by Subject|2|||
155647050|NCT00356421|561799681|FG000|Overall Study|Related to study drug|15|||
155505227|NCT03672396|561276116|FG000|Overall Study|Physician Decision|1|||
155505228|NCT03672396|561276116|FG000|Overall Study|Adverse Event|1|||
155505229|NCT01254045|561276117|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
155505230|NCT01254045|561276118|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
155505231|NCT01254045|561276119|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
155505232|NCT01254045|561276120|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
155505233|NCT01254045|561276121|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
155505234|NCT01254045|561276122|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
155505235|NCT00597207|561276123|FG000|Overall Study|Lost to Follow-up|5|||
155505236|NCT00597207|561276124|FG001|Overall Study|Lost to Follow-up|7|||
155505237|NCT00520351|561276125|FG000|First Intervention|Withdrawal by Subject|1|||
155505238|NCT00520351|561276126|FG001|First Intervention|Withdrawal by Subject|1|||
155505239|NCT03797222|561276128|FG000|Overall Study|Withdrawal by Subject|1|||
155505240|NCT03077828|561276130|FG000|Treatment Cycles|Death|1|||
155505241|NCT03077828|561276130|FG000|Treatment Cycles|Withdrawal by Subject|1|||
155505242|NCT03077828|561276130|FG000|Treatment Cycles|Screen Fail|2|||
155505243|NCT03077828|561276130|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
155505244|NCT03077828|561276130|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
155505245|NCT03077828|561276130|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
155423702|NCT01752023|560978746|FG000|Overall Study|Physician Decision|2|||
155423703|NCT01752023|560978747|FG001|Overall Study|Physician Decision|1|||
155423704|NCT02899156|560978748|FG000|Overall Study|Death|1|||
155423705|NCT02899156|560978749|FG001|Overall Study|Death|0|||
155423706|NCT02899156|560978748|FG000|Overall Study|Physician Decision|0|||
155423707|NCT02899156|560978749|FG001|Overall Study|Physician Decision|1|||
155423708|NCT02440581|560978750|FG000|Overall Study|Death|0|||
155423709|NCT02440581|560978751|FG001|Overall Study|Death|0|||
155423710|NCT02440581|560978752|FG002|Overall Study|Death|7|||
155423711|NCT02440581|560978753|FG003|Overall Study|Death|5|||
155423712|NCT02440581|560978750|FG000|Overall Study|Transplanted|1|||
155423713|NCT02440581|560978751|FG001|Overall Study|Transplanted|0|||
155423714|NCT02440581|560978752|FG002|Overall Study|Transplanted|3|||
155423715|NCT02440581|560978753|FG003|Overall Study|Transplanted|2|||
155423716|NCT02440581|560978750|FG000|Overall Study|Withdrawal by Subject|4|||
155423717|NCT02440581|560978751|FG001|Overall Study|Withdrawal by Subject|11|||
155423718|NCT02440581|560978752|FG002|Overall Study|Withdrawal by Subject|3|||
155423719|NCT02440581|560978753|FG003|Overall Study|Withdrawal by Subject|7|||
155423720|NCT01468987|560978754|FG000|Overall Study|Adverse Event|12|||
155423721|NCT01468987|560978755|FG001|Overall Study|Adverse Event|9|||
155423722|NCT01468987|560978754|FG000|Overall Study|Death|4|||
155423723|NCT01468987|560978755|FG001|Overall Study|Death|1|||
155423724|NCT01468987|560978754|FG000|Overall Study|Lost to Follow-up|10|||
155423725|NCT01468987|560978755|FG001|Overall Study|Lost to Follow-up|5|||
155423726|NCT01468987|560978754|FG000|Overall Study|Protocol Violation|8|||
155423727|NCT01468987|560978755|FG001|Overall Study|Protocol Violation|2|||
155423728|NCT01468987|560978754|FG000|Overall Study|Withdrawal by Subject|28|||
155423729|NCT01468987|560978755|FG001|Overall Study|Withdrawal by Subject|28|||
155423730|NCT01468987|560978754|FG000|Overall Study|Physician Decision|8|||
155423731|NCT01468987|560978755|FG001|Overall Study|Physician Decision|15|||
155423732|NCT01468987|560978754|FG000|Overall Study|Sponsor Decision|1|||
155423733|NCT01468987|560978755|FG001|Overall Study|Sponsor Decision|0|||
155423734|NCT00787787|560978756|FG000|Overall Study|Lack of Efficacy|4|||
155423735|NCT00787787|560978756|FG000|Overall Study|Adverse Event|3|||
155423736|NCT01889602|560978759|FG000|First Intervention|Adverse Event|1|||
155342416|NCT00103857|560687068|FG000|54-Week Base Study|Pregnancy|1|||
155342417|NCT00103857|560687069|FG001|54-Week Base Study|Pregnancy|0|||
155342418|NCT00103857|560687070|FG002|54-Week Base Study|Pregnancy|0|||
155342419|NCT00103857|560687071|FG003|54-Week Base Study|Pregnancy|0|||
155342420|NCT00103857|560687072|FG004|54-Week Base Study|Pregnancy|1|||
155342421|NCT00103857|560687073|FG005|54-Week Base Study|Pregnancy|0|||
155342422|NCT00103857|560687074|FG006|54-Week Base Study|Pregnancy|1|||
155342423|NCT00103857|560687068|FG000|54-Week Base Study|Protocol Violation|6|||
155342424|NCT00103857|560687069|FG001|54-Week Base Study|Protocol Violation|4|||
155342425|NCT00103857|560687070|FG002|54-Week Base Study|Protocol Violation|2|||
155342426|NCT00103857|560687071|FG003|54-Week Base Study|Protocol Violation|4|||
155342427|NCT00103857|560687072|FG004|54-Week Base Study|Protocol Violation|0|||
155342428|NCT00103857|560687073|FG005|54-Week Base Study|Protocol Violation|3|||
155342429|NCT00103857|560687074|FG006|54-Week Base Study|Protocol Violation|3|||
155342430|NCT00103857|560687068|FG000|54-Week Base Study|Withdrawal by Subject|17|||
155342431|NCT00103857|560687069|FG001|54-Week Base Study|Withdrawal by Subject|16|||
155342432|NCT00103857|560687070|FG002|54-Week Base Study|Withdrawal by Subject|16|||
155342433|NCT00103857|560687071|FG003|54-Week Base Study|Withdrawal by Subject|15|||
155342434|NCT00103857|560687072|FG004|54-Week Base Study|Withdrawal by Subject|10|||
155342435|NCT00103857|560687073|FG005|54-Week Base Study|Withdrawal by Subject|15|||
155342436|NCT00103857|560687074|FG006|54-Week Base Study|Withdrawal by Subject|4|||
155342437|NCT00103857|560687068|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
155342438|NCT00103857|560687069|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
155342439|NCT00103857|560687070|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
155342440|NCT00103857|560687071|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
155342441|NCT00103857|560687072|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
155342442|NCT00103857|560687073|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
155342443|NCT00103857|560687074|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
155342444|NCT00103857|560687068|FG000|54-Week Base Study|patient moved|0|||
155342445|NCT00103857|560687069|FG001|54-Week Base Study|patient moved|1|||
155342446|NCT00103857|560687070|FG002|54-Week Base Study|patient moved|1|||
155342447|NCT00103857|560687071|FG003|54-Week Base Study|patient moved|2|||
155342448|NCT00103857|560687072|FG004|54-Week Base Study|patient moved|3|||
155505246|NCT03077828|561276130|FG000|Follow-up|Patients still in follow-up|15|||
155505247|NCT04288115|561276133|FG000|Overall Study|Withdrawal by Subject|0|||
155505248|NCT04288115|561276134|FG001|Overall Study|Withdrawal by Subject|1|||
155647051|NCT00356421|561799682|FG001|Overall Study|Related to study drug|12|||
155342449|NCT00103857|560687073|FG005|54-Week Base Study|patient moved|1|||
155342450|NCT00103857|560687074|FG006|54-Week Base Study|patient moved|0|||
155342451|NCT00103857|560687068|FG000|54-Week Base Study|non-compliance with study procedures|1|||
155342452|NCT00103857|560687069|FG001|54-Week Base Study|non-compliance with study procedures|2|||
155342453|NCT00103857|560687070|FG002|54-Week Base Study|non-compliance with study procedures|0|||
155342454|NCT00103857|560687071|FG003|54-Week Base Study|non-compliance with study procedures|0|||
155342455|NCT00103857|560687072|FG004|54-Week Base Study|non-compliance with study procedures|0|||
155342456|NCT00103857|560687073|FG005|54-Week Base Study|non-compliance with study procedures|2|||
155342457|NCT00103857|560687074|FG006|54-Week Base Study|non-compliance with study procedures|0|||
155342458|NCT00103857|560687068|FG000|54-Week Base Study|patient incarcerated|0|||
155505249|NCT04288115|561276133|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
155647052|NCT00356421|561799681|FG000|Overall Study|Not related to study drug|5|||
155647053|NCT00356421|561799682|FG001|Overall Study|Not related to study drug|3|||
155647054|NCT00663351|561799683|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
155647055|NCT00663351|561799684|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
155647056|NCT00663351|561799683|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
155647057|NCT00663351|561799684|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
155647058|NCT00663351|561799683|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
155647059|NCT00663351|561799684|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
155647060|NCT00663351|561799683|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
155647061|NCT00663351|561799684|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
155647062|NCT00663351|561799683|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
155647063|NCT00663351|561799684|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
155647064|NCT00663351|561799683|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
155647065|NCT00663351|561799684|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
155647066|NCT03336866|561799685|FG000|Overall Study|Lost to Follow-up|2|||
155647067|NCT03336866|561799686|FG001|Overall Study|Lost to Follow-up|0|||
155647068|NCT03336866|561799687|FG002|Overall Study|Lost to Follow-up|3|||
155647069|NCT03336866|561799685|FG000|Overall Study|Withdrawal by Subject|1|||
155647070|NCT03336866|561799686|FG001|Overall Study|Withdrawal by Subject|1|||
155647071|NCT03336866|561799687|FG002|Overall Study|Withdrawal by Subject|0|||
155647072|NCT03336866|561799685|FG000|Overall Study|Noncompliance with clinic house rules|0|||
155647073|NCT03336866|561799686|FG001|Overall Study|Noncompliance with clinic house rules|0|||
155647074|NCT03336866|561799687|FG002|Overall Study|Noncompliance with clinic house rules|1|||
155647075|NCT03462563|561799688|FG000|Overall Study|Death|1|||
155647076|NCT03462563|561799689|FG001|Overall Study|Death|1|||
155647077|NCT03462563|561799688|FG000|Overall Study|Termination of study|2|||
155647078|NCT03462563|561799689|FG001|Overall Study|Termination of study|1|||
155647079|NCT03462563|561799688|FG000|Overall Study|Adverse Event|1|||
155647080|NCT03462563|561799689|FG001|Overall Study|Adverse Event|3|||
155647081|NCT03462563|561799688|FG000|Overall Study|Unspecified reason|10|||
155647082|NCT03462563|561799689|FG001|Overall Study|Unspecified reason|12|||
155647083|NCT03462563|561799688|FG000|Overall Study|Physician Decision|1|||
155647084|NCT03462563|561799689|FG001|Overall Study|Physician Decision|0|||
155647085|NCT03011372|561799692|FG000|Overall Study|Death|16|||
155647086|NCT03011372|561799692|FG000|Overall Study|Lost to Follow-up|2|||
155647087|NCT03011372|561799692|FG000|Overall Study|Sponsor Decision|17|||
155647088|NCT03011372|561799692|FG000|Overall Study|Withdrawal by Subject|7|||
155647089|NCT03011372|561799692|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
155647090|NCT03011372|561799692|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
155647091|NCT03011372|561799692|FG000|Overall Study|Sponsor's Decision|2|||
155647092|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155647093|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
155647094|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155647095|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
155647096|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
155647097|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155647098|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
155647099|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
155647100|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
155647101|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
155647102|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
155647103|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
155647104|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
155342459|NCT00103857|560687069|FG001|54-Week Base Study|patient incarcerated|0|||
155342460|NCT00103857|560687070|FG002|54-Week Base Study|patient incarcerated|0|||
155342461|NCT00103857|560687071|FG003|54-Week Base Study|patient incarcerated|0|||
155342462|NCT00103857|560687072|FG004|54-Week Base Study|patient incarcerated|1|||
155342463|NCT00103857|560687073|FG005|54-Week Base Study|patient incarcerated|1|||
155342464|NCT00103857|560687074|FG006|54-Week Base Study|patient incarcerated|0|||
155342465|NCT00103857|560687068|FG000|54-Week Base Study|laboratory reporting error|0|||
155342466|NCT00103857|560687069|FG001|54-Week Base Study|laboratory reporting error|0|||
155342467|NCT00103857|560687070|FG002|54-Week Base Study|laboratory reporting error|0|||
155342468|NCT00103857|560687071|FG003|54-Week Base Study|laboratory reporting error|0|||
155342469|NCT00103857|560687072|FG004|54-Week Base Study|laboratory reporting error|1|||
155342470|NCT00103857|560687073|FG005|54-Week Base Study|laboratory reporting error|0|||
155342471|NCT00103857|560687074|FG006|54-Week Base Study|laboratory reporting error|0|||
155342472|NCT00103857|560687068|FG000|54-Week Base Study|site error|0|||
155342473|NCT00103857|560687069|FG001|54-Week Base Study|site error|0|||
155342474|NCT00103857|560687070|FG002|54-Week Base Study|site error|0|||
155342475|NCT00103857|560687071|FG003|54-Week Base Study|site error|0|||
155342476|NCT00103857|560687072|FG004|54-Week Base Study|site error|0|||
155342477|NCT00103857|560687073|FG005|54-Week Base Study|site error|1|||
155342478|NCT00103857|560687074|FG006|54-Week Base Study|site error|0|||
155342479|NCT00103857|560687068|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
155342480|NCT00103857|560687069|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342481|NCT00103857|560687070|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342482|NCT00103857|560687071|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342483|NCT00103857|560687072|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
155423737|NCT01889602|560978760|FG001|First Intervention|Adverse Event|1|||
155423738|NCT01889602|560978761|FG002|First Intervention|Adverse Event|1|||
155342484|NCT00103857|560687073|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342485|NCT00103857|560687074|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342486|NCT00103857|560687068|FG000|50-Week Extension Study|Adverse Event|2|||
155342487|NCT00103857|560687069|FG001|50-Week Extension Study|Adverse Event|3|||
155342488|NCT00103857|560687070|FG002|50-Week Extension Study|Adverse Event|2|||
155342489|NCT00103857|560687071|FG003|50-Week Extension Study|Adverse Event|0|||
155342490|NCT00103857|560687072|FG004|50-Week Extension Study|Adverse Event|1|||
155342491|NCT00103857|560687073|FG005|50-Week Extension Study|Adverse Event|1|||
155342492|NCT00103857|560687074|FG006|50-Week Extension Study|Adverse Event|0|||
155342493|NCT00103857|560687068|FG000|50-Week Extension Study|Death|0|||
155342494|NCT00103857|560687069|FG001|50-Week Extension Study|Death|0|||
155342495|NCT00103857|560687070|FG002|50-Week Extension Study|Death|0|||
155342496|NCT00103857|560687071|FG003|50-Week Extension Study|Death|1|||
155342497|NCT00103857|560687072|FG004|50-Week Extension Study|Death|0|||
155342498|NCT00103857|560687073|FG005|50-Week Extension Study|Death|1|||
155342499|NCT00103857|560687074|FG006|50-Week Extension Study|Death|0|||
155342500|NCT00103857|560687068|FG000|50-Week Extension Study|Lack of Efficacy|26|||
155342501|NCT00103857|560687069|FG001|50-Week Extension Study|Lack of Efficacy|15|||
155342502|NCT00103857|560687070|FG002|50-Week Extension Study|Lack of Efficacy|13|||
155342503|NCT00103857|560687071|FG003|50-Week Extension Study|Lack of Efficacy|16|||
155342504|NCT00103857|560687072|FG004|50-Week Extension Study|Lack of Efficacy|8|||
155342505|NCT00103857|560687073|FG005|50-Week Extension Study|Lack of Efficacy|8|||
155342506|NCT00103857|560687074|FG006|50-Week Extension Study|Lack of Efficacy|0|||
155342507|NCT00103857|560687068|FG000|50-Week Extension Study|Lost to Follow-up|4|||
155342508|NCT00103857|560687069|FG001|50-Week Extension Study|Lost to Follow-up|0|||
155342509|NCT00103857|560687070|FG002|50-Week Extension Study|Lost to Follow-up|1|||
155342510|NCT00103857|560687071|FG003|50-Week Extension Study|Lost to Follow-up|4|||
155342511|NCT00103857|560687072|FG004|50-Week Extension Study|Lost to Follow-up|3|||
155342512|NCT00103857|560687073|FG005|50-Week Extension Study|Lost to Follow-up|3|||
155342513|NCT00103857|560687074|FG006|50-Week Extension Study|Lost to Follow-up|0|||
155342514|NCT00103857|560687068|FG000|50-Week Extension Study|Physician Decision|0|||
155423739|NCT01889602|560978759|FG000|First Intervention|Protocol Violation|0|||
155423740|NCT01889602|560978760|FG001|First Intervention|Protocol Violation|1|||
155423741|NCT01889602|560978761|FG002|First Intervention|Protocol Violation|1|||
155423742|NCT01889602|560978759|FG000|First Intervention|Study ending|0|||
155423743|NCT01889602|560978760|FG001|First Intervention|Study ending|1|||
155423744|NCT01889602|560978761|FG002|First Intervention|Study ending|0|||
155423745|NCT01889602|560978759|FG000|Second Intervention|Adverse Event|0|||
155423746|NCT01889602|560978760|FG001|Second Intervention|Adverse Event|0|||
155423747|NCT01889602|560978761|FG002|Second Intervention|Adverse Event|1|||
155423748|NCT01889602|560978759|FG000|Second Intervention|Study ending|1|||
155423749|NCT01889602|560978760|FG001|Second Intervention|Study ending|0|||
155423750|NCT01889602|560978761|FG002|Second Intervention|Study ending|0|||
155423751|NCT01889602|560978759|FG000|Second Intervention|Withdrawal by Subject|0|||
155423752|NCT01889602|560978760|FG001|Second Intervention|Withdrawal by Subject|0|||
155423753|NCT01889602|560978761|FG002|Second Intervention|Withdrawal by Subject|1|||
155423754|NCT01889602|560978759|FG000|Third Intervention|Protocol Violation|1|||
155423755|NCT01889602|560978760|FG001|Third Intervention|Protocol Violation|0|||
155423756|NCT01889602|560978761|FG002|Third Intervention|Protocol Violation|0|||
155423757|NCT01889602|560978759|FG000|Third Intervention|Withdrawal by Subject|2|||
155423758|NCT01889602|560978760|FG001|Third Intervention|Withdrawal by Subject|2|||
155423759|NCT01889602|560978761|FG002|Third Intervention|Withdrawal by Subject|0|||
155423760|NCT01078805|560978765|FG000|Overall Study|Clinically significant abnormal lab|5|||
155423761|NCT01078805|560978765|FG000|Overall Study|Death|134|||
155505250|NCT04288115|561276134|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
155505251|NCT00729365|561276136|FG000|Overall Study|Physician Decision|33|||
155505252|NCT00729365|561276137|FG001|Overall Study|Physician Decision|6|||
155505253|NCT00729365|561276138|FG002|Overall Study|Physician Decision|7|||
155505254|NCT02766400|561276139|FG000|Overall Study|Death|1|||
155505255|NCT02766400|561276140|FG001|Overall Study|Death|2|||
155505256|NCT02766400|561276139|FG000|Overall Study|Withdrawal by Subject|1|||
155505257|NCT02766400|561276140|FG001|Overall Study|Withdrawal by Subject|0|||
155505258|NCT01309828|561276141|FG000|Overall Study|Adverse Event|10|||
155505259|NCT01309828|561276142|FG001|Overall Study|Adverse Event|11|||
155505260|NCT01309828|561276141|FG000|Overall Study|Voluntary Withdrawal|5|||
155505261|NCT01309828|561276142|FG001|Overall Study|Voluntary Withdrawal|4|||
155505262|NCT01309828|561276141|FG000|Overall Study|Major Protocol Deviation|0|||
155505263|NCT01309828|561276142|FG001|Overall Study|Major Protocol Deviation|1|||
155505264|NCT01309828|561276141|FG000|Overall Study|Other|1|||
155505265|NCT01309828|561276142|FG001|Overall Study|Other|0|||
155505266|NCT00295620|561276143|FG000|Overall Study|Lost to Follow-up|9|||
155505267|NCT00295620|561276144|FG001|Overall Study|Lost to Follow-up|5|||
155505268|NCT00295620|561276143|FG000|Overall Study|Withdrawal by Subject|37|||
155505269|NCT00295620|561276144|FG001|Overall Study|Withdrawal by Subject|50|||
155505270|NCT00295620|561276143|FG000|Overall Study|Death|206|||
155505271|NCT00295620|561276144|FG001|Overall Study|Death|207|||
155342515|NCT00103857|560687069|FG001|50-Week Extension Study|Physician Decision|1|||
155505272|NCT00295620|561276143|FG000|Overall Study|Other reasons|10|||
155342516|NCT00103857|560687070|FG002|50-Week Extension Study|Physician Decision|1|||
155505273|NCT00295620|561276144|FG001|Overall Study|Other reasons|9|||
155342517|NCT00103857|560687071|FG003|50-Week Extension Study|Physician Decision|0|||
155342518|NCT00103857|560687072|FG004|50-Week Extension Study|Physician Decision|0|||
155647105|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155647106|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155647107|NCT03738215|561799693|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155647108|NCT03738215|561799694|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155342519|NCT00103857|560687073|FG005|50-Week Extension Study|Physician Decision|0|||
155342520|NCT00103857|560687074|FG006|50-Week Extension Study|Physician Decision|0|||
155342521|NCT00103857|560687068|FG000|50-Week Extension Study|Pregnancy|0|||
155342522|NCT00103857|560687069|FG001|50-Week Extension Study|Pregnancy|0|||
155342523|NCT00103857|560687070|FG002|50-Week Extension Study|Pregnancy|1|||
155342524|NCT00103857|560687071|FG003|50-Week Extension Study|Pregnancy|0|||
155342525|NCT00103857|560687072|FG004|50-Week Extension Study|Pregnancy|1|||
155342526|NCT00103857|560687073|FG005|50-Week Extension Study|Pregnancy|0|||
155342527|NCT00103857|560687074|FG006|50-Week Extension Study|Pregnancy|0|||
155342528|NCT00103857|560687068|FG000|50-Week Extension Study|Protocol Violation|1|||
155342529|NCT00103857|560687069|FG001|50-Week Extension Study|Protocol Violation|1|||
155342530|NCT00103857|560687070|FG002|50-Week Extension Study|Protocol Violation|1|||
155342531|NCT00103857|560687071|FG003|50-Week Extension Study|Protocol Violation|2|||
155342532|NCT00103857|560687072|FG004|50-Week Extension Study|Protocol Violation|0|||
155342533|NCT00103857|560687073|FG005|50-Week Extension Study|Protocol Violation|1|||
155342534|NCT00103857|560687074|FG006|50-Week Extension Study|Protocol Violation|0|||
155342535|NCT00103857|560687068|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
155342536|NCT00103857|560687069|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
155342537|NCT00103857|560687070|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
155342538|NCT00103857|560687071|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
155342539|NCT00103857|560687072|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
155342540|NCT00103857|560687073|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
155342541|NCT00103857|560687074|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
155342542|NCT00103857|560687068|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
155342543|NCT00103857|560687069|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
155342544|NCT00103857|560687070|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
155342545|NCT00103857|560687071|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
155342546|NCT00103857|560687072|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
155342547|NCT00103857|560687073|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
155342548|NCT00103857|560687074|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
155342549|NCT00103857|560687068|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
155342550|NCT00103857|560687069|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
155342551|NCT00103857|560687070|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
155342552|NCT00103857|560687071|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
155342553|NCT00103857|560687072|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
155342554|NCT00103857|560687073|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
155342555|NCT00103857|560687074|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
155342556|NCT00103857|560687068|FG000|50-Week Extension Study|patient moved|0|||
155342557|NCT00103857|560687069|FG001|50-Week Extension Study|patient moved|0|||
155647109|NCT03738215|561799695|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
155647110|NCT03738215|561799693|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
155647111|NCT03738215|561799694|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
155647112|NCT03738215|561799695|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
155647113|NCT03738215|561799693|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
155647114|NCT03738215|561799694|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
155647115|NCT03738215|561799695|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
155647116|NCT03738215|561799693|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
155647117|NCT03738215|561799694|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
155647118|NCT03738215|561799695|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
155647119|NCT03738215|561799693|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
155647120|NCT03738215|561799694|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
155647121|NCT03738215|561799695|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
155647122|NCT02724644|561801481|FG000|Overall Study|Adverse Event|7|||
155647123|NCT02724644|561801482|FG001|Overall Study|Adverse Event|1|||
155647124|NCT02724644|561801481|FG000|Overall Study|Lost to Follow-up|6|||
155647125|NCT02724644|561801482|FG001|Overall Study|Lost to Follow-up|2|||
155647126|NCT02724644|561801481|FG000|Overall Study|Withdrawal by Subject|7|||
155647127|NCT02724644|561801482|FG001|Overall Study|Withdrawal by Subject|1|||
155647128|NCT02724644|561801481|FG000|Overall Study|Administrative|1|||
155647129|NCT02724644|561801482|FG001|Overall Study|Administrative|0|||
155342558|NCT00103857|560687070|FG002|50-Week Extension Study|patient moved|1|||
155342559|NCT00103857|560687071|FG003|50-Week Extension Study|patient moved|2|||
155342560|NCT00103857|560687072|FG004|50-Week Extension Study|patient moved|0|||
155342561|NCT00103857|560687073|FG005|50-Week Extension Study|patient moved|0|||
155342562|NCT00103857|560687074|FG006|50-Week Extension Study|patient moved|0|||
155342563|NCT00103857|560687068|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342564|NCT00103857|560687069|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342565|NCT00103857|560687070|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
155342566|NCT00103857|560687071|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342567|NCT00103857|560687072|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342568|NCT00103857|560687073|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342569|NCT00103857|560687074|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342570|NCT00103857|560687068|FG000|50-Week Extension Study|reason unspecified|0|||
155342571|NCT00103857|560687069|FG001|50-Week Extension Study|reason unspecified|0|||
155342572|NCT00103857|560687070|FG002|50-Week Extension Study|reason unspecified|0|||
155342573|NCT00103857|560687071|FG003|50-Week Extension Study|reason unspecified|0|||
155342574|NCT00103857|560687072|FG004|50-Week Extension Study|reason unspecified|1|||
155342575|NCT00103857|560687073|FG005|50-Week Extension Study|reason unspecified|0|||
155342576|NCT00103857|560687074|FG006|50-Week Extension Study|reason unspecified|0|||
155342577|NCT00636168|560687077|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
155423762|NCT01078805|560978765|FG000|Overall Study|Lost to Follow-up|676|||
155423763|NCT01078805|560978765|FG000|Overall Study|Physician Decision|169|||
155423764|NCT01078805|560978765|FG000|Overall Study|Serious adverse event|26|||
155423765|NCT01078805|560978765|FG000|Overall Study|Sponsor decision|46|||
155423766|NCT01078805|560978765|FG000|Overall Study|Withdrawal by Subject|739|||
155423767|NCT01078805|560978765|FG000|Overall Study|Other|173|||
155423768|NCT01078805|560978765|FG000|Overall Study|Didn't take study drug|82|||
155423769|NCT02246621|560978766|FG000|Overall Study|Withdrawal by Subject|28|||
155423770|NCT02246621|560978767|FG001|Overall Study|Withdrawal by Subject|16|||
155423771|NCT02246621|560978766|FG000|Overall Study|Lost to Follow-up|1|||
155423772|NCT02246621|560978767|FG001|Overall Study|Lost to Follow-up|0|||
155423773|NCT02246621|560978766|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
155423774|NCT02246621|560978767|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
155423775|NCT01292057|560978771|FG000|Overall Study|Protocol Violation|1|||
155423776|NCT01292057|560978772|FG001|Overall Study|Protocol Violation|1|||
155423777|NCT01292057|560978771|FG000|Overall Study|Lost to Follow-up|1|||
155423778|NCT01292057|560978772|FG001|Overall Study|Lost to Follow-up|1|||
155423779|NCT01974817|560980486|FG000|Overall Study|Death|4|||
155423780|NCT01974817|560980486|FG000|Overall Study|Lost to Follow-up|2|||
155423781|NCT01974817|560980486|FG000|Overall Study|Protocol Violation|2|||
155423782|NCT03658889|560980487|FG000|Overall Study|Protocol Violation|2|||
155423783|NCT03658889|560980488|FG001|Overall Study|Protocol Violation|0|||
155423784|NCT01524991|560980493|FG000|Overall Study|Adverse Event|12|||
155423785|NCT01524991|560980493|FG000|Overall Study|Death|1|||
155423786|NCT01524991|560980493|FG000|Overall Study|Disease ProgressionDu|17|||
155423787|NCT01524991|560980493|FG000|Overall Study|Other complicating disease|1|||
155423788|NCT01524991|560980493|FG000|Overall Study|Withdrawal by Subject|2|||
155423789|NCT01524991|560980493|FG000|Overall Study|Symptomatic Deterioration|1|||
155423790|NCT01805180|560980494|FG000|Lead-in Donor Phase|screen failure|1|||
155423791|NCT01805180|560980495|FG001|Lead-in Donor Phase|screen failure|0|||
155423792|NCT01805180|560980496|FG002|Lead-in Donor Phase|screen failure|0|||
155423793|NCT00206726|560980499|FG000|Overall Study|Delayed recovery of blood counts|1|||
155423794|NCT00206726|560980499|FG000|Overall Study|Progressive disease or relapsed disease|18|||
155423795|NCT00206726|560980499|FG000|Overall Study|Placed on new protocol|1|||
155423796|NCT00206726|560980499|FG000|Overall Study|Bone marrow transplant|1|||
155423797|NCT00206726|560980499|FG000|Overall Study|Adverse Event|17|||
155423798|NCT00206726|560980499|FG000|Overall Study|Death|4|||
155423799|NCT00206726|560980499|FG000|Overall Study|Protocol Violation|1|||
155423800|NCT00206726|560980499|FG000|Overall Study|Withdrawal by Subject|8|||
155423801|NCT01341457|560980502|FG000|Overall Study|Adverse Event|2|||
155423802|NCT01341457|560980503|FG001|Overall Study|Adverse Event|0|||
155423803|NCT00365989|560980504|FG000|Overall Study|Withdrawal by Subject|1|||
155423804|NCT00365989|560980504|FG000|Overall Study|Non-compliance|1|||
155505274|NCT00295620|561276143|FG000|Overall Study|Discontinuation by sponsor|580|||
155505275|NCT00295620|561276144|FG001|Overall Study|Discontinuation by sponsor|593|||
155505276|NCT00295620|561276143|FG000|Overall Study|Protocol Violation|30|||
155505277|NCT00295620|561276144|FG001|Overall Study|Protocol Violation|32|||
155505278|NCT00217971|561276145|FG000|Overall Study|Adverse Event|1|||
155505279|NCT00217971|561276146|FG001|Overall Study|Adverse Event|1|||
155505280|NCT00217971|561276145|FG000|Overall Study|Lost to Follow-up|15|||
155505281|NCT00217971|561276146|FG001|Overall Study|Lost to Follow-up|19|||
155505282|NCT00217971|561276145|FG000|Overall Study|Physician Decision|0|||
155505283|NCT00217971|561276146|FG001|Overall Study|Physician Decision|1|||
155505284|NCT00217971|561276145|FG000|Overall Study|Withdrawal by Subject|7|||
155505285|NCT00217971|561276146|FG001|Overall Study|Withdrawal by Subject|12|||
155505286|NCT00217971|561276145|FG000|Overall Study|non compliant|1|||
155505287|NCT00217971|561276146|FG001|Overall Study|non compliant|0|||
155505288|NCT02556632|561276147|FG000|Overall Study|Lost to Follow-up|1|||
155505289|NCT02556632|561276148|FG001|Overall Study|Lost to Follow-up|0|||
155505290|NCT02556632|561276149|FG002|Overall Study|Lost to Follow-up|0|||
155505291|NCT02556632|561276147|FG000|Overall Study|Disliked Intervention|1|||
155505292|NCT02556632|561276148|FG001|Overall Study|Disliked Intervention|1|||
155505293|NCT02556632|561276149|FG002|Overall Study|Disliked Intervention|1|||
155505294|NCT02556632|561276147|FG000|Overall Study|No Reason|1|||
155505295|NCT02556632|561276148|FG001|Overall Study|No Reason|0|||
155505296|NCT02556632|561276149|FG002|Overall Study|No Reason|1|||
155505297|NCT02556632|561276147|FG000|Overall Study|Personal Issues|0|||
155505298|NCT02556632|561276148|FG001|Overall Study|Personal Issues|1|||
155505299|NCT02556632|561276149|FG002|Overall Study|Personal Issues|1|||
155505300|NCT02556632|561276147|FG000|Overall Study|Changed Mind|0|||
155505301|NCT02556632|561276148|FG001|Overall Study|Changed Mind|1|||
155505302|NCT02556632|561276149|FG002|Overall Study|Changed Mind|0|||
155505303|NCT02556632|561276147|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
155505304|NCT02556632|561276148|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
155505305|NCT02556632|561276149|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
155505306|NCT02556632|561276147|FG000|Overall Study|Unrelated Adverse Event|1|||
155505307|NCT02556632|561276148|FG001|Overall Study|Unrelated Adverse Event|0|||
155505308|NCT02556632|561276149|FG002|Overall Study|Unrelated Adverse Event|3|||
155505309|NCT02556632|561276147|FG000|Overall Study|Related Adverse Event|0|||
155505310|NCT02556632|561276148|FG001|Overall Study|Related Adverse Event|1|||
155505311|NCT02556632|561276149|FG002|Overall Study|Related Adverse Event|0|||
155505312|NCT02556632|561276147|FG000|Overall Study|Possibly Related Adverse Event|0|||
155505313|NCT02556632|561276148|FG001|Overall Study|Possibly Related Adverse Event|0|||
155505314|NCT02556632|561276149|FG002|Overall Study|Possibly Related Adverse Event|1|||
155505315|NCT02556632|561276147|FG000|Overall Study|Did Not Start RT|0|||
155505316|NCT02556632|561276148|FG001|Overall Study|Did Not Start RT|1|||
155505317|NCT02556632|561276149|FG002|Overall Study|Did Not Start RT|0|||
155505318|NCT02556632|561276147|FG000|Overall Study|Ineligible|0|||
155505319|NCT02556632|561276148|FG001|Overall Study|Ineligible|1|||
155505320|NCT02556632|561276149|FG002|Overall Study|Ineligible|0|||
155423805|NCT00832819|560980505|FG000|Overall Study|Adverse Event|0|||
155423806|NCT00832819|560980506|FG001|Overall Study|Adverse Event|1|||
155423807|NCT00832819|560980507|FG002|Overall Study|Adverse Event|0|||
155423808|NCT00832819|560980505|FG000|Overall Study|Protocol Violation|0|||
155423809|NCT00832819|560980506|FG001|Overall Study|Protocol Violation|0|||
155423810|NCT00832819|560980507|FG002|Overall Study|Protocol Violation|1|||
155423811|NCT02318095|560980508|FG000|Overall Study|Adverse Event|1|||
155423812|NCT01717638|560980509|FG000|Overall Study|Lost to Follow-up|0|||
155423813|NCT01717638|560980510|FG001|Overall Study|Lost to Follow-up|0|||
155423814|NCT01717638|560980511|FG002|Overall Study|Lost to Follow-up|0|||
155423815|NCT01717638|560980512|FG003|Overall Study|Lost to Follow-up|0|||
155423816|NCT01717638|560980513|FG004|Overall Study|Lost to Follow-up|0|||
155423817|NCT01717638|560980514|FG005|Overall Study|Lost to Follow-up|1|||
155423818|NCT01717638|560980515|FG006|Overall Study|Lost to Follow-up|0|||
155423819|NCT01717638|560980516|FG007|Overall Study|Lost to Follow-up|0|||
155423820|NCT01717638|560980517|FG008|Overall Study|Lost to Follow-up|0|||
155423821|NCT01717638|560980518|FG009|Overall Study|Lost to Follow-up|0|||
155423822|NCT01717638|560980519|FG010|Overall Study|Lost to Follow-up|0|||
155423823|NCT01717638|560980520|FG011|Overall Study|Lost to Follow-up|0|||
155423824|NCT01717638|560980521|FG012|Overall Study|Lost to Follow-up|0|||
155423825|NCT01717638|560980509|FG000|Overall Study|Father in hospital|0|||
155423826|NCT01717638|560980510|FG001|Overall Study|Father in hospital|0|||
155423827|NCT01717638|560980511|FG002|Overall Study|Father in hospital|0|||
155423828|NCT01717638|560980512|FG003|Overall Study|Father in hospital|0|||
155423829|NCT01717638|560980513|FG004|Overall Study|Father in hospital|0|||
155423830|NCT01717638|560980514|FG005|Overall Study|Father in hospital|0|||
155423831|NCT01717638|560980515|FG006|Overall Study|Father in hospital|0|||
155423832|NCT01717638|560980516|FG007|Overall Study|Father in hospital|0|||
155423833|NCT01717638|560980517|FG008|Overall Study|Father in hospital|0|||
155423834|NCT01717638|560980518|FG009|Overall Study|Father in hospital|0|||
155423835|NCT01717638|560980519|FG010|Overall Study|Father in hospital|0|||
155423836|NCT01717638|560980520|FG011|Overall Study|Father in hospital|0|||
155423837|NCT01717638|560980521|FG012|Overall Study|Father in hospital|1|||
155423838|NCT01717638|560980509|FG000|Overall Study|Withdrawal by Subject|0|||
155423839|NCT01717638|560980510|FG001|Overall Study|Withdrawal by Subject|1|||
155423840|NCT01717638|560980511|FG002|Overall Study|Withdrawal by Subject|1|||
155423841|NCT01717638|560980512|FG003|Overall Study|Withdrawal by Subject|0|||
155423842|NCT01717638|560980513|FG004|Overall Study|Withdrawal by Subject|1|||
155423843|NCT01717638|560980514|FG005|Overall Study|Withdrawal by Subject|0|||
155423844|NCT01717638|560980515|FG006|Overall Study|Withdrawal by Subject|2|||
155423845|NCT01717638|560980516|FG007|Overall Study|Withdrawal by Subject|1|||
155423846|NCT01717638|560980517|FG008|Overall Study|Withdrawal by Subject|2|||
155423847|NCT01717638|560980518|FG009|Overall Study|Withdrawal by Subject|1|||
155423848|NCT01717638|560980519|FG010|Overall Study|Withdrawal by Subject|0|||
155423849|NCT01717638|560980520|FG011|Overall Study|Withdrawal by Subject|0|||
155423850|NCT01717638|560980521|FG012|Overall Study|Withdrawal by Subject|18|||
155647130|NCT00676052|561801484|FG000|Overall Study|Adverse Event|0|||
155647131|NCT00676052|561801485|FG001|Overall Study|Adverse Event|1|||
155647132|NCT00676052|561801486|FG002|Overall Study|Adverse Event|1|||
155647133|NCT00676052|561801487|FG003|Overall Study|Adverse Event|2|||
155647134|NCT00676052|561801488|FG004|Overall Study|Adverse Event|2|||
155647135|NCT00676052|561801489|FG005|Overall Study|Adverse Event|2|||
155647136|NCT00676052|561801484|FG000|Overall Study|Lack of Efficacy|2|||
155647137|NCT00676052|561801485|FG001|Overall Study|Lack of Efficacy|2|||
155647138|NCT00676052|561801486|FG002|Overall Study|Lack of Efficacy|1|||
155647139|NCT00676052|561801487|FG003|Overall Study|Lack of Efficacy|1|||
155647140|NCT00676052|561801488|FG004|Overall Study|Lack of Efficacy|2|||
155647141|NCT00676052|561801489|FG005|Overall Study|Lack of Efficacy|1|||
155647142|NCT00676052|561801484|FG000|Overall Study|Protocol Violation|5|||
155647143|NCT00676052|561801485|FG001|Overall Study|Protocol Violation|3|||
155647144|NCT00676052|561801486|FG002|Overall Study|Protocol Violation|2|||
155647145|NCT00676052|561801487|FG003|Overall Study|Protocol Violation|2|||
155647146|NCT00676052|561801488|FG004|Overall Study|Protocol Violation|1|||
155647147|NCT00676052|561801489|FG005|Overall Study|Protocol Violation|2|||
155647148|NCT00676052|561801484|FG000|Overall Study|Lost to Follow-up|0|||
155647149|NCT00676052|561801485|FG001|Overall Study|Lost to Follow-up|0|||
155647150|NCT00676052|561801486|FG002|Overall Study|Lost to Follow-up|0|||
155647151|NCT00676052|561801487|FG003|Overall Study|Lost to Follow-up|0|||
155647152|NCT00676052|561801488|FG004|Overall Study|Lost to Follow-up|1|||
155647153|NCT00676052|561801489|FG005|Overall Study|Lost to Follow-up|0|||
155647154|NCT00676052|561801484|FG000|Overall Study|Physician Decision|1|||
155647155|NCT00676052|561801485|FG001|Overall Study|Physician Decision|1|||
155647156|NCT00676052|561801486|FG002|Overall Study|Physician Decision|1|||
155647157|NCT00676052|561801487|FG003|Overall Study|Physician Decision|0|||
155647158|NCT00676052|561801488|FG004|Overall Study|Physician Decision|0|||
155647159|NCT00676052|561801489|FG005|Overall Study|Physician Decision|1|||
155647160|NCT00676052|561801484|FG000|Overall Study|Withdrawal by Subject|1|||
155647161|NCT00676052|561801485|FG001|Overall Study|Withdrawal by Subject|0|||
155647162|NCT00676052|561801486|FG002|Overall Study|Withdrawal by Subject|1|||
155647163|NCT00676052|561801487|FG003|Overall Study|Withdrawal by Subject|0|||
155647164|NCT00676052|561801488|FG004|Overall Study|Withdrawal by Subject|0|||
155647165|NCT00676052|561801489|FG005|Overall Study|Withdrawal by Subject|0|||
155647166|NCT02930941|561801490|FG000|Overall Study|Lost to Follow-up|1|||
155647167|NCT02930941|561801491|FG001|Overall Study|Lost to Follow-up|2|||
155647168|NCT00527748|561801504|FG000|Overall Study|Other|3|||
155647169|NCT00710554|561801505|FG000|Overall Study|Adverse Event|24|||
155647170|NCT00710554|561801506|FG001|Overall Study|Adverse Event|7|||
155647171|NCT00710554|561801505|FG000|Overall Study|Withdrawal by Subject|7|||
155647172|NCT00710554|561801506|FG001|Overall Study|Withdrawal by Subject|3|||
155647173|NCT00710554|561801505|FG000|Overall Study|Lost to Follow-up|7|||
155647174|NCT00710554|561801506|FG001|Overall Study|Lost to Follow-up|1|||
155647175|NCT00710554|561801505|FG000|Overall Study|Lack of Efficacy|11|||
155505321|NCT02556632|561276147|FG000|Overall Study|Disliked Study Procedures|0|||
155505322|NCT02556632|561276148|FG001|Overall Study|Disliked Study Procedures|0|||
155505323|NCT02556632|561276149|FG002|Overall Study|Disliked Study Procedures|1|||
155505324|NCT02556632|561276147|FG000|Overall Study|Treatment or Change Delay|0|||
155505325|NCT02556632|561276148|FG001|Overall Study|Treatment or Change Delay|0|||
155505326|NCT02556632|561276149|FG002|Overall Study|Treatment or Change Delay|1|||
155505327|NCT00808015|561276150|FG000|Overall Study|Death|1|||
155505328|NCT00808015|561276150|FG000|Overall Study|Lack of Efficacy|58|||
155505329|NCT00808015|561276150|FG000|Overall Study|Lost to Follow-up|76|||
155505330|NCT00808015|561276150|FG000|Overall Study|Participants not willing to participate|158|||
155505331|NCT00808015|561276150|FG000|Overall Study|Adverse Event|22|||
155505332|NCT00808015|561276150|FG000|Overall Study|Other|25|||
155505333|NCT00808015|561276150|FG000|Overall Study|Enrolled but not treated|4|||
155505334|NCT00084617|561276162|FG000|Overall Study|Withdrawal by Subject|7|||
155505335|NCT00084617|561276162|FG000|Overall Study|Lack of Efficacy|1|||
155505336|NCT00084617|561276162|FG000|Overall Study|Protocol Violation|1|||
155505337|NCT01625286|561276163|FG000|Overall Study|Adverse Event|0|||
155505338|NCT01625286|561276164|FG001|Overall Study|Adverse Event|0|||
155505339|NCT01625286|561276165|FG002|Overall Study|Adverse Event|0|||
155505340|NCT01625286|561276166|FG003|Overall Study|Adverse Event|0|||
155505341|NCT01625286|561276167|FG004|Overall Study|Adverse Event|1|||
155505342|NCT01625286|561276168|FG005|Overall Study|Adverse Event|2|||
155505343|NCT01625286|561276169|FG006|Overall Study|Adverse Event|1|||
155505344|NCT01625286|561276163|FG000|Overall Study|Death|0|||
155505345|NCT01625286|561276164|FG001|Overall Study|Death|0|||
155505346|NCT01625286|561276165|FG002|Overall Study|Death|1|||
155505347|NCT01625286|561276166|FG003|Overall Study|Death|1|||
155505348|NCT01625286|561276167|FG004|Overall Study|Death|0|||
155505349|NCT01625286|561276168|FG005|Overall Study|Death|11|||
155505350|NCT01625286|561276169|FG006|Overall Study|Death|16|||
155505351|NCT01625286|561276163|FG000|Overall Study|Withdrawal by Subject|0|||
155505352|NCT01625286|561276164|FG001|Overall Study|Withdrawal by Subject|1|||
155505353|NCT01625286|561276165|FG002|Overall Study|Withdrawal by Subject|0|||
155505354|NCT01625286|561276166|FG003|Overall Study|Withdrawal by Subject|1|||
155647176|NCT00710554|561801506|FG001|Overall Study|Lack of Efficacy|12|||
155647177|NCT00710554|561801505|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
155647178|NCT00710554|561801506|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
155647179|NCT01346709|561801507|FG000|Overall Study|Protocol Violation|35|||
155647180|NCT01346709|561801507|FG000|Overall Study|Lost to Follow-up|31|||
155647181|NCT01346709|561801507|FG000|Overall Study|Missing data in candidate risk factor|285|||
155647182|NCT02773537|561801521|FG000|Overall Study|Lost to Follow-up|0|||
155647183|NCT02773537|561801522|FG001|Overall Study|Lost to Follow-up|1|||
155647184|NCT02773537|561801523|FG002|Overall Study|Lost to Follow-up|4|||
155647185|NCT02421510|561801525|FG000|Overall Study|Other|4|||
155647186|NCT02421510|561801526|FG001|Overall Study|Other|2|||
155647187|NCT02421510|561801527|FG002|Overall Study|Other|3|||
155647188|NCT02421510|561801525|FG000|Overall Study|Protocol Violation|1|||
155647189|NCT02421510|561801526|FG001|Overall Study|Protocol Violation|2|||
155647190|NCT02421510|561801527|FG002|Overall Study|Protocol Violation|0|||
155647191|NCT02421510|561801525|FG000|Overall Study|Death|1|||
155647192|NCT02421510|561801526|FG001|Overall Study|Death|0|||
155647193|NCT02421510|561801527|FG002|Overall Study|Death|0|||
155647194|NCT02421510|561801525|FG000|Overall Study|Noncompliance with study drug|1|||
155647195|NCT02421510|561801526|FG001|Overall Study|Noncompliance with study drug|0|||
155647196|NCT02421510|561801527|FG002|Overall Study|Noncompliance with study drug|0|||
155647197|NCT02421510|561801525|FG000|Overall Study|Physician Decision|1|||
155647198|NCT02421510|561801526|FG001|Overall Study|Physician Decision|1|||
155647199|NCT02421510|561801527|FG002|Overall Study|Physician Decision|3|||
155647200|NCT02421510|561801525|FG000|Overall Study|Adverse Event|9|||
155647201|NCT02421510|561801526|FG001|Overall Study|Adverse Event|10|||
155647202|NCT02421510|561801527|FG002|Overall Study|Adverse Event|18|||
155647203|NCT02421510|561801525|FG000|Overall Study|Pregnancy|1|||
155647204|NCT02421510|561801526|FG001|Overall Study|Pregnancy|1|||
155647205|NCT02421510|561801527|FG002|Overall Study|Pregnancy|0|||
155647206|NCT02421510|561801525|FG000|Overall Study|Withdrawal by Subject|14|||
155647207|NCT02421510|561801526|FG001|Overall Study|Withdrawal by Subject|18|||
155647208|NCT02421510|561801527|FG002|Overall Study|Withdrawal by Subject|12|||
155647209|NCT02421510|561801525|FG000|Overall Study|Lost to Follow-up|1|||
155647210|NCT02421510|561801526|FG001|Overall Study|Lost to Follow-up|1|||
155647211|NCT02421510|561801527|FG002|Overall Study|Lost to Follow-up|0|||
155647212|NCT02264821|561801533|FG000|Overall Study|Protocol Violation|1|||
155647213|NCT02264821|561801534|FG001|Overall Study|Protocol Violation|3|||
155647214|NCT02264821|561801535|FG002|Overall Study|Protocol Violation|6|||
155647215|NCT03142334|561801537|FG000|Overall Study|Death|18|||
155647216|NCT03142334|561801538|FG001|Overall Study|Death|33|||
155647217|NCT03142334|561801537|FG000|Overall Study|Withdrawal by Subject|15|||
155647218|NCT03142334|561801538|FG001|Overall Study|Withdrawal by Subject|11|||
155647219|NCT03142334|561801537|FG000|Overall Study|Ongoing on trial follow up|463|||
155647220|NCT03142334|561801538|FG001|Overall Study|Ongoing on trial follow up|454|||
155647221|NCT03528577|561801541|FG000|Sequence 1|Failed Spirometry|1|||
155647222|NCT03528577|561801541|FG000|Sequence 1|Restricted medication|1|||
155647223|NCT03528577|561801541|FG000|Sequence 2|Adverse Event|1|||
155647224|NCT03528577|561801541|FG000|Sequence 2|Withdrawal by Subject|1|||
155647225|NCT03528577|561801541|FG000|Sequence 2|Failed Spirometry|1|||
155647226|NCT03528577|561801541|FG000|Sequence 3|Failed Spirometry|1|||
155647227|NCT03528577|561801541|FG000|Sequence 4|Failed Spirometry|2|||
155647228|NCT03528577|561801541|FG000|Sequence 4|Adverse Event|1|||
155647229|NCT04882215|561801542|FG000|Overall Study|Withdrawal by Subject|5|||
155647230|NCT04882215|561801543|FG001|Overall Study|Withdrawal by Subject|0|||
155647231|NCT04098302|561801546|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
155647232|NCT04098302|561801547|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
155647233|NCT04098302|561801548|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
155647234|NCT04098302|561801549|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
155647235|NCT04098302|561801546|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
155647236|NCT04098302|561801547|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155647237|NCT04098302|561801548|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155647238|NCT04098302|561801549|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155647239|NCT04098302|561801546|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
155647240|NCT04098302|561801547|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
155647241|NCT04098302|561801548|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
155647242|NCT04098302|561801549|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
155647243|NCT04098302|561801546|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
155647244|NCT04098302|561801547|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
155647245|NCT04098302|561801548|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
155647246|NCT04098302|561801549|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
155647247|NCT04098302|561801546|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
155647248|NCT04098302|561801547|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
155647249|NCT04098302|561801548|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
155647250|NCT04098302|561801549|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
155647251|NCT04098302|561801546|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155647252|NCT04098302|561801547|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155342578|NCT00636168|560687078|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
155647253|NCT04098302|561801548|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155647254|NCT04098302|561801549|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
155647255|NCT04098302|561801546|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155647256|NCT04098302|561801547|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155647257|NCT04098302|561801548|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
155647258|NCT04098302|561801549|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155647259|NCT04098302|561801546|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155647260|NCT04098302|561801547|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155647261|NCT04098302|561801548|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155647262|NCT04098302|561801549|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
155647263|NCT05061706|561801550|FG000|Overall Study|Adverse Event|29|||
155647264|NCT05061706|561801551|FG001|Overall Study|Adverse Event|1|||
155647265|NCT05061706|561801550|FG000|Overall Study|Lack of Efficacy|0|||
155647266|NCT05061706|561801551|FG001|Overall Study|Lack of Efficacy|1|||
155647267|NCT05061706|561801550|FG000|Overall Study|Lost to Follow-up|2|||
155647268|NCT05061706|561801551|FG001|Overall Study|Lost to Follow-up|2|||
155647269|NCT05061706|561801550|FG000|Overall Study|Protocol Violation|3|||
155647270|NCT05061706|561801551|FG001|Overall Study|Protocol Violation|1|||
155647271|NCT05061706|561801550|FG000|Overall Study|Withdrawal by Subject|3|||
155647272|NCT05061706|561801551|FG001|Overall Study|Withdrawal by Subject|9|||
155647273|NCT00601107|561801555|FG000|Overall Study|Adverse Event|0|||
155647274|NCT00601107|561801556|FG001|Overall Study|Adverse Event|1|||
155647275|NCT00601107|561801557|FG002|Overall Study|Adverse Event|3|||
155647276|NCT00601107|561801558|FG003|Overall Study|Adverse Event|0|||
155647277|NCT00601107|561801555|FG000|Overall Study|Withdrawal by Subject|5|||
155647278|NCT00601107|561801556|FG001|Overall Study|Withdrawal by Subject|4|||
155647279|NCT00601107|561801557|FG002|Overall Study|Withdrawal by Subject|7|||
155647280|NCT00601107|561801558|FG003|Overall Study|Withdrawal by Subject|4|||
155647281|NCT00601107|561801555|FG000|Overall Study|Lost to Follow-up|3|||
155647282|NCT00601107|561801556|FG001|Overall Study|Lost to Follow-up|3|||
155647283|NCT00601107|561801557|FG002|Overall Study|Lost to Follow-up|0|||
155647284|NCT00601107|561801558|FG003|Overall Study|Lost to Follow-up|3|||
155647285|NCT00601107|561801555|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155647286|NCT00601107|561801556|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155647287|NCT00601107|561801557|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155647288|NCT00601107|561801558|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
155647289|NCT00601107|561801555|FG000|Overall Study|Worsening of Psoriasis|4|||
155647290|NCT00601107|561801556|FG001|Overall Study|Worsening of Psoriasis|1|||
155647291|NCT00601107|561801557|FG002|Overall Study|Worsening of Psoriasis|1|||
155647292|NCT00601107|561801558|FG003|Overall Study|Worsening of Psoriasis|4|||
155647293|NCT00601107|561801555|FG000|Overall Study|Undefined|1|||
155647294|NCT00601107|561801556|FG001|Overall Study|Undefined|0|||
155647295|NCT00601107|561801557|FG002|Overall Study|Undefined|1|||
155647296|NCT00601107|561801558|FG003|Overall Study|Undefined|0|||
155647297|NCT03892915|561801559|FG000|Overall Study|Lost to Follow-up|6|||
155647298|NCT03892915|561801560|FG001|Overall Study|Lost to Follow-up|12|||
155647299|NCT03892915|561801559|FG000|Overall Study|Death|0|||
155647300|NCT03892915|561801560|FG001|Overall Study|Death|2|||
155647301|NCT03892915|561801559|FG000|Overall Study|Withdrawal by Subject|1|||
155647302|NCT03892915|561801560|FG001|Overall Study|Withdrawal by Subject|1|||
155647303|NCT03892915|561801559|FG000|Overall Study|unsuccessful delivery|13|||
155647304|NCT03892915|561801560|FG001|Overall Study|unsuccessful delivery|18|||
155647305|NCT01181128|561801561|FG000|Overall Study|Withdrawal by Subject|2|||
155647306|NCT01181128|561801562|FG001|Overall Study|Withdrawal by Subject|2|||
155647307|NCT01181128|561801563|FG002|Overall Study|Withdrawal by Subject|0|||
155647308|NCT01181128|561801561|FG000|Overall Study|Death|1|||
155647309|NCT01181128|561801562|FG001|Overall Study|Death|0|||
155647310|NCT01181128|561801563|FG002|Overall Study|Death|0|||
155647311|NCT01181128|561801561|FG000|Overall Study|Physician Decision|2|||
155647312|NCT01181128|561801562|FG001|Overall Study|Physician Decision|0|||
155647313|NCT01181128|561801563|FG002|Overall Study|Physician Decision|0|||
155647314|NCT01181128|561801561|FG000|Overall Study|Adverse Event|0|||
155647315|NCT01181128|561801562|FG001|Overall Study|Adverse Event|2|||
155647316|NCT01181128|561801563|FG002|Overall Study|Adverse Event|0|||
155647317|NCT01181128|561801561|FG000|Overall Study|Other|1|||
155647318|NCT01181128|561801562|FG001|Overall Study|Other|1|||
155647319|NCT01181128|561801563|FG002|Overall Study|Other|1|||
155647320|NCT04477486|561801564|FG000|Overall Study|Death|2|||
155647321|NCT04477486|561801564|FG000|Overall Study|Ongoing at Time of Analysis|11|||
155423851|NCT01061008|560980523|FG000|Overall Study|Badiocephalic fistula failed|3|||
155423852|NCT01061008|560980524|FG001|Overall Study|Badiocephalic fistula failed|2|||
155423853|NCT01061008|560980523|FG000|Overall Study|Death|1|||
155423854|NCT01061008|560980524|FG001|Overall Study|Death|0|||
155423855|NCT01061008|560980523|FG000|Overall Study|Withdrawal by Subject|1|||
155423856|NCT01061008|560980524|FG001|Overall Study|Withdrawal by Subject|3|||
155423857|NCT01061008|560980523|FG000|Overall Study|Unable to exercise following surgery|1|||
155647322|NCT02336503|561801566|FG000|Overall Study|Lost to Follow-up|0|||
155647323|NCT02336503|561801567|FG001|Overall Study|Lost to Follow-up|3|||
155647324|NCT02336503|561801568|FG002|Overall Study|Lost to Follow-up|0|||
155647325|NCT02336503|561801569|FG003|Overall Study|Lost to Follow-up|2|||
155647326|NCT02336503|561801566|FG000|Overall Study|Withdrawal by Subject|2|||
155647327|NCT02336503|561801567|FG001|Overall Study|Withdrawal by Subject|0|||
155647328|NCT02336503|561801568|FG002|Overall Study|Withdrawal by Subject|0|||
155647329|NCT02336503|561801569|FG003|Overall Study|Withdrawal by Subject|4|||
155647330|NCT02336503|561801566|FG000|Overall Study|Adverse Event|0|||
155647331|NCT02336503|561801567|FG001|Overall Study|Adverse Event|0|||
155647332|NCT02336503|561801568|FG002|Overall Study|Adverse Event|1|||
155647333|NCT02336503|561801569|FG003|Overall Study|Adverse Event|0|||
155647334|NCT01543503|561801570|FG000|Overall Study|Lost to Follow-up|32|||
155647335|NCT01543503|561801571|FG001|Overall Study|Lost to Follow-up|36|||
155647336|NCT01543503|561801570|FG000|Overall Study|Adverse Event|9|||
155647337|NCT01543503|561801571|FG001|Overall Study|Adverse Event|13|||
155647338|NCT01543503|561801570|FG000|Overall Study|Lack of Efficacy|4|||
155647339|NCT01543503|561801571|FG001|Overall Study|Lack of Efficacy|16|||
155647340|NCT01543503|561801570|FG000|Overall Study|Participant withdrew informed consent|8|||
155647341|NCT01543503|561801571|FG001|Overall Study|Participant withdrew informed consent|10|||
155647342|NCT01543503|561801570|FG000|Overall Study|Change of jobs|0|||
155647343|NCT01543503|561801571|FG001|Overall Study|Change of jobs|1|||
155647344|NCT01543503|561801570|FG000|Overall Study|Intolerance to the biologic treatment|0|||
155647345|NCT01543503|561801571|FG001|Overall Study|Intolerance to the biologic treatment|1|||
155647346|NCT01543503|561801570|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
155647347|NCT01543503|561801571|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
155647348|NCT01543503|561801570|FG000|Overall Study|Participant did not complete last visit|0|||
155647349|NCT01543503|561801571|FG001|Overall Study|Participant did not complete last visit|2|||
155647350|NCT01543503|561801570|FG000|Overall Study|Refused to continue treatment|7|||
155647351|NCT01543503|561801571|FG001|Overall Study|Refused to continue treatment|0|||
155647352|NCT01543503|561801570|FG000|Overall Study|Incorrect medication received|1|||
155647353|NCT01543503|561801571|FG001|Overall Study|Incorrect medication received|0|||
155647354|NCT01543503|561801570|FG000|Overall Study|Participant moved to another city|2|||
155647355|NCT01543503|561801571|FG001|Overall Study|Participant moved to another city|0|||
155647356|NCT01543503|561801570|FG000|Overall Study|Participant will not return for visits|0|||
155647357|NCT01543503|561801571|FG001|Overall Study|Participant will not return for visits|2|||
155342579|NCT00636168|560687077|FG000|Randomized to Study Drug|Adverse Event|1|||
155342580|NCT00636168|560687078|FG001|Randomized to Study Drug|Adverse Event|0|||
155342581|NCT00636168|560687077|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
155423858|NCT01061008|560980524|FG001|Overall Study|Unable to exercise following surgery|0|||
155423859|NCT01061008|560980523|FG000|Overall Study|Adverse Event|0|||
155423860|NCT01061008|560980524|FG001|Overall Study|Adverse Event|1|||
155423861|NCT04067518|560980526|FG000|Overall Study|Adverse Event|1|||
155423862|NCT04067518|560980527|FG001|Overall Study|Adverse Event|3|||
155423863|NCT04067518|560980526|FG000|Overall Study|Screen failures|0|||
155423864|NCT04067518|560980527|FG001|Overall Study|Screen failures|1|||
155423865|NCT04067518|560980526|FG000|Overall Study|Enrolled but not treated|0|||
155423866|NCT04067518|560980527|FG001|Overall Study|Enrolled but not treated|1|||
155423867|NCT00862251|560980528|FG000|Overall Study|Adverse Event|8|||
155505355|NCT01625286|561276167|FG004|Overall Study|Withdrawal by Subject|0|||
155505356|NCT01625286|561276168|FG005|Overall Study|Withdrawal by Subject|0|||
155647358|NCT01543503|561801570|FG000|Overall Study|Participant transferred to another city|1|||
155423868|NCT00862251|560980529|FG001|Overall Study|Adverse Event|3|||
155647359|NCT01543503|561801571|FG001|Overall Study|Participant transferred to another city|0|||
155647360|NCT01543503|561801570|FG000|Overall Study|Participant moved to Scotland|1|||
155647361|NCT01543503|561801571|FG001|Overall Study|Participant moved to Scotland|0|||
155647362|NCT01543503|561801570|FG000|Overall Study|Participant decision to stop treatment|1|||
155647363|NCT01543503|561801571|FG001|Overall Study|Participant decision to stop treatment|0|||
155647364|NCT01543503|561801570|FG000|Overall Study|Investigator did not wish to participate|1|||
155647365|NCT01543503|561801571|FG001|Overall Study|Investigator did not wish to participate|1|||
155342582|NCT00636168|560687078|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
155342583|NCT00636168|560687077|FG000|Treated With Study Drug|Recurrence of disease|135|||
155342584|NCT00636168|560687078|FG001|Treated With Study Drug|Recurrence of disease|282|||
155342585|NCT00636168|560687077|FG000|Treated With Study Drug|Adverse Event|250|||
155342586|NCT00636168|560687078|FG001|Treated With Study Drug|Adverse Event|22|||
155342587|NCT00636168|560687077|FG000|Treated With Study Drug|Participant withdrew consent|16|||
155342588|NCT00636168|560687078|FG001|Treated With Study Drug|Participant withdrew consent|21|||
155342589|NCT00636168|560687077|FG000|Treated With Study Drug|Poor/non-compliance|1|||
155342590|NCT00636168|560687078|FG001|Treated With Study Drug|Poor/non-compliance|3|||
155342591|NCT00636168|560687077|FG000|Treated With Study Drug|Death|3|||
155647366|NCT01543503|561801570|FG000|Overall Study|Participant recruited after closing date|0|||
155647367|NCT01543503|561801571|FG001|Overall Study|Participant recruited after closing date|1|||
155647368|NCT01543503|561801570|FG000|Overall Study|Site stopped participation|5|||
155647369|NCT01543503|561801571|FG001|Overall Study|Site stopped participation|1|||
155647370|NCT01543503|561801570|FG000|Overall Study|Participant did not attend a visit|1|||
155647371|NCT01543503|561801571|FG001|Overall Study|Participant did not attend a visit|0|||
155647372|NCT01543503|561801570|FG000|Overall Study|Moved to other rheumatologic site|0|||
155647373|NCT01543503|561801571|FG001|Overall Study|Moved to other rheumatologic site|1|||
155647374|NCT01543503|561801570|FG000|Overall Study|Participant consented to another study|0|||
155647375|NCT01543503|561801571|FG001|Overall Study|Participant consented to another study|2|||
155647376|NCT01543503|561801570|FG000|Overall Study|Participant went to United States|1|||
155647377|NCT01543503|561801571|FG001|Overall Study|Participant went to United States|0|||
155647378|NCT01543503|561801570|FG000|Overall Study|Screen failure|1|||
155647379|NCT01543503|561801571|FG001|Overall Study|Screen failure|0|||
155647380|NCT02460380|561801572|FG000|Overall Study|Withdrawal by Subject|10|||
155647381|NCT02460380|561801573|FG001|Overall Study|Withdrawal by Subject|5|||
155647382|NCT01478087|561801576|FG000|Overall Study|due to sponsor closing study|1|||
155647383|NCT03566550|561801578|FG000|Overall Study|Withdrawal by Subject|0|||
155647384|NCT03566550|561801579|FG001|Overall Study|Withdrawal by Subject|1|||
155647385|NCT04576949|561801581|FG000|Overall Study|Adverse Event|1|||
155647386|NCT04576949|561801582|FG001|Overall Study|Adverse Event|3|||
155647387|NCT04576949|561801583|FG002|Overall Study|Adverse Event|2|||
155647388|NCT04576949|561801581|FG000|Overall Study|Withdrawal by Subject|41|||
155647389|NCT04576949|561801582|FG001|Overall Study|Withdrawal by Subject|26|||
155647390|NCT04576949|561801583|FG002|Overall Study|Withdrawal by Subject|18|||
155647391|NCT04576949|561801581|FG000|Overall Study|Physician Decision|3|||
155647392|NCT04576949|561801582|FG001|Overall Study|Physician Decision|0|||
155647393|NCT04576949|561801583|FG002|Overall Study|Physician Decision|0|||
155647394|NCT04576949|561801581|FG000|Overall Study|Death|0|||
155647395|NCT04576949|561801582|FG001|Overall Study|Death|1|||
155647396|NCT04576949|561801583|FG002|Overall Study|Death|0|||
155647397|NCT04576949|561801581|FG000|Overall Study|Lost to Follow-up|29|||
155647398|NCT04576949|561801582|FG001|Overall Study|Lost to Follow-up|37|||
155647399|NCT04576949|561801583|FG002|Overall Study|Lost to Follow-up|24|||
155647400|NCT04576949|561801581|FG000|Overall Study|Other, Not Specified|2|||
155647401|NCT04576949|561801582|FG001|Overall Study|Other, Not Specified|3|||
155647402|NCT04576949|561801583|FG002|Overall Study|Other, Not Specified|1|||
155647403|NCT04576949|561801581|FG000|Overall Study|Other|1|||
155647404|NCT04576949|561801582|FG001|Overall Study|Other|0|||
155647405|NCT04576949|561801583|FG002|Overall Study|Other|0|||
155647406|NCT00052715|561801587|FG000|Overall Study|wrong histology|1|||
155647407|NCT01936974|561801588|FG000|Overall Study|Physician Decision|2|||
155647408|NCT01936974|561801589|FG001|Overall Study|Physician Decision|5|||
155647409|NCT00063999|561801592|FG000|Overall Study|Withdrawal by Subject|1|||
155647410|NCT00063999|561801593|FG001|Overall Study|Withdrawal by Subject|0|||
155647411|NCT00063999|561801592|FG000|Overall Study|Ineligible|44|||
155647412|NCT00063999|561801593|FG001|Overall Study|Ineligible|24|||
155647413|NCT01078545|561801597|FG000|Overall Study|Lost to Follow-up|13|||
155647414|NCT01078545|561801597|FG000|Overall Study|Physician Decision|6|||
155647415|NCT01078545|561801597|FG000|Overall Study|Withdrawal by Subject|3|||
155647416|NCT01078545|561801597|FG000|Overall Study|Death|3|||
155647417|NCT01078545|561801597|FG000|Overall Study|Participant moved to another physician|1|||
155647418|NCT02497755|561801598|FG000|Overall Study|Protocol Violation|1|||
155647419|NCT02497755|561801599|FG001|Overall Study|Protocol Violation|0|||
155647420|NCT01774370|561801602|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
155647421|NCT01774370|561801602|FG000|Overall Study|Administered prior to the contract date|4|||
155647422|NCT01774370|561801602|FG000|Overall Study|Subjects of contraindications|34|||
155647423|NCT01774370|561801602|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
155647424|NCT01774370|561801602|FG000|Overall Study|Follow-up failure|34|||
155647425|NCT00514917|561801605|FG000|Overall Study|Death|4|||
155647426|NCT00514917|561801606|FG001|Overall Study|Death|10|||
155647427|NCT00514917|561801605|FG000|Overall Study|Protocol Violation|1|||
155647428|NCT00514917|561801606|FG001|Overall Study|Protocol Violation|0|||
155647429|NCT00514917|561801605|FG000|Overall Study|Lost to Follow-up|4|||
155647430|NCT00514917|561801606|FG001|Overall Study|Lost to Follow-up|3|||
155647431|NCT00514917|561801605|FG000|Overall Study|Withdrawal by Subject|18|||
155647432|NCT00514917|561801606|FG001|Overall Study|Withdrawal by Subject|16|||
155647433|NCT00514917|561801605|FG000|Overall Study|Discontinued due to study closure|88|||
155647434|NCT00514917|561801606|FG001|Overall Study|Discontinued due to study closure|81|||
155647435|NCT00514917|561801605|FG000|Overall Study|Undefined|11|||
155647436|NCT00514917|561801606|FG001|Overall Study|Undefined|5|||
155647437|NCT04243837|561801610|FG000|Overall Study|Adverse Event|2|||
155647438|NCT04243837|561801611|FG001|Overall Study|Adverse Event|1|||
155647439|NCT04243837|561801610|FG000|Overall Study|Withdrawal by Subject|4|||
155647440|NCT04243837|561801611|FG001|Overall Study|Withdrawal by Subject|2|||
155647441|NCT04243837|561801610|FG000|Overall Study|Covid-19 lock down|1|||
155647442|NCT04243837|561801611|FG001|Overall Study|Covid-19 lock down|0|||
155647443|NCT04243837|561801610|FG000|Overall Study|Study Terminated by Sponsor|11|||
155647444|NCT04243837|561801611|FG001|Overall Study|Study Terminated by Sponsor|12|||
155647445|NCT03501277|561801615|FG000|Intervention Period 1 (4 Days)|Other|0|||
155647446|NCT03501277|561801616|FG001|Intervention Period 1 (4 Days)|Other|0|||
155647447|NCT03501277|561801617|FG002|Intervention Period 1 (4 Days)|Other|1|||
155647448|NCT03501277|561801618|FG003|Intervention Period 1 (4 Days)|Other|0|||
155647449|NCT03501277|561801615|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
155647450|NCT03501277|561801616|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
155647451|NCT03501277|561801617|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
155647452|NCT03501277|561801618|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
155342592|NCT00636168|560687078|FG001|Treated With Study Drug|Death|0|||
155647453|NCT03501277|561801615|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
155647454|NCT03501277|561801616|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
155342593|NCT00636168|560687077|FG000|Treated With Study Drug|Pregnancy|1|||
155647455|NCT03501277|561801617|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
155647456|NCT03501277|561801618|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
155647457|NCT03501277|561801615|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
155647458|NCT03501277|561801616|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
155647459|NCT03501277|561801617|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
155342594|NCT00636168|560687078|FG001|Treated With Study Drug|Pregnancy|0|||
155647460|NCT03501277|561801618|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
155647461|NCT01873833|561801623|FG000|Overall Study|Withdrawal by Subject|1|||
155423869|NCT00862251|560980530|FG002|Overall Study|Adverse Event|1|||
155423870|NCT00862251|560980528|FG000|Overall Study|Lost to Follow-up|0|||
155423871|NCT00862251|560980529|FG001|Overall Study|Lost to Follow-up|0|||
155423872|NCT00862251|560980530|FG002|Overall Study|Lost to Follow-up|1|||
155423873|NCT00862251|560980528|FG000|Overall Study|Protocol Violation|2|||
155423874|NCT00862251|560980529|FG001|Overall Study|Protocol Violation|0|||
155423875|NCT00862251|560980530|FG002|Overall Study|Protocol Violation|1|||
155423876|NCT00862251|560980528|FG000|Overall Study|Withdrawal by Subject|9|||
155423877|NCT00862251|560980529|FG001|Overall Study|Withdrawal by Subject|2|||
155423878|NCT00862251|560980530|FG002|Overall Study|Withdrawal by Subject|6|||
155423879|NCT02796755|560980531|FG000|Overall Study|Adverse Event|2|||
155423880|NCT02796755|560980532|FG001|Overall Study|Adverse Event|0|||
155423881|NCT02304926|560980534|FG000|Overall Study|Lost to Follow-up|2|||
155423882|NCT02304926|560980535|FG001|Overall Study|Lost to Follow-up|1|||
155647462|NCT04193527|561801629|FG000|Overall Study|Other|1|||
155647463|NCT04193527|561801630|FG001|Overall Study|Other|1|||
155647464|NCT04193527|561801631|FG002|Overall Study|Other|0|||
155647465|NCT03808909|561801632|FG000|Overall Study|Lost to Follow-up|3|||
155647466|NCT03808909|561801633|FG001|Overall Study|Lost to Follow-up|0|||
155647467|NCT01487161|561801636|FG000|Overall Study|Adverse Event|1|||
155647468|NCT01487161|561801637|FG001|Overall Study|Adverse Event|0|||
155647469|NCT01487161|561801638|FG002|Overall Study|Adverse Event|0|||
155647470|NCT01487161|561801639|FG003|Overall Study|Adverse Event|0|||
155647471|NCT01487161|561801636|FG000|Overall Study|Withdrawal by Subject|1|||
155647472|NCT01487161|561801637|FG001|Overall Study|Withdrawal by Subject|1|||
155647473|NCT01487161|561801638|FG002|Overall Study|Withdrawal by Subject|1|||
155647474|NCT01487161|561801639|FG003|Overall Study|Withdrawal by Subject|2|||
155647475|NCT01487161|561801636|FG000|Overall Study|missing data|0|||
155647476|NCT01487161|561801637|FG001|Overall Study|missing data|1|||
155647477|NCT01487161|561801638|FG002|Overall Study|missing data|0|||
155647478|NCT01487161|561801639|FG003|Overall Study|missing data|0|||
155647479|NCT03113136|561801640|FG000|Overall Study|Lost to Follow-up|22|||
155647480|NCT03113136|561801641|FG001|Overall Study|Lost to Follow-up|47|||
155647481|NCT03113136|561801642|FG002|Overall Study|Lost to Follow-up|54|||
155647482|NCT03113136|561801640|FG000|Overall Study|Withdrawal by Subject|4|||
155647483|NCT03113136|561801641|FG001|Overall Study|Withdrawal by Subject|13|||
155647484|NCT03113136|561801642|FG002|Overall Study|Withdrawal by Subject|14|||
155647485|NCT03113136|561801640|FG000|Overall Study|Ineligible|0|||
155423883|NCT04258579|560980536|FG000|Overall Study|Withdrawal by Subject|7|||
155423884|NCT04258579|560980536|FG000|Overall Study|Lost to Follow-up|3|||
155423885|NCT04258579|560980536|FG000|Overall Study|Protocol Violation|2|||
155647486|NCT03113136|561801641|FG001|Overall Study|Ineligible|2|||
155647487|NCT03113136|561801642|FG002|Overall Study|Ineligible|1|||
155647488|NCT03113136|561801640|FG000|Overall Study|Study Team Decision|1|||
155647489|NCT03113136|561801641|FG001|Overall Study|Study Team Decision|4|||
155647490|NCT03113136|561801642|FG002|Overall Study|Study Team Decision|0|||
155647491|NCT00977561|561801644|FG000|Overall Study|Death|3|||
155647492|NCT00977561|561801645|FG001|Overall Study|Death|2|||
155647493|NCT00977561|561801644|FG000|Overall Study|Study terminated|0|||
155647494|NCT00977561|561801645|FG001|Overall Study|Study terminated|2|||
155647495|NCT00977561|561801644|FG000|Overall Study|Other|2|||
155647496|NCT00977561|561801645|FG001|Overall Study|Other|0|||
155647497|NCT02187055|561801646|FG000|Overall Study|Lack of Efficacy|10|||
155647498|NCT02187055|561801647|FG001|Overall Study|Lack of Efficacy|3|||
155647499|NCT02187055|561801648|FG002|Overall Study|Lack of Efficacy|7|||
155647500|NCT02187055|561801646|FG000|Overall Study|Lost to Follow-up|2|||
155647501|NCT02187055|561801647|FG001|Overall Study|Lost to Follow-up|7|||
155647502|NCT02187055|561801648|FG002|Overall Study|Lost to Follow-up|3|||
155647503|NCT02187055|561801646|FG000|Overall Study|No longer meets eligibility criteria|0|||
155647504|NCT02187055|561801647|FG001|Overall Study|No longer meets eligibility criteria|2|||
155647505|NCT02187055|561801648|FG002|Overall Study|No longer meets eligibility criteria|0|||
155647506|NCT02187055|561801646|FG000|Overall Study|No longer willing to participate|6|||
155647507|NCT02187055|561801647|FG001|Overall Study|No longer willing to participate|8|||
155647508|NCT02187055|561801648|FG002|Overall Study|No longer willing to participate|10|||
155647509|NCT02187055|561801646|FG000|Overall Study|Other|5|||
155647510|NCT02187055|561801647|FG001|Overall Study|Other|6|||
155647511|NCT02187055|561801648|FG002|Overall Study|Other|3|||
155647512|NCT02187055|561801646|FG000|Overall Study|Protocol Violation|9|||
155647513|NCT02187055|561801647|FG001|Overall Study|Protocol Violation|9|||
155647514|NCT02187055|561801648|FG002|Overall Study|Protocol Violation|4|||
155647515|NCT02187055|561801646|FG000|Overall Study|Pregnancy|3|||
155647516|NCT02187055|561801647|FG001|Overall Study|Pregnancy|1|||
155647517|NCT02187055|561801648|FG002|Overall Study|Pregnancy|0|||
155647518|NCT02187055|561801646|FG000|Overall Study|Withdrawal by Subject|11|||
155647519|NCT02187055|561801647|FG001|Overall Study|Withdrawal by Subject|11|||
155647520|NCT02187055|561801648|FG002|Overall Study|Withdrawal by Subject|11|||
155647521|NCT02187055|561801646|FG000|Overall Study|Adverse Event|21|||
155647522|NCT02187055|561801647|FG001|Overall Study|Adverse Event|26|||
155647523|NCT02187055|561801648|FG002|Overall Study|Adverse Event|36|||
155647524|NCT02187055|561801646|FG000|Overall Study|Death|2|||
155647525|NCT02187055|561801647|FG001|Overall Study|Death|0|||
155647526|NCT02187055|561801648|FG002|Overall Study|Death|0|||
155647527|NCT01751685|561801651|FG000|6-mo Followup|Missed study visit|1|||
155647528|NCT01751685|561801652|FG001|6-mo Followup|Missed study visit|0|||
155647529|NCT01751685|561801651|FG000|6-mo Followup|Withdrawal by Subject|2|||
155647530|NCT01751685|561801652|FG001|6-mo Followup|Withdrawal by Subject|2|||
155647531|NCT01751685|561801651|FG000|6-mo Followup|Lost to Follow-up|0|||
155647532|NCT01751685|561801652|FG001|6-mo Followup|Lost to Follow-up|1|||
155647533|NCT01751685|561801651|FG000|12-mo Followup|Lost to Follow-up|5|||
155647534|NCT01751685|561801652|FG001|12-mo Followup|Lost to Follow-up|0|||
155647535|NCT01107457|561801653|FG000|Part A|Adverse Event|1|||
155647536|NCT01107457|561801654|FG001|Part A|Adverse Event|2|||
155647537|NCT01107457|561801655|FG002|Part A|Adverse Event|1|||
155647538|NCT01107457|561801656|FG003|Part A|Adverse Event|0|||
155647539|NCT01107457|561801657|FG004|Part A|Adverse Event|0|||
155647540|NCT01107457|561801658|FG005|Part A|Adverse Event|0|||
155647541|NCT01107457|561801653|FG000|Part A|Withdrawal by Subject|3|||
155647542|NCT01107457|561801654|FG001|Part A|Withdrawal by Subject|3|||
155647543|NCT01107457|561801655|FG002|Part A|Withdrawal by Subject|0|||
155647544|NCT01107457|561801656|FG003|Part A|Withdrawal by Subject|3|||
155647545|NCT01107457|561801657|FG004|Part A|Withdrawal by Subject|1|||
155647546|NCT01107457|561801658|FG005|Part A|Withdrawal by Subject|0|||
155647547|NCT01107457|561801653|FG000|Part A|Lost to Follow-up|0|||
155647548|NCT01107457|561801654|FG001|Part A|Lost to Follow-up|1|||
155647549|NCT01107457|561801655|FG002|Part A|Lost to Follow-up|0|||
155647550|NCT01107457|561801656|FG003|Part A|Lost to Follow-up|0|||
155342595|NCT00636168|560687077|FG000|Treated With Study Drug|No longer meets study criteria|1|||
155342596|NCT00636168|560687078|FG001|Treated With Study Drug|No longer meets study criteria|0|||
155342597|NCT00636168|560687077|FG000|Treated With Study Drug|Other reason|1|||
155342598|NCT00636168|560687078|FG001|Treated With Study Drug|Other reason|3|||
155342599|NCT00636168|560687077|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
155342600|NCT00636168|560687078|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
155342601|NCT00636168|560687077|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
155342602|NCT00636168|560687078|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
155423886|NCT04258579|560980536|FG000|Overall Study|Adverse Event|1|||
155423887|NCT04007159|560980537|FG000|Induction Phase|(missed study visits)|16|||
155423888|NCT04007159|560980537|FG000|Induction Phase|Withdrawal by Subject|4|||
155423889|NCT04007159|560980537|FG000|Induction Phase|Adverse Event|2|||
155423890|NCT04007159|560980537|FG000|Challenge Phase|missed study visits|3|||
155423891|NCT02076165|560980540|FG000|Overall Study|Lost to Follow-up|7|||
155423892|NCT02076165|560980541|FG001|Overall Study|Lost to Follow-up|5|||
155423893|NCT02076165|560980540|FG000|Overall Study|Refused follow-up assessment|1|||
155423894|NCT02076165|560980541|FG001|Overall Study|Refused follow-up assessment|1|||
155423895|NCT03804684|560980542|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
155423896|NCT03804684|560980543|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
155423897|NCT03183128|560980545|FG000|Overall Study|Adverse Event|1|||
155423898|NCT03183128|560980546|FG001|Overall Study|Adverse Event|2|||
155423899|NCT03183128|560980545|FG000|Overall Study|Withdrawal by Subject|1|||
155423900|NCT03183128|560980546|FG001|Overall Study|Withdrawal by Subject|8|||
155423901|NCT03183128|560980545|FG000|Overall Study|Protocol Violation|2|||
155423902|NCT03183128|560980546|FG001|Overall Study|Protocol Violation|0|||
155423903|NCT03183128|560980545|FG000|Overall Study|Lack of Efficacy|4|||
155423904|NCT03183128|560980546|FG001|Overall Study|Lack of Efficacy|27|||
155423905|NCT03183128|560980545|FG000|Overall Study|Lost to Follow-up|1|||
155423906|NCT03183128|560980546|FG001|Overall Study|Lost to Follow-up|0|||
155423907|NCT03183128|560980545|FG000|Overall Study|Death|2|||
155423908|NCT03183128|560980546|FG001|Overall Study|Death|0|||
155423909|NCT03183128|560980545|FG000|Overall Study|Physician Decision|1|||
155423910|NCT03183128|560980546|FG001|Overall Study|Physician Decision|0|||
155423911|NCT02266433|560980548|FG000|Overall Study|Lost to Follow-up|54|||
155423912|NCT02266433|560980549|FG001|Overall Study|Lost to Follow-up|46|||
155423913|NCT02266433|560980548|FG000|Overall Study|Withdrawal by Subject|5|||
155423914|NCT02266433|560980549|FG001|Overall Study|Withdrawal by Subject|7|||
155423915|NCT02658812|560980550|FG000|Overall Study|Disease Progression|7|||
155423916|NCT02658812|560980550|FG000|Overall Study|Unrelated to study treatment|1|||
155423917|NCT02658812|560980550|FG000|Overall Study|Adverse Event|1|||
155423918|NCT01512264|560980553|FG000|Overall Study|Lost to Follow-up|0|||
155423919|NCT01512264|560980554|FG001|Overall Study|Lost to Follow-up|0|||
155423920|NCT01512264|560980555|FG002|Overall Study|Lost to Follow-up|0|||
155423921|NCT01512264|560980556|FG003|Overall Study|Lost to Follow-up|1|||
155423922|NCT01194440|560980557|FG000|Baseline (First Dose)|Reason not specified|4|||
155423923|NCT01194440|560980557|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
155423924|NCT01194440|560980557|FG000|Baseline (First Dose)|Change in therapy|1|||
155423925|NCT01194440|560980557|FG000|Baseline (First Dose)|Adverse Event|1|||
155423926|NCT01194440|560980557|FG000|6-months (2nd Dose)|Change in therapy|4|||
155423927|NCT01931059|560980558|FG000|Day 1|Pregnancy|0|||
155342603|NCT00636168|560687077|FG000|Long Term Follow-Up|Death|8|||
155342604|NCT00636168|560687078|FG001|Long Term Follow-Up|Death|9|||
155342605|NCT03541369|560687081|FG000|Overall Study|Death|0|||
155342606|NCT03541369|560687082|FG001|Overall Study|Death|0|||
155342607|NCT03541369|560687083|FG002|Overall Study|Death|0|||
155342608|NCT03541369|560687084|FG003|Overall Study|Death|0|||
155342609|NCT03541369|560687085|FG004|Overall Study|Death|1|||
155342610|NCT03541369|560687086|FG005|Overall Study|Death|1|||
155342611|NCT03541369|560687087|FG006|Overall Study|Death|0|||
155342612|NCT03541369|560687088|FG007|Overall Study|Death|2|||
155342613|NCT03541369|560687089|FG008|Overall Study|Death|1|||
155342614|NCT03541369|560687090|FG009|Overall Study|Death|2|||
155342615|NCT03541369|560687091|FG010|Overall Study|Death|1|||
155342616|NCT03541369|560687092|FG011|Overall Study|Death|0|||
155423928|NCT01931059|560980559|FG001|Day 1|Pregnancy|1|||
155423929|NCT01931059|560980558|FG000|Day3|Lost to Follow-up|1|||
155423930|NCT01931059|560980559|FG001|Day3|Lost to Follow-up|0|||
155423931|NCT02675075|560980569|FG000|Overall Study|Lost to Follow-up|3|||
155647551|NCT01107457|561801657|FG004|Part A|Lost to Follow-up|0|||
155647552|NCT01107457|561801658|FG005|Part A|Lost to Follow-up|0|||
155647553|NCT01107457|561801653|FG000|Part A|Lack of Efficacy|1|||
155647554|NCT01107457|561801654|FG001|Part A|Lack of Efficacy|0|||
155647555|NCT01107457|561801655|FG002|Part A|Lack of Efficacy|0|||
155647556|NCT01107457|561801656|FG003|Part A|Lack of Efficacy|0|||
155647557|NCT01107457|561801657|FG004|Part A|Lack of Efficacy|0|||
155647558|NCT01107457|561801658|FG005|Part A|Lack of Efficacy|0|||
155647559|NCT01107457|561801653|FG000|Part A|Protocol Violation|0|||
155647560|NCT01107457|561801654|FG001|Part A|Protocol Violation|1|||
155647561|NCT01107457|561801655|FG002|Part A|Protocol Violation|0|||
155647562|NCT01107457|561801656|FG003|Part A|Protocol Violation|0|||
155647563|NCT01107457|561801657|FG004|Part A|Protocol Violation|0|||
155647564|NCT01107457|561801658|FG005|Part A|Protocol Violation|0|||
155647565|NCT01107457|561801653|FG000|Part B and C|Adverse Event|0|||
155647566|NCT01107457|561801654|FG001|Part B and C|Adverse Event|0|||
155647567|NCT01107457|561801655|FG002|Part B and C|Adverse Event|0|||
155647568|NCT01107457|561801656|FG003|Part B and C|Adverse Event|0|||
155423932|NCT02675075|560980570|FG001|Overall Study|Lost to Follow-up|0|||
155423933|NCT03686969|560980571|FG000|Overall Study|Study terminated|1|||
155423934|NCT03686969|560980572|FG001|Overall Study|Study terminated|0|||
155423935|NCT01988090|560980577|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
155647569|NCT01107457|561801657|FG004|Part B and C|Adverse Event|0|||
155647570|NCT01107457|561801658|FG005|Part B and C|Adverse Event|12|||
155647571|NCT01107457|561801653|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155647572|NCT01107457|561801654|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155647573|NCT01107457|561801655|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155647574|NCT01107457|561801656|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155647575|NCT01107457|561801657|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155647576|NCT01107457|561801658|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
155342617|NCT03541369|560687093|FG012|Overall Study|Death|2|||
155342618|NCT03541369|560687094|FG013|Overall Study|Death|1|||
155342619|NCT03541369|560687095|FG014|Overall Study|Death|1|||
155342620|NCT03541369|560687096|FG015|Overall Study|Death|1|||
155342621|NCT03541369|560687097|FG016|Overall Study|Death|0|||
155342622|NCT03541369|560687098|FG017|Overall Study|Death|1|||
155342623|NCT03541369|560687081|FG000|Overall Study|Decision by sponsor|0|||
155342624|NCT03541369|560687082|FG001|Overall Study|Decision by sponsor|0|||
155342625|NCT03541369|560687083|FG002|Overall Study|Decision by sponsor|0|||
155342626|NCT03541369|560687084|FG003|Overall Study|Decision by sponsor|1|||
155342627|NCT03541369|560687085|FG004|Overall Study|Decision by sponsor|0|||
155342628|NCT03541369|560687086|FG005|Overall Study|Decision by sponsor|2|||
155647577|NCT01107457|561801653|FG000|Part B and C|Physician Decision|0|||
155647578|NCT01107457|561801654|FG001|Part B and C|Physician Decision|0|||
155647579|NCT01107457|561801655|FG002|Part B and C|Physician Decision|0|||
155647580|NCT01107457|561801656|FG003|Part B and C|Physician Decision|0|||
155647581|NCT01107457|561801657|FG004|Part B and C|Physician Decision|0|||
155647582|NCT01107457|561801658|FG005|Part B and C|Physician Decision|3|||
155647583|NCT01107457|561801653|FG000|Part B and C|Lack of Efficacy|0|||
155647584|NCT01107457|561801654|FG001|Part B and C|Lack of Efficacy|0|||
155647585|NCT01107457|561801655|FG002|Part B and C|Lack of Efficacy|0|||
155647586|NCT01107457|561801656|FG003|Part B and C|Lack of Efficacy|0|||
155647587|NCT01107457|561801657|FG004|Part B and C|Lack of Efficacy|0|||
155647588|NCT01107457|561801658|FG005|Part B and C|Lack of Efficacy|7|||
155647589|NCT01107457|561801653|FG000|Part B and C|Lost to Follow-up|0|||
155647590|NCT01107457|561801654|FG001|Part B and C|Lost to Follow-up|0|||
155647591|NCT01107457|561801655|FG002|Part B and C|Lost to Follow-up|0|||
155647592|NCT01107457|561801656|FG003|Part B and C|Lost to Follow-up|0|||
155647593|NCT01107457|561801657|FG004|Part B and C|Lost to Follow-up|0|||
155647594|NCT01107457|561801658|FG005|Part B and C|Lost to Follow-up|10|||
155647595|NCT01107457|561801653|FG000|Part B and C|Protocol Violation|0|||
155647596|NCT01107457|561801654|FG001|Part B and C|Protocol Violation|0|||
155647597|NCT01107457|561801655|FG002|Part B and C|Protocol Violation|0|||
155647598|NCT01107457|561801656|FG003|Part B and C|Protocol Violation|0|||
155647599|NCT01107457|561801657|FG004|Part B and C|Protocol Violation|0|||
155647600|NCT01107457|561801658|FG005|Part B and C|Protocol Violation|1|||
155342629|NCT03541369|560687087|FG006|Overall Study|Decision by sponsor|0|||
155342630|NCT03541369|560687088|FG007|Overall Study|Decision by sponsor|1|||
155342631|NCT03541369|560687089|FG008|Overall Study|Decision by sponsor|2|||
155342632|NCT03541369|560687090|FG009|Overall Study|Decision by sponsor|0|||
155342633|NCT03541369|560687091|FG010|Overall Study|Decision by sponsor|0|||
155342634|NCT03541369|560687092|FG011|Overall Study|Decision by sponsor|0|||
155342635|NCT03541369|560687093|FG012|Overall Study|Decision by sponsor|2|||
155342636|NCT03541369|560687094|FG013|Overall Study|Decision by sponsor|2|||
155342637|NCT03541369|560687095|FG014|Overall Study|Decision by sponsor|0|||
155342638|NCT03541369|560687096|FG015|Overall Study|Decision by sponsor|1|||
155342639|NCT03541369|560687097|FG016|Overall Study|Decision by sponsor|1|||
155342640|NCT03541369|560687098|FG017|Overall Study|Decision by sponsor|1|||
155342641|NCT03541369|560687081|FG000|Overall Study|Withdrawal by Subject|0|||
155342642|NCT03541369|560687082|FG001|Overall Study|Withdrawal by Subject|0|||
155342643|NCT03541369|560687083|FG002|Overall Study|Withdrawal by Subject|0|||
155342644|NCT03541369|560687084|FG003|Overall Study|Withdrawal by Subject|0|||
155342645|NCT03541369|560687085|FG004|Overall Study|Withdrawal by Subject|0|||
155342646|NCT03541369|560687086|FG005|Overall Study|Withdrawal by Subject|0|||
155342647|NCT03541369|560687087|FG006|Overall Study|Withdrawal by Subject|1|||
155342648|NCT03541369|560687088|FG007|Overall Study|Withdrawal by Subject|0|||
155342649|NCT03541369|560687089|FG008|Overall Study|Withdrawal by Subject|0|||
155342650|NCT03541369|560687090|FG009|Overall Study|Withdrawal by Subject|0|||
155342651|NCT03541369|560687091|FG010|Overall Study|Withdrawal by Subject|0|||
155342652|NCT03541369|560687092|FG011|Overall Study|Withdrawal by Subject|1|||
155342653|NCT03541369|560687093|FG012|Overall Study|Withdrawal by Subject|0|||
155342654|NCT03541369|560687094|FG013|Overall Study|Withdrawal by Subject|0|||
155342655|NCT03541369|560687095|FG014|Overall Study|Withdrawal by Subject|3|||
155342656|NCT03541369|560687096|FG015|Overall Study|Withdrawal by Subject|0|||
155342657|NCT03541369|560687097|FG016|Overall Study|Withdrawal by Subject|4|||
155342658|NCT03541369|560687098|FG017|Overall Study|Withdrawal by Subject|2|||
155342659|NCT03541369|560687081|FG000|Overall Study|Lost to Follow-up|0|||
155342660|NCT03541369|560687082|FG001|Overall Study|Lost to Follow-up|0|||
155342661|NCT03541369|560687083|FG002|Overall Study|Lost to Follow-up|0|||
155342662|NCT03541369|560687084|FG003|Overall Study|Lost to Follow-up|0|||
155342663|NCT03541369|560687085|FG004|Overall Study|Lost to Follow-up|1|||
155342664|NCT03541369|560687086|FG005|Overall Study|Lost to Follow-up|0|||
155342665|NCT03541369|560687087|FG006|Overall Study|Lost to Follow-up|0|||
155342666|NCT03541369|560687088|FG007|Overall Study|Lost to Follow-up|0|||
155342667|NCT03541369|560687089|FG008|Overall Study|Lost to Follow-up|1|||
155342668|NCT03541369|560687090|FG009|Overall Study|Lost to Follow-up|0|||
155342669|NCT03541369|560687091|FG010|Overall Study|Lost to Follow-up|0|||
155342670|NCT03541369|560687092|FG011|Overall Study|Lost to Follow-up|0|||
155342671|NCT03541369|560687093|FG012|Overall Study|Lost to Follow-up|1|||
155342672|NCT03541369|560687094|FG013|Overall Study|Lost to Follow-up|0|||
155342673|NCT03541369|560687095|FG014|Overall Study|Lost to Follow-up|0|||
155342674|NCT03541369|560687096|FG015|Overall Study|Lost to Follow-up|0|||
155342675|NCT03541369|560687097|FG016|Overall Study|Lost to Follow-up|0|||
155342676|NCT03541369|560687098|FG017|Overall Study|Lost to Follow-up|0|||
155342677|NCT01856569|560687099|FG000|Overall Study|Other|1|||
155342678|NCT01856569|560687099|FG000|Overall Study|Changed Site/Structure|1|||
155342679|NCT01856569|560687099|FG000|Overall Study|Lost to Follow-up|3|||
155342680|NCT01856569|560687099|FG000|Overall Study|Did not met inclusion criteria|8|||
155342681|NCT02707952|560687100|FG000|Overall Study|Adverse Event|1|||
155342682|NCT02707952|560687101|FG001|Overall Study|Adverse Event|0|||
155647601|NCT01107457|561801653|FG000|Part B and C|Sponsor Decision|0|||
155647602|NCT01107457|561801654|FG001|Part B and C|Sponsor Decision|0|||
155647603|NCT01107457|561801655|FG002|Part B and C|Sponsor Decision|0|||
155647604|NCT01107457|561801656|FG003|Part B and C|Sponsor Decision|0|||
155647605|NCT01107457|561801657|FG004|Part B and C|Sponsor Decision|0|||
155647606|NCT01107457|561801658|FG005|Part B and C|Sponsor Decision|66|||
155647607|NCT01107457|561801653|FG000|Part B and C|Withdrawal by Subject|0|||
155647608|NCT01107457|561801654|FG001|Part B and C|Withdrawal by Subject|0|||
155647609|NCT01107457|561801655|FG002|Part B and C|Withdrawal by Subject|0|||
155647610|NCT01107457|561801656|FG003|Part B and C|Withdrawal by Subject|0|||
155647611|NCT01107457|561801657|FG004|Part B and C|Withdrawal by Subject|0|||
155647612|NCT01107457|561801658|FG005|Part B and C|Withdrawal by Subject|16|||
155647613|NCT01107457|561801653|FG000|Part B and C|Clinical Relapse|0|||
155647614|NCT01107457|561801654|FG001|Part B and C|Clinical Relapse|0|||
155647615|NCT01107457|561801655|FG002|Part B and C|Clinical Relapse|0|||
155647616|NCT01107457|561801656|FG003|Part B and C|Clinical Relapse|0|||
155647617|NCT01107457|561801657|FG004|Part B and C|Clinical Relapse|0|||
155647618|NCT01107457|561801658|FG005|Part B and C|Clinical Relapse|4|||
155647619|NCT00694161|561801659|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
155647620|NCT00694161|561801659|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
155647621|NCT00694161|561801659|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
155647622|NCT03601052|561801660|FG000|Overall Study|Lost to Follow-up|2|||
155647623|NCT01179399|561801661|FG000|Overall Study|Adverse Event|1|||
155647624|NCT01179399|561801661|FG000|Overall Study|Lack of Efficacy|30|||
155647625|NCT01179399|561801661|FG000|Overall Study|Withdrawal by Subject|1|||
155647626|NCT03572218|561801662|FG000|Overall Study|Lost to Follow-up|3|||
155647627|NCT03572218|561801663|FG001|Overall Study|Lost to Follow-up|2|||
155647628|NCT03572218|561801662|FG000|Overall Study|No longer available for study visits|2|||
155647629|NCT03572218|561801663|FG001|Overall Study|No longer available for study visits|1|||
155647630|NCT03572218|561801662|FG000|Overall Study|No longer interested|1|||
155647631|NCT03572218|561801663|FG001|Overall Study|No longer interested|2|||
155647632|NCT00520572|561803631|FG000|Overall Study|Adverse Event|9|||
155647633|NCT00520572|561803632|FG001|Overall Study|Adverse Event|3|||
155647634|NCT00520572|561803633|FG002|Overall Study|Adverse Event|6|||
155647635|NCT00520572|561803634|FG003|Overall Study|Adverse Event|9|||
155647636|NCT00520572|561803635|FG004|Overall Study|Adverse Event|7|||
155647637|NCT00520572|561803636|FG005|Overall Study|Adverse Event|2|||
155647638|NCT00520572|561803631|FG000|Overall Study|Withdrawal by Subject|0|||
155647639|NCT00520572|561803632|FG001|Overall Study|Withdrawal by Subject|9|||
155647640|NCT00520572|561803633|FG002|Overall Study|Withdrawal by Subject|5|||
155647641|NCT00520572|561803634|FG003|Overall Study|Withdrawal by Subject|2|||
155647642|NCT00520572|561803635|FG004|Overall Study|Withdrawal by Subject|2|||
155647643|NCT00520572|561803636|FG005|Overall Study|Withdrawal by Subject|0|||
155647644|NCT00520572|561803631|FG000|Overall Study|Protocol Violation|0|||
155647645|NCT00520572|561803632|FG001|Overall Study|Protocol Violation|0|||
155647646|NCT00520572|561803633|FG002|Overall Study|Protocol Violation|1|||
155647647|NCT00520572|561803634|FG003|Overall Study|Protocol Violation|0|||
155647648|NCT00520572|561803635|FG004|Overall Study|Protocol Violation|0|||
155647649|NCT00520572|561803636|FG005|Overall Study|Protocol Violation|0|||
155647650|NCT00520572|561803631|FG000|Overall Study|Lack of Efficacy|1|||
155647651|NCT00520572|561803632|FG001|Overall Study|Lack of Efficacy|1|||
155647652|NCT00520572|561803633|FG002|Overall Study|Lack of Efficacy|1|||
155647653|NCT00520572|561803634|FG003|Overall Study|Lack of Efficacy|2|||
155647654|NCT00520572|561803635|FG004|Overall Study|Lack of Efficacy|1|||
155647655|NCT00520572|561803636|FG005|Overall Study|Lack of Efficacy|0|||
155647656|NCT00520572|561803631|FG000|Overall Study|Lost to Follow-up|0|||
155647657|NCT00520572|561803632|FG001|Overall Study|Lost to Follow-up|0|||
155647658|NCT00520572|561803633|FG002|Overall Study|Lost to Follow-up|0|||
155647659|NCT00520572|561803634|FG003|Overall Study|Lost to Follow-up|0|||
155647660|NCT00520572|561803635|FG004|Overall Study|Lost to Follow-up|1|||
155647661|NCT00520572|561803636|FG005|Overall Study|Lost to Follow-up|0|||
155647662|NCT00520572|561803631|FG000|Overall Study|Incorrect enrollment|1|||
155647663|NCT00520572|561803632|FG001|Overall Study|Incorrect enrollment|0|||
155647664|NCT00520572|561803633|FG002|Overall Study|Incorrect enrollment|1|||
155647665|NCT00520572|561803634|FG003|Overall Study|Incorrect enrollment|0|||
155647666|NCT00520572|561803635|FG004|Overall Study|Incorrect enrollment|1|||
155647667|NCT00520572|561803636|FG005|Overall Study|Incorrect enrollment|0|||
155647668|NCT00520572|561803631|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
155647669|NCT00520572|561803632|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
155505357|NCT01625286|561276169|FG006|Overall Study|Withdrawal by Subject|1|||
155423936|NCT01988090|560980578|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
155423937|NCT01988090|560980577|FG000|Start Treament After Randomization|Protocol Violation|0|||
155423938|NCT01988090|560980578|FG001|Start Treament After Randomization|Protocol Violation|1|||
155423939|NCT01988090|560980577|FG000|Complete Study After Start|Withdrawal by Subject|2|||
155423940|NCT01988090|560980578|FG001|Complete Study After Start|Withdrawal by Subject|0|||
155423941|NCT01988090|560980577|FG000|Complete Study After Start|Protocol Violation|1|||
155423942|NCT01988090|560980578|FG001|Complete Study After Start|Protocol Violation|1|||
155423943|NCT03887130|560980581|FG000|Overall Study|Progressive disease|23|||
155423944|NCT03887130|560980582|FG001|Overall Study|Progressive disease|14|||
155423945|NCT03887130|560980583|FG002|Overall Study|Progressive disease|7|||
155423946|NCT03887130|560980581|FG000|Overall Study|Protocol Violation|3|||
155423947|NCT03887130|560980582|FG001|Overall Study|Protocol Violation|1|||
155423948|NCT03887130|560980583|FG002|Overall Study|Protocol Violation|2|||
155423949|NCT03887130|560980581|FG000|Overall Study|Drug related toxicity|7|||
155423950|NCT03887130|560980582|FG001|Overall Study|Drug related toxicity|7|||
155423951|NCT03887130|560980583|FG002|Overall Study|Drug related toxicity|13|||
155423952|NCT03887130|560980581|FG000|Overall Study|Non drug related toxicity|3|||
155423953|NCT03887130|560980582|FG001|Overall Study|Non drug related toxicity|0|||
155423954|NCT03887130|560980583|FG002|Overall Study|Non drug related toxicity|0|||
155423955|NCT03887130|560980581|FG000|Overall Study|Death|2|||
155423956|NCT03887130|560980582|FG001|Overall Study|Death|2|||
155423957|NCT03887130|560980583|FG002|Overall Study|Death|1|||
155423958|NCT03887130|560980581|FG000|Overall Study|Withdrawal by Subject|7|||
155423959|NCT03887130|560980582|FG001|Overall Study|Withdrawal by Subject|6|||
155423960|NCT03887130|560980583|FG002|Overall Study|Withdrawal by Subject|11|||
155423961|NCT03887130|560980581|FG000|Overall Study|other reason|6|||
155423962|NCT03887130|560980582|FG001|Overall Study|other reason|20|||
155423963|NCT03887130|560980583|FG002|Overall Study|other reason|17|||
155423964|NCT00927563|560980584|FG000|Overall Study|Lost to Follow-up|1|||
155423965|NCT00927563|560980584|FG000|Overall Study|Withdrawal by Subject|1|||
155423966|NCT02497001|560980587|FG000|Overall Study|Lost to Follow-up|10|||
155423967|NCT02497001|560980588|FG001|Overall Study|Lost to Follow-up|2|||
155423968|NCT02497001|560980589|FG002|Overall Study|Lost to Follow-up|0|||
155423969|NCT02497001|560980590|FG003|Overall Study|Lost to Follow-up|2|||
155423970|NCT02497001|560980587|FG000|Overall Study|Adverse Event|28|||
155423971|NCT02497001|560980588|FG001|Overall Study|Adverse Event|30|||
155423972|NCT02497001|560980589|FG002|Overall Study|Adverse Event|11|||
155423973|NCT02497001|560980590|FG003|Overall Study|Adverse Event|11|||
155423974|NCT02497001|560980587|FG000|Overall Study|Withdrawal by Subject|14|||
155423975|NCT02497001|560980588|FG001|Overall Study|Withdrawal by Subject|37|||
155505358|NCT01625286|561276163|FG000|Overall Study|Any reason not specifically recorded|0|||
155505359|NCT01625286|561276164|FG001|Overall Study|Any reason not specifically recorded|0|||
155423976|NCT02497001|560980589|FG002|Overall Study|Withdrawal by Subject|19|||
155423977|NCT02497001|560980590|FG003|Overall Study|Withdrawal by Subject|15|||
155423978|NCT02497001|560980587|FG000|Overall Study|Physician Decision|5|||
155423979|NCT02497001|560980588|FG001|Overall Study|Physician Decision|11|||
155423980|NCT02497001|560980589|FG002|Overall Study|Physician Decision|5|||
155423981|NCT02497001|560980590|FG003|Overall Study|Physician Decision|1|||
155423982|NCT02497001|560980587|FG000|Overall Study|subjects that were not treated|1|||
155423983|NCT02497001|560980588|FG001|Overall Study|subjects that were not treated|2|||
155423984|NCT02497001|560980589|FG002|Overall Study|subjects that were not treated|2|||
155423985|NCT02497001|560980590|FG003|Overall Study|subjects that were not treated|1|||
155423986|NCT02497001|560980587|FG000|Overall Study|Major Protocol Deviation|3|||
155423987|NCT02497001|560980588|FG001|Overall Study|Major Protocol Deviation|4|||
155423988|NCT02497001|560980589|FG002|Overall Study|Major Protocol Deviation|4|||
155423989|NCT02497001|560980590|FG003|Overall Study|Major Protocol Deviation|4|||
155423990|NCT02497001|560980587|FG000|Overall Study|Lack of Efficacy|10|||
155423991|NCT02497001|560980588|FG001|Overall Study|Lack of Efficacy|16|||
155423992|NCT02497001|560980589|FG002|Overall Study|Lack of Efficacy|6|||
155423993|NCT02497001|560980590|FG003|Overall Study|Lack of Efficacy|6|||
155423994|NCT02497001|560980587|FG000|Overall Study|Protocol Violation|3|||
155423995|NCT02497001|560980588|FG001|Overall Study|Protocol Violation|1|||
155505360|NCT01625286|561276165|FG002|Overall Study|Any reason not specifically recorded|0|||
155505361|NCT01625286|561276166|FG003|Overall Study|Any reason not specifically recorded|0|||
155505362|NCT01625286|561276167|FG004|Overall Study|Any reason not specifically recorded|0|||
155505363|NCT01625286|561276168|FG005|Overall Study|Any reason not specifically recorded|1|||
155505364|NCT01625286|561276169|FG006|Overall Study|Any reason not specifically recorded|0|||
155505365|NCT01625286|561276163|FG000|Overall Study|Progressive disease|6|||
155505366|NCT01625286|561276164|FG001|Overall Study|Progressive disease|3|||
155505367|NCT01625286|561276165|FG002|Overall Study|Progressive disease|4|||
155505368|NCT01625286|561276166|FG003|Overall Study|Progressive disease|5|||
155505369|NCT01625286|561276167|FG004|Overall Study|Progressive disease|5|||
155423996|NCT02497001|560980589|FG002|Overall Study|Protocol Violation|3|||
155505370|NCT01625286|561276168|FG005|Overall Study|Progressive disease|0|||
155423997|NCT02497001|560980590|FG003|Overall Study|Protocol Violation|1|||
155423998|NCT00654498|560980593|FG000|Overall Study|Not Treated|1|||
155423999|NCT00654498|560980594|FG001|Overall Study|Not Treated|0|||
155424000|NCT00654498|560980593|FG000|Overall Study|Adverse Event|6|||
155424001|NCT00654498|560980594|FG001|Overall Study|Adverse Event|1|||
155505371|NCT01625286|561276169|FG006|Overall Study|Progressive disease|0|||
155505372|NCT01625286|561276163|FG000|Overall Study|Lost to Follow-up|0|||
155505373|NCT01625286|561276164|FG001|Overall Study|Lost to Follow-up|0|||
155505374|NCT01625286|561276165|FG002|Overall Study|Lost to Follow-up|0|||
155505375|NCT01625286|561276166|FG003|Overall Study|Lost to Follow-up|0|||
155505376|NCT01625286|561276167|FG004|Overall Study|Lost to Follow-up|0|||
155505377|NCT01625286|561276168|FG005|Overall Study|Lost to Follow-up|0|||
155505378|NCT01625286|561276169|FG006|Overall Study|Lost to Follow-up|1|||
155505379|NCT00928135|561276170|FG000|Overall Study|Withdrawal by Subject|1|||
155505380|NCT00928135|561276171|FG001|Overall Study|Withdrawal by Subject|0|||
155505381|NCT01458119|561276172|FG000|Overall Study|Physician Decision|4|||
155505382|NCT01458119|561276172|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
155505383|NCT01458119|561276172|FG000|Overall Study|Pregnancy|1|||
155424002|NCT00654498|560980593|FG000|Overall Study|Protocol Violation|1|||
155424003|NCT00654498|560980594|FG001|Overall Study|Protocol Violation|1|||
155424004|NCT00654498|560980593|FG000|Overall Study|Lost to Follow-up|1|||
155505384|NCT01458119|561276172|FG000|Overall Study|Death|2|||
155505385|NCT01458119|561276172|FG000|Overall Study|Adverse Event|1|||
155505386|NCT01458119|561276172|FG000|Overall Study|Consent Withdrawn by Participant|8|||
155505387|NCT01458119|561276172|FG000|Overall Study|Non-compliance With Study Drug|3|||
155505388|NCT03033069|561276173|FG000|Overall Study|Adverse Event|6|||
155505389|NCT03033069|561276174|FG001|Overall Study|Adverse Event|7|||
155505390|NCT03033069|561276175|FG002|Overall Study|Adverse Event|4|||
155505391|NCT03033069|561276176|FG003|Overall Study|Adverse Event|6|||
155505392|NCT03033069|561276173|FG000|Overall Study|Lack of Efficacy|0|||
155424005|NCT00654498|560980594|FG001|Overall Study|Lost to Follow-up|5|||
155424006|NCT00654498|560980593|FG000|Overall Study|Withdrawal by Subject|1|||
155424007|NCT00654498|560980594|FG001|Overall Study|Withdrawal by Subject|0|||
155424008|NCT00654498|560980593|FG000|Overall Study|Other reason not defined above|4|||
155424009|NCT00654498|560980594|FG001|Overall Study|Other reason not defined above|5|||
155424010|NCT03430986|560980596|FG000|24-week Control Period|Adverse Event|1|||
155424011|NCT03430986|560980597|FG001|24-week Control Period|Adverse Event|0|||
155424012|NCT03430986|560980596|FG000|24-week Control Period|Lost to Follow-up|2|||
155424013|NCT03430986|560980597|FG001|24-week Control Period|Lost to Follow-up|2|||
155424014|NCT03430986|560980596|FG000|24-week Control Period|Withdrawal by Participant|5|||
155424015|NCT03430986|560980597|FG001|24-week Control Period|Withdrawal by Participant|0|||
155424016|NCT03430986|560980596|FG000|24-week Control Period|Protocol Deviation|0|||
155424017|NCT03430986|560980597|FG001|24-week Control Period|Protocol Deviation|2|||
155424018|NCT03430986|560980596|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
155424019|NCT03430986|560980597|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
155424020|NCT03430986|560980596|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
155424021|NCT03430986|560980597|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
155424022|NCT01412957|560980599|FG000|Overall Study|Withdrawal by Subject|6|||
155424023|NCT01412957|560980600|FG001|Overall Study|Withdrawal by Subject|22|||
155424024|NCT01412957|560980599|FG000|Overall Study|Lost to Follow-up|7|||
155424025|NCT01412957|560980600|FG001|Overall Study|Lost to Follow-up|2|||
155424026|NCT01412957|560980599|FG000|Overall Study|Death|136|||
155424027|NCT01412957|560980600|FG001|Overall Study|Death|133|||
155424028|NCT01245673|560980601|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
155424029|NCT04722991|560980610|FG000|Overall Study|Adverse Event|12|||
155424030|NCT04722991|560980611|FG001|Overall Study|Adverse Event|4|||
155424031|NCT04722991|560980610|FG000|Overall Study|Death|2|||
155424032|NCT04722991|560980611|FG001|Overall Study|Death|0|||
155424033|NCT04722991|560980610|FG000|Overall Study|Lost to Follow-up|1|||
155424034|NCT04722991|560980611|FG001|Overall Study|Lost to Follow-up|1|||
155424035|NCT04722991|560980610|FG000|Overall Study|Withdrawal cirterion met|2|||
155424036|NCT04722991|560980611|FG001|Overall Study|Withdrawal cirterion met|2|||
155424037|NCT04722991|560980610|FG000|Overall Study|Other|1|||
155424038|NCT04722991|560980611|FG001|Overall Study|Other|0|||
155424039|NCT04722991|560980610|FG000|Overall Study|Non-compliance|0|||
155424040|NCT04722991|560980611|FG001|Overall Study|Non-compliance|1|||
155424041|NCT04722991|560980610|FG000|Overall Study|Withdrawal by Subject|0|||
155424042|NCT04722991|560980611|FG001|Overall Study|Withdrawal by Subject|1|||
155424043|NCT01445678|560980615|FG000|Overall Study|Adverse Event|12|||
155424044|NCT01445678|560980616|FG001|Overall Study|Adverse Event|8|||
155424045|NCT01445678|560980615|FG000|Overall Study|Lack of Efficacy|0|||
155424046|NCT01445678|560980616|FG001|Overall Study|Lack of Efficacy|2|||
155424047|NCT01445678|560980615|FG000|Overall Study|Lost to Follow-up|8|||
155424048|NCT01445678|560980616|FG001|Overall Study|Lost to Follow-up|5|||
155424049|NCT01445678|560980615|FG000|Overall Study|Protocol Violation|1|||
155424050|NCT01445678|560980616|FG001|Overall Study|Protocol Violation|1|||
155424051|NCT01445678|560980615|FG000|Overall Study|Withdrawal by Subject|9|||
155424052|NCT01445678|560980616|FG001|Overall Study|Withdrawal by Subject|5|||
155424053|NCT01459614|560980619|FG000|Overall Study|Adverse Event|1|||
155424054|NCT01459614|560980620|FG001|Overall Study|Adverse Event|0|||
155424055|NCT00630331|560980624|FG000|Overall Study|Death|2|||
155424056|NCT00630331|560980625|FG001|Overall Study|Death|1|||
155424057|NCT00630331|560980626|FG002|Overall Study|Death|1|||
155424058|NCT00630331|560980624|FG000|Overall Study|Adverse Event|1|||
155424059|NCT00630331|560980625|FG001|Overall Study|Adverse Event|0|||
155424060|NCT00630331|560980626|FG002|Overall Study|Adverse Event|0|||
155424061|NCT00630331|560980624|FG000|Overall Study|Withdrawal by Subject|12|||
155424062|NCT00630331|560980625|FG001|Overall Study|Withdrawal by Subject|7|||
155424063|NCT00630331|560980626|FG002|Overall Study|Withdrawal by Subject|5|||
155424064|NCT00630331|560980624|FG000|Overall Study|Lost to Follow-up|175|||
155424065|NCT00630331|560980625|FG001|Overall Study|Lost to Follow-up|143|||
155424066|NCT00630331|560980626|FG002|Overall Study|Lost to Follow-up|170|||
155647670|NCT00520572|561803633|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
155647671|NCT00520572|561803634|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
155647672|NCT00520572|561803635|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
155647673|NCT00520572|561803636|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
155647674|NCT00520572|561803631|FG000|Overall Study|Long break in taking Medication|0|||
155647675|NCT00520572|561803632|FG001|Overall Study|Long break in taking Medication|0|||
155647676|NCT00520572|561803633|FG002|Overall Study|Long break in taking Medication|0|||
155647677|NCT00520572|561803634|FG003|Overall Study|Long break in taking Medication|1|||
155647678|NCT00520572|561803635|FG004|Overall Study|Long break in taking Medication|0|||
155647679|NCT00520572|561803636|FG005|Overall Study|Long break in taking Medication|0|||
155647680|NCT00520572|561803631|FG000|Overall Study|Did not receive Treatment|1|||
155647681|NCT00520572|561803632|FG001|Overall Study|Did not receive Treatment|0|||
155647682|NCT00520572|561803633|FG002|Overall Study|Did not receive Treatment|1|||
155647683|NCT00520572|561803634|FG003|Overall Study|Did not receive Treatment|0|||
155647684|NCT00520572|561803635|FG004|Overall Study|Did not receive Treatment|0|||
155647685|NCT00520572|561803636|FG005|Overall Study|Did not receive Treatment|0|||
155647686|NCT03548415|561803639|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155647687|NCT03548415|561803640|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155647688|NCT03548415|561803641|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
155647689|NCT03548415|561803642|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
155647690|NCT03548415|561803643|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
155647691|NCT04605588|561803645|FG000|Overall Study|Withdrawal by Subject|1|||
155647692|NCT04605588|561803646|FG001|Overall Study|Withdrawal by Subject|0|||
155647693|NCT01230814|561803647|FG000|Overall Study|Lost to Follow-up|11|||
155647694|NCT01230814|561803648|FG001|Overall Study|Lost to Follow-up|3|||
155647695|NCT01230814|561803647|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
155647696|NCT01230814|561803648|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
155647697|NCT01803737|561803651|FG000|Overall Study|Lack of Time|1|||
155647698|NCT01803737|561803652|FG001|Overall Study|Lack of Time|0|||
155647699|NCT01803737|561803651|FG000|Overall Study|Medical Reason|0|||
155647700|NCT01803737|561803652|FG001|Overall Study|Medical Reason|1|||
155647701|NCT01803737|561803651|FG000|Overall Study|Lost to Follow-up|0|||
155647702|NCT01803737|561803652|FG001|Overall Study|Lost to Follow-up|2|||
155647703|NCT01748552|561803653|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
155647704|NCT01748552|561803654|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
155647705|NCT01748552|561803655|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
155647706|NCT01748552|561803656|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
155647707|NCT01748552|561803657|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
155647708|NCT01748552|561803658|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
155647709|NCT01748552|561803659|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
155647710|NCT01748552|561803660|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
155647711|NCT01748552|561803661|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
155647712|NCT01748552|561803662|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
155647713|NCT01748552|561803663|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
155647714|NCT01748552|561803664|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
155647715|NCT01748552|561803653|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647716|NCT01748552|561803654|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647717|NCT01748552|561803655|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647718|NCT01748552|561803656|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647719|NCT01748552|561803657|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647720|NCT01748552|561803658|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647721|NCT01748552|561803659|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155647722|NCT01748552|561803660|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155647723|NCT01748552|561803661|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155647724|NCT01748552|561803662|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647725|NCT01748552|561803663|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647726|NCT01748552|561803664|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155647727|NCT00292370|561803667|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
155647728|NCT00292370|561803668|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
155647729|NCT00292370|561803669|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
155647730|NCT00292370|561803667|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
155647731|NCT00292370|561803668|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
155647732|NCT00292370|561803669|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
155647733|NCT00292370|561803667|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
155647734|NCT00292370|561803668|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
155647735|NCT00292370|561803669|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
155647736|NCT00292370|561803667|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
155647737|NCT00292370|561803668|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
155647738|NCT00292370|561803669|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
155647739|NCT00292370|561803667|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
155647740|NCT00292370|561803668|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
155342683|NCT02707952|560687102|FG002|Overall Study|Adverse Event|0|||
155342684|NCT02707952|560687103|FG003|Overall Study|Adverse Event|0|||
155342685|NCT02707952|560687100|FG000|Overall Study|Lost to Follow-up|1|||
155505393|NCT03033069|561276174|FG001|Overall Study|Lack of Efficacy|0|||
155505394|NCT03033069|561276175|FG002|Overall Study|Lack of Efficacy|1|||
155505395|NCT03033069|561276176|FG003|Overall Study|Lack of Efficacy|0|||
155505396|NCT03033069|561276173|FG000|Overall Study|Lost to Follow-up|6|||
155647741|NCT00292370|561803669|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
155647742|NCT00292370|561803667|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
155647743|NCT00292370|561803668|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
155647744|NCT00292370|561803669|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
155647745|NCT02365064|561803673|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
155647746|NCT02365064|561803674|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
155647747|NCT02365064|561803673|FG000|Overall Study|Withdrawal by Subject|6|||
155505397|NCT03033069|561276174|FG001|Overall Study|Lost to Follow-up|5|||
155647748|NCT02365064|561803674|FG001|Overall Study|Withdrawal by Subject|9|||
155647749|NCT02365064|561803673|FG000|Overall Study|Treatment intolerance|2|||
155647750|NCT02365064|561803674|FG001|Overall Study|Treatment intolerance|4|||
155342686|NCT02707952|560687101|FG001|Overall Study|Lost to Follow-up|0|||
155342687|NCT02707952|560687102|FG002|Overall Study|Lost to Follow-up|0|||
155342688|NCT02707952|560687103|FG003|Overall Study|Lost to Follow-up|0|||
155342689|NCT02707952|560687100|FG000|Overall Study|Withdrawal by Subject|0|||
155342690|NCT02707952|560687101|FG001|Overall Study|Withdrawal by Subject|1|||
155342691|NCT02707952|560687102|FG002|Overall Study|Withdrawal by Subject|2|||
155342692|NCT02707952|560687103|FG003|Overall Study|Withdrawal by Subject|0|||
155342693|NCT00696241|560687105|FG000|Overall Study|Adverse Event|11|||
155342694|NCT00696241|560687106|FG001|Overall Study|Adverse Event|3|||
155342695|NCT00696241|560687107|FG002|Overall Study|Adverse Event|6|||
155342696|NCT00696241|560687108|FG003|Overall Study|Adverse Event|4|||
155342697|NCT00696241|560687109|FG004|Overall Study|Adverse Event|5|||
155505398|NCT03033069|561276175|FG002|Overall Study|Lost to Follow-up|5|||
155342698|NCT00696241|560687105|FG000|Overall Study|Protocol Violation|1|||
155342699|NCT00696241|560687106|FG001|Overall Study|Protocol Violation|1|||
155342700|NCT00696241|560687107|FG002|Overall Study|Protocol Violation|2|||
155342701|NCT00696241|560687108|FG003|Overall Study|Protocol Violation|0|||
155647751|NCT00662038|561803675|FG000|Overall Study|Reason not specified|3|||
155647752|NCT00662038|561803675|FG000|Overall Study|Withdrawn consent|22|||
155647753|NCT00662038|561803675|FG000|Overall Study|Withdrawal by Subject|83|||
155647754|NCT00662038|561803675|FG000|Overall Study|Sponsor decision|1|||
155647755|NCT00662038|561803675|FG000|Overall Study|Physician Decision|19|||
155647756|NCT00662038|561803675|FG000|Overall Study|Lung transplantation|44|||
155647757|NCT00662038|561803675|FG000|Overall Study|Lost to Follow-up|1|||
155647758|NCT00662038|561803675|FG000|Overall Study|Death|95|||
155647759|NCT00662038|561803675|FG000|Overall Study|Adverse Event|358|||
155647760|NCT00662038|561803675|FG000|Overall Study|Continued treatment|5|||
155647761|NCT01840163|561803676|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
155647762|NCT01840163|561803677|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
155647763|NCT01840163|561803676|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
155505399|NCT03033069|561276176|FG003|Overall Study|Lost to Follow-up|6|||
155505400|NCT03033069|561276173|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155505401|NCT03033069|561276174|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155505402|NCT03033069|561276175|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155505403|NCT03033069|561276176|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155505404|NCT03033069|561276173|FG000|Overall Study|Protocol Deviation|0|||
155505405|NCT03033069|561276174|FG001|Overall Study|Protocol Deviation|1|||
155505406|NCT03033069|561276175|FG002|Overall Study|Protocol Deviation|0|||
155505407|NCT03033069|561276176|FG003|Overall Study|Protocol Deviation|0|||
155505408|NCT03033069|561276173|FG000|Overall Study|Withdrawal by Subject|10|||
155342702|NCT00696241|560687109|FG004|Overall Study|Protocol Violation|3|||
155342703|NCT00696241|560687105|FG000|Overall Study|Lost to Follow-up|1|||
155505409|NCT03033069|561276174|FG001|Overall Study|Withdrawal by Subject|10|||
155342704|NCT00696241|560687106|FG001|Overall Study|Lost to Follow-up|4|||
155505410|NCT03033069|561276175|FG002|Overall Study|Withdrawal by Subject|11|||
155505411|NCT03033069|561276176|FG003|Overall Study|Withdrawal by Subject|6|||
155505412|NCT03033069|561276173|FG000|Overall Study|Withdrawal By Caregiver|1|||
155342705|NCT00696241|560687107|FG002|Overall Study|Lost to Follow-up|1|||
155342706|NCT00696241|560687108|FG003|Overall Study|Lost to Follow-up|2|||
155342707|NCT00696241|560687109|FG004|Overall Study|Lost to Follow-up|0|||
155342708|NCT00696241|560687105|FG000|Overall Study|Withdrawal by Subject|4|||
155342709|NCT00696241|560687106|FG001|Overall Study|Withdrawal by Subject|8|||
155342710|NCT00696241|560687107|FG002|Overall Study|Withdrawal by Subject|6|||
155342711|NCT00696241|560687108|FG003|Overall Study|Withdrawal by Subject|1|||
155342712|NCT00696241|560687109|FG004|Overall Study|Withdrawal by Subject|0|||
155342713|NCT00696241|560687105|FG000|Overall Study|Lack of Efficacy|1|||
155342714|NCT00696241|560687106|FG001|Overall Study|Lack of Efficacy|5|||
155505413|NCT03033069|561276174|FG001|Overall Study|Withdrawal By Caregiver|0|||
155342715|NCT00696241|560687107|FG002|Overall Study|Lack of Efficacy|4|||
155342716|NCT00696241|560687108|FG003|Overall Study|Lack of Efficacy|5|||
155342717|NCT00696241|560687109|FG004|Overall Study|Lack of Efficacy|3|||
155342718|NCT00696241|560687105|FG000|Overall Study|Other|6|||
155342719|NCT00696241|560687106|FG001|Overall Study|Other|1|||
155342720|NCT00696241|560687107|FG002|Overall Study|Other|5|||
155342721|NCT00696241|560687108|FG003|Overall Study|Other|2|||
155342722|NCT00696241|560687109|FG004|Overall Study|Other|1|||
155342723|NCT01287832|560687110|FG000|Overall Study|Adverse Event|1|||
155342724|NCT01287832|560687111|FG001|Overall Study|Adverse Event|0|||
155342725|NCT01287832|560687110|FG000|Overall Study|Death|0|||
155342726|NCT01287832|560687111|FG001|Overall Study|Death|1|||
155342727|NCT03065400|560687115|FG000|Overall Study|Adverse Event|1|||
155342728|NCT03065400|560687115|FG000|Overall Study|Physician Decision|3|||
155342729|NCT03065400|560687115|FG000|Overall Study|Withdrawal by Subject|1|||
155342730|NCT03065400|560687115|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
155342731|NCT02513667|560687116|FG000|Overall Study|Withdrawal by Subject|0|||
155424067|NCT00630331|560980624|FG000|Overall Study|Inappropriate enrollment|3|||
155424068|NCT00630331|560980625|FG001|Overall Study|Inappropriate enrollment|6|||
155424069|NCT00630331|560980626|FG002|Overall Study|Inappropriate enrollment|3|||
155424070|NCT00630331|560980624|FG000|Overall Study|Unable to classify|9|||
155424071|NCT00630331|560980625|FG001|Overall Study|Unable to classify|4|||
155424072|NCT00630331|560980626|FG002|Overall Study|Unable to classify|3|||
155424073|NCT00630331|560980624|FG000|Overall Study|Protocol Violation|4|||
155424074|NCT00630331|560980625|FG001|Overall Study|Protocol Violation|5|||
155424075|NCT00630331|560980626|FG002|Overall Study|Protocol Violation|6|||
155505414|NCT03033069|561276175|FG002|Overall Study|Withdrawal By Caregiver|0|||
155505415|NCT03033069|561276176|FG003|Overall Study|Withdrawal By Caregiver|0|||
155505416|NCT03033069|561276173|FG000|Overall Study|Reason not Specified|0|||
155505417|NCT03033069|561276174|FG001|Overall Study|Reason not Specified|1|||
155505418|NCT03033069|561276175|FG002|Overall Study|Reason not Specified|0|||
155505419|NCT03033069|561276176|FG003|Overall Study|Reason not Specified|1|||
155505420|NCT03053622|561278098|FG000|Overall Study|Lost to Follow-up|0|||
155505421|NCT03053622|561278099|FG001|Overall Study|Lost to Follow-up|0|||
155505422|NCT03053622|561278100|FG002|Overall Study|Lost to Follow-up|0|||
155505423|NCT03053622|561278101|FG003|Overall Study|Lost to Follow-up|1|||
155505424|NCT01246986|561278102|FG000|Overall Study|Lost to Follow-up|0|||
155505425|NCT01246986|561278103|FG001|Overall Study|Lost to Follow-up|1|||
155505426|NCT01246986|561278104|FG002|Overall Study|Lost to Follow-up|3|||
155505427|NCT01246986|561278105|FG003|Overall Study|Lost to Follow-up|0|||
155505428|NCT01246986|561278106|FG004|Overall Study|Lost to Follow-up|0|||
155505429|NCT01246986|561278107|FG005|Overall Study|Lost to Follow-up|1|||
155505430|NCT01246986|561278108|FG006|Overall Study|Lost to Follow-up|0|||
155505431|NCT01246986|561278102|FG000|Overall Study|Withdrawal by Subject|3|||
155505432|NCT01246986|561278103|FG001|Overall Study|Withdrawal by Subject|4|||
155505433|NCT01246986|561278104|FG002|Overall Study|Withdrawal by Subject|3|||
155505434|NCT01246986|561278105|FG003|Overall Study|Withdrawal by Subject|0|||
155505435|NCT01246986|561278106|FG004|Overall Study|Withdrawal by Subject|4|||
155505436|NCT01246986|561278107|FG005|Overall Study|Withdrawal by Subject|0|||
155505437|NCT01246986|561278108|FG006|Overall Study|Withdrawal by Subject|0|||
155505438|NCT01406873|561278113|FG000|Overall Study|Withdrawal by Subject|1|||
155505439|NCT01406873|561278114|FG001|Overall Study|Withdrawal by Subject|1|||
155505440|NCT03990389|561278115|FG000|Overall Study|Lost to Follow-up|3|||
155505441|NCT03990389|561278116|FG001|Overall Study|Lost to Follow-up|0|||
155505442|NCT03770000|561278120|FG000|Overall Study|Premature discontinuation due to PD|0|||
155505443|NCT03770000|561278121|FG001|Overall Study|Premature discontinuation due to PD|0|||
155505444|NCT03770000|561278122|FG002|Overall Study|Premature discontinuation due to PD|1|||
155505445|NCT03770000|561278123|FG003|Overall Study|Premature discontinuation due to PD|3|||
155505446|NCT03770000|561278124|FG004|Overall Study|Premature discontinuation due to PD|2|||
155505447|NCT02290028|561278125|FG000|Overall Study|Death|217|||
155505448|NCT02290028|561278125|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
155505449|NCT02290028|561278125|FG000|Overall Study|No longer under care of study physician|76|||
155505450|NCT02290028|561278125|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
155424076|NCT01929135|560980633|FG000|Overall Study|Lost to Follow-up|1|||
155424077|NCT01929135|560980634|FG001|Overall Study|Lost to Follow-up|1|||
155424078|NCT02425098|560980635|FG000|Overall Study|Lost to Follow-up|7|||
155424079|NCT02425098|560980636|FG001|Overall Study|Lost to Follow-up|7|||
155424080|NCT02425098|560980635|FG000|Overall Study|Withdrawal by Subject|4|||
155424081|NCT02425098|560980636|FG001|Overall Study|Withdrawal by Subject|8|||
155424082|NCT02425098|560980635|FG000|Overall Study|Pregnancy|2|||
155424083|NCT02425098|560980636|FG001|Overall Study|Pregnancy|0|||
155424084|NCT02425098|560980635|FG000|Overall Study|Reason not Specified|0|||
155424085|NCT02425098|560980636|FG001|Overall Study|Reason not Specified|1|||
155424086|NCT02078219|560980637|FG000|Overall Study|Other|2|||
155424087|NCT02078219|560980638|FG001|Overall Study|Other|2|||
155424088|NCT02078219|560980639|FG002|Overall Study|Other|3|||
155424089|NCT02078219|560980640|FG003|Overall Study|Other|0|||
155424090|NCT02078219|560980641|FG004|Overall Study|Other|1|||
155505451|NCT02290028|561278125|FG000|Overall Study|Withdrawal by Subject|52|||
155424091|NCT02078219|560980637|FG000|Overall Study|Withdrawal by Subject|0|||
155424092|NCT02078219|560980638|FG001|Overall Study|Withdrawal by Subject|1|||
155424093|NCT02078219|560980639|FG002|Overall Study|Withdrawal by Subject|0|||
155505452|NCT02290028|561278125|FG000|Overall Study|Study site closure|44|||
155505453|NCT02290028|561278125|FG000|Overall Study|Lost to Follow-up|34|||
155505454|NCT02290028|561278125|FG000|Overall Study|Miscellaneous|10|||
155505455|NCT02290028|561278125|FG000|Overall Study|Transition to EP PASSION|1295|||
155424094|NCT02078219|560980640|FG003|Overall Study|Withdrawal by Subject|1|||
155505456|NCT02290028|561278125|FG000|Overall Study|Planned study completion at 12 months|257|||
155505457|NCT00833547|561278126|FG000|Overall Study|Withdrawal by Subject|2|||
155505458|NCT00833547|561278127|FG001|Overall Study|Withdrawal by Subject|2|||
155505459|NCT00686790|561278130|FG000|Overall Study|Adverse Event|2|||
155505460|NCT00686790|561278130|FG000|Overall Study|Withdrawal by Subject|1|||
155505461|NCT00686790|561278130|FG000|Overall Study|Death|1|||
155505462|NCT00686790|561278130|FG000|Overall Study|Lost to Follow-up|12|||
155505463|NCT00096382|561278131|FG000|Overall Study|Not treated|1|||
155505464|NCT00096382|561278132|FG001|Overall Study|Not treated|0|||
155505465|NCT00096382|561278131|FG000|Overall Study|Death during treatment|1|||
155505466|NCT00096382|561278132|FG001|Overall Study|Death during treatment|0|||
155505467|NCT03862625|561278136|FG000|Overall Study|Lost to Follow-up|0|||
155505468|NCT03862625|561278137|FG001|Overall Study|Lost to Follow-up|1|||
155505469|NCT01326702|561278138|FG000|Overall Study|Other|1|||
155505470|NCT01326702|561278139|FG001|Overall Study|Other|0|||
155505471|NCT01326702|561278140|FG002|Overall Study|Other|0|||
155505472|NCT01326702|561278141|FG003|Overall Study|Other|0|||
155505473|NCT01326702|561278142|FG004|Overall Study|Other|0|||
155505474|NCT01326702|561278143|FG005|Overall Study|Other|1|||
155505475|NCT01326702|561278144|FG006|Overall Study|Other|0|||
155342732|NCT02513667|560687117|FG001|Overall Study|Withdrawal by Subject|1|||
155342733|NCT02291549|560687120|FG000|Overall Study|Lost to Follow-up|1|||
155342734|NCT02291549|560687121|FG001|Overall Study|Lost to Follow-up|0|||
155342735|NCT02291549|560687120|FG000|Overall Study|Withdrawal by Subject|0|||
155342736|NCT02291549|560687121|FG001|Overall Study|Withdrawal by Subject|1|||
155342737|NCT00537914|560687122|FG000|Overall Study|Death|1|||
155342738|NCT00537914|560687122|FG000|Overall Study|Adverse Event|7|||
155342739|NCT00537914|560687122|FG000|Overall Study|Treatment failure|10|||
155342740|NCT00537914|560687122|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
155342741|NCT00537914|560687122|FG000|Overall Study|Lost to Follow-up|19|||
155342742|NCT00537914|560687122|FG000|Overall Study|Withdrawal of informed consent|59|||
155505476|NCT01326702|561278138|FG000|Overall Study|progressive disease|1|||
155505477|NCT01326702|561278139|FG001|Overall Study|progressive disease|1|||
155342743|NCT01697956|560687124|FG000|Overall Study|Protocol Violation|1|||
155342744|NCT01697956|560687125|FG001|Overall Study|Protocol Violation|1|||
155342745|NCT01115309|560687126|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
155342746|NCT01115309|560687126|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
155342747|NCT01115309|560687126|FG000|Long-term Follow-up|Lost to Follow-up|6|||
155342748|NCT05700851|560687127|FG000|Overall Study|Received a kidney transplant|1|||
155342749|NCT05700851|560687127|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
155342750|NCT05700851|560687127|FG000|Overall Study|Withdrawal by Subject|1|||
155342751|NCT03246724|560687128|FG000|Overall Study|Withdrawal by Subject|5|||
155342752|NCT03246724|560687129|FG001|Overall Study|Withdrawal by Subject|2|||
155342753|NCT03246724|560687130|FG002|Overall Study|Withdrawal by Subject|4|||
155342754|NCT03246724|560687131|FG003|Overall Study|Withdrawal by Subject|2|||
155342755|NCT03246724|560687128|FG000|Overall Study|Ineligible on day of surgery|7|||
155342756|NCT03246724|560687129|FG001|Overall Study|Ineligible on day of surgery|2|||
155342757|NCT03246724|560687130|FG002|Overall Study|Ineligible on day of surgery|0|||
155342758|NCT03246724|560687131|FG003|Overall Study|Ineligible on day of surgery|3|||
155342759|NCT03246724|560687128|FG000|Overall Study|Study completed before surgical date|2|||
155342760|NCT03246724|560687129|FG001|Overall Study|Study completed before surgical date|1|||
155342761|NCT03246724|560687130|FG002|Overall Study|Study completed before surgical date|8|||
155342762|NCT03246724|560687131|FG003|Overall Study|Study completed before surgical date|1|||
155342763|NCT03246724|560687128|FG000|Overall Study|Transferred to other arm|0|||
155342764|NCT03246724|560687129|FG001|Overall Study|Transferred to other arm|0|||
155342765|NCT03246724|560687130|FG002|Overall Study|Transferred to other arm|1|||
155342766|NCT03246724|560687131|FG003|Overall Study|Transferred to other arm|0|||
155505478|NCT01326702|561278140|FG002|Overall Study|progressive disease|3|||
155424095|NCT02078219|560980641|FG004|Overall Study|Withdrawal by Subject|1|||
155424096|NCT02078219|560980637|FG000|Overall Study|Protocol Violation|0|||
155424097|NCT02078219|560980638|FG001|Overall Study|Protocol Violation|0|||
155424098|NCT02078219|560980639|FG002|Overall Study|Protocol Violation|0|||
155424099|NCT02078219|560980640|FG003|Overall Study|Protocol Violation|1|||
155647764|NCT01840163|561803677|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
155424100|NCT02078219|560980641|FG004|Overall Study|Protocol Violation|0|||
155424101|NCT02078219|560980637|FG000|Overall Study|Death|0|||
155424102|NCT02078219|560980638|FG001|Overall Study|Death|0|||
155424103|NCT02078219|560980639|FG002|Overall Study|Death|0|||
155424104|NCT02078219|560980640|FG003|Overall Study|Death|1|||
155424105|NCT02078219|560980641|FG004|Overall Study|Death|0|||
155424106|NCT02078219|560980637|FG000|Overall Study|Adverse Event|1|||
155424107|NCT02078219|560980638|FG001|Overall Study|Adverse Event|1|||
155505479|NCT01326702|561278141|FG003|Overall Study|progressive disease|1|||
155505480|NCT01326702|561278142|FG004|Overall Study|progressive disease|3|||
155505481|NCT01326702|561278143|FG005|Overall Study|progressive disease|2|||
155505482|NCT01326702|561278144|FG006|Overall Study|progressive disease|3|||
155505483|NCT01326702|561278138|FG000|Overall Study|Death|0|||
155505484|NCT01326702|561278139|FG001|Overall Study|Death|1|||
155505485|NCT01326702|561278140|FG002|Overall Study|Death|0|||
155505486|NCT01326702|561278141|FG003|Overall Study|Death|0|||
155505487|NCT01326702|561278142|FG004|Overall Study|Death|0|||
155505488|NCT01326702|561278143|FG005|Overall Study|Death|0|||
155505489|NCT01326702|561278144|FG006|Overall Study|Death|0|||
155505490|NCT01326702|561278138|FG000|Overall Study|Adverse Event|0|||
155505491|NCT01326702|561278139|FG001|Overall Study|Adverse Event|0|||
155505492|NCT01326702|561278140|FG002|Overall Study|Adverse Event|1|||
155505493|NCT01326702|561278141|FG003|Overall Study|Adverse Event|1|||
155505494|NCT01326702|561278142|FG004|Overall Study|Adverse Event|0|||
155505495|NCT01326702|561278143|FG005|Overall Study|Adverse Event|3|||
155505496|NCT01326702|561278144|FG006|Overall Study|Adverse Event|1|||
155505497|NCT01326702|561278138|FG000|Overall Study|Withdrawal by Subject|0|||
155505498|NCT01326702|561278139|FG001|Overall Study|Withdrawal by Subject|0|||
155505499|NCT01326702|561278140|FG002|Overall Study|Withdrawal by Subject|1|||
155505500|NCT01326702|561278141|FG003|Overall Study|Withdrawal by Subject|0|||
155505501|NCT01326702|561278142|FG004|Overall Study|Withdrawal by Subject|1|||
155505502|NCT01326702|561278143|FG005|Overall Study|Withdrawal by Subject|1|||
155505503|NCT01326702|561278144|FG006|Overall Study|Withdrawal by Subject|3|||
155424108|NCT02078219|560980639|FG002|Overall Study|Adverse Event|3|||
155424109|NCT02078219|560980640|FG003|Overall Study|Adverse Event|1|||
155424110|NCT02078219|560980641|FG004|Overall Study|Adverse Event|0|||
155424111|NCT03641560|560980642|FG000|Overall Study|Withdrawal by Subject|6|||
155424112|NCT03641560|560980642|FG000|Overall Study|Progressive disease|40|||
155424113|NCT03641560|560980642|FG000|Overall Study|Death|6|||
155424114|NCT04439279|560982301|FG000|Overall Study|Adverse Event|7|||
155424115|NCT04439279|560982301|FG000|Overall Study|Death|4|||
155424116|NCT04439279|560982301|FG000|Overall Study|Disease progression|17|||
155424117|NCT04439279|560982301|FG000|Overall Study|Complicating disease|3|||
155424118|NCT04439279|560982301|FG000|Overall Study|Withdrawal by Subject|2|||
155424119|NCT04439279|560982301|FG000|Overall Study|Ineligible|1|||
155424120|NCT04439279|560982301|FG000|Overall Study|Treatment still ongoing|1|||
155424121|NCT02689492|560982302|FG000|Overall Study|Lost to Follow-up|61|||
155424122|NCT02689492|560982302|FG000|Overall Study|Withdrawal by Subject|11|||
155424123|NCT02689492|560982302|FG000|Overall Study|Death|9|||
155424124|NCT02689492|560982302|FG000|Overall Study|Physician Decision|2|||
155424125|NCT02689492|560982302|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
155424126|NCT02689492|560982302|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
155424127|NCT02689492|560982302|FG000|Overall Study|Other than listed|1|||
155424128|NCT02732951|560982303|FG000|Overall Study|Other than listed|1|||
155424129|NCT02732951|560982304|FG001|Overall Study|Other than listed|0|||
155424130|NCT02732951|560982303|FG000|Overall Study|Lost to Follow-up|0|||
155424131|NCT02732951|560982304|FG001|Overall Study|Lost to Follow-up|1|||
155424132|NCT02732951|560982303|FG000|Overall Study|Adverse Event|4|||
155424133|NCT02732951|560982304|FG001|Overall Study|Adverse Event|4|||
155505504|NCT01326702|561278138|FG000|Overall Study|Not Treated|0|||
155424134|NCT02732951|560982303|FG000|Overall Study|Protocol Violation|0|||
155505505|NCT01326702|561278139|FG001|Overall Study|Not Treated|0|||
155424135|NCT02732951|560982304|FG001|Overall Study|Protocol Violation|1|||
155424136|NCT01750918|560982305|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
155424137|NCT01750918|560982306|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
155424138|NCT01750918|560982307|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
155424139|NCT01750918|560982308|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
155424140|NCT01750918|560982309|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
155424141|NCT01750918|560982310|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
155424142|NCT01750918|560982311|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
155424143|NCT01750918|560982312|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
155424144|NCT01750918|560982305|FG000|Overall Study|Lost to Follow-up|0|||
155424145|NCT01750918|560982306|FG001|Overall Study|Lost to Follow-up|0|||
155424146|NCT01750918|560982307|FG002|Overall Study|Lost to Follow-up|2|||
155424147|NCT01750918|560982308|FG003|Overall Study|Lost to Follow-up|2|||
155424148|NCT01750918|560982309|FG004|Overall Study|Lost to Follow-up|0|||
155424149|NCT01750918|560982310|FG005|Overall Study|Lost to Follow-up|0|||
155424150|NCT01750918|560982311|FG006|Overall Study|Lost to Follow-up|0|||
155424151|NCT01750918|560982312|FG007|Overall Study|Lost to Follow-up|1|||
155424152|NCT01750918|560982305|FG000|Overall Study|Withdrawal by Subject|0|||
155424153|NCT01750918|560982306|FG001|Overall Study|Withdrawal by Subject|0|||
155424154|NCT01750918|560982307|FG002|Overall Study|Withdrawal by Subject|1|||
155424155|NCT01750918|560982308|FG003|Overall Study|Withdrawal by Subject|2|||
155342767|NCT03246724|560687128|FG000|Overall Study|Unable to obtain medication timely|0|||
155342768|NCT03246724|560687129|FG001|Overall Study|Unable to obtain medication timely|2|||
155342769|NCT03246724|560687130|FG002|Overall Study|Unable to obtain medication timely|2|||
155342770|NCT03246724|560687131|FG003|Overall Study|Unable to obtain medication timely|1|||
155342771|NCT03246724|560687128|FG000|Overall Study|Re-consented to participate|0|||
155342772|NCT03246724|560687129|FG001|Overall Study|Re-consented to participate|0|||
155342773|NCT03246724|560687130|FG002|Overall Study|Re-consented to participate|0|||
155342774|NCT03246724|560687131|FG003|Overall Study|Re-consented to participate|1|||
155342775|NCT00655824|560687132|FG000|Overall Study|Adverse Event|3|||
155342776|NCT00655824|560687132|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
155342777|NCT00655824|560687132|FG000|Overall Study|Protocol Violation|1|||
155342778|NCT00655824|560687132|FG000|Overall Study|Withdrawal by Subject|4|||
155342779|NCT00655824|560687132|FG000|Overall Study|Deterioration of Trial Disease|2|||
155342780|NCT00589628|560687133|FG000|Overall Study|Lost to Follow-up|0|||
155342781|NCT00589628|560687134|FG001|Overall Study|Lost to Follow-up|1|||
155342782|NCT02189759|560687142|FG000|Overall Study|Lost to Follow-up|0|||
155342783|NCT02189759|560687143|FG001|Overall Study|Lost to Follow-up|0|||
155342784|NCT02189759|560687144|FG002|Overall Study|Lost to Follow-up|2|||
155342785|NCT02189759|560687145|FG003|Overall Study|Lost to Follow-up|5|||
155342786|NCT02470806|560687146|FG000|Overall Study|Lost to Follow-up|1|||
155342787|NCT02470806|560687147|FG001|Overall Study|Lost to Follow-up|1|||
155342788|NCT02470806|560687146|FG000|Overall Study|Adverse Event|5|||
155342789|NCT02470806|560687147|FG001|Overall Study|Adverse Event|2|||
155342790|NCT02470806|560687146|FG000|Overall Study|Protocol Violation|4|||
155342791|NCT02470806|560687147|FG001|Overall Study|Protocol Violation|11|||
155342792|NCT02470806|560687146|FG000|Overall Study|Physician Decision|0|||
155342793|NCT02470806|560687147|FG001|Overall Study|Physician Decision|3|||
155342794|NCT02470806|560687146|FG000|Overall Study|Withdrawal by Subject|3|||
155342795|NCT02470806|560687147|FG001|Overall Study|Withdrawal by Subject|10|||
155342796|NCT02470806|560687146|FG000|Overall Study|Lack of Efficacy|5|||
155342797|NCT02470806|560687147|FG001|Overall Study|Lack of Efficacy|15|||
155342798|NCT03032198|560687148|FG000|Overall Study|Screen Fail|1|||
155342799|NCT00866619|560687149|FG000|Overall Study|Adverse Event|112|||
155342800|NCT00866619|560687150|FG001|Overall Study|Adverse Event|106|||
155342801|NCT00866619|560687151|FG002|Overall Study|Adverse Event|47|||
155342802|NCT00866619|560687152|FG003|Overall Study|Adverse Event|44|||
155342803|NCT00866619|560687149|FG000|Overall Study|Protocol Violation|2|||
155424156|NCT01750918|560982309|FG004|Overall Study|Withdrawal by Subject|1|||
155424157|NCT01750918|560982310|FG005|Overall Study|Withdrawal by Subject|1|||
155424158|NCT01750918|560982311|FG006|Overall Study|Withdrawal by Subject|2|||
155424159|NCT01750918|560982312|FG007|Overall Study|Withdrawal by Subject|2|||
155647765|NCT01840163|561803676|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
155647766|NCT01840163|561803677|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
155342804|NCT00866619|560687150|FG001|Overall Study|Protocol Violation|39|||
155342805|NCT00866619|560687151|FG002|Overall Study|Protocol Violation|2|||
155342806|NCT00866619|560687152|FG003|Overall Study|Protocol Violation|17|||
155424160|NCT02031679|560982315|FG000|Overall Study|Protocol Violation|0|||
155647767|NCT03774810|561803678|FG000|Phase 1|Lack of Efficacy|21|||
155342807|NCT00866619|560687149|FG000|Overall Study|Withdrawal by Subject|587|||
155342808|NCT00866619|560687150|FG001|Overall Study|Withdrawal by Subject|295|||
155342809|NCT00866619|560687151|FG002|Overall Study|Withdrawal by Subject|272|||
155342810|NCT00866619|560687152|FG003|Overall Study|Withdrawal by Subject|144|||
155342811|NCT00866619|560687149|FG000|Overall Study|Lost to Follow-up|1145|||
155342812|NCT00866619|560687150|FG001|Overall Study|Lost to Follow-up|830|||
155342813|NCT00866619|560687151|FG002|Overall Study|Lost to Follow-up|568|||
155342814|NCT00866619|560687152|FG003|Overall Study|Lost to Follow-up|425|||
155424161|NCT02031679|560982316|FG001|Overall Study|Protocol Violation|1|||
155424162|NCT02031679|560982315|FG000|Overall Study|Lack of Efficacy|0|||
155424163|NCT02031679|560982316|FG001|Overall Study|Lack of Efficacy|1|||
155424164|NCT02338843|560982318|FG000|Overall Study|Adverse Event|2|||
155342815|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
155342816|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
155342817|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
155342818|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
155342819|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
155342820|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
155342821|NCT01147471|560687153|FG000|3 Month Follow Up|Lost to Follow-up|1|||
155342822|NCT01147471|560687154|FG001|3 Month Follow Up|Lost to Follow-up|1|||
155342823|NCT01147471|560687153|FG000|3 Month Follow Up|Physician Decision|0|||
155342824|NCT01147471|560687154|FG001|3 Month Follow Up|Physician Decision|1|||
155342825|NCT01147471|560687153|FG000|6 Month Follow Up|Lost to Follow-up|4|||
155342826|NCT01147471|560687154|FG001|6 Month Follow Up|Lost to Follow-up|2|||
155342827|NCT00946998|560688485|FG000|Overall Study|Exited prior to first outcome assessment|5|||
155342828|NCT00946998|560688486|FG001|Overall Study|Exited prior to first outcome assessment|3|||
155342829|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
155342830|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
155342831|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
155342832|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
155342833|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
155342834|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
155342835|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
155342836|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
155342837|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
155342838|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
155342839|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
155342840|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
155342841|NCT01020487|560688491|FG000|Part 2 Open-label Period|Adverse Event|0|||
155342842|NCT01020487|560688492|FG001|Part 2 Open-label Period|Adverse Event|4|||
155342843|NCT01020487|560688493|FG002|Part 2 Open-label Period|Adverse Event|1|||
155342844|NCT01922102|560688496|FG000|Overall Study|Withdrawal by Subject|7|||
155342845|NCT01922102|560688497|FG001|Overall Study|Withdrawal by Subject|3|||
155342846|NCT01922102|560688498|FG002|Overall Study|Withdrawal by Subject|7|||
155342847|NCT01922102|560688496|FG000|Overall Study|Physician Decision|0|||
155342848|NCT01922102|560688497|FG001|Overall Study|Physician Decision|2|||
155342849|NCT01922102|560688498|FG002|Overall Study|Physician Decision|1|||
155342850|NCT01922102|560688496|FG000|Overall Study|Adverse Event|1|||
155342851|NCT01922102|560688497|FG001|Overall Study|Adverse Event|2|||
155342852|NCT01922102|560688498|FG002|Overall Study|Adverse Event|0|||
155342853|NCT01922102|560688496|FG000|Overall Study|Lost to Follow-up|1|||
155342854|NCT01922102|560688497|FG001|Overall Study|Lost to Follow-up|0|||
155342855|NCT01922102|560688498|FG002|Overall Study|Lost to Follow-up|0|||
155342856|NCT01922102|560688496|FG000|Overall Study|Administrative problems|0|||
155342857|NCT01922102|560688497|FG001|Overall Study|Administrative problems|2|||
155342858|NCT01922102|560688498|FG002|Overall Study|Administrative problems|0|||
155342859|NCT00447499|560688501|FG000|Overall Study|Adverse Event|1|||
155342860|NCT00447499|560688501|FG000|Overall Study|Patient Decision|4|||
155342861|NCT00447499|560688501|FG000|Overall Study|Sponsor Decision|1|||
155342862|NCT00447499|560688501|FG000|Overall Study|Physician Decision|1|||
155342863|NCT01322347|560688503|FG000|Overall Study|Adverse Event|7|||
155424165|NCT02338843|560982319|FG001|Overall Study|Adverse Event|1|||
155424166|NCT02338843|560982318|FG000|Overall Study|Death|40|||
155424167|NCT02338843|560982319|FG001|Overall Study|Death|53|||
155424168|NCT02338843|560982318|FG000|Overall Study|Physician Decision|1|||
155424169|NCT02338843|560982319|FG001|Overall Study|Physician Decision|0|||
155424170|NCT02338843|560982318|FG000|Overall Study|Withdrawal by Subject|0|||
155424171|NCT02338843|560982319|FG001|Overall Study|Withdrawal by Subject|2|||
155424172|NCT02338843|560982318|FG000|Overall Study|Subject Recovered|0|||
155342864|NCT01322347|560688504|FG001|Overall Study|Adverse Event|2|||
155342865|NCT01322347|560688503|FG000|Overall Study|Death|5|||
155342866|NCT01322347|560688504|FG001|Overall Study|Death|3|||
155342867|NCT01322347|560688503|FG000|Overall Study|Physician Decision|2|||
155342868|NCT01322347|560688504|FG001|Overall Study|Physician Decision|1|||
155342869|NCT01322347|560688503|FG000|Overall Study|Protocol Violation|5|||
155342870|NCT01322347|560688504|FG001|Overall Study|Protocol Violation|2|||
155342871|NCT01322347|560688503|FG000|Overall Study|Withdrawal by Subject|1|||
155342872|NCT01322347|560688504|FG001|Overall Study|Withdrawal by Subject|4|||
155424173|NCT02338843|560982319|FG001|Overall Study|Subject Recovered|2|||
155424174|NCT02338843|560982318|FG000|Overall Study|Discontinued prior to randomizat|1|||
155424175|NCT02338843|560982319|FG001|Overall Study|Discontinued prior to randomizat|0|||
155424176|NCT00110305|560982324|FG000|Overall Study|Adverse Event|46|||
155424177|NCT00110305|560982325|FG001|Overall Study|Adverse Event|13|||
155424178|NCT00110305|560982324|FG000|Overall Study|Sponsors Decision|1|||
155342873|NCT01322347|560688503|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
155342874|NCT01322347|560688504|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
155342875|NCT01322347|560688503|FG000|Overall Study|blood transfusion|5|||
155342876|NCT01322347|560688504|FG001|Overall Study|blood transfusion|5|||
155342877|NCT01322347|560688503|FG000|Overall Study|sponsor decision|1|||
155342878|NCT01322347|560688504|FG001|Overall Study|sponsor decision|3|||
155342879|NCT01322347|560688503|FG000|Overall Study|ineligible|6|||
155342880|NCT01322347|560688504|FG001|Overall Study|ineligible|3|||
155342881|NCT01322347|560688503|FG000|Overall Study|kidney transplant|3|||
155342882|NCT01322347|560688504|FG001|Overall Study|kidney transplant|1|||
155342883|NCT01322347|560688503|FG000|Overall Study|study drug withheld > 12 wks|0|||
155342884|NCT01322347|560688504|FG001|Overall Study|study drug withheld > 12 wks|1|||
155342885|NCT01322347|560688503|FG000|Overall Study|moved/changed dialysis|2|||
155342886|NCT01322347|560688504|FG001|Overall Study|moved/changed dialysis|4|||
155342887|NCT01193283|560688505|FG000|Overall Study|Death|1|||
155342888|NCT04883541|560688506|FG000|Overall Study|Not attending regular yoga class|16|||
155342889|NCT04883541|560688507|FG001|Overall Study|Not attending regular yoga class|0|||
155342890|NCT04883541|560688506|FG000|Overall Study|Not attending the pregnancy school|0|||
155342891|NCT04883541|560688507|FG001|Overall Study|Not attending the pregnancy school|9|||
155342892|NCT02823574|560688513|FG000|Randomization|Disease Progression|0|||
155342893|NCT02823574|560688514|FG001|Randomization|Disease Progression|0|||
155342894|NCT02823574|560688515|FG002|Randomization|Disease Progression|1|||
155342895|NCT02823574|560688516|FG003|Randomization|Disease Progression|0|||
155342896|NCT02823574|560688513|FG000|Randomization|AE unrelated to Study Drug|1|||
155342897|NCT02823574|560688514|FG001|Randomization|AE unrelated to Study Drug|0|||
155342898|NCT02823574|560688515|FG002|Randomization|AE unrelated to Study Drug|0|||
155342899|NCT02823574|560688516|FG003|Randomization|AE unrelated to Study Drug|0|||
155342900|NCT02823574|560688513|FG000|Treatment Period|Poor/Non Compliance|1|||
155342901|NCT02823574|560688514|FG001|Treatment Period|Poor/Non Compliance|0|||
155342902|NCT02823574|560688515|FG002|Treatment Period|Poor/Non Compliance|0|||
155342903|NCT02823574|560688516|FG003|Treatment Period|Poor/Non Compliance|1|||
155342904|NCT02823574|560688513|FG000|Treatment Period|Maximum Clinical Benefit|8|||
155342905|NCT02823574|560688514|FG001|Treatment Period|Maximum Clinical Benefit|4|||
155342906|NCT02823574|560688515|FG002|Treatment Period|Maximum Clinical Benefit|7|||
155342907|NCT02823574|560688516|FG003|Treatment Period|Maximum Clinical Benefit|1|||
155342908|NCT02823574|560688513|FG000|Treatment Period|Lost to Follow-up|1|||
155342909|NCT02823574|560688514|FG001|Treatment Period|Lost to Follow-up|1|||
155342910|NCT02823574|560688515|FG002|Treatment Period|Lost to Follow-up|0|||
155342911|NCT02823574|560688516|FG003|Treatment Period|Lost to Follow-up|0|||
155342912|NCT02823574|560688513|FG000|Treatment Period|Participant withdrew consent|4|||
155342913|NCT02823574|560688514|FG001|Treatment Period|Participant withdrew consent|0|||
155342914|NCT02823574|560688515|FG002|Treatment Period|Participant withdrew consent|0|||
155342915|NCT02823574|560688516|FG003|Treatment Period|Participant withdrew consent|1|||
155342916|NCT02823574|560688513|FG000|Treatment Period|Participant request to discontinue|5|||
155342917|NCT02823574|560688514|FG001|Treatment Period|Participant request to discontinue|0|||
155342918|NCT02823574|560688515|FG002|Treatment Period|Participant request to discontinue|3|||
155342919|NCT02823574|560688516|FG003|Treatment Period|Participant request to discontinue|2|||
155424179|NCT00110305|560982325|FG001|Overall Study|Sponsors Decision|0|||
155424180|NCT00110305|560982324|FG000|Overall Study|Subject Non-Compliant|9|||
155424181|NCT00110305|560982325|FG001|Overall Study|Subject Non-Compliant|2|||
155424182|NCT00110305|560982324|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
155424183|NCT00110305|560982325|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
155424184|NCT00110305|560982324|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
155424185|NCT00110305|560982325|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
155424186|NCT00110305|560982324|FG000|Overall Study|Protocol Violation|0|||
155424187|NCT00110305|560982325|FG001|Overall Study|Protocol Violation|1|||
155424188|NCT00110305|560982324|FG000|Overall Study|Withdrawal by Subject|7|||
155424189|NCT00110305|560982325|FG001|Overall Study|Withdrawal by Subject|7|||
155505506|NCT01326702|561278140|FG002|Overall Study|Not Treated|0|||
155342920|NCT02823574|560688513|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
155342921|NCT02823574|560688514|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
155342922|NCT02823574|560688515|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
155342923|NCT02823574|560688516|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
155342924|NCT02823574|560688513|FG000|Treatment Period|Study Drug Toxicity|11|||
155342925|NCT02823574|560688514|FG001|Treatment Period|Study Drug Toxicity|2|||
155424190|NCT00110305|560982324|FG000|Overall Study|Lost to Follow-up|20|||
155424191|NCT00110305|560982325|FG001|Overall Study|Lost to Follow-up|3|||
155424192|NCT00110305|560982324|FG000|Overall Study|Other|8|||
155424193|NCT00110305|560982325|FG001|Overall Study|Other|2|||
155505507|NCT01326702|561278141|FG003|Overall Study|Not Treated|1|||
155342926|NCT02823574|560688515|FG002|Treatment Period|Study Drug Toxicity|14|||
155342927|NCT02823574|560688516|FG003|Treatment Period|Study Drug Toxicity|4|||
155342928|NCT02823574|560688513|FG000|Treatment Period|Disease Progression|113|||
155342929|NCT02823574|560688514|FG001|Treatment Period|Disease Progression|64|||
155342930|NCT02823574|560688515|FG002|Treatment Period|Disease Progression|82|||
155342931|NCT02823574|560688516|FG003|Treatment Period|Disease Progression|43|||
155342932|NCT02823574|560688513|FG000|Treatment Period|Other reasons|5|||
155342933|NCT02823574|560688514|FG001|Treatment Period|Other reasons|9|||
155342934|NCT02823574|560688515|FG002|Treatment Period|Other reasons|3|||
155342935|NCT02823574|560688516|FG003|Treatment Period|Other reasons|6|||
155342936|NCT02823574|560688513|FG000|Treatment Period|Participant no longer meets study criteria|0|||
155342937|NCT02823574|560688514|FG001|Treatment Period|Participant no longer meets study criteria|0|||
155342938|NCT02823574|560688515|FG002|Treatment Period|Participant no longer meets study criteria|1|||
155342939|NCT02823574|560688516|FG003|Treatment Period|Participant no longer meets study criteria|0|||
155342940|NCT02823574|560688513|FG000|Treatment Period|Death|0|||
155342941|NCT02823574|560688514|FG001|Treatment Period|Death|0|||
155342942|NCT02823574|560688515|FG002|Treatment Period|Death|3|||
155342943|NCT02823574|560688516|FG003|Treatment Period|Death|1|||
155342944|NCT00590759|560688517|FG000|Overall Study|Death|52|||
155342945|NCT00590759|560688517|FG000|Overall Study|Lost to Follow-up|28|||
155342946|NCT02542696|560688523|FG000|Overall Study|Adverse Event|167|||
155342947|NCT02542696|560688523|FG000|Overall Study|Lack of Efficacy|26|||
155342948|NCT02542696|560688523|FG000|Overall Study|Lost to Follow-up|6|||
155342949|NCT02542696|560688523|FG000|Overall Study|Withdrawal by Subject|104|||
155342950|NCT02542696|560688523|FG000|Overall Study|Protocol Violation|5|||
155342951|NCT02542696|560688523|FG000|Overall Study|Death|8|||
155342952|NCT02542696|560688523|FG000|Overall Study|DECREASED OFF TIME|1|||
155342953|NCT02542696|560688523|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
155342954|NCT02542696|560688523|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
155342955|NCT02542696|560688523|FG000|Overall Study|MEDICAL HISTORY|1|||
155342956|NCT02542696|560688523|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
155342957|NCT02542696|560688523|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
155342958|NCT02542696|560688523|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
155342959|NCT02542696|560688523|FG000|Overall Study|SPONSOR DECISION|3|||
155342960|NCT02542696|560688523|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
155342961|NCT02542696|560688523|FG000|Overall Study|SUBJECT DECISION|2|||
155342962|NCT03345407|560688524|FG000|Overall Study|Withdrawal by Subject|11|||
155342963|NCT03345407|560688525|FG001|Overall Study|Withdrawal by Subject|1|||
155342964|NCT03345407|560688526|FG002|Overall Study|Withdrawal by Subject|5|||
155342965|NCT03345407|560688527|FG003|Overall Study|Withdrawal by Subject|6|||
155342966|NCT03345407|560688528|FG004|Overall Study|Withdrawal by Subject|3|||
155342967|NCT03345407|560688529|FG005|Overall Study|Withdrawal by Subject|6|||
155342968|NCT03345407|560688530|FG006|Overall Study|Withdrawal by Subject|16|||
155342969|NCT03345407|560688524|FG000|Overall Study|Physician Decision|3|||
155342970|NCT03345407|560688525|FG001|Overall Study|Physician Decision|1|||
155342971|NCT03345407|560688526|FG002|Overall Study|Physician Decision|0|||
155342972|NCT03345407|560688527|FG003|Overall Study|Physician Decision|0|||
155342973|NCT03345407|560688528|FG004|Overall Study|Physician Decision|1|||
155505508|NCT01326702|561278142|FG004|Overall Study|Not Treated|0|||
155505509|NCT01326702|561278143|FG005|Overall Study|Not Treated|1|||
155505510|NCT01326702|561278144|FG006|Overall Study|Not Treated|0|||
155342974|NCT03345407|560688529|FG005|Overall Study|Physician Decision|2|||
155342975|NCT03345407|560688530|FG006|Overall Study|Physician Decision|3|||
155342976|NCT03345407|560688524|FG000|Overall Study|Lost to Follow-up|2|||
155342977|NCT03345407|560688525|FG001|Overall Study|Lost to Follow-up|0|||
155342978|NCT03345407|560688526|FG002|Overall Study|Lost to Follow-up|1|||
155342979|NCT03345407|560688527|FG003|Overall Study|Lost to Follow-up|0|||
155342980|NCT03345407|560688528|FG004|Overall Study|Lost to Follow-up|1|||
155342981|NCT03345407|560688529|FG005|Overall Study|Lost to Follow-up|2|||
155342982|NCT03345407|560688530|FG006|Overall Study|Lost to Follow-up|3|||
155342983|NCT03345407|560688524|FG000|Overall Study|Protocol-defined stopping criteria|9|||
155342984|NCT03345407|560688525|FG001|Overall Study|Protocol-defined stopping criteria|0|||
155342985|NCT03345407|560688526|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155342986|NCT03345407|560688527|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155342987|NCT03345407|560688528|FG004|Overall Study|Protocol-defined stopping criteria|2|||
155342988|NCT03345407|560688529|FG005|Overall Study|Protocol-defined stopping criteria|1|||
155342989|NCT03345407|560688530|FG006|Overall Study|Protocol-defined stopping criteria|1|||
155342990|NCT03345407|560688524|FG000|Overall Study|Protocol Violation|2|||
155342991|NCT03345407|560688525|FG001|Overall Study|Protocol Violation|0|||
155342992|NCT03345407|560688526|FG002|Overall Study|Protocol Violation|0|||
155342993|NCT03345407|560688527|FG003|Overall Study|Protocol Violation|0|||
155342994|NCT03345407|560688528|FG004|Overall Study|Protocol Violation|1|||
155342995|NCT03345407|560688529|FG005|Overall Study|Protocol Violation|0|||
155342996|NCT03345407|560688530|FG006|Overall Study|Protocol Violation|3|||
155342997|NCT03345407|560688524|FG000|Overall Study|Lack of Efficacy|1|||
155342998|NCT03345407|560688525|FG001|Overall Study|Lack of Efficacy|1|||
155342999|NCT03345407|560688526|FG002|Overall Study|Lack of Efficacy|1|||
155343000|NCT03345407|560688527|FG003|Overall Study|Lack of Efficacy|1|||
155343001|NCT03345407|560688528|FG004|Overall Study|Lack of Efficacy|1|||
155343002|NCT03345407|560688529|FG005|Overall Study|Lack of Efficacy|0|||
155343003|NCT03345407|560688530|FG006|Overall Study|Lack of Efficacy|3|||
155343004|NCT03345407|560688524|FG000|Overall Study|Adverse Event|4|||
155343005|NCT03345407|560688525|FG001|Overall Study|Adverse Event|0|||
155343006|NCT03345407|560688526|FG002|Overall Study|Adverse Event|5|||
155343007|NCT03345407|560688527|FG003|Overall Study|Adverse Event|4|||
155343008|NCT03345407|560688528|FG004|Overall Study|Adverse Event|6|||
155343009|NCT03345407|560688529|FG005|Overall Study|Adverse Event|5|||
155343010|NCT03345407|560688530|FG006|Overall Study|Adverse Event|16|||
155343011|NCT03262389|560688533|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
155343012|NCT03262389|560688533|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
155343013|NCT03262389|560688533|FG000|Overall Study|opted out of PET/MR|1|||
155343014|NCT02256553|560688535|FG000|Period I|Adverse Event|5|||
155343015|NCT02256553|560688535|FG000|Period I|Protocol Violation|1|||
155343016|NCT02256553|560688535|FG000|Period II|Adverse Event|1|||
155343017|NCT02256553|560688535|FG000|Period II|Subject Moved|1|||
155343018|NCT02256553|560688535|FG000|Period III|Adverse Event|3|||
155343019|NCT02865083|560688536|FG000|Overall Study|Early Termination|3|||
155343020|NCT02865083|560688537|FG001|Overall Study|Early Termination|1|||
155343021|NCT03651271|560688538|FG000|Overall Study|Death|4|||
155343022|NCT03651271|560688539|FG001|Overall Study|Death|37|||
155343023|NCT03651271|560688540|FG002|Overall Study|Death|0|||
155343024|NCT03651271|560688541|FG003|Overall Study|Death|2|||
155343025|NCT03651271|560688542|FG004|Overall Study|Death|6|||
155343026|NCT03651271|560688538|FG000|Overall Study|Lost to Follow-up|1|||
155343027|NCT03651271|560688539|FG001|Overall Study|Lost to Follow-up|5|||
155343028|NCT03651271|560688540|FG002|Overall Study|Lost to Follow-up|0|||
155343029|NCT03651271|560688541|FG003|Overall Study|Lost to Follow-up|1|||
155343030|NCT03651271|560688542|FG004|Overall Study|Lost to Follow-up|0|||
155343031|NCT03651271|560688538|FG000|Overall Study|Physician Decision|0|||
155343032|NCT03651271|560688539|FG001|Overall Study|Physician Decision|2|||
155343033|NCT03651271|560688540|FG002|Overall Study|Physician Decision|0|||
155343034|NCT03651271|560688541|FG003|Overall Study|Physician Decision|0|||
155343035|NCT03651271|560688542|FG004|Overall Study|Physician Decision|0|||
155343036|NCT03651271|560688538|FG000|Overall Study|Withdrawal by Subject|1|||
155343037|NCT03651271|560688539|FG001|Overall Study|Withdrawal by Subject|15|||
155343038|NCT03651271|560688540|FG002|Overall Study|Withdrawal by Subject|0|||
155343039|NCT03651271|560688541|FG003|Overall Study|Withdrawal by Subject|0|||
155343040|NCT03651271|560688542|FG004|Overall Study|Withdrawal by Subject|1|||
155343041|NCT03651271|560688538|FG000|Overall Study|Patient medically unable to continue|0|||
155343042|NCT03651271|560688539|FG001|Overall Study|Patient medically unable to continue|0|||
155343043|NCT03651271|560688540|FG002|Overall Study|Patient medically unable to continue|0|||
155343044|NCT03651271|560688541|FG003|Overall Study|Patient medically unable to continue|1|||
155343045|NCT03651271|560688542|FG004|Overall Study|Patient medically unable to continue|0|||
155343046|NCT00821093|560688544|FG000|Overall Study|Adverse Event|20|||
155343047|NCT00821093|560688545|FG001|Overall Study|Adverse Event|12|||
155343048|NCT00821093|560688544|FG000|Overall Study|Withdrawal by Subject|9|||
155343049|NCT00821093|560688545|FG001|Overall Study|Withdrawal by Subject|13|||
155343050|NCT00821093|560688544|FG000|Overall Study|Lost to Follow-up|9|||
155343051|NCT00821093|560688545|FG001|Overall Study|Lost to Follow-up|3|||
155343052|NCT00821093|560688544|FG000|Overall Study|Protocol deviation|3|||
155343053|NCT00821093|560688545|FG001|Overall Study|Protocol deviation|6|||
155343054|NCT00821093|560688544|FG000|Overall Study|Abnormal laboratory value(s)|2|||
155343055|NCT00821093|560688545|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155343056|NCT00821093|560688544|FG000|Overall Study|Lack of Efficacy|2|||
155343057|NCT00821093|560688545|FG001|Overall Study|Lack of Efficacy|2|||
155343058|NCT00821093|560688544|FG000|Overall Study|Death|2|||
155343059|NCT00821093|560688545|FG001|Overall Study|Death|1|||
155343060|NCT00821093|560688544|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155343061|NCT00821093|560688545|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155343062|NCT00821093|560688544|FG000|Overall Study|Administrative problems|1|||
155343063|NCT00821093|560688545|FG001|Overall Study|Administrative problems|2|||
155343064|NCT02469155|560688548|FG000|Overall Study|Adverse Event|6|||
155343065|NCT02469155|560688549|FG001|Overall Study|Adverse Event|0|||
155343066|NCT02469155|560688550|FG002|Overall Study|Adverse Event|1|||
155343067|NCT02469155|560688551|FG003|Overall Study|Adverse Event|10|||
155343068|NCT02469155|560688548|FG000|Overall Study|Lack of Efficacy|13|||
155343069|NCT02469155|560688549|FG001|Overall Study|Lack of Efficacy|10|||
155343070|NCT02469155|560688550|FG002|Overall Study|Lack of Efficacy|10|||
155343071|NCT02469155|560688551|FG003|Overall Study|Lack of Efficacy|8|||
155343072|NCT02469155|560688548|FG000|Overall Study|Death|0|||
155343073|NCT02469155|560688549|FG001|Overall Study|Death|0|||
155343074|NCT02469155|560688550|FG002|Overall Study|Death|0|||
155343075|NCT02469155|560688551|FG003|Overall Study|Death|1|||
155343076|NCT02469155|560688548|FG000|Overall Study|Lost to Follow-up|5|||
155343077|NCT02469155|560688549|FG001|Overall Study|Lost to Follow-up|2|||
155343078|NCT02469155|560688550|FG002|Overall Study|Lost to Follow-up|7|||
155343079|NCT02469155|560688551|FG003|Overall Study|Lost to Follow-up|2|||
155343080|NCT02469155|560688548|FG000|Overall Study|Physician Decision|0|||
155343081|NCT02469155|560688549|FG001|Overall Study|Physician Decision|0|||
155343082|NCT02469155|560688550|FG002|Overall Study|Physician Decision|1|||
155343083|NCT02469155|560688551|FG003|Overall Study|Physician Decision|0|||
155343084|NCT02469155|560688548|FG000|Overall Study|Withdrawal by Subject|34|||
155343085|NCT02469155|560688549|FG001|Overall Study|Withdrawal by Subject|30|||
155343086|NCT02469155|560688550|FG002|Overall Study|Withdrawal by Subject|20|||
155343087|NCT02469155|560688551|FG003|Overall Study|Withdrawal by Subject|37|||
155343088|NCT02469155|560688548|FG000|Overall Study|Other|3|||
155343089|NCT02469155|560688549|FG001|Overall Study|Other|3|||
155343090|NCT02469155|560688550|FG002|Overall Study|Other|2|||
155343091|NCT02469155|560688551|FG003|Overall Study|Other|10|||
155343092|NCT02469155|560688548|FG000|Overall Study|Protocol Violation|0|||
155343093|NCT02469155|560688549|FG001|Overall Study|Protocol Violation|1|||
155343094|NCT02469155|560688550|FG002|Overall Study|Protocol Violation|0|||
155343095|NCT02469155|560688551|FG003|Overall Study|Protocol Violation|1|||
155343096|NCT03150589|560688553|FG000|Overall Study|Withdrawal by Subject|16|||
155343097|NCT03150589|560688554|FG001|Overall Study|Withdrawal by Subject|9|||
155343098|NCT03150589|560688553|FG000|Overall Study|Adverse Event|7|||
155343099|NCT03150589|560688554|FG001|Overall Study|Adverse Event|6|||
155343100|NCT03150589|560688553|FG000|Overall Study|Protocol Violation|4|||
155343101|NCT03150589|560688554|FG001|Overall Study|Protocol Violation|3|||
155343102|NCT03150589|560688553|FG000|Overall Study|Lost to Follow-up|3|||
155343103|NCT03150589|560688554|FG001|Overall Study|Lost to Follow-up|3|||
155343104|NCT03150589|560688553|FG000|Overall Study|Death|2|||
155343105|NCT03150589|560688554|FG001|Overall Study|Death|3|||
155343106|NCT03150589|560688553|FG000|Overall Study|IP non-compliance and other reasons|12|||
155343107|NCT03150589|560688554|FG001|Overall Study|IP non-compliance and other reasons|3|||
155343108|NCT01405508|560688555|FG000|Overall Study|AE, non-serious non-fatal|1|||
155343109|NCT01405508|560688556|FG001|Overall Study|AE, non-serious non-fatal|1|||
155343110|NCT01405508|560688557|FG002|Overall Study|AE, non-serious non-fatal|0|||
155343111|NCT01405508|560688558|FG003|Overall Study|AE, non-serious non-fatal|0|||
155343112|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
155343113|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155343114|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
155343115|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
155343116|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
155343117|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
155343118|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
155343119|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
155424194|NCT05047523|560982333|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
155424195|NCT05047523|560982334|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
155424196|NCT05047523|560982335|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
155424197|NCT05047523|560982336|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
155343120|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
155343121|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343122|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343123|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343124|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
155343125|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
155343126|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
155343127|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
155343128|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
155343129|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
155343130|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
155343131|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
155343132|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
155343133|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
155343134|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
155343135|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
155343136|NCT03839355|560688564|FG000|Overall Study|Withdrawal by Subject|1|||
155343137|NCT03839355|560688565|FG001|Overall Study|Withdrawal by Subject|0|||
155343138|NCT02892019|560688567|FG000|Overall Study|randomized but not treated|0|||
155343139|NCT02892019|560688568|FG001|Overall Study|randomized but not treated|1|||
155343140|NCT02892019|560688567|FG000|Overall Study|Withdrawal by Subject|0|||
155343141|NCT02892019|560688568|FG001|Overall Study|Withdrawal by Subject|1|||
155343142|NCT02892019|560688567|FG000|Overall Study|Adverse Event|1|||
155343143|NCT02892019|560688568|FG001|Overall Study|Adverse Event|1|||
155343144|NCT00689351|560688569|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
155343145|NCT00689351|560688570|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
155343146|NCT00689351|560688569|FG000|Infant Series of Dosing|Adverse Event|1|||
155343147|NCT00689351|560688570|FG001|Infant Series of Dosing|Adverse Event|0|||
155343148|NCT00689351|560688569|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
155343149|NCT00689351|560688570|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
155343150|NCT00689351|560688569|FG000|After Infant Series|Parent/legal guardian request|1|||
155343151|NCT00689351|560688570|FG001|After Infant Series|Parent/legal guardian request|0|||
155343152|NCT01766206|560688571|FG000|Overall Study|Withdrawal by Subject|22|||
155343153|NCT01766206|560688571|FG000|Overall Study|Lost to Follow-up|10|||
155343154|NCT01766206|560688571|FG000|Overall Study|Inappropriate enrollment|18|||
155343155|NCT01766206|560688571|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
155343156|NCT01662505|560688572|FG000|Overall Study|Progressive disease|6|||
155343157|NCT01662505|560688573|FG001|Overall Study|Progressive disease|1|||
155343158|NCT01662505|560688574|FG002|Overall Study|Progressive disease|5|||
155343159|NCT01662505|560688572|FG000|Overall Study|Refused cont. medication|0|||
155343160|NCT01662505|560688573|FG001|Overall Study|Refused cont. medication|0|||
155343161|NCT01662505|560688574|FG002|Overall Study|Refused cont. medication|1|||
155343162|NCT01662505|560688572|FG000|Overall Study|Not specified above|1|||
155343163|NCT01662505|560688573|FG001|Overall Study|Not specified above|3|||
155343164|NCT01662505|560688574|FG002|Overall Study|Not specified above|2|||
155343165|NCT01313663|560688575|FG000|Overall Study|Study Closed/Terminated|2|||
155343166|NCT01313663|560688576|FG001|Overall Study|Study Closed/Terminated|4|||
155343167|NCT01313663|560688575|FG000|Overall Study|Lost to Follow-up|0|||
155343168|NCT01313663|560688576|FG001|Overall Study|Lost to Follow-up|1|||
155343169|NCT01313663|560688575|FG000|Overall Study|Physician Decision|0|||
155343170|NCT01313663|560688576|FG001|Overall Study|Physician Decision|2|||
155343171|NCT01313663|560688575|FG000|Overall Study|Withdrawal by Subject|2|||
155343172|NCT01313663|560688576|FG001|Overall Study|Withdrawal by Subject|1|||
155343173|NCT01661972|560688579|FG000|Overall Study|Adverse Event|1|||
155343174|NCT01661972|560688580|FG001|Overall Study|Adverse Event|2|||
155343175|NCT01661972|560688579|FG000|Overall Study|Death during Treatment period|1|||
155343176|NCT01661972|560688580|FG001|Overall Study|Death during Treatment period|1|||
155343177|NCT01661972|560688579|FG000|Overall Study|Withdrawal by Subject|0|||
155343178|NCT01661972|560688580|FG001|Overall Study|Withdrawal by Subject|1|||
155343179|NCT02138838|560688584|FG000|Overall Study|Study Closure|7|||
155343180|NCT02138838|560688585|FG001|Overall Study|Study Closure|6|||
155343181|NCT02138838|560688584|FG000|Overall Study|Withdrawal by Subject|1|||
155343182|NCT02138838|560688585|FG001|Overall Study|Withdrawal by Subject|5|||
155343183|NCT01294644|560688587|FG000|Overall Study|Adverse Event|2|||
155343184|NCT01294644|560688588|FG001|Overall Study|Adverse Event|0|||
155343185|NCT01294644|560688589|FG002|Overall Study|Adverse Event|1|||
155343186|NCT01294644|560688587|FG000|Overall Study|Withdrawal by Subject|3|||
155343187|NCT01294644|560688588|FG001|Overall Study|Withdrawal by Subject|7|||
155343188|NCT01294644|560688589|FG002|Overall Study|Withdrawal by Subject|4|||
155343189|NCT01294644|560688587|FG000|Overall Study|Lost to Follow-up|3|||
155343190|NCT01294644|560688588|FG001|Overall Study|Lost to Follow-up|2|||
155343191|NCT01294644|560688589|FG002|Overall Study|Lost to Follow-up|5|||
155343192|NCT01294644|560688587|FG000|Overall Study|Miscellaneous Reason|2|||
155343193|NCT01294644|560688588|FG001|Overall Study|Miscellaneous Reason|1|||
155343194|NCT01294644|560688589|FG002|Overall Study|Miscellaneous Reason|4|||
155343195|NCT02367794|560688590|FG000|Overall Study|Death|252|||
155343196|NCT02367794|560688591|FG001|Overall Study|Death|245|||
155343197|NCT02367794|560688592|FG002|Overall Study|Death|243|||
155343198|NCT02367794|560688590|FG000|Overall Study|Lost to Follow-up|1|||
155343199|NCT02367794|560688591|FG001|Overall Study|Lost to Follow-up|2|||
155343200|NCT02367794|560688592|FG002|Overall Study|Lost to Follow-up|2|||
155343201|NCT02367794|560688590|FG000|Overall Study|Physician Decision|0|||
155343202|NCT02367794|560688591|FG001|Overall Study|Physician Decision|5|||
155343203|NCT02367794|560688592|FG002|Overall Study|Physician Decision|3|||
155343204|NCT02367794|560688590|FG000|Overall Study|Protocol Violation|1|||
155343205|NCT02367794|560688591|FG001|Overall Study|Protocol Violation|0|||
155343206|NCT02367794|560688592|FG002|Overall Study|Protocol Violation|1|||
155343207|NCT02367794|560688590|FG000|Overall Study|Withdrawal by Subject|25|||
155343208|NCT02367794|560688591|FG001|Overall Study|Withdrawal by Subject|12|||
155343209|NCT02367794|560688592|FG002|Overall Study|Withdrawal by Subject|20|||
155343210|NCT02367794|560688590|FG000|Overall Study|Brain metastasis|1|||
155343211|NCT02367794|560688591|FG001|Overall Study|Brain metastasis|0|||
155343212|NCT02367794|560688592|FG002|Overall Study|Brain metastasis|0|||
155343213|NCT02367794|560688590|FG000|Overall Study|Randomized in error|0|||
155343214|NCT02367794|560688591|FG001|Overall Study|Randomized in error|0|||
155343215|NCT02367794|560688592|FG002|Overall Study|Randomized in error|1|||
155343216|NCT02367794|560688590|FG000|Overall Study|Patient unable to receive carboplatin|0|||
155343217|NCT02367794|560688591|FG001|Overall Study|Patient unable to receive carboplatin|0|||
155343218|NCT02367794|560688592|FG002|Overall Study|Patient unable to receive carboplatin|1|||
155343219|NCT02367794|560688590|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
155343220|NCT02367794|560688591|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
155343221|NCT02367794|560688592|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
155343222|NCT02367794|560688590|FG000|Overall Study|Adverse Event|0|||
155343223|NCT02367794|560688591|FG001|Overall Study|Adverse Event|0|||
155343224|NCT02367794|560688592|FG002|Overall Study|Adverse Event|2|||
155343225|NCT02367794|560688590|FG000|Overall Study|Study Terminated By Sponsor|0|||
155343226|NCT02367794|560688591|FG001|Overall Study|Study Terminated By Sponsor|1|||
155343227|NCT02367794|560688592|FG002|Overall Study|Study Terminated By Sponsor|1|||
155343228|NCT02367794|560688590|FG000|Overall Study|Moved to Roll-Over Study|0|||
155343229|NCT02367794|560688591|FG001|Overall Study|Moved to Roll-Over Study|15|||
155343230|NCT02367794|560688592|FG002|Overall Study|Moved to Roll-Over Study|13|||
155343231|NCT02367794|560688590|FG000|Overall Study|Sponsor Request|60|||
155343232|NCT02367794|560688591|FG001|Overall Study|Sponsor Request|57|||
155343233|NCT02367794|560688592|FG002|Overall Study|Sponsor Request|45|||
155343234|NCT02367794|560688590|FG000|Overall Study|Moved into PTAP Study|0|||
155343235|NCT02367794|560688591|FG001|Overall Study|Moved into PTAP Study|2|||
155343236|NCT02367794|560688592|FG002|Overall Study|Moved into PTAP Study|3|||
155343237|NCT02367794|560688590|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
155343238|NCT02367794|560688591|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
155343239|NCT02367794|560688592|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
155343240|NCT02367794|560688590|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
155343241|NCT02367794|560688591|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
155343242|NCT02367794|560688592|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
155343243|NCT02367794|560688590|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
155343244|NCT02367794|560688591|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
155343245|NCT02367794|560688592|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
155343246|NCT02367794|560688590|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
155343247|NCT02367794|560688591|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
155505511|NCT02082912|561278145|FG000|Overall Study|Physician Decision|0|||
155505512|NCT02082912|561278146|FG001|Overall Study|Physician Decision|1|||
155505513|NCT02614703|561278148|FG000|Overall Study|Withdrawal by Subject|7|||
155505514|NCT02614703|561278149|FG001|Overall Study|Withdrawal by Subject|1|||
155505515|NCT02402933|561278150|FG000|Overall Study|Withdrawal by Subject|4|||
155505516|NCT02402933|561278150|FG000|Overall Study|Discontinued; Site Termination|10|||
155505517|NCT01835132|561278161|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
155505518|NCT00856778|561278162|FG000|Overall Study|Adverse Event|7|||
155505519|NCT00856778|561278162|FG000|Overall Study|Withdrawal by Subject|10|||
155343248|NCT02367794|560688592|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
155343249|NCT01986348|560688593|FG000|Overall Study|Death|8|||
155343250|NCT01986348|560688594|FG001|Overall Study|Death|22|||
155343251|NCT01986348|560688595|FG002|Overall Study|Death|10|||
155343252|NCT01986348|560688596|FG003|Overall Study|Death|21|||
155343253|NCT01986348|560688593|FG000|Overall Study|Lost to Follow-up|0|||
155343254|NCT01986348|560688594|FG001|Overall Study|Lost to Follow-up|0|||
155343255|NCT01986348|560688595|FG002|Overall Study|Lost to Follow-up|0|||
155343256|NCT01986348|560688596|FG003|Overall Study|Lost to Follow-up|2|||
155343257|NCT01986348|560688593|FG000|Overall Study|Physician Decision|0|||
155343258|NCT01986348|560688594|FG001|Overall Study|Physician Decision|0|||
155343259|NCT01986348|560688595|FG002|Overall Study|Physician Decision|0|||
155343260|NCT01986348|560688596|FG003|Overall Study|Physician Decision|1|||
155343261|NCT01986348|560688593|FG000|Overall Study|Progressive Disease|0|||
155343262|NCT01986348|560688594|FG001|Overall Study|Progressive Disease|0|||
155343263|NCT01986348|560688595|FG002|Overall Study|Progressive Disease|2|||
155343264|NCT01986348|560688596|FG003|Overall Study|Progressive Disease|0|||
155343265|NCT01986348|560688593|FG000|Overall Study|Withdrawal by Participant|0|||
155343266|NCT01986348|560688594|FG001|Overall Study|Withdrawal by Participant|1|||
155343267|NCT01986348|560688595|FG002|Overall Study|Withdrawal by Participant|2|||
155343268|NCT01986348|560688596|FG003|Overall Study|Withdrawal by Participant|1|||
155343269|NCT01986348|560688593|FG000|Overall Study|Study Terminated by Sponsor|0|||
155424198|NCT05047523|560982337|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
155424199|NCT05047523|560982338|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
155424200|NCT05047523|560982333|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155424201|NCT05047523|560982334|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
155424202|NCT05047523|560982335|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155424203|NCT05047523|560982336|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155424204|NCT05047523|560982337|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155424205|NCT05047523|560982338|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
155424206|NCT05047523|560982333|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
155424207|NCT05047523|560982334|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
155505520|NCT00856778|561278162|FG000|Overall Study|Study deviation|2|||
155505521|NCT00856778|561278162|FG000|Overall Study|Lost to Follow-up|5|||
155505522|NCT01681771|561278163|FG000|Overall Study|Lost to Follow-up|4|||
155505523|NCT01681771|561278164|FG001|Overall Study|Lost to Follow-up|2|||
155505524|NCT00265083|561278165|FG000|Overall Study|Adverse Event|5|||
155505525|NCT00265083|561278166|FG001|Overall Study|Adverse Event|13|||
155505526|NCT00265083|561278167|FG002|Overall Study|Adverse Event|15|||
155505527|NCT00265083|561278165|FG000|Overall Study|Lost to Follow-up|3|||
155505528|NCT00265083|561278166|FG001|Overall Study|Lost to Follow-up|4|||
155505529|NCT00265083|561278167|FG002|Overall Study|Lost to Follow-up|4|||
155505530|NCT00265083|561278165|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
155505531|NCT00265083|561278166|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
155505532|NCT00265083|561278167|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
155505533|NCT00265083|561278165|FG000|Overall Study|Other|1|||
155343270|NCT01986348|560688594|FG001|Overall Study|Study Terminated by Sponsor|0|||
155343271|NCT01986348|560688595|FG002|Overall Study|Study Terminated by Sponsor|0|||
155505534|NCT00265083|561278166|FG001|Overall Study|Other|12|||
155343272|NCT01986348|560688596|FG003|Overall Study|Study Terminated by Sponsor|3|||
155343273|NCT01986348|560688593|FG000|Overall Study|Other-unspecified|0|||
155343274|NCT01986348|560688594|FG001|Overall Study|Other-unspecified|1|||
155343275|NCT01986348|560688595|FG002|Overall Study|Other-unspecified|0|||
155343276|NCT01986348|560688596|FG003|Overall Study|Other-unspecified|2|||
155343277|NCT02010684|560688597|FG000|Overall Study|Lost to Follow-up|8|||
155343278|NCT02010684|560688598|FG001|Overall Study|Lost to Follow-up|18|||
155343279|NCT02010684|560688597|FG000|Overall Study|Withdrawal by Subject|4|||
155424208|NCT05047523|560982335|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
155505535|NCT00265083|561278167|FG002|Overall Study|Other|9|||
155505536|NCT03208933|561278168|FG000|Overall Study|Death|3|||
155505537|NCT03208933|561278168|FG000|Overall Study|Withdrawal by Subject|3|||
155505538|NCT03208933|561278168|FG000|Overall Study|Adverse Event|1|||
155505539|NCT03208933|561278168|FG000|Overall Study|Lost to Follow-up|2|||
155505540|NCT03208933|561278168|FG000|Overall Study|Physician Decision|3|||
155505541|NCT03208933|561278168|FG000|Overall Study|Protocol Violation|1|||
155343280|NCT02010684|560688598|FG001|Overall Study|Withdrawal by Subject|5|||
155343281|NCT01884571|560688603|FG000|Overall Study|Adverse Event|1|||
155343282|NCT01884571|560688603|FG000|Overall Study|Death|2|||
155343283|NCT01884571|560688603|FG000|Overall Study|Withdrawal by Subject|2|||
155343284|NCT01884571|560688603|FG000|Overall Study|Disease progression|3|||
155343285|NCT02158806|560688608|FG000|Overall Study|Death|2|||
155343286|NCT02158806|560688609|FG001|Overall Study|Death|0|||
155343287|NCT02158806|560688608|FG000|Overall Study|Withdrawal by Subject|2|||
155343288|NCT02158806|560688609|FG001|Overall Study|Withdrawal by Subject|0|||
155343289|NCT02158806|560688608|FG000|Overall Study|Lost to Follow-up|0|||
155343290|NCT02158806|560688609|FG001|Overall Study|Lost to Follow-up|3|||
155343291|NCT02158806|560688608|FG000|Overall Study|Moved out of area|0|||
155343292|NCT02158806|560688609|FG001|Overall Study|Moved out of area|1|||
155343293|NCT02158806|560688608|FG000|Overall Study|Transferred to palliative care|0|||
155343294|NCT02158806|560688609|FG001|Overall Study|Transferred to palliative care|1|||
155343295|NCT01898299|560688613|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
155343296|NCT01898299|560688614|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
155343297|NCT02340806|560688615|FG000|Overall Study|Protocol Violation|2|||
155343298|NCT02340806|560688616|FG001|Overall Study|Protocol Violation|0|||
155343299|NCT02340806|560688615|FG000|Overall Study|epidural catheter replaced|2|||
155343300|NCT02340806|560688616|FG001|Overall Study|epidural catheter replaced|1|||
155343301|NCT02340806|560688615|FG000|Overall Study|history of chronic pain medication|1|||
155343302|NCT02340806|560688616|FG001|Overall Study|history of chronic pain medication|0|||
155343303|NCT02340806|560688615|FG000|Overall Study|re-dose < 90 min of CSE|1|||
155343304|NCT02340806|560688616|FG001|Overall Study|re-dose < 90 min of CSE|3|||
155343305|NCT01159600|560688618|FG000|Overall Study|Not treated|0|||
155343306|NCT01159600|560688619|FG001|Overall Study|Not treated|0|||
155343307|NCT01159600|560688620|FG002|Overall Study|Not treated|1|||
155343308|NCT01159600|560688621|FG003|Overall Study|Not treated|0|||
155343309|NCT01159600|560688622|FG004|Overall Study|Not treated|0|||
155343310|NCT01159600|560688623|FG005|Overall Study|Not treated|1|||
155343311|NCT01159600|560688624|FG006|Overall Study|Not treated|2|||
155343312|NCT01159600|560688625|FG007|Overall Study|Not treated|2|||
155343313|NCT01159600|560688618|FG000|Overall Study|Adverse Event|7|||
155343314|NCT01159600|560688619|FG001|Overall Study|Adverse Event|2|||
155343315|NCT01159600|560688620|FG002|Overall Study|Adverse Event|5|||
155343316|NCT01159600|560688621|FG003|Overall Study|Adverse Event|1|||
155343317|NCT01159600|560688622|FG004|Overall Study|Adverse Event|8|||
155343318|NCT01159600|560688623|FG005|Overall Study|Adverse Event|6|||
155343319|NCT01159600|560688624|FG006|Overall Study|Adverse Event|7|||
155343320|NCT01159600|560688625|FG007|Overall Study|Adverse Event|5|||
155343321|NCT01159600|560688618|FG000|Overall Study|Lack of Efficacy|0|||
155343322|NCT01159600|560688619|FG001|Overall Study|Lack of Efficacy|0|||
155343323|NCT01159600|560688620|FG002|Overall Study|Lack of Efficacy|0|||
155343324|NCT01159600|560688621|FG003|Overall Study|Lack of Efficacy|0|||
155343325|NCT01159600|560688622|FG004|Overall Study|Lack of Efficacy|2|||
155343326|NCT01159600|560688623|FG005|Overall Study|Lack of Efficacy|0|||
155343327|NCT01159600|560688624|FG006|Overall Study|Lack of Efficacy|0|||
155343328|NCT01159600|560688625|FG007|Overall Study|Lack of Efficacy|1|||
155343329|NCT01159600|560688618|FG000|Overall Study|Non compliant with protocol|2|||
155343330|NCT01159600|560688619|FG001|Overall Study|Non compliant with protocol|1|||
155343331|NCT01159600|560688620|FG002|Overall Study|Non compliant with protocol|0|||
155343332|NCT01159600|560688621|FG003|Overall Study|Non compliant with protocol|0|||
155343333|NCT01159600|560688622|FG004|Overall Study|Non compliant with protocol|2|||
155343334|NCT01159600|560688623|FG005|Overall Study|Non compliant with protocol|0|||
155505542|NCT00830063|561278177|FG000|Overall Study|Adverse Event|7|||
155505543|NCT00830063|561278178|FG001|Overall Study|Adverse Event|13|||
155647768|NCT03774810|561803679|FG001|Phase 1|Lack of Efficacy|0|||
155647769|NCT03774810|561803680|FG002|Phase 1|Lack of Efficacy|0|||
155647770|NCT03774810|561803681|FG003|Phase 1|Lack of Efficacy|0|||
155343335|NCT01159600|560688624|FG006|Overall Study|Non compliant with protocol|2|||
155343336|NCT01159600|560688625|FG007|Overall Study|Non compliant with protocol|0|||
155343337|NCT01159600|560688618|FG000|Overall Study|Lost to Follow-up|2|||
155343338|NCT01159600|560688619|FG001|Overall Study|Lost to Follow-up|3|||
155343339|NCT01159600|560688620|FG002|Overall Study|Lost to Follow-up|4|||
155505544|NCT00830063|561278179|FG002|Overall Study|Adverse Event|16|||
155343340|NCT01159600|560688621|FG003|Overall Study|Lost to Follow-up|3|||
155343341|NCT01159600|560688622|FG004|Overall Study|Lost to Follow-up|3|||
155343342|NCT01159600|560688623|FG005|Overall Study|Lost to Follow-up|0|||
155343343|NCT01159600|560688624|FG006|Overall Study|Lost to Follow-up|3|||
155343344|NCT01159600|560688625|FG007|Overall Study|Lost to Follow-up|2|||
155343345|NCT01159600|560688618|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
155505545|NCT00830063|561278180|FG003|Overall Study|Adverse Event|13|||
155343346|NCT01159600|560688619|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
155343347|NCT01159600|560688620|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
155343348|NCT01159600|560688621|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
155343349|NCT01159600|560688622|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
155343350|NCT01159600|560688623|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
155343351|NCT01159600|560688624|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
155343352|NCT01159600|560688625|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
155343353|NCT01159600|560688618|FG000|Overall Study|Other reason not defined above|3|||
155343354|NCT01159600|560688619|FG001|Overall Study|Other reason not defined above|0|||
155343355|NCT01159600|560688620|FG002|Overall Study|Other reason not defined above|4|||
155343356|NCT01159600|560688621|FG003|Overall Study|Other reason not defined above|2|||
155343357|NCT01159600|560688622|FG004|Overall Study|Other reason not defined above|5|||
155343358|NCT01159600|560688623|FG005|Overall Study|Other reason not defined above|7|||
155343359|NCT01159600|560688624|FG006|Overall Study|Other reason not defined above|3|||
155343360|NCT01159600|560688625|FG007|Overall Study|Other reason not defined above|3|||
155343361|NCT00760877|560689783|FG000|Overall Study|Protocol Violation|1|||
155343362|NCT00760877|560689784|FG001|Overall Study|Protocol Violation|0|||
155343363|NCT00760877|560689783|FG000|Overall Study|Non-compliance with protocol treatment|2|||
155343364|NCT00760877|560689784|FG001|Overall Study|Non-compliance with protocol treatment|1|||
155343365|NCT00760877|560689783|FG000|Overall Study|Pregnancy|1|||
155343366|NCT00760877|560689784|FG001|Overall Study|Pregnancy|4|||
155343367|NCT00760877|560689783|FG000|Overall Study|Death|2|||
155343368|NCT00760877|560689784|FG001|Overall Study|Death|1|||
155343369|NCT00760877|560689783|FG000|Overall Study|Withdrawal by Subject|7|||
155343370|NCT00760877|560689784|FG001|Overall Study|Withdrawal by Subject|3|||
155343371|NCT00760877|560689783|FG000|Overall Study|Adverse Event|19|||
155343372|NCT00760877|560689784|FG001|Overall Study|Adverse Event|12|||
155343373|NCT00760877|560689783|FG000|Overall Study|Participant diagnosed with AML|0|||
155343374|NCT00760877|560689784|FG001|Overall Study|Participant diagnosed with AML|1|||
155343375|NCT00760877|560689783|FG000|Overall Study|Participant not eligible to cross-over|0|||
155343376|NCT00760877|560689784|FG001|Overall Study|Participant not eligible to cross-over|1|||
155343377|NCT00760877|560689783|FG000|Overall Study|Physician Decision|1|||
155343378|NCT00760877|560689784|FG001|Overall Study|Physician Decision|2|||
155343379|NCT00760877|560689783|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
155343380|NCT00760877|560689784|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
155343381|NCT00760877|560689783|FG000|Overall Study|Treatment failure|1|||
155343382|NCT00760877|560689784|FG001|Overall Study|Treatment failure|0|||
155343383|NCT02101554|560689790|FG000|Overall Study|Protocol Violation|0|||
155343384|NCT02101554|560689791|FG001|Overall Study|Protocol Violation|1|||
155343385|NCT02101554|560689792|FG002|Overall Study|Protocol Violation|0|||
155343386|NCT02101554|560689790|FG000|Overall Study|Insufficient Clinical Response|0|||
155343387|NCT02101554|560689791|FG001|Overall Study|Insufficient Clinical Response|2|||
155343388|NCT02101554|560689792|FG002|Overall Study|Insufficient Clinical Response|0|||
155343389|NCT02101554|560689790|FG000|Overall Study|Adverse Event|2|||
155343390|NCT02101554|560689791|FG001|Overall Study|Adverse Event|1|||
155343391|NCT02101554|560689792|FG002|Overall Study|Adverse Event|1|||
155343392|NCT02101554|560689790|FG000|Overall Study|Lost to Follow-up|0|||
155343393|NCT02101554|560689791|FG001|Overall Study|Lost to Follow-up|1|||
155343394|NCT02101554|560689792|FG002|Overall Study|Lost to Follow-up|0|||
155343395|NCT02101554|560689790|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
155343396|NCT02101554|560689791|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
155343397|NCT02101554|560689792|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
155343398|NCT04820023|560689793|FG000|Overall Study|Death|0|||
155343399|NCT04820023|560689794|FG001|Overall Study|Death|0|||
155343400|NCT04820023|560689795|FG002|Overall Study|Death|0|||
155343401|NCT04820023|560689796|FG003|Overall Study|Death|0|||
155343402|NCT04820023|560689797|FG004|Overall Study|Death|0|||
155647771|NCT03774810|561803682|FG004|Phase 1|Lack of Efficacy|0|||
155647772|NCT03774810|561803678|FG000|Phase 1|Withdrawal by Subject|9|||
155647773|NCT03774810|561803679|FG001|Phase 1|Withdrawal by Subject|0|||
155647774|NCT03774810|561803680|FG002|Phase 1|Withdrawal by Subject|0|||
155647775|NCT03774810|561803681|FG003|Phase 1|Withdrawal by Subject|0|||
155343403|NCT04820023|560689798|FG005|Overall Study|Death|0|||
155343404|NCT04820023|560689799|FG006|Overall Study|Death|1|||
155343405|NCT04820023|560689800|FG007|Overall Study|Death|0|||
155343406|NCT04820023|560689801|FG008|Overall Study|Death|1|||
155343407|NCT04820023|560689793|FG000|Overall Study|Withdrawal by Subject|1|||
155343408|NCT04820023|560689794|FG001|Overall Study|Withdrawal by Subject|2|||
155343409|NCT04820023|560689795|FG002|Overall Study|Withdrawal by Subject|2|||
155647776|NCT03774810|561803682|FG004|Phase 1|Withdrawal by Subject|0|||
155647777|NCT03774810|561803678|FG000|Phase 1|Lost to Follow-up|2|||
155343410|NCT04820023|560689796|FG003|Overall Study|Withdrawal by Subject|1|||
155343411|NCT04820023|560689797|FG004|Overall Study|Withdrawal by Subject|4|||
155343412|NCT04820023|560689798|FG005|Overall Study|Withdrawal by Subject|3|||
155343413|NCT04820023|560689799|FG006|Overall Study|Withdrawal by Subject|3|||
155343414|NCT04820023|560689800|FG007|Overall Study|Withdrawal by Subject|6|||
155343415|NCT04820023|560689801|FG008|Overall Study|Withdrawal by Subject|5|||
155343416|NCT04820023|560689793|FG000|Overall Study|Progressive Disease|3|||
155343417|NCT04820023|560689794|FG001|Overall Study|Progressive Disease|0|||
155343418|NCT04820023|560689795|FG002|Overall Study|Progressive Disease|2|||
155343419|NCT04820023|560689796|FG003|Overall Study|Progressive Disease|2|||
155343420|NCT04820023|560689797|FG004|Overall Study|Progressive Disease|2|||
155343421|NCT04820023|560689798|FG005|Overall Study|Progressive Disease|0|||
155343422|NCT04820023|560689799|FG006|Overall Study|Progressive Disease|1|||
155343423|NCT04820023|560689800|FG007|Overall Study|Progressive Disease|1|||
155343424|NCT04820023|560689801|FG008|Overall Study|Progressive Disease|0|||
155343425|NCT04820023|560689793|FG000|Overall Study|New anti-cancer therapy|0|||
155343426|NCT04820023|560689794|FG001|Overall Study|New anti-cancer therapy|0|||
155343427|NCT04820023|560689795|FG002|Overall Study|New anti-cancer therapy|0|||
155343428|NCT04820023|560689796|FG003|Overall Study|New anti-cancer therapy|0|||
155343429|NCT04820023|560689797|FG004|Overall Study|New anti-cancer therapy|2|||
155343430|NCT04820023|560689798|FG005|Overall Study|New anti-cancer therapy|0|||
155343431|NCT04820023|560689799|FG006|Overall Study|New anti-cancer therapy|0|||
155343432|NCT04820023|560689800|FG007|Overall Study|New anti-cancer therapy|0|||
155343433|NCT04820023|560689801|FG008|Overall Study|New anti-cancer therapy|0|||
155343434|NCT04820023|560689793|FG000|Overall Study|Other|0|||
155343435|NCT04820023|560689794|FG001|Overall Study|Other|1|||
155343436|NCT04820023|560689795|FG002|Overall Study|Other|0|||
155343437|NCT04820023|560689796|FG003|Overall Study|Other|0|||
155343438|NCT04820023|560689797|FG004|Overall Study|Other|0|||
155343439|NCT04820023|560689798|FG005|Overall Study|Other|0|||
155343440|NCT04820023|560689799|FG006|Overall Study|Other|0|||
155343441|NCT04820023|560689800|FG007|Overall Study|Other|2|||
155343442|NCT04820023|560689801|FG008|Overall Study|Other|0|||
155343443|NCT04049578|560689803|FG000|Overall Study|Physician Decision|1|||
155343444|NCT01945593|560689808|FG000|Overall Study|Adverse Event|0|||
155343445|NCT01945593|560689809|FG001|Overall Study|Adverse Event|0|||
155343446|NCT01945593|560689810|FG002|Overall Study|Adverse Event|0|||
155343447|NCT01945593|560689811|FG003|Overall Study|Adverse Event|5|||
155343448|NCT01945593|560689808|FG000|Overall Study|Physician Decision|0|||
155343449|NCT01945593|560689809|FG001|Overall Study|Physician Decision|0|||
155343450|NCT01945593|560689810|FG002|Overall Study|Physician Decision|1|||
155343451|NCT01945593|560689811|FG003|Overall Study|Physician Decision|1|||
155343452|NCT01945593|560689808|FG000|Overall Study|Withdrawal by Subject|0|||
155343453|NCT01945593|560689809|FG001|Overall Study|Withdrawal by Subject|2|||
155343454|NCT01945593|560689810|FG002|Overall Study|Withdrawal by Subject|0|||
155343455|NCT01945593|560689811|FG003|Overall Study|Withdrawal by Subject|4|||
155343456|NCT01945593|560689808|FG000|Overall Study|Protocol Violation|0|||
155343457|NCT01945593|560689809|FG001|Overall Study|Protocol Violation|2|||
155343458|NCT01945593|560689810|FG002|Overall Study|Protocol Violation|1|||
155343459|NCT01945593|560689811|FG003|Overall Study|Protocol Violation|3|||
155343460|NCT01945593|560689808|FG000|Overall Study|Death|0|||
155343461|NCT01945593|560689809|FG001|Overall Study|Death|0|||
155343462|NCT01945593|560689810|FG002|Overall Study|Death|1|||
155343463|NCT01945593|560689811|FG003|Overall Study|Death|0|||
155343464|NCT01945593|560689808|FG000|Overall Study|Other: Terminated|0|||
155343465|NCT01945593|560689809|FG001|Overall Study|Other: Terminated|0|||
155343466|NCT01945593|560689810|FG002|Overall Study|Other: Terminated|0|||
155343467|NCT01945593|560689811|FG003|Overall Study|Other: Terminated|1|||
155424209|NCT05047523|560982336|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
155424210|NCT05047523|560982337|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
155424211|NCT05047523|560982338|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
155424212|NCT05047523|560982333|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
155343468|NCT01945593|560689808|FG000|Overall Study|Other: Surgical Procedure|0|||
155343469|NCT01945593|560689809|FG001|Overall Study|Other: Surgical Procedure|2|||
155343470|NCT01945593|560689810|FG002|Overall Study|Other: Surgical Procedure|0|||
155343471|NCT01945593|560689811|FG003|Overall Study|Other: Surgical Procedure|6|||
155343472|NCT01945593|560689808|FG000|Overall Study|Other: Screen Failure|0|||
155343473|NCT01945593|560689809|FG001|Overall Study|Other: Screen Failure|2|||
155343474|NCT01945593|560689810|FG002|Overall Study|Other: Screen Failure|0|||
155505546|NCT00830063|561278177|FG000|Overall Study|Death|1|||
155343475|NCT01945593|560689811|FG003|Overall Study|Other: Screen Failure|0|||
155343476|NCT00228813|560689812|FG000|Overall Study|Death|4|||
155343477|NCT02109172|560689819|FG000|Overall Study|Withdrawal by Subject|1|||
155343478|NCT02109172|560689820|FG001|Overall Study|Withdrawal by Subject|0|||
155343479|NCT02109172|560689821|FG002|Overall Study|Withdrawal by Subject|0|||
155343480|NCT02109172|560689822|FG003|Overall Study|Withdrawal by Subject|1|||
155343481|NCT02109172|560689823|FG004|Overall Study|Withdrawal by Subject|0|||
155343482|NCT02109172|560689824|FG005|Overall Study|Withdrawal by Subject|0|||
155343483|NCT02109172|560689819|FG000|Overall Study|Adverse Event|0|||
155343484|NCT02109172|560689820|FG001|Overall Study|Adverse Event|0|||
155343485|NCT02109172|560689821|FG002|Overall Study|Adverse Event|1|||
155343486|NCT02109172|560689822|FG003|Overall Study|Adverse Event|0|||
155343487|NCT02109172|560689823|FG004|Overall Study|Adverse Event|0|||
155343488|NCT02109172|560689824|FG005|Overall Study|Adverse Event|1|||
155343489|NCT02109172|560689819|FG000|Overall Study|Death|0|||
155343490|NCT02109172|560689820|FG001|Overall Study|Death|0|||
155343491|NCT02109172|560689821|FG002|Overall Study|Death|0|||
155343492|NCT02109172|560689822|FG003|Overall Study|Death|0|||
155343493|NCT02109172|560689823|FG004|Overall Study|Death|1|||
155343494|NCT02109172|560689824|FG005|Overall Study|Death|0|||
155343495|NCT03605745|560689825|FG000|Overall Study|Study was terminated for business reasons|47|||
155343496|NCT01279447|560689826|FG000|Overall Study|Lost to Follow-up|3|||
155343497|NCT01279447|560689827|FG001|Overall Study|Lost to Follow-up|1|||
155343498|NCT02213094|560689831|FG000|Overall Study|Adverse Event|1|||
155343499|NCT02213094|560689832|FG001|Overall Study|Adverse Event|0|||
155343500|NCT01074229|560689833|FG000|Overall Study|Lost to Follow-up|1|||
155343501|NCT01074229|560689834|FG001|Overall Study|Lost to Follow-up|0|||
155343502|NCT01074229|560689835|FG002|Overall Study|Lost to Follow-up|0|||
155343503|NCT01074229|560689833|FG000|Overall Study|Change to open surgical procedure|1|||
155343504|NCT01074229|560689834|FG001|Overall Study|Change to open surgical procedure|3|||
155343505|NCT01074229|560689835|FG002|Overall Study|Change to open surgical procedure|4|||
155343506|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
155343507|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
155343508|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
155343509|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
155343510|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
155343511|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
155343512|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
155343513|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
155343514|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
155343515|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
155343516|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
155343517|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
155343518|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
155343519|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
155343520|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Death|8|||
155343521|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
155343522|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
155343523|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
155343524|NCT00555620|560689838|FG000|Overall Study|Death|0|||
155343525|NCT00555620|560689839|FG001|Overall Study|Death|1|||
155343526|NCT00555620|560689840|FG002|Overall Study|Death|0|||
155343527|NCT00555620|560689841|FG003|Overall Study|Death|0|||
155343528|NCT00555620|560689842|FG004|Overall Study|Death|0|||
155343529|NCT00555620|560689843|FG005|Overall Study|Death|1|||
155343530|NCT00555620|560689838|FG000|Overall Study|Study terminated by sponsor|0|||
155343531|NCT00555620|560689839|FG001|Overall Study|Study terminated by sponsor|0|||
155343532|NCT00555620|560689840|FG002|Overall Study|Study terminated by sponsor|1|||
155343533|NCT00555620|560689841|FG003|Overall Study|Study terminated by sponsor|0|||
155343534|NCT00555620|560689842|FG004|Overall Study|Study terminated by sponsor|0|||
155343535|NCT00555620|560689843|FG005|Overall Study|Study terminated by sponsor|0|||
155343536|NCT00555620|560689838|FG000|Overall Study|Adverse Event|0|||
155343537|NCT00555620|560689839|FG001|Overall Study|Adverse Event|0|||
155343538|NCT00555620|560689840|FG002|Overall Study|Adverse Event|1|||
155343539|NCT00555620|560689841|FG003|Overall Study|Adverse Event|5|||
155343540|NCT00555620|560689842|FG004|Overall Study|Adverse Event|0|||
155343541|NCT00555620|560689843|FG005|Overall Study|Adverse Event|1|||
155343542|NCT00555620|560689838|FG000|Overall Study|Objective progression or relapse|6|||
155343543|NCT00555620|560689839|FG001|Overall Study|Objective progression or relapse|5|||
155343544|NCT00555620|560689840|FG002|Overall Study|Objective progression or relapse|12|||
155343545|NCT00555620|560689841|FG003|Overall Study|Objective progression or relapse|17|||
155343546|NCT00555620|560689842|FG004|Overall Study|Objective progression or relapse|3|||
155343547|NCT00555620|560689843|FG005|Overall Study|Objective progression or relapse|16|||
155343548|NCT00555620|560689838|FG000|Overall Study|Participant refused treatment|0|||
155343549|NCT00555620|560689839|FG001|Overall Study|Participant refused treatment|1|||
155343550|NCT00555620|560689840|FG002|Overall Study|Participant refused treatment|1|||
155343551|NCT00555620|560689841|FG003|Overall Study|Participant refused treatment|0|||
155343552|NCT00555620|560689842|FG004|Overall Study|Participant refused treatment|0|||
155343553|NCT00555620|560689843|FG005|Overall Study|Participant refused treatment|1|||
155343554|NCT00555620|560689838|FG000|Overall Study|Other|0|||
155343555|NCT00555620|560689839|FG001|Overall Study|Other|0|||
155343556|NCT00555620|560689840|FG002|Overall Study|Other|0|||
155343557|NCT00555620|560689841|FG003|Overall Study|Other|1|||
155343558|NCT00555620|560689842|FG004|Overall Study|Other|0|||
155343559|NCT00555620|560689843|FG005|Overall Study|Other|3|||
155343560|NCT05203822|560689844|FG000|Overall Study|Adverse Event|1|||
155343561|NCT05203822|560689844|FG000|Overall Study|Withdrawal by Subject|1|||
155343562|NCT05361304|560689849|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
155343563|NCT05361304|560689850|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
155343564|NCT05361304|560689849|FG000|Overall Study|COVID-19 Related|1|||
155343565|NCT05361304|560689850|FG001|Overall Study|COVID-19 Related|2|||
155343566|NCT05361304|560689849|FG000|Overall Study|Withdrawal by Subject|1|||
155343567|NCT05361304|560689850|FG001|Overall Study|Withdrawal by Subject|0|||
155343568|NCT03320941|560689851|FG000|Overall Study|subject/guardian decision|0|||
155343569|NCT03320941|560689852|FG001|Overall Study|subject/guardian decision|0|||
155343570|NCT03320941|560689853|FG002|Overall Study|subject/guardian decision|0|||
155343571|NCT03320941|560689854|FG003|Overall Study|subject/guardian decision|1|||
155343572|NCT03320941|560689855|FG004|Overall Study|subject/guardian decision|0|||
155343573|NCT03360071|560689857|FG000|Overall Study|Lost to Follow-up|1|||
155343574|NCT03360071|560689858|FG001|Overall Study|Lost to Follow-up|0|||
155343575|NCT03184519|560689863|FG000|Overall Study|Lost to Follow-up|6|||
155343576|NCT03184519|560689863|FG000|Overall Study|Physician Decision|21|||
155343577|NCT05104242|560689868|FG000|Overall Study|Withdrawal by Subject|1|||
155343578|NCT05104242|560689869|FG001|Overall Study|Withdrawal by Subject|5|||
155343579|NCT05104242|560689868|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
155343580|NCT05104242|560689869|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
155343581|NCT00901459|560689875|FG000|Overall Study|Withdrawal by Subject|6|||
155343582|NCT04765046|560689876|FG000|Overall Study|Screen Failure|2|||
155343583|NCT04765046|560689876|FG000|Overall Study|Withdrawal by Subject|4|||
155343584|NCT04765046|560689876|FG000|Overall Study|Physician Decision|4|||
155343585|NCT04765046|560689876|FG000|Overall Study|Surgery Cancelled|8|||
155343586|NCT02959866|560689880|FG000|Overall Study|Withdrawal by Subject|1|||
155343588|NCT04529941|560689885|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
155343589|NCT04529941|560689886|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
155343590|NCT01005914|560689887|FG000|Overall Study|Adverse Event|4|||
155343591|NCT01005914|560689887|FG000|Overall Study|Death|4|||
155343592|NCT01005914|560689887|FG000|Overall Study|Lack of Efficacy|1|||
155343593|NCT01005914|560689887|FG000|Overall Study|Withdrawal by Subject|1|||
155343594|NCT01240785|560689888|FG000|Overall Study|Lost to Follow-up|1|||
155343595|NCT01240785|560689889|FG001|Overall Study|Lost to Follow-up|0|||
155343596|NCT01240785|560689888|FG000|Overall Study|Protocol Violation|0|||
155343597|NCT01240785|560689889|FG001|Overall Study|Protocol Violation|3|||
155343598|NCT00321555|560689894|FG000|Overall Study|Developed antibodies|1|||
155343599|NCT00321555|560689894|FG000|Overall Study|Switched to alternative treatment|3|||
155424213|NCT05047523|560982334|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155424214|NCT05047523|560982335|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155424215|NCT05047523|560982336|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155424216|NCT05047523|560982337|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155424217|NCT05047523|560982338|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
155424218|NCT05047523|560982333|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
155424219|NCT05047523|560982334|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
155424220|NCT05047523|560982335|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
155424221|NCT05047523|560982336|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
155343600|NCT00321555|560689894|FG000|Overall Study|Physician Decision|1|||
155343601|NCT00321555|560689894|FG000|Overall Study|Disease progression on study|1|||
155505547|NCT00830063|561278178|FG001|Overall Study|Death|0|||
155343602|NCT04520256|560689897|FG000|Overall Study|Lost to Follow-up|6|||
155343603|NCT04520256|560689898|FG001|Overall Study|Lost to Follow-up|4|||
155343604|NCT04520256|560689899|FG002|Overall Study|Lost to Follow-up|2|||
155343605|NCT04520256|560689900|FG003|Overall Study|Lost to Follow-up|3|||
155343606|NCT04520256|560689901|FG004|Overall Study|Lost to Follow-up|6|||
155343607|NCT04520256|560689902|FG005|Overall Study|Lost to Follow-up|6|||
155343608|NCT04520256|560689903|FG006|Overall Study|Lost to Follow-up|4|||
155505548|NCT00830063|561278179|FG002|Overall Study|Death|0|||
155343609|NCT04520256|560689904|FG007|Overall Study|Lost to Follow-up|6|||
155343610|NCT04520256|560689905|FG008|Overall Study|Lost to Follow-up|1|||
155343611|NCT04520256|560689906|FG009|Overall Study|Lost to Follow-up|3|||
155343612|NCT04520256|560689907|FG010|Overall Study|Lost to Follow-up|3|||
155343613|NCT04520256|560689908|FG011|Overall Study|Lost to Follow-up|2|||
155343614|NCT04520256|560689909|FG012|Overall Study|Lost to Follow-up|5|||
155343615|NCT04520256|560689910|FG013|Overall Study|Lost to Follow-up|3|||
155343616|NCT04520256|560689911|FG014|Overall Study|Lost to Follow-up|3|||
155343617|NCT04520256|560689912|FG015|Overall Study|Lost to Follow-up|6|||
155343618|NCT04520256|560689913|FG016|Overall Study|Lost to Follow-up|6|||
155343619|NCT04520256|560689914|FG017|Overall Study|Lost to Follow-up|4|||
155343620|NCT04520256|560689915|FG018|Overall Study|Lost to Follow-up|3|||
155343621|NCT04520256|560689916|FG019|Overall Study|Lost to Follow-up|3|||
155343622|NCT04520256|560689917|FG020|Overall Study|Lost to Follow-up|7|||
155343623|NCT04520256|560689918|FG021|Overall Study|Lost to Follow-up|3|||
155343624|NCT04520256|560689919|FG022|Overall Study|Lost to Follow-up|3|||
155343625|NCT04520256|560689920|FG023|Overall Study|Lost to Follow-up|8|||
155343626|NCT04520256|560689921|FG024|Overall Study|Lost to Follow-up|5|||
155343627|NCT04520256|560689922|FG025|Overall Study|Lost to Follow-up|4|||
155343628|NCT04520256|560689923|FG026|Overall Study|Lost to Follow-up|3|||
155343629|NCT04520256|560689924|FG027|Overall Study|Lost to Follow-up|4|||
155343630|NCT04520256|560689925|FG028|Overall Study|Lost to Follow-up|3|||
155343631|NCT04520256|560689926|FG029|Overall Study|Lost to Follow-up|4|||
155343632|NCT04520256|560689927|FG030|Overall Study|Lost to Follow-up|4|||
155343633|NCT04520256|560689928|FG031|Overall Study|Lost to Follow-up|4|||
155343634|NCT01730118|560691323|FG000|Dose Escalation|Death on study|5|||
155343635|NCT01730118|560691324|FG001|Dose Escalation|Death on study|7|||
155343636|NCT01730118|560691325|FG002|Dose Escalation|Death on study|2|||
155343637|NCT01730118|560691326|FG003|Dose Escalation|Death on study|6|||
155343638|NCT01730118|560691327|FG004|Dose Escalation|Death on study|0|||
155343639|NCT01730118|560691328|FG005|Dose Escalation|Death on study|0|||
155343640|NCT01730118|560691329|FG006|Dose Escalation|Death on study|0|||
155343641|NCT01730118|560691323|FG000|Dose Escalation|Died before treatment|0|||
155343642|NCT01730118|560691324|FG001|Dose Escalation|Died before treatment|0|||
155343643|NCT01730118|560691325|FG002|Dose Escalation|Died before treatment|0|||
155343644|NCT01730118|560691326|FG003|Dose Escalation|Died before treatment|0|||
155343645|NCT01730118|560691327|FG004|Dose Escalation|Died before treatment|0|||
155343646|NCT01730118|560691328|FG005|Dose Escalation|Died before treatment|0|||
155343647|NCT01730118|560691329|FG006|Dose Escalation|Died before treatment|1|||
155343648|NCT01730118|560691323|FG000|Dose Escalation|Chose to start a different treatment|1|||
155343649|NCT01730118|560691324|FG001|Dose Escalation|Chose to start a different treatment|0|||
155343650|NCT01730118|560691325|FG002|Dose Escalation|Chose to start a different treatment|0|||
155343651|NCT01730118|560691326|FG003|Dose Escalation|Chose to start a different treatment|0|||
155343652|NCT01730118|560691327|FG004|Dose Escalation|Chose to start a different treatment|0|||
155343653|NCT01730118|560691328|FG005|Dose Escalation|Chose to start a different treatment|0|||
155343654|NCT01730118|560691329|FG006|Dose Escalation|Chose to start a different treatment|0|||
155343655|NCT01730118|560691323|FG000|Dose Escalation|Withdrawal by Subject|0|||
155343656|NCT01730118|560691324|FG001|Dose Escalation|Withdrawal by Subject|0|||
155343657|NCT01730118|560691325|FG002|Dose Escalation|Withdrawal by Subject|1|||
155343658|NCT01730118|560691326|FG003|Dose Escalation|Withdrawal by Subject|0|||
155343659|NCT01730118|560691327|FG004|Dose Escalation|Withdrawal by Subject|0|||
155343660|NCT01730118|560691328|FG005|Dose Escalation|Withdrawal by Subject|0|||
155343661|NCT01730118|560691329|FG006|Dose Escalation|Withdrawal by Subject|0|||
155343662|NCT01730118|560691323|FG000|Dose Escalation|Disease progression prior to treatment|0|||
155343663|NCT01730118|560691324|FG001|Dose Escalation|Disease progression prior to treatment|0|||
155343664|NCT01730118|560691325|FG002|Dose Escalation|Disease progression prior to treatment|0|||
155343665|NCT01730118|560691326|FG003|Dose Escalation|Disease progression prior to treatment|0|||
155343666|NCT01730118|560691327|FG004|Dose Escalation|Disease progression prior to treatment|0|||
155343667|NCT01730118|560691328|FG005|Dose Escalation|Disease progression prior to treatment|0|||
155343668|NCT01730118|560691329|FG006|Dose Escalation|Disease progression prior to treatment|1|||
155343669|NCT01730118|560691323|FG000|Dose Expansion|Death|0|||
155343670|NCT01730118|560691324|FG001|Dose Expansion|Death|0|||
155343671|NCT01730118|560691325|FG002|Dose Expansion|Death|0|||
155343672|NCT01730118|560691326|FG003|Dose Expansion|Death|0|||
155343673|NCT01730118|560691327|FG004|Dose Expansion|Death|1|||
155343674|NCT01730118|560691328|FG005|Dose Expansion|Death|0|||
155343675|NCT01730118|560691329|FG006|Dose Expansion|Death|0|||
155343676|NCT01730118|560691323|FG000|Dose Expansion|Other medical condition|0|||
155343677|NCT01730118|560691324|FG001|Dose Expansion|Other medical condition|0|||
155343678|NCT01730118|560691325|FG002|Dose Expansion|Other medical condition|0|||
155343679|NCT01730118|560691326|FG003|Dose Expansion|Other medical condition|0|||
155343680|NCT01730118|560691327|FG004|Dose Expansion|Other medical condition|1|||
155343681|NCT01730118|560691328|FG005|Dose Expansion|Other medical condition|0|||
155343682|NCT01730118|560691329|FG006|Dose Expansion|Other medical condition|0|||
155343683|NCT01730118|560691323|FG000|Dose Expansion|Withdrawal by Subject|0|||
155343684|NCT01730118|560691324|FG001|Dose Expansion|Withdrawal by Subject|0|||
155343685|NCT01730118|560691325|FG002|Dose Expansion|Withdrawal by Subject|0|||
155343686|NCT01730118|560691326|FG003|Dose Expansion|Withdrawal by Subject|0|||
155343687|NCT01730118|560691327|FG004|Dose Expansion|Withdrawal by Subject|1|||
155343688|NCT01730118|560691328|FG005|Dose Expansion|Withdrawal by Subject|0|||
155343689|NCT01730118|560691329|FG006|Dose Expansion|Withdrawal by Subject|0|||
155424222|NCT05047523|560982337|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
155424223|NCT05047523|560982338|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
155424224|NCT05047523|560982333|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
155424225|NCT05047523|560982334|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
155424226|NCT05047523|560982335|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
155424227|NCT05047523|560982336|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
155424228|NCT05047523|560982337|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
155343690|NCT01730118|560691323|FG000|Dose Expansion|Disease progression|0|||
155343691|NCT01730118|560691324|FG001|Dose Expansion|Disease progression|0|||
155343692|NCT01730118|560691325|FG002|Dose Expansion|Disease progression|0|||
155343693|NCT01730118|560691326|FG003|Dose Expansion|Disease progression|0|||
155343694|NCT01730118|560691327|FG004|Dose Expansion|Disease progression|0|||
155343695|NCT01730118|560691328|FG005|Dose Expansion|Disease progression|1|||
155343696|NCT01730118|560691329|FG006|Dose Expansion|Disease progression|0|||
155343697|NCT01730118|560691323|FG000|Dose Expansion|Inability to return|0|||
155343698|NCT01730118|560691324|FG001|Dose Expansion|Inability to return|0|||
155343699|NCT01730118|560691325|FG002|Dose Expansion|Inability to return|0|||
155343700|NCT01730118|560691326|FG003|Dose Expansion|Inability to return|0|||
155343701|NCT01730118|560691327|FG004|Dose Expansion|Inability to return|0|||
155343702|NCT01730118|560691328|FG005|Dose Expansion|Inability to return|1|||
155343703|NCT01730118|560691329|FG006|Dose Expansion|Inability to return|0|||
155343704|NCT01730118|560691323|FG000|Dose Expansion|Physician Decision|0|||
155343705|NCT01730118|560691324|FG001|Dose Expansion|Physician Decision|0|||
155343706|NCT01730118|560691325|FG002|Dose Expansion|Physician Decision|0|||
155343707|NCT01730118|560691326|FG003|Dose Expansion|Physician Decision|0|||
155343708|NCT01730118|560691327|FG004|Dose Expansion|Physician Decision|0|||
155343709|NCT01730118|560691328|FG005|Dose Expansion|Physician Decision|1|||
155343710|NCT01730118|560691329|FG006|Dose Expansion|Physician Decision|0|||
155343711|NCT05356130|560691331|FG000|Overall Study|Withdrawal by Subject|0|||
155424229|NCT05047523|560982338|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
155424230|NCT00224016|560982339|FG000|Titration Period|Withdrawal by Subject|0|||
155424231|NCT00224016|560982340|FG001|Titration Period|Withdrawal by Subject|1|||
155424232|NCT00224016|560982339|FG000|Titration Period|Lost to Follow-up|1|||
155424233|NCT00224016|560982340|FG001|Titration Period|Lost to Follow-up|0|||
155424234|NCT00224016|560982339|FG000|Maintenance Period|Withdrawal by Subject|2|||
155424235|NCT00224016|560982340|FG001|Maintenance Period|Withdrawal by Subject|0|||
155424236|NCT00224016|560982339|FG000|Maintenance Period|Lost to Follow-up|0|||
155343712|NCT05356130|560691332|FG001|Overall Study|Withdrawal by Subject|0|||
155343713|NCT05356130|560691333|FG002|Overall Study|Withdrawal by Subject|3|||
155343714|NCT04851587|560691334|FG000|Overall Study|Lost to Follow-up|18|||
155424237|NCT00224016|560982340|FG001|Maintenance Period|Lost to Follow-up|1|||
155424238|NCT00582556|560982343|FG000|Overall Study|Withdrawal by Subject|0|||
155424239|NCT00582556|560982344|FG001|Overall Study|Withdrawal by Subject|1|||
155424240|NCT00582556|560982345|FG002|Overall Study|Withdrawal by Subject|1|||
155343715|NCT00538629|560691336|FG000|Overall Study|At subject's request|1|||
155343716|NCT00538629|560691336|FG000|Overall Study|Adverse Event|2|||
155343717|NCT00538629|560691336|FG000|Overall Study|Lack of Efficacy|12|||
155343718|NCT00538629|560691336|FG000|Overall Study|Lost to Follow-up|6|||
155343719|NCT00538629|560691336|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
155343720|NCT04454125|560691341|FG000|Overall Study|Lost to Follow-up|0|||
155343721|NCT04454125|560691342|FG001|Overall Study|Lost to Follow-up|1|||
155343722|NCT01183013|560691345|FG000|Overall Study|Adverse Event|6|||
155343723|NCT01183013|560691346|FG001|Overall Study|Adverse Event|8|||
155343724|NCT01183013|560691347|FG002|Overall Study|Adverse Event|5|||
155343725|NCT01183013|560691348|FG003|Overall Study|Adverse Event|5|||
155343726|NCT01183013|560691349|FG004|Overall Study|Adverse Event|10|||
155343727|NCT01183013|560691350|FG005|Overall Study|Adverse Event|10|||
155343728|NCT01183013|560691351|FG006|Overall Study|Adverse Event|6|||
155343729|NCT01183013|560691345|FG000|Overall Study|Lack of Efficacy|3|||
155343730|NCT01183013|560691346|FG001|Overall Study|Lack of Efficacy|2|||
155343731|NCT01183013|560691347|FG002|Overall Study|Lack of Efficacy|1|||
155343732|NCT01183013|560691348|FG003|Overall Study|Lack of Efficacy|2|||
155343733|NCT01183013|560691349|FG004|Overall Study|Lack of Efficacy|1|||
155343734|NCT01183013|560691350|FG005|Overall Study|Lack of Efficacy|2|||
155424241|NCT00582556|560982343|FG000|Overall Study|Physician Decision|0|||
155343735|NCT01183013|560691351|FG006|Overall Study|Lack of Efficacy|0|||
155343736|NCT01183013|560691345|FG000|Overall Study|Protocol Violation|5|||
155424242|NCT00582556|560982344|FG001|Overall Study|Physician Decision|0|||
155343737|NCT01183013|560691346|FG001|Overall Study|Protocol Violation|2|||
155424243|NCT00582556|560982345|FG002|Overall Study|Physician Decision|1|||
155424244|NCT01993888|560982346|FG000|Overall Study|Death|1|||
155424245|NCT01993888|560982347|FG001|Overall Study|Death|1|||
155343738|NCT01183013|560691347|FG002|Overall Study|Protocol Violation|4|||
155424246|NCT01993888|560982346|FG000|Overall Study|Lost to Follow-up|1|||
155343739|NCT01183013|560691348|FG003|Overall Study|Protocol Violation|0|||
155343740|NCT01183013|560691349|FG004|Overall Study|Protocol Violation|4|||
155343741|NCT01183013|560691350|FG005|Overall Study|Protocol Violation|3|||
155343742|NCT01183013|560691351|FG006|Overall Study|Protocol Violation|3|||
155343743|NCT01183013|560691345|FG000|Overall Study|Lost to Follow-up|7|||
155343744|NCT01183013|560691346|FG001|Overall Study|Lost to Follow-up|3|||
155343745|NCT01183013|560691347|FG002|Overall Study|Lost to Follow-up|4|||
155343746|NCT01183013|560691348|FG003|Overall Study|Lost to Follow-up|3|||
155343747|NCT01183013|560691349|FG004|Overall Study|Lost to Follow-up|2|||
155343748|NCT01183013|560691350|FG005|Overall Study|Lost to Follow-up|6|||
155343749|NCT01183013|560691351|FG006|Overall Study|Lost to Follow-up|5|||
155343750|NCT01183013|560691345|FG000|Overall Study|Withdrawal by Subject|9|||
155343751|NCT01183013|560691346|FG001|Overall Study|Withdrawal by Subject|13|||
155343752|NCT01183013|560691347|FG002|Overall Study|Withdrawal by Subject|10|||
155343753|NCT01183013|560691348|FG003|Overall Study|Withdrawal by Subject|8|||
155343754|NCT01183013|560691349|FG004|Overall Study|Withdrawal by Subject|7|||
155343755|NCT01183013|560691350|FG005|Overall Study|Withdrawal by Subject|9|||
155343756|NCT01183013|560691351|FG006|Overall Study|Withdrawal by Subject|10|||
155343757|NCT01183013|560691345|FG000|Overall Study|Reasons other than stated above|15|||
155343758|NCT01183013|560691346|FG001|Overall Study|Reasons other than stated above|11|||
155343759|NCT01183013|560691347|FG002|Overall Study|Reasons other than stated above|17|||
155343760|NCT01183013|560691348|FG003|Overall Study|Reasons other than stated above|12|||
155343761|NCT01183013|560691349|FG004|Overall Study|Reasons other than stated above|12|||
155343762|NCT01183013|560691350|FG005|Overall Study|Reasons other than stated above|15|||
155343763|NCT01183013|560691351|FG006|Overall Study|Reasons other than stated above|13|||
155343764|NCT00584909|560691352|FG000|Overall Study|Adverse Event|4|||
155343765|NCT02092909|560691353|FG000|Overall Study|Adverse Event|0|||
155343766|NCT02092909|560691354|FG001|Overall Study|Adverse Event|0|||
155343767|NCT02092909|560691355|FG002|Overall Study|Adverse Event|4|||
155343768|NCT02092909|560691356|FG003|Overall Study|Adverse Event|2|||
155343769|NCT02092909|560691353|FG000|Overall Study|Lack of Efficacy|0|||
155343770|NCT02092909|560691354|FG001|Overall Study|Lack of Efficacy|2|||
155343771|NCT02092909|560691355|FG002|Overall Study|Lack of Efficacy|1|||
155343772|NCT02092909|560691356|FG003|Overall Study|Lack of Efficacy|0|||
155343773|NCT02092909|560691353|FG000|Overall Study|Withdrawal by Subject|0|||
155343774|NCT02092909|560691354|FG001|Overall Study|Withdrawal by Subject|0|||
155343775|NCT02092909|560691355|FG002|Overall Study|Withdrawal by Subject|2|||
155343776|NCT02092909|560691356|FG003|Overall Study|Withdrawal by Subject|1|||
155343777|NCT02092909|560691353|FG000|Overall Study|Study terminated by Sponsor|0|||
155343778|NCT02092909|560691354|FG001|Overall Study|Study terminated by Sponsor|0|||
155343779|NCT02092909|560691355|FG002|Overall Study|Study terminated by Sponsor|0|||
155343780|NCT02092909|560691356|FG003|Overall Study|Study terminated by Sponsor|2|||
155343781|NCT02092909|560691353|FG000|Overall Study|Miscellaneous|1|||
155343782|NCT02092909|560691354|FG001|Overall Study|Miscellaneous|1|||
155343783|NCT02092909|560691355|FG002|Overall Study|Miscellaneous|2|||
155343784|NCT02092909|560691356|FG003|Overall Study|Miscellaneous|1|||
155343785|NCT00910871|560691365|FG000|Overall Study|Adverse Event|5|||
155343786|NCT00910871|560691365|FG000|Overall Study|Death|12|||
155343787|NCT00910871|560691365|FG000|Overall Study|Lost to Follow-up|8|||
155343788|NCT00910871|560691365|FG000|Overall Study|Protocol Violation|11|||
155343789|NCT00910871|560691365|FG000|Overall Study|Withdrawal by Subject|12|||
155343790|NCT00910871|560691365|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
155343791|NCT00910871|560691365|FG000|Overall Study|Undefined|1|||
155343792|NCT00850993|560691366|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
155343793|NCT00850993|560691367|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
155343794|NCT00850993|560691368|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
155343795|NCT00850993|560691369|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
155343796|NCT04501614|560691374|FG000|Overall Study|Study Terminated by Sponsor|6|||
155343797|NCT04501614|560691375|FG001|Overall Study|Study Terminated by Sponsor|3|||
155343798|NCT04501614|560691374|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
155343799|NCT04501614|560691375|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
155343800|NCT02555397|560691379|FG000|Overall Study|Withdrawal by Subject|1|||
155343801|NCT02555397|560691380|FG001|Overall Study|Withdrawal by Subject|0|||
155343802|NCT02555397|560691381|FG002|Overall Study|Withdrawal by Subject|0|||
155343803|NCT02555397|560691382|FG003|Overall Study|Withdrawal by Subject|0|||
155343804|NCT02555397|560691383|FG004|Overall Study|Withdrawal by Subject|0|||
155343805|NCT00237809|560691389|FG000|Overall Study|Lost to Follow-up|11|||
155343806|NCT00237809|560691390|FG001|Overall Study|Lost to Follow-up|10|||
155343807|NCT00237809|560691391|FG002|Overall Study|Lost to Follow-up|9|||
155343808|NCT00237809|560691392|FG003|Overall Study|Lost to Follow-up|9|||
155343809|NCT02006641|560691393|FG000|Overall Study|Withdrawal before treatment|2|||
155343810|NCT02006641|560691394|FG001|Overall Study|Withdrawal before treatment|5|||
155343811|NCT02006641|560691395|FG002|Overall Study|Withdrawal before treatment|3|||
155343812|NCT02006641|560691393|FG000|Overall Study|Adverse Event|15|||
155343813|NCT02006641|560691394|FG001|Overall Study|Adverse Event|11|||
155424247|NCT01993888|560982347|FG001|Overall Study|Lost to Follow-up|1|||
155424248|NCT01993888|560982346|FG000|Overall Study|Withdrawal by Subject|0|||
155424249|NCT01993888|560982347|FG001|Overall Study|Withdrawal by Subject|1|||
155424250|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
155424251|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
155343814|NCT02006641|560691395|FG002|Overall Study|Adverse Event|15|||
155343815|NCT02006641|560691393|FG000|Overall Study|Protocol Violation|0|||
155343816|NCT02006641|560691394|FG001|Overall Study|Protocol Violation|2|||
155424252|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
155343817|NCT02006641|560691395|FG002|Overall Study|Protocol Violation|2|||
155343818|NCT02006641|560691393|FG000|Overall Study|Lost to Follow-up|0|||
155343819|NCT02006641|560691394|FG001|Overall Study|Lost to Follow-up|1|||
155343820|NCT02006641|560691395|FG002|Overall Study|Lost to Follow-up|0|||
155343821|NCT02006641|560691393|FG000|Overall Study|Withdrawal by Subject|7|||
155343822|NCT02006641|560691394|FG001|Overall Study|Withdrawal by Subject|12|||
155343823|NCT02006641|560691395|FG002|Overall Study|Withdrawal by Subject|11|||
155343824|NCT02006641|560691393|FG000|Overall Study|Other reason: patient didn't show up|1|||
155343825|NCT02006641|560691394|FG001|Overall Study|Other reason: patient didn't show up|0|||
155343826|NCT02006641|560691395|FG002|Overall Study|Other reason: patient didn't show up|0|||
155343827|NCT02006641|560691393|FG000|Overall Study|Other reason:patient didn't want to come|0|||
155343828|NCT02006641|560691394|FG001|Overall Study|Other reason:patient didn't want to come|0|||
155343829|NCT02006641|560691395|FG002|Overall Study|Other reason:patient didn't want to come|1|||
155424253|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
155424254|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
155424255|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
155424256|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
155424257|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
155424258|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
155424259|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
155424260|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
155424261|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
155424262|NCT02747927|560982351|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
155424263|NCT02747927|560982352|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
155424264|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
155424265|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
155424266|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
155343830|NCT02006641|560691393|FG000|Overall Study|Other reason: patient has moved|1|||
155343831|NCT02006641|560691394|FG001|Overall Study|Other reason: patient has moved|0|||
155343832|NCT02006641|560691395|FG002|Overall Study|Other reason: patient has moved|1|||
155343833|NCT02006641|560691393|FG000|Overall Study|Other reason: caregiver in hospital|0|||
155343834|NCT02006641|560691394|FG001|Overall Study|Other reason: caregiver in hospital|1|||
155343835|NCT02006641|560691395|FG002|Overall Study|Other reason: caregiver in hospital|0|||
155343836|NCT02006641|560691393|FG000|Overall Study|Other reason: patient's wife has died|0|||
155343837|NCT02006641|560691394|FG001|Overall Study|Other reason: patient's wife has died|0|||
155343838|NCT02006641|560691395|FG002|Overall Study|Other reason: patient's wife has died|1|||
155343839|NCT02006641|560691393|FG000|Overall Study|Other reason: hospitalisation|0|||
155343840|NCT02006641|560691394|FG001|Overall Study|Other reason: hospitalisation|1|||
155343841|NCT02006641|560691395|FG002|Overall Study|Other reason: hospitalisation|0|||
155343842|NCT02006641|560691393|FG000|Overall Study|Other reason: caregiver impossibility|0|||
155343843|NCT02006641|560691394|FG001|Overall Study|Other reason: caregiver impossibility|0|||
155343844|NCT02006641|560691395|FG002|Overall Study|Other reason: caregiver impossibility|1|||
155343845|NCT02006641|560691393|FG000|Overall Study|Other reason: protocol non-compliance|0|||
155343846|NCT02006641|560691394|FG001|Overall Study|Other reason: protocol non-compliance|0|||
155343847|NCT02006641|560691395|FG002|Overall Study|Other reason: protocol non-compliance|1|||
155343848|NCT01613599|560691396|FG000|Overall Study|Death|9|||
155343849|NCT01613599|560691396|FG000|Overall Study|Lost to Follow-up|5|||
155343850|NCT01613599|560691396|FG000|Overall Study|Withdrawal by Subject|8|||
155343851|NCT01613599|560691396|FG000|Overall Study|Reason not specified|3|||
155343852|NCT02132195|560691399|FG000|Initial Assignment|Relapsed|14|||
155343853|NCT02132195|560691400|FG001|Initial Assignment|Relapsed|0|||
155424267|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
155424268|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
155343854|NCT02132195|560691401|FG002|Initial Assignment|Relapsed|0|||
155343855|NCT02132195|560691399|FG000|Rescue Therapy|Relapsed|0|||
155343856|NCT02132195|560691400|FG001|Rescue Therapy|Relapsed|0|||
155343857|NCT02132195|560691401|FG002|Rescue Therapy|Relapsed|7|||
155343858|NCT02132195|560691399|FG000|Rescue Therapy|Physician Decision|0|||
155343859|NCT02132195|560691400|FG001|Rescue Therapy|Physician Decision|0|||
155343860|NCT02132195|560691401|FG002|Rescue Therapy|Physician Decision|1|||
155343861|NCT02132195|560691399|FG000|Rescue Therapy|Withdrawal by Subject|0|||
155343862|NCT02132195|560691400|FG001|Rescue Therapy|Withdrawal by Subject|0|||
155343863|NCT02132195|560691401|FG002|Rescue Therapy|Withdrawal by Subject|1|||
155343864|NCT02132195|560691399|FG000|Rescue Therapy|Adverse Event|0|||
155343865|NCT02132195|560691400|FG001|Rescue Therapy|Adverse Event|0|||
155343866|NCT02132195|560691401|FG002|Rescue Therapy|Adverse Event|2|||
155343867|NCT02066389|560691403|FG000|Overall Study|Adverse Event|1|||
155343868|NCT02066389|560691404|FG001|Overall Study|Adverse Event|1|||
155343869|NCT02066389|560691405|FG002|Overall Study|Adverse Event|1|||
155343870|NCT02066389|560691406|FG003|Overall Study|Adverse Event|1|||
155343871|NCT02066389|560691407|FG004|Overall Study|Adverse Event|5|||
155343872|NCT02066389|560691408|FG005|Overall Study|Adverse Event|1|||
155343873|NCT02066389|560691403|FG000|Overall Study|Withdrawal by Subject|4|||
155343874|NCT02066389|560691404|FG001|Overall Study|Withdrawal by Subject|0|||
155343875|NCT02066389|560691405|FG002|Overall Study|Withdrawal by Subject|5|||
155343876|NCT02066389|560691406|FG003|Overall Study|Withdrawal by Subject|1|||
155343877|NCT02066389|560691407|FG004|Overall Study|Withdrawal by Subject|1|||
155343878|NCT02066389|560691408|FG005|Overall Study|Withdrawal by Subject|2|||
155424269|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
155424270|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
155424271|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
155424272|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
155424273|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
155424274|NCT02747927|560982351|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
155424275|NCT02747927|560982352|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
155424276|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
155424277|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
155424278|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
155424279|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
155424280|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
155424281|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
155424282|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
155424283|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
155424284|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
155424285|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
155424286|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
155424287|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
155424288|NCT02747927|560982351|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
155424289|NCT02747927|560982352|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
155424290|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
155424291|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
155424292|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
155424293|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
155424294|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
155424295|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
155424296|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
155424297|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
155424298|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
155424299|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
155424300|NCT02747927|560982351|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
155424301|NCT02747927|560982352|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
155424302|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
155424303|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
155424304|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
155343879|NCT02066389|560691403|FG000|Overall Study|Lost to Follow-up|0|||
155343880|NCT02066389|560691404|FG001|Overall Study|Lost to Follow-up|0|||
155343881|NCT02066389|560691405|FG002|Overall Study|Lost to Follow-up|0|||
155343882|NCT02066389|560691406|FG003|Overall Study|Lost to Follow-up|1|||
155343883|NCT02066389|560691407|FG004|Overall Study|Lost to Follow-up|1|||
155343884|NCT02066389|560691408|FG005|Overall Study|Lost to Follow-up|1|||
155343885|NCT02066389|560691403|FG000|Overall Study|Randomized in Error|0|||
155343886|NCT02066389|560691404|FG001|Overall Study|Randomized in Error|0|||
155343887|NCT02066389|560691405|FG002|Overall Study|Randomized in Error|0|||
155343888|NCT02066389|560691406|FG003|Overall Study|Randomized in Error|0|||
155343889|NCT02066389|560691407|FG004|Overall Study|Randomized in Error|0|||
155343890|NCT02066389|560691408|FG005|Overall Study|Randomized in Error|1|||
155343891|NCT01468597|560691417|FG000|Overall Study|Found ineligible|17|||
155343892|NCT01468597|560691417|FG000|Overall Study|concomitant valves|12|||
155343893|NCT01468597|560691417|FG000|Overall Study|off-pump CABG|1|||
155343894|NCT01468597|560691417|FG000|Overall Study|no platelet function data|5|||
155343895|NCT02561195|560691419|FG000|Vaccination 1 to 3|Adverse Event|4|||
155343896|NCT02561195|560691420|FG001|Vaccination 1 to 3|Adverse Event|5|||
155343897|NCT02561195|560691421|FG002|Vaccination 1 to 3|Adverse Event|0|||
155343898|NCT02561195|560691422|FG003|Vaccination 1 to 3|Adverse Event|3|||
155343899|NCT02561195|560691423|FG004|Vaccination 1 to 3|Adverse Event|4|||
155343900|NCT02561195|560691424|FG005|Vaccination 1 to 3|Adverse Event|0|||
155343901|NCT02561195|560691425|FG006|Vaccination 1 to 3|Adverse Event|0|||
155343902|NCT02561195|560691426|FG007|Vaccination 1 to 3|Adverse Event|0|||
155343903|NCT02561195|560691427|FG008|Vaccination 1 to 3|Adverse Event|0|||
155343904|NCT02561195|560691428|FG009|Vaccination 1 to 3|Adverse Event|0|||
155343905|NCT02561195|560691429|FG010|Vaccination 1 to 3|Adverse Event|0|||
155343906|NCT02561195|560691430|FG011|Vaccination 1 to 3|Adverse Event|0|||
155343907|NCT02561195|560691431|FG012|Vaccination 1 to 3|Adverse Event|0|||
155343908|NCT02561195|560691432|FG013|Vaccination 1 to 3|Adverse Event|0|||
155343909|NCT02561195|560691419|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
155343910|NCT02561195|560691420|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
155343911|NCT02561195|560691421|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
155343912|NCT02561195|560691422|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
155343913|NCT02561195|560691423|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
155343914|NCT02561195|560691424|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
155343915|NCT02561195|560691425|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
155343916|NCT02561195|560691426|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
155343917|NCT02561195|560691427|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
155343918|NCT02561195|560691428|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
155343919|NCT02561195|560691429|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
155343920|NCT02561195|560691430|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
155343921|NCT02561195|560691431|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
155343922|NCT02561195|560691432|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
155343923|NCT02561195|560691419|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343924|NCT02561195|560691420|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
155343925|NCT02561195|560691421|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343926|NCT02561195|560691422|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
155343927|NCT02561195|560691423|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
155343928|NCT02561195|560691424|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
155343929|NCT02561195|560691425|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343930|NCT02561195|560691426|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343931|NCT02561195|560691427|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343932|NCT02561195|560691428|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343933|NCT02561195|560691429|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343934|NCT02561195|560691430|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343935|NCT02561195|560691431|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343936|NCT02561195|560691432|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343937|NCT02561195|560691419|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
155343938|NCT02561195|560691420|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
155343939|NCT02561195|560691421|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
155343940|NCT02561195|560691422|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
155343941|NCT02561195|560691423|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
155343942|NCT02561195|560691424|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
155343943|NCT02561195|560691425|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
155343944|NCT02561195|560691426|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
155343945|NCT02561195|560691427|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
155343946|NCT02561195|560691428|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
155343947|NCT02561195|560691429|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
155343948|NCT02561195|560691430|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
155505549|NCT00830063|561278180|FG003|Overall Study|Death|0|||
155343949|NCT02561195|560691431|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
155343950|NCT02561195|560691432|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
155343951|NCT02561195|560691419|FG000|Vaccination 1 to 3|Other|7|||
155343952|NCT02561195|560691420|FG001|Vaccination 1 to 3|Other|3|||
155343953|NCT02561195|560691421|FG002|Vaccination 1 to 3|Other|1|||
155343954|NCT02561195|560691422|FG003|Vaccination 1 to 3|Other|7|||
155343955|NCT02561195|560691423|FG004|Vaccination 1 to 3|Other|5|||
155343956|NCT02561195|560691424|FG005|Vaccination 1 to 3|Other|1|||
155343957|NCT02561195|560691425|FG006|Vaccination 1 to 3|Other|0|||
155343958|NCT02561195|560691426|FG007|Vaccination 1 to 3|Other|0|||
155343959|NCT02561195|560691427|FG008|Vaccination 1 to 3|Other|0|||
155343960|NCT02561195|560691428|FG009|Vaccination 1 to 3|Other|0|||
155343961|NCT02561195|560691429|FG010|Vaccination 1 to 3|Other|0|||
155343962|NCT02561195|560691430|FG011|Vaccination 1 to 3|Other|0|||
155343963|NCT02561195|560691431|FG012|Vaccination 1 to 3|Other|0|||
155343964|NCT02561195|560691432|FG013|Vaccination 1 to 3|Other|0|||
155343965|NCT02561195|560691419|FG000|Vaccination 1 to 3|Protocol Violation|1|||
155343966|NCT02561195|560691420|FG001|Vaccination 1 to 3|Protocol Violation|0|||
155343967|NCT02561195|560691421|FG002|Vaccination 1 to 3|Protocol Violation|1|||
155343968|NCT02561195|560691422|FG003|Vaccination 1 to 3|Protocol Violation|2|||
155343969|NCT02561195|560691423|FG004|Vaccination 1 to 3|Protocol Violation|5|||
155343970|NCT02561195|560691424|FG005|Vaccination 1 to 3|Protocol Violation|2|||
155343971|NCT02561195|560691425|FG006|Vaccination 1 to 3|Protocol Violation|0|||
155343972|NCT02561195|560691426|FG007|Vaccination 1 to 3|Protocol Violation|0|||
155343973|NCT02561195|560691427|FG008|Vaccination 1 to 3|Protocol Violation|0|||
155343974|NCT02561195|560691428|FG009|Vaccination 1 to 3|Protocol Violation|0|||
155343975|NCT02561195|560691429|FG010|Vaccination 1 to 3|Protocol Violation|0|||
155343976|NCT02561195|560691430|FG011|Vaccination 1 to 3|Protocol Violation|0|||
155343977|NCT02561195|560691431|FG012|Vaccination 1 to 3|Protocol Violation|0|||
155343978|NCT02561195|560691432|FG013|Vaccination 1 to 3|Protocol Violation|0|||
155343979|NCT02561195|560691419|FG000|Vaccination 1 to 3|Death|2|||
155343980|NCT02561195|560691420|FG001|Vaccination 1 to 3|Death|1|||
155343981|NCT02561195|560691421|FG002|Vaccination 1 to 3|Death|0|||
155343982|NCT02561195|560691422|FG003|Vaccination 1 to 3|Death|2|||
155343983|NCT02561195|560691423|FG004|Vaccination 1 to 3|Death|0|||
155343984|NCT02561195|560691424|FG005|Vaccination 1 to 3|Death|0|||
155343985|NCT02561195|560691425|FG006|Vaccination 1 to 3|Death|0|||
155343986|NCT02561195|560691426|FG007|Vaccination 1 to 3|Death|0|||
155343987|NCT02561195|560691427|FG008|Vaccination 1 to 3|Death|0|||
155343988|NCT02561195|560691428|FG009|Vaccination 1 to 3|Death|0|||
155343989|NCT02561195|560691429|FG010|Vaccination 1 to 3|Death|0|||
155343990|NCT02561195|560691430|FG011|Vaccination 1 to 3|Death|0|||
155343991|NCT02561195|560691431|FG012|Vaccination 1 to 3|Death|0|||
155424305|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
155424306|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
155424307|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
155424308|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
155424309|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
155424310|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
155343992|NCT02561195|560691432|FG013|Vaccination 1 to 3|Death|0|||
155343993|NCT02561195|560691419|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
155343994|NCT02561195|560691420|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
155343995|NCT02561195|560691421|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
155343996|NCT02561195|560691422|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
155424311|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
155424312|NCT02747927|560982351|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
155343997|NCT02561195|560691423|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
155343998|NCT02561195|560691424|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
155343999|NCT02561195|560691425|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344000|NCT02561195|560691426|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344001|NCT02561195|560691427|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344002|NCT02561195|560691428|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344003|NCT02561195|560691429|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344004|NCT02561195|560691430|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344005|NCT02561195|560691431|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344006|NCT02561195|560691432|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344007|NCT02561195|560691419|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
155344008|NCT02561195|560691420|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
155344009|NCT02561195|560691421|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
155344010|NCT02561195|560691422|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
155344011|NCT02561195|560691423|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
155344012|NCT02561195|560691424|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
155344013|NCT02561195|560691425|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
155344014|NCT02561195|560691426|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
155344015|NCT02561195|560691427|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
155344016|NCT02561195|560691428|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
155344017|NCT02561195|560691429|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
155344018|NCT02561195|560691430|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
155344019|NCT02561195|560691431|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
155344020|NCT02561195|560691432|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
155344021|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344022|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344023|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344024|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344025|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344026|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344027|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344028|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344029|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
155344030|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
155344031|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
155344032|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
155344033|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
155344034|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344035|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344036|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344037|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344038|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344039|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344040|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344041|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344042|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344043|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344044|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344045|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344046|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344047|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344048|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
155344049|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Death|0|||
155344050|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Death|0|||
155344051|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Death|0|||
155344052|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Death|0|||
155344053|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Death|0|||
155344054|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Death|0|||
155344055|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Death|0|||
155344056|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Death|0|||
155344057|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Death|0|||
155344058|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Death|1|||
155344059|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Death|0|||
155344060|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Death|0|||
155344061|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Death|0|||
155344062|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Death|0|||
155344063|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344064|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344065|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344066|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344067|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344068|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344069|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344070|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344071|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344072|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344073|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
155344074|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344075|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
155344076|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344077|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344078|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344079|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344080|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344081|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344082|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344083|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344084|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344085|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344086|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344087|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344088|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344089|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344090|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344091|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Other|0|||
155344092|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Other|0|||
155344093|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Other|0|||
155344094|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Other|0|||
155344095|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Other|0|||
155344096|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Other|0|||
155344097|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Other|0|||
155344098|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Other|0|||
155344099|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Other|0|||
155344100|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Other|0|||
155344101|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Other|2|||
155344102|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Other|2|||
155344103|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Other|1|||
155344104|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Other|0|||
155344105|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344106|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344107|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344108|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344109|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344110|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344111|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344112|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344113|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344114|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344115|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
155344116|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344117|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344118|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344119|NCT03905512|560691433|FG000|Overall Study|Withdrawal by Subject|9|||
155344120|NCT03905512|560691434|FG001|Overall Study|Withdrawal by Subject|8|||
155344121|NCT03905512|560691433|FG000|Overall Study|Adverse Event|1|||
155344122|NCT03905512|560691434|FG001|Overall Study|Adverse Event|2|||
155344123|NCT03905512|560691433|FG000|Overall Study|Lost to Follow-up|4|||
155344124|NCT03905512|560691434|FG001|Overall Study|Lost to Follow-up|3|||
155344125|NCT03905512|560691433|FG000|Overall Study|Other than Specified|7|||
155344126|NCT03905512|560691434|FG001|Overall Study|Other than Specified|4|||
155344127|NCT00736502|560691439|FG000|Overall Study|Adverse Event|22|||
155344128|NCT00736502|560691439|FG000|Overall Study|Lack of Efficacy|16|||
155344129|NCT00736502|560691439|FG000|Overall Study|Lost to Follow-up|27|||
155344130|NCT03987074|560691441|FG000|Overall Study|Withdrew Consent|1|||
155344131|NCT03987074|560691442|FG001|Overall Study|Withdrew Consent|1|||
155344132|NCT03987074|560691443|FG002|Overall Study|Withdrew Consent|0|||
155344133|NCT03987074|560691444|FG003|Overall Study|Withdrew Consent|2|||
155344134|NCT03987074|560691445|FG004|Overall Study|Withdrew Consent|1|||
155344135|NCT03987074|560691441|FG000|Overall Study|Adverse Event|2|||
155344136|NCT03987074|560691442|FG001|Overall Study|Adverse Event|1|||
155344137|NCT03987074|560691443|FG002|Overall Study|Adverse Event|0|||
155344138|NCT03987074|560691444|FG003|Overall Study|Adverse Event|0|||
155344139|NCT03987074|560691445|FG004|Overall Study|Adverse Event|1|||
155344140|NCT03987074|560691441|FG000|Overall Study|Lost to Follow-up|0|||
155344141|NCT03987074|560691442|FG001|Overall Study|Lost to Follow-up|0|||
155344142|NCT03987074|560691443|FG002|Overall Study|Lost to Follow-up|1|||
155344143|NCT03987074|560691444|FG003|Overall Study|Lost to Follow-up|1|||
155344144|NCT03987074|560691445|FG004|Overall Study|Lost to Follow-up|0|||
155344145|NCT03987074|560691441|FG000|Overall Study|Investigator's Discretion|0|||
155344146|NCT03987074|560691442|FG001|Overall Study|Investigator's Discretion|0|||
155344147|NCT03987074|560691443|FG002|Overall Study|Investigator's Discretion|0|||
155344148|NCT03987074|560691444|FG003|Overall Study|Investigator's Discretion|1|||
155344149|NCT03987074|560691445|FG004|Overall Study|Investigator's Discretion|0|||
155344150|NCT01307800|560691446|FG000|Overall Study|Adverse Event|9|||
155344151|NCT01307800|560691447|FG001|Overall Study|Adverse Event|8|||
155344152|NCT01307800|560691448|FG002|Overall Study|Adverse Event|10|||
155344153|NCT01307800|560691449|FG003|Overall Study|Adverse Event|14|||
155344154|NCT01307800|560691446|FG000|Overall Study|Entry Criteria Not Met|0|||
155344155|NCT01307800|560691447|FG001|Overall Study|Entry Criteria Not Met|0|||
155344156|NCT01307800|560691448|FG002|Overall Study|Entry Criteria Not Met|0|||
155344157|NCT01307800|560691449|FG003|Overall Study|Entry Criteria Not Met|2|||
155344158|NCT01307800|560691446|FG000|Overall Study|Lost to Follow-up|5|||
155344159|NCT01307800|560691447|FG001|Overall Study|Lost to Follow-up|6|||
155344160|NCT01307800|560691448|FG002|Overall Study|Lost to Follow-up|2|||
155344161|NCT01307800|560691449|FG003|Overall Study|Lost to Follow-up|8|||
155344162|NCT01307800|560691446|FG000|Overall Study|Perceived Lack of Efficacy|24|||
155344163|NCT01307800|560691447|FG001|Overall Study|Perceived Lack of Efficacy|23|||
155344164|NCT01307800|560691448|FG002|Overall Study|Perceived Lack of Efficacy|20|||
155344165|NCT01307800|560691449|FG003|Overall Study|Perceived Lack of Efficacy|33|||
155344166|NCT01307800|560691446|FG000|Overall Study|Protocol Violation|0|||
155344167|NCT01307800|560691447|FG001|Overall Study|Protocol Violation|3|||
155344168|NCT01307800|560691448|FG002|Overall Study|Protocol Violation|4|||
155344169|NCT01307800|560691449|FG003|Overall Study|Protocol Violation|5|||
155344170|NCT01307800|560691446|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
155344171|NCT01307800|560691447|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
155344172|NCT01307800|560691448|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
155344173|NCT01307800|560691449|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
155344174|NCT01307800|560691446|FG000|Overall Study|Sponsor Decision|6|||
155344175|NCT01307800|560691447|FG001|Overall Study|Sponsor Decision|9|||
155344176|NCT01307800|560691448|FG002|Overall Study|Sponsor Decision|12|||
155344177|NCT01307800|560691449|FG003|Overall Study|Sponsor Decision|28|||
155344178|NCT01307800|560691446|FG000|Overall Study|Withdrawal by Subject|10|||
155344179|NCT01307800|560691447|FG001|Overall Study|Withdrawal by Subject|11|||
155344180|NCT01307800|560691448|FG002|Overall Study|Withdrawal by Subject|8|||
155344181|NCT01307800|560691449|FG003|Overall Study|Withdrawal by Subject|15|||
155344182|NCT01307800|560691446|FG000|Overall Study|Participant Moved|0|||
155344183|NCT01307800|560691447|FG001|Overall Study|Participant Moved|2|||
155344184|NCT01307800|560691448|FG002|Overall Study|Participant Moved|1|||
155344185|NCT01307800|560691449|FG003|Overall Study|Participant Moved|3|||
155344186|NCT01517282|560691452|FG000|Overall Study|Consent withdrawn|0|||
155344187|NCT01517282|560691453|FG001|Overall Study|Consent withdrawn|1|||
155344188|NCT01517282|560691454|FG002|Overall Study|Consent withdrawn|1|||
155344189|NCT01517282|560691455|FG003|Overall Study|Consent withdrawn|1|||
155344190|NCT01517282|560691452|FG000|Overall Study|Physician Decision|1|||
155344191|NCT01517282|560691453|FG001|Overall Study|Physician Decision|0|||
155344192|NCT01517282|560691454|FG002|Overall Study|Physician Decision|0|||
155344193|NCT01517282|560691455|FG003|Overall Study|Physician Decision|0|||
155344194|NCT01199302|560691462|FG000|Overall Study|Adverse Event|1|||
155344195|NCT01199302|560691463|FG001|Overall Study|Adverse Event|1|||
155344196|NCT01199302|560691464|FG002|Overall Study|Adverse Event|2|||
155344197|NCT01199302|560691465|FG003|Overall Study|Adverse Event|0|||
155344198|NCT01199302|560691462|FG000|Overall Study|Withdrawal by Subject|2|||
155344199|NCT01199302|560691463|FG001|Overall Study|Withdrawal by Subject|2|||
155344200|NCT01199302|560691464|FG002|Overall Study|Withdrawal by Subject|3|||
155344201|NCT01199302|560691465|FG003|Overall Study|Withdrawal by Subject|0|||
155344202|NCT01199302|560691462|FG000|Overall Study|Disease Progression|3|||
155344203|NCT01199302|560691463|FG001|Overall Study|Disease Progression|4|||
155344204|NCT01199302|560691464|FG002|Overall Study|Disease Progression|4|||
155344205|NCT01199302|560691465|FG003|Overall Study|Disease Progression|2|||
155344206|NCT01199302|560691462|FG000|Overall Study|Study Termination|13|||
155344207|NCT01199302|560691463|FG001|Overall Study|Study Termination|8|||
155344208|NCT01199302|560691464|FG002|Overall Study|Study Termination|11|||
155344209|NCT01199302|560691465|FG003|Overall Study|Study Termination|9|||
155344210|NCT01199302|560691462|FG000|Overall Study|Lost to Follow-up|0|||
155344211|NCT01199302|560691463|FG001|Overall Study|Lost to Follow-up|1|||
155344212|NCT01199302|560691464|FG002|Overall Study|Lost to Follow-up|0|||
155344213|NCT01199302|560691465|FG003|Overall Study|Lost to Follow-up|0|||
155344214|NCT01199302|560691462|FG000|Overall Study|Other|1|||
155344215|NCT01199302|560691463|FG001|Overall Study|Other|0|||
155344216|NCT01199302|560691464|FG002|Overall Study|Other|0|||
155344217|NCT01199302|560691465|FG003|Overall Study|Other|0|||
155344218|NCT04433091|560691466|FG000|Overall Study|Lost to Follow-up|1|||
155344219|NCT04433091|560691467|FG001|Overall Study|Lost to Follow-up|0|||
155344220|NCT04433091|560691466|FG000|Overall Study|Withdrawn .|2|||
155344221|NCT04433091|560691467|FG001|Overall Study|Withdrawn .|4|||
155505550|NCT00830063|561278177|FG000|Overall Study|Lost to Follow-up|0|||
155344222|NCT03820024|560691468|FG000|Overall Study|Physician Decision|1|||
155344223|NCT03820024|560691469|FG001|Overall Study|Physician Decision|2|||
155344224|NCT05379400|560692866|FG000|Overall Study|Lost to Follow-up|1|||
155344225|NCT05379400|560692867|FG001|Overall Study|Lost to Follow-up|1|||
155344226|NCT03409276|560692870|FG000|Overall Study|Withdrawal by Subject|0|||
155344227|NCT03409276|560692871|FG001|Overall Study|Withdrawal by Subject|0|||
155344228|NCT03409276|560692872|FG002|Overall Study|Withdrawal by Subject|0|||
155344229|NCT03409276|560692873|FG003|Overall Study|Withdrawal by Subject|0|||
155344230|NCT03409276|560692874|FG004|Overall Study|Withdrawal by Subject|1|||
155647778|NCT03774810|561803679|FG001|Phase 1|Lost to Follow-up|0|||
155344231|NCT03409276|560692870|FG000|Overall Study|Lost to Follow-up|0|||
155344232|NCT03409276|560692871|FG001|Overall Study|Lost to Follow-up|0|||
155344233|NCT03409276|560692872|FG002|Overall Study|Lost to Follow-up|0|||
155344234|NCT03409276|560692873|FG003|Overall Study|Lost to Follow-up|2|||
155344235|NCT03409276|560692874|FG004|Overall Study|Lost to Follow-up|2|||
155344236|NCT01816165|560692877|FG000|Overall Study|Adverse Event|1|||
155344237|NCT01816165|560692878|FG001|Overall Study|Adverse Event|0|||
155344238|NCT01816165|560692879|FG002|Overall Study|Adverse Event|0|||
155344239|NCT01816165|560692880|FG003|Overall Study|Adverse Event|0|||
155344240|NCT03960437|560692881|FG000|Overall Study|Removed by PI|4|||
155344241|NCT03960437|560692881|FG000|Overall Study|Lost to Follow-up|2|||
155344242|NCT03960437|560692881|FG000|Overall Study|Withdrawal by Subject|1|||
155344243|NCT03960437|560692881|FG000|Overall Study|Death|2|||
155344244|NCT02368691|560692882|FG000|Overall Study|Death|13|||
155344245|NCT02368691|560692882|FG000|Overall Study|Lack of Efficacy|15|||
155344246|NCT02368691|560692882|FG000|Overall Study|Physician Decision|4|||
155344247|NCT01838447|560692883|FG000|Overall Study|Change in surgical plan|1|||
155344248|NCT01838447|560692884|FG001|Overall Study|Change in surgical plan|2|||
155344249|NCT01838447|560692883|FG000|Overall Study|Withdrawal by Subject|1|||
155344250|NCT01838447|560692884|FG001|Overall Study|Withdrawal by Subject|1|||
155344251|NCT01114217|560692885|FG000|Overall Study|Adverse Event|5|||
155344252|NCT01114217|560692886|FG001|Overall Study|Adverse Event|3|||
155344253|NCT01114217|560692885|FG000|Overall Study|Lost to Follow-up|17|||
155344254|NCT01114217|560692886|FG001|Overall Study|Lost to Follow-up|33|||
155344255|NCT01114217|560692885|FG000|Overall Study|Withdrawal by Subject|21|||
155344256|NCT01114217|560692886|FG001|Overall Study|Withdrawal by Subject|28|||
155344257|NCT01114217|560692885|FG000|Overall Study|Other-Clerical Error|3|||
155344258|NCT01114217|560692886|FG001|Overall Study|Other-Clerical Error|0|||
155344259|NCT01114217|560692885|FG000|Overall Study|Other-Early termination|6|||
155344260|NCT01114217|560692886|FG001|Overall Study|Other-Early termination|10|||
155344261|NCT01114217|560692885|FG000|Overall Study|Other-Procedure|1|||
155344262|NCT01114217|560692886|FG001|Overall Study|Other-Procedure|1|||
155344263|NCT01114217|560692885|FG000|Overall Study|Other-Pregnancy|2|||
155344264|NCT01114217|560692886|FG001|Overall Study|Other-Pregnancy|4|||
155424313|NCT02747927|560982352|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
155424314|NCT00522392|560982356|FG000|Overall Study|Disease progression|0|||
155424315|NCT00522392|560982357|FG001|Overall Study|Disease progression|3|||
155424316|NCT00522392|560982356|FG000|Overall Study|Adverse Event|7|||
155424317|NCT00522392|560982357|FG001|Overall Study|Adverse Event|7|||
155424318|NCT00522392|560982356|FG000|Overall Study|Withdrawal by Subject|1|||
155424319|NCT00522392|560982357|FG001|Overall Study|Withdrawal by Subject|1|||
155424320|NCT00522392|560982356|FG000|Overall Study|Physician Decision|0|||
155424321|NCT00522392|560982357|FG001|Overall Study|Physician Decision|1|||
155424322|NCT00522392|560982356|FG000|Overall Study|Non-compliance|0|||
155424323|NCT00522392|560982357|FG001|Overall Study|Non-compliance|1|||
155424324|NCT00430755|560982360|FG000|Overall Study|Withdrawal by Subject|53|||
155424325|NCT00988247|560982361|FG000|Overall Study|Adverse Event|17|||
155424326|NCT00988247|560982362|FG001|Overall Study|Adverse Event|3|||
155424327|NCT00988247|560982361|FG000|Overall Study|Withdrawal by Subject|44|||
155424328|NCT00988247|560982362|FG001|Overall Study|Withdrawal by Subject|13|||
155424329|NCT00988247|560982361|FG000|Overall Study|Pregnancy|1|||
155424330|NCT00988247|560982362|FG001|Overall Study|Pregnancy|2|||
155424331|NCT00988247|560982361|FG000|Overall Study|Lost to Follow-up|11|||
155424332|NCT00988247|560982362|FG001|Overall Study|Lost to Follow-up|2|||
155424333|NCT00988247|560982361|FG000|Overall Study|Protocol Violation|4|||
155424334|NCT00988247|560982362|FG001|Overall Study|Protocol Violation|5|||
155424335|NCT00988247|560982361|FG000|Overall Study|Sponsor requested withdrawal|3|||
155424336|NCT00988247|560982362|FG001|Overall Study|Sponsor requested withdrawal|1|||
155424337|NCT00988247|560982361|FG000|Overall Study|Other|3|||
155424338|NCT00988247|560982362|FG001|Overall Study|Other|0|||
155424339|NCT01409928|560982363|FG000|Overall Study|Physician Decision|12|||
155424340|NCT01354132|560982364|FG000|Randomization|Physician Decision|1|||
155424341|NCT01354132|560982365|FG001|Randomization|Physician Decision|0|||
155424342|NCT01354132|560982364|FG000|Randomization|Withdrawal by Subject|0|||
155424343|NCT01354132|560982365|FG001|Randomization|Withdrawal by Subject|1|||
155424344|NCT01354132|560982364|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
155424345|NCT01354132|560982365|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
155424346|NCT01354132|560982364|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
155424347|NCT01354132|560982365|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
155424348|NCT01354132|560982364|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
155424349|NCT01354132|560982365|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
155424350|NCT00928070|560982368|FG000|Overall Study|Lost to Follow-up|1|||
155344265|NCT01114217|560692885|FG000|Overall Study|Other-Protocol Violation|1|||
155344266|NCT01114217|560692886|FG001|Overall Study|Other-Protocol Violation|3|||
155344267|NCT01114217|560692885|FG000|Overall Study|Other-Lack of Efficacy|1|||
155344268|NCT01114217|560692886|FG001|Overall Study|Other-Lack of Efficacy|0|||
155344269|NCT01114217|560692885|FG000|Overall Study|Other-Non Compliance|2|||
155344270|NCT01114217|560692886|FG001|Overall Study|Other-Non Compliance|0|||
155344271|NCT01114217|560692885|FG000|Overall Study|Other-Physician Decision|1|||
155344272|NCT01114217|560692886|FG001|Overall Study|Other-Physician Decision|1|||
155344273|NCT01114217|560692885|FG000|Overall Study|Other-Sponsor Decision|10|||
155344274|NCT01114217|560692886|FG001|Overall Study|Other-Sponsor Decision|12|||
155344275|NCT01114217|560692885|FG000|Overall Study|Other-Study Termination|0|||
155344276|NCT01114217|560692886|FG001|Overall Study|Other-Study Termination|1|||
155344277|NCT01114217|560692885|FG000|Overall Study|Other-Study Withdrawn|1|||
155344278|NCT01114217|560692886|FG001|Overall Study|Other-Study Withdrawn|1|||
155344279|NCT01114217|560692885|FG000|Overall Study|Other-Site Stopped Communicating|2|||
155344280|NCT01114217|560692886|FG001|Overall Study|Other-Site Stopped Communicating|0|||
155344281|NCT01114217|560692885|FG000|Overall Study|Other-Lost to Follow-up|1|||
155344282|NCT01114217|560692886|FG001|Overall Study|Other-Lost to Follow-up|0|||
155344283|NCT01114217|560692885|FG000|Overall Study|Other-Withdrawal by Subject|1|||
155344284|NCT01114217|560692886|FG001|Overall Study|Other-Withdrawal by Subject|1|||
155344285|NCT06247488|560692887|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
155344286|NCT06247488|560692888|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344287|NCT06247488|560692889|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344288|NCT06247488|560692890|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344289|NCT06247488|560692891|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344290|NCT06247488|560692892|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155424351|NCT00928070|560982369|FG001|Overall Study|Lost to Follow-up|2|||
155424352|NCT00928070|560982368|FG000|Overall Study|Withdrawal by Subject|10|||
155424353|NCT00928070|560982369|FG001|Overall Study|Withdrawal by Subject|3|||
155344291|NCT06247488|560692887|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155424354|NCT00928070|560982368|FG000|Overall Study|Adverse Event|14|||
155424355|NCT00928070|560982369|FG001|Overall Study|Adverse Event|26|||
155344292|NCT06247488|560692888|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155424356|NCT00928070|560982368|FG000|Overall Study|Lack of Efficacy|9|||
155424357|NCT00928070|560982369|FG001|Overall Study|Lack of Efficacy|5|||
155424358|NCT00928070|560982368|FG000|Overall Study|Did not meet entrance criteria|16|||
155424359|NCT00928070|560982369|FG001|Overall Study|Did not meet entrance criteria|9|||
155344293|NCT06247488|560692889|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344294|NCT06247488|560692890|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
155344295|NCT06247488|560692891|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344296|NCT06247488|560692892|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344297|NCT06247488|560692887|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
155344298|NCT06247488|560692888|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155424360|NCT00928070|560982368|FG000|Overall Study|Protocol Violation|6|||
155424361|NCT00928070|560982369|FG001|Overall Study|Protocol Violation|5|||
155424362|NCT00928070|560982368|FG000|Overall Study|Randomized but not treated|2|||
155424363|NCT00928070|560982369|FG001|Overall Study|Randomized but not treated|2|||
155424364|NCT00928070|560982368|FG000|Overall Study|Other|5|||
155424365|NCT00928070|560982369|FG001|Overall Study|Other|5|||
155424366|NCT02360098|560982370|FG000|Overall Study|Physician Decision|7|||
155424367|NCT01919307|560982376|FG000|Overall Study|Withdrawal by Subject|9|||
155424368|NCT02771522|560982379|FG000|Overall Study|Lost to Follow-up|3|||
155424369|NCT02771522|560982379|FG000|Overall Study|Withdrawal by Subject|2|||
155424370|NCT02771522|560982379|FG000|Overall Study|No white spot lesions|3|||
155424371|NCT02388295|560982380|FG000|Dose Escalation Week 1|Adverse Event|1|||
155424372|NCT02388295|560982381|FG001|Dose Escalation Week 1|Adverse Event|2|||
155424373|NCT02388295|560982382|FG002|Dose Escalation Week 1|Adverse Event|1|||
155424374|NCT02388295|560982380|FG000|Dose Escalation Week 1|Determined not eligible|1|||
155424375|NCT02388295|560982381|FG001|Dose Escalation Week 1|Determined not eligible|1|||
155424376|NCT02388295|560982382|FG002|Dose Escalation Week 1|Determined not eligible|1|||
155424377|NCT02388295|560982380|FG000|Dose Escalation Week 2|Protocol Violation|0|||
155424378|NCT02388295|560982381|FG001|Dose Escalation Week 2|Protocol Violation|1|||
155424379|NCT02388295|560982382|FG002|Dose Escalation Week 2|Protocol Violation|0|||
155424380|NCT02388295|560982380|FG000|Dose Escalation Week 2|Determined not eligible|1|||
155424381|NCT02388295|560982381|FG001|Dose Escalation Week 2|Determined not eligible|1|||
155424382|NCT02388295|560982382|FG002|Dose Escalation Week 2|Determined not eligible|1|||
155424383|NCT02388295|560982380|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
155424384|NCT02388295|560982381|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
155424385|NCT02388295|560982382|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
155424386|NCT01551693|560982383|FG000|Overall Study|Disease Progression|1|||
155424387|NCT01551693|560982384|FG001|Overall Study|Disease Progression|0|||
155424388|NCT01551693|560982383|FG000|Overall Study|Adverse Event|0|||
155424389|NCT01551693|560982384|FG001|Overall Study|Adverse Event|1|||
155424390|NCT01551693|560982383|FG000|Overall Study|Withdrawal by Subject|0|||
155424391|NCT01551693|560982384|FG001|Overall Study|Withdrawal by Subject|1|||
155424392|NCT02429856|560982385|FG000|Overall Study|Death|12|||
155424393|NCT02429856|560982386|FG001|Overall Study|Death|13|||
155424394|NCT02429856|560982385|FG000|Overall Study|Lost to Follow-up|6|||
155424395|NCT02429856|560982386|FG001|Overall Study|Lost to Follow-up|5|||
155424396|NCT02429856|560982385|FG000|Overall Study|Withdrawal by Subject|1|||
155424397|NCT02429856|560982386|FG001|Overall Study|Withdrawal by Subject|1|||
155424398|NCT04134494|560982390|FG000|Overall Study|Lost to Follow-up|2|||
155424399|NCT00781365|560982391|FG000|Overall Study|Withdrawal by Subject|13|||
155424400|NCT00781365|560982392|FG001|Overall Study|Withdrawal by Subject|8|||
155424401|NCT00781365|560982391|FG000|Overall Study|Did Not Attend Visit|20|||
155424402|NCT00781365|560982392|FG001|Overall Study|Did Not Attend Visit|28|||
155424403|NCT00781365|560982391|FG000|Overall Study|Language barrier|1|||
155424404|NCT00781365|560982392|FG001|Overall Study|Language barrier|0|||
155424405|NCT00348140|560982402|FG000|Overall Study|Adverse Event|46|||
155424406|NCT00348140|560982403|FG001|Overall Study|Adverse Event|49|||
155424407|NCT00348140|560982404|FG002|Overall Study|Adverse Event|78|||
155424408|NCT00348140|560982402|FG000|Overall Study|Lost to Follow-up|4|||
155424409|NCT00348140|560982403|FG001|Overall Study|Lost to Follow-up|4|||
155424410|NCT00348140|560982404|FG002|Overall Study|Lost to Follow-up|4|||
155424411|NCT00348140|560982402|FG000|Overall Study|Protocol Violation|12|||
155424412|NCT00348140|560982403|FG001|Overall Study|Protocol Violation|13|||
155424413|NCT00348140|560982404|FG002|Overall Study|Protocol Violation|14|||
155424414|NCT00348140|560982402|FG000|Overall Study|Withdrawal by Subject|32|||
155424415|NCT00348140|560982403|FG001|Overall Study|Withdrawal by Subject|40|||
155424416|NCT00348140|560982404|FG002|Overall Study|Withdrawal by Subject|40|||
155424417|NCT00348140|560982402|FG000|Overall Study|Non-compliance|8|||
155424418|NCT00348140|560982403|FG001|Overall Study|Non-compliance|13|||
155424419|NCT00348140|560982404|FG002|Overall Study|Non-compliance|5|||
155424420|NCT00348140|560982402|FG000|Overall Study|Participant at risk due to study drug|2|||
155424421|NCT00348140|560982403|FG001|Overall Study|Participant at risk due to study drug|0|||
155424422|NCT00348140|560982404|FG002|Overall Study|Participant at risk due to study drug|0|||
155424423|NCT00348140|560982402|FG000|Overall Study|Conditional medication increased dose|1|||
155424424|NCT00348140|560982403|FG001|Overall Study|Conditional medication increased dose|0|||
155424425|NCT00348140|560982404|FG002|Overall Study|Conditional medication increased dose|0|||
155424426|NCT00348140|560982402|FG000|Overall Study|Caregiver related|4|||
155424427|NCT00348140|560982403|FG001|Overall Study|Caregiver related|7|||
155344299|NCT06247488|560692889|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344300|NCT06247488|560692890|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344301|NCT06247488|560692891|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344302|NCT06247488|560692892|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344303|NCT06247488|560692887|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344304|NCT06247488|560692888|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344305|NCT06247488|560692889|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344306|NCT06247488|560692890|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
155424428|NCT00348140|560982404|FG002|Overall Study|Caregiver related|3|||
155344307|NCT06247488|560692891|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344308|NCT06247488|560692892|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344309|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344310|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344311|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344312|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344313|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344314|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
155344315|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344316|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344317|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344318|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344319|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344320|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344321|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344322|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344323|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155505551|NCT00830063|561278178|FG001|Overall Study|Lost to Follow-up|0|||
155505552|NCT00830063|561278179|FG002|Overall Study|Lost to Follow-up|3|||
155647779|NCT03774810|561803680|FG002|Phase 1|Lost to Follow-up|0|||
155647780|NCT03774810|561803681|FG003|Phase 1|Lost to Follow-up|0|||
155647781|NCT03774810|561803682|FG004|Phase 1|Lost to Follow-up|0|||
155505553|NCT00830063|561278180|FG003|Overall Study|Lost to Follow-up|1|||
155647782|NCT03774810|561803678|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
155344324|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344325|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344326|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
155344327|NCT03436797|560692896|FG000|Main Study|Withdrawal by Subject|2|||
155344328|NCT03436797|560692896|FG000|Main Study|Adverse Event|4|||
155344329|NCT03436797|560692896|FG000|Main Study|Lost to Follow-up|1|||
155344330|NCT03436797|560692896|FG000|Main Study|Death|1|||
155344331|NCT03436797|560692896|FG000|Main Study|Non-Specific|2|||
155344332|NCT03436797|560692896|FG000|Extended Dosing|Patient decision|1|||
155344333|NCT04739306|560692897|FG000|Main Study Period|Adverse Event|6|||
155344334|NCT04739306|560692898|FG001|Main Study Period|Adverse Event|7|||
155344335|NCT04739306|560692897|FG000|Main Study Period|Lost to Follow-up|4|||
155344336|NCT04739306|560692898|FG001|Main Study Period|Lost to Follow-up|6|||
155344337|NCT04739306|560692897|FG000|Main Study Period|Physician Decision|1|||
155344338|NCT04739306|560692898|FG001|Main Study Period|Physician Decision|1|||
155344339|NCT04739306|560692897|FG000|Main Study Period|Withdrawal by Subject|8|||
155344340|NCT04739306|560692898|FG001|Main Study Period|Withdrawal by Subject|6|||
155505554|NCT00830063|561278177|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
155505555|NCT00830063|561278178|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
155505556|NCT00830063|561278179|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
155505557|NCT00830063|561278180|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
155505558|NCT00830063|561278177|FG000|Overall Study|Lack of Efficacy|51|||
155505559|NCT00830063|561278178|FG001|Overall Study|Lack of Efficacy|23|||
155505560|NCT00830063|561278179|FG002|Overall Study|Lack of Efficacy|25|||
155505561|NCT00830063|561278180|FG003|Overall Study|Lack of Efficacy|32|||
155505562|NCT00830063|561278177|FG000|Overall Study|Other|5|||
155505563|NCT00830063|561278178|FG001|Overall Study|Other|5|||
155505564|NCT00830063|561278179|FG002|Overall Study|Other|8|||
155505565|NCT00830063|561278180|FG003|Overall Study|Other|6|||
155505566|NCT00830063|561278177|FG000|Overall Study|Withdrawal by Subject|16|||
155505567|NCT00830063|561278178|FG001|Overall Study|Withdrawal by Subject|10|||
155505568|NCT00830063|561278179|FG002|Overall Study|Withdrawal by Subject|16|||
155505569|NCT00830063|561278180|FG003|Overall Study|Withdrawal by Subject|13|||
155505570|NCT00830063|561278177|FG000|Overall Study|Protocol Violation|1|||
155505571|NCT00830063|561278178|FG001|Overall Study|Protocol Violation|0|||
155505572|NCT00830063|561278179|FG002|Overall Study|Protocol Violation|3|||
155505573|NCT00830063|561278180|FG003|Overall Study|Protocol Violation|2|||
155505574|NCT00830063|561278177|FG000|Overall Study|Randomized But Not Treated|0|||
155505575|NCT00830063|561278178|FG001|Overall Study|Randomized But Not Treated|2|||
155505576|NCT00830063|561278179|FG002|Overall Study|Randomized But Not Treated|0|||
155505577|NCT00830063|561278180|FG003|Overall Study|Randomized But Not Treated|2|||
155505578|NCT01814761|561278181|FG000|Overall Study|Other Reasons|1|||
155505579|NCT01814761|561278182|FG001|Overall Study|Other Reasons|10|||
155505580|NCT01814761|561278181|FG000|Overall Study|Ocular Adverse Event|6|||
155505581|NCT01814761|561278182|FG001|Overall Study|Ocular Adverse Event|15|||
155505582|NCT01814761|561278181|FG000|Overall Study|Lost to Follow-up|1|||
155505583|NCT01814761|561278182|FG001|Overall Study|Lost to Follow-up|5|||
155505584|NCT01059071|561278183|FG000|Overall Study|Lack of Efficacy|1|||
155505585|NCT01059071|561278184|FG001|Overall Study|Lack of Efficacy|4|||
155505586|NCT01059071|561278185|FG002|Overall Study|Lack of Efficacy|2|||
155505587|NCT01059071|561278186|FG003|Overall Study|Lack of Efficacy|3|||
155505588|NCT01059071|561278183|FG000|Overall Study|Withdrawal by Subject|1|||
155505589|NCT01059071|561278184|FG001|Overall Study|Withdrawal by Subject|0|||
155505590|NCT01059071|561278185|FG002|Overall Study|Withdrawal by Subject|0|||
155505591|NCT01059071|561278186|FG003|Overall Study|Withdrawal by Subject|2|||
155505592|NCT01059071|561278183|FG000|Overall Study|Physician Decision|0|||
155505593|NCT01059071|561278184|FG001|Overall Study|Physician Decision|0|||
155505594|NCT01059071|561278185|FG002|Overall Study|Physician Decision|0|||
155505595|NCT01059071|561278186|FG003|Overall Study|Physician Decision|1|||
155505596|NCT02962882|561278187|FG000|Overall Study|Adverse Event|2|||
155505597|NCT02962882|561278187|FG000|Overall Study|Withdrawal by Subject|2|||
155505598|NCT02962882|561278187|FG000|Overall Study|Transfer from ICU|32|||
155505599|NCT03763331|561278188|FG000|Overall Study|Lost to Follow-up|1|||
155505600|NCT03763331|561278189|FG001|Overall Study|Lost to Follow-up|0|||
155505601|NCT03763331|561278188|FG000|Overall Study|Withdrawal by Subject|1|||
155505602|NCT03763331|561278189|FG001|Overall Study|Withdrawal by Subject|0|||
155505603|NCT03763331|561278188|FG000|Overall Study|Non-compliance|0|||
155505604|NCT03763331|561278189|FG001|Overall Study|Non-compliance|3|||
155505605|NCT00936884|561278190|FG000|Double-blind|Withdrawal by Subject|6|||
155505606|NCT00936884|561278191|FG001|Double-blind|Withdrawal by Subject|4|||
155505607|NCT00936884|561278192|FG002|Double-blind|Withdrawal by Subject|0|||
155505608|NCT00936884|561278190|FG000|Double-blind|Death|2|||
155505609|NCT00936884|561278191|FG001|Double-blind|Death|1|||
155505610|NCT00936884|561278192|FG002|Double-blind|Death|0|||
155505611|NCT00936884|561278190|FG000|Double-blind|Lack of Efficacy|1|||
155505612|NCT00936884|561278191|FG001|Double-blind|Lack of Efficacy|1|||
155505613|NCT00936884|561278192|FG002|Double-blind|Lack of Efficacy|0|||
155505614|NCT00936884|561278190|FG000|Double-blind|Adverse Event|1|||
155505615|NCT00936884|561278191|FG001|Double-blind|Adverse Event|0|||
155505616|NCT00936884|561278192|FG002|Double-blind|Adverse Event|0|||
155505617|NCT00936884|561278190|FG000|Double-blind|Physician Decision|1|||
155505618|NCT00936884|561278191|FG001|Double-blind|Physician Decision|0|||
155505619|NCT00936884|561278192|FG002|Double-blind|Physician Decision|0|||
155505620|NCT00936884|561278190|FG000|Double-blind|No post baseline diary entry|1|||
155505621|NCT00936884|561278191|FG001|Double-blind|No post baseline diary entry|0|||
155505622|NCT00936884|561278192|FG002|Double-blind|No post baseline diary entry|0|||
155505623|NCT00936884|561278190|FG000|Double-blind|Did not receive study drug|0|||
155505624|NCT00936884|561278191|FG001|Double-blind|Did not receive study drug|1|||
155344341|NCT04739306|560692897|FG000|Main Study Period|Protocol Violation|0|||
155505625|NCT00936884|561278192|FG002|Double-blind|Did not receive study drug|0|||
155505626|NCT04741503|561278193|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
155505627|NCT04741503|561278194|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
155505628|NCT04741503|561278195|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
155505629|NCT04741503|561278193|FG000|Initial Enrollment|Overquotas removed|0|||
155505630|NCT04741503|561278194|FG001|Initial Enrollment|Overquotas removed|0|||
155505631|NCT04741503|561278195|FG002|Initial Enrollment|Overquotas removed|186|||
155505632|NCT04741503|561278193|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
155505633|NCT04741503|561278194|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
155505634|NCT04741503|561278195|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
155505635|NCT00597584|561278196|FG000|Overall Study|Adverse Event|4|||
155505636|NCT00597584|561278197|FG001|Overall Study|Adverse Event|2|||
155505637|NCT00597584|561278196|FG000|Overall Study|Death|53|||
155505638|NCT00597584|561278197|FG001|Overall Study|Death|30|||
155505639|NCT00597584|561278196|FG000|Overall Study|Lack of Efficacy|1|||
155505640|NCT00597584|561278197|FG001|Overall Study|Lack of Efficacy|0|||
155505641|NCT00597584|561278196|FG000|Overall Study|Lost to Follow-up|2|||
155505642|NCT00597584|561278197|FG001|Overall Study|Lost to Follow-up|4|||
155505643|NCT00597584|561278196|FG000|Overall Study|Physician Decision|3|||
155505644|NCT00597584|561278197|FG001|Overall Study|Physician Decision|0|||
155505645|NCT00597584|561278196|FG000|Overall Study|Pregnancy|2|||
155505646|NCT00597584|561278197|FG001|Overall Study|Pregnancy|0|||
155505647|NCT00597584|561278196|FG000|Overall Study|Withdrawal by Subject|44|||
155505648|NCT00597584|561278197|FG001|Overall Study|Withdrawal by Subject|12|||
155505649|NCT00597584|561278196|FG000|Overall Study|Discontinued Dialysis|0|||
155505650|NCT00597584|561278197|FG001|Overall Study|Discontinued Dialysis|1|||
155505651|NCT00597584|561278196|FG000|Overall Study|Lost ability to consent|1|||
155505652|NCT00597584|561278197|FG001|Overall Study|Lost ability to consent|1|||
155505653|NCT00597584|561278196|FG000|Overall Study|Never dosed|1|||
155505654|NCT00597584|561278197|FG001|Overall Study|Never dosed|0|||
155505655|NCT00597584|561278196|FG000|Overall Study|Relocation|8|||
155505656|NCT00597584|561278197|FG001|Overall Study|Relocation|6|||
155505657|NCT00597584|561278196|FG000|Overall Study|Renal transplant|9|||
155505658|NCT00597584|561278197|FG001|Overall Study|Renal transplant|7|||
155505659|NCT02791659|561278209|FG000|Overall Study|Protocol Violation|0|||
155505660|NCT02791659|561278210|FG001|Overall Study|Protocol Violation|1|||
155505661|NCT01456052|561278211|FG000|Overall Study|Adverse Event|1|||
155505662|NCT01456052|561278212|FG001|Overall Study|Adverse Event|1|||
155505663|NCT01456052|561278213|FG002|Overall Study|Adverse Event|2|||
155505664|NCT01456052|561278211|FG000|Overall Study|Consent withdrawn|0|||
155505665|NCT01456052|561278212|FG001|Overall Study|Consent withdrawn|2|||
155505666|NCT01456052|561278213|FG002|Overall Study|Consent withdrawn|1|||
155505667|NCT01456052|561278211|FG000|Overall Study|Protocol Violation|0|||
155505668|NCT01456052|561278212|FG001|Overall Study|Protocol Violation|1|||
155505669|NCT01456052|561278213|FG002|Overall Study|Protocol Violation|0|||
155505670|NCT01456052|561278211|FG000|Overall Study|Physician Decision|1|||
155505671|NCT01456052|561278212|FG001|Overall Study|Physician Decision|0|||
155505672|NCT01456052|561278213|FG002|Overall Study|Physician Decision|1|||
155505673|NCT01456052|561278211|FG000|Overall Study|Treatment Failure|0|||
155505674|NCT01456052|561278212|FG001|Overall Study|Treatment Failure|1|||
155505675|NCT01456052|561278213|FG002|Overall Study|Treatment Failure|1|||
155505676|NCT02853929|561278216|FG000|Overall Study|Lost to Follow-up|3|||
155505677|NCT02853929|561278217|FG001|Overall Study|Lost to Follow-up|0|||
155505678|NCT02853929|561278216|FG000|Overall Study|Withdrawal by Subject|1|||
155505679|NCT02853929|561278217|FG001|Overall Study|Withdrawal by Subject|0|||
155505680|NCT02853929|561278216|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
155505681|NCT02853929|561278217|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
155505682|NCT02762565|561278218|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
155505683|NCT01113710|561278219|FG000|Overall Study|Adverse Event|64|||
155505684|NCT01113710|561278219|FG000|Overall Study|Lack of Efficacy|41|||
155505685|NCT01113710|561278219|FG000|Overall Study|No Information Available|40|||
155505686|NCT01113710|561278219|FG000|Overall Study|Withdrawal by Subject|28|||
155505687|NCT01113710|561278219|FG000|Overall Study|Lost to Follow-up|20|||
155505688|NCT01113710|561278219|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
155505689|NCT01113710|561278219|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
155505690|NCT01113710|561278219|FG000|Overall Study|Lack of Patient's Compliance|8|||
155505691|NCT01113710|561278219|FG000|Overall Study|Other|7|||
155505692|NCT01113710|561278219|FG000|Overall Study|Adverse Event/Other|5|||
155505693|NCT01113710|561278219|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
155505694|NCT01113710|561278219|FG000|Overall Study|Lack of Efficacy/Other|4|||
155505695|NCT01113710|561278219|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
155505696|NCT01113710|561278219|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
155505697|NCT01113710|561278219|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
155505698|NCT01113710|561278219|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
155505699|NCT01113710|561278219|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
155505700|NCT01113710|561278219|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
155505701|NCT01113710|561278219|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
155505702|NCT01113710|561278219|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
155505703|NCT01113710|561278219|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
155505704|NCT01113710|561278219|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
155505705|NCT01113710|561278219|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
155505706|NCT01113710|561278219|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
155505707|NCT01113710|561278219|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
155505708|NCT01042977|561278221|FG000|Overall Study|Adverse Event|4|||
155505709|NCT01042977|561278222|FG001|Overall Study|Adverse Event|12|||
155505710|NCT01042977|561278221|FG000|Overall Study|Death|2|||
155505711|NCT01042977|561278222|FG001|Overall Study|Death|1|||
155505712|NCT01042977|561278221|FG000|Overall Study|Withdrawal by Subject|8|||
155505713|NCT01042977|561278222|FG001|Overall Study|Withdrawal by Subject|16|||
155505714|NCT01042977|561278221|FG000|Overall Study|Lost to Follow-up|0|||
155505715|NCT01042977|561278222|FG001|Overall Study|Lost to Follow-up|2|||
155505716|NCT01042977|561278221|FG000|Overall Study|Poor/non-compliance|3|||
155505717|NCT01042977|561278222|FG001|Overall Study|Poor/non-compliance|4|||
155505718|NCT01042977|561278221|FG000|Overall Study|Subject no longer meets study criteria|15|||
155505719|NCT01042977|561278222|FG001|Overall Study|Subject no longer meets study criteria|13|||
155505720|NCT01042977|561278221|FG000|Overall Study|Incorrect enrollment|6|||
155505721|NCT01042977|561278222|FG001|Overall Study|Incorrect enrollment|4|||
155505722|NCT01042977|561278221|FG000|Overall Study|Safety|0|||
155505723|NCT01042977|561278222|FG001|Overall Study|Safety|2|||
155505724|NCT01042977|561278221|FG000|Overall Study|Administrative reason by sponsor|0|||
155505725|NCT01042977|561278222|FG001|Overall Study|Administrative reason by sponsor|1|||
155505726|NCT01042977|561278221|FG000|Overall Study|Various|3|||
155505727|NCT01042977|561278222|FG001|Overall Study|Various|0|||
155505728|NCT02499354|561278223|FG000|Overall Study|Withdrawal by Subject|1|||
155505729|NCT02499354|561278224|FG001|Overall Study|Withdrawal by Subject|0|||
155505730|NCT01677910|561278226|FG000|Double-Blind Treatment Period|Adverse Event|6|||
155505731|NCT01677910|561278227|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155505732|NCT01677910|561278228|FG002|Double-Blind Treatment Period|Adverse Event|3|||
155505733|NCT01677910|561278229|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155505734|NCT01677910|561278226|FG000|Double-Blind Treatment Period|Physician Decision|0|||
155505735|NCT01677910|561278227|FG001|Double-Blind Treatment Period|Physician Decision|0|||
155505736|NCT01677910|561278228|FG002|Double-Blind Treatment Period|Physician Decision|1|||
155505737|NCT01677910|561278229|FG003|Double-Blind Treatment Period|Physician Decision|0|||
155505738|NCT01677910|561278226|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
155505739|NCT01677910|561278227|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
155505740|NCT01677910|561278228|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
155505741|NCT01677910|561278229|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
155505742|NCT01677910|561278226|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
155505743|NCT01677910|561278227|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
155505744|NCT01677910|561278228|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
155505745|NCT01677910|561278229|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
155505746|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
155505747|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
155505748|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
155505749|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
155344342|NCT04739306|560692898|FG001|Main Study Period|Protocol Violation|1|||
155344343|NCT04739306|560692897|FG000|Main Study Period|War in Ukraine|1|||
155344344|NCT04739306|560692898|FG001|Main Study Period|War in Ukraine|1|||
155505750|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155505751|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155505752|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155505753|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
155505754|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155505755|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155505756|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155505757|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
155505758|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155505759|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155344345|NCT01951105|560692903|FG000|Overall Study|Adverse Event|0|||
155344346|NCT01951105|560692904|FG001|Overall Study|Adverse Event|5|||
155344347|NCT01951105|560692905|FG002|Overall Study|Adverse Event|0|||
155344348|NCT01951105|560692903|FG000|Overall Study|Lost to Follow-up|0|||
155344349|NCT01951105|560692904|FG001|Overall Study|Lost to Follow-up|1|||
155344350|NCT01951105|560692905|FG002|Overall Study|Lost to Follow-up|0|||
155344351|NCT01951105|560692903|FG000|Overall Study|Protocol Violation|1|||
155344352|NCT01951105|560692904|FG001|Overall Study|Protocol Violation|1|||
155344353|NCT01951105|560692905|FG002|Overall Study|Protocol Violation|1|||
155344354|NCT01951105|560692903|FG000|Overall Study|Withdrawal by Subject|0|||
155344355|NCT01951105|560692904|FG001|Overall Study|Withdrawal by Subject|3|||
155344356|NCT01951105|560692905|FG002|Overall Study|Withdrawal by Subject|1|||
155505760|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155505761|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
155505762|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
155505763|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
155505764|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
155505765|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
155505766|NCT01677910|561278226|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
155505767|NCT01677910|561278227|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
155505768|NCT01677910|561278228|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
155505769|NCT01677910|561278229|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
155505770|NCT01808209|561278232|FG000|Overall Study|Lost to Follow-up|0|||
155505771|NCT01808209|561278233|FG001|Overall Study|Lost to Follow-up|1|||
155505772|NCT01703741|561278234|FG000|Overall Study|Withdrawal by Subject|6|||
155505773|NCT01703741|561278234|FG000|Overall Study|Adverse Event|2|||
155505774|NCT01703741|561278234|FG000|Overall Study|Physician Decision|2|||
155505775|NCT01703741|561278234|FG000|Overall Study|Protocol Violation|1|||
155505776|NCT01703741|561278234|FG000|Overall Study|Lost to Follow-up|3|||
155505777|NCT01703741|561278234|FG000|Overall Study|Subject did not want to continue|2|||
155505778|NCT01703741|561278234|FG000|Overall Study|Subject cannot comply with study visits|1|||
155505779|NCT01703741|561278234|FG000|Overall Study|Subject started testosterone injections|1|||
155505780|NCT00368537|561278235|FG000|Randomization|No study drug dosed|13|||
155505781|NCT00368537|561278236|FG001|Randomization|No study drug dosed|6|||
155505782|NCT00368537|561278235|FG000|Baseline Participants|Lost to Follow-up|16|||
155505783|NCT00368537|561278236|FG001|Baseline Participants|Lost to Follow-up|17|||
155505784|NCT00368537|561278235|FG000|Baseline Participants|Withdrawal by Subject|6|||
155505785|NCT00368537|561278236|FG001|Baseline Participants|Withdrawal by Subject|4|||
155505786|NCT00368537|561278235|FG000|Baseline Participants|Death|1|||
155505787|NCT00368537|561278236|FG001|Baseline Participants|Death|2|||
155505788|NCT00368537|561278235|FG000|Baseline Participants|No susceptibility|1|||
155505789|NCT00368537|561278236|FG001|Baseline Participants|No susceptibility|0|||
155505790|NCT00368537|561278235|FG000|Baseline Participants|Patient uncompliant|0|||
155505791|NCT00368537|561278236|FG001|Baseline Participants|Patient uncompliant|1|||
155505792|NCT00685919|561278247|FG000|Overall Study|Withdrawal by Subject|0|||
155505793|NCT00685919|561278248|FG001|Overall Study|Withdrawal by Subject|0|||
155505794|NCT00685919|561278249|FG002|Overall Study|Withdrawal by Subject|1|||
155505795|NCT00685919|561278250|FG003|Overall Study|Withdrawal by Subject|0|||
155505796|NCT00685919|561278247|FG000|Overall Study|Physician Decision|1|||
155505797|NCT00685919|561278248|FG001|Overall Study|Physician Decision|0|||
155505798|NCT00685919|561278249|FG002|Overall Study|Physician Decision|0|||
155505799|NCT00685919|561278250|FG003|Overall Study|Physician Decision|0|||
155505800|NCT01717456|561278253|FG000|End of Treatment|Physician Decision|0|||
155505801|NCT01717456|561278254|FG001|End of Treatment|Physician Decision|1|||
155505802|NCT01717456|561278253|FG000|End of Treatment|Lost to Follow-up|0|||
155505803|NCT01717456|561278254|FG001|End of Treatment|Lost to Follow-up|1|||
155505804|NCT01717456|561278253|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
155505805|NCT01717456|561278254|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
155505806|NCT02732561|561278260|FG000|Overall Study|Lost to Follow-up|1|||
155505807|NCT02732561|561278261|FG001|Overall Study|Lost to Follow-up|1|||
155505808|NCT02732561|561278260|FG000|Overall Study|Withdrawal by Subject|1|||
155505809|NCT02732561|561278261|FG001|Overall Study|Withdrawal by Subject|0|||
155505810|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
155505811|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
155505812|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
155505813|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
155505814|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
155505815|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
155505816|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
155505817|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
155505818|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
155505819|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
155505820|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
155505821|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
155505822|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
155505823|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155505824|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155505825|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
155505826|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
155505827|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
155505828|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
155505829|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
155505830|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
155505831|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
155505832|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
155505833|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
155505834|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
155505835|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
155505836|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
155505837|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
155344357|NCT04175392|560692906|FG000|Overall Study|Withdrawal by Subject|3|||
155344358|NCT04175392|560692907|FG001|Overall Study|Withdrawal by Subject|2|||
155344359|NCT02727998|560692908|FG000|Overall Study|Lost to Follow-up|3|||
155344360|NCT02727998|560692909|FG001|Overall Study|Lost to Follow-up|3|||
155344361|NCT02727998|560692908|FG000|Overall Study|Withdrawal by Subject|0|||
155344362|NCT02727998|560692909|FG001|Overall Study|Withdrawal by Subject|1|||
155344363|NCT02105688|560692910|FG000|Part A: Double-Blind|Adverse Event|1|||
155344364|NCT02105688|560692911|FG001|Part A: Double-Blind|Adverse Event|0|||
155344365|NCT02105688|560692910|FG000|Part A: Double-Blind|Death|0|||
155344366|NCT02105688|560692911|FG001|Part A: Double-Blind|Death|1|||
155344367|NCT02105688|560692910|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
155344368|NCT02105688|560692911|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
155344369|NCT02105688|560692910|FG000|Part A: Double-Blind|Physician Decision|0|||
155344370|NCT02105688|560692911|FG001|Part A: Double-Blind|Physician Decision|1|||
155344371|NCT02105688|560692910|FG000|Part A: Double-Blind|Status Unknown|0|||
155344372|NCT02105688|560692911|FG001|Part A: Double-Blind|Status Unknown|2|||
155344373|NCT02105688|560692910|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
155344374|NCT02105688|560692911|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
155344375|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Death|2|||
155344376|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Death|1|||
155344377|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
155344378|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
155344379|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
155344380|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
155344381|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Physician Decision|3|||
155344382|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Physician Decision|1|||
155344383|NCT00561678|560692912|FG000|Overall Study|Withdrawal by Subject|4|||
155344384|NCT00561678|560692913|FG001|Overall Study|Withdrawal by Subject|3|||
155344385|NCT00561678|560692912|FG000|Overall Study|surgery cancelled|1|||
155344386|NCT00561678|560692913|FG001|Overall Study|surgery cancelled|1|||
155344387|NCT00561678|560692912|FG000|Overall Study|surgery rescheduled to different site|2|||
155344388|NCT00561678|560692913|FG001|Overall Study|surgery rescheduled to different site|2|||
155344389|NCT00561678|560692912|FG000|Overall Study|anesthesia provider refusal|1|||
155344390|NCT00561678|560692913|FG001|Overall Study|anesthesia provider refusal|0|||
155344391|NCT01103141|560692914|FG000|Overall Study|Death|0|||
155344392|NCT01103141|560692915|FG001|Overall Study|Death|1|||
155344393|NCT01103141|560692914|FG000|Overall Study|Lost to Follow-up|2|||
155344394|NCT01103141|560692915|FG001|Overall Study|Lost to Follow-up|1|||
155344395|NCT05072795|560692916|FG000|Overall Study|Lost to Follow-up|5|||
155344396|NCT00422162|560692924|FG000|Overall Study|Adverse Event|11|||
155344397|NCT00422162|560692925|FG001|Overall Study|Adverse Event|9|||
155344398|NCT00422162|560692924|FG000|Overall Study|Lack of Efficacy|4|||
155344399|NCT00422162|560692925|FG001|Overall Study|Lack of Efficacy|10|||
155344400|NCT00422162|560692924|FG000|Overall Study|Withdrawal by Subject|7|||
155344401|NCT00422162|560692925|FG001|Overall Study|Withdrawal by Subject|6|||
155344402|NCT00422162|560692924|FG000|Overall Study|Lost to Follow-up|1|||
155344403|NCT00422162|560692925|FG001|Overall Study|Lost to Follow-up|2|||
155344404|NCT00422162|560692924|FG000|Overall Study|Non-Compliant with Protocol|1|||
155344405|NCT00422162|560692925|FG001|Overall Study|Non-Compliant with Protocol|1|||
155344406|NCT00422162|560692924|FG000|Overall Study|Other|0|||
155344407|NCT00422162|560692925|FG001|Overall Study|Other|1|||
155647783|NCT03774810|561803679|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
155344408|NCT00422162|560692924|FG000|Overall Study|Didn't Receive Treatment|0|||
155344409|NCT00422162|560692925|FG001|Overall Study|Didn't Receive Treatment|1|||
155344410|NCT05274906|560692926|FG000|Overall Study|Withdrawal by Subject|2|||
155344411|NCT05274906|560692927|FG001|Overall Study|Withdrawal by Subject|1|||
155344412|NCT00848198|560692928|FG000|Overall Study|Incomplete Case Report Forms|15|||
155344413|NCT02062827|560692929|FG000|Overall Study|Death|1|||
155344414|NCT02062827|560692930|FG001|Overall Study|Death|0|||
155505838|NCT00528879|561278266|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
155344415|NCT02062827|560692931|FG002|Overall Study|Death|0|||
155344416|NCT02062827|560692932|FG003|Overall Study|Death|0|||
155344417|NCT02062827|560692933|FG004|Overall Study|Death|0|||
155344418|NCT02062827|560692934|FG005|Overall Study|Death|0|||
155344419|NCT02062827|560692935|FG006|Overall Study|Death|0|||
155344420|NCT02062827|560692936|FG007|Overall Study|Death|0|||
155344421|NCT02062827|560692929|FG000|Overall Study|Withdrawal by Subject|3|||
155344422|NCT02062827|560692930|FG001|Overall Study|Withdrawal by Subject|1|||
155344423|NCT02062827|560692931|FG002|Overall Study|Withdrawal by Subject|1|||
155344424|NCT02062827|560692932|FG003|Overall Study|Withdrawal by Subject|2|||
155344425|NCT02062827|560692933|FG004|Overall Study|Withdrawal by Subject|6|||
155344426|NCT02062827|560692934|FG005|Overall Study|Withdrawal by Subject|0|||
155344427|NCT02062827|560692935|FG006|Overall Study|Withdrawal by Subject|5|||
155344428|NCT02062827|560692936|FG007|Overall Study|Withdrawal by Subject|0|||
155344429|NCT02062827|560692929|FG000|Overall Study|Screen Fail|0|||
155344430|NCT02062827|560692930|FG001|Overall Study|Screen Fail|0|||
155344431|NCT02062827|560692931|FG002|Overall Study|Screen Fail|0|||
155344432|NCT02062827|560692932|FG003|Overall Study|Screen Fail|0|||
155344433|NCT02062827|560692933|FG004|Overall Study|Screen Fail|0|||
155344434|NCT02062827|560692934|FG005|Overall Study|Screen Fail|0|||
155344435|NCT02062827|560692935|FG006|Overall Study|Screen Fail|0|||
155344436|NCT02062827|560692936|FG007|Overall Study|Screen Fail|8|||
155344437|NCT04930263|560692937|FG000|Overall Study|Withdrawal by Subject|3|||
155344438|NCT04930263|560692938|FG001|Overall Study|Withdrawal by Subject|5|||
155344439|NCT02812706|560692939|FG000|Phase 1|Adverse Event|0|||
155344440|NCT02812706|560692940|FG001|Phase 1|Adverse Event|2|||
155344441|NCT02812706|560692941|FG002|Phase 1|Adverse Event|0|||
155344442|NCT02812706|560692939|FG000|Phase 1|Progressive disease|3|||
155344443|NCT02812706|560692940|FG001|Phase 1|Progressive disease|3|||
155344444|NCT02812706|560692941|FG002|Phase 1|Progressive disease|0|||
155344445|NCT02812706|560692939|FG000|Phase 2|Adverse Event|0|||
155344446|NCT02812706|560692940|FG001|Phase 2|Adverse Event|0|||
155344447|NCT02812706|560692941|FG002|Phase 2|Adverse Event|2|||
155344448|NCT02812706|560692939|FG000|Phase 2|Progressive disease|0|||
155344449|NCT02812706|560692940|FG001|Phase 2|Progressive disease|0|||
155344450|NCT02812706|560692941|FG002|Phase 2|Progressive disease|22|||
155344451|NCT02812706|560692939|FG000|Phase 2|Other-Unspecified|0|||
155344452|NCT02812706|560692940|FG001|Phase 2|Other-Unspecified|0|||
155344453|NCT02812706|560692941|FG002|Phase 2|Other-Unspecified|4|||
155344454|NCT04362176|560692942|FG000|Overall Study|Lost to Follow-up|5|||
155344455|NCT04362176|560692943|FG001|Overall Study|Lost to Follow-up|8|||
155344456|NCT04362176|560692942|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
155344457|NCT04362176|560692943|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
155344458|NCT06312566|560692944|FG000|Overall Study|Protocol Violation|0|||
155344459|NCT06312566|560692945|FG001|Overall Study|Protocol Violation|1|||
155344460|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
155344461|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
155344462|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
155344463|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
155344464|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
155344465|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
155424429|NCT00348140|560982402|FG000|Overall Study|Participant hospitalised|3|||
155424430|NCT00348140|560982403|FG001|Overall Study|Participant hospitalised|0|||
155424431|NCT00348140|560982404|FG002|Overall Study|Participant hospitalised|0|||
155424432|NCT00348140|560982402|FG000|Overall Study|Efficacy related|1|||
155424433|NCT00348140|560982403|FG001|Overall Study|Efficacy related|1|||
155424434|NCT00348140|560982404|FG002|Overall Study|Efficacy related|0|||
155344466|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
155344467|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
155344468|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
155344469|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
155344470|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
155344471|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
155344472|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
155344473|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
155344474|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
155424435|NCT00348140|560982402|FG000|Overall Study|Administration related|3|||
155344475|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
155344476|NCT02971683|560692946|FG000|Open-Label|Lost to Follow-up|1|||
155344477|NCT02971683|560692947|FG001|Open-Label|Lost to Follow-up|0|||
155344478|NCT02971683|560692946|FG000|Open-Label|Participants withdrew consent|0|||
155344479|NCT02971683|560692947|FG001|Open-Label|Participants withdrew consent|2|||
155344480|NCT02971683|560692946|FG000|Open-Label|Participant request to discontinue study treatment|1|||
155344481|NCT02971683|560692947|FG001|Open-Label|Participant request to discontinue study treatment|0|||
155344482|NCT02971683|560692946|FG000|Open-Label|Lack of Efficacy|2|||
155344483|NCT02971683|560692947|FG001|Open-Label|Lack of Efficacy|0|||
155344484|NCT02971683|560692946|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
155344485|NCT02971683|560692947|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
155344486|NCT02971683|560692946|FG000|Long-Term Open Label|Participant withdrew consent|1|||
155344487|NCT02971683|560692947|FG001|Long-Term Open Label|Participant withdrew consent|0|||
155344488|NCT02971683|560692946|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
155344489|NCT02971683|560692947|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
155344490|NCT02971683|560692946|FG000|Long-Term Open Label|Adverse Event|1|||
155344491|NCT02971683|560692947|FG001|Long-Term Open Label|Adverse Event|2|||
155344492|NCT02971683|560692946|FG000|Long-Term Open Label|Lack of Efficacy|1|||
155344493|NCT02971683|560692947|FG001|Long-Term Open Label|Lack of Efficacy|1|||
155344494|NCT01699178|560692948|FG000|Overall Study|Adverse Event|1|||
155344495|NCT01699178|560692949|FG001|Overall Study|Adverse Event|5|||
155344496|NCT01699178|560692948|FG000|Overall Study|Lost to Follow-up|1|||
155344497|NCT01699178|560692949|FG001|Overall Study|Lost to Follow-up|6|||
155344498|NCT01699178|560692948|FG000|Overall Study|Non-compliance with Study Drug|3|||
155344499|NCT01699178|560692949|FG001|Overall Study|Non-compliance with Study Drug|1|||
155344500|NCT01699178|560692948|FG000|Overall Study|Physician Decision|1|||
155344501|NCT01699178|560692949|FG001|Overall Study|Physician Decision|0|||
155344502|NCT01699178|560692948|FG000|Overall Study|Withdrawal by Subject|4|||
155344503|NCT01699178|560692949|FG001|Overall Study|Withdrawal by Subject|12|||
155344504|NCT01699178|560692948|FG000|Overall Study|Hematocrit >54%|1|||
155344505|NCT01699178|560692949|FG001|Overall Study|Hematocrit >54%|1|||
155344506|NCT01699178|560692948|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
155344507|NCT01699178|560692949|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
155344508|NCT01699178|560692948|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
155344509|NCT01699178|560692949|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
155344510|NCT04016415|560692952|FG000|Overall Study|Adverse Event|2|||
155344511|NCT04016415|560692953|FG001|Overall Study|Adverse Event|1|||
155344512|NCT04016415|560692952|FG000|Overall Study|Lost to Follow-up|6|||
155344513|NCT04016415|560692953|FG001|Overall Study|Lost to Follow-up|2|||
155344514|NCT04016415|560692952|FG000|Overall Study|Physician Decision|5|||
155344515|NCT04016415|560692953|FG001|Overall Study|Physician Decision|1|||
155344516|NCT04016415|560692952|FG000|Overall Study|Pregnancy|0|||
155344517|NCT04016415|560692953|FG001|Overall Study|Pregnancy|1|||
155344518|NCT04016415|560692952|FG000|Overall Study|Withdrawal by Subject|24|||
155344519|NCT04016415|560692953|FG001|Overall Study|Withdrawal by Subject|27|||
155344520|NCT04016415|560692952|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
155344521|NCT04016415|560692953|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
155344522|NCT00912964|560692956|FG000|Overall Study|Eligibility criterion not met|1|||
155344523|NCT00912964|560692957|FG001|Overall Study|Eligibility criterion not met|1|||
155344524|NCT00912964|560692958|FG002|Overall Study|Eligibility criterion not met|0|||
155344525|NCT00912964|560692956|FG000|Overall Study|Adverse Event|15|||
155344526|NCT00912964|560692957|FG001|Overall Study|Adverse Event|18|||
155344527|NCT00912964|560692958|FG002|Overall Study|Adverse Event|12|||
155344528|NCT00912964|560692956|FG000|Overall Study|Lack of Efficacy|11|||
155344529|NCT00912964|560692957|FG001|Overall Study|Lack of Efficacy|4|||
155344530|NCT00912964|560692958|FG002|Overall Study|Lack of Efficacy|3|||
155344531|NCT00912964|560692956|FG000|Overall Study|Withdrawal by Subject|20|||
155344532|NCT00912964|560692957|FG001|Overall Study|Withdrawal by Subject|12|||
155344533|NCT00912964|560692958|FG002|Overall Study|Withdrawal by Subject|18|||
155344534|NCT00912964|560692956|FG000|Overall Study|Lost to Follow-up|4|||
155344535|NCT00912964|560692957|FG001|Overall Study|Lost to Follow-up|3|||
155344536|NCT00912964|560692958|FG002|Overall Study|Lost to Follow-up|3|||
155344537|NCT00912964|560692956|FG000|Overall Study|Protocol Violation|5|||
155344538|NCT00912964|560692957|FG001|Overall Study|Protocol Violation|3|||
155344539|NCT00912964|560692958|FG002|Overall Study|Protocol Violation|8|||
155344540|NCT00912964|560692956|FG000|Overall Study|Taking exclusionary medications|7|||
155424436|NCT00348140|560982403|FG001|Overall Study|Administration related|1|||
155344541|NCT00912964|560692957|FG001|Overall Study|Taking exclusionary medications|4|||
155344542|NCT00912964|560692958|FG002|Overall Study|Taking exclusionary medications|8|||
155344543|NCT00912964|560692956|FG000|Overall Study|Medical History|1|||
155344544|NCT00912964|560692957|FG001|Overall Study|Medical History|0|||
155344545|NCT00912964|560692958|FG002|Overall Study|Medical History|0|||
155344546|NCT00912964|560692956|FG000|Overall Study|Non-compliance with study procedures|2|||
155344547|NCT00912964|560692957|FG001|Overall Study|Non-compliance with study procedures|0|||
155344548|NCT00912964|560692958|FG002|Overall Study|Non-compliance with study procedures|0|||
155344549|NCT00912964|560692956|FG000|Overall Study|Violation of exclusion criterion|0|||
155344550|NCT00912964|560692957|FG001|Overall Study|Violation of exclusion criterion|0|||
155344551|NCT00912964|560692958|FG002|Overall Study|Violation of exclusion criterion|2|||
155344552|NCT00912964|560692956|FG000|Overall Study|Randomized but never received study drug|0|||
155344553|NCT00912964|560692957|FG001|Overall Study|Randomized but never received study drug|1|||
155344554|NCT00912964|560692958|FG002|Overall Study|Randomized but never received study drug|0|||
155344555|NCT02260154|560692959|FG000|Overall Study|Screening failure|2|||
155344556|NCT03547167|560692964|FG000|Overall Study|Withdrawal by Subject|34|||
155344557|NCT03547167|560692965|FG001|Overall Study|Withdrawal by Subject|12|||
155344558|NCT03547167|560692964|FG000|Overall Study|Screen Failure|0|||
155344559|NCT03547167|560692965|FG001|Overall Study|Screen Failure|1|||
155344560|NCT03547167|560692964|FG000|Overall Study|Lost to Follow-up|59|||
155344561|NCT03547167|560692965|FG001|Overall Study|Lost to Follow-up|15|||
155344562|NCT03547167|560692964|FG000|Overall Study|Death|4|||
155344563|NCT03547167|560692965|FG001|Overall Study|Death|2|||
155344564|NCT00070317|560692966|FG000|Overall Study|Inevaluable (Never Treated)|1|||
155344565|NCT00070317|560692966|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
155344566|NCT00070317|560692966|FG000|Overall Study|Ineligible required test not done|1|||
155344567|NCT00070317|560692966|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
155344568|NCT00070317|560692966|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
155344569|NCT01885559|560692967|FG000|Overall Study|Lost to Follow-up|15|||
155344570|NCT01885559|560692968|FG001|Overall Study|Lost to Follow-up|16|||
155344571|NCT01885559|560692967|FG000|Overall Study|Less than full participation|9|||
155344572|NCT01885559|560692968|FG001|Overall Study|Less than full participation|19|||
155344573|NCT01885559|560692967|FG000|Overall Study|Protocol Violation|0|||
155344574|NCT01885559|560692968|FG001|Overall Study|Protocol Violation|1|||
155344575|NCT00645411|560692969|FG000|Overall Study|Adverse Event|0|||
155344576|NCT00645411|560692970|FG001|Overall Study|Adverse Event|0|||
155344577|NCT00645411|560692971|FG002|Overall Study|Adverse Event|0|||
155344578|NCT00645411|560692972|FG003|Overall Study|Adverse Event|2|||
155344579|NCT00645411|560692969|FG000|Overall Study|Withdrawal by Subject|2|||
155344580|NCT00645411|560692970|FG001|Overall Study|Withdrawal by Subject|1|||
155344581|NCT00645411|560692971|FG002|Overall Study|Withdrawal by Subject|19|||
155344582|NCT00645411|560692972|FG003|Overall Study|Withdrawal by Subject|21|||
155344583|NCT00645411|560692969|FG000|Overall Study|Lost to Follow-up|10|||
155344584|NCT00645411|560692970|FG001|Overall Study|Lost to Follow-up|5|||
155344585|NCT00645411|560692971|FG002|Overall Study|Lost to Follow-up|124|||
155344586|NCT00645411|560692972|FG003|Overall Study|Lost to Follow-up|75|||
155344587|NCT00645411|560692969|FG000|Overall Study|Protocol Violation|1|||
155344588|NCT00645411|560692970|FG001|Overall Study|Protocol Violation|0|||
155344589|NCT00645411|560692971|FG002|Overall Study|Protocol Violation|1|||
155344590|NCT00645411|560692972|FG003|Overall Study|Protocol Violation|0|||
155344591|NCT00645411|560692969|FG000|Overall Study|Inappropriate enrollment|0|||
155344592|NCT00645411|560692970|FG001|Overall Study|Inappropriate enrollment|0|||
155344593|NCT00645411|560692971|FG002|Overall Study|Inappropriate enrollment|4|||
155344594|NCT00645411|560692972|FG003|Overall Study|Inappropriate enrollment|1|||
155344595|NCT00645411|560692969|FG000|Overall Study|Unable to classify|0|||
155344596|NCT00645411|560692970|FG001|Overall Study|Unable to classify|0|||
155344597|NCT00645411|560692971|FG002|Overall Study|Unable to classify|3|||
155344598|NCT00645411|560692972|FG003|Overall Study|Unable to classify|4|||
155344599|NCT03560206|560692973|FG000|Overall Study|Lost to Follow-up|19|||
155344600|NCT03560206|560692974|FG001|Overall Study|Lost to Follow-up|11|||
155424437|NCT00348140|560982404|FG002|Overall Study|Administration related|1|||
155424438|NCT00348140|560982402|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
155424439|NCT00348140|560982403|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
155424440|NCT00348140|560982404|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
155344601|NCT03560206|560692973|FG000|Overall Study|Withdrawal by Subject|2|||
155344602|NCT03560206|560692974|FG001|Overall Study|Withdrawal by Subject|4|||
155344603|NCT03560206|560692973|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
155344604|NCT03560206|560692974|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
155344605|NCT03560206|560692973|FG000|Overall Study|Busy schedule|14|||
155344606|NCT03560206|560692974|FG001|Overall Study|Busy schedule|2|||
155344607|NCT03560206|560692973|FG000|Overall Study|patients' new health condition such as cancer|10|||
155344608|NCT03560206|560692974|FG001|Overall Study|patients' new health condition such as cancer|1|||
155344609|NCT03100370|560692975|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344610|NCT03100370|560692976|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344611|NCT03100370|560692977|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155424441|NCT00348140|560982402|FG000|Overall Study|Participant unwell|1|||
155344612|NCT03100370|560692978|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155344613|NCT03100370|560692979|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344614|NCT03100370|560692980|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344615|NCT00738400|560692981|FG000|Overall Study|Adverse Event|3|||
155344616|NCT00738400|560692982|FG001|Overall Study|Adverse Event|1|||
155344617|NCT00738400|560692981|FG000|Overall Study|Withdrawal by Subject|0|||
155344618|NCT00738400|560692982|FG001|Overall Study|Withdrawal by Subject|1|||
155344619|NCT00738400|560692981|FG000|Overall Study|Lack of Efficacy|0|||
155344620|NCT00738400|560692982|FG001|Overall Study|Lack of Efficacy|1|||
155344621|NCT00738400|560692981|FG000|Overall Study|Lost to Follow-up|0|||
155344622|NCT00738400|560692982|FG001|Overall Study|Lost to Follow-up|3|||
155344623|NCT00738400|560692981|FG000|Overall Study|Protocol Violation|1|||
155344624|NCT00738400|560692982|FG001|Overall Study|Protocol Violation|0|||
155344625|NCT00738400|560692981|FG000|Overall Study|Non-compliant with study medication|0|||
155344626|NCT00738400|560692982|FG001|Overall Study|Non-compliant with study medication|1|||
155344627|NCT02674399|560692983|FG000|Overall Study|Lost to Follow-up|2|||
155344628|NCT02674399|560692984|FG001|Overall Study|Lost to Follow-up|0|||
155344629|NCT00508144|560692985|FG000|Overall Study|Not eligible|6|||
155344630|NCT00508144|560692985|FG000|Overall Study|Death|5|||
155344631|NCT01084772|560692989|FG000|Baseline|Withdrawal by Subject|7|||
155344632|NCT01084772|560692990|FG001|Baseline|Withdrawal by Subject|6|||
155344633|NCT01084772|560692989|FG000|3 Months|Death|1|||
155344634|NCT01084772|560692990|FG001|3 Months|Death|0|||
155344635|NCT01084772|560692989|FG000|3 Months|Study Termination|2|||
155344636|NCT01084772|560692990|FG001|3 Months|Study Termination|2|||
155344637|NCT01084772|560692989|FG000|1 Year|Withdrawal by Subject|0|||
155344638|NCT01084772|560692990|FG001|1 Year|Withdrawal by Subject|1|||
155344639|NCT01084772|560692989|FG000|1 Year|Lost to Follow-up|3|||
155344640|NCT01084772|560692990|FG001|1 Year|Lost to Follow-up|0|||
155344641|NCT01084772|560692989|FG000|1 Year|Study Termination|0|||
155344642|NCT01084772|560692990|FG001|1 Year|Study Termination|7|||
155344643|NCT01084772|560692989|FG000|2 Years|Withdrawal by Subject|1|||
155344644|NCT01084772|560692990|FG001|2 Years|Withdrawal by Subject|0|||
155344645|NCT01084772|560692989|FG000|2 Years|Lost to Follow-up|5|||
155344646|NCT01084772|560692990|FG001|2 Years|Lost to Follow-up|2|||
155344647|NCT01084772|560692989|FG000|2 Years|Study Termination|3|||
155344648|NCT01084772|560692990|FG001|2 Years|Study Termination|2|||
155344649|NCT00091572|560693004|FG000|Overall Study|Lost to Follow-up|1|||
155344650|NCT00091572|560693005|FG001|Overall Study|Lost to Follow-up|1|||
155344651|NCT00091572|560693004|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
155344652|NCT00091572|560693005|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
155344653|NCT00091572|560693004|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
155344654|NCT00091572|560693005|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
155344655|NCT00091572|560693004|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
155344656|NCT00091572|560693005|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
155344657|NCT00091572|560693004|FG000|Overall Study|Other Reason|6|||
155344658|NCT00091572|560693005|FG001|Overall Study|Other Reason|13|||
155344659|NCT00091572|560693004|FG000|Overall Study|Ongoing (still on treatment)|8|||
155344660|NCT00091572|560693005|FG001|Overall Study|Ongoing (still on treatment)|12|||
155344661|NCT00091572|560693004|FG000|Overall Study|Major Protocol Violation|2|||
155344662|NCT00091572|560693005|FG001|Overall Study|Major Protocol Violation|0|||
155344663|NCT00091572|560693004|FG000|Overall Study|Toxicity (Related AE)|53|||
155344664|NCT00091572|560693005|FG001|Overall Study|Toxicity (Related AE)|9|||
155344665|NCT04097535|560693006|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
155344666|NCT03070301|560693007|FG000|Overall Study|Progression of disease|16|||
155344667|NCT03070301|560693007|FG000|Overall Study|Physician Decision|3|||
155344668|NCT03070301|560693007|FG000|Overall Study|Withdrawal by Subject|1|||
155344669|NCT04413149|560694052|FG000|Overall Study|Death|10|||
155344670|NCT04413149|560694053|FG001|Overall Study|Death|5|||
155344671|NCT04413149|560694052|FG000|Overall Study|Lung transplantation|1|||
155344672|NCT04413149|560694053|FG001|Overall Study|Lung transplantation|0|||
155344673|NCT02878590|560694054|FG000|Overall Study|Withdrawal by Subject|2|||
155344674|NCT00814632|560694055|FG000|Overall Study|Lack of Efficacy|2|||
155344675|NCT02514577|560694061|FG000|Overall Study|Lost to Follow-up|6|||
155344676|NCT02514577|560694062|FG001|Overall Study|Lost to Follow-up|6|||
155344677|NCT02514577|560694061|FG000|Overall Study|Protocol Violation|1|||
155344678|NCT02514577|560694062|FG001|Overall Study|Protocol Violation|0|||
155344679|NCT02514577|560694061|FG000|Overall Study|Withdrawal by Subject|6|||
155344680|NCT02514577|560694062|FG001|Overall Study|Withdrawal by Subject|6|||
155344681|NCT02514577|560694061|FG000|Overall Study|Adverse Event|1|||
155344682|NCT02514577|560694062|FG001|Overall Study|Adverse Event|1|||
155344683|NCT00489489|560694063|FG000|Overall Study|Not treated due to protocol violation|0|||
155344684|NCT00489489|560694064|FG001|Overall Study|Not treated due to protocol violation|1|||
155344685|NCT00489489|560694065|FG002|Overall Study|Not treated due to protocol violation|1|||
155344686|NCT00489489|560694063|FG000|Overall Study|Adverse Event|1|||
155344687|NCT00489489|560694064|FG001|Overall Study|Adverse Event|1|||
155344688|NCT00489489|560694065|FG002|Overall Study|Adverse Event|1|||
155344689|NCT00489489|560694063|FG000|Overall Study|Protocol Violation|1|||
155344690|NCT00489489|560694064|FG001|Overall Study|Protocol Violation|0|||
155344691|NCT00489489|560694065|FG002|Overall Study|Protocol Violation|1|||
155344692|NCT00489489|560694063|FG000|Overall Study|Progressive disease|0|||
155344693|NCT00489489|560694064|FG001|Overall Study|Progressive disease|1|||
155344694|NCT00489489|560694065|FG002|Overall Study|Progressive disease|0|||
155344695|NCT00489489|560694063|FG000|Overall Study|Participant did not wish to continue|1|||
155344696|NCT00489489|560694064|FG001|Overall Study|Participant did not wish to continue|1|||
155344697|NCT00489489|560694065|FG002|Overall Study|Participant did not wish to continue|0|||
155344698|NCT00489489|560694063|FG000|Overall Study|Other than above|0|||
155344699|NCT00489489|560694064|FG001|Overall Study|Other than above|1|||
155344700|NCT00489489|560694065|FG002|Overall Study|Other than above|0|||
155344701|NCT03978130|560694070|FG000|Overall Study|Lost to Follow-up|13|||
155344702|NCT03978130|560694071|FG001|Overall Study|Lost to Follow-up|14|||
155344703|NCT03978130|560694070|FG000|Overall Study|Withdrawal by Subject|12|||
155344704|NCT03978130|560694071|FG001|Overall Study|Withdrawal by Subject|2|||
155344705|NCT03978130|560694070|FG000|Overall Study|Adverse Event|2|||
155344706|NCT03978130|560694071|FG001|Overall Study|Adverse Event|1|||
155344707|NCT02880293|560694072|FG000|Overall Study|Inevaluable|5|||
155344708|NCT04198428|560694075|FG000|Overall Study|Withdrawal by Subject|150|||
155344709|NCT04198428|560694076|FG001|Overall Study|Withdrawal by Subject|156|||
155344710|NCT05878990|560694078|FG000|Overall Study|Lost to Follow-up|7|||
155344711|NCT05878990|560694078|FG000|Overall Study|Withdrawal by Subject|1|||
155344712|NCT00668746|560694079|FG000|Overall Study|Lost to Follow-up|2|||
155344713|NCT00668746|560694080|FG001|Overall Study|Lost to Follow-up|1|||
155344714|NCT01038128|560694082|FG000|Overall Study|Lack of Efficacy|1|||
155344715|NCT01038128|560694082|FG000|Overall Study|Lost to Follow-up|1|||
155344716|NCT01038128|560694082|FG000|Overall Study|Withdrawal by Subject|2|||
155344717|NCT04203199|560694091|FG000|First Intervention Period|Lost to Follow-up|0|||
155344718|NCT04203199|560694092|FG001|First Intervention Period|Lost to Follow-up|1|||
155344719|NCT04203199|560694091|FG000|Second Intervention Period|Medication change|1|||
155344720|NCT04203199|560694092|FG001|Second Intervention Period|Medication change|0|||
155344721|NCT01838499|560694093|FG000|Overall Study|Protocol Violation|0|||
155344722|NCT01838499|560694094|FG001|Overall Study|Protocol Violation|1|||
155344723|NCT01838499|560694093|FG000|Overall Study|Lost to Follow-up|2|||
155344724|NCT01838499|560694094|FG001|Overall Study|Lost to Follow-up|4|||
155344725|NCT01838499|560694093|FG000|Overall Study|Lack of Efficacy|1|||
155344726|NCT01838499|560694094|FG001|Overall Study|Lack of Efficacy|2|||
155344727|NCT01838499|560694093|FG000|Overall Study|Adverse Event|2|||
155344728|NCT01838499|560694094|FG001|Overall Study|Adverse Event|1|||
155344729|NCT01838499|560694093|FG000|Overall Study|Withdrawal by Subject|19|||
155344730|NCT01838499|560694094|FG001|Overall Study|Withdrawal by Subject|9|||
155344731|NCT03614923|560694095|FG000|Overall Study|Withdrawal by Subject|2|||
155344732|NCT03614923|560694096|FG001|Overall Study|Withdrawal by Subject|1|||
155344733|NCT03614923|560694097|FG002|Overall Study|Withdrawal by Subject|1|||
155344734|NCT03614923|560694095|FG000|Overall Study|Adverse Event|0|||
155344735|NCT03614923|560694096|FG001|Overall Study|Adverse Event|2|||
155344736|NCT03614923|560694097|FG002|Overall Study|Adverse Event|1|||
155344737|NCT03614923|560694095|FG000|Overall Study|Lost to Follow-up|1|||
155344738|NCT03614923|560694096|FG001|Overall Study|Lost to Follow-up|0|||
155344739|NCT03614923|560694097|FG002|Overall Study|Lost to Follow-up|1|||
155344740|NCT03614923|560694095|FG000|Overall Study|Lack of Efficacy|2|||
155344741|NCT03614923|560694096|FG001|Overall Study|Lack of Efficacy|0|||
155344742|NCT03614923|560694097|FG002|Overall Study|Lack of Efficacy|1|||
155344743|NCT03614923|560694095|FG000|Overall Study|Non-compliance|0|||
155344744|NCT03614923|560694096|FG001|Overall Study|Non-compliance|1|||
155344745|NCT03614923|560694097|FG002|Overall Study|Non-compliance|0|||
155344746|NCT03614923|560694095|FG000|Overall Study|Other|0|||
155344747|NCT03614923|560694096|FG001|Overall Study|Other|1|||
155344748|NCT03614923|560694097|FG002|Overall Study|Other|1|||
155344749|NCT01136733|560694098|FG000|Phase 1b|Adverse Event|0|||
155344750|NCT01136733|560694099|FG001|Phase 1b|Adverse Event|3|||
155344751|NCT01136733|560694100|FG002|Phase 1b|Adverse Event|1|||
155344752|NCT01136733|560694101|FG003|Phase 1b|Adverse Event|0|||
155344753|NCT01136733|560694102|FG004|Phase 1b|Adverse Event|0|||
155344754|NCT01136733|560694103|FG005|Phase 1b|Adverse Event|0|||
155344755|NCT01136733|560694104|FG006|Phase 1b|Adverse Event|0|||
155344756|NCT01136733|560694098|FG000|Phase 1b|Participant Choice|0|||
155344757|NCT01136733|560694099|FG001|Phase 1b|Participant Choice|0|||
155344758|NCT01136733|560694100|FG002|Phase 1b|Participant Choice|1|||
155344759|NCT01136733|560694101|FG003|Phase 1b|Participant Choice|0|||
155344760|NCT01136733|560694102|FG004|Phase 1b|Participant Choice|0|||
155344761|NCT01136733|560694103|FG005|Phase 1b|Participant Choice|0|||
155344762|NCT01136733|560694104|FG006|Phase 1b|Participant Choice|0|||
155344763|NCT01136733|560694098|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
155344764|NCT01136733|560694099|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
155344765|NCT01136733|560694100|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
155344766|NCT01136733|560694101|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
155344767|NCT01136733|560694102|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
155344768|NCT01136733|560694103|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
155344769|NCT01136733|560694104|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
155344770|NCT01136733|560694098|FG000|Phase 1b|Clinical Progression|1|||
155344771|NCT01136733|560694099|FG001|Phase 1b|Clinical Progression|1|||
155344772|NCT01136733|560694100|FG002|Phase 1b|Clinical Progression|0|||
155344773|NCT01136733|560694101|FG003|Phase 1b|Clinical Progression|0|||
155344774|NCT01136733|560694102|FG004|Phase 1b|Clinical Progression|0|||
155344775|NCT01136733|560694103|FG005|Phase 1b|Clinical Progression|0|||
155344776|NCT01136733|560694104|FG006|Phase 1b|Clinical Progression|0|||
155344777|NCT01136733|560694098|FG000|Phase 2|Disease Progression|0|||
155344778|NCT01136733|560694099|FG001|Phase 2|Disease Progression|0|||
155344779|NCT01136733|560694100|FG002|Phase 2|Disease Progression|0|||
155344780|NCT01136733|560694101|FG003|Phase 2|Disease Progression|0|||
155344781|NCT01136733|560694102|FG004|Phase 2|Disease Progression|30|||
155344782|NCT01136733|560694103|FG005|Phase 2|Disease Progression|32|||
155344783|NCT01136733|560694104|FG006|Phase 2|Disease Progression|38|||
155344784|NCT01136733|560694098|FG000|Phase 2|Adverse Event|0|||
155344785|NCT01136733|560694099|FG001|Phase 2|Adverse Event|0|||
155344786|NCT01136733|560694100|FG002|Phase 2|Adverse Event|0|||
155344787|NCT01136733|560694101|FG003|Phase 2|Adverse Event|0|||
155344788|NCT01136733|560694102|FG004|Phase 2|Adverse Event|11|||
155344789|NCT01136733|560694103|FG005|Phase 2|Adverse Event|13|||
155344790|NCT01136733|560694104|FG006|Phase 2|Adverse Event|5|||
155344791|NCT01136733|560694098|FG000|Phase 2|Participant Choice|0|||
155344792|NCT01136733|560694099|FG001|Phase 2|Participant Choice|0|||
155344793|NCT01136733|560694100|FG002|Phase 2|Participant Choice|0|||
155344794|NCT01136733|560694101|FG003|Phase 2|Participant Choice|0|||
155344795|NCT01136733|560694102|FG004|Phase 2|Participant Choice|3|||
155344796|NCT01136733|560694103|FG005|Phase 2|Participant Choice|0|||
155344797|NCT01136733|560694104|FG006|Phase 2|Participant Choice|1|||
155344798|NCT01136733|560694098|FG000|Phase 2|Administrative-Withdrew Consent|0|||
155344799|NCT01136733|560694099|FG001|Phase 2|Administrative-Withdrew Consent|0|||
155344800|NCT01136733|560694100|FG002|Phase 2|Administrative-Withdrew Consent|0|||
155344801|NCT01136733|560694101|FG003|Phase 2|Administrative-Withdrew Consent|0|||
155344802|NCT01136733|560694102|FG004|Phase 2|Administrative-Withdrew Consent|1|||
155344803|NCT01136733|560694103|FG005|Phase 2|Administrative-Withdrew Consent|0|||
155344804|NCT01136733|560694104|FG006|Phase 2|Administrative-Withdrew Consent|0|||
155344805|NCT01136733|560694098|FG000|Phase 2|Other|0|||
155344806|NCT01136733|560694099|FG001|Phase 2|Other|0|||
155344807|NCT01136733|560694100|FG002|Phase 2|Other|0|||
155344808|NCT01136733|560694101|FG003|Phase 2|Other|0|||
155344809|NCT01136733|560694102|FG004|Phase 2|Other|6|||
155344810|NCT01136733|560694103|FG005|Phase 2|Other|7|||
155344811|NCT01136733|560694104|FG006|Phase 2|Other|6|||
155344812|NCT01882088|560694106|FG000|Overall Study|Intolerance of esophageal manometry|1|||
155344813|NCT01882088|560694106|FG000|Overall Study|no possibility to place the catheter|1|||
155344814|NCT01882088|560694106|FG000|Overall Study|Protocol Violation|1|||
155344815|NCT01882088|560694106|FG000|Overall Study|inadequate pH-impedance tracings|2|||
155344816|NCT02186015|560694107|FG000|Overall Study|Physician Decision|1|||
155344817|NCT02186015|560694108|FG001|Overall Study|Physician Decision|0|||
155344818|NCT02069366|560694111|FG000|Overall Study|Lost to Follow-up|0|||
155344819|NCT02069366|560694112|FG001|Overall Study|Lost to Follow-up|0|||
155344820|NCT02069366|560694113|FG002|Overall Study|Lost to Follow-up|1|||
155344821|NCT02069366|560694114|FG003|Overall Study|Lost to Follow-up|0|||
155344822|NCT02069366|560694115|FG004|Overall Study|Lost to Follow-up|0|||
155344823|NCT02069366|560694116|FG005|Overall Study|Lost to Follow-up|2|||
155344824|NCT02069366|560694111|FG000|Overall Study|Protocol Violation|0|||
155344825|NCT02069366|560694112|FG001|Overall Study|Protocol Violation|0|||
155344826|NCT02069366|560694113|FG002|Overall Study|Protocol Violation|1|||
155344827|NCT02069366|560694114|FG003|Overall Study|Protocol Violation|0|||
155344828|NCT02069366|560694115|FG004|Overall Study|Protocol Violation|0|||
155344829|NCT02069366|560694116|FG005|Overall Study|Protocol Violation|0|||
155344830|NCT02069366|560694111|FG000|Overall Study|Withdrawal by Subject|1|||
155344831|NCT02069366|560694112|FG001|Overall Study|Withdrawal by Subject|0|||
155344832|NCT02069366|560694113|FG002|Overall Study|Withdrawal by Subject|1|||
155344833|NCT02069366|560694114|FG003|Overall Study|Withdrawal by Subject|2|||
155344834|NCT02069366|560694115|FG004|Overall Study|Withdrawal by Subject|0|||
155344835|NCT02069366|560694116|FG005|Overall Study|Withdrawal by Subject|0|||
155344836|NCT00168805|560694119|FG000|Overall Study|Adverse Event|7|||
155344837|NCT00168805|560694120|FG001|Overall Study|Adverse Event|11|||
155344838|NCT00168805|560694121|FG002|Overall Study|Adverse Event|16|||
155344839|NCT00168805|560694119|FG000|Overall Study|Protocol Violation|12|||
155344840|NCT00168805|560694120|FG001|Overall Study|Protocol Violation|11|||
155344841|NCT00168805|560694121|FG002|Overall Study|Protocol Violation|8|||
155344842|NCT00168805|560694119|FG000|Overall Study|Lost to Follow-up|12|||
155344843|NCT00168805|560694120|FG001|Overall Study|Lost to Follow-up|17|||
155344844|NCT00168805|560694121|FG002|Overall Study|Lost to Follow-up|11|||
155344845|NCT00168805|560694119|FG000|Overall Study|Withdrawal by Subject|16|||
155344846|NCT00168805|560694120|FG001|Overall Study|Withdrawal by Subject|18|||
155344847|NCT00168805|560694121|FG002|Overall Study|Withdrawal by Subject|21|||
155344848|NCT00168805|560694119|FG000|Overall Study|Other|24|||
155344849|NCT00168805|560694120|FG001|Overall Study|Other|21|||
155344850|NCT00168805|560694121|FG002|Overall Study|Other|22|||
155344851|NCT00168805|560694119|FG000|Treatment|Adverse Event|25|||
155344852|NCT00168805|560694120|FG001|Treatment|Adverse Event|26|||
155344853|NCT00168805|560694121|FG002|Treatment|Adverse Event|32|||
155344854|NCT00168805|560694119|FG000|Treatment|Protocol Violation|3|||
155344855|NCT00168805|560694120|FG001|Treatment|Protocol Violation|5|||
155344856|NCT00168805|560694121|FG002|Treatment|Protocol Violation|5|||
155344857|NCT00168805|560694119|FG000|Treatment|Withdrawal by Subject|3|||
155344858|NCT00168805|560694120|FG001|Treatment|Withdrawal by Subject|7|||
155344859|NCT00168805|560694121|FG002|Treatment|Withdrawal by Subject|8|||
155344860|NCT00168805|560694119|FG000|Treatment|Other|18|||
155344861|NCT00168805|560694120|FG001|Treatment|Other|18|||
155344862|NCT00168805|560694121|FG002|Treatment|Other|17|||
155344863|NCT01837719|560694122|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
155344864|NCT01837719|560694122|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
155344865|NCT02604199|560694124|FG000|Overall Study|Pregnancy|0|||
155344866|NCT02604199|560694125|FG001|Overall Study|Pregnancy|0|||
155505839|NCT00528879|561278267|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
155505840|NCT00528879|561278268|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
155505841|NCT00528879|561278269|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
155505842|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
155505843|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
155505844|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
155505845|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
155505846|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
155505847|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
155505848|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
155505849|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
155505850|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
155505851|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
155505852|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
155505853|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
155505854|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
155505855|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
155505856|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
155505857|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
155505858|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
155505859|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
155505860|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
155505861|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
155505862|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
155505863|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
155505864|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
155505865|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
155344867|NCT02604199|560694126|FG002|Overall Study|Pregnancy|0|||
155344868|NCT02604199|560694127|FG003|Overall Study|Pregnancy|1|||
155344869|NCT02604199|560694124|FG000|Overall Study|Study terminated by sponsor|0|||
155344870|NCT02604199|560694125|FG001|Overall Study|Study terminated by sponsor|2|||
155344871|NCT02604199|560694126|FG002|Overall Study|Study terminated by sponsor|0|||
155344872|NCT02604199|560694127|FG003|Overall Study|Study terminated by sponsor|2|||
155344873|NCT02604199|560694124|FG000|Overall Study|Withdrawal by Subject|0|||
155344874|NCT02604199|560694125|FG001|Overall Study|Withdrawal by Subject|1|||
155344875|NCT02604199|560694126|FG002|Overall Study|Withdrawal by Subject|0|||
155344876|NCT02604199|560694127|FG003|Overall Study|Withdrawal by Subject|0|||
155344877|NCT02255474|560694129|FG000|Overall Study|Lost to Follow-up|1|||
155344878|NCT02255474|560694130|FG001|Overall Study|Lost to Follow-up|1|||
155344879|NCT02255474|560694131|FG002|Overall Study|Lost to Follow-up|3|||
155344880|NCT02255474|560694129|FG000|Overall Study|Withdrawal by Subject|1|||
155344881|NCT02255474|560694130|FG001|Overall Study|Withdrawal by Subject|1|||
155344882|NCT02255474|560694131|FG002|Overall Study|Withdrawal by Subject|0|||
155344883|NCT02993926|560694132|FG000|Enantone Treatment Phase|Adverse Event|1|||
155344884|NCT02993926|560694133|FG001|Enantone Treatment Phase|Adverse Event|0|||
155344885|NCT02993926|560694134|FG002|Enantone Treatment Phase|Adverse Event|0|||
155344886|NCT02993926|560694132|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
155344887|NCT02993926|560694133|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
155344888|NCT02993926|560694134|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
155344889|NCT02993926|560694132|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
155344890|NCT02993926|560694133|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
155344891|NCT02993926|560694134|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
155344892|NCT02993926|560694132|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
155344893|NCT02993926|560694133|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
155344894|NCT02993926|560694134|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
155344895|NCT01867307|560694135|FG000|Overall Study|Protocol Violation|2|||
155344896|NCT01867307|560694136|FG001|Overall Study|Protocol Violation|0|||
155344897|NCT01867307|560694135|FG000|Overall Study|Other Adverse Event|1|||
155344898|NCT01867307|560694136|FG001|Overall Study|Other Adverse Event|3|||
155344899|NCT02009865|560694140|FG000|Overall Study|Adverse Event|0|||
155344900|NCT02009865|560694141|FG001|Overall Study|Adverse Event|2|||
155344901|NCT02009865|560694140|FG000|Overall Study|Protocol Violation|0|||
155344902|NCT02009865|560694141|FG001|Overall Study|Protocol Violation|2|||
155344903|NCT02009865|560694140|FG000|Overall Study|Withdrawal by Subject|1|||
155344904|NCT02009865|560694141|FG001|Overall Study|Withdrawal by Subject|1|||
155344905|NCT01760876|560694142|FG000|Overall Study|Non-cardiac death (head injury)|1|||
155344906|NCT01760876|560694142|FG000|Overall Study|Carcinoma of prostate|1|||
155344907|NCT01760876|560694142|FG000|Overall Study|Impaired renal function|1|||
155344908|NCT01760876|560694142|FG000|Overall Study|Major depression|1|||
155344909|NCT01760876|560694142|FG000|Overall Study|Very poor baseline OCT quality|2|||
155344910|NCT00525915|560694146|FG000|Overall Study|Non-Compliance|0|||
155344911|NCT00525915|560694147|FG001|Overall Study|Non-Compliance|1|||
155344912|NCT00525915|560694146|FG000|Overall Study|Disease Progression|5|||
155344913|NCT00525915|560694147|FG001|Overall Study|Disease Progression|6|||
155344914|NCT00525915|560694146|FG000|Overall Study|Withdrawal by Subject|1|||
155344915|NCT00525915|560694147|FG001|Overall Study|Withdrawal by Subject|0|||
155344916|NCT00525915|560694146|FG000|Overall Study|Refused Surgery|1|||
155344917|NCT00525915|560694147|FG001|Overall Study|Refused Surgery|2|||
155344918|NCT00525915|560694146|FG000|Overall Study|Unrelated illness|1|||
155344919|NCT00525915|560694147|FG001|Overall Study|Unrelated illness|0|||
155344920|NCT00732498|560694148|FG000|Overall Study|Ineligible|1|||
155344921|NCT00732498|560694148|FG000|Overall Study|Adverse Event|2|||
155344922|NCT00732498|560694148|FG000|Overall Study|Physician Decision|3|||
155344923|NCT03394508|560694149|FG000|Overall Study|Protocol Violation|0|||
155344924|NCT03394508|560694150|FG001|Overall Study|Protocol Violation|3|||
155344925|NCT03394508|560694149|FG000|Overall Study|Lost to Follow-up|1|||
155344926|NCT03394508|560694150|FG001|Overall Study|Lost to Follow-up|0|||
155344927|NCT00267865|560694151|FG000|Induction Treatment|Died before completing.|2|||
155344928|NCT00267865|560694151|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
155344929|NCT04295499|560694155|FG000|Overall Study|moving out of state|1|||
155344930|NCT04295499|560694156|FG001|Overall Study|moving out of state|0|||
155344931|NCT04295499|560694155|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
155344932|NCT04295499|560694156|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
155344933|NCT01755598|560694157|FG000|Overall Study|Other|109|||
155344934|NCT01755598|560694158|FG001|Overall Study|Other|109|||
155344935|NCT01755598|560694157|FG000|Overall Study|Lost to Follow-up|32|||
155344936|NCT01755598|560694158|FG001|Overall Study|Lost to Follow-up|43|||
155344937|NCT01755598|560694157|FG000|Overall Study|Migrated/moved from study area|76|||
155344938|NCT01755598|560694158|FG001|Overall Study|Migrated/moved from study area|65|||
155344939|NCT01755598|560694157|FG000|Overall Study|Withdrawal by Subject|22|||
155344940|NCT01755598|560694158|FG001|Overall Study|Withdrawal by Subject|31|||
155344941|NCT01755598|560694157|FG000|Overall Study|Protocol Violation|7|||
155344942|NCT01755598|560694158|FG001|Overall Study|Protocol Violation|7|||
155344943|NCT01755598|560694157|FG000|Overall Study|Adverse Event|19|||
155344944|NCT01755598|560694158|FG001|Overall Study|Adverse Event|28|||
155344945|NCT03122548|560694159|FG000|Overall Study|Death|2|||
155344946|NCT03122548|560694159|FG000|Overall Study|Progression - subject went into hospice|1|||
155344947|NCT03122548|560694159|FG000|Overall Study|Study Terminated by Sponsor|2|||
155344948|NCT02332889|560694162|FG000|Overall Study|Physician Decision|1|||
155344949|NCT00308113|560694163|FG000|Overall Study|Protocol closure|0|||
155344950|NCT00308113|560694164|FG001|Overall Study|Protocol closure|0|||
155344951|NCT00308113|560694165|FG002|Overall Study|Protocol closure|0|||
155344952|NCT00308113|560694166|FG003|Overall Study|Protocol closure|1|||
155344953|NCT01634165|560694167|FG000|Period 2|Adverse Event|0|||
155344954|NCT01634165|560694168|FG001|Period 2|Adverse Event|1|||
155344955|NCT01634165|560694169|FG002|Period 2|Adverse Event|0|||
155344956|NCT01634165|560694170|FG003|Period 2|Adverse Event|0|||
155344957|NCT02135445|560694171|FG000|Overall Study|Lost to Follow-up|1|||
155344958|NCT02135445|560694172|FG001|Overall Study|Lost to Follow-up|0|||
155344959|NCT02135445|560694171|FG000|Overall Study|Withdrawal by Subject|1|||
155344960|NCT02135445|560694172|FG001|Overall Study|Withdrawal by Subject|0|||
155344961|NCT00676195|560695372|FG000|Overall Study|Lost to Follow-up|1|||
155344962|NCT00676195|560695372|FG000|Overall Study|Adverse Event|1|||
155344963|NCT00676195|560695372|FG000|Overall Study|Physician Decision|1|||
155424442|NCT00348140|560982403|FG001|Overall Study|Participant unwell|0|||
155344964|NCT03322514|560695373|FG000|Overall Study|Withdrawal by Subject|1|||
155344965|NCT03322514|560695374|FG001|Overall Study|Withdrawal by Subject|1|||
155344966|NCT04523571|560695375|FG000|Received 2 Doses|Withdrawal by Subject|0|||
155344967|NCT04523571|560695376|FG001|Received 2 Doses|Withdrawal by Subject|0|||
155344968|NCT04523571|560695377|FG002|Received 2 Doses|Withdrawal by Subject|0|||
155344969|NCT04523571|560695378|FG003|Received 2 Doses|Withdrawal by Subject|1|||
155344970|NCT04523571|560695379|FG004|Received 2 Doses|Withdrawal by Subject|1|||
155344971|NCT04523571|560695380|FG005|Received 2 Doses|Withdrawal by Subject|0|||
155344972|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
155344973|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344974|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
155344975|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344976|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344977|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344978|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344979|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344980|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344981|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344982|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344983|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
155344984|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344985|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344986|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344987|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
155344988|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
155344989|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344990|NCT00627523|560695381|FG000|Overall Study|Lack of Efficacy|1|||
155344991|NCT00627523|560695382|FG001|Overall Study|Lack of Efficacy|0|||
155344992|NCT00627523|560695381|FG000|Overall Study|Withdrawal by Subject|0|||
155344993|NCT00627523|560695382|FG001|Overall Study|Withdrawal by Subject|2|||
155344994|NCT00627523|560695381|FG000|Overall Study|Other|1|||
155344995|NCT00627523|560695382|FG001|Overall Study|Other|0|||
155344996|NCT02011568|560695387|FG000|Overall Study|Withdrawal by Subject|8|||
155344997|NCT02011568|560695388|FG001|Overall Study|Withdrawal by Subject|10|||
155344998|NCT02011568|560695387|FG000|Overall Study|Physician Decision|1|||
155344999|NCT02011568|560695388|FG001|Overall Study|Physician Decision|3|||
155345000|NCT03344458|560695389|FG000|Overall Study|Physician Decision|1|||
155345001|NCT03344458|560695389|FG000|Overall Study|Withdrawal by Subject|16|||
155345002|NCT03344458|560695389|FG000|Overall Study|Other reasons|10|||
155345003|NCT03344458|560695389|FG000|Overall Study|Lost to Follow-up|9|||
155345004|NCT03344458|560695389|FG000|Overall Study|Protocol Violation|3|||
155345005|NCT00396409|560695395|FG000|Period 1 - 2007|Adverse Event|0|||
155424443|NCT00348140|560982404|FG002|Overall Study|Participant unwell|0|||
155424444|NCT00348140|560982402|FG000|Overall Study|Screen failure|1|||
155424445|NCT00348140|560982403|FG001|Overall Study|Screen failure|0|||
155424446|NCT00348140|560982404|FG002|Overall Study|Screen failure|0|||
155424447|NCT00348140|560982402|FG000|Overall Study|Investigator decided to discontinue|4|||
155424448|NCT00348140|560982403|FG001|Overall Study|Investigator decided to discontinue|1|||
155424449|NCT00348140|560982404|FG002|Overall Study|Investigator decided to discontinue|4|||
155424450|NCT00348140|560982402|FG000|Overall Study|Decided to discontinue on their own|1|||
155424451|NCT00348140|560982403|FG001|Overall Study|Decided to discontinue on their own|4|||
155424452|NCT00348140|560982404|FG002|Overall Study|Decided to discontinue on their own|1|||
155424453|NCT00348140|560982402|FG000|Overall Study|Use of prohibited drug|1|||
155424454|NCT00348140|560982403|FG001|Overall Study|Use of prohibited drug|0|||
155424455|NCT00348140|560982404|FG002|Overall Study|Use of prohibited drug|2|||
155424456|NCT00348140|560982402|FG000|Overall Study|Disease progression|1|||
155424457|NCT00348140|560982403|FG001|Overall Study|Disease progression|2|||
155424458|NCT00348140|560982404|FG002|Overall Study|Disease progression|5|||
155424459|NCT00348140|560982402|FG000|Overall Study|Increased risk of cardiac infarction|0|||
155424460|NCT00348140|560982403|FG001|Overall Study|Increased risk of cardiac infarction|1|||
155424461|NCT00348140|560982404|FG002|Overall Study|Increased risk of cardiac infarction|0|||
155424462|NCT00348140|560982402|FG000|Overall Study|Serious adverse event|0|||
155424463|NCT00348140|560982403|FG001|Overall Study|Serious adverse event|1|||
155424464|NCT00348140|560982404|FG002|Overall Study|Serious adverse event|0|||
155424465|NCT00348140|560982402|FG000|Overall Study|Abnormal ECG|0|||
155345006|NCT00396409|560695396|FG001|Period 1 - 2007|Adverse Event|1|||
155345007|NCT00396409|560695395|FG000|Period 1 - 2007|Lack of Efficacy|0|||
155345008|NCT00396409|560695396|FG001|Period 1 - 2007|Lack of Efficacy|1|||
155345009|NCT00396409|560695395|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
155424466|NCT00348140|560982403|FG001|Overall Study|Abnormal ECG|1|||
155424467|NCT00348140|560982404|FG002|Overall Study|Abnormal ECG|3|||
155424468|NCT00348140|560982402|FG000|Overall Study|Participant died|0|||
155345010|NCT00396409|560695396|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
155345011|NCT00396409|560695395|FG000|Period 1 - 2007|Lost to Follow-up|2|||
155345012|NCT00396409|560695396|FG001|Period 1 - 2007|Lost to Follow-up|3|||
155345013|NCT00396409|560695395|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
155345014|NCT00396409|560695396|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
155345015|NCT00396409|560695395|FG000|Period 2 - 2008|Protocol Violation|1|||
155345016|NCT00396409|560695396|FG001|Period 2 - 2008|Protocol Violation|0|||
155345017|NCT00396409|560695395|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
155345018|NCT00396409|560695396|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
155345019|NCT00396409|560695395|FG000|Period 2 - 2008|Lost to Follow-up|3|||
155345020|NCT00396409|560695396|FG001|Period 2 - 2008|Lost to Follow-up|1|||
155345021|NCT00331799|560695397|FG000|Overall Study|Withdrawal by Subject|2|||
155345022|NCT00331799|560695397|FG000|Overall Study|Sedation|1|||
155345023|NCT02889809|560695398|FG000|Overall Study|Withdrawal by Subject|30|||
155345024|NCT02889809|560695399|FG001|Overall Study|Withdrawal by Subject|21|||
155345025|NCT02889809|560695398|FG000|Overall Study|Lost to Follow-up|1|||
155345026|NCT02889809|560695399|FG001|Overall Study|Lost to Follow-up|1|||
155345027|NCT02889809|560695398|FG000|Overall Study|Site Closed|12|||
155345028|NCT02889809|560695399|FG001|Overall Study|Site Closed|11|||
155345029|NCT03696342|560695400|FG000|Overall Study|Lost to Follow-up|1|||
155345030|NCT03696342|560695401|FG001|Overall Study|Lost to Follow-up|0|||
155345031|NCT02409732|560695402|FG000|Overall Study|Withdrawal by Subject|4|||
155345032|NCT02409732|560695402|FG000|Overall Study|Lost to Follow-up|2|||
155345033|NCT03314233|560695412|FG000|Overall Study|No longer eligible at time of delivery|1|||
155345034|NCT01797705|560695413|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
155345035|NCT01797705|560695413|FG000|Overall Study|Withdrawal by Subject|1|||
155345036|NCT03785210|560695414|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
155345037|NCT03785210|560695415|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
155345038|NCT04468633|560695416|FG000|Overall Study|Withdrawal by Subject|4|||
155345039|NCT04468633|560695417|FG001|Overall Study|Withdrawal by Subject|0|||
155345040|NCT00460434|560695418|FG000|Overall Study|Lost to Follow-up|3|||
155345041|NCT00460434|560695419|FG001|Overall Study|Lost to Follow-up|7|||
155345042|NCT01498445|560695420|FG000|Overall Study|Lack of Efficacy|0|||
155345043|NCT01498445|560695421|FG001|Overall Study|Lack of Efficacy|0|||
155345044|NCT01498445|560695422|FG002|Overall Study|Lack of Efficacy|1|||
155345045|NCT01498445|560695423|FG003|Overall Study|Lack of Efficacy|2|||
155345046|NCT01498445|560695424|FG004|Overall Study|Lack of Efficacy|0|||
155345047|NCT01498445|560695425|FG005|Overall Study|Lack of Efficacy|0|||
155345048|NCT01498445|560695420|FG000|Overall Study|Screen Failure|0|||
155345049|NCT01498445|560695421|FG001|Overall Study|Screen Failure|0|||
155345050|NCT01498445|560695422|FG002|Overall Study|Screen Failure|0|||
155345051|NCT01498445|560695423|FG003|Overall Study|Screen Failure|0|||
155345052|NCT01498445|560695424|FG004|Overall Study|Screen Failure|1|||
155345053|NCT01498445|560695425|FG005|Overall Study|Screen Failure|1|||
155345054|NCT02722278|560695426|FG000|Overall Study|Withdrawal by Subject|5|||
155345055|NCT02722278|560695427|FG001|Overall Study|Withdrawal by Subject|3|||
155345056|NCT02722278|560695426|FG000|Overall Study|Adverse Event|4|||
155345057|NCT02722278|560695427|FG001|Overall Study|Adverse Event|1|||
155345058|NCT02722278|560695426|FG000|Overall Study|Lost to Follow-up|2|||
155345059|NCT02722278|560695427|FG001|Overall Study|Lost to Follow-up|0|||
155345060|NCT02722278|560695426|FG000|Overall Study|Protocol Violation|1|||
155345061|NCT02722278|560695427|FG001|Overall Study|Protocol Violation|0|||
155345062|NCT02722278|560695426|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
155345063|NCT02722278|560695427|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
155345064|NCT02722278|560695426|FG000|Overall Study|Subject declined after tx assignment|0|||
155424469|NCT00348140|560982403|FG001|Overall Study|Participant died|1|||
155424470|NCT00348140|560982404|FG002|Overall Study|Participant died|0|||
155424471|NCT00348140|560982402|FG000|Overall Study|Exclusion criteria met|0|||
155424472|NCT00348140|560982403|FG001|Overall Study|Exclusion criteria met|0|||
155647784|NCT03774810|561803680|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
155345065|NCT02722278|560695427|FG001|Overall Study|Subject declined after tx assignment|1|||
155345066|NCT02722278|560695426|FG000|Overall Study|Site closure not study related|0|||
155345067|NCT02722278|560695427|FG001|Overall Study|Site closure not study related|1|||
155345068|NCT02465866|560695428|FG000|Period 3|Withdrawal by Subject|0|||
155345069|NCT02465866|560695429|FG001|Period 3|Withdrawal by Subject|1|||
155345070|NCT02465866|560695430|FG002|Period 3|Withdrawal by Subject|0|||
155345071|NCT02465866|560695431|FG003|Period 3|Withdrawal by Subject|0|||
155345072|NCT02023099|560695432|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
155345073|NCT02023099|560695433|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
155345074|NCT02023099|560695434|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
155345075|NCT02023099|560695432|FG000|Overall Study|Withdrawn Consent|3|||
155345076|NCT02023099|560695433|FG001|Overall Study|Withdrawn Consent|0|||
155345077|NCT02023099|560695434|FG002|Overall Study|Withdrawn Consent|1|||
155345078|NCT02023099|560695432|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
155345079|NCT02023099|560695433|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
155424473|NCT00348140|560982404|FG002|Overall Study|Exclusion criteria met|1|||
155345080|NCT02023099|560695434|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
155345081|NCT00203502|560695435|FG000|Overall Study|Death|1|||
155345082|NCT01469819|560695436|FG000|Overall Study|Withdrawal by Subject|1|||
155345083|NCT01469819|560695436|FG000|Overall Study|Did not meet inclusionary criteria|2|||
155345084|NCT01469819|560695436|FG000|Overall Study|Could not swallow SmartPill|2|||
155345085|NCT01469819|560695436|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
155345086|NCT01403805|560695439|FG000|Overall Study|Withdrawal by Subject|0|||
155345087|NCT01403805|560695440|FG001|Overall Study|Withdrawal by Subject|4|||
155345088|NCT01403805|560695439|FG000|Overall Study|Lost to Follow-up|0|||
155345089|NCT01403805|560695440|FG001|Overall Study|Lost to Follow-up|2|||
155345090|NCT01403805|560695439|FG000|Overall Study|Death|0|||
155345091|NCT01403805|560695440|FG001|Overall Study|Death|1|||
155345092|NCT01695993|560695441|FG000|Overall Study|Lost to Follow-up|2|||
155345093|NCT01695993|560695442|FG001|Overall Study|Lost to Follow-up|1|||
155345094|NCT01695993|560695443|FG002|Overall Study|Lost to Follow-up|3|||
155345095|NCT01695993|560695441|FG000|Overall Study|Withdrawal by Subject|2|||
155345096|NCT01695993|560695442|FG001|Overall Study|Withdrawal by Subject|2|||
155345097|NCT01695993|560695443|FG002|Overall Study|Withdrawal by Subject|2|||
155345098|NCT01695993|560695441|FG000|Overall Study|To ill to continue|1|||
155345099|NCT01695993|560695442|FG001|Overall Study|To ill to continue|2|||
155345100|NCT01695993|560695443|FG002|Overall Study|To ill to continue|0|||
155345101|NCT01695993|560695441|FG000|Overall Study|Changed Medical Facility|0|||
155345102|NCT01695993|560695442|FG001|Overall Study|Changed Medical Facility|0|||
155345103|NCT01695993|560695443|FG002|Overall Study|Changed Medical Facility|1|||
155345104|NCT01601821|560695444|FG000|Overall Study|Death|2|||
155345105|NCT01601821|560695445|FG001|Overall Study|Death|5|||
155345106|NCT01601821|560695444|FG000|Overall Study|Protocol Violation|2|||
155345107|NCT01601821|560695445|FG001|Overall Study|Protocol Violation|2|||
155345108|NCT01601821|560695444|FG000|Overall Study|Lost to Follow-up|6|||
155345109|NCT01601821|560695445|FG001|Overall Study|Lost to Follow-up|14|||
155345110|NCT01601821|560695444|FG000|Overall Study|Withdrawal by Subject|1|||
155345111|NCT01601821|560695445|FG001|Overall Study|Withdrawal by Subject|0|||
155345112|NCT01601821|560695444|FG000|Overall Study|Graft Loss|6|||
155345113|NCT01601821|560695445|FG001|Overall Study|Graft Loss|6|||
155345114|NCT01601821|560695444|FG000|Overall Study|Study Events|7|||
155345115|NCT01601821|560695445|FG001|Overall Study|Study Events|1|||
155345116|NCT01601821|560695444|FG000|Overall Study|Other|5|||
155345117|NCT01601821|560695445|FG001|Overall Study|Other|1|||
155345118|NCT00147745|560695446|FG000|Overall Study|Withdrawal by Subject|1|||
155345119|NCT00147745|560695447|FG001|Overall Study|Withdrawal by Subject|0|||
155345120|NCT00147745|560695448|FG002|Overall Study|Withdrawal by Subject|0|||
155345121|NCT01901302|560695449|FG000|Overall Study|Adverse Event|2|||
155345122|NCT01901302|560695450|FG001|Overall Study|Adverse Event|1|||
155345123|NCT01901302|560695449|FG000|Overall Study|Lack of Efficacy|0|||
155345124|NCT01901302|560695450|FG001|Overall Study|Lack of Efficacy|2|||
155345125|NCT01901302|560695449|FG000|Overall Study|Study Terminated by Sponsor|23|||
155345126|NCT01901302|560695450|FG001|Overall Study|Study Terminated by Sponsor|20|||
155345127|NCT01901302|560695449|FG000|Overall Study|Withdrawal by Subject|2|||
155345128|NCT01901302|560695450|FG001|Overall Study|Withdrawal by Subject|0|||
155345129|NCT00510783|560695452|FG000|Overall Study|Lost to Follow-up|29|||
155345130|NCT00510783|560695453|FG001|Overall Study|Lost to Follow-up|25|||
155345131|NCT00510783|560695452|FG000|Overall Study|Withdrawal by Subject|2|||
155345132|NCT00510783|560695453|FG001|Overall Study|Withdrawal by Subject|3|||
155345133|NCT00510783|560695452|FG000|Overall Study|Protocol Violation|0|||
155345134|NCT00510783|560695453|FG001|Overall Study|Protocol Violation|1|||
155345135|NCT00316121|560695454|FG000|Overall Study|Death|1|||
155345136|NCT00316121|560695455|FG001|Overall Study|Death|0|||
155345137|NCT00316121|560695454|FG000|Overall Study|Lost to Follow-up|14|||
155345138|NCT00316121|560695455|FG001|Overall Study|Lost to Follow-up|8|||
155345139|NCT00316121|560695454|FG000|Overall Study|Withdrawal by Subject|2|||
155345140|NCT00316121|560695455|FG001|Overall Study|Withdrawal by Subject|0|||
155345141|NCT00316121|560695454|FG000|Overall Study|Reason is missing|1|||
155345142|NCT00316121|560695455|FG001|Overall Study|Reason is missing|0|||
155345143|NCT00316121|560695454|FG000|Overall Study|Subject relocated|1|||
155345144|NCT00316121|560695455|FG001|Overall Study|Subject relocated|1|||
155345145|NCT00316121|560695454|FG000|Overall Study|Subject refused to return|1|||
155345146|NCT00316121|560695455|FG001|Overall Study|Subject refused to return|0|||
155345147|NCT00316121|560695454|FG000|Overall Study|Subject no show for visit x 3|1|||
155345148|NCT00316121|560695455|FG001|Overall Study|Subject no show for visit x 3|0|||
155345149|NCT00316121|560695454|FG000|Overall Study|Subject did not have 24 month visit|1|||
155345150|NCT00316121|560695455|FG001|Overall Study|Subject did not have 24 month visit|0|||
155345151|NCT03708744|560695461|FG000|Overall Study|Withdrawal by Subject|0|||
155345152|NCT03708744|560695462|FG001|Overall Study|Withdrawal by Subject|0|||
155345153|NCT03708744|560695463|FG002|Overall Study|Withdrawal by Subject|1|||
155345154|NCT03708744|560695464|FG003|Overall Study|Withdrawal by Subject|0|||
155345155|NCT00460577|560695472|FG000|Overall Study|Protocol Violation|2|||
155345156|NCT00460577|560695473|FG001|Overall Study|Protocol Violation|6|||
155345157|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
155345158|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
155345159|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
155345160|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
155345161|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
155345162|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
155345163|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
155345164|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
155345165|NCT02213458|560695474|FG000|Overall Study|Refused re-consent|6|||
155345166|NCT02213458|560695475|FG001|Overall Study|Refused re-consent|0|||
155345167|NCT02213458|560695474|FG000|Overall Study|Lost to Follow-up|2|||
155345168|NCT02213458|560695475|FG001|Overall Study|Lost to Follow-up|2|||
155345169|NCT02213458|560695474|FG000|Overall Study|Withdrawal by Subject|26|||
155345170|NCT02213458|560695475|FG001|Overall Study|Withdrawal by Subject|8|||
155345171|NCT04043806|560695476|FG000|Overall Study|Commercial drug is available for participants|13|||
155345172|NCT04043806|560695476|FG000|Overall Study|Physician Decision|2|||
155345173|NCT04043806|560695476|FG000|Overall Study|Other|12|||
155345174|NCT04043806|560695476|FG000|Overall Study|Adverse Event|2|||
155345175|NCT04043806|560695476|FG000|Overall Study|Lost to Follow-up|6|||
155345176|NCT04043806|560695476|FG000|Overall Study|Other non-compliance|2|||
155345177|NCT04043806|560695476|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
155345178|NCT04043806|560695476|FG000|Overall Study|Never Dosed|1|||
155345179|NCT03166215|560695477|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
155345180|NCT03166215|560695478|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
155345181|NCT03166215|560695479|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
155345182|NCT03166215|560695477|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
155345183|NCT03166215|560695478|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
155345184|NCT03166215|560695479|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
155345185|NCT04985604|560695483|FG000|Overall Study|Death|4|||
155345186|NCT04985604|560695484|FG001|Overall Study|Death|6|||
155345187|NCT04985604|560695483|FG000|Overall Study|Withdrawal by Subject|0|||
155345188|NCT04985604|560695484|FG001|Overall Study|Withdrawal by Subject|1|||
155345189|NCT00658632|560695485|FG000|Overall Study|Adverse Event|13|||
155345190|NCT00658632|560695486|FG001|Overall Study|Adverse Event|11|||
155345191|NCT00658632|560695485|FG000|Overall Study|Lost to Follow-up|25|||
155345192|NCT00658632|560695486|FG001|Overall Study|Lost to Follow-up|23|||
155345193|NCT00658632|560695485|FG000|Overall Study|Withdrawal by Subject|10|||
155345194|NCT00658632|560695486|FG001|Overall Study|Withdrawal by Subject|7|||
155345195|NCT00658632|560695485|FG000|Overall Study|Lack of Efficacy|0|||
155345196|NCT00658632|560695486|FG001|Overall Study|Lack of Efficacy|1|||
155345197|NCT00658632|560695485|FG000|Overall Study|Withdrawal of consent|8|||
155345198|NCT00658632|560695486|FG001|Overall Study|Withdrawal of consent|14|||
155345199|NCT00658632|560695485|FG000|Overall Study|Pregnancy|1|||
155345200|NCT00658632|560695486|FG001|Overall Study|Pregnancy|1|||
155345201|NCT00658632|560695485|FG000|Overall Study|Other|7|||
155345202|NCT00658632|560695486|FG001|Overall Study|Other|8|||
155345203|NCT05263492|560695488|FG000|Overall Study|Adverse Event|1|||
155345204|NCT05263492|560695488|FG000|Overall Study|Disease progression during active treatment|3|||
155345206|NCT04551053|560695492|FG000|Overall Study|Death|10|||
155345207|NCT04551053|560695493|FG001|Overall Study|Death|9|||
155345208|NCT04551053|560695492|FG000|Overall Study|Lost to Follow-up|0|||
155345209|NCT04551053|560695493|FG001|Overall Study|Lost to Follow-up|2|||
155345210|NCT04551053|560695492|FG000|Overall Study|Study Terminated by Sponsor|57|||
155345211|NCT04551053|560695493|FG001|Overall Study|Study Terminated by Sponsor|65|||
155345212|NCT04551053|560695492|FG000|Overall Study|Withdrawal by Subject|12|||
155345213|NCT04551053|560695493|FG001|Overall Study|Withdrawal by Subject|5|||
155345214|NCT04551053|560695492|FG000|Overall Study|Adverse Event|2|||
155345215|NCT04551053|560695493|FG001|Overall Study|Adverse Event|0|||
155345216|NCT04551053|560695492|FG000|Overall Study|Lack of Efficacy|2|||
155345217|NCT04551053|560695493|FG001|Overall Study|Lack of Efficacy|1|||
155345218|NCT04551053|560695492|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
155345219|NCT04551053|560695493|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
155345220|NCT04551053|560695492|FG000|Overall Study|Splenapendectomi|1|||
155345221|NCT04551053|560695493|FG001|Overall Study|Splenapendectomi|0|||
155345222|NCT04551053|560695492|FG000|Overall Study|Medical Decision|1|||
155345223|NCT04551053|560695493|FG001|Overall Study|Medical Decision|1|||
155345224|NCT00596960|560695495|FG000|Overall Study|Death|1|||
155345225|NCT00596960|560695496|FG001|Overall Study|Death|2|||
155345226|NCT00596960|560695495|FG000|Overall Study|Lost to Follow-up|6|||
155345227|NCT00596960|560695496|FG001|Overall Study|Lost to Follow-up|5|||
155345228|NCT00596960|560695495|FG000|Overall Study|Withdrawal by Subject|1|||
155345229|NCT00596960|560695496|FG001|Overall Study|Withdrawal by Subject|0|||
155345230|NCT00596960|560695495|FG000|Overall Study|Incarcerated|2|||
155345231|NCT00596960|560695496|FG001|Overall Study|Incarcerated|0|||
155345232|NCT00596960|560695495|FG000|Overall Study|Physician Decision|1|||
155345233|NCT00596960|560695496|FG001|Overall Study|Physician Decision|0|||
155345234|NCT00596960|560695495|FG000|Overall Study|Protocol Violation|0|||
155345235|NCT00596960|560695496|FG001|Overall Study|Protocol Violation|1|||
155345236|NCT00596960|560695495|FG000|Overall Study|No alcohol use data|0|||
155345237|NCT00596960|560695496|FG001|Overall Study|No alcohol use data|1|||
155345238|NCT03503188|560695497|FG000|Overall Study|Non eligible in the sub study|0|||
155345239|NCT03503188|560695498|FG001|Overall Study|Non eligible in the sub study|1|||
155345240|NCT03556891|560695508|FG000|Initial Pivotal Study|Adverse Event|4|||
155345241|NCT03556891|560695508|FG000|Initial Pivotal Study|MRI Need|3|||
155345242|NCT03556891|560695508|FG000|Initial Pivotal Study|Device Failure|1|||
155345243|NCT03556891|560695508|FG000|Initial Pivotal Study|Death|1|||
155345244|NCT03556891|560695508|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
155345245|NCT03556891|560695508|FG000|Initial Pivotal Study|Missing at random|1|||
155345246|NCT03556891|560695508|FG000|Initial Pivotal Study|Missing due to COVID|1|||
155345247|NCT03556891|560695508|FG000|Initial Pivotal Study|Protocol Violation|1|||
155345248|NCT02661490|560698086|FG000|Overall Study|Lost to Follow-up|0|||
155345249|NCT02661490|560698087|FG001|Overall Study|Lost to Follow-up|1|||
155345250|NCT02661490|560698088|FG002|Overall Study|Lost to Follow-up|0|||
155345251|NCT02661490|560698089|FG003|Overall Study|Lost to Follow-up|0|||
155345252|NCT02661490|560698090|FG004|Overall Study|Lost to Follow-up|2|||
155345253|NCT02661490|560698086|FG000|Overall Study|Withdrawal by Subject|2|||
155345254|NCT02661490|560698087|FG001|Overall Study|Withdrawal by Subject|0|||
155345255|NCT02661490|560698088|FG002|Overall Study|Withdrawal by Subject|2|||
155345256|NCT02661490|560698089|FG003|Overall Study|Withdrawal by Subject|0|||
155345257|NCT02661490|560698090|FG004|Overall Study|Withdrawal by Subject|0|||
155345258|NCT02661490|560698086|FG000|Overall Study|Death|1|||
155345259|NCT02661490|560698087|FG001|Overall Study|Death|1|||
155345260|NCT02661490|560698088|FG002|Overall Study|Death|0|||
155345261|NCT02661490|560698089|FG003|Overall Study|Death|1|||
155345262|NCT02661490|560698090|FG004|Overall Study|Death|0|||
155345263|NCT02661490|560698086|FG000|Overall Study|Reason not Specified|0|||
155345264|NCT02661490|560698087|FG001|Overall Study|Reason not Specified|0|||
155345265|NCT02661490|560698088|FG002|Overall Study|Reason not Specified|0|||
155345266|NCT02661490|560698089|FG003|Overall Study|Reason not Specified|0|||
155345267|NCT02661490|560698090|FG004|Overall Study|Reason not Specified|1|||
155345268|NCT00961298|560698091|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
155345269|NCT00961298|560698091|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
155345270|NCT00961298|560698091|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
155345271|NCT02388932|560698096|FG000|Overall Study|Death|1|||
155345272|NCT05927753|560698099|FG000|Overall Study|Withdrawal by Subject|0|||
155345273|NCT05927753|560698100|FG001|Overall Study|Withdrawal by Subject|2|||
155345274|NCT05927753|560698099|FG000|Overall Study|Physician Decision|0|||
155345275|NCT05927753|560698100|FG001|Overall Study|Physician Decision|1|||
155345276|NCT02136797|560698102|FG000|Overall Study|Not Treated|8|||
155345277|NCT00409006|560698104|FG000|Overall Study|Death|15|||
155345278|NCT00409006|560698105|FG001|Overall Study|Death|6|||
155345279|NCT00409006|560698104|FG000|Overall Study|Lost to Follow-up|1|||
155345280|NCT00409006|560698105|FG001|Overall Study|Lost to Follow-up|2|||
155345281|NCT00409006|560698104|FG000|Overall Study|Withdrawal by Subject|3|||
155345282|NCT00409006|560698105|FG001|Overall Study|Withdrawal by Subject|2|||
155424474|NCT00348140|560982402|FG000|Overall Study|Memory declined|0|||
155424475|NCT00348140|560982403|FG001|Overall Study|Memory declined|0|||
155345283|NCT00409006|560698104|FG000|Overall Study|Physician Decision|1|||
155345284|NCT00409006|560698105|FG001|Overall Study|Physician Decision|2|||
155345285|NCT02123797|560698106|FG000|Baseline Intervention|Death|9|||
155345286|NCT02123797|560698107|FG001|Baseline Intervention|Death|16|||
155345287|NCT02123797|560698108|FG002|Baseline Intervention|Death|0|||
155345288|NCT02123797|560698109|FG003|Baseline Intervention|Death|0|||
155345289|NCT02123797|560698110|FG004|Baseline Intervention|Death|0|||
155345290|NCT02123797|560698106|FG000|Baseline Intervention|Withdrawal by Subject|2|||
155345291|NCT02123797|560698107|FG001|Baseline Intervention|Withdrawal by Subject|8|||
155345292|NCT02123797|560698108|FG002|Baseline Intervention|Withdrawal by Subject|0|||
155345293|NCT02123797|560698109|FG003|Baseline Intervention|Withdrawal by Subject|0|||
155345294|NCT02123797|560698110|FG004|Baseline Intervention|Withdrawal by Subject|0|||
155345295|NCT02123797|560698106|FG000|Baseline Intervention|Relocation|2|||
155345296|NCT02123797|560698107|FG001|Baseline Intervention|Relocation|0|||
155345297|NCT02123797|560698108|FG002|Baseline Intervention|Relocation|0|||
155345298|NCT02123797|560698109|FG003|Baseline Intervention|Relocation|0|||
155345299|NCT02123797|560698110|FG004|Baseline Intervention|Relocation|0|||
155345300|NCT02123797|560698106|FG000|Baseline Intervention|Out of window for initial survey|6|||
155345301|NCT02123797|560698107|FG001|Baseline Intervention|Out of window for initial survey|13|||
155345302|NCT02123797|560698108|FG002|Baseline Intervention|Out of window for initial survey|0|||
155345303|NCT02123797|560698109|FG003|Baseline Intervention|Out of window for initial survey|0|||
155345304|NCT02123797|560698110|FG004|Baseline Intervention|Out of window for initial survey|0|||
155345305|NCT02123797|560698106|FG000|Baseline Intervention|Lost to Follow-up|0|||
155345306|NCT02123797|560698107|FG001|Baseline Intervention|Lost to Follow-up|5|||
155345307|NCT02123797|560698108|FG002|Baseline Intervention|Lost to Follow-up|0|||
155345308|NCT02123797|560698109|FG003|Baseline Intervention|Lost to Follow-up|0|||
155345309|NCT02123797|560698110|FG004|Baseline Intervention|Lost to Follow-up|0|||
155345310|NCT02123797|560698106|FG000|Baseline Intervention|Other Disease|3|||
155345311|NCT02123797|560698107|FG001|Baseline Intervention|Other Disease|0|||
155345312|NCT02123797|560698108|FG002|Baseline Intervention|Other Disease|0|||
155345313|NCT02123797|560698109|FG003|Baseline Intervention|Other Disease|0|||
155345314|NCT02123797|560698110|FG004|Baseline Intervention|Other Disease|0|||
155345315|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
155345316|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
155345317|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
155345318|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
155345319|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
155345320|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
155345321|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
155345322|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
155345323|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
155345324|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345325|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
155345326|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
155345327|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345328|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345329|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345330|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345331|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
155345332|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345333|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345334|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345335|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
155345336|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
155345337|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345338|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345339|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345340|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
155345341|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
155345342|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
155345343|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
155345344|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
155345345|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345346|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
155345347|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
155345348|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
155345349|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345350|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
155345351|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
155345352|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345353|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345354|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345355|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345356|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
155345357|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345358|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345359|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345360|NCT03602053|560698120|FG000|Overall Study|Withdrawal by Subject|7|||
155345361|NCT03602053|560698121|FG001|Overall Study|Withdrawal by Subject|9|||
155345362|NCT03602053|560698122|FG002|Overall Study|Withdrawal by Subject|7|||
155345363|NCT03602053|560698120|FG000|Overall Study|Lost to Follow-up|5|||
155345364|NCT03602053|560698121|FG001|Overall Study|Lost to Follow-up|6|||
155345365|NCT03602053|560698122|FG002|Overall Study|Lost to Follow-up|0|||
155345366|NCT03602053|560698120|FG000|Overall Study|Protocol Violation|3|||
155345367|NCT03602053|560698121|FG001|Overall Study|Protocol Violation|0|||
155345368|NCT03602053|560698122|FG002|Overall Study|Protocol Violation|4|||
155345369|NCT03602053|560698120|FG000|Overall Study|Physician Decision|1|||
155345370|NCT03602053|560698121|FG001|Overall Study|Physician Decision|0|||
155345371|NCT03602053|560698122|FG002|Overall Study|Physician Decision|0|||
155345372|NCT03602053|560698120|FG000|Overall Study|migration|2|||
155345373|NCT03602053|560698121|FG001|Overall Study|migration|3|||
155345374|NCT03602053|560698122|FG002|Overall Study|migration|0|||
155345375|NCT03602053|560698120|FG000|Overall Study|Other|1|||
155345376|NCT03602053|560698121|FG001|Overall Study|Other|0|||
155345377|NCT03602053|560698122|FG002|Overall Study|Other|0|||
155345378|NCT03672188|560698133|FG000|Overall Study|Withdrawal by Subject|0|||
155345379|NCT03672188|560698134|FG001|Overall Study|Withdrawal by Subject|0|||
155345380|NCT03672188|560698135|FG002|Overall Study|Withdrawal by Subject|0|||
155345381|NCT03672188|560698136|FG003|Overall Study|Withdrawal by Subject|3|||
155345382|NCT03672188|560698137|FG004|Overall Study|Withdrawal by Subject|0|||
155345383|NCT03672188|560698138|FG005|Overall Study|Withdrawal by Subject|0|||
155345384|NCT03672188|560698139|FG006|Overall Study|Withdrawal by Subject|0|||
155345385|NCT03672188|560698140|FG007|Overall Study|Withdrawal by Subject|0|||
155345386|NCT03672188|560698141|FG008|Overall Study|Withdrawal by Subject|0|||
155345387|NCT03672188|560698142|FG009|Overall Study|Withdrawal by Subject|0|||
155345388|NCT03672188|560698143|FG010|Overall Study|Withdrawal by Subject|0|||
155345389|NCT03672188|560698144|FG011|Overall Study|Withdrawal by Subject|0|||
155345390|NCT03672188|560698145|FG012|Overall Study|Withdrawal by Subject|0|||
155345391|NCT03672188|560698146|FG013|Overall Study|Withdrawal by Subject|0|||
155345392|NCT03672188|560698147|FG014|Overall Study|Withdrawal by Subject|0|||
155345393|NCT03672188|560698133|FG000|Overall Study|Death|0|||
155345394|NCT03672188|560698134|FG001|Overall Study|Death|0|||
155345395|NCT03672188|560698135|FG002|Overall Study|Death|0|||
155345396|NCT03672188|560698136|FG003|Overall Study|Death|0|||
155345397|NCT03672188|560698137|FG004|Overall Study|Death|0|||
155345398|NCT03672188|560698138|FG005|Overall Study|Death|0|||
155345399|NCT03672188|560698139|FG006|Overall Study|Death|0|||
155345400|NCT03672188|560698140|FG007|Overall Study|Death|0|||
155345401|NCT03672188|560698141|FG008|Overall Study|Death|0|||
155345402|NCT03672188|560698142|FG009|Overall Study|Death|0|||
155345403|NCT03672188|560698143|FG010|Overall Study|Death|0|||
155345404|NCT03672188|560698144|FG011|Overall Study|Death|0|||
155345405|NCT03672188|560698145|FG012|Overall Study|Death|1|||
155345406|NCT03672188|560698146|FG013|Overall Study|Death|0|||
155345407|NCT03672188|560698147|FG014|Overall Study|Death|0|||
155345408|NCT03672188|560698133|FG000|Overall Study|Lost to Follow-up|0|||
155345409|NCT03672188|560698134|FG001|Overall Study|Lost to Follow-up|0|||
155345410|NCT03672188|560698135|FG002|Overall Study|Lost to Follow-up|1|||
155345411|NCT03672188|560698136|FG003|Overall Study|Lost to Follow-up|0|||
155345412|NCT03672188|560698137|FG004|Overall Study|Lost to Follow-up|0|||
155345413|NCT03672188|560698138|FG005|Overall Study|Lost to Follow-up|0|||
155345414|NCT03672188|560698139|FG006|Overall Study|Lost to Follow-up|0|||
155345415|NCT03672188|560698140|FG007|Overall Study|Lost to Follow-up|0|||
155345416|NCT03672188|560698141|FG008|Overall Study|Lost to Follow-up|0|||
155345417|NCT03672188|560698142|FG009|Overall Study|Lost to Follow-up|0|||
155345418|NCT03672188|560698143|FG010|Overall Study|Lost to Follow-up|0|||
155345419|NCT03672188|560698144|FG011|Overall Study|Lost to Follow-up|0|||
155345420|NCT03672188|560698145|FG012|Overall Study|Lost to Follow-up|0|||
155345421|NCT03672188|560698146|FG013|Overall Study|Lost to Follow-up|0|||
155345422|NCT03672188|560698147|FG014|Overall Study|Lost to Follow-up|0|||
155345423|NCT01234675|560698148|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
155345424|NCT01234675|560698149|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155345425|NCT01234675|560698148|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155345426|NCT01234675|560698149|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155345427|NCT03997409|560698150|FG000|Overall Study|Protocol Violation|1|||
155345428|NCT03997409|560698151|FG001|Overall Study|Protocol Violation|1|||
155345429|NCT03997409|560698152|FG002|Overall Study|Protocol Violation|0|||
155345430|NCT03997409|560698150|FG000|Overall Study|Withdrawal by Subject|3|||
155345431|NCT03997409|560698151|FG001|Overall Study|Withdrawal by Subject|0|||
155345432|NCT03997409|560698152|FG002|Overall Study|Withdrawal by Subject|0|||
155345433|NCT03997409|560698150|FG000|Overall Study|Lost to Follow-up|0|||
155345434|NCT03997409|560698151|FG001|Overall Study|Lost to Follow-up|0|||
155345435|NCT03997409|560698152|FG002|Overall Study|Lost to Follow-up|1|||
155345436|NCT01753323|560698153|FG000|Overall Study|Lack of Efficacy|0|||
155345437|NCT01753323|560698154|FG001|Overall Study|Lack of Efficacy|0|||
155345438|NCT01753323|560698155|FG002|Overall Study|Lack of Efficacy|8|||
155345439|NCT01753323|560698153|FG000|Overall Study|Protocol deviation|1|||
155345440|NCT01753323|560698154|FG001|Overall Study|Protocol deviation|0|||
155345441|NCT01753323|560698155|FG002|Overall Study|Protocol deviation|0|||
155345442|NCT01753323|560698153|FG000|Overall Study|Adverse Event|0|||
155345443|NCT01753323|560698154|FG001|Overall Study|Adverse Event|0|||
155345444|NCT01753323|560698155|FG002|Overall Study|Adverse Event|1|||
155345445|NCT01870999|560698156|FG000|Overall Study|Adverse Event|0|||
155345446|NCT01870999|560698157|FG001|Overall Study|Adverse Event|4|||
155345447|NCT01870999|560698158|FG002|Overall Study|Adverse Event|1|||
155345448|NCT01870999|560698156|FG000|Overall Study|Subject met withdrawal criteria|3|||
155345449|NCT01870999|560698157|FG001|Overall Study|Subject met withdrawal criteria|2|||
155345450|NCT01870999|560698158|FG002|Overall Study|Subject met withdrawal criteria|0|||
155345451|NCT01870999|560698156|FG000|Overall Study|Subject withdrawn by Investigator|1|||
155345452|NCT01870999|560698157|FG001|Overall Study|Subject withdrawn by Investigator|0|||
155345453|NCT01870999|560698158|FG002|Overall Study|Subject withdrawn by Investigator|0|||
155345454|NCT01870999|560698156|FG000|Overall Study|Withdrawal by Subject|0|||
155345455|NCT01870999|560698157|FG001|Overall Study|Withdrawal by Subject|2|||
155345456|NCT01870999|560698158|FG002|Overall Study|Withdrawal by Subject|5|||
155345457|NCT01870999|560698156|FG000|Overall Study|Protocol Violation|0|||
155345458|NCT01870999|560698157|FG001|Overall Study|Protocol Violation|0|||
155345459|NCT01870999|560698158|FG002|Overall Study|Protocol Violation|1|||
155345460|NCT00116584|560698169|FG000|Overall Study|Withdrawal by Subject|1|||
155345461|NCT00116584|560698170|FG001|Overall Study|Withdrawal by Subject|0|||
155345462|NCT00116584|560698169|FG000|Overall Study|Protocol Violation|1|||
155345463|NCT00116584|560698170|FG001|Overall Study|Protocol Violation|1|||
155345464|NCT01745380|560698171|FG000|Overall Study|Lost to Follow-up|1|||
155345465|NCT01745380|560698172|FG001|Overall Study|Lost to Follow-up|0|||
155345466|NCT01745380|560698171|FG000|Overall Study|Lack of Efficacy|0|||
155345467|NCT01745380|560698172|FG001|Overall Study|Lack of Efficacy|1|||
155345468|NCT02660034|560698173|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
155345469|NCT02660034|560698174|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
155345470|NCT02660034|560698175|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
155345471|NCT02660034|560698176|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
155345472|NCT02660034|560698177|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
155345473|NCT02660034|560698178|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
155345474|NCT02660034|560698179|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
155345475|NCT02660034|560698180|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
155345476|NCT02660034|560698181|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
155345477|NCT02660034|560698182|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
155345478|NCT02660034|560698183|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
155345479|NCT02660034|560698184|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
155345480|NCT02660034|560698185|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
155345481|NCT02660034|560698186|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
155345482|NCT02660034|560698173|FG000|Overall Study|Progressive Disease (Clinical)|7|||
155345483|NCT02660034|560698174|FG001|Overall Study|Progressive Disease (Clinical)|8|||
155345484|NCT02660034|560698175|FG002|Overall Study|Progressive Disease (Clinical)|3|||
155345485|NCT02660034|560698176|FG003|Overall Study|Progressive Disease (Clinical)|9|||
155345486|NCT02660034|560698177|FG004|Overall Study|Progressive Disease (Clinical)|3|||
155345487|NCT02660034|560698178|FG005|Overall Study|Progressive Disease (Clinical)|0|||
155345488|NCT02660034|560698179|FG006|Overall Study|Progressive Disease (Clinical)|0|||
155345489|NCT02660034|560698180|FG007|Overall Study|Progressive Disease (Clinical)|0|||
155345490|NCT02660034|560698181|FG008|Overall Study|Progressive Disease (Clinical)|0|||
155345491|NCT02660034|560698182|FG009|Overall Study|Progressive Disease (Clinical)|0|||
155345492|NCT02660034|560698183|FG010|Overall Study|Progressive Disease (Clinical)|0|||
155345493|NCT02660034|560698184|FG011|Overall Study|Progressive Disease (Clinical)|0|||
155345494|NCT02660034|560698185|FG012|Overall Study|Progressive Disease (Clinical)|0|||
155345495|NCT02660034|560698186|FG013|Overall Study|Progressive Disease (Clinical)|0|||
155345496|NCT02660034|560698173|FG000|Overall Study|Lost to Follow-up|0|||
155345497|NCT02660034|560698174|FG001|Overall Study|Lost to Follow-up|0|||
155345498|NCT02660034|560698175|FG002|Overall Study|Lost to Follow-up|1|||
155345499|NCT02660034|560698176|FG003|Overall Study|Lost to Follow-up|1|||
155345500|NCT02660034|560698177|FG004|Overall Study|Lost to Follow-up|0|||
155345501|NCT02660034|560698178|FG005|Overall Study|Lost to Follow-up|0|||
155345502|NCT02660034|560698179|FG006|Overall Study|Lost to Follow-up|0|||
155345503|NCT02660034|560698180|FG007|Overall Study|Lost to Follow-up|0|||
155505866|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
155345504|NCT02660034|560698181|FG008|Overall Study|Lost to Follow-up|0|||
155345505|NCT02660034|560698182|FG009|Overall Study|Lost to Follow-up|1|||
155345506|NCT02660034|560698183|FG010|Overall Study|Lost to Follow-up|1|||
155345507|NCT02660034|560698184|FG011|Overall Study|Lost to Follow-up|1|||
155345508|NCT02660034|560698185|FG012|Overall Study|Lost to Follow-up|0|||
155345509|NCT02660034|560698186|FG013|Overall Study|Lost to Follow-up|0|||
155345510|NCT02660034|560698173|FG000|Overall Study|Participant moved into special access scheme|1|||
155345511|NCT02660034|560698174|FG001|Overall Study|Participant moved into special access scheme|2|||
155345512|NCT02660034|560698175|FG002|Overall Study|Participant moved into special access scheme|0|||
155345513|NCT02660034|560698176|FG003|Overall Study|Participant moved into special access scheme|0|||
155345514|NCT02660034|560698177|FG004|Overall Study|Participant moved into special access scheme|0|||
155345515|NCT02660034|560698178|FG005|Overall Study|Participant moved into special access scheme|0|||
155345516|NCT02660034|560698179|FG006|Overall Study|Participant moved into special access scheme|0|||
155345517|NCT02660034|560698180|FG007|Overall Study|Participant moved into special access scheme|0|||
155345518|NCT02660034|560698181|FG008|Overall Study|Participant moved into special access scheme|0|||
155345519|NCT02660034|560698182|FG009|Overall Study|Participant moved into special access scheme|0|||
155345520|NCT02660034|560698183|FG010|Overall Study|Participant moved into special access scheme|0|||
155345521|NCT02660034|560698184|FG011|Overall Study|Participant moved into special access scheme|0|||
155345522|NCT02660034|560698185|FG012|Overall Study|Participant moved into special access scheme|0|||
155345523|NCT02660034|560698186|FG013|Overall Study|Participant moved into special access scheme|0|||
155345524|NCT02660034|560698173|FG000|Overall Study|Adverse Event|1|||
155345525|NCT02660034|560698174|FG001|Overall Study|Adverse Event|0|||
155345526|NCT02660034|560698175|FG002|Overall Study|Adverse Event|0|||
155345527|NCT02660034|560698176|FG003|Overall Study|Adverse Event|0|||
155345528|NCT02660034|560698177|FG004|Overall Study|Adverse Event|0|||
155345529|NCT02660034|560698178|FG005|Overall Study|Adverse Event|0|||
155345530|NCT02660034|560698179|FG006|Overall Study|Adverse Event|0|||
155345531|NCT02660034|560698180|FG007|Overall Study|Adverse Event|0|||
155345532|NCT02660034|560698181|FG008|Overall Study|Adverse Event|0|||
155345533|NCT02660034|560698182|FG009|Overall Study|Adverse Event|0|||
155345534|NCT02660034|560698183|FG010|Overall Study|Adverse Event|0|||
155345535|NCT02660034|560698184|FG011|Overall Study|Adverse Event|0|||
155345536|NCT02660034|560698185|FG012|Overall Study|Adverse Event|0|||
155345537|NCT02660034|560698186|FG013|Overall Study|Adverse Event|0|||
155345538|NCT02660034|560698173|FG000|Overall Study|Sponsor Decision|0|||
155345539|NCT02660034|560698174|FG001|Overall Study|Sponsor Decision|1|||
155345540|NCT02660034|560698175|FG002|Overall Study|Sponsor Decision|2|||
155345541|NCT02660034|560698176|FG003|Overall Study|Sponsor Decision|2|||
155345542|NCT02660034|560698177|FG004|Overall Study|Sponsor Decision|3|||
155345543|NCT02660034|560698178|FG005|Overall Study|Sponsor Decision|0|||
155345544|NCT02660034|560698179|FG006|Overall Study|Sponsor Decision|0|||
155345545|NCT02660034|560698180|FG007|Overall Study|Sponsor Decision|0|||
155345546|NCT02660034|560698181|FG008|Overall Study|Sponsor Decision|0|||
155345547|NCT02660034|560698182|FG009|Overall Study|Sponsor Decision|0|||
155345548|NCT02660034|560698183|FG010|Overall Study|Sponsor Decision|0|||
155345549|NCT02660034|560698184|FG011|Overall Study|Sponsor Decision|0|||
155345550|NCT02660034|560698185|FG012|Overall Study|Sponsor Decision|0|||
155345551|NCT02660034|560698186|FG013|Overall Study|Sponsor Decision|1|||
155345552|NCT02660034|560698173|FG000|Overall Study|Withdrawal by Subject|0|||
155345553|NCT02660034|560698174|FG001|Overall Study|Withdrawal by Subject|0|||
155345554|NCT02660034|560698175|FG002|Overall Study|Withdrawal by Subject|0|||
155345555|NCT02660034|560698176|FG003|Overall Study|Withdrawal by Subject|0|||
155345556|NCT02660034|560698177|FG004|Overall Study|Withdrawal by Subject|0|||
155345557|NCT02660034|560698178|FG005|Overall Study|Withdrawal by Subject|0|||
155345558|NCT02660034|560698179|FG006|Overall Study|Withdrawal by Subject|1|||
155345559|NCT02660034|560698180|FG007|Overall Study|Withdrawal by Subject|1|||
155345560|NCT02660034|560698181|FG008|Overall Study|Withdrawal by Subject|1|||
155345561|NCT02660034|560698182|FG009|Overall Study|Withdrawal by Subject|0|||
155345562|NCT02660034|560698183|FG010|Overall Study|Withdrawal by Subject|0|||
155345563|NCT02660034|560698184|FG011|Overall Study|Withdrawal by Subject|1|||
155345564|NCT02660034|560698185|FG012|Overall Study|Withdrawal by Subject|2|||
155345565|NCT02660034|560698186|FG013|Overall Study|Withdrawal by Subject|0|||
155345566|NCT02660034|560698173|FG000|Overall Study|Death|0|||
155345567|NCT02660034|560698174|FG001|Overall Study|Death|0|||
155345568|NCT02660034|560698175|FG002|Overall Study|Death|0|||
155345569|NCT02660034|560698176|FG003|Overall Study|Death|0|||
155345570|NCT02660034|560698177|FG004|Overall Study|Death|0|||
155345571|NCT02660034|560698178|FG005|Overall Study|Death|13|||
155345572|NCT02660034|560698179|FG006|Overall Study|Death|14|||
155345573|NCT02660034|560698180|FG007|Overall Study|Death|10|||
155345574|NCT02660034|560698181|FG008|Overall Study|Death|9|||
155345575|NCT02660034|560698182|FG009|Overall Study|Death|21|||
155345576|NCT02660034|560698183|FG010|Overall Study|Death|17|||
155345577|NCT02660034|560698184|FG011|Overall Study|Death|15|||
155345578|NCT02660034|560698185|FG012|Overall Study|Death|18|||
155345579|NCT02660034|560698186|FG013|Overall Study|Death|7|||
155345580|NCT02660034|560698173|FG000|Overall Study|Physician Decision|0|||
155345581|NCT02660034|560698174|FG001|Overall Study|Physician Decision|0|||
155345582|NCT02660034|560698175|FG002|Overall Study|Physician Decision|0|||
155345583|NCT02660034|560698176|FG003|Overall Study|Physician Decision|0|||
155345584|NCT02660034|560698177|FG004|Overall Study|Physician Decision|0|||
155345585|NCT02660034|560698178|FG005|Overall Study|Physician Decision|0|||
155345586|NCT02660034|560698179|FG006|Overall Study|Physician Decision|0|||
155345587|NCT02660034|560698180|FG007|Overall Study|Physician Decision|0|||
155345588|NCT02660034|560698181|FG008|Overall Study|Physician Decision|0|||
155345589|NCT02660034|560698182|FG009|Overall Study|Physician Decision|0|||
155345590|NCT02660034|560698183|FG010|Overall Study|Physician Decision|0|||
155345591|NCT02660034|560698184|FG011|Overall Study|Physician Decision|0|||
155345592|NCT02660034|560698185|FG012|Overall Study|Physician Decision|0|||
155345593|NCT02660034|560698186|FG013|Overall Study|Physician Decision|1|||
155345594|NCT02660034|560698173|FG000|Overall Study|Participants transferred to LTE|0|||
155345595|NCT02660034|560698174|FG001|Overall Study|Participants transferred to LTE|0|||
155345596|NCT02660034|560698175|FG002|Overall Study|Participants transferred to LTE|0|||
155345597|NCT02660034|560698176|FG003|Overall Study|Participants transferred to LTE|0|||
155345598|NCT02660034|560698177|FG004|Overall Study|Participants transferred to LTE|0|||
155345599|NCT02660034|560698178|FG005|Overall Study|Participants transferred to LTE|10|||
155345600|NCT02660034|560698179|FG006|Overall Study|Participants transferred to LTE|8|||
155345601|NCT02660034|560698180|FG007|Overall Study|Participants transferred to LTE|8|||
155345602|NCT02660034|560698181|FG008|Overall Study|Participants transferred to LTE|10|||
155345603|NCT02660034|560698182|FG009|Overall Study|Participants transferred to LTE|1|||
155345604|NCT02660034|560698183|FG010|Overall Study|Participants transferred to LTE|2|||
155345605|NCT02660034|560698184|FG011|Overall Study|Participants transferred to LTE|4|||
155345606|NCT02660034|560698185|FG012|Overall Study|Participants transferred to LTE|1|||
155345607|NCT02660034|560698186|FG013|Overall Study|Participants transferred to LTE|1|||
155345608|NCT01533181|560698189|FG000|Overall Study|Disease progression pre-active treatment|0|||
155345609|NCT01533181|560698190|FG001|Overall Study|Disease progression pre-active treatment|1|||
155345610|NCT01533181|560698189|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
155345611|NCT01533181|560698190|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
155345612|NCT02030847|560698191|FG000|Overall Study|Death|10|||
155345613|NCT02030847|560698191|FG000|Overall Study|Disease Progression|15|||
155345614|NCT02030847|560698191|FG000|Overall Study|New Cancer Therapy|8|||
155345615|NCT02030847|560698191|FG000|Overall Study|Physician Decision|3|||
155345616|NCT02030847|560698191|FG000|Overall Study|Withdrawal by Subject|1|||
155345617|NCT01703988|560698192|FG000|Overall Study|Investigator Judgment|0|||
155345618|NCT01703988|560698193|FG001|Overall Study|Investigator Judgment|0|||
155345619|NCT01703988|560698194|FG002|Overall Study|Investigator Judgment|0|||
155345620|NCT01703988|560698195|FG003|Overall Study|Investigator Judgment|1|||
155345621|NCT02995733|560698196|FG000|Overall Study|Study site closed|9|||
155345622|NCT02995733|560698197|FG001|Overall Study|Study site closed|10|||
155345623|NCT02995733|560698196|FG000|Overall Study|Death|3|||
155345624|NCT02995733|560698197|FG001|Overall Study|Death|4|||
155345625|NCT02995733|560698196|FG000|Overall Study|Withdrawal by Subject|6|||
155345626|NCT02995733|560698197|FG001|Overall Study|Withdrawal by Subject|2|||
155345627|NCT02995733|560698196|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
155345628|NCT02995733|560698197|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
155345629|NCT02995733|560698196|FG000|Overall Study|Lost to Follow-up|48|||
155345630|NCT02995733|560698197|FG001|Overall Study|Lost to Follow-up|37|||
155345631|NCT02995733|560698196|FG000|Overall Study|Other|0|||
155345632|NCT02995733|560698197|FG001|Overall Study|Other|1|||
155345633|NCT02720198|560698200|FG000|Overall Study|Withdrawal by Subject|0|||
155345634|NCT02720198|560698201|FG001|Overall Study|Withdrawal by Subject|1|||
155345635|NCT04879823|560698202|FG000|Overall Study|Physician Decision|3|||
155345636|NCT04879823|560698203|FG001|Overall Study|Physician Decision|1|||
155345637|NCT04879823|560698202|FG000|Overall Study|Protocol Violation|2|||
155345638|NCT04879823|560698203|FG001|Overall Study|Protocol Violation|3|||
155345639|NCT04879823|560698202|FG000|Overall Study|Lost to Follow-up|43|||
155345640|NCT04879823|560698203|FG001|Overall Study|Lost to Follow-up|35|||
155345641|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
155345642|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
155345643|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
155345644|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
155424476|NCT00348140|560982404|FG002|Overall Study|Memory declined|1|||
155424477|NCT00868790|560982407|FG000|Period 1|Adverse Event|1|||
155424478|NCT00868790|560982408|FG001|Period 1|Adverse Event|0|||
155424479|NCT00868790|560982409|FG002|Period 1|Adverse Event|0|||
155424480|NCT00868790|560982410|FG003|Period 1|Adverse Event|0|||
155424481|NCT00868790|560982411|FG004|Period 1|Adverse Event|0|||
155345645|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
155345646|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
155345647|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Other|3|||
155345648|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Other|0|||
155345649|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Other|0|||
155345650|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
155345651|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
155345652|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
155345653|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
155345654|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
155345655|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
155345656|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
155345657|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
155345658|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
155345659|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Other|0|||
155345660|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Other|1|||
155345661|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Other|0|||
155345662|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
155345663|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
155345664|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
155345665|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
155345666|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
155345667|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
155345668|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
155345669|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
155345670|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
155345671|NCT00472199|560698209|FG000|Overall Study|Adverse Event|19|||
155345672|NCT00472199|560698210|FG001|Overall Study|Adverse Event|23|||
155345673|NCT00472199|560698209|FG000|Overall Study|Lack of Efficacy|4|||
155345674|NCT00472199|560698210|FG001|Overall Study|Lack of Efficacy|25|||
155345675|NCT00472199|560698209|FG000|Overall Study|Lost to Follow-up|2|||
155345676|NCT00472199|560698210|FG001|Overall Study|Lost to Follow-up|4|||
155345677|NCT00472199|560698209|FG000|Overall Study|Protocol Violation|3|||
155345678|NCT00472199|560698210|FG001|Overall Study|Protocol Violation|2|||
155345679|NCT00472199|560698209|FG000|Overall Study|Withdrawal by Subject|6|||
155345680|NCT00472199|560698210|FG001|Overall Study|Withdrawal by Subject|5|||
155345681|NCT00472199|560698209|FG000|Overall Study|personal reason|0|||
155345682|NCT00472199|560698210|FG001|Overall Study|personal reason|1|||
155345683|NCT00472199|560698209|FG000|Overall Study|patient was asymptomatic|1|||
155345684|NCT00472199|560698210|FG001|Overall Study|patient was asymptomatic|0|||
155345685|NCT01106586|560698212|FG000|Overall Study|Adverse Event|9|||
155345686|NCT01106586|560698213|FG001|Overall Study|Adverse Event|15|||
155345687|NCT01106586|560698212|FG000|Overall Study|Death|1|||
155345688|NCT01106586|560698213|FG001|Overall Study|Death|3|||
155345689|NCT01106586|560698212|FG000|Overall Study|Pregnancy|2|||
155345690|NCT01106586|560698213|FG001|Overall Study|Pregnancy|2|||
155345691|NCT01106586|560698212|FG000|Overall Study|Lack of Efficacy|1|||
155345692|NCT01106586|560698213|FG001|Overall Study|Lack of Efficacy|0|||
155345693|NCT01106586|560698212|FG000|Overall Study|Investigator's Discretion|5|||
155345694|NCT01106586|560698213|FG001|Overall Study|Investigator's Discretion|8|||
155345695|NCT01106586|560698212|FG000|Overall Study|Withdrew Consent|18|||
155345696|NCT01106586|560698213|FG001|Overall Study|Withdrew Consent|30|||
155345697|NCT01106586|560698212|FG000|Overall Study|Lost to Follow-up|24|||
155345698|NCT01106586|560698213|FG001|Overall Study|Lost to Follow-up|20|||
155345699|NCT01106586|560698212|FG000|Overall Study|Participant Noncompliance|12|||
155345700|NCT01106586|560698213|FG001|Overall Study|Participant Noncompliance|10|||
155345701|NCT01106586|560698212|FG000|Overall Study|Protocol Violation|1|||
155345702|NCT01106586|560698213|FG001|Overall Study|Protocol Violation|0|||
155345703|NCT01106586|560698212|FG000|Overall Study|Participant Transferred to Another Study|212|||
155345704|NCT01106586|560698213|FG001|Overall Study|Participant Transferred to Another Study|197|||
155345705|NCT00105521|560698214|FG000|Overall Study|Other|1|||
155345706|NCT00105521|560698215|FG001|Overall Study|Other|1|||
155345707|NCT00105521|560698216|FG002|Overall Study|Other|2|||
155345708|NCT00105521|560698217|FG003|Overall Study|Other|0|||
155345709|NCT00105521|560698214|FG000|Overall Study|Adverse Event|10|||
155505867|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
155345710|NCT00105521|560698215|FG001|Overall Study|Adverse Event|4|||
155345711|NCT00105521|560698216|FG002|Overall Study|Adverse Event|10|||
155345712|NCT00105521|560698217|FG003|Overall Study|Adverse Event|8|||
155505868|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
155505869|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
155345713|NCT00105521|560698214|FG000|Overall Study|Withdrawal by Subject|1|||
155345714|NCT00105521|560698215|FG001|Overall Study|Withdrawal by Subject|0|||
155345715|NCT00105521|560698216|FG002|Overall Study|Withdrawal by Subject|1|||
155345716|NCT00105521|560698217|FG003|Overall Study|Withdrawal by Subject|4|||
155345717|NCT00105521|560698214|FG000|Overall Study|Lack of Efficacy|0|||
155345718|NCT00105521|560698215|FG001|Overall Study|Lack of Efficacy|0|||
155345719|NCT00105521|560698216|FG002|Overall Study|Lack of Efficacy|0|||
155345720|NCT00105521|560698217|FG003|Overall Study|Lack of Efficacy|1|||
155345721|NCT00105521|560698214|FG000|Overall Study|Protocol Violation|3|||
155345722|NCT00105521|560698215|FG001|Overall Study|Protocol Violation|5|||
155345723|NCT00105521|560698216|FG002|Overall Study|Protocol Violation|4|||
155345724|NCT00105521|560698217|FG003|Overall Study|Protocol Violation|4|||
155345725|NCT00105521|560698214|FG000|Overall Study|Lost to Follow-up|0|||
155345726|NCT00105521|560698215|FG001|Overall Study|Lost to Follow-up|1|||
155345727|NCT00105521|560698216|FG002|Overall Study|Lost to Follow-up|0|||
155345728|NCT00105521|560698217|FG003|Overall Study|Lost to Follow-up|0|||
155345729|NCT01622088|560698222|FG000|Overall Study|Adverse Event|20|||
155345730|NCT01622088|560698222|FG000|Overall Study|Lost to Follow-up|1|||
155345731|NCT01622088|560698222|FG000|Overall Study|Withdrawal by Subject|20|||
155345732|NCT01622088|560698222|FG000|Overall Study|Investigator Decision|1|||
155345733|NCT01622088|560698222|FG000|Overall Study|Death|53|||
155345734|NCT01622088|560698222|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
155345735|NCT01721109|560698228|FG000|Overall Study|Lack of Efficacy|1|||
155345736|NCT01721109|560698228|FG000|Overall Study|Non- Compliance with Study Drug|3|||
155345737|NCT01721109|560698228|FG000|Overall Study|Withdrew Consent|1|||
155345738|NCT01721109|560698228|FG000|Overall Study|Lost to Follow-up|2|||
155345739|NCT03045302|560698229|FG000|Overall Study|Pre-treatment adverse event|1|||
155345740|NCT00134056|560698230|FG000|Randomization|Not eligible for assigned treatment|22|||
155345741|NCT00134056|560698231|FG001|Randomization|Not eligible for assigned treatment|20|||
155345742|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
155345743|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
155345744|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
155345745|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
155345746|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
155345747|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
155345748|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
155345749|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
155345750|NCT00742560|560698233|FG000|Overall Study|Adverse Event|0|||
155345751|NCT00742560|560698234|FG001|Overall Study|Adverse Event|0|||
155345752|NCT00742560|560698235|FG002|Overall Study|Adverse Event|1|||
155345753|NCT00742560|560698236|FG003|Overall Study|Adverse Event|1|||
155345754|NCT00742560|560698237|FG004|Overall Study|Adverse Event|1|||
155345755|NCT00742560|560698233|FG000|Overall Study|Death|0|||
155345756|NCT00742560|560698234|FG001|Overall Study|Death|2|||
155345757|NCT00742560|560698235|FG002|Overall Study|Death|0|||
155345758|NCT00742560|560698236|FG003|Overall Study|Death|2|||
155345759|NCT00742560|560698237|FG004|Overall Study|Death|3|||
155345760|NCT00742560|560698233|FG000|Overall Study|Subject's Decision|1|||
155345761|NCT00742560|560698234|FG001|Overall Study|Subject's Decision|0|||
155345762|NCT00742560|560698235|FG002|Overall Study|Subject's Decision|2|||
155345763|NCT00742560|560698236|FG003|Overall Study|Subject's Decision|3|||
155345764|NCT00742560|560698237|FG004|Overall Study|Subject's Decision|3|||
155345765|NCT00742560|560698233|FG000|Overall Study|Investigator's Decision|0|||
155345766|NCT00742560|560698234|FG001|Overall Study|Investigator's Decision|0|||
155345767|NCT00742560|560698235|FG002|Overall Study|Investigator's Decision|4|||
155345768|NCT00742560|560698236|FG003|Overall Study|Investigator's Decision|1|||
155345769|NCT00742560|560698237|FG004|Overall Study|Investigator's Decision|0|||
155345770|NCT00742560|560698233|FG000|Overall Study|Disease Progression|1|||
155345771|NCT00742560|560698234|FG001|Overall Study|Disease Progression|0|||
155345772|NCT00742560|560698235|FG002|Overall Study|Disease Progression|5|||
155345773|NCT00742560|560698236|FG003|Overall Study|Disease Progression|17|||
155345774|NCT00742560|560698237|FG004|Overall Study|Disease Progression|16|||
155345775|NCT00742560|560698233|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
155345776|NCT00742560|560698234|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
155345777|NCT00742560|560698235|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
155345778|NCT00742560|560698236|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
155345779|NCT00742560|560698237|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
155345780|NCT00742560|560698233|FG000|Overall Study|Other|0|||
155345781|NCT00742560|560698234|FG001|Overall Study|Other|1|||
155345782|NCT00742560|560698235|FG002|Overall Study|Other|8|||
155345783|NCT00742560|560698236|FG003|Overall Study|Other|9|||
155345784|NCT00742560|560698237|FG004|Overall Study|Other|9|||
155424482|NCT00868790|560982412|FG005|Period 1|Adverse Event|0|||
155345785|NCT00742560|560698233|FG000|Overall Study|MIssing|0|||
155345786|NCT00742560|560698234|FG001|Overall Study|MIssing|0|||
155345787|NCT00742560|560698235|FG002|Overall Study|MIssing|0|||
155345788|NCT00742560|560698236|FG003|Overall Study|MIssing|0|||
155345789|NCT00742560|560698237|FG004|Overall Study|MIssing|1|||
155345790|NCT01536795|560698238|FG000|Overall Study|Lost to Follow-up|0|||
155345791|NCT01536795|560698239|FG001|Overall Study|Lost to Follow-up|2|||
155424483|NCT00868790|560982413|FG006|Period 1|Adverse Event|0|||
155424484|NCT00868790|560982414|FG007|Period 1|Adverse Event|3|||
155345792|NCT01536795|560698238|FG000|Overall Study|Lack of Efficacy|1|||
155345793|NCT01536795|560698239|FG001|Overall Study|Lack of Efficacy|0|||
155345794|NCT01812837|560698240|FG000|Overall Study|Lost to Follow-up|1|||
155345795|NCT01812837|560698241|FG001|Overall Study|Lost to Follow-up|1|||
155345796|NCT01812837|560698242|FG002|Overall Study|Lost to Follow-up|0|||
155345797|NCT01812837|560698240|FG000|Overall Study|Protocol Violation|1|||
155345798|NCT01812837|560698241|FG001|Overall Study|Protocol Violation|0|||
155345799|NCT01812837|560698242|FG002|Overall Study|Protocol Violation|0|||
155345800|NCT05008224|560698243|FG000|Overall Study|Death|3|||
155345801|NCT05008224|560698243|FG000|Overall Study|Lost to Follow-up|2|||
155345802|NCT05008224|560698243|FG000|Overall Study|Did Not Continue on Extension Study|39|||
155345803|NCT05008224|560698243|FG000|Overall Study|Transferred to Extension Study|100|||
155345804|NCT05008224|560698243|FG000|Overall Study|Withdrawal by Subject|2|||
155345805|NCT04598776|560698244|FG000|Overall Study|Protocol Violation|5|||
155345806|NCT04598776|560698244|FG000|Overall Study|Physician Decision|4|||
155345807|NCT00348283|560698245|FG000|Induction|Adverse Event|0|||
155345808|NCT00348283|560698246|FG001|Induction|Adverse Event|2|||
155345809|NCT00348283|560698245|FG000|Induction|Protocol Violation|0|||
155345810|NCT00348283|560698246|FG001|Induction|Protocol Violation|4|||
155345811|NCT00348283|560698245|FG000|Double Blind|Adverse Event|2|||
155345812|NCT00348283|560698246|FG001|Double Blind|Adverse Event|5|||
155345813|NCT00348283|560698245|FG000|Double Blind|Withdrawal by Subject|1|||
155345814|NCT00348283|560698246|FG001|Double Blind|Withdrawal by Subject|1|||
155345815|NCT00348283|560698245|FG000|Double Blind|Protocol Violation|0|||
155345816|NCT00348283|560698246|FG001|Double Blind|Protocol Violation|1|||
155345817|NCT00348283|560698245|FG000|Double Blind|Lack of Efficacy|2|||
155345818|NCT00348283|560698246|FG001|Double Blind|Lack of Efficacy|2|||
155345819|NCT00348283|560698245|FG000|Double Blind|Pregnancy|0|||
155345820|NCT00348283|560698246|FG001|Double Blind|Pregnancy|1|||
155345821|NCT00348283|560698245|FG000|Open Label|Adverse Event|0|||
155345822|NCT00348283|560698246|FG001|Open Label|Adverse Event|8|||
155345823|NCT00348283|560698245|FG000|Open Label|Withdrawal by Subject|0|||
155345824|NCT00348283|560698246|FG001|Open Label|Withdrawal by Subject|4|||
155345825|NCT00348283|560698245|FG000|Open Label|Lost to Follow-up|0|||
155345826|NCT00348283|560698246|FG001|Open Label|Lost to Follow-up|1|||
155345827|NCT00348283|560698245|FG000|Open Label|Lack of Efficacy|0|||
155345828|NCT00348283|560698246|FG001|Open Label|Lack of Efficacy|13|||
155345829|NCT00348283|560698245|FG000|Open Label|Administrative reasons|0|||
155345830|NCT00348283|560698246|FG001|Open Label|Administrative reasons|5|||
155345831|NCT00348283|560698245|FG000|Open Label|Subject moved to the United States|0|||
155345832|NCT00348283|560698246|FG001|Open Label|Subject moved to the United States|1|||
155345833|NCT00348283|560698245|FG000|Open Label|Pregnancy|0|||
155345834|NCT00348283|560698246|FG001|Open Label|Pregnancy|1|||
155345835|NCT00348283|560698245|FG000|Open Label|Sponsor decision|0|||
155345836|NCT00348283|560698246|FG001|Open Label|Sponsor decision|1|||
155345837|NCT02282761|560698249|FG000|Overall Study|Death|0|||
155345838|NCT02282761|560698250|FG001|Overall Study|Death|0|||
155345839|NCT02282761|560698251|FG002|Overall Study|Death|1|||
155345840|NCT02282761|560698249|FG000|Overall Study|Adverse Event|6|||
155345841|NCT02282761|560698250|FG001|Overall Study|Adverse Event|2|||
155345842|NCT02282761|560698251|FG002|Overall Study|Adverse Event|0|||
155345843|NCT02282761|560698249|FG000|Overall Study|Lack of Efficacy|11|||
155345844|NCT02282761|560698250|FG001|Overall Study|Lack of Efficacy|6|||
155345845|NCT02282761|560698251|FG002|Overall Study|Lack of Efficacy|17|||
155345846|NCT02282761|560698249|FG000|Overall Study|Lost to Follow-up|2|||
155345847|NCT02282761|560698250|FG001|Overall Study|Lost to Follow-up|2|||
155345848|NCT02282761|560698251|FG002|Overall Study|Lost to Follow-up|1|||
155345849|NCT02282761|560698249|FG000|Overall Study|Physician Decision|0|||
155345850|NCT02282761|560698250|FG001|Overall Study|Physician Decision|0|||
155345851|NCT02282761|560698251|FG002|Overall Study|Physician Decision|2|||
155345852|NCT02282761|560698249|FG000|Overall Study|Withdrawal by Subject|8|||
155345853|NCT02282761|560698250|FG001|Overall Study|Withdrawal by Subject|10|||
155345854|NCT02282761|560698251|FG002|Overall Study|Withdrawal by Subject|16|||
155345855|NCT02282761|560698249|FG000|Overall Study|Other|3|||
155345856|NCT02282761|560698250|FG001|Overall Study|Other|2|||
155345857|NCT02282761|560698251|FG002|Overall Study|Other|1|||
155647785|NCT03774810|561803681|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
155345858|NCT02632045|560698254|FG000|Overall Study|Withdrawal by Subject|1|||
155345859|NCT02632045|560698255|FG001|Overall Study|Withdrawal by Subject|2|||
155345860|NCT05878522|560698256|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345861|NCT05878522|560698257|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345862|NCT05878522|560698258|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345863|NCT05878522|560698259|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345864|NCT05878522|560698260|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345865|NCT05878522|560698261|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345866|NCT05878522|560698262|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345867|NCT05878522|560698263|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345868|NCT05878522|560698264|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
155345869|NCT05878522|560698265|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345870|NCT05878522|560698266|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345871|NCT05878522|560698267|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345872|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
155345873|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345874|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345875|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345876|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345877|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345878|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345879|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345880|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345881|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
155345882|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345883|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345884|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345885|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
155345886|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345887|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
155345888|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345889|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345890|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345891|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345892|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345893|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345894|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345895|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345896|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345897|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345898|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345899|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345900|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
155345901|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345902|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345903|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345904|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345905|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345906|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345907|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345908|NCT05216835|560698268|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345909|NCT05216835|560698269|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345910|NCT05216835|560698270|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345911|NCT05216835|560698271|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345912|NCT05216835|560698272|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
155345913|NCT05216835|560698273|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
155345914|NCT05216835|560698274|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
155345915|NCT05216835|560698275|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
155345916|NCT05216835|560698268|FG000|Overall Study|Death|0|||
155345917|NCT05216835|560698269|FG001|Overall Study|Death|0|||
155345918|NCT05216835|560698270|FG002|Overall Study|Death|0|||
155345919|NCT05216835|560698271|FG003|Overall Study|Death|1|||
155345920|NCT05216835|560698272|FG004|Overall Study|Death|1|||
155345921|NCT05216835|560698273|FG005|Overall Study|Death|1|||
155345922|NCT05216835|560698274|FG006|Overall Study|Death|1|||
155345923|NCT05216835|560698275|FG007|Overall Study|Death|1|||
155345924|NCT05216835|560698268|FG000|Overall Study|Physician Decision|0|||
155345925|NCT05216835|560698269|FG001|Overall Study|Physician Decision|0|||
155345926|NCT05216835|560698270|FG002|Overall Study|Physician Decision|0|||
155345927|NCT05216835|560698271|FG003|Overall Study|Physician Decision|0|||
155345928|NCT05216835|560698272|FG004|Overall Study|Physician Decision|0|||
155345929|NCT05216835|560698273|FG005|Overall Study|Physician Decision|1|||
155345930|NCT05216835|560698274|FG006|Overall Study|Physician Decision|1|||
155345931|NCT05216835|560698275|FG007|Overall Study|Physician Decision|0|||
155345932|NCT05216835|560698268|FG000|Overall Study|Study terminated by Sponsor|0|||
155345933|NCT05216835|560698269|FG001|Overall Study|Study terminated by Sponsor|0|||
155345934|NCT05216835|560698270|FG002|Overall Study|Study terminated by Sponsor|0|||
155345935|NCT05216835|560698271|FG003|Overall Study|Study terminated by Sponsor|0|||
155345936|NCT05216835|560698272|FG004|Overall Study|Study terminated by Sponsor|0|||
155345937|NCT05216835|560698273|FG005|Overall Study|Study terminated by Sponsor|0|||
155345938|NCT05216835|560698274|FG006|Overall Study|Study terminated by Sponsor|0|||
155345939|NCT05216835|560698275|FG007|Overall Study|Study terminated by Sponsor|1|||
155345940|NCT05216835|560698268|FG000|Overall Study|Withdrawal by Subject|1|||
155345941|NCT05216835|560698269|FG001|Overall Study|Withdrawal by Subject|0|||
155345942|NCT05216835|560698270|FG002|Overall Study|Withdrawal by Subject|1|||
155345943|NCT05216835|560698271|FG003|Overall Study|Withdrawal by Subject|0|||
155345944|NCT05216835|560698272|FG004|Overall Study|Withdrawal by Subject|1|||
155345945|NCT05216835|560698273|FG005|Overall Study|Withdrawal by Subject|0|||
155345946|NCT05216835|560698274|FG006|Overall Study|Withdrawal by Subject|0|||
155345947|NCT05216835|560698275|FG007|Overall Study|Withdrawal by Subject|1|||
155345948|NCT05216835|560698268|FG000|Overall Study|Other|0|||
155345949|NCT05216835|560698269|FG001|Overall Study|Other|1|||
155345950|NCT05216835|560698270|FG002|Overall Study|Other|0|||
155345951|NCT05216835|560698271|FG003|Overall Study|Other|0|||
155345952|NCT05216835|560698272|FG004|Overall Study|Other|0|||
155345953|NCT05216835|560698273|FG005|Overall Study|Other|0|||
155345954|NCT05216835|560698274|FG006|Overall Study|Other|0|||
155345955|NCT05216835|560698275|FG007|Overall Study|Other|0|||
155345956|NCT03861078|560698276|FG000|Overall Study|COVID-19 shut down|4|||
155345957|NCT03861078|560698276|FG000|Overall Study|Lost to Follow-up|1|||
155345958|NCT03861078|560698276|FG000|Overall Study|Protocol Violation|2|||
155345959|NCT03861078|560698276|FG000|Overall Study|lack of venous access|1|||
155345960|NCT01075815|560698277|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
155345961|NCT01075815|560698278|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
155345962|NCT01075815|560698277|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
155345963|NCT01075815|560698278|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
155345964|NCT01075815|560698277|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
155345965|NCT01075815|560698278|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
155345966|NCT00617708|560698279|FG000|Overall Study|Adverse Event|0|||
155345967|NCT00617708|560698280|FG001|Overall Study|Adverse Event|6|||
155345968|NCT00617708|560698281|FG002|Overall Study|Adverse Event|9|||
155345969|NCT00617708|560698279|FG000|Overall Study|Withdrawal by Subject|1|||
155345970|NCT00617708|560698280|FG001|Overall Study|Withdrawal by Subject|1|||
155345971|NCT00617708|560698281|FG002|Overall Study|Withdrawal by Subject|7|||
155345972|NCT00617708|560698279|FG000|Overall Study|Death|0|||
155345973|NCT00617708|560698280|FG001|Overall Study|Death|6|||
155345974|NCT00617708|560698281|FG002|Overall Study|Death|5|||
155345975|NCT00617708|560698279|FG000|Overall Study|Progression/Relapse|7|||
155345976|NCT00617708|560698280|FG001|Overall Study|Progression/Relapse|40|||
155345977|NCT00617708|560698281|FG002|Overall Study|Progression/Relapse|36|||
155345978|NCT00617708|560698279|FG000|Overall Study|Not protocol specified|1|||
155345979|NCT00617708|560698280|FG001|Overall Study|Not protocol specified|4|||
155345980|NCT00617708|560698281|FG002|Overall Study|Not protocol specified|2|||
155345981|NCT00617708|560698279|FG000|Overall Study|Not eligible|1|||
155345982|NCT00617708|560698280|FG001|Overall Study|Not eligible|3|||
155345983|NCT00617708|560698281|FG002|Overall Study|Not eligible|5|||
155345984|NCT02058992|560698282|FG000|Overall Study|Lost to Follow-up|4|||
155345985|NCT02058992|560698282|FG000|Overall Study|Protocol Violation|92|||
155345986|NCT02058992|560698282|FG000|Overall Study|CRF Uncollected|20|||
155345987|NCT02991456|560698283|FG000|Overall Study|Adverse Event|2|||
155345988|NCT02991456|560698284|FG001|Overall Study|Adverse Event|0|||
155345989|NCT02991456|560698283|FG000|Overall Study|Lost to Follow-up|0|||
155345990|NCT02991456|560698284|FG001|Overall Study|Lost to Follow-up|2|||
155345991|NCT02991456|560698283|FG000|Overall Study|Withdrawal by Subject|1|||
155345992|NCT02991456|560698284|FG001|Overall Study|Withdrawal by Subject|0|||
155345993|NCT03747575|560698285|FG000|Overall Study|Withdrawal by Subject|6|||
155345994|NCT03747575|560698286|FG001|Overall Study|Withdrawal by Subject|3|||
155345995|NCT03747575|560698285|FG000|Overall Study|Lost to Follow-up|3|||
155345996|NCT03747575|560698286|FG001|Overall Study|Lost to Follow-up|3|||
155345997|NCT03747575|560698285|FG000|Overall Study|Adverse Event|0|||
155345998|NCT03747575|560698286|FG001|Overall Study|Adverse Event|1|||
155345999|NCT00936065|560698291|FG000|Overall Study|Adverse Event|1|||
155346000|NCT00936065|560698292|FG001|Overall Study|Adverse Event|0|||
155346001|NCT00936065|560698293|FG002|Overall Study|Adverse Event|1|||
155346002|NCT00936065|560698291|FG000|Overall Study|Lack of Efficacy|1|||
155346003|NCT00936065|560698292|FG001|Overall Study|Lack of Efficacy|0|||
155346004|NCT00936065|560698293|FG002|Overall Study|Lack of Efficacy|1|||
155346005|NCT00936065|560698291|FG000|Overall Study|Lost to Follow-up|1|||
155424485|NCT00868790|560982415|FG008|Period 1|Adverse Event|1|||
155424486|NCT00868790|560982416|FG009|Period 1|Adverse Event|0|||
155346006|NCT00936065|560698292|FG001|Overall Study|Lost to Follow-up|0|||
155424487|NCT00868790|560982417|FG010|Period 1|Adverse Event|0|||
155346007|NCT00936065|560698293|FG002|Overall Study|Lost to Follow-up|0|||
155346008|NCT00936065|560698291|FG000|Overall Study|Protocol Violation|1|||
155346009|NCT00936065|560698292|FG001|Overall Study|Protocol Violation|2|||
155346010|NCT00936065|560698293|FG002|Overall Study|Protocol Violation|1|||
155424488|NCT00868790|560982418|FG011|Period 1|Adverse Event|0|||
155346011|NCT00936065|560698291|FG000|Overall Study|Withdrawal by Subject|0|||
155346012|NCT00936065|560698292|FG001|Overall Study|Withdrawal by Subject|2|||
155346013|NCT00936065|560698293|FG002|Overall Study|Withdrawal by Subject|4|||
155346014|NCT01549951|560698296|FG000|Overall Study|Adverse Event|15|||
155346015|NCT01549951|560698296|FG000|Overall Study|Withdrawal by Subject|2|||
155346016|NCT01549951|560698296|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
155346017|NCT01549951|560698296|FG000|Overall Study|Progressive disease|29|||
155346018|NCT01549951|560698296|FG000|Overall Study|Symptomatic deterioration|1|||
155346019|NCT01549951|560698296|FG000|Overall Study|Other|2|||
155346020|NCT00990314|560698297|FG000|Overall Study|Death|2|||
155346021|NCT00990314|560698297|FG000|Overall Study|Adverse Event|2|||
155346022|NCT00990314|560698297|FG000|Overall Study|Withdrawal by Subject|3|||
155346023|NCT00990314|560698297|FG000|Overall Study|Non-Compliance|1|||
155346024|NCT00990314|560698297|FG000|Overall Study|Physician Decision|3|||
155346025|NCT00990314|560698297|FG000|Overall Study|Lack of Efficacy|1|||
155346026|NCT02819141|560698300|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
155346027|NCT02819141|560698301|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
155346028|NCT00705614|560699579|FG000|Initial Intervention|Adverse Event|40|||
155346029|NCT00705614|560699580|FG001|Initial Intervention|Adverse Event|21|||
155346030|NCT00705614|560699579|FG000|Initial Intervention|Lost to Follow-up|310|||
155346031|NCT00705614|560699580|FG001|Initial Intervention|Lost to Follow-up|191|||
155346032|NCT00705614|560699579|FG000|Initial Intervention|Withdrawal by Subject|114|||
155346033|NCT00705614|560699580|FG001|Initial Intervention|Withdrawal by Subject|71|||
155346034|NCT00705614|560699579|FG000|Initial Intervention|Administrative Reason|51|||
155346035|NCT00705614|560699580|FG001|Initial Intervention|Administrative Reason|38|||
155346036|NCT00705614|560699579|FG000|Initial Intervention|Status completion unknown|3|||
155346037|NCT00705614|560699580|FG001|Initial Intervention|Status completion unknown|0|||
155346038|NCT00705614|560699579|FG000|Switch to Remicade|Adverse Event|0|||
155346039|NCT00705614|560699580|FG001|Switch to Remicade|Adverse Event|5|||
155346040|NCT00705614|560699579|FG000|Switch to Remicade|Lost to Follow-up|0|||
155346041|NCT00705614|560699580|FG001|Switch to Remicade|Lost to Follow-up|23|||
155346042|NCT00705614|560699579|FG000|Switch to Remicade|Withdrawal by Subject|0|||
155346043|NCT00705614|560699580|FG001|Switch to Remicade|Withdrawal by Subject|12|||
155346044|NCT00705614|560699579|FG000|Switch to Remicade|Administrative Reason|0|||
155346045|NCT00705614|560699580|FG001|Switch to Remicade|Administrative Reason|9|||
155346046|NCT00088452|560699584|FG000|Overall Study|Did not receive intervention|1|||
155346047|NCT00088452|560699585|FG001|Overall Study|Did not receive intervention|0|||
155346048|NCT00088452|560699586|FG002|Overall Study|Did not receive intervention|1|||
155346049|NCT01184859|560699587|FG000|Period 1: Single Dose|Insufficient urine production|0|||
155346050|NCT01184859|560699588|FG001|Period 1: Single Dose|Insufficient urine production|1|||
155346051|NCT01184859|560699589|FG002|Period 1: Single Dose|Insufficient urine production|0|||
155346052|NCT01184859|560699590|FG003|Period 1: Single Dose|Insufficient urine production|0|||
155346053|NCT01184859|560699591|FG004|Period 1: Single Dose|Insufficient urine production|0|||
155346054|NCT01184859|560699587|FG000|Period 1: Single Dose|Protocol Violation|0|||
155346055|NCT01184859|560699588|FG001|Period 1: Single Dose|Protocol Violation|1|||
155346056|NCT01184859|560699589|FG002|Period 1: Single Dose|Protocol Violation|0|||
155346057|NCT01184859|560699590|FG003|Period 1: Single Dose|Protocol Violation|0|||
155346058|NCT01184859|560699591|FG004|Period 1: Single Dose|Protocol Violation|0|||
155346059|NCT01184859|560699587|FG000|Period 1: Single Dose|Adverse Event|0|||
155346060|NCT01184859|560699588|FG001|Period 1: Single Dose|Adverse Event|0|||
155346061|NCT01184859|560699589|FG002|Period 1: Single Dose|Adverse Event|0|||
155346062|NCT01184859|560699590|FG003|Period 1: Single Dose|Adverse Event|0|||
155346063|NCT01184859|560699591|FG004|Period 1: Single Dose|Adverse Event|1|||
155346064|NCT01184859|560699587|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346065|NCT01184859|560699588|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346066|NCT01184859|560699589|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346067|NCT01184859|560699590|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346068|NCT01184859|560699591|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
155346069|NCT01184859|560699587|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
155346070|NCT01184859|560699588|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346071|NCT01184859|560699589|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155424489|NCT00868790|560982419|FG012|Period 1|Adverse Event|0|||
155346072|NCT01184859|560699590|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155424490|NCT00868790|560982420|FG013|Period 1|Adverse Event|1|||
155346073|NCT01184859|560699591|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346074|NCT02081196|560699593|FG000|Overall Study|Lost to Follow-up|1|||
155424491|NCT00868790|560982407|FG000|Period 1|Protocol Violation|1|||
155346075|NCT05335005|560699601|FG000|Overall Study|Lost to Follow-up|1|||
155346076|NCT04385849|560699604|FG000|Overall Study|Lost to Follow-up|1|||
155346077|NCT04385849|560699605|FG001|Overall Study|Lost to Follow-up|0|||
155346078|NCT01375777|560699606|FG000|Overall Study|Withdrawal by Subject|0|||
155346079|NCT01375777|560699607|FG001|Overall Study|Withdrawal by Subject|2|||
155424492|NCT00868790|560982408|FG001|Period 1|Protocol Violation|0|||
155424493|NCT00868790|560982409|FG002|Period 1|Protocol Violation|0|||
155346080|NCT01375777|560699608|FG002|Overall Study|Withdrawal by Subject|1|||
155346081|NCT01375777|560699609|FG003|Overall Study|Withdrawal by Subject|0|||
155346082|NCT01375777|560699610|FG004|Overall Study|Withdrawal by Subject|1|||
155346083|NCT01375777|560699611|FG005|Overall Study|Withdrawal by Subject|1|||
155346084|NCT01375777|560699612|FG006|Overall Study|Withdrawal by Subject|1|||
155346085|NCT01375777|560699613|FG007|Overall Study|Withdrawal by Subject|2|||
155346086|NCT01375777|560699614|FG008|Overall Study|Withdrawal by Subject|1|||
155346087|NCT01375777|560699606|FG000|Overall Study|Lost to Follow-up|1|||
155346088|NCT01375777|560699607|FG001|Overall Study|Lost to Follow-up|0|||
155346089|NCT01375777|560699608|FG002|Overall Study|Lost to Follow-up|0|||
155346090|NCT01375777|560699609|FG003|Overall Study|Lost to Follow-up|0|||
155346091|NCT01375777|560699610|FG004|Overall Study|Lost to Follow-up|0|||
155346092|NCT01375777|560699611|FG005|Overall Study|Lost to Follow-up|0|||
155346093|NCT01375777|560699612|FG006|Overall Study|Lost to Follow-up|1|||
155346094|NCT01375777|560699613|FG007|Overall Study|Lost to Follow-up|0|||
155346095|NCT01375777|560699614|FG008|Overall Study|Lost to Follow-up|0|||
155346096|NCT01375777|560699606|FG000|Overall Study|Other|1|||
155346097|NCT01375777|560699607|FG001|Overall Study|Other|1|||
155346098|NCT01375777|560699608|FG002|Overall Study|Other|0|||
155346099|NCT01375777|560699609|FG003|Overall Study|Other|0|||
155346100|NCT01375777|560699610|FG004|Overall Study|Other|0|||
155346101|NCT01375777|560699611|FG005|Overall Study|Other|0|||
155346102|NCT01375777|560699612|FG006|Overall Study|Other|0|||
155346103|NCT01375777|560699613|FG007|Overall Study|Other|0|||
155346104|NCT01375777|560699614|FG008|Overall Study|Other|1|||
155346105|NCT00355784|560699615|FG000|Overall Study|Withdrawal by Subject|0|||
155346106|NCT00355784|560699616|FG001|Overall Study|Withdrawal by Subject|0|||
155346107|NCT00355784|560699617|FG002|Overall Study|Withdrawal by Subject|2|||
155346108|NCT03034772|560699618|FG000|Overall Study|Adverse Event|0|||
155346109|NCT03034772|560699619|FG001|Overall Study|Adverse Event|1|||
155346110|NCT03034772|560699618|FG000|Overall Study|Withdrawal by Subject|0|||
155346111|NCT03034772|560699619|FG001|Overall Study|Withdrawal by Subject|1|||
155346112|NCT00730925|560699629|FG000|Overall Study|Progressive Disease|21|||
155346113|NCT00730925|560699629|FG000|Overall Study|Dose reducing Event|2|||
155346114|NCT00730925|560699629|FG000|Overall Study|Other Averse Event|7|||
155346115|NCT00730925|560699629|FG000|Overall Study|Protocol Violation|1|||
155346116|NCT00730925|560699629|FG000|Overall Study|Withdrawal by Subject|1|||
155346117|NCT00730925|560699629|FG000|Overall Study|Switch to combination therapy|8|||
155346118|NCT00730925|560699629|FG000|Overall Study|Other|1|||
155346119|NCT02137239|560699630|FG000|Overall Study|Discontinued Study Treatment|0|||
155346120|NCT02137239|560699631|FG001|Overall Study|Discontinued Study Treatment|3|||
155346121|NCT02137239|560699630|FG000|Overall Study|Withdrew Consent|1|||
155346122|NCT02137239|560699631|FG001|Overall Study|Withdrew Consent|1|||
155346123|NCT02137239|560699630|FG000|Overall Study|Adverse Event|2|||
155346124|NCT02137239|560699631|FG001|Overall Study|Adverse Event|2|||
155346125|NCT02446912|560699632|FG000|Overall Study|Adverse Event|3|||
155346126|NCT02446912|560699633|FG001|Overall Study|Adverse Event|13|||
155346127|NCT02446912|560699634|FG002|Overall Study|Adverse Event|5|||
155346128|NCT02446912|560699632|FG000|Overall Study|Condition under investigation worsened|0|||
155346129|NCT02446912|560699633|FG001|Overall Study|Condition under investigation worsened|1|||
155346130|NCT02446912|560699634|FG002|Overall Study|Condition under investigation worsened|1|||
155346131|NCT02446912|560699632|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155346132|NCT02446912|560699633|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155346133|NCT02446912|560699634|FG002|Overall Study|Study-specific withdrawal criteria|0|||
155346134|NCT02446912|560699632|FG000|Overall Study|Lack of Efficacy|1|||
155346135|NCT02446912|560699633|FG001|Overall Study|Lack of Efficacy|4|||
155346136|NCT02446912|560699634|FG002|Overall Study|Lack of Efficacy|7|||
155346137|NCT02446912|560699632|FG000|Overall Study|Lost to Follow-up|0|||
155346138|NCT02446912|560699633|FG001|Overall Study|Lost to Follow-up|0|||
155346139|NCT02446912|560699634|FG002|Overall Study|Lost to Follow-up|2|||
155346140|NCT02446912|560699632|FG000|Overall Study|Severe non-compliance to protocol|1|||
155424494|NCT00868790|560982410|FG003|Period 1|Protocol Violation|0|||
155424495|NCT00868790|560982411|FG004|Period 1|Protocol Violation|0|||
155346141|NCT02446912|560699633|FG001|Overall Study|Severe non-compliance to protocol|0|||
155346142|NCT02446912|560699634|FG002|Overall Study|Severe non-compliance to protocol|1|||
155346143|NCT02446912|560699632|FG000|Overall Study|Withdrawal by Subject|10|||
155346144|NCT02446912|560699633|FG001|Overall Study|Withdrawal by Subject|15|||
155346145|NCT02446912|560699634|FG002|Overall Study|Withdrawal by Subject|15|||
155346146|NCT02446912|560699632|FG000|Overall Study|Miscellaneous|2|||
155346147|NCT02446912|560699633|FG001|Overall Study|Miscellaneous|2|||
155346148|NCT02446912|560699634|FG002|Overall Study|Miscellaneous|4|||
155346149|NCT01757171|560699637|FG000|Overall Study|Adverse Event|5|||
155346150|NCT01757171|560699638|FG001|Overall Study|Adverse Event|1|||
155346151|NCT01757171|560699637|FG000|Overall Study|Disease Progression|1|||
155346152|NCT01757171|560699638|FG001|Overall Study|Disease Progression|0|||
155346153|NCT01757171|560699637|FG000|Overall Study|Hospitalization|1|||
155346154|NCT01757171|560699638|FG001|Overall Study|Hospitalization|0|||
155346155|NCT01757171|560699637|FG000|Overall Study|ECOG decline|1|||
155424496|NCT00868790|560982412|FG005|Period 1|Protocol Violation|0|||
155505870|NCT00528879|561278266|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
155505871|NCT00528879|561278267|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
155505872|NCT00528879|561278268|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
155505873|NCT00528879|561278269|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
155505874|NCT01159769|561278272|FG000|Overall Study|Adverse Event|1|||
155505875|NCT03056001|561278275|FG000|Overall Study|Death|24|||
155505876|NCT01374906|561278276|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155505877|NCT01374906|561278277|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155346156|NCT01757171|560699638|FG001|Overall Study|ECOG decline|0|||
155346157|NCT00385697|560699643|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
155346158|NCT00385697|560699644|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
155346159|NCT00385697|560699645|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
155346160|NCT00385697|560699646|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
155346161|NCT00385697|560699647|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
155346162|NCT00385697|560699643|FG000|Open-label Segment 1|Lost to Follow-up|1|||
155346163|NCT00385697|560699644|FG001|Open-label Segment 1|Lost to Follow-up|0|||
155346164|NCT00385697|560699645|FG002|Open-label Segment 1|Lost to Follow-up|0|||
155346165|NCT00385697|560699646|FG003|Open-label Segment 1|Lost to Follow-up|0|||
155346166|NCT00385697|560699647|FG004|Open-label Segment 1|Lost to Follow-up|0|||
155346167|NCT00385697|560699643|FG000|Double-blind Segment 2|Adverse Event|0|||
155346168|NCT00385697|560699644|FG001|Double-blind Segment 2|Adverse Event|3|||
155346169|NCT00385697|560699645|FG002|Double-blind Segment 2|Adverse Event|1|||
155346170|NCT00385697|560699646|FG003|Double-blind Segment 2|Adverse Event|0|||
155346171|NCT00385697|560699647|FG004|Double-blind Segment 2|Adverse Event|0|||
155346172|NCT00385697|560699643|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
155346173|NCT00385697|560699644|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
155346174|NCT00385697|560699645|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
155346175|NCT00385697|560699646|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
155346176|NCT00385697|560699647|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
155346177|NCT00385697|560699643|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
155346178|NCT00385697|560699644|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
155346179|NCT00385697|560699645|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
155346180|NCT00385697|560699646|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
155346181|NCT00385697|560699647|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
155346182|NCT00385697|560699643|FG000|Double-blind Segment 2|Other|0|||
155346183|NCT00385697|560699644|FG001|Double-blind Segment 2|Other|2|||
155346184|NCT00385697|560699645|FG002|Double-blind Segment 2|Other|0|||
155346185|NCT00385697|560699646|FG003|Double-blind Segment 2|Other|0|||
155346186|NCT00385697|560699647|FG004|Double-blind Segment 2|Other|0|||
155346187|NCT00442559|560699650|FG000|Overall Study|Lost to Follow-up|32|||
155346188|NCT00442559|560699651|FG001|Overall Study|Lost to Follow-up|34|||
155346189|NCT00442559|560699650|FG000|Overall Study|Protocol Violation|1|||
155346190|NCT00442559|560699651|FG001|Overall Study|Protocol Violation|1|||
155346191|NCT00442559|560699650|FG000|Overall Study|Withdrawal by Subject|1|||
155346192|NCT00442559|560699651|FG001|Overall Study|Withdrawal by Subject|0|||
155346193|NCT02305797|560699652|FG000|Overall Study|Adverse Event|11|||
155346194|NCT02305797|560699653|FG001|Overall Study|Adverse Event|2|||
155346195|NCT02305797|560699652|FG000|Overall Study|Withdrawal by Subject|9|||
155346196|NCT02305797|560699653|FG001|Overall Study|Withdrawal by Subject|10|||
155346197|NCT02305797|560699652|FG000|Overall Study|Lack of Efficacy|6|||
155346198|NCT02305797|560699653|FG001|Overall Study|Lack of Efficacy|0|||
155346199|NCT02305797|560699652|FG000|Overall Study|Lost to Follow-up|5|||
155346200|NCT02305797|560699653|FG001|Overall Study|Lost to Follow-up|11|||
155346201|NCT02305797|560699652|FG000|Overall Study|Pregnancy|0|||
155346202|NCT02305797|560699653|FG001|Overall Study|Pregnancy|2|||
155346203|NCT02305797|560699652|FG000|Overall Study|Noncompliance|14|||
155346204|NCT02305797|560699653|FG001|Overall Study|Noncompliance|12|||
155346205|NCT02305797|560699652|FG000|Overall Study|Reason not collected|0|||
155346206|NCT02305797|560699653|FG001|Overall Study|Reason not collected|1|||
155346207|NCT03906240|560699654|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
155346208|NCT03906240|560699655|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
155346209|NCT03906240|560699654|FG000|Overall Study|Lost to Follow-up|1|||
155346210|NCT03906240|560699655|FG001|Overall Study|Lost to Follow-up|0|||
155346211|NCT03906240|560699654|FG000|Overall Study|Withdrawal by Subject|0|||
155346212|NCT03906240|560699655|FG001|Overall Study|Withdrawal by Subject|1|||
155346213|NCT02267746|560699656|FG000|Overall Study|Adverse Event|0|||
155346214|NCT02267746|560699657|FG001|Overall Study|Adverse Event|2|||
155346215|NCT02267746|560699658|FG002|Overall Study|Adverse Event|1|||
155346216|NCT02267746|560699656|FG000|Overall Study|Protocol Violation|8|||
155346217|NCT02267746|560699657|FG001|Overall Study|Protocol Violation|7|||
155346218|NCT02267746|560699658|FG002|Overall Study|Protocol Violation|3|||
155346219|NCT02267746|560699656|FG000|Overall Study|Lack of Efficacy|11|||
155346220|NCT02267746|560699657|FG001|Overall Study|Lack of Efficacy|11|||
155346221|NCT02267746|560699658|FG002|Overall Study|Lack of Efficacy|15|||
155346222|NCT02267746|560699656|FG000|Overall Study|Protocol Violation|1|||
155346223|NCT02267746|560699657|FG001|Overall Study|Protocol Violation|2|||
155346224|NCT02267746|560699658|FG002|Overall Study|Protocol Violation|1|||
155346225|NCT02267746|560699656|FG000|Overall Study|Miscellaneous|1|||
155346226|NCT02267746|560699657|FG001|Overall Study|Miscellaneous|0|||
155346227|NCT02267746|560699658|FG002|Overall Study|Miscellaneous|1|||
155346228|NCT05234632|560699663|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
155346229|NCT05234632|560699664|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
155346230|NCT05234632|560699663|FG000|Overall Study|Withdrawal by Subject|2|||
155346231|NCT05234632|560699664|FG001|Overall Study|Withdrawal by Subject|0|||
155346232|NCT05234632|560699663|FG000|Overall Study|Adverse Event|0|||
155346233|NCT05234632|560699664|FG001|Overall Study|Adverse Event|4|||
155346234|NCT05234632|560699663|FG000|Overall Study|Physician Decision|1|||
155346235|NCT05234632|560699664|FG001|Overall Study|Physician Decision|1|||
155346236|NCT05234632|560699663|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
155346237|NCT05234632|560699664|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
155346238|NCT05234632|560699663|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
155346239|NCT05234632|560699664|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
155346240|NCT02849509|560699666|FG000|Overall Study|Worsening of disease under study|1|||
155346241|NCT02849509|560699667|FG001|Overall Study|Worsening of disease under study|1|||
155346242|NCT02849509|560699668|FG002|Overall Study|Worsening of disease under study|1|||
155346243|NCT02849509|560699666|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155346244|NCT02849509|560699667|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155346245|NCT02849509|560699668|FG002|Overall Study|Worsening of other pre-existing disease|2|||
155346246|NCT02849509|560699666|FG000|Overall Study|Other adverse event|36|||
155346247|NCT02849509|560699667|FG001|Overall Study|Other adverse event|41|||
155346248|NCT02849509|560699668|FG002|Overall Study|Other adverse event|8|||
155346249|NCT02849509|560699666|FG000|Overall Study|Withdrawal by Subject|6|||
155346250|NCT02849509|560699667|FG001|Overall Study|Withdrawal by Subject|17|||
155346251|NCT02849509|560699668|FG002|Overall Study|Withdrawal by Subject|12|||
155346252|NCT02849509|560699666|FG000|Overall Study|Lost to Follow-up|27|||
155346253|NCT02849509|560699667|FG001|Overall Study|Lost to Follow-up|67|||
155346254|NCT02849509|560699668|FG002|Overall Study|Lost to Follow-up|36|||
155346255|NCT02849509|560699666|FG000|Overall Study|Other, reason not specified|14|||
155346256|NCT02849509|560699667|FG001|Overall Study|Other, reason not specified|29|||
155346257|NCT02849509|560699668|FG002|Overall Study|Other, reason not specified|25|||
155346258|NCT02849509|560699666|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
155346259|NCT02849509|560699667|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
155346260|NCT02849509|560699668|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
155346261|NCT02924051|560699675|FG000|Overall Study|Withdrawal by Subject|1|||
155346262|NCT02924051|560699676|FG001|Overall Study|Withdrawal by Subject|9|||
155346263|NCT05615870|560699677|FG000|Overall Study|Lost to Follow-up|10|||
155346264|NCT05615870|560699678|FG001|Overall Study|Lost to Follow-up|13|||
155346265|NCT05615870|560699677|FG000|Overall Study|Physician Decision|2|||
155346266|NCT05615870|560699678|FG001|Overall Study|Physician Decision|0|||
155346267|NCT05615870|560699677|FG000|Overall Study|Withdrawal by Subject|0|||
155346268|NCT05615870|560699678|FG001|Overall Study|Withdrawal by Subject|2|||
155346269|NCT05615870|560699677|FG000|Overall Study|Protocol Violation|0|||
155346270|NCT05615870|560699678|FG001|Overall Study|Protocol Violation|3|||
155346271|NCT05615870|560699677|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
155346272|NCT05615870|560699678|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
155346273|NCT05615870|560699677|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
155346274|NCT05615870|560699678|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
155346275|NCT05615870|560699677|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
155346276|NCT05615870|560699678|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
155346277|NCT02130401|560699679|FG000|Overall Study|Poor enrollment|6|||
155346278|NCT03019289|560699680|FG000|Overall Study|Adverse Event|1|||
155346279|NCT03019289|560699681|FG001|Overall Study|Adverse Event|0|||
155346280|NCT03019289|560699682|FG002|Overall Study|Adverse Event|0|||
155346281|NCT03019289|560699683|FG003|Overall Study|Adverse Event|0|||
155424497|NCT00868790|560982413|FG006|Period 1|Protocol Violation|0|||
155424498|NCT00868790|560982414|FG007|Period 1|Protocol Violation|0|||
155424499|NCT00868790|560982415|FG008|Period 1|Protocol Violation|0|||
155424500|NCT00868790|560982416|FG009|Period 1|Protocol Violation|0|||
155424501|NCT00868790|560982417|FG010|Period 1|Protocol Violation|0|||
155346282|NCT03019289|560699684|FG004|Overall Study|Adverse Event|0|||
155346283|NCT03019289|560699685|FG005|Overall Study|Adverse Event|0|||
155346284|NCT03019289|560699686|FG006|Overall Study|Adverse Event|0|||
155346285|NCT03019289|560699687|FG007|Overall Study|Adverse Event|0|||
155346286|NCT03019289|560699688|FG008|Overall Study|Adverse Event|1|||
155346287|NCT03019289|560699680|FG000|Overall Study|Other|1|||
155346288|NCT03019289|560699681|FG001|Overall Study|Other|0|||
155424502|NCT00868790|560982418|FG011|Period 1|Protocol Violation|0|||
155424503|NCT00868790|560982419|FG012|Period 1|Protocol Violation|0|||
155647786|NCT03774810|561803682|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
155346289|NCT03019289|560699682|FG002|Overall Study|Other|0|||
155346290|NCT03019289|560699683|FG003|Overall Study|Other|0|||
155346291|NCT03019289|560699684|FG004|Overall Study|Other|0|||
155346292|NCT03019289|560699685|FG005|Overall Study|Other|0|||
155346293|NCT03019289|560699686|FG006|Overall Study|Other|0|||
155346294|NCT03019289|560699687|FG007|Overall Study|Other|0|||
155346295|NCT03019289|560699688|FG008|Overall Study|Other|0|||
155346296|NCT01334606|560699691|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
155346297|NCT02312245|560699692|FG000|Overall Study|Death|0|||
155346298|NCT02312245|560699693|FG001|Overall Study|Death|0|||
155346299|NCT02312245|560699694|FG002|Overall Study|Death|0|||
155346300|NCT02312245|560699695|FG003|Overall Study|Death|1|||
155346301|NCT02312245|560699692|FG000|Overall Study|Withdrawal by Subject|1|||
155346302|NCT02312245|560699693|FG001|Overall Study|Withdrawal by Subject|1|||
155346303|NCT02312245|560699694|FG002|Overall Study|Withdrawal by Subject|0|||
155346304|NCT02312245|560699695|FG003|Overall Study|Withdrawal by Subject|2|||
155346305|NCT02312245|560699692|FG000|Overall Study|Alternative Therapy|1|||
155346306|NCT02312245|560699693|FG001|Overall Study|Alternative Therapy|0|||
155346307|NCT02312245|560699694|FG002|Overall Study|Alternative Therapy|0|||
155346308|NCT02312245|560699695|FG003|Overall Study|Alternative Therapy|0|||
155346309|NCT02312245|560699692|FG000|Overall Study|Progression|0|||
155346310|NCT02312245|560699693|FG001|Overall Study|Progression|0|||
155346311|NCT02312245|560699694|FG002|Overall Study|Progression|0|||
155346312|NCT02312245|560699695|FG003|Overall Study|Progression|5|||
155346313|NCT02312245|560699692|FG000|Overall Study|Patient went to hospice|0|||
155346314|NCT02312245|560699693|FG001|Overall Study|Patient went to hospice|0|||
155346315|NCT02312245|560699694|FG002|Overall Study|Patient went to hospice|0|||
155346316|NCT02312245|560699695|FG003|Overall Study|Patient went to hospice|1|||
155346317|NCT02312245|560699692|FG000|Overall Study|Ineligible|1|||
155346318|NCT02312245|560699693|FG001|Overall Study|Ineligible|0|||
155346319|NCT02312245|560699694|FG002|Overall Study|Ineligible|0|||
155346320|NCT02312245|560699695|FG003|Overall Study|Ineligible|0|||
155346321|NCT03689452|560699699|FG000|Overall Study|Lost to Follow-up|1|||
155346322|NCT03689452|560699700|FG001|Overall Study|Lost to Follow-up|1|||
155424504|NCT00868790|560982420|FG013|Period 1|Protocol Violation|0|||
155424505|NCT00868790|560982407|FG000|Period 1|Withdrawal by Subject|0|||
155424506|NCT00868790|560982408|FG001|Period 1|Withdrawal by Subject|1|||
155424507|NCT00868790|560982409|FG002|Period 1|Withdrawal by Subject|0|||
155424508|NCT00868790|560982410|FG003|Period 1|Withdrawal by Subject|0|||
155424509|NCT00868790|560982411|FG004|Period 1|Withdrawal by Subject|0|||
155424510|NCT00868790|560982412|FG005|Period 1|Withdrawal by Subject|0|||
155424511|NCT00868790|560982413|FG006|Period 1|Withdrawal by Subject|0|||
155424512|NCT00868790|560982414|FG007|Period 1|Withdrawal by Subject|0|||
155424513|NCT00868790|560982415|FG008|Period 1|Withdrawal by Subject|0|||
155424514|NCT00868790|560982416|FG009|Period 1|Withdrawal by Subject|0|||
155424515|NCT00868790|560982417|FG010|Period 1|Withdrawal by Subject|0|||
155424516|NCT00868790|560982418|FG011|Period 1|Withdrawal by Subject|0|||
155424517|NCT00868790|560982419|FG012|Period 1|Withdrawal by Subject|0|||
155424518|NCT00868790|560982420|FG013|Period 1|Withdrawal by Subject|1|||
155424519|NCT00868790|560982407|FG000|Period 1|Abnormal Triglycerides|0|||
155424520|NCT00868790|560982408|FG001|Period 1|Abnormal Triglycerides|0|||
155346323|NCT02676778|560699701|FG000|Overall Study|Disease Progression|7|||
155346324|NCT02676778|560699702|FG001|Overall Study|Disease Progression|3|||
155346325|NCT02676778|560699703|FG002|Overall Study|Disease Progression|1|||
155346326|NCT02676778|560699701|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
155346327|NCT02676778|560699702|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
155346328|NCT02676778|560699703|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
155346329|NCT02676778|560699701|FG000|Overall Study|Withdrawal by Subject|3|||
155346330|NCT02676778|560699702|FG001|Overall Study|Withdrawal by Subject|2|||
155424521|NCT00868790|560982409|FG002|Period 1|Abnormal Triglycerides|0|||
155424522|NCT00868790|560982410|FG003|Period 1|Abnormal Triglycerides|0|||
155424523|NCT00868790|560982411|FG004|Period 1|Abnormal Triglycerides|1|||
155424524|NCT00868790|560982412|FG005|Period 1|Abnormal Triglycerides|0|||
155424525|NCT00868790|560982413|FG006|Period 1|Abnormal Triglycerides|0|||
155346331|NCT02676778|560699703|FG002|Overall Study|Withdrawal by Subject|0|||
155346332|NCT02676778|560699701|FG000|Overall Study|Other|4|||
155346333|NCT02676778|560699702|FG001|Overall Study|Other|3|||
155346334|NCT02676778|560699703|FG002|Overall Study|Other|0|||
155346335|NCT02676778|560699701|FG000|Overall Study|Adverse Event|2|||
155346336|NCT02676778|560699702|FG001|Overall Study|Adverse Event|3|||
155346337|NCT02676778|560699703|FG002|Overall Study|Adverse Event|0|||
155346338|NCT03686176|560699708|FG000|Overall Study|Procedure cancelled|1|||
155346339|NCT03686176|560699709|FG001|Overall Study|Procedure cancelled|0|||
155346340|NCT03686176|560699710|FG002|Overall Study|Procedure cancelled|0|||
155346341|NCT03686176|560699708|FG000|Overall Study|VR Malfunction|1|||
155346342|NCT03686176|560699709|FG001|Overall Study|VR Malfunction|0|||
155346343|NCT03686176|560699710|FG002|Overall Study|VR Malfunction|0|||
155346344|NCT01232569|560701261|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
155346345|NCT01232569|560701262|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155346346|NCT01232569|560701263|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155346347|NCT01232569|560701264|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
155346348|NCT01232569|560701261|FG000|Double-blind Treatment Period|Escape|2|||
155346349|NCT01232569|560701262|FG001|Double-blind Treatment Period|Escape|2|||
155346350|NCT01232569|560701263|FG002|Double-blind Treatment Period|Escape|0|||
155346351|NCT01232569|560701264|FG003|Double-blind Treatment Period|Escape|0|||
155346352|NCT01232569|560701261|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
155346353|NCT01232569|560701262|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155346354|NCT01232569|560701263|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155346355|NCT01232569|560701264|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155346356|NCT01232569|560701261|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
155346357|NCT01232569|560701262|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
155346358|NCT01232569|560701263|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155346359|NCT01232569|560701264|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
155346360|NCT01232569|560701261|FG000|Double-blind Treatment Period|Physician Decision|1|||
155346361|NCT01232569|560701262|FG001|Double-blind Treatment Period|Physician Decision|0|||
155346362|NCT01232569|560701263|FG002|Double-blind Treatment Period|Physician Decision|0|||
155346363|NCT01232569|560701264|FG003|Double-blind Treatment Period|Physician Decision|0|||
155346364|NCT01232569|560701261|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
155346365|NCT01232569|560701262|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
155346366|NCT01232569|560701263|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
155346367|NCT01232569|560701264|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
155346368|NCT01232569|560701261|FG000|Double-blind Treatment Period|Death|2|||
155346369|NCT01232569|560701262|FG001|Double-blind Treatment Period|Death|0|||
155346370|NCT01232569|560701263|FG002|Double-blind Treatment Period|Death|0|||
155346371|NCT01232569|560701264|FG003|Double-blind Treatment Period|Death|0|||
155346372|NCT04044352|560701265|FG000|Overall Study|Lost to Follow-up|9|||
155346373|NCT04044352|560701265|FG000|Overall Study|Withdrawal by Subject|2|||
155346374|NCT02176356|560701271|FG000|Overall Study|Screen Failure|14|||
155346375|NCT02176356|560701271|FG000|Overall Study|Lost to Follow-up|4|||
155346376|NCT02176356|560701271|FG000|Overall Study|Personal Reasons|3|||
155346377|NCT02176356|560701271|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155346378|NCT00958711|560701273|FG000|Overall Study|Withdrawal by Subject|0|||
155346379|NCT00958711|560701274|FG001|Overall Study|Withdrawal by Subject|4|||
155346380|NCT00958711|560701273|FG000|Overall Study|Physician Decision|5|||
155346381|NCT00958711|560701274|FG001|Overall Study|Physician Decision|7|||
155346382|NCT00958711|560701273|FG000|Overall Study|Lost to Follow-up|4|||
155346383|NCT00958711|560701274|FG001|Overall Study|Lost to Follow-up|1|||
155346384|NCT00958711|560701273|FG000|Overall Study|Other|2|||
155346385|NCT00958711|560701274|FG001|Overall Study|Other|5|||
155346386|NCT00958711|560701273|FG000|Overall Study|Death|1|||
155346387|NCT00958711|560701274|FG001|Overall Study|Death|2|||
155346388|NCT00958711|560701273|FG000|Overall Study|Adverse Event|1|||
155346389|NCT00958711|560701274|FG001|Overall Study|Adverse Event|2|||
155346390|NCT03722485|560701275|FG000|Overall Study|Withdrawal by Subject|1|||
155346391|NCT03722485|560701276|FG001|Overall Study|Withdrawal by Subject|0|||
155346392|NCT03722485|560701275|FG000|Overall Study|Adverse Event|0|||
155346393|NCT03722485|560701276|FG001|Overall Study|Adverse Event|2|||
155346394|NCT03722485|560701275|FG000|Overall Study|subject discharged prior to study completion|1|||
155346395|NCT03722485|560701276|FG001|Overall Study|subject discharged prior to study completion|5|||
155346396|NCT03722485|560701275|FG000|Overall Study|eligibility criteria not met|2|||
155346397|NCT03722485|560701276|FG001|Overall Study|eligibility criteria not met|0|||
155346398|NCT02151643|560701279|FG000|Overall Study|Adverse Event|2|||
155346399|NCT02151643|560701280|FG001|Overall Study|Adverse Event|0|||
155346400|NCT02151643|560701281|FG002|Overall Study|Adverse Event|1|||
155346401|NCT02151643|560701282|FG003|Overall Study|Adverse Event|4|||
155346402|NCT02151643|560701283|FG004|Overall Study|Adverse Event|0|||
155346403|NCT02151643|560701279|FG000|Overall Study|Withdrawal by Subject|0|||
155346404|NCT02151643|560701280|FG001|Overall Study|Withdrawal by Subject|1|||
155346405|NCT02151643|560701281|FG002|Overall Study|Withdrawal by Subject|1|||
155346406|NCT02151643|560701282|FG003|Overall Study|Withdrawal by Subject|1|||
155346407|NCT02151643|560701283|FG004|Overall Study|Withdrawal by Subject|1|||
155346408|NCT02151643|560701279|FG000|Overall Study|Hyperphosphataemia|1|||
155346409|NCT02151643|560701280|FG001|Overall Study|Hyperphosphataemia|0|||
155346410|NCT02151643|560701281|FG002|Overall Study|Hyperphosphataemia|0|||
155346411|NCT02151643|560701282|FG003|Overall Study|Hyperphosphataemia|0|||
155346412|NCT02151643|560701283|FG004|Overall Study|Hyperphosphataemia|1|||
155346413|NCT02151643|560701279|FG000|Overall Study|High Ferritin levels|3|||
155346414|NCT02151643|560701280|FG001|Overall Study|High Ferritin levels|3|||
155346415|NCT02151643|560701281|FG002|Overall Study|High Ferritin levels|2|||
155346416|NCT02151643|560701282|FG003|Overall Study|High Ferritin levels|2|||
155346417|NCT02151643|560701283|FG004|Overall Study|High Ferritin levels|1|||
155346418|NCT03087851|560701285|FG000|Overall Study|Withdraw on medical grounds|0|||
155346419|NCT03087851|560701286|FG001|Overall Study|Withdraw on medical grounds|1|||
155346420|NCT03087851|560701287|FG002|Overall Study|Withdraw on medical grounds|2|||
155346421|NCT00644332|560701288|FG000|Overall Study|Adverse Event|11|||
155346422|NCT00644332|560701288|FG000|Overall Study|Withdrawal by Subject|6|||
155346423|NCT00644332|560701288|FG000|Overall Study|Completion Status Unknown|2|||
155346424|NCT00644332|560701288|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
155346425|NCT00644332|560701288|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
155346426|NCT03694210|560701289|FG000|Overall Study|Death|1|||
155346427|NCT03694210|560701289|FG000|Overall Study|Screen Failure|7|||
155346428|NCT03050372|560701290|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
155346429|NCT03050372|560701291|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
155346430|NCT03050372|560701290|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
155346431|NCT03050372|560701291|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
155346432|NCT00443755|560701296|FG000|Overall Study|Withdrawal by Subject|2|||
155346433|NCT00443755|560701297|FG001|Overall Study|Withdrawal by Subject|1|||
155346434|NCT02775214|560701298|FG000|Overall Study|Withdrawal by Subject|2|||
155346435|NCT02775214|560701299|FG001|Overall Study|Withdrawal by Subject|0|||
155346436|NCT02706834|560701301|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155346437|NCT02706834|560701302|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155346438|NCT02706834|560701303|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155424526|NCT00868790|560982414|FG007|Period 1|Abnormal Triglycerides|0|||
155424527|NCT00868790|560982415|FG008|Period 1|Abnormal Triglycerides|0|||
155346439|NCT02706834|560701304|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
155346440|NCT02706834|560701305|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155346441|NCT02706834|560701306|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155346442|NCT02706834|560701307|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
155346443|NCT02706834|560701308|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
155346444|NCT02706834|560701309|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
155346445|NCT02706834|560701310|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
155346446|NCT02706834|560701311|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
155346447|NCT02706834|560701301|FG000|Overall Study|Lost to Follow-up|0|||
155346448|NCT02706834|560701302|FG001|Overall Study|Lost to Follow-up|0|||
155346449|NCT02706834|560701303|FG002|Overall Study|Lost to Follow-up|1|||
155346450|NCT02706834|560701304|FG003|Overall Study|Lost to Follow-up|0|||
155346451|NCT02706834|560701305|FG004|Overall Study|Lost to Follow-up|0|||
155346452|NCT02706834|560701306|FG005|Overall Study|Lost to Follow-up|0|||
155346453|NCT02706834|560701307|FG006|Overall Study|Lost to Follow-up|0|||
155424528|NCT00868790|560982416|FG009|Period 1|Abnormal Triglycerides|0|||
155346454|NCT02706834|560701308|FG007|Overall Study|Lost to Follow-up|0|||
155346455|NCT02706834|560701309|FG008|Overall Study|Lost to Follow-up|0|||
155346456|NCT02706834|560701310|FG009|Overall Study|Lost to Follow-up|0|||
155346457|NCT02706834|560701311|FG010|Overall Study|Lost to Follow-up|0|||
155346458|NCT02706834|560701301|FG000|Overall Study|Voluntary Withdrawal|1|||
155346459|NCT02706834|560701302|FG001|Overall Study|Voluntary Withdrawal|0|||
155346460|NCT02706834|560701303|FG002|Overall Study|Voluntary Withdrawal|0|||
155346461|NCT02706834|560701304|FG003|Overall Study|Voluntary Withdrawal|0|||
155346462|NCT02706834|560701305|FG004|Overall Study|Voluntary Withdrawal|0|||
155346463|NCT02706834|560701306|FG005|Overall Study|Voluntary Withdrawal|0|||
155346464|NCT02706834|560701307|FG006|Overall Study|Voluntary Withdrawal|0|||
155346465|NCT02706834|560701308|FG007|Overall Study|Voluntary Withdrawal|0|||
155346466|NCT02706834|560701309|FG008|Overall Study|Voluntary Withdrawal|0|||
155346467|NCT02706834|560701310|FG009|Overall Study|Voluntary Withdrawal|1|||
155346468|NCT02706834|560701311|FG010|Overall Study|Voluntary Withdrawal|0|||
155346469|NCT02706834|560701301|FG000|Overall Study|Other Reason Not Specified|1|||
155346470|NCT02706834|560701302|FG001|Overall Study|Other Reason Not Specified|0|||
155346471|NCT02706834|560701303|FG002|Overall Study|Other Reason Not Specified|0|||
155346472|NCT02706834|560701304|FG003|Overall Study|Other Reason Not Specified|0|||
155346473|NCT02706834|560701305|FG004|Overall Study|Other Reason Not Specified|1|||
155346474|NCT02706834|560701306|FG005|Overall Study|Other Reason Not Specified|0|||
155346475|NCT02706834|560701307|FG006|Overall Study|Other Reason Not Specified|0|||
155346476|NCT02706834|560701308|FG007|Overall Study|Other Reason Not Specified|0|||
155346477|NCT02706834|560701309|FG008|Overall Study|Other Reason Not Specified|0|||
155346478|NCT02706834|560701310|FG009|Overall Study|Other Reason Not Specified|0|||
155346479|NCT02706834|560701311|FG010|Overall Study|Other Reason Not Specified|0|||
155346480|NCT00678899|560701312|FG000|Overall Study|Adverse Event|1|||
155346481|NCT02543294|560701313|FG000|Overall Study|Lost to Follow-up|3|||
155346482|NCT02543294|560701313|FG000|Overall Study|Physician Decision|2|||
155346483|NCT02543294|560701313|FG000|Overall Study|Withdrawal by Subject|7|||
155346484|NCT01636258|560701319|FG000|Overall Study|Lost to Follow-up|1|||
155346485|NCT01636258|560701320|FG001|Overall Study|Lost to Follow-up|0|||
155346486|NCT01107353|560701321|FG000|Overall Study|Positive Drug Screen|1|||
155346487|NCT01107353|560701322|FG001|Overall Study|Positive Drug Screen|0|||
155346488|NCT02798861|560701325|FG000|Overall Study|Lost to Follow-up|22|||
155346489|NCT02798861|560701325|FG000|Overall Study|Withdrawal by Subject|1|||
155346490|NCT00907517|560701326|FG000|Overall Study|Progressive Disease|3|||
155346491|NCT00907517|560701327|FG001|Overall Study|Progressive Disease|3|||
155346492|NCT00907517|560701328|FG002|Overall Study|Progressive Disease|4|||
155346493|NCT00907517|560701329|FG003|Overall Study|Progressive Disease|4|||
155346494|NCT00907517|560701330|FG004|Overall Study|Progressive Disease|4|||
155346495|NCT00907517|560701326|FG000|Overall Study|Symptomatic Deterioration|0|||
155346496|NCT00907517|560701327|FG001|Overall Study|Symptomatic Deterioration|0|||
155346497|NCT00907517|560701328|FG002|Overall Study|Symptomatic Deterioration|0|||
155346498|NCT00907517|560701329|FG003|Overall Study|Symptomatic Deterioration|0|||
155346499|NCT00907517|560701330|FG004|Overall Study|Symptomatic Deterioration|1|||
155346500|NCT04057937|560701353|FG000|Placebo-controlled Phase|Adverse Event|3|||
155346501|NCT04057937|560701354|FG001|Placebo-controlled Phase|Adverse Event|0|||
155346502|NCT04057937|560701353|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
155346503|NCT04057937|560701354|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
155346504|NCT04057937|560701353|FG000|Active-treatment Phase|Pregnancy|0|||
155346505|NCT04057937|560701354|FG001|Active-treatment Phase|Pregnancy|1|||
155346506|NCT04057937|560701353|FG000|Active-treatment Phase|Physician Decision|0|||
155346507|NCT04057937|560701354|FG001|Active-treatment Phase|Physician Decision|1|||
155346508|NCT02029521|560701355|FG000|Overall Study|Protocol Violation|1|||
155346509|NCT02029521|560701356|FG001|Overall Study|Protocol Violation|0|||
155346510|NCT02029521|560701355|FG000|Overall Study|Withdrawal by Subject|1|||
155346511|NCT02029521|560701356|FG001|Overall Study|Withdrawal by Subject|1|||
155346512|NCT01072396|560701357|FG000|Period One|Adverse Event|1|||
155346513|NCT01072396|560701358|FG001|Period One|Adverse Event|1|||
155346514|NCT01072396|560701357|FG000|Period One|Protocol Violation|2|||
155346515|NCT01072396|560701358|FG001|Period One|Protocol Violation|1|||
155346516|NCT01072396|560701357|FG000|Period One|Withdrawal by Subject|2|||
155346517|NCT01072396|560701358|FG001|Period One|Withdrawal by Subject|0|||
155346518|NCT01072396|560701357|FG000|Washout Period|Missing termination information|0|||
155346519|NCT01072396|560701358|FG001|Washout Period|Missing termination information|1|||
155346520|NCT01072396|560701357|FG000|Period Two|Adverse Event|0|||
155346521|NCT01072396|560701358|FG001|Period Two|Adverse Event|3|||
155346522|NCT01072396|560701357|FG000|Period Two|Lost to Follow-up|1|||
155346523|NCT01072396|560701358|FG001|Period Two|Lost to Follow-up|0|||
155346524|NCT01268488|560701359|FG000|Overall Study|Adverse Event|3|||
155346525|NCT01268488|560701359|FG000|Overall Study|Physician Decision|2|||
155346526|NCT05287178|560701361|FG000|Overall Study|Lost to Follow-up|2|||
155346527|NCT01426217|560701362|FG000|Overall Study|lost sample|8|||
155346528|NCT01426217|560701363|FG001|Overall Study|lost sample|14|||
155346529|NCT01648699|560701364|FG000|Overall Study|Death|1|||
155346530|NCT01648699|560701364|FG000|Overall Study|Lost to Follow-up|2|||
155346531|NCT01648699|560701364|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
155346532|NCT01920178|560701365|FG000|Overall Study|Lost to Follow-up|2|||
155346533|NCT01920178|560701366|FG001|Overall Study|Lost to Follow-up|1|||
155346534|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
155346535|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Death|1|||
155346536|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
155346537|NCT03023878|560701367|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
155346538|NCT03023878|560701367|FG000|Treatment Period|Disease Progression|1|||
155346539|NCT03023878|560701367|FG000|Treatment Period|Withdrawal by Subject|1|||
155346540|NCT03023878|560701367|FG000|Treatment Period|Adverse Event|1|||
155346541|NCT03023878|560701367|FG000|Long Term Follow-Up Period|Death|2|||
155346542|NCT00288353|560701368|FG000|Overall Study|Lack of Efficacy|2|||
155346543|NCT00288353|560701369|FG001|Overall Study|Lack of Efficacy|2|||
155346544|NCT00288353|560701368|FG000|Overall Study|Withdrawal by Subject|5|||
155346545|NCT00288353|560701369|FG001|Overall Study|Withdrawal by Subject|5|||
155346546|NCT04799587|560701370|FG000|Overall Study|Withdrawal by Subject|0|||
155346547|NCT04799587|560701371|FG001|Overall Study|Withdrawal by Subject|1|||
155346548|NCT00728884|560701372|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
155346549|NCT00728884|560701372|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
155346550|NCT02374476|560701380|FG000|VT Induced Ablation|Screening Failures|36|||
155346551|NCT02374476|560701381|FG001|VT Induced Ablation|Screening Failures|0|||
155346552|NCT02374476|560701382|FG002|VT Induced Ablation|Screening Failures|0|||
155346553|NCT02374476|560701380|FG000|Arm Assignment|Withdrawal by Subject|0|||
155346554|NCT02374476|560701381|FG001|Arm Assignment|Withdrawal by Subject|0|||
155346555|NCT02374476|560701382|FG002|Arm Assignment|Withdrawal by Subject|1|||
155346556|NCT05431543|560701383|FG000|Overall Study|Medical History|1|||
155346557|NCT05431543|560701384|FG001|Overall Study|Medical History|0|||
155346558|NCT05431543|560701385|FG002|Overall Study|Medical History|0|||
155346559|NCT02784535|560701386|FG000|Overall Study|Adverse Event|1|||
155346560|NCT02784535|560701387|FG001|Overall Study|Adverse Event|0|||
155346561|NCT02784535|560701386|FG000|Overall Study|Withdrawal by Subject|0|||
155346562|NCT02784535|560701387|FG001|Overall Study|Withdrawal by Subject|1|||
155346563|NCT02784535|560701386|FG000|Overall Study|Physician Decision|0|||
155346564|NCT02784535|560701387|FG001|Overall Study|Physician Decision|1|||
155346565|NCT00914732|560701388|FG000|Overall Study|Lost to Follow-up|6|||
155346566|NCT00914732|560701389|FG001|Overall Study|Lost to Follow-up|7|||
155346567|NCT00914732|560701390|FG002|Overall Study|Lost to Follow-up|9|||
155346568|NCT00914732|560701388|FG000|Overall Study|Withdrawal by Subject|3|||
155346569|NCT00914732|560701389|FG001|Overall Study|Withdrawal by Subject|0|||
155346570|NCT00914732|560701390|FG002|Overall Study|Withdrawal by Subject|2|||
155346571|NCT00914732|560701388|FG000|Overall Study|Adverse Event|1|||
155346572|NCT00914732|560701389|FG001|Overall Study|Adverse Event|0|||
155346573|NCT00914732|560701390|FG002|Overall Study|Adverse Event|0|||
155346574|NCT03005106|560701393|FG000|Overall Study|Lost to Follow-up|16|||
155346575|NCT03005106|560701393|FG000|Overall Study|Adverse Event|1|||
155346576|NCT03005106|560701393|FG000|Overall Study|Physician Decision|1|||
155346577|NCT03005106|560701393|FG000|Overall Study|Death|2|||
155346578|NCT00321672|560701396|FG000|Overall Study|Withdrawal by Subject|5|||
155346579|NCT00321672|560701397|FG001|Overall Study|Withdrawal by Subject|1|||
155346580|NCT00321672|560701398|FG002|Overall Study|Withdrawal by Subject|2|||
155346581|NCT00321672|560701399|FG003|Overall Study|Withdrawal by Subject|0|||
155346582|NCT00321672|560701396|FG000|Overall Study|Noncompliance|1|||
155346583|NCT00321672|560701397|FG001|Overall Study|Noncompliance|2|||
155346584|NCT00321672|560701398|FG002|Overall Study|Noncompliance|1|||
155346585|NCT00321672|560701399|FG003|Overall Study|Noncompliance|0|||
155346586|NCT00321672|560701396|FG000|Overall Study|Adverse Event|1|||
155424529|NCT00868790|560982417|FG010|Period 1|Abnormal Triglycerides|0|||
155424530|NCT00868790|560982418|FG011|Period 1|Abnormal Triglycerides|0|||
155647787|NCT03774810|561803678|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
155346587|NCT00321672|560701397|FG001|Overall Study|Adverse Event|1|||
155346588|NCT00321672|560701398|FG002|Overall Study|Adverse Event|0|||
155346589|NCT00321672|560701399|FG003|Overall Study|Adverse Event|0|||
155346590|NCT00321672|560701396|FG000|Overall Study|Lack of Efficacy|1|||
155346591|NCT00321672|560701397|FG001|Overall Study|Lack of Efficacy|1|||
155346592|NCT00321672|560701398|FG002|Overall Study|Lack of Efficacy|0|||
155346593|NCT00321672|560701399|FG003|Overall Study|Lack of Efficacy|0|||
155346594|NCT00321672|560701396|FG000|Overall Study|Lost to Follow-up|2|||
155346595|NCT00321672|560701397|FG001|Overall Study|Lost to Follow-up|0|||
155346596|NCT00321672|560701398|FG002|Overall Study|Lost to Follow-up|4|||
155346597|NCT00321672|560701399|FG003|Overall Study|Lost to Follow-up|2|||
155346598|NCT00321672|560701396|FG000|Overall Study|Death|1|||
155346599|NCT00321672|560701397|FG001|Overall Study|Death|0|||
155346600|NCT00321672|560701398|FG002|Overall Study|Death|0|||
155346601|NCT00321672|560701399|FG003|Overall Study|Death|0|||
155346602|NCT00321672|560701396|FG000|Overall Study|Too far to travel for visits|1|||
155346603|NCT00321672|560701397|FG001|Overall Study|Too far to travel for visits|0|||
155346604|NCT00321672|560701398|FG002|Overall Study|Too far to travel for visits|0|||
155346605|NCT00321672|560701399|FG003|Overall Study|Too far to travel for visits|0|||
155424531|NCT00868790|560982419|FG012|Period 1|Abnormal Triglycerides|0|||
155346606|NCT00321672|560701396|FG000|Overall Study|Incarcerated|0|||
155346607|NCT00321672|560701397|FG001|Overall Study|Incarcerated|0|||
155346608|NCT00321672|560701398|FG002|Overall Study|Incarcerated|2|||
155346609|NCT00321672|560701399|FG003|Overall Study|Incarcerated|0|||
155346610|NCT00321672|560701396|FG000|Overall Study|Moved out of state|0|||
155346611|NCT00321672|560701397|FG001|Overall Study|Moved out of state|1|||
155346612|NCT00321672|560701398|FG002|Overall Study|Moved out of state|1|||
155346613|NCT00321672|560701399|FG003|Overall Study|Moved out of state|0|||
155346614|NCT00321672|560701396|FG000|Overall Study|Protocol Violation|0|||
155346615|NCT00321672|560701397|FG001|Overall Study|Protocol Violation|0|||
155346616|NCT00321672|560701398|FG002|Overall Study|Protocol Violation|1|||
155346617|NCT00321672|560701399|FG003|Overall Study|Protocol Violation|0|||
155346618|NCT00321672|560701396|FG000|Overall Study|Diagnosis of testicular cancer|0|||
155346619|NCT00321672|560701397|FG001|Overall Study|Diagnosis of testicular cancer|1|||
155346620|NCT00321672|560701398|FG002|Overall Study|Diagnosis of testicular cancer|0|||
155346621|NCT00321672|560701399|FG003|Overall Study|Diagnosis of testicular cancer|0|||
155346622|NCT00321672|560701396|FG000|Overall Study|Extensive travel required for new job|0|||
155346623|NCT00321672|560701397|FG001|Overall Study|Extensive travel required for new job|1|||
155346624|NCT00321672|560701398|FG002|Overall Study|Extensive travel required for new job|0|||
155346625|NCT00321672|560701399|FG003|Overall Study|Extensive travel required for new job|0|||
155346626|NCT03953079|560701400|FG000|Core Study|Withdrawal by Subject|1|||
155346627|NCT03953079|560701401|FG001|Core Study|Withdrawal by Subject|2|||
155346628|NCT03953079|560701402|FG002|Core Study|Withdrawal by Subject|1|||
155346629|NCT03953079|560701400|FG000|Core Study|COVID-19|0|||
155346630|NCT03953079|560701401|FG001|Core Study|COVID-19|1|||
155346631|NCT03953079|560701402|FG002|Core Study|COVID-19|0|||
155346632|NCT03953079|560701400|FG000|Core Study|Difficulties leaving the house|0|||
155346633|NCT03953079|560701401|FG001|Core Study|Difficulties leaving the house|1|||
155346634|NCT03953079|560701402|FG002|Core Study|Difficulties leaving the house|0|||
155346635|NCT03953079|560701400|FG000|Extension Study|Withdrawal by Subject|1|||
155346636|NCT03953079|560701401|FG001|Extension Study|Withdrawal by Subject|0|||
155346637|NCT03953079|560701402|FG002|Extension Study|Withdrawal by Subject|0|||
155346638|NCT03953079|560701400|FG000|Extension Study|Received Rescue Treatment|5|||
155346639|NCT03953079|560701401|FG001|Extension Study|Received Rescue Treatment|6|||
155346640|NCT03953079|560701402|FG002|Extension Study|Received Rescue Treatment|5|||
155346641|NCT02389894|560701404|FG000|Overall Study|Death|4|||
155346642|NCT02389894|560701405|FG001|Overall Study|Death|5|||
155346643|NCT02389894|560701406|FG002|Overall Study|Death|3|||
155346644|NCT02389894|560701404|FG000|Overall Study|Withdrawal by Subject|2|||
155346645|NCT02389894|560701405|FG001|Overall Study|Withdrawal by Subject|4|||
155346646|NCT02389894|560701406|FG002|Overall Study|Withdrawal by Subject|5|||
155346647|NCT02389894|560701404|FG000|Overall Study|Lost to Follow-up|2|||
155346648|NCT02389894|560701405|FG001|Overall Study|Lost to Follow-up|1|||
155346649|NCT02389894|560701406|FG002|Overall Study|Lost to Follow-up|1|||
155346650|NCT00145496|560701407|FG000|Overall Study|Adverse Event|42|||
155346651|NCT00145496|560701408|FG001|Overall Study|Adverse Event|30|||
155346652|NCT00145496|560701407|FG000|Overall Study|Lack of Efficacy|12|||
155346653|NCT00145496|560701408|FG001|Overall Study|Lack of Efficacy|7|||
155346654|NCT00145496|560701407|FG000|Overall Study|Withdrawal by Subject|32|||
155346655|NCT00145496|560701408|FG001|Overall Study|Withdrawal by Subject|26|||
155346656|NCT00145496|560701407|FG000|Overall Study|Lost to Follow-up|12|||
155346657|NCT00145496|560701408|FG001|Overall Study|Lost to Follow-up|5|||
155346658|NCT00145496|560701407|FG000|Overall Study|Other|25|||
155346659|NCT00145496|560701408|FG001|Overall Study|Other|13|||
155346660|NCT01429285|560701412|FG000|Overall Study|Protocol Violation|9|||
155346661|NCT01429285|560701413|FG001|Overall Study|Protocol Violation|4|||
155346662|NCT01429285|560701412|FG000|Overall Study|Missing Data|5|||
155346663|NCT01429285|560701413|FG001|Overall Study|Missing Data|3|||
155346664|NCT01429285|560701412|FG000|Overall Study|Erroneously Enrolled Twice|8|||
155346665|NCT01429285|560701413|FG001|Overall Study|Erroneously Enrolled Twice|2|||
155346666|NCT01288729|560701414|FG000|Overall Study|Withdrawal by Subject|1|||
155424532|NCT00868790|560982420|FG013|Period 1|Abnormal Triglycerides|0|||
155346667|NCT01288729|560701415|FG001|Overall Study|Withdrawal by Subject|0|||
155346668|NCT01002547|560703343|FG000|Overall Study|Withdrawal by Subject|4|||
155346669|NCT01002547|560703344|FG001|Overall Study|Withdrawal by Subject|0|||
155346670|NCT01002547|560703345|FG002|Overall Study|Withdrawal by Subject|5|||
155346671|NCT01002547|560703343|FG000|Overall Study|Lost to Follow-up|2|||
155346672|NCT01002547|560703344|FG001|Overall Study|Lost to Follow-up|1|||
155346673|NCT01002547|560703345|FG002|Overall Study|Lost to Follow-up|1|||
155346674|NCT01002547|560703343|FG000|Overall Study|Physician Decision|1|||
155346675|NCT01002547|560703344|FG001|Overall Study|Physician Decision|0|||
155346676|NCT01002547|560703345|FG002|Overall Study|Physician Decision|0|||
155346677|NCT01002547|560703343|FG000|Overall Study|Death|0|||
155346678|NCT01002547|560703344|FG001|Overall Study|Death|2|||
155346679|NCT01002547|560703345|FG002|Overall Study|Death|2|||
155424533|NCT00868790|560982407|FG000|Period 1|Lost to Follow-up|0|||
155346680|NCT01002547|560703343|FG000|Overall Study|Adverse Event|1|||
155346681|NCT01002547|560703344|FG001|Overall Study|Adverse Event|0|||
155346682|NCT01002547|560703345|FG002|Overall Study|Adverse Event|0|||
155346683|NCT00925288|560703348|FG000|Overall Study|Lost to Follow-up|9|||
155346684|NCT00925288|560703349|FG001|Overall Study|Lost to Follow-up|7|||
155346685|NCT00434577|560703350|FG000|Months 0-3|Serious Adverse Event|0|||
155346686|NCT00434577|560703351|FG001|Months 0-3|Serious Adverse Event|0|||
155346687|NCT00434577|560703352|FG002|Months 0-3|Serious Adverse Event|1|||
155346688|NCT00434577|560703353|FG003|Months 0-3|Serious Adverse Event|0|||
155346689|NCT00434577|560703354|FG004|Months 0-3|Serious Adverse Event|0|||
155346690|NCT00434577|560703350|FG000|Months 0-3|Adverse Event|0|||
155346691|NCT00434577|560703351|FG001|Months 0-3|Adverse Event|1|||
155346692|NCT00434577|560703352|FG002|Months 0-3|Adverse Event|1|||
155346693|NCT00434577|560703353|FG003|Months 0-3|Adverse Event|0|||
155346694|NCT00434577|560703354|FG004|Months 0-3|Adverse Event|0|||
155346695|NCT00434577|560703350|FG000|Months 0-3|Lost to Follow-up|0|||
155346696|NCT00434577|560703351|FG001|Months 0-3|Lost to Follow-up|0|||
155346697|NCT00434577|560703352|FG002|Months 0-3|Lost to Follow-up|0|||
155346698|NCT00434577|560703353|FG003|Months 0-3|Lost to Follow-up|0|||
155346699|NCT00434577|560703354|FG004|Months 0-3|Lost to Follow-up|2|||
155346700|NCT00434577|560703350|FG000|Months 0-3|Protocol Violation|1|||
155346701|NCT00434577|560703351|FG001|Months 0-3|Protocol Violation|0|||
155346702|NCT00434577|560703352|FG002|Months 0-3|Protocol Violation|1|||
155346703|NCT00434577|560703353|FG003|Months 0-3|Protocol Violation|0|||
155346704|NCT00434577|560703354|FG004|Months 0-3|Protocol Violation|0|||
155346705|NCT00434577|560703350|FG000|Months 0-3|Withdrawal by Subject|2|||
155346706|NCT00434577|560703351|FG001|Months 0-3|Withdrawal by Subject|1|||
155346707|NCT00434577|560703352|FG002|Months 0-3|Withdrawal by Subject|1|||
155346708|NCT00434577|560703353|FG003|Months 0-3|Withdrawal by Subject|1|||
155346709|NCT00434577|560703354|FG004|Months 0-3|Withdrawal by Subject|1|||
155346710|NCT00651937|560703355|FG000|Overall Study|Withdrawal by Subject|4|||
155346711|NCT00651937|560703356|FG001|Overall Study|Withdrawal by Subject|1|||
155346712|NCT01904019|560703359|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
155346713|NCT01904019|560703359|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
155346714|NCT01904019|560703359|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
155346715|NCT01904019|560703359|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
155346716|NCT01904019|560703359|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
155346717|NCT01904019|560703359|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
155346718|NCT01537120|560703363|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
155346719|NCT01537120|560703363|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
155346720|NCT04816708|560703366|FG000|Overall Study|Lost to Follow-up|10|||
155346721|NCT04816708|560703367|FG001|Overall Study|Lost to Follow-up|4|||
155346722|NCT01732627|560703368|FG000|Overall Study|Withdrawal by Subject|1|||
155346723|NCT01732627|560703369|FG001|Overall Study|Withdrawal by Subject|0|||
155346724|NCT02475733|560703372|FG000|Overall Study|Withdrawal by Subject|1|||
155346725|NCT02475733|560703373|FG001|Overall Study|Withdrawal by Subject|0|||
155346726|NCT02475733|560703372|FG000|Overall Study|Physician Decision|1|||
155346727|NCT02475733|560703373|FG001|Overall Study|Physician Decision|0|||
155346728|NCT02131155|560703375|FG000|Overall Study|Adverse Event|1|||
155346729|NCT02131155|560703376|FG001|Overall Study|Adverse Event|0|||
155346730|NCT02131155|560703375|FG000|Overall Study|Treatment completed|1|||
155346731|NCT02131155|560703376|FG001|Overall Study|Treatment completed|0|||
155346732|NCT02131155|560703375|FG000|Overall Study|Primary tumour recurrence|2|||
155647788|NCT03774810|561803679|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
155647789|NCT03774810|561803680|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
155346733|NCT02131155|560703376|FG001|Overall Study|Primary tumour recurrence|1|||
155346734|NCT02131155|560703375|FG000|Overall Study|Refused to continue study medication|1|||
155346735|NCT02131155|560703376|FG001|Overall Study|Refused to continue study medication|0|||
155346736|NCT02131155|560703375|FG000|Overall Study|Study early termination|20|||
155346737|NCT02131155|560703376|FG001|Overall Study|Study early termination|10|||
155346738|NCT01887418|560703379|FG000|Overall Study|Travelling difficulties|0|||
155346739|NCT01887418|560703380|FG001|Overall Study|Travelling difficulties|0|||
155346740|NCT01887418|560703381|FG002|Overall Study|Travelling difficulties|1|||
155346741|NCT02744898|560703382|FG000|Overall Study|Progressive Disease|2|||
155346742|NCT02744898|560703382|FG000|Overall Study|Physician Decision|1|||
155346743|NCT02744898|560703382|FG000|Overall Study|Toxicity|1|||
155346744|NCT01014013|560703383|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
155346745|NCT01014013|560703384|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
155346746|NCT01014013|560703383|FG000|Overall Study|Clinical adverse experience|4|||
155346747|NCT01014013|560703384|FG001|Overall Study|Clinical adverse experience|2|||
155346748|NCT01014013|560703383|FG000|Overall Study|Laboratory adverse experience|1|||
155346749|NCT01014013|560703384|FG001|Overall Study|Laboratory adverse experience|1|||
155346750|NCT01014013|560703383|FG000|Overall Study|Protocol Violation|1|||
155346751|NCT01014013|560703384|FG001|Overall Study|Protocol Violation|3|||
155346752|NCT01014013|560703383|FG000|Overall Study|Withdrawal by Subject|7|||
155346753|NCT01014013|560703384|FG001|Overall Study|Withdrawal by Subject|4|||
155346754|NCT01014013|560703383|FG000|Overall Study|Clinical/microbiologic failure|1|||
155424534|NCT00868790|560982408|FG001|Period 1|Lost to Follow-up|0|||
155346755|NCT01014013|560703384|FG001|Overall Study|Clinical/microbiologic failure|2|||
155346756|NCT01014013|560703383|FG000|Overall Study|Pathogen culture = no growth|26|||
155346757|NCT01014013|560703384|FG001|Overall Study|Pathogen culture = no growth|34|||
155346758|NCT01014013|560703383|FG000|Overall Study|Negative urine culture|2|||
155346759|NCT01014013|560703384|FG001|Overall Study|Negative urine culture|0|||
155346760|NCT01014013|560703383|FG000|Overall Study|Pathogen resistant|7|||
155346761|NCT01014013|560703384|FG001|Overall Study|Pathogen resistant|4|||
155346762|NCT01014013|560703383|FG000|Overall Study|Physician Decision|0|||
155346763|NCT01014013|560703384|FG001|Overall Study|Physician Decision|1|||
155346764|NCT01014013|560703383|FG000|Overall Study|Another antibiotic therapy required|0|||
155346765|NCT01014013|560703384|FG001|Overall Study|Another antibiotic therapy required|1|||
155346766|NCT01014013|560703383|FG000|Overall Study|Appendectomy|1|||
155346767|NCT01014013|560703384|FG001|Overall Study|Appendectomy|0|||
155346768|NCT01014013|560703383|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
155346769|NCT01014013|560703384|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
155346770|NCT03508830|560703391|FG000|Overall Study|Withdrawal by Subject|3|||
155346771|NCT03508830|560703392|FG001|Overall Study|Withdrawal by Subject|4|||
155346772|NCT03508830|560703391|FG000|Overall Study|Physician Decision|2|||
155346773|NCT03508830|560703392|FG001|Overall Study|Physician Decision|2|||
155346774|NCT02522299|560703393|FG000|Overall Study|Adverse Event|2|||
155346775|NCT02522299|560703394|FG001|Overall Study|Adverse Event|0|||
155346776|NCT02522299|560703393|FG000|Overall Study|Physician Decision|0|||
155346777|NCT02522299|560703394|FG001|Overall Study|Physician Decision|1|||
155346778|NCT02522299|560703393|FG000|Overall Study|Withdrawal by Subject|2|||
155346779|NCT02522299|560703394|FG001|Overall Study|Withdrawal by Subject|0|||
155346780|NCT02097056|560703397|FG000|Overall Study|Protocol Violation|2|||
155346781|NCT02097056|560703397|FG000|Overall Study|Withdrawal by Subject|15|||
155346782|NCT02097056|560703397|FG000|Overall Study|Lost to Follow-up|2|||
155346783|NCT02097056|560703397|FG000|Overall Study|Adverse Event|37|||
155346784|NCT02097056|560703397|FG000|Overall Study|Other|2|||
155346785|NCT01446042|560703398|FG000|Overall Study|Withdrawal by Subject|12|||
155346786|NCT01446042|560703399|FG001|Overall Study|Withdrawal by Subject|2|||
155346787|NCT01446042|560703400|FG002|Overall Study|Withdrawal by Subject|4|||
155346788|NCT01446042|560703398|FG000|Overall Study|Adverse Event|1|||
155346789|NCT01446042|560703399|FG001|Overall Study|Adverse Event|0|||
155346790|NCT01446042|560703400|FG002|Overall Study|Adverse Event|4|||
155346791|NCT01446042|560703398|FG000|Overall Study|Lost to Follow-up|5|||
155346792|NCT01446042|560703399|FG001|Overall Study|Lost to Follow-up|0|||
155346793|NCT01446042|560703400|FG002|Overall Study|Lost to Follow-up|0|||
155346794|NCT01446042|560703398|FG000|Overall Study|Other reasons|2|||
155346795|NCT01446042|560703399|FG001|Overall Study|Other reasons|1|||
155346796|NCT01446042|560703400|FG002|Overall Study|Other reasons|1|||
155346797|NCT03575572|560703407|FG000|Overall Study|Withdrawal by Subject|2|||
155346798|NCT03575572|560703407|FG000|Overall Study|Physician Decision|2|||
155346799|NCT04908800|560703408|FG000|Overall Study|Adverse Event|0|||
155346800|NCT04908800|560703409|FG001|Overall Study|Adverse Event|0|||
155346801|NCT04908800|560703410|FG002|Overall Study|Adverse Event|0|||
155346802|NCT04908800|560703411|FG003|Overall Study|Adverse Event|0|||
155346803|NCT04908800|560703412|FG004|Overall Study|Adverse Event|0|||
155346804|NCT04908800|560703413|FG005|Overall Study|Adverse Event|0|||
155346805|NCT04908800|560703414|FG006|Overall Study|Adverse Event|0|||
155346806|NCT04908800|560703415|FG007|Overall Study|Adverse Event|0|||
155346807|NCT04908800|560703416|FG008|Overall Study|Adverse Event|0|||
155346808|NCT04908800|560703417|FG009|Overall Study|Adverse Event|0|||
155346809|NCT04908800|560703418|FG010|Overall Study|Adverse Event|1|||
155346810|NCT04908800|560703419|FG011|Overall Study|Adverse Event|0|||
155346811|NCT04908800|560703420|FG012|Overall Study|Adverse Event|0|||
155346812|NCT03751280|560703421|FG000|Overall Study|Adverse Event|0|||
155346813|NCT03751280|560703422|FG001|Overall Study|Adverse Event|1|||
155346814|NCT03751280|560703421|FG000|Overall Study|Lost to Follow-up|3|||
155346815|NCT03751280|560703422|FG001|Overall Study|Lost to Follow-up|5|||
155346816|NCT03751280|560703421|FG000|Overall Study|Physician Decision|0|||
155346817|NCT03751280|560703422|FG001|Overall Study|Physician Decision|2|||
155346818|NCT03751280|560703421|FG000|Overall Study|Protocol Violation|0|||
155346819|NCT03751280|560703422|FG001|Overall Study|Protocol Violation|2|||
155346820|NCT03751280|560703421|FG000|Overall Study|Withdrawal by Subject|5|||
155346821|NCT03751280|560703422|FG001|Overall Study|Withdrawal by Subject|2|||
155346822|NCT00296504|560703424|FG000|Interim Analysis|Withdrawal by Subject|8|||
155346823|NCT00296504|560703425|FG001|Interim Analysis|Withdrawal by Subject|0|||
155346824|NCT00296504|560703426|FG002|Interim Analysis|Withdrawal by Subject|12|||
155346825|NCT00296504|560703427|FG003|Interim Analysis|Withdrawal by Subject|0|||
155346826|NCT00296504|560703428|FG004|Interim Analysis|Withdrawal by Subject|5|||
155346827|NCT00296504|560703429|FG005|Interim Analysis|Withdrawal by Subject|5|||
155346828|NCT00296504|560703430|FG006|Interim Analysis|Withdrawal by Subject|9|||
155346829|NCT00296504|560703431|FG007|Interim Analysis|Withdrawal by Subject|3|||
155424535|NCT00868790|560982409|FG002|Period 1|Lost to Follow-up|0|||
155424536|NCT00868790|560982410|FG003|Period 1|Lost to Follow-up|0|||
155424537|NCT00868790|560982411|FG004|Period 1|Lost to Follow-up|0|||
155424538|NCT00868790|560982412|FG005|Period 1|Lost to Follow-up|1|||
155647790|NCT03774810|561803681|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
155346830|NCT00296504|560703432|FG008|Interim Analysis|Withdrawal by Subject|0|||
155346831|NCT00296504|560703424|FG000|Interim Analysis|Lost to Follow-up|13|||
155346832|NCT00296504|560703425|FG001|Interim Analysis|Lost to Follow-up|3|||
155346833|NCT00296504|560703426|FG002|Interim Analysis|Lost to Follow-up|26|||
155346834|NCT00296504|560703427|FG003|Interim Analysis|Lost to Follow-up|8|||
155346835|NCT00296504|560703428|FG004|Interim Analysis|Lost to Follow-up|14|||
155346836|NCT00296504|560703429|FG005|Interim Analysis|Lost to Follow-up|4|||
155346837|NCT00296504|560703430|FG006|Interim Analysis|Lost to Follow-up|11|||
155346838|NCT00296504|560703431|FG007|Interim Analysis|Lost to Follow-up|4|||
155346839|NCT00296504|560703432|FG008|Interim Analysis|Lost to Follow-up|0|||
155346840|NCT00296504|560703424|FG000|Interim Analysis|Clinical Progression|1|||
155346841|NCT00296504|560703425|FG001|Interim Analysis|Clinical Progression|0|||
155346842|NCT00296504|560703426|FG002|Interim Analysis|Clinical Progression|1|||
155346843|NCT00296504|560703427|FG003|Interim Analysis|Clinical Progression|1|||
155346844|NCT00296504|560703428|FG004|Interim Analysis|Clinical Progression|0|||
155346845|NCT00296504|560703429|FG005|Interim Analysis|Clinical Progression|2|||
155346846|NCT00296504|560703430|FG006|Interim Analysis|Clinical Progression|1|||
155346847|NCT00296504|560703431|FG007|Interim Analysis|Clinical Progression|2|||
155346848|NCT00296504|560703432|FG008|Interim Analysis|Clinical Progression|0|||
155346849|NCT00296504|560703424|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
155346850|NCT00296504|560703425|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
155346851|NCT00296504|560703426|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
155346852|NCT00296504|560703427|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
155346853|NCT00296504|560703428|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
155346854|NCT00296504|560703429|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
155346855|NCT00296504|560703430|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
155346856|NCT00296504|560703431|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
155346857|NCT00296504|560703432|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
155346858|NCT00296504|560703424|FG000|Interim Analysis|Adverse Event|0|||
155346859|NCT00296504|560703425|FG001|Interim Analysis|Adverse Event|0|||
155346860|NCT00296504|560703426|FG002|Interim Analysis|Adverse Event|13|||
155346861|NCT00296504|560703427|FG003|Interim Analysis|Adverse Event|4|||
155346862|NCT00296504|560703428|FG004|Interim Analysis|Adverse Event|6|||
155346863|NCT00296504|560703429|FG005|Interim Analysis|Adverse Event|3|||
155346864|NCT00296504|560703430|FG006|Interim Analysis|Adverse Event|4|||
155346865|NCT00296504|560703431|FG007|Interim Analysis|Adverse Event|5|||
155346866|NCT00296504|560703432|FG008|Interim Analysis|Adverse Event|0|||
155346867|NCT00296504|560703424|FG000|Interim Analysis|Protocol Violation|0|||
155346868|NCT00296504|560703425|FG001|Interim Analysis|Protocol Violation|0|||
155346869|NCT00296504|560703426|FG002|Interim Analysis|Protocol Violation|2|||
155346870|NCT00296504|560703427|FG003|Interim Analysis|Protocol Violation|0|||
155346871|NCT00296504|560703428|FG004|Interim Analysis|Protocol Violation|1|||
155346872|NCT00296504|560703429|FG005|Interim Analysis|Protocol Violation|0|||
155346873|NCT00296504|560703430|FG006|Interim Analysis|Protocol Violation|0|||
155346874|NCT00296504|560703431|FG007|Interim Analysis|Protocol Violation|1|||
155346875|NCT00296504|560703432|FG008|Interim Analysis|Protocol Violation|0|||
155346876|NCT00296504|560703424|FG000|Interim Analysis|Insufficient CD4 Response|0|||
155346877|NCT00296504|560703425|FG001|Interim Analysis|Insufficient CD4 Response|0|||
155346878|NCT00296504|560703426|FG002|Interim Analysis|Insufficient CD4 Response|0|||
155346879|NCT00296504|560703427|FG003|Interim Analysis|Insufficient CD4 Response|0|||
155346880|NCT00296504|560703428|FG004|Interim Analysis|Insufficient CD4 Response|1|||
155346881|NCT00296504|560703429|FG005|Interim Analysis|Insufficient CD4 Response|1|||
155346882|NCT00296504|560703430|FG006|Interim Analysis|Insufficient CD4 Response|0|||
155346883|NCT00296504|560703431|FG007|Interim Analysis|Insufficient CD4 Response|0|||
155346884|NCT00296504|560703432|FG008|Interim Analysis|Insufficient CD4 Response|0|||
155346885|NCT00296504|560703424|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
155346886|NCT00296504|560703425|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
155346887|NCT00296504|560703426|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
155346888|NCT00296504|560703427|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
155346889|NCT00296504|560703428|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
155346890|NCT00296504|560703429|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
155346891|NCT00296504|560703430|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
155346892|NCT00296504|560703431|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
155346893|NCT00296504|560703432|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
155346894|NCT00296504|560703424|FG000|Interim Analysis|Pregnancy|4|||
155346895|NCT00296504|560703425|FG001|Interim Analysis|Pregnancy|1|||
155346896|NCT00296504|560703426|FG002|Interim Analysis|Pregnancy|4|||
155346897|NCT00296504|560703427|FG003|Interim Analysis|Pregnancy|2|||
155346898|NCT00296504|560703428|FG004|Interim Analysis|Pregnancy|0|||
155346899|NCT00296504|560703429|FG005|Interim Analysis|Pregnancy|1|||
155346900|NCT00296504|560703430|FG006|Interim Analysis|Pregnancy|1|||
155346901|NCT00296504|560703431|FG007|Interim Analysis|Pregnancy|1|||
155346902|NCT00296504|560703432|FG008|Interim Analysis|Pregnancy|0|||
155346903|NCT00296504|560703424|FG000|Interim Analysis|Death|1|||
155647791|NCT03774810|561803682|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
155647792|NCT03774810|561803678|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
155647793|NCT03774810|561803679|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
155647794|NCT03774810|561803680|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
155346904|NCT00296504|560703425|FG001|Interim Analysis|Death|0|||
155346905|NCT00296504|560703426|FG002|Interim Analysis|Death|3|||
155346906|NCT00296504|560703427|FG003|Interim Analysis|Death|0|||
155346907|NCT00296504|560703428|FG004|Interim Analysis|Death|0|||
155346908|NCT00296504|560703429|FG005|Interim Analysis|Death|0|||
155346909|NCT00296504|560703430|FG006|Interim Analysis|Death|0|||
155346910|NCT00296504|560703431|FG007|Interim Analysis|Death|0|||
155346911|NCT00296504|560703432|FG008|Interim Analysis|Death|0|||
155346912|NCT00296504|560703424|FG000|Interim Analysis|Participant Non-compliant|0|||
155346913|NCT00296504|560703425|FG001|Interim Analysis|Participant Non-compliant|1|||
155346914|NCT00296504|560703426|FG002|Interim Analysis|Participant Non-compliant|2|||
155346915|NCT00296504|560703427|FG003|Interim Analysis|Participant Non-compliant|1|||
155346916|NCT00296504|560703428|FG004|Interim Analysis|Participant Non-compliant|1|||
155346917|NCT00296504|560703429|FG005|Interim Analysis|Participant Non-compliant|3|||
155346918|NCT00296504|560703430|FG006|Interim Analysis|Participant Non-compliant|6|||
155346919|NCT00296504|560703431|FG007|Interim Analysis|Participant Non-compliant|2|||
155346920|NCT00296504|560703432|FG008|Interim Analysis|Participant Non-compliant|0|||
155346921|NCT00296504|560703424|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346922|NCT00296504|560703425|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346923|NCT00296504|560703426|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
155346924|NCT00296504|560703427|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346925|NCT00296504|560703428|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155424539|NCT00868790|560982413|FG006|Period 1|Lost to Follow-up|0|||
155424540|NCT00868790|560982414|FG007|Period 1|Lost to Follow-up|0|||
155424541|NCT00868790|560982415|FG008|Period 1|Lost to Follow-up|0|||
155424542|NCT00868790|560982416|FG009|Period 1|Lost to Follow-up|0|||
155424543|NCT00868790|560982417|FG010|Period 1|Lost to Follow-up|0|||
155424544|NCT00868790|560982418|FG011|Period 1|Lost to Follow-up|0|||
155424545|NCT00868790|560982419|FG012|Period 1|Lost to Follow-up|0|||
155424546|NCT00868790|560982420|FG013|Period 1|Lost to Follow-up|0|||
155424547|NCT00868790|560982407|FG000|Period 2|Adverse Event|0|||
155424548|NCT00868790|560982408|FG001|Period 2|Adverse Event|0|||
155424549|NCT00868790|560982409|FG002|Period 2|Adverse Event|0|||
155424550|NCT00868790|560982410|FG003|Period 2|Adverse Event|0|||
155424551|NCT00868790|560982411|FG004|Period 2|Adverse Event|0|||
155346926|NCT00296504|560703429|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
155346927|NCT00296504|560703430|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346928|NCT00296504|560703431|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346929|NCT00296504|560703432|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346930|NCT00296504|560703424|FG000|Interim Analysis|To Simplify Treatment|0|||
155346931|NCT00296504|560703425|FG001|Interim Analysis|To Simplify Treatment|0|||
155346932|NCT00296504|560703426|FG002|Interim Analysis|To Simplify Treatment|1|||
155346933|NCT00296504|560703427|FG003|Interim Analysis|To Simplify Treatment|0|||
155346934|NCT00296504|560703428|FG004|Interim Analysis|To Simplify Treatment|0|||
155346935|NCT00296504|560703429|FG005|Interim Analysis|To Simplify Treatment|0|||
155346936|NCT00296504|560703430|FG006|Interim Analysis|To Simplify Treatment|2|||
155346937|NCT00296504|560703431|FG007|Interim Analysis|To Simplify Treatment|0|||
155346938|NCT00296504|560703432|FG008|Interim Analysis|To Simplify Treatment|0|||
155346939|NCT00296504|560703424|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346940|NCT00296504|560703425|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346941|NCT00296504|560703426|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
155346942|NCT00296504|560703427|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346943|NCT00296504|560703428|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346944|NCT00296504|560703429|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346945|NCT00296504|560703430|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346946|NCT00296504|560703431|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346947|NCT00296504|560703432|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346948|NCT00296504|560703424|FG000|Interim Analysis|Participant Moved|1|||
155346949|NCT00296504|560703425|FG001|Interim Analysis|Participant Moved|0|||
155346950|NCT00296504|560703426|FG002|Interim Analysis|Participant Moved|1|||
155346951|NCT00296504|560703427|FG003|Interim Analysis|Participant Moved|0|||
155346952|NCT00296504|560703428|FG004|Interim Analysis|Participant Moved|0|||
155346953|NCT00296504|560703429|FG005|Interim Analysis|Participant Moved|1|||
155346954|NCT00296504|560703430|FG006|Interim Analysis|Participant Moved|1|||
155346955|NCT00296504|560703431|FG007|Interim Analysis|Participant Moved|0|||
155346956|NCT00296504|560703432|FG008|Interim Analysis|Participant Moved|0|||
155346957|NCT00296504|560703424|FG000|Interim Analysis|Participant Was Incarcerated|2|||
155346958|NCT00296504|560703425|FG001|Interim Analysis|Participant Was Incarcerated|0|||
155346959|NCT00296504|560703426|FG002|Interim Analysis|Participant Was Incarcerated|1|||
155346960|NCT00296504|560703427|FG003|Interim Analysis|Participant Was Incarcerated|0|||
155346961|NCT00296504|560703428|FG004|Interim Analysis|Participant Was Incarcerated|0|||
155346962|NCT00296504|560703429|FG005|Interim Analysis|Participant Was Incarcerated|0|||
155346963|NCT00296504|560703430|FG006|Interim Analysis|Participant Was Incarcerated|0|||
155346964|NCT00296504|560703431|FG007|Interim Analysis|Participant Was Incarcerated|0|||
155346965|NCT00296504|560703432|FG008|Interim Analysis|Participant Was Incarcerated|0|||
155424552|NCT00868790|560982412|FG005|Period 2|Adverse Event|0|||
155424553|NCT00868790|560982413|FG006|Period 2|Adverse Event|0|||
155505878|NCT01374906|561278276|FG000|Overall Study|Administrative problems|2|||
155424554|NCT00868790|560982414|FG007|Period 2|Adverse Event|0|||
155424555|NCT00868790|560982415|FG008|Period 2|Adverse Event|1|||
155346966|NCT00296504|560703424|FG000|Interim Analysis|Resistance to FPV|0|||
155346967|NCT00296504|560703425|FG001|Interim Analysis|Resistance to FPV|0|||
155346968|NCT00296504|560703426|FG002|Interim Analysis|Resistance to FPV|1|||
155346969|NCT00296504|560703427|FG003|Interim Analysis|Resistance to FPV|0|||
155346970|NCT00296504|560703428|FG004|Interim Analysis|Resistance to FPV|0|||
155346971|NCT00296504|560703429|FG005|Interim Analysis|Resistance to FPV|0|||
155346972|NCT00296504|560703430|FG006|Interim Analysis|Resistance to FPV|0|||
155424556|NCT00868790|560982416|FG009|Period 2|Adverse Event|0|||
155424557|NCT00868790|560982417|FG010|Period 2|Adverse Event|0|||
155346973|NCT00296504|560703431|FG007|Interim Analysis|Resistance to FPV|0|||
155346974|NCT00296504|560703432|FG008|Interim Analysis|Resistance to FPV|0|||
155346975|NCT00296504|560703424|FG000|Interim Analysis|Physician Decision|0|||
155346976|NCT00296504|560703425|FG001|Interim Analysis|Physician Decision|0|||
155346977|NCT00296504|560703426|FG002|Interim Analysis|Physician Decision|1|||
155346978|NCT00296504|560703427|FG003|Interim Analysis|Physician Decision|0|||
155346979|NCT00296504|560703428|FG004|Interim Analysis|Physician Decision|0|||
155346980|NCT00296504|560703429|FG005|Interim Analysis|Physician Decision|0|||
155346981|NCT00296504|560703430|FG006|Interim Analysis|Physician Decision|0|||
155346982|NCT00296504|560703431|FG007|Interim Analysis|Physician Decision|0|||
155346983|NCT00296504|560703432|FG008|Interim Analysis|Physician Decision|0|||
155346984|NCT00296504|560703424|FG000|Interim Analysis|Principle Investigator Discretion|2|||
155346985|NCT00296504|560703425|FG001|Interim Analysis|Principle Investigator Discretion|0|||
155346986|NCT00296504|560703426|FG002|Interim Analysis|Principle Investigator Discretion|1|||
155346987|NCT00296504|560703427|FG003|Interim Analysis|Principle Investigator Discretion|1|||
155346988|NCT00296504|560703428|FG004|Interim Analysis|Principle Investigator Discretion|0|||
155346989|NCT00296504|560703429|FG005|Interim Analysis|Principle Investigator Discretion|0|||
155346990|NCT00296504|560703430|FG006|Interim Analysis|Principle Investigator Discretion|0|||
155424558|NCT00868790|560982418|FG011|Period 2|Adverse Event|0|||
155424559|NCT00868790|560982419|FG012|Period 2|Adverse Event|0|||
155424560|NCT00868790|560982420|FG013|Period 2|Adverse Event|0|||
155424561|NCT00868790|560982407|FG000|Period 2|Lost to Follow-up|0|||
155424562|NCT00868790|560982408|FG001|Period 2|Lost to Follow-up|1|||
155424563|NCT00868790|560982409|FG002|Period 2|Lost to Follow-up|0|||
155424564|NCT00868790|560982410|FG003|Period 2|Lost to Follow-up|0|||
155424565|NCT00868790|560982411|FG004|Period 2|Lost to Follow-up|0|||
155424566|NCT00868790|560982412|FG005|Period 2|Lost to Follow-up|1|||
155424567|NCT00868790|560982413|FG006|Period 2|Lost to Follow-up|0|||
155424568|NCT00868790|560982414|FG007|Period 2|Lost to Follow-up|0|||
155424569|NCT00868790|560982415|FG008|Period 2|Lost to Follow-up|0|||
155424570|NCT00868790|560982416|FG009|Period 2|Lost to Follow-up|0|||
155424571|NCT00868790|560982417|FG010|Period 2|Lost to Follow-up|0|||
155424572|NCT00868790|560982418|FG011|Period 2|Lost to Follow-up|0|||
155424573|NCT00868790|560982419|FG012|Period 2|Lost to Follow-up|0|||
155424574|NCT00868790|560982420|FG013|Period 2|Lost to Follow-up|0|||
155424575|NCT00868790|560982407|FG000|Period 2|Withdrawal by Subject|0|||
155424576|NCT00868790|560982408|FG001|Period 2|Withdrawal by Subject|0|||
155424577|NCT00868790|560982409|FG002|Period 2|Withdrawal by Subject|0|||
155424578|NCT00868790|560982410|FG003|Period 2|Withdrawal by Subject|0|||
155424579|NCT00868790|560982411|FG004|Period 2|Withdrawal by Subject|0|||
155424580|NCT00868790|560982412|FG005|Period 2|Withdrawal by Subject|0|||
155424581|NCT00868790|560982413|FG006|Period 2|Withdrawal by Subject|0|||
155424582|NCT00868790|560982414|FG007|Period 2|Withdrawal by Subject|0|||
155424583|NCT00868790|560982415|FG008|Period 2|Withdrawal by Subject|1|||
155424584|NCT00868790|560982416|FG009|Period 2|Withdrawal by Subject|0|||
155424585|NCT00868790|560982417|FG010|Period 2|Withdrawal by Subject|0|||
155505879|NCT01374906|561278277|FG001|Overall Study|Administrative problems|2|||
155424586|NCT00868790|560982418|FG011|Period 2|Withdrawal by Subject|0|||
155424587|NCT00868790|560982419|FG012|Period 2|Withdrawal by Subject|0|||
155424588|NCT00868790|560982420|FG013|Period 2|Withdrawal by Subject|1|||
155424589|NCT00868790|560982407|FG000|Period 3|Adverse Event|0|||
155424590|NCT00868790|560982408|FG001|Period 3|Adverse Event|0|||
155424591|NCT00868790|560982409|FG002|Period 3|Adverse Event|0|||
155424592|NCT00868790|560982410|FG003|Period 3|Adverse Event|0|||
155424593|NCT00868790|560982411|FG004|Period 3|Adverse Event|0|||
155424594|NCT00868790|560982412|FG005|Period 3|Adverse Event|0|||
155424595|NCT00868790|560982413|FG006|Period 3|Adverse Event|0|||
155505880|NCT01374906|561278276|FG000|Overall Study|Adverse Event|10|||
155505881|NCT01374906|561278277|FG001|Overall Study|Adverse Event|11|||
155505882|NCT01374906|561278276|FG000|Overall Study|Death|0|||
155505883|NCT01374906|561278277|FG001|Overall Study|Death|2|||
155505884|NCT01374906|561278276|FG000|Overall Study|Protocol Violation|2|||
155505885|NCT01374906|561278277|FG001|Overall Study|Protocol Violation|2|||
155505886|NCT01374906|561278276|FG000|Overall Study|Withdrawal by Subject|15|||
155505887|NCT01374906|561278277|FG001|Overall Study|Withdrawal by Subject|9|||
155505888|NCT01374906|561278276|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
155505889|NCT01374906|561278277|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
155505890|NCT00435825|561278280|FG000|Overall Study|Abnormality of Laboratory Test|0|||
155505891|NCT00435825|561278281|FG001|Overall Study|Abnormality of Laboratory Test|1|||
155505892|NCT00435825|561278282|FG002|Overall Study|Abnormality of Laboratory Test|0|||
155505893|NCT00435825|561278283|FG003|Overall Study|Abnormality of Laboratory Test|0|||
155505894|NCT00435825|561278280|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155505895|NCT00435825|561278281|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155424596|NCT00868790|560982414|FG007|Period 3|Adverse Event|0|||
155424597|NCT00868790|560982415|FG008|Period 3|Adverse Event|0|||
155424598|NCT00868790|560982416|FG009|Period 3|Adverse Event|1|||
155424599|NCT00868790|560982417|FG010|Period 3|Adverse Event|0|||
155424600|NCT00868790|560982418|FG011|Period 3|Adverse Event|0|||
155424601|NCT00868790|560982419|FG012|Period 3|Adverse Event|0|||
155424602|NCT00868790|560982420|FG013|Period 3|Adverse Event|0|||
155424603|NCT00868790|560982407|FG000|Period 3|Protocol Violation|0|||
155424604|NCT00868790|560982408|FG001|Period 3|Protocol Violation|0|||
155424605|NCT00868790|560982409|FG002|Period 3|Protocol Violation|0|||
155424606|NCT00868790|560982410|FG003|Period 3|Protocol Violation|0|||
155424607|NCT00868790|560982411|FG004|Period 3|Protocol Violation|0|||
155424608|NCT00868790|560982412|FG005|Period 3|Protocol Violation|0|||
155424609|NCT00868790|560982413|FG006|Period 3|Protocol Violation|0|||
155424610|NCT00868790|560982414|FG007|Period 3|Protocol Violation|0|||
155424611|NCT00868790|560982415|FG008|Period 3|Protocol Violation|0|||
155424612|NCT00868790|560982416|FG009|Period 3|Protocol Violation|0|||
155424613|NCT00868790|560982417|FG010|Period 3|Protocol Violation|1|||
155424614|NCT00868790|560982418|FG011|Period 3|Protocol Violation|0|||
155424615|NCT00868790|560982419|FG012|Period 3|Protocol Violation|0|||
155424616|NCT00868790|560982420|FG013|Period 3|Protocol Violation|0|||
155424617|NCT00868790|560982407|FG000|Period 3|Study Terminated by Sponsor|0|||
155424618|NCT00868790|560982408|FG001|Period 3|Study Terminated by Sponsor|0|||
155424619|NCT00868790|560982409|FG002|Period 3|Study Terminated by Sponsor|0|||
155424620|NCT00868790|560982410|FG003|Period 3|Study Terminated by Sponsor|1|||
155424621|NCT00868790|560982411|FG004|Period 3|Study Terminated by Sponsor|0|||
155424622|NCT00868790|560982412|FG005|Period 3|Study Terminated by Sponsor|0|||
155424623|NCT00868790|560982413|FG006|Period 3|Study Terminated by Sponsor|0|||
155424624|NCT00868790|560982414|FG007|Period 3|Study Terminated by Sponsor|0|||
155424625|NCT00868790|560982415|FG008|Period 3|Study Terminated by Sponsor|0|||
155424626|NCT00868790|560982416|FG009|Period 3|Study Terminated by Sponsor|0|||
155424627|NCT00868790|560982417|FG010|Period 3|Study Terminated by Sponsor|0|||
155424628|NCT00868790|560982418|FG011|Period 3|Study Terminated by Sponsor|0|||
155424629|NCT00868790|560982419|FG012|Period 3|Study Terminated by Sponsor|0|||
155424630|NCT00868790|560982420|FG013|Period 3|Study Terminated by Sponsor|0|||
155424631|NCT00868790|560982407|FG000|Period 4|Adverse Event|0|||
155424632|NCT00868790|560982408|FG001|Period 4|Adverse Event|0|||
155424633|NCT00868790|560982409|FG002|Period 4|Adverse Event|0|||
155424634|NCT00868790|560982410|FG003|Period 4|Adverse Event|0|||
155424635|NCT00868790|560982411|FG004|Period 4|Adverse Event|0|||
155424636|NCT00868790|560982412|FG005|Period 4|Adverse Event|0|||
155424637|NCT00868790|560982413|FG006|Period 4|Adverse Event|0|||
155424638|NCT00868790|560982414|FG007|Period 4|Adverse Event|1|||
155424639|NCT00868790|560982415|FG008|Period 4|Adverse Event|0|||
155424640|NCT00868790|560982416|FG009|Period 4|Adverse Event|0|||
155505896|NCT00435825|561278282|FG002|Overall Study|Insufficient Therapeutic Response|0|||
155505897|NCT00435825|561278283|FG003|Overall Study|Insufficient Therapeutic Response|3|||
155647795|NCT03774810|561803681|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
155647796|NCT03774810|561803682|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
155346991|NCT00296504|560703431|FG007|Interim Analysis|Principle Investigator Discretion|0|||
155346992|NCT00296504|560703432|FG008|Interim Analysis|Principle Investigator Discretion|0|||
155346993|NCT00296504|560703424|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
155346994|NCT00296504|560703425|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
155346995|NCT00296504|560703426|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
155346996|NCT00296504|560703427|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
155346997|NCT00296504|560703428|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
155346998|NCT00296504|560703429|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
155346999|NCT00296504|560703430|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
155347000|NCT00296504|560703431|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
155347001|NCT00296504|560703432|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
155347002|NCT00296504|560703424|FG000|Interim Analysis|Non-adherence|2|||
155347003|NCT00296504|560703425|FG001|Interim Analysis|Non-adherence|0|||
155505898|NCT00435825|561278280|FG000|Overall Study|Other Protocol Violation|1|||
155347004|NCT00296504|560703426|FG002|Interim Analysis|Non-adherence|0|||
155347005|NCT00296504|560703427|FG003|Interim Analysis|Non-adherence|0|||
155347006|NCT00296504|560703428|FG004|Interim Analysis|Non-adherence|1|||
155347007|NCT00296504|560703429|FG005|Interim Analysis|Non-adherence|0|||
155347008|NCT00296504|560703430|FG006|Interim Analysis|Non-adherence|0|||
155347009|NCT00296504|560703431|FG007|Interim Analysis|Non-adherence|1|||
155347010|NCT00296504|560703432|FG008|Interim Analysis|Non-adherence|0|||
155347011|NCT00296504|560703424|FG000|Interim Analysis|Site Closing|1|||
155347012|NCT00296504|560703425|FG001|Interim Analysis|Site Closing|0|||
155347013|NCT00296504|560703426|FG002|Interim Analysis|Site Closing|0|||
155347014|NCT00296504|560703427|FG003|Interim Analysis|Site Closing|0|||
155347015|NCT00296504|560703428|FG004|Interim Analysis|Site Closing|0|||
155347016|NCT00296504|560703429|FG005|Interim Analysis|Site Closing|1|||
155347017|NCT00296504|560703430|FG006|Interim Analysis|Site Closing|2|||
155347018|NCT00296504|560703431|FG007|Interim Analysis|Site Closing|0|||
155347019|NCT00296504|560703432|FG008|Interim Analysis|Site Closing|0|||
155347020|NCT00296504|560703424|FG000|Interim Analysis|Lack of Personnel at Site|1|||
155347021|NCT00296504|560703425|FG001|Interim Analysis|Lack of Personnel at Site|0|||
155347022|NCT00296504|560703426|FG002|Interim Analysis|Lack of Personnel at Site|0|||
155347023|NCT00296504|560703427|FG003|Interim Analysis|Lack of Personnel at Site|0|||
155347024|NCT00296504|560703428|FG004|Interim Analysis|Lack of Personnel at Site|0|||
155347025|NCT00296504|560703429|FG005|Interim Analysis|Lack of Personnel at Site|0|||
155347026|NCT00296504|560703430|FG006|Interim Analysis|Lack of Personnel at Site|0|||
155347027|NCT00296504|560703431|FG007|Interim Analysis|Lack of Personnel at Site|0|||
155347028|NCT00296504|560703432|FG008|Interim Analysis|Lack of Personnel at Site|0|||
155347029|NCT00296504|560703424|FG000|Interim Analysis|Missed Schedule Date|1|||
155347030|NCT00296504|560703425|FG001|Interim Analysis|Missed Schedule Date|0|||
155347031|NCT00296504|560703426|FG002|Interim Analysis|Missed Schedule Date|0|||
155347032|NCT00296504|560703427|FG003|Interim Analysis|Missed Schedule Date|0|||
155347033|NCT00296504|560703428|FG004|Interim Analysis|Missed Schedule Date|0|||
155347034|NCT00296504|560703429|FG005|Interim Analysis|Missed Schedule Date|0|||
155347035|NCT00296504|560703430|FG006|Interim Analysis|Missed Schedule Date|0|||
155347036|NCT00296504|560703431|FG007|Interim Analysis|Missed Schedule Date|0|||
155347037|NCT00296504|560703432|FG008|Interim Analysis|Missed Schedule Date|0|||
155347038|NCT00296504|560703424|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
155347039|NCT00296504|560703425|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
155424641|NCT00868790|560982417|FG010|Period 4|Adverse Event|1|||
155347040|NCT00296504|560703426|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
155347041|NCT00296504|560703427|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
155347042|NCT00296504|560703428|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
155347043|NCT00296504|560703429|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
155347044|NCT00296504|560703430|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
155505899|NCT00435825|561278281|FG001|Overall Study|Other Protocol Violation|0|||
155347045|NCT00296504|560703431|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
155347046|NCT00296504|560703432|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
155347047|NCT00296504|560703424|FG000|Interim Analysis|Participant Stopped|0|||
155347048|NCT00296504|560703425|FG001|Interim Analysis|Participant Stopped|0|||
155347049|NCT00296504|560703426|FG002|Interim Analysis|Participant Stopped|0|||
155347050|NCT00296504|560703427|FG003|Interim Analysis|Participant Stopped|0|||
155347051|NCT00296504|560703428|FG004|Interim Analysis|Participant Stopped|1|||
155347052|NCT00296504|560703429|FG005|Interim Analysis|Participant Stopped|0|||
155347053|NCT00296504|560703430|FG006|Interim Analysis|Participant Stopped|0|||
155347054|NCT00296504|560703431|FG007|Interim Analysis|Participant Stopped|0|||
155347055|NCT00296504|560703432|FG008|Interim Analysis|Participant Stopped|0|||
155347056|NCT00296504|560703424|FG000|Interim Analysis|Physician and Participant Decision|0|||
155347057|NCT00296504|560703425|FG001|Interim Analysis|Physician and Participant Decision|0|||
155347058|NCT00296504|560703426|FG002|Interim Analysis|Physician and Participant Decision|0|||
155347059|NCT00296504|560703427|FG003|Interim Analysis|Physician and Participant Decision|0|||
155347060|NCT00296504|560703428|FG004|Interim Analysis|Physician and Participant Decision|0|||
155347061|NCT00296504|560703429|FG005|Interim Analysis|Physician and Participant Decision|1|||
155347062|NCT00296504|560703430|FG006|Interim Analysis|Physician and Participant Decision|0|||
155347063|NCT00296504|560703431|FG007|Interim Analysis|Physician and Participant Decision|0|||
155347064|NCT00296504|560703432|FG008|Interim Analysis|Physician and Participant Decision|0|||
155347065|NCT00296504|560703424|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
155347066|NCT00296504|560703425|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
155347067|NCT00296504|560703426|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
155347068|NCT00296504|560703427|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
155347069|NCT00296504|560703428|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
155347070|NCT00296504|560703429|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
155347071|NCT00296504|560703430|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
155505900|NCT00435825|561278282|FG002|Overall Study|Other Protocol Violation|0|||
155505901|NCT00435825|561278283|FG003|Overall Study|Other Protocol Violation|0|||
155505902|NCT00435825|561278280|FG000|Overall Study|Refused treatment|2|||
155505903|NCT00435825|561278281|FG001|Overall Study|Refused treatment|0|||
155505904|NCT00435825|561278282|FG002|Overall Study|Refused treatment|0|||
155505905|NCT00435825|561278283|FG003|Overall Study|Refused treatment|5|||
155505906|NCT00435825|561278280|FG000|Overall Study|Failure to return|5|||
155505907|NCT00435825|561278281|FG001|Overall Study|Failure to return|0|||
155505908|NCT00435825|561278282|FG002|Overall Study|Failure to return|4|||
155505909|NCT00435825|561278283|FG003|Overall Study|Failure to return|0|||
155505910|NCT00435825|561278280|FG000|Overall Study|Did not receive study drug|1|||
155505911|NCT00435825|561278281|FG001|Overall Study|Did not receive study drug|0|||
155505912|NCT00435825|561278282|FG002|Overall Study|Did not receive study drug|2|||
155505913|NCT00435825|561278283|FG003|Overall Study|Did not receive study drug|0|||
155505914|NCT00435825|561278280|FG000|Overall Study|Did not enter follow-up|0|||
155647797|NCT03774810|561803678|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
155647798|NCT03774810|561803679|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
155505915|NCT00435825|561278281|FG001|Overall Study|Did not enter follow-up|4|||
155505916|NCT00435825|561278282|FG002|Overall Study|Did not enter follow-up|1|||
155505917|NCT00435825|561278283|FG003|Overall Study|Did not enter follow-up|3|||
155347072|NCT00296504|560703431|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
155347073|NCT00296504|560703432|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
155505918|NCT00435825|561278280|FG000|Overall Study|Did not complete full follow-up period|6|||
155505919|NCT00435825|561278281|FG001|Overall Study|Did not complete full follow-up period|6|||
155347074|NCT00296504|560703424|FG000|Interim Analysis|Study Ended|0|||
155347075|NCT00296504|560703425|FG001|Interim Analysis|Study Ended|0|||
155347076|NCT00296504|560703426|FG002|Interim Analysis|Study Ended|0|||
155347077|NCT00296504|560703427|FG003|Interim Analysis|Study Ended|0|||
155347078|NCT00296504|560703428|FG004|Interim Analysis|Study Ended|0|||
155347079|NCT00296504|560703429|FG005|Interim Analysis|Study Ended|0|||
155347080|NCT00296504|560703430|FG006|Interim Analysis|Study Ended|1|||
155347081|NCT00296504|560703431|FG007|Interim Analysis|Study Ended|0|||
155347082|NCT00296504|560703432|FG008|Interim Analysis|Study Ended|0|||
155347083|NCT00296504|560703424|FG000|Interim Analysis|Participant Needed Interferon|0|||
155347084|NCT00296504|560703425|FG001|Interim Analysis|Participant Needed Interferon|0|||
155347085|NCT00296504|560703426|FG002|Interim Analysis|Participant Needed Interferon|0|||
155347086|NCT00296504|560703427|FG003|Interim Analysis|Participant Needed Interferon|0|||
155347087|NCT00296504|560703428|FG004|Interim Analysis|Participant Needed Interferon|0|||
155347088|NCT00296504|560703429|FG005|Interim Analysis|Participant Needed Interferon|0|||
155347089|NCT00296504|560703430|FG006|Interim Analysis|Participant Needed Interferon|0|||
155347090|NCT00296504|560703431|FG007|Interim Analysis|Participant Needed Interferon|1|||
155347091|NCT00296504|560703432|FG008|Interim Analysis|Participant Needed Interferon|0|||
155347092|NCT00296504|560703424|FG000|Interim Analysis|Ongoing|32|||
155347093|NCT00296504|560703425|FG001|Interim Analysis|Ongoing|12|||
155347094|NCT00296504|560703426|FG002|Interim Analysis|Ongoing|16|||
155347095|NCT00296504|560703427|FG003|Interim Analysis|Ongoing|22|||
155347096|NCT00296504|560703428|FG004|Interim Analysis|Ongoing|0|||
155347097|NCT00296504|560703429|FG005|Interim Analysis|Ongoing|0|||
155347098|NCT00296504|560703430|FG006|Interim Analysis|Ongoing|30|||
155347099|NCT00296504|560703431|FG007|Interim Analysis|Ongoing|1|||
155347100|NCT00296504|560703432|FG008|Interim Analysis|Ongoing|0|||
155347101|NCT00296504|560703424|FG000|Final Analysis|Withdrawal by Subject|0|||
155347102|NCT00296504|560703425|FG001|Final Analysis|Withdrawal by Subject|0|||
155347103|NCT00296504|560703426|FG002|Final Analysis|Withdrawal by Subject|0|||
155347104|NCT00296504|560703427|FG003|Final Analysis|Withdrawal by Subject|0|||
155347105|NCT00296504|560703428|FG004|Final Analysis|Withdrawal by Subject|0|||
155347106|NCT00296504|560703429|FG005|Final Analysis|Withdrawal by Subject|0|||
155347107|NCT00296504|560703430|FG006|Final Analysis|Withdrawal by Subject|0|||
155347108|NCT00296504|560703431|FG007|Final Analysis|Withdrawal by Subject|0|||
155347109|NCT00296504|560703432|FG008|Final Analysis|Withdrawal by Subject|1|||
155347110|NCT00296504|560703424|FG000|Final Analysis|Lost to Follow-up|0|||
155347111|NCT00296504|560703425|FG001|Final Analysis|Lost to Follow-up|0|||
155347112|NCT00296504|560703426|FG002|Final Analysis|Lost to Follow-up|0|||
155347113|NCT00296504|560703427|FG003|Final Analysis|Lost to Follow-up|0|||
155347114|NCT00296504|560703428|FG004|Final Analysis|Lost to Follow-up|0|||
155347115|NCT00296504|560703429|FG005|Final Analysis|Lost to Follow-up|0|||
155347116|NCT00296504|560703430|FG006|Final Analysis|Lost to Follow-up|0|||
155347117|NCT00296504|560703431|FG007|Final Analysis|Lost to Follow-up|0|||
155347118|NCT00296504|560703432|FG008|Final Analysis|Lost to Follow-up|5|||
155347119|NCT00296504|560703424|FG000|Final Analysis|Insufficient Viral Load Response|0|||
155347120|NCT00296504|560703425|FG001|Final Analysis|Insufficient Viral Load Response|0|||
155347121|NCT00296504|560703426|FG002|Final Analysis|Insufficient Viral Load Response|0|||
155347122|NCT00296504|560703427|FG003|Final Analysis|Insufficient Viral Load Response|0|||
155347123|NCT00296504|560703428|FG004|Final Analysis|Insufficient Viral Load Response|0|||
155347124|NCT00296504|560703429|FG005|Final Analysis|Insufficient Viral Load Response|0|||
155347125|NCT00296504|560703430|FG006|Final Analysis|Insufficient Viral Load Response|0|||
155347126|NCT00296504|560703431|FG007|Final Analysis|Insufficient Viral Load Response|0|||
155347127|NCT00296504|560703432|FG008|Final Analysis|Insufficient Viral Load Response|6|||
155347128|NCT00296504|560703424|FG000|Final Analysis|Adverse Event|0|||
155347129|NCT00296504|560703425|FG001|Final Analysis|Adverse Event|0|||
155347130|NCT00296504|560703426|FG002|Final Analysis|Adverse Event|0|||
155347131|NCT00296504|560703427|FG003|Final Analysis|Adverse Event|0|||
155424642|NCT00868790|560982418|FG011|Period 4|Adverse Event|0|||
155424643|NCT00868790|560982419|FG012|Period 4|Adverse Event|1|||
155424644|NCT00868790|560982420|FG013|Period 4|Adverse Event|0|||
155424645|NCT00868790|560982407|FG000|Period 4|Lost to Follow-up|0|||
155424646|NCT00868790|560982408|FG001|Period 4|Lost to Follow-up|0|||
155424647|NCT00868790|560982409|FG002|Period 4|Lost to Follow-up|0|||
155424648|NCT00868790|560982410|FG003|Period 4|Lost to Follow-up|0|||
155424649|NCT00868790|560982411|FG004|Period 4|Lost to Follow-up|0|||
155424650|NCT00868790|560982412|FG005|Period 4|Lost to Follow-up|0|||
155424651|NCT00868790|560982413|FG006|Period 4|Lost to Follow-up|0|||
155424652|NCT00868790|560982414|FG007|Period 4|Lost to Follow-up|1|||
155424653|NCT00868790|560982415|FG008|Period 4|Lost to Follow-up|0|||
155424654|NCT00868790|560982416|FG009|Period 4|Lost to Follow-up|0|||
155424655|NCT00868790|560982417|FG010|Period 4|Lost to Follow-up|0|||
155424656|NCT00868790|560982418|FG011|Period 4|Lost to Follow-up|0|||
155424657|NCT00868790|560982419|FG012|Period 4|Lost to Follow-up|0|||
155424658|NCT00868790|560982420|FG013|Period 4|Lost to Follow-up|0|||
155424659|NCT00868790|560982407|FG000|Period 4|Study Terminated by Sponsor|2|||
155424660|NCT00868790|560982408|FG001|Period 4|Study Terminated by Sponsor|0|||
155424661|NCT00868790|560982409|FG002|Period 4|Study Terminated by Sponsor|0|||
155424662|NCT00868790|560982410|FG003|Period 4|Study Terminated by Sponsor|0|||
155424663|NCT00868790|560982411|FG004|Period 4|Study Terminated by Sponsor|0|||
155424664|NCT00868790|560982412|FG005|Period 4|Study Terminated by Sponsor|0|||
155424665|NCT00868790|560982413|FG006|Period 4|Study Terminated by Sponsor|0|||
155424666|NCT00868790|560982414|FG007|Period 4|Study Terminated by Sponsor|1|||
155424667|NCT00868790|560982415|FG008|Period 4|Study Terminated by Sponsor|2|||
155424668|NCT00868790|560982416|FG009|Period 4|Study Terminated by Sponsor|0|||
155424669|NCT00868790|560982417|FG010|Period 4|Study Terminated by Sponsor|2|||
155424670|NCT00868790|560982418|FG011|Period 4|Study Terminated by Sponsor|1|||
155424671|NCT00868790|560982419|FG012|Period 4|Study Terminated by Sponsor|0|||
155424672|NCT00868790|560982420|FG013|Period 4|Study Terminated by Sponsor|1|||
155424673|NCT00868790|560982407|FG000|Period 4|Abnormal ALT/AST|0|||
155424674|NCT00868790|560982408|FG001|Period 4|Abnormal ALT/AST|0|||
155424675|NCT00868790|560982409|FG002|Period 4|Abnormal ALT/AST|1|||
155424676|NCT00868790|560982410|FG003|Period 4|Abnormal ALT/AST|0|||
155424677|NCT00868790|560982411|FG004|Period 4|Abnormal ALT/AST|0|||
155424678|NCT00868790|560982412|FG005|Period 4|Abnormal ALT/AST|0|||
155424679|NCT00868790|560982413|FG006|Period 4|Abnormal ALT/AST|0|||
155424680|NCT00868790|560982414|FG007|Period 4|Abnormal ALT/AST|0|||
155424681|NCT00868790|560982415|FG008|Period 4|Abnormal ALT/AST|0|||
155424682|NCT00868790|560982416|FG009|Period 4|Abnormal ALT/AST|0|||
155424683|NCT00868790|560982417|FG010|Period 4|Abnormal ALT/AST|0|||
155424684|NCT00868790|560982418|FG011|Period 4|Abnormal ALT/AST|0|||
155424685|NCT00868790|560982419|FG012|Period 4|Abnormal ALT/AST|0|||
155424686|NCT00868790|560982420|FG013|Period 4|Abnormal ALT/AST|0|||
155424687|NCT00868790|560982407|FG000|Post-study|Withdrawal by Subject|0|||
155424688|NCT00868790|560982408|FG001|Post-study|Withdrawal by Subject|0|||
155424689|NCT00868790|560982409|FG002|Post-study|Withdrawal by Subject|0|||
155424690|NCT00868790|560982410|FG003|Post-study|Withdrawal by Subject|0|||
155424691|NCT00868790|560982411|FG004|Post-study|Withdrawal by Subject|1|||
155424692|NCT00868790|560982412|FG005|Post-study|Withdrawal by Subject|0|||
155424693|NCT00868790|560982413|FG006|Post-study|Withdrawal by Subject|0|||
155424694|NCT00868790|560982414|FG007|Post-study|Withdrawal by Subject|0|||
155647799|NCT03774810|561803680|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
155647800|NCT03774810|561803681|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
155647801|NCT03774810|561803682|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
155647802|NCT03774810|561803678|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
155647803|NCT03774810|561803679|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
155424695|NCT00868790|560982415|FG008|Post-study|Withdrawal by Subject|0|||
155424696|NCT00868790|560982416|FG009|Post-study|Withdrawal by Subject|0|||
155424697|NCT00868790|560982417|FG010|Post-study|Withdrawal by Subject|0|||
155424698|NCT00868790|560982418|FG011|Post-study|Withdrawal by Subject|0|||
155424699|NCT00868790|560982419|FG012|Post-study|Withdrawal by Subject|0|||
155424700|NCT00868790|560982420|FG013|Post-study|Withdrawal by Subject|0|||
155424701|NCT00868790|560982407|FG000|Post-study|Excluded Medication|0|||
155424702|NCT00868790|560982408|FG001|Post-study|Excluded Medication|0|||
155424703|NCT00868790|560982409|FG002|Post-study|Excluded Medication|0|||
155424704|NCT00868790|560982410|FG003|Post-study|Excluded Medication|0|||
155424705|NCT00868790|560982411|FG004|Post-study|Excluded Medication|0|||
155424706|NCT00868790|560982412|FG005|Post-study|Excluded Medication|0|||
155424707|NCT00868790|560982413|FG006|Post-study|Excluded Medication|0|||
155424708|NCT00868790|560982414|FG007|Post-study|Excluded Medication|2|||
155424709|NCT00868790|560982415|FG008|Post-study|Excluded Medication|0|||
155424710|NCT00868790|560982416|FG009|Post-study|Excluded Medication|1|||
155424711|NCT00868790|560982417|FG010|Post-study|Excluded Medication|0|||
155424712|NCT00868790|560982418|FG011|Post-study|Excluded Medication|0|||
155424713|NCT00868790|560982419|FG012|Post-study|Excluded Medication|0|||
155424714|NCT00868790|560982420|FG013|Post-study|Excluded Medication|0|||
155424715|NCT01264939|560982421|FG000|Overall Study|Adverse Event|1|||
155424716|NCT01264939|560982422|FG001|Overall Study|Adverse Event|3|||
155347132|NCT00296504|560703428|FG004|Final Analysis|Adverse Event|0|||
155347133|NCT00296504|560703429|FG005|Final Analysis|Adverse Event|0|||
155347134|NCT00296504|560703430|FG006|Final Analysis|Adverse Event|0|||
155347135|NCT00296504|560703431|FG007|Final Analysis|Adverse Event|0|||
155347136|NCT00296504|560703432|FG008|Final Analysis|Adverse Event|2|||
155347137|NCT00296504|560703424|FG000|Final Analysis|Pregnancy|0|||
155347138|NCT00296504|560703425|FG001|Final Analysis|Pregnancy|0|||
155347139|NCT00296504|560703426|FG002|Final Analysis|Pregnancy|0|||
155347140|NCT00296504|560703427|FG003|Final Analysis|Pregnancy|0|||
155347141|NCT00296504|560703428|FG004|Final Analysis|Pregnancy|0|||
155347142|NCT00296504|560703429|FG005|Final Analysis|Pregnancy|0|||
155347143|NCT00296504|560703430|FG006|Final Analysis|Pregnancy|0|||
155347144|NCT00296504|560703431|FG007|Final Analysis|Pregnancy|0|||
155347145|NCT00296504|560703432|FG008|Final Analysis|Pregnancy|4|||
155347146|NCT00296504|560703424|FG000|Final Analysis|Tuberculosis|0|||
155347147|NCT00296504|560703425|FG001|Final Analysis|Tuberculosis|0|||
155347148|NCT00296504|560703426|FG002|Final Analysis|Tuberculosis|0|||
155347149|NCT00296504|560703427|FG003|Final Analysis|Tuberculosis|0|||
155347150|NCT00296504|560703428|FG004|Final Analysis|Tuberculosis|0|||
155347151|NCT00296504|560703429|FG005|Final Analysis|Tuberculosis|0|||
155347152|NCT00296504|560703430|FG006|Final Analysis|Tuberculosis|0|||
155347153|NCT00296504|560703431|FG007|Final Analysis|Tuberculosis|0|||
155347154|NCT00296504|560703432|FG008|Final Analysis|Tuberculosis|1|||
155347155|NCT00296504|560703424|FG000|Final Analysis|Participant Moved to Another Country|0|||
155347156|NCT00296504|560703425|FG001|Final Analysis|Participant Moved to Another Country|0|||
155347157|NCT00296504|560703426|FG002|Final Analysis|Participant Moved to Another Country|0|||
155347158|NCT00296504|560703427|FG003|Final Analysis|Participant Moved to Another Country|0|||
155347159|NCT00296504|560703428|FG004|Final Analysis|Participant Moved to Another Country|0|||
155347160|NCT00296504|560703429|FG005|Final Analysis|Participant Moved to Another Country|0|||
155347161|NCT00296504|560703430|FG006|Final Analysis|Participant Moved to Another Country|0|||
155347162|NCT00296504|560703431|FG007|Final Analysis|Participant Moved to Another Country|0|||
155347163|NCT00296504|560703432|FG008|Final Analysis|Participant Moved to Another Country|1|||
155347164|NCT00296504|560703424|FG000|Final Analysis|Poor Adherence|0|||
155347165|NCT00296504|560703425|FG001|Final Analysis|Poor Adherence|0|||
155347166|NCT00296504|560703426|FG002|Final Analysis|Poor Adherence|0|||
155347167|NCT00296504|560703427|FG003|Final Analysis|Poor Adherence|0|||
155347168|NCT00296504|560703428|FG004|Final Analysis|Poor Adherence|0|||
155347169|NCT00296504|560703429|FG005|Final Analysis|Poor Adherence|0|||
155347170|NCT00296504|560703430|FG006|Final Analysis|Poor Adherence|0|||
155347171|NCT00296504|560703431|FG007|Final Analysis|Poor Adherence|0|||
155347172|NCT00296504|560703432|FG008|Final Analysis|Poor Adherence|1|||
155347173|NCT01323309|560703438|FG000|Overall Study|Death|9|||
155347174|NCT01323309|560703439|FG001|Overall Study|Death|15|||
155347175|NCT01323309|560703440|FG002|Overall Study|Death|5|||
155347176|NCT01323309|560703438|FG000|Overall Study|Lost to Follow-up|11|||
155347177|NCT01323309|560703439|FG001|Overall Study|Lost to Follow-up|14|||
155347178|NCT01323309|560703440|FG002|Overall Study|Lost to Follow-up|24|||
155347179|NCT01323309|560703438|FG000|Overall Study|Withdrawal by Subject|14|||
155347180|NCT01323309|560703439|FG001|Overall Study|Withdrawal by Subject|14|||
155347181|NCT01323309|560703440|FG002|Overall Study|Withdrawal by Subject|18|||
155347182|NCT01323309|560703438|FG000|Overall Study|Disease progression|5|||
155347183|NCT01323309|560703439|FG001|Overall Study|Disease progression|11|||
155347184|NCT01323309|560703440|FG002|Overall Study|Disease progression|4|||
155424717|NCT01264939|560982421|FG000|Overall Study|Lost to Follow-up|0|||
155424718|NCT01264939|560982422|FG001|Overall Study|Lost to Follow-up|3|||
155424719|NCT01264939|560982421|FG000|Overall Study|Physician Decision|1|||
155424720|NCT01264939|560982422|FG001|Overall Study|Physician Decision|1|||
155347185|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
155347186|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
155347187|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Adverse Event|4|||
155347188|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Adverse Event|1|||
155347189|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
155424721|NCT01264939|560982421|FG000|Overall Study|Patient/Guardian Decision|8|||
155424722|NCT01264939|560982422|FG001|Overall Study|Patient/Guardian Decision|10|||
155347190|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
155347191|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Physician Decision|0|||
155347192|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Physician Decision|2|||
155347193|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Death|1|||
155347194|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Death|0|||
155347195|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
155347196|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
155347197|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
155347198|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
155347199|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Death|2|||
155347200|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Death|1|||
155347201|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
155347202|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
155347203|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
155347204|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
155347205|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
155347206|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
155347207|NCT01348763|560703443|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
155347208|NCT01348763|560703443|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
155347209|NCT01078571|560703447|FG000|Overall Study|Adverse Event|36|||
155347210|NCT01078571|560703447|FG000|Overall Study|Lack of effectiveness|36|||
155347211|NCT01078571|560703447|FG000|Overall Study|Reason not reported|21|||
155347212|NCT01078571|560703447|FG000|Overall Study|Withdrawal by Subject|12|||
155347213|NCT01078571|560703447|FG000|Overall Study|Lost to Follow-up|8|||
155347214|NCT01078571|560703447|FG000|Overall Study|Protocol Violation|2|||
155347215|NCT01047306|560703460|FG000|Overall Study|Withdrawal by Subject|2|||
155347216|NCT01047306|560703461|FG001|Overall Study|Withdrawal by Subject|0|||
155347217|NCT01047306|560703460|FG000|Overall Study|Lost to Follow-up|1|||
155347218|NCT01047306|560703461|FG001|Overall Study|Lost to Follow-up|0|||
155347219|NCT01878253|560703463|FG000|Overall Study|Death|1|||
155347220|NCT01878253|560703463|FG000|Overall Study|SIdus System Removal|3|||
155347221|NCT01878253|560703463|FG000|Overall Study|Withdrawal by Subject|1|||
155347222|NCT01878253|560703463|FG000|Overall Study|Lost to Follow-up|2|||
155347223|NCT01878253|560703463|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
155347224|NCT03647709|560703468|FG000|Overall Study|Lost to Follow-up|5|||
155347225|NCT03647709|560703468|FG000|Overall Study|Physician Decision|6|||
155347226|NCT03647709|560703468|FG000|Overall Study|Withdrawal by Subject|3|||
155347227|NCT00449033|560703471|FG000|Treatment Period|Adverse Event|117|||
155347228|NCT00449033|560703472|FG001|Treatment Period|Adverse Event|83|||
155347229|NCT00449033|560703471|FG000|Treatment Period|Death|21|||
155347230|NCT00449033|560703472|FG001|Treatment Period|Death|12|||
155347231|NCT00449033|560703471|FG000|Treatment Period|Lost to Follow-up|0|||
155347232|NCT00449033|560703472|FG001|Treatment Period|Lost to Follow-up|2|||
155347233|NCT00449033|560703471|FG000|Treatment Period|Physician Decision|4|||
155347234|NCT00449033|560703472|FG001|Treatment Period|Physician Decision|5|||
155347235|NCT00449033|560703471|FG000|Treatment Period|Protocol Violation|8|||
155347236|NCT00449033|560703472|FG001|Treatment Period|Protocol Violation|7|||
155347237|NCT00449033|560703471|FG000|Treatment Period|Disease Progression|231|||
155347238|NCT00449033|560703472|FG001|Treatment Period|Disease Progression|288|||
155347239|NCT00449033|560703471|FG000|Treatment Period|Consent Withdrawn|36|||
155347240|NCT00449033|560703472|FG001|Treatment Period|Consent Withdrawn|20|||
155347241|NCT00449033|560703471|FG000|Treatment Period|Amended Protocol Criteria|22|||
155347242|NCT00449033|560703472|FG001|Treatment Period|Amended Protocol Criteria|18|||
155347243|NCT00449033|560703471|FG000|Treatment Period|Non-compliance|7|||
155347244|NCT00449033|560703472|FG001|Treatment Period|Non-compliance|8|||
155347245|NCT00449033|560703471|FG000|Treatment Period|Second Malignancy|0|||
155347246|NCT00449033|560703472|FG001|Treatment Period|Second Malignancy|1|||
155347247|NCT00449033|560703471|FG000|Treatment Period|Reason Missing|0|||
155347248|NCT00449033|560703472|FG001|Treatment Period|Reason Missing|4|||
155347249|NCT00449033|560703471|FG000|Treatment Period|Treatment Ongoing|6|||
155347250|NCT00449033|560703472|FG001|Treatment Period|Treatment Ongoing|4|||
155347251|NCT00449033|560703471|FG000|Follow-up Period|Death|299|||
155347252|NCT00449033|560703472|FG001|Follow-up Period|Death|311|||
155347253|NCT00449033|560703471|FG000|Follow-up Period|Lost to Follow-up|6|||
155347254|NCT00449033|560703472|FG001|Follow-up Period|Lost to Follow-up|10|||
155347255|NCT00449033|560703471|FG000|Follow-up Period|Reason Missing|120|||
155347256|NCT00449033|560703472|FG001|Follow-up Period|Reason Missing|113|||
155347257|NCT04393779|560703473|FG000|Overall Study|Death|1|||
155347258|NCT04393779|560703473|FG000|Overall Study|Device reintervention or explant|4|||
155347259|NCT03802513|560703475|FG000|Overall Study|Lost to Follow-up|1|||
155347260|NCT01190228|560703478|FG000|Overall Study|Protocol Violation|4|||
155347261|NCT01190228|560703479|FG001|Overall Study|Protocol Violation|0|||
155347262|NCT01190228|560703480|FG002|Overall Study|Protocol Violation|0|||
155347263|NCT01190228|560703478|FG000|Overall Study|Withdrawal by Subject|1|||
155347264|NCT01190228|560703479|FG001|Overall Study|Withdrawal by Subject|0|||
155347265|NCT01190228|560703480|FG002|Overall Study|Withdrawal by Subject|0|||
155347266|NCT01855399|560703482|FG000|6 Month|Lost to Follow-up|12|||
155347267|NCT01855399|560703483|FG001|6 Month|Lost to Follow-up|9|||
155347268|NCT01855399|560703482|FG000|6 Month|Withdrawal by Subject|8|||
155347269|NCT01855399|560703483|FG001|6 Month|Withdrawal by Subject|6|||
155347270|NCT01855399|560703482|FG000|12 Month|Lost to Follow-up|7|||
155347271|NCT01855399|560703483|FG001|12 Month|Lost to Follow-up|11|||
155347272|NCT00512902|560703484|FG000|Overall Study|Adverse Event|7|||
155347273|NCT00512902|560703484|FG000|Overall Study|Lost to Follow-up|1|||
155347274|NCT03214198|560703485|FG000|Overall Study|Case Report Forms Uncollected|18|||
155347275|NCT03214198|560703485|FG000|Overall Study|Protocol Deviation|18|||
155347276|NCT02577315|560703488|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155347277|NCT02577315|560703489|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
155347278|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
155505920|NCT00435825|561278282|FG002|Overall Study|Did not complete full follow-up period|4|||
155505921|NCT00435825|561278283|FG003|Overall Study|Did not complete full follow-up period|5|||
155347279|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
155347280|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
155347281|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
155347282|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
155347283|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
155347284|NCT03530345|560703495|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
155347285|NCT03530345|560703496|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
155347286|NCT02442622|560703501|FG000|Overall Study|Withdrawal by Subject|3|||
155347287|NCT02442622|560703502|FG001|Overall Study|Withdrawal by Subject|1|||
155347288|NCT04448561|560703503|FG000|Overall Study|Noncompliance|1|||
155347289|NCT04448561|560703504|FG001|Overall Study|Noncompliance|0|||
155347290|NCT00635570|560704869|FG000|Overall Study|Lost to Follow-up|8|||
155347291|NCT00635570|560704870|FG001|Overall Study|Lost to Follow-up|8|||
155347292|NCT00635570|560704869|FG000|Overall Study|Withdrawal by Subject|1|||
155347293|NCT00635570|560704870|FG001|Overall Study|Withdrawal by Subject|1|||
155347294|NCT00635570|560704869|FG000|Overall Study|Adverse Event|2|||
155347295|NCT00635570|560704870|FG001|Overall Study|Adverse Event|0|||
155347296|NCT00635570|560704869|FG000|Overall Study|Physician Decision|1|||
155347297|NCT00635570|560704870|FG001|Overall Study|Physician Decision|0|||
155347298|NCT00635570|560704869|FG000|Overall Study|Did not complete survey|2|||
155347299|NCT00635570|560704870|FG001|Overall Study|Did not complete survey|1|||
155347300|NCT00635570|560704869|FG000|Overall Study|Early termination(No sexual activity)|1|||
155347301|NCT00635570|560704870|FG001|Overall Study|Early termination(No sexual activity)|1|||
155347302|NCT01816685|560704873|FG000|Overall Study|Lost to Follow-up|7|||
155347303|NCT01816685|560704874|FG001|Overall Study|Lost to Follow-up|9|||
155347304|NCT01816685|560704873|FG000|Overall Study|Surgery Cancelled|3|||
155347305|NCT01816685|560704874|FG001|Overall Study|Surgery Cancelled|2|||
155347306|NCT00381888|560704875|FG000|Overall Study|Death|1|||
155347307|NCT00381888|560704875|FG000|Overall Study|Withdrawal by Subject|1|||
155347308|NCT00381888|560704875|FG000|Overall Study|Physician Decision|1|||
155505922|NCT02367781|561278286|FG000|Overall Study|Withdrawal by Subject|20|||
155505923|NCT02367781|561278287|FG001|Overall Study|Withdrawal by Subject|13|||
155347309|NCT00381888|560704875|FG000|Overall Study|Protocol Violation|9|||
155347310|NCT00381888|560704875|FG000|Overall Study|Had laparoscopic surgery|2|||
155505924|NCT02367781|561278286|FG000|Overall Study|Protocol Violation|0|||
155347311|NCT00381888|560704875|FG000|Overall Study|Surgery was cancelled|2|||
155347312|NCT00381888|560704875|FG000|Overall Study|Adverse Event|1|||
155347313|NCT00197106|560704879|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
155505925|NCT02367781|561278287|FG001|Overall Study|Protocol Violation|1|||
155347314|NCT00197106|560704880|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
155347315|NCT00197106|560704881|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
155347316|NCT00197106|560704879|FG000|Overall Treatment Period|Lack of Efficacy|0|||
155347317|NCT00197106|560704880|FG001|Overall Treatment Period|Lack of Efficacy|1|||
155347318|NCT00197106|560704881|FG002|Overall Treatment Period|Lack of Efficacy|0|||
155347319|NCT00197106|560704879|FG000|Overall Treatment Period|Lost to Follow-up|0|||
155347320|NCT00197106|560704880|FG001|Overall Treatment Period|Lost to Follow-up|0|||
155347321|NCT00197106|560704881|FG002|Overall Treatment Period|Lost to Follow-up|2|||
155347322|NCT00197106|560704879|FG000|Overall Treatment Period|Protocol Violation|0|||
155347323|NCT00197106|560704880|FG001|Overall Treatment Period|Protocol Violation|0|||
155347324|NCT00197106|560704881|FG002|Overall Treatment Period|Protocol Violation|2|||
155347325|NCT00197106|560704879|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
155347326|NCT00197106|560704880|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
155347327|NCT00197106|560704881|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
155347328|NCT00762723|560704882|FG000|Overall Study|Study Terminated slow enrollement|5|||
155347329|NCT00762723|560704883|FG001|Overall Study|Study Terminated slow enrollement|5|||
155347330|NCT00762723|560704884|FG002|Overall Study|Study Terminated slow enrollement|3|||
155347331|NCT00382408|560704885|FG000|Overall Study|Did not meet protocol requirement|3|||
155347332|NCT00382408|560704886|FG001|Overall Study|Did not meet protocol requirement|3|||
155347333|NCT00382408|560704885|FG000|Overall Study|Protocol Violation|2|||
155347334|NCT00382408|560704886|FG001|Overall Study|Protocol Violation|2|||
155347335|NCT00382408|560704885|FG000|Overall Study|Physician Decision|1|||
155347336|NCT00382408|560704886|FG001|Overall Study|Physician Decision|0|||
155347337|NCT00382408|560704885|FG000|Overall Study|Withdrawal by Subject|17|||
155347338|NCT00382408|560704886|FG001|Overall Study|Withdrawal by Subject|6|||
155347339|NCT00382408|560704885|FG000|Overall Study|Pregnancy|2|||
155347340|NCT00382408|560704886|FG001|Overall Study|Pregnancy|0|||
155347341|NCT00382408|560704885|FG000|Overall Study|Lost to Follow-up|19|||
155347342|NCT00382408|560704886|FG001|Overall Study|Lost to Follow-up|8|||
155347343|NCT00382408|560704885|FG000|Overall Study|Other|100|||
155347344|NCT00382408|560704886|FG001|Overall Study|Other|35|||
155424723|NCT01264939|560982421|FG000|Overall Study|Disease Progression|8|||
155424724|NCT01264939|560982422|FG001|Overall Study|Disease Progression|11|||
155424725|NCT00737529|560982428|FG000|Overall Study|Disease Progression|95|||
155424726|NCT00737529|560982428|FG000|Overall Study|Adverse Event|24|||
155424727|NCT00737529|560982428|FG000|Overall Study|Withdrawal by Subject|5|||
155424728|NCT00737529|560982428|FG000|Overall Study|Death|4|||
155647804|NCT03774810|561803680|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
155647805|NCT03774810|561803681|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
155647806|NCT03774810|561803682|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
155647807|NCT03774810|561803678|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155647808|NCT03774810|561803679|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155647809|NCT03774810|561803680|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155647810|NCT03774810|561803681|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
155647811|NCT03774810|561803682|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
155647812|NCT00927186|561803685|FG000|12 Months Primary Study|Adverse Event|5|||
155647813|NCT00927186|561803686|FG001|12 Months Primary Study|Adverse Event|2|||
155647814|NCT00927186|561803685|FG000|12 Months Primary Study|Lost to Follow-up|1|||
155647815|NCT00927186|561803686|FG001|12 Months Primary Study|Lost to Follow-up|0|||
155647816|NCT00927186|561803685|FG000|12 Months Primary Study|Protocol Violation|0|||
155647817|NCT00927186|561803686|FG001|12 Months Primary Study|Protocol Violation|1|||
155647818|NCT00927186|561803685|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
155647819|NCT00927186|561803686|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
155647820|NCT03994120|561803687|FG000|Overall Study|Lost to Follow-up|3|||
155647821|NCT03994120|561803688|FG001|Overall Study|Lost to Follow-up|1|||
155647822|NCT04914000|561803689|FG000|Overall Study|Lost to Follow-up|8|||
155647823|NCT04914000|561803689|FG000|Overall Study|Withdrawal by Subject|1|||
155647824|NCT04641975|561803690|FG000|Overall Study|Protocol Violation|1|||
155647825|NCT04641975|561803691|FG001|Overall Study|Protocol Violation|2|||
155647826|NCT04641975|561803692|FG002|Overall Study|Protocol Violation|0|||
155647827|NCT04641975|561803693|FG003|Overall Study|Protocol Violation|0|||
155347345|NCT02402465|560704889|FG000|Overall Study|Withdrawal by Subject|0|||
155347346|NCT02402465|560704890|FG001|Overall Study|Withdrawal by Subject|0|||
155347347|NCT02402465|560704891|FG002|Overall Study|Withdrawal by Subject|0|||
155347348|NCT02402465|560704892|FG003|Overall Study|Withdrawal by Subject|0|||
155347349|NCT02402465|560704893|FG004|Overall Study|Withdrawal by Subject|0|||
155347350|NCT02402465|560704894|FG005|Overall Study|Withdrawal by Subject|1|||
155347351|NCT02402465|560704889|FG000|Overall Study|Lost to Follow-up|0|||
155347352|NCT02402465|560704890|FG001|Overall Study|Lost to Follow-up|1|||
155347353|NCT02402465|560704891|FG002|Overall Study|Lost to Follow-up|0|||
155424729|NCT00737529|560982428|FG000|Overall Study|Protocol Violation|1|||
155647828|NCT04641975|561803690|FG000|Overall Study|Adverse Event|0|||
155347354|NCT02402465|560704892|FG003|Overall Study|Lost to Follow-up|0|||
155347355|NCT02402465|560704893|FG004|Overall Study|Lost to Follow-up|1|||
155424730|NCT00737529|560982428|FG000|Overall Study|Other|4|||
155647829|NCT04641975|561803691|FG001|Overall Study|Adverse Event|0|||
155647830|NCT04641975|561803692|FG002|Overall Study|Adverse Event|1|||
155647831|NCT04641975|561803693|FG003|Overall Study|Adverse Event|1|||
155647832|NCT04641975|561803690|FG000|Overall Study|Withdrawal by Subject|1|||
155647833|NCT04641975|561803691|FG001|Overall Study|Withdrawal by Subject|0|||
155647834|NCT04641975|561803692|FG002|Overall Study|Withdrawal by Subject|0|||
155647835|NCT04641975|561803693|FG003|Overall Study|Withdrawal by Subject|0|||
155647836|NCT01259024|561803697|FG000|Overall Study|Physician Decision|1|||
155647837|NCT00756444|561803698|FG000|Overall Study|Adverse Event|1|||
155647838|NCT00756444|561803699|FG001|Overall Study|Adverse Event|1|||
155647839|NCT00756444|561803698|FG000|Overall Study|Withdrawal by Subject|6|||
155647840|NCT00756444|561803699|FG001|Overall Study|Withdrawal by Subject|8|||
155647841|NCT00756444|561803698|FG000|Overall Study|Lost to Follow-up|0|||
155647842|NCT00756444|561803699|FG001|Overall Study|Lost to Follow-up|1|||
155647843|NCT00756444|561803698|FG000|Overall Study|Death|5|||
155647844|NCT00756444|561803699|FG001|Overall Study|Death|4|||
155647845|NCT00756444|561803698|FG000|Overall Study|Disease Progression|2|||
155647846|NCT00756444|561803699|FG001|Overall Study|Disease Progression|7|||
155647847|NCT00756444|561803698|FG000|Overall Study|Ineligibility Determined|1|||
155647848|NCT00756444|561803699|FG001|Overall Study|Ineligibility Determined|0|||
155647849|NCT00564070|561803700|FG000|Overall Study|Lost to Follow-up|9|||
155647850|NCT00564070|561803701|FG001|Overall Study|Lost to Follow-up|7|||
155647851|NCT00564070|561803700|FG000|Overall Study|Worsening depression, referred to care|3|||
155647852|NCT00564070|561803701|FG001|Overall Study|Worsening depression, referred to care|0|||
155647853|NCT02346370|561803702|FG000|Overall Study|Not treated|1|||
155647854|NCT02346370|561803703|FG001|Overall Study|Not treated|0|||
155647855|NCT02346370|561803704|FG002|Overall Study|Not treated|0|||
155647856|NCT02346370|561803702|FG000|Overall Study|Withdrawal of consent|1|||
155647857|NCT02346370|561803703|FG001|Overall Study|Withdrawal of consent|0|||
155647858|NCT02346370|561803704|FG002|Overall Study|Withdrawal of consent|0|||
155647859|NCT02346370|561803702|FG000|Overall Study|Death|1|||
155647860|NCT02346370|561803703|FG001|Overall Study|Death|3|||
155647861|NCT02346370|561803704|FG002|Overall Study|Death|1|||
155647862|NCT02346370|561803702|FG000|Overall Study|Sponsor discontinued study|5|||
155647863|NCT02346370|561803703|FG001|Overall Study|Sponsor discontinued study|0|||
155647864|NCT02346370|561803704|FG002|Overall Study|Sponsor discontinued study|2|||
155647865|NCT02346370|561803702|FG000|Overall Study|Radiologic progression|0|||
155647866|NCT02346370|561803703|FG001|Overall Study|Radiologic progression|0|||
155647867|NCT02346370|561803704|FG002|Overall Study|Radiologic progression|1|||
155647868|NCT02346370|561803702|FG000|Overall Study|Physician Decision|0|||
155647869|NCT02346370|561803703|FG001|Overall Study|Physician Decision|1|||
155647870|NCT02346370|561803704|FG002|Overall Study|Physician Decision|0|||
155647871|NCT01217047|561803705|FG000|Overall Study|Lost to Follow-up|0|||
155647872|NCT01217047|561803706|FG001|Overall Study|Lost to Follow-up|1|||
155647873|NCT01217047|561803707|FG002|Overall Study|Lost to Follow-up|0|||
155647874|NCT04865978|561803708|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
155647875|NCT04865978|561803709|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
155647876|NCT05587998|561803710|FG000|Overall Study|Withdrawal by Subject|1|||
155647877|NCT05587998|561803711|FG001|Overall Study|Withdrawal by Subject|1|||
155647878|NCT05587998|561803710|FG000|Overall Study|Not treated|3|||
155647879|NCT05587998|561803711|FG001|Overall Study|Not treated|1|||
155647880|NCT05587998|561803710|FG000|Overall Study|Non-compliance with study procedures|0|||
155647881|NCT05587998|561803711|FG001|Overall Study|Non-compliance with study procedures|1|||
155647882|NCT03835117|561803712|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
155647883|NCT03835117|561803713|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
155647884|NCT04263532|561803714|FG000|Overall Study|Withdrawal by Subject|2|||
155424731|NCT00854828|560982431|FG000|Overall Study|Death|1|||
155424732|NCT00854828|560982432|FG001|Overall Study|Death|0|||
155424733|NCT00854828|560982433|FG002|Overall Study|Death|0|||
155424734|NCT00854828|560982434|FG003|Overall Study|Death|0|||
155424735|NCT00854828|560982431|FG000|Overall Study|Withdrawal by Subject|1|||
155424736|NCT00854828|560982432|FG001|Overall Study|Withdrawal by Subject|1|||
155424737|NCT00854828|560982433|FG002|Overall Study|Withdrawal by Subject|0|||
155647885|NCT04263532|561803715|FG001|Overall Study|Withdrawal by Subject|0|||
155424738|NCT00854828|560982434|FG003|Overall Study|Withdrawal by Subject|9|||
155647886|NCT06083493|561803716|FG000|Overall Study|Technical issues with the interventional device|2|||
155647887|NCT06083493|561803717|FG001|Overall Study|Technical issues with the interventional device|2|||
155647888|NCT06083493|561803716|FG000|Overall Study|Performed incorrect visual task|1|||
155647889|NCT06083493|561803717|FG001|Overall Study|Performed incorrect visual task|0|||
155647890|NCT06083493|561803716|FG000|Overall Study|Insufficient baseline performance|0|||
155647891|NCT06083493|561803717|FG001|Overall Study|Insufficient baseline performance|1|||
155424739|NCT00854828|560982431|FG000|Overall Study|Missed 24mo visit|1|||
155647892|NCT03225989|561803721|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
155647893|NCT03225989|561803722|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
155647894|NCT03225989|561803723|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
155424740|NCT00854828|560982432|FG001|Overall Study|Missed 24mo visit|1|||
155647895|NCT03225989|561803721|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
155647896|NCT03225989|561803722|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
155647897|NCT03225989|561803723|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
155647898|NCT03225989|561803721|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155647899|NCT03225989|561803722|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
155647900|NCT03225989|561803723|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155647901|NCT03225989|561803721|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
155647902|NCT03225989|561803722|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
155647903|NCT03225989|561803723|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
155647904|NCT03225989|561803721|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
155647905|NCT03225989|561803722|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
155647906|NCT03225989|561803723|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
155647907|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
155647908|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
155647909|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
155647910|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
155647911|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
155647912|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
155647913|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
155647914|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
155647915|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
155647916|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
155647917|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
155647918|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
155647919|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
155647920|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
155647921|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
155647922|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
155647923|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
155647924|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
155647925|NCT03225989|561803721|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
155647926|NCT03225989|561803722|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
155647927|NCT03225989|561803723|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
155647928|NCT03093870|561803724|FG000|Overall Study|Withdrawal by Subject|2|||
155647929|NCT03093870|561803725|FG001|Overall Study|Withdrawal by Subject|6|||
155647930|NCT03093870|561803726|FG002|Overall Study|Withdrawal by Subject|5|||
155647931|NCT03093870|561803724|FG000|Overall Study|Death|1|||
155647932|NCT03093870|561803725|FG001|Overall Study|Death|35|||
155647933|NCT03093870|561803726|FG002|Overall Study|Death|35|||
155647934|NCT03093870|561803724|FG000|Overall Study|Radiographic disease progression|10|||
155647935|NCT03093870|561803725|FG001|Overall Study|Radiographic disease progression|0|||
155647936|NCT03093870|561803726|FG002|Overall Study|Radiographic disease progression|0|||
155647937|NCT03093870|561803724|FG000|Overall Study|Clinical disease progression|1|||
155647938|NCT03093870|561803725|FG001|Overall Study|Clinical disease progression|0|||
155647939|NCT03093870|561803726|FG002|Overall Study|Clinical disease progression|0|||
155647940|NCT03093870|561803724|FG000|Overall Study|Physician Decision|2|||
155647941|NCT03093870|561803725|FG001|Overall Study|Physician Decision|0|||
155647942|NCT03093870|561803726|FG002|Overall Study|Physician Decision|0|||
155647943|NCT03093870|561803724|FG000|Overall Study|Adverse Event|7|||
155647944|NCT03093870|561803725|FG001|Overall Study|Adverse Event|0|||
155647945|NCT03093870|561803726|FG002|Overall Study|Adverse Event|0|||
155647946|NCT03093870|561803724|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
155647947|NCT03093870|561803725|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
155647948|NCT03093870|561803726|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
155647949|NCT03093870|561803724|FG000|Overall Study|Lost to Follow-up|0|||
155424741|NCT00854828|560982433|FG002|Overall Study|Missed 24mo visit|8|||
155424742|NCT00854828|560982434|FG003|Overall Study|Missed 24mo visit|8|||
155424743|NCT01282229|560982435|FG000|Overall Study|Protocol Violation|2|||
155424744|NCT01671280|560982436|FG000|Overall Study|Withdrawal by Subject|2|||
155424745|NCT00996203|560982437|FG000|Overall Study|Adverse Event|3|||
155424746|NCT00996203|560982437|FG000|Overall Study|Lost to Follow-up|1|||
155424747|NCT00996203|560982437|FG000|Overall Study|Lack of Efficacy|1|||
155424748|NCT00996203|560982437|FG000|Overall Study|Protocol Violation|2|||
155424749|NCT01959165|560982438|FG000|Overall Study|Adverse Event|0|||
155424750|NCT01959165|560982439|FG001|Overall Study|Adverse Event|0|||
155424751|NCT01959165|560982440|FG002|Overall Study|Adverse Event|0|||
155347356|NCT02402465|560704894|FG005|Overall Study|Lost to Follow-up|0|||
155347357|NCT01284634|560704895|FG000|Overall Study|Adverse Event|1|||
155347358|NCT01284634|560704896|FG001|Overall Study|Adverse Event|0|||
155347359|NCT01284634|560704897|FG002|Overall Study|Adverse Event|2|||
155347360|NCT01284634|560704898|FG003|Overall Study|Adverse Event|1|||
155347361|NCT02236598|560704899|FG000|Overall Study|Adverse Event|0|||
155347362|NCT02236598|560704900|FG001|Overall Study|Adverse Event|1|||
155347363|NCT02236598|560704899|FG000|Overall Study|Withdrawal by Subject|0|||
155347364|NCT02236598|560704900|FG001|Overall Study|Withdrawal by Subject|1|||
155347365|NCT00428441|560704906|FG000|Overall Study|Lost to Follow-up|1|||
155347366|NCT00125853|560704907|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
155347367|NCT00125853|560704908|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
155347368|NCT03048058|560704913|FG000|Overall Study|Lost to Follow-up|4|||
155347369|NCT03048058|560704914|FG001|Overall Study|Lost to Follow-up|0|||
155347370|NCT03048058|560704913|FG000|Overall Study|Withdrawal by Subject|0|||
155347371|NCT03048058|560704914|FG001|Overall Study|Withdrawal by Subject|4|||
155347372|NCT01257698|560704915|FG000|Overall Study|Protocol Violation|4|||
155347373|NCT01257698|560704916|FG001|Overall Study|Protocol Violation|0|||
155347374|NCT01395914|560704917|FG000|Overall Study|Unrelated to study drug AE|6|||
155347375|NCT01395914|560704918|FG001|Overall Study|Unrelated to study drug AE|1|||
155347376|NCT01395914|560704917|FG000|Overall Study|Death|23|||
155347377|NCT01395914|560704918|FG001|Overall Study|Death|17|||
155347378|NCT01395914|560704917|FG000|Overall Study|Other|9|||
155347379|NCT01395914|560704918|FG001|Overall Study|Other|3|||
155347380|NCT01395914|560704917|FG000|Overall Study|Withdrawal by patient|27|||
155347381|NCT01395914|560704918|FG001|Overall Study|Withdrawal by patient|14|||
155347382|NCT01395914|560704917|FG000|Overall Study|Study drug-related AE|1|||
155347383|NCT01395914|560704918|FG001|Overall Study|Study drug-related AE|0|||
155347384|NCT01395914|560704917|FG000|Overall Study|Lost to Follow-up|6|||
155347385|NCT01395914|560704918|FG001|Overall Study|Lost to Follow-up|2|||
155347386|NCT02256488|560704921|FG000|Overall Study|Lost to Follow-up|6|||
155347387|NCT02256488|560704922|FG001|Overall Study|Lost to Follow-up|6|||
155347388|NCT02256488|560704923|FG002|Overall Study|Lost to Follow-up|9|||
155347389|NCT02256488|560704924|FG003|Overall Study|Lost to Follow-up|3|||
155347390|NCT02256488|560704921|FG000|Overall Study|OTHER|1|||
155347391|NCT02256488|560704922|FG001|Overall Study|OTHER|0|||
155347392|NCT02256488|560704923|FG002|Overall Study|OTHER|1|||
155347393|NCT02256488|560704924|FG003|Overall Study|OTHER|1|||
155347394|NCT02256488|560704921|FG000|Overall Study|Withdrawal by Subject|1|||
155347395|NCT02256488|560704922|FG001|Overall Study|Withdrawal by Subject|0|||
155347396|NCT02256488|560704923|FG002|Overall Study|Withdrawal by Subject|0|||
155347397|NCT02256488|560704924|FG003|Overall Study|Withdrawal by Subject|2|||
155347398|NCT02268526|560704925|FG000|Overall Study|Adverse Event|0|||
155505926|NCT02367781|561278286|FG000|Overall Study|Physician Decision|7|||
155505927|NCT02367781|561278287|FG001|Overall Study|Physician Decision|0|||
155505928|NCT02367781|561278286|FG000|Overall Study|Randomized in Error|5|||
155505929|NCT02367781|561278287|FG001|Overall Study|Randomized in Error|4|||
155505930|NCT02367781|561278286|FG000|Overall Study|Non-Compliance|1|||
155505931|NCT02367781|561278287|FG001|Overall Study|Non-Compliance|0|||
155505932|NCT02367781|561278286|FG000|Overall Study|Lost to Follow-up|1|||
155505933|NCT02367781|561278287|FG001|Overall Study|Lost to Follow-up|2|||
155505934|NCT02367781|561278286|FG000|Overall Study|Death|330|||
155505935|NCT02367781|561278287|FG001|Overall Study|Death|176|||
155505936|NCT02367781|561278286|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
155505937|NCT02367781|561278287|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
155505938|NCT02367781|561278286|FG000|Overall Study|Prolonged Hospitalization|1|||
155505939|NCT02367781|561278287|FG001|Overall Study|Prolonged Hospitalization|0|||
155505940|NCT02367781|561278286|FG000|Overall Study|Death Prior First Dose|1|||
155505941|NCT02367781|561278287|FG001|Overall Study|Death Prior First Dose|0|||
155505942|NCT02367781|561278286|FG000|Overall Study|Administrative-Change Facility|1|||
155505943|NCT02367781|561278287|FG001|Overall Study|Administrative-Change Facility|0|||
155505944|NCT02367781|561278286|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
155347399|NCT02268526|560704926|FG001|Overall Study|Adverse Event|2|||
155347400|NCT02268526|560704927|FG002|Overall Study|Adverse Event|1|||
155347401|NCT02268526|560704925|FG000|Overall Study|Death|1|||
155347402|NCT02268526|560704926|FG001|Overall Study|Death|11|||
155505945|NCT02367781|561278287|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
155505946|NCT02367781|561278286|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
155505947|NCT02367781|561278287|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
155347403|NCT02268526|560704927|FG002|Overall Study|Death|0|||
155347404|NCT02268526|560704925|FG000|Overall Study|protocol deviation|0|||
155347405|NCT02268526|560704926|FG001|Overall Study|protocol deviation|1|||
155347406|NCT02268526|560704927|FG002|Overall Study|protocol deviation|0|||
155347407|NCT02268526|560704925|FG000|Overall Study|Physician Decision|0|||
155347408|NCT02268526|560704926|FG001|Overall Study|Physician Decision|0|||
155347409|NCT02268526|560704927|FG002|Overall Study|Physician Decision|1|||
155347410|NCT02268526|560704925|FG000|Overall Study|Subject/guardian decision|0|||
155347411|NCT02268526|560704926|FG001|Overall Study|Subject/guardian decision|7|||
155347412|NCT02268526|560704927|FG002|Overall Study|Subject/guardian decision|3|||
155347413|NCT00975130|560704928|FG000|Study Part 1|Adverse Event|150|||
155347414|NCT00975130|560704929|FG001|Study Part 1|Adverse Event|0|||
155347415|NCT00975130|560704930|FG002|Study Part 1|Adverse Event|0|||
155347416|NCT00975130|560704928|FG000|Study Part 1|Lost to Follow-up|19|||
155347417|NCT00975130|560704929|FG001|Study Part 1|Lost to Follow-up|0|||
155347418|NCT00975130|560704930|FG002|Study Part 1|Lost to Follow-up|0|||
155347419|NCT00975130|560704928|FG000|Study Part 1|Withdrawal by Subject|61|||
155347420|NCT00975130|560704929|FG001|Study Part 1|Withdrawal by Subject|0|||
155347421|NCT00975130|560704930|FG002|Study Part 1|Withdrawal by Subject|0|||
155347422|NCT00975130|560704928|FG000|Study Part 1|Protocol Violation|13|||
155347423|NCT00975130|560704929|FG001|Study Part 1|Protocol Violation|0|||
155347424|NCT00975130|560704930|FG002|Study Part 1|Protocol Violation|0|||
155347425|NCT00975130|560704928|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
155347426|NCT00975130|560704929|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
155347427|NCT00975130|560704930|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
155347428|NCT00975130|560704928|FG000|Study Part 1|Administrative|4|||
155347429|NCT00975130|560704929|FG001|Study Part 1|Administrative|0|||
155347430|NCT00975130|560704930|FG002|Study Part 1|Administrative|0|||
155347431|NCT00975130|560704928|FG000|Study Part 1|Withdrew Consent|24|||
155347432|NCT00975130|560704929|FG001|Study Part 1|Withdrew Consent|0|||
155347433|NCT00975130|560704930|FG002|Study Part 1|Withdrew Consent|0|||
155347434|NCT00975130|560704928|FG000|Study Part 2|Adverse Event|0|||
155347435|NCT00975130|560704929|FG001|Study Part 2|Adverse Event|14|||
155347436|NCT00975130|560704930|FG002|Study Part 2|Adverse Event|7|||
155347437|NCT00975130|560704928|FG000|Study Part 2|Lost to Follow-up|0|||
155347438|NCT00975130|560704929|FG001|Study Part 2|Lost to Follow-up|0|||
155347439|NCT00975130|560704930|FG002|Study Part 2|Lost to Follow-up|1|||
155347440|NCT00975130|560704928|FG000|Study Part 2|Withdrawal by Subject|0|||
155347441|NCT00975130|560704929|FG001|Study Part 2|Withdrawal by Subject|13|||
155347442|NCT00975130|560704930|FG002|Study Part 2|Withdrawal by Subject|5|||
155347443|NCT00975130|560704928|FG000|Study Part 2|Withdrew Consent|0|||
155347444|NCT00975130|560704929|FG001|Study Part 2|Withdrew Consent|6|||
155424752|NCT01959165|560982441|FG003|Overall Study|Adverse Event|1|||
155424753|NCT01959165|560982438|FG000|Overall Study|Lack of Efficacy|1|||
155424754|NCT01959165|560982439|FG001|Overall Study|Lack of Efficacy|0|||
155647950|NCT03093870|561803725|FG001|Overall Study|Lost to Follow-up|0|||
155347445|NCT00975130|560704930|FG002|Study Part 2|Withdrew Consent|2|||
155347446|NCT00975130|560704928|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
155347447|NCT00975130|560704929|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
155347448|NCT00975130|560704930|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
155347449|NCT00975130|560704928|FG000|Study Part 2|Administrative|0|||
155424755|NCT01959165|560982440|FG002|Overall Study|Lack of Efficacy|0|||
155424756|NCT01959165|560982441|FG003|Overall Study|Lack of Efficacy|0|||
155347450|NCT00975130|560704929|FG001|Study Part 2|Administrative|1|||
155347451|NCT00975130|560704930|FG002|Study Part 2|Administrative|0|||
155347452|NCT00975130|560704928|FG000|Study Part 2|Protocol Violation|0|||
155347453|NCT00975130|560704929|FG001|Study Part 2|Protocol Violation|0|||
155347454|NCT00975130|560704930|FG002|Study Part 2|Protocol Violation|1|||
155347455|NCT01261793|560704931|FG000|Overall Study|Lack of Efficacy|44|||
155347456|NCT01261793|560704932|FG001|Overall Study|Lack of Efficacy|37|||
155347457|NCT01261793|560704933|FG002|Overall Study|Lack of Efficacy|32|||
155347458|NCT01261793|560704931|FG000|Overall Study|Protocol Violation|3|||
155347459|NCT01261793|560704932|FG001|Overall Study|Protocol Violation|5|||
155347460|NCT01261793|560704933|FG002|Overall Study|Protocol Violation|6|||
155347461|NCT01261793|560704931|FG000|Overall Study|Lost to Follow-up|10|||
155347462|NCT01261793|560704932|FG001|Overall Study|Lost to Follow-up|3|||
155347463|NCT01261793|560704933|FG002|Overall Study|Lost to Follow-up|7|||
155347464|NCT01261793|560704931|FG000|Overall Study|Withdrawal by Subject|12|||
155347465|NCT01261793|560704932|FG001|Overall Study|Withdrawal by Subject|14|||
155347466|NCT01261793|560704933|FG002|Overall Study|Withdrawal by Subject|14|||
155347467|NCT01261793|560704931|FG000|Overall Study|Death|3|||
155347468|NCT01261793|560704932|FG001|Overall Study|Death|1|||
155347469|NCT01261793|560704933|FG002|Overall Study|Death|0|||
155347470|NCT01261793|560704931|FG000|Overall Study|Adverse Event|9|||
155347471|NCT01261793|560704932|FG001|Overall Study|Adverse Event|24|||
155347472|NCT01261793|560704933|FG002|Overall Study|Adverse Event|19|||
155347473|NCT01261793|560704931|FG000|Overall Study|Patient non-availability|1|||
155347474|NCT01261793|560704932|FG001|Overall Study|Patient non-availability|1|||
155347475|NCT01261793|560704933|FG002|Overall Study|Patient non-availability|1|||
155347476|NCT01261793|560704931|FG000|Overall Study|Suspected pregnancy|1|||
155347477|NCT01261793|560704932|FG001|Overall Study|Suspected pregnancy|1|||
155347478|NCT01261793|560704933|FG002|Overall Study|Suspected pregnancy|0|||
155424757|NCT01959165|560982438|FG000|Overall Study|overdose|0|||
155424758|NCT01959165|560982439|FG001|Overall Study|overdose|0|||
155424759|NCT01959165|560982440|FG002|Overall Study|overdose|0|||
155424760|NCT01959165|560982441|FG003|Overall Study|overdose|1|||
155424761|NCT01959165|560982438|FG000|Overall Study|Welfare recipient|0|||
155424762|NCT01959165|560982439|FG001|Overall Study|Welfare recipient|1|||
155424763|NCT01959165|560982440|FG002|Overall Study|Welfare recipient|0|||
155424764|NCT01959165|560982441|FG003|Overall Study|Welfare recipient|0|||
155424765|NCT00961961|560982442|FG000|Phase I|Withdrawal by Subject|7|||
155347479|NCT01261793|560704931|FG000|Overall Study|Patient non-compliance|1|||
155347480|NCT01261793|560704932|FG001|Overall Study|Patient non-compliance|0|||
155347481|NCT01261793|560704933|FG002|Overall Study|Patient non-compliance|1|||
155347482|NCT01261793|560704931|FG000|Overall Study|Patient pregnant|1|||
155424766|NCT00961961|560982443|FG001|Phase I|Withdrawal by Subject|0|||
155424767|NCT00961961|560982444|FG002|Phase I|Withdrawal by Subject|0|||
155424768|NCT00961961|560982445|FG003|Phase I|Withdrawal by Subject|0|||
155347483|NCT01261793|560704932|FG001|Overall Study|Patient pregnant|0|||
155505948|NCT02367781|561278286|FG000|Overall Study|Study Terminated by Sponsor|3|||
155505949|NCT02367781|561278287|FG001|Overall Study|Study Terminated by Sponsor|1|||
155647951|NCT03093870|561803726|FG002|Overall Study|Lost to Follow-up|1|||
155647952|NCT02318277|561803727|FG000|Overall Study|Physician Decision|0|||
155347484|NCT01261793|560704933|FG002|Overall Study|Patient pregnant|0|||
155347485|NCT01261793|560704931|FG000|Overall Study|Outside the study area|0|||
155347486|NCT01261793|560704932|FG001|Overall Study|Outside the study area|2|||
155347487|NCT01261793|560704933|FG002|Overall Study|Outside the study area|1|||
155347488|NCT01261793|560704931|FG000|Overall Study|Lack of efficacy & patient not available|0|||
155347489|NCT01261793|560704932|FG001|Overall Study|Lack of efficacy & patient not available|1|||
155347490|NCT01261793|560704933|FG002|Overall Study|Lack of efficacy & patient not available|0|||
155347491|NCT01261793|560704931|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
155347492|NCT01261793|560704932|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
155347493|NCT01261793|560704933|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
155347494|NCT01261793|560704931|FG000|Overall Study|Randomization error|0|||
155347495|NCT01261793|560704932|FG001|Overall Study|Randomization error|1|||
155505950|NCT02367781|561278286|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
155505951|NCT02367781|561278287|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
155505952|NCT02367781|561278286|FG000|Overall Study|Sponsor Decision|2|||
155505953|NCT02367781|561278287|FG001|Overall Study|Sponsor Decision|0|||
155505954|NCT02367781|561278286|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
155647953|NCT02318277|561803728|FG001|Overall Study|Physician Decision|0|||
155505955|NCT02367781|561278287|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
155647954|NCT02318277|561803729|FG002|Overall Study|Physician Decision|0|||
155647955|NCT02318277|561803730|FG003|Overall Study|Physician Decision|0|||
155347496|NCT01261793|560704933|FG002|Overall Study|Randomization error|0|||
155347497|NCT01261793|560704931|FG000|Overall Study|Patient unable to start IV line|0|||
155347498|NCT01261793|560704932|FG001|Overall Study|Patient unable to start IV line|0|||
155347499|NCT01261793|560704933|FG002|Overall Study|Patient unable to start IV line|1|||
155347500|NCT03219216|560704934|FG000|Overall Study|Lost to Follow-up|0|||
155347501|NCT03219216|560704935|FG001|Overall Study|Lost to Follow-up|1|||
155347502|NCT03305458|560704936|FG000|Overall Study|Withdrawal by Subject|50|||
155347503|NCT03305458|560704937|FG001|Overall Study|Withdrawal by Subject|46|||
155347504|NCT03305458|560704938|FG002|Overall Study|Withdrawal by Subject|93|||
155347505|NCT03305458|560704936|FG000|Overall Study|Lost to Follow-up|85|||
155347506|NCT03305458|560704937|FG001|Overall Study|Lost to Follow-up|85|||
155347507|NCT03305458|560704938|FG002|Overall Study|Lost to Follow-up|35|||
155347508|NCT02332824|560704939|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
155347509|NCT02332824|560704940|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155347510|NCT02332824|560704941|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155347511|NCT02332824|560704942|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155347512|NCT02332824|560704943|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
155347513|NCT02332824|560704944|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
155347514|NCT02332824|560704939|FG000|Overall Study|Voluntary Withdrawal|1|||
155347515|NCT02332824|560704940|FG001|Overall Study|Voluntary Withdrawal|0|||
155347516|NCT02332824|560704941|FG002|Overall Study|Voluntary Withdrawal|0|||
155347517|NCT02332824|560704942|FG003|Overall Study|Voluntary Withdrawal|0|||
155347518|NCT02332824|560704943|FG004|Overall Study|Voluntary Withdrawal|0|||
155347519|NCT02332824|560704944|FG005|Overall Study|Voluntary Withdrawal|0|||
155347520|NCT02332824|560704939|FG000|Overall Study|Inconvenient schedule|1|||
155347521|NCT02332824|560704940|FG001|Overall Study|Inconvenient schedule|1|||
155347522|NCT02332824|560704941|FG002|Overall Study|Inconvenient schedule|0|||
155347523|NCT02332824|560704942|FG003|Overall Study|Inconvenient schedule|0|||
155347524|NCT02332824|560704943|FG004|Overall Study|Inconvenient schedule|0|||
155347525|NCT02332824|560704944|FG005|Overall Study|Inconvenient schedule|0|||
155347526|NCT02332824|560704939|FG000|Overall Study|Transfer|0|||
155647956|NCT02318277|561803731|FG004|Overall Study|Physician Decision|0|||
155647957|NCT02318277|561803732|FG005|Overall Study|Physician Decision|0|||
155647958|NCT02318277|561803733|FG006|Overall Study|Physician Decision|0|||
155347527|NCT02332824|560704940|FG001|Overall Study|Transfer|0|||
155347528|NCT02332824|560704941|FG002|Overall Study|Transfer|1|||
155347529|NCT02332824|560704942|FG003|Overall Study|Transfer|1|||
155347530|NCT02332824|560704943|FG004|Overall Study|Transfer|0|||
155347531|NCT02332824|560704944|FG005|Overall Study|Transfer|0|||
155347532|NCT00498797|560704945|FG000|Overall Study|Withdrawal by Subject|4|||
155347533|NCT00498797|560704946|FG001|Overall Study|Withdrawal by Subject|2|||
155347534|NCT00498797|560704945|FG000|Overall Study|Adverse Event|12|||
155347535|NCT00498797|560704946|FG001|Overall Study|Adverse Event|5|||
155347536|NCT00498797|560704945|FG000|Overall Study|Condition under investigation worsened|19|||
155347537|NCT00498797|560704946|FG001|Overall Study|Condition under investigation worsened|21|||
155347538|NCT00498797|560704945|FG000|Overall Study|Other|3|||
155347539|NCT00498797|560704946|FG001|Overall Study|Other|1|||
155347540|NCT03562117|560704947|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
155347541|NCT03562117|560704948|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
155347542|NCT03562117|560704949|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
155347543|NCT03928821|560704950|FG000|Overall Study|Death|0|||
155347544|NCT03928821|560704951|FG001|Overall Study|Death|1|||
155347545|NCT03928821|560704952|FG002|Overall Study|Death|0|||
155347546|NCT03928821|560704953|FG003|Overall Study|Death|0|||
155347547|NCT03928821|560704950|FG000|Overall Study|Lost to Follow-up|0|||
155347548|NCT03928821|560704951|FG001|Overall Study|Lost to Follow-up|2|||
155347549|NCT03928821|560704952|FG002|Overall Study|Lost to Follow-up|3|||
155347550|NCT03928821|560704953|FG003|Overall Study|Lost to Follow-up|0|||
155347551|NCT03928821|560704950|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347552|NCT03928821|560704951|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347553|NCT03928821|560704952|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347554|NCT03928821|560704953|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155347555|NCT04743999|560704960|FG000|3-month Questionnaire|Death|1|||
155347556|NCT04743999|560704960|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
155347557|NCT04743999|560704960|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
155347558|NCT04743999|560704960|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
155347559|NCT01721759|560704961|FG000|Treatment Period|Disease Progression|85|||
155347560|NCT01721759|560704961|FG000|Treatment Period|Study drug toxicity|14|||
155347561|NCT01721759|560704961|FG000|Treatment Period|Death|1|||
155347562|NCT01721759|560704961|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
155347563|NCT01721759|560704961|FG000|Treatment Period|Participant request to withdraw|3|||
155347564|NCT01721759|560704961|FG000|Treatment Period|Other Reasons|3|||
155347565|NCT01721759|560704961|FG000|End of Study Period|Participant Withdrew Consent|5|||
155347566|NCT01721759|560704961|FG000|End of Study Period|Death|101|||
155347567|NCT01721759|560704961|FG000|End of Study Period|Lost to Follow-up|1|||
155347568|NCT01721759|560704961|FG000|End of Study Period|Other Reasons|10|||
155347569|NCT03138499|560704967|FG000|Overall Study|Lost to Follow-up|1|||
155347570|NCT03138499|560704968|FG001|Overall Study|Lost to Follow-up|0|||
155347571|NCT03138499|560704967|FG000|Overall Study|Participants withdrew consent|1|||
155347572|NCT03138499|560704968|FG001|Overall Study|Participants withdrew consent|0|||
155347573|NCT03138499|560704967|FG000|Overall Study|Participant discontinued study before treatment|0|||
155347574|NCT03138499|560704968|FG001|Overall Study|Participant discontinued study before treatment|1|||
155347575|NCT03138499|560704967|FG000|Overall Study|Disease Progression|2|||
155347576|NCT03138499|560704968|FG001|Overall Study|Disease Progression|6|||
155347577|NCT03138499|560704967|FG000|Overall Study|Study drug toxicity|2|||
155347578|NCT03138499|560704968|FG001|Overall Study|Study drug toxicity|2|||
155347579|NCT03138499|560704967|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155347580|NCT03138499|560704968|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155347581|NCT03138499|560704967|FG000|Overall Study|Other reasons|2|||
155347582|NCT03138499|560704968|FG001|Overall Study|Other reasons|0|||
155347583|NCT01123200|560704972|FG000|Overall Study|Withdrawal by Subject|1|||
155347584|NCT01052714|560704975|FG000|Overall Study|Adverse Event|6|||
155347585|NCT01052714|560704976|FG001|Overall Study|Adverse Event|3|||
155347586|NCT01052714|560704977|FG002|Overall Study|Adverse Event|0|||
155347587|NCT01052714|560704975|FG000|Overall Study|Death|1|||
155347588|NCT01052714|560704976|FG001|Overall Study|Death|2|||
155347589|NCT01052714|560704977|FG002|Overall Study|Death|0|||
155347590|NCT01052714|560704975|FG000|Overall Study|Lost to Follow-up|2|||
155347591|NCT01052714|560704976|FG001|Overall Study|Lost to Follow-up|3|||
155347592|NCT01052714|560704977|FG002|Overall Study|Lost to Follow-up|0|||
155347593|NCT01052714|560704975|FG000|Overall Study|Physician Decision|9|||
155347594|NCT01052714|560704976|FG001|Overall Study|Physician Decision|9|||
155347595|NCT01052714|560704977|FG002|Overall Study|Physician Decision|1|||
155347596|NCT01052714|560704975|FG000|Overall Study|Withdrawal by Subject|7|||
155347597|NCT01052714|560704976|FG001|Overall Study|Withdrawal by Subject|12|||
155347598|NCT01052714|560704977|FG002|Overall Study|Withdrawal by Subject|1|||
155347599|NCT01636778|560704990|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
155347600|NCT01636778|560704991|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
155347601|NCT01636778|560704992|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
155347602|NCT01636778|560704990|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
155347603|NCT01636778|560704991|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
155347604|NCT01636778|560704992|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
155347605|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
155424769|NCT00961961|560982442|FG000|Phase I|Lost to Follow-up|10|||
155347606|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
155347607|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
155347608|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
155347609|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
155347610|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
155347611|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
155347612|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
155347613|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
155347614|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Other|0|||
155347615|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Other|0|||
155347616|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Other|1|||
155347617|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
155347618|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
155347619|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
155347620|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
155347621|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
155347622|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
155347623|NCT00170950|560704993|FG000|Overall Study|Death|236|||
155347624|NCT00170950|560704994|FG001|Overall Study|Death|274|||
155347625|NCT00170950|560704993|FG000|Overall Study|Withdrawal by Subject|496|||
155347626|NCT00170950|560704994|FG001|Overall Study|Withdrawal by Subject|498|||
155347627|NCT00170950|560704993|FG000|Overall Study|Lost to Follow-up|134|||
155347628|NCT00170950|560704994|FG001|Overall Study|Lost to Follow-up|115|||
155347629|NCT00170950|560704993|FG000|Overall Study|Missing|2|||
155347630|NCT00170950|560704994|FG001|Overall Study|Missing|1|||
155347631|NCT00170950|560704993|FG000|Overall Study|Termination Data Not Recorded|17|||
155347632|NCT00170950|560704994|FG001|Overall Study|Termination Data Not Recorded|22|||
155347633|NCT00748098|560704995|FG000|First Treatment Intervention Period|Adverse Event|1|||
155347634|NCT00748098|560704996|FG001|First Treatment Intervention Period|Adverse Event|1|||
155347635|NCT00748098|560704995|FG000|First Treatment Intervention Period|Protocol Violation|1|||
155347636|NCT00748098|560704996|FG001|First Treatment Intervention Period|Protocol Violation|0|||
155347637|NCT00748098|560704995|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
155347638|NCT00748098|560704996|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
155347639|NCT00748098|560704995|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
155347640|NCT00748098|560704996|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
155347641|NCT00748098|560704995|FG000|First Taper Period|Protocol Violation|1|||
155347642|NCT00748098|560704996|FG001|First Taper Period|Protocol Violation|0|||
155347643|NCT00748098|560704995|FG000|First Taper Period|Withdrawal by Subject|2|||
155347644|NCT00748098|560704996|FG001|First Taper Period|Withdrawal by Subject|0|||
155347645|NCT00748098|560704995|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
155347646|NCT00748098|560704996|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
155347647|NCT00748098|560704995|FG000|1-Week Washout Period|Adverse Event|0|||
155347648|NCT00748098|560704996|FG001|1-Week Washout Period|Adverse Event|1|||
155347649|NCT00748098|560704995|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
155347650|NCT00748098|560704996|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
155347651|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Adverse Event|4|||
155347652|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Adverse Event|1|||
155347653|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
155347654|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
155347655|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
155424770|NCT00961961|560982443|FG001|Phase I|Lost to Follow-up|0|||
155424771|NCT00961961|560982444|FG002|Phase I|Lost to Follow-up|0|||
155424772|NCT00961961|560982445|FG003|Phase I|Lost to Follow-up|0|||
155424773|NCT00961961|560982442|FG000|Phase I|Lack of Efficacy|94|||
155424774|NCT00961961|560982443|FG001|Phase I|Lack of Efficacy|0|||
155424775|NCT00961961|560982444|FG002|Phase I|Lack of Efficacy|0|||
155424776|NCT00961961|560982445|FG003|Phase I|Lack of Efficacy|0|||
155424777|NCT00961961|560982442|FG000|Phase I|Adverse Event|7|||
155424778|NCT00961961|560982443|FG001|Phase I|Adverse Event|0|||
155424779|NCT00961961|560982444|FG002|Phase I|Adverse Event|0|||
155424780|NCT00961961|560982445|FG003|Phase I|Adverse Event|0|||
155347656|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
155347657|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
155347658|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
155347659|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
155347660|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
155347661|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
155347662|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
155347663|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
155424781|NCT00961961|560982442|FG000|Phase I|Physician Decision|8|||
155424782|NCT00961961|560982443|FG001|Phase I|Physician Decision|0|||
155347664|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
155347665|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
155347666|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
155347667|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
155347668|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
155347669|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
155347670|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
155347671|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
155347672|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
155347673|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
155347674|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
155347675|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
155347676|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
155347677|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
155347678|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
155347679|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
155347680|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
155347681|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
155347682|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
155347683|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
155347684|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
155347685|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
155347686|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
155347687|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
155347688|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
155347689|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
155347690|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
155347691|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
155347692|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
155347693|NCT00792259|560706464|FG000|Overall Study|Poor Quality Scans|1|||
155347694|NCT00792259|560706465|FG001|Overall Study|Poor Quality Scans|0|||
155347695|NCT00792259|560706466|FG002|Overall Study|Poor Quality Scans|0|||
155347696|NCT03721978|560706467|FG000|Overall Study|Withdrawal by Subject|6|||
155347697|NCT03721978|560706468|FG001|Overall Study|Withdrawal by Subject|1|||
155347698|NCT03721978|560706467|FG000|Overall Study|Adverse Event|1|||
155347699|NCT03721978|560706468|FG001|Overall Study|Adverse Event|1|||
155347700|NCT03721978|560706467|FG000|Overall Study|Progressive Disease|1|||
155347701|NCT03721978|560706468|FG001|Overall Study|Progressive Disease|0|||
155347702|NCT03721978|560706467|FG000|Overall Study|Lost to Follow-up|5|||
155347703|NCT03721978|560706468|FG001|Overall Study|Lost to Follow-up|1|||
155347704|NCT03721978|560706467|FG000|Overall Study|Reason not Specified|0|||
155347705|NCT03721978|560706468|FG001|Overall Study|Reason not Specified|2|||
155347706|NCT05244226|560706469|FG000|Overall Study|Adverse Event|1|||
155424783|NCT00961961|560982444|FG002|Phase I|Physician Decision|0|||
155424784|NCT00961961|560982445|FG003|Phase I|Physician Decision|0|||
155424785|NCT00961961|560982442|FG000|Phase II|Lost to Follow-up|0|||
155424786|NCT00961961|560982443|FG001|Phase II|Lost to Follow-up|0|||
155347707|NCT05244226|560706470|FG001|Overall Study|Adverse Event|0|||
155347708|NCT05244226|560706471|FG002|Overall Study|Adverse Event|0|||
155347709|NCT05244226|560706469|FG000|Overall Study|Lost to Follow-up|0|||
155347710|NCT05244226|560706470|FG001|Overall Study|Lost to Follow-up|0|||
155347711|NCT05244226|560706471|FG002|Overall Study|Lost to Follow-up|1|||
155347712|NCT05244226|560706469|FG000|Overall Study|Protocol Violation|0|||
155347713|NCT05244226|560706470|FG001|Overall Study|Protocol Violation|2|||
155347714|NCT05244226|560706471|FG002|Overall Study|Protocol Violation|2|||
155347715|NCT04050722|560706480|FG000|Overall Study|Withdrawal by Subject|1|||
155347716|NCT04050722|560706481|FG001|Overall Study|Withdrawal by Subject|0|||
155347717|NCT00377312|560706482|FG000|Overall Study|Adverse Event|1|||
155347718|NCT00377312|560706483|FG001|Overall Study|Adverse Event|1|||
155347719|NCT03451292|560706486|FG000|Overall Study|Death|44|||
155347720|NCT03451292|560706487|FG001|Overall Study|Death|59|||
155347721|NCT03451292|560706486|FG000|Overall Study|Withdrawal by Subject|18|||
155347722|NCT03451292|560706487|FG001|Overall Study|Withdrawal by Subject|13|||
155347723|NCT03451292|560706486|FG000|Overall Study|Transplantation|18|||
155347724|NCT03451292|560706487|FG001|Overall Study|Transplantation|12|||
155347725|NCT03451292|560706486|FG000|Overall Study|Lost to Follow-up|4|||
155347726|NCT03451292|560706487|FG001|Overall Study|Lost to Follow-up|12|||
155347727|NCT03451292|560706486|FG000|Overall Study|Physician Decision|4|||
155347728|NCT03451292|560706487|FG001|Overall Study|Physician Decision|3|||
155347729|NCT03451292|560706486|FG000|Overall Study|Adverse Event|3|||
155347730|NCT03451292|560706487|FG001|Overall Study|Adverse Event|3|||
155347731|NCT03451292|560706486|FG000|Overall Study|Non-compliance with Study Drug|2|||
155347732|NCT03451292|560706487|FG001|Overall Study|Non-compliance with Study Drug|0|||
155347733|NCT01572493|560706490|FG000|Overall Study|Physician Decision|1|||
155347734|NCT01572493|560706491|FG001|Overall Study|Physician Decision|0|||
155347735|NCT01572493|560706492|FG002|Overall Study|Physician Decision|0|||
155347736|NCT01572493|560706493|FG003|Overall Study|Physician Decision|0|||
155347737|NCT01572493|560706494|FG004|Overall Study|Physician Decision|0|||
155347738|NCT01572493|560706495|FG005|Overall Study|Physician Decision|0|||
155347739|NCT01572493|560706496|FG006|Overall Study|Physician Decision|0|||
155347740|NCT01572493|560706497|FG007|Overall Study|Physician Decision|0|||
155347741|NCT01572493|560706498|FG008|Overall Study|Physician Decision|0|||
155347742|NCT01572493|560706490|FG000|Overall Study|Switched to alternative treatment|0|||
155347743|NCT01572493|560706491|FG001|Overall Study|Switched to alternative treatment|1|||
155347744|NCT01572493|560706492|FG002|Overall Study|Switched to alternative treatment|2|||
155347745|NCT01572493|560706493|FG003|Overall Study|Switched to alternative treatment|1|||
155347746|NCT01572493|560706494|FG004|Overall Study|Switched to alternative treatment|2|||
155347747|NCT01572493|560706495|FG005|Overall Study|Switched to alternative treatment|0|||
155347748|NCT01572493|560706496|FG006|Overall Study|Switched to alternative treatment|2|||
155347749|NCT01572493|560706497|FG007|Overall Study|Switched to alternative treatment|0|||
155347750|NCT01572493|560706498|FG008|Overall Study|Switched to alternative treatment|2|||
155347751|NCT01572493|560706490|FG000|Overall Study|Death|0|||
155347752|NCT01572493|560706491|FG001|Overall Study|Death|0|||
155347753|NCT01572493|560706492|FG002|Overall Study|Death|0|||
155347754|NCT01572493|560706493|FG003|Overall Study|Death|1|||
155347755|NCT01572493|560706494|FG004|Overall Study|Death|0|||
155347756|NCT01572493|560706495|FG005|Overall Study|Death|1|||
155347757|NCT01572493|560706496|FG006|Overall Study|Death|0|||
155347758|NCT01572493|560706497|FG007|Overall Study|Death|0|||
155347759|NCT01572493|560706498|FG008|Overall Study|Death|0|||
155347760|NCT01572493|560706490|FG000|Overall Study|Adverse Event|0|||
155347761|NCT01572493|560706491|FG001|Overall Study|Adverse Event|0|||
155347762|NCT01572493|560706492|FG002|Overall Study|Adverse Event|0|||
155347763|NCT01572493|560706493|FG003|Overall Study|Adverse Event|0|||
155347764|NCT01572493|560706494|FG004|Overall Study|Adverse Event|0|||
155347765|NCT01572493|560706495|FG005|Overall Study|Adverse Event|0|||
155347766|NCT01572493|560706496|FG006|Overall Study|Adverse Event|1|||
155347767|NCT01572493|560706497|FG007|Overall Study|Adverse Event|0|||
155347768|NCT01572493|560706498|FG008|Overall Study|Adverse Event|0|||
155347769|NCT01090076|560706499|FG000|Overall Study|Death|1|||
155347770|NCT01090076|560706500|FG001|Overall Study|Death|1|||
155347771|NCT01090076|560706499|FG000|Overall Study|Withdrawal by Subject|0|||
155347772|NCT01090076|560706500|FG001|Overall Study|Withdrawal by Subject|1|||
155424787|NCT00961961|560982444|FG002|Phase II|Lost to Follow-up|10|||
155424788|NCT00961961|560982445|FG003|Phase II|Lost to Follow-up|7|||
155347773|NCT00191984|560706510|FG000|Overall Study|Disease Progression|21|||
155347774|NCT00191984|560706510|FG000|Overall Study|Adverse Event|4|||
155347775|NCT00191984|560706510|FG000|Overall Study|Death|2|||
155347776|NCT00191984|560706510|FG000|Overall Study|Entry Criteria Exclusion|1|||
155347777|NCT00191984|560706510|FG000|Overall Study|Withdrawal by Subject|7|||
155347778|NCT00191984|560706510|FG000|Overall Study|Physician Decision|4|||
155347779|NCT01654289|560706511|FG000|Overall Study|Withdrawal by Subject|10|||
155347780|NCT01654289|560706512|FG001|Overall Study|Withdrawal by Subject|8|||
155347781|NCT01654289|560706513|FG002|Overall Study|Withdrawal by Subject|5|||
155347782|NCT01654289|560706511|FG000|Overall Study|Withdrew from intervention only|17|||
155347783|NCT01654289|560706512|FG001|Overall Study|Withdrew from intervention only|20|||
155347784|NCT01654289|560706513|FG002|Overall Study|Withdrew from intervention only|0|||
155347785|NCT04748445|560706517|FG000|Overall Study|No longer met eligibility criteria|12|||
155347786|NCT04748445|560706517|FG000|Overall Study|Other|36|||
155347787|NCT04748445|560706517|FG000|Overall Study|Withdrawal by Subject|553|||
155347788|NCT04748445|560706517|FG000|Overall Study|Lost to Follow-up|30|||
155347789|NCT04736602|560706518|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
155347790|NCT04736602|560706518|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
155347791|NCT00938041|560706525|FG000|Overall Study|Lost to Follow-up|6|||
155347792|NCT00938041|560706525|FG000|Overall Study|Received Alternative Therapy|1|||
155347793|NCT00938041|560706525|FG000|Overall Study|Progressive Disease|5|||
155347794|NCT00938041|560706525|FG000|Overall Study|Death|12|||
155347795|NCT00938041|560706525|FG000|Overall Study|Adrenal Insufficiency|3|||
155347796|NCT03042559|560706526|FG000|Overall Study|drop out|1|||
155347797|NCT03042559|560706527|FG001|Overall Study|drop out|1|||
155347798|NCT01536535|560706531|FG000|Overall Study|Withdrawal by Subject|10|||
155347799|NCT01536535|560706532|FG001|Overall Study|Withdrawal by Subject|5|||
155347800|NCT01536535|560706531|FG000|Overall Study|Lost to Follow-up|4|||
155347801|NCT01536535|560706532|FG001|Overall Study|Lost to Follow-up|6|||
155347802|NCT01536535|560706531|FG000|Overall Study|Physician Decision|1|||
155347803|NCT01536535|560706532|FG001|Overall Study|Physician Decision|1|||
155347804|NCT01536535|560706531|FG000|Overall Study|Participant moved|0|||
155347805|NCT01536535|560706532|FG001|Overall Study|Participant moved|1|||
155347806|NCT00404547|560706533|FG000|Overall Study|Adverse Event|39|||
155347807|NCT00404547|560706534|FG001|Overall Study|Adverse Event|6|||
155347808|NCT00404547|560706533|FG000|Overall Study|Withdrawal by Subject|19|||
155347809|NCT00404547|560706534|FG001|Overall Study|Withdrawal by Subject|2|||
155347810|NCT00404547|560706533|FG000|Overall Study|Protocol Violation|0|||
155347811|NCT00404547|560706534|FG001|Overall Study|Protocol Violation|1|||
155347812|NCT00404547|560706533|FG000|Overall Study|Lost to Follow-up|20|||
155347813|NCT00404547|560706534|FG001|Overall Study|Lost to Follow-up|9|||
155347814|NCT00404547|560706533|FG000|Overall Study|Lack of compliance|5|||
155347815|NCT00404547|560706534|FG001|Overall Study|Lack of compliance|1|||
155347816|NCT00404547|560706533|FG000|Overall Study|Other|4|||
155347817|NCT00404547|560706534|FG001|Overall Study|Other|0|||
155347818|NCT00404547|560706533|FG000|Overall Study|Reason not stated|3|||
155347819|NCT00404547|560706534|FG001|Overall Study|Reason not stated|6|||
155347820|NCT01485991|560706535|FG000|Overall Study|Adverse Event|0|||
155347821|NCT01485991|560706536|FG001|Overall Study|Adverse Event|4|||
155347822|NCT01485991|560706535|FG000|Overall Study|Lost to Follow-up|13|||
155347823|NCT01485991|560706536|FG001|Overall Study|Lost to Follow-up|10|||
155347824|NCT01485991|560706535|FG000|Overall Study|Withdrawal by Subject|13|||
155347825|NCT01485991|560706536|FG001|Overall Study|Withdrawal by Subject|20|||
155347826|NCT01485991|560706535|FG000|Overall Study|randomized but not treated|6|||
155347827|NCT01485991|560706536|FG001|Overall Study|randomized but not treated|2|||
155347828|NCT01475370|560706537|FG000|Overall Study|Exacerbation of primary disease|2|||
155347829|NCT01475370|560706538|FG001|Overall Study|Exacerbation of primary disease|2|||
155347830|NCT01475370|560706539|FG002|Overall Study|Exacerbation of primary disease|2|||
155347831|NCT01475370|560706537|FG000|Overall Study|Study drug administration difficult|0|||
155347832|NCT01475370|560706538|FG001|Overall Study|Study drug administration difficult|1|||
155347833|NCT01475370|560706539|FG002|Overall Study|Study drug administration difficult|1|||
155347834|NCT01475370|560706537|FG000|Overall Study|Other than specified|1|||
155347835|NCT01475370|560706538|FG001|Overall Study|Other than specified|0|||
155347836|NCT01475370|560706539|FG002|Overall Study|Other than specified|0|||
155347837|NCT02538471|560706540|FG000|Overall Study|Progression of disease|2|||
155347838|NCT00475735|560706541|FG000|Treatment Period 1|Adverse Event|2|||
155347839|NCT00475735|560706542|FG001|Treatment Period 1|Adverse Event|0|||
155347840|NCT00475735|560706543|FG002|Treatment Period 1|Adverse Event|0|||
155347841|NCT00475735|560706544|FG003|Treatment Period 1|Adverse Event|0|||
155347842|NCT00475735|560706545|FG004|Treatment Period 1|Adverse Event|0|||
155347843|NCT00475735|560706546|FG005|Treatment Period 1|Adverse Event|0|||
155347844|NCT00475735|560706541|FG000|Treatment Period 1|Lack of Efficacy|1|||
155347845|NCT00475735|560706542|FG001|Treatment Period 1|Lack of Efficacy|0|||
155347846|NCT00475735|560706543|FG002|Treatment Period 1|Lack of Efficacy|0|||
155347847|NCT00475735|560706544|FG003|Treatment Period 1|Lack of Efficacy|0|||
155347848|NCT00475735|560706545|FG004|Treatment Period 1|Lack of Efficacy|0|||
155347849|NCT00475735|560706546|FG005|Treatment Period 1|Lack of Efficacy|0|||
155347850|NCT00475735|560706541|FG000|Treatment Period 1|Lost to Follow-up|0|||
155347851|NCT00475735|560706542|FG001|Treatment Period 1|Lost to Follow-up|0|||
155347852|NCT00475735|560706543|FG002|Treatment Period 1|Lost to Follow-up|0|||
155347853|NCT00475735|560706544|FG003|Treatment Period 1|Lost to Follow-up|0|||
155347854|NCT00475735|560706545|FG004|Treatment Period 1|Lost to Follow-up|0|||
155347855|NCT00475735|560706546|FG005|Treatment Period 1|Lost to Follow-up|1|||
155347856|NCT00475735|560706541|FG000|Treatment Period 1|Protocol Violation|0|||
155347857|NCT00475735|560706542|FG001|Treatment Period 1|Protocol Violation|0|||
155347858|NCT00475735|560706543|FG002|Treatment Period 1|Protocol Violation|0|||
155347859|NCT00475735|560706544|FG003|Treatment Period 1|Protocol Violation|1|||
155347860|NCT00475735|560706545|FG004|Treatment Period 1|Protocol Violation|0|||
155347861|NCT00475735|560706546|FG005|Treatment Period 1|Protocol Violation|0|||
155347862|NCT00475735|560706541|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155424789|NCT00961961|560982442|FG000|Phase II|Adverse Event|0|||
155424790|NCT00961961|560982443|FG001|Phase II|Adverse Event|0|||
155424791|NCT00961961|560982444|FG002|Phase II|Adverse Event|0|||
155424792|NCT00961961|560982445|FG003|Phase II|Adverse Event|1|||
155424793|NCT00961961|560982442|FG000|Phase II|Physician Decision|0|||
155424794|NCT00961961|560982443|FG001|Phase II|Physician Decision|0|||
155424795|NCT00961961|560982444|FG002|Phase II|Physician Decision|1|||
155424796|NCT00961961|560982445|FG003|Phase II|Physician Decision|0|||
155424797|NCT00961961|560982442|FG000|Phase II|Withdrawal by Subject|0|||
155424798|NCT00961961|560982443|FG001|Phase II|Withdrawal by Subject|0|||
155424799|NCT00961961|560982444|FG002|Phase II|Withdrawal by Subject|1|||
155424800|NCT00961961|560982445|FG003|Phase II|Withdrawal by Subject|0|||
155424801|NCT01870739|560982453|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
155424802|NCT01870739|560982454|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
155347863|NCT00475735|560706542|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155347864|NCT00475735|560706543|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155347865|NCT00475735|560706544|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155347866|NCT00475735|560706545|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155424803|NCT01870739|560982453|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
155424804|NCT01870739|560982454|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
155647959|NCT02318277|561803734|FG007|Overall Study|Physician Decision|1|||
155424805|NCT01870739|560982453|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
155424806|NCT01870739|560982454|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
155424807|NCT01870739|560982453|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
155424808|NCT01870739|560982454|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
155424809|NCT01870739|560982453|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
155424810|NCT01870739|560982454|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
155424811|NCT01870739|560982453|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
155424812|NCT01870739|560982454|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
155424813|NCT01870739|560982453|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
155424814|NCT01870739|560982454|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
155424815|NCT01926626|560982456|FG000|Overall Study|Withdrawal by Subject|15|||
155424816|NCT01926626|560982456|FG000|Overall Study|Lost to Follow-up|7|||
155424817|NCT03283085|560982459|FG000|Overall Study|Adverse Event|18|||
155424818|NCT03283085|560982460|FG001|Overall Study|Adverse Event|3|||
155424819|NCT03283085|560982461|FG002|Overall Study|Adverse Event|13|||
155424820|NCT03283085|560982462|FG003|Overall Study|Adverse Event|0|||
155424821|NCT03283085|560982463|FG004|Overall Study|Adverse Event|0|||
155424822|NCT03283085|560982464|FG005|Overall Study|Adverse Event|5|||
155424823|NCT03283085|560982459|FG000|Overall Study|Death|0|||
155424824|NCT03283085|560982460|FG001|Overall Study|Death|0|||
155424825|NCT03283085|560982461|FG002|Overall Study|Death|3|||
155424826|NCT03283085|560982462|FG003|Overall Study|Death|1|||
155424827|NCT03283085|560982463|FG004|Overall Study|Death|0|||
155424828|NCT03283085|560982464|FG005|Overall Study|Death|0|||
155424829|NCT03283085|560982459|FG000|Overall Study|Withdrawal by Subject|42|||
155424830|NCT03283085|560982460|FG001|Overall Study|Withdrawal by Subject|21|||
155424831|NCT03283085|560982461|FG002|Overall Study|Withdrawal by Subject|66|||
155424832|NCT03283085|560982462|FG003|Overall Study|Withdrawal by Subject|3|||
155424833|NCT03283085|560982463|FG004|Overall Study|Withdrawal by Subject|3|||
155424834|NCT03283085|560982464|FG005|Overall Study|Withdrawal by Subject|5|||
155424835|NCT03283085|560982459|FG000|Overall Study|Physician Decision|14|||
155424836|NCT03283085|560982460|FG001|Overall Study|Physician Decision|8|||
155424837|NCT03283085|560982461|FG002|Overall Study|Physician Decision|19|||
155424838|NCT03283085|560982462|FG003|Overall Study|Physician Decision|0|||
155424839|NCT03283085|560982463|FG004|Overall Study|Physician Decision|0|||
155424840|NCT03283085|560982464|FG005|Overall Study|Physician Decision|2|||
155424841|NCT03283085|560982459|FG000|Overall Study|Site Terminated by Sponsor|1|||
155424842|NCT03283085|560982460|FG001|Overall Study|Site Terminated by Sponsor|0|||
155424843|NCT03283085|560982461|FG002|Overall Study|Site Terminated by Sponsor|3|||
155424844|NCT03283085|560982462|FG003|Overall Study|Site Terminated by Sponsor|0|||
155424845|NCT03283085|560982463|FG004|Overall Study|Site Terminated by Sponsor|0|||
155424846|NCT03283085|560982464|FG005|Overall Study|Site Terminated by Sponsor|0|||
155424847|NCT03283085|560982459|FG000|Overall Study|Lost to Follow-up|2|||
155424848|NCT03283085|560982460|FG001|Overall Study|Lost to Follow-up|0|||
155424849|NCT03283085|560982461|FG002|Overall Study|Lost to Follow-up|2|||
155424850|NCT03283085|560982462|FG003|Overall Study|Lost to Follow-up|0|||
155424851|NCT03283085|560982463|FG004|Overall Study|Lost to Follow-up|0|||
155424852|NCT03283085|560982464|FG005|Overall Study|Lost to Follow-up|1|||
155424853|NCT03283085|560982459|FG000|Overall Study|Pregnancy|0|||
155424854|NCT03283085|560982460|FG001|Overall Study|Pregnancy|0|||
155424855|NCT03283085|560982461|FG002|Overall Study|Pregnancy|1|||
155424856|NCT03283085|560982462|FG003|Overall Study|Pregnancy|0|||
155424857|NCT03283085|560982463|FG004|Overall Study|Pregnancy|0|||
155424858|NCT03283085|560982464|FG005|Overall Study|Pregnancy|0|||
155424859|NCT03283085|560982459|FG000|Overall Study|Lack of Efficacy|12|||
155424860|NCT03283085|560982460|FG001|Overall Study|Lack of Efficacy|6|||
155424861|NCT03283085|560982461|FG002|Overall Study|Lack of Efficacy|24|||
155424862|NCT03283085|560982462|FG003|Overall Study|Lack of Efficacy|1|||
155424863|NCT03283085|560982463|FG004|Overall Study|Lack of Efficacy|1|||
155424864|NCT03283085|560982464|FG005|Overall Study|Lack of Efficacy|0|||
155424865|NCT03283085|560982459|FG000|Overall Study|Reason not Specified|0|||
155424866|NCT03283085|560982460|FG001|Overall Study|Reason not Specified|4|||
155424867|NCT03283085|560982461|FG002|Overall Study|Reason not Specified|8|||
155424868|NCT03283085|560982462|FG003|Overall Study|Reason not Specified|0|||
155424869|NCT03283085|560982463|FG004|Overall Study|Reason not Specified|0|||
155424870|NCT03283085|560982464|FG005|Overall Study|Reason not Specified|1|||
155424871|NCT03136107|560982465|FG000|Overall Study|Other (Not specified)|1|||
155424872|NCT00891202|560982466|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
155424873|NCT00891202|560982467|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
155424874|NCT00891202|560982468|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
155424875|NCT00891202|560982469|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
155424876|NCT00891202|560982466|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
155424877|NCT00891202|560982467|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
155424878|NCT00891202|560982468|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
155424879|NCT00891202|560982469|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
155424880|NCT00891202|560982466|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
155424881|NCT00891202|560982467|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
155424882|NCT00891202|560982468|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
155424883|NCT00891202|560982469|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
155424884|NCT00891202|560982466|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
155424885|NCT00891202|560982467|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
155424886|NCT00891202|560982468|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
155424887|NCT00891202|560982469|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
155424888|NCT02292771|560982473|FG000|Overall Study|Withdrawal by Subject|2|||
155424889|NCT02292771|560982474|FG001|Overall Study|Withdrawal by Subject|1|||
155424890|NCT02292771|560982473|FG000|Overall Study|Lost to Follow-up|2|||
155424891|NCT02292771|560982474|FG001|Overall Study|Lost to Follow-up|1|||
155424892|NCT01468311|560982475|FG000|Overall Study|mobilization failure|1|||
155424893|NCT01468311|560982475|FG000|Overall Study|Withdrawal by Subject|1|||
155424894|NCT04840667|560984531|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
155424895|NCT04854499|560984534|FG000|Overall Study|Study Terminated by Sponsor|5|||
155424896|NCT04854499|560984535|FG001|Overall Study|Study Terminated by Sponsor|27|||
155424897|NCT04854499|560984536|FG002|Overall Study|Study Terminated by Sponsor|28|||
155424898|NCT04854499|560984537|FG003|Overall Study|Study Terminated by Sponsor|19|||
155424899|NCT04854499|560984538|FG004|Overall Study|Study Terminated by Sponsor|1|||
155424900|NCT04854499|560984539|FG005|Overall Study|Study Terminated by Sponsor|10|||
155424901|NCT04854499|560984534|FG000|Overall Study|Death|1|||
155424902|NCT04854499|560984535|FG001|Overall Study|Death|23|||
155424903|NCT04854499|560984536|FG002|Overall Study|Death|21|||
155424904|NCT04854499|560984537|FG003|Overall Study|Death|7|||
155347867|NCT00475735|560706546|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155347868|NCT00475735|560706541|FG000|Treatment Period 1|DC due to AE but continuing|0|||
155347869|NCT00475735|560706542|FG001|Treatment Period 1|DC due to AE but continuing|0|||
155347870|NCT00475735|560706543|FG002|Treatment Period 1|DC due to AE but continuing|0|||
155347871|NCT00475735|560706544|FG003|Treatment Period 1|DC due to AE but continuing|1|||
155347872|NCT00475735|560706545|FG004|Treatment Period 1|DC due to AE but continuing|2|||
155347873|NCT00475735|560706546|FG005|Treatment Period 1|DC due to AE but continuing|2|||
155347874|NCT00475735|560706541|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347875|NCT00475735|560706542|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
155347876|NCT00475735|560706543|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347877|NCT00475735|560706544|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347878|NCT00475735|560706545|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347879|NCT00475735|560706546|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347880|NCT00475735|560706541|FG000|Treatment Washout|Lost to Follow-up|0|||
155347881|NCT00475735|560706542|FG001|Treatment Washout|Lost to Follow-up|1|||
155347882|NCT00475735|560706543|FG002|Treatment Washout|Lost to Follow-up|0|||
155347883|NCT00475735|560706544|FG003|Treatment Washout|Lost to Follow-up|0|||
155347884|NCT00475735|560706545|FG004|Treatment Washout|Lost to Follow-up|0|||
155347885|NCT00475735|560706546|FG005|Treatment Washout|Lost to Follow-up|0|||
155347886|NCT00475735|560706541|FG000|Treatment Washout|Protocol Violation|0|||
155347887|NCT00475735|560706542|FG001|Treatment Washout|Protocol Violation|1|||
155347888|NCT00475735|560706543|FG002|Treatment Washout|Protocol Violation|0|||
155347889|NCT00475735|560706544|FG003|Treatment Washout|Protocol Violation|0|||
155347890|NCT00475735|560706545|FG004|Treatment Washout|Protocol Violation|0|||
155347891|NCT00475735|560706546|FG005|Treatment Washout|Protocol Violation|0|||
155424905|NCT04854499|560984538|FG004|Overall Study|Death|6|||
155424906|NCT04854499|560984539|FG005|Overall Study|Death|24|||
155424907|NCT04854499|560984534|FG000|Overall Study|Investigator's Discretion|0|||
155424908|NCT04854499|560984535|FG001|Overall Study|Investigator's Discretion|1|||
155424909|NCT04854499|560984536|FG002|Overall Study|Investigator's Discretion|3|||
155424910|NCT04854499|560984537|FG003|Overall Study|Investigator's Discretion|4|||
155424911|NCT04854499|560984538|FG004|Overall Study|Investigator's Discretion|1|||
155424912|NCT04854499|560984539|FG005|Overall Study|Investigator's Discretion|5|||
155424913|NCT04854499|560984534|FG000|Overall Study|Withdrew Consent|0|||
155424914|NCT04854499|560984535|FG001|Overall Study|Withdrew Consent|1|||
155424915|NCT04854499|560984536|FG002|Overall Study|Withdrew Consent|2|||
155347892|NCT00475735|560706541|FG000|Treatment Period 2|Adverse Event|0|||
155347893|NCT00475735|560706542|FG001|Treatment Period 2|Adverse Event|1|||
155347894|NCT00475735|560706543|FG002|Treatment Period 2|Adverse Event|0|||
155347895|NCT00475735|560706544|FG003|Treatment Period 2|Adverse Event|2|||
155347896|NCT00475735|560706545|FG004|Treatment Period 2|Adverse Event|0|||
155347897|NCT00475735|560706546|FG005|Treatment Period 2|Adverse Event|0|||
155347898|NCT00475735|560706541|FG000|Treatment Period 2|Lack of Efficacy|0|||
155347899|NCT00475735|560706542|FG001|Treatment Period 2|Lack of Efficacy|0|||
155347900|NCT00475735|560706543|FG002|Treatment Period 2|Lack of Efficacy|0|||
155347901|NCT00475735|560706544|FG003|Treatment Period 2|Lack of Efficacy|0|||
155347902|NCT00475735|560706545|FG004|Treatment Period 2|Lack of Efficacy|0|||
155347903|NCT00475735|560706546|FG005|Treatment Period 2|Lack of Efficacy|1|||
155347904|NCT00475735|560706541|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155347905|NCT00475735|560706542|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155347906|NCT00475735|560706543|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155347907|NCT00475735|560706544|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155347908|NCT00475735|560706545|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155347909|NCT00475735|560706546|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155347910|NCT03132753|560706547|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
155347911|NCT03132753|560706548|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
155347912|NCT03132753|560706547|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
155347913|NCT03132753|560706548|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
155347914|NCT00084747|560706549|FG000|Overall Study|Relapsed|8|||
155347915|NCT00084747|560706549|FG000|Overall Study|Death|3|||
155347916|NCT00084747|560706549|FG000|Overall Study|Withdrawal by Subject|2|||
155347917|NCT00679549|560706551|FG000|Overall Study|dropout|2|||
155347918|NCT00679549|560706552|FG001|Overall Study|dropout|4|||
155347919|NCT00679549|560706551|FG000|Overall Study|missing outcome echocardiograms|4|||
155347920|NCT00679549|560706552|FG001|Overall Study|missing outcome echocardiograms|5|||
155347921|NCT02350127|560706556|FG000|4-Month Assessment|Withdrawal by Subject|10|||
155347922|NCT02350127|560706557|FG001|4-Month Assessment|Withdrawal by Subject|9|||
155347923|NCT02350127|560706556|FG000|4-Month Assessment|Death|1|||
155347924|NCT02350127|560706557|FG001|4-Month Assessment|Death|0|||
155347925|NCT02350127|560706556|FG000|8-Month Assessment|Death|1|||
155347926|NCT02350127|560706557|FG001|8-Month Assessment|Death|1|||
155347927|NCT02350127|560706556|FG000|8-Month Assessment|Withdrawal by Subject|5|||
155347928|NCT02350127|560706557|FG001|8-Month Assessment|Withdrawal by Subject|8|||
155347929|NCT00157209|560706558|FG000|Overall Study|Ongoing at data cut-off|10|||
155347930|NCT00157209|560706559|FG001|Overall Study|Ongoing at data cut-off|0|||
155347931|NCT04474691|560706560|FG000|Overall Study|Withdrawal by Subject|9|||
155347932|NCT00274846|560706566|FG000|Overall Study|Did not receive adequate NK cells|1|||
155347933|NCT00050167|560706573|FG000|Overall Study|not eligible not invasive|1|||
155347934|NCT00050167|560706574|FG001|Overall Study|not eligible not invasive|1|||
155347935|NCT02038803|560706578|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
155347936|NCT02038803|560706578|FG000|Overall Study|Lost to Follow-up|1|||
155347937|NCT04754594|560706579|FG000|Blinded Period|Withdrawal by Subject|4|||
155347938|NCT04754594|560706580|FG001|Blinded Period|Withdrawal by Subject|9|||
155347939|NCT04754594|560706581|FG002|Blinded Period|Withdrawal by Subject|0|||
155347940|NCT04754594|560706582|FG003|Blinded Period|Withdrawal by Subject|0|||
155347941|NCT04754594|560706579|FG000|Blinded Period|Protocol Violation|2|||
155347942|NCT04754594|560706580|FG001|Blinded Period|Protocol Violation|2|||
155347943|NCT04754594|560706581|FG002|Blinded Period|Protocol Violation|0|||
155347944|NCT04754594|560706582|FG003|Blinded Period|Protocol Violation|0|||
155347945|NCT04754594|560706579|FG000|Blinded Period|Lost to Follow-up|1|||
155347946|NCT04754594|560706580|FG001|Blinded Period|Lost to Follow-up|1|||
155347947|NCT04754594|560706581|FG002|Blinded Period|Lost to Follow-up|0|||
155347948|NCT04754594|560706582|FG003|Blinded Period|Lost to Follow-up|0|||
155347949|NCT04754594|560706579|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
155347950|NCT04754594|560706580|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
155347951|NCT04754594|560706581|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
155347952|NCT04754594|560706582|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
155347953|NCT04754594|560706579|FG000|Unblinded Period|Withdrawal by Subject|6|||
155347954|NCT04754594|560706580|FG001|Unblinded Period|Withdrawal by Subject|8|||
155347955|NCT04754594|560706581|FG002|Unblinded Period|Withdrawal by Subject|0|||
155347956|NCT04754594|560706582|FG003|Unblinded Period|Withdrawal by Subject|0|||
155647960|NCT02318277|561803727|FG000|Overall Study|Other|0|||
155647961|NCT02318277|561803728|FG001|Overall Study|Other|0|||
155647962|NCT02318277|561803729|FG002|Overall Study|Other|0|||
155347957|NCT04754594|560706579|FG000|Unblinded Period|Lost to Follow-up|5|||
155347958|NCT04754594|560706580|FG001|Unblinded Period|Lost to Follow-up|3|||
155347959|NCT04754594|560706581|FG002|Unblinded Period|Lost to Follow-up|0|||
155347960|NCT04754594|560706582|FG003|Unblinded Period|Lost to Follow-up|0|||
155347961|NCT04754594|560706579|FG000|Unblinded Period|Protocol Violation|2|||
155347962|NCT04754594|560706580|FG001|Unblinded Period|Protocol Violation|4|||
155347963|NCT04754594|560706581|FG002|Unblinded Period|Protocol Violation|0|||
155347964|NCT04754594|560706582|FG003|Unblinded Period|Protocol Violation|0|||
155347965|NCT04754594|560706579|FG000|Unblinded Period|Other|3|||
155347966|NCT04754594|560706580|FG001|Unblinded Period|Other|0|||
155347967|NCT04754594|560706581|FG002|Unblinded Period|Other|0|||
155347968|NCT04754594|560706582|FG003|Unblinded Period|Other|0|||
155347969|NCT04754594|560706579|FG000|Infant Participants|Withdrawal by Subject|0|||
155347970|NCT04754594|560706580|FG001|Infant Participants|Withdrawal by Subject|0|||
155347971|NCT04754594|560706581|FG002|Infant Participants|Withdrawal by Subject|9|||
155347972|NCT04754594|560706582|FG003|Infant Participants|Withdrawal by Subject|17|||
155347973|NCT04754594|560706579|FG000|Infant Participants|Lost to Follow-up|0|||
155347974|NCT04754594|560706580|FG001|Infant Participants|Lost to Follow-up|0|||
155347975|NCT04754594|560706581|FG002|Infant Participants|Lost to Follow-up|4|||
155347976|NCT04754594|560706582|FG003|Infant Participants|Lost to Follow-up|10|||
155347977|NCT04754594|560706579|FG000|Infant Participants|Death|0|||
155647963|NCT02318277|561803730|FG003|Overall Study|Other|0|||
155347978|NCT04754594|560706580|FG001|Infant Participants|Death|0|||
155347979|NCT04754594|560706581|FG002|Infant Participants|Death|1|||
155347980|NCT04754594|560706582|FG003|Infant Participants|Death|1|||
155347981|NCT04754594|560706579|FG000|Infant Participants|Other|0|||
155347982|NCT04754594|560706580|FG001|Infant Participants|Other|0|||
155347983|NCT04754594|560706581|FG002|Infant Participants|Other|1|||
155347984|NCT04754594|560706582|FG003|Infant Participants|Other|1|||
155347985|NCT01247922|560706583|FG000|Overall Study|Disease progression|4|||
155347986|NCT04372186|560706584|FG000|Overall Study|Death|24|||
155347987|NCT04372186|560706585|FG001|Overall Study|Death|11|||
155347988|NCT04372186|560706584|FG000|Overall Study|Transferred to a different facility for care|0|||
155347989|NCT04372186|560706585|FG001|Overall Study|Transferred to a different facility for care|2|||
155347990|NCT04736472|560706586|FG000|Overall Study|Lost to Follow-up|1|||
155347991|NCT04736472|560706587|FG001|Overall Study|Lost to Follow-up|0|||
155347992|NCT04736472|560706588|FG002|Overall Study|Lost to Follow-up|0|||
155347993|NCT04736472|560706586|FG000|Overall Study|Withdrawal by Subject|2|||
155347994|NCT04736472|560706587|FG001|Overall Study|Withdrawal by Subject|0|||
155347995|NCT04736472|560706588|FG002|Overall Study|Withdrawal by Subject|0|||
155347996|NCT04736472|560706586|FG000|Overall Study|Protocol Violation|48|||
155347997|NCT04736472|560706587|FG001|Overall Study|Protocol Violation|0|||
155347998|NCT04736472|560706588|FG002|Overall Study|Protocol Violation|6|||
155347999|NCT01911819|560706591|FG000|Overall Study|Adverse Event|0|||
155348000|NCT01911819|560706592|FG001|Overall Study|Adverse Event|1|||
155348001|NCT01911819|560706593|FG002|Overall Study|Adverse Event|0|||
155348002|NCT01911819|560706591|FG000|Overall Study|Withdrawal by Subject|1|||
155348003|NCT01911819|560706592|FG001|Overall Study|Withdrawal by Subject|1|||
155348004|NCT01911819|560706593|FG002|Overall Study|Withdrawal by Subject|0|||
155348005|NCT04374253|560706594|FG000|Overall Study|Adverse Event|0|||
155348006|NCT04374253|560706595|FG001|Overall Study|Adverse Event|26|||
155348007|NCT04374253|560706596|FG002|Overall Study|Adverse Event|2|||
155348008|NCT04374253|560706597|FG003|Overall Study|Adverse Event|12|||
155348009|NCT04374253|560706594|FG000|Overall Study|Study terminated by sponsor|13|||
155348010|NCT04374253|560706595|FG001|Overall Study|Study terminated by sponsor|593|||
155348011|NCT04374253|560706596|FG002|Overall Study|Study terminated by sponsor|21|||
155348012|NCT04374253|560706597|FG003|Overall Study|Study terminated by sponsor|567|||
155348013|NCT04374253|560706594|FG000|Overall Study|Withdrawal by Subject|0|||
155348014|NCT04374253|560706595|FG001|Overall Study|Withdrawal by Subject|55|||
155348015|NCT04374253|560706596|FG002|Overall Study|Withdrawal by Subject|3|||
155348016|NCT04374253|560706597|FG003|Overall Study|Withdrawal by Subject|40|||
155348017|NCT04374253|560706594|FG000|Overall Study|Physician Decision|1|||
155348018|NCT04374253|560706595|FG001|Overall Study|Physician Decision|10|||
155348019|NCT04374253|560706596|FG002|Overall Study|Physician Decision|1|||
155348020|NCT04374253|560706597|FG003|Overall Study|Physician Decision|10|||
155348021|NCT04374253|560706594|FG000|Overall Study|Protocol Violation|0|||
155348022|NCT04374253|560706595|FG001|Overall Study|Protocol Violation|0|||
155348023|NCT04374253|560706596|FG002|Overall Study|Protocol Violation|0|||
155348024|NCT04374253|560706597|FG003|Overall Study|Protocol Violation|2|||
155348025|NCT04374253|560706594|FG000|Overall Study|Death|0|||
155348026|NCT04374253|560706595|FG001|Overall Study|Death|3|||
155348027|NCT04374253|560706596|FG002|Overall Study|Death|1|||
155348028|NCT04374253|560706597|FG003|Overall Study|Death|1|||
155348029|NCT04374253|560706594|FG000|Overall Study|Lack of Efficacy|0|||
155348030|NCT04374253|560706595|FG001|Overall Study|Lack of Efficacy|0|||
155348031|NCT04374253|560706596|FG002|Overall Study|Lack of Efficacy|0|||
155348032|NCT04374253|560706597|FG003|Overall Study|Lack of Efficacy|1|||
155348033|NCT04374253|560706594|FG000|Overall Study|Lost to Follow-up|1|||
155348034|NCT04374253|560706595|FG001|Overall Study|Lost to Follow-up|1|||
155348035|NCT04374253|560706596|FG002|Overall Study|Lost to Follow-up|0|||
155348036|NCT04374253|560706597|FG003|Overall Study|Lost to Follow-up|2|||
155348037|NCT04374253|560706594|FG000|Overall Study|Reason Not Specified|0|||
155348038|NCT04374253|560706595|FG001|Overall Study|Reason Not Specified|8|||
155348039|NCT04374253|560706596|FG002|Overall Study|Reason Not Specified|0|||
155348040|NCT04374253|560706597|FG003|Overall Study|Reason Not Specified|8|||
155348041|NCT00448344|560706598|FG000|Overall Study|Lost to Follow-up|20|||
155348042|NCT00448344|560706599|FG001|Overall Study|Lost to Follow-up|22|||
155348043|NCT00448344|560706598|FG000|Overall Study|Withdrawal by Subject|6|||
155348044|NCT00448344|560706599|FG001|Overall Study|Withdrawal by Subject|8|||
155348045|NCT00448344|560706598|FG000|Overall Study|Death|3|||
155348046|NCT00448344|560706599|FG001|Overall Study|Death|4|||
155348047|NCT00448344|560706598|FG000|Overall Study|Physician Decision|1|||
155348048|NCT00448344|560706599|FG001|Overall Study|Physician Decision|2|||
155348049|NCT00417989|560706600|FG000|Overall Study|Withdrawal by Subject|13|||
155348050|NCT00417989|560706601|FG001|Overall Study|Withdrawal by Subject|13|||
155348051|NCT00417989|560706600|FG000|Overall Study|Lost to Follow-up|1|||
155348052|NCT00417989|560706601|FG001|Overall Study|Lost to Follow-up|6|||
155348053|NCT00417989|560706600|FG000|Overall Study|Protocol Violation|1|||
155348054|NCT00417989|560706601|FG001|Overall Study|Protocol Violation|0|||
155348055|NCT00417989|560706600|FG000|Overall Study|Death|0|||
155348056|NCT00417989|560706601|FG001|Overall Study|Death|1|||
155348057|NCT00417989|560706600|FG000|Overall Study|Physician Decision|5|||
155348058|NCT00417989|560706601|FG001|Overall Study|Physician Decision|2|||
155348059|NCT00990821|560706602|FG000|Overall Study|Withdrawal by Subject|0|||
155348060|NCT00990821|560706603|FG001|Overall Study|Withdrawal by Subject|2|||
155348061|NCT00990821|560706604|FG002|Overall Study|Withdrawal by Subject|0|||
155348062|NCT00990821|560706605|FG003|Overall Study|Withdrawal by Subject|0|||
155348063|NCT00990821|560706606|FG004|Overall Study|Withdrawal by Subject|3|||
155348064|NCT00990821|560706607|FG005|Overall Study|Withdrawal by Subject|3|||
155348065|NCT00990821|560706608|FG006|Overall Study|Withdrawal by Subject|1|||
155348066|NCT00990821|560706609|FG007|Overall Study|Withdrawal by Subject|0|||
155348067|NCT00990821|560706610|FG008|Overall Study|Withdrawal by Subject|0|||
155348068|NCT00990821|560706611|FG009|Overall Study|Withdrawal by Subject|1|||
155348069|NCT00990821|560706612|FG010|Overall Study|Withdrawal by Subject|3|||
155348070|NCT00990821|560706613|FG011|Overall Study|Withdrawal by Subject|5|||
155348071|NCT00990821|560706614|FG012|Overall Study|Withdrawal by Subject|2|||
155348072|NCT00990821|560706615|FG013|Overall Study|Withdrawal by Subject|1|||
155348073|NCT04150250|560706616|FG000|Overall Study|Lost to Follow-up|0|||
155348074|NCT04150250|560706617|FG001|Overall Study|Lost to Follow-up|2|||
155348075|NCT01945086|560706620|FG000|Overall Study|Withdrawal by Subject|1|||
155348076|NCT01945086|560706621|FG001|Overall Study|Withdrawal by Subject|0|||
155348077|NCT01945086|560706622|FG002|Overall Study|Withdrawal by Subject|1|||
155348078|NCT01945086|560706620|FG000|Overall Study|Adverse Event|0|||
155348079|NCT01945086|560706621|FG001|Overall Study|Adverse Event|0|||
155348080|NCT01945086|560706622|FG002|Overall Study|Adverse Event|1|||
155348081|NCT04212299|560706627|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
155348082|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Death|0|||
155505956|NCT00789828|561278288|FG000|Core Period (48 Weeks)|Administrative problems|0|||
155348083|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Death|1|||
155348084|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Adverse Event|0|||
155505957|NCT00789828|561278289|FG001|Core Period (48 Weeks)|Administrative problems|1|||
155505958|NCT00789828|561278288|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
155505959|NCT00789828|561278289|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
155505960|NCT00789828|561278288|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
155505961|NCT00789828|561278289|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
155505962|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
155505963|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
155348085|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Adverse Event|2|||
155348086|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
155348087|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
155348088|NCT02720185|560708307|FG000|Overall Study|Lost to Follow-up|1|||
155348089|NCT01157351|560708308|FG000|Overall Study|Adverse Event|5|||
155348090|NCT01157351|560708309|FG001|Overall Study|Adverse Event|4|||
155348091|NCT01157351|560708308|FG000|Overall Study|Death|1|||
155348092|NCT01157351|560708309|FG001|Overall Study|Death|0|||
155348093|NCT01157351|560708308|FG000|Overall Study|Lost to Follow-up|53|||
155348094|NCT01157351|560708309|FG001|Overall Study|Lost to Follow-up|55|||
155647964|NCT02318277|561803731|FG004|Overall Study|Other|0|||
155348095|NCT01157351|560708308|FG000|Overall Study|Withdrawal by Subject|37|||
155348096|NCT01157351|560708309|FG001|Overall Study|Withdrawal by Subject|27|||
155348097|NCT01157351|560708308|FG000|Overall Study|Physician Decision|5|||
155348098|NCT01157351|560708309|FG001|Overall Study|Physician Decision|4|||
155348099|NCT01157351|560708308|FG000|Overall Study|Protocol Violation|0|||
155348100|NCT01157351|560708309|FG001|Overall Study|Protocol Violation|1|||
155348101|NCT01157351|560708308|FG000|Overall Study|Other|32|||
155348102|NCT01157351|560708309|FG001|Overall Study|Other|36|||
155348103|NCT01157351|560708308|FG000|Overall Study|Noncompliance with Study Drug|0|||
155348104|NCT01157351|560708309|FG001|Overall Study|Noncompliance with Study Drug|3|||
155348105|NCT01157351|560708308|FG000|Overall Study|Randomized but not Treated|4|||
155424916|NCT04854499|560984537|FG003|Overall Study|Withdrew Consent|2|||
155505964|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
155505965|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
155647965|NCT02318277|561803732|FG005|Overall Study|Other|0|||
155348106|NCT01157351|560708309|FG001|Overall Study|Randomized but not Treated|2|||
155348107|NCT01589523|560708310|FG000|Overall Study|Withdrawal by Subject|1|||
155348108|NCT00506922|560708311|FG000|Overall Study|Physician Decision|0|||
155348109|NCT00506922|560708312|FG001|Overall Study|Physician Decision|0|||
155348110|NCT00506922|560708313|FG002|Overall Study|Physician Decision|0|||
155348111|NCT00506922|560708314|FG003|Overall Study|Physician Decision|2|||
155348112|NCT00506922|560708315|FG004|Overall Study|Physician Decision|0|||
155348113|NCT00506922|560708311|FG000|Overall Study|Withdrawal by Subject|0|||
155348114|NCT00506922|560708312|FG001|Overall Study|Withdrawal by Subject|0|||
155348115|NCT00506922|560708313|FG002|Overall Study|Withdrawal by Subject|0|||
155348116|NCT00506922|560708314|FG003|Overall Study|Withdrawal by Subject|0|||
155348117|NCT00506922|560708315|FG004|Overall Study|Withdrawal by Subject|1|||
155348118|NCT02507687|560708318|FG000|Overall Study|Adverse Event|3|||
155348119|NCT02507687|560708319|FG001|Overall Study|Adverse Event|2|||
155348120|NCT02507687|560708320|FG002|Overall Study|Adverse Event|2|||
155348121|NCT02507687|560708321|FG003|Overall Study|Adverse Event|2|||
155348122|NCT02507687|560708318|FG000|Overall Study|Withdrawal by Subject|1|||
155348123|NCT02507687|560708319|FG001|Overall Study|Withdrawal by Subject|4|||
155348124|NCT02507687|560708320|FG002|Overall Study|Withdrawal by Subject|6|||
155348125|NCT02507687|560708321|FG003|Overall Study|Withdrawal by Subject|6|||
155348126|NCT02507687|560708318|FG000|Overall Study|Protocol Violation|1|||
155348127|NCT02507687|560708319|FG001|Overall Study|Protocol Violation|0|||
155348128|NCT02507687|560708320|FG002|Overall Study|Protocol Violation|2|||
155348129|NCT02507687|560708321|FG003|Overall Study|Protocol Violation|0|||
155348130|NCT02507687|560708318|FG000|Overall Study|Lost to Follow-up|0|||
155348131|NCT02507687|560708319|FG001|Overall Study|Lost to Follow-up|0|||
155348132|NCT02507687|560708320|FG002|Overall Study|Lost to Follow-up|2|||
155348133|NCT02507687|560708321|FG003|Overall Study|Lost to Follow-up|1|||
155505966|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
155505967|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
155647966|NCT02318277|561803733|FG006|Overall Study|Other|1|||
155647967|NCT02318277|561803734|FG007|Overall Study|Other|0|||
155348134|NCT02507687|560708318|FG000|Overall Study|Screen Failure|0|||
155348135|NCT02507687|560708319|FG001|Overall Study|Screen Failure|0|||
155348136|NCT02507687|560708320|FG002|Overall Study|Screen Failure|1|||
155348137|NCT02507687|560708321|FG003|Overall Study|Screen Failure|0|||
155348138|NCT02507687|560708318|FG000|Overall Study|Other, Not Specified|0|||
155348139|NCT02507687|560708319|FG001|Overall Study|Other, Not Specified|0|||
155348140|NCT02507687|560708320|FG002|Overall Study|Other, Not Specified|2|||
155348141|NCT02507687|560708321|FG003|Overall Study|Other, Not Specified|4|||
155348142|NCT02675998|560708322|FG000|8-Week Treatment Period|Adverse Event|6|||
155348143|NCT02675998|560708323|FG001|8-Week Treatment Period|Adverse Event|5|||
155348144|NCT02675998|560708324|FG002|8-Week Treatment Period|Adverse Event|6|||
155348145|NCT02675998|560708325|FG003|8-Week Treatment Period|Adverse Event|0|||
155348146|NCT02675998|560708322|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
155348147|NCT02675998|560708323|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
155348148|NCT02675998|560708324|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
155348149|NCT02675998|560708325|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
155348150|NCT02675998|560708322|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
155348151|NCT02675998|560708323|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
155348152|NCT02675998|560708324|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
155348153|NCT02675998|560708325|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
155348154|NCT02675998|560708322|FG000|8-Week Treatment Period|Physician Decision|1|||
155348155|NCT02675998|560708323|FG001|8-Week Treatment Period|Physician Decision|0|||
155348156|NCT02675998|560708324|FG002|8-Week Treatment Period|Physician Decision|2|||
155348157|NCT02675998|560708325|FG003|8-Week Treatment Period|Physician Decision|0|||
155348158|NCT02675998|560708322|FG000|8-Week Treatment Period|GI side Effects|1|||
155348159|NCT02675998|560708323|FG001|8-Week Treatment Period|GI side Effects|4|||
155348160|NCT02675998|560708324|FG002|8-Week Treatment Period|GI side Effects|2|||
155348161|NCT02675998|560708325|FG003|8-Week Treatment Period|GI side Effects|0|||
155348162|NCT02675998|560708322|FG000|8-Week Treatment Period|Protocol Violation|1|||
155348163|NCT02675998|560708323|FG001|8-Week Treatment Period|Protocol Violation|1|||
155348164|NCT02675998|560708324|FG002|8-Week Treatment Period|Protocol Violation|1|||
155348165|NCT02675998|560708325|FG003|8-Week Treatment Period|Protocol Violation|0|||
155348166|NCT02675998|560708322|FG000|8-Week Treatment Period|Other|3|||
155348167|NCT02675998|560708323|FG001|8-Week Treatment Period|Other|1|||
155348168|NCT02675998|560708324|FG002|8-Week Treatment Period|Other|2|||
155348169|NCT02675998|560708325|FG003|8-Week Treatment Period|Other|0|||
155348170|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
155348171|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
155348172|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
155348173|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
155348174|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
155348175|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
155348176|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
155348177|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
155348178|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348179|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348180|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348181|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
155348182|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
155348183|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155348184|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155348185|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155348186|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155348187|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155424917|NCT04854499|560984538|FG004|Overall Study|Withdrew Consent|0|||
155348188|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155348189|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
155348190|NCT00275301|560708326|FG000|Overall Study|Adverse Event|5|||
155348191|NCT02561078|560708331|FG000|Overall Study|Adverse Event|5|||
155348192|NCT02561078|560708332|FG001|Overall Study|Adverse Event|2|||
155348193|NCT02561078|560708331|FG000|Overall Study|Death|2|||
155348194|NCT02561078|560708332|FG001|Overall Study|Death|1|||
155424918|NCT04854499|560984539|FG005|Overall Study|Withdrew Consent|1|||
155424919|NCT04854499|560984534|FG000|Overall Study|Lost to Follow-up|0|||
155424920|NCT04854499|560984535|FG001|Overall Study|Lost to Follow-up|0|||
155348195|NCT02561078|560708331|FG000|Overall Study|Lost to Follow-up|2|||
155348196|NCT02561078|560708332|FG001|Overall Study|Lost to Follow-up|6|||
155348197|NCT02561078|560708331|FG000|Overall Study|Non-Compliance with Study Drug|6|||
155348198|NCT02561078|560708332|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155348199|NCT02561078|560708331|FG000|Overall Study|Physician Decision|2|||
155348200|NCT02561078|560708332|FG001|Overall Study|Physician Decision|3|||
155348201|NCT02561078|560708331|FG000|Overall Study|Withdrawal by Subject|13|||
155505968|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
155505969|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
155505970|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Death|1|||
155505971|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Death|0|||
155505972|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
155505973|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
155505974|NCT00789828|561278288|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
155505975|NCT00789828|561278289|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
155505976|NCT02623426|561278290|FG000|Overall Study|Lost to Follow-up|0|||
155505977|NCT02623426|561278291|FG001|Overall Study|Lost to Follow-up|0|||
155505978|NCT02623426|561278292|FG002|Overall Study|Lost to Follow-up|1|||
155505979|NCT02623426|561278290|FG000|Overall Study|Withdrawal by Subject|1|||
155505980|NCT02623426|561278291|FG001|Overall Study|Withdrawal by Subject|2|||
155647968|NCT02318277|561803727|FG000|Overall Study|Withdrawal by Subject|0|||
155647969|NCT02318277|561803728|FG001|Overall Study|Withdrawal by Subject|0|||
155647970|NCT02318277|561803729|FG002|Overall Study|Withdrawal by Subject|1|||
155348202|NCT02561078|560708332|FG001|Overall Study|Withdrawal by Subject|10|||
155348203|NCT00598871|560708335|FG000|Overall Study|Adverse Event|0|||
155647971|NCT02318277|561803730|FG003|Overall Study|Withdrawal by Subject|0|||
155647972|NCT02318277|561803731|FG004|Overall Study|Withdrawal by Subject|1|||
155348204|NCT00598871|560708336|FG001|Overall Study|Adverse Event|1|||
155348205|NCT01194271|560708337|FG000|Overall Study|Withdrawal by Subject|1|||
155348206|NCT01194271|560708337|FG000|Overall Study|Ineligible, Screen Failure|1|||
155647973|NCT02318277|561803732|FG005|Overall Study|Withdrawal by Subject|1|||
155647974|NCT02318277|561803733|FG006|Overall Study|Withdrawal by Subject|6|||
155348207|NCT01194271|560708337|FG000|Overall Study|Death|1|||
155348208|NCT00349622|560708338|FG000|Overall Study|Death|168|||
155348209|NCT00349622|560708339|FG001|Overall Study|Death|86|||
155348210|NCT00349622|560708338|FG000|Overall Study|Lost to Follow-up|5|||
155348211|NCT00349622|560708339|FG001|Overall Study|Lost to Follow-up|1|||
155348212|NCT00349622|560708338|FG000|Overall Study|Withdrawal by Subject|5|||
155348213|NCT00349622|560708339|FG001|Overall Study|Withdrawal by Subject|9|||
155348214|NCT03296566|560708342|FG000|Overall Study|Lost to Follow-up|19|||
155348215|NCT03296566|560708343|FG001|Overall Study|Lost to Follow-up|46|||
155348216|NCT03296566|560708342|FG000|Overall Study|Withdrawal by Subject|0|||
155348217|NCT03296566|560708343|FG001|Overall Study|Withdrawal by Subject|3|||
155348218|NCT01503515|560708349|FG000|Overall Study|Adverse Event|4|||
155348219|NCT01503515|560708350|FG001|Overall Study|Adverse Event|5|||
155348220|NCT01503515|560708349|FG000|Overall Study|Death|0|||
155348221|NCT01503515|560708350|FG001|Overall Study|Death|1|||
155348222|NCT01503515|560708349|FG000|Overall Study|Physician Decision|14|||
155348223|NCT01503515|560708350|FG001|Overall Study|Physician Decision|23|||
155348224|NCT01503515|560708349|FG000|Overall Study|Withdrawal by Subject|0|||
155348225|NCT01503515|560708350|FG001|Overall Study|Withdrawal by Subject|1|||
155348226|NCT01503515|560708349|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
155348227|NCT01503515|560708350|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
155348228|NCT01503515|560708349|FG000|Overall Study|Ineligible|1|||
155348229|NCT01503515|560708350|FG001|Overall Study|Ineligible|1|||
155348230|NCT01350102|560708351|FG000|Overall Study|Adverse Event|0|||
155348231|NCT01350102|560708352|FG001|Overall Study|Adverse Event|0|||
155348232|NCT01350102|560708353|FG002|Overall Study|Adverse Event|1|||
155348233|NCT01350102|560708354|FG003|Overall Study|Adverse Event|0|||
155348234|NCT00726388|560708361|FG000|Overall Study|Withdrawal by Subject|5|||
155348235|NCT00726388|560708361|FG000|Overall Study|Adverse Event|3|||
155348236|NCT00726388|560708361|FG000|Overall Study|Lost to Follow-up|10|||
155348237|NCT00726388|560708361|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
155348238|NCT00726388|560708361|FG000|Overall Study|Other|5|||
155348239|NCT00726388|560708361|FG000|Overall Study|Enrolled, Not Treated|79|||
155348240|NCT00609245|560708364|FG000|Overall Study|Adverse Event|1|||
155348241|NCT01631825|560708365|FG000|Overall Study|Adverse Event|42|||
155348242|NCT01631825|560708365|FG000|Overall Study|Lack of Efficacy|7|||
155348243|NCT01631825|560708365|FG000|Overall Study|Withdrawal by Subject|9|||
155348244|NCT01631825|560708365|FG000|Overall Study|Protocol Violation|4|||
155348245|NCT01631825|560708365|FG000|Overall Study|Discontinuation criteria|1|||
155348246|NCT01631825|560708365|FG000|Overall Study|Physician Decision|2|||
155348247|NCT03022045|560708368|FG000|Overall Study|Adverse Event|0|||
155348248|NCT03022045|560708369|FG001|Overall Study|Adverse Event|1|||
155348249|NCT03022045|560708368|FG000|Overall Study|Withdrawal by Subject|1|||
155348250|NCT03022045|560708369|FG001|Overall Study|Withdrawal by Subject|1|||
155348251|NCT05372913|560708370|FG000|Overall Study|Withdrawal by Subject|0|||
155348252|NCT05372913|560708371|FG001|Overall Study|Withdrawal by Subject|2|||
155348253|NCT05372913|560708370|FG000|Overall Study|Protocol Violation|2|||
155348254|NCT05372913|560708371|FG001|Overall Study|Protocol Violation|2|||
155348255|NCT05372913|560708370|FG000|Overall Study|Adverse Event|0|||
155348256|NCT05372913|560708371|FG001|Overall Study|Adverse Event|1|||
155348257|NCT05012397|560708375|FG000|Overall Study|Death|10|||
155348258|NCT05012397|560708375|FG000|Overall Study|Physician Decision|9|||
155348259|NCT05012397|560708375|FG000|Overall Study|Withdrawal by Subject|5|||
155348260|NCT05012397|560708375|FG000|Overall Study|Lost to Follow-up|2|||
155348261|NCT03334747|560708376|FG000|Treatment Phase|Technical problems|0|||
155348262|NCT03334747|560708377|FG001|Treatment Phase|Technical problems|0|||
155348263|NCT03334747|560708378|FG002|Treatment Phase|Technical problems|0|||
155348264|NCT03334747|560708379|FG003|Treatment Phase|Technical problems|0|||
155348265|NCT03334747|560708380|FG004|Treatment Phase|Technical problems|1|||
155348266|NCT03334747|560708381|FG005|Treatment Phase|Technical problems|0|||
155348267|NCT03334747|560708382|FG006|Treatment Phase|Technical problems|0|||
155348268|NCT03334747|560708383|FG007|Treatment Phase|Technical problems|0|||
155348269|NCT03334747|560708384|FG008|Treatment Phase|Technical problems|0|||
155348270|NCT03334747|560708376|FG000|Treatment Phase|Subject/guardian decision|1|||
155348271|NCT03334747|560708377|FG001|Treatment Phase|Subject/guardian decision|0|||
155348272|NCT03334747|560708378|FG002|Treatment Phase|Subject/guardian decision|0|||
155348273|NCT03334747|560708379|FG003|Treatment Phase|Subject/guardian decision|0|||
155348274|NCT03334747|560708380|FG004|Treatment Phase|Subject/guardian decision|0|||
155348275|NCT03334747|560708381|FG005|Treatment Phase|Subject/guardian decision|1|||
155348276|NCT03334747|560708382|FG006|Treatment Phase|Subject/guardian decision|0|||
155348277|NCT03334747|560708383|FG007|Treatment Phase|Subject/guardian decision|0|||
155348278|NCT03334747|560708384|FG008|Treatment Phase|Subject/guardian decision|0|||
155348279|NCT03334747|560708376|FG000|Follow-Up Phase|Subject/guardian decision|0|||
155348280|NCT03334747|560708377|FG001|Follow-Up Phase|Subject/guardian decision|0|||
155348281|NCT03334747|560708378|FG002|Follow-Up Phase|Subject/guardian decision|0|||
155348282|NCT03334747|560708379|FG003|Follow-Up Phase|Subject/guardian decision|0|||
155348283|NCT03334747|560708380|FG004|Follow-Up Phase|Subject/guardian decision|0|||
155348284|NCT03334747|560708381|FG005|Follow-Up Phase|Subject/guardian decision|0|||
155348285|NCT03334747|560708382|FG006|Follow-Up Phase|Subject/guardian decision|1|||
155348286|NCT03334747|560708383|FG007|Follow-Up Phase|Subject/guardian decision|0|||
155348287|NCT03334747|560708384|FG008|Follow-Up Phase|Subject/guardian decision|1|||
155348288|NCT03303521|560708385|FG000|Overall Study|Withdrawal by Subject|2|||
155348289|NCT03303521|560708386|FG001|Overall Study|Withdrawal by Subject|0|||
155348290|NCT03303521|560708385|FG000|Overall Study|Death|1|||
155348291|NCT03303521|560708386|FG001|Overall Study|Death|0|||
155348292|NCT03303521|560708385|FG000|Overall Study|Kidney transplantation|0|||
155348293|NCT03303521|560708386|FG001|Overall Study|Kidney transplantation|1|||
155348294|NCT03303521|560708385|FG000|Overall Study|Investigational product discontinuation|0|||
155348295|NCT03303521|560708386|FG001|Overall Study|Investigational product discontinuation|1|||
155348296|NCT03303521|560708385|FG000|Overall Study|Transferred to non-study dialysis center|1|||
155348297|NCT03303521|560708386|FG001|Overall Study|Transferred to non-study dialysis center|0|||
155348298|NCT03303521|560708385|FG000|Overall Study|Non-comliance to study protocol|0|||
155348299|NCT03303521|560708386|FG001|Overall Study|Non-comliance to study protocol|1|||
155348300|NCT03303521|560708385|FG000|Overall Study|Adverse Event|1|||
155348301|NCT03303521|560708386|FG001|Overall Study|Adverse Event|0|||
155348302|NCT00005908|560708387|FG000|Overall Study|Withdrawal by Subject|1|||
155348303|NCT00005908|560708388|FG001|Overall Study|Withdrawal by Subject|0|||
155348304|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Adverse Event|3|||
155348305|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Adverse Event|0|||
155348306|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
155348307|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
155348308|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Disease Progression|23|||
155348309|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Disease Progression|22|||
155348310|NCT01379521|560708389|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
155348311|NCT01379521|560708390|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
155348312|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
155348313|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
155348314|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
155348315|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
155348316|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
155348317|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
155348318|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Death|2|||
155348319|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Death|1|||
155348320|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Disease Progression|22|||
155348321|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Disease Progression|20|||
155348322|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
155348323|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
155348324|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Death|1|||
155348325|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Death|0|||
155348326|NCT02504502|560708391|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
155348327|NCT02504502|560708392|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
155348328|NCT02504502|560708391|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
155348329|NCT02504502|560708392|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
155348330|NCT00577096|560708399|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
155348331|NCT00577096|560708400|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
155348332|NCT00577096|560708399|FG000|Short Term Participation|Withdrawal by Subject|3|||
155348333|NCT00577096|560708400|FG001|Short Term Participation|Withdrawal by Subject|5|||
155348334|NCT00577096|560708399|FG000|Short Term Participation|Death|1|||
155348335|NCT00577096|560708400|FG001|Short Term Participation|Death|1|||
155348336|NCT00832650|560708401|FG000|Overall Study|Randomized but not treated|0|||
155348337|NCT00832650|560708402|FG001|Overall Study|Randomized but not treated|0|||
155348338|NCT00832650|560708403|FG002|Overall Study|Randomized but not treated|1|||
155348339|NCT00440037|560708405|FG000|Overall Study|Withdrawal by Subject|6|||
155348340|NCT00440037|560708405|FG000|Overall Study|Administrative decision|3|||
155348341|NCT03356145|560708406|FG000|Overall Study|Withdrawal by Subject|2|||
155348342|NCT03356145|560708407|FG001|Overall Study|Withdrawal by Subject|1|||
155348343|NCT03356145|560708406|FG000|Overall Study|Did not meet inclusion criteria|1|||
155348344|NCT03356145|560708407|FG001|Overall Study|Did not meet inclusion criteria|0|||
155348345|NCT03740919|560708410|FG000|Lead-in Period|Lost to Follow-up|1|||
155348346|NCT03740919|560708411|FG001|Lead-in Period|Lost to Follow-up|0|||
155348347|NCT03740919|560708412|FG002|Lead-in Period|Lost to Follow-up|0|||
155348348|NCT03740919|560708413|FG003|Lead-in Period|Lost to Follow-up|0|||
155348349|NCT03740919|560708410|FG000|Lead-in Period|Physician Decision|2|||
155348350|NCT03740919|560708411|FG001|Lead-in Period|Physician Decision|0|||
155348351|NCT03740919|560708412|FG002|Lead-in Period|Physician Decision|0|||
155348352|NCT03740919|560708413|FG003|Lead-in Period|Physician Decision|0|||
155348353|NCT03740919|560708410|FG000|Lead-in Period|Protocol Violation|1|||
155348354|NCT03740919|560708411|FG001|Lead-in Period|Protocol Violation|0|||
155348355|NCT03740919|560708412|FG002|Lead-in Period|Protocol Violation|0|||
155348356|NCT03740919|560708413|FG003|Lead-in Period|Protocol Violation|0|||
155348357|NCT03740919|560708410|FG000|Lead-in Period|Withdrawal by Subject|10|||
155348358|NCT03740919|560708411|FG001|Lead-in Period|Withdrawal by Subject|0|||
155348359|NCT03740919|560708412|FG002|Lead-in Period|Withdrawal by Subject|0|||
155348360|NCT03740919|560708413|FG003|Lead-in Period|Withdrawal by Subject|0|||
155348361|NCT03740919|560708410|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
155348362|NCT03740919|560708411|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348363|NCT03740919|560708412|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348364|NCT03740919|560708413|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348365|NCT03740919|560708410|FG000|Lead-in Period|Study Task Too Burdensome|1|||
155348366|NCT03740919|560708411|FG001|Lead-in Period|Study Task Too Burdensome|0|||
155348367|NCT03740919|560708412|FG002|Lead-in Period|Study Task Too Burdensome|0|||
155348368|NCT03740919|560708413|FG003|Lead-in Period|Study Task Too Burdensome|0|||
155348369|NCT03740919|560708410|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
155348370|NCT03740919|560708411|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348371|NCT03740919|560708412|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348372|NCT03740919|560708413|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348373|NCT03740919|560708410|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
155348374|NCT03740919|560708411|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348375|NCT03740919|560708412|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348376|NCT03740919|560708413|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348377|NCT03740919|560708410|FG000|Treatment Period|Adverse Event|0|||
155348378|NCT03740919|560708411|FG001|Treatment Period|Adverse Event|0|||
155348379|NCT03740919|560708412|FG002|Treatment Period|Adverse Event|2|||
155348380|NCT03740919|560708413|FG003|Treatment Period|Adverse Event|0|||
155348381|NCT03740919|560708410|FG000|Treatment Period|Protocol Violation|0|||
155348382|NCT03740919|560708411|FG001|Treatment Period|Protocol Violation|1|||
155348383|NCT03740919|560708412|FG002|Treatment Period|Protocol Violation|0|||
155348384|NCT03740919|560708413|FG003|Treatment Period|Protocol Violation|0|||
155348385|NCT03740919|560708410|FG000|Treatment Period|Withdrawal by Subject|0|||
155348386|NCT03740919|560708411|FG001|Treatment Period|Withdrawal by Subject|7|||
155348387|NCT03740919|560708412|FG002|Treatment Period|Withdrawal by Subject|6|||
155348388|NCT03740919|560708413|FG003|Treatment Period|Withdrawal by Subject|2|||
155348389|NCT03740919|560708410|FG000|Treatment Period|Terminated by Sponsor|0|||
155348390|NCT03740919|560708411|FG001|Treatment Period|Terminated by Sponsor|1|||
155348391|NCT03740919|560708412|FG002|Treatment Period|Terminated by Sponsor|0|||
155348392|NCT03740919|560708413|FG003|Treatment Period|Terminated by Sponsor|0|||
155348393|NCT03740919|560708410|FG000|Treatment Period|Issue with Insulin Pump|0|||
155348394|NCT03740919|560708411|FG001|Treatment Period|Issue with Insulin Pump|1|||
155348395|NCT03740919|560708412|FG002|Treatment Period|Issue with Insulin Pump|0|||
155348396|NCT03740919|560708413|FG003|Treatment Period|Issue with Insulin Pump|0|||
155348397|NCT03740919|560708410|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
155348398|NCT03740919|560708411|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
155348399|NCT03740919|560708412|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
155348400|NCT03740919|560708413|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
155348401|NCT03740919|560708410|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
155424921|NCT04854499|560984536|FG002|Overall Study|Lost to Follow-up|0|||
155424922|NCT04854499|560984537|FG003|Overall Study|Lost to Follow-up|0|||
155348402|NCT03740919|560708411|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
155348403|NCT03740919|560708412|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
155348404|NCT03740919|560708413|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
155348405|NCT03740919|560708410|FG000|Treatment Period|Not Completing Diary|0|||
155348406|NCT03740919|560708411|FG001|Treatment Period|Not Completing Diary|0|||
155424923|NCT04854499|560984538|FG004|Overall Study|Lost to Follow-up|0|||
155348407|NCT03740919|560708412|FG002|Treatment Period|Not Completing Diary|1|||
155348408|NCT03740919|560708413|FG003|Treatment Period|Not Completing Diary|0|||
155348409|NCT03740919|560708410|FG000|Treatment Period|Insulin Painful to Participant|0|||
155348410|NCT03740919|560708411|FG001|Treatment Period|Insulin Painful to Participant|0|||
155348411|NCT03740919|560708412|FG002|Treatment Period|Insulin Painful to Participant|1|||
155348412|NCT03740919|560708413|FG003|Treatment Period|Insulin Painful to Participant|0|||
155348413|NCT00985621|560708416|FG000|Overall Study|Adverse Event|2|||
155348414|NCT00985621|560708417|FG001|Overall Study|Adverse Event|3|||
155348415|NCT00985621|560708418|FG002|Overall Study|Adverse Event|4|||
155348416|NCT00985621|560708419|FG003|Overall Study|Adverse Event|16|||
155348417|NCT00985621|560708416|FG000|Overall Study|Lack of Efficacy|10|||
155348418|NCT00985621|560708417|FG001|Overall Study|Lack of Efficacy|6|||
155348419|NCT00985621|560708418|FG002|Overall Study|Lack of Efficacy|5|||
155348420|NCT00985621|560708419|FG003|Overall Study|Lack of Efficacy|12|||
155348421|NCT00985621|560708416|FG000|Overall Study|Lost to Follow-up|2|||
155348422|NCT00985621|560708417|FG001|Overall Study|Lost to Follow-up|3|||
155348423|NCT00985621|560708418|FG002|Overall Study|Lost to Follow-up|4|||
155348424|NCT00985621|560708419|FG003|Overall Study|Lost to Follow-up|4|||
155424924|NCT04854499|560984539|FG005|Overall Study|Lost to Follow-up|1|||
155424925|NCT00398112|560984556|FG000|Overall Study|Adverse Event|4|||
155424926|NCT00398112|560984556|FG000|Overall Study|Disease progression|9|||
155424927|NCT00398112|560984556|FG000|Overall Study|Alternative treatment|1|||
155424928|NCT00398112|560984556|FG000|Overall Study|Withdrawal by Subject|3|||
155424929|NCT00398112|560984556|FG000|Overall Study|Death|1|||
155424930|NCT02300129|560984558|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
155424931|NCT02300129|560984559|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
155424932|NCT02300129|560984560|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
155424933|NCT02300129|560984561|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
155424934|NCT02300129|560984558|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
155424935|NCT02300129|560984559|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
155424936|NCT02300129|560984560|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
155424937|NCT02300129|560984561|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
155424938|NCT02300129|560984558|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
155424939|NCT02300129|560984559|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
155424940|NCT02300129|560984560|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
155424941|NCT02300129|560984561|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
155424942|NCT03932812|560984563|FG000|Overall Study|Lost to Follow-up|12|||
155424943|NCT03932812|560984564|FG001|Overall Study|Lost to Follow-up|14|||
155424944|NCT03932812|560984563|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
155424945|NCT03932812|560984564|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
155424946|NCT01154101|560984569|FG000|Overall Study|Adverse Event|0|||
155424947|NCT01154101|560984570|FG001|Overall Study|Adverse Event|2|||
155424948|NCT01154101|560984571|FG002|Overall Study|Adverse Event|1|||
155424949|NCT01154101|560984572|FG003|Overall Study|Adverse Event|1|||
155424950|NCT01154101|560984573|FG004|Overall Study|Adverse Event|0|||
155647975|NCT02318277|561803734|FG007|Overall Study|Withdrawal by Subject|14|||
155348425|NCT00985621|560708416|FG000|Overall Study|Study Terminated by Sponsor|89|||
155348426|NCT00985621|560708417|FG001|Overall Study|Study Terminated by Sponsor|108|||
155348427|NCT00985621|560708418|FG002|Overall Study|Study Terminated by Sponsor|99|||
155348428|NCT00985621|560708419|FG003|Overall Study|Study Terminated by Sponsor|92|||
155348429|NCT00985621|560708416|FG000|Overall Study|Protocol Violation|1|||
155348430|NCT00985621|560708417|FG001|Overall Study|Protocol Violation|1|||
155424951|NCT01154101|560984569|FG000|Overall Study|Lost to Follow-up|0|||
155348431|NCT00985621|560708418|FG002|Overall Study|Protocol Violation|1|||
155424952|NCT01154101|560984570|FG001|Overall Study|Lost to Follow-up|1|||
155348432|NCT00985621|560708419|FG003|Overall Study|Protocol Violation|0|||
155424953|NCT01154101|560984571|FG002|Overall Study|Lost to Follow-up|0|||
155647976|NCT02318277|561803727|FG000|Overall Study|Participant trial terminated by sponsor|0|||
155348433|NCT00985621|560708416|FG000|Overall Study|Withdrawal by Subject|8|||
155348434|NCT00985621|560708417|FG001|Overall Study|Withdrawal by Subject|10|||
155348435|NCT00985621|560708418|FG002|Overall Study|Withdrawal by Subject|8|||
155348436|NCT00985621|560708419|FG003|Overall Study|Withdrawal by Subject|12|||
155348437|NCT00985621|560708416|FG000|Overall Study|Other|1|||
155348438|NCT00985621|560708417|FG001|Overall Study|Other|0|||
155348439|NCT00985621|560708418|FG002|Overall Study|Other|0|||
155348440|NCT00985621|560708419|FG003|Overall Study|Other|0|||
155348441|NCT00985621|560708416|FG000|Overall Study|Randomized but not Treated|1|||
155348442|NCT00985621|560708417|FG001|Overall Study|Randomized but not Treated|0|||
155348443|NCT00985621|560708418|FG002|Overall Study|Randomized but not Treated|2|||
155348444|NCT00985621|560708419|FG003|Overall Study|Randomized but not Treated|1|||
155348445|NCT04394624|560708423|FG000|Overall Study|Adverse Event|6|||
155348446|NCT04394624|560708424|FG001|Overall Study|Adverse Event|0|||
155348447|NCT04394624|560708423|FG000|Overall Study|Progressive disease|24|||
155348448|NCT04394624|560708424|FG001|Overall Study|Progressive disease|0|||
155348449|NCT04394624|560708423|FG000|Overall Study|Not related to COVID-19|1|||
155348450|NCT04394624|560708424|FG001|Overall Study|Not related to COVID-19|0|||
155348451|NCT00905255|560708425|FG000|Overall Study|Adverse Event|7|||
155348452|NCT00905255|560708426|FG001|Overall Study|Adverse Event|5|||
155348453|NCT00905255|560708425|FG000|Overall Study|Withdrawal by Subject|5|||
155348454|NCT00905255|560708426|FG001|Overall Study|Withdrawal by Subject|4|||
155348455|NCT00905255|560708425|FG000|Overall Study|Familial and Personal Reasons|1|||
155348456|NCT00905255|560708426|FG001|Overall Study|Familial and Personal Reasons|0|||
155348457|NCT00603278|560708429|FG000|Overall Study|Lack of Efficacy|35|||
155348458|NCT00603278|560708430|FG001|Overall Study|Lack of Efficacy|10|||
155348459|NCT00603278|560708431|FG002|Overall Study|Lack of Efficacy|11|||
155348460|NCT00603278|560708432|FG003|Overall Study|Lack of Efficacy|8|||
155348461|NCT00603278|560708433|FG004|Overall Study|Lack of Efficacy|7|||
155348462|NCT00603278|560708434|FG005|Overall Study|Lack of Efficacy|14|||
155348463|NCT00603278|560708429|FG000|Overall Study|Adverse Event|0|||
155348464|NCT00603278|560708430|FG001|Overall Study|Adverse Event|3|||
155348465|NCT00603278|560708431|FG002|Overall Study|Adverse Event|1|||
155348466|NCT00603278|560708432|FG003|Overall Study|Adverse Event|0|||
155348467|NCT00603278|560708433|FG004|Overall Study|Adverse Event|2|||
155348468|NCT00603278|560708434|FG005|Overall Study|Adverse Event|1|||
155348469|NCT00603278|560708429|FG000|Overall Study|Withdrawal by Subject|2|||
155348470|NCT00603278|560708430|FG001|Overall Study|Withdrawal by Subject|3|||
155348471|NCT00603278|560708431|FG002|Overall Study|Withdrawal by Subject|1|||
155348472|NCT00603278|560708432|FG003|Overall Study|Withdrawal by Subject|2|||
155348473|NCT00603278|560708433|FG004|Overall Study|Withdrawal by Subject|1|||
155348474|NCT00603278|560708434|FG005|Overall Study|Withdrawal by Subject|2|||
155348475|NCT00603278|560708429|FG000|Overall Study|Protocol Violation|3|||
155348476|NCT00603278|560708430|FG001|Overall Study|Protocol Violation|0|||
155348477|NCT00603278|560708431|FG002|Overall Study|Protocol Violation|1|||
155348478|NCT00603278|560708432|FG003|Overall Study|Protocol Violation|1|||
155348479|NCT00603278|560708433|FG004|Overall Study|Protocol Violation|0|||
155348480|NCT00603278|560708434|FG005|Overall Study|Protocol Violation|1|||
155348481|NCT00603278|560708429|FG000|Overall Study|Physician Decision|0|||
155348482|NCT00603278|560708430|FG001|Overall Study|Physician Decision|1|||
155348483|NCT00603278|560708431|FG002|Overall Study|Physician Decision|0|||
155348484|NCT00603278|560708432|FG003|Overall Study|Physician Decision|0|||
155348485|NCT00603278|560708433|FG004|Overall Study|Physician Decision|2|||
155348486|NCT00603278|560708434|FG005|Overall Study|Physician Decision|1|||
155348487|NCT00603278|560708429|FG000|Overall Study|Lost to Follow-up|1|||
155348488|NCT00603278|560708430|FG001|Overall Study|Lost to Follow-up|0|||
155348489|NCT00603278|560708431|FG002|Overall Study|Lost to Follow-up|0|||
155348490|NCT00603278|560708432|FG003|Overall Study|Lost to Follow-up|0|||
155348491|NCT00603278|560708433|FG004|Overall Study|Lost to Follow-up|1|||
155348492|NCT00603278|560708434|FG005|Overall Study|Lost to Follow-up|0|||
155348493|NCT02418819|560708436|FG000|Overall Study|Adverse Event|0|||
155348494|NCT02418819|560708437|FG001|Overall Study|Adverse Event|0|||
155348495|NCT02418819|560708438|FG002|Overall Study|Adverse Event|1|||
155348496|NCT02418819|560708439|FG003|Overall Study|Adverse Event|0|||
155348497|NCT02418819|560708436|FG000|Overall Study|Lost to Follow-up|1|||
155348498|NCT02418819|560708437|FG001|Overall Study|Lost to Follow-up|0|||
155348499|NCT02418819|560708438|FG002|Overall Study|Lost to Follow-up|0|||
155348500|NCT02418819|560708439|FG003|Overall Study|Lost to Follow-up|0|||
155348501|NCT02418819|560708436|FG000|Overall Study|No longer meets eligibility criteria|0|||
155348502|NCT02418819|560708437|FG001|Overall Study|No longer meets eligibility criteria|0|||
155348503|NCT02418819|560708438|FG002|Overall Study|No longer meets eligibility criteria|1|||
155348504|NCT02418819|560708439|FG003|Overall Study|No longer meets eligibility criteria|0|||
155348505|NCT02418819|560708436|FG000|Overall Study|No longer willing to participate|0|||
155348506|NCT02418819|560708437|FG001|Overall Study|No longer willing to participate|0|||
155348507|NCT02418819|560708438|FG002|Overall Study|No longer willing to participate|2|||
155348508|NCT02418819|560708439|FG003|Overall Study|No longer willing to participate|1|||
155348509|NCT01332318|560708443|FG000|Overall Study|Adverse Event|0|||
155348510|NCT01332318|560708444|FG001|Overall Study|Adverse Event|3|||
155348511|NCT01332318|560708445|FG002|Overall Study|Adverse Event|0|||
155348512|NCT01332318|560708446|FG003|Overall Study|Adverse Event|0|||
155348513|NCT01332318|560708443|FG000|Overall Study|Withdrawal by Subject|1|||
155348514|NCT01332318|560708444|FG001|Overall Study|Withdrawal by Subject|1|||
155348515|NCT01332318|560708445|FG002|Overall Study|Withdrawal by Subject|0|||
155348516|NCT01332318|560708446|FG003|Overall Study|Withdrawal by Subject|1|||
155348517|NCT01332318|560708443|FG000|Overall Study|Protocol Violation|1|||
155348518|NCT01332318|560708444|FG001|Overall Study|Protocol Violation|0|||
155348519|NCT01332318|560708445|FG002|Overall Study|Protocol Violation|1|||
155348520|NCT01332318|560708446|FG003|Overall Study|Protocol Violation|1|||
155348521|NCT02040532|560708447|FG000|Overall Study|Lost to Follow-up|1|||
155348522|NCT02040532|560708447|FG000|Overall Study|Physician Decision|4|||
155348523|NCT02040532|560708447|FG000|Overall Study|Adverse Event|4|||
155348524|NCT02040532|560708447|FG000|Overall Study|Withdrawal by Subject|3|||
155348525|NCT01207453|560708448|FG000|First Intervention|Adverse Event|2|||
155348526|NCT01207453|560708449|FG001|First Intervention|Adverse Event|1|||
155348527|NCT01207453|560708448|FG000|Washout|Adverse Event|1|||
155348528|NCT01207453|560708449|FG001|Washout|Adverse Event|0|||
155348529|NCT01207453|560708448|FG000|Washout|Lost to Follow-up|1|||
155348530|NCT01207453|560708449|FG001|Washout|Lost to Follow-up|0|||
155348531|NCT01207453|560708448|FG000|2nd Intervention|Adverse Event|1|||
155348532|NCT01207453|560708449|FG001|2nd Intervention|Adverse Event|2|||
155348533|NCT01207453|560708448|FG000|2nd Intervention|Lost to Follow-up|1|||
155348534|NCT01207453|560708449|FG001|2nd Intervention|Lost to Follow-up|0|||
155348535|NCT00676663|560708452|FG000|Overall Study|Death|43|||
155348536|NCT00676663|560708453|FG001|Overall Study|Death|27|||
155348537|NCT00676663|560708452|FG000|Overall Study|Withdrew Consent|1|||
155348538|NCT00676663|560708453|FG001|Overall Study|Withdrew Consent|8|||
155348539|NCT00676663|560708452|FG000|Overall Study|Lost to Follow-up|1|||
155348540|NCT00676663|560708453|FG001|Overall Study|Lost to Follow-up|3|||
155348541|NCT04382053|560708454|FG000|Overall Study|Death|6|||
155348542|NCT04382053|560708455|FG001|Overall Study|Death|8|||
155348543|NCT04382053|560708454|FG000|Overall Study|Lost to Follow-up|0|||
155348544|NCT04382053|560708455|FG001|Overall Study|Lost to Follow-up|2|||
155348545|NCT04382053|560708454|FG000|Overall Study|Protocol Deviation|1|||
155348546|NCT04382053|560708455|FG001|Overall Study|Protocol Deviation|2|||
155348547|NCT04382053|560708454|FG000|Overall Study|Withdrawal by Subject|2|||
155348548|NCT04382053|560708455|FG001|Overall Study|Withdrawal by Subject|1|||
155348549|NCT01399905|560708456|FG000|Overall Study|Withdrawal by Subject|1|||
155348550|NCT01399905|560708457|FG001|Overall Study|Withdrawal by Subject|1|||
155348551|NCT00714688|560708465|FG000|Overall Study|Lack of Efficacy|14|||
155348552|NCT00714688|560708466|FG001|Overall Study|Lack of Efficacy|1|||
155348553|NCT00714688|560708467|FG002|Overall Study|Lack of Efficacy|4|||
155348554|NCT00714688|560708465|FG000|Overall Study|Withdrawal by Subject|4|||
155348555|NCT00714688|560708466|FG001|Overall Study|Withdrawal by Subject|3|||
155348556|NCT00714688|560708467|FG002|Overall Study|Withdrawal by Subject|3|||
155348557|NCT00714688|560708465|FG000|Overall Study|Lost to Follow-up|5|||
155348558|NCT00714688|560708466|FG001|Overall Study|Lost to Follow-up|2|||
155348559|NCT00714688|560708467|FG002|Overall Study|Lost to Follow-up|0|||
155348560|NCT00714688|560708465|FG000|Overall Study|Adverse Event|2|||
155348561|NCT00714688|560708466|FG001|Overall Study|Adverse Event|15|||
155348562|NCT00714688|560708467|FG002|Overall Study|Adverse Event|19|||
155348563|NCT00714688|560708465|FG000|Overall Study|Subject Non-compliant|3|||
155348564|NCT00714688|560708466|FG001|Overall Study|Subject Non-compliant|5|||
155348565|NCT00714688|560708467|FG002|Overall Study|Subject Non-compliant|5|||
155348566|NCT00714688|560708465|FG000|Overall Study|Ineligible to Continue the Study|0|||
155348567|NCT00714688|560708466|FG001|Overall Study|Ineligible to Continue the Study|1|||
155647977|NCT02318277|561803728|FG001|Overall Study|Participant trial terminated by sponsor|0|||
155647978|NCT02318277|561803729|FG002|Overall Study|Participant trial terminated by sponsor|1|||
155348568|NCT00714688|560708467|FG002|Overall Study|Ineligible to Continue the Study|1|||
155348569|NCT00714688|560708465|FG000|Overall Study|Sponsor's Decision|0|||
155348570|NCT00714688|560708466|FG001|Overall Study|Sponsor's Decision|2|||
155348571|NCT00714688|560708467|FG002|Overall Study|Sponsor's Decision|0|||
155348572|NCT00714688|560708465|FG000|Overall Study|Other|1|||
155348573|NCT00714688|560708466|FG001|Overall Study|Other|6|||
155348574|NCT00714688|560708467|FG002|Overall Study|Other|5|||
155348575|NCT01786551|560708468|FG000|Overall Study|Participant withdrew consent|2|||
155348576|NCT04853394|560708471|FG000|Follow-up Interviews|Lost to Follow-up|22|||
155348577|NCT04853394|560708472|FG001|Follow-up Interviews|Lost to Follow-up|15|||
155348578|NCT01524887|560708473|FG000|Overall Study|Withdrawal by Subject|6|||
155348579|NCT01524887|560708474|FG001|Overall Study|Withdrawal by Subject|2|||
155348580|NCT01524887|560708475|FG002|Overall Study|Withdrawal by Subject|3|||
155348581|NCT01524887|560708473|FG000|Overall Study|Adverse Event|5|||
155348582|NCT01524887|560708474|FG001|Overall Study|Adverse Event|1|||
155348583|NCT01524887|560708475|FG002|Overall Study|Adverse Event|1|||
155348584|NCT01524887|560708473|FG000|Overall Study|Protocol Violation|0|||
155348585|NCT01524887|560708474|FG001|Overall Study|Protocol Violation|0|||
155348586|NCT01524887|560708475|FG002|Overall Study|Protocol Violation|1|||
155348587|NCT01524887|560708473|FG000|Overall Study|Study termination|73|||
155348588|NCT01524887|560708474|FG001|Overall Study|Study termination|87|||
155348589|NCT01524887|560708475|FG002|Overall Study|Study termination|79|||
155348590|NCT01524887|560708473|FG000|Overall Study|Withdrawal by Caregiver|0|||
155348591|NCT01524887|560708474|FG001|Overall Study|Withdrawal by Caregiver|0|||
155348592|NCT01524887|560708475|FG002|Overall Study|Withdrawal by Caregiver|2|||
155348593|NCT01524887|560708473|FG000|Overall Study|Use of prohibited medication|1|||
155348594|NCT01524887|560708474|FG001|Overall Study|Use of prohibited medication|0|||
155348595|NCT01524887|560708475|FG002|Overall Study|Use of prohibited medication|0|||
155348596|NCT01808144|560708476|FG000|Overall Study|Death|1|||
155348597|NCT01808144|560708477|FG001|Overall Study|Death|0|||
155348598|NCT01808144|560708476|FG000|Overall Study|Withdrawal by Subject|16|||
155348599|NCT01808144|560708477|FG001|Overall Study|Withdrawal by Subject|23|||
155348600|NCT01808144|560708476|FG000|Overall Study|Lost to Follow-up|6|||
155348601|NCT01808144|560708477|FG001|Overall Study|Lost to Follow-up|3|||
155348602|NCT01808144|560708476|FG000|Overall Study|Protocol Violation|6|||
155348603|NCT01808144|560708477|FG001|Overall Study|Protocol Violation|6|||
155348604|NCT01808144|560708476|FG000|Overall Study|Gout flare|0|||
155348605|NCT01808144|560708477|FG001|Overall Study|Gout flare|1|||
155348606|NCT01808144|560708476|FG000|Overall Study|Adverse Event|11|||
155348607|NCT01808144|560708477|FG001|Overall Study|Adverse Event|15|||
155348608|NCT03098797|560710574|FG000|Part 2 Open Label Extension|Adverse Event|2|||
155348609|NCT03098797|560710575|FG001|Part 2 Open Label Extension|Adverse Event|0|||
155348610|NCT02956278|560710576|FG000|Overall Study|Withdrawal by Subject|6|||
155348611|NCT02956278|560710577|FG001|Overall Study|Withdrawal by Subject|2|||
155348612|NCT02956278|560710578|FG002|Overall Study|Withdrawal by Subject|0|||
155348613|NCT02329223|560710579|FG000|Overall Study|Withdrawal by Subject|1|||
155348614|NCT02329223|560710580|FG001|Overall Study|Withdrawal by Subject|2|||
155348615|NCT02329223|560710581|FG002|Overall Study|Withdrawal by Subject|5|||
155348616|NCT02329223|560710579|FG000|Overall Study|Physician Decision|0|||
155348617|NCT02329223|560710580|FG001|Overall Study|Physician Decision|0|||
155348618|NCT02329223|560710581|FG002|Overall Study|Physician Decision|1|||
155348619|NCT02329223|560710579|FG000|Overall Study|Adverse Event|0|||
155348620|NCT02329223|560710580|FG001|Overall Study|Adverse Event|1|||
155348621|NCT02329223|560710581|FG002|Overall Study|Adverse Event|0|||
155348622|NCT00552513|560710586|FG000|Overall Study|Lost to Follow-up|5|||
155348623|NCT00552513|560710587|FG001|Overall Study|Lost to Follow-up|1|||
155348624|NCT04357964|560710588|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
155348625|NCT04357964|560710589|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
155348626|NCT04357964|560710588|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
155348627|NCT04357964|560710589|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
155348628|NCT04357964|560710588|FG000|Overall Study|Adipose sample was insufficient quality|0|||
155647979|NCT02318277|561803730|FG003|Overall Study|Participant trial terminated by sponsor|0|||
155348629|NCT04357964|560710589|FG001|Overall Study|Adipose sample was insufficient quality|1|||
155348630|NCT00733226|560710590|FG000|Overall Study|Withdrawal by Subject|1|||
155348631|NCT00733226|560710591|FG001|Overall Study|Withdrawal by Subject|0|||
155348632|NCT00733226|560710590|FG000|Overall Study|Lost to Follow-up|2|||
155348633|NCT00733226|560710591|FG001|Overall Study|Lost to Follow-up|0|||
155348634|NCT00733226|560710590|FG000|Overall Study|moved to another place|2|||
155348635|NCT00733226|560710591|FG001|Overall Study|moved to another place|0|||
155348636|NCT00848393|560710592|FG000|Overall Study|Protocol Violation|0|||
155348637|NCT00848393|560710593|FG001|Overall Study|Protocol Violation|0|||
155348638|NCT00848393|560710594|FG002|Overall Study|Protocol Violation|1|||
155348639|NCT00848393|560710592|FG000|Overall Study|surgical complications unrelated to stud|0|||
155348640|NCT00848393|560710593|FG001|Overall Study|surgical complications unrelated to stud|0|||
155348641|NCT00848393|560710594|FG002|Overall Study|surgical complications unrelated to stud|2|||
155348642|NCT00443898|560710599|FG000|Overall Study|Adverse Event|0|||
155348643|NCT00443898|560710600|FG001|Overall Study|Adverse Event|0|||
155348644|NCT00443898|560710601|FG002|Overall Study|Adverse Event|1|||
155348645|NCT00443898|560710602|FG003|Overall Study|Adverse Event|1|||
155348646|NCT00443898|560710599|FG000|Overall Study|Lack of Efficacy|2|||
155348647|NCT00443898|560710600|FG001|Overall Study|Lack of Efficacy|3|||
155348648|NCT00443898|560710601|FG002|Overall Study|Lack of Efficacy|3|||
155348649|NCT00443898|560710602|FG003|Overall Study|Lack of Efficacy|1|||
155348650|NCT00443898|560710599|FG000|Overall Study|Protocol Violation|1|||
155348651|NCT00443898|560710600|FG001|Overall Study|Protocol Violation|1|||
155348652|NCT00443898|560710601|FG002|Overall Study|Protocol Violation|1|||
155348653|NCT00443898|560710602|FG003|Overall Study|Protocol Violation|0|||
155348654|NCT00443898|560710599|FG000|Overall Study|Withdrawal by Subject|11|||
155348655|NCT00443898|560710600|FG001|Overall Study|Withdrawal by Subject|10|||
155348656|NCT00443898|560710601|FG002|Overall Study|Withdrawal by Subject|10|||
155348657|NCT00443898|560710602|FG003|Overall Study|Withdrawal by Subject|6|||
155348658|NCT00443898|560710599|FG000|Overall Study|Lost to Follow-up|10|||
155348659|NCT00443898|560710600|FG001|Overall Study|Lost to Follow-up|10|||
155348660|NCT00443898|560710601|FG002|Overall Study|Lost to Follow-up|14|||
155348661|NCT00443898|560710602|FG003|Overall Study|Lost to Follow-up|10|||
155348662|NCT00443898|560710599|FG000|Overall Study|Death|0|||
155348663|NCT00443898|560710600|FG001|Overall Study|Death|1|||
155348664|NCT00443898|560710601|FG002|Overall Study|Death|0|||
155348665|NCT00443898|560710602|FG003|Overall Study|Death|0|||
155348666|NCT00043186|560710603|FG000|Overall Study|Physician Decision|0|||
155348667|NCT00043186|560710604|FG001|Overall Study|Physician Decision|0|||
155348668|NCT00043186|560710605|FG002|Overall Study|Physician Decision|3|||
155348669|NCT00043186|560710606|FG003|Overall Study|Physician Decision|0|||
155348670|NCT00043186|560710607|FG004|Overall Study|Physician Decision|1|||
155505981|NCT02623426|561278292|FG002|Overall Study|Withdrawal by Subject|2|||
155505982|NCT03751124|561278293|FG000|Overall Study|Adverse Event|4|||
155505983|NCT03751124|561278294|FG001|Overall Study|Adverse Event|3|||
155505984|NCT03751124|561278293|FG000|Overall Study|Protocol Deviation|0|||
155505985|NCT03751124|561278294|FG001|Overall Study|Protocol Deviation|1|||
155505986|NCT03751124|561278293|FG000|Overall Study|Lost to Follow-up|6|||
155505987|NCT03751124|561278294|FG001|Overall Study|Lost to Follow-up|4|||
155647980|NCT02318277|561803731|FG004|Overall Study|Participant trial terminated by sponsor|1|||
155647981|NCT02318277|561803732|FG005|Overall Study|Participant trial terminated by sponsor|2|||
155348671|NCT00043186|560710608|FG005|Overall Study|Physician Decision|0|||
155348672|NCT00043186|560710609|FG006|Overall Study|Physician Decision|0|||
155348673|NCT00043186|560710610|FG007|Overall Study|Physician Decision|1|||
155348674|NCT00043186|560710611|FG008|Overall Study|Physician Decision|1|||
155348675|NCT00043186|560710603|FG000|Overall Study|Adverse Event|2|||
155348676|NCT00043186|560710604|FG001|Overall Study|Adverse Event|2|||
155348677|NCT00043186|560710605|FG002|Overall Study|Adverse Event|2|||
155348678|NCT00043186|560710606|FG003|Overall Study|Adverse Event|3|||
155348679|NCT00043186|560710607|FG004|Overall Study|Adverse Event|2|||
155348680|NCT00043186|560710608|FG005|Overall Study|Adverse Event|1|||
155348681|NCT00043186|560710609|FG006|Overall Study|Adverse Event|2|||
155505988|NCT03751124|561278293|FG000|Overall Study|Withdrawal by Subject|6|||
155505989|NCT03751124|561278294|FG001|Overall Study|Withdrawal by Subject|8|||
155647982|NCT02318277|561803733|FG006|Overall Study|Participant trial terminated by sponsor|5|||
155348682|NCT00043186|560710610|FG007|Overall Study|Adverse Event|1|||
155348683|NCT00043186|560710611|FG008|Overall Study|Adverse Event|3|||
155348684|NCT00043186|560710603|FG000|Overall Study|Withdrawal by Subject|11|||
155348685|NCT00043186|560710604|FG001|Overall Study|Withdrawal by Subject|8|||
155348686|NCT00043186|560710605|FG002|Overall Study|Withdrawal by Subject|11|||
155348687|NCT00043186|560710606|FG003|Overall Study|Withdrawal by Subject|13|||
155348688|NCT00043186|560710607|FG004|Overall Study|Withdrawal by Subject|14|||
155348689|NCT00043186|560710608|FG005|Overall Study|Withdrawal by Subject|6|||
155348690|NCT00043186|560710609|FG006|Overall Study|Withdrawal by Subject|12|||
155348691|NCT00043186|560710610|FG007|Overall Study|Withdrawal by Subject|9|||
155348692|NCT00043186|560710611|FG008|Overall Study|Withdrawal by Subject|10|||
155505990|NCT03751124|561278293|FG000|Overall Study|Lack of Efficacy|1|||
155348693|NCT00043186|560710603|FG000|Overall Study|Death|0|||
155348694|NCT00043186|560710604|FG001|Overall Study|Death|0|||
155348695|NCT00043186|560710605|FG002|Overall Study|Death|1|||
155348696|NCT00043186|560710606|FG003|Overall Study|Death|0|||
155348697|NCT00043186|560710607|FG004|Overall Study|Death|0|||
155348698|NCT00043186|560710608|FG005|Overall Study|Death|0|||
155348699|NCT00043186|560710609|FG006|Overall Study|Death|2|||
155348700|NCT00043186|560710610|FG007|Overall Study|Death|0|||
155348701|NCT00043186|560710611|FG008|Overall Study|Death|0|||
155348702|NCT00043186|560710603|FG000|Overall Study|Disease progression|1|||
155348703|NCT00043186|560710604|FG001|Overall Study|Disease progression|0|||
155348704|NCT00043186|560710605|FG002|Overall Study|Disease progression|0|||
155348705|NCT00043186|560710606|FG003|Overall Study|Disease progression|3|||
155348706|NCT00043186|560710607|FG004|Overall Study|Disease progression|0|||
155348707|NCT00043186|560710608|FG005|Overall Study|Disease progression|0|||
155348708|NCT00043186|560710609|FG006|Overall Study|Disease progression|0|||
155348709|NCT00043186|560710610|FG007|Overall Study|Disease progression|4|||
155348710|NCT00043186|560710611|FG008|Overall Study|Disease progression|0|||
155348711|NCT00043186|560710603|FG000|Overall Study|Ineligibility determined|0|||
155348712|NCT00043186|560710604|FG001|Overall Study|Ineligibility determined|0|||
155348713|NCT00043186|560710605|FG002|Overall Study|Ineligibility determined|0|||
155348714|NCT00043186|560710606|FG003|Overall Study|Ineligibility determined|0|||
155348715|NCT00043186|560710607|FG004|Overall Study|Ineligibility determined|0|||
155348716|NCT00043186|560710608|FG005|Overall Study|Ineligibility determined|0|||
155348717|NCT00043186|560710609|FG006|Overall Study|Ineligibility determined|0|||
155348718|NCT00043186|560710610|FG007|Overall Study|Ineligibility determined|0|||
155348719|NCT00043186|560710611|FG008|Overall Study|Ineligibility determined|1|||
155348720|NCT00043186|560710603|FG000|Overall Study|Lost to Follow-up|3|||
155348721|NCT00043186|560710604|FG001|Overall Study|Lost to Follow-up|5|||
155348722|NCT00043186|560710605|FG002|Overall Study|Lost to Follow-up|1|||
155348723|NCT00043186|560710606|FG003|Overall Study|Lost to Follow-up|1|||
155348724|NCT00043186|560710607|FG004|Overall Study|Lost to Follow-up|1|||
155348725|NCT00043186|560710608|FG005|Overall Study|Lost to Follow-up|1|||
155348726|NCT00043186|560710609|FG006|Overall Study|Lost to Follow-up|1|||
155348727|NCT00043186|560710610|FG007|Overall Study|Lost to Follow-up|1|||
155348728|NCT00043186|560710611|FG008|Overall Study|Lost to Follow-up|2|||
155348729|NCT00043186|560710603|FG000|Overall Study|Noncompliance|0|||
155348730|NCT00043186|560710604|FG001|Overall Study|Noncompliance|0|||
155348731|NCT00043186|560710605|FG002|Overall Study|Noncompliance|1|||
155348732|NCT00043186|560710606|FG003|Overall Study|Noncompliance|1|||
155348733|NCT00043186|560710607|FG004|Overall Study|Noncompliance|0|||
155348734|NCT00043186|560710608|FG005|Overall Study|Noncompliance|0|||
155348735|NCT00043186|560710609|FG006|Overall Study|Noncompliance|0|||
155348736|NCT00043186|560710610|FG007|Overall Study|Noncompliance|0|||
155348737|NCT00043186|560710611|FG008|Overall Study|Noncompliance|0|||
155348738|NCT00043186|560710603|FG000|Overall Study|Other|0|||
155348739|NCT00043186|560710604|FG001|Overall Study|Other|0|||
155348740|NCT00043186|560710605|FG002|Overall Study|Other|1|||
155348741|NCT00043186|560710606|FG003|Overall Study|Other|1|||
155348742|NCT00043186|560710607|FG004|Overall Study|Other|0|||
155348743|NCT00043186|560710608|FG005|Overall Study|Other|0|||
155348744|NCT00043186|560710609|FG006|Overall Study|Other|0|||
155348745|NCT00043186|560710610|FG007|Overall Study|Other|0|||
155348746|NCT00043186|560710611|FG008|Overall Study|Other|0|||
155348747|NCT00508274|560710612|FG000|Overall Study|Adverse Event|5|||
155348748|NCT00508274|560710612|FG000|Overall Study|Death|7|||
155348749|NCT00508274|560710612|FG000|Overall Study|Disease progression|32|||
155348750|NCT00508274|560710612|FG000|Overall Study|Withdrawal by Subject|1|||
155348751|NCT00508274|560710612|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
155348752|NCT00508274|560710612|FG000|Overall Study|Missing|3|||
155348753|NCT00550771|560710615|FG000|Overall Study|Adverse Event|11|||
155348754|NCT00550771|560710616|FG001|Overall Study|Adverse Event|3|||
155348755|NCT00550771|560710615|FG000|Overall Study|Discontinued for study-related reasons|0|||
155348756|NCT00550771|560710616|FG001|Overall Study|Discontinued for study-related reasons|1|||
155348757|NCT00550771|560710615|FG000|Overall Study|Physician Decision|2|||
155348758|NCT00550771|560710616|FG001|Overall Study|Physician Decision|0|||
155348759|NCT00550771|560710615|FG000|Overall Study|Withdrawal by Subject|0|||
155348760|NCT00550771|560710616|FG001|Overall Study|Withdrawal by Subject|1|||
155348761|NCT00550771|560710615|FG000|Overall Study|Protocol Violation|4|||
155348762|NCT00550771|560710616|FG001|Overall Study|Protocol Violation|5|||
155505991|NCT03751124|561278294|FG001|Overall Study|Lack of Efficacy|1|||
155647983|NCT02318277|561803734|FG007|Overall Study|Participant trial terminated by sponsor|16|||
155647984|NCT02318277|561803727|FG000|Overall Study|Lost to Follow-up|1|||
155348763|NCT03681353|560710617|FG000|Overall Study|Lost to Follow-up|2|||
155348764|NCT03681353|560710617|FG000|Overall Study|Withdrawal by Subject|3|||
155348765|NCT03681353|560710617|FG000|Overall Study|withdrawn by PI|2|||
155348766|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
155348767|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
155647985|NCT02318277|561803728|FG001|Overall Study|Lost to Follow-up|0|||
155348768|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
155348769|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
155348770|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
155348771|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
155348772|NCT00520403|560710623|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
155348773|NCT00520403|560710623|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
155348774|NCT03924947|560710624|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348775|NCT03924947|560710625|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348776|NCT03924947|560710626|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
155348777|NCT03924947|560710627|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348778|NCT03924947|560710628|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348779|NCT03924947|560710629|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348780|NCT01145417|560710630|FG000|Overall Study|Death|1|||
155348781|NCT01145417|560710631|FG001|Overall Study|Death|0|||
155348782|NCT01145417|560710630|FG000|Overall Study|Lost to Follow-up|2|||
155348783|NCT01145417|560710631|FG001|Overall Study|Lost to Follow-up|1|||
155348784|NCT01145417|560710630|FG000|Overall Study|Withdrawal by Subject|1|||
155348785|NCT01145417|560710631|FG001|Overall Study|Withdrawal by Subject|2|||
155348786|NCT01145417|560710630|FG000|Overall Study|Pregnancy|1|||
155348787|NCT01145417|560710631|FG001|Overall Study|Pregnancy|0|||
155348788|NCT01145417|560710630|FG000|Overall Study|Adverse Event|0|||
155348789|NCT01145417|560710631|FG001|Overall Study|Adverse Event|1|||
155348790|NCT01145417|560710630|FG000|Overall Study|Study terminated by sponsor|35|||
155348791|NCT01145417|560710631|FG001|Overall Study|Study terminated by sponsor|43|||
155348792|NCT01145417|560710630|FG000|Overall Study|Other|1|||
155348793|NCT01145417|560710631|FG001|Overall Study|Other|0|||
155348794|NCT01797562|560710632|FG000|Overall Study|Protocol Violation|5|||
155348795|NCT00917462|560710635|FG000|Overall Study|Clinical Deterioration|1|||
155348796|NCT03341312|560710642|FG000|Period 1|Withdrawal by Subject|0|||
155348797|NCT03341312|560710643|FG001|Period 1|Withdrawal by Subject|1|||
155424954|NCT01154101|560984572|FG003|Overall Study|Lost to Follow-up|1|||
155424955|NCT01154101|560984573|FG004|Overall Study|Lost to Follow-up|0|||
155424956|NCT01154101|560984569|FG000|Overall Study|Withdrawal by Subject|0|||
155424957|NCT01154101|560984570|FG001|Overall Study|Withdrawal by Subject|1|||
155424958|NCT01154101|560984571|FG002|Overall Study|Withdrawal by Subject|2|||
155424959|NCT01154101|560984572|FG003|Overall Study|Withdrawal by Subject|0|||
155424960|NCT01154101|560984573|FG004|Overall Study|Withdrawal by Subject|1|||
155424961|NCT05019131|560984574|FG000|Overall Study|Lost to Follow-up|0|||
155424962|NCT05019131|560984575|FG001|Overall Study|Lost to Follow-up|3|||
155424963|NCT03575104|560984576|FG000|Overall Study|Adverse Event|4|||
155424964|NCT03575104|560984577|FG001|Overall Study|Adverse Event|3|||
155424965|NCT03575104|560984578|FG002|Overall Study|Adverse Event|4|||
155424966|NCT03575104|560984576|FG000|Overall Study|Withdrawal by Subject|13|||
155424967|NCT03575104|560984577|FG001|Overall Study|Withdrawal by Subject|16|||
155424968|NCT03575104|560984578|FG002|Overall Study|Withdrawal by Subject|11|||
155424969|NCT03575104|560984576|FG000|Overall Study|Other reasons|6|||
155424970|NCT03575104|560984577|FG001|Overall Study|Other reasons|8|||
155424971|NCT03575104|560984578|FG002|Overall Study|Other reasons|6|||
155424972|NCT03575104|560984576|FG000|Overall Study|Lost to Follow-up|1|||
155424973|NCT03575104|560984577|FG001|Overall Study|Lost to Follow-up|2|||
155424974|NCT03575104|560984578|FG002|Overall Study|Lost to Follow-up|1|||
155424975|NCT02661594|560984579|FG000|Overall Study|Protocol Violation|1|||
155424976|NCT02661594|560984580|FG001|Overall Study|Protocol Violation|0|||
155424977|NCT02661594|560984581|FG002|Overall Study|Protocol Violation|1|||
155424978|NCT02661594|560984582|FG003|Overall Study|Protocol Violation|0|||
155424979|NCT00432237|560984583|FG000|Overall Study|Adverse Event|0|||
155424980|NCT00432237|560984584|FG001|Overall Study|Adverse Event|0|||
155424981|NCT00432237|560984585|FG002|Overall Study|Adverse Event|0|||
155424982|NCT00432237|560984586|FG003|Overall Study|Adverse Event|1|||
155348798|NCT03341312|560710644|FG002|Period 1|Withdrawal by Subject|0|||
155424983|NCT00432237|560984583|FG000|Overall Study|Lack of Efficacy|0|||
155424984|NCT00432237|560984584|FG001|Overall Study|Lack of Efficacy|0|||
155424985|NCT00432237|560984585|FG002|Overall Study|Lack of Efficacy|0|||
155348799|NCT03341312|560710645|FG003|Period 1|Withdrawal by Subject|0|||
155348800|NCT00839306|560710646|FG000|Overall Study|Adverse Event|3|||
155424986|NCT00432237|560984586|FG003|Overall Study|Lack of Efficacy|1|||
155424987|NCT00432237|560984583|FG000|Overall Study|Lost to Follow-up|10|||
155424988|NCT00432237|560984584|FG001|Overall Study|Lost to Follow-up|10|||
155424989|NCT00432237|560984585|FG002|Overall Study|Lost to Follow-up|18|||
155424990|NCT00432237|560984586|FG003|Overall Study|Lost to Follow-up|18|||
155424991|NCT00432237|560984583|FG000|Overall Study|Physician Decision|1|||
155348801|NCT00839306|560710647|FG001|Overall Study|Adverse Event|5|||
155348802|NCT00839306|560710646|FG000|Overall Study|Lost to Follow-up|6|||
155424992|NCT00432237|560984584|FG001|Overall Study|Physician Decision|3|||
155424993|NCT00432237|560984585|FG002|Overall Study|Physician Decision|2|||
155348803|NCT00839306|560710647|FG001|Overall Study|Lost to Follow-up|9|||
155348804|NCT00839306|560710646|FG000|Overall Study|Withdrawal by Subject|5|||
155348805|NCT00839306|560710647|FG001|Overall Study|Withdrawal by Subject|7|||
155348806|NCT00839306|560710646|FG000|Overall Study|Lack of Efficacy|5|||
155348807|NCT00839306|560710647|FG001|Overall Study|Lack of Efficacy|4|||
155348808|NCT00839306|560710646|FG000|Overall Study|Other|6|||
155348809|NCT00839306|560710647|FG001|Overall Study|Other|18|||
155348810|NCT01812707|560710648|FG000|Overall Study|Adverse Event|0|||
155348811|NCT01812707|560710649|FG001|Overall Study|Adverse Event|0|||
155348812|NCT01812707|560710650|FG002|Overall Study|Adverse Event|0|||
155505992|NCT03751124|561278293|FG000|Overall Study|Pregnancy|0|||
155505993|NCT03751124|561278294|FG001|Overall Study|Pregnancy|1|||
155505994|NCT03751124|561278293|FG000|Overall Study|Other|9|||
155505995|NCT03751124|561278294|FG001|Overall Study|Other|9|||
155505996|NCT03751124|561278293|FG000|Overall Study|Participants who did not receive any study drug|0|||
155505997|NCT03751124|561278294|FG001|Overall Study|Participants who did not receive any study drug|1|||
155505998|NCT05458895|561278297|FG000|Overall Study|Withdrawal by Subject|8|||
155505999|NCT05458895|561278297|FG000|Overall Study|Lost to Follow-up|17|||
155506000|NCT05458895|561278297|FG000|Overall Study|Pregnancy|2|||
155506001|NCT05458895|561278297|FG000|Overall Study|Withdrawal by Study Team|1|||
155506002|NCT05166421|561278300|FG000|Overall Study|Other|3|||
155506003|NCT05166421|561278301|FG001|Overall Study|Other|1|||
155506004|NCT05166421|561278302|FG002|Overall Study|Other|1|||
155506005|NCT05166421|561278300|FG000|Overall Study|Withdrawal by Subject|5|||
155506006|NCT05166421|561278301|FG001|Overall Study|Withdrawal by Subject|3|||
155506007|NCT05166421|561278302|FG002|Overall Study|Withdrawal by Subject|6|||
155506008|NCT05166421|561278300|FG000|Overall Study|Lost to Follow-up|4|||
155506009|NCT05166421|561278301|FG001|Overall Study|Lost to Follow-up|1|||
155506010|NCT05166421|561278302|FG002|Overall Study|Lost to Follow-up|7|||
155506011|NCT00382291|561280197|FG000|Overall Study|Adverse Event|1|||
155506012|NCT00382291|561280198|FG001|Overall Study|Adverse Event|2|||
155506013|NCT00382291|561280199|FG002|Overall Study|Adverse Event|2|||
155506014|NCT00382291|561280197|FG000|Overall Study|Protocol Violation|1|||
155506015|NCT00382291|561280198|FG001|Overall Study|Protocol Violation|0|||
155506016|NCT00382291|561280199|FG002|Overall Study|Protocol Violation|0|||
155506017|NCT00382291|561280197|FG000|Overall Study|Temporary study suspension|2|||
155506018|NCT00382291|561280198|FG001|Overall Study|Temporary study suspension|2|||
155506019|NCT00382291|561280199|FG002|Overall Study|Temporary study suspension|5|||
155348813|NCT01812707|560710651|FG003|Overall Study|Adverse Event|2|||
155348814|NCT01812707|560710648|FG000|Overall Study|Poor compliance to protocol|1|||
155348815|NCT01812707|560710649|FG001|Overall Study|Poor compliance to protocol|0|||
155348816|NCT01812707|560710650|FG002|Overall Study|Poor compliance to protocol|0|||
155348817|NCT01812707|560710651|FG003|Overall Study|Poor compliance to protocol|0|||
155348818|NCT01812707|560710648|FG000|Overall Study|Consent withdrawn by participant|1|||
155348819|NCT01812707|560710649|FG001|Overall Study|Consent withdrawn by participant|0|||
155348820|NCT01812707|560710650|FG002|Overall Study|Consent withdrawn by participant|0|||
155506020|NCT00382291|561280197|FG000|Overall Study|Withdrawal by Subject|0|||
155506021|NCT00382291|561280198|FG001|Overall Study|Withdrawal by Subject|2|||
155506022|NCT00382291|561280199|FG002|Overall Study|Withdrawal by Subject|0|||
155506023|NCT00382291|561280197|FG000|Overall Study|Physician Decision|0|||
155506024|NCT00382291|561280198|FG001|Overall Study|Physician Decision|1|||
155506025|NCT00382291|561280199|FG002|Overall Study|Physician Decision|0|||
155506026|NCT00382291|561280197|FG000|Overall Study|Lack of Efficacy|0|||
155348821|NCT01812707|560710651|FG003|Overall Study|Consent withdrawn by participant|0|||
155506027|NCT00382291|561280198|FG001|Overall Study|Lack of Efficacy|0|||
155506028|NCT00382291|561280199|FG002|Overall Study|Lack of Efficacy|1|||
155506029|NCT01375010|561280200|FG000|Overall Study|Lost to Follow-up|8|||
155348822|NCT05060237|560710653|FG000|Overall Study|Withdrawal by Subject|4|||
155348823|NCT05060237|560710653|FG000|Overall Study|Screening failure|8|||
155348824|NCT02396758|560710654|FG000|Overall Study|Withdrawal by Subject|2|||
155348825|NCT02396758|560710655|FG001|Overall Study|Withdrawal by Subject|0|||
155348826|NCT02396758|560710656|FG002|Overall Study|Withdrawal by Subject|0|||
155348827|NCT02396758|560710657|FG003|Overall Study|Withdrawal by Subject|1|||
155348828|NCT02396758|560710654|FG000|Overall Study|Lost to Follow-up|8|||
155348829|NCT02396758|560710655|FG001|Overall Study|Lost to Follow-up|5|||
155348830|NCT02396758|560710656|FG002|Overall Study|Lost to Follow-up|3|||
155348831|NCT02396758|560710657|FG003|Overall Study|Lost to Follow-up|3|||
155348832|NCT02396758|560710654|FG000|Overall Study|Death|1|||
155348833|NCT02396758|560710655|FG001|Overall Study|Death|1|||
155348834|NCT02396758|560710656|FG002|Overall Study|Death|0|||
155348835|NCT02396758|560710657|FG003|Overall Study|Death|1|||
155348836|NCT02396758|560710654|FG000|Overall Study|Randomized but not treated|1|||
155348837|NCT02396758|560710655|FG001|Overall Study|Randomized but not treated|0|||
155348838|NCT02396758|560710656|FG002|Overall Study|Randomized but not treated|1|||
155348839|NCT02396758|560710657|FG003|Overall Study|Randomized but not treated|0|||
155348840|NCT02176018|560710658|FG000|Overall Study|Adverse Event|0|||
155348841|NCT02176018|560710659|FG001|Overall Study|Adverse Event|2|||
155348842|NCT02176018|560710658|FG000|Overall Study|Lost to Follow-up|3|||
155348843|NCT02176018|560710659|FG001|Overall Study|Lost to Follow-up|1|||
155348844|NCT02176018|560710658|FG000|Overall Study|Protocol Violation|1|||
155348845|NCT02176018|560710659|FG001|Overall Study|Protocol Violation|1|||
155348846|NCT02176018|560710658|FG000|Overall Study|Withdrawal by Subject|1|||
155348847|NCT02176018|560710659|FG001|Overall Study|Withdrawal by Subject|2|||
155348848|NCT00265096|560710661|FG000|Overall Study|Adverse Event|14|||
155348849|NCT00265096|560710662|FG001|Overall Study|Adverse Event|18|||
155348850|NCT00265096|560710663|FG002|Overall Study|Adverse Event|18|||
155348851|NCT00265096|560710661|FG000|Overall Study|Lost to Follow-up|2|||
155348852|NCT00265096|560710662|FG001|Overall Study|Lost to Follow-up|5|||
155348853|NCT00265096|560710663|FG002|Overall Study|Lost to Follow-up|3|||
155348854|NCT00265096|560710661|FG000|Overall Study|Death|0|||
155348855|NCT00265096|560710662|FG001|Overall Study|Death|1|||
155348856|NCT00265096|560710663|FG002|Overall Study|Death|2|||
155348857|NCT00265096|560710661|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
155348858|NCT00265096|560710662|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155348859|NCT00265096|560710663|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155348860|NCT00265096|560710661|FG000|Overall Study|Other|11|||
155348861|NCT00265096|560710662|FG001|Overall Study|Other|19|||
155424994|NCT00432237|560984586|FG003|Overall Study|Physician Decision|1|||
155424995|NCT00432237|560984583|FG000|Overall Study|Pregnancy|0|||
155424996|NCT00432237|560984584|FG001|Overall Study|Pregnancy|1|||
155424997|NCT00432237|560984585|FG002|Overall Study|Pregnancy|0|||
155424998|NCT00432237|560984586|FG003|Overall Study|Pregnancy|0|||
155348862|NCT00265096|560710663|FG002|Overall Study|Other|10|||
155348863|NCT01116440|560710664|FG000|Treatment|Withdrawal by Subject|2|||
155348864|NCT01116440|560710665|FG001|Treatment|Withdrawal by Subject|2|||
155348865|NCT01116440|560710664|FG000|Treatment|Lost to Follow-up|1|||
155348866|NCT01116440|560710665|FG001|Treatment|Lost to Follow-up|1|||
155348867|NCT01116440|560710664|FG000|Treatment|Protocol Violation|0|||
155348868|NCT01116440|560710665|FG001|Treatment|Protocol Violation|2|||
155424999|NCT00432237|560984583|FG000|Overall Study|Protocol Violation|13|||
155425000|NCT00432237|560984584|FG001|Overall Study|Protocol Violation|10|||
155425001|NCT00432237|560984585|FG002|Overall Study|Protocol Violation|11|||
155425002|NCT00432237|560984586|FG003|Overall Study|Protocol Violation|8|||
155425003|NCT00432237|560984583|FG000|Overall Study|Withdrawal by Subject|5|||
155425004|NCT00432237|560984584|FG001|Overall Study|Withdrawal by Subject|6|||
155425005|NCT00432237|560984585|FG002|Overall Study|Withdrawal by Subject|9|||
155425006|NCT00432237|560984586|FG003|Overall Study|Withdrawal by Subject|11|||
155425007|NCT00432237|560984583|FG000|Overall Study|Lack of Qualifying Event|38|||
155425008|NCT00432237|560984584|FG001|Overall Study|Lack of Qualifying Event|71|||
155425009|NCT00432237|560984585|FG002|Overall Study|Lack of Qualifying Event|69|||
155425010|NCT00432237|560984586|FG003|Overall Study|Lack of Qualifying Event|84|||
155425011|NCT03049449|560984590|FG000|Overall Study|Did not receive treatment.|0|||
155425012|NCT03049449|560984591|FG001|Overall Study|Did not receive treatment.|0|||
155425013|NCT03049449|560984592|FG002|Overall Study|Did not receive treatment.|0|||
155425014|NCT03049449|560984593|FG003|Overall Study|Did not receive treatment.|0|||
155425015|NCT03049449|560984594|FG004|Overall Study|Did not receive treatment.|0|||
155425016|NCT03049449|560984595|FG005|Overall Study|Did not receive treatment.|0|||
155425017|NCT03049449|560984596|FG006|Overall Study|Did not receive treatment.|0|||
155425018|NCT03049449|560984597|FG007|Overall Study|Did not receive treatment.|0|||
155425019|NCT03049449|560984598|FG008|Overall Study|Did not receive treatment.|1|||
155425020|NCT03049449|560984599|FG009|Overall Study|Did not receive treatment.|0|||
155506030|NCT01375010|561280201|FG001|Overall Study|Lost to Follow-up|2|||
155348869|NCT01116440|560710664|FG000|Treatment|Lack of Efficacy|0|||
155348870|NCT01116440|560710665|FG001|Treatment|Lack of Efficacy|1|||
155348871|NCT01116440|560710664|FG000|Treatment|Adverse Event|0|||
155348872|NCT01116440|560710665|FG001|Treatment|Adverse Event|1|||
155348873|NCT01116440|560710664|FG000|Withdrawal|Withdrawal by Subject|0|||
155348874|NCT01116440|560710665|FG001|Withdrawal|Withdrawal by Subject|1|||
155506031|NCT01375010|561280200|FG000|Overall Study|Withdrawal by Subject|4|||
155506032|NCT01375010|561280201|FG001|Overall Study|Withdrawal by Subject|2|||
155506033|NCT02266706|561280202|FG000|Overall Study|Withdrawal by Subject|0|||
155506034|NCT02266706|561280203|FG001|Overall Study|Withdrawal by Subject|1|||
155506035|NCT02266706|561280204|FG002|Overall Study|Withdrawal by Subject|1|||
155506036|NCT02266706|561280205|FG003|Overall Study|Withdrawal by Subject|0|||
155506037|NCT02266706|561280206|FG004|Overall Study|Withdrawal by Subject|0|||
155348875|NCT01116440|560710664|FG000|Withdrawal|Lost to Follow-up|0|||
155348876|NCT01116440|560710665|FG001|Withdrawal|Lost to Follow-up|1|||
155348877|NCT01116440|560710664|FG000|Follow-up|Lost to Follow-up|0|||
155348878|NCT01116440|560710665|FG001|Follow-up|Lost to Follow-up|1|||
155348879|NCT01116440|560710664|FG000|Follow-up|Withdrawal by Subject|0|||
155506038|NCT02266706|561280207|FG005|Overall Study|Withdrawal by Subject|1|||
155506039|NCT02266706|561280208|FG006|Overall Study|Withdrawal by Subject|0|||
155506040|NCT02266706|561280209|FG007|Overall Study|Withdrawal by Subject|0|||
155506041|NCT02266706|561280210|FG008|Overall Study|Withdrawal by Subject|0|||
155506042|NCT02266706|561280202|FG000|Overall Study|Screen failure|0|||
155506043|NCT02266706|561280203|FG001|Overall Study|Screen failure|0|||
155506044|NCT02266706|561280204|FG002|Overall Study|Screen failure|0|||
155506045|NCT02266706|561280205|FG003|Overall Study|Screen failure|0|||
155506046|NCT02266706|561280206|FG004|Overall Study|Screen failure|0|||
155506047|NCT02266706|561280207|FG005|Overall Study|Screen failure|1|||
155506048|NCT02266706|561280208|FG006|Overall Study|Screen failure|1|||
155506049|NCT02266706|561280209|FG007|Overall Study|Screen failure|0|||
155506050|NCT02266706|561280210|FG008|Overall Study|Screen failure|0|||
155506051|NCT02266706|561280202|FG000|Overall Study|Enrollment in another study|0|||
155647986|NCT02318277|561803729|FG002|Overall Study|Lost to Follow-up|1|||
155647987|NCT02318277|561803730|FG003|Overall Study|Lost to Follow-up|0|||
155647988|NCT02318277|561803731|FG004|Overall Study|Lost to Follow-up|0|||
155506052|NCT02266706|561280203|FG001|Overall Study|Enrollment in another study|0|||
155506053|NCT02266706|561280204|FG002|Overall Study|Enrollment in another study|0|||
155647989|NCT02318277|561803732|FG005|Overall Study|Lost to Follow-up|0|||
155348880|NCT01116440|560710665|FG001|Follow-up|Withdrawal by Subject|1|||
155506054|NCT02266706|561280205|FG003|Overall Study|Enrollment in another study|1|||
155348881|NCT00774306|560710666|FG000|Overall Study|Adverse Event|3|||
155348882|NCT00774306|560710667|FG001|Overall Study|Adverse Event|0|||
155348883|NCT00774306|560710668|FG002|Overall Study|Adverse Event|0|||
155348884|NCT00774306|560710669|FG003|Overall Study|Adverse Event|0|||
155348885|NCT00774306|560710666|FG000|Overall Study|Protocol Violation|2|||
155348886|NCT00774306|560710667|FG001|Overall Study|Protocol Violation|0|||
155348887|NCT00774306|560710668|FG002|Overall Study|Protocol Violation|3|||
155348888|NCT00774306|560710669|FG003|Overall Study|Protocol Violation|0|||
155348889|NCT00774306|560710666|FG000|Overall Study|Withdrawal by Subject|6|||
155348890|NCT00774306|560710667|FG001|Overall Study|Withdrawal by Subject|1|||
155348891|NCT00774306|560710668|FG002|Overall Study|Withdrawal by Subject|1|||
155348892|NCT00774306|560710669|FG003|Overall Study|Withdrawal by Subject|0|||
155348893|NCT00774306|560710666|FG000|Overall Study|Lost to Follow-up|6|||
155348894|NCT00774306|560710667|FG001|Overall Study|Lost to Follow-up|0|||
155348895|NCT00774306|560710668|FG002|Overall Study|Lost to Follow-up|4|||
155348896|NCT00774306|560710669|FG003|Overall Study|Lost to Follow-up|5|||
155348897|NCT00774306|560710666|FG000|Overall Study|Death|1|||
155348898|NCT00774306|560710667|FG001|Overall Study|Death|1|||
155348899|NCT00774306|560710668|FG002|Overall Study|Death|0|||
155348900|NCT00774306|560710669|FG003|Overall Study|Death|0|||
155348901|NCT03568708|560710673|FG000|Overall Study|Withdrawal by Subject|1|||
155348902|NCT03568708|560710674|FG001|Overall Study|Withdrawal by Subject|1|||
155348903|NCT03568708|560710673|FG000|Overall Study|Lost to Follow-up|0|||
155348904|NCT03568708|560710674|FG001|Overall Study|Lost to Follow-up|1|||
155348905|NCT01126879|560710675|FG000|Overall Study|Progressive Disease|3|||
155348906|NCT01126879|560710676|FG001|Overall Study|Progressive Disease|1|||
155348907|NCT01126879|560710675|FG000|Overall Study|Withdrawal by Subject|1|||
155348908|NCT01126879|560710676|FG001|Overall Study|Withdrawal by Subject|0|||
155348909|NCT01126879|560710675|FG000|Overall Study|Adverse Event|0|||
155348910|NCT01126879|560710676|FG001|Overall Study|Adverse Event|1|||
155348911|NCT01126879|560710675|FG000|Overall Study|Physician Decision|1|||
155348912|NCT01126879|560710676|FG001|Overall Study|Physician Decision|0|||
155348913|NCT00666835|560710677|FG000|Overall Study|Withdrawal by Subject|5|||
155348914|NCT00666835|560710678|FG001|Overall Study|Withdrawal by Subject|2|||
155348915|NCT00666835|560710677|FG000|Overall Study|Lack of Efficacy|0|||
155348916|NCT00666835|560710678|FG001|Overall Study|Lack of Efficacy|1|||
155348917|NCT00666835|560710677|FG000|Overall Study|Incl./excl. not fulfilled|7|||
155348918|NCT00666835|560710678|FG001|Overall Study|Incl./excl. not fulfilled|2|||
155348919|NCT00666835|560710677|FG000|Overall Study|Adverse Event|7|||
155348920|NCT00666835|560710678|FG001|Overall Study|Adverse Event|6|||
155348921|NCT00666835|560710677|FG000|Overall Study|Protocol Violation|2|||
155348922|NCT00666835|560710678|FG001|Overall Study|Protocol Violation|0|||
155348923|NCT00666835|560710677|FG000|Overall Study|Death|15|||
155348924|NCT00666835|560710678|FG001|Overall Study|Death|4|||
155348925|NCT00666835|560710677|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
155348926|NCT00666835|560710678|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
155348927|NCT00666835|560710677|FG000|Overall Study|Hemoglobulin concentration|4|||
155348928|NCT00666835|560710678|FG001|Overall Study|Hemoglobulin concentration|3|||
155348929|NCT00666835|560710677|FG000|Overall Study|Planned operation|2|||
155348930|NCT00666835|560710678|FG001|Overall Study|Planned operation|0|||
155348931|NCT00666835|560710677|FG000|Overall Study|Physician Decision|1|||
155348932|NCT00666835|560710678|FG001|Overall Study|Physician Decision|2|||
155348933|NCT00511147|560710681|FG000|Overall Study|Withdrawal by Subject|1|||
155348934|NCT00511147|560710681|FG000|Overall Study|Disease progression|5|||
155348935|NCT00511147|560710681|FG000|Overall Study|Required platelet transfusion|1|||
155348936|NCT00899379|560710682|FG000|Overall Study|Adverse Event|2|||
155348937|NCT00899379|560710683|FG001|Overall Study|Adverse Event|2|||
155348938|NCT00899379|560710684|FG002|Overall Study|Adverse Event|1|||
155348939|NCT00899379|560710685|FG003|Overall Study|Adverse Event|1|||
155348940|NCT00899379|560710686|FG004|Overall Study|Adverse Event|2|||
155348941|NCT00899379|560710682|FG000|Overall Study|Lack of Efficacy|0|||
155348942|NCT00899379|560710683|FG001|Overall Study|Lack of Efficacy|4|||
155348943|NCT00899379|560710684|FG002|Overall Study|Lack of Efficacy|3|||
155348944|NCT00899379|560710685|FG003|Overall Study|Lack of Efficacy|0|||
155348945|NCT00899379|560710686|FG004|Overall Study|Lack of Efficacy|1|||
155348946|NCT00899379|560710682|FG000|Overall Study|Lost to Follow-up|9|||
155348947|NCT00899379|560710683|FG001|Overall Study|Lost to Follow-up|3|||
155348948|NCT00899379|560710684|FG002|Overall Study|Lost to Follow-up|0|||
155348949|NCT00899379|560710685|FG003|Overall Study|Lost to Follow-up|6|||
155348950|NCT00899379|560710686|FG004|Overall Study|Lost to Follow-up|2|||
155348951|NCT00899379|560710682|FG000|Overall Study|Protocol Violation|0|||
155348952|NCT00899379|560710683|FG001|Overall Study|Protocol Violation|0|||
155348953|NCT00899379|560710684|FG002|Overall Study|Protocol Violation|1|||
155348954|NCT00899379|560710685|FG003|Overall Study|Protocol Violation|1|||
155348955|NCT00899379|560710686|FG004|Overall Study|Protocol Violation|0|||
155348956|NCT00899379|560710682|FG000|Overall Study|Withdrawal by Subject|2|||
155348957|NCT00899379|560710683|FG001|Overall Study|Withdrawal by Subject|4|||
155348958|NCT00899379|560710684|FG002|Overall Study|Withdrawal by Subject|2|||
155348959|NCT00899379|560710685|FG003|Overall Study|Withdrawal by Subject|3|||
155348960|NCT00899379|560710686|FG004|Overall Study|Withdrawal by Subject|6|||
155647990|NCT02318277|561803733|FG006|Overall Study|Lost to Follow-up|3|||
155647991|NCT02318277|561803734|FG007|Overall Study|Lost to Follow-up|4|||
155647992|NCT02318277|561803727|FG000|Overall Study|Death|5|||
155647993|NCT02318277|561803728|FG001|Overall Study|Death|3|||
155348961|NCT00899379|560710682|FG000|Overall Study|Pregnancy|0|||
155348962|NCT00899379|560710683|FG001|Overall Study|Pregnancy|0|||
155348963|NCT00899379|560710684|FG002|Overall Study|Pregnancy|1|||
155348964|NCT00899379|560710685|FG003|Overall Study|Pregnancy|0|||
155348965|NCT00899379|560710686|FG004|Overall Study|Pregnancy|1|||
155647994|NCT02318277|561803729|FG002|Overall Study|Death|1|||
155647995|NCT02318277|561803730|FG003|Overall Study|Death|4|||
155348966|NCT00899379|560710682|FG000|Overall Study|Patient Uncooperative|0|||
155348967|NCT00899379|560710683|FG001|Overall Study|Patient Uncooperative|1|||
155348968|NCT00899379|560710684|FG002|Overall Study|Patient Uncooperative|0|||
155348969|NCT00899379|560710685|FG003|Overall Study|Patient Uncooperative|1|||
155348970|NCT00899379|560710686|FG004|Overall Study|Patient Uncooperative|2|||
155348971|NCT00899379|560710682|FG000|Overall Study|Abnormal Baseline ECG|0|||
155348972|NCT00899379|560710683|FG001|Overall Study|Abnormal Baseline ECG|0|||
155348973|NCT00899379|560710684|FG002|Overall Study|Abnormal Baseline ECG|0|||
155348974|NCT00899379|560710685|FG003|Overall Study|Abnormal Baseline ECG|1|||
155348975|NCT00899379|560710686|FG004|Overall Study|Abnormal Baseline ECG|0|||
155425021|NCT03049449|560984590|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
155348976|NCT00899379|560710682|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155425022|NCT03049449|560984591|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
155348977|NCT00899379|560710683|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155348978|NCT00899379|560710684|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155647996|NCT02318277|561803731|FG004|Overall Study|Death|6|||
155647997|NCT02318277|561803732|FG005|Overall Study|Death|5|||
155647998|NCT02318277|561803733|FG006|Overall Study|Death|34|||
155647999|NCT02318277|561803734|FG007|Overall Study|Death|58|||
155648000|NCT02318277|561803727|FG000|Overall Study|Transitioned to Hospice|0|||
155348979|NCT00899379|560710685|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155348980|NCT00899379|560710686|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155348981|NCT00899379|560710682|FG000|Overall Study|Not Completed/Entered Extn|5|||
155348982|NCT00899379|560710683|FG001|Overall Study|Not Completed/Entered Extn|1|||
155348983|NCT00899379|560710684|FG002|Overall Study|Not Completed/Entered Extn|6|||
155348984|NCT00899379|560710685|FG003|Overall Study|Not Completed/Entered Extn|4|||
155348985|NCT00899379|560710686|FG004|Overall Study|Not Completed/Entered Extn|3|||
155348986|NCT00899379|560710682|FG000|Overall Study|Study Terminated|3|||
155348987|NCT00899379|560710683|FG001|Overall Study|Study Terminated|0|||
155348988|NCT00899379|560710684|FG002|Overall Study|Study Terminated|3|||
155348989|NCT00899379|560710685|FG003|Overall Study|Study Terminated|3|||
155348990|NCT00899379|560710686|FG004|Overall Study|Study Terminated|1|||
155348991|NCT00899379|560710682|FG000|Overall Study|Lost to Follow-up|3|||
155348992|NCT00899379|560710683|FG001|Overall Study|Lost to Follow-up|1|||
155348993|NCT00899379|560710684|FG002|Overall Study|Lost to Follow-up|0|||
155348994|NCT00899379|560710685|FG003|Overall Study|Lost to Follow-up|2|||
155348995|NCT00899379|560710686|FG004|Overall Study|Lost to Follow-up|5|||
155348996|NCT00899379|560710682|FG000|Overall Study|Withdrawal by Subject|4|||
155348997|NCT00899379|560710683|FG001|Overall Study|Withdrawal by Subject|7|||
155348998|NCT00899379|560710684|FG002|Overall Study|Withdrawal by Subject|4|||
155348999|NCT00899379|560710685|FG003|Overall Study|Withdrawal by Subject|7|||
155349000|NCT00899379|560710686|FG004|Overall Study|Withdrawal by Subject|2|||
155349001|NCT00899379|560710682|FG000|Overall Study|Pregnancy|1|||
155349002|NCT00899379|560710683|FG001|Overall Study|Pregnancy|0|||
155349003|NCT00899379|560710684|FG002|Overall Study|Pregnancy|0|||
155349004|NCT00899379|560710685|FG003|Overall Study|Pregnancy|0|||
155349005|NCT00899379|560710686|FG004|Overall Study|Pregnancy|0|||
155349006|NCT00899379|560710682|FG000|Overall Study|Patient Uncooperative|0|||
155349007|NCT00899379|560710683|FG001|Overall Study|Patient Uncooperative|0|||
155349008|NCT00899379|560710684|FG002|Overall Study|Patient Uncooperative|0|||
155349009|NCT00899379|560710685|FG003|Overall Study|Patient Uncooperative|1|||
155349010|NCT00899379|560710686|FG004|Overall Study|Patient Uncooperative|0|||
155349011|NCT00899379|560710682|FG000|Overall Study|Abnormal Prestudy Labs|0|||
155349012|NCT00899379|560710683|FG001|Overall Study|Abnormal Prestudy Labs|0|||
155349013|NCT00899379|560710684|FG002|Overall Study|Abnormal Prestudy Labs|0|||
155349014|NCT00899379|560710685|FG003|Overall Study|Abnormal Prestudy Labs|0|||
155349015|NCT00899379|560710686|FG004|Overall Study|Abnormal Prestudy Labs|2|||
155349016|NCT00899379|560710682|FG000|Overall Study|Abnormal Baseline ECG|0|||
155349017|NCT00899379|560710683|FG001|Overall Study|Abnormal Baseline ECG|0|||
155349018|NCT00899379|560710684|FG002|Overall Study|Abnormal Baseline ECG|1|||
155349019|NCT00899379|560710685|FG003|Overall Study|Abnormal Baseline ECG|1|||
155349020|NCT00899379|560710686|FG004|Overall Study|Abnormal Baseline ECG|0|||
155349021|NCT00899379|560710682|FG000|Overall Study|No Attack Pretreatment|3|||
155349022|NCT00899379|560710683|FG001|Overall Study|No Attack Pretreatment|5|||
155349023|NCT00899379|560710684|FG002|Overall Study|No Attack Pretreatment|5|||
155349024|NCT00899379|560710685|FG003|Overall Study|No Attack Pretreatment|6|||
155349025|NCT00899379|560710686|FG004|Overall Study|No Attack Pretreatment|4|||
155349026|NCT00899379|560710682|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155349027|NCT00899379|560710683|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349028|NCT00899379|560710684|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349029|NCT00899379|560710685|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349030|NCT00899379|560710686|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349031|NCT00899379|560710682|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
155349032|NCT00899379|560710683|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
155349033|NCT00899379|560710684|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
155349034|NCT00899379|560710685|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
155349035|NCT00899379|560710686|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
155349036|NCT00744796|560710690|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
155349037|NCT05135156|560710691|FG000|Overall Study|Lost to Follow-up|0|||
155349038|NCT05135156|560710692|FG001|Overall Study|Lost to Follow-up|0|||
155349039|NCT05135156|560710693|FG002|Overall Study|Lost to Follow-up|2|||
155349040|NCT02986659|560710695|FG000|First Intervention Period|Adverse Event|3|||
155349041|NCT02986659|560710696|FG001|First Intervention Period|Adverse Event|1|||
155349042|NCT02986659|560710695|FG000|First Intervention Period|Lost to Follow-up|1|||
155349043|NCT02986659|560710696|FG001|First Intervention Period|Lost to Follow-up|0|||
155349044|NCT02986659|560710695|FG000|First Intervention Period|Withdrawal by Subject|0|||
155349045|NCT02986659|560710696|FG001|First Intervention Period|Withdrawal by Subject|1|||
155648001|NCT02318277|561803728|FG001|Overall Study|Transitioned to Hospice|0|||
155648002|NCT02318277|561803729|FG002|Overall Study|Transitioned to Hospice|0|||
155648003|NCT02318277|561803730|FG003|Overall Study|Transitioned to Hospice|0|||
155648004|NCT02318277|561803731|FG004|Overall Study|Transitioned to Hospice|0|||
155648005|NCT02318277|561803732|FG005|Overall Study|Transitioned to Hospice|1|||
155648006|NCT02318277|561803733|FG006|Overall Study|Transitioned to Hospice|0|||
155648007|NCT02318277|561803734|FG007|Overall Study|Transitioned to Hospice|0|||
155648008|NCT03364686|561803735|FG000|Overall Study|Physician Decision|2|||
155648009|NCT01986751|561803741|FG000|Overall Study|improperly consented|10|||
155648010|NCT01986751|561803742|FG001|Overall Study|improperly consented|2|||
155648011|NCT01968785|561803744|FG000|Overall Study|Withdrawal by Subject|1|||
155648012|NCT01968785|561803745|FG001|Overall Study|Withdrawal by Subject|0|||
155648013|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Adverse Event|14|||
155648014|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Adverse Event|27|||
155648015|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Adverse Event|60|||
155648016|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Adverse Event|0|||
155648017|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Adverse Event|0|||
155648018|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Pregnancy|0|||
155648019|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Pregnancy|7|||
155648020|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Pregnancy|9|||
155648021|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Pregnancy|0|||
155648022|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Pregnancy|0|||
155648023|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
155648024|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
155648025|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
155648026|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
155648027|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
155349046|NCT02986659|560710695|FG000|Second Intervention Period|Adverse Event|0|||
155349047|NCT02986659|560710696|FG001|Second Intervention Period|Adverse Event|6|||
155349048|NCT02253147|560710697|FG000|Overall Study|Protocol Violation|30|||
155349049|NCT02253147|560710697|FG000|Overall Study|Did not consent to study extension|9|||
155349050|NCT02253147|560710697|FG000|Overall Study|Conditional re-treatment at W52|5|||
155349051|NCT02253147|560710697|FG000|Overall Study|Lost to Follow-up|2|||
155349052|NCT02253147|560710697|FG000|Overall Study|Withdrawal by Subject|1|||
155349053|NCT02254681|560710705|FG000|Overall Study|Lack of Efficacy|6|||
155349054|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
155349055|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
155349056|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Relocated|1|||
155349057|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Relocated|1|||
155349058|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
155349059|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
155349060|NCT02469077|560710706|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
155349061|NCT02469077|560710707|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
155349062|NCT00396097|560710708|FG000|Overall Study|Withdrawal by Subject|17|||
155349063|NCT00396097|560710709|FG001|Overall Study|Withdrawal by Subject|17|||
155349064|NCT00396097|560710708|FG000|Overall Study|Lost to Follow-up|4|||
155349065|NCT00396097|560710709|FG001|Overall Study|Lost to Follow-up|9|||
155349066|NCT00396097|560710708|FG000|Overall Study|Other|3|||
155349067|NCT00396097|560710709|FG001|Overall Study|Other|5|||
155349068|NCT00396097|560710708|FG000|Overall Study|Protocol Violation|0|||
155349069|NCT00396097|560710709|FG001|Overall Study|Protocol Violation|6|||
155349070|NCT00396097|560710708|FG000|Overall Study|Adverse Event|1|||
155349071|NCT00396097|560710709|FG001|Overall Study|Adverse Event|5|||
155349072|NCT00396097|560710708|FG000|Overall Study|Insufficient Clinical Response|1|||
155349073|NCT00396097|560710709|FG001|Overall Study|Insufficient Clinical Response|4|||
155349074|NCT02973477|560710710|FG000|First Intervention|Lost to Follow-up|0|||
155349075|NCT02973477|560710711|FG001|First Intervention|Lost to Follow-up|2|||
155349076|NCT02973477|560710710|FG000|Washout|Withdrawal by Subject|1|||
155349077|NCT02973477|560710711|FG001|Washout|Withdrawal by Subject|0|||
155349078|NCT02973477|560710710|FG000|Second Intervention|Lost to Follow-up|1|||
155349079|NCT02973477|560710711|FG001|Second Intervention|Lost to Follow-up|0|||
155349080|NCT03461211|560710712|FG000|Overall Study|Adverse Event|1|||
155349081|NCT03461211|560710713|FG001|Overall Study|Adverse Event|1|||
155349082|NCT03461211|560710712|FG000|Overall Study|Lack of Efficacy|0|||
155349083|NCT03461211|560710713|FG001|Overall Study|Lack of Efficacy|1|||
155349084|NCT03807700|560710714|FG000|Overall Study|Withdrawal by Subject|2|||
155349085|NCT03807700|560710715|FG001|Overall Study|Withdrawal by Subject|1|||
155349086|NCT01059526|560710716|FG000|Overall Study|Patient enrolled but not treated|20|||
155648028|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
155648029|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
155648030|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
155648031|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
155648032|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
155349087|NCT01059526|560710717|FG001|Overall Study|Patient enrolled but not treated|17|||
155349088|NCT01059526|560710716|FG000|Overall Study|Adverse Event|2|||
155349089|NCT01059526|560710717|FG001|Overall Study|Adverse Event|2|||
155349090|NCT01059526|560710716|FG000|Overall Study|Protocol Violation|0|||
155349091|NCT01059526|560710717|FG001|Overall Study|Protocol Violation|1|||
155349092|NCT01059526|560710716|FG000|Overall Study|Withdrawal by Subject|3|||
155349093|NCT01059526|560710717|FG001|Overall Study|Withdrawal by Subject|1|||
155349094|NCT01059526|560710716|FG000|Overall Study|Lost to Follow-up|4|||
155349095|NCT01059526|560710717|FG001|Overall Study|Lost to Follow-up|1|||
155349096|NCT01059526|560710716|FG000|Overall Study|Patient found to be dermatographic|1|||
155349097|NCT01059526|560710717|FG001|Overall Study|Patient found to be dermatographic|0|||
155349098|NCT01732588|560710718|FG000|First Intervention (7 Days)|Adverse Event|0|||
155349099|NCT01732588|560710719|FG001|First Intervention (7 Days)|Adverse Event|1|||
155349100|NCT01732588|560710720|FG002|First Intervention (7 Days)|Adverse Event|0|||
155349101|NCT02720081|560710721|FG000|Overall Study|Adverse Event|0|||
155349102|NCT02720081|560710722|FG001|Overall Study|Adverse Event|3|||
155349103|NCT02720081|560710721|FG000|Overall Study|Protocol Violation|4|||
155349104|NCT02720081|560710722|FG001|Overall Study|Protocol Violation|1|||
155349105|NCT02005029|560710724|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
155349106|NCT02005029|560710725|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
155349107|NCT02316847|560710726|FG000|Overall Study|Adverse Event|0|||
155349108|NCT02316847|560710727|FG001|Overall Study|Adverse Event|3|||
155349109|NCT02316847|560710726|FG000|Overall Study|Lost to Follow-up|0|||
155349110|NCT02316847|560710727|FG001|Overall Study|Lost to Follow-up|2|||
155349111|NCT02316847|560710726|FG000|Overall Study|Physician Decision|0|||
155349112|NCT02316847|560710727|FG001|Overall Study|Physician Decision|1|||
155349113|NCT02316847|560710726|FG000|Overall Study|Pregnancy|0|||
155349114|NCT02316847|560710727|FG001|Overall Study|Pregnancy|1|||
155349115|NCT02316847|560710726|FG000|Overall Study|Withdrawal by Subject|2|||
155425023|NCT03049449|560984592|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
155425024|NCT03049449|560984593|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
155425025|NCT03049449|560984594|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
155425026|NCT03049449|560984595|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
155425027|NCT03049449|560984596|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
155425028|NCT03049449|560984597|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
155425029|NCT03049449|560984598|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
155425030|NCT03049449|560984599|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
155425031|NCT03049449|560984590|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425032|NCT03049449|560984591|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425033|NCT03049449|560984592|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425034|NCT03049449|560984593|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425035|NCT03049449|560984594|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425036|NCT03049449|560984595|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425037|NCT03049449|560984596|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425038|NCT03049449|560984597|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
155425039|NCT03049449|560984598|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
155425040|NCT03049449|560984599|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
155425041|NCT03304522|560984607|FG000|Overall Study|Adverse Event|0|||
155425042|NCT03304522|560984608|FG001|Overall Study|Adverse Event|4|||
155425043|NCT03304522|560984607|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
155425044|NCT03304522|560984608|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
155425045|NCT03304522|560984607|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
155425046|NCT03304522|560984608|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
155349116|NCT02316847|560710727|FG001|Overall Study|Withdrawal by Subject|9|||
155349117|NCT02316847|560710726|FG000|Overall Study|Noncompliance with study drug|0|||
155349118|NCT02316847|560710727|FG001|Overall Study|Noncompliance with study drug|3|||
155349119|NCT02316847|560710726|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
155349120|NCT02316847|560710727|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
155349121|NCT02621047|560710728|FG000|Overall Study|Adverse Event|0|||
155349122|NCT02621047|560710729|FG001|Overall Study|Adverse Event|0|||
155349123|NCT02621047|560710730|FG002|Overall Study|Adverse Event|1|||
155349124|NCT01370018|560710731|FG000|Overall Study|Did not meet criteria for analysis|1|||
155349125|NCT01525641|560710734|FG000|Overall Study|Case report form not collected|25|||
155349126|NCT01525641|560710734|FG000|Overall Study|No visit since the first visit|16|||
155349127|NCT01525641|560710734|FG000|Overall Study|Adverse Event|73|||
155349128|NCT01525641|560710734|FG000|Overall Study|Lack of Efficacy|24|||
155349129|NCT01525641|560710734|FG000|Overall Study|Improvement|5|||
155349130|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (relocation)|1|||
155349131|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
155349132|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
155349133|NCT01525641|560710734|FG000|Overall Study|Other than stated above|7|||
155349134|NCT03772041|560710735|FG000|Overall Study|Adverse Event|8|||
155349135|NCT03772041|560710736|FG001|Overall Study|Adverse Event|3|||
155349136|NCT03772041|560710735|FG000|Overall Study|Withdrawal by Subject|0|||
155349137|NCT03772041|560710736|FG001|Overall Study|Withdrawal by Subject|2|||
155349138|NCT03772041|560710735|FG000|Overall Study|Protocol Violation|4|||
155349139|NCT03772041|560710736|FG001|Overall Study|Protocol Violation|2|||
155349140|NCT03772041|560710735|FG000|Overall Study|Physician Decision|2|||
155349141|NCT03772041|560710736|FG001|Overall Study|Physician Decision|3|||
155349142|NCT02204319|560710737|FG000|Overall Study|Pregnancy|1|||
155349143|NCT02204319|560710737|FG000|Overall Study|Withdrawal by Subject|2|||
155349144|NCT03544229|560710744|FG000|Overall Study|Adverse Event|1|||
155349145|NCT03544229|560710745|FG001|Overall Study|Adverse Event|0|||
155349146|NCT03544229|560710746|FG002|Overall Study|Adverse Event|1|||
155349147|NCT03544229|560710747|FG003|Overall Study|Adverse Event|0|||
155349148|NCT03544229|560710744|FG000|Overall Study|Protocol Deviation|0|||
155349149|NCT03544229|560710745|FG001|Overall Study|Protocol Deviation|0|||
155349150|NCT03544229|560710746|FG002|Overall Study|Protocol Deviation|1|||
155349151|NCT03544229|560710747|FG003|Overall Study|Protocol Deviation|0|||
155349152|NCT03544229|560710744|FG000|Overall Study|Lost to Follow-up|3|||
155349153|NCT03544229|560710745|FG001|Overall Study|Lost to Follow-up|0|||
155349154|NCT03544229|560710746|FG002|Overall Study|Lost to Follow-up|0|||
155349155|NCT03544229|560710747|FG003|Overall Study|Lost to Follow-up|2|||
155349156|NCT03544229|560710744|FG000|Overall Study|Voluntary Withdrawal|2|||
155349157|NCT03544229|560710745|FG001|Overall Study|Voluntary Withdrawal|1|||
155349158|NCT03544229|560710746|FG002|Overall Study|Voluntary Withdrawal|3|||
155349159|NCT03544229|560710747|FG003|Overall Study|Voluntary Withdrawal|0|||
155349160|NCT03544229|560710744|FG000|Overall Study|Lack of Efficacy|0|||
155349161|NCT03544229|560710745|FG001|Overall Study|Lack of Efficacy|1|||
155349162|NCT03544229|560710746|FG002|Overall Study|Lack of Efficacy|0|||
155349163|NCT03544229|560710747|FG003|Overall Study|Lack of Efficacy|0|||
155349164|NCT01954771|560710748|FG000|Overall Study|Missing HbA1c of end-point|1|||
155349165|NCT01954771|560710749|FG001|Overall Study|Missing HbA1c of end-point|1|||
155349166|NCT01954771|560710750|FG002|Overall Study|Missing HbA1c of end-point|0|||
155349167|NCT01954771|560710748|FG000|Overall Study|Missing CGMS of end-point|1|||
155425047|NCT03304522|560984607|FG000|Overall Study|Other|0|||
155648033|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Death|1|||
155648034|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Death|2|||
155648035|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Death|2|||
155648036|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Death|0|||
155648037|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Death|0|||
155648038|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
155648039|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
155648040|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
155648041|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
155648042|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
155648043|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
155648044|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
155648045|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
155648046|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
155648047|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
155648048|NCT00098293|561803746|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
155648049|NCT00098293|561803747|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
155648050|NCT00098293|561803748|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
155648051|NCT00098293|561803749|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
155648052|NCT00098293|561803750|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
155648053|NCT00098293|561803746|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155648054|NCT00098293|561803747|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155648055|NCT00098293|561803748|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
155648056|NCT00098293|561803749|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155648057|NCT00098293|561803750|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155648058|NCT00098293|561803746|FG000|Open-label (OL) Phase|Adverse Event|0|||
155648059|NCT00098293|561803747|FG001|Open-label (OL) Phase|Adverse Event|3|||
155349168|NCT01954771|560710749|FG001|Overall Study|Missing CGMS of end-point|1|||
155349169|NCT01954771|560710750|FG002|Overall Study|Missing CGMS of end-point|0|||
155349170|NCT01954771|560710748|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
155349171|NCT01954771|560710749|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
155349172|NCT01954771|560710750|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
155349173|NCT03635775|560710751|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349174|NCT03635775|560710752|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349175|NCT03635775|560710753|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349176|NCT03635775|560710754|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
155349177|NCT02588027|560710769|FG000|Overall Study|Withdrawal by Subject|1|||
155349178|NCT02588027|560710770|FG001|Overall Study|Withdrawal by Subject|3|||
155349179|NCT02588027|560710769|FG000|Overall Study|Protocol Violation|4|||
155349180|NCT02588027|560710770|FG001|Overall Study|Protocol Violation|1|||
155349181|NCT02116582|560710771|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
155349182|NCT02116582|560710771|FG000|Overall Study|Adverse Event|22|||
155349183|NCT02116582|560710771|FG000|Overall Study|Death|9|||
155349184|NCT02116582|560710771|FG000|Overall Study|Progressive Disease|148|||
155349185|NCT02116582|560710771|FG000|Overall Study|Protocol Violation|3|||
155349186|NCT02116582|560710771|FG000|Overall Study|Withdrawal by Subject|8|||
155349187|NCT02116582|560710771|FG000|Overall Study|Other: Miscellaneous|11|||
155349188|NCT02116582|560710771|FG000|Overall Study|Lost to Follow-up|1|||
155349189|NCT02116582|560710771|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
155349190|NCT01876823|560710772|FG000|Overall Study|Withdrawal by Subject|5|||
155349191|NCT01876823|560710772|FG000|Overall Study|Physician Decision|2|||
155349192|NCT01876823|560710772|FG000|Overall Study|Patients moved|2|||
155349193|NCT00961896|560712097|FG000|Overall Study|Abnormal laboratory value|0|||
155349194|NCT00961896|560712098|FG001|Overall Study|Abnormal laboratory value|0|||
155349195|NCT00961896|560712099|FG002|Overall Study|Abnormal laboratory value|1|||
155349196|NCT00755716|560712102|FG000|Overall Study|Adverse Event|1|||
155648060|NCT00098293|561803748|FG002|Open-label (OL) Phase|Adverse Event|7|||
155648061|NCT00098293|561803749|FG003|Open-label (OL) Phase|Adverse Event|6|||
155648062|NCT00098293|561803750|FG004|Open-label (OL) Phase|Adverse Event|0|||
155648063|NCT00098293|561803746|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
155648064|NCT00098293|561803747|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
155648065|NCT00098293|561803748|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
155648066|NCT00098293|561803749|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
155648067|NCT00098293|561803750|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
155648068|NCT00098293|561803746|FG000|Open-label (OL) Phase|Pregnancy|0|||
155349197|NCT00755716|560712103|FG001|Overall Study|Adverse Event|4|||
155349198|NCT00755716|560712104|FG002|Overall Study|Adverse Event|1|||
155349199|NCT00755716|560712102|FG000|Overall Study|Lack of Efficacy|2|||
155648069|NCT00098293|561803747|FG001|Open-label (OL) Phase|Pregnancy|1|||
155648070|NCT00098293|561803748|FG002|Open-label (OL) Phase|Pregnancy|0|||
155648071|NCT00098293|561803749|FG003|Open-label (OL) Phase|Pregnancy|3|||
155648072|NCT00098293|561803750|FG004|Open-label (OL) Phase|Pregnancy|0|||
155349200|NCT00755716|560712103|FG001|Overall Study|Lack of Efficacy|0|||
155349201|NCT00755716|560712104|FG002|Overall Study|Lack of Efficacy|0|||
155349202|NCT00755716|560712102|FG000|Overall Study|Lost to Follow-up|5|||
155349203|NCT00755716|560712103|FG001|Overall Study|Lost to Follow-up|3|||
155349204|NCT00755716|560712104|FG002|Overall Study|Lost to Follow-up|1|||
155349205|NCT00755716|560712102|FG000|Overall Study|work schedule issues|0|||
155349206|NCT00755716|560712103|FG001|Overall Study|work schedule issues|1|||
155349207|NCT00755716|560712104|FG002|Overall Study|work schedule issues|1|||
155349208|NCT03022578|560712105|FG000|Overall Study|Adverse Event|1|||
155349209|NCT03022578|560712105|FG000|Overall Study|Lack of Efficacy|2|||
155349210|NCT03022578|560712105|FG000|Overall Study|Withdrawal by Subject|1|||
155349211|NCT00111839|560712106|FG000|Overall Study|Disease Progression|30|||
155349212|NCT00111839|560712107|FG001|Overall Study|Disease Progression|33|||
155349213|NCT00111839|560712108|FG002|Overall Study|Disease Progression|33|||
155349214|NCT00111839|560712106|FG000|Overall Study|Adverse Event|5|||
155349215|NCT00111839|560712107|FG001|Overall Study|Adverse Event|3|||
155349216|NCT00111839|560712108|FG002|Overall Study|Adverse Event|1|||
155349217|NCT00111839|560712106|FG000|Overall Study|Protocol Violation|2|||
155349218|NCT00111839|560712107|FG001|Overall Study|Protocol Violation|4|||
155349219|NCT00111839|560712108|FG002|Overall Study|Protocol Violation|2|||
155349220|NCT00111839|560712106|FG000|Overall Study|Death|1|||
155349221|NCT00111839|560712107|FG001|Overall Study|Death|1|||
155349222|NCT00111839|560712108|FG002|Overall Study|Death|6|||
155349223|NCT00111839|560712106|FG000|Overall Study|Withdrawal by Subject|2|||
155349224|NCT00111839|560712107|FG001|Overall Study|Withdrawal by Subject|2|||
155349225|NCT00111839|560712108|FG002|Overall Study|Withdrawal by Subject|2|||
155349226|NCT00111839|560712106|FG000|Overall Study|Lost to Follow-up|1|||
155349227|NCT00111839|560712107|FG001|Overall Study|Lost to Follow-up|0|||
155349228|NCT00111839|560712108|FG002|Overall Study|Lost to Follow-up|0|||
155349229|NCT00111839|560712106|FG000|Overall Study|Logistical Constraint|1|||
155349230|NCT00111839|560712107|FG001|Overall Study|Logistical Constraint|0|||
155349231|NCT00111839|560712108|FG002|Overall Study|Logistical Constraint|0|||
155349232|NCT00111839|560712106|FG000|Overall Study|Other|6|||
155349233|NCT00111839|560712107|FG001|Overall Study|Other|3|||
155349234|NCT00111839|560712108|FG002|Overall Study|Other|3|||
155349235|NCT00111839|560712106|FG000|Overall Study|Randomized but Not Treated|0|||
155349236|NCT00111839|560712107|FG001|Overall Study|Randomized but Not Treated|0|||
155349237|NCT00111839|560712108|FG002|Overall Study|Randomized but Not Treated|2|||
155349238|NCT00805285|560712113|FG000|Overall Study|Lack of Efficacy|1|||
155349239|NCT01441583|560712114|FG000|Overall Study|Withdrawal by Subject|1|||
155349240|NCT01441583|560712115|FG001|Overall Study|Withdrawal by Subject|1|||
155349241|NCT01441583|560712116|FG002|Overall Study|Withdrawal by Subject|1|||
155349242|NCT01441583|560712114|FG000|Overall Study|Death|1|||
155349243|NCT01441583|560712115|FG001|Overall Study|Death|0|||
155349244|NCT01441583|560712116|FG002|Overall Study|Death|4|||
155349245|NCT01441583|560712114|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
155349246|NCT01441583|560712115|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
155349247|NCT01441583|560712116|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
155349248|NCT01066897|560712117|FG000|Overall Study|Withdrawal by Subject|1|||
155349249|NCT01066897|560712118|FG001|Overall Study|Withdrawal by Subject|0|||
155349250|NCT01066897|560712117|FG000|Overall Study|stopped study after developing the flu.|1|||
155349251|NCT01066897|560712118|FG001|Overall Study|stopped study after developing the flu.|0|||
155349252|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
155349253|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349254|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349255|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349256|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349257|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349258|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349259|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349260|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349261|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349262|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349263|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349264|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349265|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349266|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349267|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
155349268|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349269|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349270|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349271|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349272|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
155349273|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349274|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349275|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349276|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349277|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349278|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349279|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349280|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349281|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349282|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349283|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349284|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349285|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349286|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349287|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349288|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349289|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349290|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349291|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349292|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349293|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155349294|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349295|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155349296|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349297|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349298|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349299|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349300|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349301|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349302|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
155349303|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349304|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349305|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
155349306|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349307|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349308|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349309|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349310|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349311|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349312|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
155349313|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349314|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349315|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349316|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349317|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
155349318|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349319|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
155349320|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349321|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349322|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349323|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349324|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349325|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349326|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155425048|NCT03304522|560984608|FG001|Overall Study|Other|1|||
155349327|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349328|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349329|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155349330|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349331|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155349332|NCT02110225|560712131|FG000|Overall Study|Lost to Follow-up|0|||
155349333|NCT02110225|560712132|FG001|Overall Study|Lost to Follow-up|1|||
155349334|NCT02110225|560712133|FG002|Overall Study|Lost to Follow-up|0|||
155349335|NCT00809783|560712136|FG000|Overall Study|Death|1|||
155349336|NCT00809783|560712137|FG001|Overall Study|Death|0|||
155349337|NCT00809783|560712138|FG002|Overall Study|Death|0|||
155349338|NCT00809783|560712136|FG000|Overall Study|Adverse Event|34|||
155349339|NCT00809783|560712137|FG001|Overall Study|Adverse Event|52|||
155349340|NCT00809783|560712138|FG002|Overall Study|Adverse Event|71|||
155349341|NCT00809783|560712136|FG000|Overall Study|Lack of Efficacy|39|||
155349342|NCT00809783|560712137|FG001|Overall Study|Lack of Efficacy|52|||
155349343|NCT00809783|560712138|FG002|Overall Study|Lack of Efficacy|63|||
155349344|NCT00809783|560712136|FG000|Overall Study|Lost to Follow-up|0|||
155349345|NCT00809783|560712137|FG001|Overall Study|Lost to Follow-up|3|||
155349346|NCT00809783|560712138|FG002|Overall Study|Lost to Follow-up|4|||
155349347|NCT00809783|560712136|FG000|Overall Study|Withdrawal by Subject|47|||
155349348|NCT00809783|560712137|FG001|Overall Study|Withdrawal by Subject|72|||
155349349|NCT00809783|560712138|FG002|Overall Study|Withdrawal by Subject|64|||
155349350|NCT00809783|560712136|FG000|Overall Study|Protocol Violation|2|||
155349351|NCT00809783|560712137|FG001|Overall Study|Protocol Violation|6|||
155349352|NCT00809783|560712138|FG002|Overall Study|Protocol Violation|5|||
155506055|NCT02266706|561280206|FG004|Overall Study|Enrollment in another study|0|||
155506056|NCT02266706|561280207|FG005|Overall Study|Enrollment in another study|0|||
155506057|NCT02266706|561280208|FG006|Overall Study|Enrollment in another study|0|||
155506058|NCT02266706|561280209|FG007|Overall Study|Enrollment in another study|0|||
155506059|NCT02266706|561280210|FG008|Overall Study|Enrollment in another study|0|||
155506060|NCT01977352|561280211|FG000|Overall Study|Lost to Follow-up|1|||
155506061|NCT01977352|561280212|FG001|Overall Study|Lost to Follow-up|2|||
155506062|NCT00409188|561280213|FG000|Overall Study|Ongoing at data cut-off|383|||
155506063|NCT00409188|561280214|FG001|Overall Study|Ongoing at data cut-off|175|||
155506064|NCT02270983|561280215|FG000|Overall Study|Adverse Event|3|||
155506065|NCT02270983|561280216|FG001|Overall Study|Adverse Event|2|||
155506066|NCT02270983|561280217|FG002|Overall Study|Adverse Event|6|||
155506067|NCT02270983|561280215|FG000|Overall Study|Lack of Efficacy|2|||
155506068|NCT02270983|561280216|FG001|Overall Study|Lack of Efficacy|1|||
155506069|NCT02270983|561280217|FG002|Overall Study|Lack of Efficacy|1|||
155506070|NCT02270983|561280215|FG000|Overall Study|Withdrawal by Subject|1|||
155506071|NCT02270983|561280216|FG001|Overall Study|Withdrawal by Subject|0|||
155506072|NCT02270983|561280217|FG002|Overall Study|Withdrawal by Subject|2|||
155506073|NCT02270983|561280215|FG000|Overall Study|Lost to Follow-up|1|||
155506074|NCT02270983|561280216|FG001|Overall Study|Lost to Follow-up|1|||
155506075|NCT02270983|561280217|FG002|Overall Study|Lost to Follow-up|2|||
155506076|NCT02270983|561280215|FG000|Overall Study|Protocol Violation|1|||
155506077|NCT02270983|561280216|FG001|Overall Study|Protocol Violation|1|||
155506078|NCT02270983|561280217|FG002|Overall Study|Protocol Violation|1|||
155506079|NCT02270983|561280215|FG000|Overall Study|family emergency|0|||
155506080|NCT02270983|561280216|FG001|Overall Study|family emergency|1|||
155506081|NCT02270983|561280217|FG002|Overall Study|family emergency|0|||
155506082|NCT02270983|561280215|FG000|Overall Study|study procedure non-compliance|1|||
155506083|NCT02270983|561280216|FG001|Overall Study|study procedure non-compliance|0|||
155506084|NCT02270983|561280217|FG002|Overall Study|study procedure non-compliance|0|||
155506085|NCT02270983|561280215|FG000|Overall Study|moved away from study site|0|||
155506086|NCT02270983|561280216|FG001|Overall Study|moved away from study site|1|||
155349353|NCT00809783|560712136|FG000|Overall Study|Randomized, but not treated|3|||
155349354|NCT00809783|560712137|FG001|Overall Study|Randomized, but not treated|0|||
155349355|NCT00809783|560712138|FG002|Overall Study|Randomized, but not treated|2|||
155506087|NCT02270983|561280217|FG002|Overall Study|moved away from study site|0|||
155506088|NCT00854620|561280221|FG000|Overall Study|Adverse Event|1|||
155506089|NCT03237611|561280223|FG000|Overall Study|Withdrawal by Subject|1|||
155349356|NCT00809783|560712136|FG000|Overall Study|Study Terminated by Sponsor|378|||
155349357|NCT00809783|560712137|FG001|Overall Study|Study Terminated by Sponsor|626|||
155349358|NCT00809783|560712138|FG002|Overall Study|Study Terminated by Sponsor|565|||
155349359|NCT00809783|560712136|FG000|Overall Study|Other|21|||
155349360|NCT00809783|560712137|FG001|Overall Study|Other|21|||
155349361|NCT00809783|560712138|FG002|Overall Study|Other|16|||
155349362|NCT00126555|560712139|FG000|Overall Study|Withdrawal by Subject|1|||
155349363|NCT00126555|560712139|FG000|Overall Study|Adverse Event|2|||
155349364|NCT00126555|560712139|FG000|Overall Study|Progressive Disease|3|||
155349365|NCT03441789|560712146|FG000|Overall Study|Withdrawal by Subject|1|||
155506090|NCT03237611|561280223|FG000|Overall Study|Ineligible|1|||
155506091|NCT00534092|561280224|FG000|Overall Study|Lost to Follow-up|1|||
155506092|NCT00534092|561280225|FG001|Overall Study|Lost to Follow-up|0|||
155506093|NCT00534092|561280224|FG000|Overall Study|personal reasons/family concerns|1|||
155506094|NCT00534092|561280225|FG001|Overall Study|personal reasons/family concerns|0|||
155648073|NCT00098293|561803746|FG000|Open-label (OL) Phase|Protocol Violation|0|||
155648074|NCT00098293|561803747|FG001|Open-label (OL) Phase|Protocol Violation|6|||
155648075|NCT00098293|561803748|FG002|Open-label (OL) Phase|Protocol Violation|13|||
155648076|NCT00098293|561803749|FG003|Open-label (OL) Phase|Protocol Violation|16|||
155648077|NCT00098293|561803750|FG004|Open-label (OL) Phase|Protocol Violation|0|||
155349366|NCT03441789|560712147|FG001|Overall Study|Withdrawal by Subject|1|||
155349367|NCT03441789|560712146|FG000|Overall Study|Adverse Event|0|||
155349368|NCT03441789|560712147|FG001|Overall Study|Adverse Event|1|||
155349369|NCT03441789|560712146|FG000|Overall Study|Protocol Violation|0|||
155349370|NCT03441789|560712147|FG001|Overall Study|Protocol Violation|1|||
155349371|NCT03441789|560712146|FG000|Overall Study|Lost to Follow-up|0|||
155349372|NCT03441789|560712147|FG001|Overall Study|Lost to Follow-up|1|||
155349373|NCT01780545|560712148|FG000|Overall Study|Withdrawal by Subject|3|||
155349374|NCT01780545|560712149|FG001|Overall Study|Withdrawal by Subject|1|||
155349375|NCT01780545|560712148|FG000|Overall Study|Lost to Follow-up|1|||
155349376|NCT01780545|560712149|FG001|Overall Study|Lost to Follow-up|1|||
155349377|NCT02581189|560712154|FG000|Overall Study|Failure to return|36|||
155349378|NCT02581189|560712154|FG000|Overall Study|Withdrew consent|5|||
155349379|NCT02581189|560712154|FG000|Overall Study|Death|3|||
155349380|NCT02581189|560712154|FG000|Overall Study|Insufficient virological response|2|||
155349381|NCT02581189|560712154|FG000|Overall Study|Other, not specified|7|||
155349382|NCT03275402|560712159|FG000|Overall Study|Death|17|||
155349383|NCT03275402|560712159|FG000|Overall Study|Study terminated by sponsor|21|||
155349384|NCT03275402|560712159|FG000|Overall Study|Withdrawal by Subject|1|||
155349385|NCT01514864|560712160|FG000|Overall Study|Disease progression|7|||
155349386|NCT01514864|560712161|FG001|Overall Study|Disease progression|5|||
155349387|NCT01514864|560712160|FG000|Overall Study|Study drug toxicity|2|||
155349388|NCT01514864|560712161|FG001|Overall Study|Study drug toxicity|0|||
155349389|NCT03371485|560712162|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
155349390|NCT03371485|560712162|FG000|2-year Follow-up|Death|5|||
155349391|NCT03187353|560712163|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
155349392|NCT03187353|560712164|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
155349393|NCT03187353|560712163|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155349394|NCT03187353|560712164|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155349395|NCT03187353|560712163|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155349396|NCT03187353|560712164|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155349397|NCT03187353|560712163|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155349398|NCT03187353|560712164|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
155349399|NCT03187353|560712163|FG000|Washout (2 Weeks)|Adverse Event|2|||
155349400|NCT03187353|560712164|FG001|Washout (2 Weeks)|Adverse Event|0|||
155349401|NCT03187353|560712163|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
155349402|NCT03187353|560712164|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
155349403|NCT02567227|560712165|FG000|9 Weeks|Adverse Event|5|||
155349404|NCT02567227|560712166|FG001|9 Weeks|Adverse Event|5|||
155349405|NCT02567227|560712165|FG000|9 Weeks|Withdrawal by Subject|18|||
155349406|NCT02567227|560712166|FG001|9 Weeks|Withdrawal by Subject|8|||
155349407|NCT02567227|560712165|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
155349408|NCT02567227|560712166|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
155349409|NCT02567227|560712165|FG000|6 Month|Death|2|||
155349410|NCT02567227|560712166|FG001|6 Month|Death|0|||
155349411|NCT02567227|560712165|FG000|6 Month|Lost to Follow-up|43|||
155425049|NCT02649634|560984610|FG000|Overall Study|Withdrawal by Subject|3|||
155349412|NCT02567227|560712166|FG001|6 Month|Lost to Follow-up|40|||
155349413|NCT02567227|560712165|FG000|12 Months|Lost to Follow-up|31|||
155349414|NCT02567227|560712166|FG001|12 Months|Lost to Follow-up|32|||
155425050|NCT02649634|560984611|FG001|Overall Study|Withdrawal by Subject|5|||
155349415|NCT02567227|560712165|FG000|12 Months|Death|0|||
155349416|NCT02567227|560712166|FG001|12 Months|Death|2|||
155349417|NCT01026103|560712169|FG000|Overall Study|Physician Decision|1|||
155349418|NCT01026103|560712169|FG000|Overall Study|did not receive study device bc of error|1|||
155425051|NCT02649634|560984610|FG000|Overall Study|Lost to Follow-up|0|||
155349419|NCT02498418|560712170|FG000|Overall Study|Lack of Efficacy|0|||
155648078|NCT00098293|561803746|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
155349420|NCT02498418|560712171|FG001|Overall Study|Lack of Efficacy|0|||
155349421|NCT02498418|560712172|FG002|Overall Study|Lack of Efficacy|1|||
155349422|NCT02498418|560712170|FG000|Overall Study|Withdrawal by Subject|2|||
155349423|NCT02498418|560712171|FG001|Overall Study|Withdrawal by Subject|0|||
155349424|NCT02498418|560712172|FG002|Overall Study|Withdrawal by Subject|3|||
155349425|NCT02498418|560712170|FG000|Overall Study|Lost to Follow-up|0|||
155425052|NCT02649634|560984611|FG001|Overall Study|Lost to Follow-up|1|||
155425053|NCT00763009|560984613|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
155425054|NCT01111604|560984614|FG000|Overall Study|Lost to Follow-up|0|||
155425055|NCT01111604|560984615|FG001|Overall Study|Lost to Follow-up|0|||
155425056|NCT01111604|560984616|FG002|Overall Study|Lost to Follow-up|1|||
155425057|NCT01111604|560984614|FG000|Overall Study|Withdrew Consent|3|||
155425058|NCT01111604|560984615|FG001|Overall Study|Withdrew Consent|0|||
155425059|NCT01111604|560984616|FG002|Overall Study|Withdrew Consent|2|||
155425060|NCT01111604|560984614|FG000|Overall Study|Withdrawal by Subject|2|||
155425061|NCT01111604|560984615|FG001|Overall Study|Withdrawal by Subject|0|||
155425062|NCT01111604|560984616|FG002|Overall Study|Withdrawal by Subject|0|||
155425063|NCT01111604|560984614|FG000|Overall Study|Death|1|||
155425064|NCT01111604|560984615|FG001|Overall Study|Death|0|||
155425065|NCT01111604|560984616|FG002|Overall Study|Death|0|||
155425066|NCT01111604|560984614|FG000|Overall Study|Met Exclusion Criteria|2|||
155425067|NCT01111604|560984615|FG001|Overall Study|Met Exclusion Criteria|0|||
155425068|NCT01111604|560984616|FG002|Overall Study|Met Exclusion Criteria|0|||
155425069|NCT01295125|560984618|FG000|Overall Study|Study stopped prematurely|9|||
155425070|NCT01355289|560984621|FG000|Core Study|Adverse Event, Non-Fatal|1|||
155425071|NCT01355289|560984622|FG001|Core Study|Adverse Event, Non-Fatal|0|||
155425072|NCT01355289|560984623|FG002|Core Study|Adverse Event, Non-Fatal|0|||
155425073|NCT01355289|560984624|FG003|Core Study|Adverse Event, Non-Fatal|0|||
155425074|NCT01355289|560984625|FG004|Core Study|Adverse Event, Non-Fatal|0|||
155425075|NCT01355289|560984621|FG000|Core Study|Inadequate Therapeutic Effect|0|||
155425076|NCT01355289|560984622|FG001|Core Study|Inadequate Therapeutic Effect|0|||
155425077|NCT01355289|560984623|FG002|Core Study|Inadequate Therapeutic Effect|0|||
155425078|NCT01355289|560984624|FG003|Core Study|Inadequate Therapeutic Effect|1|||
155425079|NCT01355289|560984625|FG004|Core Study|Inadequate Therapeutic Effect|0|||
155425080|NCT01355289|560984621|FG000|Core Study|Other|0|||
155425081|NCT01355289|560984622|FG001|Core Study|Other|0|||
155425082|NCT01355289|560984623|FG002|Core Study|Other|0|||
155425083|NCT01355289|560984624|FG003|Core Study|Other|1|||
155425084|NCT01355289|560984625|FG004|Core Study|Other|0|||
155425085|NCT01355289|560984621|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
155425086|NCT01355289|560984622|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
155425087|NCT01355289|560984623|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
155425088|NCT01355289|560984624|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
155425089|NCT01355289|560984625|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
155425090|NCT01355289|560984621|FG000|Open Label Extension|Lost to Follow-up|0|||
155425091|NCT01355289|560984622|FG001|Open Label Extension|Lost to Follow-up|0|||
155425092|NCT01355289|560984623|FG002|Open Label Extension|Lost to Follow-up|0|||
155425093|NCT01355289|560984624|FG003|Open Label Extension|Lost to Follow-up|0|||
155425094|NCT01355289|560984625|FG004|Open Label Extension|Lost to Follow-up|1|||
155425095|NCT01355289|560984621|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
155425096|NCT01355289|560984622|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
155425097|NCT01355289|560984623|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
155425098|NCT01355289|560984624|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
155425099|NCT01355289|560984625|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
155425100|NCT01355289|560984621|FG000|Open Label Extension|Other|0|||
155425101|NCT01355289|560984622|FG001|Open Label Extension|Other|0|||
155425102|NCT01355289|560984623|FG002|Open Label Extension|Other|0|||
155425103|NCT01355289|560984624|FG003|Open Label Extension|Other|0|||
155425104|NCT01355289|560984625|FG004|Open Label Extension|Other|3|||
155425105|NCT01756456|560984630|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
155425106|NCT01756456|560984631|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
155425107|NCT01756456|560984632|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
155425108|NCT01756456|560984633|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
155425109|NCT01756456|560984634|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
155425110|NCT01756456|560984635|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
155425111|NCT01756456|560984630|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
155506095|NCT00275028|561280226|FG000|Overall Study|Withdrew consent before treatment began|1|||
155506096|NCT00275028|561280226|FG000|Overall Study|Withdrawal by Subject|5|||
155506097|NCT00275028|561280226|FG000|Overall Study|Adverse Event|9|||
155425112|NCT01756456|560984631|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
155506098|NCT00275028|561280226|FG000|Overall Study|Progressive Disease|30|||
155506099|NCT00275028|561280226|FG000|Overall Study|Physician Decision|2|||
155349426|NCT02498418|560712171|FG001|Overall Study|Lost to Follow-up|1|||
155349427|NCT02498418|560712172|FG002|Overall Study|Lost to Follow-up|1|||
155349428|NCT02498418|560712170|FG000|Overall Study|Participant taken prohibited medication|0|||
155349429|NCT02498418|560712171|FG001|Overall Study|Participant taken prohibited medication|1|||
155349430|NCT02498418|560712172|FG002|Overall Study|Participant taken prohibited medication|1|||
155349431|NCT01363297|560712181|FG000|Overall Study|Other|0|||
155349432|NCT01363297|560712182|FG001|Overall Study|Other|0|||
155349433|NCT01363297|560712183|FG002|Overall Study|Other|0|||
155349434|NCT01363297|560712184|FG003|Overall Study|Other|0|||
155349435|NCT01363297|560712185|FG004|Overall Study|Other|1|||
155349436|NCT01363297|560712181|FG000|Overall Study|Death|3|||
155349437|NCT01363297|560712182|FG001|Overall Study|Death|6|||
155349438|NCT01363297|560712183|FG002|Overall Study|Death|6|||
155349439|NCT01363297|560712184|FG003|Overall Study|Death|10|||
155349440|NCT01363297|560712185|FG004|Overall Study|Death|30|||
155349441|NCT00794573|560712190|FG000|Overall Study|Death|3|||
155349442|NCT00794573|560712191|FG001|Overall Study|Death|0|||
155349443|NCT00794573|560712190|FG000|Overall Study|Withdrawal by Subject|9|||
155425113|NCT01756456|560984632|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
155425114|NCT01756456|560984633|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
155425115|NCT01756456|560984634|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
155425116|NCT01756456|560984635|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
155425117|NCT01756456|560984630|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
155425118|NCT01756456|560984631|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
155425119|NCT01756456|560984632|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
155425120|NCT01756456|560984633|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
155425121|NCT01756456|560984634|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
155425122|NCT01756456|560984635|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
155425123|NCT01756456|560984630|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
155425124|NCT01756456|560984631|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
155425125|NCT01756456|560984632|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
155425126|NCT01756456|560984633|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
155425127|NCT01756456|560984634|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
155425128|NCT01756456|560984635|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
155425129|NCT01756456|560984630|FG000|Treatment Period: Phase I/II|Other causes|0|||
155425130|NCT01756456|560984631|FG001|Treatment Period: Phase I/II|Other causes|0|||
155425131|NCT01756456|560984632|FG002|Treatment Period: Phase I/II|Other causes|0|||
155425132|NCT01756456|560984633|FG003|Treatment Period: Phase I/II|Other causes|1|||
155425133|NCT01756456|560984634|FG004|Treatment Period: Phase I/II|Other causes|2|||
155425134|NCT01756456|560984635|FG005|Treatment Period: Phase I/II|Other causes|2|||
155425135|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
155425136|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
155425137|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
155425138|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
155425139|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
155425140|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
155425141|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
155425142|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
155425143|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
155425144|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
155425145|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
155425146|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
155425147|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155425148|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155425149|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155425150|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155425151|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155425152|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
155425153|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
155425154|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
155349444|NCT00794573|560712191|FG001|Overall Study|Withdrawal by Subject|12|||
155425155|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
155425156|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
155349445|NCT00794573|560712190|FG000|Overall Study|Lost to Follow-up|26|||
155349446|NCT00794573|560712191|FG001|Overall Study|Lost to Follow-up|33|||
155425157|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
155425158|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
155425159|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
155349447|NCT01774929|560712194|FG000|Overall Study|Adverse Event|3|||
155349448|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
155349449|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
155349450|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
155349451|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
155349452|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
155349453|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
155349454|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
155349455|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
155349456|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
155349457|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
155349458|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Death|1|||
155349459|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
155349460|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Missing|3|||
155349461|NCT03993054|560712198|FG000|Overall Study|PI Decision|1|||
155349462|NCT00383500|560712199|FG000|Overall Study|Withdrawal by Subject|8|||
155349463|NCT00383500|560712200|FG001|Overall Study|Withdrawal by Subject|3|||
155349464|NCT00383500|560712201|FG002|Overall Study|Withdrawal by Subject|0|||
155349465|NCT00383500|560712199|FG000|Overall Study|Lost to Follow-up|0|||
155349466|NCT00383500|560712200|FG001|Overall Study|Lost to Follow-up|0|||
155349467|NCT00383500|560712201|FG002|Overall Study|Lost to Follow-up|2|||
155349468|NCT01123642|560712205|FG000|Overall Study|Lost to Follow-up|23|||
155349469|NCT01123642|560712205|FG000|Overall Study|Withdrawal by Subject|9|||
155349470|NCT01123642|560712205|FG000|Overall Study|ineligible at baseline assessment|36|||
155349471|NCT04853238|560712206|FG000|Overall Study|Death|4|||
155349472|NCT04853238|560712207|FG001|Overall Study|Death|0|||
155349473|NCT04853238|560712208|FG002|Overall Study|Death|2|||
155349474|NCT04853238|560712206|FG000|Overall Study|Lost to Follow-up|16|||
155349475|NCT04853238|560712207|FG001|Overall Study|Lost to Follow-up|2|||
155349476|NCT04853238|560712208|FG002|Overall Study|Lost to Follow-up|37|||
155349477|NCT04853238|560712206|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
155349478|NCT04853238|560712207|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
155349479|NCT04853238|560712208|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
155349480|NCT04853238|560712206|FG000|Overall Study|Withdrawal by Subject|6|||
155349481|NCT04853238|560712207|FG001|Overall Study|Withdrawal by Subject|0|||
155349482|NCT04853238|560712208|FG002|Overall Study|Withdrawal by Subject|21|||
155349483|NCT04853238|560712206|FG000|Overall Study|Physician Decision|0|||
155349484|NCT04853238|560712207|FG001|Overall Study|Physician Decision|0|||
155349485|NCT04853238|560712208|FG002|Overall Study|Physician Decision|2|||
155349486|NCT04853238|560712206|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
155349487|NCT04853238|560712207|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
155349488|NCT04853238|560712208|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
155349489|NCT02093897|560713685|FG000|Overall Study|Physician Decision|1|||
155349490|NCT02093897|560713685|FG000|Overall Study|Planned age group closure - no's reached|17|||
155349491|NCT02093897|560713685|FG000|Overall Study|Adverse event, non-fatal|1|||
155349492|NCT02972242|560713686|FG000|Overall Study|Withdrawal by Subject|1|||
155648079|NCT00098293|561803747|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
155349493|NCT02972242|560713687|FG001|Overall Study|Withdrawal by Subject|0|||
155349494|NCT04572997|560713691|FG000|Overall Study|Adverse Event|1|||
155349495|NCT01967719|560713692|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349496|NCT01967719|560713693|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349497|NCT01967719|560713694|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349498|NCT01967719|560713695|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349499|NCT01967719|560713692|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349500|NCT01967719|560713693|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
155349501|NCT01967719|560713694|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349502|NCT01967719|560713695|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349503|NCT00371462|560713697|FG000|Overall Study|Withdrawal by Subject|1|||
155349504|NCT00371462|560713698|FG001|Overall Study|Withdrawal by Subject|0|||
155349505|NCT00371462|560713697|FG000|Overall Study|Other|7|||
155349506|NCT00371462|560713698|FG001|Overall Study|Other|8|||
155349507|NCT01983462|560713699|FG000|Overall Study|Adverse Event|1|||
155349508|NCT01983462|560713700|FG001|Overall Study|Adverse Event|0|||
155349509|NCT01983462|560713701|FG002|Overall Study|Adverse Event|0|||
155349510|NCT03511378|560713702|FG000|Overall Study|Withdrawal by Subject|2|||
155349511|NCT03511378|560713703|FG001|Overall Study|Withdrawal by Subject|2|||
155349512|NCT03511378|560713702|FG000|Overall Study|Patient not coming or schedule visit|1|||
155349513|NCT03511378|560713703|FG001|Overall Study|Patient not coming or schedule visit|0|||
155349514|NCT02229396|560713705|FG000|Overall Study|Adverse Event|6|||
155349515|NCT02229396|560713706|FG001|Overall Study|Adverse Event|12|||
155648080|NCT00098293|561803748|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
155425160|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
155425161|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
155425162|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
155425163|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
155425164|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
155425165|NCT01756456|560984630|FG000|Follow Up Period Phase I/II|Other causes|0|||
155425166|NCT01756456|560984631|FG001|Follow Up Period Phase I/II|Other causes|0|||
155425167|NCT01756456|560984632|FG002|Follow Up Period Phase I/II|Other causes|0|||
155425168|NCT01756456|560984633|FG003|Follow Up Period Phase I/II|Other causes|1|||
155425169|NCT01756456|560984634|FG004|Follow Up Period Phase I/II|Other causes|3|||
155425170|NCT01756456|560984635|FG005|Follow Up Period Phase I/II|Other causes|5|||
155425171|NCT03838484|560984638|FG000|Overall Study|Lost to Follow-up|0|||
155425172|NCT03838484|560984639|FG001|Overall Study|Lost to Follow-up|1|||
155425173|NCT03838484|560984640|FG002|Overall Study|Lost to Follow-up|0|||
155425174|NCT03838484|560984641|FG003|Overall Study|Lost to Follow-up|0|||
155425175|NCT00813995|560984642|FG000|Overall Study|Clinical adverse event|9|||
155349516|NCT02229396|560713707|FG002|Overall Study|Adverse Event|12|||
155425176|NCT00813995|560984643|FG001|Overall Study|Clinical adverse event|3|||
155425177|NCT00813995|560984642|FG000|Overall Study|Laboratory adverse event|0|||
155425178|NCT00813995|560984643|FG001|Overall Study|Laboratory adverse event|2|||
155425179|NCT00813995|560984642|FG000|Overall Study|Lack of Efficacy|1|||
155425180|NCT00813995|560984643|FG001|Overall Study|Lack of Efficacy|0|||
155425181|NCT00813995|560984642|FG000|Overall Study|Lost to Follow-up|4|||
155425182|NCT00813995|560984643|FG001|Overall Study|Lost to Follow-up|2|||
155425183|NCT00813995|560984642|FG000|Overall Study|Other reason|2|||
155425184|NCT00813995|560984643|FG001|Overall Study|Other reason|2|||
155425185|NCT00813995|560984642|FG000|Overall Study|Protocol Violation|3|||
155425186|NCT00813995|560984643|FG001|Overall Study|Protocol Violation|2|||
155425187|NCT00813995|560984642|FG000|Overall Study|Subject moved|4|||
155425188|NCT00813995|560984643|FG001|Overall Study|Subject moved|0|||
155425189|NCT00813995|560984642|FG000|Overall Study|Withdrawal by Subject|0|||
155425190|NCT00813995|560984643|FG001|Overall Study|Withdrawal by Subject|5|||
155425191|NCT02507349|560984644|FG000|Overall Study|Death|12|||
155425192|NCT02507349|560984645|FG001|Overall Study|Death|16|||
155425193|NCT02507349|560984644|FG000|Overall Study|Withdrawal by Subject|1|||
155425194|NCT02507349|560984645|FG001|Overall Study|Withdrawal by Subject|1|||
155349517|NCT02229396|560713705|FG000|Overall Study|Death|2|||
155349518|NCT02229396|560713706|FG001|Overall Study|Death|3|||
155349519|NCT02229396|560713707|FG002|Overall Study|Death|1|||
155349520|NCT02229396|560713705|FG000|Overall Study|Lost to Follow-up|14|||
155349521|NCT02229396|560713706|FG001|Overall Study|Lost to Follow-up|14|||
155349522|NCT02229396|560713707|FG002|Overall Study|Lost to Follow-up|21|||
155349523|NCT02229396|560713705|FG000|Overall Study|Protocol Violation|2|||
155349524|NCT02229396|560713706|FG001|Overall Study|Protocol Violation|1|||
155349525|NCT02229396|560713707|FG002|Overall Study|Protocol Violation|0|||
155349526|NCT02229396|560713705|FG000|Overall Study|Patient Incorrectly Randomized|0|||
155349527|NCT02229396|560713706|FG001|Overall Study|Patient Incorrectly Randomized|0|||
155349528|NCT02229396|560713707|FG002|Overall Study|Patient Incorrectly Randomized|1|||
155425195|NCT02507349|560984644|FG000|Overall Study|Lost to Follow-up|174|||
155425196|NCT02507349|560984645|FG001|Overall Study|Lost to Follow-up|144|||
155425197|NCT01614964|560984646|FG000|Overall Study|Withdrawal by Subject|2|||
155425198|NCT01614964|560984647|FG001|Overall Study|Withdrawal by Subject|0|||
155425199|NCT01614964|560984646|FG000|Overall Study|Lost to Follow-up|3|||
155425200|NCT01614964|560984647|FG001|Overall Study|Lost to Follow-up|0|||
155425201|NCT00860470|560984656|FG000|Overall Study|Death|6|||
155425202|NCT00860470|560984657|FG001|Overall Study|Death|10|||
155425203|NCT00860470|560984656|FG000|Overall Study|Moved away|8|||
155425204|NCT00860470|560984657|FG001|Overall Study|Moved away|10|||
155425205|NCT00860470|560984656|FG000|Overall Study|Lost to Follow-up|34|||
155425206|NCT00860470|560984657|FG001|Overall Study|Lost to Follow-up|39|||
155425207|NCT02700984|560984659|FG000|Overall Study|Death|2|||
155349529|NCT02229396|560713705|FG000|Overall Study|Other|10|||
155349530|NCT02229396|560713706|FG001|Overall Study|Other|18|||
155349531|NCT02229396|560713707|FG002|Overall Study|Other|15|||
155349532|NCT02229396|560713705|FG000|Overall Study|Withdrawal by Subject|42|||
155349533|NCT02229396|560713706|FG001|Overall Study|Withdrawal by Subject|28|||
155349534|NCT02229396|560713707|FG002|Overall Study|Withdrawal by Subject|41|||
155349535|NCT02229396|560713705|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155349536|NCT02229396|560713706|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155349537|NCT02229396|560713707|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
155349538|NCT02229396|560713705|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
155349539|NCT02229396|560713706|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
155349540|NCT02229396|560713707|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
155349541|NCT02679079|560713711|FG000|Overall Study|Adverse Event|2|||
155349542|NCT02679079|560713712|FG001|Overall Study|Adverse Event|0|||
155349543|NCT02679079|560713713|FG002|Overall Study|Adverse Event|2|||
155349544|NCT02679079|560713711|FG000|Overall Study|Protocol Violation|0|||
155349545|NCT02679079|560713712|FG001|Overall Study|Protocol Violation|1|||
155349546|NCT02679079|560713713|FG002|Overall Study|Protocol Violation|0|||
155349547|NCT02679079|560713711|FG000|Overall Study|Withdrawal by Subject|2|||
155349548|NCT02679079|560713712|FG001|Overall Study|Withdrawal by Subject|1|||
155349549|NCT02679079|560713713|FG002|Overall Study|Withdrawal by Subject|0|||
155349550|NCT03193216|560713717|FG000|Overall Study|Lost to Follow-up|1|||
155349551|NCT03193216|560713718|FG001|Overall Study|Lost to Follow-up|0|||
155349552|NCT03193216|560713717|FG000|Overall Study|Withdrawal by Subject|5|||
155349553|NCT03193216|560713718|FG001|Overall Study|Withdrawal by Subject|0|||
155349554|NCT03193216|560713717|FG000|Overall Study|Physician Decision|4|||
155349555|NCT03193216|560713718|FG001|Overall Study|Physician Decision|0|||
155349556|NCT02490878|560713719|FG000|Overall Study|deemed ineligible|0|||
155349557|NCT02490878|560713720|FG001|Overall Study|deemed ineligible|1|||
155349558|NCT02490878|560713719|FG000|Overall Study|progression prior to treatment|0|||
155349559|NCT02490878|560713720|FG001|Overall Study|progression prior to treatment|1|||
155349560|NCT02490878|560713719|FG000|Overall Study|only submitted baseline QOL|0|||
155349561|NCT02490878|560713720|FG001|Overall Study|only submitted baseline QOL|1|||
155349562|NCT01264887|560713721|FG000|Overall Study|Adverse Event|5|||
155349563|NCT01264887|560713721|FG000|Overall Study|Death|7|||
155349564|NCT01264887|560713721|FG000|Overall Study|Lack of Efficacy|5|||
155349565|NCT01264887|560713721|FG000|Overall Study|Physician Decision|4|||
155349566|NCT01264887|560713721|FG000|Overall Study|Withdrawal by Subject|6|||
155349567|NCT01264887|560713721|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
155349568|NCT01264887|560713721|FG000|Overall Study|Other|2|||
155349569|NCT02171130|560713722|FG000|Overall Study|Death|1|||
155349570|NCT02171130|560713722|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
155349571|NCT02171130|560713722|FG000|Overall Study|Discontinued; Site Termination|5|||
155349572|NCT02171130|560713722|FG000|Overall Study|Withdrawal by Subject|3|||
155349573|NCT02171130|560713722|FG000|Overall Study|Physician Decision|1|||
155349574|NCT02171130|560713722|FG000|Overall Study|Lost to Follow-up|1|||
155506100|NCT01847313|561280230|FG000|Overall Study|Death|0|||
155506101|NCT01847313|561280231|FG001|Overall Study|Death|1|||
155506102|NCT01847313|561280230|FG000|Overall Study|Withdrawal by Subject|0|||
155506103|NCT01847313|561280231|FG001|Overall Study|Withdrawal by Subject|1|||
155506104|NCT00598559|561280232|FG000|Overall Study|Adverse Event|11|||
155506105|NCT00598559|561280233|FG001|Overall Study|Adverse Event|7|||
155506106|NCT00598559|561280234|FG002|Overall Study|Adverse Event|0|||
155506107|NCT00598559|561280232|FG000|Overall Study|Withdrawal by Subject|2|||
155506108|NCT00598559|561280233|FG001|Overall Study|Withdrawal by Subject|2|||
155506109|NCT00598559|561280234|FG002|Overall Study|Withdrawal by Subject|0|||
155506110|NCT00598559|561280232|FG000|Overall Study|Protocol Non-compliance|1|||
155506111|NCT00598559|561280233|FG001|Overall Study|Protocol Non-compliance|0|||
155506112|NCT00598559|561280234|FG002|Overall Study|Protocol Non-compliance|0|||
155506113|NCT00598559|561280232|FG000|Overall Study|Early discharge from hospital|9|||
155506114|NCT00598559|561280233|FG001|Overall Study|Early discharge from hospital|12|||
155506115|NCT00598559|561280234|FG002|Overall Study|Early discharge from hospital|3|||
155506116|NCT00598559|561280232|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
155506117|NCT00598559|561280233|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
155506118|NCT00598559|561280234|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
155506119|NCT00515073|561280239|FG000|Overall Study|Withdrawal by Subject|1|||
155506120|NCT00515073|561280239|FG000|Overall Study|Physician Decision|1|||
155506121|NCT02764489|561280240|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
155349575|NCT02171130|560713722|FG000|Overall Study|Met Exclusion Criteria|1|||
155349576|NCT04531813|560713723|FG000|Overall Study|Protocol Violation|1|||
155506122|NCT02764489|561280241|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
155506123|NCT02764489|561280240|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
155506124|NCT02764489|561280241|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
155506125|NCT02764489|561280240|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
155349577|NCT04531813|560713723|FG000|Overall Study|Withdrawal by Subject|1|||
155349578|NCT01340300|560713726|FG000|Overall Study|Lost to Follow-up|3|||
155349579|NCT01340300|560713727|FG001|Overall Study|Lost to Follow-up|0|||
155506126|NCT02764489|561280241|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
155349580|NCT01340300|560713728|FG002|Overall Study|Lost to Follow-up|5|||
155349581|NCT01340300|560713729|FG003|Overall Study|Lost to Follow-up|10|||
155349582|NCT01340300|560713726|FG000|Overall Study|Withdrawal by Subject|5|||
155349583|NCT01340300|560713727|FG001|Overall Study|Withdrawal by Subject|6|||
155349584|NCT01340300|560713728|FG002|Overall Study|Withdrawal by Subject|6|||
155349585|NCT01340300|560713729|FG003|Overall Study|Withdrawal by Subject|3|||
155349586|NCT01340300|560713726|FG000|Overall Study|Adverse Event|1|||
155349587|NCT01340300|560713727|FG001|Overall Study|Adverse Event|0|||
155349588|NCT01340300|560713728|FG002|Overall Study|Adverse Event|4|||
155349589|NCT01340300|560713729|FG003|Overall Study|Adverse Event|0|||
155349590|NCT01340300|560713726|FG000|Overall Study|Physician Decision|0|||
155349591|NCT01340300|560713727|FG001|Overall Study|Physician Decision|1|||
155349592|NCT01340300|560713728|FG002|Overall Study|Physician Decision|0|||
155349593|NCT01340300|560713729|FG003|Overall Study|Physician Decision|0|||
155349594|NCT01340300|560713726|FG000|Overall Study|Unrelated sickness|0|||
155349595|NCT01340300|560713727|FG001|Overall Study|Unrelated sickness|2|||
155349596|NCT01340300|560713728|FG002|Overall Study|Unrelated sickness|0|||
155349597|NCT01340300|560713729|FG003|Overall Study|Unrelated sickness|1|||
155349598|NCT01061775|560713732|FG000|Overall Study|Physician Decision|2|||
155349599|NCT01061775|560713732|FG000|Overall Study|Lost to Follow-up|1|||
155349600|NCT00784277|560713733|FG000|IR Treatment|Adverse Event|4|||
155349601|NCT00784277|560713734|FG001|IR Treatment|Adverse Event|8|||
155349602|NCT00784277|560713735|FG002|IR Treatment|Adverse Event|19|||
155349603|NCT00784277|560713736|FG003|IR Treatment|Adverse Event|35|||
155349604|NCT00784277|560713737|FG004|IR Treatment|Adverse Event|0|||
155349605|NCT00784277|560713738|FG005|IR Treatment|Adverse Event|0|||
155349606|NCT00784277|560713739|FG006|IR Treatment|Adverse Event|0|||
155349607|NCT00784277|560713733|FG000|IR Treatment|Lack of Efficacy|4|||
155349608|NCT00784277|560713734|FG001|IR Treatment|Lack of Efficacy|4|||
155349609|NCT00784277|560713735|FG002|IR Treatment|Lack of Efficacy|1|||
155349610|NCT00784277|560713736|FG003|IR Treatment|Lack of Efficacy|0|||
155425208|NCT02700984|560984660|FG001|Overall Study|Death|1|||
155425209|NCT02700984|560984659|FG000|Overall Study|Lost to Follow-up|2|||
155425210|NCT02700984|560984660|FG001|Overall Study|Lost to Follow-up|1|||
155425211|NCT02700984|560984659|FG000|Overall Study|Physician Decision|0|||
155425212|NCT02700984|560984660|FG001|Overall Study|Physician Decision|1|||
155425213|NCT02700984|560984659|FG000|Overall Study|Withdrawal by Subject|8|||
155425214|NCT02700984|560984660|FG001|Overall Study|Withdrawal by Subject|9|||
155425215|NCT02700984|560984659|FG000|Overall Study|Reason not specified|3|||
155425216|NCT02700984|560984660|FG001|Overall Study|Reason not specified|2|||
155425217|NCT01032629|560984661|FG000|Overall Study|Closed Site|21|||
155425218|NCT01032629|560984662|FG001|Overall Study|Closed Site|18|||
155425219|NCT01032629|560984663|FG002|Overall Study|Closed Site|16|||
155425220|NCT01032629|560984661|FG000|Overall Study|Withdrawal by Subject|50|||
155425221|NCT01032629|560984662|FG001|Overall Study|Withdrawal by Subject|36|||
155349611|NCT00784277|560713737|FG004|IR Treatment|Lack of Efficacy|0|||
155349612|NCT00784277|560713738|FG005|IR Treatment|Lack of Efficacy|0|||
155349613|NCT00784277|560713739|FG006|IR Treatment|Lack of Efficacy|0|||
155349614|NCT00784277|560713733|FG000|IR Treatment|Lost to Follow-up|1|||
155349615|NCT00784277|560713734|FG001|IR Treatment|Lost to Follow-up|0|||
155349616|NCT00784277|560713735|FG002|IR Treatment|Lost to Follow-up|1|||
155349617|NCT00784277|560713736|FG003|IR Treatment|Lost to Follow-up|0|||
155349618|NCT00784277|560713737|FG004|IR Treatment|Lost to Follow-up|0|||
155349619|NCT00784277|560713738|FG005|IR Treatment|Lost to Follow-up|0|||
155349620|NCT00784277|560713739|FG006|IR Treatment|Lost to Follow-up|0|||
155349621|NCT00784277|560713733|FG000|IR Treatment|Withdrawal by Subject|5|||
155349622|NCT00784277|560713734|FG001|IR Treatment|Withdrawal by Subject|1|||
155349623|NCT00784277|560713735|FG002|IR Treatment|Withdrawal by Subject|4|||
155349624|NCT00784277|560713736|FG003|IR Treatment|Withdrawal by Subject|6|||
155349625|NCT00784277|560713737|FG004|IR Treatment|Withdrawal by Subject|0|||
155349626|NCT00784277|560713738|FG005|IR Treatment|Withdrawal by Subject|0|||
155349627|NCT00784277|560713739|FG006|IR Treatment|Withdrawal by Subject|0|||
155349628|NCT00784277|560713733|FG000|IR Treatment|Resolution Of Pain|0|||
155349629|NCT00784277|560713734|FG001|IR Treatment|Resolution Of Pain|1|||
155349630|NCT00784277|560713735|FG002|IR Treatment|Resolution Of Pain|0|||
155349631|NCT00784277|560713736|FG003|IR Treatment|Resolution Of Pain|0|||
155349632|NCT00784277|560713737|FG004|IR Treatment|Resolution Of Pain|0|||
155349633|NCT00784277|560713738|FG005|IR Treatment|Resolution Of Pain|0|||
155349634|NCT00784277|560713739|FG006|IR Treatment|Resolution Of Pain|0|||
155349635|NCT00784277|560713733|FG000|IR Treatment|Other|2|||
155349636|NCT00784277|560713734|FG001|IR Treatment|Other|3|||
155349637|NCT00784277|560713735|FG002|IR Treatment|Other|3|||
155425222|NCT01032629|560984663|FG002|Overall Study|Withdrawal by Subject|35|||
155425223|NCT01032629|560984661|FG000|Overall Study|Lost to Follow-up|74|||
155425224|NCT01032629|560984662|FG001|Overall Study|Lost to Follow-up|47|||
155425225|NCT01032629|560984663|FG002|Overall Study|Lost to Follow-up|37|||
155425226|NCT03371355|560984664|FG000|Overall Study|Investigator judgment|0|||
155425227|NCT03371355|560984665|FG001|Overall Study|Investigator judgment|0|||
155425228|NCT03371355|560984666|FG002|Overall Study|Investigator judgment|1|||
155425229|NCT03371355|560984667|FG003|Overall Study|Investigator judgment|1|||
155425230|NCT03371355|560984664|FG000|Overall Study|Voluntary withdrawal|1|||
155425231|NCT03371355|560984665|FG001|Overall Study|Voluntary withdrawal|0|||
155425232|NCT03371355|560984666|FG002|Overall Study|Voluntary withdrawal|1|||
155425233|NCT03371355|560984667|FG003|Overall Study|Voluntary withdrawal|2|||
155425234|NCT03371355|560984664|FG000|Overall Study|Adverse Event|0|||
155425235|NCT03371355|560984665|FG001|Overall Study|Adverse Event|1|||
155425236|NCT03371355|560984666|FG002|Overall Study|Adverse Event|2|||
155425237|NCT03371355|560984667|FG003|Overall Study|Adverse Event|3|||
155425238|NCT03371355|560984664|FG000|Overall Study|Reason not Specified|0|||
155506127|NCT02764489|561280240|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
155349638|NCT00784277|560713736|FG003|IR Treatment|Other|2|||
155349639|NCT00784277|560713737|FG004|IR Treatment|Other|0|||
155506128|NCT02764489|561280241|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
155349640|NCT00784277|560713738|FG005|IR Treatment|Other|0|||
155349641|NCT00784277|560713739|FG006|IR Treatment|Other|0|||
155349642|NCT00784277|560713733|FG000|ER Treatment|Adverse Event|0|||
155349643|NCT00784277|560713734|FG001|ER Treatment|Adverse Event|0|||
155349644|NCT00784277|560713735|FG002|ER Treatment|Adverse Event|0|||
155349645|NCT00784277|560713736|FG003|ER Treatment|Adverse Event|0|||
155349646|NCT00784277|560713737|FG004|ER Treatment|Adverse Event|1|||
155349647|NCT00784277|560713738|FG005|ER Treatment|Adverse Event|7|||
155349648|NCT00784277|560713739|FG006|ER Treatment|Adverse Event|7|||
155349649|NCT00784277|560713733|FG000|ER Treatment|Lack of Efficacy|0|||
155425239|NCT03371355|560984665|FG001|Overall Study|Reason not Specified|1|||
155425240|NCT03371355|560984666|FG002|Overall Study|Reason not Specified|0|||
155425241|NCT03371355|560984667|FG003|Overall Study|Reason not Specified|1|||
155349650|NCT00784277|560713734|FG001|ER Treatment|Lack of Efficacy|0|||
155425242|NCT00619957|560984672|FG000|Month 24 Double-Blind|Adverse Event|9|||
155425243|NCT00619957|560984673|FG001|Month 24 Double-Blind|Adverse Event|7|||
155425244|NCT00619957|560984672|FG000|Month 24 Double-Blind|Protocol Violation|1|||
155506129|NCT00881959|561280242|FG000|Overall Study|Lost to Follow-up|2|||
155506130|NCT00881959|561280243|FG001|Overall Study|Lost to Follow-up|4|||
155506131|NCT03840811|561280244|FG000|Overall Study|Lost to Follow-up|0|||
155506132|NCT03840811|561280245|FG001|Overall Study|Lost to Follow-up|0|||
155506133|NCT03840811|561280246|FG002|Overall Study|Lost to Follow-up|1|||
155506134|NCT01904383|561280247|FG000|Overall Study|CRF not collected|117|||
155506135|NCT01904383|561280247|FG000|Overall Study|Reason not listed|147|||
155506136|NCT01904383|561280247|FG000|Overall Study|Lost to Follow-up|674|||
155506137|NCT01904383|561280247|FG000|Overall Study|Lack of Efficacy|370|||
155506138|NCT01904383|561280247|FG000|Overall Study|Improvement|141|||
155349651|NCT00784277|560713735|FG002|ER Treatment|Lack of Efficacy|0|||
155349652|NCT00784277|560713736|FG003|ER Treatment|Lack of Efficacy|0|||
155349653|NCT00784277|560713737|FG004|ER Treatment|Lack of Efficacy|3|||
155349654|NCT00784277|560713738|FG005|ER Treatment|Lack of Efficacy|4|||
155349655|NCT00784277|560713739|FG006|ER Treatment|Lack of Efficacy|0|||
155349656|NCT00784277|560713733|FG000|ER Treatment|Lost to Follow-up|0|||
155349657|NCT00784277|560713734|FG001|ER Treatment|Lost to Follow-up|0|||
155349658|NCT00784277|560713735|FG002|ER Treatment|Lost to Follow-up|0|||
155349659|NCT00784277|560713736|FG003|ER Treatment|Lost to Follow-up|0|||
155349660|NCT00784277|560713737|FG004|ER Treatment|Lost to Follow-up|0|||
155349661|NCT00784277|560713738|FG005|ER Treatment|Lost to Follow-up|2|||
155349662|NCT00784277|560713739|FG006|ER Treatment|Lost to Follow-up|0|||
155349663|NCT00784277|560713733|FG000|ER Treatment|Withdrawal by Subject|0|||
155349664|NCT00784277|560713734|FG001|ER Treatment|Withdrawal by Subject|0|||
155349665|NCT00784277|560713735|FG002|ER Treatment|Withdrawal by Subject|0|||
155349666|NCT00784277|560713736|FG003|ER Treatment|Withdrawal by Subject|0|||
155349667|NCT00784277|560713737|FG004|ER Treatment|Withdrawal by Subject|2|||
155349668|NCT00784277|560713738|FG005|ER Treatment|Withdrawal by Subject|5|||
155349669|NCT00784277|560713739|FG006|ER Treatment|Withdrawal by Subject|3|||
155349670|NCT00784277|560713733|FG000|ER Treatment|Study Medication Non-Compliant|0|||
155349671|NCT00784277|560713734|FG001|ER Treatment|Study Medication Non-Compliant|0|||
155349672|NCT00784277|560713735|FG002|ER Treatment|Study Medication Non-Compliant|0|||
155349673|NCT00784277|560713736|FG003|ER Treatment|Study Medication Non-Compliant|0|||
155349674|NCT00784277|560713737|FG004|ER Treatment|Study Medication Non-Compliant|2|||
155349675|NCT00784277|560713738|FG005|ER Treatment|Study Medication Non-Compliant|3|||
155349676|NCT00784277|560713739|FG006|ER Treatment|Study Medication Non-Compliant|3|||
155349677|NCT00784277|560713733|FG000|ER Treatment|Other|0|||
155349678|NCT00784277|560713734|FG001|ER Treatment|Other|0|||
155349679|NCT00784277|560713735|FG002|ER Treatment|Other|0|||
155349680|NCT00784277|560713736|FG003|ER Treatment|Other|0|||
155349681|NCT00784277|560713737|FG004|ER Treatment|Other|1|||
155349682|NCT00784277|560713738|FG005|ER Treatment|Other|3|||
155349683|NCT00784277|560713739|FG006|ER Treatment|Other|2|||
155349684|NCT01093222|560713740|FG000|Overall Study|Ineligible|6|||
155349685|NCT01093222|560713740|FG000|Overall Study|Adverse Event|7|||
155349686|NCT01093222|560713740|FG000|Overall Study|Progression/relapse|24|||
155349687|NCT01093222|560713740|FG000|Overall Study|Death|2|||
155349688|NCT01093222|560713740|FG000|Overall Study|Not protocol specified|1|||
155349689|NCT00588341|560713741|FG000|Overall Study|Withdrawal by Subject|3|||
155349690|NCT00588341|560713741|FG000|Overall Study|Not treated due to metastatic disease|1|||
155349691|NCT00588341|560713741|FG000|Overall Study|Patient ineligible|1|||
155349692|NCT03746483|560713742|FG000|Overall Study|Adverse Event|0|||
155349693|NCT03746483|560713743|FG001|Overall Study|Adverse Event|1|||
155349694|NCT03746483|560713742|FG000|Overall Study|Lack of Efficacy|3|||
155349695|NCT03746483|560713743|FG001|Overall Study|Lack of Efficacy|2|||
155349696|NCT03746483|560713742|FG000|Overall Study|Lost to Follow-up|1|||
155349697|NCT03746483|560713743|FG001|Overall Study|Lost to Follow-up|0|||
155349698|NCT03746483|560713742|FG000|Overall Study|Protocol Violation|2|||
155349699|NCT03746483|560713743|FG001|Overall Study|Protocol Violation|0|||
155349700|NCT01924806|560713746|FG000|Overall Study|Physician Decision|2|||
155349701|NCT01924806|560713747|FG001|Overall Study|Physician Decision|1|||
155506139|NCT01904383|561280247|FG000|Overall Study|Adverse Event|271|||
155506140|NCT01904383|561280247|FG000|Overall Study|No patient visit after entry|54|||
155506141|NCT01625845|561280248|FG000|Overall Study|Adverse Event|1|||
155349702|NCT00762502|560713752|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
155506142|NCT01625845|561280249|FG001|Overall Study|Adverse Event|2|||
155506143|NCT01625845|561280248|FG000|Overall Study|Lost to Follow-up|2|||
155506144|NCT01625845|561280249|FG001|Overall Study|Lost to Follow-up|1|||
155506145|NCT01625845|561280248|FG000|Overall Study|Withdrawal by Subject|2|||
155506146|NCT01625845|561280249|FG001|Overall Study|Withdrawal by Subject|0|||
155506147|NCT01294592|561280250|FG000|Overall Study|Adverse Event|28|||
155349703|NCT00762502|560713753|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
155349704|NCT00762502|560713754|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
155506148|NCT01294592|561280251|FG001|Overall Study|Adverse Event|13|||
155506149|NCT01294592|561280250|FG000|Overall Study|Lack of Efficacy|7|||
155349705|NCT00762502|560713752|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
155349706|NCT00762502|560713753|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
155349707|NCT00762502|560713754|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
155506150|NCT01294592|561280251|FG001|Overall Study|Lack of Efficacy|5|||
155349708|NCT00762502|560713752|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
155349709|NCT00762502|560713753|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
155349710|NCT00762502|560713754|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
155349711|NCT01675050|560713755|FG000|Period One Treatment|Withdrawal by Subject|1|||
155349712|NCT01675050|560713756|FG001|Period One Treatment|Withdrawal by Subject|0|||
155349713|NCT00264498|560713760|FG000|Randomized Treatment|Death|0|||
155349714|NCT00264498|560713761|FG001|Randomized Treatment|Death|3|||
155349715|NCT00264498|560713760|FG000|Randomized Treatment|Withdrawal by Subject|0|||
155349716|NCT00264498|560713761|FG001|Randomized Treatment|Withdrawal by Subject|1|||
155349717|NCT00264498|560713760|FG000|Randomized Treatment|Objective disease Progression|13|||
155349718|NCT00264498|560713761|FG001|Randomized Treatment|Objective disease Progression|14|||
155349719|NCT00264498|560713760|FG000|Randomized Treatment|Physician Decision|1|||
155349720|NCT00264498|560713761|FG001|Randomized Treatment|Physician Decision|0|||
155349721|NCT00264498|560713760|FG000|Randomized Treatment|Incorrectly randomized|1|||
155349722|NCT00264498|560713761|FG001|Randomized Treatment|Incorrectly randomized|0|||
155349723|NCT00264498|560713760|FG000|Randomized Treatment|Study Closure|1|||
155349724|NCT00264498|560713761|FG001|Randomized Treatment|Study Closure|0|||
155349725|NCT00264498|560713760|FG000|Randomized Treatment|Protocol Violation|1|||
155349726|NCT00264498|560713761|FG001|Randomized Treatment|Protocol Violation|0|||
155349727|NCT00264498|560713760|FG000|Crossover Treatment|Death|1|||
155349728|NCT00264498|560713761|FG001|Crossover Treatment|Death|3|||
155349729|NCT00264498|560713760|FG000|Crossover Treatment|Objective disease progression|4|||
155349730|NCT00264498|560713761|FG001|Crossover Treatment|Objective disease progression|5|||
155349731|NCT00264498|560713760|FG000|Crossover Treatment|Study closure|0|||
155349732|NCT00264498|560713761|FG001|Crossover Treatment|Study closure|1|||
155349733|NCT00264498|560713760|FG000|Crossover Treatment|Withdrawal by Subject|1|||
155349734|NCT00264498|560713761|FG001|Crossover Treatment|Withdrawal by Subject|0|||
155349735|NCT03794609|560713762|FG000|Overall Study|Other|10|||
155349736|NCT03794609|560713762|FG000|Overall Study|Withdrawal by Subject|66|||
155349737|NCT03794609|560713762|FG000|Overall Study|The child is enrolled in an interventional study|70|||
155349738|NCT03794609|560713762|FG000|Overall Study|Inclusion/exclusion criteria|8|||
155349739|NCT03794609|560713762|FG000|Overall Study|At sponsor's request|151|||
155349740|NCT03794609|560713762|FG000|Overall Study|Physician Decision|1|||
155349741|NCT03794609|560713762|FG000|Overall Study|Lost to Follow-up|5|||
155349742|NCT03638258|560713763|FG000|Overall Study|Adverse Event|1|||
155349743|NCT03638258|560713764|FG001|Overall Study|Adverse Event|0|||
155349744|NCT03638258|560713765|FG002|Overall Study|Adverse Event|2|||
155349745|NCT03638258|560713763|FG000|Overall Study|Lost to Follow-up|2|||
155349746|NCT03638258|560713764|FG001|Overall Study|Lost to Follow-up|4|||
155349747|NCT03638258|560713765|FG002|Overall Study|Lost to Follow-up|5|||
155349748|NCT03638258|560713763|FG000|Overall Study|Pregnancy|0|||
155349749|NCT03638258|560713764|FG001|Overall Study|Pregnancy|0|||
155349750|NCT03638258|560713765|FG002|Overall Study|Pregnancy|1|||
155349751|NCT03638258|560713763|FG000|Overall Study|Protocol Violation|0|||
155349752|NCT03638258|560713764|FG001|Overall Study|Protocol Violation|0|||
155349753|NCT03638258|560713765|FG002|Overall Study|Protocol Violation|1|||
155349754|NCT03638258|560713763|FG000|Overall Study|Withdrawal by Subject|4|||
155349755|NCT03638258|560713764|FG001|Overall Study|Withdrawal by Subject|5|||
155349756|NCT03638258|560713765|FG002|Overall Study|Withdrawal by Subject|12|||
155349757|NCT03638258|560713763|FG000|Overall Study|Lack of Efficacy|0|||
155349758|NCT03638258|560713764|FG001|Overall Study|Lack of Efficacy|0|||
155349759|NCT03638258|560713765|FG002|Overall Study|Lack of Efficacy|2|||
155349760|NCT04543942|560713766|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
155349761|NCT04543942|560713767|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
155349762|NCT04543942|560713766|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
155349763|NCT04543942|560713767|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
155349764|NCT02205476|560713768|FG000|Overall Study|Study termination by Sponsor|7|||
155349765|NCT02205476|560713769|FG001|Overall Study|Study termination by Sponsor|3|||
155349766|NCT00139659|560713774|FG000|Overall Study|Adverse Event|12|||
155349767|NCT00139659|560713775|FG001|Overall Study|Adverse Event|1|||
155349768|NCT00139659|560713774|FG000|Overall Study|Lack of Efficacy|1|||
155349769|NCT00139659|560713775|FG001|Overall Study|Lack of Efficacy|1|||
155349770|NCT00139659|560713774|FG000|Overall Study|Lost to Follow-up|7|||
155349771|NCT00139659|560713775|FG001|Overall Study|Lost to Follow-up|3|||
155349772|NCT00139659|560713774|FG000|Overall Study|Reason not Specified|6|||
155349773|NCT00139659|560713775|FG001|Overall Study|Reason not Specified|3|||
155349774|NCT00139659|560713774|FG000|Overall Study|Withdrawal by Subject|14|||
155349775|NCT00139659|560713775|FG001|Overall Study|Withdrawal by Subject|10|||
155349776|NCT02625922|560713781|FG000|Overall Study|Non-availability of IMP|1|||
155349777|NCT02625922|560713782|FG001|Overall Study|Non-availability of IMP|1|||
155349778|NCT02625922|560713781|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
155349779|NCT02625922|560713782|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
155349780|NCT02359552|560713783|FG000|Overall Study|Lost to Follow-up|3|||
155349781|NCT02359552|560713784|FG001|Overall Study|Lost to Follow-up|4|||
155349782|NCT01747629|560713796|FG000|Overall Study|Adverse Event|1|||
155349783|NCT01747629|560713797|FG001|Overall Study|Adverse Event|2|||
155349784|NCT01747629|560713796|FG000|Overall Study|Withdrawal by Subject|2|||
155349785|NCT01747629|560713797|FG001|Overall Study|Withdrawal by Subject|2|||
155349786|NCT01747629|560713796|FG000|Overall Study|Noncompliance|1|||
155349787|NCT01747629|560713797|FG001|Overall Study|Noncompliance|1|||
155349788|NCT01747629|560713796|FG000|Overall Study|Inclusion criteria not met|1|||
155349789|NCT01747629|560713797|FG001|Overall Study|Inclusion criteria not met|0|||
155349790|NCT01747629|560713796|FG000|Overall Study|Not treated|1|||
155349791|NCT01747629|560713797|FG001|Overall Study|Not treated|0|||
155349792|NCT01747629|560713796|FG000|Overall Study|Other|2|||
155349793|NCT01747629|560713797|FG001|Overall Study|Other|1|||
155349794|NCT01313299|560713798|FG000|Overall Study|Adverse Event|3|||
155349795|NCT01313299|560713799|FG001|Overall Study|Adverse Event|1|||
155349796|NCT01313299|560713800|FG002|Overall Study|Adverse Event|1|||
155349797|NCT01313299|560713798|FG000|Overall Study|Lost to Follow-up|1|||
155349798|NCT01313299|560713799|FG001|Overall Study|Lost to Follow-up|0|||
155349799|NCT01313299|560713800|FG002|Overall Study|Lost to Follow-up|0|||
155349800|NCT01313299|560713798|FG000|Overall Study|Protocol Violation|2|||
155349801|NCT01313299|560713799|FG001|Overall Study|Protocol Violation|0|||
155349802|NCT01313299|560713800|FG002|Overall Study|Protocol Violation|0|||
155349803|NCT01313299|560713798|FG000|Overall Study|Withdrawal by Subject|1|||
155349804|NCT01313299|560713799|FG001|Overall Study|Withdrawal by Subject|0|||
155349805|NCT01313299|560713800|FG002|Overall Study|Withdrawal by Subject|2|||
155349806|NCT01313299|560713798|FG000|Overall Study|Family reason and moved out of state|0|||
155349807|NCT01313299|560713799|FG001|Overall Study|Family reason and moved out of state|2|||
155349808|NCT01313299|560713800|FG002|Overall Study|Family reason and moved out of state|0|||
155349809|NCT01313299|560713798|FG000|Overall Study|Lack of subject compliance|0|||
155349810|NCT01313299|560713799|FG001|Overall Study|Lack of subject compliance|0|||
155349811|NCT01313299|560713800|FG002|Overall Study|Lack of subject compliance|1|||
155349812|NCT02506881|560713801|FG000|First Intervention (Day 1)|Protocol Violation|0|||
155349813|NCT02506881|560713802|FG001|First Intervention (Day 1)|Protocol Violation|0|||
155349814|NCT02506881|560713803|FG002|First Intervention (Day 1)|Protocol Violation|1|||
155349815|NCT02506881|560713804|FG003|First Intervention (Day 1)|Protocol Violation|0|||
155349816|NCT02506881|560713801|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349817|NCT02506881|560713802|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349818|NCT02506881|560713803|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349819|NCT02506881|560713804|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349820|NCT02506881|560713801|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
155349821|NCT02506881|560713802|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
155349822|NCT02506881|560713803|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
155349823|NCT02506881|560713804|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
155349824|NCT01919398|560713805|FG000|Overall Study|Progressive Disease|0|||
155349825|NCT01919398|560713806|FG001|Overall Study|Progressive Disease|0|||
155349826|NCT01919398|560713807|FG002|Overall Study|Progressive Disease|4|||
155349827|NCT02391545|560713809|FG000|Overall Study|Death|0|||
155349828|NCT02391545|560713810|FG001|Overall Study|Death|2|||
155349829|NCT02391545|560713809|FG000|Overall Study|Lost to Follow-up|0|||
155349830|NCT02391545|560713810|FG001|Overall Study|Lost to Follow-up|1|||
155349831|NCT02391545|560713809|FG000|Overall Study|Termination of study by sponsor|20|||
155349832|NCT02391545|560713810|FG001|Overall Study|Termination of study by sponsor|20|||
155349833|NCT02391545|560713809|FG000|Overall Study|Withdrawal by Subject|0|||
155349834|NCT02391545|560713810|FG001|Overall Study|Withdrawal by Subject|1|||
155648081|NCT00098293|561803749|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
155349835|NCT02391545|560713809|FG000|Overall Study|Other Reasons|6|||
155349836|NCT02391545|560713810|FG001|Overall Study|Other Reasons|4|||
155349837|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
155349838|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Duplication|2|||
155349839|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
155349840|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
155349841|NCT02016690|560713811|FG000|Overall Study|Did not meet inclusion criteria|13|||
155349842|NCT02016690|560713811|FG000|Overall Study|Hospitalized for RSV at study start|3|||
155349843|NCT01222078|560713812|FG000|Overall Study|Early termination of the study|1|||
155349844|NCT04089332|560713813|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
155349845|NCT04089332|560713813|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
155349846|NCT04089332|560713813|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
155349847|NCT00495612|560713817|FG000|Overall Study|Lost to Follow-up|1|||
155349848|NCT00495612|560713818|FG001|Overall Study|Lost to Follow-up|0|||
155349849|NCT00495612|560713817|FG000|Overall Study|Subject's Decision to Withdraw|3|||
155349850|NCT00495612|560713818|FG001|Overall Study|Subject's Decision to Withdraw|0|||
155349851|NCT01770509|560713827|FG000|Overall Study|Injury|0|||
155349852|NCT01770509|560713828|FG001|Overall Study|Injury|1|||
155349853|NCT01770509|560713827|FG000|Overall Study|Lost to Follow-up|1|||
155349854|NCT01770509|560713828|FG001|Overall Study|Lost to Follow-up|2|||
155349855|NCT02865135|560713832|FG000|Overall Study|Death|0|||
155349856|NCT02865135|560713833|FG001|Overall Study|Death|1|||
155425245|NCT00619957|560984673|FG001|Month 24 Double-Blind|Protocol Violation|0|||
155425246|NCT00619957|560984672|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
155425247|NCT00619957|560984673|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
155425248|NCT00619957|560984672|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
155425249|NCT00619957|560984673|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
155425250|NCT00619957|560984672|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
155425251|NCT00619957|560984673|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
155425252|NCT00619957|560984672|FG000|Month 48 Open-Label|Adverse Event|4|||
155425253|NCT00619957|560984673|FG001|Month 48 Open-Label|Adverse Event|4|||
155425254|NCT00619957|560984672|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
155425255|NCT00619957|560984673|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
155425256|NCT00619957|560984672|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
155425257|NCT00619957|560984673|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
155425258|NCT00723957|560984674|FG000|Overall Study|Adverse event unrelated to study drug|1|||
155425259|NCT00723957|560984675|FG001|Overall Study|Adverse event unrelated to study drug|4|||
155425260|NCT00723957|560984674|FG000|Overall Study|Death|3|||
155425261|NCT00723957|560984675|FG001|Overall Study|Death|4|||
155425262|NCT00723957|560984674|FG000|Overall Study|Disease progression|27|||
155425263|NCT00723957|560984675|FG001|Overall Study|Disease progression|25|||
155425264|NCT00723957|560984674|FG000|Overall Study|Maximum clinical benefit|4|||
155425265|NCT00723957|560984675|FG001|Overall Study|Maximum clinical benefit|5|||
155425266|NCT00723957|560984674|FG000|Overall Study|Investigator decision|1|||
155425267|NCT00723957|560984675|FG001|Overall Study|Investigator decision|1|||
155425268|NCT00723957|560984674|FG000|Overall Study|Study drug toxicity|4|||
155425269|NCT00723957|560984675|FG001|Overall Study|Study drug toxicity|6|||
155425270|NCT00723957|560984674|FG000|Overall Study|Withdrawal by Subject|7|||
155425271|NCT00723957|560984675|FG001|Overall Study|Withdrawal by Subject|5|||
155425272|NCT00723957|560984674|FG000|Overall Study|Reason not analyzed|1|||
155425273|NCT00723957|560984675|FG001|Overall Study|Reason not analyzed|0|||
155425274|NCT00723957|560984674|FG000|Overall Study|Never received treatment|3|||
155425275|NCT00723957|560984675|FG001|Overall Study|Never received treatment|3|||
155425276|NCT01360996|560984680|FG000|Overall Study|Withdrawal by Subject|4|||
155425277|NCT01360996|560984681|FG001|Overall Study|Withdrawal by Subject|3|||
155425278|NCT01360996|560984682|FG002|Overall Study|Withdrawal by Subject|2|||
155425279|NCT01360996|560984680|FG000|Overall Study|Noncompliant|2|||
155425280|NCT01360996|560984681|FG001|Overall Study|Noncompliant|0|||
155425281|NCT01360996|560984682|FG002|Overall Study|Noncompliant|0|||
155425282|NCT01763164|560984683|FG000|Treatment Phase|Participant/Guardian decision|26|||
155349857|NCT02865135|560713834|FG002|Overall Study|Death|0|||
155349858|NCT02865135|560713832|FG000|Overall Study|Progression|6|||
155349859|NCT02865135|560713833|FG001|Overall Study|Progression|2|||
155425283|NCT01763164|560984684|FG001|Treatment Phase|Participant/Guardian decision|14|||
155425284|NCT01763164|560984683|FG000|Treatment Phase|Protocol Violation|1|||
155425285|NCT01763164|560984684|FG001|Treatment Phase|Protocol Violation|1|||
155425286|NCT01763164|560984683|FG000|Treatment Phase|Progressive Disease|142|||
155425287|NCT01763164|560984684|FG001|Treatment Phase|Progressive Disease|76|||
155425288|NCT01763164|560984683|FG000|Treatment Phase|Physician Decision|24|||
155425289|NCT01763164|560984684|FG001|Treatment Phase|Physician Decision|13|||
155349860|NCT02865135|560713834|FG002|Overall Study|Progression|2|||
155349861|NCT02762500|560716095|FG000|Overall Study|Lack of Efficacy|1|||
155349862|NCT02762500|560716096|FG001|Overall Study|Lack of Efficacy|0|||
155349863|NCT02762500|560716095|FG000|Overall Study|Withdrawal by Subject|1|||
155349864|NCT02762500|560716096|FG001|Overall Study|Withdrawal by Subject|1|||
155349865|NCT02762500|560716095|FG000|Overall Study|Adverse Event|0|||
155349866|NCT02762500|560716096|FG001|Overall Study|Adverse Event|2|||
155349867|NCT00730847|560716097|FG000|Overall Study|Adverse Event|1|||
155349868|NCT00730847|560716097|FG000|Overall Study|Protocol Violation|2|||
155349869|NCT00730847|560716097|FG000|Overall Study|Withdrawal by Subject|16|||
155349870|NCT00730847|560716097|FG000|Overall Study|Lost to Follow-up|67|||
155349871|NCT00730847|560716097|FG000|Overall Study|Unknown completion status|21|||
155349872|NCT00730847|560716097|FG000|Overall Study|Other|24|||
155349873|NCT00280683|560716098|FG000|Overall Study|Withdrawal by Subject|1|||
155349874|NCT00280683|560716099|FG001|Overall Study|Withdrawal by Subject|2|||
155349875|NCT00280683|560716098|FG000|Overall Study|Adverse Event|1|||
155349876|NCT00280683|560716099|FG001|Overall Study|Adverse Event|1|||
155349877|NCT01243411|560716100|FG000|Overall Study|Withdrawal by Subject|18|||
155349878|NCT01243411|560716100|FG000|Overall Study|Lost to Follow-up|10|||
155349879|NCT01243411|560716100|FG000|Overall Study|Adverse Event|5|||
155349880|NCT01243411|560716100|FG000|Overall Study|Other|8|||
155349881|NCT00488319|560716109|FG000|Overall Study|Adverse Event|1|||
155349882|NCT00488319|560716110|FG001|Overall Study|Adverse Event|2|||
155349883|NCT00488319|560716111|FG002|Overall Study|Adverse Event|23|||
155349884|NCT00488319|560716109|FG000|Overall Study|Lack of Efficacy|6|||
155349885|NCT00488319|560716110|FG001|Overall Study|Lack of Efficacy|12|||
155349886|NCT00488319|560716111|FG002|Overall Study|Lack of Efficacy|27|||
155349887|NCT00488319|560716109|FG000|Overall Study|Lost to Follow-up|3|||
155349888|NCT00488319|560716110|FG001|Overall Study|Lost to Follow-up|5|||
155349889|NCT00488319|560716111|FG002|Overall Study|Lost to Follow-up|16|||
155349890|NCT00488319|560716109|FG000|Overall Study|Withdrawal by Subject|5|||
155349891|NCT00488319|560716110|FG001|Overall Study|Withdrawal by Subject|20|||
155349892|NCT00488319|560716111|FG002|Overall Study|Withdrawal by Subject|44|||
155349893|NCT00488319|560716109|FG000|Overall Study|Other reasons for withdrawal|0|||
155349894|NCT00488319|560716110|FG001|Overall Study|Other reasons for withdrawal|4|||
155349895|NCT00488319|560716111|FG002|Overall Study|Other reasons for withdrawal|12|||
155349896|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
155349897|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
155349898|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
155349899|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
155349900|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
155349901|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
155349902|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
155349903|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
155349904|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
155349905|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
155349906|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
155349907|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
155349908|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
155349909|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
155349910|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
155349911|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
155349912|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
155349913|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
155349914|NCT00352053|560716114|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
155425290|NCT01763164|560984683|FG000|Treatment Phase|Death|10|||
155425291|NCT01763164|560984684|FG001|Treatment Phase|Death|1|||
155425292|NCT01763164|560984683|FG000|Treatment Phase|Adverse Event|66|||
155425293|NCT01763164|560984684|FG001|Treatment Phase|Adverse Event|8|||
155425294|NCT01763164|560984683|FG000|Treatment Phase|Randomized but not Treated|0|||
155425295|NCT01763164|560984684|FG001|Treatment Phase|Randomized but not Treated|19|||
155425296|NCT01763164|560984683|FG000|Treatment Phase|Other|0|||
155349915|NCT00352053|560716115|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
155349916|NCT00352053|560716114|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
155425297|NCT01763164|560984684|FG001|Treatment Phase|Other|1|||
155425298|NCT01763164|560984683|FG000|Follow up Phase|New therapy for study indication|12|||
155349917|NCT00352053|560716115|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
155349918|NCT00352053|560716114|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
155349919|NCT00352053|560716115|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
155349920|NCT00352053|560716114|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
155349921|NCT00352053|560716115|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
155349922|NCT02499835|560716121|FG000|Overall Study|Withdrawal by Subject|1|||
155349923|NCT02499835|560716122|FG001|Overall Study|Withdrawal by Subject|0|||
155349924|NCT02499835|560716123|FG002|Overall Study|Withdrawal by Subject|0|||
155349925|NCT02499835|560716124|FG003|Overall Study|Withdrawal by Subject|1|||
155349926|NCT02499835|560716121|FG000|Overall Study|Physician Decision|0|||
155349927|NCT02499835|560716122|FG001|Overall Study|Physician Decision|3|||
155349928|NCT02499835|560716123|FG002|Overall Study|Physician Decision|18|||
155349929|NCT02499835|560716124|FG003|Overall Study|Physician Decision|7|||
155349930|NCT02499835|560716121|FG000|Overall Study|Adverse Event|0|||
155349931|NCT02499835|560716122|FG001|Overall Study|Adverse Event|0|||
155425299|NCT01763164|560984684|FG001|Follow up Phase|New therapy for study indication|3|||
155425300|NCT01763164|560984683|FG000|Follow up Phase|Death|21|||
155425301|NCT01763164|560984684|FG001|Follow up Phase|Death|4|||
155425302|NCT01763164|560984683|FG000|Follow up Phase|Subject/guardian decision|9|||
155425303|NCT01763164|560984684|FG001|Follow up Phase|Subject/guardian decision|2|||
155425304|NCT01763164|560984683|FG000|Follow up Phase|Progressive disease|127|||
155425305|NCT01763164|560984684|FG001|Follow up Phase|Progressive disease|62|||
155425306|NCT01763164|560984683|FG000|Follow up Phase|Physician Decision|10|||
155425307|NCT01763164|560984684|FG001|Follow up Phase|Physician Decision|3|||
155425308|NCT01763164|560984683|FG000|Follow up Phase|Lost to Follow-up|1|||
155425309|NCT01763164|560984684|FG001|Follow up Phase|Lost to Follow-up|0|||
155425310|NCT01763164|560984683|FG000|Follow up Phase|Adverse Event|17|||
155425311|NCT01763164|560984684|FG001|Follow up Phase|Adverse Event|1|||
155425312|NCT03377634|560984685|FG000|Study Period|Adverse Event|1|||
155425313|NCT03377634|560984686|FG001|Study Period|Adverse Event|0|||
155425314|NCT03377634|560984685|FG000|Study Period|Withdrawal by Subject|1|||
155425315|NCT03377634|560984686|FG001|Study Period|Withdrawal by Subject|0|||
155425316|NCT02965378|560984687|FG000|Overall Study|Progression|16|||
155425317|NCT02965378|560984688|FG001|Overall Study|Progression|4|||
155425318|NCT02965378|560984687|FG000|Overall Study|Adverse Event|5|||
155425319|NCT02965378|560984688|FG001|Overall Study|Adverse Event|2|||
155425320|NCT02965378|560984687|FG000|Overall Study|Death|2|||
155425321|NCT02965378|560984688|FG001|Overall Study|Death|0|||
155425322|NCT02965378|560984687|FG000|Overall Study|Refusal|2|||
155425323|NCT02965378|560984688|FG001|Overall Study|Refusal|1|||
155425324|NCT02965378|560984687|FG000|Overall Study|Not protocol specified|0|||
155425325|NCT02965378|560984688|FG001|Overall Study|Not protocol specified|2|||
155425326|NCT04964258|560984689|FG000|Overall Study|Lost to Follow-up|1|||
155425327|NCT04964258|560984690|FG001|Overall Study|Lost to Follow-up|0|||
155425328|NCT04964258|560984691|FG002|Overall Study|Lost to Follow-up|0|||
155425329|NCT04964258|560984692|FG003|Overall Study|Lost to Follow-up|0|||
155425330|NCT04964258|560984693|FG004|Overall Study|Lost to Follow-up|0|||
155425331|NCT04964258|560984694|FG005|Overall Study|Lost to Follow-up|1|||
155425332|NCT04964258|560984695|FG006|Overall Study|Lost to Follow-up|0|||
155425333|NCT04964258|560984696|FG007|Overall Study|Lost to Follow-up|0|||
155425334|NCT04964258|560984697|FG008|Overall Study|Lost to Follow-up|0|||
155425335|NCT04964258|560984698|FG009|Overall Study|Lost to Follow-up|0|||
155425336|NCT04964258|560984699|FG010|Overall Study|Lost to Follow-up|0|||
155425337|NCT01384292|560984702|FG000|Part B|Severe non-compliance to protocol|1|||
155425338|NCT01384292|560984703|FG001|Part B|Severe non-compliance to protocol|0|||
155425339|NCT01384292|560984704|FG002|Part B|Severe non-compliance to protocol|0|||
155425340|NCT01171612|560984705|FG000|Overall Study|Lost to Follow-up|51|||
155425341|NCT04525703|560984706|FG000|Overall Study|Lost to Follow-up|6|||
155349932|NCT02499835|560716123|FG002|Overall Study|Adverse Event|0|||
155349933|NCT02499835|560716124|FG003|Overall Study|Adverse Event|1|||
155349934|NCT02499835|560716121|FG000|Overall Study|Disease progression|2|||
155425342|NCT04525703|560984707|FG001|Overall Study|Lost to Follow-up|15|||
155425343|NCT04525703|560984708|FG002|Overall Study|Lost to Follow-up|8|||
155425344|NCT01285349|560984709|FG000|Overall Study|Lost to Follow-up|27|||
155425345|NCT01285349|560984710|FG001|Overall Study|Lost to Follow-up|20|||
155425346|NCT01285349|560984711|FG002|Overall Study|Lost to Follow-up|27|||
155425347|NCT02909153|560984712|FG000|Overall Study|Withdrawal by Subject|0|||
155425348|NCT02909153|560984713|FG001|Overall Study|Withdrawal by Subject|1|||
155425349|NCT02909153|560984714|FG002|Overall Study|Withdrawal by Subject|0|||
155425350|NCT02909153|560984715|FG003|Overall Study|Withdrawal by Subject|0|||
155425351|NCT02909153|560984716|FG004|Overall Study|Withdrawal by Subject|0|||
155425352|NCT00565617|560984717|FG000|Overall Study|Withdrawal by Subject|1|||
155425353|NCT03040024|560984718|FG000|Overall Study|Adverse Event|0|||
155425354|NCT03040024|560984719|FG001|Overall Study|Adverse Event|1|||
155349935|NCT02499835|560716122|FG001|Overall Study|Disease progression|1|||
155349936|NCT02499835|560716123|FG002|Overall Study|Disease progression|0|||
155349937|NCT02499835|560716124|FG003|Overall Study|Disease progression|7|||
155349938|NCT03226353|560716133|FG000|Overall Study|Withdrawal by Subject|1|||
155349939|NCT03226353|560716133|FG000|Overall Study|Screen Failure|5|||
155349940|NCT03319719|560716134|FG000|Overall Study|Lost to Follow-up|1|||
155349941|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
155349942|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
155349943|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155349944|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
155349945|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
155349946|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
155349947|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
155349948|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155506151|NCT01294592|561280250|FG000|Overall Study|Protocol Violation|1|||
155506152|NCT01294592|561280251|FG001|Overall Study|Protocol Violation|7|||
155506153|NCT01294592|561280250|FG000|Overall Study|Lost to Follow-up|7|||
155506154|NCT01294592|561280251|FG001|Overall Study|Lost to Follow-up|9|||
155506155|NCT01294592|561280250|FG000|Overall Study|Physician Decision|6|||
155506156|NCT01294592|561280251|FG001|Overall Study|Physician Decision|11|||
155506157|NCT01294592|561280250|FG000|Overall Study|Withdrawal by Subject|28|||
155506158|NCT01294592|561280251|FG001|Overall Study|Withdrawal by Subject|28|||
155506159|NCT00623623|561280252|FG000|Overall Study|Previous enrolment into this study|1|||
155506160|NCT00623623|561280253|FG001|Overall Study|Previous enrolment into this study|1|||
155506161|NCT00693784|561280255|FG000|Overall Study|Lost to Follow-up|2|||
155506162|NCT00693784|561280255|FG000|Overall Study|Withdrawal by Subject|2|||
155506163|NCT02265952|561280256|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
155506164|NCT02265952|561280257|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
155506165|NCT02265952|561280256|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
155506166|NCT02265952|561280257|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
155506167|NCT00326885|561280261|FG000|Overall Study|Adverse Event|1|||
155506168|NCT00326885|561280261|FG000|Overall Study|Withdrawal by Subject|3|||
155506169|NCT00326885|561280261|FG000|Overall Study|Physician Decision|1|||
155349949|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155425355|NCT03040024|560984720|FG002|Overall Study|Adverse Event|0|||
155425356|NCT03040024|560984718|FG000|Overall Study|Death|0|||
155425357|NCT03040024|560984719|FG001|Overall Study|Death|1|||
155425358|NCT03040024|560984720|FG002|Overall Study|Death|0|||
155425359|NCT03040024|560984718|FG000|Overall Study|Physician Decision|0|||
155425360|NCT03040024|560984719|FG001|Overall Study|Physician Decision|0|||
155425361|NCT03040024|560984720|FG002|Overall Study|Physician Decision|1|||
155425362|NCT00484315|560984724|FG000|12-Month Clinical Follow-up|Death|6|||
155425363|NCT00484315|560984725|FG001|12-Month Clinical Follow-up|Death|2|||
155648082|NCT00098293|561803750|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
155648083|NCT00098293|561803746|FG000|Open-label (OL) Phase|Death|0|||
155648084|NCT00098293|561803747|FG001|Open-label (OL) Phase|Death|2|||
155648085|NCT00098293|561803748|FG002|Open-label (OL) Phase|Death|3|||
155648086|NCT00098293|561803749|FG003|Open-label (OL) Phase|Death|0|||
155648087|NCT00098293|561803750|FG004|Open-label (OL) Phase|Death|0|||
155648088|NCT00098293|561803746|FG000|Supplemental Phase (SP)|Death|0|||
155648089|NCT00098293|561803747|FG001|Supplemental Phase (SP)|Death|0|||
155648090|NCT00098293|561803748|FG002|Supplemental Phase (SP)|Death|0|||
155648091|NCT00098293|561803749|FG003|Supplemental Phase (SP)|Death|0|||
155648092|NCT00098293|561803750|FG004|Supplemental Phase (SP)|Death|1|||
155648093|NCT00098293|561803746|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
155648094|NCT00098293|561803747|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
155648095|NCT00098293|561803748|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
155648096|NCT00098293|561803749|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
155648097|NCT00098293|561803750|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
155648098|NCT00098293|561803746|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155648099|NCT00098293|561803747|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155648100|NCT00098293|561803748|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155648101|NCT00098293|561803749|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155648102|NCT00098293|561803750|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
155648103|NCT00098293|561803746|FG000|Supplemental Phase (SP)|Other|0|||
155648104|NCT00098293|561803747|FG001|Supplemental Phase (SP)|Other|0|||
155648105|NCT00098293|561803748|FG002|Supplemental Phase (SP)|Other|0|||
155648106|NCT00098293|561803749|FG003|Supplemental Phase (SP)|Other|0|||
155648107|NCT00098293|561803750|FG004|Supplemental Phase (SP)|Other|22|||
155648108|NCT02829957|561803751|FG000|Overall Study|Lost to Follow-up|2|||
155648109|NCT02829957|561803752|FG001|Overall Study|Lost to Follow-up|1|||
155648110|NCT00676689|561803753|FG000|Overall Study|Screen Failure|2|||
155648111|NCT00676689|561803753|FG000|Overall Study|Death|2|||
155648112|NCT00676689|561803753|FG000|Overall Study|Lost to Follow-up|4|||
155648113|NCT00676689|561803753|FG000|Overall Study|Physician Decision|1|||
155648114|NCT00676689|561803753|FG000|Overall Study|Withdrawal by Subject|3|||
155648115|NCT00676689|561803753|FG000|Overall Study|Continuing FU|49|||
155648116|NCT01827943|561803754|FG000|Overall Study|Protocol Violation|8|||
155648117|NCT01827943|561803754|FG000|Overall Study|Never treated because of an rapid progression|1|||
155648118|NCT00501085|561803755|FG000|Overall Study|Lost to Follow-up|195|||
155648119|NCT00501085|561803755|FG000|Overall Study|Withdrawal by Subject|34|||
155648120|NCT00501085|561803755|FG000|Overall Study|Subject Decision|1|||
155648121|NCT00501085|561803755|FG000|Overall Study|Revision Surgery|7|||
155648122|NCT00501085|561803755|FG000|Overall Study|Explantation Surgery|26|||
155648123|NCT00501085|561803755|FG000|Overall Study|Adverse Event|4|||
155648124|NCT00501085|561803755|FG000|Overall Study|Non-Compliance|24|||
155648125|NCT00501085|561803755|FG000|Overall Study|Study closed by sponsor|109|||
155648126|NCT00501085|561803755|FG000|Overall Study|Other loss to follow-up|32|||
155648127|NCT02362412|561803759|FG000|Treatment Period III|Lost to Follow-up|0|||
155648128|NCT02362412|561803760|FG001|Treatment Period III|Lost to Follow-up|1|||
155648129|NCT00545948|561803761|FG000|Overall Study|Not Treated|1|||
155648130|NCT00545948|561803762|FG001|Overall Study|Not Treated|1|||
155648131|NCT00545948|561803763|FG002|Overall Study|Not Treated|7|||
155648132|NCT03467945|561803764|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155425364|NCT00484315|560984724|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
155648133|NCT03467945|561803765|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155648134|NCT03467945|561803766|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155648135|NCT03467945|561803767|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155425365|NCT00484315|560984725|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
155425366|NCT00484315|560984724|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
155425367|NCT00484315|560984725|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
155425368|NCT00484315|560984724|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
155425369|NCT00484315|560984725|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
155425370|NCT00484315|560984724|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
155425371|NCT00484315|560984725|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
155425372|NCT00484315|560984724|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
155425373|NCT00484315|560984725|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
155425374|NCT00484315|560984724|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
155648136|NCT03467945|561803764|FG000|Treatment Period 3|Withdrawal by Subject|1|||
155648137|NCT03467945|561803765|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155648138|NCT03467945|561803766|FG002|Treatment Period 3|Withdrawal by Subject|2|||
155648139|NCT03467945|561803767|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155648140|NCT02975700|561803772|FG000|Overall Study|Adverse Event|1|||
155648141|NCT02975700|561803772|FG000|Overall Study|Progressive disease|3|||
155648142|NCT02975700|561803772|FG000|Overall Study|Failed screening criteria|2|||
155648143|NCT01541254|561803775|FG000|Overall Study|Withdrawal by Subject|1|||
155648144|NCT01541254|561803775|FG000|Overall Study|excluded - metal allergy|1|||
155349950|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155349951|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155349952|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155349953|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
155349954|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
155349955|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
155349956|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
155349957|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
155349958|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
155349959|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
155349960|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
155349961|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
155349962|NCT00591409|560716145|FG000|Overall Study|Not Treated|0|||
155349963|NCT00591409|560716146|FG001|Overall Study|Not Treated|0|||
155349964|NCT00591409|560716147|FG002|Overall Study|Not Treated|0|||
155349965|NCT00591409|560716148|FG003|Overall Study|Not Treated|0|||
155349966|NCT00591409|560716149|FG004|Overall Study|Not Treated|1|||
155349967|NCT00591409|560716150|FG005|Overall Study|Not Treated|0|||
155349968|NCT00591409|560716151|FG006|Overall Study|Not Treated|0|||
155349969|NCT00591409|560716152|FG007|Overall Study|Not Treated|0|||
155349970|NCT00591409|560716153|FG008|Overall Study|Not Treated|0|||
155349971|NCT00591409|560716154|FG009|Overall Study|Not Treated|1|||
155349972|NCT02853305|560716155|FG000|Overall Study|Death|287|||
155349973|NCT02853305|560716156|FG001|Overall Study|Death|249|||
155349974|NCT02853305|560716157|FG002|Overall Study|Death|300|||
155425375|NCT00484315|560984725|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
155425376|NCT00943683|560984726|FG000|Overall Study|Adverse Event|3|||
155425377|NCT00943683|560984727|FG001|Overall Study|Adverse Event|3|||
155425378|NCT00943683|560984726|FG000|Overall Study|Lost to Follow-up|1|||
155425379|NCT00943683|560984727|FG001|Overall Study|Lost to Follow-up|1|||
155425380|NCT00943683|560984726|FG000|Overall Study|Protocol Violation|1|||
155425381|NCT00943683|560984727|FG001|Overall Study|Protocol Violation|2|||
155425382|NCT00943683|560984726|FG000|Overall Study|Withdrawal by Subject|1|||
155425383|NCT00943683|560984727|FG001|Overall Study|Withdrawal by Subject|0|||
155425384|NCT00943683|560984726|FG000|Overall Study|Patient Moved|1|||
155425385|NCT00943683|560984727|FG001|Overall Study|Patient Moved|0|||
155506170|NCT00326885|561280261|FG000|Overall Study|Hospice withdrew consent|2|||
155506171|NCT04313283|561280262|FG000|Overall Study|did not complete intervention|4|||
155506172|NCT04356573|561280263|FG000|Overall Study|Didn't Qualify|1|||
155506173|NCT04356573|561280264|FG001|Overall Study|Didn't Qualify|0|||
155506174|NCT03650400|561280265|FG000|Overall Study|Study terminated by sponsor|0|||
155506175|NCT03650400|561280266|FG001|Overall Study|Study terminated by sponsor|5|||
155506176|NCT01170364|561280268|FG000|Overall Study|Protocol Violation|4|||
155506177|NCT01170364|561280269|FG001|Overall Study|Protocol Violation|1|||
155506178|NCT04132232|561280270|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
155506179|NCT04132232|561280271|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
155506180|NCT04132232|561280270|FG000|Overall Study|Lost to Follow-up|6|||
155506181|NCT04132232|561280271|FG001|Overall Study|Lost to Follow-up|7|||
155506182|NCT01368276|561280275|FG000|Overall Study|Death|1|||
155506183|NCT01368276|561280276|FG001|Overall Study|Death|10|||
155506184|NCT03341273|561280277|FG000|Overall Study|Lost to Follow-up|7|||
155506185|NCT03341273|561280278|FG001|Overall Study|Lost to Follow-up|7|||
155506186|NCT03341273|561280277|FG000|Overall Study|Withdrawal by Subject|4|||
155506187|NCT03341273|561280278|FG001|Overall Study|Withdrawal by Subject|2|||
155506188|NCT03341273|561280277|FG000|Overall Study|Physician Decision|1|||
155506189|NCT03341273|561280278|FG001|Overall Study|Physician Decision|0|||
155506190|NCT03341273|561280277|FG000|Overall Study|Protocol Violation|0|||
155506191|NCT03341273|561280278|FG001|Overall Study|Protocol Violation|1|||
155506192|NCT03341273|561280277|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
155506193|NCT03341273|561280278|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
155506194|NCT03341273|561280277|FG000|Overall Study|Became ineligible after enrollment|1|||
155506195|NCT03341273|561280278|FG001|Overall Study|Became ineligible after enrollment|0|||
155506196|NCT03341273|561280277|FG000|Overall Study|Not Eligible at Enrollment|0|||
155506197|NCT03341273|561280278|FG001|Overall Study|Not Eligible at Enrollment|1|||
155506198|NCT03341273|561280277|FG000|Overall Study|Participant incarcerated|1|||
155506199|NCT03341273|561280278|FG001|Overall Study|Participant incarcerated|0|||
155349975|NCT02853305|560716155|FG000|Overall Study|Withdrawal by Subject|2|||
155349976|NCT02853305|560716156|FG001|Overall Study|Withdrawal by Subject|8|||
155425386|NCT01565980|560984729|FG000|Overall Study|Death|1|||
155425387|NCT01565980|560984730|FG001|Overall Study|Death|0|||
155349977|NCT02853305|560716157|FG002|Overall Study|Withdrawal by Subject|3|||
155349978|NCT02853305|560716155|FG000|Overall Study|Transferred to Extension Study|46|||
155349979|NCT02853305|560716156|FG001|Overall Study|Transferred to Extension Study|30|||
155425388|NCT01565980|560984729|FG000|Overall Study|Lost to Follow-up|1|||
155506200|NCT02041494|561280279|FG000|Overall Study|Death|1|||
155506201|NCT02041494|561280280|FG001|Overall Study|Death|3|||
155506202|NCT02041494|561280279|FG000|Overall Study|Lost to Follow-up|2|||
155349980|NCT02853305|560716157|FG002|Overall Study|Transferred to Extension Study|25|||
155349981|NCT02853305|560716155|FG000|Overall Study|Did Not Continue on Extension Study|16|||
155349982|NCT02853305|560716156|FG001|Overall Study|Did Not Continue on Extension Study|20|||
155349983|NCT02853305|560716157|FG002|Overall Study|Did Not Continue on Extension Study|24|||
155349984|NCT02381652|560716160|FG000|Overall Study|Withdrawal by Subject|0|||
155349985|NCT02381652|560716161|FG001|Overall Study|Withdrawal by Subject|0|||
155349986|NCT02381652|560716162|FG002|Overall Study|Withdrawal by Subject|1|||
155349987|NCT04772313|560716163|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
155349988|NCT04772313|560716163|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
155349989|NCT01836198|560716164|FG000|Part A, Period 2|Protocol Violation|0|||
155349990|NCT01836198|560716165|FG001|Part A, Period 2|Protocol Violation|1|||
155349991|NCT01836198|560716166|FG002|Part A, Period 2|Protocol Violation|0|||
155349992|NCT02215954|560716167|FG000|Overall Study|Adverse Event|0|||
155349993|NCT02215954|560716168|FG001|Overall Study|Adverse Event|0|||
155349994|NCT02215954|560716169|FG002|Overall Study|Adverse Event|1|||
155349995|NCT02215954|560716167|FG000|Overall Study|Withdrawal by Subject|0|||
155349996|NCT02215954|560716168|FG001|Overall Study|Withdrawal by Subject|0|||
155349997|NCT02215954|560716169|FG002|Overall Study|Withdrawal by Subject|2|||
155349998|NCT02215954|560716167|FG000|Overall Study|Not exposed|1|||
155349999|NCT02215954|560716168|FG001|Overall Study|Not exposed|1|||
155350000|NCT02215954|560716169|FG002|Overall Study|Not exposed|3|||
155350001|NCT00187135|560716174|FG000|Visit One|Withdrawal by Subject|1|||
155350002|NCT00187135|560716175|FG001|Visit One|Withdrawal by Subject|0|||
155350003|NCT00187135|560716176|FG002|Visit One|Withdrawal by Subject|0|||
155350004|NCT00187135|560716177|FG003|Visit One|Withdrawal by Subject|0|||
155350005|NCT00187135|560716178|FG004|Visit One|Withdrawal by Subject|0|||
155350006|NCT00187135|560716179|FG005|Visit One|Withdrawal by Subject|1|||
155350007|NCT00187135|560716174|FG000|Visit One|Physician Decision|3|||
155350008|NCT00187135|560716175|FG001|Visit One|Physician Decision|1|||
155350009|NCT00187135|560716176|FG002|Visit One|Physician Decision|0|||
155350010|NCT00187135|560716177|FG003|Visit One|Physician Decision|0|||
155350011|NCT00187135|560716178|FG004|Visit One|Physician Decision|0|||
155350012|NCT00187135|560716179|FG005|Visit One|Physician Decision|1|||
155350013|NCT00187135|560716174|FG000|Visit Two|Death|0|||
155350014|NCT00187135|560716175|FG001|Visit Two|Death|0|||
155350015|NCT00187135|560716176|FG002|Visit Two|Death|0|||
155350016|NCT00187135|560716177|FG003|Visit Two|Death|1|||
155350017|NCT00187135|560716178|FG004|Visit Two|Death|0|||
155350018|NCT00187135|560716179|FG005|Visit Two|Death|1|||
155350019|NCT00187135|560716174|FG000|Visit Two|Physician Decision|1|||
155350020|NCT00187135|560716175|FG001|Visit Two|Physician Decision|0|||
155350021|NCT00187135|560716176|FG002|Visit Two|Physician Decision|0|||
155350022|NCT00187135|560716177|FG003|Visit Two|Physician Decision|0|||
155350023|NCT00187135|560716178|FG004|Visit Two|Physician Decision|0|||
155425389|NCT01565980|560984730|FG001|Overall Study|Lost to Follow-up|0|||
155425390|NCT01565980|560984729|FG000|Overall Study|health complications|1|||
155425391|NCT01565980|560984730|FG001|Overall Study|health complications|1|||
155350024|NCT00187135|560716179|FG005|Visit Two|Physician Decision|0|||
155350025|NCT00187135|560716174|FG000|Visit Two|Withdrawal by Subject|1|||
155350026|NCT00187135|560716175|FG001|Visit Two|Withdrawal by Subject|1|||
155350027|NCT00187135|560716176|FG002|Visit Two|Withdrawal by Subject|1|||
155350028|NCT00187135|560716177|FG003|Visit Two|Withdrawal by Subject|0|||
155350029|NCT00187135|560716178|FG004|Visit Two|Withdrawal by Subject|1|||
155350030|NCT00187135|560716179|FG005|Visit Two|Withdrawal by Subject|1|||
155350031|NCT00187135|560716174|FG000|Visit Two|Study Discontinued|3|||
155350032|NCT00187135|560716175|FG001|Visit Two|Study Discontinued|2|||
155350033|NCT00187135|560716176|FG002|Visit Two|Study Discontinued|1|||
155350034|NCT00187135|560716177|FG003|Visit Two|Study Discontinued|7|||
155350035|NCT00187135|560716178|FG004|Visit Two|Study Discontinued|5|||
155350036|NCT00187135|560716179|FG005|Visit Two|Study Discontinued|6|||
155350037|NCT00187135|560716174|FG000|Visit Three|Death|0|||
155350038|NCT00187135|560716175|FG001|Visit Three|Death|0|||
155350039|NCT00187135|560716176|FG002|Visit Three|Death|1|||
155350040|NCT00187135|560716177|FG003|Visit Three|Death|0|||
155350041|NCT00187135|560716178|FG004|Visit Three|Death|1|||
155350042|NCT00187135|560716179|FG005|Visit Three|Death|0|||
155350043|NCT00187135|560716174|FG000|Visit Three|Withdrawal by Subject|0|||
155350044|NCT00187135|560716175|FG001|Visit Three|Withdrawal by Subject|1|||
155350045|NCT00187135|560716176|FG002|Visit Three|Withdrawal by Subject|1|||
155350046|NCT00187135|560716177|FG003|Visit Three|Withdrawal by Subject|2|||
155350047|NCT00187135|560716178|FG004|Visit Three|Withdrawal by Subject|0|||
155350048|NCT00187135|560716179|FG005|Visit Three|Withdrawal by Subject|0|||
155350049|NCT00187135|560716174|FG000|Visit Three|Study Discontinued|7|||
155350050|NCT00187135|560716175|FG001|Visit Three|Study Discontinued|6|||
155350051|NCT00187135|560716176|FG002|Visit Three|Study Discontinued|7|||
155350052|NCT00187135|560716177|FG003|Visit Three|Study Discontinued|7|||
155350053|NCT00187135|560716178|FG004|Visit Three|Study Discontinued|7|||
155350054|NCT00187135|560716179|FG005|Visit Three|Study Discontinued|6|||
155350055|NCT00745121|560716183|FG000|Overall Study|Death|3|||
155350056|NCT00745121|560716184|FG001|Overall Study|Death|0|||
155350057|NCT00745121|560716183|FG000|Overall Study|Adverse Event|1|||
155350058|NCT00745121|560716184|FG001|Overall Study|Adverse Event|0|||
155350059|NCT00745121|560716183|FG000|Overall Study|Lost to Follow-up|1|||
155350060|NCT00745121|560716184|FG001|Overall Study|Lost to Follow-up|0|||
155350061|NCT00745121|560716183|FG000|Overall Study|Withdrawal by Subject|4|||
155350062|NCT00745121|560716184|FG001|Overall Study|Withdrawal by Subject|2|||
155350063|NCT03280108|560716185|FG000|Overall Study|Lost to Follow-up|2|||
155350064|NCT03280108|560716186|FG001|Overall Study|Lost to Follow-up|0|||
155350065|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
155350066|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350067|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350068|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350069|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350070|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
155350071|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350072|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350073|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350074|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350075|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
155350076|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350077|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350078|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350079|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350080|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
155350081|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350082|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350083|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155425392|NCT01565980|560984729|FG000|Overall Study|stopped medical treatment|1|||
155425393|NCT01565980|560984730|FG001|Overall Study|stopped medical treatment|0|||
155425394|NCT01565980|560984729|FG000|Overall Study|Withdrawal by Subject|0|||
155425395|NCT01565980|560984730|FG001|Overall Study|Withdrawal by Subject|3|||
155425396|NCT01817790|560984741|FG000|Overall Study|Adverse Event|0|||
155425397|NCT01817790|560984742|FG001|Overall Study|Adverse Event|2|||
155425398|NCT01817790|560984741|FG000|Overall Study|Lost to Follow-up|0|||
155425399|NCT01817790|560984742|FG001|Overall Study|Lost to Follow-up|1|||
155425400|NCT01817790|560984741|FG000|Overall Study|Protocol Violation|2|||
155425401|NCT01817790|560984742|FG001|Overall Study|Protocol Violation|1|||
155425402|NCT01817790|560984741|FG000|Overall Study|Withdrawal by Subject|1|||
155425403|NCT01817790|560984742|FG001|Overall Study|Withdrawal by Subject|3|||
155425404|NCT01817790|560984741|FG000|Overall Study|Other: Could not attend appointment|1|||
155425405|NCT01817790|560984742|FG001|Overall Study|Other: Could not attend appointment|1|||
155425406|NCT01671345|560984743|FG000|Overall Study|Lost to Follow-up|10|||
155425407|NCT01671345|560984744|FG001|Overall Study|Lost to Follow-up|6|||
155425408|NCT01671345|560984743|FG000|Overall Study|visit with non-participating physician|3|||
155425409|NCT01671345|560984744|FG001|Overall Study|visit with non-participating physician|3|||
155425410|NCT03636906|560984745|FG000|Overall Study|Adverse Event|0|||
155425411|NCT03636906|560984746|FG001|Overall Study|Adverse Event|0|||
155425412|NCT03636906|560984747|FG002|Overall Study|Adverse Event|1|||
155425413|NCT03636906|560984745|FG000|Overall Study|Lost to Follow-up|1|||
155425414|NCT03636906|560984746|FG001|Overall Study|Lost to Follow-up|0|||
155425415|NCT03636906|560984747|FG002|Overall Study|Lost to Follow-up|0|||
155425416|NCT03636906|560984745|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
155425417|NCT03636906|560984746|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
155425418|NCT03636906|560984747|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
155506203|NCT02041494|561280280|FG001|Overall Study|Lost to Follow-up|6|||
155350084|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350085|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
155350086|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350087|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350088|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350089|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350090|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
155350091|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350092|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350093|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350094|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350095|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
155350096|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350097|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350098|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350099|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350100|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155350101|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155350102|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
155350103|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
155350104|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
155350105|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155350106|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
155350107|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
155350108|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
155350109|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
155350110|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155350111|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
155350112|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
155350113|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
155350114|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
155350115|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350116|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350117|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350118|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155350119|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155350120|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155350121|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
155648145|NCT01541254|561803775|FG000|Overall Study|enrolled after study closed|1|||
155648146|NCT01541254|561803775|FG000|Overall Study|GI bleed prior to procedure|1|||
155350122|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155350123|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
155350124|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
155350125|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155350126|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155350127|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155350128|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
155350129|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
155350130|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155425419|NCT03636906|560984745|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155425420|NCT03636906|560984746|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155350131|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350132|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350133|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350134|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
155350135|NCT02996097|560716192|FG000|Overall Study|Lost to Follow-up|11|||
155350136|NCT02996097|560716193|FG001|Overall Study|Lost to Follow-up|11|||
155350137|NCT01820637|560716194|FG000|Overall Study|Death|2|||
155350138|NCT01820637|560716194|FG000|Overall Study|Withdrawal by Subject|1|||
155350139|NCT02382406|560716195|FG000|Study Treatment|Disease Progression|8|||
155350140|NCT02382406|560716196|FG001|Study Treatment|Disease Progression|0|||
155350141|NCT02382406|560716197|FG002|Study Treatment|Disease Progression|20|||
155350142|NCT02382406|560716195|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
155350143|NCT02382406|560716196|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
155350144|NCT02382406|560716197|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
155350145|NCT02382406|560716195|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
155350146|NCT02382406|560716196|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
155350147|NCT02382406|560716197|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
155350148|NCT02382406|560716195|FG000|Study Treatment|symptomatic deterioration|1|||
155350149|NCT02382406|560716196|FG001|Study Treatment|symptomatic deterioration|0|||
155350150|NCT02382406|560716197|FG002|Study Treatment|symptomatic deterioration|1|||
155648147|NCT01541254|561803775|FG000|Overall Study|stent not required|1|||
155350151|NCT02382406|560716195|FG000|Study Treatment|Death|0|||
155425421|NCT03636906|560984747|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
155425422|NCT03636906|560984745|FG000|Overall Study|Other|0|||
155425423|NCT03636906|560984746|FG001|Overall Study|Other|0|||
155425424|NCT03636906|560984747|FG002|Overall Study|Other|1|||
155425425|NCT03690869|560984749|FG000|Overall Study|Adverse Event|0|||
155425426|NCT03690869|560984750|FG001|Overall Study|Adverse Event|0|||
155425427|NCT03690869|560984751|FG002|Overall Study|Adverse Event|0|||
155425428|NCT03690869|560984752|FG003|Overall Study|Adverse Event|1|||
155425429|NCT03690869|560984753|FG004|Overall Study|Adverse Event|0|||
155425430|NCT03690869|560984754|FG005|Overall Study|Adverse Event|0|||
155425431|NCT03690869|560984755|FG006|Overall Study|Adverse Event|0|||
155425432|NCT03690869|560984756|FG007|Overall Study|Adverse Event|1|||
155425433|NCT03690869|560984757|FG008|Overall Study|Adverse Event|0|||
155425434|NCT03690869|560984758|FG009|Overall Study|Adverse Event|1|||
155425435|NCT03690869|560984749|FG000|Overall Study|Death|1|||
155425436|NCT03690869|560984750|FG001|Overall Study|Death|1|||
155425437|NCT03690869|560984751|FG002|Overall Study|Death|1|||
155425438|NCT03690869|560984752|FG003|Overall Study|Death|4|||
155425439|NCT03690869|560984753|FG004|Overall Study|Death|2|||
155425440|NCT03690869|560984754|FG005|Overall Study|Death|5|||
155425441|NCT03690869|560984755|FG006|Overall Study|Death|3|||
155425442|NCT03690869|560984756|FG007|Overall Study|Death|2|||
155425443|NCT03690869|560984757|FG008|Overall Study|Death|0|||
155425444|NCT03690869|560984758|FG009|Overall Study|Death|3|||
155425445|NCT03690869|560984749|FG000|Overall Study|Lost to Follow-up|0|||
155425446|NCT03690869|560984750|FG001|Overall Study|Lost to Follow-up|0|||
155425447|NCT03690869|560984751|FG002|Overall Study|Lost to Follow-up|1|||
155425448|NCT03690869|560984752|FG003|Overall Study|Lost to Follow-up|0|||
155425449|NCT03690869|560984753|FG004|Overall Study|Lost to Follow-up|0|||
155425450|NCT03690869|560984754|FG005|Overall Study|Lost to Follow-up|0|||
155425451|NCT03690869|560984755|FG006|Overall Study|Lost to Follow-up|0|||
155425452|NCT03690869|560984756|FG007|Overall Study|Lost to Follow-up|0|||
155425453|NCT03690869|560984757|FG008|Overall Study|Lost to Follow-up|0|||
155425454|NCT03690869|560984758|FG009|Overall Study|Lost to Follow-up|0|||
155425455|NCT03690869|560984749|FG000|Overall Study|Other Treatment|1|||
155350152|NCT02382406|560716196|FG001|Study Treatment|Death|0|||
155425456|NCT03690869|560984750|FG001|Overall Study|Other Treatment|1|||
155425457|NCT03690869|560984751|FG002|Overall Study|Other Treatment|1|||
155425458|NCT03690869|560984752|FG003|Overall Study|Other Treatment|2|||
155425459|NCT03690869|560984753|FG004|Overall Study|Other Treatment|3|||
155425460|NCT03690869|560984754|FG005|Overall Study|Other Treatment|1|||
155425461|NCT03690869|560984755|FG006|Overall Study|Other Treatment|2|||
155425462|NCT03690869|560984756|FG007|Overall Study|Other Treatment|7|||
155506204|NCT02041494|561280279|FG000|Overall Study|study terminated|16|||
155506205|NCT02041494|561280280|FG001|Overall Study|study terminated|11|||
155648148|NCT01541254|561803775|FG000|Overall Study|alternate stent used|1|||
155648149|NCT05737745|561803776|FG000|Overall Study|Withdrawal by Subject|0|||
155648150|NCT05737745|561803777|FG001|Overall Study|Withdrawal by Subject|6|||
155506206|NCT04126733|561280281|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
155506207|NCT04126733|561280281|FG000|Treatment Period|Adverse Event|8|||
155506208|NCT04126733|561280281|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
155506209|NCT04126733|561280281|FG000|Treatment Period|Physician Decision|5|||
155506210|NCT04126733|561280281|FG000|Treatment Period|Death|1|||
155506211|NCT04126733|561280281|FG000|Treatment Period|Other Reasons|2|||
155506212|NCT04126733|561280281|FG000|Active Follow-up Period|Death|13|||
155506213|NCT04126733|561280281|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
155506214|NCT04126733|561280281|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
155506215|NCT04126733|561280281|FG000|Active Follow-up Period|Other Reasons|1|||
155506216|NCT04126733|561280281|FG000|Long-term Follow-up Period|Death|22|||
155506217|NCT04126733|561280281|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
155506218|NCT04126733|561280281|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
155506219|NCT03726437|561280282|FG000|Overall Study|Lost to Follow-up|85|||
155506220|NCT03726437|561280283|FG001|Overall Study|Lost to Follow-up|76|||
155506221|NCT00267007|561280284|FG000|Overall Study|Withdrawal by Subject|6|||
155506222|NCT00267007|561280285|FG001|Overall Study|Withdrawal by Subject|0|||
155506223|NCT00267007|561280284|FG000|Overall Study|Lost to Follow-up|1|||
155506224|NCT00267007|561280285|FG001|Overall Study|Lost to Follow-up|0|||
155506225|NCT00267007|561280284|FG000|Overall Study|Non-compliance|0|||
155506226|NCT00267007|561280285|FG001|Overall Study|Non-compliance|1|||
155506227|NCT00267007|561280284|FG000|Overall Study|Adverse Event|1|||
155506228|NCT00267007|561280285|FG001|Overall Study|Adverse Event|0|||
155350153|NCT02382406|560716197|FG002|Study Treatment|Death|2|||
155506229|NCT04133519|561280291|FG000|Overall Study|Withdrawal by Subject|5|||
155506230|NCT04133519|561280292|FG001|Overall Study|Withdrawal by Subject|4|||
155506231|NCT04133519|561280291|FG000|Overall Study|Protocol Violation|0|||
155506232|NCT04133519|561280292|FG001|Overall Study|Protocol Violation|1|||
155648151|NCT05737745|561803778|FG002|Overall Study|Withdrawal by Subject|1|||
155506233|NCT04133519|561280291|FG000|Overall Study|Never started treatment|1|||
155506234|NCT04133519|561280292|FG001|Overall Study|Never started treatment|1|||
155648152|NCT02569242|561803779|FG000|Overall Study|Death|1|||
155350154|NCT02382406|560716195|FG000|Follow up|Death|11|||
155350155|NCT02382406|560716196|FG001|Follow up|Death|0|||
155506235|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506236|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506237|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506238|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
155506239|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155350156|NCT02382406|560716197|FG002|Follow up|Death|19|||
155350157|NCT02382406|560716195|FG000|Follow up|Symptomatic deterioration|1|||
155350158|NCT02382406|560716196|FG001|Follow up|Symptomatic deterioration|0|||
155350159|NCT02382406|560716197|FG002|Follow up|Symptomatic deterioration|1|||
155350160|NCT02382406|560716195|FG000|Follow up|Patient Refused Follow-up|1|||
155350161|NCT02382406|560716196|FG001|Follow up|Patient Refused Follow-up|0|||
155350162|NCT02382406|560716197|FG002|Follow up|Patient Refused Follow-up|0|||
155350163|NCT02382406|560716195|FG000|Follow up|Study Terminated|1|||
155350164|NCT02382406|560716196|FG001|Follow up|Study Terminated|0|||
155350165|NCT02382406|560716197|FG002|Follow up|Study Terminated|8|||
155350166|NCT02382406|560716195|FG000|Follow up|Withdrawal by Subject|0|||
155350167|NCT02382406|560716196|FG001|Follow up|Withdrawal by Subject|0|||
155350168|NCT02382406|560716197|FG002|Follow up|Withdrawal by Subject|2|||
155350169|NCT01713998|560716198|FG000|Overall Study|Lost to Follow-up|2|||
155350170|NCT01713998|560716199|FG001|Overall Study|Lost to Follow-up|0|||
155350171|NCT01713998|560716200|FG002|Overall Study|Lost to Follow-up|2|||
155350172|NCT01713998|560716198|FG000|Overall Study|Withdrawal by Subject|1|||
155350173|NCT01713998|560716199|FG001|Overall Study|Withdrawal by Subject|0|||
155350174|NCT01713998|560716200|FG002|Overall Study|Withdrawal by Subject|0|||
155350175|NCT00640042|560716201|FG000|Enrollment|Did not receive study drug|83|||
155350176|NCT02391116|560716202|FG000|Treatment|Withdrawal by Subject|1|||
155350177|NCT02391116|560716202|FG000|Treatment|Protocol Violation|1|||
155350178|NCT02391116|560716202|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
155350179|NCT02391116|560716202|FG000|Treatment|AE with Clinical PD|3|||
155350180|NCT02391116|560716202|FG000|Safety Follow-up|Adverse Event|1|||
155350181|NCT02391116|560716202|FG000|Safety Follow-up|Withdrawal by Subject|4|||
155350182|NCT02391116|560716202|FG000|Safety Follow-up|Switching to Other Therapy|4|||
155350183|NCT02391116|560716202|FG000|Safety Follow-up|No Follow Up|1|||
155350184|NCT02391116|560716202|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
155350185|NCT02391116|560716202|FG000|Active Follow-up|Withdrawal by Subject|1|||
155350186|NCT02391116|560716202|FG000|Active Follow-up|Switching to Other Therapy|2|||
155350187|NCT02391116|560716202|FG000|Survival Follow-up|Withdrawal by Subject|3|||
155350188|NCT02391116|560716202|FG000|Survival Follow-up|Switching to Other Therapy|1|||
155350189|NCT00607789|560716204|FG000|Overall Study|Adverse Event|3|||
155350190|NCT00607789|560716205|FG001|Overall Study|Adverse Event|0|||
155350191|NCT00607789|560716204|FG000|Overall Study|Lack of Efficacy|0|||
155350192|NCT00607789|560716205|FG001|Overall Study|Lack of Efficacy|1|||
155350193|NCT00607789|560716204|FG000|Overall Study|Inadequate adherence|3|||
155350194|NCT00607789|560716205|FG001|Overall Study|Inadequate adherence|0|||
155506240|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506241|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506242|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506243|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506244|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155506245|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155506246|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155506247|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Adverse Event|1|||
155350195|NCT00607789|560716204|FG000|Overall Study|Lost to Follow-up|0|||
155350196|NCT00607789|560716205|FG001|Overall Study|Lost to Follow-up|5|||
155350197|NCT00607789|560716204|FG000|Overall Study|Withdrawal by Subject|1|||
155350198|NCT00607789|560716205|FG001|Overall Study|Withdrawal by Subject|0|||
155350199|NCT06016127|560716208|FG000|Overall Study|Withdrawal by Subject|4|||
155350200|NCT06016127|560716209|FG001|Overall Study|Withdrawal by Subject|3|||
155350201|NCT03340766|560716214|FG000|Overall Study|Withdrawal by Subject|2|||
155350202|NCT03340766|560716215|FG001|Overall Study|Withdrawal by Subject|1|||
155350203|NCT03340766|560716216|FG002|Overall Study|Withdrawal by Subject|3|||
155350204|NCT03340766|560716214|FG000|Overall Study|Lost to Follow-up|0|||
155350205|NCT03340766|560716215|FG001|Overall Study|Lost to Follow-up|0|||
155350206|NCT03340766|560716216|FG002|Overall Study|Lost to Follow-up|1|||
155350207|NCT03340766|560716214|FG000|Overall Study|Death|6|||
155350208|NCT03340766|560716215|FG001|Overall Study|Death|7|||
155350209|NCT03340766|560716216|FG002|Overall Study|Death|4|||
155350210|NCT00853021|560716217|FG000|Overall Study|Adverse Event|2|||
155350211|NCT00853021|560716217|FG000|Overall Study|Withdrawal by Subject|2|||
155350212|NCT00853021|560716217|FG000|Overall Study|Death|1|||
155350213|NCT02864147|560716218|FG000|Overall Study|Withdrawal by Subject|3|||
155350214|NCT02864147|560716219|FG001|Overall Study|Withdrawal by Subject|2|||
155350215|NCT02864147|560716220|FG002|Overall Study|Withdrawal by Subject|1|||
155350216|NCT02864147|560716218|FG000|Overall Study|Lost to Follow-up|0|||
155350217|NCT02864147|560716219|FG001|Overall Study|Lost to Follow-up|4|||
155350218|NCT02864147|560716220|FG002|Overall Study|Lost to Follow-up|0|||
155350219|NCT02864147|560716218|FG000|Overall Study|Adverse Event|0|||
155350220|NCT02864147|560716219|FG001|Overall Study|Adverse Event|1|||
155350221|NCT02864147|560716220|FG002|Overall Study|Adverse Event|0|||
155350222|NCT02864147|560716218|FG000|Overall Study|Pregnancy|4|||
155350223|NCT02864147|560716219|FG001|Overall Study|Pregnancy|0|||
155350224|NCT02864147|560716220|FG002|Overall Study|Pregnancy|0|||
155350225|NCT02864147|560716218|FG000|Overall Study|Physician Decision|0|||
155350226|NCT02864147|560716219|FG001|Overall Study|Physician Decision|0|||
155350227|NCT02864147|560716220|FG002|Overall Study|Physician Decision|1|||
155350228|NCT02864147|560716218|FG000|Overall Study|Opted for excisional procedures|0|||
155350229|NCT02864147|560716219|FG001|Overall Study|Opted for excisional procedures|0|||
155350230|NCT02864147|560716220|FG002|Overall Study|Opted for excisional procedures|3|||
155350231|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
155350232|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
155350233|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
155350234|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
155350235|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
155350236|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
155350237|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
155350238|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
155350239|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
155350240|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
155350241|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
155648153|NCT02569242|561803780|FG001|Overall Study|Death|0|||
155648154|NCT02569242|561803779|FG000|Overall Study|Withdrawal by Subject|0|||
155350242|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
155350243|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
155350244|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
155350245|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
155425463|NCT03690869|560984757|FG008|Overall Study|Other Treatment|0|||
155425464|NCT03690869|560984758|FG009|Overall Study|Other Treatment|3|||
155425465|NCT03690869|560984749|FG000|Overall Study|Physician Decision|0|||
155425466|NCT03690869|560984750|FG001|Overall Study|Physician Decision|1|||
155425467|NCT03690869|560984751|FG002|Overall Study|Physician Decision|0|||
155425468|NCT03690869|560984752|FG003|Overall Study|Physician Decision|0|||
155425469|NCT03690869|560984753|FG004|Overall Study|Physician Decision|0|||
155425470|NCT03690869|560984754|FG005|Overall Study|Physician Decision|0|||
155425471|NCT03690869|560984755|FG006|Overall Study|Physician Decision|0|||
155425472|NCT03690869|560984756|FG007|Overall Study|Physician Decision|0|||
155425473|NCT03690869|560984757|FG008|Overall Study|Physician Decision|0|||
155425474|NCT03690869|560984758|FG009|Overall Study|Physician Decision|0|||
155425475|NCT03690869|560984749|FG000|Overall Study|Progressive Disease|1|||
155425476|NCT03690869|560984750|FG001|Overall Study|Progressive Disease|2|||
155425477|NCT03690869|560984751|FG002|Overall Study|Progressive Disease|0|||
155425478|NCT03690869|560984752|FG003|Overall Study|Progressive Disease|1|||
155425479|NCT03690869|560984753|FG004|Overall Study|Progressive Disease|0|||
155425480|NCT03690869|560984754|FG005|Overall Study|Progressive Disease|0|||
155425481|NCT03690869|560984755|FG006|Overall Study|Progressive Disease|0|||
155425482|NCT03690869|560984756|FG007|Overall Study|Progressive Disease|0|||
155425483|NCT03690869|560984757|FG008|Overall Study|Progressive Disease|1|||
155425484|NCT03690869|560984758|FG009|Overall Study|Progressive Disease|1|||
155425485|NCT03690869|560984749|FG000|Overall Study|Subject Decision|0|||
155425486|NCT03690869|560984750|FG001|Overall Study|Subject Decision|0|||
155425487|NCT03690869|560984751|FG002|Overall Study|Subject Decision|0|||
155425488|NCT03690869|560984752|FG003|Overall Study|Subject Decision|1|||
155425489|NCT03690869|560984753|FG004|Overall Study|Subject Decision|0|||
155425490|NCT03690869|560984754|FG005|Overall Study|Subject Decision|0|||
155425491|NCT03690869|560984755|FG006|Overall Study|Subject Decision|0|||
155425492|NCT03690869|560984756|FG007|Overall Study|Subject Decision|1|||
155425493|NCT03690869|560984757|FG008|Overall Study|Subject Decision|0|||
155648155|NCT02569242|561803780|FG001|Overall Study|Withdrawal by Subject|1|||
155648156|NCT03651336|561803781|FG000|Overall Study|Withdrawal by Subject|4|||
155425494|NCT03690869|560984758|FG009|Overall Study|Subject Decision|0|||
155425495|NCT04280081|560984759|FG000|Overall Study|Adverse Event|4|||
155425496|NCT04280081|560984759|FG000|Overall Study|Death|2|||
155425497|NCT04280081|560984759|FG000|Overall Study|Progressive Disease|6|||
155425498|NCT03263806|560986584|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
155425499|NCT03263806|560986585|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
155506248|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Adverse Event|1|||
155506249|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Adverse Event|1|||
155506250|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Adverse Event|1|||
155506251|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Adverse Event|0|||
155506252|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Adverse Event|0|||
155506253|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Adverse Event|0|||
155506254|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Adverse Event|0|||
155506255|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
155506256|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
155506257|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
155506258|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
155506259|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
155506260|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
155506261|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
155506262|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
155506263|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
155506264|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
155506265|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506266|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506267|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506268|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
155350246|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
155350247|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
155350248|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
155350249|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
155350250|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
155350251|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
155350252|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
155350253|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
155350254|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
155350255|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
155350256|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
155350257|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
155350258|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155350259|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155350260|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
155350261|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155350262|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155350263|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
155350264|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155350265|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155350266|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
155350267|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155350268|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155350269|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
155350270|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
155350271|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
155350272|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
155350273|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155350274|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155350275|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
155506269|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
155506270|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
155506271|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506272|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
155506273|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506274|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
155506275|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
155506276|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
155350276|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155350277|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155350278|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
155350279|NCT00240097|560716224|FG000|Part I|Adverse Event|1|||
155350280|NCT00240097|560716224|FG000|Part I|Death|1|||
155350281|NCT00240097|560716224|FG000|Part I|histology|1|||
155350282|NCT00240097|560716224|FG000|Part I|unevaluable|1|||
155350283|NCT00240097|560716224|FG000|Part II|did not continue from Part I|23|||
155350284|NCT00981578|560716228|FG000|Overall Study|Death|1|||
155350285|NCT00981578|560716228|FG000|Overall Study|Withdrawal by Subject|2|||
155350286|NCT01294358|560716231|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350287|NCT01294358|560716232|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
155350288|NCT01294358|560716233|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350289|NCT01294358|560716234|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350290|NCT01294358|560716235|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350291|NCT01294358|560716231|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350292|NCT01294358|560716232|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350293|NCT01294358|560716233|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
155350294|NCT01294358|560716234|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350295|NCT01294358|560716235|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350296|NCT01294358|560716231|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350297|NCT01294358|560716232|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350298|NCT01294358|560716233|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350299|NCT01294358|560716234|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
155350300|NCT01294358|560716235|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350301|NCT01294358|560716231|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350302|NCT01294358|560716232|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350303|NCT01294358|560716233|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350304|NCT01294358|560716234|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350305|NCT01294358|560716235|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
155350306|NCT02963922|560716236|FG000|Overall Study|Adverse Event|15|||
155350307|NCT02963922|560716237|FG001|Overall Study|Adverse Event|6|||
155350308|NCT02963922|560716236|FG000|Overall Study|Protocol deviation|6|||
155350309|NCT02963922|560716237|FG001|Overall Study|Protocol deviation|6|||
155350310|NCT02963922|560716236|FG000|Overall Study|Lack of Efficacy|1|||
155350311|NCT02963922|560716237|FG001|Overall Study|Lack of Efficacy|1|||
155350312|NCT02963922|560716236|FG000|Overall Study|Lost to Follow-up|2|||
155350313|NCT02963922|560716237|FG001|Overall Study|Lost to Follow-up|3|||
155350314|NCT02963922|560716236|FG000|Overall Study|Other|8|||
155350315|NCT02963922|560716237|FG001|Overall Study|Other|14|||
155350316|NCT01180790|560716247|FG000|Overall Study|Adverse Event|1|||
155350317|NCT01180790|560716248|FG001|Overall Study|Adverse Event|1|||
155350318|NCT01180790|560716249|FG002|Overall Study|Adverse Event|2|||
155350319|NCT01180790|560716250|FG003|Overall Study|Adverse Event|0|||
155350320|NCT01180790|560716251|FG004|Overall Study|Adverse Event|1|||
155350321|NCT01180790|560716252|FG005|Overall Study|Adverse Event|3|||
155350322|NCT01180790|560716253|FG006|Overall Study|Adverse Event|0|||
155350323|NCT01180790|560716247|FG000|Overall Study|Withdrawal by Subject|3|||
155350324|NCT01180790|560716248|FG001|Overall Study|Withdrawal by Subject|0|||
155350325|NCT01180790|560716249|FG002|Overall Study|Withdrawal by Subject|5|||
155350326|NCT01180790|560716250|FG003|Overall Study|Withdrawal by Subject|0|||
155350327|NCT01180790|560716251|FG004|Overall Study|Withdrawal by Subject|2|||
155350328|NCT01180790|560716252|FG005|Overall Study|Withdrawal by Subject|1|||
155350329|NCT01180790|560716253|FG006|Overall Study|Withdrawal by Subject|0|||
155350330|NCT01180790|560716247|FG000|Overall Study|Lost to Follow-up|3|||
155350331|NCT01180790|560716248|FG001|Overall Study|Lost to Follow-up|1|||
155350332|NCT01180790|560716249|FG002|Overall Study|Lost to Follow-up|0|||
155350333|NCT01180790|560716250|FG003|Overall Study|Lost to Follow-up|2|||
155350334|NCT01180790|560716251|FG004|Overall Study|Lost to Follow-up|1|||
155350335|NCT01180790|560716252|FG005|Overall Study|Lost to Follow-up|0|||
155350336|NCT01180790|560716253|FG006|Overall Study|Lost to Follow-up|1|||
155350337|NCT01180790|560716247|FG000|Overall Study|Physician Decision|1|||
155350338|NCT01180790|560716248|FG001|Overall Study|Physician Decision|0|||
155350339|NCT01180790|560716249|FG002|Overall Study|Physician Decision|0|||
155350340|NCT01180790|560716250|FG003|Overall Study|Physician Decision|1|||
155350341|NCT01180790|560716251|FG004|Overall Study|Physician Decision|0|||
155350342|NCT01180790|560716252|FG005|Overall Study|Physician Decision|0|||
155350343|NCT01180790|560716253|FG006|Overall Study|Physician Decision|0|||
155350344|NCT01180790|560716247|FG000|Overall Study|Lack of Efficacy|1|||
155350345|NCT01180790|560716248|FG001|Overall Study|Lack of Efficacy|2|||
155350346|NCT01180790|560716249|FG002|Overall Study|Lack of Efficacy|5|||
155350347|NCT01180790|560716250|FG003|Overall Study|Lack of Efficacy|6|||
155350348|NCT01180790|560716251|FG004|Overall Study|Lack of Efficacy|1|||
155350349|NCT01180790|560716252|FG005|Overall Study|Lack of Efficacy|3|||
155350350|NCT01180790|560716253|FG006|Overall Study|Lack of Efficacy|0|||
155350351|NCT01180790|560716247|FG000|Overall Study|compliance|0|||
155350352|NCT01180790|560716248|FG001|Overall Study|compliance|1|||
155350353|NCT01180790|560716249|FG002|Overall Study|compliance|0|||
155350354|NCT01180790|560716250|FG003|Overall Study|compliance|0|||
155350355|NCT01180790|560716251|FG004|Overall Study|compliance|0|||
155350356|NCT01180790|560716252|FG005|Overall Study|compliance|0|||
155350357|NCT01180790|560716253|FG006|Overall Study|compliance|0|||
155350358|NCT01180790|560716247|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350359|NCT01180790|560716248|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350360|NCT01180790|560716249|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
155350361|NCT01180790|560716250|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350362|NCT01180790|560716251|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350363|NCT01180790|560716252|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350364|NCT01180790|560716253|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350365|NCT00655668|560716254|FG000|Overall Study|Adverse Event|6|||
155350366|NCT00655668|560716254|FG000|Overall Study|Death|5|||
155350367|NCT00655668|560716254|FG000|Overall Study|Disease Progression|27|||
155350368|NCT00655668|560716254|FG000|Overall Study|Study Terminated|9|||
155350369|NCT00655668|560716254|FG000|Overall Study|Other|1|||
155350370|NCT00655668|560716254|FG000|Overall Study|New Lymphoma Treatment Started|4|||
155350371|NCT00655668|560716254|FG000|Overall Study|Withdrawal by Subject|2|||
155350372|NCT02335242|560716255|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
155350373|NCT02335242|560716256|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
155350374|NCT02335242|560716255|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
155350375|NCT02335242|560716256|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155350376|NCT02335242|560716255|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
155350377|NCT02335242|560716256|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
155350378|NCT03840148|560716257|FG000|Study Drug Disposition|Adverse Event|13|||
155350379|NCT03840148|560716258|FG001|Study Drug Disposition|Adverse Event|2|||
155350380|NCT03840148|560716257|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
155350381|NCT03840148|560716258|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
155350382|NCT03840148|560716257|FG000|Study Drug Disposition|Lack of Efficacy|3|||
155648157|NCT01125748|561803783|FG000|Overall Study|Adverse Event|0|||
155648158|NCT01125748|561803784|FG001|Overall Study|Adverse Event|2|||
155648159|NCT01125748|561803783|FG000|Overall Study|Lost to Follow-up|0|||
155648160|NCT01125748|561803784|FG001|Overall Study|Lost to Follow-up|1|||
155648161|NCT01125748|561803783|FG000|Overall Study|Physician Decision|8|||
155350383|NCT03840148|560716258|FG001|Study Drug Disposition|Lack of Efficacy|0|||
155350384|NCT03840148|560716257|FG000|Study Drug Disposition|Physician Decision|2|||
155350385|NCT03840148|560716258|FG001|Study Drug Disposition|Physician Decision|0|||
155350386|NCT03840148|560716257|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
155350387|NCT03840148|560716258|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
155350388|NCT03840148|560716257|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
155350389|NCT03840148|560716258|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
155350390|NCT03840148|560716257|FG000|Study Completion Disposition|Physician Decision|2|||
155350391|NCT03840148|560716258|FG001|Study Completion Disposition|Physician Decision|0|||
155350392|NCT03840148|560716257|FG000|Study Completion Disposition|Covid-19 related|2|||
155350393|NCT03840148|560716258|FG001|Study Completion Disposition|Covid-19 related|0|||
155350394|NCT03840148|560716257|FG000|Study Completion Disposition|Lost to Follow-up|1|||
155350395|NCT03840148|560716258|FG001|Study Completion Disposition|Lost to Follow-up|1|||
155350396|NCT03840148|560716257|FG000|Study Completion Disposition|Death|1|||
155350397|NCT03840148|560716258|FG001|Study Completion Disposition|Death|0|||
155350398|NCT03840148|560716257|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
155350399|NCT03840148|560716258|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
155350400|NCT03615404|560716259|FG000|Overall Study|Death|1|||
155350401|NCT03615404|560716259|FG000|Overall Study|vaccine did not pass quality assurance|1|||
155350402|NCT00257556|560716260|FG000|Overall Study|Adverse Event|1|||
155350403|NCT00257556|560716261|FG001|Overall Study|Adverse Event|4|||
155350404|NCT00257556|560716260|FG000|Overall Study|Physician Decision|6|||
155350405|NCT00257556|560716261|FG001|Overall Study|Physician Decision|0|||
155350406|NCT00257556|560716260|FG000|Overall Study|Did not meet hCG criterion|3|||
155648162|NCT01125748|561803784|FG001|Overall Study|Physician Decision|7|||
155350407|NCT00257556|560716261|FG001|Overall Study|Did not meet hCG criterion|0|||
155350408|NCT00257556|560716260|FG000|Overall Study|other reason|4|||
155350409|NCT00257556|560716261|FG001|Overall Study|other reason|6|||
155350410|NCT03873038|560716262|FG000|Part 2|Withdrawal by Subject|0|||
155350411|NCT03873038|560716263|FG001|Part 2|Withdrawal by Subject|0|||
155350412|NCT03873038|560716264|FG002|Part 2|Withdrawal by Subject|0|||
155350413|NCT03873038|560716265|FG003|Part 2|Withdrawal by Subject|0|||
155350414|NCT03873038|560716266|FG004|Part 2|Withdrawal by Subject|0|||
155350415|NCT03873038|560716267|FG005|Part 2|Withdrawal by Subject|1|||
155350416|NCT03873038|560716262|FG000|Part 2|Unknon|0|||
155350417|NCT03873038|560716263|FG001|Part 2|Unknon|0|||
155350418|NCT03873038|560716264|FG002|Part 2|Unknon|0|||
155350419|NCT03873038|560716265|FG003|Part 2|Unknon|0|||
155350420|NCT03873038|560716266|FG004|Part 2|Unknon|1|||
155350421|NCT03873038|560716267|FG005|Part 2|Unknon|0|||
155350422|NCT04222088|560716269|FG000|Overall Study|Lost to Follow-up|5|||
155350423|NCT04222088|560716270|FG001|Overall Study|Lost to Follow-up|1|||
155350424|NCT04222088|560716269|FG000|Overall Study|Withdrawal by Subject|4|||
155350425|NCT04222088|560716270|FG001|Overall Study|Withdrawal by Subject|0|||
155350426|NCT00595764|560716271|FG000|Overall Study|Protocol Violation|24|||
155350427|NCT00595764|560716272|FG001|Overall Study|Protocol Violation|19|||
155350428|NCT00595764|560716271|FG000|Overall Study|Missed Medication >1 week|10|||
155350429|NCT00595764|560716272|FG001|Overall Study|Missed Medication >1 week|17|||
155350430|NCT00595764|560716271|FG000|Overall Study|Missed 3 PM visits|1|||
155350431|NCT00595764|560716272|FG001|Overall Study|Missed 3 PM visits|7|||
155425500|NCT03263806|560986584|FG000|Overall Study|Withdrawal by Subject|0|||
155425501|NCT03263806|560986585|FG001|Overall Study|Withdrawal by Subject|1|||
155425502|NCT03263806|560986584|FG000|Overall Study|Study Termination|5|||
155425503|NCT03263806|560986585|FG001|Overall Study|Study Termination|6|||
155425504|NCT00023322|560986592|FG000|Overall Study|Lost to Follow-up|1|||
155425505|NCT01609933|560986598|FG000|Overall Study|Adverse Event|1|||
155425506|NCT01609933|560986598|FG000|Overall Study|Withdrawal by Subject|3|||
155425507|NCT01252966|560986599|FG000|Overall Study|Lost to Follow-up|16|||
155425508|NCT01252966|560986600|FG001|Overall Study|Lost to Follow-up|10|||
155425509|NCT01252966|560986599|FG000|Overall Study|Withdrawal by Subject|7|||
155425510|NCT01252966|560986600|FG001|Overall Study|Withdrawal by Subject|3|||
155425511|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
155425512|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
155425513|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
155425514|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
155425515|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
155425516|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
155425517|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
155425518|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
155425519|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
155425520|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
155425521|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
155425522|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
155425523|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
155425524|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
155425525|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
155425526|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
155425527|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
155425528|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
155425529|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
155506277|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155506278|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155425530|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
155425531|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
155506279|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155350432|NCT00595764|560716271|FG000|Overall Study|Withdrawal by Subject|4|||
155350433|NCT00595764|560716272|FG001|Overall Study|Withdrawal by Subject|0|||
155350434|NCT03849300|560716273|FG000|Overall Study|move out to different area|1|||
155350435|NCT03849300|560716274|FG001|Overall Study|move out to different area|3|||
155350436|NCT03849300|560716275|FG002|Overall Study|move out to different area|1|||
155425532|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
155350437|NCT03849300|560716276|FG003|Overall Study|move out to different area|4|||
155350438|NCT03849300|560716273|FG000|Overall Study|scheduling/transportation conflict|4|||
155350439|NCT03849300|560716274|FG001|Overall Study|scheduling/transportation conflict|4|||
155350440|NCT03849300|560716275|FG002|Overall Study|scheduling/transportation conflict|3|||
155506280|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155350441|NCT03849300|560716276|FG003|Overall Study|scheduling/transportation conflict|2|||
155350442|NCT04839289|560716277|FG000|Overall Study|Withdrawal by Subject|1|||
155350443|NCT04839289|560716278|FG001|Overall Study|Withdrawal by Subject|0|||
155350444|NCT00663923|560716281|FG000|Overall Study|Lost to Follow-up|2|||
155350445|NCT02785900|560716282|FG000|Overall Study|Study Termination by Sponsor|64|||
155350446|NCT02785900|560716283|FG001|Overall Study|Study Termination by Sponsor|81|||
155350447|NCT02785900|560716282|FG000|Overall Study|Death|46|||
155350448|NCT02785900|560716283|FG001|Overall Study|Death|32|||
155350449|NCT02785900|560716282|FG000|Overall Study|Withdrawal by Subject|4|||
155350450|NCT02785900|560716283|FG001|Overall Study|Withdrawal by Subject|8|||
155350451|NCT02785900|560716282|FG000|Overall Study|Physician Decision|3|||
155350452|NCT02785900|560716283|FG001|Overall Study|Physician Decision|2|||
155350453|NCT04341584|560716284|FG000|Overall Study|Withdrew consent|0|||
155350454|NCT04341584|560716285|FG001|Overall Study|Withdrew consent|2|||
155350455|NCT04341584|560716286|FG002|Overall Study|Withdrew consent|2|||
155350456|NCT04341584|560716287|FG003|Overall Study|Withdrew consent|1|||
155350457|NCT00497198|560716288|FG000|Overall Study|Adverse Event|4|||
155350458|NCT00497198|560716289|FG001|Overall Study|Adverse Event|2|||
155350459|NCT00497198|560716288|FG000|Overall Study|Physician Decision|1|||
155350460|NCT00497198|560716289|FG001|Overall Study|Physician Decision|2|||
155350461|NCT00497198|560716288|FG000|Overall Study|Withdrawal by Subject|0|||
155350462|NCT00497198|560716289|FG001|Overall Study|Withdrawal by Subject|1|||
155350463|NCT01772147|560717976|FG000|Overall Study|Adverse Event|13|||
155350464|NCT01772147|560717977|FG001|Overall Study|Adverse Event|10|||
155350465|NCT01772147|560717978|FG002|Overall Study|Adverse Event|6|||
155350466|NCT01772147|560717976|FG000|Overall Study|Withdrew Consent|7|||
155350467|NCT01772147|560717977|FG001|Overall Study|Withdrew Consent|8|||
155350468|NCT01772147|560717978|FG002|Overall Study|Withdrew Consent|4|||
155350469|NCT01772147|560717976|FG000|Overall Study|Lost to Follow-up|1|||
155350470|NCT01772147|560717977|FG001|Overall Study|Lost to Follow-up|0|||
155350471|NCT01772147|560717978|FG002|Overall Study|Lost to Follow-up|1|||
155350472|NCT01772147|560717976|FG000|Overall Study|Protocol Deviation|2|||
155350473|NCT01772147|560717977|FG001|Overall Study|Protocol Deviation|1|||
155350474|NCT01772147|560717978|FG002|Overall Study|Protocol Deviation|1|||
155350475|NCT01772147|560717976|FG000|Overall Study|Lack of Efficacy|8|||
155350476|NCT01772147|560717977|FG001|Overall Study|Lack of Efficacy|6|||
155350477|NCT01772147|560717978|FG002|Overall Study|Lack of Efficacy|6|||
155350478|NCT00796614|560717986|FG000|Overall Study|Adverse Event|1|||
155350479|NCT00796614|560717987|FG001|Overall Study|Adverse Event|2|||
155350480|NCT00796614|560717988|FG002|Overall Study|Adverse Event|0|||
155350481|NCT00796614|560717989|FG003|Overall Study|Adverse Event|0|||
155506281|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155350482|NCT00796614|560717986|FG000|Overall Study|Protocol Violation|0|||
155350483|NCT00796614|560717987|FG001|Overall Study|Protocol Violation|0|||
155350484|NCT00796614|560717988|FG002|Overall Study|Protocol Violation|2|||
155350485|NCT00796614|560717989|FG003|Overall Study|Protocol Violation|0|||
155350486|NCT00796614|560717986|FG000|Overall Study|Lost to Follow-up|2|||
155350487|NCT00796614|560717987|FG001|Overall Study|Lost to Follow-up|2|||
155350488|NCT00796614|560717988|FG002|Overall Study|Lost to Follow-up|1|||
155350489|NCT00796614|560717989|FG003|Overall Study|Lost to Follow-up|0|||
155350490|NCT00796614|560717986|FG000|Overall Study|Withdrawal by Subject|1|||
155350491|NCT00796614|560717987|FG001|Overall Study|Withdrawal by Subject|0|||
155350492|NCT00796614|560717988|FG002|Overall Study|Withdrawal by Subject|0|||
155350493|NCT00796614|560717989|FG003|Overall Study|Withdrawal by Subject|1|||
155350494|NCT00796614|560717986|FG000|Overall Study|Other than stated|1|||
155350495|NCT00796614|560717987|FG001|Overall Study|Other than stated|0|||
155350496|NCT00796614|560717988|FG002|Overall Study|Other than stated|0|||
155350497|NCT00796614|560717989|FG003|Overall Study|Other than stated|0|||
155350498|NCT00740597|560717990|FG000|Overall Study|insurance would not cover treatment|1|||
155350499|NCT00746785|560717992|FG000|Overall Study|Lost to Follow-up|29|||
155350500|NCT00746785|560717993|FG001|Overall Study|Lost to Follow-up|25|||
155350501|NCT00746785|560717994|FG002|Overall Study|Lost to Follow-up|27|||
155350502|NCT01231464|560717995|FG000|Overall Study|Adverse Event|0|||
155350503|NCT01231464|560717996|FG001|Overall Study|Adverse Event|1|||
155350504|NCT01231464|560717995|FG000|Overall Study|Protocol Violation|1|||
155350505|NCT01231464|560717996|FG001|Overall Study|Protocol Violation|2|||
155350506|NCT01231464|560717995|FG000|Overall Study|Lost to Follow-up|1|||
155350507|NCT01231464|560717996|FG001|Overall Study|Lost to Follow-up|2|||
155350508|NCT01231464|560717995|FG000|Overall Study|Withdrawal by Subject|3|||
155350509|NCT01231464|560717996|FG001|Overall Study|Withdrawal by Subject|2|||
155350510|NCT00957996|560718002|FG000|Overall Study|Death|4|||
155350511|NCT00957996|560718003|FG001|Overall Study|Death|10|||
155350512|NCT00957996|560718002|FG000|Overall Study|Lost to Follow-up|4|||
155350513|NCT00957996|560718003|FG001|Overall Study|Lost to Follow-up|7|||
155350514|NCT00957996|560718002|FG000|Overall Study|Withdrawal by Subject|9|||
155350515|NCT00957996|560718003|FG001|Overall Study|Withdrawal by Subject|2|||
155350516|NCT00957996|560718002|FG000|Overall Study|Adverse Event|2|||
155350517|NCT00957996|560718003|FG001|Overall Study|Adverse Event|1|||
155350518|NCT00957996|560718002|FG000|Overall Study|Physician Decision|1|||
155350519|NCT00957996|560718003|FG001|Overall Study|Physician Decision|1|||
155350520|NCT00957996|560718002|FG000|Overall Study|Influenza-related complication|0|||
155350521|NCT00957996|560718003|FG001|Overall Study|Influenza-related complication|1|||
155350522|NCT00957996|560718002|FG000|Overall Study|Missing|1|||
155350523|NCT00957996|560718003|FG001|Overall Study|Missing|0|||
155350524|NCT00957996|560718002|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
155350525|NCT00957996|560718003|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
155350526|NCT00381797|560718011|FG000|Overall Study|Withdrawal by Subject|1|||
155350527|NCT00381797|560718012|FG001|Overall Study|Withdrawal by Subject|1|||
155350528|NCT00381797|560718013|FG002|Overall Study|Withdrawal by Subject|0|||
155350529|NCT00381797|560718014|FG003|Overall Study|Withdrawal by Subject|0|||
155350530|NCT00381797|560718015|FG004|Overall Study|Withdrawal by Subject|2|||
155350531|NCT00381797|560718011|FG000|Overall Study|Ineligible|0|||
155350532|NCT00381797|560718012|FG001|Overall Study|Ineligible|0|||
155350533|NCT00381797|560718013|FG002|Overall Study|Ineligible|0|||
155350534|NCT00381797|560718014|FG003|Overall Study|Ineligible|1|||
155350535|NCT00381797|560718015|FG004|Overall Study|Ineligible|0|||
155350536|NCT00684203|560718016|FG000|Overall Study|Adverse Event|6|||
155350537|NCT00684203|560718017|FG001|Overall Study|Adverse Event|4|||
155350538|NCT00684203|560718018|FG002|Overall Study|Adverse Event|8|||
155350539|NCT00684203|560718019|FG003|Overall Study|Adverse Event|0|||
155350540|NCT00684203|560718020|FG004|Overall Study|Adverse Event|0|||
155350541|NCT00684203|560718021|FG005|Overall Study|Adverse Event|0|||
155350542|NCT00684203|560718016|FG000|Overall Study|Protocol-defined clinical event|3|||
155350543|NCT00684203|560718017|FG001|Overall Study|Protocol-defined clinical event|1|||
155350544|NCT00684203|560718018|FG002|Overall Study|Protocol-defined clinical event|0|||
155350545|NCT00684203|560718019|FG003|Overall Study|Protocol-defined clinical event|0|||
155350546|NCT00684203|560718020|FG004|Overall Study|Protocol-defined clinical event|0|||
155350547|NCT00684203|560718021|FG005|Overall Study|Protocol-defined clinical event|0|||
155350548|NCT00684203|560718016|FG000|Overall Study|Withdrawal by Subject|0|||
155350549|NCT00684203|560718017|FG001|Overall Study|Withdrawal by Subject|2|||
155350550|NCT00684203|560718018|FG002|Overall Study|Withdrawal by Subject|1|||
155350551|NCT00684203|560718019|FG003|Overall Study|Withdrawal by Subject|0|||
155350552|NCT00684203|560718020|FG004|Overall Study|Withdrawal by Subject|0|||
155350553|NCT00684203|560718021|FG005|Overall Study|Withdrawal by Subject|0|||
155350554|NCT00684203|560718016|FG000|Overall Study|Did not meet protocol eligibility|0|||
155350555|NCT00684203|560718017|FG001|Overall Study|Did not meet protocol eligibility|1|||
155350556|NCT00684203|560718018|FG002|Overall Study|Did not meet protocol eligibility|0|||
155350557|NCT00684203|560718019|FG003|Overall Study|Did not meet protocol eligibility|0|||
155350558|NCT00684203|560718020|FG004|Overall Study|Did not meet protocol eligibility|0|||
155350559|NCT00684203|560718021|FG005|Overall Study|Did not meet protocol eligibility|0|||
155350560|NCT01902381|560718024|FG000|Overall Study|Withdrawal by Subject|1|||
155350561|NCT03972137|560718030|FG000|Overall Study|Lost to Follow-up|2|||
155350562|NCT03972137|560718030|FG000|Overall Study|Withdrawal by Subject|4|||
155350563|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
155350564|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
155350565|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
155350566|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
155350567|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
155350568|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
155350569|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
155350570|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
155350571|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
155350572|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
155350573|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
155350574|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
155350575|NCT00922441|560718034|FG000|Overall Study|Protocol Violation|0|||
155350576|NCT00922441|560718035|FG001|Overall Study|Protocol Violation|0|||
155350577|NCT00922441|560718036|FG002|Overall Study|Protocol Violation|2|||
155350578|NCT00922441|560718034|FG000|Overall Study|Withdrawal by Subject|0|||
155350579|NCT00922441|560718035|FG001|Overall Study|Withdrawal by Subject|0|||
155350580|NCT00922441|560718036|FG002|Overall Study|Withdrawal by Subject|1|||
155350581|NCT01885936|560718037|FG000|Overall Study|Withdrawal by Subject|1|||
155350582|NCT01885936|560718038|FG001|Overall Study|Withdrawal by Subject|0|||
155350583|NCT00317603|560718039|FG000|Overall Study|Progressive Disease|3|||
155350584|NCT00523549|560718040|FG000|Overall Study|Adverse Event|6|||
155350585|NCT00523549|560718041|FG001|Overall Study|Adverse Event|3|||
155350586|NCT00523549|560718040|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155350587|NCT00523549|560718041|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155350588|NCT00523549|560718040|FG000|Overall Study|Protocol Deviation|3|||
155350589|NCT00523549|560718041|FG001|Overall Study|Protocol Deviation|1|||
155350590|NCT00523549|560718040|FG000|Overall Study|Patient withdrew consent|7|||
155350591|NCT00523549|560718041|FG001|Overall Study|Patient withdrew consent|6|||
155350592|NCT00523549|560718040|FG000|Overall Study|Lost to Follow-up|3|||
155350593|NCT00523549|560718041|FG001|Overall Study|Lost to Follow-up|5|||
155350594|NCT00439647|560718047|FG000|Overall Study|Withdrawal by Subject|25|||
155350595|NCT00439647|560718048|FG001|Overall Study|Withdrawal by Subject|22|||
155350596|NCT00439647|560718047|FG000|Overall Study|Death|15|||
155350597|NCT00439647|560718048|FG001|Overall Study|Death|18|||
155350598|NCT00439647|560718047|FG000|Overall Study|Adverse Event|11|||
155350599|NCT00439647|560718048|FG001|Overall Study|Adverse Event|11|||
155350600|NCT00439647|560718047|FG000|Overall Study|Lost to Follow-up|4|||
155350601|NCT00439647|560718048|FG001|Overall Study|Lost to Follow-up|12|||
155350602|NCT00439647|560718047|FG000|Overall Study|Protocol Violation|3|||
155350603|NCT00439647|560718048|FG001|Overall Study|Protocol Violation|4|||
155350604|NCT00439647|560718047|FG000|Overall Study|Lack of Efficacy|0|||
155350605|NCT00439647|560718048|FG001|Overall Study|Lack of Efficacy|4|||
155506282|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
155506283|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155506284|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
155506285|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506286|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155648163|NCT01125748|561803783|FG000|Overall Study|Patient Decision to Withdraw|2|||
155648164|NCT01125748|561803784|FG001|Overall Study|Patient Decision to Withdraw|4|||
155350606|NCT00843115|560718049|FG000|Overall Study|Death|4|||
155350607|NCT00843115|560718049|FG000|Overall Study|Adverse Event|30|||
155350608|NCT00843115|560718049|FG000|Overall Study|Lost to Follow-up|4|||
155350609|NCT00843115|560718049|FG000|Overall Study|Withdrawal by Subject|17|||
155350610|NCT00843115|560718049|FG000|Overall Study|Family wanted meds stopped|1|||
155350611|NCT00843115|560718049|FG000|Overall Study|Family does not want continuation|1|||
155350612|NCT00843115|560718049|FG000|Overall Study|Patient forgot to take meds|1|||
155350613|NCT00843115|560718049|FG000|Overall Study|Does not meet entrance criteria|1|||
155350614|NCT00843115|560718049|FG000|Overall Study|Physician Decision|1|||
155350615|NCT00843115|560718049|FG000|Overall Study|Family discontinued meds|1|||
155350616|NCT00843115|560718049|FG000|Overall Study|patient took for 2 days then stopped|1|||
155350617|NCT00843115|560718049|FG000|Overall Study|patient never took the medication|1|||
155350618|NCT00843115|560718049|FG000|Overall Study|hospitalized due to deterioration|1|||
155350619|NCT00843115|560718049|FG000|Overall Study|week 12 not done|1|||
155350620|NCT00843115|560718049|FG000|Overall Study|Syndrome De Glissement|1|||
155350621|NCT02845375|560718050|FG000|Overall Study|upper airway obstruction|1|||
155350622|NCT02845375|560718051|FG001|Overall Study|upper airway obstruction|2|||
155350623|NCT02845375|560718052|FG002|Overall Study|upper airway obstruction|1|||
155350624|NCT00677092|560718059|FG000|Overall Study|Adverse Event|1|||
155350625|NCT00677092|560718059|FG000|Overall Study|Lost to Follow-up|1|||
155350626|NCT00677092|560718059|FG000|Overall Study|Withdrawal by Subject|3|||
155350627|NCT00677092|560718059|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
155350628|NCT02460562|560718061|FG000|Overall Study|Lost to Follow-up|15|||
155350629|NCT02460562|560718062|FG001|Overall Study|Lost to Follow-up|16|||
155350630|NCT04194541|560718063|FG000|Day 1 Through 13|Lost to Follow-up|3|||
155350631|NCT04194541|560718063|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
155350632|NCT04194541|560718063|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
155350633|NCT02642159|560718064|FG000|Overall Study|Randomized but not treated|1|||
155350634|NCT02642159|560718065|FG001|Overall Study|Randomized but not treated|0|||
155350635|NCT02642159|560718064|FG000|Overall Study|Adverse Event|10|||
155350636|NCT02642159|560718065|FG001|Overall Study|Adverse Event|4|||
155350637|NCT02642159|560718064|FG000|Overall Study|Withdrawal by Subject|9|||
155350638|NCT02642159|560718065|FG001|Overall Study|Withdrawal by Subject|1|||
155350639|NCT02642159|560718064|FG000|Overall Study|Poor compliance to study protocol|1|||
155350640|NCT02642159|560718065|FG001|Overall Study|Poor compliance to study protocol|0|||
155350641|NCT02642159|560718064|FG000|Overall Study|Other than specified above|10|||
155350642|NCT02642159|560718065|FG001|Overall Study|Other than specified above|3|||
155350643|NCT01951261|560718066|FG000|Overall Study|Death|1|||
155350644|NCT01951261|560718067|FG001|Overall Study|Death|0|||
155350645|NCT01951261|560718066|FG000|Overall Study|Lost to Follow-up|4|||
155350646|NCT01951261|560718067|FG001|Overall Study|Lost to Follow-up|3|||
155350647|NCT01951261|560718066|FG000|Overall Study|Protocol Violation|4|||
155350648|NCT01951261|560718067|FG001|Overall Study|Protocol Violation|3|||
155350649|NCT03927222|560718071|FG000|Overall Study|Progression|3|||
155350650|NCT03927222|560718071|FG000|Overall Study|CMV testing results inconclusive|1|||
155350651|NCT03927222|560718071|FG000|Overall Study|Unable to generate enough vaccines|1|||
155350652|NCT03927222|560718071|FG000|Overall Study|Early study termination|1|||
155350653|NCT03723915|560718075|FG000|Screening|Failed to meet screening requirements.|2|||
155350654|NCT03723915|560718075|FG000|On Treatment|Failed to meet treatment requirements|2|||
155506287|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506288|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506289|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
155506290|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
155506291|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506292|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506293|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506294|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
155506295|NCT00950599|561280293|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
155506296|NCT00950599|561280294|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
155506297|NCT00950599|561280295|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
155506298|NCT00950599|561280296|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
155506299|NCT00950599|561280297|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
155506300|NCT00950599|561280298|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
155506301|NCT00950599|561280299|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
155506302|NCT00950599|561280300|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
155506303|NCT00950599|561280301|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
155506304|NCT00950599|561280302|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
155350655|NCT00297778|560718076|FG000|Overall Study|Adverse Event|16|||
155350656|NCT00297778|560718077|FG001|Overall Study|Adverse Event|10|||
155350657|NCT00297778|560718076|FG000|Overall Study|Withdrawal by Subject|1|||
155350658|NCT00297778|560718077|FG001|Overall Study|Withdrawal by Subject|5|||
155350659|NCT00297778|560718076|FG000|Overall Study|Lack of Efficacy|2|||
155350660|NCT00297778|560718077|FG001|Overall Study|Lack of Efficacy|1|||
155350661|NCT00297778|560718076|FG000|Overall Study|Non-compliant with trial protocol|0|||
155350662|NCT00297778|560718077|FG001|Overall Study|Non-compliant with trial protocol|3|||
155350663|NCT00297778|560718076|FG000|Overall Study|Other|0|||
155350664|NCT00297778|560718077|FG001|Overall Study|Other|1|||
155350665|NCT02201771|560718078|FG000|Overall Study|Death|3|||
155350666|NCT02201771|560718079|FG001|Overall Study|Death|2|||
155350667|NCT02201771|560718080|FG002|Overall Study|Death|0|||
155350668|NCT02201771|560718078|FG000|Overall Study|Protocol Violation|10|||
155350669|NCT02201771|560718079|FG001|Overall Study|Protocol Violation|8|||
155350670|NCT02201771|560718080|FG002|Overall Study|Protocol Violation|10|||
155350671|NCT00583115|560718081|FG000|Overall Study|Death|1|||
155350672|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
155350673|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
155425533|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
155350674|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
155350675|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
155350676|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
155350677|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
155350678|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
155350679|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
155350680|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
155350681|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
155350682|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
155350683|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
155350684|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350685|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350686|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350687|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350688|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350689|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350690|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
155350691|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
155350692|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
155350693|NCT03569475|560718082|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
155350694|NCT03569475|560718083|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
155350695|NCT03569475|560718084|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
155350696|NCT03569475|560718082|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
155350697|NCT03569475|560718083|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
155350698|NCT03569475|560718084|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
155350699|NCT02383927|560718091|FG000|Overall Study|Disease Progression|8|||
155350700|NCT02383927|560718092|FG001|Overall Study|Disease Progression|8|||
155350701|NCT02383927|560718093|FG002|Overall Study|Disease Progression|15|||
155350702|NCT02383927|560718094|FG003|Overall Study|Disease Progression|4|||
155350703|NCT02383927|560718091|FG000|Overall Study|Physician Decision|0|||
155350704|NCT02383927|560718092|FG001|Overall Study|Physician Decision|0|||
155350705|NCT02383927|560718093|FG002|Overall Study|Physician Decision|2|||
155350706|NCT02383927|560718094|FG003|Overall Study|Physician Decision|0|||
155350707|NCT02383927|560718091|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
155350708|NCT02383927|560718092|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
155425534|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
155425535|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
155425536|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
155350709|NCT02383927|560718093|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
155350710|NCT02383927|560718094|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
155425537|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
155425538|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
155350711|NCT02383927|560718091|FG000|Overall Study|Adverse Event|4|||
155350712|NCT02383927|560718092|FG001|Overall Study|Adverse Event|1|||
155350713|NCT02383927|560718093|FG002|Overall Study|Adverse Event|3|||
155350714|NCT02383927|560718094|FG003|Overall Study|Adverse Event|5|||
155350715|NCT02383927|560718091|FG000|Overall Study|Miscellaneous|1|||
155350716|NCT02383927|560718092|FG001|Overall Study|Miscellaneous|0|||
155350717|NCT02383927|560718093|FG002|Overall Study|Miscellaneous|0|||
155350718|NCT02383927|560718094|FG003|Overall Study|Miscellaneous|1|||
155350719|NCT02383927|560718091|FG000|Overall Study|Withdrawal by Subject|0|||
155350720|NCT02383927|560718092|FG001|Overall Study|Withdrawal by Subject|1|||
155350721|NCT02383927|560718093|FG002|Overall Study|Withdrawal by Subject|4|||
155350722|NCT02383927|560718094|FG003|Overall Study|Withdrawal by Subject|0|||
155350723|NCT00734851|560718095|FG000|Overall Study|Withdrawal by Subject|2|||
155350724|NCT00734851|560718095|FG000|Overall Study|Lost to Follow-up|1|||
155350725|NCT00734851|560718095|FG000|Overall Study|Physician Decision|18|||
155350726|NCT03613454|560718098|FG000|Overall Study|Protocol Violation|1|||
155350727|NCT03613454|560718099|FG001|Overall Study|Protocol Violation|0|||
155350728|NCT03613454|560718098|FG000|Overall Study|Protocol Violation|0|||
155350729|NCT03613454|560718099|FG001|Overall Study|Protocol Violation|1|||
155350730|NCT00464737|560718101|FG000|Overall Study|Adverse Event|12|||
155350731|NCT00464737|560718102|FG001|Overall Study|Adverse Event|17|||
155350732|NCT00464737|560718103|FG002|Overall Study|Adverse Event|33|||
155350733|NCT00464737|560718101|FG000|Overall Study|Lack of Efficacy|7|||
155350734|NCT00464737|560718102|FG001|Overall Study|Lack of Efficacy|7|||
155350735|NCT00464737|560718103|FG002|Overall Study|Lack of Efficacy|4|||
155350736|NCT00464737|560718101|FG000|Overall Study|Withdrawal by Subject|5|||
155350737|NCT00464737|560718102|FG001|Overall Study|Withdrawal by Subject|3|||
155350738|NCT00464737|560718103|FG002|Overall Study|Withdrawal by Subject|5|||
155350739|NCT00464737|560718101|FG000|Overall Study|Protocol Violation|1|||
155350740|NCT00464737|560718102|FG001|Overall Study|Protocol Violation|1|||
155350741|NCT00464737|560718103|FG002|Overall Study|Protocol Violation|5|||
155350742|NCT00464737|560718101|FG000|Overall Study|Non-compliance|0|||
155350743|NCT00464737|560718102|FG001|Overall Study|Non-compliance|1|||
155350744|NCT00464737|560718103|FG002|Overall Study|Non-compliance|1|||
155350745|NCT00464737|560718101|FG000|Overall Study|Lost to Follow-up|5|||
155350746|NCT00464737|560718102|FG001|Overall Study|Lost to Follow-up|2|||
155350747|NCT00464737|560718103|FG002|Overall Study|Lost to Follow-up|5|||
155350748|NCT00464737|560718101|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
155350749|NCT00464737|560718102|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
155350750|NCT00464737|560718103|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
155350751|NCT00464737|560718101|FG000|Overall Study|Other: Subject left town; family illness|1|||
155350752|NCT00464737|560718102|FG001|Overall Study|Other: Subject left town; family illness|0|||
155350753|NCT00464737|560718103|FG002|Overall Study|Other: Subject left town; family illness|0|||
155350754|NCT00464737|560718101|FG000|Overall Study|Other: Study demands too great|0|||
155350755|NCT00464737|560718102|FG001|Overall Study|Other: Study demands too great|1|||
155350756|NCT00464737|560718103|FG002|Overall Study|Other: Study demands too great|0|||
155350757|NCT00464737|560718101|FG000|Overall Study|Other: Personal family reasons|0|||
155350758|NCT00464737|560718102|FG001|Overall Study|Other: Personal family reasons|0|||
155350759|NCT00464737|560718103|FG002|Overall Study|Other: Personal family reasons|1|||
155350760|NCT00464737|560718101|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
155350761|NCT00464737|560718102|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
155350762|NCT00464737|560718103|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
155350763|NCT01894256|560718106|FG000|Part A|Adverse Event|0|||
155350764|NCT01894256|560718107|FG001|Part A|Adverse Event|1|||
155350765|NCT01894256|560718108|FG002|Part A|Adverse Event|0|||
155350766|NCT01894256|560718106|FG000|Part B|Death|0|||
155350767|NCT01894256|560718107|FG001|Part B|Death|1|||
155350768|NCT01894256|560718108|FG002|Part B|Death|1|||
155350769|NCT01894256|560718106|FG000|Part B|Withdrawal by Subject|0|||
155350770|NCT01894256|560718107|FG001|Part B|Withdrawal by Subject|1|||
155350771|NCT01894256|560718108|FG002|Part B|Withdrawal by Subject|0|||
155350772|NCT01894256|560718106|FG000|Part B|Lack of Efficacy|15|||
155350773|NCT01894256|560718107|FG001|Part B|Lack of Efficacy|12|||
155350774|NCT01894256|560718108|FG002|Part B|Lack of Efficacy|13|||
155350775|NCT01780584|560718109|FG000|Overall Study|Death|1|||
155350776|NCT01780584|560718110|FG001|Overall Study|Death|0|||
155350777|NCT01780584|560718111|FG002|Overall Study|Death|1|||
155350778|NCT01780584|560718109|FG000|Overall Study|Adverse Event|0|||
155350779|NCT01780584|560718110|FG001|Overall Study|Adverse Event|1|||
155350780|NCT01780584|560718111|FG002|Overall Study|Adverse Event|0|||
155350781|NCT01780584|560718109|FG000|Overall Study|Protocol Violation|0|||
155350782|NCT01780584|560718110|FG001|Overall Study|Protocol Violation|0|||
155350783|NCT01780584|560718111|FG002|Overall Study|Protocol Violation|1|||
155350784|NCT01544153|560718119|FG000|Overall Study|Under 18|0|||
155350785|NCT01544153|560718120|FG001|Overall Study|Under 18|1|||
155350786|NCT01544153|560718121|FG002|Overall Study|Under 18|0|||
155350787|NCT01544153|560718122|FG003|Overall Study|Under 18|0|||
155350788|NCT01544153|560718119|FG000|Overall Study|Non-smoker|0|||
155350789|NCT01544153|560718120|FG001|Overall Study|Non-smoker|0|||
155350790|NCT01544153|560718121|FG002|Overall Study|Non-smoker|1|||
155350791|NCT01544153|560718122|FG003|Overall Study|Non-smoker|0|||
155350792|NCT00390806|560718127|FG000|Overall Study|Lost to Follow-up|7|||
155350793|NCT00390806|560718128|FG001|Overall Study|Lost to Follow-up|6|||
155350794|NCT00390806|560718127|FG000|Overall Study|Protocol Violation|2|||
155350795|NCT00390806|560718128|FG001|Overall Study|Protocol Violation|2|||
155350796|NCT00390806|560718127|FG000|Overall Study|Withdrawal by Subject|12|||
155350797|NCT00390806|560718128|FG001|Overall Study|Withdrawal by Subject|15|||
155350798|NCT00390806|560718127|FG000|Overall Study|Investigator Decision|4|||
155350799|NCT00390806|560718128|FG001|Overall Study|Investigator Decision|6|||
155350800|NCT00390806|560718127|FG000|Overall Study|Death|1|||
155350801|NCT00390806|560718128|FG001|Overall Study|Death|0|||
155350802|NCT00390806|560718127|FG000|Overall Study|Physician Decision|0|||
155350803|NCT00390806|560718128|FG001|Overall Study|Physician Decision|1|||
155350804|NCT00390806|560718127|FG000|Overall Study|Ongoing|4|||
155350805|NCT00390806|560718128|FG001|Overall Study|Ongoing|2|||
155350806|NCT00884793|560718131|FG000|Overall Study|Withdrawal by Subject|1|||
155350807|NCT03169530|560718132|FG000|Overall Study|Study ended by NIH|15|||
155350808|NCT03169530|560718133|FG001|Overall Study|Study ended by NIH|17|||
155350809|NCT04783519|560718134|FG000|Overall Study|Withdrawal by Subject|2|||
155350810|NCT04783519|560718135|FG001|Overall Study|Withdrawal by Subject|7|||
155350811|NCT04783519|560718136|FG002|Overall Study|Withdrawal by Subject|3|||
155350812|NCT04783519|560718134|FG000|Overall Study|Lost to Follow-up|9|||
155350813|NCT04783519|560718135|FG001|Overall Study|Lost to Follow-up|7|||
155350814|NCT04783519|560718136|FG002|Overall Study|Lost to Follow-up|6|||
155350815|NCT01032200|560718137|FG000|Overall Study|Death|1|||
155350816|NCT01032200|560718138|FG001|Overall Study|Death|1|||
155350817|NCT01032200|560718137|FG000|Overall Study|Withdrawal by Subject|1|||
155506305|NCT00950599|561280293|FG000|Follow-Up Period|Adverse Event|0|||
155350818|NCT01032200|560718138|FG001|Overall Study|Withdrawal by Subject|3|||
155350819|NCT01032200|560718137|FG000|Overall Study|Toxicity|0|||
155350820|NCT01032200|560718138|FG001|Overall Study|Toxicity|2|||
155350821|NCT01032200|560718137|FG000|Overall Study|Progression|1|||
155350822|NCT01032200|560718138|FG001|Overall Study|Progression|0|||
155350823|NCT01032200|560718137|FG000|Overall Study|Multiple|1|||
155350824|NCT01032200|560718138|FG001|Overall Study|Multiple|1|||
155350825|NCT00727259|560718142|FG000|Overall Study|Not all questionnaires completed|1055|||
155350826|NCT01021683|560718143|FG000|Overall Study|Lack of Efficacy|12|||
155350827|NCT01021683|560718143|FG000|Overall Study|Recovery of neutrophil count|51|||
155350828|NCT01021683|560718143|FG000|Overall Study|Other|8|||
155350829|NCT02273180|560718144|FG000|Overall Study|Adverse Event|2|||
155350830|NCT02273180|560718145|FG001|Overall Study|Adverse Event|2|||
155350831|NCT02273180|560718144|FG000|Overall Study|Lack of Efficacy|1|||
155350832|NCT02273180|560718145|FG001|Overall Study|Lack of Efficacy|0|||
155350833|NCT02273180|560718144|FG000|Overall Study|Protocol Violation|1|||
155350834|NCT02273180|560718145|FG001|Overall Study|Protocol Violation|7|||
155350835|NCT02273180|560718144|FG000|Overall Study|Randomized but not treated|1|||
155350836|NCT02273180|560718145|FG001|Overall Study|Randomized but not treated|0|||
155350837|NCT02273180|560718144|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
155506306|NCT00950599|561280294|FG001|Follow-Up Period|Adverse Event|0|||
155506307|NCT00950599|561280295|FG002|Follow-Up Period|Adverse Event|0|||
155506308|NCT00950599|561280296|FG003|Follow-Up Period|Adverse Event|0|||
155506309|NCT00950599|561280297|FG004|Follow-Up Period|Adverse Event|0|||
155506310|NCT00950599|561280298|FG005|Follow-Up Period|Adverse Event|0|||
155506311|NCT00950599|561280299|FG006|Follow-Up Period|Adverse Event|0|||
155506312|NCT00950599|561280300|FG007|Follow-Up Period|Adverse Event|0|||
155506313|NCT00950599|561280301|FG008|Follow-Up Period|Adverse Event|1|||
155506314|NCT00950599|561280302|FG009|Follow-Up Period|Adverse Event|0|||
155350838|NCT02273180|560718145|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
155350839|NCT02273180|560718144|FG000|Overall Study|Other than specified above|21|||
155350840|NCT02273180|560718145|FG001|Overall Study|Other than specified above|10|||
155350841|NCT00645099|560718146|FG000|Overall Study|Lack of Efficacy|15|||
155350842|NCT00645099|560718147|FG001|Overall Study|Lack of Efficacy|6|||
155350843|NCT00645099|560718146|FG000|Overall Study|Withdrawal by Subject|30|||
155350844|NCT00645099|560718147|FG001|Overall Study|Withdrawal by Subject|22|||
155350845|NCT00645099|560718146|FG000|Overall Study|Lost to Follow-up|6|||
155350846|NCT00645099|560718147|FG001|Overall Study|Lost to Follow-up|4|||
155350847|NCT00645099|560718146|FG000|Overall Study|Adverse Event|11|||
155350848|NCT00645099|560718147|FG001|Overall Study|Adverse Event|5|||
155506315|NCT00950599|561280293|FG000|Follow-Up Period|Lack of Efficacy|0|||
155506316|NCT00950599|561280294|FG001|Follow-Up Period|Lack of Efficacy|0|||
155506317|NCT00950599|561280295|FG002|Follow-Up Period|Lack of Efficacy|0|||
155506318|NCT00950599|561280296|FG003|Follow-Up Period|Lack of Efficacy|0|||
155506319|NCT00950599|561280297|FG004|Follow-Up Period|Lack of Efficacy|0|||
155506320|NCT00950599|561280298|FG005|Follow-Up Period|Lack of Efficacy|0|||
155506321|NCT00950599|561280299|FG006|Follow-Up Period|Lack of Efficacy|0|||
155350849|NCT00645099|560718146|FG000|Overall Study|Other|9|||
155350850|NCT00645099|560718147|FG001|Overall Study|Other|5|||
155350851|NCT01201915|560718148|FG000|Overall Study|Adverse Event|2|||
155350852|NCT01201915|560718149|FG001|Overall Study|Adverse Event|1|||
155506322|NCT00950599|561280300|FG007|Follow-Up Period|Lack of Efficacy|0|||
155506323|NCT00950599|561280301|FG008|Follow-Up Period|Lack of Efficacy|3|||
155506324|NCT00950599|561280302|FG009|Follow-Up Period|Lack of Efficacy|0|||
155506325|NCT00950599|561280293|FG000|Follow-Up Period|Lost to Follow-up|0|||
155350853|NCT01201915|560718150|FG002|Overall Study|Adverse Event|1|||
155350854|NCT01201915|560718148|FG000|Overall Study|Lost to Follow-up|0|||
155506326|NCT00950599|561280294|FG001|Follow-Up Period|Lost to Follow-up|0|||
155350855|NCT01201915|560718149|FG001|Overall Study|Lost to Follow-up|4|||
155350856|NCT01201915|560718150|FG002|Overall Study|Lost to Follow-up|0|||
155350857|NCT01201915|560718148|FG000|Overall Study|Physician Decision|3|||
155350858|NCT01201915|560718149|FG001|Overall Study|Physician Decision|0|||
155350859|NCT01201915|560718150|FG002|Overall Study|Physician Decision|0|||
155350860|NCT01201915|560718148|FG000|Overall Study|Subject Decision|3|||
155350861|NCT01201915|560718149|FG001|Overall Study|Subject Decision|3|||
155350862|NCT01201915|560718150|FG002|Overall Study|Subject Decision|5|||
155350863|NCT01201915|560718148|FG000|Overall Study|Target Lesion Progression|0|||
155350864|NCT01201915|560718149|FG001|Overall Study|Target Lesion Progression|3|||
155350865|NCT01201915|560718150|FG002|Overall Study|Target Lesion Progression|0|||
155350866|NCT02316171|560718153|FG000|Overall Study|difficulties with urinary catheter|1|||
155350867|NCT02316171|560718154|FG001|Overall Study|difficulties with urinary catheter|0|||
155350868|NCT02316171|560718155|FG002|Overall Study|difficulties with urinary catheter|0|||
155350869|NCT02316171|560718156|FG003|Overall Study|difficulties with urinary catheter|0|||
155350870|NCT04130061|560718157|FG000|Overall Study|OR team forgot to request membrane|1|||
155350871|NCT04130061|560718158|FG001|Overall Study|OR team forgot to request membrane|0|||
155350872|NCT03449134|560719785|FG000|52-Week Treatment Period|Death|2|||
155350873|NCT03449134|560719786|FG001|52-Week Treatment Period|Death|1|||
155350874|NCT03449134|560719787|FG002|52-Week Treatment Period|Death|0|||
155350875|NCT03449134|560719785|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
155350876|NCT03449134|560719786|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
155350877|NCT03449134|560719787|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
155350878|NCT03449134|560719785|FG000|52-Week Treatment Period|Physician Decision|2|||
155350879|NCT03449134|560719786|FG001|52-Week Treatment Period|Physician Decision|3|||
155350880|NCT03449134|560719787|FG002|52-Week Treatment Period|Physician Decision|3|||
155350881|NCT03449134|560719785|FG000|52-Week Treatment Period|Screen Failure|1|||
155350882|NCT03449134|560719786|FG001|52-Week Treatment Period|Screen Failure|0|||
155350883|NCT03449134|560719787|FG002|52-Week Treatment Period|Screen Failure|1|||
155350884|NCT03449134|560719785|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
155350885|NCT03449134|560719786|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
155350886|NCT03449134|560719787|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
155350887|NCT03449134|560719785|FG000|52-Week Treatment Period|Site Closure|1|||
155350888|NCT03449134|560719786|FG001|52-Week Treatment Period|Site Closure|0|||
155350889|NCT03449134|560719787|FG002|52-Week Treatment Period|Site Closure|0|||
155350890|NCT02916706|560719788|FG000|Overall Study|Adverse Event|0|||
155350891|NCT02916706|560719789|FG001|Overall Study|Adverse Event|1|||
155350892|NCT02916706|560719788|FG000|Overall Study|Lost to Follow-up|0|||
155350893|NCT02916706|560719789|FG001|Overall Study|Lost to Follow-up|1|||
155350894|NCT02916706|560719788|FG000|Overall Study|Physician Decision|1|||
155648165|NCT01028391|561803785|FG000|Overall Study|Adverse Event|4|||
155350895|NCT02916706|560719789|FG001|Overall Study|Physician Decision|0|||
155350896|NCT02916706|560719788|FG000|Overall Study|Protocol Violation|3|||
155350897|NCT02916706|560719789|FG001|Overall Study|Protocol Violation|1|||
155350898|NCT02916706|560719788|FG000|Overall Study|Withdrawal by Subject|6|||
155350899|NCT02916706|560719789|FG001|Overall Study|Withdrawal by Subject|9|||
155350900|NCT02916706|560719788|FG000|Overall Study|Other|5|||
155350901|NCT02916706|560719789|FG001|Overall Study|Other|19|||
155350902|NCT01093599|560719790|FG000|Overall Study|Lost to Follow-up|32|||
155350903|NCT01093599|560719791|FG001|Overall Study|Lost to Follow-up|46|||
155350904|NCT01703845|560719792|FG000|Overall Study|Adverse Event|1|||
155350905|NCT01703845|560719793|FG001|Overall Study|Adverse Event|0|||
155350906|NCT01703845|560719792|FG000|Overall Study|Protocol Violation|1|||
155350907|NCT01703845|560719793|FG001|Overall Study|Protocol Violation|0|||
155350908|NCT01703845|560719792|FG000|Overall Study|other than stated above|1|||
155350909|NCT01703845|560719793|FG001|Overall Study|other than stated above|0|||
155350910|NCT00719212|560719794|FG000|Overall Study|Death|41|||
155350911|NCT00719212|560719794|FG000|Overall Study|Lost to Follow-up|2|||
155350912|NCT00719212|560719794|FG000|Overall Study|Withdrawal by Subject|1|||
155350913|NCT00526097|560719795|FG000|Overall Study|Adverse Event|6|||
155350914|NCT00526097|560719796|FG001|Overall Study|Adverse Event|44|||
155350915|NCT00526097|560719795|FG000|Overall Study|Protocol Violation|4|||
155350916|NCT00526097|560719796|FG001|Overall Study|Protocol Violation|10|||
155350917|NCT00526097|560719795|FG000|Overall Study|Withdrawal by Subject|3|||
155350918|NCT00526097|560719796|FG001|Overall Study|Withdrawal by Subject|1|||
155350919|NCT00526097|560719795|FG000|Overall Study|Other|2|||
155350920|NCT00526097|560719796|FG001|Overall Study|Other|1|||
155350921|NCT00966979|560719797|FG000|Overall Study|Death|1|||
155350922|NCT00966979|560719797|FG000|Overall Study|Lost to Follow-up|6|||
155350923|NCT00966979|560719797|FG000|Overall Study|Withdrawal by Subject|14|||
155350924|NCT00966979|560719797|FG000|Overall Study|Adverse Event|5|||
155350925|NCT00966979|560719797|FG000|Overall Study|Sponsor terminated early|49|||
155648166|NCT01028391|561803786|FG001|Overall Study|Adverse Event|0|||
155350926|NCT00966979|560719797|FG000|Overall Study|Censored because surgery not done|2|||
155350927|NCT00966979|560719797|FG000|Overall Study|Censored because study device was not implanted|14|||
155350928|NCT00966979|560719797|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
155350929|NCT00943618|560719801|FG000|Overall Study|Lost to Follow-up|38|||
155350930|NCT00943618|560719802|FG001|Overall Study|Lost to Follow-up|48|||
155350931|NCT00943618|560719803|FG002|Overall Study|Lost to Follow-up|20|||
155350932|NCT00943618|560719801|FG000|Overall Study|Discontinued Medication|17|||
155350933|NCT00943618|560719802|FG001|Overall Study|Discontinued Medication|29|||
155350934|NCT00943618|560719803|FG002|Overall Study|Discontinued Medication|11|||
155350935|NCT03713281|560719808|FG000|Overall Study|Lens handling difficuluties|2|||
155350936|NCT03713281|560719808|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
155350937|NCT01990313|560719810|FG000|Overall Study|Lost to Follow-up|1|||
155350938|NCT02412111|560719811|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
155350939|NCT02412111|560719812|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
155350940|NCT02412111|560719813|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
155350941|NCT02412111|560719811|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
155350942|NCT02412111|560719812|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
155350943|NCT02412111|560719813|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
155350944|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
155350945|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
155350946|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
155350947|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
155350948|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
155350949|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
155350950|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
155350951|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
155350952|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
155350953|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
155350954|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
155350955|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
155350956|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Other|0|||
155350957|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Other|0|||
155350958|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Other|2|||
155350959|NCT00837096|560719814|FG000|Overall Study|Physician Decision|1|||
155350960|NCT00837096|560719815|FG001|Overall Study|Physician Decision|1|||
155350961|NCT00837096|560719814|FG000|Overall Study|Not reported|9|||
155350962|NCT00837096|560719815|FG001|Overall Study|Not reported|8|||
155350963|NCT00329550|560719816|FG000|Overall Study|Adverse Event|3|||
155350964|NCT00329550|560719817|FG001|Overall Study|Adverse Event|4|||
155350965|NCT00329550|560719818|FG002|Overall Study|Adverse Event|2|||
155350966|NCT00329550|560719816|FG000|Overall Study|Withdrawal of Consent|1|||
155350967|NCT00329550|560719817|FG001|Overall Study|Withdrawal of Consent|0|||
155350968|NCT00329550|560719818|FG002|Overall Study|Withdrawal of Consent|1|||
155350969|NCT00329550|560719816|FG000|Overall Study|Due to Relocation|0|||
155350970|NCT00329550|560719817|FG001|Overall Study|Due to Relocation|0|||
155350971|NCT00329550|560719818|FG002|Overall Study|Due to Relocation|1|||
155425539|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
155648167|NCT01028391|561803785|FG000|Overall Study|Lack of Efficacy|0|||
155350972|NCT00494026|560719819|FG000|Overall Study|Sponsor Decision|4|||
155350973|NCT05153499|560719820|FG000|Overall Study|Withdrawal by Subject|1|||
155350974|NCT05153499|560719821|FG001|Overall Study|Withdrawal by Subject|0|||
155350975|NCT05153499|560719820|FG000|Overall Study|Clinical Hold|1|||
155350976|NCT05153499|560719821|FG001|Overall Study|Clinical Hold|0|||
155350977|NCT05153499|560719820|FG000|Overall Study|Study Termination|6|||
155350978|NCT05153499|560719821|FG001|Overall Study|Study Termination|5|||
155350979|NCT05109117|560719824|FG000|Overall Study|Lost to Follow-up|1|||
155425540|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
155648168|NCT01028391|561803786|FG001|Overall Study|Lack of Efficacy|2|||
155350980|NCT05109117|560719824|FG000|Overall Study|Discontinued for non-compliance|1|||
155350981|NCT03168425|560719827|FG000|Overall Study|Lost to Follow-up|5|||
155350982|NCT03168425|560719828|FG001|Overall Study|Lost to Follow-up|8|||
155350983|NCT03168425|560719827|FG000|Overall Study|unable to confirm post op opioids|2|||
155350984|NCT03168425|560719828|FG001|Overall Study|unable to confirm post op opioids|3|||
155350985|NCT01960114|560719829|FG000|Overall Study|Adverse Event|1|||
155350986|NCT01960114|560719830|FG001|Overall Study|Adverse Event|0|||
155350987|NCT01960114|560719829|FG000|Overall Study|Could not swallow study medication|0|||
155350988|NCT01960114|560719830|FG001|Overall Study|Could not swallow study medication|1|||
155350989|NCT00468858|560719833|FG000|Overall Study|Adverse Event|0|||
155350990|NCT00468858|560719834|FG001|Overall Study|Adverse Event|1|||
155350991|NCT00468858|560719835|FG002|Overall Study|Adverse Event|0|||
155350992|NCT00468858|560719833|FG000|Overall Study|Withdrawal by Subject|7|||
155350993|NCT00468858|560719834|FG001|Overall Study|Withdrawal by Subject|4|||
155350994|NCT00468858|560719835|FG002|Overall Study|Withdrawal by Subject|5|||
155350995|NCT00468858|560719833|FG000|Overall Study|Relocation|1|||
155350996|NCT00468858|560719834|FG001|Overall Study|Relocation|3|||
155350997|NCT00468858|560719835|FG002|Overall Study|Relocation|3|||
155350998|NCT00468858|560719833|FG000|Overall Study|Lost to Follow-up|1|||
155350999|NCT00468858|560719834|FG001|Overall Study|Lost to Follow-up|2|||
155351000|NCT00468858|560719835|FG002|Overall Study|Lost to Follow-up|5|||
155351001|NCT00468858|560719833|FG000|Overall Study|Other|0|||
155351002|NCT00468858|560719834|FG001|Overall Study|Other|0|||
155351003|NCT00468858|560719835|FG002|Overall Study|Other|1|||
155351004|NCT03214250|560719838|FG000|Overall Study|Death|5|||
155351005|NCT03214250|560719839|FG001|Overall Study|Death|5|||
155351006|NCT03214250|560719840|FG002|Overall Study|Death|7|||
155351007|NCT03214250|560719841|FG003|Overall Study|Death|4|||
155351008|NCT03214250|560719842|FG004|Overall Study|Death|23|||
155351009|NCT03214250|560719843|FG005|Overall Study|Death|23|||
155351010|NCT03214250|560719844|FG006|Overall Study|Death|24|||
155351011|NCT03214250|560719838|FG000|Overall Study|Lost to Follow-up|0|||
155351012|NCT03214250|560719839|FG001|Overall Study|Lost to Follow-up|0|||
155351013|NCT03214250|560719840|FG002|Overall Study|Lost to Follow-up|0|||
155351014|NCT03214250|560719841|FG003|Overall Study|Lost to Follow-up|1|||
155351015|NCT03214250|560719842|FG004|Overall Study|Lost to Follow-up|1|||
155351016|NCT03214250|560719843|FG005|Overall Study|Lost to Follow-up|2|||
155351017|NCT03214250|560719844|FG006|Overall Study|Lost to Follow-up|0|||
155351018|NCT03214250|560719838|FG000|Overall Study|Other|0|||
155351019|NCT03214250|560719839|FG001|Overall Study|Other|0|||
155351020|NCT03214250|560719840|FG002|Overall Study|Other|0|||
155351021|NCT03214250|560719841|FG003|Overall Study|Other|0|||
155351022|NCT03214250|560719842|FG004|Overall Study|Other|1|||
155351023|NCT03214250|560719843|FG005|Overall Study|Other|1|||
155351024|NCT03214250|560719844|FG006|Overall Study|Other|2|||
155351025|NCT03214250|560719838|FG000|Overall Study|Remains on Study|2|||
155351026|NCT03214250|560719839|FG001|Overall Study|Remains on Study|2|||
155351027|NCT03214250|560719840|FG002|Overall Study|Remains on Study|0|||
155425541|NCT02660580|560986604|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
155425542|NCT02660580|560986605|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
155425543|NCT02660580|560986606|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
155425544|NCT02660580|560986607|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
155425545|NCT02660580|560986608|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
155425546|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
155425547|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
155425548|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
155425549|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
155425550|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
155425551|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
155425552|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
155425553|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
155425554|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
155425555|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
155648169|NCT01028391|561803785|FG000|Overall Study|Lost to Follow-up|3|||
155351028|NCT03214250|560719841|FG003|Overall Study|Remains on Study|1|||
155351029|NCT03214250|560719842|FG004|Overall Study|Remains on Study|7|||
155351030|NCT03214250|560719843|FG005|Overall Study|Remains on Study|5|||
155351031|NCT03214250|560719844|FG006|Overall Study|Remains on Study|3|||
155351032|NCT03214250|560719838|FG000|Overall Study|Withdrawal by Subject|0|||
155351033|NCT03214250|560719839|FG001|Overall Study|Withdrawal by Subject|0|||
155648170|NCT01028391|561803786|FG001|Overall Study|Lost to Follow-up|4|||
155351034|NCT03214250|560719840|FG002|Overall Study|Withdrawal by Subject|1|||
155351035|NCT03214250|560719841|FG003|Overall Study|Withdrawal by Subject|2|||
155351036|NCT03214250|560719842|FG004|Overall Study|Withdrawal by Subject|5|||
155351037|NCT03214250|560719843|FG005|Overall Study|Withdrawal by Subject|0|||
155351038|NCT03214250|560719844|FG006|Overall Study|Withdrawal by Subject|2|||
155351039|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|no longer interested|1|||
155351040|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|no longer interested|0|||
155351041|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
155351042|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
155351043|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
155351044|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
155351045|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
155351046|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
155351047|NCT00225277|560719847|FG000|Overall Study|Adverse Event|30|||
155351048|NCT00225277|560719848|FG001|Overall Study|Adverse Event|34|||
155351049|NCT00225277|560719847|FG000|Overall Study|Lack of Efficacy|4|||
155351050|NCT00225277|560719848|FG001|Overall Study|Lack of Efficacy|1|||
155351051|NCT00225277|560719847|FG000|Overall Study|Lost to Follow-up|4|||
155351052|NCT00225277|560719848|FG001|Overall Study|Lost to Follow-up|6|||
155351053|NCT00225277|560719847|FG000|Overall Study|Physician Decision|6|||
155351054|NCT00225277|560719848|FG001|Overall Study|Physician Decision|8|||
155351055|NCT00225277|560719847|FG000|Overall Study|Protocol Violation|6|||
155351056|NCT00225277|560719848|FG001|Overall Study|Protocol Violation|3|||
155351057|NCT00225277|560719847|FG000|Overall Study|Withdrawal by Subject|40|||
155351058|NCT00225277|560719848|FG001|Overall Study|Withdrawal by Subject|34|||
155351059|NCT00225277|560719847|FG000|Overall Study|Other|7|||
155351060|NCT00225277|560719848|FG001|Overall Study|Other|9|||
155351061|NCT01177137|560719851|FG000|Overall Study|Withdrawal by Subject|10|||
155351062|NCT01177137|560719852|FG001|Overall Study|Withdrawal by Subject|10|||
155351063|NCT01177137|560719853|FG002|Overall Study|Withdrawal by Subject|2|||
155351064|NCT01287416|560719856|FG000|Pre-post Training|Withdrawal by Subject|17|||
155351065|NCT01287416|560719857|FG001|Pre-post Training|Withdrawal by Subject|24|||
155351066|NCT01287416|560719856|FG000|Pre-post Training|Lost to Follow-up|5|||
155351067|NCT01287416|560719857|FG001|Pre-post Training|Lost to Follow-up|1|||
155351068|NCT01287416|560719856|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155351069|NCT01287416|560719857|FG001|6 Month Follow-up|Lost to Follow-up|2|||
155351070|NCT02109107|560719858|FG000|Overall Study|Lost to Follow-up|2|||
155351071|NCT00818519|560719863|FG000|Overall Study|Adverse Event|2|||
155351072|NCT00818519|560719864|FG001|Overall Study|Adverse Event|2|||
155351073|NCT00818519|560719863|FG000|Overall Study|Lost to Follow-up|4|||
155351074|NCT00818519|560719864|FG001|Overall Study|Lost to Follow-up|6|||
155351075|NCT00818519|560719863|FG000|Overall Study|Protocol Violation|2|||
155351076|NCT00818519|560719864|FG001|Overall Study|Protocol Violation|1|||
155351077|NCT00818519|560719863|FG000|Overall Study|Pregnancy|0|||
155351078|NCT00818519|560719864|FG001|Overall Study|Pregnancy|1|||
155351079|NCT00818519|560719863|FG000|Overall Study|Withdrawal by Subject|4|||
155351080|NCT00818519|560719864|FG001|Overall Study|Withdrawal by Subject|9|||
155351081|NCT00818519|560719863|FG000|Overall Study|participant recovered completely|1|||
155351082|NCT00818519|560719864|FG001|Overall Study|participant recovered completely|0|||
155351083|NCT00818519|560719863|FG000|Overall Study|participant will leave for long tme|1|||
155351084|NCT00818519|560719864|FG001|Overall Study|participant will leave for long tme|0|||
155351085|NCT04167085|560719865|FG000|Baseline|Withdrawal by Subject|2|||
155351086|NCT04167085|560719866|FG001|Baseline|Withdrawal by Subject|1|||
155351087|NCT04167085|560719865|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
155351088|NCT04167085|560719866|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
155351089|NCT00580047|560719869|FG000|Overall Study|Lost to Follow-up|1|||
155351090|NCT00580047|560719870|FG001|Overall Study|Lost to Follow-up|1|||
155351091|NCT00580047|560719871|FG002|Overall Study|Lost to Follow-up|0|||
155351092|NCT00580047|560719869|FG000|Overall Study|Withdrawal by Subject|1|||
155351093|NCT00580047|560719870|FG001|Overall Study|Withdrawal by Subject|1|||
155351094|NCT00580047|560719871|FG002|Overall Study|Withdrawal by Subject|2|||
155351095|NCT00580047|560719869|FG000|Overall Study|Withdrawal by Subject|1|||
155351096|NCT00580047|560719870|FG001|Overall Study|Withdrawal by Subject|0|||
155351097|NCT00580047|560719871|FG002|Overall Study|Withdrawal by Subject|0|||
155351098|NCT02820298|560719872|FG000|Overall Study|Withdrawal by Subject|0|||
155351099|NCT02820298|560719873|FG001|Overall Study|Withdrawal by Subject|1|||
155351100|NCT02820298|560719872|FG000|Overall Study|Physician Decision|1|||
155351101|NCT02820298|560719873|FG001|Overall Study|Physician Decision|0|||
155351102|NCT02820298|560719872|FG000|Overall Study|Protocol Violation|0|||
155351103|NCT02820298|560719873|FG001|Overall Study|Protocol Violation|1|||
155351104|NCT00141271|560719874|FG000|Overall Study|Adverse Event|31|||
155351105|NCT00141271|560719875|FG001|Overall Study|Adverse Event|19|||
155351106|NCT00141271|560719876|FG002|Overall Study|Adverse Event|17|||
155351107|NCT00141271|560719874|FG000|Overall Study|Laboratory Abnormality|2|||
155351108|NCT00141271|560719875|FG001|Overall Study|Laboratory Abnormality|1|||
155351109|NCT00141271|560719876|FG002|Overall Study|Laboratory Abnormality|1|||
155351110|NCT00141271|560719874|FG000|Overall Study|Lack of Efficacy|7|||
155351111|NCT00141271|560719875|FG001|Overall Study|Lack of Efficacy|7|||
155351112|NCT00141271|560719876|FG002|Overall Study|Lack of Efficacy|3|||
155351113|NCT00141271|560719874|FG000|Overall Study|Lost to Follow-up|15|||
155351114|NCT00141271|560719875|FG001|Overall Study|Lost to Follow-up|15|||
155351115|NCT00141271|560719876|FG002|Overall Study|Lost to Follow-up|21|||
155351116|NCT00141271|560719874|FG000|Overall Study|Withdrawal by Subject|14|||
155351117|NCT00141271|560719875|FG001|Overall Study|Withdrawal by Subject|9|||
155351118|NCT00141271|560719876|FG002|Overall Study|Withdrawal by Subject|10|||
155351119|NCT00141271|560719874|FG000|Overall Study|Other|11|||
155351120|NCT00141271|560719875|FG001|Overall Study|Other|12|||
155351121|NCT00141271|560719876|FG002|Overall Study|Other|5|||
155351122|NCT01374971|560719879|FG000|Overall Study|Withdrawal by Subject|1|||
155351123|NCT02154516|560719880|FG000|Overall Study|Withdrawal by Subject|0|||
155351124|NCT02154516|560719881|FG001|Overall Study|Withdrawal by Subject|1|||
155351125|NCT02154516|560719880|FG000|Overall Study|Lost to Follow-up|1|||
155351126|NCT02154516|560719881|FG001|Overall Study|Lost to Follow-up|0|||
155351127|NCT02154516|560719880|FG000|Overall Study|Removal/revision of device|1|||
155351128|NCT02154516|560719881|FG001|Overall Study|Removal/revision of device|0|||
155351129|NCT02154516|560719880|FG000|Overall Study|Death|2|||
155351130|NCT02154516|560719881|FG001|Overall Study|Death|1|||
155351131|NCT03406507|560719882|FG000|Extension Period|Lack of Efficacy|0|||
155351132|NCT03406507|560719883|FG001|Extension Period|Lack of Efficacy|1|||
155351133|NCT01804140|560719886|FG000|Overall Study|No sampling or biopsy procedures done|114|||
155351134|NCT00547300|560719887|FG000|Overall Study|Study was Administratively Terminated|25|||
155351135|NCT00547300|560719888|FG001|Overall Study|Study was Administratively Terminated|24|||
155351136|NCT00547300|560719887|FG000|Overall Study|Did not Meet Entry Criteria|0|||
155351137|NCT00547300|560719888|FG001|Overall Study|Did not Meet Entry Criteria|2|||
155351138|NCT02965599|560719891|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
155351139|NCT02965599|560719892|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
155351140|NCT04435522|560719896|FG000|Overall Study|Withdrawal by Subject|2|||
155351141|NCT02799745|560719897|FG000|Overall Study|Participant moved out of state|1|||
155351142|NCT02799745|560719898|FG001|Overall Study|Participant moved out of state|0|||
155351143|NCT02799745|560719897|FG000|Overall Study|Discontinued due to planned surgery|1|||
155648171|NCT01028391|561803785|FG000|Overall Study|Physician Decision|0|||
155351144|NCT02799745|560719898|FG001|Overall Study|Discontinued due to planned surgery|0|||
155351145|NCT02799745|560719897|FG000|Overall Study|Withdrawal by Subject|16|||
155351146|NCT02799745|560719898|FG001|Overall Study|Withdrawal by Subject|25|||
155351147|NCT02799745|560719897|FG000|Overall Study|Protocol Deviation|4|||
155351148|NCT02799745|560719898|FG001|Overall Study|Protocol Deviation|5|||
155351149|NCT02799745|560719897|FG000|Overall Study|Progressive Disease|28|||
155351150|NCT02799745|560719898|FG001|Overall Study|Progressive Disease|38|||
155351151|NCT02799745|560719897|FG000|Overall Study|Lost to Follow-up|3|||
155351152|NCT02799745|560719898|FG001|Overall Study|Lost to Follow-up|2|||
155351153|NCT02799745|560719897|FG000|Overall Study|Death|3|||
155351154|NCT02799745|560719898|FG001|Overall Study|Death|0|||
155351155|NCT02799745|560719897|FG000|Overall Study|Adverse Event|0|||
155351156|NCT02799745|560719898|FG001|Overall Study|Adverse Event|1|||
155351157|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
155351158|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
155351159|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
155351160|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
155351161|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
155351162|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
155351163|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
155351164|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
155351165|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
155351166|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
155351167|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
155351168|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
155351169|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
155351170|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
155351171|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
155351172|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
155351173|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
155351174|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
155351175|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
155351176|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
155351177|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
155351178|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
155351179|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
155351180|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
155351181|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
155351182|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
155351183|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
155351184|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
155425556|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
155425557|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
155425558|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
155425559|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
155425560|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
155425561|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
155425562|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
155425563|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
155425564|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
155425565|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
155425566|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
155425567|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
155425568|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
155506327|NCT00950599|561280295|FG002|Follow-Up Period|Lost to Follow-up|0|||
155506328|NCT00950599|561280296|FG003|Follow-Up Period|Lost to Follow-up|0|||
155506329|NCT00950599|561280297|FG004|Follow-Up Period|Lost to Follow-up|0|||
155506330|NCT00950599|561280298|FG005|Follow-Up Period|Lost to Follow-up|0|||
155506331|NCT00950599|561280299|FG006|Follow-Up Period|Lost to Follow-up|0|||
155506332|NCT00950599|561280300|FG007|Follow-Up Period|Lost to Follow-up|0|||
155506333|NCT00950599|561280301|FG008|Follow-Up Period|Lost to Follow-up|5|||
155506334|NCT00950599|561280302|FG009|Follow-Up Period|Lost to Follow-up|1|||
155506335|NCT00950599|561280293|FG000|Follow-Up Period|Physician Decision|0|||
155506336|NCT00950599|561280294|FG001|Follow-Up Period|Physician Decision|0|||
155506337|NCT00950599|561280295|FG002|Follow-Up Period|Physician Decision|0|||
155506338|NCT00950599|561280296|FG003|Follow-Up Period|Physician Decision|0|||
155506339|NCT00950599|561280297|FG004|Follow-Up Period|Physician Decision|0|||
155506340|NCT00950599|561280298|FG005|Follow-Up Period|Physician Decision|0|||
155506341|NCT00950599|561280299|FG006|Follow-Up Period|Physician Decision|0|||
155506342|NCT00950599|561280300|FG007|Follow-Up Period|Physician Decision|0|||
155506343|NCT00950599|561280301|FG008|Follow-Up Period|Physician Decision|1|||
155506344|NCT00950599|561280302|FG009|Follow-Up Period|Physician Decision|0|||
155506345|NCT00950599|561280293|FG000|Follow-Up Period|Poor/Noncompliance|0|||
155506346|NCT00950599|561280294|FG001|Follow-Up Period|Poor/Noncompliance|0|||
155506347|NCT00950599|561280295|FG002|Follow-Up Period|Poor/Noncompliance|0|||
155506348|NCT00950599|561280296|FG003|Follow-Up Period|Poor/Noncompliance|0|||
155506349|NCT00950599|561280297|FG004|Follow-Up Period|Poor/Noncompliance|0|||
155506350|NCT00950599|561280298|FG005|Follow-Up Period|Poor/Noncompliance|0|||
155506351|NCT00950599|561280299|FG006|Follow-Up Period|Poor/Noncompliance|0|||
155506352|NCT00950599|561280300|FG007|Follow-Up Period|Poor/Noncompliance|0|||
155506353|NCT00950599|561280301|FG008|Follow-Up Period|Poor/Noncompliance|1|||
155506354|NCT00950599|561280302|FG009|Follow-Up Period|Poor/Noncompliance|0|||
155506355|NCT00950599|561280293|FG000|Follow-Up Period|Subject withdrew Consent|0|||
155506356|NCT00950599|561280294|FG001|Follow-Up Period|Subject withdrew Consent|0|||
155506357|NCT00950599|561280295|FG002|Follow-Up Period|Subject withdrew Consent|0|||
155506358|NCT00950599|561280296|FG003|Follow-Up Period|Subject withdrew Consent|0|||
155506359|NCT00950599|561280297|FG004|Follow-Up Period|Subject withdrew Consent|0|||
155506360|NCT00950599|561280298|FG005|Follow-Up Period|Subject withdrew Consent|0|||
155506361|NCT00950599|561280299|FG006|Follow-Up Period|Subject withdrew Consent|0|||
155506362|NCT00950599|561280300|FG007|Follow-Up Period|Subject withdrew Consent|0|||
155506363|NCT00950599|561280301|FG008|Follow-Up Period|Subject withdrew Consent|2|||
155506364|NCT00950599|561280302|FG009|Follow-Up Period|Subject withdrew Consent|1|||
155506365|NCT01361607|561280305|FG000|Overall Study|Adverse Event|38|||
155506366|NCT01361607|561280306|FG001|Overall Study|Adverse Event|29|||
155506367|NCT01361607|561280305|FG000|Overall Study|Withdrawal by Subject|19|||
155506368|NCT01361607|561280306|FG001|Overall Study|Withdrawal by Subject|8|||
155506369|NCT01361607|561280305|FG000|Overall Study|Withdrawal by Investigator|5|||
155506370|NCT01361607|561280306|FG001|Overall Study|Withdrawal by Investigator|3|||
155506371|NCT01361607|561280305|FG000|Overall Study|Lost to Follow-up|1|||
155506372|NCT01361607|561280306|FG001|Overall Study|Lost to Follow-up|0|||
155506373|NCT01361607|561280305|FG000|Overall Study|Met Withdrawal Criteria|1|||
155425569|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
155648172|NCT01028391|561803786|FG001|Overall Study|Physician Decision|1|||
155648173|NCT01028391|561803785|FG000|Overall Study|Withdrawal by Subject|6|||
155648174|NCT01028391|561803786|FG001|Overall Study|Withdrawal by Subject|3|||
155425570|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
155506374|NCT01361607|561280306|FG001|Overall Study|Met Withdrawal Criteria|1|||
155506375|NCT01507831|561280307|FG000|Overall Study|Randomized but not treated|0|||
155425571|NCT02660580|560986604|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
155506376|NCT01507831|561280308|FG001|Overall Study|Randomized but not treated|3|||
155506377|NCT01507831|561280307|FG000|Overall Study|Adverse Event|48|||
155506378|NCT01507831|561280308|FG001|Overall Study|Adverse Event|113|||
155506379|NCT01507831|561280307|FG000|Overall Study|Death|6|||
155351185|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
155351186|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351187|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351188|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351189|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
155351190|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351191|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351192|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351193|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
155351194|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
155351195|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
155351196|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
155351197|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
155351198|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
155351199|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
155351200|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
155351201|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
155351202|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
155351203|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
155351204|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
155351205|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Death|2|||
155351206|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Death|0|||
155351207|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Death|1|||
155351208|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Death|0|||
155351209|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
155351210|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
155351211|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
155351212|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
155351213|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
155351214|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
155351215|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
155351216|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
155351217|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
155351218|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
155351219|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
155351220|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
155351221|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Moved|32|||
155351222|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Moved|2|||
155351223|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Moved|28|||
155351224|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Moved|0|||
155351225|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
155351226|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
155351227|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
155351228|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
155351229|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Travel|2|||
155351230|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Travel|0|||
155351231|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Travel|0|||
155351232|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Travel|0|||
155351233|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
155351234|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
155351235|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
155351236|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
155425572|NCT02660580|560986605|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
155425573|NCT02660580|560986606|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
155425574|NCT02660580|560986607|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
155425575|NCT02660580|560986608|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
155425576|NCT05415449|560986609|FG000|Overall Study|Lost to Follow-up|2|||
155425577|NCT05415449|560986609|FG000|Overall Study|Withdrawal by Subject|4|||
155425578|NCT02185521|560986613|FG000|Overall Study|Withdrawal by Subject|1|||
155425579|NCT02185521|560986613|FG000|Overall Study|Protocol Violation|1|||
155425580|NCT01169779|560986614|FG000|Overall Study|Adverse Event|3|||
155351237|NCT00092521|560721574|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351238|NCT00092521|560721575|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351239|NCT00092521|560721576|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351240|NCT00092521|560721577|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
155351241|NCT00092521|560721574|FG000|Extension Study (Group 4)|Adverse Event|0|||
155351242|NCT00092521|560721575|FG001|Extension Study (Group 4)|Adverse Event|0|||
155351243|NCT00092521|560721576|FG002|Extension Study (Group 4)|Adverse Event|0|||
155351244|NCT00092521|560721577|FG003|Extension Study (Group 4)|Adverse Event|2|||
155351245|NCT00092521|560721574|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
155425581|NCT01169779|560986615|FG001|Overall Study|Adverse Event|11|||
155425582|NCT01169779|560986614|FG000|Overall Study|Lack of Efficacy|1|||
155351246|NCT00092521|560721575|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
155351247|NCT00092521|560721576|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
155351248|NCT00092521|560721577|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
155351249|NCT00092521|560721574|FG000|Extension Study (Group 4)|Pregnancy|0|||
155351250|NCT00092521|560721575|FG001|Extension Study (Group 4)|Pregnancy|0|||
155351251|NCT00092521|560721576|FG002|Extension Study (Group 4)|Pregnancy|0|||
155351252|NCT00092521|560721577|FG003|Extension Study (Group 4)|Pregnancy|4|||
155351253|NCT00092521|560721574|FG000|Extension Study (Group 4)|Protocol Violation|0|||
155351254|NCT00092521|560721575|FG001|Extension Study (Group 4)|Protocol Violation|0|||
155351255|NCT00092521|560721576|FG002|Extension Study (Group 4)|Protocol Violation|0|||
155351256|NCT00092521|560721577|FG003|Extension Study (Group 4)|Protocol Violation|2|||
155351257|NCT00092521|560721574|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351258|NCT00092521|560721575|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351259|NCT00092521|560721576|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351260|NCT00092521|560721577|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
155351261|NCT00092521|560721574|FG000|Extension Study (Group 4)|Moved|0|||
155351262|NCT00092521|560721575|FG001|Extension Study (Group 4)|Moved|0|||
155351263|NCT00092521|560721576|FG002|Extension Study (Group 4)|Moved|0|||
155351264|NCT00092521|560721577|FG003|Extension Study (Group 4)|Moved|16|||
155351265|NCT00092521|560721574|FG000|Extension Study (Group 4)|Site Terminated|0|||
155351266|NCT00092521|560721575|FG001|Extension Study (Group 4)|Site Terminated|0|||
155351267|NCT00092521|560721576|FG002|Extension Study (Group 4)|Site Terminated|0|||
155351268|NCT00092521|560721577|FG003|Extension Study (Group 4)|Site Terminated|4|||
155351269|NCT00092521|560721574|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351270|NCT00092521|560721575|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351271|NCT00092521|560721576|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351272|NCT00092521|560721577|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
155351273|NCT01878383|560721578|FG000|Overall Study|Lost to Follow-up|0|||
155351274|NCT01878383|560721579|FG001|Overall Study|Lost to Follow-up|1499|||
155351275|NCT03464383|560721580|FG000|Overall Study|Lost to Follow-up|1|||
155351276|NCT03464383|560721581|FG001|Overall Study|Lost to Follow-up|0|||
155351277|NCT03464383|560721582|FG002|Overall Study|Lost to Follow-up|0|||
155351278|NCT03464383|560721580|FG000|Overall Study|Withdrawal by Subject|0|||
155351279|NCT03464383|560721581|FG001|Overall Study|Withdrawal by Subject|1|||
155351280|NCT03464383|560721582|FG002|Overall Study|Withdrawal by Subject|0|||
155351281|NCT00560313|560721583|FG000|Overall Study|Adverse Events or Death|2|||
155351282|NCT00560313|560721583|FG000|Overall Study|Withdrawal by Subject|2|||
155351283|NCT00560313|560721583|FG000|Overall Study|Lost to Follow-up|1|||
155351284|NCT00560313|560721583|FG000|Overall Study|Protocol Violation|1|||
155351285|NCT03475056|560721584|FG000|Overall Study|Lost to Follow-up|0|||
155351286|NCT03475056|560721585|FG001|Overall Study|Lost to Follow-up|1|||
155351287|NCT03475056|560721584|FG000|Overall Study|Moved from Area|0|||
155351288|NCT03475056|560721585|FG001|Overall Study|Moved from Area|2|||
155351289|NCT00113269|560721588|FG000|Overall Study|Not transplanted, donor issues|4|||
155351290|NCT00113269|560721589|FG001|Overall Study|Not transplanted, donor issues|0|||
155351291|NCT00113269|560721590|FG002|Overall Study|Not transplanted, donor issues|2|||
155351292|NCT00113269|560721591|FG003|Overall Study|Not transplanted, donor issues|2|||
155351293|NCT00113269|560721588|FG000|Overall Study|Not transplanted, recipient issues|2|||
155351294|NCT00113269|560721589|FG001|Overall Study|Not transplanted, recipient issues|1|||
155351295|NCT00113269|560721590|FG002|Overall Study|Not transplanted, recipient issues|7|||
155351296|NCT00113269|560721591|FG003|Overall Study|Not transplanted, recipient issues|4|||
155351297|NCT00113269|560721588|FG000|Overall Study|Early graft loss, technical|0|||
155351298|NCT00113269|560721589|FG001|Overall Study|Early graft loss, technical|0|||
155351299|NCT00113269|560721590|FG002|Overall Study|Early graft loss, technical|2|||
155351300|NCT00113269|560721591|FG003|Overall Study|Early graft loss, technical|0|||
155351301|NCT00113269|560721588|FG000|Overall Study|Death in operating room|0|||
155351302|NCT00113269|560721589|FG001|Overall Study|Death in operating room|0|||
155351303|NCT00113269|560721590|FG002|Overall Study|Death in operating room|0|||
155351304|NCT00113269|560721591|FG003|Overall Study|Death in operating room|1|||
155351305|NCT00113269|560721588|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351306|NCT00113269|560721589|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351307|NCT00113269|560721590|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351308|NCT00113269|560721591|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
155351309|NCT00113269|560721588|FG000|Overall Study|Adverse Event|2|||
155351310|NCT00113269|560721589|FG001|Overall Study|Adverse Event|7|||
155351311|NCT00113269|560721590|FG002|Overall Study|Adverse Event|11|||
155351312|NCT00113269|560721591|FG003|Overall Study|Adverse Event|7|||
155351313|NCT00113269|560721588|FG000|Overall Study|Withdrawal by Subject|4|||
155351314|NCT00113269|560721589|FG001|Overall Study|Withdrawal by Subject|3|||
155351315|NCT00113269|560721590|FG002|Overall Study|Withdrawal by Subject|4|||
155351316|NCT00113269|560721591|FG003|Overall Study|Withdrawal by Subject|2|||
155351317|NCT00113269|560721588|FG000|Overall Study|Graft loss|6|||
155351318|NCT00113269|560721589|FG001|Overall Study|Graft loss|6|||
155351319|NCT00113269|560721590|FG002|Overall Study|Graft loss|4|||
155351320|NCT00113269|560721591|FG003|Overall Study|Graft loss|9|||
155351321|NCT00113269|560721588|FG000|Overall Study|Protocol Violation|1|||
155351322|NCT00113269|560721589|FG001|Overall Study|Protocol Violation|0|||
155351323|NCT00113269|560721590|FG002|Overall Study|Protocol Violation|4|||
155351324|NCT00113269|560721591|FG003|Overall Study|Protocol Violation|2|||
155351325|NCT00113269|560721588|FG000|Overall Study|Lost to Follow-up|2|||
155351326|NCT00113269|560721589|FG001|Overall Study|Lost to Follow-up|3|||
155351327|NCT00113269|560721590|FG002|Overall Study|Lost to Follow-up|6|||
155351328|NCT00113269|560721591|FG003|Overall Study|Lost to Follow-up|3|||
155351329|NCT00113269|560721588|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
155351330|NCT00113269|560721589|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
155351331|NCT00113269|560721590|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
155351332|NCT00113269|560721591|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
155351333|NCT00113269|560721588|FG000|Overall Study|Discontinued due to rejection|0|||
155351334|NCT00113269|560721589|FG001|Overall Study|Discontinued due to rejection|0|||
155351335|NCT00113269|560721590|FG002|Overall Study|Discontinued due to rejection|1|||
155351336|NCT00113269|560721591|FG003|Overall Study|Discontinued due to rejection|0|||
155351337|NCT00113269|560721588|FG000|Overall Study|Moved|0|||
155351338|NCT00113269|560721589|FG001|Overall Study|Moved|1|||
155351339|NCT00113269|560721590|FG002|Overall Study|Moved|0|||
155351340|NCT00113269|560721591|FG003|Overall Study|Moved|3|||
155351341|NCT00113269|560721588|FG000|Overall Study|Received pancreas transplant|0|||
155351342|NCT00113269|560721589|FG001|Overall Study|Received pancreas transplant|0|||
155425583|NCT01169779|560986615|FG001|Overall Study|Lack of Efficacy|0|||
155425584|NCT01169779|560986614|FG000|Overall Study|Protocol Violation|1|||
155425585|NCT01169779|560986615|FG001|Overall Study|Protocol Violation|1|||
155351343|NCT00113269|560721590|FG002|Overall Study|Received pancreas transplant|0|||
155351344|NCT00113269|560721591|FG003|Overall Study|Received pancreas transplant|2|||
155351345|NCT00113269|560721588|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351346|NCT00113269|560721589|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351347|NCT00113269|560721590|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351348|NCT00113269|560721591|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
155425586|NCT01169779|560986614|FG000|Overall Study|Withdrawal by Subject|3|||
155351349|NCT00113269|560721588|FG000|Overall Study|Did not meet eligibility criteria|1|||
155351350|NCT00113269|560721589|FG001|Overall Study|Did not meet eligibility criteria|0|||
155351351|NCT00113269|560721590|FG002|Overall Study|Did not meet eligibility criteria|0|||
155425587|NCT01169779|560986615|FG001|Overall Study|Withdrawal by Subject|2|||
155425588|NCT01169779|560986614|FG000|Overall Study|Familial and personal reasons|3|||
155351352|NCT00113269|560721591|FG003|Overall Study|Did not meet eligibility criteria|1|||
155351353|NCT00113269|560721588|FG000|Overall Study|Unable to return for follow up|2|||
155351354|NCT00113269|560721589|FG001|Overall Study|Unable to return for follow up|1|||
155351355|NCT00113269|560721590|FG002|Overall Study|Unable to return for follow up|0|||
155351356|NCT00113269|560721591|FG003|Overall Study|Unable to return for follow up|0|||
155351357|NCT01960348|560721598|FG000|Overall Study|Adverse event, not serious|2|||
155351358|NCT01960348|560721599|FG001|Overall Study|Adverse event, not serious|2|||
155351359|NCT01960348|560721598|FG000|Overall Study|Adverse event, serious fatal|6|||
155351360|NCT01960348|560721599|FG001|Overall Study|Adverse event, serious fatal|5|||
155351361|NCT01960348|560721598|FG000|Overall Study|Adverse event, serious non-fatal|0|||
155351362|NCT01960348|560721599|FG001|Overall Study|Adverse event, serious non-fatal|3|||
155351363|NCT01960348|560721598|FG000|Overall Study|Withdrawal by Subject|1|||
155351364|NCT01960348|560721599|FG001|Overall Study|Withdrawal by Subject|11|||
155351365|NCT01960348|560721598|FG000|Overall Study|Physician Decision|0|||
155351366|NCT01960348|560721599|FG001|Overall Study|Physician Decision|1|||
155351367|NCT01960348|560721598|FG000|Overall Study|Protocol Violation|1|||
155351368|NCT01960348|560721599|FG001|Overall Study|Protocol Violation|0|||
155351369|NCT01580995|560721600|FG000|Overall Study|Lost to Follow-up|2|||
155351370|NCT01580995|560721601|FG001|Overall Study|Lost to Follow-up|2|||
155351371|NCT01821729|560721602|FG000|Overall Study|Withdrawal by Subject|1|||
155351372|NCT02517528|560721603|FG000|Overall Study|Withdrawal by Subject|1|||
155351373|NCT01644188|560721607|FG000|Overall Study|Adverse Event|44|||
155351374|NCT01644188|560721608|FG001|Overall Study|Adverse Event|20|||
155351375|NCT01644188|560721607|FG000|Overall Study|Poor compliance to protocol|26|||
155351376|NCT01644188|560721608|FG001|Overall Study|Poor compliance to protocol|14|||
155351377|NCT01644188|560721607|FG000|Overall Study|Physician Decision|1|||
155351378|NCT01644188|560721608|FG001|Overall Study|Physician Decision|3|||
155351379|NCT01644188|560721607|FG000|Overall Study|Participant moved|7|||
155351380|NCT01644188|560721608|FG001|Overall Study|Participant moved|2|||
155351381|NCT01644188|560721607|FG000|Overall Study|Related to auto-injector administration|2|||
155351382|NCT01644188|560721608|FG001|Overall Study|Related to auto-injector administration|2|||
155351383|NCT01644188|560721607|FG000|Overall Study|Consent withdrawn by participant|14|||
155351384|NCT01644188|560721608|FG001|Overall Study|Consent withdrawn by participant|7|||
155351385|NCT01644188|560721607|FG000|Overall Study|Selection criteria finally not met|2|||
155351386|NCT01644188|560721608|FG001|Overall Study|Selection criteria finally not met|0|||
155351387|NCT01644188|560721607|FG000|Overall Study|Lost to Follow-up|1|||
155351388|NCT01644188|560721608|FG001|Overall Study|Lost to Follow-up|0|||
155351389|NCT01644188|560721607|FG000|Overall Study|Death|4|||
155506380|NCT01507831|561280308|FG001|Overall Study|Death|2|||
155506381|NCT01507831|561280307|FG000|Overall Study|Poor compliance to protocol|38|||
155506382|NCT01507831|561280308|FG001|Overall Study|Poor compliance to protocol|60|||
155506383|NCT01507831|561280307|FG000|Overall Study|Physician Decision|0|||
155506384|NCT01507831|561280308|FG001|Overall Study|Physician Decision|4|||
155506385|NCT01507831|561280307|FG000|Overall Study|Participant moved|5|||
155506386|NCT01507831|561280308|FG001|Overall Study|Participant moved|19|||
155506387|NCT01507831|561280307|FG000|Overall Study|Consent withdrawn by participant|34|||
155506388|NCT01507831|561280308|FG001|Overall Study|Consent withdrawn by participant|72|||
155648175|NCT01028391|561803785|FG000|Overall Study|Needed excluded medication|1|||
155648176|NCT01028391|561803786|FG001|Overall Study|Needed excluded medication|1|||
155648177|NCT00837330|561803787|FG000|Overall Study|Lost to Follow-up|1|||
155648178|NCT00837330|561803788|FG001|Overall Study|Lost to Follow-up|3|||
155648179|NCT01227395|561803789|FG000|Overall Study|Protocol Violation|0|||
155648180|NCT01227395|561803790|FG001|Overall Study|Protocol Violation|1|||
155648181|NCT00694122|561803795|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
155351390|NCT01644188|560721608|FG001|Overall Study|Death|3|||
155351391|NCT01644188|560721607|FG000|Overall Study|Last visit outside protocol visit window|14|||
155351392|NCT01644188|560721608|FG001|Overall Study|Last visit outside protocol visit window|16|||
155351393|NCT01644188|560721607|FG000|Overall Study|Site closure|1|||
155351394|NCT01644188|560721608|FG001|Overall Study|Site closure|1|||
155351395|NCT01644188|560721607|FG000|Overall Study|Other than specified above|6|||
155351396|NCT01644188|560721608|FG001|Overall Study|Other than specified above|7|||
155351397|NCT01845649|560721614|FG000|Overall Study|Adverse Event|7|||
155506389|NCT01507831|561280307|FG000|Overall Study|Related to study drug administration|5|||
155351398|NCT01845649|560721615|FG001|Overall Study|Adverse Event|10|||
155506390|NCT01507831|561280308|FG001|Overall Study|Related to study drug administration|14|||
155351399|NCT01845649|560721614|FG000|Overall Study|Lack of Efficacy|1|||
155351400|NCT01845649|560721615|FG001|Overall Study|Lack of Efficacy|1|||
155648182|NCT00694122|561803796|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
155648183|NCT00694122|561803795|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
155506391|NCT01507831|561280307|FG000|Overall Study|Last visit outside protocol visit window|51|||
155351401|NCT01845649|560721614|FG000|Overall Study|Lost to Follow-up|2|||
155351402|NCT01845649|560721615|FG001|Overall Study|Lost to Follow-up|2|||
155351403|NCT01845649|560721614|FG000|Overall Study|Withdrew Consent|12|||
155351404|NCT01845649|560721615|FG001|Overall Study|Withdrew Consent|4|||
155351405|NCT01845649|560721614|FG000|Overall Study|Protocol Deviation|7|||
155351406|NCT01845649|560721615|FG001|Overall Study|Protocol Deviation|4|||
155351407|NCT01845649|560721614|FG000|Overall Study|Reason not Specified|2|||
155351408|NCT01845649|560721615|FG001|Overall Study|Reason not Specified|1|||
155351409|NCT04140266|560721621|FG000|Overall Study|Physician Decision|2|||
155351410|NCT04140266|560721622|FG001|Overall Study|Physician Decision|0|||
155351411|NCT04140266|560721621|FG000|Overall Study|Withdrawal by Subject|4|||
155351412|NCT04140266|560721622|FG001|Overall Study|Withdrawal by Subject|2|||
155351413|NCT00721214|560721623|FG000|Overall Study|Chose another center for transplant|1|||
155351414|NCT00721214|560721623|FG000|Overall Study|Death|3|||
155351415|NCT00983905|560721624|FG000|Theophylline Alone|Adverse Event|1|||
155351416|NCT00983905|560721624|FG000|Colchicine Alone|Adverse Event|2|||
155351417|NCT01169636|560721625|FG000|Overall Study|Adverse Event|0|||
155351418|NCT01169636|560721626|FG001|Overall Study|Adverse Event|0|||
155351419|NCT01169636|560721627|FG002|Overall Study|Adverse Event|1|||
155351420|NCT01169636|560721628|FG003|Overall Study|Adverse Event|1|||
155351421|NCT01169636|560721629|FG004|Overall Study|Adverse Event|0|||
155351422|NCT01169636|560721625|FG000|Overall Study|Screen failure|0|||
155351423|NCT01169636|560721626|FG001|Overall Study|Screen failure|0|||
155351424|NCT01169636|560721627|FG002|Overall Study|Screen failure|2|||
155351425|NCT01169636|560721628|FG003|Overall Study|Screen failure|0|||
155351426|NCT01169636|560721629|FG004|Overall Study|Screen failure|0|||
155351427|NCT01169636|560721625|FG000|Overall Study|Withdrawal by Subject|0|||
155351428|NCT01169636|560721626|FG001|Overall Study|Withdrawal by Subject|0|||
155351429|NCT01169636|560721627|FG002|Overall Study|Withdrawal by Subject|0|||
155425589|NCT01169779|560986615|FG001|Overall Study|Familial and personal reasons|3|||
155425590|NCT03293654|560986616|FG000|Overall Study|Lost to Follow-up|0|||
155425591|NCT03293654|560986617|FG001|Overall Study|Lost to Follow-up|1|||
155425592|NCT03293654|560986618|FG002|Overall Study|Lost to Follow-up|0|||
155425593|NCT05052723|560986620|FG000|Overall Study|Death|19|||
155425594|NCT01933932|560986621|FG000|Overall Study|Death|173|||
155425595|NCT01933932|560986622|FG001|Overall Study|Death|163|||
155425596|NCT01933932|560986621|FG000|Overall Study|Withdrawal by Subject|11|||
155425597|NCT01933932|560986622|FG001|Overall Study|Withdrawal by Subject|14|||
155425598|NCT01933932|560986621|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155425599|NCT01933932|560986622|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155425600|NCT03155997|560986624|FG000|Overall Study|Withdrawal by Subject|119|||
155425601|NCT03155997|560986625|FG001|Overall Study|Withdrawal by Subject|134|||
155425602|NCT03155997|560986624|FG000|Overall Study|Lost to Follow-up|12|||
155425603|NCT03155997|560986625|FG001|Overall Study|Lost to Follow-up|13|||
155425604|NCT03155997|560986624|FG000|Overall Study|Missing disposition data|0|||
155425605|NCT03155997|560986625|FG001|Overall Study|Missing disposition data|1|||
155425606|NCT03155997|560986624|FG000|Overall Study|On study treatment|2027|||
155425607|NCT03155997|560986625|FG001|Overall Study|On study treatment|2074|||
155425608|NCT02054702|560986633|FG000|Overall Study|Lost to Follow-up|3|||
155425609|NCT02054702|560986634|FG001|Overall Study|Lost to Follow-up|5|||
155425610|NCT02054702|560986633|FG000|Overall Study|Adverse Event|3|||
155425611|NCT02054702|560986634|FG001|Overall Study|Adverse Event|1|||
155425612|NCT02054702|560986633|FG000|Overall Study|Met Withdrawal Criteria|4|||
155351430|NCT01169636|560721628|FG003|Overall Study|Withdrawal by Subject|0|||
155351431|NCT01169636|560721629|FG004|Overall Study|Withdrawal by Subject|3|||
155351432|NCT02396953|560721630|FG000|Overall Study|Withdrawal by Subject|0|||
155351433|NCT02396953|560721631|FG001|Overall Study|Withdrawal by Subject|0|||
155351434|NCT02396953|560721632|FG002|Overall Study|Withdrawal by Subject|1|||
155351435|NCT02396953|560721630|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
155351436|NCT02396953|560721631|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
155351437|NCT02396953|560721632|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
155425613|NCT02054702|560986634|FG001|Overall Study|Met Withdrawal Criteria|1|||
155425614|NCT02054702|560986633|FG000|Overall Study|Physician Decision|0|||
155351438|NCT02396953|560721630|FG000|Overall Study|Personal Reasons|1|||
155351439|NCT02396953|560721631|FG001|Overall Study|Personal Reasons|1|||
155351440|NCT02396953|560721632|FG002|Overall Study|Personal Reasons|0|||
155351441|NCT02994784|560721634|FG000|6 Months Follow-up|Lost to Follow-up|3|||
155351442|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
155351443|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
155425615|NCT02054702|560986634|FG001|Overall Study|Physician Decision|1|||
155425616|NCT02054702|560986633|FG000|Overall Study|Withdrawal by Subject|14|||
155425617|NCT02054702|560986634|FG001|Overall Study|Withdrawal by Subject|4|||
155425618|NCT00934102|560986635|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
155425619|NCT00934102|560986636|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
155425620|NCT00934102|560986637|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
155425621|NCT01262898|560986638|FG000|Overall Study|Protocol Violation|1|||
155425622|NCT01262898|560986639|FG001|Overall Study|Protocol Violation|1|||
155425623|NCT01262898|560986640|FG002|Overall Study|Protocol Violation|0|||
155351444|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
155351445|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
155351446|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
155351447|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
155351448|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Missing|2|||
155351449|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Missing|2|||
155351450|NCT01649557|560721638|FG000|Overall Study|Lost to Follow-up|5|||
155351451|NCT01649557|560721639|FG001|Overall Study|Lost to Follow-up|0|||
155425624|NCT01262898|560986641|FG003|Overall Study|Protocol Violation|0|||
155425625|NCT01262898|560986638|FG000|Overall Study|Lost to Follow-up|1|||
155351452|NCT01649557|560721640|FG002|Overall Study|Lost to Follow-up|3|||
155351453|NCT01649557|560721638|FG000|Overall Study|Adverse Event|7|||
155351454|NCT01649557|560721639|FG001|Overall Study|Adverse Event|5|||
155351455|NCT01649557|560721640|FG002|Overall Study|Adverse Event|1|||
155351456|NCT01649557|560721638|FG000|Overall Study|Met withdrawal criteria|4|||
155351457|NCT01649557|560721639|FG001|Overall Study|Met withdrawal criteria|0|||
155425626|NCT01262898|560986639|FG001|Overall Study|Lost to Follow-up|0|||
155351458|NCT01649557|560721640|FG002|Overall Study|Met withdrawal criteria|0|||
155351459|NCT01649557|560721638|FG000|Overall Study|Physician Decision|8|||
155351460|NCT01649557|560721639|FG001|Overall Study|Physician Decision|2|||
155351461|NCT01649557|560721640|FG002|Overall Study|Physician Decision|1|||
155351462|NCT01649557|560721638|FG000|Overall Study|Withdrawal by Subject|15|||
155351463|NCT01649557|560721639|FG001|Overall Study|Withdrawal by Subject|5|||
155351464|NCT01649557|560721640|FG002|Overall Study|Withdrawal by Subject|4|||
155351465|NCT01649557|560721638|FG000|Overall Study|Protocol deviation|0|||
155351466|NCT01649557|560721639|FG001|Overall Study|Protocol deviation|2|||
155351467|NCT01649557|560721640|FG002|Overall Study|Protocol deviation|0|||
155351468|NCT01649557|560721638|FG000|Overall Study|Lack of Efficacy|5|||
155351469|NCT01649557|560721639|FG001|Overall Study|Lack of Efficacy|0|||
155351470|NCT01649557|560721640|FG002|Overall Study|Lack of Efficacy|0|||
155351471|NCT01011049|560721641|FG000|Overall Study|Protocol Violation|0|||
155425627|NCT01262898|560986640|FG002|Overall Study|Lost to Follow-up|0|||
155506392|NCT01507831|561280308|FG001|Overall Study|Last visit outside protocol visit window|143|||
155425628|NCT01262898|560986641|FG003|Overall Study|Lost to Follow-up|0|||
155425629|NCT01262898|560986638|FG000|Overall Study|Withdrawal by Subject|1|||
155425630|NCT01262898|560986639|FG001|Overall Study|Withdrawal by Subject|1|||
155425631|NCT01262898|560986640|FG002|Overall Study|Withdrawal by Subject|0|||
155425632|NCT01262898|560986641|FG003|Overall Study|Withdrawal by Subject|0|||
155425633|NCT00792298|560986642|FG000|Treatment Period 1|Adverse Event|0|||
155425634|NCT00792298|560986643|FG001|Treatment Period 1|Adverse Event|1|||
155425635|NCT00792298|560986644|FG002|Treatment Period 1|Adverse Event|0|||
155425636|NCT00792298|560986645|FG003|Treatment Period 1|Adverse Event|1|||
155425637|NCT00792298|560986646|FG004|Treatment Period 1|Adverse Event|0|||
155425638|NCT00792298|560986647|FG005|Treatment Period 1|Adverse Event|1|||
155425639|NCT00792298|560986648|FG006|Treatment Period 1|Adverse Event|1|||
155425640|NCT00792298|560986649|FG007|Treatment Period 1|Adverse Event|0|||
155425641|NCT00792298|560986642|FG000|Treatment Period 1|Lack of Efficacy|0|||
155425642|NCT00792298|560986643|FG001|Treatment Period 1|Lack of Efficacy|0|||
155425643|NCT00792298|560986644|FG002|Treatment Period 1|Lack of Efficacy|1|||
155425644|NCT00792298|560986645|FG003|Treatment Period 1|Lack of Efficacy|0|||
155425645|NCT00792298|560986646|FG004|Treatment Period 1|Lack of Efficacy|0|||
155425646|NCT00792298|560986647|FG005|Treatment Period 1|Lack of Efficacy|0|||
155425647|NCT00792298|560986648|FG006|Treatment Period 1|Lack of Efficacy|0|||
155425648|NCT00792298|560986649|FG007|Treatment Period 1|Lack of Efficacy|0|||
155425649|NCT00792298|560986642|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155425650|NCT00792298|560986643|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155425651|NCT00792298|560986644|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155425652|NCT00792298|560986645|FG003|Treatment Period 1|Withdrawal by Subject|2|||
155425653|NCT00792298|560986646|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155425654|NCT00792298|560986647|FG005|Treatment Period 1|Withdrawal by Subject|2|||
155425655|NCT00792298|560986648|FG006|Treatment Period 1|Withdrawal by Subject|1|||
155425656|NCT00792298|560986649|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155425657|NCT00792298|560986642|FG000|Treatment Period 1|Lost to Follow-up|0|||
155425658|NCT00792298|560986643|FG001|Treatment Period 1|Lost to Follow-up|0|||
155425659|NCT00792298|560986644|FG002|Treatment Period 1|Lost to Follow-up|0|||
155425660|NCT00792298|560986645|FG003|Treatment Period 1|Lost to Follow-up|0|||
155425661|NCT00792298|560986646|FG004|Treatment Period 1|Lost to Follow-up|0|||
155425662|NCT00792298|560986647|FG005|Treatment Period 1|Lost to Follow-up|0|||
155425663|NCT00792298|560986648|FG006|Treatment Period 1|Lost to Follow-up|1|||
155425664|NCT00792298|560986649|FG007|Treatment Period 1|Lost to Follow-up|0|||
155351472|NCT01011049|560721642|FG001|Overall Study|Protocol Violation|0|||
155351473|NCT01011049|560721643|FG002|Overall Study|Protocol Violation|2|||
155351474|NCT01011049|560721644|FG003|Overall Study|Protocol Violation|0|||
155351475|NCT01011049|560721641|FG000|Overall Study|Lost to Follow-up|1|||
155351476|NCT01011049|560721642|FG001|Overall Study|Lost to Follow-up|2|||
155425665|NCT00792298|560986642|FG000|Treatment Period 1|Physician Decision|0|||
155425666|NCT00792298|560986643|FG001|Treatment Period 1|Physician Decision|0|||
155425667|NCT00792298|560986644|FG002|Treatment Period 1|Physician Decision|0|||
155425668|NCT00792298|560986645|FG003|Treatment Period 1|Physician Decision|1|||
155425669|NCT00792298|560986646|FG004|Treatment Period 1|Physician Decision|0|||
155425670|NCT00792298|560986647|FG005|Treatment Period 1|Physician Decision|0|||
155425671|NCT00792298|560986648|FG006|Treatment Period 1|Physician Decision|1|||
155425672|NCT00792298|560986649|FG007|Treatment Period 1|Physician Decision|0|||
155351477|NCT01011049|560721643|FG002|Overall Study|Lost to Follow-up|1|||
155351478|NCT01011049|560721644|FG003|Overall Study|Lost to Follow-up|0|||
155351479|NCT01011049|560721641|FG000|Overall Study|Withdrawal by Subject|0|||
155351480|NCT01011049|560721642|FG001|Overall Study|Withdrawal by Subject|0|||
155351481|NCT01011049|560721643|FG002|Overall Study|Withdrawal by Subject|1|||
155351482|NCT01011049|560721644|FG003|Overall Study|Withdrawal by Subject|0|||
155506393|NCT01507831|561280307|FG000|Overall Study|Selection criteria finally not met|0|||
155506394|NCT01507831|561280308|FG001|Overall Study|Selection criteria finally not met|1|||
155506395|NCT01507831|561280307|FG000|Overall Study|Site closure|0|||
155506396|NCT01507831|561280308|FG001|Overall Study|Site closure|3|||
155506397|NCT01507831|561280307|FG000|Overall Study|Potential lost to follow-up|3|||
155506398|NCT01507831|561280308|FG001|Overall Study|Potential lost to follow-up|0|||
155506399|NCT01507831|561280307|FG000|Overall Study|Other|3|||
155506400|NCT01507831|561280308|FG001|Overall Study|Other|6|||
155506401|NCT01280981|561280309|FG000|Overall Study|Withdrawal by Subject|11|||
155506402|NCT01280981|561280309|FG000|Overall Study|Protocol Violation|2|||
155506403|NCT01280981|561280309|FG000|Overall Study|Lack of Efficacy|13|||
155506404|NCT01280981|561280309|FG000|Overall Study|Lost to Follow-up|3|||
155506405|NCT01280981|561280309|FG000|Overall Study|Adverse Event|6|||
155506406|NCT01280981|561280309|FG000|Overall Study|Irregular or discontinued menses|3|||
155506407|NCT01280981|561280309|FG000|Overall Study|Failed to return|45|||
155506408|NCT01280981|561280309|FG000|Overall Study|Non-compliance with protocol|3|||
155506409|NCT01280981|561280309|FG000|Overall Study|Withdrawal of consent|3|||
155506410|NCT01280981|561280309|FG000|Overall Study|Elective surgery|2|||
155506411|NCT01280981|561280309|FG000|Overall Study|Study site closure|1|||
155506412|NCT05037409|561280314|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
155506413|NCT05037409|561280315|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
155506414|NCT05037409|561280316|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
155506415|NCT03499249|561280317|FG000|Overall Study|Physician Decision|1|||
155506416|NCT02475980|561280320|FG000|Overall Study|Lost to Follow-up|4|||
155506417|NCT02475980|561280320|FG000|Overall Study|Withdrawal by Subject|1|||
155506418|NCT02094937|561280324|FG000|8 Weeks in Period 1|Adverse Event|9|||
155506419|NCT02094937|561280325|FG001|8 Weeks in Period 1|Adverse Event|0|||
155506420|NCT02094937|561280326|FG002|8 Weeks in Period 1|Adverse Event|0|||
155506421|NCT02094937|561280327|FG003|8 Weeks in Period 1|Adverse Event|0|||
155506422|NCT02094937|561280324|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
155506423|NCT02094937|561280325|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
155506424|NCT02094937|561280326|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
155506425|NCT02094937|561280327|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
155506426|NCT02094937|561280324|FG000|8 Weeks in Period 1|Protocol Violation|2|||
155506427|NCT02094937|561280325|FG001|8 Weeks in Period 1|Protocol Violation|0|||
155506428|NCT02094937|561280326|FG002|8 Weeks in Period 1|Protocol Violation|0|||
155351483|NCT02435381|560721645|FG000|Overall Study|Lost to Follow-up|2|||
155351484|NCT02435381|560721646|FG001|Overall Study|Lost to Follow-up|1|||
155351485|NCT04150341|560721649|FG000|Overall Study|Physician Decision|0|||
155506429|NCT02094937|561280327|FG003|8 Weeks in Period 1|Protocol Violation|0|||
155506430|NCT02094937|561280324|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
155506431|NCT02094937|561280325|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
155506432|NCT02094937|561280326|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
155506433|NCT02094937|561280327|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
155506434|NCT02094937|561280324|FG000|8 Weeks in Period 1|Physician Decision|1|||
155506435|NCT02094937|561280325|FG001|8 Weeks in Period 1|Physician Decision|0|||
155506436|NCT02094937|561280326|FG002|8 Weeks in Period 1|Physician Decision|0|||
155506437|NCT02094937|561280327|FG003|8 Weeks in Period 1|Physician Decision|0|||
155506438|NCT02094937|561280324|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
155506439|NCT02094937|561280325|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
155506440|NCT02094937|561280326|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
155506441|NCT02094937|561280327|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
155648184|NCT00694122|561803796|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
155351486|NCT04150341|560721650|FG001|Overall Study|Physician Decision|0|||
155351487|NCT04150341|560721651|FG002|Overall Study|Physician Decision|1|||
155506442|NCT02094937|561280324|FG000|12 Weeks in Period 2|Adverse Event|0|||
155351488|NCT04150341|560721652|FG003|Overall Study|Physician Decision|0|||
155506443|NCT02094937|561280325|FG001|12 Weeks in Period 2|Adverse Event|2|||
155506444|NCT02094937|561280326|FG002|12 Weeks in Period 2|Adverse Event|4|||
155506445|NCT02094937|561280327|FG003|12 Weeks in Period 2|Adverse Event|1|||
155506446|NCT02094937|561280324|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
155506447|NCT02094937|561280325|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
155506448|NCT02094937|561280326|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
155506449|NCT02094937|561280327|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
155648185|NCT00694122|561803795|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
155648186|NCT00694122|561803796|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
155648187|NCT00105508|561803797|FG000|Overall Study|Prephase Dropout|1|||
155648188|NCT00105508|561803798|FG001|Overall Study|Prephase Dropout|0|||
155648189|NCT00105508|561803797|FG000|Overall Study|Adverse Event|16|||
155648190|NCT00105508|561803798|FG001|Overall Study|Adverse Event|19|||
155648191|NCT00105508|561803797|FG000|Overall Study|Insufficient Efficacy|1|||
155648192|NCT00105508|561803798|FG001|Overall Study|Insufficient Efficacy|0|||
155648193|NCT00105508|561803797|FG000|Overall Study|Withdrawal by Subject|10|||
155648194|NCT00105508|561803798|FG001|Overall Study|Withdrawal by Subject|6|||
155648195|NCT00105508|561803797|FG000|Overall Study|Lost to Follow-up|3|||
155648196|NCT00105508|561803798|FG001|Overall Study|Lost to Follow-up|0|||
155648197|NCT00105508|561803797|FG000|Overall Study|Protocol Violation|1|||
155648198|NCT00105508|561803798|FG001|Overall Study|Protocol Violation|2|||
155648199|NCT00105508|561803797|FG000|Overall Study|Other|8|||
155648200|NCT00105508|561803798|FG001|Overall Study|Other|9|||
155648201|NCT00683384|561803799|FG000|Overall Study|Death|1|||
155648202|NCT00683384|561803799|FG000|Overall Study|Adverse Event|1|||
155648203|NCT00120874|561803800|FG000|Overall Study|Death|0|||
155648204|NCT00120874|561803801|FG001|Overall Study|Death|1|||
155648205|NCT00300495|561803810|FG000|Overall Study|Protocol Violation|4|||
155648206|NCT00300495|561803811|FG001|Overall Study|Protocol Violation|1|||
155648207|NCT01348490|561803812|FG000|Overall Study|Death|1|||
155648208|NCT01348490|561803812|FG000|Overall Study|Adverse Event|3|||
155648209|NCT01348490|561803812|FG000|Overall Study|Consent withdrawn|7|||
155648210|NCT01348490|561803812|FG000|Overall Study|Disease progression|3|||
155648211|NCT01348490|561803812|FG000|Overall Study|Lost to Follow-up|1|||
155648212|NCT01348490|561803812|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
155648213|NCT01348490|561803812|FG000|Overall Study|Other Unspecified|8|||
155648214|NCT03632720|561803813|FG000|Overall Study|Adverse Event|2|||
155648215|NCT03632720|561803814|FG001|Overall Study|Adverse Event|0|||
155648216|NCT03632720|561803815|FG002|Overall Study|Adverse Event|0|||
155648217|NCT03632720|561803813|FG000|Overall Study|Lost to Follow-up|0|||
155648218|NCT03632720|561803814|FG001|Overall Study|Lost to Follow-up|1|||
155648219|NCT03632720|561803815|FG002|Overall Study|Lost to Follow-up|0|||
155648220|NCT03632720|561803813|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
155648221|NCT03632720|561803814|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
155648222|NCT03632720|561803815|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
155648223|NCT03632720|561803813|FG000|Overall Study|Screen failure|0|||
155648224|NCT03632720|561803814|FG001|Overall Study|Screen failure|1|||
155648225|NCT03632720|561803815|FG002|Overall Study|Screen failure|0|||
155648226|NCT01049828|561803816|FG000|Overall Study|Claustrophibia and Frustration|2|||
155648227|NCT03004183|561805784|FG000|Overall Study|Adverse Event|7|||
155648228|NCT03004183|561805784|FG000|Overall Study|Lost to Follow-up|1|||
155648229|NCT03004183|561805784|FG000|Overall Study|Physician Decision|40|||
155648230|NCT03004183|561805784|FG000|Overall Study|Withdrawal by Subject|1|||
155648231|NCT03004183|561805784|FG000|Overall Study|COVID-19|1|||
155648232|NCT03312114|561805787|FG000|Overall Study|All the five enrolled dropped out of the|5|||
155648233|NCT02469961|561805793|FG000|Overall Study|Physician Decision|4|||
155648234|NCT02469961|561805794|FG001|Overall Study|Physician Decision|1|||
155648235|NCT01386645|561805796|FG000|Overall Study|Physician Decision|0|||
155648236|NCT01386645|561805797|FG001|Overall Study|Physician Decision|0|||
155648237|NCT01386645|561805798|FG002|Overall Study|Physician Decision|1|||
155648238|NCT01386645|561805796|FG000|Overall Study|Withdrawal by Subject|0|||
155648239|NCT01386645|561805797|FG001|Overall Study|Withdrawal by Subject|1|||
155648240|NCT01386645|561805798|FG002|Overall Study|Withdrawal by Subject|1|||
155648241|NCT01530256|561805799|FG000|Overall Study|Death|2|||
155351489|NCT04150341|560721653|FG004|Overall Study|Physician Decision|0|||
155351490|NCT04150341|560721654|FG005|Overall Study|Physician Decision|0|||
155351491|NCT04150341|560721649|FG000|Overall Study|Adverse Event|0|||
155351492|NCT04150341|560721650|FG001|Overall Study|Adverse Event|0|||
155648242|NCT04621786|561805800|FG000|Overall Study|Lost to Follow-up|9|||
155648243|NCT04621786|561805800|FG000|Overall Study|Protocol Violation|3|||
155648244|NCT02533674|561805801|FG000|Dose Level I|Progressive disease|1|||
155648245|NCT02533674|561805802|FG001|Dose Level I|Progressive disease|0|||
155648246|NCT02533674|561805803|FG002|Dose Level I|Progressive disease|0|||
155648247|NCT02533674|561805804|FG003|Dose Level I|Progressive disease|0|||
155351493|NCT04150341|560721651|FG002|Overall Study|Adverse Event|0|||
155648248|NCT02533674|561805805|FG004|Dose Level I|Progressive disease|0|||
155648249|NCT02533674|561805806|FG005|Dose Level I|Progressive disease|0|||
155648250|NCT02533674|561805807|FG006|Dose Level I|Progressive disease|0|||
155648251|NCT02533674|561805808|FG007|Dose Level I|Progressive disease|0|||
155648252|NCT02533674|561805801|FG000|Dose Level I|Withdrawal by Subject|1|||
155648253|NCT02533674|561805802|FG001|Dose Level I|Withdrawal by Subject|0|||
155648254|NCT02533674|561805803|FG002|Dose Level I|Withdrawal by Subject|0|||
155648255|NCT02533674|561805804|FG003|Dose Level I|Withdrawal by Subject|0|||
155648256|NCT02533674|561805805|FG004|Dose Level I|Withdrawal by Subject|0|||
155648257|NCT02533674|561805806|FG005|Dose Level I|Withdrawal by Subject|0|||
155351494|NCT04150341|560721652|FG003|Overall Study|Adverse Event|0|||
155351495|NCT04150341|560721653|FG004|Overall Study|Adverse Event|1|||
155351496|NCT04150341|560721654|FG005|Overall Study|Adverse Event|0|||
155351497|NCT00875615|560721655|FG000|Overall Study|Withdrawal by Subject|1|||
155351498|NCT00405912|560721657|FG000|Overall Study|Withdrawal by Subject|12|||
155351499|NCT00405912|560721658|FG001|Overall Study|Withdrawal by Subject|11|||
155351500|NCT00405912|560721659|FG002|Overall Study|Withdrawal by Subject|12|||
155351501|NCT00405912|560721657|FG000|Overall Study|Lost to Follow-up|4|||
155351502|NCT00405912|560721658|FG001|Overall Study|Lost to Follow-up|8|||
155351503|NCT00405912|560721659|FG002|Overall Study|Lost to Follow-up|4|||
155351504|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
155351505|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
155351506|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
155351507|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
155351508|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
155351509|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
155351510|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
155351511|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
155351512|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Death|6|||
155351513|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Death|2|||
155351514|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Death|2|||
155351515|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Death|9|||
155351516|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
155351517|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155351518|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155351519|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
155351520|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
155351521|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
155351522|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
155351523|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
155351524|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
155351525|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
155351526|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
155351527|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
155351528|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155351529|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
155351530|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155351531|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
155351532|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
155351533|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
155351534|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
155425673|NCT00792298|560986642|FG000|Treatment Period 1|Protocol Violation|0|||
155425674|NCT00792298|560986643|FG001|Treatment Period 1|Protocol Violation|0|||
155425675|NCT00792298|560986644|FG002|Treatment Period 1|Protocol Violation|0|||
155425676|NCT00792298|560986645|FG003|Treatment Period 1|Protocol Violation|0|||
155425677|NCT00792298|560986646|FG004|Treatment Period 1|Protocol Violation|0|||
155425678|NCT00792298|560986647|FG005|Treatment Period 1|Protocol Violation|0|||
155425679|NCT00792298|560986648|FG006|Treatment Period 1|Protocol Violation|0|||
155425680|NCT00792298|560986649|FG007|Treatment Period 1|Protocol Violation|1|||
155425681|NCT00792298|560986642|FG000|Washout|Adverse Event|0|||
155425682|NCT00792298|560986643|FG001|Washout|Adverse Event|0|||
155425683|NCT00792298|560986644|FG002|Washout|Adverse Event|0|||
155425684|NCT00792298|560986645|FG003|Washout|Adverse Event|0|||
155425685|NCT00792298|560986646|FG004|Washout|Adverse Event|0|||
155425686|NCT00792298|560986647|FG005|Washout|Adverse Event|1|||
155425687|NCT00792298|560986648|FG006|Washout|Adverse Event|0|||
155425688|NCT00792298|560986649|FG007|Washout|Adverse Event|0|||
155425689|NCT00792298|560986642|FG000|Washout|Withdrawal by Subject|0|||
155425690|NCT00792298|560986643|FG001|Washout|Withdrawal by Subject|0|||
155425691|NCT00792298|560986644|FG002|Washout|Withdrawal by Subject|1|||
155425692|NCT00792298|560986645|FG003|Washout|Withdrawal by Subject|0|||
155425693|NCT00792298|560986646|FG004|Washout|Withdrawal by Subject|0|||
155425694|NCT00792298|560986647|FG005|Washout|Withdrawal by Subject|1|||
155425695|NCT00792298|560986648|FG006|Washout|Withdrawal by Subject|0|||
155425696|NCT00792298|560986649|FG007|Washout|Withdrawal by Subject|0|||
155425697|NCT00792298|560986642|FG000|Treatment Period 2|Lack of Efficacy|0|||
155425698|NCT00792298|560986643|FG001|Treatment Period 2|Lack of Efficacy|0|||
155425699|NCT00792298|560986644|FG002|Treatment Period 2|Lack of Efficacy|0|||
155425700|NCT00792298|560986645|FG003|Treatment Period 2|Lack of Efficacy|0|||
155425701|NCT00792298|560986646|FG004|Treatment Period 2|Lack of Efficacy|1|||
155425702|NCT00792298|560986647|FG005|Treatment Period 2|Lack of Efficacy|0|||
155425703|NCT00792298|560986648|FG006|Treatment Period 2|Lack of Efficacy|0|||
155425704|NCT00792298|560986649|FG007|Treatment Period 2|Lack of Efficacy|0|||
155425705|NCT00792298|560986642|FG000|Treatment Period 2|Physician Decision|0|||
155425706|NCT00792298|560986643|FG001|Treatment Period 2|Physician Decision|0|||
155425707|NCT00792298|560986644|FG002|Treatment Period 2|Physician Decision|0|||
155425708|NCT00792298|560986645|FG003|Treatment Period 2|Physician Decision|0|||
155425709|NCT00792298|560986646|FG004|Treatment Period 2|Physician Decision|0|||
155506450|NCT02094937|561280324|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
155351535|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
155351536|NCT03730662|560721660|FG000|Variable Treatment Period|Adverse Event|1|||
155351537|NCT03730662|560721661|FG001|Variable Treatment Period|Adverse Event|2|||
155351538|NCT03730662|560721662|FG002|Variable Treatment Period|Adverse Event|0|||
155351539|NCT03730662|560721663|FG003|Variable Treatment Period|Adverse Event|7|||
155351540|NCT03730662|560721660|FG000|Variable Treatment Period|Death|9|||
155351541|NCT03730662|560721661|FG001|Variable Treatment Period|Death|0|||
155351542|NCT03730662|560721662|FG002|Variable Treatment Period|Death|6|||
155351543|NCT03730662|560721663|FG003|Variable Treatment Period|Death|26|||
155425710|NCT00792298|560986647|FG005|Treatment Period 2|Physician Decision|0|||
155425711|NCT00792298|560986648|FG006|Treatment Period 2|Physician Decision|1|||
155425712|NCT00792298|560986649|FG007|Treatment Period 2|Physician Decision|0|||
155425713|NCT00792298|560986642|FG000|Treatment Period 2|Pregnancy|0|||
155425714|NCT00792298|560986643|FG001|Treatment Period 2|Pregnancy|0|||
155425715|NCT00792298|560986644|FG002|Treatment Period 2|Pregnancy|1|||
155425716|NCT00792298|560986645|FG003|Treatment Period 2|Pregnancy|0|||
155425717|NCT00792298|560986646|FG004|Treatment Period 2|Pregnancy|0|||
155425718|NCT00792298|560986647|FG005|Treatment Period 2|Pregnancy|0|||
155425719|NCT00792298|560986648|FG006|Treatment Period 2|Pregnancy|0|||
155351544|NCT03730662|560721660|FG000|Variable Treatment Period|Lost to Follow-up|2|||
155351545|NCT03730662|560721661|FG001|Variable Treatment Period|Lost to Follow-up|1|||
155351546|NCT03730662|560721662|FG002|Variable Treatment Period|Lost to Follow-up|4|||
155351547|NCT03730662|560721663|FG003|Variable Treatment Period|Lost to Follow-up|11|||
155351548|NCT03730662|560721660|FG000|Variable Treatment Period|Personal Reason|0|||
155351549|NCT03730662|560721661|FG001|Variable Treatment Period|Personal Reason|2|||
155351550|NCT03730662|560721662|FG002|Variable Treatment Period|Personal Reason|1|||
155351551|NCT03730662|560721663|FG003|Variable Treatment Period|Personal Reason|6|||
155351552|NCT03730662|560721660|FG000|Variable Treatment Period|Physician Decision|0|||
155351553|NCT03730662|560721661|FG001|Variable Treatment Period|Physician Decision|0|||
155351554|NCT03730662|560721662|FG002|Variable Treatment Period|Physician Decision|0|||
155351555|NCT03730662|560721663|FG003|Variable Treatment Period|Physician Decision|3|||
155351556|NCT03730662|560721660|FG000|Variable Treatment Period|Protocol Violation|0|||
155351557|NCT03730662|560721661|FG001|Variable Treatment Period|Protocol Violation|1|||
155351558|NCT03730662|560721662|FG002|Variable Treatment Period|Protocol Violation|1|||
155351559|NCT03730662|560721663|FG003|Variable Treatment Period|Protocol Violation|1|||
155351560|NCT03730662|560721660|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
155351561|NCT03730662|560721661|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
155351562|NCT03730662|560721662|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
155351563|NCT03730662|560721663|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
155351564|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
155351565|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
155351566|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
155351567|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
155351568|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Death|0|||
155351569|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Death|1|||
155351570|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
155351571|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
155351572|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
155351573|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
155351574|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
155351575|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
155351576|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
155351577|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
155351578|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
155351579|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
155351580|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
155351581|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
155351582|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
155351583|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
155351584|NCT01309243|560721669|FG000|Extension Phase|Lost to Follow-up|6|||
155351585|NCT01309243|560721670|FG001|Extension Phase|Lost to Follow-up|0|||
155351586|NCT00632931|560721671|FG000|Part 1, Period 1|Protocol Violation|1|||
155351587|NCT00632931|560721672|FG001|Part 1, Period 1|Protocol Violation|0|||
155351588|NCT00632931|560721673|FG002|Part 1, Period 1|Protocol Violation|0|||
155351589|NCT00632931|560721671|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
155351590|NCT00632931|560721672|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
155351591|NCT00632931|560721673|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
155351592|NCT00632931|560721671|FG000|Part 2|Adverse Event|0|||
155351593|NCT00632931|560721672|FG001|Part 2|Adverse Event|0|||
155351594|NCT00632931|560721673|FG002|Part 2|Adverse Event|3|||
155351595|NCT00632931|560721671|FG000|Part 2|Death|0|||
155351596|NCT00632931|560721672|FG001|Part 2|Death|0|||
155351597|NCT00632931|560721673|FG002|Part 2|Death|1|||
155351598|NCT00632931|560721671|FG000|Part 2|Lack of Efficacy|0|||
155351599|NCT00632931|560721672|FG001|Part 2|Lack of Efficacy|0|||
155351600|NCT00632931|560721673|FG002|Part 2|Lack of Efficacy|17|||
155351601|NCT00632931|560721671|FG000|Part 2|Withdrawal by Subject|0|||
155351602|NCT00632931|560721672|FG001|Part 2|Withdrawal by Subject|0|||
155351603|NCT00632931|560721673|FG002|Part 2|Withdrawal by Subject|3|||
155351604|NCT00833898|560721674|FG000|Overall Study|Withdrawal by Subject|33|||
155351605|NCT00833898|560721675|FG001|Overall Study|Withdrawal by Subject|27|||
155351606|NCT00833898|560721674|FG000|Overall Study|Lost to Follow-up|7|||
155351607|NCT00833898|560721675|FG001|Overall Study|Lost to Follow-up|7|||
155351608|NCT00833898|560721674|FG000|Overall Study|Patient did not receive transplant|0|||
155351609|NCT00833898|560721675|FG001|Overall Study|Patient did not receive transplant|2|||
155351610|NCT01402063|560721678|FG000|Overall Study|Withdrawal by Subject|3|||
155351611|NCT01402063|560721679|FG001|Overall Study|Withdrawal by Subject|3|||
155351612|NCT03712449|560721684|FG000|Overall Study|Withdraw Consent|0|||
155351613|NCT03712449|560721685|FG001|Overall Study|Withdraw Consent|1|||
155351614|NCT00666198|560721686|FG000|Overall Study|Protocol Violation|10|||
155351615|NCT00666198|560721686|FG000|Overall Study|No Visit After First Day of Treatment|13|||
155351616|NCT00666198|560721686|FG000|Overall Study|Safety Not Assessable|6|||
155351617|NCT00666198|560721686|FG000|Overall Study|No Drug Administration|4|||
155648258|NCT02533674|561805807|FG006|Dose Level I|Withdrawal by Subject|0|||
155648259|NCT02533674|561805808|FG007|Dose Level I|Withdrawal by Subject|0|||
155648260|NCT02533674|561805801|FG000|Dose Level I|Physician Decision|1|||
155648261|NCT02533674|561805802|FG001|Dose Level I|Physician Decision|0|||
155648262|NCT02533674|561805803|FG002|Dose Level I|Physician Decision|0|||
155648263|NCT02533674|561805804|FG003|Dose Level I|Physician Decision|0|||
155648264|NCT02533674|561805805|FG004|Dose Level I|Physician Decision|0|||
155648265|NCT02533674|561805806|FG005|Dose Level I|Physician Decision|0|||
155648266|NCT02533674|561805807|FG006|Dose Level I|Physician Decision|0|||
155648267|NCT02533674|561805808|FG007|Dose Level I|Physician Decision|0|||
155648268|NCT02533674|561805801|FG000|Dose Level I|Death|1|||
155648269|NCT02533674|561805802|FG001|Dose Level I|Death|0|||
155648270|NCT02533674|561805803|FG002|Dose Level I|Death|0|||
155648271|NCT02533674|561805804|FG003|Dose Level I|Death|0|||
155648272|NCT02533674|561805805|FG004|Dose Level I|Death|0|||
155648273|NCT02533674|561805806|FG005|Dose Level I|Death|0|||
155648274|NCT02533674|561805807|FG006|Dose Level I|Death|0|||
155648275|NCT02533674|561805808|FG007|Dose Level I|Death|0|||
155648276|NCT02533674|561805801|FG000|Dose Level I|Never Treated|1|||
155648277|NCT02533674|561805802|FG001|Dose Level I|Never Treated|0|||
155648278|NCT02533674|561805803|FG002|Dose Level I|Never Treated|0|||
155648279|NCT02533674|561805804|FG003|Dose Level I|Never Treated|0|||
155648280|NCT02533674|561805805|FG004|Dose Level I|Never Treated|0|||
155648281|NCT02533674|561805806|FG005|Dose Level I|Never Treated|0|||
155648282|NCT02533674|561805807|FG006|Dose Level I|Never Treated|0|||
155648283|NCT02533674|561805808|FG007|Dose Level I|Never Treated|0|||
155648284|NCT02533674|561805801|FG000|Dose Level II|Progressive disease|0|||
155648285|NCT02533674|561805802|FG001|Dose Level II|Progressive disease|3|||
155648286|NCT02533674|561805803|FG002|Dose Level II|Progressive disease|0|||
155648287|NCT02533674|561805804|FG003|Dose Level II|Progressive disease|0|||
155648288|NCT02533674|561805805|FG004|Dose Level II|Progressive disease|0|||
155648289|NCT02533674|561805806|FG005|Dose Level II|Progressive disease|0|||
155648290|NCT02533674|561805807|FG006|Dose Level II|Progressive disease|0|||
155648291|NCT02533674|561805808|FG007|Dose Level II|Progressive disease|0|||
155648292|NCT02533674|561805801|FG000|Dose Level II|Withdrawal by Subject|0|||
155648293|NCT02533674|561805802|FG001|Dose Level II|Withdrawal by Subject|1|||
155648294|NCT02533674|561805803|FG002|Dose Level II|Withdrawal by Subject|0|||
155648295|NCT02533674|561805804|FG003|Dose Level II|Withdrawal by Subject|0|||
155648296|NCT02533674|561805805|FG004|Dose Level II|Withdrawal by Subject|0|||
155648297|NCT02533674|561805806|FG005|Dose Level II|Withdrawal by Subject|0|||
155648298|NCT02533674|561805807|FG006|Dose Level II|Withdrawal by Subject|0|||
155648299|NCT02533674|561805808|FG007|Dose Level II|Withdrawal by Subject|0|||
155351618|NCT03220776|560721687|FG000|Overall Study|Claustrophobia|0|||
155351619|NCT03220776|560721688|FG001|Overall Study|Claustrophobia|1|||
155351620|NCT03220776|560721689|FG002|Overall Study|Claustrophobia|1|||
155351621|NCT03220776|560721690|FG003|Overall Study|Claustrophobia|0|||
155351622|NCT03220776|560721691|FG004|Overall Study|Claustrophobia|1|||
155351623|NCT03220776|560721692|FG005|Overall Study|Claustrophobia|0|||
155351624|NCT03220776|560721687|FG000|Overall Study|MRI Equipment Failure|1|||
155351625|NCT03220776|560721688|FG001|Overall Study|MRI Equipment Failure|0|||
155351626|NCT03220776|560721689|FG002|Overall Study|MRI Equipment Failure|0|||
155351627|NCT03220776|560721690|FG003|Overall Study|MRI Equipment Failure|0|||
155351628|NCT03220776|560721691|FG004|Overall Study|MRI Equipment Failure|0|||
155351629|NCT03220776|560721692|FG005|Overall Study|MRI Equipment Failure|0|||
155351630|NCT03220776|560721687|FG000|Overall Study|Inclimate Weather|0|||
155351631|NCT03220776|560721688|FG001|Overall Study|Inclimate Weather|0|||
155351632|NCT03220776|560721689|FG002|Overall Study|Inclimate Weather|0|||
155351633|NCT03220776|560721690|FG003|Overall Study|Inclimate Weather|0|||
155351634|NCT03220776|560721691|FG004|Overall Study|Inclimate Weather|0|||
155648300|NCT02533674|561805801|FG000|Dose Level II|Treatment-related AE|0|||
155648301|NCT02533674|561805802|FG001|Dose Level II|Treatment-related AE|1|||
155648302|NCT02533674|561805803|FG002|Dose Level II|Treatment-related AE|0|||
155648303|NCT02533674|561805804|FG003|Dose Level II|Treatment-related AE|0|||
155648304|NCT02533674|561805805|FG004|Dose Level II|Treatment-related AE|0|||
155351635|NCT03220776|560721692|FG005|Overall Study|Inclimate Weather|1|||
155351636|NCT03220776|560721687|FG000|Overall Study|Physician Decision|0|||
155351637|NCT03220776|560721688|FG001|Overall Study|Physician Decision|0|||
155351638|NCT03220776|560721689|FG002|Overall Study|Physician Decision|0|||
155351639|NCT03220776|560721690|FG003|Overall Study|Physician Decision|1|||
155351640|NCT03220776|560721691|FG004|Overall Study|Physician Decision|0|||
155351641|NCT03220776|560721692|FG005|Overall Study|Physician Decision|0|||
155351642|NCT03220776|560721687|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351643|NCT03220776|560721688|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351644|NCT03220776|560721689|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351645|NCT03220776|560721690|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
155425720|NCT00792298|560986649|FG007|Treatment Period 2|Pregnancy|0|||
155425721|NCT00792298|560986642|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155425722|NCT00792298|560986643|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155351646|NCT03220776|560721691|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351647|NCT03220776|560721692|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351648|NCT03220776|560721687|FG000|Overall Study|Protocol Violation|0|||
155351649|NCT03220776|560721688|FG001|Overall Study|Protocol Violation|0|||
155351650|NCT03220776|560721689|FG002|Overall Study|Protocol Violation|0|||
155351651|NCT03220776|560721690|FG003|Overall Study|Protocol Violation|2|||
155351652|NCT03220776|560721691|FG004|Overall Study|Protocol Violation|0|||
155351653|NCT03220776|560721692|FG005|Overall Study|Protocol Violation|1|||
155351654|NCT03220776|560721687|FG000|Overall Study|Withdrawal by Subject|1|||
155351655|NCT03220776|560721688|FG001|Overall Study|Withdrawal by Subject|0|||
155351656|NCT03220776|560721689|FG002|Overall Study|Withdrawal by Subject|0|||
155351657|NCT03220776|560721690|FG003|Overall Study|Withdrawal by Subject|0|||
155351658|NCT03220776|560721691|FG004|Overall Study|Withdrawal by Subject|0|||
155351659|NCT03220776|560721692|FG005|Overall Study|Withdrawal by Subject|0|||
155648305|NCT02533674|561805806|FG005|Dose Level II|Treatment-related AE|0|||
155351660|NCT03029234|560721694|FG000|Overall Study|Sponsor Decision|1|||
155648306|NCT02533674|561805807|FG006|Dose Level II|Treatment-related AE|0|||
155351661|NCT03029234|560721694|FG000|Overall Study|Withdrawal by Subject|5|||
155351662|NCT03029234|560721694|FG000|Overall Study|Death|91|||
155351663|NCT03029234|560721694|FG000|Overall Study|Lost to Follow-up|2|||
155351664|NCT04491006|560721695|FG000|Overall Study|Adverse Event|0|||
155351665|NCT04491006|560721696|FG001|Overall Study|Adverse Event|3|||
155351666|NCT04491006|560721697|FG002|Overall Study|Adverse Event|5|||
155351667|NCT04491006|560721695|FG000|Overall Study|Withdrawal by Subject|1|||
155351668|NCT04491006|560721696|FG001|Overall Study|Withdrawal by Subject|0|||
155351669|NCT04491006|560721697|FG002|Overall Study|Withdrawal by Subject|2|||
155351670|NCT02166047|560721698|FG000|Overall Study|Withdrawal by Participant|0|||
155351671|NCT02166047|560721699|FG001|Overall Study|Withdrawal by Participant|1|||
155351672|NCT02166047|560721700|FG002|Overall Study|Withdrawal by Participant|2|||
155351673|NCT02166047|560721701|FG003|Overall Study|Withdrawal by Participant|0|||
155351674|NCT02166047|560721702|FG004|Overall Study|Withdrawal by Participant|0|||
155351675|NCT02166047|560721703|FG005|Overall Study|Withdrawal by Participant|0|||
155351676|NCT02166047|560721704|FG006|Overall Study|Withdrawal by Participant|1|||
155351677|NCT02166047|560721705|FG007|Overall Study|Withdrawal by Participant|0|||
155351678|NCT02166047|560721706|FG008|Overall Study|Withdrawal by Participant|0|||
155351679|NCT02166047|560721707|FG009|Overall Study|Withdrawal by Participant|0|||
155351680|NCT02166047|560721708|FG010|Overall Study|Withdrawal by Participant|0|||
155351681|NCT02166047|560721709|FG011|Overall Study|Withdrawal by Participant|0|||
155351682|NCT02166047|560721698|FG000|Overall Study|Adverse Event|0|||
155351683|NCT02166047|560721699|FG001|Overall Study|Adverse Event|0|||
155351684|NCT02166047|560721700|FG002|Overall Study|Adverse Event|0|||
155351685|NCT02166047|560721701|FG003|Overall Study|Adverse Event|0|||
155351686|NCT02166047|560721702|FG004|Overall Study|Adverse Event|1|||
155351687|NCT02166047|560721703|FG005|Overall Study|Adverse Event|0|||
155351688|NCT02166047|560721704|FG006|Overall Study|Adverse Event|1|||
155351689|NCT02166047|560721705|FG007|Overall Study|Adverse Event|0|||
155351690|NCT02166047|560721706|FG008|Overall Study|Adverse Event|0|||
155351691|NCT02166047|560721707|FG009|Overall Study|Adverse Event|0|||
155351692|NCT02166047|560721708|FG010|Overall Study|Adverse Event|2|||
155351693|NCT02166047|560721709|FG011|Overall Study|Adverse Event|0|||
155351694|NCT00451555|560721718|FG000|Overall Study|Protocol Violation|2|||
155351695|NCT00451555|560721719|FG001|Overall Study|Protocol Violation|2|||
155351696|NCT00451555|560721718|FG000|Overall Study|Adverse Event|3|||
155351697|NCT00451555|560721719|FG001|Overall Study|Adverse Event|1|||
155351698|NCT00451555|560721718|FG000|Overall Study|Withdrawal by Subject|6|||
155351699|NCT00451555|560721719|FG001|Overall Study|Withdrawal by Subject|0|||
155351700|NCT00451555|560721718|FG000|Overall Study|Physician Decision|2|||
155351701|NCT00451555|560721719|FG001|Overall Study|Physician Decision|1|||
155351702|NCT01004185|560721728|FG000|Overall Study|Adverse Event|1|||
155351703|NCT01004185|560721729|FG001|Overall Study|Adverse Event|1|||
155351704|NCT01004185|560721728|FG000|Overall Study|Lost to Follow-up|0|||
155351705|NCT01004185|560721729|FG001|Overall Study|Lost to Follow-up|1|||
155351706|NCT01004185|560721728|FG000|Overall Study|Lack of Efficacy|2|||
155351707|NCT01004185|560721729|FG001|Overall Study|Lack of Efficacy|1|||
155351708|NCT01004185|560721728|FG000|Overall Study|Sponsor Terminated Study|4|||
155351709|NCT01004185|560721729|FG001|Overall Study|Sponsor Terminated Study|5|||
155351710|NCT01004185|560721728|FG000|Overall Study|Withdrawal by Subject|2|||
155351711|NCT01004185|560721729|FG001|Overall Study|Withdrawal by Subject|1|||
155351712|NCT00797511|560721730|FG000|Overall Study|Withdrawal by Subject|1|||
155351713|NCT01990664|560721731|FG000|Overall Study|Lost to Follow-up|2|||
155351714|NCT01990664|560721732|FG001|Overall Study|Lost to Follow-up|6|||
155351715|NCT01990664|560721731|FG000|Overall Study|Withdrawal by Subject|2|||
155351716|NCT01990664|560721732|FG001|Overall Study|Withdrawal by Subject|3|||
155351717|NCT01990664|560721731|FG000|Overall Study|Protocol Violation|1|||
155351718|NCT01990664|560721732|FG001|Overall Study|Protocol Violation|0|||
155351719|NCT01990664|560721731|FG000|Overall Study|Lens Discomfort|1|||
155351720|NCT01990664|560721732|FG001|Overall Study|Lens Discomfort|1|||
155351721|NCT01990664|560721731|FG000|Overall Study|Lens Handling Difficulties|1|||
155351722|NCT01990664|560721732|FG001|Overall Study|Lens Handling Difficulties|0|||
155351723|NCT01990664|560721731|FG000|Overall Study|Unsatisfactory Visual Response|0|||
155351724|NCT01990664|560721732|FG001|Overall Study|Unsatisfactory Visual Response|1|||
155351725|NCT02630706|560721737|FG000|Overall Study|Adverse Event|2|||
155351726|NCT02630706|560721738|FG001|Overall Study|Adverse Event|1|||
155351727|NCT02630706|560721739|FG002|Overall Study|Adverse Event|1|||
155351728|NCT02630706|560721737|FG000|Overall Study|Lost to Follow-up|0|||
155351729|NCT02630706|560721738|FG001|Overall Study|Lost to Follow-up|1|||
155351730|NCT02630706|560721739|FG002|Overall Study|Lost to Follow-up|2|||
155351731|NCT02630706|560721737|FG000|Overall Study|Physician Decision|1|||
155351732|NCT02630706|560721738|FG001|Overall Study|Physician Decision|1|||
155351733|NCT02630706|560721739|FG002|Overall Study|Physician Decision|0|||
155351734|NCT02630706|560721737|FG000|Overall Study|Pregnancy|0|||
155351735|NCT02630706|560721738|FG001|Overall Study|Pregnancy|1|||
155351736|NCT02630706|560721739|FG002|Overall Study|Pregnancy|0|||
155351737|NCT02630706|560721737|FG000|Overall Study|Withdrawal by Subject|4|||
155351738|NCT02630706|560721738|FG001|Overall Study|Withdrawal by Subject|5|||
155351739|NCT02630706|560721739|FG002|Overall Study|Withdrawal by Subject|7|||
155351740|NCT01678898|560721741|FG000|PB-102-F01|Adverse Event|0|||
155351741|NCT01678898|560721742|FG001|PB-102-F01|Adverse Event|1|||
155351742|NCT01678898|560721743|FG002|PB-102-F01|Adverse Event|0|||
155351743|NCT01678898|560721741|FG000|PB-102-F01|Physician Decision|0|||
155351744|NCT01678898|560721742|FG001|PB-102-F01|Physician Decision|1|||
155351745|NCT01678898|560721743|FG002|PB-102-F01|Physician Decision|0|||
155351746|NCT00853372|560722970|FG000|Overall Study|Death|30|||
155351747|NCT00853372|560722971|FG001|Overall Study|Death|26|||
155351748|NCT00853372|560722970|FG000|Overall Study|Lost to Follow-up|1|||
155351749|NCT00853372|560722971|FG001|Overall Study|Lost to Follow-up|2|||
155351750|NCT00853372|560722970|FG000|Overall Study|Full Consent Withdrawn|1|||
155351751|NCT00853372|560722971|FG001|Overall Study|Full Consent Withdrawn|1|||
155351752|NCT01268098|560722974|FG000|Overall Study|Adverse Event|1|||
155351753|NCT01268098|560722975|FG001|Overall Study|Adverse Event|0|||
155351754|NCT02624869|560722979|FG000|Overall Study|Lost to Follow-up|0|||
155351755|NCT02624869|560722980|FG001|Overall Study|Lost to Follow-up|0|||
155351756|NCT02624869|560722981|FG002|Overall Study|Lost to Follow-up|1|||
155351757|NCT02624869|560722979|FG000|Overall Study|Withdrawal by Subject|1|||
155351758|NCT02624869|560722980|FG001|Overall Study|Withdrawal by Subject|3|||
155351759|NCT02624869|560722981|FG002|Overall Study|Withdrawal by Subject|1|||
155351760|NCT00510198|560722982|FG000|Overall Study|Withdrawal by Subject|5|||
155351761|NCT00510198|560722983|FG001|Overall Study|Withdrawal by Subject|4|||
155351762|NCT01037413|560722984|FG000|Part A: Skin Testing|Adverse Event|1|||
155351763|NCT01037413|560722985|FG001|Part A: Skin Testing|Adverse Event|0|||
155351764|NCT01037413|560722984|FG000|Part A: Skin Testing|Protocol Violation|1|||
155351765|NCT01037413|560722985|FG001|Part A: Skin Testing|Protocol Violation|0|||
155351766|NCT01037413|560722984|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
155351767|NCT01037413|560722985|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
155351768|NCT01037413|560722984|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
155351769|NCT01037413|560722985|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
155351770|NCT00619983|560722986|FG000|Test Drug Alone|Withdrawal by Subject|1|||
155351771|NCT00619983|560722987|FG001|Test Drug Alone|Withdrawal by Subject|0|||
155351772|NCT00619983|560722988|FG002|Test Drug Alone|Withdrawal by Subject|0|||
155351773|NCT00619983|560722989|FG003|Test Drug Alone|Withdrawal by Subject|1|||
155351774|NCT00619983|560722986|FG000|Test Drug Alone|Failure of daily diary device|1|||
155351775|NCT00619983|560722987|FG001|Test Drug Alone|Failure of daily diary device|1|||
155351776|NCT00619983|560722988|FG002|Test Drug Alone|Failure of daily diary device|2|||
155351777|NCT00619983|560722989|FG003|Test Drug Alone|Failure of daily diary device|2|||
155351778|NCT00809341|560722990|FG000|Overall Study|Physician Decision|0|||
155351779|NCT00809341|560722991|FG001|Overall Study|Physician Decision|1|||
155351780|NCT00496626|560722992|FG000|Overall Study|Lost to Follow-up|0|||
155351781|NCT00496626|560722993|FG001|Overall Study|Lost to Follow-up|1|||
155351782|NCT00496626|560722992|FG000|Overall Study|Protocol Violation|1|||
155351783|NCT00496626|560722993|FG001|Overall Study|Protocol Violation|0|||
155351784|NCT00496626|560722992|FG000|Overall Study|Withdrawal by Subject|5|||
155351785|NCT00496626|560722993|FG001|Overall Study|Withdrawal by Subject|4|||
155351786|NCT00496626|560722992|FG000|Overall Study|Relocated|0|||
155351787|NCT00496626|560722993|FG001|Overall Study|Relocated|1|||
155351788|NCT00570921|560722997|FG000|Overall Study|Protocol Violation|1|||
155351789|NCT00570921|560722997|FG000|Overall Study|Physician Decision|1|||
155351790|NCT02560389|560723004|FG000|Overall Study|Lost to Follow-up|1|||
155351791|NCT02560389|560723005|FG001|Overall Study|Lost to Follow-up|2|||
155351792|NCT02560389|560723006|FG002|Overall Study|Lost to Follow-up|2|||
155351793|NCT02560389|560723004|FG000|Overall Study|Tested positive for illicit substance|0|||
155351794|NCT02560389|560723005|FG001|Overall Study|Tested positive for illicit substance|1|||
155351795|NCT02560389|560723006|FG002|Overall Study|Tested positive for illicit substance|0|||
155351796|NCT02716298|560723007|FG000|First Intervention (1 Month)|Lens discomfort|1|||
155351797|NCT02716298|560723008|FG001|First Intervention (1 Month)|Lens discomfort|1|||
155648307|NCT02533674|561805808|FG007|Dose Level II|Treatment-related AE|0|||
155351798|NCT01281917|560723022|FG000|Overall Study|Withdrawal by Subject|1|||
155351799|NCT00802438|560723023|FG000|Overall Study|Screen Failure|20|||
155351800|NCT00802438|560723023|FG000|Overall Study|Withdrawal by Subject|7|||
155351801|NCT00802438|560723023|FG000|Overall Study|Physician Decision|1|||
155351802|NCT04016805|560723025|FG000|Overall Study|Sponsor's Discretion|30|||
155351803|NCT04016805|560723026|FG001|Overall Study|Sponsor's Discretion|6|||
155351804|NCT04016805|560723027|FG002|Overall Study|Sponsor's Discretion|5|||
155351805|NCT00740870|560723028|FG000|Overall Study|Not Catheterized|4|||
155351806|NCT00740870|560723028|FG000|Overall Study|Further testing contraindicated implant|17|||
155351807|NCT00819013|560723029|FG000|Overall Study|Not meeting continuing study eligibility|2|||
155351808|NCT00819013|560723030|FG001|Overall Study|Not meeting continuing study eligibility|1|||
155351809|NCT00819013|560723031|FG002|Overall Study|Not meeting continuing study eligibility|2|||
155351810|NCT00819013|560723032|FG003|Overall Study|Not meeting continuing study eligibility|1|||
155351811|NCT00819013|560723029|FG000|Overall Study|Adverse Event|0|||
155351812|NCT00819013|560723030|FG001|Overall Study|Adverse Event|0|||
155351813|NCT00819013|560723031|FG002|Overall Study|Adverse Event|1|||
155351814|NCT00819013|560723032|FG003|Overall Study|Adverse Event|0|||
155351815|NCT00819013|560723029|FG000|Overall Study|Withdrawal by Subject|1|||
155351816|NCT00819013|560723030|FG001|Overall Study|Withdrawal by Subject|0|||
155351817|NCT00819013|560723031|FG002|Overall Study|Withdrawal by Subject|1|||
155351818|NCT00819013|560723032|FG003|Overall Study|Withdrawal by Subject|0|||
155351819|NCT00819013|560723029|FG000|Overall Study|Lost to Follow-up|0|||
155351820|NCT00819013|560723030|FG001|Overall Study|Lost to Follow-up|0|||
155351821|NCT00819013|560723031|FG002|Overall Study|Lost to Follow-up|1|||
155351822|NCT00819013|560723032|FG003|Overall Study|Lost to Follow-up|2|||
155351823|NCT00819013|560723029|FG000|Overall Study|Death|0|||
155351824|NCT00819013|560723030|FG001|Overall Study|Death|0|||
155351825|NCT00819013|560723031|FG002|Overall Study|Death|0|||
155351826|NCT00819013|560723032|FG003|Overall Study|Death|1|||
155351827|NCT00607997|560723034|FG000|Overall Study|Lack of Efficacy|6|||
155351828|NCT00607997|560723035|FG001|Overall Study|Lack of Efficacy|20|||
155648308|NCT02533674|561805801|FG000|Dose Level II|Physician Decision|0|||
155648309|NCT02533674|561805802|FG001|Dose Level II|Physician Decision|1|||
155648310|NCT02533674|561805803|FG002|Dose Level II|Physician Decision|0|||
155648311|NCT02533674|561805804|FG003|Dose Level II|Physician Decision|0|||
155648312|NCT02533674|561805805|FG004|Dose Level II|Physician Decision|0|||
155648313|NCT02533674|561805806|FG005|Dose Level II|Physician Decision|0|||
155351829|NCT00607997|560723036|FG002|Overall Study|Lack of Efficacy|14|||
155351830|NCT00607997|560723037|FG003|Overall Study|Lack of Efficacy|10|||
155351831|NCT00607997|560723034|FG000|Overall Study|Death|8|||
155351832|NCT00607997|560723035|FG001|Overall Study|Death|5|||
155351833|NCT00607997|560723036|FG002|Overall Study|Death|2|||
155648314|NCT02533674|561805807|FG006|Dose Level II|Physician Decision|0|||
155648315|NCT02533674|561805808|FG007|Dose Level II|Physician Decision|0|||
155648316|NCT02533674|561805801|FG000|Dose Level II|Non-treatment-related AE|0|||
155648317|NCT02533674|561805802|FG001|Dose Level II|Non-treatment-related AE|1|||
155648318|NCT02533674|561805803|FG002|Dose Level II|Non-treatment-related AE|0|||
155648319|NCT02533674|561805804|FG003|Dose Level II|Non-treatment-related AE|0|||
155648320|NCT02533674|561805805|FG004|Dose Level II|Non-treatment-related AE|0|||
155351834|NCT00607997|560723037|FG003|Overall Study|Death|5|||
155351835|NCT00607997|560723034|FG000|Overall Study|Adverse Event|3|||
155351836|NCT00607997|560723035|FG001|Overall Study|Adverse Event|1|||
155351837|NCT00607997|560723036|FG002|Overall Study|Adverse Event|2|||
155351838|NCT00607997|560723037|FG003|Overall Study|Adverse Event|0|||
155648321|NCT02533674|561805806|FG005|Dose Level II|Non-treatment-related AE|0|||
155648322|NCT02533674|561805807|FG006|Dose Level II|Non-treatment-related AE|0|||
155351839|NCT00607997|560723034|FG000|Overall Study|Physician Decision|4|||
155351840|NCT00607997|560723035|FG001|Overall Study|Physician Decision|1|||
155351841|NCT00607997|560723036|FG002|Overall Study|Physician Decision|0|||
155648323|NCT02533674|561805808|FG007|Dose Level II|Non-treatment-related AE|0|||
155648324|NCT02533674|561805801|FG000|Dose Level III|Progressive disease|0|||
155351842|NCT00607997|560723037|FG003|Overall Study|Physician Decision|0|||
155351843|NCT00607997|560723034|FG000|Overall Study|Relapse, recurrent illness|4|||
155351844|NCT00607997|560723035|FG001|Overall Study|Relapse, recurrent illness|0|||
155351845|NCT00607997|560723036|FG002|Overall Study|Relapse, recurrent illness|2|||
155351846|NCT00607997|560723037|FG003|Overall Study|Relapse, recurrent illness|0|||
155351847|NCT00607997|560723034|FG000|Overall Study|Other without explanation|2|||
155351848|NCT00607997|560723035|FG001|Overall Study|Other without explanation|0|||
155648325|NCT02533674|561805802|FG001|Dose Level III|Progressive disease|0|||
155351849|NCT00607997|560723036|FG002|Overall Study|Other without explanation|4|||
155351850|NCT00607997|560723037|FG003|Overall Study|Other without explanation|1|||
155648326|NCT02533674|561805803|FG002|Dose Level III|Progressive disease|2|||
155648327|NCT02533674|561805804|FG003|Dose Level III|Progressive disease|0|||
155648328|NCT02533674|561805805|FG004|Dose Level III|Progressive disease|0|||
155648329|NCT02533674|561805806|FG005|Dose Level III|Progressive disease|0|||
155648330|NCT02533674|561805807|FG006|Dose Level III|Progressive disease|0|||
155648331|NCT02533674|561805808|FG007|Dose Level III|Progressive disease|0|||
155648332|NCT02533674|561805801|FG000|Dose Level III|Withdrawal by Subject|0|||
155648333|NCT02533674|561805802|FG001|Dose Level III|Withdrawal by Subject|0|||
155648334|NCT02533674|561805803|FG002|Dose Level III|Withdrawal by Subject|1|||
155648335|NCT02533674|561805804|FG003|Dose Level III|Withdrawal by Subject|0|||
155648336|NCT02533674|561805805|FG004|Dose Level III|Withdrawal by Subject|0|||
155648337|NCT02533674|561805806|FG005|Dose Level III|Withdrawal by Subject|0|||
155648338|NCT02533674|561805807|FG006|Dose Level III|Withdrawal by Subject|0|||
155648339|NCT02533674|561805808|FG007|Dose Level III|Withdrawal by Subject|0|||
155648340|NCT02533674|561805801|FG000|Dose Level III|Treatment-related AE|0|||
155648341|NCT02533674|561805802|FG001|Dose Level III|Treatment-related AE|0|||
155648342|NCT02533674|561805803|FG002|Dose Level III|Treatment-related AE|1|||
155648343|NCT02533674|561805804|FG003|Dose Level III|Treatment-related AE|0|||
155648344|NCT02533674|561805805|FG004|Dose Level III|Treatment-related AE|0|||
155648345|NCT02533674|561805806|FG005|Dose Level III|Treatment-related AE|0|||
155648346|NCT02533674|561805807|FG006|Dose Level III|Treatment-related AE|0|||
155648347|NCT02533674|561805808|FG007|Dose Level III|Treatment-related AE|0|||
155648348|NCT02533674|561805801|FG000|Dose Level IV|Progressive disease|0|||
155648349|NCT02533674|561805802|FG001|Dose Level IV|Progressive disease|0|||
155648350|NCT02533674|561805803|FG002|Dose Level IV|Progressive disease|0|||
155648351|NCT02533674|561805804|FG003|Dose Level IV|Progressive disease|3|||
155648352|NCT02533674|561805805|FG004|Dose Level IV|Progressive disease|0|||
155648353|NCT02533674|561805806|FG005|Dose Level IV|Progressive disease|0|||
155648354|NCT02533674|561805807|FG006|Dose Level IV|Progressive disease|0|||
155648355|NCT02533674|561805808|FG007|Dose Level IV|Progressive disease|0|||
155648356|NCT02533674|561805801|FG000|Dose Level IV|Withdrawal by Subject|0|||
155648357|NCT02533674|561805802|FG001|Dose Level IV|Withdrawal by Subject|0|||
155648358|NCT02533674|561805803|FG002|Dose Level IV|Withdrawal by Subject|0|||
155648359|NCT02533674|561805804|FG003|Dose Level IV|Withdrawal by Subject|1|||
155648360|NCT02533674|561805805|FG004|Dose Level IV|Withdrawal by Subject|0|||
155648361|NCT02533674|561805806|FG005|Dose Level IV|Withdrawal by Subject|0|||
155648362|NCT02533674|561805807|FG006|Dose Level IV|Withdrawal by Subject|0|||
155648363|NCT02533674|561805808|FG007|Dose Level IV|Withdrawal by Subject|0|||
155648364|NCT02533674|561805801|FG000|Dose Level IV|Physician Decision|0|||
155648365|NCT02533674|561805802|FG001|Dose Level IV|Physician Decision|0|||
155648366|NCT02533674|561805803|FG002|Dose Level IV|Physician Decision|0|||
155648367|NCT02533674|561805804|FG003|Dose Level IV|Physician Decision|1|||
155648368|NCT02533674|561805805|FG004|Dose Level IV|Physician Decision|0|||
155648369|NCT02533674|561805806|FG005|Dose Level IV|Physician Decision|0|||
155648370|NCT02533674|561805807|FG006|Dose Level IV|Physician Decision|0|||
155648371|NCT02533674|561805808|FG007|Dose Level IV|Physician Decision|0|||
155648372|NCT02533674|561805801|FG000|Dose Level V|Progressive disease|0|||
155648373|NCT02533674|561805802|FG001|Dose Level V|Progressive disease|0|||
155648374|NCT02533674|561805803|FG002|Dose Level V|Progressive disease|0|||
155648375|NCT02533674|561805804|FG003|Dose Level V|Progressive disease|0|||
155648376|NCT02533674|561805805|FG004|Dose Level V|Progressive disease|3|||
155648377|NCT02533674|561805806|FG005|Dose Level V|Progressive disease|0|||
155648378|NCT02533674|561805807|FG006|Dose Level V|Progressive disease|0|||
155648379|NCT02533674|561805808|FG007|Dose Level V|Progressive disease|0|||
155648380|NCT02533674|561805801|FG000|Dose Level V|Withdrawal by Subject|0|||
155648381|NCT02533674|561805802|FG001|Dose Level V|Withdrawal by Subject|0|||
155648382|NCT02533674|561805803|FG002|Dose Level V|Withdrawal by Subject|0|||
155648383|NCT02533674|561805804|FG003|Dose Level V|Withdrawal by Subject|0|||
155648384|NCT02533674|561805805|FG004|Dose Level V|Withdrawal by Subject|1|||
155648385|NCT02533674|561805806|FG005|Dose Level V|Withdrawal by Subject|0|||
155648386|NCT02533674|561805807|FG006|Dose Level V|Withdrawal by Subject|0|||
155648387|NCT02533674|561805808|FG007|Dose Level V|Withdrawal by Subject|0|||
155648388|NCT02533674|561805801|FG000|Dose Level V|Physician Decision|0|||
155648389|NCT02533674|561805802|FG001|Dose Level V|Physician Decision|0|||
155648390|NCT02533674|561805803|FG002|Dose Level V|Physician Decision|0|||
155648391|NCT02533674|561805804|FG003|Dose Level V|Physician Decision|0|||
155648392|NCT02533674|561805805|FG004|Dose Level V|Physician Decision|1|||
155648393|NCT02533674|561805806|FG005|Dose Level V|Physician Decision|0|||
155648394|NCT02533674|561805807|FG006|Dose Level V|Physician Decision|0|||
155648395|NCT02533674|561805808|FG007|Dose Level V|Physician Decision|0|||
155648396|NCT02533674|561805801|FG000|Dose Level VI|Progressive disease|0|||
155648397|NCT02533674|561805802|FG001|Dose Level VI|Progressive disease|0|||
155648398|NCT02533674|561805803|FG002|Dose Level VI|Progressive disease|0|||
155648399|NCT02533674|561805804|FG003|Dose Level VI|Progressive disease|0|||
155648400|NCT02533674|561805805|FG004|Dose Level VI|Progressive disease|0|||
155648401|NCT02533674|561805806|FG005|Dose Level VI|Progressive disease|7|||
155648402|NCT02533674|561805807|FG006|Dose Level VI|Progressive disease|0|||
155648403|NCT02533674|561805808|FG007|Dose Level VI|Progressive disease|0|||
155351851|NCT00839332|560723038|FG000|Phase 1|Disease Progression|38|||
155351852|NCT00839332|560723039|FG001|Phase 1|Disease Progression|0|||
155351853|NCT00839332|560723040|FG002|Phase 1|Disease Progression|0|||
155351854|NCT00839332|560723038|FG000|Phase 1|Adverse Event|6|||
155351855|NCT00839332|560723039|FG001|Phase 1|Adverse Event|0|||
155351856|NCT00839332|560723040|FG002|Phase 1|Adverse Event|0|||
155351857|NCT00839332|560723038|FG000|Phase 1|Withdrawal by Subject|4|||
155351858|NCT00839332|560723039|FG001|Phase 1|Withdrawal by Subject|0|||
155351859|NCT00839332|560723040|FG002|Phase 1|Withdrawal by Subject|0|||
155351860|NCT00839332|560723038|FG000|Phase 1|Physician Decision|2|||
155425723|NCT00792298|560986644|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155425724|NCT00792298|560986645|FG003|Treatment Period 2|Withdrawal by Subject|2|||
155425725|NCT00792298|560986646|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155425726|NCT00792298|560986647|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155425727|NCT00792298|560986648|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155425728|NCT00792298|560986649|FG007|Treatment Period 2|Withdrawal by Subject|2|||
155425729|NCT00486603|560986652|FG000|Overall Study|Withdrawal by Subject|1|||
155425730|NCT00486603|560986653|FG001|Overall Study|Withdrawal by Subject|0|||
155425731|NCT00486603|560986654|FG002|Overall Study|Withdrawal by Subject|0|||
155425732|NCT00486603|560986655|FG003|Overall Study|Withdrawal by Subject|0|||
155425733|NCT00486603|560986656|FG004|Overall Study|Withdrawal by Subject|0|||
155425734|NCT00486603|560986652|FG000|Overall Study|Physician Decision|0|||
155425735|NCT00486603|560986653|FG001|Overall Study|Physician Decision|1|||
155425736|NCT00486603|560986654|FG002|Overall Study|Physician Decision|0|||
155425737|NCT00486603|560986655|FG003|Overall Study|Physician Decision|0|||
155425738|NCT00486603|560986656|FG004|Overall Study|Physician Decision|0|||
155425739|NCT02706938|560986658|FG000|First Period, 6 Weeks|Adverse Event|8|||
155425740|NCT02706938|560986659|FG001|First Period, 6 Weeks|Adverse Event|0|||
155425741|NCT02706938|560986658|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
155425742|NCT02706938|560986659|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
155425743|NCT02706938|560986658|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
155425744|NCT02706938|560986659|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
155425745|NCT02706938|560986658|FG000|Second Period, 6 Weeks|Adverse Event|0|||
155425746|NCT02706938|560986659|FG001|Second Period, 6 Weeks|Adverse Event|7|||
155425747|NCT02706938|560986658|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
155425748|NCT02706938|560986659|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
155425749|NCT00888238|560986660|FG000|Washout Period After Period 2|Adverse Event|0|||
155425750|NCT00888238|560986661|FG001|Washout Period After Period 2|Adverse Event|0|||
155425751|NCT00888238|560986662|FG002|Washout Period After Period 2|Adverse Event|1|||
155425752|NCT02868892|560986663|FG000|Overall Study|Investigator left site and no follow-up|6|||
155425753|NCT01454076|560986665|FG000|Overall Study|Other|2|||
155425754|NCT01454076|560986666|FG001|Overall Study|Other|0|||
155425755|NCT01454076|560986667|FG002|Overall Study|Other|0|||
155425756|NCT01454076|560986668|FG003|Overall Study|Other|1|||
155425757|NCT01454076|560986669|FG004|Overall Study|Other|2|||
155425758|NCT01454076|560986665|FG000|Overall Study|Withdrawal by Subject|3|||
155425759|NCT01454076|560986666|FG001|Overall Study|Withdrawal by Subject|4|||
155425760|NCT01454076|560986667|FG002|Overall Study|Withdrawal by Subject|2|||
155425761|NCT01454076|560986668|FG003|Overall Study|Withdrawal by Subject|1|||
155425762|NCT01454076|560986669|FG004|Overall Study|Withdrawal by Subject|2|||
155425763|NCT01454076|560986665|FG000|Overall Study|Adverse Event|8|||
155425764|NCT01454076|560986666|FG001|Overall Study|Adverse Event|2|||
155425765|NCT01454076|560986667|FG002|Overall Study|Adverse Event|7|||
155425766|NCT01454076|560986668|FG003|Overall Study|Adverse Event|0|||
155425767|NCT01454076|560986669|FG004|Overall Study|Adverse Event|2|||
155425768|NCT01526148|560986676|FG000|Overall Study|Adverse Event|6|||
155425769|NCT01526148|560986677|FG001|Overall Study|Adverse Event|5|||
155425770|NCT01526148|560986676|FG000|Overall Study|Lost to Follow-up|3|||
155425771|NCT01526148|560986677|FG001|Overall Study|Lost to Follow-up|6|||
155425772|NCT01526148|560986676|FG000|Overall Study|Withdrawal by Subject|2|||
155648404|NCT02533674|561805801|FG000|Dose Level VI|Withdrawal by Subject|0|||
155648405|NCT02533674|561805802|FG001|Dose Level VI|Withdrawal by Subject|0|||
155351861|NCT00839332|560723039|FG001|Phase 1|Physician Decision|0|||
155351862|NCT00839332|560723040|FG002|Phase 1|Physician Decision|0|||
155351863|NCT00839332|560723038|FG000|Phase 2|Protocol Violation|0|||
155351864|NCT00839332|560723039|FG001|Phase 2|Protocol Violation|1|||
155648406|NCT02533674|561805803|FG002|Dose Level VI|Withdrawal by Subject|0|||
155351865|NCT00839332|560723040|FG002|Phase 2|Protocol Violation|0|||
155351866|NCT00839332|560723038|FG000|Phase 2|Disease Progression|0|||
155351867|NCT00839332|560723039|FG001|Phase 2|Disease Progression|46|||
155425773|NCT01526148|560986677|FG001|Overall Study|Withdrawal by Subject|0|||
155425774|NCT01526148|560986676|FG000|Overall Study|Unstable Medical Condition|1|||
155425775|NCT01526148|560986677|FG001|Overall Study|Unstable Medical Condition|0|||
155425776|NCT01526148|560986676|FG000|Overall Study|Unable to discontinue concomitant med|1|||
155425777|NCT01526148|560986677|FG001|Overall Study|Unable to discontinue concomitant med|0|||
155425778|NCT01526148|560986676|FG000|Overall Study|Moved out of state|1|||
155425779|NCT01526148|560986677|FG001|Overall Study|Moved out of state|0|||
155351868|NCT00839332|560723040|FG002|Phase 2|Disease Progression|21|||
155351869|NCT00839332|560723038|FG000|Phase 2|Adverse Event|0|||
155351870|NCT00839332|560723039|FG001|Phase 2|Adverse Event|8|||
155351871|NCT00839332|560723040|FG002|Phase 2|Adverse Event|6|||
155351872|NCT00839332|560723038|FG000|Phase 2|Death|0|||
155351873|NCT00839332|560723039|FG001|Phase 2|Death|4|||
155351874|NCT00839332|560723040|FG002|Phase 2|Death|2|||
155351875|NCT00839332|560723038|FG000|Phase 2|Withdrawal by Subject|0|||
155351876|NCT00839332|560723039|FG001|Phase 2|Withdrawal by Subject|5|||
155351877|NCT00839332|560723040|FG002|Phase 2|Withdrawal by Subject|8|||
155351878|NCT00839332|560723038|FG000|Phase 2|Physician Decision|0|||
155351879|NCT00839332|560723039|FG001|Phase 2|Physician Decision|4|||
155351880|NCT00839332|560723040|FG002|Phase 2|Physician Decision|1|||
155351881|NCT00839332|560723038|FG000|Phase 2|Lost to Follow-up|0|||
155425780|NCT01526148|560986676|FG000|Overall Study|Incarcerated|0|||
155425781|NCT01526148|560986677|FG001|Overall Study|Incarcerated|2|||
155425782|NCT01173653|560986678|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
155425783|NCT01173653|560986679|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
155425784|NCT00291551|560986680|FG000|Overall Study|Death|7|||
155425785|NCT00291551|560986680|FG000|Overall Study|Withdrawal by Subject|6|||
155425786|NCT02452762|560986681|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
155425787|NCT02452762|560986682|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
155425788|NCT02452762|560986681|FG000|Overall Study|Withdrawal by Subject|1|||
155425789|NCT02452762|560986682|FG001|Overall Study|Withdrawal by Subject|0|||
155425790|NCT00584870|560986683|FG000|Overall Study|Adverse Event|4|||
155425791|NCT00584870|560986684|FG001|Overall Study|Adverse Event|3|||
155425792|NCT00584870|560986685|FG002|Overall Study|Adverse Event|2|||
155425793|NCT00584870|560986683|FG000|Overall Study|Lost to Follow-up|4|||
155425794|NCT00584870|560986684|FG001|Overall Study|Lost to Follow-up|1|||
155425795|NCT00584870|560986685|FG002|Overall Study|Lost to Follow-up|1|||
155425796|NCT00584870|560986683|FG000|Overall Study|Lack of Efficacy|7|||
155425797|NCT00584870|560986684|FG001|Overall Study|Lack of Efficacy|14|||
155425798|NCT00584870|560986685|FG002|Overall Study|Lack of Efficacy|8|||
155425799|NCT00584870|560986683|FG000|Overall Study|Withdrawal by Subject|10|||
155425800|NCT00584870|560986684|FG001|Overall Study|Withdrawal by Subject|5|||
155425801|NCT00584870|560986685|FG002|Overall Study|Withdrawal by Subject|3|||
155425802|NCT00584870|560986683|FG000|Overall Study|Protocol Violation|1|||
155425803|NCT00584870|560986684|FG001|Overall Study|Protocol Violation|1|||
155425804|NCT00584870|560986685|FG002|Overall Study|Protocol Violation|2|||
155425805|NCT00584870|560986683|FG000|Overall Study|Did not met entrance criteria|1|||
155425806|NCT00584870|560986684|FG001|Overall Study|Did not met entrance criteria|0|||
155425807|NCT00584870|560986685|FG002|Overall Study|Did not met entrance criteria|0|||
155425808|NCT00584870|560986683|FG000|Overall Study|Other|2|||
155425809|NCT00584870|560986684|FG001|Overall Study|Other|0|||
155425810|NCT00584870|560986685|FG002|Overall Study|Other|0|||
155425811|NCT00584870|560986683|FG000|Overall Study|Randomized but not treated|0|||
155425812|NCT00584870|560986684|FG001|Overall Study|Randomized but not treated|1|||
155425813|NCT00584870|560986685|FG002|Overall Study|Randomized but not treated|2|||
155425814|NCT00631137|560986686|FG000|Overall Study|Withdrawal by Subject|1|||
155425815|NCT00631137|560986687|FG001|Overall Study|Withdrawal by Subject|0|||
155506451|NCT02094937|561280325|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
155351882|NCT00839332|560723039|FG001|Phase 2|Lost to Follow-up|0|||
155351883|NCT00839332|560723040|FG002|Phase 2|Lost to Follow-up|1|||
155351884|NCT01200485|560723041|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
155351885|NCT01200485|560723042|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
155351886|NCT01200485|560723043|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
155351887|NCT01200485|560723041|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
155351888|NCT01200485|560723042|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
155351889|NCT01200485|560723043|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
155425816|NCT03682120|560986688|FG000|Overall Study|Lost to Follow-up|11|||
155425817|NCT03682120|560986689|FG001|Overall Study|Lost to Follow-up|4|||
155425818|NCT03682120|560986690|FG002|Overall Study|Lost to Follow-up|5|||
155425819|NCT03682120|560986691|FG003|Overall Study|Lost to Follow-up|2|||
155425820|NCT03682120|560986688|FG000|Overall Study|Physician Decision|1|||
155425821|NCT03682120|560986689|FG001|Overall Study|Physician Decision|0|||
155425822|NCT03682120|560986690|FG002|Overall Study|Physician Decision|0|||
155648407|NCT02533674|561805804|FG003|Dose Level VI|Withdrawal by Subject|0|||
155351890|NCT06080438|560723044|FG000|Overall Study|Lost to Follow-up|2|||
155351891|NCT03078751|560723049|FG000|Overall Study|Adverse Event|4|||
155351892|NCT03078751|560723050|FG001|Overall Study|Adverse Event|0|||
155351893|NCT03078751|560723049|FG000|Overall Study|Physician Decision|1|||
155351894|NCT03078751|560723050|FG001|Overall Study|Physician Decision|0|||
155351895|NCT03078751|560723049|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
155351896|NCT03078751|560723050|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
155351897|NCT03078751|560723049|FG000|Overall Study|Subject/guardian decision|8|||
155351898|NCT03078751|560723050|FG001|Overall Study|Subject/guardian decision|1|||
155351899|NCT03078751|560723049|FG000|Overall Study|Untreated|0|||
155351900|NCT03078751|560723050|FG001|Overall Study|Untreated|4|||
155351901|NCT04414397|560723051|FG000|Control Period|Withdrawal by Subject|2|||
155351902|NCT04414397|560723052|FG001|Control Period|Withdrawal by Subject|2|||
155351903|NCT04414397|560723051|FG000|Control Period|Lost to Follow-up|0|||
155351904|NCT04414397|560723052|FG001|Control Period|Lost to Follow-up|4|||
155351905|NCT04414397|560723051|FG000|Control Period|Protocol deviation|0|||
155351906|NCT04414397|560723052|FG001|Control Period|Protocol deviation|1|||
155351907|NCT04414397|560723051|FG000|Post-Control Period|Withdrawal by Subject|3|||
155351908|NCT04414397|560723052|FG001|Post-Control Period|Withdrawal by Subject|6|||
155351909|NCT04414397|560723051|FG000|Post-Control Period|Lost to Follow-up|4|||
155351910|NCT04414397|560723052|FG001|Post-Control Period|Lost to Follow-up|9|||
155351911|NCT04414397|560723051|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
155351912|NCT04414397|560723052|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
155351913|NCT04414397|560723051|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
155351914|NCT04414397|560723052|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
155351915|NCT02515097|560723058|FG000|Overall Study|Lost to Follow-up|4|||
155351916|NCT02515097|560723059|FG001|Overall Study|Lost to Follow-up|2|||
155351917|NCT02515097|560723058|FG000|Overall Study|Withdrawal by Subject|1|||
155351918|NCT02515097|560723059|FG001|Overall Study|Withdrawal by Subject|3|||
155351919|NCT02515097|560723058|FG000|Overall Study|Adverse Event|2|||
155351920|NCT02515097|560723059|FG001|Overall Study|Adverse Event|1|||
155351921|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
155351922|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
155351923|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
155351924|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Other|1|||
155351925|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Other|0|||
155351926|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Other|0|||
155351927|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Physician Decision|3|||
155351928|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Physician Decision|0|||
155351929|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Physician Decision|0|||
155351930|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
155351931|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
155351932|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
155351933|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
155351934|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
155351935|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
155351936|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Adverse Event|18|||
155351937|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Adverse Event|0|||
155351938|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Adverse Event|0|||
155351939|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
155351940|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
155351941|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
155351942|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
155351943|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
155351944|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
155351945|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
155351946|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
155351947|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
155351948|NCT03030599|560723062|FG000|Stable Dose|Protocol deviation|3|||
155351949|NCT03030599|560723063|FG001|Stable Dose|Protocol deviation|0|||
155351950|NCT03030599|560723064|FG002|Stable Dose|Protocol deviation|0|||
155351951|NCT03030599|560723062|FG000|Stable Dose|Adverse Event|1|||
155351952|NCT03030599|560723063|FG001|Stable Dose|Adverse Event|0|||
155351953|NCT03030599|560723064|FG002|Stable Dose|Adverse Event|0|||
155351954|NCT03030599|560723062|FG000|Stable Dose|Lost to Follow-up|1|||
155351955|NCT03030599|560723063|FG001|Stable Dose|Lost to Follow-up|0|||
155351956|NCT03030599|560723064|FG002|Stable Dose|Lost to Follow-up|0|||
155351957|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
155351958|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
155351959|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
155351960|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
155351961|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
155351962|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
155351963|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
155351964|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
155351965|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
155351966|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
155351967|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
155351968|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
155351969|NCT03030599|560723062|FG000|Open-label Extension|Adverse Event|3|||
155351970|NCT03030599|560723063|FG001|Open-label Extension|Adverse Event|0|||
155351971|NCT03030599|560723064|FG002|Open-label Extension|Adverse Event|0|||
155351972|NCT03030599|560723062|FG000|Open-label Extension|Lost to Follow-up|2|||
155351973|NCT03030599|560723063|FG001|Open-label Extension|Lost to Follow-up|0|||
155351974|NCT03030599|560723064|FG002|Open-label Extension|Lost to Follow-up|0|||
155351975|NCT03030599|560723062|FG000|Open-label Extension|Lack of Efficacy|1|||
155351976|NCT03030599|560723063|FG001|Open-label Extension|Lack of Efficacy|0|||
155351977|NCT03030599|560723064|FG002|Open-label Extension|Lack of Efficacy|0|||
155351978|NCT03030599|560723062|FG000|Open-label Extension|Other Reason|1|||
155351979|NCT03030599|560723063|FG001|Open-label Extension|Other Reason|0|||
155351980|NCT03030599|560723064|FG002|Open-label Extension|Other Reason|0|||
155351981|NCT01592383|560723065|FG000|Overall Study|Adverse Event|1|||
155351982|NCT01064856|560723066|FG000|Double-blind (DB) Period|Adverse Event|1|||
155351983|NCT01064856|560723067|FG001|Double-blind (DB) Period|Adverse Event|0|||
155351984|NCT01064856|560723068|FG002|Double-blind (DB) Period|Adverse Event|0|||
155351985|NCT01064856|560723069|FG003|Double-blind (DB) Period|Adverse Event|0|||
155351986|NCT01064856|560723066|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
155351987|NCT01064856|560723067|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351988|NCT01064856|560723068|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351989|NCT01064856|560723069|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351990|NCT01064856|560723066|FG000|Open-label (OL) Period|Adverse Event|0|||
155351991|NCT01064856|560723067|FG001|Open-label (OL) Period|Adverse Event|0|||
155351992|NCT01064856|560723068|FG002|Open-label (OL) Period|Adverse Event|12|||
155351993|NCT01064856|560723069|FG003|Open-label (OL) Period|Adverse Event|6|||
155351994|NCT01064856|560723066|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
155351995|NCT01064856|560723067|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
155351996|NCT01064856|560723068|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
155351997|NCT01064856|560723069|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
155351998|NCT01064856|560723066|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
155351999|NCT01064856|560723067|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
155352000|NCT01064856|560723068|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
155352001|NCT01064856|560723069|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
155352002|NCT01064856|560723066|FG000|Open-label (OL) Period|Other|0|||
155352003|NCT01064856|560723067|FG001|Open-label (OL) Period|Other|0|||
155352004|NCT01064856|560723068|FG002|Open-label (OL) Period|Other|7|||
155352005|NCT01064856|560723069|FG003|Open-label (OL) Period|Other|7|||
155352006|NCT02133131|560723070|FG000|Overall Study|Adverse Event|0|||
155352007|NCT02133131|560723071|FG001|Overall Study|Adverse Event|0|||
155352008|NCT02133131|560723072|FG002|Overall Study|Adverse Event|0|||
155352009|NCT02133131|560723073|FG003|Overall Study|Adverse Event|1|||
155648408|NCT02533674|561805805|FG004|Dose Level VI|Withdrawal by Subject|0|||
155648409|NCT02533674|561805806|FG005|Dose Level VI|Withdrawal by Subject|1|||
155648410|NCT02533674|561805807|FG006|Dose Level VI|Withdrawal by Subject|0|||
155648411|NCT02533674|561805808|FG007|Dose Level VI|Withdrawal by Subject|0|||
155352010|NCT02133131|560723074|FG004|Overall Study|Adverse Event|0|||
155352011|NCT02133131|560723075|FG005|Overall Study|Adverse Event|0|||
155352012|NCT02133131|560723076|FG006|Overall Study|Adverse Event|0|||
155352013|NCT02133131|560723070|FG000|Overall Study|Lost to Follow-up|1|||
155352014|NCT02133131|560723071|FG001|Overall Study|Lost to Follow-up|0|||
155352015|NCT02133131|560723072|FG002|Overall Study|Lost to Follow-up|0|||
155352016|NCT02133131|560723073|FG003|Overall Study|Lost to Follow-up|1|||
155352017|NCT02133131|560723074|FG004|Overall Study|Lost to Follow-up|0|||
155352018|NCT02133131|560723075|FG005|Overall Study|Lost to Follow-up|0|||
155352019|NCT02133131|560723076|FG006|Overall Study|Lost to Follow-up|0|||
155352020|NCT02133131|560723070|FG000|Overall Study|Status not recorded|4|||
155352021|NCT02133131|560723071|FG001|Overall Study|Status not recorded|5|||
155352022|NCT02133131|560723072|FG002|Overall Study|Status not recorded|1|||
155352023|NCT02133131|560723073|FG003|Overall Study|Status not recorded|4|||
155352024|NCT02133131|560723074|FG004|Overall Study|Status not recorded|0|||
155352025|NCT02133131|560723075|FG005|Overall Study|Status not recorded|0|||
155352026|NCT02133131|560723076|FG006|Overall Study|Status not recorded|0|||
155352027|NCT02133131|560723070|FG000|Overall Study|Ongoing in study|0|||
155352028|NCT02133131|560723071|FG001|Overall Study|Ongoing in study|0|||
155352029|NCT02133131|560723072|FG002|Overall Study|Ongoing in study|0|||
155352030|NCT02133131|560723073|FG003|Overall Study|Ongoing in study|0|||
155352031|NCT02133131|560723074|FG004|Overall Study|Ongoing in study|15|||
155352032|NCT02133131|560723075|FG005|Overall Study|Ongoing in study|14|||
155352033|NCT02133131|560723076|FG006|Overall Study|Ongoing in study|11|||
155352034|NCT02133131|560723070|FG000|Overall Study|Protocol Violation|0|||
155352035|NCT02133131|560723071|FG001|Overall Study|Protocol Violation|0|||
155352036|NCT02133131|560723072|FG002|Overall Study|Protocol Violation|0|||
155352037|NCT02133131|560723073|FG003|Overall Study|Protocol Violation|0|||
155352038|NCT02133131|560723074|FG004|Overall Study|Protocol Violation|0|||
155352039|NCT02133131|560723075|FG005|Overall Study|Protocol Violation|0|||
155352040|NCT02133131|560723076|FG006|Overall Study|Protocol Violation|1|||
155352041|NCT00509925|560723077|FG000|Overall Study|Personal reasons|0|||
155352042|NCT00509925|560723078|FG001|Overall Study|Personal reasons|1|||
155352043|NCT00230971|560723079|FG000|Randomization|No study drug administered|3|||
155352044|NCT00230971|560723080|FG001|Randomization|No study drug administered|3|||
155352045|NCT00230971|560723079|FG000|Baseline Participants|Lost to Follow-up|5|||
155352046|NCT00230971|560723080|FG001|Baseline Participants|Lost to Follow-up|12|||
155352047|NCT00230971|560723079|FG000|Baseline Participants|Death|6|||
155352048|NCT00230971|560723080|FG001|Baseline Participants|Death|5|||
155352049|NCT00230971|560723079|FG000|Baseline Participants|Withdrawal by Subject|7|||
155352050|NCT00230971|560723080|FG001|Baseline Participants|Withdrawal by Subject|1|||
155352051|NCT00230971|560723079|FG000|Baseline Participants|Adverse Event|1|||
155352052|NCT00230971|560723080|FG001|Baseline Participants|Adverse Event|0|||
155352053|NCT00230971|560723079|FG000|Baseline Participants|No bacteria observed|1|||
155352054|NCT00230971|560723080|FG001|Baseline Participants|No bacteria observed|0|||
155352055|NCT00230971|560723079|FG000|Baseline Participants|Failure to return|1|||
155352056|NCT00230971|560723080|FG001|Baseline Participants|Failure to return|1|||
155352057|NCT00230971|560723079|FG000|Baseline Participants|Reintervention|1|||
155425823|NCT03682120|560986691|FG003|Overall Study|Physician Decision|0|||
155425824|NCT03682120|560986688|FG000|Overall Study|Withdrawal by Subject|1|||
155425825|NCT03682120|560986689|FG001|Overall Study|Withdrawal by Subject|2|||
155425826|NCT03682120|560986690|FG002|Overall Study|Withdrawal by Subject|3|||
155425827|NCT03682120|560986691|FG003|Overall Study|Withdrawal by Subject|0|||
155425828|NCT03682120|560986688|FG000|Overall Study|Death|0|||
155425829|NCT03682120|560986689|FG001|Overall Study|Death|1|||
155425830|NCT03682120|560986690|FG002|Overall Study|Death|0|||
155648412|NCT02533674|561805801|FG000|Dose Level VI|Treatment-related AE|0|||
155648413|NCT02533674|561805802|FG001|Dose Level VI|Treatment-related AE|0|||
155648414|NCT02533674|561805803|FG002|Dose Level VI|Treatment-related AE|0|||
155648415|NCT02533674|561805804|FG003|Dose Level VI|Treatment-related AE|0|||
155648416|NCT02533674|561805805|FG004|Dose Level VI|Treatment-related AE|0|||
155648417|NCT02533674|561805806|FG005|Dose Level VI|Treatment-related AE|1|||
155648418|NCT02533674|561805807|FG006|Dose Level VI|Treatment-related AE|0|||
155648419|NCT02533674|561805808|FG007|Dose Level VI|Treatment-related AE|0|||
155648420|NCT02533674|561805801|FG000|Dose Level VII|Progressive disease|0|||
155648421|NCT02533674|561805802|FG001|Dose Level VII|Progressive disease|0|||
155648422|NCT02533674|561805803|FG002|Dose Level VII|Progressive disease|0|||
155648423|NCT02533674|561805804|FG003|Dose Level VII|Progressive disease|0|||
155648424|NCT02533674|561805805|FG004|Dose Level VII|Progressive disease|0|||
155648425|NCT02533674|561805806|FG005|Dose Level VII|Progressive disease|0|||
155648426|NCT02533674|561805807|FG006|Dose Level VII|Progressive disease|10|||
155648427|NCT02533674|561805808|FG007|Dose Level VII|Progressive disease|0|||
155648428|NCT02533674|561805801|FG000|Dose Level VII|Withdrawal by Subject|0|||
155648429|NCT02533674|561805802|FG001|Dose Level VII|Withdrawal by Subject|0|||
155648430|NCT02533674|561805803|FG002|Dose Level VII|Withdrawal by Subject|0|||
155648431|NCT02533674|561805804|FG003|Dose Level VII|Withdrawal by Subject|0|||
155648432|NCT02533674|561805805|FG004|Dose Level VII|Withdrawal by Subject|0|||
155648433|NCT02533674|561805806|FG005|Dose Level VII|Withdrawal by Subject|0|||
155648434|NCT02533674|561805807|FG006|Dose Level VII|Withdrawal by Subject|3|||
155648435|NCT02533674|561805808|FG007|Dose Level VII|Withdrawal by Subject|0|||
155648436|NCT02533674|561805801|FG000|Dose Level VII|Treatment-related AE|0|||
155648437|NCT02533674|561805802|FG001|Dose Level VII|Treatment-related AE|0|||
155648438|NCT02533674|561805803|FG002|Dose Level VII|Treatment-related AE|0|||
155648439|NCT02533674|561805804|FG003|Dose Level VII|Treatment-related AE|0|||
155648440|NCT02533674|561805805|FG004|Dose Level VII|Treatment-related AE|0|||
155648441|NCT02533674|561805806|FG005|Dose Level VII|Treatment-related AE|0|||
155648442|NCT02533674|561805807|FG006|Dose Level VII|Treatment-related AE|1|||
155648443|NCT02533674|561805808|FG007|Dose Level VII|Treatment-related AE|0|||
155648444|NCT02533674|561805801|FG000|Dose Level VII|Death|0|||
155648445|NCT02533674|561805802|FG001|Dose Level VII|Death|0|||
155648446|NCT02533674|561805803|FG002|Dose Level VII|Death|0|||
155648447|NCT02533674|561805804|FG003|Dose Level VII|Death|0|||
155506452|NCT02094937|561280326|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
155506453|NCT02094937|561280327|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
155506454|NCT02094937|561280324|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
155506455|NCT02094937|561280325|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
155506456|NCT02094937|561280326|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
155506457|NCT02094937|561280327|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
155506458|NCT02094937|561280324|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
155506459|NCT02094937|561280325|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
155506460|NCT02094937|561280326|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
155506461|NCT02094937|561280327|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
155506462|NCT00343642|561281710|FG000|Overall Study|Lost to Follow-up|0|||
155506463|NCT00343642|561281711|FG001|Overall Study|Lost to Follow-up|1|||
155506464|NCT00343642|561281712|FG002|Overall Study|Lost to Follow-up|0|||
155506465|NCT00343642|561281710|FG000|Overall Study|Pregnancy|1|||
155506466|NCT00343642|561281711|FG001|Overall Study|Pregnancy|0|||
155506467|NCT00343642|561281712|FG002|Overall Study|Pregnancy|2|||
155506468|NCT00343642|561281710|FG000|Overall Study|Withdrawal by Subject|2|||
155506469|NCT00343642|561281711|FG001|Overall Study|Withdrawal by Subject|3|||
155506470|NCT00343642|561281712|FG002|Overall Study|Withdrawal by Subject|4|||
155506471|NCT00343642|561281710|FG000|Overall Study|Adverse Event|0|||
155506472|NCT00343642|561281711|FG001|Overall Study|Adverse Event|0|||
155506473|NCT00343642|561281712|FG002|Overall Study|Adverse Event|1|||
155506474|NCT00343642|561281710|FG000|Overall Study|Flare up|6|||
155506475|NCT00343642|561281711|FG001|Overall Study|Flare up|4|||
155506476|NCT00343642|561281712|FG002|Overall Study|Flare up|0|||
155506477|NCT01963676|561281713|FG000|Overall Study|Withdrawal by Subject|1|||
155506478|NCT01963676|561281714|FG001|Overall Study|Withdrawal by Subject|0|||
155506479|NCT00766506|561281715|FG000|Overall Study|Use rescue medication after 3 hours|3|||
155506480|NCT00766506|561281716|FG001|Overall Study|Use rescue medication after 3 hours|0|||
155506481|NCT00766506|561281715|FG000|Overall Study|Other|2|||
155506482|NCT00766506|561281716|FG001|Overall Study|Other|2|||
155506483|NCT02595528|561281717|FG000|Overall Study|Withdrawal by Subject|1|||
155506484|NCT02595528|561281718|FG001|Overall Study|Withdrawal by Subject|2|||
155506485|NCT02595528|561281719|FG002|Overall Study|Withdrawal by Subject|1|||
155506486|NCT02595528|561281720|FG003|Overall Study|Withdrawal by Subject|3|||
155648448|NCT02533674|561805805|FG004|Dose Level VII|Death|0|||
155506487|NCT02595528|561281717|FG000|Overall Study|Lost to Follow-up|1|||
155506488|NCT02595528|561281718|FG001|Overall Study|Lost to Follow-up|1|||
155506489|NCT02595528|561281719|FG002|Overall Study|Lost to Follow-up|0|||
155506490|NCT02595528|561281720|FG003|Overall Study|Lost to Follow-up|1|||
155506491|NCT03202511|561281721|FG000|Overall Study|Withdrawal by Subject|1|||
155506492|NCT03202511|561281722|FG001|Overall Study|Withdrawal by Subject|0|||
155352058|NCT00230971|560723080|FG001|Baseline Participants|Reintervention|0|||
155352059|NCT00951171|560723082|FG000|Overall Study|Adverse Event|2|||
155352060|NCT00951171|560723083|FG001|Overall Study|Adverse Event|0|||
155352061|NCT05294328|560723088|FG000|Overall Study|Adverse Event|1|||
155352062|NCT05294328|560723089|FG001|Overall Study|Adverse Event|0|||
155352063|NCT05294328|560723090|FG002|Overall Study|Adverse Event|0|||
155352064|NCT05294328|560723088|FG000|Overall Study|Physician Decision|1|||
155352065|NCT05294328|560723089|FG001|Overall Study|Physician Decision|1|||
155352066|NCT05294328|560723090|FG002|Overall Study|Physician Decision|0|||
155352067|NCT05294328|560723088|FG000|Overall Study|Withdrawal by Subject|0|||
155352068|NCT05294328|560723089|FG001|Overall Study|Withdrawal by Subject|2|||
155506493|NCT02736227|561281727|FG000|Overall Study|Withdrawal by Subject|0|||
155648449|NCT02533674|561805806|FG005|Dose Level VII|Death|0|||
155648450|NCT02533674|561805807|FG006|Dose Level VII|Death|2|||
155648451|NCT02533674|561805808|FG007|Dose Level VII|Death|0|||
155648452|NCT02533674|561805801|FG000|Dose Level VIII|Progressive disease|0|||
155352069|NCT05294328|560723090|FG002|Overall Study|Withdrawal by Subject|1|||
155352070|NCT05294328|560723088|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
155352071|NCT05294328|560723089|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
155352072|NCT05294328|560723090|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
155352073|NCT04267393|560723091|FG000|Randomization|Adverse Event|1|||
155352074|NCT04267393|560723092|FG001|Randomization|Adverse Event|0|||
155352075|NCT04267393|560723093|FG002|Randomization|Adverse Event|0|||
155352076|NCT04267393|560723091|FG000|Randomization|Administrative Reasons by Sponsor|0|||
155352077|NCT04267393|560723092|FG001|Randomization|Administrative Reasons by Sponsor|1|||
155352078|NCT04267393|560723093|FG002|Randomization|Administrative Reasons by Sponsor|0|||
155352079|NCT04267393|560723091|FG000|Treatment Period|Adverse Event|0|||
155352080|NCT04267393|560723092|FG001|Treatment Period|Adverse Event|2|||
155352081|NCT04267393|560723093|FG002|Treatment Period|Adverse Event|3|||
155352082|NCT04267393|560723091|FG000|Treatment Period|Participant Withdrew Consent|0|||
155352083|NCT04267393|560723092|FG001|Treatment Period|Participant Withdrew Consent|0|||
155352084|NCT04267393|560723093|FG002|Treatment Period|Participant Withdrew Consent|1|||
155352085|NCT04267393|560723091|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
155352086|NCT04267393|560723092|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
155352087|NCT04267393|560723093|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
155352088|NCT03864341|560725578|FG000|Overall Study|Withdrawal by Subject|1|||
155352089|NCT01066936|560725579|FG000|Overall Study|Death|2|||
155352090|NCT01066936|560725579|FG000|Overall Study|Device revised/removed|1|||
155352091|NCT01066936|560725579|FG000|Overall Study|Lost to Follow-up|3|||
155352092|NCT01066936|560725579|FG000|Overall Study|Withdrawal by Subject|4|||
155352093|NCT04156399|560725585|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
155352094|NCT04156399|560725585|FG000|Overall Study|study suspension due to COVID pandemic|3|||
155352095|NCT01929876|560725588|FG000|Period 2|Non-Compliance|1|||
155352096|NCT03991988|560725589|FG000|Overall Study|Withdrawal by Subject|2|||
155352097|NCT03991988|560725590|FG001|Overall Study|Withdrawal by Subject|2|||
155352098|NCT01222533|560725592|FG000|Overall Study|Adverse Event|5|||
155648453|NCT02533674|561805802|FG001|Dose Level VIII|Progressive disease|0|||
155352099|NCT01222533|560725592|FG000|Overall Study|Withdrawal by Subject|5|||
155352100|NCT01222533|560725592|FG000|Overall Study|Other|4|||
155352101|NCT03418493|560725593|FG000|Overall Study|Adverse Event|1|||
155352102|NCT03418493|560725594|FG001|Overall Study|Adverse Event|0|||
155352103|NCT03418493|560725595|FG002|Overall Study|Adverse Event|0|||
155352104|NCT03418493|560725596|FG003|Overall Study|Adverse Event|0|||
155352105|NCT03418493|560725597|FG004|Overall Study|Adverse Event|0|||
155352106|NCT03418493|560725598|FG005|Overall Study|Adverse Event|0|||
155352107|NCT03418493|560725599|FG006|Overall Study|Adverse Event|0|||
155352108|NCT03418493|560725600|FG007|Overall Study|Adverse Event|0|||
155352109|NCT03418493|560725601|FG008|Overall Study|Adverse Event|0|||
155352110|NCT03418493|560725602|FG009|Overall Study|Adverse Event|0|||
155352111|NCT03418493|560725603|FG010|Overall Study|Adverse Event|0|||
155352112|NCT03418493|560725593|FG000|Overall Study|Protocol Violation|0|||
155352113|NCT03418493|560725594|FG001|Overall Study|Protocol Violation|0|||
155352114|NCT03418493|560725595|FG002|Overall Study|Protocol Violation|0|||
155352115|NCT03418493|560725596|FG003|Overall Study|Protocol Violation|0|||
155352116|NCT03418493|560725597|FG004|Overall Study|Protocol Violation|0|||
155352117|NCT03418493|560725598|FG005|Overall Study|Protocol Violation|0|||
155352118|NCT03418493|560725599|FG006|Overall Study|Protocol Violation|0|||
155352119|NCT03418493|560725600|FG007|Overall Study|Protocol Violation|0|||
155352120|NCT03418493|560725601|FG008|Overall Study|Protocol Violation|0|||
155352121|NCT03418493|560725602|FG009|Overall Study|Protocol Violation|1|||
155352122|NCT03418493|560725603|FG010|Overall Study|Protocol Violation|0|||
155352123|NCT01947517|560725604|FG000|Overall Study|Withdrawal by Subject|1|||
155425831|NCT03682120|560986691|FG003|Overall Study|Death|0|||
155352124|NCT01947517|560725605|FG001|Overall Study|Withdrawal by Subject|1|||
155352125|NCT05446714|560725606|FG000|Overall Study|Lost to Follow-up|1|||
155352126|NCT05446714|560725607|FG001|Overall Study|Lost to Follow-up|3|||
155352127|NCT05446714|560725608|FG002|Overall Study|Lost to Follow-up|2|||
155352128|NCT05446714|560725606|FG000|Overall Study|Protocol Violation|2|||
155352129|NCT05446714|560725607|FG001|Overall Study|Protocol Violation|0|||
155425832|NCT03682120|560986688|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
155352130|NCT05446714|560725608|FG002|Overall Study|Protocol Violation|0|||
155352131|NCT02418845|560725614|FG000|Overall Study|Lost to Follow-up|7|||
155352132|NCT02418845|560725615|FG001|Overall Study|Lost to Follow-up|2|||
155352133|NCT02418845|560725614|FG000|Overall Study|Lack of Efficacy|0|||
155352134|NCT02418845|560725615|FG001|Overall Study|Lack of Efficacy|3|||
155352135|NCT02418845|560725614|FG000|Overall Study|Physician Decision|5|||
155352136|NCT02418845|560725615|FG001|Overall Study|Physician Decision|5|||
155352137|NCT02418845|560725614|FG000|Overall Study|Protocol Violation|1|||
155352138|NCT02418845|560725615|FG001|Overall Study|Protocol Violation|0|||
155352139|NCT02418845|560725614|FG000|Overall Study|Withdrawal by Subject|3|||
155352140|NCT02418845|560725615|FG001|Overall Study|Withdrawal by Subject|2|||
155352141|NCT00460564|560725616|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
155352142|NCT00460564|560725617|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
155352143|NCT00460564|560725618|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352144|NCT00460564|560725619|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352145|NCT00460564|560725620|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352146|NCT00460564|560725621|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352147|NCT00460564|560725622|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352148|NCT00460564|560725623|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352149|NCT00460564|560725616|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
155352150|NCT00460564|560725617|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352151|NCT00460564|560725618|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352152|NCT00460564|560725619|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352153|NCT00460564|560725620|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352154|NCT00460564|560725621|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352155|NCT00460564|560725622|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352156|NCT00460564|560725623|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352157|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352158|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352159|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352160|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352161|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
155352162|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
155352163|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
155352164|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352165|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352166|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352167|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352168|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352169|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
155352170|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
155352171|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352172|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352173|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352174|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352175|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352176|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352177|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
155352178|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352179|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352180|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352181|NCT00630552|560725624|FG000|Overall Study|Adverse Event|0|||
155352182|NCT00630552|560725625|FG001|Overall Study|Adverse Event|1|||
155352183|NCT00630552|560725626|FG002|Overall Study|Adverse Event|5|||
155352184|NCT00630552|560725627|FG003|Overall Study|Adverse Event|4|||
155352185|NCT00630552|560725628|FG004|Overall Study|Adverse Event|2|||
155352186|NCT00630552|560725624|FG000|Overall Study|Disease progression|5|||
155352187|NCT00630552|560725625|FG001|Overall Study|Disease progression|6|||
155352188|NCT00630552|560725626|FG002|Overall Study|Disease progression|27|||
155352189|NCT00630552|560725627|FG003|Overall Study|Disease progression|22|||
155352190|NCT00630552|560725628|FG004|Overall Study|Disease progression|31|||
155352191|NCT00630552|560725624|FG000|Overall Study|Never received IP|0|||
155352192|NCT00630552|560725625|FG001|Overall Study|Never received IP|0|||
155352193|NCT00630552|560725626|FG002|Overall Study|Never received IP|0|||
155352194|NCT00630552|560725627|FG003|Overall Study|Never received IP|2|||
155352195|NCT00630552|560725628|FG004|Overall Study|Never received IP|2|||
155352196|NCT00630552|560725624|FG000|Overall Study|Ineligibility determined|0|||
155352197|NCT00630552|560725625|FG001|Overall Study|Ineligibility determined|0|||
155352198|NCT00630552|560725626|FG002|Overall Study|Ineligibility determined|0|||
155352199|NCT00630552|560725627|FG003|Overall Study|Ineligibility determined|0|||
155352200|NCT00630552|560725628|FG004|Overall Study|Ineligibility determined|1|||
155352201|NCT00630552|560725624|FG000|Overall Study|Protocol Violation|0|||
155352202|NCT00630552|560725625|FG001|Overall Study|Protocol Violation|0|||
155352203|NCT00630552|560725626|FG002|Overall Study|Protocol Violation|0|||
155352204|NCT00630552|560725627|FG003|Overall Study|Protocol Violation|1|||
155352205|NCT00630552|560725628|FG004|Overall Study|Protocol Violation|0|||
155352206|NCT00630552|560725624|FG000|Overall Study|Physician Decision|0|||
155352207|NCT00630552|560725625|FG001|Overall Study|Physician Decision|0|||
155352208|NCT00630552|560725626|FG002|Overall Study|Physician Decision|0|||
155352209|NCT00630552|560725627|FG003|Overall Study|Physician Decision|0|||
155352210|NCT00630552|560725628|FG004|Overall Study|Physician Decision|1|||
155352211|NCT00630552|560725624|FG000|Overall Study|Death|0|||
155352212|NCT00630552|560725625|FG001|Overall Study|Death|0|||
155352213|NCT00630552|560725626|FG002|Overall Study|Death|1|||
155352214|NCT00630552|560725627|FG003|Overall Study|Death|2|||
155352215|NCT00630552|560725628|FG004|Overall Study|Death|2|||
155352216|NCT00630552|560725624|FG000|Overall Study|Withdrawal by Subject|0|||
155352217|NCT00630552|560725625|FG001|Overall Study|Withdrawal by Subject|0|||
155352218|NCT00630552|560725626|FG002|Overall Study|Withdrawal by Subject|0|||
155352219|NCT00630552|560725627|FG003|Overall Study|Withdrawal by Subject|1|||
155352220|NCT00630552|560725628|FG004|Overall Study|Withdrawal by Subject|0|||
155352221|NCT00630552|560725624|FG000|Overall Study|Other|0|||
155352222|NCT00630552|560725625|FG001|Overall Study|Other|0|||
155352223|NCT00630552|560725626|FG002|Overall Study|Other|4|||
155352224|NCT00630552|560725627|FG003|Overall Study|Other|2|||
155352225|NCT00630552|560725628|FG004|Overall Study|Other|0|||
155352226|NCT03226106|560725629|FG000|Overall Study|Withdrawal by Subject|2|||
155352227|NCT03226106|560725630|FG001|Overall Study|Withdrawal by Subject|0|||
155352228|NCT03226106|560725629|FG000|Overall Study|Adverse Event|1|||
155352229|NCT03226106|560725630|FG001|Overall Study|Adverse Event|0|||
155352230|NCT03226106|560725629|FG000|Overall Study|Lost to Follow-up|2|||
155352231|NCT03226106|560725630|FG001|Overall Study|Lost to Follow-up|0|||
155352232|NCT04349644|560725631|FG000|Allocation/Pretest|Lost to pretest|0|||
155352233|NCT04349644|560725632|FG001|Allocation/Pretest|Lost to pretest|3|||
155352234|NCT04349644|560725631|FG000|Posttest|Lost to posttest|0|||
155352235|NCT04349644|560725632|FG001|Posttest|Lost to posttest|8|||
155352236|NCT04349644|560725631|FG000|Posttest|Discontinued intervention|6|||
155352237|NCT04349644|560725632|FG001|Posttest|Discontinued intervention|0|||
155352238|NCT04349644|560725631|FG000|Follow-up|Lost to Follow-up|0|||
155352239|NCT04349644|560725632|FG001|Follow-up|Lost to Follow-up|2|||
155352240|NCT01084239|560725633|FG000|28-Day Follow-up|Lost to Follow-up|4|||
155352241|NCT01084239|560725634|FG001|28-Day Follow-up|Lost to Follow-up|9|||
155425833|NCT03682120|560986689|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
155352242|NCT05006417|560725635|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
155352243|NCT00863798|560725636|FG000|Overall Study|Adverse Event|5|||
155352244|NCT00863798|560725637|FG001|Overall Study|Adverse Event|2|||
155352245|NCT00863798|560725638|FG002|Overall Study|Adverse Event|4|||
155352246|NCT00863798|560725636|FG000|Overall Study|Participant failed to return|2|||
155352247|NCT00863798|560725637|FG001|Overall Study|Participant failed to return|1|||
155352248|NCT00863798|560725638|FG002|Overall Study|Participant failed to return|0|||
155352249|NCT00863798|560725636|FG000|Overall Study|Investigator request|1|||
155352250|NCT00863798|560725637|FG001|Overall Study|Investigator request|2|||
155352251|NCT00863798|560725638|FG002|Overall Study|Investigator request|1|||
155352252|NCT00863798|560725636|FG000|Overall Study|Lack of Efficacy|4|||
155352253|NCT00863798|560725637|FG001|Overall Study|Lack of Efficacy|3|||
155352254|NCT00863798|560725638|FG002|Overall Study|Lack of Efficacy|6|||
155352255|NCT00863798|560725636|FG000|Overall Study|Lost to Follow-up|6|||
155352256|NCT00863798|560725637|FG001|Overall Study|Lost to Follow-up|9|||
155352257|NCT00863798|560725638|FG002|Overall Study|Lost to Follow-up|5|||
155352258|NCT00863798|560725636|FG000|Overall Study|Other|2|||
155352259|NCT00863798|560725637|FG001|Overall Study|Other|3|||
155352260|NCT00863798|560725638|FG002|Overall Study|Other|1|||
155352261|NCT00863798|560725636|FG000|Overall Study|Protocol Violation|0|||
155352262|NCT00863798|560725637|FG001|Overall Study|Protocol Violation|1|||
155352263|NCT00863798|560725638|FG002|Overall Study|Protocol Violation|1|||
155352264|NCT00863798|560725636|FG000|Overall Study|Withdrawal by Subject|8|||
155352265|NCT00863798|560725637|FG001|Overall Study|Withdrawal by Subject|7|||
155352266|NCT00863798|560725638|FG002|Overall Study|Withdrawal by Subject|4|||
155352267|NCT00863798|560725636|FG000|Overall Study|Randomized not treated|4|||
155352268|NCT00863798|560725637|FG001|Overall Study|Randomized not treated|2|||
155425834|NCT03682120|560986690|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
155425835|NCT03682120|560986691|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
155425836|NCT01015833|560986692|FG000|Overall Study|Death|1|||
155425837|NCT01015833|560986693|FG001|Overall Study|Death|0|||
155425838|NCT01015833|560986692|FG000|Overall Study|Withdrawal by Subject|3|||
155425839|NCT01015833|560986693|FG001|Overall Study|Withdrawal by Subject|2|||
155425840|NCT01015833|560986692|FG000|Overall Study|Adverse Event|0|||
155425841|NCT01015833|560986693|FG001|Overall Study|Adverse Event|1|||
155425842|NCT01015833|560986692|FG000|Overall Study|Physician Decision|2|||
155425843|NCT01015833|560986693|FG001|Overall Study|Physician Decision|0|||
155425844|NCT01015833|560986692|FG000|Overall Study|Symptomatic deterioration|0|||
155425845|NCT01015833|560986693|FG001|Overall Study|Symptomatic deterioration|1|||
155425846|NCT01015833|560986692|FG000|Overall Study|Other|5|||
155425847|NCT01015833|560986693|FG001|Overall Study|Other|1|||
155425848|NCT01015833|560986692|FG000|Overall Study|Motor Vehicle Accidents|1|||
155425849|NCT01015833|560986693|FG001|Overall Study|Motor Vehicle Accidents|0|||
155425850|NCT01015833|560986692|FG000|Overall Study|Did not start treatment|1|||
155425851|NCT01015833|560986693|FG001|Overall Study|Did not start treatment|0|||
155425852|NCT03529409|560986702|FG000|Randomized|Lost to Follow-up|0|||
155425853|NCT03529409|560986703|FG001|Randomized|Lost to Follow-up|0|||
155425854|NCT03529409|560986704|FG002|Randomized|Lost to Follow-up|4|||
155425855|NCT03529409|560986702|FG000|Randomized|Excluded|0|||
155425856|NCT03529409|560986703|FG001|Randomized|Excluded|0|||
155425857|NCT03529409|560986704|FG002|Randomized|Excluded|1|||
155425858|NCT03529409|560986702|FG000|Post-treatment Assessment|Death|1|||
155425859|NCT03529409|560986703|FG001|Post-treatment Assessment|Death|0|||
155425860|NCT03529409|560986704|FG002|Post-treatment Assessment|Death|0|||
155425861|NCT03529409|560986702|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
155425862|NCT03529409|560986703|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
155425863|NCT03529409|560986704|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
155425864|NCT03529409|560986702|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
155425865|NCT03529409|560986703|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
155425866|NCT03529409|560986704|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
155425867|NCT03529409|560986702|FG000|Follow-up Assessment|Death|1|||
155506494|NCT02736227|561281728|FG001|Overall Study|Withdrawal by Subject|0|||
155506495|NCT02736227|561281729|FG002|Overall Study|Withdrawal by Subject|1|||
155506496|NCT02736227|561281727|FG000|Overall Study|Physician Decision|0|||
155352269|NCT00863798|560725638|FG002|Overall Study|Randomized not treated|3|||
155352270|NCT04238520|560725639|FG000|Overall Study|Withdrawal by Subject|1|||
155352271|NCT04238520|560725640|FG001|Overall Study|Withdrawal by Subject|1|||
155352272|NCT04238520|560725639|FG000|Overall Study|Lost to Follow-up|1|||
155352273|NCT04238520|560725640|FG001|Overall Study|Lost to Follow-up|2|||
155425868|NCT03529409|560986703|FG001|Follow-up Assessment|Death|0|||
155425869|NCT03529409|560986704|FG002|Follow-up Assessment|Death|0|||
155425870|NCT03529409|560986702|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
155425871|NCT03529409|560986703|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
155425872|NCT03529409|560986704|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
155506497|NCT02736227|561281728|FG001|Overall Study|Physician Decision|0|||
155352274|NCT04238520|560725639|FG000|Overall Study|Death|0|||
155352275|NCT04238520|560725640|FG001|Overall Study|Death|2|||
155352276|NCT04238520|560725639|FG000|Overall Study|Unsafe home environment for research staff|0|||
155352277|NCT04238520|560725640|FG001|Overall Study|Unsafe home environment for research staff|1|||
155352278|NCT01470599|560725641|FG000|Overall Study|Did not meet entrance criteria|1|||
155352279|NCT01470599|560725642|FG001|Overall Study|Did not meet entrance criteria|0|||
155352280|NCT01470599|560725641|FG000|Overall Study|Lost to Follow-up|2|||
155352281|NCT01470599|560725642|FG001|Overall Study|Lost to Follow-up|1|||
155352282|NCT01470599|560725641|FG000|Overall Study|Withdrawal by Subject|3|||
155352283|NCT01470599|560725642|FG001|Overall Study|Withdrawal by Subject|4|||
155352284|NCT01470599|560725641|FG000|Overall Study|Other|1|||
155352285|NCT01470599|560725642|FG001|Overall Study|Other|0|||
155352286|NCT01470599|560725641|FG000|Overall Study|Protocol Violation|3|||
155352287|NCT01470599|560725642|FG001|Overall Study|Protocol Violation|1|||
155425873|NCT01497262|560986705|FG000|Overall Study|Abnormal Lab Values|4|||
155425874|NCT01497262|560986705|FG000|Overall Study|Abnormal Test Procedure Result|1|||
155425875|NCT01497262|560986705|FG000|Overall Study|Physician Decision|1|||
155425876|NCT01497262|560986705|FG000|Overall Study|Withdrawal by Subject|2|||
155425877|NCT01497262|560986705|FG000|Overall Study|Adverse Event|2|||
155425878|NCT01497262|560986705|FG000|Overall Study|Protocol Violation|1|||
155425879|NCT03898063|560986708|FG000|Overall Study|Withdrawal by Subject|10|||
155425880|NCT03898063|560986709|FG001|Overall Study|Withdrawal by Subject|8|||
155425881|NCT01651780|560986710|FG000|Overall Study|Physician decision: No 30-day visit|2|||
155425882|NCT01651780|560986711|FG001|Overall Study|Physician decision: No 30-day visit|1|||
155425883|NCT01651780|560986710|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
155425884|NCT01651780|560986711|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
155425885|NCT01651780|560986710|FG000|Overall Study|Withdrawal by Subject|2|||
155425886|NCT01651780|560986711|FG001|Overall Study|Withdrawal by Subject|0|||
155425887|NCT01651780|560986710|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
155425888|NCT01651780|560986711|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155425889|NCT01651780|560986710|FG000|Overall Study|Lost to Follow-up|1|||
155425890|NCT01651780|560986711|FG001|Overall Study|Lost to Follow-up|2|||
155425891|NCT01651780|560986710|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
155425892|NCT01651780|560986711|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
155425893|NCT02949830|560986712|FG000|Overall Study|Adverse Event|1|||
155425894|NCT02949830|560986712|FG000|Overall Study|Withdrawal by Subject|1|||
155425895|NCT01290887|560986713|FG000|Overall Study|Adverse Event|6|||
155425896|NCT01290887|560986714|FG001|Overall Study|Adverse Event|11|||
155425897|NCT01290887|560986713|FG000|Overall Study|Lack of Efficacy|4|||
155425898|NCT01290887|560986714|FG001|Overall Study|Lack of Efficacy|5|||
155425899|NCT01290887|560986713|FG000|Overall Study|Withdrawal by Subject|26|||
155425900|NCT01290887|560986714|FG001|Overall Study|Withdrawal by Subject|32|||
155425901|NCT01290887|560986713|FG000|Overall Study|Protocol Violation|2|||
155425902|NCT01290887|560986714|FG001|Overall Study|Protocol Violation|1|||
155425903|NCT01290887|560986713|FG000|Overall Study|Lost to Follow-up|4|||
155425904|NCT01290887|560986714|FG001|Overall Study|Lost to Follow-up|4|||
155425905|NCT01290887|560986713|FG000|Overall Study|Non-compliance to study procedures|0|||
155425906|NCT01290887|560986714|FG001|Overall Study|Non-compliance to study procedures|1|||
155425907|NCT01290887|560986713|FG000|Overall Study|Non-compliance to study medications|1|||
155425908|NCT01290887|560986714|FG001|Overall Study|Non-compliance to study medications|0|||
155425909|NCT01290887|560986713|FG000|Overall Study|Sponsor closure of study|420|||
155425910|NCT01290887|560986714|FG001|Overall Study|Sponsor closure of study|476|||
155425911|NCT01290887|560986713|FG000|Overall Study|Other|3|||
155425912|NCT01290887|560986714|FG001|Overall Study|Other|6|||
155506498|NCT02736227|561281729|FG002|Overall Study|Physician Decision|5|||
155352288|NCT01470599|560725641|FG000|Overall Study|Adverse event related to study drug|2|||
155506499|NCT02736227|561281727|FG000|Overall Study|Non Compliant|0|||
155352289|NCT01470599|560725642|FG001|Overall Study|Adverse event related to study drug|5|||
155352290|NCT01470599|560725641|FG000|Overall Study|Insufficient clinical response|6|||
155425913|NCT01628926|560986715|FG000|Overall Study|Adverse Event|13|||
155425914|NCT01628926|560986716|FG001|Overall Study|Adverse Event|11|||
155425915|NCT01628926|560986717|FG002|Overall Study|Adverse Event|9|||
155425916|NCT01628926|560986715|FG000|Overall Study|Lack of Efficacy|2|||
155425917|NCT01628926|560986716|FG001|Overall Study|Lack of Efficacy|1|||
155425918|NCT01628926|560986717|FG002|Overall Study|Lack of Efficacy|5|||
155425919|NCT01628926|560986715|FG000|Overall Study|Withdrawal by Subject|6|||
155648454|NCT02533674|561805803|FG002|Dose Level VIII|Progressive disease|0|||
155648455|NCT02533674|561805804|FG003|Dose Level VIII|Progressive disease|0|||
155352291|NCT01470599|560725642|FG001|Overall Study|Insufficient clinical response|27|||
155352292|NCT01470599|560725641|FG000|Overall Study|Adverse event not related to study drug|1|||
155352293|NCT01470599|560725642|FG001|Overall Study|Adverse event not related to study drug|5|||
155352294|NCT00195442|560725643|FG000|Overall Study|Less than expected therapeutic effect|38|||
155352295|NCT00195442|560725643|FG000|Overall Study|Lost to Follow-up|27|||
155352296|NCT00195442|560725643|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
155352297|NCT00195442|560725643|FG000|Overall Study|Intermittent product shortage|21|||
155352298|NCT00195442|560725643|FG000|Overall Study|Death|7|||
155352299|NCT00195442|560725643|FG000|Overall Study|No reason specified|4|||
155352300|NCT00195442|560725643|FG000|Overall Study|Poor cooperation|2|||
155352301|NCT00195442|560725643|FG000|Overall Study|Other|14|||
155352302|NCT01917006|560725644|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
155352303|NCT01917006|560725645|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
155352304|NCT01917006|560725646|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
155352305|NCT01917006|560725647|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
155352306|NCT01917006|560725648|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
155352307|NCT01917006|560725649|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
155352308|NCT01917006|560725650|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
155352309|NCT01917006|560725651|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
155352310|NCT01917006|560725644|FG000|Randomized-treatment Period|Personal Reasons|0|||
155352311|NCT01917006|560725645|FG001|Randomized-treatment Period|Personal Reasons|0|||
155352312|NCT01917006|560725646|FG002|Randomized-treatment Period|Personal Reasons|0|||
155352313|NCT01917006|560725647|FG003|Randomized-treatment Period|Personal Reasons|0|||
155352314|NCT01917006|560725648|FG004|Randomized-treatment Period|Personal Reasons|0|||
155352315|NCT01917006|560725649|FG005|Randomized-treatment Period|Personal Reasons|1|||
155352316|NCT01917006|560725650|FG006|Randomized-treatment Period|Personal Reasons|0|||
155352317|NCT01917006|560725651|FG007|Randomized-treatment Period|Personal Reasons|0|||
155352318|NCT01917006|560725644|FG000|Randomized-treatment Period|Protocol Violation|1|||
155352319|NCT01917006|560725645|FG001|Randomized-treatment Period|Protocol Violation|0|||
155352320|NCT01917006|560725646|FG002|Randomized-treatment Period|Protocol Violation|0|||
155352321|NCT01917006|560725647|FG003|Randomized-treatment Period|Protocol Violation|0|||
155352322|NCT01917006|560725648|FG004|Randomized-treatment Period|Protocol Violation|0|||
155352323|NCT01917006|560725649|FG005|Randomized-treatment Period|Protocol Violation|0|||
155352324|NCT01917006|560725650|FG006|Randomized-treatment Period|Protocol Violation|0|||
155352325|NCT01917006|560725651|FG007|Randomized-treatment Period|Protocol Violation|0|||
155352326|NCT01917006|560725644|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352327|NCT01917006|560725645|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352328|NCT01917006|560725646|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352329|NCT01917006|560725647|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352330|NCT01917006|560725648|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352331|NCT01917006|560725649|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352332|NCT01917006|560725650|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
155352333|NCT01917006|560725651|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352334|NCT01917006|560725644|FG000|Open-label Period|Adverse Event|0|||
155352335|NCT01917006|560725645|FG001|Open-label Period|Adverse Event|0|||
155352336|NCT01917006|560725646|FG002|Open-label Period|Adverse Event|0|||
155352337|NCT01917006|560725647|FG003|Open-label Period|Adverse Event|0|||
155352338|NCT01917006|560725648|FG004|Open-label Period|Adverse Event|0|||
155506500|NCT02736227|561281728|FG001|Overall Study|Non Compliant|0|||
155506501|NCT02736227|561281729|FG002|Overall Study|Non Compliant|2|||
155506502|NCT03870997|561281742|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
155352339|NCT01917006|560725649|FG005|Open-label Period|Adverse Event|0|||
155352340|NCT01917006|560725650|FG006|Open-label Period|Adverse Event|0|||
155506503|NCT03870997|561281743|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
155648456|NCT02533674|561805805|FG004|Dose Level VIII|Progressive disease|0|||
155425920|NCT01628926|560986716|FG001|Overall Study|Withdrawal by Subject|4|||
155425921|NCT01628926|560986717|FG002|Overall Study|Withdrawal by Subject|2|||
155425922|NCT01628926|560986715|FG000|Overall Study|Protocol Violation|0|||
155425923|NCT01628926|560986716|FG001|Overall Study|Protocol Violation|1|||
155425924|NCT01628926|560986717|FG002|Overall Study|Protocol Violation|0|||
155425925|NCT01628926|560986715|FG000|Overall Study|Discontinuation criteria|3|||
155425926|NCT01628926|560986716|FG001|Overall Study|Discontinuation criteria|4|||
155425927|NCT01628926|560986717|FG002|Overall Study|Discontinuation criteria|0|||
155648457|NCT02533674|561805806|FG005|Dose Level VIII|Progressive disease|0|||
155648458|NCT02533674|561805807|FG006|Dose Level VIII|Progressive disease|0|||
155425928|NCT01628926|560986715|FG000|Overall Study|Physician Decision|2|||
155425929|NCT01628926|560986716|FG001|Overall Study|Physician Decision|2|||
155425930|NCT01628926|560986717|FG002|Overall Study|Physician Decision|1|||
155648459|NCT02533674|561805808|FG007|Dose Level VIII|Progressive disease|3|||
155648460|NCT02533674|561805801|FG000|Dose Level VIII|Withdrawal by Subject|0|||
155648461|NCT02533674|561805802|FG001|Dose Level VIII|Withdrawal by Subject|0|||
155648462|NCT02533674|561805803|FG002|Dose Level VIII|Withdrawal by Subject|0|||
155648463|NCT02533674|561805804|FG003|Dose Level VIII|Withdrawal by Subject|0|||
155648464|NCT02533674|561805805|FG004|Dose Level VIII|Withdrawal by Subject|0|||
155648465|NCT02533674|561805806|FG005|Dose Level VIII|Withdrawal by Subject|0|||
155648466|NCT02533674|561805807|FG006|Dose Level VIII|Withdrawal by Subject|0|||
155648467|NCT02533674|561805808|FG007|Dose Level VIII|Withdrawal by Subject|1|||
155648468|NCT02533674|561805801|FG000|Dose Level VIII|Treatment-related AE|0|||
155648469|NCT02533674|561805802|FG001|Dose Level VIII|Treatment-related AE|0|||
155648470|NCT02533674|561805803|FG002|Dose Level VIII|Treatment-related AE|0|||
155648471|NCT02533674|561805804|FG003|Dose Level VIII|Treatment-related AE|0|||
155648472|NCT02533674|561805805|FG004|Dose Level VIII|Treatment-related AE|0|||
155648473|NCT02533674|561805806|FG005|Dose Level VIII|Treatment-related AE|0|||
155648474|NCT02533674|561805807|FG006|Dose Level VIII|Treatment-related AE|0|||
155648475|NCT02533674|561805808|FG007|Dose Level VIII|Treatment-related AE|1|||
155648476|NCT02533674|561805801|FG000|Dose Level VIII|Never treated|0|||
155648477|NCT02533674|561805802|FG001|Dose Level VIII|Never treated|0|||
155648478|NCT02533674|561805803|FG002|Dose Level VIII|Never treated|0|||
155648479|NCT02533674|561805804|FG003|Dose Level VIII|Never treated|0|||
155648480|NCT02533674|561805805|FG004|Dose Level VIII|Never treated|0|||
155648481|NCT02533674|561805806|FG005|Dose Level VIII|Never treated|0|||
155648482|NCT02533674|561805807|FG006|Dose Level VIII|Never treated|0|||
155648483|NCT02533674|561805808|FG007|Dose Level VIII|Never treated|1|||
155648484|NCT03021005|561805809|FG000|Overall Study|Lost to Follow-up|39|||
155648485|NCT03021005|561805810|FG001|Overall Study|Lost to Follow-up|26|||
155648486|NCT03188705|561805811|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
155648487|NCT03188705|561805811|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
155648488|NCT01174459|561805815|FG000|Overall Study|case report form (CRF) not collected|5|||
155648489|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
155648490|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
155648491|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
155648492|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
155648493|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
155648494|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
155648495|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
155648496|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
155648497|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
155648498|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
155648499|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
155425931|NCT02116621|560986718|FG000|Baseline|Withdrawal by Subject|0|||
155648500|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
155648501|NCT00290758|561805816|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
155648502|NCT00290758|561805817|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
155648503|NCT00290758|561805816|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
155648504|NCT00290758|561805817|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
155648505|NCT00474968|561805819|FG000|Overall Study|Withdrawal by Subject|8|||
155648506|NCT00474968|561805820|FG001|Overall Study|Withdrawal by Subject|7|||
155648507|NCT00474968|561805819|FG000|Overall Study|Protocol Violation|9|||
155648508|NCT00474968|561805820|FG001|Overall Study|Protocol Violation|8|||
155648509|NCT00474968|561805819|FG000|Overall Study|Sample not collected|1|||
155425932|NCT02116621|560986719|FG001|Baseline|Withdrawal by Subject|4|||
155425933|NCT02116621|560986718|FG000|Three Month Follow-up|Death|1|||
155425934|NCT02116621|560986719|FG001|Three Month Follow-up|Death|1|||
155425935|NCT02116621|560986718|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
155425936|NCT02116621|560986719|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
155425937|NCT02116621|560986718|FG000|Three Month Follow-up|Lost to Follow-up|0|||
155425938|NCT02116621|560986719|FG001|Three Month Follow-up|Lost to Follow-up|1|||
155425939|NCT02116621|560986718|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
155425940|NCT02116621|560986719|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
155425941|NCT02116621|560986718|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
155425942|NCT02116621|560986719|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
155425943|NCT02116621|560986718|FG000|Six Month Follow-up|Lost to Follow-up|2|||
155425944|NCT02116621|560986719|FG001|Six Month Follow-up|Lost to Follow-up|1|||
155425945|NCT02116621|560986718|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
155648510|NCT00474968|561805820|FG001|Overall Study|Sample not collected|1|||
155648511|NCT01111292|561805821|FG000|Treatment|Physician Decision|1|||
155648512|NCT01111292|561805822|FG001|Treatment|Physician Decision|1|||
155648513|NCT00215553|561805823|FG000|Overall Study|Adverse Event|0|||
155425946|NCT02116621|560986719|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
155425947|NCT02116621|560986718|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
155425948|NCT02116621|560986719|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
155352341|NCT01917006|560725651|FG007|Open-label Period|Adverse Event|1|||
155352342|NCT01917006|560725644|FG000|Open-label Period|Lost to Follow-up|0|||
155352343|NCT01917006|560725645|FG001|Open-label Period|Lost to Follow-up|0|||
155352344|NCT01917006|560725646|FG002|Open-label Period|Lost to Follow-up|0|||
155352345|NCT01917006|560725647|FG003|Open-label Period|Lost to Follow-up|0|||
155352346|NCT01917006|560725648|FG004|Open-label Period|Lost to Follow-up|0|||
155352347|NCT01917006|560725649|FG005|Open-label Period|Lost to Follow-up|0|||
155352348|NCT01917006|560725650|FG006|Open-label Period|Lost to Follow-up|0|||
155352349|NCT01917006|560725651|FG007|Open-label Period|Lost to Follow-up|1|||
155352350|NCT02158247|560725657|FG000|Overall Study|Invisible vocal cords|5|||
155352351|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
155352352|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
155352353|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
155352354|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
155352355|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
155352356|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
155352357|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
155352358|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
155352359|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
155352360|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
155352361|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
155648514|NCT00215553|561805824|FG001|Overall Study|Adverse Event|1|||
155648515|NCT00215553|561805825|FG002|Overall Study|Adverse Event|2|||
155352362|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
155352363|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
155425949|NCT02116621|560986718|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
155648516|NCT00215553|561805826|FG003|Overall Study|Adverse Event|1|||
155648517|NCT00215553|561805827|FG004|Overall Study|Adverse Event|2|||
155648518|NCT00215553|561805828|FG005|Overall Study|Adverse Event|6|||
155648519|NCT00215553|561805829|FG006|Overall Study|Adverse Event|0|||
155648520|NCT01429623|561805830|FG000|Overall Study|Death|1|||
155352364|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
155352365|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
155352366|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
155352367|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
155352368|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
155352369|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
155352370|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
155352371|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
155352372|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
155352373|NCT02637856|560725664|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
155352374|NCT02637856|560725665|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
155352375|NCT02637856|560725664|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
155352376|NCT02637856|560725665|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
155352377|NCT02509312|560725666|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
155352378|NCT02509312|560725667|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
155352379|NCT02509312|560725666|FG000|Overall Study|Obstetrician refusal|0|||
155352380|NCT02509312|560725667|FG001|Overall Study|Obstetrician refusal|1|||
155352381|NCT02509312|560725666|FG000|Overall Study|Patient elected for TOLAC|1|||
155352382|NCT02509312|560725667|FG001|Overall Study|Patient elected for TOLAC|0|||
155352383|NCT02509312|560725666|FG000|Overall Study|Cesarean deemed stat|1|||
155352384|NCT02509312|560725667|FG001|Overall Study|Cesarean deemed stat|0|||
155352385|NCT02509312|560725666|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
155352386|NCT02509312|560725667|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
155352387|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Discomfort|1|||
155352388|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Discomfort|0|||
155352389|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155352390|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155352391|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
155352392|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
155352393|NCT02815735|560725668|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
155352394|NCT02815735|560725669|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
155352395|NCT00702650|560725670|FG000|Overall Study|Withdrawal by Subject|9|||
155352396|NCT00702650|560725670|FG000|Overall Study|Non-Compliance of Study Drug|3|||
155352397|NCT00702650|560725670|FG000|Overall Study|Lost to Follow-up|2|||
155352398|NCT00702650|560725670|FG000|Overall Study|Non-Compliance with Site Directives|1|||
155425950|NCT02116621|560986719|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
155425951|NCT02116621|560986718|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
155425952|NCT02116621|560986719|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
155425953|NCT02116621|560986718|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
155425954|NCT02116621|560986719|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
155425955|NCT03437447|560986720|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155425956|NCT03437447|560986721|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155425957|NCT03437447|560986722|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155425958|NCT04752384|560986724|FG000|Overall Study|Withdrawal by Subject|1|||
155425959|NCT04752384|560986724|FG000|Overall Study|Death|1|||
155425960|NCT03726268|560986725|FG000|Overall Study|Physician Decision|2|||
155425961|NCT03726268|560986726|FG001|Overall Study|Physician Decision|8|||
155425962|NCT03726268|560986727|FG002|Overall Study|Physician Decision|6|||
155425963|NCT03726268|560986728|FG003|Overall Study|Physician Decision|3|||
155425964|NCT03726268|560986725|FG000|Overall Study|Withdrawal by Subject|11|||
155425965|NCT03726268|560986726|FG001|Overall Study|Withdrawal by Subject|5|||
155425966|NCT03726268|560986727|FG002|Overall Study|Withdrawal by Subject|9|||
155425967|NCT03726268|560986728|FG003|Overall Study|Withdrawal by Subject|8|||
155425968|NCT01986062|560986729|FG000|Overall Study|Lost to Follow-up|1|||
155425969|NCT01986062|560986730|FG001|Overall Study|Lost to Follow-up|0|||
155425970|NCT01986062|560986729|FG000|Overall Study|Withdrawal by Subject|0|||
155425971|NCT01986062|560986730|FG001|Overall Study|Withdrawal by Subject|1|||
155425972|NCT03538743|560986731|FG000|Overall Study|Adverse Event|0|||
155425973|NCT03538743|560986732|FG001|Overall Study|Adverse Event|0|||
155425974|NCT03538743|560986733|FG002|Overall Study|Adverse Event|1|||
155425975|NCT03538743|560986734|FG003|Overall Study|Adverse Event|1|||
155425976|NCT03538743|560986735|FG004|Overall Study|Adverse Event|0|||
155425977|NCT03538743|560986736|FG005|Overall Study|Adverse Event|0|||
155425978|NCT03538743|560986737|FG006|Overall Study|Adverse Event|0|||
155425979|NCT03538743|560986738|FG007|Overall Study|Adverse Event|0|||
155425980|NCT03538743|560986739|FG008|Overall Study|Adverse Event|0|||
155425981|NCT03538743|560986731|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
155425982|NCT03538743|560986732|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
155425983|NCT03538743|560986733|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
155425984|NCT03538743|560986734|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
155425985|NCT03538743|560986735|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
155425986|NCT03538743|560986736|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
155425987|NCT03538743|560986737|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
155425988|NCT03538743|560986738|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
155425989|NCT03538743|560986739|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
155425990|NCT03538743|560986731|FG000|Overall Study|Withdrawal by Subject|0|||
155425991|NCT03538743|560986732|FG001|Overall Study|Withdrawal by Subject|0|||
155425992|NCT03538743|560986733|FG002|Overall Study|Withdrawal by Subject|0|||
155425993|NCT03538743|560986734|FG003|Overall Study|Withdrawal by Subject|1|||
155425994|NCT03538743|560986735|FG004|Overall Study|Withdrawal by Subject|0|||
155425995|NCT03538743|560986736|FG005|Overall Study|Withdrawal by Subject|0|||
155425996|NCT03538743|560986737|FG006|Overall Study|Withdrawal by Subject|0|||
155425997|NCT03538743|560986738|FG007|Overall Study|Withdrawal by Subject|0|||
155425998|NCT03538743|560986739|FG008|Overall Study|Withdrawal by Subject|0|||
155352399|NCT00702650|560725670|FG000|Overall Study|Sponsor Request|1|||
155352400|NCT00702650|560725670|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
155352401|NCT00702650|560725670|FG000|Overall Study|Adverse Event|3|||
155352402|NCT00943722|560725672|FG000|Base Study|Adverse Event|0|||
155352403|NCT00943722|560725673|FG001|Base Study|Adverse Event|0|||
155352404|NCT00943722|560725674|FG002|Base Study|Adverse Event|0|||
155352405|NCT00943722|560725675|FG003|Base Study|Adverse Event|1|||
155352406|NCT00943722|560725676|FG004|Base Study|Adverse Event|0|||
155352407|NCT00943722|560725677|FG005|Base Study|Adverse Event|0|||
155352408|NCT00943722|560725678|FG006|Base Study|Adverse Event|0|||
155352409|NCT00943722|560725672|FG000|Base Study|Lost to Follow-up|12|||
155352410|NCT00943722|560725673|FG001|Base Study|Lost to Follow-up|8|||
155352411|NCT00943722|560725674|FG002|Base Study|Lost to Follow-up|10|||
155352412|NCT00943722|560725675|FG003|Base Study|Lost to Follow-up|8|||
155352413|NCT00943722|560725676|FG004|Base Study|Lost to Follow-up|11|||
155352414|NCT00943722|560725677|FG005|Base Study|Lost to Follow-up|0|||
155352415|NCT00943722|560725678|FG006|Base Study|Lost to Follow-up|0|||
155352416|NCT00943722|560725672|FG000|Base Study|Physician Decision|1|||
155352417|NCT00943722|560725673|FG001|Base Study|Physician Decision|0|||
155352418|NCT00943722|560725674|FG002|Base Study|Physician Decision|0|||
155352419|NCT00943722|560725675|FG003|Base Study|Physician Decision|0|||
155352420|NCT00943722|560725676|FG004|Base Study|Physician Decision|1|||
155352421|NCT00943722|560725677|FG005|Base Study|Physician Decision|0|||
155352422|NCT00943722|560725678|FG006|Base Study|Physician Decision|0|||
155352423|NCT00943722|560725672|FG000|Base Study|Pregnancy|0|||
155352424|NCT00943722|560725673|FG001|Base Study|Pregnancy|0|||
155352425|NCT00943722|560725674|FG002|Base Study|Pregnancy|1|||
155352426|NCT00943722|560725675|FG003|Base Study|Pregnancy|0|||
155352427|NCT00943722|560725676|FG004|Base Study|Pregnancy|2|||
155352428|NCT00943722|560725677|FG005|Base Study|Pregnancy|0|||
155352429|NCT00943722|560725678|FG006|Base Study|Pregnancy|0|||
155352430|NCT00943722|560725672|FG000|Base Study|Protocol Violation|0|||
155352431|NCT00943722|560725673|FG001|Base Study|Protocol Violation|1|||
155352432|NCT00943722|560725674|FG002|Base Study|Protocol Violation|0|||
155352433|NCT00943722|560725675|FG003|Base Study|Protocol Violation|0|||
155352434|NCT00943722|560725676|FG004|Base Study|Protocol Violation|2|||
155352435|NCT00943722|560725677|FG005|Base Study|Protocol Violation|0|||
155352436|NCT00943722|560725678|FG006|Base Study|Protocol Violation|0|||
155352437|NCT00943722|560725672|FG000|Base Study|Withdrawal by Subject|12|||
155352438|NCT00943722|560725673|FG001|Base Study|Withdrawal by Subject|13|||
155352439|NCT00943722|560725674|FG002|Base Study|Withdrawal by Subject|2|||
155352440|NCT00943722|560725675|FG003|Base Study|Withdrawal by Subject|13|||
155352441|NCT00943722|560725676|FG004|Base Study|Withdrawal by Subject|8|||
155352442|NCT00943722|560725677|FG005|Base Study|Withdrawal by Subject|0|||
155352443|NCT00943722|560725678|FG006|Base Study|Withdrawal by Subject|0|||
155352444|NCT00943722|560725672|FG000|Base Study|Month 12 visit not completed|0|||
155352445|NCT00943722|560725673|FG001|Base Study|Month 12 visit not completed|0|||
155352446|NCT00943722|560725674|FG002|Base Study|Month 12 visit not completed|0|||
155352447|NCT00943722|560725675|FG003|Base Study|Month 12 visit not completed|0|||
155352448|NCT00943722|560725676|FG004|Base Study|Month 12 visit not completed|2|||
155425999|NCT01955707|560986741|FG000|Overall Study|Adverse Event|1|||
155426000|NCT01955707|560986742|FG001|Overall Study|Adverse Event|2|||
155426001|NCT01955707|560986741|FG000|Overall Study|Lost to Follow-up|2|||
155426002|NCT01955707|560986742|FG001|Overall Study|Lost to Follow-up|1|||
155426003|NCT01955707|560986741|FG000|Overall Study|Withdrawal by Subject|0|||
155426004|NCT01955707|560986742|FG001|Overall Study|Withdrawal by Subject|3|||
155352449|NCT00943722|560725677|FG005|Base Study|Month 12 visit not completed|0|||
155352450|NCT00943722|560725678|FG006|Base Study|Month 12 visit not completed|0|||
155352451|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Adverse Event|0|||
155352452|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Adverse Event|0|||
155352453|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Adverse Event|0|||
155352454|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Adverse Event|0|||
155352455|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Adverse Event|0|||
155352456|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Adverse Event|1|||
155352457|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Adverse Event|0|||
155352458|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352459|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352460|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352461|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
155648521|NCT01429623|561805831|FG001|Overall Study|Death|0|||
155648522|NCT01429623|561805830|FG000|Overall Study|Adverse Event|7|||
155352462|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352463|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
155648523|NCT01429623|561805831|FG001|Overall Study|Adverse Event|14|||
155648524|NCT01429623|561805830|FG000|Overall Study|Withdrawal by Subject|19|||
155648525|NCT01429623|561805831|FG001|Overall Study|Withdrawal by Subject|13|||
155648526|NCT01429623|561805830|FG000|Overall Study|Physician Decision|2|||
155648527|NCT01429623|561805831|FG001|Overall Study|Physician Decision|3|||
155648528|NCT01429623|561805830|FG000|Overall Study|Protocol Violation|3|||
155426005|NCT01955707|560986741|FG000|Overall Study|Death|13|||
155426006|NCT01955707|560986742|FG001|Overall Study|Death|14|||
155426007|NCT01955707|560986741|FG000|Overall Study|Other|4|||
155426008|NCT01955707|560986742|FG001|Overall Study|Other|2|||
155426009|NCT06001307|560988000|FG000|Overall Study|Lost to Follow-up|1|||
155426010|NCT06001307|560988001|FG001|Overall Study|Lost to Follow-up|2|||
155426011|NCT03532100|560988002|FG000|Overall Study|Intervention malfunction|1|||
155426012|NCT03896581|560988003|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
155426013|NCT03896581|560988004|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
155426014|NCT03896581|560988003|FG000|Overall Study|Withdrawal by Subject|4|||
155426015|NCT03896581|560988004|FG001|Overall Study|Withdrawal by Subject|1|||
155426016|NCT03896581|560988003|FG000|Overall Study|Lost to Follow-up|1|||
155426017|NCT03896581|560988004|FG001|Overall Study|Lost to Follow-up|0|||
155426018|NCT03896581|560988003|FG000|Overall Study|Lack of Efficacy|2|||
155426019|NCT03896581|560988004|FG001|Overall Study|Lack of Efficacy|1|||
155426020|NCT03896581|560988003|FG000|Overall Study|Adverse event, non-fatal|0|||
155426021|NCT03896581|560988004|FG001|Overall Study|Adverse event, non-fatal|2|||
155426022|NCT00960076|560988005|FG000|Overall Study|Adverse Event|1|||
155426023|NCT00960076|560988006|FG001|Overall Study|Adverse Event|7|||
155426024|NCT00960076|560988005|FG000|Overall Study|No longer met study criteria|1|||
155426025|NCT00960076|560988006|FG001|Overall Study|No longer met study criteria|5|||
155426026|NCT00960076|560988005|FG000|Overall Study|Withdrawal by Subject|1|||
155426027|NCT00960076|560988006|FG001|Overall Study|Withdrawal by Subject|2|||
155426028|NCT00960076|560988005|FG000|Overall Study|Lost to Follow-up|3|||
155426029|NCT00960076|560988006|FG001|Overall Study|Lost to Follow-up|3|||
155426030|NCT00960076|560988005|FG000|Overall Study|Severe non-compliance to protocol|1|||
155426031|NCT00960076|560988006|FG001|Overall Study|Severe non-compliance to protocol|2|||
155426032|NCT00960076|560988005|FG000|Overall Study|Hyperglycemia|1|||
155426033|NCT00960076|560988006|FG001|Overall Study|Hyperglycemia|5|||
155426034|NCT00960076|560988005|FG000|Overall Study|Did not attend the termination visit|0|||
155426035|NCT00960076|560988006|FG001|Overall Study|Did not attend the termination visit|1|||
155426036|NCT02029976|560988007|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
155426037|NCT02029976|560988008|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
155426038|NCT02029976|560988007|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
155426039|NCT02029976|560988008|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
155426040|NCT02029976|560988007|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
155426041|NCT02029976|560988008|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
155426042|NCT02029976|560988007|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
155426043|NCT02029976|560988008|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
155426044|NCT01445171|560988009|FG000|Overall Study|Lost to Follow-up|11|||
155426045|NCT01445171|560988009|FG000|Overall Study|Withdrawal by Subject|16|||
155426046|NCT01445171|560988009|FG000|Overall Study|Death|51|||
155426047|NCT01445171|560988009|FG000|Overall Study|Subjects declined to return for followup|9|||
155426048|NCT01445171|560988009|FG000|Overall Study|Consented but did not receive device|8|||
155426049|NCT00162773|560988010|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
155426050|NCT05194345|560988013|FG000|Overall Study|Withdrawal by Subject|6|||
155426051|NCT05194345|560988014|FG001|Overall Study|Withdrawal by Subject|4|||
155426052|NCT05194345|560988015|FG002|Overall Study|Withdrawal by Subject|0|||
155426053|NCT05194345|560988013|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
155426054|NCT05194345|560988014|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
155426055|NCT05194345|560988015|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
155426056|NCT03124459|560988019|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
155426057|NCT03124459|560988020|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
155426058|NCT03124459|560988021|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
155426059|NCT03124459|560988022|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
155426060|NCT03124459|560988023|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
155426061|NCT03124459|560988024|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
155426062|NCT03124459|560988019|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
155426063|NCT03124459|560988020|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
155426064|NCT03124459|560988021|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
155426065|NCT03124459|560988022|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
155426066|NCT03124459|560988023|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
155426067|NCT03124459|560988024|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
155426068|NCT03124459|560988019|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
155426069|NCT03124459|560988020|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
155426070|NCT03124459|560988021|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
155426071|NCT03124459|560988022|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
155426072|NCT03124459|560988023|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
155426073|NCT03124459|560988024|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
155426074|NCT03124459|560988019|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
155426075|NCT03124459|560988020|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
155426076|NCT03124459|560988021|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
155426077|NCT03124459|560988022|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
155426078|NCT03124459|560988023|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
155426079|NCT03124459|560988024|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
155648529|NCT01429623|561805831|FG001|Overall Study|Protocol Violation|2|||
155648530|NCT01429623|561805830|FG000|Overall Study|Assorted|1|||
155506504|NCT03870997|561281744|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
155506505|NCT03870997|561281745|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
155506506|NCT03870997|561281746|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
155506507|NCT03870997|561281747|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
155506508|NCT00986154|561281748|FG000|Overall Study|Death|136|||
155506509|NCT00986154|561281749|FG001|Overall Study|Death|127|||
155506510|NCT00986154|561281748|FG000|Overall Study|Lost to Follow-up|7|||
155506511|NCT00986154|561281749|FG001|Overall Study|Lost to Follow-up|4|||
155506512|NCT00986154|561281748|FG000|Overall Study|Withdrawal by Subject|32|||
155506513|NCT00986154|561281749|FG001|Overall Study|Withdrawal by Subject|33|||
155506514|NCT00986154|561281748|FG000|Overall Study|investigator/subject decide not continue|6|||
155506515|NCT00986154|561281749|FG001|Overall Study|investigator/subject decide not continue|3|||
155506516|NCT00986154|561281748|FG000|Overall Study|never received study drug|25|||
155506517|NCT00986154|561281749|FG001|Overall Study|never received study drug|27|||
155506518|NCT03840135|561281750|FG000|Overall Study|Protocol Violation|6|||
155506519|NCT03840135|561281751|FG001|Overall Study|Protocol Violation|1|||
155506520|NCT03840135|561281750|FG000|Overall Study|Withdrawal by Subject|1|||
155506521|NCT03840135|561281751|FG001|Overall Study|Withdrawal by Subject|0|||
155506522|NCT01827371|561281752|FG000|Overall Study|Adverse Event|0|||
155506523|NCT01827371|561281753|FG001|Overall Study|Adverse Event|0|||
155506524|NCT01827371|561281754|FG002|Overall Study|Adverse Event|4|||
155506525|NCT01827371|561281755|FG003|Overall Study|Adverse Event|2|||
155506526|NCT01827371|561281752|FG000|Overall Study|Lost to Follow-up|0|||
155506527|NCT01827371|561281753|FG001|Overall Study|Lost to Follow-up|2|||
155506528|NCT01827371|561281754|FG002|Overall Study|Lost to Follow-up|0|||
155506529|NCT01827371|561281755|FG003|Overall Study|Lost to Follow-up|4|||
155506530|NCT01827371|561281752|FG000|Overall Study|Protocol Violation|1|||
155506531|NCT01827371|561281753|FG001|Overall Study|Protocol Violation|0|||
155506532|NCT01827371|561281754|FG002|Overall Study|Protocol Violation|0|||
155506533|NCT01827371|561281755|FG003|Overall Study|Protocol Violation|0|||
155506534|NCT01827371|561281752|FG000|Overall Study|Withdrawal by Subject|1|||
155506535|NCT01827371|561281753|FG001|Overall Study|Withdrawal by Subject|2|||
155506536|NCT01827371|561281754|FG002|Overall Study|Withdrawal by Subject|2|||
155506537|NCT01827371|561281755|FG003|Overall Study|Withdrawal by Subject|3|||
155352464|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
155352465|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352466|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352467|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352468|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352469|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352470|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
155352471|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
155352472|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
155352473|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
155352474|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
155352475|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
155352476|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
155506538|NCT01827371|561281752|FG000|Overall Study|Physician Decision|0|||
155506539|NCT01827371|561281753|FG001|Overall Study|Physician Decision|1|||
155506540|NCT01827371|561281754|FG002|Overall Study|Physician Decision|0|||
155506541|NCT01827371|561281755|FG003|Overall Study|Physician Decision|1|||
155506542|NCT01827371|561281752|FG000|Overall Study|Temporary study halt to vaccinations|11|||
155506543|NCT01827371|561281753|FG001|Overall Study|Temporary study halt to vaccinations|2|||
155506544|NCT01827371|561281754|FG002|Overall Study|Temporary study halt to vaccinations|5|||
155506545|NCT01827371|561281755|FG003|Overall Study|Temporary study halt to vaccinations|13|||
155506546|NCT02741271|561281761|FG000|Overall Study|Lost to Follow-up|2|||
155506547|NCT02741271|561281762|FG001|Overall Study|Lost to Follow-up|0|||
155506548|NCT02741271|561281761|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155506549|NCT02741271|561281762|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155506550|NCT02570165|561281763|FG000|Overall Study|Adverse Event|1|||
155506551|NCT02570165|561281764|FG001|Overall Study|Adverse Event|0|||
155506552|NCT02570165|561281765|FG002|Overall Study|Adverse Event|2|||
155352477|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
155352478|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
155352479|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
155506553|NCT02570165|561281766|FG003|Overall Study|Adverse Event|0|||
155506554|NCT02570165|561281767|FG004|Overall Study|Adverse Event|0|||
155506555|NCT02570165|561281768|FG005|Overall Study|Adverse Event|0|||
155506556|NCT02570165|561281769|FG006|Overall Study|Adverse Event|0|||
155426080|NCT03124459|560988019|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
155426081|NCT03124459|560988020|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
155426082|NCT03124459|560988021|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
155426083|NCT03124459|560988022|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
155426084|NCT03124459|560988023|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
155426085|NCT03124459|560988024|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
155426086|NCT03124459|560988019|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
155426087|NCT03124459|560988020|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
155426088|NCT03124459|560988021|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
155426089|NCT03124459|560988022|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
155426090|NCT03124459|560988023|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
155426091|NCT03124459|560988024|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
155426092|NCT01028352|560988025|FG000|Overall Study|Ineligible due to baseline average pain|5|||
155426093|NCT01028352|560988025|FG000|Overall Study|Withdrawal by Subject|1|||
155426094|NCT01903876|560988026|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
155426095|NCT01903876|560988027|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
155426096|NCT01903876|560988026|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
155426097|NCT01903876|560988027|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
155426098|NCT00826748|560988037|FG000|Overall Study|Withdrawal by Subject|0|||
155426099|NCT00826748|560988038|FG001|Overall Study|Withdrawal by Subject|0|||
155506557|NCT02570165|561281763|FG000|Overall Study|Lack of Efficacy|0|||
155506558|NCT02570165|561281764|FG001|Overall Study|Lack of Efficacy|1|||
155506559|NCT02570165|561281765|FG002|Overall Study|Lack of Efficacy|0|||
155506560|NCT02570165|561281766|FG003|Overall Study|Lack of Efficacy|0|||
155506561|NCT02570165|561281767|FG004|Overall Study|Lack of Efficacy|4|||
155506562|NCT02570165|561281768|FG005|Overall Study|Lack of Efficacy|0|||
155506563|NCT02570165|561281769|FG006|Overall Study|Lack of Efficacy|0|||
155506564|NCT02570165|561281763|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
155506565|NCT02570165|561281764|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
155506566|NCT02570165|561281765|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
155506567|NCT02570165|561281766|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
155506568|NCT02570165|561281767|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
155506569|NCT02570165|561281768|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
155506570|NCT02570165|561281769|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
155506571|NCT02570165|561281763|FG000|Overall Study|Lost to Follow-up|0|||
155506572|NCT02570165|561281764|FG001|Overall Study|Lost to Follow-up|0|||
155506573|NCT02570165|561281765|FG002|Overall Study|Lost to Follow-up|1|||
155506574|NCT02570165|561281766|FG003|Overall Study|Lost to Follow-up|1|||
155506575|NCT02570165|561281767|FG004|Overall Study|Lost to Follow-up|0|||
155506576|NCT02570165|561281768|FG005|Overall Study|Lost to Follow-up|0|||
155506577|NCT02570165|561281769|FG006|Overall Study|Lost to Follow-up|0|||
155506578|NCT02570165|561281763|FG000|Overall Study|Physician Decision|0|||
155506579|NCT02570165|561281764|FG001|Overall Study|Physician Decision|1|||
155506580|NCT02570165|561281765|FG002|Overall Study|Physician Decision|0|||
155506581|NCT02570165|561281766|FG003|Overall Study|Physician Decision|0|||
155506582|NCT02570165|561281767|FG004|Overall Study|Physician Decision|0|||
155506583|NCT02570165|561281768|FG005|Overall Study|Physician Decision|0|||
155506584|NCT02570165|561281769|FG006|Overall Study|Physician Decision|0|||
155506585|NCT02570165|561281763|FG000|Overall Study|Withdrawal by Subject|0|||
155506586|NCT02570165|561281764|FG001|Overall Study|Withdrawal by Subject|0|||
155506587|NCT02570165|561281765|FG002|Overall Study|Withdrawal by Subject|0|||
155506588|NCT02570165|561281766|FG003|Overall Study|Withdrawal by Subject|2|||
155506589|NCT02570165|561281767|FG004|Overall Study|Withdrawal by Subject|1|||
155506590|NCT02570165|561281768|FG005|Overall Study|Withdrawal by Subject|0|||
155506591|NCT02570165|561281769|FG006|Overall Study|Withdrawal by Subject|0|||
155506592|NCT02570165|561281763|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506593|NCT02570165|561281764|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506594|NCT02570165|561281765|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506595|NCT02570165|561281766|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506596|NCT02570165|561281767|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506597|NCT02570165|561281768|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
155506598|NCT02570165|561281769|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
155506599|NCT02570165|561281763|FG000|Overall Study|Withdrawal Request by GSK|0|||
155506600|NCT02570165|561281764|FG001|Overall Study|Withdrawal Request by GSK|0|||
155506601|NCT02570165|561281765|FG002|Overall Study|Withdrawal Request by GSK|2|||
155506602|NCT02570165|561281766|FG003|Overall Study|Withdrawal Request by GSK|0|||
155506603|NCT02570165|561281767|FG004|Overall Study|Withdrawal Request by GSK|0|||
155506604|NCT02570165|561281768|FG005|Overall Study|Withdrawal Request by GSK|0|||
155506605|NCT02570165|561281769|FG006|Overall Study|Withdrawal Request by GSK|0|||
155506606|NCT01252238|561281772|FG000|Overall Study|Sponsor terminated study|4|||
155506607|NCT01252238|561281773|FG001|Overall Study|Sponsor terminated study|4|||
155426100|NCT00826748|560988039|FG002|Overall Study|Withdrawal by Subject|2|||
155426101|NCT00826748|560988037|FG000|Overall Study|Physician Decision|0|||
155352480|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
155352481|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
155352482|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
155352483|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
155352484|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
155352485|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
155352486|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155426102|NCT00826748|560988038|FG001|Overall Study|Physician Decision|0|||
155506608|NCT01252238|561281774|FG002|Overall Study|Sponsor terminated study|4|||
155506609|NCT01610167|561281777|FG000|Overall Study|Scheduling conflict.|0|||
155506610|NCT01610167|561281778|FG001|Overall Study|Scheduling conflict.|0|||
155506611|NCT01610167|561281779|FG002|Overall Study|Scheduling conflict.|2|||
155506612|NCT03276962|561281785|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
155506613|NCT03276962|561281786|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
155506614|NCT03276962|561281787|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
155506615|NCT03276962|561281788|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
155506616|NCT03276962|561281789|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
155506617|NCT03276962|561281785|FG000|Overall Study|Protocol Deviation|2|||
155506618|NCT03276962|561281786|FG001|Overall Study|Protocol Deviation|0|||
155506619|NCT03276962|561281787|FG002|Overall Study|Protocol Deviation|1|||
155506620|NCT03276962|561281788|FG003|Overall Study|Protocol Deviation|2|||
155506621|NCT03276962|561281789|FG004|Overall Study|Protocol Deviation|1|||
155506622|NCT03276962|561281785|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
155506623|NCT03276962|561281786|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155506624|NCT03276962|561281787|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
155506625|NCT03276962|561281788|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155506626|NCT03276962|561281789|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
155506627|NCT03276962|561281785|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
155506628|NCT03276962|561281786|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
155506629|NCT03276962|561281787|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
155506630|NCT03276962|561281788|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
155506631|NCT03276962|561281789|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
155506632|NCT03276962|561281785|FG000|Overall Study|Lost to Follow-up|10|||
155506633|NCT03276962|561281786|FG001|Overall Study|Lost to Follow-up|10|||
155506634|NCT03276962|561281787|FG002|Overall Study|Lost to Follow-up|4|||
155506635|NCT03276962|561281788|FG003|Overall Study|Lost to Follow-up|6|||
155506636|NCT03276962|561281789|FG004|Overall Study|Lost to Follow-up|10|||
155506637|NCT03276962|561281785|FG000|Overall Study|Other|0|||
155506638|NCT03276962|561281786|FG001|Overall Study|Other|2|||
155506639|NCT03276962|561281787|FG002|Overall Study|Other|0|||
155506640|NCT03276962|561281788|FG003|Overall Study|Other|2|||
155506641|NCT03276962|561281789|FG004|Overall Study|Other|1|||
155506642|NCT00411762|561281790|FG000|Overall Study|Withdrawal by Subject|5|||
155506643|NCT04428502|561281791|FG000|Overall Study|Did not meet entrance criteria|14|||
155506644|NCT01358708|561281792|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
155506645|NCT01358708|561281793|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155506646|NCT01358708|561281792|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
155506647|NCT01358708|561281793|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
155506648|NCT01364298|561281797|FG000|Overall Study|Adverse Event|3|||
155506649|NCT01364298|561281798|FG001|Overall Study|Adverse Event|4|||
155506650|NCT01364298|561281797|FG000|Overall Study|Lack of adherence to treatment|1|||
155506651|NCT01364298|561281798|FG001|Overall Study|Lack of adherence to treatment|3|||
155506652|NCT01364298|561281797|FG000|Overall Study|Lack of Efficacy|1|||
155506653|NCT01364298|561281798|FG001|Overall Study|Lack of Efficacy|0|||
155506654|NCT01364298|561281797|FG000|Overall Study|Lost to Follow-up|5|||
155506655|NCT01364298|561281798|FG001|Overall Study|Lost to Follow-up|10|||
155648531|NCT01429623|561805831|FG001|Overall Study|Assorted|2|||
155648532|NCT01429623|561805830|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
155648533|NCT01429623|561805831|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
155352487|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155426103|NCT00826748|560988039|FG002|Overall Study|Physician Decision|1|||
155426104|NCT00826748|560988037|FG000|Overall Study|Samples Did Not pass QC|0|||
155426105|NCT00826748|560988038|FG001|Overall Study|Samples Did Not pass QC|0|||
155426106|NCT00826748|560988039|FG002|Overall Study|Samples Did Not pass QC|1|||
155426107|NCT01887912|560988040|FG000|Overall Study|Serious adverse event|400|||
155426108|NCT01887912|560988041|FG001|Overall Study|Serious adverse event|198|||
155426109|NCT01887912|560988040|FG000|Overall Study|Other Adverse Event|34|||
155426110|NCT01887912|560988041|FG001|Overall Study|Other Adverse Event|15|||
155426111|NCT01887912|560988040|FG000|Overall Study|Protocol Violation|67|||
155352488|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352489|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352490|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352491|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
155352492|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
155352493|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
155352494|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
155352495|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
155352496|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
155352497|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
155352498|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
155352499|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
155352500|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
155352501|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
155352502|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
155352503|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
155352504|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
155352505|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
155352506|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
155352507|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352508|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352509|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352510|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352511|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352512|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
155352513|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
155352514|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
155352515|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
155352516|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
155352517|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
155352518|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
155352519|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
155352520|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
155352521|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
155352522|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
155352523|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
155352524|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
155352525|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
155352526|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
155352527|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
155352528|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
155352529|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
155352530|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
155352531|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
155352532|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
155352533|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
155352534|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
155352535|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
155352536|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
155352537|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
155352538|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
155352539|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
155352540|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
155352541|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
155352542|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
155352543|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
155352544|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
155352545|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
155352546|NCT01036165|560725685|FG000|Overall Study|Adverse Event|6|||
155352547|NCT01036165|560725685|FG000|Overall Study|Lost to Follow-up|2|||
155352548|NCT01036165|560725685|FG000|Overall Study|Withdrawal by Subject|3|||
155352549|NCT01036165|560725685|FG000|Overall Study|Device Related Issues|3|||
155352550|NCT01036165|560725685|FG000|Overall Study|Problems finding proper area to inject|1|||
155352551|NCT02895360|560725690|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
155352552|NCT02895360|560725691|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352553|NCT02895360|560725692|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352554|NCT02895360|560725693|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352555|NCT02895360|560725694|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352556|NCT02895360|560725695|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352557|NCT02895360|560725690|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352558|NCT02895360|560725691|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
155352559|NCT02895360|560725692|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155426112|NCT01887912|560988041|FG001|Overall Study|Protocol Violation|37|||
155426113|NCT01887912|560988040|FG000|Overall Study|Lost to Follow-up|163|||
155426114|NCT01887912|560988041|FG001|Overall Study|Lost to Follow-up|74|||
155352560|NCT02895360|560725693|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352561|NCT02895360|560725694|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352562|NCT02895360|560725695|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352563|NCT02895360|560725690|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352564|NCT02895360|560725691|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352565|NCT02895360|560725692|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
155352566|NCT02895360|560725693|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352567|NCT02895360|560725694|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352568|NCT02895360|560725695|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352569|NCT02895360|560725690|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352570|NCT02895360|560725691|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352571|NCT02895360|560725692|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
155352572|NCT02895360|560725693|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352573|NCT02895360|560725694|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352574|NCT02895360|560725695|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352575|NCT02895360|560725690|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352576|NCT02895360|560725691|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352577|NCT02895360|560725692|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352578|NCT02895360|560725693|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
155352579|NCT02895360|560725694|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352580|NCT02895360|560725695|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352581|NCT02895360|560725690|FG000|Phase 2a|Adverse Event|0|||
155352582|NCT02895360|560725691|FG001|Phase 2a|Adverse Event|0|||
155352583|NCT02895360|560725692|FG002|Phase 2a|Adverse Event|0|||
155426115|NCT01887912|560988040|FG000|Overall Study|Withdrawal by Subject|606|||
155426116|NCT01887912|560988041|FG001|Overall Study|Withdrawal by Subject|349|||
155426117|NCT01887912|560988040|FG000|Overall Study|Other|122|||
155426118|NCT01887912|560988041|FG001|Overall Study|Other|58|||
155426119|NCT04462536|560988042|FG000|Overall Study|Withdrawal by Subject|3|||
155426120|NCT04462536|560988043|FG001|Overall Study|Withdrawal by Subject|9|||
155426121|NCT04462536|560988042|FG000|Overall Study|Lost to Follow-up|2|||
155426122|NCT04462536|560988043|FG001|Overall Study|Lost to Follow-up|4|||
155426123|NCT00450580|560988046|FG000|Overall Study|Adverse Event|5|||
155426124|NCT00450580|560988047|FG001|Overall Study|Adverse Event|7|||
155426125|NCT00450580|560988046|FG000|Overall Study|Lost to Follow-up|4|||
155426126|NCT00450580|560988047|FG001|Overall Study|Lost to Follow-up|5|||
155426127|NCT00450580|560988046|FG000|Overall Study|Withdrawal by Subject|2|||
155426128|NCT00450580|560988047|FG001|Overall Study|Withdrawal by Subject|2|||
155426129|NCT00450580|560988046|FG000|Overall Study|Protocol Violation|1|||
155426130|NCT00450580|560988047|FG001|Overall Study|Protocol Violation|1|||
155426131|NCT00450580|560988046|FG000|Overall Study|Protocol-defined virologic failure|1|||
155426132|NCT00450580|560988047|FG001|Overall Study|Protocol-defined virologic failure|0|||
155426133|NCT00450580|560988046|FG000|Overall Study|Could not comply with scheduled visits|1|||
155426134|NCT00450580|560988047|FG001|Overall Study|Could not comply with scheduled visits|0|||
155426135|NCT00450580|560988046|FG000|Overall Study|Patient went to Brazil|1|||
155426136|NCT00450580|560988047|FG001|Overall Study|Patient went to Brazil|0|||
155426137|NCT00450580|560988046|FG000|Overall Study|Patient could not swallow Norvir|1|||
155426138|NCT00450580|560988047|FG001|Overall Study|Patient could not swallow Norvir|0|||
155426139|NCT00450580|560988046|FG000|Overall Study|Withdrawal due to pregnancy|0|||
155426140|NCT00450580|560988047|FG001|Overall Study|Withdrawal due to pregnancy|1|||
155426141|NCT00332709|560988052|FG000|Overall Study|Adverse Event|11|||
155426142|NCT00332709|560988053|FG001|Overall Study|Adverse Event|14|||
155426143|NCT00332709|560988052|FG000|Overall Study|Withdrawal by Subject|2|||
155426144|NCT00332709|560988053|FG001|Overall Study|Withdrawal by Subject|3|||
155426145|NCT00332709|560988052|FG000|Overall Study|Lost to Follow-up|2|||
155426146|NCT00332709|560988053|FG001|Overall Study|Lost to Follow-up|0|||
155426147|NCT00332709|560988052|FG000|Overall Study|Administrative Problems|0|||
155426148|NCT00332709|560988053|FG001|Overall Study|Administrative Problems|3|||
155426149|NCT00332709|560988052|FG000|Overall Study|Abnormal test procedure result|1|||
155352584|NCT02895360|560725693|FG003|Phase 2a|Adverse Event|0|||
155352585|NCT02895360|560725694|FG004|Phase 2a|Adverse Event|0|||
155426150|NCT00332709|560988053|FG001|Overall Study|Abnormal test procedure result|0|||
155426151|NCT00191854|560988058|FG000|Overall Study|Death|26|||
155426152|NCT00191854|560988059|FG001|Overall Study|Death|23|||
155426153|NCT00191854|560988060|FG002|Overall Study|Death|29|||
155426154|NCT00191854|560988058|FG000|Overall Study|Lost to Follow-up|7|||
155426155|NCT00191854|560988059|FG001|Overall Study|Lost to Follow-up|5|||
155426156|NCT00191854|560988060|FG002|Overall Study|Lost to Follow-up|5|||
155426157|NCT00191854|560988058|FG000|Overall Study|Withdrawal by Subject|4|||
155426158|NCT00191854|560988059|FG001|Overall Study|Withdrawal by Subject|2|||
155426159|NCT00191854|560988060|FG002|Overall Study|Withdrawal by Subject|3|||
155426160|NCT00191854|560988058|FG000|Overall Study|Sponsor Decision|0|||
155426161|NCT00191854|560988059|FG001|Overall Study|Sponsor Decision|0|||
155426162|NCT00191854|560988060|FG002|Overall Study|Sponsor Decision|1|||
155426163|NCT00191854|560988058|FG000|Overall Study|Screen Failure|0|||
155426164|NCT00191854|560988059|FG001|Overall Study|Screen Failure|0|||
155426165|NCT00191854|560988060|FG002|Overall Study|Screen Failure|1|||
155426166|NCT02601950|560988061|FG000|Overall Study|Participant enrolled in rollover study|0|||
155426167|NCT02601950|560988062|FG001|Overall Study|Participant enrolled in rollover study|0|||
155426168|NCT02601950|560988063|FG002|Overall Study|Participant enrolled in rollover study|1|||
155426169|NCT02601950|560988064|FG003|Overall Study|Participant enrolled in rollover study|0|||
155426170|NCT02601950|560988065|FG004|Overall Study|Participant enrolled in rollover study|1|||
155426171|NCT02601950|560988066|FG005|Overall Study|Participant enrolled in rollover study|1|||
155426172|NCT02601950|560988067|FG006|Overall Study|Participant enrolled in rollover study|1|||
155426173|NCT02601950|560988068|FG007|Overall Study|Participant enrolled in rollover study|0|||
155426174|NCT02601950|560988061|FG000|Overall Study|Disease progression - radiological|21|||
155426175|NCT02601950|560988062|FG001|Overall Study|Disease progression - radiological|26|||
155426176|NCT02601950|560988063|FG002|Overall Study|Disease progression - radiological|22|||
155426177|NCT02601950|560988064|FG003|Overall Study|Disease progression - radiological|11|||
155426178|NCT02601950|560988065|FG004|Overall Study|Disease progression - radiological|46|||
155426179|NCT02601950|560988066|FG005|Overall Study|Disease progression - radiological|52|||
155426180|NCT02601950|560988067|FG006|Overall Study|Disease progression - radiological|7|||
155426181|NCT02601950|560988068|FG007|Overall Study|Disease progression - radiological|5|||
155426182|NCT02601950|560988061|FG000|Overall Study|Disease progression - clinical|3|||
155426183|NCT02601950|560988062|FG001|Overall Study|Disease progression - clinical|5|||
155426184|NCT02601950|560988063|FG002|Overall Study|Disease progression - clinical|4|||
155426185|NCT02601950|560988064|FG003|Overall Study|Disease progression - clinical|2|||
155426186|NCT02601950|560988065|FG004|Overall Study|Disease progression - clinical|6|||
155426187|NCT02601950|560988066|FG005|Overall Study|Disease progression - clinical|6|||
155426188|NCT02601950|560988067|FG006|Overall Study|Disease progression - clinical|5|||
155426189|NCT02601950|560988068|FG007|Overall Study|Disease progression - clinical|1|||
155426190|NCT02601950|560988061|FG000|Overall Study|Death|6|||
155426191|NCT02601950|560988062|FG001|Overall Study|Death|0|||
155352586|NCT02895360|560725695|FG005|Phase 2a|Adverse Event|1|||
155352587|NCT02895360|560725690|FG000|Phase 2a|Progressive disease|0|||
155352588|NCT02895360|560725691|FG001|Phase 2a|Progressive disease|0|||
155352589|NCT02895360|560725692|FG002|Phase 2a|Progressive disease|0|||
155352590|NCT02895360|560725693|FG003|Phase 2a|Progressive disease|0|||
155352591|NCT02895360|560725694|FG004|Phase 2a|Progressive disease|11|||
155352592|NCT02895360|560725695|FG005|Phase 2a|Progressive disease|11|||
155352593|NCT00307164|560725696|FG000|Overall Study|Death|1|||
155352594|NCT00307164|560725697|FG001|Overall Study|Death|0|||
155352595|NCT00307164|560725696|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155352596|NCT00307164|560725697|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155352597|NCT00307164|560725696|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
155352598|NCT00307164|560725697|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
155352599|NCT00307164|560725696|FG000|Overall Study|Withdrawal by Subject|1|||
155352600|NCT00307164|560725697|FG001|Overall Study|Withdrawal by Subject|8|||
155352601|NCT00307164|560725696|FG000|Overall Study|Not compliant with requirements|4|||
155352602|NCT00307164|560725697|FG001|Overall Study|Not compliant with requirements|4|||
155352603|NCT00307164|560725696|FG000|Overall Study|Lost to Follow-up|6|||
155352604|NCT00307164|560725697|FG001|Overall Study|Lost to Follow-up|1|||
155426192|NCT02601950|560988063|FG002|Overall Study|Death|3|||
155352605|NCT02544113|560725700|FG000|Overall Study|Death|3|||
155352606|NCT02544113|560725701|FG001|Overall Study|Death|4|||
155352607|NCT02847637|560725703|FG000|Overall Study|Withdrawal by Subject|0|||
155352608|NCT02847637|560725704|FG001|Overall Study|Withdrawal by Subject|1|||
155426193|NCT02601950|560988064|FG003|Overall Study|Death|1|||
155426194|NCT02601950|560988065|FG004|Overall Study|Death|4|||
155426195|NCT02601950|560988066|FG005|Overall Study|Death|1|||
155426196|NCT02601950|560988067|FG006|Overall Study|Death|0|||
155426197|NCT02601950|560988068|FG007|Overall Study|Death|0|||
155352609|NCT02847637|560725705|FG002|Overall Study|Withdrawal by Subject|1|||
155352610|NCT02847637|560725706|FG003|Overall Study|Withdrawal by Subject|0|||
155352611|NCT02847637|560725703|FG000|Overall Study|Lost to Follow-up|1|||
155352612|NCT02847637|560725704|FG001|Overall Study|Lost to Follow-up|1|||
155352613|NCT02847637|560725705|FG002|Overall Study|Lost to Follow-up|0|||
155352614|NCT02847637|560725706|FG003|Overall Study|Lost to Follow-up|0|||
155352615|NCT01746108|560725709|FG000|Overall Study|Migrated /moved from study area|0|||
155352616|NCT01746108|560725710|FG001|Overall Study|Migrated /moved from study area|1|||
155352617|NCT01746108|560725711|FG002|Overall Study|Migrated /moved from study area|0|||
155352618|NCT01746108|560725709|FG000|Overall Study|Adverse event, non-fatal|0|||
155352619|NCT01746108|560725710|FG001|Overall Study|Adverse event, non-fatal|1|||
155352620|NCT01746108|560725711|FG002|Overall Study|Adverse event, non-fatal|0|||
155352621|NCT01746108|560725709|FG000|Overall Study|Withdrawal by Subject|0|||
155352622|NCT01746108|560725710|FG001|Overall Study|Withdrawal by Subject|1|||
155352623|NCT01746108|560725711|FG002|Overall Study|Withdrawal by Subject|0|||
155352624|NCT01746108|560725709|FG000|Overall Study|Lost to Follow-up|0|||
155352625|NCT01746108|560725710|FG001|Overall Study|Lost to Follow-up|1|||
155352626|NCT01746108|560725711|FG002|Overall Study|Lost to Follow-up|0|||
155352627|NCT03036150|560725712|FG000|Overall Study|Withdrawal by Subject|8|||
155352628|NCT03036150|560725713|FG001|Overall Study|Withdrawal by Subject|3|||
155352629|NCT03036150|560725712|FG000|Overall Study|Lost to Follow-up|2|||
155352630|NCT03036150|560725713|FG001|Overall Study|Lost to Follow-up|2|||
155352631|NCT00053352|560725724|FG000|Overall Study|Lost to Follow-up|0|||
155352632|NCT00053352|560725725|FG001|Overall Study|Lost to Follow-up|1|||
155352633|NCT00053352|560725724|FG000|Overall Study|Physician Decision|11|||
155352634|NCT00053352|560725725|FG001|Overall Study|Physician Decision|1|||
155352635|NCT00053352|560725724|FG000|Overall Study|Withdrawal by Subject|1|||
155352636|NCT00053352|560725725|FG001|Overall Study|Withdrawal by Subject|0|||
155352637|NCT00053352|560725724|FG000|Overall Study|Ineligible|8|||
155352638|NCT00053352|560725725|FG001|Overall Study|Ineligible|8|||
155352639|NCT00053352|560725724|FG000|Overall Study|Disease at new site|1|||
155352640|NCT00053352|560725725|FG001|Overall Study|Disease at new site|0|||
155352641|NCT02741713|560725728|FG000|Overall Study|Surgery type changed intra-operatively|2|||
155352642|NCT02741713|560725729|FG001|Overall Study|Surgery type changed intra-operatively|1|||
155352643|NCT01388478|560725730|FG000|Overall Study|Adverse Event|4|||
155352644|NCT01388478|560725730|FG000|Overall Study|Withdrawal by Subject|1|||
155352645|NCT00550446|560725733|FG000|Up To Week 12|Adverse Event|2|||
155352646|NCT00550446|560725734|FG001|Up To Week 12|Adverse Event|2|||
155426198|NCT02601950|560988061|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426199|NCT02601950|560988062|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426200|NCT02601950|560988063|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426201|NCT02601950|560988064|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426202|NCT02601950|560988065|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426203|NCT02601950|560988066|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
155352647|NCT00550446|560725735|FG002|Up To Week 12|Adverse Event|0|||
155352648|NCT00550446|560725736|FG003|Up To Week 12|Adverse Event|0|||
155352649|NCT00550446|560725737|FG004|Up To Week 12|Adverse Event|2|||
155506656|NCT01364298|561281797|FG000|Overall Study|Withdrawal by Subject|3|||
155352650|NCT00550446|560725738|FG005|Up To Week 12|Adverse Event|2|||
155352651|NCT00550446|560725739|FG006|Up To Week 12|Adverse Event|1|||
155352652|NCT00550446|560725740|FG007|Up To Week 12|Adverse Event|0|||
155352653|NCT00550446|560725741|FG008|Up To Week 12|Adverse Event|0|||
155352654|NCT00550446|560725742|FG009|Up To Week 12|Adverse Event|0|||
155352655|NCT00550446|560725743|FG010|Up To Week 12|Adverse Event|0|||
155352656|NCT00550446|560725733|FG000|Up To Week 12|Lack of Efficacy|3|||
155352657|NCT00550446|560725734|FG001|Up To Week 12|Lack of Efficacy|1|||
155426204|NCT02601950|560988067|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426205|NCT02601950|560988068|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
155426206|NCT02601950|560988061|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
155352658|NCT00550446|560725735|FG002|Up To Week 12|Lack of Efficacy|0|||
155426207|NCT02601950|560988062|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
155426208|NCT02601950|560988063|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
155426209|NCT02601950|560988064|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
155426210|NCT02601950|560988065|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
155426211|NCT02601950|560988066|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
155426212|NCT02601950|560988067|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
155426213|NCT02601950|560988068|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
155426214|NCT02601950|560988061|FG000|Overall Study|Non-compliance|0|||
155426215|NCT02601950|560988062|FG001|Overall Study|Non-compliance|1|||
155426216|NCT02601950|560988063|FG002|Overall Study|Non-compliance|0|||
155352659|NCT00550446|560725736|FG003|Up To Week 12|Lack of Efficacy|1|||
155426217|NCT02601950|560988064|FG003|Overall Study|Non-compliance|0|||
155426218|NCT02601950|560988065|FG004|Overall Study|Non-compliance|0|||
155352660|NCT00550446|560725737|FG004|Up To Week 12|Lack of Efficacy|0|||
155352661|NCT00550446|560725738|FG005|Up To Week 12|Lack of Efficacy|3|||
155426219|NCT02601950|560988066|FG005|Overall Study|Non-compliance|1|||
155352662|NCT00550446|560725739|FG006|Up To Week 12|Lack of Efficacy|3|||
155352663|NCT00550446|560725740|FG007|Up To Week 12|Lack of Efficacy|0|||
155352664|NCT00550446|560725741|FG008|Up To Week 12|Lack of Efficacy|0|||
155352665|NCT00550446|560725742|FG009|Up To Week 12|Lack of Efficacy|0|||
155352666|NCT00550446|560725743|FG010|Up To Week 12|Lack of Efficacy|0|||
155352667|NCT00550446|560725733|FG000|Up To Week 12|Lost to Follow-up|0|||
155352668|NCT00550446|560725734|FG001|Up To Week 12|Lost to Follow-up|1|||
155352669|NCT00550446|560725735|FG002|Up To Week 12|Lost to Follow-up|0|||
155352670|NCT00550446|560725736|FG003|Up To Week 12|Lost to Follow-up|0|||
155352671|NCT00550446|560725737|FG004|Up To Week 12|Lost to Follow-up|1|||
155352672|NCT00550446|560725738|FG005|Up To Week 12|Lost to Follow-up|1|||
155352673|NCT00550446|560725739|FG006|Up To Week 12|Lost to Follow-up|2|||
155352674|NCT00550446|560725740|FG007|Up To Week 12|Lost to Follow-up|0|||
155352675|NCT00550446|560725741|FG008|Up To Week 12|Lost to Follow-up|0|||
155352676|NCT00550446|560725742|FG009|Up To Week 12|Lost to Follow-up|0|||
155506657|NCT01364298|561281798|FG001|Overall Study|Withdrawal by Subject|3|||
155506658|NCT01364298|561281797|FG000|Overall Study|Other|1|||
155506659|NCT01364298|561281798|FG001|Overall Study|Other|3|||
155506660|NCT03712228|561281799|FG000|Treatment Period 1|Lack of Efficacy|0|||
155506661|NCT03712228|561281800|FG001|Treatment Period 1|Lack of Efficacy|0|||
155506662|NCT03712228|561281801|FG002|Treatment Period 1|Lack of Efficacy|0|||
155506663|NCT03712228|561281802|FG003|Treatment Period 1|Lack of Efficacy|0|||
155506664|NCT03712228|561281803|FG004|Treatment Period 1|Lack of Efficacy|0|||
155506665|NCT03712228|561281804|FG005|Treatment Period 1|Lack of Efficacy|1|||
155506666|NCT03712228|561281799|FG000|Treatment Period 2|Pregnancy|0|||
155352677|NCT00550446|560725743|FG010|Up To Week 12|Lost to Follow-up|0|||
155352678|NCT00550446|560725733|FG000|Up To Week 12|Withdrawal by Subject|2|||
155352679|NCT00550446|560725734|FG001|Up To Week 12|Withdrawal by Subject|0|||
155352680|NCT00550446|560725735|FG002|Up To Week 12|Withdrawal by Subject|3|||
155352681|NCT00550446|560725736|FG003|Up To Week 12|Withdrawal by Subject|2|||
155352682|NCT00550446|560725737|FG004|Up To Week 12|Withdrawal by Subject|0|||
155352683|NCT00550446|560725738|FG005|Up To Week 12|Withdrawal by Subject|1|||
155352684|NCT00550446|560725739|FG006|Up To Week 12|Withdrawal by Subject|3|||
155352685|NCT00550446|560725740|FG007|Up To Week 12|Withdrawal by Subject|0|||
155352686|NCT00550446|560725741|FG008|Up To Week 12|Withdrawal by Subject|0|||
155352687|NCT00550446|560725742|FG009|Up To Week 12|Withdrawal by Subject|0|||
155352688|NCT00550446|560725743|FG010|Up To Week 12|Withdrawal by Subject|0|||
155352689|NCT00550446|560725733|FG000|Up To Week 12|Other|3|||
155352690|NCT00550446|560725734|FG001|Up To Week 12|Other|0|||
155352691|NCT00550446|560725735|FG002|Up To Week 12|Other|0|||
155352692|NCT00550446|560725736|FG003|Up To Week 12|Other|0|||
155352693|NCT00550446|560725737|FG004|Up To Week 12|Other|0|||
155352694|NCT00550446|560725738|FG005|Up To Week 12|Other|1|||
155352695|NCT00550446|560725739|FG006|Up To Week 12|Other|4|||
155352696|NCT00550446|560725740|FG007|Up To Week 12|Other|0|||
155352697|NCT00550446|560725741|FG008|Up To Week 12|Other|0|||
155352698|NCT00550446|560725742|FG009|Up To Week 12|Other|0|||
155352699|NCT00550446|560725743|FG010|Up To Week 12|Other|0|||
155352700|NCT00550446|560725733|FG000|Up To Week 12|Randomized not treated|0|||
155352701|NCT00550446|560725734|FG001|Up To Week 12|Randomized not treated|1|||
155352702|NCT00550446|560725735|FG002|Up To Week 12|Randomized not treated|1|||
155352703|NCT00550446|560725736|FG003|Up To Week 12|Randomized not treated|0|||
155352704|NCT00550446|560725737|FG004|Up To Week 12|Randomized not treated|0|||
155506667|NCT03712228|561281800|FG001|Treatment Period 2|Pregnancy|0|||
155506668|NCT03712228|561281801|FG002|Treatment Period 2|Pregnancy|0|||
155352705|NCT00550446|560725738|FG005|Up To Week 12|Randomized not treated|0|||
155352706|NCT00550446|560725739|FG006|Up To Week 12|Randomized not treated|0|||
155352707|NCT00550446|560725740|FG007|Up To Week 12|Randomized not treated|0|||
155352708|NCT00550446|560725741|FG008|Up To Week 12|Randomized not treated|0|||
155352709|NCT00550446|560725742|FG009|Up To Week 12|Randomized not treated|0|||
155352710|NCT00550446|560725743|FG010|Up To Week 12|Randomized not treated|0|||
155352711|NCT00550446|560725733|FG000|Post Week 12|Adverse Event|2|||
155506669|NCT03712228|561281802|FG003|Treatment Period 2|Pregnancy|1|||
155352712|NCT00550446|560725734|FG001|Post Week 12|Adverse Event|1|||
155352713|NCT00550446|560725735|FG002|Post Week 12|Adverse Event|1|||
155352714|NCT00550446|560725736|FG003|Post Week 12|Adverse Event|1|||
155506670|NCT03712228|561281803|FG004|Treatment Period 2|Pregnancy|0|||
155352715|NCT00550446|560725737|FG004|Post Week 12|Adverse Event|1|||
155352716|NCT00550446|560725738|FG005|Post Week 12|Adverse Event|1|||
155352717|NCT00550446|560725739|FG006|Post Week 12|Adverse Event|0|||
155352718|NCT00550446|560725740|FG007|Post Week 12|Adverse Event|0|||
155352719|NCT00550446|560725741|FG008|Post Week 12|Adverse Event|0|||
155352720|NCT00550446|560725742|FG009|Post Week 12|Adverse Event|4|||
155352721|NCT00550446|560725743|FG010|Post Week 12|Adverse Event|0|||
155352722|NCT00550446|560725733|FG000|Post Week 12|Lack of Efficacy|0|||
155352723|NCT00550446|560725734|FG001|Post Week 12|Lack of Efficacy|0|||
155352724|NCT00550446|560725735|FG002|Post Week 12|Lack of Efficacy|1|||
155352725|NCT00550446|560725736|FG003|Post Week 12|Lack of Efficacy|0|||
155352726|NCT00550446|560725737|FG004|Post Week 12|Lack of Efficacy|0|||
155352727|NCT00550446|560725738|FG005|Post Week 12|Lack of Efficacy|0|||
155352728|NCT00550446|560725739|FG006|Post Week 12|Lack of Efficacy|0|||
155352729|NCT00550446|560725740|FG007|Post Week 12|Lack of Efficacy|1|||
155352730|NCT00550446|560725741|FG008|Post Week 12|Lack of Efficacy|1|||
155352731|NCT00550446|560725742|FG009|Post Week 12|Lack of Efficacy|2|||
155352732|NCT00550446|560725743|FG010|Post Week 12|Lack of Efficacy|1|||
155426220|NCT02601950|560988067|FG006|Overall Study|Non-compliance|1|||
155426221|NCT02601950|560988068|FG007|Overall Study|Non-compliance|0|||
155426222|NCT02601950|560988061|FG000|Overall Study|Participant refused further study treatment|0|||
155426223|NCT02601950|560988062|FG001|Overall Study|Participant refused further study treatment|1|||
155426224|NCT02601950|560988063|FG002|Overall Study|Participant refused further study treatment|1|||
155426225|NCT02601950|560988064|FG003|Overall Study|Participant refused further study treatment|0|||
155352733|NCT00550446|560725733|FG000|Post Week 12|Lost to Follow-up|0|||
155352734|NCT00550446|560725734|FG001|Post Week 12|Lost to Follow-up|0|||
155352735|NCT00550446|560725735|FG002|Post Week 12|Lost to Follow-up|1|||
155352736|NCT00550446|560725736|FG003|Post Week 12|Lost to Follow-up|1|||
155352737|NCT00550446|560725737|FG004|Post Week 12|Lost to Follow-up|0|||
155352738|NCT00550446|560725738|FG005|Post Week 12|Lost to Follow-up|0|||
155352739|NCT00550446|560725739|FG006|Post Week 12|Lost to Follow-up|1|||
155352740|NCT00550446|560725740|FG007|Post Week 12|Lost to Follow-up|0|||
155352741|NCT00550446|560725741|FG008|Post Week 12|Lost to Follow-up|0|||
155352742|NCT00550446|560725742|FG009|Post Week 12|Lost to Follow-up|0|||
155352743|NCT00550446|560725743|FG010|Post Week 12|Lost to Follow-up|0|||
155352744|NCT00550446|560725733|FG000|Post Week 12|Withdrawal by Subject|0|||
155352745|NCT00550446|560725734|FG001|Post Week 12|Withdrawal by Subject|0|||
155352746|NCT00550446|560725735|FG002|Post Week 12|Withdrawal by Subject|0|||
155352747|NCT00550446|560725736|FG003|Post Week 12|Withdrawal by Subject|0|||
155352748|NCT00550446|560725737|FG004|Post Week 12|Withdrawal by Subject|1|||
155352749|NCT00550446|560725738|FG005|Post Week 12|Withdrawal by Subject|0|||
155352750|NCT00550446|560725739|FG006|Post Week 12|Withdrawal by Subject|0|||
155352751|NCT00550446|560725740|FG007|Post Week 12|Withdrawal by Subject|0|||
155352752|NCT00550446|560725741|FG008|Post Week 12|Withdrawal by Subject|0|||
155352753|NCT00550446|560725742|FG009|Post Week 12|Withdrawal by Subject|0|||
155352754|NCT00550446|560725743|FG010|Post Week 12|Withdrawal by Subject|0|||
155352755|NCT00550446|560725733|FG000|Post Week 12|Other|1|||
155352756|NCT00550446|560725734|FG001|Post Week 12|Other|1|||
155352757|NCT00550446|560725735|FG002|Post Week 12|Other|0|||
155352758|NCT00550446|560725736|FG003|Post Week 12|Other|1|||
155352759|NCT00550446|560725737|FG004|Post Week 12|Other|0|||
155352760|NCT00550446|560725738|FG005|Post Week 12|Other|0|||
155352761|NCT00550446|560725739|FG006|Post Week 12|Other|1|||
155506671|NCT03712228|561281804|FG005|Treatment Period 2|Pregnancy|0|||
155506672|NCT03712228|561281799|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155506673|NCT03712228|561281800|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155506674|NCT03712228|561281801|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155506675|NCT03712228|561281802|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155506676|NCT03712228|561281803|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155352762|NCT00550446|560725740|FG007|Post Week 12|Other|0|||
155352763|NCT00550446|560725741|FG008|Post Week 12|Other|1|||
155352764|NCT00550446|560725742|FG009|Post Week 12|Other|1|||
155352765|NCT00550446|560725743|FG010|Post Week 12|Other|0|||
155426226|NCT02601950|560988065|FG004|Overall Study|Participant refused further study treatment|2|||
155426227|NCT02601950|560988066|FG005|Overall Study|Participant refused further study treatment|2|||
155426228|NCT02601950|560988067|FG006|Overall Study|Participant refused further study treatment|2|||
155426229|NCT02601950|560988068|FG007|Overall Study|Participant refused further study treatment|1|||
155426230|NCT02601950|560988061|FG000|Overall Study|Investigator discretion|1|||
155426231|NCT02601950|560988062|FG001|Overall Study|Investigator discretion|0|||
155426232|NCT02601950|560988063|FG002|Overall Study|Investigator discretion|1|||
155426233|NCT02601950|560988064|FG003|Overall Study|Investigator discretion|0|||
155426234|NCT02601950|560988065|FG004|Overall Study|Investigator discretion|1|||
155426235|NCT02601950|560988066|FG005|Overall Study|Investigator discretion|1|||
155426236|NCT02601950|560988067|FG006|Overall Study|Investigator discretion|1|||
155426237|NCT02601950|560988068|FG007|Overall Study|Investigator discretion|0|||
155426238|NCT02601950|560988061|FG000|Overall Study|Other|0|||
155426239|NCT02601950|560988062|FG001|Overall Study|Other|0|||
155426240|NCT02601950|560988063|FG002|Overall Study|Other|0|||
155426241|NCT02601950|560988064|FG003|Overall Study|Other|0|||
155426242|NCT02601950|560988065|FG004|Overall Study|Other|2|||
155426243|NCT02601950|560988066|FG005|Overall Study|Other|2|||
155426244|NCT02601950|560988067|FG006|Overall Study|Other|1|||
155426245|NCT02601950|560988068|FG007|Overall Study|Other|0|||
155426246|NCT02157883|560988071|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
155426247|NCT02157883|560988071|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
155426248|NCT02157883|560988071|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
155426249|NCT02157883|560988071|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
155426250|NCT02157883|560988071|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
155426251|NCT01323478|560988072|FG000|Overall Study|Adverse Event|7|||
155426252|NCT01323478|560988072|FG000|Overall Study|Lack of Efficacy|4|||
155426253|NCT01323478|560988072|FG000|Overall Study|Non-compliance With Study Product|3|||
155506677|NCT03712228|561281804|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155352766|NCT04081389|560725750|FG000|Overall Study|Withdrawal by Subject|0|||
155426254|NCT01323478|560988072|FG000|Overall Study|Protocol Violation|1|||
155426255|NCT01323478|560988072|FG000|Overall Study|Withdrawal of Consent|1|||
155426256|NCT01323478|560988072|FG000|Overall Study|Administrative or Other Reasons|8|||
155506678|NCT01964105|561281805|FG000|Overall Study|Lost to Follow-up|2|||
155352767|NCT04081389|560725751|FG001|Overall Study|Withdrawal by Subject|0|||
155426257|NCT01756274|560988076|FG000|Overall Study|Protocol Violation|2|||
155506679|NCT01964105|561281806|FG001|Overall Study|Lost to Follow-up|13|||
155352768|NCT04081389|560725752|FG002|Overall Study|Withdrawal by Subject|1|||
155352769|NCT04081389|560725753|FG003|Overall Study|Withdrawal by Subject|0|||
155352770|NCT01114672|560725759|FG000|Overall Study|Death|0|||
155352771|NCT01114672|560725760|FG001|Overall Study|Death|1|||
155352772|NCT01114672|560725759|FG000|Overall Study|Withdrawal by Subject|2|||
155352773|NCT01114672|560725760|FG001|Overall Study|Withdrawal by Subject|1|||
155352774|NCT01114672|560725759|FG000|Overall Study|Lost to Follow-up|1|||
155352775|NCT01114672|560725760|FG001|Overall Study|Lost to Follow-up|0|||
155352776|NCT01114672|560725759|FG000|Overall Study|transplanted|1|||
155352777|NCT01114672|560725760|FG001|Overall Study|transplanted|0|||
155352778|NCT01710800|560725761|FG000|Overall Study|Withdrawal by Subject|21|||
155352779|NCT01710800|560725761|FG000|Overall Study|Protocol Violation|1|||
155352780|NCT00827775|560725762|FG000|Overall Study|Withdrawal by Subject|0|||
155352781|NCT00827775|560725763|FG001|Overall Study|Withdrawal by Subject|5|||
155352782|NCT03891641|560725764|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
155352783|NCT03891641|560725765|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
155352784|NCT02212301|560725766|FG000|Period 1|Lost to Follow-up|0|||
155352785|NCT02212301|560725767|FG001|Period 1|Lost to Follow-up|1|||
155352786|NCT00866918|560725770|FG000|Overall Study|Death|1|||
155352787|NCT00866918|560725771|FG001|Overall Study|Death|5|||
155352788|NCT00866918|560725770|FG000|Overall Study|Lack of Efficacy|1|||
155352789|NCT00866918|560725771|FG001|Overall Study|Lack of Efficacy|1|||
155352790|NCT00866918|560725770|FG000|Overall Study|Physician Decision|10|||
155352791|NCT00866918|560725771|FG001|Overall Study|Physician Decision|2|||
155352792|NCT00866918|560725770|FG000|Overall Study|Ineligible|2|||
155352793|NCT00866918|560725771|FG001|Overall Study|Ineligible|4|||
155352794|NCT00866918|560725770|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
155352795|NCT00866918|560725771|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
155426258|NCT01756274|560988076|FG000|Overall Study|Laboratory error|1|||
155426259|NCT03367871|560988079|FG000|Overall Study|Lost to Follow-up|1|||
155426260|NCT01670994|560988081|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
155426261|NCT01670994|560988082|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
155352796|NCT00866918|560725770|FG000|Overall Study|Secondary malignancy|1|||
155352797|NCT00866918|560725771|FG001|Overall Study|Secondary malignancy|0|||
155352798|NCT03041701|560725772|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
155352799|NCT03041701|560725773|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
155352800|NCT03041701|560725774|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
155352801|NCT03041701|560725772|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
155352802|NCT03041701|560725773|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
155352803|NCT03041701|560725774|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
155426262|NCT01670994|560988081|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
155426263|NCT01670994|560988082|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
155426264|NCT01670994|560988081|FG000|Overall Study|Patient experienced DLT|0|||
155426265|NCT01670994|560988082|FG001|Overall Study|Patient experienced DLT|1|||
155426266|NCT02013544|560988083|FG000|Overall Study|Adverse Event|5|||
155352804|NCT00527514|560725775|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
155352805|NCT00527514|560725775|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
155352806|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
155352807|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
155352808|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
155352809|NCT00527514|560725775|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
155352810|NCT00527514|560725775|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
155352811|NCT00001941|560725776|FG000|Overall Study|not treated- rapidly progressing disease|0|||
155352812|NCT00001941|560725777|FG001|Overall Study|not treated- rapidly progressing disease|0|||
155352813|NCT00001941|560725778|FG002|Overall Study|not treated- rapidly progressing disease|0|||
155352814|NCT00001941|560725779|FG003|Overall Study|not treated- rapidly progressing disease|0|||
155352815|NCT00001941|560725780|FG004|Overall Study|not treated- rapidly progressing disease|1|||
155352816|NCT04380688|560725784|FG000|Overall Study|Death|2|||
155352817|NCT04380688|560725785|FG001|Overall Study|Death|2|||
155352818|NCT04380688|560725784|FG000|Overall Study|Lost to Follow-up|2|||
155352819|NCT04380688|560725785|FG001|Overall Study|Lost to Follow-up|4|||
155352820|NCT04380688|560725784|FG000|Overall Study|Withdrawal by Subject|3|||
155352821|NCT04380688|560725785|FG001|Overall Study|Withdrawal by Subject|3|||
155352822|NCT00919061|560725786|FG000|Overall Study|Adverse Event|1|||
155352823|NCT00919061|560725786|FG000|Overall Study|Withdrawal by Subject|1|||
155352824|NCT02056873|560725787|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
155352825|NCT00605566|560727700|FG000|Overall Study|Adverse Event|1|||
155352826|NCT00605566|560727700|FG000|Overall Study|Clinical deterioration|1|||
155352827|NCT00605566|560727700|FG000|Overall Study|Poor compliance in run-in period|1|||
155352828|NCT01904136|560727701|FG000|Overall Study|Physician Decision|0|||
155352829|NCT01904136|560727702|FG001|Overall Study|Physician Decision|0|||
155352830|NCT01904136|560727703|FG002|Overall Study|Physician Decision|0|||
155426267|NCT02013544|560988084|FG001|Overall Study|Adverse Event|5|||
155426268|NCT02013544|560988083|FG000|Overall Study|Lost to Follow-up|2|||
155352831|NCT01904136|560727704|FG003|Overall Study|Physician Decision|0|||
155352832|NCT01904136|560727705|FG004|Overall Study|Physician Decision|0|||
155426269|NCT02013544|560988084|FG001|Overall Study|Lost to Follow-up|3|||
155426270|NCT02013544|560988083|FG000|Overall Study|Withdrawal by Subject|2|||
155426271|NCT02013544|560988084|FG001|Overall Study|Withdrawal by Subject|8|||
155426272|NCT02013544|560988083|FG000|Overall Study|Physician Decision|0|||
155426273|NCT02013544|560988084|FG001|Overall Study|Physician Decision|1|||
155426274|NCT02013544|560988083|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
155426275|NCT02013544|560988084|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
155426276|NCT00891735|560988087|FG000|Overall Study|Adverse Event|2|||
155426277|NCT00891735|560988088|FG001|Overall Study|Adverse Event|0|||
155426278|NCT00891735|560988089|FG002|Overall Study|Adverse Event|2|||
155506680|NCT01964105|561281807|FG002|Overall Study|Lost to Follow-up|0|||
155506681|NCT02295280|561281809|FG000|Overall Study|Adverse Event|0|||
155506682|NCT02295280|561281810|FG001|Overall Study|Adverse Event|1|||
155506683|NCT02875067|561281811|FG000|Overall Study|Withdrawal by Subject|1|||
155506684|NCT02875067|561281811|FG000|Overall Study|Withdrawal by Termination of Study|5|||
155506685|NCT01430104|561281812|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
155506686|NCT02713243|561281814|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
155506687|NCT02713243|561281815|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
155506688|NCT02713243|561281814|FG000|Overall Study|Administrative problems|0|||
155506689|NCT02713243|561281815|FG001|Overall Study|Administrative problems|1|||
155506690|NCT02713243|561281814|FG000|Overall Study|Protocol deviation|0|||
155506691|NCT02713243|561281815|FG001|Overall Study|Protocol deviation|1|||
155506692|NCT03056352|561281816|FG000|Overall Study|Lost to Follow-up|1|||
155506693|NCT02971605|561281817|FG000|Overall Study|Withdrawal by Subject|1|||
155506694|NCT03439293|561281818|FG000|Overall Study|Death|22|||
155506695|NCT03439293|561281818|FG000|Overall Study|Withdrawal by Subject|8|||
155506696|NCT03439293|561281818|FG000|Overall Study|Lost to Follow-up|2|||
155352833|NCT01904136|560727706|FG005|Overall Study|Physician Decision|1|||
155352834|NCT01904136|560727707|FG006|Overall Study|Physician Decision|0|||
155352835|NCT01904136|560727708|FG007|Overall Study|Physician Decision|0|||
155352836|NCT01904136|560727709|FG008|Overall Study|Physician Decision|0|||
155426279|NCT00891735|560988090|FG003|Overall Study|Adverse Event|0|||
155506697|NCT03439293|561281818|FG000|Overall Study|Reason Not Specified|28|||
155506698|NCT03439293|561281818|FG000|Overall Study|Missing|1|||
155352837|NCT02202109|560727711|FG000|Overall Study|Lost to Follow-up|88|||
155352838|NCT02202109|560727712|FG001|Overall Study|Lost to Follow-up|87|||
155426280|NCT00891735|560988087|FG000|Overall Study|Death|8|||
155506699|NCT00869089|561281824|FG000|Overall Study|Lost to Follow-up|1|||
155506700|NCT00869089|561281824|FG000|Overall Study|Withdrawal by Subject|1|||
155352839|NCT02202109|560727711|FG000|Overall Study|Withdrawal by Subject|2|||
155352840|NCT02202109|560727712|FG001|Overall Study|Withdrawal by Subject|0|||
155352841|NCT03834623|560727715|FG000|Overall Study|Progression|0|||
155352842|NCT03834623|560727716|FG001|Overall Study|Progression|1|||
155352843|NCT03024996|560727717|FG000|Overall Study|Death|57|||
155352844|NCT03024996|560727718|FG001|Overall Study|Death|55|||
155352845|NCT03024996|560727717|FG000|Overall Study|Disease relapse|1|||
155352846|NCT03024996|560727718|FG001|Overall Study|Disease relapse|0|||
155352847|NCT03024996|560727717|FG000|Overall Study|Lost to Follow-up|5|||
155352848|NCT03024996|560727718|FG001|Overall Study|Lost to Follow-up|10|||
155352849|NCT03024996|560727717|FG000|Overall Study|Other|3|||
155352850|NCT03024996|560727718|FG001|Overall Study|Other|3|||
155352851|NCT03024996|560727717|FG000|Overall Study|Physician Decision|0|||
155352852|NCT03024996|560727718|FG001|Overall Study|Physician Decision|1|||
155352853|NCT03024996|560727717|FG000|Overall Study|Study terminated by sponsor|303|||
155352854|NCT03024996|560727718|FG001|Overall Study|Study terminated by sponsor|283|||
155352855|NCT03024996|560727717|FG000|Overall Study|Withdrawal by Subject|21|||
155352856|NCT03024996|560727718|FG001|Overall Study|Withdrawal by Subject|36|||
155352857|NCT00478647|560727719|FG000|Overall Study|Adverse Event|1|||
155352858|NCT00478647|560727719|FG000|Overall Study|Withdrawal by Subject|1|||
155352859|NCT00487552|560727732|FG000|Overall Study|Unsuccessful magnet placements|3|||
155352860|NCT00487552|560727732|FG000|Overall Study|Death due to progressive malignancy|2|||
155352861|NCT00487552|560727732|FG000|Overall Study|Stent not placed|1|||
155352862|NCT03119688|560727733|FG000|Overall Study|Adverse Event|4|||
155352863|NCT00320398|560727734|FG000|Overall Study|Adverse Event|1|||
155352864|NCT00320398|560727735|FG001|Overall Study|Adverse Event|4|||
155352865|NCT00320398|560727734|FG000|Overall Study|Other|1|||
155506701|NCT00869089|561281824|FG000|Overall Study|Screen Fail|1|||
155506702|NCT05003167|561281832|FG000|Overall Study|Withdrawal by Subject|1|||
155506703|NCT00430638|561281833|FG000|Overall Study|Adverse Event|15|||
155648534|NCT01429623|561805830|FG000|Overall Study|No post baseline data|4|||
155648535|NCT01429623|561805831|FG001|Overall Study|No post baseline data|4|||
155352866|NCT00320398|560727735|FG001|Overall Study|Other|0|||
155352867|NCT02705625|560727736|FG000|Overall Study|Protocol Violation|1|||
155352868|NCT02705625|560727737|FG001|Overall Study|Protocol Violation|0|||
155352869|NCT02705625|560727738|FG002|Overall Study|Protocol Violation|0|||
155352870|NCT02705625|560727736|FG000|Overall Study|Adverse Event|6|||
155506704|NCT00430638|561281834|FG001|Overall Study|Adverse Event|15|||
155352871|NCT02705625|560727737|FG001|Overall Study|Adverse Event|5|||
155506705|NCT00430638|561281833|FG000|Overall Study|Uncontrolled blood pressure|48|||
155506706|NCT00430638|561281834|FG001|Overall Study|Uncontrolled blood pressure|13|||
155506707|NCT00430638|561281833|FG000|Overall Study|Lost to Follow-up|1|||
155506708|NCT00430638|561281834|FG001|Overall Study|Lost to Follow-up|7|||
155506709|NCT00430638|561281833|FG000|Overall Study|Protocol Violation|6|||
155506710|NCT00430638|561281834|FG001|Overall Study|Protocol Violation|4|||
155506711|NCT00430638|561281833|FG000|Overall Study|Withdrawal by Subject|4|||
155506712|NCT00430638|561281834|FG001|Overall Study|Withdrawal by Subject|6|||
155506713|NCT00430638|561281833|FG000|Overall Study|Non-compliant|2|||
155506714|NCT00430638|561281834|FG001|Overall Study|Non-compliant|1|||
155506715|NCT00430638|561281833|FG000|Overall Study|Other|2|||
155506716|NCT00430638|561281834|FG001|Overall Study|Other|2|||
155506717|NCT01529749|561281835|FG000|Overall Study|Lost to Follow-up|0|||
155506718|NCT01529749|561281836|FG001|Overall Study|Lost to Follow-up|1|||
155506719|NCT01529749|561281837|FG002|Overall Study|Lost to Follow-up|1|||
155506720|NCT01529749|561281838|FG003|Overall Study|Lost to Follow-up|0|||
155506721|NCT01529749|561281835|FG000|Overall Study|Physician Decision|0|||
155506722|NCT01529749|561281836|FG001|Overall Study|Physician Decision|0|||
155506723|NCT01529749|561281837|FG002|Overall Study|Physician Decision|0|||
155506724|NCT01529749|561281838|FG003|Overall Study|Physician Decision|1|||
155506725|NCT01529749|561281835|FG000|Overall Study|Withdrawal by Subject|0|||
155506726|NCT01529749|561281836|FG001|Overall Study|Withdrawal by Subject|1|||
155506727|NCT01529749|561281837|FG002|Overall Study|Withdrawal by Subject|1|||
155506728|NCT01529749|561281838|FG003|Overall Study|Withdrawal by Subject|0|||
155506729|NCT01529749|561281835|FG000|Overall Study|Protocol Violation|0|||
155506730|NCT01529749|561281836|FG001|Overall Study|Protocol Violation|0|||
155506731|NCT01529749|561281837|FG002|Overall Study|Protocol Violation|0|||
155506732|NCT01529749|561281838|FG003|Overall Study|Protocol Violation|1|||
155506733|NCT01133392|561281839|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
155506734|NCT01133392|561281840|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
155506735|NCT01133392|561281839|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
155506736|NCT01133392|561281840|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
155506737|NCT00378482|561281841|FG000|Overall Study|Lost to Follow-up|1|||
155506738|NCT00378482|561281841|FG000|Overall Study|Lack of Efficacy|8|||
155506739|NCT00378482|561281841|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
155506740|NCT00378482|561281841|FG000|Overall Study|Withdrawal by Subject|4|||
155506741|NCT00378482|561281841|FG000|Overall Study|Adverse Event|9|||
155506742|NCT03185949|561281842|FG000|ITT Analysis|Withdrawal by Subject|4|||
155506743|NCT03185949|561281843|FG001|ITT Analysis|Withdrawal by Subject|3|||
155506744|NCT03185949|561281842|FG000|PP Analysis|Protocol Violation|2|||
155506745|NCT03185949|561281843|FG001|PP Analysis|Protocol Violation|2|||
155506746|NCT03185949|561281842|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
155506747|NCT03185949|561281843|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
155506748|NCT00555399|561281849|FG000|Overall Study|Withdrawal by Subject|0|||
155506749|NCT00555399|561281850|FG001|Overall Study|Withdrawal by Subject|0|||
155506750|NCT00555399|561281851|FG002|Overall Study|Withdrawal by Subject|1|||
155506751|NCT00555399|561281852|FG003|Overall Study|Withdrawal by Subject|0|||
155506752|NCT00555399|561281853|FG004|Overall Study|Withdrawal by Subject|0|||
155506753|NCT00555399|561281854|FG005|Overall Study|Withdrawal by Subject|0|||
155506754|NCT00555399|561281855|FG006|Overall Study|Withdrawal by Subject|0|||
155506755|NCT00555399|561281856|FG007|Overall Study|Withdrawal by Subject|0|||
155506756|NCT00555399|561281857|FG008|Overall Study|Withdrawal by Subject|0|||
155506757|NCT00555399|561281858|FG009|Overall Study|Withdrawal by Subject|0|||
155506758|NCT00555399|561281859|FG010|Overall Study|Withdrawal by Subject|0|||
155506759|NCT00555399|561281860|FG011|Overall Study|Withdrawal by Subject|1|||
155506760|NCT00555399|561281849|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
155506761|NCT00555399|561281850|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
155506762|NCT00555399|561281851|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
155506763|NCT00555399|561281852|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
155506764|NCT00555399|561281853|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
155506765|NCT00555399|561281854|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
155506766|NCT00555399|561281855|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
155506767|NCT00555399|561281856|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
155506768|NCT00555399|561281857|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
155506769|NCT00555399|561281858|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
155506770|NCT00555399|561281859|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
155506771|NCT00555399|561281860|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
155506772|NCT04639310|561281861|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
155506773|NCT04639310|561281862|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
155506774|NCT00860574|561283438|FG000|Overall Study|Death|2|||
155506775|NCT00860574|561283438|FG000|Overall Study|Relapse|1|||
155352872|NCT02705625|560727738|FG002|Overall Study|Adverse Event|2|||
155352873|NCT02705625|560727736|FG000|Overall Study|Death|0|||
155352874|NCT02705625|560727737|FG001|Overall Study|Death|0|||
155352875|NCT02705625|560727738|FG002|Overall Study|Death|1|||
155352876|NCT02705625|560727736|FG000|Overall Study|Withdrawal by Subject|1|||
155352877|NCT02705625|560727737|FG001|Overall Study|Withdrawal by Subject|4|||
155352878|NCT02705625|560727738|FG002|Overall Study|Withdrawal by Subject|5|||
155352879|NCT02705625|560727736|FG000|Overall Study|Lost to Follow-up|0|||
155352880|NCT02705625|560727737|FG001|Overall Study|Lost to Follow-up|0|||
155352881|NCT02705625|560727738|FG002|Overall Study|Lost to Follow-up|1|||
155352882|NCT02705625|560727736|FG000|Overall Study|Non-compliance|0|||
155352883|NCT02705625|560727737|FG001|Overall Study|Non-compliance|1|||
155352884|NCT02705625|560727738|FG002|Overall Study|Non-compliance|1|||
155352885|NCT02705625|560727736|FG000|Overall Study|Overdosing|0|||
155352886|NCT02705625|560727737|FG001|Overall Study|Overdosing|0|||
155352887|NCT02705625|560727738|FG002|Overall Study|Overdosing|1|||
155352888|NCT04544865|560727740|FG000|Overall Study|Death|0|||
155352889|NCT04544865|560727741|FG001|Overall Study|Death|2|||
155352890|NCT04544865|560727740|FG000|Overall Study|Lost to Follow-up|11|||
155352891|NCT04544865|560727741|FG001|Overall Study|Lost to Follow-up|7|||
155352892|NCT04544865|560727740|FG000|Overall Study|Withdrawal by Subject|0|||
155352893|NCT04544865|560727741|FG001|Overall Study|Withdrawal by Subject|1|||
155352894|NCT04544865|560727740|FG000|Overall Study|Other|0|||
155352895|NCT04544865|560727741|FG001|Overall Study|Other|1|||
155352896|NCT01649297|560727743|FG000|Overall Study|Adverse Event|5|||
155352897|NCT01649297|560727744|FG001|Overall Study|Adverse Event|5|||
155352898|NCT01649297|560727745|FG002|Overall Study|Adverse Event|4|||
155352899|NCT01649297|560727746|FG003|Overall Study|Adverse Event|13|||
155352900|NCT01649297|560727747|FG004|Overall Study|Adverse Event|1|||
155352901|NCT01649297|560727743|FG000|Overall Study|Lack of Efficacy|0|||
155352902|NCT01649297|560727744|FG001|Overall Study|Lack of Efficacy|0|||
155352903|NCT01649297|560727745|FG002|Overall Study|Lack of Efficacy|0|||
155352904|NCT01649297|560727746|FG003|Overall Study|Lack of Efficacy|0|||
155352905|NCT01649297|560727747|FG004|Overall Study|Lack of Efficacy|1|||
155352906|NCT01649297|560727743|FG000|Overall Study|Non compliant with Protocol|1|||
155352907|NCT01649297|560727744|FG001|Overall Study|Non compliant with Protocol|0|||
155352908|NCT01649297|560727745|FG002|Overall Study|Non compliant with Protocol|3|||
155352909|NCT01649297|560727746|FG003|Overall Study|Non compliant with Protocol|2|||
155352910|NCT01649297|560727747|FG004|Overall Study|Non compliant with Protocol|1|||
155352911|NCT01649297|560727743|FG000|Overall Study|Lost to Follow-up|1|||
155352912|NCT01649297|560727744|FG001|Overall Study|Lost to Follow-up|1|||
155352913|NCT01649297|560727745|FG002|Overall Study|Lost to Follow-up|4|||
155352914|NCT01649297|560727746|FG003|Overall Study|Lost to Follow-up|3|||
155352915|NCT01649297|560727747|FG004|Overall Study|Lost to Follow-up|0|||
155352916|NCT01649297|560727743|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
155352917|NCT01649297|560727744|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
155352918|NCT01649297|560727745|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
155352919|NCT01649297|560727746|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
155352920|NCT01649297|560727747|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
155352921|NCT01649297|560727743|FG000|Overall Study|For other reason|4|||
155352922|NCT01649297|560727744|FG001|Overall Study|For other reason|1|||
155352923|NCT01649297|560727745|FG002|Overall Study|For other reason|2|||
155352924|NCT01649297|560727746|FG003|Overall Study|For other reason|0|||
155352925|NCT01649297|560727747|FG004|Overall Study|For other reason|0|||
155352926|NCT01685047|560727748|FG000|Overall Study|Withdrawal by Subject|20|||
155352927|NCT01685047|560727748|FG000|Overall Study|Death|26|||
155352928|NCT01685047|560727748|FG000|Overall Study|Lost to Follow-up|8|||
155352929|NCT01685047|560727748|FG000|Overall Study|Physician Decision|25|||
155352930|NCT01685047|560727748|FG000|Overall Study|Adverse Event|5|||
155352931|NCT01685047|560727748|FG000|Overall Study|patient withdrawn by sponsor|1|||
155352932|NCT01732926|560727750|FG000|Overall Study|Study Terminated by Sponsor|168|||
155506776|NCT02496221|561283440|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
155648536|NCT00981175|561805832|FG000|Primary Dose Vaccination|Adverse Event|1|||
155352933|NCT01732926|560727751|FG001|Overall Study|Study Terminated by Sponsor|80|||
155352934|NCT01732926|560727750|FG000|Overall Study|Withdrawal by Subject|46|||
155352935|NCT01732926|560727751|FG001|Overall Study|Withdrawal by Subject|8|||
155352936|NCT01732926|560727750|FG000|Overall Study|Physician Decision|24|||
155352937|NCT01732926|560727751|FG001|Overall Study|Physician Decision|11|||
155352938|NCT01732926|560727750|FG000|Overall Study|Other Reason|21|||
155352939|NCT01732926|560727751|FG001|Overall Study|Other Reason|4|||
155352940|NCT01732926|560727750|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
155352941|NCT01732926|560727751|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
155352942|NCT01732926|560727750|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
155352943|NCT01732926|560727751|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
155352944|NCT02262364|560727754|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
155352945|NCT01049984|560727755|FG000|Overall Study|Withdrawal by Subject|1|||
155352946|NCT01049984|560727756|FG001|Overall Study|Withdrawal by Subject|5|||
155352947|NCT01049984|560727755|FG000|Overall Study|Protocol Violation|3|||
155352948|NCT01049984|560727756|FG001|Overall Study|Protocol Violation|4|||
155352949|NCT01049984|560727755|FG000|Overall Study|Lost to Follow-up|2|||
155352950|NCT01049984|560727756|FG001|Overall Study|Lost to Follow-up|1|||
155352951|NCT01049984|560727755|FG000|Overall Study|Adverse Event|13|||
155352952|NCT01049984|560727756|FG001|Overall Study|Adverse Event|7|||
155352953|NCT01049984|560727755|FG000|Overall Study|Treatment failure|0|||
155352954|NCT01049984|560727756|FG001|Overall Study|Treatment failure|2|||
155352955|NCT00337285|560727757|FG000|Overall Study|Withdrawal by Subject|42|||
155352956|NCT00337285|560727757|FG000|Overall Study|Lost to Follow-up|41|||
155352957|NCT00337285|560727757|FG000|Overall Study|Adverse Event|28|||
155352958|NCT00337285|560727757|FG000|Overall Study|Protocol Violation|27|||
155352959|NCT00337285|560727757|FG000|Overall Study|Lack of Efficacy|11|||
155352960|NCT00337285|560727757|FG000|Overall Study|Death|1|||
155352961|NCT00337285|560727757|FG000|Overall Study|Physician Decision|1|||
155352962|NCT00337285|560727757|FG000|Overall Study|Lack of protocol compliance|7|||
155352963|NCT01040403|560727758|FG000|Overall Study|Adverse Event|10|||
155352964|NCT01040403|560727758|FG000|Overall Study|Protocol Violation|2|||
155352965|NCT01040403|560727758|FG000|Overall Study|Lost to Follow-up|1|||
155352966|NCT01040403|560727758|FG000|Overall Study|Not treated|1|||
155352967|NCT01040403|560727758|FG000|Overall Study|Other reason not defined above|6|||
155352968|NCT00931918|560727762|FG000|Overall Study|Adverse Event|4|||
155352969|NCT00931918|560727763|FG001|Overall Study|Adverse Event|6|||
155352970|NCT00931918|560727762|FG000|Overall Study|Progressive Disease|2|||
155352971|NCT00931918|560727763|FG001|Overall Study|Progressive Disease|1|||
155352972|NCT00931918|560727762|FG000|Overall Study|Symptomatic Deterioration|1|||
155352973|NCT00931918|560727763|FG001|Overall Study|Symptomatic Deterioration|0|||
155352974|NCT00931918|560727762|FG000|Overall Study|Withdrawal by Patient|3|||
155352975|NCT00931918|560727763|FG001|Overall Study|Withdrawal by Patient|4|||
155352976|NCT00931918|560727762|FG000|Overall Study|Other Reason not Specified|4|||
155352977|NCT00931918|560727763|FG001|Overall Study|Other Reason not Specified|4|||
155352978|NCT00931918|560727762|FG000|Overall Study|Did not receive study drug|3|||
155352979|NCT00931918|560727763|FG001|Overall Study|Did not receive study drug|2|||
155352980|NCT04191148|560727766|FG000|Overall Study|Withdrawal by Subject|1|||
155352981|NCT04191148|560727767|FG001|Overall Study|Withdrawal by Subject|0|||
155352982|NCT04191148|560727766|FG000|Overall Study|Adverse Event|1|||
155352983|NCT04191148|560727767|FG001|Overall Study|Adverse Event|0|||
155352984|NCT02647788|560727768|FG000|Overall Study|Lost to Follow-up|13|||
155352985|NCT02647788|560727769|FG001|Overall Study|Lost to Follow-up|11|||
155352986|NCT02647788|560727768|FG000|Overall Study|Did not want opiate|0|||
155352987|NCT02647788|560727769|FG001|Overall Study|Did not want opiate|1|||
155352988|NCT02647788|560727768|FG000|Overall Study|Withdrawal by Subject|1|||
155352989|NCT02647788|560727769|FG001|Overall Study|Withdrawal by Subject|0|||
155352990|NCT02647788|560727768|FG000|Overall Study|Felt itchy with assigned medication|1|||
155352991|NCT02647788|560727769|FG001|Overall Study|Felt itchy with assigned medication|0|||
155352992|NCT02647788|560727768|FG000|Overall Study|Felt nauseous with assigned medication|1|||
155352993|NCT02647788|560727769|FG001|Overall Study|Felt nauseous with assigned medication|1|||
155352994|NCT03245619|560727770|FG000|Part A (Up to Day 22)|Physician Decision|4|||
155352995|NCT03245619|560727771|FG001|Part A (Up to Day 22)|Physician Decision|6|||
155352996|NCT03245619|560727772|FG002|Part A (Up to Day 22)|Physician Decision|6|||
155352997|NCT03245619|560727773|FG003|Part A (Up to Day 22)|Physician Decision|0|||
155352998|NCT03245619|560727774|FG004|Part A (Up to Day 22)|Physician Decision|0|||
155352999|NCT03245619|560727775|FG005|Part A (Up to Day 22)|Physician Decision|0|||
155353000|NCT03245619|560727776|FG006|Part A (Up to Day 22)|Physician Decision|0|||
155353001|NCT03245619|560727777|FG007|Part A (Up to Day 22)|Physician Decision|0|||
155353002|NCT03245619|560727778|FG008|Part A (Up to Day 22)|Physician Decision|0|||
155426281|NCT00891735|560988088|FG001|Overall Study|Death|5|||
155353003|NCT03245619|560727779|FG009|Part A (Up to Day 22)|Physician Decision|0|||
155353004|NCT03245619|560727780|FG010|Part A (Up to Day 22)|Physician Decision|0|||
155353005|NCT03245619|560727781|FG011|Part A (Up to Day 22)|Physician Decision|0|||
155353006|NCT03245619|560727782|FG012|Part A (Up to Day 22)|Physician Decision|0|||
155353007|NCT03245619|560727783|FG013|Part A (Up to Day 22)|Physician Decision|0|||
155353008|NCT03245619|560727784|FG014|Part A (Up to Day 22)|Physician Decision|0|||
155648537|NCT00981175|561805833|FG001|Primary Dose Vaccination|Adverse Event|0|||
155648538|NCT00981175|561805832|FG000|Primary Dose Vaccination|Protocol Violation|0|||
155648539|NCT00981175|561805833|FG001|Primary Dose Vaccination|Protocol Violation|1|||
155648540|NCT00981175|561805832|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
155353009|NCT03245619|560727785|FG015|Part A (Up to Day 22)|Physician Decision|0|||
155353010|NCT03245619|560727786|FG016|Part A (Up to Day 22)|Physician Decision|0|||
155353011|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
155353012|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
155353013|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
155353014|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
155353015|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
155353016|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
155353017|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
155353018|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
155353019|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
155353020|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
155353021|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
155353022|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
155353023|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
155353024|NCT02971228|560727804|FG000|Overall Study|Withdrawal by Subject|1|||
155353025|NCT02971228|560727805|FG001|Overall Study|Withdrawal by Subject|1|||
155353026|NCT02971228|560727806|FG002|Overall Study|Withdrawal by Subject|0|||
155353027|NCT02971228|560727807|FG003|Overall Study|Withdrawal by Subject|0|||
155353028|NCT02971228|560727808|FG004|Overall Study|Withdrawal by Subject|0|||
155353029|NCT02971228|560727804|FG000|Overall Study|Logistical challenges|0|||
155353030|NCT02971228|560727805|FG001|Overall Study|Logistical challenges|1|||
155353031|NCT02971228|560727806|FG002|Overall Study|Logistical challenges|0|||
155353032|NCT02971228|560727807|FG003|Overall Study|Logistical challenges|0|||
155353033|NCT02971228|560727808|FG004|Overall Study|Logistical challenges|0|||
155353034|NCT01233999|560727809|FG000|Overall Study|Withdrawal by Subject|1|||
155353035|NCT01233999|560727809|FG000|Overall Study|Lost to Follow-up|1|||
155353036|NCT00129649|560727810|FG000|Overall Study|Withdrawal by Subject|76|||
155353037|NCT00129649|560727811|FG001|Overall Study|Withdrawal by Subject|65|||
155353038|NCT00025506|560727812|FG000|Overall Study|Ineligible: clerical error|1|||
155353039|NCT00025506|560727812|FG000|Overall Study|Ineligible: wrong cell type|5|||
155353040|NCT00025506|560727812|FG000|Overall Study|Ineligible: inadequate pathology|2|||
155353041|NCT00025506|560727812|FG000|Overall Study|Never Treated|2|||
155353042|NCT00713206|560727813|FG000|Overall Study|Lost to Follow-up|4|||
155353043|NCT00713206|560727814|FG001|Overall Study|Lost to Follow-up|4|||
155353044|NCT00713206|560727813|FG000|Overall Study|Death|1|||
155353045|NCT00713206|560727814|FG001|Overall Study|Death|0|||
155353046|NCT04952701|560727815|FG000|Control Lens|Physician Decision|4|||
155353047|NCT04952701|560727815|FG000|Test Lens|Physician Decision|1|||
155353048|NCT01657877|560727816|FG000|Overall Study|Withdrawal by Subject|4|||
155353049|NCT01657877|560727816|FG000|Overall Study|Protocol Violation|6|||
155353050|NCT01657877|560727816|FG000|Overall Study|Adverse Event|2|||
155426282|NCT00891735|560988089|FG002|Overall Study|Death|4|||
155426283|NCT00891735|560988090|FG003|Overall Study|Death|5|||
155353051|NCT01657877|560727816|FG000|Overall Study|Other Reason|2|||
155353052|NCT01670188|560727824|FG000|Overall Study|Death|0|||
155353053|NCT01670188|560727825|FG001|Overall Study|Death|1|||
155353054|NCT02427958|560727828|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
155353055|NCT02427958|560727828|FG000|Overall Study|Lost to Follow-up|6|||
155353056|NCT02427958|560727828|FG000|Overall Study|Withdrawal by Subject|14|||
155353057|NCT02427958|560727828|FG000|Overall Study|Lack of Efficacy|1|||
155353058|NCT00578318|560727829|FG000|Overall Study|Lost to Follow-up|2|||
155353059|NCT00578318|560727830|FG001|Overall Study|Lost to Follow-up|0|||
155353060|NCT00578318|560727829|FG000|Overall Study|Physician Decision|1|||
155353061|NCT00578318|560727830|FG001|Overall Study|Physician Decision|0|||
155353062|NCT02025985|560727831|FG000|Overall Study|Consent withdrawn|0|||
155353063|NCT02025985|560727832|FG001|Overall Study|Consent withdrawn|0|||
155353064|NCT02025985|560727833|FG002|Overall Study|Consent withdrawn|1|||
155353065|NCT02025985|560727834|FG003|Overall Study|Consent withdrawn|0|||
155353066|NCT02025985|560727835|FG004|Overall Study|Consent withdrawn|0|||
155353067|NCT02025985|560727831|FG000|Overall Study|Termination of study by Sponsor|4|||
155353068|NCT02025985|560727832|FG001|Overall Study|Termination of study by Sponsor|3|||
155353069|NCT02025985|560727833|FG002|Overall Study|Termination of study by Sponsor|1|||
155353070|NCT02025985|560727834|FG003|Overall Study|Termination of study by Sponsor|1|||
155353071|NCT02025985|560727835|FG004|Overall Study|Termination of study by Sponsor|3|||
155353072|NCT02025985|560727831|FG000|Overall Study|Death|21|||
155353073|NCT02025985|560727832|FG001|Overall Study|Death|20|||
155353074|NCT02025985|560727833|FG002|Overall Study|Death|23|||
155648541|NCT00981175|561805833|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
155648542|NCT00981175|561805832|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
155648543|NCT00981175|561805833|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
155353075|NCT02025985|560727834|FG003|Overall Study|Death|20|||
155353076|NCT02025985|560727835|FG004|Overall Study|Death|17|||
155353077|NCT00920699|560727843|FG000|Overall Study|Withdrawal by Subject|2|||
155648544|NCT01096186|561805834|FG000|Overall Study|Adverse Event|16|||
155353078|NCT00920699|560727844|FG001|Overall Study|Withdrawal by Subject|0|||
155353079|NCT00920699|560727845|FG002|Overall Study|Withdrawal by Subject|2|||
155353080|NCT00920699|560727843|FG000|Overall Study|no longer met eligibility|0|||
155353081|NCT00920699|560727844|FG001|Overall Study|no longer met eligibility|1|||
155353082|NCT00920699|560727845|FG002|Overall Study|no longer met eligibility|0|||
155353083|NCT00920699|560727843|FG000|Overall Study|Lost to Follow-up|0|||
155353084|NCT00920699|560727844|FG001|Overall Study|Lost to Follow-up|0|||
155353085|NCT00920699|560727845|FG002|Overall Study|Lost to Follow-up|2|||
155353086|NCT02287883|560727847|FG000|Overall Study|Death|8|||
155353087|NCT02287883|560727848|FG001|Overall Study|Death|7|||
155353088|NCT02287883|560727847|FG000|Overall Study|No longer eligible|222|||
155353089|NCT02287883|560727848|FG001|Overall Study|No longer eligible|182|||
155353090|NCT02287883|560727847|FG000|Overall Study|Non-response to survey|229|||
155353091|NCT02287883|560727848|FG001|Overall Study|Non-response to survey|237|||
155353092|NCT02101268|560727854|FG000|Randomized Treatment Phase|Subject Decision|8|||
155353093|NCT02101268|560727855|FG001|Randomized Treatment Phase|Subject Decision|4|||
155353094|NCT02101268|560727856|FG002|Randomized Treatment Phase|Subject Decision|0|||
155353095|NCT02101268|560727857|FG003|Randomized Treatment Phase|Subject Decision|0|||
155353096|NCT02101268|560727854|FG000|Randomized Treatment Phase|Physician Decision|4|||
155353097|NCT02101268|560727855|FG001|Randomized Treatment Phase|Physician Decision|1|||
155353098|NCT02101268|560727856|FG002|Randomized Treatment Phase|Physician Decision|0|||
155353099|NCT02101268|560727857|FG003|Randomized Treatment Phase|Physician Decision|0|||
155353100|NCT02101268|560727854|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353101|NCT02101268|560727855|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
155353102|NCT02101268|560727856|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353103|NCT02101268|560727857|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353104|NCT02101268|560727854|FG000|Randomized Treatment Phase|Adverse Event|6|||
155353105|NCT02101268|560727855|FG001|Randomized Treatment Phase|Adverse Event|0|||
155353106|NCT02101268|560727856|FG002|Randomized Treatment Phase|Adverse Event|0|||
155353107|NCT02101268|560727857|FG003|Randomized Treatment Phase|Adverse Event|0|||
155353108|NCT02101268|560727854|FG000|Randomized Treatment Phase|Death|5|||
155353109|NCT02101268|560727855|FG001|Randomized Treatment Phase|Death|4|||
155353110|NCT02101268|560727856|FG002|Randomized Treatment Phase|Death|0|||
155353111|NCT02101268|560727857|FG003|Randomized Treatment Phase|Death|0|||
155353112|NCT02101268|560727854|FG000|Randomized Treatment Phase|Disease Progression|4|||
155353113|NCT02101268|560727855|FG001|Randomized Treatment Phase|Disease Progression|1|||
155353114|NCT02101268|560727856|FG002|Randomized Treatment Phase|Disease Progression|0|||
155353115|NCT02101268|560727857|FG003|Randomized Treatment Phase|Disease Progression|0|||
155353116|NCT02101268|560727854|FG000|Extended Treatment Phase|Subject Decision|0|||
155353117|NCT02101268|560727855|FG001|Extended Treatment Phase|Subject Decision|0|||
155353118|NCT02101268|560727856|FG002|Extended Treatment Phase|Subject Decision|3|||
155353119|NCT02101268|560727857|FG003|Extended Treatment Phase|Subject Decision|2|||
155353120|NCT02101268|560727854|FG000|Extended Treatment Phase|Physician Decision|0|||
155353121|NCT02101268|560727855|FG001|Extended Treatment Phase|Physician Decision|0|||
155353122|NCT02101268|560727856|FG002|Extended Treatment Phase|Physician Decision|5|||
155353123|NCT02101268|560727857|FG003|Extended Treatment Phase|Physician Decision|2|||
155353124|NCT02101268|560727854|FG000|Extended Treatment Phase|Adverse Event|0|||
155353125|NCT02101268|560727855|FG001|Extended Treatment Phase|Adverse Event|0|||
155353126|NCT02101268|560727856|FG002|Extended Treatment Phase|Adverse Event|14|||
155353127|NCT02101268|560727857|FG003|Extended Treatment Phase|Adverse Event|18|||
155353128|NCT02101268|560727854|FG000|Extended Treatment Phase|Death|0|||
155353129|NCT02101268|560727855|FG001|Extended Treatment Phase|Death|0|||
155353130|NCT02101268|560727856|FG002|Extended Treatment Phase|Death|5|||
155353131|NCT02101268|560727857|FG003|Extended Treatment Phase|Death|1|||
155353132|NCT02101268|560727854|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
155353133|NCT02101268|560727855|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
155426284|NCT00891735|560988087|FG000|Overall Study|Lost to Follow-up|2|||
155426285|NCT00891735|560988088|FG001|Overall Study|Lost to Follow-up|2|||
155426286|NCT00891735|560988089|FG002|Overall Study|Lost to Follow-up|2|||
155426287|NCT00891735|560988090|FG003|Overall Study|Lost to Follow-up|2|||
155426288|NCT00891735|560988087|FG000|Overall Study|Physician's decision to withdraw patient|1|||
155426289|NCT00891735|560988088|FG001|Overall Study|Physician's decision to withdraw patient|0|||
155426290|NCT00891735|560988089|FG002|Overall Study|Physician's decision to withdraw patient|0|||
155353134|NCT02101268|560727856|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
155353135|NCT02101268|560727857|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
155353136|NCT02101268|560727854|FG000|Extended Treatment Phase|Disease Progression|0|||
155353137|NCT02101268|560727855|FG001|Extended Treatment Phase|Disease Progression|0|||
155353138|NCT02101268|560727856|FG002|Extended Treatment Phase|Disease Progression|13|||
155353139|NCT02101268|560727857|FG003|Extended Treatment Phase|Disease Progression|6|||
155353140|NCT02101268|560727854|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
155353141|NCT02101268|560727855|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
155353142|NCT02101268|560727856|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
155426291|NCT00891735|560988090|FG003|Overall Study|Physician's decision to withdraw patient|0|||
155353143|NCT02101268|560727857|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
155648545|NCT01096186|561805834|FG000|Overall Study|Death|4|||
155648546|NCT01096186|561805834|FG000|Overall Study|Lack of Efficacy|4|||
155648547|NCT01096186|561805834|FG000|Overall Study|Lost to Follow-up|2|||
155648548|NCT01096186|561805834|FG000|Overall Study|Withdrawal by Subject|22|||
155648549|NCT01096186|561805834|FG000|Overall Study|Physician Decision|1|||
155648550|NCT01096186|561805834|FG000|Overall Study|Noncompliance with study drug|1|||
155648551|NCT03156621|561805839|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
155648552|NCT03156621|561805840|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
155648553|NCT03156621|561805839|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155648554|NCT03156621|561805840|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155648555|NCT00799864|561805841|FG000|Overall Study|Participant reached a virologic endpoint|9|||
155648556|NCT00799864|561805842|FG001|Overall Study|Participant reached a virologic endpoint|2|||
155648557|NCT00799864|561805843|FG002|Overall Study|Participant reached a virologic endpoint|2|||
155648558|NCT00799864|561805844|FG003|Overall Study|Participant reached a virologic endpoint|0|||
155648559|NCT00799864|561805845|FG004|Overall Study|Participant reached a virologic endpoint|0|||
155353144|NCT00576823|560727861|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
155353145|NCT00576823|560727862|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
155353146|NCT00576823|560727863|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
155353147|NCT00576823|560727861|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
155353148|NCT00576823|560727862|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
155353149|NCT00576823|560727863|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
155353150|NCT01242371|560727864|FG000|Overall Study|Withdrawal by Subject|2|||
155353151|NCT01242371|560727865|FG001|Overall Study|Withdrawal by Subject|2|||
155353152|NCT01242371|560727864|FG000|Overall Study|Protocol Violation|0|||
155353153|NCT01242371|560727865|FG001|Overall Study|Protocol Violation|3|||
155353154|NCT00510146|560727868|FG000|Double-Blind Treatment|Adverse Event|30|||
155353155|NCT00510146|560727869|FG001|Double-Blind Treatment|Adverse Event|13|||
155353156|NCT00510146|560727868|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
155353157|NCT00510146|560727869|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
155353158|NCT00510146|560727868|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
155353159|NCT00510146|560727869|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
155353160|NCT00510146|560727868|FG000|Double-Blind Treatment|Physician Decision|6|||
155353161|NCT00510146|560727869|FG001|Double-Blind Treatment|Physician Decision|0|||
155353162|NCT00510146|560727868|FG000|Double-Blind Treatment|Protocol Violation|1|||
155353163|NCT00510146|560727869|FG001|Double-Blind Treatment|Protocol Violation|2|||
155353164|NCT00510146|560727868|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
155353165|NCT00510146|560727869|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
155353166|NCT00510146|560727868|FG000|Double-Blind Treatment|Clinical Relapse|0|||
155353167|NCT00510146|560727869|FG001|Double-Blind Treatment|Clinical Relapse|1|||
155353168|NCT00510146|560727868|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
155353169|NCT00510146|560727869|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
155353170|NCT00510146|560727868|FG000|Open-Label Treatment|Adverse Event|22|||
155353171|NCT00510146|560727869|FG001|Open-Label Treatment|Adverse Event|8|||
155353172|NCT00510146|560727868|FG000|Open-Label Treatment|Death|1|||
155353173|NCT00510146|560727869|FG001|Open-Label Treatment|Death|1|||
155353174|NCT00510146|560727868|FG000|Open-Label Treatment|Lack of Efficacy|4|||
155353175|NCT00510146|560727869|FG001|Open-Label Treatment|Lack of Efficacy|0|||
155353176|NCT00510146|560727868|FG000|Open-Label Treatment|Lost to Follow-up|10|||
155353177|NCT00510146|560727869|FG001|Open-Label Treatment|Lost to Follow-up|1|||
155353178|NCT00510146|560727868|FG000|Open-Label Treatment|Physician Decision|3|||
155353179|NCT00510146|560727869|FG001|Open-Label Treatment|Physician Decision|1|||
155353180|NCT00510146|560727868|FG000|Open-Label Treatment|Protocol Violation|4|||
155353181|NCT00510146|560727869|FG001|Open-Label Treatment|Protocol Violation|2|||
155353182|NCT00510146|560727868|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
155353183|NCT00510146|560727869|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
155353184|NCT00510146|560727868|FG000|Open-Label Treatment|Clinical Relapse|1|||
155353185|NCT00510146|560727869|FG001|Open-Label Treatment|Clinical Relapse|1|||
155353186|NCT00510146|560727868|FG000|Open-Label Treatment|Sponsor Decision|2|||
155353187|NCT00510146|560727869|FG001|Open-Label Treatment|Sponsor Decision|0|||
155353188|NCT02132117|560727870|FG000|Overall Study|Adverse Event|6|||
155353189|NCT02132117|560727871|FG001|Overall Study|Adverse Event|1|||
155353190|NCT02132117|560727870|FG000|Overall Study|Lost to Follow-up|2|||
155426292|NCT00891735|560988087|FG000|Overall Study|Patient's decision to withdraw|4|||
155426293|NCT00891735|560988088|FG001|Overall Study|Patient's decision to withdraw|9|||
155426294|NCT00891735|560988089|FG002|Overall Study|Patient's decision to withdraw|4|||
155426295|NCT00891735|560988090|FG003|Overall Study|Patient's decision to withdraw|8|||
155426296|NCT00481065|560988091|FG000|Overall Study|Adverse event or death|1|||
155426297|NCT00481065|560988092|FG001|Overall Study|Adverse event or death|1|||
155426298|NCT00481065|560988093|FG002|Overall Study|Adverse event or death|3|||
155648560|NCT00799864|561805841|FG000|Overall Study|Other|2|||
155353191|NCT02132117|560727871|FG001|Overall Study|Lost to Follow-up|2|||
155353192|NCT02132117|560727870|FG000|Overall Study|Personal Reasons|1|||
155353193|NCT02132117|560727871|FG001|Overall Study|Personal Reasons|2|||
155353194|NCT02132117|560727870|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155426299|NCT00481065|560988094|FG003|Overall Study|Adverse event or death|0|||
155426300|NCT00481065|560988095|FG004|Overall Study|Adverse event or death|2|||
155426301|NCT00481065|560988096|FG005|Overall Study|Adverse event or death|0|||
155426302|NCT00481065|560988097|FG006|Overall Study|Adverse event or death|1|||
155426303|NCT00481065|560988098|FG007|Overall Study|Adverse event or death|1|||
155426304|NCT00481065|560988091|FG000|Overall Study|Withdrawal by Subject|11|||
155426305|NCT00481065|560988092|FG001|Overall Study|Withdrawal by Subject|12|||
155426306|NCT00481065|560988093|FG002|Overall Study|Withdrawal by Subject|7|||
155426307|NCT00481065|560988094|FG003|Overall Study|Withdrawal by Subject|11|||
155426308|NCT00481065|560988095|FG004|Overall Study|Withdrawal by Subject|13|||
155426309|NCT00481065|560988096|FG005|Overall Study|Withdrawal by Subject|12|||
155426310|NCT00481065|560988097|FG006|Overall Study|Withdrawal by Subject|9|||
155426311|NCT00481065|560988098|FG007|Overall Study|Withdrawal by Subject|10|||
155426312|NCT00481065|560988091|FG000|Overall Study|Lost to Follow-up|4|||
155426313|NCT00481065|560988092|FG001|Overall Study|Lost to Follow-up|2|||
155426314|NCT00481065|560988093|FG002|Overall Study|Lost to Follow-up|4|||
155426315|NCT00481065|560988094|FG003|Overall Study|Lost to Follow-up|3|||
155426316|NCT00481065|560988095|FG004|Overall Study|Lost to Follow-up|3|||
155426317|NCT00481065|560988096|FG005|Overall Study|Lost to Follow-up|3|||
155426318|NCT00481065|560988097|FG006|Overall Study|Lost to Follow-up|2|||
155426319|NCT00481065|560988098|FG007|Overall Study|Lost to Follow-up|5|||
155426320|NCT00481065|560988091|FG000|Overall Study|Inappropriate enrollment|4|||
155426321|NCT00481065|560988092|FG001|Overall Study|Inappropriate enrollment|0|||
155426322|NCT00481065|560988093|FG002|Overall Study|Inappropriate enrollment|2|||
155353195|NCT02132117|560727871|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155353196|NCT03589300|560727873|FG000|Overall Study|Adverse Event|2|||
155426323|NCT00481065|560988094|FG003|Overall Study|Inappropriate enrollment|0|||
155426324|NCT00481065|560988095|FG004|Overall Study|Inappropriate enrollment|2|||
155426325|NCT00481065|560988096|FG005|Overall Study|Inappropriate enrollment|1|||
155426326|NCT00481065|560988097|FG006|Overall Study|Inappropriate enrollment|0|||
155426327|NCT00481065|560988098|FG007|Overall Study|Inappropriate enrollment|1|||
155426328|NCT00481065|560988091|FG000|Overall Study|Administrative reason|0|||
155426329|NCT00481065|560988092|FG001|Overall Study|Administrative reason|0|||
155426330|NCT00481065|560988093|FG002|Overall Study|Administrative reason|0|||
155426331|NCT00481065|560988094|FG003|Overall Study|Administrative reason|0|||
155426332|NCT00481065|560988095|FG004|Overall Study|Administrative reason|0|||
155426333|NCT00481065|560988096|FG005|Overall Study|Administrative reason|2|||
155353197|NCT03589300|560727873|FG000|Overall Study|Death|4|||
155353198|NCT03589300|560727873|FG000|Overall Study|Lost to Follow-up|12|||
155353199|NCT03589300|560727873|FG000|Overall Study|Withdrawal by Subject|5|||
155353200|NCT04947436|560727874|FG000|Overall Study|Lost to Follow-up|3|||
155353201|NCT04947436|560727875|FG001|Overall Study|Lost to Follow-up|7|||
155353202|NCT04947436|560727876|FG002|Overall Study|Lost to Follow-up|5|||
155353203|NCT04947436|560727874|FG000|Overall Study|Death|1|||
155353204|NCT04947436|560727875|FG001|Overall Study|Death|1|||
155353205|NCT04947436|560727876|FG002|Overall Study|Death|1|||
155353206|NCT02551692|560727879|FG000|Overall Study|Lost to Follow-up|0|||
155353207|NCT02551692|560727880|FG001|Overall Study|Lost to Follow-up|1|||
155353208|NCT02551692|560727881|FG002|Overall Study|Lost to Follow-up|4|||
155353209|NCT02551692|560727879|FG000|Overall Study|Withdrawal by Subject|1|||
155353210|NCT02551692|560727880|FG001|Overall Study|Withdrawal by Subject|0|||
155353211|NCT02551692|560727881|FG002|Overall Study|Withdrawal by Subject|1|||
155353212|NCT01196741|560727882|FG000|Overall Study|Disease progression|34|||
155353213|NCT01196741|560727883|FG001|Overall Study|Disease progression|14|||
155353214|NCT01196741|560727882|FG000|Overall Study|Adverse Event|10|||
155353215|NCT01196741|560727883|FG001|Overall Study|Adverse Event|6|||
155353216|NCT01196741|560727882|FG000|Overall Study|Serious Adverse Event|3|||
155353217|NCT01196741|560727883|FG001|Overall Study|Serious Adverse Event|1|||
155353218|NCT01196741|560727882|FG000|Overall Study|Dose limiting Adverse Event|2|||
155353219|NCT01196741|560727883|FG001|Overall Study|Dose limiting Adverse Event|1|||
155353220|NCT01196741|560727882|FG000|Overall Study|Withdrawal by Subject|3|||
155353221|NCT01196741|560727883|FG001|Overall Study|Withdrawal by Subject|0|||
155353222|NCT01196741|560727882|FG000|Overall Study|Other reason|3|||
155353223|NCT01196741|560727883|FG001|Overall Study|Other reason|3|||
155353224|NCT01196741|560727882|FG000|Overall Study|Other|3|||
155353225|NCT01196741|560727883|FG001|Overall Study|Other|2|||
155353226|NCT01196741|560727882|FG000|Overall Study|Protocol Violation|2|||
155353227|NCT01196741|560727883|FG001|Overall Study|Protocol Violation|1|||
155353228|NCT04582864|560727884|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
155353229|NCT04582864|560727884|FG000|Overall Study|Death|1|||
155353230|NCT03640754|560727885|FG000|Overall Study|Withdrawal by Subject|1|||
155353231|NCT03640754|560727886|FG001|Overall Study|Withdrawal by Subject|0|||
155353232|NCT03640754|560727885|FG000|Overall Study|Lost to Follow-up|0|||
155353233|NCT03640754|560727886|FG001|Overall Study|Lost to Follow-up|1|||
155353234|NCT01679613|560727889|FG000|Overall Study|other than stated above|0|||
155353235|NCT01679613|560727890|FG001|Overall Study|other than stated above|1|||
155353236|NCT01679613|560727891|FG002|Overall Study|other than stated above|2|||
155353237|NCT01679613|560727892|FG003|Overall Study|other than stated above|2|||
155426334|NCT00481065|560988097|FG006|Overall Study|Administrative reason|1|||
155426335|NCT00481065|560988098|FG007|Overall Study|Administrative reason|0|||
155426336|NCT00481065|560988091|FG000|Overall Study|Protocol Violation|2|||
155426337|NCT00481065|560988092|FG001|Overall Study|Protocol Violation|1|||
155426338|NCT00481065|560988093|FG002|Overall Study|Protocol Violation|1|||
155426339|NCT00481065|560988094|FG003|Overall Study|Protocol Violation|1|||
155426340|NCT00481065|560988095|FG004|Overall Study|Protocol Violation|2|||
155426341|NCT00481065|560988096|FG005|Overall Study|Protocol Violation|6|||
155426342|NCT00481065|560988097|FG006|Overall Study|Protocol Violation|3|||
155426343|NCT00481065|560988098|FG007|Overall Study|Protocol Violation|2|||
155426344|NCT00481065|560988091|FG000|Overall Study|Unable to classify|0|||
155426345|NCT00481065|560988092|FG001|Overall Study|Unable to classify|1|||
155426346|NCT00481065|560988093|FG002|Overall Study|Unable to classify|2|||
155426347|NCT00481065|560988094|FG003|Overall Study|Unable to classify|0|||
155426348|NCT00481065|560988095|FG004|Overall Study|Unable to classify|1|||
155426349|NCT00481065|560988096|FG005|Overall Study|Unable to classify|0|||
155426350|NCT00481065|560988097|FG006|Overall Study|Unable to classify|0|||
155426351|NCT00481065|560988098|FG007|Overall Study|Unable to classify|0|||
155426352|NCT03094195|560988104|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
155426353|NCT03094195|560988105|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
155426354|NCT03094195|560988106|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
155426355|NCT03094195|560988107|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155426356|NCT03094195|560988108|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155426357|NCT03094195|560988109|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155426358|NCT03094195|560988110|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155426359|NCT03094195|560988111|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155426360|NCT03094195|560988104|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
155426361|NCT03094195|560988105|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
155426362|NCT03094195|560988106|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
155426363|NCT03094195|560988107|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155426364|NCT03094195|560988108|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155648561|NCT00799864|561805842|FG001|Overall Study|Other|1|||
155353238|NCT01932762|560729558|FG000|Overall Study|Withdrawal by Subject|1|||
155353239|NCT01932762|560729559|FG001|Overall Study|Withdrawal by Subject|2|||
155353240|NCT01932762|560729560|FG002|Overall Study|Withdrawal by Subject|0|||
155353241|NCT01932762|560729561|FG003|Overall Study|Withdrawal by Subject|0|||
155353242|NCT01932762|560729558|FG000|Overall Study|Lost to Follow-up|4|||
155353243|NCT01932762|560729559|FG001|Overall Study|Lost to Follow-up|0|||
155353244|NCT01932762|560729560|FG002|Overall Study|Lost to Follow-up|0|||
155353245|NCT01932762|560729561|FG003|Overall Study|Lost to Follow-up|1|||
155353246|NCT01932762|560729558|FG000|Overall Study|Physician Decision|1|||
155353247|NCT01932762|560729559|FG001|Overall Study|Physician Decision|0|||
155353248|NCT01932762|560729560|FG002|Overall Study|Physician Decision|0|||
155353249|NCT01932762|560729561|FG003|Overall Study|Physician Decision|0|||
155353250|NCT02210208|560729562|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
155353251|NCT02210208|560729562|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
155648562|NCT00799864|561805843|FG002|Overall Study|Other|0|||
155648563|NCT00799864|561805844|FG003|Overall Study|Other|0|||
155648564|NCT00799864|561805845|FG004|Overall Study|Other|0|||
155648565|NCT00079781|561805846|FG000|Pre-implant Period|Withdrawal by Subject|2|||
155648566|NCT00079781|561805847|FG001|Pre-implant Period|Withdrawal by Subject|0|||
155648567|NCT00079781|561805848|FG002|Pre-implant Period|Withdrawal by Subject|0|||
155648568|NCT00079781|561805846|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
155648569|NCT00079781|561805847|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
155648570|NCT00079781|561805848|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
155648571|NCT00079781|561805846|FG000|Follow-up Period|Withdrawal by Subject|3|||
155648572|NCT00079781|561805847|FG001|Follow-up Period|Withdrawal by Subject|0|||
155648573|NCT00079781|561805848|FG002|Follow-up Period|Withdrawal by Subject|1|||
155648574|NCT00079781|561805846|FG000|Follow-up Period|Lost to Follow-up|1|||
155648575|NCT00079781|561805847|FG001|Follow-up Period|Lost to Follow-up|0|||
155648576|NCT00079781|561805848|FG002|Follow-up Period|Lost to Follow-up|0|||
155648577|NCT00079781|561805846|FG000|Follow-up Period|Death|0|||
155648578|NCT00079781|561805847|FG001|Follow-up Period|Death|0|||
155648579|NCT00079781|561805848|FG002|Follow-up Period|Death|1|||
155648580|NCT00225758|561805849|FG000|Overall Study|Adverse Event|4|||
155648581|NCT00576407|561805850|FG000|Overall Study|Death|7|||
155648582|NCT00576407|561805850|FG000|Overall Study|Physician Decision|1|||
155648583|NCT00621322|561805851|FG000|Overall Study|Lost to Follow-up|0|||
155648584|NCT00621322|561805852|FG001|Overall Study|Lost to Follow-up|0|||
155648585|NCT00621322|561805853|FG002|Overall Study|Lost to Follow-up|0|||
155648586|NCT00621322|561805854|FG003|Overall Study|Lost to Follow-up|0|||
155648587|NCT00621322|561805855|FG004|Overall Study|Lost to Follow-up|1|||
155648588|NCT00621322|561805856|FG005|Overall Study|Lost to Follow-up|0|||
155648589|NCT00621322|561805851|FG000|Overall Study|Physician Decision|0|||
155648590|NCT00621322|561805852|FG001|Overall Study|Physician Decision|0|||
155648591|NCT00621322|561805853|FG002|Overall Study|Physician Decision|1|||
155648592|NCT00621322|561805854|FG003|Overall Study|Physician Decision|1|||
155648593|NCT00621322|561805855|FG004|Overall Study|Physician Decision|0|||
155648594|NCT00621322|561805856|FG005|Overall Study|Physician Decision|0|||
155648595|NCT00621322|561805851|FG000|Overall Study|Withdrawal by Subject|0|||
155648596|NCT00621322|561805852|FG001|Overall Study|Withdrawal by Subject|0|||
155648597|NCT00621322|561805853|FG002|Overall Study|Withdrawal by Subject|0|||
155648598|NCT00621322|561805854|FG003|Overall Study|Withdrawal by Subject|1|||
155648599|NCT00621322|561805855|FG004|Overall Study|Withdrawal by Subject|0|||
155648600|NCT00621322|561805856|FG005|Overall Study|Withdrawal by Subject|2|||
155648601|NCT00621322|561805851|FG000|Overall Study|Migrated/moved from study area|1|||
155648602|NCT00621322|561805852|FG001|Overall Study|Migrated/moved from study area|0|||
155648603|NCT00621322|561805853|FG002|Overall Study|Migrated/moved from study area|1|||
155648604|NCT00621322|561805854|FG003|Overall Study|Migrated/moved from study area|1|||
155648605|NCT00621322|561805855|FG004|Overall Study|Migrated/moved from study area|0|||
155648606|NCT00621322|561805856|FG005|Overall Study|Migrated/moved from study area|2|||
155648607|NCT01657500|561805858|FG000|Overall Study|set impropperly matched|3|||
155353252|NCT02210208|560729562|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
155353253|NCT00695136|560729563|FG000|Overall Study|Withdrawal by Subject|1|||
155353254|NCT00695136|560729563|FG000|Overall Study|unrelated adverse event|1|||
155648608|NCT01657500|561805859|FG001|Overall Study|set impropperly matched|3|||
155648609|NCT01657500|561805858|FG000|Overall Study|Lost to Follow-up|2|||
155353255|NCT01726049|560729565|FG000|Overall Study|Death|1|||
155648610|NCT01657500|561805859|FG001|Overall Study|Lost to Follow-up|2|||
155648611|NCT00552279|561805863|FG000|Overall Study|Adverse Event|0|||
155648612|NCT00552279|561805864|FG001|Overall Study|Adverse Event|1|||
155648613|NCT00552279|561805863|FG000|Overall Study|Withdrawal by Subject|12|||
155353256|NCT01726049|560729566|FG001|Overall Study|Death|1|||
155353257|NCT01726049|560729565|FG000|Overall Study|Adverse Event|4|||
155353258|NCT01726049|560729566|FG001|Overall Study|Adverse Event|1|||
155648614|NCT00552279|561805864|FG001|Overall Study|Withdrawal by Subject|1|||
155648615|NCT00552279|561805863|FG000|Overall Study|Lost to Follow-up|1|||
155648616|NCT00552279|561805864|FG001|Overall Study|Lost to Follow-up|0|||
155648617|NCT00552279|561805863|FG000|Overall Study|Other|1|||
155648618|NCT00552279|561805864|FG001|Overall Study|Other|1|||
155353259|NCT01726049|560729565|FG000|Overall Study|refused second HC|0|||
155353260|NCT01726049|560729566|FG001|Overall Study|refused second HC|2|||
155353261|NCT01333111|560729569|FG000|Overall Study|patient undergoing major surgery|0|||
155353262|NCT01333111|560729570|FG001|Overall Study|patient undergoing major surgery|2|||
155353263|NCT01333111|560729571|FG002|Overall Study|patient undergoing major surgery|0|||
155353264|NCT01333111|560729569|FG000|Overall Study|personal reasons|0|||
155353265|NCT01333111|560729570|FG001|Overall Study|personal reasons|0|||
155353266|NCT01333111|560729571|FG002|Overall Study|personal reasons|1|||
155353267|NCT01333111|560729569|FG000|Overall Study|unclassified|1|||
155353268|NCT01333111|560729570|FG001|Overall Study|unclassified|0|||
155353269|NCT01333111|560729571|FG002|Overall Study|unclassified|0|||
155353270|NCT01333111|560729569|FG000|Overall Study|withdrawal criteria|0|||
155353271|NCT01333111|560729570|FG001|Overall Study|withdrawal criteria|1|||
155353272|NCT01333111|560729571|FG002|Overall Study|withdrawal criteria|0|||
155353273|NCT01333111|560729569|FG000|Overall Study|Non-compliance|1|||
155353274|NCT01333111|560729570|FG001|Overall Study|Non-compliance|0|||
155353275|NCT01333111|560729571|FG002|Overall Study|Non-compliance|0|||
155353276|NCT01333111|560729569|FG000|Overall Study|Ineffective therapy|0|||
155353277|NCT01333111|560729570|FG001|Overall Study|Ineffective therapy|0|||
155353278|NCT01333111|560729571|FG002|Overall Study|Ineffective therapy|1|||
155353279|NCT02161406|560729572|FG000|Overall Study|Death|2|||
155353280|NCT02161406|560729573|FG001|Overall Study|Death|1|||
155353281|NCT02161406|560729572|FG000|Overall Study|Lost to Follow-up|2|||
155353282|NCT02161406|560729573|FG001|Overall Study|Lost to Follow-up|1|||
155353283|NCT02161406|560729572|FG000|Overall Study|Withdrawal by Subject|2|||
155353284|NCT02161406|560729573|FG001|Overall Study|Withdrawal by Subject|4|||
155353285|NCT02161406|560729572|FG000|Overall Study|investigator withdrew subject|3|||
155353286|NCT02161406|560729573|FG001|Overall Study|investigator withdrew subject|1|||
155353287|NCT02161406|560729572|FG000|Overall Study|Lack of Efficacy|1|||
155353288|NCT02161406|560729573|FG001|Overall Study|Lack of Efficacy|1|||
155353289|NCT02161406|560729572|FG000|Overall Study|relocation|0|||
155353290|NCT02161406|560729573|FG001|Overall Study|relocation|1|||
155353291|NCT00664105|560729574|FG000|Overall Study|Death|3|||
155353292|NCT00664105|560729574|FG000|Overall Study|Withdrawal by Subject|5|||
155353293|NCT00664105|560729574|FG000|Overall Study|Adverse Event|9|||
155353294|NCT00664105|560729574|FG000|Overall Study|Disease progression|7|||
155353295|NCT00847132|560729578|FG000|Overall Study|Death|1|||
155353296|NCT00847132|560729579|FG001|Overall Study|Death|1|||
155353297|NCT01057251|560729580|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
155353298|NCT01057251|560729581|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
155353299|NCT01057251|560729580|FG000|Overall Study|Adverse Event|4|||
155353300|NCT01057251|560729581|FG001|Overall Study|Adverse Event|2|||
155353301|NCT01057251|560729580|FG000|Overall Study|Lack of Efficacy|2|||
155353302|NCT01057251|560729581|FG001|Overall Study|Lack of Efficacy|11|||
155353303|NCT01057251|560729580|FG000|Overall Study|Protocol Violation|6|||
155426365|NCT03094195|560988109|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155426366|NCT03094195|560988110|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155426367|NCT03094195|560988111|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155353304|NCT01057251|560729581|FG001|Overall Study|Protocol Violation|2|||
155353305|NCT01057251|560729580|FG000|Overall Study|Withdrawal by Subject|4|||
155353306|NCT01057251|560729581|FG001|Overall Study|Withdrawal by Subject|5|||
155353307|NCT01057251|560729580|FG000|Overall Study|Lost to Follow-up|7|||
155353308|NCT01057251|560729581|FG001|Overall Study|Lost to Follow-up|6|||
155353309|NCT01057251|560729580|FG000|Overall Study|Other Reason|1|||
155353310|NCT01057251|560729581|FG001|Overall Study|Other Reason|1|||
155426368|NCT03094195|560988104|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426369|NCT03094195|560988105|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155353311|NCT00784147|560729582|FG000|Overall Study|Lost to Follow-up|2|||
155353312|NCT00784147|560729583|FG001|Overall Study|Lost to Follow-up|4|||
155353313|NCT00784147|560729582|FG000|Overall Study|Withdrawal by Subject|1|||
155353314|NCT00784147|560729583|FG001|Overall Study|Withdrawal by Subject|3|||
155353315|NCT00784147|560729582|FG000|Overall Study|Physician Decision|2|||
155353316|NCT00784147|560729583|FG001|Overall Study|Physician Decision|1|||
155353317|NCT00784147|560729582|FG000|Overall Study|Protocol Violation|1|||
155353318|NCT00784147|560729583|FG001|Overall Study|Protocol Violation|1|||
155353319|NCT00784147|560729582|FG000|Overall Study|Death|2|||
155353320|NCT00784147|560729583|FG001|Overall Study|Death|0|||
155353321|NCT03596242|560729584|FG000|Overall Study|Lost to Follow-up|2|||
155353322|NCT03596242|560729585|FG001|Overall Study|Lost to Follow-up|2|||
155353323|NCT02973802|560729591|FG000|Overall Study|Lost to Follow-up|1|||
155353324|NCT02973802|560729591|FG000|Overall Study|Withdrawal by Subject|1|||
155353325|NCT03357471|560729592|FG000|Overall Study|Adverse Event|1|||
155353326|NCT03357471|560729593|FG001|Overall Study|Adverse Event|0|||
155353327|NCT03357471|560729592|FG000|Overall Study|Lost to Follow-up|1|||
155353328|NCT03357471|560729593|FG001|Overall Study|Lost to Follow-up|0|||
155353329|NCT01202409|560729594|FG000|Overall Study|Adverse Event|1|||
155353330|NCT01202409|560729594|FG000|Overall Study|Ineligible - KRAS mutants|7|||
155353331|NCT00292981|560729599|FG000|Overall Study|Adverse Event|1|||
155353332|NCT00292981|560729599|FG000|Overall Study|Lost to Follow-up|13|||
155353333|NCT00292981|560729599|FG000|Overall Study|Withdrawal by Subject|22|||
155353334|NCT00292981|560729599|FG000|Overall Study|Other|3|||
155353335|NCT01085812|560729600|FG000|Open-Label Period|Adverse Event|0|||
155353336|NCT01085812|560729601|FG001|Open-Label Period|Adverse Event|80|||
155353337|NCT01085812|560729600|FG000|Open-Label Period|Lack of Efficacy|0|||
155353338|NCT01085812|560729601|FG001|Open-Label Period|Lack of Efficacy|26|||
155353339|NCT01085812|560729600|FG000|Open-Label Period|Protocol Violation|0|||
155353340|NCT01085812|560729601|FG001|Open-Label Period|Protocol Violation|39|||
155353341|NCT01085812|560729600|FG000|Open-Label Period|Withdrawal by Subject|0|||
155353342|NCT01085812|560729601|FG001|Open-Label Period|Withdrawal by Subject|53|||
155353343|NCT01085812|560729600|FG000|Open-Label Period|Lost to Follow-up|0|||
155353344|NCT01085812|560729601|FG001|Open-Label Period|Lost to Follow-up|42|||
155353345|NCT01085812|560729600|FG000|Double-Blind Period|Adverse Event|3|||
155353346|NCT01085812|560729601|FG001|Double-Blind Period|Adverse Event|8|||
155353347|NCT01085812|560729600|FG000|Double-Blind Period|Protocol Violation|2|||
155353348|NCT01085812|560729601|FG001|Double-Blind Period|Protocol Violation|7|||
155353349|NCT01085812|560729600|FG000|Double-Blind Period|Withdrawal by Subject|11|||
155353350|NCT01085812|560729601|FG001|Double-Blind Period|Withdrawal by Subject|24|||
155353351|NCT01085812|560729600|FG000|Double-Blind Period|Lost to Follow-up|5|||
155353352|NCT01085812|560729601|FG001|Double-Blind Period|Lost to Follow-up|17|||
155353353|NCT01085812|560729600|FG000|Double-Blind Period|Other Reasons|0|||
155353354|NCT01085812|560729601|FG001|Double-Blind Period|Other Reasons|2|||
155353355|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
155353356|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
155353357|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
155353358|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
155353359|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
155353360|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
155353361|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
155353362|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
155353363|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
155353364|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
155353365|NCT00594178|560729604|FG000|Overall Study|Physician Decision|5|||
155353366|NCT04582669|560729607|FG000|Overall Study|Subject missed appointment(s).|1|||
155353367|NCT04582669|560729608|FG001|Overall Study|Subject missed appointment(s).|0|||
155353368|NCT04582669|560729609|FG002|Overall Study|Subject missed appointment(s).|1|||
155353369|NCT04582669|560729610|FG003|Overall Study|Subject missed appointment(s).|2|||
155353370|NCT04582669|560729607|FG000|Overall Study|Protocol Violation|0|||
155353371|NCT04582669|560729608|FG001|Overall Study|Protocol Violation|1|||
155353372|NCT04582669|560729609|FG002|Overall Study|Protocol Violation|1|||
155506777|NCT02496221|561283441|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
155353373|NCT04582669|560729610|FG003|Overall Study|Protocol Violation|0|||
155353374|NCT01274559|560729611|FG000|Overall Study|Adverse Event|57|||
155353375|NCT01274559|560729612|FG001|Overall Study|Adverse Event|13|||
155353376|NCT01274559|560729611|FG000|Overall Study|Death|1|||
155353377|NCT01274559|560729612|FG001|Overall Study|Death|1|||
155353378|NCT01274559|560729611|FG000|Overall Study|Lost to Follow-up|3|||
155353379|NCT01274559|560729612|FG001|Overall Study|Lost to Follow-up|3|||
155506778|NCT02496221|561283440|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
155506779|NCT02496221|561283441|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
155648619|NCT02453191|561805865|FG000|Overall Study|Withdrawal by Subject|1|||
155648620|NCT01520714|561805866|FG000|Overall Study|Protocol Violation|0|||
155648621|NCT01520714|561805867|FG001|Overall Study|Protocol Violation|3|||
155648622|NCT01520714|561805866|FG000|Overall Study|Adverse Event|0|||
155648623|NCT01520714|561805867|FG001|Overall Study|Adverse Event|2|||
155648624|NCT01520714|561805866|FG000|Overall Study|Lack of Efficacy|0|||
155648625|NCT01520714|561805867|FG001|Overall Study|Lack of Efficacy|1|||
155648626|NCT01210443|561805870|FG000|Overall Study|Study terminated by sponsor|2|||
155648627|NCT02807181|561805873|FG000|Overall Study|Death|28|||
155648628|NCT02807181|561805874|FG001|Overall Study|Death|24|||
155648629|NCT02807181|561805873|FG000|Overall Study|Withdrawal by Subject|1|||
155648630|NCT02807181|561805874|FG001|Overall Study|Withdrawal by Subject|1|||
155648631|NCT02807181|561805873|FG000|Overall Study|Lost to Follow-up|0|||
155648632|NCT02807181|561805874|FG001|Overall Study|Lost to Follow-up|2|||
155648633|NCT02807181|561805873|FG000|Overall Study|Subject decision|1|||
155648634|NCT02807181|561805874|FG001|Overall Study|Subject decision|0|||
155648635|NCT02807181|561805873|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
155353380|NCT01274559|560729611|FG000|Overall Study|Non-compliance with Study Drug|2|||
155353381|NCT01274559|560729612|FG001|Overall Study|Non-compliance with Study Drug|4|||
155353382|NCT01274559|560729611|FG000|Overall Study|Physician Decision|2|||
155353383|NCT01274559|560729612|FG001|Overall Study|Physician Decision|1|||
155353384|NCT01274559|560729611|FG000|Overall Study|Protocol Violation|28|||
155353385|NCT01274559|560729612|FG001|Overall Study|Protocol Violation|23|||
155353386|NCT01274559|560729611|FG000|Overall Study|Study Terminated by Sponsor|79|||
155353387|NCT01274559|560729612|FG001|Overall Study|Study Terminated by Sponsor|87|||
155353388|NCT01274559|560729611|FG000|Overall Study|Withdrawal by Subject|25|||
155353389|NCT01274559|560729612|FG001|Overall Study|Withdrawal by Subject|13|||
155353390|NCT01167192|560729615|FG000|Overall Study|Adverse Event|1|||
155353391|NCT01167192|560729615|FG000|Overall Study|Death|1|||
155353392|NCT01167192|560729615|FG000|Overall Study|Withdrawal by Subject|1|||
155353393|NCT01167192|560729615|FG000|Overall Study|Insurance denial|1|||
155353394|NCT02482935|560729629|FG000|Period 1|Withdrawal by Subject|1|||
155353395|NCT02482935|560729630|FG001|Period 1|Withdrawal by Subject|0|||
155353396|NCT03503162|560729631|FG000|Overall Study|did not meet eligibility|1|||
155353397|NCT02835092|560729632|FG000|Overall Study|Withdrawal by Subject|3|||
155353398|NCT02835092|560729633|FG001|Overall Study|Withdrawal by Subject|6|||
155353399|NCT02835092|560729634|FG002|Overall Study|Withdrawal by Subject|3|||
155353400|NCT02835092|560729632|FG000|Overall Study|Lost to Follow-up|0|||
155353401|NCT02835092|560729633|FG001|Overall Study|Lost to Follow-up|2|||
155353402|NCT02835092|560729634|FG002|Overall Study|Lost to Follow-up|0|||
155353403|NCT02246218|560729635|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155353404|NCT02246218|560729636|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155353405|NCT02246218|560729635|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
155353406|NCT02246218|560729636|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
155353407|NCT02246218|560729635|FG000|Overall Study|Adverse Event|1|||
155353408|NCT02246218|560729636|FG001|Overall Study|Adverse Event|1|||
155353409|NCT02246218|560729635|FG000|Overall Study|Lost to Follow-up|1|||
155353410|NCT02246218|560729636|FG001|Overall Study|Lost to Follow-up|0|||
155353411|NCT01321723|560729637|FG000|Overall Study|Adverse Event|3|||
155353412|NCT01321723|560729638|FG001|Overall Study|Adverse Event|5|||
155353413|NCT01321723|560729639|FG002|Overall Study|Adverse Event|2|||
155353414|NCT01321723|560729637|FG000|Overall Study|Withdrawal by Subject|2|||
155353415|NCT01321723|560729638|FG001|Overall Study|Withdrawal by Subject|0|||
155353416|NCT01321723|560729639|FG002|Overall Study|Withdrawal by Subject|2|||
155353417|NCT02561806|560729640|FG000|Induction Period|Adverse Event|0|||
155353418|NCT02561806|560729641|FG001|Induction Period|Adverse Event|2|||
155353419|NCT02561806|560729640|FG000|Induction Period|Lack of Efficacy|1|||
155353420|NCT02561806|560729641|FG001|Induction Period|Lack of Efficacy|0|||
155353421|NCT02561806|560729640|FG000|Induction Period|Withdrawal by Subject|0|||
155648636|NCT02807181|561805874|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
155648637|NCT02807181|561805873|FG000|Overall Study|In Study|3|||
155648638|NCT02807181|561805874|FG001|Overall Study|In Study|3|||
155353422|NCT02561806|560729641|FG001|Induction Period|Withdrawal by Subject|2|||
155353423|NCT02561806|560729640|FG000|Induction Period|Site staff became unblinded|1|||
155648639|NCT02807181|561805873|FG000|Overall Study|Post Progression|3|||
155648640|NCT02807181|561805874|FG001|Overall Study|Post Progression|2|||
155648641|NCT01489358|561805875|FG000|Overall Study|Lost to Follow-up|0|||
155506780|NCT02496221|561283440|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
155506781|NCT02496221|561283441|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
155506782|NCT01335399|561283442|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
155506783|NCT01335399|561283443|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
155506784|NCT01335399|561283442|FG000|Pre-treatment Period|Participant request to discontinue|0|||
155506785|NCT01335399|561283443|FG001|Pre-treatment Period|Participant request to discontinue|1|||
155506786|NCT01335399|561283442|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
155506787|NCT01335399|561283443|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
155506788|NCT01335399|561283442|FG000|Pre-treatment Period|Consent withdrawal|3|||
155506789|NCT01335399|561283443|FG001|Pre-treatment Period|Consent withdrawal|0|||
155506790|NCT01335399|561283442|FG000|Treatment Period|Disease progression|117|||
155506791|NCT01335399|561283443|FG001|Treatment Period|Disease progression|145|||
155506792|NCT01335399|561283442|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
155506793|NCT01335399|561283443|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
155506794|NCT01335399|561283442|FG000|Treatment Period|Study drug toxicity|52|||
155506795|NCT01335399|561283443|FG001|Treatment Period|Study drug toxicity|64|||
155506796|NCT01335399|561283442|FG000|Treatment Period|Participant request to discontinue|30|||
155506797|NCT01335399|561283443|FG001|Treatment Period|Participant request to discontinue|22|||
155506798|NCT01335399|561283442|FG000|Treatment Period|Other reasons|30|||
155353424|NCT02561806|560729641|FG001|Induction Period|Site staff became unblinded|0|||
155353425|NCT02561806|560729640|FG000|Induction Period|Randomized but not treated|0|||
155353426|NCT02561806|560729641|FG001|Induction Period|Randomized but not treated|1|||
155353427|NCT02561806|560729640|FG000|Maintenance Period|Adverse Event|2|||
155353428|NCT02561806|560729641|FG001|Maintenance Period|Adverse Event|1|||
155353429|NCT02561806|560729640|FG000|Maintenance Period|Lack of Efficacy|3|||
155353430|NCT02561806|560729641|FG001|Maintenance Period|Lack of Efficacy|1|||
155353431|NCT02561806|560729640|FG000|Maintenance Period|Lost to Follow-up|2|||
155353432|NCT02561806|560729641|FG001|Maintenance Period|Lost to Follow-up|2|||
155353433|NCT02561806|560729640|FG000|Maintenance Period|Protocol Violation|1|||
155353434|NCT02561806|560729641|FG001|Maintenance Period|Protocol Violation|0|||
155353435|NCT02561806|560729640|FG000|Maintenance Period|Withdrawal by Subject|5|||
155353436|NCT02561806|560729641|FG001|Maintenance Period|Withdrawal by Subject|3|||
155353437|NCT02561806|560729640|FG000|Maintenance Period|Site staff became unblinded|0|||
155353438|NCT02561806|560729641|FG001|Maintenance Period|Site staff became unblinded|1|||
155353439|NCT02561806|560729640|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
155353440|NCT02561806|560729641|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
155353441|NCT02561806|560729640|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
155353442|NCT02561806|560729641|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
155353443|NCT02547441|560729642|FG000|Double-Blind Study Period|Adverse Event|4|||
155353444|NCT02547441|560729643|FG001|Double-Blind Study Period|Adverse Event|9|||
155353445|NCT02547441|560729642|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
155353446|NCT02547441|560729643|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
155353447|NCT02547441|560729642|FG000|Double-Blind Study Period|Physician Decision|1|||
155353448|NCT02547441|560729643|FG001|Double-Blind Study Period|Physician Decision|0|||
155353449|NCT02547441|560729642|FG000|Double-Blind Study Period|Protocol Violation|1|||
155353450|NCT02547441|560729643|FG001|Double-Blind Study Period|Protocol Violation|2|||
155353451|NCT02547441|560729642|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
155353452|NCT02547441|560729643|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
155353453|NCT02547441|560729642|FG000|Double-Blind Study Period|Sponsor Decision|1|||
155353454|NCT02547441|560729643|FG001|Double-Blind Study Period|Sponsor Decision|0|||
155353455|NCT02547441|560729642|FG000|Open-Label Study Period|Adverse Event|10|||
155353456|NCT02547441|560729643|FG001|Open-Label Study Period|Adverse Event|11|||
155353457|NCT02547441|560729642|FG000|Open-Label Study Period|Lack of Efficacy|3|||
155353458|NCT02547441|560729643|FG001|Open-Label Study Period|Lack of Efficacy|2|||
155353459|NCT02547441|560729642|FG000|Open-Label Study Period|Lost to Follow-up|7|||
155353460|NCT02547441|560729643|FG001|Open-Label Study Period|Lost to Follow-up|8|||
155353461|NCT02547441|560729642|FG000|Open-Label Study Period|Physician Decision|1|||
155353462|NCT02547441|560729643|FG001|Open-Label Study Period|Physician Decision|0|||
155353463|NCT02547441|560729642|FG000|Open-Label Study Period|Protocol Violation|2|||
155353464|NCT02547441|560729643|FG001|Open-Label Study Period|Protocol Violation|0|||
155353465|NCT02547441|560729642|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
155353466|NCT02547441|560729643|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
155353467|NCT02547441|560729642|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
155648642|NCT01489358|561805876|FG001|Overall Study|Lost to Follow-up|0|||
155353468|NCT02547441|560729643|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
155353469|NCT01322009|560729644|FG000|Overall Study|Death|0|||
155353470|NCT01322009|560729645|FG001|Overall Study|Death|1|||
155426370|NCT03094195|560988106|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
155426371|NCT03094195|560988107|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426372|NCT03094195|560988108|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426373|NCT03094195|560988109|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426374|NCT03094195|560988110|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426375|NCT03094195|560988111|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155426376|NCT03094195|560988104|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426377|NCT03094195|560988105|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
155426378|NCT03094195|560988106|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
155426379|NCT03094195|560988107|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426380|NCT03094195|560988108|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426381|NCT03094195|560988109|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426382|NCT03094195|560988110|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426383|NCT03094195|560988111|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155426384|NCT01957137|560988112|FG000|Randomized Portion|Adverse Event|1|||
155426385|NCT01957137|560988112|FG000|Randomized Portion|Withdrawal by Subject|1|||
155426386|NCT00054132|560988113|FG000|Overall Study|Not Treated|1|||
155426387|NCT01795547|560988118|FG000|Overall Study|Adverse Event|16|||
155426388|NCT01795547|560988119|FG001|Overall Study|Adverse Event|27|||
155426389|NCT01795547|560988118|FG000|Overall Study|Lack of Efficacy|8|||
155426390|NCT01795547|560988119|FG001|Overall Study|Lack of Efficacy|3|||
155426391|NCT01795547|560988118|FG000|Overall Study|Protocol Violation|6|||
155426392|NCT01795547|560988119|FG001|Overall Study|Protocol Violation|4|||
155426393|NCT01795547|560988118|FG000|Overall Study|Lost to Follow-up|2|||
155426394|NCT01795547|560988119|FG001|Overall Study|Lost to Follow-up|5|||
155426395|NCT01795547|560988118|FG000|Overall Study|Withdrawal of consent|7|||
155426396|NCT01795547|560988119|FG001|Overall Study|Withdrawal of consent|12|||
155426397|NCT01795547|560988118|FG000|Overall Study|Not Treated|4|||
155426398|NCT01795547|560988119|FG001|Overall Study|Not Treated|10|||
155426399|NCT01795547|560988118|FG000|Overall Study|Non-compliance with IMP|1|||
155426400|NCT01795547|560988119|FG001|Overall Study|Non-compliance with IMP|1|||
155426401|NCT01795547|560988118|FG000|Overall Study|Others|4|||
155426402|NCT01795547|560988119|FG001|Overall Study|Others|1|||
155426403|NCT01795547|560988118|FG000|Overall Study|Not stated|0|||
155426404|NCT01795547|560988119|FG001|Overall Study|Not stated|1|||
155426405|NCT00591734|560988124|FG000|Overall Study|Lack of Efficacy|35|||
155426406|NCT00591734|560988124|FG000|Overall Study|Adverse Event|5|||
155426407|NCT00591734|560988124|FG000|Overall Study|Physician Decision|5|||
155426408|NCT00591734|560988124|FG000|Overall Study|Intercurrent Illness|8|||
155426409|NCT00784758|560988127|FG000|Overall Study|Withdrawal by Subject|3|||
155426410|NCT00784758|560988128|FG001|Overall Study|Withdrawal by Subject|0|||
155426411|NCT00784758|560988127|FG000|Overall Study|Adverse Event|1|||
155426412|NCT00784758|560988128|FG001|Overall Study|Adverse Event|0|||
155426413|NCT02040142|560988129|FG000|Overall Study|Lost to Follow-up|5|||
155426414|NCT02040142|560988129|FG000|Overall Study|Death|17|||
155426415|NCT02040142|560988129|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
155426416|NCT04439331|560988136|FG000|Overall Study|Never Start Protocol Therapy|2|||
155426417|NCT04439331|560988136|FG000|Overall Study|Ineligible|2|||
155426418|NCT04439331|560988136|FG000|Overall Study|Mutation Status Not Confirmed|1|||
155426419|NCT04439331|560988136|FG000|Overall Study|Adverse Event|1|||
155426420|NCT04439331|560988136|FG000|Overall Study|Death|1|||
155426421|NCT04439331|560988136|FG000|Overall Study|Disease Progression|20|||
155353471|NCT01322009|560729644|FG000|Overall Study|Adverse Event|0|||
155353472|NCT01322009|560729645|FG001|Overall Study|Adverse Event|1|||
155353473|NCT01322009|560729644|FG000|Overall Study|ng tube discontinued|0|||
155353474|NCT01322009|560729645|FG001|Overall Study|ng tube discontinued|1|||
155353475|NCT00905034|560729646|FG000|Overall Study|Withdrawal by Subject|1|||
155353476|NCT00394589|560729647|FG000|Overall Study|Adverse Event|2|||
155353477|NCT00394589|560729648|FG001|Overall Study|Adverse Event|1|||
155353478|NCT00394589|560729649|FG002|Overall Study|Adverse Event|2|||
155353479|NCT00394589|560729647|FG000|Overall Study|Lack of Efficacy|2|||
155353480|NCT00394589|560729648|FG001|Overall Study|Lack of Efficacy|2|||
155353481|NCT00394589|560729649|FG002|Overall Study|Lack of Efficacy|3|||
155353482|NCT00394589|560729647|FG000|Overall Study|Protocol Violation|4|||
155353483|NCT00394589|560729648|FG001|Overall Study|Protocol Violation|0|||
155353484|NCT00394589|560729649|FG002|Overall Study|Protocol Violation|2|||
155353485|NCT03409731|560729650|FG000|Overall Study|Withdrawal by Subject|17|||
155353486|NCT03409731|560729650|FG000|Overall Study|Death|4|||
155353487|NCT04545476|560729651|FG000|Overall Study|Lost to Follow-up|1|||
155353488|NCT04545476|560729652|FG001|Overall Study|Lost to Follow-up|1|||
155353489|NCT04545476|560729653|FG002|Overall Study|Lost to Follow-up|0|||
155353490|NCT04545476|560729654|FG003|Overall Study|Lost to Follow-up|0|||
155353491|NCT03175198|560729657|FG000|Overall Study|Adverse Event|480|||
155353492|NCT03175198|560729657|FG000|Overall Study|No actual visit|120|||
155353493|NCT03175198|560729657|FG000|Overall Study|Registration rule not followed|4|||
155353494|NCT03175198|560729657|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
155353495|NCT03175198|560729657|FG000|Overall Study|Other personal reason|509|||
155353496|NCT03175198|560729657|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
155353497|NCT03175198|560729657|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
155353498|NCT03175198|560729657|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
155353499|NCT03175198|560729657|FG000|Overall Study|To conduct invasive treatment of operation|53|||
155353500|NCT03175198|560729657|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
155353501|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
155353502|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
155353503|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
155353504|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
155353505|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
155353506|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
155353507|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Rejections|0|||
155353508|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Rejections|0|||
155353509|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Rejections|55|||
155353510|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
155353511|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
155353512|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
155353513|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
155353514|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
155353515|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
155353516|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Other issues|0|||
155353517|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Other issues|0|||
155353518|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Other issues|6|||
155353519|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
155353520|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
155353521|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
155353522|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Rejection|11|||
155353523|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Rejection|5|||
155353524|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Rejection|0|||
155353525|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Death|2|||
155353526|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Death|5|||
155353527|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Death|0|||
155353528|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
155353529|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
155648643|NCT01489358|561805877|FG002|Overall Study|Lost to Follow-up|2|||
155353530|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
155353531|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
155353532|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
155506799|NCT01335399|561283443|FG001|Treatment Period|Other reasons|30|||
155353533|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
155353534|NCT01193218|560729662|FG000|0-12 Weeks|Adverse Event|6|||
155353535|NCT01193218|560729663|FG001|0-12 Weeks|Adverse Event|0|||
155353536|NCT01193218|560729664|FG002|0-12 Weeks|Adverse Event|1|||
155353537|NCT01193218|560729665|FG003|0-12 Weeks|Adverse Event|0|||
155353538|NCT01193218|560729666|FG004|0-12 Weeks|Adverse Event|0|||
155353539|NCT01193218|560729667|FG005|0-12 Weeks|Adverse Event|2|||
155353540|NCT01193218|560729668|FG006|0-12 Weeks|Adverse Event|2|||
155353541|NCT01193218|560729669|FG007|0-12 Weeks|Adverse Event|0|||
155353542|NCT01193218|560729662|FG000|0-12 Weeks|Protocol Violation|0|||
155353543|NCT01193218|560729663|FG001|0-12 Weeks|Protocol Violation|0|||
155353544|NCT01193218|560729664|FG002|0-12 Weeks|Protocol Violation|0|||
155353545|NCT01193218|560729665|FG003|0-12 Weeks|Protocol Violation|0|||
155353546|NCT01193218|560729666|FG004|0-12 Weeks|Protocol Violation|1|||
155353547|NCT01193218|560729667|FG005|0-12 Weeks|Protocol Violation|1|||
155353548|NCT01193218|560729668|FG006|0-12 Weeks|Protocol Violation|0|||
155353549|NCT01193218|560729669|FG007|0-12 Weeks|Protocol Violation|0|||
155353550|NCT01193218|560729662|FG000|0-12 Weeks|Withdrawal by Subject|3|||
155353551|NCT01193218|560729663|FG001|0-12 Weeks|Withdrawal by Subject|0|||
155353552|NCT01193218|560729664|FG002|0-12 Weeks|Withdrawal by Subject|2|||
155353553|NCT01193218|560729665|FG003|0-12 Weeks|Withdrawal by Subject|0|||
155353554|NCT01193218|560729666|FG004|0-12 Weeks|Withdrawal by Subject|0|||
155353555|NCT01193218|560729667|FG005|0-12 Weeks|Withdrawal by Subject|0|||
155353556|NCT01193218|560729668|FG006|0-12 Weeks|Withdrawal by Subject|1|||
155353557|NCT01193218|560729669|FG007|0-12 Weeks|Withdrawal by Subject|0|||
155353558|NCT01193218|560729662|FG000|12-52 Weeks|Adverse Event|1|||
155353559|NCT01193218|560729663|FG001|12-52 Weeks|Adverse Event|0|||
155353560|NCT01193218|560729664|FG002|12-52 Weeks|Adverse Event|1|||
155353561|NCT01193218|560729665|FG003|12-52 Weeks|Adverse Event|2|||
155353562|NCT01193218|560729666|FG004|12-52 Weeks|Adverse Event|3|||
155353563|NCT01193218|560729667|FG005|12-52 Weeks|Adverse Event|3|||
155353564|NCT01193218|560729668|FG006|12-52 Weeks|Adverse Event|1|||
155353565|NCT01193218|560729669|FG007|12-52 Weeks|Adverse Event|2|||
155426422|NCT04439331|560988136|FG000|Overall Study|Withdrawal by Subject|6|||
155426423|NCT04439331|560988136|FG000|Overall Study|Physician Decision|1|||
155353566|NCT01193218|560729662|FG000|12-52 Weeks|Lack of Efficacy|0|||
155426424|NCT04439331|560988136|FG000|Overall Study|Other Complicating Disease|1|||
155426425|NCT00413959|560988139|FG000|Overall Study|Pt had only one cycle.|1|||
155426426|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
155426427|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
155426428|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
155426429|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
155426430|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
155426431|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
155426432|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
155426433|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
155426434|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
155426435|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
155426436|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
155426437|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
155426438|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
155426439|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
155426440|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
155426441|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
155426442|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
155426443|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
155426444|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
155426445|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
155426446|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
155426447|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
155426448|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
155426449|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
155426450|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
155353567|NCT01193218|560729663|FG001|12-52 Weeks|Lack of Efficacy|0|||
155426451|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
155426452|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
155353568|NCT01193218|560729664|FG002|12-52 Weeks|Lack of Efficacy|0|||
155353569|NCT01193218|560729665|FG003|12-52 Weeks|Lack of Efficacy|0|||
155353570|NCT01193218|560729666|FG004|12-52 Weeks|Lack of Efficacy|0|||
155353571|NCT01193218|560729667|FG005|12-52 Weeks|Lack of Efficacy|0|||
155353572|NCT01193218|560729668|FG006|12-52 Weeks|Lack of Efficacy|1|||
155353573|NCT01193218|560729669|FG007|12-52 Weeks|Lack of Efficacy|0|||
155353574|NCT01193218|560729662|FG000|12-52 Weeks|Withdrawal by Subject|3|||
155353575|NCT01193218|560729663|FG001|12-52 Weeks|Withdrawal by Subject|0|||
155353576|NCT01193218|560729664|FG002|12-52 Weeks|Withdrawal by Subject|3|||
155353577|NCT01193218|560729665|FG003|12-52 Weeks|Withdrawal by Subject|0|||
155353578|NCT01193218|560729666|FG004|12-52 Weeks|Withdrawal by Subject|0|||
155353579|NCT01193218|560729667|FG005|12-52 Weeks|Withdrawal by Subject|2|||
155353580|NCT01193218|560729668|FG006|12-52 Weeks|Withdrawal by Subject|1|||
155353581|NCT01193218|560729669|FG007|12-52 Weeks|Withdrawal by Subject|2|||
155353582|NCT01193218|560729662|FG000|12-52 Weeks|Other reason than above|1|||
155353583|NCT01193218|560729663|FG001|12-52 Weeks|Other reason than above|0|||
155353584|NCT01193218|560729664|FG002|12-52 Weeks|Other reason than above|0|||
155353585|NCT01193218|560729665|FG003|12-52 Weeks|Other reason than above|1|||
155353586|NCT01193218|560729666|FG004|12-52 Weeks|Other reason than above|1|||
155353587|NCT01193218|560729667|FG005|12-52 Weeks|Other reason than above|0|||
155353588|NCT01193218|560729668|FG006|12-52 Weeks|Other reason than above|0|||
155353589|NCT01193218|560729669|FG007|12-52 Weeks|Other reason than above|0|||
155353590|NCT00363649|560729670|FG000|Overall Study|Withdrawal by Subject|1|||
155353591|NCT00363649|560729671|FG001|Overall Study|Withdrawal by Subject|1|||
155353592|NCT00363649|560729670|FG000|Overall Study|Adverse Event|6|||
155353593|NCT00363649|560729671|FG001|Overall Study|Adverse Event|0|||
155353594|NCT01013740|560729672|FG000|Overall Study|Lost to Follow-up|3|||
155353595|NCT01013740|560729673|FG001|Overall Study|Lost to Follow-up|5|||
155353596|NCT01013740|560729672|FG000|Overall Study|Physician Decision|2|||
155353597|NCT01013740|560729673|FG001|Overall Study|Physician Decision|0|||
155353598|NCT01013740|560729672|FG000|Overall Study|Withdrawal by Subject|2|||
155353599|NCT01013740|560729673|FG001|Overall Study|Withdrawal by Subject|10|||
155353600|NCT01013740|560729672|FG000|Overall Study|study close / terminated : done in error|2|||
155353601|NCT01013740|560729673|FG001|Overall Study|study close / terminated : done in error|1|||
155353602|NCT01013740|560729672|FG000|Overall Study|Missing|2|||
155353603|NCT01013740|560729673|FG001|Overall Study|Missing|1|||
155353604|NCT01013740|560729672|FG000|Overall Study|Ongoing: Study records not completed|0|||
155353605|NCT01013740|560729673|FG001|Overall Study|Ongoing: Study records not completed|2|||
155353606|NCT02161185|560729674|FG000|Treatment Phase|Administrative/Other|7|||
155353607|NCT00776984|560729676|FG000|Overall Study|Adverse Event|8|||
155353608|NCT00776984|560729677|FG001|Overall Study|Adverse Event|2|||
155353609|NCT00776984|560729676|FG000|Overall Study|Protocol Violation|4|||
155353610|NCT00776984|560729677|FG001|Overall Study|Protocol Violation|2|||
155353611|NCT00776984|560729676|FG000|Overall Study|Lost to Follow-up|2|||
155353612|NCT00776984|560729677|FG001|Overall Study|Lost to Follow-up|0|||
155353613|NCT00776984|560729676|FG000|Overall Study|Withdrawal by Subject|12|||
155353614|NCT00776984|560729677|FG001|Overall Study|Withdrawal by Subject|7|||
155353615|NCT00776984|560729676|FG000|Overall Study|Lack of Efficacy|0|||
155353616|NCT00776984|560729677|FG001|Overall Study|Lack of Efficacy|1|||
155353617|NCT00776984|560729676|FG000|Overall Study|Other|5|||
155353618|NCT00776984|560729677|FG001|Overall Study|Other|9|||
155353619|NCT01544309|560729680|FG000|Overall Study|Withdrawal by Subject|12|||
155353620|NCT01544309|560729681|FG001|Overall Study|Withdrawal by Subject|7|||
155353621|NCT01544309|560729680|FG000|Overall Study|Protocol Violation|2|||
155353622|NCT01544309|560729681|FG001|Overall Study|Protocol Violation|1|||
155353623|NCT01544309|560729680|FG000|Overall Study|Physician Decision|4|||
155353624|NCT01544309|560729681|FG001|Overall Study|Physician Decision|1|||
155353625|NCT01544309|560729680|FG000|Overall Study|Not performed pre-dose examination|1|||
155353626|NCT01544309|560729681|FG001|Overall Study|Not performed pre-dose examination|2|||
155353627|NCT01544309|560729680|FG000|Overall Study|Administered prohibit prior medication|1|||
155353628|NCT01544309|560729681|FG001|Overall Study|Administered prohibit prior medication|0|||
155353629|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
155353630|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
155353631|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
155353632|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
155353633|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
155353634|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
155353635|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
155353636|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
155426453|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
155426454|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
155426455|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
155426456|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
155426457|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
155353637|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
155353638|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
155353639|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
155353640|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
155353641|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
155353642|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
155353643|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
155353644|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
155353645|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
155353646|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
155353647|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
155353648|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
155353649|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
155353650|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
155353651|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
155353652|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
155353653|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
155353654|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
155353655|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
155353656|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
155353657|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
155353658|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
155353659|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
155353660|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
155426458|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
155426459|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
155426460|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
155426461|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
155426462|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
155426463|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
155353661|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
155353662|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
155353663|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
155353664|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
155353665|NCT00988117|560729694|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
155353666|NCT00988117|560729694|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
155353667|NCT04088500|560729695|FG000|Overall Study|Reason unknown|1|||
155353668|NCT04088500|560729695|FG000|Overall Study|Participant withdrew consent|1|||
155353669|NCT04088500|560729695|FG000|Overall Study|Disease progression|3|||
155353670|NCT01091519|560729698|FG000|Overall Study|Adverse Event|12|||
155353671|NCT01091519|560729699|FG001|Overall Study|Adverse Event|16|||
155353672|NCT01091519|560729698|FG000|Overall Study|Death|1|||
155353673|NCT01091519|560729699|FG001|Overall Study|Death|0|||
155353674|NCT01091519|560729698|FG000|Overall Study|Lack of Efficacy|16|||
155353675|NCT01091519|560729699|FG001|Overall Study|Lack of Efficacy|19|||
155353676|NCT01091519|560729698|FG000|Overall Study|Lost to Follow-up|14|||
155353677|NCT01091519|560729699|FG001|Overall Study|Lost to Follow-up|24|||
155353678|NCT01091519|560729698|FG000|Overall Study|Withdrawal by Subject|2|||
155353679|NCT01091519|560729699|FG001|Overall Study|Withdrawal by Subject|2|||
155353680|NCT01091519|560729698|FG000|Overall Study|Other|6|||
155353681|NCT01091519|560729699|FG001|Overall Study|Other|8|||
155353682|NCT01091519|560729698|FG000|Overall Study|Randomized not treated|4|||
155353683|NCT01091519|560729699|FG001|Overall Study|Randomized not treated|4|||
155353684|NCT01227928|560729702|FG000|Overall Study|Lost to Follow-up|4|||
155353685|NCT01227928|560729703|FG001|Overall Study|Lost to Follow-up|2|||
155353686|NCT01227928|560729702|FG000|Overall Study|Withdrawal by Subject|4|||
155353687|NCT01227928|560729703|FG001|Overall Study|Withdrawal by Subject|3|||
155353688|NCT01227928|560729702|FG000|Overall Study|Death|14|||
155353689|NCT01227928|560729703|FG001|Overall Study|Death|12|||
155353690|NCT01204775|560729704|FG000|Overall Study|Poor/non-compliance|0|||
155353691|NCT01204775|560729705|FG001|Overall Study|Poor/non-compliance|1|||
155353692|NCT01204775|560729704|FG000|Overall Study|Withdrawal by Subject|1|||
155353693|NCT01204775|560729705|FG001|Overall Study|Withdrawal by Subject|0|||
155353694|NCT00276016|560729706|FG000|Intervention 1|Withdrawal by Subject|0|||
155353695|NCT00276016|560729707|FG001|Intervention 1|Withdrawal by Subject|1|||
155353696|NCT00276016|560729708|FG002|Intervention 1|Withdrawal by Subject|0|||
155353697|NCT00276016|560729709|FG003|Intervention 1|Withdrawal by Subject|0|||
155353698|NCT00276016|560729710|FG004|Intervention 1|Withdrawal by Subject|0|||
155353699|NCT00276016|560729711|FG005|Intervention 1|Withdrawal by Subject|0|||
155353700|NCT01468077|560731369|FG000|Overall Study|Adverse Event|2|||
155353701|NCT01468077|560731370|FG001|Overall Study|Adverse Event|2|||
155353702|NCT01468077|560731369|FG000|Overall Study|Lack of Efficacy|1|||
155353703|NCT01468077|560731370|FG001|Overall Study|Lack of Efficacy|1|||
155353704|NCT01468077|560731369|FG000|Overall Study|Physician Decision|1|||
155353705|NCT01468077|560731370|FG001|Overall Study|Physician Decision|0|||
155353706|NCT04333147|560731371|FG000|Overall Study|Adverse Event|43|||
155353707|NCT04333147|560731372|FG001|Overall Study|Adverse Event|40|||
155353708|NCT04333147|560731371|FG000|Overall Study|Lack of Efficacy|49|||
155353709|NCT04333147|560731372|FG001|Overall Study|Lack of Efficacy|48|||
155353710|NCT04333147|560731371|FG000|Overall Study|Lost to Follow-up|19|||
155353711|NCT04333147|560731372|FG001|Overall Study|Lost to Follow-up|16|||
155353712|NCT04333147|560731371|FG000|Overall Study|Physician Decision|17|||
155353713|NCT04333147|560731372|FG001|Overall Study|Physician Decision|20|||
155353714|NCT04333147|560731371|FG000|Overall Study|Withdrawal by Subject|65|||
155353715|NCT04333147|560731372|FG001|Overall Study|Withdrawal by Subject|68|||
155353716|NCT04333147|560731371|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
155353717|NCT04333147|560731372|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
155353718|NCT04333147|560731371|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
155353719|NCT04333147|560731372|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
155353720|NCT04333147|560731371|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
155353721|NCT04333147|560731372|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
155353722|NCT00706914|560731377|FG000|Overall Study|Lack of Efficacy|0|||
155353723|NCT00706914|560731378|FG001|Overall Study|Lack of Efficacy|1|||
155353724|NCT00706914|560731379|FG002|Overall Study|Lack of Efficacy|0|||
155353725|NCT00706914|560731377|FG000|Overall Study|Lost to Follow-up|1|||
155353726|NCT00706914|560731378|FG001|Overall Study|Lost to Follow-up|0|||
155353727|NCT00706914|560731379|FG002|Overall Study|Lost to Follow-up|0|||
155353728|NCT00706914|560731377|FG000|Overall Study|Adverse Event|2|||
155353729|NCT00706914|560731378|FG001|Overall Study|Adverse Event|2|||
155353730|NCT00706914|560731379|FG002|Overall Study|Adverse Event|0|||
155353731|NCT00706914|560731377|FG000|Overall Study|Protocol Violation|3|||
155353732|NCT00706914|560731378|FG001|Overall Study|Protocol Violation|1|||
155353733|NCT00706914|560731379|FG002|Overall Study|Protocol Violation|1|||
155353734|NCT01850823|560731381|FG000|Overall Study|Early Visit Window|0|||
155353735|NCT01850823|560731382|FG001|Overall Study|Early Visit Window|1|||
155353736|NCT01850823|560731383|FG002|Overall Study|Early Visit Window|4|||
155353737|NCT01850823|560731381|FG000|Overall Study|Enrolled in Error|0|||
155353738|NCT01850823|560731382|FG001|Overall Study|Enrolled in Error|1|||
155353739|NCT01850823|560731383|FG002|Overall Study|Enrolled in Error|2|||
155353740|NCT01850823|560731381|FG000|Overall Study|Lack of Efficacy|1|||
155353741|NCT01850823|560731382|FG001|Overall Study|Lack of Efficacy|0|||
155353742|NCT01850823|560731383|FG002|Overall Study|Lack of Efficacy|0|||
155353743|NCT01850823|560731381|FG000|Overall Study|Lost to Follow-up|0|||
155353744|NCT01850823|560731382|FG001|Overall Study|Lost to Follow-up|0|||
155353745|NCT01850823|560731383|FG002|Overall Study|Lost to Follow-up|1|||
155353746|NCT01850823|560731381|FG000|Overall Study|Restricted Medication|0|||
155353747|NCT01850823|560731382|FG001|Overall Study|Restricted Medication|0|||
155353748|NCT01850823|560731383|FG002|Overall Study|Restricted Medication|2|||
155353749|NCT01850823|560731381|FG000|Overall Study|Significant worstening of SAR|0|||
155353750|NCT01850823|560731382|FG001|Overall Study|Significant worstening of SAR|1|||
155353751|NCT01850823|560731383|FG002|Overall Study|Significant worstening of SAR|0|||
155353752|NCT01850823|560731381|FG000|Overall Study|Withdrawal by Subject|2|||
155353753|NCT01850823|560731382|FG001|Overall Study|Withdrawal by Subject|0|||
155353754|NCT01850823|560731383|FG002|Overall Study|Withdrawal by Subject|1|||
155353755|NCT01751165|560731384|FG000|Overall Study|Adverse event, serious fatal|1|||
155353756|NCT01751165|560731385|FG001|Overall Study|Adverse event, serious fatal|0|||
155353757|NCT01751165|560731386|FG002|Overall Study|Adverse event, serious fatal|1|||
155353758|NCT01751165|560731384|FG000|Overall Study|Withdrawal by Subject|0|||
155353759|NCT01751165|560731385|FG001|Overall Study|Withdrawal by Subject|0|||
155353760|NCT01751165|560731386|FG002|Overall Study|Withdrawal by Subject|1|||
155353761|NCT01751165|560731384|FG000|Overall Study|Serious adverse event|0|||
155353762|NCT01751165|560731385|FG001|Overall Study|Serious adverse event|2|||
155353763|NCT01751165|560731386|FG002|Overall Study|Serious adverse event|0|||
155353764|NCT01751165|560731384|FG000|Overall Study|Lost to Follow-up|1|||
155353765|NCT01751165|560731385|FG001|Overall Study|Lost to Follow-up|1|||
155353766|NCT01751165|560731386|FG002|Overall Study|Lost to Follow-up|1|||
155353767|NCT00988533|560731387|FG000|Overall Study|Lost to Follow-up|3|||
155353768|NCT00913523|560731389|FG000|Overall Study|Withdrawal by Subject|3|||
155353769|NCT00913523|560731390|FG001|Overall Study|Withdrawal by Subject|2|||
155353770|NCT00913523|560731391|FG002|Overall Study|Withdrawal by Subject|2|||
155353771|NCT00913523|560731389|FG000|Overall Study|Lost to Follow-up|1|||
155353772|NCT00913523|560731390|FG001|Overall Study|Lost to Follow-up|1|||
155353773|NCT00913523|560731391|FG002|Overall Study|Lost to Follow-up|1|||
155353774|NCT00913523|560731389|FG000|Overall Study|Adverse Event|1|||
155353775|NCT00913523|560731390|FG001|Overall Study|Adverse Event|0|||
155353776|NCT00913523|560731391|FG002|Overall Study|Adverse Event|0|||
155353777|NCT00913523|560731389|FG000|Overall Study|Protocol Violation|5|||
155353778|NCT00913523|560731390|FG001|Overall Study|Protocol Violation|8|||
155353779|NCT00913523|560731391|FG002|Overall Study|Protocol Violation|8|||
155353780|NCT00913523|560731389|FG000|Overall Study|Pregnancy|1|||
155353781|NCT00913523|560731390|FG001|Overall Study|Pregnancy|3|||
155353782|NCT00913523|560731391|FG002|Overall Study|Pregnancy|0|||
155353783|NCT00913523|560731389|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
155353784|NCT00913523|560731390|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
155353785|NCT00913523|560731391|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
155353786|NCT01475461|560731392|FG000|Run-in Period|Not meet eligibility criteria|16|||
155353787|NCT01475461|560731393|FG001|Run-in Period|Not meet eligibility criteria|0|||
155353788|NCT01475461|560731394|FG002|Run-in Period|Not meet eligibility criteria|0|||
155353789|NCT01475461|560731395|FG003|Run-in Period|Not meet eligibility criteria|0|||
155353790|NCT01475461|560731396|FG004|Run-in Period|Not meet eligibility criteria|0|||
155353791|NCT01475461|560731397|FG005|Run-in Period|Not meet eligibility criteria|0|||
155353792|NCT01475461|560731398|FG006|Run-in Period|Not meet eligibility criteria|0|||
155353793|NCT01475461|560731392|FG000|Run-in Period|Lost to Follow-up|7|||
155353794|NCT01475461|560731393|FG001|Run-in Period|Lost to Follow-up|0|||
155353795|NCT01475461|560731394|FG002|Run-in Period|Lost to Follow-up|0|||
155353796|NCT01475461|560731395|FG003|Run-in Period|Lost to Follow-up|0|||
155353797|NCT01475461|560731396|FG004|Run-in Period|Lost to Follow-up|0|||
155353798|NCT01475461|560731397|FG005|Run-in Period|Lost to Follow-up|0|||
155353799|NCT01475461|560731398|FG006|Run-in Period|Lost to Follow-up|0|||
155353800|NCT01475461|560731392|FG000|Run-in Period|Withdrawal by Subject|11|||
155353801|NCT01475461|560731393|FG001|Run-in Period|Withdrawal by Subject|0|||
155353802|NCT01475461|560731394|FG002|Run-in Period|Withdrawal by Subject|0|||
155353803|NCT01475461|560731395|FG003|Run-in Period|Withdrawal by Subject|0|||
155353804|NCT01475461|560731396|FG004|Run-in Period|Withdrawal by Subject|0|||
155353805|NCT01475461|560731397|FG005|Run-in Period|Withdrawal by Subject|0|||
155353806|NCT01475461|560731398|FG006|Run-in Period|Withdrawal by Subject|0|||
155353807|NCT01475461|560731392|FG000|Run-in Period|Other|3|||
155353808|NCT01475461|560731393|FG001|Run-in Period|Other|0|||
155353809|NCT01475461|560731394|FG002|Run-in Period|Other|0|||
155353810|NCT01475461|560731395|FG003|Run-in Period|Other|0|||
155353811|NCT01475461|560731396|FG004|Run-in Period|Other|0|||
155353812|NCT01475461|560731397|FG005|Run-in Period|Other|0|||
155353813|NCT01475461|560731398|FG006|Run-in Period|Other|0|||
155353814|NCT01475461|560731392|FG000|Run-in Period|Protocol Violation|4|||
155353815|NCT01475461|560731393|FG001|Run-in Period|Protocol Violation|0|||
155353816|NCT01475461|560731394|FG002|Run-in Period|Protocol Violation|0|||
155353817|NCT01475461|560731395|FG003|Run-in Period|Protocol Violation|0|||
155353818|NCT01475461|560731396|FG004|Run-in Period|Protocol Violation|0|||
155353819|NCT01475461|560731397|FG005|Run-in Period|Protocol Violation|0|||
155353820|NCT01475461|560731398|FG006|Run-in Period|Protocol Violation|0|||
155353821|NCT01475461|560731392|FG000|Treatment Period|Death|0|||
155353822|NCT01475461|560731393|FG001|Treatment Period|Death|0|||
155353823|NCT01475461|560731394|FG002|Treatment Period|Death|0|||
155353824|NCT01475461|560731395|FG003|Treatment Period|Death|1|||
155353825|NCT01475461|560731396|FG004|Treatment Period|Death|0|||
155353826|NCT01475461|560731397|FG005|Treatment Period|Death|0|||
155353827|NCT01475461|560731398|FG006|Treatment Period|Death|0|||
155353828|NCT01475461|560731392|FG000|Treatment Period|Lost to Follow-up|0|||
155353829|NCT01475461|560731393|FG001|Treatment Period|Lost to Follow-up|3|||
155353830|NCT01475461|560731394|FG002|Treatment Period|Lost to Follow-up|2|||
155353831|NCT01475461|560731395|FG003|Treatment Period|Lost to Follow-up|3|||
155353832|NCT01475461|560731396|FG004|Treatment Period|Lost to Follow-up|1|||
155353833|NCT01475461|560731397|FG005|Treatment Period|Lost to Follow-up|2|||
155353834|NCT01475461|560731398|FG006|Treatment Period|Lost to Follow-up|1|||
155353835|NCT01475461|560731392|FG000|Treatment Period|Withdrawal by Subject|0|||
155353836|NCT01475461|560731393|FG001|Treatment Period|Withdrawal by Subject|2|||
155353837|NCT01475461|560731394|FG002|Treatment Period|Withdrawal by Subject|2|||
155353838|NCT01475461|560731395|FG003|Treatment Period|Withdrawal by Subject|0|||
155353839|NCT01475461|560731396|FG004|Treatment Period|Withdrawal by Subject|2|||
155353840|NCT01475461|560731397|FG005|Treatment Period|Withdrawal by Subject|2|||
155353841|NCT01475461|560731398|FG006|Treatment Period|Withdrawal by Subject|0|||
155353842|NCT01475461|560731392|FG000|Treatment Period|Other|0|||
155353843|NCT01475461|560731393|FG001|Treatment Period|Other|1|||
155353844|NCT01475461|560731394|FG002|Treatment Period|Other|0|||
155353845|NCT01475461|560731395|FG003|Treatment Period|Other|0|||
155353846|NCT01475461|560731396|FG004|Treatment Period|Other|0|||
155353847|NCT01475461|560731397|FG005|Treatment Period|Other|0|||
155353848|NCT01475461|560731398|FG006|Treatment Period|Other|0|||
155353849|NCT01475461|560731392|FG000|Treatment Period|Protocol Violation|0|||
155353850|NCT01475461|560731393|FG001|Treatment Period|Protocol Violation|1|||
155353851|NCT01475461|560731394|FG002|Treatment Period|Protocol Violation|0|||
155353852|NCT01475461|560731395|FG003|Treatment Period|Protocol Violation|0|||
155353853|NCT01475461|560731396|FG004|Treatment Period|Protocol Violation|0|||
155353854|NCT01475461|560731397|FG005|Treatment Period|Protocol Violation|0|||
155353855|NCT01475461|560731398|FG006|Treatment Period|Protocol Violation|1|||
155353856|NCT01475461|560731392|FG000|Treatment Period|Lack of Efficacy|0|||
155353857|NCT01475461|560731393|FG001|Treatment Period|Lack of Efficacy|2|||
155353858|NCT01475461|560731394|FG002|Treatment Period|Lack of Efficacy|0|||
155353859|NCT01475461|560731395|FG003|Treatment Period|Lack of Efficacy|2|||
155353860|NCT01475461|560731396|FG004|Treatment Period|Lack of Efficacy|1|||
155353861|NCT01475461|560731397|FG005|Treatment Period|Lack of Efficacy|1|||
155353862|NCT01475461|560731398|FG006|Treatment Period|Lack of Efficacy|0|||
155353863|NCT01475461|560731392|FG000|Treatment Period|Medication Error|0|||
155353864|NCT01475461|560731393|FG001|Treatment Period|Medication Error|0|||
155353865|NCT01475461|560731394|FG002|Treatment Period|Medication Error|0|||
155353866|NCT01475461|560731395|FG003|Treatment Period|Medication Error|1|||
155353867|NCT01475461|560731396|FG004|Treatment Period|Medication Error|0|||
155353868|NCT01475461|560731397|FG005|Treatment Period|Medication Error|0|||
155353869|NCT01475461|560731398|FG006|Treatment Period|Medication Error|0|||
155353870|NCT01475461|560731392|FG000|Treatment Period|Adverse Event|0|||
155426464|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
155426465|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
155426466|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
155353871|NCT01475461|560731393|FG001|Treatment Period|Adverse Event|0|||
155353872|NCT01475461|560731394|FG002|Treatment Period|Adverse Event|0|||
155353873|NCT01475461|560731395|FG003|Treatment Period|Adverse Event|1|||
155353874|NCT01475461|560731396|FG004|Treatment Period|Adverse Event|0|||
155353875|NCT01475461|560731397|FG005|Treatment Period|Adverse Event|0|||
155353876|NCT01475461|560731398|FG006|Treatment Period|Adverse Event|0|||
155353877|NCT04051242|560731399|FG000|Overall Study|Withdrawal by Subject|1|||
155353878|NCT04051242|560731399|FG000|Overall Study|Physician Decision|1|||
155353879|NCT02512861|560731402|FG000|Overall Study|Protocol Violation|3|||
155353880|NCT02512861|560731403|FG001|Overall Study|Protocol Violation|7|||
155353881|NCT02512861|560731402|FG000|Overall Study|Physician Decision|3|||
155353882|NCT02512861|560731403|FG001|Overall Study|Physician Decision|1|||
155353883|NCT02512861|560731402|FG000|Overall Study|Withdrawal by Subject|0|||
155353884|NCT02512861|560731403|FG001|Overall Study|Withdrawal by Subject|1|||
155353885|NCT00553605|560731404|FG000|Overall Study|Did not meet entrance criteria|1|||
155353886|NCT00553605|560731405|FG001|Overall Study|Did not meet entrance criteria|3|||
155353887|NCT00553605|560731404|FG000|Overall Study|Did not receive full dose|1|||
155353888|NCT00553605|560731405|FG001|Overall Study|Did not receive full dose|0|||
155353889|NCT00553605|560731404|FG000|Overall Study|Randomized but not treated|2|||
155353890|NCT00553605|560731405|FG001|Overall Study|Randomized but not treated|0|||
155353891|NCT01874665|560731407|FG000|Overall Study|Adverse Event|6|||
155353892|NCT01874665|560731408|FG001|Overall Study|Adverse Event|2|||
155353893|NCT01874665|560731407|FG000|Overall Study|Withdrawal by Subject|4|||
155353894|NCT01874665|560731408|FG001|Overall Study|Withdrawal by Subject|1|||
155353895|NCT01874665|560731407|FG000|Overall Study|Physician Decision|3|||
155353896|NCT01874665|560731408|FG001|Overall Study|Physician Decision|0|||
155353897|NCT01874665|560731407|FG000|Overall Study|Clinical Progressive Disease|4|||
155353898|NCT01874665|560731408|FG001|Overall Study|Clinical Progressive Disease|3|||
155353899|NCT01874665|560731407|FG000|Overall Study|Study Terminated by Sponsor|0|||
155353900|NCT01874665|560731408|FG001|Overall Study|Study Terminated by Sponsor|2|||
155353901|NCT01874665|560731407|FG000|Overall Study|Documented Progressive Disease|11|||
155353902|NCT01874665|560731408|FG001|Overall Study|Documented Progressive Disease|7|||
155353903|NCT01874665|560731407|FG000|Overall Study|Other|2|||
155353904|NCT01874665|560731408|FG001|Overall Study|Other|0|||
155353905|NCT00776659|560731413|FG000|Overall Study|Lost to Follow-up|15|||
155353906|NCT00776659|560731413|FG000|Overall Study|Withdrawal by Subject|10|||
155353907|NCT00776659|560731413|FG000|Overall Study|Study Terminated by Sponsor|1|||
155353908|NCT01585298|560731414|FG000|Overall Study|Study completion was not documented.|1|||
155353909|NCT01585298|560731414|FG000|Overall Study|Protocol deviation|1|||
155353910|NCT01585298|560731414|FG000|Overall Study|Administrative problems|4|||
155353911|NCT01585298|560731414|FG000|Overall Study|Lost to Follow-up|2|||
155353912|NCT01585298|560731414|FG000|Overall Study|Withdrawal by Subject|4|||
155353913|NCT01585298|560731414|FG000|Overall Study|Abnormal test procedure results|1|||
155353914|NCT01585298|560731414|FG000|Overall Study|Adverse Event|24|||
155353915|NCT01978236|560731417|FG000|Overall Study|Discontinued due to study close|2|||
155353916|NCT03811834|560731418|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
155353917|NCT01527500|560731419|FG000|Part A|Administrative|11|||
155353918|NCT01527500|560731420|FG001|Part A|Administrative|7|||
155353919|NCT01527500|560731419|FG000|Part A|Adverse Event|4|||
155353920|NCT01527500|560731420|FG001|Part A|Adverse Event|2|||
155353921|NCT01527500|560731419|FG000|Part A|Death|4|||
155353922|NCT01527500|560731420|FG001|Part A|Death|1|||
155353923|NCT01527500|560731419|FG000|Part A|Lost to Follow-up|0|||
155353924|NCT01527500|560731420|FG001|Part A|Lost to Follow-up|1|||
155353925|NCT01527500|560731419|FG000|Part A|Protocol Deviation|9|||
155353926|NCT01527500|560731420|FG001|Part A|Protocol Deviation|2|||
155353927|NCT01527500|560731419|FG000|Part A|Withdrawal by Subject|2|||
155353928|NCT01527500|560731420|FG001|Part A|Withdrawal by Subject|0|||
155353929|NCT01527500|560731419|FG000|Part B|Adverse Event|1|||
155353930|NCT01527500|560731420|FG001|Part B|Adverse Event|0|||
155353931|NCT00372255|560731421|FG000|Overall Study|Withdrawn for other reasons|2|||
155353932|NCT00372255|560731422|FG001|Overall Study|Withdrawn for other reasons|1|||
155426467|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
155426468|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
155426469|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
155426470|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
155353933|NCT02573883|560731426|FG000|Six Month Follow Up|Lost to Follow-up|1|||
155426471|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
155353934|NCT02573883|560731427|FG001|Six Month Follow Up|Lost to Follow-up|0|||
155353935|NCT02573883|560731428|FG002|Six Month Follow Up|Lost to Follow-up|0|||
155353936|NCT02573883|560731429|FG003|Six Month Follow Up|Lost to Follow-up|0|||
155353937|NCT02573883|560731426|FG000|One Year Follow Up|Lost to Follow-up|2|||
155353938|NCT02573883|560731427|FG001|One Year Follow Up|Lost to Follow-up|1|||
155353939|NCT02573883|560731428|FG002|One Year Follow Up|Lost to Follow-up|0|||
155353940|NCT02573883|560731429|FG003|One Year Follow Up|Lost to Follow-up|0|||
155353941|NCT00582114|560731430|FG000|Overall Study|Death|4|||
155353942|NCT00582114|560731431|FG001|Overall Study|Death|4|||
155353943|NCT00582114|560731430|FG000|Overall Study|Kidney Transplant|3|||
155353944|NCT00582114|560731431|FG001|Overall Study|Kidney Transplant|1|||
155353945|NCT00582114|560731430|FG000|Overall Study|Lost to Follow-up|7|||
155353946|NCT00582114|560731431|FG001|Overall Study|Lost to Follow-up|6|||
155353947|NCT00582114|560731430|FG000|Overall Study|Withdrawal by Subject|8|||
155353948|NCT00582114|560731431|FG001|Overall Study|Withdrawal by Subject|16|||
155353949|NCT00582114|560731430|FG000|Overall Study|Adverse Event|1|||
155353950|NCT00582114|560731431|FG001|Overall Study|Adverse Event|1|||
155353951|NCT00582114|560731430|FG000|Overall Study|Physician Decision|0|||
155353952|NCT00582114|560731431|FG001|Overall Study|Physician Decision|6|||
155353953|NCT00582114|560731430|FG000|Overall Study|Stopped by data safety monitoring board|19|||
155353954|NCT00582114|560731431|FG001|Overall Study|Stopped by data safety monitoring board|20|||
155353955|NCT00130728|560731432|FG000|Overall Study|Death|258|||
155353956|NCT00130728|560731433|FG001|Overall Study|Death|258|||
155353957|NCT00130728|560731432|FG000|Overall Study|Lost to Follow-up|4|||
155353958|NCT00130728|560731433|FG001|Overall Study|Lost to Follow-up|0|||
155353959|NCT00130728|560731432|FG000|Overall Study|Withdrawal by Subject|0|||
155353960|NCT00130728|560731433|FG001|Overall Study|Withdrawal by Subject|2|||
155353961|NCT03796208|560731435|FG000|Overall Study|Withdrawal by Subject|3|||
155353962|NCT03796208|560731436|FG001|Overall Study|Withdrawal by Subject|0|||
155353963|NCT03796208|560731435|FG000|Overall Study|Loss of pregnancy|1|||
155353964|NCT03796208|560731436|FG001|Overall Study|Loss of pregnancy|1|||
155353965|NCT03796208|560731435|FG000|Overall Study|Changed prenatal clinics|0|||
155353966|NCT03796208|560731436|FG001|Overall Study|Changed prenatal clinics|5|||
155353967|NCT03796208|560731435|FG000|Overall Study|Lost to Follow-up|20|||
155353968|NCT03796208|560731436|FG001|Overall Study|Lost to Follow-up|16|||
155506800|NCT01335399|561283442|FG000|Treatment Period|Consent withdrawal|10|||
155353969|NCT01560585|560731438|FG000|Overall Study|Physician Decision|3|||
155353970|NCT00519285|560731439|FG000|Overall Study|Adverse Event|127|||
155353971|NCT00519285|560731440|FG001|Overall Study|Adverse Event|266|||
155353972|NCT00519285|560731439|FG000|Overall Study|Disease progression|334|||
155353973|NCT00519285|560731440|FG001|Overall Study|Disease progression|186|||
155353974|NCT00519285|560731439|FG000|Overall Study|Physician Decision|75|||
155353975|NCT00519285|560731440|FG001|Overall Study|Physician Decision|47|||
155353976|NCT00519285|560731439|FG000|Overall Study|Participant's request|53|||
155353977|NCT00519285|560731440|FG001|Overall Study|Participant's request|84|||
155353978|NCT00519285|560731439|FG000|Overall Study|Consent withdrawn|4|||
155353979|NCT00519285|560731440|FG001|Overall Study|Consent withdrawn|5|||
155353980|NCT00519285|560731439|FG000|Overall Study|Poor compliance to protocol|5|||
155353981|NCT00519285|560731440|FG001|Overall Study|Poor compliance to protocol|7|||
155353982|NCT00519285|560731439|FG000|Overall Study|Reason unspecified|5|||
155353983|NCT00519285|560731440|FG001|Overall Study|Reason unspecified|8|||
155353984|NCT00519285|560731439|FG000|Overall Study|Not treated|8|||
155353985|NCT00519285|560731440|FG001|Overall Study|Not treated|7|||
155353986|NCT00519285|560731439|FG000|Overall Study|Treatment ongoing|1|||
155353987|NCT00519285|560731440|FG001|Overall Study|Treatment ongoing|2|||
155353988|NCT04206384|560731443|FG000|Overall Study|Withdrawal by Subject|8|||
155353989|NCT04206384|560731443|FG000|Overall Study|Adverse Event|2|||
155353990|NCT01078584|560731446|FG000|Overall Study|Final Status Unknown|1073|||
155353991|NCT01078584|560731446|FG000|Overall Study|Lost to Follow-up|670|||
155353992|NCT01078584|560731446|FG000|Overall Study|Non-serious Adverse Event|577|||
155353993|NCT01078584|560731446|FG000|Overall Study|Withdrawal of Consent|244|||
155353994|NCT01078584|560731446|FG000|Overall Study|Physician Withdrew from Study|90|||
155353995|NCT01078584|560731446|FG000|Overall Study|Non-compliance|67|||
155353996|NCT01078584|560731446|FG000|Overall Study|Blood Pressure Controlled|49|||
155353997|NCT01078584|560731446|FG000|Overall Study|Physician Switched Medication|26|||
155353998|NCT01078584|560731446|FG000|Overall Study|Physician Discontinued Patient|12|||
155353999|NCT01078584|560731446|FG000|Overall Study|Lack of Efficacy|98|||
155354000|NCT01078584|560731446|FG000|Overall Study|Protocol Violation|75|||
155354001|NCT01078584|560731446|FG000|Overall Study|Serious Adverse Event|27|||
155354002|NCT01078584|560731446|FG000|Overall Study|Multiple Reasons|2|||
155354003|NCT01208870|560731447|FG000|Overall Study|Lost to Follow-up|2|||
155354004|NCT01208870|560731448|FG001|Overall Study|Lost to Follow-up|8|||
155354005|NCT01121185|560731449|FG000|Overall Study|Not infused|0|||
155354006|NCT01121185|560731450|FG001|Overall Study|Not infused|1|||
155354007|NCT01121185|560731449|FG000|Overall Study|Not transplanted|1|||
155354008|NCT01121185|560731450|FG001|Overall Study|Not transplanted|0|||
155354009|NCT01260142|560731451|FG000|Treatment Period 1|Study on hold|1|||
155354010|NCT01260142|560731452|FG001|Treatment Period 1|Study on hold|1|||
155354011|NCT01260142|560731453|FG002|Treatment Period 1|Study on hold|0|||
155354012|NCT01260142|560731454|FG003|Treatment Period 1|Study on hold|0|||
155354013|NCT01260142|560731455|FG004|Treatment Period 1|Study on hold|1|||
155354014|NCT01260142|560731456|FG005|Treatment Period 1|Study on hold|2|||
155354015|NCT01260142|560731451|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354016|NCT01260142|560731452|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354017|NCT01260142|560731453|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354018|NCT01260142|560731454|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354019|NCT01260142|560731455|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
155506801|NCT01335399|561283443|FG001|Treatment Period|Consent withdrawal|7|||
155506802|NCT01335399|561283442|FG000|Treatment Period|Death|7|||
155354020|NCT01260142|560731456|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354021|NCT01260142|560731451|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155354022|NCT01260142|560731452|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155354023|NCT01260142|560731453|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155354024|NCT01260142|560731454|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155354025|NCT01260142|560731455|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155354026|NCT01260142|560731456|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155354027|NCT00496834|560731462|FG000|Overall Study|Withdrawal by Subject|4|||
155354028|NCT00496834|560731463|FG001|Overall Study|Withdrawal by Subject|6|||
155354029|NCT00496834|560731462|FG000|Overall Study|Contraindicated medication administered|0|||
155354030|NCT00496834|560731463|FG001|Overall Study|Contraindicated medication administered|1|||
155354031|NCT00496834|560731462|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
155354032|NCT00496834|560731463|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
155354033|NCT00496834|560731462|FG000|Overall Study|Adverse Event|5|||
155354034|NCT00496834|560731463|FG001|Overall Study|Adverse Event|3|||
155354035|NCT00496834|560731462|FG000|Overall Study|IP administration violation|2|||
155354036|NCT00496834|560731463|FG001|Overall Study|IP administration violation|0|||
155354037|NCT00496834|560731462|FG000|Overall Study|Lost to Follow-up|2|||
155354038|NCT00496834|560731463|FG001|Overall Study|Lost to Follow-up|0|||
155354039|NCT00496834|560731462|FG000|Overall Study|Blood Pressure control failure|2|||
155354040|NCT00496834|560731463|FG001|Overall Study|Blood Pressure control failure|1|||
155354041|NCT00356759|560731466|FG000|Overall Study|Death|5|||
155354042|NCT00356759|560731467|FG001|Overall Study|Death|2|||
155354043|NCT00356759|560731466|FG000|Overall Study|Withdrawal by Subject|2|||
155354044|NCT00356759|560731467|FG001|Overall Study|Withdrawal by Subject|2|||
155354045|NCT00356759|560731466|FG000|Overall Study|Adverse Event|1|||
155354046|NCT00356759|560731467|FG001|Overall Study|Adverse Event|3|||
155354047|NCT00356759|560731466|FG000|Overall Study|Lost to Follow-up|1|||
155354048|NCT00356759|560731467|FG001|Overall Study|Lost to Follow-up|1|||
155354049|NCT00356759|560731466|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
155506803|NCT01335399|561283443|FG001|Treatment Period|Death|6|||
155354050|NCT00356759|560731467|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
155354051|NCT01494298|560731468|FG000|Overall Study|Protocol Violation|2|||
155354052|NCT01494298|560731469|FG001|Overall Study|Protocol Violation|8|||
155354053|NCT04159805|560731470|FG000|Overall Study|Withdrawal by Subject|0|||
155354054|NCT04159805|560731471|FG001|Overall Study|Withdrawal by Subject|2|||
155354055|NCT04159805|560731472|FG002|Overall Study|Withdrawal by Subject|2|||
155354056|NCT02930837|560731473|FG000|Overall Study|Adverse Event|6|||
155354057|NCT02930837|560731473|FG000|Overall Study|Lost to Follow-up|5|||
155354058|NCT02930837|560731473|FG000|Overall Study|Withdrawal by Subject|1|||
155354059|NCT01393613|560731474|FG000|Overall Study|Adverse Event|11|||
155354060|NCT01393613|560731475|FG001|Overall Study|Adverse Event|11|||
155354061|NCT01393613|560731476|FG002|Overall Study|Adverse Event|13|||
155354062|NCT01393613|560731477|FG003|Overall Study|Adverse Event|22|||
155354063|NCT01393613|560731474|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
155354064|NCT01393613|560731475|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
155354065|NCT01393613|560731476|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
155354066|NCT01393613|560731477|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155354067|NCT01393613|560731474|FG000|Overall Study|Physician Decision|2|||
155354068|NCT01393613|560731475|FG001|Overall Study|Physician Decision|0|||
155354069|NCT01393613|560731476|FG002|Overall Study|Physician Decision|0|||
155354070|NCT01393613|560731477|FG003|Overall Study|Physician Decision|1|||
155354071|NCT01393613|560731474|FG000|Overall Study|Withdrawal by Subject|15|||
155354072|NCT01393613|560731475|FG001|Overall Study|Withdrawal by Subject|25|||
155354073|NCT01393613|560731476|FG002|Overall Study|Withdrawal by Subject|23|||
155354074|NCT01393613|560731477|FG003|Overall Study|Withdrawal by Subject|21|||
155354075|NCT01393613|560731474|FG000|Overall Study|Protocol Deviation|2|||
155354076|NCT01393613|560731475|FG001|Overall Study|Protocol Deviation|1|||
155354077|NCT01393613|560731476|FG002|Overall Study|Protocol Deviation|0|||
155354078|NCT01393613|560731477|FG003|Overall Study|Protocol Deviation|0|||
155354079|NCT01393613|560731474|FG000|Overall Study|Lack of Efficacy|9|||
155354080|NCT01393613|560731475|FG001|Overall Study|Lack of Efficacy|20|||
155354081|NCT01393613|560731476|FG002|Overall Study|Lack of Efficacy|16|||
155354082|NCT01393613|560731477|FG003|Overall Study|Lack of Efficacy|21|||
155354083|NCT02998918|560731483|FG000|Overall Study|Withdrawal by Subject|1|||
155354084|NCT02998918|560731484|FG001|Overall Study|Withdrawal by Subject|0|||
155354087|NCT01071317|560731486|FG000|Overall Study|Lost to Follow-up|2|||
155354088|NCT01071317|560731487|FG001|Overall Study|Lost to Follow-up|2|||
155354089|NCT00316589|560731488|FG000|Overall Study|Withdrawal by Subject|0|||
155354090|NCT00316589|560731489|FG001|Overall Study|Withdrawal by Subject|5|||
155354091|NCT00316589|560731490|FG002|Overall Study|Withdrawal by Subject|0|||
155354092|NCT00316589|560731491|FG003|Overall Study|Withdrawal by Subject|1|||
155354093|NCT00316589|560731488|FG000|Overall Study|Subject unwilling/unable to comply|0|||
155354094|NCT00316589|560731489|FG001|Overall Study|Subject unwilling/unable to comply|6|||
155354095|NCT00316589|560731490|FG002|Overall Study|Subject unwilling/unable to comply|0|||
155354096|NCT00316589|560731491|FG003|Overall Study|Subject unwilling/unable to comply|2|||
155354097|NCT00316589|560731488|FG000|Overall Study|Adverse Event|1|||
155354098|NCT00316589|560731489|FG001|Overall Study|Adverse Event|0|||
155354099|NCT00316589|560731490|FG002|Overall Study|Adverse Event|0|||
155354100|NCT00316589|560731491|FG003|Overall Study|Adverse Event|1|||
155354101|NCT00316589|560731488|FG000|Overall Study|Physician Decision|0|||
155354102|NCT00316589|560731489|FG001|Overall Study|Physician Decision|1|||
155354103|NCT00316589|560731490|FG002|Overall Study|Physician Decision|0|||
155354104|NCT00316589|560731491|FG003|Overall Study|Physician Decision|0|||
155354105|NCT00316589|560731488|FG000|Overall Study|Other reason|0|||
155354106|NCT00316589|560731489|FG001|Overall Study|Other reason|12|||
155354107|NCT00316589|560731490|FG002|Overall Study|Other reason|1|||
155354108|NCT00316589|560731491|FG003|Overall Study|Other reason|1|||
155354109|NCT01283971|560731496|FG000|Overall Study|Adverse Event|3|||
155354110|NCT01283971|560731497|FG001|Overall Study|Adverse Event|5|||
155354111|NCT01283971|560731496|FG000|Overall Study|Insufficient therapeutic responses|3|||
155648644|NCT03518203|561805878|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
155354112|NCT01283971|560731497|FG001|Overall Study|Insufficient therapeutic responses|3|||
155354113|NCT01283971|560731496|FG000|Overall Study|Protocol Violation|5|||
155354114|NCT01283971|560731497|FG001|Overall Study|Protocol Violation|1|||
155354115|NCT01283971|560731496|FG000|Overall Study|Refused treatment|3|||
155354116|NCT01283971|560731497|FG001|Overall Study|Refused treatment|1|||
155354117|NCT01283971|560731496|FG000|Overall Study|Failure to return|0|||
155354118|NCT01283971|560731497|FG001|Overall Study|Failure to return|1|||
155426472|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
155426473|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
155426474|NCT01707992|560988142|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
155426475|NCT01707992|560988143|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
155426476|NCT01707992|560988144|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
155426477|NCT01707992|560988145|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
155426478|NCT01707992|560988146|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
155426479|NCT01707992|560988147|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
155426480|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
155426481|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
155426482|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
155426483|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
155426484|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
155426485|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
155426486|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
155426487|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
155426488|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
155426489|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
155426490|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
155426491|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
155426492|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
155426493|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
155426494|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
155426495|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
155426496|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
155426497|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
155426498|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
155426499|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
155426500|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
155426501|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
155426502|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
155426503|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
155426504|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
155426505|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
155426506|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
155426507|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
155426508|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
155426509|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
155426510|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Death|0|||
155426511|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Death|0|||
155426512|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Death|0|||
155426513|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Death|2|||
155426514|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Death|0|||
155426515|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Death|0|||
155426516|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
155426517|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
155426518|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
155426519|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
155426520|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
155426521|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
155426522|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
155426523|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
155426524|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
155426525|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
155426526|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
155426527|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
155506804|NCT01335399|561283442|FG000|Treatment Period|Poor/Non-compliance|3|||
155506805|NCT01335399|561283443|FG001|Treatment Period|Poor/Non-compliance|4|||
155506806|NCT01335399|561283442|FG000|Treatment Period|Lost to Follow-up|2|||
155506807|NCT01335399|561283443|FG001|Treatment Period|Lost to Follow-up|2|||
155506808|NCT01335399|561283442|FG000|Treatment Period|Maximum clinical benefit|1|||
155426528|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
155426529|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
155426530|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
155426531|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
155426532|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
155426533|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
155354119|NCT01283971|560731496|FG000|Overall Study|Administrative reasons|1|||
155354120|NCT01283971|560731497|FG001|Overall Study|Administrative reasons|1|||
155354121|NCT00562484|560731506|FG000|Overall Study|Adverse Event|6|||
155354122|NCT00562484|560731507|FG001|Overall Study|Adverse Event|1|||
155354123|NCT00562484|560731506|FG000|Overall Study|Protocol Violation|11|||
155354124|NCT00562484|560731507|FG001|Overall Study|Protocol Violation|2|||
155354125|NCT00562484|560731506|FG000|Overall Study|Withdrawal by Subject|12|||
155354126|NCT00562484|560731507|FG001|Overall Study|Withdrawal by Subject|9|||
155354127|NCT00562484|560731506|FG000|Overall Study|Moved away from the study area|20|||
155354128|NCT00562484|560731507|FG001|Overall Study|Moved away from the study area|9|||
155354129|NCT00562484|560731506|FG000|Overall Study|Lost to Follow-up|132|||
155354130|NCT00562484|560731507|FG001|Overall Study|Lost to Follow-up|71|||
155426534|NCT01707992|560988142|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
155354131|NCT00562484|560731506|FG000|Overall Study|Reason not provided or not specified|25|||
155354132|NCT00562484|560731507|FG001|Overall Study|Reason not provided or not specified|12|||
155354133|NCT02598934|560731508|FG000|Overall Study|Adverse Event|11|||
155354134|NCT02598934|560731509|FG001|Overall Study|Adverse Event|13|||
155354135|NCT02598934|560731508|FG000|Overall Study|Failure to Return|3|||
155354136|NCT02598934|560731509|FG001|Overall Study|Failure to Return|3|||
155354137|NCT02598934|560731508|FG000|Overall Study|Withdrawal by Subject|2|||
155354138|NCT02598934|560731509|FG001|Overall Study|Withdrawal by Subject|3|||
155354139|NCT02598934|560731508|FG000|Overall Study|Administrative|2|||
155426535|NCT01707992|560988143|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
155426536|NCT01707992|560988144|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
155354140|NCT02598934|560731509|FG001|Overall Study|Administrative|1|||
155354141|NCT02598934|560731508|FG000|Overall Study|Protocol Violation|1|||
155426537|NCT01707992|560988145|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
155354142|NCT02598934|560731509|FG001|Overall Study|Protocol Violation|2|||
155426538|NCT01707992|560988146|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
155426539|NCT01707992|560988147|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
155354143|NCT00702520|560731511|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354144|NCT00702520|560731512|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
155354145|NCT00702520|560731513|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354146|NCT00702520|560731514|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354147|NCT00702520|560731511|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
155354148|NCT00702520|560731512|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
155354149|NCT00702520|560731513|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
155354150|NCT00702520|560731514|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
155354151|NCT00702520|560731511|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
155354152|NCT00702520|560731512|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
155354153|NCT00702520|560731513|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
155354154|NCT00702520|560731514|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
155354155|NCT02154347|560731515|FG000|Double-blind Period|Adverse Event|1|||
155354156|NCT02154347|560731516|FG001|Double-blind Period|Adverse Event|2|||
155354157|NCT02154347|560731515|FG000|Double-blind Period|Lack of Efficacy|1|||
155354158|NCT02154347|560731516|FG001|Double-blind Period|Lack of Efficacy|0|||
155354159|NCT02154347|560731515|FG000|Double-blind Period|Physician Decision|0|||
155506809|NCT01335399|561283443|FG001|Treatment Period|Maximum clinical benefit|1|||
155506810|NCT01335399|561283442|FG000|Treatment Period|No longer meet study criteria|1|||
155354160|NCT02154347|560731516|FG001|Double-blind Period|Physician Decision|1|||
155354161|NCT02154347|560731515|FG000|Double-blind Period|Withdrawal by Subject|1|||
155354162|NCT02154347|560731516|FG001|Double-blind Period|Withdrawal by Subject|1|||
155354163|NCT02154347|560731515|FG000|Open-label Period|Adverse Event|3|||
155354164|NCT02154347|560731516|FG001|Open-label Period|Adverse Event|4|||
155354165|NCT02154347|560731515|FG000|Open-label Period|Lack of Efficacy|4|||
155354166|NCT02154347|560731516|FG001|Open-label Period|Lack of Efficacy|19|||
155354167|NCT02154347|560731515|FG000|Open-label Period|Protocol Violation|0|||
155354168|NCT02154347|560731516|FG001|Open-label Period|Protocol Violation|1|||
155354169|NCT02154347|560731515|FG000|Open-label Period|Withdrawal by Subject|0|||
155354170|NCT02154347|560731516|FG001|Open-label Period|Withdrawal by Subject|1|||
155354171|NCT02481934|560731517|FG000|Overall Study|Death|2|||
155354172|NCT03302559|560731521|FG000|Overall Study|Adverse Event|2|||
155354173|NCT03302559|560731521|FG000|Overall Study|Lost to Follow-up|1|||
155354174|NCT03302559|560731521|FG000|Overall Study|Withdrew Consent|3|||
155354175|NCT01181609|560733201|FG000|Overall Study|Adverse Event|1|||
155354176|NCT01181609|560733201|FG000|Overall Study|Withdrawal by Subject|1|||
155354177|NCT01181609|560733201|FG000|Overall Study|Lost to Follow-up|1|||
155354178|NCT01181609|560733201|FG000|Overall Study|Death|50|||
155354179|NCT00612352|560733202|FG000|Overall Study|Adverse Event|1|||
155354180|NCT00612352|560733203|FG001|Overall Study|Adverse Event|0|||
155354181|NCT00612352|560733202|FG000|Overall Study|Withdrawal by Subject|3|||
155354182|NCT00612352|560733203|FG001|Overall Study|Withdrawal by Subject|5|||
155354183|NCT00612352|560733202|FG000|Overall Study|moved out of state|1|||
155354184|NCT00612352|560733203|FG001|Overall Study|moved out of state|0|||
155354185|NCT00612352|560733202|FG000|Overall Study|didn't return calls/show up on test date|4|||
155354186|NCT00612352|560733203|FG001|Overall Study|didn't return calls/show up on test date|1|||
155354187|NCT00263211|560733206|FG000|Overall Study|Death|1|||
155354188|NCT00263211|560733207|FG001|Overall Study|Death|0|||
155354189|NCT00263211|560733206|FG000|Overall Study|Withdrawal by Subject|3|||
155354190|NCT00263211|560733207|FG001|Overall Study|Withdrawal by Subject|0|||
155354191|NCT00263211|560733206|FG000|Overall Study|Protocol Violation|1|||
155354192|NCT00263211|560733207|FG001|Overall Study|Protocol Violation|0|||
155354193|NCT00263211|560733206|FG000|Overall Study|Disease Progression|0|||
155354194|NCT00263211|560733207|FG001|Overall Study|Disease Progression|1|||
155354195|NCT02820597|560733208|FG000|Overall Study|Lost to Follow-up|12|||
155354196|NCT00545571|560733211|FG000|Overall Study|Administrative Reasons|1|||
155354197|NCT00545571|560733211|FG000|Overall Study|Adverse Event|2|||
155354198|NCT00545571|560733211|FG000|Overall Study|Death|5|||
155354199|NCT00545571|560733211|FG000|Overall Study|Lack of Efficacy|1|||
155354200|NCT00545571|560733211|FG000|Overall Study|Protocol Violation|2|||
155354201|NCT00545571|560733211|FG000|Overall Study|Refused Treatment|1|||
155354202|NCT00545571|560733211|FG000|Overall Study|Screen Failure|16|||
155354203|NCT00545571|560733211|FG000|Overall Study|Transfusion|12|||
155354204|NCT00545571|560733211|FG000|Overall Study|Early Termination of Study|24|||
155354205|NCT00545571|560733211|FG000|Overall Study|Kidney Transplantation|3|||
155354206|NCT00874497|560733212|FG000|Overall Study|Lost to Follow-up|2|||
155354207|NCT00874497|560733213|FG001|Overall Study|Lost to Follow-up|4|||
155354208|NCT00874497|560733212|FG000|Overall Study|Adverse Event|9|||
155354209|NCT00874497|560733213|FG001|Overall Study|Adverse Event|4|||
155354210|NCT00874497|560733212|FG000|Overall Study|Sponsor Discontinued Trial|7|||
155354211|NCT00874497|560733213|FG001|Overall Study|Sponsor Discontinued Trial|3|||
155354212|NCT00874497|560733212|FG000|Overall Study|Met Withdrawal Criteria|4|||
155354213|NCT00874497|560733213|FG001|Overall Study|Met Withdrawal Criteria|2|||
155354214|NCT00874497|560733212|FG000|Overall Study|Physician Decision|1|||
155354215|NCT00874497|560733213|FG001|Overall Study|Physician Decision|1|||
155354216|NCT00874497|560733212|FG000|Overall Study|Withdrawal by Subject|5|||
155354217|NCT00874497|560733213|FG001|Overall Study|Withdrawal by Subject|4|||
155354218|NCT00644878|560733215|FG000|Overall Study|Adverse Event|2|||
155354219|NCT00644878|560733215|FG000|Overall Study|Abnormal laboratory value|3|||
155354220|NCT00644878|560733215|FG000|Overall Study|Protocol deviation|2|||
155354221|NCT00644878|560733215|FG000|Overall Study|Treatment duration completed as per protocol|11|||
155354222|NCT04353817|560733216|FG000|Overall Study|Adverse Event|0|||
155354223|NCT04353817|560733217|FG001|Overall Study|Adverse Event|1|||
155354224|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
155354225|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
155354226|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
155354227|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Death|0|||
155354228|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Death|0|||
155354229|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Death|1|||
155354230|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
155354231|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
155354232|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
155354233|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
155354234|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
155354235|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
155354236|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
155354237|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
155354238|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
155354239|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
155354240|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
155354241|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
155354242|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Death|0|||
155354243|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Death|1|||
155354244|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Death|0|||
155354245|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
155354246|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
155354247|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
155354248|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
155354249|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
155354250|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
155354251|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
155354252|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
155354253|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
155354254|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
155354255|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
155354256|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
155354257|NCT00591591|560733223|FG000|Overall Study|Withdrawal by Subject|1|||
155354258|NCT00591591|560733224|FG001|Overall Study|Withdrawal by Subject|37|||
155354259|NCT00591591|560733223|FG000|Overall Study|Lack of Efficacy|10|||
155354260|NCT00591591|560733224|FG001|Overall Study|Lack of Efficacy|2|||
155354261|NCT00338949|560733229|FG000|Subject Screening|Screen failures|11|||
155354262|NCT00338949|560733230|FG001|Subject Screening|Screen failures|11|||
155354263|NCT00338949|560733229|FG000|Randomization|Withdrawal by Subject|1|||
155354264|NCT00338949|560733230|FG001|Randomization|Withdrawal by Subject|0|||
155354265|NCT00338949|560733229|FG000|Randomization|Adverse Event|0|||
155354266|NCT00338949|560733230|FG001|Randomization|Adverse Event|5|||
155354267|NCT00878553|560733231|FG000|Sleep Study|Withdrawal by Subject|2|||
155354268|NCT00878553|560733232|FG001|Sleep Study|Withdrawal by Subject|0|||
155354269|NCT00878553|560733233|FG002|Sleep Study|Withdrawal by Subject|0|||
155354270|NCT00878553|560733234|FG003|Sleep Study|Withdrawal by Subject|0|||
155354271|NCT00878553|560733235|FG004|Sleep Study|Withdrawal by Subject|0|||
155354272|NCT00878553|560733231|FG000|Sleep Study|Lost to Follow-up|1|||
155354273|NCT00878553|560733232|FG001|Sleep Study|Lost to Follow-up|0|||
155426540|NCT03498521|560988148|FG000|Overall Study|Death|227|||
155426541|NCT03498521|560988149|FG001|Overall Study|Death|79|||
155426542|NCT03498521|560988150|FG002|Overall Study|Death|84|||
155426543|NCT03498521|560988148|FG000|Overall Study|Exclusion criteria|1|||
155426544|NCT03498521|560988149|FG001|Overall Study|Exclusion criteria|0|||
155426545|NCT03498521|560988150|FG002|Overall Study|Exclusion criteria|0|||
155426546|NCT03498521|560988148|FG000|Overall Study|Lost to Follow-up|4|||
155426547|NCT03498521|560988149|FG001|Overall Study|Lost to Follow-up|3|||
155426548|NCT03498521|560988150|FG002|Overall Study|Lost to Follow-up|3|||
155426549|NCT03498521|560988148|FG000|Overall Study|No profile due to technical failure|1|||
155426550|NCT03498521|560988149|FG001|Overall Study|No profile due to technical failure|0|||
155426551|NCT03498521|560988150|FG002|Overall Study|No profile due to technical failure|0|||
155426552|NCT03498521|560988148|FG000|Overall Study|Physician Decision|3|||
155426553|NCT03498521|560988149|FG001|Overall Study|Physician Decision|1|||
155354274|NCT00878553|560733233|FG002|Sleep Study|Lost to Follow-up|0|||
155354275|NCT00878553|560733234|FG003|Sleep Study|Lost to Follow-up|0|||
155354276|NCT00878553|560733235|FG004|Sleep Study|Lost to Follow-up|0|||
155354277|NCT00878553|560733231|FG000|Sleep Study|car accident|1|||
155354278|NCT00878553|560733232|FG001|Sleep Study|car accident|0|||
155354279|NCT00878553|560733233|FG002|Sleep Study|car accident|0|||
155354280|NCT00878553|560733234|FG003|Sleep Study|car accident|0|||
155354281|NCT00878553|560733235|FG004|Sleep Study|car accident|0|||
155426554|NCT03498521|560988150|FG002|Overall Study|Physician Decision|0|||
155354282|NCT00878553|560733231|FG000|Sleep Study|family emergency|1|||
155354283|NCT00878553|560733232|FG001|Sleep Study|family emergency|0|||
155354284|NCT00878553|560733233|FG002|Sleep Study|family emergency|0|||
155354285|NCT00878553|560733234|FG003|Sleep Study|family emergency|0|||
155354286|NCT00878553|560733235|FG004|Sleep Study|family emergency|0|||
155354287|NCT00878553|560733231|FG000|PK Study|Withdrawal by Subject|0|||
155354288|NCT00878553|560733232|FG001|PK Study|Withdrawal by Subject|0|||
155354289|NCT00878553|560733233|FG002|PK Study|Withdrawal by Subject|0|||
155354290|NCT00878553|560733234|FG003|PK Study|Withdrawal by Subject|1|||
155354291|NCT00878553|560733235|FG004|PK Study|Withdrawal by Subject|0|||
155506811|NCT01335399|561283443|FG001|Treatment Period|No longer meet study criteria|1|||
155506812|NCT01335399|561283442|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
155506813|NCT01335399|561283443|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
155506814|NCT03262233|561283444|FG000|Overall Study|Withdrawal by Subject|12|||
155506815|NCT03262233|561283445|FG001|Overall Study|Withdrawal by Subject|8|||
155506816|NCT03262233|561283446|FG002|Overall Study|Withdrawal by Subject|21|||
155506817|NCT03262233|561283447|FG003|Overall Study|Withdrawal by Subject|13|||
155354292|NCT03517111|560733236|FG000|Enrolled|Withdrawal by Subject|0|||
155354293|NCT03517111|560733237|FG001|Enrolled|Withdrawal by Subject|1|||
155354294|NCT03517111|560733238|FG002|Enrolled|Withdrawal by Subject|0|||
155354295|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
155354296|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
155354297|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
155354298|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
155354299|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
155354300|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
155354301|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
155506818|NCT03262233|561283444|FG000|Overall Study|Declined due to shock|1|||
155506819|NCT03262233|561283445|FG001|Overall Study|Declined due to shock|2|||
155506820|NCT03262233|561283446|FG002|Overall Study|Declined due to shock|2|||
155506821|NCT03262233|561283447|FG003|Overall Study|Declined due to shock|3|||
155354302|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
155354303|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
155354304|NCT03517111|560733236|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
155354305|NCT03517111|560733237|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
155506822|NCT03262233|561283444|FG000|Overall Study|Protocol Violation|5|||
155506823|NCT03262233|561283445|FG001|Overall Study|Protocol Violation|10|||
155506824|NCT03262233|561283446|FG002|Overall Study|Protocol Violation|2|||
155354306|NCT03517111|560733238|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
155354307|NCT03188536|560733239|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
155354308|NCT03188536|560733239|FG000|Overall Study|Not participated/met inclusion criteria|1|||
155354309|NCT01930214|560733240|FG000|Overall Study|Death|4|||
155354310|NCT01930214|560733241|FG001|Overall Study|Death|4|||
155354311|NCT01930214|560733242|FG002|Overall Study|Death|11|||
155354312|NCT01930214|560733240|FG000|Overall Study|Lost to Follow-up|12|||
155354313|NCT01930214|560733241|FG001|Overall Study|Lost to Follow-up|13|||
155426555|NCT03498521|560988148|FG000|Overall Study|Withdrawal by Subject|11|||
155426556|NCT03498521|560988149|FG001|Overall Study|Withdrawal by Subject|6|||
155426557|NCT03498521|560988150|FG002|Overall Study|Withdrawal by Subject|2|||
155426558|NCT03498521|560988148|FG000|Overall Study|Study terminated by sponsor|79|||
155426559|NCT03498521|560988149|FG001|Overall Study|Study terminated by sponsor|21|||
155354314|NCT01930214|560733242|FG002|Overall Study|Lost to Follow-up|12|||
155354315|NCT01930214|560733240|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
155354316|NCT01930214|560733241|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
155354317|NCT01930214|560733242|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
155354318|NCT01930214|560733240|FG000|Overall Study|Physician Decision|2|||
155354319|NCT01930214|560733241|FG001|Overall Study|Physician Decision|0|||
155354320|NCT01930214|560733242|FG002|Overall Study|Physician Decision|0|||
155354321|NCT00025662|560733245|FG000|Overall Study|Withdrawal by Subject|2|||
155354322|NCT00025662|560733245|FG000|Overall Study|Technical failure of manipulation|1|||
155354323|NCT02062645|560733248|FG000|Overall Study|Adverse Event|2|||
155354324|NCT02062645|560733248|FG000|Overall Study|Protocol Violation|8|||
155354325|NCT02062645|560733248|FG000|Overall Study|Lost to Follow-up|5|||
155354326|NCT02864342|560733250|FG000|Overall Study|Eligibility Criteria Deviation|2|||
155354327|NCT02864342|560733251|FG001|Overall Study|Eligibility Criteria Deviation|3|||
155354328|NCT02864342|560733250|FG000|Overall Study|Withdrawal by Subject|4|||
155354329|NCT02864342|560733251|FG001|Overall Study|Withdrawal by Subject|2|||
155354330|NCT02864342|560733250|FG000|Overall Study|Device Technology Issue|6|||
155354331|NCT02864342|560733251|FG001|Overall Study|Device Technology Issue|7|||
155354332|NCT02864342|560733250|FG000|Overall Study|Death|0|||
155354333|NCT02864342|560733251|FG001|Overall Study|Death|1|||
155354334|NCT02864342|560733250|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
155354335|NCT02864342|560733251|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
155354336|NCT02864342|560733250|FG000|Overall Study|Lost to Follow-up|1|||
155354337|NCT02864342|560733251|FG001|Overall Study|Lost to Follow-up|5|||
155354338|NCT02864342|560733250|FG000|Overall Study|Lost Device|1|||
155354339|NCT02864342|560733251|FG001|Overall Study|Lost Device|0|||
155354340|NCT02864342|560733250|FG000|Overall Study|Adverse Event|1|||
155354341|NCT02864342|560733251|FG001|Overall Study|Adverse Event|0|||
155354342|NCT00118703|560733252|FG000|Overall Study|Protocol Violation|1|||
155354343|NCT00118703|560733253|FG001|Overall Study|Protocol Violation|0|||
155354344|NCT00118703|560733252|FG000|Overall Study|Adverse Event|1|||
155354345|NCT00118703|560733253|FG001|Overall Study|Adverse Event|1|||
155354346|NCT00118703|560733252|FG000|Overall Study|Participant took two different treatment|0|||
155354347|NCT00118703|560733253|FG001|Overall Study|Participant took two different treatment|1|||
155354348|NCT00118703|560733252|FG000|Overall Study|Withdrawal by Subject|2|||
155354349|NCT00118703|560733253|FG001|Overall Study|Withdrawal by Subject|5|||
155354350|NCT00118703|560733252|FG000|Overall Study|Lost to Follow-up|1|||
155354351|NCT00118703|560733253|FG001|Overall Study|Lost to Follow-up|2|||
155354352|NCT02261285|560733254|FG000|Overall Study|Disease progression|0|||
155354353|NCT02261285|560733255|FG001|Overall Study|Disease progression|0|||
155354354|NCT02261285|560733256|FG002|Overall Study|Disease progression|1|||
155354355|NCT02344173|560733257|FG000|Procedure|Ablation Procedure Not Performed|7|||
155354356|NCT02344173|560733257|FG000|12-month Visit|Death|8|||
155354357|NCT02344173|560733257|FG000|12-month Visit|Withdrawal by Subject|30|||
155354358|NCT02344173|560733257|FG000|12-month Visit|Lost to Follow-up|58|||
155354359|NCT01209286|560733258|FG000|Overall Study|Adverse Event|4|||
155354360|NCT01209286|560733259|FG001|Overall Study|Adverse Event|3|||
155354361|NCT01209286|560733260|FG002|Overall Study|Adverse Event|1|||
155354362|NCT01209286|560733258|FG000|Overall Study|Hematological Relapse After Remission|0|||
155426560|NCT03498521|560988150|FG002|Overall Study|Study terminated by sponsor|4|||
155426561|NCT02612909|560989813|FG000|Phase 2|Withdrawal by Subject|2|||
155426562|NCT02612909|560989814|FG001|Phase 2|Withdrawal by Subject|5|||
155426563|NCT02612909|560989815|FG002|Phase 2|Withdrawal by Subject|0|||
155426564|NCT02612909|560989816|FG003|Phase 2|Withdrawal by Subject|0|||
155426565|NCT02612909|560989817|FG004|Phase 2|Withdrawal by Subject|0|||
155426566|NCT02612909|560989813|FG000|Phase 2|Pregnancy|0|||
155426567|NCT02612909|560989814|FG001|Phase 2|Pregnancy|0|||
155426568|NCT02612909|560989815|FG002|Phase 2|Pregnancy|1|||
155426569|NCT02612909|560989816|FG003|Phase 2|Pregnancy|0|||
155426570|NCT02612909|560989817|FG004|Phase 2|Pregnancy|0|||
155426571|NCT02612909|560989813|FG000|Phase 3|Withdrawal by Subject|0|||
155426572|NCT02612909|560989814|FG001|Phase 3|Withdrawal by Subject|0|||
155426573|NCT02612909|560989815|FG002|Phase 3|Withdrawal by Subject|0|||
155426574|NCT02612909|560989816|FG003|Phase 3|Withdrawal by Subject|1|||
155354363|NCT01209286|560733259|FG001|Overall Study|Hematological Relapse After Remission|1|||
155354364|NCT01209286|560733260|FG002|Overall Study|Hematological Relapse After Remission|1|||
155354365|NCT01209286|560733258|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
155354366|NCT01209286|560733259|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
155354367|NCT01209286|560733260|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
155354368|NCT01209286|560733258|FG000|Overall Study|Physician Decision|0|||
155354369|NCT01209286|560733259|FG001|Overall Study|Physician Decision|2|||
155354370|NCT01209286|560733260|FG002|Overall Study|Physician Decision|0|||
155354371|NCT01209286|560733258|FG000|Overall Study|Other|0|||
155354372|NCT01209286|560733259|FG001|Overall Study|Other|1|||
155506825|NCT03262233|561283447|FG003|Overall Study|Protocol Violation|13|||
155354373|NCT01209286|560733260|FG002|Overall Study|Other|0|||
155354374|NCT01349036|560733261|FG000|Overall Study|Disease progression|13|||
155354375|NCT01349036|560733262|FG001|Overall Study|Disease progression|22|||
155354376|NCT01349036|560733261|FG000|Overall Study|Other|1|||
155354377|NCT01349036|560733262|FG001|Overall Study|Other|0|||
155354378|NCT01349036|560733261|FG000|Overall Study|Withdrawal by Subject|0|||
155354379|NCT01349036|560733262|FG001|Overall Study|Withdrawal by Subject|2|||
155354380|NCT01161628|560733263|FG000|Overall Study|Death|6|||
155354381|NCT01161628|560733263|FG000|Overall Study|Lack of Efficacy|2|||
155354382|NCT01263925|560733266|FG000|Overall Study|Protocol Violation|1|||
155354383|NCT01263925|560733267|FG001|Overall Study|Protocol Violation|0|||
155354384|NCT01263925|560733266|FG000|Overall Study|Lack of Efficacy|0|||
155354385|NCT01263925|560733267|FG001|Overall Study|Lack of Efficacy|1|||
155354386|NCT01263925|560733266|FG000|Overall Study|Adverse Event|23|||
155354387|NCT01263925|560733267|FG001|Overall Study|Adverse Event|22|||
155354388|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
155354389|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
155354390|NCT01263925|560733266|FG000|Overall Study|Withdrawal by Subject|6|||
155354391|NCT01263925|560733267|FG001|Overall Study|Withdrawal by Subject|8|||
155354392|NCT01263925|560733266|FG000|Overall Study|Other|4|||
155354393|NCT01263925|560733267|FG001|Overall Study|Other|4|||
155354394|NCT01263925|560733266|FG000|Overall Study|Lost to Follow-up|3|||
155354395|NCT01263925|560733267|FG001|Overall Study|Lost to Follow-up|1|||
155354396|NCT01263925|560733266|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
155354397|NCT01263925|560733267|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
155354398|NCT01263925|560733266|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
155354399|NCT01263925|560733267|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
155354400|NCT01263925|560733266|FG000|Overall Study|AE/ Withdrawal|1|||
155354401|NCT01263925|560733267|FG001|Overall Study|AE/ Withdrawal|4|||
155354402|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
155354403|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
155354404|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
155354405|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
155354406|NCT01263925|560733266|FG000|Overall Study|Withdrawal/ Not specified|0|||
155354407|NCT01263925|560733267|FG001|Overall Study|Withdrawal/ Not specified|1|||
155354408|NCT03029819|560733268|FG000|Overall Study|Lost to Follow-up|3|||
155354409|NCT03029819|560733269|FG001|Overall Study|Lost to Follow-up|5|||
155354410|NCT03029819|560733268|FG000|Overall Study|Removed due to disruptive behavior|0|||
155354411|NCT03029819|560733269|FG001|Overall Study|Removed due to disruptive behavior|1|||
155354412|NCT01215032|560733273|FG000|Overall Study|Adverse Event|3|||
155354413|NCT01215032|560733273|FG000|Overall Study|Lack of Efficacy|17|||
155354414|NCT01020747|560733278|FG000|Overall Study|Withdrawal by Subject|1|||
155354415|NCT02970305|560733279|FG000|Overall Study|Adverse Event|10|||
155354416|NCT02970305|560733280|FG001|Overall Study|Adverse Event|6|||
155354417|NCT02970305|560733279|FG000|Overall Study|Lack of Efficacy|1|||
155354418|NCT02970305|560733280|FG001|Overall Study|Lack of Efficacy|1|||
155354419|NCT02970305|560733279|FG000|Overall Study|Noncompliance with study drug|2|||
155354420|NCT02970305|560733280|FG001|Overall Study|Noncompliance with study drug|4|||
155506826|NCT03262233|561283444|FG000|Overall Study|data collection artifact|0|||
155506827|NCT03262233|561283445|FG001|Overall Study|data collection artifact|1|||
155354421|NCT02970305|560733279|FG000|Overall Study|Protocol Violation|2|||
155354422|NCT02970305|560733280|FG001|Overall Study|Protocol Violation|2|||
155354423|NCT02970305|560733279|FG000|Overall Study|Withdrawal by Subject|12|||
155354424|NCT02970305|560733280|FG001|Overall Study|Withdrawal by Subject|11|||
155354425|NCT02970305|560733279|FG000|Overall Study|Not further specified|1|||
155354426|NCT02970305|560733280|FG001|Overall Study|Not further specified|2|||
155354427|NCT02970305|560733279|FG000|Overall Study|Lost to Follow-up|1|||
155354428|NCT02970305|560733280|FG001|Overall Study|Lost to Follow-up|2|||
155354429|NCT02175745|560733281|FG000|Overall Study|Not Eligible|1|||
155354430|NCT00983892|560733282|FG000|Overall Study|Withdrawal by Subject|10|||
155354431|NCT00983892|560733283|FG001|Overall Study|Withdrawal by Subject|12|||
155354432|NCT00808899|560733284|FG000|Overall Study|Death|1|||
155354433|NCT00808899|560733284|FG000|Overall Study|Physician Decision|3|||
155354434|NCT02881047|560733285|FG000|Overall Study|Adverse Event|1|||
155354435|NCT02881047|560733285|FG000|Overall Study|Withdrawal by Subject|1|||
155354436|NCT01726517|560733286|FG000|Overall Study|Withdrawal by Subject|0|||
155354437|NCT01726517|560733287|FG001|Overall Study|Withdrawal by Subject|0|||
155354438|NCT01726517|560733288|FG002|Overall Study|Withdrawal by Subject|1|||
155354439|NCT01726517|560733289|FG003|Overall Study|Withdrawal by Subject|0|||
155354440|NCT01726517|560733290|FG004|Overall Study|Withdrawal by Subject|0|||
155354441|NCT03765164|560733295|FG000|Pre-intervention|Withdrawal by Subject|5|||
155354442|NCT03765164|560733296|FG001|Pre-intervention|Withdrawal by Subject|6|||
155354443|NCT01813305|560733297|FG000|Overall Study|Withdrawal by Subject|12|||
155354444|NCT01813305|560733298|FG001|Overall Study|Withdrawal by Subject|5|||
155354445|NCT01813305|560733297|FG000|Overall Study|Safety Concern|4|||
155354446|NCT01813305|560733298|FG001|Overall Study|Safety Concern|0|||
155354447|NCT01813305|560733297|FG000|Overall Study|Ulcer became worse|4|||
155354448|NCT01813305|560733298|FG001|Overall Study|Ulcer became worse|0|||
155354449|NCT01813305|560733297|FG000|Overall Study|Physician Decision|4|||
155354450|NCT01813305|560733298|FG001|Overall Study|Physician Decision|0|||
155354451|NCT01813305|560733297|FG000|Overall Study|Lost to Follow-up|3|||
155354452|NCT01813305|560733298|FG001|Overall Study|Lost to Follow-up|1|||
155354453|NCT01813305|560733297|FG000|Overall Study|Protocol Violation|1|||
155354454|NCT01813305|560733298|FG001|Overall Study|Protocol Violation|0|||
155354455|NCT01813305|560733297|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
155354456|NCT01813305|560733298|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
155354457|NCT00770588|560733302|FG000|Overall Study|Adverse Event|9|||
155354458|NCT00770588|560733303|FG001|Overall Study|Adverse Event|2|||
155506828|NCT03262233|561283446|FG002|Overall Study|data collection artifact|0|||
155354459|NCT00770588|560733302|FG000|Overall Study|Death caused by progression of disease|70|||
155354460|NCT00770588|560733303|FG001|Overall Study|Death caused by progression of disease|91|||
155354461|NCT00770588|560733302|FG000|Overall Study|Lost to Follow-up|1|||
155354462|NCT00770588|560733303|FG001|Overall Study|Lost to Follow-up|1|||
155354463|NCT00770588|560733302|FG000|Overall Study|Withdrawal by Subject|1|||
155506829|NCT03262233|561283447|FG003|Overall Study|data collection artifact|0|||
155506830|NCT01120600|561283448|FG000|Overall Study|Adverse Event|7|||
155506831|NCT01120600|561283449|FG001|Overall Study|Adverse Event|7|||
155506832|NCT01120600|561283448|FG000|Overall Study|Excessive Bone Loss|0|||
155506833|NCT01120600|561283449|FG001|Overall Study|Excessive Bone Loss|4|||
155506834|NCT01120600|561283448|FG000|Overall Study|Lost to Follow-up|1|||
155506835|NCT01120600|561283449|FG001|Overall Study|Lost to Follow-up|3|||
155506836|NCT01120600|561283448|FG000|Overall Study|Physician Decision|1|||
155506837|NCT01120600|561283449|FG001|Overall Study|Physician Decision|3|||
155506838|NCT01120600|561283448|FG000|Overall Study|Protocol Violation|0|||
155506839|NCT01120600|561283449|FG001|Overall Study|Protocol Violation|4|||
155506840|NCT01120600|561283448|FG000|Overall Study|Withdrawal by Subject|10|||
155506841|NCT01120600|561283449|FG001|Overall Study|Withdrawal by Subject|11|||
155506842|NCT01165242|561283452|FG000|Overall Study|Unreachable Subjects|1|||
155506843|NCT01165242|561283453|FG001|Overall Study|Unreachable Subjects|0|||
155506844|NCT01165242|561283454|FG002|Overall Study|Unreachable Subjects|0|||
155506845|NCT01165242|561283452|FG000|Overall Study|Incarcerated Subjects|0|||
155506846|NCT01165242|561283453|FG001|Overall Study|Incarcerated Subjects|1|||
155506847|NCT01165242|561283454|FG002|Overall Study|Incarcerated Subjects|0|||
155506848|NCT01165242|561283452|FG000|Overall Study|Visit 2 Declined by Subject|0|||
155506849|NCT01165242|561283453|FG001|Overall Study|Visit 2 Declined by Subject|0|||
155506850|NCT01165242|561283454|FG002|Overall Study|Visit 2 Declined by Subject|1|||
155506851|NCT01165242|561283452|FG000|Overall Study|Withdrawal by Subject|0|||
155506852|NCT01165242|561283453|FG001|Overall Study|Withdrawal by Subject|2|||
155506853|NCT01165242|561283454|FG002|Overall Study|Withdrawal by Subject|2|||
155506854|NCT01165242|561283452|FG000|Overall Study|Extended Holiday|0|||
155506855|NCT01165242|561283453|FG001|Overall Study|Extended Holiday|0|||
155506856|NCT01165242|561283454|FG002|Overall Study|Extended Holiday|1|||
155506857|NCT01165242|561283452|FG000|Overall Study|Lost to Follow-up|9|||
155506858|NCT01165242|561283453|FG001|Overall Study|Lost to Follow-up|7|||
155506859|NCT01165242|561283454|FG002|Overall Study|Lost to Follow-up|10|||
155354464|NCT00770588|560733303|FG001|Overall Study|Withdrawal by Subject|1|||
155354465|NCT01424189|560733304|FG000|Overall Study|Adverse Event|1|||
155354466|NCT01424189|560733305|FG001|Overall Study|Adverse Event|0|||
155354467|NCT01424189|560733304|FG000|Overall Study|Lost to Follow-up|4|||
155354468|NCT01424189|560733305|FG001|Overall Study|Lost to Follow-up|1|||
155354469|NCT01424189|560733304|FG000|Overall Study|Withdrawal by Subject|4|||
155506860|NCT03877237|561283455|FG000|Overall Study|Adverse Event|1|||
155506861|NCT03877237|561283456|FG001|Overall Study|Adverse Event|2|||
155506862|NCT03877237|561283455|FG000|Overall Study|Death|3|||
155506863|NCT03877237|561283456|FG001|Overall Study|Death|2|||
155506864|NCT03877237|561283455|FG000|Overall Study|Physician Decision|1|||
155506865|NCT03877237|561283456|FG001|Overall Study|Physician Decision|0|||
155506866|NCT03877237|561283455|FG000|Overall Study|Withdrawal by Subject|0|||
155506867|NCT03877237|561283456|FG001|Overall Study|Withdrawal by Subject|2|||
155506868|NCT03372083|561283458|FG000|Overall Study|Adverse Event|3|||
155506869|NCT03372083|561283458|FG000|Overall Study|Physician Decision|1|||
155506870|NCT03372083|561283458|FG000|Overall Study|Withdrawal by Subject|1|||
155506871|NCT00566098|561283459|FG000|Collection of MILs|Withdrawal by Subject|1|||
155506872|NCT00566098|561283459|FG000|Collection of MILs|Relapsed|1|||
155506873|NCT00566098|561283459|FG000|Generation of MILs Product|Relapsed|1|||
155506874|NCT00566098|561283459|FG000|Administration of ASCT+MILs|Death|10|||
155506875|NCT00566098|561283459|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
155506876|NCT01690520|561283460|FG000|Overall Study|Death|25|||
155506877|NCT01690520|561283461|FG001|Overall Study|Death|21|||
155506878|NCT01690520|561283460|FG000|Overall Study|Lost to Follow-up|2|||
155506879|NCT01690520|561283461|FG001|Overall Study|Lost to Follow-up|3|||
155506880|NCT01690520|561283460|FG000|Overall Study|Withdrawal by Subject|2|||
155506881|NCT01690520|561283461|FG001|Overall Study|Withdrawal by Subject|0|||
155506882|NCT01690520|561283460|FG000|Overall Study|Relapse|0|||
155506883|NCT01690520|561283461|FG001|Overall Study|Relapse|1|||
155506884|NCT01690520|561283460|FG000|Overall Study|Other|0|||
155506885|NCT01690520|561283461|FG001|Overall Study|Other|1|||
155506886|NCT01690520|561283460|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
155506887|NCT01690520|561283461|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
155506888|NCT02236754|561283462|FG000|Overall Study|Withdrawal by Subject|1|||
155506889|NCT02236754|561283463|FG001|Overall Study|Withdrawal by Subject|0|||
155506890|NCT01270841|561283464|FG000|Overall Study|Adverse Event|0|||
155506891|NCT01270841|561283465|FG001|Overall Study|Adverse Event|1|||
155506892|NCT01270841|561283466|FG002|Overall Study|Adverse Event|0|||
155506893|NCT01270841|561283467|FG003|Overall Study|Adverse Event|3|||
155506894|NCT01270841|561283464|FG000|Overall Study|Withdrawal by Subject|3|||
155506895|NCT01270841|561283465|FG001|Overall Study|Withdrawal by Subject|2|||
155506896|NCT01270841|561283466|FG002|Overall Study|Withdrawal by Subject|3|||
155506897|NCT01270841|561283467|FG003|Overall Study|Withdrawal by Subject|3|||
155506898|NCT01270841|561283464|FG000|Overall Study|Lost to Follow-up|3|||
155506899|NCT01270841|561283465|FG001|Overall Study|Lost to Follow-up|1|||
155506900|NCT01270841|561283466|FG002|Overall Study|Lost to Follow-up|4|||
155506901|NCT01270841|561283467|FG003|Overall Study|Lost to Follow-up|2|||
155506902|NCT01270841|561283464|FG000|Overall Study|Physician Decision|0|||
155506903|NCT01270841|561283465|FG001|Overall Study|Physician Decision|1|||
155506904|NCT01270841|561283466|FG002|Overall Study|Physician Decision|0|||
155506905|NCT01270841|561283467|FG003|Overall Study|Physician Decision|0|||
155506906|NCT01270841|561283464|FG000|Overall Study|Did not qualify|6|||
155506907|NCT01270841|561283465|FG001|Overall Study|Did not qualify|3|||
155506908|NCT01270841|561283466|FG002|Overall Study|Did not qualify|4|||
155506909|NCT01270841|561283467|FG003|Overall Study|Did not qualify|5|||
155506910|NCT01270841|561283464|FG000|Overall Study|Protocol Violation|1|||
155506911|NCT01270841|561283465|FG001|Overall Study|Protocol Violation|5|||
155506912|NCT01270841|561283466|FG002|Overall Study|Protocol Violation|0|||
155506913|NCT01270841|561283467|FG003|Overall Study|Protocol Violation|0|||
155506914|NCT01270841|561283464|FG000|Overall Study|Enrolled in error|0|||
155506915|NCT01270841|561283465|FG001|Overall Study|Enrolled in error|1|||
155506916|NCT01270841|561283466|FG002|Overall Study|Enrolled in error|0|||
155506917|NCT01270841|561283467|FG003|Overall Study|Enrolled in error|0|||
155506918|NCT02092961|561283468|FG000|Overall Study|Not reported|1|||
155506919|NCT02092961|561283469|FG001|Overall Study|Not reported|0|||
155506920|NCT02092961|561283470|FG002|Overall Study|Not reported|1|||
155506921|NCT02092961|561283468|FG000|Overall Study|Study stopped|13|||
155506922|NCT02092961|561283469|FG001|Overall Study|Study stopped|9|||
155506923|NCT02092961|561283470|FG002|Overall Study|Study stopped|12|||
155506924|NCT02092961|561283468|FG000|Overall Study|Lack of therapeutic response|2|||
155506925|NCT02092961|561283469|FG001|Overall Study|Lack of therapeutic response|1|||
155506926|NCT02092961|561283470|FG002|Overall Study|Lack of therapeutic response|3|||
155506927|NCT02092961|561283468|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
155506928|NCT02092961|561283469|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
155506929|NCT02092961|561283470|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
155506930|NCT02092961|561283468|FG000|Overall Study|Adverse Event|2|||
155506931|NCT02092961|561283469|FG001|Overall Study|Adverse Event|4|||
155506932|NCT02092961|561283470|FG002|Overall Study|Adverse Event|0|||
155506933|NCT01623830|561283473|FG000|Overall Study|Withdrawal by Subject|6|||
155506934|NCT01623830|561283474|FG001|Overall Study|Withdrawal by Subject|7|||
155506935|NCT01623830|561283473|FG000|Overall Study|Exclusion from Study|1|||
155506936|NCT01623830|561283474|FG001|Overall Study|Exclusion from Study|2|||
155506937|NCT01859390|561283475|FG000|Overall Study|Insufficient Sputum Collected|1|||
155506938|NCT01859390|561283476|FG001|Overall Study|Insufficient Sputum Collected|3|||
155354470|NCT01424189|560733305|FG001|Overall Study|Withdrawal by Subject|4|||
155354471|NCT01424189|560733304|FG000|Overall Study|Subject moved|1|||
155354472|NCT01424189|560733305|FG001|Overall Study|Subject moved|0|||
155354473|NCT01424189|560733304|FG000|Overall Study|Death|3|||
155354474|NCT01424189|560733305|FG001|Overall Study|Death|1|||
155354475|NCT03120949|560733306|FG000|Overall Study|randomized in error|1|||
155354476|NCT03120949|560733307|FG001|Overall Study|randomized in error|0|||
155354477|NCT03120949|560733306|FG000|Overall Study|Death|13|||
155354478|NCT03120949|560733307|FG001|Overall Study|Death|13|||
155354479|NCT03120949|560733306|FG000|Overall Study|Lost to Follow-up|23|||
155354480|NCT03120949|560733307|FG001|Overall Study|Lost to Follow-up|13|||
155354481|NCT03120949|560733306|FG000|Overall Study|Withdrawal by Subject|139|||
155354482|NCT03120949|560733307|FG001|Overall Study|Withdrawal by Subject|124|||
155354483|NCT03120949|560733306|FG000|Overall Study|Covid-19|43|||
155354484|NCT03120949|560733307|FG001|Overall Study|Covid-19|34|||
155354485|NCT03120949|560733306|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
155354486|NCT03120949|560733307|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
155354487|NCT03120949|560733306|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
155354488|NCT03120949|560733307|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
155354489|NCT03120949|560733306|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
155354490|NCT03120949|560733307|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
155354491|NCT03120949|560733306|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
155354492|NCT03120949|560733307|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
155354493|NCT03120949|560733306|FG000|Overall Study|Site was closed|2|||
155354494|NCT03120949|560733307|FG001|Overall Study|Site was closed|3|||
155354495|NCT03120949|560733306|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
155354496|NCT03120949|560733307|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
155354497|NCT03120949|560733306|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
155354498|NCT03120949|560733307|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
155354499|NCT03120949|560733306|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
155354500|NCT03120949|560733307|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
155354501|NCT03120949|560733306|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
155354502|NCT03120949|560733307|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
155354503|NCT03120949|560733306|FG000|Overall Study|Other: Adverse Event|0|||
155354504|NCT03120949|560733307|FG001|Overall Study|Other: Adverse Event|1|||
155354505|NCT03120949|560733306|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
155354506|NCT03120949|560733307|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
155354507|NCT03120949|560733306|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
155354508|NCT03120949|560733307|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
155354509|NCT03120949|560733306|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
155354510|NCT03120949|560733307|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
155354511|NCT03120949|560733306|FG000|Overall Study|Personal Reasons|0|||
155354512|NCT03120949|560733307|FG001|Overall Study|Personal Reasons|1|||
155354513|NCT03120949|560733306|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
155354514|NCT03120949|560733307|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
155354515|NCT03120949|560733306|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
155354516|NCT03120949|560733307|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
155354517|NCT03120949|560733306|FG000|Overall Study|Compliance With Medication|0|||
155354518|NCT03120949|560733307|FG001|Overall Study|Compliance With Medication|1|||
155354519|NCT03120949|560733306|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
155354520|NCT03120949|560733307|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
155354521|NCT03120949|560733306|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
155354522|NCT03120949|560733307|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
155354523|NCT03120949|560733306|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
155354524|NCT03120949|560733307|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
155354525|NCT01705145|560733308|FG000|Part B|Adverse Event|1|||
155354526|NCT01203956|560733309|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
155354527|NCT01203956|560733310|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
155354528|NCT02230306|560733313|FG000|Overall Study|Did not receive study treatment|1|||
155354529|NCT00312845|560733314|FG000|Overall Study|Adverse Event|19|||
155354530|NCT00312845|560733315|FG001|Overall Study|Adverse Event|5|||
155354531|NCT00312845|560733314|FG000|Overall Study|Death|2|||
155354532|NCT00312845|560733315|FG001|Overall Study|Death|2|||
155354533|NCT00312845|560733314|FG000|Overall Study|Withdrawal by Subject|14|||
155354534|NCT00312845|560733315|FG001|Overall Study|Withdrawal by Subject|6|||
155354535|NCT00312845|560733314|FG000|Overall Study|Disease Progression|56|||
155354536|NCT00312845|560733315|FG001|Overall Study|Disease Progression|77|||
155354537|NCT00312845|560733314|FG000|Overall Study|Lost to Follow-up|2|||
155354538|NCT00312845|560733315|FG001|Overall Study|Lost to Follow-up|0|||
155354539|NCT00312845|560733314|FG000|Overall Study|Other|6|||
155354540|NCT00312845|560733315|FG001|Overall Study|Other|5|||
155354541|NCT02212197|560733316|FG000|Overall Study|Need for radiotherapy|1|||
155354542|NCT02212197|560733317|FG001|Overall Study|Need for radiotherapy|0|||
155354543|NCT02212197|560733318|FG002|Overall Study|Need for radiotherapy|0|||
155354544|NCT01077622|560733320|FG000|Overall Study|Physician Decision|2|||
155354545|NCT01077622|560733320|FG000|Overall Study|Withdrawal by Subject|1|||
155354546|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
155354547|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
155354548|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
155354549|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
155354550|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
155354551|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
155354552|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
155354553|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
155354554|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
155354555|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
155354556|NCT01503164|560733322|FG000|Overall Study|Withdrawal by Subject|2|||
155354557|NCT01503164|560733323|FG001|Overall Study|Withdrawal by Subject|1|||
155354558|NCT04088136|560733324|FG000|Overall Study|Withdrawal by Subject|5|||
155354559|NCT04088136|560733325|FG001|Overall Study|Withdrawal by Subject|0|||
155354560|NCT04088136|560733324|FG000|Overall Study|Lack of Efficacy|0|||
155354561|NCT04088136|560733325|FG001|Overall Study|Lack of Efficacy|1|||
155354562|NCT02473913|560733326|FG000|Overall Study|Lost to Follow-up|3|||
155354563|NCT02473913|560733327|FG001|Overall Study|Lost to Follow-up|3|||
155426575|NCT02612909|560989817|FG004|Phase 3|Withdrawal by Subject|0|||
155354564|NCT05041439|560733328|FG000|Overall Study|Withdrawal by Subject|1|||
155354565|NCT05041439|560733329|FG001|Overall Study|Withdrawal by Subject|1|||
155354566|NCT05041439|560733328|FG000|Overall Study|Death|1|||
155354567|NCT05041439|560733329|FG001|Overall Study|Death|0|||
155354568|NCT02979613|560733332|FG000|Double-Blind Phase|Withdrew Consent|2|||
155354569|NCT02979613|560733333|FG001|Double-Blind Phase|Withdrew Consent|4|||
155354570|NCT02979613|560733332|FG000|Double-Blind Phase|Pregnancy|2|||
155354571|NCT02979613|560733333|FG001|Double-Blind Phase|Pregnancy|2|||
155354572|NCT02979613|560733332|FG000|Double-Blind Phase|Adverse Event|2|||
155354573|NCT02979613|560733333|FG001|Double-Blind Phase|Adverse Event|0|||
155354574|NCT02979613|560733332|FG000|Double-Blind Phase|Lost to Follow-up|1|||
155354575|NCT02979613|560733333|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155354576|NCT02979613|560733332|FG000|Double-Blind Phase|Protocol Violation|1|||
155354577|NCT02979613|560733333|FG001|Double-Blind Phase|Protocol Violation|1|||
155354578|NCT02979613|560733332|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
155354579|NCT02979613|560733333|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
155354580|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
155354581|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
155354582|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
155354583|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
155354584|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Death|0|||
155354585|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Death|1|||
155354586|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
155354587|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
155354588|NCT02250183|560733339|FG000|Overall Study|Withdrawal by Subject|2|||
155354589|NCT02250183|560733339|FG000|Overall Study|Adverse Event|5|||
155354590|NCT02250183|560733339|FG000|Overall Study|Lost to Follow-up|1|||
155354591|NCT03282799|560733340|FG000|Overall Study|Pregnancy|1|||
155354592|NCT03282799|560733341|FG001|Overall Study|Pregnancy|0|||
155354593|NCT03282799|560733340|FG000|Overall Study|Physician Decision|1|||
155354594|NCT03282799|560733341|FG001|Overall Study|Physician Decision|0|||
155354595|NCT03749616|560733342|FG000|Overall Study|Lost to Follow-up|4|||
155354596|NCT03749616|560733343|FG001|Overall Study|Lost to Follow-up|7|||
155354597|NCT03749616|560733342|FG000|Overall Study|Screen Failure|1|||
155354598|NCT03749616|560733343|FG001|Overall Study|Screen Failure|1|||
155354599|NCT03749616|560733342|FG000|Overall Study|Withdrawal by Subject|2|||
155354600|NCT03749616|560733343|FG001|Overall Study|Withdrawal by Subject|0|||
155354601|NCT03614676|560734891|FG000|Overall Study|Delivery before planned visit|2|||
155354602|NCT03614676|560734892|FG001|Overall Study|Delivery before planned visit|0|||
155354603|NCT03614676|560734891|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
155354604|NCT03614676|560734892|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
155354605|NCT03614676|560734891|FG000|Overall Study|Migrated / moved from the study area|30|||
155354606|NCT03614676|560734892|FG001|Overall Study|Migrated / moved from the study area|22|||
155354607|NCT03614676|560734891|FG000|Overall Study|Lost to Follow-up|17|||
155354608|NCT03614676|560734892|FG001|Overall Study|Lost to Follow-up|42|||
155354609|NCT03614676|560734891|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
155354610|NCT03614676|560734892|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
155354611|NCT03614676|560734891|FG000|Overall Study|Other|16|||
155354612|NCT03614676|560734892|FG001|Overall Study|Other|47|||
155354613|NCT03614676|560734891|FG000|Overall Study|Protocol Violation|0|||
155354614|NCT03614676|560734892|FG001|Overall Study|Protocol Violation|2|||
155354615|NCT03614676|560734891|FG000|Overall Study|Neonatal event of interest|0|||
155354616|NCT03614676|560734892|FG001|Overall Study|Neonatal event of interest|6|||
155354617|NCT03614676|560734891|FG000|Overall Study|Death in infant greater than 28 days old|0|||
155354618|NCT03614676|560734892|FG001|Overall Study|Death in infant greater than 28 days old|12|||
155354619|NCT03614676|560734891|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
155354620|NCT03614676|560734892|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
155354621|NCT02388347|560734893|FG000|Overall Study|Withdrawal by Subject|0|||
155354622|NCT02388347|560734894|FG001|Overall Study|Withdrawal by Subject|0|||
155354623|NCT02388347|560734895|FG002|Overall Study|Withdrawal by Subject|1|||
155354624|NCT02388347|560734896|FG003|Overall Study|Withdrawal by Subject|0|||
155354625|NCT02388347|560734897|FG004|Overall Study|Withdrawal by Subject|0|||
155354626|NCT00497874|560734898|FG000|Overall Study|Withdrawal by Subject|48|||
155354627|NCT00497874|560734899|FG001|Overall Study|Withdrawal by Subject|17|||
155354628|NCT00497874|560734898|FG000|Overall Study|Illness|8|||
155354629|NCT00497874|560734899|FG001|Overall Study|Illness|4|||
155354630|NCT00497874|560734898|FG000|Overall Study|Death|2|||
155354631|NCT00497874|560734899|FG001|Overall Study|Death|4|||
155354632|NCT00497874|560734898|FG000|Overall Study|Unable to contact|52|||
155354633|NCT00497874|560734899|FG001|Overall Study|Unable to contact|67|||
155354634|NCT00497874|560734898|FG000|Overall Study|Unable to schedule|37|||
155354635|NCT00497874|560734899|FG001|Overall Study|Unable to schedule|24|||
155354636|NCT02080403|560734900|FG000|Overall Study|Adverse Event|5|||
155426576|NCT05067127|560989820|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
155354637|NCT02080403|560734901|FG001|Overall Study|Adverse Event|1|||
155426577|NCT05067127|560989821|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
155354638|NCT02080403|560734900|FG000|Overall Study|Death|0|||
155354639|NCT02080403|560734901|FG001|Overall Study|Death|2|||
155354640|NCT02080403|560734900|FG000|Overall Study|Lost to Follow-up|2|||
155354641|NCT02080403|560734901|FG001|Overall Study|Lost to Follow-up|0|||
155354642|NCT02080403|560734900|FG000|Overall Study|Pregnancy|0|||
155354643|NCT02080403|560734901|FG001|Overall Study|Pregnancy|1|||
155354644|NCT02080403|560734900|FG000|Overall Study|Protocol Violation|3|||
155354645|NCT02080403|560734901|FG001|Overall Study|Protocol Violation|7|||
155354646|NCT02080403|560734900|FG000|Overall Study|Withdrawal by Subject|5|||
155354647|NCT02080403|560734901|FG001|Overall Study|Withdrawal by Subject|1|||
155354648|NCT01999972|560734902|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
155354649|NCT01999972|560734903|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
155354650|NCT01999972|560734904|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
155354651|NCT01999972|560734905|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
155354652|NCT01999972|560734906|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
155354653|NCT01999972|560734907|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
155354654|NCT01999972|560734902|FG000|Dose Escalation Part|Death|0|||
155354655|NCT01999972|560734903|FG001|Dose Escalation Part|Death|1|||
155354656|NCT01999972|560734904|FG002|Dose Escalation Part|Death|0|||
155354657|NCT01999972|560734905|FG003|Dose Escalation Part|Death|0|||
155354658|NCT01999972|560734906|FG004|Dose Escalation Part|Death|0|||
155354659|NCT01999972|560734907|FG005|Dose Escalation Part|Death|0|||
155354660|NCT01999972|560734902|FG000|Dose Escalation Part|Enrolled but not treated|0|||
155354661|NCT01999972|560734903|FG001|Dose Escalation Part|Enrolled but not treated|0|||
155354662|NCT01999972|560734904|FG002|Dose Escalation Part|Enrolled but not treated|1|||
155354663|NCT01999972|560734905|FG003|Dose Escalation Part|Enrolled but not treated|1|||
155354664|NCT01999972|560734906|FG004|Dose Escalation Part|Enrolled but not treated|0|||
155354665|NCT01999972|560734907|FG005|Dose Escalation Part|Enrolled but not treated|0|||
155354666|NCT01999972|560734902|FG000|Dose Escalation Part|Disease progression|3|||
155354667|NCT01999972|560734903|FG001|Dose Escalation Part|Disease progression|2|||
155354668|NCT01999972|560734904|FG002|Dose Escalation Part|Disease progression|3|||
155354669|NCT01999972|560734905|FG003|Dose Escalation Part|Disease progression|6|||
155354670|NCT01999972|560734906|FG004|Dose Escalation Part|Disease progression|0|||
155354671|NCT01999972|560734907|FG005|Dose Escalation Part|Disease progression|0|||
155354672|NCT01999972|560734902|FG000|Dose Escalation Part|Adverse Event|0|||
155354673|NCT01999972|560734903|FG001|Dose Escalation Part|Adverse Event|0|||
155354674|NCT01999972|560734904|FG002|Dose Escalation Part|Adverse Event|0|||
155354675|NCT01999972|560734905|FG003|Dose Escalation Part|Adverse Event|2|||
155354676|NCT01999972|560734906|FG004|Dose Escalation Part|Adverse Event|0|||
155354677|NCT01999972|560734907|FG005|Dose Escalation Part|Adverse Event|0|||
155354678|NCT01999972|560734902|FG000|Dose Escalation Part|Global deterioration of health status|1|||
155354679|NCT01999972|560734903|FG001|Dose Escalation Part|Global deterioration of health status|0|||
155354680|NCT01999972|560734904|FG002|Dose Escalation Part|Global deterioration of health status|0|||
155354681|NCT01999972|560734905|FG003|Dose Escalation Part|Global deterioration of health status|1|||
155426578|NCT05067127|560989822|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
155426579|NCT05067127|560989823|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
155426580|NCT05067127|560989820|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
155426581|NCT05067127|560989821|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
155506939|NCT01859390|561283475|FG000|Overall Study|Sample Missing Collection Date|0|||
155506940|NCT01859390|561283476|FG001|Overall Study|Sample Missing Collection Date|1|||
155506941|NCT01859390|561283475|FG000|Overall Study|Tube Cracked|0|||
155506942|NCT01859390|561283476|FG001|Overall Study|Tube Cracked|2|||
155506943|NCT01859390|561283475|FG000|Overall Study|Shipment Error|0|||
155506944|NCT01859390|561283476|FG001|Overall Study|Shipment Error|1|||
155506945|NCT01886300|561283484|FG000|Overall Study|Trial terminated by sponsor|16|||
155506946|NCT00295854|561283485|FG000|Overall Study|Adverse Event|7|||
155506947|NCT00295854|561283486|FG001|Overall Study|Adverse Event|7|||
155506948|NCT00295854|561283487|FG002|Overall Study|Adverse Event|6|||
155506949|NCT00295854|561283485|FG000|Overall Study|Protocol Violation|1|||
155506950|NCT00295854|561283486|FG001|Overall Study|Protocol Violation|1|||
155506951|NCT00295854|561283487|FG002|Overall Study|Protocol Violation|1|||
155506952|NCT00295854|561283485|FG000|Overall Study|Lost to Follow-up|2|||
155506953|NCT00295854|561283486|FG001|Overall Study|Lost to Follow-up|0|||
155506954|NCT00295854|561283487|FG002|Overall Study|Lost to Follow-up|1|||
155506955|NCT00295854|561283485|FG000|Overall Study|Withdrawal by Subject|3|||
155506956|NCT00295854|561283486|FG001|Overall Study|Withdrawal by Subject|7|||
155506957|NCT00295854|561283487|FG002|Overall Study|Withdrawal by Subject|4|||
155506958|NCT00295854|561283485|FG000|Overall Study|did not continue to meet criteria|1|||
155426582|NCT05067127|560989822|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
155426583|NCT05067127|560989823|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
155426584|NCT05067127|560989820|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
155426585|NCT05067127|560989821|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
155426586|NCT05067127|560989822|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
155426587|NCT05067127|560989823|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
155426588|NCT05067127|560989820|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
155426589|NCT05067127|560989821|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
155426590|NCT05067127|560989822|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
155426591|NCT05067127|560989823|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
155426592|NCT05067127|560989820|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
155426593|NCT05067127|560989821|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
155506959|NCT00295854|561283486|FG001|Overall Study|did not continue to meet criteria|1|||
155506960|NCT00295854|561283487|FG002|Overall Study|did not continue to meet criteria|2|||
155506961|NCT00295854|561283485|FG000|Overall Study|required a prohibited medication|1|||
155506962|NCT00295854|561283486|FG001|Overall Study|required a prohibited medication|0|||
155354682|NCT01999972|560734906|FG004|Dose Escalation Part|Global deterioration of health status|0|||
155354683|NCT01999972|560734907|FG005|Dose Escalation Part|Global deterioration of health status|0|||
155354684|NCT01999972|560734902|FG000|Dose Expansion Part|Death|0|||
155354685|NCT01999972|560734903|FG001|Dose Expansion Part|Death|0|||
155354686|NCT01999972|560734904|FG002|Dose Expansion Part|Death|0|||
155354687|NCT01999972|560734905|FG003|Dose Expansion Part|Death|0|||
155354688|NCT01999972|560734906|FG004|Dose Expansion Part|Death|2|||
155354689|NCT01999972|560734907|FG005|Dose Expansion Part|Death|1|||
155354690|NCT01999972|560734902|FG000|Dose Expansion Part|Disease progression|0|||
155426594|NCT05067127|560989822|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
155426595|NCT05067127|560989823|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
155426596|NCT05067127|560989820|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
155426597|NCT05067127|560989821|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
155426598|NCT05067127|560989822|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
155426599|NCT05067127|560989823|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
155426600|NCT05067127|560989820|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
155426601|NCT05067127|560989821|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
155426602|NCT05067127|560989822|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
155426603|NCT05067127|560989823|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
155426604|NCT05540652|560989828|FG000|Overall Study|Withdrawal by Subject|1|||
155426605|NCT05113940|560989829|FG000|Part A (18 Days)|Adverse Event|0|||
155426606|NCT05113940|560989830|FG001|Part A (18 Days)|Adverse Event|0|||
155426607|NCT05113940|560989831|FG002|Part A (18 Days)|Adverse Event|1|||
155426608|NCT05113940|560989832|FG003|Part A (18 Days)|Adverse Event|1|||
155426609|NCT05113940|560989833|FG004|Part A (18 Days)|Adverse Event|1|||
155426610|NCT05113940|560989834|FG005|Part A (18 Days)|Adverse Event|0|||
155426611|NCT05113940|560989835|FG006|Part A (18 Days)|Adverse Event|0|||
155426612|NCT05113940|560989836|FG007|Part A (18 Days)|Adverse Event|0|||
155426613|NCT05113940|560989837|FG008|Part A (18 Days)|Adverse Event|0|||
155426614|NCT05113940|560989838|FG009|Part A (18 Days)|Adverse Event|0|||
155426615|NCT05113940|560989839|FG010|Part A (18 Days)|Adverse Event|0|||
155426616|NCT05113940|560989840|FG011|Part A (18 Days)|Adverse Event|2|||
155426617|NCT05113940|560989841|FG012|Part A (18 Days)|Adverse Event|0|||
155426618|NCT05113940|560989842|FG013|Part A (18 Days)|Adverse Event|0|||
155426619|NCT05113940|560989843|FG014|Part A (18 Days)|Adverse Event|0|||
155426620|NCT05113940|560989829|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426621|NCT05113940|560989830|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426622|NCT05113940|560989831|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426623|NCT05113940|560989832|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426624|NCT05113940|560989833|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426625|NCT05113940|560989834|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426626|NCT05113940|560989835|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426627|NCT05113940|560989836|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426628|NCT05113940|560989837|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426629|NCT05113940|560989838|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426630|NCT05113940|560989839|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426631|NCT05113940|560989840|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426632|NCT05113940|560989841|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426633|NCT05113940|560989842|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
155426634|NCT05113940|560989843|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
155426635|NCT01701258|560989844|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
155426636|NCT01701258|560989845|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
155426637|NCT01701258|560989846|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
155426638|NCT01701258|560989847|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
155426639|NCT01701258|560989848|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
155426640|NCT01701258|560989849|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
155426641|NCT01701258|560989850|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
155426642|NCT01701258|560989851|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
155426643|NCT01701258|560989852|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
155506963|NCT00295854|561283487|FG002|Overall Study|required a prohibited medication|0|||
155506964|NCT00295854|561283485|FG000|Overall Study|Other|3|||
155426644|NCT01701258|560989853|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
155426645|NCT01701258|560989854|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
155426646|NCT01701258|560989855|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
155426647|NCT01701258|560989856|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
155426648|NCT01701258|560989844|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
155506965|NCT00295854|561283486|FG001|Overall Study|Other|5|||
155506966|NCT00295854|561283487|FG002|Overall Study|Other|1|||
155426649|NCT01701258|560989845|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
155426650|NCT01701258|560989846|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
155426651|NCT01701258|560989847|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
155426652|NCT01701258|560989848|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
155426653|NCT01701258|560989849|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
155354691|NCT01999972|560734903|FG001|Dose Expansion Part|Disease progression|0|||
155354692|NCT01999972|560734904|FG002|Dose Expansion Part|Disease progression|0|||
155354693|NCT01999972|560734905|FG003|Dose Expansion Part|Disease progression|0|||
155354694|NCT01999972|560734906|FG004|Dose Expansion Part|Disease progression|9|||
155354695|NCT01999972|560734907|FG005|Dose Expansion Part|Disease progression|3|||
155354696|NCT01999972|560734902|FG000|Dose Expansion Part|Sponsor decision|0|||
155354697|NCT01999972|560734903|FG001|Dose Expansion Part|Sponsor decision|0|||
155354698|NCT01999972|560734904|FG002|Dose Expansion Part|Sponsor decision|0|||
155354699|NCT01999972|560734905|FG003|Dose Expansion Part|Sponsor decision|0|||
155506967|NCT00672620|561283488|FG000|Overall Study|Adverse Event|7|||
155506968|NCT00672620|561283489|FG001|Overall Study|Adverse Event|7|||
155506969|NCT00672620|561283490|FG002|Overall Study|Adverse Event|12|||
155506970|NCT00672620|561283491|FG003|Overall Study|Adverse Event|17|||
155506971|NCT00672620|561283488|FG000|Overall Study|Lack of Efficacy|1|||
155354700|NCT01999972|560734906|FG004|Dose Expansion Part|Sponsor decision|1|||
155354701|NCT01999972|560734907|FG005|Dose Expansion Part|Sponsor decision|0|||
155354702|NCT01999972|560734902|FG000|Dose Expansion Part|Adverse Event|0|||
155354703|NCT01999972|560734903|FG001|Dose Expansion Part|Adverse Event|0|||
155354704|NCT01999972|560734904|FG002|Dose Expansion Part|Adverse Event|0|||
155354705|NCT01999972|560734905|FG003|Dose Expansion Part|Adverse Event|0|||
155354706|NCT01999972|560734906|FG004|Dose Expansion Part|Adverse Event|4|||
155354707|NCT01999972|560734907|FG005|Dose Expansion Part|Adverse Event|2|||
155354708|NCT01999972|560734902|FG000|Dose Expansion Part|Participant's non-compliance|0|||
155354709|NCT01999972|560734903|FG001|Dose Expansion Part|Participant's non-compliance|0|||
155354710|NCT01999972|560734904|FG002|Dose Expansion Part|Participant's non-compliance|0|||
155354711|NCT01999972|560734905|FG003|Dose Expansion Part|Participant's non-compliance|0|||
155354712|NCT01999972|560734906|FG004|Dose Expansion Part|Participant's non-compliance|0|||
155354713|NCT01999972|560734907|FG005|Dose Expansion Part|Participant's non-compliance|1|||
155354714|NCT01999972|560734902|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
155354715|NCT01999972|560734903|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
155354716|NCT01999972|560734904|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
155354717|NCT01999972|560734905|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
155354718|NCT01999972|560734906|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
155354719|NCT01999972|560734907|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
155354720|NCT01999972|560734902|FG000|Dose Expansion Part|Changed to standard of care|0|||
155354721|NCT01999972|560734903|FG001|Dose Expansion Part|Changed to standard of care|0|||
155354722|NCT01999972|560734904|FG002|Dose Expansion Part|Changed to standard of care|0|||
155354723|NCT01999972|560734905|FG003|Dose Expansion Part|Changed to standard of care|0|||
155354724|NCT01999972|560734906|FG004|Dose Expansion Part|Changed to standard of care|1|||
155354725|NCT01999972|560734907|FG005|Dose Expansion Part|Changed to standard of care|0|||
155354726|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
155354727|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
155354728|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
155354729|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
155354730|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
155354731|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
155354732|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
155354733|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
155354734|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
155354735|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
155506972|NCT00672620|561283489|FG001|Overall Study|Lack of Efficacy|2|||
155506973|NCT00672620|561283490|FG002|Overall Study|Lack of Efficacy|2|||
155506974|NCT00672620|561283491|FG003|Overall Study|Lack of Efficacy|0|||
155506975|NCT00672620|561283488|FG000|Overall Study|Noncompliance with Study Drug|3|||
155506976|NCT00672620|561283489|FG001|Overall Study|Noncompliance with Study Drug|4|||
155506977|NCT00672620|561283490|FG002|Overall Study|Noncompliance with Study Drug|0|||
155354736|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
155354737|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
155354738|NCT01101334|560734910|FG000|Overall Study|Adverse Event|9|||
155354739|NCT01101334|560734911|FG001|Overall Study|Adverse Event|4|||
155354740|NCT01101334|560734910|FG000|Overall Study|Death|7|||
155354741|NCT01101334|560734911|FG001|Overall Study|Death|1|||
155354742|NCT01101334|560734910|FG000|Overall Study|Withdrawal by Subject|4|||
155354743|NCT01101334|560734911|FG001|Overall Study|Withdrawal by Subject|3|||
155354744|NCT01101334|560734910|FG000|Overall Study|Withdrawal by Sponsor|1|||
155354745|NCT01101334|560734911|FG001|Overall Study|Withdrawal by Sponsor|1|||
155354746|NCT01101334|560734910|FG000|Overall Study|Progressive Disease|22|||
155354747|NCT01101334|560734911|FG001|Overall Study|Progressive Disease|35|||
155354748|NCT01101334|560734910|FG000|Overall Study|Other|2|||
155354749|NCT01101334|560734911|FG001|Overall Study|Other|1|||
155354750|NCT02826798|560734914|FG000|Overall Study|Withdrawal by Subject|0|||
155354751|NCT02826798|560734915|FG001|Overall Study|Withdrawal by Subject|1|||
155354752|NCT02826798|560734916|FG002|Overall Study|Withdrawal by Subject|0|||
155354753|NCT02826798|560734917|FG003|Overall Study|Withdrawal by Subject|1|||
155354754|NCT02826798|560734918|FG004|Overall Study|Withdrawal by Subject|0|||
155354755|NCT02806505|560734919|FG000|Overall Study|Adverse event/intercurrent illness|1|||
155354756|NCT02806505|560734920|FG001|Overall Study|Adverse event/intercurrent illness|3|||
155354757|NCT02806505|560734919|FG000|Overall Study|Death|4|||
155354758|NCT02806505|560734920|FG001|Overall Study|Death|0|||
155354759|NCT02806505|560734919|FG000|Overall Study|Did not cooperate/refused treatment|3|||
155354760|NCT02806505|560734920|FG001|Overall Study|Did not cooperate/refused treatment|3|||
155354761|NCT02806505|560734919|FG000|Overall Study|Failure to return|0|||
155354762|NCT02806505|560734920|FG001|Overall Study|Failure to return|1|||
155354763|NCT02806505|560734919|FG000|Overall Study|Insufficient therapeutic response|2|||
155354764|NCT02806505|560734920|FG001|Overall Study|Insufficient therapeutic response|4|||
155354765|NCT03440047|560734922|FG000|Overall Study|Withdrawal by Subject|2|||
155354766|NCT04843579|560734931|FG000|Overall Study|Adverse Event|1|||
155354767|NCT04843579|560734931|FG000|Overall Study|Disease Progression|1|||
155354768|NCT04009629|560734932|FG000|Overall Study|Withdrawal by Subject|2|||
155354769|NCT04009629|560734933|FG001|Overall Study|Withdrawal by Subject|0|||
155354770|NCT04702893|560734939|FG000|Overall Study|Other reasons than listed|11|||
155354771|NCT04702893|560734939|FG000|Overall Study|Withdrawal by Subject|3|||
155354772|NCT04702893|560734939|FG000|Overall Study|Lost to Follow-up|7|||
155354773|NCT04702893|560734939|FG000|Overall Study|Death|10|||
155354774|NCT04702893|560734939|FG000|Overall Study|Not treated|6|||
155354775|NCT04606199|560734940|FG000|Overall Study|Withdrawal by Subject|2|||
155354776|NCT00408928|560734941|FG000|Overall Study|Withdrawal by Subject|1|||
155426654|NCT01701258|560989850|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
155426655|NCT01701258|560989851|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
155426656|NCT01701258|560989852|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
155426657|NCT01701258|560989853|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
155426658|NCT01701258|560989854|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
155426659|NCT01701258|560989855|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
155426660|NCT01701258|560989856|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
155426661|NCT01701258|560989844|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
155426662|NCT01701258|560989845|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
155426663|NCT01701258|560989846|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
155426664|NCT01701258|560989847|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
155426665|NCT01701258|560989848|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
155426666|NCT01701258|560989849|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
155426667|NCT01701258|560989850|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
155426668|NCT01701258|560989851|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
155426669|NCT01701258|560989852|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
155426670|NCT01701258|560989853|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
155426671|NCT01701258|560989854|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
155426672|NCT01701258|560989855|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
155426673|NCT01701258|560989856|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
155426674|NCT01701258|560989844|FG000|Assessment and Scheduling|Investigator Terminated|2|||
155354777|NCT00408928|560734941|FG000|Overall Study|Death|1|||
155354778|NCT00408928|560734941|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
155426675|NCT01701258|560989845|FG001|Assessment and Scheduling|Investigator Terminated|0|||
155426676|NCT01701258|560989846|FG002|Assessment and Scheduling|Investigator Terminated|0|||
155426677|NCT01701258|560989847|FG003|Assessment and Scheduling|Investigator Terminated|0|||
155426678|NCT01701258|560989848|FG004|Assessment and Scheduling|Investigator Terminated|0|||
155426679|NCT01701258|560989849|FG005|Assessment and Scheduling|Investigator Terminated|0|||
155354779|NCT01114139|560734944|FG000|Overall Study|Adverse Event|3|||
155354780|NCT01114139|560734945|FG001|Overall Study|Adverse Event|2|||
155354781|NCT01114139|560734944|FG000|Overall Study|Lost to Follow-up|15|||
155354782|NCT01114139|560734945|FG001|Overall Study|Lost to Follow-up|3|||
155354783|NCT01114139|560734944|FG000|Overall Study|Withdrawal by Subject|17|||
155354784|NCT01114139|560734945|FG001|Overall Study|Withdrawal by Subject|6|||
155354785|NCT01114139|560734944|FG000|Overall Study|Other-Missed 1 visit|1|||
155354786|NCT01114139|560734945|FG001|Overall Study|Other-Missed 1 visit|0|||
155354787|NCT01114139|560734944|FG000|Overall Study|Other-Protocol Violation|1|||
155354788|NCT01114139|560734945|FG001|Overall Study|Other-Protocol Violation|0|||
155354789|NCT01114139|560734944|FG000|Overall Study|Other-Out of window for study drug dose|1|||
155354790|NCT01114139|560734945|FG001|Overall Study|Other-Out of window for study drug dose|0|||
155354791|NCT01114139|560734944|FG000|Overall Study|Other-Participant falsified records|0|||
155354792|NCT01114139|560734945|FG001|Overall Study|Other-Participant falsified records|1|||
155354793|NCT01114139|560734944|FG000|Overall Study|Other-Participant went on hospice|0|||
155354794|NCT01114139|560734945|FG001|Overall Study|Other-Participant went on hospice|1|||
155354795|NCT01114139|560734944|FG000|Overall Study|Other-Physician changed treatment|1|||
155354796|NCT01114139|560734945|FG001|Overall Study|Other-Physician changed treatment|0|||
155354797|NCT01114139|560734944|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
155354798|NCT01114139|560734945|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
155354799|NCT01951378|560734946|FG000|Overall Study|Study Terminated-Not completed|23|||
155354800|NCT01951378|560734947|FG001|Overall Study|Study Terminated-Not completed|17|||
155354801|NCT00477464|560734949|FG000|Overall Study|Lost to Follow-up|1|||
155354802|NCT00477464|560734949|FG000|Overall Study|Death|36|||
155354803|NCT00477464|560734949|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
155354804|NCT03568812|560734950|FG000|Overall Study|Physician Decision|0|||
155354805|NCT03568812|560734951|FG001|Overall Study|Physician Decision|1|||
155354806|NCT00639769|560734956|FG000|Overall Study|Death|2|||
155354807|NCT00639769|560734956|FG000|Overall Study|Adverse Event|7|||
155354808|NCT00639769|560734956|FG000|Overall Study|Lack of Efficacy|1|||
155354809|NCT00639769|560734956|FG000|Overall Study|Disease progression|26|||
155354810|NCT00639769|560734956|FG000|Overall Study|Withdrawal by Subject|4|||
155354811|NCT00634842|560734957|FG000|Overall Study|Adverse Event|2|||
155354812|NCT00634842|560734958|FG001|Overall Study|Adverse Event|3|||
155354813|NCT00634842|560734957|FG000|Overall Study|Protocol Violation|8|||
155354814|NCT00634842|560734958|FG001|Overall Study|Protocol Violation|4|||
155354815|NCT00634842|560734957|FG000|Overall Study|Move to another state|1|||
155354816|NCT00634842|560734958|FG001|Overall Study|Move to another state|0|||
155354817|NCT00634842|560734957|FG000|Overall Study|Inclusion criteria were not met|1|||
155354818|NCT00634842|560734958|FG001|Overall Study|Inclusion criteria were not met|0|||
155354819|NCT00634842|560734957|FG000|Overall Study|Lost to Follow-up|1|||
155354820|NCT00634842|560734958|FG001|Overall Study|Lost to Follow-up|2|||
155354821|NCT00634842|560734957|FG000|Overall Study|Physician Decision|1|||
155354822|NCT00634842|560734958|FG001|Overall Study|Physician Decision|0|||
155354823|NCT00634842|560734957|FG000|Overall Study|Withdrawal by Subject|1|||
155354824|NCT00634842|560734958|FG001|Overall Study|Withdrawal by Subject|3|||
155354825|NCT00634842|560734957|FG000|Overall Study|Lack of time and intolerance to drug|0|||
155354826|NCT00634842|560734958|FG001|Overall Study|Lack of time and intolerance to drug|1|||
155354827|NCT00634842|560734957|FG000|Overall Study|Discontinued due to injection|0|||
155354828|NCT00634842|560734958|FG001|Overall Study|Discontinued due to injection|2|||
155354829|NCT00634842|560734957|FG000|Overall Study|No need of study drug to treat diabetes|0|||
155354830|NCT00634842|560734958|FG001|Overall Study|No need of study drug to treat diabetes|1|||
155354831|NCT00634842|560734957|FG000|Overall Study|No wish to keep taking Avandia|0|||
155354832|NCT00634842|560734958|FG001|Overall Study|No wish to keep taking Avandia|1|||
155354833|NCT00634842|560734957|FG000|Overall Study|Subject off study drug for too long|0|||
155354834|NCT00634842|560734958|FG001|Overall Study|Subject off study drug for too long|1|||
155354835|NCT01774019|560734960|FG000|Overall Study|No longer meets protocol criteria|2|||
155354836|NCT01774019|560734961|FG001|Overall Study|No longer meets protocol criteria|0|||
155426680|NCT01701258|560989850|FG006|Assessment and Scheduling|Investigator Terminated|0|||
155354837|NCT01774019|560734960|FG000|Overall Study|Withdrawal by Subject|1|||
155354838|NCT01774019|560734961|FG001|Overall Study|Withdrawal by Subject|0|||
155354839|NCT01774019|560734960|FG000|Overall Study|Surgery delayed > 120 days|1|||
155354840|NCT01774019|560734961|FG001|Overall Study|Surgery delayed > 120 days|0|||
155354841|NCT01774019|560734960|FG000|Overall Study|Patient refused surgery|1|||
155354842|NCT01774019|560734961|FG001|Overall Study|Patient refused surgery|1|||
155354843|NCT01774019|560734960|FG000|Overall Study|Unable to implant study device|1|||
155354844|NCT01774019|560734961|FG001|Overall Study|Unable to implant study device|0|||
155354845|NCT01774019|560734960|FG000|Overall Study|Lost to Follow-up|0|||
155354846|NCT01774019|560734961|FG001|Overall Study|Lost to Follow-up|3|||
155354847|NCT02447432|560734962|FG000|Epoch 001|Adverse Event|1|||
155354848|NCT02447432|560734963|FG001|Epoch 001|Adverse Event|1|||
155354849|NCT02447432|560734962|FG000|Epoch 001|Withdrawal by Subject|0|||
155354850|NCT02447432|560734963|FG001|Epoch 001|Withdrawal by Subject|4|||
155354851|NCT02447432|560734962|FG000|Epoch 001|Migrated/moved from study area|3|||
155354852|NCT02447432|560734963|FG001|Epoch 001|Migrated/moved from study area|5|||
155354853|NCT02447432|560734962|FG000|Epoch 001|Lost to Follow-up|1|||
155354854|NCT02447432|560734963|FG001|Epoch 001|Lost to Follow-up|3|||
155354855|NCT03470545|560734964|FG000|Overall Study|Death|0|||
155354856|NCT03470545|560734965|FG001|Overall Study|Death|1|||
155354857|NCT03470545|560734964|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
155354858|NCT03470545|560734965|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
155354859|NCT03470545|560734964|FG000|Overall Study|Adverse Event|2|||
155354860|NCT03470545|560734965|FG001|Overall Study|Adverse Event|0|||
155354861|NCT03470545|560734964|FG000|Overall Study|Withdrawal by Subject|1|||
155354862|NCT03470545|560734965|FG001|Overall Study|Withdrawal by Subject|1|||
155354863|NCT03470545|560734964|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
155354864|NCT03470545|560734965|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
155354865|NCT04035577|560734968|FG000|Overall Study|Lost to Follow-up|1|||
155354866|NCT04035577|560734968|FG000|Overall Study|Withdrawal by Subject|1|||
155354867|NCT00505414|560734970|FG000|Titration Phase|Adverse Event|0|||
155354868|NCT00505414|560734971|FG001|Titration Phase|Adverse Event|0|||
155354869|NCT00505414|560734972|FG002|Titration Phase|Adverse Event|0|||
155354870|NCT00505414|560734973|FG003|Titration Phase|Adverse Event|8|||
155354871|NCT00505414|560734974|FG004|Titration Phase|Adverse Event|3|||
155354872|NCT00505414|560734970|FG000|Titration Phase|Death|0|||
155354873|NCT00505414|560734971|FG001|Titration Phase|Death|0|||
155354874|NCT00505414|560734972|FG002|Titration Phase|Death|0|||
155354875|NCT00505414|560734973|FG003|Titration Phase|Death|2|||
155354876|NCT00505414|560734974|FG004|Titration Phase|Death|0|||
155354877|NCT00505414|560734970|FG000|Titration Phase|Lack of Efficacy|0|||
155354878|NCT00505414|560734971|FG001|Titration Phase|Lack of Efficacy|0|||
155354879|NCT00505414|560734972|FG002|Titration Phase|Lack of Efficacy|0|||
155354880|NCT00505414|560734973|FG003|Titration Phase|Lack of Efficacy|10|||
155354881|NCT00505414|560734974|FG004|Titration Phase|Lack of Efficacy|1|||
155354882|NCT00505414|560734970|FG000|Titration Phase|Protocol Violation|0|||
155354883|NCT00505414|560734971|FG001|Titration Phase|Protocol Violation|0|||
155354884|NCT00505414|560734972|FG002|Titration Phase|Protocol Violation|0|||
155354885|NCT00505414|560734973|FG003|Titration Phase|Protocol Violation|0|||
155354886|NCT00505414|560734974|FG004|Titration Phase|Protocol Violation|1|||
155354887|NCT00505414|560734970|FG000|Titration Phase|Withdrawal by Subject|0|||
155354888|NCT00505414|560734971|FG001|Titration Phase|Withdrawal by Subject|0|||
155354889|NCT00505414|560734972|FG002|Titration Phase|Withdrawal by Subject|0|||
155354890|NCT00505414|560734973|FG003|Titration Phase|Withdrawal by Subject|3|||
155354891|NCT00505414|560734974|FG004|Titration Phase|Withdrawal by Subject|4|||
155354892|NCT00505414|560734970|FG000|Titration Phase|Underlying disease and therapy required|0|||
155354893|NCT00505414|560734971|FG001|Titration Phase|Underlying disease and therapy required|0|||
155354894|NCT00505414|560734972|FG002|Titration Phase|Underlying disease and therapy required|0|||
155354895|NCT00505414|560734973|FG003|Titration Phase|Underlying disease and therapy required|7|||
155354896|NCT00505414|560734974|FG004|Titration Phase|Underlying disease and therapy required|3|||
155354897|NCT00505414|560734970|FG000|Maintenance Phase|Adverse Event|2|||
155354898|NCT00505414|560734971|FG001|Maintenance Phase|Adverse Event|2|||
155354899|NCT00505414|560734972|FG002|Maintenance Phase|Adverse Event|3|||
155354900|NCT00505414|560734973|FG003|Maintenance Phase|Adverse Event|0|||
155506978|NCT00672620|561283491|FG003|Overall Study|Noncompliance with Study Drug|2|||
155506979|NCT00672620|561283488|FG000|Overall Study|Protocol Deviations|5|||
155506980|NCT00672620|561283489|FG001|Overall Study|Protocol Deviations|7|||
155506981|NCT00672620|561283490|FG002|Overall Study|Protocol Deviations|2|||
155354901|NCT00505414|560734974|FG004|Maintenance Phase|Adverse Event|0|||
155354902|NCT00505414|560734970|FG000|Maintenance Phase|Death|2|||
155354903|NCT00505414|560734971|FG001|Maintenance Phase|Death|0|||
155354904|NCT00505414|560734972|FG002|Maintenance Phase|Death|1|||
155354905|NCT00505414|560734973|FG003|Maintenance Phase|Death|0|||
155354906|NCT00505414|560734974|FG004|Maintenance Phase|Death|0|||
155506982|NCT00672620|561283491|FG003|Overall Study|Protocol Deviations|5|||
155506983|NCT00672620|561283488|FG000|Overall Study|Withdrawal of Consent|6|||
155506984|NCT00672620|561283489|FG001|Overall Study|Withdrawal of Consent|12|||
155506985|NCT00672620|561283490|FG002|Overall Study|Withdrawal of Consent|5|||
155354907|NCT00505414|560734970|FG000|Maintenance Phase|Lack of Efficacy|2|||
155354908|NCT00505414|560734971|FG001|Maintenance Phase|Lack of Efficacy|1|||
155354909|NCT00505414|560734972|FG002|Maintenance Phase|Lack of Efficacy|1|||
155354910|NCT00505414|560734973|FG003|Maintenance Phase|Lack of Efficacy|0|||
155506986|NCT00672620|561283491|FG003|Overall Study|Withdrawal of Consent|6|||
155354911|NCT00505414|560734974|FG004|Maintenance Phase|Lack of Efficacy|0|||
155354912|NCT00505414|560734970|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155354913|NCT00505414|560734971|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155354914|NCT00505414|560734972|FG002|Maintenance Phase|Withdrawal by Subject|1|||
155354915|NCT00505414|560734973|FG003|Maintenance Phase|Withdrawal by Subject|0|||
155354916|NCT00505414|560734974|FG004|Maintenance Phase|Withdrawal by Subject|0|||
155354917|NCT00505414|560734970|FG000|Maintenance Phase|underlying disease and therapy required|0|||
155354918|NCT00505414|560734971|FG001|Maintenance Phase|underlying disease and therapy required|2|||
155354919|NCT00505414|560734972|FG002|Maintenance Phase|underlying disease and therapy required|2|||
155354920|NCT00505414|560734973|FG003|Maintenance Phase|underlying disease and therapy required|0|||
155354921|NCT00505414|560734974|FG004|Maintenance Phase|underlying disease and therapy required|0|||
155354922|NCT00846768|560734975|FG000|Overall Study|Adverse Event|0|||
155354923|NCT00846768|560734976|FG001|Overall Study|Adverse Event|1|||
155354924|NCT00846768|560734977|FG002|Overall Study|Adverse Event|0|||
155354925|NCT00846768|560734978|FG003|Overall Study|Adverse Event|0|||
155354926|NCT00002597|560734979|FG000|Overall Study|Protocol Violation|19|||
155354927|NCT00002597|560734980|FG001|Overall Study|Protocol Violation|17|||
155354928|NCT00002597|560734979|FG000|Overall Study|Withdrawal by Subject|7|||
155354929|NCT00002597|560734980|FG001|Overall Study|Withdrawal by Subject|6|||
155354930|NCT02143063|560734981|FG000|Overall Study|Lost to Follow-up|16|||
155354931|NCT02143063|560734982|FG001|Overall Study|Lost to Follow-up|28|||
155354932|NCT02143063|560734983|FG002|Overall Study|Lost to Follow-up|29|||
155354933|NCT02143063|560734981|FG000|Overall Study|Withdrawal by Subject|0|||
155354934|NCT02143063|560734982|FG001|Overall Study|Withdrawal by Subject|1|||
155354935|NCT02143063|560734983|FG002|Overall Study|Withdrawal by Subject|0|||
155354936|NCT02143063|560734981|FG000|Overall Study|Death|0|||
155354937|NCT02143063|560734982|FG001|Overall Study|Death|1|||
155354938|NCT02143063|560734983|FG002|Overall Study|Death|1|||
155354939|NCT00912223|560734986|FG000|Overall Study|Withdrawal by Subject|1|||
155354940|NCT00912223|560734986|FG000|Overall Study|Not transplanted|1|||
155354941|NCT00912223|560734986|FG000|Overall Study|Transformed disease|1|||
155354942|NCT02601209|560734987|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354943|NCT02601209|560734988|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354944|NCT02601209|560734989|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354945|NCT02601209|560734990|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354946|NCT02601209|560734991|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354947|NCT02601209|560734992|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354948|NCT02601209|560734993|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354949|NCT02601209|560734994|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354950|NCT02601209|560734995|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354951|NCT02601209|560734987|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354952|NCT02601209|560734988|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354953|NCT02601209|560734989|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354954|NCT02601209|560734990|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354955|NCT02601209|560734991|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
155354956|NCT02601209|560734992|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
155354957|NCT02601209|560734993|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
155354958|NCT02601209|560734994|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354959|NCT02601209|560734995|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354960|NCT00927901|560734996|FG000|Treatment Period 1|Subject withdrew consent|0|||
155354961|NCT00927901|560734997|FG001|Treatment Period 1|Subject withdrew consent|0|||
155354962|NCT00927901|560734998|FG002|Treatment Period 1|Subject withdrew consent|1|||
155354963|NCT00927901|560734999|FG003|Treatment Period 1|Subject withdrew consent|0|||
155354964|NCT00927901|560734996|FG000|Treatment Period 4|Adverse Event|0|||
155354965|NCT00927901|560734997|FG001|Treatment Period 4|Adverse Event|0|||
155354966|NCT00927901|560734998|FG002|Treatment Period 4|Adverse Event|0|||
155426681|NCT01701258|560989851|FG007|Assessment and Scheduling|Investigator Terminated|0|||
155426682|NCT01701258|560989852|FG008|Assessment and Scheduling|Investigator Terminated|0|||
155426683|NCT01701258|560989853|FG009|Assessment and Scheduling|Investigator Terminated|0|||
155426684|NCT01701258|560989854|FG010|Assessment and Scheduling|Investigator Terminated|0|||
155426685|NCT01701258|560989855|FG011|Assessment and Scheduling|Investigator Terminated|0|||
155426686|NCT01701258|560989856|FG012|Assessment and Scheduling|Investigator Terminated|0|||
155426687|NCT00885365|560989858|FG000|4 Weeks ON Treatment|Adverse Event|2|||
155426688|NCT00885365|560989859|FG001|4 Weeks ON Treatment|Adverse Event|4|||
155426689|NCT00885365|560989858|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
155426690|NCT00885365|560989859|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
155426691|NCT00885365|560989858|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
155426692|NCT00885365|560989859|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
155426693|NCT01824979|560989860|FG000|Overall Study|Withdrawal by Subject|5|||
155426694|NCT01824979|560989861|FG001|Overall Study|Withdrawal by Subject|0|||
155354967|NCT00927901|560734999|FG003|Treatment Period 4|Adverse Event|1|||
155354968|NCT00927901|560734996|FG000|Treatment Period 4|Subject withdrew consent|0|||
155354969|NCT00927901|560734997|FG001|Treatment Period 4|Subject withdrew consent|0|||
155354970|NCT00927901|560734998|FG002|Treatment Period 4|Subject withdrew consent|1|||
155354971|NCT00927901|560734999|FG003|Treatment Period 4|Subject withdrew consent|0|||
155354972|NCT00746356|560735002|FG000|Overall Study|Withdrawal by Subject|2|||
155354973|NCT00746356|560735003|FG001|Overall Study|Withdrawal by Subject|3|||
155354974|NCT00746356|560735002|FG000|Overall Study|Death|7|||
155354975|NCT00746356|560735003|FG001|Overall Study|Death|3|||
155354976|NCT00746356|560735002|FG000|Overall Study|Lost to Follow-up|1|||
155354977|NCT00746356|560735003|FG001|Overall Study|Lost to Follow-up|0|||
155354978|NCT00746356|560735002|FG000|Overall Study|Removal of Device|0|||
155354979|NCT00746356|560735003|FG001|Overall Study|Removal of Device|1|||
155354980|NCT00746356|560735002|FG000|Overall Study|Patient relocated|1|||
155354981|NCT00746356|560735003|FG001|Overall Study|Patient relocated|0|||
155354982|NCT03605368|560735006|FG000|Overall Study|Lost to Follow-up|2|||
155354983|NCT03605368|560735007|FG001|Overall Study|Lost to Follow-up|1|||
155354984|NCT03605368|560735008|FG002|Overall Study|Lost to Follow-up|3|||
155354985|NCT03605368|560735009|FG003|Overall Study|Lost to Follow-up|2|||
155354986|NCT03605368|560735006|FG000|Overall Study|Withdrawal by Subject|0|||
155354987|NCT03605368|560735007|FG001|Overall Study|Withdrawal by Subject|0|||
155354988|NCT03605368|560735008|FG002|Overall Study|Withdrawal by Subject|4|||
155354989|NCT03605368|560735009|FG003|Overall Study|Withdrawal by Subject|3|||
155354990|NCT03028012|560735012|FG000|Overall Study|Lost to Follow-up|2|||
155354991|NCT03028012|560735013|FG001|Overall Study|Lost to Follow-up|3|||
155354992|NCT03028012|560735014|FG002|Overall Study|Lost to Follow-up|3|||
155354993|NCT02484547|560735019|FG000|Placebo-Controlled Period|Adverse Event|10|||
155354994|NCT02484547|560735020|FG001|Placebo-Controlled Period|Adverse Event|13|||
155354995|NCT02484547|560735021|FG002|Placebo-Controlled Period|Adverse Event|20|||
155354996|NCT02484547|560735022|FG003|Placebo-Controlled Period|Adverse Event|0|||
155354997|NCT02484547|560735023|FG004|Placebo-Controlled Period|Adverse Event|0|||
155354998|NCT02484547|560735024|FG005|Placebo-Controlled Period|Adverse Event|0|||
155354999|NCT02484547|560735025|FG006|Placebo-Controlled Period|Adverse Event|0|||
155355000|NCT02484547|560735019|FG000|Placebo-Controlled Period|Change of Treatment|0|||
155355001|NCT02484547|560735020|FG001|Placebo-Controlled Period|Change of Treatment|0|||
155355002|NCT02484547|560735021|FG002|Placebo-Controlled Period|Change of Treatment|1|||
155355003|NCT02484547|560735022|FG003|Placebo-Controlled Period|Change of Treatment|0|||
155355004|NCT02484547|560735023|FG004|Placebo-Controlled Period|Change of Treatment|0|||
155355005|NCT02484547|560735024|FG005|Placebo-Controlled Period|Change of Treatment|0|||
155355006|NCT02484547|560735025|FG006|Placebo-Controlled Period|Change of Treatment|0|||
155355007|NCT02484547|560735019|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
155355008|NCT02484547|560735020|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
155355009|NCT02484547|560735021|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
155355010|NCT02484547|560735022|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
155355011|NCT02484547|560735023|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
155355012|NCT02484547|560735024|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
155355013|NCT02484547|560735025|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
155355014|NCT02484547|560735019|FG000|Placebo-Controlled Period|Death|5|||
155355015|NCT02484547|560735020|FG001|Placebo-Controlled Period|Death|0|||
155355016|NCT02484547|560735021|FG002|Placebo-Controlled Period|Death|6|||
155355017|NCT02484547|560735022|FG003|Placebo-Controlled Period|Death|0|||
155355018|NCT02484547|560735023|FG004|Placebo-Controlled Period|Death|0|||
155355019|NCT02484547|560735024|FG005|Placebo-Controlled Period|Death|0|||
155355020|NCT02484547|560735025|FG006|Placebo-Controlled Period|Death|0|||
155355021|NCT02484547|560735019|FG000|Placebo-Controlled Period|Disease Progression|2|||
155355022|NCT02484547|560735020|FG001|Placebo-Controlled Period|Disease Progression|0|||
155355023|NCT02484547|560735021|FG002|Placebo-Controlled Period|Disease Progression|1|||
155355024|NCT02484547|560735022|FG003|Placebo-Controlled Period|Disease Progression|0|||
155355025|NCT02484547|560735023|FG004|Placebo-Controlled Period|Disease Progression|0|||
155355026|NCT02484547|560735024|FG005|Placebo-Controlled Period|Disease Progression|0|||
155355027|NCT02484547|560735025|FG006|Placebo-Controlled Period|Disease Progression|0|||
155355028|NCT02484547|560735019|FG000|Placebo-Controlled Period|Investigator Decision|2|||
155355029|NCT02484547|560735020|FG001|Placebo-Controlled Period|Investigator Decision|2|||
155355030|NCT02484547|560735021|FG002|Placebo-Controlled Period|Investigator Decision|5|||
155355031|NCT02484547|560735022|FG003|Placebo-Controlled Period|Investigator Decision|0|||
155355032|NCT02484547|560735023|FG004|Placebo-Controlled Period|Investigator Decision|0|||
155355033|NCT02484547|560735024|FG005|Placebo-Controlled Period|Investigator Decision|0|||
155355034|NCT02484547|560735025|FG006|Placebo-Controlled Period|Investigator Decision|0|||
155355035|NCT02484547|560735019|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
155355036|NCT02484547|560735020|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
155355037|NCT02484547|560735021|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
155355038|NCT02484547|560735022|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
155355039|NCT02484547|560735023|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
155355040|NCT02484547|560735024|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
155355041|NCT02484547|560735025|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
155355042|NCT02484547|560735019|FG000|Placebo-Controlled Period|Relocation|1|||
155355043|NCT02484547|560735020|FG001|Placebo-Controlled Period|Relocation|1|||
155355044|NCT02484547|560735021|FG002|Placebo-Controlled Period|Relocation|1|||
155355045|NCT02484547|560735022|FG003|Placebo-Controlled Period|Relocation|0|||
155355046|NCT02484547|560735023|FG004|Placebo-Controlled Period|Relocation|0|||
155355047|NCT02484547|560735024|FG005|Placebo-Controlled Period|Relocation|0|||
155355048|NCT02484547|560735025|FG006|Placebo-Controlled Period|Relocation|0|||
155355049|NCT02484547|560735019|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
155355050|NCT02484547|560735020|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
155426695|NCT01824979|560989860|FG000|Overall Study|Physician Decision|2|||
155355051|NCT02484547|560735021|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
155426696|NCT01824979|560989861|FG001|Overall Study|Physician Decision|0|||
155355052|NCT02484547|560735022|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
155355053|NCT02484547|560735023|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
155355054|NCT02484547|560735024|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
155355055|NCT02484547|560735025|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
155355056|NCT02484547|560735019|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
155355057|NCT02484547|560735020|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155355058|NCT02484547|560735021|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155355059|NCT02484547|560735022|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355060|NCT02484547|560735023|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355061|NCT02484547|560735024|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355062|NCT02484547|560735025|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355063|NCT02484547|560735019|FG000|Placebo-Controlled Period|Reason not Specified|216|||
155355064|NCT02484547|560735020|FG001|Placebo-Controlled Period|Reason not Specified|194|||
155355065|NCT02484547|560735021|FG002|Placebo-Controlled Period|Reason not Specified|183|||
155355066|NCT02484547|560735022|FG003|Placebo-Controlled Period|Reason not Specified|0|||
155355067|NCT02484547|560735023|FG004|Placebo-Controlled Period|Reason not Specified|0|||
155355068|NCT02484547|560735024|FG005|Placebo-Controlled Period|Reason not Specified|0|||
155355069|NCT02484547|560735025|FG006|Placebo-Controlled Period|Reason not Specified|0|||
155355070|NCT02484547|560735019|FG000|Long-Term Extension Period|Adverse Event|0|||
155355071|NCT02484547|560735020|FG001|Long-Term Extension Period|Adverse Event|0|||
155355072|NCT02484547|560735021|FG002|Long-Term Extension Period|Adverse Event|0|||
155355073|NCT02484547|560735022|FG003|Long-Term Extension Period|Adverse Event|0|||
155355074|NCT02484547|560735023|FG004|Long-Term Extension Period|Adverse Event|1|||
155355075|NCT02484547|560735024|FG005|Long-Term Extension Period|Adverse Event|3|||
155355076|NCT02484547|560735025|FG006|Long-Term Extension Period|Adverse Event|2|||
155355077|NCT02484547|560735019|FG000|Long-Term Extension Period|Death|0|||
155355078|NCT02484547|560735020|FG001|Long-Term Extension Period|Death|0|||
155355079|NCT02484547|560735021|FG002|Long-Term Extension Period|Death|0|||
155355080|NCT02484547|560735022|FG003|Long-Term Extension Period|Death|0|||
155355081|NCT02484547|560735023|FG004|Long-Term Extension Period|Death|0|||
155355082|NCT02484547|560735024|FG005|Long-Term Extension Period|Death|3|||
155355083|NCT02484547|560735025|FG006|Long-Term Extension Period|Death|0|||
155355084|NCT02484547|560735019|FG000|Long-Term Extension Period|Disease Progression|0|||
155426697|NCT01824979|560989860|FG000|Overall Study|Protocol Violation|6|||
155426698|NCT01824979|560989861|FG001|Overall Study|Protocol Violation|13|||
155426699|NCT01193686|560989873|FG000|Overall Study|Withdrawal by Subject|4|||
155426700|NCT01193686|560989874|FG001|Overall Study|Withdrawal by Subject|1|||
155426701|NCT01193686|560989873|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
155426702|NCT01193686|560989874|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
155426703|NCT04373460|560989879|FG000|Overall Study|Did not receive tranfusion|18|||
155426704|NCT04373460|560989880|FG001|Overall Study|Did not receive tranfusion|26|||
155426705|NCT00454207|560989881|FG000|Overall Study|Adverse Event|3|||
155426706|NCT00454207|560989882|FG001|Overall Study|Adverse Event|1|||
155426707|NCT00454207|560989881|FG000|Overall Study|Lack of Efficacy|1|||
155426708|NCT00454207|560989882|FG001|Overall Study|Lack of Efficacy|0|||
155426709|NCT00454207|560989881|FG000|Overall Study|Protocol Violation|0|||
155426710|NCT00454207|560989882|FG001|Overall Study|Protocol Violation|1|||
155426711|NCT01672957|560989883|FG000|Overall Study|Protocol Violation|48|||
155426712|NCT01672957|560989883|FG000|Overall Study|Death|2|||
155426713|NCT01672957|560989883|FG000|Overall Study|ICF Signed After Transplantation|5|||
155426714|NCT00151892|560989884|FG000|Overall Study|Lack of Efficacy|50|||
155426715|NCT00151892|560989885|FG001|Overall Study|Lack of Efficacy|57|||
155426716|NCT00151892|560989884|FG000|Overall Study|Patient request|10|||
155426717|NCT00151892|560989885|FG001|Overall Study|Patient request|7|||
155426718|NCT00151892|560989884|FG000|Overall Study|Lost to Follow-up|5|||
155426719|NCT00151892|560989885|FG001|Overall Study|Lost to Follow-up|10|||
155426720|NCT00151892|560989884|FG000|Overall Study|Adverse Event|6|||
155426721|NCT00151892|560989885|FG001|Overall Study|Adverse Event|3|||
155355085|NCT02484547|560735020|FG001|Long-Term Extension Period|Disease Progression|0|||
155355086|NCT02484547|560735021|FG002|Long-Term Extension Period|Disease Progression|0|||
155355087|NCT02484547|560735022|FG003|Long-Term Extension Period|Disease Progression|0|||
155355088|NCT02484547|560735023|FG004|Long-Term Extension Period|Disease Progression|2|||
155426722|NCT00151892|560989884|FG000|Overall Study|Protocol Violation|3|||
155426723|NCT00151892|560989885|FG001|Overall Study|Protocol Violation|3|||
155426724|NCT00151892|560989884|FG000|Overall Study|Non-compliance|0|||
155426725|NCT00151892|560989885|FG001|Overall Study|Non-compliance|1|||
155426726|NCT00151892|560989884|FG000|Overall Study|Pregnancy|0|||
155426727|NCT00151892|560989885|FG001|Overall Study|Pregnancy|1|||
155426728|NCT00151892|560989884|FG000|Overall Study|Did not return for a visit|1|||
155355089|NCT02484547|560735024|FG005|Long-Term Extension Period|Disease Progression|4|||
155355090|NCT02484547|560735025|FG006|Long-Term Extension Period|Disease Progression|0|||
155355091|NCT02484547|560735019|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
155355092|NCT02484547|560735020|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
155355093|NCT02484547|560735021|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
155355094|NCT02484547|560735022|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
155355095|NCT02484547|560735023|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
155355096|NCT02484547|560735024|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
155355097|NCT02484547|560735025|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
155355098|NCT02484547|560735019|FG000|Long-Term Extension Period|Loss of Capacity|0|||
155355099|NCT02484547|560735020|FG001|Long-Term Extension Period|Loss of Capacity|0|||
155355100|NCT02484547|560735021|FG002|Long-Term Extension Period|Loss of Capacity|0|||
155355101|NCT02484547|560735022|FG003|Long-Term Extension Period|Loss of Capacity|0|||
155355102|NCT02484547|560735023|FG004|Long-Term Extension Period|Loss of Capacity|1|||
155355103|NCT02484547|560735024|FG005|Long-Term Extension Period|Loss of Capacity|0|||
155355104|NCT02484547|560735025|FG006|Long-Term Extension Period|Loss of Capacity|0|||
155355105|NCT02484547|560735019|FG000|Long-Term Extension Period|Change of Treatment|0|||
155355106|NCT02484547|560735020|FG001|Long-Term Extension Period|Change of Treatment|0|||
155355107|NCT02484547|560735021|FG002|Long-Term Extension Period|Change of Treatment|0|||
155355108|NCT02484547|560735022|FG003|Long-Term Extension Period|Change of Treatment|0|||
155355109|NCT02484547|560735023|FG004|Long-Term Extension Period|Change of Treatment|0|||
155355110|NCT02484547|560735024|FG005|Long-Term Extension Period|Change of Treatment|0|||
155355111|NCT02484547|560735025|FG006|Long-Term Extension Period|Change of Treatment|1|||
155355112|NCT02484547|560735019|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
155355113|NCT02484547|560735020|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
155355114|NCT02484547|560735021|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
155355115|NCT02484547|560735022|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
155355116|NCT02484547|560735023|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
155355117|NCT02484547|560735024|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
155355118|NCT02484547|560735025|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
155355119|NCT02484547|560735019|FG000|Long-Term Extension Period|Investigator Decision|0|||
155355120|NCT02484547|560735020|FG001|Long-Term Extension Period|Investigator Decision|0|||
155355121|NCT02484547|560735021|FG002|Long-Term Extension Period|Investigator Decision|0|||
155355122|NCT02484547|560735022|FG003|Long-Term Extension Period|Investigator Decision|2|||
155355123|NCT02484547|560735023|FG004|Long-Term Extension Period|Investigator Decision|1|||
155426729|NCT00151892|560989885|FG001|Overall Study|Did not return for a visit|0|||
155426730|NCT00151892|560989884|FG000|Overall Study|Used prohibited corticosteroids|1|||
155426731|NCT00151892|560989885|FG001|Overall Study|Used prohibited corticosteroids|0|||
155426732|NCT00151892|560989884|FG000|Overall Study|Lack of study medication at center|0|||
155426733|NCT00151892|560989885|FG001|Overall Study|Lack of study medication at center|1|||
155426734|NCT02901431|560989886|FG000|PK Part|Adverse Event|0|||
155648645|NCT03518203|561805878|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
155648646|NCT02675452|561805881|FG000|Overall Study|Sponsor decision|0|||
155648647|NCT02675452|561805882|FG001|Overall Study|Sponsor decision|0|||
155648648|NCT02675452|561805883|FG002|Overall Study|Sponsor decision|0|||
155648649|NCT02675452|561805884|FG003|Overall Study|Sponsor decision|0|||
155355124|NCT02484547|560735024|FG005|Long-Term Extension Period|Investigator Decision|0|||
155355125|NCT02484547|560735025|FG006|Long-Term Extension Period|Investigator Decision|1|||
155355126|NCT02484547|560735019|FG000|Long-Term Extension Period|Relocation|0|||
155355127|NCT02484547|560735020|FG001|Long-Term Extension Period|Relocation|0|||
155355128|NCT02484547|560735021|FG002|Long-Term Extension Period|Relocation|0|||
155355129|NCT02484547|560735022|FG003|Long-Term Extension Period|Relocation|1|||
155426735|NCT02901431|560989887|FG001|PK Part|Adverse Event|1|||
155426736|NCT02901431|560989888|FG002|PK Part|Adverse Event|0|||
155355130|NCT02484547|560735023|FG004|Long-Term Extension Period|Relocation|1|||
155355131|NCT02484547|560735024|FG005|Long-Term Extension Period|Relocation|0|||
155355132|NCT02484547|560735025|FG006|Long-Term Extension Period|Relocation|0|||
155355133|NCT02484547|560735019|FG000|Long-Term Extension Period|Study Visit Burden|0|||
155355134|NCT02484547|560735020|FG001|Long-Term Extension Period|Study Visit Burden|0|||
155355135|NCT02484547|560735021|FG002|Long-Term Extension Period|Study Visit Burden|0|||
155355136|NCT02484547|560735022|FG003|Long-Term Extension Period|Study Visit Burden|2|||
155355137|NCT02484547|560735023|FG004|Long-Term Extension Period|Study Visit Burden|0|||
155355138|NCT02484547|560735024|FG005|Long-Term Extension Period|Study Visit Burden|0|||
155355139|NCT02484547|560735025|FG006|Long-Term Extension Period|Study Visit Burden|3|||
155355140|NCT02484547|560735019|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355141|NCT02484547|560735020|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355142|NCT02484547|560735021|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355143|NCT02484547|560735022|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155648650|NCT02675452|561805885|FG004|Overall Study|Sponsor decision|0|||
155648651|NCT02675452|561805886|FG005|Overall Study|Sponsor decision|0|||
155648652|NCT02675452|561805887|FG006|Overall Study|Sponsor decision|0|||
155648653|NCT02675452|561805888|FG007|Overall Study|Sponsor decision|0|||
155648654|NCT02675452|561805889|FG008|Overall Study|Sponsor decision|0|||
155648655|NCT02675452|561805890|FG009|Overall Study|Sponsor decision|1|||
155648656|NCT02675452|561805891|FG010|Overall Study|Sponsor decision|0|||
155648657|NCT02675452|561805892|FG011|Overall Study|Sponsor decision|0|||
155648658|NCT02675452|561805893|FG012|Overall Study|Sponsor decision|0|||
155648659|NCT02675452|561805894|FG013|Overall Study|Sponsor decision|2|||
155648660|NCT02675452|561805895|FG014|Overall Study|Sponsor decision|1|||
155648661|NCT02675452|561805896|FG015|Overall Study|Sponsor decision|0|||
155355144|NCT02484547|560735023|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
155355145|NCT02484547|560735024|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
155355146|NCT02484547|560735025|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
155355147|NCT02484547|560735019|FG000|Long-Term Extension Period|Reason not Specified|0|||
155355148|NCT02484547|560735020|FG001|Long-Term Extension Period|Reason not Specified|0|||
155355149|NCT02484547|560735021|FG002|Long-Term Extension Period|Reason not Specified|0|||
155355150|NCT02484547|560735022|FG003|Long-Term Extension Period|Reason not Specified|119|||
155355151|NCT02484547|560735023|FG004|Long-Term Extension Period|Reason not Specified|117|||
155355152|NCT02484547|560735024|FG005|Long-Term Extension Period|Reason not Specified|223|||
155355153|NCT02484547|560735025|FG006|Long-Term Extension Period|Reason not Specified|231|||
155355154|NCT03448536|560735026|FG000|Overall Study|Protocol Violation|2|||
155355155|NCT03448536|560735027|FG001|Overall Study|Protocol Violation|0|||
155355156|NCT03448536|560735026|FG000|Overall Study|Pregnancy|1|||
155355157|NCT03448536|560735027|FG001|Overall Study|Pregnancy|0|||
155355158|NCT03448536|560735026|FG000|Overall Study|Withdrawal by Subject|1|||
155355159|NCT03448536|560735027|FG001|Overall Study|Withdrawal by Subject|2|||
155355160|NCT03448536|560735026|FG000|Overall Study|Lost to Follow-up|3|||
155355161|NCT03448536|560735027|FG001|Overall Study|Lost to Follow-up|2|||
155355162|NCT03448536|560735026|FG000|Overall Study|Inadequate pain reporter|1|||
155355163|NCT03448536|560735027|FG001|Overall Study|Inadequate pain reporter|0|||
155355164|NCT03448536|560735026|FG000|Overall Study|Other|3|||
155355165|NCT03448536|560735027|FG001|Overall Study|Other|0|||
155355166|NCT03448536|560735026|FG000|Overall Study|Physician Decision|1|||
155355167|NCT03448536|560735027|FG001|Overall Study|Physician Decision|0|||
155355168|NCT01665599|560735028|FG000|Overall Study|Adverse Event|1|||
155355169|NCT01665599|560735028|FG000|Overall Study|Consent Withdrawn|1|||
155355170|NCT01665599|560735028|FG000|Overall Study|Investigator/Sponsor decision|1|||
155355171|NCT01665599|560735028|FG000|Overall Study|Death|1|||
155355172|NCT01665599|560735028|FG000|Overall Study|Lost to Follow-up|2|||
155355173|NCT01665599|560735028|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
155648662|NCT02675452|561805897|FG016|Overall Study|Sponsor decision|1|||
155355174|NCT01665599|560735028|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
155355175|NCT04688086|560735029|FG000|Overall Study|Lost to Follow-up|164|||
155355176|NCT04688086|560735029|FG000|Overall Study|Imaging error;|64|||
155355177|NCT03015181|560735033|FG000|Overall Study|Enrolled, but product never administered|1|||
155355178|NCT03015181|560735034|FG001|Overall Study|Enrolled, but product never administered|0|||
155355179|NCT03015181|560735035|FG002|Overall Study|Enrolled, but product never administered|0|||
155355180|NCT03015181|560735036|FG003|Overall Study|Enrolled, but product never administered|0|||
155355181|NCT03015181|560735037|FG004|Overall Study|Enrolled, but product never administered|0|||
155648663|NCT02675452|561805898|FG017|Overall Study|Sponsor decision|0|||
155355182|NCT03015181|560735038|FG005|Overall Study|Enrolled, but product never administered|0|||
155355183|NCT03015181|560735039|FG006|Overall Study|Enrolled, but product never administered|0|||
155355184|NCT03015181|560735033|FG000|Overall Study|Withdrawal by Subject|0|||
155355185|NCT03015181|560735034|FG001|Overall Study|Withdrawal by Subject|0|||
155355186|NCT03015181|560735035|FG002|Overall Study|Withdrawal by Subject|0|||
155355187|NCT03015181|560735036|FG003|Overall Study|Withdrawal by Subject|0|||
155648664|NCT02675452|561805899|FG018|Overall Study|Sponsor decision|0|||
155648665|NCT02675452|561805900|FG019|Overall Study|Sponsor decision|0|||
155648666|NCT02675452|561805901|FG020|Overall Study|Sponsor decision|0|||
155355188|NCT03015181|560735037|FG004|Overall Study|Withdrawal by Subject|0|||
155355189|NCT03015181|560735038|FG005|Overall Study|Withdrawal by Subject|1|||
155355190|NCT03015181|560735039|FG006|Overall Study|Withdrawal by Subject|0|||
155355191|NCT03015181|560735033|FG000|Overall Study|Physician Decision|0|||
155355192|NCT03015181|560735034|FG001|Overall Study|Physician Decision|0|||
155355193|NCT03015181|560735035|FG002|Overall Study|Physician Decision|0|||
155355194|NCT03015181|560735036|FG003|Overall Study|Physician Decision|0|||
155355195|NCT03015181|560735037|FG004|Overall Study|Physician Decision|0|||
155355196|NCT03015181|560735038|FG005|Overall Study|Physician Decision|0|||
155355197|NCT03015181|560735039|FG006|Overall Study|Physician Decision|1|||
155355198|NCT01831726|560735042|FG000|Overall Study|Adverse Event|16|||
155355199|NCT01831726|560735042|FG000|Overall Study|Death|7|||
155355200|NCT01831726|560735042|FG000|Overall Study|Disease Progression|49|||
155355201|NCT01831726|560735042|FG000|Overall Study|Physician Decision|1|||
155355202|NCT01831726|560735042|FG000|Overall Study|Subject/guardian decision|7|||
155355203|NCT03821064|560735043|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
155355204|NCT00474383|560735044|FG000|Main Study|Adverse Event|11|||
155355205|NCT00474383|560735045|FG001|Main Study|Adverse Event|0|||
155355206|NCT00474383|560735044|FG000|Main Study|Symptomatic Deterioration|1|||
155355207|NCT00474383|560735045|FG001|Main Study|Symptomatic Deterioration|0|||
155355208|NCT00474383|560735044|FG000|Main Study|Progressive Disease|23|||
155355209|NCT00474383|560735045|FG001|Main Study|Progressive Disease|0|||
155355210|NCT00474383|560735044|FG000|Main Study|Other|1|||
155355211|NCT00474383|560735045|FG001|Main Study|Other|0|||
155355212|NCT00474383|560735044|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
155355213|NCT00474383|560735045|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
155355214|NCT00474383|560735044|FG000|Extension|Progressive Disease|0|||
155355215|NCT00474383|560735045|FG001|Extension|Progressive Disease|5|||
155355216|NCT01482819|560735047|FG000|Overall Study|Lost to Follow-up|2|||
155355217|NCT01502371|560735052|FG000|Overall Study|Withdrawal by Subject|1|||
155355218|NCT01502371|560735053|FG001|Overall Study|Withdrawal by Subject|2|||
155355219|NCT01502371|560735054|FG002|Overall Study|Withdrawal by Subject|1|||
155426737|NCT02901431|560989889|FG003|PK Part|Adverse Event|0|||
155426738|NCT02901431|560989890|FG004|PK Part|Adverse Event|0|||
155426739|NCT02901431|560989891|FG005|PK Part|Adverse Event|0|||
155426740|NCT02901431|560989892|FG006|PK Part|Adverse Event|0|||
155426741|NCT02901431|560989893|FG007|PK Part|Adverse Event|0|||
155426742|NCT02901431|560989894|FG008|PK Part|Adverse Event|0|||
155426743|NCT02901431|560989895|FG009|PK Part|Adverse Event|0|||
155426744|NCT02901431|560989896|FG010|PK Part|Adverse Event|0|||
155426745|NCT02901431|560989897|FG011|PK Part|Adverse Event|0|||
155426746|NCT02901431|560989898|FG012|PK Part|Adverse Event|0|||
155426747|NCT02901431|560989886|FG000|PK Part|Lost to Follow-up|0|||
155426748|NCT02901431|560989887|FG001|PK Part|Lost to Follow-up|0|||
155426749|NCT02901431|560989888|FG002|PK Part|Lost to Follow-up|1|||
155426750|NCT02901431|560989889|FG003|PK Part|Lost to Follow-up|0|||
155426751|NCT02901431|560989890|FG004|PK Part|Lost to Follow-up|0|||
155426752|NCT02901431|560989891|FG005|PK Part|Lost to Follow-up|0|||
155426753|NCT02901431|560989892|FG006|PK Part|Lost to Follow-up|0|||
155426754|NCT02901431|560989893|FG007|PK Part|Lost to Follow-up|0|||
155426755|NCT02901431|560989894|FG008|PK Part|Lost to Follow-up|0|||
155426756|NCT02901431|560989895|FG009|PK Part|Lost to Follow-up|0|||
155426757|NCT02901431|560989896|FG010|PK Part|Lost to Follow-up|0|||
155426758|NCT02901431|560989897|FG011|PK Part|Lost to Follow-up|0|||
155426759|NCT02901431|560989898|FG012|PK Part|Lost to Follow-up|0|||
155648667|NCT02675452|561805902|FG021|Overall Study|Sponsor decision|0|||
155648668|NCT02675452|561805903|FG022|Overall Study|Sponsor decision|0|||
155355220|NCT01502371|560735055|FG003|Overall Study|Withdrawal by Subject|1|||
155355221|NCT01502371|560735056|FG004|Overall Study|Withdrawal by Subject|1|||
155355222|NCT01502371|560735052|FG000|Overall Study|Adverse Event|2|||
155426760|NCT02901431|560989886|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
155426761|NCT02901431|560989887|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426762|NCT02901431|560989888|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426763|NCT02901431|560989889|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155648669|NCT02675452|561805904|FG023|Overall Study|Sponsor decision|0|||
155426764|NCT02901431|560989890|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155355223|NCT01502371|560735053|FG001|Overall Study|Adverse Event|1|||
155355224|NCT01502371|560735054|FG002|Overall Study|Adverse Event|0|||
155355225|NCT01502371|560735055|FG003|Overall Study|Adverse Event|4|||
155355226|NCT01502371|560735056|FG004|Overall Study|Adverse Event|3|||
155355227|NCT01502371|560735052|FG000|Overall Study|Treatment Failure|22|||
155355228|NCT01502371|560735053|FG001|Overall Study|Treatment Failure|20|||
155355229|NCT01502371|560735054|FG002|Overall Study|Treatment Failure|12|||
155355230|NCT01502371|560735055|FG003|Overall Study|Treatment Failure|19|||
155426765|NCT02901431|560989891|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426766|NCT02901431|560989892|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426767|NCT02901431|560989893|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426768|NCT02901431|560989894|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426769|NCT02901431|560989895|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426770|NCT02901431|560989896|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426771|NCT02901431|560989897|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426772|NCT02901431|560989898|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
155426773|NCT02901431|560989886|FG000|PK Part|Pending dose confirmation|0|||
155426774|NCT02901431|560989887|FG001|PK Part|Pending dose confirmation|1|||
155426775|NCT02901431|560989888|FG002|PK Part|Pending dose confirmation|0|||
155426776|NCT02901431|560989889|FG003|PK Part|Pending dose confirmation|0|||
155426777|NCT02901431|560989890|FG004|PK Part|Pending dose confirmation|0|||
155426778|NCT02901431|560989891|FG005|PK Part|Pending dose confirmation|0|||
155426779|NCT02901431|560989892|FG006|PK Part|Pending dose confirmation|0|||
155426780|NCT02901431|560989893|FG007|PK Part|Pending dose confirmation|0|||
155426781|NCT02901431|560989894|FG008|PK Part|Pending dose confirmation|0|||
155426782|NCT02901431|560989895|FG009|PK Part|Pending dose confirmation|0|||
155426783|NCT02901431|560989896|FG010|PK Part|Pending dose confirmation|0|||
155426784|NCT02901431|560989897|FG011|PK Part|Pending dose confirmation|0|||
155426785|NCT02901431|560989898|FG012|PK Part|Pending dose confirmation|0|||
155426786|NCT02901431|560989886|FG000|PK Part|8 weeks of treatment ran out|2|||
155426787|NCT02901431|560989887|FG001|PK Part|8 weeks of treatment ran out|0|||
155426788|NCT02901431|560989888|FG002|PK Part|8 weeks of treatment ran out|0|||
155426789|NCT02901431|560989889|FG003|PK Part|8 weeks of treatment ran out|0|||
155426790|NCT02901431|560989890|FG004|PK Part|8 weeks of treatment ran out|0|||
155426791|NCT02901431|560989891|FG005|PK Part|8 weeks of treatment ran out|0|||
155426792|NCT02901431|560989892|FG006|PK Part|8 weeks of treatment ran out|0|||
155426793|NCT02901431|560989893|FG007|PK Part|8 weeks of treatment ran out|0|||
155426794|NCT02901431|560989894|FG008|PK Part|8 weeks of treatment ran out|0|||
155426795|NCT02901431|560989895|FG009|PK Part|8 weeks of treatment ran out|0|||
155426796|NCT02901431|560989896|FG010|PK Part|8 weeks of treatment ran out|0|||
155426797|NCT02901431|560989897|FG011|PK Part|8 weeks of treatment ran out|0|||
155426798|NCT02901431|560989898|FG012|PK Part|8 weeks of treatment ran out|0|||
155426799|NCT02901431|560989886|FG000|PK Part|Stopped treatment after 8 weeks|1|||
155426800|NCT02901431|560989887|FG001|PK Part|Stopped treatment after 8 weeks|0|||
155426801|NCT02901431|560989888|FG002|PK Part|Stopped treatment after 8 weeks|1|||
155426802|NCT02901431|560989889|FG003|PK Part|Stopped treatment after 8 weeks|0|||
155426803|NCT02901431|560989890|FG004|PK Part|Stopped treatment after 8 weeks|0|||
155426804|NCT02901431|560989891|FG005|PK Part|Stopped treatment after 8 weeks|0|||
155426805|NCT02901431|560989892|FG006|PK Part|Stopped treatment after 8 weeks|0|||
155426806|NCT02901431|560989893|FG007|PK Part|Stopped treatment after 8 weeks|0|||
155426807|NCT02901431|560989894|FG008|PK Part|Stopped treatment after 8 weeks|0|||
155426808|NCT02901431|560989895|FG009|PK Part|Stopped treatment after 8 weeks|0|||
155426809|NCT02901431|560989896|FG010|PK Part|Stopped treatment after 8 weeks|0|||
155426810|NCT02901431|560989897|FG011|PK Part|Stopped treatment after 8 weeks|0|||
155426811|NCT02901431|560989898|FG012|PK Part|Stopped treatment after 8 weeks|0|||
155426812|NCT02901431|560989886|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
155426813|NCT02901431|560989887|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426814|NCT02901431|560989888|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
155426815|NCT02901431|560989889|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426816|NCT02901431|560989890|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426817|NCT02901431|560989891|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426818|NCT02901431|560989892|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426819|NCT02901431|560989893|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426820|NCT02901431|560989894|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426821|NCT02901431|560989895|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426822|NCT02901431|560989896|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426823|NCT02901431|560989897|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426824|NCT02901431|560989898|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
155426825|NCT02901431|560989886|FG000|PK Part|Discontinued per Sponsor|0|||
155426826|NCT02901431|560989887|FG001|PK Part|Discontinued per Sponsor|3|||
155426827|NCT02901431|560989888|FG002|PK Part|Discontinued per Sponsor|0|||
155426828|NCT02901431|560989889|FG003|PK Part|Discontinued per Sponsor|0|||
155426829|NCT02901431|560989890|FG004|PK Part|Discontinued per Sponsor|0|||
155426830|NCT02901431|560989891|FG005|PK Part|Discontinued per Sponsor|0|||
155426831|NCT02901431|560989892|FG006|PK Part|Discontinued per Sponsor|0|||
155426832|NCT02901431|560989893|FG007|PK Part|Discontinued per Sponsor|0|||
155426833|NCT02901431|560989894|FG008|PK Part|Discontinued per Sponsor|0|||
155426834|NCT02901431|560989895|FG009|PK Part|Discontinued per Sponsor|0|||
155426835|NCT02901431|560989896|FG010|PK Part|Discontinued per Sponsor|0|||
155426836|NCT02901431|560989897|FG011|PK Part|Discontinued per Sponsor|0|||
155355231|NCT01502371|560735056|FG004|Overall Study|Treatment Failure|30|||
155355232|NCT01502371|560735052|FG000|Overall Study|Lack of Efficacy|3|||
155355233|NCT01502371|560735053|FG001|Overall Study|Lack of Efficacy|3|||
155355234|NCT01502371|560735054|FG002|Overall Study|Lack of Efficacy|2|||
155355235|NCT01502371|560735055|FG003|Overall Study|Lack of Efficacy|2|||
155355236|NCT01502371|560735056|FG004|Overall Study|Lack of Efficacy|4|||
155355237|NCT01502371|560735052|FG000|Overall Study|Physician Decision|3|||
155355238|NCT01502371|560735053|FG001|Overall Study|Physician Decision|0|||
155355239|NCT01502371|560735054|FG002|Overall Study|Physician Decision|0|||
155355240|NCT01502371|560735055|FG003|Overall Study|Physician Decision|0|||
155355241|NCT01502371|560735056|FG004|Overall Study|Physician Decision|1|||
155355242|NCT01502371|560735052|FG000|Overall Study|Noncompliance with Study Drug|0|||
155355243|NCT01502371|560735053|FG001|Overall Study|Noncompliance with Study Drug|0|||
155355244|NCT01502371|560735054|FG002|Overall Study|Noncompliance with Study Drug|1|||
155355245|NCT01502371|560735055|FG003|Overall Study|Noncompliance with Study Drug|2|||
155355246|NCT01502371|560735056|FG004|Overall Study|Noncompliance with Study Drug|1|||
155355247|NCT01502371|560735052|FG000|Overall Study|Technical Problems|1|||
155355248|NCT01502371|560735053|FG001|Overall Study|Technical Problems|0|||
155355249|NCT01502371|560735054|FG002|Overall Study|Technical Problems|2|||
155355250|NCT01502371|560735055|FG003|Overall Study|Technical Problems|4|||
155355251|NCT01502371|560735056|FG004|Overall Study|Technical Problems|1|||
155355252|NCT01502371|560735052|FG000|Overall Study|Protocol Violation|9|||
155355253|NCT01502371|560735053|FG001|Overall Study|Protocol Violation|5|||
155355254|NCT01502371|560735054|FG002|Overall Study|Protocol Violation|6|||
155355255|NCT01502371|560735055|FG003|Overall Study|Protocol Violation|5|||
155355256|NCT01502371|560735056|FG004|Overall Study|Protocol Violation|10|||
155355257|NCT01502371|560735052|FG000|Overall Study|Excluded Medication|0|||
155355258|NCT01502371|560735053|FG001|Overall Study|Excluded Medication|1|||
155355259|NCT01502371|560735054|FG002|Overall Study|Excluded Medication|1|||
155355260|NCT01502371|560735055|FG003|Overall Study|Excluded Medication|0|||
155355261|NCT01502371|560735056|FG004|Overall Study|Excluded Medication|1|||
155355262|NCT00514813|560735061|FG000|Overall Study|Study terminated|14|||
155355263|NCT00514813|560735062|FG001|Overall Study|Study terminated|74|||
155355264|NCT00514813|560735063|FG002|Overall Study|Study terminated|40|||
155355265|NCT00514813|560735064|FG003|Overall Study|Study terminated|2|||
155355266|NCT00514813|560735061|FG000|Overall Study|Adverse Event|0|||
155355267|NCT00514813|560735062|FG001|Overall Study|Adverse Event|2|||
155355268|NCT00514813|560735063|FG002|Overall Study|Adverse Event|2|||
155355269|NCT00514813|560735064|FG003|Overall Study|Adverse Event|0|||
155355270|NCT00514813|560735061|FG000|Overall Study|Protocol Violation|1|||
155355271|NCT00514813|560735062|FG001|Overall Study|Protocol Violation|0|||
155355272|NCT00514813|560735063|FG002|Overall Study|Protocol Violation|0|||
155355273|NCT00514813|560735064|FG003|Overall Study|Protocol Violation|0|||
155355274|NCT00514813|560735061|FG000|Overall Study|Withdrawal by Subject|0|||
155355275|NCT00514813|560735062|FG001|Overall Study|Withdrawal by Subject|1|||
155355276|NCT00514813|560735063|FG002|Overall Study|Withdrawal by Subject|0|||
155355277|NCT00514813|560735064|FG003|Overall Study|Withdrawal by Subject|0|||
155355278|NCT00514813|560735061|FG000|Overall Study|Lack of Efficacy|0|||
155355279|NCT00514813|560735062|FG001|Overall Study|Lack of Efficacy|1|||
155355280|NCT00514813|560735063|FG002|Overall Study|Lack of Efficacy|0|||
155355281|NCT00514813|560735064|FG003|Overall Study|Lack of Efficacy|0|||
155355282|NCT00514813|560735061|FG000|Overall Study|Kidney transplant|0|||
155355283|NCT00514813|560735062|FG001|Overall Study|Kidney transplant|6|||
155355284|NCT00514813|560735063|FG002|Overall Study|Kidney transplant|2|||
155355285|NCT00514813|560735064|FG003|Overall Study|Kidney transplant|0|||
155355286|NCT00514813|560735061|FG000|Overall Study|Death|0|||
155355287|NCT00514813|560735062|FG001|Overall Study|Death|2|||
155355288|NCT00514813|560735063|FG002|Overall Study|Death|3|||
155355289|NCT00514813|560735064|FG003|Overall Study|Death|2|||
155355290|NCT01075100|560735069|FG000|Overall Study|Adverse Event|15|||
155355291|NCT01075100|560735070|FG001|Overall Study|Adverse Event|18|||
155355292|NCT01075100|560735069|FG000|Overall Study|Patient Request|4|||
155355293|NCT01075100|560735070|FG001|Overall Study|Patient Request|4|||
155355294|NCT01075100|560735069|FG000|Overall Study|Investigator Request|2|||
155355295|NCT01075100|560735070|FG001|Overall Study|Investigator Request|1|||
155355296|NCT01075100|560735069|FG000|Overall Study|Disease Progression|25|||
155355297|NCT01075100|560735070|FG001|Overall Study|Disease Progression|29|||
155355298|NCT01075100|560735069|FG000|Overall Study|Other|3|||
155355299|NCT01075100|560735070|FG001|Overall Study|Other|1|||
155355300|NCT04944784|560735071|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
155355301|NCT04944784|560735072|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
155355302|NCT04944784|560735073|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
155355303|NCT04944784|560735074|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
155355304|NCT04944784|560735071|FG000|Double-blind Period|Adverse Event|20|||
155506987|NCT00672620|561283488|FG000|Overall Study|Lost to Follow-up|8|||
155506988|NCT00672620|561283489|FG001|Overall Study|Lost to Follow-up|19|||
155355305|NCT04944784|560735072|FG001|Double-blind Period|Adverse Event|4|||
155355306|NCT04944784|560735073|FG002|Double-blind Period|Adverse Event|0|||
155355307|NCT04944784|560735074|FG003|Double-blind Period|Adverse Event|0|||
155355308|NCT04944784|560735071|FG000|Double-blind Period|Withdrawal by Subject|15|||
155506989|NCT00672620|561283490|FG002|Overall Study|Lost to Follow-up|8|||
155355309|NCT04944784|560735072|FG001|Double-blind Period|Withdrawal by Subject|4|||
155355310|NCT04944784|560735073|FG002|Double-blind Period|Withdrawal by Subject|0|||
155355311|NCT04944784|560735074|FG003|Double-blind Period|Withdrawal by Subject|0|||
155355312|NCT04944784|560735071|FG000|Double-blind Period|Death|7|||
155355313|NCT04944784|560735072|FG001|Double-blind Period|Death|2|||
155355314|NCT04944784|560735073|FG002|Double-blind Period|Death|0|||
155355315|NCT04944784|560735074|FG003|Double-blind Period|Death|0|||
155355316|NCT04944784|560735071|FG000|Double-blind Period|Physician Decision|2|||
155355317|NCT04944784|560735072|FG001|Double-blind Period|Physician Decision|1|||
155355318|NCT04944784|560735073|FG002|Double-blind Period|Physician Decision|0|||
155355319|NCT04944784|560735074|FG003|Double-blind Period|Physician Decision|0|||
155355320|NCT04944784|560735071|FG000|Double-blind Period|Lack of Efficacy|0|||
155355321|NCT04944784|560735072|FG001|Double-blind Period|Lack of Efficacy|1|||
155355322|NCT04944784|560735073|FG002|Double-blind Period|Lack of Efficacy|0|||
155355323|NCT04944784|560735074|FG003|Double-blind Period|Lack of Efficacy|0|||
155355324|NCT04944784|560735071|FG000|Double-blind Period|Sponsor Request|2|||
155355325|NCT04944784|560735072|FG001|Double-blind Period|Sponsor Request|1|||
155355326|NCT04944784|560735073|FG002|Double-blind Period|Sponsor Request|0|||
155355327|NCT04944784|560735074|FG003|Double-blind Period|Sponsor Request|0|||
155355328|NCT04944784|560735071|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355329|NCT04944784|560735072|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
155355330|NCT04944784|560735073|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355331|NCT04944784|560735074|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355332|NCT04944784|560735071|FG000|Double-blind Period|Participant Choice|1|||
155355333|NCT04944784|560735072|FG001|Double-blind Period|Participant Choice|1|||
155355334|NCT04944784|560735073|FG002|Double-blind Period|Participant Choice|0|||
155355335|NCT04944784|560735074|FG003|Double-blind Period|Participant Choice|0|||
155355336|NCT04944784|560735071|FG000|Double-blind Period|Progressive Disease|2|||
155355337|NCT04944784|560735072|FG001|Double-blind Period|Progressive Disease|2|||
155355338|NCT04944784|560735073|FG002|Double-blind Period|Progressive Disease|0|||
155355339|NCT04944784|560735074|FG003|Double-blind Period|Progressive Disease|0|||
155355340|NCT04944784|560735071|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
155355341|NCT04944784|560735072|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
155355342|NCT04944784|560735073|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
155355343|NCT04944784|560735074|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
155355344|NCT04944784|560735071|FG000|Active Drug Period|Adverse Event|0|||
155355345|NCT04944784|560735072|FG001|Active Drug Period|Adverse Event|0|||
155355346|NCT04944784|560735073|FG002|Active Drug Period|Adverse Event|3|||
155355347|NCT04944784|560735074|FG003|Active Drug Period|Adverse Event|6|||
155355348|NCT04944784|560735071|FG000|Active Drug Period|Withdrawal by Subject|0|||
155355349|NCT04944784|560735072|FG001|Active Drug Period|Withdrawal by Subject|0|||
155355350|NCT04944784|560735073|FG002|Active Drug Period|Withdrawal by Subject|4|||
155355351|NCT04944784|560735074|FG003|Active Drug Period|Withdrawal by Subject|7|||
155355352|NCT04944784|560735071|FG000|Active Drug Period|Death|0|||
155355353|NCT04944784|560735072|FG001|Active Drug Period|Death|0|||
155355354|NCT04944784|560735073|FG002|Active Drug Period|Death|3|||
155355355|NCT04944784|560735074|FG003|Active Drug Period|Death|4|||
155355356|NCT04944784|560735071|FG000|Active Drug Period|Lack of Efficacy|0|||
155355357|NCT04944784|560735072|FG001|Active Drug Period|Lack of Efficacy|0|||
155355358|NCT04944784|560735073|FG002|Active Drug Period|Lack of Efficacy|2|||
155355359|NCT04944784|560735074|FG003|Active Drug Period|Lack of Efficacy|2|||
155355360|NCT04944784|560735071|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355361|NCT04944784|560735072|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355362|NCT04944784|560735073|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355363|NCT04944784|560735074|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
155506990|NCT00672620|561283491|FG003|Overall Study|Lost to Follow-up|11|||
155506991|NCT00672620|561283488|FG000|Overall Study|Reason not Specified|3|||
155506992|NCT00672620|561283489|FG001|Overall Study|Reason not Specified|3|||
155355364|NCT04944784|560735071|FG000|Active Drug Period|Participant Choice|0|||
155355365|NCT04944784|560735072|FG001|Active Drug Period|Participant Choice|0|||
155355366|NCT04944784|560735073|FG002|Active Drug Period|Participant Choice|0|||
155355367|NCT04944784|560735074|FG003|Active Drug Period|Participant Choice|1|||
155355368|NCT04944784|560735071|FG000|Active Drug Period|Progressive Disease|0|||
155355369|NCT04944784|560735072|FG001|Active Drug Period|Progressive Disease|0|||
155355370|NCT04944784|560735073|FG002|Active Drug Period|Progressive Disease|4|||
155355371|NCT04944784|560735074|FG003|Active Drug Period|Progressive Disease|4|||
155355372|NCT04944784|560735071|FG000|Active Drug Period|Lost to Follow-up|0|||
155355373|NCT04944784|560735072|FG001|Active Drug Period|Lost to Follow-up|0|||
155506993|NCT00672620|561283490|FG002|Overall Study|Reason not Specified|2|||
155355374|NCT04944784|560735073|FG002|Active Drug Period|Lost to Follow-up|0|||
155355375|NCT04944784|560735074|FG003|Active Drug Period|Lost to Follow-up|1|||
155355376|NCT04398368|560736547|FG000|Overall Study|Withdrawal by Subject|2|||
155355377|NCT03602586|560736548|FG000|Overall Study|Withdrawal by Subject|3|||
155355378|NCT00511836|560736553|FG000|Double-blind Period|Lost to Follow-up|1|||
155355379|NCT00511836|560736554|FG001|Double-blind Period|Lost to Follow-up|0|||
155355380|NCT00030823|560736555|FG000|Overall Study|Withdrawal by Subject|1|||
155355381|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
155355382|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
155355383|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
155355384|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
155355385|NCT01755546|560736556|FG000|Titration Phase|Adverse Event|11|||
155355386|NCT01755546|560736556|FG000|Titration Phase|Lack of Efficacy|18|||
155355387|NCT01755546|560736556|FG000|Titration Phase|Protocol Violation|9|||
155355388|NCT01755546|560736556|FG000|Titration Phase|Lost to Follow-up|2|||
155355389|NCT01755546|560736556|FG000|Titration Phase|Other and Continuing|22|||
155355390|NCT01755546|560736556|FG000|Titration Phase|Withdrawal by Subject|8|||
155355391|NCT01755546|560736556|FG000|Long Term Treatment|Adverse Event|12|||
155355392|NCT01755546|560736556|FG000|Long Term Treatment|Lack of Efficacy|6|||
155355393|NCT01755546|560736556|FG000|Long Term Treatment|Protocol Violation|10|||
155355394|NCT01755546|560736556|FG000|Long Term Treatment|Withdrawal by Subject|35|||
155355395|NCT01755546|560736556|FG000|Long Term Treatment|Lost to Follow-up|17|||
155355396|NCT01755546|560736556|FG000|Long Term Treatment|other and ongoing|41|||
155355397|NCT00891046|560736557|FG000|Overall Study|Protocol Violation|1|||
155355398|NCT00891046|560736558|FG001|Overall Study|Protocol Violation|1|||
155355399|NCT00891046|560736559|FG002|Overall Study|Protocol Violation|0|||
155355400|NCT00891046|560736560|FG003|Overall Study|Protocol Violation|0|||
155355401|NCT00891046|560736561|FG004|Overall Study|Protocol Violation|1|||
155355402|NCT00891046|560736557|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155355403|NCT00891046|560736558|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155355404|NCT00891046|560736559|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
155355405|NCT00891046|560736560|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155355406|NCT00891046|560736561|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
155355407|NCT00891046|560736557|FG000|Overall Study|Administrative problems|0|||
155355408|NCT00891046|560736558|FG001|Overall Study|Administrative problems|0|||
155355409|NCT00891046|560736559|FG002|Overall Study|Administrative problems|0|||
155355410|NCT00891046|560736560|FG003|Overall Study|Administrative problems|0|||
155355411|NCT00891046|560736561|FG004|Overall Study|Administrative problems|1|||
155355412|NCT00891046|560736557|FG000|Overall Study|Participant no longer required drug|0|||
155355413|NCT00891046|560736558|FG001|Overall Study|Participant no longer required drug|2|||
155355414|NCT00891046|560736559|FG002|Overall Study|Participant no longer required drug|0|||
155355415|NCT00891046|560736560|FG003|Overall Study|Participant no longer required drug|0|||
155355416|NCT00891046|560736561|FG004|Overall Study|Participant no longer required drug|1|||
155355417|NCT00891046|560736557|FG000|Overall Study|Adverse Event|4|||
155355418|NCT00891046|560736558|FG001|Overall Study|Adverse Event|3|||
155355419|NCT00891046|560736559|FG002|Overall Study|Adverse Event|2|||
155355420|NCT00891046|560736560|FG003|Overall Study|Adverse Event|0|||
155355421|NCT00891046|560736561|FG004|Overall Study|Adverse Event|14|||
155355422|NCT00891046|560736557|FG000|Overall Study|Withdrawal by Subject|2|||
155355423|NCT00891046|560736558|FG001|Overall Study|Withdrawal by Subject|1|||
155355424|NCT00891046|560736559|FG002|Overall Study|Withdrawal by Subject|2|||
155355425|NCT00891046|560736560|FG003|Overall Study|Withdrawal by Subject|1|||
155355426|NCT00891046|560736561|FG004|Overall Study|Withdrawal by Subject|1|||
155355427|NCT00891046|560736557|FG000|Overall Study|Lost to Follow-up|0|||
155355428|NCT00891046|560736558|FG001|Overall Study|Lost to Follow-up|0|||
155355429|NCT00891046|560736559|FG002|Overall Study|Lost to Follow-up|0|||
155355430|NCT00891046|560736560|FG003|Overall Study|Lost to Follow-up|0|||
155355431|NCT00891046|560736561|FG004|Overall Study|Lost to Follow-up|1|||
155426837|NCT02901431|560989898|FG012|PK Part|Discontinued per Sponsor|0|||
155426838|NCT02901431|560989886|FG000|PK Part|Withdrawal by Subject|1|||
155426839|NCT02901431|560989887|FG001|PK Part|Withdrawal by Subject|1|||
155426840|NCT02901431|560989888|FG002|PK Part|Withdrawal by Subject|3|||
155355432|NCT00362375|560736562|FG000|Overall Study|Lost to Follow-up|40|||
155355433|NCT00362375|560736563|FG001|Overall Study|Lost to Follow-up|35|||
155355434|NCT02106195|560736564|FG000|Overall Study|Adverse Event|2|||
155355435|NCT02106195|560736564|FG000|Overall Study|Protocol Violation|1|||
155355436|NCT04984239|560736565|FG000|Overall Study|Lost to Follow-up|1|||
155355437|NCT03294941|560736566|FG000|Overall Study|Withdrawal by Subject|0|||
155355438|NCT03294941|560736567|FG001|Overall Study|Withdrawal by Subject|2|||
155355439|NCT04629443|560736568|FG000|Overall Study|Adverse Event|2|||
155355440|NCT04629443|560736569|FG001|Overall Study|Adverse Event|1|||
155355441|NCT04629443|560736570|FG002|Overall Study|Adverse Event|2|||
155355442|NCT04629443|560736568|FG000|Overall Study|Progressive Disease|2|||
155355443|NCT04629443|560736569|FG001|Overall Study|Progressive Disease|3|||
155355444|NCT04629443|560736570|FG002|Overall Study|Progressive Disease|3|||
155355445|NCT04629443|560736568|FG000|Overall Study|Physician Decision|1|||
155355446|NCT04629443|560736569|FG001|Overall Study|Physician Decision|3|||
155355447|NCT04629443|560736570|FG002|Overall Study|Physician Decision|0|||
155355448|NCT00916305|560736576|FG000|Overall Study|Lost to Follow-up|21|||
155355449|NCT00916305|560736577|FG001|Overall Study|Lost to Follow-up|27|||
155355450|NCT00916305|560736576|FG000|Overall Study|Withdrawal by Subject|0|||
155355451|NCT00916305|560736577|FG001|Overall Study|Withdrawal by Subject|1|||
155355452|NCT00858247|560736582|FG000|Baseline Assessment|Withdrawal by Subject|1|||
155355453|NCT00858247|560736583|FG001|Baseline Assessment|Withdrawal by Subject|1|||
155355454|NCT00858247|560736582|FG000|Baseline Assessment|Poor IV access|1|||
155355455|NCT00858247|560736583|FG001|Baseline Assessment|Poor IV access|0|||
155355456|NCT00858247|560736582|FG000|Baseline Assessment|Protocol Violation|0|||
155355457|NCT00858247|560736583|FG001|Baseline Assessment|Protocol Violation|1|||
155355458|NCT00858247|560736582|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
155355459|NCT00858247|560736583|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
155355460|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
155355461|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
155355462|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
155355463|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
155355464|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
155355465|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
155355466|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
155355467|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
155355468|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
155355469|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
155355470|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
155355471|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
155355472|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
155355473|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
155355474|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
155355475|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
155355476|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
155355477|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
155355478|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
155355479|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
155355480|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
155355481|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
155355482|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
155355483|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
155355484|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
155355485|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
155355486|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
155355487|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
155355488|NCT01336205|560736588|FG000|Overall Study|Other|22|||
155355489|NCT01336205|560736589|FG001|Overall Study|Other|9|||
155355490|NCT01336205|560736588|FG000|Overall Study|Lost to Follow-up|40|||
155355491|NCT01336205|560736589|FG001|Overall Study|Lost to Follow-up|20|||
155355492|NCT01336205|560736588|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
155355493|NCT01336205|560736589|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
155355494|NCT01336205|560736588|FG000|Overall Study|Lack of Efficacy|4|||
155355495|NCT01336205|560736589|FG001|Overall Study|Lack of Efficacy|0|||
155355496|NCT01336205|560736588|FG000|Overall Study|Severe noncompliance with protocol|9|||
155355497|NCT01336205|560736589|FG001|Overall Study|Severe noncompliance with protocol|2|||
155355498|NCT01336205|560736588|FG000|Overall Study|Adverse Event|56|||
155355499|NCT01336205|560736589|FG001|Overall Study|Adverse Event|6|||
155355500|NCT01336205|560736588|FG000|Overall Study|Death|1|||
155355501|NCT01336205|560736589|FG001|Overall Study|Death|1|||
155355502|NCT01336205|560736588|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
155355503|NCT01336205|560736589|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
155355504|NCT01336205|560736588|FG000|Overall Study|Withdrawal by Subject|72|||
155355505|NCT01336205|560736589|FG001|Overall Study|Withdrawal by Subject|38|||
155355506|NCT01336205|560736588|FG000|Overall Study|Did not receive treatment|4|||
155355507|NCT01336205|560736589|FG001|Overall Study|Did not receive treatment|0|||
155355508|NCT01086384|560736591|FG000|2-week Run-in Period|Adverse Event|1|||
155355509|NCT01086384|560736592|FG001|2-week Run-in Period|Adverse Event|0|||
155355510|NCT01086384|560736593|FG002|2-week Run-in Period|Adverse Event|0|||
155355511|NCT01086384|560736591|FG000|2-week Run-in Period|Protocol Violation|1|||
155355512|NCT01086384|560736592|FG001|2-week Run-in Period|Protocol Violation|0|||
155355513|NCT01086384|560736593|FG002|2-week Run-in Period|Protocol Violation|0|||
155355514|NCT01086384|560736591|FG000|2-week Run-in Period|Lost to Follow-up|1|||
155355515|NCT01086384|560736592|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155355516|NCT01086384|560736593|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155355517|NCT01086384|560736591|FG000|2-week Run-in Period|Physician Decision|6|||
155355518|NCT01086384|560736592|FG001|2-week Run-in Period|Physician Decision|0|||
155355519|NCT01086384|560736593|FG002|2-week Run-in Period|Physician Decision|0|||
155355520|NCT01086384|560736591|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
155355521|NCT01086384|560736592|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155355522|NCT01086384|560736593|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155355523|NCT01086384|560736591|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
155355524|NCT01086384|560736592|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
155355525|NCT01086384|560736593|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
155355526|NCT01086384|560736591|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
155355527|NCT01086384|560736592|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155355528|NCT01086384|560736593|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155355529|NCT01086384|560736591|FG000|2-week Run-in Period|Randomized in Error|1|||
155355530|NCT01086384|560736592|FG001|2-week Run-in Period|Randomized in Error|0|||
155355531|NCT01086384|560736593|FG002|2-week Run-in Period|Randomized in Error|0|||
155355532|NCT01086384|560736591|FG000|Treatment Period|Withdrawal by Subject|0|||
155355533|NCT01086384|560736592|FG001|Treatment Period|Withdrawal by Subject|53|||
155355534|NCT01086384|560736593|FG002|Treatment Period|Withdrawal by Subject|55|||
155355535|NCT01086384|560736591|FG000|Treatment Period|Protocol Violation|0|||
155355536|NCT01086384|560736592|FG001|Treatment Period|Protocol Violation|26|||
155355537|NCT01086384|560736593|FG002|Treatment Period|Protocol Violation|17|||
155355538|NCT01086384|560736591|FG000|Treatment Period|Lack of Efficacy|0|||
155355539|NCT01086384|560736592|FG001|Treatment Period|Lack of Efficacy|22|||
155355540|NCT01086384|560736593|FG002|Treatment Period|Lack of Efficacy|13|||
155355541|NCT01086384|560736591|FG000|Treatment Period|Adverse Event|0|||
155355542|NCT01086384|560736592|FG001|Treatment Period|Adverse Event|19|||
155355543|NCT01086384|560736593|FG002|Treatment Period|Adverse Event|15|||
155355544|NCT01086384|560736591|FG000|Treatment Period|Lost to Follow-up|0|||
155355545|NCT01086384|560736592|FG001|Treatment Period|Lost to Follow-up|11|||
155355546|NCT01086384|560736593|FG002|Treatment Period|Lost to Follow-up|9|||
155355547|NCT01086384|560736591|FG000|Treatment Period|Physician Decision|0|||
155355548|NCT01086384|560736592|FG001|Treatment Period|Physician Decision|9|||
155355549|NCT01086384|560736593|FG002|Treatment Period|Physician Decision|6|||
155355550|NCT01086384|560736591|FG000|Treatment Period|Study Closed/Terminated|0|||
155355551|NCT01086384|560736592|FG001|Treatment Period|Study Closed/Terminated|7|||
155355552|NCT01086384|560736593|FG002|Treatment Period|Study Closed/Terminated|8|||
155355553|NCT01086384|560736591|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
155355554|NCT01086384|560736592|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
155355555|NCT01086384|560736593|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
155355556|NCT01086384|560736591|FG000|Treatment Period|Received Treatment in Error|0|||
155355557|NCT01086384|560736592|FG001|Treatment Period|Received Treatment in Error|1|||
155355558|NCT01086384|560736593|FG002|Treatment Period|Received Treatment in Error|0|||
155355559|NCT02586415|560736596|FG000|Overall Study|Death|13|||
155355560|NCT02586415|560736597|FG001|Overall Study|Death|23|||
155355561|NCT02586415|560736596|FG000|Overall Study|Lost to Follow-up|1|||
155355562|NCT02586415|560736597|FG001|Overall Study|Lost to Follow-up|2|||
155355563|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
155355564|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
155355565|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355566|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355567|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355568|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Death|1|||
155355569|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Death|0|||
155355570|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Death|0|||
155355571|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Death|0|||
155355572|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Death|0|||
155355573|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355574|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
155355575|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355576|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355577|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355578|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355579|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
155355580|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355581|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355582|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355583|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
155355584|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
155355585|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
155355586|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
155355587|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
155355588|NCT03974100|560736598|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355589|NCT03974100|560736599|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355590|NCT03974100|560736600|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355591|NCT03974100|560736601|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
155355592|NCT03974100|560736602|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355593|NCT03974100|560736598|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
155355594|NCT03974100|560736599|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
155355595|NCT03974100|560736600|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
155355596|NCT03974100|560736601|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
155355597|NCT03974100|560736602|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
155355598|NCT03318783|560736603|FG000|Overall Study|Withdrawal by Subject|0|||
155355599|NCT03318783|560736604|FG001|Overall Study|Withdrawal by Subject|1|||
155355600|NCT03318783|560736603|FG000|Overall Study|Death|0|||
155355601|NCT03318783|560736604|FG001|Overall Study|Death|1|||
155355602|NCT04358068|560736611|FG000|Overall Study|Did not initiate study treatment|2|||
155355603|NCT04358068|560736612|FG001|Overall Study|Did not initiate study treatment|2|||
155355604|NCT01426113|560736613|FG000|Overall Study|Study Discontinued|1|||
155355605|NCT01426113|560736614|FG001|Overall Study|Study Discontinued|1|||
155355606|NCT01426113|560736613|FG000|Overall Study|Adverse Event|0|||
155355607|NCT01426113|560736614|FG001|Overall Study|Adverse Event|1|||
155355608|NCT02719743|560736617|FG000|Overall Study|Consent withdrawal|0|||
155355609|NCT02719743|560736618|FG001|Overall Study|Consent withdrawal|2|||
155355610|NCT02719743|560736619|FG002|Overall Study|Consent withdrawal|0|||
155355611|NCT02719743|560736620|FG003|Overall Study|Consent withdrawal|1|||
155355612|NCT02719743|560736621|FG004|Overall Study|Consent withdrawal|0|||
155355613|NCT02719743|560736617|FG000|Overall Study|Migrated/moved from study area|0|||
155355614|NCT02719743|560736618|FG001|Overall Study|Migrated/moved from study area|0|||
155355615|NCT02719743|560736619|FG002|Overall Study|Migrated/moved from study area|0|||
155355616|NCT02719743|560736620|FG003|Overall Study|Migrated/moved from study area|0|||
155355617|NCT02719743|560736621|FG004|Overall Study|Migrated/moved from study area|2|||
155355618|NCT02719743|560736617|FG000|Overall Study|Lost to Follow-up|1|||
155355619|NCT02719743|560736618|FG001|Overall Study|Lost to Follow-up|1|||
155355620|NCT02719743|560736619|FG002|Overall Study|Lost to Follow-up|0|||
155355621|NCT02719743|560736620|FG003|Overall Study|Lost to Follow-up|0|||
155355622|NCT02719743|560736621|FG004|Overall Study|Lost to Follow-up|0|||
155355623|NCT01438840|560736622|FG000|Core Study|Adverse Event|0|||
155355624|NCT01438840|560736623|FG001|Core Study|Adverse Event|3|||
155355625|NCT01438840|560736624|FG002|Core Study|Adverse Event|0|||
155426841|NCT02901431|560989889|FG003|PK Part|Withdrawal by Subject|0|||
155355626|NCT01438840|560736622|FG000|Core Study|Lack of Efficacy|15|||
155355627|NCT01438840|560736623|FG001|Core Study|Lack of Efficacy|7|||
155355628|NCT01438840|560736624|FG002|Core Study|Lack of Efficacy|0|||
155355629|NCT01438840|560736622|FG000|Core Study|Withdrawal of consent|1|||
155355630|NCT01438840|560736623|FG001|Core Study|Withdrawal of consent|0|||
155355631|NCT01438840|560736624|FG002|Core Study|Withdrawal of consent|0|||
155355632|NCT01438840|560736622|FG000|Extension Phase|Adverse Event|0|||
155355633|NCT01438840|560736623|FG001|Extension Phase|Adverse Event|0|||
155355634|NCT01438840|560736624|FG002|Extension Phase|Adverse Event|3|||
155426842|NCT02901431|560989890|FG004|PK Part|Withdrawal by Subject|0|||
155426843|NCT02901431|560989891|FG005|PK Part|Withdrawal by Subject|0|||
155426844|NCT02901431|560989892|FG006|PK Part|Withdrawal by Subject|0|||
155426845|NCT02901431|560989893|FG007|PK Part|Withdrawal by Subject|0|||
155426846|NCT02901431|560989894|FG008|PK Part|Withdrawal by Subject|0|||
155426847|NCT02901431|560989895|FG009|PK Part|Withdrawal by Subject|0|||
155355635|NCT01438840|560736622|FG000|Extension Phase|Lost to Follow-up|0|||
155355636|NCT01438840|560736623|FG001|Extension Phase|Lost to Follow-up|0|||
155355637|NCT01438840|560736624|FG002|Extension Phase|Lost to Follow-up|1|||
155355638|NCT01438840|560736622|FG000|Extension Phase|Withdrawal by Subject|0|||
155355639|NCT01438840|560736623|FG001|Extension Phase|Withdrawal by Subject|0|||
155426848|NCT02901431|560989896|FG010|PK Part|Withdrawal by Subject|0|||
155426849|NCT02901431|560989897|FG011|PK Part|Withdrawal by Subject|0|||
155426850|NCT02901431|560989898|FG012|PK Part|Withdrawal by Subject|0|||
155426851|NCT02901431|560989886|FG000|Main Treatment Part|Adverse Event|0|||
155355640|NCT01438840|560736624|FG002|Extension Phase|Withdrawal by Subject|3|||
155355641|NCT01438840|560736622|FG000|Extension Phase|Lack of Efficacy|0|||
155355642|NCT01438840|560736623|FG001|Extension Phase|Lack of Efficacy|0|||
155355643|NCT01438840|560736624|FG002|Extension Phase|Lack of Efficacy|2|||
155355644|NCT01438840|560736622|FG000|Extension Phase|Other|0|||
155355645|NCT01438840|560736623|FG001|Extension Phase|Other|0|||
155355646|NCT01438840|560736624|FG002|Extension Phase|Other|1|||
155355647|NCT00461123|560736627|FG000|Overall Study|Adverse Event|1|||
155426852|NCT02901431|560989887|FG001|Main Treatment Part|Adverse Event|0|||
155426853|NCT02901431|560989888|FG002|Main Treatment Part|Adverse Event|0|||
155426854|NCT02901431|560989889|FG003|Main Treatment Part|Adverse Event|3|||
155426855|NCT02901431|560989890|FG004|Main Treatment Part|Adverse Event|3|||
155426856|NCT02901431|560989891|FG005|Main Treatment Part|Adverse Event|4|||
155426857|NCT02901431|560989892|FG006|Main Treatment Part|Adverse Event|1|||
155426858|NCT02901431|560989893|FG007|Main Treatment Part|Adverse Event|0|||
155426859|NCT02901431|560989894|FG008|Main Treatment Part|Adverse Event|0|||
155426860|NCT02901431|560989895|FG009|Main Treatment Part|Adverse Event|0|||
155426861|NCT02901431|560989896|FG010|Main Treatment Part|Adverse Event|0|||
155648670|NCT02675452|561805905|FG024|Overall Study|Sponsor decision|0|||
155648671|NCT02675452|561805906|FG025|Overall Study|Sponsor decision|0|||
155648672|NCT02675452|561805907|FG026|Overall Study|Sponsor decision|2|||
155648673|NCT02675452|561805908|FG027|Overall Study|Sponsor decision|0|||
155355648|NCT00461123|560736628|FG001|Overall Study|Adverse Event|0|||
155355649|NCT00461123|560736627|FG000|Overall Study|Lost to Follow-up|1|||
155355650|NCT00461123|560736628|FG001|Overall Study|Lost to Follow-up|1|||
155355651|NCT00461123|560736627|FG000|Overall Study|Protocol Violation|3|||
155355652|NCT00461123|560736628|FG001|Overall Study|Protocol Violation|2|||
155355653|NCT00461123|560736627|FG000|Overall Study|Withdrawal by Subject|1|||
155355654|NCT00461123|560736628|FG001|Overall Study|Withdrawal by Subject|3|||
155355655|NCT02024750|560736629|FG000|Overall Study|Withdrawal by Subject|2|||
155355656|NCT02024750|560736630|FG001|Overall Study|Withdrawal by Subject|1|||
155355657|NCT01891890|560736632|FG000|Overall Study|Lost to Follow-up|0|||
155355658|NCT01891890|560736633|FG001|Overall Study|Lost to Follow-up|0|||
155355659|NCT01891890|560736634|FG002|Overall Study|Lost to Follow-up|1|||
155355660|NCT01891890|560736632|FG000|Overall Study|Study ended before endpoint reached|7|||
155355661|NCT01891890|560736633|FG001|Overall Study|Study ended before endpoint reached|3|||
155355662|NCT01891890|560736634|FG002|Overall Study|Study ended before endpoint reached|6|||
155355663|NCT02725008|560736637|FG000|Overall Study|Lost to Follow-up|7|||
155355664|NCT02725008|560736638|FG001|Overall Study|Lost to Follow-up|9|||
155355665|NCT02725008|560736637|FG000|Overall Study|Withdrawal by Subject|2|||
155355666|NCT02725008|560736638|FG001|Overall Study|Withdrawal by Subject|2|||
155355667|NCT02725008|560736637|FG000|Overall Study|Admitted to hospital|0|||
155355668|NCT02725008|560736638|FG001|Overall Study|Admitted to hospital|1|||
155355669|NCT01329419|560736641|FG000|Overall Study|Protocol Violation|235|||
155355670|NCT00361842|560736642|FG000|Overall Study|Withdrawal by Subject|2|||
155355671|NCT00361842|560736643|FG001|Overall Study|Withdrawal by Subject|3|||
155355672|NCT00361842|560736642|FG000|Overall Study|Death|2|||
155355673|NCT00361842|560736643|FG001|Overall Study|Death|1|||
155355674|NCT00361842|560736642|FG000|Overall Study|Disease progression|19|||
155426862|NCT02901431|560989897|FG011|Main Treatment Part|Adverse Event|0|||
155426863|NCT02901431|560989898|FG012|Main Treatment Part|Adverse Event|0|||
155426864|NCT02901431|560989886|FG000|Main Treatment Part|Lack of Efficacy|0|||
155426865|NCT02901431|560989887|FG001|Main Treatment Part|Lack of Efficacy|0|||
155426866|NCT02901431|560989888|FG002|Main Treatment Part|Lack of Efficacy|0|||
155648674|NCT02675452|561805909|FG028|Overall Study|Sponsor decision|0|||
155355675|NCT00361842|560736643|FG001|Overall Study|Disease progression|20|||
155355676|NCT00361842|560736642|FG000|Overall Study|Adverse Event|2|||
155355677|NCT00361842|560736643|FG001|Overall Study|Adverse Event|3|||
155355678|NCT00361842|560736642|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
155355679|NCT00361842|560736643|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
155355680|NCT00361842|560736642|FG000|Overall Study|Other|1|||
155355681|NCT00361842|560736643|FG001|Overall Study|Other|0|||
155426867|NCT02901431|560989889|FG003|Main Treatment Part|Lack of Efficacy|1|||
155426868|NCT02901431|560989890|FG004|Main Treatment Part|Lack of Efficacy|0|||
155648675|NCT02675452|561805881|FG000|Overall Study|Withdrawal by Subject|0|||
155355682|NCT00361842|560736642|FG000|Overall Study|Other|0|||
155355683|NCT00361842|560736643|FG001|Overall Study|Other|2|||
155355684|NCT03512288|560736644|FG000|Overall Study|Adverse Event|1|||
155355685|NCT03512288|560736645|FG001|Overall Study|Adverse Event|0|||
155355686|NCT03512288|560736644|FG000|Overall Study|Lost to Follow-up|12|||
155355687|NCT03512288|560736645|FG001|Overall Study|Lost to Follow-up|15|||
155355688|NCT03512288|560736644|FG000|Overall Study|Physician Decision|0|||
155355689|NCT03512288|560736645|FG001|Overall Study|Physician Decision|2|||
155426869|NCT02901431|560989891|FG005|Main Treatment Part|Lack of Efficacy|0|||
155426870|NCT02901431|560989892|FG006|Main Treatment Part|Lack of Efficacy|0|||
155426871|NCT02901431|560989893|FG007|Main Treatment Part|Lack of Efficacy|0|||
155426872|NCT02901431|560989894|FG008|Main Treatment Part|Lack of Efficacy|0|||
155426873|NCT02901431|560989895|FG009|Main Treatment Part|Lack of Efficacy|0|||
155426874|NCT02901431|560989896|FG010|Main Treatment Part|Lack of Efficacy|0|||
155355690|NCT03512288|560736644|FG000|Overall Study|Protocol Violation|6|||
155355691|NCT03512288|560736645|FG001|Overall Study|Protocol Violation|4|||
155355692|NCT03512288|560736644|FG000|Overall Study|Medication error without associated adverse event|1|||
155355693|NCT03512288|560736645|FG001|Overall Study|Medication error without associated adverse event|0|||
155355694|NCT03512288|560736644|FG000|Overall Study|No longer met eligibility criteria|5|||
155355695|NCT03512288|560736645|FG001|Overall Study|No longer met eligibility criteria|2|||
155355696|NCT03512288|560736644|FG000|Overall Study|Withdrawal by parent/guardian|14|||
155426875|NCT02901431|560989897|FG011|Main Treatment Part|Lack of Efficacy|0|||
155426876|NCT02901431|560989898|FG012|Main Treatment Part|Lack of Efficacy|0|||
155426877|NCT02901431|560989886|FG000|Main Treatment Part|Lost to Follow-up|0|||
155426878|NCT02901431|560989887|FG001|Main Treatment Part|Lost to Follow-up|0|||
155426879|NCT02901431|560989888|FG002|Main Treatment Part|Lost to Follow-up|0|||
155426880|NCT02901431|560989889|FG003|Main Treatment Part|Lost to Follow-up|3|||
155426881|NCT02901431|560989890|FG004|Main Treatment Part|Lost to Follow-up|1|||
155426882|NCT02901431|560989891|FG005|Main Treatment Part|Lost to Follow-up|2|||
155426883|NCT02901431|560989892|FG006|Main Treatment Part|Lost to Follow-up|3|||
155426884|NCT02901431|560989893|FG007|Main Treatment Part|Lost to Follow-up|0|||
155426885|NCT02901431|560989894|FG008|Main Treatment Part|Lost to Follow-up|0|||
155426886|NCT02901431|560989895|FG009|Main Treatment Part|Lost to Follow-up|0|||
155426887|NCT02901431|560989896|FG010|Main Treatment Part|Lost to Follow-up|0|||
155426888|NCT02901431|560989897|FG011|Main Treatment Part|Lost to Follow-up|0|||
155426889|NCT02901431|560989898|FG012|Main Treatment Part|Lost to Follow-up|0|||
155426890|NCT02901431|560989886|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
155426891|NCT02901431|560989887|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
155426892|NCT02901431|560989888|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
155426893|NCT02901431|560989889|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
155426894|NCT02901431|560989890|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
155426895|NCT02901431|560989891|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
155426896|NCT02901431|560989892|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
155426897|NCT02901431|560989893|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
155426898|NCT02901431|560989894|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
155426899|NCT02901431|560989895|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
155426900|NCT02901431|560989896|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
155426901|NCT02901431|560989897|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
155426902|NCT02901431|560989898|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
155426903|NCT02901431|560989886|FG000|Main Treatment Part|Physician Decision|0|||
155426904|NCT02901431|560989887|FG001|Main Treatment Part|Physician Decision|0|||
155426905|NCT02901431|560989888|FG002|Main Treatment Part|Physician Decision|0|||
155426906|NCT02901431|560989889|FG003|Main Treatment Part|Physician Decision|1|||
155426907|NCT02901431|560989890|FG004|Main Treatment Part|Physician Decision|0|||
155426908|NCT02901431|560989891|FG005|Main Treatment Part|Physician Decision|0|||
155426909|NCT02901431|560989892|FG006|Main Treatment Part|Physician Decision|1|||
155426910|NCT02901431|560989893|FG007|Main Treatment Part|Physician Decision|0|||
155426911|NCT02901431|560989894|FG008|Main Treatment Part|Physician Decision|0|||
155426912|NCT02901431|560989895|FG009|Main Treatment Part|Physician Decision|0|||
155426913|NCT02901431|560989896|FG010|Main Treatment Part|Physician Decision|0|||
155426914|NCT02901431|560989897|FG011|Main Treatment Part|Physician Decision|0|||
155426915|NCT02901431|560989898|FG012|Main Treatment Part|Physician Decision|0|||
155426916|NCT02901431|560989886|FG000|Main Treatment Part|Withdrawal by Subject|0|||
155426917|NCT02901431|560989887|FG001|Main Treatment Part|Withdrawal by Subject|0|||
155426918|NCT02901431|560989888|FG002|Main Treatment Part|Withdrawal by Subject|0|||
155355697|NCT03512288|560736645|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155355698|NCT03512288|560736644|FG000|Overall Study|Other|1|||
155355699|NCT03512288|560736645|FG001|Overall Study|Other|1|||
155426919|NCT02901431|560989889|FG003|Main Treatment Part|Withdrawal by Subject|18|||
155426920|NCT02901431|560989890|FG004|Main Treatment Part|Withdrawal by Subject|3|||
155355700|NCT03512288|560736644|FG000|Overall Study|Randomized but not treated|1|||
155355701|NCT03512288|560736645|FG001|Overall Study|Randomized but not treated|1|||
155426921|NCT02901431|560989891|FG005|Main Treatment Part|Withdrawal by Subject|5|||
155355702|NCT01177228|560736653|FG000|Overall Study|Positive tuberculosis test|0|||
155355703|NCT01177228|560736654|FG001|Overall Study|Positive tuberculosis test|1|||
155355704|NCT01177228|560736655|FG002|Overall Study|Positive tuberculosis test|0|||
155355705|NCT01177228|560736656|FG003|Overall Study|Positive tuberculosis test|0|||
155355706|NCT01177228|560736653|FG000|Overall Study|Worsening disease activity|1|||
155355707|NCT01177228|560736654|FG001|Overall Study|Worsening disease activity|0|||
155355708|NCT01177228|560736655|FG002|Overall Study|Worsening disease activity|0|||
155355709|NCT01177228|560736656|FG003|Overall Study|Worsening disease activity|0|||
155355710|NCT01177228|560736653|FG000|Overall Study|Withdrawal by Subject|0|||
155355711|NCT01177228|560736654|FG001|Overall Study|Withdrawal by Subject|1|||
155355712|NCT01177228|560736655|FG002|Overall Study|Withdrawal by Subject|0|||
155355713|NCT01177228|560736656|FG003|Overall Study|Withdrawal by Subject|0|||
155355714|NCT03325608|560736657|FG000|Overall Study|Lost to Follow-up|23|||
155355715|NCT03325608|560736658|FG001|Overall Study|Lost to Follow-up|23|||
155355716|NCT03325608|560736659|FG002|Overall Study|Lost to Follow-up|30|||
155355717|NCT03325608|560736660|FG003|Overall Study|Lost to Follow-up|30|||
155355718|NCT03325608|560736657|FG000|Overall Study|Death of Caregiver|0|||
155355719|NCT03325608|560736658|FG001|Overall Study|Death of Caregiver|0|||
155355720|NCT03325608|560736659|FG002|Overall Study|Death of Caregiver|2|||
155355721|NCT03325608|560736660|FG003|Overall Study|Death of Caregiver|2|||
155355722|NCT03325608|560736657|FG000|Overall Study|Death of Care Recipient|34|||
155355723|NCT03325608|560736658|FG001|Overall Study|Death of Care Recipient|34|||
155355724|NCT03325608|560736659|FG002|Overall Study|Death of Care Recipient|28|||
155355725|NCT03325608|560736660|FG003|Overall Study|Death of Care Recipient|28|||
155355726|NCT03325608|560736657|FG000|Overall Study|Withdrawal by Subject|49|||
155355727|NCT03325608|560736658|FG001|Overall Study|Withdrawal by Subject|49|||
155355728|NCT03325608|560736659|FG002|Overall Study|Withdrawal by Subject|35|||
155355729|NCT03325608|560736660|FG003|Overall Study|Withdrawal by Subject|35|||
155355730|NCT03325608|560736657|FG000|Overall Study|Ineligible|7|||
155355731|NCT03325608|560736658|FG001|Overall Study|Ineligible|7|||
155355732|NCT03325608|560736659|FG002|Overall Study|Ineligible|5|||
155355733|NCT03325608|560736660|FG003|Overall Study|Ineligible|5|||
155355734|NCT00942188|560736661|FG000|Overall Study|Adverse Event|0|||
155355735|NCT00942188|560736662|FG001|Overall Study|Adverse Event|3|||
155355736|NCT00942188|560736663|FG002|Overall Study|Adverse Event|2|||
155355737|NCT00942188|560736664|FG003|Overall Study|Adverse Event|0|||
155355738|NCT00942188|560736661|FG000|Overall Study|Lack of Efficacy|0|||
155355739|NCT00942188|560736662|FG001|Overall Study|Lack of Efficacy|0|||
155355740|NCT00942188|560736663|FG002|Overall Study|Lack of Efficacy|0|||
155355741|NCT00942188|560736664|FG003|Overall Study|Lack of Efficacy|1|||
155355742|NCT00942188|560736661|FG000|Overall Study|Protocol Violation|1|||
155355743|NCT00942188|560736662|FG001|Overall Study|Protocol Violation|1|||
155355744|NCT00942188|560736663|FG002|Overall Study|Protocol Violation|0|||
155355745|NCT00942188|560736664|FG003|Overall Study|Protocol Violation|0|||
155355746|NCT00942188|560736661|FG000|Overall Study|Lost to Follow-up|2|||
155355747|NCT00942188|560736662|FG001|Overall Study|Lost to Follow-up|1|||
155355748|NCT00942188|560736663|FG002|Overall Study|Lost to Follow-up|2|||
155355749|NCT00942188|560736664|FG003|Overall Study|Lost to Follow-up|0|||
155355750|NCT00942188|560736661|FG000|Overall Study|Withdrawal by Subject|1|||
155355751|NCT00942188|560736662|FG001|Overall Study|Withdrawal by Subject|3|||
155355752|NCT00942188|560736663|FG002|Overall Study|Withdrawal by Subject|4|||
155355753|NCT00942188|560736664|FG003|Overall Study|Withdrawal by Subject|2|||
155355754|NCT00942188|560736661|FG000|Overall Study|Physician Decision|0|||
155355755|NCT00942188|560736662|FG001|Overall Study|Physician Decision|0|||
155648676|NCT02675452|561805882|FG001|Overall Study|Withdrawal by Subject|0|||
155355756|NCT00942188|560736663|FG002|Overall Study|Physician Decision|1|||
155355757|NCT00942188|560736664|FG003|Overall Study|Physician Decision|0|||
155355758|NCT00942188|560736661|FG000|Overall Study|Sponsor Decision|0|||
155355759|NCT00942188|560736662|FG001|Overall Study|Sponsor Decision|2|||
155355760|NCT00942188|560736663|FG002|Overall Study|Sponsor Decision|0|||
155355761|NCT00942188|560736664|FG003|Overall Study|Sponsor Decision|1|||
155355762|NCT02188784|560736665|FG000|Overall Study|Death|3|||
155355763|NCT02188784|560736666|FG001|Overall Study|Death|1|||
155355764|NCT02188784|560736665|FG000|Overall Study|Lost to Follow-up|1|||
155355765|NCT02188784|560736666|FG001|Overall Study|Lost to Follow-up|0|||
155355766|NCT02188784|560736665|FG000|Overall Study|Withdrawal by Subject|3|||
155355767|NCT02188784|560736666|FG001|Overall Study|Withdrawal by Subject|9|||
155355768|NCT02188784|560736665|FG000|Overall Study|Physician Decision|2|||
155355769|NCT02188784|560736666|FG001|Overall Study|Physician Decision|3|||
155355770|NCT01568112|560736672|FG000|Overall Study|Randomized But Not Treated|0|||
155355771|NCT01568112|560736673|FG001|Overall Study|Randomized But Not Treated|1|||
155355772|NCT01568112|560736674|FG002|Overall Study|Randomized But Not Treated|0|||
155355773|NCT01568112|560736675|FG003|Overall Study|Randomized But Not Treated|0|||
155355774|NCT01568112|560736672|FG000|Overall Study|Withdrew due to Adverse Event|2|||
155355775|NCT01568112|560736673|FG001|Overall Study|Withdrew due to Adverse Event|4|||
155355776|NCT01568112|560736674|FG002|Overall Study|Withdrew due to Adverse Event|6|||
155355777|NCT01568112|560736675|FG003|Overall Study|Withdrew due to Adverse Event|3|||
155355778|NCT01568112|560736672|FG000|Overall Study|Lost to Follow-up|0|||
155355779|NCT01568112|560736673|FG001|Overall Study|Lost to Follow-up|0|||
155355780|NCT01568112|560736674|FG002|Overall Study|Lost to Follow-up|0|||
155355781|NCT01568112|560736675|FG003|Overall Study|Lost to Follow-up|1|||
155355782|NCT01568112|560736672|FG000|Overall Study|Withdrawal by Subject|2|||
155355783|NCT01568112|560736673|FG001|Overall Study|Withdrawal by Subject|3|||
155355784|NCT01568112|560736674|FG002|Overall Study|Withdrawal by Subject|0|||
155355785|NCT01568112|560736675|FG003|Overall Study|Withdrawal by Subject|7|||
155355786|NCT01568112|560736672|FG000|Overall Study|Withdrawal by Physician|1|||
155355787|NCT01568112|560736673|FG001|Overall Study|Withdrawal by Physician|0|||
155355788|NCT01568112|560736674|FG002|Overall Study|Withdrawal by Physician|1|||
155355789|NCT01568112|560736675|FG003|Overall Study|Withdrawal by Physician|1|||
155355790|NCT01722045|560738160|FG000|Overall Study|Adverse Event|8|||
155355791|NCT01722045|560738160|FG000|Overall Study|Death|3|||
155355792|NCT01722045|560738160|FG000|Overall Study|Withdrawal by Subject|8|||
155355793|NCT01722045|560738160|FG000|Overall Study|Lost to Follow-up|4|||
155355794|NCT01722045|560738160|FG000|Overall Study|Protocol Deviation|1|||
155355795|NCT01722045|560738160|FG000|Overall Study|Physician Decision|3|||
155355796|NCT01722045|560738160|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
155355797|NCT02034162|560738161|FG000|Double-blind|Lost to Follow-up|3|||
155355798|NCT02034162|560738162|FG001|Double-blind|Lost to Follow-up|0|||
155355799|NCT02034162|560738163|FG002|Double-blind|Lost to Follow-up|0|||
155355800|NCT02034162|560738161|FG000|Double-blind|Physician Decision|1|||
155355801|NCT02034162|560738162|FG001|Double-blind|Physician Decision|0|||
155355802|NCT02034162|560738163|FG002|Double-blind|Physician Decision|0|||
155355803|NCT02034162|560738161|FG000|Double-blind|Protocol Violation|0|||
155355804|NCT02034162|560738162|FG001|Double-blind|Protocol Violation|1|||
155355805|NCT02034162|560738163|FG002|Double-blind|Protocol Violation|0|||
155355806|NCT02034162|560738161|FG000|Double-blind|Withdrawal by Subject|5|||
155355807|NCT02034162|560738162|FG001|Double-blind|Withdrawal by Subject|7|||
155355808|NCT02034162|560738163|FG002|Double-blind|Withdrawal by Subject|0|||
155355809|NCT00760513|560738164|FG000|Overall Study|Withdrawal by Subject|5|||
155355810|NCT00760513|560738165|FG001|Overall Study|Withdrawal by Subject|7|||
155355811|NCT01053247|560738166|FG000|Overall Study|Withdrawal by Subject|9|||
155355812|NCT01053247|560738167|FG001|Overall Study|Withdrawal by Subject|4|||
155355813|NCT01053247|560738168|FG002|Overall Study|Withdrawal by Subject|15|||
155355814|NCT01053247|560738166|FG000|Overall Study|Lack of Efficacy|1|||
155355815|NCT01053247|560738167|FG001|Overall Study|Lack of Efficacy|0|||
155355816|NCT01053247|560738168|FG002|Overall Study|Lack of Efficacy|1|||
155355817|NCT01053247|560738166|FG000|Overall Study|Protocol Violation|2|||
155355818|NCT01053247|560738167|FG001|Overall Study|Protocol Violation|1|||
155355819|NCT01053247|560738168|FG002|Overall Study|Protocol Violation|2|||
155355820|NCT01053247|560738166|FG000|Overall Study|Lost to Follow-up|8|||
155355821|NCT01053247|560738167|FG001|Overall Study|Lost to Follow-up|5|||
155355822|NCT01053247|560738168|FG002|Overall Study|Lost to Follow-up|7|||
155355823|NCT01053247|560738166|FG000|Overall Study|Adverse Event|0|||
155355824|NCT01053247|560738167|FG001|Overall Study|Adverse Event|9|||
155355825|NCT01053247|560738168|FG002|Overall Study|Adverse Event|3|||
155355826|NCT03458728|560738169|FG000|Overall Study|Adverse Event|1|||
155355827|NCT03458728|560738170|FG001|Overall Study|Adverse Event|0|||
155355828|NCT03458728|560738169|FG000|Overall Study|Physician Decision|1|||
155355829|NCT03458728|560738170|FG001|Overall Study|Physician Decision|0|||
155355830|NCT03458728|560738169|FG000|Overall Study|Progressive disease - clinical assessment|1|||
155355831|NCT03458728|560738170|FG001|Overall Study|Progressive disease - clinical assessment|0|||
155355832|NCT03458728|560738169|FG000|Overall Study|Progressive disease - radiological progression|21|||
155355833|NCT03458728|560738170|FG001|Overall Study|Progressive disease - radiological progression|6|||
155355834|NCT03458728|560738169|FG000|Overall Study|Withdrawal by Subject|0|||
155355835|NCT03458728|560738170|FG001|Overall Study|Withdrawal by Subject|1|||
155355836|NCT03898700|560738173|FG000|Overall Study|Withdrawal by Subject|2|||
155355837|NCT00701909|560738177|FG000|Overall Study|Withdrawal by Subject|0|||
155355838|NCT00701909|560738178|FG001|Overall Study|Withdrawal by Subject|1|||
155355839|NCT00908349|560738179|FG000|Overall Study|Adverse Event|10|||
155355840|NCT00908349|560738179|FG000|Overall Study|Withdrawal by Subject|9|||
155355841|NCT00908349|560738179|FG000|Overall Study|Physician Decision|5|||
155426922|NCT02901431|560989892|FG006|Main Treatment Part|Withdrawal by Subject|6|||
155355842|NCT00908349|560738179|FG000|Overall Study|Lost to Follow-up|5|||
155355843|NCT00908349|560738179|FG000|Overall Study|Various|6|||
155355844|NCT00971997|560738182|FG000|Overall Study|Adverse Event|2|||
155355845|NCT00971997|560738182|FG000|Overall Study|Death|1|||
155355846|NCT00971997|560738182|FG000|Overall Study|Protocol Violation|4|||
155355847|NCT00971997|560738182|FG000|Overall Study|Withdrawal by Subject|5|||
155355848|NCT00971997|560738182|FG000|Overall Study|Physician Decision|7|||
155355849|NCT00761956|560738184|FG000|Overall Study|Lost to Follow-up|6|||
155355850|NCT00761956|560738185|FG001|Overall Study|Lost to Follow-up|11|||
155355851|NCT00761956|560738184|FG000|Overall Study|Withdrawal by Subject|3|||
155355852|NCT00761956|560738185|FG001|Overall Study|Withdrawal by Subject|8|||
155355853|NCT00761956|560738184|FG000|Overall Study|Death|0|||
155355854|NCT00761956|560738185|FG001|Overall Study|Death|1|||
155355855|NCT00761956|560738184|FG000|Overall Study|Adverse Event|26|||
155355856|NCT00761956|560738185|FG001|Overall Study|Adverse Event|34|||
155355857|NCT02808975|560738191|FG000|Overall Study|Adverse Event|3|||
155355858|NCT02808975|560738192|FG001|Overall Study|Adverse Event|4|||
155355859|NCT02808975|560738191|FG000|Overall Study|Withdrew consent|9|||
155355860|NCT02808975|560738192|FG001|Overall Study|Withdrew consent|8|||
155355861|NCT02808975|560738191|FG000|Overall Study|Lost to Follow-up|4|||
155355862|NCT02808975|560738192|FG001|Overall Study|Lost to Follow-up|6|||
155355863|NCT02808975|560738191|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
155355864|NCT02808975|560738192|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
155355865|NCT02808975|560738191|FG000|Overall Study|Other, not specified|5|||
155355866|NCT02808975|560738192|FG001|Overall Study|Other, not specified|1|||
155355867|NCT01288209|560738193|FG000|Overall Study|Withdrawal by Subject|1|||
155355868|NCT01288209|560738194|FG001|Overall Study|Withdrawal by Subject|3|||
155355869|NCT01288209|560738193|FG000|Overall Study|Other|1|||
155355870|NCT01288209|560738194|FG001|Overall Study|Other|0|||
155355871|NCT01379703|560738195|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
155355872|NCT01379703|560738196|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
155355873|NCT01379703|560738197|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
155355874|NCT01379703|560738195|FG000|Study Start Through 9 Months|Adverse Event|0|||
155355875|NCT01379703|560738196|FG001|Study Start Through 9 Months|Adverse Event|14|||
155355876|NCT01379703|560738197|FG002|Study Start Through 9 Months|Adverse Event|10|||
155355877|NCT01379703|560738195|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
155355878|NCT01379703|560738196|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
155355879|NCT01379703|560738197|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
155355880|NCT01379703|560738195|FG000|Study Start Through 9 Months|Treatment Failure|0|||
155355881|NCT01379703|560738196|FG001|Study Start Through 9 Months|Treatment Failure|2|||
155355882|NCT01379703|560738197|FG002|Study Start Through 9 Months|Treatment Failure|2|||
155355883|NCT01379703|560738195|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
155355884|NCT01379703|560738196|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
155355885|NCT01379703|560738197|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
155355886|NCT01379703|560738195|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
155355887|NCT01379703|560738196|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
155355888|NCT01379703|560738197|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
155355889|NCT01379703|560738195|FG000|Study Start Through 9 Months|Medication not available|0|||
155355890|NCT01379703|560738196|FG001|Study Start Through 9 Months|Medication not available|2|||
155355891|NCT01379703|560738197|FG002|Study Start Through 9 Months|Medication not available|1|||
155355892|NCT01379703|560738195|FG000|Study Start Through 9 Months|Poor general condition|0|||
155355893|NCT01379703|560738196|FG001|Study Start Through 9 Months|Poor general condition|1|||
155355894|NCT01379703|560738197|FG002|Study Start Through 9 Months|Poor general condition|0|||
155355895|NCT01379703|560738195|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
155355896|NCT01379703|560738196|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
155355897|NCT01379703|560738197|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
155355898|NCT01379703|560738195|FG000|Study Start Through 9 Months|Reason unknown|2|||
155355899|NCT01379703|560738196|FG001|Study Start Through 9 Months|Reason unknown|31|||
155355900|NCT01379703|560738197|FG002|Study Start Through 9 Months|Reason unknown|24|||
155355901|NCT01379703|560738195|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
155355902|NCT01379703|560738196|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
155355903|NCT01379703|560738197|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
155355904|NCT01379703|560738195|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
155355905|NCT01379703|560738196|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
155355906|NCT01379703|560738197|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
155355907|NCT01379703|560738195|FG000|9 Months Through 18 Months|Adverse Event|0|||
155355908|NCT01379703|560738196|FG001|9 Months Through 18 Months|Adverse Event|6|||
155355909|NCT01379703|560738197|FG002|9 Months Through 18 Months|Adverse Event|0|||
155355910|NCT01379703|560738195|FG000|9 Months Through 18 Months|Treatment failure|0|||
155355911|NCT01379703|560738196|FG001|9 Months Through 18 Months|Treatment failure|5|||
155355912|NCT01379703|560738197|FG002|9 Months Through 18 Months|Treatment failure|0|||
155355913|NCT01379703|560738195|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
155355914|NCT01379703|560738196|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
155355915|NCT01379703|560738197|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
155355916|NCT01379703|560738195|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
155355917|NCT01379703|560738196|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
155355918|NCT01379703|560738197|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
155355919|NCT01379703|560738195|FG000|9 Months Through 18 Months|Fatigue|0|||
155355920|NCT01379703|560738196|FG001|9 Months Through 18 Months|Fatigue|1|||
155355921|NCT01379703|560738197|FG002|9 Months Through 18 Months|Fatigue|0|||
155355922|NCT01379703|560738195|FG000|9 Months Through 18 Months|Reason Unknown|0|||
155355923|NCT01379703|560738196|FG001|9 Months Through 18 Months|Reason Unknown|23|||
155355924|NCT01379703|560738197|FG002|9 Months Through 18 Months|Reason Unknown|0|||
155355925|NCT03463577|560738198|FG000|Overall Study|Lost to Follow-up|238|||
155355926|NCT03463577|560738199|FG001|Overall Study|Lost to Follow-up|435|||
155355927|NCT03463577|560738200|FG002|Overall Study|Lost to Follow-up|0|||
155355928|NCT03463577|560738201|FG003|Overall Study|Lost to Follow-up|0|||
155355929|NCT03463577|560738202|FG004|Overall Study|Lost to Follow-up|0|||
155355930|NCT03463577|560738203|FG005|Overall Study|Lost to Follow-up|0|||
155355931|NCT03463577|560738198|FG000|Overall Study|With unknown pregnancy outcome|0|||
155355932|NCT03463577|560738199|FG001|Overall Study|With unknown pregnancy outcome|5|||
155355933|NCT03463577|560738200|FG002|Overall Study|With unknown pregnancy outcome|0|||
155355934|NCT03463577|560738201|FG003|Overall Study|With unknown pregnancy outcome|0|||
155355935|NCT03463577|560738202|FG004|Overall Study|With unknown pregnancy outcome|0|||
155355936|NCT03463577|560738203|FG005|Overall Study|With unknown pregnancy outcome|0|||
155355937|NCT03463577|560738198|FG000|Overall Study|Maternal death|2|||
155355938|NCT03463577|560738199|FG001|Overall Study|Maternal death|0|||
155355939|NCT03463577|560738200|FG002|Overall Study|Maternal death|0|||
155355940|NCT03463577|560738201|FG003|Overall Study|Maternal death|0|||
155355941|NCT03463577|560738202|FG004|Overall Study|Maternal death|0|||
155355942|NCT03463577|560738203|FG005|Overall Study|Maternal death|0|||
155355943|NCT03463577|560738198|FG000|Overall Study|Neonatal death|0|||
155355944|NCT03463577|560738199|FG001|Overall Study|Neonatal death|0|||
155355945|NCT03463577|560738200|FG002|Overall Study|Neonatal death|0|||
155355946|NCT03463577|560738201|FG003|Overall Study|Neonatal death|15|||
155355947|NCT03463577|560738202|FG004|Overall Study|Neonatal death|17|||
155355948|NCT03463577|560738203|FG005|Overall Study|Neonatal death|0|||
155355949|NCT00236184|560738204|FG000|Overall Study|Adverse Event|5|||
155355950|NCT00236184|560738205|FG001|Overall Study|Adverse Event|2|||
155355951|NCT00236184|560738204|FG000|Overall Study|Lack of Efficacy|0|||
155355952|NCT00236184|560738205|FG001|Overall Study|Lack of Efficacy|1|||
155355953|NCT00236184|560738204|FG000|Overall Study|Lost to Follow-up|3|||
155355954|NCT00236184|560738205|FG001|Overall Study|Lost to Follow-up|4|||
155355955|NCT00236184|560738204|FG000|Overall Study|Physician Decision|1|||
155355956|NCT00236184|560738205|FG001|Overall Study|Physician Decision|1|||
155355957|NCT00236184|560738204|FG000|Overall Study|Withdrawal by Subject|3|||
155355958|NCT00236184|560738205|FG001|Overall Study|Withdrawal by Subject|0|||
155355959|NCT00236184|560738204|FG000|Overall Study|Protocol Violation|3|||
155355960|NCT00236184|560738205|FG001|Overall Study|Protocol Violation|0|||
155355961|NCT00236184|560738204|FG000|Overall Study|non-compliance with study drug|2|||
155355962|NCT00236184|560738205|FG001|Overall Study|non-compliance with study drug|1|||
155355963|NCT00236184|560738204|FG000|Overall Study|other|1|||
155355964|NCT00236184|560738205|FG001|Overall Study|other|2|||
155355965|NCT01172639|560738206|FG000|Overall Study|Death|1|||
155355966|NCT01172639|560738207|FG001|Overall Study|Death|1|||
155355967|NCT01172639|560738208|FG002|Overall Study|Death|0|||
155355968|NCT01172639|560738209|FG003|Overall Study|Death|0|||
155355969|NCT01172639|560738210|FG004|Overall Study|Death|0|||
155355970|NCT01172639|560738206|FG000|Overall Study|Lost to Follow-up|9|||
155355971|NCT01172639|560738207|FG001|Overall Study|Lost to Follow-up|7|||
155355972|NCT01172639|560738208|FG002|Overall Study|Lost to Follow-up|11|||
155355973|NCT01172639|560738209|FG003|Overall Study|Lost to Follow-up|6|||
155355974|NCT01172639|560738210|FG004|Overall Study|Lost to Follow-up|6|||
155355975|NCT01172639|560738206|FG000|Overall Study|Withdrawal by Subject|3|||
155355976|NCT01172639|560738207|FG001|Overall Study|Withdrawal by Subject|3|||
155355977|NCT01172639|560738208|FG002|Overall Study|Withdrawal by Subject|5|||
155355978|NCT01172639|560738209|FG003|Overall Study|Withdrawal by Subject|5|||
155355979|NCT01172639|560738210|FG004|Overall Study|Withdrawal by Subject|0|||
155355980|NCT02172950|560738211|FG000|Overall Study|Physician Decision|3|||
155355981|NCT02172950|560738212|FG001|Overall Study|Physician Decision|3|||
155355982|NCT02172950|560738211|FG000|Overall Study|Lack of Efficacy|1|||
155355983|NCT02172950|560738212|FG001|Overall Study|Lack of Efficacy|0|||
155355984|NCT02172950|560738211|FG000|Overall Study|Adverse Event|4|||
155355985|NCT02172950|560738212|FG001|Overall Study|Adverse Event|1|||
155355986|NCT02172950|560738211|FG000|Overall Study|Withdrawal by Subject|10|||
155355987|NCT02172950|560738212|FG001|Overall Study|Withdrawal by Subject|0|||
155355988|NCT02172950|560738211|FG000|Overall Study|Protocol Violation|1|||
155355989|NCT02172950|560738212|FG001|Overall Study|Protocol Violation|0|||
155355990|NCT02172950|560738211|FG000|Overall Study|Lost to Follow-up|1|||
155355991|NCT02172950|560738212|FG001|Overall Study|Lost to Follow-up|0|||
155355992|NCT02172950|560738211|FG000|Overall Study|Death|1|||
155355993|NCT02172950|560738212|FG001|Overall Study|Death|0|||
155355994|NCT02172950|560738211|FG000|Overall Study|Patient traveling|1|||
155355995|NCT02172950|560738212|FG001|Overall Study|Patient traveling|0|||
155355996|NCT02172950|560738211|FG000|Overall Study|Patient went to other country|1|||
155355997|NCT02172950|560738212|FG001|Overall Study|Patient went to other country|0|||
155355998|NCT02172950|560738211|FG000|Overall Study|Patient relocated overseas|1|||
155355999|NCT02172950|560738212|FG001|Overall Study|Patient relocated overseas|1|||
155356000|NCT02172950|560738211|FG000|Overall Study|Patient moving|1|||
155356001|NCT02172950|560738212|FG001|Overall Study|Patient moving|0|||
155356002|NCT00704171|560738217|FG000|Overall Study|Withdrawal by Subject|1|||
155356003|NCT00704171|560738218|FG001|Overall Study|Withdrawal by Subject|0|||
155356004|NCT00813098|560738223|FG000|Overall Study|Adverse Event|2|||
155356005|NCT00813098|560738224|FG001|Overall Study|Adverse Event|4|||
155356006|NCT00813098|560738225|FG002|Overall Study|Adverse Event|1|||
155356007|NCT00813098|560738223|FG000|Overall Study|Withdrawal by Subject|0|||
155356008|NCT00813098|560738224|FG001|Overall Study|Withdrawal by Subject|1|||
155356009|NCT00813098|560738225|FG002|Overall Study|Withdrawal by Subject|0|||
155356010|NCT00813098|560738223|FG000|Overall Study|Inability to complete study procedures|1|||
155356011|NCT00813098|560738224|FG001|Overall Study|Inability to complete study procedures|0|||
155356012|NCT00813098|560738225|FG002|Overall Study|Inability to complete study procedures|0|||
155356013|NCT00813098|560738223|FG000|Overall Study|Lost to Follow-up|0|||
155356014|NCT00813098|560738224|FG001|Overall Study|Lost to Follow-up|1|||
155356015|NCT00813098|560738225|FG002|Overall Study|Lost to Follow-up|0|||
155356016|NCT00813098|560738223|FG000|Overall Study|Protocol Violation|0|||
155356017|NCT00813098|560738224|FG001|Overall Study|Protocol Violation|0|||
155356018|NCT00813098|560738225|FG002|Overall Study|Protocol Violation|1|||
155356019|NCT00813098|560738223|FG000|Overall Study|Principal Investigator decision|0|||
155356020|NCT00813098|560738224|FG001|Overall Study|Principal Investigator decision|1|||
155356021|NCT00813098|560738225|FG002|Overall Study|Principal Investigator decision|0|||
155356022|NCT00813098|560738223|FG000|Overall Study|Withdrew Consent|0|||
155356023|NCT00813098|560738224|FG001|Overall Study|Withdrew Consent|1|||
155356024|NCT00813098|560738225|FG002|Overall Study|Withdrew Consent|0|||
155356025|NCT01777490|560738228|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
155426923|NCT02901431|560989893|FG007|Main Treatment Part|Withdrawal by Subject|0|||
155426924|NCT02901431|560989894|FG008|Main Treatment Part|Withdrawal by Subject|0|||
155356026|NCT01777490|560738229|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
155356027|NCT01777490|560738230|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
155356028|NCT01777490|560738231|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
155356029|NCT01772563|560738232|FG000|Cycle 1|Dose limiting toxicity|2|||
155426925|NCT02901431|560989895|FG009|Main Treatment Part|Withdrawal by Subject|0|||
155426926|NCT02901431|560989896|FG010|Main Treatment Part|Withdrawal by Subject|0|||
155426927|NCT02901431|560989897|FG011|Main Treatment Part|Withdrawal by Subject|0|||
155426928|NCT02901431|560989898|FG012|Main Treatment Part|Withdrawal by Subject|0|||
155426929|NCT02901431|560989886|FG000|Open Label Part|Adverse Event|0|||
155426930|NCT02901431|560989887|FG001|Open Label Part|Adverse Event|0|||
155426931|NCT02901431|560989888|FG002|Open Label Part|Adverse Event|0|||
155426932|NCT02901431|560989889|FG003|Open Label Part|Adverse Event|0|||
155426933|NCT02901431|560989890|FG004|Open Label Part|Adverse Event|0|||
155426934|NCT02901431|560989891|FG005|Open Label Part|Adverse Event|0|||
155426935|NCT02901431|560989892|FG006|Open Label Part|Adverse Event|0|||
155426936|NCT02901431|560989893|FG007|Open Label Part|Adverse Event|0|||
155426937|NCT02901431|560989894|FG008|Open Label Part|Adverse Event|4|||
155426938|NCT02901431|560989895|FG009|Open Label Part|Adverse Event|4|||
155426939|NCT02901431|560989896|FG010|Open Label Part|Adverse Event|0|||
155426940|NCT02901431|560989897|FG011|Open Label Part|Adverse Event|4|||
155426941|NCT02901431|560989898|FG012|Open Label Part|Adverse Event|1|||
155426942|NCT02901431|560989886|FG000|Open Label Part|Lost to Follow-up|0|||
155426943|NCT02901431|560989887|FG001|Open Label Part|Lost to Follow-up|0|||
155426944|NCT02901431|560989888|FG002|Open Label Part|Lost to Follow-up|0|||
155356030|NCT01772563|560738232|FG000|Cycle 1|Progressive disease|2|||
155356031|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Progressive disease|17|||
155356032|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
155356033|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
155356034|NCT00832000|560738233|FG000|Overall Study|Adverse Event|2|||
155356035|NCT00832000|560738234|FG001|Overall Study|Adverse Event|0|||
155356036|NCT00832000|560738233|FG000|Overall Study|Withdrawal by Subject|1|||
155356037|NCT00832000|560738234|FG001|Overall Study|Withdrawal by Subject|0|||
155356038|NCT00832000|560738233|FG000|Overall Study|No calls to IVR in either period|1|||
155356039|NCT00832000|560738234|FG001|Overall Study|No calls to IVR in either period|1|||
155356040|NCT00832000|560738233|FG000|Overall Study|No calls to IVR in period 2|2|||
155356041|NCT00832000|560738234|FG001|Overall Study|No calls to IVR in period 2|0|||
155356042|NCT01898442|560738236|FG000|Overall Study|Hemolysis/technical problems|1|||
155356043|NCT01898442|560738237|FG001|Overall Study|Hemolysis/technical problems|2|||
155356044|NCT01898442|560738238|FG002|Overall Study|Hemolysis/technical problems|2|||
155356045|NCT01898442|560738236|FG000|Overall Study|Patient vomited pills|0|||
155356046|NCT01898442|560738237|FG001|Overall Study|Patient vomited pills|0|||
155356047|NCT01898442|560738238|FG002|Overall Study|Patient vomited pills|1|||
155356048|NCT00255944|560738239|FG000|Overall Study|Lost to Follow-up|797|||
155356049|NCT00255944|560738240|FG001|Overall Study|Lost to Follow-up|834|||
155426945|NCT02901431|560989889|FG003|Open Label Part|Lost to Follow-up|0|||
155426946|NCT02901431|560989890|FG004|Open Label Part|Lost to Follow-up|0|||
155426947|NCT02901431|560989891|FG005|Open Label Part|Lost to Follow-up|0|||
155426948|NCT02901431|560989892|FG006|Open Label Part|Lost to Follow-up|0|||
155426949|NCT02901431|560989893|FG007|Open Label Part|Lost to Follow-up|0|||
155426950|NCT02901431|560989894|FG008|Open Label Part|Lost to Follow-up|2|||
155426951|NCT02901431|560989895|FG009|Open Label Part|Lost to Follow-up|2|||
155426952|NCT02901431|560989896|FG010|Open Label Part|Lost to Follow-up|1|||
155426953|NCT02901431|560989897|FG011|Open Label Part|Lost to Follow-up|1|||
155426954|NCT02901431|560989898|FG012|Open Label Part|Lost to Follow-up|1|||
155426955|NCT02901431|560989886|FG000|Open Label Part|Physician Decision|0|||
155426956|NCT02901431|560989887|FG001|Open Label Part|Physician Decision|0|||
155426957|NCT02901431|560989888|FG002|Open Label Part|Physician Decision|0|||
155426958|NCT02901431|560989889|FG003|Open Label Part|Physician Decision|0|||
155426959|NCT02901431|560989890|FG004|Open Label Part|Physician Decision|0|||
155426960|NCT02901431|560989891|FG005|Open Label Part|Physician Decision|0|||
155426961|NCT02901431|560989892|FG006|Open Label Part|Physician Decision|0|||
155426962|NCT02901431|560989893|FG007|Open Label Part|Physician Decision|0|||
155356050|NCT01121913|560738242|FG000|First Intervention Period|Adverse Event|0|||
155426963|NCT02901431|560989894|FG008|Open Label Part|Physician Decision|1|||
155426964|NCT02901431|560989895|FG009|Open Label Part|Physician Decision|1|||
155426965|NCT02901431|560989896|FG010|Open Label Part|Physician Decision|0|||
155426966|NCT02901431|560989897|FG011|Open Label Part|Physician Decision|0|||
155356051|NCT01121913|560738243|FG001|First Intervention Period|Adverse Event|0|||
155356052|NCT01121913|560738244|FG002|First Intervention Period|Adverse Event|1|||
155356053|NCT01121913|560738245|FG003|First Intervention Period|Adverse Event|0|||
155356054|NCT01121913|560738242|FG000|First Washout Period|Withdrawal by Subject|1|||
155356055|NCT01121913|560738243|FG001|First Washout Period|Withdrawal by Subject|0|||
155356056|NCT01121913|560738244|FG002|First Washout Period|Withdrawal by Subject|0|||
155356057|NCT01121913|560738245|FG003|First Washout Period|Withdrawal by Subject|0|||
155356058|NCT01121913|560738242|FG000|Second Intervention Period|Adverse Event|0|||
155356059|NCT01121913|560738243|FG001|Second Intervention Period|Adverse Event|0|||
155356060|NCT01121913|560738244|FG002|Second Intervention Period|Adverse Event|1|||
155356061|NCT01121913|560738245|FG003|Second Intervention Period|Adverse Event|0|||
155356062|NCT01121913|560738242|FG000|Second Washout Period|Withdrawal by Subject|0|||
155356063|NCT01121913|560738243|FG001|Second Washout Period|Withdrawal by Subject|0|||
155356064|NCT01121913|560738244|FG002|Second Washout Period|Withdrawal by Subject|1|||
155356065|NCT01121913|560738245|FG003|Second Washout Period|Withdrawal by Subject|0|||
155356066|NCT01121913|560738242|FG000|Third Washout Period|Adverse Event|1|||
155356067|NCT01121913|560738243|FG001|Third Washout Period|Adverse Event|0|||
155356068|NCT01121913|560738244|FG002|Third Washout Period|Adverse Event|0|||
155356069|NCT01121913|560738245|FG003|Third Washout Period|Adverse Event|0|||
155356070|NCT00690378|560738246|FG000|Overall Study|Adverse Event|1|||
155356071|NCT00690378|560738247|FG001|Overall Study|Adverse Event|0|||
155356072|NCT00690378|560738246|FG000|Overall Study|Withdrawal by Subject|2|||
155356073|NCT00690378|560738247|FG001|Overall Study|Withdrawal by Subject|0|||
155356074|NCT00690378|560738246|FG000|Overall Study|Protocol Violation|1|||
155356075|NCT00690378|560738247|FG001|Overall Study|Protocol Violation|0|||
155356076|NCT00690378|560738246|FG000|Overall Study|Lost to Follow-up|2|||
155356077|NCT00690378|560738247|FG001|Overall Study|Lost to Follow-up|3|||
155356078|NCT00690378|560738246|FG000|Overall Study|Did not meet inc/exc criteria|13|||
155356079|NCT00690378|560738247|FG001|Overall Study|Did not meet inc/exc criteria|11|||
155356080|NCT00690378|560738246|FG000|Overall Study|Social problem|1|||
155356081|NCT00690378|560738247|FG001|Overall Study|Social problem|0|||
155356082|NCT02019641|560738257|FG000|10-Week Follow up|Withdrawal by investigator|2|||
155356083|NCT02019641|560738258|FG001|10-Week Follow up|Withdrawal by investigator|0|||
155356084|NCT02019641|560738259|FG002|10-Week Follow up|Withdrawal by investigator|0|||
155356085|NCT02019641|560738257|FG000|10-Week Follow up|Withdrawal by Subject|1|||
155356086|NCT02019641|560738258|FG001|10-Week Follow up|Withdrawal by Subject|1|||
155356087|NCT02019641|560738259|FG002|10-Week Follow up|Withdrawal by Subject|0|||
155356088|NCT02019641|560738257|FG000|20-Week Follow up|Withdrawal by investigator|0|||
155356089|NCT02019641|560738258|FG001|20-Week Follow up|Withdrawal by investigator|0|||
155356090|NCT02019641|560738259|FG002|20-Week Follow up|Withdrawal by investigator|1|||
155356091|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356092|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356093|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
155356094|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356095|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356096|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356097|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
155356098|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356099|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
155356100|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356101|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
155356102|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
155356103|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356104|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
155356105|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
155356106|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356107|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356108|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356109|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
155356110|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
155356111|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356112|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356113|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356114|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356115|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356116|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
155356117|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356118|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356119|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
155356120|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
155356121|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
155356122|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356123|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
155356124|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356125|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356126|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356127|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356128|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356129|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
155356130|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356131|NCT00937521|560738260|FG000|Booster Phase|Adverse Event|0|||
155356132|NCT00937521|560738261|FG001|Booster Phase|Adverse Event|0|||
155356133|NCT00937521|560738262|FG002|Booster Phase|Adverse Event|0|||
155356134|NCT00937521|560738263|FG003|Booster Phase|Adverse Event|0|||
155356135|NCT00937521|560738264|FG004|Booster Phase|Adverse Event|0|||
155356136|NCT00937521|560738265|FG005|Booster Phase|Adverse Event|0|||
155356137|NCT00937521|560738266|FG006|Booster Phase|Adverse Event|1|||
155356138|NCT00937521|560738267|FG007|Booster Phase|Adverse Event|0|||
155356139|NCT00937521|560738260|FG000|Booster Phase|Withdrawal by Subject|1|||
155356140|NCT00937521|560738261|FG001|Booster Phase|Withdrawal by Subject|0|||
155356141|NCT00937521|560738262|FG002|Booster Phase|Withdrawal by Subject|0|||
155356142|NCT00937521|560738263|FG003|Booster Phase|Withdrawal by Subject|1|||
155356143|NCT00937521|560738264|FG004|Booster Phase|Withdrawal by Subject|0|||
155356144|NCT00937521|560738265|FG005|Booster Phase|Withdrawal by Subject|0|||
155356145|NCT00937521|560738266|FG006|Booster Phase|Withdrawal by Subject|0|||
155356146|NCT00937521|560738267|FG007|Booster Phase|Withdrawal by Subject|2|||
155356147|NCT00937521|560738260|FG000|Booster Phase|Lost to Follow-up|2|||
155356148|NCT00937521|560738261|FG001|Booster Phase|Lost to Follow-up|2|||
155356149|NCT00937521|560738262|FG002|Booster Phase|Lost to Follow-up|4|||
155356150|NCT00937521|560738263|FG003|Booster Phase|Lost to Follow-up|2|||
155356151|NCT00937521|560738264|FG004|Booster Phase|Lost to Follow-up|4|||
155356152|NCT00937521|560738265|FG005|Booster Phase|Lost to Follow-up|4|||
155356153|NCT00937521|560738266|FG006|Booster Phase|Lost to Follow-up|3|||
155356154|NCT00937521|560738267|FG007|Booster Phase|Lost to Follow-up|0|||
155356155|NCT00937521|560738260|FG000|Booster Phase|Administrative Reason|0|||
155356156|NCT00937521|560738261|FG001|Booster Phase|Administrative Reason|0|||
155356157|NCT00937521|560738262|FG002|Booster Phase|Administrative Reason|1|||
155356158|NCT00937521|560738263|FG003|Booster Phase|Administrative Reason|0|||
155356159|NCT00937521|560738264|FG004|Booster Phase|Administrative Reason|1|||
155356160|NCT00937521|560738265|FG005|Booster Phase|Administrative Reason|1|||
155356161|NCT00937521|560738266|FG006|Booster Phase|Administrative Reason|0|||
155356162|NCT00937521|560738267|FG007|Booster Phase|Administrative Reason|0|||
155356163|NCT00937521|560738260|FG000|Booster Phase|Protocol Deviation|0|||
155356164|NCT00937521|560738261|FG001|Booster Phase|Protocol Deviation|0|||
155356165|NCT00937521|560738262|FG002|Booster Phase|Protocol Deviation|0|||
155356166|NCT00937521|560738263|FG003|Booster Phase|Protocol Deviation|0|||
155356167|NCT00937521|560738264|FG004|Booster Phase|Protocol Deviation|0|||
155356168|NCT00937521|560738265|FG005|Booster Phase|Protocol Deviation|0|||
155356169|NCT00937521|560738266|FG006|Booster Phase|Protocol Deviation|1|||
155356170|NCT00937521|560738267|FG007|Booster Phase|Protocol Deviation|0|||
155356171|NCT00468130|560738268|FG000|Overall Study|Adverse Event|2|||
155356172|NCT00468130|560738269|FG001|Overall Study|Adverse Event|1|||
155356173|NCT00468130|560738268|FG000|Overall Study|Withdrawal by Subject|0|||
155356174|NCT00468130|560738269|FG001|Overall Study|Withdrawal by Subject|1|||
155356175|NCT02485899|560738270|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
155356176|NCT02485899|560738271|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155356177|NCT02485899|560738270|FG000|Overall Study|Withdrawal by Subject|1|||
155356178|NCT02485899|560738271|FG001|Overall Study|Withdrawal by Subject|0|||
155356179|NCT02485899|560738270|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
155356180|NCT02485899|560738271|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
155356181|NCT00436956|560738272|FG000|Overall Study|Not evaluable|1|||
155356182|NCT00436956|560738273|FG001|Overall Study|Not evaluable|0|||
155356183|NCT01841112|560738275|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
155356184|NCT01841112|560738276|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
155356185|NCT01841112|560738277|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
155356186|NCT01841112|560738278|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
155356187|NCT01841112|560738279|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
155356188|NCT00623363|560738280|FG000|Overall Study|Adverse Event|2|||
155356189|NCT00623363|560738281|FG001|Overall Study|Adverse Event|2|||
155356190|NCT03713320|560738282|FG000|Randomized Period|Adverse Event|1|||
155356191|NCT03713320|560738283|FG001|Randomized Period|Adverse Event|5|||
155356192|NCT03713320|560738284|FG002|Randomized Period|Adverse Event|0|||
155356193|NCT03713320|560738282|FG000|Randomized Period|Physician Decision|1|||
155356194|NCT03713320|560738283|FG001|Randomized Period|Physician Decision|1|||
155356195|NCT03713320|560738284|FG002|Randomized Period|Physician Decision|0|||
155356196|NCT03713320|560738282|FG000|Randomized Period|Withdrawal by Subject|4|||
155356197|NCT03713320|560738283|FG001|Randomized Period|Withdrawal by Subject|0|||
155356198|NCT03713320|560738284|FG002|Randomized Period|Withdrawal by Subject|0|||
155356199|NCT03713320|560738282|FG000|Randomized Period|Participant decision|3|||
155356200|NCT03713320|560738283|FG001|Randomized Period|Participant decision|1|||
155356201|NCT03713320|560738284|FG002|Randomized Period|Participant decision|0|||
155356202|NCT03713320|560738282|FG000|Randomized Period|Study terminated by sponsor|6|||
155356203|NCT03713320|560738283|FG001|Randomized Period|Study terminated by sponsor|3|||
155356204|NCT03713320|560738284|FG002|Randomized Period|Study terminated by sponsor|0|||
155356205|NCT03713320|560738282|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
155356206|NCT03713320|560738283|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
155356207|NCT03713320|560738284|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
155356208|NCT03713320|560738282|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
155356209|NCT03713320|560738283|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
155356210|NCT03713320|560738284|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
155356211|NCT01880437|560738285|FG000|Overall Study|Death|12|||
155356212|NCT01880437|560738286|FG001|Overall Study|Death|4|||
155356213|NCT01880437|560738287|FG002|Overall Study|Death|17|||
155356214|NCT01880437|560738285|FG000|Overall Study|Study terminated by Sponsor|3|||
155356215|NCT01880437|560738286|FG001|Overall Study|Study terminated by Sponsor|0|||
155356216|NCT01880437|560738287|FG002|Overall Study|Study terminated by Sponsor|2|||
155356217|NCT00909532|560738288|FG000|Overall Study|Adverse Event|4|||
155356218|NCT00909532|560738289|FG001|Overall Study|Adverse Event|1|||
155356219|NCT00909532|560738288|FG000|Overall Study|Pregnancy|0|||
155356220|NCT00909532|560738289|FG001|Overall Study|Pregnancy|1|||
155356221|NCT00909532|560738288|FG000|Overall Study|Prohibited Medication|2|||
155356222|NCT00909532|560738289|FG001|Overall Study|Prohibited Medication|1|||
155356223|NCT00909532|560738288|FG000|Overall Study|Withdrawal of Consent|1|||
155356224|NCT00909532|560738289|FG001|Overall Study|Withdrawal of Consent|1|||
155356225|NCT00909532|560738288|FG000|Overall Study|Noncompliance with Study Requirements|0|||
155356226|NCT00909532|560738289|FG001|Overall Study|Noncompliance with Study Requirements|2|||
155356227|NCT00909532|560738288|FG000|Overall Study|Physician Decision|1|||
155356228|NCT00909532|560738289|FG001|Overall Study|Physician Decision|0|||
155356229|NCT00909532|560738288|FG000|Overall Study|Wrong Genotype|1|||
155356230|NCT00909532|560738289|FG001|Overall Study|Wrong Genotype|0|||
155356231|NCT00909532|560738288|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
155356232|NCT00909532|560738289|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
155356233|NCT01209598|560738290|FG000|Overall Study|Withdrawal by Subject|1|||
155356234|NCT01209598|560738291|FG001|Overall Study|Withdrawal by Subject|0|||
155426967|NCT02901431|560989898|FG012|Open Label Part|Physician Decision|0|||
155426968|NCT02901431|560989886|FG000|Open Label Part|Study Terminated By Sponsor|0|||
155426969|NCT02901431|560989887|FG001|Open Label Part|Study Terminated By Sponsor|0|||
155426970|NCT02901431|560989888|FG002|Open Label Part|Study Terminated By Sponsor|0|||
155426971|NCT02901431|560989889|FG003|Open Label Part|Study Terminated By Sponsor|0|||
155426972|NCT02901431|560989890|FG004|Open Label Part|Study Terminated By Sponsor|0|||
155426973|NCT02901431|560989891|FG005|Open Label Part|Study Terminated By Sponsor|0|||
155426974|NCT02901431|560989892|FG006|Open Label Part|Study Terminated By Sponsor|0|||
155426975|NCT02901431|560989893|FG007|Open Label Part|Study Terminated By Sponsor|0|||
155426976|NCT02901431|560989894|FG008|Open Label Part|Study Terminated By Sponsor|35|||
155426977|NCT02901431|560989895|FG009|Open Label Part|Study Terminated By Sponsor|12|||
155426978|NCT02901431|560989896|FG010|Open Label Part|Study Terminated By Sponsor|21|||
155648677|NCT02675452|561805883|FG002|Overall Study|Withdrawal by Subject|0|||
155648678|NCT02675452|561805884|FG003|Overall Study|Withdrawal by Subject|0|||
155356235|NCT00085566|560738293|FG000|Overall Study|Adverse Event|0|||
155426979|NCT02901431|560989897|FG011|Open Label Part|Study Terminated By Sponsor|31|||
155356236|NCT00085566|560738294|FG001|Overall Study|Adverse Event|0|||
155356237|NCT00085566|560738295|FG002|Overall Study|Adverse Event|10|||
155356238|NCT00085566|560738293|FG000|Overall Study|Patient Not treated|0|||
155356239|NCT00085566|560738294|FG001|Overall Study|Patient Not treated|0|||
155356240|NCT00085566|560738295|FG002|Overall Study|Patient Not treated|3|||
155356241|NCT00085566|560738293|FG000|Overall Study|Clinical progression|0|||
155356242|NCT00085566|560738294|FG001|Overall Study|Clinical progression|0|||
155356243|NCT00085566|560738295|FG002|Overall Study|Clinical progression|1|||
155356244|NCT02604342|560738297|FG000|Overall Study|Death|32|||
155356245|NCT02604342|560738298|FG001|Overall Study|Death|16|||
155356246|NCT02604342|560738297|FG000|Overall Study|Progression of disease|1|||
155356247|NCT02604342|560738298|FG001|Overall Study|Progression of disease|0|||
155356248|NCT02604342|560738297|FG000|Overall Study|Withdrawal by Subject|5|||
155356249|NCT02604342|560738298|FG001|Overall Study|Withdrawal by Subject|6|||
155356250|NCT02604342|560738297|FG000|Overall Study|Other|1|||
155356251|NCT02604342|560738298|FG001|Overall Study|Other|0|||
155356252|NCT02604342|560738297|FG000|Overall Study|Study Termination by Sponsor|1|||
155356253|NCT02604342|560738298|FG001|Overall Study|Study Termination by Sponsor|0|||
155356254|NCT02604342|560738297|FG000|Overall Study|Lost to Follow-up|1|||
155356255|NCT02604342|560738298|FG001|Overall Study|Lost to Follow-up|1|||
155356256|NCT02604342|560738297|FG000|Overall Study|Physician Decision|2|||
155356257|NCT02604342|560738298|FG001|Overall Study|Physician Decision|0|||
155356258|NCT01702519|560738299|FG000|Washout Period|Lost to Follow-up|1|||
155356259|NCT01702519|560738300|FG001|Washout Period|Lost to Follow-up|0|||
155356260|NCT01702519|560738299|FG000|Washout Period|Withdrawal by Subject|0|||
155356261|NCT01702519|560738300|FG001|Washout Period|Withdrawal by Subject|2|||
155356262|NCT01837797|560738302|FG000|Period 1|Adverse Event|9|||
155356263|NCT01837797|560738303|FG001|Period 1|Adverse Event|0|||
155356264|NCT01837797|560738304|FG002|Period 1|Adverse Event|0|||
155356265|NCT01837797|560738305|FG003|Period 1|Adverse Event|0|||
155356266|NCT01837797|560738306|FG004|Period 1|Adverse Event|0|||
155356267|NCT01837797|560738302|FG000|Period 1|Withdrawal by Subject|6|||
155356268|NCT01837797|560738303|FG001|Period 1|Withdrawal by Subject|0|||
155356269|NCT01837797|560738304|FG002|Period 1|Withdrawal by Subject|0|||
155356270|NCT01837797|560738305|FG003|Period 1|Withdrawal by Subject|0|||
155356271|NCT01837797|560738306|FG004|Period 1|Withdrawal by Subject|0|||
155356272|NCT01837797|560738302|FG000|Period 1|Administrative reasons|76|||
155356273|NCT01837797|560738303|FG001|Period 1|Administrative reasons|0|||
155356274|NCT01837797|560738304|FG002|Period 1|Administrative reasons|0|||
155356275|NCT01837797|560738305|FG003|Period 1|Administrative reasons|0|||
155356276|NCT01837797|560738306|FG004|Period 1|Administrative reasons|0|||
155426980|NCT02901431|560989898|FG012|Open Label Part|Study Terminated By Sponsor|0|||
155426981|NCT02901431|560989886|FG000|Open Label Part|Withdrawal by Subject|0|||
155426982|NCT02901431|560989887|FG001|Open Label Part|Withdrawal by Subject|0|||
155426983|NCT02901431|560989888|FG002|Open Label Part|Withdrawal by Subject|0|||
155426984|NCT02901431|560989889|FG003|Open Label Part|Withdrawal by Subject|0|||
155426985|NCT02901431|560989890|FG004|Open Label Part|Withdrawal by Subject|0|||
155426986|NCT02901431|560989891|FG005|Open Label Part|Withdrawal by Subject|0|||
155426987|NCT02901431|560989892|FG006|Open Label Part|Withdrawal by Subject|0|||
155426988|NCT02901431|560989893|FG007|Open Label Part|Withdrawal by Subject|0|||
155426989|NCT02901431|560989894|FG008|Open Label Part|Withdrawal by Subject|6|||
155426990|NCT02901431|560989895|FG009|Open Label Part|Withdrawal by Subject|5|||
155426991|NCT02901431|560989896|FG010|Open Label Part|Withdrawal by Subject|7|||
155426992|NCT02901431|560989897|FG011|Open Label Part|Withdrawal by Subject|3|||
155426993|NCT02901431|560989898|FG012|Open Label Part|Withdrawal by Subject|1|||
155426994|NCT03440944|560989899|FG000|Overall Study|Physician Decision|1|||
155426995|NCT03440944|560989900|FG001|Overall Study|Physician Decision|0|||
155426996|NCT03440944|560989899|FG000|Overall Study|No Acceptable Vasculature|0|||
155426997|NCT03440944|560989900|FG001|Overall Study|No Acceptable Vasculature|1|||
155426998|NCT04672083|560989901|FG000|Overall Study|Lost to Follow-up|1|||
155426999|NCT04672083|560989902|FG001|Overall Study|Lost to Follow-up|0|||
155427000|NCT04672083|560989903|FG002|Overall Study|Lost to Follow-up|0|||
155427001|NCT04672083|560989904|FG003|Overall Study|Lost to Follow-up|0|||
155427002|NCT04672083|560989905|FG004|Overall Study|Lost to Follow-up|0|||
155427003|NCT01551745|560989906|FG000|Overall Study|Withdrawal by Subject|1|||
155427004|NCT01551745|560989906|FG000|Overall Study|Disease Progression|2|||
155506994|NCT00672620|561283491|FG003|Overall Study|Reason not Specified|1|||
155506995|NCT00738673|561283492|FG000|Overall Study|Adverse Event|1|||
155356277|NCT01837797|560738302|FG000|Period 1|Withdrawal of consent before treatment|1|||
155356278|NCT01837797|560738303|FG001|Period 1|Withdrawal of consent before treatment|0|||
155356279|NCT01837797|560738304|FG002|Period 1|Withdrawal of consent before treatment|0|||
155356280|NCT01837797|560738305|FG003|Period 1|Withdrawal of consent before treatment|0|||
155356281|NCT01837797|560738306|FG004|Period 1|Withdrawal of consent before treatment|0|||
155356282|NCT01837797|560738302|FG000|Period 1|Other|10|||
155356283|NCT01837797|560738303|FG001|Period 1|Other|0|||
155356284|NCT01837797|560738304|FG002|Period 1|Other|0|||
155356285|NCT01837797|560738305|FG003|Period 1|Other|0|||
155356286|NCT01837797|560738306|FG004|Period 1|Other|0|||
155356287|NCT01837797|560738302|FG000|Period 2|Administrative or other reasons|0|||
155356288|NCT01837797|560738303|FG001|Period 2|Administrative or other reasons|5|||
155356289|NCT01837797|560738304|FG002|Period 2|Administrative or other reasons|2|||
155356290|NCT01837797|560738305|FG003|Period 2|Administrative or other reasons|4|||
155356291|NCT01837797|560738306|FG004|Period 2|Administrative or other reasons|0|||
155356292|NCT01837797|560738302|FG000|Period 2|Adverse Event|0|||
155356293|NCT01837797|560738303|FG001|Period 2|Adverse Event|0|||
155356294|NCT01837797|560738304|FG002|Period 2|Adverse Event|0|||
155356295|NCT01837797|560738305|FG003|Period 2|Adverse Event|1|||
155356296|NCT01837797|560738306|FG004|Period 2|Adverse Event|0|||
155356297|NCT01837797|560738302|FG000|Period 3|Adverse Event|0|||
155356298|NCT01837797|560738303|FG001|Period 3|Adverse Event|0|||
155356299|NCT01837797|560738304|FG002|Period 3|Adverse Event|0|||
155356300|NCT01837797|560738305|FG003|Period 3|Adverse Event|0|||
155356301|NCT01837797|560738306|FG004|Period 3|Adverse Event|1|||
155356302|NCT01837797|560738302|FG000|Period 3|Administrative reasons|0|||
155356303|NCT01837797|560738303|FG001|Period 3|Administrative reasons|0|||
155356304|NCT01837797|560738304|FG002|Period 3|Administrative reasons|0|||
155356305|NCT01837797|560738305|FG003|Period 3|Administrative reasons|0|||
155356306|NCT01837797|560738306|FG004|Period 3|Administrative reasons|20|||
155356307|NCT01837797|560738302|FG000|Period 3|Other|0|||
155356308|NCT01837797|560738303|FG001|Period 3|Other|0|||
155356309|NCT01837797|560738304|FG002|Period 3|Other|0|||
155356310|NCT01837797|560738305|FG003|Period 3|Other|0|||
155356311|NCT01837797|560738306|FG004|Period 3|Other|2|||
155356312|NCT04522778|560738308|FG000|Overall Study|Patient did not want to wear the device|1|||
155356313|NCT04522778|560738309|FG001|Overall Study|Patient did not want to wear the device|0|||
155356314|NCT04522778|560738308|FG000|Overall Study|Lost to Follow-up|0|||
155356315|NCT04522778|560738309|FG001|Overall Study|Lost to Follow-up|1|||
155356316|NCT00069277|560738310|FG000|Overall Study|Adverse Event|3|||
155356317|NCT00069277|560738310|FG000|Overall Study|Withdrawal by Subject|1|||
155356318|NCT00069277|560738310|FG000|Overall Study|Progressive Disease|15|||
155356319|NCT00069277|560738310|FG000|Overall Study|Physician Decision|2|||
155356320|NCT01225159|560738313|FG000|Overall Study|Change operation|1|||
155356321|NCT01225159|560738314|FG001|Overall Study|Change operation|0|||
155356322|NCT01220856|560738321|FG000|Overall Study|graft loss|3|||
155356323|NCT01220856|560738322|FG001|Overall Study|graft loss|3|||
155356324|NCT01220856|560738321|FG000|Overall Study|Lost to Follow-up|1|||
155356325|NCT01220856|560738322|FG001|Overall Study|Lost to Follow-up|0|||
155356326|NCT04814992|560738323|FG000|Overall Study|Withdrawal by Subject|6|||
155356327|NCT04814992|560738324|FG001|Overall Study|Withdrawal by Subject|3|||
155356328|NCT04814992|560738323|FG000|Overall Study|Lost to Follow-up|1|||
155356329|NCT04814992|560738324|FG001|Overall Study|Lost to Follow-up|4|||
155356330|NCT00934700|560738327|FG000|Overall Study|missing scan|5|||
155356331|NCT00934700|560738328|FG001|Overall Study|missing scan|9|||
155356332|NCT00934700|560738327|FG000|Overall Study|Death|8|||
155356333|NCT00934700|560738328|FG001|Overall Study|Death|3|||
155356334|NCT00143598|560738329|FG000|Overall Study|Lost to Follow-up|23|||
155356335|NCT00143598|560738330|FG001|Overall Study|Lost to Follow-up|21|||
155356336|NCT00143598|560738329|FG000|Overall Study|Withdrawal by Subject|33|||
155356337|NCT00143598|560738330|FG001|Overall Study|Withdrawal by Subject|37|||
155356338|NCT00143598|560738329|FG000|Overall Study|Death|36|||
155356339|NCT00143598|560738330|FG001|Overall Study|Death|36|||
155356340|NCT03900715|560738331|FG000|Overall Study|Protocol Deviation|1|||
155356341|NCT03900715|560738331|FG000|Overall Study|Lack of Efficacy|1|||
155356342|NCT03900715|560738331|FG000|Overall Study|Progressive Disease|6|||
155356343|NCT03900715|560738331|FG000|Overall Study|Adverse Event|2|||
155356344|NCT03900715|560738331|FG000|Overall Study|Other reasons|11|||
155356345|NCT03113383|560740347|FG000|Overall Study|Death|4|||
155356346|NCT03113383|560740348|FG001|Overall Study|Death|0|||
155356347|NCT03062449|560740350|FG000|Overall Study|Withdrawal by Subject|7|||
155356348|NCT03062449|560740351|FG001|Overall Study|Withdrawal by Subject|1|||
155356349|NCT03194867|560740356|FG000|Overall Study|Incorrect completion of end of study form|0|||
155356350|NCT03194867|560740357|FG001|Overall Study|Incorrect completion of end of study form|0|||
155356351|NCT03194867|560740358|FG002|Overall Study|Incorrect completion of end of study form|1|||
155356352|NCT03194867|560740359|FG003|Overall Study|Incorrect completion of end of study form|0|||
155356353|NCT00543062|560740360|FG000|Overall Study|Withdrawal by Subject|1|||
155356354|NCT00543062|560740361|FG001|Overall Study|Withdrawal by Subject|0|||
155356355|NCT00543062|560740362|FG002|Overall Study|Withdrawal by Subject|2|||
155356356|NCT00543062|560740363|FG003|Overall Study|Withdrawal by Subject|0|||
155356357|NCT00543062|560740360|FG000|Overall Study|Adverse Event|0|||
155356358|NCT00543062|560740361|FG001|Overall Study|Adverse Event|1|||
155356359|NCT00543062|560740362|FG002|Overall Study|Adverse Event|1|||
155356360|NCT00543062|560740363|FG003|Overall Study|Adverse Event|1|||
155356361|NCT00543062|560740360|FG000|Overall Study|Protocol Violation|1|||
155356362|NCT00543062|560740361|FG001|Overall Study|Protocol Violation|0|||
155356363|NCT00543062|560740362|FG002|Overall Study|Protocol Violation|0|||
155356364|NCT00543062|560740363|FG003|Overall Study|Protocol Violation|0|||
155356365|NCT00464945|560740364|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
155356366|NCT00464945|560740365|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
155356367|NCT00464945|560740364|FG000|Infant Series|Protocol Violation|1|||
155356368|NCT00464945|560740365|FG001|Infant Series|Protocol Violation|0|||
155356369|NCT00464945|560740364|FG000|Infant Series|Lost to Follow-up|1|||
155356370|NCT00464945|560740365|FG001|Infant Series|Lost to Follow-up|0|||
155356371|NCT00464945|560740364|FG000|After Infant Series|Withdrawal by Subject|0|||
155356372|NCT00464945|560740365|FG001|After Infant Series|Withdrawal by Subject|2|||
155356373|NCT00464945|560740364|FG000|Toddler Dose|Lost to Follow-up|0|||
155356374|NCT00464945|560740365|FG001|Toddler Dose|Lost to Follow-up|1|||
155427005|NCT01661790|560989907|FG000|Overall Study|Lost to Follow-up|0|||
155427006|NCT01661790|560989908|FG001|Overall Study|Lost to Follow-up|2|||
155427007|NCT02764541|560989909|FG000|Overall Study|Withdrawal by Subject|0|||
155427008|NCT02764541|560989910|FG001|Overall Study|Withdrawal by Subject|0|||
155427009|NCT02764541|560989911|FG002|Overall Study|Withdrawal by Subject|0|||
155427010|NCT02764541|560989912|FG003|Overall Study|Withdrawal by Subject|0|||
155427011|NCT02764541|560989913|FG004|Overall Study|Withdrawal by Subject|1|||
155427012|NCT02764541|560989914|FG005|Overall Study|Withdrawal by Subject|1|||
155427013|NCT02764541|560989915|FG006|Overall Study|Withdrawal by Subject|0|||
155427014|NCT02764541|560989916|FG007|Overall Study|Withdrawal by Subject|1|||
155427015|NCT02764541|560989909|FG000|Overall Study|Adverse Event|1|||
155427016|NCT02764541|560989910|FG001|Overall Study|Adverse Event|0|||
155427017|NCT02764541|560989911|FG002|Overall Study|Adverse Event|0|||
155427018|NCT02764541|560989912|FG003|Overall Study|Adverse Event|0|||
155427019|NCT02764541|560989913|FG004|Overall Study|Adverse Event|0|||
155427020|NCT02764541|560989914|FG005|Overall Study|Adverse Event|0|||
155427021|NCT02764541|560989915|FG006|Overall Study|Adverse Event|1|||
155427022|NCT02764541|560989916|FG007|Overall Study|Adverse Event|0|||
155427023|NCT02764541|560989909|FG000|Overall Study|Metastasis|1|||
155427024|NCT02764541|560989910|FG001|Overall Study|Metastasis|0|||
155427025|NCT02764541|560989911|FG002|Overall Study|Metastasis|0|||
155427026|NCT02764541|560989912|FG003|Overall Study|Metastasis|0|||
155427027|NCT02764541|560989913|FG004|Overall Study|Metastasis|0|||
155427028|NCT02764541|560989914|FG005|Overall Study|Metastasis|0|||
155427029|NCT02764541|560989915|FG006|Overall Study|Metastasis|0|||
155427030|NCT02764541|560989916|FG007|Overall Study|Metastasis|0|||
155427031|NCT02764541|560989909|FG000|Overall Study|Disease progression|1|||
155427032|NCT02764541|560989910|FG001|Overall Study|Disease progression|1|||
155427033|NCT02764541|560989911|FG002|Overall Study|Disease progression|0|||
155427034|NCT02764541|560989912|FG003|Overall Study|Disease progression|0|||
155427035|NCT02764541|560989913|FG004|Overall Study|Disease progression|0|||
155427036|NCT02764541|560989914|FG005|Overall Study|Disease progression|0|||
155427037|NCT02764541|560989915|FG006|Overall Study|Disease progression|0|||
155427038|NCT02764541|560989916|FG007|Overall Study|Disease progression|1|||
155356375|NCT02438371|560740368|FG000|Overall Study|Lost to Follow-up|3|||
155356376|NCT02438371|560740369|FG001|Overall Study|Lost to Follow-up|2|||
155356377|NCT02438371|560740368|FG000|Overall Study|Withdrawal by Subject|1|||
155356378|NCT02438371|560740369|FG001|Overall Study|Withdrawal by Subject|1|||
155427039|NCT02764541|560989909|FG000|Overall Study|Protocol Violation|0|||
155427040|NCT02764541|560989910|FG001|Overall Study|Protocol Violation|0|||
155427041|NCT02764541|560989911|FG002|Overall Study|Protocol Violation|0|||
155427042|NCT02764541|560989912|FG003|Overall Study|Protocol Violation|1|||
155356379|NCT01161446|560740370|FG000|Overall Study|Lost to Follow-up|18|||
155356380|NCT01161446|560740371|FG001|Overall Study|Lost to Follow-up|14|||
155356381|NCT01161446|560740370|FG000|Overall Study|Withdrawal by Subject|0|||
155356382|NCT01161446|560740371|FG001|Overall Study|Withdrawal by Subject|1|||
155356383|NCT02536742|560740372|FG000|Overall Study|Did not start protocol therapy|1|||
155356384|NCT02536742|560740372|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
155356385|NCT01844726|560740373|FG000|Overall Study|Withdrawal by Subject|0|||
155356386|NCT01844726|560740374|FG001|Overall Study|Withdrawal by Subject|1|||
155356387|NCT01844726|560740373|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
155356388|NCT01844726|560740374|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
155356389|NCT03898960|560740375|FG000|Overall Study|Death|10|||
155356390|NCT03481556|560740376|FG000|Overall Study|Adverse Event|1|||
155356391|NCT03481556|560740377|FG001|Overall Study|Adverse Event|0|||
155356392|NCT03481556|560740378|FG002|Overall Study|Adverse Event|0|||
155356393|NCT03481556|560740379|FG003|Overall Study|Adverse Event|0|||
155356394|NCT03481556|560740376|FG000|Overall Study|Death|4|||
155356395|NCT03481556|560740377|FG001|Overall Study|Death|2|||
155356396|NCT03481556|560740378|FG002|Overall Study|Death|3|||
155356397|NCT03481556|560740379|FG003|Overall Study|Death|16|||
155356398|NCT03481556|560740376|FG000|Overall Study|Study Terminated by Sponsor|10|||
155356399|NCT03481556|560740377|FG001|Overall Study|Study Terminated by Sponsor|5|||
155356400|NCT03481556|560740378|FG002|Overall Study|Study Terminated by Sponsor|2|||
155356401|NCT03481556|560740379|FG003|Overall Study|Study Terminated by Sponsor|9|||
155356402|NCT01101997|560740380|FG000|Overall Study|Withdrawal by Subject|2|||
155356403|NCT01316887|560740381|FG000|Overall Study|Adverse Event|13|||
155356404|NCT01316887|560740382|FG001|Overall Study|Adverse Event|21|||
155356405|NCT01316887|560740383|FG002|Overall Study|Adverse Event|17|||
155356406|NCT01316887|560740381|FG000|Overall Study|Lack of Efficacy|9|||
155356407|NCT01316887|560740382|FG001|Overall Study|Lack of Efficacy|3|||
155356408|NCT01316887|560740383|FG002|Overall Study|Lack of Efficacy|1|||
155427043|NCT02764541|560989913|FG004|Overall Study|Protocol Violation|0|||
155427044|NCT02764541|560989914|FG005|Overall Study|Protocol Violation|1|||
155427045|NCT02764541|560989915|FG006|Overall Study|Protocol Violation|0|||
155427046|NCT02764541|560989916|FG007|Overall Study|Protocol Violation|0|||
155427047|NCT02764541|560989909|FG000|Overall Study|Physician Decision|0|||
155427048|NCT02764541|560989910|FG001|Overall Study|Physician Decision|0|||
155427049|NCT02764541|560989911|FG002|Overall Study|Physician Decision|0|||
155427050|NCT02764541|560989912|FG003|Overall Study|Physician Decision|1|||
155427051|NCT02764541|560989913|FG004|Overall Study|Physician Decision|0|||
155427052|NCT02764541|560989914|FG005|Overall Study|Physician Decision|0|||
155427053|NCT02764541|560989915|FG006|Overall Study|Physician Decision|0|||
155427054|NCT02764541|560989916|FG007|Overall Study|Physician Decision|1|||
155427055|NCT02764541|560989909|FG000|Overall Study|Three Cycles completed before surgery|0|||
155427056|NCT02764541|560989910|FG001|Overall Study|Three Cycles completed before surgery|0|||
155427057|NCT02764541|560989911|FG002|Overall Study|Three Cycles completed before surgery|0|||
155427058|NCT02764541|560989912|FG003|Overall Study|Three Cycles completed before surgery|1|||
155427059|NCT02764541|560989913|FG004|Overall Study|Three Cycles completed before surgery|0|||
155427060|NCT02764541|560989914|FG005|Overall Study|Three Cycles completed before surgery|0|||
155427061|NCT02764541|560989915|FG006|Overall Study|Three Cycles completed before surgery|0|||
155427062|NCT02764541|560989916|FG007|Overall Study|Three Cycles completed before surgery|0|||
155427063|NCT02764541|560989909|FG000|Overall Study|Patient Compliance|0|||
155427064|NCT02764541|560989910|FG001|Overall Study|Patient Compliance|0|||
155427065|NCT02764541|560989911|FG002|Overall Study|Patient Compliance|1|||
155427066|NCT02764541|560989912|FG003|Overall Study|Patient Compliance|0|||
155427067|NCT02764541|560989913|FG004|Overall Study|Patient Compliance|0|||
155427068|NCT02764541|560989914|FG005|Overall Study|Patient Compliance|0|||
155427069|NCT02764541|560989915|FG006|Overall Study|Patient Compliance|0|||
155356409|NCT01316887|560740381|FG000|Overall Study|Protocol Violation|2|||
155356410|NCT01316887|560740382|FG001|Overall Study|Protocol Violation|6|||
155356411|NCT01316887|560740383|FG002|Overall Study|Protocol Violation|6|||
155356412|NCT01316887|560740381|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
155356413|NCT01316887|560740382|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
155356414|NCT01316887|560740383|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
155356415|NCT01316887|560740381|FG000|Overall Study|Study Closed/Terminated|2|||
155356416|NCT01316887|560740382|FG001|Overall Study|Study Closed/Terminated|4|||
155356417|NCT01316887|560740383|FG002|Overall Study|Study Closed/Terminated|3|||
155356418|NCT01316887|560740381|FG000|Overall Study|Lost to Follow-up|1|||
155356419|NCT01316887|560740382|FG001|Overall Study|Lost to Follow-up|7|||
155356420|NCT01316887|560740383|FG002|Overall Study|Lost to Follow-up|5|||
155356421|NCT01316887|560740381|FG000|Overall Study|Withdrawal by Subject|8|||
155427070|NCT02764541|560989916|FG007|Overall Study|Patient Compliance|0|||
155427071|NCT02764541|560989909|FG000|Overall Study|Death|0|||
155427072|NCT02764541|560989910|FG001|Overall Study|Death|0|||
155356422|NCT01316887|560740382|FG001|Overall Study|Withdrawal by Subject|16|||
155356423|NCT01316887|560740383|FG002|Overall Study|Withdrawal by Subject|15|||
155356424|NCT00469456|560740384|FG000|Overall Study|Adverse Event|4|||
155356425|NCT00469456|560740385|FG001|Overall Study|Adverse Event|3|||
155356426|NCT00469456|560740384|FG000|Overall Study|Protocol Violation|1|||
155356427|NCT00469456|560740385|FG001|Overall Study|Protocol Violation|0|||
155356428|NCT00469456|560740384|FG000|Overall Study|Withdrawal by Subject|4|||
155356429|NCT00469456|560740385|FG001|Overall Study|Withdrawal by Subject|1|||
155356430|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
155356431|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
155356432|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
155356433|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
155356434|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
155356435|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
155356436|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
155356437|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
155356438|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
155356439|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
155356440|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
155356441|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
155356442|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
155356443|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
155356444|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
155356445|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
155356446|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
155356447|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
155356448|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
155356449|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
155356450|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
155356451|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
155356452|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
155356453|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
155356454|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
155356455|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
155356456|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
155356457|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
155356458|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
155356459|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
155356460|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
155356461|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
155356462|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
155356463|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
155356464|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
155356465|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
155356466|NCT01129115|560740395|FG000|Overall Study|Adverse Event|1|||
155356467|NCT01129115|560740396|FG001|Overall Study|Adverse Event|2|||
155356468|NCT01129115|560740397|FG002|Overall Study|Adverse Event|3|||
155356469|NCT01129115|560740398|FG003|Overall Study|Adverse Event|3|||
155356470|NCT01129115|560740395|FG000|Overall Study|Withdrawal by Subject|1|||
155356471|NCT01129115|560740396|FG001|Overall Study|Withdrawal by Subject|3|||
155356472|NCT01129115|560740397|FG002|Overall Study|Withdrawal by Subject|1|||
155356473|NCT01129115|560740398|FG003|Overall Study|Withdrawal by Subject|4|||
155356474|NCT01129115|560740395|FG000|Overall Study|Protocol Violation|0|||
155356475|NCT01129115|560740396|FG001|Overall Study|Protocol Violation|2|||
155356476|NCT01129115|560740397|FG002|Overall Study|Protocol Violation|2|||
155356477|NCT01129115|560740398|FG003|Overall Study|Protocol Violation|2|||
155356478|NCT01747837|560740399|FG000|Overall Study|Lost to Follow-up|5|||
155356479|NCT01747837|560740400|FG001|Overall Study|Lost to Follow-up|2|||
155356480|NCT01747837|560740399|FG000|Overall Study|Death|4|||
155356481|NCT01747837|560740400|FG001|Overall Study|Death|4|||
155356482|NCT00935259|560740401|FG000|Period 1|Administrative (scheduling conflict)|1|||
155356483|NCT00935259|560740402|FG001|Period 1|Administrative (scheduling conflict)|1|||
155356484|NCT03856047|560740405|FG000|Overall Study|Withdrawal by Subject|0|||
155356485|NCT03856047|560740406|FG001|Overall Study|Withdrawal by Subject|1|||
155356486|NCT03856047|560740407|FG002|Overall Study|Withdrawal by Subject|1|||
155356487|NCT03856047|560740408|FG003|Overall Study|Withdrawal by Subject|0|||
155356488|NCT03856047|560740409|FG004|Overall Study|Withdrawal by Subject|3|||
155356489|NCT03856047|560740410|FG005|Overall Study|Withdrawal by Subject|0|||
155356490|NCT03856047|560740411|FG006|Overall Study|Withdrawal by Subject|2|||
155356491|NCT03856047|560740405|FG000|Overall Study|Lost to Follow-up|4|||
155356492|NCT03856047|560740406|FG001|Overall Study|Lost to Follow-up|2|||
155356493|NCT03856047|560740407|FG002|Overall Study|Lost to Follow-up|3|||
155356494|NCT03856047|560740408|FG003|Overall Study|Lost to Follow-up|1|||
155356495|NCT03856047|560740409|FG004|Overall Study|Lost to Follow-up|4|||
155356496|NCT03856047|560740410|FG005|Overall Study|Lost to Follow-up|4|||
155356497|NCT03856047|560740411|FG006|Overall Study|Lost to Follow-up|4|||
155356498|NCT03410108|560740412|FG000|Overall Study|Ongoing|41|||
155356499|NCT03410108|560740412|FG000|Overall Study|Adverse Event|4|||
155356500|NCT03410108|560740412|FG000|Overall Study|Progressive Disease|58|||
155356501|NCT03410108|560740412|FG000|Overall Study|Withdrawal by Subject|1|||
155356502|NCT01313624|560740417|FG000|Double-Blind Phase|Adverse Event|27|||
155356503|NCT01313624|560740418|FG001|Double-Blind Phase|Adverse Event|4|||
155356504|NCT01313624|560740417|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
155356505|NCT01313624|560740418|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
155356506|NCT01313624|560740417|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155356507|NCT01313624|560740418|FG001|Double-Blind Phase|Lost to Follow-up|2|||
155356508|NCT01313624|560740417|FG000|Double-Blind Phase|Physician Decision|1|||
155356509|NCT01313624|560740418|FG001|Double-Blind Phase|Physician Decision|0|||
155356510|NCT01313624|560740417|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155356511|NCT01313624|560740418|FG001|Double-Blind Phase|Lack of Efficacy|0|||
155356512|NCT01313624|560740417|FG000|Open-Label Phase|Adverse Event|1|||
155356513|NCT01313624|560740418|FG001|Open-Label Phase|Adverse Event|10|||
155356514|NCT01313624|560740417|FG000|Open-Label Phase|Withdrawal by Subject|2|||
155356515|NCT01313624|560740418|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155356516|NCT01313624|560740417|FG000|Open-Label Phase|Lost to Follow-up|1|||
155356517|NCT01313624|560740418|FG001|Open-Label Phase|Lost to Follow-up|1|||
155356518|NCT01017263|560740419|FG000|Overall Study|not eligible|12|||
155356519|NCT02980705|560740420|FG000|Overall Study|Adverse Event|0|||
155356520|NCT02980705|560740421|FG001|Overall Study|Adverse Event|1|||
155356521|NCT02980705|560740420|FG000|Overall Study|Withdrawal by Subject|6|||
155356522|NCT02980705|560740421|FG001|Overall Study|Withdrawal by Subject|9|||
155356523|NCT02980705|560740420|FG000|Overall Study|withdrew participation|0|||
155356524|NCT02980705|560740421|FG001|Overall Study|withdrew participation|1|||
155356525|NCT02980705|560740420|FG000|Overall Study|Lost to Follow-up|2|||
155356526|NCT02980705|560740421|FG001|Overall Study|Lost to Follow-up|0|||
155356527|NCT01721746|560740422|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
155356528|NCT01721746|560740423|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
155356529|NCT01721746|560740422|FG000|Pre-Treatment|Withdrawal by Subject|1|||
155356530|NCT01721746|560740423|FG001|Pre-Treatment|Withdrawal by Subject|16|||
155356531|NCT01721746|560740422|FG000|Pre-Treatment|Poor/Non-compliance|1|||
155356532|NCT01721746|560740423|FG001|Pre-Treatment|Poor/Non-compliance|0|||
155356533|NCT01721746|560740422|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
155356534|NCT01721746|560740423|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
155356535|NCT01721746|560740422|FG000|Treatment|Disease Progression|192|||
155356536|NCT01721746|560740423|FG001|Treatment|Disease Progression|74|||
155356537|NCT01721746|560740422|FG000|Treatment|Study Drug Toxicity|19|||
155356538|NCT01721746|560740423|FG001|Treatment|Study Drug Toxicity|11|||
155356539|NCT01721746|560740422|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
155356540|NCT01721746|560740423|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
155356541|NCT01721746|560740422|FG000|Treatment|Participant request to discontinue Study treatment|26|||
155356542|NCT01721746|560740423|FG001|Treatment|Participant request to discontinue Study treatment|7|||
155356543|NCT01721746|560740422|FG000|Treatment|Participant withdrew consent|4|||
155356544|NCT01721746|560740423|FG001|Treatment|Participant withdrew consent|2|||
155356545|NCT01721746|560740422|FG000|Treatment|Maximum Clinical Benefit|9|||
155427073|NCT02764541|560989911|FG002|Overall Study|Death|0|||
155427074|NCT02764541|560989912|FG003|Overall Study|Death|0|||
155427075|NCT02764541|560989913|FG004|Overall Study|Death|0|||
155427076|NCT02764541|560989914|FG005|Overall Study|Death|0|||
155427077|NCT02764541|560989915|FG006|Overall Study|Death|1|||
155356546|NCT01721746|560740423|FG001|Treatment|Maximum Clinical Benefit|3|||
155356547|NCT01721746|560740422|FG000|Treatment|Poor/Non-compliance|2|||
155356548|NCT01721746|560740423|FG001|Treatment|Poor/Non-compliance|0|||
155356549|NCT01721746|560740422|FG000|Treatment|Participant no longer met Study criteria|4|||
155356550|NCT01721746|560740423|FG001|Treatment|Participant no longer met Study criteria|0|||
155356551|NCT01721746|560740422|FG000|Treatment|Other reasons|6|||
155356552|NCT01721746|560740423|FG001|Treatment|Other reasons|2|||
155356553|NCT00263575|560740424|FG000|Titration Period|Adverse Event|14|||
155356554|NCT00263575|560740424|FG000|Titration Period|Withdrawal by Subject|10|||
155356555|NCT00263575|560740424|FG000|Titration Period|Protocol Violation|9|||
155356556|NCT00263575|560740424|FG000|Titration Period|Sponsor Decision|2|||
155427078|NCT02764541|560989916|FG007|Overall Study|Death|0|||
155427079|NCT02764541|560989909|FG000|Overall Study|Insurance reasons|0|||
155427080|NCT02764541|560989910|FG001|Overall Study|Insurance reasons|0|||
155427081|NCT02764541|560989911|FG002|Overall Study|Insurance reasons|0|||
155427082|NCT02764541|560989912|FG003|Overall Study|Insurance reasons|0|||
155427083|NCT02764541|560989913|FG004|Overall Study|Insurance reasons|0|||
155427084|NCT02764541|560989914|FG005|Overall Study|Insurance reasons|0|||
155427085|NCT02764541|560989915|FG006|Overall Study|Insurance reasons|1|||
155427086|NCT02764541|560989916|FG007|Overall Study|Insurance reasons|0|||
155427087|NCT02048904|560989919|FG000|Overall Study|Withdrawal by Subject|7|||
155427088|NCT02048904|560989919|FG000|Overall Study|Physician Decision|70|||
155356557|NCT00263575|560740424|FG000|Titration Period|Other|2|||
155427089|NCT00749190|560989920|FG000|Overall Study|Adverse Event|0|||
155427090|NCT00749190|560989921|FG001|Overall Study|Adverse Event|2|||
155427091|NCT00749190|560989922|FG002|Overall Study|Adverse Event|0|||
155427092|NCT00749190|560989923|FG003|Overall Study|Adverse Event|4|||
155427093|NCT00749190|560989924|FG004|Overall Study|Adverse Event|0|||
155427094|NCT00749190|560989925|FG005|Overall Study|Adverse Event|3|||
155427095|NCT00749190|560989926|FG006|Overall Study|Adverse Event|0|||
155427096|NCT00749190|560989920|FG000|Overall Study|Lack of Efficacy|3|||
155427097|NCT00749190|560989921|FG001|Overall Study|Lack of Efficacy|1|||
155427098|NCT00749190|560989922|FG002|Overall Study|Lack of Efficacy|1|||
155427099|NCT00749190|560989923|FG003|Overall Study|Lack of Efficacy|0|||
155427100|NCT00749190|560989924|FG004|Overall Study|Lack of Efficacy|0|||
155427101|NCT00749190|560989925|FG005|Overall Study|Lack of Efficacy|1|||
155427102|NCT00749190|560989926|FG006|Overall Study|Lack of Efficacy|0|||
155427103|NCT00749190|560989920|FG000|Overall Study|Withdrawal by Subject|2|||
155356558|NCT00263575|560740424|FG000|Titration Period|Lack of Efficacy|6|||
155356559|NCT00263575|560740424|FG000|Maintence Period|Adverse Event|23|||
155356560|NCT00263575|560740424|FG000|Maintence Period|Withdrawal by Subject|8|||
155356561|NCT00263575|560740424|FG000|Maintence Period|Protocol Violation|4|||
155356562|NCT00263575|560740424|FG000|Maintence Period|Lack of Efficacy|4|||
155356563|NCT00263575|560740424|FG000|Maintence Period|Physician Decision|6|||
155356564|NCT00263575|560740424|FG000|Maintence Period|Lost to Follow-up|1|||
155356565|NCT00263575|560740424|FG000|Maintence Period|Sponsor Decision|24|||
155356566|NCT00263575|560740424|FG000|Maintence Period|Other|7|||
155427104|NCT00749190|560989921|FG001|Overall Study|Withdrawal by Subject|1|||
155427105|NCT00749190|560989922|FG002|Overall Study|Withdrawal by Subject|0|||
155427106|NCT00749190|560989923|FG003|Overall Study|Withdrawal by Subject|0|||
155427107|NCT00749190|560989924|FG004|Overall Study|Withdrawal by Subject|0|||
155427108|NCT00749190|560989925|FG005|Overall Study|Withdrawal by Subject|1|||
155427109|NCT00749190|560989926|FG006|Overall Study|Withdrawal by Subject|0|||
155427110|NCT00749190|560989920|FG000|Overall Study|Protocol Violation|0|||
155427111|NCT00749190|560989921|FG001|Overall Study|Protocol Violation|1|||
155427112|NCT00749190|560989922|FG002|Overall Study|Protocol Violation|0|||
155427113|NCT00749190|560989923|FG003|Overall Study|Protocol Violation|0|||
155427114|NCT00749190|560989924|FG004|Overall Study|Protocol Violation|0|||
155427115|NCT00749190|560989925|FG005|Overall Study|Protocol Violation|0|||
155427116|NCT00749190|560989926|FG006|Overall Study|Protocol Violation|1|||
155427117|NCT00749190|560989920|FG000|Overall Study|Other reason not defined above|0|||
155427118|NCT00749190|560989921|FG001|Overall Study|Other reason not defined above|0|||
155427119|NCT00749190|560989922|FG002|Overall Study|Other reason not defined above|0|||
155427120|NCT00749190|560989923|FG003|Overall Study|Other reason not defined above|1|||
155427121|NCT00749190|560989924|FG004|Overall Study|Other reason not defined above|0|||
155427122|NCT00749190|560989925|FG005|Overall Study|Other reason not defined above|0|||
155427123|NCT00749190|560989926|FG006|Overall Study|Other reason not defined above|0|||
155427124|NCT02330419|560989930|FG000|Overall Study|Lost to Follow-up|3|||
155427125|NCT02330419|560989931|FG001|Overall Study|Lost to Follow-up|7|||
155427126|NCT04370509|560989932|FG000|Overall Study|Adverse Event|1|||
155427127|NCT04370509|560989933|FG001|Overall Study|Adverse Event|0|||
155427128|NCT04370509|560989932|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
155427129|NCT04370509|560989933|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
155427130|NCT04743856|560989934|FG000|Overall Study|Lost to Follow-up|6|||
155427131|NCT04743856|560989935|FG001|Overall Study|Lost to Follow-up|7|||
155427132|NCT04743856|560989934|FG000|Overall Study|Withdrawal by Subject|1|||
155427133|NCT04743856|560989935|FG001|Overall Study|Withdrawal by Subject|0|||
155356567|NCT02447718|560740427|FG000|Overall Study|Lost to Follow-up|8|||
155356568|NCT02447718|560740428|FG001|Overall Study|Lost to Follow-up|0|||
155356569|NCT02447718|560740427|FG000|Overall Study|Withdrawal by Subject|3|||
155427134|NCT04696861|560989936|FG000|Overall Study|Death|1|||
155427135|NCT04696861|560989937|FG001|Overall Study|Death|0|||
155427136|NCT04696861|560989936|FG000|Overall Study|Lost to Follow-up|3|||
155356570|NCT02447718|560740428|FG001|Overall Study|Withdrawal by Subject|0|||
155427137|NCT04696861|560989937|FG001|Overall Study|Lost to Follow-up|0|||
155427138|NCT04439188|560989938|FG000|Overall Study|Ineligible|3|||
155427139|NCT04439188|560989938|FG000|Overall Study|Adverse Event|4|||
155427140|NCT04439188|560989938|FG000|Overall Study|Death|1|||
155427141|NCT04439188|560989938|FG000|Overall Study|Disease Progression|25|||
155356571|NCT02447718|560740427|FG000|Overall Study|Screen Failure|1|||
155356572|NCT02447718|560740428|FG001|Overall Study|Screen Failure|0|||
155356573|NCT00239681|560740429|FG000|Overall Study|Adverse Event|100|||
155356574|NCT00239681|560740430|FG001|Overall Study|Adverse Event|99|||
155356575|NCT00239681|560740429|FG000|Overall Study|Withdrawal by Subject|458|||
155356576|NCT00239681|560740430|FG001|Overall Study|Withdrawal by Subject|489|||
155356577|NCT00239681|560740429|FG000|Overall Study|Lost to Follow-up|28|||
155356578|NCT00239681|560740430|FG001|Overall Study|Lost to Follow-up|22|||
155356579|NCT00239681|560740429|FG000|Overall Study|Protocol Violation|4|||
155356580|NCT00239681|560740430|FG001|Overall Study|Protocol Violation|4|||
155356581|NCT00239681|560740429|FG000|Overall Study|Physician Decision|13|||
155356582|NCT00239681|560740430|FG001|Overall Study|Physician Decision|17|||
155356583|NCT00239681|560740429|FG000|Overall Study|No information chacked on CaseReportForm|90|||
155356584|NCT00239681|560740430|FG001|Overall Study|No information chacked on CaseReportForm|84|||
155356585|NCT02654132|560740433|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
155356586|NCT02654132|560740434|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
155356587|NCT02654132|560740433|FG000|Treatment Period|Disease progression|43|||
155356588|NCT02654132|560740434|FG001|Treatment Period|Disease progression|38|||
155356589|NCT02654132|560740433|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
155356590|NCT02654132|560740434|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
155356591|NCT02654132|560740433|FG000|Treatment Period|Other reasons|4|||
155356592|NCT02654132|560740434|FG001|Treatment Period|Other reasons|2|||
155356593|NCT02654132|560740433|FG000|Treatment Period|Study drug toxicity|2|||
155356594|NCT02654132|560740434|FG001|Treatment Period|Study drug toxicity|2|||
155356595|NCT02654132|560740433|FG000|Treatment Period|Withdrawal by Subject|2|||
155356596|NCT02654132|560740434|FG001|Treatment Period|Withdrawal by Subject|1|||
155356597|NCT02654132|560740433|FG000|Treatment Period|Maximum Clinical Benefit|0|||
155356598|NCT02654132|560740434|FG001|Treatment Period|Maximum Clinical Benefit|2|||
155356599|NCT02654132|560740433|FG000|Treatment Period|Participant request to discontinue|2|||
155356600|NCT02654132|560740434|FG001|Treatment Period|Participant request to discontinue|0|||
155356601|NCT02654132|560740433|FG000|Treatment Period|Administrative reasons by sponsor|0|||
155356602|NCT02654132|560740434|FG001|Treatment Period|Administrative reasons by sponsor|1|||
155356603|NCT02654132|560740433|FG000|Treatment Period|Death|1|||
155356604|NCT02654132|560740434|FG001|Treatment Period|Death|0|||
155356605|NCT01781832|560740438|FG000|Overall Study|Withdrawal by Subject|1|||
155356606|NCT03772613|560740440|FG000|Overall Study|Lost to Follow-up|0|||
155356607|NCT03772613|560740441|FG001|Overall Study|Lost to Follow-up|1|||
155356608|NCT03772613|560740442|FG002|Overall Study|Lost to Follow-up|1|||
155356609|NCT01185171|560740445|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
155356610|NCT01185171|560740445|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
155356611|NCT01185171|560740445|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
155356612|NCT01185171|560740445|FG000|Maintenance|Elevated liver transaminases|3|||
155356613|NCT01185171|560740445|FG000|Maintenance|Rush|2|||
155356614|NCT01185171|560740445|FG000|Maintenance|Diarrhea|1|||
155356615|NCT01185171|560740445|FG000|Maintenance|Xerostomia|1|||
155356616|NCT01185171|560740445|FG000|Maintenance|Nausea|1|||
155356617|NCT01185171|560740445|FG000|Maintenance|Comorbid Illness|2|||
155356618|NCT01185171|560740445|FG000|Maintenance|Withdrawal by Subject|1|||
155356619|NCT01185171|560740445|FG000|Maintenance|Disease Recurrence|1|||
155356620|NCT01482429|560740446|FG000|Care Usual|Protocol Violation|0|||
155356621|NCT01482429|560740447|FG001|Care Usual|Protocol Violation|172|||
155356622|NCT01482429|560740446|FG000|Care Usual|Lost to Follow-up|0|||
155356623|NCT01482429|560740447|FG001|Care Usual|Lost to Follow-up|1|||
155356624|NCT01482429|560740446|FG000|Protocol|Protocol Violation|275|||
155356625|NCT01482429|560740447|FG001|Protocol|Protocol Violation|0|||
155356626|NCT03561597|560740451|FG000|Overall Study|Lost to Follow-up|20|||
155356627|NCT00573651|560740452|FG000|Overall Study|Lost to Follow-up|3|||
155356628|NCT00573651|560740452|FG000|Overall Study|Withdrawal by Subject|1|||
155356629|NCT03797989|560740480|FG000|VAC069A|Withdrawal by Subject|0|||
155356630|NCT03797989|560740481|FG001|VAC069A|Withdrawal by Subject|0|||
155356631|NCT03797989|560740482|FG002|VAC069A|Withdrawal by Subject|1|||
155356632|NCT03797989|560740483|FG003|VAC069A|Withdrawal by Subject|0|||
155356633|NCT03797989|560740484|FG004|VAC069A|Withdrawal by Subject|0|||
155356634|NCT03797989|560740485|FG005|VAC069A|Withdrawal by Subject|0|||
155356635|NCT03797989|560740486|FG006|VAC069A|Withdrawal by Subject|0|||
155356636|NCT03797989|560740487|FG007|VAC069A|Withdrawal by Subject|0|||
155356637|NCT03797989|560740488|FG008|VAC069A|Withdrawal by Subject|0|||
155356638|NCT03797989|560740489|FG009|VAC069A|Withdrawal by Subject|0|||
155356639|NCT03797989|560740490|FG010|VAC069A|Withdrawal by Subject|0|||
155356640|NCT03797989|560740491|FG011|VAC069A|Withdrawal by Subject|0|||
155356641|NCT04052997|560740492|FG000|Overall Study|Withdrawal by Subject|17|||
155356642|NCT04052997|560740492|FG000|Overall Study|Physician Decision|50|||
155356643|NCT04052997|560740492|FG000|Overall Study|Death|43|||
155356644|NCT04052997|560740492|FG000|Overall Study|Lost to Follow-up|5|||
155356645|NCT04052997|560740492|FG000|Overall Study|Progression of Disease|1|||
155356646|NCT04594733|560740493|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155356647|NCT04594733|560740494|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155356648|NCT04594733|560740493|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
155356649|NCT04594733|560740494|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
155356650|NCT04594733|560740493|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
155356651|NCT04594733|560740494|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155356652|NCT01024036|560740499|FG000|Blinded Treatment|Adverse Event|1|||
155356653|NCT01024036|560740500|FG001|Blinded Treatment|Adverse Event|1|||
155356654|NCT01024036|560740499|FG000|Blinded Treatment|Lack of Efficacy|16|||
155356655|NCT01024036|560740500|FG001|Blinded Treatment|Lack of Efficacy|14|||
155356656|NCT01024036|560740499|FG000|Blinded Treatment|Physician Decision|1|||
155356657|NCT01024036|560740500|FG001|Blinded Treatment|Physician Decision|0|||
155356658|NCT01024036|560740499|FG000|Blinded Treatment|Death|0|||
155356659|NCT01024036|560740500|FG001|Blinded Treatment|Death|2|||
155356660|NCT01024036|560740499|FG000|Blinded Treatment|Withdrawal by Subject|4|||
155356661|NCT01024036|560740500|FG001|Blinded Treatment|Withdrawal by Subject|3|||
155356662|NCT01024036|560740499|FG000|Unblinded Treatment|Adverse Event|0|||
155356663|NCT01024036|560740500|FG001|Unblinded Treatment|Adverse Event|1|||
155356664|NCT01024036|560740499|FG000|Unblinded Treatment|Lack of Efficacy|0|||
155356665|NCT01024036|560740500|FG001|Unblinded Treatment|Lack of Efficacy|2|||
155356666|NCT01024036|560740499|FG000|Follow-Up Period|Lost to Follow-up|1|||
155356667|NCT01024036|560740500|FG001|Follow-Up Period|Lost to Follow-up|1|||
155356668|NCT01024036|560740499|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155356669|NCT01024036|560740500|FG001|Follow-Up Period|Withdrawal by Subject|1|||
155356670|NCT01024036|560740499|FG000|Follow-Up Period|Adverse Event|4|||
155356671|NCT01024036|560740500|FG001|Follow-Up Period|Adverse Event|1|||
155356672|NCT01251887|560740505|FG000|Overall Study|Scheduling conflict|1|||
155356673|NCT01251887|560740506|FG001|Overall Study|Scheduling conflict|2|||
155356674|NCT01251887|560740507|FG002|Overall Study|Scheduling conflict|2|||
155356675|NCT01251887|560740505|FG000|Overall Study|Physician Decision|0|||
155356676|NCT01251887|560740506|FG001|Overall Study|Physician Decision|1|||
155356677|NCT01251887|560740507|FG002|Overall Study|Physician Decision|0|||
155356678|NCT04811339|560740508|FG000|Overall Study|lack of transportation not wanting to return|4|||
155356679|NCT04811339|560740509|FG001|Overall Study|lack of transportation not wanting to return|8|||
155356680|NCT04811339|560740510|FG002|Overall Study|lack of transportation not wanting to return|0|||
155356681|NCT04811339|560740508|FG000|Overall Study|Adverse Event|3|||
155356682|NCT04811339|560740509|FG001|Overall Study|Adverse Event|0|||
155356683|NCT04811339|560740510|FG002|Overall Study|Adverse Event|0|||
155356684|NCT04811339|560740508|FG000|Overall Study|Lost to Follow-up|1|||
155356685|NCT04811339|560740509|FG001|Overall Study|Lost to Follow-up|0|||
155356686|NCT04811339|560740510|FG002|Overall Study|Lost to Follow-up|0|||
155356687|NCT04811339|560740508|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
155356688|NCT04811339|560740509|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
155356689|NCT04811339|560740510|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
155356690|NCT04811339|560740508|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
155356691|NCT04811339|560740509|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
155356692|NCT04811339|560740510|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
155356693|NCT04811339|560740508|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
155356694|NCT04811339|560740509|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
155356695|NCT04811339|560740510|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
155356696|NCT04811339|560740508|FG000|Overall Study|Withdrawal by Subject|0|||
155356697|NCT04811339|560740509|FG001|Overall Study|Withdrawal by Subject|3|||
155356698|NCT04811339|560740510|FG002|Overall Study|Withdrawal by Subject|0|||
155356699|NCT04811339|560740508|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
155356700|NCT04811339|560740509|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
155356701|NCT04811339|560740510|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
155356702|NCT04811339|560740508|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
155356703|NCT04811339|560740509|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
155356704|NCT04811339|560740510|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
155356705|NCT05896696|560740511|FG000|Overall Study|Screening Failure|7|||
155356706|NCT05896696|560740511|FG000|Overall Study|Withdrawal by Subject|2|||
155356707|NCT01131104|560742353|FG000|Overall Study|Withdrawal by Subject|3|||
155356708|NCT01131104|560742353|FG000|Overall Study|Physician Decision|4|||
155356709|NCT01131104|560742353|FG000|Overall Study|Information Not Available|5|||
155356710|NCT01131104|560742353|FG000|Overall Study|No Information on Index Date of Onset|1|||
155356711|NCT04523207|560742354|FG000|Overall Study|Adverse Event|5|||
155356712|NCT04523207|560742355|FG001|Overall Study|Adverse Event|1|||
155506996|NCT00738673|561283493|FG001|Overall Study|Adverse Event|0|||
155356713|NCT04523207|560742354|FG000|Overall Study|Lost to Follow-up|2|||
155356714|NCT04523207|560742355|FG001|Overall Study|Lost to Follow-up|0|||
155356715|NCT04523207|560742354|FG000|Overall Study|Withdrawal by Subject|2|||
155356716|NCT04523207|560742355|FG001|Overall Study|Withdrawal by Subject|0|||
155356717|NCT04523207|560742354|FG000|Overall Study|Progressive Disease|2|||
155356718|NCT04523207|560742355|FG001|Overall Study|Progressive Disease|1|||
155356719|NCT04523207|560742354|FG000|Overall Study|Other|7|||
155356720|NCT04523207|560742355|FG001|Overall Study|Other|1|||
155356721|NCT02641587|560742356|FG000|Confinement Period|Adverse Event|1|||
155356722|NCT02641587|560742357|FG001|Confinement Period|Adverse Event|0|||
155356723|NCT02641587|560742356|FG000|Confinement Period|Withdrawal by Subject|2|||
155356724|NCT02641587|560742357|FG001|Confinement Period|Withdrawal by Subject|1|||
155356725|NCT02641587|560742356|FG000|Ambulatory Period|Withdrawal by Subject|1|||
155356726|NCT02641587|560742357|FG001|Ambulatory Period|Withdrawal by Subject|0|||
155356727|NCT01663506|560742359|FG000|Overall Study|Lack of Efficacy|3|||
155356728|NCT01663506|560742359|FG000|Overall Study|Consent Withdrawal by Subject|1|||
155356729|NCT01663506|560742359|FG000|Overall Study|Lost to Follow-up|1|||
155356730|NCT01663506|560742359|FG000|Overall Study|Adverse Event|1|||
155356731|NCT01663506|560742359|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
155356732|NCT02094898|560742365|FG000|Overall Study|Clinical Worsening|2|||
155356733|NCT02094898|560742365|FG000|Overall Study|Adverse Event|2|||
155356734|NCT02094898|560742365|FG000|Overall Study|Lack of Efficacy|1|||
155356735|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Death|2|||
155356736|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Death|2|||
155356737|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Death|3|||
155356738|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Death|2|||
155356739|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Death|6|||
155356740|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Death|5|||
155356741|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Death|3|||
155356742|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Death|2|||
155356743|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Death|3|||
155356744|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Death|1|||
155356745|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Death|5|||
155356746|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Death|7|||
155356747|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Death|11|||
155356748|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Death|0|||
155356749|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Death|0|||
155356750|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Death|0|||
155356751|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Death|0|||
155356752|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Death|0|||
155356753|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Death|0|||
155356754|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356755|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356756|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356757|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
155356758|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
155356759|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
155356760|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356761|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356762|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356763|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356764|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356765|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356766|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
155356767|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356768|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356769|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356770|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356771|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356772|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356773|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356774|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356775|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356776|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356777|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356778|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356779|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155427142|NCT04439188|560989938|FG000|Overall Study|Withdrawal by Subject|2|||
155427143|NCT01813890|560989939|FG000|Overall Study|Adverse Event|0|||
155427144|NCT01813890|560989940|FG001|Overall Study|Adverse Event|3|||
155427145|NCT01813890|560989941|FG002|Overall Study|Adverse Event|4|||
155356780|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356781|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356782|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356783|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155427146|NCT01813890|560989939|FG000|Overall Study|Lack of Efficacy|9|||
155356784|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356785|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356786|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356787|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356788|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356789|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356790|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356791|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155506997|NCT00738673|561283492|FG000|Overall Study|Lack of Efficacy|19|||
155506998|NCT00738673|561283493|FG001|Overall Study|Lack of Efficacy|8|||
155506999|NCT00738673|561283492|FG000|Overall Study|Protocol Violation|1|||
155507000|NCT00738673|561283493|FG001|Overall Study|Protocol Violation|2|||
155507001|NCT00738673|561283492|FG000|Overall Study|Withdrawal by Subject|3|||
155507002|NCT00738673|561283493|FG001|Overall Study|Withdrawal by Subject|1|||
155507003|NCT02622074|561283495|FG000|Overall Study|Death|4|||
155507004|NCT02622074|561283496|FG001|Overall Study|Death|0|||
155507005|NCT02622074|561283497|FG002|Overall Study|Death|0|||
155507006|NCT02622074|561283498|FG003|Overall Study|Death|1|||
155507007|NCT02622074|561283499|FG004|Overall Study|Death|1|||
155507008|NCT02622074|561283500|FG005|Overall Study|Death|0|||
155507009|NCT02622074|561283495|FG000|Overall Study|Withdrawal by Subject|0|||
155507010|NCT02622074|561283496|FG001|Overall Study|Withdrawal by Subject|1|||
155507011|NCT02622074|561283497|FG002|Overall Study|Withdrawal by Subject|0|||
155507012|NCT02622074|561283498|FG003|Overall Study|Withdrawal by Subject|0|||
155507013|NCT02622074|561283499|FG004|Overall Study|Withdrawal by Subject|0|||
155648679|NCT02675452|561805885|FG004|Overall Study|Withdrawal by Subject|0|||
155356792|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356793|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356794|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356795|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356796|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356797|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356798|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356799|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356800|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356801|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
155356802|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356803|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356804|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
155356805|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356806|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356807|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356808|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356809|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356810|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356811|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Death|0|||
155356812|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Death|0|||
155356813|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Death|0|||
155356814|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Death|0|||
155356815|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Death|0|||
155356816|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Death|0|||
155356817|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Death|0|||
155356818|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Death|0|||
155356819|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Death|0|||
155356820|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Death|0|||
155356821|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Death|0|||
155356822|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Death|0|||
155356823|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Death|0|||
155356824|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Death|20|||
155356825|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Death|13|||
155356826|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Death|9|||
155356827|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Death|5|||
155356828|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Death|14|||
155356829|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Death|12|||
155356830|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356831|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356832|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356833|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356834|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356835|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155507014|NCT02622074|561283500|FG005|Overall Study|Withdrawal by Subject|0|||
155356836|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356837|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356838|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356839|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356840|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356841|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356842|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356843|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356844|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
155356845|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
155356846|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
155356847|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
155356848|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
155356849|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356850|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356851|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356852|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356853|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356854|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356855|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356856|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356857|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356858|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356859|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356860|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356861|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356862|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356863|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356864|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356865|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356866|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356867|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356868|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356869|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356870|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356871|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356872|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356873|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356874|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356875|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356876|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356877|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356878|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356879|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356880|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356881|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
155356882|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356883|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356884|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
155356885|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
155356886|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356887|NCT00328562|560742387|FG000|Overall Study|Disease progression|1|||
155356888|NCT03305809|560742388|FG000|Overall Study|Adverse Event|2|||
155356889|NCT03305809|560742389|FG001|Overall Study|Adverse Event|2|||
155356890|NCT03305809|560742390|FG002|Overall Study|Adverse Event|6|||
155356891|NCT03305809|560742391|FG003|Overall Study|Adverse Event|6|||
155356892|NCT03305809|560742388|FG000|Overall Study|Death|0|||
155356893|NCT03305809|560742389|FG001|Overall Study|Death|0|||
155356894|NCT03305809|560742390|FG002|Overall Study|Death|1|||
155356895|NCT03305809|560742391|FG003|Overall Study|Death|1|||
155427147|NCT01813890|560989940|FG001|Overall Study|Lack of Efficacy|1|||
155356896|NCT03305809|560742388|FG000|Overall Study|Lost to Follow-up|1|||
155356897|NCT03305809|560742389|FG001|Overall Study|Lost to Follow-up|2|||
155356898|NCT03305809|560742390|FG002|Overall Study|Lost to Follow-up|0|||
155356899|NCT03305809|560742391|FG003|Overall Study|Lost to Follow-up|0|||
155356900|NCT03305809|560742388|FG000|Overall Study|Sponsor Decision|1|||
155356901|NCT03305809|560742389|FG001|Overall Study|Sponsor Decision|0|||
155356902|NCT03305809|560742390|FG002|Overall Study|Sponsor Decision|1|||
155356903|NCT03305809|560742391|FG003|Overall Study|Sponsor Decision|8|||
155427148|NCT01813890|560989941|FG002|Overall Study|Lack of Efficacy|2|||
155356904|NCT03305809|560742388|FG000|Overall Study|Physician Decision|0|||
155356905|NCT03305809|560742389|FG001|Overall Study|Physician Decision|0|||
155356906|NCT03305809|560742390|FG002|Overall Study|Physician Decision|2|||
155356907|NCT03305809|560742391|FG003|Overall Study|Physician Decision|4|||
155356908|NCT03305809|560742388|FG000|Overall Study|Progressive Disease|0|||
155356909|NCT03305809|560742389|FG001|Overall Study|Progressive Disease|0|||
155356910|NCT03305809|560742390|FG002|Overall Study|Progressive Disease|1|||
155356911|NCT03305809|560742391|FG003|Overall Study|Progressive Disease|0|||
155356912|NCT03305809|560742388|FG000|Overall Study|Protocol Violation|1|||
155356913|NCT03305809|560742389|FG001|Overall Study|Protocol Violation|0|||
155356914|NCT03305809|560742390|FG002|Overall Study|Protocol Violation|2|||
155356915|NCT03305809|560742391|FG003|Overall Study|Protocol Violation|3|||
155356916|NCT03305809|560742388|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155356917|NCT03305809|560742389|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155356918|NCT03305809|560742390|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155507015|NCT01205529|561283506|FG000|Overall Study|Procedure Cancelled|4|||
155356919|NCT03305809|560742391|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
155356920|NCT03305809|560742388|FG000|Overall Study|Withdrawal by Subject|2|||
155356921|NCT03305809|560742389|FG001|Overall Study|Withdrawal by Subject|4|||
155356922|NCT03305809|560742390|FG002|Overall Study|Withdrawal by Subject|5|||
155356923|NCT03305809|560742391|FG003|Overall Study|Withdrawal by Subject|2|||
155356924|NCT03305809|560742388|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
155356925|NCT03305809|560742389|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
155356926|NCT03305809|560742390|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
155356927|NCT03305809|560742391|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
155356928|NCT00816556|560742392|FG000|Overall Study|Adverse Event|1|||
155356929|NCT00816556|560742393|FG001|Overall Study|Adverse Event|1|||
155356930|NCT00816556|560742394|FG002|Overall Study|Adverse Event|1|||
155356931|NCT00816556|560742392|FG000|Overall Study|Withdrawal by Subject|1|||
155356932|NCT00816556|560742393|FG001|Overall Study|Withdrawal by Subject|1|||
155356933|NCT00816556|560742394|FG002|Overall Study|Withdrawal by Subject|1|||
155356934|NCT00816556|560742392|FG000|Overall Study|Lost to Follow-up|0|||
155356935|NCT00816556|560742393|FG001|Overall Study|Lost to Follow-up|0|||
155356936|NCT00816556|560742394|FG002|Overall Study|Lost to Follow-up|1|||
155356937|NCT04014790|560742397|FG000|Overall Study|Death|4|||
155356938|NCT04014790|560742397|FG000|Overall Study|Adverse Event|1|||
155356939|NCT04014790|560742397|FG000|Overall Study|Withdrawal by Subject|1|||
155356940|NCT03546816|560742398|FG000|Overall Study|Adverse Event|5|||
155356941|NCT03546816|560742399|FG001|Overall Study|Adverse Event|3|||
155356942|NCT03546816|560742398|FG000|Overall Study|Lack of Efficacy|2|||
155356943|NCT03546816|560742399|FG001|Overall Study|Lack of Efficacy|4|||
155356944|NCT03546816|560742398|FG000|Overall Study|Pregnancy|1|||
155356945|NCT03546816|560742399|FG001|Overall Study|Pregnancy|0|||
155507016|NCT01205529|561283506|FG000|Overall Study|Withdrawal by Subject|2|||
155507017|NCT01205529|561283506|FG000|Overall Study|Physician Decision|4|||
155507018|NCT01205529|561283506|FG000|Overall Study|Unstable post op|15|||
155507019|NCT01205529|561283506|FG000|Overall Study|No longer met criteria|30|||
155507020|NCT00667719|561283507|FG000|Overall Study|Adverse Event|39|||
155507021|NCT00667719|561283507|FG000|Overall Study|Abnormal Test Procedure|1|||
155507022|NCT00667719|561283507|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155507023|NCT00667719|561283507|FG000|Overall Study|Protocol Violation|3|||
155507024|NCT00667719|561283507|FG000|Overall Study|Withdrawal by Subject|17|||
155507025|NCT00667719|561283507|FG000|Overall Study|Lost to Follow-up|8|||
155507026|NCT03063632|561283510|FG000|Overall Study|Death|4|||
155507027|NCT03063632|561283511|FG001|Overall Study|Death|6|||
155507028|NCT03063632|561283510|FG000|Overall Study|Lost to Follow-up|0|||
155507029|NCT03063632|561283511|FG001|Overall Study|Lost to Follow-up|1|||
155507030|NCT03063632|561283510|FG000|Overall Study|Withdrawal by Subject|0|||
155356946|NCT03546816|560742398|FG000|Overall Study|Physician Decision|2|||
155356947|NCT03546816|560742399|FG001|Overall Study|Physician Decision|0|||
155356948|NCT03546816|560742398|FG000|Overall Study|Withdrawal by Subject|8|||
155356949|NCT03546816|560742399|FG001|Overall Study|Withdrawal by Subject|10|||
155507031|NCT03063632|561283511|FG001|Overall Study|Withdrawal by Subject|2|||
155507032|NCT03063632|561283510|FG000|Overall Study|Physician Decision|2|||
155507033|NCT03063632|561283511|FG001|Overall Study|Physician Decision|0|||
155507034|NCT03063632|561283510|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
155648680|NCT02675452|561805886|FG005|Overall Study|Withdrawal by Subject|0|||
155648681|NCT02675452|561805887|FG006|Overall Study|Withdrawal by Subject|0|||
155356950|NCT03546816|560742398|FG000|Overall Study|Lost to Follow-up|3|||
155356951|NCT03546816|560742399|FG001|Overall Study|Lost to Follow-up|2|||
155356952|NCT00810342|560742400|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
155356953|NCT00810342|560742401|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
155356954|NCT00810342|560742400|FG000|Month 1 Follow-up|Pregnancy|1|||
155356955|NCT00810342|560742401|FG001|Month 1 Follow-up|Pregnancy|0|||
155356956|NCT00810342|560742400|FG000|6-month Follow-up|Lost to Follow-up|18|||
155356957|NCT00810342|560742401|FG001|6-month Follow-up|Lost to Follow-up|6|||
155356958|NCT00810342|560742400|FG000|6-month Follow-up|Pregnancy|6|||
155507035|NCT03063632|561283511|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
155356959|NCT00810342|560742401|FG001|6-month Follow-up|Pregnancy|2|||
155356960|NCT00810342|560742400|FG000|12-month Followup|Pregnancy|9|||
155356961|NCT00810342|560742401|FG001|12-month Followup|Pregnancy|10|||
155356962|NCT00810342|560742400|FG000|12-month Followup|Lost to Follow-up|3|||
155356963|NCT00810342|560742401|FG001|12-month Followup|Lost to Follow-up|1|||
155356964|NCT03065933|560742403|FG000|Overall Study|study terminated|5|||
155356965|NCT04504630|560742404|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
155356966|NCT04504630|560742405|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
155356967|NCT04504630|560742404|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
155356968|NCT04504630|560742405|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
155356969|NCT01010204|560742406|FG000|Overall Study|Lost to Follow-up|2|||
155356970|NCT01010204|560742407|FG001|Overall Study|Lost to Follow-up|2|||
155356971|NCT01010204|560742406|FG000|Overall Study|Adverse Event|1|||
155356972|NCT01010204|560742407|FG001|Overall Study|Adverse Event|3|||
155356973|NCT01010204|560742406|FG000|Overall Study|Withdrawal by Subject|2|||
155356974|NCT01010204|560742407|FG001|Overall Study|Withdrawal by Subject|3|||
155356975|NCT01010204|560742406|FG000|Overall Study|psychiatric hospitalization|2|||
155356976|NCT01010204|560742407|FG001|Overall Study|psychiatric hospitalization|1|||
155356977|NCT01513330|560742408|FG000|SenSura Mio First,|Adverse Event|2|||
155356978|NCT01513330|560742409|FG001|SenSura Mio First,|Adverse Event|0|||
155356979|NCT01513330|560742408|FG000|SenSura Mio First,|Lack of Efficacy|0|||
155356980|NCT01513330|560742409|FG001|SenSura Mio First,|Lack of Efficacy|1|||
155356981|NCT01513330|560742408|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
155356982|NCT01513330|560742409|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
155356983|NCT01513330|560742408|FG000|SenSura Mio First,|Other|1|||
155356984|NCT01513330|560742409|FG001|SenSura Mio First,|Other|0|||
155356985|NCT01513330|560742408|FG000|Standard Care First,|Lack of Efficacy|2|||
155356986|NCT01513330|560742409|FG001|Standard Care First,|Lack of Efficacy|2|||
155356987|NCT01513330|560742408|FG000|Standard Care First,|Withdrawal by Subject|1|||
155356988|NCT01513330|560742409|FG001|Standard Care First,|Withdrawal by Subject|2|||
155356989|NCT01513330|560742408|FG000|Standard Care First,|Other|1|||
155356990|NCT01513330|560742409|FG001|Standard Care First,|Other|0|||
155356991|NCT01519778|560742410|FG000|Overall Study|Withdrawal by Subject|3|||
155356992|NCT01519778|560742410|FG000|Overall Study|Lost to Follow-up|10|||
155356993|NCT01519778|560742410|FG000|Overall Study|Physician Decision|1|||
155356994|NCT02270671|560742411|FG000|Overall Study|Withdrawal by Subject|1|||
155356995|NCT02270671|560742412|FG001|Overall Study|Withdrawal by Subject|1|||
155356996|NCT02270671|560742411|FG000|Overall Study|Protocol Violation|0|||
155356997|NCT02270671|560742412|FG001|Overall Study|Protocol Violation|1|||
155356998|NCT02270671|560742411|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
155356999|NCT02270671|560742412|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
155357000|NCT02270671|560742411|FG000|Overall Study|Lost to Follow-up|2|||
155357001|NCT02270671|560742412|FG001|Overall Study|Lost to Follow-up|1|||
155357002|NCT02330562|560742420|FG000|Overall Study|Adverse Event|0|||
155357003|NCT02330562|560742421|FG001|Overall Study|Adverse Event|0|||
155357004|NCT02330562|560742422|FG002|Overall Study|Adverse Event|3|||
155357005|NCT02330562|560742423|FG003|Overall Study|Adverse Event|0|||
155357006|NCT02330562|560742424|FG004|Overall Study|Adverse Event|3|||
155357007|NCT02330562|560742425|FG005|Overall Study|Adverse Event|1|||
155357008|NCT02330562|560742426|FG006|Overall Study|Adverse Event|0|||
155357009|NCT02330562|560742427|FG007|Overall Study|Adverse Event|0|||
155357010|NCT02330562|560742428|FG008|Overall Study|Adverse Event|0|||
155357011|NCT02330562|560742429|FG009|Overall Study|Adverse Event|1|||
155357012|NCT02330562|560742430|FG010|Overall Study|Adverse Event|1|||
155357013|NCT02330562|560742420|FG000|Overall Study|Participant decision|1|||
155357014|NCT02330562|560742421|FG001|Overall Study|Participant decision|0|||
155357015|NCT02330562|560742422|FG002|Overall Study|Participant decision|4|||
155357016|NCT02330562|560742423|FG003|Overall Study|Participant decision|1|||
155357017|NCT02330562|560742424|FG004|Overall Study|Participant decision|5|||
155427149|NCT04482647|560989942|FG000|Overall Study|Time constraints|2|||
155357018|NCT02330562|560742425|FG005|Overall Study|Participant decision|2|||
155357019|NCT02330562|560742426|FG006|Overall Study|Participant decision|0|||
155357020|NCT02330562|560742427|FG007|Overall Study|Participant decision|0|||
155357021|NCT02330562|560742428|FG008|Overall Study|Participant decision|0|||
155357022|NCT02330562|560742429|FG009|Overall Study|Participant decision|3|||
155357023|NCT02330562|560742430|FG010|Overall Study|Participant decision|0|||
155357024|NCT02330562|560742420|FG000|Overall Study|Disease progression|5|||
155357025|NCT02330562|560742421|FG001|Overall Study|Disease progression|3|||
155357026|NCT02330562|560742422|FG002|Overall Study|Disease progression|20|||
155357027|NCT02330562|560742423|FG003|Overall Study|Disease progression|28|||
155357028|NCT02330562|560742424|FG004|Overall Study|Disease progression|23|||
155357029|NCT02330562|560742425|FG005|Overall Study|Disease progression|7|||
155357030|NCT02330562|560742426|FG006|Overall Study|Disease progression|1|||
155357031|NCT02330562|560742427|FG007|Overall Study|Disease progression|1|||
155357032|NCT02330562|560742428|FG008|Overall Study|Disease progression|1|||
155357033|NCT02330562|560742429|FG009|Overall Study|Disease progression|0|||
155357034|NCT02330562|560742430|FG010|Overall Study|Disease progression|5|||
155357035|NCT02330562|560742420|FG000|Overall Study|Other reasons|0|||
155357036|NCT02330562|560742421|FG001|Overall Study|Other reasons|0|||
155357037|NCT02330562|560742422|FG002|Overall Study|Other reasons|0|||
155357038|NCT02330562|560742423|FG003|Overall Study|Other reasons|1|||
155648682|NCT02675452|561805888|FG007|Overall Study|Withdrawal by Subject|0|||
155357039|NCT02330562|560742424|FG004|Overall Study|Other reasons|0|||
155357040|NCT02330562|560742425|FG005|Overall Study|Other reasons|0|||
155357041|NCT02330562|560742426|FG006|Overall Study|Other reasons|0|||
155357042|NCT02330562|560742427|FG007|Overall Study|Other reasons|0|||
155357043|NCT02330562|560742428|FG008|Overall Study|Other reasons|0|||
155357044|NCT02330562|560742429|FG009|Overall Study|Other reasons|0|||
155357045|NCT02330562|560742430|FG010|Overall Study|Other reasons|0|||
155357046|NCT02330562|560742420|FG000|Overall Study|Withdrawal by Subject|0|||
155357047|NCT02330562|560742421|FG001|Overall Study|Withdrawal by Subject|0|||
155357048|NCT02330562|560742422|FG002|Overall Study|Withdrawal by Subject|0|||
155357049|NCT02330562|560742423|FG003|Overall Study|Withdrawal by Subject|0|||
155357050|NCT02330562|560742424|FG004|Overall Study|Withdrawal by Subject|0|||
155357051|NCT02330562|560742425|FG005|Overall Study|Withdrawal by Subject|0|||
155357052|NCT02330562|560742426|FG006|Overall Study|Withdrawal by Subject|0|||
155357053|NCT02330562|560742427|FG007|Overall Study|Withdrawal by Subject|0|||
155357054|NCT02330562|560742428|FG008|Overall Study|Withdrawal by Subject|0|||
155357055|NCT02330562|560742429|FG009|Overall Study|Withdrawal by Subject|1|||
155357056|NCT02330562|560742430|FG010|Overall Study|Withdrawal by Subject|0|||
155357057|NCT01547117|560742431|FG000|Overall Study|Physician Decision|0|||
155357058|NCT01547117|560742432|FG001|Overall Study|Physician Decision|1|||
155357059|NCT01547117|560742433|FG002|Overall Study|Physician Decision|1|||
155357060|NCT01547117|560742434|FG003|Overall Study|Physician Decision|3|||
155357061|NCT01547117|560742431|FG000|Overall Study|Withdrawal by Subject|1|||
155357062|NCT01547117|560742432|FG001|Overall Study|Withdrawal by Subject|2|||
155357063|NCT01547117|560742433|FG002|Overall Study|Withdrawal by Subject|1|||
155357064|NCT01547117|560742434|FG003|Overall Study|Withdrawal by Subject|2|||
155357065|NCT03927690|560742436|FG000|Overall Study|Withdrawal by Subject|3|||
155357066|NCT03927690|560742437|FG001|Overall Study|Withdrawal by Subject|1|||
155357067|NCT03927690|560742438|FG002|Overall Study|Withdrawal by Subject|1|||
155357068|NCT03927690|560742436|FG000|Overall Study|Adverse Event|1|||
155357069|NCT03927690|560742437|FG001|Overall Study|Adverse Event|0|||
155357070|NCT03927690|560742438|FG002|Overall Study|Adverse Event|0|||
155357071|NCT03927690|560742436|FG000|Overall Study|Death|1|||
155357072|NCT03927690|560742437|FG001|Overall Study|Death|0|||
155357073|NCT03927690|560742438|FG002|Overall Study|Death|0|||
155357074|NCT03927690|560742436|FG000|Overall Study|Lost to Follow-up|2|||
155357075|NCT03927690|560742437|FG001|Overall Study|Lost to Follow-up|2|||
155357076|NCT03927690|560742438|FG002|Overall Study|Lost to Follow-up|1|||
155357077|NCT01496365|560742451|FG000|Overall Study|Adverse Event|2|||
155357078|NCT01496365|560742452|FG001|Overall Study|Adverse Event|3|||
155357079|NCT01496365|560742453|FG002|Overall Study|Adverse Event|3|||
155427150|NCT04482647|560989942|FG000|Overall Study|Health issues|1|||
155427151|NCT04482647|560989942|FG000|Overall Study|Death in the family|1|||
155427152|NCT04482647|560989942|FG000|Overall Study|Disliked the intervention|1|||
155357080|NCT01496365|560742454|FG003|Overall Study|Adverse Event|2|||
155357081|NCT01496365|560742455|FG004|Overall Study|Adverse Event|5|||
155357082|NCT01496365|560742456|FG005|Overall Study|Adverse Event|6|||
155357083|NCT01496365|560742457|FG006|Overall Study|Adverse Event|4|||
155357084|NCT01496365|560742451|FG000|Overall Study|Withdrawal by Subject|6|||
155357085|NCT01496365|560742452|FG001|Overall Study|Withdrawal by Subject|6|||
155357086|NCT01496365|560742453|FG002|Overall Study|Withdrawal by Subject|0|||
155357087|NCT01496365|560742454|FG003|Overall Study|Withdrawal by Subject|1|||
155357088|NCT01496365|560742455|FG004|Overall Study|Withdrawal by Subject|3|||
155357089|NCT01496365|560742456|FG005|Overall Study|Withdrawal by Subject|2|||
155357090|NCT01496365|560742457|FG006|Overall Study|Withdrawal by Subject|1|||
155357091|NCT01496365|560742451|FG000|Overall Study|Protocol Violation|2|||
155357092|NCT01496365|560742452|FG001|Overall Study|Protocol Violation|1|||
155357093|NCT01496365|560742453|FG002|Overall Study|Protocol Violation|1|||
155357094|NCT01496365|560742454|FG003|Overall Study|Protocol Violation|0|||
155357095|NCT01496365|560742455|FG004|Overall Study|Protocol Violation|0|||
155357096|NCT01496365|560742456|FG005|Overall Study|Protocol Violation|1|||
155357097|NCT01496365|560742457|FG006|Overall Study|Protocol Violation|0|||
155357098|NCT01496365|560742451|FG000|Overall Study|Lack of Efficacy|1|||
155357099|NCT01496365|560742452|FG001|Overall Study|Lack of Efficacy|0|||
155357100|NCT01496365|560742453|FG002|Overall Study|Lack of Efficacy|0|||
155357101|NCT01496365|560742454|FG003|Overall Study|Lack of Efficacy|0|||
155357102|NCT01496365|560742455|FG004|Overall Study|Lack of Efficacy|0|||
155357103|NCT01496365|560742456|FG005|Overall Study|Lack of Efficacy|1|||
155357104|NCT01496365|560742457|FG006|Overall Study|Lack of Efficacy|0|||
155357105|NCT01496365|560742451|FG000|Overall Study|Lost to Follow-up|0|||
155357106|NCT01496365|560742452|FG001|Overall Study|Lost to Follow-up|1|||
155357107|NCT01496365|560742453|FG002|Overall Study|Lost to Follow-up|0|||
155357108|NCT01496365|560742454|FG003|Overall Study|Lost to Follow-up|0|||
155357109|NCT01496365|560742455|FG004|Overall Study|Lost to Follow-up|2|||
155357110|NCT01496365|560742456|FG005|Overall Study|Lost to Follow-up|0|||
155357111|NCT01496365|560742457|FG006|Overall Study|Lost to Follow-up|0|||
155357112|NCT01496365|560742451|FG000|Overall Study|Other|4|||
155357113|NCT01496365|560742452|FG001|Overall Study|Other|4|||
155357114|NCT01496365|560742453|FG002|Overall Study|Other|2|||
155357115|NCT01496365|560742454|FG003|Overall Study|Other|1|||
155357116|NCT01496365|560742455|FG004|Overall Study|Other|3|||
155357117|NCT01496365|560742456|FG005|Overall Study|Other|0|||
155357118|NCT01496365|560742457|FG006|Overall Study|Other|1|||
155357119|NCT01015677|560742458|FG000|Overall Study|Adverse Event|0|||
155357120|NCT01015677|560742459|FG001|Overall Study|Adverse Event|1|||
155357121|NCT01015677|560742460|FG002|Overall Study|Adverse Event|0|||
155357122|NCT01015677|560742458|FG000|Overall Study|Lack of Efficacy|0|||
155357123|NCT01015677|560742459|FG001|Overall Study|Lack of Efficacy|1|||
155357124|NCT01015677|560742460|FG002|Overall Study|Lack of Efficacy|0|||
155357125|NCT01015677|560742458|FG000|Overall Study|Protocol Violation|0|||
155357126|NCT01015677|560742459|FG001|Overall Study|Protocol Violation|1|||
155357127|NCT01015677|560742460|FG002|Overall Study|Protocol Violation|0|||
155357128|NCT01015677|560742458|FG000|Overall Study|Withdrawal by Subject|1|||
155357129|NCT01015677|560742459|FG001|Overall Study|Withdrawal by Subject|1|||
155357130|NCT01015677|560742460|FG002|Overall Study|Withdrawal by Subject|0|||
155357131|NCT01660256|560742461|FG000|Overall Study|Adverse Event|4|||
155357132|NCT01660256|560742462|FG001|Overall Study|Adverse Event|0|||
155648683|NCT02675452|561805889|FG008|Overall Study|Withdrawal by Subject|0|||
155357133|NCT01660256|560742463|FG002|Overall Study|Adverse Event|2|||
155357134|NCT01660256|560742461|FG000|Overall Study|Withdrawal by Subject|1|||
155357135|NCT01660256|560742462|FG001|Overall Study|Withdrawal by Subject|0|||
155357136|NCT01660256|560742463|FG002|Overall Study|Withdrawal by Subject|2|||
155357137|NCT01646385|560742465|FG000|Overall Study|Death|202|||
155357138|NCT01646385|560742466|FG001|Overall Study|Death|222|||
155357139|NCT01646385|560742465|FG000|Overall Study|Switched to alternate biologic|636|||
155357140|NCT01646385|560742466|FG001|Overall Study|Switched to alternate biologic|649|||
155357141|NCT03491215|560742467|FG000|Overall Study|Death|6|||
155357142|NCT03491215|560742468|FG001|Overall Study|Death|2|||
155357143|NCT03491215|560742469|FG002|Overall Study|Death|1|||
155648684|NCT02675452|561805890|FG009|Overall Study|Withdrawal by Subject|1|||
155357144|NCT03491215|560742470|FG003|Overall Study|Death|0|||
155357145|NCT03491215|560742467|FG000|Overall Study|Physician Decision|1|||
155357146|NCT03491215|560742468|FG001|Overall Study|Physician Decision|0|||
155357147|NCT03491215|560742469|FG002|Overall Study|Physician Decision|0|||
155357148|NCT03491215|560742470|FG003|Overall Study|Physician Decision|0|||
155357149|NCT00548847|560742477|FG000|Overall Study|Disease progression|7|||
155357150|NCT00511797|560742481|FG000|Overall Study|Adverse Event|1|||
155357151|NCT00511797|560742482|FG001|Overall Study|Adverse Event|2|||
155357152|NCT00511797|560742483|FG002|Overall Study|Adverse Event|2|||
155357153|NCT00511797|560742484|FG003|Overall Study|Adverse Event|2|||
155357154|NCT00511797|560742481|FG000|Overall Study|Lost to Follow-up|1|||
155357155|NCT00511797|560742482|FG001|Overall Study|Lost to Follow-up|0|||
155357156|NCT00511797|560742483|FG002|Overall Study|Lost to Follow-up|0|||
155357157|NCT00511797|560742484|FG003|Overall Study|Lost to Follow-up|1|||
155357158|NCT00511797|560742481|FG000|Overall Study|Pregnancy|0|||
155357159|NCT00511797|560742482|FG001|Overall Study|Pregnancy|0|||
155357160|NCT00511797|560742483|FG002|Overall Study|Pregnancy|0|||
155357161|NCT00511797|560742484|FG003|Overall Study|Pregnancy|1|||
155357162|NCT00511797|560742481|FG000|Overall Study|Protocol Violation|0|||
155357163|NCT00511797|560742482|FG001|Overall Study|Protocol Violation|2|||
155427153|NCT04482647|560989942|FG000|Overall Study|No reasons specified|7|||
155427154|NCT03952559|560989943|FG000|Double Blind Treatment Period|Adverse Event|0|||
155427155|NCT03952559|560989944|FG001|Double Blind Treatment Period|Adverse Event|2|||
155427156|NCT03952559|560989945|FG002|Double Blind Treatment Period|Adverse Event|1|||
155427157|NCT03952559|560989946|FG003|Double Blind Treatment Period|Adverse Event|0|||
155427158|NCT03952559|560989947|FG004|Double Blind Treatment Period|Adverse Event|1|||
155427159|NCT03952559|560989943|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
155427160|NCT03952559|560989944|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
155427161|NCT03952559|560989945|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
155427162|NCT03952559|560989946|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
155427163|NCT03952559|560989947|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
155427164|NCT03952559|560989943|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155427165|NCT03952559|560989944|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
155427166|NCT03952559|560989945|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
155427167|NCT03952559|560989946|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
155427168|NCT03952559|560989947|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155427169|NCT03952559|560989943|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
155427170|NCT03952559|560989944|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
155427171|NCT03952559|560989945|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
155427172|NCT03952559|560989946|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
155427173|NCT03952559|560989947|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
155427174|NCT02875223|560989948|FG000|Overall Study|Other reasons|0|||
155427175|NCT02875223|560989949|FG001|Overall Study|Other reasons|0|||
155427176|NCT02875223|560989950|FG002|Overall Study|Other reasons|1|||
155427177|NCT02875223|560989951|FG003|Overall Study|Other reasons|0|||
155427178|NCT02875223|560989952|FG004|Overall Study|Other reasons|1|||
155427179|NCT02875223|560989953|FG005|Overall Study|Other reasons|2|||
155427180|NCT02875223|560989954|FG006|Overall Study|Other reasons|0|||
155427181|NCT02875223|560989955|FG007|Overall Study|Other reasons|2|||
155427182|NCT02875223|560989956|FG008|Overall Study|Other reasons|0|||
155427183|NCT02875223|560989957|FG009|Overall Study|Other reasons|0|||
155427184|NCT02875223|560989958|FG010|Overall Study|Other reasons|0|||
155427185|NCT02875223|560989959|FG011|Overall Study|Other reasons|0|||
155427186|NCT02875223|560989960|FG012|Overall Study|Other reasons|0|||
155427187|NCT02875223|560989948|FG000|Overall Study|Withdrawal by Subject|0|||
155427188|NCT02875223|560989949|FG001|Overall Study|Withdrawal by Subject|0|||
155427189|NCT02875223|560989950|FG002|Overall Study|Withdrawal by Subject|0|||
155427190|NCT02875223|560989951|FG003|Overall Study|Withdrawal by Subject|0|||
155427191|NCT02875223|560989952|FG004|Overall Study|Withdrawal by Subject|1|||
155427192|NCT02875223|560989953|FG005|Overall Study|Withdrawal by Subject|1|||
155427193|NCT02875223|560989954|FG006|Overall Study|Withdrawal by Subject|0|||
155427194|NCT02875223|560989955|FG007|Overall Study|Withdrawal by Subject|0|||
155427195|NCT02875223|560989956|FG008|Overall Study|Withdrawal by Subject|1|||
155427196|NCT02875223|560989957|FG009|Overall Study|Withdrawal by Subject|0|||
155427197|NCT02875223|560989958|FG010|Overall Study|Withdrawal by Subject|0|||
155427198|NCT02875223|560989959|FG011|Overall Study|Withdrawal by Subject|0|||
155427199|NCT02875223|560989960|FG012|Overall Study|Withdrawal by Subject|0|||
155427200|NCT02875223|560989948|FG000|Overall Study|Progressive disease|0|||
155427201|NCT02875223|560989949|FG001|Overall Study|Progressive disease|0|||
155427202|NCT02875223|560989950|FG002|Overall Study|Progressive disease|1|||
155427203|NCT02875223|560989951|FG003|Overall Study|Progressive disease|0|||
155427204|NCT02875223|560989952|FG004|Overall Study|Progressive disease|0|||
155427205|NCT02875223|560989953|FG005|Overall Study|Progressive disease|0|||
155427206|NCT02875223|560989954|FG006|Overall Study|Progressive disease|0|||
155427207|NCT02875223|560989955|FG007|Overall Study|Progressive disease|0|||
155427208|NCT02875223|560989956|FG008|Overall Study|Progressive disease|0|||
155427209|NCT02875223|560989957|FG009|Overall Study|Progressive disease|12|||
155427210|NCT02875223|560989958|FG010|Overall Study|Progressive disease|2|||
155427211|NCT02875223|560989959|FG011|Overall Study|Progressive disease|3|||
155427212|NCT02875223|560989960|FG012|Overall Study|Progressive disease|6|||
155427213|NCT02875223|560989948|FG000|Overall Study|Death|4|||
155427214|NCT02875223|560989949|FG001|Overall Study|Death|4|||
155427215|NCT02875223|560989950|FG002|Overall Study|Death|3|||
155427216|NCT02875223|560989951|FG003|Overall Study|Death|4|||
155427217|NCT02875223|560989952|FG004|Overall Study|Death|2|||
155427218|NCT02875223|560989953|FG005|Overall Study|Death|3|||
155427219|NCT02875223|560989954|FG006|Overall Study|Death|5|||
155427220|NCT02875223|560989955|FG007|Overall Study|Death|7|||
155427221|NCT02875223|560989956|FG008|Overall Study|Death|3|||
155427222|NCT02875223|560989957|FG009|Overall Study|Death|2|||
155427223|NCT02875223|560989958|FG010|Overall Study|Death|0|||
155427224|NCT02875223|560989959|FG011|Overall Study|Death|0|||
155427225|NCT02875223|560989960|FG012|Overall Study|Death|0|||
155427226|NCT02875223|560989948|FG000|Overall Study|Lost to Follow-up|0|||
155427227|NCT02875223|560989949|FG001|Overall Study|Lost to Follow-up|1|||
155427228|NCT02875223|560989950|FG002|Overall Study|Lost to Follow-up|1|||
155427229|NCT02875223|560989951|FG003|Overall Study|Lost to Follow-up|0|||
155357164|NCT00511797|560742483|FG002|Overall Study|Protocol Violation|2|||
155357165|NCT00511797|560742484|FG003|Overall Study|Protocol Violation|3|||
155357166|NCT00511797|560742481|FG000|Overall Study|Withdrawal by Subject|3|||
155357167|NCT00511797|560742482|FG001|Overall Study|Withdrawal by Subject|3|||
155357168|NCT00511797|560742483|FG002|Overall Study|Withdrawal by Subject|4|||
155357169|NCT00511797|560742484|FG003|Overall Study|Withdrawal by Subject|2|||
155357170|NCT00511797|560742481|FG000|Overall Study|Never dispensed|1|||
155357171|NCT00511797|560742482|FG001|Overall Study|Never dispensed|0|||
155357172|NCT00511797|560742483|FG002|Overall Study|Never dispensed|1|||
155357173|NCT00511797|560742484|FG003|Overall Study|Never dispensed|3|||
155357174|NCT00511797|560742481|FG000|Overall Study|Study drug not taken|0|||
155357175|NCT00511797|560742482|FG001|Overall Study|Study drug not taken|1|||
155357176|NCT00511797|560742483|FG002|Overall Study|Study drug not taken|0|||
155357177|NCT00511797|560742484|FG003|Overall Study|Study drug not taken|1|||
155357178|NCT00511797|560742481|FG000|Overall Study|Partially missing diary|0|||
155357179|NCT00511797|560742482|FG001|Overall Study|Partially missing diary|0|||
155357180|NCT00511797|560742483|FG002|Overall Study|Partially missing diary|1|||
155357181|NCT00511797|560742484|FG003|Overall Study|Partially missing diary|0|||
155357182|NCT00511797|560742481|FG000|Overall Study|Other (moving etc)|1|||
155357183|NCT00511797|560742482|FG001|Overall Study|Other (moving etc)|0|||
155357184|NCT00511797|560742483|FG002|Overall Study|Other (moving etc)|1|||
155357185|NCT00511797|560742484|FG003|Overall Study|Other (moving etc)|2|||
155357186|NCT03269695|560742485|FG000|Overall Study|Adverse Event|2|||
155357187|NCT03269695|560742486|FG001|Overall Study|Adverse Event|1|||
155357188|NCT03269695|560742485|FG000|Overall Study|Lack of Efficacy|0|||
155357189|NCT03269695|560742486|FG001|Overall Study|Lack of Efficacy|1|||
155357190|NCT03269695|560742485|FG000|Overall Study|Withdrawal by Subject|0|||
155357191|NCT03269695|560742486|FG001|Overall Study|Withdrawal by Subject|1|||
155357192|NCT05043883|560742487|FG000|Overall Study|Minimum required measurements could not be taken|4|||
155357193|NCT00905359|560742492|FG000|Overall Study|Lost to Follow-up|17|||
155357194|NCT00905359|560742493|FG001|Overall Study|Lost to Follow-up|10|||
155357195|NCT00905359|560742492|FG000|Overall Study|Death|2|||
155357196|NCT00905359|560742493|FG001|Overall Study|Death|0|||
155357197|NCT00905359|560742492|FG000|Overall Study|Withdrawal consent|5|||
155357198|NCT00905359|560742493|FG001|Overall Study|Withdrawal consent|6|||
155357199|NCT04354168|560742500|FG000|Overall Study|Lost to Follow-up|22|||
155357200|NCT02287233|560742501|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
155357201|NCT02287233|560742502|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
155357202|NCT02287233|560742503|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
155357203|NCT02287233|560742501|FG000|Overall Study|Adverse Event Related to Progression|0|||
155357204|NCT02287233|560742502|FG001|Overall Study|Adverse Event Related to Progression|2|||
155357205|NCT02287233|560742503|FG002|Overall Study|Adverse Event Related to Progression|8|||
155357206|NCT02287233|560742501|FG000|Overall Study|Physician Decision|1|||
155357207|NCT02287233|560742502|FG001|Overall Study|Physician Decision|2|||
155357208|NCT02287233|560742503|FG002|Overall Study|Physician Decision|4|||
155357209|NCT02287233|560742501|FG000|Overall Study|Progressive Disease with Death|0|||
155357210|NCT02287233|560742502|FG001|Overall Study|Progressive Disease with Death|0|||
155427230|NCT02875223|560989952|FG004|Overall Study|Lost to Follow-up|1|||
155357211|NCT02287233|560742503|FG002|Overall Study|Progressive Disease with Death|10|||
155357212|NCT02287233|560742501|FG000|Overall Study|Progressive Disease Without Death|2|||
155357213|NCT02287233|560742502|FG001|Overall Study|Progressive Disease Without Death|3|||
155357214|NCT02287233|560742503|FG002|Overall Study|Progressive Disease Without Death|20|||
155357215|NCT02287233|560742501|FG000|Overall Study|Withdrawal by Subject|1|||
155357216|NCT02287233|560742502|FG001|Overall Study|Withdrawal by Subject|1|||
155357217|NCT02287233|560742503|FG002|Overall Study|Withdrawal by Subject|7|||
155357218|NCT02287233|560742501|FG000|Overall Study|Other|3|||
155357219|NCT02287233|560742502|FG001|Overall Study|Other|0|||
155357220|NCT02287233|560742503|FG002|Overall Study|Other|15|||
155357221|NCT02287233|560742501|FG000|Overall Study|Did Not Receive Treatment|0|||
155357222|NCT02287233|560742502|FG001|Overall Study|Did Not Receive Treatment|0|||
155357223|NCT02287233|560742503|FG002|Overall Study|Did Not Receive Treatment|2|||
155357224|NCT02804399|560742506|FG000|Period 2|Adverse Event|0|||
155357225|NCT02804399|560742507|FG001|Period 2|Adverse Event|1|||
155357226|NCT01174264|560742508|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
155357227|NCT01174264|560742509|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
155357228|NCT01174264|560742510|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
155357229|NCT01174264|560742508|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
155357230|NCT01174264|560742509|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
155357231|NCT01174264|560742510|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
155357232|NCT01174264|560742508|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
155357233|NCT01174264|560742509|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
155357234|NCT01174264|560742510|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
155357235|NCT03432390|560742511|FG000|Apnea Period|Protocol Violation|2|||
155357236|NCT03432390|560742512|FG001|Apnea Period|Protocol Violation|2|||
155357237|NCT01774305|560742515|FG000|Overall Study|Physician Decision|1|||
155357238|NCT01774305|560742516|FG001|Overall Study|Physician Decision|0|||
155357239|NCT03738397|560742517|FG000|Overall Study|Adverse Event|3|||
155357240|NCT03738397|560742518|FG001|Overall Study|Adverse Event|7|||
155357241|NCT03738397|560742517|FG000|Overall Study|Withdrawal by Subject|8|||
155357242|NCT03738397|560742518|FG001|Overall Study|Withdrawal by Subject|11|||
155357243|NCT03738397|560742517|FG000|Overall Study|Lost to Follow-up|7|||
155357244|NCT03738397|560742518|FG001|Overall Study|Lost to Follow-up|5|||
155357245|NCT03738397|560742517|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155357246|NCT03738397|560742518|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
155357247|NCT03738397|560742517|FG000|Overall Study|Other|4|||
155357248|NCT03738397|560742518|FG001|Overall Study|Other|6|||
155357249|NCT00691678|560742519|FG000|Overall Study|Adverse Event|5|||
155357250|NCT00691678|560742519|FG000|Overall Study|life events, pain|11|||
155357251|NCT03049306|560742520|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
155357252|NCT03049306|560742521|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
155357253|NCT00903760|560744326|FG000|Overall Study|Disease Progression/Death|8|||
155357254|NCT00903760|560744327|FG001|Overall Study|Disease Progression/Death|6|||
155357255|NCT00903760|560744326|FG000|Overall Study|Stem Cell Transplant|8|||
155357256|NCT00903760|560744327|FG001|Overall Study|Stem Cell Transplant|4|||
155357257|NCT00903760|560744326|FG000|Overall Study|Physician Decision|1|||
155357258|NCT00903760|560744327|FG001|Overall Study|Physician Decision|2|||
155357259|NCT00903760|560744326|FG000|Overall Study|Death|0|||
155357260|NCT00903760|560744327|FG001|Overall Study|Death|1|||
155357261|NCT00903760|560744326|FG000|Overall Study|Lost to Follow-up|1|||
155357262|NCT00903760|560744327|FG001|Overall Study|Lost to Follow-up|0|||
155357263|NCT00903760|560744326|FG000|Overall Study|Withdrawal by Subject|1|||
155357264|NCT00903760|560744327|FG001|Overall Study|Withdrawal by Subject|2|||
155357265|NCT00903760|560744326|FG000|Overall Study|Off treatment for long period|0|||
155357266|NCT00903760|560744327|FG001|Overall Study|Off treatment for long period|1|||
155357267|NCT01639742|560744329|FG000|Overall Study|Study Ongoing|17|||
155357268|NCT01639742|560744329|FG000|Overall Study|Lost to Follow-up|1|||
155357269|NCT01256671|560744333|FG000|Overall Study|Adverse Event|29|||
155357270|NCT01256671|560744333|FG000|Overall Study|Lost to Follow-up|16|||
155357271|NCT01256671|560744333|FG000|Overall Study|Withdrawal by Subject|31|||
155357272|NCT01256671|560744333|FG000|Overall Study|Physician Decision|3|||
155357273|NCT01256671|560744333|FG000|Overall Study|Lack of Efficacy|4|||
155357274|NCT01256671|560744333|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
155357275|NCT01266018|560744334|FG000|Overall Study|Physician Decision|1|||
155357276|NCT01266018|560744335|FG001|Overall Study|Physician Decision|0|||
155357277|NCT01266018|560744334|FG000|Overall Study|Progressive disease|0|||
155507036|NCT03652961|561283514|FG000|Overall Study|Lost to Follow-up|3|||
155507037|NCT03652961|561283514|FG000|Overall Study|Screen Failure|1|||
155507038|NCT00373685|561283515|FG000|Overall Study|Death|2|||
155507039|NCT00373685|561283516|FG001|Overall Study|Death|1|||
155507040|NCT00373685|561283515|FG000|Overall Study|Adverse Event|278|||
155507041|NCT00373685|561283516|FG001|Overall Study|Adverse Event|253|||
155507042|NCT00373685|561283515|FG000|Overall Study|Insufficient clinical response|169|||
155507043|NCT00373685|561283516|FG001|Overall Study|Insufficient clinical response|119|||
155648685|NCT02675452|561805891|FG010|Overall Study|Withdrawal by Subject|0|||
155357278|NCT01266018|560744335|FG001|Overall Study|Progressive disease|1|||
155357279|NCT03167151|560744336|FG000|Overall Study|Withdrawal by Subject|1|||
155357280|NCT03167151|560744337|FG001|Overall Study|Withdrawal by Subject|0|||
155357281|NCT03167151|560744338|FG002|Overall Study|Withdrawal by Subject|0|||
155357282|NCT03167151|560744336|FG000|Overall Study|No evidence of tumour at surgery|0|||
155648686|NCT02675452|561805892|FG011|Overall Study|Withdrawal by Subject|1|||
155648687|NCT02675452|561805893|FG012|Overall Study|Withdrawal by Subject|0|||
155648688|NCT02675452|561805894|FG013|Overall Study|Withdrawal by Subject|1|||
155357283|NCT03167151|560744337|FG001|Overall Study|No evidence of tumour at surgery|1|||
155357284|NCT03167151|560744338|FG002|Overall Study|No evidence of tumour at surgery|1|||
155357285|NCT01458522|560744339|FG000|Overall Study|Withdrawal by Subject|2|||
155357286|NCT01458522|560744340|FG001|Overall Study|Withdrawal by Subject|2|||
155357287|NCT01458522|560744339|FG000|Overall Study|Physician Decision|1|||
155357288|NCT01458522|560744340|FG001|Overall Study|Physician Decision|9|||
155357289|NCT00516139|560744341|FG000|Overall Study|Adverse Event|27|||
155357290|NCT00516139|560744341|FG000|Overall Study|Lost to Follow-up|1|||
155507044|NCT00373685|561283515|FG000|Overall Study|Did not meet entrance criteria|167|||
155648689|NCT02675452|561805895|FG014|Overall Study|Withdrawal by Subject|1|||
155357291|NCT00516139|560744341|FG000|Overall Study|Protocol Violation|1|||
155357292|NCT00516139|560744341|FG000|Overall Study|Withdrawal by Subject|8|||
155357293|NCT00516139|560744341|FG000|Overall Study|Lack of Efficacy|1|||
155357294|NCT00416598|560744342|FG000|Induction & Intensification|Adverse Event|38|||
155357295|NCT00416598|560744342|FG000|Induction & Intensification|Death|32|||
155357296|NCT00416598|560744342|FG000|Induction & Intensification|Withdrawal by Subject|46|||
155357297|NCT00416598|560744342|FG000|Induction & Intensification|Alternative Treatment|135|||
155357298|NCT00416598|560744342|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
155357299|NCT00416598|560744342|FG000|Induction & Intensification|Relapse/progression|29|||
155357300|NCT00416598|560744342|FG000|Induction & Intensification|Failed induction|87|||
155357301|NCT00416598|560744342|FG000|Decitabine Maintenance|Adverse Event|5|||
155357302|NCT00416598|560744342|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
155357303|NCT00416598|560744342|FG000|Decitabine Maintenance|Progression/relapse|38|||
155357304|NCT00416598|560744342|FG000|Decitabine Maintenance|Alternative treatment|2|||
155357305|NCT00416598|560744342|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
155357306|NCT02166476|560744349|FG000|Overall Study|Withdrawal by Subject|5|||
155357307|NCT02166476|560744350|FG001|Overall Study|Withdrawal by Subject|7|||
155357308|NCT02166476|560744349|FG000|Overall Study|Adverse Event|3|||
155357309|NCT02166476|560744350|FG001|Overall Study|Adverse Event|3|||
155357310|NCT02166476|560744349|FG000|Overall Study|Lost to Follow-up|5|||
155357311|NCT02166476|560744350|FG001|Overall Study|Lost to Follow-up|10|||
155357312|NCT02166476|560744349|FG000|Overall Study|Physician Decision|1|||
155357313|NCT02166476|560744350|FG001|Overall Study|Physician Decision|0|||
155357314|NCT02166476|560744349|FG000|Overall Study|Unable to Come for Visit|0|||
155357315|NCT02166476|560744350|FG001|Overall Study|Unable to Come for Visit|3|||
155357316|NCT04367480|560744357|FG000|Overall Study|Adverse Event|1|||
155357317|NCT04367480|560744358|FG001|Overall Study|Adverse Event|1|||
155357318|NCT04367480|560744357|FG000|Overall Study|Death|1|||
155357319|NCT04367480|560744358|FG001|Overall Study|Death|0|||
155357320|NCT04367480|560744357|FG000|Overall Study|Lost to Follow-up|1|||
155357321|NCT04367480|560744358|FG001|Overall Study|Lost to Follow-up|1|||
155357322|NCT04367480|560744357|FG000|Overall Study|Withdrawal by Subject|0|||
155357323|NCT04367480|560744358|FG001|Overall Study|Withdrawal by Subject|3|||
155357324|NCT04367480|560744357|FG000|Overall Study|App glitch during the study|1|||
155357325|NCT04367480|560744358|FG001|Overall Study|App glitch during the study|0|||
155357326|NCT04367480|560744357|FG000|Overall Study|Device Distribution Error|0|||
155357327|NCT04367480|560744358|FG001|Overall Study|Device Distribution Error|2|||
155357328|NCT04367480|560744357|FG000|Overall Study|Ineligible after Randomization|0|||
155357329|NCT04367480|560744358|FG001|Overall Study|Ineligible after Randomization|1|||
155357330|NCT04367480|560744357|FG000|Overall Study|Other Medical Reasons|0|||
155357331|NCT04367480|560744358|FG001|Overall Study|Other Medical Reasons|2|||
155357332|NCT03382561|560744359|FG000|Overall Study|Disease progression|47|||
155357333|NCT03382561|560744360|FG001|Overall Study|Disease progression|6|||
155357334|NCT03382561|560744359|FG000|Overall Study|Adverse Event|10|||
155357335|NCT03382561|560744360|FG001|Overall Study|Adverse Event|2|||
155357336|NCT03382561|560744359|FG000|Overall Study|Death|8|||
155357337|NCT03382561|560744360|FG001|Overall Study|Death|3|||
155357338|NCT03382561|560744359|FG000|Overall Study|Withdrawal by Subject|6|||
155357339|NCT03382561|560744360|FG001|Overall Study|Withdrawal by Subject|5|||
155357340|NCT03382561|560744359|FG000|Overall Study|Alternative therapy|2|||
155357341|NCT03382561|560744360|FG001|Overall Study|Alternative therapy|8|||
155357342|NCT03382561|560744359|FG000|Overall Study|Never started treatment|3|||
155357343|NCT03382561|560744360|FG001|Overall Study|Never started treatment|6|||
155357344|NCT03382561|560744359|FG000|Overall Study|Lack of Efficacy|0|||
155357345|NCT03382561|560744360|FG001|Overall Study|Lack of Efficacy|1|||
155357346|NCT03382561|560744359|FG000|Overall Study|Physician Decision|0|||
155357347|NCT03382561|560744360|FG001|Overall Study|Physician Decision|1|||
155357348|NCT03382561|560744359|FG000|Overall Study|Other complicating disease|0|||
155357349|NCT03382561|560744360|FG001|Overall Study|Other complicating disease|1|||
155357350|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
155357351|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
155357352|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
155357353|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
155357354|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
155357355|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
155357356|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
155357357|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
155357358|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Unclassified|10|||
155357359|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Unclassified|15|||
155357360|NCT00781937|560744363|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
155357361|NCT00781937|560744364|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
155357362|NCT00781937|560744363|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
155357363|NCT00781937|560744364|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
155357364|NCT00013611|560744365|FG000|Overall Study|Lost to Follow-up|91|||
155357365|NCT00013611|560744366|FG001|Overall Study|Lost to Follow-up|100|||
155357366|NCT01150045|560744367|FG000|Overall Study|Protocol Violation|0|||
155357367|NCT01150045|560744368|FG001|Overall Study|Protocol Violation|1|||
155357368|NCT01150045|560744369|FG002|Overall Study|Protocol Violation|0|||
155357369|NCT01150045|560744370|FG003|Overall Study|Protocol Violation|1|||
155357370|NCT01432626|560744371|FG000|Overall Study|LV function recovered|2|||
155357371|NCT01432626|560744371|FG000|Overall Study|Withdrawal by Subject|2|||
155357372|NCT01432626|560744371|FG000|Overall Study|Only 1 image competed|2|||
155357373|NCT01432626|560744371|FG000|Overall Study|Imaging agent not available|1|||
155357374|NCT01657799|560744374|FG000|Overall Study|Adverse Event Related to progression|6|||
155357375|NCT01657799|560744375|FG001|Overall Study|Adverse Event Related to progression|8|||
155357376|NCT01657799|560744376|FG002|Overall Study|Adverse Event Related to progression|12|||
155357377|NCT01657799|560744374|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
155357378|NCT01657799|560744375|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
155357379|NCT01657799|560744376|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
155357380|NCT01657799|560744374|FG000|Overall Study|Withdrawal by Subject|13|||
155357381|NCT01657799|560744375|FG001|Overall Study|Withdrawal by Subject|10|||
155357382|NCT01657799|560744376|FG002|Overall Study|Withdrawal by Subject|10|||
155357383|NCT01657799|560744374|FG000|Overall Study|Lost to Follow-up|1|||
155357384|NCT01657799|560744375|FG001|Overall Study|Lost to Follow-up|0|||
155357385|NCT01657799|560744376|FG002|Overall Study|Lost to Follow-up|1|||
155357386|NCT01657799|560744374|FG000|Overall Study|Disease Progression|2|||
155357387|NCT01657799|560744375|FG001|Overall Study|Disease Progression|4|||
155357388|NCT01657799|560744376|FG002|Overall Study|Disease Progression|4|||
155357389|NCT01657799|560744374|FG000|Overall Study|Progressive Disease Clinical|7|||
155357390|NCT01657799|560744375|FG001|Overall Study|Progressive Disease Clinical|4|||
155357391|NCT01657799|560744376|FG002|Overall Study|Progressive Disease Clinical|7|||
155357392|NCT01657799|560744374|FG000|Overall Study|Radiographic & Clinical Progression|16|||
155357393|NCT01657799|560744375|FG001|Overall Study|Radiographic & Clinical Progression|11|||
155357394|NCT01657799|560744376|FG002|Overall Study|Radiographic & Clinical Progression|15|||
155357395|NCT01657799|560744374|FG000|Overall Study|Other|52|||
155357396|NCT01657799|560744375|FG001|Overall Study|Other|62|||
155357397|NCT01657799|560744376|FG002|Overall Study|Other|49|||
155357398|NCT00174447|560744377|FG000|Overall Study|Adverse Event|19|||
155357399|NCT00174447|560744377|FG000|Overall Study|Withdrawal by Subject|15|||
155357400|NCT00174447|560744377|FG000|Overall Study|Protocol Violation|1|||
155357401|NCT00174447|560744377|FG000|Overall Study|Lack of Efficacy|1|||
155357402|NCT00174447|560744377|FG000|Overall Study|Administrative reason/Other|2|||
155357403|NCT03021551|560744380|FG000|Overall Study|Equipment Issues|2|||
155357404|NCT03021551|560744380|FG000|Overall Study|Protocol Violation|1|||
155357405|NCT02229578|560744381|FG000|Overall Study|Withdrawal by Subject|1|||
155357406|NCT02229578|560744382|FG001|Overall Study|Withdrawal by Subject|3|||
155357407|NCT02229578|560744381|FG000|Overall Study|Protocol Violation|2|||
155357408|NCT02229578|560744382|FG001|Overall Study|Protocol Violation|0|||
155357409|NCT00412880|560744385|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
155357410|NCT00412880|560744385|FG000|Overall Study|Consent withdrawn|1|||
155357411|NCT00412880|560744385|FG000|Overall Study|Adverse Event|1|||
155357412|NCT00412880|560744385|FG000|Overall Study|Progressive disease|20|||
155357413|NCT02232399|560744387|FG000|Overall Study|Adverse Event|1|||
155357414|NCT02232399|560744388|FG001|Overall Study|Adverse Event|0|||
155357415|NCT02232399|560744387|FG000|Overall Study|Withdrawal by Subject|0|||
155357416|NCT02232399|560744388|FG001|Overall Study|Withdrawal by Subject|1|||
155357417|NCT02706951|560744390|FG000|Period 1|Adverse Event|1|||
155357418|NCT02706951|560744391|FG001|Period 1|Adverse Event|5|||
155357419|NCT02706951|560744392|FG002|Period 1|Adverse Event|3|||
155357420|NCT02706951|560744393|FG003|Period 1|Adverse Event|0|||
155357421|NCT02706951|560744394|FG004|Period 1|Adverse Event|0|||
155357422|NCT02706951|560744390|FG000|Period 1|Withdrawal by Subject|10|||
155427231|NCT02875223|560989953|FG005|Overall Study|Lost to Follow-up|0|||
155357423|NCT02706951|560744391|FG001|Period 1|Withdrawal by Subject|6|||
155357424|NCT02706951|560744392|FG002|Period 1|Withdrawal by Subject|6|||
155357425|NCT02706951|560744393|FG003|Period 1|Withdrawal by Subject|0|||
155357426|NCT02706951|560744394|FG004|Period 1|Withdrawal by Subject|0|||
155357427|NCT02706951|560744390|FG000|Period 1|Lost to Follow-up|0|||
155357428|NCT02706951|560744391|FG001|Period 1|Lost to Follow-up|4|||
155357429|NCT02706951|560744392|FG002|Period 1|Lost to Follow-up|1|||
155357430|NCT02706951|560744393|FG003|Period 1|Lost to Follow-up|0|||
155357431|NCT02706951|560744394|FG004|Period 1|Lost to Follow-up|0|||
155357432|NCT02706951|560744390|FG000|Period 1|Other|2|||
155357433|NCT02706951|560744391|FG001|Period 1|Other|1|||
155357434|NCT02706951|560744392|FG002|Period 1|Other|0|||
155357435|NCT02706951|560744393|FG003|Period 1|Other|0|||
155427232|NCT02875223|560989954|FG006|Overall Study|Lost to Follow-up|1|||
155357436|NCT02706951|560744394|FG004|Period 1|Other|0|||
155357437|NCT02706951|560744390|FG000|Period 2|Adverse Event|0|||
155357438|NCT02706951|560744391|FG001|Period 2|Adverse Event|0|||
155357439|NCT02706951|560744392|FG002|Period 2|Adverse Event|0|||
155357440|NCT02706951|560744393|FG003|Period 2|Adverse Event|25|||
155357441|NCT02706951|560744394|FG004|Period 2|Adverse Event|34|||
155357442|NCT02706951|560744390|FG000|Period 2|Withdrawal by Subject|0|||
155357443|NCT02706951|560744391|FG001|Period 2|Withdrawal by Subject|0|||
155357444|NCT02706951|560744392|FG002|Period 2|Withdrawal by Subject|0|||
155357445|NCT02706951|560744393|FG003|Period 2|Withdrawal by Subject|38|||
155357446|NCT02706951|560744394|FG004|Period 2|Withdrawal by Subject|44|||
155357447|NCT02706951|560744390|FG000|Period 2|Lost to Follow-up|0|||
155357448|NCT02706951|560744391|FG001|Period 2|Lost to Follow-up|0|||
155357449|NCT02706951|560744392|FG002|Period 2|Lost to Follow-up|0|||
155357450|NCT02706951|560744393|FG003|Period 2|Lost to Follow-up|17|||
155357451|NCT02706951|560744394|FG004|Period 2|Lost to Follow-up|9|||
155357452|NCT02706951|560744390|FG000|Period 2|COVID-19 Related|0|||
155357453|NCT02706951|560744391|FG001|Period 2|COVID-19 Related|0|||
155357454|NCT02706951|560744392|FG002|Period 2|COVID-19 Related|0|||
155357455|NCT02706951|560744393|FG003|Period 2|COVID-19 Related|1|||
155357456|NCT02706951|560744394|FG004|Period 2|COVID-19 Related|2|||
155357457|NCT02706951|560744390|FG000|Period 2|Other|0|||
155357458|NCT02706951|560744391|FG001|Period 2|Other|0|||
155357459|NCT02706951|560744392|FG002|Period 2|Other|0|||
155357460|NCT02706951|560744393|FG003|Period 2|Other|37|||
155357461|NCT02706951|560744394|FG004|Period 2|Other|31|||
155357462|NCT03603639|560744398|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357463|NCT03603639|560744399|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357464|NCT03603639|560744400|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357465|NCT03603639|560744401|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
155357466|NCT03603639|560744402|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357467|NCT03603639|560744403|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357468|NCT03603639|560744398|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357469|NCT03603639|560744399|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357470|NCT03603639|560744400|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357471|NCT03603639|560744401|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357472|NCT03603639|560744402|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357473|NCT03603639|560744403|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357474|NCT00551135|560744409|FG000|Overall Study|Adverse Event|1|||
155357475|NCT00551135|560744410|FG001|Overall Study|Adverse Event|0|||
155357476|NCT00551135|560744411|FG002|Overall Study|Adverse Event|1|||
155357477|NCT00551135|560744412|FG003|Overall Study|Adverse Event|1|||
155357478|NCT00551135|560744409|FG000|Overall Study|Lost to Follow-up|0|||
155357479|NCT00551135|560744410|FG001|Overall Study|Lost to Follow-up|0|||
155357480|NCT00551135|560744411|FG002|Overall Study|Lost to Follow-up|0|||
155357481|NCT00551135|560744412|FG003|Overall Study|Lost to Follow-up|1|||
155357482|NCT00551135|560744409|FG000|Overall Study|Other|3|||
155357483|NCT00551135|560744410|FG001|Overall Study|Other|2|||
155357484|NCT00551135|560744411|FG002|Overall Study|Other|1|||
155357485|NCT00551135|560744412|FG003|Overall Study|Other|2|||
155357486|NCT00551135|560744409|FG000|Overall Study|Withdrawal by Subject|1|||
155357487|NCT00551135|560744410|FG001|Overall Study|Withdrawal by Subject|0|||
155357488|NCT00551135|560744411|FG002|Overall Study|Withdrawal by Subject|3|||
155357489|NCT00551135|560744412|FG003|Overall Study|Withdrawal by Subject|1|||
155357490|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
155357491|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
155357492|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
155357493|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
155357494|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
155357495|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
155357496|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
155357497|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
155357498|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
155357499|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
155357500|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
155357501|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
155357502|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
155357503|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
155357504|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
155357505|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
155357506|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
155357507|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
155357508|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
155357509|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
155357510|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
155427233|NCT02875223|560989955|FG007|Overall Study|Lost to Follow-up|1|||
155357511|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
155357512|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
155357513|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
155357514|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
155357515|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
155357516|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
155357517|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
155357518|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
155357519|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
155357520|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
155357521|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
155357522|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
155357523|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
155357524|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
155357525|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
155357526|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
155357527|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
155357528|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
155357529|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
155357530|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
155357531|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
155357532|NCT04294667|560744416|FG000|Overall Study|Lack of Efficacy|4|||
155357533|NCT04294667|560744417|FG001|Overall Study|Lack of Efficacy|4|||
155357534|NCT04294667|560744416|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
155357535|NCT04294667|560744417|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
155357536|NCT04294667|560744416|FG000|Overall Study|Patient has a Renal Flare|1|||
155357537|NCT04294667|560744417|FG001|Overall Study|Patient has a Renal Flare|0|||
155357538|NCT04294667|560744416|FG000|Overall Study|SLE Worsening|0|||
155357539|NCT04294667|560744417|FG001|Overall Study|SLE Worsening|1|||
155357540|NCT04294667|560744416|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
155357541|NCT04294667|560744417|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
155357542|NCT04294667|560744416|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
155357543|NCT04294667|560744417|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
155357544|NCT04294667|560744416|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
155357545|NCT04294667|560744417|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
155357546|NCT04294667|560744416|FG000|Overall Study|Subject Moved to Another State|0|||
155357547|NCT04294667|560744417|FG001|Overall Study|Subject Moved to Another State|1|||
155357548|NCT04294667|560744416|FG000|Overall Study|Adverse event, serious fatal|0|||
155357549|NCT04294667|560744417|FG001|Overall Study|Adverse event, serious fatal|1|||
155357550|NCT04294667|560744416|FG000|Overall Study|Adverse event, non-fatal|3|||
155357551|NCT04294667|560744417|FG001|Overall Study|Adverse event, non-fatal|4|||
155357552|NCT02165397|560744418|FG000|Overall Study|Death|7|||
155357553|NCT02165397|560744419|FG001|Overall Study|Death|10|||
155357554|NCT02165397|560744420|FG002|Overall Study|Death|8|||
155357555|NCT02165397|560744418|FG000|Overall Study|Lost to Follow-up|1|||
155357556|NCT02165397|560744419|FG001|Overall Study|Lost to Follow-up|3|||
155357557|NCT02165397|560744420|FG002|Overall Study|Lost to Follow-up|0|||
155357558|NCT02165397|560744418|FG000|Overall Study|Withdrawal by Subject|6|||
155357559|NCT02165397|560744419|FG001|Overall Study|Withdrawal by Subject|6|||
155357560|NCT02165397|560744420|FG002|Overall Study|Withdrawal by Subject|1|||
155357561|NCT02165397|560744418|FG000|Overall Study|Other, Not Specified|0|||
155357562|NCT02165397|560744419|FG001|Overall Study|Other, Not Specified|0|||
155357563|NCT02165397|560744420|FG002|Overall Study|Other, Not Specified|1|||
155357564|NCT04799418|560744421|FG000|Overall Study|Death|1|||
155357565|NCT04799418|560744422|FG001|Overall Study|Death|1|||
155357566|NCT04799418|560744421|FG000|Overall Study|Lack of Efficacy|14|||
155357567|NCT04799418|560744422|FG001|Overall Study|Lack of Efficacy|14|||
155357568|NCT04799418|560744421|FG000|Overall Study|Withdrawal by Subject|10|||
155507045|NCT00373685|561283516|FG001|Overall Study|Did not meet entrance criteria|184|||
155507046|NCT00373685|561283515|FG000|Overall Study|Lost to follow up|83|||
155507047|NCT00373685|561283516|FG001|Overall Study|Lost to follow up|103|||
155357569|NCT04799418|560744422|FG001|Overall Study|Withdrawal by Subject|7|||
155357570|NCT04799418|560744421|FG000|Overall Study|Adverse Event|3|||
155357571|NCT04799418|560744422|FG001|Overall Study|Adverse Event|2|||
155357572|NCT03297398|560744423|FG000|Overall Study|Sponsor's decision|6|||
155357573|NCT03297398|560744424|FG001|Overall Study|Sponsor's decision|9|||
155648690|NCT02675452|561805896|FG015|Overall Study|Withdrawal by Subject|0|||
155357574|NCT03297398|560744425|FG002|Overall Study|Sponsor's decision|7|||
155357575|NCT03297398|560744423|FG000|Overall Study|Adverse Event|1|||
155357576|NCT03297398|560744424|FG001|Overall Study|Adverse Event|4|||
155357577|NCT03297398|560744425|FG002|Overall Study|Adverse Event|4|||
155357578|NCT03297398|560744423|FG000|Overall Study|Withdrawal by Subject|1|||
155427234|NCT02875223|560989956|FG008|Overall Study|Lost to Follow-up|0|||
155427235|NCT02875223|560989957|FG009|Overall Study|Lost to Follow-up|0|||
155427236|NCT02875223|560989958|FG010|Overall Study|Lost to Follow-up|0|||
155427237|NCT02875223|560989959|FG011|Overall Study|Lost to Follow-up|0|||
155427238|NCT02875223|560989960|FG012|Overall Study|Lost to Follow-up|0|||
155427239|NCT01827384|560989963|FG000|Overall Study|Switched to alternative treatment|0|||
155427240|NCT01827384|560989964|FG001|Overall Study|Switched to alternative treatment|0|||
155427241|NCT01827384|560989965|FG002|Overall Study|Switched to alternative treatment|0|||
155427242|NCT01827384|560989966|FG003|Overall Study|Switched to alternative treatment|0|||
155427243|NCT01827384|560989967|FG004|Overall Study|Switched to alternative treatment|0|||
155427244|NCT01827384|560989968|FG005|Overall Study|Switched to alternative treatment|0|||
155427245|NCT01827384|560989969|FG006|Overall Study|Switched to alternative treatment|0|||
155427246|NCT01827384|560989970|FG007|Overall Study|Switched to alternative treatment|0|||
155427247|NCT01827384|560989971|FG008|Overall Study|Switched to alternative treatment|0|||
155427248|NCT01827384|560989972|FG009|Overall Study|Switched to alternative treatment|0|||
155427249|NCT01827384|560989973|FG010|Overall Study|Switched to alternative treatment|0|||
155427250|NCT01827384|560989974|FG011|Overall Study|Switched to alternative treatment|0|||
155427251|NCT01827384|560989975|FG012|Overall Study|Switched to alternative treatment|0|||
155427252|NCT01827384|560989976|FG013|Overall Study|Switched to alternative treatment|2|||
155427253|NCT01827384|560989963|FG000|Overall Study|Disease progression before treatment|0|||
155427254|NCT01827384|560989964|FG001|Overall Study|Disease progression before treatment|0|||
155427255|NCT01827384|560989965|FG002|Overall Study|Disease progression before treatment|0|||
155427256|NCT01827384|560989966|FG003|Overall Study|Disease progression before treatment|0|||
155427257|NCT01827384|560989967|FG004|Overall Study|Disease progression before treatment|0|||
155427258|NCT01827384|560989968|FG005|Overall Study|Disease progression before treatment|0|||
155427259|NCT01827384|560989969|FG006|Overall Study|Disease progression before treatment|0|||
155427260|NCT01827384|560989970|FG007|Overall Study|Disease progression before treatment|0|||
155427261|NCT01827384|560989971|FG008|Overall Study|Disease progression before treatment|0|||
155427262|NCT01827384|560989972|FG009|Overall Study|Disease progression before treatment|0|||
155427263|NCT01827384|560989973|FG010|Overall Study|Disease progression before treatment|0|||
155427264|NCT01827384|560989974|FG011|Overall Study|Disease progression before treatment|0|||
155427265|NCT01827384|560989975|FG012|Overall Study|Disease progression before treatment|0|||
155427266|NCT01827384|560989976|FG013|Overall Study|Disease progression before treatment|4|||
155427267|NCT01827384|560989963|FG000|Overall Study|Ineligible|0|||
155427268|NCT01827384|560989964|FG001|Overall Study|Ineligible|0|||
155427269|NCT01827384|560989965|FG002|Overall Study|Ineligible|0|||
155427270|NCT01827384|560989966|FG003|Overall Study|Ineligible|0|||
155427271|NCT01827384|560989967|FG004|Overall Study|Ineligible|0|||
155648691|NCT02675452|561805897|FG016|Overall Study|Withdrawal by Subject|2|||
155648692|NCT02675452|561805898|FG017|Overall Study|Withdrawal by Subject|0|||
155648693|NCT02675452|561805899|FG018|Overall Study|Withdrawal by Subject|0|||
155648694|NCT02675452|561805900|FG019|Overall Study|Withdrawal by Subject|0|||
155648695|NCT02675452|561805901|FG020|Overall Study|Withdrawal by Subject|0|||
155648696|NCT02675452|561805902|FG021|Overall Study|Withdrawal by Subject|0|||
155648697|NCT02675452|561805903|FG022|Overall Study|Withdrawal by Subject|3|||
155648698|NCT02675452|561805904|FG023|Overall Study|Withdrawal by Subject|0|||
155648699|NCT02675452|561805905|FG024|Overall Study|Withdrawal by Subject|1|||
155648700|NCT02675452|561805906|FG025|Overall Study|Withdrawal by Subject|0|||
155648701|NCT02675452|561805907|FG026|Overall Study|Withdrawal by Subject|1|||
155648702|NCT02675452|561805908|FG027|Overall Study|Withdrawal by Subject|3|||
155648703|NCT02675452|561805909|FG028|Overall Study|Withdrawal by Subject|4|||
155648704|NCT02675452|561805881|FG000|Overall Study|Death|0|||
155648705|NCT02675452|561805882|FG001|Overall Study|Death|0|||
155648706|NCT02675452|561805883|FG002|Overall Study|Death|1|||
155648707|NCT02675452|561805884|FG003|Overall Study|Death|0|||
155648708|NCT02675452|561805885|FG004|Overall Study|Death|0|||
155648709|NCT02675452|561805886|FG005|Overall Study|Death|1|||
155648710|NCT02675452|561805887|FG006|Overall Study|Death|0|||
155648711|NCT02675452|561805888|FG007|Overall Study|Death|0|||
155357579|NCT03297398|560744424|FG001|Overall Study|Withdrawal by Subject|2|||
155357580|NCT03297398|560744425|FG002|Overall Study|Withdrawal by Subject|2|||
155357581|NCT03297398|560744423|FG000|Overall Study|Protocol Violation|0|||
155357582|NCT03297398|560744424|FG001|Overall Study|Protocol Violation|2|||
155357583|NCT03297398|560744425|FG002|Overall Study|Protocol Violation|0|||
155357584|NCT03297398|560744423|FG000|Overall Study|Physician Decision|0|||
155357585|NCT03297398|560744424|FG001|Overall Study|Physician Decision|0|||
155357586|NCT03297398|560744425|FG002|Overall Study|Physician Decision|1|||
155357587|NCT03297398|560744423|FG000|Overall Study|Lost to Follow-up|0|||
155357588|NCT03297398|560744424|FG001|Overall Study|Lost to Follow-up|0|||
155357589|NCT03297398|560744425|FG002|Overall Study|Lost to Follow-up|1|||
155357590|NCT00611715|560744430|FG000|Overall Study|Disease Progression|24|||
155357591|NCT00611715|560744431|FG001|Overall Study|Disease Progression|4|||
155357592|NCT00611715|560744430|FG000|Overall Study|Withdrawal by Subject|5|||
155357593|NCT00611715|560744431|FG001|Overall Study|Withdrawal by Subject|1|||
155357594|NCT00611715|560744430|FG000|Overall Study|Adverse Event|9|||
155357595|NCT00611715|560744431|FG001|Overall Study|Adverse Event|1|||
155357596|NCT00611715|560744430|FG000|Overall Study|Death|1|||
155357597|NCT00611715|560744431|FG001|Overall Study|Death|0|||
155357598|NCT00611715|560744430|FG000|Overall Study|two patients are still on treatment|2|||
155357599|NCT00611715|560744431|FG001|Overall Study|two patients are still on treatment|0|||
155357600|NCT00107978|560744432|FG000|Overall Study|Adverse Event|1|||
155357601|NCT00107978|560744433|FG001|Overall Study|Adverse Event|5|||
155357602|NCT00107978|560744432|FG000|Overall Study|Death|3|||
155357603|NCT00107978|560744433|FG001|Overall Study|Death|3|||
155357604|NCT00107978|560744432|FG000|Overall Study|Lost to Follow-up|20|||
155357605|NCT00107978|560744433|FG001|Overall Study|Lost to Follow-up|28|||
155357606|NCT00107978|560744432|FG000|Overall Study|Withdrawal by Subject|4|||
155357607|NCT00107978|560744433|FG001|Overall Study|Withdrawal by Subject|9|||
155357608|NCT00107978|560744432|FG000|Overall Study|Protocol Violation|0|||
155357609|NCT00107978|560744433|FG001|Overall Study|Protocol Violation|1|||
155357610|NCT00107978|560744432|FG000|Overall Study|Other|5|||
155357611|NCT00107978|560744433|FG001|Overall Study|Other|4|||
155357612|NCT02669407|560744434|FG000|Overall Study|Physician Decision|3|||
155357613|NCT01841697|560744435|FG000|Overall Study|Death|0|||
155357614|NCT01841697|560744436|FG001|Overall Study|Death|1|||
155648712|NCT02675452|561805889|FG008|Overall Study|Death|1|||
155648713|NCT02675452|561805890|FG009|Overall Study|Death|0|||
155648714|NCT02675452|561805891|FG010|Overall Study|Death|0|||
155357615|NCT01841697|560744435|FG000|Overall Study|Lost to Follow-up|4|||
155357616|NCT01841697|560744436|FG001|Overall Study|Lost to Follow-up|1|||
155357617|NCT01841697|560744435|FG000|Overall Study|Withdrawal by Subject|16|||
155357618|NCT01841697|560744436|FG001|Overall Study|Withdrawal by Subject|16|||
155648715|NCT02675452|561805892|FG011|Overall Study|Death|0|||
155648716|NCT02675452|561805893|FG012|Overall Study|Death|1|||
155357619|NCT00727415|560744437|FG000|Phase I|Dose Limiting Toxicity|2|||
155357620|NCT03634839|560744442|FG000|First Intervention (2 Hours)|Adverse Event|0|||
155357621|NCT03634839|560744443|FG001|First Intervention (2 Hours)|Adverse Event|2|||
155648717|NCT02675452|561805894|FG013|Overall Study|Death|0|||
155648718|NCT02675452|561805895|FG014|Overall Study|Death|0|||
155648719|NCT02675452|561805896|FG015|Overall Study|Death|2|||
155648720|NCT02675452|561805897|FG016|Overall Study|Death|0|||
155648721|NCT02675452|561805898|FG017|Overall Study|Death|0|||
155357622|NCT00350298|560744444|FG000|Overall Study|Death|7|||
155357623|NCT00350298|560744445|FG001|Overall Study|Death|8|||
155357624|NCT00350298|560744444|FG000|Overall Study|Lost to Follow-up|1|||
155357625|NCT00350298|560744445|FG001|Overall Study|Lost to Follow-up|2|||
155357626|NCT00350298|560744444|FG000|Overall Study|Withdrawal by Subject|1|||
155357627|NCT00350298|560744445|FG001|Overall Study|Withdrawal by Subject|3|||
155357628|NCT00233389|560744448|FG000|Overall Study|Adverse Event|5|||
155357629|NCT00233389|560744449|FG001|Overall Study|Adverse Event|5|||
155357630|NCT00233389|560744448|FG000|Overall Study|Lack of Efficacy|11|||
155357631|NCT00233389|560744449|FG001|Overall Study|Lack of Efficacy|8|||
155357632|NCT00233389|560744448|FG000|Overall Study|Lost to Follow-up|1|||
155357633|NCT00233389|560744449|FG001|Overall Study|Lost to Follow-up|1|||
155357634|NCT00233389|560744448|FG000|Overall Study|Physician Decision|1|||
155357635|NCT00233389|560744449|FG001|Overall Study|Physician Decision|0|||
155507048|NCT00373685|561283515|FG000|Overall Study|No longer willing to participate|337|||
155507049|NCT00373685|561283516|FG001|Overall Study|No longer willing to participate|352|||
155507050|NCT00373685|561283515|FG000|Overall Study|Other|149|||
155357636|NCT00233389|560744448|FG000|Overall Study|Protocol Violation|0|||
155357637|NCT00233389|560744449|FG001|Overall Study|Protocol Violation|1|||
155357638|NCT00233389|560744448|FG000|Overall Study|Withdrawal by Subject|0|||
155357639|NCT00233389|560744449|FG001|Overall Study|Withdrawal by Subject|1|||
155357640|NCT00719043|560744455|FG000|Overall Study|Adverse Event|5|||
155357641|NCT00719043|560744456|FG001|Overall Study|Adverse Event|1|||
155357642|NCT00719043|560744457|FG002|Overall Study|Adverse Event|2|||
155357643|NCT00719043|560744458|FG003|Overall Study|Adverse Event|2|||
155357644|NCT00719043|560744459|FG004|Overall Study|Adverse Event|1|||
155357645|NCT00719043|560744460|FG005|Overall Study|Adverse Event|4|||
155357646|NCT00719043|560744461|FG006|Overall Study|Adverse Event|4|||
155357647|NCT00719043|560744455|FG000|Overall Study|Lost to Follow-up|14|||
155357648|NCT00719043|560744456|FG001|Overall Study|Lost to Follow-up|10|||
155357649|NCT00719043|560744457|FG002|Overall Study|Lost to Follow-up|8|||
155357650|NCT00719043|560744458|FG003|Overall Study|Lost to Follow-up|9|||
155357651|NCT00719043|560744459|FG004|Overall Study|Lost to Follow-up|10|||
155357652|NCT00719043|560744460|FG005|Overall Study|Lost to Follow-up|9|||
155357653|NCT00719043|560744461|FG006|Overall Study|Lost to Follow-up|9|||
155357654|NCT00719043|560744455|FG000|Overall Study|Protocol Violation|0|||
155357655|NCT00719043|560744456|FG001|Overall Study|Protocol Violation|0|||
155507051|NCT00373685|561283516|FG001|Overall Study|Other|146|||
155507052|NCT00373685|561283515|FG000|Overall Study|Protocol Violation|191|||
155507053|NCT00373685|561283516|FG001|Overall Study|Protocol Violation|182|||
155507054|NCT00373685|561283515|FG000|Overall Study|Final Status Unknown|12|||
155507055|NCT00373685|561283516|FG001|Overall Study|Final Status Unknown|4|||
155507056|NCT00373685|561283515|FG000|Overall Study|Randomized, not treated|51|||
155507057|NCT00373685|561283516|FG001|Overall Study|Randomized, not treated|77|||
155507058|NCT01783496|561283517|FG000|Overall Study|Lost to Follow-up|0|||
155507059|NCT01783496|561283518|FG001|Overall Study|Lost to Follow-up|0|||
155507060|NCT01783496|561283519|FG002|Overall Study|Lost to Follow-up|0|||
155507061|NCT01783496|561283520|FG003|Overall Study|Lost to Follow-up|2|||
155507062|NCT01783496|561283521|FG004|Overall Study|Lost to Follow-up|0|||
155507063|NCT01783496|561283522|FG005|Overall Study|Lost to Follow-up|1|||
155507064|NCT01783496|561283517|FG000|Overall Study|Withdrawal by Subject|1|||
155507065|NCT01783496|561283518|FG001|Overall Study|Withdrawal by Subject|0|||
155357656|NCT00719043|560744457|FG002|Overall Study|Protocol Violation|0|||
155357657|NCT00719043|560744458|FG003|Overall Study|Protocol Violation|0|||
155357658|NCT00719043|560744459|FG004|Overall Study|Protocol Violation|0|||
155357659|NCT00719043|560744460|FG005|Overall Study|Protocol Violation|1|||
155357660|NCT00719043|560744461|FG006|Overall Study|Protocol Violation|0|||
155357661|NCT00719043|560744455|FG000|Overall Study|Other|1|||
155357662|NCT00719043|560744456|FG001|Overall Study|Other|0|||
155357663|NCT00719043|560744457|FG002|Overall Study|Other|1|||
155357664|NCT00719043|560744458|FG003|Overall Study|Other|2|||
155357665|NCT00719043|560744459|FG004|Overall Study|Other|0|||
155357666|NCT00719043|560744460|FG005|Overall Study|Other|2|||
155357667|NCT00719043|560744461|FG006|Overall Study|Other|1|||
155357668|NCT00719043|560744455|FG000|Overall Study|Withdrawal by Subject|12|||
155357669|NCT00719043|560744456|FG001|Overall Study|Withdrawal by Subject|14|||
155357670|NCT00719043|560744457|FG002|Overall Study|Withdrawal by Subject|9|||
155357671|NCT00719043|560744458|FG003|Overall Study|Withdrawal by Subject|10|||
155357672|NCT00719043|560744459|FG004|Overall Study|Withdrawal by Subject|16|||
155357673|NCT00719043|560744460|FG005|Overall Study|Withdrawal by Subject|18|||
155357674|NCT00719043|560744461|FG006|Overall Study|Withdrawal by Subject|14|||
155507066|NCT01783496|561283519|FG002|Overall Study|Withdrawal by Subject|0|||
155507067|NCT01783496|561283520|FG003|Overall Study|Withdrawal by Subject|0|||
155507068|NCT01783496|561283521|FG004|Overall Study|Withdrawal by Subject|0|||
155507069|NCT01783496|561283522|FG005|Overall Study|Withdrawal by Subject|0|||
155507070|NCT00947011|561283523|FG000|Overall Study|Study was terminated,PI left institution|12|||
155507071|NCT05266456|561283524|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
155357675|NCT01588366|560744464|FG000|Overall Study|Adverse Event|0|||
155357676|NCT01588366|560744465|FG001|Overall Study|Adverse Event|1|||
155357677|NCT01588366|560744466|FG002|Overall Study|Adverse Event|0|||
155357678|NCT01588366|560744467|FG003|Overall Study|Adverse Event|1|||
155357679|NCT01588366|560744468|FG004|Overall Study|Adverse Event|0|||
155357680|NCT01588366|560744469|FG005|Overall Study|Adverse Event|2|||
155357681|NCT00302159|560744470|FG000|Overall Study|pt declined before treatment started|1|||
155357682|NCT00302159|560744470|FG000|Overall Study|pt started Avastin|1|||
155357683|NCT04962698|560744473|FG000|Motor Imagery|Technical difficulty|1|||
155507072|NCT05266456|561283525|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
155648722|NCT02675452|561805899|FG018|Overall Study|Death|4|||
155357684|NCT04962698|560744474|FG001|Motor Imagery|Technical difficulty|0|||
155357685|NCT04962698|560744473|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
155357686|NCT04962698|560744474|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
155648723|NCT02675452|561805900|FG019|Overall Study|Death|3|||
155648724|NCT02675452|561805901|FG020|Overall Study|Death|3|||
155507073|NCT05266456|561283526|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
155357687|NCT04962698|560744473|FG000|Kinesthetic MI|Technical difficulty|1|||
155357688|NCT04962698|560744474|FG001|Kinesthetic MI|Technical difficulty|0|||
155357689|NCT04962698|560744473|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
155357690|NCT04962698|560744474|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
155357691|NCT04962698|560744473|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
155648725|NCT02675452|561805902|FG021|Overall Study|Death|3|||
155357692|NCT04962698|560744474|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
155357693|NCT04962698|560744473|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
155357694|NCT04962698|560744474|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
155357695|NCT04962698|560744473|FG000|Virtual-hand Interaction|Technical difficulty|1|||
155357696|NCT04962698|560744474|FG001|Virtual-hand Interaction|Technical difficulty|0|||
155357697|NCT04962698|560744473|FG000|Robotic Action Observation|Technical difficulty|1|||
155357698|NCT04962698|560744474|FG001|Robotic Action Observation|Technical difficulty|0|||
155357699|NCT04962698|560744473|FG000|Rest|Technical difficulty|1|||
155357700|NCT04962698|560744474|FG001|Rest|Technical difficulty|0|||
155357701|NCT04962698|560744473|FG000|Rest|Exclusion criteria met after enrollment|0|||
155357702|NCT04962698|560744474|FG001|Rest|Exclusion criteria met after enrollment|2|||
155357703|NCT00853229|560744475|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
155357704|NCT00853229|560744476|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
155357705|NCT00585975|560744480|FG000|Overall Study|Withdrawal by Subject|3|||
155357706|NCT00585975|560744481|FG001|Overall Study|Withdrawal by Subject|3|||
155357707|NCT00585975|560744480|FG000|Overall Study|Lost to Follow-up|2|||
155357708|NCT00585975|560744481|FG001|Overall Study|Lost to Follow-up|1|||
155357709|NCT00585975|560744480|FG000|Overall Study|Enrollment met/over-enrolled|10|||
155357710|NCT00585975|560744481|FG001|Overall Study|Enrollment met/over-enrolled|9|||
155357711|NCT03082612|560744482|FG000|Overall Study|Lost to Follow-up|2|||
155357712|NCT03082612|560744483|FG001|Overall Study|Lost to Follow-up|0|||
155357713|NCT00952848|560744488|FG000|Overall Study|Withdrawal by Subject|4|||
155357714|NCT02413593|560744489|FG000|Overall Study|Lost to Follow-up|3|||
155357715|NCT02413593|560744489|FG000|Overall Study|Adverse Event|1|||
155357716|NCT03845075|560744490|FG000|Part 1 - DB|Withdrawal by Subject|1|||
155357717|NCT03845075|560744491|FG001|Part 1 - DB|Withdrawal by Subject|1|||
155507074|NCT05266456|561283527|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
155507075|NCT05266456|561283524|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
155507076|NCT05266456|561283525|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
155507077|NCT05266456|561283526|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
155507078|NCT05266456|561283527|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
155507079|NCT05266456|561283524|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
155507080|NCT05266456|561283525|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
155507081|NCT05266456|561283526|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
155507082|NCT05266456|561283527|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
155507083|NCT05266456|561283524|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
155507084|NCT05266456|561283525|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
155507085|NCT05266456|561283526|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
155507086|NCT05266456|561283527|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
155507087|NCT05266456|561283524|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
155507088|NCT05266456|561283525|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
155507089|NCT05266456|561283526|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
155357718|NCT03845075|560744492|FG002|Part 1 - DB|Withdrawal by Subject|0|||
155357719|NCT03845075|560744493|FG003|Part 1 - DB|Withdrawal by Subject|0|||
155357720|NCT03845075|560744490|FG000|Part 1 - DB|Adverse Event|0|||
155357721|NCT03845075|560744491|FG001|Part 1 - DB|Adverse Event|1|||
155357722|NCT03845075|560744492|FG002|Part 1 - DB|Adverse Event|0|||
155357723|NCT03845075|560744493|FG003|Part 1 - DB|Adverse Event|0|||
155507090|NCT05266456|561283527|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
155507091|NCT00068237|561283528|FG000|Overall Study|Ineligible|3|||
155507092|NCT00068237|561283528|FG000|Overall Study|No protocol treatment received|2|||
155507093|NCT03124381|561283532|FG000|Overall Study|Lost to Follow-up|1|||
155507094|NCT03124381|561283533|FG001|Overall Study|Lost to Follow-up|1|||
155507095|NCT03124381|561283532|FG000|Overall Study|Withdrawal by Subject|6|||
155507096|NCT03124381|561283533|FG001|Overall Study|Withdrawal by Subject|3|||
155507097|NCT03124381|561283532|FG000|Overall Study|Protocol Violation|0|||
155507098|NCT03124381|561283533|FG001|Overall Study|Protocol Violation|1|||
155507099|NCT03124381|561283532|FG000|Overall Study|Adverse Event|1|||
155357724|NCT03845075|560744490|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
155357725|NCT03845075|560744491|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155507100|NCT03124381|561283533|FG001|Overall Study|Adverse Event|1|||
155507101|NCT03124381|561283532|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
155507102|NCT03124381|561283533|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
155357726|NCT03845075|560744492|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155357727|NCT03845075|560744493|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155357728|NCT02564718|560744494|FG000|Overall Study|Withdrew from treatment|0|||
155357729|NCT02564718|560744495|FG001|Overall Study|Withdrew from treatment|1|||
155357730|NCT00104637|560744496|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
155357731|NCT00104637|560744497|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
155507103|NCT05017493|561283541|FG000|Overall Study|Withdrawal by Subject|26|||
155507104|NCT05017493|561283542|FG001|Overall Study|Withdrawal by Subject|0|||
155507105|NCT05017493|561283541|FG000|Overall Study|Physician Decision|15|||
155357732|NCT00857233|560744498|FG000|Overall Study|Adverse Event|24|||
155357733|NCT00857233|560744498|FG000|Overall Study|Lack of Efficacy|1|||
155357734|NCT00857233|560744498|FG000|Overall Study|Non-compliance|1|||
155357735|NCT00857233|560744498|FG000|Overall Study|Withdrawal of Consent|9|||
155357736|NCT00857233|560744498|FG000|Overall Study|Lost to Follow-up|4|||
155357737|NCT00857233|560744498|FG000|Overall Study|Nursing Home Placement|14|||
155357738|NCT00857233|560744498|FG000|Overall Study|Other Reasons|2|||
155357739|NCT01130168|560744499|FG000|Period 1|Withdrawal by Subject|0|||
155357740|NCT01130168|560744500|FG001|Period 1|Withdrawal by Subject|1|||
155357741|NCT01130168|560744501|FG002|Period 1|Withdrawal by Subject|0|||
155357742|NCT01130168|560744502|FG003|Period 1|Withdrawal by Subject|1|||
155357743|NCT01130168|560744503|FG004|Period 1|Withdrawal by Subject|0|||
155357744|NCT01130168|560744504|FG005|Period 1|Withdrawal by Subject|0|||
155357745|NCT01130168|560744499|FG000|Period 1|Discontinued For Other Reason|0|||
155357746|NCT01130168|560744500|FG001|Period 1|Discontinued For Other Reason|0|||
155357747|NCT01130168|560744501|FG002|Period 1|Discontinued For Other Reason|1|||
155357748|NCT01130168|560744502|FG003|Period 1|Discontinued For Other Reason|1|||
155357749|NCT01130168|560744503|FG004|Period 1|Discontinued For Other Reason|0|||
155357750|NCT01130168|560744504|FG005|Period 1|Discontinued For Other Reason|0|||
155357751|NCT01130168|560744499|FG000|Period 1|Adverse Event|0|||
155357752|NCT01130168|560744500|FG001|Period 1|Adverse Event|0|||
155357753|NCT01130168|560744501|FG002|Period 1|Adverse Event|0|||
155357754|NCT01130168|560744502|FG003|Period 1|Adverse Event|1|||
155357755|NCT01130168|560744503|FG004|Period 1|Adverse Event|0|||
155357756|NCT01130168|560744504|FG005|Period 1|Adverse Event|0|||
155357757|NCT02725528|560744505|FG000|Overall Study|Lost to Follow-up|1|||
155357758|NCT02725528|560744506|FG001|Overall Study|Lost to Follow-up|4|||
155357759|NCT02725528|560744505|FG000|Overall Study|Withdrawal by Subject|0|||
155357760|NCT02725528|560744506|FG001|Overall Study|Withdrawal by Subject|1|||
155357761|NCT02058836|560744507|FG000|Overall Study|Withdrawal by Subject|1|||
155357762|NCT02058836|560744508|FG001|Overall Study|Withdrawal by Subject|1|||
155357763|NCT03151551|560744514|FG000|Open-Label Treatment Period|Adverse Event|0|||
155357764|NCT03151551|560744515|FG001|Open-Label Treatment Period|Adverse Event|2|||
155357765|NCT03151551|560744514|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
155357766|NCT03151551|560744515|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155357767|NCT03151551|560744514|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
155357768|NCT03151551|560744515|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
155357769|NCT03151551|560744514|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
155357770|NCT03151551|560744515|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
155357771|NCT03151551|560744514|FG000|Open-Label Treatment Period|Physician Decision|3|||
155357772|NCT03151551|560744515|FG001|Open-Label Treatment Period|Physician Decision|0|||
155357773|NCT03151551|560744514|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
155357774|NCT03151551|560744515|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
155357775|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
155357776|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
155357777|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155357778|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155357779|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
155357780|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
155357781|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
155357782|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
155357783|NCT03526679|560746393|FG000|Overall Study|still under treatment|2|||
155357784|NCT00966264|560746394|FG000|Overall Study|Lost to Follow-up|4|||
155357785|NCT00966264|560746395|FG001|Overall Study|Lost to Follow-up|3|||
155357786|NCT02366143|560746398|FG000|Overall Study|Death|307|||
155357787|NCT02366143|560746399|FG001|Overall Study|Death|278|||
155357788|NCT02366143|560746400|FG002|Overall Study|Death|280|||
155357789|NCT02366143|560746398|FG000|Overall Study|Lost to Follow-up|2|||
155357790|NCT02366143|560746399|FG001|Overall Study|Lost to Follow-up|4|||
155357791|NCT02366143|560746400|FG002|Overall Study|Lost to Follow-up|2|||
155357792|NCT02366143|560746398|FG000|Overall Study|Physician Decision|1|||
155507106|NCT05017493|561283542|FG001|Overall Study|Physician Decision|0|||
155507107|NCT05017493|561283541|FG000|Overall Study|Protocol Violation|81|||
155507108|NCT05017493|561283542|FG001|Overall Study|Protocol Violation|0|||
155357793|NCT02366143|560746399|FG001|Overall Study|Physician Decision|2|||
155357794|NCT02366143|560746400|FG002|Overall Study|Physician Decision|1|||
155357795|NCT02366143|560746398|FG000|Overall Study|Protocol Violation|0|||
155357796|NCT02366143|560746399|FG001|Overall Study|Protocol Violation|0|||
155357797|NCT02366143|560746400|FG002|Overall Study|Protocol Violation|2|||
155357798|NCT02366143|560746398|FG000|Overall Study|Withdrawal by Subject|16|||
155357799|NCT02366143|560746399|FG001|Overall Study|Withdrawal by Subject|17|||
155357800|NCT02366143|560746400|FG002|Overall Study|Withdrawal by Subject|22|||
155357801|NCT02366143|560746398|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
155357802|NCT02366143|560746399|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
155648726|NCT02675452|561805903|FG022|Overall Study|Death|7|||
155648727|NCT02675452|561805904|FG023|Overall Study|Death|5|||
155648728|NCT02675452|561805905|FG024|Overall Study|Death|3|||
155648729|NCT02675452|561805906|FG025|Overall Study|Death|4|||
155648730|NCT02675452|561805907|FG026|Overall Study|Death|7|||
155648731|NCT02675452|561805908|FG027|Overall Study|Death|6|||
155648732|NCT02675452|561805909|FG028|Overall Study|Death|9|||
155648733|NCT02675452|561805881|FG000|Overall Study|Lost to Follow-up|0|||
155648734|NCT02675452|561805882|FG001|Overall Study|Lost to Follow-up|1|||
155648735|NCT02675452|561805883|FG002|Overall Study|Lost to Follow-up|0|||
155648736|NCT02675452|561805884|FG003|Overall Study|Lost to Follow-up|0|||
155648737|NCT02675452|561805885|FG004|Overall Study|Lost to Follow-up|0|||
155648738|NCT02675452|561805886|FG005|Overall Study|Lost to Follow-up|0|||
155648739|NCT02675452|561805887|FG006|Overall Study|Lost to Follow-up|0|||
155648740|NCT02675452|561805888|FG007|Overall Study|Lost to Follow-up|0|||
155648741|NCT02675452|561805889|FG008|Overall Study|Lost to Follow-up|0|||
155648742|NCT02675452|561805890|FG009|Overall Study|Lost to Follow-up|0|||
155648743|NCT02675452|561805891|FG010|Overall Study|Lost to Follow-up|0|||
155648744|NCT02675452|561805892|FG011|Overall Study|Lost to Follow-up|0|||
155648745|NCT02675452|561805893|FG012|Overall Study|Lost to Follow-up|1|||
155648746|NCT02675452|561805894|FG013|Overall Study|Lost to Follow-up|0|||
155648747|NCT02675452|561805895|FG014|Overall Study|Lost to Follow-up|0|||
155648748|NCT02675452|561805896|FG015|Overall Study|Lost to Follow-up|0|||
155357803|NCT02366143|560746400|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
155357804|NCT02366143|560746398|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
155357805|NCT02366143|560746399|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
155357806|NCT02366143|560746400|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
155357807|NCT02366143|560746398|FG000|Overall Study|Randomization Error|1|||
155357808|NCT02366143|560746399|FG001|Overall Study|Randomization Error|0|||
155357809|NCT02366143|560746400|FG002|Overall Study|Randomization Error|0|||
155357810|NCT02366143|560746398|FG000|Overall Study|PI Move and Site Closure|1|||
155357811|NCT02366143|560746399|FG001|Overall Study|PI Move and Site Closure|0|||
155357812|NCT02366143|560746400|FG002|Overall Study|PI Move and Site Closure|1|||
155357813|NCT02366143|560746398|FG000|Overall Study|Study Terminated By Sponsor|0|||
155357814|NCT02366143|560746399|FG001|Overall Study|Study Terminated By Sponsor|0|||
155357815|NCT02366143|560746400|FG002|Overall Study|Study Terminated By Sponsor|2|||
155357816|NCT02366143|560746398|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
155357817|NCT02366143|560746399|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
155357818|NCT02366143|560746400|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
155357819|NCT02366143|560746398|FG000|Overall Study|Patient moved to roll-over study|1|||
155357820|NCT02366143|560746399|FG001|Overall Study|Patient moved to roll-over study|19|||
155357821|NCT02366143|560746400|FG002|Overall Study|Patient moved to roll-over study|28|||
155357822|NCT02366143|560746398|FG000|Overall Study|Patient moved to commercial stock|0|||
155357823|NCT02366143|560746399|FG001|Overall Study|Patient moved to commercial stock|0|||
155427272|NCT01827384|560989968|FG005|Overall Study|Ineligible|0|||
155648749|NCT02675452|561805897|FG016|Overall Study|Lost to Follow-up|0|||
155648750|NCT02675452|561805898|FG017|Overall Study|Lost to Follow-up|0|||
155648751|NCT02675452|561805899|FG018|Overall Study|Lost to Follow-up|0|||
155648752|NCT02675452|561805900|FG019|Overall Study|Lost to Follow-up|0|||
155648753|NCT02675452|561805901|FG020|Overall Study|Lost to Follow-up|0|||
155357824|NCT02366143|560746400|FG002|Overall Study|Patient moved to commercial stock|1|||
155357825|NCT02366143|560746398|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
155357826|NCT02366143|560746399|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
155357827|NCT02366143|560746400|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
155357828|NCT02366143|560746398|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
155357829|NCT02366143|560746399|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
155357830|NCT02366143|560746400|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
155357831|NCT02366143|560746398|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
155357832|NCT02366143|560746399|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
155357833|NCT02366143|560746400|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
155357834|NCT02366143|560746398|FG000|Overall Study|Requester's instructions|1|||
155357835|NCT02366143|560746399|FG001|Overall Study|Requester's instructions|1|||
155357836|NCT02366143|560746400|FG002|Overall Study|Requester's instructions|1|||
155357837|NCT02366143|560746398|FG000|Overall Study|Uneligible|0|||
155357838|NCT02366143|560746399|FG001|Overall Study|Uneligible|1|||
155357839|NCT02366143|560746400|FG002|Overall Study|Uneligible|0|||
155357840|NCT02366143|560746398|FG000|Overall Study|Post Trial Migration|0|||
155357841|NCT02366143|560746399|FG001|Overall Study|Post Trial Migration|1|||
155357842|NCT02366143|560746400|FG002|Overall Study|Post Trial Migration|0|||
155357843|NCT02366143|560746398|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
155357844|NCT02366143|560746399|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
155357845|NCT02366143|560746400|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
155357846|NCT02366143|560746398|FG000|Overall Study|Patient switched to PTAP|0|||
155357847|NCT02366143|560746399|FG001|Overall Study|Patient switched to PTAP|1|||
155357848|NCT02366143|560746400|FG002|Overall Study|Patient switched to PTAP|0|||
155357849|NCT02366143|560746398|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
155357850|NCT02366143|560746399|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
155357851|NCT02366143|560746400|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
155357852|NCT00575042|560746401|FG000|Overall Study|Adverse Event|2|||
155357853|NCT00575042|560746401|FG000|Overall Study|Lost to Follow-up|1|||
155357854|NCT00589303|560746406|FG000|Overall Study|Withdrawal by Subject|2|||
155357855|NCT00589303|560746407|FG001|Overall Study|Withdrawal by Subject|1|||
155357856|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357857|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
155357858|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
155357859|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
155357860|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357861|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357862|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357863|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357864|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357865|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155357866|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155357867|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
155357868|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357869|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357870|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357871|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357872|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
155357873|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357874|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357875|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357876|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357877|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357878|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357879|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357880|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
155357881|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357882|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357883|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357884|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357885|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357886|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357887|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
155427273|NCT01827384|560989969|FG006|Overall Study|Ineligible|0|||
155427274|NCT01827384|560989970|FG007|Overall Study|Ineligible|0|||
155357888|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357889|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357890|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155427275|NCT01827384|560989971|FG008|Overall Study|Ineligible|0|||
155357891|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
155357892|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357893|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357894|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357895|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357896|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357897|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357898|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357899|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357900|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
155357901|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
155427276|NCT01827384|560989972|FG009|Overall Study|Ineligible|0|||
155427277|NCT01827384|560989973|FG010|Overall Study|Ineligible|0|||
155427278|NCT01827384|560989974|FG011|Overall Study|Ineligible|0|||
155427279|NCT01827384|560989975|FG012|Overall Study|Ineligible|0|||
155427280|NCT01827384|560989976|FG013|Overall Study|Ineligible|19|||
155427281|NCT01827384|560989963|FG000|Overall Study|Participant died before treatment|0|||
155427282|NCT01827384|560989964|FG001|Overall Study|Participant died before treatment|0|||
155427283|NCT01827384|560989965|FG002|Overall Study|Participant died before treatment|0|||
155427284|NCT01827384|560989966|FG003|Overall Study|Participant died before treatment|0|||
155427285|NCT01827384|560989967|FG004|Overall Study|Participant died before treatment|0|||
155427286|NCT01827384|560989968|FG005|Overall Study|Participant died before treatment|0|||
155427287|NCT01827384|560989969|FG006|Overall Study|Participant died before treatment|0|||
155648754|NCT02675452|561805902|FG021|Overall Study|Lost to Follow-up|0|||
155648755|NCT02675452|561805903|FG022|Overall Study|Lost to Follow-up|0|||
155648756|NCT02675452|561805904|FG023|Overall Study|Lost to Follow-up|0|||
155648757|NCT02675452|561805905|FG024|Overall Study|Lost to Follow-up|0|||
155427288|NCT01827384|560989970|FG007|Overall Study|Participant died before treatment|0|||
155427289|NCT01827384|560989971|FG008|Overall Study|Participant died before treatment|0|||
155427290|NCT01827384|560989972|FG009|Overall Study|Participant died before treatment|0|||
155427291|NCT01827384|560989973|FG010|Overall Study|Participant died before treatment|0|||
155427292|NCT01827384|560989974|FG011|Overall Study|Participant died before treatment|0|||
155507109|NCT01154153|561283543|FG000|Overall Study|Poor compliance to protocol|2|||
155507110|NCT01154153|561283544|FG001|Overall Study|Poor compliance to protocol|0|||
155507111|NCT01154153|561283543|FG000|Overall Study|Unable to use labs|2|||
155507112|NCT01154153|561283544|FG001|Overall Study|Unable to use labs|3|||
155507113|NCT01154153|561283543|FG000|Overall Study|Withdrew consent|1|||
155507114|NCT01154153|561283544|FG001|Overall Study|Withdrew consent|0|||
155507115|NCT02473510|561283545|FG000|Overall Study|Lost to Follow-up|1|||
155507116|NCT02473510|561283546|FG001|Overall Study|Lost to Follow-up|2|||
155507117|NCT03940586|561283553|FG000|Overall Study|Death|3|||
155507118|NCT03940586|561283554|FG001|Overall Study|Death|2|||
155507119|NCT03940586|561283555|FG002|Overall Study|Death|0|||
155507120|NCT03940586|561283553|FG000|Overall Study|Physician Decision|1|||
155507121|NCT03940586|561283554|FG001|Overall Study|Physician Decision|0|||
155507122|NCT03940586|561283555|FG002|Overall Study|Physician Decision|1|||
155507123|NCT03940586|561283553|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
155507124|NCT03940586|561283554|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
155507125|NCT03940586|561283555|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
155507126|NCT03940586|561283553|FG000|Overall Study|Not Treated|0|||
155427293|NCT01827384|560989975|FG012|Overall Study|Participant died before treatment|0|||
155507127|NCT03940586|561283554|FG001|Overall Study|Not Treated|2|||
155507128|NCT03940586|561283555|FG002|Overall Study|Not Treated|0|||
155507129|NCT00964223|561283556|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
155648758|NCT02675452|561805906|FG025|Overall Study|Lost to Follow-up|0|||
155427294|NCT01827384|560989976|FG013|Overall Study|Participant died before treatment|5|||
155507130|NCT02006147|561283557|FG000|Overall Study|Protocol Violation|1|||
155507131|NCT02006147|561283558|FG001|Overall Study|Protocol Violation|1|||
155507132|NCT02006147|561283559|FG002|Overall Study|Protocol Violation|0|||
155648759|NCT02675452|561805907|FG026|Overall Study|Lost to Follow-up|1|||
155357902|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
155357903|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
155357904|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357905|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357906|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357907|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357908|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
155357909|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
155357910|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
155357911|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
155357912|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357913|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357914|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357915|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357916|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
155357917|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
155357918|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357919|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
155357920|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357921|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357922|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357923|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357924|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357925|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357926|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357927|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
155357928|NCT00730015|560746416|FG000|Overall Study|Adverse Event|11|||
155357929|NCT00730015|560746417|FG001|Overall Study|Adverse Event|10|||
155357930|NCT00730015|560746418|FG002|Overall Study|Adverse Event|8|||
155357931|NCT00730015|560746416|FG000|Overall Study|Protocol Violation|2|||
155357932|NCT00730015|560746417|FG001|Overall Study|Protocol Violation|6|||
155357933|NCT00730015|560746418|FG002|Overall Study|Protocol Violation|4|||
155357934|NCT00730015|560746416|FG000|Overall Study|Withdrawal by Subject|12|||
155357935|NCT00730015|560746417|FG001|Overall Study|Withdrawal by Subject|12|||
155357936|NCT00730015|560746418|FG002|Overall Study|Withdrawal by Subject|8|||
155357937|NCT00730015|560746416|FG000|Overall Study|Lost to Follow-up|4|||
155357938|NCT00730015|560746417|FG001|Overall Study|Lost to Follow-up|10|||
155357939|NCT00730015|560746418|FG002|Overall Study|Lost to Follow-up|3|||
155357940|NCT00730015|560746416|FG000|Overall Study|Lack of Efficacy|1|||
155357941|NCT00730015|560746417|FG001|Overall Study|Lack of Efficacy|2|||
155357942|NCT00730015|560746418|FG002|Overall Study|Lack of Efficacy|8|||
155357943|NCT00730015|560746416|FG000|Overall Study|Other Reason|1|||
155357944|NCT00730015|560746417|FG001|Overall Study|Other Reason|0|||
155357945|NCT00730015|560746418|FG002|Overall Study|Other Reason|1|||
155357946|NCT04978350|560746419|FG000|Overall Study|Lost to Follow-up|6|||
155357947|NCT02370251|560746420|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
155357948|NCT02370251|560746420|FG000|Overall Study|Death|4|||
155357949|NCT04469465|560746421|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
155357950|NCT04469465|560746422|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
155357951|NCT04469465|560746421|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
155357952|NCT04469465|560746422|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
155357953|NCT04469465|560746421|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
155357954|NCT04469465|560746422|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
155357955|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
155357956|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
155357957|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
155357958|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
155357959|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
155357960|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
155357961|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Death|0|||
155357962|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Death|1|||
155357963|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
155357964|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
155427295|NCT01827384|560989963|FG000|Overall Study|Insufficient tumor cells|0|||
155427296|NCT01827384|560989964|FG001|Overall Study|Insufficient tumor cells|0|||
155427297|NCT01827384|560989965|FG002|Overall Study|Insufficient tumor cells|0|||
155357965|NCT04120376|560746423|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
155357966|NCT04120376|560746424|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
155357967|NCT02053610|560746425|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
155357968|NCT02053610|560746426|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
155357969|NCT02053610|560746425|FG000|Overall Study|Withdrew Consent|2|||
155357970|NCT02053610|560746426|FG001|Overall Study|Withdrew Consent|9|||
155357971|NCT02053610|560746425|FG000|Overall Study|Death|5|||
155357972|NCT02053610|560746426|FG001|Overall Study|Death|5|||
155357973|NCT02053610|560746425|FG000|Overall Study|Administrative/Other|1|||
155357974|NCT02053610|560746426|FG001|Overall Study|Administrative/Other|1|||
155357975|NCT02053610|560746425|FG000|Overall Study|Disease Progression|2|||
155357976|NCT02053610|560746426|FG001|Overall Study|Disease Progression|3|||
155357977|NCT02053610|560746425|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
155357978|NCT02053610|560746426|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
155357979|NCT02053610|560746425|FG000|Overall Study|Did not Receive Treatment|4|||
155357980|NCT02053610|560746426|FG001|Overall Study|Did not Receive Treatment|2|||
155357981|NCT02053610|560746425|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155357982|NCT02053610|560746426|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155357983|NCT02053610|560746425|FG000|Overall Study|Violation of Selection Criteria|1|||
155357984|NCT02053610|560746426|FG001|Overall Study|Violation of Selection Criteria|0|||
155357985|NCT01165177|560746427|FG000|Overall Study|Serious Adverse Event|227|||
155357986|NCT01165177|560746428|FG001|Overall Study|Serious Adverse Event|235|||
155357987|NCT01165177|560746427|FG000|Overall Study|Withdrawal by Subject|368|||
155357988|NCT01165177|560746428|FG001|Overall Study|Withdrawal by Subject|354|||
155357989|NCT01165177|560746427|FG000|Overall Study|Protocol Violation|19|||
155357990|NCT01165177|560746428|FG001|Overall Study|Protocol Violation|21|||
155357991|NCT01165177|560746427|FG000|Overall Study|Non-serious adverse event|30|||
155357992|NCT01165177|560746428|FG001|Overall Study|Non-serious adverse event|18|||
155357993|NCT01165177|560746427|FG000|Overall Study|Other unspecified reasons|47|||
155357994|NCT01165177|560746428|FG001|Overall Study|Other unspecified reasons|35|||
155357995|NCT01165177|560746427|FG000|Overall Study|Suspected HZ episode|0|||
155357996|NCT01165177|560746428|FG001|Overall Study|Suspected HZ episode|2|||
155357997|NCT01165177|560746427|FG000|Overall Study|Lost to Follow-up|183|||
155357998|NCT01165177|560746428|FG001|Overall Study|Lost to Follow-up|194|||
155357999|NCT01165177|560746427|FG000|Overall Study|Migrated/ moved from study area|48|||
155358000|NCT01165177|560746428|FG001|Overall Study|Migrated/ moved from study area|43|||
155358001|NCT00126659|560746429|FG000|Overall Study|Adverse Event|0|||
155358002|NCT00126659|560746430|FG001|Overall Study|Adverse Event|0|||
155358003|NCT00126659|560746431|FG002|Overall Study|Adverse Event|2|||
155358004|NCT00490945|560746442|FG000|Overall Study|Adverse Event|0|||
155358005|NCT00490945|560746443|FG001|Overall Study|Adverse Event|1|||
155358006|NCT00490945|560746444|FG002|Overall Study|Adverse Event|0|||
155358007|NCT00490945|560746445|FG003|Overall Study|Adverse Event|0|||
155358008|NCT00490945|560746446|FG004|Overall Study|Adverse Event|0|||
155358009|NCT02312206|560746457|FG000|Overall Study|Adverse Event|3|||
155358010|NCT02312206|560746458|FG001|Overall Study|Adverse Event|6|||
155358011|NCT02312206|560746457|FG000|Overall Study|Withdrawal by Subject|6|||
155358012|NCT02312206|560746458|FG001|Overall Study|Withdrawal by Subject|6|||
155358013|NCT02312206|560746457|FG000|Overall Study|Physician Decision|7|||
155358014|NCT02312206|560746458|FG001|Overall Study|Physician Decision|6|||
155358015|NCT02312206|560746457|FG000|Overall Study|Death|31|||
155358016|NCT02312206|560746458|FG001|Overall Study|Death|36|||
155358017|NCT02312206|560746457|FG000|Overall Study|Study Terminated by Sponsor|81|||
155358018|NCT02312206|560746458|FG001|Overall Study|Study Terminated by Sponsor|74|||
155358019|NCT02312206|560746457|FG000|Overall Study|Patient transferred to hospice|0|||
155358020|NCT02312206|560746458|FG001|Overall Study|Patient transferred to hospice|1|||
155358021|NCT02312206|560746457|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
155358022|NCT02312206|560746458|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
155358023|NCT02312206|560746457|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
155358024|NCT02312206|560746458|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
155358025|NCT02312206|560746457|FG000|Overall Study|Disease Progression|1|||
155358026|NCT02312206|560746458|FG001|Overall Study|Disease Progression|0|||
155358027|NCT01006616|560746461|FG000|Period 1 (6 Months)|Adverse Event|10|||
155358028|NCT01006616|560746462|FG001|Period 1 (6 Months)|Adverse Event|31|||
155358029|NCT01006616|560746463|FG002|Period 1 (6 Months)|Adverse Event|37|||
155358030|NCT01006616|560746464|FG003|Period 1 (6 Months)|Adverse Event|9|||
155358031|NCT01006616|560746461|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
155358032|NCT01006616|560746462|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
155358033|NCT01006616|560746463|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
155358034|NCT01006616|560746464|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
155358035|NCT01006616|560746461|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
155358036|NCT01006616|560746462|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
155358037|NCT01006616|560746463|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
155358038|NCT01006616|560746464|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
155358039|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
155358040|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
155358041|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
155358042|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358043|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
155648760|NCT02675452|561805908|FG027|Overall Study|Lost to Follow-up|0|||
155648761|NCT02675452|561805909|FG028|Overall Study|Lost to Follow-up|0|||
155648762|NCT02675452|561805881|FG000|Overall Study|Other|0|||
155648763|NCT02675452|561805882|FG001|Overall Study|Other|0|||
155648764|NCT02675452|561805883|FG002|Overall Study|Other|0|||
155648765|NCT02675452|561805884|FG003|Overall Study|Other|0|||
155648766|NCT02675452|561805885|FG004|Overall Study|Other|0|||
155648767|NCT02675452|561805886|FG005|Overall Study|Other|0|||
155648768|NCT02675452|561805887|FG006|Overall Study|Other|0|||
155648769|NCT02675452|561805888|FG007|Overall Study|Other|0|||
155648770|NCT02675452|561805889|FG008|Overall Study|Other|0|||
155648771|NCT02675452|561805890|FG009|Overall Study|Other|0|||
155648772|NCT02675452|561805891|FG010|Overall Study|Other|0|||
155648773|NCT02675452|561805892|FG011|Overall Study|Other|0|||
155358044|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
155358045|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
155648774|NCT02675452|561805893|FG012|Overall Study|Other|0|||
155648775|NCT02675452|561805894|FG013|Overall Study|Other|0|||
155648776|NCT02675452|561805895|FG014|Overall Study|Other|0|||
155648777|NCT02675452|561805896|FG015|Overall Study|Other|0|||
155648778|NCT02675452|561805897|FG016|Overall Study|Other|0|||
155648779|NCT02675452|561805898|FG017|Overall Study|Other|0|||
155648780|NCT02675452|561805899|FG018|Overall Study|Other|0|||
155648781|NCT02675452|561805900|FG019|Overall Study|Other|0|||
155648782|NCT02675452|561805901|FG020|Overall Study|Other|0|||
155648783|NCT02675452|561805902|FG021|Overall Study|Other|0|||
155648784|NCT02675452|561805903|FG022|Overall Study|Other|0|||
155648785|NCT02675452|561805904|FG023|Overall Study|Other|0|||
155358046|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
155358047|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358048|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358049|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358050|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
155358051|NCT01006616|560746461|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358052|NCT01006616|560746462|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
155358053|NCT01006616|560746463|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358054|NCT01006616|560746464|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358055|NCT01006616|560746461|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
155358056|NCT01006616|560746462|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
155358057|NCT01006616|560746463|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
155358058|NCT01006616|560746464|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
155358059|NCT01006616|560746461|FG000|Period 1 (6 Months)|Not Treated|0|||
155358060|NCT01006616|560746462|FG001|Period 1 (6 Months)|Not Treated|0|||
155358061|NCT01006616|560746463|FG002|Period 1 (6 Months)|Not Treated|1|||
155358062|NCT01006616|560746464|FG003|Period 1 (6 Months)|Not Treated|1|||
155358063|NCT01006616|560746461|FG000|Period 2 (18 Months)|Adverse Event|6|||
155358064|NCT01006616|560746462|FG001|Period 2 (18 Months)|Adverse Event|6|||
155358065|NCT01006616|560746463|FG002|Period 2 (18 Months)|Adverse Event|6|||
155358066|NCT01006616|560746464|FG003|Period 2 (18 Months)|Adverse Event|4|||
155358067|NCT01006616|560746461|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
155358068|NCT01006616|560746462|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
155358069|NCT01006616|560746463|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
155358070|NCT01006616|560746464|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
155358071|NCT01006616|560746461|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
155358072|NCT01006616|560746462|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
155358073|NCT01006616|560746463|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
155358074|NCT01006616|560746464|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
155358075|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358076|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
155358077|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358078|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
155358079|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
155358080|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
155358081|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
155358082|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
155358083|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
155358084|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
155358085|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
155358086|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
155358087|NCT01006616|560746461|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
155358088|NCT01006616|560746462|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
155358089|NCT01006616|560746463|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
155358090|NCT01006616|560746464|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
155358091|NCT01006616|560746461|FG000|Period 2 (18 Months)|Study Terminated|63|||
155358092|NCT01006616|560746462|FG001|Period 2 (18 Months)|Study Terminated|46|||
155358093|NCT01006616|560746463|FG002|Period 2 (18 Months)|Study Terminated|44|||
155358094|NCT01006616|560746464|FG003|Period 2 (18 Months)|Study Terminated|70|||
155358095|NCT03414047|560746465|FG000|Overall Study|Adverse Event|0|||
155358096|NCT03414047|560746466|FG001|Overall Study|Adverse Event|0|||
155358097|NCT03414047|560746467|FG002|Overall Study|Adverse Event|1|||
155358098|NCT03414047|560746468|FG003|Overall Study|Adverse Event|1|||
155358099|NCT03414047|560746465|FG000|Overall Study|Physician Decision|1|||
155358100|NCT03414047|560746466|FG001|Overall Study|Physician Decision|0|||
155358101|NCT03414047|560746467|FG002|Overall Study|Physician Decision|0|||
155358102|NCT03414047|560746468|FG003|Overall Study|Physician Decision|1|||
155358103|NCT03414047|560746465|FG000|Overall Study|Withdrawal by Subject|1|||
155358104|NCT03414047|560746466|FG001|Overall Study|Withdrawal by Subject|0|||
155358105|NCT03414047|560746467|FG002|Overall Study|Withdrawal by Subject|2|||
155358106|NCT03414047|560746468|FG003|Overall Study|Withdrawal by Subject|0|||
155358107|NCT04593823|560746469|FG000|Overall Study|Withdrawal by Subject|1|||
155358108|NCT04593823|560746470|FG001|Overall Study|Withdrawal by Subject|1|||
155358109|NCT04593823|560746469|FG000|Overall Study|Lost to Follow-up|0|||
155358110|NCT04593823|560746470|FG001|Overall Study|Lost to Follow-up|1|||
155358111|NCT00992992|560746476|FG000|Overall Study|Lost to Follow-up|3|||
155358112|NCT00992992|560746476|FG000|Overall Study|Death|16|||
155358113|NCT00992992|560746476|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
155358114|NCT00992992|560746476|FG000|Overall Study|Sponsor Closed the Study|4|||
155358115|NCT00217022|560746478|FG000|Overall Study|Withdrawal by Subject|1|||
155358116|NCT00217022|560746479|FG001|Overall Study|Withdrawal by Subject|1|||
155358117|NCT00458393|560746480|FG000|Overall Study|Withdrawal by Subject|67|||
155358118|NCT00458393|560746481|FG001|Overall Study|Withdrawal by Subject|80|||
155358119|NCT00458393|560746480|FG000|Overall Study|Physician Decision|31|||
155358120|NCT00458393|560746481|FG001|Overall Study|Physician Decision|22|||
155358121|NCT00458393|560746480|FG000|Overall Study|Relocated|77|||
155358122|NCT00458393|560746481|FG001|Overall Study|Relocated|81|||
155358123|NCT00458393|560746480|FG000|Overall Study|Lost to Follow-up|115|||
155358124|NCT00458393|560746481|FG001|Overall Study|Lost to Follow-up|92|||
155358125|NCT00458393|560746480|FG000|Overall Study|Sites marked other on the form.|19|||
155358126|NCT00458393|560746481|FG001|Overall Study|Sites marked other on the form.|20|||
155358127|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
155358128|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
155358129|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
155358130|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
155358131|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
155358132|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
155358133|NCT02777242|560746485|FG000|Overall Study|Other|2|||
155358134|NCT02777242|560746485|FG000|Overall Study|Lost to Follow-up|1|||
155358135|NCT02777242|560746485|FG000|Overall Study|Multiple|1|||
155358136|NCT02777242|560746485|FG000|Overall Study|Sponsor's request|1|||
155358137|NCT02777242|560746485|FG000|Overall Study|Withdrawal by Subject|1|||
155358138|NCT05178979|560746486|FG000|Overall Study|Death|0|||
155358139|NCT05178979|560746487|FG001|Overall Study|Death|5|||
155358140|NCT05178979|560746488|FG002|Overall Study|Death|0|||
155358141|NCT05178979|560746489|FG003|Overall Study|Death|3|||
155358142|NCT05178979|560746486|FG000|Overall Study|Adverse Event|0|||
155358143|NCT05178979|560746487|FG001|Overall Study|Adverse Event|1|||
155358144|NCT05178979|560746488|FG002|Overall Study|Adverse Event|0|||
155358145|NCT05178979|560746489|FG003|Overall Study|Adverse Event|0|||
155358146|NCT05178979|560746486|FG000|Overall Study|Lost to Follow-up|1|||
155358147|NCT05178979|560746487|FG001|Overall Study|Lost to Follow-up|8|||
155358148|NCT05178979|560746488|FG002|Overall Study|Lost to Follow-up|3|||
155358149|NCT05178979|560746489|FG003|Overall Study|Lost to Follow-up|8|||
155358150|NCT00817336|560746491|FG000|Overall Study|Withdrawal by Subject|1|||
155358151|NCT00817336|560746492|FG001|Overall Study|Withdrawal by Subject|1|||
155358152|NCT01253447|560746493|FG000|Overall Study|Adverse Event|2|||
155358153|NCT02299427|560746494|FG000|Overall Study|Withdrawal by Subject|1|||
155358154|NCT02299427|560746495|FG001|Overall Study|Withdrawal by Subject|0|||
155358155|NCT02299427|560746494|FG000|Overall Study|Lost to Follow-up|1|||
155358156|NCT02299427|560746495|FG001|Overall Study|Lost to Follow-up|3|||
155358157|NCT02299427|560746494|FG000|Overall Study|not adherent to dog website use|21|||
155358158|NCT02299427|560746495|FG001|Overall Study|not adherent to dog website use|0|||
155358159|NCT02108652|560746496|FG000|Overall Study|Death|253|||
155358160|NCT02108652|560746496|FG000|Overall Study|Lost to Follow-up|2|||
155358161|NCT02108652|560746496|FG000|Overall Study|Withdrawal by Subject|16|||
155358162|NCT02108652|560746496|FG000|Overall Study|Study Terminated By Sponsor|31|||
155358163|NCT02108652|560746496|FG000|Overall Study|Non-Compliance|1|||
155358164|NCT02108652|560746496|FG000|Overall Study|Physician Decision|6|||
155358165|NCT02108652|560746496|FG000|Overall Study|Progression Of Disease|1|||
155358166|NCT01182181|560746504|FG000|First Intervention|Adverse Event|1|||
155358167|NCT01182181|560746505|FG001|First Intervention|Adverse Event|0|||
155358168|NCT01182181|560746504|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
155358169|NCT01182181|560746505|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
155358170|NCT04706793|560746509|FG000|Treatment|Disease worsening|10|||
155358171|NCT04706793|560746510|FG001|Treatment|Disease worsening|10|||
155358172|NCT04706793|560746509|FG000|Follow-up|Lack of Efficacy|1|||
155358173|NCT04706793|560746510|FG001|Follow-up|Lack of Efficacy|0|||
155358174|NCT04706793|560746509|FG000|Follow-up|Disease worsening|8|||
155358175|NCT04706793|560746510|FG001|Follow-up|Disease worsening|10|||
155358176|NCT04706793|560746509|FG000|Follow-up|Adverse Event|1|||
155358177|NCT04706793|560746510|FG001|Follow-up|Adverse Event|0|||
155358178|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
155358179|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
155358180|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
155358181|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
155358182|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
155358183|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
155358184|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
155358185|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
155358186|NCT00823836|560746513|FG000|Long-term Phase|Adverse Event|3|||
155358187|NCT00823836|560746514|FG001|Long-term Phase|Adverse Event|2|||
155358188|NCT00823836|560746513|FG000|Long-term Phase|Physician Decision|1|||
155358189|NCT00823836|560746514|FG001|Long-term Phase|Physician Decision|2|||
155358190|NCT00823836|560746513|FG000|Long-term Phase|Withdrawal by Subject|1|||
155358191|NCT00823836|560746514|FG001|Long-term Phase|Withdrawal by Subject|1|||
155358192|NCT00745498|560746517|FG000|Overall Study|Lost to Follow-up|1|||
155358193|NCT00745498|560746518|FG001|Overall Study|Lost to Follow-up|1|||
155358194|NCT00745498|560746519|FG002|Overall Study|Lost to Follow-up|3|||
155358195|NCT00745498|560746517|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
155358196|NCT00745498|560746518|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
155358197|NCT00745498|560746519|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
155358198|NCT00745498|560746517|FG000|Overall Study|Non-PDR related VH|0|||
155358199|NCT00745498|560746518|FG001|Overall Study|Non-PDR related VH|1|||
155358200|NCT00745498|560746519|FG002|Overall Study|Non-PDR related VH|1|||
155358201|NCT00745498|560746517|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
155358202|NCT00745498|560746518|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
155358203|NCT00745498|560746519|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
155358204|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
155358205|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
155358206|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
155358207|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
155358208|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
155358209|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
155358210|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
155358211|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
155358212|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
155358213|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
155358214|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
155358215|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
155358216|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Other|4|||
155358217|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Other|4|||
155358218|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Other|2|||
155358219|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Other|2|||
155358220|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358221|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358222|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
155358223|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358224|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
155358225|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
155358226|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
155358227|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
155358228|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
155358229|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
155358230|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
155507133|NCT02006147|561283560|FG003|Overall Study|Protocol Violation|0|||
155507134|NCT02006147|561283557|FG000|Overall Study|Withdrawal by Subject|0|||
155507135|NCT02006147|561283558|FG001|Overall Study|Withdrawal by Subject|1|||
155507136|NCT02006147|561283559|FG002|Overall Study|Withdrawal by Subject|0|||
155507137|NCT02006147|561283560|FG003|Overall Study|Withdrawal by Subject|0|||
155507138|NCT02006147|561283557|FG000|Overall Study|Withdrawal by Sponsor|1|||
155507139|NCT02006147|561283558|FG001|Overall Study|Withdrawal by Sponsor|0|||
155507140|NCT02006147|561283559|FG002|Overall Study|Withdrawal by Sponsor|0|||
155507141|NCT02006147|561283560|FG003|Overall Study|Withdrawal by Sponsor|0|||
155507142|NCT03404206|561283561|FG000|Overall Study|Withdrawal by Subject|1|||
155507143|NCT03404206|561283562|FG001|Overall Study|Withdrawal by Subject|1|||
155507144|NCT03404206|561283563|FG002|Overall Study|Withdrawal by Subject|0|||
155507145|NCT03404206|561283561|FG000|Overall Study|Lost to Follow-up|3|||
155507146|NCT03404206|561283562|FG001|Overall Study|Lost to Follow-up|1|||
155507147|NCT03404206|561283563|FG002|Overall Study|Lost to Follow-up|0|||
155507148|NCT05478603|561283564|FG000|Overall Study|Withdrawal by Subject|0|||
155507149|NCT05478603|561283565|FG001|Overall Study|Withdrawal by Subject|1|||
155507150|NCT05478603|561283566|FG002|Overall Study|Withdrawal by Subject|0|||
155507151|NCT05478603|561283567|FG003|Overall Study|Withdrawal by Subject|0|||
155507152|NCT01010230|561283568|FG000|Overall Study|Withdrawal by Subject|6|||
155507153|NCT01010230|561283569|FG001|Overall Study|Withdrawal by Subject|5|||
155507154|NCT01010230|561283568|FG000|Overall Study|Lost to Follow-up|4|||
155507155|NCT01010230|561283569|FG001|Overall Study|Lost to Follow-up|2|||
155507156|NCT01585831|561283572|FG000|Overall Study|Physician Decision|0|||
155507157|NCT01585831|561283573|FG001|Overall Study|Physician Decision|1|||
155507158|NCT01585831|561283572|FG000|Overall Study|Withdrawal by Subject|2|||
155648786|NCT02675452|561805905|FG024|Overall Study|Other|0|||
155507159|NCT01585831|561283573|FG001|Overall Study|Withdrawal by Subject|1|||
155507160|NCT01123980|561283574|FG000|Overall Study|Adverse Event|1|||
155507161|NCT01123980|561283575|FG001|Overall Study|Adverse Event|1|||
155507162|NCT01123980|561283574|FG000|Overall Study|Lack of Efficacy|1|||
155507163|NCT01123980|561283575|FG001|Overall Study|Lack of Efficacy|0|||
155507164|NCT01123980|561283574|FG000|Overall Study|Physician Decision|0|||
155648787|NCT02675452|561805906|FG025|Overall Study|Other|0|||
155358231|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
155358232|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358233|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358234|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358235|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
155358236|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Other|1|||
155358237|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Other|0|||
155358238|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Other|1|||
155358239|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Other|4|||
155358240|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
155358241|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
155358242|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
155358243|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
155358244|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
155358245|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
155358246|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
155358247|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
155358248|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
155358249|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
155358250|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
155358251|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
155358252|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
155358253|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
155358254|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
155358255|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
155358256|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Other|8|||
155358257|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Other|5|||
155358258|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Other|15|||
155358259|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Other|15|||
155358260|NCT01062971|560746524|FG000|Overall Study|Protocol Violation|1|||
155358261|NCT01062971|560746525|FG001|Overall Study|Protocol Violation|3|||
155358262|NCT01062971|560746524|FG000|Overall Study|Lost to Follow-up|3|||
155358263|NCT01062971|560746525|FG001|Overall Study|Lost to Follow-up|4|||
155358264|NCT00904722|560746536|FG000|Overall Study|Physician Decision|1|||
155358265|NCT00661713|560746537|FG000|Overall Study|Death|1|||
155358266|NCT00661713|560746538|FG001|Overall Study|Death|0|||
155358267|NCT00661713|560746539|FG002|Overall Study|Death|0|||
155358268|NCT00661713|560746540|FG003|Overall Study|Death|0|||
155358269|NCT00661713|560746541|FG004|Overall Study|Death|1|||
155358270|NCT00661713|560746542|FG005|Overall Study|Death|0|||
155358271|NCT00661713|560746543|FG006|Overall Study|Death|0|||
155358272|NCT00661713|560746544|FG007|Overall Study|Death|0|||
155358273|NCT00661713|560746537|FG000|Overall Study|Unable to Classify|1|||
155358274|NCT00661713|560746538|FG001|Overall Study|Unable to Classify|0|||
155358275|NCT00661713|560746539|FG002|Overall Study|Unable to Classify|0|||
155358276|NCT00661713|560746540|FG003|Overall Study|Unable to Classify|0|||
155358277|NCT00661713|560746541|FG004|Overall Study|Unable to Classify|0|||
155358278|NCT00661713|560746542|FG005|Overall Study|Unable to Classify|0|||
155358279|NCT00661713|560746543|FG006|Overall Study|Unable to Classify|0|||
155358280|NCT00661713|560746544|FG007|Overall Study|Unable to Classify|0|||
155358281|NCT00661713|560746537|FG000|Overall Study|Protocol Violation|1|||
155358282|NCT00661713|560746538|FG001|Overall Study|Protocol Violation|6|||
155358283|NCT00661713|560746539|FG002|Overall Study|Protocol Violation|3|||
155358284|NCT00661713|560746540|FG003|Overall Study|Protocol Violation|3|||
155358285|NCT00661713|560746541|FG004|Overall Study|Protocol Violation|0|||
155358286|NCT00661713|560746542|FG005|Overall Study|Protocol Violation|2|||
155358287|NCT00661713|560746543|FG006|Overall Study|Protocol Violation|2|||
155358288|NCT00661713|560746544|FG007|Overall Study|Protocol Violation|1|||
155358289|NCT00661713|560746537|FG000|Overall Study|Withdrawal by Subject|11|||
155358290|NCT00661713|560746538|FG001|Overall Study|Withdrawal by Subject|25|||
155358291|NCT00661713|560746539|FG002|Overall Study|Withdrawal by Subject|12|||
155358292|NCT00661713|560746540|FG003|Overall Study|Withdrawal by Subject|21|||
155358293|NCT00661713|560746541|FG004|Overall Study|Withdrawal by Subject|12|||
155358294|NCT00661713|560746542|FG005|Overall Study|Withdrawal by Subject|26|||
155358295|NCT00661713|560746543|FG006|Overall Study|Withdrawal by Subject|45|||
155358296|NCT00661713|560746544|FG007|Overall Study|Withdrawal by Subject|9|||
155358297|NCT00661713|560746537|FG000|Overall Study|Lost to Follow-up|2|||
155358298|NCT00661713|560746538|FG001|Overall Study|Lost to Follow-up|7|||
155358299|NCT00661713|560746539|FG002|Overall Study|Lost to Follow-up|2|||
155358300|NCT00661713|560746540|FG003|Overall Study|Lost to Follow-up|2|||
155358301|NCT00661713|560746541|FG004|Overall Study|Lost to Follow-up|5|||
155358302|NCT00661713|560746542|FG005|Overall Study|Lost to Follow-up|7|||
155358303|NCT00661713|560746543|FG006|Overall Study|Lost to Follow-up|14|||
155358304|NCT00661713|560746544|FG007|Overall Study|Lost to Follow-up|1|||
155358305|NCT00661713|560746537|FG000|Overall Study|Administrative Reason|0|||
155358306|NCT00661713|560746538|FG001|Overall Study|Administrative Reason|1|||
155358307|NCT00661713|560746539|FG002|Overall Study|Administrative Reason|0|||
155358308|NCT00661713|560746540|FG003|Overall Study|Administrative Reason|2|||
155358309|NCT00661713|560746541|FG004|Overall Study|Administrative Reason|2|||
155358310|NCT00661713|560746542|FG005|Overall Study|Administrative Reason|2|||
155358311|NCT00661713|560746543|FG006|Overall Study|Administrative Reason|1|||
155358312|NCT00661713|560746544|FG007|Overall Study|Administrative Reason|0|||
155358313|NCT00661713|560746537|FG000|Overall Study|Adverse Event|0|||
155358314|NCT00661713|560746538|FG001|Overall Study|Adverse Event|0|||
155358315|NCT00661713|560746539|FG002|Overall Study|Adverse Event|0|||
155358316|NCT00661713|560746540|FG003|Overall Study|Adverse Event|0|||
155648788|NCT02675452|561805907|FG026|Overall Study|Other|1|||
155648789|NCT02675452|561805908|FG027|Overall Study|Other|0|||
155648790|NCT02675452|561805909|FG028|Overall Study|Other|0|||
155648791|NCT04595370|561805910|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
155648792|NCT04595370|561805911|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155648793|NCT04595370|561805912|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155648794|NCT04595370|561805913|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155648795|NCT04595370|561805914|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155648796|NCT04595370|561805915|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155648797|NCT04595370|561805910|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155648798|NCT04595370|561805911|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155648799|NCT04595370|561805912|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
155648800|NCT04595370|561805913|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155648801|NCT04595370|561805914|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155648802|NCT04595370|561805915|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155648803|NCT04595370|561805910|FG000|Overall Study|Adverse Event|0|||
155648804|NCT04595370|561805911|FG001|Overall Study|Adverse Event|4|||
155648805|NCT04595370|561805912|FG002|Overall Study|Adverse Event|3|||
155648806|NCT04595370|561805913|FG003|Overall Study|Adverse Event|1|||
155648807|NCT04595370|561805914|FG004|Overall Study|Adverse Event|1|||
155648808|NCT04595370|561805915|FG005|Overall Study|Adverse Event|1|||
155648809|NCT04595370|561805910|FG000|Overall Study|Withdrawal of Consent|1|||
155648810|NCT04595370|561805911|FG001|Overall Study|Withdrawal of Consent|1|||
155648811|NCT04595370|561805912|FG002|Overall Study|Withdrawal of Consent|1|||
155648812|NCT04595370|561805913|FG003|Overall Study|Withdrawal of Consent|0|||
155648813|NCT04595370|561805914|FG004|Overall Study|Withdrawal of Consent|0|||
155358317|NCT00661713|560746541|FG004|Overall Study|Adverse Event|0|||
155358318|NCT00661713|560746542|FG005|Overall Study|Adverse Event|0|||
155358319|NCT00661713|560746543|FG006|Overall Study|Adverse Event|1|||
155358320|NCT00661713|560746544|FG007|Overall Study|Adverse Event|0|||
155358321|NCT00661713|560746537|FG000|Overall Study|Inappropriate Enrollment|0|||
155358322|NCT00661713|560746538|FG001|Overall Study|Inappropriate Enrollment|0|||
155358323|NCT00661713|560746539|FG002|Overall Study|Inappropriate Enrollment|0|||
155358324|NCT00661713|560746540|FG003|Overall Study|Inappropriate Enrollment|0|||
155358325|NCT00661713|560746541|FG004|Overall Study|Inappropriate Enrollment|0|||
155358326|NCT00661713|560746542|FG005|Overall Study|Inappropriate Enrollment|0|||
155358327|NCT00661713|560746543|FG006|Overall Study|Inappropriate Enrollment|1|||
155358328|NCT00661713|560746544|FG007|Overall Study|Inappropriate Enrollment|0|||
155358329|NCT01801982|560746545|FG000|Overall Study|Lost to Follow-up|1|||
155358330|NCT00727506|560746548|FG000|Overall Study|Adverse Event|0|||
155358331|NCT00727506|560746549|FG001|Overall Study|Adverse Event|0|||
155648814|NCT04595370|561805915|FG005|Overall Study|Withdrawal of Consent|0|||
155648815|NCT04595370|561805910|FG000|Overall Study|Death|0|||
155648816|NCT04595370|561805911|FG001|Overall Study|Death|1|||
155648817|NCT04595370|561805912|FG002|Overall Study|Death|0|||
155648818|NCT04595370|561805913|FG003|Overall Study|Death|0|||
155648819|NCT04595370|561805914|FG004|Overall Study|Death|1|||
155648820|NCT04595370|561805915|FG005|Overall Study|Death|0|||
155648821|NCT04595370|561805910|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155648822|NCT04595370|561805911|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155648823|NCT04595370|561805912|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155648824|NCT04595370|561805913|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155358332|NCT00727506|560746550|FG002|Overall Study|Adverse Event|4|||
155648825|NCT04595370|561805914|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155648826|NCT04595370|561805915|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155358333|NCT00727506|560746551|FG003|Overall Study|Adverse Event|4|||
155358334|NCT00727506|560746552|FG004|Overall Study|Adverse Event|1|||
155358335|NCT00727506|560746553|FG005|Overall Study|Adverse Event|8|||
155358336|NCT00727506|560746548|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155358337|NCT00727506|560746549|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358338|NCT00727506|560746550|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155358339|NCT00727506|560746551|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358340|NCT00727506|560746552|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358341|NCT00727506|560746553|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358342|NCT00727506|560746548|FG000|Overall Study|Progressive disease|4|||
155358343|NCT00727506|560746549|FG001|Overall Study|Progressive disease|7|||
155358344|NCT00727506|560746550|FG002|Overall Study|Progressive disease|9|||
155358345|NCT00727506|560746551|FG003|Overall Study|Progressive disease|28|||
155358346|NCT00727506|560746552|FG004|Overall Study|Progressive disease|38|||
155358347|NCT00727506|560746553|FG005|Overall Study|Progressive disease|28|||
155358348|NCT00727506|560746548|FG000|Overall Study|Refused to continue medication|0|||
155358349|NCT00727506|560746549|FG001|Overall Study|Refused to continue medication|1|||
155358350|NCT00727506|560746550|FG002|Overall Study|Refused to continue medication|2|||
155358351|NCT00727506|560746551|FG003|Overall Study|Refused to continue medication|3|||
155358352|NCT00727506|560746552|FG004|Overall Study|Refused to continue medication|1|||
155358353|NCT00727506|560746553|FG005|Overall Study|Refused to continue medication|2|||
155358354|NCT00727506|560746548|FG000|Overall Study|Other reason not described above|0|||
155358355|NCT00727506|560746549|FG001|Overall Study|Other reason not described above|0|||
155358356|NCT00727506|560746550|FG002|Overall Study|Other reason not described above|1|||
155358357|NCT00727506|560746551|FG003|Overall Study|Other reason not described above|4|||
155358358|NCT00727506|560746552|FG004|Overall Study|Other reason not described above|1|||
155358359|NCT00727506|560746553|FG005|Overall Study|Other reason not described above|1|||
155358360|NCT01214421|560746554|FG000|Overall Study|Lost to Follow-up|7|||
155358361|NCT01214421|560746555|FG001|Overall Study|Lost to Follow-up|3|||
155358362|NCT01214421|560746556|FG002|Overall Study|Lost to Follow-up|7|||
155358363|NCT01214421|560746557|FG003|Overall Study|Lost to Follow-up|3|||
155358364|NCT01214421|560746554|FG000|Overall Study|Adverse Event|16|||
155358365|NCT01214421|560746555|FG001|Overall Study|Adverse Event|35|||
155358366|NCT01214421|560746556|FG002|Overall Study|Adverse Event|14|||
155358367|NCT01214421|560746557|FG003|Overall Study|Adverse Event|3|||
155358368|NCT01214421|560746554|FG000|Overall Study|Sponsor Discontinued Site|1|||
155358369|NCT01214421|560746555|FG001|Overall Study|Sponsor Discontinued Site|2|||
155358370|NCT01214421|560746556|FG002|Overall Study|Sponsor Discontinued Site|0|||
155358371|NCT01214421|560746557|FG003|Overall Study|Sponsor Discontinued Site|0|||
155358372|NCT01214421|560746554|FG000|Overall Study|Withdrawal Criteria Met|3|||
155358373|NCT01214421|560746555|FG001|Overall Study|Withdrawal Criteria Met|0|||
155358374|NCT01214421|560746556|FG002|Overall Study|Withdrawal Criteria Met|2|||
155358375|NCT01214421|560746557|FG003|Overall Study|Withdrawal Criteria Met|1|||
155358376|NCT01214421|560746554|FG000|Overall Study|Physician Decision|2|||
155358377|NCT01214421|560746555|FG001|Overall Study|Physician Decision|0|||
155358378|NCT01214421|560746556|FG002|Overall Study|Physician Decision|4|||
155358379|NCT01214421|560746557|FG003|Overall Study|Physician Decision|0|||
155358380|NCT01214421|560746554|FG000|Overall Study|Withdrawal by Subject|21|||
155358381|NCT01214421|560746555|FG001|Overall Study|Withdrawal by Subject|18|||
155358382|NCT01214421|560746556|FG002|Overall Study|Withdrawal by Subject|11|||
155358383|NCT01214421|560746557|FG003|Overall Study|Withdrawal by Subject|2|||
155358384|NCT03783689|560746558|FG000|Overall Study|Adverse Event|2|||
155358385|NCT03783689|560746559|FG001|Overall Study|Adverse Event|0|||
155358386|NCT03783689|560746558|FG000|Overall Study|Lost to Follow-up|2|||
155358387|NCT03783689|560746559|FG001|Overall Study|Lost to Follow-up|1|||
155358388|NCT03783689|560746558|FG000|Overall Study|Physician Decision|2|||
155358389|NCT03783689|560746559|FG001|Overall Study|Physician Decision|1|||
155358390|NCT03783689|560746558|FG000|Overall Study|Withdrawal by Subject|3|||
155358391|NCT03783689|560746559|FG001|Overall Study|Withdrawal by Subject|3|||
155358392|NCT04887506|560746561|FG000|Overall Study|Death|1|||
155358393|NCT04887506|560746562|FG001|Overall Study|Death|1|||
155358394|NCT04887506|560746561|FG000|Overall Study|Withdrawal by Subject|0|||
155358395|NCT04887506|560746562|FG001|Overall Study|Withdrawal by Subject|3|||
155358396|NCT04887506|560746561|FG000|Overall Study|Adverse Event|4|||
155358397|NCT04887506|560746562|FG001|Overall Study|Adverse Event|3|||
155358398|NCT04887506|560746561|FG000|Overall Study|Other - Not Reported|1|||
155358399|NCT04887506|560746562|FG001|Overall Study|Other - Not Reported|1|||
155358400|NCT01190449|560746566|FG000|Overall Study|Ineligible|0|||
155358401|NCT01190449|560746567|FG001|Overall Study|Ineligible|4|||
155358402|NCT00487825|560748302|FG000|Overall Study|Adverse Event|2|||
155358403|NCT00487825|560748303|FG001|Overall Study|Adverse Event|2|||
155358404|NCT00487825|560748302|FG000|Overall Study|Lack of Efficacy|1|||
155358405|NCT00487825|560748303|FG001|Overall Study|Lack of Efficacy|1|||
155358406|NCT00487825|560748302|FG000|Overall Study|Other|3|||
155358407|NCT00487825|560748303|FG001|Overall Study|Other|2|||
155358408|NCT01986114|560748304|FG000|Overall Study|Adverse Event|59|||
155358409|NCT01986114|560748304|FG000|Overall Study|Lack of Efficacy|23|||
155358410|NCT01986114|560748304|FG000|Overall Study|Withdrawal by Subject|58|||
155358411|NCT01986114|560748304|FG000|Overall Study|Noncompliance|3|||
155358412|NCT01986114|560748304|FG000|Overall Study|Protocol Violation|1|||
155358413|NCT01986114|560748304|FG000|Overall Study|Lost to Follow-up|5|||
155358414|NCT01986114|560748304|FG000|Overall Study|Other reason|7|||
155358415|NCT01190644|560748305|FG000|Overall Study|Death|2|||
155358416|NCT01190644|560748305|FG000|Overall Study|Disease progression|1|||
155358417|NCT04411186|560748306|FG000|Overall Study|Withdrawn due to protocol violation|0|||
155358418|NCT04411186|560748307|FG001|Overall Study|Withdrawn due to protocol violation|1|||
155358419|NCT02172911|560748308|FG000|Overall Study|Serious Adverse Event|0|||
155358420|NCT02172911|560748309|FG001|Overall Study|Serious Adverse Event|1|||
155358421|NCT02172911|560748308|FG000|Overall Study|Progression of Disease|0|||
155358422|NCT02172911|560748309|FG001|Overall Study|Progression of Disease|1|||
155358423|NCT02172911|560748308|FG000|Overall Study|Loss of insurance coverage|1|||
155358424|NCT02172911|560748309|FG001|Overall Study|Loss of insurance coverage|0|||
155358425|NCT04795336|560748314|FG000|Overall Study|Withdrawal by Subject|3|||
155358426|NCT04795336|560748315|FG001|Overall Study|Withdrawal by Subject|4|||
155358427|NCT04795336|560748316|FG002|Overall Study|Withdrawal by Subject|3|||
155358428|NCT04795336|560748317|FG003|Overall Study|Withdrawal by Subject|12|||
155358429|NCT04795336|560748314|FG000|Overall Study|Lost study logs|0|||
155358430|NCT04795336|560748315|FG001|Overall Study|Lost study logs|1|||
155358431|NCT04795336|560748316|FG002|Overall Study|Lost study logs|0|||
155358432|NCT04795336|560748317|FG003|Overall Study|Lost study logs|2|||
155358433|NCT04795336|560748314|FG000|Overall Study|Did not take study medication|2|||
155358434|NCT04795336|560748315|FG001|Overall Study|Did not take study medication|0|||
155358435|NCT04795336|560748316|FG002|Overall Study|Did not take study medication|0|||
155358436|NCT04795336|560748317|FG003|Overall Study|Did not take study medication|0|||
155358437|NCT01638390|560748318|FG000|Overall Study|screening failures|21|||
155358438|NCT04596995|560748321|FG000|Overall Study|Lack of Efficacy|8|||
155358439|NCT04596995|560748321|FG000|Overall Study|Lost to Follow-up|3|||
155358440|NCT04596995|560748321|FG000|Overall Study|Withdrawal by Subject|12|||
155358441|NCT04596995|560748321|FG000|Overall Study|Sponsor decision|3|||
155358442|NCT04596995|560748321|FG000|Overall Study|Enrolled in managed access program|3|||
155358443|NCT05499130|560748322|FG000|Overall Study|Adverse Event|2|||
155358444|NCT05499130|560748323|FG001|Overall Study|Adverse Event|0|||
155358445|NCT05499130|560748324|FG002|Overall Study|Adverse Event|1|||
155358446|NCT05499130|560748325|FG003|Overall Study|Adverse Event|0|||
155358447|NCT05499130|560748326|FG004|Overall Study|Adverse Event|1|||
155358448|NCT05499130|560748327|FG005|Overall Study|Adverse Event|4|||
155358449|NCT05499130|560748328|FG006|Overall Study|Adverse Event|1|||
155358450|NCT05499130|560748329|FG007|Overall Study|Adverse Event|0|||
155507165|NCT01123980|561283575|FG001|Overall Study|Physician Decision|1|||
155358451|NCT05499130|560748322|FG000|Overall Study|Lack of Efficacy|1|||
155358452|NCT05499130|560748323|FG001|Overall Study|Lack of Efficacy|0|||
155358453|NCT05499130|560748324|FG002|Overall Study|Lack of Efficacy|0|||
155358454|NCT05499130|560748325|FG003|Overall Study|Lack of Efficacy|0|||
155358455|NCT05499130|560748326|FG004|Overall Study|Lack of Efficacy|5|||
155358456|NCT05499130|560748327|FG005|Overall Study|Lack of Efficacy|0|||
155358457|NCT05499130|560748328|FG006|Overall Study|Lack of Efficacy|1|||
155358458|NCT05499130|560748329|FG007|Overall Study|Lack of Efficacy|0|||
155358459|NCT05499130|560748322|FG000|Overall Study|Withdrawal by Subject|2|||
155358460|NCT05499130|560748323|FG001|Overall Study|Withdrawal by Subject|0|||
155358461|NCT05499130|560748324|FG002|Overall Study|Withdrawal by Subject|0|||
155358462|NCT05499130|560748325|FG003|Overall Study|Withdrawal by Subject|0|||
155358463|NCT05499130|560748326|FG004|Overall Study|Withdrawal by Subject|1|||
155358464|NCT05499130|560748327|FG005|Overall Study|Withdrawal by Subject|2|||
155358465|NCT05499130|560748328|FG006|Overall Study|Withdrawal by Subject|0|||
155358466|NCT05499130|560748329|FG007|Overall Study|Withdrawal by Subject|0|||
155358467|NCT05499130|560748322|FG000|Overall Study|Lost to Follow-up|0|||
155358468|NCT05499130|560748323|FG001|Overall Study|Lost to Follow-up|0|||
155358469|NCT05499130|560748324|FG002|Overall Study|Lost to Follow-up|0|||
155358470|NCT05499130|560748325|FG003|Overall Study|Lost to Follow-up|0|||
155358471|NCT05499130|560748326|FG004|Overall Study|Lost to Follow-up|0|||
155358472|NCT05499130|560748327|FG005|Overall Study|Lost to Follow-up|2|||
155358473|NCT05499130|560748328|FG006|Overall Study|Lost to Follow-up|0|||
155358474|NCT05499130|560748329|FG007|Overall Study|Lost to Follow-up|0|||
155358475|NCT05499130|560748322|FG000|Overall Study|Other Than Specified|0|||
155358476|NCT05499130|560748323|FG001|Overall Study|Other Than Specified|0|||
155358477|NCT05499130|560748324|FG002|Overall Study|Other Than Specified|0|||
155358478|NCT05499130|560748325|FG003|Overall Study|Other Than Specified|0|||
155358479|NCT05499130|560748326|FG004|Overall Study|Other Than Specified|1|||
155358480|NCT05499130|560748327|FG005|Overall Study|Other Than Specified|1|||
155358481|NCT05499130|560748328|FG006|Overall Study|Other Than Specified|2|||
155358482|NCT05499130|560748329|FG007|Overall Study|Other Than Specified|0|||
155358483|NCT05499130|560748322|FG000|Overall Study|Protocol Violation|0|||
155358484|NCT05499130|560748323|FG001|Overall Study|Protocol Violation|0|||
155358485|NCT05499130|560748324|FG002|Overall Study|Protocol Violation|0|||
155358486|NCT05499130|560748325|FG003|Overall Study|Protocol Violation|0|||
155358487|NCT05499130|560748326|FG004|Overall Study|Protocol Violation|1|||
155358488|NCT05499130|560748327|FG005|Overall Study|Protocol Violation|0|||
155648827|NCT04595370|561805910|FG000|Overall Study|Withdrawal by Subject|0|||
155648828|NCT04595370|561805911|FG001|Overall Study|Withdrawal by Subject|0|||
155648829|NCT04595370|561805912|FG002|Overall Study|Withdrawal by Subject|1|||
155648830|NCT04595370|561805913|FG003|Overall Study|Withdrawal by Subject|0|||
155648831|NCT04595370|561805914|FG004|Overall Study|Withdrawal by Subject|2|||
155648832|NCT04595370|561805915|FG005|Overall Study|Withdrawal by Subject|0|||
155648833|NCT04595370|561805910|FG000|Overall Study|Lost to Follow-up|0|||
155648834|NCT04595370|561805911|FG001|Overall Study|Lost to Follow-up|0|||
155648835|NCT04595370|561805912|FG002|Overall Study|Lost to Follow-up|0|||
155648836|NCT04595370|561805913|FG003|Overall Study|Lost to Follow-up|0|||
155648837|NCT04595370|561805914|FG004|Overall Study|Lost to Follow-up|1|||
155648838|NCT04595370|561805915|FG005|Overall Study|Lost to Follow-up|0|||
155648839|NCT04595370|561805910|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155648840|NCT04595370|561805911|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
155648841|NCT04595370|561805912|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
155648842|NCT04595370|561805913|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155648843|NCT04595370|561805914|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
155648844|NCT04595370|561805915|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155648845|NCT03520387|561805916|FG000|Pre-Randomization|Withdrawal by Subject|1|||
155358489|NCT05499130|560748328|FG006|Overall Study|Protocol Violation|0|||
155358490|NCT05499130|560748329|FG007|Overall Study|Protocol Violation|0|||
155648846|NCT03520387|561805917|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155648847|NCT03520387|561805918|FG002|Pre-Randomization|Withdrawal by Subject|0|||
155648848|NCT03520387|561805919|FG003|Pre-Randomization|Withdrawal by Subject|0|||
155648849|NCT03520387|561805920|FG004|Pre-Randomization|Withdrawal by Subject|0|||
155648850|NCT03520387|561805916|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
155648851|NCT03520387|561805917|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155648852|NCT03520387|561805918|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155648853|NCT03520387|561805919|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155648854|NCT03520387|561805920|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155648855|NCT00541775|561805921|FG000|Overall Study|Adverse Event|3|||
155648856|NCT00541775|561805922|FG001|Overall Study|Adverse Event|2|||
155648857|NCT00541775|561805923|FG002|Overall Study|Adverse Event|1|||
155648858|NCT00541775|561805921|FG000|Overall Study|Lack of Efficacy|0|||
155648859|NCT00541775|561805922|FG001|Overall Study|Lack of Efficacy|0|||
155648860|NCT00541775|561805923|FG002|Overall Study|Lack of Efficacy|3|||
155648861|NCT00541775|561805921|FG000|Overall Study|Lost to Follow-up|0|||
155648862|NCT00541775|561805922|FG001|Overall Study|Lost to Follow-up|0|||
155648863|NCT00541775|561805923|FG002|Overall Study|Lost to Follow-up|2|||
155648864|NCT00541775|561805921|FG000|Overall Study|Protocol Violation|1|||
155358491|NCT05382039|560748330|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
155358492|NCT05382039|560748331|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
155358493|NCT05382039|560748332|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
155358494|NCT05382039|560748330|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
155358495|NCT05382039|560748331|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
155648865|NCT00541775|561805922|FG001|Overall Study|Protocol Violation|0|||
155648866|NCT00541775|561805923|FG002|Overall Study|Protocol Violation|0|||
155648867|NCT00541775|561805921|FG000|Overall Study|Withdrawal by Subject and Other|5|||
155648868|NCT00541775|561805922|FG001|Overall Study|Withdrawal by Subject and Other|0|||
155648869|NCT00541775|561805923|FG002|Overall Study|Withdrawal by Subject and Other|2|||
155648870|NCT01945242|561805924|FG000|Overall Study|Physician Decision|3|||
155648871|NCT01945242|561805925|FG001|Overall Study|Physician Decision|3|||
155648872|NCT04913675|561805926|FG000|Main Study (Up to Week 36)|Death|0|||
155648873|NCT04913675|561805927|FG001|Main Study (Up to Week 36)|Death|2|||
155648874|NCT04913675|561805928|FG002|Main Study (Up to Week 36)|Death|2|||
155648875|NCT04913675|561805929|FG003|Main Study (Up to Week 36)|Death|0|||
155648876|NCT04913675|561805926|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
155648877|NCT04913675|561805927|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
155648878|NCT04913675|561805928|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
155648879|NCT04913675|561805929|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
155648880|NCT04913675|561805926|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
155648881|NCT04913675|561805927|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
155507166|NCT01123980|561283574|FG000|Overall Study|Lost to Follow-up|0|||
155358496|NCT05382039|560748332|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
155358497|NCT05382039|560748330|FG000|Overall Study|waiting for confirmation|0|||
155358498|NCT05382039|560748331|FG001|Overall Study|waiting for confirmation|0|||
155358499|NCT05382039|560748332|FG002|Overall Study|waiting for confirmation|1|||
155358500|NCT04464421|560748333|FG000|Overall Study|Lost to Follow-up|2|||
155358501|NCT04464421|560748334|FG001|Overall Study|Lost to Follow-up|2|||
155358502|NCT02577003|560748335|FG000|Overall Study|Adverse Event|2|||
155358503|NCT02577003|560748336|FG001|Overall Study|Adverse Event|4|||
155358504|NCT02577003|560748335|FG000|Overall Study|Withdrawal by Subject|0|||
155358505|NCT02577003|560748336|FG001|Overall Study|Withdrawal by Subject|1|||
155358506|NCT02786004|560748337|FG000|Overall Study|Withdrawal by Subject|0|||
155358507|NCT02786004|560748338|FG001|Overall Study|Withdrawal by Subject|1|||
155358508|NCT01234883|560748339|FG000|Overall Study|Early treatment release|8|||
155358509|NCT01234883|560748340|FG001|Overall Study|Early treatment release|10|||
155358510|NCT01234883|560748339|FG000|Overall Study|Parent/guardian withdrew consent|1|||
155358511|NCT01234883|560748340|FG001|Overall Study|Parent/guardian withdrew consent|2|||
155358512|NCT01234883|560748339|FG000|Overall Study|Technical difficulties with IV infusion|0|||
155358513|NCT01234883|560748340|FG001|Overall Study|Technical difficulties with IV infusion|1|||
155358514|NCT01234883|560748339|FG000|Overall Study|Inclusion/exclusion failure|1|||
155358515|NCT01234883|560748340|FG001|Overall Study|Inclusion/exclusion failure|0|||
155358516|NCT03210519|560748341|FG000|Overall Study|Adverse Event|2|||
155358517|NCT03210519|560748342|FG001|Overall Study|Adverse Event|0|||
155358518|NCT03865953|560748345|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
155358519|NCT03865953|560748346|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155358520|NCT03865953|560748345|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
155358521|NCT03865953|560748346|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
155358522|NCT03865953|560748345|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
155358523|NCT03865953|560748346|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
155358524|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
155358525|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
155358526|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
155358527|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
155358528|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
155358529|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
155358530|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
155358531|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
155358532|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
155358533|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
155358534|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
155358535|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
155358536|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
155358537|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
155358538|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
155507167|NCT01123980|561283575|FG001|Overall Study|Lost to Follow-up|6|||
155648882|NCT04913675|561805928|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
155358539|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
155358540|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
155358541|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
155427298|NCT01827384|560989966|FG003|Overall Study|Insufficient tumor cells|0|||
155427299|NCT01827384|560989967|FG004|Overall Study|Insufficient tumor cells|0|||
155427300|NCT01827384|560989968|FG005|Overall Study|Insufficient tumor cells|0|||
155427301|NCT01827384|560989969|FG006|Overall Study|Insufficient tumor cells|0|||
155427302|NCT01827384|560989970|FG007|Overall Study|Insufficient tumor cells|0|||
155427303|NCT01827384|560989971|FG008|Overall Study|Insufficient tumor cells|0|||
155427304|NCT01827384|560989972|FG009|Overall Study|Insufficient tumor cells|0|||
155427305|NCT01827384|560989973|FG010|Overall Study|Insufficient tumor cells|0|||
155427306|NCT01827384|560989974|FG011|Overall Study|Insufficient tumor cells|0|||
155427307|NCT01827384|560989975|FG012|Overall Study|Insufficient tumor cells|0|||
155427308|NCT01827384|560989976|FG013|Overall Study|Insufficient tumor cells|13|||
155427309|NCT01827384|560989963|FG000|Overall Study|No actionable mutation|0|||
155427310|NCT01827384|560989964|FG001|Overall Study|No actionable mutation|0|||
155427311|NCT01827384|560989965|FG002|Overall Study|No actionable mutation|0|||
155427312|NCT01827384|560989966|FG003|Overall Study|No actionable mutation|0|||
155427313|NCT01827384|560989967|FG004|Overall Study|No actionable mutation|0|||
155427314|NCT01827384|560989968|FG005|Overall Study|No actionable mutation|0|||
155427315|NCT01827384|560989969|FG006|Overall Study|No actionable mutation|0|||
155427316|NCT01827384|560989970|FG007|Overall Study|No actionable mutation|0|||
155427317|NCT01827384|560989971|FG008|Overall Study|No actionable mutation|0|||
155427318|NCT01827384|560989972|FG009|Overall Study|No actionable mutation|0|||
155427319|NCT01827384|560989973|FG010|Overall Study|No actionable mutation|0|||
155427320|NCT01827384|560989974|FG011|Overall Study|No actionable mutation|0|||
155427321|NCT01827384|560989975|FG012|Overall Study|No actionable mutation|0|||
155427322|NCT01827384|560989976|FG013|Overall Study|No actionable mutation|73|||
155427323|NCT01827384|560989963|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
155427324|NCT01827384|560989964|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
155427325|NCT01827384|560989965|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
155427326|NCT01827384|560989966|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
155427327|NCT01827384|560989967|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
155427328|NCT01827384|560989968|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
155427329|NCT01827384|560989969|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
155358542|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
155358543|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
155358544|NCT01704547|560748357|FG000|Overall Study|Physician Decision|4|||
155358545|NCT01704547|560748357|FG000|Overall Study|Withdrawal by Subject|1|||
155358546|NCT01560871|560748358|FG000|Overall Study|transportation issues|2|||
155358547|NCT01560871|560748359|FG001|Overall Study|transportation issues|1|||
155358548|NCT01560871|560748358|FG000|Overall Study|relocation|1|||
155358549|NCT01560871|560748359|FG001|Overall Study|relocation|0|||
155358550|NCT01560871|560748358|FG000|Overall Study|readmission to a hospital|2|||
155358551|NCT01560871|560748359|FG001|Overall Study|readmission to a hospital|1|||
155358552|NCT01560871|560748358|FG000|Overall Study|Lost to Follow-up|1|||
155358553|NCT01560871|560748359|FG001|Overall Study|Lost to Follow-up|0|||
155358554|NCT00409409|560748360|FG000|Overall Study|Adverse Event|7|||
155358555|NCT00409409|560748361|FG001|Overall Study|Adverse Event|2|||
155358556|NCT00409409|560748360|FG000|Overall Study|Withdrawal by Subject|1|||
155358557|NCT00409409|560748361|FG001|Overall Study|Withdrawal by Subject|1|||
155358558|NCT00409409|560748360|FG000|Overall Study|Any other reason not above-mentioned|0|||
155358559|NCT00409409|560748361|FG001|Overall Study|Any other reason not above-mentioned|1|||
155358560|NCT01278615|560748362|FG000|Overall Study|Withdrawal by Subject|2|||
155358561|NCT02138253|560748363|FG000|Overall Study|Adverse Event|3|||
155358562|NCT02138253|560748364|FG001|Overall Study|Adverse Event|3|||
155358563|NCT02138253|560748363|FG000|Overall Study|Lost to Follow-up|2|||
155358564|NCT02138253|560748364|FG001|Overall Study|Lost to Follow-up|1|||
155358565|NCT02138253|560748363|FG000|Overall Study|Physician Decision|2|||
155358566|NCT02138253|560748364|FG001|Overall Study|Physician Decision|0|||
155358567|NCT02138253|560748363|FG000|Overall Study|Non compliance|1|||
155427330|NCT01827384|560989970|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
155427331|NCT01827384|560989971|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
155427332|NCT01827384|560989972|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
155427333|NCT01827384|560989973|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
155427334|NCT01827384|560989974|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
155427335|NCT01827384|560989975|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
155358568|NCT02138253|560748364|FG001|Overall Study|Non compliance|0|||
155358569|NCT02138253|560748363|FG000|Overall Study|Withdrawal by Subject|1|||
155427336|NCT01827384|560989976|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
155358570|NCT02138253|560748364|FG001|Overall Study|Withdrawal by Subject|0|||
155427337|NCT04167345|560989981|FG000|Overall Study|Other|1|||
155358571|NCT01918371|560748365|FG000|Overall Study|Missing Data|1|||
155358572|NCT01918371|560748366|FG001|Overall Study|Missing Data|1|||
155358573|NCT01006889|560748367|FG000|Overall Study|Withdrawal by Subject|3|||
155358574|NCT00243022|560748368|FG000|Overall Study|Withdrawal by Subject|1|||
155358575|NCT00243022|560748369|FG001|Overall Study|Withdrawal by Subject|0|||
155358576|NCT00243022|560748368|FG000|Overall Study|Death|1|||
155358577|NCT00243022|560748369|FG001|Overall Study|Death|0|||
155358578|NCT00243022|560748368|FG000|Overall Study|Difficult Travel Distance|0|||
155358579|NCT00243022|560748369|FG001|Overall Study|Difficult Travel Distance|1|||
155358580|NCT01390441|560748374|FG000|Treatment Period|Protocol Violation|0|||
155358581|NCT01390441|560748375|FG001|Treatment Period|Protocol Violation|1|||
155358582|NCT01390441|560748376|FG002|Treatment Period|Protocol Violation|0|||
155358583|NCT01390441|560748377|FG003|Treatment Period|Protocol Violation|0|||
155358584|NCT01390441|560748378|FG004|Treatment Period|Protocol Violation|0|||
155358585|NCT01390441|560748374|FG000|Treatment Period|Physician Decision|0|||
155358586|NCT01390441|560748375|FG001|Treatment Period|Physician Decision|0|||
155358587|NCT01390441|560748376|FG002|Treatment Period|Physician Decision|0|||
155358588|NCT01390441|560748377|FG003|Treatment Period|Physician Decision|1|||
155358589|NCT01390441|560748378|FG004|Treatment Period|Physician Decision|0|||
155358590|NCT01390441|560748374|FG000|Treatment Period|Lack of Efficacy|0|||
155358591|NCT01390441|560748375|FG001|Treatment Period|Lack of Efficacy|0|||
155358592|NCT01390441|560748376|FG002|Treatment Period|Lack of Efficacy|0|||
155358593|NCT01390441|560748377|FG003|Treatment Period|Lack of Efficacy|0|||
155358594|NCT01390441|560748378|FG004|Treatment Period|Lack of Efficacy|1|||
155358595|NCT01390441|560748374|FG000|Treatment Period|Unknown due to early stopping of study|0|||
155358596|NCT01390441|560748375|FG001|Treatment Period|Unknown due to early stopping of study|0|||
155358597|NCT01390441|560748376|FG002|Treatment Period|Unknown due to early stopping of study|8|||
155358598|NCT01390441|560748377|FG003|Treatment Period|Unknown due to early stopping of study|11|||
155358599|NCT01390441|560748378|FG004|Treatment Period|Unknown due to early stopping of study|7|||
155358600|NCT01390441|560748374|FG000|Treatment Period|Adverse Event|0|||
155358601|NCT01390441|560748375|FG001|Treatment Period|Adverse Event|0|||
155358602|NCT01390441|560748376|FG002|Treatment Period|Adverse Event|1|||
155358603|NCT01390441|560748377|FG003|Treatment Period|Adverse Event|1|||
155358604|NCT01390441|560748378|FG004|Treatment Period|Adverse Event|2|||
155427338|NCT04167345|560989982|FG001|Overall Study|Other|1|||
155427339|NCT04167345|560989983|FG002|Overall Study|Other|0|||
155427340|NCT04167345|560989984|FG003|Overall Study|Other|0|||
155427341|NCT04167345|560989985|FG004|Overall Study|Other|0|||
155427342|NCT04375761|560991785|FG000|Overall Study|Death|1|||
155427343|NCT04375761|560991786|FG001|Overall Study|Death|2|||
155427344|NCT04375761|560991785|FG000|Overall Study|Lost to Follow-up|203|||
155427345|NCT04375761|560991786|FG001|Overall Study|Lost to Follow-up|380|||
155427346|NCT04375761|560991785|FG000|Overall Study|Withdrawal by Subject|47|||
155427347|NCT04375761|560991786|FG001|Overall Study|Withdrawal by Subject|98|||
155427348|NCT04375761|560991785|FG000|Overall Study|Noncompliance with study procedure|121|||
155648883|NCT04913675|561805929|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
155358605|NCT01390441|560748374|FG000|Treatment Period|Withdrawal by Subject|0|||
155358606|NCT01390441|560748375|FG001|Treatment Period|Withdrawal by Subject|0|||
155358607|NCT01390441|560748376|FG002|Treatment Period|Withdrawal by Subject|1|||
155358608|NCT01390441|560748377|FG003|Treatment Period|Withdrawal by Subject|0|||
155427349|NCT04375761|560991786|FG001|Overall Study|Noncompliance with study procedure|251|||
155427350|NCT04375761|560991785|FG000|Overall Study|Reimbursement not enough|1|||
155427351|NCT04375761|560991786|FG001|Overall Study|Reimbursement not enough|2|||
155358609|NCT01390441|560748378|FG004|Treatment Period|Withdrawal by Subject|1|||
155358610|NCT01390441|560748374|FG000|Treatment Period|Lost to Follow-up|1|||
155358611|NCT01390441|560748375|FG001|Treatment Period|Lost to Follow-up|0|||
155358612|NCT01390441|560748376|FG002|Treatment Period|Lost to Follow-up|0|||
155358613|NCT01390441|560748377|FG003|Treatment Period|Lost to Follow-up|0|||
155358614|NCT01390441|560748378|FG004|Treatment Period|Lost to Follow-up|0|||
155358615|NCT01390441|560748374|FG000|Extension Period|Protocol Violation|3|||
155358616|NCT01390441|560748375|FG001|Extension Period|Protocol Violation|1|||
155358617|NCT01390441|560748376|FG002|Extension Period|Protocol Violation|0|||
155358618|NCT01390441|560748377|FG003|Extension Period|Protocol Violation|1|||
155358619|NCT01390441|560748378|FG004|Extension Period|Protocol Violation|0|||
155358620|NCT03802617|560748379|FG000|Overall Study|Adverse Event|0|||
155358621|NCT03802617|560748380|FG001|Overall Study|Adverse Event|4|||
155358622|NCT03802617|560748381|FG002|Overall Study|Adverse Event|5|||
155358623|NCT03802617|560748382|FG003|Overall Study|Adverse Event|1|||
155358624|NCT03802617|560748379|FG000|Overall Study|Lack of Efficacy|0|||
155358625|NCT03802617|560748380|FG001|Overall Study|Lack of Efficacy|1|||
155358626|NCT03802617|560748381|FG002|Overall Study|Lack of Efficacy|0|||
155358627|NCT03802617|560748382|FG003|Overall Study|Lack of Efficacy|2|||
155358628|NCT03802617|560748379|FG000|Overall Study|Protocol Violation|1|||
155358629|NCT03802617|560748380|FG001|Overall Study|Protocol Violation|1|||
155358630|NCT03802617|560748381|FG002|Overall Study|Protocol Violation|1|||
155358631|NCT03802617|560748382|FG003|Overall Study|Protocol Violation|0|||
155358632|NCT03802617|560748379|FG000|Overall Study|Withdrawal by Subject|1|||
155358633|NCT03802617|560748380|FG001|Overall Study|Withdrawal by Subject|1|||
155358634|NCT03802617|560748381|FG002|Overall Study|Withdrawal by Subject|1|||
155358635|NCT03802617|560748382|FG003|Overall Study|Withdrawal by Subject|0|||
155358636|NCT03802617|560748379|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
155358637|NCT03802617|560748380|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
155358638|NCT03802617|560748381|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
155358639|NCT03802617|560748382|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
155358640|NCT00621192|560748383|FG000|Overall Study|Withdrawal by Subject|0|||
155358641|NCT00621192|560748384|FG001|Overall Study|Withdrawal by Subject|0|||
155358642|NCT00621192|560748385|FG002|Overall Study|Withdrawal by Subject|2|||
155358643|NCT00621192|560748386|FG003|Overall Study|Withdrawal by Subject|0|||
155358644|NCT00621192|560748383|FG000|Overall Study|Physician Decision|1|||
155358645|NCT00621192|560748384|FG001|Overall Study|Physician Decision|3|||
155358646|NCT00621192|560748385|FG002|Overall Study|Physician Decision|0|||
155358647|NCT00621192|560748386|FG003|Overall Study|Physician Decision|0|||
155358648|NCT00621192|560748383|FG000|Overall Study|Protocol Violation|1|||
155358649|NCT00621192|560748384|FG001|Overall Study|Protocol Violation|0|||
155358650|NCT00621192|560748385|FG002|Overall Study|Protocol Violation|0|||
155358651|NCT00621192|560748386|FG003|Overall Study|Protocol Violation|1|||
155358652|NCT00621192|560748383|FG000|Overall Study|Adverse Event|0|||
155358653|NCT00621192|560748384|FG001|Overall Study|Adverse Event|1|||
155358654|NCT00621192|560748385|FG002|Overall Study|Adverse Event|0|||
155358655|NCT00621192|560748386|FG003|Overall Study|Adverse Event|1|||
155358656|NCT00621192|560748383|FG000|Overall Study|Death|2|||
155358657|NCT00621192|560748384|FG001|Overall Study|Death|5|||
155358658|NCT00621192|560748385|FG002|Overall Study|Death|0|||
155358659|NCT00621192|560748386|FG003|Overall Study|Death|0|||
155358660|NCT00621192|560748383|FG000|Overall Study|Final Assessments not Completed|0|||
155358661|NCT00621192|560748384|FG001|Overall Study|Final Assessments not Completed|0|||
155358662|NCT00621192|560748385|FG002|Overall Study|Final Assessments not Completed|3|||
155358663|NCT00621192|560748386|FG003|Overall Study|Final Assessments not Completed|1|||
155358664|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
155358665|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
155358666|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
155358667|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
155358668|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
155358669|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
155358670|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
155358671|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
155358672|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
155358673|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
155358674|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
155358675|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
155358676|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
155358677|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
155358678|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
155358679|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358680|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358681|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358682|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
155358683|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
155358684|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
155358685|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358686|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358687|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358688|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
155358689|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
155358690|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
155358691|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
155358692|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
155358693|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
155358694|NCT02569957|560748390|FG000|Overall Study|Withdrawal by Subject|0|||
155358695|NCT02569957|560748391|FG001|Overall Study|Withdrawal by Subject|1|||
155358696|NCT02635386|560748392|FG000|Overall Study|Pregnancy|2|||
155358697|NCT02635386|560748393|FG001|Overall Study|Pregnancy|0|||
155358698|NCT02635386|560748394|FG002|Overall Study|Pregnancy|0|||
155358699|NCT02635386|560748395|FG003|Overall Study|Pregnancy|0|||
155358700|NCT02635386|560748396|FG004|Overall Study|Pregnancy|2|||
155358701|NCT02635386|560748392|FG000|Overall Study|Withdrawal by Subject|1|||
155358702|NCT02635386|560748393|FG001|Overall Study|Withdrawal by Subject|1|||
155358703|NCT02635386|560748394|FG002|Overall Study|Withdrawal by Subject|0|||
155358704|NCT02635386|560748395|FG003|Overall Study|Withdrawal by Subject|1|||
155358705|NCT02635386|560748396|FG004|Overall Study|Withdrawal by Subject|0|||
155358706|NCT02635386|560748392|FG000|Overall Study|Physician Decision|0|||
155358707|NCT02635386|560748393|FG001|Overall Study|Physician Decision|1|||
155358708|NCT02635386|560748394|FG002|Overall Study|Physician Decision|0|||
155358709|NCT02635386|560748395|FG003|Overall Study|Physician Decision|0|||
155358710|NCT02635386|560748396|FG004|Overall Study|Physician Decision|0|||
155358711|NCT02635386|560748392|FG000|Overall Study|Moved Out of State|0|||
155358712|NCT02635386|560748393|FG001|Overall Study|Moved Out of State|1|||
155358713|NCT02635386|560748394|FG002|Overall Study|Moved Out of State|0|||
155358714|NCT02635386|560748395|FG003|Overall Study|Moved Out of State|0|||
155358715|NCT02635386|560748396|FG004|Overall Study|Moved Out of State|0|||
155358716|NCT02635386|560748392|FG000|Overall Study|Noncompliant|0|||
155358717|NCT02635386|560748393|FG001|Overall Study|Noncompliant|2|||
155358718|NCT02635386|560748394|FG002|Overall Study|Noncompliant|1|||
155358719|NCT02635386|560748395|FG003|Overall Study|Noncompliant|1|||
155358720|NCT02635386|560748396|FG004|Overall Study|Noncompliant|1|||
155358721|NCT02635386|560748392|FG000|Overall Study|side effects|0|||
155358722|NCT02635386|560748393|FG001|Overall Study|side effects|0|||
155358723|NCT02635386|560748394|FG002|Overall Study|side effects|1|||
155358724|NCT02635386|560748395|FG003|Overall Study|side effects|4|||
155358725|NCT02635386|560748396|FG004|Overall Study|side effects|6|||
155358726|NCT02635386|560748392|FG000|Overall Study|needed other major surgery|0|||
155358727|NCT02635386|560748393|FG001|Overall Study|needed other major surgery|1|||
155358728|NCT02635386|560748394|FG002|Overall Study|needed other major surgery|0|||
155358729|NCT02635386|560748395|FG003|Overall Study|needed other major surgery|0|||
155427352|NCT04375761|560991785|FG000|Overall Study|Unforeseen family circumstances|1|||
155427353|NCT04375761|560991786|FG001|Overall Study|Unforeseen family circumstances|3|||
155358730|NCT02635386|560748396|FG004|Overall Study|needed other major surgery|0|||
155358731|NCT02635386|560748392|FG000|Overall Study|Other medical problems not drug related|0|||
155358732|NCT02635386|560748393|FG001|Overall Study|Other medical problems not drug related|0|||
155358733|NCT02635386|560748394|FG002|Overall Study|Other medical problems not drug related|0|||
155427354|NCT04375761|560991785|FG000|Overall Study|Test too painful|1|||
155358734|NCT02635386|560748395|FG003|Overall Study|Other medical problems not drug related|1|||
155358735|NCT02635386|560748396|FG004|Overall Study|Other medical problems not drug related|0|||
155358736|NCT03174782|560748397|FG000|Overall Study|Protocol Violation|1|||
155358737|NCT03174782|560748398|FG001|Overall Study|Protocol Violation|0|||
155358738|NCT03174782|560748397|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
155358739|NCT03174782|560748398|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
155358740|NCT03178045|560748399|FG000|Overall Study|Withdrawal by Subject|5|||
155358741|NCT03178045|560748400|FG001|Overall Study|Withdrawal by Subject|7|||
155358742|NCT03178045|560748399|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
155358743|NCT03178045|560748400|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
155358744|NCT03178045|560748399|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
155358745|NCT03178045|560748400|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
155358746|NCT01078922|560748401|FG000|Overall Study|Adverse Event|1|||
155358747|NCT00725543|560748410|FG000|Overall Study|Adverse Event|10|||
155358748|NCT00725543|560748410|FG000|Overall Study|Lack of Efficacy|3|||
155358749|NCT00725543|560748410|FG000|Overall Study|Withdrawal by Subject|10|||
155358750|NCT00725543|560748410|FG000|Overall Study|Physician Decision|5|||
155358751|NCT00725543|560748410|FG000|Overall Study|Lost to Follow-up|4|||
155358752|NCT00725543|560748410|FG000|Overall Study|Non-compliance|2|||
155358753|NCT00725543|560748410|FG000|Overall Study|Other|119|||
155358754|NCT02168478|560748411|FG000|Overall Study|Withdrawal by Subject|1|||
155358755|NCT02168478|560748411|FG000|Overall Study|Did Not Consent to Participation|2|||
155358756|NCT02168478|560748411|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
155358757|NCT01157377|560748412|FG000|Overall Study|Lost to Follow-up|0|||
155358758|NCT01157377|560748413|FG001|Overall Study|Lost to Follow-up|0|||
155358759|NCT01157377|560748414|FG002|Overall Study|Lost to Follow-up|1|||
155358760|NCT01157377|560748415|FG003|Overall Study|Lost to Follow-up|0|||
155358761|NCT01157377|560748416|FG004|Overall Study|Lost to Follow-up|1|||
155358762|NCT01157377|560748417|FG005|Overall Study|Lost to Follow-up|1|||
155358763|NCT01157377|560748418|FG006|Overall Study|Lost to Follow-up|0|||
155358764|NCT01157377|560748412|FG000|Overall Study|Personal Reasons|2|||
155358765|NCT01157377|560748413|FG001|Overall Study|Personal Reasons|1|||
155358766|NCT01157377|560748414|FG002|Overall Study|Personal Reasons|0|||
155358767|NCT01157377|560748415|FG003|Overall Study|Personal Reasons|1|||
155358768|NCT01157377|560748416|FG004|Overall Study|Personal Reasons|0|||
155358769|NCT01157377|560748417|FG005|Overall Study|Personal Reasons|0|||
155358770|NCT01157377|560748418|FG006|Overall Study|Personal Reasons|0|||
155358771|NCT01157377|560748412|FG000|Overall Study|Protocol Violation|0|||
155358772|NCT01157377|560748413|FG001|Overall Study|Protocol Violation|0|||
155358773|NCT01157377|560748414|FG002|Overall Study|Protocol Violation|0|||
155358774|NCT01157377|560748415|FG003|Overall Study|Protocol Violation|0|||
155358775|NCT01157377|560748416|FG004|Overall Study|Protocol Violation|0|||
155358776|NCT01157377|560748417|FG005|Overall Study|Protocol Violation|1|||
155358777|NCT01157377|560748418|FG006|Overall Study|Protocol Violation|0|||
155358778|NCT01157377|560748412|FG000|Overall Study|Lack of Efficacy|0|||
155358779|NCT01157377|560748413|FG001|Overall Study|Lack of Efficacy|0|||
155358780|NCT01157377|560748414|FG002|Overall Study|Lack of Efficacy|0|||
155358781|NCT01157377|560748415|FG003|Overall Study|Lack of Efficacy|0|||
155358782|NCT01157377|560748416|FG004|Overall Study|Lack of Efficacy|0|||
155358783|NCT01157377|560748417|FG005|Overall Study|Lack of Efficacy|0|||
155358784|NCT01157377|560748418|FG006|Overall Study|Lack of Efficacy|1|||
155358785|NCT01157377|560748412|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155358786|NCT01157377|560748413|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155358787|NCT01157377|560748414|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155358788|NCT01157377|560748415|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155358789|NCT01157377|560748416|FG004|Overall Study|Other Miscellaneous Reasons|1|||
155358790|NCT01157377|560748417|FG005|Overall Study|Other Miscellaneous Reasons|1|||
155358791|NCT01157377|560748418|FG006|Overall Study|Other Miscellaneous Reasons|1|||
155358792|NCT05523219|560748419|FG000|Overall Study|Wrong inclusion|1|||
155358793|NCT05523219|560748419|FG000|Overall Study|Lost to Follow-up|7|||
155358794|NCT01087814|560748420|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
155358795|NCT01087814|560748421|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
155358796|NCT01087814|560748420|FG000|Second Intervention (5 Days)|Physician Decision|1|||
155358797|NCT01087814|560748421|FG001|Second Intervention (5 Days)|Physician Decision|0|||
155358798|NCT02918292|560748422|FG000|Study Enrollment Prior to Transplant|Death|1|||
155358799|NCT02918292|560748422|FG000|Study Follow up After Transplant|Death|6|||
155358800|NCT02650466|560748423|FG000|Overall Study|Physician Decision|1|||
155358801|NCT02650466|560748423|FG000|Overall Study|Withdrawal by Subject|5|||
155358802|NCT02650466|560748423|FG000|Overall Study|Lost to Follow-up|1|||
155358803|NCT02392104|560748425|FG000|Overall Study|discontinuation of warfarin|3|||
155358804|NCT02392104|560748425|FG000|Overall Study|bleeding event|1|||
155358805|NCT02392104|560748425|FG000|Overall Study|transferred care to another doctor|2|||
155358806|NCT02392104|560748425|FG000|Overall Study|INR goal range changed|1|||
155648884|NCT04913675|561805926|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
155648885|NCT04913675|561805927|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
155648886|NCT04913675|561805928|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
155648887|NCT04913675|561805929|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
155648888|NCT04913675|561805926|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155648889|NCT04913675|561805927|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155648890|NCT04913675|561805928|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155648891|NCT04913675|561805929|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
155648892|NCT05660538|561805930|FG000|Overall Study|Adverse Event|0|||
155648893|NCT05660538|561805931|FG001|Overall Study|Adverse Event|0|||
155358807|NCT02392104|560748425|FG000|Overall Study|admitted to skilled nursing facility|3|||
155358808|NCT02392104|560748425|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
155358809|NCT02636608|560748429|FG000|Overall Study|Failure to Return|4|||
155358810|NCT02636608|560748429|FG000|Overall Study|Insufficient Virological Response|1|||
155358811|NCT02636608|560748429|FG000|Overall Study|Death|3|||
155358812|NCT02636608|560748429|FG000|Overall Study|Other|2|||
155358813|NCT02636608|560748429|FG000|Overall Study|Did Not Receive Treatment|1|||
155358814|NCT03912532|560748430|FG000|Overall Study|Adverse Event|3|||
155358815|NCT03912532|560748431|FG001|Overall Study|Adverse Event|3|||
155358816|NCT03912532|560748432|FG002|Overall Study|Adverse Event|2|||
155358817|NCT03912532|560748433|FG003|Overall Study|Adverse Event|2|||
155358818|NCT03912532|560748430|FG000|Overall Study|Lost to Follow-up|3|||
155358819|NCT03912532|560748431|FG001|Overall Study|Lost to Follow-up|2|||
155358820|NCT03912532|560748432|FG002|Overall Study|Lost to Follow-up|1|||
155358821|NCT03912532|560748433|FG003|Overall Study|Lost to Follow-up|2|||
155358822|NCT03912532|560748430|FG000|Overall Study|Withdrawal by Subject|1|||
155358823|NCT03912532|560748431|FG001|Overall Study|Withdrawal by Subject|1|||
155358824|NCT03912532|560748432|FG002|Overall Study|Withdrawal by Subject|2|||
155358825|NCT03912532|560748433|FG003|Overall Study|Withdrawal by Subject|0|||
155358826|NCT03912532|560748430|FG000|Overall Study|Physician Decision|1|||
155358827|NCT03912532|560748431|FG001|Overall Study|Physician Decision|0|||
155358828|NCT03912532|560748432|FG002|Overall Study|Physician Decision|0|||
155358829|NCT03912532|560748433|FG003|Overall Study|Physician Decision|3|||
155358830|NCT03912532|560748430|FG000|Overall Study|Other|0|||
155358831|NCT03912532|560748431|FG001|Overall Study|Other|1|||
155358832|NCT03912532|560748432|FG002|Overall Study|Other|1|||
155358833|NCT03912532|560748433|FG003|Overall Study|Other|0|||
155358834|NCT04913948|560748434|FG000|Overall Study|Withdrawal by Subject|2|||
155358835|NCT04913948|560748434|FG000|Overall Study|Sample processing issues|1|||
155358836|NCT04913948|560748434|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
155358837|NCT03783871|560748437|FG000|Overall Study|Withdrawal by Subject|15|||
155358838|NCT03783871|560748437|FG000|Overall Study|Death|13|||
155648894|NCT05660538|561805932|FG002|Overall Study|Adverse Event|1|||
155358839|NCT03783871|560748437|FG000|Overall Study|Lost to Follow-up|2|||
155358840|NCT05990387|560748439|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
155358841|NCT05990387|560748440|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
155648895|NCT05660538|561805933|FG003|Overall Study|Adverse Event|0|||
155358842|NCT00815919|560748441|FG000|Overall Study|Unrelated Fungal Infection|1|||
155358843|NCT00815919|560748441|FG000|Overall Study|AML Relapse|1|||
155648896|NCT05660538|561805930|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155358844|NCT00815919|560748441|FG000|Overall Study|Lack of Efficacy|2|||
155358845|NCT03522389|560748442|FG000|Overall Study|Lost to Follow-up|1|||
155358846|NCT03522389|560748443|FG001|Overall Study|Lost to Follow-up|1|||
155358847|NCT03522389|560748444|FG002|Overall Study|Lost to Follow-up|2|||
155358848|NCT03522389|560748442|FG000|Overall Study|had herniated nucleus pulposus|0|||
155358849|NCT03522389|560748443|FG001|Overall Study|had herniated nucleus pulposus|1|||
155358850|NCT03522389|560748444|FG002|Overall Study|had herniated nucleus pulposus|0|||
155358851|NCT03522389|560748442|FG000|Overall Study|go to work in other province|1|||
155358852|NCT03522389|560748443|FG001|Overall Study|go to work in other province|0|||
155358853|NCT03522389|560748444|FG002|Overall Study|go to work in other province|0|||
155358854|NCT04680637|560748445|FG000|Overall Study|Lost to Follow-up|0|||
155358855|NCT04680637|560748446|FG001|Overall Study|Lost to Follow-up|1|||
155358856|NCT04680637|560748447|FG002|Overall Study|Lost to Follow-up|0|||
155358857|NCT04680637|560748448|FG003|Overall Study|Lost to Follow-up|1|||
155358858|NCT04680637|560748445|FG000|Overall Study|Death|1|||
155358859|NCT04680637|560748446|FG001|Overall Study|Death|0|||
155358860|NCT04680637|560748447|FG002|Overall Study|Death|0|||
155358861|NCT04680637|560748448|FG003|Overall Study|Death|0|||
155358862|NCT04680637|560748445|FG000|Overall Study|Withdrawal by Subject|7|||
155358863|NCT04680637|560748446|FG001|Overall Study|Withdrawal by Subject|10|||
155358864|NCT04680637|560748447|FG002|Overall Study|Withdrawal by Subject|17|||
155358865|NCT04680637|560748448|FG003|Overall Study|Withdrawal by Subject|15|||
155358866|NCT04680637|560748445|FG000|Overall Study|Decision by Sponsor|21|||
155358867|NCT04680637|560748446|FG001|Overall Study|Decision by Sponsor|15|||
155358868|NCT04680637|560748447|FG002|Overall Study|Decision by Sponsor|7|||
155358869|NCT04680637|560748448|FG003|Overall Study|Decision by Sponsor|32|||
155358870|NCT00604188|560748449|FG000|Overall Study|Adverse Event|1|||
155358871|NCT00604188|560748450|FG001|Overall Study|Adverse Event|4|||
155358872|NCT00604188|560748449|FG000|Overall Study|Lost to Follow-up|17|||
155358873|NCT00604188|560748450|FG001|Overall Study|Lost to Follow-up|15|||
155358874|NCT00604188|560748449|FG000|Overall Study|Withdrawal by Subject|5|||
155358875|NCT00604188|560748450|FG001|Overall Study|Withdrawal by Subject|1|||
155358876|NCT00604188|560748449|FG000|Overall Study|Non-compliance with protocol|4|||
155358877|NCT00604188|560748450|FG001|Overall Study|Non-compliance with protocol|4|||
155358878|NCT00604188|560748449|FG000|Overall Study|Did not receive study drug|0|||
155358879|NCT00604188|560748450|FG001|Overall Study|Did not receive study drug|1|||
155358880|NCT02242643|560748453|FG000|Overall Study|Protocol Violation|1|||
155358881|NCT02242643|560748454|FG001|Overall Study|Protocol Violation|2|||
155358882|NCT02242643|560748453|FG000|Overall Study|Withdrawal by Subject|15|||
155358883|NCT02242643|560748454|FG001|Overall Study|Withdrawal by Subject|10|||
155358884|NCT02242643|560748453|FG000|Overall Study|Migrated/moved from study area|1|||
155358885|NCT02242643|560748454|FG001|Overall Study|Migrated/moved from study area|3|||
155358886|NCT02242643|560748453|FG000|Overall Study|Lost to Follow-up|54|||
155358887|NCT02242643|560748454|FG001|Overall Study|Lost to Follow-up|61|||
155358888|NCT02242643|560748453|FG000|Overall Study|Child placed in foster care by family|0|||
155358889|NCT02242643|560748454|FG001|Overall Study|Child placed in foster care by family|1|||
155358890|NCT02242643|560748453|FG000|Overall Study|Non-compliance|1|||
155358891|NCT02242643|560748454|FG001|Overall Study|Non-compliance|0|||
155358892|NCT02242643|560748453|FG000|Overall Study|Consent withdrawal by parent|1|||
155358893|NCT02242643|560748454|FG001|Overall Study|Consent withdrawal by parent|0|||
155358894|NCT02242643|560748453|FG000|Overall Study|Protocol requirements not followed|1|||
155358895|NCT02242643|560748454|FG001|Overall Study|Protocol requirements not followed|0|||
155358896|NCT02242643|560748453|FG000|Overall Study|Language barrier|1|||
155358897|NCT02242643|560748454|FG001|Overall Study|Language barrier|0|||
155358898|NCT02242643|560748453|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
155358899|NCT02242643|560748454|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
155358900|NCT01103232|560748456|FG000|Overall Study|Withdrawal by Subject|1|||
155358901|NCT01103232|560748457|FG001|Overall Study|Withdrawal by Subject|1|||
155358902|NCT01103232|560748456|FG000|Overall Study|Protocol Violation|0|||
155358903|NCT01103232|560748457|FG001|Overall Study|Protocol Violation|1|||
155358904|NCT00443599|560748461|FG000|Overall Study|Physician Decision|2|||
155358905|NCT00443599|560748462|FG001|Overall Study|Physician Decision|1|||
155358906|NCT00443599|560748461|FG000|Overall Study|Death|1|||
155358907|NCT00443599|560748462|FG001|Overall Study|Death|1|||
155358908|NCT00443599|560748461|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
155358909|NCT00443599|560748462|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
155358910|NCT05093504|560748463|FG000|Overall Study|Death|0|||
155358911|NCT05093504|560748464|FG001|Overall Study|Death|1|||
155358912|NCT05347485|560748469|FG000|Overall Study|Death|14|||
155358913|NCT05347485|560748469|FG000|Overall Study|Lost to Follow-up|2|||
155358914|NCT05347485|560748469|FG000|Overall Study|Withdrawal by Subject|13|||
155358915|NCT05347485|560748469|FG000|Overall Study|Progressive Disease|1|||
155358916|NCT05347485|560748469|FG000|Overall Study|Study Terminated by Sponsor|49|||
155358917|NCT05347485|560748469|FG000|Overall Study|Other|1|||
155358918|NCT05347485|560748469|FG000|Overall Study|Enrolled (consented) but not treated|4|||
155358919|NCT05347485|560748469|FG000|Overall Study|Disease Relapse|2|||
155358920|NCT01536587|560750024|FG000|Overall Study|Adverse Event|2|||
155358921|NCT02666664|560750025|FG000|Overall Study|Physician Decision|0|||
155358922|NCT02666664|560750026|FG001|Overall Study|Physician Decision|1|||
155358923|NCT02666664|560750025|FG000|Overall Study|Protocol Violation|0|||
155358924|NCT02666664|560750026|FG001|Overall Study|Protocol Violation|2|||
155358925|NCT02666664|560750025|FG000|Overall Study|Other|0|||
155358926|NCT02666664|560750026|FG001|Overall Study|Other|1|||
155358927|NCT02666664|560750025|FG000|Overall Study|Adverse Event|12|||
155358928|NCT02666664|560750026|FG001|Overall Study|Adverse Event|37|||
155358929|NCT02666664|560750025|FG000|Overall Study|Withdrawal by participant|23|||
155358930|NCT02666664|560750026|FG001|Overall Study|Withdrawal by participant|40|||
155358931|NCT02666664|560750025|FG000|Overall Study|Sponsor decision|0|||
155358932|NCT02666664|560750026|FG001|Overall Study|Sponsor decision|1|||
155358933|NCT02666664|560750025|FG000|Overall Study|Lost to Follow-up|1|||
155358934|NCT02666664|560750026|FG001|Overall Study|Lost to Follow-up|2|||
155358935|NCT03616964|560750027|FG000|Overall Study|Adverse Event|15|||
155358936|NCT03616964|560750028|FG001|Overall Study|Adverse Event|10|||
155358937|NCT03616964|560750029|FG002|Overall Study|Adverse Event|16|||
155358938|NCT03616964|560750027|FG000|Overall Study|Death|3|||
155358939|NCT03616964|560750028|FG001|Overall Study|Death|0|||
155358940|NCT03616964|560750029|FG002|Overall Study|Death|4|||
155358941|NCT03616964|560750027|FG000|Overall Study|Lack of Efficacy|4|||
155358942|NCT03616964|560750028|FG001|Overall Study|Lack of Efficacy|8|||
155358943|NCT03616964|560750029|FG002|Overall Study|Lack of Efficacy|8|||
155358944|NCT03616964|560750027|FG000|Overall Study|Lost to Follow-up|2|||
155358945|NCT03616964|560750028|FG001|Overall Study|Lost to Follow-up|1|||
155358946|NCT03616964|560750029|FG002|Overall Study|Lost to Follow-up|3|||
155358947|NCT03616964|560750027|FG000|Overall Study|Withdrawal by Subject|18|||
155358948|NCT03616964|560750028|FG001|Overall Study|Withdrawal by Subject|14|||
155507168|NCT01123980|561283574|FG000|Overall Study|Protocol Violation|6|||
155507169|NCT01123980|561283575|FG001|Overall Study|Protocol Violation|6|||
155507170|NCT01123980|561283574|FG000|Overall Study|Withdrawal by Subject|5|||
155507171|NCT01123980|561283575|FG001|Overall Study|Withdrawal by Subject|3|||
155507172|NCT01123980|561283574|FG000|Overall Study|Unclassified|6|||
155507173|NCT01123980|561283575|FG001|Overall Study|Unclassified|7|||
155507174|NCT01225991|561283576|FG000|Overall Study|Withdrawal by Subject|6|||
155507175|NCT04444752|561283577|FG000|Overall Study|Adverse Event|1|||
155507176|NCT04444752|561283578|FG001|Overall Study|Adverse Event|0|||
155507177|NCT04444752|561283579|FG002|Overall Study|Adverse Event|0|||
155507178|NCT04444752|561283580|FG003|Overall Study|Adverse Event|2|||
155507179|NCT04444752|561283577|FG000|Overall Study|Lost to Follow-up|2|||
155507180|NCT04444752|561283578|FG001|Overall Study|Lost to Follow-up|6|||
155507181|NCT04444752|561283579|FG002|Overall Study|Lost to Follow-up|2|||
155507182|NCT04444752|561283580|FG003|Overall Study|Lost to Follow-up|5|||
155358949|NCT03616964|560750029|FG002|Overall Study|Withdrawal by Subject|21|||
155358950|NCT03616964|560750027|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358951|NCT03616964|560750028|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358952|NCT03616964|560750029|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358953|NCT03616964|560750027|FG000|Overall Study|Sponsor's Decision|1|||
155358954|NCT03616964|560750028|FG001|Overall Study|Sponsor's Decision|0|||
155358955|NCT03616964|560750029|FG002|Overall Study|Sponsor's Decision|0|||
155358956|NCT03616964|560750027|FG000|Overall Study|Physician Decision|0|||
155358957|NCT03616964|560750028|FG001|Overall Study|Physician Decision|2|||
155358958|NCT03616964|560750029|FG002|Overall Study|Physician Decision|0|||
155507183|NCT04444752|561283577|FG000|Overall Study|Physician Decision|0|||
155507184|NCT04444752|561283578|FG001|Overall Study|Physician Decision|0|||
155507185|NCT04444752|561283579|FG002|Overall Study|Physician Decision|0|||
155507186|NCT04444752|561283580|FG003|Overall Study|Physician Decision|2|||
155507187|NCT04444752|561283577|FG000|Overall Study|Pregnancy|0|||
155358959|NCT03616964|560750027|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
155507188|NCT04444752|561283578|FG001|Overall Study|Pregnancy|0|||
155358960|NCT03616964|560750028|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
155358961|NCT03616964|560750029|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
155358962|NCT03616964|560750027|FG000|Overall Study|Protocol Violation|0|||
155358963|NCT03616964|560750028|FG001|Overall Study|Protocol Violation|1|||
155358964|NCT03616964|560750029|FG002|Overall Study|Protocol Violation|0|||
155358965|NCT03616964|560750027|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
155358966|NCT03616964|560750028|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
155358967|NCT03616964|560750029|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
155358968|NCT03616964|560750027|FG000|Overall Study|Randomized but Never Treated|1|||
155358969|NCT03616964|560750028|FG001|Overall Study|Randomized but Never Treated|1|||
155358970|NCT03616964|560750029|FG002|Overall Study|Randomized but Never Treated|1|||
155358971|NCT04090528|560750033|FG000|Overall Study|participants still on study|9|||
155358972|NCT04090528|560750034|FG001|Overall Study|participants still on study|13|||
155358973|NCT02056626|560750035|FG000|Overall Study|patient did not follow directions|3|||
155358974|NCT02056626|560750036|FG001|Overall Study|patient did not follow directions|1|||
155358975|NCT02056626|560750037|FG002|Overall Study|patient did not follow directions|0|||
155358976|NCT02056626|560750038|FG003|Overall Study|patient did not follow directions|0|||
155358977|NCT04916002|560750042|FG000|Overall Study|Adverse Event|0|||
155358978|NCT04916002|560750043|FG001|Overall Study|Adverse Event|1|||
155358979|NCT04916002|560750044|FG002|Overall Study|Adverse Event|0|||
155358980|NCT04916002|560750045|FG003|Overall Study|Adverse Event|1|||
155358981|NCT04916002|560750046|FG004|Overall Study|Adverse Event|0|||
155358982|NCT04916002|560750042|FG000|Overall Study|Withdrawal by Subject|3|||
155358983|NCT04916002|560750043|FG001|Overall Study|Withdrawal by Subject|1|||
155358984|NCT04916002|560750044|FG002|Overall Study|Withdrawal by Subject|0|||
155358985|NCT04916002|560750045|FG003|Overall Study|Withdrawal by Subject|1|||
155358986|NCT04916002|560750046|FG004|Overall Study|Withdrawal by Subject|0|||
155358987|NCT04916002|560750042|FG000|Overall Study|Death|8|||
155358988|NCT04916002|560750043|FG001|Overall Study|Death|7|||
155358989|NCT04916002|560750044|FG002|Overall Study|Death|4|||
155358990|NCT04916002|560750045|FG003|Overall Study|Death|9|||
155358991|NCT04916002|560750046|FG004|Overall Study|Death|0|||
155358992|NCT04916002|560750042|FG000|Overall Study|Study Terminated by Sponsor|11|||
155358993|NCT04916002|560750043|FG001|Overall Study|Study Terminated by Sponsor|10|||
155358994|NCT04916002|560750044|FG002|Overall Study|Study Terminated by Sponsor|8|||
155358995|NCT04916002|560750045|FG003|Overall Study|Study Terminated by Sponsor|5|||
155358996|NCT04916002|560750046|FG004|Overall Study|Study Terminated by Sponsor|4|||
155358997|NCT04916002|560750042|FG000|Overall Study|End of trial|1|||
155358998|NCT04916002|560750043|FG001|Overall Study|End of trial|0|||
155358999|NCT04916002|560750044|FG002|Overall Study|End of trial|0|||
155359000|NCT04916002|560750045|FG003|Overall Study|End of trial|0|||
155359001|NCT04916002|560750046|FG004|Overall Study|End of trial|0|||
155359002|NCT04916002|560750042|FG000|Overall Study|Progressive disease|0|||
155359003|NCT04916002|560750043|FG001|Overall Study|Progressive disease|0|||
155359004|NCT04916002|560750044|FG002|Overall Study|Progressive disease|1|||
155359005|NCT04916002|560750045|FG003|Overall Study|Progressive disease|0|||
155359006|NCT04916002|560750046|FG004|Overall Study|Progressive disease|0|||
155359007|NCT04916002|560750042|FG000|Overall Study|Participant non-compliance|2|||
155359008|NCT04916002|560750043|FG001|Overall Study|Participant non-compliance|0|||
155359009|NCT04916002|560750044|FG002|Overall Study|Participant non-compliance|0|||
155359010|NCT04916002|560750045|FG003|Overall Study|Participant non-compliance|0|||
155359011|NCT04916002|560750046|FG004|Overall Study|Participant non-compliance|0|||
155359012|NCT05923112|560750047|FG000|Overall Study|Protocol Violation|4|||
155359013|NCT05923112|560750047|FG000|Overall Study|No informed consent on publication of study results|243|||
155359014|NCT04351269|560750048|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
155359015|NCT04351269|560750049|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
155359016|NCT04351269|560750050|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
155359017|NCT04351269|560750048|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
155359018|NCT04351269|560750049|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
155359019|NCT04351269|560750050|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
155359020|NCT04351269|560750048|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
155359021|NCT04351269|560750049|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
155359022|NCT04351269|560750050|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
155359023|NCT04351269|560750048|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
155359024|NCT04351269|560750049|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
155359025|NCT04351269|560750050|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
155359026|NCT04351269|560750048|FG000|Overall Study|Lost to Follow-up|1|||
155359027|NCT04351269|560750049|FG001|Overall Study|Lost to Follow-up|3|||
155359028|NCT04351269|560750050|FG002|Overall Study|Lost to Follow-up|0|||
155359029|NCT04486313|560750051|FG000|Overall Study|Lost to Follow-up|7|||
155359030|NCT04486313|560750052|FG001|Overall Study|Lost to Follow-up|9|||
155427355|NCT04375761|560991786|FG001|Overall Study|Test too painful|1|||
155359031|NCT04486313|560750051|FG000|Overall Study|Withdrawal by Subject|8|||
155359032|NCT04486313|560750052|FG001|Overall Study|Withdrawal by Subject|6|||
155359033|NCT04486313|560750051|FG000|Overall Study|Physician Decision|1|||
155359034|NCT04486313|560750052|FG001|Overall Study|Physician Decision|1|||
155359035|NCT04486313|560750051|FG000|Overall Study|Death|2|||
155359036|NCT04486313|560750052|FG001|Overall Study|Death|0|||
155359037|NCT04486313|560750051|FG000|Overall Study|Protocol Violation|1|||
155359038|NCT04486313|560750052|FG001|Overall Study|Protocol Violation|1|||
155359039|NCT01162135|560750061|FG000|Overall Study|Withdrawal by Subject|1|||
155359040|NCT01162135|560750061|FG000|Overall Study|Severe back pain|1|||
155359041|NCT01162135|560750061|FG000|Overall Study|Ineligible|1|||
155359042|NCT01777334|560750062|FG000|Overall Study|Adverse Event|18|||
155359043|NCT01777334|560750063|FG001|Overall Study|Adverse Event|14|||
155359044|NCT01777334|560750062|FG000|Overall Study|Lack of Efficacy|15|||
155359045|NCT01777334|560750063|FG001|Overall Study|Lack of Efficacy|29|||
155359046|NCT01777334|560750062|FG000|Overall Study|Protocol Violation|3|||
155359047|NCT01777334|560750063|FG001|Overall Study|Protocol Violation|7|||
155359048|NCT01777334|560750062|FG000|Overall Study|Lost to Follow-up|3|||
155359049|NCT01777334|560750063|FG001|Overall Study|Lost to Follow-up|2|||
155359050|NCT01777334|560750062|FG000|Overall Study|Withdrawal by Subject|14|||
155359051|NCT01777334|560750063|FG001|Overall Study|Withdrawal by Subject|11|||
155359052|NCT06136897|560750070|FG000|Overall Study|Ineligible|3|||
155359053|NCT06136897|560750070|FG000|Overall Study|Mutation status not confirmed|7|||
155359054|NCT06136897|560750070|FG000|Overall Study|Adverse Event|2|||
155359055|NCT06136897|560750070|FG000|Overall Study|Death|1|||
155359056|NCT06136897|560750070|FG000|Overall Study|Disease progression|18|||
155359057|NCT06136897|560750070|FG000|Overall Study|Other complicating disease|1|||
155359058|NCT06136897|560750070|FG000|Overall Study|Withdrawal by Subject|1|||
155359059|NCT06136897|560750070|FG000|Overall Study|Still on treatment|1|||
155359060|NCT06136897|560750070|FG000|Overall Study|Lost to Follow-up|1|||
155359061|NCT00756457|560750071|FG000|Overall Study|Lost to Follow-up|1|||
155359062|NCT00756457|560750072|FG001|Overall Study|Lost to Follow-up|2|||
155359063|NCT02947100|560750073|FG000|Overall Study|study terminated early|3|||
155359064|NCT02947100|560750073|FG000|Overall Study|did not meet inclusion criteria|1|||
155359065|NCT00822770|560750074|FG000|Overall Study|Not treated|1|||
155359066|NCT00822770|560750075|FG001|Overall Study|Not treated|0|||
155359067|NCT00822770|560750074|FG000|Overall Study|Complication/Incomplete treatment|1|||
155359068|NCT00822770|560750075|FG001|Overall Study|Complication/Incomplete treatment|0|||
155359069|NCT00822770|560750074|FG000|Overall Study|Death|1|||
155359070|NCT00822770|560750075|FG001|Overall Study|Death|1|||
155359071|NCT02402322|560750076|FG000|Pretreatment|Withdrawal by Subject|3|||
155359072|NCT02402322|560750077|FG001|Pretreatment|Withdrawal by Subject|1|||
155359073|NCT02402322|560750078|FG002|Pretreatment|Withdrawal by Subject|1|||
155359074|NCT02402322|560750076|FG000|Follow-up|Withdrawal by Subject|6|||
155359075|NCT02402322|560750077|FG001|Follow-up|Withdrawal by Subject|3|||
155359076|NCT02402322|560750078|FG002|Follow-up|Withdrawal by Subject|24|||
155359077|NCT02818998|560750079|FG000|Overall Study|Adverse Event|3|||
155359078|NCT02818998|560750080|FG001|Overall Study|Adverse Event|2|||
155359079|NCT02818998|560750081|FG002|Overall Study|Adverse Event|1|||
155359080|NCT02818998|560750079|FG000|Overall Study|Lost to Follow-up|4|||
155359081|NCT02818998|560750080|FG001|Overall Study|Lost to Follow-up|1|||
155359082|NCT02818998|560750081|FG002|Overall Study|Lost to Follow-up|2|||
155359083|NCT02818998|560750079|FG000|Overall Study|Withdrawal by sponsor|0|||
155359084|NCT02818998|560750080|FG001|Overall Study|Withdrawal by sponsor|1|||
155359085|NCT02818998|560750081|FG002|Overall Study|Withdrawal by sponsor|1|||
155359086|NCT02818998|560750079|FG000|Overall Study|Death|3|||
155359087|NCT02818998|560750080|FG001|Overall Study|Death|6|||
155359088|NCT02818998|560750081|FG002|Overall Study|Death|8|||
155359089|NCT02818998|560750079|FG000|Overall Study|Withdrawal by Subject|7|||
155359090|NCT02818998|560750080|FG001|Overall Study|Withdrawal by Subject|6|||
155359091|NCT02818998|560750081|FG002|Overall Study|Withdrawal by Subject|6|||
155359092|NCT02818998|560750079|FG000|Overall Study|Physician Decision|1|||
155359093|NCT02818998|560750080|FG001|Overall Study|Physician Decision|0|||
155359094|NCT02818998|560750081|FG002|Overall Study|Physician Decision|0|||
155359095|NCT00632021|560750086|FG000|Overall Study|Withdrawal/death|4|||
155359096|NCT00632021|560750087|FG001|Overall Study|Withdrawal/death|7|||
155359097|NCT01296555|560750088|FG000|Overall Study|Adverse Event|0|||
155359098|NCT01296555|560750089|FG001|Overall Study|Adverse Event|0|||
155359099|NCT01296555|560750090|FG002|Overall Study|Adverse Event|1|||
155359100|NCT01296555|560750091|FG003|Overall Study|Adverse Event|1|||
155359101|NCT01296555|560750092|FG004|Overall Study|Adverse Event|2|||
155359102|NCT01296555|560750093|FG005|Overall Study|Adverse Event|4|||
155359103|NCT01296555|560750094|FG006|Overall Study|Adverse Event|1|||
155648897|NCT05660538|561805931|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155359104|NCT01296555|560750095|FG007|Overall Study|Adverse Event|4|||
155359105|NCT01296555|560750096|FG008|Overall Study|Adverse Event|3|||
155359106|NCT01296555|560750097|FG009|Overall Study|Adverse Event|1|||
155359107|NCT01296555|560750098|FG010|Overall Study|Adverse Event|0|||
155359108|NCT01296555|560750099|FG011|Overall Study|Adverse Event|4|||
155359109|NCT01296555|560750100|FG012|Overall Study|Adverse Event|1|||
155359110|NCT01296555|560750101|FG013|Overall Study|Adverse Event|4|||
155359111|NCT01296555|560750102|FG014|Overall Study|Adverse Event|0|||
155359112|NCT01296555|560750103|FG015|Overall Study|Adverse Event|0|||
155359113|NCT01296555|560750104|FG016|Overall Study|Adverse Event|0|||
155359114|NCT01296555|560750105|FG017|Overall Study|Adverse Event|0|||
155359115|NCT01296555|560750106|FG018|Overall Study|Adverse Event|0|||
155359116|NCT01296555|560750107|FG019|Overall Study|Adverse Event|1|||
155359117|NCT01296555|560750108|FG020|Overall Study|Adverse Event|0|||
155359118|NCT01296555|560750109|FG021|Overall Study|Adverse Event|0|||
155359119|NCT01296555|560750110|FG022|Overall Study|Adverse Event|0|||
155359120|NCT01296555|560750111|FG023|Overall Study|Adverse Event|0|||
155359121|NCT01296555|560750112|FG024|Overall Study|Adverse Event|0|||
155359122|NCT01296555|560750113|FG025|Overall Study|Adverse Event|0|||
155359123|NCT01296555|560750114|FG026|Overall Study|Adverse Event|0|||
155359124|NCT01296555|560750115|FG027|Overall Study|Adverse Event|0|||
155359125|NCT01296555|560750116|FG028|Overall Study|Adverse Event|0|||
155359126|NCT01296555|560750088|FG000|Overall Study|Reason Not Specified|0|||
155359127|NCT01296555|560750089|FG001|Overall Study|Reason Not Specified|0|||
155359128|NCT01296555|560750090|FG002|Overall Study|Reason Not Specified|0|||
155359129|NCT01296555|560750091|FG003|Overall Study|Reason Not Specified|0|||
155359130|NCT01296555|560750092|FG004|Overall Study|Reason Not Specified|0|||
155359131|NCT01296555|560750093|FG005|Overall Study|Reason Not Specified|0|||
155359132|NCT01296555|560750094|FG006|Overall Study|Reason Not Specified|0|||
155359133|NCT01296555|560750095|FG007|Overall Study|Reason Not Specified|0|||
155359134|NCT01296555|560750096|FG008|Overall Study|Reason Not Specified|0|||
155359135|NCT01296555|560750097|FG009|Overall Study|Reason Not Specified|0|||
155359136|NCT01296555|560750098|FG010|Overall Study|Reason Not Specified|0|||
155359137|NCT01296555|560750099|FG011|Overall Study|Reason Not Specified|0|||
155359138|NCT01296555|560750100|FG012|Overall Study|Reason Not Specified|0|||
155359139|NCT01296555|560750101|FG013|Overall Study|Reason Not Specified|1|||
155359140|NCT01296555|560750102|FG014|Overall Study|Reason Not Specified|2|||
155359141|NCT01296555|560750103|FG015|Overall Study|Reason Not Specified|3|||
155359142|NCT01296555|560750104|FG016|Overall Study|Reason Not Specified|7|||
155359143|NCT01296555|560750105|FG017|Overall Study|Reason Not Specified|4|||
155359144|NCT01296555|560750106|FG018|Overall Study|Reason Not Specified|3|||
155359145|NCT01296555|560750107|FG019|Overall Study|Reason Not Specified|7|||
155359146|NCT01296555|560750108|FG020|Overall Study|Reason Not Specified|11|||
155359147|NCT01296555|560750109|FG021|Overall Study|Reason Not Specified|5|||
155359148|NCT01296555|560750110|FG022|Overall Study|Reason Not Specified|5|||
155359149|NCT01296555|560750111|FG023|Overall Study|Reason Not Specified|7|||
155359150|NCT01296555|560750112|FG024|Overall Study|Reason Not Specified|2|||
155359151|NCT01296555|560750113|FG025|Overall Study|Reason Not Specified|2|||
155359152|NCT01296555|560750114|FG026|Overall Study|Reason Not Specified|19|||
155359153|NCT01296555|560750115|FG027|Overall Study|Reason Not Specified|11|||
155359154|NCT01296555|560750116|FG028|Overall Study|Reason Not Specified|9|||
155359155|NCT01296555|560750088|FG000|Overall Study|Physician Decision|0|||
155359156|NCT01296555|560750089|FG001|Overall Study|Physician Decision|0|||
155359157|NCT01296555|560750090|FG002|Overall Study|Physician Decision|0|||
155359158|NCT01296555|560750091|FG003|Overall Study|Physician Decision|0|||
155359159|NCT01296555|560750092|FG004|Overall Study|Physician Decision|1|||
155359160|NCT01296555|560750093|FG005|Overall Study|Physician Decision|0|||
155359161|NCT01296555|560750094|FG006|Overall Study|Physician Decision|0|||
155359162|NCT01296555|560750095|FG007|Overall Study|Physician Decision|0|||
155359163|NCT01296555|560750096|FG008|Overall Study|Physician Decision|0|||
155359164|NCT01296555|560750097|FG009|Overall Study|Physician Decision|0|||
155359165|NCT01296555|560750098|FG010|Overall Study|Physician Decision|0|||
155359166|NCT01296555|560750099|FG011|Overall Study|Physician Decision|0|||
155359167|NCT01296555|560750100|FG012|Overall Study|Physician Decision|0|||
155359168|NCT01296555|560750101|FG013|Overall Study|Physician Decision|1|||
155359169|NCT01296555|560750102|FG014|Overall Study|Physician Decision|0|||
155359170|NCT01296555|560750103|FG015|Overall Study|Physician Decision|0|||
155359171|NCT01296555|560750104|FG016|Overall Study|Physician Decision|0|||
155359172|NCT01296555|560750105|FG017|Overall Study|Physician Decision|0|||
155359173|NCT01296555|560750106|FG018|Overall Study|Physician Decision|0|||
155359174|NCT01296555|560750107|FG019|Overall Study|Physician Decision|1|||
155359175|NCT01296555|560750108|FG020|Overall Study|Physician Decision|0|||
155359176|NCT01296555|560750109|FG021|Overall Study|Physician Decision|0|||
155359177|NCT01296555|560750110|FG022|Overall Study|Physician Decision|0|||
155359178|NCT01296555|560750111|FG023|Overall Study|Physician Decision|0|||
155359179|NCT01296555|560750112|FG024|Overall Study|Physician Decision|0|||
155359180|NCT01296555|560750113|FG025|Overall Study|Physician Decision|0|||
155359181|NCT01296555|560750114|FG026|Overall Study|Physician Decision|0|||
155359182|NCT01296555|560750115|FG027|Overall Study|Physician Decision|0|||
155359183|NCT01296555|560750116|FG028|Overall Study|Physician Decision|0|||
155359184|NCT01296555|560750088|FG000|Overall Study|Progressive Disease|6|||
155359185|NCT01296555|560750089|FG001|Overall Study|Progressive Disease|3|||
155359186|NCT01296555|560750090|FG002|Overall Study|Progressive Disease|3|||
155359187|NCT01296555|560750091|FG003|Overall Study|Progressive Disease|7|||
155359188|NCT01296555|560750092|FG004|Overall Study|Progressive Disease|6|||
155359189|NCT01296555|560750093|FG005|Overall Study|Progressive Disease|16|||
155359190|NCT01296555|560750094|FG006|Overall Study|Progressive Disease|16|||
155359191|NCT01296555|560750095|FG007|Overall Study|Progressive Disease|8|||
155359192|NCT01296555|560750096|FG008|Overall Study|Progressive Disease|7|||
155359193|NCT01296555|560750097|FG009|Overall Study|Progressive Disease|18|||
155359194|NCT01296555|560750098|FG010|Overall Study|Progressive Disease|7|||
155359195|NCT01296555|560750099|FG011|Overall Study|Progressive Disease|14|||
155359196|NCT01296555|560750100|FG012|Overall Study|Progressive Disease|5|||
155359197|NCT01296555|560750101|FG013|Overall Study|Progressive Disease|12|||
155359198|NCT01296555|560750102|FG014|Overall Study|Progressive Disease|1|||
155359199|NCT01296555|560750103|FG015|Overall Study|Progressive Disease|1|||
155359200|NCT01296555|560750104|FG016|Overall Study|Progressive Disease|0|||
155359201|NCT01296555|560750105|FG017|Overall Study|Progressive Disease|0|||
155359202|NCT01296555|560750106|FG018|Overall Study|Progressive Disease|0|||
155359203|NCT01296555|560750107|FG019|Overall Study|Progressive Disease|1|||
155359204|NCT01296555|560750108|FG020|Overall Study|Progressive Disease|0|||
155359205|NCT01296555|560750109|FG021|Overall Study|Progressive Disease|0|||
155359206|NCT01296555|560750110|FG022|Overall Study|Progressive Disease|0|||
155359207|NCT01296555|560750111|FG023|Overall Study|Progressive Disease|0|||
155359208|NCT01296555|560750112|FG024|Overall Study|Progressive Disease|1|||
155359209|NCT01296555|560750113|FG025|Overall Study|Progressive Disease|0|||
155359210|NCT01296555|560750114|FG026|Overall Study|Progressive Disease|5|||
155359211|NCT01296555|560750115|FG027|Overall Study|Progressive Disease|1|||
155359212|NCT01296555|560750116|FG028|Overall Study|Progressive Disease|0|||
155359213|NCT01296555|560750088|FG000|Overall Study|Protocol Violation|0|||
155359214|NCT01296555|560750089|FG001|Overall Study|Protocol Violation|0|||
155359215|NCT01296555|560750090|FG002|Overall Study|Protocol Violation|0|||
155359216|NCT01296555|560750091|FG003|Overall Study|Protocol Violation|0|||
155359217|NCT01296555|560750092|FG004|Overall Study|Protocol Violation|0|||
155359218|NCT01296555|560750093|FG005|Overall Study|Protocol Violation|0|||
155359219|NCT01296555|560750094|FG006|Overall Study|Protocol Violation|0|||
155359220|NCT01296555|560750095|FG007|Overall Study|Protocol Violation|0|||
155359221|NCT01296555|560750096|FG008|Overall Study|Protocol Violation|0|||
155359222|NCT01296555|560750097|FG009|Overall Study|Protocol Violation|0|||
155359223|NCT01296555|560750098|FG010|Overall Study|Protocol Violation|0|||
155359224|NCT01296555|560750099|FG011|Overall Study|Protocol Violation|0|||
155359225|NCT01296555|560750100|FG012|Overall Study|Protocol Violation|0|||
155359226|NCT01296555|560750101|FG013|Overall Study|Protocol Violation|1|||
155359227|NCT01296555|560750102|FG014|Overall Study|Protocol Violation|0|||
155359228|NCT01296555|560750103|FG015|Overall Study|Protocol Violation|0|||
155359229|NCT01296555|560750104|FG016|Overall Study|Protocol Violation|0|||
155359230|NCT01296555|560750105|FG017|Overall Study|Protocol Violation|0|||
155359231|NCT01296555|560750106|FG018|Overall Study|Protocol Violation|0|||
155359232|NCT01296555|560750107|FG019|Overall Study|Protocol Violation|0|||
155359233|NCT01296555|560750108|FG020|Overall Study|Protocol Violation|0|||
155359234|NCT01296555|560750109|FG021|Overall Study|Protocol Violation|0|||
155359235|NCT01296555|560750110|FG022|Overall Study|Protocol Violation|0|||
155359236|NCT01296555|560750111|FG023|Overall Study|Protocol Violation|0|||
155359237|NCT01296555|560750112|FG024|Overall Study|Protocol Violation|0|||
155359238|NCT01296555|560750113|FG025|Overall Study|Protocol Violation|0|||
155359239|NCT01296555|560750114|FG026|Overall Study|Protocol Violation|0|||
155359240|NCT01296555|560750115|FG027|Overall Study|Protocol Violation|0|||
155359241|NCT01296555|560750116|FG028|Overall Study|Protocol Violation|0|||
155359242|NCT01296555|560750088|FG000|Overall Study|Study Terminated By Sponsor|0|||
155359243|NCT01296555|560750089|FG001|Overall Study|Study Terminated By Sponsor|0|||
155359244|NCT01296555|560750090|FG002|Overall Study|Study Terminated By Sponsor|0|||
155359245|NCT01296555|560750091|FG003|Overall Study|Study Terminated By Sponsor|0|||
155359246|NCT01296555|560750092|FG004|Overall Study|Study Terminated By Sponsor|0|||
155359247|NCT01296555|560750093|FG005|Overall Study|Study Terminated By Sponsor|0|||
155359248|NCT01296555|560750094|FG006|Overall Study|Study Terminated By Sponsor|0|||
155359249|NCT01296555|560750095|FG007|Overall Study|Study Terminated By Sponsor|0|||
155359250|NCT01296555|560750096|FG008|Overall Study|Study Terminated By Sponsor|0|||
155359251|NCT01296555|560750097|FG009|Overall Study|Study Terminated By Sponsor|0|||
155359252|NCT01296555|560750098|FG010|Overall Study|Study Terminated By Sponsor|0|||
155359253|NCT01296555|560750099|FG011|Overall Study|Study Terminated By Sponsor|0|||
155359254|NCT01296555|560750100|FG012|Overall Study|Study Terminated By Sponsor|0|||
155359255|NCT01296555|560750101|FG013|Overall Study|Study Terminated By Sponsor|0|||
155359256|NCT01296555|560750102|FG014|Overall Study|Study Terminated By Sponsor|0|||
155359257|NCT01296555|560750103|FG015|Overall Study|Study Terminated By Sponsor|0|||
155359258|NCT01296555|560750104|FG016|Overall Study|Study Terminated By Sponsor|0|||
155359259|NCT01296555|560750105|FG017|Overall Study|Study Terminated By Sponsor|0|||
155359260|NCT01296555|560750106|FG018|Overall Study|Study Terminated By Sponsor|0|||
155359261|NCT01296555|560750107|FG019|Overall Study|Study Terminated By Sponsor|0|||
155359262|NCT01296555|560750108|FG020|Overall Study|Study Terminated By Sponsor|0|||
155648898|NCT05660538|561805932|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
155359263|NCT01296555|560750109|FG021|Overall Study|Study Terminated By Sponsor|0|||
155359264|NCT01296555|560750110|FG022|Overall Study|Study Terminated By Sponsor|0|||
155359265|NCT01296555|560750111|FG023|Overall Study|Study Terminated By Sponsor|0|||
155359266|NCT01296555|560750112|FG024|Overall Study|Study Terminated By Sponsor|0|||
155359267|NCT01296555|560750113|FG025|Overall Study|Study Terminated By Sponsor|1|||
155359268|NCT01296555|560750114|FG026|Overall Study|Study Terminated By Sponsor|0|||
155359269|NCT01296555|560750115|FG027|Overall Study|Study Terminated By Sponsor|0|||
155359270|NCT01296555|560750116|FG028|Overall Study|Study Terminated By Sponsor|0|||
155359271|NCT01296555|560750088|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359272|NCT01296555|560750089|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359273|NCT01296555|560750090|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359274|NCT01296555|560750091|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359275|NCT01296555|560750092|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359276|NCT01296555|560750093|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359277|NCT01296555|560750094|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359278|NCT01296555|560750095|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359279|NCT01296555|560750096|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359280|NCT01296555|560750097|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359281|NCT01296555|560750098|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359282|NCT01296555|560750099|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359283|NCT01296555|560750100|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359284|NCT01296555|560750101|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359285|NCT01296555|560750102|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359286|NCT01296555|560750103|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359287|NCT01296555|560750104|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359288|NCT01296555|560750105|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359289|NCT01296555|560750106|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359290|NCT01296555|560750107|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
155359291|NCT01296555|560750108|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359292|NCT01296555|560750109|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359293|NCT01296555|560750110|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359294|NCT01296555|560750111|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359295|NCT01296555|560750112|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359296|NCT01296555|560750113|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359297|NCT01296555|560750114|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359298|NCT01296555|560750115|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359299|NCT01296555|560750116|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359300|NCT01296555|560750088|FG000|Overall Study|Death|0|||
155359301|NCT01296555|560750089|FG001|Overall Study|Death|0|||
155359302|NCT01296555|560750090|FG002|Overall Study|Death|0|||
155359303|NCT01296555|560750091|FG003|Overall Study|Death|2|||
155359304|NCT01296555|560750092|FG004|Overall Study|Death|1|||
155359305|NCT01296555|560750093|FG005|Overall Study|Death|0|||
155359306|NCT01296555|560750094|FG006|Overall Study|Death|2|||
155359307|NCT01296555|560750095|FG007|Overall Study|Death|0|||
155359308|NCT01296555|560750096|FG008|Overall Study|Death|0|||
155359309|NCT01296555|560750097|FG009|Overall Study|Death|1|||
155359310|NCT01296555|560750098|FG010|Overall Study|Death|0|||
155359311|NCT01296555|560750099|FG011|Overall Study|Death|1|||
155359312|NCT01296555|560750100|FG012|Overall Study|Death|0|||
155359313|NCT01296555|560750101|FG013|Overall Study|Death|2|||
155359314|NCT01296555|560750102|FG014|Overall Study|Death|27|||
155359315|NCT01296555|560750103|FG015|Overall Study|Death|15|||
155359316|NCT01296555|560750104|FG016|Overall Study|Death|11|||
155359317|NCT01296555|560750105|FG017|Overall Study|Death|11|||
155359318|NCT01296555|560750106|FG018|Overall Study|Death|17|||
155359319|NCT01296555|560750107|FG019|Overall Study|Death|12|||
155359320|NCT01296555|560750108|FG020|Overall Study|Death|13|||
155507189|NCT04444752|561283579|FG002|Overall Study|Pregnancy|0|||
155507190|NCT04444752|561283580|FG003|Overall Study|Pregnancy|1|||
155359321|NCT01296555|560750109|FG021|Overall Study|Death|12|||
155359322|NCT01296555|560750110|FG022|Overall Study|Death|12|||
155359323|NCT01296555|560750111|FG023|Overall Study|Death|13|||
155359324|NCT01296555|560750112|FG024|Overall Study|Death|7|||
155359325|NCT01296555|560750113|FG025|Overall Study|Death|7|||
155507191|NCT04444752|561283577|FG000|Overall Study|Withdrawal by Subject|6|||
155507192|NCT04444752|561283578|FG001|Overall Study|Withdrawal by Subject|5|||
155359326|NCT01296555|560750114|FG026|Overall Study|Death|35|||
155359327|NCT01296555|560750115|FG027|Overall Study|Death|92|||
155359328|NCT01296555|560750116|FG028|Overall Study|Death|44|||
155359329|NCT01296555|560750088|FG000|Overall Study|Lost to Follow-up|0|||
155359330|NCT01296555|560750089|FG001|Overall Study|Lost to Follow-up|0|||
155359331|NCT01296555|560750090|FG002|Overall Study|Lost to Follow-up|0|||
155359332|NCT01296555|560750091|FG003|Overall Study|Lost to Follow-up|0|||
155359333|NCT01296555|560750092|FG004|Overall Study|Lost to Follow-up|0|||
155359334|NCT01296555|560750093|FG005|Overall Study|Lost to Follow-up|0|||
155359335|NCT01296555|560750094|FG006|Overall Study|Lost to Follow-up|0|||
155359336|NCT01296555|560750095|FG007|Overall Study|Lost to Follow-up|0|||
155359337|NCT01296555|560750096|FG008|Overall Study|Lost to Follow-up|0|||
155507193|NCT04444752|561283579|FG002|Overall Study|Withdrawal by Subject|3|||
155359338|NCT01296555|560750097|FG009|Overall Study|Lost to Follow-up|0|||
155359339|NCT01296555|560750098|FG010|Overall Study|Lost to Follow-up|0|||
155359340|NCT01296555|560750099|FG011|Overall Study|Lost to Follow-up|0|||
155359341|NCT01296555|560750100|FG012|Overall Study|Lost to Follow-up|0|||
155359342|NCT01296555|560750101|FG013|Overall Study|Lost to Follow-up|0|||
155359343|NCT01296555|560750102|FG014|Overall Study|Lost to Follow-up|2|||
155359344|NCT01296555|560750103|FG015|Overall Study|Lost to Follow-up|1|||
155359345|NCT01296555|560750104|FG016|Overall Study|Lost to Follow-up|0|||
155359346|NCT01296555|560750105|FG017|Overall Study|Lost to Follow-up|2|||
155359347|NCT01296555|560750106|FG018|Overall Study|Lost to Follow-up|0|||
155359348|NCT01296555|560750107|FG019|Overall Study|Lost to Follow-up|2|||
155359349|NCT01296555|560750108|FG020|Overall Study|Lost to Follow-up|3|||
155359350|NCT01296555|560750109|FG021|Overall Study|Lost to Follow-up|2|||
155359351|NCT01296555|560750110|FG022|Overall Study|Lost to Follow-up|0|||
155359352|NCT01296555|560750111|FG023|Overall Study|Lost to Follow-up|0|||
155359353|NCT01296555|560750112|FG024|Overall Study|Lost to Follow-up|0|||
155359354|NCT01296555|560750113|FG025|Overall Study|Lost to Follow-up|0|||
155359355|NCT01296555|560750114|FG026|Overall Study|Lost to Follow-up|3|||
155359356|NCT01296555|560750115|FG027|Overall Study|Lost to Follow-up|13|||
155359357|NCT01296555|560750116|FG028|Overall Study|Lost to Follow-up|5|||
155359358|NCT01296555|560750088|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155359359|NCT01296555|560750089|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155359360|NCT01296555|560750090|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155359361|NCT01296555|560750091|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155359362|NCT01296555|560750092|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155359363|NCT01296555|560750093|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155359364|NCT01296555|560750094|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155359365|NCT01296555|560750095|FG007|Overall Study|Non-Compliance With Study Drug|1|||
155359366|NCT01296555|560750096|FG008|Overall Study|Non-Compliance With Study Drug|0|||
155359367|NCT01296555|560750097|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155359368|NCT01296555|560750098|FG010|Overall Study|Non-Compliance With Study Drug|0|||
155359369|NCT01296555|560750099|FG011|Overall Study|Non-Compliance With Study Drug|0|||
155359370|NCT01296555|560750100|FG012|Overall Study|Non-Compliance With Study Drug|0|||
155359371|NCT01296555|560750101|FG013|Overall Study|Non-Compliance With Study Drug|0|||
155359372|NCT01296555|560750102|FG014|Overall Study|Non-Compliance With Study Drug|0|||
155359373|NCT01296555|560750103|FG015|Overall Study|Non-Compliance With Study Drug|0|||
155359374|NCT01296555|560750104|FG016|Overall Study|Non-Compliance With Study Drug|0|||
155359375|NCT01296555|560750105|FG017|Overall Study|Non-Compliance With Study Drug|0|||
155359376|NCT01296555|560750106|FG018|Overall Study|Non-Compliance With Study Drug|0|||
155359377|NCT01296555|560750107|FG019|Overall Study|Non-Compliance With Study Drug|0|||
155359378|NCT01296555|560750108|FG020|Overall Study|Non-Compliance With Study Drug|0|||
155359379|NCT01296555|560750109|FG021|Overall Study|Non-Compliance With Study Drug|0|||
155359380|NCT01296555|560750110|FG022|Overall Study|Non-Compliance With Study Drug|0|||
155359381|NCT01296555|560750111|FG023|Overall Study|Non-Compliance With Study Drug|0|||
155359382|NCT01296555|560750112|FG024|Overall Study|Non-Compliance With Study Drug|0|||
155359383|NCT01296555|560750113|FG025|Overall Study|Non-Compliance With Study Drug|0|||
155359384|NCT01296555|560750114|FG026|Overall Study|Non-Compliance With Study Drug|0|||
155359385|NCT01296555|560750115|FG027|Overall Study|Non-Compliance With Study Drug|0|||
155359386|NCT01296555|560750116|FG028|Overall Study|Non-Compliance With Study Drug|0|||
155359387|NCT01296555|560750088|FG000|Overall Study|Withdrawal by Subject|0|||
155359388|NCT01296555|560750089|FG001|Overall Study|Withdrawal by Subject|0|||
155359389|NCT01296555|560750090|FG002|Overall Study|Withdrawal by Subject|0|||
155359390|NCT01296555|560750091|FG003|Overall Study|Withdrawal by Subject|0|||
155359391|NCT01296555|560750092|FG004|Overall Study|Withdrawal by Subject|1|||
155359392|NCT01296555|560750093|FG005|Overall Study|Withdrawal by Subject|0|||
155359393|NCT01296555|560750094|FG006|Overall Study|Withdrawal by Subject|1|||
155359394|NCT01296555|560750095|FG007|Overall Study|Withdrawal by Subject|0|||
155359395|NCT01296555|560750096|FG008|Overall Study|Withdrawal by Subject|0|||
155359396|NCT01296555|560750097|FG009|Overall Study|Withdrawal by Subject|0|||
155359397|NCT01296555|560750098|FG010|Overall Study|Withdrawal by Subject|1|||
155359398|NCT01296555|560750099|FG011|Overall Study|Withdrawal by Subject|1|||
155359399|NCT01296555|560750100|FG012|Overall Study|Withdrawal by Subject|0|||
155359400|NCT01296555|560750101|FG013|Overall Study|Withdrawal by Subject|0|||
155359401|NCT01296555|560750102|FG014|Overall Study|Withdrawal by Subject|3|||
155359402|NCT01296555|560750103|FG015|Overall Study|Withdrawal by Subject|0|||
155359403|NCT01296555|560750104|FG016|Overall Study|Withdrawal by Subject|2|||
155359404|NCT01296555|560750105|FG017|Overall Study|Withdrawal by Subject|1|||
155359405|NCT01296555|560750106|FG018|Overall Study|Withdrawal by Subject|0|||
155359406|NCT01296555|560750107|FG019|Overall Study|Withdrawal by Subject|1|||
155359407|NCT01296555|560750108|FG020|Overall Study|Withdrawal by Subject|1|||
155359408|NCT01296555|560750109|FG021|Overall Study|Withdrawal by Subject|1|||
155359409|NCT01296555|560750110|FG022|Overall Study|Withdrawal by Subject|3|||
155359410|NCT01296555|560750111|FG023|Overall Study|Withdrawal by Subject|0|||
155359411|NCT01296555|560750112|FG024|Overall Study|Withdrawal by Subject|0|||
155359412|NCT01296555|560750113|FG025|Overall Study|Withdrawal by Subject|0|||
155359413|NCT01296555|560750114|FG026|Overall Study|Withdrawal by Subject|8|||
155359414|NCT01296555|560750115|FG027|Overall Study|Withdrawal by Subject|4|||
155359415|NCT01296555|560750116|FG028|Overall Study|Withdrawal by Subject|2|||
155359416|NCT02250534|560750117|FG000|Overall Study|Lost to Follow-up|18|||
155359417|NCT02250534|560750118|FG001|Overall Study|Lost to Follow-up|28|||
155359418|NCT02250534|560750119|FG002|Overall Study|Lost to Follow-up|33|||
155359419|NCT02250534|560750117|FG000|Overall Study|Personal reasons|7|||
155359420|NCT02250534|560750118|FG001|Overall Study|Personal reasons|8|||
155359421|NCT02250534|560750119|FG002|Overall Study|Personal reasons|14|||
155359422|NCT02250534|560750117|FG000|Overall Study|Adverse Event|6|||
155359423|NCT02250534|560750118|FG001|Overall Study|Adverse Event|3|||
155359424|NCT02250534|560750119|FG002|Overall Study|Adverse Event|8|||
155359425|NCT02250534|560750117|FG000|Overall Study|incarcerated|2|||
155359426|NCT02250534|560750118|FG001|Overall Study|incarcerated|1|||
155359427|NCT02250534|560750119|FG002|Overall Study|incarcerated|2|||
155359428|NCT02250534|560750117|FG000|Overall Study|Withdrawal by Subject|0|||
155359429|NCT02250534|560750118|FG001|Overall Study|Withdrawal by Subject|1|||
155359430|NCT02250534|560750119|FG002|Overall Study|Withdrawal by Subject|2|||
155359431|NCT02250534|560750117|FG000|Overall Study|Death|0|||
155359432|NCT02250534|560750118|FG001|Overall Study|Death|1|||
155359433|NCT02250534|560750119|FG002|Overall Study|Death|1|||
155359434|NCT02250534|560750117|FG000|Overall Study|Physician Decision|1|||
155359435|NCT02250534|560750118|FG001|Overall Study|Physician Decision|3|||
155359436|NCT02250534|560750119|FG002|Overall Study|Physician Decision|1|||
155359437|NCT02250534|560750117|FG000|Overall Study|Protocol Violation|1|||
155359438|NCT02250534|560750118|FG001|Overall Study|Protocol Violation|0|||
155359439|NCT02250534|560750119|FG002|Overall Study|Protocol Violation|1|||
155359440|NCT02250534|560750117|FG000|Overall Study|Reason unknown|1|||
155359441|NCT02250534|560750118|FG001|Overall Study|Reason unknown|0|||
155359442|NCT02250534|560750119|FG002|Overall Study|Reason unknown|0|||
155359443|NCT01101061|560750120|FG000|Overall Study|Adverse Event|0|||
155359444|NCT01101061|560750121|FG001|Overall Study|Adverse Event|0|||
155359445|NCT01101061|560750122|FG002|Overall Study|Adverse Event|1|||
155359446|NCT01101061|560750123|FG003|Overall Study|Adverse Event|0|||
155359447|NCT01101061|560750124|FG004|Overall Study|Adverse Event|0|||
155359448|NCT01101061|560750125|FG005|Overall Study|Adverse Event|0|||
155359449|NCT01587118|560750126|FG000|Overall Study|Adverse Event|3|||
155359450|NCT01587118|560750126|FG000|Overall Study|Lost to Follow-up|2|||
155359451|NCT01587118|560750126|FG000|Overall Study|Relocation|1|||
155359452|NCT01587118|560750126|FG000|Overall Study|nonresponse|1|||
155359453|NCT00537329|560750127|FG000|Overall Study|Death|10|||
155359454|NCT00537329|560750127|FG000|Overall Study|Adverse Event|3|||
155359455|NCT00537329|560750127|FG000|Overall Study|Lack of Efficacy|2|||
155359456|NCT00537329|560750127|FG000|Overall Study|Lost to Follow-up|6|||
155359457|NCT00537329|560750127|FG000|Overall Study|Withdrawal by Subject|4|||
155359458|NCT00537329|560750127|FG000|Overall Study|Other|1|||
155359459|NCT03599622|560750128|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
155359460|NCT03599622|560750129|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
155359461|NCT03599622|560750130|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
155359462|NCT03599622|560750131|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
155359463|NCT03599622|560750128|FG000|Pre-Treatment Period|Other reasons|1|||
155359464|NCT03599622|560750129|FG001|Pre-Treatment Period|Other reasons|1|||
155359465|NCT03599622|560750130|FG002|Pre-Treatment Period|Other reasons|1|||
155359466|NCT03599622|560750131|FG003|Pre-Treatment Period|Other reasons|0|||
155359467|NCT03599622|560750128|FG000|Treatment Period|Adverse Event|11|||
155359468|NCT03599622|560750129|FG001|Treatment Period|Adverse Event|20|||
155359469|NCT03599622|560750130|FG002|Treatment Period|Adverse Event|18|||
155359470|NCT03599622|560750131|FG003|Treatment Period|Adverse Event|2|||
155359471|NCT03599622|560750128|FG000|Treatment Period|Lack of Efficacy|18|||
155359472|NCT03599622|560750129|FG001|Treatment Period|Lack of Efficacy|12|||
155359473|NCT03599622|560750130|FG002|Treatment Period|Lack of Efficacy|13|||
155359474|NCT03599622|560750131|FG003|Treatment Period|Lack of Efficacy|2|||
155359475|NCT03599622|560750128|FG000|Treatment Period|Withdrawal by Subject|5|||
155359476|NCT03599622|560750129|FG001|Treatment Period|Withdrawal by Subject|11|||
155359477|NCT03599622|560750130|FG002|Treatment Period|Withdrawal by Subject|16|||
155359478|NCT03599622|560750131|FG003|Treatment Period|Withdrawal by Subject|1|||
155359479|NCT03599622|560750128|FG000|Treatment Period|Other reasons|4|||
155359480|NCT03599622|560750129|FG001|Treatment Period|Other reasons|6|||
155359481|NCT03599622|560750130|FG002|Treatment Period|Other reasons|7|||
155359482|NCT03599622|560750131|FG003|Treatment Period|Other reasons|0|||
155359483|NCT03599622|560750128|FG000|Treatment Period|Lost to Follow-up|1|||
155359484|NCT03599622|560750129|FG001|Treatment Period|Lost to Follow-up|0|||
155359485|NCT03599622|560750130|FG002|Treatment Period|Lost to Follow-up|0|||
155359486|NCT03599622|560750131|FG003|Treatment Period|Lost to Follow-up|0|||
155359487|NCT03599622|560750128|FG000|Treatment Period|Study terminated by sponsor|7|||
155359488|NCT03599622|560750129|FG001|Treatment Period|Study terminated by sponsor|20|||
155359489|NCT03599622|560750130|FG002|Treatment Period|Study terminated by sponsor|15|||
155359490|NCT03599622|560750131|FG003|Treatment Period|Study terminated by sponsor|0|||
155359491|NCT03599622|560750128|FG000|Treatment Period|Site terminated by sponsor|0|||
155359492|NCT03599622|560750129|FG001|Treatment Period|Site terminated by sponsor|1|||
155359493|NCT03599622|560750130|FG002|Treatment Period|Site terminated by sponsor|0|||
155359494|NCT03599622|560750131|FG003|Treatment Period|Site terminated by sponsor|0|||
155359495|NCT00778921|560750132|FG000|Overall Study|Adverse Event|9|||
155359496|NCT00778921|560750133|FG001|Overall Study|Adverse Event|10|||
155359497|NCT00778921|560750134|FG002|Overall Study|Adverse Event|14|||
155359498|NCT00778921|560750132|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155359499|NCT00778921|560750133|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
155359500|NCT00778921|560750134|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155359501|NCT00778921|560750132|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
155359502|NCT00778921|560750133|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155359503|NCT00778921|560750134|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
155359504|NCT00778921|560750132|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
155359505|NCT00778921|560750133|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
155359506|NCT00778921|560750134|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
155359507|NCT00778921|560750132|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
155359508|NCT00778921|560750133|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
155359509|NCT00778921|560750134|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
155359510|NCT00778921|560750132|FG000|Overall Study|Patient withdrew request|3|||
155359511|NCT00778921|560750133|FG001|Overall Study|Patient withdrew request|1|||
155359512|NCT00778921|560750134|FG002|Overall Study|Patient withdrew request|6|||
155359513|NCT00778921|560750132|FG000|Overall Study|Lost to Follow-up|0|||
155359514|NCT00778921|560750133|FG001|Overall Study|Lost to Follow-up|2|||
155359515|NCT00778921|560750134|FG002|Overall Study|Lost to Follow-up|1|||
155359516|NCT00778921|560750132|FG000|Overall Study|Administrative Problems|1|||
155359517|NCT00778921|560750133|FG001|Overall Study|Administrative Problems|2|||
155359518|NCT00778921|560750134|FG002|Overall Study|Administrative Problems|0|||
155359519|NCT00778921|560750132|FG000|Overall Study|Protocol Violation|3|||
155359520|NCT00778921|560750133|FG001|Overall Study|Protocol Violation|0|||
155359521|NCT00778921|560750134|FG002|Overall Study|Protocol Violation|2|||
155359522|NCT00778921|560750132|FG000|Overall Study|Not treated|0|||
155359523|NCT00778921|560750133|FG001|Overall Study|Not treated|2|||
155359524|NCT00778921|560750134|FG002|Overall Study|Not treated|2|||
155359525|NCT00572533|560750135|FG000|Overall Study|Death|4|||
155359526|NCT00572533|560750136|FG001|Overall Study|Death|1|||
155359527|NCT00572533|560750135|FG000|Overall Study|Received Kidney Transplant|2|||
155359528|NCT00572533|560750136|FG001|Overall Study|Received Kidney Transplant|1|||
155359529|NCT00572533|560750135|FG000|Overall Study|Social Issues|1|||
155359530|NCT00572533|560750136|FG001|Overall Study|Social Issues|0|||
155359531|NCT00572533|560750135|FG000|Overall Study|Transfer out of Facility|0|||
155359532|NCT00572533|560750136|FG001|Overall Study|Transfer out of Facility|1|||
155359533|NCT00267098|560750137|FG000|Overall Study|Death|0|||
155359534|NCT00267098|560750138|FG001|Overall Study|Death|0|||
155359535|NCT00267098|560750139|FG002|Overall Study|Death|57|||
155359536|NCT00267098|560750140|FG003|Overall Study|Death|66|||
155359537|NCT00267098|560750141|FG004|Overall Study|Death|14|||
155427356|NCT04375761|560991785|FG000|Overall Study|Moved|0|||
155427357|NCT04375761|560991786|FG001|Overall Study|Moved|2|||
155648899|NCT05660538|561805933|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
155359538|NCT00267098|560750142|FG005|Overall Study|Death|23|||
155359539|NCT00267098|560750143|FG006|Overall Study|Death|28|||
155359540|NCT00267098|560750144|FG007|Overall Study|Death|9|||
155359541|NCT00267098|560750137|FG000|Overall Study|Lost to Follow-up|0|||
155359542|NCT00267098|560750138|FG001|Overall Study|Lost to Follow-up|0|||
155359543|NCT00267098|560750139|FG002|Overall Study|Lost to Follow-up|6|||
155359544|NCT00267098|560750140|FG003|Overall Study|Lost to Follow-up|5|||
155359545|NCT00267098|560750141|FG004|Overall Study|Lost to Follow-up|2|||
155359546|NCT00267098|560750142|FG005|Overall Study|Lost to Follow-up|3|||
155359547|NCT00267098|560750143|FG006|Overall Study|Lost to Follow-up|1|||
155359548|NCT00267098|560750144|FG007|Overall Study|Lost to Follow-up|1|||
155359549|NCT00267098|560750137|FG000|Overall Study|Withdrawal by Subject|8|||
155359550|NCT00267098|560750138|FG001|Overall Study|Withdrawal by Subject|0|||
155359551|NCT00267098|560750139|FG002|Overall Study|Withdrawal by Subject|24|||
155359552|NCT00267098|560750140|FG003|Overall Study|Withdrawal by Subject|21|||
155359553|NCT00267098|560750141|FG004|Overall Study|Withdrawal by Subject|12|||
155359554|NCT00267098|560750142|FG005|Overall Study|Withdrawal by Subject|9|||
155359555|NCT00267098|560750143|FG006|Overall Study|Withdrawal by Subject|12|||
155359556|NCT00267098|560750144|FG007|Overall Study|Withdrawal by Subject|5|||
155359557|NCT00267098|560750137|FG000|Overall Study|Physician Decision|5|||
155359558|NCT00267098|560750138|FG001|Overall Study|Physician Decision|0|||
155359559|NCT00267098|560750139|FG002|Overall Study|Physician Decision|7|||
155359560|NCT00267098|560750140|FG003|Overall Study|Physician Decision|11|||
155359561|NCT00267098|560750141|FG004|Overall Study|Physician Decision|5|||
155359562|NCT00267098|560750142|FG005|Overall Study|Physician Decision|4|||
155359563|NCT00267098|560750143|FG006|Overall Study|Physician Decision|3|||
155359564|NCT00267098|560750144|FG007|Overall Study|Physician Decision|0|||
155359565|NCT00267098|560750137|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
155359566|NCT00267098|560750138|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359567|NCT00267098|560750139|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359568|NCT00267098|560750140|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359569|NCT00267098|560750141|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155359570|NCT00267098|560750142|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359571|NCT00267098|560750143|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359572|NCT00267098|560750144|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359573|NCT00267098|560750137|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359574|NCT00267098|560750138|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
155359575|NCT00267098|560750139|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359576|NCT00267098|560750140|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359577|NCT00267098|560750141|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359578|NCT00267098|560750142|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359579|NCT00267098|560750143|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359580|NCT00267098|560750144|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359581|NCT00267098|560750137|FG000|Overall Study|Site closure|0|||
155359582|NCT00267098|560750138|FG001|Overall Study|Site closure|0|||
155359583|NCT00267098|560750139|FG002|Overall Study|Site closure|0|||
155359584|NCT00267098|560750140|FG003|Overall Study|Site closure|1|||
155359585|NCT00267098|560750141|FG004|Overall Study|Site closure|0|||
155359586|NCT00267098|560750142|FG005|Overall Study|Site closure|1|||
155359587|NCT00267098|560750143|FG006|Overall Study|Site closure|1|||
155359588|NCT00267098|560750144|FG007|Overall Study|Site closure|0|||
155359589|NCT00267098|560750137|FG000|Overall Study|Explanted Medtronic device|0|||
155359590|NCT00267098|560750138|FG001|Overall Study|Explanted Medtronic device|0|||
155359591|NCT00267098|560750139|FG002|Overall Study|Explanted Medtronic device|0|||
155359592|NCT00267098|560750140|FG003|Overall Study|Explanted Medtronic device|1|||
155359593|NCT00267098|560750141|FG004|Overall Study|Explanted Medtronic device|0|||
155359594|NCT00267098|560750142|FG005|Overall Study|Explanted Medtronic device|0|||
155359595|NCT00267098|560750143|FG006|Overall Study|Explanted Medtronic device|0|||
155359596|NCT00267098|560750144|FG007|Overall Study|Explanted Medtronic device|0|||
155359597|NCT00267098|560750137|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359598|NCT00267098|560750138|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359599|NCT00267098|560750139|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359600|NCT00267098|560750140|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359601|NCT00267098|560750141|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
155359602|NCT00267098|560750142|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155507194|NCT04444752|561283580|FG003|Overall Study|Withdrawal by Subject|4|||
155507195|NCT04444752|561283577|FG000|Overall Study|Protocol Violation|1|||
155507196|NCT04444752|561283578|FG001|Overall Study|Protocol Violation|1|||
155507197|NCT04444752|561283579|FG002|Overall Study|Protocol Violation|0|||
155507198|NCT04444752|561283580|FG003|Overall Study|Protocol Violation|0|||
155507199|NCT04444752|561283577|FG000|Overall Study|Patient moving out of town|1|||
155507200|NCT04444752|561283578|FG001|Overall Study|Patient moving out of town|0|||
155507201|NCT04444752|561283579|FG002|Overall Study|Patient moving out of town|0|||
155507202|NCT04444752|561283580|FG003|Overall Study|Patient moving out of town|1|||
155507203|NCT04444752|561283577|FG000|Overall Study|Lack of Efficacy|0|||
155507204|NCT04444752|561283578|FG001|Overall Study|Lack of Efficacy|0|||
155359603|NCT00267098|560750143|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359604|NCT00267098|560750144|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359605|NCT00267098|560750137|FG000|Overall Study|Subject listed for heart transplant|0|||
155359606|NCT00267098|560750138|FG001|Overall Study|Subject listed for heart transplant|0|||
155359607|NCT00267098|560750139|FG002|Overall Study|Subject listed for heart transplant|0|||
155359608|NCT00267098|560750140|FG003|Overall Study|Subject listed for heart transplant|0|||
155359609|NCT00267098|560750141|FG004|Overall Study|Subject listed for heart transplant|0|||
155507205|NCT04444752|561283579|FG002|Overall Study|Lack of Efficacy|0|||
155507206|NCT04444752|561283580|FG003|Overall Study|Lack of Efficacy|1|||
155507207|NCT04444752|561283577|FG000|Overall Study|Death|0|||
155359610|NCT00267098|560750142|FG005|Overall Study|Subject listed for heart transplant|0|||
155507208|NCT04444752|561283578|FG001|Overall Study|Death|0|||
155359611|NCT00267098|560750143|FG006|Overall Study|Subject listed for heart transplant|1|||
155359612|NCT00267098|560750144|FG007|Overall Study|Subject listed for heart transplant|0|||
155359613|NCT00267098|560750137|FG000|Overall Study|Sponsor withdrew subject|0|||
155359614|NCT00267098|560750138|FG001|Overall Study|Sponsor withdrew subject|0|||
155359615|NCT00267098|560750139|FG002|Overall Study|Sponsor withdrew subject|0|||
155359616|NCT00267098|560750140|FG003|Overall Study|Sponsor withdrew subject|1|||
155359617|NCT00267098|560750141|FG004|Overall Study|Sponsor withdrew subject|0|||
155359618|NCT00267098|560750142|FG005|Overall Study|Sponsor withdrew subject|0|||
155359619|NCT00267098|560750143|FG006|Overall Study|Sponsor withdrew subject|0|||
155359620|NCT00267098|560750144|FG007|Overall Study|Sponsor withdrew subject|0|||
155359621|NCT00798304|560750145|FG000|Overall Study|Adverse Event|0|||
155359622|NCT00798304|560750146|FG001|Overall Study|Adverse Event|1|||
155359623|NCT00798304|560750147|FG002|Overall Study|Adverse Event|1|||
155359624|NCT00798304|560750145|FG000|Overall Study|Discontinuation by Sponsor|14|||
155359625|NCT00798304|560750146|FG001|Overall Study|Discontinuation by Sponsor|21|||
155359626|NCT00798304|560750147|FG002|Overall Study|Discontinuation by Sponsor|9|||
155359627|NCT02031536|560750148|FG000|Overall Study|ineligible|1|||
155359628|NCT02031536|560750149|FG001|Overall Study|ineligible|0|||
155359629|NCT04211389|560750150|FG000|Overall Study|Adverse Event|1|||
155359630|NCT04211389|560750151|FG001|Overall Study|Adverse Event|2|||
155359631|NCT04211389|560750150|FG000|Overall Study|Lost to Follow-up|15|||
155359632|NCT04211389|560750151|FG001|Overall Study|Lost to Follow-up|7|||
155359633|NCT04211389|560750150|FG000|Overall Study|Protocol Violation|0|||
155359634|NCT04211389|560750151|FG001|Overall Study|Protocol Violation|1|||
155359635|NCT04211389|560750150|FG000|Overall Study|Withdrawal by Subject|10|||
155359636|NCT04211389|560750151|FG001|Overall Study|Withdrawal by Subject|11|||
155359637|NCT00547534|560750153|FG000|Overall Study|Adverse Event|7|||
155359638|NCT00547534|560750153|FG000|Overall Study|Disease Progression|4|||
155359639|NCT04206085|560750154|FG000|Overall Study|Lost to Follow-up|0|||
155359640|NCT04206085|560750155|FG001|Overall Study|Lost to Follow-up|1|||
155359641|NCT04206085|560750156|FG002|Overall Study|Lost to Follow-up|0|||
155359642|NCT04206085|560750154|FG000|Overall Study|Lost to Follow-up|0|||
155359643|NCT04206085|560750155|FG001|Overall Study|Lost to Follow-up|0|||
155359644|NCT04206085|560750156|FG002|Overall Study|Lost to Follow-up|1|||
155359645|NCT00087555|560750163|FG000|Overall Study|Adverse Event|3|||
155359646|NCT00087555|560750164|FG001|Overall Study|Adverse Event|6|||
155359647|NCT00087555|560750165|FG002|Overall Study|Adverse Event|14|||
155359648|NCT00087555|560750163|FG000|Overall Study|Lost to Follow-up|0|||
155359649|NCT00087555|560750164|FG001|Overall Study|Lost to Follow-up|1|||
155359650|NCT00087555|560750165|FG002|Overall Study|Lost to Follow-up|1|||
155359651|NCT00087555|560750163|FG000|Overall Study|Non - Compliance|1|||
155359652|NCT00087555|560750164|FG001|Overall Study|Non - Compliance|0|||
155359653|NCT00087555|560750165|FG002|Overall Study|Non - Compliance|0|||
155359654|NCT00087555|560750163|FG000|Overall Study|Protocol Violation|0|||
155359655|NCT00087555|560750164|FG001|Overall Study|Protocol Violation|0|||
155359656|NCT00087555|560750165|FG002|Overall Study|Protocol Violation|2|||
155359657|NCT00087555|560750163|FG000|Overall Study|Screen Failure|1|||
155359658|NCT00087555|560750164|FG001|Overall Study|Screen Failure|1|||
155359659|NCT00087555|560750165|FG002|Overall Study|Screen Failure|0|||
155359660|NCT00087555|560750163|FG000|Overall Study|Pregnancy|0|||
155359661|NCT00087555|560750164|FG001|Overall Study|Pregnancy|1|||
155359662|NCT00087555|560750165|FG002|Overall Study|Pregnancy|1|||
155359663|NCT00087555|560750163|FG000|Overall Study|Withdrawal by Subject|3|||
155359664|NCT00087555|560750164|FG001|Overall Study|Withdrawal by Subject|2|||
155359665|NCT00087555|560750165|FG002|Overall Study|Withdrawal by Subject|1|||
155359666|NCT00087555|560750163|FG000|Overall Study|Lack of Efficacy|2|||
155359667|NCT00087555|560750164|FG001|Overall Study|Lack of Efficacy|0|||
155359668|NCT00087555|560750165|FG002|Overall Study|Lack of Efficacy|1|||
155359669|NCT00087555|560750163|FG000|Overall Study|Non Compliance|0|||
155359670|NCT00087555|560750164|FG001|Overall Study|Non Compliance|0|||
155359671|NCT00087555|560750165|FG002|Overall Study|Non Compliance|1|||
155359672|NCT00087555|560750163|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
155359673|NCT00087555|560750164|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
155359674|NCT00087555|560750165|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
155359675|NCT00087555|560750163|FG000|Overall Study|Patient wanted to go back on Med|1|||
155359676|NCT00087555|560750164|FG001|Overall Study|Patient wanted to go back on Med|0|||
155359677|NCT00087555|560750165|FG002|Overall Study|Patient wanted to go back on Med|0|||
155359678|NCT01530087|560750166|FG000|Overall Study|Physician Decision|2|||
155359679|NCT02760485|560750167|FG000|Phase 1|Death|3|||
155359680|NCT02760485|560750168|FG001|Phase 1|Death|6|||
155359681|NCT02760485|560750169|FG002|Phase 1|Death|0|||
155359682|NCT02760485|560750167|FG000|Phase 1|Withdrawal by Subject|2|||
155359683|NCT02760485|560750168|FG001|Phase 1|Withdrawal by Subject|0|||
155359684|NCT02760485|560750169|FG002|Phase 1|Withdrawal by Subject|0|||
155359685|NCT02760485|560750167|FG000|Phase 1|Progressive Disease|1|||
155359686|NCT02760485|560750168|FG001|Phase 1|Progressive Disease|0|||
155359687|NCT02760485|560750169|FG002|Phase 1|Progressive Disease|0|||
155359688|NCT02760485|560750167|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
155359689|NCT02760485|560750168|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
155648900|NCT05660538|561805930|FG000|Overall Study|Lost to Follow-up|0|||
155648901|NCT05660538|561805931|FG001|Overall Study|Lost to Follow-up|0|||
155648902|NCT05660538|561805932|FG002|Overall Study|Lost to Follow-up|1|||
155648903|NCT05660538|561805933|FG003|Overall Study|Lost to Follow-up|1|||
155359690|NCT02760485|560750169|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
155359691|NCT02760485|560750167|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
155359692|NCT02760485|560750168|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
155359693|NCT02760485|560750169|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
155359694|NCT02760485|560750167|FG000|Phase 2|Death|0|||
155359695|NCT02760485|560750168|FG001|Phase 2|Death|0|||
155359696|NCT02760485|560750169|FG002|Phase 2|Death|12|||
155359697|NCT02760485|560750167|FG000|Phase 2|Withdrawal by Subject|0|||
155359698|NCT02760485|560750168|FG001|Phase 2|Withdrawal by Subject|0|||
155359699|NCT02760485|560750169|FG002|Phase 2|Withdrawal by Subject|3|||
155359700|NCT02760485|560750167|FG000|Phase 2|Progressive Disease|0|||
155359701|NCT02760485|560750168|FG001|Phase 2|Progressive Disease|0|||
155359702|NCT02760485|560750169|FG002|Phase 2|Progressive Disease|1|||
155359703|NCT02760485|560750167|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
155359704|NCT02760485|560750168|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
155359705|NCT02760485|560750169|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
155359706|NCT03845023|560750170|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
155359707|NCT03845023|560750171|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
155427358|NCT04375761|560991785|FG000|Overall Study|Nonresponsive|0|||
155427359|NCT04375761|560991786|FG001|Overall Study|Nonresponsive|5|||
155359708|NCT03845023|560750172|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
155359709|NCT03845023|560750173|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
155359710|NCT03845023|560750170|FG000|Follow-Up (14 Days)|Adverse Event|0|||
155359711|NCT03845023|560750171|FG001|Follow-Up (14 Days)|Adverse Event|0|||
155359712|NCT03845023|560750172|FG002|Follow-Up (14 Days)|Adverse Event|1|||
155359713|NCT03845023|560750173|FG003|Follow-Up (14 Days)|Adverse Event|1|||
155359714|NCT01182207|560750174|FG000|First Intervention|Positive Hepatitis Results|0|||
155359715|NCT01182207|560750175|FG001|First Intervention|Positive Hepatitis Results|1|||
155359716|NCT01182207|560750174|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
155427360|NCT03797001|560991787|FG000|Overall Study|Withdrawn due to COVID19|4|||
155648904|NCT05660538|561805930|FG000|Overall Study|Death|0|||
155648905|NCT05660538|561805931|FG001|Overall Study|Death|0|||
155359717|NCT01182207|560750175|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
155359718|NCT01427738|560750176|FG000|Overall Study|Death|12|||
155359719|NCT01427738|560750177|FG001|Overall Study|Death|9|||
155359720|NCT01427738|560750176|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155359721|NCT01427738|560750177|FG001|Overall Study|Severe debilitation, unable to continue|1|||
155359722|NCT01427738|560750176|FG000|Overall Study|Subject unable to get to clinic|5|||
155359723|NCT01427738|560750177|FG001|Overall Study|Subject unable to get to clinic|2|||
155359724|NCT01427738|560750176|FG000|Overall Study|Withdrawal by Subject|0|||
155359725|NCT01427738|560750177|FG001|Overall Study|Withdrawal by Subject|2|||
155359726|NCT01427738|560750176|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
155359727|NCT01427738|560750177|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
155359728|NCT01427738|560750176|FG000|Overall Study|Lost to Follow-up|1|||
155359729|NCT01427738|560750177|FG001|Overall Study|Lost to Follow-up|5|||
155359730|NCT02353871|560750178|FG000|Overall Study|Protocol deviation|0|||
155359731|NCT02353871|560750179|FG001|Overall Study|Protocol deviation|1|||
155359732|NCT02353871|560750178|FG000|Overall Study|Consent withdrawn|1|||
155359733|NCT02353871|560750179|FG001|Overall Study|Consent withdrawn|8|||
155359734|NCT02353871|560750178|FG000|Overall Study|Lost to Follow-up|2|||
155359735|NCT02353871|560750179|FG001|Overall Study|Lost to Follow-up|0|||
155359736|NCT05314374|560750180|FG000|Overall Study|Adverse Event|2|||
155359737|NCT05314374|560750181|FG001|Overall Study|Adverse Event|2|||
155359738|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
155359739|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
155359740|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
155359741|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
155359742|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
155359743|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
155648906|NCT05660538|561805932|FG002|Overall Study|Death|1|||
155359744|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
155359745|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
155359746|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
155359747|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
155359748|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
155359749|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
155359750|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
155359751|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
155359752|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
155359753|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
155359754|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
155359755|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
155359756|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
155359757|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
155359758|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
155359759|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
155359760|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
155359761|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
155359762|NCT02658175|560750184|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
155359763|NCT02658175|560750185|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
155359764|NCT02658175|560750186|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
155359765|NCT02658175|560750184|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
155359766|NCT02658175|560750185|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
155359767|NCT02658175|560750186|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
155359768|NCT05739994|560750194|FG000|Overall Study|Withdrawal by Subject|2|||
155359769|NCT05739994|560750195|FG001|Overall Study|Withdrawal by Subject|2|||
155359770|NCT05739994|560750196|FG002|Overall Study|Withdrawal by Subject|4|||
155359771|NCT02647645|560750197|FG000|Overall Study|Lost to Follow-up|2|||
155359772|NCT02647645|560750198|FG001|Overall Study|Lost to Follow-up|1|||
155359773|NCT04599907|560750201|FG000|Overall Study|Withdrawal by Subject|1|||
155359774|NCT04599907|560750202|FG001|Overall Study|Withdrawal by Subject|7|||
155359775|NCT04599907|560750203|FG002|Overall Study|Withdrawal by Subject|6|||
155359776|NCT04599907|560750201|FG000|Overall Study|Lost to Follow-up|0|||
155359777|NCT04599907|560750202|FG001|Overall Study|Lost to Follow-up|1|||
155359778|NCT04599907|560750203|FG002|Overall Study|Lost to Follow-up|0|||
155359779|NCT01466790|560750204|FG000|Overall Study|Adverse Event|1|||
155359780|NCT01466790|560750205|FG001|Overall Study|Adverse Event|0|||
155359781|NCT01466790|560750206|FG002|Overall Study|Adverse Event|0|||
155359782|NCT01466790|560750207|FG003|Overall Study|Adverse Event|0|||
155359783|NCT01466790|560750208|FG004|Overall Study|Adverse Event|2|||
155359784|NCT01466790|560750209|FG005|Overall Study|Adverse Event|0|||
155359785|NCT01466790|560750210|FG006|Overall Study|Adverse Event|0|||
155359786|NCT01466790|560750211|FG007|Overall Study|Adverse Event|0|||
155359787|NCT01466790|560750204|FG000|Overall Study|Lost to Follow-up|2|||
155359788|NCT01466790|560750205|FG001|Overall Study|Lost to Follow-up|0|||
155359789|NCT01466790|560750206|FG002|Overall Study|Lost to Follow-up|0|||
155359790|NCT01466790|560750207|FG003|Overall Study|Lost to Follow-up|0|||
155359791|NCT01466790|560750208|FG004|Overall Study|Lost to Follow-up|0|||
155359792|NCT01466790|560750209|FG005|Overall Study|Lost to Follow-up|0|||
155359793|NCT01466790|560750210|FG006|Overall Study|Lost to Follow-up|0|||
155359794|NCT01466790|560750211|FG007|Overall Study|Lost to Follow-up|0|||
155359795|NCT01466790|560750204|FG000|Overall Study|Withdrawal by Subject|1|||
155427361|NCT03797001|560991788|FG001|Overall Study|Withdrawn due to COVID19|0|||
155427362|NCT03797001|560991787|FG000|Overall Study|Withdrawal by Subject|7|||
155427363|NCT03797001|560991788|FG001|Overall Study|Withdrawal by Subject|6|||
155427364|NCT03797001|560991787|FG000|Overall Study|Adverse Event|0|||
155359796|NCT01466790|560750205|FG001|Overall Study|Withdrawal by Subject|1|||
155359797|NCT01466790|560750206|FG002|Overall Study|Withdrawal by Subject|0|||
155648907|NCT05660538|561805933|FG003|Overall Study|Death|0|||
155648908|NCT05660538|561805930|FG000|Overall Study|Physician Decision|0|||
155359798|NCT01466790|560750207|FG003|Overall Study|Withdrawal by Subject|0|||
155359799|NCT01466790|560750208|FG004|Overall Study|Withdrawal by Subject|1|||
155359800|NCT01466790|560750209|FG005|Overall Study|Withdrawal by Subject|0|||
155359801|NCT01466790|560750210|FG006|Overall Study|Withdrawal by Subject|1|||
155427365|NCT03797001|560991788|FG001|Overall Study|Adverse Event|1|||
155648909|NCT05660538|561805931|FG001|Overall Study|Physician Decision|0|||
155648910|NCT05660538|561805932|FG002|Overall Study|Physician Decision|0|||
155648911|NCT05660538|561805933|FG003|Overall Study|Physician Decision|1|||
155648912|NCT05660538|561805930|FG000|Overall Study|Sponsor Decision|1|||
155648913|NCT05660538|561805931|FG001|Overall Study|Sponsor Decision|0|||
155648914|NCT05660538|561805932|FG002|Overall Study|Sponsor Decision|0|||
155648915|NCT05660538|561805933|FG003|Overall Study|Sponsor Decision|0|||
155648916|NCT05660538|561805930|FG000|Overall Study|Other|1|||
155648917|NCT05660538|561805931|FG001|Overall Study|Other|0|||
155648918|NCT05660538|561805932|FG002|Overall Study|Other|0|||
155648919|NCT05660538|561805933|FG003|Overall Study|Other|1|||
155648920|NCT05660538|561805930|FG000|Overall Study|Randomized but did not receive study drug|1|||
155648921|NCT05660538|561805931|FG001|Overall Study|Randomized but did not receive study drug|0|||
155648922|NCT05660538|561805932|FG002|Overall Study|Randomized but did not receive study drug|0|||
155648923|NCT05660538|561805933|FG003|Overall Study|Randomized but did not receive study drug|1|||
155648924|NCT05660538|561805930|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155648925|NCT05660538|561805931|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
155648926|NCT05660538|561805932|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155648927|NCT05660538|561805933|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155648928|NCT04518410|561805934|FG000|Overall Study|Lost to Follow-up|1|||
155648929|NCT04518410|561805935|FG001|Overall Study|Lost to Follow-up|1|||
155648930|NCT04518410|561805936|FG002|Overall Study|Lost to Follow-up|8|||
155648931|NCT04518410|561805937|FG003|Overall Study|Lost to Follow-up|5|||
155648932|NCT04518410|561805938|FG004|Overall Study|Lost to Follow-up|92|||
155359802|NCT01466790|560750211|FG007|Overall Study|Withdrawal by Subject|1|||
155359803|NCT00356811|560750212|FG000|Overall Study|Death|35|||
155359804|NCT00356811|560750212|FG000|Overall Study|Lost to Follow-up|2|||
155648933|NCT04518410|561805939|FG005|Overall Study|Lost to Follow-up|25|||
155648934|NCT04518410|561805940|FG006|Overall Study|Lost to Follow-up|25|||
155648935|NCT04518410|561805941|FG007|Overall Study|Lost to Follow-up|3|||
155648936|NCT04518410|561805942|FG008|Overall Study|Lost to Follow-up|2|||
155359805|NCT00356811|560750212|FG000|Overall Study|Withdrawal by Subject|6|||
155359806|NCT00356811|560750212|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
155359807|NCT00356811|560750212|FG000|Overall Study|Study Is Terminating|3|||
155359808|NCT00356811|560750212|FG000|Overall Study|Site Closed during Follow-up|2|||
155359809|NCT03668223|560750213|FG000|Overall Study|Death|10|||
155359810|NCT03668223|560750214|FG001|Overall Study|Death|5|||
155359811|NCT03668223|560750213|FG000|Overall Study|Lost to Follow-up|12|||
155359812|NCT03668223|560750214|FG001|Overall Study|Lost to Follow-up|12|||
155359813|NCT03668223|560750213|FG000|Overall Study|Withdrawal by Subject|8|||
155359814|NCT03668223|560750214|FG001|Overall Study|Withdrawal by Subject|3|||
155359815|NCT05502783|560750215|FG000|Overall Study|Lack of Efficacy|1|||
155359816|NCT00129935|560751546|FG000|Overall Study|Adverse Event|18|||
155359817|NCT00129935|560751547|FG001|Overall Study|Adverse Event|56|||
155359818|NCT00129935|560751546|FG000|Overall Study|Death|1|||
155359819|NCT00129935|560751547|FG001|Overall Study|Death|1|||
155359820|NCT00129935|560751546|FG000|Overall Study|Withdrawal by Subject|7|||
155359821|NCT00129935|560751547|FG001|Overall Study|Withdrawal by Subject|20|||
155359822|NCT00129935|560751546|FG000|Overall Study|Protocol Violation|0|||
155359823|NCT00129935|560751547|FG001|Overall Study|Protocol Violation|4|||
155359824|NCT00129935|560751546|FG000|Overall Study|Physician Decision|3|||
155359825|NCT00129935|560751547|FG001|Overall Study|Physician Decision|4|||
155359826|NCT00129935|560751546|FG000|Overall Study|Recurrence|1|||
155359827|NCT00129935|560751547|FG001|Overall Study|Recurrence|3|||
155359828|NCT00129935|560751546|FG000|Overall Study|Second primary|0|||
155359829|NCT00129935|560751547|FG001|Overall Study|Second primary|1|||
155507209|NCT04444752|561283579|FG002|Overall Study|Death|1|||
155648937|NCT04518410|561805943|FG009|Overall Study|Lost to Follow-up|13|||
155648938|NCT04518410|561805944|FG010|Overall Study|Lost to Follow-up|9|||
155648939|NCT04518410|561805945|FG011|Overall Study|Lost to Follow-up|13|||
155648940|NCT04518410|561805946|FG012|Overall Study|Lost to Follow-up|9|||
155359830|NCT00129935|560751546|FG000|Overall Study|Other|3|||
155359831|NCT00129935|560751547|FG001|Overall Study|Other|2|||
155648941|NCT04518410|561805947|FG013|Overall Study|Lost to Follow-up|13|||
155648942|NCT04518410|561805948|FG014|Overall Study|Lost to Follow-up|8|||
155648943|NCT04518410|561805949|FG015|Overall Study|Lost to Follow-up|10|||
155648944|NCT04518410|561805950|FG016|Overall Study|Lost to Follow-up|6|||
155359832|NCT00129935|560751546|FG000|Overall Study|Crossed to the other arm|2|||
155359833|NCT00129935|560751547|FG001|Overall Study|Crossed to the other arm|1|||
155359834|NCT00129935|560751546|FG000|Overall Study|Incorrect study treatment|1|||
155359835|NCT00129935|560751547|FG001|Overall Study|Incorrect study treatment|0|||
155359836|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
155359837|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
155359838|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
155359839|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Death|4|||
155507210|NCT04444752|561283580|FG003|Overall Study|Death|0|||
155648945|NCT04518410|561805951|FG017|Overall Study|Lost to Follow-up|13|||
155648946|NCT04518410|561805952|FG018|Overall Study|Lost to Follow-up|21|||
155359840|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Death|2|||
155359841|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Death|3|||
155359842|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155359843|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155359844|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
155359845|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
155359846|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
155359847|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
155359848|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
155359849|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
155359850|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
155359851|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
155359852|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
155359853|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
155359854|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
155359855|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
155359856|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
155359857|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
155359858|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
155359859|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
155359860|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
155359861|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
155359862|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
155359863|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
155359864|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
155359865|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
155359866|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
155359867|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
155359868|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
155359869|NCT02783573|560751548|FG000|Delayed-Start Period|Sponsor Decision|0|||
155359870|NCT02783573|560751549|FG001|Delayed-Start Period|Sponsor Decision|17|||
155359871|NCT02783573|560751550|FG002|Delayed-Start Period|Sponsor Decision|12|||
155359872|NCT01434680|560751553|FG000|Overall Study|Withdrawal by Subject|1|||
155359873|NCT01434680|560751554|FG001|Overall Study|Withdrawal by Subject|0|||
155359874|NCT01434680|560751555|FG002|Overall Study|Withdrawal by Subject|2|||
155359875|NCT01434680|560751556|FG003|Overall Study|Withdrawal by Subject|0|||
155359876|NCT01434680|560751553|FG000|Overall Study|Lost to Follow-up|1|||
155359877|NCT01434680|560751554|FG001|Overall Study|Lost to Follow-up|1|||
155359878|NCT01434680|560751555|FG002|Overall Study|Lost to Follow-up|0|||
155359879|NCT01434680|560751556|FG003|Overall Study|Lost to Follow-up|0|||
155359880|NCT01434680|560751553|FG000|Overall Study|Protocol Violation|1|||
155359881|NCT01434680|560751554|FG001|Overall Study|Protocol Violation|1|||
155359882|NCT01434680|560751555|FG002|Overall Study|Protocol Violation|0|||
155359883|NCT01434680|560751556|FG003|Overall Study|Protocol Violation|0|||
155359884|NCT04991766|560751557|FG000|Overall Study|Withdrawal by Subject|2|||
155359885|NCT04991766|560751558|FG001|Overall Study|Withdrawal by Subject|0|||
155359886|NCT05765435|560751568|FG000|Overall Study|Lost to Follow-up|0|||
155359887|NCT05765435|560751569|FG001|Overall Study|Lost to Follow-up|1|||
155359888|NCT05765435|560751570|FG002|Overall Study|Lost to Follow-up|0|||
155359889|NCT05765435|560751568|FG000|Overall Study|Withdrawal by Subject|0|||
155359890|NCT05765435|560751569|FG001|Overall Study|Withdrawal by Subject|0|||
155359891|NCT05765435|560751570|FG002|Overall Study|Withdrawal by Subject|1|||
155359892|NCT01952847|560751571|FG000|Overall Study|Ineligible|1|||
155359893|NCT01952847|560751572|FG001|Overall Study|Ineligible|0|||
155359894|NCT01952847|560751573|FG002|Overall Study|Ineligible|0|||
155359895|NCT01952847|560751574|FG003|Overall Study|Ineligible|0|||
155427366|NCT00500266|560991803|FG000|Overall Study|Death|3|||
155359896|NCT01952847|560751571|FG000|Overall Study|Lack of Insurance Coverage|0|||
155359897|NCT01952847|560751572|FG001|Overall Study|Lack of Insurance Coverage|1|||
155359898|NCT01952847|560751573|FG002|Overall Study|Lack of Insurance Coverage|0|||
155359899|NCT01952847|560751574|FG003|Overall Study|Lack of Insurance Coverage|0|||
155359900|NCT01952847|560751571|FG000|Overall Study|Withdrawal by Subject|1|||
155359901|NCT01952847|560751572|FG001|Overall Study|Withdrawal by Subject|1|||
155359902|NCT01952847|560751573|FG002|Overall Study|Withdrawal by Subject|0|||
155359903|NCT01952847|560751574|FG003|Overall Study|Withdrawal by Subject|1|||
155359904|NCT01013961|560751580|FG000|Overall Study|Adverse Event|2|||
155359905|NCT01013961|560751581|FG001|Overall Study|Adverse Event|2|||
155359906|NCT01013961|560751580|FG000|Overall Study|Withdrawal by Subject|1|||
155359907|NCT01013961|560751581|FG001|Overall Study|Withdrawal by Subject|0|||
155359908|NCT01013961|560751580|FG000|Overall Study|Physician Decision|0|||
155359909|NCT01013961|560751581|FG001|Overall Study|Physician Decision|1|||
155359910|NCT01271504|560751584|FG000|Overall Study|Death|7|||
155359911|NCT01271504|560751585|FG001|Overall Study|Death|6|||
155359912|NCT01271504|560751586|FG002|Overall Study|Death|32|||
155359913|NCT01271504|560751587|FG003|Overall Study|Death|32|||
155359914|NCT01271504|560751584|FG000|Overall Study|Lost to Follow-up|0|||
155359915|NCT01271504|560751585|FG001|Overall Study|Lost to Follow-up|1|||
155359916|NCT01271504|560751586|FG002|Overall Study|Lost to Follow-up|3|||
155359917|NCT01271504|560751587|FG003|Overall Study|Lost to Follow-up|1|||
155359918|NCT01271504|560751584|FG000|Overall Study|Protocol Violation|0|||
155359919|NCT01271504|560751585|FG001|Overall Study|Protocol Violation|0|||
155359920|NCT01271504|560751586|FG002|Overall Study|Protocol Violation|0|||
155359921|NCT01271504|560751587|FG003|Overall Study|Protocol Violation|2|||
155359922|NCT01271504|560751584|FG000|Overall Study|Administrative Reasons|0|||
155359923|NCT01271504|560751585|FG001|Overall Study|Administrative Reasons|0|||
155359924|NCT01271504|560751586|FG002|Overall Study|Administrative Reasons|6|||
155359925|NCT01271504|560751587|FG003|Overall Study|Administrative Reasons|5|||
155359926|NCT01271504|560751584|FG000|Overall Study|Withdrawal by Subject|0|||
155359927|NCT01271504|560751585|FG001|Overall Study|Withdrawal by Subject|0|||
155359928|NCT01271504|560751586|FG002|Overall Study|Withdrawal by Subject|1|||
155359929|NCT01271504|560751587|FG003|Overall Study|Withdrawal by Subject|3|||
155359930|NCT01271504|560751584|FG000|Overall Study|Other|0|||
155359931|NCT01271504|560751585|FG001|Overall Study|Other|1|||
155359932|NCT01271504|560751586|FG002|Overall Study|Other|2|||
155359933|NCT01271504|560751587|FG003|Overall Study|Other|0|||
155359934|NCT00940875|560751588|FG000|Treatment Phase|Adverse Event|9|||
155359935|NCT00940875|560751589|FG001|Treatment Phase|Adverse Event|3|||
155359936|NCT00940875|560751588|FG000|Treatment Phase|Death|3|||
155359937|NCT00940875|560751589|FG001|Treatment Phase|Death|5|||
155359938|NCT00940875|560751588|FG000|Treatment Phase|Lack of Efficacy|1|||
155359939|NCT00940875|560751589|FG001|Treatment Phase|Lack of Efficacy|0|||
155359940|NCT00940875|560751588|FG000|Treatment Phase|Withdrawal by Subject|3|||
155359941|NCT00940875|560751589|FG001|Treatment Phase|Withdrawal by Subject|0|||
155359942|NCT00940875|560751588|FG000|Treatment Phase|Disease progression|9|||
155359943|NCT00940875|560751589|FG001|Treatment Phase|Disease progression|11|||
155359944|NCT00940875|560751588|FG000|Treatment Phase|Physician Decision|1|||
155359945|NCT00940875|560751589|FG001|Treatment Phase|Physician Decision|0|||
155359946|NCT00940875|560751588|FG000|Post-Study Treatment|Death|0|||
155359947|NCT00940875|560751589|FG001|Post-Study Treatment|Death|1|||
155359948|NCT00940875|560751588|FG000|Post-Study Treatment|Disease Progression|0|||
155359949|NCT00940875|560751589|FG001|Post-Study Treatment|Disease Progression|2|||
155359950|NCT00943787|560751590|FG000|Overall Study|Physician Decision|4|||
155359951|NCT00943787|560751590|FG000|Overall Study|Withdrawal by Subject|3|||
155359952|NCT01850589|560751591|FG000|Overall Study|Withdrawal by Subject|8|||
155359953|NCT01850589|560751592|FG001|Overall Study|Withdrawal by Subject|0|||
155359954|NCT03721705|560751593|FG000|Overall Study|Adverse Event|2|||
155359955|NCT03721705|560751594|FG001|Overall Study|Adverse Event|0|||
155359956|NCT03721705|560751593|FG000|Overall Study|Withdrawal by Subject|4|||
155359957|NCT03721705|560751594|FG001|Overall Study|Withdrawal by Subject|10|||
155359958|NCT03721705|560751593|FG000|Overall Study|No Suitable Study Partner|1|||
155359959|NCT03721705|560751594|FG001|Overall Study|No Suitable Study Partner|0|||
155359960|NCT03721705|560751593|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
155359961|NCT03721705|560751594|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
155359962|NCT03721705|560751593|FG000|Overall Study|Death|0|||
155359963|NCT03721705|560751594|FG001|Overall Study|Death|1|||
155359964|NCT01843777|560751595|FG000|Overall Study|Withdrawal by Subject|1|||
155359965|NCT01843777|560751596|FG001|Overall Study|Withdrawal by Subject|0|||
155359966|NCT05147350|560751598|FG000|Overall Study|Death|2|||
155359967|NCT05147350|560751599|FG001|Overall Study|Death|3|||
155359968|NCT05147350|560751600|FG002|Overall Study|Death|3|||
155359969|NCT05147350|560751601|FG003|Overall Study|Death|2|||
155359970|NCT05147350|560751602|FG004|Overall Study|Death|2|||
155359971|NCT05147350|560751603|FG005|Overall Study|Death|1|||
155359972|NCT05147350|560751604|FG006|Overall Study|Death|1|||
155359973|NCT05147350|560751605|FG007|Overall Study|Death|3|||
155359974|NCT05147350|560751598|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
155359975|NCT05147350|560751599|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
155359976|NCT05147350|560751600|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
155359977|NCT05147350|560751601|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
155359978|NCT05147350|560751602|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
155359979|NCT05147350|560751603|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
155359980|NCT05147350|560751604|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
155359981|NCT05147350|560751605|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
155359982|NCT05147350|560751598|FG000|Overall Study|Withdrawal by Subject|0|||
155359983|NCT05147350|560751599|FG001|Overall Study|Withdrawal by Subject|0|||
155359984|NCT05147350|560751600|FG002|Overall Study|Withdrawal by Subject|3|||
155359985|NCT05147350|560751601|FG003|Overall Study|Withdrawal by Subject|1|||
155359986|NCT05147350|560751602|FG004|Overall Study|Withdrawal by Subject|1|||
155359987|NCT05147350|560751603|FG005|Overall Study|Withdrawal by Subject|0|||
155359988|NCT05147350|560751604|FG006|Overall Study|Withdrawal by Subject|1|||
155359989|NCT05147350|560751605|FG007|Overall Study|Withdrawal by Subject|0|||
155359990|NCT05147350|560751598|FG000|Overall Study|Other Reasons|0|||
155359991|NCT05147350|560751599|FG001|Overall Study|Other Reasons|0|||
155359992|NCT05147350|560751600|FG002|Overall Study|Other Reasons|2|||
155359993|NCT05147350|560751601|FG003|Overall Study|Other Reasons|0|||
155359994|NCT05147350|560751602|FG004|Overall Study|Other Reasons|0|||
155359995|NCT05147350|560751603|FG005|Overall Study|Other Reasons|2|||
155359996|NCT05147350|560751604|FG006|Overall Study|Other Reasons|1|||
155359997|NCT05147350|560751605|FG007|Overall Study|Other Reasons|1|||
155359998|NCT01080326|560751606|FG000|Overall Study|Patient deterioration prior to procedure|3|||
155359999|NCT01080326|560751606|FG000|Overall Study|Surgeon decision|1|||
155360000|NCT01628692|560751611|FG000|Overall Study|Lack of Efficacy|4|||
155360001|NCT01628692|560751612|FG001|Overall Study|Lack of Efficacy|4|||
155360002|NCT01628692|560751613|FG002|Overall Study|Lack of Efficacy|5|||
155360003|NCT01628692|560751614|FG003|Overall Study|Lack of Efficacy|1|||
155360004|NCT01628692|560751615|FG004|Overall Study|Lack of Efficacy|4|||
155360005|NCT01628692|560751616|FG005|Overall Study|Lack of Efficacy|7|||
155360006|NCT01628692|560751611|FG000|Overall Study|Adverse Event|2|||
155360007|NCT01628692|560751612|FG001|Overall Study|Adverse Event|0|||
155360008|NCT01628692|560751613|FG002|Overall Study|Adverse Event|2|||
155360009|NCT01628692|560751614|FG003|Overall Study|Adverse Event|0|||
155360010|NCT01628692|560751615|FG004|Overall Study|Adverse Event|0|||
155360011|NCT01628692|560751616|FG005|Overall Study|Adverse Event|0|||
155360012|NCT01628692|560751611|FG000|Overall Study|Withdrawal by Subject|0|||
155360013|NCT01628692|560751612|FG001|Overall Study|Withdrawal by Subject|1|||
155360014|NCT01628692|560751613|FG002|Overall Study|Withdrawal by Subject|1|||
155360015|NCT01628692|560751614|FG003|Overall Study|Withdrawal by Subject|0|||
155360016|NCT01628692|560751615|FG004|Overall Study|Withdrawal by Subject|0|||
155360017|NCT01628692|560751616|FG005|Overall Study|Withdrawal by Subject|0|||
155360018|NCT01628692|560751611|FG000|Overall Study|Death|0|||
155360019|NCT01628692|560751612|FG001|Overall Study|Death|1|||
155360020|NCT01628692|560751613|FG002|Overall Study|Death|0|||
155360021|NCT01628692|560751614|FG003|Overall Study|Death|0|||
155360022|NCT01628692|560751615|FG004|Overall Study|Death|0|||
155360023|NCT01628692|560751616|FG005|Overall Study|Death|0|||
155360024|NCT01628692|560751611|FG000|Overall Study|Poor compliance/noncompliance|1|||
155360025|NCT01628692|560751612|FG001|Overall Study|Poor compliance/noncompliance|0|||
155360026|NCT01628692|560751613|FG002|Overall Study|Poor compliance/noncompliance|0|||
155360027|NCT01628692|560751614|FG003|Overall Study|Poor compliance/noncompliance|0|||
155360028|NCT01628692|560751615|FG004|Overall Study|Poor compliance/noncompliance|0|||
155360029|NCT01628692|560751616|FG005|Overall Study|Poor compliance/noncompliance|0|||
155360030|NCT01628692|560751611|FG000|Overall Study|Administrative reason by sponsor|0|||
155360031|NCT01628692|560751612|FG001|Overall Study|Administrative reason by sponsor|0|||
155360032|NCT01628692|560751613|FG002|Overall Study|Administrative reason by sponsor|0|||
155360033|NCT01628692|560751614|FG003|Overall Study|Administrative reason by sponsor|0|||
155360034|NCT01628692|560751615|FG004|Overall Study|Administrative reason by sponsor|0|||
155360035|NCT01628692|560751616|FG005|Overall Study|Administrative reason by sponsor|1|||
155360036|NCT01628692|560751611|FG000|Overall Study|Completed 12 Week only|0|||
155360037|NCT01628692|560751612|FG001|Overall Study|Completed 12 Week only|0|||
155360038|NCT01628692|560751613|FG002|Overall Study|Completed 12 Week only|0|||
155360039|NCT01628692|560751614|FG003|Overall Study|Completed 12 Week only|0|||
155360040|NCT01628692|560751615|FG004|Overall Study|Completed 12 Week only|0|||
155360041|NCT01628692|560751616|FG005|Overall Study|Completed 12 Week only|1|||
155360042|NCT02437071|560751617|FG000|Overall Study|Withdrawal by Subject|1|||
155360043|NCT02437071|560751618|FG001|Overall Study|Withdrawal by Subject|0|||
155360044|NCT03513068|560751621|FG000|Overall Study|Death|1|||
155360045|NCT03513068|560751622|FG001|Overall Study|Death|0|||
155360046|NCT03513068|560751621|FG000|Overall Study|Withdrawal by Subject|4|||
155360047|NCT03513068|560751622|FG001|Overall Study|Withdrawal by Subject|6|||
155360048|NCT04788511|560751623|FG000|Overall Study|Withdrawal by Subject|2|||
155360049|NCT04788511|560751624|FG001|Overall Study|Withdrawal by Subject|1|||
155360050|NCT04788511|560751623|FG000|Overall Study|Lost to Follow-up|2|||
155648947|NCT04518410|561805953|FG019|Overall Study|Lost to Follow-up|6|||
155648948|NCT04518410|561805954|FG020|Overall Study|Lost to Follow-up|7|||
155648949|NCT04518410|561805955|FG021|Overall Study|Lost to Follow-up|21|||
155648950|NCT04518410|561805956|FG022|Overall Study|Lost to Follow-up|1|||
155648951|NCT04518410|561805957|FG023|Overall Study|Lost to Follow-up|7|||
155648952|NCT04518410|561805958|FG024|Overall Study|Lost to Follow-up|6|||
155648953|NCT04518410|561805934|FG000|Overall Study|Withdrawal by Subject|1|||
155648954|NCT04518410|561805935|FG001|Overall Study|Withdrawal by Subject|2|||
155648955|NCT04518410|561805936|FG002|Overall Study|Withdrawal by Subject|2|||
155648956|NCT04518410|561805937|FG003|Overall Study|Withdrawal by Subject|3|||
155648957|NCT04518410|561805938|FG004|Overall Study|Withdrawal by Subject|20|||
155648958|NCT04518410|561805939|FG005|Overall Study|Withdrawal by Subject|20|||
155648959|NCT04518410|561805940|FG006|Overall Study|Withdrawal by Subject|25|||
155648960|NCT04518410|561805941|FG007|Overall Study|Withdrawal by Subject|6|||
155648961|NCT04518410|561805942|FG008|Overall Study|Withdrawal by Subject|1|||
155360051|NCT04788511|560751624|FG001|Overall Study|Lost to Follow-up|7|||
155360052|NCT04788511|560751623|FG000|Overall Study|Death|3|||
155360053|NCT04788511|560751624|FG001|Overall Study|Death|4|||
155360054|NCT03636373|560751625|FG000|Overall Study|Study closure due to Covid-19|1|||
155360055|NCT03636373|560751626|FG001|Overall Study|Study closure due to Covid-19|0|||
155360056|NCT02353468|560751627|FG000|Overall Study|Study terminated|3|||
155360057|NCT00003477|560751628|FG000|Overall Study|Not evalauable|4|||
155360058|NCT01236352|560751630|FG000|Overall Study|Death|0|||
155360059|NCT01236352|560751631|FG001|Overall Study|Death|0|||
155360060|NCT01236352|560751632|FG002|Overall Study|Death|0|||
155360061|NCT01236352|560751633|FG003|Overall Study|Death|0|||
155360062|NCT01236352|560751634|FG004|Overall Study|Death|0|||
155360063|NCT01236352|560751635|FG005|Overall Study|Death|0|||
155360064|NCT01236352|560751636|FG006|Overall Study|Death|0|||
155360065|NCT01236352|560751637|FG007|Overall Study|Death|1|||
155360066|NCT01236352|560751638|FG008|Overall Study|Death|0|||
155360067|NCT01236352|560751639|FG009|Overall Study|Death|0|||
155360068|NCT01236352|560751640|FG010|Overall Study|Death|0|||
155360069|NCT01236352|560751630|FG000|Overall Study|Withdrawal by Subject|0|||
155360070|NCT01236352|560751631|FG001|Overall Study|Withdrawal by Subject|0|||
155360071|NCT01236352|560751632|FG002|Overall Study|Withdrawal by Subject|0|||
155360072|NCT01236352|560751633|FG003|Overall Study|Withdrawal by Subject|0|||
155360073|NCT01236352|560751634|FG004|Overall Study|Withdrawal by Subject|0|||
155360074|NCT01236352|560751635|FG005|Overall Study|Withdrawal by Subject|0|||
155360075|NCT01236352|560751636|FG006|Overall Study|Withdrawal by Subject|0|||
155360076|NCT01236352|560751637|FG007|Overall Study|Withdrawal by Subject|0|||
155360077|NCT01236352|560751638|FG008|Overall Study|Withdrawal by Subject|0|||
155360078|NCT01236352|560751639|FG009|Overall Study|Withdrawal by Subject|2|||
155360079|NCT01236352|560751640|FG010|Overall Study|Withdrawal by Subject|1|||
155360080|NCT01236352|560751630|FG000|Overall Study|Adverse Event|0|||
155360081|NCT01236352|560751631|FG001|Overall Study|Adverse Event|0|||
155360082|NCT01236352|560751632|FG002|Overall Study|Adverse Event|0|||
155360083|NCT01236352|560751633|FG003|Overall Study|Adverse Event|0|||
155360084|NCT01236352|560751634|FG004|Overall Study|Adverse Event|0|||
155360085|NCT01236352|560751635|FG005|Overall Study|Adverse Event|0|||
155360086|NCT01236352|560751636|FG006|Overall Study|Adverse Event|2|||
155360087|NCT01236352|560751637|FG007|Overall Study|Adverse Event|0|||
155360088|NCT01236352|560751638|FG008|Overall Study|Adverse Event|0|||
155360089|NCT01236352|560751639|FG009|Overall Study|Adverse Event|4|||
155360090|NCT01236352|560751640|FG010|Overall Study|Adverse Event|1|||
155360091|NCT01236352|560751630|FG000|Overall Study|Study drug toxicity|0|||
155360092|NCT01236352|560751631|FG001|Overall Study|Study drug toxicity|0|||
155360093|NCT01236352|560751632|FG002|Overall Study|Study drug toxicity|0|||
155360094|NCT01236352|560751633|FG003|Overall Study|Study drug toxicity|0|||
155360095|NCT01236352|560751634|FG004|Overall Study|Study drug toxicity|0|||
155360096|NCT01236352|560751635|FG005|Overall Study|Study drug toxicity|1|||
155360097|NCT01236352|560751636|FG006|Overall Study|Study drug toxicity|1|||
155360098|NCT01236352|560751637|FG007|Overall Study|Study drug toxicity|0|||
155360099|NCT01236352|560751638|FG008|Overall Study|Study drug toxicity|0|||
155360100|NCT01236352|560751639|FG009|Overall Study|Study drug toxicity|2|||
155360101|NCT01236352|560751640|FG010|Overall Study|Study drug toxicity|2|||
155360102|NCT01236352|560751630|FG000|Overall Study|Disease progression|1|||
155360103|NCT01236352|560751631|FG001|Overall Study|Disease progression|2|||
155360104|NCT01236352|560751632|FG002|Overall Study|Disease progression|1|||
155360105|NCT01236352|560751633|FG003|Overall Study|Disease progression|2|||
155360106|NCT01236352|560751634|FG004|Overall Study|Disease progression|2|||
155360107|NCT01236352|560751635|FG005|Overall Study|Disease progression|2|||
155360108|NCT01236352|560751636|FG006|Overall Study|Disease progression|1|||
155648962|NCT04518410|561805943|FG009|Overall Study|Withdrawal by Subject|12|||
155648963|NCT04518410|561805944|FG010|Overall Study|Withdrawal by Subject|5|||
155648964|NCT04518410|561805945|FG011|Overall Study|Withdrawal by Subject|7|||
155360109|NCT01236352|560751637|FG007|Overall Study|Disease progression|3|||
155360110|NCT01236352|560751638|FG008|Overall Study|Disease progression|2|||
155360111|NCT01236352|560751639|FG009|Overall Study|Disease progression|2|||
155360112|NCT01236352|560751640|FG010|Overall Study|Disease progression|2|||
155360113|NCT01236352|560751630|FG000|Overall Study|Poor/Non-compliance|1|||
155360114|NCT01236352|560751631|FG001|Overall Study|Poor/Non-compliance|0|||
155360115|NCT01236352|560751632|FG002|Overall Study|Poor/Non-compliance|0|||
155360116|NCT01236352|560751633|FG003|Overall Study|Poor/Non-compliance|0|||
155360117|NCT01236352|560751634|FG004|Overall Study|Poor/Non-compliance|0|||
155360118|NCT01236352|560751635|FG005|Overall Study|Poor/Non-compliance|0|||
155360119|NCT01236352|560751636|FG006|Overall Study|Poor/Non-compliance|0|||
155360120|NCT01236352|560751637|FG007|Overall Study|Poor/Non-compliance|0|||
155360121|NCT01236352|560751638|FG008|Overall Study|Poor/Non-compliance|0|||
155360122|NCT01236352|560751639|FG009|Overall Study|Poor/Non-compliance|0|||
155360123|NCT01236352|560751640|FG010|Overall Study|Poor/Non-compliance|0|||
155360124|NCT01236352|560751630|FG000|Overall Study|Maximum clinical benefit|1|||
155360125|NCT01236352|560751631|FG001|Overall Study|Maximum clinical benefit|1|||
155360126|NCT01236352|560751632|FG002|Overall Study|Maximum clinical benefit|1|||
155360127|NCT01236352|560751633|FG003|Overall Study|Maximum clinical benefit|0|||
155360128|NCT01236352|560751634|FG004|Overall Study|Maximum clinical benefit|2|||
155360129|NCT01236352|560751635|FG005|Overall Study|Maximum clinical benefit|0|||
155360130|NCT01236352|560751636|FG006|Overall Study|Maximum clinical benefit|3|||
155360131|NCT01236352|560751637|FG007|Overall Study|Maximum clinical benefit|1|||
155360132|NCT01236352|560751638|FG008|Overall Study|Maximum clinical benefit|1|||
155360133|NCT01236352|560751639|FG009|Overall Study|Maximum clinical benefit|4|||
155360134|NCT01236352|560751640|FG010|Overall Study|Maximum clinical benefit|2|||
155427367|NCT00500266|560991803|FG000|Overall Study|Lost to Follow-up|3|||
155427368|NCT00500266|560991803|FG000|Overall Study|Withdrawal by Subject|3|||
155427369|NCT00500266|560991803|FG000|Overall Study|Assigned, not treated|4|||
155427370|NCT01431287|560991804|FG000|Overall Study|not treated|0|||
155427371|NCT01431287|560991805|FG001|Overall Study|not treated|0|||
155427372|NCT01431287|560991806|FG002|Overall Study|not treated|1|||
155427373|NCT01431287|560991807|FG003|Overall Study|not treated|0|||
155427374|NCT01431287|560991808|FG004|Overall Study|not treated|0|||
155427375|NCT01431287|560991804|FG000|Overall Study|Adverse Event|59|||
155427376|NCT01431287|560991805|FG001|Overall Study|Adverse Event|57|||
155427377|NCT01431287|560991806|FG002|Overall Study|Adverse Event|53|||
155427378|NCT01431287|560991807|FG003|Overall Study|Adverse Event|33|||
155427379|NCT01431287|560991808|FG004|Overall Study|Adverse Event|41|||
155427380|NCT01431287|560991804|FG000|Overall Study|Non compliant with protocol|6|||
155427381|NCT01431287|560991805|FG001|Overall Study|Non compliant with protocol|6|||
155427382|NCT01431287|560991806|FG002|Overall Study|Non compliant with protocol|5|||
155427383|NCT01431287|560991807|FG003|Overall Study|Non compliant with protocol|6|||
155427384|NCT01431287|560991808|FG004|Overall Study|Non compliant with protocol|5|||
155427385|NCT01431287|560991804|FG000|Overall Study|Lost to Follow-up|0|||
155427386|NCT01431287|560991805|FG001|Overall Study|Lost to Follow-up|3|||
155427387|NCT01431287|560991806|FG002|Overall Study|Lost to Follow-up|2|||
155427388|NCT01431287|560991807|FG003|Overall Study|Lost to Follow-up|3|||
155427389|NCT01431287|560991808|FG004|Overall Study|Lost to Follow-up|1|||
155427390|NCT01431287|560991804|FG000|Overall Study|Consent withdrawn not due to AE|29|||
155427391|NCT01431287|560991805|FG001|Overall Study|Consent withdrawn not due to AE|30|||
155427392|NCT01431287|560991806|FG002|Overall Study|Consent withdrawn not due to AE|34|||
155427393|NCT01431287|560991807|FG003|Overall Study|Consent withdrawn not due to AE|19|||
155427394|NCT01431287|560991808|FG004|Overall Study|Consent withdrawn not due to AE|29|||
155427395|NCT01431287|560991804|FG000|Overall Study|not stated above|4|||
155427396|NCT01431287|560991805|FG001|Overall Study|not stated above|2|||
155360135|NCT01236352|560751630|FG000|Overall Study|Subject request to discontinue treatment|0|||
155360136|NCT01236352|560751631|FG001|Overall Study|Subject request to discontinue treatment|0|||
155360137|NCT01236352|560751632|FG002|Overall Study|Subject request to discontinue treatment|1|||
155360138|NCT01236352|560751633|FG003|Overall Study|Subject request to discontinue treatment|1|||
155360139|NCT01236352|560751634|FG004|Overall Study|Subject request to discontinue treatment|0|||
155360140|NCT01236352|560751635|FG005|Overall Study|Subject request to discontinue treatment|1|||
155360141|NCT01236352|560751636|FG006|Overall Study|Subject request to discontinue treatment|0|||
155360142|NCT01236352|560751637|FG007|Overall Study|Subject request to discontinue treatment|0|||
155360143|NCT01236352|560751638|FG008|Overall Study|Subject request to discontinue treatment|0|||
155360144|NCT01236352|560751639|FG009|Overall Study|Subject request to discontinue treatment|1|||
155360145|NCT01236352|560751640|FG010|Overall Study|Subject request to discontinue treatment|4|||
155360146|NCT01236352|560751630|FG000|Overall Study|Subject to receive drug via EAP|1|||
155360147|NCT01236352|560751631|FG001|Overall Study|Subject to receive drug via EAP|1|||
155360148|NCT01236352|560751632|FG002|Overall Study|Subject to receive drug via EAP|1|||
155360149|NCT01236352|560751633|FG003|Overall Study|Subject to receive drug via EAP|0|||
155360150|NCT01236352|560751634|FG004|Overall Study|Subject to receive drug via EAP|0|||
155360151|NCT01236352|560751635|FG005|Overall Study|Subject to receive drug via EAP|0|||
155360152|NCT01236352|560751636|FG006|Overall Study|Subject to receive drug via EAP|0|||
155360153|NCT01236352|560751637|FG007|Overall Study|Subject to receive drug via EAP|2|||
155360154|NCT01236352|560751638|FG008|Overall Study|Subject to receive drug via EAP|0|||
155360155|NCT01236352|560751639|FG009|Overall Study|Subject to receive drug via EAP|4|||
155360156|NCT01236352|560751640|FG010|Overall Study|Subject to receive drug via EAP|0|||
155360157|NCT01236352|560751630|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
155360158|NCT01236352|560751631|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
155360159|NCT01236352|560751632|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
155360160|NCT01236352|560751633|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
155427397|NCT01431287|560991806|FG002|Overall Study|not stated above|2|||
155427398|NCT01431287|560991807|FG003|Overall Study|not stated above|2|||
155427399|NCT01431287|560991808|FG004|Overall Study|not stated above|1|||
155427400|NCT00278629|560991811|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
155427401|NCT05224258|560991814|FG000|Overall Study|Withdrawal by Subject|1|||
155427402|NCT05224258|560991815|FG001|Overall Study|Withdrawal by Subject|1|||
155427403|NCT05224258|560991814|FG000|Overall Study|Physician Decision|1|||
155427404|NCT05224258|560991815|FG001|Overall Study|Physician Decision|1|||
155427405|NCT05224258|560991814|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155360161|NCT01236352|560751634|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
155360162|NCT01236352|560751635|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
155427406|NCT05224258|560991815|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155427407|NCT05224258|560991814|FG000|Overall Study|Study Product No Longer in Use|1|||
155360163|NCT01236352|560751636|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
155360164|NCT01236352|560751637|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
155360165|NCT01236352|560751638|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
155360166|NCT01236352|560751639|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
155360167|NCT01236352|560751640|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
155360168|NCT01236352|560751630|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360169|NCT01236352|560751631|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360170|NCT01236352|560751632|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360171|NCT01236352|560751633|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360172|NCT01236352|560751634|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360173|NCT01236352|560751635|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360174|NCT01236352|560751636|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360175|NCT01236352|560751637|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360176|NCT01236352|560751638|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360177|NCT01236352|560751639|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360178|NCT01236352|560751640|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
155360179|NCT01236352|560751630|FG000|Overall Study|Lack of response to drug|0|||
155360180|NCT01236352|560751631|FG001|Overall Study|Lack of response to drug|0|||
155360181|NCT01236352|560751632|FG002|Overall Study|Lack of response to drug|0|||
155360182|NCT01236352|560751633|FG003|Overall Study|Lack of response to drug|0|||
155360183|NCT01236352|560751634|FG004|Overall Study|Lack of response to drug|0|||
155360184|NCT01236352|560751635|FG005|Overall Study|Lack of response to drug|0|||
155360185|NCT01236352|560751636|FG006|Overall Study|Lack of response to drug|0|||
155360186|NCT01236352|560751637|FG007|Overall Study|Lack of response to drug|0|||
155360187|NCT01236352|560751638|FG008|Overall Study|Lack of response to drug|0|||
155360188|NCT01236352|560751639|FG009|Overall Study|Lack of response to drug|1|||
155360189|NCT01236352|560751640|FG010|Overall Study|Lack of response to drug|1|||
155360190|NCT01236352|560751630|FG000|Overall Study|Patient transferred to IST|0|||
155360191|NCT01236352|560751631|FG001|Overall Study|Patient transferred to IST|0|||
155360192|NCT01236352|560751632|FG002|Overall Study|Patient transferred to IST|0|||
155360193|NCT01236352|560751633|FG003|Overall Study|Patient transferred to IST|0|||
155360194|NCT01236352|560751634|FG004|Overall Study|Patient transferred to IST|0|||
155360195|NCT01236352|560751635|FG005|Overall Study|Patient transferred to IST|0|||
155360196|NCT01236352|560751636|FG006|Overall Study|Patient transferred to IST|0|||
155360197|NCT01236352|560751637|FG007|Overall Study|Patient transferred to IST|0|||
155360198|NCT01236352|560751638|FG008|Overall Study|Patient transferred to IST|0|||
155360199|NCT01236352|560751639|FG009|Overall Study|Patient transferred to IST|2|||
155360200|NCT01236352|560751640|FG010|Overall Study|Patient transferred to IST|6|||
155360201|NCT01575873|560751641|FG000|Overall Study|Withdrawal by Subject|15|||
155360202|NCT01575873|560751642|FG001|Overall Study|Withdrawal by Subject|20|||
155360203|NCT01575873|560751643|FG002|Overall Study|Withdrawal by Subject|34|||
155360204|NCT01575873|560751644|FG003|Overall Study|Withdrawal by Subject|34|||
155360205|NCT01575873|560751641|FG000|Overall Study|Adverse Event|7|||
155360206|NCT01575873|560751642|FG001|Overall Study|Adverse Event|7|||
155360207|NCT01575873|560751643|FG002|Overall Study|Adverse Event|9|||
155360208|NCT01575873|560751644|FG003|Overall Study|Adverse Event|12|||
155360209|NCT01575873|560751641|FG000|Overall Study|Lost to Follow-up|1|||
155360210|NCT01575873|560751642|FG001|Overall Study|Lost to Follow-up|3|||
155360211|NCT01575873|560751643|FG002|Overall Study|Lost to Follow-up|13|||
155360212|NCT01575873|560751644|FG003|Overall Study|Lost to Follow-up|5|||
155360213|NCT01575873|560751641|FG000|Overall Study|Death|3|||
155360214|NCT01575873|560751642|FG001|Overall Study|Death|2|||
155360215|NCT01575873|560751643|FG002|Overall Study|Death|8|||
155360216|NCT01575873|560751644|FG003|Overall Study|Death|9|||
155360217|NCT01575873|560751641|FG000|Overall Study|Noncompliance|1|||
155360218|NCT01575873|560751642|FG001|Overall Study|Noncompliance|2|||
155360219|NCT01575873|560751643|FG002|Overall Study|Noncompliance|4|||
155360220|NCT01575873|560751644|FG003|Overall Study|Noncompliance|3|||
155360221|NCT01575873|560751641|FG000|Overall Study|Administrative decision|1|||
155360222|NCT01575873|560751642|FG001|Overall Study|Administrative decision|1|||
155360223|NCT01575873|560751643|FG002|Overall Study|Administrative decision|1|||
155360224|NCT01575873|560751644|FG003|Overall Study|Administrative decision|0|||
155360225|NCT01575873|560751641|FG000|Overall Study|Protocol deviation|0|||
155360226|NCT01575873|560751642|FG001|Overall Study|Protocol deviation|1|||
155360227|NCT01575873|560751643|FG002|Overall Study|Protocol deviation|0|||
155360228|NCT01575873|560751644|FG003|Overall Study|Protocol deviation|1|||
155360229|NCT01575873|560751641|FG000|Overall Study|Requirement for Alternative Therapy|0|||
155360230|NCT01575873|560751642|FG001|Overall Study|Requirement for Alternative Therapy|0|||
155360231|NCT01575873|560751643|FG002|Overall Study|Requirement for Alternative Therapy|1|||
155507211|NCT00579254|561283581|FG000|Overall Study|Lost to Follow-up|39|||
155360232|NCT01575873|560751644|FG003|Overall Study|Requirement for Alternative Therapy|1|||
155360233|NCT01575873|560751641|FG000|Overall Study|Other|0|||
155360234|NCT01575873|560751642|FG001|Overall Study|Other|0|||
155360235|NCT01575873|560751643|FG002|Overall Study|Other|4|||
155360236|NCT01575873|560751644|FG003|Overall Study|Other|2|||
155360237|NCT02688530|560751650|FG000|Overall Study|Withdrawal by Subject|0|||
155360238|NCT02688530|560751651|FG001|Overall Study|Withdrawal by Subject|1|||
155360239|NCT02688530|560751652|FG002|Overall Study|Withdrawal by Subject|0|||
155360240|NCT02688530|560751653|FG003|Overall Study|Withdrawal by Subject|0|||
155360241|NCT02688530|560751650|FG000|Overall Study|Lost to Follow-up|0|||
155360242|NCT02688530|560751651|FG001|Overall Study|Lost to Follow-up|0|||
155360243|NCT02688530|560751652|FG002|Overall Study|Lost to Follow-up|2|||
155360244|NCT02688530|560751653|FG003|Overall Study|Lost to Follow-up|0|||
155360245|NCT01658020|560751654|FG000|Overall Study|Adverse Event|3|||
155360246|NCT01658020|560751655|FG001|Overall Study|Adverse Event|3|||
155360247|NCT01658020|560751654|FG000|Overall Study|Lost to Follow-up|1|||
155360248|NCT01658020|560751655|FG001|Overall Study|Lost to Follow-up|0|||
155360249|NCT01658020|560751654|FG000|Overall Study|Withdrawal by Subject|4|||
155360250|NCT01658020|560751655|FG001|Overall Study|Withdrawal by Subject|5|||
155360251|NCT01658020|560751654|FG000|Overall Study|Protocol Violation|0|||
155360252|NCT01658020|560751655|FG001|Overall Study|Protocol Violation|1|||
155360253|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Death|1|||
155360254|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Death|0|||
155360255|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Death|0|||
155360256|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Death|0|||
155360257|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Death|0|||
155360258|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Other|1|||
155360259|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Other|2|||
155360260|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Other|1|||
155360261|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Other|0|||
155360262|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Other|0|||
155360263|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360264|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360265|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
155360266|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360267|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360268|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
155360269|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360270|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360271|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360272|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360273|NCT05903183|560751658|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360274|NCT05903183|560751659|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360275|NCT05903183|560751660|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360276|NCT05903183|560751661|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
155360277|NCT05903183|560751662|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
155360278|NCT03371823|560751663|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
155360279|NCT03371823|560751664|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
155360280|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360281|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360282|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360283|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360284|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
155360285|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360286|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360287|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360288|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360289|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360290|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
155360291|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360292|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360293|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360294|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360295|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360296|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
155360297|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360298|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360299|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360300|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360301|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360302|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
155360303|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360304|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Adverse Event|1|||
155360305|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Adverse Event|1|||
155360306|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Adverse Event|0|||
155360307|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Adverse Event|0|||
155360308|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Adverse Event|0|||
155360309|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Adverse Event|0|||
155360310|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
155360311|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360312|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
155360313|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
155360314|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360315|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360316|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
155360317|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
155360318|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
155360319|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
155360320|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
155360321|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
155360322|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Physician Decision|0|||
155360323|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Physician Decision|0|||
155360324|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Physician Decision|2|||
155360325|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Physician Decision|1|||
155360326|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Physician Decision|0|||
155360327|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Physician Decision|0|||
155360328|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
155360329|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
155360330|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
155360331|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
155360332|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
155360333|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
155360334|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
155360335|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
155360336|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
155360337|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
155360338|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
155360339|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
155360340|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
155360341|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
155360342|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
155360343|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
155360344|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
155360345|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
155360346|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
155360347|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
155360348|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
155360349|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
155360350|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
155360351|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
155360352|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
155360353|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
155360354|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
155360355|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
155360356|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
155360357|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
155360358|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
155360359|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
155360360|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
155360361|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
155360362|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
155360363|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
155360364|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360365|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360366|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360367|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360368|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360369|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
155360370|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360371|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360372|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360373|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360374|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360375|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
155360376|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360377|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
155427408|NCT05224258|560991815|FG001|Overall Study|Study Product No Longer in Use|0|||
155360378|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360379|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360380|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360381|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
155360382|NCT05970640|560751671|FG000|Overall Study|Adverse Event|1|||
155360383|NCT05970640|560751672|FG001|Overall Study|Adverse Event|3|||
155360384|NCT05970640|560751673|FG002|Overall Study|Adverse Event|1|||
155360385|NCT05970640|560751674|FG003|Overall Study|Adverse Event|0|||
155360386|NCT05970640|560751671|FG000|Overall Study|Withdrawal by Subject|0|||
155360387|NCT05970640|560751672|FG001|Overall Study|Withdrawal by Subject|0|||
155360388|NCT05970640|560751673|FG002|Overall Study|Withdrawal by Subject|1|||
155360389|NCT05970640|560751674|FG003|Overall Study|Withdrawal by Subject|1|||
155360390|NCT05970640|560751671|FG000|Overall Study|Sponsor decision|0|||
155360391|NCT05970640|560751672|FG001|Overall Study|Sponsor decision|0|||
155360392|NCT05970640|560751673|FG002|Overall Study|Sponsor decision|1|||
155360393|NCT05970640|560751674|FG003|Overall Study|Sponsor decision|1|||
155360394|NCT04340843|560751675|FG000|Overall Study|Adverse Event|0|||
155360395|NCT04340843|560751676|FG001|Overall Study|Adverse Event|2|||
155360396|NCT04340843|560751675|FG000|Overall Study|Withdrawal by Subject|0|||
155360397|NCT04340843|560751676|FG001|Overall Study|Withdrawal by Subject|2|||
155360398|NCT03733899|560751681|FG000|Period 1|Protocol Violation|0|||
155360399|NCT03733899|560751682|FG001|Period 1|Protocol Violation|0|||
155360400|NCT03733899|560751683|FG002|Period 1|Protocol Violation|0|||
155360401|NCT03733899|560751684|FG003|Period 1|Protocol Violation|0|||
155360402|NCT03733899|560751685|FG004|Period 1|Protocol Violation|0|||
155360403|NCT03733899|560751686|FG005|Period 1|Protocol Violation|1|||
155360404|NCT03733899|560751681|FG000|Period 2|Unscuccessful Treatment|0|||
155360405|NCT03733899|560751682|FG001|Period 2|Unscuccessful Treatment|1|||
155360406|NCT03733899|560751683|FG002|Period 2|Unscuccessful Treatment|0|||
155360407|NCT03733899|560751684|FG003|Period 2|Unscuccessful Treatment|0|||
155360408|NCT03733899|560751685|FG004|Period 2|Unscuccessful Treatment|0|||
155360409|NCT03733899|560751686|FG005|Period 2|Unscuccessful Treatment|0|||
155360410|NCT03733899|560751681|FG000|Period 3|Withdrawal by Subject|1|||
155360411|NCT03733899|560751682|FG001|Period 3|Withdrawal by Subject|0|||
155360412|NCT03733899|560751683|FG002|Period 3|Withdrawal by Subject|0|||
155360413|NCT03733899|560751684|FG003|Period 3|Withdrawal by Subject|0|||
155360414|NCT03733899|560751685|FG004|Period 3|Withdrawal by Subject|0|||
155360415|NCT03733899|560751686|FG005|Period 3|Withdrawal by Subject|0|||
155360416|NCT00307047|560753824|FG000|Overall Study|Lost to Follow-up|35|||
155360417|NCT00307047|560753825|FG001|Overall Study|Lost to Follow-up|24|||
155360418|NCT00307047|560753824|FG000|Overall Study|Withdrawal by Subject|6|||
155360419|NCT00307047|560753825|FG001|Overall Study|Withdrawal by Subject|6|||
155360420|NCT00307047|560753824|FG000|Overall Study|Physician Decision|1|||
155360421|NCT00307047|560753825|FG001|Overall Study|Physician Decision|2|||
155360422|NCT00307047|560753824|FG000|Overall Study|Lost to follow-up for other reasons|0|||
155360423|NCT00307047|560753825|FG001|Overall Study|Lost to follow-up for other reasons|1|||
155360424|NCT00307047|560753824|FG000|Overall Study|All death, all MI, all Revascularization|27|||
155360425|NCT00307047|560753825|FG001|Overall Study|All death, all MI, all Revascularization|16|||
155427409|NCT05224258|560991814|FG000|Overall Study|Adverse Event|0|||
155427410|NCT05224258|560991815|FG001|Overall Study|Adverse Event|1|||
155427411|NCT05224258|560991814|FG000|Overall Study|Protocol Deviation|0|||
155427412|NCT05224258|560991815|FG001|Overall Study|Protocol Deviation|1|||
155427413|NCT03615222|560991824|FG000|Overall Study|Ineligible|26|||
155427414|NCT03615222|560991824|FG000|Overall Study|Withdrawal by Subject|7|||
155427415|NCT03615222|560991824|FG000|Overall Study|Death|1|||
155360426|NCT00379769|560753826|FG000|Main Study|Death|57|||
155360427|NCT00379769|560753827|FG001|Main Study|Death|67|||
155360428|NCT00379769|560753828|FG002|Main Study|Death|54|||
155360429|NCT00379769|560753829|FG003|Main Study|Death|72|||
155360430|NCT00379769|560753830|FG004|Main Study|Death|0|||
155427416|NCT01552057|560991825|FG000|Overall Study|Adverse Event|14|||
155427417|NCT01552057|560991826|FG001|Overall Study|Adverse Event|15|||
155360431|NCT00379769|560753831|FG005|Main Study|Death|0|||
155360432|NCT00379769|560753826|FG000|Main Study|Adverse Event|5|||
155360433|NCT00379769|560753827|FG001|Main Study|Adverse Event|8|||
155360434|NCT00379769|560753828|FG002|Main Study|Adverse Event|10|||
155360435|NCT00379769|560753829|FG003|Main Study|Adverse Event|11|||
155427418|NCT01552057|560991825|FG000|Overall Study|Lack of Efficacy|8|||
155427419|NCT01552057|560991826|FG001|Overall Study|Lack of Efficacy|23|||
155427420|NCT01552057|560991825|FG000|Overall Study|Withdrawal by Subject|5|||
155360436|NCT00379769|560753830|FG004|Main Study|Adverse Event|0|||
155360437|NCT00379769|560753831|FG005|Main Study|Adverse Event|0|||
155360438|NCT00379769|560753826|FG000|Main Study|Lost to Follow-up|29|||
155360439|NCT00379769|560753827|FG001|Main Study|Lost to Follow-up|29|||
155360440|NCT00379769|560753828|FG002|Main Study|Lost to Follow-up|25|||
155360441|NCT00379769|560753829|FG003|Main Study|Lost to Follow-up|26|||
155360442|NCT00379769|560753830|FG004|Main Study|Lost to Follow-up|0|||
155360443|NCT00379769|560753831|FG005|Main Study|Lost to Follow-up|0|||
155360444|NCT00379769|560753826|FG000|Main Study|Withdrawal by Subject|46|||
155360445|NCT00379769|560753827|FG001|Main Study|Withdrawal by Subject|56|||
155360446|NCT00379769|560753828|FG002|Main Study|Withdrawal by Subject|72|||
155360447|NCT00379769|560753829|FG003|Main Study|Withdrawal by Subject|70|||
155360448|NCT00379769|560753830|FG004|Main Study|Withdrawal by Subject|0|||
155360449|NCT00379769|560753831|FG005|Main Study|Withdrawal by Subject|0|||
155360450|NCT00379769|560753826|FG000|Main Study|Moved to survival status follow-up only|27|||
155360451|NCT00379769|560753827|FG001|Main Study|Moved to survival status follow-up only|25|||
155360452|NCT00379769|560753828|FG002|Main Study|Moved to survival status follow-up only|32|||
155360453|NCT00379769|560753829|FG003|Main Study|Moved to survival status follow-up only|36|||
155360454|NCT00379769|560753830|FG004|Main Study|Moved to survival status follow-up only|0|||
155360455|NCT00379769|560753831|FG005|Main Study|Moved to survival status follow-up only|0|||
155360456|NCT00379769|560753826|FG000|Main Study|Participant moved|3|||
155427421|NCT01552057|560991826|FG001|Overall Study|Withdrawal by Subject|8|||
155427422|NCT01552057|560991825|FG000|Overall Study|Entry Criteria Not Met|2|||
155427423|NCT01552057|560991826|FG001|Overall Study|Entry Criteria Not Met|2|||
155427424|NCT01552057|560991825|FG000|Overall Study|Physician Decision|1|||
155427425|NCT01552057|560991826|FG001|Overall Study|Physician Decision|0|||
155427426|NCT04572633|560991827|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
155427427|NCT03480802|560991828|FG000|Overall Study|Lost to Follow-up|5|||
155427428|NCT03480802|560991829|FG001|Overall Study|Lost to Follow-up|1|||
155427429|NCT03480802|560991828|FG000|Overall Study|Withdrawal by Subject|2|||
155427430|NCT03480802|560991829|FG001|Overall Study|Withdrawal by Subject|1|||
155427431|NCT03480802|560991828|FG000|Overall Study|Relocated|0|||
155427432|NCT03480802|560991829|FG001|Overall Study|Relocated|1|||
155427433|NCT04439266|560991832|FG000|Overall Study|Ineligible|1|||
155360457|NCT00379769|560753827|FG001|Main Study|Participant moved|2|||
155360458|NCT00379769|560753828|FG002|Main Study|Participant moved|3|||
155360459|NCT00379769|560753829|FG003|Main Study|Participant moved|3|||
155427434|NCT04439266|560991832|FG000|Overall Study|Adverse Event|1|||
155427435|NCT04439266|560991832|FG000|Overall Study|Death|1|||
155427436|NCT04439266|560991832|FG000|Overall Study|Disease progression|1|||
155427437|NCT04439266|560991832|FG000|Overall Study|Still on treatment|1|||
155360460|NCT00379769|560753830|FG004|Main Study|Participant moved|0|||
155360461|NCT00379769|560753831|FG005|Main Study|Participant moved|0|||
155360462|NCT00379769|560753826|FG000|Main Study|Poor compliance|3|||
155360463|NCT00379769|560753827|FG001|Main Study|Poor compliance|2|||
155360464|NCT00379769|560753828|FG002|Main Study|Poor compliance|2|||
155360465|NCT00379769|560753829|FG003|Main Study|Poor compliance|1|||
155360466|NCT00379769|560753830|FG004|Main Study|Poor compliance|0|||
155360467|NCT00379769|560753831|FG005|Main Study|Poor compliance|0|||
155360468|NCT00379769|560753826|FG000|Main Study|Prohibited glucose lowering medication|0|||
155360469|NCT00379769|560753827|FG001|Main Study|Prohibited glucose lowering medication|3|||
155360470|NCT00379769|560753828|FG002|Main Study|Prohibited glucose lowering medication|0|||
155360471|NCT00379769|560753829|FG003|Main Study|Prohibited glucose lowering medication|1|||
155360472|NCT00379769|560753830|FG004|Main Study|Prohibited glucose lowering medication|0|||
155360473|NCT00379769|560753831|FG005|Main Study|Prohibited glucose lowering medication|0|||
155360474|NCT00379769|560753826|FG000|Main Study|Site closed|4|||
155360475|NCT00379769|560753827|FG001|Main Study|Site closed|4|||
155360476|NCT00379769|560753828|FG002|Main Study|Site closed|4|||
155360477|NCT00379769|560753829|FG003|Main Study|Site closed|8|||
155360478|NCT00379769|560753830|FG004|Main Study|Site closed|0|||
155360479|NCT00379769|560753831|FG005|Main Study|Site closed|0|||
155360480|NCT00379769|560753826|FG000|Main Study|Entry criteria violation|0|||
155360481|NCT00379769|560753827|FG001|Main Study|Entry criteria violation|0|||
155360482|NCT00379769|560753828|FG002|Main Study|Entry criteria violation|1|||
155360483|NCT00379769|560753829|FG003|Main Study|Entry criteria violation|1|||
155360484|NCT00379769|560753830|FG004|Main Study|Entry criteria violation|0|||
155360485|NCT00379769|560753831|FG005|Main Study|Entry criteria violation|0|||
155360486|NCT00379769|560753826|FG000|Main Study|Participant did not take study drug|0|||
155360487|NCT00379769|560753827|FG001|Main Study|Participant did not take study drug|0|||
155360488|NCT00379769|560753828|FG002|Main Study|Participant did not take study drug|1|||
155360489|NCT00379769|560753829|FG003|Main Study|Participant did not take study drug|0|||
155360490|NCT00379769|560753830|FG004|Main Study|Participant did not take study drug|0|||
155360491|NCT00379769|560753831|FG005|Main Study|Participant did not take study drug|0|||
155360492|NCT00379769|560753826|FG000|Main Study|Physician Decision|2|||
155360493|NCT00379769|560753827|FG001|Main Study|Physician Decision|2|||
155360494|NCT00379769|560753828|FG002|Main Study|Physician Decision|1|||
155360495|NCT00379769|560753829|FG003|Main Study|Physician Decision|1|||
155360496|NCT00379769|560753830|FG004|Main Study|Physician Decision|0|||
155360497|NCT00379769|560753831|FG005|Main Study|Physician Decision|0|||
155360498|NCT00379769|560753826|FG000|Main Study|Participant completed study at visit 27|1|||
155360499|NCT00379769|560753827|FG001|Main Study|Participant completed study at visit 27|0|||
155360500|NCT00379769|560753828|FG002|Main Study|Participant completed study at visit 27|0|||
155360501|NCT00379769|560753829|FG003|Main Study|Participant completed study at visit 27|0|||
155360502|NCT00379769|560753830|FG004|Main Study|Participant completed study at visit 27|0|||
155360503|NCT00379769|560753831|FG005|Main Study|Participant completed study at visit 27|0|||
155360504|NCT00379769|560753826|FG000|Main Study|Personal reasons|1|||
155360505|NCT00379769|560753827|FG001|Main Study|Personal reasons|0|||
155360506|NCT00379769|560753828|FG002|Main Study|Personal reasons|0|||
155360507|NCT00379769|560753829|FG003|Main Study|Personal reasons|0|||
155360508|NCT00379769|560753830|FG004|Main Study|Personal reasons|0|||
155360509|NCT00379769|560753831|FG005|Main Study|Personal reasons|0|||
155360510|NCT00379769|560753826|FG000|Main Study|Risk of heart failure|0|||
155360511|NCT00379769|560753827|FG001|Main Study|Risk of heart failure|1|||
155360512|NCT00379769|560753828|FG002|Main Study|Risk of heart failure|0|||
155360513|NCT00379769|560753829|FG003|Main Study|Risk of heart failure|0|||
155360514|NCT00379769|560753830|FG004|Main Study|Risk of heart failure|0|||
155360515|NCT00379769|560753831|FG005|Main Study|Risk of heart failure|0|||
155360516|NCT00379769|560753826|FG000|Main Study|Investigator refused to log temperature|0|||
155360517|NCT00379769|560753827|FG001|Main Study|Investigator refused to log temperature|0|||
155360518|NCT00379769|560753828|FG002|Main Study|Investigator refused to log temperature|1|||
155360519|NCT00379769|560753829|FG003|Main Study|Investigator refused to log temperature|0|||
155360520|NCT00379769|560753830|FG004|Main Study|Investigator refused to log temperature|0|||
155360521|NCT00379769|560753831|FG005|Main Study|Investigator refused to log temperature|0|||
155360522|NCT00379769|560753826|FG000|Main Study|Reason unspecified|0|||
155360523|NCT00379769|560753827|FG001|Main Study|Reason unspecified|0|||
155360524|NCT00379769|560753828|FG002|Main Study|Reason unspecified|1|||
155360525|NCT00379769|560753829|FG003|Main Study|Reason unspecified|0|||
155360526|NCT00379769|560753830|FG004|Main Study|Reason unspecified|0|||
155360527|NCT00379769|560753831|FG005|Main Study|Reason unspecified|0|||
155360528|NCT00379769|560753826|FG000|Observational Follow-up|Death|0|||
155360529|NCT00379769|560753827|FG001|Observational Follow-up|Death|0|||
155360530|NCT00379769|560753828|FG002|Observational Follow-up|Death|0|||
155360531|NCT00379769|560753829|FG003|Observational Follow-up|Death|0|||
155360532|NCT00379769|560753830|FG004|Observational Follow-up|Death|78|||
155360533|NCT00379769|560753831|FG005|Observational Follow-up|Death|70|||
155360534|NCT00379769|560753826|FG000|Observational Follow-up|Adverse Event|0|||
155360535|NCT00379769|560753827|FG001|Observational Follow-up|Adverse Event|0|||
155360536|NCT00379769|560753828|FG002|Observational Follow-up|Adverse Event|0|||
155360537|NCT00379769|560753829|FG003|Observational Follow-up|Adverse Event|0|||
155360538|NCT00379769|560753830|FG004|Observational Follow-up|Adverse Event|1|||
155360539|NCT00379769|560753831|FG005|Observational Follow-up|Adverse Event|0|||
155360540|NCT00379769|560753826|FG000|Observational Follow-up|Lost to Follow-up|0|||
155427438|NCT06161012|560991834|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155427439|NCT06161012|560991835|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
155427440|NCT00408005|560991836|FG000|Induction|Adverse Event|19|||
155427441|NCT00408005|560991837|FG001|Induction|Adverse Event|3|||
155427442|NCT00408005|560991838|FG002|Induction|Adverse Event|0|||
155427443|NCT00408005|560991839|FG003|Induction|Adverse Event|0|||
155427444|NCT00408005|560991840|FG004|Induction|Adverse Event|0|||
155427445|NCT00408005|560991841|FG005|Induction|Adverse Event|0|||
155427446|NCT00408005|560991842|FG006|Induction|Adverse Event|0|||
155427447|NCT00408005|560991843|FG007|Induction|Adverse Event|0|||
155427448|NCT00408005|560991836|FG000|Induction|Death|6|||
155427449|NCT00408005|560991837|FG001|Induction|Death|0|||
155427450|NCT00408005|560991838|FG002|Induction|Death|0|||
155427451|NCT00408005|560991839|FG003|Induction|Death|0|||
155427452|NCT00408005|560991840|FG004|Induction|Death|0|||
155427453|NCT00408005|560991841|FG005|Induction|Death|0|||
155427454|NCT00408005|560991842|FG006|Induction|Death|0|||
155427455|NCT00408005|560991843|FG007|Induction|Death|0|||
155427456|NCT00408005|560991836|FG000|Induction|Physician Decision|83|||
155427457|NCT00408005|560991837|FG001|Induction|Physician Decision|9|||
155427458|NCT00408005|560991838|FG002|Induction|Physician Decision|0|||
155427459|NCT00408005|560991839|FG003|Induction|Physician Decision|0|||
155360541|NCT00379769|560753827|FG001|Observational Follow-up|Lost to Follow-up|0|||
155360542|NCT00379769|560753828|FG002|Observational Follow-up|Lost to Follow-up|0|||
155360543|NCT00379769|560753829|FG003|Observational Follow-up|Lost to Follow-up|0|||
155360544|NCT00379769|560753830|FG004|Observational Follow-up|Lost to Follow-up|25|||
155360545|NCT00379769|560753831|FG005|Observational Follow-up|Lost to Follow-up|27|||
155360546|NCT00379769|560753826|FG000|Observational Follow-up|Withdrawal by Subject|0|||
155427460|NCT00408005|560991840|FG004|Induction|Physician Decision|0|||
155427461|NCT00408005|560991841|FG005|Induction|Physician Decision|0|||
155427462|NCT00408005|560991842|FG006|Induction|Physician Decision|0|||
155427463|NCT00408005|560991843|FG007|Induction|Physician Decision|0|||
155427464|NCT00408005|560991836|FG000|Induction|Withdrawal by Subject|2|||
155427465|NCT00408005|560991837|FG001|Induction|Withdrawal by Subject|4|||
155648965|NCT04518410|561805946|FG012|Overall Study|Withdrawal by Subject|2|||
155648966|NCT04518410|561805947|FG013|Overall Study|Withdrawal by Subject|13|||
155648967|NCT04518410|561805948|FG014|Overall Study|Withdrawal by Subject|4|||
155648968|NCT04518410|561805949|FG015|Overall Study|Withdrawal by Subject|9|||
155648969|NCT04518410|561805950|FG016|Overall Study|Withdrawal by Subject|0|||
155648970|NCT04518410|561805951|FG017|Overall Study|Withdrawal by Subject|15|||
155360547|NCT00379769|560753827|FG001|Observational Follow-up|Withdrawal by Subject|0|||
155360548|NCT00379769|560753828|FG002|Observational Follow-up|Withdrawal by Subject|0|||
155360549|NCT00379769|560753829|FG003|Observational Follow-up|Withdrawal by Subject|0|||
155360550|NCT00379769|560753830|FG004|Observational Follow-up|Withdrawal by Subject|12|||
155360551|NCT00379769|560753831|FG005|Observational Follow-up|Withdrawal by Subject|12|||
155360552|NCT00379769|560753826|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360553|NCT00379769|560753827|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360554|NCT00379769|560753828|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360555|NCT00379769|560753829|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360556|NCT00379769|560753830|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
155360557|NCT00379769|560753831|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
155360558|NCT00379769|560753826|FG000|Observational Follow-up|Physician Decision|0|||
155360559|NCT00379769|560753827|FG001|Observational Follow-up|Physician Decision|0|||
155360560|NCT00379769|560753828|FG002|Observational Follow-up|Physician Decision|0|||
155360561|NCT00379769|560753829|FG003|Observational Follow-up|Physician Decision|0|||
155360562|NCT00379769|560753830|FG004|Observational Follow-up|Physician Decision|8|||
155360563|NCT00379769|560753831|FG005|Observational Follow-up|Physician Decision|8|||
155360564|NCT00379769|560753826|FG000|Observational Follow-up|Site Closed Early|0|||
155360565|NCT00379769|560753827|FG001|Observational Follow-up|Site Closed Early|0|||
155360566|NCT00379769|560753828|FG002|Observational Follow-up|Site Closed Early|0|||
155360567|NCT00379769|560753829|FG003|Observational Follow-up|Site Closed Early|0|||
155360568|NCT00379769|560753830|FG004|Observational Follow-up|Site Closed Early|6|||
155360569|NCT00379769|560753831|FG005|Observational Follow-up|Site Closed Early|7|||
155360570|NCT00379769|560753826|FG000|Observational Follow-up|Participant Moved|0|||
155360571|NCT00379769|560753827|FG001|Observational Follow-up|Participant Moved|0|||
155360572|NCT00379769|560753828|FG002|Observational Follow-up|Participant Moved|0|||
155360573|NCT00379769|560753829|FG003|Observational Follow-up|Participant Moved|0|||
155360574|NCT00379769|560753830|FG004|Observational Follow-up|Participant Moved|0|||
155360575|NCT00379769|560753831|FG005|Observational Follow-up|Participant Moved|1|||
155360576|NCT00379769|560753826|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360577|NCT00379769|560753827|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
155648971|NCT04518410|561805952|FG018|Overall Study|Withdrawal by Subject|12|||
155360578|NCT00379769|560753828|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360579|NCT00379769|560753829|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360580|NCT00379769|560753830|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
155360581|NCT00379769|560753831|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
155360582|NCT02825251|560753832|FG000|Overall Study|Adverse Event|0|||
155360583|NCT02825251|560753833|FG001|Overall Study|Adverse Event|1|||
155360584|NCT02825251|560753832|FG000|Overall Study|Lost to Follow-up|0|||
155648972|NCT04518410|561805953|FG019|Overall Study|Withdrawal by Subject|9|||
155360585|NCT02825251|560753833|FG001|Overall Study|Lost to Follow-up|1|||
155360586|NCT02825251|560753832|FG000|Overall Study|Withdrawal by Subject|1|||
155360587|NCT02825251|560753833|FG001|Overall Study|Withdrawal by Subject|4|||
155360588|NCT02825251|560753832|FG000|Overall Study|Unclassified|2|||
155648973|NCT04518410|561805954|FG020|Overall Study|Withdrawal by Subject|14|||
155360589|NCT02825251|560753833|FG001|Overall Study|Unclassified|0|||
155360590|NCT01689363|560753840|FG000|Overall Study|Protocol Violation|0|||
155360591|NCT01689363|560753841|FG001|Overall Study|Protocol Violation|1|||
155360592|NCT01689363|560753842|FG002|Overall Study|Protocol Violation|0|||
155360593|NCT01689363|560753843|FG003|Overall Study|Protocol Violation|0|||
155360594|NCT01689363|560753844|FG004|Overall Study|Protocol Violation|0|||
155360595|NCT01689363|560753845|FG005|Overall Study|Protocol Violation|0|||
155360596|NCT01689363|560753846|FG006|Overall Study|Protocol Violation|0|||
155360597|NCT01689363|560753847|FG007|Overall Study|Protocol Violation|0|||
155360598|NCT00321685|560753848|FG000|Overall Study|Adverse Event|18|||
155507212|NCT00579254|561283581|FG000|Overall Study|Discontinued when study terminated|73|||
155507213|NCT02557672|561283582|FG000|Overall Study|Withdrawal by Subject|4|||
155507214|NCT02557672|561283583|FG001|Overall Study|Withdrawal by Subject|2|||
155360599|NCT00321685|560753848|FG000|Overall Study|Death|2|||
155507215|NCT03705169|561283584|FG000|Overall Study|Lost to Follow-up|0|||
155360600|NCT00321685|560753848|FG000|Overall Study|Withdrawal by Subject|8|||
155360601|NCT00321685|560753848|FG000|Overall Study|Alternative therapy|1|||
155360602|NCT00321685|560753848|FG000|Overall Study|Complicating disese|1|||
155360603|NCT00321685|560753848|FG000|Overall Study|Other|5|||
155360604|NCT00321685|560753848|FG000|Overall Study|Not start protocol therapy|2|||
155360605|NCT00321685|560753848|FG000|Overall Study|Ineligible|2|||
155360606|NCT05064488|560753852|FG000|Overall Study|Withdrawal by Subject|2|||
155360607|NCT05064488|560753853|FG001|Overall Study|Withdrawal by Subject|0|||
155360608|NCT03023722|560753854|FG000|Overall Study|No follow-up assessment|4|||
155648974|NCT04518410|561805955|FG021|Overall Study|Withdrawal by Subject|3|||
155648975|NCT04518410|561805956|FG022|Overall Study|Withdrawal by Subject|2|||
155648976|NCT04518410|561805957|FG023|Overall Study|Withdrawal by Subject|9|||
155648977|NCT04518410|561805958|FG024|Overall Study|Withdrawal by Subject|8|||
155648978|NCT04518410|561805934|FG000|Overall Study|Other|1|||
155648979|NCT04518410|561805935|FG001|Overall Study|Other|0|||
155648980|NCT04518410|561805936|FG002|Overall Study|Other|0|||
155648981|NCT04518410|561805937|FG003|Overall Study|Other|1|||
155648982|NCT04518410|561805938|FG004|Overall Study|Other|6|||
155648983|NCT04518410|561805939|FG005|Overall Study|Other|6|||
155648984|NCT04518410|561805940|FG006|Overall Study|Other|5|||
155648985|NCT04518410|561805941|FG007|Overall Study|Other|2|||
155648986|NCT04518410|561805942|FG008|Overall Study|Other|0|||
155648987|NCT04518410|561805943|FG009|Overall Study|Other|1|||
155648988|NCT04518410|561805944|FG010|Overall Study|Other|0|||
155648989|NCT04518410|561805945|FG011|Overall Study|Other|2|||
155648990|NCT04518410|561805946|FG012|Overall Study|Other|0|||
155648991|NCT04518410|561805947|FG013|Overall Study|Other|0|||
155648992|NCT04518410|561805948|FG014|Overall Study|Other|0|||
155648993|NCT04518410|561805949|FG015|Overall Study|Other|3|||
155648994|NCT04518410|561805950|FG016|Overall Study|Other|1|||
155648995|NCT04518410|561805951|FG017|Overall Study|Other|1|||
155648996|NCT04518410|561805952|FG018|Overall Study|Other|1|||
155648997|NCT04518410|561805953|FG019|Overall Study|Other|0|||
155648998|NCT04518410|561805954|FG020|Overall Study|Other|1|||
155648999|NCT04518410|561805955|FG021|Overall Study|Other|0|||
155649000|NCT04518410|561805956|FG022|Overall Study|Other|1|||
155360609|NCT00590564|560753855|FG000|Overall Study|Withdrawal by Subject|4|||
155360610|NCT00590564|560753855|FG000|Overall Study|Lost to Follow-up|6|||
155360611|NCT00590564|560753855|FG000|Overall Study|Protocol Violation|1|||
155360612|NCT00590564|560753855|FG000|Overall Study|Patient Found to be Ineligible|1|||
155360613|NCT00590564|560753855|FG000|Overall Study|Patient Non-compliance|6|||
155649001|NCT04518410|561805957|FG023|Overall Study|Other|2|||
155649002|NCT04518410|561805958|FG024|Overall Study|Other|2|||
155649003|NCT04518410|561805934|FG000|Overall Study|Protocol Violation|0|||
155649004|NCT04518410|561805935|FG001|Overall Study|Protocol Violation|0|||
155360614|NCT02684123|560753857|FG000|Phase 1|Lack of Efficacy|5|||
155360615|NCT02684123|560753858|FG001|Phase 1|Lack of Efficacy|0|||
155360616|NCT02684123|560753857|FG000|Phase 1|Adverse Event|3|||
155649005|NCT04518410|561805936|FG002|Overall Study|Protocol Violation|0|||
155649006|NCT04518410|561805937|FG003|Overall Study|Protocol Violation|2|||
155360617|NCT02684123|560753858|FG001|Phase 1|Adverse Event|0|||
155649007|NCT04518410|561805938|FG004|Overall Study|Protocol Violation|17|||
155649008|NCT04518410|561805939|FG005|Overall Study|Protocol Violation|1|||
155649009|NCT04518410|561805940|FG006|Overall Study|Protocol Violation|2|||
155649010|NCT04518410|561805941|FG007|Overall Study|Protocol Violation|1|||
155360618|NCT02684123|560753857|FG000|Phase 1|Lost to Follow-up|0|||
155360619|NCT02684123|560753858|FG001|Phase 1|Lost to Follow-up|1|||
155360620|NCT02684123|560753857|FG000|Phase 2|Lack of Efficacy|1|||
155360621|NCT02684123|560753858|FG001|Phase 2|Lack of Efficacy|8|||
155360622|NCT02037477|560753861|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360623|NCT02037477|560753862|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360624|NCT02037477|560753863|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
155360625|NCT02037477|560753864|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360626|NCT01245140|560753865|FG000|Overall Study|Adverse Event|1|||
155360627|NCT01245140|560753866|FG001|Overall Study|Adverse Event|3|||
155360628|NCT01245140|560753865|FG000|Overall Study|Lack of Efficacy|2|||
155360629|NCT01245140|560753866|FG001|Overall Study|Lack of Efficacy|4|||
155360630|NCT01245140|560753865|FG000|Overall Study|Protocol Violation|0|||
155360631|NCT01245140|560753866|FG001|Overall Study|Protocol Violation|1|||
155360632|NCT01245140|560753865|FG000|Overall Study|Withdrawal by Subject|0|||
155360633|NCT01245140|560753866|FG001|Overall Study|Withdrawal by Subject|1|||
155360634|NCT01245140|560753865|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
155360635|NCT01245140|560753866|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
155360636|NCT02635360|560753867|FG000|Overall Study|Adverse Event|0|||
155360637|NCT02635360|560753868|FG001|Overall Study|Adverse Event|3|||
155360638|NCT02635360|560753867|FG000|Overall Study|Withdrawal by Subject|2|||
155360639|NCT02635360|560753868|FG001|Overall Study|Withdrawal by Subject|0|||
155360640|NCT02635360|560753867|FG000|Overall Study|Non-Compliance|3|||
155360641|NCT02635360|560753868|FG001|Overall Study|Non-Compliance|1|||
155360642|NCT02635360|560753867|FG000|Overall Study|Disease Progression|0|||
155360643|NCT02635360|560753868|FG001|Overall Study|Disease Progression|2|||
155360644|NCT02635360|560753867|FG000|Overall Study|Lost to Follow-up|1|||
155360645|NCT02635360|560753868|FG001|Overall Study|Lost to Follow-up|1|||
155360646|NCT04082429|560753869|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360647|NCT04082429|560753870|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360648|NCT04082429|560753871|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360649|NCT04082429|560753872|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360650|NCT04082429|560753873|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
155360651|NCT04082429|560753874|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360652|NCT04082429|560753875|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360653|NCT04082429|560753876|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360654|NCT04082429|560753877|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360655|NCT04082429|560753869|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360656|NCT04082429|560753870|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360657|NCT04082429|560753871|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360658|NCT04082429|560753872|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360659|NCT04082429|560753873|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
155360660|NCT04082429|560753874|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360661|NCT04082429|560753875|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360662|NCT04082429|560753876|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360663|NCT04082429|560753877|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360664|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Death|0|||
155360665|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Death|0|||
155360666|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Death|0|||
155360667|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Death|0|||
155360668|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Death|1|||
155360669|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Death|0|||
155507216|NCT03705169|561283585|FG001|Overall Study|Lost to Follow-up|0|||
155507217|NCT03705169|561283586|FG002|Overall Study|Lost to Follow-up|0|||
155507218|NCT03705169|561283587|FG003|Overall Study|Lost to Follow-up|2|||
155507219|NCT03705169|561283588|FG004|Overall Study|Lost to Follow-up|0|||
155507220|NCT03705169|561283589|FG005|Overall Study|Lost to Follow-up|2|||
155507221|NCT03705169|561283590|FG006|Overall Study|Lost to Follow-up|1|||
155507222|NCT03705169|561283591|FG007|Overall Study|Lost to Follow-up|0|||
155507223|NCT03705169|561283592|FG008|Overall Study|Lost to Follow-up|0|||
155507224|NCT03705169|561283593|FG009|Overall Study|Lost to Follow-up|1|||
155360670|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Death|0|||
155360671|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Death|0|||
155649011|NCT04518410|561805942|FG008|Overall Study|Protocol Violation|0|||
155360672|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Death|0|||
155360673|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360674|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360675|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360676|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
155507225|NCT03705169|561283584|FG000|Overall Study|Adverse Event|0|||
155360677|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360678|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
155360679|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360680|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360681|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360682|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360683|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360684|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360685|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360686|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360687|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360688|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360689|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360690|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
155360691|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
155360692|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360693|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360694|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360695|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360696|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
155360697|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360698|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360699|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360700|NCT04082429|560753869|FG000|Extension Part|Ongoing|0|||
155360701|NCT04082429|560753870|FG001|Extension Part|Ongoing|7|||
155360702|NCT04082429|560753871|FG002|Extension Part|Ongoing|17|||
155360703|NCT04082429|560753872|FG003|Extension Part|Ongoing|6|||
155360704|NCT04082429|560753873|FG004|Extension Part|Ongoing|45|||
155360705|NCT04082429|560753874|FG005|Extension Part|Ongoing|0|||
155360706|NCT04082429|560753875|FG006|Extension Part|Ongoing|10|||
155360707|NCT04082429|560753876|FG007|Extension Part|Ongoing|23|||
155360708|NCT04082429|560753877|FG008|Extension Part|Ongoing|25|||
155360709|NCT00334542|560753878|FG000|Overall Study|Adverse Event|3|||
155360710|NCT00334542|560753878|FG000|Overall Study|Withdrawal by Subject|1|||
155360711|NCT00334542|560753878|FG000|Overall Study|New cancer diagnosis|1|||
155360712|NCT03118050|560753879|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
155360713|NCT03118050|560753880|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360714|NCT03118050|560753881|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
155360715|NCT03118050|560753882|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360716|NCT03118050|560753883|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
155360717|NCT03118050|560753884|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
155360718|NCT03118050|560753885|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360719|NCT02125279|560753889|FG000|Overall Study|Lack of Efficacy|2|||
155360720|NCT02125279|560753889|FG000|Overall Study|Withdrawal by Subject|6|||
155360721|NCT02125279|560753889|FG000|Overall Study|Protocol Violation|1|||
155360722|NCT02125279|560753889|FG000|Overall Study|Lost to Follow-up|4|||
155360723|NCT01607879|560753890|FG000|Overall Study|Death|1|||
155360724|NCT01607879|560753891|FG001|Overall Study|Death|0|||
155360725|NCT03845140|560753892|FG000|Overall Study|Participant travelled outside study area|0|||
155360726|NCT03845140|560753893|FG001|Overall Study|Participant travelled outside study area|1|||
155360727|NCT03845140|560753894|FG002|Overall Study|Participant travelled outside study area|0|||
155360728|NCT03845140|560753895|FG003|Overall Study|Participant travelled outside study area|0|||
155360729|NCT03845140|560753896|FG004|Overall Study|Participant travelled outside study area|0|||
155360730|NCT03845140|560753897|FG005|Overall Study|Participant travelled outside study area|0|||
155360731|NCT01592045|560753900|FG000|Overall Study|Disease Progression|1|||
155360732|NCT01592045|560753901|FG001|Overall Study|Disease Progression|1|||
155360733|NCT01592045|560753900|FG000|Overall Study|Adverse Event|1|||
155360734|NCT01592045|560753901|FG001|Overall Study|Adverse Event|1|||
155427466|NCT00408005|560991838|FG002|Induction|Withdrawal by Subject|0|||
155427467|NCT00408005|560991839|FG003|Induction|Withdrawal by Subject|0|||
155427468|NCT00408005|560991840|FG004|Induction|Withdrawal by Subject|0|||
155427469|NCT00408005|560991841|FG005|Induction|Withdrawal by Subject|0|||
155427470|NCT00408005|560991842|FG006|Induction|Withdrawal by Subject|0|||
155427471|NCT00408005|560991843|FG007|Induction|Withdrawal by Subject|0|||
155427472|NCT00408005|560991836|FG000|Induction|Ineligible|33|||
155427473|NCT00408005|560991837|FG001|Induction|Ineligible|14|||
155427474|NCT00408005|560991838|FG002|Induction|Ineligible|0|||
155427475|NCT00408005|560991839|FG003|Induction|Ineligible|0|||
155427476|NCT00408005|560991840|FG004|Induction|Ineligible|0|||
155360735|NCT01592045|560753900|FG000|Overall Study|Withdrawal by Subject|1|||
155360736|NCT01592045|560753901|FG001|Overall Study|Withdrawal by Subject|0|||
155360737|NCT01592045|560753900|FG000|Overall Study|Moved out of country|2|||
155360738|NCT01592045|560753901|FG001|Overall Study|Moved out of country|0|||
155360739|NCT02472145|560753904|FG000|Overall Study|Death|10|||
155360740|NCT02472145|560753905|FG001|Overall Study|Death|101|||
155360741|NCT02472145|560753906|FG002|Overall Study|Death|99|||
155360742|NCT02472145|560753904|FG000|Overall Study|Lost to Follow-up|0|||
155360743|NCT02472145|560753905|FG001|Overall Study|Lost to Follow-up|1|||
155360744|NCT02472145|560753906|FG002|Overall Study|Lost to Follow-up|0|||
155360745|NCT02472145|560753904|FG000|Overall Study|Withdrawal by Subject|0|||
155360746|NCT02472145|560753905|FG001|Overall Study|Withdrawal by Subject|9|||
155360747|NCT02472145|560753906|FG002|Overall Study|Withdrawal by Subject|13|||
155360748|NCT02472145|560753904|FG000|Overall Study|Sponsor decision|0|||
155360749|NCT02472145|560753905|FG001|Overall Study|Sponsor decision|3|||
155360750|NCT02472145|560753906|FG002|Overall Study|Sponsor decision|2|||
155360751|NCT02472145|560753904|FG000|Overall Study|Other|0|||
155360752|NCT02472145|560753905|FG001|Overall Study|Other|45|||
155360753|NCT02472145|560753906|FG002|Overall Study|Other|43|||
155360754|NCT02049515|560753909|FG000|Overall Study|Adverse Event|46|||
155360755|NCT02049515|560753910|FG001|Overall Study|Adverse Event|2|||
155360756|NCT02049515|560753909|FG000|Overall Study|Protocol-specified Disease Progression|23|||
155360757|NCT02049515|560753910|FG001|Overall Study|Protocol-specified Disease Progression|2|||
155360758|NCT02049515|560753909|FG000|Overall Study|Death|6|||
155360759|NCT02049515|560753910|FG001|Overall Study|Death|0|||
155360760|NCT02049515|560753909|FG000|Overall Study|Physician Decision|5|||
155360761|NCT02049515|560753910|FG001|Overall Study|Physician Decision|1|||
155360762|NCT02049515|560753909|FG000|Overall Study|Withdrawal by Subject|3|||
155360763|NCT02049515|560753910|FG001|Overall Study|Withdrawal by Subject|0|||
155360764|NCT02049515|560753909|FG000|Overall Study|Termination of the Study by Sponsor|2|||
155360765|NCT02049515|560753910|FG001|Overall Study|Termination of the Study by Sponsor|0|||
155360766|NCT02049515|560753909|FG000|Overall Study|Protocol Violation|1|||
155360767|NCT02049515|560753910|FG001|Overall Study|Protocol Violation|1|||
155360768|NCT02049515|560753909|FG000|Overall Study|Clinical Deterioration|1|||
155360769|NCT02049515|560753910|FG001|Overall Study|Clinical Deterioration|0|||
155360770|NCT02049515|560753909|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
155360771|NCT02049515|560753910|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
155360772|NCT02049515|560753909|FG000|Overall Study|Treatment Interruption >42 Days|1|||
155360773|NCT02049515|560753910|FG001|Overall Study|Treatment Interruption >42 Days|0|||
155360774|NCT02049515|560753909|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
155360775|NCT02049515|560753910|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
155360776|NCT00825305|560753927|FG000|Overall Study|Adverse Event|1|||
155360777|NCT00825305|560753928|FG001|Overall Study|Adverse Event|1|||
155360778|NCT00825305|560753927|FG000|Overall Study|Withdrawal by Subject|6|||
155360779|NCT00825305|560753928|FG001|Overall Study|Withdrawal by Subject|12|||
155360780|NCT00825305|560753927|FG000|Overall Study|Inappropriate inclusion|1|||
155360781|NCT00825305|560753928|FG001|Overall Study|Inappropriate inclusion|0|||
155360782|NCT00825305|560753927|FG000|Overall Study|Protocol Violation|9|||
155360783|NCT00825305|560753928|FG001|Overall Study|Protocol Violation|9|||
155360784|NCT00825305|560753927|FG000|Overall Study|Can not be classified|0|||
155360785|NCT00825305|560753928|FG001|Overall Study|Can not be classified|1|||
155360786|NCT01850030|560753932|FG000|Overall Study|Adverse Event|64|||
155360787|NCT01850030|560753933|FG001|Overall Study|Adverse Event|82|||
155360788|NCT01850030|560753932|FG000|Overall Study|Lack of Efficacy|3|||
155360789|NCT01850030|560753933|FG001|Overall Study|Lack of Efficacy|1|||
155360790|NCT01850030|560753932|FG000|Overall Study|Lost to Follow-up|5|||
155360791|NCT01850030|560753933|FG001|Overall Study|Lost to Follow-up|5|||
155360792|NCT01850030|560753932|FG000|Overall Study|Withdrawal by Subject|3|||
155360793|NCT01850030|560753933|FG001|Overall Study|Withdrawal by Subject|4|||
155360794|NCT01850030|560753932|FG000|Overall Study|Protocol Violation|24|||
155360795|NCT01850030|560753933|FG001|Overall Study|Protocol Violation|28|||
155360796|NCT01850030|560753932|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
155427477|NCT00408005|560991841|FG005|Induction|Ineligible|0|||
155427478|NCT00408005|560991842|FG006|Induction|Ineligible|0|||
155427479|NCT00408005|560991843|FG007|Induction|Ineligible|0|||
155427480|NCT00408005|560991836|FG000|Induction|Refusal of Further Protocol Therapy|225|||
155427481|NCT00408005|560991837|FG001|Induction|Refusal of Further Protocol Therapy|44|||
155427482|NCT00408005|560991838|FG002|Induction|Refusal of Further Protocol Therapy|0|||
155427483|NCT00408005|560991839|FG003|Induction|Refusal of Further Protocol Therapy|0|||
155427484|NCT00408005|560991840|FG004|Induction|Refusal of Further Protocol Therapy|0|||
155427485|NCT00408005|560991841|FG005|Induction|Refusal of Further Protocol Therapy|0|||
155427486|NCT00408005|560991842|FG006|Induction|Refusal of Further Protocol Therapy|0|||
155427487|NCT00408005|560991843|FG007|Induction|Refusal of Further Protocol Therapy|0|||
155427488|NCT00408005|560991836|FG000|Induction|Entered another COG therapeutic protocol|4|||
155427489|NCT00408005|560991837|FG001|Induction|Entered another COG therapeutic protocol|0|||
155507226|NCT03705169|561283585|FG001|Overall Study|Adverse Event|0|||
155507227|NCT03705169|561283586|FG002|Overall Study|Adverse Event|0|||
155507228|NCT03705169|561283587|FG003|Overall Study|Adverse Event|1|||
155507229|NCT03705169|561283588|FG004|Overall Study|Adverse Event|0|||
155507230|NCT03705169|561283589|FG005|Overall Study|Adverse Event|0|||
155507231|NCT03705169|561283590|FG006|Overall Study|Adverse Event|0|||
155507232|NCT03705169|561283591|FG007|Overall Study|Adverse Event|0|||
155507233|NCT03705169|561283592|FG008|Overall Study|Adverse Event|0|||
155507234|NCT03705169|561283593|FG009|Overall Study|Adverse Event|0|||
155507235|NCT03705169|561283584|FG000|Overall Study|Site Closure|0|||
155507236|NCT03705169|561283585|FG001|Overall Study|Site Closure|0|||
155507237|NCT03705169|561283586|FG002|Overall Study|Site Closure|0|||
155507238|NCT03705169|561283587|FG003|Overall Study|Site Closure|1|||
155507239|NCT03705169|561283588|FG004|Overall Study|Site Closure|0|||
155507240|NCT03705169|561283589|FG005|Overall Study|Site Closure|0|||
155507241|NCT03705169|561283590|FG006|Overall Study|Site Closure|0|||
155507242|NCT03705169|561283591|FG007|Overall Study|Site Closure|0|||
155507243|NCT03705169|561283592|FG008|Overall Study|Site Closure|0|||
155507244|NCT03705169|561283593|FG009|Overall Study|Site Closure|0|||
155507245|NCT03705169|561283584|FG000|Overall Study|Did not receive study treatment|0|||
155507246|NCT03705169|561283585|FG001|Overall Study|Did not receive study treatment|0|||
155360797|NCT01850030|560753933|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
155360798|NCT00246090|560753934|FG000|Overall Study|Adverse Event|25|||
155360799|NCT00246090|560753934|FG000|Overall Study|Withdrawal by Subject|7|||
155360800|NCT00246090|560753934|FG000|Overall Study|Progressive Disease|212|||
155427490|NCT00408005|560991838|FG002|Induction|Entered another COG therapeutic protocol|0|||
155427491|NCT00408005|560991839|FG003|Induction|Entered another COG therapeutic protocol|0|||
155427492|NCT00408005|560991840|FG004|Induction|Entered another COG therapeutic protocol|0|||
155507247|NCT03705169|561283586|FG002|Overall Study|Did not receive study treatment|0|||
155360801|NCT00246090|560753934|FG000|Overall Study|Clinical Progression|30|||
155360802|NCT00246090|560753934|FG000|Overall Study|Physician Decision|11|||
155360803|NCT00246090|560753934|FG000|Overall Study|Not Otherwise Specified|10|||
155360804|NCT02554383|560753937|FG000|Overall Study|Ineligible|3|||
155360805|NCT02554383|560753938|FG001|Overall Study|Ineligible|2|||
155360806|NCT02554383|560753937|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
155360807|NCT02554383|560753938|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
155360808|NCT02554383|560753937|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
155360809|NCT02554383|560753938|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
155360810|NCT02554383|560753937|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
155360811|NCT02554383|560753938|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
155360812|NCT00715117|560753941|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
155427493|NCT00408005|560991841|FG005|Induction|Entered another COG therapeutic protocol|0|||
155427494|NCT00408005|560991842|FG006|Induction|Entered another COG therapeutic protocol|0|||
155507248|NCT03705169|561283587|FG003|Overall Study|Did not receive study treatment|1|||
155507249|NCT03705169|561283588|FG004|Overall Study|Did not receive study treatment|0|||
155507250|NCT03705169|561283589|FG005|Overall Study|Did not receive study treatment|0|||
155507251|NCT03705169|561283590|FG006|Overall Study|Did not receive study treatment|0|||
155507252|NCT03705169|561283591|FG007|Overall Study|Did not receive study treatment|0|||
155360813|NCT00715117|560753942|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
155360814|NCT02581059|560753946|FG000|Study Treatment|Disease Progression|1|||
155360815|NCT02581059|560753947|FG001|Study Treatment|Disease Progression|1|||
155360816|NCT02581059|560753946|FG000|Study Treatment|Adverse Event|2|||
155360817|NCT02581059|560753947|FG001|Study Treatment|Adverse Event|1|||
155360818|NCT02581059|560753946|FG000|Study Treatment|Death|1|||
155360819|NCT02581059|560753947|FG001|Study Treatment|Death|1|||
155360820|NCT02581059|560753946|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155360821|NCT02581059|560753947|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
155360822|NCT02581059|560753946|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
155360823|NCT02581059|560753947|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
155360824|NCT02581059|560753946|FG000|Follow up|Death|1|||
155360825|NCT02581059|560753947|FG001|Follow up|Death|3|||
155360826|NCT02581059|560753946|FG000|Follow up|study terminated|1|||
155360827|NCT02581059|560753947|FG001|Follow up|study terminated|1|||
155360828|NCT02581059|560753946|FG000|Follow up|screen failure|0|||
155360829|NCT02581059|560753947|FG001|Follow up|screen failure|1|||
155360830|NCT02581059|560753946|FG000|Follow up|Patient started new clinical trial|1|||
155360831|NCT02581059|560753947|FG001|Follow up|Patient started new clinical trial|0|||
155360832|NCT04590404|560753951|FG000|Overall Study|Death|16|||
155360833|NCT04590404|560753952|FG001|Overall Study|Death|17|||
155360834|NCT04590404|560753951|FG000|Overall Study|Withdrawal by Subject|7|||
155360835|NCT04590404|560753952|FG001|Overall Study|Withdrawal by Subject|2|||
155360836|NCT02394665|560753953|FG000|Overall Study|Physician Decision|1|||
155360837|NCT02394665|560753954|FG001|Overall Study|Physician Decision|0|||
155360838|NCT02394665|560753955|FG002|Overall Study|Physician Decision|0|||
155360839|NCT00569127|560753956|FG000|Overall Study|Adverse Event|57|||
155360840|NCT00569127|560753957|FG001|Overall Study|Adverse Event|47|||
155360841|NCT00569127|560753956|FG000|Overall Study|Withdrawal by Subject|13|||
155360842|NCT00569127|560753957|FG001|Overall Study|Withdrawal by Subject|27|||
155360843|NCT00569127|560753956|FG000|Overall Study|Progression|99|||
155360844|NCT00569127|560753957|FG001|Overall Study|Progression|100|||
155360845|NCT00569127|560753956|FG000|Overall Study|Death|4|||
155360846|NCT00569127|560753957|FG001|Overall Study|Death|3|||
155360847|NCT00569127|560753956|FG000|Overall Study|Other|20|||
155360848|NCT00569127|560753957|FG001|Overall Study|Other|19|||
155360849|NCT00569127|560753956|FG000|Overall Study|Lost to Follow-up|0|||
155360850|NCT00569127|560753957|FG001|Overall Study|Lost to Follow-up|3|||
155360851|NCT00569127|560753956|FG000|Overall Study|Not Eligible|14|||
155360852|NCT00569127|560753957|FG001|Overall Study|Not Eligible|11|||
155360853|NCT00569127|560753956|FG000|Overall Study|Still on Treatment|7|||
155360854|NCT00569127|560753957|FG001|Overall Study|Still on Treatment|3|||
155360855|NCT03149029|560753972|FG000|Overall Study|Adverse Event|2|||
155360856|NCT03149029|560753973|FG001|Overall Study|Adverse Event|0|||
155360857|NCT03735121|560753978|FG000|Overall Study|Death|3|||
155360858|NCT03735121|560753979|FG001|Overall Study|Death|6|||
155360859|NCT03735121|560753980|FG002|Overall Study|Death|19|||
155360860|NCT03735121|560753981|FG003|Overall Study|Death|97|||
155427495|NCT00408005|560991843|FG007|Induction|Entered another COG therapeutic protocol|0|||
155427496|NCT00408005|560991836|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
155360861|NCT03735121|560753982|FG004|Overall Study|Death|205|||
155360862|NCT03735121|560753978|FG000|Overall Study|Lost to Follow-up|0|||
155360863|NCT03735121|560753979|FG001|Overall Study|Lost to Follow-up|0|||
155360864|NCT03735121|560753980|FG002|Overall Study|Lost to Follow-up|0|||
155360865|NCT03735121|560753981|FG003|Overall Study|Lost to Follow-up|2|||
155360866|NCT03735121|560753982|FG004|Overall Study|Lost to Follow-up|3|||
155360867|NCT03735121|560753978|FG000|Overall Study|New Therapy|0|||
155360868|NCT03735121|560753979|FG001|Overall Study|New Therapy|1|||
155360869|NCT03735121|560753980|FG002|Overall Study|New Therapy|0|||
155360870|NCT03735121|560753981|FG003|Overall Study|New Therapy|0|||
155360871|NCT03735121|560753982|FG004|Overall Study|New Therapy|0|||
155360872|NCT03735121|560753978|FG000|Overall Study|Study Ended by Sponsor|1|||
155360873|NCT03735121|560753979|FG001|Overall Study|Study Ended by Sponsor|0|||
155360874|NCT03735121|560753980|FG002|Overall Study|Study Ended by Sponsor|1|||
155360875|NCT03735121|560753981|FG003|Overall Study|Study Ended by Sponsor|17|||
155360876|NCT03735121|560753982|FG004|Overall Study|Study Ended by Sponsor|28|||
155360877|NCT03735121|560753978|FG000|Overall Study|Withdrawal by Subject|1|||
155360878|NCT03735121|560753979|FG001|Overall Study|Withdrawal by Subject|1|||
155360879|NCT03735121|560753980|FG002|Overall Study|Withdrawal by Subject|6|||
155360880|NCT03735121|560753981|FG003|Overall Study|Withdrawal by Subject|8|||
155360881|NCT03735121|560753982|FG004|Overall Study|Withdrawal by Subject|11|||
155360882|NCT04750577|560753983|FG000|Overall Study|Adverse Event|2|||
155360883|NCT04750577|560753984|FG001|Overall Study|Adverse Event|10|||
155649012|NCT04518410|561805943|FG009|Overall Study|Protocol Violation|0|||
155649013|NCT04518410|561805944|FG010|Overall Study|Protocol Violation|0|||
155649014|NCT04518410|561805945|FG011|Overall Study|Protocol Violation|0|||
155649015|NCT04518410|561805946|FG012|Overall Study|Protocol Violation|0|||
155649016|NCT04518410|561805947|FG013|Overall Study|Protocol Violation|0|||
155360884|NCT04750577|560753985|FG002|Overall Study|Adverse Event|8|||
155360885|NCT04750577|560753986|FG003|Overall Study|Adverse Event|1|||
155360886|NCT04750577|560753983|FG000|Overall Study|Change of residence|0|||
155360887|NCT04750577|560753984|FG001|Overall Study|Change of residence|0|||
155360888|NCT04750577|560753985|FG002|Overall Study|Change of residence|1|||
155360889|NCT04750577|560753986|FG003|Overall Study|Change of residence|0|||
155360890|NCT04750577|560753983|FG000|Overall Study|Burden of study procedures|0|||
155360891|NCT04750577|560753984|FG001|Overall Study|Burden of study procedures|2|||
155360892|NCT04750577|560753985|FG002|Overall Study|Burden of study procedures|2|||
155360893|NCT04750577|560753986|FG003|Overall Study|Burden of study procedures|0|||
155360894|NCT04750577|560753983|FG000|Overall Study|Prematurely discontinued|0|||
155649017|NCT04518410|561805948|FG014|Overall Study|Protocol Violation|0|||
155649018|NCT04518410|561805949|FG015|Overall Study|Protocol Violation|0|||
155360895|NCT04750577|560753984|FG001|Overall Study|Prematurely discontinued|0|||
155649019|NCT04518410|561805950|FG016|Overall Study|Protocol Violation|1|||
155360896|NCT04750577|560753985|FG002|Overall Study|Prematurely discontinued|0|||
155360897|NCT04750577|560753986|FG003|Overall Study|Prematurely discontinued|2|||
155360898|NCT04750577|560753983|FG000|Overall Study|Protocol deviation|1|||
155360899|NCT04750577|560753984|FG001|Overall Study|Protocol deviation|1|||
155360900|NCT04750577|560753985|FG002|Overall Study|Protocol deviation|1|||
155360901|NCT04750577|560753986|FG003|Overall Study|Protocol deviation|1|||
155360902|NCT04750577|560753983|FG000|Overall Study|Other than listed|3|||
155360903|NCT04750577|560753984|FG001|Overall Study|Other than listed|2|||
155360904|NCT04750577|560753985|FG002|Overall Study|Other than listed|2|||
155360905|NCT04750577|560753986|FG003|Overall Study|Other than listed|1|||
155360906|NCT04750577|560753983|FG000|Overall Study|Not treated|0|||
155360907|NCT04750577|560753984|FG001|Overall Study|Not treated|0|||
155360908|NCT04750577|560753985|FG002|Overall Study|Not treated|0|||
155360909|NCT04750577|560753986|FG003|Overall Study|Not treated|2|||
155360910|NCT02473042|560753989|FG000|Overall Study|Withdrawal by Subject|1|||
155360911|NCT02473042|560753990|FG001|Overall Study|Withdrawal by Subject|0|||
155360912|NCT02473042|560753989|FG000|Overall Study|Patient became ineligible after enrollment|2|||
155360913|NCT02473042|560753990|FG001|Overall Study|Patient became ineligible after enrollment|5|||
155360914|NCT02473042|560753989|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
155360915|NCT02473042|560753990|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
155360916|NCT02473042|560753989|FG000|Overall Study|PACU data unable to be collected|3|||
155360917|NCT02473042|560753990|FG001|Overall Study|PACU data unable to be collected|0|||
155360918|NCT02037256|560753993|FG000|Overall Study|Protocol Violation|0|||
155360919|NCT02037256|560753994|FG001|Overall Study|Protocol Violation|1|||
155360920|NCT02037256|560753993|FG000|Overall Study|Withdrawn prior to Velcade|0|||
155360921|NCT02037256|560753994|FG001|Overall Study|Withdrawn prior to Velcade|2|||
155360922|NCT03007732|560753995|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
155360923|NCT03007732|560753996|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
155360924|NCT03007732|560753997|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
155360925|NCT03007732|560753998|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
155360926|NCT02386839|560754000|FG000|Overall Study|Death|1|||
155360927|NCT02386839|560754001|FG001|Overall Study|Death|0|||
155360928|NCT02386839|560754000|FG000|Overall Study|Withdrawal by Subject|9|||
155360929|NCT02386839|560754001|FG001|Overall Study|Withdrawal by Subject|10|||
155360930|NCT02386839|560754000|FG000|Overall Study|Lost to Follow-up|4|||
155360931|NCT02386839|560754001|FG001|Overall Study|Lost to Follow-up|4|||
155360932|NCT02386839|560754000|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
155360933|NCT02386839|560754001|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
155360934|NCT02386839|560754000|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
155360935|NCT02386839|560754001|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
155360936|NCT02386839|560754000|FG000|Overall Study|Other (unspecified)|1|||
155360937|NCT02386839|560754001|FG001|Overall Study|Other (unspecified)|0|||
155360938|NCT02101983|560754002|FG000|Overall Study|Physician Decision|1|||
155360939|NCT02101983|560754003|FG001|Overall Study|Physician Decision|0|||
155360940|NCT03725605|560754007|FG000|Overall Study|Unsuccessful TIL expansion|2|||
155360941|NCT01503086|560754008|FG000|Overall Study|Lost to Follow-up|0|||
155360942|NCT01503086|560754009|FG001|Overall Study|Lost to Follow-up|1|||
155360943|NCT01503086|560754010|FG002|Overall Study|Lost to Follow-up|0|||
155360944|NCT01503086|560754008|FG000|Overall Study|Did Not Start Treatment|4|||
155360945|NCT01503086|560754009|FG001|Overall Study|Did Not Start Treatment|3|||
155360946|NCT01503086|560754010|FG002|Overall Study|Did Not Start Treatment|3|||
155507253|NCT03705169|561283592|FG008|Overall Study|Did not receive study treatment|0|||
155360947|NCT01503086|560754008|FG000|Overall Study|Progressive disease|3|||
155360948|NCT01503086|560754009|FG001|Overall Study|Progressive disease|1|||
155360949|NCT01503086|560754010|FG002|Overall Study|Progressive disease|0|||
155649020|NCT04518410|561805951|FG017|Overall Study|Protocol Violation|1|||
155507254|NCT03705169|561283593|FG009|Overall Study|Did not receive study treatment|0|||
155507255|NCT03705169|561283584|FG000|Overall Study|Concerns about study visit compliance|0|||
155507256|NCT03705169|561283585|FG001|Overall Study|Concerns about study visit compliance|0|||
155507257|NCT03705169|561283586|FG002|Overall Study|Concerns about study visit compliance|0|||
155360950|NCT01503086|560754008|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
155360951|NCT01503086|560754009|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
155360952|NCT01503086|560754010|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
155360953|NCT01503086|560754008|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
155360954|NCT01503086|560754009|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
155360955|NCT01503086|560754010|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
155360956|NCT04021043|560755497|FG000|Overall Study|Adverse Event|3|||
155360957|NCT04021043|560755498|FG001|Overall Study|Adverse Event|1|||
155360958|NCT04021043|560755499|FG002|Overall Study|Adverse Event|1|||
155360959|NCT04021043|560755500|FG003|Overall Study|Adverse Event|0|||
155360960|NCT04021043|560755497|FG000|Overall Study|Death|2|||
155360961|NCT04021043|560755498|FG001|Overall Study|Death|3|||
155360962|NCT04021043|560755499|FG002|Overall Study|Death|1|||
155360963|NCT04021043|560755500|FG003|Overall Study|Death|3|||
155360964|NCT04021043|560755497|FG000|Overall Study|Withdrawal by Subject|1|||
155360965|NCT04021043|560755498|FG001|Overall Study|Withdrawal by Subject|1|||
155360966|NCT04021043|560755499|FG002|Overall Study|Withdrawal by Subject|1|||
155360967|NCT04021043|560755500|FG003|Overall Study|Withdrawal by Subject|6|||
155360968|NCT04021043|560755497|FG000|Overall Study|Discontinued due to disease progression|4|||
155360969|NCT04021043|560755498|FG001|Overall Study|Discontinued due to disease progression|5|||
155360970|NCT04021043|560755499|FG002|Overall Study|Discontinued due to disease progression|7|||
155360971|NCT04021043|560755500|FG003|Overall Study|Discontinued due to disease progression|10|||
155360972|NCT00826228|560755501|FG000|Overall Study|Withdrawal by Subject|1|||
155360973|NCT01246999|560755502|FG000|Overall Study|Lost to Follow-up|0|||
155360974|NCT01246999|560755503|FG001|Overall Study|Lost to Follow-up|1|||
155360975|NCT01246999|560755504|FG002|Overall Study|Lost to Follow-up|0|||
155360976|NCT01246999|560755505|FG003|Overall Study|Lost to Follow-up|0|||
155360977|NCT01246999|560755502|FG000|Overall Study|Withdrawal by Subject|0|||
155360978|NCT01246999|560755503|FG001|Overall Study|Withdrawal by Subject|0|||
155360979|NCT01246999|560755504|FG002|Overall Study|Withdrawal by Subject|0|||
155360980|NCT01246999|560755505|FG003|Overall Study|Withdrawal by Subject|2|||
155360981|NCT01867047|560755506|FG000|Overall Study|Lost to Follow-up|3|||
155360982|NCT01867047|560755507|FG001|Overall Study|Lost to Follow-up|3|||
155360983|NCT01867047|560755506|FG000|Overall Study|Withdrawal by Subject|2|||
155360984|NCT01867047|560755507|FG001|Overall Study|Withdrawal by Subject|0|||
155360985|NCT01867047|560755506|FG000|Overall Study|Physician Decision|2|||
155360986|NCT01867047|560755507|FG001|Overall Study|Physician Decision|0|||
155360987|NCT01867047|560755506|FG000|Overall Study|surgery not indicated in protocol|1|||
155360988|NCT01867047|560755507|FG001|Overall Study|surgery not indicated in protocol|2|||
155360989|NCT04650698|560755508|FG000|Overall Study|Protocol Violation|2|||
155360990|NCT04650698|560755509|FG001|Overall Study|Protocol Violation|1|||
155360991|NCT04650698|560755508|FG000|Overall Study|Withdrawal by Subject|0|||
155360992|NCT04650698|560755509|FG001|Overall Study|Withdrawal by Subject|1|||
155360993|NCT01090011|560755510|FG000|Overall Study|Progressive disease|128|||
155360994|NCT01090011|560755510|FG000|Overall Study|Adverse Event|32|||
155360995|NCT01090011|560755510|FG000|Overall Study|Protocol Violation|1|||
155360996|NCT01090011|560755510|FG000|Overall Study|Refusal to start/continue medication|5|||
155360997|NCT01090011|560755510|FG000|Overall Study|Other reason not defined above|5|||
155360998|NCT03778294|560755511|FG000|Overall Study|Death|1|||
155360999|NCT03778294|560755511|FG000|Overall Study|Issues with insurance|1|||
155361000|NCT03778294|560755511|FG000|Overall Study|disease progression before treatment|2|||
155361001|NCT02859064|560755513|FG000|Overall Study|Progressive Disease|3|||
155361002|NCT02859064|560755513|FG000|Overall Study|Physician Decision|1|||
155361003|NCT02859064|560755513|FG000|Overall Study|Withdrawal by Subject|1|||
155361004|NCT02859064|560755513|FG000|Overall Study|Death|1|||
155361005|NCT01730950|560755519|FG000|Overall Study|Protocol Violation|6|||
155361006|NCT01730950|560755520|FG001|Overall Study|Protocol Violation|6|||
155361007|NCT02737826|560755521|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
155361008|NCT02737826|560755522|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
155361009|NCT02737826|560755523|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
155361010|NCT00667459|560755524|FG000|Overall Study|Death|0|||
155361011|NCT00667459|560755525|FG001|Overall Study|Death|2|||
155361012|NCT00667459|560755524|FG000|Overall Study|Lost to Follow-up|8|||
155361013|NCT00667459|560755525|FG001|Overall Study|Lost to Follow-up|43|||
155361014|NCT02568397|560755526|FG000|Period 2|Withdrawal by Subject|0|||
155361015|NCT02568397|560755527|FG001|Period 2|Withdrawal by Subject|1|||
155361016|NCT02568397|560755526|FG000|Period 2|Physician Decision|0|||
155361017|NCT02568397|560755527|FG001|Period 2|Physician Decision|1|||
155361018|NCT00078377|560755528|FG000|Overall Study|Adverse Event|2|||
155361019|NCT00078377|560755529|FG001|Overall Study|Adverse Event|5|||
155361020|NCT00078377|560755530|FG002|Overall Study|Adverse Event|1|||
155361021|NCT00078377|560755528|FG000|Overall Study|Lack of Efficacy|2|||
155361022|NCT00078377|560755529|FG001|Overall Study|Lack of Efficacy|0|||
155361023|NCT00078377|560755530|FG002|Overall Study|Lack of Efficacy|2|||
155361024|NCT00078377|560755528|FG000|Overall Study|Lost to Follow-up|0|||
155361025|NCT00078377|560755529|FG001|Overall Study|Lost to Follow-up|1|||
155361026|NCT00078377|560755530|FG002|Overall Study|Lost to Follow-up|1|||
155361027|NCT00078377|560755528|FG000|Overall Study|Physician Decision|2|||
155361028|NCT00078377|560755529|FG001|Overall Study|Physician Decision|0|||
155507258|NCT03705169|561283587|FG003|Overall Study|Concerns about study visit compliance|1|||
155507259|NCT03705169|561283588|FG004|Overall Study|Concerns about study visit compliance|0|||
155361029|NCT00078377|560755530|FG002|Overall Study|Physician Decision|0|||
155361030|NCT00078377|560755528|FG000|Overall Study|Withdrawal by Subject|3|||
155361031|NCT00078377|560755529|FG001|Overall Study|Withdrawal by Subject|4|||
155361032|NCT00078377|560755530|FG002|Overall Study|Withdrawal by Subject|4|||
155361033|NCT00078377|560755528|FG000|Overall Study|Miscellaneous|2|||
155361034|NCT00078377|560755529|FG001|Overall Study|Miscellaneous|6|||
155361035|NCT00078377|560755530|FG002|Overall Study|Miscellaneous|1|||
155361036|NCT02354651|560755531|FG000|Overall Study|Withdrawal by Subject|2|||
155361037|NCT02354651|560755531|FG000|Overall Study|Physician Decision|1|||
155361038|NCT00581893|560755532|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
155649021|NCT04518410|561805952|FG018|Overall Study|Protocol Violation|0|||
155361039|NCT00581893|560755533|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
155361040|NCT02550938|560755534|FG000|Overall Study|Lost to Follow-up|8|||
155361041|NCT02550938|560755535|FG001|Overall Study|Lost to Follow-up|7|||
155361042|NCT02550938|560755536|FG002|Overall Study|Lost to Follow-up|12|||
155361043|NCT02550938|560755537|FG003|Overall Study|Lost to Follow-up|11|||
155361044|NCT01367847|560755538|FG000|Overall Study|Withdrawal by Subject|2|||
155361045|NCT01367847|560755539|FG001|Overall Study|Withdrawal by Subject|2|||
155361046|NCT01454739|560755540|FG000|Overall Study|Protocol Violation|2|||
155361047|NCT01454739|560755541|FG001|Overall Study|Protocol Violation|3|||
155361048|NCT01454739|560755540|FG000|Overall Study|Withdrawal by Subject|2|||
155361049|NCT01454739|560755541|FG001|Overall Study|Withdrawal by Subject|6|||
155361050|NCT01454739|560755540|FG000|Overall Study|Other|3|||
155361051|NCT01454739|560755541|FG001|Overall Study|Other|5|||
155361052|NCT01454739|560755540|FG000|Overall Study|Physician Decision|0|||
155361053|NCT01454739|560755541|FG001|Overall Study|Physician Decision|5|||
155361054|NCT01454739|560755540|FG000|Overall Study|Lost to Follow-up|0|||
155361055|NCT01454739|560755541|FG001|Overall Study|Lost to Follow-up|1|||
155361056|NCT01454739|560755540|FG000|Overall Study|Adverse Event|0|||
155361057|NCT01454739|560755541|FG001|Overall Study|Adverse Event|1|||
155361058|NCT01375751|560755544|FG000|Overall Study|Other|0|||
155361059|NCT01375751|560755545|FG001|Overall Study|Other|1|||
155361060|NCT01375751|560755546|FG002|Overall Study|Other|0|||
155361061|NCT02980523|560755547|FG000|Overall Study|Lost to Follow-up|1|||
155361062|NCT02980523|560755548|FG001|Overall Study|Lost to Follow-up|4|||
155361063|NCT02980523|560755549|FG002|Overall Study|Lost to Follow-up|1|||
155361064|NCT02980523|560755550|FG003|Overall Study|Lost to Follow-up|2|||
155361065|NCT02980523|560755551|FG004|Overall Study|Lost to Follow-up|1|||
155361066|NCT02980523|560755547|FG000|Overall Study|Excluded from analysis|1|||
155361067|NCT02980523|560755548|FG001|Overall Study|Excluded from analysis|3|||
155361068|NCT02980523|560755549|FG002|Overall Study|Excluded from analysis|1|||
155361069|NCT02980523|560755550|FG003|Overall Study|Excluded from analysis|1|||
155361070|NCT02980523|560755551|FG004|Overall Study|Excluded from analysis|1|||
155361071|NCT02980523|560755547|FG000|Overall Study|Lack of Efficacy|1|||
155361072|NCT02980523|560755548|FG001|Overall Study|Lack of Efficacy|4|||
155361073|NCT02980523|560755549|FG002|Overall Study|Lack of Efficacy|4|||
155361074|NCT02980523|560755550|FG003|Overall Study|Lack of Efficacy|5|||
155361075|NCT02980523|560755551|FG004|Overall Study|Lack of Efficacy|8|||
155361076|NCT02980523|560755547|FG000|Overall Study|Did not receive intervention|0|||
155361077|NCT02980523|560755548|FG001|Overall Study|Did not receive intervention|0|||
155361078|NCT02980523|560755549|FG002|Overall Study|Did not receive intervention|0|||
155361079|NCT02980523|560755550|FG003|Overall Study|Did not receive intervention|1|||
155361080|NCT02980523|560755551|FG004|Overall Study|Did not receive intervention|0|||
155361081|NCT00633945|560755552|FG000|Overall Study|Physician Decision|2|||
155361082|NCT00882115|560755553|FG000|Overall Study|Withdrawal by Subject|3|||
155361083|NCT00882115|560755553|FG000|Overall Study|did not respond to DEP challe|6|||
155361084|NCT02552147|560755554|FG000|First Intervention (7 Days)|Protocol Violation|1|||
155361085|NCT02552147|560755555|FG001|First Intervention (7 Days)|Protocol Violation|0|||
155361086|NCT02552147|560755554|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
155361087|NCT02552147|560755555|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
155361088|NCT01547598|560755556|FG000|Overall Study|Withdrew consent|1|||
155361089|NCT01547598|560755557|FG001|Overall Study|Withdrew consent|1|||
155361090|NCT01547598|560755556|FG000|Overall Study|Lost to Follow-up|1|||
155361091|NCT01547598|560755557|FG001|Overall Study|Lost to Follow-up|1|||
155361092|NCT01547598|560755556|FG000|Overall Study|Adverse Event|1|||
155361093|NCT01547598|560755557|FG001|Overall Study|Adverse Event|1|||
155361094|NCT01547598|560755556|FG000|Overall Study|Protocol Violation|1|||
155361095|NCT01547598|560755557|FG001|Overall Study|Protocol Violation|1|||
155361096|NCT01547598|560755556|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155361097|NCT01547598|560755557|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155361098|NCT00872001|560755561|FG000|Overall Study|Adverse Event|34|||
155361099|NCT00872001|560755562|FG001|Overall Study|Adverse Event|23|||
155361100|NCT00872001|560755561|FG000|Overall Study|Protocol Defined Clinical Event|5|||
155361101|NCT00872001|560755562|FG001|Overall Study|Protocol Defined Clinical Event|7|||
155361102|NCT00872001|560755561|FG000|Overall Study|Lost to Follow-up|13|||
155361103|NCT00872001|560755562|FG001|Overall Study|Lost to Follow-up|12|||
155361104|NCT00872001|560755561|FG000|Overall Study|Withdrawal by Subject|18|||
155361105|NCT00872001|560755562|FG001|Overall Study|Withdrawal by Subject|30|||
155361106|NCT00872001|560755561|FG000|Overall Study|Protocol Violation|5|||
155361107|NCT00872001|560755562|FG001|Overall Study|Protocol Violation|8|||
155361108|NCT00872001|560755561|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
155361109|NCT00872001|560755562|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
155361110|NCT00872001|560755561|FG000|Overall Study|Administrative|23|||
155361111|NCT00872001|560755562|FG001|Overall Study|Administrative|15|||
155361112|NCT04071301|560755563|FG000|Overall Study|Withdrawal by Subject|6|||
155361113|NCT04071301|560755563|FG000|Overall Study|Death|1|||
155361114|NCT00121667|560755564|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
155361115|NCT00121667|560755565|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
155361116|NCT00121667|560755566|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
155361117|NCT00121667|560755567|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
155361118|NCT00121667|560755564|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
155361119|NCT00121667|560755565|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
155361120|NCT00121667|560755566|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
155361121|NCT00121667|560755567|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
155361122|NCT00121667|560755564|FG000|Short Term (ST) Period|Adverse Event|5|||
155361123|NCT00121667|560755565|FG001|Short Term (ST) Period|Adverse Event|6|||
155361124|NCT00121667|560755566|FG002|Short Term (ST) Period|Adverse Event|5|||
155361125|NCT00121667|560755567|FG003|Short Term (ST) Period|Adverse Event|3|||
155361126|NCT00121667|560755564|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
155361127|NCT00121667|560755565|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
155361128|NCT00121667|560755566|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
155361129|NCT00121667|560755567|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
155361130|NCT00121667|560755564|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
155361131|NCT00121667|560755565|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
155361132|NCT00121667|560755566|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
155361133|NCT00121667|560755567|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
155361134|NCT00121667|560755564|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
155361135|NCT00121667|560755565|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
155361136|NCT00121667|560755566|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
155361137|NCT00121667|560755567|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
155361138|NCT00121667|560755564|FG000|Short Term (ST) Period|Other Reason|3|||
155361139|NCT00121667|560755565|FG001|Short Term (ST) Period|Other Reason|0|||
155361140|NCT00121667|560755566|FG002|Short Term (ST) Period|Other Reason|0|||
155361141|NCT00121667|560755567|FG003|Short Term (ST) Period|Other Reason|0|||
155361142|NCT00121667|560755564|FG000|Short Term (ST) Period|Death|0|||
155361143|NCT00121667|560755565|FG001|Short Term (ST) Period|Death|0|||
155361144|NCT00121667|560755566|FG002|Short Term (ST) Period|Death|0|||
155361145|NCT00121667|560755567|FG003|Short Term (ST) Period|Death|1|||
155361146|NCT00121667|560755564|FG000|Short Term (ST) Period|Pregnancy|0|||
155361147|NCT00121667|560755565|FG001|Short Term (ST) Period|Pregnancy|0|||
155361148|NCT00121667|560755566|FG002|Short Term (ST) Period|Pregnancy|0|||
155361149|NCT00121667|560755567|FG003|Short Term (ST) Period|Pregnancy|1|||
155361150|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
155361151|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
155361152|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
155361153|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
155361154|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
155361155|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
155361156|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
155361157|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
155361158|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
155361159|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
155361160|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
155361161|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
155361162|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
155649022|NCT04518410|561805953|FG019|Overall Study|Protocol Violation|0|||
155361163|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
155361164|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
155427497|NCT00408005|560991837|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
155649023|NCT04518410|561805954|FG020|Overall Study|Protocol Violation|1|||
155361165|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
155361166|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
155361167|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
155361168|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
155361169|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
155361170|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
155361171|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
155507260|NCT03705169|561283589|FG005|Overall Study|Concerns about study visit compliance|0|||
155507261|NCT03705169|561283590|FG006|Overall Study|Concerns about study visit compliance|0|||
155507262|NCT03705169|561283591|FG007|Overall Study|Concerns about study visit compliance|0|||
155507263|NCT03705169|561283592|FG008|Overall Study|Concerns about study visit compliance|0|||
155507264|NCT03705169|561283593|FG009|Overall Study|Concerns about study visit compliance|0|||
155507265|NCT02544633|561285043|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
155507266|NCT02544633|561285044|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
155507267|NCT02544633|561285045|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
155507268|NCT02544633|561285046|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
155507269|NCT02544633|561285043|FG000|Treatment Period|Adverse Event|7|||
155507270|NCT02544633|561285044|FG001|Treatment Period|Adverse Event|4|||
155507271|NCT02544633|561285045|FG002|Treatment Period|Adverse Event|0|||
155507272|NCT02544633|561285046|FG003|Treatment Period|Adverse Event|5|||
155507273|NCT02544633|561285043|FG000|Treatment Period|Lack of Efficacy|17|||
155649024|NCT04518410|561805955|FG021|Overall Study|Protocol Violation|2|||
155649025|NCT04518410|561805956|FG022|Overall Study|Protocol Violation|0|||
155361172|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
155361173|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
155361174|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
155361175|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
155361176|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
155361177|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
155361178|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361179|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361180|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
155361181|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361182|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
155361183|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
155361184|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
155361185|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
155361186|NCT05186311|560755568|FG000|Part A: Serum|Withdrawal by Subject|1|||
155361187|NCT02879383|560755569|FG000|First 24 Weeks|Physician Decision|0|||
155361188|NCT02879383|560755570|FG001|First 24 Weeks|Physician Decision|1|||
155361189|NCT02879383|560755571|FG002|First 24 Weeks|Physician Decision|0|||
155361190|NCT02879383|560755572|FG003|First 24 Weeks|Physician Decision|0|||
155361191|NCT04468230|560755580|FG000|Overall Study|Adverse Event|2|||
155361192|NCT00983853|560755585|FG000|Overall Study|Lost to Follow-up|1|||
155361193|NCT00983853|560755586|FG001|Overall Study|Lost to Follow-up|1|||
155361194|NCT00983853|560755587|FG002|Overall Study|Lost to Follow-up|2|||
155361195|NCT00983853|560755588|FG003|Overall Study|Lost to Follow-up|2|||
155361196|NCT00983853|560755589|FG004|Overall Study|Lost to Follow-up|2|||
155361197|NCT00983853|560755590|FG005|Overall Study|Lost to Follow-up|1|||
155361198|NCT00983853|560755585|FG000|Overall Study|Withdrawal by Subject|0|||
155361199|NCT00983853|560755586|FG001|Overall Study|Withdrawal by Subject|0|||
155361200|NCT00983853|560755587|FG002|Overall Study|Withdrawal by Subject|1|||
155361201|NCT00983853|560755588|FG003|Overall Study|Withdrawal by Subject|0|||
155361202|NCT00983853|560755589|FG004|Overall Study|Withdrawal by Subject|1|||
155361203|NCT00983853|560755590|FG005|Overall Study|Withdrawal by Subject|0|||
155361204|NCT00983853|560755585|FG000|Overall Study|Unable to come to study follow-up visits|0|||
155361205|NCT00983853|560755586|FG001|Overall Study|Unable to come to study follow-up visits|1|||
155361206|NCT00983853|560755587|FG002|Overall Study|Unable to come to study follow-up visits|0|||
155361207|NCT00983853|560755588|FG003|Overall Study|Unable to come to study follow-up visits|0|||
155361208|NCT00983853|560755589|FG004|Overall Study|Unable to come to study follow-up visits|0|||
155427498|NCT00408005|560991838|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
155361209|NCT00983853|560755590|FG005|Overall Study|Unable to come to study follow-up visits|0|||
155361210|NCT02599688|560755591|FG000|Overall Study|Lack of Efficacy|1|||
155361211|NCT02599688|560755591|FG000|Overall Study|Withdrawal by Subject|1|||
155361212|NCT02599688|560755591|FG000|Overall Study|Termination by Sponsor|2|||
155361213|NCT01318876|560755595|FG000|Day 8 Survey|email address invalid|96|||
155361214|NCT01318876|560755595|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
155361215|NCT01318876|560755595|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
155361216|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
155361217|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
155361218|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
155361219|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
155361220|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
155361221|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
155361222|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
155361223|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
155361224|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
155361225|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
155361226|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
155361227|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
155361228|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
155361229|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
155361230|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
155361231|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
155361232|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
155361233|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
155361234|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Missing|2|||
155361235|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Missing|1|||
155361236|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
155361237|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
155361238|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
155361239|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
155361240|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
155361241|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
155361242|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
155361243|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
155361244|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
155361245|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
155361246|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
155361247|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
155361248|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
155361249|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
155361250|NCT00224029|560755598|FG000|Overall Study|Lost to Follow-up|1|||
155361251|NCT00224029|560755598|FG000|Overall Study|Withdrawal by Subject|4|||
155361252|NCT00224029|560755598|FG000|Overall Study|Other|1|||
155361253|NCT04016272|560755600|FG000|Overall Study|Withdrawal by Subject|1|||
155361254|NCT04016272|560755601|FG001|Overall Study|Withdrawal by Subject|2|||
155361255|NCT00763451|560755609|FG000|Overall Study|Adverse Event|4|||
155361256|NCT00763451|560755610|FG001|Overall Study|Adverse Event|6|||
155361257|NCT00763451|560755611|FG002|Overall Study|Adverse Event|19|||
155361258|NCT00763451|560755612|FG003|Overall Study|Adverse Event|14|||
155361259|NCT00763451|560755609|FG000|Overall Study|Lack of Efficacy|1|||
155361260|NCT00763451|560755610|FG001|Overall Study|Lack of Efficacy|4|||
155361261|NCT00763451|560755611|FG002|Overall Study|Lack of Efficacy|3|||
155361262|NCT00763451|560755612|FG003|Overall Study|Lack of Efficacy|2|||
155361263|NCT00763451|560755609|FG000|Overall Study|Withdrawal by Subject|1|||
155361264|NCT00763451|560755610|FG001|Overall Study|Withdrawal by Subject|6|||
155361265|NCT00763451|560755611|FG002|Overall Study|Withdrawal by Subject|9|||
155361266|NCT00763451|560755612|FG003|Overall Study|Withdrawal by Subject|7|||
155361267|NCT00763451|560755609|FG000|Overall Study|Protocol Violation|0|||
155361268|NCT00763451|560755610|FG001|Overall Study|Protocol Violation|0|||
155361269|NCT00763451|560755611|FG002|Overall Study|Protocol Violation|1|||
155361270|NCT00763451|560755612|FG003|Overall Study|Protocol Violation|0|||
155361271|NCT00763451|560755609|FG000|Overall Study|Poor Compliance to Protocol|1|||
155361272|NCT00763451|560755610|FG001|Overall Study|Poor Compliance to Protocol|1|||
155361273|NCT00763451|560755611|FG002|Overall Study|Poor Compliance to Protocol|2|||
155361274|NCT00763451|560755612|FG003|Overall Study|Poor Compliance to Protocol|2|||
155361275|NCT00763451|560755609|FG000|Overall Study|Familial and Personal Reasons|5|||
155361276|NCT00763451|560755610|FG001|Overall Study|Familial and Personal Reasons|3|||
155361277|NCT00763451|560755611|FG002|Overall Study|Familial and Personal Reasons|5|||
155361278|NCT00763451|560755612|FG003|Overall Study|Familial and Personal Reasons|4|||
155361279|NCT00763451|560755609|FG000|Overall Study|Randomized but not Treated|1|||
155361280|NCT00763451|560755610|FG001|Overall Study|Randomized but not Treated|1|||
155361281|NCT00763451|560755611|FG002|Overall Study|Randomized but not Treated|0|||
155361282|NCT00763451|560755612|FG003|Overall Study|Randomized but not Treated|0|||
155361283|NCT00763451|560755609|FG000|Overall Study|Study Site Reason|0|||
155361284|NCT00763451|560755610|FG001|Overall Study|Study Site Reason|1|||
155361285|NCT00763451|560755611|FG002|Overall Study|Study Site Reason|1|||
155361286|NCT00763451|560755612|FG003|Overall Study|Study Site Reason|1|||
155361287|NCT01827046|560755613|FG000|Overall Study|Lost to Follow-up|1|||
155361288|NCT01827046|560755614|FG001|Overall Study|Lost to Follow-up|5|||
155361289|NCT01827046|560755613|FG000|Overall Study|Withdrawal by Subject|0|||
155361290|NCT01827046|560755614|FG001|Overall Study|Withdrawal by Subject|4|||
155361291|NCT02282917|560755622|FG000|Overall Study|Withdrawal by Subject|1|||
155361292|NCT02282917|560755622|FG000|Overall Study|Screen Failure/Not Eligible|1|||
155649026|NCT04518410|561805957|FG023|Overall Study|Protocol Violation|3|||
155649027|NCT04518410|561805958|FG024|Overall Study|Protocol Violation|0|||
155649028|NCT04518410|561805934|FG000|Overall Study|Death|0|||
155361293|NCT00115336|560755623|FG000|Overall Study|Hospital discharge before study drug|0|||
155649029|NCT04518410|561805935|FG001|Overall Study|Death|0|||
155361294|NCT00115336|560755624|FG001|Overall Study|Hospital discharge before study drug|1|||
155361295|NCT02165826|560755633|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
155507274|NCT02544633|561285044|FG001|Treatment Period|Lack of Efficacy|11|||
155649030|NCT04518410|561805936|FG002|Overall Study|Death|0|||
155649031|NCT04518410|561805937|FG003|Overall Study|Death|0|||
155649032|NCT04518410|561805938|FG004|Overall Study|Death|12|||
155649033|NCT04518410|561805939|FG005|Overall Study|Death|2|||
155649034|NCT04518410|561805940|FG006|Overall Study|Death|11|||
155649035|NCT04518410|561805941|FG007|Overall Study|Death|0|||
155649036|NCT04518410|561805942|FG008|Overall Study|Death|1|||
155649037|NCT04518410|561805943|FG009|Overall Study|Death|0|||
155649038|NCT04518410|561805944|FG010|Overall Study|Death|0|||
155649039|NCT04518410|561805945|FG011|Overall Study|Death|0|||
155649040|NCT04518410|561805946|FG012|Overall Study|Death|0|||
155649041|NCT04518410|561805947|FG013|Overall Study|Death|1|||
155649042|NCT04518410|561805948|FG014|Overall Study|Death|1|||
155649043|NCT04518410|561805949|FG015|Overall Study|Death|0|||
155649044|NCT04518410|561805950|FG016|Overall Study|Death|0|||
155649045|NCT04518410|561805951|FG017|Overall Study|Death|1|||
155649046|NCT04518410|561805952|FG018|Overall Study|Death|4|||
155649047|NCT04518410|561805953|FG019|Overall Study|Death|4|||
155649048|NCT04518410|561805954|FG020|Overall Study|Death|1|||
155649049|NCT04518410|561805955|FG021|Overall Study|Death|0|||
155649050|NCT04518410|561805956|FG022|Overall Study|Death|0|||
155649051|NCT04518410|561805957|FG023|Overall Study|Death|0|||
155649052|NCT04518410|561805958|FG024|Overall Study|Death|0|||
155649053|NCT04518410|561805934|FG000|Overall Study|Requirement to start alternative therapy|0|||
155649054|NCT04518410|561805935|FG001|Overall Study|Requirement to start alternative therapy|0|||
155649055|NCT04518410|561805936|FG002|Overall Study|Requirement to start alternative therapy|1|||
155649056|NCT04518410|561805937|FG003|Overall Study|Requirement to start alternative therapy|0|||
155649057|NCT04518410|561805938|FG004|Overall Study|Requirement to start alternative therapy|0|||
155649058|NCT04518410|561805939|FG005|Overall Study|Requirement to start alternative therapy|0|||
155649059|NCT04518410|561805940|FG006|Overall Study|Requirement to start alternative therapy|0|||
155649060|NCT04518410|561805941|FG007|Overall Study|Requirement to start alternative therapy|0|||
155649061|NCT04518410|561805942|FG008|Overall Study|Requirement to start alternative therapy|0|||
155649062|NCT04518410|561805943|FG009|Overall Study|Requirement to start alternative therapy|0|||
155649063|NCT04518410|561805944|FG010|Overall Study|Requirement to start alternative therapy|0|||
155649064|NCT04518410|561805945|FG011|Overall Study|Requirement to start alternative therapy|0|||
155649065|NCT04518410|561805946|FG012|Overall Study|Requirement to start alternative therapy|0|||
155649066|NCT04518410|561805947|FG013|Overall Study|Requirement to start alternative therapy|0|||
155361296|NCT02165826|560755634|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
155649067|NCT04518410|561805948|FG014|Overall Study|Requirement to start alternative therapy|0|||
155649068|NCT04518410|561805949|FG015|Overall Study|Requirement to start alternative therapy|0|||
155649069|NCT04518410|561805950|FG016|Overall Study|Requirement to start alternative therapy|0|||
155649070|NCT04518410|561805951|FG017|Overall Study|Requirement to start alternative therapy|0|||
155649071|NCT04518410|561805952|FG018|Overall Study|Requirement to start alternative therapy|0|||
155649072|NCT04518410|561805953|FG019|Overall Study|Requirement to start alternative therapy|0|||
155649073|NCT04518410|561805954|FG020|Overall Study|Requirement to start alternative therapy|0|||
155649074|NCT04518410|561805955|FG021|Overall Study|Requirement to start alternative therapy|0|||
155361297|NCT02165826|560755635|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
155361298|NCT02165826|560755633|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
155361299|NCT02165826|560755634|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
155361300|NCT02165826|560755635|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
155361301|NCT02165826|560755633|FG000|Main Treatment Period|Lost to Follow-up|4|||
155361302|NCT02165826|560755634|FG001|Main Treatment Period|Lost to Follow-up|2|||
155507275|NCT02544633|561285045|FG002|Treatment Period|Lack of Efficacy|5|||
155507276|NCT02544633|561285046|FG003|Treatment Period|Lack of Efficacy|5|||
155361303|NCT02165826|560755635|FG002|Main Treatment Period|Lost to Follow-up|1|||
155361304|NCT02165826|560755633|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
155361305|NCT02165826|560755634|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
155361306|NCT02165826|560755635|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
155361307|NCT02165826|560755633|FG000|Main Treatment Period|Lack of Efficacy|2|||
155361308|NCT02165826|560755634|FG001|Main Treatment Period|Lack of Efficacy|0|||
155361309|NCT02165826|560755635|FG002|Main Treatment Period|Lack of Efficacy|0|||
155361310|NCT02165826|560755633|FG000|Main Treatment Period|Reason Not Specified|8|||
155361311|NCT02165826|560755634|FG001|Main Treatment Period|Reason Not Specified|5|||
155361312|NCT02165826|560755635|FG002|Main Treatment Period|Reason Not Specified|16|||
155361313|NCT02165826|560755633|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
155361314|NCT02165826|560755634|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
155361315|NCT02165826|560755635|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
155361316|NCT02165826|560755633|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
155361317|NCT02165826|560755634|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
155361318|NCT02165826|560755635|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
155361319|NCT02165826|560755633|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
155361320|NCT02165826|560755634|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
155361321|NCT02165826|560755635|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
155361322|NCT02165826|560755633|FG000|Down-Titration Period|Reason Not Specified|1|||
155361323|NCT02165826|560755634|FG001|Down-Titration Period|Reason Not Specified|0|||
155361324|NCT02165826|560755635|FG002|Down-Titration Period|Reason Not Specified|2|||
155361325|NCT03698019|560755636|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
155361326|NCT03698019|560755637|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
155361327|NCT03698019|560755636|FG000|Step 1: Registration|Withdrawal by Subject|7|||
155361328|NCT03698019|560755637|FG001|Step 1: Registration|Withdrawal by Subject|2|||
155361329|NCT03698019|560755636|FG000|Step 1: Registration|Toxicity|0|||
155361330|NCT03698019|560755637|FG001|Step 1: Registration|Toxicity|1|||
155361331|NCT03698019|560755636|FG000|Step 1: Registration|Disease Progression|0|||
155361332|NCT03698019|560755637|FG001|Step 1: Registration|Disease Progression|12|||
155361333|NCT03698019|560755636|FG000|Step 1: Registration|Co-morbidities|0|||
155361334|NCT03698019|560755637|FG001|Step 1: Registration|Co-morbidities|1|||
155361335|NCT03698019|560755636|FG000|Step 1: Registration|Scheduling Issues|1|||
155507277|NCT02544633|561285043|FG000|Treatment Period|Global Deterioration of Health|3|||
155361336|NCT03698019|560755637|FG001|Step 1: Registration|Scheduling Issues|0|||
155507278|NCT02544633|561285044|FG001|Treatment Period|Global Deterioration of Health|3|||
155361337|NCT03698019|560755636|FG000|Step 1: Registration|Participant Refusal|0|||
155361338|NCT03698019|560755637|FG001|Step 1: Registration|Participant Refusal|1|||
155361339|NCT03698019|560755636|FG000|Step 2: Surgery|Participant Refusal|2|||
155361340|NCT03698019|560755637|FG001|Step 2: Surgery|Participant Refusal|1|||
155361341|NCT03698019|560755636|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
155361342|NCT03698019|560755637|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
155361343|NCT03698019|560755636|FG000|Step 2: Surgery|Metastatic Disease|16|||
155361344|NCT03698019|560755637|FG001|Step 2: Surgery|Metastatic Disease|9|||
155361345|NCT03698019|560755636|FG000|Step 2: Surgery|Residual Disease|2|||
155361346|NCT03698019|560755637|FG001|Step 2: Surgery|Residual Disease|1|||
155361347|NCT03698019|560755636|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
155361348|NCT03698019|560755637|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
155361349|NCT03698019|560755636|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
155361350|NCT03698019|560755637|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
155361351|NCT03698019|560755636|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
155361352|NCT03698019|560755637|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
155361353|NCT03698019|560755636|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
155361354|NCT03698019|560755637|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
155361355|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
155361356|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
155361357|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
155361358|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
155361359|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
155361360|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
155361361|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
155361362|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
155361363|NCT03569891|560755638|FG000|Lead-in|Ineligible during lead-in|8|||
155361364|NCT03569891|560755638|FG000|Lead-in|Withdrawal by Subject|3|||
155361365|NCT03569891|560755638|FG000|Lead-in|Risks related to COVID-19|2|||
155361366|NCT03569891|560755638|FG000|AMT-061|Adverse Event|1|||
155361367|NCT02176863|560755639|FG000|Overall Study|Physician Decision|1|||
155361368|NCT02176863|560755640|FG001|Overall Study|Physician Decision|0|||
155361369|NCT02176863|560755641|FG002|Overall Study|Physician Decision|0|||
155361370|NCT02176863|560755642|FG003|Overall Study|Physician Decision|0|||
155361371|NCT02176863|560755643|FG004|Overall Study|Physician Decision|0|||
155361372|NCT02176863|560755639|FG000|Overall Study|Adverse Event|10|||
155361373|NCT02176863|560755640|FG001|Overall Study|Adverse Event|4|||
155361374|NCT02176863|560755641|FG002|Overall Study|Adverse Event|4|||
155507279|NCT02544633|561285045|FG002|Treatment Period|Global Deterioration of Health|0|||
155507280|NCT02544633|561285046|FG003|Treatment Period|Global Deterioration of Health|1|||
155507281|NCT02544633|561285043|FG000|Treatment Period|Withdrawal by Subject|1|||
155361375|NCT02176863|560755642|FG003|Overall Study|Adverse Event|1|||
155361376|NCT02176863|560755643|FG004|Overall Study|Adverse Event|1|||
155361377|NCT02176863|560755639|FG000|Overall Study|Protocol Violation|2|||
155361378|NCT02176863|560755640|FG001|Overall Study|Protocol Violation|0|||
155361379|NCT02176863|560755641|FG002|Overall Study|Protocol Violation|1|||
155361380|NCT02176863|560755642|FG003|Overall Study|Protocol Violation|1|||
155361381|NCT02176863|560755643|FG004|Overall Study|Protocol Violation|0|||
155361382|NCT02176863|560755639|FG000|Overall Study|Withdrawal by Subject|4|||
155361383|NCT02176863|560755640|FG001|Overall Study|Withdrawal by Subject|2|||
155361384|NCT02176863|560755641|FG002|Overall Study|Withdrawal by Subject|2|||
155361385|NCT02176863|560755642|FG003|Overall Study|Withdrawal by Subject|3|||
155361386|NCT02176863|560755643|FG004|Overall Study|Withdrawal by Subject|4|||
155361387|NCT02176863|560755639|FG000|Overall Study|Reason not specified|0|||
155361388|NCT02176863|560755640|FG001|Overall Study|Reason not specified|1|||
155361389|NCT02176863|560755641|FG002|Overall Study|Reason not specified|1|||
155361390|NCT02176863|560755642|FG003|Overall Study|Reason not specified|2|||
155361391|NCT02176863|560755643|FG004|Overall Study|Reason not specified|1|||
155361392|NCT02176863|560755639|FG000|Overall Study|Lost to Follow-up|0|||
155361393|NCT02176863|560755640|FG001|Overall Study|Lost to Follow-up|1|||
155361394|NCT02176863|560755641|FG002|Overall Study|Lost to Follow-up|1|||
155361395|NCT02176863|560755642|FG003|Overall Study|Lost to Follow-up|0|||
155361396|NCT02176863|560755643|FG004|Overall Study|Lost to Follow-up|0|||
155361397|NCT02419417|560757307|FG000|Overall Study|Disease progression|5|||
155361398|NCT02419417|560757308|FG001|Overall Study|Disease progression|4|||
155361399|NCT02419417|560757309|FG002|Overall Study|Disease progression|13|||
155361400|NCT02419417|560757310|FG003|Overall Study|Disease progression|10|||
155361401|NCT02419417|560757311|FG004|Overall Study|Disease progression|10|||
155361402|NCT02419417|560757312|FG005|Overall Study|Disease progression|3|||
155361403|NCT02419417|560757313|FG006|Overall Study|Disease progression|4|||
155361404|NCT02419417|560757314|FG007|Overall Study|Disease progression|5|||
155361405|NCT02419417|560757315|FG008|Overall Study|Disease progression|13|||
155361406|NCT02419417|560757316|FG009|Overall Study|Disease progression|9|||
155361407|NCT02419417|560757317|FG010|Overall Study|Disease progression|0|||
155361408|NCT02419417|560757307|FG000|Overall Study|Study drug toxicity|0|||
155361409|NCT02419417|560757308|FG001|Overall Study|Study drug toxicity|0|||
155361410|NCT02419417|560757309|FG002|Overall Study|Study drug toxicity|0|||
155361411|NCT02419417|560757310|FG003|Overall Study|Study drug toxicity|0|||
155361412|NCT02419417|560757311|FG004|Overall Study|Study drug toxicity|1|||
155361413|NCT02419417|560757312|FG005|Overall Study|Study drug toxicity|0|||
155361414|NCT02419417|560757313|FG006|Overall Study|Study drug toxicity|0|||
155361415|NCT02419417|560757314|FG007|Overall Study|Study drug toxicity|0|||
155361416|NCT02419417|560757315|FG008|Overall Study|Study drug toxicity|0|||
155361417|NCT02419417|560757316|FG009|Overall Study|Study drug toxicity|0|||
155361418|NCT02419417|560757317|FG010|Overall Study|Study drug toxicity|0|||
155361419|NCT02419417|560757307|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155361420|NCT02419417|560757308|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155361421|NCT02419417|560757309|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155361422|NCT02419417|560757310|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155361423|NCT02419417|560757311|FG004|Overall Study|Adverse event unrelated to study drug|2|||
155361424|NCT02419417|560757312|FG005|Overall Study|Adverse event unrelated to study drug|1|||
155361425|NCT02419417|560757313|FG006|Overall Study|Adverse event unrelated to study drug|0|||
155361426|NCT02419417|560757314|FG007|Overall Study|Adverse event unrelated to study drug|1|||
155361427|NCT02419417|560757315|FG008|Overall Study|Adverse event unrelated to study drug|0|||
155361428|NCT02419417|560757316|FG009|Overall Study|Adverse event unrelated to study drug|0|||
155361429|NCT02419417|560757317|FG010|Overall Study|Adverse event unrelated to study drug|0|||
155361430|NCT02419417|560757307|FG000|Overall Study|Participant request to discontinue|0|||
155361431|NCT02419417|560757308|FG001|Overall Study|Participant request to discontinue|0|||
155361432|NCT02419417|560757309|FG002|Overall Study|Participant request to discontinue|0|||
155361433|NCT02419417|560757310|FG003|Overall Study|Participant request to discontinue|0|||
155361434|NCT02419417|560757311|FG004|Overall Study|Participant request to discontinue|0|||
155361435|NCT02419417|560757312|FG005|Overall Study|Participant request to discontinue|0|||
155361436|NCT02419417|560757313|FG006|Overall Study|Participant request to discontinue|0|||
155361437|NCT02419417|560757314|FG007|Overall Study|Participant request to discontinue|0|||
155361438|NCT02419417|560757315|FG008|Overall Study|Participant request to discontinue|0|||
155361439|NCT02419417|560757316|FG009|Overall Study|Participant request to discontinue|1|||
155361440|NCT02419417|560757317|FG010|Overall Study|Participant request to discontinue|0|||
155361441|NCT02419417|560757307|FG000|Overall Study|Withdrawal by Subject|0|||
155361442|NCT02419417|560757308|FG001|Overall Study|Withdrawal by Subject|0|||
155361443|NCT02419417|560757309|FG002|Overall Study|Withdrawal by Subject|0|||
155361444|NCT02419417|560757310|FG003|Overall Study|Withdrawal by Subject|0|||
155361445|NCT02419417|560757311|FG004|Overall Study|Withdrawal by Subject|0|||
155361446|NCT02419417|560757312|FG005|Overall Study|Withdrawal by Subject|0|||
155361447|NCT02419417|560757313|FG006|Overall Study|Withdrawal by Subject|0|||
155361448|NCT02419417|560757314|FG007|Overall Study|Withdrawal by Subject|0|||
155361449|NCT02419417|560757315|FG008|Overall Study|Withdrawal by Subject|0|||
155361450|NCT02419417|560757316|FG009|Overall Study|Withdrawal by Subject|0|||
155361451|NCT02419417|560757317|FG010|Overall Study|Withdrawal by Subject|1|||
155361452|NCT01240551|560757318|FG000|Overall Study|Refused further treatment|3|||
155361453|NCT01240551|560757319|FG001|Overall Study|Refused further treatment|2|||
155361454|NCT01240551|560757318|FG000|Overall Study|Lost to Follow-up|1|||
155361455|NCT01240551|560757319|FG001|Overall Study|Lost to Follow-up|1|||
155361456|NCT03945773|560757326|FG000|Overall Study|Consent Withdrawn|1|||
155361457|NCT03945773|560757327|FG001|Overall Study|Consent Withdrawn|1|||
155361458|NCT03945773|560757326|FG000|Overall Study|Lost to Follow-up|1|||
155361459|NCT03945773|560757327|FG001|Overall Study|Lost to Follow-up|0|||
155361460|NCT03945773|560757326|FG000|Overall Study|Death|46|||
155361461|NCT03945773|560757327|FG001|Overall Study|Death|22|||
155361462|NCT03945773|560757326|FG000|Overall Study|Physician Decision|1|||
155361463|NCT03945773|560757327|FG001|Overall Study|Physician Decision|0|||
155361464|NCT03945773|560757326|FG000|Overall Study|Other|1|||
155361465|NCT03945773|560757327|FG001|Overall Study|Other|0|||
155361466|NCT03945773|560757326|FG000|Overall Study|Ongoing at the time of DCO|4|||
155361467|NCT03945773|560757327|FG001|Overall Study|Ongoing at the time of DCO|3|||
155361468|NCT00725712|560757328|FG000|Overall Study|Withdrawal by Subject|2|||
155361469|NCT00725712|560757329|FG001|Overall Study|Withdrawal by Subject|1|||
155507282|NCT02544633|561285044|FG001|Treatment Period|Withdrawal by Subject|0|||
155361470|NCT00725712|560757328|FG000|Overall Study|Protocol Violation|1|||
155361471|NCT00725712|560757329|FG001|Overall Study|Protocol Violation|0|||
155361472|NCT00725712|560757328|FG000|Overall Study|Progressive disease|37|||
155361473|NCT00725712|560757329|FG001|Overall Study|Progressive disease|16|||
155361474|NCT00725712|560757328|FG000|Overall Study|Clinical progression not based on RECIST|0|||
155361475|NCT00725712|560757329|FG001|Overall Study|Clinical progression not based on RECIST|3|||
155361476|NCT00725712|560757328|FG000|Overall Study|Adverse Event|5|||
155361477|NCT00725712|560757329|FG001|Overall Study|Adverse Event|5|||
155361478|NCT00725712|560757328|FG000|Overall Study|Death|2|||
155361479|NCT00725712|560757329|FG001|Overall Study|Death|0|||
155361480|NCT00725712|560757328|FG000|Overall Study|Other: Death|1|||
155361481|NCT00725712|560757329|FG001|Overall Study|Other: Death|0|||
155361482|NCT00725712|560757328|FG000|Overall Study|Hospitalized, unable to continue|0|||
155361483|NCT00725712|560757329|FG001|Overall Study|Hospitalized, unable to continue|1|||
155361484|NCT04024462|560757335|FG000|Overall Study|Withdrawal by Subject|6|||
155361485|NCT04024462|560757336|FG001|Overall Study|Withdrawal by Subject|7|||
155361486|NCT04024462|560757335|FG000|Overall Study|Progressive Disease|0|||
155361487|NCT04024462|560757336|FG001|Overall Study|Progressive Disease|1|||
155361488|NCT04024462|560757335|FG000|Overall Study|Adverse Event|0|||
155361489|NCT04024462|560757336|FG001|Overall Study|Adverse Event|1|||
155361490|NCT04024462|560757335|FG000|Overall Study|Death|0|||
155361491|NCT04024462|560757336|FG001|Overall Study|Death|1|||
155361492|NCT04024462|560757335|FG000|Overall Study|Lost to Follow-up|1|||
155361493|NCT04024462|560757336|FG001|Overall Study|Lost to Follow-up|0|||
155361494|NCT04024462|560757335|FG000|Overall Study|Ongoing in the Study|94|||
155361495|NCT04024462|560757336|FG001|Overall Study|Ongoing in the Study|89|||
155361496|NCT05687032|560757340|FG000|Treatment Phase|Adverse Event|13|||
155649075|NCT04518410|561805956|FG022|Overall Study|Requirement to start alternative therapy|0|||
155361497|NCT05687032|560757340|FG000|Treatment Phase|Death|1|||
155361498|NCT05687032|560757340|FG000|Treatment Phase|Physician Decision|3|||
155507283|NCT02544633|561285045|FG002|Treatment Period|Withdrawal by Subject|0|||
155507284|NCT02544633|561285046|FG003|Treatment Period|Withdrawal by Subject|0|||
155507285|NCT02544633|561285043|FG000|Treatment Period|Lost to Follow-up|0|||
155507286|NCT02544633|561285044|FG001|Treatment Period|Lost to Follow-up|1|||
155507287|NCT02544633|561285045|FG002|Treatment Period|Lost to Follow-up|0|||
155507288|NCT02544633|561285046|FG003|Treatment Period|Lost to Follow-up|0|||
155507289|NCT02544633|561285043|FG000|Treatment Period|Death|0|||
155507290|NCT02544633|561285044|FG001|Treatment Period|Death|0|||
155507291|NCT02544633|561285045|FG002|Treatment Period|Death|1|||
155507292|NCT02544633|561285046|FG003|Treatment Period|Death|0|||
155507293|NCT02544633|561285043|FG000|Treatment Period|Non-compliance|0|||
155507294|NCT02544633|561285044|FG001|Treatment Period|Non-compliance|0|||
155507295|NCT02544633|561285045|FG002|Treatment Period|Non-compliance|1|||
155507296|NCT02544633|561285046|FG003|Treatment Period|Non-compliance|0|||
155507297|NCT02544633|561285043|FG000|Treatment Period|Clinical Disease Progression|0|||
155507298|NCT02544633|561285044|FG001|Treatment Period|Clinical Disease Progression|0|||
155507299|NCT02544633|561285045|FG002|Treatment Period|Clinical Disease Progression|0|||
155507300|NCT02544633|561285046|FG003|Treatment Period|Clinical Disease Progression|1|||
155507301|NCT02544633|561285043|FG000|Survival Follow-up Period|Death|12|||
155507302|NCT02544633|561285044|FG001|Survival Follow-up Period|Death|14|||
155507303|NCT02544633|561285045|FG002|Survival Follow-up Period|Death|3|||
155507304|NCT02544633|561285046|FG003|Survival Follow-up Period|Death|9|||
155507305|NCT02544633|561285043|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
155507306|NCT02544633|561285044|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
155507307|NCT02544633|561285045|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
155507308|NCT02544633|561285046|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
155507309|NCT02544633|561285043|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
155361499|NCT05687032|560757340|FG000|Treatment Phase|Progressive disease|9|||
155361500|NCT05687032|560757340|FG000|Treatment Phase|Withdrawal by Subject|5|||
155361501|NCT05687032|560757340|FG000|Follow-Up Phase|Death|16|||
155361502|NCT05687032|560757340|FG000|Follow-Up Phase|Ongoing|26|||
155361503|NCT01437423|560757349|FG000|Overall Study|Lost to Follow-up|12|||
155361504|NCT01437423|560757349|FG000|Overall Study|Off label usage|3|||
155361505|NCT03912662|560757355|FG000|Overall Study|Adverse Event|3|||
155361506|NCT03912662|560757355|FG000|Overall Study|Adverse Event and Death|1|||
155361507|NCT03912662|560757355|FG000|Overall Study|Death|1|||
155361508|NCT03912662|560757355|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
155361509|NCT03912662|560757355|FG000|Overall Study|Mesh Removal|1|||
155427499|NCT00408005|560991839|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
155361510|NCT03912662|560757355|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
155361511|NCT03912662|560757355|FG000|Overall Study|Early study termination|20|||
155361512|NCT01790295|560757364|FG000|Overall Study|Adverse Event|1|||
155361513|NCT01790295|560757364|FG000|Overall Study|Death|4|||
155361514|NCT01790295|560757364|FG000|Overall Study|Lack of Efficacy|2|||
155361515|NCT01790295|560757364|FG000|Overall Study|Study closure|4|||
155361516|NCT02872012|560757382|FG000|Overall Study|Withdrawal by Subject|1|||
155361517|NCT02872012|560757383|FG001|Overall Study|Withdrawal by Subject|0|||
155361518|NCT02872012|560757384|FG002|Overall Study|Withdrawal by Subject|0|||
155361519|NCT02872012|560757385|FG003|Overall Study|Withdrawal by Subject|0|||
155361520|NCT02872012|560757386|FG004|Overall Study|Withdrawal by Subject|0|||
155361521|NCT03000348|560757387|FG000|Overall Study|Adverse Event|1|||
155361522|NCT03000348|560757388|FG001|Overall Study|Adverse Event|1|||
155361523|NCT03000348|560757389|FG002|Overall Study|Adverse Event|1|||
155361524|NCT03000348|560757390|FG003|Overall Study|Adverse Event|1|||
155361525|NCT03000348|560757391|FG004|Overall Study|Adverse Event|1|||
155361526|NCT03000348|560757392|FG005|Overall Study|Adverse Event|1|||
155361527|NCT03000348|560757387|FG000|Overall Study|Lost to Follow-up|0|||
155361528|NCT03000348|560757388|FG001|Overall Study|Lost to Follow-up|0|||
155361529|NCT03000348|560757389|FG002|Overall Study|Lost to Follow-up|1|||
155361530|NCT03000348|560757390|FG003|Overall Study|Lost to Follow-up|0|||
155361531|NCT03000348|560757391|FG004|Overall Study|Lost to Follow-up|0|||
155361532|NCT03000348|560757392|FG005|Overall Study|Lost to Follow-up|0|||
155361533|NCT03000348|560757387|FG000|Overall Study|Withdrawal by Subject|0|||
155361534|NCT03000348|560757388|FG001|Overall Study|Withdrawal by Subject|1|||
155361535|NCT03000348|560757389|FG002|Overall Study|Withdrawal by Subject|0|||
155361536|NCT03000348|560757390|FG003|Overall Study|Withdrawal by Subject|0|||
155361537|NCT03000348|560757391|FG004|Overall Study|Withdrawal by Subject|0|||
155361538|NCT03000348|560757392|FG005|Overall Study|Withdrawal by Subject|0|||
155361539|NCT03000348|560757387|FG000|Overall Study|Consent|0|||
155361540|NCT03000348|560757388|FG001|Overall Study|Consent|0|||
155361541|NCT03000348|560757389|FG002|Overall Study|Consent|0|||
155361542|NCT03000348|560757390|FG003|Overall Study|Consent|0|||
155361543|NCT03000348|560757391|FG004|Overall Study|Consent|1|||
155361544|NCT03000348|560757392|FG005|Overall Study|Consent|0|||
155361545|NCT03000348|560757387|FG000|Overall Study|Failure to expectorate sputum|1|||
155361546|NCT03000348|560757388|FG001|Overall Study|Failure to expectorate sputum|0|||
155361547|NCT03000348|560757389|FG002|Overall Study|Failure to expectorate sputum|1|||
155361548|NCT03000348|560757390|FG003|Overall Study|Failure to expectorate sputum|0|||
155361549|NCT03000348|560757391|FG004|Overall Study|Failure to expectorate sputum|1|||
155361550|NCT03000348|560757392|FG005|Overall Study|Failure to expectorate sputum|0|||
155361551|NCT03000348|560757387|FG000|Overall Study|No gram negative|1|||
155361552|NCT03000348|560757388|FG001|Overall Study|No gram negative|2|||
155361553|NCT03000348|560757389|FG002|Overall Study|No gram negative|1|||
155361554|NCT03000348|560757390|FG003|Overall Study|No gram negative|1|||
155361555|NCT03000348|560757391|FG004|Overall Study|No gram negative|1|||
155361556|NCT03000348|560757392|FG005|Overall Study|No gram negative|1|||
155361557|NCT03000348|560757387|FG000|Overall Study|Patient had no transport|0|||
155361558|NCT03000348|560757388|FG001|Overall Study|Patient had no transport|0|||
155361559|NCT03000348|560757389|FG002|Overall Study|Patient had no transport|0|||
155361560|NCT03000348|560757390|FG003|Overall Study|Patient had no transport|1|||
155361561|NCT03000348|560757391|FG004|Overall Study|Patient had no transport|0|||
155361562|NCT03000348|560757392|FG005|Overall Study|Patient had no transport|0|||
155361563|NCT03000348|560757387|FG000|Overall Study|Dosing|0|||
155361564|NCT03000348|560757388|FG001|Overall Study|Dosing|0|||
155361565|NCT03000348|560757389|FG002|Overall Study|Dosing|0|||
155361566|NCT03000348|560757390|FG003|Overall Study|Dosing|0|||
155361567|NCT03000348|560757391|FG004|Overall Study|Dosing|1|||
155361568|NCT03000348|560757392|FG005|Overall Study|Dosing|0|||
155361569|NCT00723125|560757393|FG000|Overall Study|Met Dx|1|||
155361570|NCT00723125|560757394|FG001|Overall Study|Met Dx|0|||
155361571|NCT00723125|560757393|FG000|Overall Study|Withdrawal by Subject|15|||
155361572|NCT00723125|560757394|FG001|Overall Study|Withdrawal by Subject|6|||
155361573|NCT00723125|560757393|FG000|Overall Study|Adverse Event|2|||
155361574|NCT00723125|560757394|FG001|Overall Study|Adverse Event|0|||
155507310|NCT02544633|561285044|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
155507311|NCT02544633|561285045|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
155507312|NCT02544633|561285046|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
155507313|NCT02544633|561285043|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
155507314|NCT02544633|561285044|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
155507315|NCT02544633|561285045|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
155507316|NCT02544633|561285046|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
155507317|NCT01605461|561285047|FG000|Overall Study|Lost to Follow-up|3|||
155361575|NCT01807182|560757395|FG000|Overall Study|Death|1|||
155361576|NCT01807182|560757395|FG000|Overall Study|New therapy|1|||
155361577|NCT01807182|560757395|FG000|Overall Study|Moved to hospice care|1|||
155507318|NCT01605461|561285047|FG000|Overall Study|Withdrawal by Subject|1|||
155361578|NCT00478205|560757397|FG000|Overall Study|Adverse Event|182|||
155507319|NCT02024698|561285048|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
155361579|NCT00478205|560757398|FG001|Overall Study|Adverse Event|39|||
155361580|NCT00478205|560757397|FG000|Overall Study|Medication Non-compliance|9|||
155361581|NCT00478205|560757398|FG001|Overall Study|Medication Non-compliance|4|||
155361582|NCT00478205|560757397|FG000|Overall Study|Protocol Violation|15|||
155361583|NCT00478205|560757398|FG001|Overall Study|Protocol Violation|5|||
155361584|NCT00478205|560757397|FG000|Overall Study|Request of Investigator or Sponsor|4|||
155361585|NCT00478205|560757398|FG001|Overall Study|Request of Investigator or Sponsor|5|||
155361586|NCT00478205|560757397|FG000|Overall Study|Withdrawal by Subject|61|||
155361587|NCT00478205|560757398|FG001|Overall Study|Withdrawal by Subject|22|||
155361588|NCT00478205|560757397|FG000|Overall Study|Lack of Efficacy|1|||
155361589|NCT00478205|560757398|FG001|Overall Study|Lack of Efficacy|0|||
155361590|NCT00478205|560757397|FG000|Overall Study|Other|24|||
155361591|NCT00478205|560757398|FG001|Overall Study|Other|12|||
155361592|NCT01012947|560757399|FG000|Overall Study|Lost to Follow-up|131|||
155361593|NCT01012947|560757400|FG001|Overall Study|Lost to Follow-up|135|||
155361594|NCT01012947|560757401|FG002|Overall Study|Lost to Follow-up|130|||
155361595|NCT01012947|560757402|FG003|Overall Study|Lost to Follow-up|118|||
155361596|NCT01012947|560757403|FG004|Overall Study|Lost to Follow-up|142|||
155361597|NCT02127125|560757404|FG000|Overall Study|Lost to Follow-up|0|||
155361598|NCT02127125|560757405|FG001|Overall Study|Lost to Follow-up|0|||
155361599|NCT02127125|560757406|FG002|Overall Study|Lost to Follow-up|0|||
155361600|NCT02127125|560757407|FG003|Overall Study|Lost to Follow-up|0|||
155361601|NCT02127125|560757408|FG004|Overall Study|Lost to Follow-up|2|||
155361602|NCT02127125|560757409|FG005|Overall Study|Lost to Follow-up|1|||
155361603|NCT02127125|560757410|FG006|Overall Study|Lost to Follow-up|0|||
155361604|NCT02127125|560757411|FG007|Overall Study|Lost to Follow-up|0|||
155361605|NCT02127125|560757412|FG008|Overall Study|Lost to Follow-up|0|||
155361606|NCT02127125|560757404|FG000|Overall Study|Withdrawal by Subject|0|||
155361607|NCT02127125|560757405|FG001|Overall Study|Withdrawal by Subject|0|||
155361608|NCT02127125|560757406|FG002|Overall Study|Withdrawal by Subject|0|||
155361609|NCT02127125|560757407|FG003|Overall Study|Withdrawal by Subject|1|||
155361610|NCT02127125|560757408|FG004|Overall Study|Withdrawal by Subject|0|||
155361611|NCT02127125|560757409|FG005|Overall Study|Withdrawal by Subject|0|||
155361612|NCT02127125|560757410|FG006|Overall Study|Withdrawal by Subject|0|||
155361613|NCT02127125|560757411|FG007|Overall Study|Withdrawal by Subject|0|||
155361614|NCT02127125|560757412|FG008|Overall Study|Withdrawal by Subject|0|||
155361615|NCT02127125|560757404|FG000|Overall Study|Physician Decision|0|||
155361616|NCT02127125|560757405|FG001|Overall Study|Physician Decision|0|||
155361617|NCT02127125|560757406|FG002|Overall Study|Physician Decision|1|||
155361618|NCT02127125|560757407|FG003|Overall Study|Physician Decision|0|||
155361619|NCT02127125|560757408|FG004|Overall Study|Physician Decision|1|||
155361620|NCT02127125|560757409|FG005|Overall Study|Physician Decision|2|||
155361621|NCT02127125|560757410|FG006|Overall Study|Physician Decision|0|||
155361622|NCT02127125|560757411|FG007|Overall Study|Physician Decision|0|||
155361623|NCT02127125|560757412|FG008|Overall Study|Physician Decision|0|||
155507320|NCT02024698|561285049|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
155507321|NCT02451670|561285053|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
155507322|NCT02451670|561285054|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
155649076|NCT04518410|561805957|FG023|Overall Study|Requirement to start alternative therapy|0|||
155649077|NCT04518410|561805958|FG024|Overall Study|Requirement to start alternative therapy|0|||
155649078|NCT04518410|561805934|FG000|Overall Study|Randomized but not treated|0|||
155649079|NCT04518410|561805935|FG001|Overall Study|Randomized but not treated|0|||
155649080|NCT04518410|561805936|FG002|Overall Study|Randomized but not treated|0|||
155361624|NCT03332784|560757416|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361625|NCT03332784|560757417|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
155361626|NCT03332784|560757418|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361627|NCT03332784|560757419|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361628|NCT03332784|560757420|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361629|NCT03332784|560757421|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361630|NCT03332784|560757422|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361631|NCT03332784|560757423|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361632|NCT03332784|560757424|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361633|NCT03332784|560757425|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361634|NCT03332784|560757426|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361635|NCT03332784|560757427|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361636|NCT03332784|560757428|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361637|NCT03332784|560757429|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361638|NCT03332784|560757430|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
155361639|NCT03332784|560757431|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361640|NCT03332784|560757432|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361641|NCT03332784|560757433|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361642|NCT03332784|560757434|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361643|NCT03332784|560757435|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361644|NCT01018732|560757436|FG000|Overall Study|Lost to Follow-up|0|||
155361645|NCT01018732|560757437|FG001|Overall Study|Lost to Follow-up|0|||
155361646|NCT01018732|560757438|FG002|Overall Study|Lost to Follow-up|3|||
155361647|NCT01018732|560757436|FG000|Overall Study|Protocol Violation|1|||
155361648|NCT01018732|560757437|FG001|Overall Study|Protocol Violation|1|||
155361649|NCT01018732|560757438|FG002|Overall Study|Protocol Violation|0|||
155361650|NCT01018732|560757436|FG000|Overall Study|Inappropriate Enrollment|0|||
155361651|NCT01018732|560757437|FG001|Overall Study|Inappropriate Enrollment|1|||
155361652|NCT01018732|560757438|FG002|Overall Study|Inappropriate Enrollment|0|||
155427500|NCT00408005|560991840|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
155427501|NCT00408005|560991841|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
155427502|NCT00408005|560991842|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
155427503|NCT00408005|560991843|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
155427504|NCT00408005|560991836|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
155427505|NCT00408005|560991837|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
155427506|NCT00408005|560991838|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
155427507|NCT00408005|560991839|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
155427508|NCT00408005|560991840|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
155427509|NCT00408005|560991841|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
155427510|NCT00408005|560991842|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
155427511|NCT00408005|560991843|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
155427512|NCT00408005|560991836|FG000|Induction|Progressive Disease|0|||
155649081|NCT04518410|561805937|FG003|Overall Study|Randomized but not treated|2|||
155361653|NCT01018732|560757436|FG000|Overall Study|Unable to Classify|0|||
155361654|NCT01018732|560757437|FG001|Overall Study|Unable to Classify|0|||
155361655|NCT01018732|560757438|FG002|Overall Study|Unable to Classify|1|||
155427513|NCT00408005|560991837|FG001|Induction|Progressive Disease|1|||
155427514|NCT00408005|560991838|FG002|Induction|Progressive Disease|0|||
155361656|NCT00978562|560757439|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
155361657|NCT03299959|560757440|FG000|Overall Study|Lost to Follow-up|7|||
155361658|NCT03299959|560757441|FG001|Overall Study|Lost to Follow-up|9|||
155361659|NCT03299959|560757440|FG000|Overall Study|Death|1|||
155361660|NCT03299959|560757441|FG001|Overall Study|Death|0|||
155361661|NCT03299959|560757440|FG000|Overall Study|Withdrawal by Subject|13|||
155361662|NCT03299959|560757441|FG001|Overall Study|Withdrawal by Subject|9|||
155361663|NCT03299959|560757440|FG000|Overall Study|Changes in study team and government regulations|1|||
155361664|NCT03299959|560757441|FG001|Overall Study|Changes in study team and government regulations|1|||
155361665|NCT03299959|560757440|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
155361666|NCT03299959|560757441|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
155507323|NCT03549130|561285060|FG000|Overall Study|Adverse Event|0|||
155507324|NCT03549130|561285061|FG001|Overall Study|Adverse Event|1|||
155507325|NCT03549130|561285060|FG000|Overall Study|Lost to Follow-up|0|||
155507326|NCT03549130|561285061|FG001|Overall Study|Lost to Follow-up|1|||
155507327|NCT01078623|561285062|FG000|Treatment Period 1|Adverse Event|1|||
155507328|NCT01078623|561285063|FG001|Treatment Period 1|Adverse Event|1|||
155507329|NCT01078623|561285064|FG002|Treatment Period 1|Adverse Event|1|||
155507330|NCT01078623|561285065|FG003|Treatment Period 1|Adverse Event|0|||
155507331|NCT01078623|561285066|FG004|Treatment Period 1|Adverse Event|0|||
155507332|NCT01078623|561285067|FG005|Treatment Period 1|Adverse Event|0|||
155507333|NCT01078623|561285068|FG006|Treatment Period 1|Adverse Event|1|||
155507334|NCT01078623|561285069|FG007|Treatment Period 1|Adverse Event|0|||
155507335|NCT01078623|561285070|FG008|Treatment Period 1|Adverse Event|1|||
155507336|NCT01078623|561285071|FG009|Treatment Period 1|Adverse Event|1|||
155507337|NCT01078623|561285072|FG010|Treatment Period 1|Adverse Event|0|||
155361667|NCT01310699|560757442|FG000|Overall Study|Patients did not complete tandem.|4|||
155361668|NCT01310699|560757443|FG001|Overall Study|Patients did not complete tandem.|6|||
155361669|NCT00926575|560757444|FG000|Overall Study|Adverse Event|1|||
155361670|NCT00926575|560757445|FG001|Overall Study|Adverse Event|1|||
155361671|NCT00926575|560757444|FG000|Overall Study|Death|4|||
155361672|NCT00926575|560757445|FG001|Overall Study|Death|4|||
155361673|NCT00926575|560757444|FG000|Overall Study|Lost to Follow-up|1|||
155361674|NCT00926575|560757445|FG001|Overall Study|Lost to Follow-up|1|||
155361675|NCT00926575|560757444|FG000|Overall Study|Physician Decision|1|||
155361676|NCT00926575|560757445|FG001|Overall Study|Physician Decision|2|||
155361677|NCT00926575|560757444|FG000|Overall Study|Protocol Violation|1|||
155361678|NCT00926575|560757445|FG001|Overall Study|Protocol Violation|0|||
155361679|NCT00926575|560757444|FG000|Overall Study|Withdrawal by Subject|8|||
155361680|NCT00926575|560757445|FG001|Overall Study|Withdrawal by Subject|9|||
155361681|NCT00490698|560757446|FG000|Overall Study|Withdrawal by Subject|1|||
155361682|NCT00490698|560757446|FG000|Overall Study|Disease Progression|7|||
155361683|NCT00490698|560757446|FG000|Overall Study|Physician Decision|2|||
155361684|NCT00469859|560757448|FG000|Overall Study|Inevaluable|0|||
155361685|NCT00469859|560757449|FG001|Overall Study|Inevaluable|2|||
155361686|NCT04124471|560757450|FG000|Overall Study|screen failure|1|||
155361687|NCT02394925|560757453|FG000|Overall Study|Adverse Event|1|||
155361688|NCT02394925|560757453|FG000|Overall Study|Lens Discomfort|3|||
155507338|NCT01078623|561285073|FG011|Treatment Period 1|Adverse Event|0|||
155507339|NCT01078623|561285074|FG012|Treatment Period 1|Adverse Event|0|||
155507340|NCT01078623|561285075|FG013|Treatment Period 1|Adverse Event|0|||
155427515|NCT00408005|560991839|FG003|Induction|Progressive Disease|0|||
155427516|NCT00408005|560991840|FG004|Induction|Progressive Disease|0|||
155427517|NCT00408005|560991841|FG005|Induction|Progressive Disease|0|||
155427518|NCT00408005|560991842|FG006|Induction|Progressive Disease|0|||
155427519|NCT00408005|560991843|FG007|Induction|Progressive Disease|0|||
155427520|NCT00408005|560991836|FG000|Induction|Inevaluable|18|||
155427521|NCT00408005|560991837|FG001|Induction|Inevaluable|14|||
155427522|NCT00408005|560991838|FG002|Induction|Inevaluable|0|||
155427523|NCT00408005|560991839|FG003|Induction|Inevaluable|0|||
155427524|NCT00408005|560991840|FG004|Induction|Inevaluable|0|||
155427525|NCT00408005|560991841|FG005|Induction|Inevaluable|0|||
155427526|NCT00408005|560991842|FG006|Induction|Inevaluable|0|||
155427527|NCT00408005|560991843|FG007|Induction|Inevaluable|0|||
155427528|NCT00408005|560991836|FG000|Induction|Failed to Complete Randomization|3|||
155427529|NCT00408005|560991837|FG001|Induction|Failed to Complete Randomization|2|||
155427530|NCT00408005|560991838|FG002|Induction|Failed to Complete Randomization|0|||
155427531|NCT00408005|560991839|FG003|Induction|Failed to Complete Randomization|0|||
155427532|NCT00408005|560991840|FG004|Induction|Failed to Complete Randomization|0|||
155427533|NCT00408005|560991841|FG005|Induction|Failed to Complete Randomization|0|||
155427534|NCT00408005|560991842|FG006|Induction|Failed to Complete Randomization|0|||
155427535|NCT00408005|560991843|FG007|Induction|Failed to Complete Randomization|0|||
155427536|NCT00408005|560991836|FG000|Induction|Protocol Deviation|3|||
155427537|NCT00408005|560991837|FG001|Induction|Protocol Deviation|1|||
155427538|NCT00408005|560991838|FG002|Induction|Protocol Deviation|0|||
155427539|NCT00408005|560991839|FG003|Induction|Protocol Deviation|0|||
155507341|NCT01078623|561285076|FG014|Treatment Period 1|Adverse Event|0|||
155507342|NCT01078623|561285077|FG015|Treatment Period 1|Adverse Event|0|||
155507343|NCT01078623|561285078|FG016|Treatment Period 1|Adverse Event|0|||
155507344|NCT01078623|561285079|FG017|Treatment Period 1|Adverse Event|0|||
155507345|NCT01078623|561285080|FG018|Treatment Period 1|Adverse Event|0|||
155507346|NCT01078623|561285081|FG019|Treatment Period 1|Adverse Event|0|||
155507347|NCT01078623|561285062|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155507348|NCT01078623|561285063|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155507349|NCT01078623|561285064|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155507350|NCT01078623|561285065|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155507351|NCT01078623|561285066|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155507352|NCT01078623|561285067|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155507353|NCT01078623|561285068|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155507354|NCT01078623|561285069|FG007|Treatment Period 1|Withdrawal by Subject|1|||
155507355|NCT01078623|561285070|FG008|Treatment Period 1|Withdrawal by Subject|0|||
155507356|NCT01078623|561285071|FG009|Treatment Period 1|Withdrawal by Subject|0|||
155507357|NCT01078623|561285072|FG010|Treatment Period 1|Withdrawal by Subject|1|||
155507358|NCT01078623|561285073|FG011|Treatment Period 1|Withdrawal by Subject|0|||
155507359|NCT01078623|561285074|FG012|Treatment Period 1|Withdrawal by Subject|0|||
155507360|NCT01078623|561285075|FG013|Treatment Period 1|Withdrawal by Subject|0|||
155507361|NCT01078623|561285076|FG014|Treatment Period 1|Withdrawal by Subject|0|||
155361689|NCT02394925|560757453|FG000|Overall Study|Lens handling difficulities|5|||
155361690|NCT02394925|560757453|FG000|Overall Study|Lost to Follow-up|9|||
155361691|NCT02394925|560757453|FG000|Overall Study|Protocol Violation|5|||
155361692|NCT02394925|560757453|FG000|Overall Study|No longer meet eligibility criteria|1|||
155361693|NCT02394925|560757453|FG000|Overall Study|Unsatisfactory Visual Response|5|||
155361694|NCT03459846|560757457|FG000|Overall Study|Death|52|||
155507362|NCT01078623|561285077|FG015|Treatment Period 1|Withdrawal by Subject|0|||
155507363|NCT01078623|561285078|FG016|Treatment Period 1|Withdrawal by Subject|0|||
155507364|NCT01078623|561285079|FG017|Treatment Period 1|Withdrawal by Subject|0|||
155507365|NCT01078623|561285080|FG018|Treatment Period 1|Withdrawal by Subject|0|||
155361695|NCT03459846|560757458|FG001|Overall Study|Death|46|||
155361696|NCT03459846|560757457|FG000|Overall Study|Study terminated by sponsor|24|||
155361697|NCT03459846|560757458|FG001|Overall Study|Study terminated by sponsor|28|||
155361698|NCT03459846|560757457|FG000|Overall Study|Withdrawal by Subject|2|||
155361699|NCT03459846|560757458|FG001|Overall Study|Withdrawal by Subject|2|||
155361700|NCT02035696|560759121|FG000|Overall Study|Lost to Follow-up|0|||
155361701|NCT02035696|560759122|FG001|Overall Study|Lost to Follow-up|3|||
155361702|NCT02035696|560759123|FG002|Overall Study|Lost to Follow-up|1|||
155361703|NCT02035696|560759124|FG003|Overall Study|Lost to Follow-up|2|||
155361704|NCT02035696|560759121|FG000|Overall Study|Withdrawal by Subject|3|||
155361705|NCT02035696|560759122|FG001|Overall Study|Withdrawal by Subject|0|||
155361706|NCT02035696|560759123|FG002|Overall Study|Withdrawal by Subject|2|||
155361707|NCT02035696|560759124|FG003|Overall Study|Withdrawal by Subject|1|||
155361708|NCT02358668|560759126|FG000|Overall Study|Adverse Event|2|||
155649082|NCT04518410|561805938|FG004|Overall Study|Randomized but not treated|6|||
155361709|NCT02358668|560759127|FG001|Overall Study|Adverse Event|0|||
155361710|NCT02358668|560759128|FG002|Overall Study|Adverse Event|0|||
155361711|NCT02358668|560759126|FG000|Overall Study|Withdrawal by Subject|0|||
155361712|NCT02358668|560759127|FG001|Overall Study|Withdrawal by Subject|1|||
155427540|NCT00408005|560991840|FG004|Induction|Protocol Deviation|0|||
155649083|NCT04518410|561805939|FG005|Overall Study|Randomized but not treated|4|||
155649084|NCT04518410|561805940|FG006|Overall Study|Randomized but not treated|3|||
155649085|NCT04518410|561805941|FG007|Overall Study|Randomized but not treated|3|||
155649086|NCT04518410|561805942|FG008|Overall Study|Randomized but not treated|0|||
155649087|NCT04518410|561805943|FG009|Overall Study|Randomized but not treated|4|||
155361713|NCT02358668|560759128|FG002|Overall Study|Withdrawal by Subject|0|||
155361714|NCT02104505|560759129|FG000|First Intervention (14 Days)|Adverse Event|2|||
155361715|NCT02104505|560759130|FG001|First Intervention (14 Days)|Adverse Event|0|||
155361716|NCT02104505|560759129|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
155361717|NCT02104505|560759130|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
155361718|NCT02104505|560759129|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
155361719|NCT02104505|560759130|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
155361720|NCT02104505|560759129|FG000|First Intervention (14 Days)|exclusionary condition|0|||
155361721|NCT02104505|560759130|FG001|First Intervention (14 Days)|exclusionary condition|1|||
155361722|NCT02104505|560759129|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155361723|NCT02104505|560759130|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155361724|NCT02104505|560759129|FG000|Second Intervention (14 Days)|Adverse Event|2|||
155361725|NCT02104505|560759130|FG001|Second Intervention (14 Days)|Adverse Event|0|||
155361726|NCT01845805|560759131|FG000|Overall Study|Withdrawal by Subject|1|||
155361727|NCT01845805|560759132|FG001|Overall Study|Withdrawal by Subject|2|||
155361728|NCT01845805|560759131|FG000|Overall Study|Disease Progression|13|||
155361729|NCT01845805|560759132|FG001|Overall Study|Disease Progression|14|||
155427541|NCT00408005|560991841|FG005|Induction|Protocol Deviation|0|||
155427542|NCT00408005|560991842|FG006|Induction|Protocol Deviation|0|||
155427543|NCT00408005|560991843|FG007|Induction|Protocol Deviation|0|||
155427544|NCT00408005|560991836|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
155427545|NCT00408005|560991837|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427546|NCT00408005|560991838|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427547|NCT00408005|560991839|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427548|NCT00408005|560991840|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427549|NCT00408005|560991841|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427550|NCT00408005|560991842|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427551|NCT00408005|560991843|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
155427552|NCT00408005|560991836|FG000|Induction|Recurrent leukemia|1|||
155427553|NCT00408005|560991837|FG001|Induction|Recurrent leukemia|0|||
155427554|NCT00408005|560991838|FG002|Induction|Recurrent leukemia|0|||
155427555|NCT00408005|560991839|FG003|Induction|Recurrent leukemia|0|||
155427556|NCT00408005|560991840|FG004|Induction|Recurrent leukemia|0|||
155427557|NCT00408005|560991841|FG005|Induction|Recurrent leukemia|0|||
155361730|NCT01845805|560759131|FG000|Overall Study|Drug-related Toxicity|4|||
155361731|NCT01845805|560759132|FG001|Overall Study|Drug-related Toxicity|0|||
155361732|NCT01317875|560759133|FG000|Overall Study|Other|0|||
155361733|NCT01317875|560759134|FG001|Overall Study|Other|0|||
155361734|NCT01317875|560759135|FG002|Overall Study|Other|1|||
155361735|NCT01317875|560759136|FG003|Overall Study|Other|0|||
155361736|NCT01317875|560759137|FG004|Overall Study|Other|0|||
155361737|NCT01317875|560759138|FG005|Overall Study|Other|0|||
155649088|NCT04518410|561805944|FG010|Overall Study|Randomized but not treated|0|||
155361738|NCT01317875|560759139|FG006|Overall Study|Other|0|||
155361739|NCT01317875|560759140|FG007|Overall Study|Other|0|||
155361740|NCT01317875|560759141|FG008|Overall Study|Other|0|||
155361741|NCT01317875|560759142|FG009|Overall Study|Other|0|||
155361742|NCT01317875|560759133|FG000|Overall Study|Noncompliance with study drug|0|||
155361743|NCT01317875|560759134|FG001|Overall Study|Noncompliance with study drug|0|||
155361744|NCT01317875|560759135|FG002|Overall Study|Noncompliance with study drug|1|||
155361745|NCT01317875|560759136|FG003|Overall Study|Noncompliance with study drug|0|||
155361746|NCT01317875|560759137|FG004|Overall Study|Noncompliance with study drug|0|||
155361747|NCT01317875|560759138|FG005|Overall Study|Noncompliance with study drug|0|||
155361748|NCT01317875|560759139|FG006|Overall Study|Noncompliance with study drug|0|||
155361749|NCT01317875|560759140|FG007|Overall Study|Noncompliance with study drug|0|||
155361750|NCT01317875|560759141|FG008|Overall Study|Noncompliance with study drug|0|||
155361751|NCT01317875|560759142|FG009|Overall Study|Noncompliance with study drug|0|||
155361752|NCT01317875|560759133|FG000|Overall Study|Progressive Disease|1|||
155361753|NCT01317875|560759134|FG001|Overall Study|Progressive Disease|0|||
155361754|NCT01317875|560759135|FG002|Overall Study|Progressive Disease|2|||
155361755|NCT01317875|560759136|FG003|Overall Study|Progressive Disease|0|||
155361756|NCT01317875|560759137|FG004|Overall Study|Progressive Disease|1|||
155361757|NCT01317875|560759138|FG005|Overall Study|Progressive Disease|0|||
155361758|NCT01317875|560759139|FG006|Overall Study|Progressive Disease|0|||
155361759|NCT01317875|560759140|FG007|Overall Study|Progressive Disease|1|||
155361760|NCT01317875|560759141|FG008|Overall Study|Progressive Disease|0|||
155361761|NCT01317875|560759142|FG009|Overall Study|Progressive Disease|0|||
155361762|NCT01317875|560759133|FG000|Overall Study|Withdrawal by Subject|0|||
155361763|NCT01317875|560759134|FG001|Overall Study|Withdrawal by Subject|0|||
155361764|NCT01317875|560759135|FG002|Overall Study|Withdrawal by Subject|0|||
155361765|NCT01317875|560759136|FG003|Overall Study|Withdrawal by Subject|0|||
155361766|NCT01317875|560759137|FG004|Overall Study|Withdrawal by Subject|1|||
155361767|NCT01317875|560759138|FG005|Overall Study|Withdrawal by Subject|0|||
155361768|NCT01317875|560759139|FG006|Overall Study|Withdrawal by Subject|0|||
155427558|NCT00408005|560991842|FG006|Induction|Recurrent leukemia|0|||
155427559|NCT00408005|560991843|FG007|Induction|Recurrent leukemia|0|||
155427560|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155361769|NCT01317875|560759140|FG007|Overall Study|Withdrawal by Subject|3|||
155427561|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155361770|NCT01317875|560759141|FG008|Overall Study|Withdrawal by Subject|0|||
155361771|NCT01317875|560759142|FG009|Overall Study|Withdrawal by Subject|0|||
155361772|NCT01317875|560759133|FG000|Overall Study|Physician Decision|0|||
155361773|NCT01317875|560759134|FG001|Overall Study|Physician Decision|1|||
155361774|NCT01317875|560759135|FG002|Overall Study|Physician Decision|1|||
155361775|NCT01317875|560759136|FG003|Overall Study|Physician Decision|0|||
155361776|NCT01317875|560759137|FG004|Overall Study|Physician Decision|2|||
155361777|NCT01317875|560759138|FG005|Overall Study|Physician Decision|0|||
155361778|NCT01317875|560759139|FG006|Overall Study|Physician Decision|0|||
155361779|NCT01317875|560759140|FG007|Overall Study|Physician Decision|2|||
155361780|NCT01317875|560759141|FG008|Overall Study|Physician Decision|0|||
155361781|NCT01317875|560759142|FG009|Overall Study|Physician Decision|0|||
155361782|NCT01317875|560759133|FG000|Overall Study|Death|0|||
155361783|NCT01317875|560759134|FG001|Overall Study|Death|0|||
155361784|NCT01317875|560759135|FG002|Overall Study|Death|2|||
155361785|NCT01317875|560759136|FG003|Overall Study|Death|1|||
155361786|NCT01317875|560759137|FG004|Overall Study|Death|0|||
155361787|NCT01317875|560759138|FG005|Overall Study|Death|1|||
155361788|NCT01317875|560759139|FG006|Overall Study|Death|0|||
155361789|NCT01317875|560759140|FG007|Overall Study|Death|4|||
155361790|NCT01317875|560759141|FG008|Overall Study|Death|0|||
155361791|NCT01317875|560759142|FG009|Overall Study|Death|0|||
155361792|NCT01317875|560759133|FG000|Overall Study|Adverse Event|2|||
155361793|NCT01317875|560759134|FG001|Overall Study|Adverse Event|1|||
155361794|NCT01317875|560759135|FG002|Overall Study|Adverse Event|2|||
155361795|NCT01317875|560759136|FG003|Overall Study|Adverse Event|1|||
155361796|NCT01317875|560759137|FG004|Overall Study|Adverse Event|5|||
155361797|NCT01317875|560759138|FG005|Overall Study|Adverse Event|1|||
155361798|NCT01317875|560759139|FG006|Overall Study|Adverse Event|2|||
155361799|NCT01317875|560759140|FG007|Overall Study|Adverse Event|5|||
155361800|NCT01317875|560759141|FG008|Overall Study|Adverse Event|0|||
155361801|NCT01317875|560759142|FG009|Overall Study|Adverse Event|0|||
155361802|NCT01381575|560759143|FG000|Overall Study|Serious Adverse Event|1|||
155361803|NCT01381575|560759144|FG001|Overall Study|Serious Adverse Event|0|||
155361804|NCT01381575|560759145|FG002|Overall Study|Serious Adverse Event|0|||
155361805|NCT01381575|560759143|FG000|Overall Study|Non-Serious Adverse Event|0|||
155361806|NCT01381575|560759144|FG001|Overall Study|Non-Serious Adverse Event|0|||
155361807|NCT01381575|560759145|FG002|Overall Study|Non-Serious Adverse Event|1|||
155361808|NCT01381575|560759143|FG000|Overall Study|Protocol Violation|0|||
155361809|NCT01381575|560759144|FG001|Overall Study|Protocol Violation|1|||
155361810|NCT01381575|560759145|FG002|Overall Study|Protocol Violation|1|||
155361811|NCT01381575|560759143|FG000|Overall Study|Withdrawal by Subject|15|||
155361812|NCT01381575|560759144|FG001|Overall Study|Withdrawal by Subject|9|||
155361813|NCT01381575|560759145|FG002|Overall Study|Withdrawal by Subject|7|||
155361814|NCT01381575|560759143|FG000|Overall Study|Migrated/moved from study area|2|||
155361815|NCT01381575|560759144|FG001|Overall Study|Migrated/moved from study area|12|||
155361816|NCT01381575|560759145|FG002|Overall Study|Migrated/moved from study area|2|||
155361817|NCT01381575|560759143|FG000|Overall Study|Lost to Follow-up|8|||
155361818|NCT01381575|560759144|FG001|Overall Study|Lost to Follow-up|17|||
155361819|NCT01381575|560759145|FG002|Overall Study|Lost to Follow-up|9|||
155361820|NCT01377389|560759146|FG000|Overall Study|Withdrawal by Subject|1|||
155361821|NCT01377389|560759146|FG000|Overall Study|Screen failure|2|||
155361822|NCT04546217|560759147|FG000|Overall Study|Withdrawal by Subject|2|||
155361823|NCT04546217|560759148|FG001|Overall Study|Withdrawal by Subject|0|||
155361824|NCT04546217|560759147|FG000|Overall Study|Uncontrolled hypertension|1|||
155361825|NCT04546217|560759148|FG001|Overall Study|Uncontrolled hypertension|0|||
155361826|NCT03020069|560759149|FG000|Overall Study|Lost to Follow-up|0|||
155361827|NCT03020069|560759150|FG001|Overall Study|Lost to Follow-up|1|||
155361828|NCT01439867|560759154|FG000|Overall Study|Non-compliance|0|||
155361829|NCT01439867|560759155|FG001|Overall Study|Non-compliance|1|||
155361830|NCT01439867|560759154|FG000|Overall Study|Withdrawal by Subject|1|||
155361831|NCT01439867|560759155|FG001|Overall Study|Withdrawal by Subject|2|||
155361832|NCT01439867|560759154|FG000|Overall Study|Administrative Decision|4|||
155361833|NCT01439867|560759155|FG001|Overall Study|Administrative Decision|5|||
155361834|NCT01439867|560759154|FG000|Overall Study|Protocol-specified Criteria|1|||
155361835|NCT01439867|560759155|FG001|Overall Study|Protocol-specified Criteria|0|||
155507366|NCT01078623|561285081|FG019|Treatment Period 1|Withdrawal by Subject|0|||
155507367|NCT01078623|561285062|FG000|Treatment Period 1|Protocol Violation|0|||
155507368|NCT01078623|561285063|FG001|Treatment Period 1|Protocol Violation|0|||
155507369|NCT01078623|561285064|FG002|Treatment Period 1|Protocol Violation|0|||
155507370|NCT01078623|561285065|FG003|Treatment Period 1|Protocol Violation|0|||
155507371|NCT01078623|561285066|FG004|Treatment Period 1|Protocol Violation|0|||
155361836|NCT00863512|560759156|FG000|Overall Study|Adverse Event|2|||
155361837|NCT00863512|560759157|FG001|Overall Study|Adverse Event|0|||
155361838|NCT00863512|560759156|FG000|Overall Study|Withdrawal by Subject|11|||
155361839|NCT00863512|560759157|FG001|Overall Study|Withdrawal by Subject|0|||
155361840|NCT00863512|560759156|FG000|Overall Study|Physician Decision|1|||
155507372|NCT01078623|561285067|FG005|Treatment Period 1|Protocol Violation|1|||
155507373|NCT01078623|561285068|FG006|Treatment Period 1|Protocol Violation|0|||
155361841|NCT00863512|560759157|FG001|Overall Study|Physician Decision|0|||
155361842|NCT01920932|560759160|FG000|Overall Study|Death|1|||
155361843|NCT01920932|560759160|FG000|Overall Study|Withdrawal of consent|1|||
155361844|NCT02906020|560759161|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
155361845|NCT02906020|560759162|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
155361846|NCT02906020|560759163|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
155361847|NCT02906020|560759164|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
155361848|NCT02906020|560759165|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
155361849|NCT02906020|560759166|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
155361850|NCT02906020|560759167|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
155361851|NCT02906020|560759168|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
155361852|NCT02906020|560759169|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
155361853|NCT02906020|560759170|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
155361854|NCT02906020|560759171|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
155361855|NCT02906020|560759172|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
155361856|NCT02906020|560759173|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
155361857|NCT02906020|560759174|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
155361858|NCT02906020|560759175|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
155361859|NCT02906020|560759176|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
155361860|NCT02906020|560759161|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361861|NCT02906020|560759162|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361862|NCT02906020|560759163|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361863|NCT02906020|560759164|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361864|NCT02906020|560759165|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361865|NCT02906020|560759166|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361866|NCT02906020|560759167|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361867|NCT02906020|560759168|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361868|NCT02906020|560759169|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
155361869|NCT02906020|560759170|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
155361870|NCT02906020|560759171|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361871|NCT02906020|560759172|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361872|NCT02906020|560759173|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361873|NCT02906020|560759174|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361874|NCT02906020|560759175|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361875|NCT02906020|560759176|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361876|NCT02906020|560759161|FG000|Part 2: Double-blind Treatment Period|Other|0|||
155361877|NCT02906020|560759162|FG001|Part 2: Double-blind Treatment Period|Other|0|||
155361878|NCT02906020|560759163|FG002|Part 2: Double-blind Treatment Period|Other|0|||
155361879|NCT02906020|560759164|FG003|Part 2: Double-blind Treatment Period|Other|0|||
155361880|NCT02906020|560759165|FG004|Part 2: Double-blind Treatment Period|Other|0|||
155361881|NCT02906020|560759166|FG005|Part 2: Double-blind Treatment Period|Other|0|||
155361882|NCT02906020|560759167|FG006|Part 2: Double-blind Treatment Period|Other|0|||
155361883|NCT02906020|560759168|FG007|Part 2: Double-blind Treatment Period|Other|0|||
155361884|NCT02906020|560759169|FG008|Part 2: Double-blind Treatment Period|Other|6|||
155361885|NCT02906020|560759170|FG009|Part 2: Double-blind Treatment Period|Other|10|||
155361886|NCT02906020|560759171|FG010|Part 2: Double-blind Treatment Period|Other|0|||
155361887|NCT02906020|560759172|FG011|Part 2: Double-blind Treatment Period|Other|0|||
155361888|NCT02906020|560759173|FG012|Part 2: Double-blind Treatment Period|Other|0|||
155361889|NCT02906020|560759174|FG013|Part 2: Double-blind Treatment Period|Other|0|||
155361890|NCT02906020|560759175|FG014|Part 2: Double-blind Treatment Period|Other|0|||
155361891|NCT02906020|560759176|FG015|Part 2: Double-blind Treatment Period|Other|0|||
155361892|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361893|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361894|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361895|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361896|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361897|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361898|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361899|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361900|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361901|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361902|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361903|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361904|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
155361905|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
155361906|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361907|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361908|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361909|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361910|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361911|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361912|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361913|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361914|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361915|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361916|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361917|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361918|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361919|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361920|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
155361921|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
155361922|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361923|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
155361924|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361925|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361926|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361927|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361928|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361929|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361930|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361931|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361932|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361933|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361934|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361935|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361936|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
155361937|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
155361938|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361939|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361940|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361941|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361942|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361943|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361944|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361945|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361946|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361947|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361948|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361949|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361950|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155649089|NCT04518410|561805945|FG011|Overall Study|Randomized but not treated|0|||
155649090|NCT04518410|561805946|FG012|Overall Study|Randomized but not treated|1|||
155361951|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361952|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
155361953|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
155361954|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361955|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361956|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155649091|NCT04518410|561805947|FG013|Overall Study|Randomized but not treated|3|||
155361957|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361958|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361959|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361960|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361961|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361962|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361963|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361964|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361965|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361966|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361967|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361968|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
155361969|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
155361970|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
155361971|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
155361972|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Other|0|||
155361973|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Other|0|||
155361974|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Other|0|||
155361975|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Other|0|||
155361976|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Other|0|||
155361977|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Other|0|||
155361978|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Other|0|||
155361979|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Other|0|||
155361980|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Other|0|||
155361981|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Other|0|||
155361982|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Other|0|||
155361983|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Other|0|||
155361984|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Other|13|||
155361985|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Other|8|||
155361986|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Other|3|||
155361987|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Other|2|||
155361988|NCT01124097|560759177|FG000|Overall Study|Withdrawal by Subject|4|||
155361989|NCT01124097|560759178|FG001|Overall Study|Withdrawal by Subject|3|||
155361990|NCT01124097|560759179|FG002|Overall Study|Withdrawal by Subject|2|||
155361991|NCT01124097|560759180|FG003|Overall Study|Withdrawal by Subject|3|||
155361992|NCT01124097|560759177|FG000|Overall Study|Lack of Efficacy|2|||
155361993|NCT01124097|560759178|FG001|Overall Study|Lack of Efficacy|3|||
155361994|NCT01124097|560759179|FG002|Overall Study|Lack of Efficacy|1|||
155361995|NCT01124097|560759180|FG003|Overall Study|Lack of Efficacy|3|||
155361996|NCT01124097|560759177|FG000|Overall Study|Adverse Event|24|||
155361997|NCT01124097|560759178|FG001|Overall Study|Adverse Event|15|||
155361998|NCT01124097|560759179|FG002|Overall Study|Adverse Event|15|||
155361999|NCT01124097|560759180|FG003|Overall Study|Adverse Event|7|||
155362000|NCT01124097|560759177|FG000|Overall Study|Protocol Violation|2|||
155362001|NCT01124097|560759178|FG001|Overall Study|Protocol Violation|0|||
155362002|NCT01124097|560759179|FG002|Overall Study|Protocol Violation|2|||
155362003|NCT01124097|560759180|FG003|Overall Study|Protocol Violation|1|||
155362004|NCT01124097|560759177|FG000|Overall Study|Physician Decision|2|||
155362005|NCT01124097|560759178|FG001|Overall Study|Physician Decision|1|||
155362006|NCT01124097|560759179|FG002|Overall Study|Physician Decision|0|||
155362007|NCT01124097|560759180|FG003|Overall Study|Physician Decision|0|||
155362008|NCT00425607|560759181|FG000|Overall Study|Death|1|||
155362009|NCT00425607|560759181|FG000|Overall Study|Withdrawal by Subject|1|||
155362010|NCT00193479|560759182|FG000|Induction Chemotherapy|Adverse Event|2|||
155362011|NCT00193479|560759182|FG000|Induction Chemotherapy|Disease Progression|1|||
155362012|NCT00193479|560759182|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
155362013|NCT00193479|560759182|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
155362014|NCT00079339|560759183|FG000|Overall Study|Adverse Event|1|||
155362015|NCT00079339|560759184|FG001|Overall Study|Adverse Event|7|||
155362016|NCT00079339|560759185|FG002|Overall Study|Adverse Event|2|||
155362017|NCT00079339|560759183|FG000|Overall Study|Death|1|||
155362018|NCT00079339|560759184|FG001|Overall Study|Death|0|||
155362019|NCT00079339|560759185|FG002|Overall Study|Death|0|||
155362020|NCT00079339|560759183|FG000|Overall Study|Non-compliance|0|||
155362021|NCT00079339|560759184|FG001|Overall Study|Non-compliance|0|||
155362022|NCT00079339|560759185|FG002|Overall Study|Non-compliance|1|||
155362023|NCT00079339|560759183|FG000|Overall Study|Withdrawal by Subject|0|||
155362024|NCT00079339|560759184|FG001|Overall Study|Withdrawal by Subject|4|||
155362025|NCT00079339|560759185|FG002|Overall Study|Withdrawal by Subject|1|||
155362026|NCT00079339|560759183|FG000|Overall Study|Disease progression|3|||
155362027|NCT00079339|560759184|FG001|Overall Study|Disease progression|28|||
155362028|NCT00079339|560759185|FG002|Overall Study|Disease progression|2|||
155362029|NCT00559377|560759186|FG000|Overall Study|Withdrawal by Subject|9|||
155362030|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
155362031|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362032|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362033|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
155362034|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362035|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362036|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
155362037|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
155362038|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
155362039|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362040|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362041|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362042|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362043|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362044|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
155362045|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362046|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362047|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362048|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362049|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362050|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
155362051|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
155362052|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362053|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362054|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362055|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362056|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362057|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362058|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
155362059|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
155362060|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362061|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362062|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362063|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362064|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
155362065|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
155362066|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362067|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362068|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362069|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362070|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
155362071|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362072|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362073|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362074|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362075|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362076|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
155362077|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
155362078|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362079|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362080|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362081|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362082|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362083|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
155362084|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362085|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362086|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362087|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362088|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362089|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
155362090|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362091|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362092|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362093|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362094|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155649092|NCT04518410|561805948|FG014|Overall Study|Randomized but not treated|3|||
155649093|NCT04518410|561805949|FG015|Overall Study|Randomized but not treated|3|||
155649094|NCT04518410|561805950|FG016|Overall Study|Randomized but not treated|4|||
155362095|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
155362096|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362097|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362098|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362099|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362100|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
155362101|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362102|NCT00203047|560759198|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
155362103|NCT00203047|560759199|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
155362104|NCT00203047|560759198|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
155362105|NCT00203047|560759199|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
155362106|NCT00203047|560759198|FG000|Overall Study|Withdrawal by Subject|13|||
155362107|NCT00203047|560759199|FG001|Overall Study|Withdrawal by Subject|47|||
155362108|NCT00203047|560759198|FG000|Overall Study|Teva requested participant withdrawal|1|||
155362109|NCT00203047|560759199|FG001|Overall Study|Teva requested participant withdrawal|1|||
155362110|NCT00203047|560759198|FG000|Overall Study|Physician Decision|8|||
155362111|NCT00203047|560759199|FG001|Overall Study|Physician Decision|7|||
155362112|NCT00203047|560759198|FG000|Overall Study|Non-compliance|4|||
155362113|NCT00203047|560759199|FG001|Overall Study|Non-compliance|8|||
155362114|NCT00203047|560759198|FG000|Overall Study|Protocol Violation|1|||
155362115|NCT00203047|560759199|FG001|Overall Study|Protocol Violation|0|||
155362116|NCT00203047|560759198|FG000|Overall Study|Lost to Follow-up|11|||
155362117|NCT00203047|560759199|FG001|Overall Study|Lost to Follow-up|5|||
155362118|NCT00203047|560759198|FG000|Overall Study|Adverse Event|8|||
155362119|NCT00203047|560759199|FG001|Overall Study|Adverse Event|18|||
155362120|NCT00203047|560759198|FG000|Overall Study|Death|1|||
155362121|NCT00203047|560759199|FG001|Overall Study|Death|2|||
155362122|NCT00203047|560759198|FG000|Overall Study|Pregnancy|3|||
155362123|NCT00203047|560759199|FG001|Overall Study|Pregnancy|0|||
155362124|NCT00203047|560759198|FG000|Overall Study|Other|5|||
155362125|NCT00203047|560759199|FG001|Overall Study|Other|5|||
155362126|NCT01453023|560759202|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
155362127|NCT01453023|560759203|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
155362128|NCT01453023|560759202|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
155362129|NCT01453023|560759203|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
155362130|NCT01453023|560759202|FG000|Treatment Period 2|Protocol Violation|0|||
155362131|NCT01453023|560759203|FG001|Treatment Period 2|Protocol Violation|1|||
155362132|NCT03721172|560759204|FG000|Placebo-controlled Phase|Adverse Event|7|||
155362133|NCT03721172|560759205|FG001|Placebo-controlled Phase|Adverse Event|7|||
155362134|NCT03721172|560759206|FG002|Placebo-controlled Phase|Adverse Event|0|||
155362135|NCT03721172|560759204|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
155362136|NCT03721172|560759205|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
155649095|NCT04518410|561805951|FG017|Overall Study|Randomized but not treated|5|||
155649096|NCT04518410|561805952|FG018|Overall Study|Randomized but not treated|4|||
155649097|NCT04518410|561805953|FG019|Overall Study|Randomized but not treated|0|||
155649098|NCT04518410|561805954|FG020|Overall Study|Randomized but not treated|0|||
155649099|NCT04518410|561805955|FG021|Overall Study|Randomized but not treated|5|||
155649100|NCT04518410|561805956|FG022|Overall Study|Randomized but not treated|0|||
155649101|NCT04518410|561805957|FG023|Overall Study|Randomized but not treated|3|||
155649102|NCT04518410|561805958|FG024|Overall Study|Randomized but not treated|1|||
155649103|NCT04518410|561805934|FG000|Overall Study|Screen Fail but Randomized|0|||
155649104|NCT04518410|561805935|FG001|Overall Study|Screen Fail but Randomized|0|||
155362137|NCT03721172|560759206|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
155649105|NCT04518410|561805936|FG002|Overall Study|Screen Fail but Randomized|0|||
155649106|NCT04518410|561805937|FG003|Overall Study|Screen Fail but Randomized|0|||
155362138|NCT03721172|560759204|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
155362139|NCT03721172|560759205|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
155362140|NCT03721172|560759206|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
155362141|NCT03721172|560759204|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
155362142|NCT03721172|560759205|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
155362143|NCT03721172|560759206|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155362144|NCT03721172|560759204|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
155362145|NCT03721172|560759205|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
155649107|NCT04518410|561805938|FG004|Overall Study|Screen Fail but Randomized|2|||
155362146|NCT03721172|560759206|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155649108|NCT04518410|561805939|FG005|Overall Study|Screen Fail but Randomized|0|||
155362147|NCT03721172|560759204|FG000|Placebo-controlled Phase|Other|3|||
155362148|NCT03721172|560759205|FG001|Placebo-controlled Phase|Other|0|||
155362149|NCT03721172|560759206|FG002|Placebo-controlled Phase|Other|0|||
155362150|NCT03721172|560759204|FG000|Apremilast Extension Phase|Adverse Event|0|||
155362151|NCT03721172|560759205|FG001|Apremilast Extension Phase|Adverse Event|0|||
155362152|NCT03721172|560759206|FG002|Apremilast Extension Phase|Adverse Event|10|||
155362153|NCT03721172|560759204|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155362154|NCT03721172|560759205|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155362155|NCT03721172|560759206|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
155362156|NCT03721172|560759204|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
155362157|NCT03721172|560759205|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
155362158|NCT03721172|560759206|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
155362159|NCT03721172|560759204|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155362160|NCT03721172|560759205|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155362161|NCT03721172|560759206|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
155362162|NCT03721172|560759204|FG000|Apremilast Extension Phase|Protocol Violation|0|||
155362163|NCT03721172|560759205|FG001|Apremilast Extension Phase|Protocol Violation|0|||
155362164|NCT03721172|560759206|FG002|Apremilast Extension Phase|Protocol Violation|1|||
155362165|NCT03721172|560759204|FG000|Apremilast Extension Phase|Physician Decision|0|||
155362166|NCT03721172|560759205|FG001|Apremilast Extension Phase|Physician Decision|0|||
155362167|NCT03721172|560759206|FG002|Apremilast Extension Phase|Physician Decision|1|||
155362168|NCT03721172|560759204|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155362169|NCT03721172|560759205|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155362170|NCT03721172|560759206|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
155362171|NCT03721172|560759204|FG000|Apremilast Extension Phase|Other|0|||
155362172|NCT03721172|560759205|FG001|Apremilast Extension Phase|Other|0|||
155362173|NCT03721172|560759206|FG002|Apremilast Extension Phase|Other|3|||
155362174|NCT03721172|560759204|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
155362175|NCT03721172|560759205|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
155362176|NCT03721172|560759206|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
155362177|NCT00420784|560759207|FG000|Overall Study|Adverse Event|11|||
155362178|NCT00420784|560759208|FG001|Overall Study|Adverse Event|29|||
155362179|NCT00420784|560759209|FG002|Overall Study|Adverse Event|10|||
155362180|NCT00420784|560759210|FG003|Overall Study|Adverse Event|5|||
155362181|NCT00420784|560759207|FG000|Overall Study|Withdrawal by Subject|0|||
155362182|NCT00420784|560759208|FG001|Overall Study|Withdrawal by Subject|1|||
155362183|NCT00420784|560759209|FG002|Overall Study|Withdrawal by Subject|0|||
155362184|NCT00420784|560759210|FG003|Overall Study|Withdrawal by Subject|0|||
155362185|NCT00420784|560759207|FG000|Overall Study|Lost to Follow-up|0|||
155362186|NCT00420784|560759208|FG001|Overall Study|Lost to Follow-up|0|||
155362187|NCT00420784|560759209|FG002|Overall Study|Lost to Follow-up|2|||
155362188|NCT00420784|560759210|FG003|Overall Study|Lost to Follow-up|1|||
155362189|NCT00420784|560759207|FG000|Overall Study|Virologic Stopping Rule|17|||
155362190|NCT00420784|560759208|FG001|Overall Study|Virologic Stopping Rule|26|||
155362191|NCT00420784|560759209|FG002|Overall Study|Virologic Stopping Rule|41|||
155362192|NCT00420784|560759210|FG003|Overall Study|Virologic Stopping Rule|67|||
155362193|NCT00420784|560759207|FG000|Overall Study|Other|1|||
155362194|NCT00420784|560759208|FG001|Overall Study|Other|2|||
155362195|NCT00420784|560759209|FG002|Overall Study|Other|0|||
155362196|NCT00420784|560759210|FG003|Overall Study|Other|5|||
155362197|NCT03934099|560759213|FG000|Overall Study|Adverse Event|0|||
155362198|NCT03934099|560759214|FG001|Overall Study|Adverse Event|3|||
155362199|NCT03934099|560759215|FG002|Overall Study|Adverse Event|1|||
155362200|NCT03934099|560759216|FG003|Overall Study|Adverse Event|0|||
155362201|NCT03934099|560759213|FG000|Overall Study|Lost to Follow-up|1|||
155362202|NCT03934099|560759214|FG001|Overall Study|Lost to Follow-up|2|||
155362203|NCT03934099|560759215|FG002|Overall Study|Lost to Follow-up|1|||
155362204|NCT03934099|560759216|FG003|Overall Study|Lost to Follow-up|1|||
155362205|NCT03934099|560759213|FG000|Overall Study|Protocol Violation|1|||
155362206|NCT03934099|560759214|FG001|Overall Study|Protocol Violation|0|||
155362207|NCT03934099|560759215|FG002|Overall Study|Protocol Violation|0|||
155362208|NCT03934099|560759216|FG003|Overall Study|Protocol Violation|0|||
155362209|NCT03934099|560759213|FG000|Overall Study|Withdrawal by Subject|2|||
155362210|NCT03934099|560759214|FG001|Overall Study|Withdrawal by Subject|0|||
155362211|NCT03934099|560759215|FG002|Overall Study|Withdrawal by Subject|1|||
155362212|NCT03934099|560759216|FG003|Overall Study|Withdrawal by Subject|1|||
155362213|NCT03934099|560759213|FG000|Overall Study|Other reasons|0|||
155362214|NCT03934099|560759214|FG001|Overall Study|Other reasons|1|||
155362215|NCT03934099|560759215|FG002|Overall Study|Other reasons|0|||
155362216|NCT03934099|560759216|FG003|Overall Study|Other reasons|0|||
155362217|NCT02417441|560759217|FG000|Overall Study|Inconclusive due to missing data|52|||
155362218|NCT02417441|560759218|FG001|Overall Study|Inconclusive due to missing data|19|||
155362219|NCT05628285|560759219|FG000|Overall Study|Lost to Follow-up|1|||
155362220|NCT02339506|560759220|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
155362221|NCT02339506|560759221|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
155362222|NCT02339506|560759220|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
155362223|NCT02339506|560759221|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
155362224|NCT02869867|560759222|FG000|Overall Study|Protocol Violation|1|||
155362225|NCT02869867|560759223|FG001|Overall Study|Protocol Violation|0|||
155362226|NCT02869867|560759222|FG000|Overall Study|Lost to Follow-up|5|||
155362227|NCT02869867|560759223|FG001|Overall Study|Lost to Follow-up|5|||
155362228|NCT05555615|560759228|FG000|Overall Study|Adverse Event|7|||
155362229|NCT05555615|560759228|FG000|Overall Study|Lack of Efficacy|12|||
155362230|NCT05555615|560759228|FG000|Overall Study|Lost to Follow-up|10|||
155362231|NCT05555615|560759228|FG000|Overall Study|Noncompliance with study drug|5|||
155362232|NCT05555615|560759228|FG000|Overall Study|Physician Decision|2|||
155362233|NCT05555615|560759228|FG000|Overall Study|Study terminated by sponsor|80|||
155362234|NCT05555615|560759228|FG000|Overall Study|Prohibited medication use|2|||
155362235|NCT05555615|560759228|FG000|Overall Study|Withdrawal by Subject|20|||
155362236|NCT05555615|560759228|FG000|Overall Study|Not further specified|4|||
155362237|NCT03016598|560759229|FG000|Overall Study|Lost to Follow-up|0|||
155362238|NCT03016598|560759230|FG001|Overall Study|Lost to Follow-up|2|||
155362239|NCT01728623|560759234|FG000|Overall Study|Disease progression|26|||
155362240|NCT01728623|560759234|FG000|Overall Study|Adverse Event|1|||
155362241|NCT01728623|560759234|FG000|Overall Study|Withdrawal by Subject|1|||
155362242|NCT01667549|560759235|FG000|Overall Study|Withdrawal by Subject|3|||
155362243|NCT01667549|560759236|FG001|Overall Study|Withdrawal by Subject|5|||
155362244|NCT01667549|560759237|FG002|Overall Study|Withdrawal by Subject|7|||
155362245|NCT01667549|560759238|FG003|Overall Study|Withdrawal by Subject|6|||
155362246|NCT01667549|560759239|FG004|Overall Study|Withdrawal by Subject|1|||
155362247|NCT01407276|560759240|FG000|Overall Study|Withdrawal by Subject|0|||
155362248|NCT01407276|560759241|FG001|Overall Study|Withdrawal by Subject|0|||
155362249|NCT01407276|560759242|FG002|Overall Study|Withdrawal by Subject|0|||
155362250|NCT01407276|560759243|FG003|Overall Study|Withdrawal by Subject|0|||
155362251|NCT01407276|560759244|FG004|Overall Study|Withdrawal by Subject|0|||
155362252|NCT01407276|560759245|FG005|Overall Study|Withdrawal by Subject|0|||
155362253|NCT01407276|560759246|FG006|Overall Study|Withdrawal by Subject|0|||
155362254|NCT01407276|560759247|FG007|Overall Study|Withdrawal by Subject|1|||
155362255|NCT04092452|560759249|FG000|Overall Study|Adverse Event|1|||
155362256|NCT04092452|560759250|FG001|Overall Study|Adverse Event|3|||
155362257|NCT04092452|560759251|FG002|Overall Study|Adverse Event|3|||
155362258|NCT04092452|560759252|FG003|Overall Study|Adverse Event|7|||
155362259|NCT04092452|560759249|FG000|Overall Study|Lack of Efficacy|1|||
155362260|NCT04092452|560759250|FG001|Overall Study|Lack of Efficacy|1|||
155362261|NCT04092452|560759251|FG002|Overall Study|Lack of Efficacy|1|||
155362262|NCT04092452|560759252|FG003|Overall Study|Lack of Efficacy|0|||
155362263|NCT04092452|560759249|FG000|Overall Study|Lost to Follow-up|4|||
155362264|NCT04092452|560759250|FG001|Overall Study|Lost to Follow-up|3|||
155362265|NCT04092452|560759251|FG002|Overall Study|Lost to Follow-up|5|||
155362266|NCT04092452|560759252|FG003|Overall Study|Lost to Follow-up|1|||
155362267|NCT04092452|560759249|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155362268|NCT04092452|560759250|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155362269|NCT04092452|560759251|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155362270|NCT04092452|560759252|FG003|Overall Study|Non-Compliance With Study Drug|1|||
155362271|NCT04092452|560759249|FG000|Overall Study|Physician Decision|1|||
155362272|NCT04092452|560759250|FG001|Overall Study|Physician Decision|0|||
155362273|NCT04092452|560759251|FG002|Overall Study|Physician Decision|1|||
155362274|NCT04092452|560759252|FG003|Overall Study|Physician Decision|0|||
155362275|NCT04092452|560759249|FG000|Overall Study|Pregnancy|2|||
155649109|NCT04518410|561805940|FG006|Overall Study|Screen Fail but Randomized|0|||
155649110|NCT04518410|561805941|FG007|Overall Study|Screen Fail but Randomized|0|||
155362276|NCT04092452|560759250|FG001|Overall Study|Pregnancy|0|||
155362277|NCT04092452|560759251|FG002|Overall Study|Pregnancy|0|||
155362278|NCT04092452|560759252|FG003|Overall Study|Pregnancy|0|||
155362279|NCT04092452|560759249|FG000|Overall Study|Protocol Deviation|1|||
155362280|NCT04092452|560759250|FG001|Overall Study|Protocol Deviation|0|||
155362281|NCT04092452|560759251|FG002|Overall Study|Protocol Deviation|0|||
155362282|NCT04092452|560759252|FG003|Overall Study|Protocol Deviation|0|||
155362283|NCT04092452|560759249|FG000|Overall Study|Withdrawal by Subject|3|||
155362284|NCT04092452|560759250|FG001|Overall Study|Withdrawal by Subject|10|||
155362285|NCT04092452|560759251|FG002|Overall Study|Withdrawal by Subject|3|||
155362286|NCT04092452|560759252|FG003|Overall Study|Withdrawal by Subject|5|||
155362287|NCT04092452|560759249|FG000|Overall Study|Other|0|||
155362288|NCT04092452|560759250|FG001|Overall Study|Other|0|||
155362289|NCT04092452|560759251|FG002|Overall Study|Other|1|||
155362290|NCT04092452|560759252|FG003|Overall Study|Other|2|||
155362291|NCT01791413|560759261|FG000|Overall Study|Lost to Follow-up|5|||
155362292|NCT01791413|560759262|FG001|Overall Study|Lost to Follow-up|1|||
155362293|NCT05594589|560759265|FG000|Overall Study|Other|0|||
155362294|NCT05594589|560759266|FG001|Overall Study|Other|1|||
155362295|NCT05594589|560759267|FG002|Overall Study|Other|0|||
155362296|NCT01536171|560759268|FG000|Overall Study|Withdrawal by Subject|1|||
155362297|NCT01262092|560759269|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
155362298|NCT01262092|560759270|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
155362299|NCT01262092|560759269|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
155362300|NCT01262092|560759270|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
155362301|NCT01262092|560759269|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
155362302|NCT01262092|560759270|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
155362303|NCT01262092|560759269|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
155362304|NCT01262092|560759270|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
155362305|NCT03784820|560759271|FG000|Overall Study|Lost to Follow-up|5|||
155362306|NCT03784820|560759272|FG001|Overall Study|Lost to Follow-up|5|||
155362307|NCT03784820|560759273|FG002|Overall Study|Lost to Follow-up|3|||
155362308|NCT03784820|560759274|FG003|Overall Study|Lost to Follow-up|3|||
155362309|NCT02336425|560759275|FG000|Overall Study|Study terminated.|2|||
155362310|NCT02336425|560759276|FG001|Overall Study|Study terminated.|2|||
155362311|NCT02336425|560759277|FG002|Overall Study|Study terminated.|3|||
155362312|NCT02336425|560759278|FG003|Overall Study|Study terminated.|3|||
155362313|NCT01191008|560759279|FG000|Overall Study|Protocol Violation|7|||
155362314|NCT01191008|560759279|FG000|Overall Study|Lost to Follow-up|8|||
155362315|NCT02201901|560759283|FG000|Overall Study|Randomized but never treated|0|||
155362316|NCT02201901|560759284|FG001|Overall Study|Randomized but never treated|1|||
155362317|NCT02201901|560759285|FG002|Overall Study|Randomized but never treated|0|||
155362318|NCT02201901|560759283|FG000|Overall Study|Lack of Efficacy|7|||
155362319|NCT02201901|560759284|FG001|Overall Study|Lack of Efficacy|1|||
155362320|NCT02201901|560759285|FG002|Overall Study|Lack of Efficacy|6|||
155362321|NCT02201901|560759283|FG000|Overall Study|Death|3|||
155362322|NCT02201901|560759284|FG001|Overall Study|Death|3|||
155362323|NCT02201901|560759285|FG002|Overall Study|Death|3|||
155362324|NCT02201901|560759283|FG000|Overall Study|Lost to Follow-up|2|||
155362325|NCT02201901|560759284|FG001|Overall Study|Lost to Follow-up|3|||
155362326|NCT02201901|560759285|FG002|Overall Study|Lost to Follow-up|2|||
155362327|NCT02201901|560759283|FG000|Overall Study|Withdrew Consent|2|||
155362328|NCT02201901|560759284|FG001|Overall Study|Withdrew Consent|0|||
155362329|NCT02201901|560759285|FG002|Overall Study|Withdrew Consent|2|||
155362330|NCT02201901|560759283|FG000|Overall Study|Adverse Event|1|||
155362331|NCT02201901|560759284|FG001|Overall Study|Adverse Event|1|||
155362332|NCT02201901|560759285|FG002|Overall Study|Adverse Event|0|||
155362333|NCT04441905|560761471|FG000|Overall Study|Lost to Follow-up|1|||
155362334|NCT04441905|560761472|FG001|Overall Study|Lost to Follow-up|0|||
155362335|NCT04441905|560761473|FG002|Overall Study|Lost to Follow-up|0|||
155362336|NCT04441905|560761474|FG003|Overall Study|Lost to Follow-up|0|||
155362337|NCT04441905|560761475|FG004|Overall Study|Lost to Follow-up|0|||
155362338|NCT04441905|560761476|FG005|Overall Study|Lost to Follow-up|0|||
155362339|NCT04441905|560761471|FG000|Overall Study|Enrolled but treatment not administered|0|||
155362340|NCT04441905|560761472|FG001|Overall Study|Enrolled but treatment not administered|1|||
155362341|NCT04441905|560761473|FG002|Overall Study|Enrolled but treatment not administered|0|||
155362342|NCT04441905|560761474|FG003|Overall Study|Enrolled but treatment not administered|0|||
155362343|NCT04441905|560761475|FG004|Overall Study|Enrolled but treatment not administered|0|||
155362344|NCT04441905|560761476|FG005|Overall Study|Enrolled but treatment not administered|0|||
155362345|NCT04441905|560761471|FG000|Overall Study|Became ineligible after enrollment|0|||
155362346|NCT04441905|560761472|FG001|Overall Study|Became ineligible after enrollment|0|||
155362347|NCT04441905|560761473|FG002|Overall Study|Became ineligible after enrollment|0|||
155362348|NCT04441905|560761474|FG003|Overall Study|Became ineligible after enrollment|0|||
155362349|NCT04441905|560761475|FG004|Overall Study|Became ineligible after enrollment|1|||
155362350|NCT04441905|560761476|FG005|Overall Study|Became ineligible after enrollment|0|||
155362351|NCT00127842|560761477|FG000|Overall Study|Adverse Event|15|||
155362352|NCT00127842|560761477|FG000|Overall Study|Withdrawal by Subject|3|||
155362353|NCT00127842|560761477|FG000|Overall Study|Lost to Follow-up|1|||
155362354|NCT00127842|560761477|FG000|Overall Study|Lack of Efficacy|12|||
155362355|NCT00127842|560761477|FG000|Overall Study|Noncompliance|2|||
155362356|NCT00127842|560761477|FG000|Overall Study|Protocol Violation|1|||
155362357|NCT00127842|560761477|FG000|Overall Study|Other|5|||
155362358|NCT01385748|560761478|FG000|Overall Study|Withdrawal by Subject|7|||
155362359|NCT01385748|560761479|FG001|Overall Study|Withdrawal by Subject|4|||
155362360|NCT01385748|560761480|FG002|Overall Study|Withdrawal by Subject|5|||
155362361|NCT01385748|560761478|FG000|Overall Study|Noncompliance|3|||
155362362|NCT01385748|560761479|FG001|Overall Study|Noncompliance|1|||
155362363|NCT01385748|560761480|FG002|Overall Study|Noncompliance|6|||
155362364|NCT01385748|560761478|FG000|Overall Study|Other|1|||
155362365|NCT01385748|560761479|FG001|Overall Study|Other|7|||
155362366|NCT01385748|560761480|FG002|Overall Study|Other|1|||
155362367|NCT01385748|560761478|FG000|Overall Study|Adverse Event|4|||
155362368|NCT01385748|560761479|FG001|Overall Study|Adverse Event|2|||
155362369|NCT01385748|560761480|FG002|Overall Study|Adverse Event|1|||
155362370|NCT01443403|560761481|FG000|Overall Study|Adverse Event|1|||
155362371|NCT01443403|560761482|FG001|Overall Study|Adverse Event|1|||
155362372|NCT01443403|560761483|FG002|Overall Study|Adverse Event|4|||
155362373|NCT01443403|560761484|FG003|Overall Study|Adverse Event|5|||
155362374|NCT01443403|560761481|FG000|Overall Study|Withdrawal by Subject|0|||
155362375|NCT01443403|560761482|FG001|Overall Study|Withdrawal by Subject|1|||
155362376|NCT01443403|560761483|FG002|Overall Study|Withdrawal by Subject|2|||
155362377|NCT01443403|560761484|FG003|Overall Study|Withdrawal by Subject|1|||
155362378|NCT01443403|560761481|FG000|Overall Study|Lost to Follow-up|0|||
155362379|NCT01443403|560761482|FG001|Overall Study|Lost to Follow-up|0|||
155362380|NCT01443403|560761483|FG002|Overall Study|Lost to Follow-up|0|||
155362381|NCT01443403|560761484|FG003|Overall Study|Lost to Follow-up|1|||
155362382|NCT01443403|560761481|FG000|Overall Study|Protocol Violation|2|||
155362383|NCT01443403|560761482|FG001|Overall Study|Protocol Violation|1|||
155362384|NCT01443403|560761483|FG002|Overall Study|Protocol Violation|1|||
155362385|NCT01443403|560761484|FG003|Overall Study|Protocol Violation|1|||
155362386|NCT01443403|560761481|FG000|Overall Study|Use of Prohibited Treatment|2|||
155362387|NCT01443403|560761482|FG001|Overall Study|Use of Prohibited Treatment|3|||
155362388|NCT01443403|560761483|FG002|Overall Study|Use of Prohibited Treatment|0|||
155362389|NCT01443403|560761484|FG003|Overall Study|Use of Prohibited Treatment|0|||
155362390|NCT01443403|560761481|FG000|Overall Study|Other - Miscellaneous|1|||
155362391|NCT01443403|560761482|FG001|Overall Study|Other - Miscellaneous|0|||
155362392|NCT01443403|560761483|FG002|Overall Study|Other - Miscellaneous|0|||
155362393|NCT01443403|560761484|FG003|Overall Study|Other - Miscellaneous|1|||
155362394|NCT02562235|560761485|FG000|Overall Study|Adverse Event|3|||
155362395|NCT01200342|560761486|FG000|Overall Study|Disease Progression|1|||
155362396|NCT03595124|560761489|FG000|Overall Study|Physician Decision|1|||
155362397|NCT03595124|560761490|FG001|Overall Study|Physician Decision|1|||
155362398|NCT03595124|560761491|FG002|Overall Study|Physician Decision|1|||
155362399|NCT03595124|560761489|FG000|Overall Study|Ineligible|1|||
155362400|NCT03595124|560761490|FG001|Overall Study|Ineligible|1|||
155362401|NCT03595124|560761491|FG002|Overall Study|Ineligible|0|||
155362402|NCT03595124|560761489|FG000|Overall Study|Disease Progression|4|||
155362403|NCT03595124|560761490|FG001|Overall Study|Disease Progression|1|||
155362404|NCT03595124|560761491|FG002|Overall Study|Disease Progression|4|||
155362405|NCT03607422|560761494|FG000|Overall Study|Adverse Event|7|||
155362406|NCT03607422|560761495|FG001|Overall Study|Adverse Event|3|||
155362407|NCT03607422|560761496|FG002|Overall Study|Adverse Event|2|||
155507374|NCT01078623|561285069|FG007|Treatment Period 1|Protocol Violation|0|||
155507375|NCT01078623|561285070|FG008|Treatment Period 1|Protocol Violation|0|||
155507376|NCT01078623|561285071|FG009|Treatment Period 1|Protocol Violation|0|||
155507377|NCT01078623|561285072|FG010|Treatment Period 1|Protocol Violation|0|||
155362408|NCT03607422|560761497|FG003|Overall Study|Adverse Event|0|||
155362409|NCT03607422|560761498|FG004|Overall Study|Adverse Event|2|||
155362410|NCT03607422|560761499|FG005|Overall Study|Adverse Event|0|||
155362411|NCT03607422|560761494|FG000|Overall Study|Withdrawal by Subject|11|||
155362412|NCT03607422|560761495|FG001|Overall Study|Withdrawal by Subject|3|||
155362413|NCT03607422|560761496|FG002|Overall Study|Withdrawal by Subject|6|||
155362414|NCT03607422|560761497|FG003|Overall Study|Withdrawal by Subject|2|||
155362415|NCT03607422|560761498|FG004|Overall Study|Withdrawal by Subject|0|||
155362416|NCT03607422|560761499|FG005|Overall Study|Withdrawal by Subject|0|||
155362417|NCT03607422|560761494|FG000|Overall Study|Lost to Follow-up|0|||
155362418|NCT03607422|560761495|FG001|Overall Study|Lost to Follow-up|0|||
155362419|NCT03607422|560761496|FG002|Overall Study|Lost to Follow-up|1|||
155362420|NCT03607422|560761497|FG003|Overall Study|Lost to Follow-up|0|||
155362421|NCT03607422|560761498|FG004|Overall Study|Lost to Follow-up|0|||
155362422|NCT03607422|560761499|FG005|Overall Study|Lost to Follow-up|0|||
155362423|NCT03607422|560761494|FG000|Overall Study|Other|12|||
155362424|NCT03607422|560761495|FG001|Overall Study|Other|4|||
155362425|NCT03607422|560761496|FG002|Overall Study|Other|1|||
155362426|NCT03607422|560761497|FG003|Overall Study|Other|2|||
155362427|NCT03607422|560761498|FG004|Overall Study|Other|0|||
155362428|NCT03607422|560761499|FG005|Overall Study|Other|2|||
155362429|NCT03607422|560761494|FG000|Overall Study|Ongoing at Time of Analysis|8|||
155362430|NCT03607422|560761495|FG001|Overall Study|Ongoing at Time of Analysis|0|||
155507378|NCT01078623|561285073|FG011|Treatment Period 1|Protocol Violation|0|||
155362431|NCT03607422|560761496|FG002|Overall Study|Ongoing at Time of Analysis|2|||
155362432|NCT03607422|560761497|FG003|Overall Study|Ongoing at Time of Analysis|1|||
155362433|NCT03607422|560761498|FG004|Overall Study|Ongoing at Time of Analysis|1|||
155362434|NCT03607422|560761499|FG005|Overall Study|Ongoing at Time of Analysis|1|||
155362435|NCT03258723|560761500|FG000|Overall Study|COVID Interruption of study|54|||
155362436|NCT03258723|560761500|FG000|Overall Study|Lost to Follow-up|8|||
155362437|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Death|1|||
155362438|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Death|0|||
155362439|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Death|0|||
155362440|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Death|0|||
155362441|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Death|0|||
155362442|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Death|0|||
155362443|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Death|0|||
155362444|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Death|0|||
155362445|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Death|0|||
155362446|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Death|0|||
155362447|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362448|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362449|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362450|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362451|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362452|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362453|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362454|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362455|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362456|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362457|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155362458|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
155362459|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
155362460|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155362461|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362462|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362463|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362464|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362465|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362466|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362467|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362468|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
155362469|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362470|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362471|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362472|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362473|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362474|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362475|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362476|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362477|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362478|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155427562|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
155427563|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
155427564|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
155427565|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
155427566|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
155427567|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155427568|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
155427569|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
155427570|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
155427571|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
155427572|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
155427573|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
155427574|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
155427575|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
155427576|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427577|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427578|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
155427579|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427580|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
155427581|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427582|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427583|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
155427584|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
155427585|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
155362479|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362480|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362481|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362482|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362483|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
155362484|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362485|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362486|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362487|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Death|0|||
155362488|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Death|0|||
155362489|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Death|0|||
155362490|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Death|0|||
155362491|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Death|0|||
155362492|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Death|0|||
155362493|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Death|0|||
155362494|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Death|1|||
155362495|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Death|0|||
155362496|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Death|0|||
155362497|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362498|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362499|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362500|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362501|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362502|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362503|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155362504|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155362505|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362506|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362507|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362508|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362509|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362510|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362511|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
155362512|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
155362513|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
155362514|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
155362515|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
155362516|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
155362517|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362518|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362519|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362520|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362521|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
155362522|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
155362523|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362524|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155362525|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155362526|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155362527|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362528|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362529|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362530|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362531|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362532|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362533|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362534|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362535|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362536|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362537|NCT01107899|560761511|FG000|Overall Study|Physician Decision|5|||
155362538|NCT01107899|560761512|FG001|Overall Study|Physician Decision|0|||
155362539|NCT01107899|560761513|FG002|Overall Study|Physician Decision|3|||
155362540|NCT01107899|560761511|FG000|Overall Study|Withdrawal by Subject|0|||
155362541|NCT01107899|560761512|FG001|Overall Study|Withdrawal by Subject|0|||
155362542|NCT01107899|560761513|FG002|Overall Study|Withdrawal by Subject|1|||
155362543|NCT03584152|560761514|FG000|Overall Study|Discontinued intervention|7|||
155362544|NCT03584152|560761515|FG001|Overall Study|Discontinued intervention|4|||
155362545|NCT05274750|560761520|FG000|Overall Study|Adverse Event|0|||
155362546|NCT05274750|560761521|FG001|Overall Study|Adverse Event|1|||
155362547|NCT05274750|560761520|FG000|Overall Study|Lost to Follow-up|2|||
155362548|NCT05274750|560761521|FG001|Overall Study|Lost to Follow-up|3|||
155362549|NCT05274750|560761520|FG000|Overall Study|Physician Decision|3|||
155362550|NCT05274750|560761521|FG001|Overall Study|Physician Decision|0|||
155362551|NCT05274750|560761520|FG000|Overall Study|Withdrawal by Subject|10|||
155362552|NCT05274750|560761521|FG001|Overall Study|Withdrawal by Subject|9|||
155362553|NCT05274750|560761520|FG000|Overall Study|GCP Violation|0|||
155362554|NCT05274750|560761521|FG001|Overall Study|GCP Violation|4|||
155362555|NCT05274750|560761520|FG000|Overall Study|Randomized, not treated|0|||
155362556|NCT05274750|560761521|FG001|Overall Study|Randomized, not treated|1|||
155362557|NCT00983749|560761522|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
155362558|NCT00983749|560761523|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
155362559|NCT04292470|560761524|FG000|Overall Study|Withdrawal by Subject|0|||
155362560|NCT04292470|560761525|FG001|Overall Study|Withdrawal by Subject|1|||
155362561|NCT01375673|560761548|FG000|Overall Study|Withdrawal by Subject|0|||
155362562|NCT01375673|560761549|FG001|Overall Study|Withdrawal by Subject|1|||
155362563|NCT04340947|560761554|FG000|7-day Washout Period|Lost to Follow-up|5|||
155362564|NCT04340947|560761555|FG001|7-day Washout Period|Lost to Follow-up|4|||
155362565|NCT04698915|560761556|FG000|Overall Study|Adverse Event|2|||
155362566|NCT04698915|560761557|FG001|Overall Study|Adverse Event|0|||
155362567|NCT04698915|560761556|FG000|Overall Study|Death|23|||
155507379|NCT01078623|561285074|FG012|Treatment Period 1|Protocol Violation|0|||
155507380|NCT01078623|561285075|FG013|Treatment Period 1|Protocol Violation|0|||
155507381|NCT01078623|561285076|FG014|Treatment Period 1|Protocol Violation|0|||
155507382|NCT01078623|561285077|FG015|Treatment Period 1|Protocol Violation|0|||
155507383|NCT01078623|561285078|FG016|Treatment Period 1|Protocol Violation|0|||
155507384|NCT01078623|561285079|FG017|Treatment Period 1|Protocol Violation|0|||
155507385|NCT01078623|561285080|FG018|Treatment Period 1|Protocol Violation|0|||
155507386|NCT01078623|561285081|FG019|Treatment Period 1|Protocol Violation|0|||
155507387|NCT01078623|561285062|FG000|Treatment Period 2|Adverse Event|0|||
155507388|NCT01078623|561285063|FG001|Treatment Period 2|Adverse Event|0|||
155507389|NCT01078623|561285064|FG002|Treatment Period 2|Adverse Event|0|||
155507390|NCT01078623|561285065|FG003|Treatment Period 2|Adverse Event|0|||
155507391|NCT01078623|561285066|FG004|Treatment Period 2|Adverse Event|0|||
155507392|NCT01078623|561285067|FG005|Treatment Period 2|Adverse Event|0|||
155507393|NCT01078623|561285068|FG006|Treatment Period 2|Adverse Event|1|||
155507394|NCT01078623|561285069|FG007|Treatment Period 2|Adverse Event|0|||
155507395|NCT01078623|561285070|FG008|Treatment Period 2|Adverse Event|0|||
155507396|NCT01078623|561285071|FG009|Treatment Period 2|Adverse Event|0|||
155507397|NCT01078623|561285072|FG010|Treatment Period 2|Adverse Event|0|||
155507398|NCT01078623|561285073|FG011|Treatment Period 2|Adverse Event|0|||
155507399|NCT01078623|561285074|FG012|Treatment Period 2|Adverse Event|0|||
155507400|NCT01078623|561285075|FG013|Treatment Period 2|Adverse Event|0|||
155507401|NCT01078623|561285076|FG014|Treatment Period 2|Adverse Event|0|||
155507402|NCT01078623|561285077|FG015|Treatment Period 2|Adverse Event|0|||
155507403|NCT01078623|561285078|FG016|Treatment Period 2|Adverse Event|0|||
155507404|NCT01078623|561285079|FG017|Treatment Period 2|Adverse Event|0|||
155507405|NCT01078623|561285080|FG018|Treatment Period 2|Adverse Event|1|||
155507406|NCT01078623|561285081|FG019|Treatment Period 2|Adverse Event|0|||
155507407|NCT01078623|561285062|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155507408|NCT01078623|561285063|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155507409|NCT01078623|561285064|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155362568|NCT04698915|560761557|FG001|Overall Study|Death|20|||
155362569|NCT04698915|560761556|FG000|Overall Study|Physician Decision|1|||
155362570|NCT04698915|560761557|FG001|Overall Study|Physician Decision|1|||
155362571|NCT04698915|560761556|FG000|Overall Study|Lost to Follow-up|1|||
155507410|NCT01078623|561285065|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155507411|NCT01078623|561285066|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155507412|NCT01078623|561285067|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155507413|NCT01078623|561285068|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155362572|NCT04698915|560761557|FG001|Overall Study|Lost to Follow-up|0|||
155362573|NCT04698915|560761556|FG000|Overall Study|Study Terminated by Sponsor|55|||
155362574|NCT04698915|560761557|FG001|Overall Study|Study Terminated by Sponsor|60|||
155362575|NCT04698915|560761556|FG000|Overall Study|Withdrawal by Subject|2|||
155507414|NCT01078623|561285069|FG007|Treatment Period 2|Withdrawal by Subject|0|||
155507415|NCT01078623|561285070|FG008|Treatment Period 2|Withdrawal by Subject|0|||
155507416|NCT01078623|561285071|FG009|Treatment Period 2|Withdrawal by Subject|0|||
155507417|NCT01078623|561285072|FG010|Treatment Period 2|Withdrawal by Subject|0|||
155507418|NCT01078623|561285073|FG011|Treatment Period 2|Withdrawal by Subject|0|||
155507419|NCT01078623|561285074|FG012|Treatment Period 2|Withdrawal by Subject|0|||
155362576|NCT04698915|560761557|FG001|Overall Study|Withdrawal by Subject|3|||
155362577|NCT02312557|560761558|FG000|Overall Study|Survival follow-up|4|||
155362578|NCT00979953|560761559|FG000|Overall Study|Adverse Event|5|||
155362579|NCT00979953|560761560|FG001|Overall Study|Adverse Event|2|||
155362580|NCT00979953|560761561|FG002|Overall Study|Adverse Event|17|||
155362581|NCT00979953|560761562|FG003|Overall Study|Adverse Event|4|||
155362582|NCT00979953|560761559|FG000|Overall Study|Lack of Efficacy|1|||
155362583|NCT00979953|560761560|FG001|Overall Study|Lack of Efficacy|2|||
155362584|NCT00979953|560761561|FG002|Overall Study|Lack of Efficacy|0|||
155362585|NCT00979953|560761562|FG003|Overall Study|Lack of Efficacy|0|||
155362586|NCT00979953|560761559|FG000|Overall Study|Lost to Follow-up|1|||
155362587|NCT00979953|560761560|FG001|Overall Study|Lost to Follow-up|1|||
155362588|NCT00979953|560761561|FG002|Overall Study|Lost to Follow-up|1|||
155362589|NCT00979953|560761562|FG003|Overall Study|Lost to Follow-up|0|||
155362590|NCT00979953|560761559|FG000|Overall Study|Withdrawal by Subject|0|||
155362591|NCT00979953|560761560|FG001|Overall Study|Withdrawal by Subject|0|||
155362592|NCT00979953|560761561|FG002|Overall Study|Withdrawal by Subject|2|||
155362593|NCT00979953|560761562|FG003|Overall Study|Withdrawal by Subject|1|||
155362594|NCT00979953|560761559|FG000|Overall Study|Protocol Violation|1|||
155362595|NCT00979953|560761560|FG001|Overall Study|Protocol Violation|0|||
155362596|NCT00979953|560761561|FG002|Overall Study|Protocol Violation|2|||
155362597|NCT00979953|560761562|FG003|Overall Study|Protocol Violation|2|||
155362598|NCT04829747|560761566|FG000|Overall Study|Protocol Violation|1|||
155362599|NCT02367352|560761569|FG000|Overall Study|Progressive disease|7|||
155362600|NCT02367352|560761570|FG001|Overall Study|Progressive disease|0|||
155362601|NCT02367352|560761571|FG002|Overall Study|Progressive disease|0|||
155362602|NCT02367352|560761569|FG000|Overall Study|Participant Received Alternative Therapy|1|||
155362603|NCT02367352|560761570|FG001|Overall Study|Participant Received Alternative Therapy|0|||
155362604|NCT02367352|560761571|FG002|Overall Study|Participant Received Alternative Therapy|0|||
155362605|NCT02367352|560761569|FG000|Overall Study|Adverse Event|1|||
155362606|NCT02367352|560761570|FG001|Overall Study|Adverse Event|0|||
155362607|NCT02367352|560761571|FG002|Overall Study|Adverse Event|0|||
155362608|NCT05878873|560761572|FG000|Overall Study|Lost to Follow-up|2|||
155362609|NCT05878873|560761573|FG001|Overall Study|Lost to Follow-up|0|||
155362610|NCT02375347|560761580|FG000|Overall Study|Protocol Violation|1|||
155362611|NCT02229227|560761581|FG000|Overall Study|Adverse Event|14|||
155362612|NCT02229227|560761582|FG001|Overall Study|Adverse Event|9|||
155362613|NCT02229227|560761581|FG000|Overall Study|Lack of Efficacy|3|||
155362614|NCT02229227|560761582|FG001|Overall Study|Lack of Efficacy|3|||
155362615|NCT02229227|560761581|FG000|Overall Study|Protocol Violation|6|||
155362616|NCT02229227|560761582|FG001|Overall Study|Protocol Violation|8|||
155362617|NCT02229227|560761581|FG000|Overall Study|Protocol defined stopping criteria|1|||
155362618|NCT02229227|560761582|FG001|Overall Study|Protocol defined stopping criteria|3|||
155362619|NCT02229227|560761581|FG000|Overall Study|Lost to Follow-up|3|||
155362620|NCT02229227|560761582|FG001|Overall Study|Lost to Follow-up|3|||
155362621|NCT02229227|560761581|FG000|Overall Study|Study terminated by sponsor|11|||
155362622|NCT02229227|560761582|FG001|Overall Study|Study terminated by sponsor|11|||
155362623|NCT02229227|560761581|FG000|Overall Study|Withdrawal by Subject|8|||
155362624|NCT02229227|560761582|FG001|Overall Study|Withdrawal by Subject|12|||
155362625|NCT02229227|560761581|FG000|Overall Study|Other|0|||
155362626|NCT02229227|560761582|FG001|Overall Study|Other|1|||
155362627|NCT02229227|560761581|FG000|Overall Study|Physician Decision|5|||
155362628|NCT02229227|560761582|FG001|Overall Study|Physician Decision|12|||
155362629|NCT00340704|560761583|FG000|PK Study|Adverse Event|0|||
155362630|NCT00340704|560761584|FG001|PK Study|Adverse Event|1|||
155362631|NCT00340704|560761585|FG002|PK Study|Adverse Event|0|||
155362632|NCT00340704|560761586|FG003|PK Study|Adverse Event|0|||
155362633|NCT00340704|560761587|FG004|PK Study|Adverse Event|0|||
155362634|NCT00340704|560761588|FG005|PK Study|Adverse Event|0|||
155362635|NCT00340704|560761589|FG006|PK Study|Adverse Event|0|||
155362636|NCT00340704|560761590|FG007|PK Study|Adverse Event|0|||
155362637|NCT00340704|560761591|FG008|PK Study|Adverse Event|0|||
155362638|NCT00340704|560761583|FG000|PK Study|Not treated|0|||
155362639|NCT00340704|560761584|FG001|PK Study|Not treated|0|||
155362640|NCT00340704|560761585|FG002|PK Study|Not treated|1|||
155362641|NCT00340704|560761586|FG003|PK Study|Not treated|0|||
155362642|NCT00340704|560761587|FG004|PK Study|Not treated|0|||
155362643|NCT00340704|560761588|FG005|PK Study|Not treated|0|||
155362644|NCT00340704|560761589|FG006|PK Study|Not treated|0|||
155362645|NCT00340704|560761590|FG007|PK Study|Not treated|0|||
155362646|NCT00340704|560761591|FG008|PK Study|Not treated|0|||
155362647|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362648|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362649|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362650|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
155362651|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
155362652|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362653|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155507420|NCT01078623|561285075|FG013|Treatment Period 2|Withdrawal by Subject|0|||
155507421|NCT01078623|561285076|FG014|Treatment Period 2|Withdrawal by Subject|0|||
155507422|NCT01078623|561285077|FG015|Treatment Period 2|Withdrawal by Subject|0|||
155507423|NCT01078623|561285078|FG016|Treatment Period 2|Withdrawal by Subject|0|||
155362654|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
155362655|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
155362656|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362657|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362658|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362659|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362660|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362661|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
155362662|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362663|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362664|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362665|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362666|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362667|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362668|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362669|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
155362670|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
155362671|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362672|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362673|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155507424|NCT01078623|561285079|FG017|Treatment Period 2|Withdrawal by Subject|0|||
155507425|NCT01078623|561285080|FG018|Treatment Period 2|Withdrawal by Subject|0|||
155649111|NCT04518410|561805942|FG008|Overall Study|Screen Fail but Randomized|0|||
155649112|NCT04518410|561805943|FG009|Overall Study|Screen Fail but Randomized|0|||
155649113|NCT04518410|561805944|FG010|Overall Study|Screen Fail but Randomized|0|||
155649114|NCT04518410|561805945|FG011|Overall Study|Screen Fail but Randomized|0|||
155649115|NCT04518410|561805946|FG012|Overall Study|Screen Fail but Randomized|0|||
155649116|NCT04518410|561805947|FG013|Overall Study|Screen Fail but Randomized|0|||
155649117|NCT04518410|561805948|FG014|Overall Study|Screen Fail but Randomized|0|||
155649118|NCT04518410|561805949|FG015|Overall Study|Screen Fail but Randomized|0|||
155649119|NCT04518410|561805950|FG016|Overall Study|Screen Fail but Randomized|0|||
155649120|NCT04518410|561805951|FG017|Overall Study|Screen Fail but Randomized|0|||
155649121|NCT04518410|561805952|FG018|Overall Study|Screen Fail but Randomized|0|||
155649122|NCT04518410|561805953|FG019|Overall Study|Screen Fail but Randomized|0|||
155649123|NCT04518410|561805954|FG020|Overall Study|Screen Fail but Randomized|0|||
155649124|NCT04518410|561805955|FG021|Overall Study|Screen Fail but Randomized|0|||
155649125|NCT04518410|561805956|FG022|Overall Study|Screen Fail but Randomized|0|||
155649126|NCT04518410|561805957|FG023|Overall Study|Screen Fail but Randomized|0|||
155649127|NCT04518410|561805958|FG024|Overall Study|Screen Fail but Randomized|0|||
155649128|NCT04518410|561805934|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649129|NCT04518410|561805935|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649130|NCT04518410|561805936|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649131|NCT04518410|561805937|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649132|NCT04518410|561805938|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
155649133|NCT04518410|561805939|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
155649134|NCT04518410|561805940|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
155649135|NCT04518410|561805941|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155362674|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362675|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362676|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362677|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362678|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362679|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
155362680|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
155362681|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
155362682|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
155362683|NCT03880019|560761596|FG000|Overall Study|Competing disease|1|||
155362684|NCT05218499|560761597|FG000|Overall Study|Not treated|1|||
155362685|NCT05218499|560761598|FG001|Overall Study|Not treated|1|||
155362686|NCT05218499|560761599|FG002|Overall Study|Not treated|8|||
155362687|NCT05218499|560761597|FG000|Overall Study|Death|2|||
155362688|NCT05218499|560761598|FG001|Overall Study|Death|0|||
155362689|NCT05218499|560761599|FG002|Overall Study|Death|0|||
155362690|NCT05218499|560761597|FG000|Overall Study|Other than listed|3|||
155362691|NCT05218499|560761598|FG001|Overall Study|Other than listed|7|||
155362692|NCT05218499|560761599|FG002|Overall Study|Other than listed|10|||
155362693|NCT05218499|560761597|FG000|Overall Study|Protocol deviation|5|||
155362694|NCT05218499|560761598|FG001|Overall Study|Protocol deviation|6|||
155362695|NCT05218499|560761599|FG002|Overall Study|Protocol deviation|4|||
155362696|NCT05218499|560761597|FG000|Overall Study|Technical problems|0|||
155362697|NCT05218499|560761598|FG001|Overall Study|Technical problems|1|||
155362698|NCT05218499|560761599|FG002|Overall Study|Technical problems|0|||
155362699|NCT05218499|560761597|FG000|Overall Study|Burden of trial procedures|0|||
155362700|NCT05218499|560761598|FG001|Overall Study|Burden of trial procedures|1|||
155362701|NCT05218499|560761599|FG002|Overall Study|Burden of trial procedures|2|||
155362702|NCT05218499|560761597|FG000|Overall Study|Clinical disease progression|6|||
155362703|NCT05218499|560761598|FG001|Overall Study|Clinical disease progression|6|||
155362704|NCT05218499|560761599|FG002|Overall Study|Clinical disease progression|11|||
155362705|NCT05218499|560761597|FG000|Overall Study|Objective disease progression|44|||
155362706|NCT05218499|560761598|FG001|Overall Study|Objective disease progression|61|||
155362707|NCT05218499|560761599|FG002|Overall Study|Objective disease progression|42|||
155362708|NCT05218499|560761597|FG000|Overall Study|Adverse Event|11|||
155362709|NCT05218499|560761598|FG001|Overall Study|Adverse Event|36|||
155362710|NCT05218499|560761599|FG002|Overall Study|Adverse Event|9|||
155362711|NCT05218499|560761597|FG000|Overall Study|On treatment at time of snapshot|18|||
155362712|NCT05218499|560761598|FG001|Overall Study|On treatment at time of snapshot|29|||
155362713|NCT05218499|560761599|FG002|Overall Study|On treatment at time of snapshot|0|||
155362714|NCT03635086|560761605|FG000|Overall Study|Withdrawal of consent|0|||
155362715|NCT03635086|560761606|FG001|Overall Study|Withdrawal of consent|0|||
155362716|NCT03635086|560761607|FG002|Overall Study|Withdrawal of consent|1|||
155362717|NCT03635086|560761608|FG003|Overall Study|Withdrawal of consent|0|||
155362718|NCT03635086|560761609|FG004|Overall Study|Withdrawal of consent|0|||
155362719|NCT03635086|560761605|FG000|Overall Study|Adverse Event|0|||
155362720|NCT03635086|560761606|FG001|Overall Study|Adverse Event|1|||
155362721|NCT03635086|560761607|FG002|Overall Study|Adverse Event|0|||
155362722|NCT03635086|560761608|FG003|Overall Study|Adverse Event|0|||
155362723|NCT03635086|560761609|FG004|Overall Study|Adverse Event|0|||
155362724|NCT03635086|560761605|FG000|Overall Study|Lost to Follow-up|1|||
155362725|NCT03635086|560761606|FG001|Overall Study|Lost to Follow-up|0|||
155362726|NCT03635086|560761607|FG002|Overall Study|Lost to Follow-up|0|||
155362727|NCT03635086|560761608|FG003|Overall Study|Lost to Follow-up|0|||
155362728|NCT03635086|560761609|FG004|Overall Study|Lost to Follow-up|0|||
155362729|NCT02196077|560761610|FG000|Overall Study|Adverse Event|4|||
155362730|NCT02196077|560761610|FG000|Overall Study|Lack of Efficacy|1|||
155362731|NCT02196077|560761610|FG000|Overall Study|Withdrawal by Subject|14|||
155362732|NCT02196077|560761610|FG000|Overall Study|Physician Decision|1|||
155362733|NCT02196077|560761610|FG000|Overall Study|Lost to Follow-up|3|||
155362734|NCT02196077|560761610|FG000|Overall Study|Protocol Violation|24|||
155362735|NCT03482752|560761615|FG000|Overall Study|Withdrawal by Subject|2|||
155362736|NCT03482752|560761615|FG000|Overall Study|Lost to Follow-up|1|||
155362737|NCT03482752|560761615|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
155362738|NCT03566979|560761616|FG000|Overall Study|Withdrawal by Subject|2|||
155362739|NCT03566979|560761617|FG001|Overall Study|Withdrawal by Subject|0|||
155362740|NCT03566979|560761618|FG002|Overall Study|Withdrawal by Subject|1|||
155362741|NCT03566979|560761619|FG003|Overall Study|Withdrawal by Subject|1|||
155362742|NCT03566979|560761616|FG000|Overall Study|Lost to Follow-up|2|||
155362743|NCT03566979|560761617|FG001|Overall Study|Lost to Follow-up|7|||
155362744|NCT03566979|560761618|FG002|Overall Study|Lost to Follow-up|9|||
155362745|NCT03566979|560761619|FG003|Overall Study|Lost to Follow-up|5|||
155362746|NCT03566979|560761616|FG000|Overall Study|Adverse Event|1|||
155507426|NCT01078623|561285081|FG019|Treatment Period 2|Withdrawal by Subject|0|||
155507427|NCT01078623|561285062|FG000|Treatment Period 3|Adverse Event|0|||
155507428|NCT01078623|561285063|FG001|Treatment Period 3|Adverse Event|0|||
155507429|NCT01078623|561285064|FG002|Treatment Period 3|Adverse Event|0|||
155507430|NCT01078623|561285065|FG003|Treatment Period 3|Adverse Event|0|||
155507431|NCT01078623|561285066|FG004|Treatment Period 3|Adverse Event|1|||
155507432|NCT01078623|561285067|FG005|Treatment Period 3|Adverse Event|0|||
155507433|NCT01078623|561285068|FG006|Treatment Period 3|Adverse Event|0|||
155362747|NCT03566979|560761617|FG001|Overall Study|Adverse Event|0|||
155362748|NCT03566979|560761618|FG002|Overall Study|Adverse Event|0|||
155362749|NCT03566979|560761619|FG003|Overall Study|Adverse Event|0|||
155362750|NCT00658606|560761620|FG000|Overall Study|Adverse Event|2|||
155362751|NCT00658606|560761621|FG001|Overall Study|Adverse Event|1|||
155507434|NCT01078623|561285069|FG007|Treatment Period 3|Adverse Event|0|||
155649136|NCT04518410|561805942|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
155362752|NCT00658606|560761620|FG000|Overall Study|Lack of Efficacy|6|||
155362753|NCT00658606|560761621|FG001|Overall Study|Lack of Efficacy|3|||
155507435|NCT01078623|561285070|FG008|Treatment Period 3|Adverse Event|0|||
155362754|NCT00658606|560761620|FG000|Overall Study|Lost to Follow-up|1|||
155362755|NCT00658606|560761621|FG001|Overall Study|Lost to Follow-up|0|||
155362756|NCT00658606|560761620|FG000|Overall Study|Withdrawal by Subject|7|||
155362757|NCT00658606|560761621|FG001|Overall Study|Withdrawal by Subject|16|||
155362758|NCT00658606|560761620|FG000|Overall Study|Lack of Compliance|0|||
155362759|NCT00658606|560761621|FG001|Overall Study|Lack of Compliance|3|||
155362760|NCT01056263|560761622|FG000|Overall Study|Adverse Event|12|||
155362761|NCT01056263|560761622|FG000|Overall Study|Death|1|||
155362762|NCT01056263|560761622|FG000|Overall Study|Withdrawal by Subject|1|||
155362763|NCT01056263|560761622|FG000|Overall Study|Lack of Efficacy|29|||
155362764|NCT01056263|560761622|FG000|Overall Study|Progressive disease|2|||
155362765|NCT01056263|560761622|FG000|Overall Study|Neoplasm progression|1|||
155362766|NCT01056263|560761622|FG000|Overall Study|Objective progression or relapse|1|||
155362767|NCT01056263|560761622|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
155362768|NCT01358331|560761627|FG000|Overall Study|Lost to Follow-up|0|||
155362769|NCT01358331|560761628|FG001|Overall Study|Lost to Follow-up|0|||
155362770|NCT01358331|560761629|FG002|Overall Study|Lost to Follow-up|0|||
155362771|NCT01358331|560761630|FG003|Overall Study|Lost to Follow-up|1|||
155362772|NCT01358331|560761631|FG004|Overall Study|Lost to Follow-up|0|||
155362773|NCT01358331|560761632|FG005|Overall Study|Lost to Follow-up|0|||
155362774|NCT01358331|560761627|FG000|Overall Study|Withdrawal by Subject|0|||
155362775|NCT01358331|560761628|FG001|Overall Study|Withdrawal by Subject|0|||
155362776|NCT01358331|560761629|FG002|Overall Study|Withdrawal by Subject|0|||
155362777|NCT01358331|560761630|FG003|Overall Study|Withdrawal by Subject|1|||
155362778|NCT01358331|560761631|FG004|Overall Study|Withdrawal by Subject|1|||
155362779|NCT01358331|560761632|FG005|Overall Study|Withdrawal by Subject|1|||
155362780|NCT01358331|560761627|FG000|Overall Study|Adverse Events|1|||
155362781|NCT01358331|560761628|FG001|Overall Study|Adverse Events|1|||
155362782|NCT01358331|560761629|FG002|Overall Study|Adverse Events|1|||
155362783|NCT01358331|560761630|FG003|Overall Study|Adverse Events|0|||
155362784|NCT01358331|560761631|FG004|Overall Study|Adverse Events|1|||
155362785|NCT01358331|560761632|FG005|Overall Study|Adverse Events|5|||
155362786|NCT01358331|560761627|FG000|Overall Study|Symptomatic Deterioration|0|||
155362787|NCT01358331|560761628|FG001|Overall Study|Symptomatic Deterioration|0|||
155362788|NCT01358331|560761629|FG002|Overall Study|Symptomatic Deterioration|0|||
155362789|NCT01358331|560761630|FG003|Overall Study|Symptomatic Deterioration|0|||
155362790|NCT01358331|560761631|FG004|Overall Study|Symptomatic Deterioration|1|||
155362791|NCT01358331|560761632|FG005|Overall Study|Symptomatic Deterioration|0|||
155362792|NCT01358331|560761627|FG000|Overall Study|Participants did not wish to continue|0|||
155362793|NCT01358331|560761628|FG001|Overall Study|Participants did not wish to continue|0|||
155362794|NCT01358331|560761629|FG002|Overall Study|Participants did not wish to continue|0|||
155362795|NCT01358331|560761630|FG003|Overall Study|Participants did not wish to continue|0|||
155362796|NCT01358331|560761631|FG004|Overall Study|Participants did not wish to continue|1|||
155362797|NCT01358331|560761632|FG005|Overall Study|Participants did not wish to continue|0|||
155362798|NCT01358331|560761627|FG000|Overall Study|Progress of disease under investigation|1|||
155362799|NCT01358331|560761628|FG001|Overall Study|Progress of disease under investigation|2|||
155362800|NCT01358331|560761629|FG002|Overall Study|Progress of disease under investigation|3|||
155362801|NCT01358331|560761630|FG003|Overall Study|Progress of disease under investigation|1|||
155362802|NCT01358331|560761631|FG004|Overall Study|Progress of disease under investigation|3|||
155362803|NCT01358331|560761632|FG005|Overall Study|Progress of disease under investigation|0|||
155362804|NCT01431950|560761641|FG000|Overall Study|Study Site Closed/Terminated|7|||
155362805|NCT01431950|560761642|FG001|Overall Study|Study Site Closed/Terminated|3|||
155362806|NCT01431950|560761641|FG000|Overall Study|Withdrawal by Subject|4|||
155362807|NCT01431950|560761642|FG001|Overall Study|Withdrawal by Subject|3|||
155362808|NCT01431950|560761641|FG000|Overall Study|Protocol Violation|2|||
155362809|NCT01431950|560761642|FG001|Overall Study|Protocol Violation|3|||
155362810|NCT01431950|560761641|FG000|Overall Study|Adverse Event|2|||
155362811|NCT01431950|560761642|FG001|Overall Study|Adverse Event|2|||
155362812|NCT01431950|560761641|FG000|Overall Study|Physician Decision|2|||
155362813|NCT01431950|560761642|FG001|Overall Study|Physician Decision|1|||
155362814|NCT01431950|560761641|FG000|Overall Study|Lack of Efficacy|2|||
155362815|NCT01431950|560761642|FG001|Overall Study|Lack of Efficacy|1|||
155362816|NCT01431950|560761641|FG000|Overall Study|Lost to Follow-up|0|||
155362817|NCT01431950|560761642|FG001|Overall Study|Lost to Follow-up|1|||
155362818|NCT01431950|560761641|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155362819|NCT01431950|560761642|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155362820|NCT00738283|560761643|FG000|Overall Study|Death|1|||
155362821|NCT00738283|560761643|FG000|Overall Study|Transfer to another facility|2|||
155362822|NCT00738283|560761643|FG000|Overall Study|Discharge home prior to end of study|1|||
155362823|NCT01210651|560761644|FG000|Overall Study|Lost to Follow-up|1|||
155362824|NCT01210651|560761645|FG001|Overall Study|Lost to Follow-up|1|||
155362825|NCT01210651|560761644|FG000|Overall Study|schedule conflicts|1|||
155362826|NCT01210651|560761645|FG001|Overall Study|schedule conflicts|5|||
155362827|NCT01210651|560761644|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
155362828|NCT01210651|560761645|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
155362829|NCT01210651|560761644|FG000|Overall Study|Withdrawal by Subject|1|||
155362830|NCT01210651|560761645|FG001|Overall Study|Withdrawal by Subject|1|||
155362831|NCT01210651|560761644|FG000|Overall Study|Injury outside study|2|||
155362832|NCT01210651|560761645|FG001|Overall Study|Injury outside study|0|||
155362833|NCT02559310|560761646|FG000|Overall Study|Death|4|||
155362834|NCT02559310|560761647|FG001|Overall Study|Death|3|||
155362835|NCT02559310|560761646|FG000|Overall Study|Lost to Follow-up|5|||
155362836|NCT02559310|560761647|FG001|Overall Study|Lost to Follow-up|3|||
155362837|NCT02559310|560761646|FG000|Overall Study|Physician Decision|2|||
155362838|NCT02559310|560761647|FG001|Overall Study|Physician Decision|1|||
155362839|NCT02559310|560761646|FG000|Overall Study|Withdrawal by Subject|13|||
155362840|NCT02559310|560761647|FG001|Overall Study|Withdrawal by Subject|9|||
155362841|NCT02559310|560761646|FG000|Overall Study|Sponsor Decision|0|||
155362842|NCT02559310|560761647|FG001|Overall Study|Sponsor Decision|1|||
155362843|NCT02559310|560761646|FG000|Overall Study|Randomized but not treated|3|||
155362844|NCT02559310|560761647|FG001|Overall Study|Randomized but not treated|2|||
155362845|NCT03595878|560761648|FG000|Overall Study|Death|2|||
155362846|NCT03595878|560761649|FG001|Overall Study|Death|1|||
155362847|NCT03595878|560761650|FG002|Overall Study|Death|0|||
155362848|NCT03595878|560761648|FG000|Overall Study|Disease progression|2|||
155362849|NCT03595878|560761649|FG001|Overall Study|Disease progression|1|||
155362850|NCT03595878|560761650|FG002|Overall Study|Disease progression|2|||
155362851|NCT03494985|560761651|FG000|Overall Study|Adverse Event|3|||
155362852|NCT03494985|560761652|FG001|Overall Study|Adverse Event|2|||
155362853|NCT03494985|560761653|FG002|Overall Study|Adverse Event|3|||
155362854|NCT03494985|560761654|FG003|Overall Study|Adverse Event|0|||
155362855|NCT03494985|560761651|FG000|Overall Study|Other (Withdrawal of consent)|2|||
155362856|NCT03494985|560761652|FG001|Overall Study|Other (Withdrawal of consent)|3|||
155362857|NCT03494985|560761653|FG002|Overall Study|Other (Withdrawal of consent)|2|||
155362858|NCT03494985|560761654|FG003|Overall Study|Other (Withdrawal of consent)|5|||
155427586|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
155427587|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
155427588|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
155427589|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
155427590|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
155362859|NCT03494985|560761651|FG000|Overall Study|Other (Not specified)|0|||
155362860|NCT03494985|560761652|FG001|Overall Study|Other (Not specified)|1|||
155362861|NCT03494985|560761653|FG002|Overall Study|Other (Not specified)|1|||
155362862|NCT03494985|560761654|FG003|Overall Study|Other (Not specified)|0|||
155362863|NCT03036124|560761655|FG000|Overall Study|Lost to Follow-up|0|||
155362864|NCT03036124|560761656|FG001|Overall Study|Lost to Follow-up|2|||
155362865|NCT03036124|560761655|FG000|Overall Study|Withdrawal by Subject|5|||
155362866|NCT03036124|560761656|FG001|Overall Study|Withdrawal by Subject|4|||
155362867|NCT02282059|560761657|FG000|Overall Study|Other|15|||
155427591|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
155362868|NCT02282059|560761658|FG001|Overall Study|Other|3|||
155362869|NCT02282059|560761657|FG000|Overall Study|Participant refused further follow-up|8|||
155362870|NCT02282059|560761658|FG001|Overall Study|Participant refused further follow-up|4|||
155362871|NCT02282059|560761657|FG000|Overall Study|Lost to Follow-up|19|||
155362872|NCT02282059|560761658|FG001|Overall Study|Lost to Follow-up|3|||
155362873|NCT02282059|560761657|FG000|Overall Study|Death|40|||
155362874|NCT02282059|560761658|FG001|Overall Study|Death|8|||
155362875|NCT04886518|560761661|FG000|Overall Study|Noncompliance with study drug|1|||
155362876|NCT04886518|560761662|FG001|Overall Study|Noncompliance with study drug|0|||
155362877|NCT04886518|560761663|FG002|Overall Study|Noncompliance with study drug|0|||
155362878|NCT04886518|560761661|FG000|Overall Study|Adverse Event|0|||
155362879|NCT04886518|560761662|FG001|Overall Study|Adverse Event|1|||
155362880|NCT04886518|560761663|FG002|Overall Study|Adverse Event|0|||
155362881|NCT04886518|560761661|FG000|Overall Study|Withdrawal by Subject|1|||
155362882|NCT04886518|560761662|FG001|Overall Study|Withdrawal by Subject|0|||
155362883|NCT04886518|560761663|FG002|Overall Study|Withdrawal by Subject|0|||
155362884|NCT00433511|560763718|FG000|Step 1|Adverse Event|50|||
155362885|NCT00433511|560763719|FG001|Step 1|Adverse Event|157|||
155362886|NCT00433511|560763720|FG002|Step 1|Adverse Event|153|||
155362887|NCT00433511|560763718|FG000|Step 1|Withdrawal by Subject|45|||
155362888|NCT00433511|560763719|FG001|Step 1|Withdrawal by Subject|143|||
155362889|NCT00433511|560763720|FG002|Step 1|Withdrawal by Subject|154|||
155362890|NCT00433511|560763718|FG000|Step 1|Death|3|||
155362891|NCT00433511|560763719|FG001|Step 1|Death|1|||
155362892|NCT00433511|560763720|FG002|Step 1|Death|1|||
155362893|NCT00433511|560763718|FG000|Step 1|Physician Decision|1|||
155362894|NCT00433511|560763719|FG001|Step 1|Physician Decision|4|||
155362895|NCT00433511|560763720|FG002|Step 1|Physician Decision|3|||
155362896|NCT00433511|560763718|FG000|Step 1|Never started protocol therapy|28|||
155362897|NCT00433511|560763719|FG001|Step 1|Never started protocol therapy|64|||
155362898|NCT00433511|560763720|FG002|Step 1|Never started protocol therapy|66|||
155362899|NCT00433511|560763718|FG000|Step 1|Alternative therapy|2|||
155362900|NCT00433511|560763719|FG001|Step 1|Alternative therapy|1|||
155362901|NCT00433511|560763720|FG002|Step 1|Alternative therapy|3|||
155362902|NCT00433511|560763718|FG000|Step 1|Disease progression, relapse|5|||
155362903|NCT00433511|560763719|FG001|Step 1|Disease progression, relapse|3|||
155362904|NCT00433511|560763720|FG002|Step 1|Disease progression, relapse|3|||
155362905|NCT00433511|560763718|FG000|Step 1|Other complicating disease|2|||
155362906|NCT00433511|560763719|FG001|Step 1|Other complicating disease|6|||
155362907|NCT00433511|560763720|FG002|Step 1|Other complicating disease|3|||
155362908|NCT00433511|560763718|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
155362909|NCT00433511|560763719|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
155507436|NCT01078623|561285071|FG009|Treatment Period 3|Adverse Event|0|||
155507437|NCT01078623|561285072|FG010|Treatment Period 3|Adverse Event|0|||
155507438|NCT01078623|561285073|FG011|Treatment Period 3|Adverse Event|0|||
155507439|NCT01078623|561285074|FG012|Treatment Period 3|Adverse Event|0|||
155507440|NCT01078623|561285075|FG013|Treatment Period 3|Adverse Event|1|||
155507441|NCT01078623|561285076|FG014|Treatment Period 3|Adverse Event|0|||
155507442|NCT01078623|561285077|FG015|Treatment Period 3|Adverse Event|0|||
155507443|NCT01078623|561285078|FG016|Treatment Period 3|Adverse Event|0|||
155507444|NCT01078623|561285079|FG017|Treatment Period 3|Adverse Event|0|||
155507445|NCT01078623|561285080|FG018|Treatment Period 3|Adverse Event|0|||
155362910|NCT00433511|560763720|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
155362911|NCT00433511|560763718|FG000|Step 1|Suspected recurrence|0|||
155362912|NCT00433511|560763719|FG001|Step 1|Suspected recurrence|1|||
155362913|NCT00433511|560763720|FG002|Step 1|Suspected recurrence|0|||
155362914|NCT00433511|560763718|FG000|Step 1|Insurance/drug distribution issues|0|||
155362915|NCT00433511|560763719|FG001|Step 1|Insurance/drug distribution issues|1|||
155362916|NCT00433511|560763720|FG002|Step 1|Insurance/drug distribution issues|2|||
155362917|NCT00433511|560763718|FG000|Step 1|Patient moved|0|||
155362918|NCT00433511|560763719|FG001|Step 1|Patient moved|0|||
155362919|NCT00433511|560763720|FG002|Step 1|Patient moved|1|||
155507446|NCT01078623|561285081|FG019|Treatment Period 3|Adverse Event|0|||
155362920|NCT00433511|560763718|FG000|Step 2 (Arm D)|Adverse Event|0|||
155362921|NCT00433511|560763719|FG001|Step 2 (Arm D)|Adverse Event|0|||
155362922|NCT00433511|560763720|FG002|Step 2 (Arm D)|Adverse Event|135|||
155507447|NCT01078623|561285062|FG000|Treatment Period 4|Adverse Event|0|||
155362923|NCT00433511|560763718|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
155362924|NCT00433511|560763719|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
155362925|NCT00433511|560763720|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
155362926|NCT00433511|560763718|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
155362927|NCT00433511|560763719|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
155362928|NCT00433511|560763720|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
155362929|NCT00433511|560763718|FG000|Step 2 (Arm D)|Physician Decision|0|||
155362930|NCT00433511|560763719|FG001|Step 2 (Arm D)|Physician Decision|0|||
155362931|NCT00433511|560763720|FG002|Step 2 (Arm D)|Physician Decision|9|||
155362932|NCT00433511|560763718|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
155362933|NCT00433511|560763719|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
155362934|NCT00433511|560763720|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
155362935|NCT00433511|560763718|FG000|Step 2 (Arm D)|Other complicating disease|0|||
155362936|NCT00433511|560763719|FG001|Step 2 (Arm D)|Other complicating disease|0|||
155362937|NCT00433511|560763720|FG002|Step 2 (Arm D)|Other complicating disease|3|||
155362938|NCT00433511|560763718|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
155362939|NCT00433511|560763719|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
155362940|NCT00433511|560763720|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
155362941|NCT00433511|560763718|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
155362942|NCT00433511|560763719|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
155362943|NCT00433511|560763720|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
155362944|NCT00433511|560763718|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
155362945|NCT00433511|560763719|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
155362946|NCT00433511|560763720|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
155362947|NCT00433511|560763718|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
155362948|NCT00433511|560763719|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
155362949|NCT00433511|560763720|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
155362950|NCT04328623|560763721|FG000|Overall Study|Protocol Violation|0|||
155362951|NCT04328623|560763722|FG001|Overall Study|Protocol Violation|1|||
155362952|NCT00742326|560763725|FG000|Overall Study|Physician Decision|0|||
155362953|NCT00742326|560763726|FG001|Overall Study|Physician Decision|1|||
155362954|NCT00150618|560763727|FG000|Overall Study|Adverse Event|2|||
155362955|NCT00150618|560763728|FG001|Overall Study|Adverse Event|2|||
155362956|NCT00150618|560763729|FG002|Overall Study|Adverse Event|6|||
155362957|NCT00150618|560763730|FG003|Overall Study|Adverse Event|9|||
155362958|NCT00150618|560763731|FG004|Overall Study|Adverse Event|5|||
155362959|NCT00150618|560763727|FG000|Overall Study|Withdrawal by Subject|6|||
155362960|NCT00150618|560763728|FG001|Overall Study|Withdrawal by Subject|8|||
155362961|NCT00150618|560763729|FG002|Overall Study|Withdrawal by Subject|8|||
155362962|NCT00150618|560763730|FG003|Overall Study|Withdrawal by Subject|4|||
155362963|NCT00150618|560763731|FG004|Overall Study|Withdrawal by Subject|5|||
155362964|NCT00150618|560763727|FG000|Overall Study|Lost to Follow-up|4|||
155362965|NCT00150618|560763728|FG001|Overall Study|Lost to Follow-up|1|||
155362966|NCT00150618|560763729|FG002|Overall Study|Lost to Follow-up|5|||
155362967|NCT00150618|560763730|FG003|Overall Study|Lost to Follow-up|8|||
155362968|NCT00150618|560763731|FG004|Overall Study|Lost to Follow-up|4|||
155362969|NCT00150618|560763727|FG000|Overall Study|Protocol Violation|1|||
155362970|NCT00150618|560763728|FG001|Overall Study|Protocol Violation|0|||
155362971|NCT00150618|560763729|FG002|Overall Study|Protocol Violation|0|||
155362972|NCT00150618|560763730|FG003|Overall Study|Protocol Violation|0|||
155427592|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
155427593|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
155427594|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
155427595|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
155427596|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
155362973|NCT00150618|560763731|FG004|Overall Study|Protocol Violation|1|||
155362974|NCT00150618|560763727|FG000|Overall Study|Lack of Efficacy|1|||
155362975|NCT00150618|560763728|FG001|Overall Study|Lack of Efficacy|4|||
155362976|NCT00150618|560763729|FG002|Overall Study|Lack of Efficacy|7|||
155362977|NCT00150618|560763730|FG003|Overall Study|Lack of Efficacy|4|||
155362978|NCT00150618|560763731|FG004|Overall Study|Lack of Efficacy|6|||
155362979|NCT00150618|560763727|FG000|Overall Study|No study meds|0|||
155362980|NCT00150618|560763728|FG001|Overall Study|No study meds|0|||
155362981|NCT00150618|560763729|FG002|Overall Study|No study meds|0|||
155427597|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
155427598|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
155427599|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
155427600|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
155427601|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
155427602|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
155362982|NCT00150618|560763730|FG003|Overall Study|No study meds|0|||
155362983|NCT00150618|560763731|FG004|Overall Study|No study meds|2|||
155362984|NCT00150618|560763727|FG000|Overall Study|Physician Decision|0|||
155362985|NCT00150618|560763728|FG001|Overall Study|Physician Decision|2|||
155362986|NCT00150618|560763729|FG002|Overall Study|Physician Decision|0|||
155362987|NCT00150618|560763730|FG003|Overall Study|Physician Decision|0|||
155362988|NCT00150618|560763731|FG004|Overall Study|Physician Decision|1|||
155362989|NCT00150618|560763727|FG000|Overall Study|Lack of compliance|2|||
155362990|NCT00150618|560763728|FG001|Overall Study|Lack of compliance|1|||
155362991|NCT00150618|560763729|FG002|Overall Study|Lack of compliance|1|||
155362992|NCT00150618|560763730|FG003|Overall Study|Lack of compliance|0|||
155362993|NCT00150618|560763731|FG004|Overall Study|Lack of compliance|1|||
155362994|NCT00150618|560763727|FG000|Overall Study|Abnormal ECG|1|||
155362995|NCT00150618|560763728|FG001|Overall Study|Abnormal ECG|0|||
155362996|NCT00150618|560763729|FG002|Overall Study|Abnormal ECG|0|||
155362997|NCT00150618|560763730|FG003|Overall Study|Abnormal ECG|0|||
155362998|NCT00150618|560763731|FG004|Overall Study|Abnormal ECG|0|||
155362999|NCT00150618|560763727|FG000|Overall Study|Sponsor's decision|0|||
155363000|NCT00150618|560763728|FG001|Overall Study|Sponsor's decision|0|||
155363001|NCT00150618|560763729|FG002|Overall Study|Sponsor's decision|0|||
155363002|NCT00150618|560763730|FG003|Overall Study|Sponsor's decision|1|||
155363003|NCT00150618|560763731|FG004|Overall Study|Sponsor's decision|0|||
155363004|NCT02493946|560763733|FG000|DB Period|Withdrawal by Subject|8|||
155363005|NCT02493946|560763734|FG001|DB Period|Withdrawal by Subject|5|||
155363006|NCT02493946|560763735|FG002|DB Period|Withdrawal by Subject|0|||
155363007|NCT02493946|560763733|FG000|Open Label Period|Withdrawal by Subject|0|||
155363008|NCT02493946|560763734|FG001|Open Label Period|Withdrawal by Subject|0|||
155363009|NCT02493946|560763735|FG002|Open Label Period|Withdrawal by Subject|74|||
155363010|NCT02493946|560763733|FG000|Open Label Period|Adverse Event|0|||
155363011|NCT02493946|560763734|FG001|Open Label Period|Adverse Event|0|||
155363012|NCT02493946|560763735|FG002|Open Label Period|Adverse Event|4|||
155363013|NCT02493946|560763733|FG000|Open Label Period|Lost to Follow-up|0|||
155363014|NCT02493946|560763734|FG001|Open Label Period|Lost to Follow-up|0|||
155363015|NCT02493946|560763735|FG002|Open Label Period|Lost to Follow-up|1|||
155363016|NCT02493946|560763733|FG000|Open Label Period|Investigator decision, non-compliance|0|||
155363017|NCT02493946|560763734|FG001|Open Label Period|Investigator decision, non-compliance|0|||
155363018|NCT02493946|560763735|FG002|Open Label Period|Investigator decision, non-compliance|2|||
155363019|NCT02493946|560763733|FG000|Open Label Period|Investigator decision, non-availability|0|||
155363020|NCT02493946|560763734|FG001|Open Label Period|Investigator decision, non-availability|0|||
155363021|NCT02493946|560763735|FG002|Open Label Period|Investigator decision, non-availability|1|||
155363022|NCT02493946|560763733|FG000|Open Label Period|Pregnancy|0|||
155507448|NCT01078623|561285063|FG001|Treatment Period 4|Adverse Event|0|||
155507449|NCT01078623|561285064|FG002|Treatment Period 4|Adverse Event|1|||
155507450|NCT01078623|561285065|FG003|Treatment Period 4|Adverse Event|0|||
155507451|NCT01078623|561285066|FG004|Treatment Period 4|Adverse Event|0|||
155507452|NCT01078623|561285067|FG005|Treatment Period 4|Adverse Event|0|||
155507453|NCT01078623|561285068|FG006|Treatment Period 4|Adverse Event|0|||
155507454|NCT01078623|561285069|FG007|Treatment Period 4|Adverse Event|0|||
155507455|NCT01078623|561285070|FG008|Treatment Period 4|Adverse Event|0|||
155507456|NCT01078623|561285071|FG009|Treatment Period 4|Adverse Event|0|||
155507457|NCT01078623|561285072|FG010|Treatment Period 4|Adverse Event|0|||
155507458|NCT01078623|561285073|FG011|Treatment Period 4|Adverse Event|0|||
155507459|NCT01078623|561285074|FG012|Treatment Period 4|Adverse Event|0|||
155507460|NCT01078623|561285075|FG013|Treatment Period 4|Adverse Event|0|||
155507461|NCT01078623|561285076|FG014|Treatment Period 4|Adverse Event|0|||
155507462|NCT01078623|561285077|FG015|Treatment Period 4|Adverse Event|0|||
155507463|NCT01078623|561285078|FG016|Treatment Period 4|Adverse Event|0|||
155507464|NCT01078623|561285079|FG017|Treatment Period 4|Adverse Event|0|||
155507465|NCT01078623|561285080|FG018|Treatment Period 4|Adverse Event|0|||
155363023|NCT02493946|560763734|FG001|Open Label Period|Pregnancy|0|||
155363024|NCT02493946|560763735|FG002|Open Label Period|Pregnancy|3|||
155363025|NCT02493946|560763733|FG000|Open Label Period|Site error|0|||
155507466|NCT01078623|561285081|FG019|Treatment Period 4|Adverse Event|0|||
155363026|NCT02493946|560763734|FG001|Open Label Period|Site error|0|||
155363027|NCT02493946|560763735|FG002|Open Label Period|Site error|1|||
155363028|NCT00965497|560763736|FG000|Overall Study|Physician Decision|1|||
155507467|NCT01078623|561285062|FG000|Treatment Period 4|Withdrawal by Subject|0|||
155507468|NCT01078623|561285063|FG001|Treatment Period 4|Withdrawal by Subject|0|||
155507469|NCT01078623|561285064|FG002|Treatment Period 4|Withdrawal by Subject|0|||
155507470|NCT01078623|561285065|FG003|Treatment Period 4|Withdrawal by Subject|0|||
155363029|NCT02878603|560763737|FG000|Overall Study|Lost to Follow-up|4|||
155507471|NCT01078623|561285066|FG004|Treatment Period 4|Withdrawal by Subject|0|||
155363030|NCT02878603|560763738|FG001|Overall Study|Lost to Follow-up|1|||
155363031|NCT02878603|560763737|FG000|Overall Study|Withdrawal by Subject|1|||
155363032|NCT02878603|560763738|FG001|Overall Study|Withdrawal by Subject|1|||
155363033|NCT02878603|560763737|FG000|Overall Study|Death|1|||
155363034|NCT02878603|560763738|FG001|Overall Study|Death|0|||
155363035|NCT02878603|560763737|FG000|Overall Study|Physician Decision|0|||
155363036|NCT02878603|560763738|FG001|Overall Study|Physician Decision|3|||
155363037|NCT02689453|560763739|FG000|Overall Study|Progressive disease|0|||
155363038|NCT02689453|560763740|FG001|Overall Study|Progressive disease|1|||
155363039|NCT02689453|560763741|FG002|Overall Study|Progressive disease|1|||
155363040|NCT01162486|560763742|FG000|Overall Study|low ANC|1|||
155363041|NCT01162486|560763743|FG001|Overall Study|low ANC|0|||
155363042|NCT01162486|560763744|FG002|Overall Study|low ANC|0|||
155363043|NCT01162486|560763745|FG003|Overall Study|low ANC|0|||
155363044|NCT01162486|560763746|FG004|Overall Study|low ANC|0|||
155363045|NCT01162486|560763742|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
155363046|NCT01162486|560763743|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363047|NCT01162486|560763744|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363048|NCT01162486|560763745|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363049|NCT01162486|560763746|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363050|NCT01162486|560763742|FG000|Overall Study|elevated LFTs|0|||
155363051|NCT01162486|560763743|FG001|Overall Study|elevated LFTs|0|||
155363052|NCT01162486|560763744|FG002|Overall Study|elevated LFTs|1|||
155363053|NCT01162486|560763745|FG003|Overall Study|elevated LFTs|0|||
155363054|NCT01162486|560763746|FG004|Overall Study|elevated LFTs|0|||
155363055|NCT01162486|560763742|FG000|Overall Study|Pregnancy|0|||
155363056|NCT01162486|560763743|FG001|Overall Study|Pregnancy|0|||
155363057|NCT01162486|560763744|FG002|Overall Study|Pregnancy|0|||
155363058|NCT01162486|560763745|FG003|Overall Study|Pregnancy|1|||
155363059|NCT01162486|560763746|FG004|Overall Study|Pregnancy|0|||
155363060|NCT00794924|560763747|FG000|Overall Study|Lost to Follow-up|6|||
155363061|NCT00794924|560763748|FG001|Overall Study|Lost to Follow-up|8|||
155363062|NCT00794924|560763747|FG000|Overall Study|Withdrawal by Subject|48|||
155363063|NCT00794924|560763748|FG001|Overall Study|Withdrawal by Subject|60|||
155363064|NCT00794924|560763747|FG000|Overall Study|Adverse Event|6|||
155363065|NCT00794924|560763748|FG001|Overall Study|Adverse Event|2|||
155363066|NCT00953615|560763749|FG000|Overall Study|Adverse Event|1|||
155363067|NCT03274895|560763750|FG000|Overall Study|Lack of Efficacy|1|||
155363068|NCT03274895|560763751|FG001|Overall Study|Lack of Efficacy|0|||
155363069|NCT03274895|560763750|FG000|Overall Study|Adverse Event|8|||
155363070|NCT03274895|560763751|FG001|Overall Study|Adverse Event|7|||
155363071|NCT03274895|560763750|FG000|Overall Study|Lost to Follow-up|1|||
155363072|NCT03274895|560763751|FG001|Overall Study|Lost to Follow-up|0|||
155363073|NCT03274895|560763750|FG000|Overall Study|Diagnosis not confirmed|3|||
155363074|NCT03274895|560763751|FG001|Overall Study|Diagnosis not confirmed|4|||
155363075|NCT01969851|560763756|FG000|Overall Study|Adverse Event|0|||
155507472|NCT01078623|561285067|FG005|Treatment Period 4|Withdrawal by Subject|0|||
155507473|NCT01078623|561285068|FG006|Treatment Period 4|Withdrawal by Subject|0|||
155507474|NCT01078623|561285069|FG007|Treatment Period 4|Withdrawal by Subject|0|||
155507475|NCT01078623|561285070|FG008|Treatment Period 4|Withdrawal by Subject|0|||
155507476|NCT01078623|561285071|FG009|Treatment Period 4|Withdrawal by Subject|0|||
155507477|NCT01078623|561285072|FG010|Treatment Period 4|Withdrawal by Subject|0|||
155507478|NCT01078623|561285073|FG011|Treatment Period 4|Withdrawal by Subject|0|||
155507479|NCT01078623|561285074|FG012|Treatment Period 4|Withdrawal by Subject|0|||
155363076|NCT01969851|560763757|FG001|Overall Study|Adverse Event|0|||
155363077|NCT01969851|560763758|FG002|Overall Study|Adverse Event|3|||
155363078|NCT01969851|560763756|FG000|Overall Study|Lack of Efficacy|0|||
155507480|NCT01078623|561285075|FG013|Treatment Period 4|Withdrawal by Subject|0|||
155363079|NCT01969851|560763757|FG001|Overall Study|Lack of Efficacy|3|||
155507481|NCT01078623|561285076|FG014|Treatment Period 4|Withdrawal by Subject|0|||
155363080|NCT01969851|560763758|FG002|Overall Study|Lack of Efficacy|1|||
155363081|NCT01969851|560763756|FG000|Overall Study|Withdrawal by Subject|1|||
155363082|NCT01969851|560763757|FG001|Overall Study|Withdrawal by Subject|0|||
155507482|NCT01078623|561285077|FG015|Treatment Period 4|Withdrawal by Subject|1|||
155363083|NCT01969851|560763758|FG002|Overall Study|Withdrawal by Subject|1|||
155363084|NCT01969851|560763756|FG000|Overall Study|No effective dose in Titration period|0|||
155363085|NCT01969851|560763757|FG001|Overall Study|No effective dose in Titration period|0|||
155363086|NCT01969851|560763758|FG002|Overall Study|No effective dose in Titration period|1|||
155363087|NCT01969851|560763756|FG000|Overall Study|Sponsor decision|0|||
155363088|NCT01969851|560763757|FG001|Overall Study|Sponsor decision|0|||
155363089|NCT01969851|560763758|FG002|Overall Study|Sponsor decision|1|||
155363090|NCT01294436|560763759|FG000|Overall Study|Adverse Event|10|||
155363091|NCT01294436|560763760|FG001|Overall Study|Adverse Event|17|||
155363092|NCT01294436|560763759|FG000|Overall Study|Withdrawal by Subject|11|||
155363093|NCT01294436|560763760|FG001|Overall Study|Withdrawal by Subject|28|||
155363094|NCT01294436|560763759|FG000|Overall Study|subject no longer meets study criteria|5|||
155363095|NCT01294436|560763760|FG001|Overall Study|subject no longer meets study criteria|20|||
155363096|NCT01294436|560763759|FG000|Overall Study|poor/non-compliance|2|||
155363097|NCT01294436|560763760|FG001|Overall Study|poor/non-compliance|5|||
155363098|NCT02389764|560763761|FG000|Overall Study|Lack of Efficacy|9|||
155363099|NCT02498236|560763769|FG000|Overall Study|Did not show for testing|1|||
155363100|NCT02498236|560763770|FG001|Overall Study|Did not show for testing|0|||
155363101|NCT02498236|560763771|FG002|Overall Study|Did not show for testing|0|||
155363102|NCT02498236|560763772|FG003|Overall Study|Did not show for testing|0|||
155363103|NCT02498236|560763773|FG004|Overall Study|Did not show for testing|0|||
155363104|NCT02498236|560763774|FG005|Overall Study|Did not show for testing|0|||
155363105|NCT02498236|560763775|FG006|Overall Study|Did not show for testing|0|||
155363106|NCT02498236|560763776|FG007|Overall Study|Did not show for testing|1|||
155363107|NCT02498236|560763769|FG000|Overall Study|Equipment failure|0|||
155363108|NCT02498236|560763770|FG001|Overall Study|Equipment failure|0|||
155363109|NCT02498236|560763771|FG002|Overall Study|Equipment failure|0|||
155363110|NCT02498236|560763772|FG003|Overall Study|Equipment failure|0|||
155363111|NCT02498236|560763773|FG004|Overall Study|Equipment failure|0|||
155363112|NCT02498236|560763774|FG005|Overall Study|Equipment failure|0|||
155363113|NCT02498236|560763775|FG006|Overall Study|Equipment failure|1|||
155363114|NCT02498236|560763776|FG007|Overall Study|Equipment failure|0|||
155363115|NCT02498236|560763769|FG000|Overall Study|Withdrawal by Subject|0|||
155363116|NCT02498236|560763770|FG001|Overall Study|Withdrawal by Subject|0|||
155363117|NCT02498236|560763771|FG002|Overall Study|Withdrawal by Subject|0|||
155363118|NCT02498236|560763772|FG003|Overall Study|Withdrawal by Subject|0|||
155363119|NCT02498236|560763773|FG004|Overall Study|Withdrawal by Subject|1|||
155363120|NCT02498236|560763774|FG005|Overall Study|Withdrawal by Subject|0|||
155363121|NCT02498236|560763775|FG006|Overall Study|Withdrawal by Subject|0|||
155363122|NCT02498236|560763776|FG007|Overall Study|Withdrawal by Subject|0|||
155363123|NCT02296892|560763777|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
155363124|NCT02296892|560763778|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
155363125|NCT02296892|560763779|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
155363126|NCT02296892|560763777|FG000|Overall Study|Lost to Follow-up|5|||
155363127|NCT02296892|560763778|FG001|Overall Study|Lost to Follow-up|0|||
155363128|NCT02296892|560763779|FG002|Overall Study|Lost to Follow-up|1|||
155363129|NCT00585078|560763780|FG000|Overall Study|Withdrawal by Subject|4|||
155363130|NCT00585078|560763780|FG000|Overall Study|Poor performance status|1|||
155363131|NCT00585078|560763780|FG000|Overall Study|Disease Progression|24|||
155363132|NCT00585078|560763780|FG000|Overall Study|Adverse Event|10|||
155363133|NCT00585078|560763780|FG000|Overall Study|Death|1|||
155363134|NCT01814072|560763785|FG000|Overall Study|Lost to Follow-up|2|||
155363135|NCT01814072|560763786|FG001|Overall Study|Lost to Follow-up|2|||
155363136|NCT01814072|560763787|FG002|Overall Study|Lost to Follow-up|2|||
155363137|NCT01814072|560763788|FG003|Overall Study|Lost to Follow-up|0|||
155363138|NCT01814072|560763789|FG004|Overall Study|Lost to Follow-up|2|||
155363139|NCT01814072|560763790|FG005|Overall Study|Lost to Follow-up|3|||
155363140|NCT01814072|560763791|FG006|Overall Study|Lost to Follow-up|3|||
155363141|NCT01814072|560763792|FG007|Overall Study|Lost to Follow-up|1|||
155363142|NCT01814072|560763793|FG008|Overall Study|Lost to Follow-up|2|||
155363143|NCT01814072|560763794|FG009|Overall Study|Lost to Follow-up|3|||
155363144|NCT01814072|560763795|FG010|Overall Study|Lost to Follow-up|1|||
155363145|NCT01814072|560763796|FG011|Overall Study|Lost to Follow-up|2|||
155363146|NCT01814072|560763797|FG012|Overall Study|Lost to Follow-up|2|||
155363147|NCT01814072|560763798|FG013|Overall Study|Lost to Follow-up|1|||
155363148|NCT01814072|560763799|FG014|Overall Study|Lost to Follow-up|2|||
155363149|NCT01814072|560763800|FG015|Overall Study|Lost to Follow-up|1|||
155363150|NCT01814072|560763801|FG016|Overall Study|Lost to Follow-up|3|||
155363151|NCT01814072|560763802|FG017|Overall Study|Lost to Follow-up|1|||
155363152|NCT01814072|560763803|FG018|Overall Study|Lost to Follow-up|3|||
155363153|NCT01814072|560763804|FG019|Overall Study|Lost to Follow-up|3|||
155363154|NCT01814072|560763805|FG020|Overall Study|Lost to Follow-up|2|||
155650640|NCT02006654|561812522|FG001|Overall Study|Withdrawal before treatment|2|||
155363155|NCT01814072|560763806|FG021|Overall Study|Lost to Follow-up|1|||
155363156|NCT01814072|560763807|FG022|Overall Study|Lost to Follow-up|3|||
155363157|NCT01814072|560763808|FG023|Overall Study|Lost to Follow-up|1|||
155363158|NCT01814072|560763809|FG024|Overall Study|Lost to Follow-up|4|||
155363159|NCT01814072|560763810|FG025|Overall Study|Lost to Follow-up|1|||
155363160|NCT01814072|560763811|FG026|Overall Study|Lost to Follow-up|1|||
155363161|NCT01814072|560763812|FG027|Overall Study|Lost to Follow-up|2|||
155363162|NCT01814072|560763813|FG028|Overall Study|Lost to Follow-up|3|||
155363163|NCT01814072|560763814|FG029|Overall Study|Lost to Follow-up|3|||
155363164|NCT01814072|560763815|FG030|Overall Study|Lost to Follow-up|2|||
155363165|NCT01814072|560763816|FG031|Overall Study|Lost to Follow-up|0|||
155363166|NCT01814072|560763785|FG000|Overall Study|Withdrawal by Subject|2|||
155363167|NCT01814072|560763786|FG001|Overall Study|Withdrawal by Subject|0|||
155363168|NCT01814072|560763787|FG002|Overall Study|Withdrawal by Subject|1|||
155363169|NCT01814072|560763788|FG003|Overall Study|Withdrawal by Subject|0|||
155363170|NCT01814072|560763789|FG004|Overall Study|Withdrawal by Subject|2|||
155363171|NCT01814072|560763790|FG005|Overall Study|Withdrawal by Subject|3|||
155363172|NCT01814072|560763791|FG006|Overall Study|Withdrawal by Subject|1|||
155363173|NCT01814072|560763792|FG007|Overall Study|Withdrawal by Subject|0|||
155363174|NCT01814072|560763793|FG008|Overall Study|Withdrawal by Subject|1|||
155363175|NCT01814072|560763794|FG009|Overall Study|Withdrawal by Subject|2|||
155363176|NCT01814072|560763795|FG010|Overall Study|Withdrawal by Subject|0|||
155363177|NCT01814072|560763796|FG011|Overall Study|Withdrawal by Subject|0|||
155363178|NCT01814072|560763797|FG012|Overall Study|Withdrawal by Subject|1|||
155363179|NCT01814072|560763798|FG013|Overall Study|Withdrawal by Subject|1|||
155363180|NCT01814072|560763799|FG014|Overall Study|Withdrawal by Subject|1|||
155363181|NCT01814072|560763800|FG015|Overall Study|Withdrawal by Subject|1|||
155363182|NCT01814072|560763801|FG016|Overall Study|Withdrawal by Subject|0|||
155363183|NCT01814072|560763802|FG017|Overall Study|Withdrawal by Subject|0|||
155363184|NCT01814072|560763803|FG018|Overall Study|Withdrawal by Subject|0|||
155363185|NCT01814072|560763804|FG019|Overall Study|Withdrawal by Subject|2|||
155363186|NCT01814072|560763805|FG020|Overall Study|Withdrawal by Subject|0|||
155363187|NCT01814072|560763806|FG021|Overall Study|Withdrawal by Subject|0|||
155363188|NCT01814072|560763807|FG022|Overall Study|Withdrawal by Subject|1|||
155363189|NCT01814072|560763808|FG023|Overall Study|Withdrawal by Subject|0|||
155363190|NCT01814072|560763809|FG024|Overall Study|Withdrawal by Subject|2|||
155363191|NCT01814072|560763810|FG025|Overall Study|Withdrawal by Subject|1|||
155363192|NCT01814072|560763811|FG026|Overall Study|Withdrawal by Subject|1|||
155363193|NCT01814072|560763812|FG027|Overall Study|Withdrawal by Subject|2|||
155363194|NCT01814072|560763813|FG028|Overall Study|Withdrawal by Subject|1|||
155363195|NCT01814072|560763814|FG029|Overall Study|Withdrawal by Subject|0|||
155363196|NCT01814072|560763815|FG030|Overall Study|Withdrawal by Subject|0|||
155363197|NCT01814072|560763816|FG031|Overall Study|Withdrawal by Subject|0|||
155363198|NCT01011868|560763822|FG000|After Week 18 Follow-up|Adverse Event|8|||
155363199|NCT01011868|560763823|FG001|After Week 18 Follow-up|Adverse Event|6|||
155363200|NCT01011868|560763824|FG002|After Week 18 Follow-up|Adverse Event|13|||
155363201|NCT01011868|560763822|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
155363202|NCT01011868|560763823|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
155363203|NCT01011868|560763824|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
155363204|NCT01011868|560763822|FG000|After Week 18 Follow-up|Protocol Violation|1|||
155363205|NCT01011868|560763823|FG001|After Week 18 Follow-up|Protocol Violation|1|||
155363206|NCT01011868|560763824|FG002|After Week 18 Follow-up|Protocol Violation|1|||
155363207|NCT01011868|560763822|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
155363208|NCT01011868|560763823|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
155363209|NCT01011868|560763824|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
155363210|NCT01011868|560763822|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
155363211|NCT01011868|560763823|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
155363212|NCT01011868|560763824|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
155363213|NCT01011868|560763822|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
155363214|NCT01011868|560763823|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
155363215|NCT01011868|560763824|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
155363216|NCT01011868|560763822|FG000|After Week 78 Follow-up|Adverse Event|14|||
155363217|NCT01011868|560763823|FG001|After Week 78 Follow-up|Adverse Event|18|||
155363218|NCT01011868|560763824|FG002|After Week 78 Follow-up|Adverse Event|21|||
155363219|NCT01011868|560763822|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
155363220|NCT01011868|560763823|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
155363221|NCT01011868|560763824|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
155363222|NCT01011868|560763822|FG000|After Week 78 Follow-up|Protocol Violation|9|||
155363223|NCT01011868|560763823|FG001|After Week 78 Follow-up|Protocol Violation|1|||
155363224|NCT01011868|560763824|FG002|After Week 78 Follow-up|Protocol Violation|2|||
155363225|NCT01011868|560763822|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
155363226|NCT01011868|560763823|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
155363227|NCT01011868|560763824|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
155363228|NCT01011868|560763822|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
155363229|NCT01011868|560763823|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
155363230|NCT01011868|560763824|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
155363231|NCT01011868|560763822|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
155363232|NCT01011868|560763823|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
155363233|NCT01011868|560763824|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
155363234|NCT01255761|560763825|FG000|Overall Study|Adverse Event|29|||
155363235|NCT01255761|560763826|FG001|Overall Study|Adverse Event|43|||
155363236|NCT01255761|560763825|FG000|Overall Study|Lack of Efficacy|86|||
155363237|NCT01255761|560763826|FG001|Overall Study|Lack of Efficacy|74|||
155363238|NCT01255761|560763825|FG000|Overall Study|Protocol Violation|9|||
155363239|NCT01255761|560763826|FG001|Overall Study|Protocol Violation|5|||
155363240|NCT01255761|560763825|FG000|Overall Study|Lost to Follow-up|10|||
155363241|NCT01255761|560763826|FG001|Overall Study|Lost to Follow-up|8|||
155363242|NCT01255761|560763825|FG000|Overall Study|Withdrawal by Subject|11|||
155363243|NCT01255761|560763826|FG001|Overall Study|Withdrawal by Subject|27|||
155363244|NCT01255761|560763825|FG000|Overall Study|Other Reasons|37|||
155363245|NCT01255761|560763826|FG001|Overall Study|Other Reasons|18|||
155363246|NCT04147858|560763827|FG000|Overall Study|Adverse Event|6|||
155363247|NCT04147858|560763828|FG001|Overall Study|Adverse Event|6|||
155363248|NCT04147858|560763829|FG002|Overall Study|Adverse Event|6|||
155363249|NCT04147858|560763827|FG000|Overall Study|Lack of Efficacy|3|||
155363250|NCT04147858|560763828|FG001|Overall Study|Lack of Efficacy|3|||
155363251|NCT04147858|560763829|FG002|Overall Study|Lack of Efficacy|1|||
155363252|NCT04147858|560763827|FG000|Overall Study|Lost to Follow-up|1|||
155363253|NCT04147858|560763828|FG001|Overall Study|Lost to Follow-up|6|||
155363254|NCT04147858|560763829|FG002|Overall Study|Lost to Follow-up|2|||
155363255|NCT04147858|560763827|FG000|Overall Study|Withdrawal by Subject|3|||
155363256|NCT04147858|560763828|FG001|Overall Study|Withdrawal by Subject|4|||
155363257|NCT04147858|560763829|FG002|Overall Study|Withdrawal by Subject|10|||
155363258|NCT04147858|560763827|FG000|Overall Study|Subject Noncompliance, Other|4|||
155363259|NCT04147858|560763828|FG001|Overall Study|Subject Noncompliance, Other|3|||
155363260|NCT04147858|560763829|FG002|Overall Study|Subject Noncompliance, Other|1|||
155363261|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
155363262|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
155363263|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363264|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363265|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
155363266|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155363267|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155363268|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155363269|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363270|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363271|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
155363272|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363273|NCT04905849|560763837|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
155363274|NCT04905849|560763838|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
155427603|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
155363275|NCT00838929|560763848|FG000|Overall Study|Protocol Violation|0|||
155363276|NCT00838929|560763849|FG001|Overall Study|Protocol Violation|1|||
155363277|NCT00838929|560763850|FG002|Overall Study|Protocol Violation|0|||
155363278|NCT00838929|560763848|FG000|Overall Study|Disease progression|0|||
155363279|NCT00838929|560763849|FG001|Overall Study|Disease progression|2|||
155363280|NCT00838929|560763850|FG002|Overall Study|Disease progression|1|||
155363281|NCT03375320|560763857|FG000|Overall Study|Adverse Event|34|||
155363282|NCT03375320|560763858|FG001|Overall Study|Adverse Event|9|||
155363283|NCT03375320|560763859|FG002|Overall Study|Adverse Event|10|||
155363284|NCT03375320|560763860|FG003|Overall Study|Adverse Event|0|||
155363285|NCT03375320|560763857|FG000|Overall Study|Death|6|||
155363286|NCT03375320|560763858|FG001|Overall Study|Death|3|||
155363287|NCT03375320|560763859|FG002|Overall Study|Death|0|||
155363288|NCT03375320|560763860|FG003|Overall Study|Death|0|||
155363289|NCT03375320|560763857|FG000|Overall Study|Withdrawal by Subject|7|||
155363290|NCT03375320|560763858|FG001|Overall Study|Withdrawal by Subject|4|||
155363291|NCT03375320|560763859|FG002|Overall Study|Withdrawal by Subject|5|||
155363292|NCT03375320|560763860|FG003|Overall Study|Withdrawal by Subject|4|||
155363293|NCT03375320|560763857|FG000|Overall Study|Progressive disease|55|||
155363294|NCT03375320|560763858|FG001|Overall Study|Progressive disease|41|||
155363295|NCT03375320|560763859|FG002|Overall Study|Progressive disease|29|||
155363296|NCT03375320|560763860|FG003|Overall Study|Progressive disease|24|||
155363297|NCT03375320|560763857|FG000|Overall Study|Alternative treatment|6|||
155363298|NCT03375320|560763858|FG001|Overall Study|Alternative treatment|1|||
155363299|NCT03375320|560763859|FG002|Overall Study|Alternative treatment|1|||
155363300|NCT03375320|560763860|FG003|Overall Study|Alternative treatment|0|||
155363301|NCT03375320|560763857|FG000|Overall Study|Other disease|1|||
155363302|NCT03375320|560763858|FG001|Overall Study|Other disease|1|||
155363303|NCT03375320|560763859|FG002|Overall Study|Other disease|3|||
155363304|NCT03375320|560763860|FG003|Overall Study|Other disease|0|||
155363305|NCT03375320|560763857|FG000|Overall Study|Withdrawal prior to initiation|2|||
155363306|NCT03375320|560763858|FG001|Overall Study|Withdrawal prior to initiation|2|||
155363307|NCT03375320|560763859|FG002|Overall Study|Withdrawal prior to initiation|1|||
155363308|NCT03375320|560763860|FG003|Overall Study|Withdrawal prior to initiation|0|||
155363309|NCT03375320|560763857|FG000|Overall Study|Physician Decision|1|||
155363310|NCT03375320|560763858|FG001|Overall Study|Physician Decision|1|||
155363311|NCT03375320|560763859|FG002|Overall Study|Physician Decision|1|||
155363312|NCT03375320|560763860|FG003|Overall Study|Physician Decision|1|||
155363313|NCT03375320|560763857|FG000|Overall Study|Non-compliance|1|||
155363314|NCT03375320|560763858|FG001|Overall Study|Non-compliance|0|||
155363315|NCT03375320|560763859|FG002|Overall Study|Non-compliance|0|||
155363316|NCT03375320|560763860|FG003|Overall Study|Non-compliance|0|||
155363317|NCT03348631|560763861|FG000|Overall Study|Not Eligible, No treatment|0|||
155363318|NCT03348631|560763862|FG001|Overall Study|Not Eligible, No treatment|1|||
155363319|NCT03348631|560763861|FG000|Overall Study|Not Eligible, Treated|2|||
155363320|NCT03348631|560763862|FG001|Overall Study|Not Eligible, Treated|0|||
155363321|NCT03348631|560763861|FG000|Overall Study|Eligible, No Treatment|1|||
155363322|NCT03348631|560763862|FG001|Overall Study|Eligible, No Treatment|0|||
155363323|NCT01068210|560763863|FG000|Overall Study|Lost to Follow-up|1|||
155363324|NCT01068210|560763864|FG001|Overall Study|Lost to Follow-up|2|||
155363325|NCT01068210|560763865|FG002|Overall Study|Lost to Follow-up|2|||
155363326|NCT01068210|560763866|FG003|Overall Study|Lost to Follow-up|1|||
155363327|NCT01068210|560763863|FG000|Overall Study|Second cancer|0|||
155363328|NCT01068210|560763864|FG001|Overall Study|Second cancer|1|||
155363329|NCT01068210|560763865|FG002|Overall Study|Second cancer|0|||
155363330|NCT01068210|560763866|FG003|Overall Study|Second cancer|0|||
155363331|NCT01068210|560763863|FG000|Overall Study|Disease progression|0|||
155363332|NCT01068210|560763864|FG001|Overall Study|Disease progression|0|||
155363333|NCT01068210|560763865|FG002|Overall Study|Disease progression|0|||
155363334|NCT01068210|560763866|FG003|Overall Study|Disease progression|2|||
155363335|NCT00699842|560763867|FG000|Overall Study|Death|0|||
155363336|NCT00699842|560763868|FG001|Overall Study|Death|1|||
155363337|NCT00699842|560763869|FG002|Overall Study|Death|0|||
155363338|NCT03170518|560763870|FG000|Overall Study|Lost to Follow-up|4|||
155363339|NCT03170518|560763871|FG001|Overall Study|Lost to Follow-up|1|||
155363340|NCT03170518|560763872|FG002|Overall Study|Lost to Follow-up|0|||
155363341|NCT03170518|560763870|FG000|Overall Study|Physician Decision|1|||
155363342|NCT03170518|560763871|FG001|Overall Study|Physician Decision|0|||
155427604|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
155427605|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
155427606|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
155427607|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
155427608|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155427609|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155427610|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155650641|NCT02006654|561812521|FG000|Overall Study|Adverse Event|16|||
155363343|NCT03170518|560763872|FG002|Overall Study|Physician Decision|0|||
155363344|NCT03170518|560763870|FG000|Overall Study|Withdrawal by Subject|4|||
155363345|NCT03170518|560763871|FG001|Overall Study|Withdrawal by Subject|5|||
155363346|NCT03170518|560763872|FG002|Overall Study|Withdrawal by Subject|2|||
155363347|NCT03170518|560763870|FG000|Overall Study|Site terminated by sponsor|0|||
155363348|NCT03170518|560763871|FG001|Overall Study|Site terminated by sponsor|1|||
155363349|NCT03170518|560763872|FG002|Overall Study|Site terminated by sponsor|0|||
155363350|NCT03170518|560763870|FG000|Overall Study|Non-compliance with study drug|1|||
155363351|NCT03170518|560763871|FG001|Overall Study|Non-compliance with study drug|0|||
155363352|NCT03170518|560763872|FG002|Overall Study|Non-compliance with study drug|1|||
155363353|NCT03170518|560763870|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155363354|NCT03170518|560763871|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155363355|NCT03170518|560763872|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155363356|NCT03342196|560763873|FG000|Overall Study|Physician Decision|1|||
155363357|NCT00546078|560763874|FG000|Overall Study|Lost to Follow-up|1|||
155363358|NCT00546078|560763875|FG001|Overall Study|Lost to Follow-up|3|||
155363359|NCT00546078|560763874|FG000|Overall Study|Withdrawal by Subject|2|||
155363360|NCT00546078|560763875|FG001|Overall Study|Withdrawal by Subject|3|||
155363361|NCT00546078|560763874|FG000|Overall Study|Other reason|1|||
155363362|NCT00546078|560763875|FG001|Overall Study|Other reason|1|||
155363363|NCT03512197|560763878|FG000|Overall Study|Guardian decision|1|||
155363364|NCT03512197|560763879|FG001|Overall Study|Guardian decision|1|||
155363365|NCT03512197|560763878|FG000|Overall Study|Lack of Efficacy|19|||
155363366|NCT03512197|560763879|FG001|Overall Study|Lack of Efficacy|11|||
155363367|NCT03512197|560763878|FG000|Overall Study|New Therapy for Study Indication|16|||
155363368|NCT03512197|560763879|FG001|Overall Study|New Therapy for Study Indication|16|||
155363369|NCT03512197|560763878|FG000|Overall Study|Physician Decision|60|||
155363370|NCT03512197|560763879|FG001|Overall Study|Physician Decision|60|||
155363371|NCT03512197|560763878|FG000|Overall Study|Protocol Violation|0|||
155363372|NCT03512197|560763879|FG001|Overall Study|Protocol Violation|2|||
155363373|NCT03512197|560763878|FG000|Overall Study|Terminated by Sponsored|46|||
155363374|NCT03512197|560763879|FG001|Overall Study|Terminated by Sponsored|50|||
155363375|NCT03512197|560763878|FG000|Overall Study|Subject Decision|15|||
155363376|NCT03512197|560763879|FG001|Overall Study|Subject Decision|12|||
155363377|NCT03512197|560763878|FG000|Overall Study|Withdrawal of informed consent|20|||
155363378|NCT03512197|560763879|FG001|Overall Study|Withdrawal of informed consent|14|||
155363379|NCT03512197|560763878|FG000|Overall Study|Adverse Event|30|||
155363380|NCT03512197|560763879|FG001|Overall Study|Adverse Event|34|||
155363381|NCT03512197|560763878|FG000|Overall Study|Death|14|||
155363382|NCT03512197|560763879|FG001|Overall Study|Death|9|||
155363383|NCT03512197|560763878|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
155363384|NCT03512197|560763879|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
155363385|NCT03512197|560763878|FG000|Overall Study|Missing|3|||
155363386|NCT03512197|560763879|FG001|Overall Study|Missing|13|||
155363387|NCT01806389|560763880|FG000|Overall Study|Withdrawal by Subject|4|||
155363388|NCT03842436|560763881|FG000|Overall Study|Lost to Follow-up|1|||
155363389|NCT01948076|560763882|FG000|Overall Study|Withdrawal by Subject|0|||
155363390|NCT01948076|560763883|FG001|Overall Study|Withdrawal by Subject|1|||
155363391|NCT01151423|560763886|FG000|Overall Study|Study terminated by Sponsor|9|||
155363392|NCT01151423|560763887|FG001|Overall Study|Study terminated by Sponsor|10|||
155363393|NCT01151423|560763886|FG000|Overall Study|Protocol Violation|0|||
155363394|NCT01151423|560763887|FG001|Overall Study|Protocol Violation|1|||
155363395|NCT01151423|560763886|FG000|Overall Study|Physician Decision|1|||
155363396|NCT01151423|560763887|FG001|Overall Study|Physician Decision|1|||
155363397|NCT01151423|560763886|FG000|Overall Study|Pregnancy|0|||
155363398|NCT01151423|560763887|FG001|Overall Study|Pregnancy|1|||
155363399|NCT01151423|560763886|FG000|Overall Study|Death|0|||
155363400|NCT01151423|560763887|FG001|Overall Study|Death|1|||
155363401|NCT01151423|560763886|FG000|Overall Study|Adverse Event|3|||
155507483|NCT01078623|561285078|FG016|Treatment Period 4|Withdrawal by Subject|0|||
155507484|NCT01078623|561285079|FG017|Treatment Period 4|Withdrawal by Subject|0|||
155650642|NCT02006654|561812522|FG001|Overall Study|Adverse Event|17|||
155363402|NCT01151423|560763887|FG001|Overall Study|Adverse Event|0|||
155363403|NCT01151423|560763886|FG000|Overall Study|Withdrawal by Subject|1|||
155363404|NCT01151423|560763887|FG001|Overall Study|Withdrawal by Subject|3|||
155363405|NCT01151423|560763886|FG000|Overall Study|Lost to Follow-up|1|||
155363406|NCT01151423|560763887|FG001|Overall Study|Lost to Follow-up|0|||
155363407|NCT01151423|560763886|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
155363408|NCT01151423|560763887|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
155363409|NCT01151423|560763886|FG000|Overall Study|Participated in other clinical trial|1|||
155363410|NCT01151423|560763887|FG001|Overall Study|Participated in other clinical trial|0|||
155363411|NCT01263054|560763889|FG000|Overall Study|Death|1|||
155363412|NCT01263054|560763890|FG001|Overall Study|Death|0|||
155363413|NCT01263054|560763889|FG000|Overall Study|Lost to Follow-up|2|||
155363414|NCT01263054|560763890|FG001|Overall Study|Lost to Follow-up|2|||
155363415|NCT01263054|560763889|FG000|Overall Study|Withdrawal by Subject|1|||
155363416|NCT01263054|560763890|FG001|Overall Study|Withdrawal by Subject|3|||
155363417|NCT01263054|560763889|FG000|Overall Study|Qualification Violation|1|||
155363418|NCT01263054|560763890|FG001|Overall Study|Qualification Violation|0|||
155363419|NCT01263054|560763889|FG000|Overall Study|Other|0|||
155363420|NCT01263054|560763890|FG001|Overall Study|Other|1|||
155363421|NCT03358238|560763891|FG000|Overall Study|Withdrawal by Subject|0|||
155363422|NCT03358238|560763892|FG001|Overall Study|Withdrawal by Subject|1|||
155363423|NCT04596540|560763896|FG000|Overall Study|Withdrawal by Subject|9|||
155363424|NCT04596540|560763897|FG001|Overall Study|Withdrawal by Subject|8|||
155363425|NCT04596540|560763898|FG002|Overall Study|Withdrawal by Subject|5|||
155363426|NCT04596540|560763896|FG000|Overall Study|Lost to Follow-up|1|||
155363427|NCT04596540|560763897|FG001|Overall Study|Lost to Follow-up|2|||
155363428|NCT04596540|560763898|FG002|Overall Study|Lost to Follow-up|1|||
155363429|NCT04596540|560763896|FG000|Overall Study|Sponsor Decision|2|||
155363430|NCT04596540|560763897|FG001|Overall Study|Sponsor Decision|0|||
155363431|NCT04596540|560763898|FG002|Overall Study|Sponsor Decision|0|||
155363432|NCT04596540|560763896|FG000|Overall Study|Physician Decision|0|||
155363433|NCT04596540|560763897|FG001|Overall Study|Physician Decision|1|||
155363434|NCT04596540|560763898|FG002|Overall Study|Physician Decision|1|||
155363435|NCT04596540|560763896|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
155363436|NCT04596540|560763897|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155363437|NCT04596540|560763898|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155363438|NCT04596540|560763896|FG000|Overall Study|Other Than Specified|5|||
155363439|NCT04596540|560763897|FG001|Overall Study|Other Than Specified|5|||
155363440|NCT04596540|560763898|FG002|Overall Study|Other Than Specified|2|||
155363441|NCT02633397|560763899|FG000|Overall Study|Adverse Event|8|||
155363442|NCT02633397|560763900|FG001|Overall Study|Adverse Event|8|||
155363443|NCT02633397|560763899|FG000|Overall Study|Study Burden|4|||
155363444|NCT02633397|560763900|FG001|Overall Study|Study Burden|1|||
155363445|NCT02633397|560763899|FG000|Overall Study|Treatment interruption|2|||
155363446|NCT02633397|560763900|FG001|Overall Study|Treatment interruption|5|||
155363447|NCT02633397|560763899|FG000|Overall Study|Death|2|||
155363448|NCT02633397|560763900|FG001|Overall Study|Death|2|||
155427611|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155427612|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
155427613|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155427614|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155363449|NCT02633397|560763899|FG000|Overall Study|Physician Decision|0|||
155427615|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
155427616|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
155363450|NCT02633397|560763900|FG001|Overall Study|Physician Decision|1|||
155363451|NCT02520310|560763903|FG000|At 6 Months Clinical Follow-up|Death|1|||
155650643|NCT02006654|561812521|FG000|Overall Study|Death|1|||
155363452|NCT02520310|560763903|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
155363453|NCT02520310|560763903|FG000|AT 3 Year Clinical Follow-up|Death|2|||
155363454|NCT02520310|560763903|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
155363455|NCT02520310|560763903|FG000|AT 4 Year Clinical Follow-up|Death|1|||
155363456|NCT02520310|560763903|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
155363457|NCT01340014|560763904|FG000|Period 1, First 7 Days|Adverse Event|1|||
155363458|NCT01340014|560763905|FG001|Period 1, First 7 Days|Adverse Event|0|||
155363459|NCT01340014|560763904|FG000|Period 1, First 7 Days|Personal Reasons|1|||
155363460|NCT01340014|560763905|FG001|Period 1, First 7 Days|Personal Reasons|0|||
155363461|NCT01340014|560763904|FG000|Period 2, Second 7 Days|Adverse Event|0|||
155363462|NCT01340014|560763905|FG001|Period 2, Second 7 Days|Adverse Event|1|||
155363463|NCT05101993|560763906|FG000|Overall Study|Withdrawal by Subject|1|||
155363464|NCT04577573|560763907|FG000|Overall Study|Technical - invalid protocol|0|||
155363465|NCT04577573|560763908|FG001|Overall Study|Technical - invalid protocol|2|||
155363466|NCT04577573|560763909|FG002|Overall Study|Technical - invalid protocol|0|||
155363467|NCT01124838|560763910|FG000|Overall Study|Miscellaneous|4|||
155363468|NCT01124838|560763911|FG001|Overall Study|Miscellaneous|2|||
155363469|NCT01124838|560763910|FG000|Overall Study|Adverse Event|7|||
155363470|NCT01124838|560763911|FG001|Overall Study|Adverse Event|11|||
155363471|NCT01124838|560763910|FG000|Overall Study|Lack of Efficacy|2|||
155363472|NCT01124838|560763911|FG001|Overall Study|Lack of Efficacy|0|||
155363473|NCT01124838|560763910|FG000|Overall Study|Withdrawal by Subject|3|||
155363474|NCT01124838|560763911|FG001|Overall Study|Withdrawal by Subject|2|||
155363475|NCT01124838|560763910|FG000|Overall Study|Lost to Follow-up|2|||
155363476|NCT01124838|560763911|FG001|Overall Study|Lost to Follow-up|0|||
155363477|NCT04526665|560763912|FG000|Overall Study|Withdrawal by Subject|6|||
155363478|NCT04526665|560763913|FG001|Overall Study|Withdrawal by Subject|3|||
155363479|NCT04526665|560763912|FG000|Overall Study|Adverse Event|4|||
155363480|NCT04526665|560763913|FG001|Overall Study|Adverse Event|1|||
155363481|NCT04526665|560763912|FG000|Overall Study|Physician Decision|2|||
155363482|NCT04526665|560763913|FG001|Overall Study|Physician Decision|2|||
155363483|NCT04526665|560763912|FG000|Overall Study|Death|2|||
155363484|NCT04526665|560763913|FG001|Overall Study|Death|0|||
155363485|NCT04526665|560763912|FG000|Overall Study|Other|0|||
155363486|NCT04526665|560763913|FG001|Overall Study|Other|1|||
155363487|NCT02065882|560763915|FG000|Part I: PK/PD|Screening failure|5|||
155363488|NCT02065882|560763915|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
155363489|NCT02065882|560763915|FG000|Part I: PK/PD|Adverse Event|1|||
155363490|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Screening failure|7|||
155363491|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
155363492|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
155363493|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
155363494|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
155363495|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
155363496|NCT01784523|560765199|FG000|Overall Study|Study closed early|7|||
155363497|NCT01784523|560765200|FG001|Overall Study|Study closed early|4|||
155363498|NCT01907906|560765201|FG000|Overall Study|Withdrawal by Subject|1|||
155363499|NCT01907906|560765202|FG001|Overall Study|Withdrawal by Subject|0|||
155363500|NCT01907906|560765201|FG000|Overall Study|Physician Decision|3|||
155363501|NCT01907906|560765202|FG001|Overall Study|Physician Decision|1|||
155363502|NCT04052425|560765203|FG000|24-Week Double-blind Period|Adverse Event|0|||
155363503|NCT04052425|560765204|FG001|24-Week Double-blind Period|Adverse Event|1|||
155363504|NCT04052425|560765205|FG002|24-Week Double-blind Period|Adverse Event|0|||
155363505|NCT04052425|560765206|FG003|24-Week Double-blind Period|Adverse Event|0|||
155363506|NCT04052425|560765203|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
155363507|NCT04052425|560765204|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
155363508|NCT04052425|560765205|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
155363509|NCT04052425|560765206|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
155363510|NCT04052425|560765203|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
155363511|NCT04052425|560765204|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
155363512|NCT04052425|560765205|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
155363513|NCT04052425|560765206|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
155363514|NCT04052425|560765203|FG000|24-Week Double-blind Period|Physician Decision|1|||
155363515|NCT04052425|560765204|FG001|24-Week Double-blind Period|Physician Decision|0|||
155363516|NCT04052425|560765205|FG002|24-Week Double-blind Period|Physician Decision|0|||
155363517|NCT04052425|560765206|FG003|24-Week Double-blind Period|Physician Decision|0|||
155363518|NCT04052425|560765203|FG000|24-Week Double-blind Period|Protocol Violation|1|||
155363519|NCT04052425|560765204|FG001|24-Week Double-blind Period|Protocol Violation|0|||
155363520|NCT04052425|560765205|FG002|24-Week Double-blind Period|Protocol Violation|0|||
155363521|NCT04052425|560765206|FG003|24-Week Double-blind Period|Protocol Violation|0|||
155363522|NCT04052425|560765203|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
155363523|NCT04052425|560765204|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
155649137|NCT04518410|561805943|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
155649138|NCT04518410|561805944|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155363524|NCT04052425|560765205|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
155363525|NCT04052425|560765206|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
155363526|NCT04052425|560765203|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
155363527|NCT04052425|560765204|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363528|NCT04052425|560765205|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363529|NCT04052425|560765206|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363530|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
155649139|NCT04518410|561805945|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649140|NCT04518410|561805946|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649141|NCT04518410|561805947|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155649142|NCT04518410|561805948|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155649143|NCT04518410|561805949|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
155649144|NCT04518410|561805950|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
155650644|NCT02006654|561812522|FG001|Overall Study|Death|0|||
155363531|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
155363532|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
155363533|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
155363534|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363535|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363536|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
155363537|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363538|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155363539|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155363540|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
155363541|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
155363542|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
155363543|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
155363544|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
155363545|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
155363546|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155363547|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155363548|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
155363549|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
155363550|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363551|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363552|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
155363553|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363554|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
155363555|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
155363556|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
155507485|NCT01078623|561285080|FG018|Treatment Period 4|Withdrawal by Subject|0|||
155363557|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
155363558|NCT04334278|560765207|FG000|Overall Study|Lost to Follow-up|0|||
155363559|NCT04334278|560765208|FG001|Overall Study|Lost to Follow-up|3|||
155363560|NCT04334278|560765207|FG000|Overall Study|Withdrawal by Subject|4|||
155363561|NCT04334278|560765208|FG001|Overall Study|Withdrawal by Subject|2|||
155507486|NCT01078623|561285081|FG019|Treatment Period 4|Withdrawal by Subject|0|||
155507487|NCT00463866|561285082|FG000|Overall Study|Adverse Event|70|||
155507488|NCT00463866|561285083|FG001|Overall Study|Adverse Event|93|||
155507489|NCT00463866|561285082|FG000|Overall Study|Withdrawal by Subject|81|||
155507490|NCT00463866|561285083|FG001|Overall Study|Withdrawal by Subject|79|||
155507491|NCT00463866|561285082|FG000|Overall Study|Lost to Follow-up|46|||
155507492|NCT00463866|561285083|FG001|Overall Study|Lost to Follow-up|55|||
155507493|NCT00463866|561285082|FG000|Overall Study|Incorrect Enrolment|64|||
155507494|NCT00463866|561285083|FG001|Overall Study|Incorrect Enrolment|66|||
155363562|NCT01732549|560765211|FG000|Overall Study|Adverse Event|13|||
155363563|NCT01732549|560765212|FG001|Overall Study|Adverse Event|3|||
155363564|NCT01732549|560765211|FG000|Overall Study|Consent withdrawn|13|||
155363565|NCT01732549|560765212|FG001|Overall Study|Consent withdrawn|6|||
155363566|NCT01732549|560765211|FG000|Overall Study|Disease progression|37|||
155363567|NCT01732549|560765212|FG001|Overall Study|Disease progression|50|||
155363568|NCT01732549|560765211|FG000|Overall Study|Other|8|||
155363569|NCT01732549|560765212|FG001|Overall Study|Other|14|||
155363570|NCT01681992|560765215|FG000|Overall Study|Adverse Event|3|||
155363571|NCT01681992|560765216|FG001|Overall Study|Adverse Event|2|||
155363572|NCT01681992|560765217|FG002|Overall Study|Adverse Event|3|||
155363573|NCT01681992|560765215|FG000|Overall Study|Lost to Follow-up|36|||
155363574|NCT01681992|560765216|FG001|Overall Study|Lost to Follow-up|38|||
155363575|NCT01681992|560765217|FG002|Overall Study|Lost to Follow-up|53|||
155363576|NCT01681992|560765215|FG000|Overall Study|As Per Sponsor Decision|0|||
155363577|NCT01681992|560765216|FG001|Overall Study|As Per Sponsor Decision|0|||
155363578|NCT01681992|560765217|FG002|Overall Study|As Per Sponsor Decision|1|||
155363579|NCT01681992|560765215|FG000|Overall Study|Protocol Violation|0|||
155363580|NCT01681992|560765216|FG001|Overall Study|Protocol Violation|0|||
155363581|NCT01681992|560765217|FG002|Overall Study|Protocol Violation|1|||
155507495|NCT00463866|561285082|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
155363582|NCT01681992|560765215|FG000|Overall Study|Withdrawal by Subject|27|||
155363583|NCT01681992|560765216|FG001|Overall Study|Withdrawal by Subject|30|||
155507496|NCT00463866|561285083|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
155507497|NCT00463866|561285082|FG000|Overall Study|Safety Reason|1|||
155507498|NCT00463866|561285083|FG001|Overall Study|Safety Reason|3|||
155507499|NCT00463866|561285082|FG000|Overall Study|Mis-Randomization of subject|0|||
155507500|NCT00463866|561285083|FG001|Overall Study|Mis-Randomization of subject|1|||
155507501|NCT00463866|561285082|FG000|Overall Study|Other|22|||
155507502|NCT00463866|561285083|FG001|Overall Study|Other|22|||
155507503|NCT01084005|561285085|FG000|Overall Study|Adverse Event|1|||
155507504|NCT01084005|561285086|FG001|Overall Study|Adverse Event|8|||
155507505|NCT01084005|561285085|FG000|Overall Study|Protocol Violation|3|||
155507506|NCT01084005|561285086|FG001|Overall Study|Protocol Violation|7|||
155507507|NCT01084005|561285085|FG000|Overall Study|Withdrawal by Subject|1|||
155507508|NCT01084005|561285086|FG001|Overall Study|Withdrawal by Subject|1|||
155507509|NCT03568500|561285088|FG000|Overall Study|Lost to Follow-up|1|||
155507510|NCT03568500|561285089|FG001|Overall Study|Lost to Follow-up|1|||
155507511|NCT03568500|561285090|FG002|Overall Study|Lost to Follow-up|2|||
155507512|NCT03568500|561285088|FG000|Overall Study|Adverse Event|1|||
155507513|NCT03568500|561285089|FG001|Overall Study|Adverse Event|1|||
155507514|NCT03568500|561285090|FG002|Overall Study|Adverse Event|2|||
155507515|NCT03568500|561285088|FG000|Overall Study|Physician Decision|1|||
155507516|NCT03568500|561285089|FG001|Overall Study|Physician Decision|0|||
155507517|NCT03568500|561285090|FG002|Overall Study|Physician Decision|0|||
155507518|NCT03568500|561285088|FG000|Overall Study|Withdrawal by Subject|4|||
155507519|NCT03568500|561285089|FG001|Overall Study|Withdrawal by Subject|2|||
155507520|NCT03568500|561285090|FG002|Overall Study|Withdrawal by Subject|0|||
155507521|NCT03568500|561285088|FG000|Overall Study|Technical Problems|2|||
155507522|NCT03568500|561285089|FG001|Overall Study|Technical Problems|1|||
155507523|NCT03568500|561285090|FG002|Overall Study|Technical Problems|0|||
155507524|NCT03568500|561285088|FG000|Overall Study|Participant Noncompliance|1|||
155507525|NCT03568500|561285089|FG001|Overall Study|Participant Noncompliance|1|||
155507526|NCT03568500|561285090|FG002|Overall Study|Participant Noncompliance|0|||
155507527|NCT00472446|561285099|FG000|Overall Study|Protocol Violation|0|||
155507528|NCT00472446|561285100|FG001|Overall Study|Protocol Violation|0|||
155363584|NCT01681992|560765217|FG002|Overall Study|Withdrawal by Subject|25|||
155363585|NCT03377361|560765220|FG000|Pre-Treatment|Subject withdrew consent|0|||
155363586|NCT03377361|560765221|FG001|Pre-Treatment|Subject withdrew consent|0|||
155363587|NCT03377361|560765222|FG002|Pre-Treatment|Subject withdrew consent|0|||
155363588|NCT03377361|560765223|FG003|Pre-Treatment|Subject withdrew consent|0|||
155507529|NCT00472446|561285101|FG002|Overall Study|Protocol Violation|0|||
155363589|NCT03377361|560765224|FG004|Pre-Treatment|Subject withdrew consent|0|||
155363590|NCT03377361|560765225|FG005|Pre-Treatment|Subject withdrew consent|0|||
155363591|NCT03377361|560765226|FG006|Pre-Treatment|Subject withdrew consent|0|||
155363592|NCT03377361|560765227|FG007|Pre-Treatment|Subject withdrew consent|3|||
155507530|NCT00472446|561285102|FG003|Overall Study|Protocol Violation|1|||
155507531|NCT00472446|561285099|FG000|Overall Study|Reintervention|0|||
155507532|NCT00472446|561285100|FG001|Overall Study|Reintervention|0|||
155507533|NCT00472446|561285101|FG002|Overall Study|Reintervention|1|||
155507534|NCT00472446|561285102|FG003|Overall Study|Reintervention|1|||
155507535|NCT00472446|561285099|FG000|Overall Study|Questionnaires not returned|5|||
155507536|NCT00472446|561285100|FG001|Overall Study|Questionnaires not returned|6|||
155507537|NCT00472446|561285101|FG002|Overall Study|Questionnaires not returned|6|||
155363593|NCT03377361|560765228|FG008|Pre-Treatment|Subject withdrew consent|1|||
155507538|NCT00472446|561285102|FG003|Overall Study|Questionnaires not returned|4|||
155507539|NCT00910858|561285103|FG000|Pharmacokinetic Phase|Adverse Event|1|||
155649145|NCT04518410|561805951|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
155649146|NCT04518410|561805952|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
155649147|NCT04518410|561805953|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
155649148|NCT04518410|561805954|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
155649149|NCT04518410|561805955|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
155649150|NCT04518410|561805956|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
155649151|NCT04518410|561805957|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155649152|NCT04518410|561805958|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
155649153|NCT04518410|561805934|FG000|Overall Study|Dual Enrolled Subject|0|||
155649154|NCT04518410|561805935|FG001|Overall Study|Dual Enrolled Subject|0|||
155363594|NCT03377361|560765229|FG009|Pre-Treatment|Subject withdrew consent|0|||
155649155|NCT04518410|561805936|FG002|Overall Study|Dual Enrolled Subject|0|||
155649156|NCT04518410|561805937|FG003|Overall Study|Dual Enrolled Subject|0|||
155649157|NCT04518410|561805938|FG004|Overall Study|Dual Enrolled Subject|0|||
155649158|NCT04518410|561805939|FG005|Overall Study|Dual Enrolled Subject|0|||
155649159|NCT04518410|561805940|FG006|Overall Study|Dual Enrolled Subject|0|||
155363595|NCT03377361|560765220|FG000|Pre-Treatment|Not Reported|0|||
155363596|NCT03377361|560765221|FG001|Pre-Treatment|Not Reported|0|||
155363597|NCT03377361|560765222|FG002|Pre-Treatment|Not Reported|0|||
155363598|NCT03377361|560765223|FG003|Pre-Treatment|Not Reported|0|||
155363599|NCT03377361|560765224|FG004|Pre-Treatment|Not Reported|0|||
155363600|NCT03377361|560765225|FG005|Pre-Treatment|Not Reported|0|||
155363601|NCT03377361|560765226|FG006|Pre-Treatment|Not Reported|0|||
155363602|NCT03377361|560765227|FG007|Pre-Treatment|Not Reported|0|||
155363603|NCT03377361|560765228|FG008|Pre-Treatment|Not Reported|3|||
155363604|NCT03377361|560765229|FG009|Pre-Treatment|Not Reported|0|||
155363605|NCT03377361|560765220|FG000|Treatment Period|Disease Progression|3|||
155363606|NCT03377361|560765221|FG001|Treatment Period|Disease Progression|2|||
155363607|NCT03377361|560765222|FG002|Treatment Period|Disease Progression|5|||
155363608|NCT03377361|560765223|FG003|Treatment Period|Disease Progression|3|||
155363609|NCT03377361|560765224|FG004|Treatment Period|Disease Progression|3|||
155363610|NCT03377361|560765225|FG005|Treatment Period|Disease Progression|3|||
155363611|NCT03377361|560765226|FG006|Treatment Period|Disease Progression|6|||
155363612|NCT03377361|560765227|FG007|Treatment Period|Disease Progression|106|||
155363613|NCT03377361|560765228|FG008|Treatment Period|Disease Progression|48|||
155363614|NCT03377361|560765229|FG009|Treatment Period|Disease Progression|59|||
155363615|NCT03377361|560765220|FG000|Treatment Period|Study Drug Toxicity|0|||
155363616|NCT03377361|560765221|FG001|Treatment Period|Study Drug Toxicity|0|||
155363617|NCT03377361|560765222|FG002|Treatment Period|Study Drug Toxicity|0|||
155363618|NCT03377361|560765223|FG003|Treatment Period|Study Drug Toxicity|1|||
155363619|NCT03377361|560765224|FG004|Treatment Period|Study Drug Toxicity|0|||
155363620|NCT03377361|560765225|FG005|Treatment Period|Study Drug Toxicity|0|||
155363621|NCT03377361|560765226|FG006|Treatment Period|Study Drug Toxicity|0|||
155363622|NCT03377361|560765227|FG007|Treatment Period|Study Drug Toxicity|7|||
155363623|NCT03377361|560765228|FG008|Treatment Period|Study Drug Toxicity|2|||
155363624|NCT03377361|560765229|FG009|Treatment Period|Study Drug Toxicity|16|||
155363625|NCT03377361|560765220|FG000|Treatment Period|Death|0|||
155363626|NCT03377361|560765221|FG001|Treatment Period|Death|0|||
155363627|NCT03377361|560765222|FG002|Treatment Period|Death|1|||
155363628|NCT03377361|560765223|FG003|Treatment Period|Death|0|||
155363629|NCT03377361|560765224|FG004|Treatment Period|Death|0|||
155363630|NCT03377361|560765225|FG005|Treatment Period|Death|0|||
155363631|NCT03377361|560765226|FG006|Treatment Period|Death|0|||
155363632|NCT03377361|560765227|FG007|Treatment Period|Death|2|||
155363633|NCT03377361|560765228|FG008|Treatment Period|Death|1|||
155363634|NCT03377361|560765229|FG009|Treatment Period|Death|3|||
155363635|NCT03377361|560765220|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363636|NCT03377361|560765221|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363637|NCT03377361|560765222|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363638|NCT03377361|560765223|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363639|NCT03377361|560765224|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363640|NCT03377361|560765225|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363641|NCT03377361|560765226|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
155649160|NCT04518410|561805941|FG007|Overall Study|Dual Enrolled Subject|0|||
155649161|NCT04518410|561805942|FG008|Overall Study|Dual Enrolled Subject|0|||
155649162|NCT04518410|561805943|FG009|Overall Study|Dual Enrolled Subject|0|||
155649163|NCT04518410|561805944|FG010|Overall Study|Dual Enrolled Subject|0|||
155649164|NCT04518410|561805945|FG011|Overall Study|Dual Enrolled Subject|0|||
155649165|NCT04518410|561805946|FG012|Overall Study|Dual Enrolled Subject|0|||
155649166|NCT04518410|561805947|FG013|Overall Study|Dual Enrolled Subject|0|||
155649167|NCT04518410|561805948|FG014|Overall Study|Dual Enrolled Subject|0|||
155649168|NCT04518410|561805949|FG015|Overall Study|Dual Enrolled Subject|0|||
155649169|NCT04518410|561805950|FG016|Overall Study|Dual Enrolled Subject|0|||
155649170|NCT04518410|561805951|FG017|Overall Study|Dual Enrolled Subject|1|||
155649171|NCT04518410|561805952|FG018|Overall Study|Dual Enrolled Subject|0|||
155649172|NCT04518410|561805953|FG019|Overall Study|Dual Enrolled Subject|0|||
155649173|NCT04518410|561805954|FG020|Overall Study|Dual Enrolled Subject|0|||
155649174|NCT04518410|561805955|FG021|Overall Study|Dual Enrolled Subject|0|||
155649175|NCT04518410|561805956|FG022|Overall Study|Dual Enrolled Subject|0|||
155649176|NCT04518410|561805957|FG023|Overall Study|Dual Enrolled Subject|0|||
155649177|NCT04518410|561805958|FG024|Overall Study|Dual Enrolled Subject|0|||
155649178|NCT02218268|561805959|FG000|24 Hour Washout|Physician Decision|11|||
155649179|NCT02218268|561805960|FG001|24 Hour Washout|Physician Decision|9|||
155649180|NCT01341990|561805961|FG000|Overall Study|Adverse Event|0|||
155649181|NCT01341990|561805962|FG001|Overall Study|Adverse Event|1|||
155649182|NCT01341990|561805961|FG000|Overall Study|Torn Study Lens|1|||
155649183|NCT01341990|561805962|FG001|Overall Study|Torn Study Lens|0|||
155649184|NCT01341990|561805961|FG000|Overall Study|Withdrawal by Subject|2|||
155649185|NCT01341990|561805962|FG001|Overall Study|Withdrawal by Subject|0|||
155649186|NCT03259308|561805963|FG000|Overall Study|Adverse Event|5|||
155363642|NCT03377361|560765227|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
155363643|NCT03377361|560765228|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
155363644|NCT03377361|560765229|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363645|NCT03377361|560765220|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
155363646|NCT03377361|560765221|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
155363647|NCT03377361|560765222|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
155363648|NCT03377361|560765223|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
155363649|NCT03377361|560765224|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
155363650|NCT03377361|560765225|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
155363651|NCT03377361|560765226|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
155363652|NCT03377361|560765227|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
155363653|NCT03377361|560765228|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
155363654|NCT03377361|560765229|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
155363655|NCT03377361|560765220|FG000|Treatment Period|Subject Withdrew Consent|0|||
155363656|NCT03377361|560765221|FG001|Treatment Period|Subject Withdrew Consent|0|||
155363657|NCT03377361|560765222|FG002|Treatment Period|Subject Withdrew Consent|0|||
155363658|NCT03377361|560765223|FG003|Treatment Period|Subject Withdrew Consent|0|||
155363659|NCT03377361|560765224|FG004|Treatment Period|Subject Withdrew Consent|0|||
155363660|NCT03377361|560765225|FG005|Treatment Period|Subject Withdrew Consent|0|||
155363661|NCT03377361|560765226|FG006|Treatment Period|Subject Withdrew Consent|0|||
155363662|NCT03377361|560765227|FG007|Treatment Period|Subject Withdrew Consent|0|||
155363663|NCT03377361|560765228|FG008|Treatment Period|Subject Withdrew Consent|2|||
155363664|NCT03377361|560765229|FG009|Treatment Period|Subject Withdrew Consent|1|||
155363665|NCT03377361|560765220|FG000|Treatment Period|No longer meets study criteria|0|||
155363666|NCT03377361|560765221|FG001|Treatment Period|No longer meets study criteria|1|||
155363667|NCT03377361|560765222|FG002|Treatment Period|No longer meets study criteria|0|||
155363668|NCT03377361|560765223|FG003|Treatment Period|No longer meets study criteria|0|||
155363669|NCT03377361|560765224|FG004|Treatment Period|No longer meets study criteria|0|||
155363670|NCT03377361|560765225|FG005|Treatment Period|No longer meets study criteria|0|||
155363671|NCT03377361|560765226|FG006|Treatment Period|No longer meets study criteria|0|||
155363672|NCT03377361|560765227|FG007|Treatment Period|No longer meets study criteria|1|||
155363673|NCT03377361|560765228|FG008|Treatment Period|No longer meets study criteria|0|||
155363674|NCT03377361|560765229|FG009|Treatment Period|No longer meets study criteria|0|||
155363675|NCT03377361|560765220|FG000|Treatment Period|Other Reasons|0|||
155363676|NCT03377361|560765221|FG001|Treatment Period|Other Reasons|0|||
155649187|NCT03259308|561805964|FG001|Overall Study|Adverse Event|4|||
155363677|NCT03377361|560765222|FG002|Treatment Period|Other Reasons|0|||
155363678|NCT03377361|560765223|FG003|Treatment Period|Other Reasons|3|||
155363679|NCT03377361|560765224|FG004|Treatment Period|Other Reasons|0|||
155363680|NCT03377361|560765225|FG005|Treatment Period|Other Reasons|0|||
155649188|NCT03259308|561805965|FG002|Overall Study|Adverse Event|1|||
155649189|NCT03259308|561805963|FG000|Overall Study|Withdrawal by Subject|2|||
155649190|NCT03259308|561805964|FG001|Overall Study|Withdrawal by Subject|1|||
155649191|NCT03259308|561805965|FG002|Overall Study|Withdrawal by Subject|3|||
155649192|NCT03259308|561805963|FG000|Overall Study|Lost to Follow-up|0|||
155649193|NCT03259308|561805964|FG001|Overall Study|Lost to Follow-up|0|||
155363681|NCT03377361|560765226|FG006|Treatment Period|Other Reasons|0|||
155363682|NCT03377361|560765227|FG007|Treatment Period|Other Reasons|2|||
155363683|NCT03377361|560765228|FG008|Treatment Period|Other Reasons|0|||
155363684|NCT03377361|560765229|FG009|Treatment Period|Other Reasons|1|||
155363685|NCT03698994|560765230|FG000|Overall Study|Adverse Event|2|||
155363686|NCT03698994|560765230|FG000|Overall Study|Death|1|||
155363687|NCT03698994|560765230|FG000|Overall Study|Physician Decision|1|||
155363688|NCT03698994|560765230|FG000|Overall Study|Withdrawal by Subject|3|||
155363689|NCT03698994|560765230|FG000|Overall Study|Progressive Disease|12|||
155363690|NCT04042077|560765231|FG000|Overall Study|Adverse Event|0|||
155363691|NCT04042077|560765232|FG001|Overall Study|Adverse Event|1|||
155363692|NCT04042077|560765231|FG000|Overall Study|Death|2|||
155363693|NCT04042077|560765232|FG001|Overall Study|Death|1|||
155363694|NCT04042077|560765231|FG000|Overall Study|Physician Decision|2|||
155363695|NCT04042077|560765232|FG001|Overall Study|Physician Decision|0|||
155363696|NCT04042077|560765231|FG000|Overall Study|Withdrawal by Subject|3|||
155363697|NCT04042077|560765232|FG001|Overall Study|Withdrawal by Subject|2|||
155507540|NCT00910858|561285104|FG001|Pharmacokinetic Phase|Adverse Event|0|||
155507541|NCT00910858|561285105|FG002|Pharmacokinetic Phase|Adverse Event|0|||
155363698|NCT04042077|560765231|FG000|Overall Study|Lack of Efficacy|0|||
155363699|NCT04042077|560765232|FG001|Overall Study|Lack of Efficacy|1|||
155363700|NCT01080300|560765233|FG000|Overall Study|Adverse Event|49|||
155363701|NCT01080300|560765234|FG001|Overall Study|Adverse Event|35|||
155363702|NCT01080300|560765233|FG000|Overall Study|Lack of Efficacy|12|||
155363703|NCT01080300|560765234|FG001|Overall Study|Lack of Efficacy|15|||
155363704|NCT01080300|560765233|FG000|Overall Study|Protocol Violation|7|||
155363705|NCT01080300|560765234|FG001|Overall Study|Protocol Violation|13|||
155363706|NCT01080300|560765233|FG000|Overall Study|Lost to Follow-up|10|||
155363707|NCT01080300|560765234|FG001|Overall Study|Lost to Follow-up|6|||
155363708|NCT01080300|560765233|FG000|Overall Study|Death|0|||
155363709|NCT01080300|560765234|FG001|Overall Study|Death|1|||
155363710|NCT01080300|560765233|FG000|Overall Study|Withdrawal by Subject|12|||
155363711|NCT01080300|560765234|FG001|Overall Study|Withdrawal by Subject|28|||
155363712|NCT01080300|560765233|FG000|Overall Study|Reasons not specified|4|||
155363713|NCT01080300|560765234|FG001|Overall Study|Reasons not specified|6|||
155363714|NCT02844777|560765235|FG000|Overall Study|Withdrawal by Subject|2|||
155363715|NCT02844777|560765236|FG001|Overall Study|Withdrawal by Subject|0|||
155363716|NCT02844777|560765237|FG002|Overall Study|Withdrawal by Subject|0|||
155363717|NCT01776008|560765238|FG000|Overall Study|ineligible|2|||
155363718|NCT01163474|560765239|FG000|Overall Study|Withdrawal by Subject|1|||
155363719|NCT01163474|560765239|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
155363720|NCT01163474|560765239|FG000|Overall Study|Lost to Follow-up|3|||
155363721|NCT00383123|560765240|FG000|Overall Study|Adverse Event|1|||
155363722|NCT00383123|560765241|FG001|Overall Study|Adverse Event|0|||
155363723|NCT00383123|560765240|FG000|Overall Study|Lost to Follow-up|68|||
155363724|NCT00383123|560765241|FG001|Overall Study|Lost to Follow-up|61|||
155363725|NCT00383123|560765240|FG000|Overall Study|Protocol Violation|5|||
155363726|NCT00383123|560765241|FG001|Overall Study|Protocol Violation|1|||
155363727|NCT00383123|560765240|FG000|Overall Study|Withdrawal by Subject|27|||
155507542|NCT00910858|561285103|FG000|Monotherapy Phase|Adverse Event|3|||
155507543|NCT00910858|561285104|FG001|Monotherapy Phase|Adverse Event|2|||
155363728|NCT00383123|560765241|FG001|Overall Study|Withdrawal by Subject|18|||
155363729|NCT00383123|560765240|FG000|Overall Study|Other reason|10|||
155363730|NCT00383123|560765241|FG001|Overall Study|Other reason|6|||
155363731|NCT02781311|560765242|FG000|Overall Study|Adverse Event|2|||
155363732|NCT02781311|560765243|FG001|Overall Study|Adverse Event|6|||
155363733|NCT02781311|560765244|FG002|Overall Study|Adverse Event|1|||
155363734|NCT02781311|560765242|FG000|Overall Study|Withdrawal of Consent|11|||
155363735|NCT02781311|560765243|FG001|Overall Study|Withdrawal of Consent|12|||
155363736|NCT02781311|560765244|FG002|Overall Study|Withdrawal of Consent|2|||
155507544|NCT00910858|561285105|FG002|Monotherapy Phase|Adverse Event|0|||
155363737|NCT02781311|560765242|FG000|Overall Study|Lost to Follow-up|11|||
155363738|NCT02781311|560765243|FG001|Overall Study|Lost to Follow-up|8|||
155363739|NCT02781311|560765244|FG002|Overall Study|Lost to Follow-up|1|||
155363740|NCT02781311|560765242|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155363741|NCT02781311|560765243|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155363742|NCT02781311|560765244|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155363743|NCT04547023|560765247|FG000|Overall Study|Did Not Receive Intervention|3|||
155363744|NCT04547023|560765248|FG001|Overall Study|Did Not Receive Intervention|2|||
155363745|NCT04547023|560765247|FG000|Overall Study|Lost to Follow-up|1|||
155363746|NCT04547023|560765248|FG001|Overall Study|Lost to Follow-up|1|||
155363747|NCT00250432|560765249|FG000|Overall Study|Adverse Event|25|||
155363748|NCT00250432|560765250|FG001|Overall Study|Adverse Event|29|||
155363749|NCT00250432|560765249|FG000|Overall Study|Lack of Efficacy|2|||
155363750|NCT00250432|560765250|FG001|Overall Study|Lack of Efficacy|1|||
155363751|NCT00250432|560765249|FG000|Overall Study|Lost to Follow-up|6|||
155363752|NCT00250432|560765250|FG001|Overall Study|Lost to Follow-up|5|||
155363753|NCT00250432|560765249|FG000|Overall Study|Patient Moved|0|||
155363754|NCT00250432|560765250|FG001|Overall Study|Patient Moved|1|||
155363755|NCT00250432|560765249|FG000|Overall Study|Protocol Violation|0|||
155363756|NCT00250432|560765250|FG001|Overall Study|Protocol Violation|3|||
155363757|NCT00250432|560765249|FG000|Overall Study|Withdrawal by Subject|6|||
155363758|NCT00250432|560765250|FG001|Overall Study|Withdrawal by Subject|2|||
155363759|NCT00250432|560765249|FG000|Overall Study|Pt died out of posttherapy report period|6|||
155363760|NCT00250432|560765250|FG001|Overall Study|Pt died out of posttherapy report period|5|||
155363761|NCT00250432|560765249|FG000|Overall Study|Pt was considered untreatable|0|||
155363762|NCT00250432|560765250|FG001|Overall Study|Pt was considered untreatable|1|||
155363763|NCT01637077|560765251|FG000|Overall Study|Cancel|1|||
155363764|NCT01637077|560765252|FG001|Overall Study|Cancel|1|||
155363765|NCT01637077|560765251|FG000|Overall Study|Withdrawal by Subject|1|||
155363766|NCT01637077|560765252|FG001|Overall Study|Withdrawal by Subject|0|||
155363767|NCT01637077|560765251|FG000|Overall Study|No cycle 1 questionnaire data|2|||
155363768|NCT01637077|560765252|FG001|Overall Study|No cycle 1 questionnaire data|0|||
155507545|NCT00910858|561285103|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
155507546|NCT00910858|561285104|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
155507547|NCT00910858|561285105|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
155507548|NCT00910858|561285103|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
155507549|NCT00910858|561285104|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
155507550|NCT00910858|561285105|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
155507551|NCT00910858|561285103|FG000|Monotherapy Phase|Protocol Violation|1|||
155507552|NCT00910858|561285104|FG001|Monotherapy Phase|Protocol Violation|0|||
155507553|NCT00910858|561285105|FG002|Monotherapy Phase|Protocol Violation|0|||
155507554|NCT00910858|561285103|FG000|Monotherapy Phase|Other|3|||
155507555|NCT00910858|561285104|FG001|Monotherapy Phase|Other|4|||
155507556|NCT00910858|561285105|FG002|Monotherapy Phase|Other|2|||
155507557|NCT00910858|561285103|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
155507558|NCT00910858|561285104|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
155507559|NCT00910858|561285105|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
155507560|NCT00910858|561285103|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
155507561|NCT00910858|561285104|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
155507562|NCT00910858|561285105|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
155507563|NCT00910858|561285103|FG000|Combined Treatment Phase|Protocol Violation|1|||
155507564|NCT00910858|561285104|FG001|Combined Treatment Phase|Protocol Violation|0|||
155507565|NCT00910858|561285105|FG002|Combined Treatment Phase|Protocol Violation|0|||
155507566|NCT00910858|561285103|FG000|Combined Treatment Phase|Other|0|||
155507567|NCT00910858|561285104|FG001|Combined Treatment Phase|Other|2|||
155507568|NCT00910858|561285105|FG002|Combined Treatment Phase|Other|1|||
155507569|NCT01165684|561285109|FG000|Overall Study|Adverse Event|1|||
155507570|NCT01165684|561285110|FG001|Overall Study|Adverse Event|1|||
155507571|NCT01165684|561285109|FG000|Overall Study|Lack of Efficacy|2|||
155507572|NCT01165684|561285110|FG001|Overall Study|Lack of Efficacy|1|||
155507573|NCT01165684|561285109|FG000|Overall Study|Protocol Violation|7|||
155507574|NCT01165684|561285110|FG001|Overall Study|Protocol Violation|15|||
155507575|NCT01165684|561285109|FG000|Overall Study|Withdrawal Criteria|2|||
155363769|NCT02638103|560765253|FG000|Overall Study|Adverse Event|13|||
155363770|NCT02638103|560765254|FG001|Overall Study|Adverse Event|12|||
155363771|NCT02638103|560765255|FG002|Overall Study|Adverse Event|19|||
155363772|NCT02638103|560765256|FG003|Overall Study|Adverse Event|12|||
155363773|NCT02638103|560765253|FG000|Overall Study|Withdrawal by Subject|43|||
155507576|NCT01165684|561285110|FG001|Overall Study|Withdrawal Criteria|13|||
155507577|NCT01165684|561285109|FG000|Overall Study|Unclassified|16|||
155507578|NCT01165684|561285110|FG001|Overall Study|Unclassified|22|||
155507579|NCT02008721|561285111|FG000|Overall Study|Withdrawal by Subject|5|||
155507580|NCT02008721|561285112|FG001|Overall Study|Withdrawal by Subject|1|||
155507581|NCT02008721|561285111|FG000|Overall Study|Death|4|||
155507582|NCT02008721|561285112|FG001|Overall Study|Death|2|||
155363774|NCT02638103|560765254|FG001|Overall Study|Withdrawal by Subject|53|||
155507583|NCT02008721|561285111|FG000|Overall Study|Adverse Event|3|||
155507584|NCT02008721|561285112|FG001|Overall Study|Adverse Event|5|||
155507585|NCT02008721|561285111|FG000|Overall Study|Protocol Violation|3|||
155507586|NCT02008721|561285112|FG001|Overall Study|Protocol Violation|2|||
155507587|NCT01797120|561285115|FG000|Overall Study|Disesae progression|37|||
155507588|NCT01797120|561285116|FG001|Overall Study|Disesae progression|49|||
155507589|NCT01797120|561285115|FG000|Overall Study|Adverse Event|13|||
155507590|NCT01797120|561285116|FG001|Overall Study|Adverse Event|5|||
155507591|NCT01797120|561285115|FG000|Overall Study|Withdrawal by Subject|6|||
155649194|NCT03259308|561805965|FG002|Overall Study|Lost to Follow-up|1|||
155649195|NCT03259308|561805963|FG000|Overall Study|Pregnancy|0|||
155363775|NCT02638103|560765255|FG002|Overall Study|Withdrawal by Subject|30|||
155363776|NCT02638103|560765256|FG003|Overall Study|Withdrawal by Subject|61|||
155363777|NCT02638103|560765253|FG000|Overall Study|Protocol Violation|1|||
155363778|NCT02638103|560765254|FG001|Overall Study|Protocol Violation|2|||
155363779|NCT02638103|560765255|FG002|Overall Study|Protocol Violation|1|||
155363780|NCT02638103|560765256|FG003|Overall Study|Protocol Violation|4|||
155363781|NCT02638103|560765253|FG000|Overall Study|Pregnancy|2|||
155363782|NCT02638103|560765254|FG001|Overall Study|Pregnancy|3|||
155363783|NCT02638103|560765255|FG002|Overall Study|Pregnancy|0|||
155363784|NCT02638103|560765256|FG003|Overall Study|Pregnancy|1|||
155363785|NCT02638103|560765253|FG000|Overall Study|Non-compliance to Study Procedures|2|||
155363786|NCT02638103|560765254|FG001|Overall Study|Non-compliance to Study Procedures|1|||
155363787|NCT02638103|560765255|FG002|Overall Study|Non-compliance to Study Procedures|1|||
155363788|NCT02638103|560765256|FG003|Overall Study|Non-compliance to Study Procedures|1|||
155363789|NCT02638103|560765253|FG000|Overall Study|Lost to Follow-up|26|||
155363790|NCT02638103|560765254|FG001|Overall Study|Lost to Follow-up|33|||
155363791|NCT02638103|560765255|FG002|Overall Study|Lost to Follow-up|20|||
155363792|NCT02638103|560765256|FG003|Overall Study|Lost to Follow-up|37|||
155363793|NCT02638103|560765253|FG000|Overall Study|Lack of Efficacy|14|||
155363794|NCT02638103|560765254|FG001|Overall Study|Lack of Efficacy|10|||
155363795|NCT02638103|560765255|FG002|Overall Study|Lack of Efficacy|12|||
155649196|NCT03259308|561805964|FG001|Overall Study|Pregnancy|0|||
155363796|NCT02638103|560765256|FG003|Overall Study|Lack of Efficacy|22|||
155363797|NCT02638103|560765253|FG000|Overall Study|Other than specified|5|||
155363798|NCT02638103|560765254|FG001|Overall Study|Other than specified|4|||
155363799|NCT02638103|560765255|FG002|Overall Study|Other than specified|2|||
155363800|NCT02638103|560765256|FG003|Overall Study|Other than specified|4|||
155507592|NCT01797120|561285116|FG001|Overall Study|Withdrawal by Subject|6|||
155507593|NCT01797120|561285115|FG000|Overall Study|Symptomatic progression|2|||
155507594|NCT01797120|561285116|FG001|Overall Study|Symptomatic progression|1|||
155649197|NCT03259308|561805965|FG002|Overall Study|Pregnancy|1|||
155507595|NCT01797120|561285115|FG000|Overall Study|Non-compliance|1|||
155507596|NCT01797120|561285116|FG001|Overall Study|Non-compliance|0|||
155507597|NCT01797120|561285115|FG000|Overall Study|Physician Decision|3|||
155363801|NCT04199052|560765262|FG000|Overall Study|Lost to Follow-up|11|||
155363802|NCT04199052|560765263|FG001|Overall Study|Lost to Follow-up|18|||
155363803|NCT04907357|560765264|FG000|Overall Study|Death|0|||
155363804|NCT04907357|560765265|FG001|Overall Study|Death|1|||
155363805|NCT04907357|560765264|FG000|Overall Study|Lost to Follow-up|9|||
155363806|NCT04907357|560765265|FG001|Overall Study|Lost to Follow-up|18|||
155363807|NCT04907357|560765264|FG000|Overall Study|Physician Decision|1|||
155363808|NCT04907357|560765265|FG001|Overall Study|Physician Decision|0|||
155363809|NCT04907357|560765264|FG000|Overall Study|Withdrawal by Subject|0|||
155363810|NCT04907357|560765265|FG001|Overall Study|Withdrawal by Subject|1|||
155363811|NCT04907357|560765264|FG000|Overall Study|Unable to attend visits|1|||
155363812|NCT04907357|560765265|FG001|Overall Study|Unable to attend visits|0|||
155363813|NCT04907357|560765264|FG000|Overall Study|Incarcerated|1|||
155363814|NCT04907357|560765265|FG001|Overall Study|Incarcerated|1|||
155363815|NCT00365547|560765266|FG000|Overall Study|Insurance did not cover Avastin|1|||
155363816|NCT00365547|560765266|FG000|Overall Study|Screen failure|1|||
155363817|NCT00365547|560765266|FG000|Overall Study|Withdrawal by Subject|1|||
155363818|NCT03692052|560765267|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
155363819|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
155363820|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
155363821|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
155363822|NCT02257918|560765268|FG000|Overall Study|Lost to Follow-up|4|||
155363823|NCT02257918|560765269|FG001|Overall Study|Lost to Follow-up|1|||
155363824|NCT02257918|560765270|FG002|Overall Study|Lost to Follow-up|0|||
155363825|NCT02257918|560765268|FG000|Overall Study|Withdrawal by Subject|0|||
155363826|NCT02257918|560765269|FG001|Overall Study|Withdrawal by Subject|0|||
155363827|NCT02257918|560765270|FG002|Overall Study|Withdrawal by Subject|1|||
155363828|NCT02257918|560765268|FG000|Overall Study|Pregnancy|0|||
155363829|NCT02257918|560765269|FG001|Overall Study|Pregnancy|0|||
155363830|NCT02257918|560765270|FG002|Overall Study|Pregnancy|1|||
155363831|NCT00936598|560765271|FG000|Overall Study|Withdrawal by Subject|1|||
155363832|NCT00936598|560765272|FG001|Overall Study|Withdrawal by Subject|0|||
155363833|NCT00936598|560765271|FG000|Overall Study|Ineligible after consent|1|||
155363834|NCT00936598|560765272|FG001|Overall Study|Ineligible after consent|0|||
155363835|NCT00486252|560765276|FG000|Overall Study|Adverse Event|7|||
155363836|NCT00486252|560765276|FG000|Overall Study|Lack of Efficacy|9|||
155363837|NCT00486252|560765276|FG000|Overall Study|Lost to Follow-up|24|||
155363838|NCT00486252|560765276|FG000|Overall Study|Other|18|||
155363839|NCT01261247|560765277|FG000|Overall Study|Ineligible|2|||
155507598|NCT01797120|561285116|FG001|Overall Study|Physician Decision|0|||
155507599|NCT01797120|561285115|FG000|Overall Study|still on treatment|2|||
155507600|NCT01797120|561285116|FG001|Overall Study|still on treatment|4|||
155507601|NCT01797120|561285115|FG000|Overall Study|never start protocol therapy|2|||
155507602|NCT01797120|561285116|FG001|Overall Study|never start protocol therapy|0|||
155507603|NCT03211156|561285117|FG000|Overall Study|Withdrawal by Subject|0|||
155507604|NCT03211156|561285118|FG001|Overall Study|Withdrawal by Subject|2|||
155507605|NCT03211156|561285117|FG000|Overall Study|Lost to Follow-up|1|||
155507606|NCT03211156|561285118|FG001|Overall Study|Lost to Follow-up|1|||
155507607|NCT03211156|561285117|FG000|Overall Study|Adverse Event|1|||
155507608|NCT03211156|561285118|FG001|Overall Study|Adverse Event|0|||
155507609|NCT04120194|561285122|FG000|Overall Study|Lost to Follow-up|11|||
155507610|NCT04120194|561285123|FG001|Overall Study|Lost to Follow-up|8|||
155507611|NCT04120194|561285122|FG000|Overall Study|Adverse Event|4|||
155507612|NCT04120194|561285123|FG001|Overall Study|Adverse Event|5|||
155507613|NCT04120194|561285122|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
155507614|NCT04120194|561285123|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
155507615|NCT04120194|561285122|FG000|Overall Study|Miscellaneous|4|||
155507616|NCT04120194|561285123|FG001|Overall Study|Miscellaneous|5|||
155507617|NCT02114931|561285124|FG000|Overall Study|Withdrawal by Subject|15|||
155507618|NCT02114931|561285125|FG001|Overall Study|Withdrawal by Subject|18|||
155363840|NCT01740154|560765278|FG000|Overall Study|Adverse Event|1|||
155363841|NCT03358472|560765282|FG000|Overall Study|Death|6|||
155363842|NCT03358472|560765283|FG001|Overall Study|Death|3|||
155363843|NCT03358472|560765284|FG002|Overall Study|Death|10|||
155363844|NCT03358472|560765282|FG000|Overall Study|Physician Decision|0|||
155363845|NCT03358472|560765283|FG001|Overall Study|Physician Decision|1|||
155507619|NCT02114931|561285124|FG000|Overall Study|Adverse Event|4|||
155507620|NCT02114931|561285125|FG001|Overall Study|Adverse Event|6|||
155507621|NCT02114931|561285124|FG000|Overall Study|Lost to Follow-up|3|||
155507622|NCT02114931|561285125|FG001|Overall Study|Lost to Follow-up|3|||
155507623|NCT02114931|561285124|FG000|Overall Study|Physician Decision|1|||
155507624|NCT02114931|561285125|FG001|Overall Study|Physician Decision|2|||
155507625|NCT02114931|561285124|FG000|Overall Study|Other|2|||
155507626|NCT02114931|561285125|FG001|Overall Study|Other|1|||
155507627|NCT03565211|561285126|FG000|Overall Study|Withdrawal by Subject|2|||
155507628|NCT03565211|561285126|FG000|Overall Study|Lost to Follow-up|1|||
155363846|NCT03358472|560765284|FG002|Overall Study|Physician Decision|0|||
155363847|NCT03358472|560765282|FG000|Overall Study|Withdrawal by Subject|0|||
155363848|NCT03358472|560765283|FG001|Overall Study|Withdrawal by Subject|0|||
155363849|NCT03358472|560765284|FG002|Overall Study|Withdrawal by Subject|1|||
155363850|NCT03358472|560765282|FG000|Overall Study|On-going at clinical cut off date|9|||
155363851|NCT03358472|560765283|FG001|Overall Study|On-going at clinical cut off date|6|||
155363852|NCT03358472|560765284|FG002|Overall Study|On-going at clinical cut off date|5|||
155363853|NCT04013971|560765287|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
155363854|NCT04013971|560765288|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
155363855|NCT04013971|560765287|FG000|Overall Study|Missing biomechanical data|0|||
155363856|NCT04013971|560765288|FG001|Overall Study|Missing biomechanical data|1|||
155363857|NCT04704219|560765295|FG000|Overall Study|Screen Failure|1|||
155649198|NCT03259308|561805963|FG000|Overall Study|Protocol Deviation|0|||
155649199|NCT03259308|561805964|FG001|Overall Study|Protocol Deviation|3|||
155649200|NCT03259308|561805965|FG002|Overall Study|Protocol Deviation|0|||
155649201|NCT03259308|561805963|FG000|Overall Study|Lack of Efficacy|0|||
155649202|NCT03259308|561805964|FG001|Overall Study|Lack of Efficacy|0|||
155649203|NCT03259308|561805965|FG002|Overall Study|Lack of Efficacy|1|||
155649204|NCT00290238|561805966|FG000|Overall Study|Study terminated|27|||
155649205|NCT00290238|561805967|FG001|Overall Study|Study terminated|27|||
155649206|NCT00290238|561805966|FG000|Overall Study|Lost to Follow-up|0|||
155649207|NCT00290238|561805967|FG001|Overall Study|Lost to Follow-up|1|||
155649208|NCT00290238|561805966|FG000|Overall Study|Withdrawal by Subject|15|||
155363858|NCT04704219|560765295|FG000|Overall Study|Withdrawal by Subject|1|||
155363859|NCT04704219|560765295|FG000|Overall Study|Death|78|||
155363860|NCT04704219|560765295|FG000|Overall Study|Participants Ongoing|80|||
155363861|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363862|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363863|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363864|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
155363865|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363866|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363867|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363868|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
155363869|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
155363870|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
155649209|NCT00290238|561805967|FG001|Overall Study|Withdrawal by Subject|13|||
155649210|NCT03834883|561805968|FG000|Second Treatment|Withdrawal by Subject|1|||
155649211|NCT03834883|561805969|FG001|Second Treatment|Withdrawal by Subject|0|||
155649212|NCT03834883|561805970|FG002|Second Treatment|Withdrawal by Subject|0|||
155649213|NCT03834883|561805971|FG003|Second Treatment|Withdrawal by Subject|0|||
155649214|NCT03834883|561805968|FG000|Second Treatment|COVID-19 pandemic|1|||
155649215|NCT03834883|561805969|FG001|Second Treatment|COVID-19 pandemic|0|||
155649216|NCT03834883|561805970|FG002|Second Treatment|COVID-19 pandemic|1|||
155649217|NCT03834883|561805971|FG003|Second Treatment|COVID-19 pandemic|1|||
155649218|NCT01569763|561808166|FG000|Overall Study|Lack of Efficacy|2|||
155649219|NCT01569763|561808167|FG001|Overall Study|Lack of Efficacy|7|||
155649220|NCT01569763|561808166|FG000|Overall Study|Adverse Event|1|||
155363871|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
155649221|NCT01569763|561808167|FG001|Overall Study|Adverse Event|0|||
155363872|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
155363873|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363874|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363875|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363876|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
155649222|NCT01926509|561808168|FG000|Overall Study|vital sign met discontinuation criteria|1|||
155649223|NCT01926509|561808169|FG001|Overall Study|vital sign met discontinuation criteria|0|||
155649224|NCT01926509|561808170|FG002|Overall Study|vital sign met discontinuation criteria|0|||
155649225|NCT01926509|561808171|FG003|Overall Study|vital sign met discontinuation criteria|0|||
155649226|NCT02730169|561808172|FG000|Overall Study|Protocol Violation|1|||
155649227|NCT02730169|561808173|FG001|Overall Study|Protocol Violation|0|||
155363877|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363878|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363879|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363880|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
155363881|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363882|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363883|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363884|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
155363885|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363886|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363887|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363888|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
155363889|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363890|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363891|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363892|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
155363893|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363894|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363895|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363896|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
155363897|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363898|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363899|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363900|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
155363901|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363902|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363903|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363904|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
155363905|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
155363906|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
155363907|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
155363908|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
155363909|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363910|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363911|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363912|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
155363913|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363914|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363915|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363916|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
155363917|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155507629|NCT03565211|561285126|FG000|Overall Study|Adverse Event|44|||
155507630|NCT03565211|561285126|FG000|Overall Study|Personal issues|1|||
155507631|NCT00323609|561285127|FG000|Overall Study|Death|16|||
155507632|NCT00323609|561285128|FG001|Overall Study|Death|21|||
155507633|NCT00323609|561285129|FG002|Overall Study|Death|0|||
155507634|NCT00323609|561285130|FG003|Overall Study|Death|0|||
155507635|NCT00323609|561285127|FG000|Overall Study|Lost to Follow-up|9|||
155507636|NCT00323609|561285128|FG001|Overall Study|Lost to Follow-up|10|||
155507637|NCT00323609|561285129|FG002|Overall Study|Lost to Follow-up|0|||
155507638|NCT00323609|561285130|FG003|Overall Study|Lost to Follow-up|0|||
155507639|NCT00323609|561285127|FG000|Overall Study|Physician Decision|2|||
155507640|NCT00323609|561285128|FG001|Overall Study|Physician Decision|0|||
155507641|NCT00323609|561285129|FG002|Overall Study|Physician Decision|0|||
155507642|NCT00323609|561285130|FG003|Overall Study|Physician Decision|1|||
155507643|NCT00323609|561285127|FG000|Overall Study|Withdrawal by Subject|11|||
155507644|NCT00323609|561285128|FG001|Overall Study|Withdrawal by Subject|23|||
155507645|NCT00323609|561285129|FG002|Overall Study|Withdrawal by Subject|4|||
155507646|NCT00323609|561285130|FG003|Overall Study|Withdrawal by Subject|4|||
155649228|NCT02730169|561808174|FG002|Overall Study|Protocol Violation|0|||
155649229|NCT02730169|561808175|FG003|Overall Study|Protocol Violation|1|||
155649230|NCT02730169|561808172|FG000|Overall Study|Adverse Event|2|||
155649231|NCT02730169|561808173|FG001|Overall Study|Adverse Event|3|||
155649232|NCT02730169|561808174|FG002|Overall Study|Adverse Event|3|||
155649233|NCT02730169|561808175|FG003|Overall Study|Adverse Event|0|||
155649234|NCT02730169|561808172|FG000|Overall Study|Adverse Event of Special Interest|0|||
155649235|NCT02730169|561808173|FG001|Overall Study|Adverse Event of Special Interest|1|||
155649236|NCT02730169|561808174|FG002|Overall Study|Adverse Event of Special Interest|2|||
155649237|NCT02730169|561808175|FG003|Overall Study|Adverse Event of Special Interest|0|||
155649238|NCT02730169|561808172|FG000|Overall Study|Withdrawal by Subject|6|||
155649239|NCT02730169|561808173|FG001|Overall Study|Withdrawal by Subject|11|||
155363918|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155363919|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155363920|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
155363921|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
155507647|NCT00323609|561285127|FG000|Overall Study|Other non-VCF-related medical condition|3|||
155507648|NCT00323609|561285128|FG001|Overall Study|Other non-VCF-related medical condition|2|||
155507649|NCT00323609|561285129|FG002|Overall Study|Other non-VCF-related medical condition|0|||
155507650|NCT00323609|561285130|FG003|Overall Study|Other non-VCF-related medical condition|0|||
155507651|NCT00323609|561285127|FG000|Overall Study|Sponsor discontinued trial|29|||
155507652|NCT00323609|561285128|FG001|Overall Study|Sponsor discontinued trial|29|||
155507653|NCT00323609|561285129|FG002|Overall Study|Sponsor discontinued trial|0|||
155507654|NCT00323609|561285130|FG003|Overall Study|Sponsor discontinued trial|0|||
155507655|NCT00323609|561285127|FG000|Overall Study|Unrelenting or severe back pain|1|||
155507656|NCT00323609|561285128|FG001|Overall Study|Unrelenting or severe back pain|1|||
155507657|NCT00323609|561285129|FG002|Overall Study|Unrelenting or severe back pain|0|||
155507658|NCT00323609|561285130|FG003|Overall Study|Unrelenting or severe back pain|0|||
155507659|NCT00323609|561285127|FG000|Overall Study|Logistical withdrawal|9|||
155507660|NCT00323609|561285128|FG001|Overall Study|Logistical withdrawal|5|||
155507661|NCT00323609|561285129|FG002|Overall Study|Logistical withdrawal|0|||
155507662|NCT00323609|561285130|FG003|Overall Study|Logistical withdrawal|1|||
155507663|NCT00323609|561285127|FG000|Overall Study|Other reason|11|||
155507664|NCT00323609|561285128|FG001|Overall Study|Other reason|8|||
155507665|NCT00323609|561285129|FG002|Overall Study|Other reason|4|||
155507666|NCT00323609|561285130|FG003|Overall Study|Other reason|9|||
155507667|NCT00219557|561285135|FG000|Phase 1|Lack of Efficacy|3|||
155507668|NCT00219557|561285136|FG001|Phase 1|Lack of Efficacy|0|||
155507669|NCT00219557|561285137|FG002|Phase 1|Lack of Efficacy|0|||
155507670|NCT00219557|561285135|FG000|Phase 1|Adverse Event|2|||
155507671|NCT00219557|561285136|FG001|Phase 1|Adverse Event|0|||
155507672|NCT00219557|561285137|FG002|Phase 1|Adverse Event|0|||
155507673|NCT00219557|561285135|FG000|Phase 1|Withdrawal by Subject|1|||
155507674|NCT00219557|561285136|FG001|Phase 1|Withdrawal by Subject|0|||
155507675|NCT00219557|561285137|FG002|Phase 1|Withdrawal by Subject|0|||
155507676|NCT00219557|561285135|FG000|Phase 1|Started chemotherapy at other institute|1|||
155507677|NCT00219557|561285136|FG001|Phase 1|Started chemotherapy at other institute|0|||
155507678|NCT00219557|561285137|FG002|Phase 1|Started chemotherapy at other institute|0|||
155507679|NCT00219557|561285135|FG000|Phase 2|Lack of Efficacy|0|||
155507680|NCT00219557|561285136|FG001|Phase 2|Lack of Efficacy|21|||
155507681|NCT00219557|561285137|FG002|Phase 2|Lack of Efficacy|15|||
155507682|NCT00219557|561285135|FG000|Phase 2|Adverse Event|0|||
155507683|NCT00219557|561285136|FG001|Phase 2|Adverse Event|22|||
155507684|NCT00219557|561285137|FG002|Phase 2|Adverse Event|2|||
155507685|NCT00219557|561285135|FG000|Phase 2|Death|0|||
155507686|NCT00219557|561285136|FG001|Phase 2|Death|8|||
155507687|NCT00219557|561285137|FG002|Phase 2|Death|2|||
155507688|NCT00219557|561285135|FG000|Phase 2|Other|0|||
155507689|NCT00219557|561285136|FG001|Phase 2|Other|8|||
155507690|NCT00219557|561285137|FG002|Phase 2|Other|6|||
155507691|NCT00219557|561285135|FG000|Phase 2|Withdrawal by Subject|0|||
155507692|NCT00219557|561285136|FG001|Phase 2|Withdrawal by Subject|9|||
155507693|NCT00219557|561285137|FG002|Phase 2|Withdrawal by Subject|5|||
155507694|NCT00219557|561285135|FG000|Phase 2|Treatment not received|0|||
155507695|NCT00219557|561285136|FG001|Phase 2|Treatment not received|1|||
155507696|NCT00219557|561285137|FG002|Phase 2|Treatment not received|3|||
155507697|NCT01612156|561285142|FG000|Overall Study|Protocol Violation|2|||
155507698|NCT01612156|561285143|FG001|Overall Study|Protocol Violation|0|||
155507699|NCT00410410|561285144|FG000|Induction Period (IP)|Death|1|||
155507700|NCT00410410|561285145|FG001|Induction Period (IP)|Death|0|||
155507701|NCT00410410|561285146|FG002|Induction Period (IP)|Death|0|||
155507702|NCT00410410|561285147|FG003|Induction Period (IP)|Death|0|||
155507703|NCT00410410|561285148|FG004|Induction Period (IP)|Death|0|||
155507704|NCT00410410|561285149|FG005|Induction Period (IP)|Death|0|||
155507705|NCT00410410|561285150|FG006|Induction Period (IP)|Death|0|||
155507706|NCT00410410|561285151|FG007|Induction Period (IP)|Death|0|||
155507707|NCT00410410|561285152|FG008|Induction Period (IP)|Death|0|||
155363922|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
155363923|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
155363924|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
155363925|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363926|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363927|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363928|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
155363929|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
155363930|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
155363931|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
155363932|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
155363933|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
155363934|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
155363935|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
155363936|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
155363937|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Study suspension|0|||
155363938|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Study suspension|45|||
155363939|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Study suspension|0|||
155363940|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Study suspension|0|||
155363941|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
155363942|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
155363943|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
155363944|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
155363945|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Death|2|||
155363946|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Death|3|||
155363947|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Death|0|||
155363948|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Death|0|||
155363949|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
155363950|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
155363951|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
155427617|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
155427618|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
155427619|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
155427620|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
155427621|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
155427622|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
155427623|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
155427624|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
155427625|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
155427626|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
155427627|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
155427628|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
155427629|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
155427630|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
155427631|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
155427632|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427633|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427634|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427635|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427636|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427637|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
155427638|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427639|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
155427640|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
155427641|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
155427642|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
155427643|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
155427644|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
155507708|NCT00410410|561285144|FG000|Induction Period (IP)|Adverse Event|3|||
155507709|NCT00410410|561285145|FG001|Induction Period (IP)|Adverse Event|4|||
155363952|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
155363953|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
155363954|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
155363955|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
155363956|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
155363957|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
155363958|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
155363959|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
155363960|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
155363961|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363962|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
155363963|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363964|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363965|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363966|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
155363967|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363968|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363969|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
155363970|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363971|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363972|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363973|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
155363974|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
155363975|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
155363976|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
155363977|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Other|1|||
155363978|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Other|2|||
155363979|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Other|0|||
155363980|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Other|0|||
155363981|NCT04949802|560766441|FG000|Overall Study|Lost to Follow-up|3|||
155363982|NCT00233480|560766442|FG000|Overall Study|Underwent status II heart transplant|0|||
155363983|NCT00233480|560766443|FG001|Overall Study|Underwent status II heart transplant|1|||
155363984|NCT00474526|560766444|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
155363985|NCT00474526|560766445|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
155363986|NCT00474526|560766446|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
155363987|NCT00474526|560766447|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
155363988|NCT00474526|560766448|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
155363989|NCT00474526|560766449|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
155363990|NCT00474526|560766450|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
155363991|NCT00474526|560766451|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
155363992|NCT00474526|560766452|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
155363993|NCT00474526|560766453|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
155363994|NCT00474526|560766454|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
155363995|NCT00474526|560766455|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
155363996|NCT00474526|560766456|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
155363997|NCT00474526|560766457|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
155363998|NCT00474526|560766458|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
155363999|NCT00474526|560766459|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
155364000|NCT00474526|560766460|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
155364001|NCT00474526|560766444|FG000|Overall Study|Adverse Event|2|||
155364002|NCT00474526|560766445|FG001|Overall Study|Adverse Event|0|||
155364003|NCT00474526|560766446|FG002|Overall Study|Adverse Event|2|||
155364004|NCT00474526|560766447|FG003|Overall Study|Adverse Event|4|||
155364005|NCT00474526|560766448|FG004|Overall Study|Adverse Event|2|||
155364006|NCT00474526|560766449|FG005|Overall Study|Adverse Event|1|||
155364007|NCT00474526|560766450|FG006|Overall Study|Adverse Event|1|||
155364008|NCT00474526|560766451|FG007|Overall Study|Adverse Event|0|||
155364009|NCT00474526|560766452|FG008|Overall Study|Adverse Event|0|||
155364010|NCT00474526|560766453|FG009|Overall Study|Adverse Event|0|||
155364011|NCT00474526|560766454|FG010|Overall Study|Adverse Event|0|||
155427645|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
155427646|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
155364012|NCT00474526|560766455|FG011|Overall Study|Adverse Event|0|||
155427647|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
155427648|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155427649|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155427650|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155427651|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155364013|NCT00474526|560766456|FG012|Overall Study|Adverse Event|0|||
155364014|NCT00474526|560766457|FG013|Overall Study|Adverse Event|0|||
155364015|NCT00474526|560766458|FG014|Overall Study|Adverse Event|1|||
155364016|NCT00474526|560766459|FG015|Overall Study|Adverse Event|1|||
155364017|NCT00474526|560766460|FG016|Overall Study|Adverse Event|0|||
155364018|NCT00474526|560766444|FG000|Overall Study|Death|0|||
155364019|NCT00474526|560766445|FG001|Overall Study|Death|0|||
155364020|NCT00474526|560766446|FG002|Overall Study|Death|0|||
155364021|NCT00474526|560766447|FG003|Overall Study|Death|0|||
155364022|NCT00474526|560766448|FG004|Overall Study|Death|0|||
155364023|NCT00474526|560766449|FG005|Overall Study|Death|0|||
155364024|NCT00474526|560766450|FG006|Overall Study|Death|0|||
155364025|NCT00474526|560766451|FG007|Overall Study|Death|0|||
155364026|NCT00474526|560766452|FG008|Overall Study|Death|0|||
155364027|NCT00474526|560766453|FG009|Overall Study|Death|0|||
155364028|NCT00474526|560766454|FG010|Overall Study|Death|0|||
155364029|NCT00474526|560766455|FG011|Overall Study|Death|0|||
155364030|NCT00474526|560766456|FG012|Overall Study|Death|0|||
155364031|NCT00474526|560766457|FG013|Overall Study|Death|3|||
155364032|NCT00474526|560766458|FG014|Overall Study|Death|0|||
155364033|NCT00474526|560766459|FG015|Overall Study|Death|0|||
155364034|NCT00474526|560766460|FG016|Overall Study|Death|0|||
155364035|NCT00474526|560766444|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364036|NCT00474526|560766445|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
155364037|NCT00474526|560766446|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364038|NCT00474526|560766447|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
155364039|NCT00474526|560766448|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155364040|NCT00474526|560766449|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364041|NCT00474526|560766450|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364042|NCT00474526|560766451|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364043|NCT00474526|560766452|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364044|NCT00474526|560766453|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364045|NCT00474526|560766454|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364046|NCT00474526|560766455|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364047|NCT00474526|560766456|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364048|NCT00474526|560766457|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155364049|NCT00474526|560766458|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155427652|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
155427653|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
155427654|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155427655|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
155427656|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
155427657|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
155427658|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
155427659|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
155427660|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
155427661|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
155427662|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
155427663|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
155427664|NCT00408005|560991836|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
155427665|NCT00408005|560991837|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
155427666|NCT00408005|560991838|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
155427667|NCT00408005|560991839|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
155427668|NCT00408005|560991840|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
155427669|NCT00408005|560991841|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
155427670|NCT00408005|560991842|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
155427671|NCT00408005|560991843|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
155427672|NCT05424276|560991844|FG000|Overall Study|Adverse Event|1|||
155427673|NCT05424276|560991845|FG001|Overall Study|Adverse Event|0|||
155427674|NCT05424276|560991846|FG002|Overall Study|Adverse Event|0|||
155427675|NCT05424276|560991847|FG003|Overall Study|Adverse Event|2|||
155427676|NCT05424276|560991844|FG000|Overall Study|Withdrawal by Subject|0|||
155427677|NCT05424276|560991845|FG001|Overall Study|Withdrawal by Subject|0|||
155427678|NCT05424276|560991846|FG002|Overall Study|Withdrawal by Subject|2|||
155507710|NCT00410410|561285146|FG002|Induction Period (IP)|Adverse Event|2|||
155364050|NCT00474526|560766459|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364051|NCT00474526|560766460|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364052|NCT00474526|560766444|FG000|Overall Study|Lost to Follow-up|8|||
155364053|NCT00474526|560766445|FG001|Overall Study|Lost to Follow-up|6|||
155364054|NCT00474526|560766446|FG002|Overall Study|Lost to Follow-up|13|||
155364055|NCT00474526|560766447|FG003|Overall Study|Lost to Follow-up|29|||
155364056|NCT00474526|560766448|FG004|Overall Study|Lost to Follow-up|11|||
155364057|NCT00474526|560766449|FG005|Overall Study|Lost to Follow-up|5|||
155364058|NCT00474526|560766450|FG006|Overall Study|Lost to Follow-up|8|||
155364059|NCT00474526|560766451|FG007|Overall Study|Lost to Follow-up|1|||
155364060|NCT00474526|560766452|FG008|Overall Study|Lost to Follow-up|0|||
155364061|NCT00474526|560766453|FG009|Overall Study|Lost to Follow-up|6|||
155364062|NCT00474526|560766454|FG010|Overall Study|Lost to Follow-up|2|||
155364063|NCT00474526|560766455|FG011|Overall Study|Lost to Follow-up|4|||
155364064|NCT00474526|560766456|FG012|Overall Study|Lost to Follow-up|6|||
155364065|NCT00474526|560766457|FG013|Overall Study|Lost to Follow-up|74|||
155364066|NCT00474526|560766458|FG014|Overall Study|Lost to Follow-up|29|||
155364067|NCT00474526|560766459|FG015|Overall Study|Lost to Follow-up|4|||
155364068|NCT00474526|560766460|FG016|Overall Study|Lost to Follow-up|5|||
155364069|NCT00474526|560766444|FG000|Overall Study|Protocol Violation|2|||
155364070|NCT00474526|560766445|FG001|Overall Study|Protocol Violation|6|||
155364071|NCT00474526|560766446|FG002|Overall Study|Protocol Violation|4|||
155364072|NCT00474526|560766447|FG003|Overall Study|Protocol Violation|12|||
155364073|NCT00474526|560766448|FG004|Overall Study|Protocol Violation|3|||
155364074|NCT00474526|560766449|FG005|Overall Study|Protocol Violation|1|||
155364075|NCT00474526|560766450|FG006|Overall Study|Protocol Violation|3|||
155364076|NCT00474526|560766451|FG007|Overall Study|Protocol Violation|0|||
155364077|NCT00474526|560766452|FG008|Overall Study|Protocol Violation|0|||
155364078|NCT00474526|560766453|FG009|Overall Study|Protocol Violation|4|||
155364079|NCT00474526|560766454|FG010|Overall Study|Protocol Violation|2|||
155364080|NCT00474526|560766455|FG011|Overall Study|Protocol Violation|2|||
155364081|NCT00474526|560766456|FG012|Overall Study|Protocol Violation|4|||
155364082|NCT00474526|560766457|FG013|Overall Study|Protocol Violation|19|||
155364083|NCT00474526|560766458|FG014|Overall Study|Protocol Violation|9|||
155364084|NCT00474526|560766459|FG015|Overall Study|Protocol Violation|6|||
155364085|NCT00474526|560766460|FG016|Overall Study|Protocol Violation|2|||
155364086|NCT00474526|560766444|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
155364087|NCT00474526|560766445|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
155427679|NCT05424276|560991847|FG003|Overall Study|Withdrawal by Subject|0|||
155427680|NCT05424276|560991844|FG000|Overall Study|Protocol Violation|0|||
155427681|NCT05424276|560991845|FG001|Overall Study|Protocol Violation|1|||
155427682|NCT05424276|560991846|FG002|Overall Study|Protocol Violation|0|||
155427683|NCT05424276|560991847|FG003|Overall Study|Protocol Violation|0|||
155427684|NCT05424276|560991844|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
155427685|NCT05424276|560991845|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
155364088|NCT00474526|560766446|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
155364089|NCT00474526|560766447|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
155364090|NCT00474526|560766448|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
155364091|NCT00474526|560766449|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
155427686|NCT05424276|560991846|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
155427687|NCT05424276|560991847|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
155427688|NCT04454489|560991849|FG000|Overall Study|Disease progression|12|||
155427689|NCT04454489|560991849|FG000|Overall Study|Death|4|||
155427690|NCT04454489|560991849|FG000|Overall Study|Adverse Event|1|||
155427691|NCT04454489|560991849|FG000|Overall Study|Physician Decision|1|||
155427692|NCT00501228|560991850|FG000|Overall Study|Withdrawal by Subject|1|||
155364092|NCT00474526|560766450|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
155507711|NCT00410410|561285147|FG003|Induction Period (IP)|Adverse Event|4|||
155507712|NCT00410410|561285148|FG004|Induction Period (IP)|Adverse Event|1|||
155507713|NCT00410410|561285149|FG005|Induction Period (IP)|Adverse Event|0|||
155364093|NCT00474526|560766451|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
155364094|NCT00474526|560766452|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
155364095|NCT00474526|560766453|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
155364096|NCT00474526|560766454|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
155364097|NCT00474526|560766455|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
155364098|NCT00474526|560766456|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
155364099|NCT00474526|560766457|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
155364100|NCT00474526|560766458|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
155364101|NCT00474526|560766459|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
155364102|NCT00474526|560766460|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
155364103|NCT00474526|560766444|FG000|Overall Study|Withdrawal by Subject|9|||
155364104|NCT00474526|560766445|FG001|Overall Study|Withdrawal by Subject|24|||
155364105|NCT00474526|560766446|FG002|Overall Study|Withdrawal by Subject|21|||
155364106|NCT00474526|560766447|FG003|Overall Study|Withdrawal by Subject|52|||
155364107|NCT00474526|560766448|FG004|Overall Study|Withdrawal by Subject|38|||
155364108|NCT00474526|560766449|FG005|Overall Study|Withdrawal by Subject|6|||
155364109|NCT00474526|560766450|FG006|Overall Study|Withdrawal by Subject|12|||
155364110|NCT00474526|560766451|FG007|Overall Study|Withdrawal by Subject|4|||
155364111|NCT00474526|560766452|FG008|Overall Study|Withdrawal by Subject|4|||
155364112|NCT00474526|560766453|FG009|Overall Study|Withdrawal by Subject|13|||
155364113|NCT00474526|560766454|FG010|Overall Study|Withdrawal by Subject|5|||
155507714|NCT00410410|561285150|FG006|Induction Period (IP)|Adverse Event|0|||
155364114|NCT00474526|560766455|FG011|Overall Study|Withdrawal by Subject|4|||
155364115|NCT00474526|560766456|FG012|Overall Study|Withdrawal by Subject|4|||
155364116|NCT00474526|560766457|FG013|Overall Study|Withdrawal by Subject|37|||
155364117|NCT00474526|560766458|FG014|Overall Study|Withdrawal by Subject|22|||
155507715|NCT00410410|561285151|FG007|Induction Period (IP)|Adverse Event|0|||
155364118|NCT00474526|560766459|FG015|Overall Study|Withdrawal by Subject|1|||
155364119|NCT00474526|560766460|FG016|Overall Study|Withdrawal by Subject|1|||
155364120|NCT00953147|560766461|FG000|Overall Study|Adverse Event|8|||
155364121|NCT00953147|560766462|FG001|Overall Study|Adverse Event|16|||
155364122|NCT00953147|560766463|FG002|Overall Study|Adverse Event|6|||
155364123|NCT00953147|560766461|FG000|Overall Study|Protocol Violation|2|||
155364124|NCT00953147|560766462|FG001|Overall Study|Protocol Violation|8|||
155427693|NCT01147926|560991851|FG000|Overall Study|Subject Withdrew Consent|9|||
155427694|NCT01147926|560991852|FG001|Overall Study|Subject Withdrew Consent|10|||
155427695|NCT01147926|560991851|FG000|Overall Study|Adverse Event|7|||
155427696|NCT01147926|560991852|FG001|Overall Study|Adverse Event|6|||
155427697|NCT01147926|560991851|FG000|Overall Study|Subject Non-Compliant|5|||
155427698|NCT01147926|560991852|FG001|Overall Study|Subject Non-Compliant|4|||
155427699|NCT01147926|560991851|FG000|Overall Study|Principal investigator left hospital|1|||
155427700|NCT01147926|560991852|FG001|Overall Study|Principal investigator left hospital|3|||
155427701|NCT01147926|560991851|FG000|Overall Study|Selection criteria not met|3|||
155427702|NCT01147926|560991852|FG001|Overall Study|Selection criteria not met|1|||
155427703|NCT01147926|560991851|FG000|Overall Study|Lost to Follow-up|0|||
155427704|NCT01147926|560991852|FG001|Overall Study|Lost to Follow-up|2|||
155427705|NCT01147926|560991851|FG000|Overall Study|Sponsor's Decision|0|||
155427706|NCT01147926|560991852|FG001|Overall Study|Sponsor's Decision|1|||
155427707|NCT01147926|560991851|FG000|Overall Study|Lack of Efficacy|1|||
155427708|NCT01147926|560991852|FG001|Overall Study|Lack of Efficacy|0|||
155427709|NCT01147926|560991851|FG000|Overall Study|Too busy, no time for study|1|||
155427710|NCT01147926|560991852|FG001|Overall Study|Too busy, no time for study|0|||
155427711|NCT01147926|560991851|FG000|Overall Study|Went on holiday|0|||
155364125|NCT00953147|560766463|FG002|Overall Study|Protocol Violation|4|||
155364126|NCT00953147|560766461|FG000|Overall Study|Withdrawal by Subject|13|||
155364127|NCT00953147|560766462|FG001|Overall Study|Withdrawal by Subject|15|||
155364128|NCT00953147|560766463|FG002|Overall Study|Withdrawal by Subject|12|||
155427712|NCT01147926|560991852|FG001|Overall Study|Went on holiday|1|||
155427713|NCT01147926|560991851|FG000|Overall Study|Colonoscopy result|0|||
155364129|NCT00953147|560766461|FG000|Overall Study|Lost to Follow-up|8|||
155364130|NCT00953147|560766462|FG001|Overall Study|Lost to Follow-up|9|||
155364131|NCT00953147|560766463|FG002|Overall Study|Lost to Follow-up|4|||
155364132|NCT00953147|560766461|FG000|Overall Study|Physician Decision|2|||
155364133|NCT00953147|560766462|FG001|Overall Study|Physician Decision|7|||
155364134|NCT00953147|560766463|FG002|Overall Study|Physician Decision|3|||
155427714|NCT01147926|560991852|FG001|Overall Study|Colonoscopy result|1|||
155364135|NCT00953147|560766461|FG000|Overall Study|Other|4|||
155427715|NCT03514914|560991853|FG000|Overall Study|Death|3|||
155427716|NCT03514914|560991854|FG001|Overall Study|Death|3|||
155507716|NCT00410410|561285152|FG008|Induction Period (IP)|Adverse Event|0|||
155364136|NCT00953147|560766462|FG001|Overall Study|Other|11|||
155364137|NCT00953147|560766463|FG002|Overall Study|Other|13|||
155364138|NCT01484431|560766464|FG000|Period 1: High Dose|Physician Decision|0|||
155364139|NCT01484431|560766465|FG001|Period 1: High Dose|Physician Decision|1|||
155364140|NCT01484431|560766466|FG002|Period 1: High Dose|Physician Decision|0|||
155364141|NCT01484431|560766464|FG000|Period 2|Death|0|||
155364142|NCT01484431|560766465|FG001|Period 2|Death|1|||
155364143|NCT01484431|560766466|FG002|Period 2|Death|1|||
155364144|NCT01484431|560766464|FG000|Period 2|Physician Decision|0|||
155364145|NCT01484431|560766465|FG001|Period 2|Physician Decision|0|||
155364146|NCT01484431|560766466|FG002|Period 2|Physician Decision|1|||
155364147|NCT01484431|560766464|FG000|Period 2|Non-Compliance with Study Drug|1|||
155364148|NCT01484431|560766465|FG001|Period 2|Non-Compliance with Study Drug|0|||
155364149|NCT01484431|560766466|FG002|Period 2|Non-Compliance with Study Drug|0|||
155364150|NCT01251770|560766468|FG000|Overall Study|Protocol Violation|13|||
155364151|NCT01251770|560766469|FG001|Overall Study|Protocol Violation|7|||
155364152|NCT02763215|560766470|FG000|Overall Study|Participants withdrew from study|3|||
155364153|NCT02763215|560766470|FG000|Overall Study|Missed visit|1|||
155364154|NCT02763215|560766470|FG000|Overall Study|Visit outside visit-window|1|||
155364155|NCT02763215|560766470|FG000|Overall Study|Death|1|||
155364156|NCT02763215|560766470|FG000|Overall Study|Lost to Follow-up|1|||
155364157|NCT01020877|560766475|FG000|Second Intervention|Withdrawal by Subject|1|||
155364158|NCT01020877|560766476|FG001|Second Intervention|Withdrawal by Subject|0|||
155364159|NCT00953771|560766477|FG000|Overall Study|Death|1|||
155364160|NCT00953771|560766478|FG001|Overall Study|Death|0|||
155364161|NCT00974259|560766479|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
155364162|NCT00974259|560766480|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
155364163|NCT00944229|560766481|FG000|Overall Study|Withdrawal by Subject|11|||
155364164|NCT00944229|560766481|FG000|Overall Study|Physician Decision|14|||
155364165|NCT02963090|560766482|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
155364166|NCT02963090|560766483|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
155364167|NCT00709228|560766487|FG000|Overall Study|Not treated|14|||
155364168|NCT00709228|560766487|FG000|Overall Study|Eligibility criteria not met|281|||
155364169|NCT00709228|560766487|FG000|Overall Study|Adverse events|2|||
155364170|NCT00709228|560766487|FG000|Overall Study|Discontinued treatment|14|||
155364171|NCT00709228|560766487|FG000|Overall Study|Did not enter follow-up|4|||
155364172|NCT00709228|560766487|FG000|Overall Study|Discontinued follow-up|5|||
155364173|NCT00709228|560766487|FG000|Overall Study|Disease progression|1|||
155364174|NCT00709228|560766487|FG000|Overall Study|Lost to Follow-up|6|||
155364175|NCT00709228|560766487|FG000|Overall Study|Non-compliance|5|||
155364176|NCT02179177|560766490|FG000|Overall Study|Lost to Follow-up|1|||
155364177|NCT02179177|560766491|FG001|Overall Study|Lost to Follow-up|1|||
155364178|NCT02179177|560766490|FG000|Overall Study|Withdrawal by Subject|1|||
155364179|NCT02179177|560766491|FG001|Overall Study|Withdrawal by Subject|1|||
155364180|NCT00022659|560766492|FG000|Overall Study|Ineligible: wrong primary|1|||
155364181|NCT00022659|560766492|FG000|Overall Study|Never treated|1|||
155364182|NCT00884650|560766495|FG000|Overall Study|Did not return complete pain diaries|7|||
155364183|NCT00884650|560766496|FG001|Overall Study|Did not return complete pain diaries|7|||
155364184|NCT00884650|560766495|FG000|Overall Study|Admitted Post-Op|1|||
155364185|NCT00884650|560766496|FG001|Overall Study|Admitted Post-Op|0|||
155364186|NCT00884650|560766495|FG000|Overall Study|Femoral Stress Fracture|1|||
155364187|NCT00884650|560766496|FG001|Overall Study|Femoral Stress Fracture|0|||
155364188|NCT00884650|560766495|FG000|Overall Study|Pain Pump Complication|0|||
155364189|NCT00884650|560766496|FG001|Overall Study|Pain Pump Complication|1|||
155364190|NCT01516749|560766505|FG000|Active Therapy|Lost to Follow-up|1|||
155364191|NCT01516749|560766505|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
155364192|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Death|2|||
155364193|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Death|0|||
155364194|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
155364195|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
155364196|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
155364197|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
155364198|NCT00732992|560766511|FG000|Overall Study|Adverse Event|1|||
155364199|NCT00732992|560766512|FG001|Overall Study|Adverse Event|1|||
155364200|NCT00732992|560766511|FG000|Overall Study|Objective Progression or Relapse|3|||
155364201|NCT00732992|560766512|FG001|Overall Study|Objective Progression or Relapse|5|||
155364202|NCT00732992|560766511|FG000|Overall Study|Global Deterioration of Health Status|1|||
155364203|NCT00732992|560766512|FG001|Overall Study|Global Deterioration of Health Status|0|||
155364204|NCT00732992|560766511|FG000|Overall Study|Withdrawal by Subject|1|||
155364205|NCT00732992|560766512|FG001|Overall Study|Withdrawal by Subject|0|||
155427717|NCT03514914|560991853|FG000|Overall Study|Lost to Follow-up|117|||
155427718|NCT03514914|560991854|FG001|Overall Study|Lost to Follow-up|89|||
155364206|NCT00762476|560766516|FG000|Overall Study|Adverse Event|7|||
155364207|NCT00762476|560766517|FG001|Overall Study|Adverse Event|1|||
155364208|NCT00762476|560766516|FG000|Overall Study|Lost to Follow-up|2|||
155364209|NCT00762476|560766517|FG001|Overall Study|Lost to Follow-up|0|||
155364210|NCT00762476|560766516|FG000|Overall Study|Protocol Violation|5|||
155364211|NCT00762476|560766517|FG001|Overall Study|Protocol Violation|6|||
155364212|NCT00762476|560766516|FG000|Overall Study|Physician Decision|2|||
155364213|NCT00762476|560766517|FG001|Overall Study|Physician Decision|14|||
155364214|NCT00762476|560766516|FG000|Overall Study|Withdrawal by Subject|6|||
155364215|NCT00762476|560766517|FG001|Overall Study|Withdrawal by Subject|12|||
155364216|NCT00762476|560766516|FG000|Overall Study|antibiotic use|0|||
155364217|NCT00762476|560766517|FG001|Overall Study|antibiotic use|1|||
155364218|NCT00762476|560766516|FG000|Overall Study|non-compliance with study visits|0|||
155364219|NCT00762476|560766517|FG001|Overall Study|non-compliance with study visits|2|||
155364220|NCT00762476|560766516|FG000|Overall Study|Seasonal allergies|1|||
155364221|NCT00762476|560766517|FG001|Overall Study|Seasonal allergies|0|||
155364222|NCT02838134|560766518|FG000|Overall Study|Lost to Follow-up|1|||
155364223|NCT02838134|560766519|FG001|Overall Study|Lost to Follow-up|2|||
155364224|NCT02838134|560766518|FG000|Overall Study|logistic problems|1|||
155364225|NCT02838134|560766519|FG001|Overall Study|logistic problems|1|||
155364226|NCT04674189|560766527|FG000|Overall Study|Adverse Event|0|||
155364227|NCT04674189|560766528|FG001|Overall Study|Adverse Event|0|||
155364228|NCT04674189|560766529|FG002|Overall Study|Adverse Event|1|||
155364229|NCT04674189|560766527|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
155364230|NCT04674189|560766528|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
155364231|NCT04674189|560766529|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
155364232|NCT04674189|560766527|FG000|Overall Study|Physician Decision|1|||
155364233|NCT04674189|560766528|FG001|Overall Study|Physician Decision|0|||
155364234|NCT04674189|560766529|FG002|Overall Study|Physician Decision|0|||
155364235|NCT04674189|560766527|FG000|Overall Study|Withdrawal by Participant|83|||
155364236|NCT04674189|560766528|FG001|Overall Study|Withdrawal by Participant|71|||
155364237|NCT04674189|560766529|FG002|Overall Study|Withdrawal by Participant|142|||
155364238|NCT04674189|560766527|FG000|Overall Study|Lost to Follow-up|55|||
155364239|NCT04674189|560766528|FG001|Overall Study|Lost to Follow-up|53|||
155364240|NCT04674189|560766529|FG002|Overall Study|Lost to Follow-up|44|||
155364241|NCT04674189|560766527|FG000|Overall Study|Miscellaneous|27|||
155364242|NCT04674189|560766528|FG001|Overall Study|Miscellaneous|23|||
155364243|NCT04674189|560766529|FG002|Overall Study|Miscellaneous|207|||
155364244|NCT04674189|560766527|FG000|Overall Study|Did Not Receive Treatment|3|||
155364245|NCT04674189|560766528|FG001|Overall Study|Did Not Receive Treatment|1|||
155364246|NCT04674189|560766529|FG002|Overall Study|Did Not Receive Treatment|2|||
155364247|NCT03023423|560766531|FG000|Overall Study|Death|5|||
155364248|NCT03023423|560766532|FG001|Overall Study|Death|12|||
155364249|NCT03023423|560766533|FG002|Overall Study|Death|20|||
155364250|NCT03023423|560766531|FG000|Overall Study|Other|0|||
155364251|NCT03023423|560766532|FG001|Overall Study|Other|2|||
155364252|NCT03023423|560766533|FG002|Overall Study|Other|2|||
155364253|NCT03023423|560766531|FG000|Overall Study|Ongoing|2|||
155364254|NCT03023423|560766532|FG001|Overall Study|Ongoing|32|||
155364255|NCT03023423|560766533|FG002|Overall Study|Ongoing|24|||
155364256|NCT00681668|560766534|FG000|Overall Study|Protocol Violation|1|||
155364257|NCT00681668|560766534|FG000|Overall Study|Withdrawal by Subject|1|||
155364258|NCT04277507|560766535|FG000|Overall Study|Lost to Follow-up|17|||
155364259|NCT04277507|560766535|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
155364260|NCT04277507|560766535|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
155364261|NCT04277507|560766535|FG000|Overall Study|Withdrawal by Subject|3|||
155364262|NCT04277507|560766535|FG000|Overall Study|Death due to COVID-19|1|||
155364263|NCT04277507|560766535|FG000|Overall Study|Data missing for full evaluation|5|||
155364264|NCT00583947|560766536|FG000|Cross-over Period|Adverse Event|2|||
155364265|NCT00583947|560766537|FG001|Cross-over Period|Adverse Event|0|||
155364266|NCT00583947|560766536|FG000|Cross-over Period|Withdrawal by Subject|2|||
155364267|NCT00583947|560766537|FG001|Cross-over Period|Withdrawal by Subject|0|||
155364268|NCT00583947|560766536|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
155364269|NCT00583947|560766537|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
155364270|NCT00583947|560766536|FG000|Cross-over Period|Other|1|||
155364271|NCT00583947|560766537|FG001|Cross-over Period|Other|1|||
155364272|NCT05226130|560766538|FG000|Overall Study|Lost to Follow-up|0|||
155364273|NCT05226130|560766539|FG001|Overall Study|Lost to Follow-up|1|||
155364274|NCT05226130|560766538|FG000|Overall Study|Not treatment adherent|0|||
155364275|NCT05226130|560766539|FG001|Overall Study|Not treatment adherent|2|||
155364276|NCT03974022|560766540|FG000|Overall Study|Death|0|||
155649240|NCT02730169|561808174|FG002|Overall Study|Withdrawal by Subject|6|||
155649241|NCT02730169|561808175|FG003|Overall Study|Withdrawal by Subject|8|||
155364277|NCT03974022|560766541|FG001|Overall Study|Death|1|||
155364278|NCT03974022|560766542|FG002|Overall Study|Death|0|||
155364279|NCT03974022|560766543|FG003|Overall Study|Death|2|||
155364280|NCT03974022|560766544|FG004|Overall Study|Death|0|||
155364281|NCT03974022|560766545|FG005|Overall Study|Death|1|||
155364282|NCT03974022|560766546|FG006|Overall Study|Death|0|||
155364283|NCT03974022|560766547|FG007|Overall Study|Death|2|||
155364284|NCT03974022|560766548|FG008|Overall Study|Death|1|||
155364285|NCT03974022|560766549|FG009|Overall Study|Death|4|||
155364286|NCT03974022|560766550|FG010|Overall Study|Death|0|||
155364287|NCT03974022|560766551|FG011|Overall Study|Death|0|||
155364288|NCT03974022|560766552|FG012|Overall Study|Death|0|||
155364289|NCT03974022|560766553|FG013|Overall Study|Death|33|||
155364290|NCT03974022|560766554|FG014|Overall Study|Death|40|||
155364291|NCT03974022|560766540|FG000|Overall Study|Withdrawal by Subject|0|||
155364292|NCT03974022|560766541|FG001|Overall Study|Withdrawal by Subject|0|||
155364293|NCT03974022|560766542|FG002|Overall Study|Withdrawal by Subject|0|||
155364294|NCT03974022|560766543|FG003|Overall Study|Withdrawal by Subject|0|||
155364295|NCT03974022|560766544|FG004|Overall Study|Withdrawal by Subject|0|||
155364296|NCT03974022|560766545|FG005|Overall Study|Withdrawal by Subject|4|||
155364297|NCT03974022|560766546|FG006|Overall Study|Withdrawal by Subject|4|||
155364298|NCT03974022|560766547|FG007|Overall Study|Withdrawal by Subject|2|||
155364299|NCT03974022|560766548|FG008|Overall Study|Withdrawal by Subject|2|||
155364300|NCT03974022|560766549|FG009|Overall Study|Withdrawal by Subject|3|||
155364301|NCT03974022|560766550|FG010|Overall Study|Withdrawal by Subject|0|||
155364302|NCT03974022|560766551|FG011|Overall Study|Withdrawal by Subject|1|||
155364303|NCT03974022|560766552|FG012|Overall Study|Withdrawal by Subject|0|||
155364304|NCT03974022|560766553|FG013|Overall Study|Withdrawal by Subject|3|||
155364305|NCT03974022|560766554|FG014|Overall Study|Withdrawal by Subject|9|||
155364306|NCT03974022|560766540|FG000|Overall Study|Lost to Follow-up|0|||
155364307|NCT03974022|560766541|FG001|Overall Study|Lost to Follow-up|0|||
155364308|NCT03974022|560766542|FG002|Overall Study|Lost to Follow-up|0|||
155364309|NCT03974022|560766543|FG003|Overall Study|Lost to Follow-up|0|||
155364310|NCT03974022|560766544|FG004|Overall Study|Lost to Follow-up|0|||
155364311|NCT03974022|560766545|FG005|Overall Study|Lost to Follow-up|0|||
155364312|NCT03974022|560766546|FG006|Overall Study|Lost to Follow-up|1|||
155364313|NCT03974022|560766547|FG007|Overall Study|Lost to Follow-up|0|||
155364314|NCT03974022|560766548|FG008|Overall Study|Lost to Follow-up|0|||
155364315|NCT03974022|560766549|FG009|Overall Study|Lost to Follow-up|0|||
155364316|NCT03974022|560766550|FG010|Overall Study|Lost to Follow-up|0|||
155364317|NCT03974022|560766551|FG011|Overall Study|Lost to Follow-up|0|||
155364318|NCT03974022|560766552|FG012|Overall Study|Lost to Follow-up|0|||
155364319|NCT03974022|560766553|FG013|Overall Study|Lost to Follow-up|1|||
155364320|NCT03974022|560766554|FG014|Overall Study|Lost to Follow-up|1|||
155364321|NCT03974022|560766540|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
155364322|NCT03974022|560766541|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
155364323|NCT03974022|560766542|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
155364324|NCT03974022|560766543|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
155364325|NCT03974022|560766544|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
155364326|NCT03974022|560766545|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
155364327|NCT03974022|560766546|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
155364328|NCT03974022|560766547|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
155364329|NCT03974022|560766548|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
155364330|NCT03974022|560766549|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
155364331|NCT03974022|560766550|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
155364332|NCT03974022|560766551|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
155427719|NCT03926143|560991855|FG000|Overall Study|Physician Decision|3|||
155649242|NCT02730169|561808172|FG000|Overall Study|Lost to Follow-up|5|||
155649243|NCT02730169|561808173|FG001|Overall Study|Lost to Follow-up|6|||
155649244|NCT02730169|561808174|FG002|Overall Study|Lost to Follow-up|5|||
155649245|NCT02730169|561808175|FG003|Overall Study|Lost to Follow-up|6|||
155649246|NCT02730169|561808172|FG000|Overall Study|Other|0|||
155649247|NCT02730169|561808173|FG001|Overall Study|Other|0|||
155649248|NCT02730169|561808174|FG002|Overall Study|Other|1|||
155649249|NCT02730169|561808175|FG003|Overall Study|Other|1|||
155649250|NCT03681093|561808176|FG000|Overall Study|Subject decision|0|||
155649251|NCT03681093|561808177|FG001|Overall Study|Subject decision|2|||
155649252|NCT03681093|561808178|FG002|Overall Study|Subject decision|1|||
155649253|NCT01213251|561808180|FG000|Overall Study|Death|2|||
155649254|NCT01213251|561808181|FG001|Overall Study|Death|1|||
155649255|NCT01213251|561808182|FG002|Overall Study|Death|2|||
155649256|NCT01213251|561808180|FG000|Overall Study|Exit|3|||
155649257|NCT01213251|561808181|FG001|Overall Study|Exit|2|||
155364333|NCT03974022|560766552|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
155364334|NCT03974022|560766553|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
155364335|NCT03974022|560766554|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
155364336|NCT06719986|560766557|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
155364337|NCT06719986|560766558|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
155364338|NCT06719986|560766559|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
155364339|NCT06719986|560766557|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
155364340|NCT06719986|560766558|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
155364341|NCT06719986|560766559|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
155364342|NCT03213704|560766561|FG000|Overall Study|Physician Decision|3|||
155364343|NCT03213704|560766561|FG000|Overall Study|Protocol Violation|1|||
155364344|NCT03213704|560766561|FG000|Overall Study|Progressive disease|4|||
155364345|NCT01183390|560768161|FG000|First Intervention|Adverse Event|0|||
155364346|NCT01183390|560768162|FG001|First Intervention|Adverse Event|1|||
155364347|NCT02113124|560768169|FG000|Overall Study|Unable to retrieve blood sample|1|||
155364348|NCT02113124|560768170|FG001|Overall Study|Unable to retrieve blood sample|1|||
155364349|NCT02514239|560768171|FG000|Overall Study|Refused to continue trial medication|0|||
155364350|NCT02514239|560768172|FG001|Overall Study|Refused to continue trial medication|0|||
155364351|NCT02514239|560768173|FG002|Overall Study|Refused to continue trial medication|0|||
155364352|NCT02514239|560768174|FG003|Overall Study|Refused to continue trial medication|0|||
155364353|NCT02514239|560768175|FG004|Overall Study|Refused to continue trial medication|0|||
155364354|NCT02514239|560768176|FG005|Overall Study|Refused to continue trial medication|0|||
155364355|NCT02514239|560768177|FG006|Overall Study|Refused to continue trial medication|0|||
155364356|NCT02514239|560768178|FG007|Overall Study|Refused to continue trial medication|0|||
155364357|NCT02514239|560768179|FG008|Overall Study|Refused to continue trial medication|0|||
155427720|NCT03926143|560991855|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
155427721|NCT03926143|560991855|FG000|Overall Study|Adverse Event|2|||
155427722|NCT03926143|560991855|FG000|Overall Study|Progressive disease|3|||
155427723|NCT00473876|560991861|FG000|Overall Study|Lost to Follow-up|3|||
155427724|NCT00473876|560991862|FG001|Overall Study|Lost to Follow-up|1|||
155427725|NCT01276288|560991863|FG000|Overall Study|Adverse Event|1|||
155427726|NCT01276288|560991864|FG001|Overall Study|Adverse Event|1|||
155427727|NCT01276288|560991865|FG002|Overall Study|Adverse Event|0|||
155427728|NCT01276288|560991866|FG003|Overall Study|Adverse Event|0|||
155427729|NCT01276288|560991863|FG000|Overall Study|not treated|1|||
155427730|NCT01276288|560991864|FG001|Overall Study|not treated|0|||
155427731|NCT01276288|560991865|FG002|Overall Study|not treated|0|||
155427732|NCT01276288|560991866|FG003|Overall Study|not treated|0|||
155427733|NCT03401749|560991867|FG000|Overall Study|Lost to Follow-up|20|||
155427734|NCT03401749|560991868|FG001|Overall Study|Lost to Follow-up|16|||
155427735|NCT03401749|560991869|FG002|Overall Study|Lost to Follow-up|26|||
155427736|NCT03406962|560991870|FG000|Overall Study|Death|2|||
155427737|NCT03406962|560991870|FG000|Overall Study|Adverse Event|1|||
155427738|NCT03853694|560991871|FG000|Overall Study|Protocol Violation|3|||
155427739|NCT03853694|560991872|FG001|Overall Study|Protocol Violation|5|||
155427740|NCT03853694|560991873|FG002|Overall Study|Protocol Violation|3|||
155427741|NCT03853694|560991871|FG000|Overall Study|Delivered early|0|||
155427742|NCT03853694|560991872|FG001|Overall Study|Delivered early|1|||
155427743|NCT03853694|560991873|FG002|Overall Study|Delivered early|0|||
155427744|NCT03853694|560991871|FG000|Overall Study|not suitable to proceed|0|||
155427745|NCT03853694|560991872|FG001|Overall Study|not suitable to proceed|1|||
155427746|NCT03853694|560991873|FG002|Overall Study|not suitable to proceed|0|||
155427747|NCT03853694|560991871|FG000|Overall Study|difficult surgery|0|||
155427748|NCT03853694|560991872|FG001|Overall Study|difficult surgery|0|||
155427749|NCT03853694|560991873|FG002|Overall Study|difficult surgery|1|||
155427750|NCT03853694|560991871|FG000|Overall Study|Lost to Follow-up|0|||
155427751|NCT03853694|560991872|FG001|Overall Study|Lost to Follow-up|1|||
155364358|NCT02514239|560768180|FG009|Overall Study|Refused to continue trial medication|1|||
155427752|NCT03853694|560991873|FG002|Overall Study|Lost to Follow-up|0|||
155649258|NCT01213251|561808182|FG002|Overall Study|Exit|8|||
155649259|NCT01213251|561808180|FG000|Overall Study|Protocol Violation|1|||
155649260|NCT01213251|561808181|FG001|Overall Study|Protocol Violation|1|||
155364359|NCT02514239|560768171|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364360|NCT02514239|560768172|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364361|NCT02514239|560768173|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364362|NCT02514239|560768174|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364363|NCT02514239|560768175|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364364|NCT02514239|560768176|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364365|NCT02514239|560768177|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364366|NCT02514239|560768178|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364367|NCT02514239|560768179|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
155364368|NCT02514239|560768180|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
155364369|NCT02514239|560768171|FG000|Overall Study|Not treated|0|||
155364370|NCT02514239|560768172|FG001|Overall Study|Not treated|1|||
155364371|NCT02514239|560768173|FG002|Overall Study|Not treated|0|||
155364372|NCT02514239|560768174|FG003|Overall Study|Not treated|0|||
155364373|NCT02514239|560768175|FG004|Overall Study|Not treated|0|||
155364374|NCT02514239|560768176|FG005|Overall Study|Not treated|0|||
155364375|NCT02514239|560768177|FG006|Overall Study|Not treated|0|||
155364376|NCT02514239|560768178|FG007|Overall Study|Not treated|0|||
155364377|NCT02514239|560768179|FG008|Overall Study|Not treated|0|||
155364378|NCT02514239|560768180|FG009|Overall Study|Not treated|0|||
155364379|NCT02514239|560768171|FG000|Overall Study|Other Adverse Events|2|||
155364380|NCT02514239|560768172|FG001|Overall Study|Other Adverse Events|0|||
155364381|NCT02514239|560768173|FG002|Overall Study|Other Adverse Events|0|||
155364382|NCT02514239|560768174|FG003|Overall Study|Other Adverse Events|1|||
155364383|NCT02514239|560768175|FG004|Overall Study|Other Adverse Events|0|||
155364384|NCT02514239|560768176|FG005|Overall Study|Other Adverse Events|1|||
155364385|NCT02514239|560768177|FG006|Overall Study|Other Adverse Events|0|||
155364386|NCT02514239|560768178|FG007|Overall Study|Other Adverse Events|1|||
155364387|NCT02514239|560768179|FG008|Overall Study|Other Adverse Events|2|||
155364388|NCT02514239|560768180|FG009|Overall Study|Other Adverse Events|0|||
155364389|NCT02514239|560768171|FG000|Overall Study|Progressive disease|3|||
155364390|NCT02514239|560768172|FG001|Overall Study|Progressive disease|3|||
155364391|NCT02514239|560768173|FG002|Overall Study|Progressive disease|2|||
155364392|NCT02514239|560768174|FG003|Overall Study|Progressive disease|2|||
155364393|NCT02514239|560768175|FG004|Overall Study|Progressive disease|3|||
155364394|NCT02514239|560768176|FG005|Overall Study|Progressive disease|3|||
155364395|NCT02514239|560768177|FG006|Overall Study|Progressive disease|4|||
155364396|NCT02514239|560768178|FG007|Overall Study|Progressive disease|2|||
155364397|NCT02514239|560768179|FG008|Overall Study|Progressive disease|5|||
155364398|NCT02514239|560768180|FG009|Overall Study|Progressive disease|0|||
155364399|NCT03299049|560768181|FG000|Overall Study|On-going|486|||
155364400|NCT03299049|560768182|FG001|Overall Study|On-going|481|||
155364401|NCT03299049|560768181|FG000|Overall Study|Withdrawal by Subject|6|||
155364402|NCT03299049|560768182|FG001|Overall Study|Withdrawal by Subject|21|||
155364403|NCT03299049|560768181|FG000|Overall Study|Physician Decision|5|||
155364404|NCT03299049|560768182|FG001|Overall Study|Physician Decision|1|||
155364405|NCT03299049|560768181|FG000|Overall Study|Lost to Follow-up|2|||
155364406|NCT03299049|560768182|FG001|Overall Study|Lost to Follow-up|0|||
155364407|NCT03299049|560768181|FG000|Overall Study|Pregnancy|1|||
155364408|NCT03299049|560768182|FG001|Overall Study|Pregnancy|3|||
155364409|NCT03299049|560768181|FG000|Overall Study|Protocol Violation|1|||
155427753|NCT03853694|560991871|FG000|Overall Study|Withdrawal by Subject|0|||
155427754|NCT03853694|560991872|FG001|Overall Study|Withdrawal by Subject|1|||
155427755|NCT03853694|560991873|FG002|Overall Study|Withdrawal by Subject|0|||
155427756|NCT01818297|560991874|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
155427757|NCT01818297|560991875|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
155427758|NCT01818297|560991874|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
155427759|NCT01818297|560991875|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
155427760|NCT01818297|560991874|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
155427761|NCT01818297|560991875|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
155427762|NCT03896295|560991876|FG000|Overall Study|Adverse Event|0|||
155427763|NCT03896295|560991877|FG001|Overall Study|Adverse Event|1|||
155427764|NCT03896295|560991876|FG000|Overall Study|COVID-19|7|||
155427765|NCT03896295|560991877|FG001|Overall Study|COVID-19|29|||
155427766|NCT03029832|560991878|FG000|Overall Study|Safety Follow-Up Completed|2|||
155364410|NCT03299049|560768182|FG001|Overall Study|Protocol Violation|1|||
155364411|NCT03299049|560768181|FG000|Overall Study|Lack of Efficacy|9|||
155364412|NCT03299049|560768182|FG001|Overall Study|Lack of Efficacy|3|||
155364413|NCT03299049|560768181|FG000|Overall Study|Adverse Event|12|||
155364414|NCT03299049|560768182|FG001|Overall Study|Adverse Event|13|||
155364415|NCT02980042|560768183|FG000|Overall Study|Lost to Follow-up|5|||
155364416|NCT02980042|560768184|FG001|Overall Study|Lost to Follow-up|0|||
155364417|NCT02980042|560768183|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
155364418|NCT02980042|560768184|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
155364419|NCT02460575|560768187|FG000|Overall Study|Lost to Follow-up|1|||
155364420|NCT02460575|560768188|FG001|Overall Study|Lost to Follow-up|0|||
155364421|NCT02521363|560768189|FG000|Overall Study|Withdrawal by Subject|1|||
155364422|NCT02521363|560768190|FG001|Overall Study|Withdrawal by Subject|2|||
155364423|NCT00592293|560768194|FG000|Overall Study|Withdrawal by Subject|1|||
155364424|NCT01606319|560768197|FG000|Overall Study|Lost to Follow-up|17|||
155364425|NCT01606319|560768198|FG001|Overall Study|Lost to Follow-up|14|||
155364426|NCT01606319|560768197|FG000|Overall Study|Withdrawal by Subject|9|||
155364427|NCT01606319|560768198|FG001|Overall Study|Withdrawal by Subject|12|||
155364428|NCT01606319|560768197|FG000|Overall Study|Physician Decision|1|||
155364429|NCT01606319|560768198|FG001|Overall Study|Physician Decision|2|||
155364430|NCT01606319|560768197|FG000|Overall Study|Lack of Efficacy|6|||
155364431|NCT01606319|560768198|FG001|Overall Study|Lack of Efficacy|8|||
155364432|NCT01606319|560768197|FG000|Overall Study|Adverse Event|1|||
155364433|NCT01606319|560768198|FG001|Overall Study|Adverse Event|4|||
155364434|NCT01270828|560768199|FG000|Pregabalin CR SB|Reason Unspecified|0|||
155364435|NCT01270828|560768200|FG001|Pregabalin CR SB|Reason Unspecified|0|||
155364436|NCT01270828|560768201|FG002|Pregabalin CR SB|Reason Unspecified|8|||
155364437|NCT01270828|560768199|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
155364438|NCT01270828|560768200|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
155364439|NCT01270828|560768201|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
155364440|NCT01270828|560768199|FG000|Pregabalin CR SB|Related adverse event|0|||
155364441|NCT01270828|560768200|FG001|Pregabalin CR SB|Related adverse event|0|||
155364442|NCT01270828|560768201|FG002|Pregabalin CR SB|Related adverse event|46|||
155364443|NCT01270828|560768199|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
155364444|NCT01270828|560768200|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
155364445|NCT01270828|560768201|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
155364446|NCT01270828|560768199|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
155364447|NCT01270828|560768200|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
155364448|NCT01270828|560768201|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
155364449|NCT01270828|560768199|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
155364450|NCT01270828|560768200|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
155364451|NCT01270828|560768201|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
155364452|NCT01270828|560768199|FG000|Pregabalin CR SB|Unrelated AE|0|||
155364453|NCT01270828|560768200|FG001|Pregabalin CR SB|Unrelated AE|0|||
155364454|NCT01270828|560768201|FG002|Pregabalin CR SB|Unrelated AE|8|||
155364455|NCT01270828|560768199|FG000|Pregabalin CR SB|Protocol Violation|0|||
155364456|NCT01270828|560768200|FG001|Pregabalin CR SB|Protocol Violation|0|||
155364457|NCT01270828|560768201|FG002|Pregabalin CR SB|Protocol Violation|8|||
155364458|NCT01270828|560768199|FG000|Double Blind Phase|Death|0|||
155364459|NCT01270828|560768200|FG001|Double Blind Phase|Death|1|||
155364460|NCT01270828|560768201|FG002|Double Blind Phase|Death|0|||
155364461|NCT01270828|560768199|FG000|Double Blind Phase|Protocol Violation|0|||
155364462|NCT01270828|560768200|FG001|Double Blind Phase|Protocol Violation|1|||
155427767|NCT03029832|560991879|FG001|Overall Study|Safety Follow-Up Completed|0|||
155427768|NCT03029832|560991878|FG000|Overall Study|Death due to Disease Progression|1|||
155427769|NCT03029832|560991879|FG001|Overall Study|Death due to Disease Progression|0|||
155427770|NCT03029832|560991878|FG000|Overall Study|Study Terminated By Sponsor|1|||
155427771|NCT03029832|560991879|FG001|Overall Study|Study Terminated By Sponsor|1|||
155427772|NCT01412229|560991880|FG000|Overall Study|Physician Decision|1|||
155427773|NCT00700804|560991882|FG000|Overall Study|Withdrawal by Subject|1|||
155427774|NCT00700804|560991883|FG001|Overall Study|Withdrawal by Subject|2|||
155427775|NCT00700804|560991882|FG000|Overall Study|Protocol Violation|1|||
155427776|NCT00700804|560991883|FG001|Overall Study|Protocol Violation|1|||
155427777|NCT00700804|560991882|FG000|Overall Study|Loose Stools|1|||
155427778|NCT00700804|560991883|FG001|Overall Study|Loose Stools|1|||
155427779|NCT04223609|560991884|FG000|Overall Study|Adverse Event|0|||
155427780|NCT04223609|560991885|FG001|Overall Study|Adverse Event|1|||
155427781|NCT04223609|560991884|FG000|Overall Study|Missed last visit|0|||
155427782|NCT04223609|560991885|FG001|Overall Study|Missed last visit|1|||
155427783|NCT03832387|560991888|FG000|Overall Study|Protocol Violation|2|||
155427784|NCT03832387|560991889|FG001|Overall Study|Protocol Violation|6|||
155427785|NCT03832387|560991888|FG000|Overall Study|EXCLUSION CRITERIA|3|||
155427786|NCT03832387|560991889|FG001|Overall Study|EXCLUSION CRITERIA|1|||
155427787|NCT05775289|560991890|FG000|Overall Study|Study Ongoing|20|||
155427788|NCT05775289|560991891|FG001|Overall Study|Study Ongoing|53|||
155427789|NCT05775289|560991892|FG002|Overall Study|Study Ongoing|15|||
155427790|NCT05775289|560991893|FG003|Overall Study|Study Ongoing|55|||
155427791|NCT05775289|560991890|FG000|Overall Study|Death|4|||
155427792|NCT05775289|560991891|FG001|Overall Study|Death|11|||
155427793|NCT05775289|560991892|FG002|Overall Study|Death|8|||
155427794|NCT05775289|560991893|FG003|Overall Study|Death|12|||
155427795|NCT05775289|560991890|FG000|Overall Study|Lost to Follow-up|0|||
155427796|NCT05775289|560991891|FG001|Overall Study|Lost to Follow-up|1|||
155427797|NCT05775289|560991892|FG002|Overall Study|Lost to Follow-up|0|||
155427798|NCT05775289|560991893|FG003|Overall Study|Lost to Follow-up|0|||
155427799|NCT05775289|560991890|FG000|Overall Study|Progressive Disease|0|||
155427800|NCT05775289|560991891|FG001|Overall Study|Progressive Disease|0|||
155427801|NCT05775289|560991892|FG002|Overall Study|Progressive Disease|1|||
155427802|NCT05775289|560991893|FG003|Overall Study|Progressive Disease|0|||
155427803|NCT05775289|560991890|FG000|Overall Study|Withdrawal by Subject|1|||
155427804|NCT05775289|560991891|FG001|Overall Study|Withdrawal by Subject|1|||
155427805|NCT05775289|560991892|FG002|Overall Study|Withdrawal by Subject|0|||
155427806|NCT05775289|560991893|FG003|Overall Study|Withdrawal by Subject|0|||
155507717|NCT00410410|561285144|FG000|Induction Period (IP)|Lack of Efficacy|26|||
155507718|NCT00410410|561285145|FG001|Induction Period (IP)|Lack of Efficacy|24|||
155507719|NCT00410410|561285146|FG002|Induction Period (IP)|Lack of Efficacy|8|||
155427807|NCT00490542|560991895|FG000|Overall Study|Lost to Follow-up|3|||
155427808|NCT00490542|560991896|FG001|Overall Study|Lost to Follow-up|0|||
155427809|NCT00490542|560991895|FG000|Overall Study|Adverse Event|3|||
155427810|NCT00490542|560991896|FG001|Overall Study|Adverse Event|3|||
155427811|NCT00490542|560991895|FG000|Overall Study|Lack of Efficacy|1|||
155427812|NCT00490542|560991896|FG001|Overall Study|Lack of Efficacy|1|||
155649261|NCT01213251|561808182|FG002|Overall Study|Protocol Violation|0|||
155364463|NCT01270828|560768201|FG002|Double Blind Phase|Protocol Violation|0|||
155364464|NCT01270828|560768199|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
155364465|NCT01270828|560768200|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
155364466|NCT01270828|560768201|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
155427813|NCT02848833|560991901|FG000|Overall Study|subject who are duplicated|1|||
155364467|NCT01270828|560768199|FG000|Double Blind Phase|Reason Unspecified|7|||
155364468|NCT01270828|560768200|FG001|Double Blind Phase|Reason Unspecified|4|||
155364469|NCT01270828|560768201|FG002|Double Blind Phase|Reason Unspecified|0|||
155364470|NCT01270828|560768199|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155364471|NCT01270828|560768200|FG001|Double Blind Phase|Withdrawal by Subject|15|||
155364472|NCT01270828|560768201|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155364473|NCT01270828|560768199|FG000|Double Blind Phase|Lost to Follow-up|1|||
155364474|NCT01270828|560768200|FG001|Double Blind Phase|Lost to Follow-up|2|||
155364475|NCT01270828|560768201|FG002|Double Blind Phase|Lost to Follow-up|0|||
155364476|NCT01270828|560768199|FG000|Double Blind Phase|Lack of Efficacy|2|||
155364477|NCT01270828|560768200|FG001|Double Blind Phase|Lack of Efficacy|11|||
155364478|NCT01270828|560768201|FG002|Double Blind Phase|Lack of Efficacy|0|||
155364479|NCT01270828|560768199|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
155364480|NCT01270828|560768200|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
155364481|NCT01270828|560768201|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
155364482|NCT01270828|560768199|FG000|Double Blind Phase|Adverse event related to study drug|5|||
155364483|NCT01270828|560768200|FG001|Double Blind Phase|Adverse event related to study drug|7|||
155364484|NCT01270828|560768201|FG002|Double Blind Phase|Adverse event related to study drug|0|||
155364485|NCT01810939|560768202|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
155364486|NCT01810939|560768203|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
155364487|NCT01810939|560768204|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
155364488|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol Violation|2|||
155364489|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol Violation|0|||
155364490|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol Violation|0|||
155364491|NCT01810939|560768202|FG000|Part A Treatment Period|Adverse Event|10|||
155364492|NCT01810939|560768203|FG001|Part A Treatment Period|Adverse Event|0|||
155364493|NCT01810939|560768204|FG002|Part A Treatment Period|Adverse Event|0|||
155364494|NCT01810939|560768202|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
155364495|NCT01810939|560768203|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
155364496|NCT01810939|560768204|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
155364497|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
155364498|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
155364499|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
155364500|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
155364501|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
155364502|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
155364503|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
155364504|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
155364505|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
155364506|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
155364507|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
155364508|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
155507720|NCT00410410|561285147|FG003|Induction Period (IP)|Lack of Efficacy|8|||
155507721|NCT00410410|561285148|FG004|Induction Period (IP)|Lack of Efficacy|7|||
155507722|NCT00410410|561285149|FG005|Induction Period (IP)|Lack of Efficacy|7|||
155507723|NCT00410410|561285150|FG006|Induction Period (IP)|Lack of Efficacy|0|||
155507724|NCT00410410|561285151|FG007|Induction Period (IP)|Lack of Efficacy|0|||
155507725|NCT00410410|561285152|FG008|Induction Period (IP)|Lack of Efficacy|0|||
155507726|NCT00410410|561285144|FG000|Induction Period (IP)|Lost to Follow-up|2|||
155507727|NCT00410410|561285145|FG001|Induction Period (IP)|Lost to Follow-up|2|||
155507728|NCT00410410|561285146|FG002|Induction Period (IP)|Lost to Follow-up|2|||
155507729|NCT00410410|561285147|FG003|Induction Period (IP)|Lost to Follow-up|3|||
155507730|NCT00410410|561285148|FG004|Induction Period (IP)|Lost to Follow-up|0|||
155507731|NCT00410410|561285149|FG005|Induction Period (IP)|Lost to Follow-up|1|||
155649262|NCT01213251|561808180|FG000|Overall Study|Missed 18-Month Follow-up|0|||
155507732|NCT00410410|561285150|FG006|Induction Period (IP)|Lost to Follow-up|0|||
155507733|NCT00410410|561285151|FG007|Induction Period (IP)|Lost to Follow-up|0|||
155507734|NCT00410410|561285152|FG008|Induction Period (IP)|Lost to Follow-up|0|||
155364509|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
155364510|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
155507735|NCT00410410|561285144|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
155507736|NCT00410410|561285145|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
155649263|NCT01213251|561808181|FG001|Overall Study|Missed 18-Month Follow-up|0|||
155507737|NCT00410410|561285146|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
155507738|NCT00410410|561285147|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
155507739|NCT00410410|561285148|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
155507740|NCT00410410|561285149|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
155649264|NCT01213251|561808182|FG002|Overall Study|Missed 18-Month Follow-up|1|||
155364511|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
155364512|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
155364513|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
155364514|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
155364515|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
155364516|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
155364517|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
155364518|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
155364519|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
155364520|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
155364521|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
155364522|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
155364523|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
155364524|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
155364525|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
155364526|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
155364527|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
155364528|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
155364529|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
155364530|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
155364531|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
155364532|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
155364533|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
155364534|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
155364535|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
155364536|NCT02870972|560768205|FG000|Overall Study|Adverse Event|1|||
155364537|NCT02870972|560768206|FG001|Overall Study|Adverse Event|0|||
155364538|NCT02870972|560768207|FG002|Overall Study|Adverse Event|0|||
155364539|NCT02870972|560768208|FG003|Overall Study|Adverse Event|0|||
155364540|NCT02870972|560768209|FG004|Overall Study|Adverse Event|0|||
155364541|NCT04497389|560768210|FG000|Overall Study|Withdrawal by Subject|1|||
155364542|NCT04497389|560768211|FG001|Overall Study|Withdrawal by Subject|0|||
155507741|NCT00410410|561285150|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
155507742|NCT00410410|561285151|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
155507743|NCT00410410|561285152|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
155507744|NCT00410410|561285144|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507745|NCT00410410|561285145|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507746|NCT00410410|561285146|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
155507747|NCT00410410|561285147|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507748|NCT00410410|561285148|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507749|NCT00410410|561285149|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507750|NCT00410410|561285150|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507751|NCT00410410|561285151|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507752|NCT00410410|561285152|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
155507753|NCT00410410|561285144|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507754|NCT00410410|561285145|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507755|NCT00410410|561285146|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507756|NCT00410410|561285147|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507757|NCT00410410|561285148|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
155507758|NCT00410410|561285149|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
155507759|NCT00410410|561285150|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507760|NCT00410410|561285151|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507761|NCT00410410|561285152|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
155507762|NCT00410410|561285144|FG000|Induction Period (IP)|Other|0|||
155507763|NCT00410410|561285145|FG001|Induction Period (IP)|Other|0|||
155507764|NCT00410410|561285146|FG002|Induction Period (IP)|Other|1|||
155507765|NCT00410410|561285147|FG003|Induction Period (IP)|Other|0|||
155364543|NCT04400487|560768212|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155364544|NCT04400487|560768212|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
155364545|NCT04400487|560768212|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
155364546|NCT01821937|560768213|FG000|Overall Study|Adverse Event|0|||
155364547|NCT01821937|560768214|FG001|Overall Study|Adverse Event|3|||
155364548|NCT01677299|560768215|FG000|Overall Study|Adverse Event|0|||
155507766|NCT00410410|561285148|FG004|Induction Period (IP)|Other|0|||
155507767|NCT00410410|561285149|FG005|Induction Period (IP)|Other|0|||
155507768|NCT00410410|561285150|FG006|Induction Period (IP)|Other|0|||
155507769|NCT00410410|561285151|FG007|Induction Period (IP)|Other|0|||
155507770|NCT00410410|561285152|FG008|Induction Period (IP)|Other|0|||
155507771|NCT00410410|561285144|FG000|Maintenance Period (MP)|Death|0|||
155507772|NCT00410410|561285145|FG001|Maintenance Period (MP)|Death|0|||
155649265|NCT02698787|561808183|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
155649266|NCT02698787|561808184|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
155649267|NCT01882829|561808187|FG000|Overall Study|Adverse Event|4|||
155649268|NCT01882829|561808187|FG000|Overall Study|Protocol Violation|1|||
155649269|NCT01882829|561808187|FG000|Overall Study|Withdrawal by Subject|1|||
155649270|NCT00326495|561808194|FG000|Overall Study|Switched to alternative treatment|1|||
155649271|NCT00326495|561808194|FG000|Overall Study|Disease progression before treatment|1|||
155649272|NCT00326495|561808194|FG000|Overall Study|Refused further treatment|2|||
155649273|NCT00326495|561808194|FG000|Overall Study|Subject off study before assessment|1|||
155649274|NCT02802865|561808195|FG000|Overall Study|Pregnancy|1|||
155649275|NCT02802865|561808196|FG001|Overall Study|Pregnancy|1|||
155649276|NCT02802865|561808195|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
155649277|NCT02802865|561808196|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
155649278|NCT01862029|561808197|FG000|Overall Study|Physician Decision|1|||
155649279|NCT03931785|561808198|FG000|Overall Study|Lost to Follow-up|4|||
155649280|NCT03931785|561808199|FG001|Overall Study|Lost to Follow-up|1|||
155427814|NCT02848833|560991901|FG000|Overall Study|have not taken the study drug|11|||
155427815|NCT02848833|560991901|FG000|Overall Study|follow-up failure|6|||
155427816|NCT02848833|560991901|FG000|Overall Study|Protocol Violation|119|||
155427817|NCT02847598|560991902|FG000|Overall Study|Adverse Event|0|||
155427818|NCT02847598|560991903|FG001|Overall Study|Adverse Event|0|||
155427819|NCT02847598|560991904|FG002|Overall Study|Adverse Event|0|||
155427820|NCT02847598|560991905|FG003|Overall Study|Adverse Event|0|||
155427821|NCT02847598|560991906|FG004|Overall Study|Adverse Event|0|||
155427822|NCT02847598|560991907|FG005|Overall Study|Adverse Event|0|||
155427823|NCT02847598|560991908|FG006|Overall Study|Adverse Event|0|||
155427824|NCT02847598|560991909|FG007|Overall Study|Adverse Event|1|||
155427825|NCT02847598|560991902|FG000|Overall Study|Consent withdrawn|2|||
155427826|NCT02847598|560991903|FG001|Overall Study|Consent withdrawn|0|||
155427827|NCT02847598|560991904|FG002|Overall Study|Consent withdrawn|0|||
155427828|NCT02847598|560991905|FG003|Overall Study|Consent withdrawn|4|||
155427829|NCT02847598|560991906|FG004|Overall Study|Consent withdrawn|3|||
155427830|NCT02847598|560991907|FG005|Overall Study|Consent withdrawn|2|||
155427831|NCT02847598|560991908|FG006|Overall Study|Consent withdrawn|1|||
155427832|NCT02847598|560991909|FG007|Overall Study|Consent withdrawn|3|||
155427833|NCT02847598|560991902|FG000|Overall Study|Death|3|||
155427834|NCT02847598|560991903|FG001|Overall Study|Death|0|||
155427835|NCT02847598|560991904|FG002|Overall Study|Death|0|||
155427836|NCT02847598|560991905|FG003|Overall Study|Death|0|||
155427837|NCT02847598|560991906|FG004|Overall Study|Death|0|||
155427838|NCT02847598|560991907|FG005|Overall Study|Death|0|||
155427839|NCT02847598|560991908|FG006|Overall Study|Death|0|||
155427840|NCT02847598|560991909|FG007|Overall Study|Death|0|||
155427841|NCT02847598|560991902|FG000|Overall Study|Lost to Follow-up|0|||
155427842|NCT02847598|560991903|FG001|Overall Study|Lost to Follow-up|0|||
155427843|NCT02847598|560991904|FG002|Overall Study|Lost to Follow-up|0|||
155427844|NCT02847598|560991905|FG003|Overall Study|Lost to Follow-up|0|||
155427845|NCT02847598|560991906|FG004|Overall Study|Lost to Follow-up|0|||
155427846|NCT02847598|560991907|FG005|Overall Study|Lost to Follow-up|1|||
155427847|NCT02847598|560991908|FG006|Overall Study|Lost to Follow-up|1|||
155427848|NCT02847598|560991909|FG007|Overall Study|Lost to Follow-up|0|||
155427849|NCT00215150|560993311|FG000|Open Label Phase|Lost to Follow-up|7|||
155427850|NCT00215150|560993311|FG000|Open Label Phase|Withdrawal by Subject|1|||
155427851|NCT00215150|560993311|FG000|Open Label Phase|Did not complete a post base visit|13|||
155427852|NCT00215150|560993311|FG000|Open Label Phase|Did not meet randomization criteria|9|||
155427853|NCT00215150|560993311|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
155427854|NCT00215150|560993311|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
155427855|NCT00215150|560993311|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
155427856|NCT02251743|560993312|FG000|Overall Study|Withdrawal by Subject|1|||
155427857|NCT02251743|560993313|FG001|Overall Study|Withdrawal by Subject|1|||
155427858|NCT00476086|560993317|FG000|Overall Study|Alternative therapy|1|||
155427859|NCT00476086|560993317|FG000|Overall Study|Progressive Disease|4|||
155427860|NCT02900092|560993318|FG000|Overall Study|Adverse Event|1|||
155427861|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
155427862|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
155427863|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
155427864|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
155427865|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
155427866|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
155427867|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
155649281|NCT03931785|561808200|FG002|Overall Study|Lost to Follow-up|4|||
155427868|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
155427869|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
155427870|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
155649282|NCT03931785|561808201|FG003|Overall Study|Lost to Follow-up|3|||
155364549|NCT01677299|560768216|FG001|Overall Study|Adverse Event|2|||
155364550|NCT01677299|560768217|FG002|Overall Study|Adverse Event|1|||
155364551|NCT01677299|560768218|FG003|Overall Study|Adverse Event|0|||
155364552|NCT01677299|560768215|FG000|Overall Study|Withdrawal by Subject|0|||
155364553|NCT01677299|560768216|FG001|Overall Study|Withdrawal by Subject|1|||
155364554|NCT01677299|560768217|FG002|Overall Study|Withdrawal by Subject|0|||
155364555|NCT01677299|560768218|FG003|Overall Study|Withdrawal by Subject|1|||
155364556|NCT03445533|560768219|FG000|Overall Study|Progressive Disease|48|||
155427871|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
155507773|NCT00410410|561285146|FG002|Maintenance Period (MP)|Death|0|||
155507774|NCT00410410|561285147|FG003|Maintenance Period (MP)|Death|0|||
155507775|NCT00410410|561285148|FG004|Maintenance Period (MP)|Death|0|||
155507776|NCT00410410|561285149|FG005|Maintenance Period (MP)|Death|0|||
155507777|NCT00410410|561285150|FG006|Maintenance Period (MP)|Death|1|||
155507778|NCT00410410|561285151|FG007|Maintenance Period (MP)|Death|0|||
155507779|NCT00410410|561285152|FG008|Maintenance Period (MP)|Death|0|||
155507780|NCT00410410|561285144|FG000|Maintenance Period (MP)|Adverse Event|0|||
155507781|NCT00410410|561285145|FG001|Maintenance Period (MP)|Adverse Event|0|||
155507782|NCT00410410|561285146|FG002|Maintenance Period (MP)|Adverse Event|0|||
155507783|NCT00410410|561285147|FG003|Maintenance Period (MP)|Adverse Event|0|||
155507784|NCT00410410|561285148|FG004|Maintenance Period (MP)|Adverse Event|0|||
155507785|NCT00410410|561285149|FG005|Maintenance Period (MP)|Adverse Event|0|||
155507786|NCT00410410|561285150|FG006|Maintenance Period (MP)|Adverse Event|1|||
155507787|NCT00410410|561285151|FG007|Maintenance Period (MP)|Adverse Event|3|||
155507788|NCT00410410|561285152|FG008|Maintenance Period (MP)|Adverse Event|0|||
155507789|NCT00410410|561285144|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
155507790|NCT00410410|561285145|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
155507791|NCT00410410|561285146|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
155507792|NCT00410410|561285147|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
155507793|NCT00410410|561285148|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
155507794|NCT00410410|561285149|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
155507795|NCT00410410|561285150|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
155507796|NCT00410410|561285151|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
155507797|NCT00410410|561285152|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
155507798|NCT00410410|561285144|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
155507799|NCT00410410|561285145|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
155507800|NCT00410410|561285146|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
155507801|NCT00410410|561285147|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
155507802|NCT00410410|561285148|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
155507803|NCT00410410|561285149|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
155507804|NCT00410410|561285150|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
155507805|NCT00410410|561285151|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
155507806|NCT00410410|561285152|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
155507807|NCT00410410|561285144|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507808|NCT00410410|561285145|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507809|NCT00410410|561285146|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507810|NCT00410410|561285147|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507811|NCT00410410|561285148|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507812|NCT00410410|561285149|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507813|NCT00410410|561285150|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
155507814|NCT00410410|561285151|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
155507815|NCT00410410|561285152|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
155507816|NCT00410410|561285144|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155427872|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
155427873|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
155427874|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
155427875|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
155427876|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
155427877|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
155427878|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
155427879|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
155427880|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
155427881|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
155427882|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
155507817|NCT00410410|561285145|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155507818|NCT00410410|561285146|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155507819|NCT00410410|561285147|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155507820|NCT00410410|561285148|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155507821|NCT00410410|561285149|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155364557|NCT03445533|560768220|FG001|Overall Study|Progressive Disease|81|||
155507822|NCT00410410|561285150|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
155364558|NCT03445533|560768219|FG000|Overall Study|Adverse Event|60|||
155507823|NCT00410410|561285151|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
155507824|NCT00410410|561285152|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
155507825|NCT00410410|561285144|FG000|Open-Label Period (OL)|Death|0|||
155507826|NCT00410410|561285145|FG001|Open-Label Period (OL)|Death|0|||
155507827|NCT00410410|561285146|FG002|Open-Label Period (OL)|Death|0|||
155507828|NCT00410410|561285147|FG003|Open-Label Period (OL)|Death|0|||
155507829|NCT00410410|561285148|FG004|Open-Label Period (OL)|Death|0|||
155507830|NCT00410410|561285149|FG005|Open-Label Period (OL)|Death|0|||
155507831|NCT00410410|561285150|FG006|Open-Label Period (OL)|Death|0|||
155507832|NCT00410410|561285151|FG007|Open-Label Period (OL)|Death|0|||
155507833|NCT00410410|561285152|FG008|Open-Label Period (OL)|Death|1|||
155507834|NCT00410410|561285144|FG000|Open-Label Period (OL)|Adverse Event|0|||
155507835|NCT00410410|561285145|FG001|Open-Label Period (OL)|Adverse Event|0|||
155507836|NCT00410410|561285146|FG002|Open-Label Period (OL)|Adverse Event|0|||
155507837|NCT00410410|561285147|FG003|Open-Label Period (OL)|Adverse Event|0|||
155507838|NCT00410410|561285148|FG004|Open-Label Period (OL)|Adverse Event|0|||
155507839|NCT00410410|561285149|FG005|Open-Label Period (OL)|Adverse Event|0|||
155507840|NCT00410410|561285150|FG006|Open-Label Period (OL)|Adverse Event|0|||
155507841|NCT00410410|561285151|FG007|Open-Label Period (OL)|Adverse Event|0|||
155507842|NCT00410410|561285152|FG008|Open-Label Period (OL)|Adverse Event|10|||
155507843|NCT00410410|561285144|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
155507844|NCT00410410|561285145|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
155507845|NCT00410410|561285146|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
155507846|NCT00410410|561285147|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
155507847|NCT00410410|561285148|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
155507848|NCT00410410|561285149|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
155507849|NCT00410410|561285150|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
155507850|NCT00410410|561285151|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
155507851|NCT00410410|561285152|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
155507852|NCT00410410|561285144|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
155507853|NCT00410410|561285145|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
155507854|NCT00410410|561285146|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
155507855|NCT00410410|561285147|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
155507856|NCT00410410|561285148|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
155507857|NCT00410410|561285149|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
155507858|NCT00410410|561285150|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
155507859|NCT00410410|561285151|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
155507860|NCT00410410|561285152|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
155507861|NCT00410410|561285144|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507862|NCT00410410|561285145|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507863|NCT00410410|561285146|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507864|NCT00410410|561285147|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507865|NCT00410410|561285148|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507866|NCT00410410|561285149|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507867|NCT00410410|561285150|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507868|NCT00410410|561285151|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
155507869|NCT00410410|561285152|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
155507870|NCT00410410|561285144|FG000|Open-Label Period (OL)|Pregnancy|0|||
155507871|NCT00410410|561285145|FG001|Open-Label Period (OL)|Pregnancy|0|||
155507872|NCT00410410|561285146|FG002|Open-Label Period (OL)|Pregnancy|0|||
155507873|NCT00410410|561285147|FG003|Open-Label Period (OL)|Pregnancy|0|||
155507874|NCT00410410|561285148|FG004|Open-Label Period (OL)|Pregnancy|0|||
155364559|NCT03445533|560768220|FG001|Overall Study|Adverse Event|64|||
155364560|NCT03445533|560768219|FG000|Overall Study|Death|9|||
155364561|NCT03445533|560768220|FG001|Overall Study|Death|19|||
155364562|NCT03445533|560768219|FG000|Overall Study|Miscellaneous|0|||
155364563|NCT03445533|560768220|FG001|Overall Study|Miscellaneous|16|||
155364564|NCT03445533|560768219|FG000|Overall Study|Withdrawal by Subject|3|||
155364565|NCT03445533|560768220|FG001|Overall Study|Withdrawal by Subject|4|||
155364566|NCT03445533|560768219|FG000|Overall Study|Physician Decision|1|||
155364567|NCT03445533|560768220|FG001|Overall Study|Physician Decision|3|||
155364568|NCT03445533|560768219|FG000|Overall Study|Sponsor Decision|0|||
155364569|NCT03445533|560768220|FG001|Overall Study|Sponsor Decision|1|||
155364570|NCT03445533|560768219|FG000|Overall Study|Lost to Follow-up|0|||
155364571|NCT03445533|560768220|FG001|Overall Study|Lost to Follow-up|1|||
155364572|NCT03445533|560768219|FG000|Overall Study|Never Received any Study Treatment|7|||
155364573|NCT03445533|560768220|FG001|Overall Study|Never Received any Study Treatment|4|||
155507875|NCT00410410|561285149|FG005|Open-Label Period (OL)|Pregnancy|0|||
155507876|NCT00410410|561285150|FG006|Open-Label Period (OL)|Pregnancy|0|||
155507877|NCT00410410|561285151|FG007|Open-Label Period (OL)|Pregnancy|0|||
155507878|NCT00410410|561285152|FG008|Open-Label Period (OL)|Pregnancy|1|||
155507879|NCT00410410|561285144|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507880|NCT00410410|561285145|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507881|NCT00410410|561285146|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507882|NCT00410410|561285147|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155364574|NCT02615509|560768221|FG000|Overall Study|Lost to Follow-up|134|||
155364575|NCT02615509|560768221|FG000|Overall Study|Death|4|||
155364576|NCT02615509|560768221|FG000|Overall Study|Withdrawal by Subject|8|||
155364577|NCT03274453|560768222|FG000|Overall Study|Lost to Follow-up|2|||
155364578|NCT03274453|560768223|FG001|Overall Study|Lost to Follow-up|5|||
155364579|NCT03274453|560768224|FG002|Overall Study|Lost to Follow-up|4|||
155364580|NCT03274453|560768225|FG003|Overall Study|Lost to Follow-up|1|||
155364581|NCT03274453|560768222|FG000|Overall Study|Physician Decision|2|||
155364582|NCT03274453|560768223|FG001|Overall Study|Physician Decision|0|||
155364583|NCT03274453|560768224|FG002|Overall Study|Physician Decision|0|||
155364584|NCT03274453|560768225|FG003|Overall Study|Physician Decision|3|||
155364585|NCT03274453|560768222|FG000|Overall Study|Surgery Cancelled|0|||
155364586|NCT03274453|560768223|FG001|Overall Study|Surgery Cancelled|1|||
155364587|NCT03274453|560768224|FG002|Overall Study|Surgery Cancelled|0|||
155364588|NCT03274453|560768225|FG003|Overall Study|Surgery Cancelled|0|||
155364589|NCT00945672|560768226|FG000|Overall Study|Withdrawal by Subject|0|||
155364590|NCT00945672|560768227|FG001|Overall Study|Withdrawal by Subject|0|||
155364591|NCT00945672|560768228|FG002|Overall Study|Withdrawal by Subject|0|||
155364592|NCT00945672|560768229|FG003|Overall Study|Withdrawal by Subject|1|||
155364593|NCT00447590|560768230|FG000|Overall Study|Withdrawal by Subject|26|||
155507883|NCT00410410|561285148|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507884|NCT00410410|561285149|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507885|NCT00410410|561285150|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155507886|NCT00410410|561285151|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
155364594|NCT00447590|560768230|FG000|Overall Study|Lost to Follow-up|24|||
155364595|NCT00447590|560768230|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
155364596|NCT00609947|560768231|FG000|Overall Study|Death|1|||
155364597|NCT00504075|560768232|FG000|Overall Study|Adverse Event|1|||
155364598|NCT00504075|560768232|FG000|Overall Study|Lost to Follow-up|5|||
155364599|NCT00504075|560768232|FG000|Overall Study|Withdrawal by Subject|1|||
155364600|NCT00504075|560768232|FG000|Overall Study|Required other therapeutic intervention|1|||
155364601|NCT01689857|560768234|FG000|Overall Study|Lost to Follow-up|5|||
155364602|NCT01689857|560768235|FG001|Overall Study|Lost to Follow-up|2|||
155364603|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
155364604|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
155364605|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
155364606|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Death|1|||
155364607|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Death|0|||
155364608|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Death|0|||
155364609|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
155364610|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
155364611|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
155364612|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
155364613|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
155364614|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
155364615|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
155364616|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
155364617|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
155364618|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
155364619|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
155364620|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
155427883|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
155427884|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
155427885|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
155427886|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
155427887|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
155427888|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
155427889|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
155427890|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
155427891|NCT03895203|560993319|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
155507887|NCT00410410|561285152|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
155507888|NCT00410410|561285144|FG000|Open-Label Period (OL)|Other|0|||
155507889|NCT00410410|561285145|FG001|Open-Label Period (OL)|Other|0|||
155507890|NCT00410410|561285146|FG002|Open-Label Period (OL)|Other|0|||
155507891|NCT00410410|561285147|FG003|Open-Label Period (OL)|Other|0|||
155507892|NCT00410410|561285148|FG004|Open-Label Period (OL)|Other|0|||
155364621|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
155364622|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
155364623|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
155364624|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
155364625|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
155427892|NCT03895203|560993320|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
155507893|NCT00410410|561285149|FG005|Open-Label Period (OL)|Other|0|||
155507894|NCT00410410|561285150|FG006|Open-Label Period (OL)|Other|0|||
155364626|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
155364627|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
155364628|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
155364629|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
155364630|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
155364631|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
155364632|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
155364633|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
155364634|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
155364635|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
155364636|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
155364637|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
155364638|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
155364639|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
155364640|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
155364641|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
155364642|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
155364643|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
155364644|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
155364645|NCT02643628|560768243|FG000|Overall Study|Lost to Follow-up|1|||
155364646|NCT02643628|560768244|FG001|Overall Study|Lost to Follow-up|4|||
155364647|NCT02643628|560768243|FG000|Overall Study|Withdrawal by Subject|0|||
155364648|NCT02643628|560768244|FG001|Overall Study|Withdrawal by Subject|1|||
155364649|NCT02643628|560768243|FG000|Overall Study|Relocated out of state|0|||
155364650|NCT02643628|560768244|FG001|Overall Study|Relocated out of state|1|||
155364651|NCT04148651|560768253|FG000|Overall Study|Lost to Follow-up|2|||
155364652|NCT03392168|560768257|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
155364653|NCT03392168|560768258|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
155364654|NCT03392168|560768259|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
155364655|NCT03392168|560768260|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
155364656|NCT03392168|560768257|FG000|Period 2: Cohort 2|Other|0|||
155364657|NCT03392168|560768258|FG001|Period 2: Cohort 2|Other|1|||
155364658|NCT03392168|560768259|FG002|Period 2: Cohort 2|Other|0|||
155364659|NCT03392168|560768260|FG003|Period 2: Cohort 2|Other|0|||
155507895|NCT00410410|561285151|FG007|Open-Label Period (OL)|Other|0|||
155364660|NCT01245374|560768264|FG000|Overall Study|Protocol Violation|1|||
155364661|NCT01245374|560768264|FG000|Overall Study|Withdrawal by Subject|3|||
155364662|NCT01782690|560768266|FG000|Overall Study|Not reported|7|||
155427893|NCT03895203|560993321|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
155427894|NCT03895203|560993322|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
155427895|NCT03895203|560993323|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
155427896|NCT03895203|560993324|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
155427897|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
155427898|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
155427899|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
155427900|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
155507896|NCT00410410|561285152|FG008|Open-Label Period (OL)|Other|7|||
155507897|NCT01023269|561285153|FG000|Overall Study|early termination of the study|2|||
155507898|NCT01023269|561285154|FG001|Overall Study|early termination of the study|0|||
155507899|NCT01953783|561285155|FG000|Overall Study|Progressive disease|2|||
155507900|NCT01789281|561285156|FG000|Overall Study|Disease progression|15|||
155507901|NCT01789281|561285157|FG001|Overall Study|Disease progression|4|||
155507902|NCT01789281|561285156|FG000|Overall Study|Adverse Event|5|||
155507903|NCT01789281|561285157|FG001|Overall Study|Adverse Event|5|||
155507904|NCT01789281|561285156|FG000|Overall Study|Withdrawal by Subject|1|||
155507905|NCT01789281|561285157|FG001|Overall Study|Withdrawal by Subject|0|||
155507906|NCT01789281|561285156|FG000|Overall Study|Lost to Follow-up|1|||
155364663|NCT01782690|560768266|FG000|Overall Study|Toxicity of gemcitabine|1|||
155364664|NCT01782690|560768266|FG000|Overall Study|Toxicity of erlotinib|1|||
155364665|NCT01782690|560768266|FG000|Overall Study|Lost to Follow-up|31|||
155364666|NCT01782690|560768266|FG000|Overall Study|Withdrawal of informed consent|2|||
155427901|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
155507907|NCT01789281|561285157|FG001|Overall Study|Lost to Follow-up|0|||
155364667|NCT01782690|560768266|FG000|Overall Study|Absent rash|9|||
155364668|NCT01782690|560768266|FG000|Overall Study|Physician Decision|13|||
155364669|NCT01782690|560768266|FG000|Overall Study|Patient's wish|21|||
155507908|NCT01789281|561285156|FG000|Overall Study|Administrative problems|0|||
155507909|NCT01789281|561285157|FG001|Overall Study|Administrative problems|1|||
155507910|NCT00106028|561285158|FG000|Overall Study|Adverse Event|3|||
155427902|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
155507911|NCT00106028|561285159|FG001|Overall Study|Adverse Event|2|||
155507912|NCT00106028|561285158|FG000|Overall Study|Protocol Violation|1|||
155507913|NCT00106028|561285159|FG001|Overall Study|Protocol Violation|1|||
155364670|NCT01782690|560768266|FG000|Overall Study|Tumor progression|74|||
155507914|NCT00106028|561285158|FG000|Overall Study|Withdrawal by Subject|2|||
155507915|NCT00106028|561285159|FG001|Overall Study|Withdrawal by Subject|8|||
155507916|NCT00106028|561285158|FG000|Overall Study|Lost to Follow-up|0|||
155507917|NCT00106028|561285159|FG001|Overall Study|Lost to Follow-up|1|||
155507918|NCT00814658|561285161|FG000|Overall Study|Lost to Follow-up|0|||
155507919|NCT00814658|561285162|FG001|Overall Study|Lost to Follow-up|1|||
155364671|NCT01782690|560768266|FG000|Overall Study|Death|133|||
155364672|NCT01782690|560768266|FG000|Overall Study|Study completion unknown|7|||
155507920|NCT00814658|561285161|FG000|Overall Study|Physician Decision|1|||
155507921|NCT00814658|561285162|FG001|Overall Study|Physician Decision|0|||
155507922|NCT00814658|561285161|FG000|Overall Study|Adverse Event|3|||
155507923|NCT00814658|561285162|FG001|Overall Study|Adverse Event|3|||
155507924|NCT01141283|561285164|FG000|Overall Study|Adverse Event|56|||
155507925|NCT01141283|561285164|FG000|Overall Study|Lost to Follow-up|4|||
155507926|NCT01141283|561285164|FG000|Overall Study|Withdrawal by Subject|14|||
155507927|NCT01141283|561285164|FG000|Overall Study|Administrative|4|||
155507928|NCT01141283|561285164|FG000|Overall Study|Lack of Efficacy|10|||
155507929|NCT00545233|561285166|FG000|Overall Study|Adverse Event|10|||
155507930|NCT00545233|561285167|FG001|Overall Study|Adverse Event|5|||
155507931|NCT00545233|561285166|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
155507932|NCT00545233|561285167|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155507933|NCT00545233|561285166|FG000|Overall Study|Protocol Violation|2|||
155507934|NCT00545233|561285167|FG001|Overall Study|Protocol Violation|0|||
155507935|NCT00545233|561285166|FG000|Overall Study|Refused Treatment|9|||
155507936|NCT00545233|561285167|FG001|Overall Study|Refused Treatment|7|||
155507937|NCT00545233|561285166|FG000|Overall Study|Failure to Return|4|||
155507938|NCT00545233|561285167|FG001|Overall Study|Failure to Return|6|||
155507939|NCT00545233|561285166|FG000|Overall Study|Insufficient response|14|||
155507940|NCT00545233|561285167|FG001|Overall Study|Insufficient response|15|||
155507941|NCT00545233|561285166|FG000|Overall Study|Physician Decision|2|||
155507942|NCT00545233|561285167|FG001|Overall Study|Physician Decision|1|||
155507943|NCT06371079|561285168|FG000|Overall Study|Missing data|88|||
155507944|NCT06371079|561285169|FG001|Overall Study|Missing data|247|||
155507945|NCT01238211|561285170|FG000|Overall Study|Continues active treatment|31|||
155507946|NCT01238211|561285170|FG000|Overall Study|Adverse Event|7|||
155507947|NCT01238211|561285170|FG000|Overall Study|Death|4|||
155507948|NCT01238211|561285170|FG000|Overall Study|Relapse/Progression|2|||
155507949|NCT01238211|561285170|FG000|Overall Study|Withdrawal by Subject|7|||
155507950|NCT01238211|561285170|FG000|Overall Study|Non-protocol treatment|4|||
155507951|NCT01238211|561285170|FG000|Overall Study|Investigator/Patient Decision|3|||
155507952|NCT00449930|561285171|FG000|Overall Study|Adverse Event|9|||
155507953|NCT00449930|561285172|FG001|Overall Study|Adverse Event|19|||
155507954|NCT00449930|561285171|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
155507955|NCT00449930|561285172|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
155507956|NCT00449930|561285171|FG000|Overall Study|Lack of Efficacy|10|||
155364673|NCT04946942|560768267|FG000|Overall Study|Lost to Follow-up|6|||
155364674|NCT04946942|560768268|FG001|Overall Study|Lost to Follow-up|2|||
155364675|NCT04946942|560768269|FG002|Overall Study|Lost to Follow-up|0|||
155364676|NCT05032066|560768279|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
155364677|NCT05032066|560768280|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
155364678|NCT05032066|560768281|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
155364679|NCT05032066|560768279|FG000|Part 1: Core Phase|Physician Decision|0|||
155364680|NCT05032066|560768280|FG001|Part 1: Core Phase|Physician Decision|1|||
155364681|NCT05032066|560768281|FG002|Part 1: Core Phase|Physician Decision|1|||
155364682|NCT05032066|560768279|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
155364683|NCT05032066|560768280|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
155364684|NCT05032066|560768281|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
155364685|NCT05032066|560768279|FG000|Part 1: Core Phase|Death|3|||
155364686|NCT05032066|560768280|FG001|Part 1: Core Phase|Death|4|||
155507957|NCT00449930|561285172|FG001|Overall Study|Lack of Efficacy|1|||
155507958|NCT00449930|561285171|FG000|Overall Study|Lost to Follow-up|9|||
155507959|NCT00449930|561285172|FG001|Overall Study|Lost to Follow-up|14|||
155507960|NCT00449930|561285171|FG000|Overall Study|Physician Decision|1|||
155507961|NCT00449930|561285172|FG001|Overall Study|Physician Decision|2|||
155507962|NCT00449930|561285171|FG000|Overall Study|Protocol Violation|14|||
155507963|NCT00449930|561285172|FG001|Overall Study|Protocol Violation|15|||
155507964|NCT00449930|561285171|FG000|Overall Study|Withdrawal by Subject|16|||
155507965|NCT00449930|561285172|FG001|Overall Study|Withdrawal by Subject|23|||
155507966|NCT00449930|561285171|FG000|Overall Study|Glycemic discontinuation criteria|1|||
155507967|NCT00449930|561285172|FG001|Overall Study|Glycemic discontinuation criteria|1|||
155507968|NCT02746705|561285173|FG000|Overall Study|Physician Decision|1|||
155507969|NCT02746705|561285174|FG001|Overall Study|Physician Decision|1|||
155507970|NCT02746705|561285173|FG000|Overall Study|Lost to Follow-up|1|||
155364687|NCT05032066|560768281|FG002|Part 1: Core Phase|Death|2|||
155507971|NCT02746705|561285174|FG001|Overall Study|Lost to Follow-up|0|||
155427903|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
155427904|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
155427905|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
155427906|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
155427907|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
155427908|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
155427909|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
155427910|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
155427911|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
155427912|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
155427913|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
155427914|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
155427915|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
155427916|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
155427917|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
155427918|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
155427919|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
155427920|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
155427921|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
155427922|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
155427923|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
155427924|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
155427925|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
155427926|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
155427927|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
155427928|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
155427929|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
155427930|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
155427931|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
155427932|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
155427933|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
155427934|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
155427935|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
155427936|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
155427937|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
155427938|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
155427939|NCT03895203|560993319|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
155427940|NCT03895203|560993320|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
155427941|NCT03895203|560993321|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
155427942|NCT03895203|560993322|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
155427943|NCT03895203|560993323|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
155427944|NCT03895203|560993324|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
155427945|NCT01389245|560993325|FG000|Overall Study|Protocol Violation|10|||
155427946|NCT01389245|560993325|FG000|Overall Study|Lost to Follow-up|3|||
155427947|NCT01389245|560993325|FG000|Overall Study|Withdrawal by Subject|2|||
155427948|NCT02542267|560993331|FG000|Overall Study|Withdrawal by Subject|10|||
155427949|NCT02542267|560993331|FG000|Overall Study|Physician Decision|6|||
155427950|NCT02542267|560993331|FG000|Overall Study|Lost to Follow-up|4|||
155427951|NCT02542267|560993331|FG000|Overall Study|Death|13|||
155427952|NCT02542267|560993331|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
155427953|NCT02542267|560993331|FG000|Overall Study|Other|9|||
155427954|NCT00442598|560993332|FG000|Overall Study|Adverse Event|1|||
155427955|NCT00442598|560993333|FG001|Overall Study|Adverse Event|0|||
155427956|NCT00442598|560993334|FG002|Overall Study|Adverse Event|0|||
155427957|NCT00442598|560993332|FG000|Overall Study|Tumor progression|3|||
155427958|NCT00442598|560993333|FG001|Overall Study|Tumor progression|4|||
155427959|NCT00442598|560993334|FG002|Overall Study|Tumor progression|0|||
155427960|NCT00442598|560993332|FG000|Overall Study|Clinical deterioration|1|||
155427961|NCT00442598|560993333|FG001|Overall Study|Clinical deterioration|2|||
155427962|NCT00442598|560993334|FG002|Overall Study|Clinical deterioration|0|||
155427963|NCT00442598|560993332|FG000|Overall Study|CA125 progression|0|||
155427964|NCT00442598|560993333|FG001|Overall Study|CA125 progression|1|||
155427965|NCT00442598|560993334|FG002|Overall Study|CA125 progression|0|||
155427966|NCT00442598|560993332|FG000|Overall Study|Reduced creatinine clearance|1|||
155427967|NCT00442598|560993333|FG001|Overall Study|Reduced creatinine clearance|0|||
155427968|NCT00442598|560993334|FG002|Overall Study|Reduced creatinine clearance|0|||
155364688|NCT05032066|560768279|FG000|Part 1: Core Phase|Adverse Event|2|||
155364689|NCT05032066|560768280|FG001|Part 1: Core Phase|Adverse Event|3|||
155364690|NCT05032066|560768281|FG002|Part 1: Core Phase|Adverse Event|0|||
155364691|NCT05032066|560768279|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
155364692|NCT05032066|560768280|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
155364693|NCT05032066|560768281|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
155364694|NCT05032066|560768279|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
155364695|NCT05032066|560768280|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
155507972|NCT02746705|561285173|FG000|Overall Study|outlier scores deemed not valid|0|||
155507973|NCT02746705|561285174|FG001|Overall Study|outlier scores deemed not valid|1|||
155364696|NCT05032066|560768281|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
155364697|NCT05032066|560768279|FG000|Part 2: Extension Phase|Physician Decision|1|||
155364698|NCT05032066|560768280|FG001|Part 2: Extension Phase|Physician Decision|2|||
155364699|NCT05032066|560768281|FG002|Part 2: Extension Phase|Physician Decision|0|||
155364700|NCT05032066|560768279|FG000|Part 2: Extension Phase|Death|2|||
155364701|NCT05032066|560768280|FG001|Part 2: Extension Phase|Death|4|||
155364702|NCT05032066|560768281|FG002|Part 2: Extension Phase|Death|5|||
155364703|NCT04297618|560768282|FG000|Overall Study|Adverse Event|1|||
155364704|NCT04297618|560768282|FG000|Overall Study|Withdrawal by Subject|1|||
155364705|NCT02600897|560768283|FG000|Overall Study|Death|1|||
155364706|NCT02600897|560768284|FG001|Overall Study|Death|2|||
155364707|NCT02600897|560768285|FG002|Overall Study|Death|1|||
155364708|NCT02600897|560768286|FG003|Overall Study|Death|2|||
155364709|NCT02600897|560768287|FG004|Overall Study|Death|3|||
155364710|NCT02600897|560768288|FG005|Overall Study|Death|2|||
155364711|NCT02600897|560768289|FG006|Overall Study|Death|10|||
155364712|NCT02600897|560768290|FG007|Overall Study|Death|7|||
155364713|NCT02600897|560768291|FG008|Overall Study|Death|20|||
155364714|NCT02600897|560768283|FG000|Overall Study|Lost to Follow-up|1|||
155364715|NCT02600897|560768284|FG001|Overall Study|Lost to Follow-up|0|||
155364716|NCT02600897|560768285|FG002|Overall Study|Lost to Follow-up|0|||
155364717|NCT02600897|560768286|FG003|Overall Study|Lost to Follow-up|0|||
155364718|NCT02600897|560768287|FG004|Overall Study|Lost to Follow-up|0|||
155364719|NCT02600897|560768288|FG005|Overall Study|Lost to Follow-up|0|||
155364720|NCT02600897|560768289|FG006|Overall Study|Lost to Follow-up|0|||
155364721|NCT02600897|560768290|FG007|Overall Study|Lost to Follow-up|1|||
155364722|NCT02600897|560768291|FG008|Overall Study|Lost to Follow-up|0|||
155364723|NCT02600897|560768283|FG000|Overall Study|Withdrawal by Subject|0|||
155507974|NCT05288673|561285175|FG000|Overall Study|Consent withdrawn by subject|0|||
155364724|NCT02600897|560768284|FG001|Overall Study|Withdrawal by Subject|0|||
155364725|NCT02600897|560768285|FG002|Overall Study|Withdrawal by Subject|0|||
155364726|NCT02600897|560768286|FG003|Overall Study|Withdrawal by Subject|0|||
155364727|NCT02600897|560768287|FG004|Overall Study|Withdrawal by Subject|0|||
155364728|NCT02600897|560768288|FG005|Overall Study|Withdrawal by Subject|0|||
155364729|NCT02600897|560768289|FG006|Overall Study|Withdrawal by Subject|0|||
155507975|NCT05288673|561285176|FG001|Overall Study|Consent withdrawn by subject|0|||
155364730|NCT02600897|560768290|FG007|Overall Study|Withdrawal by Subject|4|||
155364731|NCT02600897|560768291|FG008|Overall Study|Withdrawal by Subject|2|||
155364732|NCT02600897|560768283|FG000|Overall Study|Reason Not Specified|0|||
155507976|NCT05288673|561285177|FG002|Overall Study|Consent withdrawn by subject|1|||
155364733|NCT02600897|560768284|FG001|Overall Study|Reason Not Specified|0|||
155364734|NCT02600897|560768285|FG002|Overall Study|Reason Not Specified|0|||
155364735|NCT02600897|560768286|FG003|Overall Study|Reason Not Specified|0|||
155364736|NCT02600897|560768287|FG004|Overall Study|Reason Not Specified|0|||
155364737|NCT02600897|560768288|FG005|Overall Study|Reason Not Specified|0|||
155364738|NCT02600897|560768289|FG006|Overall Study|Reason Not Specified|0|||
155364739|NCT02600897|560768290|FG007|Overall Study|Reason Not Specified|0|||
155364740|NCT02600897|560768291|FG008|Overall Study|Reason Not Specified|1|||
155364741|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Adverse Event|10|||
155364742|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Adverse Event|9|||
155364743|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Adverse Event|7|||
155364744|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
155364745|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
155364746|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
155364747|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
155364748|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
155364749|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
155364750|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Physician Decision|7|||
155364751|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Physician Decision|3|||
155364752|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Physician Decision|2|||
155427969|NCT00442598|560993332|FG000|Overall Study|Death|0|||
155427970|NCT00442598|560993333|FG001|Overall Study|Death|1|||
155427971|NCT00442598|560993334|FG002|Overall Study|Death|0|||
155427972|NCT03093402|560993335|FG000|Overall Study|Lost to Follow-up|1|||
155427973|NCT03093402|560993336|FG001|Overall Study|Lost to Follow-up|0|||
155364753|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Pregnancy|2|||
155427974|NCT03093402|560993337|FG002|Overall Study|Lost to Follow-up|0|||
155427975|NCT03093402|560993338|FG003|Overall Study|Lost to Follow-up|0|||
155427976|NCT03093402|560993335|FG000|Overall Study|Withdrawal by Subject|3|||
155364754|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Pregnancy|1|||
155427977|NCT03093402|560993336|FG001|Overall Study|Withdrawal by Subject|3|||
155427978|NCT03093402|560993337|FG002|Overall Study|Withdrawal by Subject|0|||
155364755|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Pregnancy|3|||
155364756|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
155364757|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
155364758|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
155364759|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
155364760|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
155364761|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
155364762|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
155364763|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
155364764|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
155364765|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
155364766|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
155364767|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
155364768|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
155364769|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
155364770|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
155364771|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
155364772|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
155364773|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
155364774|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
155364775|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
155364776|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
155364777|NCT05992922|560768300|FG000|Overall Study|Adverse Event|6|||
155364778|NCT05992922|560768301|FG001|Overall Study|Adverse Event|0|||
155364779|NCT05992922|560768300|FG000|Overall Study|Sponsor Termination of Study|14|||
155364780|NCT05992922|560768301|FG001|Overall Study|Sponsor Termination of Study|20|||
155364781|NCT04680533|560768302|FG000|Overall Study|Screen failure|1|||
155364782|NCT04991753|560770835|FG000|Overall Study|Withdrawal by Subject|0|||
155364783|NCT04991753|560770836|FG001|Overall Study|Withdrawal by Subject|1|||
155364784|NCT02797522|560770837|FG000|Overall Study|Study Terminated by Sponsor|0|||
155364785|NCT02797522|560770838|FG001|Overall Study|Study Terminated by Sponsor|0|||
155364786|NCT02797522|560770839|FG002|Overall Study|Study Terminated by Sponsor|0|||
155364787|NCT02797522|560770840|FG003|Overall Study|Study Terminated by Sponsor|0|||
155364788|NCT02797522|560770841|FG004|Overall Study|Study Terminated by Sponsor|0|||
155364789|NCT02797522|560770842|FG005|Overall Study|Study Terminated by Sponsor|0|||
155364790|NCT02797522|560770843|FG006|Overall Study|Study Terminated by Sponsor|0|||
155364791|NCT02797522|560770844|FG007|Overall Study|Study Terminated by Sponsor|4|||
155364792|NCT02797522|560770845|FG008|Overall Study|Study Terminated by Sponsor|2|||
155364793|NCT02797522|560770846|FG009|Overall Study|Study Terminated by Sponsor|4|||
155364794|NCT02797522|560770847|FG010|Overall Study|Study Terminated by Sponsor|1|||
155364795|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
155364796|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
155364797|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
155364798|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
155364799|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
155364800|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
155364801|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
155427979|NCT03093402|560993338|FG003|Overall Study|Withdrawal by Subject|1|||
155427980|NCT03093402|560993335|FG000|Overall Study|Withdrew prior to dosing|2|||
155427981|NCT03093402|560993336|FG001|Overall Study|Withdrew prior to dosing|1|||
155427982|NCT03093402|560993337|FG002|Overall Study|Withdrew prior to dosing|2|||
155427983|NCT03093402|560993338|FG003|Overall Study|Withdrew prior to dosing|3|||
155427984|NCT03093402|560993335|FG000|Overall Study|Ineligible for study|1|||
155427985|NCT03093402|560993336|FG001|Overall Study|Ineligible for study|0|||
155427986|NCT03093402|560993337|FG002|Overall Study|Ineligible for study|0|||
155427987|NCT03093402|560993338|FG003|Overall Study|Ineligible for study|0|||
155427988|NCT03093402|560993335|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
155427989|NCT03093402|560993336|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
155427990|NCT03093402|560993337|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
155427991|NCT03093402|560993338|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
155427992|NCT02886702|560993339|FG000|Overall Study|Other|4|||
155427993|NCT02886702|560993340|FG001|Overall Study|Other|3|||
155427994|NCT02886702|560993341|FG002|Overall Study|Other|9|||
155427995|NCT02886702|560993339|FG000|Overall Study|Withdrawal by Subject|24|||
155427996|NCT02886702|560993340|FG001|Overall Study|Withdrawal by Subject|18|||
155427997|NCT02886702|560993341|FG002|Overall Study|Withdrawal by Subject|22|||
155427998|NCT02886702|560993339|FG000|Overall Study|Significant Worsening of Condition|0|||
155427999|NCT02886702|560993340|FG001|Overall Study|Significant Worsening of Condition|1|||
155428000|NCT02886702|560993341|FG002|Overall Study|Significant Worsening of Condition|0|||
155428001|NCT02886702|560993339|FG000|Overall Study|Protocol Violation|2|||
155428002|NCT02886702|560993340|FG001|Overall Study|Protocol Violation|2|||
155428003|NCT02886702|560993341|FG002|Overall Study|Protocol Violation|1|||
155428004|NCT02886702|560993339|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155428005|NCT02886702|560993340|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155428006|NCT02886702|560993341|FG002|Overall Study|Non-Compliance With Study Drug|4|||
155428007|NCT02886702|560993339|FG000|Overall Study|Lost to Follow-up|11|||
155428008|NCT02886702|560993340|FG001|Overall Study|Lost to Follow-up|13|||
155428009|NCT02886702|560993341|FG002|Overall Study|Lost to Follow-up|8|||
155428010|NCT02886702|560993339|FG000|Overall Study|Lack of Efficacy|3|||
155428011|NCT02886702|560993340|FG001|Overall Study|Lack of Efficacy|4|||
155428012|NCT02886702|560993341|FG002|Overall Study|Lack of Efficacy|5|||
155428013|NCT02886702|560993339|FG000|Overall Study|Adverse Event|4|||
155428014|NCT02886702|560993340|FG001|Overall Study|Adverse Event|9|||
155428015|NCT02886702|560993341|FG002|Overall Study|Adverse Event|3|||
155428016|NCT02886702|560993339|FG000|Overall Study|Administrative Reasons|0|||
155428017|NCT02886702|560993340|FG001|Overall Study|Administrative Reasons|0|||
155428018|NCT02886702|560993341|FG002|Overall Study|Administrative Reasons|1|||
155428019|NCT01147497|560993351|FG000|Overall Study|failed insertion|2|||
155428020|NCT01147497|560993352|FG001|Overall Study|failed insertion|0|||
155428021|NCT02731742|560993355|FG000|Overall Study|Death|1|||
155428022|NCT02731742|560993356|FG001|Overall Study|Death|2|||
155428023|NCT02731742|560993357|FG002|Overall Study|Death|5|||
155428024|NCT02731742|560993358|FG003|Overall Study|Death|0|||
155428025|NCT02731742|560993355|FG000|Overall Study|Physician Decision|0|||
155428026|NCT02731742|560993356|FG001|Overall Study|Physician Decision|0|||
155428027|NCT02731742|560993357|FG002|Overall Study|Physician Decision|0|||
155428028|NCT02731742|560993358|FG003|Overall Study|Physician Decision|1|||
155428029|NCT02731742|560993355|FG000|Overall Study|Study Terminated by Sponsor|2|||
155428030|NCT02731742|560993356|FG001|Overall Study|Study Terminated by Sponsor|1|||
155428031|NCT02731742|560993357|FG002|Overall Study|Study Terminated by Sponsor|1|||
155428032|NCT02731742|560993358|FG003|Overall Study|Study Terminated by Sponsor|1|||
155428033|NCT02561156|560993368|FG000|Part 2|Adverse Event|0|||
155428034|NCT02561156|560993369|FG001|Part 2|Adverse Event|0|||
155428035|NCT02561156|560993370|FG002|Part 2|Adverse Event|0|||
155428036|NCT02561156|560993371|FG003|Part 2|Adverse Event|0|||
155428037|NCT02561156|560993372|FG004|Part 2|Adverse Event|0|||
155364802|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
155364803|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
155364804|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
155364805|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
155364806|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
155364807|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
155364808|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
155364809|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
155364810|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
155364811|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
155364812|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
155364813|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
155364814|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
155364815|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
155364816|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Death|2|||
155364817|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Death|0|||
155364818|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Death|0|||
155364819|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
155364820|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
155364821|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
155364822|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
155364823|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
155364824|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
155364825|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
155364826|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
155364827|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
155364828|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
155364829|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
155364830|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
155364831|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
155364832|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
155364833|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
155364834|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
155364835|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
155364836|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
155364837|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
155364838|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
155364839|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
155364840|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
155364841|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
155364842|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
155364843|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
155364844|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
155364845|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
155364846|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
155364847|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
155364848|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
155364849|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
155364850|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
155364851|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
155364852|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
155364853|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
155364854|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
155364855|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
155364856|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
155364857|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
155364858|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
155364859|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
155364860|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
155364861|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
155364862|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
155364863|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
155364864|NCT01901419|560770851|FG000|Overall Study|Protocol Violation|2|||
155364865|NCT01901419|560770852|FG001|Overall Study|Protocol Violation|6|||
155364866|NCT01901419|560770851|FG000|Overall Study|unavailable researchers|6|||
155364867|NCT01901419|560770852|FG001|Overall Study|unavailable researchers|3|||
155364868|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155364869|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155364870|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
155364871|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
155364872|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
155364873|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
155364874|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
155364875|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
155428038|NCT02561156|560993373|FG005|Part 2|Adverse Event|0|||
155364876|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
155364877|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
155364878|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
155364879|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
155364880|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
155364881|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
155649283|NCT03931785|561808198|FG000|Overall Study|Adverse Event|1|||
155364882|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364883|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364884|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364885|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364886|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364887|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364888|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
155364889|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155364890|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
155364891|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
155364892|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
155364893|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
155364894|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
155364895|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155364896|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364897|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364898|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364899|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364900|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
155364901|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364902|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364903|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364904|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
155364905|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364906|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364907|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155428039|NCT02561156|560993374|FG006|Part 2|Adverse Event|0|||
155428040|NCT02561156|560993375|FG007|Part 2|Adverse Event|0|||
155428041|NCT02561156|560993376|FG008|Part 2|Adverse Event|0|||
155649284|NCT03931785|561808199|FG001|Overall Study|Adverse Event|0|||
155507977|NCT01504867|561285178|FG000|Overall Study|Inclusion criteria not met|2|||
155507978|NCT01504867|561285179|FG001|Overall Study|Inclusion criteria not met|2|||
155507979|NCT01504867|561285178|FG000|Overall Study|Consent revoked|5|||
155507980|NCT01504867|561285179|FG001|Overall Study|Consent revoked|1|||
155507981|NCT00571922|561285180|FG000|Overall Study|Completion unknown|36|||
155507982|NCT00571922|561285181|FG001|Overall Study|Completion unknown|36|||
155507983|NCT03210259|561285187|FG000|12-Week Run-in Period|Adverse Event|1|||
155507984|NCT03210259|561285188|FG001|12-Week Run-in Period|Adverse Event|0|||
155507985|NCT03210259|561285189|FG002|12-Week Run-in Period|Adverse Event|0|||
155507986|NCT03210259|561285187|FG000|12-Week Run-in Period|Death|1|||
155507987|NCT03210259|561285188|FG001|12-Week Run-in Period|Death|0|||
155649285|NCT03931785|561808200|FG002|Overall Study|Adverse Event|3|||
155649286|NCT03931785|561808201|FG003|Overall Study|Adverse Event|4|||
155507988|NCT03210259|561285189|FG002|12-Week Run-in Period|Death|0|||
155507989|NCT03210259|561285187|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
155507990|NCT03210259|561285188|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
155507991|NCT03210259|561285189|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
155507992|NCT03210259|561285187|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
155507993|NCT03210259|561285188|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
155507994|NCT03210259|561285189|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
155649287|NCT03931785|561808198|FG000|Overall Study|Protocol Violation|0|||
155364908|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364909|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364910|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155507995|NCT03210259|561285187|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
155507996|NCT03210259|561285188|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
155507997|NCT03210259|561285189|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
155507998|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
155507999|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
155649288|NCT03931785|561808199|FG001|Overall Study|Protocol Violation|1|||
155364911|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
155364912|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364913|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364914|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364915|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
155364916|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364917|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364918|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364919|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
155364920|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364921|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364922|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364923|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364924|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364925|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364926|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364927|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364928|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
155364929|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364930|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364931|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364932|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364933|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
155364934|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364935|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364936|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
155364937|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364938|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364939|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364940|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
155364941|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364942|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364943|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364944|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364945|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
155364946|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
155364947|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
155364948|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
155364949|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
155364950|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
155364951|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
155364952|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364953|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
155364954|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364955|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364956|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364957|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
155364958|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364959|NCT00475644|560770861|FG000|Overall Study|Protocol Violation|13|||
155364960|NCT01411241|560770864|FG000|Overall Study|Protocol Violation|0|||
155364961|NCT01411241|560770865|FG001|Overall Study|Protocol Violation|5|||
155364962|NCT01411241|560770864|FG000|Overall Study|Withdrawal by Subject|9|||
155364963|NCT01411241|560770865|FG001|Overall Study|Withdrawal by Subject|10|||
155364964|NCT01411241|560770864|FG000|Overall Study|Serious Adverse Event|0|||
155364965|NCT01411241|560770865|FG001|Overall Study|Serious Adverse Event|3|||
155364966|NCT01411241|560770864|FG000|Overall Study|Lost to Follow-up|2|||
155364967|NCT01411241|560770865|FG001|Overall Study|Lost to Follow-up|4|||
155364968|NCT02412735|560770871|FG000|Overall Study|Adverse Event|0|||
155364969|NCT02412735|560770872|FG001|Overall Study|Adverse Event|1|||
155364970|NCT02412735|560770873|FG002|Overall Study|Adverse Event|2|||
155364971|NCT02412735|560770871|FG000|Overall Study|Withdrawal by Subject|23|||
155364972|NCT02412735|560770872|FG001|Overall Study|Withdrawal by Subject|27|||
155508000|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
155364973|NCT02412735|560770873|FG002|Overall Study|Withdrawal by Subject|22|||
155364974|NCT02412735|560770871|FG000|Overall Study|Investigator Decision|3|||
155364975|NCT02412735|560770872|FG001|Overall Study|Investigator Decision|3|||
155364976|NCT02412735|560770873|FG002|Overall Study|Investigator Decision|2|||
155364977|NCT02412735|560770871|FG000|Overall Study|Lost to Follow-up|17|||
155364978|NCT02412735|560770872|FG001|Overall Study|Lost to Follow-up|11|||
155364979|NCT02412735|560770873|FG002|Overall Study|Lost to Follow-up|18|||
155364980|NCT02412735|560770871|FG000|Overall Study|Reason not Specified|3|||
155364981|NCT02412735|560770872|FG001|Overall Study|Reason not Specified|2|||
155364982|NCT02412735|560770873|FG002|Overall Study|Reason not Specified|2|||
155364983|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
155364984|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
155364985|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
155364986|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
155364987|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Death|13|||
155364988|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Death|12|||
155364989|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Progression|257|||
155364990|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Progression|218|||
155364991|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
155364992|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
155364993|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
155364994|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
155364995|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
155364996|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
155364997|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
155364998|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
155364999|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
155365000|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
155365001|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
155365002|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
155365003|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
155508001|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
155508002|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
155365004|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
155365005|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
155365006|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
155365007|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
155365008|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
155365009|NCT01483144|560770876|FG000|Overall Study|Adverse Event|9|||
155365010|NCT01483144|560770877|FG001|Overall Study|Adverse Event|4|||
155365011|NCT01483144|560770878|FG002|Overall Study|Adverse Event|6|||
155365012|NCT01483144|560770876|FG000|Overall Study|Withdrawal by Subject|0|||
155365013|NCT01483144|560770877|FG001|Overall Study|Withdrawal by Subject|2|||
155365014|NCT01483144|560770878|FG002|Overall Study|Withdrawal by Subject|5|||
155365015|NCT01483144|560770876|FG000|Overall Study|Physician Decision|1|||
155365016|NCT01483144|560770877|FG001|Overall Study|Physician Decision|0|||
155365017|NCT01483144|560770878|FG002|Overall Study|Physician Decision|0|||
155365018|NCT01483144|560770876|FG000|Overall Study|Lost to Follow-up|2|||
155365019|NCT01483144|560770877|FG001|Overall Study|Lost to Follow-up|4|||
155365020|NCT01483144|560770878|FG002|Overall Study|Lost to Follow-up|1|||
155365021|NCT01483144|560770876|FG000|Overall Study|Protocol Violation|3|||
155365022|NCT01483144|560770877|FG001|Overall Study|Protocol Violation|3|||
155365023|NCT01483144|560770878|FG002|Overall Study|Protocol Violation|3|||
155365024|NCT02124811|560770879|FG000|Overall Study|Early termination|2|||
155365025|NCT02124811|560770880|FG001|Overall Study|Early termination|2|||
155365026|NCT02124811|560770879|FG000|Overall Study|Withdrawal by Subject|1|||
155365027|NCT02124811|560770880|FG001|Overall Study|Withdrawal by Subject|0|||
155365028|NCT04896008|560770886|FG000|Overall Study|Ongoing|70|||
155365029|NCT04896008|560770887|FG001|Overall Study|Ongoing|38|||
155365030|NCT04896008|560770886|FG000|Overall Study|Adverse Event|0|||
155365031|NCT04896008|560770887|FG001|Overall Study|Adverse Event|2|||
155365032|NCT04896008|560770886|FG000|Overall Study|Death|5|||
155365033|NCT04896008|560770887|FG001|Overall Study|Death|10|||
155365034|NCT04896008|560770886|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
155365035|NCT04896008|560770887|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
155365036|NCT04896008|560770886|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
155365037|NCT04896008|560770887|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
155365038|NCT04896008|560770886|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
155365039|NCT04896008|560770887|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
155365040|NCT04896008|560770886|FG000|Overall Study|Withdrawal by Subject|1|||
155365041|NCT04896008|560770887|FG001|Overall Study|Withdrawal by Subject|4|||
155508003|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
155508004|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
155508005|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
155508006|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
155508007|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
155508008|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
155508009|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
155508010|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
155508011|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
155508012|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
155508013|NCT03210259|561285187|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
155508014|NCT03210259|561285188|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
155508015|NCT03210259|561285189|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
155508016|NCT02533999|561285190|FG000|Overall Study|Lost to Follow-up|3|||
155508017|NCT02533999|561285191|FG001|Overall Study|Lost to Follow-up|5|||
155508018|NCT02533999|561285190|FG000|Overall Study|Protocol Violation|3|||
155508019|NCT02533999|561285191|FG001|Overall Study|Protocol Violation|0|||
155508020|NCT02533999|561285190|FG000|Overall Study|Adverse Event|0|||
155508021|NCT02533999|561285191|FG001|Overall Study|Adverse Event|1|||
155508022|NCT02533999|561285190|FG000|Overall Study|Randomized but intervention not received|0|||
155508023|NCT02533999|561285191|FG001|Overall Study|Randomized but intervention not received|1|||
155508024|NCT00345683|561285197|FG000|Overall Study|Lost to Follow-up|19|||
155508025|NCT00345683|561285198|FG001|Overall Study|Lost to Follow-up|7|||
155508026|NCT00345683|561285197|FG000|Overall Study|Other|6|||
155508027|NCT00345683|561285198|FG001|Overall Study|Other|2|||
155508028|NCT00990093|561285201|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
155508029|NCT00990093|561285202|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
155508030|NCT00990093|561285201|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
155508031|NCT00990093|561285202|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
155508032|NCT00990093|561285201|FG000|Test Period 1 (1-14 Days)|Other|1|||
155508033|NCT00990093|561285202|FG001|Test Period 1 (1-14 Days)|Other|0|||
155508034|NCT00990093|561285201|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
155508035|NCT00990093|561285202|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
155508036|NCT00990093|561285201|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
155508037|NCT00990093|561285202|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
155508038|NCT00990093|561285201|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
155508039|NCT00990093|561285202|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
155508040|NCT00990093|561285201|FG000|Test Period 2 (15-28 Days)|Other|0|||
155508041|NCT00990093|561285202|FG001|Test Period 2 (15-28 Days)|Other|1|||
155508042|NCT04147611|561285204|FG000|Overall Study|Physician Decision|0|||
155508043|NCT04147611|561285205|FG001|Overall Study|Physician Decision|1|||
155508044|NCT00530439|561285206|FG000|Overall Study|GDM|9|||
155508045|NCT00530439|561285207|FG001|Overall Study|GDM|3|||
155508046|NCT00530439|561285206|FG000|Overall Study|Withdraw|18|||
155508047|NCT00530439|561285207|FG001|Overall Study|Withdraw|14|||
155508048|NCT00530439|561285206|FG000|Overall Study|Missed abortion|1|||
155508049|NCT00530439|561285207|FG001|Overall Study|Missed abortion|4|||
155508050|NCT00530439|561285206|FG000|Overall Study|Misclassification|2|||
155508051|NCT00530439|561285207|FG001|Overall Study|Misclassification|0|||
155365042|NCT04896008|560770886|FG000|Overall Study|Investigator Decision|2|||
155365043|NCT04896008|560770887|FG001|Overall Study|Investigator Decision|0|||
155365044|NCT04896008|560770886|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
155365045|NCT04896008|560770887|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
155365046|NCT04201288|560770890|FG000|Overall Study|Death|1|||
155365047|NCT04201288|560770891|FG001|Overall Study|Death|1|||
155365048|NCT04201288|560770890|FG000|Overall Study|Lost to Follow-up|5|||
155365049|NCT04201288|560770891|FG001|Overall Study|Lost to Follow-up|3|||
155365050|NCT04201288|560770890|FG000|Overall Study|Withdrawal by Subject|1|||
155365051|NCT04201288|560770891|FG001|Overall Study|Withdrawal by Subject|0|||
155508052|NCT00530439|561285206|FG000|Overall Study|Twin pregnancy|0|||
155508053|NCT00530439|561285207|FG001|Overall Study|Twin pregnancy|2|||
155508054|NCT00530439|561285206|FG000|Overall Study|Severe malformation/abortion|0|||
155365052|NCT01594827|560770901|FG000|Overall Study|Adverse Event|1|||
155365053|NCT01594827|560770902|FG001|Overall Study|Adverse Event|0|||
155508055|NCT00530439|561285207|FG001|Overall Study|Severe malformation/abortion|3|||
155365054|NCT01594827|560770901|FG000|Overall Study|Physician Decision|3|||
155508056|NCT04385199|561285212|FG000|Overall Study|Withdrawal by Subject|1|||
155508057|NCT04385199|561285213|FG001|Overall Study|Withdrawal by Subject|0|||
155508058|NCT00928252|561286742|FG000|Overall Study|Physician Decision|3|||
155508059|NCT02257632|561286743|FG000|Overall Study|Withdrawal by Subject|0|||
155508060|NCT02257632|561286744|FG001|Overall Study|Withdrawal by Subject|1|||
155508061|NCT02257632|561286743|FG000|Overall Study|Adverse Event|1|||
155508062|NCT02257632|561286744|FG001|Overall Study|Adverse Event|2|||
155508063|NCT02468557|561286745|FG000|Overall Study|Adverse Event|1|||
155508064|NCT02468557|561286745|FG000|Overall Study|Death|1|||
155508065|NCT02468557|561286745|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
155508066|NCT02468557|561286745|FG000|Overall Study|All Enrolled but Never Dosed|4|||
155508067|NCT03322462|561286749|FG000|Overall Study|Technical difficulties|2|||
155508068|NCT03322462|561286749|FG000|Overall Study|Other|1|||
155508069|NCT01393990|561286750|FG000|Overall Study|Adverse Event|0|||
155508070|NCT01393990|561286751|FG001|Overall Study|Adverse Event|0|||
155508071|NCT01393990|561286752|FG002|Overall Study|Adverse Event|0|||
155508072|NCT01393990|561286753|FG003|Overall Study|Adverse Event|0|||
155508073|NCT01393990|561286754|FG004|Overall Study|Adverse Event|0|||
155508074|NCT01393990|561286755|FG005|Overall Study|Adverse Event|0|||
155508075|NCT01393990|561286756|FG006|Overall Study|Adverse Event|0|||
155508076|NCT01393990|561286757|FG007|Overall Study|Adverse Event|0|||
155508077|NCT01393990|561286758|FG008|Overall Study|Adverse Event|0|||
155508078|NCT01393990|561286759|FG009|Overall Study|Adverse Event|0|||
155508079|NCT01393990|561286760|FG010|Overall Study|Adverse Event|0|||
155508080|NCT01393990|561286761|FG011|Overall Study|Adverse Event|0|||
155508081|NCT01393990|561286762|FG012|Overall Study|Adverse Event|0|||
155508082|NCT01393990|561286763|FG013|Overall Study|Adverse Event|0|||
155508083|NCT01393990|561286764|FG014|Overall Study|Adverse Event|1|||
155508084|NCT01393990|561286765|FG015|Overall Study|Adverse Event|1|||
155508085|NCT01393990|561286766|FG016|Overall Study|Adverse Event|0|||
155508086|NCT01393990|561286767|FG017|Overall Study|Adverse Event|0|||
155508087|NCT01393990|561286750|FG000|Overall Study|Progressive Disease|1|||
155508088|NCT01393990|561286751|FG001|Overall Study|Progressive Disease|0|||
155508089|NCT01393990|561286752|FG002|Overall Study|Progressive Disease|0|||
155508090|NCT01393990|561286753|FG003|Overall Study|Progressive Disease|1|||
155508091|NCT01393990|561286754|FG004|Overall Study|Progressive Disease|1|||
155508092|NCT01393990|561286755|FG005|Overall Study|Progressive Disease|1|||
155508093|NCT01393990|561286756|FG006|Overall Study|Progressive Disease|1|||
155508094|NCT01393990|561286757|FG007|Overall Study|Progressive Disease|1|||
155508095|NCT01393990|561286758|FG008|Overall Study|Progressive Disease|3|||
155508096|NCT01393990|561286759|FG009|Overall Study|Progressive Disease|1|||
155508097|NCT01393990|561286760|FG010|Overall Study|Progressive Disease|0|||
155508098|NCT01393990|561286761|FG011|Overall Study|Progressive Disease|0|||
155508099|NCT01393990|561286762|FG012|Overall Study|Progressive Disease|0|||
155508100|NCT01393990|561286763|FG013|Overall Study|Progressive Disease|1|||
155508101|NCT01393990|561286764|FG014|Overall Study|Progressive Disease|6|||
155508102|NCT01393990|561286765|FG015|Overall Study|Progressive Disease|1|||
155508103|NCT01393990|561286766|FG016|Overall Study|Progressive Disease|0|||
155508104|NCT01393990|561286767|FG017|Overall Study|Progressive Disease|0|||
155508105|NCT01393990|561286750|FG000|Overall Study|Death|0|||
155508106|NCT01393990|561286751|FG001|Overall Study|Death|0|||
155508107|NCT01393990|561286752|FG002|Overall Study|Death|0|||
155508108|NCT01393990|561286753|FG003|Overall Study|Death|0|||
155508109|NCT01393990|561286754|FG004|Overall Study|Death|1|||
155365055|NCT01594827|560770902|FG001|Overall Study|Physician Decision|0|||
155508110|NCT01393990|561286755|FG005|Overall Study|Death|0|||
155508111|NCT01393990|561286756|FG006|Overall Study|Death|0|||
155508112|NCT01393990|561286757|FG007|Overall Study|Death|0|||
155508113|NCT01393990|561286758|FG008|Overall Study|Death|0|||
155508114|NCT01393990|561286759|FG009|Overall Study|Death|0|||
155508115|NCT01393990|561286760|FG010|Overall Study|Death|0|||
155508116|NCT01393990|561286761|FG011|Overall Study|Death|0|||
155508117|NCT01393990|561286762|FG012|Overall Study|Death|0|||
155508118|NCT01393990|561286763|FG013|Overall Study|Death|1|||
155508119|NCT01393990|561286764|FG014|Overall Study|Death|1|||
155508120|NCT01393990|561286765|FG015|Overall Study|Death|0|||
155365056|NCT03334253|560770903|FG000|Overall Study|Withdrawal by Subject|1|||
155508121|NCT01393990|561286766|FG016|Overall Study|Death|0|||
155508122|NCT01393990|561286767|FG017|Overall Study|Death|0|||
155508123|NCT01393990|561286750|FG000|Overall Study|Withdrawal by Subject|0|||
155508124|NCT01393990|561286751|FG001|Overall Study|Withdrawal by Subject|0|||
155508125|NCT01393990|561286752|FG002|Overall Study|Withdrawal by Subject|0|||
155508126|NCT01393990|561286753|FG003|Overall Study|Withdrawal by Subject|0|||
155508127|NCT01393990|561286754|FG004|Overall Study|Withdrawal by Subject|0|||
155508128|NCT01393990|561286755|FG005|Overall Study|Withdrawal by Subject|0|||
155365057|NCT03334253|560770904|FG001|Overall Study|Withdrawal by Subject|0|||
155508129|NCT01393990|561286756|FG006|Overall Study|Withdrawal by Subject|0|||
155508130|NCT01393990|561286757|FG007|Overall Study|Withdrawal by Subject|0|||
155508131|NCT01393990|561286758|FG008|Overall Study|Withdrawal by Subject|0|||
155508132|NCT01393990|561286759|FG009|Overall Study|Withdrawal by Subject|0|||
155508133|NCT01393990|561286760|FG010|Overall Study|Withdrawal by Subject|0|||
155365058|NCT03334253|560770903|FG000|Overall Study|Lost to Follow-up|4|||
155365059|NCT03334253|560770904|FG001|Overall Study|Lost to Follow-up|3|||
155365060|NCT03334253|560770903|FG000|Overall Study|Moved residence|2|||
155365061|NCT03334253|560770904|FG001|Overall Study|Moved residence|2|||
155365062|NCT00968526|560770905|FG000|Overall Study|Adverse Event|2|||
155365063|NCT00968526|560770906|FG001|Overall Study|Adverse Event|0|||
155365064|NCT00968526|560770905|FG000|Overall Study|Migrated/moved from study area|1|||
155365065|NCT00968526|560770906|FG001|Overall Study|Migrated/moved from study area|0|||
155365066|NCT02030002|560770910|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
155365067|NCT02030002|560770910|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
155365068|NCT02030002|560770910|FG000|Follow-up|Lost to Follow-up|2|||
155365069|NCT01327612|560770911|FG000|Overall Study|Withdrawal by Subject|0|||
155365070|NCT01327612|560770912|FG001|Overall Study|Withdrawal by Subject|0|||
155365071|NCT01327612|560770913|FG002|Overall Study|Withdrawal by Subject|0|||
155365072|NCT01327612|560770914|FG003|Overall Study|Withdrawal by Subject|0|||
155365073|NCT01327612|560770915|FG004|Overall Study|Withdrawal by Subject|0|||
155365074|NCT01327612|560770916|FG005|Overall Study|Withdrawal by Subject|1|||
155365075|NCT01327612|560770917|FG006|Overall Study|Withdrawal by Subject|0|||
155365076|NCT01327612|560770911|FG000|Overall Study|Disease Progression|1|||
155365077|NCT01327612|560770912|FG001|Overall Study|Disease Progression|1|||
155365078|NCT01327612|560770913|FG002|Overall Study|Disease Progression|1|||
155365079|NCT01327612|560770914|FG003|Overall Study|Disease Progression|0|||
155365080|NCT01327612|560770915|FG004|Overall Study|Disease Progression|1|||
155365081|NCT01327612|560770916|FG005|Overall Study|Disease Progression|2|||
155365082|NCT01327612|560770917|FG006|Overall Study|Disease Progression|2|||
155365083|NCT01327612|560770911|FG000|Overall Study|Administrative Decision|0|||
155365084|NCT01327612|560770912|FG001|Overall Study|Administrative Decision|0|||
155365085|NCT01327612|560770913|FG002|Overall Study|Administrative Decision|0|||
155365086|NCT01327612|560770914|FG003|Overall Study|Administrative Decision|1|||
155365087|NCT01327612|560770915|FG004|Overall Study|Administrative Decision|0|||
155365088|NCT01327612|560770916|FG005|Overall Study|Administrative Decision|0|||
155365089|NCT01327612|560770917|FG006|Overall Study|Administrative Decision|0|||
155365090|NCT01327612|560770911|FG000|Overall Study|Death|0|||
155365091|NCT01327612|560770912|FG001|Overall Study|Death|0|||
155365092|NCT01327612|560770913|FG002|Overall Study|Death|0|||
155365093|NCT01327612|560770914|FG003|Overall Study|Death|0|||
155365094|NCT01327612|560770915|FG004|Overall Study|Death|1|||
155365095|NCT01327612|560770916|FG005|Overall Study|Death|0|||
155365096|NCT01327612|560770917|FG006|Overall Study|Death|0|||
155365097|NCT01294397|560770918|FG000|Overall Study|Withdrawal by Subject|1|||
155365098|NCT01294397|560770918|FG000|Overall Study|Administrative Decision|1|||
155365099|NCT05569421|560770919|FG000|Overall Study|Withdrawal by Subject|1|||
155365100|NCT05569421|560770920|FG001|Overall Study|Withdrawal by Subject|0|||
155365101|NCT05569421|560770921|FG002|Overall Study|Withdrawal by Subject|0|||
155428042|NCT02561156|560993377|FG009|Part 2|Adverse Event|0|||
155428043|NCT02561156|560993378|FG010|Part 2|Adverse Event|0|||
155428044|NCT02561156|560993379|FG011|Part 2|Adverse Event|1|||
155428045|NCT02561156|560993380|FG012|Part 2|Adverse Event|0|||
155428046|NCT01071070|560993384|FG000|Overall Study|Adverse Event|0|||
155365102|NCT02406248|560770922|FG000|Overall Study|Death|7|||
155365103|NCT02406248|560770922|FG000|Overall Study|Withdrawal by Subject|2|||
155365104|NCT03812029|560770925|FG000|Overall Study|Protocol Violation|1|||
155365105|NCT03812029|560770926|FG001|Overall Study|Protocol Violation|0|||
155365106|NCT03812029|560770927|FG002|Overall Study|Protocol Violation|0|||
155365107|NCT03812029|560770928|FG003|Overall Study|Protocol Violation|1|||
155365108|NCT03812029|560770929|FG004|Overall Study|Protocol Violation|0|||
155365109|NCT03812029|560770925|FG000|Overall Study|Withdrawal by Subject|1|||
155365110|NCT03812029|560770926|FG001|Overall Study|Withdrawal by Subject|0|||
155428047|NCT01071070|560993385|FG001|Overall Study|Adverse Event|3|||
155365111|NCT03812029|560770927|FG002|Overall Study|Withdrawal by Subject|0|||
155508134|NCT01393990|561286761|FG011|Overall Study|Withdrawal by Subject|0|||
155508135|NCT01393990|561286762|FG012|Overall Study|Withdrawal by Subject|0|||
155365112|NCT03812029|560770928|FG003|Overall Study|Withdrawal by Subject|2|||
155365113|NCT03812029|560770929|FG004|Overall Study|Withdrawal by Subject|2|||
155365114|NCT03812029|560770925|FG000|Overall Study|Stopping rules|0|||
155365115|NCT03812029|560770926|FG001|Overall Study|Stopping rules|1|||
155365116|NCT03812029|560770927|FG002|Overall Study|Stopping rules|0|||
155365117|NCT03812029|560770928|FG003|Overall Study|Stopping rules|0|||
155365118|NCT03812029|560770929|FG004|Overall Study|Stopping rules|0|||
155365119|NCT03812029|560770925|FG000|Overall Study|Adverse Event|0|||
155365120|NCT03812029|560770926|FG001|Overall Study|Adverse Event|9|||
155365121|NCT03812029|560770927|FG002|Overall Study|Adverse Event|0|||
155365122|NCT03812029|560770928|FG003|Overall Study|Adverse Event|3|||
155365123|NCT03812029|560770929|FG004|Overall Study|Adverse Event|5|||
155508136|NCT01393990|561286763|FG013|Overall Study|Withdrawal by Subject|0|||
155508137|NCT01393990|561286764|FG014|Overall Study|Withdrawal by Subject|1|||
155365124|NCT03812029|560770925|FG000|Overall Study|Lost to Follow-up|0|||
155428048|NCT01071070|560993384|FG000|Overall Study|Withdrawal by Subject|1|||
155428049|NCT01071070|560993385|FG001|Overall Study|Withdrawal by Subject|0|||
155428050|NCT01071070|560993384|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
155508138|NCT01393990|561286765|FG015|Overall Study|Withdrawal by Subject|1|||
155428051|NCT01071070|560993385|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
155428052|NCT01071070|560993384|FG000|Overall Study|Hypercalcemia|1|||
155428053|NCT01071070|560993385|FG001|Overall Study|Hypercalcemia|0|||
155428054|NCT02207907|560993386|FG000|Overall Study|Lost to Follow-up|3|||
155428055|NCT02207907|560993387|FG001|Overall Study|Lost to Follow-up|1|||
155428056|NCT02207907|560993386|FG000|Overall Study|Withdrawal by Subject|5|||
155428057|NCT02207907|560993387|FG001|Overall Study|Withdrawal by Subject|6|||
155428058|NCT02207907|560993386|FG000|Overall Study|Did not meet study criteria|3|||
155428059|NCT02207907|560993387|FG001|Overall Study|Did not meet study criteria|0|||
155428060|NCT02207907|560993386|FG000|Overall Study|Pregnancy|0|||
155428061|NCT02207907|560993387|FG001|Overall Study|Pregnancy|1|||
155428062|NCT03545282|560993392|FG000|Overall Study|Lost to Follow-up|15|||
155428063|NCT03545282|560993393|FG001|Overall Study|Lost to Follow-up|10|||
155428064|NCT03545282|560993392|FG000|Overall Study|Withdrawal by Subject|2|||
155428065|NCT03545282|560993393|FG001|Overall Study|Withdrawal by Subject|2|||
155428066|NCT00755079|560993394|FG000|Overall Study|Lost to Follow-up|1|||
155428067|NCT00755079|560993395|FG001|Overall Study|Lost to Follow-up|3|||
155428068|NCT00755079|560993394|FG000|Overall Study|Adverse Event|0|||
155428069|NCT00755079|560993395|FG001|Overall Study|Adverse Event|1|||
155365125|NCT03812029|560770926|FG001|Overall Study|Lost to Follow-up|0|||
155428070|NCT00755079|560993394|FG000|Overall Study|Withdrawal by Subject|0|||
155428071|NCT00755079|560993395|FG001|Overall Study|Withdrawal by Subject|2|||
155428072|NCT02209506|560993396|FG000|Overall Study|Withdrawal by Subject|0|||
155508139|NCT01393990|561286766|FG016|Overall Study|Withdrawal by Subject|0|||
155365126|NCT03812029|560770927|FG002|Overall Study|Lost to Follow-up|0|||
155365127|NCT03812029|560770928|FG003|Overall Study|Lost to Follow-up|0|||
155365128|NCT03812029|560770929|FG004|Overall Study|Lost to Follow-up|3|||
155365129|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
155365130|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
155508140|NCT01393990|561286767|FG017|Overall Study|Withdrawal by Subject|0|||
155508141|NCT00720798|561286775|FG000|Overall Study|Adverse Event|304|||
155508142|NCT00720798|561286775|FG000|Overall Study|Death|39|||
155508143|NCT00720798|561286775|FG000|Overall Study|Insufficient Therapeutic Response|129|||
155365131|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
155365132|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
155365133|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
155508144|NCT00720798|561286775|FG000|Overall Study|Protocol Violation|4|||
155508145|NCT00720798|561286775|FG000|Overall Study|Refused Treatment|151|||
155508146|NCT00720798|561286775|FG000|Overall Study|Failure to Return|46|||
155508147|NCT00720798|561286775|FG000|Overall Study|Reason not Specified|83|||
155508148|NCT02806232|561286778|FG000|Overall Study|Lost to Follow-up|1|||
155508149|NCT02806232|561286779|FG001|Overall Study|Lost to Follow-up|2|||
155508150|NCT02806232|561286780|FG002|Overall Study|Lost to Follow-up|1|||
155508151|NCT02806232|561286781|FG003|Overall Study|Lost to Follow-up|0|||
155508152|NCT02806232|561286782|FG004|Overall Study|Lost to Follow-up|0|||
155508153|NCT02806232|561286783|FG005|Overall Study|Lost to Follow-up|1|||
155508154|NCT02806232|561286784|FG006|Overall Study|Lost to Follow-up|0|||
155508155|NCT02806232|561286785|FG007|Overall Study|Lost to Follow-up|0|||
155508156|NCT02806232|561286786|FG008|Overall Study|Lost to Follow-up|0|||
155508157|NCT02806232|561286778|FG000|Overall Study|Withdrawal by Subject|0|||
155508158|NCT02806232|561286779|FG001|Overall Study|Withdrawal by Subject|2|||
155508159|NCT02806232|561286780|FG002|Overall Study|Withdrawal by Subject|0|||
155508160|NCT02806232|561286781|FG003|Overall Study|Withdrawal by Subject|0|||
155508161|NCT02806232|561286782|FG004|Overall Study|Withdrawal by Subject|2|||
155508162|NCT02806232|561286783|FG005|Overall Study|Withdrawal by Subject|1|||
155508163|NCT02806232|561286784|FG006|Overall Study|Withdrawal by Subject|0|||
155365134|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155508164|NCT02806232|561286785|FG007|Overall Study|Withdrawal by Subject|0|||
155508165|NCT02806232|561286786|FG008|Overall Study|Withdrawal by Subject|0|||
155508166|NCT00434161|561286789|FG000|Overall Study|Adverse Event|5|||
155508167|NCT00434161|561286790|FG001|Overall Study|Adverse Event|1|||
155508168|NCT00434161|561286791|FG002|Overall Study|Adverse Event|4|||
155508169|NCT00434161|561286789|FG000|Overall Study|Lost to Follow-up|0|||
155508170|NCT00434161|561286790|FG001|Overall Study|Lost to Follow-up|1|||
155508171|NCT00434161|561286791|FG002|Overall Study|Lost to Follow-up|0|||
155508172|NCT00434161|561286789|FG000|Overall Study|Death|1|||
155508173|NCT00434161|561286790|FG001|Overall Study|Death|0|||
155508174|NCT00434161|561286791|FG002|Overall Study|Death|1|||
155508175|NCT00434161|561286789|FG000|Overall Study|Non-Compliance|1|||
155508176|NCT00434161|561286790|FG001|Overall Study|Non-Compliance|1|||
155365135|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155365136|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155365137|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
155365138|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
155365139|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
155365140|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
155365141|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
155365142|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
155508177|NCT00434161|561286791|FG002|Overall Study|Non-Compliance|0|||
155508178|NCT00434161|561286789|FG000|Overall Study|Withdrawal by Subject|2|||
155508179|NCT00434161|561286790|FG001|Overall Study|Withdrawal by Subject|0|||
155508180|NCT00434161|561286791|FG002|Overall Study|Withdrawal by Subject|3|||
155508181|NCT00434161|561286789|FG000|Overall Study|Logistical error study assessments|1|||
155508182|NCT00434161|561286790|FG001|Overall Study|Logistical error study assessments|0|||
155508183|NCT00434161|561286791|FG002|Overall Study|Logistical error study assessments|3|||
155508184|NCT01312779|561286792|FG000|Overall Study|Withdrawal by Subject|2|||
155508185|NCT01312779|561286792|FG000|Overall Study|Death|3|||
155508186|NCT01312779|561286792|FG000|Overall Study|Not Implanted with Device|27|||
155508187|NCT00506753|561286793|FG000|Overall Study|Lost to Follow-up|21|||
155508188|NCT00506753|561286794|FG001|Overall Study|Lost to Follow-up|15|||
155508189|NCT01706198|561286795|FG000|Overall Study|Adverse Event|12|||
155508190|NCT01706198|561286796|FG001|Overall Study|Adverse Event|15|||
155508191|NCT01706198|561286795|FG000|Overall Study|Protocol Violation|7|||
155508192|NCT01706198|561286796|FG001|Overall Study|Protocol Violation|5|||
155508193|NCT01706198|561286795|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
155508194|NCT01706198|561286796|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
155365143|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
155365144|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
155365145|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
155365146|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
155365147|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
155365148|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
155365149|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
155365150|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
155365151|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
155365152|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
155365153|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
155365154|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
155365155|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
155365156|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
155365157|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
155365158|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
155365159|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
155365160|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
155365161|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
155365162|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
155365163|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
155365164|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
155365165|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365166|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
155365167|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365168|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365169|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
155365170|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
155365171|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
155365172|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
155365173|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
155365174|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
155365175|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
155365176|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
155365177|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365178|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365179|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
155365180|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365181|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365182|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365183|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
155365184|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365185|NCT03106753|560770934|FG000|Overall Study|Withdrawal by Subject|0|||
155365186|NCT03106753|560770935|FG001|Overall Study|Withdrawal by Subject|1|||
155365187|NCT03149042|560770937|FG000|Overall Study|Invasive FFR not performed|21|||
155365188|NCT03149042|560770937|FG000|Overall Study|Poor CT Image Quality|1|||
155365189|NCT03149042|560770937|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
155365190|NCT01643044|560770938|FG000|Overall Study|Lost to Follow-up|1|||
155508195|NCT01706198|561286795|FG000|Overall Study|Lost to Follow-up|97|||
155508196|NCT01706198|561286796|FG001|Overall Study|Lost to Follow-up|93|||
155508197|NCT01706198|561286795|FG000|Overall Study|Physician Decision|23|||
155508198|NCT01706198|561286796|FG001|Overall Study|Physician Decision|37|||
155365191|NCT01643044|560770939|FG001|Overall Study|Lost to Follow-up|1|||
155365192|NCT01643044|560770938|FG000|Overall Study|Miscarried baby|2|||
155365193|NCT01643044|560770939|FG001|Overall Study|Miscarried baby|2|||
155365194|NCT01643044|560770938|FG000|Overall Study|Delivered outside of hospital|1|||
155365195|NCT01643044|560770939|FG001|Overall Study|Delivered outside of hospital|2|||
155365196|NCT01023958|560770946|FG000|Overall Study|Progressive disease|48|||
155365197|NCT01023958|560770946|FG000|Overall Study|Other adverse event|1|||
155365198|NCT01023958|560770946|FG000|Overall Study|Refused to continue medication|1|||
155365199|NCT00790205|560770950|FG000|Overall Study|Lost to Follow-up|61|||
155365200|NCT00790205|560770951|FG001|Overall Study|Lost to Follow-up|71|||
155365201|NCT00790205|560770950|FG000|Overall Study|Withdrawal by Subject|299|||
155365202|NCT00790205|560770951|FG001|Overall Study|Withdrawal by Subject|363|||
155365203|NCT03933462|560770952|FG000|Overall Study|Adverse Event|2|||
155508199|NCT01706198|561286795|FG000|Overall Study|Withdrawal by Subject|23|||
155365204|NCT03933462|560770953|FG001|Overall Study|Adverse Event|0|||
155365205|NCT04805073|560770960|FG000|Overall Study|study personnel not available|2|||
155365206|NCT04805073|560770961|FG001|Overall Study|study personnel not available|0|||
155365207|NCT04805073|560770960|FG000|Overall Study|spinal anesthesia failure|0|||
155365208|NCT04805073|560770961|FG001|Overall Study|spinal anesthesia failure|1|||
155365209|NCT04805073|560770960|FG000|Overall Study|Lost to Follow-up|0|||
155365210|NCT04805073|560770961|FG001|Overall Study|Lost to Follow-up|2|||
155365211|NCT02975102|560770963|FG000|Overall Study|Adverse Event|2|||
155365212|NCT02975102|560770964|FG001|Overall Study|Adverse Event|1|||
155365213|NCT02609672|560770965|FG000|Overall Study|Lost to Follow-up|3|||
155365214|NCT02609672|560770966|FG001|Overall Study|Lost to Follow-up|1|||
155365215|NCT01441635|560770967|FG000|Overall Study|Adverse Event|4|||
155365216|NCT01441635|560770968|FG001|Overall Study|Adverse Event|3|||
155365217|NCT01441635|560770969|FG002|Overall Study|Adverse Event|1|||
155365218|NCT01441635|560770970|FG003|Overall Study|Adverse Event|5|||
155365219|NCT01441635|560770971|FG004|Overall Study|Adverse Event|1|||
155365220|NCT01441635|560770972|FG005|Overall Study|Adverse Event|2|||
155365221|NCT01441635|560770973|FG006|Overall Study|Adverse Event|2|||
155365222|NCT01441635|560770974|FG007|Overall Study|Adverse Event|2|||
155365223|NCT01441635|560770975|FG008|Overall Study|Adverse Event|1|||
155365224|NCT01441635|560770976|FG009|Overall Study|Adverse Event|0|||
155365225|NCT01441635|560770967|FG000|Overall Study|Withdrawal by Subject|1|||
155365226|NCT01441635|560770968|FG001|Overall Study|Withdrawal by Subject|1|||
155365227|NCT01441635|560770969|FG002|Overall Study|Withdrawal by Subject|0|||
155365228|NCT01441635|560770970|FG003|Overall Study|Withdrawal by Subject|1|||
155365229|NCT01441635|560770971|FG004|Overall Study|Withdrawal by Subject|0|||
155365230|NCT01441635|560770972|FG005|Overall Study|Withdrawal by Subject|0|||
155365231|NCT01441635|560770973|FG006|Overall Study|Withdrawal by Subject|2|||
155365232|NCT01441635|560770974|FG007|Overall Study|Withdrawal by Subject|0|||
155365233|NCT01441635|560770975|FG008|Overall Study|Withdrawal by Subject|1|||
155365234|NCT01441635|560770976|FG009|Overall Study|Withdrawal by Subject|1|||
155365235|NCT01441635|560770967|FG000|Overall Study|Lost to Follow-up|0|||
155365236|NCT01441635|560770968|FG001|Overall Study|Lost to Follow-up|1|||
155365237|NCT01441635|560770969|FG002|Overall Study|Lost to Follow-up|1|||
155365238|NCT01441635|560770970|FG003|Overall Study|Lost to Follow-up|1|||
155365239|NCT01441635|560770971|FG004|Overall Study|Lost to Follow-up|1|||
155365240|NCT01441635|560770972|FG005|Overall Study|Lost to Follow-up|3|||
155365241|NCT01441635|560770973|FG006|Overall Study|Lost to Follow-up|1|||
155365242|NCT01441635|560770974|FG007|Overall Study|Lost to Follow-up|1|||
155365243|NCT01441635|560770975|FG008|Overall Study|Lost to Follow-up|0|||
155365244|NCT01441635|560770976|FG009|Overall Study|Lost to Follow-up|1|||
155508200|NCT01706198|561286796|FG001|Overall Study|Withdrawal by Subject|31|||
155508201|NCT02480010|561286801|FG000|Overall Study|Adverse Event|3|||
155508202|NCT02480010|561286802|FG001|Overall Study|Adverse Event|1|||
155365245|NCT01441635|560770967|FG000|Overall Study|Noncompliance|0|||
155365246|NCT01441635|560770968|FG001|Overall Study|Noncompliance|1|||
155365247|NCT01441635|560770969|FG002|Overall Study|Noncompliance|0|||
155428073|NCT02209506|560993397|FG001|Overall Study|Withdrawal by Subject|0|||
155508203|NCT02480010|561286801|FG000|Overall Study|Death|1|||
155508204|NCT02480010|561286802|FG001|Overall Study|Death|0|||
155508205|NCT02480010|561286801|FG000|Overall Study|Insufficient therapeutic response|31|||
155508206|NCT02480010|561286802|FG001|Overall Study|Insufficient therapeutic response|29|||
155508207|NCT02480010|561286801|FG000|Overall Study|Refused Treatment|0|||
155428074|NCT02209506|560993398|FG002|Overall Study|Withdrawal by Subject|0|||
155428075|NCT02209506|560993399|FG003|Overall Study|Withdrawal by Subject|0|||
155428076|NCT02209506|560993400|FG004|Overall Study|Withdrawal by Subject|1|||
155428077|NCT00629083|560993403|FG000|Overall Study|Adverse Event|0|||
155428078|NCT00629083|560993404|FG001|Overall Study|Adverse Event|2|||
155428079|NCT00629083|560993403|FG000|Overall Study|Lack of Efficacy|3|||
155428080|NCT00629083|560993404|FG001|Overall Study|Lack of Efficacy|1|||
155428081|NCT00629083|560993403|FG000|Overall Study|Withdrawal by Subject|10|||
155428082|NCT00629083|560993404|FG001|Overall Study|Withdrawal by Subject|2|||
155428083|NCT00629083|560993403|FG000|Overall Study|Lost to Follow-up|12|||
155428084|NCT00629083|560993404|FG001|Overall Study|Lost to Follow-up|8|||
155508208|NCT02480010|561286802|FG001|Overall Study|Refused Treatment|3|||
155508209|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
155365248|NCT01441635|560770970|FG003|Overall Study|Noncompliance|0|||
155365249|NCT01441635|560770971|FG004|Overall Study|Noncompliance|0|||
155365250|NCT01441635|560770972|FG005|Overall Study|Noncompliance|0|||
155365251|NCT01441635|560770973|FG006|Overall Study|Noncompliance|1|||
155365252|NCT01441635|560770974|FG007|Overall Study|Noncompliance|0|||
155365253|NCT01441635|560770975|FG008|Overall Study|Noncompliance|0|||
155365254|NCT01441635|560770976|FG009|Overall Study|Noncompliance|0|||
155365255|NCT01441635|560770967|FG000|Overall Study|Surgery or Invasive Intervention|0|||
155365256|NCT01441635|560770968|FG001|Overall Study|Surgery or Invasive Intervention|0|||
155365257|NCT01441635|560770969|FG002|Overall Study|Surgery or Invasive Intervention|1|||
155428085|NCT00629083|560993403|FG000|Overall Study|Moved out of country/state|2|||
155428086|NCT00629083|560993404|FG001|Overall Study|Moved out of country/state|1|||
155508210|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155508211|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155508212|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155365258|NCT01441635|560770970|FG003|Overall Study|Surgery or Invasive Intervention|0|||
155365259|NCT01441635|560770971|FG004|Overall Study|Surgery or Invasive Intervention|0|||
155365260|NCT01441635|560770972|FG005|Overall Study|Surgery or Invasive Intervention|0|||
155365261|NCT01441635|560770973|FG006|Overall Study|Surgery or Invasive Intervention|0|||
155365262|NCT01441635|560770974|FG007|Overall Study|Surgery or Invasive Intervention|0|||
155365263|NCT01441635|560770975|FG008|Overall Study|Surgery or Invasive Intervention|0|||
155365264|NCT01441635|560770976|FG009|Overall Study|Surgery or Invasive Intervention|0|||
155365265|NCT01441635|560770967|FG000|Overall Study|Received Exclusionary Medication|1|||
155365266|NCT01441635|560770968|FG001|Overall Study|Received Exclusionary Medication|0|||
155365267|NCT01441635|560770969|FG002|Overall Study|Received Exclusionary Medication|0|||
155365268|NCT01441635|560770970|FG003|Overall Study|Received Exclusionary Medication|0|||
155365269|NCT01441635|560770971|FG004|Overall Study|Received Exclusionary Medication|0|||
155365270|NCT01441635|560770972|FG005|Overall Study|Received Exclusionary Medication|0|||
155365271|NCT01441635|560770973|FG006|Overall Study|Received Exclusionary Medication|0|||
155365272|NCT01441635|560770974|FG007|Overall Study|Received Exclusionary Medication|0|||
155365273|NCT01441635|560770975|FG008|Overall Study|Received Exclusionary Medication|0|||
155365274|NCT01441635|560770976|FG009|Overall Study|Received Exclusionary Medication|0|||
155365275|NCT01441635|560770967|FG000|Overall Study|Other|0|||
155365276|NCT01441635|560770968|FG001|Overall Study|Other|0|||
155365277|NCT01441635|560770969|FG002|Overall Study|Other|0|||
155365278|NCT01441635|560770970|FG003|Overall Study|Other|0|||
155365279|NCT01441635|560770971|FG004|Overall Study|Other|0|||
155365280|NCT01441635|560770972|FG005|Overall Study|Other|0|||
155365281|NCT01441635|560770973|FG006|Overall Study|Other|0|||
155365282|NCT01441635|560770974|FG007|Overall Study|Other|1|||
155365283|NCT01441635|560770975|FG008|Overall Study|Other|0|||
155365284|NCT01441635|560770976|FG009|Overall Study|Other|0|||
155365285|NCT01912404|560770977|FG000|Overall Study|Due to personal reasons|1|||
155365286|NCT01912404|560770978|FG001|Overall Study|Due to personal reasons|0|||
155365287|NCT02269423|560770985|FG000|Overall Study|Discontinued due to change in residence|0|||
155365288|NCT02269423|560770986|FG001|Overall Study|Discontinued due to change in residence|1|||
155365289|NCT02269423|560770987|FG002|Overall Study|Discontinued due to change in residence|0|||
155365290|NCT02269423|560770988|FG003|Overall Study|Discontinued due to change in residence|1|||
155365291|NCT01430468|560770989|FG000|Overall Study|Physician Decision|2|||
155365292|NCT01430468|560770990|FG001|Overall Study|Physician Decision|1|||
155365293|NCT01430468|560770989|FG000|Overall Study|Withdrawal by Subject|5|||
155365294|NCT01430468|560770990|FG001|Overall Study|Withdrawal by Subject|5|||
155365295|NCT01281839|560770991|FG000|Overall Study|Lost to Follow-up|6|||
155365296|NCT01281839|560770992|FG001|Overall Study|Lost to Follow-up|3|||
155365297|NCT01281839|560770991|FG000|Overall Study|Withdrawal by Subject|4|||
155365298|NCT01281839|560770992|FG001|Overall Study|Withdrawal by Subject|10|||
155365299|NCT01281839|560770991|FG000|Overall Study|Reason not specified|0|||
155365300|NCT01281839|560770992|FG001|Overall Study|Reason not specified|1|||
155365301|NCT01305239|560770993|FG000|Overall Study|Adverse Event|22|||
155365302|NCT01305239|560770993|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
155365303|NCT01754753|560770996|FG000|Overall Study|Study close|43|||
155365304|NCT01754753|560770997|FG001|Overall Study|Study close|44|||
155365305|NCT01754753|560770996|FG000|Overall Study|Lost to Follow-up|9|||
155365306|NCT01754753|560770997|FG001|Overall Study|Lost to Follow-up|5|||
155428087|NCT00629083|560993403|FG000|Overall Study|Refused to return for 12 month visit|1|||
155428088|NCT00629083|560993404|FG001|Overall Study|Refused to return for 12 month visit|0|||
155428089|NCT00805207|560993405|FG000|Overall Study|Protocol Violation|0|||
155428090|NCT00805207|560993406|FG001|Overall Study|Protocol Violation|0|||
155428091|NCT00805207|560993407|FG002|Overall Study|Protocol Violation|1|||
155508213|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155508214|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155508215|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
155365307|NCT03229486|560770998|FG000|Overall Study|Protocol Violation|0|||
155365308|NCT03229486|560770999|FG001|Overall Study|Protocol Violation|1|||
155365309|NCT00856245|560771000|FG000|Overall Study|Was not transplanted|5|||
155428092|NCT00805207|560993408|FG003|Overall Study|Protocol Violation|0|||
155428093|NCT00805207|560993409|FG004|Overall Study|Protocol Violation|0|||
155649289|NCT03931785|561808200|FG002|Overall Study|Protocol Violation|0|||
155365310|NCT01443923|560771001|FG000|Overall Study|Adverse Event|1|||
155365311|NCT01443923|560771002|FG001|Overall Study|Adverse Event|0|||
155365312|NCT00243074|560771006|FG000|Overall Study|Ineligible|6|||
155365313|NCT00243074|560771006|FG000|Overall Study|Adverse Event|6|||
155365314|NCT00243074|560771006|FG000|Overall Study|Withdrawal by Subject|2|||
155365315|NCT00243074|560771006|FG000|Overall Study|Lack of Efficacy|36|||
155365316|NCT00243074|560771006|FG000|Overall Study|Death|2|||
155365317|NCT00243074|560771006|FG000|Overall Study|not protocol specified|1|||
155428094|NCT00805207|560993410|FG005|Overall Study|Protocol Violation|0|||
155508216|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
155508217|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155508218|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155428095|NCT00805207|560993411|FG006|Overall Study|Protocol Violation|0|||
155428096|NCT00805207|560993412|FG007|Overall Study|Protocol Violation|0|||
155428097|NCT00805207|560993413|FG008|Overall Study|Protocol Violation|0|||
155428098|NCT00805207|560993405|FG000|Overall Study|Physician Decision|0|||
155428099|NCT00805207|560993406|FG001|Overall Study|Physician Decision|1|||
155428100|NCT00805207|560993407|FG002|Overall Study|Physician Decision|0|||
155428101|NCT00805207|560993408|FG003|Overall Study|Physician Decision|0|||
155428102|NCT00805207|560993409|FG004|Overall Study|Physician Decision|0|||
155428103|NCT00805207|560993410|FG005|Overall Study|Physician Decision|1|||
155428104|NCT00805207|560993411|FG006|Overall Study|Physician Decision|0|||
155428105|NCT00805207|560993412|FG007|Overall Study|Physician Decision|0|||
155428106|NCT00805207|560993413|FG008|Overall Study|Physician Decision|0|||
155428107|NCT00805207|560993405|FG000|Overall Study|Withdrawal by Subject|0|||
155428108|NCT00805207|560993406|FG001|Overall Study|Withdrawal by Subject|1|||
155428109|NCT00805207|560993407|FG002|Overall Study|Withdrawal by Subject|0|||
155428110|NCT00805207|560993408|FG003|Overall Study|Withdrawal by Subject|0|||
155428111|NCT00805207|560993409|FG004|Overall Study|Withdrawal by Subject|1|||
155428112|NCT00805207|560993410|FG005|Overall Study|Withdrawal by Subject|2|||
155428113|NCT00805207|560993411|FG006|Overall Study|Withdrawal by Subject|0|||
155508219|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155508220|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155508221|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155508222|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
155508223|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
155508224|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
155508225|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
155508226|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
155365318|NCT00243074|560771006|FG000|Overall Study|Did not receive any treatment|1|||
155365319|NCT00344032|560771007|FG000|Overall Study|Adverse Event|0|||
155365320|NCT00344032|560771008|FG001|Overall Study|Adverse Event|1|||
155365321|NCT00344032|560771007|FG000|Overall Study|Withdrawal by Subject|6|||
155365322|NCT00344032|560771008|FG001|Overall Study|Withdrawal by Subject|2|||
155365323|NCT00344032|560771007|FG000|Overall Study|Lost to Follow-up|4|||
155365324|NCT00344032|560771008|FG001|Overall Study|Lost to Follow-up|6|||
155365325|NCT00344032|560771007|FG000|Overall Study|Physician Decision|4|||
155365326|NCT00344032|560771008|FG001|Overall Study|Physician Decision|1|||
155365327|NCT05131477|560771011|FG000|PART 1|Withdrawal by Subject|2|||
155365328|NCT05131477|560771012|FG001|PART 1|Withdrawal by Subject|9|||
155365329|NCT05131477|560771013|FG002|PART 1|Withdrawal by Subject|6|||
155365330|NCT05131477|560771014|FG003|PART 1|Withdrawal by Subject|2|||
155365331|NCT05131477|560771015|FG004|PART 1|Withdrawal by Subject|8|||
155365332|NCT05131477|560771016|FG005|PART 1|Withdrawal by Subject|0|||
155365333|NCT05131477|560771017|FG006|PART 1|Withdrawal by Subject|0|||
155365334|NCT05131477|560771018|FG007|PART 1|Withdrawal by Subject|0|||
155365335|NCT05131477|560771019|FG008|PART 1|Withdrawal by Subject|0|||
155365336|NCT05131477|560771020|FG009|PART 1|Withdrawal by Subject|0|||
155365337|NCT05131477|560771021|FG010|PART 1|Withdrawal by Subject|0|||
155365338|NCT05131477|560771022|FG011|PART 1|Withdrawal by Subject|0|||
155365339|NCT05131477|560771023|FG012|PART 1|Withdrawal by Subject|0|||
155365340|NCT05131477|560771024|FG013|PART 1|Withdrawal by Subject|0|||
155365341|NCT05131477|560771011|FG000|PART 1|Physician Decision|1|||
155365342|NCT05131477|560771012|FG001|PART 1|Physician Decision|0|||
155365343|NCT05131477|560771013|FG002|PART 1|Physician Decision|0|||
155428114|NCT00805207|560993412|FG007|Overall Study|Withdrawal by Subject|0|||
155508227|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
155508228|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
155508229|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
155508230|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
155365344|NCT05131477|560771014|FG003|PART 1|Physician Decision|0|||
155428115|NCT00805207|560993413|FG008|Overall Study|Withdrawal by Subject|0|||
155428116|NCT00064701|560993414|FG000|One Year Post-transplant|Did not receive study drug|7|||
155428117|NCT00064701|560993415|FG001|One Year Post-transplant|Did not receive study drug|12|||
155365345|NCT05131477|560771015|FG004|PART 1|Physician Decision|0|||
155365346|NCT05131477|560771016|FG005|PART 1|Physician Decision|0|||
155365347|NCT05131477|560771017|FG006|PART 1|Physician Decision|0|||
155365348|NCT05131477|560771018|FG007|PART 1|Physician Decision|0|||
155428118|NCT00064701|560993416|FG002|One Year Post-transplant|Did not receive study drug|11|||
155428119|NCT00064701|560993414|FG000|One Year Post-transplant|Adverse Event|23|||
155428120|NCT00064701|560993415|FG001|One Year Post-transplant|Adverse Event|19|||
155428121|NCT00064701|560993416|FG002|One Year Post-transplant|Adverse Event|37|||
155365349|NCT05131477|560771019|FG008|PART 1|Physician Decision|0|||
155365350|NCT05131477|560771020|FG009|PART 1|Physician Decision|0|||
155428122|NCT00064701|560993414|FG000|One Year Post-transplant|Rejection|0|||
155365351|NCT05131477|560771021|FG010|PART 1|Physician Decision|0|||
155365352|NCT05131477|560771022|FG011|PART 1|Physician Decision|0|||
155365353|NCT05131477|560771023|FG012|PART 1|Physician Decision|0|||
155365354|NCT05131477|560771024|FG013|PART 1|Physician Decision|0|||
155365355|NCT05131477|560771011|FG000|PART 1|Adverse Event|3|||
155365356|NCT05131477|560771012|FG001|PART 1|Adverse Event|5|||
155365357|NCT05131477|560771013|FG002|PART 1|Adverse Event|1|||
155365358|NCT05131477|560771014|FG003|PART 1|Adverse Event|6|||
155365359|NCT05131477|560771015|FG004|PART 1|Adverse Event|4|||
155365360|NCT05131477|560771016|FG005|PART 1|Adverse Event|0|||
155365361|NCT05131477|560771017|FG006|PART 1|Adverse Event|0|||
155365362|NCT05131477|560771018|FG007|PART 1|Adverse Event|0|||
155365363|NCT05131477|560771019|FG008|PART 1|Adverse Event|0|||
155365364|NCT05131477|560771020|FG009|PART 1|Adverse Event|0|||
155365365|NCT05131477|560771021|FG010|PART 1|Adverse Event|0|||
155365366|NCT05131477|560771022|FG011|PART 1|Adverse Event|0|||
155365367|NCT05131477|560771023|FG012|PART 1|Adverse Event|0|||
155365368|NCT05131477|560771024|FG013|PART 1|Adverse Event|0|||
155365369|NCT05131477|560771011|FG000|PART 1|unclassified|1|||
155365370|NCT05131477|560771012|FG001|PART 1|unclassified|1|||
155365371|NCT05131477|560771013|FG002|PART 1|unclassified|0|||
155365372|NCT05131477|560771014|FG003|PART 1|unclassified|0|||
155365373|NCT05131477|560771015|FG004|PART 1|unclassified|4|||
155365374|NCT05131477|560771016|FG005|PART 1|unclassified|0|||
155365375|NCT05131477|560771017|FG006|PART 1|unclassified|0|||
155365376|NCT05131477|560771018|FG007|PART 1|unclassified|0|||
155365377|NCT05131477|560771019|FG008|PART 1|unclassified|0|||
155365378|NCT05131477|560771020|FG009|PART 1|unclassified|0|||
155365379|NCT05131477|560771021|FG010|PART 1|unclassified|0|||
155365380|NCT05131477|560771022|FG011|PART 1|unclassified|0|||
155365381|NCT05131477|560771023|FG012|PART 1|unclassified|0|||
155365382|NCT05131477|560771024|FG013|PART 1|unclassified|0|||
155365383|NCT05131477|560771011|FG000|PART 1|Randomized and not treated|0|||
155365384|NCT05131477|560771012|FG001|PART 1|Randomized and not treated|0|||
155365385|NCT05131477|560771013|FG002|PART 1|Randomized and not treated|0|||
155365386|NCT05131477|560771014|FG003|PART 1|Randomized and not treated|1|||
155365387|NCT05131477|560771015|FG004|PART 1|Randomized and not treated|1|||
155365388|NCT05131477|560771016|FG005|PART 1|Randomized and not treated|0|||
155365389|NCT05131477|560771017|FG006|PART 1|Randomized and not treated|0|||
155365390|NCT05131477|560771018|FG007|PART 1|Randomized and not treated|0|||
155365391|NCT05131477|560771019|FG008|PART 1|Randomized and not treated|0|||
155365392|NCT05131477|560771020|FG009|PART 1|Randomized and not treated|0|||
155365393|NCT05131477|560771021|FG010|PART 1|Randomized and not treated|0|||
155365394|NCT05131477|560771022|FG011|PART 1|Randomized and not treated|0|||
155365395|NCT05131477|560771023|FG012|PART 1|Randomized and not treated|0|||
155365396|NCT05131477|560771024|FG013|PART 1|Randomized and not treated|0|||
155365397|NCT05131477|560771011|FG000|PART 1|Protocol Violation|2|||
155365398|NCT05131477|560771012|FG001|PART 1|Protocol Violation|0|||
155365399|NCT05131477|560771013|FG002|PART 1|Protocol Violation|0|||
155365400|NCT05131477|560771014|FG003|PART 1|Protocol Violation|1|||
155365401|NCT05131477|560771015|FG004|PART 1|Protocol Violation|0|||
155365402|NCT05131477|560771016|FG005|PART 1|Protocol Violation|0|||
155365403|NCT05131477|560771017|FG006|PART 1|Protocol Violation|0|||
155365404|NCT05131477|560771018|FG007|PART 1|Protocol Violation|0|||
155365405|NCT05131477|560771019|FG008|PART 1|Protocol Violation|0|||
155365406|NCT05131477|560771020|FG009|PART 1|Protocol Violation|0|||
155365407|NCT05131477|560771021|FG010|PART 1|Protocol Violation|0|||
155365408|NCT05131477|560771022|FG011|PART 1|Protocol Violation|0|||
155365409|NCT05131477|560771023|FG012|PART 1|Protocol Violation|0|||
155365410|NCT05131477|560771024|FG013|PART 1|Protocol Violation|0|||
155365411|NCT05131477|560771011|FG000|PART 1|Lack of Efficacy|0|||
155365412|NCT05131477|560771012|FG001|PART 1|Lack of Efficacy|1|||
155365413|NCT05131477|560771013|FG002|PART 1|Lack of Efficacy|1|||
155365414|NCT05131477|560771014|FG003|PART 1|Lack of Efficacy|2|||
155365415|NCT05131477|560771015|FG004|PART 1|Lack of Efficacy|5|||
155365416|NCT05131477|560771016|FG005|PART 1|Lack of Efficacy|0|||
155365417|NCT05131477|560771017|FG006|PART 1|Lack of Efficacy|0|||
155365418|NCT05131477|560771018|FG007|PART 1|Lack of Efficacy|0|||
155365419|NCT05131477|560771019|FG008|PART 1|Lack of Efficacy|0|||
155365420|NCT05131477|560771020|FG009|PART 1|Lack of Efficacy|0|||
155365421|NCT05131477|560771021|FG010|PART 1|Lack of Efficacy|0|||
155365422|NCT05131477|560771022|FG011|PART 1|Lack of Efficacy|0|||
155365423|NCT05131477|560771023|FG012|PART 1|Lack of Efficacy|0|||
155365424|NCT05131477|560771024|FG013|PART 1|Lack of Efficacy|0|||
155365425|NCT05131477|560771011|FG000|PART 2|Withdrawal by Subject|0|||
155365426|NCT05131477|560771012|FG001|PART 2|Withdrawal by Subject|0|||
155365427|NCT05131477|560771013|FG002|PART 2|Withdrawal by Subject|0|||
155365428|NCT05131477|560771014|FG003|PART 2|Withdrawal by Subject|0|||
155365429|NCT05131477|560771015|FG004|PART 2|Withdrawal by Subject|0|||
155365430|NCT05131477|560771016|FG005|PART 2|Withdrawal by Subject|0|||
155365431|NCT05131477|560771017|FG006|PART 2|Withdrawal by Subject|2|||
155365432|NCT05131477|560771018|FG007|PART 2|Withdrawal by Subject|0|||
155365433|NCT05131477|560771019|FG008|PART 2|Withdrawal by Subject|0|||
155365434|NCT05131477|560771020|FG009|PART 2|Withdrawal by Subject|0|||
155365435|NCT05131477|560771021|FG010|PART 2|Withdrawal by Subject|2|||
155365436|NCT05131477|560771022|FG011|PART 2|Withdrawal by Subject|0|||
155365437|NCT05131477|560771023|FG012|PART 2|Withdrawal by Subject|2|||
155365438|NCT05131477|560771024|FG013|PART 2|Withdrawal by Subject|2|||
155365439|NCT05131477|560771011|FG000|PART 2|Other|0|||
155365440|NCT05131477|560771012|FG001|PART 2|Other|0|||
155365441|NCT05131477|560771013|FG002|PART 2|Other|0|||
155365442|NCT05131477|560771014|FG003|PART 2|Other|0|||
155365443|NCT05131477|560771015|FG004|PART 2|Other|0|||
155365444|NCT05131477|560771016|FG005|PART 2|Other|0|||
155365445|NCT05131477|560771017|FG006|PART 2|Other|0|||
155365446|NCT05131477|560771018|FG007|PART 2|Other|0|||
155365447|NCT05131477|560771019|FG008|PART 2|Other|1|||
155365448|NCT05131477|560771020|FG009|PART 2|Other|1|||
155365449|NCT05131477|560771021|FG010|PART 2|Other|0|||
155365450|NCT05131477|560771022|FG011|PART 2|Other|0|||
155365451|NCT05131477|560771023|FG012|PART 2|Other|1|||
155365452|NCT05131477|560771024|FG013|PART 2|Other|0|||
155365453|NCT05131477|560771011|FG000|PART 2|Lack of Efficacy|0|||
155365454|NCT05131477|560771012|FG001|PART 2|Lack of Efficacy|0|||
155365455|NCT05131477|560771013|FG002|PART 2|Lack of Efficacy|0|||
155365456|NCT05131477|560771014|FG003|PART 2|Lack of Efficacy|0|||
155365457|NCT05131477|560771015|FG004|PART 2|Lack of Efficacy|0|||
155365458|NCT05131477|560771016|FG005|PART 2|Lack of Efficacy|1|||
155365459|NCT05131477|560771017|FG006|PART 2|Lack of Efficacy|1|||
155365460|NCT05131477|560771018|FG007|PART 2|Lack of Efficacy|0|||
155365461|NCT05131477|560771019|FG008|PART 2|Lack of Efficacy|3|||
155365462|NCT05131477|560771020|FG009|PART 2|Lack of Efficacy|0|||
155365463|NCT05131477|560771021|FG010|PART 2|Lack of Efficacy|1|||
155365464|NCT05131477|560771022|FG011|PART 2|Lack of Efficacy|0|||
155365465|NCT05131477|560771023|FG012|PART 2|Lack of Efficacy|2|||
155365466|NCT05131477|560771024|FG013|PART 2|Lack of Efficacy|0|||
155365467|NCT05131477|560771011|FG000|PART 2|Unclassified|0|||
155365468|NCT05131477|560771012|FG001|PART 2|Unclassified|0|||
155365469|NCT05131477|560771013|FG002|PART 2|Unclassified|0|||
155365470|NCT05131477|560771014|FG003|PART 2|Unclassified|0|||
155365471|NCT05131477|560771015|FG004|PART 2|Unclassified|0|||
155365472|NCT05131477|560771016|FG005|PART 2|Unclassified|0|||
155365473|NCT05131477|560771017|FG006|PART 2|Unclassified|0|||
155365474|NCT05131477|560771018|FG007|PART 2|Unclassified|0|||
155365475|NCT05131477|560771019|FG008|PART 2|Unclassified|0|||
155365476|NCT05131477|560771020|FG009|PART 2|Unclassified|0|||
155365477|NCT05131477|560771021|FG010|PART 2|Unclassified|1|||
155365478|NCT05131477|560771022|FG011|PART 2|Unclassified|0|||
155365479|NCT05131477|560771023|FG012|PART 2|Unclassified|0|||
155365480|NCT05131477|560771024|FG013|PART 2|Unclassified|0|||
155365481|NCT05131477|560771011|FG000|PART 2|Re-randomized and not treated|0|||
155365482|NCT05131477|560771012|FG001|PART 2|Re-randomized and not treated|0|||
155365483|NCT05131477|560771013|FG002|PART 2|Re-randomized and not treated|0|||
155365484|NCT05131477|560771014|FG003|PART 2|Re-randomized and not treated|0|||
155365485|NCT05131477|560771015|FG004|PART 2|Re-randomized and not treated|0|||
155365486|NCT05131477|560771016|FG005|PART 2|Re-randomized and not treated|0|||
155365487|NCT05131477|560771017|FG006|PART 2|Re-randomized and not treated|0|||
155365488|NCT05131477|560771018|FG007|PART 2|Re-randomized and not treated|1|||
155365489|NCT05131477|560771019|FG008|PART 2|Re-randomized and not treated|0|||
155365490|NCT05131477|560771020|FG009|PART 2|Re-randomized and not treated|0|||
155365491|NCT05131477|560771021|FG010|PART 2|Re-randomized and not treated|1|||
155365492|NCT05131477|560771022|FG011|PART 2|Re-randomized and not treated|0|||
155365493|NCT05131477|560771023|FG012|PART 2|Re-randomized and not treated|1|||
155365494|NCT05131477|560771024|FG013|PART 2|Re-randomized and not treated|1|||
155365495|NCT02194829|560771025|FG000|Overall Study|Adverse Event|2|||
155365496|NCT02194829|560771026|FG001|Overall Study|Adverse Event|2|||
155365497|NCT02194829|560771025|FG000|Overall Study|Death|0|||
155365498|NCT02194829|560771026|FG001|Overall Study|Death|1|||
155365499|NCT02194829|560771025|FG000|Overall Study|Disease progression|0|||
155365500|NCT02194829|560771026|FG001|Overall Study|Disease progression|1|||
155365501|NCT02194829|560771025|FG000|Overall Study|Withdrawal by Subject|0|||
155365502|NCT02194829|560771026|FG001|Overall Study|Withdrawal by Subject|1|||
155365503|NCT02194829|560771025|FG000|Overall Study|Never started protocol therapy|0|||
155365504|NCT02194829|560771026|FG001|Overall Study|Never started protocol therapy|1|||
155365505|NCT03939689|560772678|FG000|Overall Study|Radiographic progression|14|||
155365506|NCT03939689|560772679|FG001|Overall Study|Radiographic progression|17|||
155365507|NCT03939689|560772678|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
155365508|NCT03939689|560772679|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
155365509|NCT03939689|560772678|FG000|Overall Study|Adverse Event|1|||
155365510|NCT03939689|560772679|FG001|Overall Study|Adverse Event|8|||
155365511|NCT03939689|560772678|FG000|Overall Study|Unequivocal clinical progression|2|||
155365512|NCT03939689|560772679|FG001|Overall Study|Unequivocal clinical progression|5|||
155365513|NCT03939689|560772678|FG000|Overall Study|Other|1|||
155365514|NCT03939689|560772679|FG001|Overall Study|Other|4|||
155365515|NCT03939689|560772678|FG000|Overall Study|Death|0|||
155365516|NCT03939689|560772679|FG001|Overall Study|Death|3|||
155365517|NCT03939689|560772678|FG000|Overall Study|Participant decision|0|||
155365518|NCT03939689|560772679|FG001|Overall Study|Participant decision|3|||
155365519|NCT03939689|560772678|FG000|Overall Study|Withdrawal of consent|2|||
155428123|NCT00064701|560993415|FG001|One Year Post-transplant|Rejection|1|||
155428124|NCT00064701|560993416|FG002|One Year Post-transplant|Rejection|16|||
155428125|NCT00064701|560993414|FG000|One Year Post-transplant|Non-compliance|4|||
155428126|NCT00064701|560993415|FG001|One Year Post-transplant|Non-compliance|2|||
155649290|NCT03931785|561808201|FG003|Overall Study|Protocol Violation|0|||
155649291|NCT03931785|561808198|FG000|Overall Study|Noncompliance With Study drug|0|||
155649292|NCT03931785|561808199|FG001|Overall Study|Noncompliance With Study drug|1|||
155365520|NCT03939689|560772679|FG001|Overall Study|Withdrawal of consent|1|||
155365521|NCT03939689|560772678|FG000|Overall Study|Investigator decision|1|||
155365522|NCT03939689|560772679|FG001|Overall Study|Investigator decision|0|||
155365523|NCT04427280|560772680|FG000|Overall Study|Withdrawal by Subject|0|||
155365524|NCT04427280|560772681|FG001|Overall Study|Withdrawal by Subject|2|||
155365525|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Adverse Event|2|||
155365526|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Adverse Event|0|||
155365527|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Adverse Event|0|||
155365528|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Adverse Event|0|||
155365529|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365530|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
155365531|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365532|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365533|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
155365534|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
155365535|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
155365536|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155365537|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Physician Decision|1|||
155365538|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Physician Decision|0|||
155365539|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Physician Decision|0|||
155365540|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Physician Decision|0|||
155365541|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Pregnancy|1|||
155365542|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Pregnancy|0|||
155365543|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Pregnancy|0|||
155365544|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Pregnancy|0|||
155365545|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
155365546|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
155365547|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155365548|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155365549|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
155365550|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
155365551|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
155365552|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
155365553|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
155365554|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365555|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365556|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365557|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365558|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
155365559|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365560|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365561|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Not Treated|1|||
155365562|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Not Treated|0|||
155365563|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Not Treated|0|||
155365564|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Not Treated|0|||
155365565|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
155365566|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
155365567|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
155365568|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
155365569|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365570|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365571|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
155365572|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365573|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
155365574|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
155365575|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
155365576|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
155365577|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
155365578|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
155365579|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
155365580|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
155365581|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365582|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365583|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
155365584|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365585|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
155365586|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
155365587|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
155365588|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
155365589|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
155365590|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
155365591|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
155365592|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
155365593|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
155365594|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
155365595|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
155365596|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
155365597|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Death|1|||
155365598|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Death|0|||
155365599|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
155365600|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
155365601|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
155365602|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
155365603|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
155365604|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
155365605|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
155365606|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
155365607|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
155365608|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
155365609|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Death|1|||
155365610|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Death|0|||
155365611|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
155365612|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
155365613|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
155365614|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
155365615|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
155365616|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
155365617|NCT00699153|560772694|FG000|Overall Study|Lost to Follow-up|1|||
155365618|NCT00699153|560772695|FG001|Overall Study|Lost to Follow-up|0|||
155365619|NCT00699153|560772694|FG000|Overall Study|Adverse Event|0|||
155365620|NCT00699153|560772695|FG001|Overall Study|Adverse Event|2|||
155365621|NCT00699153|560772694|FG000|Overall Study|Protocol Violation|1|||
155365622|NCT00699153|560772695|FG001|Overall Study|Protocol Violation|0|||
155365623|NCT00699153|560772694|FG000|Overall Study|Travel Problem|1|||
155365624|NCT00699153|560772695|FG001|Overall Study|Travel Problem|0|||
155365625|NCT00078338|560772699|FG000|Overall Study|Adverse Event|31|||
155365626|NCT00078338|560772700|FG001|Overall Study|Adverse Event|24|||
155365627|NCT00078338|560772699|FG000|Overall Study|Lost to Follow-up|17|||
155365628|NCT00078338|560772700|FG001|Overall Study|Lost to Follow-up|2|||
155365629|NCT00078338|560772699|FG000|Overall Study|Protocol Violation|2|||
155365630|NCT00078338|560772700|FG001|Overall Study|Protocol Violation|2|||
155365631|NCT00078338|560772699|FG000|Overall Study|Disease Progression|4|||
155365632|NCT00078338|560772700|FG001|Overall Study|Disease Progression|7|||
155365633|NCT00078338|560772699|FG000|Overall Study|Other|28|||
155365634|NCT00078338|560772700|FG001|Overall Study|Other|16|||
155365635|NCT00078338|560772699|FG000|Overall Study|Subjects randomized, but not treated|3|||
155365636|NCT00078338|560772700|FG001|Overall Study|Subjects randomized, but not treated|3|||
155365637|NCT04043143|560772701|FG000|Overall Study|Lost to Follow-up|5|||
155365638|NCT04043143|560772702|FG001|Overall Study|Lost to Follow-up|5|||
155365639|NCT04043143|560772701|FG000|Overall Study|screen failure|1|||
155365640|NCT04043143|560772702|FG001|Overall Study|screen failure|0|||
155365641|NCT04307940|560772703|FG000|Overall Study|Adverse Event|1|||
155365642|NCT04307940|560772704|FG001|Overall Study|Adverse Event|0|||
155365643|NCT04307940|560772705|FG002|Overall Study|Adverse Event|0|||
155365644|NCT04307940|560772703|FG000|Overall Study|Withdrawal by Subject|2|||
155365645|NCT04307940|560772704|FG001|Overall Study|Withdrawal by Subject|3|||
155365646|NCT04307940|560772705|FG002|Overall Study|Withdrawal by Subject|1|||
155365647|NCT04307940|560772703|FG000|Overall Study|Lost to Follow-up|2|||
155365648|NCT04307940|560772704|FG001|Overall Study|Lost to Follow-up|0|||
155365649|NCT04307940|560772705|FG002|Overall Study|Lost to Follow-up|1|||
155428127|NCT00064701|560993416|FG002|One Year Post-transplant|Non-compliance|5|||
155649293|NCT03931785|561808200|FG002|Overall Study|Noncompliance With Study drug|0|||
155365650|NCT04624243|560772709|FG000|Overall Study|Death|0|||
155365651|NCT04624243|560772710|FG001|Overall Study|Death|1|||
155365652|NCT04624243|560772711|FG002|Overall Study|Death|0|||
155365653|NCT04624243|560772712|FG003|Overall Study|Death|0|||
155365654|NCT04624243|560772713|FG004|Overall Study|Death|0|||
155365655|NCT04624243|560772709|FG000|Overall Study|Lost to Follow-up|2|||
155365656|NCT04624243|560772710|FG001|Overall Study|Lost to Follow-up|3|||
155365657|NCT04624243|560772711|FG002|Overall Study|Lost to Follow-up|7|||
155365658|NCT04624243|560772712|FG003|Overall Study|Lost to Follow-up|1|||
155365659|NCT04624243|560772713|FG004|Overall Study|Lost to Follow-up|3|||
155365660|NCT04624243|560772709|FG000|Overall Study|Physician Decision|3|||
155365661|NCT04624243|560772710|FG001|Overall Study|Physician Decision|8|||
155365662|NCT04624243|560772711|FG002|Overall Study|Physician Decision|15|||
155365663|NCT04624243|560772712|FG003|Overall Study|Physician Decision|2|||
155365664|NCT04624243|560772713|FG004|Overall Study|Physician Decision|11|||
155365665|NCT04624243|560772709|FG000|Overall Study|Withdrawal by Subject|19|||
155365666|NCT04624243|560772710|FG001|Overall Study|Withdrawal by Subject|44|||
155365667|NCT04624243|560772711|FG002|Overall Study|Withdrawal by Subject|40|||
155365668|NCT04624243|560772712|FG003|Overall Study|Withdrawal by Subject|21|||
155365669|NCT04624243|560772713|FG004|Overall Study|Withdrawal by Subject|39|||
155365670|NCT04624243|560772709|FG000|Overall Study|Miscellaneous|3|||
155365671|NCT04624243|560772710|FG001|Overall Study|Miscellaneous|12|||
155365672|NCT04624243|560772711|FG002|Overall Study|Miscellaneous|9|||
155365673|NCT04624243|560772712|FG003|Overall Study|Miscellaneous|4|||
155365674|NCT04624243|560772713|FG004|Overall Study|Miscellaneous|6|||
155365675|NCT04996004|560772714|FG000|Phase I|Death|1|||
155365676|NCT04996004|560772715|FG001|Phase I|Death|2|||
155365677|NCT04996004|560772716|FG002|Phase I|Death|1|||
155365678|NCT04996004|560772717|FG003|Phase I|Death|0|||
155365679|NCT04996004|560772718|FG004|Phase I|Death|0|||
155365680|NCT04996004|560772719|FG005|Phase I|Death|0|||
155365681|NCT04996004|560772714|FG000|Phase I|Study terminated by sponsor|2|||
155365682|NCT04996004|560772715|FG001|Phase I|Study terminated by sponsor|1|||
155365683|NCT04996004|560772716|FG002|Phase I|Study terminated by sponsor|2|||
155365684|NCT04996004|560772717|FG003|Phase I|Study terminated by sponsor|0|||
155365685|NCT04996004|560772718|FG004|Phase I|Study terminated by sponsor|0|||
155365686|NCT04996004|560772719|FG005|Phase I|Study terminated by sponsor|0|||
155365687|NCT04996004|560772714|FG000|Phase II|Study terminated by sponsor|0|||
155365688|NCT04996004|560772715|FG001|Phase II|Study terminated by sponsor|0|||
155365689|NCT04996004|560772716|FG002|Phase II|Study terminated by sponsor|0|||
155365690|NCT04996004|560772717|FG003|Phase II|Study terminated by sponsor|20|||
155365691|NCT04996004|560772718|FG004|Phase II|Study terminated by sponsor|10|||
155365692|NCT04996004|560772719|FG005|Phase II|Study terminated by sponsor|10|||
155365693|NCT04996004|560772714|FG000|Phase II|Withdrawal by Subject|0|||
155365694|NCT04996004|560772715|FG001|Phase II|Withdrawal by Subject|0|||
155365695|NCT04996004|560772716|FG002|Phase II|Withdrawal by Subject|0|||
155365696|NCT04996004|560772717|FG003|Phase II|Withdrawal by Subject|0|||
155365697|NCT04996004|560772718|FG004|Phase II|Withdrawal by Subject|1|||
155365698|NCT04996004|560772719|FG005|Phase II|Withdrawal by Subject|2|||
155365699|NCT04996004|560772714|FG000|Phase II|Death|0|||
155428128|NCT00064701|560993414|FG000|One Year Post-transplant|Graft Failure|3|||
155428129|NCT00064701|560993415|FG001|One Year Post-transplant|Graft Failure|2|||
155428130|NCT00064701|560993416|FG002|One Year Post-transplant|Graft Failure|1|||
155428131|NCT00064701|560993414|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
155428132|NCT00064701|560993415|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
155428133|NCT00064701|560993416|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
155428134|NCT00064701|560993414|FG000|One Year Post-transplant|Lost to Follow-up|1|||
155428135|NCT00064701|560993415|FG001|One Year Post-transplant|Lost to Follow-up|0|||
155428136|NCT00064701|560993416|FG002|One Year Post-transplant|Lost to Follow-up|0|||
155428137|NCT00064701|560993414|FG000|One Year Post-transplant|Converted to rapamycin|1|||
155649294|NCT03931785|561808201|FG003|Overall Study|Noncompliance With Study drug|0|||
155649295|NCT03931785|561808198|FG000|Overall Study|Other Not specified|0|||
155365700|NCT04996004|560772715|FG001|Phase II|Death|0|||
155365701|NCT04996004|560772716|FG002|Phase II|Death|0|||
155365702|NCT04996004|560772717|FG003|Phase II|Death|12|||
155428138|NCT00064701|560993415|FG001|One Year Post-transplant|Converted to rapamycin|0|||
155428139|NCT00064701|560993416|FG002|One Year Post-transplant|Converted to rapamycin|0|||
155649296|NCT03931785|561808199|FG001|Overall Study|Other Not specified|2|||
155365703|NCT04996004|560772718|FG004|Phase II|Death|2|||
155365704|NCT04996004|560772719|FG005|Phase II|Death|9|||
155365705|NCT04996004|560772714|FG000|Phase II|Other|0|||
155649297|NCT03931785|561808200|FG002|Overall Study|Other Not specified|2|||
155365706|NCT04996004|560772715|FG001|Phase II|Other|0|||
155428140|NCT00064701|560993414|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
155365707|NCT04996004|560772716|FG002|Phase II|Other|0|||
155365708|NCT04996004|560772717|FG003|Phase II|Other|0|||
155365709|NCT04996004|560772718|FG004|Phase II|Other|0|||
155365710|NCT04996004|560772719|FG005|Phase II|Other|1|||
155365711|NCT05543174|560772720|FG000|Overall Study|Ongoing|7|||
155365712|NCT03104075|560772721|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
155365713|NCT03104075|560772722|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
155365714|NCT00789360|560772723|FG000|Overall Study|Protocol Violation|3|||
155365715|NCT00789360|560772724|FG001|Overall Study|Protocol Violation|1|||
155365716|NCT03559062|560772725|FG000|Overall Study|Other|0|||
155365717|NCT03559062|560772726|FG001|Overall Study|Other|1|||
155365718|NCT03559062|560772727|FG002|Overall Study|Other|0|||
155365719|NCT01757197|560772728|FG000|Overall Study|Death|2|||
155365720|NCT03322540|560772729|FG000|Overall Study|Death|21|||
155365721|NCT03322540|560772730|FG001|Overall Study|Death|28|||
155365722|NCT03322540|560772729|FG000|Overall Study|Lost to Follow-up|0|||
155365723|NCT03322540|560772730|FG001|Overall Study|Lost to Follow-up|1|||
155365724|NCT03322540|560772729|FG000|Overall Study|Physician Decision|7|||
155365725|NCT03322540|560772730|FG001|Overall Study|Physician Decision|6|||
155365726|NCT03322540|560772729|FG000|Overall Study|Withdrawal by Subject|3|||
155365727|NCT03322540|560772730|FG001|Overall Study|Withdrawal by Subject|1|||
155365728|NCT03322540|560772729|FG000|Overall Study|Study terminated by sponsor|0|||
155365729|NCT03322540|560772730|FG001|Overall Study|Study terminated by sponsor|1|||
155365730|NCT02153905|560772731|FG000|Overall Study|Death|1|||
155365731|NCT02153905|560772732|FG001|Overall Study|Death|0|||
155365732|NCT00520845|560772733|FG000|Overall Study|Death|3|||
155365733|NCT00520845|560772733|FG000|Overall Study|Adverse Event|4|||
155365734|NCT00520845|560772733|FG000|Overall Study|Disease Progression, relapse|13|||
155365735|NCT00520845|560772733|FG000|Overall Study|Withdrawal by Subject|1|||
155365736|NCT00520845|560772733|FG000|Overall Study|Alternative Therapy|1|||
155365737|NCT00351377|560772734|FG000|Overall Study|Adverse Event|5|||
155365738|NCT00351377|560772734|FG000|Overall Study|Death|1|||
155365739|NCT00351377|560772734|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155365740|NCT02493062|560772736|FG000|Overall Study|Physician Decision|12|||
155365741|NCT01967069|560772738|FG000|Overall Study|Adverse Event|2|||
155365742|NCT01967069|560772739|FG001|Overall Study|Adverse Event|2|||
155365743|NCT01967069|560772738|FG000|Overall Study|Lost to Follow-up|5|||
155365744|NCT01967069|560772739|FG001|Overall Study|Lost to Follow-up|2|||
155365745|NCT01967069|560772738|FG000|Overall Study|Withdrawal by Subject|1|||
155365746|NCT01967069|560772739|FG001|Overall Study|Withdrawal by Subject|3|||
155365747|NCT01967069|560772738|FG000|Overall Study|Lack of Efficacy|0|||
155365748|NCT01967069|560772739|FG001|Overall Study|Lack of Efficacy|1|||
155365749|NCT00581477|560772743|FG000|Overall Study|Physician Decision|2|||
155365750|NCT03443414|560772746|FG000|Overall Study|Adverse Event|6|||
155365751|NCT03443414|560772747|FG001|Overall Study|Adverse Event|0|||
155365752|NCT03443414|560772748|FG002|Overall Study|Adverse Event|4|||
155365753|NCT03443414|560772749|FG003|Overall Study|Adverse Event|2|||
155365754|NCT03443414|560772750|FG004|Overall Study|Adverse Event|3|||
155365755|NCT03443414|560772746|FG000|Overall Study|Withdrawal by Subject|3|||
155365756|NCT03443414|560772747|FG001|Overall Study|Withdrawal by Subject|2|||
155365757|NCT03443414|560772748|FG002|Overall Study|Withdrawal by Subject|2|||
155365758|NCT03443414|560772749|FG003|Overall Study|Withdrawal by Subject|2|||
155365759|NCT03443414|560772750|FG004|Overall Study|Withdrawal by Subject|1|||
155508231|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508232|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508233|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508234|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508235|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508236|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
155508237|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
155508238|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155508239|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155508240|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155365760|NCT03443414|560772746|FG000|Overall Study|Death|0|||
155365761|NCT03443414|560772747|FG001|Overall Study|Death|1|||
155365762|NCT03443414|560772748|FG002|Overall Study|Death|0|||
155365763|NCT03443414|560772749|FG003|Overall Study|Death|1|||
155365764|NCT03443414|560772750|FG004|Overall Study|Death|0|||
155365765|NCT03443414|560772746|FG000|Overall Study|Reason not specified|2|||
155365766|NCT03443414|560772747|FG001|Overall Study|Reason not specified|0|||
155365767|NCT03443414|560772748|FG002|Overall Study|Reason not specified|0|||
155365768|NCT03443414|560772749|FG003|Overall Study|Reason not specified|0|||
155365769|NCT03443414|560772750|FG004|Overall Study|Reason not specified|1|||
155508241|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155365770|NCT03017742|560772752|FG000|Overall Study|Protocol Violation|36|||
155365771|NCT03017742|560772752|FG000|Overall Study|Withdrawal by Subject|37|||
155508242|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155508243|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
155365772|NCT05262751|560772755|FG000|Washout Period 2|Adverse Event|1|||
155365773|NCT05262751|560772756|FG001|Washout Period 2|Adverse Event|0|||
155365774|NCT05262751|560772757|FG002|Washout Period 2|Adverse Event|0|||
155365775|NCT05262751|560772758|FG003|Washout Period 2|Adverse Event|0|||
155365776|NCT05262751|560772759|FG004|Washout Period 2|Adverse Event|0|||
155365777|NCT05262751|560772760|FG005|Washout Period 2|Adverse Event|0|||
155365778|NCT05262751|560772755|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
155365779|NCT05262751|560772756|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
155365780|NCT05262751|560772757|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
155365781|NCT05262751|560772758|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
155365782|NCT05262751|560772759|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
155365783|NCT05262751|560772760|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
155365784|NCT03690427|560772761|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
155365785|NCT03690427|560772762|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
155365786|NCT03519204|560772765|FG000|Overall Study|Lost to Follow-up|3|||
155365787|NCT03519204|560772766|FG001|Overall Study|Lost to Follow-up|8|||
155365788|NCT03519204|560772765|FG000|Overall Study|Withdrawal by Subject|9|||
155365789|NCT03519204|560772766|FG001|Overall Study|Withdrawal by Subject|7|||
155365790|NCT03519204|560772765|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155365791|NCT03519204|560772766|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155365792|NCT02956837|560772767|FG000|Overall Study|Serious Adverse Events|0|||
155365793|NCT02956837|560772768|FG001|Overall Study|Serious Adverse Events|1|||
155365794|NCT02956837|560772769|FG002|Overall Study|Serious Adverse Events|0|||
155365795|NCT02956837|560772770|FG003|Overall Study|Serious Adverse Events|0|||
155365796|NCT02956837|560772767|FG000|Overall Study|Withdrawal by Subject|0|||
155365797|NCT02956837|560772768|FG001|Overall Study|Withdrawal by Subject|1|||
155365798|NCT02956837|560772769|FG002|Overall Study|Withdrawal by Subject|0|||
155365799|NCT02956837|560772770|FG003|Overall Study|Withdrawal by Subject|3|||
155365800|NCT02956837|560772767|FG000|Overall Study|Lost to Follow-up|0|||
155365801|NCT02956837|560772768|FG001|Overall Study|Lost to Follow-up|1|||
155365802|NCT02956837|560772769|FG002|Overall Study|Lost to Follow-up|2|||
155365803|NCT02956837|560772770|FG003|Overall Study|Lost to Follow-up|0|||
155365804|NCT02597712|560772775|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
155365805|NCT02597712|560772776|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
155365806|NCT02597712|560772775|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
155365807|NCT02597712|560772776|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
155365808|NCT02597712|560772775|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
155365809|NCT02597712|560772776|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
155365810|NCT01727505|560772780|FG000|First 24 Hours|Adverse Event|0|||
155365811|NCT01727505|560772781|FG001|First 24 Hours|Adverse Event|1|||
155365812|NCT01727505|560772780|FG000|Second 24 Hours|Missing data|0|||
155365813|NCT01727505|560772781|FG001|Second 24 Hours|Missing data|1|||
155365814|NCT02637323|560772783|FG000|Overall Study|Lost to Follow-up|2|||
155365815|NCT02637323|560772784|FG001|Overall Study|Lost to Follow-up|0|||
155365816|NCT02637323|560772783|FG000|Overall Study|Protocol Violation|0|||
155365817|NCT02637323|560772784|FG001|Overall Study|Protocol Violation|1|||
155365818|NCT01154140|560772785|FG000|Overall Study|Death|71|||
155365819|NCT01154140|560772786|FG001|Overall Study|Death|81|||
155365820|NCT01154140|560772785|FG000|Overall Study|Lost to Follow-up|4|||
155365821|NCT01154140|560772786|FG001|Overall Study|Lost to Follow-up|5|||
155365822|NCT01154140|560772785|FG000|Overall Study|Withdrawal by Subject|12|||
155365823|NCT01154140|560772786|FG001|Overall Study|Withdrawal by Subject|13|||
155365824|NCT01154140|560772785|FG000|Overall Study|Other|3|||
155365825|NCT01154140|560772786|FG001|Overall Study|Other|1|||
155365826|NCT01154140|560772785|FG000|Overall Study|Randomized but not treated|1|||
155365827|NCT01154140|560772786|FG001|Overall Study|Randomized but not treated|2|||
155365828|NCT00358644|560772787|FG000|Overall Study|Progressive Disease|21|||
155365829|NCT00358644|560772787|FG000|Overall Study|Adverse Event|7|||
155365830|NCT00358644|560772787|FG000|Overall Study|Death|11|||
155365831|NCT00358644|560772787|FG000|Overall Study|Withdrawal by Subject|4|||
155365832|NCT00358644|560772787|FG000|Overall Study|Physician Decision|6|||
155365833|NCT00358644|560772787|FG000|Overall Study|Patient not eligible for study|1|||
155365834|NCT00513708|560772788|FG000|Overall Study|Lost to Follow-up|4|||
155365835|NCT00513708|560772789|FG001|Overall Study|Lost to Follow-up|4|||
155365836|NCT00513708|560772790|FG002|Overall Study|Lost to Follow-up|4|||
155365837|NCT00368875|560772791|FG000|Overall Study|Adverse Event|0|||
155365838|NCT00368875|560772792|FG001|Overall Study|Adverse Event|12|||
155365839|NCT00368875|560772791|FG000|Overall Study|Progressive disease|3|||
155365840|NCT00368875|560772792|FG001|Overall Study|Progressive disease|27|||
155365841|NCT00368875|560772791|FG000|Overall Study|Withdrawal by Subject|2|||
155365842|NCT00368875|560772792|FG001|Overall Study|Withdrawal by Subject|6|||
155365843|NCT00368875|560772791|FG000|Overall Study|Other Reason|0|||
155365844|NCT00368875|560772792|FG001|Overall Study|Other Reason|2|||
155428141|NCT00064701|560993415|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
155428142|NCT00064701|560993416|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
155428143|NCT00064701|560993414|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
155428144|NCT00064701|560993415|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
155428145|NCT00064701|560993416|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
155365845|NCT00368875|560772791|FG000|Overall Study|Alternative Therapy|1|||
155365846|NCT00368875|560772792|FG001|Overall Study|Alternative Therapy|1|||
155365847|NCT03327831|560772793|FG000|Overall Study|Lost to Follow-up|2|||
155365848|NCT01564277|560772794|FG000|Overall Study|Protocol Violation|0|||
155365849|NCT01564277|560772795|FG001|Overall Study|Protocol Violation|1|||
155365850|NCT01564277|560772794|FG000|Overall Study|Physician Decision|1|||
155365851|NCT01564277|560772795|FG001|Overall Study|Physician Decision|0|||
155365852|NCT02595372|560772796|FG000|Overall Study|Adverse Event|6|||
155365853|NCT02595372|560772796|FG000|Overall Study|Physician Decision|2|||
155365854|NCT02595372|560772796|FG000|Overall Study|Disease Progression|1|||
155365855|NCT01594970|560772799|FG000|Overall Study|Non-Adverse Event Related|4|||
155365856|NCT01594970|560772800|FG001|Overall Study|Non-Adverse Event Related|5|||
155365857|NCT01594970|560772801|FG002|Overall Study|Non-Adverse Event Related|6|||
155365858|NCT01594970|560772799|FG000|Overall Study|Adverse Event|17|||
155365859|NCT01594970|560772800|FG001|Overall Study|Adverse Event|23|||
155365860|NCT01594970|560772801|FG002|Overall Study|Adverse Event|23|||
155365861|NCT01594970|560772799|FG000|Overall Study|Lost to Follow-up|54|||
155365862|NCT01594970|560772800|FG001|Overall Study|Lost to Follow-up|54|||
155365863|NCT01594970|560772801|FG002|Overall Study|Lost to Follow-up|37|||
155365864|NCT00401258|560772802|FG000|Overall Study|Adverse Event|7|||
155365865|NCT04276051|560772807|FG000|Overall Study|Lost to Follow-up|0|||
155365866|NCT04276051|560772808|FG001|Overall Study|Lost to Follow-up|1|||
155365867|NCT04276051|560772807|FG000|Overall Study|Physician Decision|0|||
155365868|NCT04276051|560772808|FG001|Overall Study|Physician Decision|1|||
155365869|NCT04276051|560772807|FG000|Overall Study|Withdrawal by Subject|1|||
155365870|NCT04276051|560772808|FG001|Overall Study|Withdrawal by Subject|1|||
155365871|NCT01299480|560772809|FG000|Overall Study|No longer willing to participate|19|||
155365872|NCT01299480|560772810|FG001|Overall Study|No longer willing to participate|17|||
155365873|NCT01299480|560772811|FG002|Overall Study|No longer willing to participate|14|||
155365874|NCT01299480|560772812|FG003|Overall Study|No longer willing to participate|13|||
155365875|NCT01299480|560772813|FG004|Overall Study|No longer willing to participate|10|||
155365876|NCT01299480|560772809|FG000|Overall Study|Protocol Violation|7|||
155365877|NCT01299480|560772810|FG001|Overall Study|Protocol Violation|5|||
155365878|NCT01299480|560772811|FG002|Overall Study|Protocol Violation|8|||
155365879|NCT01299480|560772812|FG003|Overall Study|Protocol Violation|1|||
155365880|NCT01299480|560772813|FG004|Overall Study|Protocol Violation|1|||
155365881|NCT01299480|560772809|FG000|Overall Study|Withdrawal by Subject|3|||
155365882|NCT01299480|560772810|FG001|Overall Study|Withdrawal by Subject|4|||
155365883|NCT01299480|560772811|FG002|Overall Study|Withdrawal by Subject|7|||
155365884|NCT01299480|560772812|FG003|Overall Study|Withdrawal by Subject|3|||
155365885|NCT01299480|560772813|FG004|Overall Study|Withdrawal by Subject|4|||
155365886|NCT01299480|560772809|FG000|Overall Study|Adverse Event|6|||
155365887|NCT01299480|560772810|FG001|Overall Study|Adverse Event|4|||
155365888|NCT01299480|560772811|FG002|Overall Study|Adverse Event|5|||
155428146|NCT00064701|560993414|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
155428147|NCT00064701|560993415|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
155428148|NCT00064701|560993416|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
155428149|NCT00064701|560993414|FG000|One Year Post-transplant|Poor absorption|0|||
155428150|NCT00064701|560993415|FG001|One Year Post-transplant|Poor absorption|1|||
155428151|NCT00064701|560993416|FG002|One Year Post-transplant|Poor absorption|0|||
155428152|NCT00064701|560993414|FG000|One Year Post-transplant|Pancreas transplant|0|||
155428153|NCT00064701|560993415|FG001|One Year Post-transplant|Pancreas transplant|0|||
155428154|NCT00064701|560993416|FG002|One Year Post-transplant|Pancreas transplant|1|||
155428155|NCT00064701|560993414|FG000|Clinical Continuation Phase|Adverse Event|12|||
155428156|NCT00064701|560993415|FG001|Clinical Continuation Phase|Adverse Event|21|||
155428157|NCT00064701|560993416|FG002|Clinical Continuation Phase|Adverse Event|14|||
155428158|NCT00064701|560993414|FG000|Clinical Continuation Phase|Non-compliance|8|||
155428159|NCT00064701|560993415|FG001|Clinical Continuation Phase|Non-compliance|6|||
155428160|NCT00064701|560993416|FG002|Clinical Continuation Phase|Non-compliance|7|||
155428161|NCT00064701|560993414|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
155428162|NCT00064701|560993415|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
155428163|NCT00064701|560993416|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
155428164|NCT00064701|560993414|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
155428165|NCT00064701|560993415|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
155428166|NCT00064701|560993416|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
155428167|NCT00064701|560993414|FG000|Clinical Continuation Phase|Graft Failure|5|||
155428168|NCT00064701|560993415|FG001|Clinical Continuation Phase|Graft Failure|5|||
155428169|NCT00064701|560993416|FG002|Clinical Continuation Phase|Graft Failure|2|||
155365889|NCT01299480|560772812|FG003|Overall Study|Adverse Event|4|||
155365890|NCT01299480|560772813|FG004|Overall Study|Adverse Event|0|||
155365891|NCT01299480|560772809|FG000|Overall Study|Withdrawal due to pregnancy|0|||
155365892|NCT01299480|560772810|FG001|Overall Study|Withdrawal due to pregnancy|1|||
155365893|NCT01299480|560772811|FG002|Overall Study|Withdrawal due to pregnancy|1|||
155365894|NCT01299480|560772812|FG003|Overall Study|Withdrawal due to pregnancy|0|||
155365895|NCT01299480|560772813|FG004|Overall Study|Withdrawal due to pregnancy|0|||
155365896|NCT01299480|560772809|FG000|Overall Study|Physician Decision|1|||
155365897|NCT01299480|560772810|FG001|Overall Study|Physician Decision|1|||
155365898|NCT01299480|560772811|FG002|Overall Study|Physician Decision|0|||
155365899|NCT01299480|560772812|FG003|Overall Study|Physician Decision|2|||
155365900|NCT01299480|560772813|FG004|Overall Study|Physician Decision|0|||
155365901|NCT01299480|560772809|FG000|Overall Study|Lost to Follow-up|3|||
155365902|NCT01299480|560772810|FG001|Overall Study|Lost to Follow-up|1|||
155365903|NCT01299480|560772811|FG002|Overall Study|Lost to Follow-up|2|||
155365904|NCT01299480|560772812|FG003|Overall Study|Lost to Follow-up|1|||
155365905|NCT01299480|560772813|FG004|Overall Study|Lost to Follow-up|2|||
155365906|NCT01299480|560772809|FG000|Overall Study|Other|3|||
155365907|NCT01299480|560772810|FG001|Overall Study|Other|2|||
155365908|NCT01299480|560772811|FG002|Overall Study|Other|3|||
155365909|NCT01299480|560772812|FG003|Overall Study|Other|0|||
155365910|NCT01299480|560772813|FG004|Overall Study|Other|3|||
155365911|NCT01299480|560772809|FG000|Overall Study|Started, but not vaccinated|0|||
155365912|NCT01299480|560772810|FG001|Overall Study|Started, but not vaccinated|0|||
155365913|NCT01299480|560772811|FG002|Overall Study|Started, but not vaccinated|1|||
155365914|NCT01299480|560772812|FG003|Overall Study|Started, but not vaccinated|1|||
155365915|NCT01299480|560772813|FG004|Overall Study|Started, but not vaccinated|0|||
155365916|NCT01374568|560772814|FG000|Overall Study|Lab unable to analyze BTM|0|||
155365917|NCT01374568|560772815|FG001|Overall Study|Lab unable to analyze BTM|2|||
155365918|NCT00617929|560772816|FG000|Overall Study|Physician Decision|1|||
155365919|NCT04160988|560772817|FG000|Overall Study|poor image quality|28|||
155365920|NCT00844597|560772818|FG000|Overall Study|Adverse Event|0|||
155365921|NCT00844597|560772819|FG001|Overall Study|Adverse Event|0|||
155365922|NCT00844597|560772820|FG002|Overall Study|Adverse Event|0|||
155365923|NCT00844597|560772821|FG003|Overall Study|Adverse Event|1|||
155365924|NCT00844597|560772822|FG004|Overall Study|Adverse Event|0|||
155365925|NCT00844597|560772823|FG005|Overall Study|Adverse Event|0|||
155365926|NCT01250509|560772824|FG000|Overall Study|Lost to Follow-up|5|||
155365927|NCT01250509|560772825|FG001|Overall Study|Lost to Follow-up|2|||
155365928|NCT06840769|560772828|FG000|Overall Study|Withdrawal by Subject|1|||
155365929|NCT06840769|560772829|FG001|Overall Study|Withdrawal by Subject|0|||
155365930|NCT06840769|560772830|FG002|Overall Study|Withdrawal by Subject|0|||
155365931|NCT06840769|560772831|FG003|Overall Study|Withdrawal by Subject|0|||
155365932|NCT06840769|560772832|FG004|Overall Study|Withdrawal by Subject|0|||
155365933|NCT02726945|560772833|FG000|Overall Study|Withdrawal by Subject|0|||
155365934|NCT02726945|560772834|FG001|Overall Study|Withdrawal by Subject|0|||
155365935|NCT02726945|560772835|FG002|Overall Study|Withdrawal by Subject|1|||
155365936|NCT02726945|560772833|FG000|Overall Study|Elected to have total knee replacement|0|||
155365937|NCT02726945|560772834|FG001|Overall Study|Elected to have total knee replacement|1|||
155365938|NCT02726945|560772835|FG002|Overall Study|Elected to have total knee replacement|0|||
155365939|NCT02473965|560774581|FG000|Overall Study|Adverse Event|6|||
155365940|NCT02473965|560774582|FG001|Overall Study|Adverse Event|4|||
155365941|NCT02473965|560774581|FG000|Overall Study|MG worsening|4|||
155365942|NCT02473965|560774582|FG001|Overall Study|MG worsening|1|||
155365943|NCT02473965|560774581|FG000|Overall Study|Withdrawal by Subject|2|||
155365944|NCT02473965|560774582|FG001|Overall Study|Withdrawal by Subject|3|||
155365945|NCT02473965|560774581|FG000|Overall Study|Physician Decision|0|||
155365946|NCT02473965|560774582|FG001|Overall Study|Physician Decision|2|||
155365947|NCT03816761|560774583|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365948|NCT03816761|560774584|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365949|NCT03816761|560774585|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365950|NCT03816761|560774586|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365951|NCT03816761|560774587|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365952|NCT03816761|560774588|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
155365953|NCT03816761|560774583|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
155365954|NCT03816761|560774584|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
155428170|NCT00064701|560993414|FG000|Clinical Continuation Phase|Rejection|1|||
155428171|NCT00064701|560993415|FG001|Clinical Continuation Phase|Rejection|2|||
155428172|NCT00064701|560993416|FG002|Clinical Continuation Phase|Rejection|2|||
155365955|NCT03816761|560774585|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
155365956|NCT03816761|560774586|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
155365957|NCT03816761|560774587|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
155365958|NCT03816761|560774588|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
155428173|NCT00064701|560993414|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
155428174|NCT00064701|560993415|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
155428175|NCT00064701|560993416|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
155428176|NCT00064701|560993414|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
155365959|NCT01667926|560774600|FG000|Overall Study|Withdrawal by Subject|1|||
155365960|NCT01667926|560774601|FG001|Overall Study|Withdrawal by Subject|2|||
155365961|NCT01667926|560774602|FG002|Overall Study|Withdrawal by Subject|2|||
155365962|NCT01667926|560774600|FG000|Overall Study|Physician Decision|0|||
155365963|NCT01667926|560774601|FG001|Overall Study|Physician Decision|0|||
155365964|NCT01667926|560774602|FG002|Overall Study|Physician Decision|1|||
155365965|NCT01667926|560774600|FG000|Overall Study|Time committment|0|||
155365966|NCT01667926|560774601|FG001|Overall Study|Time committment|0|||
155365967|NCT01667926|560774602|FG002|Overall Study|Time committment|2|||
155365968|NCT01667926|560774600|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
155365969|NCT01667926|560774601|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
155365970|NCT01667926|560774602|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
155365971|NCT01667926|560774600|FG000|Overall Study|Lost to Follow-up|1|||
155365972|NCT01667926|560774601|FG001|Overall Study|Lost to Follow-up|2|||
155365973|NCT01667926|560774602|FG002|Overall Study|Lost to Follow-up|1|||
155365974|NCT01667926|560774600|FG000|Overall Study|Side effects|3|||
155365975|NCT01667926|560774601|FG001|Overall Study|Side effects|0|||
155365976|NCT01667926|560774602|FG002|Overall Study|Side effects|0|||
155365977|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
155365978|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
155365979|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155365980|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
155365981|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155365982|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155428177|NCT00064701|560993415|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
155428178|NCT00064701|560993416|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
155428179|NCT00064701|560993414|FG000|Clinical Continuation Phase|Physician Decision|1|||
155508244|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
155508245|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508246|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508247|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508248|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508249|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508250|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
155508251|NCT00606684|561286803|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
155508252|NCT00606684|561286804|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508253|NCT00606684|561286805|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508254|NCT00606684|561286806|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508255|NCT00606684|561286807|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508256|NCT00606684|561286808|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508257|NCT00606684|561286809|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155508258|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155508259|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Adverse Event|3|||
155508260|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Adverse Event|2|||
155508261|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Adverse Event|4|||
155508262|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Adverse Event|2|||
155428180|NCT00064701|560993415|FG001|Clinical Continuation Phase|Physician Decision|3|||
155428181|NCT00064701|560993416|FG002|Clinical Continuation Phase|Physician Decision|0|||
155428182|NCT00064701|560993414|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
155428183|NCT00064701|560993415|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
155428184|NCT00064701|560993416|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
155428185|NCT00064701|560993414|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
155428186|NCT00064701|560993415|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
155428187|NCT00064701|560993416|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
155428188|NCT00064701|560993414|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
155428189|NCT00064701|560993415|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
155428190|NCT00064701|560993416|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
155428191|NCT00064701|560993414|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
155428192|NCT00064701|560993415|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
155428193|NCT00064701|560993416|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
155428194|NCT00064701|560993414|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
155428195|NCT00064701|560993415|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
155428196|NCT00064701|560993416|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
155428197|NCT00064701|560993414|FG000|Clinical Continuation Phase|Patient opted out|0|||
155428198|NCT00064701|560993415|FG001|Clinical Continuation Phase|Patient opted out|0|||
155428199|NCT00064701|560993416|FG002|Clinical Continuation Phase|Patient opted out|1|||
155428200|NCT03308188|560993417|FG000|Overall Study|Withdrawal by Subject|0|||
155508263|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Adverse Event|0|||
155365983|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
155365984|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
155365985|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155508264|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Adverse Event|1|||
155508265|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155508266|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
155508267|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
155508268|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
155508269|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
155365986|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155508270|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
155508271|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
155508272|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155508273|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
155508274|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
155508275|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
155508276|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
155508277|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
155508278|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
155508279|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
155508280|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
155508281|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
155508282|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
155508283|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
155508284|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
155508285|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
155508286|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Physician Decision|0|||
155508287|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Physician Decision|5|||
155508288|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Physician Decision|1|||
155508289|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Physician Decision|0|||
155508290|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Physician Decision|3|||
155508291|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Physician Decision|1|||
155508292|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Physician Decision|2|||
155365987|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
155365988|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155365989|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
155365990|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
155365991|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155365992|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
155365993|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
155365994|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
155365995|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
155365996|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
155365997|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
155365998|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155365999|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
155366000|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155366001|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155366002|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
155366003|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155366004|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155366005|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
155366006|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155366007|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155366008|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
155366009|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155366010|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155366011|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
155366012|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155366013|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155366014|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
155366015|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155508293|NCT00606684|561286803|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155508294|NCT00606684|561286804|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155366016|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155366017|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
155366018|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155366019|NCT00603525|560774605|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
155366020|NCT00603525|560774606|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
155366021|NCT00603525|560774607|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
155366022|NCT03374488|560774609|FG000|Overall Study|Death|13|||
155366023|NCT03374488|560774610|FG001|Overall Study|Death|13|||
155366024|NCT03374488|560774609|FG000|Overall Study|Withdrawal by Subject|3|||
155366025|NCT03374488|560774610|FG001|Overall Study|Withdrawal by Subject|1|||
155366026|NCT03374488|560774609|FG000|Overall Study|Physician Decision|3|||
155366027|NCT03374488|560774610|FG001|Overall Study|Physician Decision|0|||
155366028|NCT03926195|560774619|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
155366029|NCT03926195|560774620|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
155366030|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
155366031|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
155366032|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
155366033|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
155366034|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
155366035|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
155366036|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
155366037|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
155366038|NCT03926195|560774619|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
155366039|NCT03926195|560774620|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
155366040|NCT03054337|560774621|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366041|NCT03054337|560774622|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
155366042|NCT03054337|560774623|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366043|NCT03054337|560774624|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
155366044|NCT03054337|560774625|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
155366045|NCT03054337|560774626|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366046|NCT01661205|560774629|FG000|Overall Study|Physician Decision|2|||
155366047|NCT00874731|560774631|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
155366048|NCT00874731|560774632|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
155366049|NCT00874731|560774633|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
155366050|NCT00874731|560774631|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
155366051|NCT00874731|560774632|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
155366052|NCT00874731|560774633|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
155366053|NCT00874731|560774631|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
155366054|NCT00874731|560774632|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
155366055|NCT00874731|560774633|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
155366056|NCT05105087|560774634|FG000|Overall Study|Withdrawal by Subject|2|||
155366057|NCT05105087|560774634|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
155366058|NCT01736540|560774635|FG000|Overall Study|Did not complete scan within 45 days|2|||
155366059|NCT01736540|560774635|FG000|Overall Study|Death|1|||
155366060|NCT01736540|560774635|FG000|Overall Study|Abnormal test procedure|1|||
155366061|NCT01736540|560774635|FG000|Overall Study|Withdrawal by Subject|5|||
155366062|NCT01736540|560774635|FG000|Overall Study|Protocol Violation|1|||
155366063|NCT01736540|560774635|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
155366064|NCT01736540|560774635|FG000|Overall Study|No show for MRI appointment|1|||
155366065|NCT01736540|560774635|FG000|Overall Study|Unable to make MRI appointment|3|||
155366066|NCT01735175|560774638|FG000|Overall Study|Withdrawal by Subject|9|||
155366067|NCT01735175|560774639|FG001|Overall Study|Withdrawal by Subject|2|||
155366068|NCT01735175|560774638|FG000|Overall Study|Lost to Follow-up|4|||
155366069|NCT01735175|560774639|FG001|Overall Study|Lost to Follow-up|2|||
155366070|NCT01735175|560774638|FG000|Overall Study|Death|3|||
155366071|NCT01735175|560774639|FG001|Overall Study|Death|2|||
155366072|NCT01735175|560774638|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
155366073|NCT01735175|560774639|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
155366074|NCT00755417|560774642|FG000|Overall Study|Adverse Event|28|||
155366075|NCT00755417|560774643|FG001|Overall Study|Adverse Event|20|||
155428201|NCT03308188|560993418|FG001|Overall Study|Withdrawal by Subject|3|||
155366076|NCT00755417|560774644|FG002|Overall Study|Adverse Event|7|||
155428202|NCT03308188|560993417|FG000|Overall Study|Death|0|||
155428203|NCT03308188|560993418|FG001|Overall Study|Death|1|||
155428204|NCT00772447|560993419|FG000|Overall Study|Withdrawal by Subject|9|||
155428205|NCT00772447|560993420|FG001|Overall Study|Withdrawal by Subject|5|||
155428206|NCT00772447|560993419|FG000|Overall Study|Physician Decision|4|||
155428207|NCT00772447|560993420|FG001|Overall Study|Physician Decision|8|||
155366077|NCT00755417|560774642|FG000|Overall Study|Lack of Efficacy|8|||
155366078|NCT00755417|560774643|FG001|Overall Study|Lack of Efficacy|4|||
155366079|NCT00755417|560774644|FG002|Overall Study|Lack of Efficacy|9|||
155366080|NCT00755417|560774642|FG000|Overall Study|Protocol Violation|2|||
155366081|NCT00755417|560774643|FG001|Overall Study|Protocol Violation|1|||
155366082|NCT00755417|560774644|FG002|Overall Study|Protocol Violation|1|||
155366083|NCT00755417|560774642|FG000|Overall Study|Lost to Follow-up|3|||
155366084|NCT00755417|560774643|FG001|Overall Study|Lost to Follow-up|0|||
155366085|NCT00755417|560774644|FG002|Overall Study|Lost to Follow-up|1|||
155366086|NCT00755417|560774642|FG000|Overall Study|Withdrawal by Subject|12|||
155366087|NCT00755417|560774643|FG001|Overall Study|Withdrawal by Subject|12|||
155366088|NCT00755417|560774644|FG002|Overall Study|Withdrawal by Subject|12|||
155366089|NCT00755417|560774642|FG000|Overall Study|Not specified or missing data|9|||
155366090|NCT00755417|560774643|FG001|Overall Study|Not specified or missing data|18|||
155366091|NCT00755417|560774644|FG002|Overall Study|Not specified or missing data|12|||
155366092|NCT05143138|560774645|FG000|Overall Study|Death|5|||
155366093|NCT05143138|560774646|FG001|Overall Study|Death|35|||
155366094|NCT05143138|560774647|FG002|Overall Study|Death|1|||
155366095|NCT05143138|560774645|FG000|Overall Study|Lost to Follow-up|2|||
155366096|NCT05143138|560774646|FG001|Overall Study|Lost to Follow-up|4|||
155366097|NCT05143138|560774647|FG002|Overall Study|Lost to Follow-up|0|||
155366098|NCT05143138|560774645|FG000|Overall Study|withdrawal|1|||
155366099|NCT05143138|560774646|FG001|Overall Study|withdrawal|1|||
155366100|NCT05143138|560774647|FG002|Overall Study|withdrawal|0|||
155366101|NCT01266161|560774653|FG000|Overall Study|Ineligible|1|||
155366102|NCT01266161|560774654|FG001|Overall Study|Ineligible|0|||
155366103|NCT01266161|560774653|FG000|Overall Study|Lack of Efficacy|0|||
155366104|NCT01266161|560774654|FG001|Overall Study|Lack of Efficacy|1|||
155366105|NCT01266161|560774653|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
155366106|NCT01266161|560774654|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
155366107|NCT01436305|560774656|FG000|Overall Study|Death|1|||
155366108|NCT01436305|560774657|FG001|Overall Study|Death|0|||
155366109|NCT01436305|560774658|FG002|Overall Study|Death|0|||
155366110|NCT01436305|560774656|FG000|Overall Study|Lost to Follow-up|0|||
155366111|NCT01436305|560774657|FG001|Overall Study|Lost to Follow-up|1|||
155366112|NCT01436305|560774658|FG002|Overall Study|Lost to Follow-up|0|||
155366113|NCT01436305|560774656|FG000|Overall Study|Withdrawal by Subject|1|||
155366114|NCT01436305|560774657|FG001|Overall Study|Withdrawal by Subject|3|||
155366115|NCT01436305|560774658|FG002|Overall Study|Withdrawal by Subject|0|||
155366116|NCT01485120|560774666|FG000|Overall Study|Withdrawal by Subject|2|||
155366117|NCT00422734|560774667|FG000|Overall Study|Physician Decision|1|||
155366118|NCT00422734|560774668|FG001|Overall Study|Physician Decision|1|||
155366119|NCT00422734|560774667|FG000|Overall Study|Protocol Violation|1|||
155366120|NCT00422734|560774668|FG001|Overall Study|Protocol Violation|6|||
155366121|NCT00422734|560774667|FG000|Overall Study|Withdrawal by Subject|12|||
155366122|NCT00422734|560774668|FG001|Overall Study|Withdrawal by Subject|8|||
155366123|NCT00422734|560774667|FG000|Overall Study|Adverse Event|0|||
155366124|NCT00422734|560774668|FG001|Overall Study|Adverse Event|3|||
155366125|NCT00422734|560774667|FG000|Overall Study|Partner Decision|0|||
155366126|NCT00422734|560774668|FG001|Overall Study|Partner Decision|3|||
155366127|NCT02344342|560774669|FG000|Overall Study|Industry partner dropped out|11|||
155366128|NCT02344342|560774670|FG001|Overall Study|Industry partner dropped out|9|||
155366129|NCT02344342|560774671|FG002|Overall Study|Industry partner dropped out|14|||
155366130|NCT02344342|560774672|FG003|Overall Study|Industry partner dropped out|10|||
155366131|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
155366132|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
155366133|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
155649298|NCT03931785|561808201|FG003|Overall Study|Other Not specified|2|||
155649299|NCT03931785|561808198|FG000|Overall Study|Withdrawal by Subject|0|||
155649300|NCT03931785|561808199|FG001|Overall Study|Withdrawal by Subject|2|||
155366134|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
155366135|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
155366136|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
155366137|NCT00848484|560774673|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
155366138|NCT00848484|560774674|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
155366139|NCT00848484|560774673|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
155366140|NCT00848484|560774674|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
155649301|NCT03931785|561808200|FG002|Overall Study|Withdrawal by Subject|4|||
155366141|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
155366142|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
155366143|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
155366144|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
155366145|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
155366146|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
155366147|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Death|0|||
155366148|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Death|0|||
155366149|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Death|1|||
155366150|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Death|0|||
155366151|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Death|0|||
155366152|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Death|0|||
155366153|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
155366154|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
155366155|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
155366156|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
155366157|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
155366158|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
155366159|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366160|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366161|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366162|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366163|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366164|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366165|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
155366166|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
155366167|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
155366168|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
155366169|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
155366170|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
155366171|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366172|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
155366173|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366174|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366175|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366176|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366177|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
155366178|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
155366179|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
155366180|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
155366181|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
155366182|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
155366183|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366184|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366185|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366186|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
155366187|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
155366188|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
155366189|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
155366190|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
155366191|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
155366192|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155366193|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155366194|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155366195|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366196|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366197|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366198|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
155366199|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366200|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
155366201|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
155366202|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366203|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
155366204|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366205|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366206|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155428208|NCT00772447|560993419|FG000|Overall Study|Lost to Follow-up|2|||
155428209|NCT00772447|560993420|FG001|Overall Study|Lost to Follow-up|4|||
155428210|NCT00772447|560993419|FG000|Overall Study|incorrect enrolment|3|||
155428211|NCT00772447|560993420|FG001|Overall Study|incorrect enrolment|4|||
155428212|NCT00772447|560993419|FG000|Overall Study|Protocol Violation|0|||
155428213|NCT00772447|560993420|FG001|Overall Study|Protocol Violation|1|||
155428214|NCT00772447|560993419|FG000|Overall Study|all others|2|||
155428215|NCT00772447|560993420|FG001|Overall Study|all others|2|||
155428216|NCT00552110|560993421|FG000|Overall Study|Serious or Life-Threatening AE|0|||
155428217|NCT00552110|560993422|FG001|Overall Study|Serious or Life-Threatening AE|0|||
155428218|NCT00552110|560993423|FG002|Overall Study|Serious or Life-Threatening AE|1|||
155366207|NCT01081886|560774681|FG000|Overall Study|Study termination|11|||
155366208|NCT01081886|560774682|FG001|Overall Study|Study termination|13|||
155366209|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
155366210|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
155366211|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
155366212|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
155366213|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
155366214|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
155366215|NCT02567708|560774683|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
155366216|NCT02567708|560774684|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
155366217|NCT00706654|560774685|FG000|Conversion Phase|Lost to Follow-up|4|||
155366218|NCT00706654|560774686|FG001|Conversion Phase|Lost to Follow-up|0|||
155366219|NCT00706654|560774687|FG002|Conversion Phase|Lost to Follow-up|0|||
155366220|NCT00706654|560774688|FG003|Conversion Phase|Lost to Follow-up|0|||
155366221|NCT00706654|560774685|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
155366222|NCT00706654|560774686|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
155366223|NCT00706654|560774687|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
155366224|NCT00706654|560774688|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
155366225|NCT00706654|560774685|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
155366226|NCT00706654|560774686|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
155366227|NCT00706654|560774687|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
155366228|NCT00706654|560774688|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
155366229|NCT00706654|560774685|FG000|Conversion Phase|Withdrawn by Investigator|14|||
155366230|NCT00706654|560774686|FG001|Conversion Phase|Withdrawn by Investigator|0|||
155366231|NCT00706654|560774687|FG002|Conversion Phase|Withdrawn by Investigator|0|||
155366232|NCT00706654|560774688|FG003|Conversion Phase|Withdrawn by Investigator|0|||
155366233|NCT00706654|560774685|FG000|Conversion Phase|Withdrew Consent|38|||
155366234|NCT00706654|560774686|FG001|Conversion Phase|Withdrew Consent|0|||
155366235|NCT00706654|560774687|FG002|Conversion Phase|Withdrew Consent|0|||
155366236|NCT00706654|560774688|FG003|Conversion Phase|Withdrew Consent|0|||
155366237|NCT00706654|560774685|FG000|Conversion Phase|Adverse Event|18|||
155366238|NCT00706654|560774686|FG001|Conversion Phase|Adverse Event|0|||
155366239|NCT00706654|560774687|FG002|Conversion Phase|Adverse Event|0|||
155366240|NCT00706654|560774688|FG003|Conversion Phase|Adverse Event|0|||
155366241|NCT00706654|560774685|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
155366242|NCT00706654|560774686|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366243|NCT00706654|560774687|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366244|NCT00706654|560774688|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366245|NCT00706654|560774685|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
155366246|NCT00706654|560774686|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366247|NCT00706654|560774687|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366248|NCT00706654|560774688|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366249|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
155366250|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
155366251|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
155366252|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
155366253|NCT00706654|560774685|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
155366254|NCT00706654|560774686|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366255|NCT00706654|560774687|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366256|NCT00706654|560774688|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366257|NCT00706654|560774685|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
155366258|NCT00706654|560774686|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366259|NCT00706654|560774687|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366260|NCT00706654|560774688|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366261|NCT00706654|560774685|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
155366262|NCT00706654|560774686|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366263|NCT00706654|560774687|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366264|NCT00706654|560774688|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366265|NCT00706654|560774685|FG000|Oral Stabilization Phase|Withdrew consent|55|||
155366266|NCT00706654|560774686|FG001|Oral Stabilization Phase|Withdrew consent|0|||
155366267|NCT00706654|560774687|FG002|Oral Stabilization Phase|Withdrew consent|0|||
155366268|NCT00706654|560774688|FG003|Oral Stabilization Phase|Withdrew consent|0|||
155366269|NCT00706654|560774685|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
155366270|NCT00706654|560774686|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
155366271|NCT00706654|560774687|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
155366272|NCT00706654|560774688|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
155366273|NCT00706654|560774685|FG000|Oral Stabilization Phase|Adverse Event|21|||
155366274|NCT00706654|560774686|FG001|Oral Stabilization Phase|Adverse Event|0|||
155366275|NCT00706654|560774687|FG002|Oral Stabilization Phase|Adverse Event|0|||
155366276|NCT00706654|560774688|FG003|Oral Stabilization Phase|Adverse Event|0|||
155366277|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
155366278|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366279|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366280|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366281|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
155366282|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366283|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366284|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366285|NCT00706654|560774685|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
155366286|NCT00706654|560774686|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
155366287|NCT00706654|560774687|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
155366288|NCT00706654|560774688|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
155366289|NCT00706654|560774685|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
155366290|NCT00706654|560774686|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
155366291|NCT00706654|560774687|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
155366292|NCT00706654|560774688|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
155366293|NCT00706654|560774685|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
155366294|NCT00706654|560774686|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
155366295|NCT00706654|560774687|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
155366296|NCT00706654|560774688|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
155366297|NCT00706654|560774685|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
155366298|NCT00706654|560774686|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
155366299|NCT00706654|560774687|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
155366300|NCT00706654|560774688|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
155366301|NCT00706654|560774685|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
155366302|NCT00706654|560774686|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
155366303|NCT00706654|560774687|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
155366304|NCT00706654|560774688|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
155366305|NCT00706654|560774685|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
155366306|NCT00706654|560774686|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
155366307|NCT00706654|560774687|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
155366308|NCT00706654|560774688|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
155366309|NCT00706654|560774685|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
155366310|NCT00706654|560774686|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
155366311|NCT00706654|560774687|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
155366312|NCT00706654|560774688|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
155366313|NCT00706654|560774685|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
155366314|NCT00706654|560774686|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
155366315|NCT00706654|560774687|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
155366316|NCT00706654|560774688|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
155366317|NCT01261000|560774689|FG000|Overall Study|Screen failure|1|||
155366318|NCT01151215|560774690|FG000|Overall Study|Worsening of condition under study|1|||
155366319|NCT01151215|560774691|FG001|Overall Study|Worsening of condition under study|1|||
155366320|NCT01151215|560774692|FG002|Overall Study|Worsening of condition under study|1|||
155366321|NCT01151215|560774690|FG000|Overall Study|Death|16|||
155366322|NCT01151215|560774691|FG001|Overall Study|Death|20|||
155366323|NCT01151215|560774692|FG002|Overall Study|Death|11|||
155366324|NCT01151215|560774690|FG000|Overall Study|Lost to Follow-up|0|||
155366325|NCT01151215|560774691|FG001|Overall Study|Lost to Follow-up|0|||
155366326|NCT01151215|560774692|FG002|Overall Study|Lost to Follow-up|3|||
155366327|NCT01151215|560774690|FG000|Overall Study|Withdrawal by Subject|3|||
155366328|NCT01151215|560774691|FG001|Overall Study|Withdrawal by Subject|1|||
155366329|NCT01151215|560774692|FG002|Overall Study|Withdrawal by Subject|2|||
155508295|NCT00606684|561286805|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155508296|NCT00606684|561286806|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155508297|NCT00606684|561286807|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155508298|NCT00606684|561286808|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155508299|NCT00606684|561286809|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155508300|NCT01759381|561286812|FG000|Overall Study|Death|1|||
155508301|NCT01759381|561286813|FG001|Overall Study|Death|0|||
155508302|NCT03377556|561286814|FG000|Overall Study|Adverse Event|5|||
155508303|NCT03377556|561286814|FG000|Overall Study|Refusal unrelated to adverse events|1|||
155366330|NCT01151215|560774690|FG000|Overall Study|Disease progression|0|||
155366331|NCT01151215|560774691|FG001|Overall Study|Disease progression|1|||
155366332|NCT01151215|560774692|FG002|Overall Study|Disease progression|1|||
155366333|NCT01151215|560774690|FG000|Overall Study|Safety as judged by the investigator|0|||
155366334|NCT01151215|560774691|FG001|Overall Study|Safety as judged by the investigator|0|||
155508304|NCT03377556|561286814|FG000|Overall Study|Progression/relapse|38|||
155508305|NCT03377556|561286814|FG000|Overall Study|Death|3|||
155508306|NCT00827827|561286815|FG000|Overall Study|Lost to Follow-up|3|||
155366335|NCT01151215|560774692|FG002|Overall Study|Safety as judged by the investigator|1|||
155366336|NCT01427725|560774693|FG000|Overall Study|Lost to Follow-up|17|||
155366337|NCT01427725|560774693|FG000|Overall Study|Protocol Violation|1|||
155366338|NCT01427725|560774693|FG000|Overall Study|Drug not administered|1|||
155366339|NCT01427725|560774693|FG000|Overall Study|Failure to visit|7|||
155366340|NCT01427725|560774693|FG000|Overall Study|Adverse Event|46|||
155366341|NCT01427725|560774693|FG000|Overall Study|Failure to visit after administration|40|||
155366342|NCT01427725|560774693|FG000|Overall Study|Patient's rejection|27|||
155366343|NCT01427725|560774693|FG000|Overall Study|Transfer to a different hospital|17|||
155366344|NCT01427725|560774693|FG000|Overall Study|Lack of Efficacy|8|||
155366345|NCT01427725|560774693|FG000|Overall Study|Death|7|||
155366346|NCT01427725|560774693|FG000|Overall Study|Symptom improvement|6|||
155366347|NCT01427725|560774693|FG000|Overall Study|AE and Patient's rejection|5|||
155366348|NCT01427725|560774693|FG000|Overall Study|Physician Decision|5|||
155366349|NCT01427725|560774693|FG000|Overall Study|Exacerbation of underlying disease|5|||
155366350|NCT01427725|560774693|FG000|Overall Study|Oral feeding difficulty|5|||
155366351|NCT01427725|560774693|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
155366352|NCT01427725|560774693|FG000|Overall Study|Forgetting prescription|1|||
155366353|NCT01427725|560774693|FG000|Overall Study|Other|2|||
155366354|NCT00760747|560774694|FG000|Study Period II|Adverse Event|3|||
155366355|NCT00760747|560774695|FG001|Study Period II|Adverse Event|4|||
155366356|NCT00760747|560774694|FG000|Study Period II|Lack of Efficacy|0|||
155366357|NCT00760747|560774695|FG001|Study Period II|Lack of Efficacy|6|||
155366358|NCT00760747|560774694|FG000|Study Period II|Parent/Caregiver Decision|3|||
155366359|NCT00760747|560774695|FG001|Study Period II|Parent/Caregiver Decision|0|||
155366360|NCT00760747|560774694|FG000|Study Period II|Protocol Violation|6|||
155366361|NCT00760747|560774695|FG001|Study Period II|Protocol Violation|3|||
155366362|NCT00760747|560774694|FG000|Study Period II|Withdrawal by Subject|1|||
155366363|NCT00760747|560774695|FG001|Study Period II|Withdrawal by Subject|0|||
155366364|NCT00760747|560774694|FG000|Study Period II|No drug administered|0|||
155366365|NCT00760747|560774695|FG001|Study Period II|No drug administered|1|||
155366366|NCT00760747|560774694|FG000|Study Period III|Adverse Event|1|||
155366367|NCT00760747|560774695|FG001|Study Period III|Adverse Event|0|||
155366368|NCT00760747|560774694|FG000|Study Period III|Lack of Efficacy|1|||
155366369|NCT00760747|560774695|FG001|Study Period III|Lack of Efficacy|0|||
155366370|NCT00760747|560774694|FG000|Study Period III|Parent/Caregiver Decision|0|||
155366371|NCT00760747|560774695|FG001|Study Period III|Parent/Caregiver Decision|1|||
155366372|NCT00760747|560774694|FG000|Study Period III|Protocol Violation|1|||
155366373|NCT00760747|560774695|FG001|Study Period III|Protocol Violation|1|||
155366374|NCT00760747|560774694|FG000|Study Period III|Physician Decision|0|||
155366375|NCT00760747|560774695|FG001|Study Period III|Physician Decision|1|||
155366376|NCT01447576|560774696|FG000|Overall Study|Lost to Follow-up|52|||
155366377|NCT01447576|560774696|FG000|Overall Study|Adverse Event|127|||
155366378|NCT01447576|560774696|FG000|Overall Study|Participant met withdrawal criteria|40|||
155366379|NCT01447576|560774696|FG000|Overall Study|Withdrawal by Subject|100|||
155366380|NCT01447576|560774696|FG000|Overall Study|Protocol deviation|83|||
155366381|NCT01447576|560774696|FG000|Overall Study|Lack of Efficacy|68|||
155366382|NCT01447576|560774696|FG000|Overall Study|Physician Decision|6|||
155366383|NCT03128671|560774697|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
155366384|NCT03128671|560774698|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
155366385|NCT03128671|560774697|FG000|Allocation|Death|1|||
155366386|NCT03128671|560774698|FG001|Allocation|Death|0|||
155366387|NCT03128671|560774697|FG000|Allocation|Withdrawal by Subject|4|||
155366388|NCT03128671|560774698|FG001|Allocation|Withdrawal by Subject|0|||
155366389|NCT03128671|560774697|FG000|Intervention|Withdrawal by Subject|11|||
155366390|NCT03128671|560774698|FG001|Intervention|Withdrawal by Subject|10|||
155366391|NCT03128671|560774697|FG000|Intervention|Palliative/hospice care initiated|9|||
155366392|NCT03128671|560774698|FG001|Intervention|Palliative/hospice care initiated|10|||
155366393|NCT03128671|560774697|FG000|Intervention|Death|13|||
155366394|NCT03128671|560774698|FG001|Intervention|Death|11|||
155366395|NCT03128671|560774697|FG000|Intervention|Interrupted by hurricane|1|||
155366396|NCT03128671|560774698|FG001|Intervention|Interrupted by hurricane|0|||
155366397|NCT03128671|560774697|FG000|Intervention|Physician Decision|2|||
155366398|NCT03128671|560774698|FG001|Intervention|Physician Decision|3|||
155366399|NCT04463680|560774702|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
155366400|NCT04463680|560774702|FG000|Overall Study|Not eligible due to implant duration of use|1|||
155366401|NCT04463680|560774702|FG000|Overall Study|Withdrawal by Subject|3|||
155366402|NCT02592707|560774705|FG000|Overall Study|Consent Withdrawn|0|||
155366403|NCT02592707|560774706|FG001|Overall Study|Consent Withdrawn|1|||
155366404|NCT02592707|560774707|FG002|Overall Study|Consent Withdrawn|2|||
155366405|NCT02592707|560774708|FG003|Overall Study|Consent Withdrawn|0|||
155366406|NCT02592707|560774705|FG000|Overall Study|Death|1|||
155366407|NCT02592707|560774706|FG001|Overall Study|Death|0|||
155366408|NCT02592707|560774707|FG002|Overall Study|Death|0|||
155366409|NCT02592707|560774708|FG003|Overall Study|Death|0|||
155366410|NCT02592707|560774705|FG000|Overall Study|Progressive Disease|4|||
155366411|NCT02592707|560774706|FG001|Overall Study|Progressive Disease|4|||
155366412|NCT02592707|560774707|FG002|Overall Study|Progressive Disease|3|||
155366413|NCT02592707|560774708|FG003|Overall Study|Progressive Disease|3|||
155366414|NCT02592707|560774705|FG000|Overall Study|Other|0|||
155366415|NCT02592707|560774706|FG001|Overall Study|Other|0|||
155366416|NCT02592707|560774707|FG002|Overall Study|Other|1|||
155366417|NCT02592707|560774708|FG003|Overall Study|Other|2|||
155366418|NCT02592707|560774705|FG000|Overall Study|Never entered LTFU period|1|||
155366419|NCT02592707|560774706|FG001|Overall Study|Never entered LTFU period|0|||
155366420|NCT02592707|560774707|FG002|Overall Study|Never entered LTFU period|0|||
155366421|NCT02592707|560774708|FG003|Overall Study|Never entered LTFU period|2|||
155366422|NCT02998476|560774709|FG000|Overall Study|Lost to Follow-up|1|||
155366423|NCT02998476|560774710|FG001|Overall Study|Lost to Follow-up|0|||
155366424|NCT02998476|560774709|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
155366425|NCT02998476|560774710|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
155366426|NCT02998476|560774709|FG000|Overall Study|Withdrawal by Subject|1|||
155366427|NCT02998476|560774710|FG001|Overall Study|Withdrawal by Subject|2|||
155366428|NCT02998476|560774709|FG000|Overall Study|Death|45|||
155366429|NCT02998476|560774710|FG001|Overall Study|Death|2|||
155366430|NCT02998476|560774709|FG000|Overall Study|Other|6|||
155366431|NCT02998476|560774710|FG001|Overall Study|Other|1|||
155366432|NCT04855734|560774711|FG000|Overall Study|Lost to Follow-up|2|||
155366433|NCT04855734|560774712|FG001|Overall Study|Lost to Follow-up|2|||
155366434|NCT03277352|560774713|FG000|Overall Study|Study Terminated By Sponsor|2|||
155366435|NCT03277352|560774713|FG000|Overall Study|Withdrawal by Subject|4|||
155366436|NCT03277352|560774713|FG000|Overall Study|Death|4|||
155366437|NCT01920477|560776121|FG000|Overall Study|Adverse Event|0|||
155366438|NCT01920477|560776122|FG001|Overall Study|Adverse Event|1|||
155366439|NCT01920477|560776121|FG000|Overall Study|Lack of Efficacy|1|||
155366440|NCT01920477|560776122|FG001|Overall Study|Lack of Efficacy|0|||
155366441|NCT01920477|560776121|FG000|Overall Study|Study closed/terminated|14|||
155366442|NCT01920477|560776122|FG001|Overall Study|Study closed/terminated|15|||
155366443|NCT01920477|560776121|FG000|Overall Study|Withdrawal by Subject|0|||
155366444|NCT01920477|560776122|FG001|Overall Study|Withdrawal by Subject|1|||
155366445|NCT01681277|560776123|FG000|Overall Study|Adverse Event|1|||
155366446|NCT01681277|560776124|FG001|Overall Study|Adverse Event|0|||
155366447|NCT01681277|560776125|FG002|Overall Study|Adverse Event|0|||
155366448|NCT01681277|560776126|FG003|Overall Study|Adverse Event|0|||
155366449|NCT01681277|560776127|FG004|Overall Study|Adverse Event|0|||
155366450|NCT03838731|560776128|FG000|Overall Study|Pregnancy|0|||
155366451|NCT03838731|560776129|FG001|Overall Study|Pregnancy|1|||
155366452|NCT03838731|560776128|FG000|Overall Study|Withdrawal of consent|1|||
155366453|NCT03838731|560776129|FG001|Overall Study|Withdrawal of consent|0|||
155366454|NCT02271984|560776132|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366455|NCT02271984|560776133|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366456|NCT02271984|560776134|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366457|NCT02271984|560776135|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366458|NCT02271984|560776136|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366459|NCT02271984|560776137|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
155366460|NCT02271984|560776138|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366461|NCT02271984|560776139|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
155366462|NCT02271984|560776140|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366463|NCT02271984|560776141|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366464|NCT02271984|560776142|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366465|NCT02271984|560776143|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366466|NCT01088984|560776144|FG000|Phase 1|Death|2|||
155366467|NCT01088984|560776145|FG001|Phase 1|Death|1|||
155366468|NCT01088984|560776144|FG000|Phase 1|Disease Progression|2|||
155366469|NCT01088984|560776145|FG001|Phase 1|Disease Progression|4|||
155366470|NCT01088984|560776144|FG000|Phase 1|Other|1|||
155366471|NCT01088984|560776145|FG001|Phase 1|Other|1|||
155366472|NCT01088984|560776144|FG000|Phase 2|Death|0|||
155366473|NCT01088984|560776145|FG001|Phase 2|Death|5|||
155366474|NCT01088984|560776144|FG000|Phase 2|Withdrawal by Subject|0|||
155366475|NCT01088984|560776145|FG001|Phase 2|Withdrawal by Subject|1|||
155366476|NCT01088984|560776144|FG000|Phase 2|DIsease Progression|0|||
155366477|NCT01088984|560776145|FG001|Phase 2|DIsease Progression|25|||
155366478|NCT01088984|560776144|FG000|Phase 2|Other|0|||
155366479|NCT01088984|560776145|FG001|Phase 2|Other|1|||
155366480|NCT01228318|560776146|FG000|Overall Study|Clinic no show to receive intervention|1|||
155366481|NCT01228318|560776147|FG001|Overall Study|Clinic no show to receive intervention|0|||
155366482|NCT01228318|560776146|FG000|Overall Study|Unable to contact|2|||
155366483|NCT01228318|560776147|FG001|Overall Study|Unable to contact|5|||
155366484|NCT01228318|560776146|FG000|Overall Study|Moved|0|||
155366485|NCT01228318|560776147|FG001|Overall Study|Moved|2|||
155366486|NCT01228318|560776146|FG000|Overall Study|Incarcerated|1|||
155366487|NCT01228318|560776147|FG001|Overall Study|Incarcerated|0|||
155366488|NCT00770029|560776152|FG000|Overall Study|Lost to Follow-up|2|||
155366489|NCT00770029|560776153|FG001|Overall Study|Lost to Follow-up|0|||
155366490|NCT00770029|560776152|FG000|Overall Study|Withdrawal by Subject|3|||
155366491|NCT00770029|560776153|FG001|Overall Study|Withdrawal by Subject|3|||
155508307|NCT00827827|561286816|FG001|Overall Study|Lost to Follow-up|0|||
155508308|NCT00827827|561286815|FG000|Overall Study|Fall at home- hospitalization|1|||
155508309|NCT00827827|561286816|FG001|Overall Study|Fall at home- hospitalization|0|||
155508310|NCT00827827|561286815|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
155508311|NCT00827827|561286816|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
155508312|NCT00827827|561286815|FG000|Overall Study|Gout|1|||
155366492|NCT00770029|560776152|FG000|Overall Study|Adverse Event|1|||
155508313|NCT00827827|561286816|FG001|Overall Study|Gout|0|||
155366493|NCT00770029|560776153|FG001|Overall Study|Adverse Event|0|||
155366494|NCT03480932|560776154|FG000|Overall Study|Death|1|||
155366495|NCT03480932|560776155|FG001|Overall Study|Death|1|||
155366496|NCT03480932|560776156|FG002|Overall Study|Death|0|||
155366497|NCT03480932|560776154|FG000|Overall Study|Lost to Follow-up|0|||
155366498|NCT03480932|560776155|FG001|Overall Study|Lost to Follow-up|2|||
155366499|NCT03480932|560776156|FG002|Overall Study|Lost to Follow-up|3|||
155366500|NCT03480932|560776154|FG000|Overall Study|Incarcerated|2|||
155366501|NCT03480932|560776155|FG001|Overall Study|Incarcerated|2|||
155366502|NCT03480932|560776156|FG002|Overall Study|Incarcerated|2|||
155366503|NCT03057847|560776157|FG000|Overall Study|Lost to Follow-up|16|||
155366504|NCT02138786|560776161|FG000|Overall Study|Adverse Event|0|||
155366505|NCT02138786|560776162|FG001|Overall Study|Adverse Event|2|||
155366506|NCT02138786|560776163|FG002|Overall Study|Adverse Event|1|||
155366507|NCT02138786|560776161|FG000|Overall Study|Death|1|||
155366508|NCT02138786|560776162|FG001|Overall Study|Death|7|||
155366509|NCT02138786|560776163|FG002|Overall Study|Death|2|||
155366510|NCT02138786|560776161|FG000|Overall Study|Disease Progression|1|||
155366511|NCT02138786|560776162|FG001|Overall Study|Disease Progression|1|||
155366512|NCT02138786|560776163|FG002|Overall Study|Disease Progression|3|||
155366513|NCT02138786|560776161|FG000|Overall Study|Withdrawal by Subject|1|||
155366514|NCT02138786|560776162|FG001|Overall Study|Withdrawal by Subject|2|||
155366515|NCT02138786|560776163|FG002|Overall Study|Withdrawal by Subject|0|||
155366516|NCT02138786|560776161|FG000|Overall Study|Patient's Wish|0|||
155366517|NCT02138786|560776162|FG001|Overall Study|Patient's Wish|2|||
155366518|NCT02138786|560776163|FG002|Overall Study|Patient's Wish|0|||
155366519|NCT02138786|560776161|FG000|Overall Study|Sponsor Terminated Study|0|||
155366520|NCT02138786|560776162|FG001|Overall Study|Sponsor Terminated Study|1|||
155366521|NCT02138786|560776163|FG002|Overall Study|Sponsor Terminated Study|1|||
155366522|NCT02138786|560776161|FG000|Overall Study|Non-Compliance|0|||
155366523|NCT02138786|560776162|FG001|Overall Study|Non-Compliance|0|||
155366524|NCT02138786|560776163|FG002|Overall Study|Non-Compliance|1|||
155366525|NCT02088957|560776164|FG000|Overall Study|Lack of Efficacy|1|||
155366526|NCT02088957|560776165|FG001|Overall Study|Lack of Efficacy|0|||
155366527|NCT00426127|560776169|FG000|Overall Study|Adverse Event|1|||
155428219|NCT00552110|560993424|FG003|Overall Study|Serious or Life-Threatening AE|0|||
155428220|NCT00552110|560993425|FG004|Overall Study|Serious or Life-Threatening AE|0|||
155428221|NCT00552110|560993421|FG000|Overall Study|Lack of Efficacy|1|||
155428222|NCT00552110|560993422|FG001|Overall Study|Lack of Efficacy|0|||
155428223|NCT00552110|560993423|FG002|Overall Study|Lack of Efficacy|0|||
155428224|NCT00552110|560993424|FG003|Overall Study|Lack of Efficacy|1|||
155366528|NCT00426127|560776169|FG000|Overall Study|Removed due to disease progression|1|||
155366529|NCT03111095|560776172|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
155366530|NCT03111095|560776173|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
155366531|NCT03111095|560776172|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
155366532|NCT03111095|560776173|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
155428225|NCT00552110|560993425|FG004|Overall Study|Lack of Efficacy|4|||
155428226|NCT00552110|560993421|FG000|Overall Study|Withdrawal by Subject|0|||
155428227|NCT00552110|560993422|FG001|Overall Study|Withdrawal by Subject|2|||
155428228|NCT00552110|560993423|FG002|Overall Study|Withdrawal by Subject|0|||
155428229|NCT00552110|560993424|FG003|Overall Study|Withdrawal by Subject|3|||
155428230|NCT00552110|560993425|FG004|Overall Study|Withdrawal by Subject|2|||
155366533|NCT00955708|560776180|FG000|Overall Study|Death|269|||
155366534|NCT00955708|560776180|FG000|Overall Study|Lost to Follow-up|72|||
155366535|NCT00955708|560776180|FG000|Overall Study|Physician Decision|36|||
155366536|NCT00955708|560776180|FG000|Overall Study|Protocol Violation|134|||
155366537|NCT00955708|560776180|FG000|Overall Study|Registry Conclusion|186|||
155366538|NCT00955708|560776180|FG000|Overall Study|Product removed from service|94|||
155366539|NCT00955708|560776180|FG000|Overall Study|Patient Refused to participate further|116|||
155366540|NCT00955708|560776180|FG000|Overall Study|Closure of study location|60|||
155366541|NCT00955708|560776180|FG000|Overall Study|Patient changed care provider/moved|91|||
155366542|NCT01016262|560776181|FG000|Double-blind Phase|Adverse Event|0|||
155366543|NCT01016262|560776182|FG001|Double-blind Phase|Adverse Event|0|||
155366544|NCT01016262|560776183|FG002|Double-blind Phase|Adverse Event|1|||
155366545|NCT01016262|560776184|FG003|Double-blind Phase|Adverse Event|0|||
155366546|NCT01016262|560776185|FG004|Double-blind Phase|Adverse Event|0|||
155366547|NCT01016262|560776186|FG005|Double-blind Phase|Adverse Event|0|||
155366548|NCT01016262|560776181|FG000|Double-blind Phase|Lack of Efficacy|1|||
155366549|NCT01016262|560776182|FG001|Double-blind Phase|Lack of Efficacy|0|||
155366550|NCT01016262|560776183|FG002|Double-blind Phase|Lack of Efficacy|5|||
155366551|NCT01016262|560776184|FG003|Double-blind Phase|Lack of Efficacy|0|||
155366552|NCT01016262|560776185|FG004|Double-blind Phase|Lack of Efficacy|0|||
155366553|NCT01016262|560776186|FG005|Double-blind Phase|Lack of Efficacy|0|||
155366554|NCT01016262|560776181|FG000|Double-blind Phase|Disease Progression|0|||
155366555|NCT01016262|560776182|FG001|Double-blind Phase|Disease Progression|1|||
155366556|NCT01016262|560776183|FG002|Double-blind Phase|Disease Progression|2|||
155366557|NCT01016262|560776184|FG003|Double-blind Phase|Disease Progression|0|||
155366558|NCT01016262|560776185|FG004|Double-blind Phase|Disease Progression|0|||
155366559|NCT01016262|560776186|FG005|Double-blind Phase|Disease Progression|0|||
155366560|NCT01016262|560776181|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366561|NCT01016262|560776182|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366562|NCT01016262|560776183|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
155366563|NCT01016262|560776184|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366564|NCT01016262|560776185|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366565|NCT01016262|560776186|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366566|NCT01016262|560776181|FG000|Open-Label Phase|Adverse Event|0|||
155366567|NCT01016262|560776182|FG001|Open-Label Phase|Adverse Event|0|||
155366568|NCT01016262|560776183|FG002|Open-Label Phase|Adverse Event|0|||
155366569|NCT01016262|560776184|FG003|Open-Label Phase|Adverse Event|1|||
155366570|NCT01016262|560776185|FG004|Open-Label Phase|Adverse Event|0|||
155366571|NCT01016262|560776186|FG005|Open-Label Phase|Adverse Event|0|||
155366572|NCT01016262|560776181|FG000|Open-Label Phase|Lost to Follow-up|0|||
155366573|NCT01016262|560776182|FG001|Open-Label Phase|Lost to Follow-up|0|||
155366574|NCT01016262|560776183|FG002|Open-Label Phase|Lost to Follow-up|0|||
155366575|NCT01016262|560776184|FG003|Open-Label Phase|Lost to Follow-up|0|||
155366576|NCT01016262|560776185|FG004|Open-Label Phase|Lost to Follow-up|1|||
155366577|NCT01016262|560776186|FG005|Open-Label Phase|Lost to Follow-up|0|||
155366578|NCT01016262|560776181|FG000|Open-Label Phase|Lack of Efficacy|0|||
155366579|NCT01016262|560776182|FG001|Open-Label Phase|Lack of Efficacy|0|||
155366580|NCT01016262|560776183|FG002|Open-Label Phase|Lack of Efficacy|0|||
155366581|NCT01016262|560776184|FG003|Open-Label Phase|Lack of Efficacy|1|||
155366582|NCT01016262|560776185|FG004|Open-Label Phase|Lack of Efficacy|0|||
155366583|NCT01016262|560776186|FG005|Open-Label Phase|Lack of Efficacy|0|||
155366584|NCT01016262|560776181|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366585|NCT01016262|560776182|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366586|NCT01016262|560776183|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366587|NCT01016262|560776184|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366588|NCT01016262|560776185|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
155366589|NCT01016262|560776186|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366590|NCT03738475|560776188|FG000|Overall Study|Participant Non-Compliance|1|||
155366591|NCT03738475|560776189|FG001|Overall Study|Participant Non-Compliance|0|||
155366592|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
155366593|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
155366594|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
155366595|NCT04638660|560776192|FG000|Overall Study|Withdrawal by Subject|2|||
155366596|NCT04638660|560776193|FG001|Overall Study|Withdrawal by Subject|0|||
155366597|NCT04638660|560776192|FG000|Overall Study|Lost to Follow-up|1|||
155366598|NCT04638660|560776193|FG001|Overall Study|Lost to Follow-up|0|||
155366599|NCT00863681|560776200|FG000|Overall Study|Other|2|||
155366600|NCT00863681|560776201|FG001|Overall Study|Other|0|||
155366601|NCT00863681|560776202|FG002|Overall Study|Other|0|||
155366602|NCT00863681|560776200|FG000|Overall Study|Missing|1|||
155366603|NCT00863681|560776201|FG001|Overall Study|Missing|0|||
155366604|NCT00863681|560776202|FG002|Overall Study|Missing|0|||
155366605|NCT00863681|560776200|FG000|Overall Study|Death|40|||
155366606|NCT00863681|560776201|FG001|Overall Study|Death|23|||
155366607|NCT00863681|560776202|FG002|Overall Study|Death|6|||
155366608|NCT00863681|560776200|FG000|Overall Study|Withdrawal by Subject|12|||
155366609|NCT00863681|560776201|FG001|Overall Study|Withdrawal by Subject|5|||
155366610|NCT00863681|560776202|FG002|Overall Study|Withdrawal by Subject|2|||
155366611|NCT00863681|560776200|FG000|Overall Study|Protocol Violation|2|||
155366612|NCT00863681|560776201|FG001|Overall Study|Protocol Violation|0|||
155366613|NCT00863681|560776202|FG002|Overall Study|Protocol Violation|0|||
155366614|NCT00863681|560776200|FG000|Overall Study|Lost to Follow-up|3|||
155366615|NCT00863681|560776201|FG001|Overall Study|Lost to Follow-up|0|||
155366616|NCT00863681|560776202|FG002|Overall Study|Lost to Follow-up|3|||
155366617|NCT00863681|560776200|FG000|Overall Study|Adverse Event|28|||
155366618|NCT00863681|560776201|FG001|Overall Study|Adverse Event|10|||
155366619|NCT00863681|560776202|FG002|Overall Study|Adverse Event|6|||
155366620|NCT00863681|560776200|FG000|Overall Study|Lack of Efficacy|2|||
155366621|NCT00863681|560776201|FG001|Overall Study|Lack of Efficacy|2|||
155366622|NCT00863681|560776202|FG002|Overall Study|Lack of Efficacy|1|||
155366623|NCT00863681|560776200|FG000|Overall Study|Non-compliance with study drug|1|||
155366624|NCT00863681|560776201|FG001|Overall Study|Non-compliance with study drug|3|||
155366625|NCT00863681|560776202|FG002|Overall Study|Non-compliance with study drug|0|||
155366626|NCT00659880|560776204|FG000|Overall Study|Lost to Follow-up|5|||
155366627|NCT01853475|560776205|FG000|Overall Study|Withdrawal by Subject|0|||
155366628|NCT01853475|560776206|FG001|Overall Study|Withdrawal by Subject|1|||
155366629|NCT01853475|560776207|FG002|Overall Study|Withdrawal by Subject|0|||
155366630|NCT03199469|560776208|FG000|Overall Study|Randomized, not treated|0|||
155366631|NCT03199469|560776209|FG001|Overall Study|Randomized, not treated|3|||
155366632|NCT03199469|560776208|FG000|Overall Study|Withdrawal by Subject|1|||
155366633|NCT03199469|560776209|FG001|Overall Study|Withdrawal by Subject|0|||
155366634|NCT03199469|560776208|FG000|Overall Study|Death|1|||
155366635|NCT03199469|560776209|FG001|Overall Study|Death|3|||
155366636|NCT03199469|560776208|FG000|Overall Study|Ongoing|5|||
155366637|NCT03199469|560776209|FG001|Overall Study|Ongoing|14|||
155366638|NCT01031628|560776210|FG000|Overall Study|Study terminated early|0|||
155366639|NCT01031628|560776211|FG001|Overall Study|Study terminated early|1|||
155366640|NCT01031628|560776212|FG002|Overall Study|Study terminated early|3|||
155366641|NCT01031628|560776213|FG003|Overall Study|Study terminated early|0|||
155366642|NCT01304498|560776214|FG000|Overall Study|Adverse Event|1|||
155366643|NCT01304498|560776215|FG001|Overall Study|Adverse Event|1|||
155366644|NCT01304498|560776214|FG000|Overall Study|Withdrawal by Subject|2|||
155366645|NCT01304498|560776215|FG001|Overall Study|Withdrawal by Subject|3|||
155428231|NCT00552110|560993421|FG000|Overall Study|Lost to Follow-up|0|||
155366646|NCT01304498|560776214|FG000|Overall Study|Protocol Violation|1|||
155366647|NCT01304498|560776215|FG001|Overall Study|Protocol Violation|0|||
155366648|NCT01304498|560776214|FG000|Overall Study|Lost to Follow-up|2|||
155366649|NCT01304498|560776215|FG001|Overall Study|Lost to Follow-up|1|||
155366650|NCT03080493|560776216|FG000|Overall Study|Did not provide NRS pain results|1|||
155428232|NCT00552110|560993422|FG001|Overall Study|Lost to Follow-up|0|||
155366651|NCT03080493|560776217|FG001|Overall Study|Did not provide NRS pain results|0|||
155366652|NCT03080493|560776216|FG000|Overall Study|Adverse Event|0|||
155366653|NCT03080493|560776217|FG001|Overall Study|Adverse Event|1|||
155366654|NCT03080493|560776216|FG000|Overall Study|Randomization error (parity group)|0|||
155366655|NCT03080493|560776217|FG001|Overall Study|Randomization error (parity group)|1|||
155366656|NCT02803593|560776218|FG000|Overall Study|Lost to Follow-up|17|||
155366657|NCT02803593|560776219|FG001|Overall Study|Lost to Follow-up|35|||
155366658|NCT04245345|560776228|FG000|Overall Study|Death|1|||
155366659|NCT04245345|560776228|FG000|Overall Study|Exited prior to implant|5|||
155366660|NCT04245345|560776228|FG000|Overall Study|Exited prior to 1-month|9|||
155366661|NCT04245345|560776228|FG000|Overall Study|Missed 1-month visit|3|||
155366662|NCT04245345|560776228|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
155366663|NCT04245345|560776228|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
155366664|NCT01834586|560776229|FG000|Overall Study|Adverse Event|1|||
155366665|NCT03325777|560776232|FG000|Overall Study|Lost to Follow-up|9|||
155366666|NCT03325777|560776233|FG001|Overall Study|Lost to Follow-up|12|||
155366667|NCT03004404|560776234|FG000|Period 2|Adverse Event|0|||
155366668|NCT03004404|560776235|FG001|Period 2|Adverse Event|0|||
155366669|NCT03004404|560776236|FG002|Period 2|Adverse Event|0|||
155366670|NCT03004404|560776237|FG003|Period 2|Adverse Event|0|||
155366671|NCT03004404|560776238|FG004|Period 2|Adverse Event|0|||
155366672|NCT03004404|560776239|FG005|Period 2|Adverse Event|0|||
155366673|NCT03004404|560776240|FG006|Period 2|Adverse Event|0|||
155366674|NCT03004404|560776241|FG007|Period 2|Adverse Event|0|||
155366675|NCT03004404|560776242|FG008|Period 2|Adverse Event|1|||
155366676|NCT03004404|560776243|FG009|Period 2|Adverse Event|0|||
155366677|NCT03004404|560776244|FG010|Period 2|Adverse Event|0|||
155366678|NCT03004404|560776245|FG011|Period 2|Adverse Event|0|||
155366679|NCT03004404|560776246|FG012|Period 2|Adverse Event|0|||
155366680|NCT03004404|560776247|FG013|Period 2|Adverse Event|0|||
155366681|NCT03004404|560776248|FG014|Period 2|Adverse Event|0|||
155366682|NCT03004404|560776249|FG015|Period 2|Adverse Event|1|||
155366683|NCT02522728|560776253|FG000|Overall Study|Withdrawal by Subject|6|||
155366684|NCT02522728|560776254|FG001|Overall Study|Withdrawal by Subject|6|||
155366685|NCT02522728|560776253|FG000|Overall Study|Death|4|||
155366686|NCT02522728|560776254|FG001|Overall Study|Death|3|||
155366687|NCT02522728|560776253|FG000|Overall Study|Adverse Event|2|||
155366688|NCT02522728|560776254|FG001|Overall Study|Adverse Event|1|||
155366689|NCT02522728|560776253|FG000|Overall Study|Did not receive randomized study device|0|||
155366690|NCT02522728|560776254|FG001|Overall Study|Did not receive randomized study device|1|||
155366691|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
155366692|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
155366693|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
155366694|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
155366695|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
155366696|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155366697|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
155366698|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
155366699|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
155366700|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
155366701|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
155366702|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
155366703|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
155366704|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
155366705|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
155366706|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
155366707|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
155428233|NCT00552110|560993423|FG002|Overall Study|Lost to Follow-up|0|||
155428234|NCT00552110|560993424|FG003|Overall Study|Lost to Follow-up|1|||
155428235|NCT00552110|560993425|FG004|Overall Study|Lost to Follow-up|1|||
155366708|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
155366709|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
155366710|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
155366711|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
155366712|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
155366713|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155366714|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155366715|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
155366716|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
155366717|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
155366718|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
155366719|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
155366720|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
155366721|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
155366722|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
155366723|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
155366724|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
155366725|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
155366726|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
155366727|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
155366728|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
155366729|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
155366730|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
155366731|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
155366732|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
155366733|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
155366734|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
155366735|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
155366736|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
155366737|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
155366738|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
155366739|NCT01099917|560776258|FG000|Overall Study|Adverse Event|3|||
155366740|NCT01099917|560776258|FG000|Overall Study|Not Treated|24|||
155366741|NCT02990468|560776259|FG000|Phase 2: MTD|Change in treatment|0|||
155366742|NCT02990468|560776260|FG001|Phase 2: MTD|Change in treatment|0|||
155366743|NCT02990468|560776261|FG002|Phase 2: MTD|Change in treatment|1|||
155366744|NCT01001390|560776263|FG000|Overall Study|Failure to wear AFO device|2|||
155366745|NCT01001390|560776264|FG001|Overall Study|Failure to wear AFO device|0|||
155366746|NCT01721954|560776268|FG000|Overall Study|Death|58|||
155366747|NCT01721954|560776269|FG001|Overall Study|Death|64|||
155366748|NCT01721954|560776268|FG000|Overall Study|Withdrawal by Subject|8|||
155366749|NCT01721954|560776269|FG001|Overall Study|Withdrawal by Subject|4|||
155366750|NCT01721954|560776268|FG000|Overall Study|Adverse Event|2|||
155366751|NCT01721954|560776269|FG001|Overall Study|Adverse Event|0|||
155366752|NCT01721954|560776268|FG000|Overall Study|Lost to Follow-up|2|||
155366753|NCT01721954|560776269|FG001|Overall Study|Lost to Follow-up|1|||
155366754|NCT01825577|560776270|FG000|Overall Study|Physician Decision|2|||
155366755|NCT01825577|560776270|FG000|Overall Study|Withdrawal by Subject|1|||
155366756|NCT01825577|560776270|FG000|Overall Study|Withdrawn by family members|2|||
155366757|NCT01825577|560776270|FG000|Overall Study|Lack of Efficacy|3|||
155366758|NCT04230122|560776273|FG000|Overall Study|Lost to Follow-up|1|||
155366759|NCT04230122|560776274|FG001|Overall Study|Lost to Follow-up|0|||
155366760|NCT00108745|560776292|FG000|Overall Study|Withdrawal by Subject|19|||
155366761|NCT00108745|560776293|FG001|Overall Study|Withdrawal by Subject|12|||
155366762|NCT00108745|560776294|FG002|Overall Study|Withdrawal by Subject|12|||
155366763|NCT00108745|560776292|FG000|Overall Study|Never Treated|8|||
155366764|NCT00108745|560776293|FG001|Overall Study|Never Treated|10|||
155366765|NCT00108745|560776294|FG002|Overall Study|Never Treated|12|||
155366766|NCT00108745|560776292|FG000|Overall Study|Ineligible|7|||
155366767|NCT00108745|560776293|FG001|Overall Study|Ineligible|13|||
155366768|NCT00108745|560776294|FG002|Overall Study|Ineligible|13|||
155366769|NCT01228175|560776295|FG000|Overall Study|Lost to Follow-up|64|||
155508314|NCT00827827|561286815|FG000|Overall Study|Transportation issues|1|||
155508315|NCT00827827|561286816|FG001|Overall Study|Transportation issues|0|||
155508316|NCT00827827|561286815|FG000|Overall Study|Burned with water at home|1|||
155508317|NCT00827827|561286816|FG001|Overall Study|Burned with water at home|0|||
155508318|NCT00447603|561286822|FG000|Screening|Withdrawal by Subject|1|||
155366770|NCT01228175|560776296|FG001|Overall Study|Lost to Follow-up|50|||
155366771|NCT01228175|560776295|FG000|Overall Study|Withdrawal by Subject|1|||
155428236|NCT00552110|560993421|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
155428237|NCT00552110|560993422|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
155428238|NCT00552110|560993423|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
155428239|NCT00552110|560993424|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
155428240|NCT00552110|560993425|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
155428241|NCT00552110|560993421|FG000|Overall Study|Withdrawn per Sponsor|0|||
155428242|NCT00552110|560993422|FG001|Overall Study|Withdrawn per Sponsor|1|||
155428243|NCT00552110|560993423|FG002|Overall Study|Withdrawn per Sponsor|0|||
155428244|NCT00552110|560993424|FG003|Overall Study|Withdrawn per Sponsor|0|||
155366772|NCT01228175|560776296|FG001|Overall Study|Withdrawal by Subject|2|||
155366773|NCT01228175|560776295|FG000|Overall Study|Physician Decision|1|||
155508319|NCT00447603|561286823|FG001|Screening|Withdrawal by Subject|0|||
155366774|NCT01228175|560776296|FG001|Overall Study|Physician Decision|1|||
155366775|NCT00402051|560776297|FG000|Overall Study|Progressive Disease|13|||
155508320|NCT00447603|561286824|FG002|Screening|Withdrawal by Subject|0|||
155508321|NCT00447603|561286822|FG000|Screening|Protocol Violation|1|||
155508322|NCT00447603|561286823|FG001|Screening|Protocol Violation|0|||
155508323|NCT00447603|561286824|FG002|Screening|Protocol Violation|0|||
155508324|NCT00447603|561286822|FG000|Screening|Screen Failure|4|||
155508325|NCT00447603|561286823|FG001|Screening|Screen Failure|0|||
155508326|NCT00447603|561286824|FG002|Screening|Screen Failure|0|||
155508327|NCT00447603|561286822|FG000|Screening|Study Terminated by Sponsor|15|||
155508328|NCT00447603|561286823|FG001|Screening|Study Terminated by Sponsor|0|||
155366776|NCT00402051|560776298|FG001|Overall Study|Progressive Disease|20|||
155366777|NCT00402051|560776297|FG000|Overall Study|Adverse Event|11|||
155366778|NCT00402051|560776298|FG001|Overall Study|Adverse Event|4|||
155366779|NCT00402051|560776297|FG000|Overall Study|Physician Decision|7|||
155366780|NCT00402051|560776298|FG001|Overall Study|Physician Decision|3|||
155366781|NCT00402051|560776297|FG000|Overall Study|Withdrawal by Subject|3|||
155366782|NCT00402051|560776298|FG001|Overall Study|Withdrawal by Subject|3|||
155366783|NCT00402051|560776297|FG000|Overall Study|Death - Related to Study Drug|1|||
155366784|NCT00402051|560776298|FG001|Overall Study|Death - Related to Study Drug|2|||
155366785|NCT00402051|560776297|FG000|Overall Study|Death Due to Study Disease|2|||
155366786|NCT00402051|560776298|FG001|Overall Study|Death Due to Study Disease|1|||
155366787|NCT00402051|560776297|FG000|Overall Study|Death Due to Adverse Event|0|||
155366788|NCT00402051|560776298|FG001|Overall Study|Death Due to Adverse Event|2|||
155366789|NCT00402051|560776297|FG000|Overall Study|Lost to Follow-up|1|||
155366790|NCT00402051|560776298|FG001|Overall Study|Lost to Follow-up|0|||
155366791|NCT00277095|560776299|FG000|Overall Study|Death|2|||
155366792|NCT00277095|560776299|FG000|Overall Study|Explanted|7|||
155366793|NCT00277095|560776299|FG000|Overall Study|Lost to Follow-up|2|||
155366794|NCT00277095|560776299|FG000|Overall Study|Missed Follow-up|9|||
155366795|NCT00277095|560776299|FG000|Overall Study|Physician Decision|1|||
155366796|NCT05415748|560776303|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
155366797|NCT05415748|560776304|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
155366798|NCT05415748|560776305|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
155366799|NCT05415748|560776306|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
155366800|NCT05415748|560776303|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
155366801|NCT05415748|560776304|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366802|NCT05415748|560776305|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366803|NCT05415748|560776306|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366804|NCT03075527|560776307|FG000|Overall Study|Death|1|||
155366805|NCT03075527|560776307|FG000|Overall Study|Withdrawal by Subject|1|||
155366806|NCT03075527|560776307|FG000|Overall Study|Physician Decision|3|||
155366807|NCT03075527|560776307|FG000|Overall Study|Progression/Relapse|14|||
155366808|NCT03832595|560776310|FG000|Overall Study|Death|142|||
155366809|NCT03832595|560776311|FG001|Overall Study|Death|130|||
155366810|NCT03832595|560776310|FG000|Overall Study|Medical management without dialysis|37|||
155366811|NCT03832595|560776311|FG001|Overall Study|Medical management without dialysis|1|||
155366812|NCT03412773|560778402|FG000|Overall Study|Lost to Follow-up|0|||
155366813|NCT03412773|560778403|FG001|Overall Study|Lost to Follow-up|7|||
155366814|NCT03412773|560778404|FG002|Overall Study|Lost to Follow-up|6|||
155366815|NCT03412773|560778402|FG000|Overall Study|Withdrawal by Subject|0|||
155366816|NCT03412773|560778403|FG001|Overall Study|Withdrawal by Subject|15|||
155366817|NCT03412773|560778404|FG002|Overall Study|Withdrawal by Subject|19|||
155366818|NCT03412773|560778402|FG000|Overall Study|Study Closed By Sponsor|3|||
155366819|NCT03412773|560778403|FG001|Overall Study|Study Closed By Sponsor|46|||
155366820|NCT03412773|560778404|FG002|Overall Study|Study Closed By Sponsor|33|||
155366821|NCT03412773|560778402|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
155366822|NCT03412773|560778403|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
155366823|NCT03412773|560778404|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
155366824|NCT03412773|560778402|FG000|Overall Study|Death|7|||
155366825|NCT03412773|560778403|FG001|Overall Study|Death|259|||
155366826|NCT03412773|560778404|FG002|Overall Study|Death|273|||
155508329|NCT00447603|561286824|FG002|Screening|Study Terminated by Sponsor|0|||
155508330|NCT00447603|561286822|FG000|Filter Period|Adverse Event|0|||
155366827|NCT03412773|560778402|FG000|Overall Study|Physician Decision|0|||
155508331|NCT00447603|561286823|FG001|Filter Period|Adverse Event|0|||
155508332|NCT00447603|561286824|FG002|Filter Period|Adverse Event|1|||
155366828|NCT03412773|560778403|FG001|Overall Study|Physician Decision|0|||
155508333|NCT00447603|561286822|FG000|Filter Period|Screen Failure|0|||
155508334|NCT00447603|561286823|FG001|Filter Period|Screen Failure|3|||
155508335|NCT00447603|561286824|FG002|Filter Period|Screen Failure|4|||
155366829|NCT03412773|560778404|FG002|Overall Study|Physician Decision|1|||
155366830|NCT02643303|560778407|FG000|Overall Study|Progressive Disease|4|||
155366831|NCT02643303|560778408|FG001|Overall Study|Progressive Disease|4|||
155366832|NCT02643303|560778409|FG002|Overall Study|Progressive Disease|1|||
155366833|NCT02643303|560778410|FG003|Overall Study|Progressive Disease|12|||
155508336|NCT00447603|561286822|FG000|Filter Period|Study terminated by Sponsor|0|||
155366834|NCT02643303|560778411|FG004|Overall Study|Progressive Disease|6|||
155366835|NCT02643303|560778412|FG005|Overall Study|Progressive Disease|4|||
155366836|NCT02643303|560778413|FG006|Overall Study|Progressive Disease|8|||
155366837|NCT02643303|560778414|FG007|Overall Study|Progressive Disease|2|||
155366838|NCT02643303|560778415|FG008|Overall Study|Progressive Disease|6|||
155366839|NCT02643303|560778407|FG000|Overall Study|Adverse Event|0|||
155366840|NCT02643303|560778408|FG001|Overall Study|Adverse Event|1|||
155366841|NCT02643303|560778409|FG002|Overall Study|Adverse Event|0|||
155366842|NCT02643303|560778410|FG003|Overall Study|Adverse Event|0|||
155366843|NCT02643303|560778411|FG004|Overall Study|Adverse Event|1|||
155366844|NCT02643303|560778412|FG005|Overall Study|Adverse Event|0|||
155366845|NCT02643303|560778413|FG006|Overall Study|Adverse Event|0|||
155366846|NCT02643303|560778414|FG007|Overall Study|Adverse Event|0|||
155366847|NCT02643303|560778415|FG008|Overall Study|Adverse Event|0|||
155366848|NCT02643303|560778407|FG000|Overall Study|Withdrawal by Subject|0|||
155366849|NCT02643303|560778408|FG001|Overall Study|Withdrawal by Subject|0|||
155366850|NCT02643303|560778409|FG002|Overall Study|Withdrawal by Subject|0|||
155366851|NCT02643303|560778410|FG003|Overall Study|Withdrawal by Subject|1|||
155366852|NCT02643303|560778411|FG004|Overall Study|Withdrawal by Subject|0|||
155366853|NCT02643303|560778412|FG005|Overall Study|Withdrawal by Subject|0|||
155366854|NCT02643303|560778413|FG006|Overall Study|Withdrawal by Subject|1|||
155366855|NCT02643303|560778414|FG007|Overall Study|Withdrawal by Subject|1|||
155366856|NCT02643303|560778415|FG008|Overall Study|Withdrawal by Subject|1|||
155366857|NCT01174446|560778418|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366858|NCT01174446|560778419|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366859|NCT01174446|560778420|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
155366860|NCT01174446|560778421|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366861|NCT01174446|560778418|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366862|NCT01174446|560778419|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366863|NCT01174446|560778420|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
155366864|NCT01174446|560778421|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366865|NCT01174446|560778418|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
155366866|NCT01174446|560778419|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366867|NCT01174446|560778420|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366868|NCT01174446|560778421|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366869|NCT01174446|560778418|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366870|NCT01174446|560778419|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
155366871|NCT01174446|560778420|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366872|NCT01174446|560778421|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366873|NCT00847626|560778422|FG000|Overall Study|Adverse Event|10|||
155366874|NCT00847626|560778423|FG001|Overall Study|Adverse Event|10|||
155366875|NCT00847626|560778424|FG002|Overall Study|Adverse Event|6|||
155366876|NCT00847626|560778425|FG003|Overall Study|Adverse Event|19|||
155366877|NCT00847626|560778426|FG004|Overall Study|Adverse Event|11|||
155366878|NCT00847626|560778427|FG005|Overall Study|Adverse Event|22|||
155366879|NCT00847626|560778428|FG006|Overall Study|Adverse Event|4|||
155366880|NCT00847626|560778429|FG007|Overall Study|Adverse Event|6|||
155366881|NCT00847626|560778430|FG008|Overall Study|Adverse Event|3|||
155366882|NCT00847626|560778431|FG009|Overall Study|Adverse Event|6|||
155366883|NCT00847626|560778432|FG010|Overall Study|Adverse Event|6|||
155366884|NCT00847626|560778422|FG000|Overall Study|Protocol Violation|2|||
155366885|NCT00847626|560778423|FG001|Overall Study|Protocol Violation|1|||
155366886|NCT00847626|560778424|FG002|Overall Study|Protocol Violation|2|||
155366887|NCT00847626|560778425|FG003|Overall Study|Protocol Violation|1|||
155366888|NCT00847626|560778426|FG004|Overall Study|Protocol Violation|1|||
155366889|NCT00847626|560778427|FG005|Overall Study|Protocol Violation|1|||
155366890|NCT00847626|560778428|FG006|Overall Study|Protocol Violation|1|||
155366891|NCT00847626|560778429|FG007|Overall Study|Protocol Violation|1|||
155366892|NCT00847626|560778430|FG008|Overall Study|Protocol Violation|0|||
155366893|NCT00847626|560778431|FG009|Overall Study|Protocol Violation|1|||
155366894|NCT00847626|560778432|FG010|Overall Study|Protocol Violation|1|||
155366895|NCT00847626|560778422|FG000|Overall Study|Lost to Follow-up|0|||
155366896|NCT00847626|560778423|FG001|Overall Study|Lost to Follow-up|1|||
155366897|NCT00847626|560778424|FG002|Overall Study|Lost to Follow-up|1|||
155366898|NCT00847626|560778425|FG003|Overall Study|Lost to Follow-up|1|||
155366899|NCT00847626|560778426|FG004|Overall Study|Lost to Follow-up|0|||
155366900|NCT00847626|560778427|FG005|Overall Study|Lost to Follow-up|3|||
155366901|NCT00847626|560778428|FG006|Overall Study|Lost to Follow-up|1|||
155508337|NCT00447603|561286823|FG001|Filter Period|Study terminated by Sponsor|1|||
155366902|NCT00847626|560778429|FG007|Overall Study|Lost to Follow-up|3|||
155366903|NCT00847626|560778430|FG008|Overall Study|Lost to Follow-up|1|||
155366904|NCT00847626|560778431|FG009|Overall Study|Lost to Follow-up|0|||
155366905|NCT00847626|560778432|FG010|Overall Study|Lost to Follow-up|1|||
155366906|NCT00847626|560778422|FG000|Overall Study|Withdrawal by Subject|5|||
155366907|NCT00847626|560778423|FG001|Overall Study|Withdrawal by Subject|5|||
155366908|NCT00847626|560778424|FG002|Overall Study|Withdrawal by Subject|3|||
155366909|NCT00847626|560778425|FG003|Overall Study|Withdrawal by Subject|8|||
155366910|NCT00847626|560778426|FG004|Overall Study|Withdrawal by Subject|12|||
155366911|NCT00847626|560778427|FG005|Overall Study|Withdrawal by Subject|9|||
155366912|NCT00847626|560778428|FG006|Overall Study|Withdrawal by Subject|8|||
155366913|NCT00847626|560778429|FG007|Overall Study|Withdrawal by Subject|4|||
155366914|NCT00847626|560778430|FG008|Overall Study|Withdrawal by Subject|4|||
155366915|NCT00847626|560778431|FG009|Overall Study|Withdrawal by Subject|5|||
155366916|NCT00847626|560778432|FG010|Overall Study|Withdrawal by Subject|2|||
155366917|NCT00847626|560778422|FG000|Overall Study|Lack of Efficacy|3|||
155366918|NCT00847626|560778423|FG001|Overall Study|Lack of Efficacy|1|||
155366919|NCT00847626|560778424|FG002|Overall Study|Lack of Efficacy|0|||
155366920|NCT00847626|560778425|FG003|Overall Study|Lack of Efficacy|1|||
155366921|NCT00847626|560778426|FG004|Overall Study|Lack of Efficacy|2|||
155366922|NCT00847626|560778427|FG005|Overall Study|Lack of Efficacy|0|||
155366923|NCT00847626|560778428|FG006|Overall Study|Lack of Efficacy|6|||
155366924|NCT00847626|560778429|FG007|Overall Study|Lack of Efficacy|2|||
155366925|NCT00847626|560778430|FG008|Overall Study|Lack of Efficacy|5|||
155366926|NCT00847626|560778431|FG009|Overall Study|Lack of Efficacy|1|||
155366927|NCT00847626|560778432|FG010|Overall Study|Lack of Efficacy|7|||
155366928|NCT00847626|560778422|FG000|Overall Study|Other|1|||
155366929|NCT00847626|560778423|FG001|Overall Study|Other|5|||
155366930|NCT00847626|560778424|FG002|Overall Study|Other|4|||
155366931|NCT00847626|560778425|FG003|Overall Study|Other|1|||
155366932|NCT00847626|560778426|FG004|Overall Study|Other|2|||
155366933|NCT00847626|560778427|FG005|Overall Study|Other|2|||
155366934|NCT00847626|560778428|FG006|Overall Study|Other|2|||
155366935|NCT00847626|560778429|FG007|Overall Study|Other|3|||
155366936|NCT00847626|560778430|FG008|Overall Study|Other|1|||
155366937|NCT00847626|560778431|FG009|Overall Study|Other|1|||
155366938|NCT00847626|560778432|FG010|Overall Study|Other|3|||
155366939|NCT00737477|560778433|FG000|Overall Study|Adverse Event|9|||
155366940|NCT00737477|560778433|FG000|Overall Study|Death|9|||
155366941|NCT00737477|560778433|FG000|Overall Study|Treatment Refusal|1|||
155366942|NCT00737477|560778433|FG000|Overall Study|Withdrawal by Subject|1|||
155366943|NCT00737477|560778433|FG000|Overall Study|Renal Transplantation|10|||
155366944|NCT00737477|560778433|FG000|Overall Study|Other|4|||
155366945|NCT01132820|560778434|FG000|Overall Study|Ineligible: wrong cell type|1|||
155649302|NCT03931785|561808201|FG003|Overall Study|Withdrawal by Subject|1|||
155366946|NCT01132820|560778434|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
155366947|NCT01132820|560778434|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
155366948|NCT01132820|560778434|FG000|Overall Study|Never treated|1|||
155366949|NCT01132820|560778434|FG000|Overall Study|Inadequate data|1|||
155366950|NCT01370655|560778435|FG000|Period 1|Adverse Event|2|||
155366951|NCT01370655|560778436|FG001|Period 1|Adverse Event|0|||
155366952|NCT01370655|560778437|FG002|Period 1|Adverse Event|0|||
155366953|NCT01370655|560778438|FG003|Period 1|Adverse Event|0|||
155366954|NCT01370655|560778439|FG004|Period 1|Adverse Event|0|||
155366955|NCT01370655|560778440|FG005|Period 1|Adverse Event|0|||
155366956|NCT01370655|560778441|FG006|Period 1|Adverse Event|1|||
155366957|NCT01370655|560778442|FG007|Period 1|Adverse Event|0|||
155366958|NCT01370655|560778443|FG008|Period 1|Adverse Event|0|||
155366959|NCT01370655|560778444|FG009|Period 1|Adverse Event|0|||
155366960|NCT01370655|560778445|FG010|Period 1|Adverse Event|0|||
155366961|NCT01370655|560778446|FG011|Period 1|Adverse Event|0|||
155366962|NCT01370655|560778435|FG000|Period 2|Adverse Event|0|||
155366963|NCT01370655|560778436|FG001|Period 2|Adverse Event|0|||
155366964|NCT01370655|560778437|FG002|Period 2|Adverse Event|1|||
155366965|NCT01370655|560778438|FG003|Period 2|Adverse Event|0|||
155366966|NCT01370655|560778439|FG004|Period 2|Adverse Event|1|||
155366967|NCT01370655|560778440|FG005|Period 2|Adverse Event|0|||
155366968|NCT01370655|560778441|FG006|Period 2|Adverse Event|0|||
155366969|NCT01370655|560778442|FG007|Period 2|Adverse Event|1|||
155366970|NCT01370655|560778443|FG008|Period 2|Adverse Event|0|||
155366971|NCT01370655|560778444|FG009|Period 2|Adverse Event|0|||
155366972|NCT01370655|560778445|FG010|Period 2|Adverse Event|0|||
155366973|NCT01370655|560778446|FG011|Period 2|Adverse Event|0|||
155366974|NCT01370655|560778435|FG000|Period 2|met protocol specified stopping criteria|0|||
155366975|NCT01370655|560778436|FG001|Period 2|met protocol specified stopping criteria|0|||
155366976|NCT01370655|560778437|FG002|Period 2|met protocol specified stopping criteria|1|||
155366977|NCT01370655|560778438|FG003|Period 2|met protocol specified stopping criteria|0|||
155366978|NCT01370655|560778439|FG004|Period 2|met protocol specified stopping criteria|0|||
155366979|NCT01370655|560778440|FG005|Period 2|met protocol specified stopping criteria|0|||
155366980|NCT01370655|560778441|FG006|Period 2|met protocol specified stopping criteria|1|||
155366981|NCT01370655|560778442|FG007|Period 2|met protocol specified stopping criteria|0|||
155366982|NCT01370655|560778443|FG008|Period 2|met protocol specified stopping criteria|1|||
155366983|NCT01370655|560778444|FG009|Period 2|met protocol specified stopping criteria|0|||
155366984|NCT01370655|560778445|FG010|Period 2|met protocol specified stopping criteria|1|||
155366985|NCT01370655|560778446|FG011|Period 2|met protocol specified stopping criteria|0|||
155366986|NCT01370655|560778435|FG000|Period 2|Withdrawal by Subject|0|||
155366987|NCT01370655|560778436|FG001|Period 2|Withdrawal by Subject|0|||
155366988|NCT01370655|560778437|FG002|Period 2|Withdrawal by Subject|0|||
155366989|NCT01370655|560778438|FG003|Period 2|Withdrawal by Subject|0|||
155366990|NCT01370655|560778439|FG004|Period 2|Withdrawal by Subject|0|||
155366991|NCT01370655|560778440|FG005|Period 2|Withdrawal by Subject|0|||
155366992|NCT01370655|560778441|FG006|Period 2|Withdrawal by Subject|0|||
155366993|NCT01370655|560778442|FG007|Period 2|Withdrawal by Subject|0|||
155366994|NCT01370655|560778443|FG008|Period 2|Withdrawal by Subject|1|||
155366995|NCT01370655|560778444|FG009|Period 2|Withdrawal by Subject|0|||
155366996|NCT01370655|560778445|FG010|Period 2|Withdrawal by Subject|0|||
155366997|NCT01370655|560778446|FG011|Period 2|Withdrawal by Subject|0|||
155366998|NCT01730378|560778447|FG000|Overall Study|Lost to Follow-up|1|||
155366999|NCT01730378|560778448|FG001|Overall Study|Lost to Follow-up|0|||
155367000|NCT02687035|560778449|FG000|Overall Study|Withdrawal by Subject|1|||
155367001|NCT02687035|560778449|FG000|Overall Study|Death|87|||
155367002|NCT02687035|560778449|FG000|Overall Study|Lost to Follow-up|1|||
155367003|NCT02687035|560778449|FG000|Overall Study|Missed Visit|87|||
155367004|NCT02687035|560778449|FG000|Overall Study|Did not receive Study Device|8|||
155367005|NCT00667394|560778453|FG000|Overall Study|Adverse Event|3|||
155367006|NCT00667394|560778454|FG001|Overall Study|Adverse Event|0|||
155367007|NCT00667394|560778453|FG000|Overall Study|Progressive disease|1|||
155367008|NCT00667394|560778454|FG001|Overall Study|Progressive disease|0|||
155367009|NCT05000216|560778458|FG000|Stage 1|Lost to Follow-up|0|||
155367010|NCT05000216|560778459|FG001|Stage 1|Lost to Follow-up|0|||
155367011|NCT05000216|560778460|FG002|Stage 1|Lost to Follow-up|0|||
155367012|NCT05000216|560778461|FG003|Stage 1|Lost to Follow-up|0|||
155367013|NCT05000216|560778462|FG004|Stage 1|Lost to Follow-up|0|||
155367014|NCT05000216|560778463|FG005|Stage 1|Lost to Follow-up|0|||
155367015|NCT05000216|560778464|FG006|Stage 1|Lost to Follow-up|1|||
155367016|NCT05000216|560778465|FG007|Stage 1|Lost to Follow-up|1|||
155367017|NCT05000216|560778466|FG008|Stage 1|Lost to Follow-up|0|||
155367018|NCT05000216|560778467|FG009|Stage 1|Lost to Follow-up|2|||
155367019|NCT05000216|560778468|FG010|Stage 1|Lost to Follow-up|3|||
155367020|NCT05000216|560778469|FG011|Stage 1|Lost to Follow-up|0|||
155367021|NCT05000216|560778470|FG012|Stage 1|Lost to Follow-up|0|||
155367022|NCT05000216|560778471|FG013|Stage 1|Lost to Follow-up|0|||
155367023|NCT05000216|560778472|FG014|Stage 1|Lost to Follow-up|0|||
155508338|NCT00447603|561286824|FG002|Filter Period|Study terminated by Sponsor|10|||
155508339|NCT01907737|561286833|FG000|Overall Study|Withdrawal by Subject|1|||
155508340|NCT00608205|561286854|FG000|Overall Study|Adverse Event|3|||
155508341|NCT00608205|561286855|FG001|Overall Study|Adverse Event|2|||
155508342|NCT00608205|561286854|FG000|Overall Study|Patient non-compliant|0|||
155508343|NCT00608205|561286855|FG001|Overall Study|Patient non-compliant|1|||
155367024|NCT05000216|560778473|FG015|Stage 1|Lost to Follow-up|0|||
155367025|NCT05000216|560778474|FG016|Stage 1|Lost to Follow-up|0|||
155367026|NCT05000216|560778475|FG017|Stage 1|Lost to Follow-up|0|||
155508344|NCT01003886|561286856|FG000|Overall Study|Lack of Efficacy|5|||
155508345|NCT01003886|561286856|FG000|Overall Study|Lost to Follow-up|169|||
155367027|NCT05000216|560778476|FG018|Stage 1|Lost to Follow-up|0|||
155508346|NCT01003886|561286856|FG000|Overall Study|Withdrawal by Subject|39|||
155367028|NCT05000216|560778477|FG019|Stage 1|Lost to Follow-up|0|||
155367029|NCT05000216|560778478|FG020|Stage 1|Lost to Follow-up|0|||
155508347|NCT01003886|561286856|FG000|Overall Study|Other|14|||
155367030|NCT05000216|560778479|FG021|Stage 1|Lost to Follow-up|0|||
155367031|NCT05000216|560778458|FG000|Stage 1|Physician Decision|0|||
155367032|NCT05000216|560778459|FG001|Stage 1|Physician Decision|0|||
155367033|NCT05000216|560778460|FG002|Stage 1|Physician Decision|0|||
155367034|NCT05000216|560778461|FG003|Stage 1|Physician Decision|0|||
155367035|NCT05000216|560778462|FG004|Stage 1|Physician Decision|0|||
155367036|NCT05000216|560778463|FG005|Stage 1|Physician Decision|0|||
155367037|NCT05000216|560778464|FG006|Stage 1|Physician Decision|0|||
155367038|NCT05000216|560778465|FG007|Stage 1|Physician Decision|1|||
155367039|NCT05000216|560778466|FG008|Stage 1|Physician Decision|1|||
155367040|NCT05000216|560778467|FG009|Stage 1|Physician Decision|0|||
155367041|NCT05000216|560778468|FG010|Stage 1|Physician Decision|0|||
155367042|NCT05000216|560778469|FG011|Stage 1|Physician Decision|0|||
155367043|NCT05000216|560778470|FG012|Stage 1|Physician Decision|0|||
155367044|NCT05000216|560778471|FG013|Stage 1|Physician Decision|0|||
155367045|NCT05000216|560778472|FG014|Stage 1|Physician Decision|0|||
155367046|NCT05000216|560778473|FG015|Stage 1|Physician Decision|0|||
155367047|NCT05000216|560778474|FG016|Stage 1|Physician Decision|0|||
155367048|NCT05000216|560778475|FG017|Stage 1|Physician Decision|0|||
155367049|NCT05000216|560778476|FG018|Stage 1|Physician Decision|0|||
155367050|NCT05000216|560778477|FG019|Stage 1|Physician Decision|0|||
155367051|NCT05000216|560778478|FG020|Stage 1|Physician Decision|0|||
155367052|NCT05000216|560778479|FG021|Stage 1|Physician Decision|0|||
155367053|NCT05000216|560778458|FG000|Stage 1|Withdrawal by Subject|0|||
155367054|NCT05000216|560778459|FG001|Stage 1|Withdrawal by Subject|1|||
155367055|NCT05000216|560778460|FG002|Stage 1|Withdrawal by Subject|0|||
155367056|NCT05000216|560778461|FG003|Stage 1|Withdrawal by Subject|0|||
155367057|NCT05000216|560778462|FG004|Stage 1|Withdrawal by Subject|0|||
155367058|NCT05000216|560778463|FG005|Stage 1|Withdrawal by Subject|0|||
155367059|NCT05000216|560778464|FG006|Stage 1|Withdrawal by Subject|0|||
155367060|NCT05000216|560778465|FG007|Stage 1|Withdrawal by Subject|0|||
155367061|NCT05000216|560778466|FG008|Stage 1|Withdrawal by Subject|0|||
155367062|NCT05000216|560778467|FG009|Stage 1|Withdrawal by Subject|3|||
155367063|NCT05000216|560778468|FG010|Stage 1|Withdrawal by Subject|10|||
155367064|NCT05000216|560778469|FG011|Stage 1|Withdrawal by Subject|0|||
155367065|NCT05000216|560778470|FG012|Stage 1|Withdrawal by Subject|0|||
155367066|NCT05000216|560778471|FG013|Stage 1|Withdrawal by Subject|0|||
155367067|NCT05000216|560778472|FG014|Stage 1|Withdrawal by Subject|0|||
155367068|NCT05000216|560778473|FG015|Stage 1|Withdrawal by Subject|0|||
155367069|NCT05000216|560778474|FG016|Stage 1|Withdrawal by Subject|0|||
155367070|NCT05000216|560778475|FG017|Stage 1|Withdrawal by Subject|0|||
155367071|NCT05000216|560778476|FG018|Stage 1|Withdrawal by Subject|0|||
155367072|NCT05000216|560778477|FG019|Stage 1|Withdrawal by Subject|0|||
155367073|NCT05000216|560778478|FG020|Stage 1|Withdrawal by Subject|0|||
155367074|NCT05000216|560778479|FG021|Stage 1|Withdrawal by Subject|0|||
155367075|NCT05000216|560778458|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
155367076|NCT05000216|560778459|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
155367077|NCT05000216|560778460|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
155367078|NCT05000216|560778461|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
155367079|NCT05000216|560778462|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
155367080|NCT05000216|560778463|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
155367081|NCT05000216|560778464|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
155367082|NCT05000216|560778465|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
155367083|NCT05000216|560778466|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
155367084|NCT05000216|560778467|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
155367085|NCT05000216|560778468|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
155367086|NCT05000216|560778469|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
155367087|NCT05000216|560778470|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
155367088|NCT05000216|560778471|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
155367089|NCT05000216|560778472|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
155367090|NCT05000216|560778473|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
155367091|NCT05000216|560778474|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
155367092|NCT05000216|560778475|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
155367093|NCT05000216|560778476|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
155367094|NCT05000216|560778477|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
155367095|NCT05000216|560778478|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
155367096|NCT05000216|560778479|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
155367097|NCT05000216|560778458|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367098|NCT05000216|560778459|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367099|NCT05000216|560778460|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367100|NCT05000216|560778461|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367101|NCT05000216|560778462|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367102|NCT05000216|560778463|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367103|NCT05000216|560778464|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367104|NCT05000216|560778465|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367105|NCT05000216|560778466|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
155367106|NCT05000216|560778467|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155649303|NCT03931785|561808198|FG000|Overall Study|Pregnancy|0|||
155367107|NCT05000216|560778468|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367108|NCT05000216|560778469|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367109|NCT05000216|560778470|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367110|NCT05000216|560778471|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367111|NCT05000216|560778472|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367112|NCT05000216|560778473|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367113|NCT05000216|560778474|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367114|NCT05000216|560778475|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367115|NCT05000216|560778476|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367116|NCT05000216|560778477|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367117|NCT05000216|560778478|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367118|NCT05000216|560778479|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367119|NCT05000216|560778458|FG000|Stage 1|Other|0|||
155367120|NCT05000216|560778459|FG001|Stage 1|Other|0|||
155367121|NCT05000216|560778460|FG002|Stage 1|Other|0|||
155367122|NCT05000216|560778461|FG003|Stage 1|Other|0|||
155367123|NCT05000216|560778462|FG004|Stage 1|Other|1|||
155367124|NCT05000216|560778463|FG005|Stage 1|Other|0|||
155367125|NCT05000216|560778464|FG006|Stage 1|Other|0|||
155367126|NCT05000216|560778465|FG007|Stage 1|Other|2|||
155367127|NCT05000216|560778466|FG008|Stage 1|Other|0|||
155367128|NCT05000216|560778467|FG009|Stage 1|Other|0|||
155367129|NCT05000216|560778468|FG010|Stage 1|Other|1|||
155367130|NCT05000216|560778469|FG011|Stage 1|Other|1|||
155367131|NCT05000216|560778470|FG012|Stage 1|Other|0|||
155367132|NCT05000216|560778471|FG013|Stage 1|Other|0|||
155367133|NCT05000216|560778472|FG014|Stage 1|Other|0|||
155367134|NCT05000216|560778473|FG015|Stage 1|Other|0|||
155367135|NCT05000216|560778474|FG016|Stage 1|Other|0|||
155367136|NCT05000216|560778475|FG017|Stage 1|Other|0|||
155367137|NCT05000216|560778476|FG018|Stage 1|Other|0|||
155367138|NCT05000216|560778477|FG019|Stage 1|Other|0|||
155367139|NCT05000216|560778478|FG020|Stage 1|Other|0|||
155367140|NCT05000216|560778479|FG021|Stage 1|Other|0|||
155367141|NCT05000216|560778458|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
155367142|NCT05000216|560778459|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
155367143|NCT05000216|560778460|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
155367144|NCT05000216|560778461|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
155367145|NCT05000216|560778462|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
155367146|NCT05000216|560778463|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
155367147|NCT05000216|560778464|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
155367148|NCT05000216|560778465|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
155367149|NCT05000216|560778466|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
155367150|NCT05000216|560778467|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
155367151|NCT05000216|560778468|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
155367152|NCT05000216|560778469|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
155367153|NCT05000216|560778470|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
155367154|NCT05000216|560778471|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
155367155|NCT05000216|560778472|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
155428245|NCT00552110|560993425|FG004|Overall Study|Withdrawn per Sponsor|1|||
155428246|NCT00552110|560993421|FG000|Overall Study|Use of Prohibited Medication|1|||
155428247|NCT00552110|560993422|FG001|Overall Study|Use of Prohibited Medication|1|||
155428248|NCT00552110|560993423|FG002|Overall Study|Use of Prohibited Medication|0|||
155428249|NCT00552110|560993424|FG003|Overall Study|Use of Prohibited Medication|0|||
155428250|NCT00552110|560993425|FG004|Overall Study|Use of Prohibited Medication|0|||
155428251|NCT00552110|560993421|FG000|Overall Study|Delay of Study due to Relabeling|0|||
155428252|NCT00552110|560993422|FG001|Overall Study|Delay of Study due to Relabeling|0|||
155428253|NCT00552110|560993423|FG002|Overall Study|Delay of Study due to Relabeling|0|||
155428254|NCT00552110|560993424|FG003|Overall Study|Delay of Study due to Relabeling|1|||
155428255|NCT00552110|560993425|FG004|Overall Study|Delay of Study due to Relabeling|0|||
155428256|NCT00552110|560993421|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
155428257|NCT00552110|560993422|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
155428258|NCT00552110|560993423|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
155508348|NCT01003886|561286856|FG000|Overall Study|Adverse Event|3|||
155508349|NCT00909727|561286874|FG000|Overall Study|Adverse Event|1|||
155367156|NCT05000216|560778473|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
155367157|NCT05000216|560778474|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
155367158|NCT05000216|560778475|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
155367159|NCT05000216|560778476|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
155367160|NCT05000216|560778477|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
155367161|NCT05000216|560778478|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
155367162|NCT05000216|560778479|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
155367163|NCT05000216|560778458|FG000|Stage 2|Lost to Follow-up|0|||
155367164|NCT05000216|560778459|FG001|Stage 2|Lost to Follow-up|0|||
155367165|NCT05000216|560778460|FG002|Stage 2|Lost to Follow-up|0|||
155367166|NCT05000216|560778461|FG003|Stage 2|Lost to Follow-up|0|||
155367167|NCT05000216|560778462|FG004|Stage 2|Lost to Follow-up|0|||
155367168|NCT05000216|560778463|FG005|Stage 2|Lost to Follow-up|0|||
155367169|NCT05000216|560778464|FG006|Stage 2|Lost to Follow-up|0|||
155367170|NCT05000216|560778465|FG007|Stage 2|Lost to Follow-up|0|||
155367171|NCT05000216|560778466|FG008|Stage 2|Lost to Follow-up|0|||
155367172|NCT05000216|560778467|FG009|Stage 2|Lost to Follow-up|0|||
155367173|NCT05000216|560778468|FG010|Stage 2|Lost to Follow-up|0|||
155367174|NCT05000216|560778469|FG011|Stage 2|Lost to Follow-up|0|||
155367175|NCT05000216|560778470|FG012|Stage 2|Lost to Follow-up|0|||
155367176|NCT05000216|560778471|FG013|Stage 2|Lost to Follow-up|0|||
155367177|NCT05000216|560778472|FG014|Stage 2|Lost to Follow-up|0|||
155367178|NCT05000216|560778473|FG015|Stage 2|Lost to Follow-up|0|||
155367179|NCT05000216|560778474|FG016|Stage 2|Lost to Follow-up|4|||
155367180|NCT05000216|560778475|FG017|Stage 2|Lost to Follow-up|0|||
155367181|NCT05000216|560778476|FG018|Stage 2|Lost to Follow-up|0|||
155367182|NCT05000216|560778477|FG019|Stage 2|Lost to Follow-up|0|||
155367183|NCT05000216|560778478|FG020|Stage 2|Lost to Follow-up|0|||
155367184|NCT05000216|560778479|FG021|Stage 2|Lost to Follow-up|0|||
155367185|NCT05000216|560778458|FG000|Stage 2|Physician Decision|0|||
155367186|NCT05000216|560778459|FG001|Stage 2|Physician Decision|0|||
155367187|NCT05000216|560778460|FG002|Stage 2|Physician Decision|0|||
155367188|NCT05000216|560778461|FG003|Stage 2|Physician Decision|0|||
155367189|NCT05000216|560778462|FG004|Stage 2|Physician Decision|0|||
155367190|NCT05000216|560778463|FG005|Stage 2|Physician Decision|0|||
155367191|NCT05000216|560778464|FG006|Stage 2|Physician Decision|0|||
155367192|NCT05000216|560778465|FG007|Stage 2|Physician Decision|0|||
155367193|NCT05000216|560778466|FG008|Stage 2|Physician Decision|0|||
155367194|NCT05000216|560778467|FG009|Stage 2|Physician Decision|0|||
155367195|NCT05000216|560778468|FG010|Stage 2|Physician Decision|0|||
155508350|NCT00909727|561286875|FG001|Overall Study|Adverse Event|0|||
155367196|NCT05000216|560778469|FG011|Stage 2|Physician Decision|0|||
155367197|NCT05000216|560778470|FG012|Stage 2|Physician Decision|1|||
155367198|NCT05000216|560778471|FG013|Stage 2|Physician Decision|0|||
155367199|NCT05000216|560778472|FG014|Stage 2|Physician Decision|0|||
155367200|NCT05000216|560778473|FG015|Stage 2|Physician Decision|0|||
155367201|NCT05000216|560778474|FG016|Stage 2|Physician Decision|0|||
155367202|NCT05000216|560778475|FG017|Stage 2|Physician Decision|0|||
155367203|NCT05000216|560778476|FG018|Stage 2|Physician Decision|0|||
155367204|NCT05000216|560778477|FG019|Stage 2|Physician Decision|0|||
155367205|NCT05000216|560778478|FG020|Stage 2|Physician Decision|0|||
155367206|NCT05000216|560778479|FG021|Stage 2|Physician Decision|0|||
155367207|NCT05000216|560778458|FG000|Stage 2|Withdrawal by Subject|0|||
155367208|NCT05000216|560778459|FG001|Stage 2|Withdrawal by Subject|0|||
155367209|NCT05000216|560778460|FG002|Stage 2|Withdrawal by Subject|0|||
155367210|NCT05000216|560778461|FG003|Stage 2|Withdrawal by Subject|0|||
155367211|NCT05000216|560778462|FG004|Stage 2|Withdrawal by Subject|0|||
155367212|NCT05000216|560778463|FG005|Stage 2|Withdrawal by Subject|0|||
155367213|NCT05000216|560778464|FG006|Stage 2|Withdrawal by Subject|0|||
155367214|NCT05000216|560778465|FG007|Stage 2|Withdrawal by Subject|0|||
155367215|NCT05000216|560778466|FG008|Stage 2|Withdrawal by Subject|0|||
155367216|NCT05000216|560778467|FG009|Stage 2|Withdrawal by Subject|0|||
155367217|NCT05000216|560778468|FG010|Stage 2|Withdrawal by Subject|0|||
155367218|NCT05000216|560778469|FG011|Stage 2|Withdrawal by Subject|0|||
155367219|NCT05000216|560778470|FG012|Stage 2|Withdrawal by Subject|0|||
155367220|NCT05000216|560778471|FG013|Stage 2|Withdrawal by Subject|0|||
155367221|NCT05000216|560778472|FG014|Stage 2|Withdrawal by Subject|2|||
155367222|NCT05000216|560778473|FG015|Stage 2|Withdrawal by Subject|0|||
155367223|NCT05000216|560778474|FG016|Stage 2|Withdrawal by Subject|9|||
155367224|NCT05000216|560778475|FG017|Stage 2|Withdrawal by Subject|0|||
155367225|NCT05000216|560778476|FG018|Stage 2|Withdrawal by Subject|0|||
155367226|NCT05000216|560778477|FG019|Stage 2|Withdrawal by Subject|0|||
155367227|NCT05000216|560778478|FG020|Stage 2|Withdrawal by Subject|0|||
155367228|NCT05000216|560778479|FG021|Stage 2|Withdrawal by Subject|0|||
155367229|NCT05000216|560778458|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
155367230|NCT05000216|560778459|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
155367231|NCT05000216|560778460|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
155367232|NCT05000216|560778461|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
155367233|NCT05000216|560778462|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
155367234|NCT05000216|560778463|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
155508351|NCT00909727|561286874|FG000|Overall Study|Wrong Genotype|1|||
155367235|NCT05000216|560778464|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
155367236|NCT05000216|560778465|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
155367237|NCT05000216|560778466|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
155367238|NCT05000216|560778467|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
155367239|NCT05000216|560778468|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
155367240|NCT05000216|560778469|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
155367241|NCT05000216|560778470|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
155367242|NCT05000216|560778471|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
155367243|NCT05000216|560778472|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
155367244|NCT05000216|560778473|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
155367245|NCT05000216|560778474|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
155367246|NCT05000216|560778475|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
155367247|NCT05000216|560778476|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
155367248|NCT05000216|560778477|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
155367249|NCT05000216|560778478|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
155367250|NCT05000216|560778479|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
155367251|NCT05000216|560778458|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367252|NCT05000216|560778459|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367253|NCT05000216|560778460|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367254|NCT05000216|560778461|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367255|NCT05000216|560778462|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367256|NCT05000216|560778463|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367257|NCT05000216|560778464|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367258|NCT05000216|560778465|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367259|NCT05000216|560778466|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367260|NCT05000216|560778467|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367261|NCT05000216|560778468|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367262|NCT05000216|560778469|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367263|NCT05000216|560778470|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367264|NCT05000216|560778471|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367265|NCT05000216|560778472|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
155367266|NCT05000216|560778473|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367267|NCT05000216|560778474|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
155367268|NCT05000216|560778475|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367269|NCT05000216|560778476|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367270|NCT05000216|560778477|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367271|NCT05000216|560778478|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367272|NCT05000216|560778479|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367273|NCT05000216|560778458|FG000|Stage 2|Other reason|0|||
155367274|NCT05000216|560778459|FG001|Stage 2|Other reason|0|||
155367275|NCT05000216|560778460|FG002|Stage 2|Other reason|0|||
155367276|NCT05000216|560778461|FG003|Stage 2|Other reason|0|||
155367277|NCT05000216|560778462|FG004|Stage 2|Other reason|0|||
155367278|NCT05000216|560778463|FG005|Stage 2|Other reason|0|||
155367279|NCT05000216|560778464|FG006|Stage 2|Other reason|0|||
155367280|NCT05000216|560778465|FG007|Stage 2|Other reason|0|||
155367281|NCT05000216|560778466|FG008|Stage 2|Other reason|0|||
155367282|NCT05000216|560778467|FG009|Stage 2|Other reason|0|||
155367283|NCT05000216|560778468|FG010|Stage 2|Other reason|0|||
155367284|NCT05000216|560778469|FG011|Stage 2|Other reason|0|||
155367285|NCT05000216|560778470|FG012|Stage 2|Other reason|0|||
155367286|NCT05000216|560778471|FG013|Stage 2|Other reason|0|||
155367287|NCT05000216|560778472|FG014|Stage 2|Other reason|0|||
155367288|NCT05000216|560778473|FG015|Stage 2|Other reason|0|||
155367289|NCT05000216|560778474|FG016|Stage 2|Other reason|1|||
155367290|NCT05000216|560778475|FG017|Stage 2|Other reason|0|||
155367291|NCT05000216|560778476|FG018|Stage 2|Other reason|0|||
155367292|NCT05000216|560778477|FG019|Stage 2|Other reason|0|||
155367293|NCT05000216|560778478|FG020|Stage 2|Other reason|0|||
155367294|NCT05000216|560778479|FG021|Stage 2|Other reason|0|||
155367295|NCT05000216|560778458|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
155367296|NCT05000216|560778459|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
155367297|NCT05000216|560778460|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
155367298|NCT05000216|560778461|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
155367299|NCT05000216|560778462|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
155367300|NCT05000216|560778463|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
155367301|NCT05000216|560778464|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
155367302|NCT05000216|560778465|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
155367303|NCT05000216|560778466|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
155367304|NCT05000216|560778467|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
155367305|NCT05000216|560778468|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
155367306|NCT05000216|560778469|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
155367307|NCT05000216|560778470|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
155367308|NCT05000216|560778471|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
155367309|NCT05000216|560778472|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
155367310|NCT05000216|560778473|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
155367311|NCT05000216|560778474|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
155367312|NCT05000216|560778475|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
155367313|NCT05000216|560778476|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
155367314|NCT05000216|560778477|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
155367315|NCT05000216|560778478|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
155367316|NCT05000216|560778479|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
155367317|NCT05000216|560778458|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367318|NCT05000216|560778459|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367319|NCT05000216|560778460|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367320|NCT05000216|560778461|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367321|NCT05000216|560778462|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367322|NCT05000216|560778463|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367323|NCT05000216|560778464|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367324|NCT05000216|560778465|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367325|NCT05000216|560778466|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367326|NCT05000216|560778467|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367327|NCT05000216|560778468|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367328|NCT05000216|560778469|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367329|NCT05000216|560778470|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367330|NCT05000216|560778471|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367331|NCT05000216|560778472|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367332|NCT05000216|560778473|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
155367333|NCT05000216|560778474|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367334|NCT05000216|560778475|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367335|NCT05000216|560778476|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367336|NCT05000216|560778477|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367337|NCT05000216|560778478|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367338|NCT05000216|560778479|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367339|NCT05000216|560778458|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367340|NCT05000216|560778459|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155508352|NCT00909727|561286875|FG001|Overall Study|Wrong Genotype|0|||
155508353|NCT00909727|561286874|FG000|Overall Study|Withdrawal of Consent|1|||
155508354|NCT00909727|561286875|FG001|Overall Study|Withdrawal of Consent|0|||
155367341|NCT05000216|560778460|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367342|NCT05000216|560778461|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367343|NCT05000216|560778462|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367344|NCT05000216|560778463|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367345|NCT05000216|560778464|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367346|NCT05000216|560778465|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367347|NCT05000216|560778466|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367348|NCT05000216|560778467|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367349|NCT05000216|560778468|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367350|NCT05000216|560778469|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367351|NCT05000216|560778470|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367352|NCT05000216|560778471|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
155367353|NCT05000216|560778472|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367354|NCT05000216|560778473|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
155367355|NCT05000216|560778474|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367356|NCT05000216|560778475|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367357|NCT05000216|560778476|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
155367358|NCT05000216|560778477|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367359|NCT05000216|560778478|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367360|NCT05000216|560778479|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367361|NCT04076943|560778480|FG000|Overall Study|Withdrawal by Subject|12|||
155367362|NCT04076943|560778480|FG000|Overall Study|Adverse Event|1|||
155367363|NCT04076943|560778480|FG000|Overall Study|Progressive Disease|2|||
155367364|NCT04076943|560778480|FG000|Overall Study|Death|13|||
155367365|NCT04076943|560778480|FG000|Overall Study|Other than specified|6|||
155367366|NCT02224703|560778483|FG000|Overall Study|Adverse Event|0|||
155367367|NCT02224703|560778484|FG001|Overall Study|Adverse Event|5|||
155367368|NCT02224703|560778485|FG002|Overall Study|Adverse Event|0|||
155367369|NCT02224703|560778483|FG000|Overall Study|Withdrawn by investigator|1|||
155367370|NCT02224703|560778484|FG001|Overall Study|Withdrawn by investigator|0|||
155367371|NCT02224703|560778485|FG002|Overall Study|Withdrawn by investigator|0|||
155367372|NCT02224703|560778483|FG000|Overall Study|Advised by medical monitor|1|||
155367373|NCT02224703|560778484|FG001|Overall Study|Advised by medical monitor|0|||
155367374|NCT02224703|560778485|FG002|Overall Study|Advised by medical monitor|0|||
155367375|NCT02224703|560778483|FG000|Overall Study|Withdrawn by parent/guardian|0|||
155367376|NCT02224703|560778484|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155367377|NCT02224703|560778485|FG002|Overall Study|Withdrawn by parent/guardian|0|||
155367378|NCT02224703|560778483|FG000|Overall Study|Lack of Efficacy|1|||
155367379|NCT02224703|560778484|FG001|Overall Study|Lack of Efficacy|0|||
155367380|NCT02224703|560778485|FG002|Overall Study|Lack of Efficacy|0|||
155367381|NCT00332462|560778486|FG000|Overall Study|Adverse Event|5|||
155367382|NCT00332462|560778486|FG000|Overall Study|Abnormal Lab Value|1|||
155367383|NCT00332462|560778486|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155367384|NCT00332462|560778486|FG000|Overall Study|no longer requires study drug|1|||
155508355|NCT00909727|561286874|FG000|Overall Study|Prohibited Medication|1|||
155649304|NCT03931785|561808199|FG001|Overall Study|Pregnancy|0|||
155649305|NCT03931785|561808200|FG002|Overall Study|Pregnancy|0|||
155367385|NCT00332462|560778486|FG000|Overall Study|Death|3|||
155367386|NCT00332462|560778486|FG000|Overall Study|Graft Loss|2|||
155367387|NCT02922023|560778489|FG000|Overall Study|Lost to Follow-up|2|||
155367388|NCT02922023|560778490|FG001|Overall Study|Lost to Follow-up|0|||
155367389|NCT02159040|560778491|FG000|Overall Study|Death|1|||
155367390|NCT01602510|560778494|FG000|Open Label Phase|Adverse Event|46|||
155367391|NCT01602510|560778495|FG001|Open Label Phase|Adverse Event|0|||
155367392|NCT01602510|560778496|FG002|Open Label Phase|Adverse Event|0|||
155367393|NCT01602510|560778494|FG000|Open Label Phase|Lack of Efficacy|22|||
155367394|NCT01602510|560778495|FG001|Open Label Phase|Lack of Efficacy|0|||
155367395|NCT01602510|560778496|FG002|Open Label Phase|Lack of Efficacy|0|||
155367396|NCT01602510|560778494|FG000|Open Label Phase|Protocol Violation|15|||
155367397|NCT01602510|560778495|FG001|Open Label Phase|Protocol Violation|0|||
155367398|NCT01602510|560778496|FG002|Open Label Phase|Protocol Violation|0|||
155367399|NCT01602510|560778494|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
155367400|NCT01602510|560778495|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
155367401|NCT01602510|560778496|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
155367402|NCT01602510|560778494|FG000|Open Label Phase|Lost to Follow-up|22|||
155367403|NCT01602510|560778495|FG001|Open Label Phase|Lost to Follow-up|0|||
155367404|NCT01602510|560778496|FG002|Open Label Phase|Lost to Follow-up|0|||
155367405|NCT01602510|560778494|FG000|Open Label Phase|Physician Decision|19|||
155367406|NCT01602510|560778495|FG001|Open Label Phase|Physician Decision|0|||
155367407|NCT01602510|560778496|FG002|Open Label Phase|Physician Decision|0|||
155367408|NCT01602510|560778494|FG000|Open Label Phase|Withdrawal by Subject|57|||
155367409|NCT01602510|560778495|FG001|Open Label Phase|Withdrawal by Subject|0|||
155367410|NCT01602510|560778496|FG002|Open Label Phase|Withdrawal by Subject|0|||
155367411|NCT01602510|560778494|FG000|Randomized Phase|Adverse Event|0|||
155367412|NCT01602510|560778495|FG001|Randomized Phase|Adverse Event|2|||
155367413|NCT01602510|560778496|FG002|Randomized Phase|Adverse Event|6|||
155367414|NCT01602510|560778494|FG000|Randomized Phase|Lack of Efficacy|0|||
155367415|NCT01602510|560778495|FG001|Randomized Phase|Lack of Efficacy|4|||
155367416|NCT01602510|560778496|FG002|Randomized Phase|Lack of Efficacy|4|||
155367417|NCT01602510|560778494|FG000|Randomized Phase|Protocol Violation|0|||
155367418|NCT01602510|560778495|FG001|Randomized Phase|Protocol Violation|3|||
155367419|NCT01602510|560778496|FG002|Randomized Phase|Protocol Violation|3|||
155367420|NCT01602510|560778494|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
155367421|NCT01602510|560778495|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
155367422|NCT01602510|560778496|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
155367423|NCT01602510|560778494|FG000|Randomized Phase|Lost to Follow-up|0|||
155367424|NCT01602510|560778495|FG001|Randomized Phase|Lost to Follow-up|1|||
155367425|NCT01602510|560778496|FG002|Randomized Phase|Lost to Follow-up|3|||
155367426|NCT01602510|560778494|FG000|Randomized Phase|Physician Decision|0|||
155367427|NCT01602510|560778495|FG001|Randomized Phase|Physician Decision|0|||
155367428|NCT01602510|560778496|FG002|Randomized Phase|Physician Decision|2|||
155367429|NCT01602510|560778494|FG000|Randomized Phase|Withdrawal by Subject|0|||
155367430|NCT01602510|560778495|FG001|Randomized Phase|Withdrawal by Subject|6|||
155367431|NCT01602510|560778496|FG002|Randomized Phase|Withdrawal by Subject|7|||
155367432|NCT01195623|560778497|FG000|Overall Study|Lost to Follow-up|35|||
155367433|NCT01195623|560778498|FG001|Overall Study|Lost to Follow-up|37|||
155367434|NCT00534495|560778500|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
155367435|NCT00534495|560778501|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
155367436|NCT00534495|560778502|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
155367437|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
155367438|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
155367439|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
155367440|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
155367441|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
155367442|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
155367443|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
155367444|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
155367445|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
155508356|NCT00909727|561286875|FG001|Overall Study|Prohibited Medication|0|||
155508357|NCT00475852|561286886|FG000|Overall Study|Death|444|||
155508358|NCT00475852|561286887|FG001|Overall Study|Death|456|||
155508359|NCT00475852|561286886|FG000|Overall Study|Withdrawal by Subject|19|||
155508360|NCT00475852|561286887|FG001|Overall Study|Withdrawal by Subject|24|||
155508361|NCT00475852|561286886|FG000|Overall Study|Lost to Follow-up|54|||
155508362|NCT00475852|561286887|FG001|Overall Study|Lost to Follow-up|68|||
155508363|NCT02063698|561286888|FG000|Overall Study|did not complete booklet for days 2-8|1|||
155508364|NCT02063698|561286889|FG001|Overall Study|did not complete booklet for days 2-8|2|||
155508365|NCT01684722|561286890|FG000|Overall Study|Lost to Follow-up|78|||
155508366|NCT01684722|561286891|FG001|Overall Study|Lost to Follow-up|56|||
155649306|NCT03931785|561808201|FG003|Overall Study|Pregnancy|1|||
155367446|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
155367447|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
155367448|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
155367449|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
155367450|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
155367451|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
155367452|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
155367453|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
155367454|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
155367455|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
155367456|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
155367457|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
155367458|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
155367459|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
155367460|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
155367461|NCT02920970|560778503|FG000|First Intervention|Protocol Violation|0|||
155367462|NCT02920970|560778504|FG001|First Intervention|Protocol Violation|1|||
155367463|NCT02920970|560778503|FG000|First Intervention|Adverse Event|0|||
155367464|NCT02920970|560778504|FG001|First Intervention|Adverse Event|1|||
155367465|NCT02920970|560778503|FG000|Second Intervention|Poor Lens Fit|1|||
155367466|NCT02920970|560778504|FG001|Second Intervention|Poor Lens Fit|0|||
155367467|NCT01711853|560778505|FG000|Overall Study|Not treated|3|||
155367468|NCT04191616|560778506|FG000|Pre-assignment Period|Did not receive study treatment|2|||
155367469|NCT04191616|560778506|FG000|Treatment Period|Death|37|||
155367470|NCT04191616|560778506|FG000|Treatment Period|Sponsor decision|11|||
155367471|NCT04191616|560778506|FG000|Treatment Period|Withdrawal by Subject|4|||
155367472|NCT00604708|560778510|FG000|Overall Study|Withdrawal by Subject|9|||
155367473|NCT00604708|560778511|FG001|Overall Study|Withdrawal by Subject|10|||
155367474|NCT00604708|560778510|FG000|Overall Study|Protocol Violation|2|||
155367475|NCT00604708|560778511|FG001|Overall Study|Protocol Violation|8|||
155367476|NCT00604708|560778510|FG000|Overall Study|Lost to Follow-up|5|||
155367477|NCT00604708|560778511|FG001|Overall Study|Lost to Follow-up|5|||
155367478|NCT00604708|560778510|FG000|Overall Study|administrative reasons|9|||
155367479|NCT00604708|560778511|FG001|Overall Study|administrative reasons|11|||
155367480|NCT00604708|560778510|FG000|Overall Study|Adverse Event|6|||
155367481|NCT00604708|560778511|FG001|Overall Study|Adverse Event|6|||
155367482|NCT01277887|560778513|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
155367483|NCT01277887|560778514|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
155367484|NCT01277887|560778513|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
155367485|NCT01277887|560778514|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
155367486|NCT01277887|560778513|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
155367487|NCT01277887|560778514|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
155428259|NCT00552110|560993424|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
155428260|NCT00552110|560993425|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
155428261|NCT00552110|560993421|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
155367488|NCT00415051|560778515|FG000|Overall Study|Protocol Violation|1|||
155367489|NCT04916730|560778516|FG000|Overall Study|Withdrawal by Subject|4|||
155428262|NCT00552110|560993422|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
155367490|NCT04916730|560778517|FG001|Overall Study|Withdrawal by Subject|2|||
155367491|NCT04916730|560778516|FG000|Overall Study|Lost to Follow-up|0|||
155367492|NCT04916730|560778517|FG001|Overall Study|Lost to Follow-up|2|||
155367493|NCT04916730|560778516|FG000|Overall Study|Physician Decision|1|||
155367494|NCT04916730|560778517|FG001|Overall Study|Physician Decision|0|||
155428263|NCT00552110|560993423|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
155428264|NCT00552110|560993424|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
155428265|NCT00552110|560993425|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
155428266|NCT00655928|560993431|FG000|Overall Study|Withdrawal by Subject|2|||
155428267|NCT00655928|560993432|FG001|Overall Study|Withdrawal by Subject|1|||
155428268|NCT00655928|560993431|FG000|Overall Study|Physician Decision|1|||
155428269|NCT00655928|560993432|FG001|Overall Study|Physician Decision|1|||
155428270|NCT00998738|560993434|FG000|Overall Study|Uknown|1|||
155428271|NCT01291017|560993441|FG000|Overall Study|Lost to Follow-up|2|||
155428272|NCT01291017|560993441|FG000|Overall Study|Withdrawal by Subject|3|||
155428273|NCT04980391|560993442|FG000|Overall Study|Death|0|||
155428274|NCT04980391|560993443|FG001|Overall Study|Death|0|||
155428275|NCT04980391|560993444|FG002|Overall Study|Death|1|||
155428276|NCT04980391|560993445|FG003|Overall Study|Death|1|||
155428277|NCT04980391|560993442|FG000|Overall Study|Lost to Follow-up|3|||
155428278|NCT04980391|560993443|FG001|Overall Study|Lost to Follow-up|3|||
155428279|NCT04980391|560993444|FG002|Overall Study|Lost to Follow-up|2|||
155428280|NCT04980391|560993445|FG003|Overall Study|Lost to Follow-up|3|||
155428281|NCT04980391|560993442|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
155428282|NCT04980391|560993443|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
155367495|NCT02670122|560778518|FG000|Overall Study|Lost to Follow-up|4|||
155367496|NCT02762903|560778522|FG000|Overall Study|Lost to Follow-up|0|||
155367497|NCT02762903|560778523|FG001|Overall Study|Lost to Follow-up|1|||
155367498|NCT00996606|560778525|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
155367499|NCT00996606|560778525|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155367500|NCT00996606|560778525|FG000|Overall Study|Protocol Violation|1|||
155367501|NCT00996606|560778525|FG000|Overall Study|Withdrawal by Subject|3|||
155367502|NCT00281320|560778532|FG000|Overall Study|Adverse Event|12|||
155367503|NCT00281320|560778533|FG001|Overall Study|Adverse Event|9|||
155367504|NCT00281320|560778532|FG000|Overall Study|Lack of Efficacy|4|||
155367505|NCT00281320|560778533|FG001|Overall Study|Lack of Efficacy|3|||
155367506|NCT00281320|560778532|FG000|Overall Study|Withdrawal by Subject|5|||
155367507|NCT00281320|560778533|FG001|Overall Study|Withdrawal by Subject|6|||
155367508|NCT00281320|560778532|FG000|Overall Study|Lost to Follow-up|1|||
155367509|NCT00281320|560778533|FG001|Overall Study|Lost to Follow-up|2|||
155367510|NCT00281320|560778532|FG000|Overall Study|Other|3|||
155367511|NCT00281320|560778533|FG001|Overall Study|Other|1|||
155367512|NCT00475228|560778536|FG000|Overall Study|Lost to Follow-up|17|||
155367513|NCT00475228|560778537|FG001|Overall Study|Lost to Follow-up|17|||
155367514|NCT02209181|560778539|FG000|Overall Study|Adverse Event|1|||
155367515|NCT02209181|560778540|FG001|Overall Study|Adverse Event|0|||
155367516|NCT02209181|560778541|FG002|Overall Study|Adverse Event|1|||
155367517|NCT02209181|560778542|FG003|Overall Study|Adverse Event|0|||
155367518|NCT02209181|560778539|FG000|Overall Study|Withdrawal by Subject|0|||
155367519|NCT02209181|560778540|FG001|Overall Study|Withdrawal by Subject|1|||
155367520|NCT02209181|560778541|FG002|Overall Study|Withdrawal by Subject|0|||
155367521|NCT02209181|560778542|FG003|Overall Study|Withdrawal by Subject|0|||
155367522|NCT02579772|560778543|FG000|Overall Study|Withdrawal by Subject|0|||
155367523|NCT02579772|560778544|FG001|Overall Study|Withdrawal by Subject|1|||
155367524|NCT02579772|560778543|FG000|Overall Study|Usage of additional antioxidants|1|||
155367525|NCT02579772|560778544|FG001|Overall Study|Usage of additional antioxidants|0|||
155367526|NCT02579772|560778543|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
155367527|NCT02579772|560778544|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
155367528|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
155367529|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
155367530|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
155367531|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
155367532|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
155367533|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367534|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367535|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367536|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
155367537|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367538|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
155367539|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367540|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367541|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
155367542|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367543|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Death|1|||
155367544|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Death|0|||
155367545|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Death|0|||
155367546|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Death|0|||
155367547|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Death|0|||
155367548|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367549|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
155367550|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367551|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
155367552|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367553|NCT04641962|560778546|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367554|NCT04641962|560778547|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367555|NCT04641962|560778548|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
155367556|NCT04641962|560778549|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367557|NCT04641962|560778550|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
155367558|NCT04641962|560778546|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367559|NCT04641962|560778547|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367560|NCT04641962|560778548|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
155367561|NCT04641962|560778549|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367562|NCT04641962|560778550|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367563|NCT05239598|560778554|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
155367564|NCT05239598|560778555|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
155367565|NCT05239598|560778554|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
155367566|NCT05239598|560778555|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
155367567|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367568|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367569|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
155367570|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367571|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
155367572|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
155367573|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
155367574|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
155367575|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
155367576|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
155367577|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
155367578|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
155367579|NCT04535544|560778558|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
155367580|NCT04535544|560778559|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
155367581|NCT04535544|560778560|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
155367582|NCT04535544|560778561|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
155367583|NCT04535544|560778558|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
155367584|NCT04535544|560778559|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
155367585|NCT04535544|560778560|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
155367586|NCT04535544|560778561|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
155367587|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
155367588|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
155367589|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
155367590|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
155367591|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
155367592|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367593|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367594|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367595|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
155367596|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
155367597|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
155367598|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
155367599|NCT02706405|560780397|FG000|Overall Study|Death|3|||
155367600|NCT02706405|560780398|FG001|Overall Study|Death|2|||
155367601|NCT02706405|560780399|FG002|Overall Study|Death|0|||
155367602|NCT02706405|560780400|FG003|Overall Study|Death|1|||
155367603|NCT02706405|560780401|FG004|Overall Study|Death|0|||
155367604|NCT02706405|560780402|FG005|Overall Study|Death|0|||
155367605|NCT02706405|560780403|FG006|Overall Study|Death|3|||
155367606|NCT02706405|560780404|FG007|Overall Study|Death|4|||
155367607|NCT02706405|560780397|FG000|Overall Study|Disease progression|0|||
155367608|NCT02706405|560780398|FG001|Overall Study|Disease progression|0|||
155367609|NCT02706405|560780399|FG002|Overall Study|Disease progression|0|||
155367610|NCT02706405|560780400|FG003|Overall Study|Disease progression|0|||
155367611|NCT02706405|560780401|FG004|Overall Study|Disease progression|0|||
155367612|NCT02706405|560780402|FG005|Overall Study|Disease progression|0|||
155367613|NCT02706405|560780403|FG006|Overall Study|Disease progression|0|||
155367614|NCT02706405|560780404|FG007|Overall Study|Disease progression|1|||
155367615|NCT02706405|560780397|FG000|Overall Study|Pt moved to new therapy|0|||
155367616|NCT02706405|560780398|FG001|Overall Study|Pt moved to new therapy|0|||
155367617|NCT02706405|560780399|FG002|Overall Study|Pt moved to new therapy|0|||
155367618|NCT02706405|560780400|FG003|Overall Study|Pt moved to new therapy|0|||
155367619|NCT02706405|560780401|FG004|Overall Study|Pt moved to new therapy|0|||
155367620|NCT02706405|560780402|FG005|Overall Study|Pt moved to new therapy|1|||
155367621|NCT02706405|560780403|FG006|Overall Study|Pt moved to new therapy|0|||
155367622|NCT02706405|560780404|FG007|Overall Study|Pt moved to new therapy|1|||
155367623|NCT02706405|560780397|FG000|Overall Study|Physician Decision|1|||
155367624|NCT02706405|560780398|FG001|Overall Study|Physician Decision|0|||
155367625|NCT02706405|560780399|FG002|Overall Study|Physician Decision|0|||
155367626|NCT02706405|560780400|FG003|Overall Study|Physician Decision|0|||
155367627|NCT02706405|560780401|FG004|Overall Study|Physician Decision|0|||
155367628|NCT02706405|560780402|FG005|Overall Study|Physician Decision|0|||
155367629|NCT02706405|560780403|FG006|Overall Study|Physician Decision|0|||
155367630|NCT02706405|560780404|FG007|Overall Study|Physician Decision|0|||
155367631|NCT01182441|560780405|FG000|Overall Study|Patient Still in Follow-up|152|||
155367632|NCT01182441|560780406|FG001|Overall Study|Patient Still in Follow-up|72|||
155367633|NCT01182441|560780405|FG000|Overall Study|Death|37|||
155367634|NCT01182441|560780406|FG001|Overall Study|Death|25|||
155367635|NCT01182441|560780405|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
155367636|NCT01182441|560780406|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
155367637|NCT01182441|560780405|FG000|Overall Study|Lost to Follow-up|5|||
155367638|NCT01182441|560780406|FG001|Overall Study|Lost to Follow-up|8|||
155367639|NCT01182441|560780405|FG000|Overall Study|Withdrawal by Subject|6|||
155367640|NCT01182441|560780406|FG001|Overall Study|Withdrawal by Subject|13|||
155367641|NCT01182441|560780405|FG000|Overall Study|Implant Not Attempted|4|||
155367642|NCT01182441|560780406|FG001|Overall Study|Implant Not Attempted|0|||
155367643|NCT01182441|560780405|FG000|Overall Study|Adverse Event|2|||
155367644|NCT01182441|560780406|FG001|Overall Study|Adverse Event|0|||
155367645|NCT01182441|560780405|FG000|Overall Study|Physician Decision|1|||
155367646|NCT01182441|560780406|FG001|Overall Study|Physician Decision|1|||
155367647|NCT02304705|560780407|FG000|Overall Study|Withdrawal by Subject|2|||
155367648|NCT02304705|560780408|FG001|Overall Study|Withdrawal by Subject|0|||
155367649|NCT02304705|560780407|FG000|Overall Study|Physician Decision|2|||
155367650|NCT02304705|560780408|FG001|Overall Study|Physician Decision|4|||
155367651|NCT02304705|560780407|FG000|Overall Study|Death|0|||
155367652|NCT02304705|560780408|FG001|Overall Study|Death|1|||
155367653|NCT02304705|560780407|FG000|Overall Study|Lost to Follow-up|0|||
155367654|NCT02304705|560780408|FG001|Overall Study|Lost to Follow-up|2|||
155367655|NCT03140280|560780409|FG000|Overall Study|Physician Decision|5|||
155367656|NCT00663702|560780418|FG000|Overall Study|Adverse Event|8|||
155367657|NCT00663702|560780419|FG001|Overall Study|Adverse Event|4|||
155367658|NCT00663702|560780418|FG000|Overall Study|Withdrawal by Subject|3|||
155367659|NCT00663702|560780419|FG001|Overall Study|Withdrawal by Subject|1|||
155367660|NCT00663702|560780418|FG000|Overall Study|Pregnancy|0|||
155367661|NCT00663702|560780419|FG001|Overall Study|Pregnancy|1|||
155367662|NCT00663702|560780418|FG000|Overall Study|Lost to Follow-up|3|||
155367663|NCT00663702|560780419|FG001|Overall Study|Lost to Follow-up|0|||
155367664|NCT00663702|560780418|FG000|Overall Study|Death|1|||
155367665|NCT00663702|560780419|FG001|Overall Study|Death|1|||
155367666|NCT00663702|560780418|FG000|Overall Study|Lack of Efficacy|3|||
155367667|NCT00663702|560780419|FG001|Overall Study|Lack of Efficacy|3|||
155367668|NCT03056300|560780420|FG000|Overall Study|Surgical reason per study protocol|3|||
155367669|NCT04079868|560780427|FG000|Overall Study|Lost to Follow-up|100|||
155367670|NCT04079868|560780428|FG001|Overall Study|Lost to Follow-up|200|||
155367671|NCT04079868|560780427|FG000|Overall Study|Physician Decision|100|||
155367672|NCT04079868|560780428|FG001|Overall Study|Physician Decision|0|||
155367673|NCT05262517|560780429|FG000|Overall Study|Randomized but not treated|5|||
155367674|NCT05262517|560780430|FG001|Overall Study|Randomized but not treated|11|||
155367675|NCT05620108|560780431|FG000|Overall Study|Physician Decision|1|||
155367676|NCT05620108|560780432|FG001|Overall Study|Physician Decision|2|||
155367677|NCT05602727|560780433|FG000|Overall Study|Physician Decision|0|||
155367678|NCT05602727|560780434|FG001|Overall Study|Physician Decision|1|||
155367679|NCT05602727|560780435|FG002|Overall Study|Physician Decision|0|||
155367680|NCT05602727|560780433|FG000|Overall Study|Randomized by mistake without study medication|1|||
155367681|NCT05602727|560780434|FG001|Overall Study|Randomized by mistake without study medication|0|||
155367682|NCT05602727|560780435|FG002|Overall Study|Randomized by mistake without study medication|0|||
155367683|NCT05602727|560780433|FG000|Overall Study|Study termination by Sponsor|18|||
155367684|NCT05602727|560780434|FG001|Overall Study|Study termination by Sponsor|15|||
155367685|NCT05602727|560780435|FG002|Overall Study|Study termination by Sponsor|19|||
155367686|NCT05602727|560780433|FG000|Overall Study|Withdrawal by Subject|2|||
155367687|NCT05602727|560780434|FG001|Overall Study|Withdrawal by Subject|1|||
155367688|NCT05602727|560780435|FG002|Overall Study|Withdrawal by Subject|1|||
155367689|NCT05602727|560780433|FG000|Overall Study|Various reasons|1|||
155367690|NCT05602727|560780434|FG001|Overall Study|Various reasons|6|||
155367691|NCT05602727|560780435|FG002|Overall Study|Various reasons|1|||
155367692|NCT02038842|560780437|FG000|Overall Study|Withdrawal by Subject|2|||
155367693|NCT02038842|560780438|FG001|Overall Study|Withdrawal by Subject|2|||
155367694|NCT02038842|560780439|FG002|Overall Study|Withdrawal by Subject|0|||
155367695|NCT02038842|560780440|FG003|Overall Study|Withdrawal by Subject|0|||
155367696|NCT02038842|560780437|FG000|Overall Study|Participant decision|0|||
155508367|NCT01684722|561286892|FG002|Overall Study|Lost to Follow-up|75|||
155508368|NCT01684722|561286893|FG003|Overall Study|Lost to Follow-up|89|||
155508369|NCT01684722|561286890|FG000|Overall Study|Death|19|||
155508370|NCT01684722|561286891|FG001|Overall Study|Death|21|||
155508371|NCT01684722|561286892|FG002|Overall Study|Death|19|||
155508372|NCT01684722|561286893|FG003|Overall Study|Death|21|||
155508373|NCT01664494|561286894|FG000|Overall Study|Withdrawal by Subject|27|||
155508374|NCT01664494|561286894|FG000|Overall Study|Death|18|||
155367697|NCT02038842|560780438|FG001|Overall Study|Participant decision|0|||
155367698|NCT02038842|560780439|FG002|Overall Study|Participant decision|2|||
155367699|NCT02038842|560780440|FG003|Overall Study|Participant decision|1|||
155367700|NCT02038842|560780437|FG000|Overall Study|Adverse Event|0|||
155508375|NCT01664494|561286894|FG000|Overall Study|Other|49|||
155508376|NCT01664494|561286894|FG000|Overall Study|Lost to Follow-up|99|||
155508377|NCT02974114|561286897|FG000|Overall Study|Other (Not specified)|0|||
155508378|NCT02974114|561286898|FG001|Overall Study|Other (Not specified)|1|||
155367701|NCT02038842|560780438|FG001|Overall Study|Adverse Event|0|||
155367702|NCT02038842|560780439|FG002|Overall Study|Adverse Event|3|||
155367703|NCT02038842|560780440|FG003|Overall Study|Adverse Event|1|||
155367704|NCT02038842|560780437|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
155367705|NCT02038842|560780438|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
155367706|NCT02038842|560780439|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
155367707|NCT02038842|560780440|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
155367708|NCT00626197|560780445|FG000|Overall Study|Did not cooperate|2|||
155367709|NCT00626197|560780446|FG001|Overall Study|Did not cooperate|6|||
155367710|NCT00626197|560780447|FG002|Overall Study|Did not cooperate|1|||
155367711|NCT00626197|560780445|FG000|Overall Study|Failure to return|6|||
155508379|NCT02974114|561286899|FG002|Overall Study|Other (Not specified)|2|||
155367712|NCT00626197|560780446|FG001|Overall Study|Failure to return|5|||
155367713|NCT00626197|560780447|FG002|Overall Study|Failure to return|6|||
155367714|NCT00626197|560780445|FG000|Overall Study|Adverse event, serious fatal|3|||
155367715|NCT00626197|560780446|FG001|Overall Study|Adverse event, serious fatal|6|||
155367716|NCT00626197|560780447|FG002|Overall Study|Adverse event, serious fatal|6|||
155367717|NCT00626197|560780445|FG000|Overall Study|Adverse Event|1|||
155367718|NCT00626197|560780446|FG001|Overall Study|Adverse Event|1|||
155367719|NCT00626197|560780447|FG002|Overall Study|Adverse Event|2|||
155367720|NCT00626197|560780445|FG000|Overall Study|Withdrawal by Subject|17|||
155367721|NCT00626197|560780446|FG001|Overall Study|Withdrawal by Subject|17|||
155367722|NCT00626197|560780447|FG002|Overall Study|Withdrawal by Subject|7|||
155367723|NCT00626197|560780445|FG000|Overall Study|Administrative reasons|15|||
155367724|NCT00626197|560780446|FG001|Overall Study|Administrative reasons|19|||
155367725|NCT00626197|560780447|FG002|Overall Study|Administrative reasons|55|||
155367726|NCT05332912|560780448|FG000|Overall Study|Withdrawal by Subject|0|||
155508380|NCT00479401|561286904|FG000|Overall Study|Adverse Event|24|||
155508381|NCT00479401|561286905|FG001|Overall Study|Adverse Event|20|||
155508382|NCT00479401|561286906|FG002|Overall Study|Adverse Event|4|||
155508383|NCT00479401|561286904|FG000|Overall Study|Lack of Efficacy|2|||
155367727|NCT05332912|560780449|FG001|Overall Study|Withdrawal by Subject|1|||
155367728|NCT05332912|560780450|FG002|Overall Study|Withdrawal by Subject|2|||
155367729|NCT05332912|560780451|FG003|Overall Study|Withdrawal by Subject|0|||
155367730|NCT05332912|560780448|FG000|Overall Study|Lost to Follow-up|0|||
155367731|NCT05332912|560780449|FG001|Overall Study|Lost to Follow-up|0|||
155367732|NCT05332912|560780450|FG002|Overall Study|Lost to Follow-up|1|||
155367733|NCT05332912|560780451|FG003|Overall Study|Lost to Follow-up|0|||
155367734|NCT00384189|560780456|FG000|Overall Study|Reason Not Specified|50|||
155367735|NCT00384189|560780457|FG001|Overall Study|Reason Not Specified|57|||
155367736|NCT00384189|560780458|FG002|Overall Study|Reason Not Specified|58|||
155367737|NCT00384189|560780459|FG003|Overall Study|Reason Not Specified|40|||
155367738|NCT04517669|560780460|FG000|Overall Study|Lost to Follow-up|2|||
155367739|NCT04517669|560780460|FG000|Overall Study|Withdrawal by Subject|3|||
155508384|NCT00479401|561286905|FG001|Overall Study|Lack of Efficacy|2|||
155508385|NCT00479401|561286906|FG002|Overall Study|Lack of Efficacy|4|||
155508386|NCT00479401|561286904|FG000|Overall Study|Protocol Violation|2|||
155508387|NCT00479401|561286905|FG001|Overall Study|Protocol Violation|1|||
155367740|NCT04517669|560780460|FG000|Overall Study|Drug withdrawn|44|||
155367741|NCT04517669|560780460|FG000|Overall Study|Other|1|||
155367742|NCT04517669|560780460|FG000|Overall Study|Eligibility criteria not met|4|||
155367743|NCT04517669|560780460|FG000|Overall Study|Did not receive treatment|3|||
155367744|NCT03338296|560780461|FG000|Overall Study|Adverse Event|0|||
155367745|NCT03338296|560780462|FG001|Overall Study|Adverse Event|1|||
155367746|NCT03338296|560780461|FG000|Overall Study|Withdrawal by Subject|14|||
155367747|NCT03338296|560780462|FG001|Overall Study|Withdrawal by Subject|13|||
155508388|NCT00479401|561286906|FG002|Overall Study|Protocol Violation|1|||
155508389|NCT00479401|561286904|FG000|Overall Study|Lost to Follow-up|1|||
155508390|NCT00479401|561286905|FG001|Overall Study|Lost to Follow-up|1|||
155508391|NCT00479401|561286906|FG002|Overall Study|Lost to Follow-up|1|||
155508392|NCT00479401|561286904|FG000|Overall Study|Withdrawal by Subject|16|||
155508393|NCT00479401|561286905|FG001|Overall Study|Withdrawal by Subject|10|||
155367748|NCT03338296|560780461|FG000|Overall Study|Lost to Follow-up|10|||
155367749|NCT03338296|560780462|FG001|Overall Study|Lost to Follow-up|10|||
155367750|NCT03338296|560780461|FG000|Overall Study|Study Terminated by Sponsor|77|||
155367751|NCT03338296|560780462|FG001|Overall Study|Study Terminated by Sponsor|76|||
155367752|NCT03338296|560780461|FG000|Overall Study|Other|2|||
155367753|NCT03338296|560780462|FG001|Overall Study|Other|7|||
155367754|NCT03338296|560780461|FG000|Overall Study|Missing|0|||
155367755|NCT03338296|560780462|FG001|Overall Study|Missing|1|||
155367756|NCT05048238|560780463|FG000|Overall Study|Withdrawal by Subject|1|||
155367757|NCT04481373|560780466|FG000|Overall Study|Protocol Violation|1|||
155367758|NCT04481373|560780467|FG001|Overall Study|Protocol Violation|0|||
155367759|NCT04481373|560780466|FG000|Overall Study|Viral load in hospital not over 1000|2|||
155367760|NCT04481373|560780467|FG001|Overall Study|Viral load in hospital not over 1000|1|||
155367761|NCT04481373|560780466|FG000|Overall Study|Death before hospital discharge|1|||
155367762|NCT04481373|560780467|FG001|Overall Study|Death before hospital discharge|0|||
155367763|NCT02057575|560780468|FG000|Overall Study|Adverse Event|0|||
155367764|NCT02057575|560780469|FG001|Overall Study|Adverse Event|2|||
155367765|NCT02057575|560780470|FG002|Overall Study|Adverse Event|0|||
155367766|NCT02057575|560780471|FG003|Overall Study|Adverse Event|1|||
155367767|NCT02057575|560780468|FG000|Overall Study|Withdrawal by Subject|1|||
155367768|NCT02057575|560780469|FG001|Overall Study|Withdrawal by Subject|0|||
155367769|NCT02057575|560780470|FG002|Overall Study|Withdrawal by Subject|0|||
155367770|NCT02057575|560780471|FG003|Overall Study|Withdrawal by Subject|0|||
155367771|NCT02057575|560780468|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
155367772|NCT02057575|560780469|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
155367773|NCT02057575|560780470|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
155428283|NCT04980391|560993444|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
155428284|NCT04980391|560993445|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
155428285|NCT04980391|560993442|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155428286|NCT04980391|560993443|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155428287|NCT04980391|560993444|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155428288|NCT04980391|560993445|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155367774|NCT02057575|560780471|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
155367775|NCT02057575|560780468|FG000|Overall Study|Protocol Violation|0|||
155428289|NCT04980391|560993442|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
155428290|NCT04980391|560993443|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
155428291|NCT04980391|560993444|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
155428292|NCT04980391|560993445|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
155428293|NCT02091440|560995981|FG000|Overall Study|Death|2|||
155428294|NCT00783289|560995982|FG000|Overall Study|Protocol Violation|0|||
155428295|NCT00783289|560995983|FG001|Overall Study|Protocol Violation|1|||
155428296|NCT00783289|560995984|FG002|Overall Study|Protocol Violation|0|||
155428297|NCT00783289|560995985|FG003|Overall Study|Protocol Violation|0|||
155428298|NCT03095703|560995988|FG000|Overall Study|Withdrawal by Subject|1|||
155428299|NCT02443402|560995991|FG000|Overall Study|Withdrawal by Subject|3|||
155428300|NCT02443402|560995992|FG001|Overall Study|Withdrawal by Subject|1|||
155428301|NCT02443402|560995991|FG000|Overall Study|Screen Failure|1|||
155428302|NCT02443402|560995992|FG001|Overall Study|Screen Failure|2|||
155428303|NCT01562028|560995995|FG000|Overall Study|Withdrawal by Subject|1|||
155428304|NCT01562028|560995996|FG001|Overall Study|Withdrawal by Subject|1|||
155428305|NCT01562028|560995995|FG000|Overall Study|Lost to Follow-up|2|||
155428306|NCT01562028|560995996|FG001|Overall Study|Lost to Follow-up|1|||
155428307|NCT00364793|560995997|FG000|Overall Study|Adverse Event|2|||
155428308|NCT00364793|560995998|FG001|Overall Study|Adverse Event|0|||
155428309|NCT00364793|560995999|FG002|Overall Study|Adverse Event|0|||
155428310|NCT00364793|560996000|FG003|Overall Study|Adverse Event|0|||
155428311|NCT00364793|560995997|FG000|Overall Study|Death|1|||
155428312|NCT00364793|560995998|FG001|Overall Study|Death|0|||
155428313|NCT00364793|560995999|FG002|Overall Study|Death|1|||
155428314|NCT00364793|560996000|FG003|Overall Study|Death|0|||
155428315|NCT00364793|560995997|FG000|Overall Study|Lack of Efficacy|3|||
155428316|NCT00364793|560995998|FG001|Overall Study|Lack of Efficacy|3|||
155428317|NCT00364793|560995999|FG002|Overall Study|Lack of Efficacy|1|||
155428318|NCT00364793|560996000|FG003|Overall Study|Lack of Efficacy|1|||
155428319|NCT00364793|560995997|FG000|Overall Study|Lost to Follow-up|1|||
155428320|NCT00364793|560995998|FG001|Overall Study|Lost to Follow-up|0|||
155428321|NCT00364793|560995999|FG002|Overall Study|Lost to Follow-up|2|||
155428322|NCT00364793|560996000|FG003|Overall Study|Lost to Follow-up|0|||
155428323|NCT00364793|560995997|FG000|Overall Study|Poor or non-compliance|1|||
155428324|NCT00364793|560995998|FG001|Overall Study|Poor or non-compliance|1|||
155428325|NCT00364793|560995999|FG002|Overall Study|Poor or non-compliance|0|||
155428326|NCT00364793|560996000|FG003|Overall Study|Poor or non-compliance|1|||
155367776|NCT02057575|560780469|FG001|Overall Study|Protocol Violation|1|||
155367777|NCT02057575|560780470|FG002|Overall Study|Protocol Violation|0|||
155367778|NCT02057575|560780471|FG003|Overall Study|Protocol Violation|0|||
155367779|NCT02979249|560780473|FG000|Overall Study|Lost to Follow-up|2|||
155367780|NCT02979249|560780473|FG000|Overall Study|Withdrawal by Subject|4|||
155367781|NCT01125046|560780474|FG000|First 6 Months of Treatment|Death|1|||
155367782|NCT01125046|560780474|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
155367783|NCT01125046|560780474|FG000|First 6 Months of Treatment|Non-compliance|1|||
155367784|NCT01125046|560780474|FG000|First 6 Months of Treatment|Surgery|1|||
155367785|NCT01125046|560780474|FG000|First 6 Months of Treatment|Progressive Disease|7|||
155367786|NCT01125046|560780474|FG000|First 6 Months of Treatment|Adverse Event|2|||
155367787|NCT01125046|560780474|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
155367788|NCT01125046|560780474|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
155367789|NCT01125046|560780474|FG000|Follow-up/Data Cut Off Point|Death|29|||
155367790|NCT01125046|560780474|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
155367791|NCT02766777|560780485|FG000|Overall Study|Adverse Event|12|||
155367792|NCT02766777|560780485|FG000|Overall Study|Lost to Follow-up|16|||
155367793|NCT02766777|560780485|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155367794|NCT02766777|560780485|FG000|Overall Study|Protocol Violation|1|||
155367795|NCT02766777|560780485|FG000|Overall Study|Withdrawal by Subject|4|||
155367796|NCT01886287|560780486|FG000|Overall Study|Radiographic disease progression|1|||
155649307|NCT03211858|561808202|FG000|Overall Study|Adverse Event|8|||
155649308|NCT03211858|561808203|FG001|Overall Study|Adverse Event|6|||
155649309|NCT03211858|561808202|FG000|Overall Study|Lack of Efficacy|0|||
155649310|NCT03211858|561808203|FG001|Overall Study|Lack of Efficacy|4|||
155649311|NCT03211858|561808202|FG000|Overall Study|Poor compliance to protocol|6|||
155649312|NCT03211858|561808203|FG001|Overall Study|Poor compliance to protocol|2|||
155649313|NCT03211858|561808202|FG000|Overall Study|Non-serious Hypoglycemia|1|||
155649314|NCT03211858|561808203|FG001|Overall Study|Non-serious Hypoglycemia|0|||
155649315|NCT03211858|561808202|FG000|Overall Study|Other than specified above|22|||
155367797|NCT01886287|560780486|FG000|Overall Study|Clinical progression due to disease|1|||
155367798|NCT03842228|560780487|FG000|Overall Study|Adverse Event|1|||
155367799|NCT03842228|560780488|FG001|Overall Study|Adverse Event|1|||
155367800|NCT03842228|560780489|FG002|Overall Study|Adverse Event|1|||
155367801|NCT03842228|560780490|FG003|Overall Study|Adverse Event|0|||
155367802|NCT03842228|560780491|FG004|Overall Study|Adverse Event|0|||
155367803|NCT03842228|560780492|FG005|Overall Study|Adverse Event|0|||
155367804|NCT03842228|560780493|FG006|Overall Study|Adverse Event|0|||
155367805|NCT03842228|560780487|FG000|Overall Study|Death|0|||
155367806|NCT03842228|560780488|FG001|Overall Study|Death|1|||
155367807|NCT03842228|560780489|FG002|Overall Study|Death|0|||
155367808|NCT03842228|560780490|FG003|Overall Study|Death|0|||
155367809|NCT03842228|560780491|FG004|Overall Study|Death|0|||
155367810|NCT03842228|560780492|FG005|Overall Study|Death|0|||
155367811|NCT03842228|560780493|FG006|Overall Study|Death|0|||
155367812|NCT03842228|560780487|FG000|Overall Study|Withdrawal by Subject|0|||
155367813|NCT03842228|560780488|FG001|Overall Study|Withdrawal by Subject|0|||
155367814|NCT03842228|560780489|FG002|Overall Study|Withdrawal by Subject|2|||
155367815|NCT03842228|560780490|FG003|Overall Study|Withdrawal by Subject|1|||
155367816|NCT03842228|560780491|FG004|Overall Study|Withdrawal by Subject|0|||
155367817|NCT03842228|560780492|FG005|Overall Study|Withdrawal by Subject|0|||
155367818|NCT03842228|560780493|FG006|Overall Study|Withdrawal by Subject|2|||
155367819|NCT03842228|560780487|FG000|Overall Study|Progression|8|||
155367820|NCT03842228|560780488|FG001|Overall Study|Progression|1|||
155367821|NCT03842228|560780489|FG002|Overall Study|Progression|7|||
155367822|NCT03842228|560780490|FG003|Overall Study|Progression|5|||
155367823|NCT03842228|560780491|FG004|Overall Study|Progression|4|||
155428327|NCT00364793|560995997|FG000|Overall Study|No longer meets criteria|0|||
155428328|NCT00364793|560995998|FG001|Overall Study|No longer meets criteria|0|||
155428329|NCT00364793|560995999|FG002|Overall Study|No longer meets criteria|0|||
155428330|NCT00364793|560996000|FG003|Overall Study|No longer meets criteria|1|||
155428331|NCT00364793|560995997|FG000|Overall Study|Withdrawal by Subject|0|||
155649316|NCT03211858|561808203|FG001|Overall Study|Other than specified above|21|||
155367824|NCT03842228|560780492|FG005|Overall Study|Progression|2|||
155367825|NCT03842228|560780493|FG006|Overall Study|Progression|3|||
155367826|NCT01361594|560780496|FG000|Overall Study|Withdrawal by Subject|1|||
155649317|NCT01529112|561808206|FG000|Overall Study|Adverse Event|2|||
155367827|NCT01361594|560780497|FG001|Overall Study|Withdrawal by Subject|2|||
155367828|NCT03651700|560780499|FG000|Overall Study|Withdrawal by Subject|1|||
155367829|NCT03651700|560780500|FG001|Overall Study|Withdrawal by Subject|0|||
155367830|NCT01889069|560780504|FG000|Overall Study|Death|18|||
155649318|NCT01529112|561808207|FG001|Overall Study|Adverse Event|0|||
155649319|NCT01529112|561808206|FG000|Overall Study|Death|59|||
155367831|NCT01889069|560780504|FG000|Overall Study|Progression of Disease|14|||
155367832|NCT01889069|560780504|FG000|Overall Study|Lost to Follow-up|6|||
155649320|NCT01529112|561808207|FG001|Overall Study|Death|38|||
155367833|NCT01889069|560780504|FG000|Overall Study|Other|4|||
155367834|NCT01889069|560780504|FG000|Overall Study|Consent Withdrawal|3|||
155367835|NCT01426347|560780508|FG000|Overall Study|Lost to Follow-up|0|||
155367836|NCT01426347|560780509|FG001|Overall Study|Lost to Follow-up|3|||
155367837|NCT01426347|560780508|FG000|Overall Study|Protocol Violation|2|||
155367838|NCT01426347|560780509|FG001|Overall Study|Protocol Violation|0|||
155367839|NCT01426347|560780508|FG000|Overall Study|Withdrawal by Subject|5|||
155367840|NCT01426347|560780509|FG001|Overall Study|Withdrawal by Subject|0|||
155367841|NCT00455741|560780510|FG000|Overall Study|Physician Decision|0|||
155367842|NCT00455741|560780511|FG001|Overall Study|Physician Decision|1|||
155367843|NCT03041792|560780514|FG000|Overall Study|Adverse Event|4|||
155367844|NCT03041792|560780515|FG001|Overall Study|Adverse Event|0|||
155367845|NCT03041792|560780514|FG000|Overall Study|Death in the family|0|||
155367846|NCT03041792|560780515|FG001|Overall Study|Death in the family|2|||
155367847|NCT03041792|560780514|FG000|Overall Study|Randomized but not treated|0|||
155367848|NCT03041792|560780515|FG001|Overall Study|Randomized but not treated|1|||
155367849|NCT04978090|560780516|FG000|Overall Study|unable to adequately fit device|2|||
155367850|NCT02227992|560780521|FG000|Overall Study|Lost to Follow-up|1|||
155367851|NCT02227992|560780522|FG001|Overall Study|Lost to Follow-up|1|||
155367852|NCT01509547|560780525|FG000|Overall Study|Lost to Follow-up|24|||
155367853|NCT01509547|560780526|FG001|Overall Study|Lost to Follow-up|14|||
155367854|NCT01509547|560780525|FG000|Overall Study|Withdrawal by Subject|11|||
155367855|NCT01509547|560780526|FG001|Overall Study|Withdrawal by Subject|24|||
155367856|NCT01509547|560780525|FG000|Overall Study|Physician Decision|0|||
155367857|NCT01509547|560780526|FG001|Overall Study|Physician Decision|1|||
155367858|NCT00935532|560780527|FG000|Overall Study|Adverse Event|11|||
155367859|NCT00935532|560780528|FG001|Overall Study|Adverse Event|6|||
155367860|NCT00935532|560780527|FG000|Overall Study|Death|1|||
155367861|NCT00935532|560780528|FG001|Overall Study|Death|0|||
155367862|NCT00935532|560780527|FG000|Overall Study|Lost to Follow-up|1|||
155367863|NCT00935532|560780528|FG001|Overall Study|Lost to Follow-up|0|||
155367864|NCT00935532|560780527|FG000|Overall Study|Physician Decision|1|||
155367865|NCT00935532|560780528|FG001|Overall Study|Physician Decision|2|||
155367866|NCT00935532|560780527|FG000|Overall Study|Protocol Violation|2|||
155367867|NCT00935532|560780528|FG001|Overall Study|Protocol Violation|1|||
155367868|NCT00935532|560780527|FG000|Overall Study|Subject Decision|2|||
155367869|NCT00935532|560780528|FG001|Overall Study|Subject Decision|1|||
155367870|NCT00935532|560780527|FG000|Overall Study|Sponsor Decision|0|||
155367871|NCT00935532|560780528|FG001|Overall Study|Sponsor Decision|1|||
155367872|NCT00935532|560780527|FG000|Overall Study|Loss Glucose Control|4|||
155367873|NCT00935532|560780528|FG001|Overall Study|Loss Glucose Control|0|||
155428332|NCT00364793|560995998|FG001|Overall Study|Withdrawal by Subject|1|||
155428333|NCT00364793|560995999|FG002|Overall Study|Withdrawal by Subject|0|||
155428334|NCT00364793|560996000|FG003|Overall Study|Withdrawal by Subject|0|||
155428335|NCT00391976|560996001|FG000|Overall Study|Adverse Event|0|||
155428336|NCT00391976|560996002|FG001|Overall Study|Adverse Event|0|||
155428337|NCT00391976|560996003|FG002|Overall Study|Adverse Event|1|||
155428338|NCT00391976|560996001|FG000|Overall Study|Withdrawal of consent|0|||
155428339|NCT00391976|560996002|FG001|Overall Study|Withdrawal of consent|1|||
155428340|NCT00391976|560996003|FG002|Overall Study|Withdrawal of consent|1|||
155428341|NCT00391976|560996001|FG000|Overall Study|Lost to Follow-up|1|||
155428342|NCT00391976|560996002|FG001|Overall Study|Lost to Follow-up|2|||
155428343|NCT00391976|560996003|FG002|Overall Study|Lost to Follow-up|0|||
155428344|NCT00391976|560996001|FG000|Overall Study|Inappropriate enrollment|1|||
155428345|NCT00391976|560996002|FG001|Overall Study|Inappropriate enrollment|1|||
155428346|NCT00391976|560996003|FG002|Overall Study|Inappropriate enrollment|0|||
155428347|NCT00391976|560996001|FG000|Overall Study|Protocol deviation/violation|4|||
155428348|NCT00391976|560996002|FG001|Overall Study|Protocol deviation/violation|2|||
155367874|NCT01371708|560780531|FG000|Overall Study|Insufficient clinical response|3|||
155367875|NCT01371708|560780532|FG001|Overall Study|Insufficient clinical response|2|||
155367876|NCT01371708|560780533|FG002|Overall Study|Insufficient clinical response|0|||
155367877|NCT01371708|560780531|FG000|Overall Study|Lost to Follow-up|5|||
155367878|NCT01371708|560780532|FG001|Overall Study|Lost to Follow-up|9|||
155367879|NCT01371708|560780533|FG002|Overall Study|Lost to Follow-up|7|||
155367880|NCT01371708|560780531|FG000|Overall Study|Protocol Violation|2|||
155428349|NCT00391976|560996003|FG002|Overall Study|Protocol deviation/violation|1|||
155428350|NCT00391976|560996001|FG000|Overall Study|Recurrence/no eradication of infection|21|||
155428351|NCT00391976|560996002|FG001|Overall Study|Recurrence/no eradication of infection|19|||
155649321|NCT01529112|561808206|FG000|Overall Study|Protocol Violation|1|||
155367881|NCT01371708|560780532|FG001|Overall Study|Protocol Violation|1|||
155367882|NCT01371708|560780533|FG002|Overall Study|Protocol Violation|2|||
155367883|NCT01371708|560780531|FG000|Overall Study|No longer willing to participate|7|||
155367884|NCT01371708|560780532|FG001|Overall Study|No longer willing to participate|7|||
155367885|NCT01371708|560780533|FG002|Overall Study|No longer willing to participate|13|||
155367886|NCT01371708|560780531|FG000|Overall Study|Medication error/not related to AE|0|||
155508394|NCT00479401|561286906|FG002|Overall Study|Withdrawal by Subject|2|||
155508395|NCT00479401|561286904|FG000|Overall Study|Exclusion criteria, relocation|4|||
155508396|NCT00479401|561286905|FG001|Overall Study|Exclusion criteria, relocation|3|||
155508397|NCT00479401|561286906|FG002|Overall Study|Exclusion criteria, relocation|0|||
155367887|NCT01371708|560780532|FG001|Overall Study|Medication error/not related to AE|1|||
155367888|NCT01371708|560780533|FG002|Overall Study|Medication error/not related to AE|0|||
155367889|NCT01371708|560780531|FG000|Overall Study|Other|3|||
155367890|NCT01371708|560780532|FG001|Overall Study|Other|2|||
155367891|NCT01371708|560780533|FG002|Overall Study|Other|4|||
155367892|NCT01371708|560780531|FG000|Overall Study|Adverse Event|5|||
155367893|NCT01371708|560780532|FG001|Overall Study|Adverse Event|8|||
155367894|NCT01371708|560780533|FG002|Overall Study|Adverse Event|12|||
155367895|NCT01371708|560780531|FG000|Overall Study|Started but did not receive treatment|1|||
155367896|NCT01371708|560780532|FG001|Overall Study|Started but did not receive treatment|0|||
155367897|NCT01371708|560780533|FG002|Overall Study|Started but did not receive treatment|1|||
155367898|NCT02514551|560780534|FG000|Overall Study|Lost to Follow-up|0|||
155367899|NCT02514551|560780535|FG001|Overall Study|Lost to Follow-up|1|||
155367900|NCT02514551|560780534|FG000|Overall Study|Participant Never Treated|0|||
155367901|NCT02514551|560780535|FG001|Overall Study|Participant Never Treated|2|||
155367902|NCT01399918|560780546|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
155367903|NCT03197766|560780547|FG000|Overall Study|Withdrawal by Subject|2|||
155367904|NCT03197766|560780548|FG001|Overall Study|Withdrawal by Subject|0|||
155367905|NCT00632502|560780551|FG000|Overall Study|Adverse Event|0|||
155367906|NCT00632502|560780552|FG001|Overall Study|Adverse Event|1|||
155367907|NCT00632502|560780551|FG000|Overall Study|Randomized not treated|3|||
155367908|NCT00632502|560780552|FG001|Overall Study|Randomized not treated|0|||
155367909|NCT00570908|560780553|FG000|Overall Study|Adverse Event|5|||
155367910|NCT00570908|560780553|FG000|Overall Study|Withdrawal by Subject|2|||
155367911|NCT01213524|560780554|FG000|Baseline|Withdrawal by Subject|5|||
155367912|NCT01213524|560780554|FG000|Baseline|high breath alcohol levels|1|||
155367913|NCT01213524|560780554|FG000|Baseline|Physician Decision|1|||
155367914|NCT01213524|560780554|FG000|Session 2|Withdrawal by Subject|5|||
155367915|NCT01213524|560780554|FG000|Session 3|Withdrawal by Subject|4|||
155367916|NCT01213524|560780554|FG000|Session 4|Physician Decision|1|||
155367917|NCT01213524|560780554|FG000|Session 4|Withdrawal by Subject|2|||
155367918|NCT02519348|560780560|FG000|Overall Study|Death|31|||
155367919|NCT02519348|560780561|FG001|Overall Study|Death|74|||
155367920|NCT02519348|560780562|FG002|Overall Study|Death|47|||
155367921|NCT02519348|560780563|FG003|Overall Study|Death|54|||
155367922|NCT02519348|560780564|FG004|Overall Study|Death|63|||
155367923|NCT02519348|560780565|FG005|Overall Study|Death|18|||
155367924|NCT02519348|560780566|FG006|Overall Study|Death|2|||
155367925|NCT02519348|560780567|FG007|Overall Study|Death|5|||
155367926|NCT02519348|560780568|FG008|Overall Study|Death|5|||
155367927|NCT02519348|560780560|FG000|Overall Study|Withdrawal by Subject|4|||
155367928|NCT02519348|560780561|FG001|Overall Study|Withdrawal by Subject|7|||
155367929|NCT02519348|560780562|FG002|Overall Study|Withdrawal by Subject|4|||
155367930|NCT02519348|560780563|FG003|Overall Study|Withdrawal by Subject|3|||
155367931|NCT02519348|560780564|FG004|Overall Study|Withdrawal by Subject|3|||
155367932|NCT02519348|560780565|FG005|Overall Study|Withdrawal by Subject|2|||
155367933|NCT02519348|560780566|FG006|Overall Study|Withdrawal by Subject|0|||
155367934|NCT02519348|560780567|FG007|Overall Study|Withdrawal by Subject|0|||
155367935|NCT02519348|560780568|FG008|Overall Study|Withdrawal by Subject|1|||
155367936|NCT02519348|560780560|FG000|Overall Study|Lost to Follow-up|0|||
155367937|NCT02519348|560780561|FG001|Overall Study|Lost to Follow-up|0|||
155367938|NCT02519348|560780562|FG002|Overall Study|Lost to Follow-up|1|||
155367939|NCT02519348|560780563|FG003|Overall Study|Lost to Follow-up|0|||
155367940|NCT02519348|560780564|FG004|Overall Study|Lost to Follow-up|2|||
155367941|NCT02519348|560780565|FG005|Overall Study|Lost to Follow-up|1|||
155367942|NCT02519348|560780566|FG006|Overall Study|Lost to Follow-up|1|||
155508398|NCT02124746|561286907|FG000|Overall Study|Adverse Event|2|||
155508399|NCT02124746|561286908|FG001|Overall Study|Adverse Event|1|||
155508400|NCT02124746|561286909|FG002|Overall Study|Adverse Event|2|||
155508401|NCT02124746|561286907|FG000|Overall Study|Death|2|||
155508402|NCT02124746|561286908|FG001|Overall Study|Death|1|||
155508403|NCT02124746|561286909|FG002|Overall Study|Death|3|||
155508404|NCT02124746|561286907|FG000|Overall Study|Lack of Efficacy|3|||
155367943|NCT02519348|560780567|FG007|Overall Study|Lost to Follow-up|0|||
155367944|NCT02519348|560780568|FG008|Overall Study|Lost to Follow-up|0|||
155367945|NCT02519348|560780560|FG000|Overall Study|Other|0|||
155649322|NCT01529112|561808207|FG001|Overall Study|Protocol Violation|0|||
155508405|NCT02124746|561286908|FG001|Overall Study|Lack of Efficacy|2|||
155367946|NCT02519348|560780561|FG001|Overall Study|Other|3|||
155367947|NCT02519348|560780562|FG002|Overall Study|Other|0|||
155367948|NCT02519348|560780563|FG003|Overall Study|Other|0|||
155367949|NCT02519348|560780564|FG004|Overall Study|Other|1|||
155367950|NCT02519348|560780565|FG005|Overall Study|Other|0|||
155367951|NCT02519348|560780566|FG006|Overall Study|Other|0|||
155367952|NCT02519348|560780567|FG007|Overall Study|Other|0|||
155367953|NCT02519348|560780568|FG008|Overall Study|Other|0|||
155367954|NCT02519348|560780560|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
155367955|NCT02519348|560780561|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
155367956|NCT02519348|560780562|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
155367957|NCT02519348|560780563|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
155367958|NCT02519348|560780564|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
155367959|NCT02519348|560780565|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
155367960|NCT02519348|560780566|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
155649323|NCT01529112|561808206|FG000|Overall Study|Withdrawal by Subject|7|||
155428352|NCT00391976|560996003|FG002|Overall Study|Recurrence/no eradication of infection|0|||
155428353|NCT00391976|560996001|FG000|Overall Study|Unable to classify|0|||
155428354|NCT00391976|560996002|FG001|Overall Study|Unable to classify|0|||
155428355|NCT00391976|560996003|FG002|Overall Study|Unable to classify|1|||
155428356|NCT00391976|560996001|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
155428357|NCT00391976|560996002|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
155428358|NCT00391976|560996003|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
155428359|NCT00775021|560996007|FG000|First Intervention|Lost to Follow-up|1|||
155428360|NCT00775021|560996008|FG001|First Intervention|Lost to Follow-up|0|||
155428361|NCT00775021|560996007|FG000|Second Intervention|Adverse Event|0|||
155428362|NCT00775021|560996008|FG001|Second Intervention|Adverse Event|1|||
155428363|NCT05817045|560996029|FG000|Overall Study|Protocol Violation|0|||
155428364|NCT05817045|560996030|FG001|Overall Study|Protocol Violation|3|||
155428365|NCT05817045|560996029|FG000|Overall Study|Withdrawal by Subject|10|||
155428366|NCT05817045|560996030|FG001|Overall Study|Withdrawal by Subject|7|||
155428367|NCT05817045|560996029|FG000|Overall Study|Physician Decision|3|||
155428368|NCT05817045|560996030|FG001|Overall Study|Physician Decision|0|||
155428369|NCT05817045|560996029|FG000|Overall Study|Lost to Follow-up|0|||
155428370|NCT05817045|560996030|FG001|Overall Study|Lost to Follow-up|1|||
155428371|NCT05817045|560996029|FG000|Overall Study|Device Deficiency|1|||
155428372|NCT05817045|560996030|FG001|Overall Study|Device Deficiency|0|||
155428373|NCT05817045|560996029|FG000|Overall Study|System Error|1|||
155428374|NCT05817045|560996030|FG001|Overall Study|System Error|0|||
155428375|NCT01506141|560996031|FG000|Overall Study|Adverse Event|0|||
155428376|NCT01506141|560996032|FG001|Overall Study|Adverse Event|2|||
155428377|NCT01506141|560996031|FG000|Overall Study|Participation Terminated by Investigator|1|||
155428378|NCT01506141|560996032|FG001|Overall Study|Participation Terminated by Investigator|1|||
155428379|NCT01506141|560996031|FG000|Overall Study|Site Terminated by Sponsor|2|||
155428380|NCT01506141|560996032|FG001|Overall Study|Site Terminated by Sponsor|0|||
155428381|NCT01506141|560996031|FG000|Overall Study|Reason Not Specified|4|||
155428382|NCT01506141|560996032|FG001|Overall Study|Reason Not Specified|2|||
155428383|NCT04889209|560996033|FG000|All Cohorts Except 15E|Adverse Event|0|||
155428384|NCT04889209|560996034|FG001|All Cohorts Except 15E|Adverse Event|0|||
155428385|NCT04889209|560996035|FG002|All Cohorts Except 15E|Adverse Event|0|||
155428386|NCT04889209|560996036|FG003|All Cohorts Except 15E|Adverse Event|0|||
155428387|NCT04889209|560996037|FG004|All Cohorts Except 15E|Adverse Event|0|||
155428388|NCT04889209|560996038|FG005|All Cohorts Except 15E|Adverse Event|0|||
155428389|NCT04889209|560996039|FG006|All Cohorts Except 15E|Adverse Event|1|||
155428390|NCT04889209|560996040|FG007|All Cohorts Except 15E|Adverse Event|0|||
155428391|NCT04889209|560996041|FG008|All Cohorts Except 15E|Adverse Event|0|||
155649324|NCT01529112|561808207|FG001|Overall Study|Withdrawal by Subject|3|||
155508406|NCT02124746|561286909|FG002|Overall Study|Lack of Efficacy|2|||
155508407|NCT02124746|561286907|FG000|Overall Study|Physician Decision|6|||
155508408|NCT02124746|561286908|FG001|Overall Study|Physician Decision|4|||
155508409|NCT02124746|561286909|FG002|Overall Study|Physician Decision|5|||
155508410|NCT02124746|561286907|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155508411|NCT02124746|561286908|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155508412|NCT02124746|561286909|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155508413|NCT02124746|561286907|FG000|Overall Study|Withdrawal by Subject|3|||
155508414|NCT02124746|561286908|FG001|Overall Study|Withdrawal by Subject|3|||
155508415|NCT02124746|561286909|FG002|Overall Study|Withdrawal by Subject|0|||
155508416|NCT02124746|561286907|FG000|Overall Study|Study Terminated by Sponsor|0|||
155508417|NCT02124746|561286908|FG001|Overall Study|Study Terminated by Sponsor|0|||
155508418|NCT02124746|561286909|FG002|Overall Study|Study Terminated by Sponsor|6|||
155508419|NCT02124746|561286907|FG000|Overall Study|Disease Progression|3|||
155508420|NCT02124746|561286908|FG001|Overall Study|Disease Progression|6|||
155508421|NCT02124746|561286909|FG002|Overall Study|Disease Progression|4|||
155508422|NCT03634488|561286915|FG000|Overall Study|Death|1|||
155508423|NCT03634488|561286916|FG001|Overall Study|Death|0|||
155508424|NCT03634488|561286917|FG002|Overall Study|Death|0|||
155508425|NCT03634488|561286915|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
155508426|NCT03634488|561286916|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
155508427|NCT03634488|561286917|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
155508428|NCT03182686|561286918|FG000|Overall Study|Lost to Follow-up|2|||
155508429|NCT03182686|561286919|FG001|Overall Study|Lost to Follow-up|0|||
155508430|NCT03182686|561286918|FG000|Overall Study|Adverse Event|2|||
155508431|NCT03182686|561286919|FG001|Overall Study|Adverse Event|0|||
155649325|NCT02123511|561808212|FG000|Overall Study|Cancelled treatment|1|||
155428392|NCT04889209|560996042|FG009|All Cohorts Except 15E|Adverse Event|0|||
155428393|NCT04889209|560996043|FG010|All Cohorts Except 15E|Adverse Event|0|||
155428394|NCT04889209|560996044|FG011|All Cohorts Except 15E|Adverse Event|0|||
155428395|NCT04889209|560996045|FG012|All Cohorts Except 15E|Adverse Event|0|||
155508432|NCT03182686|561286918|FG000|Overall Study|Withdrawal by Subject|3|||
155508433|NCT03182686|561286919|FG001|Overall Study|Withdrawal by Subject|0|||
155649326|NCT02123511|561808213|FG001|Overall Study|Cancelled treatment|0|||
155367961|NCT02519348|560780567|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
155367962|NCT02519348|560780568|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
155367963|NCT01110408|560780569|FG000|Overall Study|Protocol Violation|1|||
155367964|NCT01110408|560780570|FG001|Overall Study|Protocol Violation|0|||
155367965|NCT00669877|560780571|FG000|Overall Study|Disease Progression/Death|4|||
155367966|NCT04103892|560780572|FG000|Overall Study|Adverse Event|0|||
155367967|NCT04103892|560780573|FG001|Overall Study|Adverse Event|0|||
155367968|NCT04103892|560780574|FG002|Overall Study|Adverse Event|0|||
155367969|NCT04103892|560780575|FG003|Overall Study|Adverse Event|3|||
155367970|NCT04103892|560780572|FG000|Overall Study|Lost to Follow-up|0|||
155367971|NCT04103892|560780573|FG001|Overall Study|Lost to Follow-up|0|||
155367972|NCT04103892|560780574|FG002|Overall Study|Lost to Follow-up|2|||
155367973|NCT04103892|560780575|FG003|Overall Study|Lost to Follow-up|0|||
155367974|NCT04103892|560780572|FG000|Overall Study|Protocol Violation|0|||
155367975|NCT04103892|560780573|FG001|Overall Study|Protocol Violation|0|||
155367976|NCT04103892|560780574|FG002|Overall Study|Protocol Violation|1|||
155367977|NCT04103892|560780575|FG003|Overall Study|Protocol Violation|1|||
155367978|NCT04103892|560780572|FG000|Overall Study|Withdrawal by Subject|1|||
155367979|NCT04103892|560780573|FG001|Overall Study|Withdrawal by Subject|0|||
155367980|NCT04103892|560780574|FG002|Overall Study|Withdrawal by Subject|2|||
155367981|NCT04103892|560780575|FG003|Overall Study|Withdrawal by Subject|5|||
155367982|NCT04103892|560780572|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
155367983|NCT04103892|560780573|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
155367984|NCT04103892|560780574|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
155367985|NCT04103892|560780575|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
155367986|NCT03008005|560780576|FG000|Overall Study|Physician Decision|1|||
155367987|NCT03008005|560780577|FG001|Overall Study|Physician Decision|0|||
155367988|NCT03008005|560780578|FG002|Overall Study|Physician Decision|0|||
155367989|NCT03008005|560780576|FG000|Overall Study|Withdrawal by Subject|1|||
155428396|NCT04889209|560996046|FG013|All Cohorts Except 15E|Adverse Event|0|||
155428397|NCT04889209|560996047|FG014|All Cohorts Except 15E|Adverse Event|0|||
155428398|NCT04889209|560996048|FG015|All Cohorts Except 15E|Adverse Event|0|||
155428399|NCT04889209|560996049|FG016|All Cohorts Except 15E|Adverse Event|0|||
155428400|NCT04889209|560996050|FG017|All Cohorts Except 15E|Adverse Event|0|||
155428401|NCT04889209|560996033|FG000|All Cohorts Except 15E|Death|0|||
155428402|NCT04889209|560996034|FG001|All Cohorts Except 15E|Death|1|||
155428403|NCT04889209|560996035|FG002|All Cohorts Except 15E|Death|0|||
155428404|NCT04889209|560996036|FG003|All Cohorts Except 15E|Death|0|||
155428405|NCT04889209|560996037|FG004|All Cohorts Except 15E|Death|0|||
155428406|NCT04889209|560996038|FG005|All Cohorts Except 15E|Death|0|||
155428407|NCT04889209|560996039|FG006|All Cohorts Except 15E|Death|0|||
155428408|NCT04889209|560996040|FG007|All Cohorts Except 15E|Death|0|||
155428409|NCT04889209|560996041|FG008|All Cohorts Except 15E|Death|0|||
155428410|NCT04889209|560996042|FG009|All Cohorts Except 15E|Death|0|||
155428411|NCT04889209|560996043|FG010|All Cohorts Except 15E|Death|0|||
155428412|NCT04889209|560996044|FG011|All Cohorts Except 15E|Death|0|||
155428413|NCT04889209|560996045|FG012|All Cohorts Except 15E|Death|0|||
155428414|NCT04889209|560996046|FG013|All Cohorts Except 15E|Death|0|||
155367990|NCT03008005|560780577|FG001|Overall Study|Withdrawal by Subject|0|||
155367991|NCT03008005|560780578|FG002|Overall Study|Withdrawal by Subject|0|||
155367992|NCT03008005|560780576|FG000|Overall Study|Ineligible|0|||
155428415|NCT04889209|560996047|FG014|All Cohorts Except 15E|Death|0|||
155428416|NCT04889209|560996048|FG015|All Cohorts Except 15E|Death|0|||
155428417|NCT04889209|560996049|FG016|All Cohorts Except 15E|Death|0|||
155367993|NCT03008005|560780577|FG001|Overall Study|Ineligible|1|||
155508434|NCT01154127|561286920|FG000|Period 1 (21 Days)|Adverse Event|3|||
155508435|NCT01154127|561286921|FG001|Period 1 (21 Days)|Adverse Event|4|||
155508436|NCT01154127|561286920|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
155508437|NCT01154127|561286921|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
155508438|NCT01154127|561286920|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
155508439|NCT01154127|561286921|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
155508440|NCT01154127|561286920|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
155508441|NCT01154127|561286921|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
155508442|NCT01154127|561286920|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
155508443|NCT01154127|561286921|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
155508444|NCT01697449|561286928|FG000|Overall Study|Disease progression|47|||
155508445|NCT01697449|561286928|FG000|Overall Study|Adverse Event|7|||
155508446|NCT01697449|561286928|FG000|Overall Study|Lost to Follow-up|5|||
155508447|NCT01697449|561286928|FG000|Overall Study|Withdrawal by Subject|2|||
155508448|NCT01697449|561286928|FG000|Overall Study|Physician Decision|1|||
155367994|NCT03008005|560780578|FG002|Overall Study|Ineligible|0|||
155367995|NCT00975676|560780579|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
155367996|NCT00975676|560780580|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
155367997|NCT02548078|560780581|FG000|Overall Study|Serious adverse event/Adverse event|1|||
155367998|NCT02548078|560780582|FG001|Overall Study|Serious adverse event/Adverse event|0|||
155367999|NCT02548078|560780581|FG000|Overall Study|Moved from study area|3|||
155368000|NCT02548078|560780582|FG001|Overall Study|Moved from study area|3|||
155368001|NCT02548078|560780581|FG000|Overall Study|Lost to Follow-up|1|||
155368002|NCT02548078|560780582|FG001|Overall Study|Lost to Follow-up|3|||
155368003|NCT00862836|560780583|FG000|Overall Study|Withdrawal by Subject|1|||
155368004|NCT05855967|560780584|FG000|Overall Study|Withdrawal by Subject|7|||
155368005|NCT05855967|560780585|FG001|Overall Study|Withdrawal by Subject|5|||
155368006|NCT05855967|560780584|FG000|Overall Study|Lost to Follow-up|2|||
155368007|NCT05855967|560780585|FG001|Overall Study|Lost to Follow-up|1|||
155368008|NCT04147195|560780586|FG000|Overall Study|Adverse Event|0|||
155368009|NCT04147195|560780587|FG001|Overall Study|Adverse Event|3|||
155368010|NCT04147195|560780586|FG000|Overall Study|Study Terminated by Sponsor|4|||
155368011|NCT04147195|560780587|FG001|Overall Study|Study Terminated by Sponsor|2|||
155368012|NCT04147195|560780586|FG000|Overall Study|Withdrawal by Subject|0|||
155368013|NCT04147195|560780587|FG001|Overall Study|Withdrawal by Subject|1|||
155368014|NCT03554629|560783129|FG000|Overall Study|Inadequate data|6|||
155368015|NCT01195948|560783132|FG000|Overall Study|Lost to Follow-up|0|||
155368016|NCT01195948|560783133|FG001|Overall Study|Lost to Follow-up|1|||
155508449|NCT01697449|561286928|FG000|Overall Study|Death|2|||
155508450|NCT01697449|561286928|FG000|Overall Study|Other|1|||
155508451|NCT01697449|561286928|FG000|Overall Study|Missing|25|||
155508452|NCT01169844|561286929|FG000|Overall Study|Adverse Event|0|||
155508453|NCT01169844|561286930|FG001|Overall Study|Adverse Event|1|||
155508454|NCT01169844|561286929|FG000|Overall Study|Patient withdrew consent|4|||
155508455|NCT01169844|561286930|FG001|Overall Study|Patient withdrew consent|0|||
155508456|NCT01169844|561286929|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155508457|NCT01169844|561286930|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155508458|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
155508459|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
155508460|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
155508461|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
155508462|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
155508463|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
155508464|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
155508465|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
155508466|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
155508467|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
155508468|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
155508469|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
155508470|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
155508471|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
155368017|NCT01195948|560783134|FG002|Overall Study|Lost to Follow-up|2|||
155368018|NCT05577715|560783135|FG000|Overall Study|Withdrawal by Subject|1|||
155368019|NCT05577715|560783135|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
155368020|NCT05577715|560783135|FG000|Overall Study|Lost to Follow-up|1|||
155368021|NCT05577715|560783135|FG000|Overall Study|Death|6|||
155508472|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
155508473|NCT00529568|561286932|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
155508474|NCT00529568|561286933|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
155508475|NCT00529568|561286934|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
155508476|NCT00529568|561286932|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
155508477|NCT00529568|561286933|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
155368022|NCT05282121|560783140|FG000|Overall Study|Adverse Event|1|||
155368023|NCT05282121|560783141|FG001|Overall Study|Adverse Event|1|||
155368024|NCT05282121|560783142|FG002|Overall Study|Adverse Event|4|||
155368025|NCT05282121|560783143|FG003|Overall Study|Adverse Event|1|||
155368026|NCT05282121|560783140|FG000|Overall Study|Study Terminated by Sponsor|1|||
155368027|NCT05282121|560783141|FG001|Overall Study|Study Terminated by Sponsor|2|||
155368028|NCT05282121|560783142|FG002|Overall Study|Study Terminated by Sponsor|2|||
155368029|NCT05282121|560783143|FG003|Overall Study|Study Terminated by Sponsor|2|||
155368030|NCT05282121|560783140|FG000|Overall Study|Other than listed|0|||
155368031|NCT05282121|560783141|FG001|Overall Study|Other than listed|0|||
155368032|NCT05282121|560783142|FG002|Overall Study|Other than listed|1|||
155368033|NCT05282121|560783143|FG003|Overall Study|Other than listed|0|||
155368034|NCT05282121|560783140|FG000|Overall Study|No reason available|0|||
155368035|NCT05282121|560783141|FG001|Overall Study|No reason available|0|||
155368036|NCT05282121|560783142|FG002|Overall Study|No reason available|1|||
155368037|NCT05282121|560783143|FG003|Overall Study|No reason available|0|||
155368038|NCT03301155|560783146|FG000|Overall Study|Сompliance with exclusion criteria|8|||
155368039|NCT03301155|560783147|FG001|Overall Study|Сompliance with exclusion criteria|7|||
155368040|NCT03510455|560783149|FG000|Overall Study|Physician Decision|1|||
155368041|NCT04958642|560783152|FG000|Overall Study|Transferred to OLEX program|3|||
155368042|NCT04958642|560783153|FG001|Overall Study|Transferred to OLEX program|0|||
155368043|NCT04958642|560783154|FG002|Overall Study|Transferred to OLEX program|5|||
155368044|NCT04958642|560783152|FG000|Overall Study|Death|0|||
155368045|NCT04958642|560783153|FG001|Overall Study|Death|0|||
155368046|NCT04958642|560783154|FG002|Overall Study|Death|1|||
155368047|NCT04958642|560783152|FG000|Overall Study|Withdrawal by Subject|4|||
155368048|NCT04958642|560783153|FG001|Overall Study|Withdrawal by Subject|9|||
155368049|NCT04958642|560783154|FG002|Overall Study|Withdrawal by Subject|13|||
155368050|NCT04958642|560783152|FG000|Overall Study|Investigator's Decision|0|||
155368051|NCT04958642|560783153|FG001|Overall Study|Investigator's Decision|0|||
155368052|NCT04958642|560783154|FG002|Overall Study|Investigator's Decision|1|||
155368053|NCT04958642|560783152|FG000|Overall Study|Adverse Event|1|||
155368054|NCT04958642|560783153|FG001|Overall Study|Adverse Event|0|||
155368055|NCT04958642|560783154|FG002|Overall Study|Adverse Event|1|||
155368056|NCT04958642|560783152|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
155368057|NCT04958642|560783153|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
155368058|NCT04958642|560783154|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
155368059|NCT04958642|560783152|FG000|Overall Study|Lost to Follow-up|1|||
155428418|NCT04889209|560996050|FG017|All Cohorts Except 15E|Death|0|||
155428419|NCT04889209|560996033|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
155428420|NCT04889209|560996034|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
155428421|NCT04889209|560996035|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
155428422|NCT04889209|560996036|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
155428423|NCT04889209|560996037|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
155428424|NCT04889209|560996038|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
155428425|NCT04889209|560996039|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
155428426|NCT04889209|560996040|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
155428427|NCT04889209|560996041|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
155428428|NCT04889209|560996042|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
155428429|NCT04889209|560996043|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
155428430|NCT04889209|560996044|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
155428431|NCT04889209|560996045|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
155428432|NCT04889209|560996046|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
155428433|NCT04889209|560996047|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
155428434|NCT04889209|560996048|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
155428435|NCT04889209|560996049|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
155428436|NCT04889209|560996050|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
155428437|NCT04889209|560996033|FG000|All Cohorts Except 15E|Physician Decision|0|||
155428438|NCT04889209|560996034|FG001|All Cohorts Except 15E|Physician Decision|0|||
155428439|NCT04889209|560996035|FG002|All Cohorts Except 15E|Physician Decision|0|||
155428440|NCT04889209|560996036|FG003|All Cohorts Except 15E|Physician Decision|0|||
155428441|NCT04889209|560996037|FG004|All Cohorts Except 15E|Physician Decision|1|||
155428442|NCT04889209|560996038|FG005|All Cohorts Except 15E|Physician Decision|0|||
155428443|NCT04889209|560996039|FG006|All Cohorts Except 15E|Physician Decision|0|||
155368060|NCT04958642|560783153|FG001|Overall Study|Lost to Follow-up|0|||
155368061|NCT04958642|560783154|FG002|Overall Study|Lost to Follow-up|0|||
155368062|NCT04958642|560783152|FG000|Overall Study|Transferred to EAP following study termination|0|||
155368063|NCT04958642|560783153|FG001|Overall Study|Transferred to EAP following study termination|0|||
155368064|NCT04958642|560783154|FG002|Overall Study|Transferred to EAP following study termination|1|||
155368065|NCT04958642|560783152|FG000|Overall Study|Transferred to Expanded Access Program|1|||
155368066|NCT04958642|560783153|FG001|Overall Study|Transferred to Expanded Access Program|0|||
155428444|NCT04889209|560996040|FG007|All Cohorts Except 15E|Physician Decision|1|||
155368067|NCT04958642|560783154|FG002|Overall Study|Transferred to Expanded Access Program|0|||
155428445|NCT04889209|560996041|FG008|All Cohorts Except 15E|Physician Decision|0|||
155428446|NCT04889209|560996042|FG009|All Cohorts Except 15E|Physician Decision|1|||
155368068|NCT02942004|560783155|FG000|Overall Study|Withdrawal by Subject|0|||
155368069|NCT02942004|560783156|FG001|Overall Study|Withdrawal by Subject|2|||
155368070|NCT02942004|560783157|FG002|Overall Study|Withdrawal by Subject|3|||
155368071|NCT02942004|560783155|FG000|Overall Study|Lost to Follow-up|1|||
155368072|NCT02942004|560783156|FG001|Overall Study|Lost to Follow-up|1|||
155368073|NCT02942004|560783157|FG002|Overall Study|Lost to Follow-up|2|||
155368074|NCT02942004|560783155|FG000|Overall Study|Randomized but not dosed|3|||
155368075|NCT02942004|560783156|FG001|Overall Study|Randomized but not dosed|9|||
155368076|NCT02942004|560783157|FG002|Overall Study|Randomized but not dosed|4|||
155368077|NCT05627258|560783158|FG000|Overall Study|Lost to Follow-up|1|||
155368078|NCT05627258|560783159|FG001|Overall Study|Lost to Follow-up|0|||
155368079|NCT05627258|560783160|FG002|Overall Study|Lost to Follow-up|0|||
155368080|NCT05627258|560783161|FG003|Overall Study|Lost to Follow-up|0|||
155368081|NCT05627258|560783162|FG004|Overall Study|Lost to Follow-up|0|||
155368082|NCT05627258|560783163|FG005|Overall Study|Lost to Follow-up|0|||
155368083|NCT05627258|560783158|FG000|Overall Study|Withdrawal by Subject|0|||
155368084|NCT05627258|560783159|FG001|Overall Study|Withdrawal by Subject|0|||
155368085|NCT05627258|560783160|FG002|Overall Study|Withdrawal by Subject|0|||
155368086|NCT05627258|560783161|FG003|Overall Study|Withdrawal by Subject|0|||
155368087|NCT05627258|560783162|FG004|Overall Study|Withdrawal by Subject|2|||
155368088|NCT05627258|560783163|FG005|Overall Study|Withdrawal by Subject|0|||
155368089|NCT05627258|560783158|FG000|Overall Study|Enrolled, but product not administered|1|||
155368090|NCT05627258|560783159|FG001|Overall Study|Enrolled, but product not administered|0|||
155368091|NCT05627258|560783160|FG002|Overall Study|Enrolled, but product not administered|0|||
155368092|NCT05627258|560783161|FG003|Overall Study|Enrolled, but product not administered|0|||
155368093|NCT05627258|560783162|FG004|Overall Study|Enrolled, but product not administered|0|||
155368094|NCT05627258|560783163|FG005|Overall Study|Enrolled, but product not administered|0|||
155368095|NCT05627258|560783158|FG000|Overall Study|Other subject illness/injury|1|||
155368096|NCT05627258|560783159|FG001|Overall Study|Other subject illness/injury|0|||
155368097|NCT05627258|560783160|FG002|Overall Study|Other subject illness/injury|0|||
155368098|NCT05627258|560783161|FG003|Overall Study|Other subject illness/injury|0|||
155368099|NCT05627258|560783162|FG004|Overall Study|Other subject illness/injury|0|||
155368100|NCT05627258|560783163|FG005|Overall Study|Other subject illness/injury|0|||
155368101|NCT05627258|560783158|FG000|Overall Study|Subject moved from area|0|||
155368102|NCT05627258|560783159|FG001|Overall Study|Subject moved from area|0|||
155368103|NCT05627258|560783160|FG002|Overall Study|Subject moved from area|1|||
155368104|NCT05627258|560783161|FG003|Overall Study|Subject moved from area|0|||
155368105|NCT05627258|560783162|FG004|Overall Study|Subject moved from area|0|||
155368106|NCT05627258|560783163|FG005|Overall Study|Subject moved from area|0|||
155368107|NCT01923662|560783167|FG000|Overall Study|Withdrawal by Subject|1|||
155368108|NCT01199068|560783168|FG000|Overall Study|Unacceptable toxicity|0|||
155368109|NCT01199068|560783169|FG001|Overall Study|Unacceptable toxicity|0|||
155368110|NCT01199068|560783170|FG002|Overall Study|Unacceptable toxicity|2|||
155368111|NCT01199068|560783168|FG000|Overall Study|Progressive disease|3|||
155368112|NCT01199068|560783169|FG001|Overall Study|Progressive disease|3|||
155368113|NCT01199068|560783170|FG002|Overall Study|Progressive disease|6|||
155368114|NCT01199068|560783168|FG000|Overall Study|Withdrawal by Subject|0|||
155368115|NCT01199068|560783169|FG001|Overall Study|Withdrawal by Subject|0|||
155368116|NCT01199068|560783170|FG002|Overall Study|Withdrawal by Subject|1|||
155368117|NCT01250925|560783171|FG000|Overall Study|Lost to Follow-up|1|||
155368118|NCT01250925|560783172|FG001|Overall Study|Lost to Follow-up|1|||
155368119|NCT01250925|560783173|FG002|Overall Study|Lost to Follow-up|0|||
155368120|NCT01250925|560783171|FG000|Overall Study|Withdrawal by Subject|2|||
155368121|NCT01250925|560783172|FG001|Overall Study|Withdrawal by Subject|0|||
155368122|NCT01250925|560783173|FG002|Overall Study|Withdrawal by Subject|0|||
155368123|NCT01250925|560783171|FG000|Overall Study|Protocol Violation|2|||
155368124|NCT01250925|560783172|FG001|Overall Study|Protocol Violation|0|||
155368125|NCT01250925|560783173|FG002|Overall Study|Protocol Violation|0|||
155368126|NCT01250925|560783171|FG000|Overall Study|Physician Decision|0|||
155368127|NCT01250925|560783172|FG001|Overall Study|Physician Decision|2|||
155368128|NCT01250925|560783173|FG002|Overall Study|Physician Decision|1|||
155368129|NCT01250925|560783171|FG000|Overall Study|Adverse Event|0|||
155368130|NCT01250925|560783172|FG001|Overall Study|Adverse Event|0|||
155368131|NCT01250925|560783173|FG002|Overall Study|Adverse Event|1|||
155368132|NCT00678301|560783174|FG000|Overall Study|Non-compliance with study procedures|0|||
155368133|NCT00678301|560783175|FG001|Overall Study|Non-compliance with study procedures|1|||
155368134|NCT00678301|560783174|FG000|Overall Study|Adverse Event|1|||
155368135|NCT00678301|560783175|FG001|Overall Study|Adverse Event|0|||
155368136|NCT00678301|560783174|FG000|Overall Study|Withdrawal by Subject|4|||
155368137|NCT00678301|560783175|FG001|Overall Study|Withdrawal by Subject|0|||
155368138|NCT00678301|560783174|FG000|Overall Study|Lost to Follow-up|3|||
155368139|NCT00678301|560783175|FG001|Overall Study|Lost to Follow-up|1|||
155368140|NCT01939353|560783176|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
155368141|NCT01939353|560783176|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
155649327|NCT02123511|561808212|FG000|Overall Study|Incomplete data|1|||
155508478|NCT00529568|561286934|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
155508479|NCT00529568|561286932|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
155508480|NCT00529568|561286933|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
155508481|NCT00529568|561286934|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
155508482|NCT00529568|561286932|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
155508483|NCT00529568|561286933|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
155508484|NCT00529568|561286934|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
155508485|NCT00529568|561286932|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
155508486|NCT00529568|561286933|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
155508487|NCT00529568|561286934|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
155508488|NCT00529568|561286932|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
155508489|NCT00529568|561286933|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
155508490|NCT00529568|561286934|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
155508491|NCT04049552|561286935|FG000|Overall Study|Lost to Follow-up|1|||
155508492|NCT00738920|561286937|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
155508493|NCT00738920|561286938|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
155508494|NCT00738920|561286939|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
155508495|NCT00738920|561286937|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
155508496|NCT00738920|561286938|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
155508497|NCT00738920|561286939|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
155508498|NCT00738920|561286937|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
155508499|NCT00738920|561286938|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
155508500|NCT00738920|561286939|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
155508501|NCT00738920|561286937|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
155508502|NCT00738920|561286938|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
155508503|NCT00738920|561286939|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
155508504|NCT00738920|561286937|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
155368142|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
155508505|NCT00738920|561286938|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
155368143|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
155368144|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
155368145|NCT00335140|560783178|FG000|Overall Study|Ineligible|1|||
155368146|NCT01685229|560783186|FG000|Overall Study|Subjects missing Study Exit form|3|||
155368147|NCT01685229|560783187|FG001|Overall Study|Subjects missing Study Exit form|1|||
155368148|NCT01685229|560783186|FG000|Overall Study|Lost to Follow-up|16|||
155368149|NCT01685229|560783187|FG001|Overall Study|Lost to Follow-up|10|||
155368150|NCT01685229|560783186|FG000|Overall Study|Withdrawal by Subject|6|||
155368151|NCT01685229|560783187|FG001|Overall Study|Withdrawal by Subject|5|||
155368152|NCT01685229|560783186|FG000|Overall Study|Death|1|||
155508506|NCT00738920|561286939|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
155508507|NCT00738920|561286937|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
155508508|NCT00738920|561286938|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
155508509|NCT00738920|561286939|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
155508510|NCT00738920|561286937|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
155508511|NCT00738920|561286938|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
155508512|NCT00738920|561286939|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
155508513|NCT00738920|561286937|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
155508514|NCT00738920|561286938|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
155508515|NCT00738920|561286939|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
155508516|NCT00738920|561286937|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
155508517|NCT00738920|561286938|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
155508518|NCT00738920|561286939|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
155508519|NCT00738920|561286937|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
155508520|NCT00738920|561286938|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
155508521|NCT00738920|561286939|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
155508522|NCT00331630|561289310|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
155508523|NCT00331630|561289310|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
155508524|NCT00331630|561289310|FG000|Follow up for 5 Years|Death|5|||
155508525|NCT00331630|561289310|FG000|Follow up for 5 Years|Data collection was stopped|24|||
155508526|NCT00433381|561289311|FG000|Overall Study|Ineligible / no protocol treatment|3|||
155508527|NCT00433381|561289312|FG001|Overall Study|Ineligible / no protocol treatment|3|||
155508528|NCT01133821|561289313|FG000|Overall Study|Lost to Follow-up|8|||
155368153|NCT01685229|560783187|FG001|Overall Study|Death|0|||
155368154|NCT03596762|560783193|FG000|Overall Study|Protocol Violation|0|||
155649328|NCT02123511|561808213|FG001|Overall Study|Incomplete data|3|||
155649329|NCT02123511|561808212|FG000|Overall Study|Ineligible|0|||
155649330|NCT02123511|561808213|FG001|Overall Study|Ineligible|1|||
155649331|NCT01423084|561808214|FG000|Overall Study|Adverse Event|0|||
155649332|NCT01423084|561808215|FG001|Overall Study|Adverse Event|1|||
155649333|NCT01423084|561808214|FG000|Overall Study|Withdrawal by Subject|2|||
155649334|NCT01423084|561808215|FG001|Overall Study|Withdrawal by Subject|3|||
155649335|NCT01133977|561808219|FG000|Overall Study|Adverse Event|0|||
155649336|NCT01133977|561808220|FG001|Overall Study|Adverse Event|0|||
155649337|NCT01133977|561808221|FG002|Overall Study|Adverse Event|1|||
155368155|NCT03596762|560783194|FG001|Overall Study|Protocol Violation|0|||
155368156|NCT03596762|560783195|FG002|Overall Study|Protocol Violation|0|||
155368157|NCT03596762|560783196|FG003|Overall Study|Protocol Violation|0|||
155368158|NCT03596762|560783197|FG004|Overall Study|Protocol Violation|1|||
155368159|NCT03596762|560783193|FG000|Overall Study|Adverse Event|2|||
155368160|NCT03596762|560783194|FG001|Overall Study|Adverse Event|0|||
155368161|NCT03596762|560783195|FG002|Overall Study|Adverse Event|1|||
155368162|NCT03596762|560783196|FG003|Overall Study|Adverse Event|0|||
155368163|NCT03596762|560783197|FG004|Overall Study|Adverse Event|5|||
155368164|NCT03596762|560783193|FG000|Overall Study|Withdrawal by Subject|2|||
155368165|NCT03596762|560783194|FG001|Overall Study|Withdrawal by Subject|1|||
155368166|NCT03596762|560783195|FG002|Overall Study|Withdrawal by Subject|0|||
155368167|NCT03596762|560783196|FG003|Overall Study|Withdrawal by Subject|1|||
155368168|NCT03596762|560783197|FG004|Overall Study|Withdrawal by Subject|1|||
155368169|NCT01371825|560783204|FG000|Overall Study|Death|4|||
155368170|NCT00895895|560783205|FG000|Period 1|Adverse Event|7|||
155368171|NCT00895895|560783206|FG001|Period 1|Adverse Event|6|||
155428447|NCT04889209|560996043|FG010|All Cohorts Except 15E|Physician Decision|0|||
155428448|NCT04889209|560996044|FG011|All Cohorts Except 15E|Physician Decision|1|||
155428449|NCT04889209|560996045|FG012|All Cohorts Except 15E|Physician Decision|1|||
155428450|NCT04889209|560996046|FG013|All Cohorts Except 15E|Physician Decision|0|||
155428451|NCT04889209|560996047|FG014|All Cohorts Except 15E|Physician Decision|0|||
155428452|NCT04889209|560996048|FG015|All Cohorts Except 15E|Physician Decision|0|||
155428453|NCT04889209|560996049|FG016|All Cohorts Except 15E|Physician Decision|0|||
155428454|NCT04889209|560996050|FG017|All Cohorts Except 15E|Physician Decision|0|||
155428455|NCT04889209|560996033|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
155428456|NCT04889209|560996034|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
155428457|NCT04889209|560996035|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
155428458|NCT04889209|560996036|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
155428459|NCT04889209|560996037|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
155428460|NCT04889209|560996038|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428461|NCT04889209|560996039|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428462|NCT04889209|560996040|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
155428463|NCT04889209|560996041|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428464|NCT04889209|560996042|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428465|NCT04889209|560996043|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428466|NCT04889209|560996044|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428467|NCT04889209|560996045|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428468|NCT04889209|560996046|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
155428469|NCT04889209|560996047|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
155428470|NCT04889209|560996048|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
155428471|NCT04889209|560996049|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
155428472|NCT04889209|560996050|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
155428473|NCT04889209|560996033|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
155428474|NCT04889209|560996034|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
155428475|NCT04889209|560996035|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428476|NCT04889209|560996036|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428477|NCT04889209|560996037|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428478|NCT04889209|560996038|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
155428479|NCT04889209|560996039|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428480|NCT04889209|560996040|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
155428481|NCT04889209|560996041|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428482|NCT04889209|560996042|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
155428483|NCT04889209|560996043|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428484|NCT04889209|560996044|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155649338|NCT01133977|561808222|FG003|Overall Study|Adverse Event|0|||
155649339|NCT01133977|561808223|FG004|Overall Study|Adverse Event|0|||
155649340|NCT01133977|561808219|FG000|Overall Study|Death|1|||
155649341|NCT01133977|561808220|FG001|Overall Study|Death|1|||
155649342|NCT01133977|561808221|FG002|Overall Study|Death|1|||
155368172|NCT00895895|560783207|FG002|Period 1|Adverse Event|4|||
155368173|NCT00895895|560783208|FG003|Period 1|Adverse Event|6|||
155368174|NCT00895895|560783209|FG004|Period 1|Adverse Event|7|||
155508529|NCT01133821|561289314|FG001|Overall Study|Lost to Follow-up|11|||
155508530|NCT01133821|561289313|FG000|Overall Study|Withdrawal by Subject|8|||
155508531|NCT01133821|561289314|FG001|Overall Study|Withdrawal by Subject|3|||
155508532|NCT01133821|561289313|FG000|Overall Study|preferred other treatment|1|||
155508533|NCT01133821|561289314|FG001|Overall Study|preferred other treatment|1|||
155508534|NCT01133821|561289313|FG000|Overall Study|Protocol Violation|0|||
155508535|NCT01133821|561289314|FG001|Overall Study|Protocol Violation|1|||
155508536|NCT01133821|561289313|FG000|Overall Study|Refused participation|1|||
155508537|NCT01133821|561289314|FG001|Overall Study|Refused participation|3|||
155508538|NCT03342898|561289315|FG000|Overall Study|Adverse Event|3|||
155508539|NCT03342898|561289316|FG001|Overall Study|Adverse Event|1|||
155508540|NCT03342898|561289317|FG002|Overall Study|Adverse Event|0|||
155508541|NCT03342898|561289315|FG000|Overall Study|Lost to Follow-up|44|||
155508542|NCT03342898|561289316|FG001|Overall Study|Lost to Follow-up|40|||
155508543|NCT03342898|561289317|FG002|Overall Study|Lost to Follow-up|42|||
155508544|NCT03342898|561289315|FG000|Overall Study|Withdrawal of Consent|5|||
155508545|NCT03342898|561289316|FG001|Overall Study|Withdrawal of Consent|9|||
155508546|NCT03342898|561289317|FG002|Overall Study|Withdrawal of Consent|11|||
155508547|NCT03342898|561289315|FG000|Overall Study|Death|0|||
155508548|NCT03342898|561289316|FG001|Overall Study|Death|1|||
155508549|NCT03342898|561289317|FG002|Overall Study|Death|1|||
155508550|NCT03342898|561289315|FG000|Overall Study|Reason not Specified|2|||
155508551|NCT03342898|561289316|FG001|Overall Study|Reason not Specified|2|||
155508552|NCT03342898|561289317|FG002|Overall Study|Reason not Specified|0|||
155508553|NCT01387282|561289318|FG000|Overall Study|Death|47|||
155508554|NCT01387282|561289319|FG001|Overall Study|Death|16|||
155508555|NCT01387282|561289318|FG000|Overall Study|Other|5|||
155508556|NCT01387282|561289319|FG001|Overall Study|Other|1|||
155508557|NCT01387282|561289318|FG000|Overall Study|Unrelated AE|6|||
155508558|NCT01387282|561289319|FG001|Overall Study|Unrelated AE|4|||
155508559|NCT01387282|561289318|FG000|Overall Study|Withdrawal by patient|33|||
155508560|NCT01387282|561289319|FG001|Overall Study|Withdrawal by patient|23|||
155508561|NCT01387282|561289318|FG000|Overall Study|Study drug-related AE|2|||
155508562|NCT01387282|561289319|FG001|Overall Study|Study drug-related AE|2|||
155508563|NCT01387282|561289318|FG000|Overall Study|Lost to Follow-up|4|||
155508564|NCT01387282|561289319|FG001|Overall Study|Lost to Follow-up|1|||
155508565|NCT03997448|561289322|FG000|Study Treatment|Disease Progression|1|||
155508566|NCT03997448|561289322|FG000|Study Treatment|Symptomatic Deterioration|1|||
155508567|NCT03997448|561289322|FG000|Follow up|Death|2|||
155508568|NCT03997448|561289322|FG000|Follow up|study terminated|1|||
155508569|NCT01621490|561289323|FG000|Overall Study|Subject no longer meets study criteria|0|||
155508570|NCT01621490|561289324|FG001|Overall Study|Subject no longer meets study criteria|0|||
155508571|NCT01621490|561289325|FG002|Overall Study|Subject no longer meets study criteria|0|||
155508572|NCT01621490|561289326|FG003|Overall Study|Subject no longer meets study criteria|0|||
155508573|NCT01621490|561289327|FG004|Overall Study|Subject no longer meets study criteria|1|||
155508574|NCT01621490|561289328|FG005|Overall Study|Subject no longer meets study criteria|0|||
155508575|NCT01621490|561289329|FG006|Overall Study|Subject no longer meets study criteria|0|||
155508576|NCT01621490|561289330|FG007|Overall Study|Subject no longer meets study criteria|0|||
155508577|NCT01621490|561289331|FG008|Overall Study|Subject no longer meets study criteria|0|||
155508578|NCT01621490|561289332|FG009|Overall Study|Subject no longer meets study criteria|0|||
155508579|NCT01621490|561289333|FG010|Overall Study|Subject no longer meets study criteria|0|||
155508580|NCT01621490|561289323|FG000|Overall Study|Maximum clinical benefit|3|||
155508581|NCT01621490|561289324|FG001|Overall Study|Maximum clinical benefit|2|||
155508582|NCT01621490|561289325|FG002|Overall Study|Maximum clinical benefit|0|||
155508583|NCT01621490|561289326|FG003|Overall Study|Maximum clinical benefit|0|||
155508584|NCT01621490|561289327|FG004|Overall Study|Maximum clinical benefit|0|||
155508585|NCT01621490|561289328|FG005|Overall Study|Maximum clinical benefit|0|||
155508586|NCT01621490|561289329|FG006|Overall Study|Maximum clinical benefit|1|||
155508587|NCT01621490|561289330|FG007|Overall Study|Maximum clinical benefit|2|||
155508588|NCT01621490|561289331|FG008|Overall Study|Maximum clinical benefit|2|||
155508589|NCT01621490|561289332|FG009|Overall Study|Maximum clinical benefit|0|||
155368175|NCT00895895|560783205|FG000|Period 1|Death|0|||
155368176|NCT00895895|560783206|FG001|Period 1|Death|0|||
155368177|NCT00895895|560783207|FG002|Period 1|Death|0|||
155368178|NCT00895895|560783208|FG003|Period 1|Death|0|||
155368179|NCT00895895|560783209|FG004|Period 1|Death|1|||
155368180|NCT00895895|560783205|FG000|Period 1|discontinued by sponsor|2|||
155368181|NCT00895895|560783206|FG001|Period 1|discontinued by sponsor|1|||
155368182|NCT00895895|560783207|FG002|Period 1|discontinued by sponsor|2|||
155368183|NCT00895895|560783208|FG003|Period 1|discontinued by sponsor|1|||
155368184|NCT00895895|560783209|FG004|Period 1|discontinued by sponsor|1|||
155368185|NCT00895895|560783205|FG000|Period 1|failed to return|0|||
155368186|NCT00895895|560783206|FG001|Period 1|failed to return|0|||
155368187|NCT00895895|560783207|FG002|Period 1|failed to return|1|||
155368188|NCT00895895|560783208|FG003|Period 1|failed to return|0|||
155368189|NCT00895895|560783209|FG004|Period 1|failed to return|1|||
155368190|NCT00895895|560783205|FG000|Period 1|investigator request|0|||
155368191|NCT00895895|560783206|FG001|Period 1|investigator request|1|||
155368192|NCT00895895|560783207|FG002|Period 1|investigator request|0|||
155368193|NCT00895895|560783208|FG003|Period 1|investigator request|0|||
155368194|NCT00895895|560783209|FG004|Period 1|investigator request|0|||
155368195|NCT00895895|560783205|FG000|Period 1|Lost to Follow-up|2|||
155368196|NCT00895895|560783206|FG001|Period 1|Lost to Follow-up|1|||
155368197|NCT00895895|560783207|FG002|Period 1|Lost to Follow-up|3|||
155368198|NCT00895895|560783208|FG003|Period 1|Lost to Follow-up|2|||
155368199|NCT00895895|560783209|FG004|Period 1|Lost to Follow-up|3|||
155368200|NCT00895895|560783205|FG000|Period 1|Other|1|||
155368201|NCT00895895|560783206|FG001|Period 1|Other|2|||
155368202|NCT00895895|560783207|FG002|Period 1|Other|1|||
155368203|NCT00895895|560783208|FG003|Period 1|Other|1|||
155368204|NCT00895895|560783209|FG004|Period 1|Other|1|||
155368205|NCT00895895|560783205|FG000|Period 1|Protocol Violation|0|||
155368206|NCT00895895|560783206|FG001|Period 1|Protocol Violation|1|||
155368207|NCT00895895|560783207|FG002|Period 1|Protocol Violation|0|||
155368208|NCT00895895|560783208|FG003|Period 1|Protocol Violation|0|||
155368209|NCT00895895|560783209|FG004|Period 1|Protocol Violation|0|||
155368210|NCT00895895|560783205|FG000|Period 1|Withdrawal by Subject|6|||
155368211|NCT00895895|560783206|FG001|Period 1|Withdrawal by Subject|6|||
155368212|NCT00895895|560783207|FG002|Period 1|Withdrawal by Subject|8|||
155368213|NCT00895895|560783208|FG003|Period 1|Withdrawal by Subject|2|||
155368214|NCT00895895|560783209|FG004|Period 1|Withdrawal by Subject|4|||
155368215|NCT00895895|560783205|FG000|Period 1|unsatisfactory response-efficacy|2|||
155368216|NCT00895895|560783206|FG001|Period 1|unsatisfactory response-efficacy|0|||
155368217|NCT00895895|560783207|FG002|Period 1|unsatisfactory response-efficacy|0|||
155368218|NCT00895895|560783208|FG003|Period 1|unsatisfactory response-efficacy|0|||
155368219|NCT00895895|560783209|FG004|Period 1|unsatisfactory response-efficacy|0|||
155368220|NCT00895895|560783205|FG000|Period 1|randomized and not treated|1|||
155368221|NCT00895895|560783206|FG001|Period 1|randomized and not treated|3|||
155368222|NCT00895895|560783207|FG002|Period 1|randomized and not treated|1|||
155368223|NCT00895895|560783208|FG003|Period 1|randomized and not treated|1|||
155368224|NCT00895895|560783209|FG004|Period 1|randomized and not treated|2|||
155368225|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
155368226|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
155368227|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
155368228|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
155368229|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
155368230|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Other|0|||
155368231|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Other|0|||
155368232|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Other|1|||
155368233|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Other|0|||
155368234|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Other|0|||
155368235|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368236|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
155428485|NCT04889209|560996045|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428486|NCT04889209|560996046|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428487|NCT04889209|560996047|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428488|NCT04889209|560996048|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155428489|NCT04889209|560996049|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
155649343|NCT01133977|561808222|FG003|Overall Study|Death|7|||
155649344|NCT01133977|561808223|FG004|Overall Study|Death|3|||
155368237|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368238|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368239|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
155368240|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368241|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368242|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368243|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368244|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
155368245|NCT00895895|560783205|FG000|Period 2|Adverse Event|3|||
155368246|NCT00895895|560783206|FG001|Period 2|Adverse Event|3|||
155368247|NCT00895895|560783207|FG002|Period 2|Adverse Event|5|||
155368248|NCT00895895|560783208|FG003|Period 2|Adverse Event|2|||
155368249|NCT00895895|560783209|FG004|Period 2|Adverse Event|5|||
155368250|NCT00895895|560783205|FG000|Period 2|Death|0|||
155368251|NCT00895895|560783206|FG001|Period 2|Death|0|||
155368252|NCT00895895|560783207|FG002|Period 2|Death|1|||
155428490|NCT04889209|560996050|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
155428491|NCT04889209|560996033|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428492|NCT04889209|560996034|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428493|NCT04889209|560996035|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428494|NCT04889209|560996036|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
155428495|NCT04889209|560996037|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428496|NCT04889209|560996038|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428497|NCT04889209|560996039|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428498|NCT04889209|560996040|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428499|NCT04889209|560996041|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428500|NCT04889209|560996042|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428501|NCT04889209|560996043|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428502|NCT04889209|560996044|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428503|NCT04889209|560996045|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428504|NCT04889209|560996046|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428505|NCT04889209|560996047|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428506|NCT04889209|560996048|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428507|NCT04889209|560996049|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428508|NCT04889209|560996050|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
155428509|NCT04889209|560996033|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428510|NCT04889209|560996034|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155508590|NCT01621490|561289333|FG010|Overall Study|Maximum clinical benefit|0|||
155508591|NCT01621490|561289323|FG000|Overall Study|Withdrawal by Subject|1|||
155508592|NCT01621490|561289324|FG001|Overall Study|Withdrawal by Subject|0|||
155508593|NCT01621490|561289325|FG002|Overall Study|Withdrawal by Subject|0|||
155508594|NCT01621490|561289326|FG003|Overall Study|Withdrawal by Subject|0|||
155508595|NCT01621490|561289327|FG004|Overall Study|Withdrawal by Subject|0|||
155508596|NCT01621490|561289328|FG005|Overall Study|Withdrawal by Subject|1|||
155508597|NCT01621490|561289329|FG006|Overall Study|Withdrawal by Subject|0|||
155508598|NCT01621490|561289330|FG007|Overall Study|Withdrawal by Subject|0|||
155508599|NCT01621490|561289331|FG008|Overall Study|Withdrawal by Subject|0|||
155508600|NCT01621490|561289332|FG009|Overall Study|Withdrawal by Subject|0|||
155508601|NCT01621490|561289333|FG010|Overall Study|Withdrawal by Subject|0|||
155508602|NCT01621490|561289323|FG000|Overall Study|Subject request to discontinue study|1|||
155508603|NCT01621490|561289324|FG001|Overall Study|Subject request to discontinue study|3|||
155508604|NCT01621490|561289325|FG002|Overall Study|Subject request to discontinue study|1|||
155508605|NCT01621490|561289326|FG003|Overall Study|Subject request to discontinue study|1|||
155508606|NCT01621490|561289327|FG004|Overall Study|Subject request to discontinue study|0|||
155508607|NCT01621490|561289328|FG005|Overall Study|Subject request to discontinue study|2|||
155508608|NCT01621490|561289329|FG006|Overall Study|Subject request to discontinue study|1|||
155508609|NCT01621490|561289330|FG007|Overall Study|Subject request to discontinue study|0|||
155508610|NCT01621490|561289331|FG008|Overall Study|Subject request to discontinue study|1|||
155508611|NCT01621490|561289332|FG009|Overall Study|Subject request to discontinue study|0|||
155508612|NCT01621490|561289333|FG010|Overall Study|Subject request to discontinue study|0|||
155508613|NCT01621490|561289323|FG000|Overall Study|Adverse event unrelated to study drug|1|||
155508614|NCT01621490|561289324|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155508615|NCT01621490|561289325|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155508616|NCT01621490|561289326|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155508617|NCT01621490|561289327|FG004|Overall Study|Adverse event unrelated to study drug|0|||
155508618|NCT01621490|561289328|FG005|Overall Study|Adverse event unrelated to study drug|0|||
155368253|NCT00895895|560783208|FG003|Period 2|Death|0|||
155368254|NCT00895895|560783209|FG004|Period 2|Death|0|||
155368255|NCT00895895|560783205|FG000|Period 2|discontinued by sponsor|44|||
155368256|NCT00895895|560783206|FG001|Period 2|discontinued by sponsor|44|||
155368257|NCT00895895|560783207|FG002|Period 2|discontinued by sponsor|38|||
155368258|NCT00895895|560783208|FG003|Period 2|discontinued by sponsor|46|||
155368259|NCT00895895|560783209|FG004|Period 2|discontinued by sponsor|37|||
155368260|NCT00895895|560783205|FG000|Period 2|failed to return|2|||
155368261|NCT00895895|560783206|FG001|Period 2|failed to return|0|||
155368262|NCT00895895|560783207|FG002|Period 2|failed to return|0|||
155368263|NCT00895895|560783208|FG003|Period 2|failed to return|0|||
155368264|NCT00895895|560783209|FG004|Period 2|failed to return|0|||
155368265|NCT00895895|560783205|FG000|Period 2|investigator request|2|||
155368266|NCT00895895|560783206|FG001|Period 2|investigator request|0|||
155368267|NCT00895895|560783207|FG002|Period 2|investigator request|0|||
155368268|NCT00895895|560783208|FG003|Period 2|investigator request|0|||
155368269|NCT00895895|560783209|FG004|Period 2|investigator request|0|||
155368270|NCT00895895|560783205|FG000|Period 2|Lost to Follow-up|1|||
155368271|NCT00895895|560783206|FG001|Period 2|Lost to Follow-up|2|||
155368272|NCT00895895|560783207|FG002|Period 2|Lost to Follow-up|1|||
155368273|NCT00895895|560783208|FG003|Period 2|Lost to Follow-up|1|||
155368274|NCT00895895|560783209|FG004|Period 2|Lost to Follow-up|0|||
155368275|NCT00895895|560783205|FG000|Period 2|Other|1|||
155368276|NCT00895895|560783206|FG001|Period 2|Other|1|||
155368277|NCT00895895|560783207|FG002|Period 2|Other|3|||
155368278|NCT00895895|560783208|FG003|Period 2|Other|1|||
155368279|NCT00895895|560783209|FG004|Period 2|Other|1|||
155368280|NCT00895895|560783205|FG000|Period 2|Protocol Violation|1|||
155368281|NCT00895895|560783206|FG001|Period 2|Protocol Violation|0|||
155368282|NCT00895895|560783207|FG002|Period 2|Protocol Violation|1|||
155368283|NCT00895895|560783208|FG003|Period 2|Protocol Violation|1|||
155368284|NCT00895895|560783209|FG004|Period 2|Protocol Violation|1|||
155368285|NCT00895895|560783205|FG000|Period 2|Withdrawal by Subject|0|||
155368286|NCT00895895|560783206|FG001|Period 2|Withdrawal by Subject|2|||
155368287|NCT00895895|560783207|FG002|Period 2|Withdrawal by Subject|0|||
155368288|NCT00895895|560783208|FG003|Period 2|Withdrawal by Subject|3|||
155368289|NCT00895895|560783209|FG004|Period 2|Withdrawal by Subject|5|||
155368290|NCT00895895|560783205|FG000|Period 2|unsatisfactory response-efficacy|2|||
155368291|NCT00895895|560783206|FG001|Period 2|unsatisfactory response-efficacy|1|||
155368292|NCT00895895|560783207|FG002|Period 2|unsatisfactory response-efficacy|0|||
155368293|NCT00895895|560783208|FG003|Period 2|unsatisfactory response-efficacy|0|||
155368294|NCT00895895|560783209|FG004|Period 2|unsatisfactory response-efficacy|0|||
155368295|NCT03019640|560783210|FG000|Overall Study|Screen Failures|4|||
155368296|NCT03019640|560783210|FG000|Overall Study|Adverse Event|3|||
155368297|NCT03019640|560783210|FG000|Overall Study|Participant Relapsed|1|||
155368298|NCT00504777|560783211|FG000|Overall Study|Adverse Event|1|||
155368299|NCT01572740|560783212|FG000|Overall Study|Adverse Event|1|||
155368300|NCT01572740|560783213|FG001|Overall Study|Adverse Event|1|||
155368301|NCT01572740|560783212|FG000|Overall Study|Withdrawal by Subject|1|||
155368302|NCT01572740|560783213|FG001|Overall Study|Withdrawal by Subject|1|||
155368303|NCT01572740|560783212|FG000|Overall Study|unclassified|4|||
155428511|NCT04889209|560996035|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428512|NCT04889209|560996036|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428513|NCT04889209|560996037|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428514|NCT04889209|560996038|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428515|NCT04889209|560996039|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428516|NCT04889209|560996040|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428517|NCT04889209|560996041|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428518|NCT04889209|560996042|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428519|NCT04889209|560996043|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428520|NCT04889209|560996044|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428521|NCT04889209|560996045|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428522|NCT04889209|560996046|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428523|NCT04889209|560996047|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428524|NCT04889209|560996048|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428525|NCT04889209|560996049|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
155428526|NCT04889209|560996050|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155428527|NCT04889209|560996033|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428528|NCT04889209|560996034|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428529|NCT04889209|560996035|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428530|NCT04889209|560996036|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155368304|NCT01572740|560783213|FG001|Overall Study|unclassified|3|||
155368305|NCT01818531|560783219|FG000|Overall Study|Withdrawn for case delay after block|1|||
155368306|NCT01818531|560783220|FG001|Overall Study|Withdrawn for case delay after block|0|||
155368307|NCT01818531|560783219|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
155368308|NCT01818531|560783220|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
155368309|NCT01818531|560783219|FG000|Overall Study|Withdrawn for failure to place block|0|||
155368310|NCT01818531|560783220|FG001|Overall Study|Withdrawn for failure to place block|1|||
155368311|NCT00214019|560783221|FG000|Overall Study|Lost to Follow-up|11|||
155649345|NCT01133977|561808219|FG000|Overall Study|Started a New Line of Therapy|2|||
155508619|NCT01621490|561289329|FG006|Overall Study|Adverse event unrelated to study drug|0|||
155508620|NCT01621490|561289330|FG007|Overall Study|Adverse event unrelated to study drug|2|||
155508621|NCT01621490|561289331|FG008|Overall Study|Adverse event unrelated to study drug|0|||
155508622|NCT01621490|561289332|FG009|Overall Study|Adverse event unrelated to study drug|0|||
155508623|NCT01621490|561289333|FG010|Overall Study|Adverse event unrelated to study drug|0|||
155508624|NCT01621490|561289323|FG000|Overall Study|Disease progression|27|||
155649346|NCT01133977|561808220|FG001|Overall Study|Started a New Line of Therapy|6|||
155649347|NCT01133977|561808221|FG002|Overall Study|Started a New Line of Therapy|4|||
155649348|NCT01133977|561808222|FG003|Overall Study|Started a New Line of Therapy|25|||
155649349|NCT01133977|561808223|FG004|Overall Study|Started a New Line of Therapy|33|||
155649350|NCT01133977|561808219|FG000|Overall Study|Lost to Follow-up|0|||
155649351|NCT01133977|561808220|FG001|Overall Study|Lost to Follow-up|0|||
155649352|NCT01133977|561808221|FG002|Overall Study|Lost to Follow-up|0|||
155649353|NCT01133977|561808222|FG003|Overall Study|Lost to Follow-up|2|||
155649354|NCT01133977|561808223|FG004|Overall Study|Lost to Follow-up|1|||
155649355|NCT01133977|561808219|FG000|Overall Study|Withdrawal by Subject|0|||
155649356|NCT01133977|561808220|FG001|Overall Study|Withdrawal by Subject|0|||
155649357|NCT01133977|561808221|FG002|Overall Study|Withdrawal by Subject|0|||
155649358|NCT01133977|561808222|FG003|Overall Study|Withdrawal by Subject|5|||
155649359|NCT01133977|561808223|FG004|Overall Study|Withdrawal by Subject|1|||
155649360|NCT02462057|561808224|FG000|Overall Study|Left Vitality|32|||
155649361|NCT02462057|561808225|FG001|Overall Study|Left Vitality|27|||
155649362|NCT02462057|561808226|FG002|Overall Study|Left Vitality|23|||
155649363|NCT02462057|561808227|FG003|Overall Study|Left Vitality|35|||
155649364|NCT02462057|561808228|FG004|Overall Study|Left Vitality|33|||
155508625|NCT01621490|561289324|FG001|Overall Study|Disease progression|28|||
155368312|NCT00214019|560783221|FG000|Overall Study|Withdrawal by Subject|2|||
155368313|NCT00214019|560783221|FG000|Overall Study|Screen Failed prior to randomization|17|||
155368314|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
155368315|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
155368316|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
155368317|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
155368318|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
155368319|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
155368320|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
155368321|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
155368322|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
155368323|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
155368324|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368325|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368326|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
155368327|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
155428531|NCT04889209|560996037|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428532|NCT04889209|560996038|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428533|NCT04889209|560996039|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428534|NCT04889209|560996040|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428535|NCT04889209|560996041|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428536|NCT04889209|560996042|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428537|NCT04889209|560996043|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428538|NCT04889209|560996044|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428539|NCT04889209|560996045|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428540|NCT04889209|560996046|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428541|NCT04889209|560996047|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428542|NCT04889209|560996048|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428543|NCT04889209|560996049|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
155428544|NCT04889209|560996050|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
155428545|NCT04889209|560996033|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428546|NCT04889209|560996034|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428547|NCT04889209|560996035|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428548|NCT04889209|560996036|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428549|NCT04889209|560996037|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428550|NCT04889209|560996038|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428551|NCT04889209|560996039|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428552|NCT04889209|560996040|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428553|NCT04889209|560996041|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155508626|NCT01621490|561289325|FG002|Overall Study|Disease progression|1|||
155649365|NCT02462057|561808224|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
155508627|NCT01621490|561289326|FG003|Overall Study|Disease progression|5|||
155508628|NCT01621490|561289327|FG004|Overall Study|Disease progression|3|||
155508629|NCT01621490|561289328|FG005|Overall Study|Disease progression|8|||
155508630|NCT01621490|561289329|FG006|Overall Study|Disease progression|7|||
155508631|NCT01621490|561289330|FG007|Overall Study|Disease progression|1|||
155508632|NCT01621490|561289331|FG008|Overall Study|Disease progression|4|||
155508633|NCT01621490|561289332|FG009|Overall Study|Disease progression|1|||
155508634|NCT01621490|561289333|FG010|Overall Study|Disease progression|1|||
155508635|NCT01621490|561289323|FG000|Overall Study|Study drug toxicity|1|||
155508636|NCT01621490|561289324|FG001|Overall Study|Study drug toxicity|4|||
155508637|NCT01621490|561289325|FG002|Overall Study|Study drug toxicity|5|||
155508638|NCT01621490|561289326|FG003|Overall Study|Study drug toxicity|3|||
155508639|NCT01621490|561289327|FG004|Overall Study|Study drug toxicity|1|||
155508640|NCT01621490|561289328|FG005|Overall Study|Study drug toxicity|10|||
155508641|NCT01621490|561289329|FG006|Overall Study|Study drug toxicity|1|||
155508642|NCT01621490|561289330|FG007|Overall Study|Study drug toxicity|4|||
155508643|NCT01621490|561289331|FG008|Overall Study|Study drug toxicity|1|||
155508644|NCT01621490|561289332|FG009|Overall Study|Study drug toxicity|0|||
155508645|NCT01621490|561289333|FG010|Overall Study|Study drug toxicity|0|||
155508646|NCT01621490|561289323|FG000|Overall Study|Death|0|||
155508647|NCT01621490|561289324|FG001|Overall Study|Death|0|||
155508648|NCT01621490|561289325|FG002|Overall Study|Death|0|||
155508649|NCT01621490|561289326|FG003|Overall Study|Death|0|||
155508650|NCT01621490|561289327|FG004|Overall Study|Death|0|||
155508651|NCT01621490|561289328|FG005|Overall Study|Death|0|||
155508652|NCT01621490|561289329|FG006|Overall Study|Death|0|||
155508653|NCT01621490|561289330|FG007|Overall Study|Death|0|||
155508654|NCT01621490|561289331|FG008|Overall Study|Death|1|||
155508655|NCT01621490|561289332|FG009|Overall Study|Death|0|||
155508656|NCT01621490|561289333|FG010|Overall Study|Death|0|||
155508657|NCT01621490|561289323|FG000|Overall Study|Other reasons|7|||
155508658|NCT01621490|561289324|FG001|Overall Study|Other reasons|6|||
155508659|NCT01621490|561289325|FG002|Overall Study|Other reasons|4|||
155508660|NCT01621490|561289326|FG003|Overall Study|Other reasons|1|||
155508661|NCT01621490|561289327|FG004|Overall Study|Other reasons|1|||
155508662|NCT01621490|561289328|FG005|Overall Study|Other reasons|3|||
155508663|NCT01621490|561289329|FG006|Overall Study|Other reasons|1|||
155508664|NCT01621490|561289330|FG007|Overall Study|Other reasons|1|||
155508665|NCT01621490|561289331|FG008|Overall Study|Other reasons|1|||
155508666|NCT01621490|561289332|FG009|Overall Study|Other reasons|0|||
155508667|NCT01621490|561289333|FG010|Overall Study|Other reasons|0|||
155508668|NCT00461500|561289334|FG000|Overall Study|Adverse Event|1|||
155368328|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368329|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368330|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368331|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368332|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
155368333|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368334|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368335|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
155508669|NCT00461500|561289335|FG001|Overall Study|Adverse Event|0|||
155508670|NCT00461500|561289334|FG000|Overall Study|Lack of Efficacy|0|||
155508671|NCT00461500|561289335|FG001|Overall Study|Lack of Efficacy|1|||
155508672|NCT00461500|561289334|FG000|Overall Study|Expired Drug Treatment|1|||
155508673|NCT00461500|561289335|FG001|Overall Study|Expired Drug Treatment|1|||
155508674|NCT00461500|561289334|FG000|Overall Study|Study Stopped|1|||
155508675|NCT00461500|561289335|FG001|Overall Study|Study Stopped|2|||
155508676|NCT00461500|561289334|FG000|Overall Study|Drug Treatment Misuse|1|||
155508677|NCT00461500|561289335|FG001|Overall Study|Drug Treatment Misuse|0|||
155508678|NCT00461500|561289334|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
155508679|NCT00461500|561289335|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
155508680|NCT00461500|561289334|FG000|Overall Study|Lost to Follow-up|2|||
155508681|NCT00461500|561289335|FG001|Overall Study|Lost to Follow-up|2|||
155508682|NCT01513551|561289336|FG000|Overall Study|Death|0|||
155508683|NCT01513551|561289337|FG001|Overall Study|Death|1|||
155508684|NCT01513551|561289338|FG002|Overall Study|Death|0|||
155508685|NCT01513551|561289336|FG000|Overall Study|Lost to Follow-up|3|||
155508686|NCT01513551|561289337|FG001|Overall Study|Lost to Follow-up|5|||
155508687|NCT01513551|561289338|FG002|Overall Study|Lost to Follow-up|2|||
155508688|NCT01513551|561289336|FG000|Overall Study|Withdrawal by Subject|1|||
155508689|NCT01513551|561289337|FG001|Overall Study|Withdrawal by Subject|0|||
155508690|NCT01513551|561289338|FG002|Overall Study|Withdrawal by Subject|2|||
155508691|NCT01513551|561289336|FG000|Overall Study|Randomized but not vaccinated|0|||
155508692|NCT01513551|561289337|FG001|Overall Study|Randomized but not vaccinated|0|||
155508693|NCT01513551|561289338|FG002|Overall Study|Randomized but not vaccinated|1|||
155508694|NCT01806597|561289342|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
155508695|NCT01806597|561289343|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
155508696|NCT01806597|561289344|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
155508697|NCT01806597|561289345|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
155368336|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
155368337|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368338|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368339|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368340|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368341|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
155368342|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
155368343|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
155368344|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
155368345|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
155368346|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368347|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368348|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368349|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368350|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
155368351|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
155368352|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
155368353|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
155368354|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
155368355|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368356|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368357|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368358|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368359|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
155368360|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
155368361|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
155368362|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
155368363|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
155368364|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
155368365|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
155368366|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
155368367|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
155368368|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
155368369|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
155368370|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
155368371|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
155368372|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
155368373|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
155368374|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
155368375|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
155368376|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
155368377|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
155368378|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
155368379|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
155368380|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
155368381|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
155368382|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
155368383|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
155508698|NCT01806597|561289346|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
155508699|NCT01806597|561289347|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
155508700|NCT01806597|561289342|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
155508701|NCT01806597|561289343|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
155508702|NCT01806597|561289344|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
155508703|NCT01806597|561289345|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
155508704|NCT01806597|561289346|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
155508705|NCT01806597|561289347|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
155368384|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
155368385|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
155368386|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
155368387|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
155368388|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
155368389|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368390|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368391|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368392|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368393|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368394|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
155368395|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368396|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
155368397|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
155368398|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155508706|NCT01806597|561289342|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
155508707|NCT01806597|561289343|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
155508708|NCT01806597|561289344|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
155508709|NCT01806597|561289345|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
155508710|NCT01806597|561289346|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
155508711|NCT01806597|561289347|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
155508712|NCT01806597|561289342|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
155368399|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
155368400|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368401|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
155368402|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368403|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368404|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368405|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368406|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368407|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368408|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368409|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368410|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368411|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368412|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368413|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368414|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
155368415|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155428554|NCT04889209|560996042|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428555|NCT04889209|560996043|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428556|NCT04889209|560996044|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428557|NCT04889209|560996045|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428558|NCT04889209|560996046|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428559|NCT04889209|560996047|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428560|NCT04889209|560996048|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428561|NCT04889209|560996049|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
155428562|NCT04889209|560996050|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
155428563|NCT04889209|560996033|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428564|NCT04889209|560996034|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428565|NCT04889209|560996035|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428566|NCT04889209|560996036|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428567|NCT04889209|560996037|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428568|NCT04889209|560996038|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428569|NCT04889209|560996039|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428570|NCT04889209|560996040|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155508713|NCT01806597|561289343|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
155508714|NCT01806597|561289344|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
155508715|NCT01806597|561289345|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
155508716|NCT01806597|561289346|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
155508717|NCT01806597|561289347|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
155508718|NCT01806597|561289342|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155508719|NCT01806597|561289343|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
155508720|NCT01806597|561289344|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155508721|NCT01806597|561289345|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155508722|NCT01806597|561289346|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155508723|NCT01806597|561289347|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155508724|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
155508725|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
155508726|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
155508727|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
155508728|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
155508729|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
155508730|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
155508731|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
155508732|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
155508733|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
155508734|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
155508735|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
155508736|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
155508737|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
155508738|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
155508739|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
155508740|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
155508741|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
155508742|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
155508743|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
155508744|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
155508745|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
155508746|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
155508747|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
155508748|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
155508749|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
155508750|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
155508751|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
155508752|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
155508753|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
155508754|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
155508755|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
155508756|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
155508757|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
155508758|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
155508759|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
155508760|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
155508761|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
155508762|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
155508763|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
155508764|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
155508765|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
155508766|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
155508767|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
155508768|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
155508769|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
155508770|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
155508771|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
155508772|NCT01806597|561289342|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
155508773|NCT01806597|561289343|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
155508774|NCT01806597|561289344|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
155508775|NCT01806597|561289345|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
155508776|NCT01806597|561289346|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
155508777|NCT01806597|561289347|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
155508778|NCT01806597|561289342|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
155508779|NCT01806597|561289343|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
155508780|NCT01806597|561289344|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
155508781|NCT01806597|561289345|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
155508782|NCT01806597|561289346|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
155508783|NCT01806597|561289347|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
155508784|NCT01806597|561289342|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
155508785|NCT01806597|561289343|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
155508786|NCT01806597|561289344|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
155508787|NCT01806597|561289345|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
155508788|NCT01806597|561289346|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
155508789|NCT01806597|561289347|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
155368416|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368417|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368418|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155508790|NCT01806597|561289342|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
155508791|NCT01806597|561289343|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
155508792|NCT01806597|561289344|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
155508793|NCT01806597|561289345|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
155508794|NCT01806597|561289346|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
155508795|NCT01806597|561289347|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
155508796|NCT01806597|561289342|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
155508797|NCT01806597|561289343|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
155508798|NCT01806597|561289344|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
155508799|NCT01806597|561289345|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
155508800|NCT01806597|561289346|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
155508801|NCT01806597|561289347|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
155508802|NCT01806597|561289342|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
155508803|NCT01806597|561289343|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
155508804|NCT01806597|561289344|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
155508805|NCT01806597|561289345|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
155508806|NCT01806597|561289346|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
155508807|NCT01806597|561289347|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
155508808|NCT01267266|561289352|FG000|Enrollment Phase|Withdrawal by Subject|2|||
155508809|NCT01267266|561289353|FG001|Enrollment Phase|Withdrawal by Subject|0|||
155508810|NCT01267266|561289352|FG000|Lead-in Phase|Lack of Efficacy|20|||
155508811|NCT01267266|561289353|FG001|Lead-in Phase|Lack of Efficacy|0|||
155508812|NCT01267266|561289352|FG000|Lead-in Phase|Adverse Event|2|||
155508813|NCT01267266|561289353|FG001|Lead-in Phase|Adverse Event|0|||
155508814|NCT01267266|561289352|FG000|Lead-in Phase|Withdrawal by Subject|1|||
155508815|NCT01267266|561289353|FG001|Lead-in Phase|Withdrawal by Subject|0|||
155508816|NCT01335477|561289355|FG000|Overall Study|Adverse Event|30|||
155508817|NCT01335477|561289356|FG001|Overall Study|Adverse Event|42|||
155508818|NCT01335477|561289355|FG000|Overall Study|Non compliant with protocol|0|||
155508819|NCT01335477|561289356|FG001|Overall Study|Non compliant with protocol|2|||
155508820|NCT01335477|561289355|FG000|Overall Study|Lost to Follow-up|1|||
155508821|NCT01335477|561289356|FG001|Overall Study|Lost to Follow-up|2|||
155508822|NCT01335477|561289355|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
155508823|NCT01335477|561289356|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
155508824|NCT01335477|561289355|FG000|Overall Study|Not treated|1|||
155508825|NCT01335477|561289356|FG001|Overall Study|Not treated|2|||
155508826|NCT01335477|561289355|FG000|Overall Study|Reason other than those stated above|2|||
155508827|NCT01335477|561289356|FG001|Overall Study|Reason other than those stated above|2|||
155508828|NCT02038634|561289358|FG000|Overall Study|Lost to Follow-up|0|||
155508829|NCT02038634|561289359|FG001|Overall Study|Lost to Follow-up|1|||
155508830|NCT00549198|561289361|FG000|Overall Study|Adverse Event|28|||
155508831|NCT00549198|561289362|FG001|Overall Study|Adverse Event|26|||
155508832|NCT00549198|561289361|FG000|Overall Study|Insufficient Viral Load Response|4|||
155508833|NCT00549198|561289362|FG001|Overall Study|Insufficient Viral Load Response|2|||
155508834|NCT00549198|561289361|FG000|Overall Study|Protocol-defined Virological Failure|7|||
155508835|NCT00549198|561289362|FG001|Overall Study|Protocol-defined Virological Failure|0|||
155508836|NCT00549198|561289361|FG000|Overall Study|Non-compliance|2|||
155508837|NCT00549198|561289362|FG001|Overall Study|Non-compliance|4|||
155508838|NCT00549198|561289361|FG000|Overall Study|Lost to Follow-up|7|||
155508839|NCT00549198|561289362|FG001|Overall Study|Lost to Follow-up|8|||
155508840|NCT00549198|561289361|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
155508841|NCT00549198|561289362|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155508842|NCT00549198|561289361|FG000|Overall Study|Protocol Violation|7|||
155508843|NCT00549198|561289362|FG001|Overall Study|Protocol Violation|2|||
155508844|NCT00549198|561289361|FG000|Overall Study|Investigator Decision|4|||
155508845|NCT00549198|561289362|FG001|Overall Study|Investigator Decision|3|||
155508846|NCT00549198|561289361|FG000|Overall Study|Withdrawal by Subject|7|||
155508847|NCT00549198|561289362|FG001|Overall Study|Withdrawal by Subject|7|||
155508848|NCT00549198|561289361|FG000|Overall Study|Disease Progression|1|||
155508849|NCT00549198|561289362|FG001|Overall Study|Disease Progression|0|||
155508850|NCT00549198|561289361|FG000|Overall Study|Participant Moved|2|||
155508851|NCT00549198|561289362|FG001|Overall Study|Participant Moved|0|||
155508852|NCT00549198|561289361|FG000|Overall Study|Participant not able to perform Week 96|1|||
155508853|NCT00549198|561289362|FG001|Overall Study|Participant not able to perform Week 96|0|||
155508854|NCT00549198|561289361|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
155508855|NCT00549198|561289362|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
155508856|NCT00549198|561289361|FG000|Overall Study|Prohibited Medication|1|||
155508857|NCT00549198|561289362|FG001|Overall Study|Prohibited Medication|2|||
155508858|NCT00549198|561289361|FG000|Overall Study|Participant planning pregnancy|1|||
155508859|NCT00549198|561289362|FG001|Overall Study|Participant planning pregnancy|0|||
155508860|NCT00549198|561289361|FG000|Overall Study|Participant overweight, no scan possible|1|||
155508861|NCT00549198|561289362|FG001|Overall Study|Participant overweight, no scan possible|0|||
155508862|NCT00549198|561289361|FG000|Overall Study|No scan facilities|0|||
155508863|NCT00549198|561289362|FG001|Overall Study|No scan facilities|2|||
155508864|NCT00549198|561289361|FG000|Overall Study|Pregnancy|0|||
155508865|NCT00549198|561289362|FG001|Overall Study|Pregnancy|3|||
155508866|NCT00549198|561289361|FG000|Overall Study|Not Exposed to Study Drug|3|||
155508867|NCT00549198|561289362|FG001|Overall Study|Not Exposed to Study Drug|4|||
155508868|NCT01473758|561289364|FG000|Cycle 1|Adverse Event|10|||
155508869|NCT01473758|561289365|FG001|Cycle 1|Adverse Event|2|||
155508870|NCT01473758|561289366|FG002|Cycle 1|Adverse Event|0|||
155508871|NCT01473758|561289367|FG003|Cycle 1|Adverse Event|0|||
155508872|NCT01473758|561289364|FG000|Cycle 1|Withdrawal by Subject|1|||
155508873|NCT01473758|561289365|FG001|Cycle 1|Withdrawal by Subject|1|||
155508874|NCT01473758|561289366|FG002|Cycle 1|Withdrawal by Subject|0|||
155508875|NCT01473758|561289367|FG003|Cycle 1|Withdrawal by Subject|0|||
155508876|NCT01473758|561289364|FG000|Cycle 2|Adverse Event|0|||
155508877|NCT01473758|561289365|FG001|Cycle 2|Adverse Event|0|||
155508878|NCT01473758|561289366|FG002|Cycle 2|Adverse Event|5|||
155508879|NCT01473758|561289367|FG003|Cycle 2|Adverse Event|0|||
155508880|NCT01764854|561289377|FG000|Overall Study|Adverse Event|0|||
155508881|NCT01764854|561289378|FG001|Overall Study|Adverse Event|0|||
155508882|NCT01764854|561289379|FG002|Overall Study|Adverse Event|2|||
155508883|NCT01764854|561289380|FG003|Overall Study|Adverse Event|0|||
155508884|NCT01764854|561289377|FG000|Overall Study|Withdrawal by Subject|0|||
155508885|NCT01764854|561289378|FG001|Overall Study|Withdrawal by Subject|0|||
155508886|NCT01764854|561289379|FG002|Overall Study|Withdrawal by Subject|1|||
155508887|NCT01764854|561289380|FG003|Overall Study|Withdrawal by Subject|0|||
155508888|NCT01764854|561289377|FG000|Overall Study|relocation|0|||
155508889|NCT01764854|561289378|FG001|Overall Study|relocation|0|||
155508890|NCT01764854|561289379|FG002|Overall Study|relocation|2|||
155508891|NCT01764854|561289380|FG003|Overall Study|relocation|0|||
155508892|NCT01764854|561289377|FG000|Overall Study|Protocol Violation|0|||
155508893|NCT01764854|561289378|FG001|Overall Study|Protocol Violation|0|||
155508894|NCT01764854|561289379|FG002|Overall Study|Protocol Violation|1|||
155508895|NCT01764854|561289380|FG003|Overall Study|Protocol Violation|2|||
155508896|NCT00901628|561289389|FG000|Overall Study|disconnection of catheter|4|||
155508897|NCT00901628|561289390|FG001|Overall Study|disconnection of catheter|8|||
155508898|NCT00901628|561289389|FG000|Overall Study|disconnection of drain|0|||
155508899|NCT00901628|561289390|FG001|Overall Study|disconnection of drain|1|||
155368419|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368420|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368421|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368422|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
155368423|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
155368424|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
155368425|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
155508900|NCT00901628|561289389|FG000|Overall Study|peroneal nerve palsy|0|||
155508901|NCT00901628|561289390|FG001|Overall Study|peroneal nerve palsy|1|||
155508902|NCT05751629|561289393|FG000|Overall Study|Withdrawal by Subject|6|||
155508903|NCT05751629|561289393|FG000|Overall Study|Death|25|||
155508904|NCT05751629|561289393|FG000|Overall Study|Study Site Closed|9|||
155508905|NCT05751629|561289393|FG000|Overall Study|Physician Decision|1|||
155508906|NCT01909466|561289394|FG000|Overall Study|Lost to Follow-up|5|||
155508907|NCT01909466|561289395|FG001|Overall Study|Lost to Follow-up|7|||
155508908|NCT01909466|561289394|FG000|Overall Study|Adverse Event|3|||
155508909|NCT01909466|561289395|FG001|Overall Study|Adverse Event|4|||
155508910|NCT01909466|561289394|FG000|Overall Study|Met Withdrawal Criteria|0|||
155508911|NCT01909466|561289395|FG001|Overall Study|Met Withdrawal Criteria|3|||
155508912|NCT01909466|561289394|FG000|Overall Study|Physician Decision|2|||
155508913|NCT01909466|561289395|FG001|Overall Study|Physician Decision|0|||
155368426|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
155368427|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368428|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368429|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
155368430|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368431|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368432|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
155368433|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
155368434|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368435|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
155368436|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368437|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155428571|NCT04889209|560996041|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428572|NCT04889209|560996042|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428573|NCT04889209|560996043|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428574|NCT04889209|560996044|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428575|NCT04889209|560996045|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428576|NCT04889209|560996046|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428577|NCT04889209|560996047|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
155428578|NCT04889209|560996048|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428579|NCT04889209|560996049|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428580|NCT04889209|560996050|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155428581|NCT04607408|560996051|FG000|Overall Study|Lost to Follow-up|0|||
155428582|NCT04607408|560996052|FG001|Overall Study|Lost to Follow-up|0|||
155428583|NCT04607408|560996053|FG002|Overall Study|Lost to Follow-up|0|||
155428584|NCT04607408|560996054|FG003|Overall Study|Lost to Follow-up|1|||
155428585|NCT04607408|560996055|FG004|Overall Study|Lost to Follow-up|0|||
155428586|NCT04607408|560996051|FG000|Overall Study|Withdrawal by Subject|0|||
155428587|NCT04607408|560996052|FG001|Overall Study|Withdrawal by Subject|1|||
155428588|NCT04607408|560996053|FG002|Overall Study|Withdrawal by Subject|0|||
155428589|NCT04607408|560996054|FG003|Overall Study|Withdrawal by Subject|1|||
155428590|NCT04607408|560996055|FG004|Overall Study|Withdrawal by Subject|0|||
155428591|NCT01725165|560996058|FG000|Overall Study|Death|11|||
155428592|NCT01725165|560996059|FG001|Overall Study|Death|18|||
155428593|NCT02688647|560996062|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
155428594|NCT02688647|560996063|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
155428595|NCT02688647|560996062|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
155428596|NCT02688647|560996063|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
155428597|NCT02688647|560996062|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
155428598|NCT02688647|560996063|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
155428599|NCT02688647|560996062|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
155428600|NCT02688647|560996063|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
155428601|NCT02688647|560996062|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
155428602|NCT02688647|560996063|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
155428603|NCT02688647|560996062|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
155428604|NCT02688647|560996063|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
155428605|NCT02688647|560996062|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
155428606|NCT02688647|560996063|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
155428607|NCT03619213|560996064|FG000|Overall Study|Lost to Follow-up|2|||
155428608|NCT03619213|560996065|FG001|Overall Study|Lost to Follow-up|1|||
155428609|NCT03619213|560996064|FG000|Overall Study|Withdrawal by Subject|8|||
155428610|NCT03619213|560996065|FG001|Overall Study|Withdrawal by Subject|10|||
155428611|NCT00382967|560996066|FG000|Overall Study|Protocol Violation|1|||
155428612|NCT00382967|560996067|FG001|Overall Study|Protocol Violation|1|||
155428613|NCT04026568|560996068|FG000|Overall Study|study terminated|0|||
155428614|NCT04026568|560996069|FG001|Overall Study|study terminated|1|||
155428615|NCT00461175|560996070|FG000|Overall Study|Protocol Violation|522|||
155428616|NCT00461175|560996071|FG001|Overall Study|Protocol Violation|365|||
155428617|NCT00331760|560996072|FG000|Overall Study|Ineligible / no protocol treatment|15|||
155428618|NCT00331760|560996073|FG001|Overall Study|Ineligible / no protocol treatment|8|||
155428619|NCT03093155|560996075|FG000|Overall Study|Not Eligible|1|||
155428620|NCT03093155|560996076|FG001|Overall Study|Not Eligible|0|||
155428621|NCT03093155|560996075|FG000|Overall Study|Withdrawal by Subject|0|||
155428622|NCT03093155|560996076|FG001|Overall Study|Withdrawal by Subject|1|||
155428623|NCT01773473|560996077|FG000|Overall Study|Adverse Event|3|||
155428624|NCT01773473|560996078|FG001|Overall Study|Adverse Event|2|||
155368438|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368439|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155428625|NCT01773473|560996077|FG000|Overall Study|Protocol Violation|0|||
155508914|NCT01909466|561289394|FG000|Overall Study|Withdrawal by Subject|11|||
155508915|NCT01909466|561289395|FG001|Overall Study|Withdrawal by Subject|9|||
155508916|NCT01909466|561289394|FG000|Overall Study|Lack of Efficacy|1|||
155508917|NCT01909466|561289395|FG001|Overall Study|Lack of Efficacy|0|||
155508918|NCT02231710|561289396|FG000|Overall Study|Physician Decision|1|||
155508919|NCT01339910|561289397|FG000|Overall Study|Withdrawal by Subject|1|||
155508920|NCT01339910|561289398|FG001|Overall Study|Withdrawal by Subject|0|||
155508921|NCT01339910|561289397|FG000|Overall Study|Physician Decision|1|||
155508922|NCT01339910|561289398|FG001|Overall Study|Physician Decision|0|||
155508923|NCT01339910|561289397|FG000|Overall Study|Disease relapse|1|||
155508924|NCT01339910|561289398|FG001|Overall Study|Disease relapse|4|||
155508925|NCT00772577|561289404|FG000|Overall Study|Adverse Event|6|||
155508926|NCT00772577|561289405|FG001|Overall Study|Adverse Event|3|||
155508927|NCT00772577|561289404|FG000|Overall Study|Abnormal laboratory values|0|||
155508928|NCT00772577|561289405|FG001|Overall Study|Abnormal laboratory values|1|||
155508929|NCT00772577|561289404|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155508930|NCT00772577|561289405|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155508931|NCT00772577|561289404|FG000|Overall Study|Patient withdrew consent|8|||
155508932|NCT00772577|561289405|FG001|Overall Study|Patient withdrew consent|5|||
155508933|NCT00772577|561289404|FG000|Overall Study|Lost to Follow-up|4|||
155508934|NCT00772577|561289405|FG001|Overall Study|Lost to Follow-up|3|||
155508935|NCT00772577|561289404|FG000|Overall Study|Administrative problems|2|||
155508936|NCT00772577|561289405|FG001|Overall Study|Administrative problems|1|||
155508937|NCT00772577|561289404|FG000|Overall Study|Protocol Deviation|3|||
155508938|NCT00772577|561289405|FG001|Overall Study|Protocol Deviation|2|||
155508939|NCT02965820|561289406|FG000|Period 2, Second 30 Days|Adverse Event|1|||
155508940|NCT02965820|561289407|FG001|Period 2, Second 30 Days|Adverse Event|1|||
155508941|NCT01567306|561289408|FG000|Overall Study|Protocol Violation|2|||
155508942|NCT01567306|561289409|FG001|Overall Study|Protocol Violation|2|||
155508943|NCT01567306|561289410|FG002|Overall Study|Protocol Violation|0|||
155508944|NCT01567306|561289411|FG003|Overall Study|Protocol Violation|3|||
155508945|NCT01567306|561289412|FG004|Overall Study|Protocol Violation|1|||
155508946|NCT01567306|561289413|FG005|Overall Study|Protocol Violation|1|||
155508947|NCT01567306|561289408|FG000|Overall Study|Change site living|1|||
155508948|NCT01567306|561289409|FG001|Overall Study|Change site living|0|||
155508949|NCT01567306|561289410|FG002|Overall Study|Change site living|0|||
155508950|NCT01567306|561289411|FG003|Overall Study|Change site living|0|||
155508951|NCT01567306|561289412|FG004|Overall Study|Change site living|0|||
155508952|NCT01567306|561289413|FG005|Overall Study|Change site living|0|||
155508953|NCT01567306|561289408|FG000|Overall Study|Adverse Event|0|||
155508954|NCT01567306|561289409|FG001|Overall Study|Adverse Event|0|||
155508955|NCT01567306|561289410|FG002|Overall Study|Adverse Event|0|||
155508956|NCT01567306|561289411|FG003|Overall Study|Adverse Event|2|||
155508957|NCT01567306|561289412|FG004|Overall Study|Adverse Event|4|||
155508958|NCT01567306|561289413|FG005|Overall Study|Adverse Event|1|||
155508959|NCT01567306|561289408|FG000|Overall Study|Lost to Follow-up|0|||
155508960|NCT01567306|561289409|FG001|Overall Study|Lost to Follow-up|0|||
155508961|NCT01567306|561289410|FG002|Overall Study|Lost to Follow-up|0|||
155508962|NCT01567306|561289411|FG003|Overall Study|Lost to Follow-up|0|||
155508963|NCT01567306|561289412|FG004|Overall Study|Lost to Follow-up|2|||
155508964|NCT01567306|561289413|FG005|Overall Study|Lost to Follow-up|0|||
155508965|NCT01567306|561289408|FG000|Overall Study|Withdrawal by Subject|0|||
155508966|NCT01567306|561289409|FG001|Overall Study|Withdrawal by Subject|0|||
155508967|NCT01567306|561289410|FG002|Overall Study|Withdrawal by Subject|0|||
155508968|NCT01567306|561289411|FG003|Overall Study|Withdrawal by Subject|0|||
155508969|NCT01567306|561289412|FG004|Overall Study|Withdrawal by Subject|0|||
155508970|NCT01567306|561289413|FG005|Overall Study|Withdrawal by Subject|1|||
155508971|NCT00673361|561289416|FG000|Overall Study|Screen Failure|2|||
155508972|NCT00829413|561289417|FG000|Overall Study|No study drug admimnistered|13|||
155508973|NCT00829413|561289417|FG000|Overall Study|Training Patients|67|||
155508974|NCT00829413|561289417|FG000|Overall Study|No truth standard procedure available|9|||
155508975|NCT00829413|561289417|FG000|Overall Study|Technically inadequate truth standard|2|||
155508976|NCT00829413|561289417|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
155508977|NCT04272775|561289418|FG000|Overall Study|Study Terminated by Sponsor|1|||
155508978|NCT04272775|561289419|FG001|Overall Study|Study Terminated by Sponsor|0|||
155508979|NCT04272775|561289418|FG000|Overall Study|Protocol Violation|0|||
155508980|NCT04272775|561289419|FG001|Overall Study|Protocol Violation|1|||
155649366|NCT02462057|561808225|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
155508981|NCT04272775|561289418|FG000|Overall Study|Symptomatic Deterioration|1|||
155508982|NCT04272775|561289419|FG001|Overall Study|Symptomatic Deterioration|1|||
155508983|NCT04272775|561289418|FG000|Overall Study|Withdrawal by Subject|1|||
155508984|NCT04272775|561289419|FG001|Overall Study|Withdrawal by Subject|2|||
155508985|NCT04272775|561289418|FG000|Overall Study|Adverse Event|1|||
155508986|NCT04272775|561289419|FG001|Overall Study|Adverse Event|2|||
155508987|NCT04272775|561289418|FG000|Overall Study|Progressive Disease|3|||
155508988|NCT04272775|561289419|FG001|Overall Study|Progressive Disease|1|||
155649367|NCT02462057|561808226|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
155508989|NCT00575328|561289423|FG000|Overall Study|Adverse Event|1|||
155428626|NCT01773473|560996078|FG001|Overall Study|Protocol Violation|4|||
155428627|NCT01773473|560996077|FG000|Overall Study|Physician Decision|3|||
155428628|NCT01773473|560996078|FG001|Overall Study|Physician Decision|5|||
155428629|NCT01773473|560996077|FG000|Overall Study|Sponsor Decision|2|||
155428630|NCT01773473|560996078|FG001|Overall Study|Sponsor Decision|0|||
155428631|NCT01773473|560996077|FG000|Overall Study|Lack of Efficacy|0|||
155368440|NCT01465763|560783233|FG000|Overall Study|Withdrawal by Subject|4|||
155368441|NCT01465763|560783234|FG001|Overall Study|Withdrawal by Subject|0|||
155368442|NCT01465763|560783235|FG002|Overall Study|Withdrawal by Subject|1|||
155368443|NCT01465763|560783233|FG000|Overall Study|Insufficient Clinical Response|11|||
155368444|NCT01465763|560783234|FG001|Overall Study|Insufficient Clinical Response|0|||
155368445|NCT01465763|560783235|FG002|Overall Study|Insufficient Clinical Response|1|||
155368446|NCT01465763|560783233|FG000|Overall Study|Adverse Event|9|||
155368447|NCT01465763|560783234|FG001|Overall Study|Adverse Event|0|||
155368448|NCT01465763|560783235|FG002|Overall Study|Adverse Event|1|||
155368449|NCT01465763|560783233|FG000|Overall Study|Other|2|||
155368450|NCT01465763|560783234|FG001|Overall Study|Other|0|||
155368451|NCT01465763|560783235|FG002|Overall Study|Other|0|||
155368452|NCT01465763|560783233|FG000|Overall Study|Protocol Violation|4|||
155368453|NCT01465763|560783234|FG001|Overall Study|Protocol Violation|1|||
155368454|NCT01465763|560783235|FG002|Overall Study|Protocol Violation|1|||
155368455|NCT01465763|560783233|FG000|Overall Study|Death|1|||
155368456|NCT01465763|560783234|FG001|Overall Study|Death|0|||
155368457|NCT01465763|560783235|FG002|Overall Study|Death|0|||
155368458|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
155368459|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
155368460|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
155368461|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
155368462|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368463|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368464|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368465|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368466|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368467|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368468|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368469|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368470|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
155368471|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
155368472|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
155368473|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
155368474|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368475|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368476|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368477|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368478|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368479|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368480|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368481|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368482|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
155368483|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
155368484|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
155368485|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
155368486|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368487|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368488|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368489|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368490|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368491|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368492|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368493|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368494|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
155368495|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
155428632|NCT01773473|560996078|FG001|Overall Study|Lack of Efficacy|1|||
155428633|NCT01773473|560996077|FG000|Overall Study|Non-Compliance with study drug|1|||
155368496|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
155368497|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
155368498|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368499|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155428634|NCT01773473|560996078|FG001|Overall Study|Non-Compliance with study drug|4|||
155428635|NCT01773473|560996077|FG000|Overall Study|Withdrawal by Subject|5|||
155368500|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368501|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368502|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368503|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368504|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368505|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368506|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368507|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368508|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
155368509|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
155368510|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368511|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368512|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368513|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368514|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368515|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368516|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368517|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368518|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
155368519|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
155368520|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
155368521|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368522|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368523|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368524|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368525|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368526|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155428636|NCT01773473|560996078|FG001|Overall Study|Withdrawal by Subject|3|||
155428637|NCT01773473|560996077|FG000|Overall Study|Lost to Follow-up|2|||
155428638|NCT01773473|560996078|FG001|Overall Study|Lost to Follow-up|0|||
155428639|NCT00826514|560996079|FG000|Overall Study|Adverse Event|1|||
155428640|NCT00826514|560996080|FG001|Overall Study|Adverse Event|1|||
155428641|NCT00826514|560996079|FG000|Overall Study|Lack of Efficacy|0|||
155428642|NCT00826514|560996080|FG001|Overall Study|Lack of Efficacy|1|||
155428643|NCT00826514|560996079|FG000|Overall Study|Withdrawal by Subject|2|||
155428644|NCT00826514|560996080|FG001|Overall Study|Withdrawal by Subject|3|||
155428645|NCT01085682|560996081|FG000|Overall Study|Withdrawal by Subject|25|||
155428646|NCT01085682|560996082|FG001|Overall Study|Withdrawal by Subject|25|||
155428647|NCT00158184|560996086|FG000|Overall Study|personal issues|3|||
155428648|NCT00158184|560996087|FG001|Overall Study|personal issues|1|||
155428649|NCT00158184|560996086|FG000|Overall Study|failed for follow unit/study rules|2|||
155428650|NCT00158184|560996087|FG001|Overall Study|failed for follow unit/study rules|0|||
155428651|NCT00158184|560996086|FG000|Overall Study|Adverse Event|1|||
155428652|NCT00158184|560996087|FG001|Overall Study|Adverse Event|1|||
155428653|NCT02620020|560996088|FG000|Overall Study|Adverse Event|8|||
155428654|NCT02620020|560996089|FG001|Overall Study|Adverse Event|4|||
155428655|NCT02620020|560996090|FG002|Overall Study|Adverse Event|3|||
155428656|NCT02620020|560996091|FG003|Overall Study|Adverse Event|5|||
155428657|NCT02620020|560996088|FG000|Overall Study|Lost to Follow-up|4|||
155428658|NCT02620020|560996089|FG001|Overall Study|Lost to Follow-up|8|||
155428659|NCT02620020|560996090|FG002|Overall Study|Lost to Follow-up|1|||
155428660|NCT02620020|560996091|FG003|Overall Study|Lost to Follow-up|4|||
155428661|NCT02620020|560996088|FG000|Overall Study|Physician Decision|7|||
155428662|NCT02620020|560996089|FG001|Overall Study|Physician Decision|4|||
155428663|NCT02620020|560996090|FG002|Overall Study|Physician Decision|3|||
155428664|NCT02620020|560996091|FG003|Overall Study|Physician Decision|4|||
155428665|NCT02620020|560996088|FG000|Overall Study|Protocol Violation|5|||
155428666|NCT02620020|560996089|FG001|Overall Study|Protocol Violation|2|||
155428667|NCT02620020|560996090|FG002|Overall Study|Protocol Violation|1|||
155428668|NCT02620020|560996091|FG003|Overall Study|Protocol Violation|1|||
155428669|NCT02620020|560996088|FG000|Overall Study|Withdrawal by Subject|20|||
155428670|NCT02620020|560996089|FG001|Overall Study|Withdrawal by Subject|16|||
155428671|NCT02620020|560996090|FG002|Overall Study|Withdrawal by Subject|17|||
155428672|NCT02620020|560996091|FG003|Overall Study|Withdrawal by Subject|12|||
155428673|NCT02620020|560996088|FG000|Overall Study|Death|0|||
155428674|NCT02620020|560996089|FG001|Overall Study|Death|1|||
155508990|NCT00575328|561289424|FG001|Overall Study|Adverse Event|1|||
155428675|NCT02620020|560996090|FG002|Overall Study|Death|0|||
155428676|NCT02620020|560996091|FG003|Overall Study|Death|0|||
155428677|NCT01025635|560996095|FG000|Overall Study|Withdrawal by Subject|6|||
155428678|NCT01025635|560996096|FG001|Overall Study|Withdrawal by Subject|7|||
155428679|NCT01025635|560996095|FG000|Overall Study|Protocol Violation|4|||
155428680|NCT01025635|560996096|FG001|Overall Study|Protocol Violation|2|||
155508991|NCT00575328|561289423|FG000|Overall Study|Lost to Follow-up|2|||
155508992|NCT00575328|561289424|FG001|Overall Study|Lost to Follow-up|1|||
155508993|NCT01722266|561289425|FG000|Overall Study|Withdrawal by Subject|1|||
155508994|NCT01722266|561289426|FG001|Overall Study|Withdrawal by Subject|2|||
155508995|NCT01722266|561289427|FG002|Overall Study|Withdrawal by Subject|0|||
155508996|NCT01722266|561289428|FG003|Overall Study|Withdrawal by Subject|0|||
155508997|NCT01722266|561289425|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
155508998|NCT01722266|561289426|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
155508999|NCT01722266|561289427|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
155509000|NCT01722266|561289428|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
155509001|NCT01722266|561289425|FG000|Overall Study|Dropped out due to Nausea|0|||
155509002|NCT01722266|561289426|FG001|Overall Study|Dropped out due to Nausea|0|||
155509003|NCT01722266|561289427|FG002|Overall Study|Dropped out due to Nausea|2|||
155509004|NCT01722266|561289428|FG003|Overall Study|Dropped out due to Nausea|0|||
155509005|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
155509006|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
155509007|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
155509008|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
155509009|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
155509010|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
155368527|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368528|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368529|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368530|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368531|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368532|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368533|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368534|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
155368535|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
155368536|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
155368537|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
155368538|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368539|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368540|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368541|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368542|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368543|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368544|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368545|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368546|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
155368547|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
155428681|NCT01025635|560996095|FG000|Overall Study|Lack of Efficacy|0|||
155428682|NCT01025635|560996096|FG001|Overall Study|Lack of Efficacy|1|||
155428683|NCT01025635|560996095|FG000|Overall Study|Lost to Follow-up|9|||
155428684|NCT01025635|560996096|FG001|Overall Study|Lost to Follow-up|13|||
155428685|NCT01025635|560996095|FG000|Overall Study|Reason not known|4|||
155428686|NCT01025635|560996096|FG001|Overall Study|Reason not known|2|||
155428687|NCT02393209|560996097|FG000|Overall Study|Study Terminated by Sponsor|1|||
155428688|NCT02393209|560996098|FG001|Overall Study|Study Terminated by Sponsor|1|||
155428689|NCT02393209|560996099|FG002|Overall Study|Study Terminated by Sponsor|0|||
155428690|NCT02393209|560996100|FG003|Overall Study|Study Terminated by Sponsor|0|||
155428691|NCT02393209|560996097|FG000|Overall Study|Withdrawal by Patient|1|||
155428692|NCT02393209|560996098|FG001|Overall Study|Withdrawal by Patient|0|||
155428693|NCT02393209|560996099|FG002|Overall Study|Withdrawal by Patient|0|||
155428694|NCT02393209|560996100|FG003|Overall Study|Withdrawal by Patient|0|||
155428695|NCT02393209|560996097|FG000|Overall Study|Death|2|||
155428696|NCT02393209|560996098|FG001|Overall Study|Death|2|||
155428697|NCT02393209|560996099|FG002|Overall Study|Death|0|||
155428698|NCT02393209|560996100|FG003|Overall Study|Death|0|||
155428699|NCT02393209|560996097|FG000|Overall Study|Death due to Disease Progression|2|||
155428700|NCT02393209|560996098|FG001|Overall Study|Death due to Disease Progression|2|||
155428701|NCT02393209|560996099|FG002|Overall Study|Death due to Disease Progression|0|||
155428702|NCT02393209|560996100|FG003|Overall Study|Death due to Disease Progression|0|||
155428703|NCT02393209|560996097|FG000|Overall Study|Death from Legionella Infection|0|||
155428704|NCT02393209|560996098|FG001|Overall Study|Death from Legionella Infection|1|||
155428705|NCT02393209|560996099|FG002|Overall Study|Death from Legionella Infection|0|||
155428706|NCT02393209|560996100|FG003|Overall Study|Death from Legionella Infection|0|||
155428707|NCT02393209|560996097|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
155428708|NCT02393209|560996098|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
155428709|NCT02393209|560996099|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
155428710|NCT02393209|560996100|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
155428711|NCT02393209|560996097|FG000|Overall Study|Lost to Follow-up|0|||
155428712|NCT02393209|560996098|FG001|Overall Study|Lost to Follow-up|1|||
155428713|NCT02393209|560996099|FG002|Overall Study|Lost to Follow-up|0|||
155428714|NCT02393209|560996100|FG003|Overall Study|Lost to Follow-up|0|||
155428715|NCT00727402|560996101|FG000|Overall Study|Physician Decision|116|||
155428716|NCT03751111|560996102|FG000|Overall Study|Lack of Efficacy|9|||
155428717|NCT03751111|560996103|FG001|Overall Study|Lack of Efficacy|30|||
155428718|NCT03751111|560996102|FG000|Overall Study|Adverse Event|3|||
155428719|NCT03751111|560996103|FG001|Overall Study|Adverse Event|2|||
155428720|NCT02582671|560996104|FG000|Overall Study|Failure to return|1|||
155428721|NCT02582671|560996104|FG000|Overall Study|Other, not specified|1|||
155428722|NCT01287104|560996109|FG000|Overall Study|Patient developed progressive disease|1|||
155428723|NCT01287104|560996110|FG001|Overall Study|Patient developed progressive disease|1|||
155428724|NCT01287104|560996111|FG002|Overall Study|Patient developed progressive disease|3|||
155428725|NCT01287104|560996112|FG003|Overall Study|Patient developed progressive disease|2|||
155428726|NCT01287104|560996109|FG000|Overall Study|Donor anaphylaxis|0|||
155428727|NCT01287104|560996110|FG001|Overall Study|Donor anaphylaxis|1|||
155428728|NCT01287104|560996111|FG002|Overall Study|Donor anaphylaxis|0|||
155428729|NCT01287104|560996112|FG003|Overall Study|Donor anaphylaxis|1|||
155428730|NCT01287104|560996109|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
155428731|NCT01287104|560996110|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
155428732|NCT01287104|560996111|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
155428733|NCT01287104|560996112|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
155428734|NCT01287104|560996109|FG000|Overall Study|Low donor chimerism|0|||
155428735|NCT01287104|560996110|FG001|Overall Study|Low donor chimerism|1|||
155428736|NCT01287104|560996111|FG002|Overall Study|Low donor chimerism|0|||
155428737|NCT01287104|560996112|FG003|Overall Study|Low donor chimerism|0|||
155428738|NCT01287104|560996109|FG000|Overall Study|NK cells did not meet release criteria|0|||
155428739|NCT01287104|560996110|FG001|Overall Study|NK cells did not meet release criteria|1|||
155428740|NCT01287104|560996111|FG002|Overall Study|NK cells did not meet release criteria|0|||
155428741|NCT01287104|560996112|FG003|Overall Study|NK cells did not meet release criteria|0|||
155428742|NCT00098787|560996113|FG000|Overall Study|Never started treatment|3|||
155428743|NCT00098787|560996114|FG001|Overall Study|Never started treatment|2|||
155428744|NCT00098787|560996115|FG002|Overall Study|Never started treatment|1|||
155428745|NCT00098787|560996113|FG000|Overall Study|Ineligible|9|||
155428746|NCT00098787|560996114|FG001|Overall Study|Ineligible|7|||
155428747|NCT00098787|560996115|FG002|Overall Study|Ineligible|3|||
155428748|NCT00098787|560996113|FG000|Overall Study|Disease progression|28|||
155428749|NCT00098787|560996114|FG001|Overall Study|Disease progression|17|||
155428750|NCT00098787|560996115|FG002|Overall Study|Disease progression|23|||
155428751|NCT00098787|560996113|FG000|Overall Study|Adverse Event|8|||
155428752|NCT00098787|560996114|FG001|Overall Study|Adverse Event|17|||
155428753|NCT00098787|560996115|FG002|Overall Study|Adverse Event|8|||
155428754|NCT00098787|560996113|FG000|Overall Study|Death|6|||
155428755|NCT00098787|560996114|FG001|Overall Study|Death|1|||
155428756|NCT00098787|560996115|FG002|Overall Study|Death|0|||
155428757|NCT00098787|560996113|FG000|Overall Study|Withdrawal by Subject|4|||
155428758|NCT00098787|560996114|FG001|Overall Study|Withdrawal by Subject|12|||
155428759|NCT00098787|560996115|FG002|Overall Study|Withdrawal by Subject|6|||
155428760|NCT00098787|560996113|FG000|Overall Study|Alternative therapy|8|||
155428761|NCT00098787|560996114|FG001|Overall Study|Alternative therapy|13|||
155428762|NCT00098787|560996115|FG002|Overall Study|Alternative therapy|13|||
155428763|NCT00098787|560996113|FG000|Overall Study|Other|7|||
155428764|NCT00098787|560996114|FG001|Overall Study|Other|6|||
155428765|NCT00098787|560996115|FG002|Overall Study|Other|9|||
155428766|NCT00195650|560996121|FG000|Overall Study|Adverse Event|194|||
155428767|NCT00195650|560996121|FG000|Overall Study|Lack of Efficacy|99|||
155428768|NCT00195650|560996121|FG000|Overall Study|Withdrawal by Subject|67|||
155428769|NCT00195650|560996121|FG000|Overall Study|Lost to Follow-up|44|||
155428770|NCT00195650|560996121|FG000|Overall Study|Death|23|||
155428771|NCT00195650|560996121|FG000|Overall Study|Protocol Violation|15|||
155428772|NCT00195650|560996121|FG000|Overall Study|Administrative reasons|83|||
155428773|NCT01478958|560996122|FG000|Overall Study|Withdrawal by Subject|1|||
155428774|NCT01478958|560996123|FG001|Overall Study|Withdrawal by Subject|1|||
155428775|NCT01478958|560996124|FG002|Overall Study|Withdrawal by Subject|1|||
155428776|NCT01478958|560996122|FG000|Overall Study|Weight loss|1|||
155428777|NCT01478958|560996123|FG001|Overall Study|Weight loss|0|||
155428778|NCT01478958|560996124|FG002|Overall Study|Weight loss|0|||
155428779|NCT01478958|560996122|FG000|Overall Study|Re-located|0|||
155428780|NCT01478958|560996123|FG001|Overall Study|Re-located|1|||
155428781|NCT01478958|560996124|FG002|Overall Study|Re-located|0|||
155428782|NCT01478958|560996122|FG000|Overall Study|Unable to comply|0|||
155428783|NCT01478958|560996123|FG001|Overall Study|Unable to comply|0|||
155509011|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
155509012|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
155509013|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
155509014|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
155509015|NCT00124449|561289435|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
155509016|NCT00124449|561289436|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
155368548|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
155368549|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
155368550|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368551|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368552|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368553|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368554|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368555|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368556|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368557|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368558|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
155368559|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
155368560|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
155368561|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
155368562|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368563|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368564|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368565|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368566|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368567|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368568|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368569|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368570|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
155368571|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
155368572|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
155368573|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
155368574|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368575|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368576|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368577|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368578|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368579|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368580|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368581|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368582|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
155368583|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368584|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368585|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368586|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368587|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368588|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368589|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368590|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368591|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368592|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368593|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368594|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
155368595|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
155368596|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368597|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
155368598|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368599|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368600|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368601|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368602|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155509017|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
155509018|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
155509019|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
155509020|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
155509021|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
155509022|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
155509023|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
155509024|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
155509025|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
155509026|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
155509027|NCT00124449|561289435|FG000|18-Month Untreated Observation Period|Relocated|1|||
155509028|NCT00124449|561289436|FG001|18-Month Untreated Observation Period|Relocated|0|||
155509029|NCT03811249|561289437|FG000|Overall Study|Withdrawal by Subject|44|||
155509030|NCT03811249|561289437|FG000|Overall Study|Missed Visit|24|||
155509031|NCT04304950|561289442|FG000|Overall Study|Lost to Follow-up|1|||
155509032|NCT04304950|561289443|FG001|Overall Study|Lost to Follow-up|1|||
155509033|NCT00408876|561289448|FG000|Overall Study|Adverse Event|9|||
155509034|NCT00408876|561289449|FG001|Overall Study|Adverse Event|17|||
155509035|NCT00408876|561289450|FG002|Overall Study|Adverse Event|27|||
155509036|NCT00408876|561289451|FG003|Overall Study|Adverse Event|10|||
155509037|NCT00408876|561289448|FG000|Overall Study|Withdrawal by Subject|3|||
155509038|NCT00408876|561289449|FG001|Overall Study|Withdrawal by Subject|6|||
155509039|NCT00408876|561289450|FG002|Overall Study|Withdrawal by Subject|6|||
155509040|NCT00408876|561289451|FG003|Overall Study|Withdrawal by Subject|14|||
155509041|NCT00408876|561289448|FG000|Overall Study|Lack of Efficacy|2|||
155509042|NCT00408876|561289449|FG001|Overall Study|Lack of Efficacy|4|||
155509043|NCT00408876|561289450|FG002|Overall Study|Lack of Efficacy|5|||
155509044|NCT00408876|561289451|FG003|Overall Study|Lack of Efficacy|6|||
155509045|NCT00408876|561289448|FG000|Overall Study|Lost to Follow-up|1|||
155509046|NCT00408876|561289449|FG001|Overall Study|Lost to Follow-up|6|||
155509047|NCT00408876|561289450|FG002|Overall Study|Lost to Follow-up|5|||
155509048|NCT00408876|561289451|FG003|Overall Study|Lost to Follow-up|2|||
155509049|NCT00408876|561289448|FG000|Overall Study|Protocol Violation|0|||
155509050|NCT00408876|561289449|FG001|Overall Study|Protocol Violation|3|||
155509051|NCT00408876|561289450|FG002|Overall Study|Protocol Violation|4|||
155509052|NCT00408876|561289451|FG003|Overall Study|Protocol Violation|3|||
155509053|NCT00408876|561289448|FG000|Overall Study|Physician Decision|1|||
155509054|NCT00408876|561289449|FG001|Overall Study|Physician Decision|0|||
155509055|NCT00408876|561289450|FG002|Overall Study|Physician Decision|3|||
155509056|NCT00408876|561289451|FG003|Overall Study|Physician Decision|0|||
155509057|NCT01337050|561289457|FG000|Overall Study|Death|0|||
155509058|NCT01337050|561289458|FG001|Overall Study|Death|0|||
155509059|NCT01337050|561289459|FG002|Overall Study|Death|4|||
155509060|NCT01337050|561289457|FG000|Overall Study|Other|4|||
155509061|NCT01337050|561289458|FG001|Overall Study|Other|6|||
155509062|NCT01337050|561289459|FG002|Overall Study|Other|8|||
155509063|NCT01337050|561289457|FG000|Overall Study|Participants refused further follow-up|0|||
155509064|NCT01337050|561289458|FG001|Overall Study|Participants refused further follow-up|7|||
155509065|NCT01337050|561289459|FG002|Overall Study|Participants refused further follow-up|7|||
155509066|NCT00003102|561289460|FG000|Overall Study|Physician Decision|1|||
155509067|NCT00003102|561289461|FG001|Overall Study|Physician Decision|1|||
155509068|NCT00003102|561289462|FG002|Overall Study|Physician Decision|0|||
155509069|NCT00003102|561289460|FG000|Overall Study|Progressive Disease|0|||
155509070|NCT00003102|561289461|FG001|Overall Study|Progressive Disease|1|||
155509071|NCT00003102|561289462|FG002|Overall Study|Progressive Disease|0|||
155509072|NCT00003102|561289460|FG000|Overall Study|Adverse Event|0|||
155509073|NCT00003102|561289461|FG001|Overall Study|Adverse Event|1|||
155509074|NCT00003102|561289462|FG002|Overall Study|Adverse Event|1|||
155509075|NCT00003102|561289460|FG000|Overall Study|Death|0|||
155509076|NCT00003102|561289461|FG001|Overall Study|Death|0|||
155509077|NCT00003102|561289462|FG002|Overall Study|Death|1|||
155509078|NCT01559818|561289465|FG000|Overall Study|Physician Decision|1|||
155509079|NCT01559818|561289465|FG000|Overall Study|Pregnancy|1|||
155509080|NCT01559818|561289465|FG000|Overall Study|Study terminated by Sponsor|4|||
155509081|NCT01559818|561289465|FG000|Overall Study|Withdrawal by Subject|1|||
155509082|NCT00096486|561289466|FG000|Overall Study|Withdrawal by Subject|0|||
155368603|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368604|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155509083|NCT00096486|561289467|FG001|Overall Study|Withdrawal by Subject|0|||
155509084|NCT00096486|561289468|FG002|Overall Study|Withdrawal by Subject|1|||
155509085|NCT00096486|561289469|FG003|Overall Study|Withdrawal by Subject|1|||
155509086|NCT00096486|561289466|FG000|Overall Study|Not Treated|0|||
155509087|NCT00096486|561289467|FG001|Overall Study|Not Treated|0|||
155509088|NCT00096486|561289468|FG002|Overall Study|Not Treated|1|||
155509089|NCT00096486|561289469|FG003|Overall Study|Not Treated|1|||
155509090|NCT01512979|561289470|FG000|Overall Study|Adverse Event|2|||
155509091|NCT01512979|561289471|FG001|Overall Study|Adverse Event|2|||
155509092|NCT01512979|561289470|FG000|Overall Study|Protocol Violation|1|||
155509093|NCT01512979|561289471|FG001|Overall Study|Protocol Violation|4|||
155509094|NCT01512979|561289470|FG000|Overall Study|Lost to Follow-up|2|||
155509095|NCT01512979|561289471|FG001|Overall Study|Lost to Follow-up|5|||
155509096|NCT01512979|561289470|FG000|Overall Study|Withdrawal by Subject|1|||
155428784|NCT01478958|560996124|FG002|Overall Study|Unable to comply|2|||
155428785|NCT01147809|560996125|FG000|Phase I (168 Days)|Adverse Event|0|||
155428786|NCT01147809|560996126|FG001|Phase I (168 Days)|Adverse Event|0|||
155428787|NCT01147809|560996127|FG002|Phase I (168 Days)|Adverse Event|0|||
155428788|NCT01147809|560996128|FG003|Phase I (168 Days)|Adverse Event|1|||
155428789|NCT01147809|560996129|FG004|Phase I (168 Days)|Adverse Event|0|||
155428790|NCT01147809|560996130|FG005|Phase I (168 Days)|Adverse Event|0|||
155428791|NCT01147809|560996125|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
155428792|NCT01147809|560996126|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
155428793|NCT01147809|560996127|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
155428794|NCT01147809|560996128|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
155428795|NCT01147809|560996129|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
155428796|NCT01147809|560996130|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
155428797|NCT01147809|560996125|FG000|Phase I (168 Days)|Physician Decision|0|||
155428798|NCT01147809|560996126|FG001|Phase I (168 Days)|Physician Decision|1|||
155428799|NCT01147809|560996127|FG002|Phase I (168 Days)|Physician Decision|2|||
155428800|NCT01147809|560996128|FG003|Phase I (168 Days)|Physician Decision|0|||
155428801|NCT01147809|560996129|FG004|Phase I (168 Days)|Physician Decision|0|||
155428802|NCT01147809|560996130|FG005|Phase I (168 Days)|Physician Decision|0|||
155428803|NCT01147809|560996125|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
155428804|NCT01147809|560996126|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
155428805|NCT01147809|560996127|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
155428806|NCT01147809|560996128|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
155428807|NCT01147809|560996129|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
155428808|NCT01147809|560996130|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
155428809|NCT01147809|560996125|FG000|Phase II (168 Days)|Adverse Event|0|||
155428810|NCT01147809|560996126|FG001|Phase II (168 Days)|Adverse Event|0|||
155428811|NCT01147809|560996127|FG002|Phase II (168 Days)|Adverse Event|0|||
155428812|NCT01147809|560996128|FG003|Phase II (168 Days)|Adverse Event|0|||
155428813|NCT01147809|560996129|FG004|Phase II (168 Days)|Adverse Event|3|||
155428814|NCT01147809|560996130|FG005|Phase II (168 Days)|Adverse Event|6|||
155428815|NCT01147809|560996125|FG000|Phase II (168 Days)|Protocol Violation|0|||
155428816|NCT01147809|560996126|FG001|Phase II (168 Days)|Protocol Violation|0|||
155428817|NCT01147809|560996127|FG002|Phase II (168 Days)|Protocol Violation|0|||
155428818|NCT01147809|560996128|FG003|Phase II (168 Days)|Protocol Violation|0|||
155428819|NCT01147809|560996129|FG004|Phase II (168 Days)|Protocol Violation|0|||
155428820|NCT01147809|560996130|FG005|Phase II (168 Days)|Protocol Violation|1|||
155428821|NCT01147809|560996125|FG000|Phase II (168 Days)|Physician Decision|0|||
155428822|NCT01147809|560996126|FG001|Phase II (168 Days)|Physician Decision|0|||
155428823|NCT01147809|560996127|FG002|Phase II (168 Days)|Physician Decision|0|||
155428824|NCT01147809|560996128|FG003|Phase II (168 Days)|Physician Decision|0|||
155428825|NCT01147809|560996129|FG004|Phase II (168 Days)|Physician Decision|5|||
155428826|NCT01147809|560996130|FG005|Phase II (168 Days)|Physician Decision|11|||
155428827|NCT01147809|560996125|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
155428828|NCT01147809|560996126|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
155428829|NCT01147809|560996127|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
155428830|NCT01147809|560996128|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
155428831|NCT01147809|560996129|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
155428832|NCT01147809|560996130|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
155428833|NCT01147809|560996125|FG000|Phase II (168 Days)|Ongoing|0|||
155428834|NCT01147809|560996126|FG001|Phase II (168 Days)|Ongoing|0|||
155428835|NCT01147809|560996127|FG002|Phase II (168 Days)|Ongoing|0|||
155428836|NCT01147809|560996128|FG003|Phase II (168 Days)|Ongoing|0|||
155428837|NCT01147809|560996129|FG004|Phase II (168 Days)|Ongoing|1|||
155428838|NCT01147809|560996130|FG005|Phase II (168 Days)|Ongoing|0|||
155428839|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
155428840|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
155428841|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
155428842|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428843|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428844|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428845|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428846|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428847|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155428848|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
155428849|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
155428850|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
155428851|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155428852|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155509097|NCT01512979|561289471|FG001|Overall Study|Withdrawal by Subject|2|||
155509098|NCT01512979|561289470|FG000|Overall Study|Reason other than stated above|13|||
155649368|NCT02462057|561808227|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
155368605|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368606|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
155368607|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368608|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368609|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368610|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368611|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368612|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368613|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155428853|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155428854|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155428855|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155428856|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155428857|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
155428858|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
155428859|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
155428860|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428861|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428862|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428863|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428864|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428865|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155428866|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428867|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428868|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
155428869|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428870|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428871|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428872|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428873|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428874|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155428875|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
155428876|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155428877|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
155428878|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428879|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428880|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428881|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428882|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428883|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155428884|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155428885|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428886|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428887|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428888|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428889|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428890|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428891|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428892|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155428893|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
155428894|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
155428895|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428896|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428897|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428898|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428899|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428900|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428901|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155428902|NCT01307423|560996131|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428903|NCT01307423|560996132|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
155428904|NCT01307423|560996133|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
155649369|NCT02462057|561808228|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
155649370|NCT01908699|561808235|FG000|Overall Study|Adverse Event|8|||
155649371|NCT01908699|561808236|FG001|Overall Study|Adverse Event|12|||
155649372|NCT01908699|561808235|FG000|Overall Study|Lack of Efficacy|2|||
155649373|NCT01908699|561808236|FG001|Overall Study|Lack of Efficacy|2|||
155649374|NCT01908699|561808235|FG000|Overall Study|Lost to Follow-up|2|||
155649375|NCT01908699|561808236|FG001|Overall Study|Lost to Follow-up|4|||
155649376|NCT01908699|561808235|FG000|Overall Study|Physician Decision|8|||
155649377|NCT01908699|561808236|FG001|Overall Study|Physician Decision|8|||
155649378|NCT01908699|561808235|FG000|Overall Study|Withdrawal by Subject|15|||
155649379|NCT01908699|561808236|FG001|Overall Study|Withdrawal by Subject|10|||
155649380|NCT01908699|561808235|FG000|Overall Study|Pregnancy|0|||
155428905|NCT01307423|560996134|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428906|NCT01307423|560996135|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428907|NCT01307423|560996136|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428908|NCT01307423|560996137|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155649381|NCT01908699|561808236|FG001|Overall Study|Pregnancy|1|||
155649382|NCT01908699|561808235|FG000|Overall Study|Randomized in Error|1|||
155649383|NCT01908699|561808236|FG001|Overall Study|Randomized in Error|0|||
155649384|NCT01908699|561808235|FG000|Overall Study|Death|9|||
155649385|NCT01908699|561808236|FG001|Overall Study|Death|12|||
155509099|NCT01512979|561289471|FG001|Overall Study|Reason other than stated above|9|||
155509100|NCT04071626|561289472|FG000|Overall Study|Withdrawal by Subject|1|||
155509101|NCT04071626|561289473|FG001|Overall Study|Withdrawal by Subject|1|||
155509102|NCT04071626|561289472|FG000|Overall Study|Protocol Violation|0|||
155509103|NCT04071626|561289473|FG001|Overall Study|Protocol Violation|1|||
155509104|NCT00125359|561289474|FG000|Overall Study|Death|4|||
155509105|NCT00125359|561289474|FG000|Overall Study|Adverse Event|5|||
155428909|NCT01307423|560996138|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428910|NCT01307423|560996139|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
155428911|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
155428912|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
155428913|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
155428914|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
155428915|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
155428916|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
155428917|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
155428918|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
155428919|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
155509106|NCT00125359|561289474|FG000|Overall Study|Physician Decision|14|||
155509107|NCT01201356|561289475|FG000|Overall Study|Adverse Event|170|||
155509108|NCT01201356|561289475|FG000|Overall Study|Abnormal laboratory value(s)|51|||
155509109|NCT01201356|561289475|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155509110|NCT01201356|561289475|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
155509111|NCT01201356|561289475|FG000|Overall Study|Condition no longer requires study drug|12|||
155509112|NCT01201356|561289475|FG000|Overall Study|Withdrawal by Subject|144|||
155509113|NCT01201356|561289475|FG000|Overall Study|Lost to Follow-up|50|||
155509114|NCT01201356|561289475|FG000|Overall Study|administrative problems|74|||
155509115|NCT01201356|561289475|FG000|Overall Study|Death|16|||
155509116|NCT01201356|561289475|FG000|Overall Study|Protocol Violation|12|||
155509117|NCT00811070|561289476|FG000|Overall Study|Death|0|||
155509118|NCT00811070|561289477|FG001|Overall Study|Death|0|||
155509119|NCT00811070|561289478|FG002|Overall Study|Death|0|||
155509120|NCT00811070|561289479|FG003|Overall Study|Death|2|||
155509121|NCT00811070|561289480|FG004|Overall Study|Death|5|||
155509122|NCT00811070|561289481|FG005|Overall Study|Death|0|||
155509123|NCT00811070|561289476|FG000|Overall Study|Other|1|||
155509124|NCT00811070|561289477|FG001|Overall Study|Other|0|||
155509125|NCT00811070|561289478|FG002|Overall Study|Other|0|||
155509126|NCT00811070|561289479|FG003|Overall Study|Other|0|||
155509127|NCT00811070|561289480|FG004|Overall Study|Other|0|||
155509128|NCT00811070|561289481|FG005|Overall Study|Other|0|||
155509129|NCT00811070|561289476|FG000|Overall Study|Withdrawal by Subject|0|||
155509130|NCT00811070|561289477|FG001|Overall Study|Withdrawal by Subject|1|||
155509131|NCT00811070|561289478|FG002|Overall Study|Withdrawal by Subject|0|||
155509132|NCT00811070|561289479|FG003|Overall Study|Withdrawal by Subject|0|||
155509133|NCT00811070|561289480|FG004|Overall Study|Withdrawal by Subject|0|||
155509134|NCT00811070|561289481|FG005|Overall Study|Withdrawal by Subject|0|||
155509135|NCT00811070|561289476|FG000|Overall Study|Physician Decision|0|||
155509136|NCT00811070|561289477|FG001|Overall Study|Physician Decision|0|||
155509137|NCT00811070|561289478|FG002|Overall Study|Physician Decision|0|||
155509138|NCT00811070|561289479|FG003|Overall Study|Physician Decision|0|||
155509139|NCT00811070|561289480|FG004|Overall Study|Physician Decision|0|||
155509140|NCT00811070|561289481|FG005|Overall Study|Physician Decision|1|||
155509141|NCT00665626|561289486|FG000|Overall Study|Lack of Efficacy|8|||
155649386|NCT01908699|561808235|FG000|Overall Study|Progressive Disease|30|||
155649387|NCT01908699|561808236|FG001|Overall Study|Progressive Disease|29|||
155649388|NCT02105012|561808237|FG000|Overall Study|Withdrawal by Subject|11|||
155509142|NCT00665626|561289487|FG001|Overall Study|Lack of Efficacy|5|||
155509143|NCT00665626|561289486|FG000|Overall Study|Lost to Follow-up|0|||
155509144|NCT00665626|561289487|FG001|Overall Study|Lost to Follow-up|2|||
155509145|NCT00665626|561289486|FG000|Overall Study|Withdrawal by Subject|0|||
155509146|NCT00665626|561289487|FG001|Overall Study|Withdrawal by Subject|1|||
155509147|NCT00665626|561289486|FG000|Overall Study|Protocol Violation|0|||
155509148|NCT00665626|561289487|FG001|Overall Study|Protocol Violation|2|||
155509149|NCT00665626|561289486|FG000|Overall Study|Adverse Event|1|||
155509150|NCT00665626|561289487|FG001|Overall Study|Adverse Event|9|||
155509151|NCT00665626|561289486|FG000|Overall Study|Due to exclusion criteria|0|||
155509152|NCT00665626|561289487|FG001|Overall Study|Due to exclusion criteria|1|||
155509153|NCT00665626|561289486|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
155509154|NCT00665626|561289487|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
155509155|NCT00665626|561289486|FG000|Overall Study|Unably to comply with dosing regimen|0|||
155509156|NCT00665626|561289487|FG001|Overall Study|Unably to comply with dosing regimen|1|||
155509157|NCT00665626|561289486|FG000|Overall Study|Death|1|||
155509158|NCT00665626|561289487|FG001|Overall Study|Death|0|||
155509159|NCT00585039|561289488|FG000|Overall Study|medication spilled|2|||
155509160|NCT00585039|561289489|FG001|Overall Study|medication spilled|0|||
155509161|NCT01629693|561289492|FG000|Overall Study|Lost to Follow-up|2|||
155509162|NCT01629693|561289493|FG001|Overall Study|Lost to Follow-up|4|||
155509163|NCT01629693|561289492|FG000|Overall Study|Withdrawal by Subject|2|||
155509164|NCT01629693|561289493|FG001|Overall Study|Withdrawal by Subject|2|||
155509165|NCT01629693|561289492|FG000|Overall Study|Adverse Event|1|||
155509166|NCT01629693|561289493|FG001|Overall Study|Adverse Event|0|||
155509167|NCT01629693|561289492|FG000|Overall Study|Investigator decision|0|||
155509168|NCT01629693|561289493|FG001|Overall Study|Investigator decision|1|||
155509169|NCT01629693|561289492|FG000|Overall Study|Poor comfort of study lenses|0|||
155509170|NCT01629693|561289493|FG001|Overall Study|Poor comfort of study lenses|2|||
155509171|NCT01629693|561289492|FG000|Overall Study|Subject decision unrelated to AE|0|||
155509172|NCT01629693|561289493|FG001|Overall Study|Subject decision unrelated to AE|1|||
155509173|NCT04079842|561289495|FG000|Overall Study|Request of subject|2|||
155509174|NCT04079842|561289495|FG000|Overall Study|Unable to draw Arterial samples|1|||
155509175|NCT01025193|561289496|FG000|Overall Study|Protocol Violation|1|||
155509176|NCT01025193|561289496|FG000|Overall Study|Adverse Event|3|||
155509177|NCT02904200|561289497|FG000|Overall Study|Withdrawal by Subject|1|||
155509178|NCT02904200|561289498|FG001|Overall Study|Withdrawal by Subject|0|||
155509179|NCT02133352|561289501|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
155509180|NCT00185211|561289502|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
155509181|NCT00185211|561289503|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
155509182|NCT00185211|561289502|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
155509183|NCT00185211|561289503|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
155509184|NCT00185211|561289502|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
155509185|NCT00185211|561289503|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
155509186|NCT00185211|561289502|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
155509187|NCT00185211|561289503|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
155509188|NCT00185211|561289502|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
155509189|NCT00185211|561289503|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
155509190|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
155509191|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
155509192|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
155509193|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
155509194|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
155509195|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
155509196|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
155509197|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
155509198|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
155509199|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
155509200|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
155509201|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
155509202|NCT00185211|561289502|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
155509203|NCT00185211|561289503|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
155509204|NCT01759537|561289504|FG000|Overall Study|Death|1|||
155509205|NCT01759537|561289505|FG001|Overall Study|Death|1|||
155509206|NCT01759537|561289504|FG000|Overall Study|Pregnancy|1|||
155509207|NCT01759537|561289505|FG001|Overall Study|Pregnancy|1|||
155509208|NCT01759537|561289504|FG000|Overall Study|Lost to Follow-up|9|||
155509209|NCT01759537|561289505|FG001|Overall Study|Lost to Follow-up|9|||
155509210|NCT01759537|561289504|FG000|Overall Study|Accident involving jaw fracture|1|||
155509211|NCT01759537|561289505|FG001|Overall Study|Accident involving jaw fracture|1|||
155509212|NCT01759537|561289504|FG000|Overall Study|Subcrestal implant too coronal|1|||
155509213|NCT01759537|561289505|FG001|Overall Study|Subcrestal implant too coronal|1|||
155509214|NCT00420290|561289506|FG000|Overall Study|Adverse Event|3|||
155509215|NCT00420290|561289507|FG001|Overall Study|Adverse Event|1|||
155509216|NCT00420290|561289506|FG000|Overall Study|Withdrawal by Subject|0|||
155509217|NCT00420290|561289507|FG001|Overall Study|Withdrawal by Subject|2|||
155509218|NCT00420290|561289506|FG000|Overall Study|did not meet inclusion/exclusion|1|||
155509219|NCT00420290|561289507|FG001|Overall Study|did not meet inclusion/exclusion|1|||
155509220|NCT00458302|561291673|FG000|Overall Study|Adverse Event|4|||
155509221|NCT00458302|561291674|FG001|Overall Study|Adverse Event|14|||
155509222|NCT00458302|561291673|FG000|Overall Study|Pregnancy|2|||
155509223|NCT00458302|561291674|FG001|Overall Study|Pregnancy|1|||
155509224|NCT00458302|561291673|FG000|Overall Study|Protocol Violation|0|||
155509225|NCT00458302|561291674|FG001|Overall Study|Protocol Violation|2|||
155509226|NCT00458302|561291673|FG000|Overall Study|Withdrawal by Subject|6|||
155509227|NCT00458302|561291674|FG001|Overall Study|Withdrawal by Subject|4|||
155509228|NCT00458302|561291673|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
155509229|NCT00458302|561291674|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
155509230|NCT00458302|561291673|FG000|Overall Study|Study Termination By Sponsor|1|||
155509231|NCT00458302|561291674|FG001|Overall Study|Study Termination By Sponsor|0|||
155509232|NCT00458302|561291673|FG000|Overall Study|Lost to Follow-up|2|||
155509233|NCT00458302|561291674|FG001|Overall Study|Lost to Follow-up|0|||
155509234|NCT00458302|561291673|FG000|Overall Study|Other|4|||
155509235|NCT00458302|561291674|FG001|Overall Study|Other|2|||
155509236|NCT02482805|561291675|FG000|Overall Study|Lost to Follow-up|4|||
155509237|NCT02482805|561291676|FG001|Overall Study|Lost to Follow-up|4|||
155509238|NCT02482805|561291677|FG002|Overall Study|Lost to Follow-up|0|||
155509239|NCT01144663|561291678|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
155509240|NCT01144663|561291679|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
155509241|NCT01144663|561291680|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
155509242|NCT01144663|561291681|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
155509243|NCT01144663|561291678|FG000|Primary Vaccination Phase|Adverse Event|1|||
155509244|NCT01144663|561291679|FG001|Primary Vaccination Phase|Adverse Event|0|||
155509245|NCT01144663|561291680|FG002|Primary Vaccination Phase|Adverse Event|0|||
155509246|NCT01144663|561291681|FG003|Primary Vaccination Phase|Adverse Event|1|||
155509247|NCT01144663|561291678|FG000|Primary Vaccination Phase|Protocol Violation|2|||
155509248|NCT01144663|561291679|FG001|Primary Vaccination Phase|Protocol Violation|0|||
155509249|NCT01144663|561291680|FG002|Primary Vaccination Phase|Protocol Violation|1|||
155509250|NCT01144663|561291681|FG003|Primary Vaccination Phase|Protocol Violation|0|||
155509251|NCT01144663|561291678|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
155509252|NCT01144663|561291679|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
155509253|NCT01144663|561291680|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
155509254|NCT01144663|561291681|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
155509255|NCT01144663|561291678|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
155509256|NCT01144663|561291679|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
155509257|NCT01144663|561291680|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
155509258|NCT01144663|561291681|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
155509259|NCT01144663|561291678|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
155509260|NCT01144663|561291679|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
155509261|NCT01144663|561291680|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
155509262|NCT01144663|561291681|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
155509263|NCT01144663|561291678|FG000|Primary Vaccination Phase|Other|0|||
155509264|NCT01144663|561291679|FG001|Primary Vaccination Phase|Other|1|||
155509265|NCT01144663|561291680|FG002|Primary Vaccination Phase|Other|0|||
155509266|NCT01144663|561291681|FG003|Primary Vaccination Phase|Other|2|||
155509267|NCT01144663|561291678|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
155649389|NCT02105012|561808237|FG000|Overall Study|Protocol Specified Criteria|9|||
155649390|NCT02105012|561808237|FG000|Overall Study|Lost to Follow-up|4|||
155649391|NCT02105012|561808237|FG000|Overall Study|Protocol Violation|4|||
155509268|NCT01144663|561291679|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155509269|NCT01144663|561291680|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
155509270|NCT01144663|561291681|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
155509271|NCT01144663|561291678|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
155509272|NCT01144663|561291679|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
155509273|NCT01144663|561291680|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
155509274|NCT01144663|561291681|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
155509275|NCT01144663|561291678|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
155509276|NCT01144663|561291679|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
155509277|NCT01144663|561291680|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
155649392|NCT02105012|561808237|FG000|Overall Study|Physician Decision|3|||
155649393|NCT02105012|561808237|FG000|Overall Study|Adverse Event|1|||
155368614|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
155368615|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
155368616|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
155368617|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
155368618|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
155368619|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
155368620|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
155368621|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
155368622|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
155368623|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
155368624|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
155368625|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
155368626|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368627|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368628|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368629|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368630|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368631|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368632|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368633|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
155368634|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368635|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368636|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368637|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368638|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368639|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368640|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368641|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368642|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368643|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368644|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368645|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
155368646|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368647|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368648|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368649|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368650|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368651|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368652|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368653|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368654|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368655|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
155368656|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
155368657|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
155368658|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368659|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368660|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368661|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368662|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368663|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368664|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368665|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368666|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368667|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368668|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368669|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368670|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
155368671|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
155368672|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
155368673|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
155368674|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155428920|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
155428921|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
155428922|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
155509278|NCT01144663|561291681|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
155509279|NCT01144663|561291678|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
155509280|NCT01144663|561291679|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
155509281|NCT01144663|561291680|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
155509282|NCT01144663|561291681|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
155509283|NCT01144663|561291678|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
155509284|NCT01144663|561291679|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
155509285|NCT01144663|561291680|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
155509286|NCT01144663|561291681|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
155509287|NCT01144663|561291678|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
155509288|NCT01144663|561291679|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
155509289|NCT01144663|561291680|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
155509290|NCT01144663|561291681|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
155509291|NCT02763579|561291682|FG000|Global Period|Death|167|||
155509292|NCT02763579|561291683|FG001|Global Period|Death|151|||
155509293|NCT02763579|561291684|FG002|Global Period|Death|0|||
155509294|NCT02763579|561291685|FG003|Global Period|Death|0|||
155509295|NCT02763579|561291682|FG000|Global Period|Lost to Follow-up|2|||
155509296|NCT02763579|561291683|FG001|Global Period|Lost to Follow-up|4|||
155509297|NCT02763579|561291684|FG002|Global Period|Lost to Follow-up|0|||
155509298|NCT02763579|561291685|FG003|Global Period|Lost to Follow-up|0|||
155509299|NCT02763579|561291682|FG000|Global Period|Physician Decision|0|||
155509300|NCT02763579|561291683|FG001|Global Period|Physician Decision|2|||
155509301|NCT02763579|561291684|FG002|Global Period|Physician Decision|0|||
155509302|NCT02763579|561291685|FG003|Global Period|Physician Decision|0|||
155509303|NCT02763579|561291682|FG000|Global Period|Study Terminated By Sponsor|21|||
155368675|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368676|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368677|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368678|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368679|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368680|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368681|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368682|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
155368683|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
155368684|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
155368685|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
155368686|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368687|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368688|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368689|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368690|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368691|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368692|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368693|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155509304|NCT02763579|561291683|FG001|Global Period|Study Terminated By Sponsor|26|||
155509305|NCT02763579|561291684|FG002|Global Period|Study Terminated By Sponsor|0|||
155509306|NCT02763579|561291685|FG003|Global Period|Study Terminated By Sponsor|0|||
155509307|NCT02763579|561291682|FG000|Global Period|Withdrawal by Subject|12|||
155509308|NCT02763579|561291683|FG001|Global Period|Withdrawal by Subject|18|||
155509309|NCT02763579|561291684|FG002|Global Period|Withdrawal by Subject|0|||
155509310|NCT02763579|561291685|FG003|Global Period|Withdrawal by Subject|0|||
155368694|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
155368695|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
155509311|NCT02763579|561291682|FG000|China Period|Death|0|||
155509312|NCT02763579|561291683|FG001|China Period|Death|0|||
155509313|NCT02763579|561291684|FG002|China Period|Death|46|||
155509314|NCT02763579|561291685|FG003|China Period|Death|48|||
155509315|NCT02763579|561291682|FG000|China Period|Lost to Follow-up|0|||
155509316|NCT02763579|561291683|FG001|China Period|Lost to Follow-up|0|||
155368696|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
155368697|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
155509317|NCT02763579|561291684|FG002|China Period|Lost to Follow-up|1|||
155509318|NCT02763579|561291685|FG003|China Period|Lost to Follow-up|1|||
155509319|NCT02763579|561291682|FG000|China Period|Physician Decision|0|||
155509320|NCT02763579|561291683|FG001|China Period|Physician Decision|0|||
155509321|NCT02763579|561291684|FG002|China Period|Physician Decision|0|||
155509322|NCT02763579|561291685|FG003|China Period|Physician Decision|1|||
155509323|NCT02763579|561291682|FG000|China Period|Study Terminated By Sponsor|0|||
155509324|NCT02763579|561291683|FG001|China Period|Study Terminated By Sponsor|0|||
155368698|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155509325|NCT02763579|561291684|FG002|China Period|Study Terminated By Sponsor|3|||
155509326|NCT02763579|561291685|FG003|China Period|Study Terminated By Sponsor|4|||
155509327|NCT02763579|561291682|FG000|China Period|Withdrawal by Subject|0|||
155509328|NCT02763579|561291683|FG001|China Period|Withdrawal by Subject|0|||
155509329|NCT02763579|561291684|FG002|China Period|Withdrawal by Subject|3|||
155509330|NCT02763579|561291685|FG003|China Period|Withdrawal by Subject|3|||
155509331|NCT01034137|561291689|FG000|Overall Study|Adverse Event|9|||
155509332|NCT01034137|561291690|FG001|Overall Study|Adverse Event|10|||
155509333|NCT01034137|561291691|FG002|Overall Study|Adverse Event|8|||
155509334|NCT01034137|561291689|FG000|Overall Study|Withdrawal by Subject|4|||
155509335|NCT01034137|561291690|FG001|Overall Study|Withdrawal by Subject|3|||
155509336|NCT01034137|561291691|FG002|Overall Study|Withdrawal by Subject|3|||
155509337|NCT01034137|561291689|FG000|Overall Study|Lack of Efficacy|9|||
155509338|NCT01034137|561291690|FG001|Overall Study|Lack of Efficacy|4|||
155509339|NCT01034137|561291691|FG002|Overall Study|Lack of Efficacy|13|||
155509340|NCT01034137|561291689|FG000|Overall Study|Protocol Violation|2|||
155509341|NCT01034137|561291690|FG001|Overall Study|Protocol Violation|2|||
155509342|NCT01034137|561291691|FG002|Overall Study|Protocol Violation|1|||
155509343|NCT01034137|561291689|FG000|Overall Study|Refused treatment or did not cooperate|2|||
155509344|NCT01034137|561291690|FG001|Overall Study|Refused treatment or did not cooperate|0|||
155509345|NCT01034137|561291691|FG002|Overall Study|Refused treatment or did not cooperate|1|||
155509346|NCT01034137|561291689|FG000|Overall Study|Administrative or other|2|||
155509347|NCT01034137|561291690|FG001|Overall Study|Administrative or other|3|||
155509348|NCT01034137|561291691|FG002|Overall Study|Administrative or other|4|||
155509349|NCT03572933|561291692|FG000|Overall Study|Adverse Event|4|||
155509350|NCT03572933|561291693|FG001|Overall Study|Adverse Event|1|||
155368699|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155509351|NCT03572933|561291692|FG000|Overall Study|Withdrawal by Subject|0|||
155509352|NCT03572933|561291693|FG001|Overall Study|Withdrawal by Subject|1|||
155509353|NCT00124020|561291707|FG000|Overall Study|Death|67|||
155509354|NCT00124020|561291708|FG001|Overall Study|Death|71|||
155509355|NCT00124020|561291707|FG000|Overall Study|Withdrawal by Subject|13|||
155509356|NCT00124020|561291708|FG001|Overall Study|Withdrawal by Subject|11|||
155509357|NCT00124020|561291707|FG000|Overall Study|Lost to Follow-up|5|||
155509358|NCT00124020|561291708|FG001|Overall Study|Lost to Follow-up|8|||
155509359|NCT00124020|561291707|FG000|Overall Study|Other|1|||
155509360|NCT00124020|561291708|FG001|Overall Study|Other|1|||
155509361|NCT00124020|561291707|FG000|Overall Study|Transfer to another hospital|2|||
155509362|NCT00124020|561291708|FG001|Overall Study|Transfer to another hospital|0|||
155509363|NCT00268346|561291709|FG000|Overall Study|Adverse Event|0|||
155509364|NCT00268346|561291710|FG001|Overall Study|Adverse Event|1|||
155509365|NCT00268346|561291709|FG000|Overall Study|Death|0|||
155509366|NCT00268346|561291710|FG001|Overall Study|Death|1|||
155509367|NCT00268346|561291709|FG000|Overall Study|Withdrawal by Subject|0|||
155509368|NCT00268346|561291710|FG001|Overall Study|Withdrawal by Subject|1|||
155509369|NCT01799590|561291711|FG000|Overall Study|Adverse Event|13|||
155509370|NCT01799590|561291712|FG001|Overall Study|Adverse Event|7|||
155509371|NCT01799590|561291713|FG002|Overall Study|Adverse Event|5|||
155509372|NCT01799590|561291711|FG000|Overall Study|Pregnancy|2|||
155509373|NCT01799590|561291712|FG001|Overall Study|Pregnancy|0|||
155509374|NCT01799590|561291713|FG002|Overall Study|Pregnancy|0|||
155509375|NCT01799590|561291711|FG000|Overall Study|Lack of Efficacy|3|||
155509376|NCT01799590|561291712|FG001|Overall Study|Lack of Efficacy|1|||
155509377|NCT01799590|561291713|FG002|Overall Study|Lack of Efficacy|3|||
155509378|NCT01799590|561291711|FG000|Overall Study|Participants convenience|4|||
155509379|NCT01799590|561291712|FG001|Overall Study|Participants convenience|4|||
155509380|NCT01799590|561291713|FG002|Overall Study|Participants convenience|2|||
155509381|NCT01799590|561291711|FG000|Overall Study|Aggravation of complications|0|||
155509382|NCT01799590|561291712|FG001|Overall Study|Aggravation of complications|1|||
155509383|NCT01799590|561291713|FG002|Overall Study|Aggravation of complications|1|||
155509384|NCT01799590|561291711|FG000|Overall Study|Using drugs with restricted days of use|0|||
155509385|NCT01799590|561291712|FG001|Overall Study|Using drugs with restricted days of use|3|||
155509386|NCT01799590|561291713|FG002|Overall Study|Using drugs with restricted days of use|2|||
155509387|NCT01799590|561291711|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
155509388|NCT01799590|561291712|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
155368700|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155509389|NCT01799590|561291713|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
155509390|NCT01799590|561291711|FG000|Overall Study|Other|3|||
155509391|NCT01799590|561291712|FG001|Overall Study|Other|0|||
155509392|NCT01799590|561291713|FG002|Overall Study|Other|1|||
155509393|NCT00294723|561291714|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
155509394|NCT00294723|561291715|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
155509395|NCT00294723|561291716|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
155509396|NCT00294723|561291714|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
155509397|NCT00294723|561291715|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
155368701|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368702|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368703|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368704|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368705|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368706|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
155368707|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
155368708|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
155368709|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
155368710|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368711|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368712|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368713|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368714|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368715|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368716|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368717|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368718|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
155368719|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
155368720|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
155368721|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
155368722|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368723|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368724|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368725|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368726|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368727|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368728|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368729|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368730|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
155368731|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
155368732|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
155368733|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
155368734|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368735|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368736|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368737|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368738|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368739|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368740|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368741|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368742|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368743|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
155368744|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
155368745|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
155368746|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368747|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368748|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368749|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368750|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368751|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368752|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368753|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368754|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368755|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155368756|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155368757|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155428923|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
155428924|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
155428925|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
155428926|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
155428927|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
155428928|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
155428929|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428930|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155509398|NCT00294723|561291716|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
155509399|NCT00294723|561291714|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
155509400|NCT00294723|561291715|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
155509401|NCT00294723|561291716|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
155509402|NCT00294723|561291714|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
155509403|NCT00294723|561291715|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
155509404|NCT00294723|561291716|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
155509405|NCT00294723|561291714|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
155509406|NCT00294723|561291715|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
155509407|NCT00294723|561291716|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
155368758|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368759|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368760|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368761|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368762|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155509408|NCT00294723|561291714|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
155509409|NCT00294723|561291715|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
155509410|NCT00294723|561291716|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
155368763|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368764|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368765|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368766|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368767|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368768|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368769|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368770|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368771|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368772|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368773|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368774|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368775|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368776|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368777|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368778|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155428931|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428932|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428933|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428934|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
155509411|NCT00294723|561291714|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
155509412|NCT00294723|561291715|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
155509413|NCT00294723|561291716|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
155509414|NCT00294723|561291714|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
155509415|NCT00294723|561291715|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
155509416|NCT00294723|561291716|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
155509417|NCT00294723|561291714|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
155509418|NCT00294723|561291715|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
155509419|NCT00294723|561291716|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
155509420|NCT00294723|561291714|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
155509421|NCT00294723|561291715|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
155509422|NCT00294723|561291716|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
155509423|NCT00294723|561291714|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
155509424|NCT00294723|561291715|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
155509425|NCT00294723|561291716|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
155509426|NCT00294723|561291714|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
155509427|NCT00294723|561291715|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
155428935|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428936|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428937|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
155428938|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155428939|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
155428940|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
155509428|NCT00294723|561291716|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
155509429|NCT01967888|561291719|FG000|Overall Study|Lost to Follow-up|6|||
155509430|NCT01967888|561291720|FG001|Overall Study|Lost to Follow-up|4|||
155509431|NCT01967888|561291719|FG000|Overall Study|Withdrawal by Subject|1|||
155368779|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368780|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
155368781|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
155368782|NCT00820170|560783250|FG000|Overall Study|Adverse Event|0|||
155368783|NCT00820170|560783251|FG001|Overall Study|Adverse Event|0|||
155368784|NCT00820170|560783252|FG002|Overall Study|Adverse Event|0|||
155368785|NCT00820170|560783253|FG003|Overall Study|Adverse Event|0|||
155368786|NCT00820170|560783254|FG004|Overall Study|Adverse Event|2|||
155368787|NCT00820170|560783250|FG000|Overall Study|Progressive Disease|0|||
155368788|NCT00820170|560783251|FG001|Overall Study|Progressive Disease|0|||
155368789|NCT00820170|560783252|FG002|Overall Study|Progressive Disease|0|||
155368790|NCT00820170|560783253|FG003|Overall Study|Progressive Disease|0|||
155368791|NCT00820170|560783254|FG004|Overall Study|Progressive Disease|2|||
155368792|NCT03995316|560783255|FG000|Overall Study|Lost to Follow-up|10|||
155368793|NCT03995316|560783256|FG001|Overall Study|Lost to Follow-up|3|||
155368794|NCT05479734|560783257|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
155368795|NCT05479734|560783258|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368796|NCT05479734|560783257|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368797|NCT05479734|560783258|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
155368798|NCT05479734|560783257|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368799|NCT05479734|560783258|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
155368800|NCT05479734|560783257|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
155368801|NCT05479734|560783258|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
155368802|NCT00664534|560783261|FG000|Overall Study|Adverse Event|2|||
155368803|NCT00664534|560783262|FG001|Overall Study|Adverse Event|3|||
155368804|NCT00664534|560783261|FG000|Overall Study|Lost to Follow-up|6|||
155368805|NCT00664534|560783262|FG001|Overall Study|Lost to Follow-up|10|||
155368806|NCT00664534|560783261|FG000|Overall Study|Protocol Violation|10|||
155368807|NCT00664534|560783262|FG001|Overall Study|Protocol Violation|8|||
155368808|NCT00664534|560783261|FG000|Overall Study|Withdrawal by Subject|7|||
155368809|NCT00664534|560783262|FG001|Overall Study|Withdrawal by Subject|6|||
155368810|NCT00664534|560783261|FG000|Overall Study|Physician Decision|8|||
155368811|NCT00664534|560783262|FG001|Overall Study|Physician Decision|0|||
155368812|NCT00664534|560783261|FG000|Overall Study|Sponsor decision|8|||
155368813|NCT00664534|560783262|FG001|Overall Study|Sponsor decision|6|||
155368814|NCT00600613|560783263|FG000|Overall Study|Protocol Deviation|1|||
155368815|NCT01436253|560783267|FG000|Overall Study|Lost to Follow-up|182|||
155368816|NCT01436253|560783267|FG000|Overall Study|Not meeting all eligibility criteria|117|||
155368817|NCT01495598|560783268|FG000|Overall Study|Death during follow up period|2|||
155368818|NCT01495598|560783268|FG000|Overall Study|Death on study|1|||
155368819|NCT01495598|560783268|FG000|Overall Study|Lost to Follow-up|3|||
155368820|NCT01495598|560783268|FG000|Overall Study|Physician Decision|8|||
155368821|NCT04844879|560783269|FG000|Overall Study|Death|1|||
155368822|NCT04844879|560783269|FG000|Overall Study|Withdrawal by Subject|1|||
155368823|NCT04844879|560783269|FG000|Overall Study|Adverse Event|1|||
155368824|NCT05576662|560783270|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
155368825|NCT05576662|560783271|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
155368826|NCT05576662|560783270|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
155368827|NCT05576662|560783271|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
155368828|NCT05576662|560783270|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
155368829|NCT05576662|560783271|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
155368830|NCT05576662|560783270|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
155368831|NCT05576662|560783271|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
155368832|NCT05217641|560783276|FG000|Overall Study|Lost to Follow-up|1|||
155368833|NCT05217641|560783277|FG001|Overall Study|Lost to Follow-up|1|||
155368834|NCT05217641|560783278|FG002|Overall Study|Lost to Follow-up|0|||
155368835|NCT05217641|560783279|FG003|Overall Study|Lost to Follow-up|1|||
155368836|NCT05217641|560783280|FG004|Overall Study|Lost to Follow-up|1|||
155368837|NCT05217641|560783281|FG005|Overall Study|Lost to Follow-up|0|||
155368838|NCT05217641|560783276|FG000|Overall Study|Withdrawal by Subject|0|||
155368839|NCT05217641|560783277|FG001|Overall Study|Withdrawal by Subject|0|||
155368840|NCT05217641|560783278|FG002|Overall Study|Withdrawal by Subject|0|||
155368841|NCT05217641|560783279|FG003|Overall Study|Withdrawal by Subject|3|||
155368842|NCT05217641|560783280|FG004|Overall Study|Withdrawal by Subject|1|||
155368843|NCT05217641|560783281|FG005|Overall Study|Withdrawal by Subject|0|||
155428941|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155368844|NCT05217641|560783276|FG000|Overall Study|Other: participant did not specify reason|0|||
155428942|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155649394|NCT02105012|561808237|FG000|Overall Study|Lack of Efficacy|1|||
155368845|NCT05217641|560783277|FG001|Overall Study|Other: participant did not specify reason|0|||
155368846|NCT05217641|560783278|FG002|Overall Study|Other: participant did not specify reason|0|||
155368847|NCT05217641|560783279|FG003|Overall Study|Other: participant did not specify reason|0|||
155368848|NCT05217641|560783280|FG004|Overall Study|Other: participant did not specify reason|1|||
155368849|NCT05217641|560783281|FG005|Overall Study|Other: participant did not specify reason|0|||
155368850|NCT05217641|560783276|FG000|Overall Study|Extended Follow up|1|||
155368851|NCT05217641|560783277|FG001|Overall Study|Extended Follow up|1|||
155368852|NCT05217641|560783278|FG002|Overall Study|Extended Follow up|0|||
155368853|NCT05217641|560783279|FG003|Overall Study|Extended Follow up|0|||
155368854|NCT05217641|560783280|FG004|Overall Study|Extended Follow up|1|||
155368855|NCT05217641|560783281|FG005|Overall Study|Extended Follow up|0|||
155368856|NCT05292586|560783282|FG000|Overall Study|Withdrawal by Subject|3|||
155368857|NCT05292586|560783283|FG001|Overall Study|Withdrawal by Subject|10|||
155368858|NCT05292586|560783282|FG000|Overall Study|Randomization error|3|||
155368859|NCT05292586|560783283|FG001|Overall Study|Randomization error|7|||
155368860|NCT05292586|560783282|FG000|Overall Study|Adverse Event|3|||
155368861|NCT05292586|560783283|FG001|Overall Study|Adverse Event|0|||
155368862|NCT05292586|560783282|FG000|Overall Study|Lost to Follow-up|0|||
155368863|NCT05292586|560783283|FG001|Overall Study|Lost to Follow-up|1|||
155368864|NCT05292586|560783282|FG000|Overall Study|Patient refused treatment|1|||
155368865|NCT05292586|560783283|FG001|Overall Study|Patient refused treatment|0|||
155368866|NCT05292586|560783282|FG000|Overall Study|Patient could not travel to the study site|1|||
155428943|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
155428944|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
155428945|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155428946|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155428947|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428948|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428949|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428950|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
155428951|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428952|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428953|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428954|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428955|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155428956|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
155428957|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
155428958|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
155428959|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
155428960|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
155428961|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
155428962|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
155428963|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
155428964|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
155428965|NCT01307423|560996131|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428966|NCT01307423|560996132|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428967|NCT01307423|560996133|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428968|NCT01307423|560996134|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428969|NCT01307423|560996135|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428970|NCT01307423|560996136|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
155428971|NCT01307423|560996137|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428972|NCT01307423|560996138|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428973|NCT01307423|560996139|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
155428974|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155428975|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
155428976|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
155428977|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155428978|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155428979|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155428980|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155428981|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
155428982|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
155428983|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155368867|NCT05292586|560783283|FG001|Overall Study|Patient could not travel to the study site|0|||
155368868|NCT05292586|560783282|FG000|Overall Study|Technical issues with the masterscope|0|||
155368869|NCT05292586|560783283|FG001|Overall Study|Technical issues with the masterscope|3|||
155428984|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
155428985|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
155428986|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155368870|NCT05292586|560783282|FG000|Overall Study|Patient moved to a different state|0|||
155368871|NCT05292586|560783283|FG001|Overall Study|Patient moved to a different state|1|||
155368872|NCT01040169|560783297|FG000|Overall Study|Lost to Follow-up|3|||
155368873|NCT01040169|560783298|FG001|Overall Study|Lost to Follow-up|8|||
155368874|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Adverse Event|4|||
155368875|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Adverse Event|0|||
155368876|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Adverse Event|0|||
155368877|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
155368878|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
155368879|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
155368880|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Death|1|||
155368881|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Death|0|||
155368882|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Death|0|||
155368883|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Physician Decision|1|||
155368884|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Physician Decision|0|||
155368885|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Physician Decision|0|||
155368886|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
155368887|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
155368888|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
155368889|NCT00350727|560783299|FG000|Phase II|Disease Progression|0|||
155368890|NCT00350727|560783300|FG001|Phase II|Disease Progression|15|||
155368891|NCT00350727|560783301|FG002|Phase II|Disease Progression|16|||
155368892|NCT00350727|560783299|FG000|Phase II|Clinical Deterioration|0|||
155368893|NCT00350727|560783300|FG001|Phase II|Clinical Deterioration|1|||
155368894|NCT00350727|560783301|FG002|Phase II|Clinical Deterioration|0|||
155428987|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155428988|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155428989|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155428990|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
155428991|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
155428992|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428993|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428994|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
155428995|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428996|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428997|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428998|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155428999|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155429000|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
155429001|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155429002|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
155429003|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
155429004|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155429005|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155429006|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155429007|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155429008|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
155429009|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
155429010|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429011|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155429012|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429013|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429014|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429015|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429016|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155429017|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155429018|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155429019|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155429020|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
155429021|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155429022|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155429023|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155429024|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155429025|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155429026|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
155429027|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
155429028|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155429029|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155429030|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
155429031|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155429032|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155429033|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155429034|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155429035|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
155368895|NCT00350727|560783299|FG000|Phase II|Withdrawal by Subject|0|||
155368896|NCT00350727|560783300|FG001|Phase II|Withdrawal by Subject|2|||
155509432|NCT01967888|561291720|FG001|Overall Study|Withdrawal by Subject|1|||
155509433|NCT01967888|561291719|FG000|Overall Study|Did Not Have Transplant|1|||
155509434|NCT01967888|561291720|FG001|Overall Study|Did Not Have Transplant|0|||
155509435|NCT01967888|561291719|FG000|Overall Study|Research visit not done, data recorded|1|||
155509436|NCT01967888|561291720|FG001|Overall Study|Research visit not done, data recorded|0|||
155509437|NCT01967888|561291719|FG000|Overall Study|Subject excluded after randomization|1|||
155509438|NCT01967888|561291720|FG001|Overall Study|Subject excluded after randomization|0|||
155509439|NCT01967888|561291719|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
155509440|NCT01967888|561291720|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
155509441|NCT01967888|561291719|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
155509442|NCT01967888|561291720|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
155509443|NCT00891774|561291721|FG000|Overall Study|Lost to Follow-up|5|||
155509444|NCT00891774|561291721|FG000|Overall Study|Illness (Self/Mother)|3|||
155509445|NCT00891774|561291721|FG000|Overall Study|Withdrawal by Subject|2|||
155509446|NCT00891774|561291721|FG000|Overall Study|Protocol Violation|4|||
155509447|NCT03175120|561291724|FG000|Overall Study|Adverse Event|2|||
155509448|NCT03175120|561291725|FG001|Overall Study|Adverse Event|2|||
155509449|NCT03175120|561291724|FG000|Overall Study|Protocol Violation|5|||
155649395|NCT00493285|561808238|FG000|Overall Study|Lost to Follow-up|0|||
155368897|NCT00350727|560783301|FG002|Phase II|Withdrawal by Subject|1|||
155368898|NCT00350727|560783299|FG000|Phase II|Adverse Event|0|||
155368899|NCT00350727|560783300|FG001|Phase II|Adverse Event|1|||
155368900|NCT00350727|560783301|FG002|Phase II|Adverse Event|1|||
155368901|NCT00350727|560783299|FG000|Phase II|Death|0|||
155368902|NCT00350727|560783300|FG001|Phase II|Death|0|||
155368903|NCT00350727|560783301|FG002|Phase II|Death|2|||
155368904|NCT00350727|560783299|FG000|Phase II|Sponsor Terminated Study|0|||
155368905|NCT00350727|560783300|FG001|Phase II|Sponsor Terminated Study|0|||
155368906|NCT00350727|560783301|FG002|Phase II|Sponsor Terminated Study|1|||
155368907|NCT00350727|560783299|FG000|Phase II|Enrolled in Rollover Study|0|||
155368908|NCT00350727|560783300|FG001|Phase II|Enrolled in Rollover Study|0|||
155368909|NCT00350727|560783301|FG002|Phase II|Enrolled in Rollover Study|1|||
155368910|NCT03633799|560783309|FG000|Overall Study|Adverse Event|349|||
155368911|NCT03633799|560783309|FG000|Overall Study|Withdrawal by Subject|288|||
155368912|NCT03633799|560783309|FG000|Overall Study|Lost to Follow-up|97|||
155368913|NCT03633799|560783309|FG000|Overall Study|Physician Decision|9|||
155368914|NCT03633799|560783309|FG000|Overall Study|Protocol Violation|4|||
155368915|NCT03633799|560783309|FG000|Overall Study|Pregnancy|20|||
155368916|NCT03633799|560783309|FG000|Overall Study|other|39|||
155368917|NCT03633799|560783309|FG000|Overall Study|ongoing within third year of study|106|||
155368918|NCT03633799|560783309|FG000|Overall Study|unsuccessful study drug placement|19|||
155368919|NCT01435772|560783311|FG000|Overall Study|Adverse Event|1|||
155368920|NCT01435772|560783312|FG001|Overall Study|Adverse Event|0|||
155368921|NCT01435772|560783313|FG002|Overall Study|Adverse Event|2|||
155368922|NCT01435772|560783311|FG000|Overall Study|Withdrawal by Subject|0|||
155368923|NCT01435772|560783312|FG001|Overall Study|Withdrawal by Subject|1|||
155368924|NCT01435772|560783313|FG002|Overall Study|Withdrawal by Subject|3|||
155368925|NCT01435772|560783311|FG000|Overall Study|Other - study termination|2|||
155368926|NCT01435772|560783312|FG001|Overall Study|Other - study termination|2|||
155368927|NCT01435772|560783313|FG002|Overall Study|Other - study termination|10|||
155368928|NCT03238963|560783314|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
155368929|NCT03238963|560783315|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
155368930|NCT03238963|560783314|FG000|Overall Study|Withdrawal by Subject|1|||
155368931|NCT03238963|560783315|FG001|Overall Study|Withdrawal by Subject|1|||
155368932|NCT03238963|560783314|FG000|Overall Study|Lost to Follow-up|1|||
155368933|NCT03238963|560783315|FG001|Overall Study|Lost to Follow-up|0|||
155368934|NCT03238963|560783314|FG000|Overall Study|Protocol Violation|1|||
155368935|NCT03238963|560783315|FG001|Overall Study|Protocol Violation|1|||
155368936|NCT03238963|560783314|FG000|Overall Study|Adverse Event|1|||
155368937|NCT03238963|560783315|FG001|Overall Study|Adverse Event|0|||
155368938|NCT05823012|560783316|FG000|Titration Period|Adverse Event|1|||
155368939|NCT05823012|560783316|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
155368940|NCT05823012|560783316|FG000|Maintenance Period|Adverse Event|1|||
155368941|NCT05823012|560783316|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
155509450|NCT03175120|561291725|FG001|Overall Study|Protocol Violation|2|||
155509451|NCT03175120|561291724|FG000|Overall Study|Lost to Follow-up|1|||
155649396|NCT00493285|561808239|FG001|Overall Study|Lost to Follow-up|0|||
155368942|NCT05823012|560783316|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
155509452|NCT03175120|561291725|FG001|Overall Study|Lost to Follow-up|0|||
155368943|NCT01424813|560783317|FG000|Overall Study|Withdrawal by Subject|3|||
155368944|NCT01424813|560783318|FG001|Overall Study|Withdrawal by Subject|0|||
155368945|NCT01424813|560783317|FG000|Overall Study|Protocol Violation|1|||
155509453|NCT03175120|561291724|FG000|Overall Study|Withdrawal by Subject|2|||
155368946|NCT01424813|560783318|FG001|Overall Study|Protocol Violation|0|||
155368947|NCT01424813|560783317|FG000|Overall Study|Other|1|||
155509454|NCT03175120|561291725|FG001|Overall Study|Withdrawal by Subject|5|||
155368948|NCT01424813|560783318|FG001|Overall Study|Other|2|||
155368949|NCT07149155|560783322|FG000|Overall Study|Lost to Follow-up|10|||
155368950|NCT00918879|560785160|FG000|Overall Study|Withdrawal by Subject|4|||
155368951|NCT00918879|560785161|FG001|Overall Study|Withdrawal by Subject|4|||
155649397|NCT00493285|561808240|FG002|Overall Study|Lost to Follow-up|0|||
155368952|NCT00918879|560785160|FG000|Overall Study|Lost to Follow-up|1|||
155368953|NCT00918879|560785161|FG001|Overall Study|Lost to Follow-up|1|||
155368954|NCT00918879|560785160|FG000|Overall Study|Severe non-compliance to protocol|1|||
155368955|NCT00918879|560785161|FG001|Overall Study|Severe non-compliance to protocol|1|||
155368956|NCT04707664|560785162|FG000|Overall Study|Adverse Event|2|||
155368957|NCT04707664|560785163|FG001|Overall Study|Adverse Event|0|||
155368958|NCT04707664|560785162|FG000|Overall Study|Death|1|||
155368959|NCT04707664|560785163|FG001|Overall Study|Death|2|||
155368960|NCT04707664|560785162|FG000|Overall Study|Withdrawal by Subject|13|||
155368961|NCT04707664|560785163|FG001|Overall Study|Withdrawal by Subject|21|||
155368962|NCT04707664|560785162|FG000|Overall Study|Lost to Follow-up|11|||
155509455|NCT03175120|561291724|FG000|Overall Study|Other|2|||
155509456|NCT03175120|561291725|FG001|Overall Study|Other|3|||
155368963|NCT04707664|560785163|FG001|Overall Study|Lost to Follow-up|13|||
155368964|NCT04707664|560785162|FG000|Overall Study|Not treated|2|||
155368965|NCT04707664|560785163|FG001|Overall Study|Not treated|0|||
155368966|NCT00357110|560785164|FG000|Overall Study|Early study termination|5|||
155368967|NCT00357110|560785165|FG001|Overall Study|Early study termination|5|||
155368968|NCT01977677|560785169|FG000|Overall Study|Unrelated Adverse Event|0|||
155368969|NCT01977677|560785170|FG001|Overall Study|Unrelated Adverse Event|0|||
155368970|NCT01977677|560785171|FG002|Overall Study|Unrelated Adverse Event|1|||
155368971|NCT01498887|560785172|FG000|Overall Study|Administrative problems|1|||
155368972|NCT01498887|560785173|FG001|Overall Study|Administrative problems|0|||
155368973|NCT01498887|560785172|FG000|Overall Study|Lost to Follow-up|1|||
155368974|NCT01498887|560785173|FG001|Overall Study|Lost to Follow-up|1|||
155368975|NCT01498887|560785172|FG000|Overall Study|Withdrawal by Subject|1|||
155368976|NCT01498887|560785173|FG001|Overall Study|Withdrawal by Subject|0|||
155368977|NCT01498887|560785172|FG000|Overall Study|Protocol Violation|1|||
155368978|NCT01498887|560785173|FG001|Overall Study|Protocol Violation|3|||
155368979|NCT01498887|560785172|FG000|Overall Study|Lack of Efficacy|5|||
155368980|NCT01498887|560785173|FG001|Overall Study|Lack of Efficacy|3|||
155368981|NCT01498887|560785172|FG000|Overall Study|Abnormal result from test procedure|1|||
155368982|NCT01498887|560785173|FG001|Overall Study|Abnormal result from test procedure|1|||
155368983|NCT01498887|560785172|FG000|Overall Study|Abnormal laboratory value|2|||
155368984|NCT01498887|560785173|FG001|Overall Study|Abnormal laboratory value|2|||
155368985|NCT01498887|560785172|FG000|Overall Study|Adverse Event|4|||
155368986|NCT01498887|560785173|FG001|Overall Study|Adverse Event|1|||
155368987|NCT04335591|560785174|FG000|Overall Study|Adverse Event|5|||
155368988|NCT04335591|560785175|FG001|Overall Study|Adverse Event|2|||
155368989|NCT04335591|560785176|FG002|Overall Study|Adverse Event|3|||
155368990|NCT04335591|560785177|FG003|Overall Study|Adverse Event|2|||
155368991|NCT04335591|560785174|FG000|Overall Study|Protocol Violation|1|||
155368992|NCT04335591|560785175|FG001|Overall Study|Protocol Violation|0|||
155368993|NCT04335591|560785176|FG002|Overall Study|Protocol Violation|0|||
155368994|NCT04335591|560785177|FG003|Overall Study|Protocol Violation|0|||
155368995|NCT04335591|560785174|FG000|Overall Study|Withdrawal by Subject|8|||
155368996|NCT04335591|560785175|FG001|Overall Study|Withdrawal by Subject|4|||
155368997|NCT04335591|560785176|FG002|Overall Study|Withdrawal by Subject|4|||
155368998|NCT04335591|560785177|FG003|Overall Study|Withdrawal by Subject|5|||
155368999|NCT04335591|560785174|FG000|Overall Study|Subject planning pregnancy|0|||
155369000|NCT04335591|560785175|FG001|Overall Study|Subject planning pregnancy|1|||
155369001|NCT04335591|560785176|FG002|Overall Study|Subject planning pregnancy|0|||
155369002|NCT04335591|560785177|FG003|Overall Study|Subject planning pregnancy|0|||
155369003|NCT04335591|560785174|FG000|Overall Study|Ukrainian Russian war conflict|4|||
155369004|NCT04335591|560785175|FG001|Overall Study|Ukrainian Russian war conflict|5|||
155369005|NCT04335591|560785176|FG002|Overall Study|Ukrainian Russian war conflict|2|||
155369006|NCT04335591|560785177|FG003|Overall Study|Ukrainian Russian war conflict|0|||
155369007|NCT01077128|560785185|FG000|Overall Study|Adverse Event|8|||
155369008|NCT01077128|560785185|FG000|Overall Study|Lack of Efficacy|1|||
155369009|NCT01077128|560785185|FG000|Overall Study|Disease exacerbation|1|||
155369010|NCT01077128|560785185|FG000|Overall Study|Adverse event and consent withdrawal|1|||
155369011|NCT01077128|560785185|FG000|Overall Study|Adverse event and disease exacerbation|1|||
155369012|NCT01077128|560785185|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
155369013|NCT01077128|560785185|FG000|Overall Study|Other|54|||
155369014|NCT01706705|560785186|FG000|Overall Study|Death|1|||
155369015|NCT01706705|560785186|FG000|Overall Study|Lack of Efficacy|13|||
155369016|NCT01706705|560785186|FG000|Overall Study|Non-clinical|6|||
155509457|NCT03038113|561291726|FG000|Overall Study|Withdrawal by Subject|0|||
155369017|NCT02476175|560785190|FG000|Overall Study|Adverse Event|2|||
155369018|NCT04421950|560785193|FG000|Overall Study|Dropped or lost to follow up|4|||
155369019|NCT04421950|560785194|FG001|Overall Study|Dropped or lost to follow up|2|||
155369020|NCT01252355|560785195|FG000|Overall Study|Adverse Event|9|||
155649398|NCT00493285|561808241|FG003|Overall Study|Lost to Follow-up|0|||
155509458|NCT03038113|561291727|FG001|Overall Study|Withdrawal by Subject|0|||
155369021|NCT01252355|560785196|FG001|Overall Study|Adverse Event|17|||
155369022|NCT01252355|560785197|FG002|Overall Study|Adverse Event|22|||
155369023|NCT01252355|560785195|FG000|Overall Study|Lack of Efficacy|6|||
155369024|NCT01252355|560785196|FG001|Overall Study|Lack of Efficacy|4|||
155369025|NCT01252355|560785197|FG002|Overall Study|Lack of Efficacy|2|||
155369026|NCT01252355|560785195|FG000|Overall Study|Lost to Follow-up|0|||
155369027|NCT01252355|560785196|FG001|Overall Study|Lost to Follow-up|0|||
155369028|NCT01252355|560785197|FG002|Overall Study|Lost to Follow-up|1|||
155369029|NCT01252355|560785195|FG000|Overall Study|Poor Compliance to Protocol|1|||
155369030|NCT01252355|560785196|FG001|Overall Study|Poor Compliance to Protocol|1|||
155369031|NCT01252355|560785197|FG002|Overall Study|Poor Compliance to Protocol|1|||
155369032|NCT01252355|560785195|FG000|Overall Study|Progressive Disease|2|||
155369033|NCT01252355|560785196|FG001|Overall Study|Progressive Disease|0|||
155369034|NCT01252355|560785197|FG002|Overall Study|Progressive Disease|0|||
155369035|NCT01252355|560785195|FG000|Overall Study|Sponsor Early Termination of Study|149|||
155369036|NCT01252355|560785196|FG001|Overall Study|Sponsor Early Termination of Study|149|||
155369037|NCT01252355|560785197|FG002|Overall Study|Sponsor Early Termination of Study|146|||
155369038|NCT01252355|560785195|FG000|Overall Study|Randomized but not Treated|2|||
155369039|NCT01252355|560785196|FG001|Overall Study|Randomized but not Treated|0|||
155369040|NCT01252355|560785197|FG002|Overall Study|Randomized but not Treated|0|||
155369041|NCT01252355|560785195|FG000|Overall Study|Other Than Above|8|||
155369042|NCT01252355|560785196|FG001|Overall Study|Other Than Above|7|||
155369043|NCT01252355|560785197|FG002|Overall Study|Other Than Above|7|||
155369044|NCT02175641|560785200|FG000|Overall Study|Death|3|||
155369045|NCT02175641|560785201|FG001|Overall Study|Death|4|||
155369046|NCT02175641|560785200|FG000|Overall Study|Lost to Follow-up|4|||
155369047|NCT02175641|560785201|FG001|Overall Study|Lost to Follow-up|4|||
155369048|NCT02175641|560785200|FG000|Overall Study|Withdrawal by Subject|7|||
155369049|NCT02175641|560785201|FG001|Overall Study|Withdrawal by Subject|4|||
155369050|NCT02175641|560785200|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
155369051|NCT02175641|560785201|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
155369052|NCT02175641|560785200|FG000|Overall Study|Developed Contraindicated Condition|8|||
155369053|NCT02175641|560785201|FG001|Overall Study|Developed Contraindicated Condition|0|||
155369054|NCT04546425|560785202|FG000|Overall Study|Protocol Violation|1|||
155369055|NCT04546425|560785203|FG001|Overall Study|Protocol Violation|1|||
155369056|NCT04546425|560785204|FG002|Overall Study|Protocol Violation|0|||
155369057|NCT04546425|560785205|FG003|Overall Study|Protocol Violation|0|||
155369058|NCT04546425|560785202|FG000|Overall Study|Adverse Event|3|||
155369059|NCT04546425|560785203|FG001|Overall Study|Adverse Event|0|||
155369060|NCT04546425|560785204|FG002|Overall Study|Adverse Event|0|||
155369061|NCT04546425|560785205|FG003|Overall Study|Adverse Event|0|||
155369062|NCT04546425|560785202|FG000|Overall Study|Lost to Follow-up|5|||
155369063|NCT04546425|560785203|FG001|Overall Study|Lost to Follow-up|4|||
155369064|NCT04546425|560785204|FG002|Overall Study|Lost to Follow-up|0|||
155369065|NCT04546425|560785205|FG003|Overall Study|Lost to Follow-up|0|||
155369066|NCT04546425|560785202|FG000|Overall Study|No Longer met eligibility criteria|3|||
155369067|NCT04546425|560785203|FG001|Overall Study|No Longer met eligibility criteria|3|||
155369068|NCT04546425|560785204|FG002|Overall Study|No Longer met eligibility criteria|1|||
155369069|NCT04546425|560785205|FG003|Overall Study|No Longer met eligibility criteria|1|||
155369070|NCT04546425|560785202|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155369071|NCT04546425|560785203|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155369072|NCT04546425|560785204|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155369073|NCT04546425|560785205|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155369074|NCT02964325|560785208|FG000|Overall Study|Lost to Follow-up|3|||
155369075|NCT02964325|560785209|FG001|Overall Study|Lost to Follow-up|3|||
155369076|NCT02964325|560785208|FG000|Overall Study|Physician Decision|5|||
155369077|NCT02964325|560785209|FG001|Overall Study|Physician Decision|4|||
155369078|NCT02964325|560785208|FG000|Overall Study|Death|1|||
155369079|NCT02964325|560785209|FG001|Overall Study|Death|3|||
155369080|NCT02964325|560785208|FG000|Overall Study|Withdrawal by Subject|2|||
155369081|NCT02964325|560785209|FG001|Overall Study|Withdrawal by Subject|1|||
155369082|NCT02964325|560785208|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
155369083|NCT02964325|560785209|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
155369084|NCT02195479|560785211|FG000|Overall Study|Lost to Follow-up|18|||
155369085|NCT02195479|560785212|FG001|Overall Study|Lost to Follow-up|15|||
155369086|NCT02195479|560785211|FG000|Overall Study|Death|217|||
155369087|NCT02195479|560785212|FG001|Overall Study|Death|171|||
155369088|NCT02195479|560785211|FG000|Overall Study|Physician Decision|1|||
155369089|NCT02195479|560785212|FG001|Overall Study|Physician Decision|0|||
155369090|NCT02195479|560785211|FG000|Overall Study|Withdrawal by Subject|30|||
155369091|NCT02195479|560785212|FG001|Overall Study|Withdrawal by Subject|30|||
155369092|NCT02195479|560785211|FG000|Overall Study|Other|3|||
155369093|NCT02195479|560785212|FG001|Overall Study|Other|4|||
155369094|NCT02195479|560785211|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
155369095|NCT02195479|560785212|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
155369096|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
155369097|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
155369098|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
155369099|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
155369100|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155369101|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155369102|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155369103|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155369104|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155369105|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155369106|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155369107|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155369108|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155369109|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155369110|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155369111|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155369112|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369113|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369114|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369115|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
155369116|NCT00967005|560785217|FG000|Overall Study|Lost to Follow-up|7|||
155369117|NCT00967005|560785218|FG001|Overall Study|Lost to Follow-up|10|||
155369118|NCT02593123|560785219|FG000|Overall Study|Physician Decision|2|||
155369119|NCT02593123|560785220|FG001|Overall Study|Physician Decision|1|||
155369120|NCT02593123|560785219|FG000|Overall Study|Relapse|1|||
155369121|NCT02593123|560785220|FG001|Overall Study|Relapse|1|||
155369122|NCT05071053|560785221|FG000|Overall Study|Progressive disease|30|||
155369123|NCT05071053|560785221|FG000|Overall Study|Adverse Event|5|||
155369124|NCT04868539|560785230|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
155369125|NCT04868539|560785231|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
155369126|NCT01401153|560785232|FG000|First Test Day|Learning disabilities; illness|1|||
155369127|NCT01401153|560785233|FG001|First Test Day|Learning disabilities; illness|10|||
155369128|NCT01401153|560785232|FG000|Second Test Day|illness|0|||
155369129|NCT01401153|560785233|FG001|Second Test Day|illness|5|||
155369130|NCT01038427|560785238|FG000|Overall Study|Lost to follow up|1|||
155369131|NCT01038427|560785239|FG001|Overall Study|Lost to follow up|1|||
155369132|NCT01038427|560785240|FG002|Overall Study|Lost to follow up|0|||
155369133|NCT01038427|560785238|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155369134|NCT01038427|560785239|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155369135|NCT01038427|560785240|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
155369136|NCT01038427|560785238|FG000|Overall Study|Withdrew consent|0|||
155369137|NCT01038427|560785239|FG001|Overall Study|Withdrew consent|0|||
155369138|NCT01038427|560785240|FG002|Overall Study|Withdrew consent|1|||
155369139|NCT01038427|560785238|FG000|Overall Study|Adverse Event|2|||
155369140|NCT01038427|560785239|FG001|Overall Study|Adverse Event|2|||
155369141|NCT01038427|560785240|FG002|Overall Study|Adverse Event|1|||
155369142|NCT01038427|560785238|FG000|Overall Study|Enrolled in error|0|||
155369143|NCT01038427|560785239|FG001|Overall Study|Enrolled in error|1|||
155369144|NCT01038427|560785240|FG002|Overall Study|Enrolled in error|1|||
155369145|NCT01038427|560785238|FG000|Overall Study|Other|0|||
155369146|NCT01038427|560785239|FG001|Overall Study|Other|2|||
155369147|NCT01038427|560785240|FG002|Overall Study|Other|0|||
155369148|NCT02180243|560785241|FG000|Overall Study|Withdrawal by Subject|12|||
155369149|NCT02180243|560785242|FG001|Overall Study|Withdrawal by Subject|12|||
155369150|NCT02180243|560785241|FG000|Overall Study|Lost to Follow-up|12|||
155369151|NCT02180243|560785242|FG001|Overall Study|Lost to Follow-up|2|||
155369152|NCT01137578|560785243|FG000|Overall Study|Participant requested to Discontinue|3|||
155369153|NCT01137578|560785244|FG001|Overall Study|Participant requested to Discontinue|0|||
155429036|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155429037|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429038|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
155429039|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
155429040|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429041|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155369154|NCT01137578|560785245|FG002|Overall Study|Participant requested to Discontinue|0|||
155369155|NCT01137578|560785243|FG000|Overall Study|Withdrawal by Subject|1|||
155369156|NCT01137578|560785244|FG001|Overall Study|Withdrawal by Subject|0|||
155369157|NCT01137578|560785245|FG002|Overall Study|Withdrawal by Subject|0|||
155369158|NCT01137578|560785243|FG000|Overall Study|Other|12|||
155369159|NCT01137578|560785244|FG001|Overall Study|Other|2|||
155369160|NCT01137578|560785245|FG002|Overall Study|Other|6|||
155509459|NCT03038113|561291728|FG002|Overall Study|Withdrawal by Subject|1|||
155509460|NCT03038113|561291729|FG003|Overall Study|Withdrawal by Subject|0|||
155509461|NCT03038113|561291730|FG004|Overall Study|Withdrawal by Subject|0|||
155509462|NCT03038113|561291731|FG005|Overall Study|Withdrawal by Subject|0|||
155509463|NCT03038113|561291732|FG006|Overall Study|Withdrawal by Subject|0|||
155509464|NCT03038113|561291733|FG007|Overall Study|Withdrawal by Subject|0|||
155509465|NCT03038113|561291734|FG008|Overall Study|Withdrawal by Subject|0|||
155509466|NCT03038113|561291735|FG009|Overall Study|Withdrawal by Subject|0|||
155509467|NCT03038113|561291736|FG010|Overall Study|Withdrawal by Subject|0|||
155509468|NCT03038113|561291737|FG011|Overall Study|Withdrawal by Subject|0|||
155509469|NCT03038113|561291738|FG012|Overall Study|Withdrawal by Subject|0|||
155509470|NCT03038113|561291739|FG013|Overall Study|Withdrawal by Subject|1|||
155509471|NCT03038113|561291726|FG000|Overall Study|Lost to Follow-up|0|||
155509472|NCT03038113|561291727|FG001|Overall Study|Lost to Follow-up|0|||
155509473|NCT03038113|561291728|FG002|Overall Study|Lost to Follow-up|0|||
155509474|NCT03038113|561291729|FG003|Overall Study|Lost to Follow-up|0|||
155509475|NCT03038113|561291730|FG004|Overall Study|Lost to Follow-up|0|||
155509476|NCT03038113|561291731|FG005|Overall Study|Lost to Follow-up|0|||
155509477|NCT03038113|561291732|FG006|Overall Study|Lost to Follow-up|1|||
155509478|NCT03038113|561291733|FG007|Overall Study|Lost to Follow-up|0|||
155509479|NCT03038113|561291734|FG008|Overall Study|Lost to Follow-up|0|||
155509480|NCT03038113|561291735|FG009|Overall Study|Lost to Follow-up|0|||
155509481|NCT03038113|561291736|FG010|Overall Study|Lost to Follow-up|0|||
155509482|NCT03038113|561291737|FG011|Overall Study|Lost to Follow-up|0|||
155509483|NCT03038113|561291738|FG012|Overall Study|Lost to Follow-up|0|||
155649399|NCT00493285|561808242|FG004|Overall Study|Lost to Follow-up|1|||
155649400|NCT00493285|561808243|FG005|Overall Study|Lost to Follow-up|0|||
155649401|NCT05345405|561808244|FG000|Overall Study|Withdrawal by Subject|2|||
155649402|NCT05345405|561808245|FG001|Overall Study|Withdrawal by Subject|0|||
155649403|NCT05345405|561808246|FG002|Overall Study|Withdrawal by Subject|0|||
155649404|NCT05345405|561808244|FG000|Overall Study|Did not meet eligibility criteria|0|||
155649405|NCT05345405|561808245|FG001|Overall Study|Did not meet eligibility criteria|2|||
155649406|NCT05345405|561808246|FG002|Overall Study|Did not meet eligibility criteria|0|||
155649407|NCT05345405|561808244|FG000|Overall Study|Lost to Follow-up|0|||
155649408|NCT05345405|561808245|FG001|Overall Study|Lost to Follow-up|0|||
155649409|NCT05345405|561808246|FG002|Overall Study|Lost to Follow-up|1|||
155649410|NCT01750281|561808248|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
155649411|NCT01750281|561808249|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
155649412|NCT01750281|561808250|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
155649413|NCT01750281|561808248|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
155649414|NCT01750281|561808249|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
155649415|NCT01750281|561808250|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
155649416|NCT01750281|561808248|FG000|Overall Study|Did not receive treatment|0|||
155649417|NCT01750281|561808249|FG001|Overall Study|Did not receive treatment|1|||
155649418|NCT01750281|561808250|FG002|Overall Study|Did not receive treatment|0|||
155649419|NCT04189588|561808251|FG000|Overall Study|Death|0|||
155649420|NCT04189588|561808252|FG001|Overall Study|Death|1|||
155649421|NCT04189588|561808251|FG000|Overall Study|Lost to Follow-up|0|||
155649422|NCT04189588|561808252|FG001|Overall Study|Lost to Follow-up|1|||
155649423|NCT01658735|561808260|FG000|Overall Study|Lack of Efficacy|1|||
155649424|NCT01658735|561808261|FG001|Overall Study|Lack of Efficacy|0|||
155649425|NCT01658735|561808262|FG002|Overall Study|Lack of Efficacy|1|||
155649426|NCT01658735|561808260|FG000|Overall Study|Lost to Follow-up|1|||
155649427|NCT01658735|561808261|FG001|Overall Study|Lost to Follow-up|1|||
155649428|NCT01658735|561808262|FG002|Overall Study|Lost to Follow-up|0|||
155649429|NCT01658735|561808260|FG000|Overall Study|Protocol Violation|0|||
155649430|NCT01658735|561808261|FG001|Overall Study|Protocol Violation|1|||
155509484|NCT03038113|561291739|FG013|Overall Study|Lost to Follow-up|0|||
155509485|NCT00553540|561291740|FG000|Overall Study|discharged after first visit|2|||
155509486|NCT00553540|561291741|FG001|Overall Study|discharged after first visit|5|||
155509487|NCT01755858|561291742|FG000|Overall Study|Adverse Event|1|||
155509488|NCT01755858|561291743|FG001|Overall Study|Adverse Event|1|||
155509489|NCT03882047|561291744|FG000|Overall Study|Adverse Event|0|||
155649431|NCT01658735|561808262|FG002|Overall Study|Protocol Violation|0|||
155649432|NCT01658735|561808260|FG000|Overall Study|Withdrawal by Subject|3|||
155509490|NCT03882047|561291745|FG001|Overall Study|Adverse Event|2|||
155509491|NCT03882047|561291746|FG002|Overall Study|Adverse Event|2|||
155509492|NCT03882047|561291744|FG000|Overall Study|Treatment Failure|3|||
155509493|NCT03882047|561291745|FG001|Overall Study|Treatment Failure|3|||
155509494|NCT03882047|561291746|FG002|Overall Study|Treatment Failure|12|||
155649433|NCT01658735|561808261|FG001|Overall Study|Withdrawal by Subject|5|||
155649434|NCT01658735|561808262|FG002|Overall Study|Withdrawal by Subject|3|||
155649435|NCT03302936|561808265|FG000|Overall Study|Protocol Violation|3|||
155649436|NCT03302936|561808266|FG001|Overall Study|Protocol Violation|4|||
155649437|NCT01379937|561808267|FG000|Overall Study|Protocol Violation|0|||
155649438|NCT01379937|561808268|FG001|Overall Study|Protocol Violation|0|||
155649439|NCT01379937|561808269|FG002|Overall Study|Protocol Violation|0|||
155649440|NCT01379937|561808270|FG003|Overall Study|Protocol Violation|1|||
155509495|NCT03882047|561291744|FG000|Overall Study|Lost to Follow-up|0|||
155509496|NCT03882047|561291745|FG001|Overall Study|Lost to Follow-up|1|||
155509497|NCT03882047|561291746|FG002|Overall Study|Lost to Follow-up|0|||
155509498|NCT03882047|561291744|FG000|Overall Study|Did Not Wish to Continue|1|||
155509499|NCT03882047|561291745|FG001|Overall Study|Did Not Wish to Continue|4|||
155429042|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429043|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429044|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429045|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
155429046|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155429047|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
155429048|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
155429049|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155429050|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155429051|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155429052|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155429053|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
155429054|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
155429055|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155429056|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
155429057|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
155429058|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155429059|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155429060|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155429061|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155429062|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
155429063|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
155429064|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429065|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155429066|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429067|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429068|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429069|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429070|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429071|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155429072|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155429073|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429074|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
155429075|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429076|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429077|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429078|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429079|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429080|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429081|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155429082|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429083|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
155429084|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429085|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429086|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429087|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429088|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429089|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155429090|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
155429091|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155429092|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
155429093|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
155429094|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155429095|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155429096|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155429097|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155429098|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
155429099|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
155429100|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155509500|NCT03882047|561291746|FG002|Overall Study|Did Not Wish to Continue|1|||
155509501|NCT03882047|561291744|FG000|Overall Study|Noncompliance With Protocol|2|||
155429101|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429102|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
155509502|NCT03882047|561291745|FG001|Overall Study|Noncompliance With Protocol|0|||
155509503|NCT03882047|561291746|FG002|Overall Study|Noncompliance With Protocol|0|||
155509504|NCT03882047|561291744|FG000|Overall Study|Did Not Meet Eligibility|0|||
155509505|NCT03882047|561291745|FG001|Overall Study|Did Not Meet Eligibility|0|||
155509506|NCT03882047|561291746|FG002|Overall Study|Did Not Meet Eligibility|1|||
155509507|NCT00723554|561291747|FG000|Overall Study|Adverse Event|12|||
155509508|NCT00723554|561291747|FG000|Overall Study|Investigator's judgement|5|||
155509509|NCT00723554|561291747|FG000|Overall Study|Inhaled medication other than iloprost|4|||
155509510|NCT00723554|561291747|FG000|Overall Study|Withdrawal of consent|3|||
155509511|NCT00723554|561291747|FG000|Overall Study|Other|3|||
155509512|NCT00723554|561291747|FG000|Overall Study|Lost to Follow-up|1|||
155509513|NCT00723554|561291747|FG000|Overall Study|Non-compliance|1|||
155509514|NCT01894984|561291753|FG000|Overall Study|Other|314|||
155509515|NCT01894984|561291754|FG001|Overall Study|Other|175|||
155509516|NCT00827359|561291755|FG000|Overall Study|Progressive Diseas|19|||
155509517|NCT00827359|561291755|FG000|Overall Study|Unacceptable Toxicity|5|||
155509518|NCT00827359|561291755|FG000|Overall Study|Ineligible|1|||
155509519|NCT02436135|561291756|FG000|Overall Study|Progressive Disease|3|||
155509520|NCT02436135|561291757|FG001|Overall Study|Progressive Disease|1|||
155509521|NCT02436135|561291756|FG000|Overall Study|Investigator Discretion|1|||
155509522|NCT02436135|561291757|FG001|Overall Study|Investigator Discretion|2|||
155509523|NCT02436135|561291756|FG000|Overall Study|Adverse Event|1|||
155509524|NCT02436135|561291757|FG001|Overall Study|Adverse Event|0|||
155509525|NCT02436135|561291756|FG000|Overall Study|Withdrawal by Participant|1|||
155509526|NCT02436135|561291757|FG001|Overall Study|Withdrawal by Participant|0|||
155509527|NCT02436135|561291756|FG000|Overall Study|Study Terminated By Sponsor|0|||
155509528|NCT02436135|561291757|FG001|Overall Study|Study Terminated By Sponsor|1|||
155509529|NCT01809314|561291758|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
155509530|NCT01809314|561291758|FG000|Overall Study|Adverse Event|6|||
155509531|NCT01809314|561291758|FG000|Overall Study|Insufficient Therapeutic Response|14|||
155509532|NCT01809314|561291758|FG000|Overall Study|Lost to Follow-up|724|||
155509533|NCT00297479|561291759|FG000|Overall Study|Lost to Follow-up|37|||
155509534|NCT00297479|561291760|FG001|Overall Study|Lost to Follow-up|54|||
155509535|NCT00297479|561291761|FG002|Overall Study|Lost to Follow-up|51|||
155509536|NCT03263819|561291762|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
155509537|NCT03263819|561291763|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
155509538|NCT01427803|561291764|FG000|Overall Study|Lost to Follow-up|32|||
155509539|NCT01427803|561291765|FG001|Overall Study|Lost to Follow-up|26|||
155509540|NCT01427803|561291764|FG000|Overall Study|Withdrawal by Subject|20|||
155509541|NCT01427803|561291765|FG001|Overall Study|Withdrawal by Subject|0|||
155509542|NCT01427803|561291764|FG000|Overall Study|Unable to complete full treatment period|6|||
155509543|NCT01427803|561291765|FG001|Overall Study|Unable to complete full treatment period|0|||
155509544|NCT01427803|561291764|FG000|Overall Study|Protocol Violation|1|||
155509545|NCT01427803|561291765|FG001|Overall Study|Protocol Violation|0|||
155509546|NCT01427803|561291764|FG000|Overall Study|Physician Decision|3|||
155509547|NCT01427803|561291765|FG001|Overall Study|Physician Decision|0|||
155509548|NCT01427803|561291764|FG000|Overall Study|did not take product|1|||
155369161|NCT01461005|560785246|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
155369162|NCT04954326|560785247|FG000|Overall Study|Protocol Violation|0|||
155369163|NCT04954326|560785248|FG001|Overall Study|Protocol Violation|1|||
155369164|NCT04954326|560785247|FG000|Overall Study|Death|0|||
155369165|NCT04954326|560785248|FG001|Overall Study|Death|2|||
155369166|NCT04954326|560785247|FG000|Overall Study|Physician Decision|0|||
155369167|NCT04954326|560785248|FG001|Overall Study|Physician Decision|1|||
155369168|NCT03083665|560785250|FG000|Double-Blind Period|Adverse Event|5|||
155369169|NCT03083665|560785251|FG001|Double-Blind Period|Adverse Event|4|||
155369170|NCT03083665|560785252|FG002|Double-Blind Period|Adverse Event|5|||
155369171|NCT03083665|560785253|FG003|Double-Blind Period|Adverse Event|0|||
155369172|NCT03083665|560785254|FG004|Double-Blind Period|Adverse Event|0|||
155369173|NCT03083665|560785255|FG005|Double-Blind Period|Adverse Event|0|||
155369174|NCT03083665|560785250|FG000|Double-Blind Period|Lack of Efficacy|0|||
155369175|NCT03083665|560785251|FG001|Double-Blind Period|Lack of Efficacy|0|||
155369176|NCT03083665|560785252|FG002|Double-Blind Period|Lack of Efficacy|1|||
155369177|NCT03083665|560785253|FG003|Double-Blind Period|Lack of Efficacy|0|||
155369178|NCT03083665|560785254|FG004|Double-Blind Period|Lack of Efficacy|0|||
155369179|NCT03083665|560785255|FG005|Double-Blind Period|Lack of Efficacy|0|||
155369180|NCT03083665|560785250|FG000|Double-Blind Period|Protocol Violation|1|||
155509549|NCT01427803|561291765|FG001|Overall Study|did not take product|0|||
155509550|NCT00863057|561291768|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
155509551|NCT00863057|561291769|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
155509552|NCT00863057|561291770|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
155509553|NCT00863057|561291771|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
155509554|NCT00863057|561291768|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
155509555|NCT00863057|561291769|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
155649441|NCT01379937|561808267|FG000|Overall Study|Consent withdrawal|0|||
155369181|NCT03083665|560785251|FG001|Double-Blind Period|Protocol Violation|0|||
155369182|NCT03083665|560785252|FG002|Double-Blind Period|Protocol Violation|1|||
155369183|NCT03083665|560785253|FG003|Double-Blind Period|Protocol Violation|0|||
155369184|NCT03083665|560785254|FG004|Double-Blind Period|Protocol Violation|0|||
155369185|NCT03083665|560785255|FG005|Double-Blind Period|Protocol Violation|0|||
155509556|NCT00863057|561291770|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
155369186|NCT03083665|560785250|FG000|Double-Blind Period|Lost to Follow-up|1|||
155369187|NCT03083665|560785251|FG001|Double-Blind Period|Lost to Follow-up|0|||
155369188|NCT03083665|560785252|FG002|Double-Blind Period|Lost to Follow-up|1|||
155369189|NCT03083665|560785253|FG003|Double-Blind Period|Lost to Follow-up|0|||
155369190|NCT03083665|560785254|FG004|Double-Blind Period|Lost to Follow-up|0|||
155369191|NCT03083665|560785255|FG005|Double-Blind Period|Lost to Follow-up|0|||
155369192|NCT03083665|560785250|FG000|Double-Blind Period|Withdrawal by Subject|3|||
155369193|NCT03083665|560785251|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155369194|NCT03083665|560785252|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155369195|NCT03083665|560785253|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155369196|NCT03083665|560785254|FG004|Double-Blind Period|Withdrawal by Subject|0|||
155369197|NCT03083665|560785255|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155369198|NCT03083665|560785250|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
155509557|NCT00863057|561291771|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
155509558|NCT00863057|561291768|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
155509559|NCT00863057|561291769|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
155509560|NCT00863057|561291770|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
155509561|NCT00863057|561291771|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
155509562|NCT00863057|561291768|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
155509563|NCT00863057|561291769|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
155509564|NCT00863057|561291770|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
155509565|NCT00863057|561291771|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
155509566|NCT03412019|561291772|FG000|Overall Study|Withdrawal by Subject|1|||
155509567|NCT03412019|561291773|FG001|Overall Study|Withdrawal by Subject|1|||
155509568|NCT01698320|561291778|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
155509569|NCT01698320|561291779|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
155509570|NCT01698320|561291780|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
155509571|NCT01698320|561291778|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
155509572|NCT01698320|561291779|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
155509573|NCT01698320|561291780|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
155509574|NCT01698320|561291778|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
155509575|NCT01698320|561291779|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
155509576|NCT01698320|561291780|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
155509577|NCT01698320|561291778|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
155509578|NCT01698320|561291779|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
155509579|NCT01698320|561291780|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
155509580|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Adverse Event|0|||
155509581|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Adverse Event|1|||
155509582|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Adverse Event|1|||
155509583|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
155509584|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
155509585|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
155509586|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
155509587|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
155509588|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
155509589|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Pregnancy|0|||
155509590|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Pregnancy|1|||
155509591|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Pregnancy|1|||
155509592|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
155509593|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
155509594|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
155509595|NCT01698320|561291778|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
155509596|NCT01698320|561291779|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
155509597|NCT01698320|561291780|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
155369199|NCT03083665|560785251|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155369200|NCT03083665|560785252|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155509598|NCT01698320|561291778|FG000|40-Week Open-Label Period|Adverse Event|0|||
155509599|NCT01698320|561291779|FG001|40-Week Open-Label Period|Adverse Event|3|||
155509600|NCT01698320|561291780|FG002|40-Week Open-Label Period|Adverse Event|2|||
155509601|NCT01698320|561291778|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
155509602|NCT01698320|561291779|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
155509603|NCT01698320|561291780|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
155509604|NCT01698320|561291778|FG000|40-Week Open-Label Period|Pregnancy|0|||
155369201|NCT03083665|560785253|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155369202|NCT03083665|560785254|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155369203|NCT03083665|560785255|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155509605|NCT01698320|561291779|FG001|40-Week Open-Label Period|Pregnancy|2|||
155509606|NCT01698320|561291780|FG002|40-Week Open-Label Period|Pregnancy|1|||
155509607|NCT01698320|561291778|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
155509608|NCT01698320|561291779|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
155509609|NCT01698320|561291780|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
155509610|NCT01698320|561291778|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
155509611|NCT01698320|561291779|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
155509612|NCT01698320|561291780|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
155509613|NCT00686920|561291782|FG000|Overall Study|Death|45|||
155509614|NCT00686920|561291783|FG001|Overall Study|Death|14|||
155509615|NCT00686920|561291782|FG000|Overall Study|Liver Transplant|23|||
155509616|NCT00686920|561291783|FG001|Overall Study|Liver Transplant|8|||
155509617|NCT00686920|561291782|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
155509618|NCT00686920|561291783|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
155509619|NCT00686920|561291782|FG000|Overall Study|Withdrawal by Subject|23|||
155509620|NCT00686920|561291783|FG001|Overall Study|Withdrawal by Subject|5|||
155369204|NCT03083665|560785250|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369205|NCT03083665|560785251|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
155369206|NCT03083665|560785252|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369207|NCT03083665|560785253|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369208|NCT03083665|560785254|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369209|NCT03083665|560785255|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369210|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369211|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369212|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369213|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
155369214|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369215|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369216|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369217|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369218|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369219|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369220|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369221|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
155369222|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369223|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369224|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369225|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369226|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369227|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369228|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369229|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369230|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369231|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369232|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369233|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
155369234|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369235|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369236|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369237|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
155369238|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369239|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369240|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369241|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369242|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369243|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155509621|NCT00686920|561291782|FG000|Overall Study|Protocol Violation|2|||
155509622|NCT00686920|561291783|FG001|Overall Study|Protocol Violation|1|||
155509623|NCT00686920|561291782|FG000|Overall Study|Adverse Event|10|||
155509624|NCT00686920|561291783|FG001|Overall Study|Adverse Event|2|||
155509625|NCT00686920|561291782|FG000|Overall Study|Personal Reason|0|||
155509626|NCT00686920|561291783|FG001|Overall Study|Personal Reason|1|||
155509627|NCT00686920|561291782|FG000|Overall Study|Lost to Follow-up|15|||
155509628|NCT00686920|561291783|FG001|Overall Study|Lost to Follow-up|3|||
155509629|NCT00686920|561291782|FG000|Overall Study|Moved to Another State|1|||
155509630|NCT00686920|561291783|FG001|Overall Study|Moved to Another State|0|||
155509631|NCT00686920|561291782|FG000|Overall Study|Transferred to Nursing Home|1|||
155509632|NCT00686920|561291783|FG001|Overall Study|Transferred to Nursing Home|0|||
155509633|NCT00686920|561291782|FG000|Overall Study|Noncompliance|9|||
155509634|NCT00686920|561291783|FG001|Overall Study|Noncompliance|0|||
155509635|NCT00686920|561291782|FG000|Overall Study|Principal Investigator Decision|2|||
155509636|NCT00686920|561291783|FG001|Overall Study|Principal Investigator Decision|0|||
155509637|NCT01107535|561291787|FG000|Overall Study|Death|5|||
155509638|NCT01155583|561291788|FG000|Phase I|Screen failure - did not start treatment|0|||
155509639|NCT01155583|561291789|FG001|Phase I|Screen failure - did not start treatment|0|||
155509640|NCT01155583|561291790|FG002|Phase I|Screen failure - did not start treatment|0|||
155509641|NCT01155583|561291791|FG003|Phase I|Screen failure - did not start treatment|0|||
155509642|NCT01155583|561291792|FG004|Phase I|Screen failure - did not start treatment|1|||
155509643|NCT01155583|561291793|FG005|Phase I|Screen failure - did not start treatment|0|||
155509644|NCT01155583|561291794|FG006|Phase I|Screen failure - did not start treatment|0|||
155509645|NCT01155583|561291795|FG007|Phase I|Screen failure - did not start treatment|2|||
155509646|NCT01155583|561291796|FG008|Phase I|Screen failure - did not start treatment|0|||
155509647|NCT01155583|561291788|FG000|Phase I|Withdrawal by Subject|0|||
155509648|NCT01155583|561291789|FG001|Phase I|Withdrawal by Subject|0|||
155509649|NCT01155583|561291790|FG002|Phase I|Withdrawal by Subject|0|||
155509650|NCT01155583|561291791|FG003|Phase I|Withdrawal by Subject|0|||
155509651|NCT01155583|561291792|FG004|Phase I|Withdrawal by Subject|0|||
155509652|NCT01155583|561291793|FG005|Phase I|Withdrawal by Subject|0|||
155509653|NCT01155583|561291794|FG006|Phase I|Withdrawal by Subject|0|||
155509654|NCT01155583|561291795|FG007|Phase I|Withdrawal by Subject|1|||
155509655|NCT01155583|561291796|FG008|Phase I|Withdrawal by Subject|0|||
155509656|NCT02040766|561291803|FG000|Overall Study|Adverse Event|1|||
155509657|NCT02040766|561291804|FG001|Overall Study|Adverse Event|1|||
155509658|NCT02040766|561291805|FG002|Overall Study|Adverse Event|1|||
155509659|NCT02040766|561291806|FG003|Overall Study|Adverse Event|0|||
155509660|NCT02040766|561291807|FG004|Overall Study|Adverse Event|2|||
155509661|NCT02040766|561291803|FG000|Overall Study|Withdrawal by Subject|4|||
155509662|NCT02040766|561291804|FG001|Overall Study|Withdrawal by Subject|3|||
155509663|NCT02040766|561291805|FG002|Overall Study|Withdrawal by Subject|2|||
155509664|NCT02040766|561291806|FG003|Overall Study|Withdrawal by Subject|3|||
155509665|NCT02040766|561291807|FG004|Overall Study|Withdrawal by Subject|2|||
155509666|NCT02040766|561291803|FG000|Overall Study|Non-compliance|0|||
155509667|NCT02040766|561291804|FG001|Overall Study|Non-compliance|1|||
155509668|NCT02040766|561291805|FG002|Overall Study|Non-compliance|0|||
155509669|NCT02040766|561291806|FG003|Overall Study|Non-compliance|0|||
155509670|NCT02040766|561291807|FG004|Overall Study|Non-compliance|0|||
155509671|NCT02040766|561291803|FG000|Overall Study|Protocol Violation|2|||
155509672|NCT02040766|561291804|FG001|Overall Study|Protocol Violation|1|||
155509673|NCT02040766|561291805|FG002|Overall Study|Protocol Violation|2|||
155509674|NCT02040766|561291806|FG003|Overall Study|Protocol Violation|3|||
155509675|NCT02040766|561291807|FG004|Overall Study|Protocol Violation|0|||
155509676|NCT02040766|561291803|FG000|Overall Study|Lost to Follow-up|4|||
155369244|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369245|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
155369246|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369247|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155509677|NCT02040766|561291804|FG001|Overall Study|Lost to Follow-up|1|||
155509678|NCT02040766|561291805|FG002|Overall Study|Lost to Follow-up|3|||
155509679|NCT02040766|561291806|FG003|Overall Study|Lost to Follow-up|1|||
155509680|NCT02040766|561291807|FG004|Overall Study|Lost to Follow-up|4|||
155509681|NCT02040766|561291803|FG000|Overall Study|Not reported|1|||
155509682|NCT02040766|561291804|FG001|Overall Study|Not reported|0|||
155509683|NCT02040766|561291805|FG002|Overall Study|Not reported|0|||
155509684|NCT02040766|561291806|FG003|Overall Study|Not reported|0|||
155509685|NCT02040766|561291807|FG004|Overall Study|Not reported|0|||
155509686|NCT02040766|561291803|FG000|Overall Study|Lack of Efficacy|6|||
155509687|NCT02040766|561291804|FG001|Overall Study|Lack of Efficacy|3|||
155509688|NCT02040766|561291805|FG002|Overall Study|Lack of Efficacy|4|||
155509689|NCT02040766|561291806|FG003|Overall Study|Lack of Efficacy|6|||
155509690|NCT02040766|561291807|FG004|Overall Study|Lack of Efficacy|5|||
155509691|NCT00602030|561291808|FG000|Lead-in Phase|Disease Progression|2|||
155509692|NCT00602030|561291809|FG001|Lead-in Phase|Disease Progression|3|||
155509693|NCT00602030|561291810|FG002|Lead-in Phase|Disease Progression|0|||
155369248|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369249|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155649442|NCT01379937|561808268|FG001|Overall Study|Consent withdrawal|1|||
155369250|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369251|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
155369252|NCT03635099|560785256|FG000|Period 1|Adverse Event|1|||
155369253|NCT03635099|560785257|FG001|Period 1|Adverse Event|0|||
155369254|NCT03635099|560785258|FG002|Period 1|Adverse Event|0|||
155369255|NCT03635099|560785259|FG003|Period 1|Adverse Event|1|||
155369256|NCT03635099|560785260|FG004|Period 1|Adverse Event|0|||
155369257|NCT03635099|560785261|FG005|Period 1|Adverse Event|0|||
155369258|NCT03635099|560785262|FG006|Period 1|Adverse Event|0|||
155369259|NCT03635099|560785263|FG007|Period 1|Adverse Event|0|||
155369260|NCT03635099|560785256|FG000|Period 1|Protocol Violation|0|||
155369261|NCT03635099|560785257|FG001|Period 1|Protocol Violation|0|||
155369262|NCT03635099|560785258|FG002|Period 1|Protocol Violation|1|||
155369263|NCT03635099|560785259|FG003|Period 1|Protocol Violation|0|||
155369264|NCT03635099|560785260|FG004|Period 1|Protocol Violation|0|||
155369265|NCT03635099|560785261|FG005|Period 1|Protocol Violation|0|||
155369266|NCT03635099|560785262|FG006|Period 1|Protocol Violation|0|||
155369267|NCT03635099|560785263|FG007|Period 1|Protocol Violation|0|||
155369268|NCT03635099|560785256|FG000|Period 1|Lost to Follow-up|0|||
155369269|NCT03635099|560785257|FG001|Period 1|Lost to Follow-up|0|||
155369270|NCT03635099|560785258|FG002|Period 1|Lost to Follow-up|1|||
155369271|NCT03635099|560785259|FG003|Period 1|Lost to Follow-up|2|||
155369272|NCT03635099|560785260|FG004|Period 1|Lost to Follow-up|1|||
155369273|NCT03635099|560785261|FG005|Period 1|Lost to Follow-up|0|||
155369274|NCT03635099|560785262|FG006|Period 1|Lost to Follow-up|1|||
155369275|NCT03635099|560785263|FG007|Period 1|Lost to Follow-up|2|||
155369276|NCT03635099|560785256|FG000|Period 1|Withdrawal by Subject|3|||
155369277|NCT03635099|560785257|FG001|Period 1|Withdrawal by Subject|3|||
155369278|NCT03635099|560785258|FG002|Period 1|Withdrawal by Subject|5|||
155369279|NCT03635099|560785259|FG003|Period 1|Withdrawal by Subject|2|||
155369280|NCT03635099|560785260|FG004|Period 1|Withdrawal by Subject|2|||
155369281|NCT03635099|560785261|FG005|Period 1|Withdrawal by Subject|0|||
155369282|NCT03635099|560785262|FG006|Period 1|Withdrawal by Subject|3|||
155369283|NCT03635099|560785263|FG007|Period 1|Withdrawal by Subject|0|||
155429103|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429104|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429105|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429106|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429107|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429108|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155429109|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429110|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429111|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429112|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429113|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429114|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429115|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429116|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
155429117|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155429118|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429119|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
155429120|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
155429121|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429122|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429123|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429124|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429125|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155429126|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
155429127|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155369284|NCT03635099|560785256|FG000|Period 1|History of suicidal ideation|0|||
155369285|NCT03635099|560785257|FG001|Period 1|History of suicidal ideation|0|||
155369286|NCT03635099|560785258|FG002|Period 1|History of suicidal ideation|1|||
155429128|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
155509694|NCT00602030|561291811|FG003|Lead-in Phase|Disease Progression|0|||
155509695|NCT00602030|561291812|FG004|Lead-in Phase|Disease Progression|0|||
155369287|NCT03635099|560785259|FG003|Period 1|History of suicidal ideation|0|||
155369288|NCT03635099|560785260|FG004|Period 1|History of suicidal ideation|0|||
155369289|NCT03635099|560785261|FG005|Period 1|History of suicidal ideation|0|||
155369290|NCT03635099|560785262|FG006|Period 1|History of suicidal ideation|0|||
155369291|NCT03635099|560785263|FG007|Period 1|History of suicidal ideation|0|||
155369292|NCT03635099|560785256|FG000|Period 1|pursue other treatment options|0|||
155369293|NCT03635099|560785257|FG001|Period 1|pursue other treatment options|0|||
155369294|NCT03635099|560785258|FG002|Period 1|pursue other treatment options|0|||
155369295|NCT03635099|560785259|FG003|Period 1|pursue other treatment options|0|||
155369296|NCT03635099|560785260|FG004|Period 1|pursue other treatment options|0|||
155369297|NCT03635099|560785261|FG005|Period 1|pursue other treatment options|1|||
155369298|NCT03635099|560785262|FG006|Period 1|pursue other treatment options|0|||
155369299|NCT03635099|560785263|FG007|Period 1|pursue other treatment options|0|||
155369300|NCT03635099|560785256|FG000|Not Eligible for Period 2|Pregnancy|0|||
155369301|NCT03635099|560785257|FG001|Not Eligible for Period 2|Pregnancy|0|||
155369302|NCT03635099|560785258|FG002|Not Eligible for Period 2|Pregnancy|0|||
155369303|NCT03635099|560785259|FG003|Not Eligible for Period 2|Pregnancy|1|||
155369304|NCT03635099|560785260|FG004|Not Eligible for Period 2|Pregnancy|0|||
155369305|NCT03635099|560785261|FG005|Not Eligible for Period 2|Pregnancy|0|||
155369306|NCT03635099|560785262|FG006|Not Eligible for Period 2|Pregnancy|0|||
155369307|NCT03635099|560785263|FG007|Not Eligible for Period 2|Pregnancy|0|||
155369308|NCT03635099|560785256|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
155369309|NCT03635099|560785257|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369310|NCT03635099|560785258|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369311|NCT03635099|560785259|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369312|NCT03635099|560785260|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369313|NCT03635099|560785261|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369314|NCT03635099|560785262|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369315|NCT03635099|560785263|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369316|NCT03635099|560785256|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369317|NCT03635099|560785257|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369318|NCT03635099|560785258|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369319|NCT03635099|560785259|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369320|NCT03635099|560785260|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369321|NCT03635099|560785261|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
155369322|NCT03635099|560785262|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
155369323|NCT03635099|560785263|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
155369324|NCT03635099|560785256|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
155369325|NCT03635099|560785257|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
155369326|NCT03635099|560785258|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
155369327|NCT03635099|560785259|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
155369328|NCT03635099|560785260|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369329|NCT03635099|560785261|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369330|NCT03635099|560785262|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369331|NCT03635099|560785263|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369332|NCT03635099|560785256|FG000|Period 2|Adverse Event|0|||
155369333|NCT03635099|560785257|FG001|Period 2|Adverse Event|0|||
155369334|NCT03635099|560785258|FG002|Period 2|Adverse Event|1|||
155369335|NCT03635099|560785259|FG003|Period 2|Adverse Event|0|||
155369336|NCT03635099|560785260|FG004|Period 2|Adverse Event|1|||
155369337|NCT03635099|560785261|FG005|Period 2|Adverse Event|0|||
155369338|NCT03635099|560785262|FG006|Period 2|Adverse Event|0|||
155369339|NCT03635099|560785263|FG007|Period 2|Adverse Event|0|||
155369340|NCT03635099|560785256|FG000|Period 2|Lost to Follow-up|0|||
155369341|NCT03635099|560785257|FG001|Period 2|Lost to Follow-up|0|||
155369342|NCT03635099|560785258|FG002|Period 2|Lost to Follow-up|1|||
155369343|NCT03635099|560785259|FG003|Period 2|Lost to Follow-up|0|||
155369344|NCT03635099|560785260|FG004|Period 2|Lost to Follow-up|4|||
155369345|NCT03635099|560785261|FG005|Period 2|Lost to Follow-up|0|||
155369346|NCT03635099|560785262|FG006|Period 2|Lost to Follow-up|0|||
155369347|NCT03635099|560785263|FG007|Period 2|Lost to Follow-up|0|||
155369348|NCT03635099|560785256|FG000|Period 2|Withdrawal by Subject|0|||
155369349|NCT03635099|560785257|FG001|Period 2|Withdrawal by Subject|0|||
155369350|NCT03635099|560785258|FG002|Period 2|Withdrawal by Subject|7|||
155369351|NCT03635099|560785259|FG003|Period 2|Withdrawal by Subject|4|||
155369352|NCT03635099|560785260|FG004|Period 2|Withdrawal by Subject|7|||
155369353|NCT03635099|560785261|FG005|Period 2|Withdrawal by Subject|0|||
155369354|NCT03635099|560785262|FG006|Period 2|Withdrawal by Subject|0|||
155369355|NCT03635099|560785263|FG007|Period 2|Withdrawal by Subject|0|||
155369356|NCT01289210|560785264|FG000|Overall Study|Adverse Event|1|||
155369357|NCT06285240|560785265|FG000|Overall Study|Withdrawal by Subject|2|||
155369358|NCT06285240|560785266|FG001|Overall Study|Withdrawal by Subject|0|||
155369359|NCT06285240|560785267|FG002|Overall Study|Withdrawal by Subject|0|||
155369360|NCT06285240|560785268|FG003|Overall Study|Withdrawal by Subject|0|||
155369361|NCT06285240|560785265|FG000|Overall Study|Serious Adverse Event|0|||
155369362|NCT06285240|560785266|FG001|Overall Study|Serious Adverse Event|0|||
155369363|NCT06285240|560785267|FG002|Overall Study|Serious Adverse Event|1|||
155369364|NCT06285240|560785268|FG003|Overall Study|Serious Adverse Event|0|||
155369365|NCT05140915|560785271|FG000|Overall Study|Lost to Follow-up|2|||
155369366|NCT05140915|560785272|FG001|Overall Study|Lost to Follow-up|1|||
155369367|NCT04520659|560785273|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
155369368|NCT04520659|560785274|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
155369369|NCT04520659|560785275|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
155369370|NCT04520659|560785276|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
155369371|NCT04485611|560785281|FG000|Prehabilitation|Physician Decision|1|||
155369372|NCT04879849|560785282|FG000|Overall Study|Lost to Follow-up|0|||
155369373|NCT04879849|560785283|FG001|Overall Study|Lost to Follow-up|0|||
155369374|NCT04879849|560785284|FG002|Overall Study|Lost to Follow-up|0|||
155369375|NCT04879849|560785285|FG003|Overall Study|Lost to Follow-up|1|||
155369376|NCT04879849|560785286|FG004|Overall Study|Lost to Follow-up|0|||
155369377|NCT04879849|560785287|FG005|Overall Study|Lost to Follow-up|0|||
155369378|NCT04879849|560785288|FG006|Overall Study|Lost to Follow-up|0|||
155369379|NCT04879849|560785289|FG007|Overall Study|Lost to Follow-up|0|||
155369380|NCT04879849|560785282|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
155369381|NCT04879849|560785283|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
155369382|NCT04879849|560785284|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
155369383|NCT04879849|560785285|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
155369384|NCT04879849|560785286|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
155369385|NCT04879849|560785287|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
155369386|NCT04879849|560785288|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
155369387|NCT04879849|560785289|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
155369388|NCT04879849|560785282|FG000|Overall Study|Withdrawal by Subject|0|||
155369389|NCT04879849|560785283|FG001|Overall Study|Withdrawal by Subject|0|||
155369390|NCT04879849|560785284|FG002|Overall Study|Withdrawal by Subject|0|||
155369391|NCT04879849|560785285|FG003|Overall Study|Withdrawal by Subject|0|||
155369392|NCT04879849|560785286|FG004|Overall Study|Withdrawal by Subject|2|||
155369393|NCT04879849|560785287|FG005|Overall Study|Withdrawal by Subject|0|||
155369394|NCT04879849|560785288|FG006|Overall Study|Withdrawal by Subject|1|||
155369395|NCT04879849|560785289|FG007|Overall Study|Withdrawal by Subject|0|||
155369396|NCT04879849|560785282|FG000|Overall Study|Progressive Disease|0|||
155369397|NCT04879849|560785283|FG001|Overall Study|Progressive Disease|0|||
155369398|NCT04879849|560785284|FG002|Overall Study|Progressive Disease|1|||
155369399|NCT04879849|560785285|FG003|Overall Study|Progressive Disease|0|||
155369400|NCT04879849|560785286|FG004|Overall Study|Progressive Disease|0|||
155369401|NCT04879849|560785287|FG005|Overall Study|Progressive Disease|0|||
155369402|NCT04879849|560785288|FG006|Overall Study|Progressive Disease|0|||
155369403|NCT04879849|560785289|FG007|Overall Study|Progressive Disease|0|||
155369404|NCT04879849|560785282|FG000|Overall Study|Death|0|||
155369405|NCT04879849|560785283|FG001|Overall Study|Death|0|||
155369406|NCT04879849|560785284|FG002|Overall Study|Death|1|||
155369407|NCT04879849|560785285|FG003|Overall Study|Death|1|||
155369408|NCT04879849|560785286|FG004|Overall Study|Death|1|||
155369409|NCT04879849|560785287|FG005|Overall Study|Death|2|||
155369410|NCT04879849|560785288|FG006|Overall Study|Death|1|||
155429129|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
155369411|NCT04879849|560785289|FG007|Overall Study|Death|2|||
155369412|NCT04879849|560785282|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369413|NCT04879849|560785283|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
155429130|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155429131|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155649443|NCT01379937|561808269|FG002|Overall Study|Consent withdrawal|0|||
155649444|NCT01379937|561808270|FG003|Overall Study|Consent withdrawal|0|||
155649445|NCT01379937|561808267|FG000|Overall Study|Lost to Follow-up|1|||
155369414|NCT04879849|560785284|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369415|NCT04879849|560785285|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
155369416|NCT04879849|560785286|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
155369417|NCT04879849|560785287|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
155369418|NCT04879849|560785288|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369419|NCT04879849|560785289|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369420|NCT04879849|560785282|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369421|NCT04879849|560785283|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369422|NCT04879849|560785284|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369423|NCT04879849|560785285|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369424|NCT04879849|560785286|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369425|NCT04879849|560785287|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369426|NCT04879849|560785288|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
155369427|NCT04879849|560785289|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369428|NCT04879849|560785282|FG000|Overall Study|Reason Not Specified|1|||
155369429|NCT04879849|560785283|FG001|Overall Study|Reason Not Specified|0|||
155369430|NCT04879849|560785284|FG002|Overall Study|Reason Not Specified|0|||
155369431|NCT04879849|560785285|FG003|Overall Study|Reason Not Specified|0|||
155369432|NCT04879849|560785286|FG004|Overall Study|Reason Not Specified|0|||
155369433|NCT04879849|560785287|FG005|Overall Study|Reason Not Specified|0|||
155369434|NCT04879849|560785288|FG006|Overall Study|Reason Not Specified|0|||
155369435|NCT04879849|560785289|FG007|Overall Study|Reason Not Specified|0|||
155369436|NCT03361865|560785290|FG000|Overall Study|Death|17|||
155369437|NCT03361865|560785291|FG001|Overall Study|Death|18|||
155369438|NCT03361865|560785290|FG000|Overall Study|Physician Decision|1|||
155369439|NCT03361865|560785291|FG001|Overall Study|Physician Decision|9|||
155369440|NCT03361865|560785290|FG000|Overall Study|Withdrawal by Subject|1|||
155369441|NCT03361865|560785291|FG001|Overall Study|Withdrawal by Subject|0|||
155369442|NCT02819024|560785293|FG000|Overall Study|Withdrawal by Subject|1|||
155369443|NCT03551691|560785297|FG000|Overall Study|Withdrawal by Subject|3|||
155369444|NCT03551691|560785298|FG001|Overall Study|Withdrawal by Subject|3|||
155369445|NCT02367040|560785299|FG000|Overall Study|Lost to Follow-up|1|||
155369446|NCT02367040|560785300|FG001|Overall Study|Lost to Follow-up|1|||
155369447|NCT02367040|560785299|FG000|Overall Study|Lack of Efficacy|1|||
155369448|NCT02367040|560785300|FG001|Overall Study|Lack of Efficacy|0|||
155369449|NCT02367040|560785299|FG000|Overall Study|Additional primary malignancy|1|||
155369450|NCT02367040|560785300|FG001|Overall Study|Additional primary malignancy|1|||
155369451|NCT02367040|560785299|FG000|Overall Study|AE not associated with clinical disease progression|117|||
155369452|NCT02367040|560785300|FG001|Overall Study|AE not associated with clinical disease progression|12|||
155369453|NCT02367040|560785299|FG000|Overall Study|AE associated with clinical disease progression|1|||
155369454|NCT02367040|560785300|FG001|Overall Study|AE associated with clinical disease progression|4|||
155369455|NCT02367040|560785299|FG000|Overall Study|Physician Decision|2|||
155369456|NCT02367040|560785300|FG001|Overall Study|Physician Decision|8|||
155369457|NCT02367040|560785299|FG000|Overall Study|Non-compliance to study drug|1|||
155369458|NCT02367040|560785300|FG001|Overall Study|Non-compliance to study drug|0|||
155369459|NCT02367040|560785299|FG000|Overall Study|Failure to meet continuation criteria|1|||
155369460|NCT02367040|560785300|FG001|Overall Study|Failure to meet continuation criteria|0|||
155369461|NCT02367040|560785299|FG000|Overall Study|Switching to other therapy|2|||
155369462|NCT02367040|560785300|FG001|Overall Study|Switching to other therapy|0|||
155649446|NCT01379937|561808268|FG001|Overall Study|Lost to Follow-up|2|||
155649447|NCT01379937|561808269|FG002|Overall Study|Lost to Follow-up|2|||
155369463|NCT02367040|560785299|FG000|Overall Study|Withdrawal by Subject|51|||
155369464|NCT02367040|560785300|FG001|Overall Study|Withdrawal by Subject|16|||
155369465|NCT02367040|560785299|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
155369466|NCT02367040|560785300|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155369467|NCT02367040|560785299|FG000|Overall Study|Patient decision|40|||
155369468|NCT02367040|560785300|FG001|Overall Study|Patient decision|14|||
155369469|NCT02367040|560785299|FG000|Overall Study|Required procedure failed|1|||
155369470|NCT02367040|560785300|FG001|Overall Study|Required procedure failed|0|||
155369471|NCT02367040|560785299|FG000|Overall Study|Randomized by mistake with study treatment|1|||
155369472|NCT02367040|560785300|FG001|Overall Study|Randomized by mistake with study treatment|0|||
155369473|NCT02367040|560785299|FG000|Overall Study|Protocol Violation|1|||
155369474|NCT02367040|560785300|FG001|Overall Study|Protocol Violation|0|||
155369475|NCT02367040|560785299|FG000|Overall Study|Progressive disease - radiological progression|54|||
155369476|NCT02367040|560785300|FG001|Overall Study|Progressive disease - radiological progression|80|||
155369477|NCT02367040|560785299|FG000|Overall Study|Progressive disease - clinical progression|6|||
155369478|NCT02367040|560785300|FG001|Overall Study|Progressive disease - clinical progression|6|||
155369479|NCT02367040|560785299|FG000|Overall Study|Drug not administered|3|||
155369480|NCT02367040|560785300|FG001|Overall Study|Drug not administered|2|||
155369481|NCT02367040|560785299|FG000|Overall Study|Progressive disease|0|||
155369482|NCT02367040|560785300|FG001|Overall Study|Progressive disease|1|||
155369483|NCT02367040|560785299|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
155369484|NCT02367040|560785300|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
155369485|NCT02367040|560785299|FG000|Overall Study|Death|2|||
155369486|NCT02367040|560785300|FG001|Overall Study|Death|0|||
155369487|NCT02367040|560785299|FG000|Overall Study|Study terminated by sponsor|19|||
155369488|NCT02367040|560785300|FG001|Overall Study|Study terminated by sponsor|2|||
155369489|NCT02477618|560785301|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
155369490|NCT02477618|560785302|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
155369491|NCT02477618|560785301|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
155369492|NCT02477618|560785302|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
155369493|NCT02477618|560785301|FG000|Overall Study|Adverse Event|1|||
155369494|NCT02477618|560785302|FG001|Overall Study|Adverse Event|1|||
155369495|NCT02477618|560785301|FG000|Overall Study|Transferred Away from Study Site|1|||
155429132|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155429133|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155429134|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155429135|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155429136|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429137|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
155429138|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
155429139|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429140|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429141|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429142|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429143|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155429144|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155429145|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429146|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
155429147|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429148|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429149|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429150|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429151|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429152|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429153|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
155429154|NCT01307423|560996131|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155429155|NCT01307423|560996132|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155369496|NCT02477618|560785302|FG001|Overall Study|Transferred Away from Study Site|0|||
155369497|NCT02477618|560785301|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
155429156|NCT01307423|560996133|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
155369498|NCT02477618|560785302|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
155369499|NCT02446821|560785303|FG000|Overall Study|Adverse Event|28|||
155369500|NCT02446821|560785303|FG000|Overall Study|Withdrawal by Subject|6|||
155369501|NCT02446821|560785303|FG000|Overall Study|Lost to Follow-up|22|||
155369502|NCT02446821|560785303|FG000|Overall Study|other|9|||
155369503|NCT02446821|560785303|FG000|Overall Study|insertion failure|3|||
155369504|NCT03007420|560785304|FG000|Overall Study|Withdrawal by Subject|0|||
155369505|NCT03007420|560785305|FG001|Overall Study|Withdrawal by Subject|2|||
155369506|NCT03007420|560785304|FG000|Overall Study|Physician Decision|0|||
155369507|NCT03007420|560785305|FG001|Overall Study|Physician Decision|1|||
155369508|NCT02284009|560785309|FG000|Overall Study|Adverse Event|3|||
155369509|NCT02284009|560785310|FG001|Overall Study|Adverse Event|0|||
155369510|NCT02284009|560785309|FG000|Overall Study|Lost to Follow-up|1|||
155369511|NCT02284009|560785310|FG001|Overall Study|Lost to Follow-up|3|||
155369512|NCT02284009|560785309|FG000|Overall Study|Physician Decision|0|||
155369513|NCT02284009|560785310|FG001|Overall Study|Physician Decision|2|||
155369514|NCT02284009|560785309|FG000|Overall Study|Withdrawal by Subject|2|||
155369515|NCT02284009|560785310|FG001|Overall Study|Withdrawal by Subject|5|||
155369516|NCT03841526|560785311|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
155369517|NCT03841526|560785312|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369518|NCT03841526|560785313|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369519|NCT03841526|560785314|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
155369520|NCT03841526|560785315|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369521|NCT03841526|560785316|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369522|NCT03841526|560785311|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
155369523|NCT03841526|560785312|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
155369524|NCT03841526|560785313|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
155369525|NCT03841526|560785314|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
155369526|NCT03841526|560785315|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
155369527|NCT03841526|560785316|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
155369528|NCT03841526|560785311|FG000|Outpatient Phase Treatment|Physician Decision|0|||
155369529|NCT03841526|560785312|FG001|Outpatient Phase Treatment|Physician Decision|1|||
155369530|NCT03841526|560785313|FG002|Outpatient Phase Treatment|Physician Decision|0|||
155369531|NCT03841526|560785314|FG003|Outpatient Phase Treatment|Physician Decision|0|||
155369532|NCT03841526|560785315|FG004|Outpatient Phase Treatment|Physician Decision|0|||
155369533|NCT03841526|560785316|FG005|Outpatient Phase Treatment|Physician Decision|0|||
155369534|NCT03841526|560785311|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369535|NCT03841526|560785312|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369536|NCT03841526|560785313|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
155369537|NCT03841526|560785314|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369538|NCT03841526|560785315|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369539|NCT03841526|560785316|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
155369540|NCT01876082|560787758|FG000|Overall Study|Withdrawal by Subject|0|||
155369541|NCT01876082|560787759|FG001|Overall Study|Withdrawal by Subject|2|||
155369542|NCT01876082|560787758|FG000|Overall Study|Protocol Violation|1|||
155369543|NCT01876082|560787759|FG001|Overall Study|Protocol Violation|0|||
155369544|NCT01876082|560787758|FG000|Overall Study|Adverse Event|1|||
155369545|NCT01876082|560787759|FG001|Overall Study|Adverse Event|1|||
155369546|NCT01876082|560787758|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
155369547|NCT01876082|560787759|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
155369548|NCT03829501|560787770|FG000|Overall Study|Withdrawal of Consent|2|||
155369549|NCT03829501|560787771|FG001|Overall Study|Withdrawal of Consent|0|||
155369550|NCT03829501|560787772|FG002|Overall Study|Withdrawal of Consent|3|||
155369551|NCT03829501|560787773|FG003|Overall Study|Withdrawal of Consent|0|||
155369552|NCT03829501|560787774|FG004|Overall Study|Withdrawal of Consent|1|||
155369553|NCT03829501|560787775|FG005|Overall Study|Withdrawal of Consent|1|||
155369554|NCT03829501|560787776|FG006|Overall Study|Withdrawal of Consent|0|||
155369555|NCT03829501|560787777|FG007|Overall Study|Withdrawal of Consent|10|||
155369556|NCT03829501|560787778|FG008|Overall Study|Withdrawal of Consent|10|||
155369557|NCT03829501|560787779|FG009|Overall Study|Withdrawal of Consent|3|||
155369558|NCT03829501|560787780|FG010|Overall Study|Withdrawal of Consent|4|||
155369559|NCT03829501|560787781|FG011|Overall Study|Withdrawal of Consent|4|||
155369560|NCT03829501|560787782|FG012|Overall Study|Withdrawal of Consent|4|||
155369561|NCT03829501|560787783|FG013|Overall Study|Withdrawal of Consent|0|||
155369562|NCT03829501|560787784|FG014|Overall Study|Withdrawal of Consent|3|||
155369563|NCT03829501|560787785|FG015|Overall Study|Withdrawal of Consent|0|||
155369564|NCT03829501|560787786|FG016|Overall Study|Withdrawal of Consent|1|||
155429157|NCT01307423|560996134|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155429158|NCT01307423|560996135|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155429159|NCT01307423|560996136|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155429160|NCT01307423|560996137|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155369565|NCT03829501|560787787|FG017|Overall Study|Withdrawal of Consent|1|||
155369566|NCT03829501|560787788|FG018|Overall Study|Withdrawal of Consent|0|||
155369567|NCT03829501|560787789|FG019|Overall Study|Withdrawal of Consent|0|||
155369568|NCT03829501|560787790|FG020|Overall Study|Withdrawal of Consent|3|||
155509696|NCT00602030|561291808|FG000|Lead-in Phase|Adverse Event|0|||
155509697|NCT00602030|561291809|FG001|Lead-in Phase|Adverse Event|2|||
155509698|NCT00602030|561291810|FG002|Lead-in Phase|Adverse Event|0|||
155509699|NCT00602030|561291811|FG003|Lead-in Phase|Adverse Event|0|||
155369569|NCT03829501|560787791|FG021|Overall Study|Withdrawal of Consent|0|||
155369570|NCT03829501|560787792|FG022|Overall Study|Withdrawal of Consent|1|||
155369571|NCT03829501|560787770|FG000|Overall Study|PD|0|||
155369572|NCT03829501|560787771|FG001|Overall Study|PD|0|||
155369573|NCT03829501|560787772|FG002|Overall Study|PD|0|||
155369574|NCT03829501|560787773|FG003|Overall Study|PD|2|||
155369575|NCT03829501|560787774|FG004|Overall Study|PD|0|||
155369576|NCT03829501|560787775|FG005|Overall Study|PD|0|||
155369577|NCT03829501|560787776|FG006|Overall Study|PD|0|||
155369578|NCT03829501|560787777|FG007|Overall Study|PD|0|||
155369579|NCT03829501|560787778|FG008|Overall Study|PD|0|||
155369580|NCT03829501|560787779|FG009|Overall Study|PD|0|||
155369581|NCT03829501|560787780|FG010|Overall Study|PD|0|||
155369582|NCT03829501|560787781|FG011|Overall Study|PD|0|||
155369583|NCT03829501|560787782|FG012|Overall Study|PD|0|||
155369584|NCT03829501|560787783|FG013|Overall Study|PD|0|||
155369585|NCT03829501|560787784|FG014|Overall Study|PD|0|||
155369586|NCT03829501|560787785|FG015|Overall Study|PD|1|||
155369587|NCT03829501|560787786|FG016|Overall Study|PD|0|||
155369588|NCT03829501|560787787|FG017|Overall Study|PD|0|||
155369589|NCT03829501|560787788|FG018|Overall Study|PD|0|||
155369590|NCT03829501|560787789|FG019|Overall Study|PD|0|||
155369591|NCT03829501|560787790|FG020|Overall Study|PD|1|||
155369592|NCT03829501|560787791|FG021|Overall Study|PD|0|||
155429161|NCT01307423|560996138|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
155429162|NCT01307423|560996139|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
155429163|NCT01499290|560996140|FG000|Overall Study|Withdrawal by Subject|22|||
155429164|NCT01499290|560996141|FG001|Overall Study|Withdrawal by Subject|15|||
155429165|NCT01499290|560996140|FG000|Overall Study|Not specified in study report|11|||
155429166|NCT01499290|560996141|FG001|Overall Study|Not specified in study report|5|||
155429167|NCT01499290|560996140|FG000|Overall Study|Condition improved/subject recovered|1|||
155429168|NCT01499290|560996141|FG001|Overall Study|Condition improved/subject recovered|0|||
155429169|NCT01499290|560996140|FG000|Overall Study|Lack of Efficacy|7|||
155429170|NCT01499290|560996141|FG001|Overall Study|Lack of Efficacy|8|||
155429171|NCT01499290|560996140|FG000|Overall Study|Adverse Event|14|||
155429172|NCT01499290|560996141|FG001|Overall Study|Adverse Event|7|||
155429173|NCT00707577|560996142|FG000|Overall Study|Withdrawal by Subject|3|||
155429174|NCT00707577|560996143|FG001|Overall Study|Withdrawal by Subject|2|||
155429175|NCT00707577|560996142|FG000|Overall Study|Lost to Follow-up|34|||
155429176|NCT00707577|560996143|FG001|Overall Study|Lost to Follow-up|25|||
155429177|NCT00707577|560996142|FG000|Overall Study|Left employment|13|||
155429178|NCT00707577|560996143|FG001|Overall Study|Left employment|10|||
155429179|NCT00707577|560996142|FG000|Overall Study|Pregnancy|4|||
155429180|NCT00707577|560996143|FG001|Overall Study|Pregnancy|1|||
155429181|NCT00190775|560996144|FG000|Overall Study|Adverse Event|57|||
155429182|NCT00190775|560996145|FG001|Overall Study|Adverse Event|22|||
155429183|NCT00190775|560996144|FG000|Overall Study|Satisfactory Response|1|||
155429184|NCT00190775|560996145|FG001|Overall Study|Satisfactory Response|0|||
155429185|NCT00190775|560996144|FG000|Overall Study|Lack of Efficacy|28|||
155429186|NCT00190775|560996145|FG001|Overall Study|Lack of Efficacy|32|||
155429187|NCT00190775|560996144|FG000|Overall Study|Lost to Follow-up|31|||
155429188|NCT00190775|560996145|FG001|Overall Study|Lost to Follow-up|23|||
155429189|NCT00190775|560996144|FG000|Overall Study|Participant Moved|0|||
155429190|NCT00190775|560996145|FG001|Overall Study|Participant Moved|1|||
155429191|NCT00190775|560996144|FG000|Overall Study|Withdrawal by Subject|24|||
155429192|NCT00190775|560996145|FG001|Overall Study|Withdrawal by Subject|13|||
155429193|NCT00190775|560996144|FG000|Overall Study|Sponsor Decision|1|||
155509700|NCT00602030|561291812|FG004|Lead-in Phase|Adverse Event|0|||
155369593|NCT03829501|560787792|FG022|Overall Study|PD|0|||
155369594|NCT03829501|560787770|FG000|Overall Study|Study Terminated by Sponsor|0|||
155429194|NCT00190775|560996145|FG001|Overall Study|Sponsor Decision|0|||
155429195|NCT00190775|560996144|FG000|Overall Study|Physician Decision|3|||
155429196|NCT00190775|560996145|FG001|Overall Study|Physician Decision|0|||
155429197|NCT00190775|560996144|FG000|Overall Study|Noncompliance|3|||
155429198|NCT00190775|560996145|FG001|Overall Study|Noncompliance|5|||
155509701|NCT00602030|561291808|FG000|Double-blind Phase|Disease progression|0|||
155509702|NCT00602030|561291809|FG001|Double-blind Phase|Disease progression|0|||
155369595|NCT03829501|560787771|FG001|Overall Study|Study Terminated by Sponsor|0|||
155369596|NCT03829501|560787772|FG002|Overall Study|Study Terminated by Sponsor|0|||
155429199|NCT00190775|560996144|FG000|Overall Study|Protocol Violation|0|||
155429200|NCT00190775|560996145|FG001|Overall Study|Protocol Violation|1|||
155429201|NCT00190775|560996144|FG000|Overall Study|Exclusion Criteria Met|1|||
155369597|NCT03829501|560787773|FG003|Overall Study|Study Terminated by Sponsor|0|||
155369598|NCT03829501|560787774|FG004|Overall Study|Study Terminated by Sponsor|0|||
155369599|NCT03829501|560787775|FG005|Overall Study|Study Terminated by Sponsor|0|||
155369600|NCT03829501|560787776|FG006|Overall Study|Study Terminated by Sponsor|0|||
155429202|NCT00190775|560996145|FG001|Overall Study|Exclusion Criteria Met|3|||
155429203|NCT01794780|560996146|FG000|Overall Study|Adverse Event|0|||
155509703|NCT00602030|561291810|FG002|Double-blind Phase|Disease progression|33|||
155509704|NCT00602030|561291811|FG003|Double-blind Phase|Disease progression|30|||
155509705|NCT00602030|561291812|FG004|Double-blind Phase|Disease progression|0|||
155509706|NCT00602030|561291808|FG000|Double-blind Phase|Adverse Event|0|||
155509707|NCT00602030|561291809|FG001|Double-blind Phase|Adverse Event|0|||
155509708|NCT00602030|561291810|FG002|Double-blind Phase|Adverse Event|9|||
155509709|NCT00602030|561291811|FG003|Double-blind Phase|Adverse Event|18|||
155509710|NCT00602030|561291812|FG004|Double-blind Phase|Adverse Event|0|||
155509711|NCT00602030|561291808|FG000|Double-blind Phase|Consent withdrawal|0|||
155509712|NCT00602030|561291809|FG001|Double-blind Phase|Consent withdrawal|0|||
155509713|NCT00602030|561291810|FG002|Double-blind Phase|Consent withdrawal|4|||
155509714|NCT00602030|561291811|FG003|Double-blind Phase|Consent withdrawal|3|||
155509715|NCT00602030|561291812|FG004|Double-blind Phase|Consent withdrawal|0|||
155509716|NCT00602030|561291808|FG000|Double-blind Phase|Death|0|||
155509717|NCT00602030|561291809|FG001|Double-blind Phase|Death|0|||
155509718|NCT00602030|561291810|FG002|Double-blind Phase|Death|3|||
155509719|NCT00602030|561291811|FG003|Double-blind Phase|Death|3|||
155509720|NCT00602030|561291812|FG004|Double-blind Phase|Death|0|||
155509721|NCT00602030|561291808|FG000|Double-blind Phase|Administrative decision|0|||
155509722|NCT00602030|561291809|FG001|Double-blind Phase|Administrative decision|0|||
155509723|NCT00602030|561291810|FG002|Double-blind Phase|Administrative decision|0|||
155509724|NCT00602030|561291811|FG003|Double-blind Phase|Administrative decision|2|||
155509725|NCT00602030|561291812|FG004|Double-blind Phase|Administrative decision|0|||
155509726|NCT00602030|561291808|FG000|Double-blind Phase|Ineligibility|0|||
155509727|NCT00602030|561291809|FG001|Double-blind Phase|Ineligibility|0|||
155509728|NCT00602030|561291810|FG002|Double-blind Phase|Ineligibility|0|||
155509729|NCT00602030|561291811|FG003|Double-blind Phase|Ineligibility|1|||
155509730|NCT00602030|561291812|FG004|Double-blind Phase|Ineligibility|0|||
155509731|NCT00602030|561291808|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
155509732|NCT00602030|561291809|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
155509733|NCT00602030|561291810|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
155509734|NCT00602030|561291811|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
155509735|NCT00602030|561291812|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
155509736|NCT00602030|561291808|FG000|Double-blind Phase|Reason not specified|0|||
155509737|NCT00602030|561291809|FG001|Double-blind Phase|Reason not specified|0|||
155509738|NCT00602030|561291810|FG002|Double-blind Phase|Reason not specified|4|||
155509739|NCT00602030|561291811|FG003|Double-blind Phase|Reason not specified|2|||
155509740|NCT00602030|561291812|FG004|Double-blind Phase|Reason not specified|0|||
155509741|NCT00602030|561291808|FG000|Crossover Phase|Disease Progression|0|||
155509742|NCT00602030|561291809|FG001|Crossover Phase|Disease Progression|0|||
155509743|NCT00602030|561291810|FG002|Crossover Phase|Disease Progression|0|||
155509744|NCT00602030|561291811|FG003|Crossover Phase|Disease Progression|0|||
155369601|NCT03829501|560787777|FG007|Overall Study|Study Terminated by Sponsor|3|||
155369602|NCT03829501|560787778|FG008|Overall Study|Study Terminated by Sponsor|1|||
155369603|NCT03829501|560787779|FG009|Overall Study|Study Terminated by Sponsor|0|||
155509745|NCT00602030|561291812|FG004|Crossover Phase|Disease Progression|11|||
155509746|NCT00602030|561291808|FG000|Crossover Phase|Adverse Event|0|||
155509747|NCT00602030|561291809|FG001|Crossover Phase|Adverse Event|0|||
155369604|NCT03829501|560787780|FG010|Overall Study|Study Terminated by Sponsor|0|||
155369605|NCT03829501|560787781|FG011|Overall Study|Study Terminated by Sponsor|0|||
155369606|NCT03829501|560787782|FG012|Overall Study|Study Terminated by Sponsor|0|||
155369607|NCT03829501|560787783|FG013|Overall Study|Study Terminated by Sponsor|0|||
155369608|NCT03829501|560787784|FG014|Overall Study|Study Terminated by Sponsor|3|||
155369609|NCT03829501|560787785|FG015|Overall Study|Study Terminated by Sponsor|2|||
155369610|NCT03829501|560787786|FG016|Overall Study|Study Terminated by Sponsor|2|||
155369611|NCT03829501|560787787|FG017|Overall Study|Study Terminated by Sponsor|0|||
155369612|NCT03829501|560787788|FG018|Overall Study|Study Terminated by Sponsor|0|||
155369613|NCT03829501|560787789|FG019|Overall Study|Study Terminated by Sponsor|0|||
155369614|NCT03829501|560787790|FG020|Overall Study|Study Terminated by Sponsor|1|||
155369615|NCT03829501|560787791|FG021|Overall Study|Study Terminated by Sponsor|0|||
155509748|NCT00602030|561291810|FG002|Crossover Phase|Adverse Event|0|||
155509749|NCT00602030|561291811|FG003|Crossover Phase|Adverse Event|0|||
155509750|NCT00602030|561291812|FG004|Crossover Phase|Adverse Event|3|||
155509751|NCT00602030|561291808|FG000|Crossover Phase|Consent withdrawal|0|||
155509752|NCT00602030|561291809|FG001|Crossover Phase|Consent withdrawal|0|||
155509753|NCT00602030|561291810|FG002|Crossover Phase|Consent withdrawal|0|||
155509754|NCT00602030|561291811|FG003|Crossover Phase|Consent withdrawal|0|||
155509755|NCT00602030|561291812|FG004|Crossover Phase|Consent withdrawal|2|||
155509756|NCT01138150|561291813|FG000|Overall Study|blood unable to be processed|0|||
155369616|NCT03829501|560787792|FG022|Overall Study|Study Terminated by Sponsor|3|||
155369617|NCT03829501|560787770|FG000|Overall Study|Lost to Follow Up|0|||
155369618|NCT03829501|560787771|FG001|Overall Study|Lost to Follow Up|0|||
155369619|NCT03829501|560787772|FG002|Overall Study|Lost to Follow Up|0|||
155369620|NCT03829501|560787773|FG003|Overall Study|Lost to Follow Up|0|||
155369621|NCT03829501|560787774|FG004|Overall Study|Lost to Follow Up|1|||
155369622|NCT03829501|560787775|FG005|Overall Study|Lost to Follow Up|0|||
155369623|NCT03829501|560787776|FG006|Overall Study|Lost to Follow Up|0|||
155369624|NCT03829501|560787777|FG007|Overall Study|Lost to Follow Up|2|||
155369625|NCT03829501|560787778|FG008|Overall Study|Lost to Follow Up|2|||
155369626|NCT03829501|560787779|FG009|Overall Study|Lost to Follow Up|0|||
155369627|NCT03829501|560787780|FG010|Overall Study|Lost to Follow Up|2|||
155369628|NCT03829501|560787781|FG011|Overall Study|Lost to Follow Up|1|||
155369629|NCT03829501|560787782|FG012|Overall Study|Lost to Follow Up|0|||
155369630|NCT03829501|560787783|FG013|Overall Study|Lost to Follow Up|1|||
155369631|NCT03829501|560787784|FG014|Overall Study|Lost to Follow Up|1|||
155369632|NCT03829501|560787785|FG015|Overall Study|Lost to Follow Up|0|||
155369633|NCT03829501|560787786|FG016|Overall Study|Lost to Follow Up|0|||
155369634|NCT03829501|560787787|FG017|Overall Study|Lost to Follow Up|0|||
155369635|NCT03829501|560787788|FG018|Overall Study|Lost to Follow Up|0|||
155369636|NCT03829501|560787789|FG019|Overall Study|Lost to Follow Up|0|||
155369637|NCT03829501|560787790|FG020|Overall Study|Lost to Follow Up|0|||
155369638|NCT03829501|560787791|FG021|Overall Study|Lost to Follow Up|0|||
155369639|NCT03829501|560787792|FG022|Overall Study|Lost to Follow Up|1|||
155369640|NCT03829501|560787770|FG000|Overall Study|Death|2|||
155369641|NCT03829501|560787771|FG001|Overall Study|Death|4|||
155369642|NCT03829501|560787772|FG002|Overall Study|Death|5|||
155369643|NCT03829501|560787773|FG003|Overall Study|Death|6|||
155429204|NCT01794780|560996147|FG001|Overall Study|Adverse Event|1|||
155429205|NCT01794780|560996148|FG002|Overall Study|Adverse Event|2|||
155429206|NCT01794780|560996149|FG003|Overall Study|Adverse Event|0|||
155429207|NCT01794780|560996150|FG004|Overall Study|Adverse Event|0|||
155429208|NCT01794780|560996151|FG005|Overall Study|Adverse Event|0|||
155429209|NCT01794780|560996152|FG006|Overall Study|Adverse Event|0|||
155429210|NCT01794780|560996153|FG007|Overall Study|Adverse Event|0|||
155429211|NCT01794780|560996146|FG000|Overall Study|Death|0|||
155429212|NCT01794780|560996147|FG001|Overall Study|Death|2|||
155429213|NCT01794780|560996148|FG002|Overall Study|Death|14|||
155429214|NCT01794780|560996149|FG003|Overall Study|Death|1|||
155429215|NCT01794780|560996150|FG004|Overall Study|Death|0|||
155429216|NCT01794780|560996151|FG005|Overall Study|Death|9|||
155429217|NCT01794780|560996152|FG006|Overall Study|Death|4|||
155429218|NCT01794780|560996153|FG007|Overall Study|Death|0|||
155429219|NCT01794780|560996146|FG000|Overall Study|Lost to Follow-up|10|||
155429220|NCT01794780|560996147|FG001|Overall Study|Lost to Follow-up|64|||
155429221|NCT01794780|560996148|FG002|Overall Study|Lost to Follow-up|165|||
155429222|NCT01794780|560996149|FG003|Overall Study|Lost to Follow-up|53|||
155429223|NCT01794780|560996150|FG004|Overall Study|Lost to Follow-up|2|||
155429224|NCT01794780|560996151|FG005|Overall Study|Lost to Follow-up|99|||
155429225|NCT01794780|560996152|FG006|Overall Study|Lost to Follow-up|30|||
155429226|NCT01794780|560996153|FG007|Overall Study|Lost to Follow-up|5|||
155429227|NCT01794780|560996146|FG000|Overall Study|Withdrew informed consent|7|||
155429228|NCT01794780|560996147|FG001|Overall Study|Withdrew informed consent|17|||
155429229|NCT01794780|560996148|FG002|Overall Study|Withdrew informed consent|36|||
155429230|NCT01794780|560996149|FG003|Overall Study|Withdrew informed consent|9|||
155429231|NCT01794780|560996150|FG004|Overall Study|Withdrew informed consent|0|||
155369644|NCT03829501|560787774|FG004|Overall Study|Death|5|||
155429232|NCT01794780|560996151|FG005|Overall Study|Withdrew informed consent|48|||
155429233|NCT01794780|560996152|FG006|Overall Study|Withdrew informed consent|4|||
155429234|NCT01794780|560996153|FG007|Overall Study|Withdrew informed consent|3|||
155429235|NCT01794780|560996146|FG000|Overall Study|Other|0|||
155429236|NCT01794780|560996147|FG001|Overall Study|Other|12|||
155429237|NCT01794780|560996148|FG002|Overall Study|Other|25|||
155429238|NCT01794780|560996149|FG003|Overall Study|Other|20|||
155429239|NCT01794780|560996150|FG004|Overall Study|Other|1|||
155429240|NCT01794780|560996151|FG005|Overall Study|Other|24|||
155369645|NCT03829501|560787775|FG005|Overall Study|Death|4|||
155369646|NCT03829501|560787776|FG006|Overall Study|Death|5|||
155369647|NCT03829501|560787777|FG007|Overall Study|Death|24|||
155369648|NCT03829501|560787778|FG008|Overall Study|Death|22|||
155369649|NCT03829501|560787779|FG009|Overall Study|Death|6|||
155429241|NCT01794780|560996152|FG006|Overall Study|Other|4|||
155429242|NCT01794780|560996153|FG007|Overall Study|Other|1|||
155429243|NCT02209766|560996155|FG000|Overall Study|Withdrawal by Subject|0|||
155429244|NCT02209766|560996156|FG001|Overall Study|Withdrawal by Subject|0|||
155369650|NCT03829501|560787780|FG010|Overall Study|Death|3|||
155429245|NCT02209766|560996157|FG002|Overall Study|Withdrawal by Subject|0|||
155429246|NCT02209766|560996158|FG003|Overall Study|Withdrawal by Subject|1|||
155429247|NCT02209766|560996159|FG004|Overall Study|Withdrawal by Subject|0|||
155429248|NCT00327444|560996160|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
155369651|NCT03829501|560787781|FG011|Overall Study|Death|10|||
155369652|NCT03829501|560787782|FG012|Overall Study|Death|10|||
155369653|NCT03829501|560787783|FG013|Overall Study|Death|5|||
155369654|NCT03829501|560787784|FG014|Overall Study|Death|7|||
155369655|NCT03829501|560787785|FG015|Overall Study|Death|2|||
155369656|NCT03829501|560787786|FG016|Overall Study|Death|2|||
155369657|NCT03829501|560787787|FG017|Overall Study|Death|1|||
155369658|NCT03829501|560787788|FG018|Overall Study|Death|1|||
155369659|NCT03829501|560787789|FG019|Overall Study|Death|1|||
155369660|NCT03829501|560787790|FG020|Overall Study|Death|1|||
155369661|NCT03829501|560787791|FG021|Overall Study|Death|2|||
155369662|NCT03829501|560787792|FG022|Overall Study|Death|3|||
155369663|NCT03829501|560787770|FG000|Overall Study|Miscellaneous|0|||
155369664|NCT03829501|560787771|FG001|Overall Study|Miscellaneous|0|||
155369665|NCT03829501|560787772|FG002|Overall Study|Miscellaneous|1|||
155369666|NCT03829501|560787773|FG003|Overall Study|Miscellaneous|0|||
155369667|NCT03829501|560787774|FG004|Overall Study|Miscellaneous|0|||
155369668|NCT03829501|560787775|FG005|Overall Study|Miscellaneous|0|||
155369669|NCT03829501|560787776|FG006|Overall Study|Miscellaneous|0|||
155369670|NCT03829501|560787777|FG007|Overall Study|Miscellaneous|1|||
155369671|NCT03829501|560787778|FG008|Overall Study|Miscellaneous|0|||
155369672|NCT03829501|560787779|FG009|Overall Study|Miscellaneous|0|||
155369673|NCT03829501|560787780|FG010|Overall Study|Miscellaneous|0|||
155369674|NCT03829501|560787781|FG011|Overall Study|Miscellaneous|0|||
155369675|NCT03829501|560787782|FG012|Overall Study|Miscellaneous|0|||
155369676|NCT03829501|560787783|FG013|Overall Study|Miscellaneous|0|||
155369677|NCT03829501|560787784|FG014|Overall Study|Miscellaneous|0|||
155369678|NCT03829501|560787785|FG015|Overall Study|Miscellaneous|0|||
155369679|NCT03829501|560787786|FG016|Overall Study|Miscellaneous|0|||
155369680|NCT03829501|560787787|FG017|Overall Study|Miscellaneous|0|||
155429249|NCT00327444|560996161|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
155429250|NCT00327444|560996160|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
155429251|NCT00327444|560996161|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
155429252|NCT00327444|560996160|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
155429253|NCT00327444|560996161|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
155429254|NCT00327444|560996160|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
155429255|NCT00327444|560996161|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
155429256|NCT00327444|560996160|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
155429257|NCT00327444|560996161|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
155429258|NCT00327444|560996160|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
155429259|NCT00327444|560996161|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
155429260|NCT00327444|560996160|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
155429261|NCT00327444|560996161|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
155429262|NCT00327444|560996160|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
155429263|NCT00327444|560996161|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
155429264|NCT01791855|560996163|FG000|Overall Study|Adverse Event|0|||
155429265|NCT01791855|560996164|FG001|Overall Study|Adverse Event|0|||
155429266|NCT01791855|560996165|FG002|Overall Study|Adverse Event|0|||
155429267|NCT01791855|560996166|FG003|Overall Study|Adverse Event|1|||
155429268|NCT01791855|560996163|FG000|Overall Study|Randomized, not treated|0|||
155429269|NCT01791855|560996164|FG001|Overall Study|Randomized, not treated|1|||
155429270|NCT01791855|560996165|FG002|Overall Study|Randomized, not treated|0|||
155429271|NCT01791855|560996166|FG003|Overall Study|Randomized, not treated|0|||
155429272|NCT01709331|560996167|FG000|Overall Study|Adverse Event|1|||
155429273|NCT04439344|560996168|FG000|Overall Study|Never started threapy|3|||
155429274|NCT04439344|560996168|FG000|Overall Study|Ineligible|3|||
155429275|NCT04439344|560996168|FG000|Overall Study|Adverse Event|13|||
155429276|NCT04439344|560996168|FG000|Overall Study|Death|2|||
155429277|NCT04439344|560996168|FG000|Overall Study|Disease progression|29|||
155429278|NCT04439344|560996168|FG000|Overall Study|Withdrawal by Subject|2|||
155429279|NCT04439344|560996168|FG000|Overall Study|Alternative therapy|1|||
155429280|NCT03770403|560996169|FG000|Overall Study|Adverse Event|8|||
155429281|NCT03770403|560996169|FG000|Overall Study|Death|5|||
155429282|NCT03770403|560996169|FG000|Overall Study|Physician Decision|1|||
155429283|NCT03770403|560996169|FG000|Overall Study|Sponsor decision|1|||
155429284|NCT03770403|560996169|FG000|Overall Study|Study terminated by Sponsor|1|||
155429285|NCT03770403|560996169|FG000|Overall Study|Withdrawal by Subject|13|||
155369681|NCT03829501|560787788|FG018|Overall Study|Miscellaneous|0|||
155429286|NCT03770403|560996169|FG000|Overall Study|Other|88|||
155369682|NCT03829501|560787789|FG019|Overall Study|Miscellaneous|0|||
155369683|NCT03829501|560787790|FG020|Overall Study|Miscellaneous|0|||
155429287|NCT00642642|560996180|FG000|Treatment & Follow Up|Adverse Event|2|||
155429288|NCT00642642|560996180|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
155429289|NCT00642642|560996180|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
155429290|NCT02500537|560996181|FG000|Overall Study|Death|2|||
155369684|NCT03829501|560787791|FG021|Overall Study|Miscellaneous|0|||
155369685|NCT03829501|560787792|FG022|Overall Study|Miscellaneous|1|||
155369686|NCT02964013|560787793|FG000|Overall Study|Death|58|||
155369687|NCT02964013|560787794|FG001|Overall Study|Death|239|||
155369688|NCT02964013|560787795|FG002|Overall Study|Death|38|||
155649448|NCT01379937|561808270|FG003|Overall Study|Lost to Follow-up|0|||
155369689|NCT02964013|560787796|FG003|Overall Study|Death|10|||
155369690|NCT02964013|560787797|FG004|Overall Study|Death|33|||
155369691|NCT02964013|560787793|FG000|Overall Study|Lost to Follow-up|1|||
155369692|NCT02964013|560787794|FG001|Overall Study|Lost to Follow-up|4|||
155369693|NCT02964013|560787795|FG002|Overall Study|Lost to Follow-up|2|||
155369694|NCT02964013|560787796|FG003|Overall Study|Lost to Follow-up|0|||
155369695|NCT02964013|560787797|FG004|Overall Study|Lost to Follow-up|0|||
155369696|NCT02964013|560787793|FG000|Overall Study|Physician Decision|0|||
155369697|NCT02964013|560787794|FG001|Overall Study|Physician Decision|1|||
155369698|NCT02964013|560787795|FG002|Overall Study|Physician Decision|0|||
155369699|NCT02964013|560787796|FG003|Overall Study|Physician Decision|0|||
155369700|NCT02964013|560787797|FG004|Overall Study|Physician Decision|0|||
155369701|NCT02964013|560787793|FG000|Overall Study|Sponsor Decision|3|||
155369702|NCT02964013|560787794|FG001|Overall Study|Sponsor Decision|22|||
155369703|NCT02964013|560787795|FG002|Overall Study|Sponsor Decision|11|||
155369704|NCT02964013|560787796|FG003|Overall Study|Sponsor Decision|0|||
155369705|NCT02964013|560787797|FG004|Overall Study|Sponsor Decision|7|||
155369706|NCT02964013|560787793|FG000|Overall Study|Withdrawal by Subject|6|||
155369707|NCT02964013|560787794|FG001|Overall Study|Withdrawal by Subject|27|||
155369708|NCT02964013|560787795|FG002|Overall Study|Withdrawal by Subject|9|||
155369709|NCT02964013|560787796|FG003|Overall Study|Withdrawal by Subject|0|||
155369710|NCT02964013|560787797|FG004|Overall Study|Withdrawal by Subject|0|||
155369711|NCT02964013|560787793|FG000|Overall Study|Not Treated|0|||
155369712|NCT02964013|560787794|FG001|Overall Study|Not Treated|2|||
155369713|NCT02964013|560787795|FG002|Overall Study|Not Treated|0|||
155369714|NCT02964013|560787796|FG003|Overall Study|Not Treated|1|||
155369715|NCT02964013|560787797|FG004|Overall Study|Not Treated|0|||
155369716|NCT01123070|560787798|FG000|Part B Double Blind Period|Protocol Violation|0|||
155369717|NCT01123070|560787799|FG001|Part B Double Blind Period|Protocol Violation|0|||
155369718|NCT01123070|560787800|FG002|Part B Double Blind Period|Protocol Violation|0|||
155369719|NCT01123070|560787801|FG003|Part B Double Blind Period|Protocol Violation|1|||
155369720|NCT01123070|560787798|FG000|Part B Double Blind Period|Adverse Event|0|||
155369721|NCT01123070|560787799|FG001|Part B Double Blind Period|Adverse Event|0|||
155369722|NCT01123070|560787800|FG002|Part B Double Blind Period|Adverse Event|2|||
155369723|NCT01123070|560787801|FG003|Part B Double Blind Period|Adverse Event|0|||
155369724|NCT01123070|560787798|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
155369725|NCT01123070|560787799|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
155369726|NCT01123070|560787800|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
155369727|NCT01123070|560787801|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
155369728|NCT04942366|560787802|FG000|Overall Study|Withdrawal by Subject|5|||
155369729|NCT04942366|560787803|FG001|Overall Study|Withdrawal by Subject|5|||
155369730|NCT00747227|560787810|FG000|Overall Study|Death|3|||
155369731|NCT00747227|560787811|FG001|Overall Study|Death|1|||
155369732|NCT00747227|560787810|FG000|Overall Study|Withdrawal by Subject|1|||
155369733|NCT00747227|560787811|FG001|Overall Study|Withdrawal by Subject|0|||
155369734|NCT00747227|560787810|FG000|Overall Study|Lost to Follow-up|1|||
155369735|NCT00747227|560787811|FG001|Overall Study|Lost to Follow-up|2|||
155369736|NCT00747227|560787810|FG000|Overall Study|Illness|1|||
155429291|NCT02500537|560996182|FG001|Overall Study|Death|0|||
155429292|NCT02500537|560996181|FG000|Overall Study|Lost to Follow-up|0|||
155429293|NCT02500537|560996182|FG001|Overall Study|Lost to Follow-up|1|||
155429294|NCT02500537|560996181|FG000|Overall Study|Withdrawal by Subject|1|||
155429295|NCT02500537|560996182|FG001|Overall Study|Withdrawal by Subject|0|||
155429296|NCT00355121|560996183|FG000|Overall Study|Did not receive study vaccine|1|||
155429297|NCT00355121|560996184|FG001|Overall Study|Did not receive study vaccine|0|||
155429298|NCT00355121|560996185|FG002|Overall Study|Did not receive study vaccine|1|||
155429299|NCT00355121|560996183|FG000|Overall Study|Adverse Event|0|||
155429300|NCT00355121|560996184|FG001|Overall Study|Adverse Event|1|||
155429301|NCT00355121|560996185|FG002|Overall Study|Adverse Event|0|||
155429302|NCT00355121|560996183|FG000|Overall Study|Protocol Violation|7|||
155369737|NCT00747227|560787811|FG001|Overall Study|Illness|1|||
155369738|NCT03284229|560787812|FG000|Overall Study|Lost to Follow-up|3|||
155429303|NCT00355121|560996184|FG001|Overall Study|Protocol Violation|9|||
155429304|NCT00355121|560996185|FG002|Overall Study|Protocol Violation|1|||
155369739|NCT04325282|560787829|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155429305|NCT00355121|560996183|FG000|Overall Study|Lost to Follow-up|4|||
155429306|NCT00355121|560996184|FG001|Overall Study|Lost to Follow-up|7|||
155429307|NCT00355121|560996185|FG002|Overall Study|Lost to Follow-up|1|||
155429308|NCT00355121|560996183|FG000|Overall Study|Withdrawal by Subject|9|||
155429309|NCT00355121|560996184|FG001|Overall Study|Withdrawal by Subject|10|||
155369740|NCT04325282|560787830|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155369741|NCT04325282|560787829|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
155369742|NCT04325282|560787830|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
155369743|NCT04833127|560787832|FG000|Overall Study|Lost to Follow-up|1|||
155429310|NCT00355121|560996185|FG002|Overall Study|Withdrawal by Subject|2|||
155509757|NCT01138150|561291814|FG001|Overall Study|blood unable to be processed|1|||
155509758|NCT01138150|561291813|FG000|Overall Study|Physician Decision|1|||
155509759|NCT01138150|561291814|FG001|Overall Study|Physician Decision|0|||
155509760|NCT01580020|561291815|FG000|Overall Study|Lack of Efficacy|0|||
155509761|NCT01580020|561291816|FG001|Overall Study|Lack of Efficacy|5|||
155509762|NCT01580020|561291817|FG002|Overall Study|Lack of Efficacy|0|||
155509763|NCT01580020|561291818|FG003|Overall Study|Lack of Efficacy|1|||
155509764|NCT01580020|561291815|FG000|Overall Study|Withdrawal by Subject|0|||
155509765|NCT01580020|561291816|FG001|Overall Study|Withdrawal by Subject|1|||
155509766|NCT01580020|561291817|FG002|Overall Study|Withdrawal by Subject|1|||
155509767|NCT01580020|561291818|FG003|Overall Study|Withdrawal by Subject|0|||
155509768|NCT01580020|561291815|FG000|Overall Study|Adverse Event|1|||
155509769|NCT01580020|561291816|FG001|Overall Study|Adverse Event|1|||
155509770|NCT01580020|561291817|FG002|Overall Study|Adverse Event|1|||
155509771|NCT01580020|561291818|FG003|Overall Study|Adverse Event|1|||
155509772|NCT01580020|561291815|FG000|Overall Study|Administrative Problems|0|||
155509773|NCT01580020|561291816|FG001|Overall Study|Administrative Problems|0|||
155509774|NCT01580020|561291817|FG002|Overall Study|Administrative Problems|1|||
155509775|NCT01580020|561291818|FG003|Overall Study|Administrative Problems|0|||
155509776|NCT01580020|561291815|FG000|Overall Study|Lost to Follow-up|0|||
155509777|NCT01580020|561291816|FG001|Overall Study|Lost to Follow-up|0|||
155369744|NCT04833127|560787833|FG001|Overall Study|Lost to Follow-up|1|||
155509778|NCT01580020|561291817|FG002|Overall Study|Lost to Follow-up|1|||
155509779|NCT01580020|561291818|FG003|Overall Study|Lost to Follow-up|0|||
155509780|NCT01208402|561291824|FG000|Overall Study|Withdrawal by Subject|1|||
155509781|NCT01208402|561291825|FG001|Overall Study|Withdrawal by Subject|0|||
155509782|NCT01571635|561291827|FG000|Overall Study|Adverse Event|3|||
155509783|NCT01571635|561291828|FG001|Overall Study|Adverse Event|0|||
155509784|NCT01571635|561291829|FG002|Overall Study|Adverse Event|2|||
155509785|NCT01571635|561291830|FG003|Overall Study|Adverse Event|3|||
155509786|NCT01571635|561291831|FG004|Overall Study|Adverse Event|5|||
155509787|NCT01571635|561291827|FG000|Overall Study|Other reasons|2|||
155509788|NCT01571635|561291828|FG001|Overall Study|Other reasons|1|||
155509789|NCT01571635|561291829|FG002|Overall Study|Other reasons|2|||
155509790|NCT01571635|561291830|FG003|Overall Study|Other reasons|2|||
155509791|NCT01571635|561291831|FG004|Overall Study|Other reasons|1|||
155509792|NCT01571635|561291827|FG000|Overall Study|Study terminated by sponsor|0|||
155509793|NCT01571635|561291828|FG001|Overall Study|Study terminated by sponsor|4|||
155509794|NCT01571635|561291829|FG002|Overall Study|Study terminated by sponsor|1|||
155509795|NCT01571635|561291830|FG003|Overall Study|Study terminated by sponsor|3|||
155509796|NCT01571635|561291831|FG004|Overall Study|Study terminated by sponsor|1|||
155509797|NCT01571635|561291827|FG000|Overall Study|Withdrew consent|1|||
155509798|NCT01571635|561291828|FG001|Overall Study|Withdrew consent|1|||
155509799|NCT01571635|561291829|FG002|Overall Study|Withdrew consent|2|||
155509800|NCT01571635|561291830|FG003|Overall Study|Withdrew consent|3|||
155509801|NCT01571635|561291831|FG004|Overall Study|Withdrew consent|0|||
155509802|NCT01571635|561291827|FG000|Overall Study|Lack of Efficacy|0|||
155509803|NCT01571635|561291828|FG001|Overall Study|Lack of Efficacy|2|||
155509804|NCT01571635|561291829|FG002|Overall Study|Lack of Efficacy|0|||
155509805|NCT01571635|561291830|FG003|Overall Study|Lack of Efficacy|1|||
155509806|NCT01571635|561291831|FG004|Overall Study|Lack of Efficacy|2|||
155509807|NCT02868281|561291832|FG000|Overall Study|Adverse Event|2|||
155509808|NCT02868281|561291833|FG001|Overall Study|Adverse Event|2|||
155509809|NCT02868281|561291832|FG000|Overall Study|Protocol Violation|13|||
155509810|NCT02868281|561291833|FG001|Overall Study|Protocol Violation|10|||
155509811|NCT02868281|561291832|FG000|Overall Study|Lost to Follow-up|3|||
155509812|NCT02868281|561291833|FG001|Overall Study|Lost to Follow-up|6|||
155509813|NCT02868281|561291832|FG000|Overall Study|Withdrawal by Subject|11|||
155509814|NCT02868281|561291833|FG001|Overall Study|Withdrawal by Subject|15|||
155509815|NCT02868281|561291832|FG000|Overall Study|Physician Decision|2|||
155509816|NCT02868281|561291833|FG001|Overall Study|Physician Decision|0|||
155509817|NCT02868281|561291832|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
155509818|NCT02868281|561291833|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
155649449|NCT01122680|561808271|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
155509819|NCT02868281|561291832|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
155509820|NCT02868281|561291833|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
155509821|NCT02868281|561291832|FG000|Overall Study|Long journey/moving away|1|||
155509822|NCT02868281|561291833|FG001|Overall Study|Long journey/moving away|1|||
155509823|NCT01335464|561291834|FG000|Overall Study|Adverse Event|15|||
155649450|NCT01122680|561808272|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
155509824|NCT01335464|561291835|FG001|Overall Study|Adverse Event|25|||
155509825|NCT01335464|561291834|FG000|Overall Study|Non compliant with protocol|2|||
155509826|NCT01335464|561291835|FG001|Overall Study|Non compliant with protocol|0|||
155369745|NCT01499303|560787838|FG000|Overall Study|Ongoing|2|||
155369746|NCT01499303|560787839|FG001|Overall Study|Ongoing|1|||
155369747|NCT01499303|560787838|FG000|Overall Study|Withdrawal by Subject|0|||
155369748|NCT01499303|560787839|FG001|Overall Study|Withdrawal by Subject|1|||
155369749|NCT01499303|560787838|FG000|Overall Study|Adverse Event|1|||
155369750|NCT01499303|560787839|FG001|Overall Study|Adverse Event|4|||
155369751|NCT01499303|560787838|FG000|Overall Study|Other|0|||
155369752|NCT01499303|560787839|FG001|Overall Study|Other|1|||
155369753|NCT00461981|560787840|FG000|Overall Study|Lost to Follow-up|9|||
155369754|NCT00461981|560787841|FG001|Overall Study|Lost to Follow-up|6|||
155369755|NCT00461981|560787840|FG000|Overall Study|Withdrawal by Subject|2|||
155369756|NCT00461981|560787841|FG001|Overall Study|Withdrawal by Subject|3|||
155369757|NCT02242097|560787842|FG000|Ibrutinib Treatment|Adverse Event|16|||
155369758|NCT02242097|560787842|FG000|Ibrutinib Treatment|Physician Decision|1|||
155369759|NCT02242097|560787842|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
155369760|NCT02242097|560787842|FG000|Ibrutinib Treatment|Death|1|||
155369761|NCT02242097|560787842|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
155369762|NCT02242097|560787842|FG000|Post Therapy Follow Up|Death|3|||
155369763|NCT02242097|560787842|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
155369764|NCT03031496|560787844|FG000|Period 1|Adverse Event|2|||
155369765|NCT03031496|560787845|FG001|Period 1|Adverse Event|0|||
155369766|NCT03031496|560787844|FG000|Period 1|Withdrawal by Subject|0|||
155369767|NCT03031496|560787845|FG001|Period 1|Withdrawal by Subject|2|||
155369768|NCT03868787|560787847|FG000|Overall Study|Withdrawal by Subject|2|||
155369769|NCT03868787|560787848|FG001|Overall Study|Withdrawal by Subject|1|||
155369770|NCT01399697|560787849|FG000|Overall Study|Adverse Event|13|||
155369771|NCT01399697|560787850|FG001|Overall Study|Adverse Event|3|||
155369772|NCT01399697|560787851|FG002|Overall Study|Adverse Event|1|||
155369773|NCT01399697|560787849|FG000|Overall Study|Lost to Follow-up|2|||
155369774|NCT01399697|560787850|FG001|Overall Study|Lost to Follow-up|0|||
155369775|NCT01399697|560787851|FG002|Overall Study|Lost to Follow-up|0|||
155369776|NCT01399697|560787849|FG000|Overall Study|Withdrawal by Subject|8|||
155369777|NCT01399697|560787850|FG001|Overall Study|Withdrawal by Subject|0|||
155369778|NCT01399697|560787851|FG002|Overall Study|Withdrawal by Subject|0|||
155369779|NCT01399697|560787849|FG000|Overall Study|Investigator Decisión|1|||
155369780|NCT01399697|560787850|FG001|Overall Study|Investigator Decisión|0|||
155369781|NCT01399697|560787851|FG002|Overall Study|Investigator Decisión|2|||
155369782|NCT01399697|560787849|FG000|Overall Study|Lack of Efficacy|9|||
155369783|NCT01399697|560787850|FG001|Overall Study|Lack of Efficacy|0|||
155369784|NCT01399697|560787851|FG002|Overall Study|Lack of Efficacy|1|||
155369785|NCT01399697|560787849|FG000|Overall Study|Protocol Violation|2|||
155369786|NCT01399697|560787850|FG001|Overall Study|Protocol Violation|0|||
155369787|NCT01399697|560787851|FG002|Overall Study|Protocol Violation|0|||
155369788|NCT01399697|560787849|FG000|Overall Study|Non-Compliant|1|||
155369789|NCT01399697|560787850|FG001|Overall Study|Non-Compliant|0|||
155369790|NCT01399697|560787851|FG002|Overall Study|Non-Compliant|0|||
155369791|NCT01399697|560787849|FG000|Overall Study|Inclusion Error|2|||
155369792|NCT01399697|560787850|FG001|Overall Study|Inclusion Error|0|||
155369793|NCT01399697|560787851|FG002|Overall Study|Inclusion Error|0|||
155369794|NCT01399697|560787849|FG000|Overall Study|Positive result for hepatitis B|1|||
155369795|NCT01399697|560787850|FG001|Overall Study|Positive result for hepatitis B|0|||
155369796|NCT01399697|560787851|FG002|Overall Study|Positive result for hepatitis B|0|||
155429311|NCT00355121|560996183|FG000|Overall Study|Serious adverse events|0|||
155369797|NCT01399697|560787849|FG000|Overall Study|Clinical RA remission|1|||
155369798|NCT01399697|560787850|FG001|Overall Study|Clinical RA remission|0|||
155369799|NCT01399697|560787851|FG002|Overall Study|Clinical RA remission|0|||
155369800|NCT01399697|560787849|FG000|Overall Study|Sponsor Decision|1|||
155369801|NCT01399697|560787850|FG001|Overall Study|Sponsor Decision|0|||
155369802|NCT01399697|560787851|FG002|Overall Study|Sponsor Decision|0|||
155369803|NCT03435692|560787852|FG000|Overall Study|Lack of Efficacy|2|||
155369804|NCT03435692|560787853|FG001|Overall Study|Lack of Efficacy|2|||
155369805|NCT03435692|560787854|FG002|Overall Study|Lack of Efficacy|0|||
155369806|NCT04313608|560787855|FG000|Overall Study|Death|12|||
155369807|NCT04313608|560787856|FG001|Overall Study|Death|3|||
155369808|NCT02510040|560787857|FG000|Overall Study|Deemed no longer eligible|18|||
155369809|NCT02510040|560787858|FG001|Overall Study|Deemed no longer eligible|3|||
155429312|NCT00355121|560996184|FG001|Overall Study|Serious adverse events|2|||
155429313|NCT00355121|560996185|FG002|Overall Study|Serious adverse events|0|||
155429314|NCT01587989|560996186|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
155369810|NCT02510040|560787859|FG002|Overall Study|Deemed no longer eligible|1|||
155369811|NCT01712061|560787860|FG000|Overall Study|Adverse Event|4|||
155369812|NCT01712061|560787861|FG001|Overall Study|Adverse Event|9|||
155369813|NCT01712061|560787862|FG002|Overall Study|Adverse Event|5|||
155369814|NCT01712061|560787860|FG000|Overall Study|Death|0|||
155369815|NCT01712061|560787861|FG001|Overall Study|Death|0|||
155369816|NCT01712061|560787862|FG002|Overall Study|Death|1|||
155369817|NCT01712061|560787860|FG000|Overall Study|Lost to Follow-up|1|||
155429315|NCT01587989|560996187|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
155429316|NCT01587989|560996188|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
155369818|NCT01712061|560787861|FG001|Overall Study|Lost to Follow-up|0|||
155369819|NCT01712061|560787862|FG002|Overall Study|Lost to Follow-up|1|||
155369820|NCT01712061|560787860|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
155369821|NCT01712061|560787861|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
155369822|NCT01712061|560787862|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
155369823|NCT01712061|560787860|FG000|Overall Study|Medication Error Without Associated AE|0|||
155369824|NCT01712061|560787861|FG001|Overall Study|Medication Error Without Associated AE|1|||
155369825|NCT01712061|560787862|FG002|Overall Study|Medication Error Without Associated AE|0|||
155369826|NCT01712061|560787860|FG000|Overall Study|Withdrawal by Subject|1|||
155369827|NCT01712061|560787861|FG001|Overall Study|Withdrawal by Subject|7|||
155369828|NCT01712061|560787862|FG002|Overall Study|Withdrawal by Subject|1|||
155369829|NCT01712061|560787860|FG000|Overall Study|Other|0|||
155369830|NCT01712061|560787861|FG001|Overall Study|Other|3|||
155369831|NCT01712061|560787862|FG002|Overall Study|Other|0|||
155369832|NCT01677767|560787869|FG000|Overall Study|Adverse Event|1|||
155369833|NCT01677767|560787869|FG000|Overall Study|Death|4|||
155369834|NCT01677767|560787869|FG000|Overall Study|Protocol Violation|4|||
155369835|NCT01677767|560787869|FG000|Overall Study|Withdrawal by Subject|10|||
155369836|NCT01677767|560787869|FG000|Overall Study|Non-compliance by the participants|3|||
155369837|NCT00842244|560787870|FG000|Overall Study|Death|3|||
155429317|NCT01587989|560996186|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
155429318|NCT01587989|560996187|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
155429319|NCT01587989|560996188|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
155429320|NCT01587989|560996186|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
155429321|NCT01587989|560996187|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
155429322|NCT01587989|560996188|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
155429323|NCT01587989|560996186|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
155429324|NCT01587989|560996187|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
155429325|NCT01587989|560996188|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
155429326|NCT01587989|560996186|FG000|Randomized Study Treatment|Screening failure|0|||
155429327|NCT01587989|560996187|FG001|Randomized Study Treatment|Screening failure|1|||
155429328|NCT01587989|560996188|FG002|Randomized Study Treatment|Screening failure|0|||
155429329|NCT01587989|560996186|FG000|Randomized Study Treatment|Physician Decision|0|||
155429330|NCT01587989|560996187|FG001|Randomized Study Treatment|Physician Decision|0|||
155429331|NCT01587989|560996188|FG002|Randomized Study Treatment|Physician Decision|1|||
155429332|NCT03313050|560996189|FG000|Stage 2: 12 Months|Adverse Event|0|||
155429333|NCT03313050|560996190|FG001|Stage 2: 12 Months|Adverse Event|0|||
155429334|NCT03313050|560996191|FG002|Stage 2: 12 Months|Adverse Event|0|||
155429335|NCT03313050|560996192|FG003|Stage 2: 12 Months|Adverse Event|1|||
155429336|NCT03313050|560996189|FG000|Stage 2: 12 Months|Death|0|||
155429337|NCT03313050|560996190|FG001|Stage 2: 12 Months|Death|0|||
155429338|NCT03313050|560996191|FG002|Stage 2: 12 Months|Death|3|||
155429339|NCT03313050|560996192|FG003|Stage 2: 12 Months|Death|0|||
155429340|NCT03313050|560996189|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
155429341|NCT03313050|560996190|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
155429342|NCT03313050|560996191|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
155429343|NCT03313050|560996192|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
155429344|NCT03313050|560996189|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
155429345|NCT03313050|560996190|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
155429346|NCT03313050|560996191|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
155429347|NCT03313050|560996192|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
155429348|NCT03313050|560996189|FG000|Stage 2: 12 Months|Protocol deviation|0|||
155429349|NCT03313050|560996190|FG001|Stage 2: 12 Months|Protocol deviation|0|||
155429350|NCT03313050|560996191|FG002|Stage 2: 12 Months|Protocol deviation|7|||
155429351|NCT03313050|560996192|FG003|Stage 2: 12 Months|Protocol deviation|7|||
155429352|NCT03313050|560996189|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
155429353|NCT03313050|560996190|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
155429354|NCT03313050|560996191|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
155429355|NCT03313050|560996192|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
155429356|NCT03313050|560996189|FG000|Stage 2: 12 Months|Other|0|||
155429357|NCT03313050|560996190|FG001|Stage 2: 12 Months|Other|0|||
155429358|NCT03313050|560996191|FG002|Stage 2: 12 Months|Other|0|||
155429359|NCT03313050|560996192|FG003|Stage 2: 12 Months|Other|1|||
155429360|NCT04211337|560996193|FG000|Overall Study|On Treatment|175|||
155429361|NCT04211337|560996194|FG001|Overall Study|On Treatment|40|||
155649451|NCT01122680|561808273|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
155369838|NCT00842244|560787870|FG000|Overall Study|Withdrawal by Subject|1|||
155369839|NCT00842244|560787870|FG000|Overall Study|Other|17|||
155369840|NCT02807272|560787871|FG000|Overall Study|Death|9|||
155369841|NCT02807272|560787872|FG001|Overall Study|Death|5|||
155369842|NCT02807272|560787873|FG002|Overall Study|Death|2|||
155369843|NCT02807272|560787874|FG003|Overall Study|Death|0|||
155429362|NCT04211337|560996193|FG000|Overall Study|Withdrawal by Subject|0|||
155429363|NCT04211337|560996194|FG001|Overall Study|Withdrawal by Subject|2|||
155429364|NCT05630846|560998928|FG000|Overall Study|Death|1|||
155429365|NCT05630846|560998929|FG001|Overall Study|Death|0|||
155369844|NCT02807272|560787875|FG004|Overall Study|Death|1|||
155369845|NCT02807272|560787871|FG000|Overall Study|Lost to Follow-up|1|||
155369846|NCT02807272|560787872|FG001|Overall Study|Lost to Follow-up|0|||
155369847|NCT02807272|560787873|FG002|Overall Study|Lost to Follow-up|0|||
155369848|NCT02807272|560787874|FG003|Overall Study|Lost to Follow-up|0|||
155369849|NCT02807272|560787875|FG004|Overall Study|Lost to Follow-up|0|||
155369850|NCT02807272|560787871|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
155369851|NCT02807272|560787872|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
155369852|NCT02807272|560787873|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
155369853|NCT02807272|560787874|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
155369854|NCT02807272|560787875|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
155369855|NCT02807272|560787871|FG000|Overall Study|Protocol-defined Disease Progression|0|||
155369856|NCT02807272|560787872|FG001|Overall Study|Protocol-defined Disease Progression|1|||
155369857|NCT02807272|560787873|FG002|Overall Study|Protocol-defined Disease Progression|0|||
155369858|NCT02807272|560787874|FG003|Overall Study|Protocol-defined Disease Progression|0|||
155369859|NCT02807272|560787875|FG004|Overall Study|Protocol-defined Disease Progression|1|||
155369860|NCT02807272|560787871|FG000|Overall Study|Study Terminated by Sponsor|1|||
155369861|NCT02807272|560787872|FG001|Overall Study|Study Terminated by Sponsor|0|||
155369862|NCT02807272|560787873|FG002|Overall Study|Study Terminated by Sponsor|0|||
155369863|NCT02807272|560787874|FG003|Overall Study|Study Terminated by Sponsor|1|||
155369864|NCT02807272|560787875|FG004|Overall Study|Study Terminated by Sponsor|0|||
155369865|NCT02807272|560787871|FG000|Overall Study|Other|1|||
155369866|NCT02807272|560787872|FG001|Overall Study|Other|0|||
155369867|NCT02807272|560787873|FG002|Overall Study|Other|0|||
155369868|NCT02807272|560787874|FG003|Overall Study|Other|0|||
155369869|NCT02807272|560787875|FG004|Overall Study|Other|1|||
155369870|NCT01162863|560787877|FG000|Overall Study|Lack of Efficacy|1|||
155369871|NCT01162863|560787878|FG001|Overall Study|Lack of Efficacy|0|||
155369872|NCT01162863|560787879|FG002|Overall Study|Lack of Efficacy|0|||
155369873|NCT01162863|560787877|FG000|Overall Study|Adverse Event|0|||
155369874|NCT01162863|560787878|FG001|Overall Study|Adverse Event|1|||
155369875|NCT01162863|560787879|FG002|Overall Study|Adverse Event|0|||
155369876|NCT02992691|560787880|FG000|Overall Study|Adverse Event|2|||
155369877|NCT02992691|560787880|FG000|Overall Study|Withdrawal by Subject|1|||
155369878|NCT00588692|560787881|FG000|Overall Study|Withdrawal by Subject|4|||
155369879|NCT00588692|560787882|FG001|Overall Study|Withdrawal by Subject|2|||
155369880|NCT00588692|560787881|FG000|Overall Study|Hip Surgery|0|||
155369881|NCT00588692|560787882|FG001|Overall Study|Hip Surgery|1|||
155369882|NCT00588692|560787881|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
155369883|NCT00588692|560787882|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
155369884|NCT00588692|560787881|FG000|Overall Study|Cancer|1|||
155369885|NCT00588692|560787882|FG001|Overall Study|Cancer|0|||
155369886|NCT00588692|560787881|FG000|Overall Study|Death|1|||
155369887|NCT00588692|560787882|FG001|Overall Study|Death|0|||
155369888|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
155369889|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369890|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369891|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369892|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
155369893|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369894|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369895|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369896|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
155369897|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369898|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369899|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369900|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
155369901|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369902|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369903|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369904|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
155369905|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369906|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369907|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369908|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
155369909|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
155369910|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
155369911|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
155369912|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
155369913|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
155429366|NCT05630846|560998930|FG002|Overall Study|Death|0|||
155649452|NCT01122680|561808274|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
155369914|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
155369915|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
155369916|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
155369917|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
155369918|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
155369919|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
155369920|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
155369921|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
155369922|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
155369923|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
155369924|NCT03538938|560787888|FG000|Overall Study|Death|0|||
155369925|NCT03538938|560787889|FG001|Overall Study|Death|0|||
155369926|NCT03538938|560787890|FG002|Overall Study|Death|2|||
155369927|NCT03538938|560787891|FG003|Overall Study|Death|0|||
155369928|NCT03538938|560787892|FG004|Overall Study|Death|0|||
155369929|NCT03538938|560787893|FG005|Overall Study|Death|1|||
155369930|NCT03538938|560787894|FG006|Overall Study|Death|0|||
155369931|NCT03538938|560787895|FG007|Overall Study|Death|1|||
155369932|NCT03538938|560787896|FG008|Overall Study|Death|1|||
155369933|NCT03538938|560787897|FG009|Overall Study|Death|1|||
155369934|NCT03538938|560787898|FG010|Overall Study|Death|0|||
155369935|NCT03538938|560787899|FG011|Overall Study|Death|0|||
155369936|NCT03538938|560787900|FG012|Overall Study|Death|1|||
155369937|NCT03538938|560787901|FG013|Overall Study|Death|1|||
155369938|NCT03538938|560787902|FG014|Overall Study|Death|0|||
155369939|NCT03538938|560787903|FG015|Overall Study|Death|1|||
155369940|NCT03538938|560787888|FG000|Overall Study|Withdrawal by Subject|4|||
155369941|NCT03538938|560787889|FG001|Overall Study|Withdrawal by Subject|6|||
155369942|NCT03538938|560787890|FG002|Overall Study|Withdrawal by Subject|5|||
155369943|NCT03538938|560787891|FG003|Overall Study|Withdrawal by Subject|3|||
155369944|NCT03538938|560787892|FG004|Overall Study|Withdrawal by Subject|0|||
155369945|NCT03538938|560787893|FG005|Overall Study|Withdrawal by Subject|0|||
155369946|NCT03538938|560787894|FG006|Overall Study|Withdrawal by Subject|3|||
155369947|NCT03538938|560787895|FG007|Overall Study|Withdrawal by Subject|1|||
155369948|NCT03538938|560787896|FG008|Overall Study|Withdrawal by Subject|5|||
155369949|NCT03538938|560787897|FG009|Overall Study|Withdrawal by Subject|1|||
155369950|NCT03538938|560787898|FG010|Overall Study|Withdrawal by Subject|2|||
155369951|NCT03538938|560787899|FG011|Overall Study|Withdrawal by Subject|1|||
155369952|NCT03538938|560787900|FG012|Overall Study|Withdrawal by Subject|3|||
155369953|NCT03538938|560787901|FG013|Overall Study|Withdrawal by Subject|0|||
155369954|NCT03538938|560787902|FG014|Overall Study|Withdrawal by Subject|2|||
155369955|NCT03538938|560787903|FG015|Overall Study|Withdrawal by Subject|4|||
155369956|NCT03538938|560787888|FG000|Overall Study|Incarcerated|0|||
155369957|NCT03538938|560787889|FG001|Overall Study|Incarcerated|0|||
155369958|NCT03538938|560787890|FG002|Overall Study|Incarcerated|0|||
155369959|NCT03538938|560787891|FG003|Overall Study|Incarcerated|0|||
155369960|NCT03538938|560787892|FG004|Overall Study|Incarcerated|0|||
155369961|NCT03538938|560787893|FG005|Overall Study|Incarcerated|0|||
155369962|NCT03538938|560787894|FG006|Overall Study|Incarcerated|0|||
155369963|NCT03538938|560787895|FG007|Overall Study|Incarcerated|0|||
155369964|NCT03538938|560787896|FG008|Overall Study|Incarcerated|0|||
155369965|NCT03538938|560787897|FG009|Overall Study|Incarcerated|0|||
155369966|NCT03538938|560787898|FG010|Overall Study|Incarcerated|0|||
155369967|NCT03538938|560787899|FG011|Overall Study|Incarcerated|1|||
155369968|NCT03538938|560787900|FG012|Overall Study|Incarcerated|0|||
155369969|NCT03538938|560787901|FG013|Overall Study|Incarcerated|0|||
155369970|NCT03538938|560787902|FG014|Overall Study|Incarcerated|0|||
155369971|NCT03538938|560787903|FG015|Overall Study|Incarcerated|0|||
155369972|NCT00755105|560787904|FG000|Overall Study|Withdrawal by Subject|9|||
155369973|NCT00755105|560787905|FG001|Overall Study|Withdrawal by Subject|11|||
155369974|NCT00755105|560787906|FG002|Overall Study|Withdrawal by Subject|4|||
155369975|NCT02202785|560787907|FG000|Overall Study|Study Terminated by Sponsor|1|||
155649453|NCT01122680|561808271|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
155649454|NCT01122680|561808272|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
155649455|NCT01122680|561808273|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
155369976|NCT02202785|560787908|FG001|Overall Study|Study Terminated by Sponsor|6|||
155649456|NCT01122680|561808274|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
155649457|NCT01122680|561808271|FG000|Period 1 (4 Weeks)|Other|1|||
155649458|NCT01122680|561808272|FG001|Period 1 (4 Weeks)|Other|1|||
155649459|NCT01122680|561808273|FG002|Period 1 (4 Weeks)|Other|0|||
155369977|NCT02202785|560787909|FG002|Overall Study|Study Terminated by Sponsor|4|||
155369978|NCT02202785|560787907|FG000|Overall Study|Withdrawal by Subject|0|||
155369979|NCT02202785|560787908|FG001|Overall Study|Withdrawal by Subject|1|||
155369980|NCT02202785|560787909|FG002|Overall Study|Withdrawal by Subject|0|||
155369981|NCT02202785|560787907|FG000|Overall Study|Lost to Follow-up|0|||
155369982|NCT02202785|560787908|FG001|Overall Study|Lost to Follow-up|1|||
155649460|NCT01122680|561808274|FG003|Period 1 (4 Weeks)|Other|0|||
155369983|NCT02202785|560787909|FG002|Overall Study|Lost to Follow-up|0|||
155369984|NCT02202785|560787907|FG000|Overall Study|Reason not Specified|10|||
155369985|NCT02202785|560787908|FG001|Overall Study|Reason not Specified|7|||
155369986|NCT02202785|560787909|FG002|Overall Study|Reason not Specified|13|||
155369987|NCT03945825|560787917|FG000|Overall Study|Enrolled but treatment not administered|0|||
155369988|NCT03945825|560787918|FG001|Overall Study|Enrolled but treatment not administered|0|||
155369989|NCT03945825|560787919|FG002|Overall Study|Enrolled but treatment not administered|0|||
155369990|NCT03945825|560787920|FG003|Overall Study|Enrolled but treatment not administered|0|||
155369991|NCT03945825|560787921|FG004|Overall Study|Enrolled but treatment not administered|1|||
155369992|NCT03945825|560787922|FG005|Overall Study|Enrolled but treatment not administered|0|||
155369993|NCT03945825|560787917|FG000|Overall Study|Lost to Follow-up|1|||
155369994|NCT03945825|560787918|FG001|Overall Study|Lost to Follow-up|5|||
155369995|NCT03945825|560787919|FG002|Overall Study|Lost to Follow-up|0|||
155369996|NCT03945825|560787920|FG003|Overall Study|Lost to Follow-up|1|||
155369997|NCT03945825|560787921|FG004|Overall Study|Lost to Follow-up|2|||
155369998|NCT03945825|560787922|FG005|Overall Study|Lost to Follow-up|2|||
155369999|NCT03945825|560787917|FG000|Overall Study|Withdrawal by Subject|1|||
155370000|NCT03945825|560787918|FG001|Overall Study|Withdrawal by Subject|0|||
155370001|NCT03945825|560787919|FG002|Overall Study|Withdrawal by Subject|1|||
155370002|NCT03945825|560787920|FG003|Overall Study|Withdrawal by Subject|1|||
155370003|NCT03945825|560787921|FG004|Overall Study|Withdrawal by Subject|0|||
155370004|NCT03945825|560787922|FG005|Overall Study|Withdrawal by Subject|1|||
155370005|NCT00203268|560787923|FG000|Early Treatment|only treated one headache|2|||
155370006|NCT00203268|560787923|FG000|Early Treatment|Lost to Follow-up|1|||
155370007|NCT00203268|560787923|FG000|Early Treatment|Withdrawal by Subject|1|||
155370008|NCT04958200|560787925|FG000|Overall Study|Withdrawal by Subject|0|||
155370009|NCT04958200|560787926|FG001|Overall Study|Withdrawal by Subject|2|||
155370010|NCT04958200|560787925|FG000|Overall Study|Lost to Follow-up|3|||
155370011|NCT04958200|560787926|FG001|Overall Study|Lost to Follow-up|2|||
155370012|NCT03852719|560787929|FG000|Overall Study|Withdrawal of consent|8|||
155370013|NCT03852719|560787930|FG001|Overall Study|Withdrawal of consent|8|||
155370014|NCT03852719|560787931|FG002|Overall Study|Withdrawal of consent|9|||
155370015|NCT03852719|560787929|FG000|Overall Study|Physician Decision|5|||
155370016|NCT03852719|560787930|FG001|Overall Study|Physician Decision|4|||
155370017|NCT03852719|560787931|FG002|Overall Study|Physician Decision|1|||
155370018|NCT03852719|560787929|FG000|Overall Study|Pregnancy|2|||
155370019|NCT03852719|560787930|FG001|Overall Study|Pregnancy|1|||
155370020|NCT03852719|560787931|FG002|Overall Study|Pregnancy|0|||
155370021|NCT03852719|560787929|FG000|Overall Study|Death|1|||
155370022|NCT03852719|560787930|FG001|Overall Study|Death|0|||
155370023|NCT03852719|560787931|FG002|Overall Study|Death|0|||
155370024|NCT03852719|560787929|FG000|Overall Study|Reason not Specified|3|||
155370025|NCT03852719|560787930|FG001|Overall Study|Reason not Specified|3|||
155370026|NCT03852719|560787931|FG002|Overall Study|Reason not Specified|5|||
155370027|NCT03852719|560787929|FG000|Overall Study|Adverse Event|2|||
155370028|NCT03852719|560787930|FG001|Overall Study|Adverse Event|1|||
155370029|NCT03852719|560787931|FG002|Overall Study|Adverse Event|4|||
155370030|NCT03852719|560787929|FG000|Overall Study|Progressive disease|1|||
155370031|NCT03852719|560787930|FG001|Overall Study|Progressive disease|4|||
155370032|NCT03852719|560787931|FG002|Overall Study|Progressive disease|1|||
155370033|NCT03852719|560787929|FG000|Overall Study|Lost to Follow-up|1|||
155370034|NCT03852719|560787930|FG001|Overall Study|Lost to Follow-up|0|||
155370035|NCT03852719|560787931|FG002|Overall Study|Lost to Follow-up|0|||
155370036|NCT01647542|560787933|FG000|Overall Study|Major Protocol Deviation|1|||
155370037|NCT01647542|560787934|FG001|Overall Study|Major Protocol Deviation|0|||
155370038|NCT01647542|560787935|FG002|Overall Study|Major Protocol Deviation|0|||
155370039|NCT01647542|560787933|FG000|Overall Study|Adverse Event|4|||
155370040|NCT01647542|560787934|FG001|Overall Study|Adverse Event|5|||
155370041|NCT01647542|560787935|FG002|Overall Study|Adverse Event|4|||
155370042|NCT01647542|560787933|FG000|Overall Study|Lost to Follow-up|0|||
155370043|NCT01647542|560787934|FG001|Overall Study|Lost to Follow-up|2|||
155370044|NCT01647542|560787935|FG002|Overall Study|Lost to Follow-up|2|||
155370045|NCT01647542|560787933|FG000|Overall Study|Withdrawal by Subject|6|||
155370046|NCT01647542|560787934|FG001|Overall Study|Withdrawal by Subject|4|||
155370047|NCT01647542|560787935|FG002|Overall Study|Withdrawal by Subject|0|||
155370048|NCT01647542|560787933|FG000|Overall Study|Study Termination|64|||
155370049|NCT01647542|560787934|FG001|Overall Study|Study Termination|61|||
155370050|NCT01647542|560787935|FG002|Overall Study|Study Termination|65|||
155370051|NCT01647542|560787933|FG000|Overall Study|Lack of Efficacy|1|||
155370052|NCT01647542|560787934|FG001|Overall Study|Lack of Efficacy|1|||
155370053|NCT01647542|560787935|FG002|Overall Study|Lack of Efficacy|0|||
155370054|NCT01647542|560787933|FG000|Overall Study|Death|0|||
155370055|NCT01647542|560787934|FG001|Overall Study|Death|0|||
155370056|NCT01647542|560787935|FG002|Overall Study|Death|1|||
155370057|NCT02397447|560787936|FG000|Overall Study|Lost to Follow-up|2|||
155370058|NCT02397447|560787937|FG001|Overall Study|Lost to Follow-up|2|||
155370059|NCT02994069|560787940|FG000|Overall Study|Death|7|||
155370060|NCT02994069|560787941|FG001|Overall Study|Death|13|||
155370061|NCT02994069|560787940|FG000|Overall Study|Adverse Event|1|||
155370062|NCT02994069|560787941|FG001|Overall Study|Adverse Event|0|||
155370063|NCT02994069|560787940|FG000|Overall Study|Other|2|||
155370064|NCT02994069|560787941|FG001|Overall Study|Other|0|||
155370065|NCT02994069|560787940|FG000|Overall Study|still on follow up/treatment|5|||
155370066|NCT02994069|560787941|FG001|Overall Study|still on follow up/treatment|6|||
155370067|NCT06926673|560787944|FG000|Overall Study|Lost to Follow-up|0|||
155370068|NCT06926673|560787945|FG001|Overall Study|Lost to Follow-up|0|||
155370069|NCT06926673|560787946|FG002|Overall Study|Lost to Follow-up|0|||
155370070|NCT06926673|560787947|FG003|Overall Study|Lost to Follow-up|1|||
155370071|NCT06926673|560787948|FG004|Overall Study|Lost to Follow-up|0|||
155370072|NCT06926673|560787949|FG005|Overall Study|Lost to Follow-up|0|||
155370073|NCT06926673|560787950|FG006|Overall Study|Lost to Follow-up|0|||
155370074|NCT06926673|560787944|FG000|Overall Study|Physician Decision|0|||
155370075|NCT06926673|560787945|FG001|Overall Study|Physician Decision|0|||
155370076|NCT06926673|560787946|FG002|Overall Study|Physician Decision|0|||
155370077|NCT06926673|560787947|FG003|Overall Study|Physician Decision|0|||
155370078|NCT06926673|560787948|FG004|Overall Study|Physician Decision|0|||
155370079|NCT06926673|560787949|FG005|Overall Study|Physician Decision|0|||
155370080|NCT06926673|560787950|FG006|Overall Study|Physician Decision|1|||
155370081|NCT06926673|560787944|FG000|Overall Study|Withdrawal by Subject|0|||
155370082|NCT06926673|560787945|FG001|Overall Study|Withdrawal by Subject|3|||
155370083|NCT06926673|560787946|FG002|Overall Study|Withdrawal by Subject|2|||
155370084|NCT06926673|560787947|FG003|Overall Study|Withdrawal by Subject|1|||
155370085|NCT06926673|560787948|FG004|Overall Study|Withdrawal by Subject|0|||
155370086|NCT06926673|560787949|FG005|Overall Study|Withdrawal by Subject|2|||
155370087|NCT06926673|560787950|FG006|Overall Study|Withdrawal by Subject|0|||
155370088|NCT03345576|560787953|FG000|Overall Study|Withdrawal by Subject|2|||
155370089|NCT03345576|560787954|FG001|Overall Study|Withdrawal by Subject|2|||
155370090|NCT03345576|560787953|FG000|Overall Study|Adverse Event|1|||
155370091|NCT03345576|560787954|FG001|Overall Study|Adverse Event|0|||
155370092|NCT01255631|560789424|FG000|Overall Study|poor enrollment, no data analyzed|9|||
155370093|NCT01255631|560789425|FG001|Overall Study|poor enrollment, no data analyzed|6|||
155370094|NCT00515671|560789426|FG000|Overall Study|Lost to Follow-up|13|||
155370095|NCT00515671|560789427|FG001|Overall Study|Lost to Follow-up|10|||
155370096|NCT00515671|560789426|FG000|Overall Study|Withdrawal by Subject|3|||
155370097|NCT00515671|560789427|FG001|Overall Study|Withdrawal by Subject|5|||
155370098|NCT00515671|560789426|FG000|Overall Study|incarcerated|1|||
155370099|NCT00515671|560789427|FG001|Overall Study|incarcerated|2|||
155370100|NCT00264303|560789428|FG000|Overall Study|Adverse Event|4|||
155370101|NCT00264303|560789429|FG001|Overall Study|Adverse Event|3|||
155370102|NCT00264303|560789428|FG000|Overall Study|Lack of Efficacy|10|||
155370103|NCT00264303|560789429|FG001|Overall Study|Lack of Efficacy|13|||
155370104|NCT00264303|560789428|FG000|Overall Study|Lost to Follow-up|3|||
155370105|NCT00264303|560789429|FG001|Overall Study|Lost to Follow-up|3|||
155370106|NCT00264303|560789428|FG000|Overall Study|Withdrawal by Subject|2|||
155370107|NCT00264303|560789429|FG001|Overall Study|Withdrawal by Subject|3|||
155370108|NCT00264303|560789428|FG000|Overall Study|Various reasons listed in study report|6|||
155370109|NCT00264303|560789429|FG001|Overall Study|Various reasons listed in study report|7|||
155370110|NCT02311673|560789430|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370111|NCT02311673|560789431|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370112|NCT02311673|560789432|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
155370113|NCT02311673|560789433|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370114|NCT04165031|560789439|FG000|Overall Study|Adverse Event|1|||
155370115|NCT04165031|560789440|FG001|Overall Study|Adverse Event|1|||
155509827|NCT01335464|561291834|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
155649461|NCT01122680|561808271|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
155370116|NCT04165031|560789441|FG002|Overall Study|Adverse Event|0|||
155370117|NCT04165031|560789442|FG003|Overall Study|Adverse Event|0|||
155370118|NCT04165031|560789443|FG004|Overall Study|Adverse Event|0|||
155370119|NCT04165031|560789444|FG005|Overall Study|Adverse Event|0|||
155370120|NCT04165031|560789439|FG000|Overall Study|Withdrawal by Subject|0|||
155370121|NCT04165031|560789440|FG001|Overall Study|Withdrawal by Subject|0|||
155370122|NCT04165031|560789441|FG002|Overall Study|Withdrawal by Subject|1|||
155370123|NCT04165031|560789442|FG003|Overall Study|Withdrawal by Subject|0|||
155370124|NCT04165031|560789443|FG004|Overall Study|Withdrawal by Subject|0|||
155370125|NCT04165031|560789444|FG005|Overall Study|Withdrawal by Subject|0|||
155370126|NCT00818168|560789445|FG000|Overall Study|Lack of Efficacy|18|||
155370127|NCT00818168|560789445|FG000|Overall Study|Pregnancy|2|||
155370128|NCT00818168|560789445|FG000|Overall Study|Withdrawal by Subject|16|||
155370129|NCT00818168|560789445|FG000|Overall Study|Lost to Follow-up|7|||
155370130|NCT00818168|560789445|FG000|Overall Study|Adverse Event|19|||
155370131|NCT00818168|560789445|FG000|Overall Study|Reason for Non-completion Not reported|6|||
155370132|NCT00818168|560789445|FG000|Overall Study|Participant Moved|2|||
155370133|NCT00667225|560789448|FG000|Overall Study|Subject had no more lesions to treat.|1|||
155370134|NCT00667225|560789449|FG001|Overall Study|Subject had no more lesions to treat.|0|||
155370135|NCT00667225|560789448|FG000|Overall Study|Lost to Follow-up|0|||
155370136|NCT00667225|560789449|FG001|Overall Study|Lost to Follow-up|1|||
155370137|NCT02993406|560789450|FG000|Overall Study|Withdrawal by Subject|170|||
155370138|NCT02993406|560789451|FG001|Overall Study|Withdrawal by Subject|196|||
155370139|NCT02993406|560789450|FG000|Overall Study|Physician Decision|3|||
155370140|NCT02993406|560789451|FG001|Overall Study|Physician Decision|5|||
155370141|NCT02993406|560789450|FG000|Overall Study|Lost to Follow-up|12|||
155370142|NCT02993406|560789451|FG001|Overall Study|Lost to Follow-up|13|||
155370143|NCT02993406|560789450|FG000|Overall Study|Unclassifiable Response|105|||
155370144|NCT02993406|560789451|FG001|Overall Study|Unclassifiable Response|139|||
155370145|NCT02993406|560789450|FG000|Overall Study|Administrative decision|1|||
155370146|NCT02993406|560789451|FG001|Overall Study|Administrative decision|0|||
155370147|NCT02993406|560789450|FG000|Overall Study|Sponsor decision|4|||
155370148|NCT02993406|560789451|FG001|Overall Study|Sponsor decision|5|||
155370149|NCT03563157|560789452|FG000|Overall Study|Progressive Disease|2|||
155370150|NCT02248818|560789453|FG000|Screening|Protocol Violation|0|||
155370151|NCT02248818|560789454|FG001|Screening|Protocol Violation|0|||
155370152|NCT02248818|560789455|FG002|Screening|Protocol Violation|0|||
155370153|NCT02248818|560789456|FG003|Screening|Protocol Violation|0|||
155370154|NCT02248818|560789457|FG004|Screening|Protocol Violation|0|||
155370155|NCT02248818|560789458|FG005|Screening|Protocol Violation|0|||
155370156|NCT02248818|560789459|FG006|Screening|Protocol Violation|0|||
155370157|NCT02248818|560789460|FG007|Screening|Protocol Violation|0|||
155370158|NCT02248818|560789461|FG008|Screening|Protocol Violation|7|||
155370159|NCT02248818|560789453|FG000|Screening|Study fully enrolled|0|||
155370160|NCT02248818|560789454|FG001|Screening|Study fully enrolled|0|||
155370161|NCT02248818|560789455|FG002|Screening|Study fully enrolled|0|||
155370162|NCT02248818|560789456|FG003|Screening|Study fully enrolled|0|||
155370163|NCT02248818|560789457|FG004|Screening|Study fully enrolled|0|||
155370164|NCT02248818|560789458|FG005|Screening|Study fully enrolled|0|||
155370165|NCT02248818|560789459|FG006|Screening|Study fully enrolled|0|||
155370166|NCT02248818|560789460|FG007|Screening|Study fully enrolled|0|||
155370167|NCT02248818|560789461|FG008|Screening|Study fully enrolled|14|||
155370168|NCT02248818|560789453|FG000|Screening|Physician Decision|0|||
155370169|NCT02248818|560789454|FG001|Screening|Physician Decision|0|||
155370170|NCT02248818|560789455|FG002|Screening|Physician Decision|0|||
155370171|NCT02248818|560789456|FG003|Screening|Physician Decision|0|||
155370172|NCT02248818|560789457|FG004|Screening|Physician Decision|0|||
155370173|NCT02248818|560789458|FG005|Screening|Physician Decision|0|||
155370174|NCT02248818|560789459|FG006|Screening|Physician Decision|0|||
155370175|NCT02248818|560789460|FG007|Screening|Physician Decision|0|||
155370176|NCT02248818|560789461|FG008|Screening|Physician Decision|73|||
155429367|NCT05630846|560998931|FG003|Overall Study|Death|0|||
155429368|NCT05630846|560998928|FG000|Overall Study|Withdrawal by Subject|3|||
155429369|NCT05630846|560998929|FG001|Overall Study|Withdrawal by Subject|3|||
155370177|NCT02248818|560789453|FG000|Screening|Withdrawal by Subject|0|||
155370178|NCT02248818|560789454|FG001|Screening|Withdrawal by Subject|0|||
155370179|NCT02248818|560789455|FG002|Screening|Withdrawal by Subject|0|||
155429370|NCT05630846|560998930|FG002|Overall Study|Withdrawal by Subject|4|||
155429371|NCT05630846|560998931|FG003|Overall Study|Withdrawal by Subject|1|||
155370180|NCT02248818|560789456|FG003|Screening|Withdrawal by Subject|0|||
155370181|NCT02248818|560789457|FG004|Screening|Withdrawal by Subject|0|||
155370182|NCT02248818|560789458|FG005|Screening|Withdrawal by Subject|0|||
155370183|NCT02248818|560789459|FG006|Screening|Withdrawal by Subject|0|||
155370184|NCT02248818|560789460|FG007|Screening|Withdrawal by Subject|0|||
155370185|NCT02248818|560789461|FG008|Screening|Withdrawal by Subject|6|||
155370186|NCT02248818|560789453|FG000|Screening|Lost to Follow-up|0|||
155370187|NCT02248818|560789454|FG001|Screening|Lost to Follow-up|0|||
155370188|NCT02248818|560789455|FG002|Screening|Lost to Follow-up|0|||
155370189|NCT02248818|560789456|FG003|Screening|Lost to Follow-up|0|||
155370190|NCT02248818|560789457|FG004|Screening|Lost to Follow-up|0|||
155370191|NCT02248818|560789458|FG005|Screening|Lost to Follow-up|0|||
155370192|NCT02248818|560789459|FG006|Screening|Lost to Follow-up|0|||
155370193|NCT02248818|560789460|FG007|Screening|Lost to Follow-up|0|||
155370194|NCT02248818|560789461|FG008|Screening|Lost to Follow-up|7|||
155370195|NCT02248818|560789453|FG000|Randomised Study|Administrative - randomization error|0|||
155370196|NCT02248818|560789454|FG001|Randomised Study|Administrative - randomization error|0|||
155370197|NCT02248818|560789455|FG002|Randomised Study|Administrative - randomization error|0|||
155370198|NCT02248818|560789456|FG003|Randomised Study|Administrative - randomization error|0|||
155370199|NCT02248818|560789457|FG004|Randomised Study|Administrative - randomization error|0|||
155370200|NCT02248818|560789458|FG005|Randomised Study|Administrative - randomization error|8|||
155370201|NCT02248818|560789459|FG006|Randomised Study|Administrative - randomization error|0|||
155370202|NCT02248818|560789460|FG007|Randomised Study|Administrative - randomization error|0|||
155370203|NCT02248818|560789461|FG008|Randomised Study|Administrative - randomization error|0|||
155370204|NCT02942277|560789462|FG000|Year 1|Withdrawal by Subject|0|||
155370205|NCT02942277|560789463|FG001|Year 1|Withdrawal by Subject|0|||
155370206|NCT02942277|560789464|FG002|Year 1|Withdrawal by Subject|0|||
155370207|NCT02942277|560789465|FG003|Year 1|Withdrawal by Subject|0|||
155370208|NCT02942277|560789466|FG004|Year 1|Withdrawal by Subject|1|||
155370209|NCT02942277|560789467|FG005|Year 1|Withdrawal by Subject|3|||
155370210|NCT02942277|560789468|FG006|Year 1|Withdrawal by Subject|0|||
155370211|NCT02942277|560789469|FG007|Year 1|Withdrawal by Subject|1|||
155370212|NCT02942277|560789470|FG008|Year 1|Withdrawal by Subject|0|||
155370213|NCT02942277|560789471|FG009|Year 1|Withdrawal by Subject|0|||
155370214|NCT02942277|560789472|FG010|Year 1|Withdrawal by Subject|3|||
155370215|NCT02942277|560789462|FG000|Year 1|Travel|0|||
155370216|NCT02942277|560789463|FG001|Year 1|Travel|1|||
155370217|NCT02942277|560789464|FG002|Year 1|Travel|0|||
155370218|NCT02942277|560789465|FG003|Year 1|Travel|0|||
155370219|NCT02942277|560789466|FG004|Year 1|Travel|4|||
155370220|NCT02942277|560789467|FG005|Year 1|Travel|5|||
155370221|NCT02942277|560789468|FG006|Year 1|Travel|0|||
155370222|NCT02942277|560789469|FG007|Year 1|Travel|0|||
155370223|NCT02942277|560789470|FG008|Year 1|Travel|0|||
155370224|NCT02942277|560789471|FG009|Year 1|Travel|0|||
155370225|NCT02942277|560789472|FG010|Year 1|Travel|8|||
155370226|NCT02942277|560789462|FG000|Year 1|Joined Army|0|||
155370227|NCT02942277|560789463|FG001|Year 1|Joined Army|1|||
155370228|NCT02942277|560789464|FG002|Year 1|Joined Army|0|||
155370229|NCT02942277|560789465|FG003|Year 1|Joined Army|0|||
155370230|NCT02942277|560789466|FG004|Year 1|Joined Army|0|||
155370231|NCT02942277|560789467|FG005|Year 1|Joined Army|0|||
155370232|NCT02942277|560789468|FG006|Year 1|Joined Army|0|||
155370233|NCT02942277|560789469|FG007|Year 1|Joined Army|0|||
155370234|NCT02942277|560789470|FG008|Year 1|Joined Army|0|||
155370235|NCT02942277|560789471|FG009|Year 1|Joined Army|0|||
155370236|NCT02942277|560789472|FG010|Year 1|Joined Army|0|||
155370237|NCT02942277|560789462|FG000|Year 1|Subject met withdrawal criteria|0|||
155370238|NCT02942277|560789463|FG001|Year 1|Subject met withdrawal criteria|0|||
155370239|NCT02942277|560789464|FG002|Year 1|Subject met withdrawal criteria|0|||
155370240|NCT02942277|560789465|FG003|Year 1|Subject met withdrawal criteria|1|||
155370241|NCT02942277|560789466|FG004|Year 1|Subject met withdrawal criteria|0|||
155370242|NCT02942277|560789467|FG005|Year 1|Subject met withdrawal criteria|0|||
155429372|NCT05630846|560998928|FG000|Overall Study|Lost to Follow-up|6|||
155429373|NCT05630846|560998929|FG001|Overall Study|Lost to Follow-up|5|||
155429374|NCT05630846|560998930|FG002|Overall Study|Lost to Follow-up|2|||
155429375|NCT05630846|560998931|FG003|Overall Study|Lost to Follow-up|5|||
155429376|NCT05630846|560998928|FG000|Overall Study|Other|1|||
155429377|NCT05630846|560998929|FG001|Overall Study|Other|0|||
155429378|NCT05630846|560998930|FG002|Overall Study|Other|0|||
155429379|NCT05630846|560998931|FG003|Overall Study|Other|0|||
155370243|NCT02942277|560789468|FG006|Year 1|Subject met withdrawal criteria|0|||
155370244|NCT02942277|560789469|FG007|Year 1|Subject met withdrawal criteria|0|||
155370245|NCT02942277|560789470|FG008|Year 1|Subject met withdrawal criteria|0|||
155370246|NCT02942277|560789471|FG009|Year 1|Subject met withdrawal criteria|0|||
155370247|NCT02942277|560789472|FG010|Year 1|Subject met withdrawal criteria|0|||
155370248|NCT02942277|560789462|FG000|Year 1|Lost to Follow-up|0|||
155370249|NCT02942277|560789463|FG001|Year 1|Lost to Follow-up|0|||
155370250|NCT02942277|560789464|FG002|Year 1|Lost to Follow-up|0|||
155370251|NCT02942277|560789465|FG003|Year 1|Lost to Follow-up|0|||
155370252|NCT02942277|560789466|FG004|Year 1|Lost to Follow-up|1|||
155370253|NCT02942277|560789467|FG005|Year 1|Lost to Follow-up|0|||
155370254|NCT02942277|560789468|FG006|Year 1|Lost to Follow-up|0|||
155370255|NCT02942277|560789469|FG007|Year 1|Lost to Follow-up|0|||
155370256|NCT02942277|560789470|FG008|Year 1|Lost to Follow-up|0|||
155370257|NCT02942277|560789471|FG009|Year 1|Lost to Follow-up|0|||
155370258|NCT02942277|560789472|FG010|Year 1|Lost to Follow-up|2|||
155370259|NCT02942277|560789462|FG000|Year 1|Protocol Violation|0|||
155370260|NCT02942277|560789463|FG001|Year 1|Protocol Violation|0|||
155370261|NCT02942277|560789464|FG002|Year 1|Protocol Violation|0|||
155370262|NCT02942277|560789465|FG003|Year 1|Protocol Violation|0|||
155370263|NCT02942277|560789466|FG004|Year 1|Protocol Violation|1|||
155429380|NCT03019549|560998932|FG000|Washout|DId not meet genotype criteria|11|||
155429381|NCT03019549|560998932|FG000|Period 2|Adverse Event|2|||
155370264|NCT02942277|560789467|FG005|Year 1|Protocol Violation|1|||
155370265|NCT02942277|560789468|FG006|Year 1|Protocol Violation|0|||
155370266|NCT02942277|560789469|FG007|Year 1|Protocol Violation|0|||
155370267|NCT02942277|560789470|FG008|Year 1|Protocol Violation|0|||
155370268|NCT02942277|560789471|FG009|Year 1|Protocol Violation|0|||
155370269|NCT02942277|560789472|FG010|Year 1|Protocol Violation|2|||
155370270|NCT02942277|560789462|FG000|Year 1|Pregnancy|0|||
155370271|NCT02942277|560789463|FG001|Year 1|Pregnancy|0|||
155370272|NCT02942277|560789464|FG002|Year 1|Pregnancy|0|||
155370273|NCT02942277|560789465|FG003|Year 1|Pregnancy|0|||
155370274|NCT02942277|560789466|FG004|Year 1|Pregnancy|0|||
155370275|NCT02942277|560789467|FG005|Year 1|Pregnancy|1|||
155370276|NCT02942277|560789468|FG006|Year 1|Pregnancy|0|||
155370277|NCT02942277|560789469|FG007|Year 1|Pregnancy|0|||
155370278|NCT02942277|560789470|FG008|Year 1|Pregnancy|0|||
155370279|NCT02942277|560789471|FG009|Year 1|Pregnancy|0|||
155370280|NCT02942277|560789472|FG010|Year 1|Pregnancy|0|||
155370281|NCT02942277|560789462|FG000|Year 2|Lost to Follow-up|0|||
155370282|NCT02942277|560789463|FG001|Year 2|Lost to Follow-up|0|||
155370283|NCT02942277|560789464|FG002|Year 2|Lost to Follow-up|0|||
155370284|NCT02942277|560789465|FG003|Year 2|Lost to Follow-up|0|||
155370285|NCT02942277|560789466|FG004|Year 2|Lost to Follow-up|2|||
155370286|NCT02942277|560789467|FG005|Year 2|Lost to Follow-up|1|||
155370287|NCT02942277|560789468|FG006|Year 2|Lost to Follow-up|0|||
155370288|NCT02942277|560789469|FG007|Year 2|Lost to Follow-up|0|||
155370289|NCT02942277|560789470|FG008|Year 2|Lost to Follow-up|0|||
155370290|NCT02942277|560789471|FG009|Year 2|Lost to Follow-up|0|||
155370291|NCT02942277|560789472|FG010|Year 2|Lost to Follow-up|0|||
155370292|NCT02942277|560789462|FG000|Year 2|Did not rescreen|0|||
155370293|NCT02942277|560789463|FG001|Year 2|Did not rescreen|0|||
155370294|NCT02942277|560789464|FG002|Year 2|Did not rescreen|1|||
155370295|NCT02942277|560789465|FG003|Year 2|Did not rescreen|1|||
155370296|NCT02942277|560789466|FG004|Year 2|Did not rescreen|9|||
155370297|NCT02942277|560789467|FG005|Year 2|Did not rescreen|6|||
155370298|NCT02942277|560789468|FG006|Year 2|Did not rescreen|0|||
155370299|NCT02942277|560789469|FG007|Year 2|Did not rescreen|1|||
155370300|NCT02942277|560789470|FG008|Year 2|Did not rescreen|0|||
155370301|NCT02942277|560789471|FG009|Year 2|Did not rescreen|0|||
155370302|NCT02942277|560789472|FG010|Year 2|Did not rescreen|21|||
155370303|NCT02942277|560789462|FG000|Year 2|Met withdrawal criteria|0|||
155370304|NCT02942277|560789463|FG001|Year 2|Met withdrawal criteria|0|||
155429382|NCT03019549|560998932|FG000|Period 2|Physician Decision|2|||
155429383|NCT03019549|560998932|FG000|Period 2|Withdrawal by Subject|1|||
155429384|NCT04030195|560998933|FG000|Overall Study|Withdrawal by Subject|2|||
155429385|NCT04030195|560998934|FG001|Overall Study|Withdrawal by Subject|0|||
155429386|NCT04030195|560998935|FG002|Overall Study|Withdrawal by Subject|0|||
155429387|NCT01412879|560998936|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
155429388|NCT01412879|560998937|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
155429389|NCT01412879|560998938|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
155429390|NCT01412879|560998936|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
155429391|NCT01412879|560998937|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
155429392|NCT01412879|560998938|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
155429393|NCT01412879|560998936|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
155429394|NCT01412879|560998937|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
155429395|NCT01412879|560998938|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
155429396|NCT01412879|560998936|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
155649462|NCT01122680|561808272|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
155649463|NCT01122680|561808273|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
155370305|NCT02942277|560789464|FG002|Year 2|Met withdrawal criteria|0|||
155509828|NCT01335464|561291835|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
155370306|NCT02942277|560789465|FG003|Year 2|Met withdrawal criteria|0|||
155370307|NCT02942277|560789466|FG004|Year 2|Met withdrawal criteria|1|||
155370308|NCT02942277|560789467|FG005|Year 2|Met withdrawal criteria|2|||
155370309|NCT02942277|560789468|FG006|Year 2|Met withdrawal criteria|0|||
155370310|NCT02942277|560789469|FG007|Year 2|Met withdrawal criteria|0|||
155370311|NCT02942277|560789470|FG008|Year 2|Met withdrawal criteria|0|||
155370312|NCT02942277|560789471|FG009|Year 2|Met withdrawal criteria|0|||
155370313|NCT02942277|560789472|FG010|Year 2|Met withdrawal criteria|1|||
155370314|NCT02942277|560789462|FG000|Year 2|Travel|0|||
155370315|NCT02942277|560789463|FG001|Year 2|Travel|1|||
155370316|NCT02942277|560789464|FG002|Year 2|Travel|0|||
155370317|NCT02942277|560789465|FG003|Year 2|Travel|0|||
155370318|NCT02942277|560789466|FG004|Year 2|Travel|0|||
155370319|NCT02942277|560789467|FG005|Year 2|Travel|1|||
155370320|NCT02942277|560789468|FG006|Year 2|Travel|0|||
155429397|NCT01412879|560998937|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
155429398|NCT01412879|560998938|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
155429399|NCT01412879|560998936|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
155429400|NCT01412879|560998937|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
155429401|NCT01412879|560998938|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
155429402|NCT01056107|560998940|FG000|Overall Study|Withdrawal by Subject|0|||
155429403|NCT01056107|560998941|FG001|Overall Study|Withdrawal by Subject|1|||
155429404|NCT01056107|560998942|FG002|Overall Study|Withdrawal by Subject|3|||
155429405|NCT01056107|560998943|FG003|Overall Study|Withdrawal by Subject|0|||
155429406|NCT00377962|560998944|FG000|Core Study: 0-12 Months|Adverse Event|18|||
155429407|NCT00377962|560998945|FG001|Core Study: 0-12 Months|Adverse Event|2|||
155429408|NCT00377962|560998944|FG000|Core Study: 0-12 Months|Death|3|||
155429409|NCT00377962|560998945|FG001|Core Study: 0-12 Months|Death|0|||
155429410|NCT00377962|560998944|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
155429411|NCT00377962|560998945|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
155429412|NCT00377962|560998944|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
155429413|NCT00377962|560998945|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
155429414|NCT00377962|560998944|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
155429415|NCT00377962|560998945|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
155429416|NCT00377962|560998944|FG000|Extension Study: 12-24 Months|Death|1|||
155429417|NCT00377962|560998945|FG001|Extension Study: 12-24 Months|Death|1|||
155429418|NCT00377962|560998944|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
155429419|NCT00377962|560998945|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
155429420|NCT00377962|560998944|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
155429421|NCT00377962|560998945|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
155429422|NCT00377962|560998944|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
155429423|NCT00377962|560998945|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
155429424|NCT00260208|560998953|FG000|Overall Study|Subject withdrew consent|11|||
155429425|NCT00260208|560998954|FG001|Overall Study|Subject withdrew consent|7|||
155429426|NCT00260208|560998953|FG000|Overall Study|Lost to Follow-up|6|||
155429427|NCT00260208|560998954|FG001|Overall Study|Lost to Follow-up|1|||
155429428|NCT00260208|560998953|FG000|Overall Study|Death|12|||
155429429|NCT00260208|560998954|FG001|Overall Study|Death|10|||
155429430|NCT00260208|560998953|FG000|Overall Study|Missing|18|||
155429431|NCT00260208|560998954|FG001|Overall Study|Missing|16|||
155429432|NCT03323749|560998955|FG000|Double-blind Period|Lost to Follow-up|4|||
155429433|NCT03323749|560998956|FG001|Double-blind Period|Lost to Follow-up|5|||
155429434|NCT03323749|560998955|FG000|Double-blind Period|Adverse Event|3|||
155429435|NCT03323749|560998956|FG001|Double-blind Period|Adverse Event|1|||
155429436|NCT03323749|560998955|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
155429437|NCT03323749|560998956|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
155429438|NCT03323749|560998955|FG000|Open-Label Period|Adverse Event|3|||
155509829|NCT01335464|561291834|FG000|Overall Study|Not treated|2|||
155509830|NCT01335464|561291835|FG001|Overall Study|Not treated|0|||
155509831|NCT01335464|561291834|FG000|Overall Study|Reason other than those stated above|1|||
155370321|NCT02942277|560789469|FG007|Year 2|Travel|0|||
155370322|NCT02942277|560789470|FG008|Year 2|Travel|0|||
155370323|NCT02942277|560789471|FG009|Year 2|Travel|1|||
155370324|NCT02942277|560789472|FG010|Year 2|Travel|3|||
155370325|NCT02942277|560789462|FG000|Year 2|Non-compliant|0|||
155370326|NCT02942277|560789463|FG001|Year 2|Non-compliant|0|||
155370327|NCT02942277|560789464|FG002|Year 2|Non-compliant|0|||
155370328|NCT02942277|560789465|FG003|Year 2|Non-compliant|0|||
155370329|NCT02942277|560789466|FG004|Year 2|Non-compliant|1|||
155370330|NCT02942277|560789467|FG005|Year 2|Non-compliant|1|||
155370331|NCT02942277|560789468|FG006|Year 2|Non-compliant|0|||
155370332|NCT02942277|560789469|FG007|Year 2|Non-compliant|0|||
155370333|NCT02942277|560789470|FG008|Year 2|Non-compliant|0|||
155370334|NCT02942277|560789471|FG009|Year 2|Non-compliant|0|||
155370335|NCT02942277|560789472|FG010|Year 2|Non-compliant|0|||
155370336|NCT02942277|560789462|FG000|Year 2|Withdrawal by Subject|0|||
155509832|NCT01335464|561291835|FG001|Overall Study|Reason other than those stated above|1|||
155370337|NCT02942277|560789463|FG001|Year 2|Withdrawal by Subject|0|||
155370338|NCT02942277|560789464|FG002|Year 2|Withdrawal by Subject|0|||
155370339|NCT02942277|560789465|FG003|Year 2|Withdrawal by Subject|0|||
155370340|NCT02942277|560789466|FG004|Year 2|Withdrawal by Subject|0|||
155370341|NCT02942277|560789467|FG005|Year 2|Withdrawal by Subject|0|||
155370342|NCT02942277|560789468|FG006|Year 2|Withdrawal by Subject|1|||
155370343|NCT02942277|560789469|FG007|Year 2|Withdrawal by Subject|0|||
155370344|NCT02942277|560789470|FG008|Year 2|Withdrawal by Subject|0|||
155370345|NCT02942277|560789471|FG009|Year 2|Withdrawal by Subject|0|||
155429439|NCT03323749|560998956|FG001|Open-Label Period|Adverse Event|10|||
155429440|NCT03323749|560998955|FG000|Open-Label Period|Withdrawal by Subject|7|||
155429441|NCT03323749|560998956|FG001|Open-Label Period|Withdrawal by Subject|5|||
155429442|NCT03263091|560998957|FG000|OL Component|Withdrawal by Subject|1|||
155370346|NCT02942277|560789472|FG010|Year 2|Withdrawal by Subject|0|||
155370347|NCT02187159|560789473|FG000|Overall Study|Protocol Violation|4|||
155370348|NCT02187159|560789474|FG001|Overall Study|Protocol Violation|6|||
155370349|NCT02187159|560789475|FG002|Overall Study|Protocol Violation|3|||
155370350|NCT02187159|560789476|FG003|Overall Study|Protocol Violation|4|||
155370351|NCT02187159|560789473|FG000|Overall Study|Lack of Efficacy|10|||
155370352|NCT02187159|560789474|FG001|Overall Study|Lack of Efficacy|5|||
155370353|NCT02187159|560789475|FG002|Overall Study|Lack of Efficacy|4|||
155370354|NCT02187159|560789476|FG003|Overall Study|Lack of Efficacy|7|||
155370355|NCT02187159|560789473|FG000|Overall Study|Adverse Event|28|||
155370356|NCT02187159|560789474|FG001|Overall Study|Adverse Event|33|||
155370357|NCT02187159|560789475|FG002|Overall Study|Adverse Event|42|||
155370358|NCT02187159|560789476|FG003|Overall Study|Adverse Event|50|||
155370359|NCT02187159|560789473|FG000|Overall Study|Withdrawal by Subject|24|||
155370360|NCT02187159|560789474|FG001|Overall Study|Withdrawal by Subject|28|||
155370361|NCT02187159|560789475|FG002|Overall Study|Withdrawal by Subject|25|||
155370362|NCT02187159|560789476|FG003|Overall Study|Withdrawal by Subject|26|||
155509833|NCT01783730|561291836|FG000|Overall Study|Failed to meet inclusion criteria|6|||
155509834|NCT02151461|561291837|FG000|Overall Study|Adverse Event|5|||
155370363|NCT02187159|560789473|FG000|Overall Study|Other|3|||
155370364|NCT02187159|560789474|FG001|Overall Study|Other|7|||
155370365|NCT02187159|560789475|FG002|Overall Study|Other|3|||
155370366|NCT02187159|560789476|FG003|Overall Study|Other|9|||
155370367|NCT01283152|560789479|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
155370368|NCT01283152|560789480|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
155370369|NCT01283152|560789479|FG000|Overall Study|Refused HESA|1|||
155370370|NCT01283152|560789480|FG001|Overall Study|Refused HESA|0|||
155370371|NCT04020185|560789483|FG000|Overall Study|Death|0|||
155370372|NCT04020185|560789484|FG001|Overall Study|Death|0|||
155370373|NCT04020185|560789485|FG002|Overall Study|Death|1|||
155370374|NCT04020185|560789486|FG003|Overall Study|Death|2|||
155370375|NCT04020185|560789487|FG004|Overall Study|Death|1|||
155370376|NCT04020185|560789488|FG005|Overall Study|Death|0|||
155370377|NCT04020185|560789489|FG006|Overall Study|Death|1|||
155370378|NCT04020185|560789490|FG007|Overall Study|Death|0|||
155370379|NCT04020185|560789483|FG000|Overall Study|Consent withdrawn|1|||
155370380|NCT04020185|560789484|FG001|Overall Study|Consent withdrawn|0|||
155370381|NCT04020185|560789485|FG002|Overall Study|Consent withdrawn|0|||
155370382|NCT04020185|560789486|FG003|Overall Study|Consent withdrawn|0|||
155370383|NCT04020185|560789487|FG004|Overall Study|Consent withdrawn|2|||
155370384|NCT04020185|560789488|FG005|Overall Study|Consent withdrawn|0|||
155370385|NCT04020185|560789489|FG006|Overall Study|Consent withdrawn|1|||
155370386|NCT04020185|560789490|FG007|Overall Study|Consent withdrawn|1|||
155370387|NCT04020185|560789483|FG000|Overall Study|Patient in hospice|0|||
155370388|NCT04020185|560789484|FG001|Overall Study|Patient in hospice|1|||
155370389|NCT04020185|560789485|FG002|Overall Study|Patient in hospice|0|||
155370390|NCT04020185|560789486|FG003|Overall Study|Patient in hospice|0|||
155370391|NCT04020185|560789487|FG004|Overall Study|Patient in hospice|0|||
155370392|NCT04020185|560789488|FG005|Overall Study|Patient in hospice|0|||
155370393|NCT04020185|560789489|FG006|Overall Study|Patient in hospice|0|||
155370394|NCT04020185|560789490|FG007|Overall Study|Patient in hospice|0|||
155370395|NCT04020185|560789483|FG000|Overall Study|Continuing on expanded access|0|||
155370396|NCT04020185|560789484|FG001|Overall Study|Continuing on expanded access|0|||
155370397|NCT04020185|560789485|FG002|Overall Study|Continuing on expanded access|0|||
155370398|NCT04020185|560789486|FG003|Overall Study|Continuing on expanded access|0|||
155370399|NCT04020185|560789487|FG004|Overall Study|Continuing on expanded access|0|||
155370400|NCT04020185|560789488|FG005|Overall Study|Continuing on expanded access|0|||
155370401|NCT04020185|560789489|FG006|Overall Study|Continuing on expanded access|1|||
155370402|NCT04020185|560789490|FG007|Overall Study|Continuing on expanded access|1|||
155370403|NCT00527787|560789491|FG000|Overall Study|Adverse Event|14|||
155370404|NCT00527787|560789492|FG001|Overall Study|Adverse Event|24|||
155370405|NCT00527787|560789491|FG000|Overall Study|Withdrawal by Subject|13|||
155370406|NCT00527787|560789492|FG001|Overall Study|Withdrawal by Subject|25|||
155509835|NCT02151461|561291838|FG001|Overall Study|Adverse Event|1|||
155509836|NCT02151461|561291839|FG002|Overall Study|Adverse Event|0|||
155509837|NCT02151461|561291840|FG003|Overall Study|Adverse Event|2|||
155509838|NCT02151461|561291837|FG000|Overall Study|Lost to Follow-up|0|||
155509839|NCT02151461|561291838|FG001|Overall Study|Lost to Follow-up|0|||
155370407|NCT00527787|560789491|FG000|Overall Study|Lost to Follow-up|5|||
155370408|NCT00527787|560789492|FG001|Overall Study|Lost to Follow-up|2|||
155370409|NCT00527787|560789491|FG000|Overall Study|Duodenal Ulcer|1|||
155370410|NCT00527787|560789492|FG001|Overall Study|Duodenal Ulcer|10|||
155370411|NCT00527787|560789491|FG000|Overall Study|misc|5|||
155370412|NCT00527787|560789492|FG001|Overall Study|misc|2|||
155370413|NCT03330405|560789493|FG000|Overall Study|Other|1|||
155370414|NCT03330405|560789494|FG001|Overall Study|Other|3|||
155509840|NCT02151461|561291839|FG002|Overall Study|Lost to Follow-up|1|||
155509841|NCT02151461|561291840|FG003|Overall Study|Lost to Follow-up|1|||
155370415|NCT03330405|560789495|FG002|Overall Study|Other|1|||
155370416|NCT03330405|560789496|FG003|Overall Study|Other|0|||
155370417|NCT03330405|560789497|FG004|Overall Study|Other|2|||
155370418|NCT03330405|560789498|FG005|Overall Study|Other|0|||
155370419|NCT03330405|560789499|FG006|Overall Study|Other|1|||
155370420|NCT03330405|560789500|FG007|Overall Study|Other|0|||
155370421|NCT03330405|560789501|FG008|Overall Study|Other|0|||
155370422|NCT03330405|560789502|FG009|Overall Study|Other|0|||
155370423|NCT03330405|560789503|FG010|Overall Study|Other|0|||
155370424|NCT03330405|560789493|FG000|Overall Study|Progressive disease|8|||
155370425|NCT03330405|560789494|FG001|Overall Study|Progressive disease|27|||
155370426|NCT03330405|560789495|FG002|Overall Study|Progressive disease|4|||
155370427|NCT03330405|560789496|FG003|Overall Study|Progressive disease|18|||
155370428|NCT03330405|560789497|FG004|Overall Study|Progressive disease|16|||
155370429|NCT03330405|560789498|FG005|Overall Study|Progressive disease|14|||
155370430|NCT03330405|560789499|FG006|Overall Study|Progressive disease|7|||
155370431|NCT03330405|560789500|FG007|Overall Study|Progressive disease|29|||
155370432|NCT03330405|560789501|FG008|Overall Study|Progressive disease|9|||
155370433|NCT03330405|560789502|FG009|Overall Study|Progressive disease|11|||
155370434|NCT03330405|560789503|FG010|Overall Study|Progressive disease|5|||
155370435|NCT03330405|560789493|FG000|Overall Study|Withdrawal by Subject|1|||
155370436|NCT03330405|560789494|FG001|Overall Study|Withdrawal by Subject|4|||
155370437|NCT03330405|560789495|FG002|Overall Study|Withdrawal by Subject|0|||
155370438|NCT03330405|560789496|FG003|Overall Study|Withdrawal by Subject|1|||
155370439|NCT03330405|560789497|FG004|Overall Study|Withdrawal by Subject|1|||
155370440|NCT03330405|560789498|FG005|Overall Study|Withdrawal by Subject|1|||
155370441|NCT03330405|560789499|FG006|Overall Study|Withdrawal by Subject|0|||
155370442|NCT03330405|560789500|FG007|Overall Study|Withdrawal by Subject|2|||
155370443|NCT03330405|560789501|FG008|Overall Study|Withdrawal by Subject|2|||
155370444|NCT03330405|560789502|FG009|Overall Study|Withdrawal by Subject|1|||
155370445|NCT03330405|560789503|FG010|Overall Study|Withdrawal by Subject|1|||
155370446|NCT03330405|560789493|FG000|Overall Study|Global deterioration of health status|2|||
155370447|NCT03330405|560789494|FG001|Overall Study|Global deterioration of health status|3|||
155370448|NCT03330405|560789495|FG002|Overall Study|Global deterioration of health status|0|||
155370449|NCT03330405|560789496|FG003|Overall Study|Global deterioration of health status|2|||
155370450|NCT03330405|560789497|FG004|Overall Study|Global deterioration of health status|3|||
155370451|NCT03330405|560789498|FG005|Overall Study|Global deterioration of health status|3|||
155370452|NCT03330405|560789499|FG006|Overall Study|Global deterioration of health status|0|||
155370453|NCT03330405|560789500|FG007|Overall Study|Global deterioration of health status|2|||
155370454|NCT03330405|560789501|FG008|Overall Study|Global deterioration of health status|8|||
155370455|NCT03330405|560789502|FG009|Overall Study|Global deterioration of health status|4|||
155370456|NCT03330405|560789503|FG010|Overall Study|Global deterioration of health status|1|||
155370457|NCT03330405|560789493|FG000|Overall Study|Adverse Event|0|||
155370458|NCT03330405|560789494|FG001|Overall Study|Adverse Event|1|||
155370459|NCT03330405|560789495|FG002|Overall Study|Adverse Event|0|||
155370460|NCT03330405|560789496|FG003|Overall Study|Adverse Event|1|||
155370461|NCT03330405|560789497|FG004|Overall Study|Adverse Event|1|||
155370462|NCT03330405|560789498|FG005|Overall Study|Adverse Event|1|||
155370463|NCT03330405|560789499|FG006|Overall Study|Adverse Event|3|||
155370464|NCT03330405|560789500|FG007|Overall Study|Adverse Event|4|||
155370465|NCT03330405|560789501|FG008|Overall Study|Adverse Event|2|||
155370466|NCT03330405|560789502|FG009|Overall Study|Adverse Event|2|||
155509842|NCT02151461|561291837|FG000|Overall Study|Withdrawal by Subject|1|||
155509843|NCT02151461|561291838|FG001|Overall Study|Withdrawal by Subject|0|||
155509844|NCT02151461|561291839|FG002|Overall Study|Withdrawal by Subject|1|||
155509845|NCT02151461|561291840|FG003|Overall Study|Withdrawal by Subject|1|||
155370467|NCT03330405|560789503|FG010|Overall Study|Adverse Event|2|||
155370468|NCT03330405|560789493|FG000|Overall Study|Death|0|||
155370469|NCT03330405|560789494|FG001|Overall Study|Death|4|||
155370470|NCT03330405|560789495|FG002|Overall Study|Death|0|||
155370471|NCT03330405|560789496|FG003|Overall Study|Death|0|||
155370472|NCT03330405|560789497|FG004|Overall Study|Death|0|||
155370473|NCT03330405|560789498|FG005|Overall Study|Death|1|||
155370474|NCT03330405|560789499|FG006|Overall Study|Death|0|||
155509846|NCT02151461|561291837|FG000|Overall Study|Treatment discontinuation|0|||
155370475|NCT03330405|560789500|FG007|Overall Study|Death|2|||
155370476|NCT03330405|560789501|FG008|Overall Study|Death|0|||
155370477|NCT03330405|560789502|FG009|Overall Study|Death|0|||
155370478|NCT03330405|560789503|FG010|Overall Study|Death|0|||
155370479|NCT03330405|560789493|FG000|Overall Study|Physician Decision|0|||
155509847|NCT02151461|561291838|FG001|Overall Study|Treatment discontinuation|0|||
155509848|NCT02151461|561291839|FG002|Overall Study|Treatment discontinuation|1|||
155649464|NCT01122680|561808274|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
155370480|NCT03330405|560789494|FG001|Overall Study|Physician Decision|0|||
155370481|NCT03330405|560789495|FG002|Overall Study|Physician Decision|0|||
155370482|NCT03330405|560789496|FG003|Overall Study|Physician Decision|0|||
155370483|NCT03330405|560789497|FG004|Overall Study|Physician Decision|0|||
155370484|NCT03330405|560789498|FG005|Overall Study|Physician Decision|0|||
155370485|NCT03330405|560789499|FG006|Overall Study|Physician Decision|0|||
155370486|NCT03330405|560789500|FG007|Overall Study|Physician Decision|1|||
155370487|NCT03330405|560789501|FG008|Overall Study|Physician Decision|0|||
155370488|NCT03330405|560789502|FG009|Overall Study|Physician Decision|0|||
155370489|NCT03330405|560789503|FG010|Overall Study|Physician Decision|0|||
155370490|NCT01736189|560789506|FG000|Overall Study|Violation of registration criteria|41|||
155370491|NCT01736189|560789506|FG000|Overall Study|Protocol Violation|4|||
155370492|NCT01736189|560789506|FG000|Overall Study|Criteria and protocol violations|1|||
155370493|NCT03809039|560789507|FG000|Part 1|Withdrawal by Subject|1|||
155370494|NCT03809039|560789508|FG001|Part 1|Withdrawal by Subject|0|||
155370495|NCT03809039|560789509|FG002|Part 1|Withdrawal by Subject|0|||
155370496|NCT03809039|560789510|FG003|Part 1|Withdrawal by Subject|1|||
155370497|NCT03809039|560789511|FG004|Part 1|Withdrawal by Subject|0|||
155370498|NCT03809039|560789512|FG005|Part 1|Withdrawal by Subject|0|||
155370499|NCT03809039|560789513|FG006|Part 1|Withdrawal by Subject|0|||
155370500|NCT03809039|560789514|FG007|Part 1|Withdrawal by Subject|0|||
155370501|NCT03809039|560789515|FG008|Part 1|Withdrawal by Subject|0|||
155370502|NCT03809039|560789507|FG000|Part 3|Withdrawn by study termination|0|||
155370503|NCT03809039|560789508|FG001|Part 3|Withdrawn by study termination|0|||
155370504|NCT03809039|560789509|FG002|Part 3|Withdrawn by study termination|0|||
155370505|NCT03809039|560789510|FG003|Part 3|Withdrawn by study termination|0|||
155370506|NCT03809039|560789511|FG004|Part 3|Withdrawn by study termination|0|||
155370507|NCT03809039|560789512|FG005|Part 3|Withdrawn by study termination|0|||
155370508|NCT03809039|560789513|FG006|Part 3|Withdrawn by study termination|0|||
155370509|NCT03809039|560789514|FG007|Part 3|Withdrawn by study termination|2|||
155370510|NCT03809039|560789515|FG008|Part 3|Withdrawn by study termination|6|||
155370511|NCT00702962|560789516|FG000|Overall Study|Progressive disease|0|||
155370512|NCT00702962|560789517|FG001|Overall Study|Progressive disease|1|||
155370513|NCT00702962|560789516|FG000|Overall Study|Hospitalized for other health disorder|1|||
155370514|NCT00702962|560789517|FG001|Overall Study|Hospitalized for other health disorder|0|||
155370515|NCT01923467|560789520|FG000|Overall Study|Lost to Follow-up|62|||
155370516|NCT01923467|560789520|FG000|Overall Study|Subject non-interest|479|||
155370517|NCT01876901|560789521|FG000|Overall Study|Protocol Violation|10|||
155370518|NCT01876901|560789522|FG001|Overall Study|Protocol Violation|2|||
155370519|NCT01876901|560789521|FG000|Overall Study|No or other surgical intervention|7|||
155370520|NCT01876901|560789522|FG001|Overall Study|No or other surgical intervention|5|||
155370521|NCT01145898|560789523|FG000|3-year Treatment|medication change by treating physician|3|||
155370522|NCT01145898|560789524|FG001|3-year Treatment|medication change by treating physician|16|||
155370523|NCT00879775|560789525|FG000|Overall Study|Lost to Follow-up|2|||
155370524|NCT00879775|560789526|FG001|Overall Study|Lost to Follow-up|1|||
155370525|NCT01068665|560789527|FG000|Overall Study|Adverse Event|5|||
155370526|NCT01068665|560789528|FG001|Overall Study|Adverse Event|4|||
155370527|NCT01068665|560789527|FG000|Overall Study|Lack of Efficacy|0|||
155370528|NCT01068665|560789528|FG001|Overall Study|Lack of Efficacy|2|||
155370529|NCT01068665|560789527|FG000|Overall Study|Protocol Violation|5|||
155370530|NCT01068665|560789528|FG001|Overall Study|Protocol Violation|2|||
155370531|NCT01068665|560789527|FG000|Overall Study|Withdrawal Criteria|3|||
155370532|NCT01068665|560789528|FG001|Overall Study|Withdrawal Criteria|9|||
155370533|NCT01068665|560789527|FG000|Overall Study|Other|17|||
155370534|NCT01068665|560789528|FG001|Overall Study|Other|12|||
155370535|NCT03552523|560789530|FG000|Overall Study|Withdrawal by Subject|1|||
155370536|NCT03552523|560789531|FG001|Overall Study|Withdrawal by Subject|1|||
155370537|NCT00694109|560789532|FG000|Overall Study|Physician Decision|3|||
155370538|NCT00694109|560789532|FG000|Overall Study|Adverse Event|74|||
155370539|NCT00694109|560789532|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
155370540|NCT00694109|560789532|FG000|Overall Study|Lack of Efficacy|2|||
155370541|NCT00694109|560789532|FG000|Overall Study|Withdrawal by Subject|13|||
155370542|NCT00694109|560789532|FG000|Overall Study|Pregnancy|1|||
155370543|NCT00694109|560789532|FG000|Overall Study|Enrolled but not treated|1|||
155370544|NCT00694109|560789532|FG000|Overall Study|Other|2|||
155370545|NCT00694109|560789532|FG000|Overall Study|Consented but no additional treatment|3|||
155370546|NCT00846807|560789535|FG000|Overall Study|Adverse Event|270|||
155370547|NCT00846807|560789535|FG000|Overall Study|Lost to Follow-up|94|||
155370548|NCT00846807|560789535|FG000|Overall Study|Withdrawal by Subject|56|||
155370549|NCT00846807|560789535|FG000|Overall Study|Non compliant with European label|7|||
155370550|NCT00846807|560789535|FG000|Overall Study|Switch to other anticoagulants|89|||
155370551|NCT00846807|560789535|FG000|Overall Study|No prescription after hospital discharge|56|||
155370552|NCT00846807|560789535|FG000|Overall Study|Other|60|||
155370553|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
155370554|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
155370555|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
155370556|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
155370557|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
155429443|NCT03263091|560998958|FG001|OL Component|Withdrawal by Subject|1|||
155370558|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
155370559|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
155370560|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
155370561|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
155370562|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
155370563|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
155370564|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
155370565|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
155370566|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
155370567|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
155370568|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
155370569|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
155370570|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
155370571|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
155370572|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
155370573|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
155370574|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
155370575|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
155370576|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
155370577|NCT00737698|560789538|FG000|Overall Study|Withdrawal by Subject|6|||
155370578|NCT00737698|560789539|FG001|Overall Study|Withdrawal by Subject|5|||
155370579|NCT00737698|560789540|FG002|Overall Study|Withdrawal by Subject|3|||
155370580|NCT00737698|560789538|FG000|Overall Study|Death|0|||
155370581|NCT00737698|560789539|FG001|Overall Study|Death|0|||
155370582|NCT00737698|560789540|FG002|Overall Study|Death|1|||
155370583|NCT01067846|560789541|FG000|Overall Study|Lost to Follow-up|17|||
155370584|NCT01067846|560789542|FG001|Overall Study|Lost to Follow-up|19|||
155370585|NCT01067846|560789541|FG000|Overall Study|Withdrawal by Subject|1|||
155370586|NCT01067846|560789542|FG001|Overall Study|Withdrawal by Subject|0|||
155370587|NCT01067846|560789541|FG000|Overall Study|participation in other tx study|1|||
155370588|NCT01067846|560789542|FG001|Overall Study|participation in other tx study|0|||
155370589|NCT02817906|560789543|FG000|Overall Study|Adverse Event|3|||
155370590|NCT02817906|560789544|FG001|Overall Study|Adverse Event|0|||
155370591|NCT02817906|560789543|FG000|Overall Study|Lack of Efficacy|1|||
155370592|NCT02817906|560789544|FG001|Overall Study|Lack of Efficacy|0|||
155370593|NCT02817906|560789543|FG000|Overall Study|Protocol Violation|1|||
155370594|NCT02817906|560789544|FG001|Overall Study|Protocol Violation|1|||
155370595|NCT02817906|560789543|FG000|Overall Study|Study Terminated by Sponsor|2|||
155370596|NCT02817906|560789544|FG001|Overall Study|Study Terminated by Sponsor|2|||
155370597|NCT02817906|560789543|FG000|Overall Study|Withdrawal by Subject|7|||
155370598|NCT02817906|560789544|FG001|Overall Study|Withdrawal by Subject|0|||
155370599|NCT02817906|560789543|FG000|Overall Study|Other|2|||
155370600|NCT02817906|560789544|FG001|Overall Study|Other|2|||
155370601|NCT03686423|560789553|FG000|Overall Study|Withdrawal by Subject|9|||
155370602|NCT03686423|560789553|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
155370603|NCT02833077|560789554|FG000|Overall Study|Adverse Event|1|||
155370604|NCT02833077|560789555|FG001|Overall Study|Adverse Event|2|||
155370605|NCT02833077|560789554|FG000|Overall Study|Lost to Follow-up|10|||
155370606|NCT02833077|560789555|FG001|Overall Study|Lost to Follow-up|1|||
155370607|NCT02833077|560789554|FG000|Overall Study|Personal Reasons|6|||
155370608|NCT02833077|560789555|FG001|Overall Study|Personal Reasons|4|||
155370609|NCT02833077|560789554|FG000|Overall Study|Protocol Deviation|0|||
155370610|NCT02833077|560789555|FG001|Overall Study|Protocol Deviation|1|||
155370611|NCT00316017|560789558|FG000|Overall Study|Protocol Violation|11|||
155370612|NCT00316017|560789559|FG001|Overall Study|Protocol Violation|13|||
155370613|NCT00316017|560789560|FG002|Overall Study|Protocol Violation|19|||
155370614|NCT04157400|560789561|FG000|Overall Study|Withdrawal by Subject|1|||
155370615|NCT04157400|560789561|FG000|Overall Study|Lost to Follow-up|3|||
155370616|NCT04201262|560789563|FG000|Primary Treatment Period|Adverse Event|1|||
155370617|NCT04201262|560789564|FG001|Primary Treatment Period|Adverse Event|2|||
155370618|NCT04201262|560789563|FG000|Primary Treatment Period|Physician Decision|1|||
155370619|NCT04201262|560789564|FG001|Primary Treatment Period|Physician Decision|1|||
155370620|NCT04201262|560789563|FG000|Long-term Extension Period|Death|1|||
155370621|NCT04201262|560789564|FG001|Long-term Extension Period|Death|0|||
155370622|NCT05718466|560790417|FG000|Overall Study|Withdrawal by Subject|1|||
155370623|NCT05718466|560790418|FG001|Overall Study|Withdrawal by Subject|2|||
155370624|NCT05718466|560790417|FG000|Overall Study|Death|0|||
155370625|NCT05718466|560790418|FG001|Overall Study|Death|1|||
155370626|NCT01253135|560790419|FG000|Original Protocol|Protocol Amendment|15|||
155370627|NCT01253135|560790419|FG000|Amended Protocol|Non-compliance|1|||
155370628|NCT00833261|560790426|FG000|Overall Study|Withdrawal by Subject|4|||
155370629|NCT03339245|560790436|FG000|Overall Study|Adverse Event|1|||
155370630|NCT03339245|560790437|FG001|Overall Study|Adverse Event|1|||
155370631|NCT03339245|560790436|FG000|Overall Study|Withdrawal by Subject|1|||
155370632|NCT03339245|560790437|FG001|Overall Study|Withdrawal by Subject|0|||
155370633|NCT00288639|560790440|FG000|Overall Study|Adverse Event|5|||
155370634|NCT00288639|560790440|FG000|Overall Study|Lack of Efficacy|4|||
155370635|NCT00288639|560790440|FG000|Overall Study|Withdrawal by Subject|2|||
155370636|NCT00288639|560790440|FG000|Overall Study|Other|1|||
155370637|NCT02815579|560790441|FG000|Overall Study|Non-payment of loan down-payment|16|||
155370638|NCT02815579|560790442|FG001|Overall Study|Non-payment of loan down-payment|0|||
155370639|NCT02815579|560790441|FG000|Overall Study|Withdrawal by Subject|7|||
155370640|NCT02815579|560790442|FG001|Overall Study|Withdrawal by Subject|1|||
155370641|NCT02815579|560790441|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
155370642|NCT02815579|560790442|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
155370643|NCT02815579|560790441|FG000|Overall Study|Lost to Follow-up|7|||
155370644|NCT02815579|560790442|FG001|Overall Study|Lost to Follow-up|4|||
155370645|NCT02815579|560790441|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
155370646|NCT02815579|560790442|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
155370647|NCT02815579|560790441|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
155370648|NCT02815579|560790442|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
155370649|NCT02815579|560790441|FG000|Overall Study|Death|5|||
155370650|NCT02815579|560790442|FG001|Overall Study|Death|4|||
155370651|NCT02815579|560790441|FG000|Overall Study|Imprisoned|0|||
155370652|NCT02815579|560790442|FG001|Overall Study|Imprisoned|2|||
155370653|NCT02815579|560790441|FG000|Overall Study|Did not meet enrollment criteria|0|||
155370654|NCT02815579|560790442|FG001|Overall Study|Did not meet enrollment criteria|1|||
155370655|NCT02389452|560790443|FG000|Overall Study|Lost to Follow-up|13|||
155370656|NCT02389452|560790443|FG000|Overall Study|Adverse Event|1|||
155370657|NCT02389452|560790443|FG000|Overall Study|Withdrawal by Subject|5|||
155370658|NCT02389452|560790443|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
155370659|NCT01014208|560790449|FG000|Overall Study|Lost to Follow-up|2|||
155370660|NCT01014208|560790450|FG001|Overall Study|Lost to Follow-up|5|||
155370661|NCT01014208|560790449|FG000|Overall Study|Participant Withdrew Consent|12|||
155370662|NCT01014208|560790450|FG001|Overall Study|Participant Withdrew Consent|12|||
155370663|NCT01014208|560790449|FG000|Overall Study|Did Not Receive Study Drug|2|||
155370664|NCT01014208|560790450|FG001|Overall Study|Did Not Receive Study Drug|0|||
155370665|NCT01014208|560790449|FG000|Overall Study|Study Closed/terminated|78|||
155370666|NCT01014208|560790450|FG001|Overall Study|Study Closed/terminated|83|||
155370667|NCT00414908|560790453|FG000|Overall Study|Protocol Violation|1|||
155370668|NCT00414908|560790454|FG001|Overall Study|Protocol Violation|1|||
155370669|NCT01076153|560790455|FG000|Overall Study|Symptoms improved/resolved|10|||
155370670|NCT01076153|560790455|FG000|Overall Study|Adverse Event|1|||
155370671|NCT00567567|560790464|FG000|Overall Study|Adverse Event|0|||
155370672|NCT00567567|560790465|FG001|Overall Study|Adverse Event|2|||
155370673|NCT00567567|560790466|FG002|Overall Study|Adverse Event|5|||
155370674|NCT00567567|560790464|FG000|Overall Study|Death|8|||
155370675|NCT00567567|560790465|FG001|Overall Study|Death|1|||
155370676|NCT00567567|560790466|FG002|Overall Study|Death|5|||
155370677|NCT00567567|560790464|FG000|Overall Study|Lack of Efficacy|16|||
155370678|NCT00567567|560790465|FG001|Overall Study|Lack of Efficacy|17|||
155370679|NCT00567567|560790466|FG002|Overall Study|Lack of Efficacy|48|||
155370680|NCT00567567|560790464|FG000|Overall Study|Lost to Follow-up|0|||
155370681|NCT00567567|560790465|FG001|Overall Study|Lost to Follow-up|0|||
155370682|NCT00567567|560790466|FG002|Overall Study|Lost to Follow-up|1|||
155370683|NCT00567567|560790464|FG000|Overall Study|Physician Decision|16|||
155370684|NCT00567567|560790465|FG001|Overall Study|Physician Decision|18|||
155370685|NCT00567567|560790466|FG002|Overall Study|Physician Decision|84|||
155370686|NCT00567567|560790464|FG000|Overall Study|Withdrawal by Subject|0|||
155429444|NCT03263091|560998959|FG002|OL Component|Withdrawal by Subject|0|||
155429445|NCT03263091|560998960|FG003|OL Component|Withdrawal by Subject|0|||
155429446|NCT03263091|560998961|FG004|OL Component|Withdrawal by Subject|0|||
155429447|NCT03263091|560998962|FG005|OL Component|Withdrawal by Subject|0|||
155370687|NCT00567567|560790465|FG001|Overall Study|Withdrawal by Subject|0|||
155429448|NCT03263091|560998957|FG000|OL Component|Physician Decision|0|||
155429449|NCT03263091|560998958|FG001|OL Component|Physician Decision|1|||
155429450|NCT03263091|560998959|FG002|OL Component|Physician Decision|2|||
155429451|NCT03263091|560998960|FG003|OL Component|Physician Decision|0|||
155429452|NCT03263091|560998961|FG004|OL Component|Physician Decision|0|||
155429453|NCT03263091|560998962|FG005|OL Component|Physician Decision|0|||
155429454|NCT03263091|560998957|FG000|OL Component|Death|1|||
155429455|NCT03263091|560998958|FG001|OL Component|Death|0|||
155429456|NCT03263091|560998959|FG002|OL Component|Death|0|||
155429457|NCT03263091|560998960|FG003|OL Component|Death|0|||
155429458|NCT03263091|560998961|FG004|OL Component|Death|0|||
155370688|NCT00567567|560790466|FG002|Overall Study|Withdrawal by Subject|2|||
155370689|NCT00567567|560790464|FG000|Overall Study|Ineligible|4|||
155370690|NCT00567567|560790465|FG001|Overall Study|Ineligible|0|||
155370691|NCT00567567|560790466|FG002|Overall Study|Ineligible|9|||
155370692|NCT00567567|560790464|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
155370693|NCT00567567|560790465|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
155370694|NCT00567567|560790466|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
155370695|NCT00567567|560790464|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
155370696|NCT00567567|560790465|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
155370697|NCT00567567|560790466|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
155370698|NCT00567567|560790464|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
155370699|NCT00567567|560790465|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
155370700|NCT00567567|560790466|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
155370701|NCT03433677|560790467|FG000|Period 1|Protocol Violation|1|||
155370702|NCT03433677|560790468|FG001|Period 1|Protocol Violation|0|||
155370703|NCT03433677|560790467|FG000|Period 2|Withdrawal by Subject|1|||
155370704|NCT03433677|560790468|FG001|Period 2|Withdrawal by Subject|1|||
155370705|NCT00608868|560790471|FG000|Overall Study|Withdrawal by Subject|7|||
155370706|NCT00608868|560790471|FG000|Overall Study|Protocol Violation|3|||
155370707|NCT00608868|560790471|FG000|Overall Study|Lost to Follow-up|2|||
155370708|NCT00608868|560790471|FG000|Overall Study|Adverse Event|1|||
155370709|NCT00608868|560790471|FG000|Overall Study|Physician Decision|2|||
155370710|NCT02440425|560790477|FG000|Overall Study|Death likely due to disease progression|1|||
155370711|NCT02440425|560790477|FG000|Overall Study|Withdrawal by Subject|2|||
155370712|NCT02440425|560790477|FG000|Overall Study|Adverse Event|1|||
155370713|NCT02440425|560790477|FG000|Overall Study|Adverse Event/Ineligible|1|||
155370714|NCT04145700|560790482|FG000|Overall Study|Withdrawal by Subject|8|||
155370715|NCT04145700|560790483|FG001|Overall Study|Withdrawal by Subject|3|||
155370716|NCT00780559|560790486|FG000|Overall Study|Lost to Follow-up|2|||
155370717|NCT00780559|560790487|FG001|Overall Study|Lost to Follow-up|7|||
155370718|NCT00780559|560790486|FG000|Overall Study|Death|1|||
155370719|NCT00780559|560790487|FG001|Overall Study|Death|0|||
155370720|NCT01840410|560790492|FG000|Overall Study|Physician Decision|1|||
155370721|NCT01840410|560790493|FG001|Overall Study|Physician Decision|2|||
155370722|NCT01840410|560790492|FG000|Overall Study|Pregnancy|1|||
155370723|NCT01840410|560790493|FG001|Overall Study|Pregnancy|0|||
155370724|NCT01840410|560790492|FG000|Overall Study|Protocol deviation|1|||
155370725|NCT01840410|560790493|FG001|Overall Study|Protocol deviation|0|||
155370726|NCT01840410|560790492|FG000|Overall Study|Lost to Follow-up|1|||
155370727|NCT01840410|560790493|FG001|Overall Study|Lost to Follow-up|0|||
155370728|NCT01840410|560790492|FG000|Overall Study|Withdrawal by Subject|2|||
155370729|NCT01840410|560790493|FG001|Overall Study|Withdrawal by Subject|1|||
155370730|NCT01840410|560790492|FG000|Overall Study|Adverse Event|1|||
155370731|NCT01840410|560790493|FG001|Overall Study|Adverse Event|1|||
155370732|NCT00839956|560790494|FG000|Overall Study|Adverse Event|2|||
155370733|NCT00839956|560790494|FG000|Overall Study|Lack of Efficacy|6|||
155370734|NCT00839956|560790494|FG000|Overall Study|Physician Decision|1|||
155370735|NCT00839956|560790494|FG000|Overall Study|Withdrawal by Subject|3|||
155370736|NCT00972322|560790495|FG000|Overall Study|Adverse Event|2|||
155370737|NCT00972322|560790496|FG001|Overall Study|Adverse Event|1|||
155370738|NCT00972322|560790495|FG000|Overall Study|Positive drug screen|0|||
155370739|NCT00972322|560790496|FG001|Overall Study|Positive drug screen|1|||
155370740|NCT00972322|560790495|FG000|Overall Study|Lost to Follow-up|0|||
155370741|NCT00972322|560790496|FG001|Overall Study|Lost to Follow-up|1|||
155370742|NCT00972322|560790495|FG000|Overall Study|Consistently high glucose values|1|||
155370743|NCT00972322|560790496|FG001|Overall Study|Consistently high glucose values|0|||
155370744|NCT03682185|560790499|FG000|Overall Study|Lost to Follow-up|4|||
155370745|NCT03682185|560790500|FG001|Overall Study|Lost to Follow-up|7|||
155370746|NCT03682185|560790501|FG002|Overall Study|Lost to Follow-up|4|||
155370747|NCT03682185|560790502|FG003|Overall Study|Lost to Follow-up|7|||
155370748|NCT03682185|560790503|FG004|Overall Study|Lost to Follow-up|1|||
155370749|NCT03682185|560790499|FG000|Overall Study|Withdrawal by Subject|7|||
155370750|NCT03682185|560790500|FG001|Overall Study|Withdrawal by Subject|3|||
155370751|NCT03682185|560790501|FG002|Overall Study|Withdrawal by Subject|7|||
155370752|NCT03682185|560790502|FG003|Overall Study|Withdrawal by Subject|3|||
155370753|NCT03682185|560790503|FG004|Overall Study|Withdrawal by Subject|0|||
155370754|NCT03548220|560790505|FG000|Overall Study|Lost to Follow-up|1|||
155429459|NCT03263091|560998962|FG005|OL Component|Death|0|||
155370755|NCT03548220|560790506|FG001|Overall Study|Lost to Follow-up|0|||
155370756|NCT03548220|560790507|FG002|Overall Study|Lost to Follow-up|0|||
155370757|NCT03548220|560790508|FG003|Overall Study|Lost to Follow-up|0|||
155370758|NCT03853551|560791914|FG000|Overall Study|Death|2|||
155370759|NCT03853551|560791914|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
155370760|NCT01075958|560791917|FG000|Overall Study|Blood sample could not be obtained|44|||
155370761|NCT01240915|560791920|FG000|Overall Study|Adverse Event|0|||
155370762|NCT01240915|560791921|FG001|Overall Study|Adverse Event|0|||
155370763|NCT01240915|560791922|FG002|Overall Study|Adverse Event|0|||
155370764|NCT01240915|560791923|FG003|Overall Study|Adverse Event|1|||
155370765|NCT01240915|560791924|FG004|Overall Study|Adverse Event|0|||
155370766|NCT01240915|560791925|FG005|Overall Study|Adverse Event|2|||
155370767|NCT01240915|560791926|FG006|Overall Study|Adverse Event|0|||
155370768|NCT01240915|560791927|FG007|Overall Study|Adverse Event|0|||
155370769|NCT01240915|560791928|FG008|Overall Study|Adverse Event|1|||
155370770|NCT01240915|560791920|FG000|Overall Study|Lost to Follow-up|0|||
155370771|NCT01240915|560791921|FG001|Overall Study|Lost to Follow-up|0|||
155370772|NCT01240915|560791922|FG002|Overall Study|Lost to Follow-up|0|||
155429460|NCT03263091|560998957|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
155429461|NCT03263091|560998958|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
155429462|NCT03263091|560998959|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
155429463|NCT03263091|560998960|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
155429464|NCT03263091|560998961|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
155429465|NCT03263091|560998962|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
155429466|NCT03263091|560998957|FG000|OL High-EPO Component|Physician Decision|0|||
155429467|NCT03263091|560998958|FG001|OL High-EPO Component|Physician Decision|0|||
155370773|NCT01240915|560791923|FG003|Overall Study|Lost to Follow-up|0|||
155370774|NCT01240915|560791924|FG004|Overall Study|Lost to Follow-up|1|||
155370775|NCT01240915|560791925|FG005|Overall Study|Lost to Follow-up|1|||
155370776|NCT01240915|560791926|FG006|Overall Study|Lost to Follow-up|0|||
155370777|NCT01240915|560791927|FG007|Overall Study|Lost to Follow-up|1|||
155370778|NCT01240915|560791928|FG008|Overall Study|Lost to Follow-up|1|||
155370779|NCT01240915|560791920|FG000|Overall Study|Withdrawal by Subject|2|||
155370780|NCT01240915|560791921|FG001|Overall Study|Withdrawal by Subject|1|||
155370781|NCT01240915|560791922|FG002|Overall Study|Withdrawal by Subject|0|||
155370782|NCT01240915|560791923|FG003|Overall Study|Withdrawal by Subject|2|||
155370783|NCT01240915|560791924|FG004|Overall Study|Withdrawal by Subject|0|||
155429468|NCT03263091|560998959|FG002|OL High-EPO Component|Physician Decision|0|||
155370784|NCT01240915|560791925|FG005|Overall Study|Withdrawal by Subject|4|||
155370785|NCT01240915|560791926|FG006|Overall Study|Withdrawal by Subject|2|||
155370786|NCT01240915|560791927|FG007|Overall Study|Withdrawal by Subject|3|||
155370787|NCT01240915|560791928|FG008|Overall Study|Withdrawal by Subject|3|||
155370788|NCT01240915|560791920|FG000|Overall Study|Other|0|||
155370789|NCT01240915|560791921|FG001|Overall Study|Other|0|||
155370790|NCT01240915|560791922|FG002|Overall Study|Other|0|||
155370791|NCT01240915|560791923|FG003|Overall Study|Other|0|||
155370792|NCT01240915|560791924|FG004|Overall Study|Other|2|||
155370793|NCT01240915|560791925|FG005|Overall Study|Other|0|||
155370794|NCT01240915|560791926|FG006|Overall Study|Other|0|||
155370795|NCT01240915|560791927|FG007|Overall Study|Other|0|||
155370796|NCT01240915|560791928|FG008|Overall Study|Other|0|||
155429469|NCT03263091|560998960|FG003|OL High-EPO Component|Physician Decision|1|||
155429470|NCT03263091|560998961|FG004|OL High-EPO Component|Physician Decision|0|||
155429471|NCT03263091|560998962|FG005|OL High-EPO Component|Physician Decision|0|||
155429472|NCT03263091|560998957|FG000|OL High-EPO Component|Death|0|||
155429473|NCT03263091|560998958|FG001|OL High-EPO Component|Death|0|||
155429474|NCT03263091|560998959|FG002|OL High-EPO Component|Death|0|||
155429475|NCT03263091|560998960|FG003|OL High-EPO Component|Death|3|||
155429476|NCT03263091|560998961|FG004|OL High-EPO Component|Death|0|||
155429477|NCT03263091|560998962|FG005|OL High-EPO Component|Death|0|||
155649465|NCT01122680|561808271|FG000|Period 2 (4 Weeks)|Other|1|||
155649466|NCT01122680|561808272|FG001|Period 2 (4 Weeks)|Other|0|||
155649467|NCT01122680|561808273|FG002|Period 2 (4 Weeks)|Other|0|||
155509849|NCT02151461|561291840|FG003|Overall Study|Treatment discontinuation|0|||
155509850|NCT00931385|561291841|FG000|Overall Study|Adverse Event|2|||
155370797|NCT01240915|560791920|FG000|Overall Study|Insufficient Clinical Response|0|||
155370798|NCT01240915|560791921|FG001|Overall Study|Insufficient Clinical Response|0|||
155370799|NCT01240915|560791922|FG002|Overall Study|Insufficient Clinical Response|0|||
155370800|NCT01240915|560791923|FG003|Overall Study|Insufficient Clinical Response|0|||
155370801|NCT01240915|560791924|FG004|Overall Study|Insufficient Clinical Response|1|||
155370802|NCT01240915|560791925|FG005|Overall Study|Insufficient Clinical Response|3|||
155370803|NCT01240915|560791926|FG006|Overall Study|Insufficient Clinical Response|6|||
155370804|NCT01240915|560791927|FG007|Overall Study|Insufficient Clinical Response|0|||
155370805|NCT01240915|560791928|FG008|Overall Study|Insufficient Clinical Response|3|||
155370806|NCT02574845|560791932|FG000|Overall Study|Consent withdrawn further participation|0|||
155370807|NCT02574845|560791933|FG001|Overall Study|Consent withdrawn further participation|0|||
155429478|NCT03263091|560998957|FG000|DB Component|Withdrawal by Subject|0|||
155509851|NCT00931385|561291842|FG001|Overall Study|Adverse Event|1|||
155509852|NCT00931385|561291843|FG002|Overall Study|Adverse Event|0|||
155509853|NCT00931385|561291844|FG003|Overall Study|Adverse Event|3|||
155509854|NCT00931385|561291841|FG000|Overall Study|Protocol Violation|0|||
155509855|NCT00931385|561291842|FG001|Overall Study|Protocol Violation|0|||
155370808|NCT02574845|560791934|FG002|Overall Study|Consent withdrawn further participation|0|||
155509856|NCT00931385|561291843|FG002|Overall Study|Protocol Violation|1|||
155370809|NCT02574845|560791935|FG003|Overall Study|Consent withdrawn further participation|0|||
155649468|NCT01122680|561808274|FG003|Period 2 (4 Weeks)|Other|0|||
155370810|NCT02574845|560791936|FG004|Overall Study|Consent withdrawn further participation|1|||
155370811|NCT02574845|560791937|FG005|Overall Study|Consent withdrawn further participation|0|||
155370812|NCT02574845|560791932|FG000|Overall Study|Adverse Event|0|||
155370813|NCT02574845|560791933|FG001|Overall Study|Adverse Event|1|||
155370814|NCT02574845|560791934|FG002|Overall Study|Adverse Event|0|||
155370815|NCT02574845|560791935|FG003|Overall Study|Adverse Event|0|||
155429479|NCT03263091|560998958|FG001|DB Component|Withdrawal by Subject|0|||
155429480|NCT03263091|560998959|FG002|DB Component|Withdrawal by Subject|0|||
155509857|NCT00931385|561291844|FG003|Overall Study|Protocol Violation|0|||
155370816|NCT02574845|560791936|FG004|Overall Study|Adverse Event|0|||
155370817|NCT02574845|560791937|FG005|Overall Study|Adverse Event|1|||
155370818|NCT01867333|560791940|FG000|Overall Study|Withdrawal by Subject|1|||
155370819|NCT01867333|560791941|FG001|Overall Study|Withdrawal by Subject|0|||
155370820|NCT01867333|560791940|FG000|Overall Study|Adverse Event|1|||
155370821|NCT01867333|560791941|FG001|Overall Study|Adverse Event|0|||
155370822|NCT01867333|560791940|FG000|Overall Study|Participant choice|1|||
155370823|NCT01867333|560791941|FG001|Overall Study|Participant choice|2|||
155370824|NCT01867333|560791940|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
155370825|NCT01867333|560791941|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
155370826|NCT01867333|560791940|FG000|Overall Study|Death|0|||
155370827|NCT01867333|560791941|FG001|Overall Study|Death|1|||
155370828|NCT01867333|560791940|FG000|Overall Study|Physician Decision|3|||
155370829|NCT01867333|560791941|FG001|Overall Study|Physician Decision|2|||
155370830|NCT01867333|560791940|FG000|Overall Study|Switched to alternative treatment|1|||
155370831|NCT01867333|560791941|FG001|Overall Study|Switched to alternative treatment|0|||
155370832|NCT03101462|560791942|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
155370833|NCT03101462|560791943|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
155370834|NCT01696045|560791948|FG000|Overall Study|Study drug toxicity|1|||
155370835|NCT01696045|560791949|FG001|Overall Study|Study drug toxicity|5|||
155370836|NCT01696045|560791948|FG000|Overall Study|Disease progression|2|||
155370837|NCT01696045|560791949|FG001|Overall Study|Disease progression|2|||
155370838|NCT01559129|560791950|FG000|Treatment Phase|Adverse Event|0|||
155370839|NCT01559129|560791951|FG001|Treatment Phase|Adverse Event|2|||
155370840|NCT01559129|560791950|FG000|Treatment Phase|Progressive Disease|1|||
155370841|NCT01559129|560791951|FG001|Treatment Phase|Progressive Disease|1|||
155370842|NCT01559129|560791950|FG000|Treatment Phase|Lack of Efficacy|0|||
155370843|NCT01559129|560791951|FG001|Treatment Phase|Lack of Efficacy|1|||
155370844|NCT01559129|560791950|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
155370845|NCT01559129|560791951|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
155370846|NCT01559129|560791950|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
155370847|NCT01559129|560791951|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
155370848|NCT01559129|560791950|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
155370849|NCT01559129|560791951|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
155370850|NCT01559129|560791950|FG000|Open-label Extension Period|Adverse Event|1|||
155370851|NCT01559129|560791951|FG001|Open-label Extension Period|Adverse Event|0|||
155370852|NCT01559129|560791950|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
155370853|NCT01559129|560791951|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
155649469|NCT01122680|561808271|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
155370854|NCT03525392|560791952|FG000|Overall Study|Adverse Event|1|||
155370855|NCT03525392|560791953|FG001|Overall Study|Adverse Event|0|||
155370856|NCT03525392|560791954|FG002|Overall Study|Adverse Event|2|||
155649470|NCT01122680|561808272|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
155649471|NCT01122680|561808273|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
155649472|NCT01122680|561808274|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
155649473|NCT01122680|561808271|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155649474|NCT01122680|561808272|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
155649475|NCT01122680|561808273|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155649476|NCT01122680|561808274|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155649477|NCT04985682|561808275|FG000|Overall Study|Withdrawal by Subject|1|||
155649478|NCT03016403|561808282|FG000|Baseline|Death|5|||
155649479|NCT03016403|561808283|FG001|Baseline|Death|8|||
155649480|NCT03016403|561808284|FG002|Baseline|Death|1|||
155649481|NCT03016403|561808285|FG003|Baseline|Death|0|||
155649482|NCT03016403|561808282|FG000|Baseline|Withdrawal by Subject|2|||
155649483|NCT03016403|561808283|FG001|Baseline|Withdrawal by Subject|8|||
155649484|NCT03016403|561808284|FG002|Baseline|Withdrawal by Subject|4|||
155649485|NCT03016403|561808285|FG003|Baseline|Withdrawal by Subject|10|||
155370857|NCT03525392|560791955|FG003|Overall Study|Adverse Event|0|||
155370858|NCT03525392|560791956|FG004|Overall Study|Adverse Event|0|||
155370859|NCT03525392|560791952|FG000|Overall Study|Progressive disease|0|||
155370860|NCT03525392|560791953|FG001|Overall Study|Progressive disease|1|||
155370861|NCT03525392|560791954|FG002|Overall Study|Progressive disease|1|||
155649486|NCT03016403|561808282|FG000|Baseline|Lost to Follow-up|9|||
155429481|NCT03263091|560998960|FG003|DB Component|Withdrawal by Subject|0|||
155429482|NCT03263091|560998961|FG004|DB Component|Withdrawal by Subject|22|||
155370862|NCT03525392|560791955|FG003|Overall Study|Progressive disease|3|||
155370863|NCT03525392|560791956|FG004|Overall Study|Progressive disease|1|||
155370864|NCT00831129|560791959|FG000|Overall Study|Adverse Event|0|||
155370865|NCT00831129|560791960|FG001|Overall Study|Adverse Event|1|||
155370866|NCT00831129|560791959|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
155370867|NCT00831129|560791960|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
155370868|NCT01669577|560791961|FG000|Overall Study|Death|22|||
155370869|NCT01669577|560791961|FG000|Overall Study|Lost to Follow-up|78|||
155370870|NCT01669577|560791961|FG000|Overall Study|Physician Decision|34|||
155370871|NCT04462289|560791964|FG000|Overall Study|Lost to Follow-up|4|||
155370872|NCT04462289|560791965|FG001|Overall Study|Lost to Follow-up|5|||
155370873|NCT04462289|560791964|FG000|Overall Study|Death|0|||
155370874|NCT04462289|560791965|FG001|Overall Study|Death|3|||
155370875|NCT04462289|560791964|FG000|Overall Study|Withdrawal by Subject|1|||
155370876|NCT04462289|560791965|FG001|Overall Study|Withdrawal by Subject|3|||
155370877|NCT00818779|560791966|FG000|Overall Study|Protocol Violation|1|||
155370878|NCT00818779|560791967|FG001|Overall Study|Protocol Violation|0|||
155370879|NCT00818779|560791966|FG000|Overall Study|Lost to Follow-up|1|||
155370880|NCT00818779|560791967|FG001|Overall Study|Lost to Follow-up|0|||
155370881|NCT00818779|560791966|FG000|Overall Study|Adverse Event|4|||
155370882|NCT00818779|560791967|FG001|Overall Study|Adverse Event|1|||
155370883|NCT01518153|560791968|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
155370884|NCT01518153|560791969|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
155370885|NCT01518153|560791970|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
155370886|NCT01518153|560791968|FG000|Stem Cell Transplant|Death|2|||
155370887|NCT01518153|560791969|FG001|Stem Cell Transplant|Death|0|||
155370888|NCT01518153|560791970|FG002|Stem Cell Transplant|Death|0|||
155429483|NCT03263091|560998962|FG005|DB Component|Withdrawal by Subject|8|||
155429484|NCT03263091|560998957|FG000|DB Component|Physician Decision|0|||
155429485|NCT03263091|560998958|FG001|DB Component|Physician Decision|0|||
155429486|NCT03263091|560998959|FG002|DB Component|Physician Decision|0|||
155429487|NCT03263091|560998960|FG003|DB Component|Physician Decision|0|||
155429488|NCT03263091|560998961|FG004|DB Component|Physician Decision|3|||
155429489|NCT03263091|560998962|FG005|DB Component|Physician Decision|1|||
155429490|NCT03263091|560998957|FG000|DB Component|Adverse Event|0|||
155429491|NCT03263091|560998958|FG001|DB Component|Adverse Event|0|||
155429492|NCT03263091|560998959|FG002|DB Component|Adverse Event|0|||
155429493|NCT03263091|560998960|FG003|DB Component|Adverse Event|0|||
155429494|NCT03263091|560998961|FG004|DB Component|Adverse Event|2|||
155429495|NCT03263091|560998962|FG005|DB Component|Adverse Event|1|||
155429496|NCT03263091|560998957|FG000|DB Component|Lost to Follow-up|0|||
155429497|NCT03263091|560998958|FG001|DB Component|Lost to Follow-up|0|||
155429498|NCT03263091|560998959|FG002|DB Component|Lost to Follow-up|0|||
155429499|NCT03263091|560998960|FG003|DB Component|Lost to Follow-up|0|||
155429500|NCT03263091|560998961|FG004|DB Component|Lost to Follow-up|2|||
155429501|NCT03263091|560998962|FG005|DB Component|Lost to Follow-up|1|||
155429502|NCT03263091|560998957|FG000|DB Component|Death|0|||
155429503|NCT03263091|560998958|FG001|DB Component|Death|0|||
155429504|NCT03263091|560998959|FG002|DB Component|Death|0|||
155429505|NCT03263091|560998960|FG003|DB Component|Death|0|||
155429506|NCT03263091|560998961|FG004|DB Component|Death|7|||
155429507|NCT03263091|560998962|FG005|DB Component|Death|4|||
155429508|NCT03263091|560998957|FG000|DB Component|Other than specified|0|||
155429509|NCT03263091|560998958|FG001|DB Component|Other than specified|0|||
155429510|NCT03263091|560998959|FG002|DB Component|Other than specified|0|||
155429511|NCT03263091|560998960|FG003|DB Component|Other than specified|0|||
155429512|NCT03263091|560998961|FG004|DB Component|Other than specified|8|||
155429513|NCT03263091|560998962|FG005|DB Component|Other than specified|6|||
155429514|NCT01821963|560998963|FG000|Overall Study|Adverse Event|1|||
155429515|NCT00506389|560998964|FG000|In-treatment Period|Other|3|||
155429516|NCT00506389|560998965|FG001|In-treatment Period|Other|3|||
155429517|NCT00506389|560998966|FG002|In-treatment Period|Other|4|||
155429518|NCT00506389|560998964|FG000|In-treatment Period|Lost to Follow-up|0|||
155429519|NCT00506389|560998965|FG001|In-treatment Period|Lost to Follow-up|0|||
155429520|NCT00506389|560998966|FG002|In-treatment Period|Lost to Follow-up|1|||
155370889|NCT01518153|560791968|FG000|Stem Cell Transplant|Secondary graft failure|1|||
155429521|NCT00506389|560998964|FG000|In-treatment Period|Lack of compliance|1|||
155370890|NCT01518153|560791969|FG001|Stem Cell Transplant|Secondary graft failure|0|||
155370891|NCT01518153|560791970|FG002|Stem Cell Transplant|Secondary graft failure|0|||
155370892|NCT01518153|560791968|FG000|Stem Cell Transplant|Adverse Event|1|||
155370893|NCT01518153|560791969|FG001|Stem Cell Transplant|Adverse Event|0|||
155370894|NCT01518153|560791970|FG002|Stem Cell Transplant|Adverse Event|0|||
155370895|NCT01518153|560791968|FG000|Donor Lymphocyte Infusion|Death|0|||
155370896|NCT01518153|560791969|FG001|Donor Lymphocyte Infusion|Death|2|||
155370897|NCT01518153|560791970|FG002|Donor Lymphocyte Infusion|Death|1|||
155429522|NCT00506389|560998965|FG001|In-treatment Period|Lack of compliance|0|||
155429523|NCT00506389|560998966|FG002|In-treatment Period|Lack of compliance|0|||
155429524|NCT00506389|560998964|FG000|In-treatment Period|Reasons not related to trial|4|||
155649487|NCT03016403|561808283|FG001|Baseline|Lost to Follow-up|11|||
155370898|NCT00132873|560791971|FG000|Overall Study|Adverse Event|3|||
155370899|NCT00132873|560791971|FG000|Overall Study|Lost to Follow-up|1|||
155370900|NCT00132873|560791971|FG000|Overall Study|Lack of Efficacy|1|||
155649488|NCT03016403|561808284|FG002|Baseline|Lost to Follow-up|6|||
155649489|NCT03016403|561808285|FG003|Baseline|Lost to Follow-up|24|||
155509858|NCT00931385|561291841|FG000|Overall Study|Withdrawal by Subject|0|||
155509859|NCT00931385|561291842|FG001|Overall Study|Withdrawal by Subject|1|||
155509860|NCT00931385|561291843|FG002|Overall Study|Withdrawal by Subject|0|||
155509861|NCT00931385|561291844|FG003|Overall Study|Withdrawal by Subject|1|||
155509862|NCT00931385|561291841|FG000|Overall Study|Lost to Follow-up|0|||
155509863|NCT00931385|561291842|FG001|Overall Study|Lost to Follow-up|0|||
155509864|NCT00931385|561291843|FG002|Overall Study|Lost to Follow-up|0|||
155509865|NCT00931385|561291844|FG003|Overall Study|Lost to Follow-up|1|||
155509866|NCT01466686|561293382|FG000|Overall Study|Withdrawal by Subject|1|||
155509867|NCT03273387|561293383|FG000|Overall Study|Death|2|||
155509868|NCT03273387|561293384|FG001|Overall Study|Death|2|||
155509869|NCT03273387|561293383|FG000|Overall Study|Withdrawal by Subject|1|||
155509870|NCT03273387|561293384|FG001|Overall Study|Withdrawal by Subject|1|||
155509871|NCT02049359|561293385|FG000|Overall Study|Lost to Follow-up|26|||
155509872|NCT02049359|561293386|FG001|Overall Study|Lost to Follow-up|19|||
155509873|NCT01405950|561293387|FG000|Overall Study|Withdrawal by Subject|1|||
155509874|NCT01405950|561293388|FG001|Overall Study|Withdrawal by Subject|0|||
155509875|NCT01405950|561293389|FG002|Overall Study|Withdrawal by Subject|0|||
155509876|NCT01405950|561293390|FG003|Overall Study|Withdrawal by Subject|0|||
155509877|NCT01381900|561293391|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
155370901|NCT00132873|560791971|FG000|Overall Study|Withdrawal by Subject|3|||
155370902|NCT00132873|560791971|FG000|Overall Study|Planned Pregnancy|1|||
155370903|NCT04276415|560791972|FG000|Overall Study|Adverse Event|0|||
155370904|NCT04276415|560791973|FG001|Overall Study|Adverse Event|0|||
155370905|NCT04276415|560791974|FG002|Overall Study|Adverse Event|0|||
155370906|NCT04276415|560791975|FG003|Overall Study|Adverse Event|3|||
155370907|NCT04276415|560791976|FG004|Overall Study|Adverse Event|0|||
155429525|NCT00506389|560998965|FG001|In-treatment Period|Reasons not related to trial|1|||
155429526|NCT00506389|560998966|FG002|In-treatment Period|Reasons not related to trial|0|||
155429527|NCT00506389|560998964|FG000|In-treatment Period|Withdrawal by Subject|3|||
155429528|NCT00506389|560998965|FG001|In-treatment Period|Withdrawal by Subject|3|||
155429529|NCT00506389|560998966|FG002|In-treatment Period|Withdrawal by Subject|4|||
155429530|NCT00506389|560998964|FG000|In-treatment Period|Lack of Efficacy|0|||
155429531|NCT00506389|560998965|FG001|In-treatment Period|Lack of Efficacy|2|||
155429532|NCT00506389|560998966|FG002|In-treatment Period|Lack of Efficacy|0|||
155429533|NCT00506389|560998964|FG000|In-treatment Period|Adverse Event|11|||
155429534|NCT00506389|560998965|FG001|In-treatment Period|Adverse Event|5|||
155429535|NCT00506389|560998966|FG002|In-treatment Period|Adverse Event|2|||
155429536|NCT00506389|560998964|FG000|In-treatment Period|Randomized but not treated|4|||
155429537|NCT00506389|560998965|FG001|In-treatment Period|Randomized but not treated|1|||
155429538|NCT00506389|560998966|FG002|In-treatment Period|Randomized but not treated|1|||
155429539|NCT03539432|560998967|FG000|Overall Study|Lost to Follow-up|0|||
155429540|NCT03539432|560998968|FG001|Overall Study|Lost to Follow-up|1|||
155429541|NCT01381094|560998969|FG000|Overall Study|Adverse Event|1|||
155429542|NCT01381094|560998970|FG001|Overall Study|Adverse Event|2|||
155429543|NCT01381094|560998971|FG002|Overall Study|Adverse Event|0|||
155429544|NCT01381094|560998972|FG003|Overall Study|Adverse Event|1|||
155429545|NCT01381094|560998973|FG004|Overall Study|Adverse Event|0|||
155509878|NCT01381900|561293392|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
155649490|NCT03016403|561808282|FG000|6-week Follow-up|Death|1|||
155370908|NCT04276415|560791977|FG005|Overall Study|Adverse Event|0|||
155370909|NCT04276415|560791972|FG000|Overall Study|Clinical progression|1|||
155509879|NCT01381900|561293393|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
155509880|NCT01381900|561293391|FG000|Overall Study|Adverse Event|4|||
155509881|NCT01381900|561293392|FG001|Overall Study|Adverse Event|6|||
155370910|NCT04276415|560791973|FG001|Overall Study|Clinical progression|1|||
155370911|NCT04276415|560791974|FG002|Overall Study|Clinical progression|0|||
155370912|NCT04276415|560791975|FG003|Overall Study|Clinical progression|0|||
155370913|NCT04276415|560791976|FG004|Overall Study|Clinical progression|1|||
155370914|NCT04276415|560791977|FG005|Overall Study|Clinical progression|0|||
155370915|NCT04276415|560791972|FG000|Overall Study|Other|0|||
155370916|NCT04276415|560791973|FG001|Overall Study|Other|0|||
155370917|NCT04276415|560791974|FG002|Overall Study|Other|0|||
155370918|NCT04276415|560791975|FG003|Overall Study|Other|1|||
155370919|NCT04276415|560791976|FG004|Overall Study|Other|0|||
155370920|NCT04276415|560791977|FG005|Overall Study|Other|0|||
155370921|NCT04276415|560791972|FG000|Overall Study|Physician Decision|0|||
155370922|NCT04276415|560791973|FG001|Overall Study|Physician Decision|0|||
155370923|NCT04276415|560791974|FG002|Overall Study|Physician Decision|1|||
155370924|NCT04276415|560791975|FG003|Overall Study|Physician Decision|3|||
155370925|NCT04276415|560791976|FG004|Overall Study|Physician Decision|2|||
155370926|NCT04276415|560791977|FG005|Overall Study|Physician Decision|0|||
155370927|NCT04276415|560791972|FG000|Overall Study|Progressive disease|3|||
155370928|NCT04276415|560791973|FG001|Overall Study|Progressive disease|3|||
155370929|NCT04276415|560791974|FG002|Overall Study|Progressive disease|4|||
155370930|NCT04276415|560791975|FG003|Overall Study|Progressive disease|5|||
155370931|NCT04276415|560791976|FG004|Overall Study|Progressive disease|1|||
155370932|NCT04276415|560791977|FG005|Overall Study|Progressive disease|2|||
155370933|NCT04276415|560791972|FG000|Overall Study|Withdrawal by patient|0|||
155370934|NCT04276415|560791973|FG001|Overall Study|Withdrawal by patient|0|||
155370935|NCT04276415|560791974|FG002|Overall Study|Withdrawal by patient|0|||
155370936|NCT04276415|560791975|FG003|Overall Study|Withdrawal by patient|1|||
155370937|NCT04276415|560791976|FG004|Overall Study|Withdrawal by patient|2|||
155370938|NCT04276415|560791977|FG005|Overall Study|Withdrawal by patient|0|||
155370939|NCT03309813|560791978|FG000|Main Randomized Study|Withdrawal by Subject|1|||
155370940|NCT03309813|560791979|FG001|Main Randomized Study|Withdrawal by Subject|0|||
155370941|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital status: missing)|1|||
155370942|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital status: missing)|2|||
155370943|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital status: missing)|2|||
155370944|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital status: missing)|1|||
155370945|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
155370946|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
155370947|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
155370948|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
155370949|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
155370950|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
155370951|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
155370952|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
155370953|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
155370954|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
155370955|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
155370956|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
155370957|NCT01327846|560791980|FG000|Core Phase|Lost to Follow-up|3|||
155370958|NCT01327846|560791981|FG001|Core Phase|Lost to Follow-up|3|||
155370959|NCT01327846|560791982|FG002|Core Phase|Lost to Follow-up|4|||
155370960|NCT01327846|560791983|FG003|Core Phase|Lost to Follow-up|5|||
155370961|NCT01327846|560791980|FG000|Extension Phase|Study terminated by sponsor|1073|||
155370962|NCT01327846|560791981|FG001|Extension Phase|Study terminated by sponsor|1124|||
155370963|NCT01327846|560791982|FG002|Extension Phase|Study terminated by sponsor|1067|||
155370964|NCT01327846|560791983|FG003|Extension Phase|Study terminated by sponsor|1660|||
155370965|NCT01327846|560791980|FG000|Extension Phase|Withdrawal by Subject|20|||
155370966|NCT01327846|560791981|FG001|Extension Phase|Withdrawal by Subject|13|||
155370967|NCT01327846|560791982|FG002|Extension Phase|Withdrawal by Subject|19|||
155370968|NCT01327846|560791983|FG003|Extension Phase|Withdrawal by Subject|37|||
155370969|NCT01327846|560791980|FG000|Extension Phase|Lost to Follow-up|4|||
155429546|NCT01381094|560998969|FG000|Overall Study|Lost to Follow-up|0|||
155429547|NCT01381094|560998970|FG001|Overall Study|Lost to Follow-up|0|||
155429548|NCT01381094|560998971|FG002|Overall Study|Lost to Follow-up|0|||
155429549|NCT01381094|560998972|FG003|Overall Study|Lost to Follow-up|0|||
155429550|NCT01381094|560998973|FG004|Overall Study|Lost to Follow-up|1|||
155370970|NCT01327846|560791981|FG001|Extension Phase|Lost to Follow-up|3|||
155370971|NCT01327846|560791982|FG002|Extension Phase|Lost to Follow-up|4|||
155370972|NCT01327846|560791983|FG003|Extension Phase|Lost to Follow-up|7|||
155370973|NCT01327846|560791980|FG000|Extension Phase|Technical Problems|2|||
155370974|NCT01327846|560791981|FG001|Extension Phase|Technical Problems|4|||
155370975|NCT01327846|560791982|FG002|Extension Phase|Technical Problems|2|||
155370976|NCT01327846|560791983|FG003|Extension Phase|Technical Problems|2|||
155370977|NCT04343976|560791987|FG000|Overall Study|Withdrawal by Subject|0|||
155370978|NCT04343976|560791988|FG001|Overall Study|Withdrawal by Subject|1|||
155370979|NCT02807883|560791989|FG000|Overall Study|Withdrawal by Subject|2|||
155370980|NCT00594880|560791990|FG000|Overall Study|Withdrawal by Subject|1|||
155370981|NCT00594880|560791991|FG001|Overall Study|Withdrawal by Subject|1|||
155370982|NCT00594880|560791990|FG000|Overall Study|Lost to Follow-up|1|||
155370983|NCT00594880|560791991|FG001|Overall Study|Lost to Follow-up|0|||
155370984|NCT02206061|560791992|FG000|Overall Study|Withdrawal by Subject|4|||
155370985|NCT02206061|560791993|FG001|Overall Study|Withdrawal by Subject|7|||
155370986|NCT02206061|560791994|FG002|Overall Study|Withdrawal by Subject|1|||
155370987|NCT02206061|560791992|FG000|Overall Study|Lost to Follow-up|14|||
155370988|NCT02206061|560791993|FG001|Overall Study|Lost to Follow-up|7|||
155370989|NCT02206061|560791994|FG002|Overall Study|Lost to Follow-up|20|||
155370990|NCT04608773|560791995|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
155370991|NCT04608773|560791996|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
155370992|NCT04608773|560791995|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
155370993|NCT04608773|560791996|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155370994|NCT04608773|560791995|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
155370995|NCT04608773|560791996|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
155429551|NCT01381094|560998969|FG000|Overall Study|Withdrawal of informed consent|0|||
155429552|NCT01381094|560998970|FG001|Overall Study|Withdrawal of informed consent|1|||
155429553|NCT01381094|560998971|FG002|Overall Study|Withdrawal of informed consent|0|||
155429554|NCT01381094|560998972|FG003|Overall Study|Withdrawal of informed consent|0|||
155429555|NCT01381094|560998973|FG004|Overall Study|Withdrawal of informed consent|0|||
155429556|NCT01381094|560998969|FG000|Overall Study|Participant given Aranesp injection|1|||
155429557|NCT01381094|560998970|FG001|Overall Study|Participant given Aranesp injection|0|||
155429558|NCT01381094|560998971|FG002|Overall Study|Participant given Aranesp injection|0|||
155429559|NCT01381094|560998972|FG003|Overall Study|Participant given Aranesp injection|0|||
155429560|NCT01381094|560998973|FG004|Overall Study|Participant given Aranesp injection|0|||
155429561|NCT01934504|560998983|FG000|Overall Study|Protocol Deviation|0|||
155429562|NCT01934504|560998984|FG001|Overall Study|Protocol Deviation|0|||
155429563|NCT01934504|560998985|FG002|Overall Study|Protocol Deviation|0|||
155429564|NCT01934504|560998986|FG003|Overall Study|Protocol Deviation|2|||
155429565|NCT01934504|560998983|FG000|Overall Study|Study Terminated by Sponsor|1|||
155509882|NCT01381900|561293393|FG002|Overall Study|Adverse Event|7|||
155509883|NCT01381900|561293391|FG000|Overall Study|Noncompliance with study drug|0|||
155429566|NCT01934504|560998984|FG001|Overall Study|Study Terminated by Sponsor|0|||
155429567|NCT01934504|560998985|FG002|Overall Study|Study Terminated by Sponsor|5|||
155429568|NCT01934504|560998986|FG003|Overall Study|Study Terminated by Sponsor|5|||
155429569|NCT02665689|560998987|FG000|Overall Study|Adverse Event|1|||
155429570|NCT02665689|560998988|FG001|Overall Study|Adverse Event|0|||
155429571|NCT02665689|560998987|FG000|Overall Study|Trial termination|1|||
155429572|NCT02665689|560998988|FG001|Overall Study|Trial termination|1|||
155429573|NCT02665689|560998987|FG000|Overall Study|Lost to Follow-up|0|||
155429574|NCT02665689|560998988|FG001|Overall Study|Lost to Follow-up|1|||
155429575|NCT00824564|560998989|FG000|Overall Study|Lost to Follow-up|5|||
155429576|NCT00824564|560998990|FG001|Overall Study|Lost to Follow-up|7|||
155429577|NCT00824564|560998989|FG000|Overall Study|Withdrawal by Subject|1|||
155429578|NCT00824564|560998990|FG001|Overall Study|Withdrawal by Subject|1|||
155429579|NCT00824564|560998989|FG000|Overall Study|Other|1|||
155429580|NCT00824564|560998990|FG001|Overall Study|Other|2|||
155429581|NCT00824564|560998989|FG000|Overall Study|Randomized, but not treated|1|||
155429582|NCT00824564|560998990|FG001|Overall Study|Randomized, but not treated|0|||
155429583|NCT00996840|560998999|FG000|Overall Study|Adverse Event|0|||
155429584|NCT00996840|560999000|FG001|Overall Study|Adverse Event|1|||
155429585|NCT00996840|560999001|FG002|Overall Study|Adverse Event|0|||
155429586|NCT00996840|560999002|FG003|Overall Study|Adverse Event|0|||
155429587|NCT00996840|560999003|FG004|Overall Study|Adverse Event|0|||
155429588|NCT00996840|560998999|FG000|Overall Study|Physician Decision|0|||
155429589|NCT00996840|560999000|FG001|Overall Study|Physician Decision|0|||
155429590|NCT00996840|560999001|FG002|Overall Study|Physician Decision|1|||
155429591|NCT00996840|560999002|FG003|Overall Study|Physician Decision|1|||
155429592|NCT00996840|560999003|FG004|Overall Study|Physician Decision|2|||
155429593|NCT00996840|560998999|FG000|Overall Study|Withdrawal by Subject|1|||
155429594|NCT00996840|560999000|FG001|Overall Study|Withdrawal by Subject|1|||
155429595|NCT00996840|560999001|FG002|Overall Study|Withdrawal by Subject|0|||
155429596|NCT00996840|560999002|FG003|Overall Study|Withdrawal by Subject|0|||
155429597|NCT00996840|560999003|FG004|Overall Study|Withdrawal by Subject|0|||
155429598|NCT00603239|560999004|FG000|Overall Study|Adverse Event|4|||
155429599|NCT00603239|560999005|FG001|Overall Study|Adverse Event|1|||
155370996|NCT04608773|560791995|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
155370997|NCT04608773|560791996|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
155509884|NCT01381900|561293392|FG001|Overall Study|Noncompliance with study drug|0|||
155370998|NCT04608773|560791995|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
155370999|NCT04608773|560791996|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
155371000|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
155371001|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
155371002|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
155371003|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
155371004|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
155371005|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
155371006|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
155371007|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
155429600|NCT00603239|560999004|FG000|Overall Study|Entry criteria not met|0|||
155429601|NCT00603239|560999005|FG001|Overall Study|Entry criteria not met|1|||
155509885|NCT01381900|561293393|FG002|Overall Study|Noncompliance with study drug|1|||
155509886|NCT01381900|561293391|FG000|Overall Study|Physician Decision|0|||
155509887|NCT01381900|561293392|FG001|Overall Study|Physician Decision|1|||
155509888|NCT01381900|561293393|FG002|Overall Study|Physician Decision|1|||
155509889|NCT01381900|561293391|FG000|Overall Study|Protocol Violation|0|||
155509890|NCT01381900|561293392|FG001|Overall Study|Protocol Violation|1|||
155509891|NCT01381900|561293393|FG002|Overall Study|Protocol Violation|1|||
155509892|NCT01381900|561293391|FG000|Overall Study|Withdrawal by Subject|0|||
155509893|NCT01381900|561293392|FG001|Overall Study|Withdrawal by Subject|0|||
155509894|NCT01381900|561293393|FG002|Overall Study|Withdrawal by Subject|1|||
155509895|NCT01381900|561293391|FG000|Overall Study|Early withdraw|3|||
155509896|NCT01381900|561293392|FG001|Overall Study|Early withdraw|1|||
155509897|NCT01381900|561293393|FG002|Overall Study|Early withdraw|1|||
155509898|NCT00387712|561293396|FG000|Overall Study|Physician Decision|6|||
155509899|NCT00387712|561293397|FG001|Overall Study|Physician Decision|4|||
155509900|NCT00387712|561293396|FG000|Overall Study|Lost to Follow-up|17|||
155509901|NCT00387712|561293397|FG001|Overall Study|Lost to Follow-up|20|||
155509902|NCT00387712|561293396|FG000|Overall Study|Withdrawal by Subject|6|||
155509903|NCT00387712|561293397|FG001|Overall Study|Withdrawal by Subject|12|||
155509904|NCT01772368|561293399|FG000|Overall Study|Adverse Event|1|||
155509905|NCT01772368|561293399|FG000|Overall Study|Withdrawal by Subject|3|||
155509906|NCT01772368|561293399|FG000|Overall Study|Protocol Violation|2|||
155509907|NCT01772368|561293399|FG000|Overall Study|Other|1|||
155509908|NCT03347695|561293416|FG000|Overall Study|Death|0|||
155509909|NCT03347695|561293417|FG001|Overall Study|Death|4|||
155509910|NCT03347695|561293416|FG000|Overall Study|Lost to Follow-up|0|||
155509911|NCT03347695|561293417|FG001|Overall Study|Lost to Follow-up|1|||
155509912|NCT04633837|561293418|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
155509913|NCT04633837|561293419|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
155509914|NCT02668783|561293420|FG000|Overall Study|Pregnancy|0|||
155509915|NCT02668783|561293421|FG001|Overall Study|Pregnancy|1|||
155509916|NCT02668783|561293420|FG000|Overall Study|Protocol Violation|2|||
155509917|NCT02668783|561293421|FG001|Overall Study|Protocol Violation|1|||
155509918|NCT02668783|561293420|FG000|Overall Study|Study terminated by sponsor|9|||
155509919|NCT02668783|561293421|FG001|Overall Study|Study terminated by sponsor|10|||
155509920|NCT02668783|561293420|FG000|Overall Study|Subject moved|1|||
155509921|NCT02668783|561293421|FG001|Overall Study|Subject moved|0|||
155509922|NCT02668783|561293420|FG000|Overall Study|Withdrawal by Subject|1|||
155509923|NCT02668783|561293421|FG001|Overall Study|Withdrawal by Subject|0|||
155509924|NCT00112489|561293422|FG000|Overall Study|Refused further treatment|8|||
155509925|NCT00112489|561293422|FG000|Overall Study|Adverse Event|12|||
155509926|NCT00112489|561293422|FG000|Overall Study|Death|2|||
155509927|NCT00112489|561293422|FG000|Overall Study|Other, Not Specified|9|||
155509928|NCT00112489|561293422|FG000|Overall Study|Patient never treated|2|||
155509929|NCT00112489|561293422|FG000|Overall Study|Ineligible|7|||
155509930|NCT02891200|561293427|FG000|Overall Study|Lost to Follow-up|31|||
155509931|NCT02891200|561293428|FG001|Overall Study|Lost to Follow-up|36|||
155509932|NCT02891200|561293427|FG000|Overall Study|Death|10|||
155509933|NCT02891200|561293428|FG001|Overall Study|Death|9|||
155509934|NCT02891200|561293427|FG000|Overall Study|Withdrawal by Subject|1|||
155509935|NCT02891200|561293428|FG001|Overall Study|Withdrawal by Subject|4|||
155509936|NCT04467697|561293430|FG000|Overall Study|Adverse Event|2|||
155509937|NCT04467697|561293430|FG000|Overall Study|Lost to Follow-up|6|||
155509938|NCT04467697|561293430|FG000|Overall Study|Withdrawal by Subject|9|||
155509939|NCT04467697|561293430|FG000|Overall Study|Protocol Violation|3|||
155509940|NCT03907280|561293431|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
155509941|NCT03907280|561293432|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
155509942|NCT03907280|561293433|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
155509943|NCT04480463|561293436|FG000|Overall Study|Death|0|||
155509944|NCT04480463|561293437|FG001|Overall Study|Death|1|||
155509945|NCT04480463|561293436|FG000|Overall Study|Adverse Event|6|||
155509946|NCT04480463|561293437|FG001|Overall Study|Adverse Event|8|||
155509947|NCT04480463|561293436|FG000|Overall Study|Lost to Follow-up|3|||
155509948|NCT04480463|561293437|FG001|Overall Study|Lost to Follow-up|2|||
155649491|NCT03016403|561808283|FG001|6-week Follow-up|Death|4|||
155509949|NCT04480463|561293436|FG000|Overall Study|Physician Decision|2|||
155509950|NCT04480463|561293437|FG001|Overall Study|Physician Decision|5|||
155509951|NCT04480463|561293436|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
155509952|NCT04480463|561293437|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
155509953|NCT04480463|561293436|FG000|Overall Study|Protocol Violation|2|||
155509954|NCT04480463|561293437|FG001|Overall Study|Protocol Violation|1|||
155509955|NCT04480463|561293436|FG000|Overall Study|Withdrawal by Subject|6|||
155509956|NCT04480463|561293437|FG001|Overall Study|Withdrawal by Subject|7|||
155514024|NCT01626859|561308227|FG000|Overall Study|Withdrawal by Subject|1|||
155371008|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
155371009|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
155371010|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
155371011|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
155371012|NCT01077518|560791999|FG000|Optional Ofa Phase|Physician Decision|0|||
155371013|NCT01077518|560792000|FG001|Optional Ofa Phase|Physician Decision|0|||
155371014|NCT01077518|560792001|FG002|Optional Ofa Phase|Physician Decision|1|||
155371015|NCT01077518|560791999|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
155371016|NCT01077518|560792000|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
155509957|NCT04480463|561293436|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
155509958|NCT04480463|561293437|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
155509959|NCT04480463|561293436|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
155509960|NCT04480463|561293437|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
155509961|NCT04480463|561293436|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
155509962|NCT04480463|561293437|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
155509963|NCT04480463|561293436|FG000|Overall Study|Other|6|||
155509964|NCT04480463|561293437|FG001|Overall Study|Other|4|||
155509965|NCT01399723|561293438|FG000|Overall Study|Lost to Follow-up|0|||
155509966|NCT01399723|561293439|FG001|Overall Study|Lost to Follow-up|1|||
155509967|NCT00752791|561293449|FG000|Overall Study|Adverse Event|7|||
155509968|NCT00752791|561293449|FG000|Overall Study|Withdrawal by Subject|1|||
155509969|NCT00752791|561293449|FG000|Overall Study|Physician Decision|1|||
155509970|NCT00752791|561293449|FG000|Overall Study|Death|1|||
155509971|NCT00752791|561293449|FG000|Overall Study|Renal transplant|3|||
155509972|NCT00752791|561293449|FG000|Overall Study|Switched to hemodialysis|2|||
155509973|NCT00752791|561293449|FG000|Overall Study|Protocol deviation|1|||
155509974|NCT01769378|561293452|FG000|Overall Study|Adverse Event|10|||
155509975|NCT01769378|561293453|FG001|Overall Study|Adverse Event|0|||
155509976|NCT01769378|561293452|FG000|Overall Study|Entry criteria not met|1|||
155509977|NCT01769378|561293453|FG001|Overall Study|Entry criteria not met|0|||
155509978|NCT01769378|561293452|FG000|Overall Study|Protocol Violation|1|||
155509979|NCT01769378|561293453|FG001|Overall Study|Protocol Violation|1|||
155509980|NCT01769378|561293452|FG000|Overall Study|Withdrawal by Subject|10|||
155509981|NCT01769378|561293453|FG001|Overall Study|Withdrawal by Subject|3|||
155509982|NCT01769378|561293452|FG000|Overall Study|Sponsor Decision|1|||
155509983|NCT01769378|561293453|FG001|Overall Study|Sponsor Decision|0|||
155509984|NCT01769378|561293452|FG000|Overall Study|Lost to Follow-up|2|||
155509985|NCT01769378|561293453|FG001|Overall Study|Lost to Follow-up|0|||
155509986|NCT01977092|561293454|FG000|Overall Study|Death|3|||
155509987|NCT01977092|561293455|FG001|Overall Study|Death|4|||
155509988|NCT01977092|561293454|FG000|Overall Study|Lost to Follow-up|23|||
155509989|NCT01977092|561293455|FG001|Overall Study|Lost to Follow-up|14|||
155509990|NCT01977092|561293454|FG000|Overall Study|Withdrawal by Subject|2|||
155509991|NCT01977092|561293455|FG001|Overall Study|Withdrawal by Subject|1|||
155509992|NCT01977092|561293454|FG000|Overall Study|In prison|3|||
155509993|NCT01977092|561293455|FG001|Overall Study|In prison|11|||
155509994|NCT01958281|561293456|FG000|Overall Study|Lack of Efficacy|5|||
155509995|NCT01958281|561293457|FG001|Overall Study|Lack of Efficacy|2|||
155509996|NCT01958281|561293458|FG002|Overall Study|Lack of Efficacy|0|||
155509997|NCT01958281|561293456|FG000|Overall Study|Adverse Event|0|||
155509998|NCT01958281|561293457|FG001|Overall Study|Adverse Event|2|||
155509999|NCT01958281|561293458|FG002|Overall Study|Adverse Event|0|||
155510000|NCT01958281|561293456|FG000|Overall Study|Withdrew Consent|1|||
155371017|NCT01077518|560792001|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
155371018|NCT01077518|560791999|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
155510001|NCT01958281|561293457|FG001|Overall Study|Withdrew Consent|0|||
155510002|NCT01958281|561293458|FG002|Overall Study|Withdrew Consent|0|||
155510003|NCT02784106|561293461|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
155510004|NCT02784106|561293462|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
155510005|NCT02784106|561293463|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155510006|NCT02784106|561293464|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155510007|NCT02784106|561293461|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
155510008|NCT02784106|561293462|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155510009|NCT02784106|561293463|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155510010|NCT02784106|561293464|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155510011|NCT02784106|561293461|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
155510012|NCT02784106|561293462|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
155510013|NCT02784106|561293463|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
155510014|NCT02784106|561293464|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
155510015|NCT02784106|561293461|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
155510016|NCT02784106|561293462|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155510017|NCT02784106|561293463|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155510018|NCT02784106|561293464|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155510019|NCT02784106|561293461|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
155510020|NCT02784106|561293462|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
155510021|NCT02784106|561293463|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
155510022|NCT02784106|561293464|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
155510023|NCT02784106|561293461|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
155510024|NCT02784106|561293462|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
155510025|NCT02784106|561293463|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
155510026|NCT02784106|561293464|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
155510027|NCT02927847|561293466|FG000|Overall Study|Lost to Follow-up|1|||
155510028|NCT02927847|561293467|FG001|Overall Study|Lost to Follow-up|0|||
155510029|NCT02927847|561293466|FG000|Overall Study|Withdrawal by Subject|4|||
155510030|NCT02927847|561293467|FG001|Overall Study|Withdrawal by Subject|2|||
155510031|NCT02927847|561293466|FG000|Overall Study|PI withdrawn due to missed visits|1|||
155510032|NCT02927847|561293467|FG001|Overall Study|PI withdrawn due to missed visits|1|||
155510033|NCT00175019|561293471|FG000|Overall Study|Adverse Event|54|||
155510034|NCT00175019|561293472|FG001|Overall Study|Adverse Event|22|||
155510035|NCT00175019|561293473|FG002|Overall Study|Adverse Event|2|||
155510036|NCT00175019|561293471|FG000|Overall Study|Protocol Violation|6|||
155510037|NCT00175019|561293472|FG001|Overall Study|Protocol Violation|3|||
155510038|NCT00175019|561293473|FG002|Overall Study|Protocol Violation|3|||
155510039|NCT00175019|561293471|FG000|Overall Study|Lost to Follow-up|42|||
155510040|NCT00175019|561293472|FG001|Overall Study|Lost to Follow-up|39|||
155510041|NCT00175019|561293473|FG002|Overall Study|Lost to Follow-up|9|||
155510042|NCT00175019|561293471|FG000|Overall Study|Did not continue under Amendment 4|1|||
155510043|NCT00175019|561293472|FG001|Overall Study|Did not continue under Amendment 4|1|||
155510044|NCT00175019|561293473|FG002|Overall Study|Did not continue under Amendment 4|2|||
155510045|NCT00175019|561293471|FG000|Overall Study|Personal Reason(s)|39|||
155510046|NCT00175019|561293472|FG001|Overall Study|Personal Reason(s)|31|||
155510047|NCT00175019|561293473|FG002|Overall Study|Personal Reason(s)|8|||
155510048|NCT00175019|561293471|FG000|Overall Study|Therapeutic Failure|10|||
155510049|NCT00175019|561293472|FG001|Overall Study|Therapeutic Failure|38|||
155510050|NCT00175019|561293473|FG002|Overall Study|Therapeutic Failure|22|||
155510051|NCT00175019|561293471|FG000|Overall Study|Gout Flare|2|||
155510052|NCT00175019|561293472|FG001|Overall Study|Gout Flare|3|||
155510053|NCT00175019|561293473|FG002|Overall Study|Gout Flare|0|||
155510054|NCT00175019|561293471|FG000|Overall Study|Reason Not Specified|40|||
155510055|NCT00175019|561293472|FG001|Overall Study|Reason Not Specified|34|||
155510056|NCT00175019|561293473|FG002|Overall Study|Reason Not Specified|11|||
155510057|NCT01405820|561293474|FG000|Randomized Treatment Period|Adverse Event|3|||
155510058|NCT01405820|561293475|FG001|Randomized Treatment Period|Adverse Event|3|||
155510059|NCT01405820|561293476|FG002|Randomized Treatment Period|Adverse Event|3|||
155510060|NCT01405820|561293477|FG003|Randomized Treatment Period|Adverse Event|0|||
155510061|NCT01405820|561293478|FG004|Randomized Treatment Period|Adverse Event|2|||
155510062|NCT01405820|561293479|FG005|Randomized Treatment Period|Adverse Event|1|||
155510063|NCT01405820|561293474|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
155510064|NCT01405820|561293475|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
155510065|NCT01405820|561293476|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
155510066|NCT01405820|561293477|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
155510067|NCT01405820|561293478|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
155510068|NCT01405820|561293479|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
155510069|NCT01405820|561293474|FG000|Randomized Treatment Period|Other|2|||
155510070|NCT01405820|561293475|FG001|Randomized Treatment Period|Other|2|||
155510071|NCT01405820|561293476|FG002|Randomized Treatment Period|Other|1|||
155510072|NCT01405820|561293477|FG003|Randomized Treatment Period|Other|1|||
155510073|NCT01405820|561293478|FG004|Randomized Treatment Period|Other|0|||
155510074|NCT01405820|561293479|FG005|Randomized Treatment Period|Other|0|||
155510075|NCT01405820|561293474|FG000|Randomized Treatment Period|Physician Decision|0|||
155510076|NCT01405820|561293475|FG001|Randomized Treatment Period|Physician Decision|2|||
155510077|NCT01405820|561293476|FG002|Randomized Treatment Period|Physician Decision|1|||
155510078|NCT01405820|561293477|FG003|Randomized Treatment Period|Physician Decision|0|||
155510079|NCT01405820|561293478|FG004|Randomized Treatment Period|Physician Decision|0|||
155510080|NCT01405820|561293479|FG005|Randomized Treatment Period|Physician Decision|0|||
155510081|NCT01405820|561293474|FG000|Randomized Treatment Period|Rescue|0|||
155510082|NCT01405820|561293475|FG001|Randomized Treatment Period|Rescue|1|||
155510083|NCT01405820|561293476|FG002|Randomized Treatment Period|Rescue|13|||
155510084|NCT01405820|561293477|FG003|Randomized Treatment Period|Rescue|10|||
155510085|NCT01405820|561293478|FG004|Randomized Treatment Period|Rescue|8|||
155371019|NCT01077518|560792000|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
155371020|NCT01077518|560792001|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
155371021|NCT00623805|560792006|FG000|Overall Study|Adverse Event|9|||
155371022|NCT00623805|560792007|FG001|Overall Study|Adverse Event|6|||
155371023|NCT00623805|560792006|FG000|Overall Study|Death|2|||
155371024|NCT00623805|560792007|FG001|Overall Study|Death|0|||
155510086|NCT01405820|561293479|FG005|Randomized Treatment Period|Rescue|8|||
155510087|NCT01405820|561293474|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
155510088|NCT01405820|561293475|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
155510089|NCT01405820|561293476|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
155510090|NCT01405820|561293477|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
155510091|NCT01405820|561293478|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
155510092|NCT01405820|561293479|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
155510093|NCT01405820|561293474|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
155510094|NCT01405820|561293475|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
155510095|NCT01405820|561293476|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
155510096|NCT01405820|561293477|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
155510097|NCT01405820|561293478|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
155510098|NCT01405820|561293479|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
155510099|NCT01405820|561293474|FG000|Randomized Treatment Period|Death|0|||
155510100|NCT01405820|561293475|FG001|Randomized Treatment Period|Death|0|||
155510101|NCT01405820|561293476|FG002|Randomized Treatment Period|Death|0|||
155510102|NCT01405820|561293477|FG003|Randomized Treatment Period|Death|1|||
155510103|NCT01405820|561293478|FG004|Randomized Treatment Period|Death|0|||
155510104|NCT01405820|561293479|FG005|Randomized Treatment Period|Death|0|||
155510105|NCT01405820|561293474|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155510106|NCT01405820|561293475|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155510107|NCT01405820|561293476|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155510108|NCT01405820|561293477|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
155510109|NCT01405820|561293478|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155510110|NCT01405820|561293479|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155510111|NCT01405820|561293474|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
155510112|NCT01405820|561293475|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
155510113|NCT01405820|561293476|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
155510114|NCT01405820|561293477|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
155510115|NCT01405820|561293478|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
155510116|NCT01405820|561293479|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
155510117|NCT01405820|561293474|FG000|Open-Label Treatment Period|Other|1|||
155510118|NCT01405820|561293475|FG001|Open-Label Treatment Period|Other|1|||
155510119|NCT01405820|561293476|FG002|Open-Label Treatment Period|Other|1|||
155510120|NCT01405820|561293477|FG003|Open-Label Treatment Period|Other|1|||
155510121|NCT01405820|561293478|FG004|Open-Label Treatment Period|Other|1|||
155510122|NCT01405820|561293479|FG005|Open-Label Treatment Period|Other|1|||
155510123|NCT01405820|561293474|FG000|Open-Label Treatment Period|Physician Decision|0|||
155510124|NCT01405820|561293475|FG001|Open-Label Treatment Period|Physician Decision|0|||
155510125|NCT01405820|561293476|FG002|Open-Label Treatment Period|Physician Decision|1|||
155510126|NCT01405820|561293477|FG003|Open-Label Treatment Period|Physician Decision|2|||
155510127|NCT01405820|561293478|FG004|Open-Label Treatment Period|Physician Decision|1|||
155510128|NCT01405820|561293479|FG005|Open-Label Treatment Period|Physician Decision|0|||
155510129|NCT01405820|561293474|FG000|Open-Label Treatment Period|Adverse Event|0|||
155510130|NCT01405820|561293475|FG001|Open-Label Treatment Period|Adverse Event|0|||
155510131|NCT01405820|561293476|FG002|Open-Label Treatment Period|Adverse Event|0|||
155510132|NCT01405820|561293477|FG003|Open-Label Treatment Period|Adverse Event|1|||
155371025|NCT00623805|560792006|FG000|Overall Study|Lack of Efficacy|3|||
155371026|NCT00623805|560792007|FG001|Overall Study|Lack of Efficacy|7|||
155371027|NCT00623805|560792006|FG000|Overall Study|Lost to Follow-up|2|||
155371028|NCT00623805|560792007|FG001|Overall Study|Lost to Follow-up|2|||
155371029|NCT00623805|560792006|FG000|Overall Study|Protocol Violation|1|||
155371030|NCT00623805|560792007|FG001|Overall Study|Protocol Violation|1|||
155371031|NCT00623805|560792006|FG000|Overall Study|Reason not Specified|3|||
155371032|NCT00623805|560792007|FG001|Overall Study|Reason not Specified|6|||
155371033|NCT01803282|560792012|FG000|Overall Study|Progressive Disease|4|||
155371034|NCT01803282|560792013|FG001|Overall Study|Progressive Disease|3|||
155371035|NCT01803282|560792014|FG002|Overall Study|Progressive Disease|6|||
155371036|NCT01803282|560792015|FG003|Overall Study|Progressive Disease|22|||
155371037|NCT01803282|560792016|FG004|Overall Study|Progressive Disease|5|||
155371038|NCT01803282|560792017|FG005|Overall Study|Progressive Disease|8|||
155371039|NCT01803282|560792018|FG006|Overall Study|Progressive Disease|23|||
155429602|NCT00603239|560999004|FG000|Overall Study|Loss of glucose control|3|||
155429603|NCT00603239|560999005|FG001|Overall Study|Loss of glucose control|0|||
155429604|NCT00603239|560999004|FG000|Overall Study|Lost to Follow-up|2|||
155429605|NCT00603239|560999005|FG001|Overall Study|Lost to Follow-up|1|||
155429606|NCT00603239|560999004|FG000|Overall Study|Physician Decision|2|||
155429607|NCT00603239|560999005|FG001|Overall Study|Physician Decision|0|||
155429608|NCT00603239|560999004|FG000|Overall Study|Protocol Violation|2|||
155429609|NCT00603239|560999005|FG001|Overall Study|Protocol Violation|0|||
155429610|NCT00603239|560999004|FG000|Overall Study|Subject decision|2|||
155429611|NCT00603239|560999005|FG001|Overall Study|Subject decision|1|||
155429612|NCT02292849|560999006|FG000|Overall Study|Lost to Follow-up|0|||
155429613|NCT02292849|560999007|FG001|Overall Study|Lost to Follow-up|2|||
155429614|NCT02292849|560999008|FG002|Overall Study|Lost to Follow-up|2|||
155429615|NCT02292849|560999006|FG000|Overall Study|Physician Decision|4|||
155429616|NCT02292849|560999007|FG001|Overall Study|Physician Decision|0|||
155429617|NCT02292849|560999008|FG002|Overall Study|Physician Decision|0|||
155429618|NCT04125680|560999010|FG000|Overall Study|Lost to Follow-up|15|||
155429619|NCT00097539|560999011|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
155429620|NCT00097539|560999012|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
155429621|NCT00097539|560999013|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
155429622|NCT00097539|560999014|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
155429623|NCT00097539|560999015|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
155429624|NCT00097539|560999016|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
155429625|NCT00097539|560999017|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
155429626|NCT00097539|560999011|FG000|Overall Study|Withdrawal by Subject|925|||
155429627|NCT00097539|560999012|FG001|Overall Study|Withdrawal by Subject|323|||
155429628|NCT00097539|560999013|FG002|Overall Study|Withdrawal by Subject|346|||
155429629|NCT00097539|560999014|FG003|Overall Study|Withdrawal by Subject|217|||
155429630|NCT00097539|560999015|FG004|Overall Study|Withdrawal by Subject|68|||
155510133|NCT01405820|561293478|FG004|Open-Label Treatment Period|Adverse Event|0|||
155510134|NCT01405820|561293479|FG005|Open-Label Treatment Period|Adverse Event|0|||
155510135|NCT03255031|561293484|FG000|Overall Study|Adverse Event|5|||
155510136|NCT03255031|561293485|FG001|Overall Study|Adverse Event|3|||
155510137|NCT03255031|561293484|FG000|Overall Study|Physician Decision|2|||
155371040|NCT01803282|560792019|FG007|Overall Study|Progressive Disease|24|||
155429631|NCT00097539|560999016|FG005|Overall Study|Withdrawal by Subject|229|||
155429632|NCT00097539|560999017|FG006|Overall Study|Withdrawal by Subject|3|||
155429633|NCT00097539|560999011|FG000|Overall Study|Participant Non-compliant|2140|||
155429634|NCT00097539|560999012|FG001|Overall Study|Participant Non-compliant|567|||
155429635|NCT00097539|560999013|FG002|Overall Study|Participant Non-compliant|1067|||
155510138|NCT03255031|561293485|FG001|Overall Study|Physician Decision|1|||
155371041|NCT01803282|560792020|FG008|Overall Study|Progressive Disease|3|||
155510139|NCT03255031|561293484|FG000|Overall Study|Withdrawal by Subject|9|||
155510140|NCT03255031|561293485|FG001|Overall Study|Withdrawal by Subject|3|||
155510141|NCT01092702|561293486|FG000|Overall Study|Withdrawal by Subject|7|||
155510142|NCT01092702|561293486|FG000|Overall Study|Lost to Follow-up|2|||
155510143|NCT02087046|561293489|FG000|Overall Study|Adverse Event|4|||
155510144|NCT02087046|561293489|FG000|Overall Study|Death|1|||
155510145|NCT02087046|561293489|FG000|Overall Study|Lost to Follow-up|3|||
155510146|NCT02087046|561293489|FG000|Overall Study|Withdrawal by Subject|2|||
155510147|NCT02087046|561293489|FG000|Overall Study|Physician Decision|1|||
155510148|NCT02444533|561293490|FG000|Overall Study|Not able to complete forms|0|||
155510149|NCT02444533|561293491|FG001|Overall Study|Not able to complete forms|2|||
155510150|NCT02444533|561293490|FG000|Overall Study|Only gave post-procedure complications|2|||
155510151|NCT02444533|561293491|FG001|Overall Study|Only gave post-procedure complications|2|||
155510152|NCT03567057|561293492|FG000|Overall Study|Adverse Event|56|||
155510153|NCT03567057|561293493|FG001|Overall Study|Adverse Event|53|||
155510154|NCT03567057|561293494|FG002|Overall Study|Adverse Event|28|||
155510155|NCT03567057|561293492|FG000|Overall Study|Withdrawal by Subject|22|||
155510156|NCT03567057|561293493|FG001|Overall Study|Withdrawal by Subject|24|||
155510157|NCT03567057|561293494|FG002|Overall Study|Withdrawal by Subject|13|||
155510158|NCT03567057|561293492|FG000|Overall Study|Lost to Follow-up|3|||
155510159|NCT03567057|561293493|FG001|Overall Study|Lost to Follow-up|5|||
155510160|NCT03567057|561293494|FG002|Overall Study|Lost to Follow-up|2|||
155510161|NCT03567057|561293492|FG000|Overall Study|COVID-19 pandemic|4|||
155510162|NCT03567057|561293493|FG001|Overall Study|COVID-19 pandemic|3|||
155510163|NCT03567057|561293494|FG002|Overall Study|COVID-19 pandemic|0|||
155510164|NCT03567057|561293492|FG000|Overall Study|Non-compliance with study drug|4|||
155510165|NCT03567057|561293493|FG001|Overall Study|Non-compliance with study drug|2|||
155510166|NCT03567057|561293494|FG002|Overall Study|Non-compliance with study drug|0|||
155510167|NCT03567057|561293492|FG000|Overall Study|Lack of Efficacy|3|||
155510168|NCT03567057|561293493|FG001|Overall Study|Lack of Efficacy|0|||
155510169|NCT03567057|561293494|FG002|Overall Study|Lack of Efficacy|1|||
155510170|NCT03567057|561293492|FG000|Overall Study|Death|1|||
155510171|NCT03567057|561293493|FG001|Overall Study|Death|0|||
155510172|NCT03567057|561293494|FG002|Overall Study|Death|0|||
155510173|NCT03567057|561293492|FG000|Overall Study|Physician Decision|1|||
155510174|NCT03567057|561293493|FG001|Overall Study|Physician Decision|0|||
155510175|NCT03567057|561293494|FG002|Overall Study|Physician Decision|0|||
155510176|NCT03567057|561293492|FG000|Overall Study|Unstable medical condition|1|||
155510177|NCT03567057|561293493|FG001|Overall Study|Unstable medical condition|0|||
155510178|NCT03567057|561293494|FG002|Overall Study|Unstable medical condition|0|||
155510179|NCT03567057|561293492|FG000|Overall Study|Medical history event|0|||
155510180|NCT03567057|561293493|FG001|Overall Study|Medical history event|0|||
155510181|NCT03567057|561293494|FG002|Overall Study|Medical history event|1|||
155510182|NCT03567057|561293492|FG000|Overall Study|Other|0|||
155510183|NCT03567057|561293493|FG001|Overall Study|Other|0|||
155510184|NCT03567057|561293494|FG002|Overall Study|Other|1|||
155510185|NCT00886483|561293497|FG000|Overall Study|Lost to Follow-up|0|||
155510186|NCT00886483|561293498|FG001|Overall Study|Lost to Follow-up|1|||
155510187|NCT00886483|561293497|FG000|Overall Study|Pursue medications|1|||
155510188|NCT00886483|561293498|FG001|Overall Study|Pursue medications|2|||
155510189|NCT00886483|561293497|FG000|Overall Study|Distance to center, poor grades|1|||
155510190|NCT00886483|561293498|FG001|Overall Study|Distance to center, poor grades|0|||
155510191|NCT01841359|561293499|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
155649492|NCT03016403|561808284|FG002|6-week Follow-up|Death|0|||
155510192|NCT01841359|561293499|FG000|Overall Study|Concommitant medical issues|2|||
155510193|NCT01841359|561293499|FG000|Overall Study|Adverse Event|3|||
155510194|NCT01841359|561293499|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
155649493|NCT03016403|561808285|FG003|6-week Follow-up|Death|0|||
155510195|NCT02168270|561293500|FG000|Overall Study|Lack of Efficacy|4|||
155510196|NCT00706706|561293501|FG000|Overall Study|Death|53|||
155510197|NCT00706706|561293501|FG000|Overall Study|Lost to Follow-up|7|||
155510198|NCT00706706|561293501|FG000|Overall Study|Study endpoint had reached|45|||
155510199|NCT00291330|561293502|FG000|Overall Study|Adverse Event|47|||
155510200|NCT00291330|561293503|FG001|Overall Study|Adverse Event|40|||
155510201|NCT00291330|561293502|FG000|Overall Study|Protocol Violation|13|||
155510202|NCT00291330|561293503|FG001|Overall Study|Protocol Violation|20|||
155510203|NCT00291330|561293502|FG000|Overall Study|Lost to Follow-up|16|||
155510204|NCT00291330|561293503|FG001|Overall Study|Lost to Follow-up|11|||
155510205|NCT00291330|561293502|FG000|Overall Study|Withdrawal by Subject|22|||
155510206|NCT00291330|561293503|FG001|Overall Study|Withdrawal by Subject|25|||
155510207|NCT00291330|561293502|FG000|Overall Study|Other|3|||
155510208|NCT00291330|561293503|FG001|Overall Study|Other|1|||
155510209|NCT02629965|561293506|FG000|Period 1|Adverse Event|1|||
155510210|NCT02629965|561293507|FG001|Period 1|Adverse Event|0|||
155510211|NCT02629965|561293506|FG000|Period 1|Unexpected worsening of disease|2|||
155510212|NCT02629965|561293507|FG001|Period 1|Unexpected worsening of disease|0|||
155510213|NCT02629965|561293506|FG000|Period 1|Other than listed above|1|||
155510214|NCT02629965|561293507|FG001|Period 1|Other than listed above|2|||
155510215|NCT02629965|561293506|FG000|Period 2|Adverse Event|1|||
155510216|NCT02629965|561293507|FG001|Period 2|Adverse Event|0|||
155510217|NCT03443869|561293508|FG000|Overall Study|Death|3|||
155510218|NCT03443869|561293509|FG001|Overall Study|Death|3|||
155510219|NCT03443869|561293508|FG000|Overall Study|Withdrawal by Subject|34|||
155510220|NCT03443869|561293509|FG001|Overall Study|Withdrawal by Subject|22|||
155510221|NCT03443869|561293508|FG000|Overall Study|Lost to Follow-up|1|||
155510222|NCT03443869|561293509|FG001|Overall Study|Lost to Follow-up|2|||
155510223|NCT03443869|561293508|FG000|Overall Study|Physician Decision|3|||
155510224|NCT03443869|561293509|FG001|Overall Study|Physician Decision|3|||
155510225|NCT03443869|561293508|FG000|Overall Study|Other|4|||
155510226|NCT03443869|561293509|FG001|Overall Study|Other|4|||
155510227|NCT02390219|561293510|FG000|Overall Study|Death|1|||
155510228|NCT02390219|561293510|FG000|Overall Study|Physician Decision|1|||
155510229|NCT02390219|561293510|FG000|Overall Study|Adverse Event|6|||
155510230|NCT02390219|561293510|FG000|Overall Study|Withdrawal by Subject|1|||
155510231|NCT02390219|561293510|FG000|Overall Study|Lost to Follow-up|2|||
155510232|NCT02390219|561293510|FG000|Overall Study|Other|2|||
155510233|NCT00299728|561293511|FG000|Overall Study|Lost to Follow-up|0|||
155510234|NCT00299728|561293512|FG001|Overall Study|Lost to Follow-up|1|||
155510235|NCT00299728|561293511|FG000|Overall Study|Withdrawal by Subject|0|||
155510236|NCT00299728|561293512|FG001|Overall Study|Withdrawal by Subject|1|||
155510237|NCT00299728|561293511|FG000|Overall Study|Progressive disease|0|||
155510238|NCT00299728|561293512|FG001|Overall Study|Progressive disease|1|||
155510239|NCT00580983|561293515|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
155371042|NCT01803282|560792021|FG009|Overall Study|Progressive Disease|29|||
155371043|NCT01803282|560792022|FG010|Overall Study|Progressive Disease|6|||
155371044|NCT01803282|560792023|FG011|Overall Study|Progressive Disease|11|||
155371045|NCT01803282|560792012|FG000|Overall Study|Death|0|||
155371046|NCT01803282|560792013|FG001|Overall Study|Death|0|||
155371047|NCT01803282|560792014|FG002|Overall Study|Death|0|||
155371048|NCT01803282|560792015|FG003|Overall Study|Death|0|||
155510240|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
155510241|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
155510242|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
155510243|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
155510244|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
155510245|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Adverse Event|60|||
155510246|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Adverse Event|0|||
155371049|NCT01803282|560792016|FG004|Overall Study|Death|2|||
155371050|NCT01803282|560792017|FG005|Overall Study|Death|1|||
155510247|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Adverse Event|0|||
155510248|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Adverse Event|0|||
155510249|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Adverse Event|0|||
155510250|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
155510251|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
155510252|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
155371051|NCT01803282|560792018|FG006|Overall Study|Death|1|||
155371052|NCT01803282|560792019|FG007|Overall Study|Death|5|||
155371053|NCT01803282|560792020|FG008|Overall Study|Death|1|||
155371054|NCT01803282|560792021|FG009|Overall Study|Death|1|||
155371055|NCT01803282|560792022|FG010|Overall Study|Death|0|||
155371056|NCT01803282|560792023|FG011|Overall Study|Death|0|||
155371057|NCT01803282|560792012|FG000|Overall Study|Withdrew Consent|0|||
155371058|NCT01803282|560792013|FG001|Overall Study|Withdrew Consent|0|||
155371059|NCT01803282|560792014|FG002|Overall Study|Withdrew Consent|0|||
155371060|NCT01803282|560792015|FG003|Overall Study|Withdrew Consent|6|||
155371061|NCT01803282|560792016|FG004|Overall Study|Withdrew Consent|1|||
155371062|NCT01803282|560792017|FG005|Overall Study|Withdrew Consent|0|||
155371063|NCT01803282|560792018|FG006|Overall Study|Withdrew Consent|8|||
155371064|NCT01803282|560792019|FG007|Overall Study|Withdrew Consent|3|||
155429636|NCT00097539|560999014|FG003|Overall Study|Participant Non-compliant|353|||
155371065|NCT01803282|560792020|FG008|Overall Study|Withdrew Consent|1|||
155371066|NCT01803282|560792021|FG009|Overall Study|Withdrew Consent|5|||
155371067|NCT01803282|560792022|FG010|Overall Study|Withdrew Consent|0|||
155371068|NCT01803282|560792023|FG011|Overall Study|Withdrew Consent|1|||
155371069|NCT01803282|560792012|FG000|Overall Study|Investigator's Discretion|0|||
155371070|NCT01803282|560792013|FG001|Overall Study|Investigator's Discretion|0|||
155371071|NCT01803282|560792014|FG002|Overall Study|Investigator's Discretion|0|||
155371072|NCT01803282|560792015|FG003|Overall Study|Investigator's Discretion|7|||
155371073|NCT01803282|560792016|FG004|Overall Study|Investigator's Discretion|2|||
155371074|NCT01803282|560792017|FG005|Overall Study|Investigator's Discretion|1|||
155371075|NCT01803282|560792018|FG006|Overall Study|Investigator's Discretion|7|||
155371076|NCT01803282|560792019|FG007|Overall Study|Investigator's Discretion|10|||
155429637|NCT00097539|560999015|FG004|Overall Study|Participant Non-compliant|136|||
155429638|NCT00097539|560999016|FG005|Overall Study|Participant Non-compliant|543|||
155429639|NCT00097539|560999017|FG006|Overall Study|Participant Non-compliant|18|||
155429640|NCT00097539|560999011|FG000|Overall Study|Lack of Efficacy|249|||
155429641|NCT00097539|560999012|FG001|Overall Study|Lack of Efficacy|122|||
155429642|NCT00097539|560999013|FG002|Overall Study|Lack of Efficacy|202|||
155429643|NCT00097539|560999014|FG003|Overall Study|Lack of Efficacy|105|||
155429644|NCT00097539|560999015|FG004|Overall Study|Lack of Efficacy|45|||
155429645|NCT00097539|560999016|FG005|Overall Study|Lack of Efficacy|228|||
155429646|NCT00097539|560999017|FG006|Overall Study|Lack of Efficacy|5|||
155429647|NCT00097539|560999011|FG000|Overall Study|Adverse Event|78|||
155429648|NCT00097539|560999012|FG001|Overall Study|Adverse Event|133|||
155429649|NCT00097539|560999013|FG002|Overall Study|Adverse Event|37|||
155429650|NCT00097539|560999014|FG003|Overall Study|Adverse Event|27|||
155429651|NCT00097539|560999015|FG004|Overall Study|Adverse Event|30|||
155429652|NCT00097539|560999016|FG005|Overall Study|Adverse Event|59|||
155429653|NCT00097539|560999017|FG006|Overall Study|Adverse Event|1|||
155429654|NCT00097539|560999011|FG000|Overall Study|Death|2|||
155429655|NCT00097539|560999012|FG001|Overall Study|Death|7|||
155429656|NCT00097539|560999013|FG002|Overall Study|Death|0|||
155429657|NCT00097539|560999014|FG003|Overall Study|Death|0|||
155429658|NCT00097539|560999015|FG004|Overall Study|Death|1|||
155429659|NCT00097539|560999016|FG005|Overall Study|Death|3|||
155429660|NCT00097539|560999017|FG006|Overall Study|Death|0|||
155429661|NCT00097539|560999011|FG000|Overall Study|Reasons Other Than Above|3602|||
155429662|NCT00097539|560999012|FG001|Overall Study|Reasons Other Than Above|1382|||
155429663|NCT00097539|560999013|FG002|Overall Study|Reasons Other Than Above|1757|||
155429664|NCT00097539|560999014|FG003|Overall Study|Reasons Other Than Above|692|||
155429665|NCT00097539|560999015|FG004|Overall Study|Reasons Other Than Above|361|||
155429666|NCT00097539|560999016|FG005|Overall Study|Reasons Other Than Above|1244|||
155429667|NCT00097539|560999017|FG006|Overall Study|Reasons Other Than Above|34|||
155429668|NCT00097539|560999011|FG000|Overall Study|Reason not Specified|111|||
155429669|NCT00097539|560999012|FG001|Overall Study|Reason not Specified|49|||
155429670|NCT00097539|560999013|FG002|Overall Study|Reason not Specified|53|||
155429671|NCT00097539|560999014|FG003|Overall Study|Reason not Specified|21|||
155429672|NCT00097539|560999015|FG004|Overall Study|Reason not Specified|11|||
155429673|NCT00097539|560999016|FG005|Overall Study|Reason not Specified|40|||
155429674|NCT00097539|560999017|FG006|Overall Study|Reason not Specified|2|||
155429675|NCT05127486|560999018|FG000|Overall Study|Adverse Event|2|||
155429676|NCT05127486|560999019|FG001|Overall Study|Adverse Event|4|||
155429677|NCT05127486|560999018|FG000|Overall Study|Lack of Efficacy|1|||
155429678|NCT05127486|560999019|FG001|Overall Study|Lack of Efficacy|0|||
155429679|NCT05127486|560999018|FG000|Overall Study|Pregnancy|0|||
155429680|NCT05127486|560999019|FG001|Overall Study|Pregnancy|1|||
155429681|NCT05127486|560999018|FG000|Overall Study|Physician Decision|4|||
155429682|NCT05127486|560999019|FG001|Overall Study|Physician Decision|1|||
155429683|NCT05127486|560999018|FG000|Overall Study|Withdrawal by Subject|14|||
155429684|NCT05127486|560999019|FG001|Overall Study|Withdrawal by Subject|13|||
155429685|NCT05127486|560999018|FG000|Overall Study|Lost to Follow-up|5|||
155429686|NCT05127486|560999019|FG001|Overall Study|Lost to Follow-up|8|||
155429687|NCT00049127|560999020|FG000|Overall Study|Withdrawal by Subject|0|||
155429688|NCT00049127|560999021|FG001|Overall Study|Withdrawal by Subject|0|||
155429689|NCT00049127|560999022|FG002|Overall Study|Withdrawal by Subject|1|||
155429690|NCT00049127|560999023|FG003|Overall Study|Withdrawal by Subject|0|||
155429691|NCT00049127|560999024|FG004|Overall Study|Withdrawal by Subject|0|||
155429692|NCT02582515|560999025|FG000|Overall Study|Withdrawal by Subject|0|||
155429693|NCT02582515|560999026|FG001|Overall Study|Withdrawal by Subject|1|||
155429694|NCT00363415|560999027|FG000|Overall Study|Progressive Disease|196|||
155429695|NCT00363415|560999028|FG001|Overall Study|Progressive Disease|107|||
155429696|NCT00363415|560999027|FG000|Overall Study|Sponsor Decision|67|||
155429697|NCT00363415|560999028|FG001|Overall Study|Sponsor Decision|31|||
155429698|NCT00363415|560999027|FG000|Overall Study|Death|32|||
155429699|NCT00363415|560999028|FG001|Overall Study|Death|29|||
155429700|NCT00363415|560999027|FG000|Overall Study|Adverse Event|24|||
155429701|NCT00363415|560999028|FG001|Overall Study|Adverse Event|15|||
155429702|NCT00363415|560999027|FG000|Overall Study|Physician Decision|18|||
155429703|NCT00363415|560999028|FG001|Overall Study|Physician Decision|35|||
155429704|NCT00363415|560999027|FG000|Overall Study|Entry Criteria Not Met|11|||
155429705|NCT00363415|560999028|FG001|Overall Study|Entry Criteria Not Met|10|||
155429706|NCT00363415|560999027|FG000|Overall Study|Withdrawal by Subject|9|||
155429707|NCT00363415|560999028|FG001|Overall Study|Withdrawal by Subject|15|||
155429708|NCT00363415|560999027|FG000|Overall Study|Lost to Follow-up|3|||
155429709|NCT00363415|560999028|FG001|Overall Study|Lost to Follow-up|3|||
155510253|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
155510254|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
155510255|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Physician Decision|10|||
155510256|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Physician Decision|0|||
155429710|NCT00363415|560999027|FG000|Overall Study|Protocol Violation|1|||
155510257|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Physician Decision|0|||
155429711|NCT00363415|560999028|FG001|Overall Study|Protocol Violation|4|||
155429712|NCT01287754|560999031|FG000|Overall Study|Death|2|||
155429713|NCT01287754|560999032|FG001|Overall Study|Death|12|||
155429714|NCT01287754|560999031|FG000|Overall Study|Lost to Follow-up|1|||
155429715|NCT01287754|560999032|FG001|Overall Study|Lost to Follow-up|6|||
155429716|NCT01287754|560999031|FG000|Overall Study|Protocol Violation|0|||
155510258|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Physician Decision|0|||
155510259|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Physician Decision|0|||
155510260|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
155510261|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
155510262|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
155510263|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
155510264|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
155510265|NCT01360632|561293516|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
155510266|NCT01360632|561293517|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
155510267|NCT01360632|561293518|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
155510268|NCT01360632|561293519|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
155510269|NCT01360632|561293520|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
155510270|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
155510271|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
155510272|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
155510273|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
155510274|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
155510275|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Adverse Event|0|||
155510276|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Adverse Event|3|||
155510277|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Adverse Event|9|||
155510278|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Adverse Event|3|||
155510279|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Adverse Event|0|||
155510280|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155510281|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155510282|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
155510283|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
155510284|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155510285|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Physician Decision|0|||
155510286|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Physician Decision|0|||
155510287|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Physician Decision|0|||
155510288|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Physician Decision|1|||
155510289|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Physician Decision|0|||
155510290|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
155510291|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
155510292|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
155510293|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
155510294|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
155510295|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
155510296|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
155510297|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
155510298|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
155510299|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
155510300|NCT01360632|561293516|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
155510301|NCT01360632|561293517|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
155510302|NCT01360632|561293518|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
155510303|NCT01360632|561293519|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
155510304|NCT01360632|561293520|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
155510305|NCT01360632|561293516|FG000|Phase A+|Lost to Follow-up|0|||
155510306|NCT01360632|561293517|FG001|Phase A+|Lost to Follow-up|0|||
155510307|NCT01360632|561293518|FG002|Phase A+|Lost to Follow-up|0|||
155510308|NCT01360632|561293519|FG003|Phase A+|Lost to Follow-up|0|||
155510309|NCT01360632|561293520|FG004|Phase A+|Lost to Follow-up|2|||
155510310|NCT01360632|561293516|FG000|Phase A+|Adverse Event|0|||
155510311|NCT01360632|561293517|FG001|Phase A+|Adverse Event|0|||
155510312|NCT01360632|561293518|FG002|Phase A+|Adverse Event|0|||
155510313|NCT01360632|561293519|FG003|Phase A+|Adverse Event|0|||
155510314|NCT01360632|561293520|FG004|Phase A+|Adverse Event|2|||
155510315|NCT01360632|561293516|FG000|Phase A+|Met Withdrawal Criteria|0|||
155510316|NCT01360632|561293517|FG001|Phase A+|Met Withdrawal Criteria|0|||
155510317|NCT01360632|561293518|FG002|Phase A+|Met Withdrawal Criteria|0|||
155510318|NCT01360632|561293519|FG003|Phase A+|Met Withdrawal Criteria|0|||
155510319|NCT01360632|561293520|FG004|Phase A+|Met Withdrawal Criteria|7|||
155510320|NCT01360632|561293516|FG000|Phase A+|Physician Decision|0|||
155510321|NCT01360632|561293517|FG001|Phase A+|Physician Decision|0|||
155510322|NCT01360632|561293518|FG002|Phase A+|Physician Decision|0|||
155510323|NCT01360632|561293519|FG003|Phase A+|Physician Decision|0|||
155510324|NCT01360632|561293520|FG004|Phase A+|Physician Decision|3|||
155510325|NCT01360632|561293516|FG000|Phase A+|Withdrawal by Subject|0|||
155510326|NCT01360632|561293517|FG001|Phase A+|Withdrawal by Subject|0|||
155510327|NCT01360632|561293518|FG002|Phase A+|Withdrawal by Subject|0|||
155510328|NCT01360632|561293519|FG003|Phase A+|Withdrawal by Subject|0|||
155510329|NCT01360632|561293520|FG004|Phase A+|Withdrawal by Subject|8|||
155510330|NCT01360632|561293516|FG000|Phase A+|Protocol Deviation|0|||
155510331|NCT01360632|561293517|FG001|Phase A+|Protocol Deviation|0|||
155510332|NCT01360632|561293518|FG002|Phase A+|Protocol Deviation|0|||
155510333|NCT01360632|561293519|FG003|Phase A+|Protocol Deviation|0|||
155510334|NCT01360632|561293520|FG004|Phase A+|Protocol Deviation|3|||
155510335|NCT01298596|561293521|FG000|Overall Study|Withdrawal by Subject|1|||
155371077|NCT01803282|560792020|FG008|Overall Study|Investigator's Discretion|6|||
155371078|NCT01803282|560792021|FG009|Overall Study|Investigator's Discretion|7|||
155371079|NCT01803282|560792022|FG010|Overall Study|Investigator's Discretion|1|||
155429717|NCT01287754|560999032|FG001|Overall Study|Protocol Violation|3|||
155429718|NCT00001337|560999033|FG000|Overall Study|Switched to alternate treatment|2|||
155429719|NCT00001337|560999034|FG001|Overall Study|Switched to alternate treatment|2|||
155429720|NCT00001337|560999035|FG002|Overall Study|Switched to alternate treatment|0|||
155429721|NCT00001337|560999033|FG000|Overall Study|Refused further treatment|2|||
155429722|NCT00001337|560999034|FG001|Overall Study|Refused further treatment|1|||
155429723|NCT00001337|560999035|FG002|Overall Study|Refused further treatment|0|||
155429724|NCT00001337|560999033|FG000|Overall Study|Began other Tx|1|||
155429725|NCT00001337|560999034|FG001|Overall Study|Began other Tx|0|||
155429726|NCT00001337|560999035|FG002|Overall Study|Began other Tx|0|||
155429727|NCT00001337|560999033|FG000|Overall Study|Physician Decision|3|||
155429728|NCT00001337|560999034|FG001|Overall Study|Physician Decision|1|||
155429729|NCT00001337|560999035|FG002|Overall Study|Physician Decision|0|||
155429730|NCT00001337|560999033|FG000|Overall Study|Doesn't have NHL|0|||
155429731|NCT00001337|560999034|FG001|Overall Study|Doesn't have NHL|1|||
155429732|NCT00001337|560999035|FG002|Overall Study|Doesn't have NHL|0|||
155429733|NCT00001337|560999033|FG000|Overall Study|Non protocol tx needed|3|||
155429734|NCT00001337|560999034|FG001|Overall Study|Non protocol tx needed|1|||
155429735|NCT00001337|560999035|FG002|Overall Study|Non protocol tx needed|0|||
155429736|NCT00001337|560999033|FG000|Overall Study|Protocol change|1|||
155429737|NCT00001337|560999034|FG001|Overall Study|Protocol change|0|||
155429738|NCT00001337|560999035|FG002|Overall Study|Protocol change|0|||
155429739|NCT00001337|560999033|FG000|Overall Study|2nd primary disease|0|||
155429740|NCT00001337|560999034|FG001|Overall Study|2nd primary disease|0|||
155429741|NCT00001337|560999035|FG002|Overall Study|2nd primary disease|1|||
155429742|NCT00001337|560999033|FG000|Overall Study|Death during follow up period|9|||
155429743|NCT00001337|560999034|FG001|Overall Study|Death during follow up period|4|||
155429744|NCT00001337|560999035|FG002|Overall Study|Death during follow up period|0|||
155429745|NCT00001337|560999033|FG000|Overall Study|Death on study|19|||
155429746|NCT00001337|560999034|FG001|Overall Study|Death on study|9|||
155429747|NCT00001337|560999035|FG002|Overall Study|Death on study|0|||
155429748|NCT00001337|560999033|FG000|Overall Study|Disease progression during follow-up period|3|||
155429749|NCT00001337|560999034|FG001|Overall Study|Disease progression during follow-up period|1|||
155429750|NCT00001337|560999035|FG002|Overall Study|Disease progression during follow-up period|0|||
155429751|NCT00001337|560999033|FG000|Overall Study|Disease progression on study|33|||
155429752|NCT00001337|560999034|FG001|Overall Study|Disease progression on study|41|||
155429753|NCT00001337|560999035|FG002|Overall Study|Disease progression on study|0|||
155429754|NCT00001337|560999033|FG000|Overall Study|Lost to further follow-up|10|||
155429755|NCT00001337|560999034|FG001|Overall Study|Lost to further follow-up|6|||
155429756|NCT00001337|560999035|FG002|Overall Study|Lost to further follow-up|0|||
155429757|NCT00001337|560999033|FG000|Overall Study|2nd malignancy|1|||
155429758|NCT00001337|560999034|FG001|Overall Study|2nd malignancy|0|||
155429759|NCT00001337|560999035|FG002|Overall Study|2nd malignancy|0|||
155429760|NCT00001337|560999033|FG000|Overall Study|Treatment for second lymphoma|0|||
155429761|NCT00001337|560999034|FG001|Overall Study|Treatment for second lymphoma|1|||
155429762|NCT00001337|560999035|FG002|Overall Study|Treatment for second lymphoma|0|||
155429763|NCT00001337|560999033|FG000|Overall Study|Transfer to transplant|0|||
155429764|NCT00001337|560999034|FG001|Overall Study|Transfer to transplant|1|||
155429765|NCT00001337|560999035|FG002|Overall Study|Transfer to transplant|0|||
155429766|NCT00809133|560999042|FG000|Overall Study|Progressive disease|2|||
155429767|NCT00809133|560999043|FG001|Overall Study|Progressive disease|5|||
155429768|NCT00809133|560999044|FG002|Overall Study|Progressive disease|5|||
155429769|NCT00809133|560999045|FG003|Overall Study|Progressive disease|3|||
155429770|NCT00809133|560999046|FG004|Overall Study|Progressive disease|4|||
155429771|NCT00809133|560999047|FG005|Overall Study|Progressive disease|1|||
155429772|NCT00809133|560999048|FG006|Overall Study|Progressive disease|3|||
155429773|NCT00809133|560999049|FG007|Overall Study|Progressive disease|3|||
155429774|NCT00809133|560999050|FG008|Overall Study|Progressive disease|3|||
155429775|NCT00809133|560999051|FG009|Overall Study|Progressive disease|9|||
155429776|NCT00809133|560999052|FG010|Overall Study|Progressive disease|5|||
155429777|NCT00809133|560999053|FG011|Overall Study|Progressive disease|7|||
155429778|NCT00809133|560999054|FG012|Overall Study|Progressive disease|5|||
155429779|NCT00809133|560999055|FG013|Overall Study|Progressive disease|4|||
155429780|NCT00809133|560999042|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429781|NCT00809133|560999043|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429782|NCT00809133|560999044|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429783|NCT00809133|560999045|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429784|NCT00809133|560999046|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429785|NCT00809133|560999047|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155429786|NCT00809133|560999048|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155429787|NCT00809133|560999049|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155429788|NCT00809133|560999050|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429789|NCT00809133|560999051|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429790|NCT00809133|560999052|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429791|NCT00809133|560999053|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155429792|NCT00809133|560999054|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155510336|NCT01298596|561293522|FG001|Overall Study|Withdrawal by Subject|1|||
155510337|NCT01298596|561293521|FG000|Overall Study|Death|5|||
155510338|NCT01298596|561293522|FG001|Overall Study|Death|3|||
155510339|NCT01298596|561293521|FG000|Overall Study|Lost to Follow-up|6|||
155510340|NCT01298596|561293522|FG001|Overall Study|Lost to Follow-up|14|||
155510341|NCT01298596|561293521|FG000|Overall Study|Referred for further management|16|||
155510342|NCT01298596|561293522|FG001|Overall Study|Referred for further management|15|||
155510343|NCT03740100|561293523|FG000|Overall Study|Adverse Event|1|||
155510344|NCT03740100|561293523|FG000|Overall Study|Death|1|||
155510345|NCT02046369|561293524|FG000|Overall Study|Adverse Event|3|||
155510346|NCT02046369|561293525|FG001|Overall Study|Adverse Event|3|||
155510347|NCT02046369|561293524|FG000|Overall Study|Lack of Efficacy|3|||
155510348|NCT02046369|561293525|FG001|Overall Study|Lack of Efficacy|3|||
155510349|NCT02046369|561293524|FG000|Overall Study|Lost to Follow-up|3|||
155510350|NCT02046369|561293525|FG001|Overall Study|Lost to Follow-up|3|||
155510351|NCT02046369|561293524|FG000|Overall Study|Protocol Violation|1|||
155510352|NCT02046369|561293525|FG001|Overall Study|Protocol Violation|2|||
155510353|NCT02046369|561293524|FG000|Overall Study|Withdrawal by Subject|3|||
155510354|NCT02046369|561293525|FG001|Overall Study|Withdrawal by Subject|6|||
155510355|NCT02046369|561293524|FG000|Overall Study|never received study drug|0|||
155510356|NCT02046369|561293525|FG001|Overall Study|never received study drug|1|||
155510357|NCT02046369|561293524|FG000|Overall Study|non compliance|1|||
155510358|NCT02046369|561293525|FG001|Overall Study|non compliance|0|||
155510359|NCT03120520|561293526|FG000|Overall Study|Lost to Follow-up|1|||
155510360|NCT03120520|561293527|FG001|Overall Study|Lost to Follow-up|1|||
155510361|NCT03120520|561293528|FG002|Overall Study|Lost to Follow-up|1|||
155510362|NCT03120520|561293529|FG003|Overall Study|Lost to Follow-up|1|||
155510363|NCT03120520|561293526|FG000|Overall Study|Withdrawal by Subject|3|||
155510364|NCT03120520|561293527|FG001|Overall Study|Withdrawal by Subject|2|||
155510365|NCT03120520|561293528|FG002|Overall Study|Withdrawal by Subject|3|||
155510366|NCT03120520|561293529|FG003|Overall Study|Withdrawal by Subject|2|||
155510367|NCT03120520|561293526|FG000|Overall Study|Other|0|||
155510368|NCT03120520|561293527|FG001|Overall Study|Other|1|||
155510369|NCT03120520|561293528|FG002|Overall Study|Other|0|||
155649494|NCT03016403|561808282|FG000|6-week Follow-up|Lost to Follow-up|2|||
155649495|NCT03016403|561808283|FG001|6-week Follow-up|Lost to Follow-up|7|||
155510370|NCT03120520|561293529|FG003|Overall Study|Other|0|||
155510371|NCT03387059|561293530|FG000|Overall Study|Study termination|5|||
155510372|NCT03387059|561293531|FG001|Overall Study|Study termination|4|||
155510373|NCT01715415|561293540|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
155510374|NCT01715415|561293541|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
155649496|NCT03016403|561808284|FG002|6-week Follow-up|Lost to Follow-up|4|||
155510375|NCT01715415|561293540|FG000|Double-blind Treatment|Adverse Event|3|||
155510376|NCT01715415|561293541|FG001|Double-blind Treatment|Adverse Event|0|||
155510377|NCT01715415|561293540|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
155510378|NCT01715415|561293541|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
155649497|NCT03016403|561808285|FG003|6-week Follow-up|Lost to Follow-up|8|||
155649498|NCT03016403|561808282|FG000|6-week Follow-up|Withdrawal by Subject|0|||
155649499|NCT03016403|561808283|FG001|6-week Follow-up|Withdrawal by Subject|2|||
155510379|NCT01715415|561293540|FG000|Double-blind Treatment|Other|1|||
155371080|NCT01803282|560792023|FG011|Overall Study|Investigator's Discretion|0|||
155371081|NCT01803282|560792012|FG000|Overall Study|Adverse Event|0|||
155371082|NCT01803282|560792013|FG001|Overall Study|Adverse Event|0|||
155371083|NCT01803282|560792014|FG002|Overall Study|Adverse Event|0|||
155371084|NCT01803282|560792015|FG003|Overall Study|Adverse Event|0|||
155371085|NCT01803282|560792016|FG004|Overall Study|Adverse Event|0|||
155371086|NCT01803282|560792017|FG005|Overall Study|Adverse Event|0|||
155510380|NCT01715415|561293541|FG001|Double-blind Treatment|Other|0|||
155510381|NCT01715415|561293540|FG000|Open-label Treatment|Adverse Event|0|||
155510382|NCT01715415|561293541|FG001|Open-label Treatment|Adverse Event|1|||
155510383|NCT01715415|561293540|FG000|Open-label Treatment|Subject Noncompliant|0|||
155510384|NCT01715415|561293541|FG001|Open-label Treatment|Subject Noncompliant|1|||
155510385|NCT02884206|561295206|FG000|Valsartan Run-in Period|Death|1|||
155510386|NCT02884206|561295207|FG001|Valsartan Run-in Period|Death|0|||
155510387|NCT02884206|561295208|FG002|Valsartan Run-in Period|Death|0|||
155510388|NCT02884206|561295206|FG000|Valsartan Run-in Period|Adverse Event|31|||
155510389|NCT02884206|561295207|FG001|Valsartan Run-in Period|Adverse Event|0|||
155510390|NCT02884206|561295208|FG002|Valsartan Run-in Period|Adverse Event|0|||
155510391|NCT02884206|561295206|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
155510392|NCT02884206|561295207|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
155510393|NCT02884206|561295208|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
155510394|NCT02884206|561295206|FG000|Valsartan Run-in Period|Protocol deviation|4|||
155510395|NCT02884206|561295207|FG001|Valsartan Run-in Period|Protocol deviation|0|||
155510396|NCT02884206|561295208|FG002|Valsartan Run-in Period|Protocol deviation|0|||
155510397|NCT02884206|561295206|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
155510398|NCT02884206|561295207|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
155510399|NCT02884206|561295208|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
155510400|NCT02884206|561295206|FG000|Valsartan Run-in Period|Physician Decision|1|||
155510401|NCT02884206|561295207|FG001|Valsartan Run-in Period|Physician Decision|0|||
155510402|NCT02884206|561295208|FG002|Valsartan Run-in Period|Physician Decision|0|||
155510403|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Adverse Event|38|||
155510404|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Adverse Event|0|||
155510405|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Adverse Event|0|||
155510406|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Death|2|||
155510407|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Death|0|||
155510408|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Death|0|||
155510409|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
155510410|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
155510411|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
155510412|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
155510413|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
155510414|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
155510415|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
155510416|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
155510417|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
155510418|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Physician Decision|1|||
155510419|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Physician Decision|0|||
155510420|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Physician Decision|0|||
155510421|NCT02884206|561295206|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
155510422|NCT02884206|561295207|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
155510423|NCT02884206|561295208|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
155510424|NCT02884206|561295206|FG000|Double-Blind Period|Death|0|||
155371087|NCT01803282|560792018|FG006|Overall Study|Adverse Event|1|||
155510425|NCT02884206|561295207|FG001|Double-Blind Period|Death|28|||
155510426|NCT02884206|561295208|FG002|Double-Blind Period|Death|39|||
155510427|NCT02884206|561295206|FG000|Double-Blind Period|Patient/guardian decision|0|||
155510428|NCT02884206|561295207|FG001|Double-Blind Period|Patient/guardian decision|10|||
155510429|NCT02884206|561295208|FG002|Double-Blind Period|Patient/guardian decision|13|||
155649500|NCT03016403|561808284|FG002|6-week Follow-up|Withdrawal by Subject|0|||
155649501|NCT03016403|561808285|FG003|6-week Follow-up|Withdrawal by Subject|1|||
155649502|NCT03016403|561808282|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
155371088|NCT01803282|560792019|FG007|Overall Study|Adverse Event|2|||
155371089|NCT01803282|560792020|FG008|Overall Study|Adverse Event|0|||
155371090|NCT01803282|560792021|FG009|Overall Study|Adverse Event|1|||
155371091|NCT01803282|560792022|FG010|Overall Study|Adverse Event|0|||
155371092|NCT01803282|560792023|FG011|Overall Study|Adverse Event|3|||
155371093|NCT01803282|560792012|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155371094|NCT01803282|560792013|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155371095|NCT01803282|560792014|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155371096|NCT01803282|560792015|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155429793|NCT00809133|560999055|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155429794|NCT00809133|560999042|FG000|Overall Study|Other adverse event|1|||
155429795|NCT00809133|560999043|FG001|Overall Study|Other adverse event|1|||
155429796|NCT00809133|560999044|FG002|Overall Study|Other adverse event|1|||
155429797|NCT00809133|560999045|FG003|Overall Study|Other adverse event|0|||
155429798|NCT00809133|560999046|FG004|Overall Study|Other adverse event|0|||
155429799|NCT00809133|560999047|FG005|Overall Study|Other adverse event|3|||
155429800|NCT00809133|560999048|FG006|Overall Study|Other adverse event|2|||
155429801|NCT00809133|560999049|FG007|Overall Study|Other adverse event|4|||
155429802|NCT00809133|560999050|FG008|Overall Study|Other adverse event|0|||
155429803|NCT00809133|560999051|FG009|Overall Study|Other adverse event|0|||
155429804|NCT00809133|560999052|FG010|Overall Study|Other adverse event|1|||
155429805|NCT00809133|560999053|FG011|Overall Study|Other adverse event|1|||
155429806|NCT00809133|560999054|FG012|Overall Study|Other adverse event|0|||
155429807|NCT00809133|560999055|FG013|Overall Study|Other adverse event|1|||
155429808|NCT00809133|560999042|FG000|Overall Study|Lost to Follow-up|0|||
155429809|NCT00809133|560999043|FG001|Overall Study|Lost to Follow-up|0|||
155429810|NCT00809133|560999044|FG002|Overall Study|Lost to Follow-up|0|||
155429811|NCT00809133|560999045|FG003|Overall Study|Lost to Follow-up|0|||
155429812|NCT00809133|560999046|FG004|Overall Study|Lost to Follow-up|0|||
155429813|NCT00809133|560999047|FG005|Overall Study|Lost to Follow-up|1|||
155429814|NCT00809133|560999048|FG006|Overall Study|Lost to Follow-up|0|||
155429815|NCT00809133|560999049|FG007|Overall Study|Lost to Follow-up|0|||
155429816|NCT00809133|560999050|FG008|Overall Study|Lost to Follow-up|0|||
155429817|NCT00809133|560999051|FG009|Overall Study|Lost to Follow-up|0|||
155429818|NCT00809133|560999052|FG010|Overall Study|Lost to Follow-up|0|||
155429819|NCT00809133|560999053|FG011|Overall Study|Lost to Follow-up|0|||
155429820|NCT00809133|560999054|FG012|Overall Study|Lost to Follow-up|0|||
155429821|NCT00809133|560999055|FG013|Overall Study|Lost to Follow-up|0|||
155429822|NCT00809133|560999042|FG000|Overall Study|Consent withdrawn|0|||
155429823|NCT00809133|560999043|FG001|Overall Study|Consent withdrawn|0|||
155429824|NCT00809133|560999044|FG002|Overall Study|Consent withdrawn|0|||
155429825|NCT00809133|560999045|FG003|Overall Study|Consent withdrawn|0|||
155429826|NCT00809133|560999046|FG004|Overall Study|Consent withdrawn|1|||
155429827|NCT00809133|560999047|FG005|Overall Study|Consent withdrawn|0|||
155429828|NCT00809133|560999048|FG006|Overall Study|Consent withdrawn|0|||
155429829|NCT00809133|560999049|FG007|Overall Study|Consent withdrawn|0|||
155429830|NCT00809133|560999050|FG008|Overall Study|Consent withdrawn|0|||
155429831|NCT00809133|560999051|FG009|Overall Study|Consent withdrawn|0|||
155429832|NCT00809133|560999052|FG010|Overall Study|Consent withdrawn|0|||
155429833|NCT00809133|560999053|FG011|Overall Study|Consent withdrawn|0|||
155429834|NCT00809133|560999054|FG012|Overall Study|Consent withdrawn|0|||
155429835|NCT00809133|560999055|FG013|Overall Study|Consent withdrawn|0|||
155429836|NCT00809133|560999042|FG000|Overall Study|Other not mentioned above|0|||
155429837|NCT00809133|560999043|FG001|Overall Study|Other not mentioned above|1|||
155429838|NCT00809133|560999044|FG002|Overall Study|Other not mentioned above|0|||
155429839|NCT00809133|560999045|FG003|Overall Study|Other not mentioned above|0|||
155429840|NCT00809133|560999046|FG004|Overall Study|Other not mentioned above|0|||
155429841|NCT00809133|560999047|FG005|Overall Study|Other not mentioned above|1|||
155429842|NCT00809133|560999048|FG006|Overall Study|Other not mentioned above|0|||
155429843|NCT00809133|560999049|FG007|Overall Study|Other not mentioned above|0|||
155429844|NCT00809133|560999050|FG008|Overall Study|Other not mentioned above|0|||
155429845|NCT00809133|560999051|FG009|Overall Study|Other not mentioned above|0|||
155429846|NCT00809133|560999052|FG010|Overall Study|Other not mentioned above|0|||
155429847|NCT00809133|560999053|FG011|Overall Study|Other not mentioned above|0|||
155429848|NCT00809133|560999054|FG012|Overall Study|Other not mentioned above|0|||
155429849|NCT00809133|560999055|FG013|Overall Study|Other not mentioned above|0|||
155429850|NCT00619229|560999056|FG000|Overall Study|Withdrawal by Subject|1|||
155429851|NCT00619229|560999057|FG001|Overall Study|Withdrawal by Subject|1|||
155429852|NCT00619229|560999056|FG000|Overall Study|Lost to Follow-up|1|||
155429853|NCT00619229|560999057|FG001|Overall Study|Lost to Follow-up|0|||
155429854|NCT00619229|560999056|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
155429855|NCT00619229|560999057|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
155429856|NCT00619229|560999056|FG000|Overall Study|Investigator planned Cataract Operation|1|||
155429857|NCT00619229|560999057|FG001|Overall Study|Investigator planned Cataract Operation|0|||
155429858|NCT03417440|560999058|FG000|Overall Study|Lost to Follow-up|0|||
155429859|NCT03417440|560999059|FG001|Overall Study|Lost to Follow-up|1|||
155429860|NCT03417440|560999060|FG002|Overall Study|Lost to Follow-up|0|||
155429861|NCT03417440|560999061|FG003|Overall Study|Lost to Follow-up|0|||
155429862|NCT03417440|560999062|FG004|Overall Study|Lost to Follow-up|1|||
155429863|NCT03417440|560999063|FG005|Overall Study|Lost to Follow-up|0|||
155510430|NCT02884206|561295206|FG000|Double-Blind Period|Lost to Follow-up|0|||
155510431|NCT02884206|561295207|FG001|Double-Blind Period|Lost to Follow-up|4|||
155429864|NCT03417440|560999064|FG006|Overall Study|Lost to Follow-up|0|||
155429865|NCT03417440|560999065|FG007|Overall Study|Lost to Follow-up|0|||
155429866|NCT03417440|560999058|FG000|Overall Study|Withdrawal by Subject|2|||
155429867|NCT03417440|560999059|FG001|Overall Study|Withdrawal by Subject|0|||
155429868|NCT03417440|560999060|FG002|Overall Study|Withdrawal by Subject|2|||
155429869|NCT03417440|560999061|FG003|Overall Study|Withdrawal by Subject|1|||
155429870|NCT03417440|560999062|FG004|Overall Study|Withdrawal by Subject|1|||
155429871|NCT03417440|560999063|FG005|Overall Study|Withdrawal by Subject|0|||
155429872|NCT03417440|560999064|FG006|Overall Study|Withdrawal by Subject|0|||
155429873|NCT03417440|560999065|FG007|Overall Study|Withdrawal by Subject|1|||
155429874|NCT02786901|560999066|FG000|Overall Study|Adverse Event|1|||
155429875|NCT02786901|560999067|FG001|Overall Study|Adverse Event|1|||
155429876|NCT02786901|560999068|FG002|Overall Study|Adverse Event|2|||
155429877|NCT02786901|560999066|FG000|Overall Study|Physician Decision|1|||
155429878|NCT02786901|560999067|FG001|Overall Study|Physician Decision|0|||
155429879|NCT02786901|560999068|FG002|Overall Study|Physician Decision|0|||
155429880|NCT02786901|560999066|FG000|Overall Study|Rescue Therapy Use|71|||
155429881|NCT02786901|560999067|FG001|Overall Study|Rescue Therapy Use|49|||
155429882|NCT02786901|560999068|FG002|Overall Study|Rescue Therapy Use|33|||
155429883|NCT02786901|560999066|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
155429884|NCT02786901|560999067|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
155429885|NCT02786901|560999068|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
155429886|NCT02786901|560999066|FG000|Overall Study|Disallowed medication|1|||
155429887|NCT02786901|560999067|FG001|Overall Study|Disallowed medication|1|||
155429888|NCT02786901|560999068|FG002|Overall Study|Disallowed medication|0|||
155429889|NCT02786901|560999066|FG000|Overall Study|Randomized in error|2|||
155429890|NCT02786901|560999067|FG001|Overall Study|Randomized in error|0|||
155429891|NCT02786901|560999068|FG002|Overall Study|Randomized in error|1|||
155429892|NCT00607048|560999070|FG000|Overall Study|Adverse Event|0|||
155429893|NCT00607048|560999071|FG001|Overall Study|Adverse Event|1|||
155429894|NCT00607048|560999072|FG002|Overall Study|Adverse Event|0|||
155429895|NCT00607048|560999073|FG003|Overall Study|Adverse Event|0|||
155429896|NCT00607048|560999074|FG004|Overall Study|Adverse Event|4|||
155429897|NCT00607048|560999075|FG005|Overall Study|Adverse Event|0|||
155429898|NCT00607048|560999070|FG000|Overall Study|Global deterioration of health|1|||
155429899|NCT00607048|560999071|FG001|Overall Study|Global deterioration of health|0|||
155429900|NCT00607048|560999072|FG002|Overall Study|Global deterioration of health|0|||
155429901|NCT00607048|560999073|FG003|Overall Study|Global deterioration of health|0|||
155429902|NCT00607048|560999074|FG004|Overall Study|Global deterioration of health|0|||
155429903|NCT00607048|560999075|FG005|Overall Study|Global deterioration of health|0|||
155429904|NCT00607048|560999070|FG000|Overall Study|Objective disease progression - relapse|1|||
155429905|NCT00607048|560999071|FG001|Overall Study|Objective disease progression - relapse|2|||
155510432|NCT02884206|561295208|FG002|Double-Blind Period|Lost to Follow-up|4|||
155371097|NCT01803282|560792016|FG004|Overall Study|Non-Compliance with Study Drug|0|||
155371098|NCT01803282|560792017|FG005|Overall Study|Non-Compliance with Study Drug|0|||
155371099|NCT01803282|560792018|FG006|Overall Study|Non-Compliance with Study Drug|0|||
155371100|NCT01803282|560792019|FG007|Overall Study|Non-Compliance with Study Drug|0|||
155371101|NCT01803282|560792020|FG008|Overall Study|Non-Compliance with Study Drug|0|||
155371102|NCT01803282|560792021|FG009|Overall Study|Non-Compliance with Study Drug|0|||
155371103|NCT01803282|560792022|FG010|Overall Study|Non-Compliance with Study Drug|0|||
155371104|NCT01803282|560792023|FG011|Overall Study|Non-Compliance with Study Drug|0|||
155371105|NCT01803282|560792012|FG000|Overall Study|Unknown Reason|0|||
155371106|NCT01803282|560792013|FG001|Overall Study|Unknown Reason|0|||
155371107|NCT01803282|560792014|FG002|Overall Study|Unknown Reason|0|||
155371108|NCT01803282|560792015|FG003|Overall Study|Unknown Reason|0|||
155371109|NCT01803282|560792016|FG004|Overall Study|Unknown Reason|0|||
155371110|NCT01803282|560792017|FG005|Overall Study|Unknown Reason|0|||
155371111|NCT01803282|560792018|FG006|Overall Study|Unknown Reason|0|||
155371112|NCT01803282|560792019|FG007|Overall Study|Unknown Reason|1|||
155371113|NCT01803282|560792020|FG008|Overall Study|Unknown Reason|0|||
155429906|NCT00607048|560999072|FG002|Overall Study|Objective disease progression - relapse|4|||
155429907|NCT00607048|560999073|FG003|Overall Study|Objective disease progression - relapse|2|||
155429908|NCT00607048|560999074|FG004|Overall Study|Objective disease progression - relapse|2|||
155429909|NCT00607048|560999075|FG005|Overall Study|Objective disease progression - relapse|2|||
155429910|NCT00607048|560999070|FG000|Overall Study|Withdrawal by Subject|0|||
155371114|NCT01803282|560792021|FG009|Overall Study|Unknown Reason|0|||
155429911|NCT00607048|560999071|FG001|Overall Study|Withdrawal by Subject|0|||
155429912|NCT00607048|560999072|FG002|Overall Study|Withdrawal by Subject|0|||
155429913|NCT00607048|560999073|FG003|Overall Study|Withdrawal by Subject|1|||
155429914|NCT00607048|560999074|FG004|Overall Study|Withdrawal by Subject|0|||
155429915|NCT00607048|560999075|FG005|Overall Study|Withdrawal by Subject|2|||
155429916|NCT00607048|560999070|FG000|Overall Study|Other|1|||
155429917|NCT00607048|560999071|FG001|Overall Study|Other|1|||
155429918|NCT00607048|560999072|FG002|Overall Study|Other|0|||
155429919|NCT00607048|560999073|FG003|Overall Study|Other|0|||
155429920|NCT00607048|560999074|FG004|Overall Study|Other|0|||
155429921|NCT00607048|560999075|FG005|Overall Study|Other|1|||
155429922|NCT00699192|560999076|FG000|Overall Study|Missing|1|||
155371115|NCT01803282|560792022|FG010|Overall Study|Unknown Reason|0|||
155371116|NCT01803282|560792023|FG011|Overall Study|Unknown Reason|0|||
155371117|NCT01803282|560792012|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
155371118|NCT01803282|560792013|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
155371119|NCT01803282|560792014|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
155371120|NCT01803282|560792015|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
155371121|NCT01803282|560792016|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
155371122|NCT01803282|560792017|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
155371123|NCT01803282|560792018|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
155371124|NCT01803282|560792019|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
155371125|NCT01803282|560792020|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
155371126|NCT01803282|560792021|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
155371127|NCT01803282|560792022|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
155371128|NCT01803282|560792023|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
155371129|NCT01803282|560792012|FG000|Overall Study|Enrolled but Never Treated|0|||
155371130|NCT01803282|560792013|FG001|Overall Study|Enrolled but Never Treated|0|||
155429923|NCT00699192|560999077|FG001|Overall Study|Missing|1|||
155429924|NCT00699192|560999078|FG002|Overall Study|Missing|1|||
155429925|NCT00699192|560999076|FG000|Overall Study|Adverse Event|9|||
155429926|NCT00699192|560999077|FG001|Overall Study|Adverse Event|4|||
155429927|NCT00699192|560999078|FG002|Overall Study|Adverse Event|3|||
155429928|NCT00699192|560999076|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155429929|NCT00699192|560999077|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155429930|NCT00699192|560999078|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155429931|NCT00699192|560999076|FG000|Overall Study|Lack of Efficacy|0|||
155429932|NCT00699192|560999077|FG001|Overall Study|Lack of Efficacy|0|||
155429933|NCT00699192|560999078|FG002|Overall Study|Lack of Efficacy|1|||
155429934|NCT00699192|560999076|FG000|Overall Study|Withdrawal by Subject|3|||
155429935|NCT00699192|560999077|FG001|Overall Study|Withdrawal by Subject|2|||
155429936|NCT00699192|560999078|FG002|Overall Study|Withdrawal by Subject|4|||
155371131|NCT01803282|560792014|FG002|Overall Study|Enrolled but Never Treated|0|||
155371132|NCT01803282|560792015|FG003|Overall Study|Enrolled but Never Treated|0|||
155371133|NCT01803282|560792016|FG004|Overall Study|Enrolled but Never Treated|1|||
155371134|NCT01803282|560792017|FG005|Overall Study|Enrolled but Never Treated|0|||
155371135|NCT01803282|560792018|FG006|Overall Study|Enrolled but Never Treated|1|||
155371136|NCT01803282|560792019|FG007|Overall Study|Enrolled but Never Treated|1|||
155371137|NCT01803282|560792020|FG008|Overall Study|Enrolled but Never Treated|0|||
155371138|NCT01803282|560792021|FG009|Overall Study|Enrolled but Never Treated|1|||
155371139|NCT01803282|560792022|FG010|Overall Study|Enrolled but Never Treated|0|||
155371140|NCT01803282|560792023|FG011|Overall Study|Enrolled but Never Treated|0|||
155371141|NCT02671500|560792025|FG000|Overall Study|Lack of Efficacy|12|||
155371142|NCT02671500|560792025|FG000|Overall Study|Lost to Follow-up|2|||
155371143|NCT03086655|560792029|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
155371144|NCT03086655|560792030|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
155371145|NCT03086655|560792029|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
155371146|NCT03086655|560792030|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
155371147|NCT03086655|560792029|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
155371148|NCT03086655|560792030|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
155371149|NCT03086655|560792029|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
155371150|NCT03086655|560792030|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
155371151|NCT03086655|560792029|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
155371152|NCT03086655|560792030|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
155371153|NCT03086655|560792029|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
155371154|NCT03086655|560792030|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
155371155|NCT03086655|560792029|FG000|12 Month Follow-up = Final Assessment|Death|0|||
155371156|NCT03086655|560792030|FG001|12 Month Follow-up = Final Assessment|Death|1|||
155371157|NCT00798434|560792031|FG000|Double-Blind|Adverse Event|22|||
155371158|NCT00798434|560792032|FG001|Double-Blind|Adverse Event|46|||
155429937|NCT00699192|560999076|FG000|Overall Study|Administrative problems|1|||
155429938|NCT00699192|560999077|FG001|Overall Study|Administrative problems|3|||
155429939|NCT00699192|560999078|FG002|Overall Study|Administrative problems|1|||
155371159|NCT00798434|560792031|FG000|Double-Blind|Death|0|||
155371160|NCT00798434|560792032|FG001|Double-Blind|Death|1|||
155429940|NCT00699192|560999076|FG000|Overall Study|Protocol Violation|2|||
155429941|NCT00699192|560999077|FG001|Overall Study|Protocol Violation|2|||
155429942|NCT00699192|560999078|FG002|Overall Study|Protocol Violation|0|||
155429943|NCT04336163|560999079|FG000|Overall Study|Lost to Follow-up|55|||
155429944|NCT04336163|560999080|FG001|Overall Study|Lost to Follow-up|0|||
155429945|NCT03663166|560999083|FG000|Overall Study|Withdrawal by Subject|1|||
155371161|NCT00798434|560792031|FG000|Double-Blind|Lost to Follow-up|1|||
155371162|NCT00798434|560792032|FG001|Double-Blind|Lost to Follow-up|0|||
155371163|NCT00798434|560792031|FG000|Double-Blind|Lack of Efficacy|8|||
155371164|NCT00798434|560792032|FG001|Double-Blind|Lack of Efficacy|12|||
155371165|NCT00798434|560792031|FG000|Double-Blind|Withdrawal by Subject|17|||
155371166|NCT00798434|560792032|FG001|Double-Blind|Withdrawal by Subject|14|||
155371167|NCT00798434|560792031|FG000|Double-Blind|Protocol Violation|1|||
155371168|NCT00798434|560792032|FG001|Double-Blind|Protocol Violation|4|||
155371169|NCT00798434|560792031|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
155371170|NCT00798434|560792032|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
155371171|NCT00798434|560792031|FG000|Double-Blind|Other|1|||
155371172|NCT00798434|560792032|FG001|Double-Blind|Other|0|||
155371173|NCT00798434|560792031|FG000|Double-Blind|Not Treated|3|||
155371174|NCT00798434|560792032|FG001|Double-Blind|Not Treated|6|||
155371175|NCT00798434|560792031|FG000|Open-Label|Adverse Event|33|||
155371176|NCT00798434|560792032|FG001|Open-Label|Adverse Event|11|||
155371177|NCT00798434|560792031|FG000|Open-Label|Lack of Efficacy|5|||
155371178|NCT00798434|560792032|FG001|Open-Label|Lack of Efficacy|11|||
155371179|NCT00798434|560792031|FG000|Open-Label|Withdrawal by Subject|2|||
155371180|NCT00798434|560792032|FG001|Open-Label|Withdrawal by Subject|7|||
155371181|NCT00798434|560792031|FG000|Open-Label|Protocol Violation|1|||
155371182|NCT00798434|560792032|FG001|Open-Label|Protocol Violation|0|||
155371183|NCT00798434|560792031|FG000|Open-Label|Other|1|||
155371184|NCT00798434|560792032|FG001|Open-Label|Other|2|||
155371185|NCT00798434|560792031|FG000|Open-Label|Not Treated|0|||
155371186|NCT00798434|560792032|FG001|Open-Label|Not Treated|1|||
155371187|NCT01217437|560792036|FG000|Overall Study|Adverse Event|0|||
155371188|NCT01217437|560792037|FG001|Overall Study|Adverse Event|8|||
155371189|NCT01217437|560792036|FG000|Overall Study|Death|5|||
155371190|NCT01217437|560792037|FG001|Overall Study|Death|0|||
155371191|NCT01217437|560792036|FG000|Overall Study|Lack of Efficacy|29|||
155371192|NCT01217437|560792037|FG001|Overall Study|Lack of Efficacy|25|||
155371193|NCT01217437|560792036|FG000|Overall Study|Physician Decision|8|||
155371194|NCT01217437|560792037|FG001|Overall Study|Physician Decision|5|||
155371195|NCT01217437|560792036|FG000|Overall Study|Withdrawal by Subject|0|||
155371196|NCT01217437|560792037|FG001|Overall Study|Withdrawal by Subject|2|||
155371197|NCT01217437|560792036|FG000|Overall Study|Ineligible|1|||
155371198|NCT01217437|560792037|FG001|Overall Study|Ineligible|1|||
155371199|NCT00387426|560793420|FG000|Overall Study|Lack of Response|7|||
155371200|NCT00387426|560793420|FG000|Overall Study|Toxicities|4|||
155371201|NCT00387426|560793420|FG000|Overall Study|Disease Progression|3|||
155371202|NCT00890695|560793421|FG000|Overall Study|Protocol Violation|1|||
155371203|NCT00890695|560793422|FG001|Overall Study|Protocol Violation|0|||
155371204|NCT02314780|560793425|FG000|Overall Study|organizational reasons|0|||
155371205|NCT02314780|560793426|FG001|Overall Study|organizational reasons|2|||
155371206|NCT02314780|560793427|FG002|Overall Study|organizational reasons|0|||
155371207|NCT02314780|560793425|FG000|Overall Study|Adverse Event|0|||
155371208|NCT02314780|560793426|FG001|Overall Study|Adverse Event|1|||
155371209|NCT02314780|560793427|FG002|Overall Study|Adverse Event|0|||
155371210|NCT03986944|560793430|FG000|Overall Study|Adverse Event|1|||
155371211|NCT03986944|560793431|FG001|Overall Study|Adverse Event|2|||
155371212|NCT03986944|560793432|FG002|Overall Study|Adverse Event|3|||
155371213|NCT03986944|560793430|FG000|Overall Study|Protocol Violation|0|||
155371214|NCT03986944|560793431|FG001|Overall Study|Protocol Violation|1|||
155371215|NCT03986944|560793432|FG002|Overall Study|Protocol Violation|1|||
155371216|NCT03986944|560793430|FG000|Overall Study|Withdrawal by Subject|3|||
155371217|NCT03986944|560793431|FG001|Overall Study|Withdrawal by Subject|5|||
155371218|NCT03986944|560793432|FG002|Overall Study|Withdrawal by Subject|5|||
155371219|NCT03986944|560793430|FG000|Overall Study|Study termination|10|||
155371220|NCT03986944|560793431|FG001|Overall Study|Study termination|10|||
155371221|NCT03986944|560793432|FG002|Overall Study|Study termination|10|||
155371222|NCT03986944|560793430|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
155371223|NCT03986944|560793431|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
155371224|NCT03986944|560793432|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
155371225|NCT03986944|560793430|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
155371226|NCT03986944|560793431|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
155371227|NCT03986944|560793432|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
155371228|NCT03002220|560793433|FG000|Overall Study|Lack of Efficacy|2|||
155371229|NCT03002220|560793433|FG000|Overall Study|Withdrawal by Subject|3|||
155371230|NCT03002220|560793433|FG000|Overall Study|Adverse Event|2|||
155371231|NCT03002220|560793433|FG000|Overall Study|Disease progression|13|||
155371232|NCT03002220|560793433|FG000|Overall Study|Physician Decision|1|||
155371233|NCT01015560|560793434|FG000|Overall Study|Adverse Event|1|||
155371234|NCT01015560|560793434|FG000|Overall Study|Not protocol specified|1|||
155371235|NCT01015560|560793434|FG000|Overall Study|Withdrawal by Subject|1|||
155371236|NCT00837694|560793435|FG000|Overall Study|Lost to Follow-up|2|||
155371237|NCT00837694|560793436|FG001|Overall Study|Lost to Follow-up|0|||
155371238|NCT00837694|560793437|FG002|Overall Study|Lost to Follow-up|2|||
155371239|NCT00837694|560793438|FG003|Overall Study|Lost to Follow-up|1|||
155371240|NCT00837694|560793439|FG004|Overall Study|Lost to Follow-up|1|||
155371241|NCT00837694|560793440|FG005|Overall Study|Lost to Follow-up|1|||
155371242|NCT01008410|560793441|FG000|Overall Study|Adverse Event|13|||
155371243|NCT01008410|560793442|FG001|Overall Study|Adverse Event|7|||
155371244|NCT01008410|560793441|FG000|Overall Study|Withdrawal by Subject|6|||
155371245|NCT01008410|560793442|FG001|Overall Study|Withdrawal by Subject|2|||
155371246|NCT01008410|560793441|FG000|Overall Study|Lost to Follow-up|1|||
155371247|NCT01008410|560793442|FG001|Overall Study|Lost to Follow-up|0|||
155371248|NCT01008410|560793441|FG000|Overall Study|Noncompliance|1|||
155371249|NCT01008410|560793442|FG001|Overall Study|Noncompliance|0|||
155371250|NCT01008410|560793441|FG000|Overall Study|Low Cortisol|2|||
155371251|NCT01008410|560793442|FG001|Overall Study|Low Cortisol|0|||
155371252|NCT01008410|560793441|FG000|Overall Study|Lack of Efficacy|2|||
155371253|NCT01008410|560793442|FG001|Overall Study|Lack of Efficacy|6|||
155371254|NCT01008410|560793441|FG000|Overall Study|Met Exclusion Criterion|0|||
155371255|NCT01008410|560793442|FG001|Overall Study|Met Exclusion Criterion|1|||
155371256|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
155371257|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
155371258|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
155371259|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
155371260|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Death|0|||
155371261|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Death|1|||
155371262|NCT00297427|560793443|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
155371263|NCT00297427|560793444|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
155371264|NCT00297427|560793443|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
155371265|NCT00297427|560793444|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
155371266|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
155371267|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
155371268|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
155371269|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
155371270|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
155371271|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
155371272|NCT01127893|560793445|FG000|Overall Study|Study Termination by the Sponsor|1|||
155371273|NCT01262677|560793446|FG000|Overall Study|Does not meet entrance criteria|0|||
155371274|NCT01262677|560793447|FG001|Overall Study|Does not meet entrance criteria|2|||
155371275|NCT01262677|560793448|FG002|Overall Study|Does not meet entrance criteria|0|||
155371276|NCT01262677|560793446|FG000|Overall Study|Insufficient clinical response|0|||
155371277|NCT01262677|560793447|FG001|Overall Study|Insufficient clinical response|0|||
155371278|NCT01262677|560793448|FG002|Overall Study|Insufficient clinical response|1|||
155371279|NCT01262677|560793446|FG000|Overall Study|Lost to Follow-up|1|||
155371280|NCT01262677|560793447|FG001|Overall Study|Lost to Follow-up|0|||
155371281|NCT01262677|560793448|FG002|Overall Study|Lost to Follow-up|2|||
155371282|NCT01262677|560793446|FG000|Overall Study|No longer willing to participate|3|||
155371283|NCT01262677|560793447|FG001|Overall Study|No longer willing to participate|3|||
155371284|NCT01262677|560793448|FG002|Overall Study|No longer willing to participate|2|||
155371285|NCT01262677|560793446|FG000|Overall Study|Reason not provided|2|||
155371286|NCT01262677|560793447|FG001|Overall Study|Reason not provided|1|||
155371287|NCT01262677|560793448|FG002|Overall Study|Reason not provided|3|||
155371288|NCT01262677|560793446|FG000|Overall Study|Protocol Violation|0|||
155371289|NCT01262677|560793447|FG001|Overall Study|Protocol Violation|1|||
155371290|NCT01262677|560793448|FG002|Overall Study|Protocol Violation|1|||
155371291|NCT01262677|560793446|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
155371292|NCT01262677|560793447|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
155371293|NCT01262677|560793448|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
155371294|NCT02787044|560793452|FG000|Overall Study|Lost to Follow-up|15|||
155371295|NCT02787044|560793453|FG001|Overall Study|Lost to Follow-up|19|||
155371296|NCT01638429|560793454|FG000|Overall Study|Withdrawal by Subject|1|||
155371297|NCT03889704|560793456|FG000|Overall Study|Study terminated due to pandemic|1|||
155371298|NCT03482466|560793457|FG000|Overall Study|Protocol Violation|2|||
155371299|NCT04552899|560793458|FG000|Overall Study|Adverse Event|4|||
155371300|NCT04552899|560793459|FG001|Overall Study|Adverse Event|3|||
155371301|NCT04552899|560793458|FG000|Overall Study|Death|4|||
155371302|NCT04552899|560793459|FG001|Overall Study|Death|4|||
155371303|NCT04552899|560793458|FG000|Overall Study|Lost to Follow-up|8|||
155371304|NCT04552899|560793459|FG001|Overall Study|Lost to Follow-up|13|||
155371305|NCT04552899|560793458|FG000|Overall Study|Lung Transplant|4|||
155371306|NCT04552899|560793459|FG001|Overall Study|Lung Transplant|3|||
155371307|NCT04552899|560793458|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
155371308|NCT04552899|560793459|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
155371309|NCT04552899|560793458|FG000|Overall Study|Physician Decision|3|||
155371310|NCT04552899|560793459|FG001|Overall Study|Physician Decision|4|||
155371311|NCT04552899|560793458|FG000|Overall Study|Study Terminated By Sponsor|237|||
155371312|NCT04552899|560793459|FG001|Overall Study|Study Terminated By Sponsor|239|||
155371313|NCT04552899|560793458|FG000|Overall Study|Withdrawal by Subject|15|||
155429946|NCT00929240|560999085|FG000|Initial Treatment Phase|Adverse Event|31|||
155429947|NCT00929240|560999086|FG001|Initial Treatment Phase|Adverse Event|0|||
155429948|NCT00929240|560999087|FG002|Initial Treatment Phase|Adverse Event|0|||
155429949|NCT00929240|560999085|FG000|Initial Treatment Phase|Disease progression|41|||
155429950|NCT00929240|560999086|FG001|Initial Treatment Phase|Disease progression|0|||
155429951|NCT00929240|560999087|FG002|Initial Treatment Phase|Disease progression|0|||
155429952|NCT00929240|560999085|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
155429953|NCT00929240|560999086|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
155429954|NCT00929240|560999087|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
155429955|NCT00929240|560999085|FG000|Initial Treatment Phase|Protocol Violation|5|||
155429956|NCT00929240|560999086|FG001|Initial Treatment Phase|Protocol Violation|0|||
155429957|NCT00929240|560999087|FG002|Initial Treatment Phase|Protocol Violation|0|||
155429958|NCT00929240|560999085|FG000|Initial Treatment Phase|Death|2|||
155429959|NCT00929240|560999086|FG001|Initial Treatment Phase|Death|0|||
155429960|NCT00929240|560999087|FG002|Initial Treatment Phase|Death|0|||
155429961|NCT00929240|560999085|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
155429962|NCT00929240|560999086|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
155429963|NCT00929240|560999087|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
155429964|NCT00929240|560999085|FG000|Initial Treatment Phase|Physician Decision|4|||
155429965|NCT00929240|560999086|FG001|Initial Treatment Phase|Physician Decision|0|||
155429966|NCT00929240|560999087|FG002|Initial Treatment Phase|Physician Decision|0|||
155429967|NCT00929240|560999085|FG000|Maintenance Phase|Disease progression|0|||
155429968|NCT00929240|560999086|FG001|Maintenance Phase|Disease progression|73|||
155429969|NCT00929240|560999087|FG002|Maintenance Phase|Disease progression|60|||
155429970|NCT00929240|560999085|FG000|Maintenance Phase|Adverse Event|0|||
155429971|NCT00929240|560999086|FG001|Maintenance Phase|Adverse Event|9|||
155429972|NCT00929240|560999087|FG002|Maintenance Phase|Adverse Event|12|||
155429973|NCT00929240|560999085|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155429974|NCT00929240|560999086|FG001|Maintenance Phase|Withdrawal by Subject|2|||
155429975|NCT00929240|560999087|FG002|Maintenance Phase|Withdrawal by Subject|6|||
155371314|NCT04552899|560793459|FG001|Overall Study|Withdrawal by Subject|17|||
155429976|NCT00929240|560999085|FG000|Maintenance Phase|Protocol Violation|0|||
155429977|NCT00929240|560999086|FG001|Maintenance Phase|Protocol Violation|1|||
155429978|NCT00929240|560999087|FG002|Maintenance Phase|Protocol Violation|0|||
155371315|NCT02383940|560793462|FG000|Overall Study|Adverse Event|1|||
155510433|NCT02884206|561295206|FG000|Double-Blind Period|Physician Decision|0|||
155510434|NCT02884206|561295207|FG001|Double-Blind Period|Physician Decision|2|||
155510435|NCT02884206|561295208|FG002|Double-Blind Period|Physician Decision|0|||
155510436|NCT02884206|561295206|FG000|Double-Blind Period|Adverse Event|0|||
155510437|NCT02884206|561295207|FG001|Double-Blind Period|Adverse Event|0|||
155510438|NCT02884206|561295208|FG002|Double-Blind Period|Adverse Event|3|||
155510439|NCT02884206|561295206|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
155510440|NCT02884206|561295207|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
155510441|NCT02884206|561295208|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
155510442|NCT02322879|561295209|FG000|First Intervention|Physician Decision|1|||
155510443|NCT02322879|561295210|FG001|First Intervention|Physician Decision|0|||
155510444|NCT03487796|561295211|FG000|Overall Study|Lost to Follow-up|18|||
155510445|NCT03487796|561295212|FG001|Overall Study|Lost to Follow-up|6|||
155510446|NCT01090765|561295213|FG000|Overall Study|Patient withdrew consent|0|||
155510447|NCT01090765|561295214|FG001|Overall Study|Patient withdrew consent|0|||
155510448|NCT01090765|561295215|FG002|Overall Study|Patient withdrew consent|0|||
155510449|NCT01090765|561295216|FG003|Overall Study|Patient withdrew consent|0|||
155510450|NCT01090765|561295217|FG004|Overall Study|Patient withdrew consent|1|||
155510451|NCT01090765|561295218|FG005|Overall Study|Patient withdrew consent|1|||
155510452|NCT01090765|561295213|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
155510453|NCT01090765|561295214|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
155510454|NCT01090765|561295215|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
155510455|NCT01090765|561295216|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
155510456|NCT01090765|561295217|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
155510457|NCT01090765|561295218|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
155510458|NCT01090765|561295213|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
155510459|NCT01090765|561295214|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
155510460|NCT01090765|561295215|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
155510461|NCT01090765|561295216|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
155510462|NCT01090765|561295217|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
155510463|NCT01090765|561295218|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
155510464|NCT00678392|561295219|FG000|Overall Study|Adverse Event|0|||
155510465|NCT00678392|561295220|FG001|Overall Study|Adverse Event|6|||
155510466|NCT00678392|561295219|FG000|Overall Study|Death|280|||
155510467|NCT00678392|561295220|FG001|Overall Study|Death|269|||
155510468|NCT00678392|561295219|FG000|Overall Study|Lost to Follow-up|15|||
155510469|NCT00678392|561295220|FG001|Overall Study|Lost to Follow-up|13|||
155510470|NCT00678392|561295219|FG000|Overall Study|Objective Progression or Relapse|3|||
155510471|NCT00678392|561295220|FG001|Overall Study|Objective Progression or Relapse|8|||
155510472|NCT00678392|561295219|FG000|Overall Study|Sponsor's Decision|1|||
155510473|NCT00678392|561295220|FG001|Overall Study|Sponsor's Decision|2|||
155510474|NCT00678392|561295219|FG000|Overall Study|Withdrawal by Subject|4|||
155510475|NCT00678392|561295220|FG001|Overall Study|Withdrawal by Subject|4|||
155510476|NCT00678392|561295219|FG000|Overall Study|Randomized But Not Treated|2|||
155510477|NCT00678392|561295220|FG001|Overall Study|Randomized But Not Treated|7|||
155510478|NCT00678392|561295219|FG000|Overall Study|Other|56|||
155510479|NCT00678392|561295220|FG001|Overall Study|Other|53|||
155510480|NCT03341507|561295221|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
155510481|NCT00718159|561295222|FG000|Overall Study|Progressive Disease|3|||
155510482|NCT00718159|561295223|FG001|Overall Study|Progressive Disease|3|||
155510483|NCT00718159|561295224|FG002|Overall Study|Progressive Disease|2|||
155510484|NCT00718159|561295225|FG003|Overall Study|Progressive Disease|0|||
155510485|NCT00718159|561295226|FG004|Overall Study|Progressive Disease|6|||
155510486|NCT00718159|561295227|FG005|Overall Study|Progressive Disease|0|||
155510487|NCT00718159|561295228|FG006|Overall Study|Progressive Disease|0|||
155510488|NCT00718159|561295222|FG000|Overall Study|Death due to Adverse Event|0|||
155510489|NCT00718159|561295223|FG001|Overall Study|Death due to Adverse Event|0|||
155510490|NCT00718159|561295224|FG002|Overall Study|Death due to Adverse Event|0|||
155510491|NCT00718159|561295225|FG003|Overall Study|Death due to Adverse Event|2|||
155510492|NCT00718159|561295226|FG004|Overall Study|Death due to Adverse Event|2|||
155510493|NCT00718159|561295227|FG005|Overall Study|Death due to Adverse Event|0|||
155510494|NCT00718159|561295228|FG006|Overall Study|Death due to Adverse Event|0|||
155510495|NCT00718159|561295222|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
155510496|NCT00718159|561295223|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
155510497|NCT00718159|561295224|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
155510498|NCT00718159|561295225|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
155510499|NCT00718159|561295226|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
155510500|NCT00718159|561295227|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
155510501|NCT00718159|561295228|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
155510502|NCT00718159|561295222|FG000|Overall Study|Investigator Decision|0|||
155510503|NCT00718159|561295223|FG001|Overall Study|Investigator Decision|0|||
155510504|NCT00718159|561295224|FG002|Overall Study|Investigator Decision|0|||
155510505|NCT00718159|561295225|FG003|Overall Study|Investigator Decision|0|||
155510506|NCT00718159|561295226|FG004|Overall Study|Investigator Decision|0|||
155510507|NCT00718159|561295227|FG005|Overall Study|Investigator Decision|1|||
155510508|NCT00718159|561295228|FG006|Overall Study|Investigator Decision|1|||
155510509|NCT00415532|561295230|FG000|Treatment Period|Adverse Event|2|||
155510510|NCT00415532|561295231|FG001|Treatment Period|Adverse Event|3|||
155371316|NCT02383940|560793463|FG001|Overall Study|Adverse Event|0|||
155371317|NCT02383940|560793462|FG000|Overall Study|Lost to Follow-up|2|||
155371318|NCT02383940|560793463|FG001|Overall Study|Lost to Follow-up|2|||
155371319|NCT02383940|560793462|FG000|Overall Study|Physician Decision|2|||
155371320|NCT02383940|560793463|FG001|Overall Study|Physician Decision|0|||
155371321|NCT02383940|560793462|FG000|Overall Study|Withdrawal by Subject|1|||
155371322|NCT02383940|560793463|FG001|Overall Study|Withdrawal by Subject|1|||
155371323|NCT02383940|560793462|FG000|Overall Study|Randomized but not treated|2|||
155371324|NCT02383940|560793463|FG001|Overall Study|Randomized but not treated|0|||
155371325|NCT02383940|560793462|FG000|Overall Study|Other than specified above|1|||
155371326|NCT02383940|560793463|FG001|Overall Study|Other than specified above|0|||
155371327|NCT00565773|560793465|FG000|Overall Study|Withdrawal by Subject|1|||
155371328|NCT00565773|560793465|FG000|Overall Study|Physician Decision|1|||
155371329|NCT01598662|560793466|FG000|Overall Study|Lost to Follow-up|10|||
155371330|NCT01598662|560793467|FG001|Overall Study|Lost to Follow-up|17|||
155371331|NCT01598662|560793466|FG000|Overall Study|Physician Decision|1|||
155371332|NCT01598662|560793467|FG001|Overall Study|Physician Decision|2|||
155371333|NCT01598662|560793466|FG000|Overall Study|IUD expelled before month 6|0|||
155371334|NCT01598662|560793467|FG001|Overall Study|IUD expelled before month 6|2|||
155371335|NCT02530970|560793468|FG000|Overall Study|Adverse Event|8|||
155371336|NCT02530970|560793468|FG000|Overall Study|Lost to Follow-up|88|||
155429979|NCT00929240|560999085|FG000|Maintenance Phase|Health authority/Study termination|0|||
155429980|NCT00929240|560999086|FG001|Maintenance Phase|Health authority/Study termination|1|||
155429981|NCT00929240|560999087|FG002|Maintenance Phase|Health authority/Study termination|2|||
155429982|NCT00929240|560999085|FG000|Maintenance Phase|Physician Decision|0|||
155429983|NCT00929240|560999086|FG001|Maintenance Phase|Physician Decision|2|||
155429984|NCT00929240|560999087|FG002|Maintenance Phase|Physician Decision|1|||
155429985|NCT00929240|560999085|FG000|Maintenance Phase|Change of treatment|0|||
155429986|NCT00929240|560999086|FG001|Maintenance Phase|Change of treatment|4|||
155429987|NCT00929240|560999087|FG002|Maintenance Phase|Change of treatment|0|||
155429988|NCT00929240|560999085|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
155429989|NCT00929240|560999086|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
155429990|NCT00929240|560999087|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
155429991|NCT00929240|560999085|FG000|Maintenance Phase|Participant not treated|0|||
155429992|NCT00929240|560999086|FG001|Maintenance Phase|Participant not treated|2|||
155429993|NCT00929240|560999087|FG002|Maintenance Phase|Participant not treated|0|||
155429994|NCT02203149|560999088|FG000|Part 1|Adverse Event|0|||
155429995|NCT02203149|560999089|FG001|Part 1|Adverse Event|1|||
155429996|NCT02203149|560999090|FG002|Part 1|Adverse Event|0|||
155429997|NCT02203149|560999091|FG003|Part 1|Adverse Event|0|||
155429998|NCT02203149|560999092|FG004|Part 1|Adverse Event|0|||
155429999|NCT02203149|560999088|FG000|Part 2|Death|0|||
155430000|NCT02203149|560999089|FG001|Part 2|Death|0|||
155430001|NCT02203149|560999090|FG002|Part 2|Death|1|||
155430002|NCT02203149|560999091|FG003|Part 2|Death|1|||
155510511|NCT00415532|561295230|FG000|Treatment Period|Death|2|||
155510512|NCT00415532|561295231|FG001|Treatment Period|Death|1|||
155371337|NCT02530970|560793468|FG000|Overall Study|Physician Decision|5|||
155371338|NCT02530970|560793468|FG000|Overall Study|Withdrawal by Subject|14|||
155430003|NCT02203149|560999092|FG004|Part 2|Death|0|||
155430004|NCT02203149|560999088|FG000|Part 2|Withdrawal by Subject|0|||
155510513|NCT00415532|561295230|FG000|Treatment Period|Lost to Follow-up|1|||
155371339|NCT02530970|560793468|FG000|Overall Study|Death|6|||
155430005|NCT02203149|560999089|FG001|Part 2|Withdrawal by Subject|0|||
155430006|NCT02203149|560999090|FG002|Part 2|Withdrawal by Subject|0|||
155430007|NCT02203149|560999091|FG003|Part 2|Withdrawal by Subject|1|||
155430008|NCT02203149|560999092|FG004|Part 2|Withdrawal by Subject|0|||
155430009|NCT02203149|560999088|FG000|Part 2|Adverse Event|0|||
155430010|NCT02203149|560999089|FG001|Part 2|Adverse Event|0|||
155430011|NCT02203149|560999090|FG002|Part 2|Adverse Event|0|||
155430012|NCT02203149|560999091|FG003|Part 2|Adverse Event|1|||
155430013|NCT02203149|560999092|FG004|Part 2|Adverse Event|1|||
155430014|NCT00684814|560999093|FG000|Washout Period of 7 Days|Adverse Event|1|||
155430015|NCT00684814|560999094|FG001|Washout Period of 7 Days|Adverse Event|2|||
155430016|NCT00684814|560999093|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
155430017|NCT00684814|560999094|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
155430018|NCT00684814|560999093|FG000|Second Intervention|Adverse Event|1|||
155430019|NCT00684814|560999094|FG001|Second Intervention|Adverse Event|0|||
155430020|NCT02537678|560999095|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
155430021|NCT02537678|560999096|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
155430022|NCT02537678|560999095|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
155430023|NCT02537678|560999096|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
155430024|NCT02537678|560999095|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
155430025|NCT02537678|560999096|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
155430026|NCT02537678|560999095|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
155430027|NCT02537678|560999096|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
155430028|NCT02537678|560999095|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
155430029|NCT02537678|560999096|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
155430030|NCT02537678|560999095|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
155430031|NCT02537678|560999096|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
155430032|NCT02537678|560999095|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
155430033|NCT02537678|560999096|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
155430034|NCT04348851|560999097|FG000|Post-Test 1|Withdrawal by Subject|0|||
155430035|NCT04348851|560999098|FG001|Post-Test 1|Withdrawal by Subject|1|||
155430036|NCT04348851|560999099|FG002|Post-Test 1|Withdrawal by Subject|0|||
155430037|NCT04348851|560999100|FG003|Post-Test 1|Withdrawal by Subject|0|||
155430038|NCT04348851|560999097|FG000|Post-Test 1|Lost to Follow-up|0|||
155430039|NCT04348851|560999098|FG001|Post-Test 1|Lost to Follow-up|1|||
155430040|NCT04348851|560999099|FG002|Post-Test 1|Lost to Follow-up|0|||
155430041|NCT04348851|560999100|FG003|Post-Test 1|Lost to Follow-up|0|||
155430042|NCT04348851|560999097|FG000|Post-Test 2|Stroke survivor death|0|||
155430043|NCT04348851|560999098|FG001|Post-Test 2|Stroke survivor death|1|||
155430044|NCT04348851|560999099|FG002|Post-Test 2|Stroke survivor death|0|||
155430045|NCT04348851|560999100|FG003|Post-Test 2|Stroke survivor death|1|||
155430046|NCT00432809|560999101|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
155430047|NCT00432809|560999102|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
155430048|NCT00432809|560999103|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
155430049|NCT00432809|560999101|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
155430050|NCT00432809|560999102|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
155430051|NCT00432809|560999103|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
155430052|NCT04052139|560999104|FG000|Overall Study|Lost to Follow-up|2|||
155430053|NCT04052139|560999105|FG001|Overall Study|Lost to Follow-up|0|||
155430054|NCT04052139|560999106|FG002|Overall Study|Lost to Follow-up|0|||
155430055|NCT04052139|560999104|FG000|Overall Study|Withdrawal by Subject|1|||
155430056|NCT04052139|560999105|FG001|Overall Study|Withdrawal by Subject|0|||
155430057|NCT04052139|560999106|FG002|Overall Study|Withdrawal by Subject|0|||
155430058|NCT01658514|560999107|FG000|Overall Study|Protocol Violation|1|||
155430059|NCT01658514|560999108|FG001|Overall Study|Protocol Violation|0|||
155430060|NCT01658514|560999109|FG002|Overall Study|Protocol Violation|2|||
155430061|NCT00144170|560999110|FG000|Overall Study|Adverse Event|84|||
155430062|NCT00144170|560999111|FG001|Overall Study|Adverse Event|41|||
155430063|NCT00144170|560999110|FG000|Overall Study|Protocol Violation|23|||
155430064|NCT00144170|560999111|FG001|Overall Study|Protocol Violation|16|||
155430065|NCT00144170|560999110|FG000|Overall Study|Lost to Follow-up|5|||
155430066|NCT00144170|560999111|FG001|Overall Study|Lost to Follow-up|10|||
155430067|NCT00144170|560999110|FG000|Overall Study|Withdrawal by Subject|29|||
155430068|NCT00144170|560999111|FG001|Overall Study|Withdrawal by Subject|13|||
155430069|NCT00144170|560999110|FG000|Overall Study|Other reason not defined above|211|||
155430070|NCT00144170|560999111|FG001|Overall Study|Other reason not defined above|316|||
155510514|NCT00415532|561295231|FG001|Treatment Period|Lost to Follow-up|1|||
155430071|NCT00981526|560999112|FG000|Overall Study|Withdrawal by Subject|0|||
155430072|NCT00981526|560999113|FG001|Overall Study|Withdrawal by Subject|2|||
155430073|NCT00981526|560999112|FG000|Overall Study|Physician Decision|4|||
155430074|NCT00981526|560999113|FG001|Overall Study|Physician Decision|4|||
155430075|NCT00332202|560999114|FG000|Overall Study|Adverse Event|72|||
155430076|NCT00332202|560999115|FG001|Overall Study|Adverse Event|28|||
155430077|NCT00332202|560999114|FG000|Overall Study|Lost to Follow-up|2|||
155371340|NCT02530970|560793468|FG000|Overall Study|Hospitalization|1|||
155371341|NCT02530970|560793468|FG000|Overall Study|Insurance|2|||
155371342|NCT02530970|560793468|FG000|Overall Study|Explant|2|||
155371343|NCT02530970|560793468|FG000|Overall Study|Change in Provider|5|||
155371344|NCT02530970|560793468|FG000|Overall Study|Relocation|3|||
155371345|NCT02770612|560793469|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
155371346|NCT02636725|560793470|FG000|Overall Study|Adverse Event|1|||
155371347|NCT00886795|560793472|FG000|Overall Study|Lack of Efficacy|1|||
155371348|NCT01283516|560793473|FG000|Overall Study|Adverse Event|0|||
155371349|NCT01283516|560793474|FG001|Overall Study|Adverse Event|0|||
155371350|NCT01283516|560793475|FG002|Overall Study|Adverse Event|0|||
155371351|NCT01283516|560793476|FG003|Overall Study|Adverse Event|0|||
155371352|NCT01283516|560793477|FG004|Overall Study|Adverse Event|0|||
155371353|NCT01283516|560793478|FG005|Overall Study|Adverse Event|0|||
155371354|NCT01283516|560793479|FG006|Overall Study|Adverse Event|2|||
155371355|NCT01283516|560793480|FG007|Overall Study|Adverse Event|0|||
155371356|NCT01283516|560793481|FG008|Overall Study|Adverse Event|28|||
155371357|NCT01283516|560793473|FG000|Overall Study|Death|0|||
155371358|NCT01283516|560793474|FG001|Overall Study|Death|0|||
155371359|NCT01283516|560793475|FG002|Overall Study|Death|0|||
155371360|NCT01283516|560793476|FG003|Overall Study|Death|0|||
155371361|NCT01283516|560793477|FG004|Overall Study|Death|0|||
155371362|NCT01283516|560793478|FG005|Overall Study|Death|1|||
155371363|NCT01283516|560793479|FG006|Overall Study|Death|0|||
155371364|NCT01283516|560793480|FG007|Overall Study|Death|1|||
155371365|NCT01283516|560793481|FG008|Overall Study|Death|12|||
155371366|NCT01283516|560793473|FG000|Overall Study|Disease Progression|2|||
155371367|NCT01283516|560793474|FG001|Overall Study|Disease Progression|2|||
155371368|NCT01283516|560793475|FG002|Overall Study|Disease Progression|3|||
155371369|NCT01283516|560793476|FG003|Overall Study|Disease Progression|3|||
155371370|NCT01283516|560793477|FG004|Overall Study|Disease Progression|13|||
155371371|NCT01283516|560793478|FG005|Overall Study|Disease Progression|8|||
155371372|NCT01283516|560793479|FG006|Overall Study|Disease Progression|6|||
155371373|NCT01283516|560793480|FG007|Overall Study|Disease Progression|3|||
155371374|NCT01283516|560793481|FG008|Overall Study|Disease Progression|139|||
155371375|NCT01283516|560793473|FG000|Overall Study|Withdrawal by Subject|0|||
155371376|NCT01283516|560793474|FG001|Overall Study|Withdrawal by Subject|0|||
155371377|NCT01283516|560793475|FG002|Overall Study|Withdrawal by Subject|0|||
155371378|NCT01283516|560793476|FG003|Overall Study|Withdrawal by Subject|0|||
155371379|NCT01283516|560793477|FG004|Overall Study|Withdrawal by Subject|1|||
155371380|NCT01283516|560793478|FG005|Overall Study|Withdrawal by Subject|0|||
155371381|NCT01283516|560793479|FG006|Overall Study|Withdrawal by Subject|1|||
155371382|NCT01283516|560793480|FG007|Overall Study|Withdrawal by Subject|0|||
155371383|NCT01283516|560793481|FG008|Overall Study|Withdrawal by Subject|36|||
155371384|NCT01283516|560793473|FG000|Overall Study|Administrative problems|0|||
155371385|NCT01283516|560793474|FG001|Overall Study|Administrative problems|0|||
155371386|NCT01283516|560793475|FG002|Overall Study|Administrative problems|0|||
155371387|NCT01283516|560793476|FG003|Overall Study|Administrative problems|0|||
155371388|NCT01283516|560793477|FG004|Overall Study|Administrative problems|0|||
155371389|NCT01283516|560793478|FG005|Overall Study|Administrative problems|1|||
155371390|NCT01283516|560793479|FG006|Overall Study|Administrative problems|1|||
155371391|NCT01283516|560793480|FG007|Overall Study|Administrative problems|1|||
155371392|NCT01283516|560793481|FG008|Overall Study|Administrative problems|39|||
155371393|NCT01283516|560793473|FG000|Overall Study|Lost to Follow-up|0|||
155371394|NCT01283516|560793474|FG001|Overall Study|Lost to Follow-up|0|||
155371395|NCT01283516|560793475|FG002|Overall Study|Lost to Follow-up|0|||
155371396|NCT01283516|560793476|FG003|Overall Study|Lost to Follow-up|0|||
155430078|NCT00332202|560999115|FG001|Overall Study|Lost to Follow-up|1|||
155430079|NCT00332202|560999114|FG000|Overall Study|Physician Decision|6|||
155430080|NCT00332202|560999115|FG001|Overall Study|Physician Decision|8|||
155430081|NCT00332202|560999114|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
155430082|NCT00332202|560999115|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
155430083|NCT00332202|560999114|FG000|Overall Study|Protocol Violation|7|||
155430084|NCT00332202|560999115|FG001|Overall Study|Protocol Violation|2|||
155430085|NCT00332202|560999114|FG000|Overall Study|Sponsor Decision|1|||
155430086|NCT00332202|560999115|FG001|Overall Study|Sponsor Decision|2|||
155430087|NCT00332202|560999114|FG000|Overall Study|Withdrawal by Subject|36|||
155430088|NCT00332202|560999115|FG001|Overall Study|Withdrawal by Subject|17|||
155371397|NCT01283516|560793477|FG004|Overall Study|Lost to Follow-up|0|||
155371398|NCT01283516|560793478|FG005|Overall Study|Lost to Follow-up|0|||
155371399|NCT01283516|560793479|FG006|Overall Study|Lost to Follow-up|0|||
155371400|NCT01283516|560793480|FG007|Overall Study|Lost to Follow-up|0|||
155371401|NCT01283516|560793481|FG008|Overall Study|Lost to Follow-up|1|||
155371402|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
155371403|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
155371404|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
155430089|NCT00332202|560999114|FG000|Overall Study|Progressive Disease|106|||
155430090|NCT00332202|560999115|FG001|Overall Study|Progressive Disease|60|||
155430091|NCT00332202|560999114|FG000|Overall Study|Death|5|||
155430092|NCT00332202|560999115|FG001|Overall Study|Death|2|||
155649503|NCT03016403|561808283|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
155649504|NCT03016403|561808284|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
155649505|NCT03016403|561808285|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
155371405|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
155371406|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
155371407|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
155371408|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
155371409|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
155371410|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
155371411|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
155371412|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155371413|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Adverse Event|0|||
155371414|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Adverse Event|3|||
155371415|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Adverse Event|2|||
155649506|NCT03016403|561808282|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
155649507|NCT03016403|561808283|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
155649508|NCT03016403|561808284|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
155649509|NCT03016403|561808285|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
155649510|NCT03016403|561808282|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155649511|NCT03016403|561808283|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155649512|NCT03016403|561808284|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155649513|NCT03016403|561808285|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
155649514|NCT05463705|561808286|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
155649515|NCT05463705|561808287|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
155649516|NCT05463705|561808288|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
155649517|NCT05463705|561808289|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
155649518|NCT05463705|561808290|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
155649519|NCT05463705|561808291|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
155649520|NCT01655069|561808292|FG000|Overall Study|Physician Decision|0|||
155649521|NCT01655069|561808293|FG001|Overall Study|Physician Decision|0|||
155649522|NCT01655069|561808294|FG002|Overall Study|Physician Decision|0|||
155649523|NCT01655069|561808295|FG003|Overall Study|Physician Decision|1|||
155649524|NCT01655069|561808292|FG000|Overall Study|Adverse Event|6|||
155649525|NCT01655069|561808293|FG001|Overall Study|Adverse Event|7|||
155649526|NCT01655069|561808294|FG002|Overall Study|Adverse Event|2|||
155649527|NCT01655069|561808295|FG003|Overall Study|Adverse Event|3|||
155649528|NCT01655069|561808292|FG000|Overall Study|Lack of Efficacy|0|||
155649529|NCT01655069|561808293|FG001|Overall Study|Lack of Efficacy|1|||
155649530|NCT01655069|561808294|FG002|Overall Study|Lack of Efficacy|0|||
155649531|NCT01655069|561808295|FG003|Overall Study|Lack of Efficacy|0|||
155649532|NCT01655069|561808292|FG000|Overall Study|No Treatment Needed|0|||
155649533|NCT01655069|561808293|FG001|Overall Study|No Treatment Needed|1|||
155649534|NCT01655069|561808294|FG002|Overall Study|No Treatment Needed|0|||
155649535|NCT01655069|561808295|FG003|Overall Study|No Treatment Needed|0|||
155649536|NCT01655069|561808292|FG000|Overall Study|Withdrawal by Subject|2|||
155371416|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Adverse Event|13|||
155430093|NCT00957853|560999116|FG000|Overall Study|Withdrawal by Subject|1|||
155430094|NCT00957853|560999117|FG001|Overall Study|Withdrawal by Subject|0|||
155430095|NCT00957853|560999118|FG002|Overall Study|Withdrawal by Subject|0|||
155649537|NCT01655069|561808293|FG001|Overall Study|Withdrawal by Subject|3|||
155649538|NCT01655069|561808294|FG002|Overall Study|Withdrawal by Subject|0|||
155430096|NCT02495948|560999121|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
155430097|NCT02495948|560999122|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
155430098|NCT02495948|560999121|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
155430099|NCT02495948|560999122|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
155430100|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
155430101|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
155430102|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
155430103|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
155430104|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
155430105|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
155510515|NCT00415532|561295230|FG000|Treatment Period|Protocol Violation|1|||
155649539|NCT01655069|561808295|FG003|Overall Study|Withdrawal by Subject|0|||
155649540|NCT01530997|561808296|FG000|Overall Study|Physician Decision|1|||
155649541|NCT01530997|561808296|FG000|Overall Study|Withdrawal by Subject|1|||
155371417|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155371418|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155430106|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
155649542|NCT01309100|561808299|FG000|Overall Study|Protocol Violation|1|||
155371419|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
155371420|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155371421|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
155371422|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Patient's wish|0|||
155371423|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Patient's wish|0|||
155371424|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Patient's wish|19|||
155371425|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Patient's wish|9|||
155371426|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Patient's wish|20|||
155371427|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
155371428|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
155371429|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
155371430|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
155371431|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
155371432|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
155371433|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
155371434|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
155371435|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
155371436|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
155371437|NCT00743431|560793495|FG000|Overall Study|Toxicity|6|||
155371438|NCT00743431|560793495|FG000|Overall Study|Tumor progression|56|||
155371439|NCT00743431|560793495|FG000|Overall Study|Withdrawal by Subject|13|||
155371440|NCT00743431|560793495|FG000|Overall Study|Death|9|||
155371441|NCT00743431|560793495|FG000|Overall Study|Reason for discontinuation not specified|29|||
155371442|NCT00743431|560793495|FG000|Overall Study|No documentation available|13|||
155371443|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
155371444|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
155371445|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Disease progression|1|||
155371446|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Disease progression|0|||
155371447|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Other|3|||
155371448|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Other|0|||
155371449|NCT03291288|560793496|FG000|Pexidartinib Only|Ongoing|0|||
155371450|NCT03291288|560793497|FG001|Pexidartinib Only|Ongoing|2|||
155371451|NCT04978493|560793498|FG000|Overall Study|No reason available|0|||
155371452|NCT04978493|560793499|FG001|Overall Study|No reason available|1|||
155430107|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
155430108|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
155430109|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
155430110|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
155430111|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
155430112|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
155430113|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
155430114|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
155430115|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
155430116|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
155430117|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
155430118|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
155430119|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
155430120|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
155430121|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
155430122|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
155430123|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
155430124|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
155430125|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
155430126|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
155371453|NCT04978493|560793498|FG000|Overall Study|Adverse Event|1|||
155371454|NCT04978493|560793499|FG001|Overall Study|Adverse Event|0|||
155649543|NCT01309100|561808299|FG000|Overall Study|Positive Slit lamp finding|1|||
155649544|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
155649545|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
155371455|NCT01896726|560793500|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
155371456|NCT01896726|560793500|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
155371457|NCT01128114|560793501|FG000|Overall Study|Treatment Withdrawn|6|||
155649546|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
155371458|NCT01128114|560793501|FG000|Overall Study|Screening Failed|2|||
155371459|NCT00208325|560793502|FG000|Overall Study|Death|18|||
155371460|NCT00208325|560793503|FG001|Overall Study|Death|19|||
155371461|NCT00208325|560793504|FG002|Overall Study|Death|7|||
155371462|NCT00208325|560793505|FG003|Overall Study|Death|5|||
155371463|NCT00208325|560793502|FG000|Overall Study|Withdrawal by Subject|0|||
155371464|NCT00208325|560793503|FG001|Overall Study|Withdrawal by Subject|1|||
155371465|NCT00208325|560793504|FG002|Overall Study|Withdrawal by Subject|0|||
155371466|NCT00208325|560793505|FG003|Overall Study|Withdrawal by Subject|0|||
155371467|NCT00208325|560793502|FG000|Overall Study|Revision|4|||
155371468|NCT00208325|560793503|FG001|Overall Study|Revision|1|||
155371469|NCT00208325|560793504|FG002|Overall Study|Revision|0|||
155371470|NCT00208325|560793505|FG003|Overall Study|Revision|4|||
155371471|NCT00208325|560793502|FG000|Overall Study|Lost to Follow-up|1|||
155371472|NCT00208325|560793503|FG001|Overall Study|Lost to Follow-up|0|||
155371473|NCT00208325|560793504|FG002|Overall Study|Lost to Follow-up|2|||
155371474|NCT00208325|560793505|FG003|Overall Study|Lost to Follow-up|0|||
155371475|NCT00208325|560793502|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
155371476|NCT00208325|560793503|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
155371477|NCT00208325|560793504|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
155371478|NCT00208325|560793505|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
155371479|NCT00208325|560793502|FG000|Overall Study|Does not wish to Continue in Study|5|||
155371480|NCT00208325|560793503|FG001|Overall Study|Does not wish to Continue in Study|8|||
155371481|NCT00208325|560793504|FG002|Overall Study|Does not wish to Continue in Study|3|||
155371482|NCT00208325|560793505|FG003|Overall Study|Does not wish to Continue in Study|2|||
155371483|NCT00208325|560793502|FG000|Overall Study|Other|2|||
155371484|NCT00208325|560793503|FG001|Overall Study|Other|1|||
155371485|NCT00208325|560793504|FG002|Overall Study|Other|1|||
155371486|NCT00208325|560793505|FG003|Overall Study|Other|0|||
155371487|NCT00208325|560793502|FG000|Overall Study|Mis-Randomized|17|||
155371488|NCT00208325|560793503|FG001|Overall Study|Mis-Randomized|20|||
155371489|NCT00208325|560793504|FG002|Overall Study|Mis-Randomized|0|||
155371490|NCT00208325|560793505|FG003|Overall Study|Mis-Randomized|0|||
155510516|NCT00415532|561295231|FG001|Treatment Period|Protocol Violation|0|||
155510517|NCT00415532|561295230|FG000|Treatment Period|Withdrawal by Subject|6|||
155510518|NCT00415532|561295231|FG001|Treatment Period|Withdrawal by Subject|6|||
155510519|NCT00415532|561295230|FG000|Treatment Period|Other|2|||
155510520|NCT00415532|561295231|FG001|Treatment Period|Other|2|||
155510521|NCT00415532|561295230|FG000|Treatment Period|Ineligibility determined|1|||
155510522|NCT00415532|561295231|FG001|Treatment Period|Ineligibility determined|1|||
155510523|NCT00415532|561295230|FG000|Treatment Period|Noncompliance|1|||
155510524|NCT00415532|561295231|FG001|Treatment Period|Noncompliance|1|||
155510525|NCT00415532|561295230|FG000|Treatment Period|Requirement for alternative therapy|1|||
155510526|NCT00415532|561295231|FG001|Treatment Period|Requirement for alternative therapy|0|||
155510527|NCT00415532|561295230|FG000|Safety Follow Up Period|Adverse Event|1|||
155510528|NCT00415532|561295231|FG001|Safety Follow Up Period|Adverse Event|3|||
155371491|NCT04662931|560793506|FG000|Overall Study|Withdrawal by Subject|17|||
155371492|NCT04662931|560793506|FG000|Overall Study|Death|3|||
155510529|NCT00415532|561295230|FG000|Safety Follow Up Period|Death|3|||
155371493|NCT04662931|560793506|FG000|Overall Study|Lost to Follow-up|3|||
155371494|NCT04662931|560793506|FG000|Overall Study|Guardian Decision|1|||
155371495|NCT01254747|560793507|FG000|Overall Study|Unacceptable subjective vision|0|||
155371496|NCT01254747|560793508|FG001|Overall Study|Unacceptable subjective vision|0|||
155371497|NCT01254747|560793509|FG002|Overall Study|Unacceptable subjective vision|0|||
155371498|NCT01254747|560793510|FG003|Overall Study|Unacceptable subjective vision|2|||
155371499|NCT01254747|560793507|FG000|Overall Study|Difficult removal handling|0|||
155371500|NCT01254747|560793508|FG001|Overall Study|Difficult removal handling|0|||
155371501|NCT01254747|560793509|FG002|Overall Study|Difficult removal handling|1|||
155510530|NCT00415532|561295231|FG001|Safety Follow Up Period|Death|0|||
155510531|NCT00415532|561295230|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
155510532|NCT00415532|561295231|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
155510533|NCT00415532|561295230|FG000|Safety Follow Up Period|Other|1|||
155510534|NCT00415532|561295231|FG001|Safety Follow Up Period|Other|4|||
155510535|NCT00415532|561295230|FG000|Safety Follow Up Period|Ineligibility determined|1|||
155510536|NCT00415532|561295231|FG001|Safety Follow Up Period|Ineligibility determined|1|||
155510537|NCT00415532|561295230|FG000|Safety Follow Up Period|Noncompliance|1|||
155510538|NCT00415532|561295231|FG001|Safety Follow Up Period|Noncompliance|0|||
155510539|NCT00415532|561295230|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
155510540|NCT00415532|561295231|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
155510541|NCT01798485|561295232|FG000|Overall Study|Adverse Event|32|||
155510542|NCT01798485|561295233|FG001|Overall Study|Adverse Event|40|||
155510543|NCT01798485|561295232|FG000|Overall Study|Withdrawal by Subject|27|||
155510544|NCT01798485|561295233|FG001|Overall Study|Withdrawal by Subject|31|||
155510545|NCT01798485|561295232|FG000|Overall Study|Lost to Follow-up|0|||
155510546|NCT01798485|561295233|FG001|Overall Study|Lost to Follow-up|3|||
155510547|NCT01798485|561295232|FG000|Overall Study|Physician Decision|14|||
155510548|NCT01798485|561295233|FG001|Overall Study|Physician Decision|10|||
155510549|NCT01798485|561295232|FG000|Overall Study|Objective Disease Progression|152|||
155510550|NCT01798485|561295233|FG001|Overall Study|Objective Disease Progression|106|||
155510551|NCT01798485|561295232|FG000|Overall Study|Death|25|||
155510552|NCT01798485|561295233|FG001|Overall Study|Death|22|||
155510553|NCT01798485|561295232|FG000|Overall Study|Sponsor Decision|61|||
155510554|NCT01798485|561295233|FG001|Overall Study|Sponsor Decision|54|||
155510555|NCT01798485|561295232|FG000|Overall Study|Clinical Progression|35|||
155510556|NCT01798485|561295233|FG001|Overall Study|Clinical Progression|24|||
155510557|NCT01952574|561295234|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
155510558|NCT01952574|561295235|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
155510559|NCT01952574|561295236|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
155510560|NCT01952574|561295237|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
155510561|NCT01952574|561295238|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155510562|NCT01952574|561295239|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155510563|NCT01952574|561295240|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155510564|NCT01952574|561295234|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
155510565|NCT01952574|561295235|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
155510566|NCT01952574|561295236|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
155510567|NCT01952574|561295237|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
155510568|NCT01952574|561295238|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
155510569|NCT01952574|561295239|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
155510570|NCT01952574|561295240|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
155510571|NCT01952574|561295234|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
155510572|NCT01952574|561295235|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
155510573|NCT01952574|561295236|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
155510574|NCT01952574|561295237|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
155510575|NCT01952574|561295238|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
155510576|NCT01952574|561295239|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
155510577|NCT01952574|561295240|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
155510578|NCT01952574|561295234|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510579|NCT01952574|561295235|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510580|NCT01952574|561295236|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510581|NCT01952574|561295237|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510582|NCT01952574|561295238|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
155510583|NCT01952574|561295239|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510584|NCT01952574|561295240|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
155510585|NCT01952574|561295234|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
155371502|NCT01254747|560793510|FG003|Overall Study|Difficult removal handling|0|||
155510586|NCT01952574|561295235|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
155510587|NCT01952574|561295236|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
155371503|NCT01254747|560793507|FG000|Overall Study|Symptoms and problems|0|||
155510588|NCT01952574|561295237|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
155510589|NCT01952574|561295238|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
155510590|NCT01952574|561295239|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
155510591|NCT01952574|561295240|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
155510592|NCT01952574|561295234|FG000|Open-label Treatment Phase|Missing|0|||
155371504|NCT01254747|560793508|FG001|Overall Study|Symptoms and problems|2|||
155371505|NCT01254747|560793509|FG002|Overall Study|Symptoms and problems|1|||
155371506|NCT01254747|560793510|FG003|Overall Study|Symptoms and problems|0|||
155371507|NCT01254747|560793507|FG000|Overall Study|Lost to Follow-up|0|||
155371508|NCT01254747|560793508|FG001|Overall Study|Lost to Follow-up|0|||
155371509|NCT01254747|560793509|FG002|Overall Study|Lost to Follow-up|1|||
155371510|NCT01254747|560793510|FG003|Overall Study|Lost to Follow-up|0|||
155371511|NCT01254747|560793507|FG000|Overall Study|Biomicroscopy|0|||
155371512|NCT01254747|560793508|FG001|Overall Study|Biomicroscopy|0|||
155371513|NCT01254747|560793509|FG002|Overall Study|Biomicroscopy|1|||
155371514|NCT01254747|560793510|FG003|Overall Study|Biomicroscopy|0|||
155371515|NCT01254747|560793507|FG000|Overall Study|Discomfort|0|||
155371516|NCT01254747|560793508|FG001|Overall Study|Discomfort|4|||
155430127|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
155430128|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
155430129|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
155430130|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
155430131|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
155430132|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
155430133|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
155430134|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
155430135|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
155430136|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
155430137|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
155430138|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
155430139|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
155430140|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
155430141|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
155430142|NCT00100048|560999124|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
155430143|NCT00100048|560999125|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
155430144|NCT00100048|560999126|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
155430145|NCT00100048|560999127|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
155430146|NCT00100048|560999128|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
155430147|NCT00100048|560999129|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
155430148|NCT00496366|561000606|FG000|Overall Study|Death|1|||
155430149|NCT00768222|561000607|FG000|Overall Study|Lost to Follow-up|1|||
155430150|NCT00768222|561000608|FG001|Overall Study|Lost to Follow-up|1|||
155430151|NCT00768222|561000607|FG000|Overall Study|Withdrawal by Subject|3|||
155430152|NCT00768222|561000608|FG001|Overall Study|Withdrawal by Subject|1|||
155430153|NCT00768222|561000607|FG000|Overall Study|Protocol Violation|0|||
155430154|NCT00768222|561000608|FG001|Overall Study|Protocol Violation|2|||
155430155|NCT04938648|561000616|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
155430156|NCT04938648|561000617|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
155430157|NCT04938648|561000616|FG000|Overall Study|Patient too ill|0|||
155430158|NCT04938648|561000617|FG001|Overall Study|Patient too ill|1|||
155430159|NCT04938648|561000616|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
155430160|NCT04938648|561000617|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
155430161|NCT04938648|561000616|FG000|Overall Study|Patient did not have memory problems|1|||
155430162|NCT04938648|561000617|FG001|Overall Study|Patient did not have memory problems|1|||
155430163|NCT04938648|561000616|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
155430164|NCT04938648|561000617|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
155430165|NCT04938648|561000616|FG000|Overall Study|Care partner could not be reached|0|||
155430166|NCT04938648|561000617|FG001|Overall Study|Care partner could not be reached|1|||
155430167|NCT04938648|561000616|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
155430168|NCT04938648|561000617|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
155430169|NCT04938648|561000616|FG000|Overall Study|Withdrawal by Subject|2|||
155430170|NCT04938648|561000617|FG001|Overall Study|Withdrawal by Subject|1|||
155430171|NCT05027802|561000618|FG000|Overall Study|Adverse Event|2|||
155430172|NCT05027802|561000618|FG000|Overall Study|Withdrawal by Subject|18|||
155430173|NCT05027802|561000618|FG000|Overall Study|Death|2|||
155430174|NCT05027802|561000618|FG000|Overall Study|Other|1|||
155430175|NCT00502840|561000619|FG000|Overall Study|Adverse Event|5|||
155430176|NCT00502840|561000619|FG000|Overall Study|Additional or changed therapy|48|||
155430177|NCT00502840|561000619|FG000|Overall Study|Lack of Efficacy|11|||
155430178|NCT00502840|561000619|FG000|Overall Study|Protocol Violation|4|||
155430179|NCT00502840|561000619|FG000|Overall Study|Withdrawal by Subject|5|||
155430180|NCT00502840|561000619|FG000|Overall Study|Lost to Follow-up|6|||
155430181|NCT00502840|561000619|FG000|Overall Study|Administrative problems|1|||
155430182|NCT00502840|561000619|FG000|Overall Study|Other|20|||
155371517|NCT01254747|560793509|FG002|Overall Study|Discomfort|0|||
155649547|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
155649548|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
155649549|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
155649550|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155649551|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155371518|NCT01254747|560793510|FG003|Overall Study|Discomfort|0|||
155430183|NCT01974323|561000620|FG000|Overall Study|Other Reasons|25|||
155510593|NCT01952574|561295235|FG001|Open-label Treatment Phase|Missing|0|||
155510594|NCT01952574|561295236|FG002|Open-label Treatment Phase|Missing|0|||
155510595|NCT01952574|561295237|FG003|Open-label Treatment Phase|Missing|0|||
155510596|NCT01952574|561295238|FG004|Open-label Treatment Phase|Missing|4|||
155510597|NCT01952574|561295239|FG005|Open-label Treatment Phase|Missing|0|||
155510598|NCT01952574|561295240|FG006|Open-label Treatment Phase|Missing|0|||
155510599|NCT01952574|561295234|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
155510600|NCT01952574|561295235|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
155510601|NCT01952574|561295236|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
155510602|NCT01952574|561295237|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
155510603|NCT01952574|561295238|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
155510604|NCT01952574|561295239|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
155510605|NCT01952574|561295240|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
155510606|NCT01952574|561295234|FG000|Open-label Treatment Phase|Death|0|||
155510607|NCT01952574|561295235|FG001|Open-label Treatment Phase|Death|0|||
155510608|NCT01952574|561295236|FG002|Open-label Treatment Phase|Death|0|||
155649552|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155371519|NCT04187326|560793511|FG000|Overall Study|Lost to Follow-up|2|||
155371520|NCT04187326|560793512|FG001|Overall Study|Lost to Follow-up|1|||
155371521|NCT04187326|560793511|FG000|Overall Study|Computer error- task was only partially completed.|0|||
155371522|NCT04187326|560793512|FG001|Overall Study|Computer error- task was only partially completed.|1|||
155371523|NCT02406677|560793513|FG000|Overall Study|Death|16|||
155371524|NCT02406677|560793514|FG001|Overall Study|Death|8|||
155371525|NCT02406677|560793513|FG000|Overall Study|Discharged without P2Y12|1|||
155371526|NCT02406677|560793514|FG001|Overall Study|Discharged without P2Y12|3|||
155371527|NCT02406677|560793513|FG000|Overall Study|Discharged on prasugrel|283|||
155371528|NCT02406677|560793514|FG001|Overall Study|Discharged on prasugrel|587|||
155371529|NCT02406677|560793513|FG000|Overall Study|Withdrawal by Subject|1|||
155371530|NCT02406677|560793514|FG001|Overall Study|Withdrawal by Subject|0|||
155371531|NCT02387970|560793517|FG000|Overall Study|Did not complete 1-year follow up|1|||
155371532|NCT02387970|560793518|FG001|Overall Study|Did not complete 1-year follow up|2|||
155371533|NCT04531098|560793521|FG000|Stage I|Adverse Event|0|||
155371534|NCT04531098|560793522|FG001|Stage I|Adverse Event|0|||
155371535|NCT04531098|560793523|FG002|Stage I|Adverse Event|3|||
155371536|NCT04531098|560793521|FG000|Stage I|Protocol Violation|0|||
155371537|NCT04531098|560793522|FG001|Stage I|Protocol Violation|0|||
155371538|NCT04531098|560793523|FG002|Stage I|Protocol Violation|5|||
155371539|NCT04531098|560793521|FG000|Stage I|Withdrawal by Subject|0|||
155371540|NCT04531098|560793522|FG001|Stage I|Withdrawal by Subject|5|||
155371541|NCT04531098|560793523|FG002|Stage I|Withdrawal by Subject|10|||
155371542|NCT04531098|560793521|FG000|Stage II|Adverse Event|1|||
155371543|NCT04531098|560793522|FG001|Stage II|Adverse Event|2|||
155371544|NCT04531098|560793523|FG002|Stage II|Adverse Event|0|||
155371545|NCT04531098|560793521|FG000|Stage II|Protocol Violation|1|||
155371546|NCT04531098|560793522|FG001|Stage II|Protocol Violation|2|||
155371547|NCT04531098|560793523|FG002|Stage II|Protocol Violation|0|||
155430184|NCT01974323|561000621|FG001|Overall Study|Other Reasons|28|||
155430185|NCT01974323|561000620|FG000|Overall Study|Protocol Violation|2|||
155430186|NCT01974323|561000621|FG001|Overall Study|Protocol Violation|2|||
155430187|NCT01974323|561000620|FG000|Overall Study|Personal Reasons|15|||
155430188|NCT01974323|561000621|FG001|Overall Study|Personal Reasons|19|||
155430189|NCT01974323|561000620|FG000|Overall Study|Lost to Follow-up|45|||
155430190|NCT01974323|561000621|FG001|Overall Study|Lost to Follow-up|40|||
155430191|NCT01974323|561000620|FG000|Overall Study|Pregnancy|2|||
155430192|NCT01974323|561000621|FG001|Overall Study|Pregnancy|1|||
155430193|NCT01974323|561000620|FG000|Overall Study|Lack of Efficacy|1|||
155430194|NCT01974323|561000621|FG001|Overall Study|Lack of Efficacy|1|||
155430195|NCT01974323|561000620|FG000|Overall Study|Adverse Event|2|||
155430196|NCT01974323|561000621|FG001|Overall Study|Adverse Event|2|||
155430197|NCT01700829|561000622|FG000|Overall Study|Withdrawal by Subject|1|||
155430198|NCT01700829|561000623|FG001|Overall Study|Withdrawal by Subject|1|||
155430199|NCT01075178|561000624|FG000|Subject Matching|eligible but not matched|130|||
155430200|NCT01075178|561000625|FG001|Subject Matching|eligible but not matched|403|||
155430201|NCT01075178|561000624|FG000|Subject Chart Review|died before chart review period|0|||
155430202|NCT01075178|561000625|FG001|Subject Chart Review|died before chart review period|2|||
155430203|NCT01075178|561000624|FG000|Subject Chart Review|no data collected due to site closure|3|||
155371548|NCT04531098|560793521|FG000|Stage II|Withdrawal by Subject|3|||
155430204|NCT01075178|561000625|FG001|Subject Chart Review|no data collected due to site closure|4|||
155430205|NCT01075178|561000624|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
155371549|NCT04531098|560793522|FG001|Stage II|Withdrawal by Subject|1|||
155371550|NCT04531098|560793523|FG002|Stage II|Withdrawal by Subject|0|||
155371551|NCT04531098|560793521|FG000|Stage II|Moved from study area|8|||
155371552|NCT04531098|560793522|FG001|Stage II|Moved from study area|5|||
155371553|NCT04531098|560793523|FG002|Stage II|Moved from study area|0|||
155371554|NCT02145468|560793524|FG000|Overall Study|Withdrawal by Subject|5|||
155371555|NCT02145468|560793525|FG001|Overall Study|Withdrawal by Subject|8|||
155371556|NCT00586612|560793526|FG000|Primary Phase|Protocol Violation|1|||
155371557|NCT00586612|560793527|FG001|Primary Phase|Protocol Violation|0|||
155371558|NCT00586612|560793526|FG000|Primary Phase|Lost to Follow-up|0|||
155371559|NCT00586612|560793527|FG001|Primary Phase|Lost to Follow-up|1|||
155371560|NCT00586612|560793526|FG000|Primary Phase|Withdrawal by Subject|0|||
155371561|NCT00586612|560793527|FG001|Primary Phase|Withdrawal by Subject|2|||
155371562|NCT00586612|560793526|FG000|Booster Phase|Lost to Follow-up|3|||
155371563|NCT00586612|560793527|FG001|Booster Phase|Lost to Follow-up|1|||
155371564|NCT05235269|560793528|FG000|Overall Study|Adverse Event|1|||
155371565|NCT05235269|560793528|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
155371566|NCT05235269|560793528|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
155371567|NCT03810235|560793529|FG000|Overall Study|Withdrawal by Subject|2|||
155371568|NCT03810235|560793530|FG001|Overall Study|Withdrawal by Subject|0|||
155371569|NCT04777864|560793531|FG000|Overall Study|Lost to Follow-up|8|||
155371570|NCT04777864|560793532|FG001|Overall Study|Lost to Follow-up|19|||
155371571|NCT04908631|560793535|FG000|Overall Study|Lost to Follow-up|1|||
155371572|NCT04908631|560793535|FG000|Overall Study|Physician Decision|1|||
155371573|NCT04908631|560793535|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
155371574|NCT06655558|560793536|FG000|Overall Study|Protocol Violation|1|||
155371575|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
155371576|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
155371577|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
155371578|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371579|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371580|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371581|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
155430206|NCT01075178|561000625|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
155430207|NCT00316264|561000626|FG000|Overall Study|Lost to Follow-up|0|||
155430208|NCT00316264|561000627|FG001|Overall Study|Lost to Follow-up|1|||
155430209|NCT00316264|561000628|FG002|Overall Study|Lost to Follow-up|0|||
155371582|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
155371583|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
155371584|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155371585|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155430210|NCT00316264|561000626|FG000|Overall Study|Withdrawal of Consent|3|||
155430211|NCT00316264|561000627|FG001|Overall Study|Withdrawal of Consent|5|||
155430212|NCT00316264|561000628|FG002|Overall Study|Withdrawal of Consent|6|||
155430213|NCT00316264|561000626|FG000|Overall Study|Death|2|||
155430214|NCT00316264|561000627|FG001|Overall Study|Death|0|||
155430215|NCT00316264|561000628|FG002|Overall Study|Death|0|||
155430216|NCT00316264|561000626|FG000|Overall Study|Other|1|||
155430217|NCT00316264|561000627|FG001|Overall Study|Other|1|||
155430218|NCT00316264|561000628|FG002|Overall Study|Other|0|||
155430219|NCT00355264|561000629|FG000|Extension (Variable Duration)|Adverse Event|1|||
155430220|NCT00355264|561000629|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
155430221|NCT01451645|561000630|FG000|Overall Study|Protocol Violation|1|||
155430222|NCT01451645|561000631|FG001|Overall Study|Protocol Violation|0|||
155430223|NCT01451645|561000630|FG000|Overall Study|Adverse Event|0|||
155430224|NCT01451645|561000631|FG001|Overall Study|Adverse Event|3|||
155430225|NCT01451645|561000630|FG000|Overall Study|Withdrawal by Subject|4|||
155430226|NCT01451645|561000631|FG001|Overall Study|Withdrawal by Subject|2|||
155430227|NCT01451645|561000630|FG000|Overall Study|Lost to Follow-up|4|||
155430228|NCT01451645|561000631|FG001|Overall Study|Lost to Follow-up|3|||
155430229|NCT04927312|561000632|FG000|Overall Study|Adverse Event|1|||
155430230|NCT04927312|561000632|FG000|Overall Study|Death|1|||
155430231|NCT04927312|561000632|FG000|Overall Study|Withdrawal by Subject|1|||
155430232|NCT04927312|561000632|FG000|Overall Study|Other|1|||
155430233|NCT04919564|561000634|FG000|Overall Study|Lost to Follow-up|1|||
155430234|NCT04919564|561000635|FG001|Overall Study|Lost to Follow-up|0|||
155430235|NCT04919564|561000634|FG000|Overall Study|Physician Decision|1|||
155430236|NCT04919564|561000635|FG001|Overall Study|Physician Decision|1|||
155430237|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
155430238|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
155430239|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
155430240|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
155430241|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
155430242|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
155430243|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
155430244|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
155430245|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
155430246|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
155430247|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
155430248|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
155430249|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
155430250|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
155430251|NCT00446030|561000646|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
155430252|NCT00446030|561000647|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
155430253|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
155430254|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
155430255|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
155430256|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
155430257|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
155430258|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
155430259|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
155430260|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
155430261|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
155430262|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
155430263|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
155430264|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
155430265|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
155430266|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
155430267|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
155430268|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
155430269|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
155430270|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
155430271|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
155510609|NCT01952574|561295237|FG003|Open-label Treatment Phase|Death|0|||
155371586|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155371587|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371588|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
155371589|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371590|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371591|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371592|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371593|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371594|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
155371595|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371596|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371597|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371598|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371599|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371600|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371601|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
155430272|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
155430273|NCT00446030|561000646|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
155430274|NCT00446030|561000647|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
155430275|NCT00858832|561000648|FG000|Overall Study|became ineligible: delivered vaginally|1|||
155430276|NCT00858832|561000649|FG001|Overall Study|became ineligible: delivered vaginally|0|||
155430277|NCT00858832|561000648|FG000|Overall Study|Adverse Event|0|||
155430278|NCT00858832|561000649|FG001|Overall Study|Adverse Event|1|||
155430279|NCT05292755|561000650|FG000|Overall Study|Lost to Follow-up|5|||
155430280|NCT05292755|561000651|FG001|Overall Study|Lost to Follow-up|9|||
155430281|NCT00519077|561000653|FG000|Overall Study|Death|6|||
155430282|NCT00519077|561000653|FG000|Overall Study|Other|2|||
155430283|NCT01967225|561000654|FG000|Overall Study|Adverse Event|3|||
155430284|NCT01967225|561000655|FG001|Overall Study|Adverse Event|1|||
155430285|NCT01967225|561000654|FG000|Overall Study|Withdrawal by Subject|2|||
155430286|NCT01967225|561000655|FG001|Overall Study|Withdrawal by Subject|1|||
155430287|NCT01967225|561000654|FG000|Overall Study|Lack of Efficacy|1|||
155430288|NCT01967225|561000655|FG001|Overall Study|Lack of Efficacy|1|||
155430289|NCT01967225|561000654|FG000|Overall Study|Switching to other therapy|2|||
155430290|NCT01967225|561000655|FG001|Overall Study|Switching to other therapy|0|||
155430291|NCT01967225|561000654|FG000|Overall Study|Protocol driven decision point|1|||
155430292|NCT01967225|561000655|FG001|Overall Study|Protocol driven decision point|0|||
155430293|NCT01967225|561000654|FG000|Overall Study|Logistical difficulties|1|||
155430294|NCT01967225|561000655|FG001|Overall Study|Logistical difficulties|0|||
155430295|NCT01967225|561000654|FG000|Overall Study|Protocol Violation|2|||
155430296|NCT01967225|561000655|FG001|Overall Study|Protocol Violation|0|||
155430297|NCT02305563|561000656|FG000|Treatment Period|Disease progression|0|||
155430298|NCT02305563|561000657|FG001|Treatment Period|Disease progression|0|||
155430299|NCT02305563|561000658|FG002|Treatment Period|Disease progression|15|||
155430300|NCT02305563|561000659|FG003|Treatment Period|Disease progression|6|||
155430301|NCT02305563|561000660|FG004|Treatment Period|Disease progression|6|||
155430302|NCT02305563|561000656|FG000|Treatment Period|Study drug toxicity|0|||
155430303|NCT02305563|561000657|FG001|Treatment Period|Study drug toxicity|0|||
155430304|NCT02305563|561000658|FG002|Treatment Period|Study drug toxicity|0|||
155430305|NCT02305563|561000659|FG003|Treatment Period|Study drug toxicity|1|||
155430306|NCT02305563|561000660|FG004|Treatment Period|Study drug toxicity|2|||
155510610|NCT01952574|561295238|FG004|Open-label Treatment Phase|Death|1|||
155510611|NCT01952574|561295239|FG005|Open-label Treatment Phase|Death|0|||
155510612|NCT01952574|561295240|FG006|Open-label Treatment Phase|Death|0|||
155510613|NCT01952574|561295234|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510614|NCT01952574|561295235|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510615|NCT01952574|561295236|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510616|NCT01952574|561295237|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510617|NCT01952574|561295238|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510618|NCT01952574|561295239|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
155510619|NCT01952574|561295240|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155510620|NCT01952574|561295234|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
155510621|NCT01952574|561295235|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
155510622|NCT01952574|561295236|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
155510623|NCT01952574|561295237|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
155510624|NCT01952574|561295238|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
155510625|NCT01952574|561295239|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
155510626|NCT01952574|561295240|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
155510627|NCT03687125|561295244|FG000|Overall Study|Progressive Disease|2|||
155510628|NCT03687125|561295245|FG001|Overall Study|Progressive Disease|1|||
155510629|NCT03687125|561295244|FG000|Overall Study|Protocol Violation|1|||
155510630|NCT03687125|561295245|FG001|Overall Study|Protocol Violation|0|||
155510631|NCT00770991|561295246|FG000|Overall Study|Physician Decision|2|||
155510632|NCT00770991|561295247|FG001|Overall Study|Physician Decision|0|||
155510633|NCT00770991|561295246|FG000|Overall Study|Withdrawal by Subject|1|||
155510634|NCT00770991|561295247|FG001|Overall Study|Withdrawal by Subject|0|||
155510635|NCT00770991|561295246|FG000|Overall Study|Adverse Event|1|||
155510636|NCT00770991|561295247|FG001|Overall Study|Adverse Event|5|||
155510637|NCT00770991|561295246|FG000|Overall Study|Pregnancy|1|||
155510638|NCT00770991|561295247|FG001|Overall Study|Pregnancy|0|||
155510639|NCT01992107|561295248|FG000|Overall Study|Administrative reasons|2|||
155510640|NCT01992107|561295249|FG001|Overall Study|Administrative reasons|0|||
155510641|NCT01992107|561295250|FG002|Overall Study|Administrative reasons|0|||
155510642|NCT01992107|561295248|FG000|Overall Study|Adverse Event|0|||
155510643|NCT01992107|561295249|FG001|Overall Study|Adverse Event|1|||
155510644|NCT01992107|561295250|FG002|Overall Study|Adverse Event|0|||
155510645|NCT01992107|561295248|FG000|Overall Study|Lost to Follow-up|46|||
155510646|NCT01992107|561295249|FG001|Overall Study|Lost to Follow-up|22|||
155510647|NCT01992107|561295250|FG002|Overall Study|Lost to Follow-up|26|||
155510648|NCT01992107|561295248|FG000|Overall Study|noncompliance and were unavailable|7|||
155510649|NCT01992107|561295249|FG001|Overall Study|noncompliance and were unavailable|3|||
155510650|NCT01992107|561295250|FG002|Overall Study|noncompliance and were unavailable|2|||
155510651|NCT01992107|561295248|FG000|Overall Study|Withdrawal by Subject|13|||
155510652|NCT01992107|561295249|FG001|Overall Study|Withdrawal by Subject|7|||
155510653|NCT01992107|561295250|FG002|Overall Study|Withdrawal by Subject|8|||
155510654|NCT02022007|561295251|FG000|Overall Study|Withdrawal by Subject|1|||
155510655|NCT02022007|561295252|FG001|Overall Study|Withdrawal by Subject|1|||
155510656|NCT02022007|561295253|FG002|Overall Study|Withdrawal by Subject|1|||
155510657|NCT02022007|561295251|FG000|Overall Study|Noncompliant|0|||
155510658|NCT02022007|561295252|FG001|Overall Study|Noncompliant|0|||
155510659|NCT02022007|561295253|FG002|Overall Study|Noncompliant|1|||
155510660|NCT01001169|561295255|FG000|Overall Study|Withdrawal by Subject|2|||
155510661|NCT01001169|561295256|FG001|Overall Study|Withdrawal by Subject|1|||
155510662|NCT02536378|561295259|FG000|Overall Study|Physician Decision|0|||
155510663|NCT02536378|561295260|FG001|Overall Study|Physician Decision|2|||
155510664|NCT02536378|561295259|FG000|Overall Study|Withdrawal by Subject|0|||
155510665|NCT02536378|561295260|FG001|Overall Study|Withdrawal by Subject|1|||
155510666|NCT02536378|561295259|FG000|Overall Study|Death|1|||
155510667|NCT02536378|561295260|FG001|Overall Study|Death|2|||
155510668|NCT02536378|561295259|FG000|Overall Study|Patient refused further follow up|6|||
155510669|NCT02536378|561295260|FG001|Overall Study|Patient refused further follow up|2|||
155510670|NCT01271933|561295261|FG000|Single-Blind Phase|Lack of Efficacy|37|||
155510671|NCT01271933|561295262|FG001|Single-Blind Phase|Lack of Efficacy|0|||
155510672|NCT01271933|561295263|FG002|Single-Blind Phase|Lack of Efficacy|0|||
155510673|NCT01271933|561295261|FG000|Single-Blind Phase|Lost to Follow-up|10|||
155510674|NCT01271933|561295262|FG001|Single-Blind Phase|Lost to Follow-up|0|||
155510675|NCT01271933|561295263|FG002|Single-Blind Phase|Lost to Follow-up|0|||
155510676|NCT01271933|561295261|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
155510677|NCT01271933|561295262|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
155510678|NCT01271933|561295263|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
155510679|NCT01271933|561295261|FG000|Single-Blind Phase|Protocol Violation|3|||
155510680|NCT01271933|561295262|FG001|Single-Blind Phase|Protocol Violation|0|||
155371602|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371603|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155510681|NCT01271933|561295263|FG002|Single-Blind Phase|Protocol Violation|0|||
155510682|NCT01271933|561295261|FG000|Single-Blind Phase|Adverse Event|52|||
155510683|NCT01271933|561295262|FG001|Single-Blind Phase|Adverse Event|0|||
155371604|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155430307|NCT02305563|561000656|FG000|Treatment Period|Death|0|||
155430308|NCT02305563|561000657|FG001|Treatment Period|Death|0|||
155430309|NCT02305563|561000658|FG002|Treatment Period|Death|1|||
155430310|NCT02305563|561000659|FG003|Treatment Period|Death|2|||
155430311|NCT02305563|561000660|FG004|Treatment Period|Death|1|||
155430312|NCT02305563|561000656|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
155430313|NCT02305563|561000657|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
155430314|NCT02305563|561000658|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
155430315|NCT02305563|561000659|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
155430316|NCT02305563|561000660|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
155430317|NCT02305563|561000656|FG000|Treatment Period|Participant request to stop therapy|0|||
155430318|NCT02305563|561000657|FG001|Treatment Period|Participant request to stop therapy|2|||
155430319|NCT02305563|561000658|FG002|Treatment Period|Participant request to stop therapy|0|||
155430320|NCT02305563|561000659|FG003|Treatment Period|Participant request to stop therapy|1|||
155430321|NCT02305563|561000660|FG004|Treatment Period|Participant request to stop therapy|0|||
155430322|NCT02305563|561000656|FG000|Treatment Period|Participant withdrew consent|0|||
155430323|NCT02305563|561000657|FG001|Treatment Period|Participant withdrew consent|0|||
155430324|NCT02305563|561000658|FG002|Treatment Period|Participant withdrew consent|1|||
155430325|NCT02305563|561000659|FG003|Treatment Period|Participant withdrew consent|1|||
155430326|NCT02305563|561000660|FG004|Treatment Period|Participant withdrew consent|1|||
155430327|NCT02305563|561000656|FG000|Treatment Period|Maximum clinical benefit|0|||
155430328|NCT02305563|561000657|FG001|Treatment Period|Maximum clinical benefit|0|||
155430329|NCT02305563|561000658|FG002|Treatment Period|Maximum clinical benefit|0|||
155430330|NCT02305563|561000659|FG003|Treatment Period|Maximum clinical benefit|0|||
155430331|NCT02305563|561000660|FG004|Treatment Period|Maximum clinical benefit|1|||
155430332|NCT02305563|561000656|FG000|Treatment Period|Poor/non-compliance|0|||
155430333|NCT02305563|561000657|FG001|Treatment Period|Poor/non-compliance|0|||
155430334|NCT02305563|561000658|FG002|Treatment Period|Poor/non-compliance|0|||
155430335|NCT02305563|561000659|FG003|Treatment Period|Poor/non-compliance|0|||
155430336|NCT02305563|561000660|FG004|Treatment Period|Poor/non-compliance|1|||
155430337|NCT02305563|561000656|FG000|Treatment Period|Administrative reason by Sponsor|0|||
155430338|NCT02305563|561000657|FG001|Treatment Period|Administrative reason by Sponsor|0|||
155430339|NCT02305563|561000658|FG002|Treatment Period|Administrative reason by Sponsor|0|||
155430340|NCT02305563|561000659|FG003|Treatment Period|Administrative reason by Sponsor|0|||
155649553|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155649554|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155430341|NCT02305563|561000660|FG004|Treatment Period|Administrative reason by Sponsor|1|||
155430342|NCT02305563|561000656|FG000|Treatment Period|other reason|2|||
155430343|NCT02305563|561000657|FG001|Treatment Period|other reason|0|||
155649555|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155510684|NCT01271933|561295263|FG002|Single-Blind Phase|Adverse Event|0|||
155510685|NCT01271933|561295261|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
155510686|NCT01271933|561295262|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
155510687|NCT01271933|561295263|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
155510688|NCT01271933|561295261|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
155510689|NCT01271933|561295262|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
155510690|NCT01271933|561295263|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
155510691|NCT01271933|561295261|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
155510692|NCT01271933|561295262|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
155510693|NCT01271933|561295263|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
155510694|NCT01271933|561295261|FG000|Double-Blind Phase|Randomized but not treated|0|||
155510695|NCT01271933|561295262|FG001|Double-Blind Phase|Randomized but not treated|0|||
155510696|NCT01271933|561295263|FG002|Double-Blind Phase|Randomized but not treated|1|||
155510697|NCT01271933|561295261|FG000|Double-Blind Phase|Lack of Efficacy|0|||
155510698|NCT01271933|561295262|FG001|Double-Blind Phase|Lack of Efficacy|6|||
155510699|NCT01271933|561295263|FG002|Double-Blind Phase|Lack of Efficacy|9|||
155510700|NCT01271933|561295261|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155510701|NCT01271933|561295262|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155510702|NCT01271933|561295263|FG002|Double-Blind Phase|Lost to Follow-up|1|||
155510703|NCT01271933|561295261|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155510704|NCT01271933|561295262|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
155510705|NCT01271933|561295263|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
155510706|NCT01271933|561295261|FG000|Double-Blind Phase|Adverse Event|0|||
155510707|NCT01271933|561295262|FG001|Double-Blind Phase|Adverse Event|3|||
155510708|NCT01271933|561295263|FG002|Double-Blind Phase|Adverse Event|0|||
155510709|NCT01271933|561295261|FG000|Double-Blind Phase|Participant request-personal reason|0|||
155510710|NCT01271933|561295262|FG001|Double-Blind Phase|Participant request-personal reason|1|||
155510711|NCT01271933|561295263|FG002|Double-Blind Phase|Participant request-personal reason|0|||
155510712|NCT03156270|561295264|FG000|Overall Study|Failed pre-treatment screening|1|||
155510713|NCT03156270|561295264|FG000|Overall Study|Lost to Follow-up|1|||
155510714|NCT00871169|561295265|FG000|Overall Study|Protocol Violation|1|||
155510715|NCT00871169|561295265|FG000|Overall Study|Patient did not receive study treatment|2|||
155510716|NCT01102777|561295268|FG000|Overall Study|Death|2|||
155510717|NCT01102777|561295269|FG001|Overall Study|Death|6|||
155510718|NCT01102777|561295268|FG000|Overall Study|Lost to Follow-up|7|||
155510719|NCT01102777|561295269|FG001|Overall Study|Lost to Follow-up|10|||
155510720|NCT02175966|561295274|FG000|Follow-up Period|Lack of Efficacy|10|||
155510721|NCT02175966|561295275|FG001|Follow-up Period|Lack of Efficacy|6|||
155510722|NCT01752920|561295276|FG000|Overall Study|Adverse Event|1|||
155510723|NCT01752920|561295277|FG001|Overall Study|Adverse Event|0|||
155510724|NCT01752920|561295278|FG002|Overall Study|Adverse Event|5|||
155510725|NCT01752920|561295279|FG003|Overall Study|Adverse Event|10|||
155510726|NCT01752920|561295276|FG000|Overall Study|Clinical Disease Progression|6|||
155510727|NCT01752920|561295277|FG001|Overall Study|Clinical Disease Progression|4|||
155510728|NCT01752920|561295278|FG002|Overall Study|Clinical Disease Progression|1|||
155510729|NCT01752920|561295279|FG003|Overall Study|Clinical Disease Progression|13|||
155510730|NCT01752920|561295276|FG000|Overall Study|Physician Decision|1|||
155510731|NCT01752920|561295277|FG001|Overall Study|Physician Decision|0|||
155510732|NCT01752920|561295278|FG002|Overall Study|Physician Decision|0|||
155510733|NCT01752920|561295279|FG003|Overall Study|Physician Decision|3|||
155510734|NCT01752920|561295276|FG000|Overall Study|Radiographic Disease Progression|20|||
155510735|NCT01752920|561295277|FG001|Overall Study|Radiographic Disease Progression|7|||
155510736|NCT01752920|561295278|FG002|Overall Study|Radiographic Disease Progression|12|||
155510737|NCT01752920|561295279|FG003|Overall Study|Radiographic Disease Progression|29|||
155510738|NCT01752920|561295276|FG000|Overall Study|Study Terminated by Sponsor|0|||
155510739|NCT01752920|561295277|FG001|Overall Study|Study Terminated by Sponsor|0|||
155510740|NCT01752920|561295278|FG002|Overall Study|Study Terminated by Sponsor|0|||
155510741|NCT01752920|561295279|FG003|Overall Study|Study Terminated by Sponsor|1|||
155510742|NCT01752920|561295276|FG000|Overall Study|Withdrawal by Subject|0|||
155510743|NCT01752920|561295277|FG001|Overall Study|Withdrawal by Subject|1|||
155510744|NCT01752920|561295278|FG002|Overall Study|Withdrawal by Subject|0|||
155510745|NCT01752920|561295279|FG003|Overall Study|Withdrawal by Subject|1|||
155510746|NCT01752920|561295276|FG000|Overall Study|Lack of clinical benefit|1|||
155510747|NCT01752920|561295277|FG001|Overall Study|Lack of clinical benefit|1|||
155510748|NCT01752920|561295278|FG002|Overall Study|Lack of clinical benefit|1|||
155510749|NCT01752920|561295279|FG003|Overall Study|Lack of clinical benefit|1|||
155510750|NCT00947856|561295286|FG000|Treatment Period|Progressive Disease|33|||
155510751|NCT00947856|561295287|FG001|Treatment Period|Progressive Disease|12|||
155510752|NCT00947856|561295286|FG000|Treatment Period|Adverse Event|15|||
155510753|NCT00947856|561295287|FG001|Treatment Period|Adverse Event|9|||
155510754|NCT00947856|561295286|FG000|Treatment Period|Physician Decision|14|||
155510755|NCT00947856|561295287|FG001|Treatment Period|Physician Decision|6|||
155510756|NCT00947856|561295286|FG000|Treatment Period|Study Stopped by Sponsor|4|||
155510757|NCT00947856|561295287|FG001|Treatment Period|Study Stopped by Sponsor|4|||
155510758|NCT00947856|561295286|FG000|Treatment Period|Withdrawal by Subject|12|||
155510759|NCT00947856|561295287|FG001|Treatment Period|Withdrawal by Subject|1|||
155510760|NCT00947856|561295286|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
155510761|NCT00947856|561295287|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
155510762|NCT00947856|561295286|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
155510763|NCT00947856|561295287|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
155510764|NCT00947856|561295286|FG000|Follow-up Period|Lost to Follow-up|7|||
155510765|NCT00947856|561295287|FG001|Follow-up Period|Lost to Follow-up|0|||
155510766|NCT00947856|561295286|FG000|Follow-up Period|Patient unavailable for site visits|1|||
155510767|NCT00947856|561295287|FG001|Follow-up Period|Patient unavailable for site visits|0|||
155510768|NCT00947856|561295286|FG000|Follow-up Period|Withdrawal by Subject|1|||
155510769|NCT00947856|561295287|FG001|Follow-up Period|Withdrawal by Subject|0|||
155510770|NCT00771901|561295288|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
155510771|NCT00771901|561295289|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
155510772|NCT00771901|561295290|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
155510773|NCT02280356|561295294|FG000|Overall Study|Not Treated|2|||
155510774|NCT02280356|561295294|FG000|Overall Study|Withdrawal by Subject|1|||
155510775|NCT02280356|561295294|FG000|Overall Study|Not evaluable|2|||
155510776|NCT01086215|561295295|FG000|Overall Study|Death|14|||
155510777|NCT01086215|561295296|FG001|Overall Study|Death|8|||
155510778|NCT01086215|561295297|FG002|Overall Study|Death|8|||
155510779|NCT01086215|561295298|FG003|Overall Study|Death|1|||
155510780|NCT01086215|561295295|FG000|Overall Study|Lost to Follow-up|22|||
155510781|NCT01086215|561295296|FG001|Overall Study|Lost to Follow-up|39|||
155510782|NCT01086215|561295297|FG002|Overall Study|Lost to Follow-up|18|||
155510783|NCT01086215|561295298|FG003|Overall Study|Lost to Follow-up|2|||
155510784|NCT03493698|561295303|FG000|Treatment Period C|Adverse Event|1|||
155510785|NCT03493698|561295303|FG000|Treatment Period C|Withdrawal by Subject|1|||
155510786|NCT00566709|561295304|FG000|Overall Study|Protocol Violation|5|||
155371605|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371606|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
155371607|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
155371608|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371609|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371610|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371611|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
155371612|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
155371613|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
155371614|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371615|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371616|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371617|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
155371618|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
155371619|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
155371620|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371621|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371622|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371623|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Adverse Event|0|||
155371624|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Adverse Event|0|||
155371625|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Adverse Event|0|||
155371626|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Adverse Event|2|||
155371627|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Adverse Event|0|||
155371628|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Adverse Event|0|||
155371629|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371630|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371631|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
155430344|NCT02305563|561000658|FG002|Treatment Period|other reason|2|||
155430345|NCT02305563|561000659|FG003|Treatment Period|other reason|2|||
155430346|NCT02305563|561000660|FG004|Treatment Period|other reason|1|||
155430347|NCT02305563|561000656|FG000|Treatment Period|Randomized but not treated|0|||
155430348|NCT02305563|561000657|FG001|Treatment Period|Randomized but not treated|0|||
155430349|NCT02305563|561000658|FG002|Treatment Period|Randomized but not treated|0|||
155430350|NCT02305563|561000659|FG003|Treatment Period|Randomized but not treated|0|||
155430351|NCT02305563|561000660|FG004|Treatment Period|Randomized but not treated|2|||
155430352|NCT02305563|561000656|FG000|Treatment Period|added ULO, then disease progression|0|||
155430353|NCT02305563|561000657|FG001|Treatment Period|added ULO, then disease progression|0|||
155430354|NCT02305563|561000658|FG002|Treatment Period|added ULO, then disease progression|0|||
155430355|NCT02305563|561000659|FG003|Treatment Period|added ULO, then disease progression|0|||
155430356|NCT02305563|561000660|FG004|Treatment Period|added ULO, then disease progression|4|||
155430357|NCT02305563|561000656|FG000|Treatment Period|added ULO; then other reason|0|||
155430358|NCT02305563|561000657|FG001|Treatment Period|added ULO; then other reason|0|||
155430359|NCT02305563|561000658|FG002|Treatment Period|added ULO; then other reason|0|||
155430360|NCT02305563|561000659|FG003|Treatment Period|added ULO; then other reason|0|||
155430361|NCT02305563|561000660|FG004|Treatment Period|added ULO; then other reason|1|||
155430362|NCT02305563|561000656|FG000|Treatment Period|added ULO, then request to stop|0|||
155430363|NCT02305563|561000657|FG001|Treatment Period|added ULO, then request to stop|0|||
155371632|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
155371633|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371634|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371635|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Pregnancy|0|||
155371636|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Pregnancy|0|||
155371637|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Pregnancy|0|||
155371638|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Pregnancy|1|||
155371639|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Pregnancy|0|||
155371640|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Pregnancy|0|||
155371641|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371642|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371643|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371644|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
155371645|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155510787|NCT00566709|561295305|FG001|Overall Study|Protocol Violation|0|||
155371646|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371647|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371648|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371649|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371650|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371651|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
155371652|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371653|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371654|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371655|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371656|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371657|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
155371658|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371659|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371660|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371661|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371662|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371663|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
155371664|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371665|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371666|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371667|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371668|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371669|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
155371670|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371671|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371672|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371673|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155510788|NCT01829295|561295306|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
155510789|NCT01829295|561295307|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
155510790|NCT01829295|561295308|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
155510791|NCT01829295|561295309|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
155510792|NCT01829295|561295306|FG000|6-12 Months|Adverse Event|0|||
155649556|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155371674|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371675|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
155371676|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371677|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371678|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371679|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371680|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371681|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
155371682|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371683|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371684|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371685|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371686|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371687|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
155371688|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371689|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371690|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371691|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371692|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371693|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371694|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
155371695|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371696|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371697|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371698|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371699|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371700|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
155371701|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371702|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371703|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371704|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371705|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371706|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
155371707|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371708|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371709|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371710|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371711|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371712|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
155371713|NCT04303780|560793547|FG000|Overall Study|Death|104|||
155371714|NCT04303780|560793548|FG001|Overall Study|Death|85|||
155371715|NCT04303780|560793547|FG000|Overall Study|Lost to Follow-up|5|||
155371716|NCT04303780|560793548|FG001|Overall Study|Lost to Follow-up|2|||
155371717|NCT04303780|560793547|FG000|Overall Study|Withdrawal by Subject|12|||
155371718|NCT04303780|560793548|FG001|Overall Study|Withdrawal by Subject|39|||
155371719|NCT04303780|560793547|FG000|Overall Study|Ongoing in study|50|||
155371720|NCT04303780|560793548|FG001|Overall Study|Ongoing in study|45|||
155371721|NCT03826030|560793549|FG000|Overall Study|Withdrawal by Subject|2|||
155371722|NCT03826030|560793550|FG001|Overall Study|Withdrawal by Subject|0|||
155371723|NCT03826030|560793551|FG002|Overall Study|Withdrawal by Subject|1|||
155371724|NCT03826030|560793549|FG000|Overall Study|Lost to Follow-up|1|||
155371725|NCT03826030|560793550|FG001|Overall Study|Lost to Follow-up|1|||
155371726|NCT03826030|560793551|FG002|Overall Study|Lost to Follow-up|1|||
155371727|NCT03826030|560793549|FG000|Overall Study|Too busy to return for visits|1|||
155371728|NCT03826030|560793550|FG001|Overall Study|Too busy to return for visits|0|||
155371729|NCT03826030|560793551|FG002|Overall Study|Too busy to return for visits|0|||
155371730|NCT04893460|560793554|FG000|Overall Study|Lost to Follow-up|18|||
155371731|NCT04500769|560795592|FG000|Overall Study|Withdrawal by Subject|5|||
155371732|NCT01967147|560795593|FG000|Overall Study|Adverse Event|5|||
155371733|NCT01967147|560795594|FG001|Overall Study|Adverse Event|2|||
155371734|NCT01967147|560795593|FG000|Overall Study|Lack of Efficacy|1|||
155371735|NCT01967147|560795594|FG001|Overall Study|Lack of Efficacy|4|||
155371736|NCT01967147|560795593|FG000|Overall Study|Lost to Follow-up|1|||
155371737|NCT01967147|560795594|FG001|Overall Study|Lost to Follow-up|2|||
155371738|NCT01967147|560795593|FG000|Overall Study|Withdrawal by Subject|2|||
155371739|NCT01967147|560795594|FG001|Overall Study|Withdrawal by Subject|4|||
155371740|NCT01967147|560795593|FG000|Overall Study|Non-compliance with Study Drug|0|||
155371741|NCT01967147|560795594|FG001|Overall Study|Non-compliance with Study Drug|3|||
155371742|NCT01967147|560795593|FG000|Overall Study|Other|4|||
155371743|NCT01967147|560795594|FG001|Overall Study|Other|5|||
155371744|NCT03843554|560795595|FG000|Overall Study|Physician Decision|0|||
155371745|NCT03843554|560795596|FG001|Overall Study|Physician Decision|2|||
155371746|NCT02218606|560795598|FG000|Overall Study|Adverse Event|1|||
155371747|NCT02218606|560795599|FG001|Overall Study|Adverse Event|1|||
155371748|NCT02218606|560795598|FG000|Overall Study|Death|15|||
155371749|NCT02218606|560795599|FG001|Overall Study|Death|28|||
155371750|NCT02218606|560795598|FG000|Overall Study|Physician Decision|0|||
155371751|NCT02218606|560795599|FG001|Overall Study|Physician Decision|1|||
155371752|NCT02218606|560795598|FG000|Overall Study|Withdrawal by Subject|4|||
155371753|NCT02218606|560795599|FG001|Overall Study|Withdrawal by Subject|0|||
155371754|NCT02218606|560795598|FG000|Overall Study|Noncompliance|1|||
155371755|NCT02218606|560795599|FG001|Overall Study|Noncompliance|0|||
155371756|NCT02218606|560795598|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
155371757|NCT02218606|560795599|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
155371758|NCT02218606|560795598|FG000|Overall Study|Other|2|||
155371759|NCT02218606|560795599|FG001|Overall Study|Other|1|||
155371760|NCT02218606|560795598|FG000|Overall Study|Never started treatment|0|||
155371761|NCT02218606|560795599|FG001|Overall Study|Never started treatment|1|||
155371762|NCT03203473|560795600|FG000|Induction Phase|Never started primary treatment|2|||
155371763|NCT03203473|560795601|FG001|Induction Phase|Never started primary treatment|0|||
155371764|NCT03203473|560795602|FG002|Induction Phase|Never started primary treatment|0|||
155371765|NCT03203473|560795600|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
155371766|NCT03203473|560795601|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
155371767|NCT03203473|560795602|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
155371768|NCT03203473|560795600|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
155371769|NCT03203473|560795601|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
155371770|NCT03203473|560795602|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
155371771|NCT03203473|560795600|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
155371772|NCT03203473|560795601|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
155371773|NCT03203473|560795602|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
155371774|NCT03203473|560795600|FG000|Arm Allocation Phase|started salvage therapy|0|||
155371775|NCT03203473|560795601|FG001|Arm Allocation Phase|started salvage therapy|5|||
155371776|NCT03203473|560795602|FG002|Arm Allocation Phase|started salvage therapy|0|||
155371777|NCT03203473|560795600|FG000|Arm Allocation Phase|Disease progression|0|||
155371778|NCT03203473|560795601|FG001|Arm Allocation Phase|Disease progression|0|||
155371779|NCT03203473|560795602|FG002|Arm Allocation Phase|Disease progression|37|||
155371780|NCT03203473|560795600|FG000|Arm Allocation Phase|Adverse Event|0|||
155371781|NCT03203473|560795601|FG001|Arm Allocation Phase|Adverse Event|0|||
155371782|NCT03203473|560795602|FG002|Arm Allocation Phase|Adverse Event|11|||
155371783|NCT03203473|560795600|FG000|Arm Allocation Phase|Physician Decision|0|||
155371784|NCT03203473|560795601|FG001|Arm Allocation Phase|Physician Decision|0|||
155371785|NCT03203473|560795602|FG002|Arm Allocation Phase|Physician Decision|3|||
155371786|NCT03203473|560795600|FG000|Arm Allocation Phase|Death|0|||
155371787|NCT03203473|560795601|FG001|Arm Allocation Phase|Death|0|||
155371788|NCT03203473|560795602|FG002|Arm Allocation Phase|Death|1|||
155371789|NCT03203473|560795600|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
155371790|NCT03203473|560795601|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
155371791|NCT03203473|560795602|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
155371792|NCT03203473|560795600|FG000|Arm Allocation Phase|Intercurrent illness|0|||
155371793|NCT03203473|560795601|FG001|Arm Allocation Phase|Intercurrent illness|0|||
155371794|NCT03203473|560795602|FG002|Arm Allocation Phase|Intercurrent illness|1|||
155371795|NCT03203473|560795600|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
155371796|NCT03203473|560795601|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
155371797|NCT03203473|560795602|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
155371798|NCT01901432|560795607|FG000|Overall Study|Adverse Event|0|||
155371799|NCT01901432|560795608|FG001|Overall Study|Adverse Event|1|||
155371800|NCT01901432|560795609|FG002|Overall Study|Adverse Event|1|||
155371801|NCT01901432|560795610|FG003|Overall Study|Adverse Event|0|||
155371802|NCT01901432|560795611|FG004|Overall Study|Adverse Event|1|||
155371803|NCT01901432|560795607|FG000|Overall Study|Withdrawal by Subject|0|||
155371804|NCT01901432|560795608|FG001|Overall Study|Withdrawal by Subject|0|||
155371805|NCT01901432|560795609|FG002|Overall Study|Withdrawal by Subject|1|||
155371806|NCT01901432|560795610|FG003|Overall Study|Withdrawal by Subject|0|||
155371807|NCT01901432|560795611|FG004|Overall Study|Withdrawal by Subject|5|||
155371808|NCT01901432|560795607|FG000|Overall Study|Physician Decision|0|||
155371809|NCT01901432|560795608|FG001|Overall Study|Physician Decision|0|||
155371810|NCT01901432|560795609|FG002|Overall Study|Physician Decision|0|||
155371811|NCT01901432|560795610|FG003|Overall Study|Physician Decision|0|||
155371812|NCT01901432|560795611|FG004|Overall Study|Physician Decision|2|||
155371813|NCT01901432|560795607|FG000|Overall Study|Patient decision to stop study drug|0|||
155371814|NCT01901432|560795608|FG001|Overall Study|Patient decision to stop study drug|0|||
155371815|NCT01901432|560795609|FG002|Overall Study|Patient decision to stop study drug|0|||
155371816|NCT01901432|560795610|FG003|Overall Study|Patient decision to stop study drug|0|||
155371817|NCT01901432|560795611|FG004|Overall Study|Patient decision to stop study drug|1|||
155371818|NCT00379288|560795612|FG000|Overall Study|Adverse Event|5|||
155371819|NCT00379288|560795613|FG001|Overall Study|Adverse Event|6|||
155371820|NCT00379288|560795614|FG002|Overall Study|Adverse Event|2|||
155371821|NCT00379288|560795615|FG003|Overall Study|Adverse Event|0|||
155371822|NCT00379288|560795612|FG000|Overall Study|Treatment Failure|0|||
155371823|NCT00379288|560795613|FG001|Overall Study|Treatment Failure|1|||
155371824|NCT00379288|560795614|FG002|Overall Study|Treatment Failure|0|||
155371825|NCT00379288|560795615|FG003|Overall Study|Treatment Failure|1|||
155371826|NCT00379288|560795612|FG000|Overall Study|Lost to Follow-up|3|||
155371827|NCT00379288|560795613|FG001|Overall Study|Lost to Follow-up|3|||
155371828|NCT00379288|560795614|FG002|Overall Study|Lost to Follow-up|2|||
155371829|NCT00379288|560795615|FG003|Overall Study|Lost to Follow-up|0|||
155371830|NCT00379288|560795612|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
155371831|NCT00379288|560795613|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
155371832|NCT00379288|560795614|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
155371833|NCT00379288|560795615|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
155371834|NCT00379288|560795612|FG000|Overall Study|Subject withdrew-related to study drug|1|||
155371835|NCT00379288|560795613|FG001|Overall Study|Subject withdrew-related to study drug|0|||
155371836|NCT00379288|560795614|FG002|Overall Study|Subject withdrew-related to study drug|0|||
155371837|NCT00379288|560795615|FG003|Overall Study|Subject withdrew-related to study drug|1|||
155371838|NCT00379288|560795612|FG000|Overall Study|Noncompliance with protocol|8|||
155371839|NCT00379288|560795613|FG001|Overall Study|Noncompliance with protocol|6|||
155371840|NCT00379288|560795614|FG002|Overall Study|Noncompliance with protocol|2|||
155371841|NCT00379288|560795615|FG003|Overall Study|Noncompliance with protocol|1|||
155371842|NCT00379288|560795612|FG000|Overall Study|Did not meet protocol eligibility|0|||
155371843|NCT00379288|560795613|FG001|Overall Study|Did not meet protocol eligibility|1|||
155371844|NCT00379288|560795614|FG002|Overall Study|Did not meet protocol eligibility|0|||
155371845|NCT00379288|560795615|FG003|Overall Study|Did not meet protocol eligibility|2|||
155371846|NCT00379288|560795612|FG000|Overall Study|Administrative|2|||
155371847|NCT00379288|560795613|FG001|Overall Study|Administrative|2|||
155371848|NCT00379288|560795614|FG002|Overall Study|Administrative|0|||
155371849|NCT00379288|560795615|FG003|Overall Study|Administrative|1|||
155371850|NCT04396366|560795618|FG000|Overall Study|Adverse Event|1|||
155371851|NCT04396366|560795619|FG001|Overall Study|Adverse Event|0|||
155371852|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
155371853|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
155371854|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
155371855|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
155371856|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
155371857|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
155371858|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
155371859|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371860|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371861|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371862|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371863|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371864|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Death|1|||
155371865|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Death|2|||
155371866|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Death|2|||
155371867|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Death|0|||
155371868|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Death|0|||
155371869|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Death|0|||
155371870|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371871|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
155371872|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
155371873|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371874|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371875|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371876|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
155371877|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371878|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371879|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371880|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371881|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371882|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
155371883|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371884|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371885|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371886|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371887|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371888|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
155371889|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371890|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371891|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371892|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371893|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371894|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371895|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
155371896|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371897|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371898|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371899|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371900|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371901|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371902|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
155371903|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371904|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371905|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371906|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371907|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371908|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
155371909|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371910|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371911|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371912|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Site closure|0|||
155371913|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Site closure|0|||
155371914|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Site closure|1|||
155371915|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Site closure|0|||
155371916|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Site closure|0|||
155371917|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Site closure|0|||
155371918|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
155371919|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
155371920|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
155371921|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
155371922|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
155371923|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
155371924|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
155371925|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371926|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371927|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371928|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371929|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371930|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
155371931|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
155510793|NCT01829295|561295307|FG001|6-12 Months|Adverse Event|0|||
155649557|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155649558|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
155371932|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
155371933|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371934|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371935|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371936|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371937|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371938|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371939|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
155371940|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
155371941|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
155371942|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371943|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371944|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371945|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
155371946|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371947|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
155371948|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371949|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371950|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371951|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371952|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371953|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
155371954|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371955|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371956|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371957|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371958|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
155371959|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371960|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371961|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371962|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371963|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371964|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
155371965|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371966|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371967|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371968|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371969|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371970|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371971|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
155371972|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371973|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371974|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371975|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
155371976|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371977|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371978|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371979|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371980|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155430364|NCT02305563|561000658|FG002|Treatment Period|added ULO, then request to stop|0|||
155430365|NCT02305563|561000659|FG003|Treatment Period|added ULO, then request to stop|0|||
155430366|NCT02305563|561000660|FG004|Treatment Period|added ULO, then request to stop|1|||
155371981|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
155371982|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
155371983|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371984|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371985|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371986|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371987|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
155371988|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
155371989|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
155430367|NCT02305563|561000656|FG000|Follow-up Period|Death|0|||
155371990|NCT00128102|560795630|FG000|Overall Study|Site Discontinued|3|||
155371991|NCT00128102|560795631|FG001|Overall Study|Site Discontinued|6|||
155430368|NCT02305563|561000657|FG001|Follow-up Period|Death|0|||
155430369|NCT02305563|561000658|FG002|Follow-up Period|Death|5|||
155430370|NCT02305563|561000659|FG003|Follow-up Period|Death|4|||
155430371|NCT02305563|561000660|FG004|Follow-up Period|Death|7|||
155430372|NCT02305563|561000656|FG000|Follow-up Period|Participant withdrew consent|0|||
155430373|NCT02305563|561000657|FG001|Follow-up Period|Participant withdrew consent|0|||
155371992|NCT00128102|560795630|FG000|Overall Study|Other|0|||
155371993|NCT00128102|560795631|FG001|Overall Study|Other|1|||
155371994|NCT00128102|560795630|FG000|Overall Study|Progressive Disease|255|||
155371995|NCT00128102|560795631|FG001|Overall Study|Progressive Disease|285|||
155371996|NCT00128102|560795630|FG000|Overall Study|Adverse Event|34|||
155371997|NCT00128102|560795631|FG001|Overall Study|Adverse Event|11|||
155371998|NCT00128102|560795630|FG000|Overall Study|Death|12|||
155371999|NCT00128102|560795631|FG001|Overall Study|Death|13|||
155372000|NCT00128102|560795630|FG000|Overall Study|Physician Decision|3|||
155372001|NCT00128102|560795631|FG001|Overall Study|Physician Decision|3|||
155372002|NCT00128102|560795630|FG000|Overall Study|Withdrawal by Subject|19|||
155372003|NCT00128102|560795631|FG001|Overall Study|Withdrawal by Subject|11|||
155372004|NCT00128102|560795630|FG000|Overall Study|Protocol Violation|2|||
155372005|NCT00128102|560795631|FG001|Overall Study|Protocol Violation|2|||
155372006|NCT01531673|560795632|FG000|Overall Study|Non-Compliance|0|||
155372007|NCT01531673|560795633|FG001|Overall Study|Non-Compliance|0|||
155372008|NCT01531673|560795634|FG002|Overall Study|Non-Compliance|0|||
155372009|NCT01531673|560795635|FG003|Overall Study|Non-Compliance|0|||
155372010|NCT01531673|560795636|FG004|Overall Study|Non-Compliance|0|||
155372011|NCT01531673|560795637|FG005|Overall Study|Non-Compliance|1|||
155372012|NCT01531673|560795638|FG006|Overall Study|Non-Compliance|0|||
155372013|NCT01531673|560795639|FG007|Overall Study|Non-Compliance|0|||
155372014|NCT01531673|560795640|FG008|Overall Study|Non-Compliance|0|||
155372015|NCT01531673|560795641|FG009|Overall Study|Non-Compliance|0|||
155372016|NCT01531673|560795642|FG010|Overall Study|Non-Compliance|0|||
155372017|NCT01531673|560795643|FG011|Overall Study|Non-Compliance|0|||
155372018|NCT01531673|560795644|FG012|Overall Study|Non-Compliance|0|||
155372019|NCT01531673|560795632|FG000|Overall Study|Adverse Event|0|||
155372020|NCT01531673|560795633|FG001|Overall Study|Adverse Event|1|||
155372021|NCT01531673|560795634|FG002|Overall Study|Adverse Event|0|||
155372022|NCT01531673|560795635|FG003|Overall Study|Adverse Event|0|||
155372023|NCT01531673|560795636|FG004|Overall Study|Adverse Event|0|||
155372024|NCT01531673|560795637|FG005|Overall Study|Adverse Event|0|||
155372025|NCT01531673|560795638|FG006|Overall Study|Adverse Event|0|||
155372026|NCT01531673|560795639|FG007|Overall Study|Adverse Event|0|||
155372027|NCT01531673|560795640|FG008|Overall Study|Adverse Event|0|||
155372028|NCT01531673|560795641|FG009|Overall Study|Adverse Event|0|||
155372029|NCT01531673|560795642|FG010|Overall Study|Adverse Event|0|||
155372030|NCT01531673|560795643|FG011|Overall Study|Adverse Event|0|||
155372031|NCT01531673|560795644|FG012|Overall Study|Adverse Event|0|||
155372032|NCT01531673|560795632|FG000|Overall Study|Lost to Follow-up|0|||
155372033|NCT01531673|560795633|FG001|Overall Study|Lost to Follow-up|0|||
155372034|NCT01531673|560795634|FG002|Overall Study|Lost to Follow-up|0|||
155372035|NCT01531673|560795635|FG003|Overall Study|Lost to Follow-up|0|||
155372036|NCT01531673|560795636|FG004|Overall Study|Lost to Follow-up|1|||
155430374|NCT02305563|561000658|FG002|Follow-up Period|Participant withdrew consent|2|||
155430375|NCT02305563|561000659|FG003|Follow-up Period|Participant withdrew consent|1|||
155430376|NCT02305563|561000660|FG004|Follow-up Period|Participant withdrew consent|0|||
155430377|NCT02305563|561000656|FG000|Follow-up Period|other reason|0|||
155430378|NCT02305563|561000657|FG001|Follow-up Period|other reason|0|||
155372037|NCT01531673|560795637|FG005|Overall Study|Lost to Follow-up|0|||
155372038|NCT01531673|560795638|FG006|Overall Study|Lost to Follow-up|0|||
155372039|NCT01531673|560795639|FG007|Overall Study|Lost to Follow-up|0|||
155372040|NCT01531673|560795640|FG008|Overall Study|Lost to Follow-up|0|||
155372041|NCT01531673|560795641|FG009|Overall Study|Lost to Follow-up|0|||
155372042|NCT01531673|560795642|FG010|Overall Study|Lost to Follow-up|0|||
155372043|NCT01531673|560795643|FG011|Overall Study|Lost to Follow-up|0|||
155372044|NCT01531673|560795644|FG012|Overall Study|Lost to Follow-up|0|||
155372045|NCT01531673|560795632|FG000|Overall Study|Other|0|||
155372046|NCT01531673|560795633|FG001|Overall Study|Other|0|||
155372047|NCT01531673|560795634|FG002|Overall Study|Other|0|||
155372048|NCT01531673|560795635|FG003|Overall Study|Other|1|||
155372049|NCT01531673|560795636|FG004|Overall Study|Other|0|||
155372050|NCT01531673|560795637|FG005|Overall Study|Other|0|||
155372051|NCT01531673|560795638|FG006|Overall Study|Other|0|||
155372052|NCT01531673|560795639|FG007|Overall Study|Other|0|||
155372053|NCT01531673|560795640|FG008|Overall Study|Other|0|||
155372054|NCT01531673|560795641|FG009|Overall Study|Other|1|||
155372055|NCT01531673|560795642|FG010|Overall Study|Other|0|||
155372056|NCT01531673|560795643|FG011|Overall Study|Other|0|||
155372057|NCT01531673|560795644|FG012|Overall Study|Other|0|||
155372058|NCT00568178|560795645|FG000|Double Blind Base Study|Adverse Event|0|||
155372059|NCT00568178|560795646|FG001|Double Blind Base Study|Adverse Event|2|||
155372060|NCT00568178|560795647|FG002|Double Blind Base Study|Adverse Event|1|||
155430379|NCT02305563|561000658|FG002|Follow-up Period|other reason|0|||
155372061|NCT00568178|560795648|FG003|Double Blind Base Study|Adverse Event|2|||
155372062|NCT00568178|560795649|FG004|Double Blind Base Study|Adverse Event|0|||
155372063|NCT00568178|560795650|FG005|Double Blind Base Study|Adverse Event|0|||
155372064|NCT00568178|560795645|FG000|Double Blind Base Study|Lost to Follow-up|1|||
155372065|NCT00568178|560795646|FG001|Double Blind Base Study|Lost to Follow-up|0|||
155372066|NCT00568178|560795647|FG002|Double Blind Base Study|Lost to Follow-up|0|||
155372067|NCT00568178|560795648|FG003|Double Blind Base Study|Lost to Follow-up|1|||
155372068|NCT00568178|560795649|FG004|Double Blind Base Study|Lost to Follow-up|0|||
155372069|NCT00568178|560795650|FG005|Double Blind Base Study|Lost to Follow-up|0|||
155372070|NCT00568178|560795645|FG000|Double Blind Base Study|Physician Decision|1|||
155372071|NCT00568178|560795646|FG001|Double Blind Base Study|Physician Decision|1|||
155372072|NCT00568178|560795647|FG002|Double Blind Base Study|Physician Decision|0|||
155372073|NCT00568178|560795648|FG003|Double Blind Base Study|Physician Decision|1|||
155372074|NCT00568178|560795649|FG004|Double Blind Base Study|Physician Decision|0|||
155372075|NCT00568178|560795650|FG005|Double Blind Base Study|Physician Decision|0|||
155372076|NCT00568178|560795645|FG000|Double Blind Base Study|Protocol Violation|3|||
155372077|NCT00568178|560795646|FG001|Double Blind Base Study|Protocol Violation|2|||
155372078|NCT00568178|560795647|FG002|Double Blind Base Study|Protocol Violation|0|||
155372079|NCT00568178|560795648|FG003|Double Blind Base Study|Protocol Violation|0|||
155372080|NCT00568178|560795649|FG004|Double Blind Base Study|Protocol Violation|0|||
155372081|NCT00568178|560795650|FG005|Double Blind Base Study|Protocol Violation|0|||
155372082|NCT00568178|560795645|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
155372083|NCT00568178|560795646|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
155372084|NCT00568178|560795647|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
155372085|NCT00568178|560795648|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
155372086|NCT00568178|560795649|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
155372087|NCT00568178|560795650|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
155372088|NCT00568178|560795645|FG000|Double Blind Base Study|Progressive Disease|0|||
155372089|NCT00568178|560795646|FG001|Double Blind Base Study|Progressive Disease|0|||
155372090|NCT00568178|560795647|FG002|Double Blind Base Study|Progressive Disease|0|||
155372091|NCT00568178|560795648|FG003|Double Blind Base Study|Progressive Disease|1|||
155372092|NCT00568178|560795649|FG004|Double Blind Base Study|Progressive Disease|0|||
155372093|NCT00568178|560795650|FG005|Double Blind Base Study|Progressive Disease|0|||
155372094|NCT00568178|560795645|FG000|Open Label Extension|Adverse Event|0|||
155372095|NCT00568178|560795646|FG001|Open Label Extension|Adverse Event|0|||
155372096|NCT00568178|560795647|FG002|Open Label Extension|Adverse Event|0|||
155372097|NCT00568178|560795648|FG003|Open Label Extension|Adverse Event|0|||
155372098|NCT00568178|560795649|FG004|Open Label Extension|Adverse Event|11|||
155372099|NCT00568178|560795650|FG005|Open Label Extension|Adverse Event|8|||
155372100|NCT00568178|560795645|FG000|Open Label Extension|Protocol Violation|0|||
155372101|NCT00568178|560795646|FG001|Open Label Extension|Protocol Violation|0|||
155372102|NCT00568178|560795647|FG002|Open Label Extension|Protocol Violation|0|||
155372103|NCT00568178|560795648|FG003|Open Label Extension|Protocol Violation|0|||
155372104|NCT00568178|560795649|FG004|Open Label Extension|Protocol Violation|1|||
155372105|NCT00568178|560795650|FG005|Open Label Extension|Protocol Violation|0|||
155372106|NCT00568178|560795645|FG000|Open Label Extension|Lost to Follow-up|0|||
155372107|NCT00568178|560795646|FG001|Open Label Extension|Lost to Follow-up|0|||
155372108|NCT00568178|560795647|FG002|Open Label Extension|Lost to Follow-up|0|||
155372109|NCT00568178|560795648|FG003|Open Label Extension|Lost to Follow-up|0|||
155372110|NCT00568178|560795649|FG004|Open Label Extension|Lost to Follow-up|6|||
155372111|NCT00568178|560795650|FG005|Open Label Extension|Lost to Follow-up|11|||
155372112|NCT00568178|560795645|FG000|Open Label Extension|Physician Decision|0|||
155372113|NCT00568178|560795646|FG001|Open Label Extension|Physician Decision|0|||
155372114|NCT00568178|560795647|FG002|Open Label Extension|Physician Decision|0|||
155372115|NCT00568178|560795648|FG003|Open Label Extension|Physician Decision|0|||
155372116|NCT00568178|560795649|FG004|Open Label Extension|Physician Decision|9|||
155372117|NCT00568178|560795650|FG005|Open Label Extension|Physician Decision|8|||
155372118|NCT00568178|560795645|FG000|Open Label Extension|Pregnancy|0|||
155372119|NCT00568178|560795646|FG001|Open Label Extension|Pregnancy|0|||
155372120|NCT00568178|560795647|FG002|Open Label Extension|Pregnancy|0|||
155372121|NCT00568178|560795648|FG003|Open Label Extension|Pregnancy|0|||
155372122|NCT00568178|560795649|FG004|Open Label Extension|Pregnancy|0|||
155372123|NCT00568178|560795650|FG005|Open Label Extension|Pregnancy|1|||
155372124|NCT00568178|560795645|FG000|Open Label Extension|Progressive Disease|0|||
155372125|NCT00568178|560795646|FG001|Open Label Extension|Progressive Disease|0|||
155372126|NCT00568178|560795647|FG002|Open Label Extension|Progressive Disease|0|||
155372127|NCT00568178|560795648|FG003|Open Label Extension|Progressive Disease|0|||
155372128|NCT00568178|560795649|FG004|Open Label Extension|Progressive Disease|3|||
155372129|NCT00568178|560795650|FG005|Open Label Extension|Progressive Disease|1|||
155372130|NCT00568178|560795645|FG000|Open Label Extension|Termination of Trial|0|||
155372131|NCT00568178|560795646|FG001|Open Label Extension|Termination of Trial|0|||
155372132|NCT00568178|560795647|FG002|Open Label Extension|Termination of Trial|0|||
155372133|NCT00568178|560795648|FG003|Open Label Extension|Termination of Trial|0|||
155372134|NCT00568178|560795649|FG004|Open Label Extension|Termination of Trial|45|||
155372135|NCT00568178|560795650|FG005|Open Label Extension|Termination of Trial|47|||
155372136|NCT00568178|560795645|FG000|Open Label Extension|Withdrawal by Subject|0|||
155372137|NCT00568178|560795646|FG001|Open Label Extension|Withdrawal by Subject|0|||
155372138|NCT00568178|560795647|FG002|Open Label Extension|Withdrawal by Subject|0|||
155372139|NCT00568178|560795648|FG003|Open Label Extension|Withdrawal by Subject|0|||
155372140|NCT00568178|560795649|FG004|Open Label Extension|Withdrawal by Subject|4|||
155372141|NCT00568178|560795650|FG005|Open Label Extension|Withdrawal by Subject|4|||
155372142|NCT01332630|560795651|FG000|Overall Study|Withdrawal by Subject|3|||
155372143|NCT04476251|560795654|FG000|Overall Study|Not treated|1|||
155372144|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Physician Decision|2|||
155372145|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Physician Decision|0|||
155372146|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Physician Decision|0|||
155372147|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Adverse Event|33|||
155372148|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Adverse Event|0|||
155372149|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Adverse Event|0|||
155372150|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
155372151|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155372152|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155372153|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
155372154|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
155372155|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
155372156|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
155372157|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155372158|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155372159|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
155372160|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
155372161|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
155372162|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
155372163|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
155372164|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
155372165|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
155372166|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
155372167|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
155430380|NCT02305563|561000659|FG003|Follow-up Period|other reason|0|||
155430381|NCT02305563|561000660|FG004|Follow-up Period|other reason|1|||
155430382|NCT02305563|561000656|FG000|Follow-up Period|Followup no longer required per protocol|3|||
155430383|NCT02305563|561000657|FG001|Follow-up Period|Followup no longer required per protocol|3|||
155430384|NCT02305563|561000658|FG002|Follow-up Period|Followup no longer required per protocol|4|||
155430385|NCT02305563|561000659|FG003|Follow-up Period|Followup no longer required per protocol|1|||
155430386|NCT02305563|561000660|FG004|Follow-up Period|Followup no longer required per protocol|4|||
155430387|NCT01275222|561000666|FG000|Phase l by Treatment|Adverse Event|1|||
155430388|NCT01275222|561000667|FG001|Phase l by Treatment|Adverse Event|4|||
155430389|NCT01275222|561000668|FG002|Phase l by Treatment|Adverse Event|2|||
155430390|NCT01275222|561000669|FG003|Phase l by Treatment|Adverse Event|3|||
155430391|NCT01275222|561000670|FG004|Phase l by Treatment|Adverse Event|0|||
155430392|NCT01275222|561000671|FG005|Phase l by Treatment|Adverse Event|0|||
155430393|NCT01275222|561000666|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
155430394|NCT01275222|561000667|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
155430395|NCT01275222|561000668|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
155430396|NCT01275222|561000669|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
155430397|NCT01275222|561000670|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
155430398|NCT01275222|561000671|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
155430399|NCT01275222|561000666|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
155430400|NCT01275222|561000667|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
155430401|NCT01275222|561000668|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
155430402|NCT01275222|561000669|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
155430403|NCT01275222|561000670|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
155430404|NCT01275222|561000671|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
155430405|NCT01275222|561000666|FG000|Phase l by Treatment|Disease progression|12|||
155430406|NCT01275222|561000667|FG001|Phase l by Treatment|Disease progression|8|||
155430407|NCT01275222|561000668|FG002|Phase l by Treatment|Disease progression|2|||
155430408|NCT01275222|561000669|FG003|Phase l by Treatment|Disease progression|5|||
155430409|NCT01275222|561000670|FG004|Phase l by Treatment|Disease progression|0|||
155430410|NCT01275222|561000671|FG005|Phase l by Treatment|Disease progression|0|||
155430411|NCT01275222|561000666|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
155430412|NCT01275222|561000667|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
155430413|NCT01275222|561000668|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
155430414|NCT01275222|561000669|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
155510794|NCT01829295|561295308|FG002|6-12 Months|Adverse Event|3|||
155510795|NCT01829295|561295309|FG003|6-12 Months|Adverse Event|2|||
155372168|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
155372169|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155372170|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155372171|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
155372172|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
155372173|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
155372174|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155372175|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
155372176|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
155372177|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
155372178|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
155372179|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
155372180|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155372181|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155430415|NCT01275222|561000670|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
155430416|NCT01275222|561000671|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
155649559|NCT00407030|561808302|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
155430417|NCT01275222|561000666|FG000|Phase l by Treatment|Death|0|||
155430418|NCT01275222|561000667|FG001|Phase l by Treatment|Death|1|||
155430419|NCT01275222|561000668|FG002|Phase l by Treatment|Death|0|||
155430420|NCT01275222|561000669|FG003|Phase l by Treatment|Death|1|||
155430421|NCT01275222|561000670|FG004|Phase l by Treatment|Death|0|||
155430422|NCT01275222|561000671|FG005|Phase l by Treatment|Death|0|||
155430423|NCT01275222|561000666|FG000|Phase ll by Stratum|Adverse Event|0|||
155430424|NCT01275222|561000667|FG001|Phase ll by Stratum|Adverse Event|0|||
155430425|NCT01275222|561000668|FG002|Phase ll by Stratum|Adverse Event|0|||
155430426|NCT01275222|561000669|FG003|Phase ll by Stratum|Adverse Event|0|||
155430427|NCT01275222|561000670|FG004|Phase ll by Stratum|Adverse Event|2|||
155430428|NCT01275222|561000671|FG005|Phase ll by Stratum|Adverse Event|10|||
155430429|NCT01275222|561000666|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
155430430|NCT01275222|561000667|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
155430431|NCT01275222|561000668|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
155430432|NCT01275222|561000669|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
155430433|NCT01275222|561000670|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
155430434|NCT01275222|561000671|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
155430435|NCT01275222|561000666|FG000|Phase ll by Stratum|Disease progression|0|||
155430436|NCT01275222|561000667|FG001|Phase ll by Stratum|Disease progression|0|||
155430437|NCT01275222|561000668|FG002|Phase ll by Stratum|Disease progression|0|||
155430438|NCT01275222|561000669|FG003|Phase ll by Stratum|Disease progression|0|||
155430439|NCT01275222|561000670|FG004|Phase ll by Stratum|Disease progression|23|||
155430440|NCT01275222|561000671|FG005|Phase ll by Stratum|Disease progression|31|||
155430441|NCT01275222|561000666|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
155430442|NCT01275222|561000667|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
155430443|NCT01275222|561000668|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
155430444|NCT01275222|561000669|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
155430445|NCT01275222|561000670|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
155430446|NCT01275222|561000671|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
155430447|NCT01275222|561000666|FG000|Phase ll by Stratum|Death|0|||
155430448|NCT01275222|561000667|FG001|Phase ll by Stratum|Death|0|||
155430449|NCT01275222|561000668|FG002|Phase ll by Stratum|Death|0|||
155430450|NCT01275222|561000669|FG003|Phase ll by Stratum|Death|0|||
155430451|NCT01275222|561000670|FG004|Phase ll by Stratum|Death|1|||
155430452|NCT01275222|561000671|FG005|Phase ll by Stratum|Death|1|||
155430453|NCT01243268|561000673|FG000|Overall Study|Lost to Follow-up|4|||
155430454|NCT01243268|561000673|FG000|Overall Study|Protocol Violation|51|||
155430455|NCT01243268|561000673|FG000|Overall Study|Deviation with contract date|7|||
155430456|NCT01243268|561000673|FG000|Overall Study|Duplicate subject|2|||
155430457|NCT01822561|561000678|FG000|Overall Study|Withdrawal by Subject|2|||
155430458|NCT01444300|561000679|FG000|Overall Study|Adverse Event|4|||
155430459|NCT01444300|561000680|FG001|Overall Study|Adverse Event|0|||
155430460|NCT02722044|561000681|FG000|Overall Study|Adverse Event|2|||
155430461|NCT02722044|561000681|FG000|Overall Study|Physician Decision|1|||
155430462|NCT02722044|561000681|FG000|Overall Study|Withdrawal by Subject|1|||
155430463|NCT02722044|561000681|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
155430464|NCT00818259|561000685|FG000|Part I|Withdrawal by Subject|1|||
155430465|NCT00818259|561000686|FG001|Part I|Withdrawal by Subject|0|||
155430466|NCT00818259|561000687|FG002|Part I|Withdrawal by Subject|0|||
155430467|NCT00818259|561000688|FG003|Part I|Withdrawal by Subject|0|||
155649560|NCT00407030|561808303|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
155430468|NCT00818259|561000689|FG004|Part I|Withdrawal by Subject|0|||
155430469|NCT00818259|561000690|FG005|Part I|Withdrawal by Subject|0|||
155430470|NCT00818259|561000691|FG006|Part I|Withdrawal by Subject|0|||
155430471|NCT00818259|561000692|FG007|Part I|Withdrawal by Subject|0|||
155372182|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
155372183|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
155372184|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
155372185|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
155372186|NCT02591953|560795682|FG000|Overall Study|Lost to Follow-up|6|||
155372187|NCT02591953|560795683|FG001|Overall Study|Lost to Follow-up|6|||
155372188|NCT02060370|560795684|FG000|Overall Study|Physician Decision|1|||
155372189|NCT01896557|560795685|FG000|Clopidogrel Alone|Adverse Event|1|||
155372190|NCT01896557|560795686|FG001|Clopidogrel Alone|Adverse Event|0|||
155372191|NCT01896557|560795685|FG000|Clopidogrel + GI Protector|low adherence|1|||
155372192|NCT01896557|560795686|FG001|Clopidogrel + GI Protector|low adherence|1|||
155372193|NCT01896557|560795685|FG000|Clopidogrel + GI Protector|Reading error|1|||
155372194|NCT01896557|560795686|FG001|Clopidogrel + GI Protector|Reading error|3|||
155372195|NCT00731133|560795687|FG000|Overall Study|Withdrawal by Subject|10|||
155372196|NCT01517295|560795692|FG000|Overall Study|Physician Decision|1|||
155372197|NCT01517295|560795693|FG001|Overall Study|Physician Decision|0|||
155372198|NCT02672852|560795694|FG000|Part A1|Disease Worsening|1|||
155372199|NCT02672852|560795695|FG001|Part A1|Disease Worsening|0|||
155372200|NCT02672852|560795696|FG002|Part A1|Disease Worsening|0|||
155372201|NCT02672852|560795697|FG003|Part A1|Disease Worsening|0|||
155372202|NCT02672852|560795698|FG004|Part A1|Disease Worsening|0|||
155372203|NCT02672852|560795699|FG005|Part A1|Disease Worsening|0|||
155372204|NCT02672852|560795700|FG006|Part A1|Disease Worsening|0|||
155372205|NCT02672852|560795694|FG000|Part A1|Adverse Event|0|||
155372206|NCT02672852|560795695|FG001|Part A1|Adverse Event|1|||
155372207|NCT02672852|560795696|FG002|Part A1|Adverse Event|0|||
155372208|NCT02672852|560795697|FG003|Part A1|Adverse Event|0|||
155372209|NCT02672852|560795698|FG004|Part A1|Adverse Event|0|||
155372210|NCT02672852|560795699|FG005|Part A1|Adverse Event|0|||
155372211|NCT02672852|560795700|FG006|Part A1|Adverse Event|0|||
155372212|NCT02672852|560795694|FG000|Part A1|Lost to Follow-up|1|||
155372213|NCT02672852|560795695|FG001|Part A1|Lost to Follow-up|2|||
155372214|NCT02672852|560795696|FG002|Part A1|Lost to Follow-up|0|||
155372215|NCT02672852|560795697|FG003|Part A1|Lost to Follow-up|0|||
155372216|NCT02672852|560795698|FG004|Part A1|Lost to Follow-up|0|||
155372217|NCT02672852|560795699|FG005|Part A1|Lost to Follow-up|0|||
155372218|NCT02672852|560795700|FG006|Part A1|Lost to Follow-up|0|||
155372219|NCT02672852|560795694|FG000|Part A1|Withdrawal by Subject|1|||
155372220|NCT02672852|560795695|FG001|Part A1|Withdrawal by Subject|1|||
155372221|NCT02672852|560795696|FG002|Part A1|Withdrawal by Subject|0|||
155372222|NCT02672852|560795697|FG003|Part A1|Withdrawal by Subject|0|||
155372223|NCT02672852|560795698|FG004|Part A1|Withdrawal by Subject|0|||
155372224|NCT02672852|560795699|FG005|Part A1|Withdrawal by Subject|0|||
155372225|NCT02672852|560795700|FG006|Part A1|Withdrawal by Subject|0|||
155372226|NCT02672852|560795694|FG000|Part A2|Disease worsening|0|||
155372227|NCT02672852|560795695|FG001|Part A2|Disease worsening|0|||
155372228|NCT02672852|560795696|FG002|Part A2|Disease worsening|1|||
155372229|NCT02672852|560795697|FG003|Part A2|Disease worsening|0|||
155372230|NCT02672852|560795698|FG004|Part A2|Disease worsening|0|||
155372231|NCT02672852|560795699|FG005|Part A2|Disease worsening|0|||
155372232|NCT02672852|560795700|FG006|Part A2|Disease worsening|0|||
155372233|NCT02672852|560795694|FG000|Part A2|Adverse Event|0|||
155430472|NCT00818259|561000693|FG008|Part I|Withdrawal by Subject|0|||
155430473|NCT00818259|561000685|FG000|Part II|Physician Decision|0|||
155430474|NCT00818259|561000686|FG001|Part II|Physician Decision|0|||
155372234|NCT02672852|560795695|FG001|Part A2|Adverse Event|0|||
155372235|NCT02672852|560795696|FG002|Part A2|Adverse Event|3|||
155372236|NCT02672852|560795697|FG003|Part A2|Adverse Event|0|||
155372237|NCT02672852|560795698|FG004|Part A2|Adverse Event|0|||
155430475|NCT00818259|561000687|FG002|Part II|Physician Decision|1|||
155430476|NCT00818259|561000688|FG003|Part II|Physician Decision|0|||
155430477|NCT00818259|561000689|FG004|Part II|Physician Decision|0|||
155372238|NCT02672852|560795699|FG005|Part A2|Adverse Event|0|||
155372239|NCT02672852|560795700|FG006|Part A2|Adverse Event|0|||
155372240|NCT02672852|560795694|FG000|Part A2|Lost to Follow-up|0|||
155372241|NCT02672852|560795695|FG001|Part A2|Lost to Follow-up|0|||
155372242|NCT02672852|560795696|FG002|Part A2|Lost to Follow-up|2|||
155372243|NCT02672852|560795697|FG003|Part A2|Lost to Follow-up|0|||
155372244|NCT02672852|560795698|FG004|Part A2|Lost to Follow-up|0|||
155430478|NCT00818259|561000690|FG005|Part II|Physician Decision|0|||
155430479|NCT00818259|561000691|FG006|Part II|Physician Decision|0|||
155372245|NCT02672852|560795699|FG005|Part A2|Lost to Follow-up|0|||
155372246|NCT02672852|560795700|FG006|Part A2|Lost to Follow-up|0|||
155372247|NCT02672852|560795694|FG000|Part A2|Withdrawal by Subject|0|||
155372248|NCT02672852|560795695|FG001|Part A2|Withdrawal by Subject|0|||
155372249|NCT02672852|560795696|FG002|Part A2|Withdrawal by Subject|1|||
155372250|NCT02672852|560795697|FG003|Part A2|Withdrawal by Subject|0|||
155372251|NCT02672852|560795698|FG004|Part A2|Withdrawal by Subject|0|||
155372252|NCT02672852|560795699|FG005|Part A2|Withdrawal by Subject|0|||
155372253|NCT02672852|560795700|FG006|Part A2|Withdrawal by Subject|0|||
155372254|NCT02672852|560795694|FG000|Part A2|Other|0|||
155372255|NCT02672852|560795695|FG001|Part A2|Other|0|||
155372256|NCT02672852|560795696|FG002|Part A2|Other|3|||
155372257|NCT02672852|560795697|FG003|Part A2|Other|0|||
155372258|NCT02672852|560795698|FG004|Part A2|Other|0|||
155372259|NCT02672852|560795699|FG005|Part A2|Other|0|||
155372260|NCT02672852|560795700|FG006|Part A2|Other|0|||
155372261|NCT02672852|560795694|FG000|Part A2|Not entered in Part B|0|||
155372262|NCT02672852|560795695|FG001|Part A2|Not entered in Part B|0|||
155372263|NCT02672852|560795696|FG002|Part A2|Not entered in Part B|0|||
155372264|NCT02672852|560795697|FG003|Part A2|Not entered in Part B|4|||
155372265|NCT02672852|560795698|FG004|Part A2|Not entered in Part B|0|||
155372266|NCT02672852|560795699|FG005|Part A2|Not entered in Part B|0|||
155372267|NCT02672852|560795700|FG006|Part A2|Not entered in Part B|0|||
155372268|NCT02672852|560795694|FG000|Part B|Disease worsening|0|||
155372269|NCT02672852|560795695|FG001|Part B|Disease worsening|0|||
155372270|NCT02672852|560795696|FG002|Part B|Disease worsening|0|||
155372271|NCT02672852|560795697|FG003|Part B|Disease worsening|0|||
155372272|NCT02672852|560795698|FG004|Part B|Disease worsening|1|||
155372273|NCT02672852|560795699|FG005|Part B|Disease worsening|0|||
155372274|NCT02672852|560795700|FG006|Part B|Disease worsening|1|||
155372275|NCT02672852|560795694|FG000|Part B|Worsening pre-existing condition|0|||
155372276|NCT02672852|560795695|FG001|Part B|Worsening pre-existing condition|0|||
155372277|NCT02672852|560795696|FG002|Part B|Worsening pre-existing condition|0|||
155372278|NCT02672852|560795697|FG003|Part B|Worsening pre-existing condition|0|||
155372279|NCT02672852|560795698|FG004|Part B|Worsening pre-existing condition|0|||
155372280|NCT02672852|560795699|FG005|Part B|Worsening pre-existing condition|1|||
155372281|NCT02672852|560795700|FG006|Part B|Worsening pre-existing condition|0|||
155372282|NCT02672852|560795694|FG000|Part B|Other adverse event|0|||
155372283|NCT02672852|560795695|FG001|Part B|Other adverse event|0|||
155372284|NCT02672852|560795696|FG002|Part B|Other adverse event|0|||
155372285|NCT02672852|560795697|FG003|Part B|Other adverse event|0|||
155372286|NCT02672852|560795698|FG004|Part B|Other adverse event|3|||
155372287|NCT02672852|560795699|FG005|Part B|Other adverse event|5|||
155372288|NCT02672852|560795700|FG006|Part B|Other adverse event|1|||
155372289|NCT02672852|560795694|FG000|Part B|Lost to Follow-up|0|||
155372290|NCT02672852|560795695|FG001|Part B|Lost to Follow-up|0|||
155372291|NCT02672852|560795696|FG002|Part B|Lost to Follow-up|0|||
155372292|NCT02672852|560795697|FG003|Part B|Lost to Follow-up|0|||
155372293|NCT02672852|560795698|FG004|Part B|Lost to Follow-up|3|||
155372294|NCT02672852|560795699|FG005|Part B|Lost to Follow-up|4|||
155372295|NCT02672852|560795700|FG006|Part B|Lost to Follow-up|1|||
155372296|NCT02672852|560795694|FG000|Part B|Withdrawal by Subject|0|||
155372297|NCT02672852|560795695|FG001|Part B|Withdrawal by Subject|0|||
155372298|NCT02672852|560795696|FG002|Part B|Withdrawal by Subject|0|||
155372299|NCT02672852|560795697|FG003|Part B|Withdrawal by Subject|0|||
155372300|NCT02672852|560795698|FG004|Part B|Withdrawal by Subject|5|||
155372301|NCT02672852|560795699|FG005|Part B|Withdrawal by Subject|0|||
155372302|NCT02672852|560795700|FG006|Part B|Withdrawal by Subject|7|||
155372303|NCT02672852|560795694|FG000|Part B|Other|0|||
155372304|NCT02672852|560795695|FG001|Part B|Other|0|||
155372305|NCT02672852|560795696|FG002|Part B|Other|0|||
155372306|NCT02672852|560795697|FG003|Part B|Other|0|||
155372307|NCT02672852|560795698|FG004|Part B|Other|4|||
155649561|NCT00407030|561808304|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
155372308|NCT02672852|560795699|FG005|Part B|Other|1|||
155649562|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
155372309|NCT02672852|560795700|FG006|Part B|Other|2|||
155372310|NCT02182947|560795701|FG000|Overall Study|Withdrawal by Subject|7|||
155372311|NCT02182947|560795701|FG000|Overall Study|Lost to Follow-up|3|||
155372312|NCT02182947|560795701|FG000|Overall Study|Failed screening activities|8|||
155649563|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
155372313|NCT03248882|560795702|FG000|Overall Study|Adverse Event|3|||
155372314|NCT03248882|560795703|FG001|Overall Study|Adverse Event|3|||
155372315|NCT03248882|560795704|FG002|Overall Study|Adverse Event|2|||
155372316|NCT03248882|560795705|FG003|Overall Study|Adverse Event|6|||
155372317|NCT03248882|560795706|FG004|Overall Study|Adverse Event|9|||
155372318|NCT03248882|560795702|FG000|Overall Study|Lost to Follow-up|0|||
155372319|NCT03248882|560795703|FG001|Overall Study|Lost to Follow-up|0|||
155372320|NCT03248882|560795704|FG002|Overall Study|Lost to Follow-up|0|||
155372321|NCT03248882|560795705|FG003|Overall Study|Lost to Follow-up|0|||
155372322|NCT03248882|560795706|FG004|Overall Study|Lost to Follow-up|1|||
155372323|NCT03248882|560795702|FG000|Overall Study|Protocol Violation|2|||
155372324|NCT03248882|560795703|FG001|Overall Study|Protocol Violation|0|||
155372325|NCT03248882|560795704|FG002|Overall Study|Protocol Violation|2|||
155372326|NCT03248882|560795705|FG003|Overall Study|Protocol Violation|0|||
155372327|NCT03248882|560795706|FG004|Overall Study|Protocol Violation|1|||
155372328|NCT03248882|560795702|FG000|Overall Study|Withdrawal by Subject|2|||
155372329|NCT03248882|560795703|FG001|Overall Study|Withdrawal by Subject|2|||
155372330|NCT03248882|560795704|FG002|Overall Study|Withdrawal by Subject|3|||
155372331|NCT03248882|560795705|FG003|Overall Study|Withdrawal by Subject|4|||
155372332|NCT03248882|560795706|FG004|Overall Study|Withdrawal by Subject|2|||
155372333|NCT04308590|560795707|FG000|Overall Study|Adverse Event|12|||
155372334|NCT04308590|560795708|FG001|Overall Study|Adverse Event|2|||
155372335|NCT04308590|560795707|FG000|Overall Study|Withdrawal by Subject|10|||
155372336|NCT04308590|560795708|FG001|Overall Study|Withdrawal by Subject|4|||
155372337|NCT04308590|560795707|FG000|Overall Study|Death|1|||
155372338|NCT04308590|560795708|FG001|Overall Study|Death|0|||
155372339|NCT04308590|560795707|FG000|Overall Study|Lost to Follow-up|1|||
155372340|NCT04308590|560795708|FG001|Overall Study|Lost to Follow-up|1|||
155372341|NCT04308590|560795707|FG000|Overall Study|Physician Decision|1|||
155372342|NCT04308590|560795708|FG001|Overall Study|Physician Decision|0|||
155372343|NCT04308590|560795707|FG000|Overall Study|Subject does not want to continue with Pi|0|||
155372344|NCT04308590|560795708|FG001|Overall Study|Subject does not want to continue with Pi|1|||
155372345|NCT01156376|560795710|FG000|Overall Study|Adverse Event|1|||
155372346|NCT01156376|560795711|FG001|Overall Study|Adverse Event|0|||
155372347|NCT01156376|560795712|FG002|Overall Study|Adverse Event|1|||
155372348|NCT01156376|560795710|FG000|Overall Study|Withdrawal by Subject|0|||
155372349|NCT01156376|560795711|FG001|Overall Study|Withdrawal by Subject|0|||
155372350|NCT01156376|560795712|FG002|Overall Study|Withdrawal by Subject|3|||
155372351|NCT01493427|560795713|FG000|Overall Study|Adverse Event|10|||
155372352|NCT01493427|560795713|FG000|Overall Study|Personal Reasons|4|||
155372353|NCT01493427|560795713|FG000|Overall Study|Lost to Follow-up|2|||
155372354|NCT01493427|560795713|FG000|Overall Study|Inability to Follow Instructions|2|||
155372355|NCT01493427|560795713|FG000|Overall Study|Other|2|||
155372356|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
155372357|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
155372358|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
155372359|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
155372360|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
155372361|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
155372362|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
155372363|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
155372364|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
155372365|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Other|2|||
155372366|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Other|0|||
155372367|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Other|0|||
155372368|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
155372369|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
155372370|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
155372371|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
155372372|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
155372373|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
155372374|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
155372375|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
155372376|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
155372377|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
155372378|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
155372379|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
155372380|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
155372381|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
155430480|NCT00818259|561000692|FG007|Part II|Physician Decision|0|||
155430481|NCT00818259|561000693|FG008|Part II|Physician Decision|0|||
155372382|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
155372383|NCT02628028|560795720|FG000|Dosing Period|Withdrawal by Subject|0|||
155372384|NCT02628028|560795721|FG001|Dosing Period|Withdrawal by Subject|0|||
155372385|NCT02628028|560795722|FG002|Dosing Period|Withdrawal by Subject|1|||
155372386|NCT02628028|560795723|FG003|Dosing Period|Withdrawal by Subject|0|||
155372387|NCT02628028|560795724|FG004|Dosing Period|Withdrawal by Subject|2|||
155510796|NCT01829295|561295306|FG000|6-12 Months|Lost to Follow-up|2|||
155510797|NCT01829295|561295307|FG001|6-12 Months|Lost to Follow-up|0|||
155372388|NCT02628028|560795725|FG005|Dosing Period|Withdrawal by Subject|4|||
155372389|NCT02628028|560795726|FG006|Dosing Period|Withdrawal by Subject|1|||
155372390|NCT02628028|560795727|FG007|Dosing Period|Withdrawal by Subject|1|||
155372391|NCT02628028|560795720|FG000|Dosing Period|Adverse Event|0|||
155372392|NCT02628028|560795721|FG001|Dosing Period|Adverse Event|0|||
155372393|NCT02628028|560795722|FG002|Dosing Period|Adverse Event|0|||
155372394|NCT02628028|560795723|FG003|Dosing Period|Adverse Event|0|||
155372395|NCT02628028|560795724|FG004|Dosing Period|Adverse Event|2|||
155372396|NCT02628028|560795725|FG005|Dosing Period|Adverse Event|1|||
155372397|NCT02628028|560795726|FG006|Dosing Period|Adverse Event|3|||
155372398|NCT02628028|560795727|FG007|Dosing Period|Adverse Event|2|||
155372399|NCT02628028|560795720|FG000|Dosing Period|Death|0|||
155372400|NCT02628028|560795721|FG001|Dosing Period|Death|0|||
155372401|NCT02628028|560795722|FG002|Dosing Period|Death|0|||
155372402|NCT02628028|560795723|FG003|Dosing Period|Death|0|||
155372403|NCT02628028|560795724|FG004|Dosing Period|Death|0|||
155372404|NCT02628028|560795725|FG005|Dosing Period|Death|0|||
155372405|NCT02628028|560795726|FG006|Dosing Period|Death|0|||
155372406|NCT02628028|560795727|FG007|Dosing Period|Death|1|||
155372407|NCT02628028|560795720|FG000|Dosing Period|Lack of Efficacy|0|||
155372408|NCT02628028|560795721|FG001|Dosing Period|Lack of Efficacy|0|||
155372409|NCT02628028|560795722|FG002|Dosing Period|Lack of Efficacy|0|||
155372410|NCT02628028|560795723|FG003|Dosing Period|Lack of Efficacy|0|||
155372411|NCT02628028|560795724|FG004|Dosing Period|Lack of Efficacy|3|||
155372412|NCT02628028|560795725|FG005|Dosing Period|Lack of Efficacy|0|||
155372413|NCT02628028|560795726|FG006|Dosing Period|Lack of Efficacy|1|||
155372414|NCT02628028|560795727|FG007|Dosing Period|Lack of Efficacy|0|||
155372415|NCT02628028|560795720|FG000|Dosing Period|Study Terminated by Sponsor|0|||
155372416|NCT02628028|560795721|FG001|Dosing Period|Study Terminated by Sponsor|0|||
155372417|NCT02628028|560795722|FG002|Dosing Period|Study Terminated by Sponsor|0|||
155372418|NCT02628028|560795723|FG003|Dosing Period|Study Terminated by Sponsor|0|||
155372419|NCT02628028|560795724|FG004|Dosing Period|Study Terminated by Sponsor|7|||
155372420|NCT02628028|560795725|FG005|Dosing Period|Study Terminated by Sponsor|6|||
155372421|NCT02628028|560795726|FG006|Dosing Period|Study Terminated by Sponsor|7|||
155372422|NCT02628028|560795727|FG007|Dosing Period|Study Terminated by Sponsor|7|||
155430482|NCT00818259|561000685|FG000|Part II|Lack of Efficacy|0|||
155430483|NCT00818259|561000686|FG001|Part II|Lack of Efficacy|0|||
155430484|NCT00818259|561000687|FG002|Part II|Lack of Efficacy|0|||
155430485|NCT00818259|561000688|FG003|Part II|Lack of Efficacy|1|||
155430486|NCT00818259|561000689|FG004|Part II|Lack of Efficacy|0|||
155430487|NCT00818259|561000690|FG005|Part II|Lack of Efficacy|0|||
155430488|NCT00818259|561000691|FG006|Part II|Lack of Efficacy|0|||
155430489|NCT00818259|561000692|FG007|Part II|Lack of Efficacy|0|||
155430490|NCT00818259|561000693|FG008|Part II|Lack of Efficacy|0|||
155430491|NCT00818259|561000685|FG000|Part II|Not Treated|0|||
155430492|NCT00818259|561000686|FG001|Part II|Not Treated|0|||
155430493|NCT00818259|561000687|FG002|Part II|Not Treated|0|||
155430494|NCT00818259|561000688|FG003|Part II|Not Treated|1|||
155430495|NCT00818259|561000689|FG004|Part II|Not Treated|0|||
155430496|NCT00818259|561000690|FG005|Part II|Not Treated|0|||
155430497|NCT00818259|561000691|FG006|Part II|Not Treated|0|||
155430498|NCT00818259|561000692|FG007|Part II|Not Treated|0|||
155510798|NCT01829295|561295308|FG002|6-12 Months|Lost to Follow-up|0|||
155372423|NCT02628028|560795720|FG000|Dosing Period|Physician Decision|0|||
155372424|NCT02628028|560795721|FG001|Dosing Period|Physician Decision|0|||
155372425|NCT02628028|560795722|FG002|Dosing Period|Physician Decision|0|||
155372426|NCT02628028|560795723|FG003|Dosing Period|Physician Decision|0|||
155430499|NCT00818259|561000693|FG008|Part II|Not Treated|0|||
155430500|NCT00818259|561000685|FG000|Part IV|Physician Decision|0|||
155430501|NCT00818259|561000686|FG001|Part IV|Physician Decision|0|||
155649564|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
155372427|NCT02628028|560795724|FG004|Dosing Period|Physician Decision|0|||
155372428|NCT02628028|560795725|FG005|Dosing Period|Physician Decision|1|||
155372429|NCT02628028|560795726|FG006|Dosing Period|Physician Decision|0|||
155372430|NCT02628028|560795727|FG007|Dosing Period|Physician Decision|0|||
155372431|NCT02628028|560795720|FG000|Dosing Period|Site Terminated by Sponsor|0|||
155372432|NCT02628028|560795721|FG001|Dosing Period|Site Terminated by Sponsor|0|||
155430502|NCT00818259|561000687|FG002|Part IV|Physician Decision|0|||
155372433|NCT02628028|560795722|FG002|Dosing Period|Site Terminated by Sponsor|0|||
155372434|NCT02628028|560795723|FG003|Dosing Period|Site Terminated by Sponsor|0|||
155430503|NCT00818259|561000688|FG003|Part IV|Physician Decision|0|||
155430504|NCT00818259|561000689|FG004|Part IV|Physician Decision|0|||
155430505|NCT00818259|561000690|FG005|Part IV|Physician Decision|1|||
155372435|NCT02628028|560795724|FG004|Dosing Period|Site Terminated by Sponsor|0|||
155372436|NCT02628028|560795725|FG005|Dosing Period|Site Terminated by Sponsor|1|||
155372437|NCT02628028|560795726|FG006|Dosing Period|Site Terminated by Sponsor|1|||
155372438|NCT02628028|560795727|FG007|Dosing Period|Site Terminated by Sponsor|0|||
155372439|NCT02628028|560795720|FG000|Dosing Period|Lost to Follow-up|0|||
155372440|NCT02628028|560795721|FG001|Dosing Period|Lost to Follow-up|0|||
155372441|NCT02628028|560795722|FG002|Dosing Period|Lost to Follow-up|0|||
155372442|NCT02628028|560795723|FG003|Dosing Period|Lost to Follow-up|0|||
155430506|NCT00818259|561000691|FG006|Part IV|Physician Decision|0|||
155430507|NCT00818259|561000692|FG007|Part IV|Physician Decision|0|||
155430508|NCT00818259|561000693|FG008|Part IV|Physician Decision|0|||
155430509|NCT00818259|561000685|FG000|Part V|Adverse Event|0|||
155430510|NCT00818259|561000686|FG001|Part V|Adverse Event|0|||
155430511|NCT00818259|561000687|FG002|Part V|Adverse Event|0|||
155430512|NCT00818259|561000688|FG003|Part V|Adverse Event|0|||
155430513|NCT00818259|561000689|FG004|Part V|Adverse Event|0|||
155649565|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
155372443|NCT02628028|560795724|FG004|Dosing Period|Lost to Follow-up|0|||
155372444|NCT02628028|560795725|FG005|Dosing Period|Lost to Follow-up|0|||
155372445|NCT02628028|560795726|FG006|Dosing Period|Lost to Follow-up|1|||
155430514|NCT00818259|561000690|FG005|Part V|Adverse Event|0|||
155372446|NCT02628028|560795727|FG007|Dosing Period|Lost to Follow-up|0|||
155372447|NCT02628028|560795720|FG000|Dosing Period|Other|0|||
155430515|NCT00818259|561000691|FG006|Part V|Adverse Event|0|||
155430516|NCT00818259|561000692|FG007|Part V|Adverse Event|1|||
155510799|NCT01829295|561295309|FG003|6-12 Months|Lost to Follow-up|0|||
155510800|NCT01829295|561295306|FG000|6-12 Months|Withdrawal by Subject|2|||
155372448|NCT02628028|560795721|FG001|Dosing Period|Other|0|||
155372449|NCT02628028|560795722|FG002|Dosing Period|Other|0|||
155372450|NCT02628028|560795723|FG003|Dosing Period|Other|0|||
155372451|NCT02628028|560795724|FG004|Dosing Period|Other|2|||
155372452|NCT02628028|560795725|FG005|Dosing Period|Other|1|||
155372453|NCT02628028|560795726|FG006|Dosing Period|Other|2|||
155372454|NCT02628028|560795727|FG007|Dosing Period|Other|4|||
155372455|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
155372456|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
155372457|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
155372458|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
155372459|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
155372460|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
155372461|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
155372462|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
155372463|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372464|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372465|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372466|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372467|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372468|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
155372469|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372470|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
155372471|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372472|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372473|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372474|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372475|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372476|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
155372477|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
155372478|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
155372479|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372480|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372481|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372482|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372483|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372484|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
155372485|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
155372486|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
155372487|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Other|0|||
155372488|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Other|0|||
155372489|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Other|0|||
155372490|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Other|0|||
155372491|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Other|0|||
155372492|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Other|3|||
155372493|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Other|4|||
155372494|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Other|3|||
155372495|NCT02738853|560795730|FG000|Enrollment|Inclusion/Exclusion not met|21|||
155372496|NCT02738853|560795730|FG000|Enrollment|Withdrawal by Subject|3|||
155372497|NCT02738853|560795730|FG000|Enrollment|Subject treated with commercially available device|6|||
155372498|NCT02738853|560795730|FG000|Enrollment|Study Enrollment Closed|3|||
155372499|NCT02738853|560795730|FG000|Procedure|Death|1|||
155372500|NCT02738853|560795730|FG000|1 Month|Death|2|||
155372501|NCT02738853|560795730|FG000|6 Month|Death|4|||
155372502|NCT02738853|560795730|FG000|6 Month|Withdrawal by Subject|2|||
155372503|NCT02738853|560795730|FG000|1 Year|Death|6|||
155372504|NCT02738853|560795730|FG000|1 Year|Withdrawal by Subject|1|||
155372505|NCT02738853|560795730|FG000|2 Year|Death|2|||
155372506|NCT02738853|560795730|FG000|2 Year|Lost to Follow-up|1|||
155372507|NCT02738853|560795730|FG000|3 Year|Death|2|||
155372508|NCT02738853|560795730|FG000|3 Year|Withdrawal by Subject|1|||
155372509|NCT02738853|560795730|FG000|4 Year|Death|9|||
155372510|NCT02738853|560795730|FG000|5 Year|Lost to Follow-up|4|||
155372511|NCT00653523|560795738|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
155372512|NCT00653523|560795738|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
155372513|NCT00653523|560795738|FG000|Overall Study|Adverse Event|7|||
155372514|NCT00653523|560795738|FG000|Overall Study|Withdrawal by Subject|6|||
155372515|NCT00653523|560795738|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
155510801|NCT01829295|561295307|FG001|6-12 Months|Withdrawal by Subject|2|||
155510802|NCT01829295|561295308|FG002|6-12 Months|Withdrawal by Subject|0|||
155372516|NCT00653523|560795738|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
155372517|NCT05543707|560795745|FG000|Overall Study|Study drug non-compliance/|5|||
155372518|NCT05543707|560795746|FG001|Overall Study|Study drug non-compliance/|0|||
155372519|NCT05543707|560795745|FG000|Overall Study|Withdrawal by Subject|1|||
155372520|NCT05543707|560795746|FG001|Overall Study|Withdrawal by Subject|1|||
155372521|NCT05543707|560795745|FG000|Overall Study|Adverse Event|1|||
155372522|NCT05543707|560795746|FG001|Overall Study|Adverse Event|0|||
155372523|NCT05543707|560795745|FG000|Overall Study|concurrent illness|0|||
155372524|NCT05543707|560795746|FG001|Overall Study|concurrent illness|1|||
155372525|NCT05543707|560795745|FG000|Overall Study|Pregnancy|1|||
155372526|NCT05543707|560795746|FG001|Overall Study|Pregnancy|1|||
155372527|NCT00186888|560795747|FG000|Overall Study|Toxicity|0|||
155372528|NCT00186888|560795748|FG001|Overall Study|Toxicity|1|||
155372529|NCT00186888|560795749|FG002|Overall Study|Toxicity|0|||
155372530|NCT00186888|560795747|FG000|Overall Study|Relapse or progression of disease|4|||
155372531|NCT00186888|560795748|FG001|Overall Study|Relapse or progression of disease|2|||
155372532|NCT00186888|560795749|FG002|Overall Study|Relapse or progression of disease|0|||
155372533|NCT05511038|560795750|FG000|Overall|Withdrawal by Subject|5|||
155372534|NCT05511038|560795751|FG001|Overall|Withdrawal by Subject|3|||
155372535|NCT05511038|560795750|FG000|Overall|Screen Failure|20|||
155372536|NCT05511038|560795751|FG001|Overall|Screen Failure|1|||
155372537|NCT05511038|560795750|FG000|Overall|Physician Decision|3|||
155372538|NCT05511038|560795751|FG001|Overall|Physician Decision|0|||
155372539|NCT05511038|560795750|FG000|Overall|Lost to Follow-up|3|||
155430517|NCT00818259|561000693|FG008|Part V|Adverse Event|0|||
155430518|NCT02970929|561000701|FG000|Overall Study|Adverse Event|18|||
155430519|NCT02970929|561000701|FG000|Overall Study|Lack of Efficacy|8|||
155430520|NCT02970929|561000701|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
155430521|NCT02970929|561000701|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
155430522|NCT02970929|561000701|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
155430523|NCT02970929|561000701|FG000|Overall Study|LOST TO FOLLOWUP|6|||
155430524|NCT02970929|561000701|FG000|Overall Study|MOVED OUT OF STATE|1|||
155430525|NCT02970929|561000701|FG000|Overall Study|Withdrawal by Subject|16|||
155430526|NCT02370121|561000706|FG000|Overall Study|Lost to Follow-up|1|||
155430527|NCT02370121|561000707|FG001|Overall Study|Lost to Follow-up|1|||
155430528|NCT01523873|561000714|FG000|Overall Study|Protocol Violation|422|||
155430529|NCT02654002|561000715|FG000|Overall Study|Adverse Event|0|||
155430530|NCT02654002|561000716|FG001|Overall Study|Adverse Event|0|||
155430531|NCT02654002|561000717|FG002|Overall Study|Adverse Event|0|||
155430532|NCT02654002|561000718|FG003|Overall Study|Adverse Event|0|||
155430533|NCT02654002|561000719|FG004|Overall Study|Adverse Event|0|||
155430534|NCT02654002|561000720|FG005|Overall Study|Adverse Event|0|||
155430535|NCT02654002|561000721|FG006|Overall Study|Adverse Event|1|||
155430536|NCT02654002|561000722|FG007|Overall Study|Adverse Event|0|||
155430537|NCT02654002|561000723|FG008|Overall Study|Adverse Event|0|||
155430538|NCT02654002|561000715|FG000|Overall Study|Withdrew Consent|0|||
155430539|NCT02654002|561000716|FG001|Overall Study|Withdrew Consent|0|||
155430540|NCT02654002|561000717|FG002|Overall Study|Withdrew Consent|0|||
155430541|NCT02654002|561000718|FG003|Overall Study|Withdrew Consent|0|||
155430542|NCT02654002|561000719|FG004|Overall Study|Withdrew Consent|0|||
155430543|NCT02654002|561000720|FG005|Overall Study|Withdrew Consent|1|||
155430544|NCT02654002|561000721|FG006|Overall Study|Withdrew Consent|0|||
155430545|NCT02654002|561000722|FG007|Overall Study|Withdrew Consent|1|||
155430546|NCT02654002|561000723|FG008|Overall Study|Withdrew Consent|0|||
155430547|NCT00275561|561000726|FG000|Overall Study|Withdrawal by Subject|0|||
155430548|NCT00275561|561000727|FG001|Overall Study|Withdrawal by Subject|1|||
155430549|NCT00275561|561000726|FG000|Overall Study|Travel|1|||
155430550|NCT00275561|561000727|FG001|Overall Study|Travel|1|||
155430551|NCT00275561|561000726|FG000|Overall Study|Scheduling|1|||
155430552|NCT00275561|561000727|FG001|Overall Study|Scheduling|2|||
155430553|NCT00275561|561000726|FG000|Overall Study|Family Issues|0|||
155430554|NCT00275561|561000727|FG001|Overall Study|Family Issues|2|||
155430555|NCT01769105|561000728|FG000|First Intervention|Protocol Violation|2|||
155430556|NCT01769105|561000729|FG001|First Intervention|Protocol Violation|2|||
155430557|NCT01769105|561000728|FG000|Cross-over|Lost to Follow-up|5|||
155430558|NCT01769105|561000729|FG001|Cross-over|Lost to Follow-up|0|||
155430559|NCT01392183|561000734|FG000|First Drug Administration|Adverse Event|3|||
155430560|NCT01392183|561000735|FG001|First Drug Administration|Adverse Event|2|||
155430561|NCT01392183|561000734|FG000|First Drug Administration|Death|1|||
155430562|NCT01392183|561000735|FG001|First Drug Administration|Death|0|||
155430563|NCT01392183|561000734|FG000|First Drug Administration|Withdrawal by Subject|10|||
155372540|NCT05511038|560795751|FG001|Overall|Lost to Follow-up|0|||
155430564|NCT01392183|561000735|FG001|First Drug Administration|Withdrawal by Subject|17|||
155430565|NCT00963807|561000738|FG000|Overall Study|Physician Decision|2|||
155430566|NCT00963807|561000738|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
155430567|NCT00963807|561000738|FG000|Overall Study|Disease progression|15|||
155430568|NCT00684177|561000741|FG000|Overall Study|Adverse Event|4|||
155430569|NCT00684177|561000742|FG001|Overall Study|Adverse Event|3|||
155372541|NCT05511038|560795750|FG000|Overall|Death|1|||
155372542|NCT05511038|560795751|FG001|Overall|Death|0|||
155372543|NCT05511038|560795750|FG000|Screening|Withdrawal by Subject|1|||
155372544|NCT05511038|560795751|FG001|Screening|Withdrawal by Subject|0|||
155372545|NCT05511038|560795750|FG000|Screening|Lost to Follow Up (1 participant)|1|||
155372546|NCT05511038|560795751|FG001|Screening|Lost to Follow Up (1 participant)|0|||
155372547|NCT05511038|560795750|FG000|Screening|Screen Failure|3|||
155372548|NCT05511038|560795751|FG001|Screening|Screen Failure|0|||
155372549|NCT05511038|560795750|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
155372550|NCT05511038|560795751|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
155372551|NCT05511038|560795750|FG000|Treatment|Withdrawal by Subject|5|||
155372552|NCT05511038|560795751|FG001|Treatment|Withdrawal by Subject|3|||
155372553|NCT05511038|560795750|FG000|Treatment|Physician Decision|4|||
155372554|NCT05511038|560795751|FG001|Treatment|Physician Decision|0|||
155372555|NCT05511038|560795750|FG000|Treatment|Lost to Follow-up|2|||
155372556|NCT05511038|560795751|FG001|Treatment|Lost to Follow-up|0|||
155372557|NCT05511038|560795750|FG000|Treatment|Death|1|||
155372558|NCT05511038|560795751|FG001|Treatment|Death|0|||
155372559|NCT05511038|560795750|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
155372560|NCT05511038|560795751|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
155372561|NCT05511038|560795750|FG000|Treatment|Refuse by subject|1|||
155372562|NCT05511038|560795751|FG001|Treatment|Refuse by subject|0|||
155372563|NCT05511038|560795750|FG000|Treatment|Subject did not go to the site for visit|1|||
155372564|NCT05511038|560795751|FG001|Treatment|Subject did not go to the site for visit|0|||
155372565|NCT02108964|560795752|FG000|Overall Study|Progressive disease|15|||
155372566|NCT02108964|560795753|FG001|Overall Study|Progressive disease|31|||
155372567|NCT02108964|560795754|FG002|Overall Study|Progressive disease|54|||
155372568|NCT02108964|560795755|FG003|Overall Study|Progressive disease|7|||
155372569|NCT02108964|560795756|FG004|Overall Study|Progressive disease|20|||
155372570|NCT02108964|560795757|FG005|Overall Study|Progressive disease|4|||
155372571|NCT02108964|560795758|FG006|Overall Study|Progressive disease|6|||
155372572|NCT02108964|560795759|FG007|Overall Study|Progressive disease|33|||
155372573|NCT02108964|560795752|FG000|Overall Study|Physician Decision|1|||
155372574|NCT02108964|560795753|FG001|Overall Study|Physician Decision|5|||
155372575|NCT02108964|560795754|FG002|Overall Study|Physician Decision|7|||
155372576|NCT02108964|560795755|FG003|Overall Study|Physician Decision|1|||
155372577|NCT02108964|560795756|FG004|Overall Study|Physician Decision|2|||
155372578|NCT02108964|560795757|FG005|Overall Study|Physician Decision|1|||
155372579|NCT02108964|560795758|FG006|Overall Study|Physician Decision|1|||
155372580|NCT02108964|560795759|FG007|Overall Study|Physician Decision|3|||
155372581|NCT02108964|560795752|FG000|Overall Study|Adverse Event|0|||
155372582|NCT02108964|560795753|FG001|Overall Study|Adverse Event|0|||
155372583|NCT02108964|560795754|FG002|Overall Study|Adverse Event|4|||
155372584|NCT02108964|560795755|FG003|Overall Study|Adverse Event|0|||
155372585|NCT02108964|560795756|FG004|Overall Study|Adverse Event|1|||
155372586|NCT02108964|560795757|FG005|Overall Study|Adverse Event|0|||
155372587|NCT02108964|560795758|FG006|Overall Study|Adverse Event|3|||
155372588|NCT02108964|560795759|FG007|Overall Study|Adverse Event|2|||
155372589|NCT02108964|560795752|FG000|Overall Study|Death|1|||
155372590|NCT02108964|560795753|FG001|Overall Study|Death|1|||
155372591|NCT02108964|560795754|FG002|Overall Study|Death|4|||
155372592|NCT02108964|560795755|FG003|Overall Study|Death|0|||
155372593|NCT02108964|560795756|FG004|Overall Study|Death|3|||
155372594|NCT02108964|560795757|FG005|Overall Study|Death|0|||
155372595|NCT02108964|560795758|FG006|Overall Study|Death|0|||
155372596|NCT02108964|560795759|FG007|Overall Study|Death|2|||
155372597|NCT02108964|560795752|FG000|Overall Study|Subject/Guardian decision|0|||
155430570|NCT00684177|561000741|FG000|Overall Study|Lack of Efficacy|10|||
155430571|NCT00684177|561000742|FG001|Overall Study|Lack of Efficacy|15|||
155430572|NCT00684177|561000741|FG000|Overall Study|Protocol Violation|1|||
155430573|NCT00684177|561000742|FG001|Overall Study|Protocol Violation|0|||
155430574|NCT00684177|561000741|FG000|Overall Study|Lost to Follow-up|2|||
155372598|NCT02108964|560795753|FG001|Overall Study|Subject/Guardian decision|1|||
155372599|NCT02108964|560795754|FG002|Overall Study|Subject/Guardian decision|4|||
155372600|NCT02108964|560795755|FG003|Overall Study|Subject/Guardian decision|0|||
155372601|NCT02108964|560795756|FG004|Overall Study|Subject/Guardian decision|2|||
155372602|NCT02108964|560795757|FG005|Overall Study|Subject/Guardian decision|0|||
155372603|NCT02108964|560795758|FG006|Overall Study|Subject/Guardian decision|1|||
155372604|NCT02108964|560795759|FG007|Overall Study|Subject/Guardian decision|2|||
155372605|NCT02108964|560795752|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372606|NCT02108964|560795753|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372607|NCT02108964|560795754|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372608|NCT02108964|560795755|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372609|NCT02108964|560795756|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155430575|NCT00684177|561000742|FG001|Overall Study|Lost to Follow-up|1|||
155649566|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
155649567|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
155372610|NCT02108964|560795757|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372611|NCT02108964|560795758|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372612|NCT02108964|560795759|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
155372613|NCT03006848|560795760|FG000|Overall Study|Adverse Event|1|||
155372614|NCT03006848|560795760|FG000|Overall Study|Physician Decision|1|||
155372615|NCT03006848|560795760|FG000|Overall Study|Lack of Efficacy|16|||
155372616|NCT05543187|560795761|FG000|Overall Study|Ongoing|3|||
155372617|NCT05543187|560795762|FG001|Overall Study|Ongoing|2|||
155372618|NCT00384397|560795763|FG000|Overall Study|Adverse Event|0|||
155372619|NCT00384397|560795764|FG001|Overall Study|Adverse Event|1|||
155372620|NCT00384397|560795765|FG002|Overall Study|Adverse Event|2|||
155372621|NCT00384397|560795763|FG000|Overall Study|Protocol Violation|7|||
155372622|NCT00384397|560795764|FG001|Overall Study|Protocol Violation|15|||
155372623|NCT00384397|560795765|FG002|Overall Study|Protocol Violation|13|||
155372624|NCT00384397|560795763|FG000|Overall Study|Lost to Follow-up|11|||
155372625|NCT00384397|560795764|FG001|Overall Study|Lost to Follow-up|13|||
155372626|NCT00384397|560795765|FG002|Overall Study|Lost to Follow-up|3|||
155372627|NCT00384397|560795763|FG000|Overall Study|Withdrawal by Subject|14|||
155372628|NCT00384397|560795764|FG001|Overall Study|Withdrawal by Subject|17|||
155372629|NCT00384397|560795765|FG002|Overall Study|Withdrawal by Subject|15|||
155372630|NCT02336451|560795766|FG000|Overall Study|Adverse Event|1|||
155372631|NCT02336451|560795767|FG001|Overall Study|Adverse Event|2|||
155372632|NCT02336451|560795768|FG002|Overall Study|Adverse Event|0|||
155372633|NCT02336451|560795769|FG003|Overall Study|Adverse Event|6|||
155372634|NCT02336451|560795770|FG004|Overall Study|Adverse Event|4|||
155372635|NCT02336451|560795766|FG000|Overall Study|Death|6|||
155372636|NCT02336451|560795767|FG001|Overall Study|Death|2|||
155372637|NCT02336451|560795768|FG002|Overall Study|Death|3|||
155372638|NCT02336451|560795769|FG003|Overall Study|Death|6|||
155372639|NCT02336451|560795770|FG004|Overall Study|Death|6|||
155372640|NCT02336451|560795766|FG000|Overall Study|Physician Decision|9|||
155372641|NCT02336451|560795767|FG001|Overall Study|Physician Decision|6|||
155372642|NCT02336451|560795768|FG002|Overall Study|Physician Decision|7|||
155372643|NCT02336451|560795769|FG003|Overall Study|Physician Decision|16|||
155372644|NCT02336451|560795770|FG004|Overall Study|Physician Decision|3|||
155372645|NCT02336451|560795766|FG000|Overall Study|Progressive disease|23|||
155372646|NCT02336451|560795767|FG001|Overall Study|Progressive disease|26|||
155372647|NCT02336451|560795768|FG002|Overall Study|Progressive disease|2|||
155372648|NCT02336451|560795769|FG003|Overall Study|Progressive disease|14|||
155372649|NCT02336451|560795770|FG004|Overall Study|Progressive disease|4|||
155372650|NCT02336451|560795766|FG000|Overall Study|Protocol Violation|1|||
155372651|NCT02336451|560795767|FG001|Overall Study|Protocol Violation|0|||
155372652|NCT02336451|560795768|FG002|Overall Study|Protocol Violation|0|||
155372653|NCT02336451|560795769|FG003|Overall Study|Protocol Violation|0|||
155372654|NCT02336451|560795770|FG004|Overall Study|Protocol Violation|0|||
155372655|NCT02336451|560795766|FG000|Overall Study|Patient/guardian decision|2|||
155372656|NCT02336451|560795767|FG001|Overall Study|Patient/guardian decision|4|||
155372657|NCT02336451|560795768|FG002|Overall Study|Patient/guardian decision|0|||
155372658|NCT02336451|560795769|FG003|Overall Study|Patient/guardian decision|2|||
155372659|NCT02336451|560795770|FG004|Overall Study|Patient/guardian decision|1|||
155372660|NCT03520712|560795771|FG000|Overall Study|Early termination of the study by Sponsor|2|||
155372661|NCT04531982|560795774|FG000|Overall Study|Withdrawal by Subject|10|||
155372662|NCT04531982|560795775|FG001|Overall Study|Withdrawal by Subject|11|||
155372663|NCT04531982|560795774|FG000|Overall Study|Adverse Event|6|||
155372664|NCT04531982|560795775|FG001|Overall Study|Adverse Event|14|||
155372665|NCT04531982|560795774|FG000|Overall Study|Protocol Violation|6|||
155372666|NCT04531982|560795775|FG001|Overall Study|Protocol Violation|9|||
155372667|NCT04531982|560795774|FG000|Overall Study|Non-compliance with study drug|3|||
155372668|NCT04531982|560795775|FG001|Overall Study|Non-compliance with study drug|2|||
155372669|NCT04531982|560795774|FG000|Overall Study|Use of prohibited medication|2|||
155372670|NCT04531982|560795775|FG001|Overall Study|Use of prohibited medication|0|||
155372671|NCT04531982|560795774|FG000|Overall Study|Lost to Follow-up|0|||
155372672|NCT04531982|560795775|FG001|Overall Study|Lost to Follow-up|1|||
155372673|NCT04531982|560795774|FG000|Overall Study|Geopolitical conflict|2|||
155372674|NCT04531982|560795775|FG001|Overall Study|Geopolitical conflict|0|||
155372675|NCT04531982|560795774|FG000|Overall Study|Lack of Efficacy|3|||
155372676|NCT04531982|560795775|FG001|Overall Study|Lack of Efficacy|1|||
155372677|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
155372678|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
155372679|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
155372680|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
155372681|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
155510803|NCT01829295|561295309|FG003|6-12 Months|Withdrawal by Subject|0|||
155510804|NCT01855126|561295312|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
155510805|NCT01855126|561295313|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
155510806|NCT01855126|561295312|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
155510807|NCT01855126|561295313|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
155510808|NCT02230085|561295314|FG000|Overall Study|Physician Decision|1|||
155372682|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
155372683|NCT04998812|560795776|FG000|Vaccination Period|Ongoing in study|23|||
155372684|NCT04998812|560795777|FG001|Vaccination Period|Ongoing in study|23|||
155372685|NCT06748729|560795781|FG000|Overall Study|Withdrawal by Subject|1|||
155372686|NCT03578887|560795782|FG000|Overall Study|Withdrawal by Subject|7|||
155372687|NCT03578887|560795783|FG001|Overall Study|Withdrawal by Subject|2|||
155372688|NCT03578887|560795784|FG002|Overall Study|Withdrawal by Subject|1|||
155372689|NCT03578887|560795782|FG000|Overall Study|Lost to Follow-up|13|||
155372690|NCT03578887|560795783|FG001|Overall Study|Lost to Follow-up|1|||
155372691|NCT03578887|560795784|FG002|Overall Study|Lost to Follow-up|4|||
155372692|NCT03578887|560795782|FG000|Overall Study|Physician Decision|0|||
155372693|NCT03578887|560795783|FG001|Overall Study|Physician Decision|1|||
155372694|NCT03578887|560795784|FG002|Overall Study|Physician Decision|1|||
155372695|NCT01099215|560798430|FG000|Overall Study|Withdrawal by Subject|1|||
155372696|NCT01099215|560798431|FG001|Overall Study|Withdrawal by Subject|0|||
155372697|NCT01099215|560798430|FG000|Overall Study|Adverse Event|0|||
155372698|NCT01099215|560798431|FG001|Overall Study|Adverse Event|1|||
155372699|NCT03333876|560798435|FG000|Screening Period|Screen Failure|4|||
155372700|NCT03333876|560798435|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
155372701|NCT03333876|560798435|FG000|Mandibular Advancement|Adverse Event|2|||
155372702|NCT03333876|560798435|FG000|Mandibular Advancement|Product Damage|2|||
155372703|NCT00095498|560798437|FG000|Overall Study|Physician Decision|9|||
155372704|NCT00095498|560798438|FG001|Overall Study|Physician Decision|10|||
155372705|NCT00095498|560798439|FG002|Overall Study|Physician Decision|8|||
155372706|NCT00095498|560798437|FG000|Overall Study|Adverse Event|1|||
155372707|NCT00095498|560798438|FG001|Overall Study|Adverse Event|0|||
155372708|NCT00095498|560798439|FG002|Overall Study|Adverse Event|1|||
155372709|NCT00095498|560798437|FG000|Overall Study|Withdrawal by Subject|15|||
155372710|NCT00095498|560798438|FG001|Overall Study|Withdrawal by Subject|16|||
155372711|NCT00095498|560798439|FG002|Overall Study|Withdrawal by Subject|15|||
155372712|NCT00095498|560798437|FG000|Overall Study|Disease progression|0|||
155372713|NCT00095498|560798438|FG001|Overall Study|Disease progression|1|||
155372714|NCT00095498|560798439|FG002|Overall Study|Disease progression|1|||
155372715|NCT00095498|560798437|FG000|Overall Study|Ineligibility determined|3|||
155372716|NCT00095498|560798438|FG001|Overall Study|Ineligibility determined|0|||
155372717|NCT00095498|560798439|FG002|Overall Study|Ineligibility determined|2|||
155372718|NCT00095498|560798437|FG000|Overall Study|Lost to Follow-up|1|||
155372719|NCT00095498|560798438|FG001|Overall Study|Lost to Follow-up|1|||
155372720|NCT00095498|560798439|FG002|Overall Study|Lost to Follow-up|2|||
155372721|NCT00095498|560798437|FG000|Overall Study|Noncompliance|1|||
155372722|NCT00095498|560798438|FG001|Overall Study|Noncompliance|0|||
155372723|NCT00095498|560798439|FG002|Overall Study|Noncompliance|1|||
155372724|NCT00095498|560798437|FG000|Overall Study|Other|6|||
155372725|NCT00095498|560798438|FG001|Overall Study|Other|7|||
155372726|NCT00095498|560798439|FG002|Overall Study|Other|6|||
155372727|NCT00095498|560798437|FG000|Overall Study|Protocol Violation|0|||
155372728|NCT00095498|560798438|FG001|Overall Study|Protocol Violation|0|||
155372729|NCT00095498|560798439|FG002|Overall Study|Protocol Violation|1|||
155372730|NCT00095498|560798437|FG000|Overall Study|Requirement for alternative therapy|1|||
155372731|NCT00095498|560798438|FG001|Overall Study|Requirement for alternative therapy|0|||
155372732|NCT00095498|560798439|FG002|Overall Study|Requirement for alternative therapy|2|||
155372733|NCT05020327|560798441|FG000|Overall Study|Physician Decision|3|||
155372734|NCT05020327|560798442|FG001|Overall Study|Physician Decision|0|||
155372735|NCT05020327|560798443|FG002|Overall Study|Physician Decision|0|||
155372736|NCT05020327|560798441|FG000|Overall Study|Withdrawal by Subject|1|||
155372737|NCT05020327|560798442|FG001|Overall Study|Withdrawal by Subject|1|||
155372738|NCT05020327|560798443|FG002|Overall Study|Withdrawal by Subject|0|||
155510809|NCT02230085|561295314|FG000|Overall Study|Withdrawal by Subject|3|||
155372739|NCT05020327|560798441|FG000|Overall Study|personal/cultural, ineligible|12|||
155372740|NCT05020327|560798442|FG001|Overall Study|personal/cultural, ineligible|0|||
155372741|NCT05020327|560798443|FG002|Overall Study|personal/cultural, ineligible|0|||
155372742|NCT00166712|560798444|FG000|Overall Study|Death|0|||
155372743|NCT00166712|560798445|FG001|Overall Study|Death|1|||
155372744|NCT00166712|560798444|FG000|Overall Study|Adverse Event|1|||
155372745|NCT00166712|560798445|FG001|Overall Study|Adverse Event|0|||
155372746|NCT00166712|560798444|FG000|Overall Study|Withdrawal by Subject|1|||
155372747|NCT00166712|560798445|FG001|Overall Study|Withdrawal by Subject|2|||
155372748|NCT00166712|560798444|FG000|Overall Study|Physician Decision|0|||
155649568|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
155649569|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
155430576|NCT00684177|561000741|FG000|Overall Study|Physician Decision|2|||
155430577|NCT00684177|561000742|FG001|Overall Study|Physician Decision|0|||
155430578|NCT00684177|561000741|FG000|Overall Study|Withdrawal by Subject|1|||
155430579|NCT00684177|561000742|FG001|Overall Study|Withdrawal by Subject|2|||
155430580|NCT00684177|561000741|FG000|Overall Study|Other|1|||
155430581|NCT00684177|561000742|FG001|Overall Study|Other|2|||
155430582|NCT02224664|561002289|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
155430583|NCT02224664|561002290|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
155430584|NCT02224664|561002291|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
155430585|NCT02224664|561002292|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
155430586|NCT02224664|561002293|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
155430587|NCT02224664|561002289|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
155430588|NCT02224664|561002290|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
155430589|NCT02224664|561002291|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
155430590|NCT02224664|561002292|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
155430591|NCT02224664|561002293|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
155430592|NCT02224664|561002289|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
155430593|NCT02224664|561002290|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
155430594|NCT02224664|561002291|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
155430595|NCT02224664|561002292|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
155430596|NCT02224664|561002293|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
155430597|NCT01024244|561002297|FG000|Overall Study|Adverse Event|1|||
155430598|NCT01024244|561002298|FG001|Overall Study|Adverse Event|2|||
155430599|NCT01024244|561002299|FG002|Overall Study|Adverse Event|0|||
155430600|NCT01024244|561002300|FG003|Overall Study|Adverse Event|1|||
155430601|NCT01024244|561002301|FG004|Overall Study|Adverse Event|2|||
155430602|NCT01024244|561002297|FG000|Overall Study|Entry Criteria Not Met|0|||
155430603|NCT01024244|561002298|FG001|Overall Study|Entry Criteria Not Met|1|||
155430604|NCT01024244|561002299|FG002|Overall Study|Entry Criteria Not Met|0|||
155510810|NCT02173301|561295317|FG000|Overall Study|Adverse Event|7|||
155510811|NCT02173301|561295318|FG001|Overall Study|Adverse Event|8|||
155510812|NCT02173301|561295319|FG002|Overall Study|Adverse Event|13|||
155510813|NCT02173301|561295320|FG003|Overall Study|Adverse Event|5|||
155510814|NCT02173301|561295317|FG000|Overall Study|Withdrawal by Subject|8|||
155510815|NCT02173301|561295318|FG001|Overall Study|Withdrawal by Subject|10|||
155510816|NCT02173301|561295319|FG002|Overall Study|Withdrawal by Subject|4|||
155510817|NCT02173301|561295320|FG003|Overall Study|Withdrawal by Subject|8|||
155510818|NCT02173301|561295317|FG000|Overall Study|Lost to Follow-up|4|||
155510819|NCT02173301|561295318|FG001|Overall Study|Lost to Follow-up|4|||
155510820|NCT02173301|561295319|FG002|Overall Study|Lost to Follow-up|2|||
155510821|NCT02173301|561295320|FG003|Overall Study|Lost to Follow-up|2|||
155510822|NCT02173301|561295317|FG000|Overall Study|Protocol Violation|0|||
155510823|NCT02173301|561295318|FG001|Overall Study|Protocol Violation|1|||
155510824|NCT02173301|561295319|FG002|Overall Study|Protocol Violation|0|||
155510825|NCT02173301|561295320|FG003|Overall Study|Protocol Violation|0|||
155510826|NCT02173301|561295317|FG000|Overall Study|Physician Decision|0|||
155510827|NCT02173301|561295318|FG001|Overall Study|Physician Decision|0|||
155510828|NCT02173301|561295319|FG002|Overall Study|Physician Decision|1|||
155510829|NCT02173301|561295320|FG003|Overall Study|Physician Decision|0|||
155510830|NCT02173301|561295317|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
155510831|NCT02173301|561295318|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
155510832|NCT02173301|561295319|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
155510833|NCT02173301|561295320|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
155510834|NCT04345471|561295322|FG000|Overall Study|Adverse Event|8|||
155510835|NCT04345471|561295323|FG001|Overall Study|Adverse Event|5|||
155510836|NCT04345471|561295324|FG002|Overall Study|Adverse Event|6|||
155510837|NCT04345471|561295322|FG000|Overall Study|Lack of Efficacy|1|||
155510838|NCT04345471|561295323|FG001|Overall Study|Lack of Efficacy|1|||
155510839|NCT04345471|561295324|FG002|Overall Study|Lack of Efficacy|0|||
155510840|NCT04345471|561295322|FG000|Overall Study|Protocol Violation|0|||
155510841|NCT04345471|561295323|FG001|Overall Study|Protocol Violation|1|||
155510842|NCT04345471|561295324|FG002|Overall Study|Protocol Violation|2|||
155510843|NCT04345471|561295322|FG000|Overall Study|Withdrawal by Subject|10|||
155510844|NCT04345471|561295323|FG001|Overall Study|Withdrawal by Subject|5|||
155510845|NCT04345471|561295324|FG002|Overall Study|Withdrawal by Subject|10|||
155510846|NCT02378506|561295328|FG000|Overall Study|Lack of Efficacy|3|||
155510847|NCT02378506|561295328|FG000|Overall Study|Withdrawal by Subject|4|||
155510848|NCT02378506|561295328|FG000|Overall Study|Protocol Violation|2|||
155510849|NCT02378506|561295328|FG000|Overall Study|Death|1|||
155510850|NCT02378506|561295328|FG000|Overall Study|Adverse Event|14|||
155510851|NCT02378506|561295328|FG000|Overall Study|Randomized But Not Treated|1|||
155510852|NCT02123459|561295329|FG000|Washout Period (1 Day)|Adverse Event|1|||
155510853|NCT02123459|561295330|FG001|Washout Period (1 Day)|Adverse Event|0|||
155510854|NCT02196506|561295335|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
155510855|NCT02196506|561295336|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
155510856|NCT02196506|561295337|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
155510857|NCT02196506|561295338|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
155510858|NCT02196506|561295335|FG000|Phase A|Withdrawal by Subject|34|||
155510859|NCT02196506|561295336|FG001|Phase A|Withdrawal by Subject|0|||
155510860|NCT02196506|561295337|FG002|Phase A|Withdrawal by Subject|0|||
155510861|NCT02196506|561295338|FG003|Phase A|Withdrawal by Subject|0|||
155372749|NCT00166712|560798445|FG001|Overall Study|Physician Decision|2|||
155372750|NCT01302080|560798446|FG000|Overall Study|Withdrew Consent|92|||
155372751|NCT01302080|560798447|FG001|Overall Study|Withdrew Consent|39|||
155372752|NCT01302080|560798446|FG000|Overall Study|Patient/Family Moved|28|||
155372753|NCT01302080|560798447|FG001|Overall Study|Patient/Family Moved|3|||
155372754|NCT01302080|560798446|FG000|Overall Study|Lost to Follow-up|192|||
155510862|NCT02196506|561295335|FG000|Phase A|Adverse Event|22|||
155510863|NCT02196506|561295336|FG001|Phase A|Adverse Event|0|||
155510864|NCT02196506|561295337|FG002|Phase A|Adverse Event|0|||
155510865|NCT02196506|561295338|FG003|Phase A|Adverse Event|0|||
155510866|NCT02196506|561295335|FG000|Phase A|Lost to Follow-up|9|||
155510867|NCT02196506|561295336|FG001|Phase A|Lost to Follow-up|0|||
155510868|NCT02196506|561295337|FG002|Phase A|Lost to Follow-up|0|||
155510869|NCT02196506|561295338|FG003|Phase A|Lost to Follow-up|0|||
155510870|NCT02196506|561295335|FG000|Phase A|Protocol deviation|12|||
155510871|NCT02196506|561295336|FG001|Phase A|Protocol deviation|0|||
155510872|NCT02196506|561295337|FG002|Phase A|Protocol deviation|0|||
155510873|NCT02196506|561295338|FG003|Phase A|Protocol deviation|0|||
155510874|NCT02196506|561295335|FG000|Phase A|Participant withdrawn by investigator|10|||
155372755|NCT01302080|560798447|FG001|Overall Study|Lost to Follow-up|93|||
155510875|NCT02196506|561295336|FG001|Phase A|Participant withdrawn by investigator|0|||
155510876|NCT02196506|561295337|FG002|Phase A|Participant withdrawn by investigator|0|||
155510877|NCT02196506|561295338|FG003|Phase A|Participant withdrawn by investigator|0|||
155510878|NCT02196506|561295335|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
155372756|NCT01302080|560798446|FG000|Overall Study|Death|1|||
155372757|NCT01302080|560798447|FG001|Overall Study|Death|0|||
155372758|NCT01302080|560798446|FG000|Overall Study|Other|52|||
155649570|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
155649571|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
155372759|NCT01302080|560798447|FG001|Overall Study|Other|8|||
155510879|NCT02196506|561295336|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
155510880|NCT02196506|561295337|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
155510881|NCT02196506|561295338|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
155510882|NCT02196506|561295335|FG000|Phase B|Lack of Efficacy|0|||
155510883|NCT02196506|561295336|FG001|Phase B|Lack of Efficacy|1|||
155510884|NCT02196506|561295337|FG002|Phase B|Lack of Efficacy|2|||
155510885|NCT02196506|561295338|FG003|Phase B|Lack of Efficacy|0|||
155510886|NCT02196506|561295335|FG000|Phase B|Withdrawal by Participant|0|||
155510887|NCT02196506|561295336|FG001|Phase B|Withdrawal by Participant|8|||
155510888|NCT02196506|561295337|FG002|Phase B|Withdrawal by Participant|1|||
155510889|NCT02196506|561295338|FG003|Phase B|Withdrawal by Participant|0|||
155510890|NCT02196506|561295335|FG000|Phase B|Adverse Event|0|||
155510891|NCT02196506|561295336|FG001|Phase B|Adverse Event|4|||
155510892|NCT02196506|561295337|FG002|Phase B|Adverse Event|1|||
155510893|NCT02196506|561295338|FG003|Phase B|Adverse Event|0|||
155510894|NCT02196506|561295335|FG000|Phase B|Lost to Follow-up|0|||
155510895|NCT02196506|561295336|FG001|Phase B|Lost to Follow-up|2|||
155510896|NCT02196506|561295337|FG002|Phase B|Lost to Follow-up|1|||
155510897|NCT02196506|561295338|FG003|Phase B|Lost to Follow-up|0|||
155510898|NCT02196506|561295335|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
155510899|NCT02196506|561295336|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
155510900|NCT02196506|561295337|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
155372760|NCT01302080|560798446|FG000|Overall Study|Reason Missing For Discontinuation|1|||
155372761|NCT01302080|560798447|FG001|Overall Study|Reason Missing For Discontinuation|0|||
155372762|NCT00503139|560798450|FG000|Overall Study|Case Report Forms were not collected|4|||
155372763|NCT00503139|560798450|FG000|Overall Study|Protocol Violation|4|||
155372764|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372765|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372766|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
155372767|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
155372768|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372769|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372770|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
155372771|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
155372772|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
155372773|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
155372774|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372775|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372776|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
155372777|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
155372778|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
155372779|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
155372780|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
155430605|NCT01024244|561002300|FG003|Overall Study|Entry Criteria Not Met|0|||
155430606|NCT01024244|561002301|FG004|Overall Study|Entry Criteria Not Met|0|||
155430607|NCT01024244|561002297|FG000|Overall Study|Lack of Efficacy|1|||
155430608|NCT01024244|561002298|FG001|Overall Study|Lack of Efficacy|0|||
155430609|NCT01024244|561002299|FG002|Overall Study|Lack of Efficacy|0|||
155430610|NCT01024244|561002300|FG003|Overall Study|Lack of Efficacy|0|||
155430611|NCT01024244|561002301|FG004|Overall Study|Lack of Efficacy|0|||
155430612|NCT01024244|561002297|FG000|Overall Study|Protocol Violation|1|||
155430613|NCT01024244|561002298|FG001|Overall Study|Protocol Violation|0|||
155430614|NCT01024244|561002299|FG002|Overall Study|Protocol Violation|0|||
155430615|NCT01024244|561002300|FG003|Overall Study|Protocol Violation|0|||
155430616|NCT01024244|561002301|FG004|Overall Study|Protocol Violation|2|||
155430617|NCT01024244|561002297|FG000|Overall Study|Sponsor Decision|14|||
155510901|NCT02196506|561295338|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
155510902|NCT02196506|561295335|FG000|Phase A+|Withdrawal by Participant|0|||
155649572|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
155649573|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
155372781|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
155430618|NCT01024244|561002298|FG001|Overall Study|Sponsor Decision|7|||
155430619|NCT01024244|561002299|FG002|Overall Study|Sponsor Decision|14|||
155430620|NCT01024244|561002300|FG003|Overall Study|Sponsor Decision|12|||
155430621|NCT01024244|561002301|FG004|Overall Study|Sponsor Decision|10|||
155430622|NCT01024244|561002297|FG000|Overall Study|Withdrawal by Subject|0|||
155430623|NCT01024244|561002298|FG001|Overall Study|Withdrawal by Subject|1|||
155510903|NCT02196506|561295336|FG001|Phase A+|Withdrawal by Participant|0|||
155510904|NCT02196506|561295337|FG002|Phase A+|Withdrawal by Participant|0|||
155430624|NCT01024244|561002299|FG002|Overall Study|Withdrawal by Subject|0|||
155430625|NCT01024244|561002300|FG003|Overall Study|Withdrawal by Subject|0|||
155430626|NCT01024244|561002301|FG004|Overall Study|Withdrawal by Subject|0|||
155430627|NCT00265941|561002305|FG000|Overall Study|Protocol Violation|22|||
155430628|NCT00265941|561002306|FG001|Overall Study|Protocol Violation|25|||
155430629|NCT00265941|561002305|FG000|Overall Study|Lost to Follow-up|1|||
155430630|NCT00265941|561002306|FG001|Overall Study|Lost to Follow-up|1|||
155430631|NCT03976401|561002311|FG000|Overall Study|Adverse Event|2|||
155430632|NCT03976401|561002312|FG001|Overall Study|Adverse Event|0|||
155430633|NCT03976401|561002313|FG002|Overall Study|Adverse Event|4|||
155430634|NCT03976401|561002314|FG003|Overall Study|Adverse Event|1|||
155430635|NCT03976401|561002315|FG004|Overall Study|Adverse Event|1|||
155430636|NCT03976401|561002316|FG005|Overall Study|Adverse Event|0|||
155430637|NCT03976401|561002311|FG000|Overall Study|Withdrawal by Subject|0|||
155430638|NCT03976401|561002312|FG001|Overall Study|Withdrawal by Subject|1|||
155510905|NCT02196506|561295338|FG003|Phase A+|Withdrawal by Participant|5|||
155510906|NCT02196506|561295335|FG000|Phase A+|Adverse Event|0|||
155510907|NCT02196506|561295336|FG001|Phase A+|Adverse Event|0|||
155510908|NCT02196506|561295337|FG002|Phase A+|Adverse Event|0|||
155510909|NCT02196506|561295338|FG003|Phase A+|Adverse Event|1|||
155510910|NCT02196506|561295335|FG000|Phase A+|Lost to Follow-up|0|||
155510911|NCT02196506|561295336|FG001|Phase A+|Lost to Follow-up|0|||
155510912|NCT02196506|561295337|FG002|Phase A+|Lost to Follow-up|0|||
155510913|NCT02196506|561295338|FG003|Phase A+|Lost to Follow-up|6|||
155510914|NCT02196506|561295335|FG000|Phase A+|Participant withdrawn by investigator|0|||
155510915|NCT02196506|561295336|FG001|Phase A+|Participant withdrawn by investigator|0|||
155510916|NCT02196506|561295337|FG002|Phase A+|Participant withdrawn by investigator|0|||
155510917|NCT02196506|561295338|FG003|Phase A+|Participant withdrawn by investigator|1|||
155510918|NCT01606137|561295339|FG000|Overall Study|Adverse Event|85|||
155510919|NCT01606137|561295339|FG000|Overall Study|Withdrawal by Subject|74|||
155510920|NCT01606137|561295339|FG000|Overall Study|Lack of Efficacy|56|||
155510921|NCT01606137|561295339|FG000|Overall Study|Lost to Follow-up|15|||
155510922|NCT01606137|561295339|FG000|Overall Study|Protocol Violation|1|||
155510923|NCT01606137|561295339|FG000|Overall Study|Patient non-compliance|9|||
155510924|NCT01606137|561295339|FG000|Overall Study|Death|1|||
155510925|NCT01606137|561295339|FG000|Overall Study|Decreased/no pain|4|||
155510926|NCT01606137|561295339|FG000|Overall Study|Issues with driving|4|||
155510927|NCT01606137|561295339|FG000|Overall Study|multiple sclerosis less stable|1|||
155510928|NCT01606137|561295339|FG000|Overall Study|Increased bilirubin|1|||
155510929|NCT01606137|561295339|FG000|Overall Study|Spray causes nausea|1|||
155510930|NCT01606137|561295339|FG000|Overall Study|Not enough improvement|4|||
155510931|NCT01606137|561295339|FG000|Overall Study|Wanted to try another treatment|1|||
155510932|NCT01606137|561295339|FG000|Overall Study|Patient leaving country|1|||
155510933|NCT01606137|561295339|FG000|Overall Study|Personal reasons|1|||
155510934|NCT01606137|561295339|FG000|Overall Study|Unable to tolerate study med. taste|1|||
155510935|NCT01606137|561295339|FG000|Overall Study|Patient moving|1|||
155510936|NCT01606137|561295339|FG000|Overall Study|Unable to collect consistent data|1|||
155510937|NCT00254397|561295340|FG000|Overall Study|Disease Progression|4|||
155510938|NCT00254397|561295341|FG001|Overall Study|Disease Progression|1|||
155430639|NCT03976401|561002313|FG002|Overall Study|Withdrawal by Subject|0|||
155510939|NCT00254397|561295342|FG002|Overall Study|Disease Progression|16|||
155510940|NCT00254397|561295343|FG003|Overall Study|Disease Progression|23|||
155510941|NCT00254397|561295340|FG000|Overall Study|Non-Compliant|0|||
155510942|NCT00254397|561295341|FG001|Overall Study|Non-Compliant|0|||
155510943|NCT00254397|561295342|FG002|Overall Study|Non-Compliant|0|||
155510944|NCT00254397|561295343|FG003|Overall Study|Non-Compliant|1|||
155510945|NCT00254397|561295340|FG000|Overall Study|Adverse Event|2|||
155510946|NCT00254397|561295341|FG001|Overall Study|Adverse Event|0|||
155510947|NCT00254397|561295342|FG002|Overall Study|Adverse Event|3|||
155510948|NCT00254397|561295343|FG003|Overall Study|Adverse Event|1|||
155510949|NCT01070394|561295344|FG000|Overall Study|Adverse Event|6|||
155430640|NCT03976401|561002314|FG003|Overall Study|Withdrawal by Subject|0|||
155430641|NCT03976401|561002315|FG004|Overall Study|Withdrawal by Subject|0|||
155430642|NCT03976401|561002316|FG005|Overall Study|Withdrawal by Subject|1|||
155430643|NCT03976401|561002311|FG000|Overall Study|Physician Decision|0|||
155430644|NCT03976401|561002312|FG001|Overall Study|Physician Decision|0|||
155430645|NCT03976401|561002313|FG002|Overall Study|Physician Decision|1|||
155430646|NCT03976401|561002314|FG003|Overall Study|Physician Decision|0|||
155510950|NCT01070394|561295344|FG000|Overall Study|Withdrawal by Subject|1|||
155510951|NCT01015612|561295349|FG000|Overall Study|Death|113|||
155510952|NCT01015612|561295349|FG000|Overall Study|Withdrawal by Subject|40|||
155510953|NCT00066807|561295350|FG000|Overall Study|Study was terminated early|14|||
155510954|NCT00066807|561295351|FG001|Overall Study|Study was terminated early|15|||
155510955|NCT05028751|561295352|FG000|Overall Study|Study Terminated by Sponsor|3|||
155510956|NCT05028751|561295353|FG001|Overall Study|Study Terminated by Sponsor|0|||
155510957|NCT05028751|561295354|FG002|Overall Study|Study Terminated by Sponsor|0|||
155510958|NCT05028751|561295355|FG003|Overall Study|Study Terminated by Sponsor|0|||
155510959|NCT05028751|561295352|FG000|Overall Study|Death|9|||
155430647|NCT03976401|561002315|FG004|Overall Study|Physician Decision|0|||
155510960|NCT05028751|561295353|FG001|Overall Study|Death|3|||
155510961|NCT05028751|561295354|FG002|Overall Study|Death|2|||
155510962|NCT05028751|561295355|FG003|Overall Study|Death|4|||
155510963|NCT05028751|561295352|FG000|Overall Study|Withdrawal by Subject|0|||
155510964|NCT05028751|561295353|FG001|Overall Study|Withdrawal by Subject|0|||
155510965|NCT05028751|561295354|FG002|Overall Study|Withdrawal by Subject|1|||
155430648|NCT03976401|561002316|FG005|Overall Study|Physician Decision|0|||
155510966|NCT05028751|561295355|FG003|Overall Study|Withdrawal by Subject|0|||
155510967|NCT05028751|561295352|FG000|Overall Study|Miscellaneous|2|||
155510968|NCT05028751|561295353|FG001|Overall Study|Miscellaneous|0|||
155510969|NCT05028751|561295354|FG002|Overall Study|Miscellaneous|0|||
155510970|NCT05028751|561295355|FG003|Overall Study|Miscellaneous|0|||
155510971|NCT03586830|561295357|FG000|Overall Study|Site terminated by Sponsor|1|||
155510972|NCT03586830|561295358|FG001|Overall Study|Site terminated by Sponsor|4|||
155510973|NCT03586830|561295359|FG002|Overall Study|Site terminated by Sponsor|3|||
155510974|NCT03586830|561295360|FG003|Overall Study|Site terminated by Sponsor|3|||
155510975|NCT03586830|561295357|FG000|Overall Study|Lost to Follow-up|0|||
155510976|NCT03586830|561295358|FG001|Overall Study|Lost to Follow-up|2|||
155510977|NCT03586830|561295359|FG002|Overall Study|Lost to Follow-up|2|||
155510978|NCT03586830|561295360|FG003|Overall Study|Lost to Follow-up|1|||
155510979|NCT03586830|561295357|FG000|Overall Study|Withdrawal by Subject|1|||
155510980|NCT03586830|561295358|FG001|Overall Study|Withdrawal by Subject|0|||
155510981|NCT03586830|561295359|FG002|Overall Study|Withdrawal by Subject|3|||
155510982|NCT03586830|561295360|FG003|Overall Study|Withdrawal by Subject|1|||
155510983|NCT04578548|561295361|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155510984|NCT04578548|561295362|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155510985|NCT04578548|561295361|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
155430649|NCT03976401|561002311|FG000|Overall Study|Lost to Follow-up|1|||
155430650|NCT03976401|561002312|FG001|Overall Study|Lost to Follow-up|2|||
155430651|NCT03976401|561002313|FG002|Overall Study|Lost to Follow-up|0|||
155430652|NCT03976401|561002314|FG003|Overall Study|Lost to Follow-up|0|||
155430653|NCT03976401|561002315|FG004|Overall Study|Lost to Follow-up|0|||
155430654|NCT03976401|561002316|FG005|Overall Study|Lost to Follow-up|0|||
155430655|NCT03976401|561002311|FG000|Overall Study|Protocol Violation|0|||
155430656|NCT03976401|561002312|FG001|Overall Study|Protocol Violation|1|||
155430657|NCT03976401|561002313|FG002|Overall Study|Protocol Violation|0|||
155430658|NCT03976401|561002314|FG003|Overall Study|Protocol Violation|0|||
155430659|NCT03976401|561002315|FG004|Overall Study|Protocol Violation|0|||
155430660|NCT03976401|561002316|FG005|Overall Study|Protocol Violation|0|||
155430661|NCT03976401|561002311|FG000|Overall Study|Withdrew Consent|0|||
155430662|NCT03976401|561002312|FG001|Overall Study|Withdrew Consent|0|||
155430663|NCT03976401|561002313|FG002|Overall Study|Withdrew Consent|0|||
155430664|NCT03976401|561002314|FG003|Overall Study|Withdrew Consent|1|||
155430665|NCT03976401|561002315|FG004|Overall Study|Withdrew Consent|0|||
155430666|NCT03976401|561002316|FG005|Overall Study|Withdrew Consent|0|||
155430667|NCT02197377|561002321|FG000|Overall Study|Insertion Failure|0|||
155430668|NCT02197377|561002322|FG001|Overall Study|Insertion Failure|3|||
155430669|NCT00833092|561002324|FG000|Overall Study|Withdrawal by Subject|2|||
155430670|NCT00833092|561002325|FG001|Overall Study|Withdrawal by Subject|3|||
155430671|NCT00833092|561002324|FG000|Overall Study|Protocol Violation|2|||
155430672|NCT00833092|561002325|FG001|Overall Study|Protocol Violation|1|||
155430673|NCT00833092|561002324|FG000|Overall Study|Diarrhea|0|||
155430674|NCT00833092|561002325|FG001|Overall Study|Diarrhea|2|||
155430675|NCT00833092|561002324|FG000|Overall Study|constipation|0|||
155430676|NCT00833092|561002325|FG001|Overall Study|constipation|1|||
155430677|NCT02983604|561002326|FG000|Overall Study|Enrolled but not Treated|0|||
155430678|NCT02983604|561002327|FG001|Overall Study|Enrolled but not Treated|0|||
155430679|NCT02983604|561002328|FG002|Overall Study|Enrolled but not Treated|1|||
155430680|NCT02983604|561002329|FG003|Overall Study|Enrolled but not Treated|0|||
155430681|NCT00466505|561002330|FG000|Overall Study|disease progression|13|||
155430682|NCT00466505|561002330|FG000|Overall Study|Adverse Event|4|||
155510986|NCT04578548|561295362|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
155510987|NCT04578548|561295361|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
155510988|NCT04578548|561295362|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
155430683|NCT01241786|561002338|FG000|Overall Study|Lack of Efficacy|5|||
155430684|NCT03182738|561002339|FG000|Overall Study|Lost to Follow-up|9|||
155430685|NCT03182738|561002340|FG001|Overall Study|Lost to Follow-up|3|||
155430686|NCT03182738|561002339|FG000|Overall Study|Pregnancy|0|||
155430687|NCT03182738|561002340|FG001|Overall Study|Pregnancy|1|||
155430688|NCT03182738|561002339|FG000|Overall Study|Withdrawal by Subject|0|||
155430689|NCT03182738|561002340|FG001|Overall Study|Withdrawal by Subject|1|||
155430690|NCT02886715|561002341|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155430691|NCT02886715|561002342|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155430692|NCT02886715|561002343|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155430693|NCT02886715|561002341|FG000|Overall Study|Adverse Event|4|||
155510989|NCT04578548|561295361|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
155510990|NCT04578548|561295362|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
155372782|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
155510991|NCT04578548|561295361|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
155510992|NCT04578548|561295362|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
155510993|NCT04578548|561295361|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
155510994|NCT04578548|561295362|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
155510995|NCT00395083|561295365|FG000|Overall Study|Withdrawal by Subject|6|||
155510996|NCT00395083|561295366|FG001|Overall Study|Withdrawal by Subject|5|||
155510997|NCT00395083|561295365|FG000|Overall Study|Developed another disease|4|||
155510998|NCT00395083|561295366|FG001|Overall Study|Developed another disease|3|||
155510999|NCT00972153|561295367|FG000|Overall Study|Equipment malfunction during case|0|||
155511000|NCT00972153|561295368|FG001|Overall Study|Equipment malfunction during case|1|||
155511001|NCT00972153|561295369|FG002|Overall Study|Equipment malfunction during case|0|||
155511002|NCT01077713|561295374|FG000|Overall Study|Withdrawal by Subject|1|||
155511003|NCT01077713|561295375|FG001|Overall Study|Withdrawal by Subject|2|||
155511004|NCT01077713|561295374|FG000|Overall Study|Progressive Disease (PD)|0|||
155511005|NCT01077713|561295375|FG001|Overall Study|Progressive Disease (PD)|1|||
155511006|NCT01077713|561295374|FG000|Overall Study|Death|28|||
155511007|NCT01077713|561295375|FG001|Overall Study|Death|29|||
155511008|NCT01077713|561295374|FG000|Overall Study|Lost to Follow-up|1|||
155511009|NCT01077713|561295375|FG001|Overall Study|Lost to Follow-up|1|||
155511010|NCT01077713|561295374|FG000|Overall Study|Adverse Event|2|||
155511011|NCT01077713|561295375|FG001|Overall Study|Adverse Event|1|||
155511012|NCT01077713|561295374|FG000|Overall Study|Other|4|||
155511013|NCT01077713|561295375|FG001|Overall Study|Other|2|||
155511014|NCT04136626|561295376|FG000|Treatment Phase|Withdrawal by Subject|1|||
155511015|NCT04136626|561295377|FG001|Treatment Phase|Withdrawal by Subject|9|||
155511016|NCT04136626|561295376|FG000|Treatment Phase|Adverse Event|1|||
155511017|NCT04136626|561295377|FG001|Treatment Phase|Adverse Event|0|||
155511018|NCT04136626|561295376|FG000|Treatment Phase|Lost to Follow-up|1|||
155511019|NCT04136626|561295377|FG001|Treatment Phase|Lost to Follow-up|5|||
155511020|NCT04136626|561295376|FG000|12-month Follow-up|Lost to Follow-up|8|||
155511021|NCT04136626|561295377|FG001|12-month Follow-up|Lost to Follow-up|7|||
155511022|NCT00628745|561295378|FG000|Overall Study|Withdrawal by Subject|63|||
155511023|NCT00628745|561295379|FG001|Overall Study|Withdrawal by Subject|3|||
155511024|NCT00628745|561295380|FG002|Overall Study|Withdrawal by Subject|9|||
155511025|NCT00628745|561295381|FG003|Overall Study|Withdrawal by Subject|2|||
155511026|NCT00628745|561295382|FG004|Overall Study|Withdrawal by Subject|69|||
155511027|NCT00628745|561295378|FG000|Overall Study|Does not meet inclusion criteria|0|||
155511028|NCT00628745|561295379|FG001|Overall Study|Does not meet inclusion criteria|12|||
155511029|NCT00628745|561295380|FG002|Overall Study|Does not meet inclusion criteria|0|||
155511030|NCT00628745|561295381|FG003|Overall Study|Does not meet inclusion criteria|0|||
155511031|NCT00628745|561295382|FG004|Overall Study|Does not meet inclusion criteria|18|||
155511032|NCT00628745|561295378|FG000|Overall Study|Participation in an interventional clinical trial|81|||
155511033|NCT00628745|561295379|FG001|Overall Study|Participation in an interventional clinical trial|4|||
155511034|NCT00628745|561295380|FG002|Overall Study|Participation in an interventional clinical trial|7|||
155511035|NCT00628745|561295381|FG003|Overall Study|Participation in an interventional clinical trial|0|||
155511036|NCT00628745|561295382|FG004|Overall Study|Participation in an interventional clinical trial|63|||
155511037|NCT00628745|561295378|FG000|Overall Study|Physician Decision|8|||
155511038|NCT00628745|561295379|FG001|Overall Study|Physician Decision|4|||
155511039|NCT00628745|561295380|FG002|Overall Study|Physician Decision|3|||
155511040|NCT00628745|561295381|FG003|Overall Study|Physician Decision|0|||
155511041|NCT00628745|561295382|FG004|Overall Study|Physician Decision|30|||
155511042|NCT00628745|561295378|FG000|Overall Study|Lost to Follow-up|109|||
155511043|NCT00628745|561295379|FG001|Overall Study|Lost to Follow-up|7|||
155511044|NCT00628745|561295380|FG002|Overall Study|Lost to Follow-up|7|||
155511045|NCT00628745|561295381|FG003|Overall Study|Lost to Follow-up|0|||
155511046|NCT00628745|561295382|FG004|Overall Study|Lost to Follow-up|498|||
155511047|NCT00628745|561295378|FG000|Overall Study|Death|197|||
155511048|NCT00628745|561295379|FG001|Overall Study|Death|81|||
155511049|NCT00628745|561295380|FG002|Overall Study|Death|12|||
155511050|NCT00628745|561295381|FG003|Overall Study|Death|4|||
155511051|NCT00628745|561295382|FG004|Overall Study|Death|939|||
155511052|NCT00628745|561295378|FG000|Overall Study|Participant transferred to another THAOS site|6|||
155511053|NCT00628745|561295379|FG001|Overall Study|Participant transferred to another THAOS site|0|||
155511054|NCT00628745|561295380|FG002|Overall Study|Participant transferred to another THAOS site|0|||
155372783|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
155372784|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
155372785|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
155372786|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
155511055|NCT00628745|561295381|FG003|Overall Study|Participant transferred to another THAOS site|0|||
155511056|NCT00628745|561295382|FG004|Overall Study|Participant transferred to another THAOS site|7|||
155511057|NCT00628745|561295378|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
155511058|NCT00628745|561295379|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
155372787|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
155372788|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
155372789|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372790|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
155372791|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372792|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372793|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372794|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
155372795|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
155372796|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
155372797|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
155372798|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
155372799|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
155372800|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372801|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372802|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372803|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372804|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
155372805|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
155372806|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372807|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372808|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372809|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372810|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
155372811|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
155372812|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
155372813|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
155372814|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
155372815|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
155372816|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
155372817|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
155372818|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372819|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372820|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372821|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372822|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
155372823|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
155372824|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372825|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372826|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372827|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372828|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
155372829|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
155372830|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
155372831|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
155372832|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
155372833|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
155372834|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
155372835|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
155372836|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372837|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372838|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372839|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372840|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372841|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
155372842|NCT02040259|560798460|FG000|Overall Study|Death|280|||
155372843|NCT02040259|560798460|FG000|Overall Study|Lost to Follow-up|76|||
155372844|NCT02040259|560798460|FG000|Overall Study|Assessment not completed|3|||
155372845|NCT02040259|560798460|FG000|Overall Study|Withdrawal by Subject|4|||
155511059|NCT00628745|561295380|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
155511060|NCT00628745|561295381|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
155511061|NCT00628745|561295382|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
155511062|NCT00628745|561295378|FG000|Overall Study|Site closure|152|||
155511063|NCT00628745|561295379|FG001|Overall Study|Site closure|146|||
155511064|NCT00628745|561295380|FG002|Overall Study|Site closure|6|||
155511065|NCT00628745|561295381|FG003|Overall Study|Site closure|8|||
155511066|NCT00628745|561295382|FG004|Overall Study|Site closure|691|||
155511067|NCT00628745|561295378|FG000|Overall Study|Duplicate participant|0|||
155511068|NCT00628745|561295379|FG001|Overall Study|Duplicate participant|0|||
155511069|NCT00628745|561295380|FG002|Overall Study|Duplicate participant|0|||
155511070|NCT00628745|561295381|FG003|Overall Study|Duplicate participant|0|||
155511071|NCT00628745|561295382|FG004|Overall Study|Duplicate participant|1|||
155511072|NCT00628745|561295378|FG000|Overall Study|Missing|4|||
155511073|NCT00628745|561295379|FG001|Overall Study|Missing|3|||
155372846|NCT00316602|560798461|FG000|Overall Study|Withdrawal by Subject|3|||
155372847|NCT00316602|560798462|FG001|Overall Study|Withdrawal by Subject|2|||
155372848|NCT00316602|560798461|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
155372849|NCT00316602|560798462|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
155372850|NCT00316602|560798461|FG000|Overall Study|Adverse Event|1|||
155372851|NCT00316602|560798462|FG001|Overall Study|Adverse Event|0|||
155372852|NCT00316602|560798461|FG000|Overall Study|Other|3|||
155372853|NCT00316602|560798462|FG001|Overall Study|Other|6|||
155372854|NCT01142232|560798463|FG000|Overall Study|Adverse Event|1|||
155372855|NCT01142232|560798464|FG001|Overall Study|Adverse Event|2|||
155372856|NCT01142232|560798465|FG002|Overall Study|Adverse Event|1|||
155372857|NCT01142232|560798466|FG003|Overall Study|Adverse Event|0|||
155372858|NCT01142232|560798467|FG004|Overall Study|Adverse Event|4|||
155372859|NCT01142232|560798463|FG000|Overall Study|Death|0|||
155372860|NCT01142232|560798464|FG001|Overall Study|Death|0|||
155372861|NCT01142232|560798465|FG002|Overall Study|Death|0|||
155372862|NCT01142232|560798466|FG003|Overall Study|Death|0|||
155372863|NCT01142232|560798467|FG004|Overall Study|Death|1|||
155372864|NCT01142232|560798463|FG000|Overall Study|Disease Progression|2|||
155372865|NCT01142232|560798464|FG001|Overall Study|Disease Progression|0|||
155372866|NCT01142232|560798465|FG002|Overall Study|Disease Progression|1|||
155372867|NCT01142232|560798466|FG003|Overall Study|Disease Progression|2|||
155372868|NCT01142232|560798467|FG004|Overall Study|Disease Progression|12|||
155372869|NCT01142232|560798463|FG000|Overall Study|Withdrawal by Subject|0|||
155372870|NCT01142232|560798464|FG001|Overall Study|Withdrawal by Subject|0|||
155430694|NCT02886715|561002342|FG001|Overall Study|Adverse Event|2|||
155430695|NCT02886715|561002343|FG002|Overall Study|Adverse Event|0|||
155430696|NCT02886715|561002341|FG000|Overall Study|Lack of Efficacy|0|||
155430697|NCT02886715|561002342|FG001|Overall Study|Lack of Efficacy|2|||
155430698|NCT02886715|561002343|FG002|Overall Study|Lack of Efficacy|1|||
155430699|NCT02886715|561002341|FG000|Overall Study|Lost to Follow-up|29|||
155430700|NCT02886715|561002342|FG001|Overall Study|Lost to Follow-up|26|||
155430701|NCT02886715|561002343|FG002|Overall Study|Lost to Follow-up|10|||
155430702|NCT02886715|561002341|FG000|Overall Study|Pregnancy|1|||
155430703|NCT02886715|561002342|FG001|Overall Study|Pregnancy|1|||
155430704|NCT02886715|561002343|FG002|Overall Study|Pregnancy|1|||
155430705|NCT02886715|561002341|FG000|Overall Study|Protocol Violation|3|||
155430706|NCT02886715|561002342|FG001|Overall Study|Protocol Violation|2|||
155430707|NCT02886715|561002343|FG002|Overall Study|Protocol Violation|1|||
155430708|NCT02886715|561002341|FG000|Overall Study|Withdrawal by Subject|20|||
155511074|NCT00628745|561295380|FG002|Overall Study|Missing|0|||
155511075|NCT00628745|561295381|FG003|Overall Study|Missing|0|||
155372871|NCT01142232|560798465|FG002|Overall Study|Withdrawal by Subject|0|||
155372872|NCT01142232|560798466|FG003|Overall Study|Withdrawal by Subject|1|||
155430709|NCT02886715|561002342|FG001|Overall Study|Withdrawal by Subject|18|||
155430710|NCT02886715|561002343|FG002|Overall Study|Withdrawal by Subject|5|||
155430711|NCT02886715|561002341|FG000|Overall Study|missing|7|||
155430712|NCT02886715|561002342|FG001|Overall Study|missing|2|||
155430713|NCT02886715|561002343|FG002|Overall Study|missing|2|||
155430714|NCT00503399|561002344|FG000|Overall Study|Death|2|||
155430715|NCT00503399|561002345|FG001|Overall Study|Death|1|||
155430716|NCT00503399|561002344|FG000|Overall Study|Protocol Violation|1|||
155372873|NCT01142232|560798467|FG004|Overall Study|Withdrawal by Subject|3|||
155372874|NCT01142232|560798463|FG000|Overall Study|Physician Decision|0|||
155372875|NCT01142232|560798464|FG001|Overall Study|Physician Decision|1|||
155372876|NCT01142232|560798465|FG002|Overall Study|Physician Decision|0|||
155372877|NCT01142232|560798466|FG003|Overall Study|Physician Decision|2|||
155372878|NCT01142232|560798467|FG004|Overall Study|Physician Decision|10|||
155372879|NCT01142232|560798463|FG000|Overall Study|Alternative Therapy|0|||
155430717|NCT00503399|561002345|FG001|Overall Study|Protocol Violation|0|||
155430718|NCT00503399|561002344|FG000|Overall Study|Withdrawal by Subject|4|||
155372880|NCT01142232|560798464|FG001|Overall Study|Alternative Therapy|1|||
155372881|NCT01142232|560798465|FG002|Overall Study|Alternative Therapy|1|||
155372882|NCT01142232|560798466|FG003|Overall Study|Alternative Therapy|0|||
155372883|NCT01142232|560798467|FG004|Overall Study|Alternative Therapy|1|||
155372884|NCT01142232|560798463|FG000|Overall Study|Off Trt for other complicating disease|0|||
155372885|NCT01142232|560798464|FG001|Overall Study|Off Trt for other complicating disease|0|||
155372886|NCT01142232|560798465|FG002|Overall Study|Off Trt for other complicating disease|0|||
155372887|NCT01142232|560798466|FG003|Overall Study|Off Trt for other complicating disease|0|||
155372888|NCT01142232|560798467|FG004|Overall Study|Off Trt for other complicating disease|1|||
155372889|NCT01142232|560798463|FG000|Overall Study|Noncompliance|0|||
155372890|NCT01142232|560798464|FG001|Overall Study|Noncompliance|0|||
155372891|NCT01142232|560798465|FG002|Overall Study|Noncompliance|0|||
155372892|NCT01142232|560798466|FG003|Overall Study|Noncompliance|0|||
155372893|NCT01142232|560798467|FG004|Overall Study|Noncompliance|2|||
155372894|NCT00626990|560798468|FG000|Overall Study|Lack of Efficacy|6|||
155372895|NCT00626990|560798469|FG001|Overall Study|Lack of Efficacy|7|||
155372896|NCT00626990|560798470|FG002|Overall Study|Lack of Efficacy|49|||
155372897|NCT00626990|560798471|FG003|Overall Study|Lack of Efficacy|40|||
155372898|NCT00626990|560798468|FG000|Overall Study|Adverse Event|1|||
155372899|NCT00626990|560798469|FG001|Overall Study|Adverse Event|7|||
155372900|NCT00626990|560798470|FG002|Overall Study|Adverse Event|14|||
155372901|NCT00626990|560798471|FG003|Overall Study|Adverse Event|28|||
155372902|NCT00626990|560798468|FG000|Overall Study|Death|0|||
155372903|NCT00626990|560798469|FG001|Overall Study|Death|1|||
155372904|NCT00626990|560798470|FG002|Overall Study|Death|0|||
155372905|NCT00626990|560798471|FG003|Overall Study|Death|0|||
155372906|NCT00626990|560798468|FG000|Overall Study|Withdrawal by Subject|3|||
155372907|NCT00626990|560798469|FG001|Overall Study|Withdrawal by Subject|1|||
155372908|NCT00626990|560798470|FG002|Overall Study|Withdrawal by Subject|5|||
155372909|NCT00626990|560798471|FG003|Overall Study|Withdrawal by Subject|11|||
155372910|NCT00626990|560798468|FG000|Overall Study|Protocol Violation|0|||
155372911|NCT00626990|560798469|FG001|Overall Study|Protocol Violation|1|||
155372912|NCT00626990|560798470|FG002|Overall Study|Protocol Violation|1|||
155372913|NCT00626990|560798471|FG003|Overall Study|Protocol Violation|0|||
155372914|NCT00626990|560798468|FG000|Overall Study|Various different reasons/missing|4|||
155372915|NCT00626990|560798469|FG001|Overall Study|Various different reasons/missing|8|||
155372916|NCT00626990|560798470|FG002|Overall Study|Various different reasons/missing|8|||
155372917|NCT00626990|560798471|FG003|Overall Study|Various different reasons/missing|16|||
155372918|NCT04138576|560798472|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
155372919|NCT01994837|560798473|FG000|Overall Study|Progressive disease per protocol|23|||
155372920|NCT01994837|560798473|FG000|Overall Study|Adv event related to progressive disease|3|||
155372921|NCT01994837|560798473|FG000|Overall Study|Fatal progressive disease|2|||
155372922|NCT01994837|560798473|FG000|Overall Study|Adverse event not related to progression|1|||
155372923|NCT01994837|560798473|FG000|Overall Study|Chose palliative care|1|||
155372924|NCT01994837|560798473|FG000|Overall Study|Proceeded to transplant|1|||
155372925|NCT01994837|560798473|FG000|Overall Study|Removed from study due to no response|1|||
155372926|NCT00574873|560798474|FG000|Overall Study|Withdrawal by Subject|18|||
155372927|NCT00574873|560798475|FG001|Overall Study|Withdrawal by Subject|19|||
155372928|NCT00574873|560798474|FG000|Overall Study|Investigator request|18|||
155372929|NCT00574873|560798475|FG001|Overall Study|Investigator request|8|||
155372930|NCT00574873|560798474|FG000|Overall Study|Death|15|||
155372931|NCT00574873|560798475|FG001|Overall Study|Death|14|||
155372932|NCT00574873|560798474|FG000|Overall Study|Lost to Follow-up|14|||
155372933|NCT00574873|560798475|FG001|Overall Study|Lost to Follow-up|5|||
155372934|NCT00574873|560798474|FG000|Overall Study|Other|40|||
155372935|NCT00574873|560798475|FG001|Overall Study|Other|4|||
155372936|NCT00574873|560798474|FG000|Overall Study|Discontinuation of study by sponsor|5|||
155372937|NCT00574873|560798475|FG001|Overall Study|Discontinuation of study by sponsor|199|||
155372938|NCT00574873|560798474|FG000|Overall Study|Blank, site closed per local regulations|2|||
155372939|NCT00574873|560798475|FG001|Overall Study|Blank, site closed per local regulations|2|||
155511076|NCT00628745|561295382|FG004|Overall Study|Missing|10|||
155511077|NCT00628745|561295378|FG000|Overall Study|Othe reasons|987|||
155511078|NCT00628745|561295379|FG001|Overall Study|Othe reasons|373|||
155511079|NCT00628745|561295380|FG002|Overall Study|Othe reasons|105|||
155372940|NCT00574873|560798474|FG000|Overall Study|Extension Study|126|||
155372941|NCT00574873|560798475|FG001|Overall Study|Extension Study|0|||
155372942|NCT00581555|560798476|FG000|Overall Study|Adverse Event|4|||
155372943|NCT00581555|560798477|FG001|Overall Study|Adverse Event|3|||
155372944|NCT00581555|560798476|FG000|Overall Study|Physician Decision|3|||
155372945|NCT00581555|560798477|FG001|Overall Study|Physician Decision|2|||
155372946|NCT00581555|560798476|FG000|Overall Study|Withdrawal by Subject|18|||
155511080|NCT00628745|561295381|FG003|Overall Study|Othe reasons|1|||
155511081|NCT00628745|561295382|FG004|Overall Study|Othe reasons|1772|||
155372947|NCT00581555|560798477|FG001|Overall Study|Withdrawal by Subject|9|||
155372948|NCT00581555|560798476|FG000|Overall Study|Lost to Follow-up|2|||
155372949|NCT00581555|560798477|FG001|Overall Study|Lost to Follow-up|2|||
155372950|NCT00581555|560798476|FG000|Overall Study|Other reasons|16|||
155372951|NCT00581555|560798477|FG001|Overall Study|Other reasons|4|||
155372952|NCT05816330|560798478|FG000|Overall Study|Withdrawal by Subject|4|||
155372953|NCT05816330|560798479|FG001|Overall Study|Withdrawal by Subject|1|||
155372954|NCT00201643|560798480|FG000|Overall Study|Withdrawal by Subject|5|||
155372955|NCT00201643|560798481|FG001|Overall Study|Withdrawal by Subject|4|||
155372956|NCT03446781|560798482|FG000|Overall Study|Lost to Follow-up|11|||
155372957|NCT03446781|560798483|FG001|Overall Study|Lost to Follow-up|5|||
155372958|NCT03446781|560798482|FG000|Overall Study|Withdrawal by Subject|9|||
155372959|NCT03446781|560798483|FG001|Overall Study|Withdrawal by Subject|7|||
155372960|NCT03446781|560798482|FG000|Overall Study|Adverse Event|8|||
155372961|NCT03446781|560798483|FG001|Overall Study|Adverse Event|2|||
155372962|NCT03446781|560798482|FG000|Overall Study|Protocol Violation|0|||
155372963|NCT03446781|560798483|FG001|Overall Study|Protocol Violation|3|||
155372964|NCT01940939|560798490|FG000|Overall Study|Withdrawal by Subject|2|||
155372965|NCT01940939|560798491|FG001|Overall Study|Withdrawal by Subject|8|||
155372966|NCT01470001|560798492|FG000|Overall Study|Lost to Follow-up|1|||
155372967|NCT01470001|560798493|FG001|Overall Study|Lost to Follow-up|1|||
155372968|NCT01470001|560798492|FG000|Overall Study|Physician Decision|2|||
155372969|NCT01470001|560798493|FG001|Overall Study|Physician Decision|0|||
155372970|NCT01470001|560798492|FG000|Overall Study|Withdrawal by Subject|2|||
155372971|NCT01470001|560798493|FG001|Overall Study|Withdrawal by Subject|1|||
155372972|NCT03268603|560798494|FG000|Overall Study|Withdrawal by Subject|6|||
155372973|NCT03268603|560798494|FG000|Overall Study|Physician Decision|1|||
155372974|NCT03268603|560798494|FG000|Overall Study|Withdrawn due to disease progression|2|||
155372975|NCT01725126|560798495|FG000|Overall Study|Protocol Violation|0|||
155372976|NCT01725126|560798496|FG001|Overall Study|Protocol Violation|1|||
155372977|NCT01725126|560798497|FG002|Overall Study|Protocol Violation|0|||
155372978|NCT01725126|560798498|FG003|Overall Study|Protocol Violation|0|||
155430719|NCT00503399|561002345|FG001|Overall Study|Withdrawal by Subject|2|||
155430720|NCT00503399|561002344|FG000|Overall Study|Adverse Event|0|||
155430721|NCT00503399|561002345|FG001|Overall Study|Adverse Event|3|||
155430722|NCT00503399|561002344|FG000|Overall Study|Lost to Follow-up|0|||
155430723|NCT00503399|561002345|FG001|Overall Study|Lost to Follow-up|2|||
155430724|NCT01676961|561002346|FG000|Overall Study|Death|3|||
155430725|NCT01676961|561002346|FG000|Overall Study|Lost to Follow-up|1|||
155430726|NCT01676961|561002346|FG000|Overall Study|Withdrawal by Subject|1|||
155430727|NCT03168867|561002349|FG000|Overall Study|Withdrawal by Subject|1|||
155430728|NCT03168867|561002350|FG001|Overall Study|Withdrawal by Subject|5|||
155430729|NCT01128387|561002351|FG000|Overall Study|Physician Decision|0|||
155430730|NCT01128387|561002352|FG001|Overall Study|Physician Decision|1|||
155430731|NCT04433117|561002359|FG000|Overall Study|Withdrawal by Subject|1|||
155430732|NCT04433117|561002360|FG001|Overall Study|Withdrawal by Subject|0|||
155430733|NCT00824421|561002362|FG000|Overall Study|Adverse Event|6|||
155430734|NCT00824421|561002363|FG001|Overall Study|Adverse Event|6|||
155430735|NCT00824421|561002364|FG002|Overall Study|Adverse Event|6|||
155430736|NCT00824421|561002362|FG000|Overall Study|Death|0|||
155430737|NCT00824421|561002363|FG001|Overall Study|Death|1|||
155430738|NCT00824421|561002364|FG002|Overall Study|Death|0|||
155430739|NCT00824421|561002362|FG000|Overall Study|Lack of Efficacy|5|||
155430740|NCT00824421|561002363|FG001|Overall Study|Lack of Efficacy|7|||
155430741|NCT00824421|561002364|FG002|Overall Study|Lack of Efficacy|4|||
155430742|NCT00824421|561002362|FG000|Overall Study|Lost to Follow-up|2|||
155430743|NCT00824421|561002363|FG001|Overall Study|Lost to Follow-up|3|||
155430744|NCT00824421|561002364|FG002|Overall Study|Lost to Follow-up|0|||
155430745|NCT00824421|561002362|FG000|Overall Study|Pregnancy|1|||
155430746|NCT00824421|561002363|FG001|Overall Study|Pregnancy|0|||
155372979|NCT01725126|560798499|FG004|Overall Study|Protocol Violation|0|||
155372980|NCT01725126|560798500|FG005|Overall Study|Protocol Violation|0|||
155430747|NCT00824421|561002364|FG002|Overall Study|Pregnancy|1|||
155430748|NCT00824421|561002362|FG000|Overall Study|Withdrawal by Subject|2|||
155430749|NCT00824421|561002363|FG001|Overall Study|Withdrawal by Subject|3|||
155430750|NCT00824421|561002364|FG002|Overall Study|Withdrawal by Subject|3|||
155430751|NCT00824421|561002362|FG000|Overall Study|Randomized but not Treated|1|||
155430752|NCT00824421|561002363|FG001|Overall Study|Randomized but not Treated|1|||
155430753|NCT00824421|561002364|FG002|Overall Study|Randomized but not Treated|0|||
155430754|NCT00824421|561002362|FG000|Overall Study|Other|0|||
155372981|NCT01725126|560798495|FG000|Overall Study|Withdrawal by Subject|0|||
155430755|NCT00824421|561002363|FG001|Overall Study|Other|1|||
155430756|NCT00824421|561002364|FG002|Overall Study|Other|0|||
155430757|NCT02499952|561002365|FG000|Overall Study|Lost to Follow-up|1|||
155430758|NCT02499952|561002365|FG000|Overall Study|Death|9|||
155430759|NCT05089708|561002366|FG000|Overall Study|Lost to Follow-up|9|||
155430760|NCT05089708|561002367|FG001|Overall Study|Lost to Follow-up|7|||
155430761|NCT05089708|561002366|FG000|Overall Study|Withdrawal by Subject|3|||
155372982|NCT01725126|560798496|FG001|Overall Study|Withdrawal by Subject|0|||
155372983|NCT01725126|560798497|FG002|Overall Study|Withdrawal by Subject|0|||
155430762|NCT05089708|561002367|FG001|Overall Study|Withdrawal by Subject|1|||
155430763|NCT05089708|561002366|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
155372984|NCT01725126|560798498|FG003|Overall Study|Withdrawal by Subject|1|||
155372985|NCT01725126|560798499|FG004|Overall Study|Withdrawal by Subject|0|||
155372986|NCT01725126|560798500|FG005|Overall Study|Withdrawal by Subject|0|||
155372987|NCT03733314|560798501|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
155372988|NCT03733314|560798502|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
155372989|NCT03733314|560798501|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
155372990|NCT03733314|560798502|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
155372991|NCT03733314|560798501|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
155372992|NCT03733314|560798502|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
155372993|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
155372994|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
155372995|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
155372996|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
155372997|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
155372998|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
155372999|NCT03214640|560798503|FG000|Overall Study|Protocol Violation|1|||
155373000|NCT03214640|560798504|FG001|Overall Study|Protocol Violation|2|||
155373001|NCT03214640|560798505|FG002|Overall Study|Protocol Violation|1|||
155373002|NCT03214640|560798506|FG003|Overall Study|Protocol Violation|4|||
155373003|NCT02075073|560798510|FG000|Overall Study|Withdrawal by Subject|0|||
155373004|NCT02075073|560798511|FG001|Overall Study|Withdrawal by Subject|1|||
155373005|NCT02075073|560798512|FG002|Overall Study|Withdrawal by Subject|0|||
155373006|NCT02683785|560798530|FG000|Overall Study|Withdrawal by Subject|1|||
155373007|NCT02683785|560798531|FG001|Overall Study|Withdrawal by Subject|1|||
155373008|NCT02683785|560798530|FG000|Overall Study|Lost to Follow-up|0|||
155373009|NCT02683785|560798531|FG001|Overall Study|Lost to Follow-up|1|||
155373010|NCT02683785|560798530|FG000|Overall Study|Adverse Event|0|||
155373011|NCT02683785|560798531|FG001|Overall Study|Adverse Event|2|||
155373012|NCT01305408|560798532|FG000|Overall Study|Adverse Event|10|||
155373013|NCT01305408|560798533|FG001|Overall Study|Adverse Event|7|||
155373014|NCT01305408|560798532|FG000|Overall Study|Lack of Efficacy|3|||
155373015|NCT01305408|560798533|FG001|Overall Study|Lack of Efficacy|4|||
155373016|NCT01305408|560798532|FG000|Overall Study|Withdrawal by Subject|9|||
155373017|NCT01305408|560798533|FG001|Overall Study|Withdrawal by Subject|9|||
155373018|NCT01305408|560798532|FG000|Overall Study|Protocol Violation|4|||
155373019|NCT01305408|560798533|FG001|Overall Study|Protocol Violation|6|||
155373020|NCT01305408|560798532|FG000|Overall Study|Lost to Follow-up|5|||
155373021|NCT01305408|560798533|FG001|Overall Study|Lost to Follow-up|3|||
155373022|NCT01305408|560798532|FG000|Overall Study|Noncompliance with study medication|0|||
155373023|NCT01305408|560798533|FG001|Overall Study|Noncompliance with study medication|1|||
155373024|NCT01305408|560798532|FG000|Overall Study|Noncompliance with study procedures|0|||
155373025|NCT01305408|560798533|FG001|Overall Study|Noncompliance with study procedures|1|||
155373026|NCT01305408|560798532|FG000|Overall Study|Other|1|||
155373027|NCT01305408|560798533|FG001|Overall Study|Other|0|||
155373028|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
155373029|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
155373030|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
155373031|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
155373032|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
155373033|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
155373034|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
155373035|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
155373036|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
155373037|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
155373038|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Physician Decision|1|||
155373039|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Physician Decision|0|||
155373040|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
155373041|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
155373042|NCT02233803|560798536|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
155373043|NCT02233803|560798537|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
155373044|NCT02233803|560798536|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
155373045|NCT02233803|560798537|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
155373046|NCT00468143|560798538|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373047|NCT00468143|560798539|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
155373048|NCT00468143|560798538|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373049|NCT00468143|560798539|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373050|NCT01204710|560798544|FG000|Randomization Treatment|Lost to Follow-up|1|||
155373051|NCT01204710|560798545|FG001|Randomization Treatment|Lost to Follow-up|0|||
155373052|NCT01204710|560798544|FG000|Randomization Treatment|Withdrawal by Subject|6|||
155373053|NCT01204710|560798545|FG001|Randomization Treatment|Withdrawal by Subject|5|||
155373054|NCT01204710|560798544|FG000|Randomization Treatment|Physician Decision|3|||
155373055|NCT01204710|560798545|FG001|Randomization Treatment|Physician Decision|2|||
155373056|NCT01204710|560798544|FG000|Randomization Treatment|Entry criteria not met|0|||
155373057|NCT01204710|560798545|FG001|Randomization Treatment|Entry criteria not met|1|||
155373058|NCT01204710|560798544|FG000|Randomization Treatment|Adverse Event|4|||
155373059|NCT01204710|560798545|FG001|Randomization Treatment|Adverse Event|2|||
155373060|NCT01204710|560798544|FG000|Randomization Treatment|Sponsor Decision|0|||
155373061|NCT01204710|560798545|FG001|Randomization Treatment|Sponsor Decision|1|||
155373062|NCT01204710|560798544|FG000|Randomization Treatment|Worsening of General condition|0|||
155373063|NCT01204710|560798545|FG001|Randomization Treatment|Worsening of General condition|1|||
155373064|NCT01204710|560798544|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
155373065|NCT01204710|560798545|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
155373066|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
155373067|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
155373068|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
155373069|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
155373070|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
155373071|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
155373072|NCT04531904|560798548|FG000|Overall Study|Lost to Follow-up|1|||
155373073|NCT04531904|560798548|FG000|Overall Study|Death|14|||
155373074|NCT01743989|560798549|FG000|Treatment Phase|Unstable MR4.0|0|||
155373075|NCT01743989|560798550|FG001|Treatment Phase|Unstable MR4.0|6|||
155373076|NCT01743989|560798551|FG002|Treatment Phase|Unstable MR4.0|263|||
155373077|NCT01743989|560798549|FG000|Treatment Phase|Adverse Event|0|||
155373078|NCT01743989|560798550|FG001|Treatment Phase|Adverse Event|4|||
155373079|NCT01743989|560798551|FG002|Treatment Phase|Adverse Event|67|||
155373080|NCT01743989|560798549|FG000|Treatment Phase|Withdrawal by Subject|1|||
155373081|NCT01743989|560798550|FG001|Treatment Phase|Withdrawal by Subject|3|||
155373082|NCT01743989|560798551|FG002|Treatment Phase|Withdrawal by Subject|28|||
155373083|NCT01743989|560798549|FG000|Treatment Phase|Death|0|||
155373084|NCT01743989|560798550|FG001|Treatment Phase|Death|1|||
155373085|NCT01743989|560798551|FG002|Treatment Phase|Death|3|||
155373086|NCT01743989|560798549|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
155373087|NCT01743989|560798550|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
155373088|NCT01743989|560798551|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
155373089|NCT01743989|560798549|FG000|Treatment Phase|Protocol deviation|0|||
155373090|NCT01743989|560798550|FG001|Treatment Phase|Protocol deviation|0|||
155373091|NCT01743989|560798551|FG002|Treatment Phase|Protocol deviation|3|||
155373092|NCT01743989|560798549|FG000|Treatment Phase|Pregnancy|0|||
155373093|NCT01743989|560798550|FG001|Treatment Phase|Pregnancy|0|||
155373094|NCT01743989|560798551|FG002|Treatment Phase|Pregnancy|2|||
155373095|NCT01743989|560798549|FG000|Treatment Phase|Lost to Follow-up|0|||
155373096|NCT01743989|560798550|FG001|Treatment Phase|Lost to Follow-up|0|||
155373097|NCT01743989|560798551|FG002|Treatment Phase|Lost to Follow-up|2|||
155373098|NCT01743989|560798549|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
155373099|NCT01743989|560798550|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
155373100|NCT01743989|560798551|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
155373101|NCT01743989|560798549|FG000|Treatment Phase|Administrative problems|0|||
155373102|NCT01743989|560798550|FG001|Treatment Phase|Administrative problems|0|||
155373103|NCT01743989|560798551|FG002|Treatment Phase|Administrative problems|1|||
155373104|NCT01743989|560798549|FG000|Treatment Phase|New cancer (CML) therapy|0|||
155373105|NCT01743989|560798550|FG001|Treatment Phase|New cancer (CML) therapy|1|||
155373106|NCT01743989|560798551|FG002|Treatment Phase|New cancer (CML) therapy|0|||
155373107|NCT01743989|560798549|FG000|Treatment Phase|Physician Decision|0|||
155373108|NCT01743989|560798550|FG001|Treatment Phase|Physician Decision|0|||
155373109|NCT01743989|560798551|FG002|Treatment Phase|Physician Decision|3|||
155373110|NCT01743989|560798549|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
155373111|NCT01743989|560798550|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
155373112|NCT01743989|560798551|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
155373113|NCT01743989|560798549|FG000|Treatment Phase|Not randomized by mistake|0|||
155430764|NCT05089708|561002367|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
155430765|NCT05089708|561002366|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
155430766|NCT05089708|561002367|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
155430767|NCT02286102|561002368|FG000|Overall Study|Screen Failure|1|||
155430768|NCT02286102|561002369|FG001|Overall Study|Screen Failure|1|||
155430769|NCT02120417|561002370|FG000|Overall Study|Death|5|||
155430770|NCT02120417|561002371|FG001|Overall Study|Death|1|||
155373114|NCT01743989|560798550|FG001|Treatment Phase|Not randomized by mistake|0|||
155430771|NCT02120417|561002370|FG000|Overall Study|Adverse Event|3|||
155373115|NCT01743989|560798551|FG002|Treatment Phase|Not randomized by mistake|1|||
155373116|NCT01743989|560798549|FG000|Treatment Phase|Included by mistake|0|||
155373117|NCT01743989|560798550|FG001|Treatment Phase|Included by mistake|0|||
155373118|NCT01743989|560798551|FG002|Treatment Phase|Included by mistake|1|||
155373119|NCT01743989|560798549|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
155373120|NCT01743989|560798550|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
155373121|NCT01743989|560798551|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
155373122|NCT01743989|560798549|FG000|TFR Phase|Adverse Event|0|||
155373123|NCT01743989|560798550|FG001|TFR Phase|Adverse Event|1|||
155373124|NCT01743989|560798551|FG002|TFR Phase|Adverse Event|0|||
155373125|NCT01743989|560798549|FG000|TFR Phase|Lost to Follow-up|0|||
155373126|NCT01743989|560798550|FG001|TFR Phase|Lost to Follow-up|2|||
155373127|NCT01743989|560798551|FG002|TFR Phase|Lost to Follow-up|0|||
155373128|NCT01743989|560798549|FG000|TFR Phase|Physician Decision|0|||
155373129|NCT01743989|560798550|FG001|TFR Phase|Physician Decision|1|||
155373130|NCT01743989|560798551|FG002|TFR Phase|Physician Decision|0|||
155373131|NCT01743989|560798549|FG000|TFR Phase|Logistical problems|0|||
155373132|NCT01743989|560798550|FG001|TFR Phase|Logistical problems|2|||
155373133|NCT01743989|560798551|FG002|TFR Phase|Logistical problems|0|||
155373134|NCT01743989|560798549|FG000|TFR Phase|Protocol deviation|0|||
155373135|NCT01743989|560798550|FG001|TFR Phase|Protocol deviation|1|||
155373136|NCT01743989|560798551|FG002|TFR Phase|Protocol deviation|0|||
155373137|NCT01743989|560798549|FG000|TFR Phase|Withdrawal by Subject|0|||
155373138|NCT01743989|560798550|FG001|TFR Phase|Withdrawal by Subject|2|||
155373139|NCT01743989|560798551|FG002|TFR Phase|Withdrawal by Subject|0|||
155373140|NCT01743989|560798549|FG000|Re-treatment Phase|Adverse Event|8|||
155373141|NCT01743989|560798550|FG001|Re-treatment Phase|Adverse Event|4|||
155373142|NCT01743989|560798551|FG002|Re-treatment Phase|Adverse Event|0|||
155373143|NCT01743989|560798549|FG000|Re-treatment Phase|Death|1|||
155373144|NCT01743989|560798550|FG001|Re-treatment Phase|Death|1|||
155373145|NCT01743989|560798551|FG002|Re-treatment Phase|Death|0|||
155373146|NCT01743989|560798549|FG000|Re-treatment Phase|Administrative problems|1|||
155373147|NCT01743989|560798550|FG001|Re-treatment Phase|Administrative problems|1|||
155373148|NCT01743989|560798551|FG002|Re-treatment Phase|Administrative problems|0|||
155373149|NCT01743989|560798549|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
155373150|NCT01743989|560798550|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
155373151|NCT01743989|560798551|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
155373152|NCT01743989|560798549|FG000|Re-treatment Phase|Unstable MR|1|||
155373153|NCT01743989|560798550|FG001|Re-treatment Phase|Unstable MR|0|||
155373154|NCT01743989|560798551|FG002|Re-treatment Phase|Unstable MR|0|||
155373155|NCT01743989|560798549|FG000|Re-treatment Phase|Physician Decision|0|||
155373156|NCT01743989|560798550|FG001|Re-treatment Phase|Physician Decision|1|||
155373157|NCT01743989|560798551|FG002|Re-treatment Phase|Physician Decision|0|||
155373158|NCT01743989|560798549|FG000|Re-treatment Phase|Lost to Follow-up|0|||
155373159|NCT01743989|560798550|FG001|Re-treatment Phase|Lost to Follow-up|1|||
155373160|NCT01743989|560798551|FG002|Re-treatment Phase|Lost to Follow-up|0|||
155373161|NCT04655027|560798552|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
155373162|NCT04655027|560798553|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
155373163|NCT03519997|560798554|FG000|Overall Study|Adverse Event|4|||
155373164|NCT03519997|560798554|FG000|Overall Study|Withdrawal by Subject|2|||
155373165|NCT03519997|560798554|FG000|Overall Study|Protocol Violation|1|||
155373166|NCT03361605|560798555|FG000|Overall Study|Analyzable data not available|3|||
155373167|NCT02906007|560798556|FG000|Overall Study|Physician Decision|0|||
155373168|NCT02906007|560798557|FG001|Overall Study|Physician Decision|0|||
155373169|NCT02906007|560798558|FG002|Overall Study|Physician Decision|1|||
155373170|NCT02906007|560798556|FG000|Overall Study|Died|1|||
155373171|NCT02906007|560798557|FG001|Overall Study|Died|0|||
155373172|NCT02906007|560798558|FG002|Overall Study|Died|0|||
155373173|NCT04372121|560798568|FG000|Overall Study|Lost to Follow-up|0|||
155373174|NCT04372121|560798569|FG001|Overall Study|Lost to Follow-up|0|||
155373175|NCT04372121|560798570|FG002|Overall Study|Lost to Follow-up|0|||
155373176|NCT04372121|560798571|FG003|Overall Study|Lost to Follow-up|1|||
155373177|NCT04372121|560798568|FG000|Overall Study|Protocol Violation|0|||
155430772|NCT02120417|561002371|FG001|Overall Study|Adverse Event|9|||
155430773|NCT02120417|561002370|FG000|Overall Study|Participant decision|4|||
155430774|NCT02120417|561002371|FG001|Overall Study|Participant decision|4|||
155430775|NCT02120417|561002370|FG000|Overall Study|Disease progression|41|||
155430776|NCT02120417|561002371|FG001|Overall Study|Disease progression|45|||
155430777|NCT02120417|561002370|FG000|Overall Study|Noncompliance with study treatment|0|||
155430778|NCT02120417|561002371|FG001|Overall Study|Noncompliance with study treatment|2|||
155430779|NCT02120417|561002370|FG000|Overall Study|Physician Decision|2|||
155430780|NCT02120417|561002371|FG001|Overall Study|Physician Decision|3|||
155430781|NCT02120417|561002370|FG000|Overall Study|Other unspecified|5|||
155373178|NCT04372121|560798569|FG001|Overall Study|Protocol Violation|0|||
155373179|NCT04372121|560798570|FG002|Overall Study|Protocol Violation|1|||
155373180|NCT04372121|560798571|FG003|Overall Study|Protocol Violation|0|||
155373181|NCT04372121|560798568|FG000|Overall Study|Withdrawal by Subject|3|||
155373182|NCT04372121|560798569|FG001|Overall Study|Withdrawal by Subject|1|||
155373183|NCT04372121|560798570|FG002|Overall Study|Withdrawal by Subject|0|||
155430782|NCT02120417|561002371|FG001|Overall Study|Other unspecified|4|||
155430783|NCT00927485|561002372|FG000|Overall Study|Adverse Event|4|||
155430784|NCT00927485|561002373|FG001|Overall Study|Adverse Event|2|||
155373184|NCT04372121|560798571|FG003|Overall Study|Withdrawal by Subject|0|||
155373185|NCT04372121|560798568|FG000|Overall Study|Study termination|6|||
155373186|NCT04372121|560798569|FG001|Overall Study|Study termination|5|||
155373187|NCT04372121|560798570|FG002|Overall Study|Study termination|1|||
155373188|NCT04372121|560798571|FG003|Overall Study|Study termination|1|||
155373189|NCT04372121|560798568|FG000|Overall Study|Hysterectomy planned|1|||
155373190|NCT04372121|560798569|FG001|Overall Study|Hysterectomy planned|0|||
155373191|NCT04372121|560798570|FG002|Overall Study|Hysterectomy planned|0|||
155373192|NCT04372121|560798571|FG003|Overall Study|Hysterectomy planned|0|||
155373193|NCT02344290|560798577|FG000|Overall Study|Withdrawal by Subject|315|||
155373194|NCT02344290|560798578|FG001|Overall Study|Withdrawal by Subject|324|||
155373195|NCT02344290|560798577|FG000|Overall Study|Lost to Follow-up|258|||
155373196|NCT02344290|560798578|FG001|Overall Study|Lost to Follow-up|249|||
155373197|NCT02344290|560798577|FG000|Overall Study|Unable to get to clinic|69|||
155373198|NCT02344290|560798578|FG001|Overall Study|Unable to get to clinic|60|||
155373199|NCT02344290|560798577|FG000|Overall Study|Physician Decision|25|||
155373200|NCT02344290|560798578|FG001|Overall Study|Physician Decision|25|||
155373201|NCT02344290|560798577|FG000|Overall Study|Site Closure|15|||
155373202|NCT02344290|560798578|FG001|Overall Study|Site Closure|19|||
155373203|NCT02344290|560798577|FG000|Overall Study|Other|5|||
155373204|NCT02344290|560798578|FG001|Overall Study|Other|3|||
155373205|NCT04047862|560798582|FG000|Overall Study|Death|0|||
155373206|NCT04047862|560798583|FG001|Overall Study|Death|0|||
155373207|NCT04047862|560798584|FG002|Overall Study|Death|4|||
155373208|NCT04047862|560798585|FG003|Overall Study|Death|7|||
155373209|NCT04047862|560798586|FG004|Overall Study|Death|2|||
155373210|NCT04047862|560798587|FG005|Overall Study|Death|4|||
155373211|NCT04047862|560798588|FG006|Overall Study|Death|3|||
155373212|NCT04047862|560798589|FG007|Overall Study|Death|24|||
155373213|NCT04047862|560798590|FG008|Overall Study|Death|24|||
155373214|NCT04047862|560798591|FG009|Overall Study|Death|22|||
155373215|NCT04047862|560798592|FG010|Overall Study|Death|35|||
155373216|NCT04047862|560798593|FG011|Overall Study|Death|18|||
155373217|NCT04047862|560798594|FG012|Overall Study|Death|14|||
155373218|NCT04047862|560798595|FG013|Overall Study|Death|6|||
155373219|NCT04047862|560798596|FG014|Overall Study|Death|19|||
155373220|NCT04047862|560798597|FG015|Overall Study|Death|42|||
155373221|NCT04047862|560798598|FG016|Overall Study|Death|9|||
155373222|NCT04047862|560798599|FG017|Overall Study|Death|8|||
155373223|NCT04047862|560798600|FG018|Overall Study|Death|10|||
155373224|NCT04047862|560798582|FG000|Overall Study|Withdrawal by Subject|0|||
155373225|NCT04047862|560798583|FG001|Overall Study|Withdrawal by Subject|0|||
155373226|NCT04047862|560798584|FG002|Overall Study|Withdrawal by Subject|0|||
155373227|NCT04047862|560798585|FG003|Overall Study|Withdrawal by Subject|5|||
155373228|NCT04047862|560798586|FG004|Overall Study|Withdrawal by Subject|2|||
155373229|NCT04047862|560798587|FG005|Overall Study|Withdrawal by Subject|0|||
155373230|NCT04047862|560798588|FG006|Overall Study|Withdrawal by Subject|1|||
155373231|NCT04047862|560798589|FG007|Overall Study|Withdrawal by Subject|0|||
155373232|NCT04047862|560798590|FG008|Overall Study|Withdrawal by Subject|4|||
155373233|NCT04047862|560798591|FG009|Overall Study|Withdrawal by Subject|4|||
155373234|NCT04047862|560798592|FG010|Overall Study|Withdrawal by Subject|4|||
155373235|NCT04047862|560798593|FG011|Overall Study|Withdrawal by Subject|2|||
155373236|NCT04047862|560798594|FG012|Overall Study|Withdrawal by Subject|3|||
155373237|NCT04047862|560798595|FG013|Overall Study|Withdrawal by Subject|0|||
155373238|NCT04047862|560798596|FG014|Overall Study|Withdrawal by Subject|9|||
155373239|NCT04047862|560798597|FG015|Overall Study|Withdrawal by Subject|5|||
155373240|NCT04047862|560798598|FG016|Overall Study|Withdrawal by Subject|1|||
155373241|NCT04047862|560798599|FG017|Overall Study|Withdrawal by Subject|3|||
155373242|NCT04047862|560798600|FG018|Overall Study|Withdrawal by Subject|1|||
155373243|NCT04047862|560798582|FG000|Overall Study|Lost to Follow-up|0|||
155373244|NCT04047862|560798583|FG001|Overall Study|Lost to Follow-up|0|||
155373245|NCT04047862|560798584|FG002|Overall Study|Lost to Follow-up|1|||
155373246|NCT04047862|560798585|FG003|Overall Study|Lost to Follow-up|0|||
155373247|NCT04047862|560798586|FG004|Overall Study|Lost to Follow-up|0|||
155373248|NCT04047862|560798587|FG005|Overall Study|Lost to Follow-up|0|||
155373249|NCT04047862|560798588|FG006|Overall Study|Lost to Follow-up|0|||
155373250|NCT04047862|560798589|FG007|Overall Study|Lost to Follow-up|1|||
155373251|NCT04047862|560798590|FG008|Overall Study|Lost to Follow-up|0|||
155373252|NCT04047862|560798591|FG009|Overall Study|Lost to Follow-up|1|||
155373253|NCT04047862|560798592|FG010|Overall Study|Lost to Follow-up|0|||
155373254|NCT04047862|560798593|FG011|Overall Study|Lost to Follow-up|3|||
155373255|NCT04047862|560798594|FG012|Overall Study|Lost to Follow-up|0|||
155373256|NCT04047862|560798595|FG013|Overall Study|Lost to Follow-up|0|||
155373257|NCT04047862|560798596|FG014|Overall Study|Lost to Follow-up|2|||
155373258|NCT04047862|560798597|FG015|Overall Study|Lost to Follow-up|2|||
155373259|NCT04047862|560798598|FG016|Overall Study|Lost to Follow-up|1|||
155373260|NCT04047862|560798599|FG017|Overall Study|Lost to Follow-up|0|||
155373261|NCT04047862|560798600|FG018|Overall Study|Lost to Follow-up|0|||
155373262|NCT04047862|560798582|FG000|Overall Study|Physician Decision|0|||
155373263|NCT04047862|560798583|FG001|Overall Study|Physician Decision|0|||
155373264|NCT04047862|560798584|FG002|Overall Study|Physician Decision|0|||
155373265|NCT04047862|560798585|FG003|Overall Study|Physician Decision|1|||
155373266|NCT04047862|560798586|FG004|Overall Study|Physician Decision|0|||
155373267|NCT04047862|560798587|FG005|Overall Study|Physician Decision|0|||
155373268|NCT04047862|560798588|FG006|Overall Study|Physician Decision|0|||
155373269|NCT04047862|560798589|FG007|Overall Study|Physician Decision|0|||
155373270|NCT04047862|560798590|FG008|Overall Study|Physician Decision|0|||
155373271|NCT04047862|560798591|FG009|Overall Study|Physician Decision|0|||
155373272|NCT04047862|560798592|FG010|Overall Study|Physician Decision|0|||
155373273|NCT04047862|560798593|FG011|Overall Study|Physician Decision|0|||
155373274|NCT04047862|560798594|FG012|Overall Study|Physician Decision|0|||
155373275|NCT04047862|560798595|FG013|Overall Study|Physician Decision|0|||
155373276|NCT04047862|560798596|FG014|Overall Study|Physician Decision|1|||
155373277|NCT04047862|560798597|FG015|Overall Study|Physician Decision|0|||
155373278|NCT04047862|560798598|FG016|Overall Study|Physician Decision|1|||
155373279|NCT04047862|560798599|FG017|Overall Study|Physician Decision|0|||
155373280|NCT04047862|560798600|FG018|Overall Study|Physician Decision|0|||
155373281|NCT04047862|560798582|FG000|Overall Study|Completed all Assessments|1|||
155373282|NCT04047862|560798583|FG001|Overall Study|Completed all Assessments|3|||
155373283|NCT04047862|560798584|FG002|Overall Study|Completed all Assessments|1|||
155373284|NCT04047862|560798585|FG003|Overall Study|Completed all Assessments|3|||
155373285|NCT04047862|560798586|FG004|Overall Study|Completed all Assessments|2|||
155373286|NCT04047862|560798587|FG005|Overall Study|Completed all Assessments|5|||
155373287|NCT04047862|560798588|FG006|Overall Study|Completed all Assessments|7|||
155373288|NCT04047862|560798589|FG007|Overall Study|Completed all Assessments|0|||
155373289|NCT04047862|560798590|FG008|Overall Study|Completed all Assessments|0|||
155373290|NCT04047862|560798591|FG009|Overall Study|Completed all Assessments|0|||
155373291|NCT04047862|560798592|FG010|Overall Study|Completed all Assessments|0|||
155373292|NCT04047862|560798593|FG011|Overall Study|Completed all Assessments|0|||
155373293|NCT04047862|560798594|FG012|Overall Study|Completed all Assessments|0|||
155373294|NCT04047862|560798595|FG013|Overall Study|Completed all Assessments|0|||
155373295|NCT04047862|560798596|FG014|Overall Study|Completed all Assessments|0|||
155373296|NCT04047862|560798597|FG015|Overall Study|Completed all Assessments|0|||
155373297|NCT04047862|560798598|FG016|Overall Study|Completed all Assessments|0|||
155373298|NCT04047862|560798599|FG017|Overall Study|Completed all Assessments|0|||
155373299|NCT04047862|560798600|FG018|Overall Study|Completed all Assessments|0|||
155373300|NCT04047862|560798582|FG000|Overall Study|Sponsor Decision|0|||
155373301|NCT04047862|560798583|FG001|Overall Study|Sponsor Decision|0|||
155373302|NCT04047862|560798584|FG002|Overall Study|Sponsor Decision|0|||
155373303|NCT04047862|560798585|FG003|Overall Study|Sponsor Decision|0|||
155373304|NCT04047862|560798586|FG004|Overall Study|Sponsor Decision|0|||
155373305|NCT04047862|560798587|FG005|Overall Study|Sponsor Decision|0|||
155373306|NCT04047862|560798588|FG006|Overall Study|Sponsor Decision|0|||
155373307|NCT04047862|560798589|FG007|Overall Study|Sponsor Decision|13|||
155373308|NCT04047862|560798590|FG008|Overall Study|Sponsor Decision|10|||
155373309|NCT04047862|560798591|FG009|Overall Study|Sponsor Decision|18|||
155373310|NCT04047862|560798592|FG010|Overall Study|Sponsor Decision|3|||
155373311|NCT04047862|560798593|FG011|Overall Study|Sponsor Decision|3|||
155373312|NCT04047862|560798594|FG012|Overall Study|Sponsor Decision|4|||
155373313|NCT04047862|560798595|FG013|Overall Study|Sponsor Decision|0|||
155373314|NCT04047862|560798596|FG014|Overall Study|Sponsor Decision|7|||
155373315|NCT04047862|560798597|FG015|Overall Study|Sponsor Decision|8|||
155373316|NCT04047862|560798598|FG016|Overall Study|Sponsor Decision|9|||
155373317|NCT04047862|560798599|FG017|Overall Study|Sponsor Decision|7|||
155373318|NCT04047862|560798600|FG018|Overall Study|Sponsor Decision|8|||
155373319|NCT04047862|560798582|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373320|NCT04047862|560798583|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373321|NCT04047862|560798584|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373322|NCT04047862|560798585|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373323|NCT04047862|560798586|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373324|NCT04047862|560798587|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373325|NCT04047862|560798588|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373326|NCT04047862|560798589|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
155373327|NCT04047862|560798590|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
155373328|NCT04047862|560798591|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155430785|NCT00927485|561002372|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
155430786|NCT00927485|561002373|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
155430787|NCT01440101|561002374|FG000|Overall Study|Adverse Event|2|||
155430788|NCT01440101|561002375|FG001|Overall Study|Adverse Event|0|||
155430789|NCT01440101|561002376|FG002|Overall Study|Adverse Event|0|||
155430790|NCT01440101|561002374|FG000|Overall Study|Withdrawal by Subject|0|||
155373329|NCT04047862|560798592|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373330|NCT04047862|560798593|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373331|NCT04047862|560798594|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373332|NCT04047862|560798595|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373333|NCT04047862|560798596|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373334|NCT04047862|560798597|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373335|NCT04047862|560798598|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373336|NCT04047862|560798599|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373337|NCT04047862|560798600|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373338|NCT04047862|560798582|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373339|NCT04047862|560798583|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373340|NCT04047862|560798584|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373341|NCT04047862|560798585|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373342|NCT04047862|560798586|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373343|NCT04047862|560798587|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373344|NCT04047862|560798588|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373345|NCT04047862|560798589|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373346|NCT04047862|560798590|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373347|NCT04047862|560798591|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373348|NCT04047862|560798592|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373349|NCT04047862|560798593|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373350|NCT04047862|560798594|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373351|NCT04047862|560798595|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373352|NCT04047862|560798596|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373353|NCT04047862|560798597|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
155373354|NCT04047862|560798598|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373355|NCT04047862|560798599|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373356|NCT04047862|560798600|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
155373357|NCT04047862|560798582|FG000|Overall Study|Other|0|||
155373358|NCT04047862|560798583|FG001|Overall Study|Other|0|||
155373359|NCT04047862|560798584|FG002|Overall Study|Other|0|||
155373360|NCT04047862|560798585|FG003|Overall Study|Other|0|||
155373361|NCT04047862|560798586|FG004|Overall Study|Other|0|||
155373362|NCT04047862|560798587|FG005|Overall Study|Other|0|||
155373363|NCT04047862|560798588|FG006|Overall Study|Other|0|||
155373364|NCT04047862|560798589|FG007|Overall Study|Other|0|||
155373365|NCT04047862|560798590|FG008|Overall Study|Other|0|||
155373366|NCT04047862|560798591|FG009|Overall Study|Other|0|||
155373367|NCT04047862|560798592|FG010|Overall Study|Other|0|||
155373368|NCT04047862|560798593|FG011|Overall Study|Other|0|||
155373369|NCT04047862|560798594|FG012|Overall Study|Other|0|||
155373370|NCT04047862|560798595|FG013|Overall Study|Other|0|||
155373371|NCT04047862|560798596|FG014|Overall Study|Other|2|||
155373372|NCT04047862|560798597|FG015|Overall Study|Other|1|||
155373373|NCT04047862|560798598|FG016|Overall Study|Other|1|||
155373374|NCT04047862|560798599|FG017|Overall Study|Other|1|||
155373375|NCT04047862|560798600|FG018|Overall Study|Other|0|||
155430791|NCT01440101|561002375|FG001|Overall Study|Withdrawal by Subject|3|||
155430792|NCT01440101|561002376|FG002|Overall Study|Withdrawal by Subject|1|||
155430793|NCT01440101|561002374|FG000|Overall Study|Other|0|||
155430794|NCT01440101|561002375|FG001|Overall Study|Other|1|||
155430795|NCT01440101|561002376|FG002|Overall Study|Other|0|||
155430796|NCT04325503|561002382|FG000|Overall Study|Withdrawal by Subject|1|||
155430797|NCT04325503|561002382|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
155430798|NCT00702143|561002383|FG000|Overall Study|Lost to Follow-up|0|||
155373411|NCT01732822|560800099|FG000|Overall Study|Withdrawal by Subject|123|||
155373412|NCT01732822|560800100|FG001|Overall Study|Withdrawal by Subject|113|||
155373413|NCT01077271|560800101|FG000|Overall Study|Parental desire|8|||
155373414|NCT01077271|560800101|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
155373415|NCT01077271|560800101|FG000|Overall Study|Noncompliance|2|||
155373416|NCT01077271|560800101|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
155373417|NCT01077271|560800101|FG000|Overall Study|Changed doctors|2|||
155373418|NCT01077271|560800101|FG000|Overall Study|Parents thought too many injections|2|||
155373419|NCT01077271|560800101|FG000|Overall Study|End of RSV season nearly reached|1|||
155373420|NCT01077271|560800101|FG000|Overall Study|Mother unconvinced of the necessity|1|||
155373421|NCT00215137|560800102|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
155373422|NCT00215137|560800103|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
155373423|NCT00215137|560800104|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
155373424|NCT00215137|560800102|FG000|Randomization Period|Lost to Follow-up|0|||
155373425|NCT00215137|560800103|FG001|Randomization Period|Lost to Follow-up|1|||
155373426|NCT00215137|560800104|FG002|Randomization Period|Lost to Follow-up|0|||
155373427|NCT00215137|560800102|FG000|Randomization Period|Withdrawal by Subject|0|||
155373428|NCT00215137|560800103|FG001|Randomization Period|Withdrawal by Subject|1|||
155373429|NCT00215137|560800104|FG002|Randomization Period|Withdrawal by Subject|0|||
155373430|NCT04684394|560800105|FG000|Overall Study|Death|1|||
155373431|NCT04684394|560800106|FG001|Overall Study|Death|2|||
155373432|NCT04684394|560800105|FG000|Overall Study|Lost to Follow-up|1|||
155373433|NCT04684394|560800106|FG001|Overall Study|Lost to Follow-up|0|||
155373434|NCT04684394|560800105|FG000|Overall Study|Withdrawal by Subject|2|||
155373435|NCT04684394|560800106|FG001|Overall Study|Withdrawal by Subject|0|||
155373436|NCT04684394|560800105|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
155373437|NCT04684394|560800106|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
155373438|NCT00591370|560800109|FG000|Overall Study|Not Treated|2|||
155373439|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
155373440|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
155373441|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
155373442|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
155373443|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
155373444|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
155373445|NCT01183260|560800112|FG000|Overall Study|Intraop screen failure|2|||
155373446|NCT01183260|560800113|FG001|Overall Study|Intraop screen failure|0|||
155373447|NCT01183260|560800112|FG000|Overall Study|Withdrawal by Subject|1|||
155373448|NCT01183260|560800113|FG001|Overall Study|Withdrawal by Subject|1|||
155373449|NCT01183260|560800112|FG000|Overall Study|Revised within 30 days|0|||
155373450|NCT01183260|560800113|FG001|Overall Study|Revised within 30 days|1|||
155373451|NCT01183260|560800112|FG000|Overall Study|Death|1|||
155373452|NCT01183260|560800113|FG001|Overall Study|Death|0|||
155373453|NCT01202903|560800115|FG000|Overall Study|Administrative Probelms|1|||
155373454|NCT01202903|560800116|FG001|Overall Study|Administrative Probelms|4|||
155373455|NCT01202903|560800115|FG000|Overall Study|Protocol Violation|0|||
155373456|NCT01202903|560800116|FG001|Overall Study|Protocol Violation|1|||
155373457|NCT01202903|560800115|FG000|Overall Study|Death|1|||
155373458|NCT01202903|560800116|FG001|Overall Study|Death|0|||
155373459|NCT01202903|560800115|FG000|Overall Study|Lost to Follow-up|1|||
155373460|NCT01202903|560800116|FG001|Overall Study|Lost to Follow-up|1|||
155373461|NCT01202903|560800115|FG000|Overall Study|Lack of Efficacy|1|||
155373462|NCT01202903|560800116|FG001|Overall Study|Lack of Efficacy|3|||
155373463|NCT01202903|560800115|FG000|Overall Study|Adverse Event|3|||
155373464|NCT01202903|560800116|FG001|Overall Study|Adverse Event|3|||
155373465|NCT01202903|560800115|FG000|Overall Study|Withdrawal by Subject|4|||
155373466|NCT01202903|560800116|FG001|Overall Study|Withdrawal by Subject|4|||
155373467|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
155373468|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
155373469|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
155373470|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
155373471|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Death|1|||
155373472|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Death|0|||
155373473|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
155430799|NCT00702143|561002384|FG001|Overall Study|Lost to Follow-up|0|||
155430800|NCT00702143|561002385|FG002|Overall Study|Lost to Follow-up|1|||
155430801|NCT03871491|561002386|FG000|Overall Study|Withdrawal by Subject|14|||
155430802|NCT03871491|561002387|FG001|Overall Study|Withdrawal by Subject|14|||
155430803|NCT03871491|561002388|FG002|Overall Study|Withdrawal by Subject|14|||
155430804|NCT03871491|561002389|FG003|Overall Study|Withdrawal by Subject|14|||
155430805|NCT03871491|561002386|FG000|Overall Study|Physician Decision|0|||
155373474|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
155430806|NCT03871491|561002387|FG001|Overall Study|Physician Decision|0|||
155373475|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
155373476|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
155373477|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
155373478|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
155373479|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
155373480|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
155373481|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
155373482|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
155430807|NCT03871491|561002388|FG002|Overall Study|Physician Decision|1|||
155430808|NCT03871491|561002389|FG003|Overall Study|Physician Decision|1|||
155430809|NCT03871491|561002386|FG000|Overall Study|Lost to Follow-up|50|||
155430810|NCT03871491|561002387|FG001|Overall Study|Lost to Follow-up|15|||
155430811|NCT03871491|561002388|FG002|Overall Study|Lost to Follow-up|36|||
155430812|NCT03871491|561002389|FG003|Overall Study|Lost to Follow-up|11|||
155430813|NCT05202808|561002390|FG000|Overall Study|Lost to Follow-up|3|||
155430814|NCT05202808|561002391|FG001|Overall Study|Lost to Follow-up|1|||
155373483|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Death|3|||
155373484|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Death|1|||
155373485|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
155373486|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
155373487|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
155373488|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
155373489|NCT00306670|560800119|FG000|Overall Study|patients recruited; Genentech, the st|0|||
155373490|NCT00306670|560800120|FG001|Overall Study|patients recruited; Genentech, the st|2|||
155373491|NCT02735577|560800124|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
155373492|NCT02735577|560800124|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
155373493|NCT02898077|560800129|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
155373494|NCT02898077|560800130|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
155373495|NCT02898077|560800129|FG000|Overall Study|Lost to Follow-up|4|||
155373496|NCT02898077|560800130|FG001|Overall Study|Lost to Follow-up|3|||
155373497|NCT02898077|560800129|FG000|Overall Study|Physician Decision|0|||
155373498|NCT02898077|560800130|FG001|Overall Study|Physician Decision|2|||
155373499|NCT02898077|560800129|FG000|Overall Study|Sponsor Decision|32|||
155373500|NCT02898077|560800130|FG001|Overall Study|Sponsor Decision|13|||
155373501|NCT02898077|560800129|FG000|Overall Study|Withdrawal by Subject|6|||
155373502|NCT02898077|560800130|FG001|Overall Study|Withdrawal by Subject|3|||
155373503|NCT02898077|560800129|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
155373504|NCT02898077|560800130|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
155373505|NCT02898077|560800129|FG000|Overall Study|Ended extension period|3|||
155373506|NCT02898077|560800130|FG001|Overall Study|Ended extension period|0|||
155373507|NCT03896152|560800137|FG000|Overall Study|Patient/guardian decision|1|||
155373508|NCT03896152|560800138|FG001|Overall Study|Patient/guardian decision|1|||
155373509|NCT03896152|560800137|FG000|Overall Study|Adverse Event|0|||
155373510|NCT03896152|560800138|FG001|Overall Study|Adverse Event|1|||
155373511|NCT03896152|560800137|FG000|Overall Study|Physician Decision|1|||
155373512|NCT03896152|560800138|FG001|Overall Study|Physician Decision|0|||
155373513|NCT03896152|560800137|FG000|Overall Study|Technical problems|1|||
155373514|NCT03896152|560800138|FG001|Overall Study|Technical problems|0|||
155373515|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
155373516|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
155373517|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
155373518|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
155373519|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
155373520|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
155373521|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
155373522|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
155373523|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
155373524|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
155373525|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
155373526|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
155373527|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
155373528|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
155373529|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
155373530|NCT04939701|560800139|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
155373531|NCT04939701|560800140|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
155373532|NCT04939701|560800141|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
155373533|NCT04939701|560800139|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
155373534|NCT04939701|560800140|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
155373535|NCT04939701|560800141|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
155373536|NCT01353859|560800144|FG000|Overall Study|Adverse Event|3|||
155373537|NCT01353859|560800144|FG000|Overall Study|Lack of Efficacy|1|||
155373538|NCT01656200|560800145|FG000|Overall Study|Withdrawal by Subject|1|||
155373539|NCT02236988|560800146|FG000|Overall Study|Lost to Follow-up|0|||
155430815|NCT04996797|561002392|FG000|Overall Study|Adverse Event|0|||
155373540|NCT02236988|560800147|FG001|Overall Study|Lost to Follow-up|0|||
155373541|NCT02236988|560800148|FG002|Overall Study|Lost to Follow-up|0|||
155373542|NCT02236988|560800149|FG003|Overall Study|Lost to Follow-up|1|||
155373543|NCT02236988|560800146|FG000|Overall Study|Unable to Comply with Study Visits|0|||
155373544|NCT02236988|560800147|FG001|Overall Study|Unable to Comply with Study Visits|0|||
155373545|NCT02236988|560800148|FG002|Overall Study|Unable to Comply with Study Visits|0|||
155373546|NCT02236988|560800149|FG003|Overall Study|Unable to Comply with Study Visits|2|||
155430816|NCT04996797|561002393|FG001|Overall Study|Adverse Event|2|||
155373547|NCT05775991|560800152|FG000|Overall Study|Withdrawal by Subject|0|||
155373548|NCT05775991|560800153|FG001|Overall Study|Withdrawal by Subject|0|||
155373549|NCT05775991|560800154|FG002|Overall Study|Withdrawal by Subject|2|||
155373550|NCT01461811|560800157|FG000|Overall Study|Adverse Event|2|||
155373551|NCT01461811|560800158|FG001|Overall Study|Adverse Event|1|||
155373552|NCT01461811|560800157|FG000|Overall Study|Subject decision unrelated to an AE|1|||
155373553|NCT01461811|560800158|FG001|Overall Study|Subject decision unrelated to an AE|1|||
155373554|NCT01461811|560800157|FG000|Overall Study|Noncompliance|1|||
155373555|NCT01461811|560800158|FG001|Overall Study|Noncompliance|1|||
155373556|NCT01072630|560800159|FG000|Overall Study|Adverse Event|11|||
155373557|NCT01072630|560800160|FG001|Overall Study|Adverse Event|19|||
155373558|NCT01072630|560800161|FG002|Overall Study|Adverse Event|2|||
155373559|NCT01072630|560800159|FG000|Overall Study|Lack of Efficacy|10|||
155373560|NCT01072630|560800160|FG001|Overall Study|Lack of Efficacy|10|||
155373561|NCT01072630|560800161|FG002|Overall Study|Lack of Efficacy|1|||
155373562|NCT01072630|560800159|FG000|Overall Study|Withdrawal by Subject|8|||
155373563|NCT01072630|560800160|FG001|Overall Study|Withdrawal by Subject|7|||
155373564|NCT01072630|560800161|FG002|Overall Study|Withdrawal by Subject|2|||
155373565|NCT01072630|560800159|FG000|Overall Study|Protocol Violation|10|||
155373566|NCT01072630|560800160|FG001|Overall Study|Protocol Violation|8|||
155373567|NCT01072630|560800161|FG002|Overall Study|Protocol Violation|4|||
155373568|NCT01072630|560800159|FG000|Overall Study|Lost to Follow-up|11|||
155373569|NCT01072630|560800160|FG001|Overall Study|Lost to Follow-up|11|||
155373570|NCT01072630|560800161|FG002|Overall Study|Lost to Follow-up|1|||
155373571|NCT01072630|560800159|FG000|Overall Study|Noncompliance with study medication|1|||
155373572|NCT01072630|560800160|FG001|Overall Study|Noncompliance with study medication|1|||
155373573|NCT01072630|560800161|FG002|Overall Study|Noncompliance with study medication|1|||
155373574|NCT01072630|560800159|FG000|Overall Study|Noncompliance with study procedures|1|||
155373575|NCT01072630|560800160|FG001|Overall Study|Noncompliance with study procedures|2|||
155373576|NCT01072630|560800161|FG002|Overall Study|Noncompliance with study procedures|1|||
155373577|NCT01072630|560800159|FG000|Overall Study|Other|3|||
155373578|NCT01072630|560800160|FG001|Overall Study|Other|2|||
155373579|NCT01072630|560800161|FG002|Overall Study|Other|1|||
155373580|NCT03046121|560800162|FG000|Overall Study|Death|32|||
155373581|NCT03046121|560800163|FG001|Overall Study|Death|60|||
155373582|NCT03046121|560800162|FG000|Overall Study|Withdrawal by Subject|14|||
155373583|NCT03046121|560800163|FG001|Overall Study|Withdrawal by Subject|12|||
155373584|NCT04155047|560800164|FG000|Overall Study|Adverse Event|1|||
155373585|NCT04155047|560800165|FG001|Overall Study|Adverse Event|0|||
155373586|NCT04155047|560800164|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
155373587|NCT04155047|560800165|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
155373588|NCT04514510|560800166|FG000|Overall Study|Lost to Follow-up|0|||
155373589|NCT04514510|560800167|FG001|Overall Study|Lost to Follow-up|1|||
155373590|NCT04514510|560800166|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
155373591|NCT04514510|560800167|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
155373592|NCT02781090|560800168|FG000|3-Month Follow-Up|Missed Visit|20|||
155373593|NCT02781090|560800169|FG001|3-Month Follow-Up|Missed Visit|20|||
155373594|NCT02781090|560800168|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
155373595|NCT02781090|560800169|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
155373596|NCT02781090|560800168|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
155373597|NCT02781090|560800169|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
155373598|NCT02781090|560800168|FG000|3-Month Follow-Up|Death|1|||
155373599|NCT02781090|560800169|FG001|3-Month Follow-Up|Death|0|||
155373600|NCT02781090|560800168|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
155373601|NCT02781090|560800169|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
155373602|NCT02781090|560800168|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
155373603|NCT02781090|560800169|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
155373604|NCT02781090|560800168|FG000|6-Month Follow-Up|Death|0|||
155373605|NCT02781090|560800169|FG001|6-Month Follow-Up|Death|1|||
155373606|NCT00643617|560800170|FG000|Overall Study|Death|6|||
155373607|NCT00643617|560800171|FG001|Overall Study|Death|9|||
155373608|NCT00643617|560800170|FG000|Overall Study|Lost to Follow-up|42|||
155373609|NCT00643617|560800171|FG001|Overall Study|Lost to Follow-up|51|||
155373610|NCT01208103|560800172|FG000|Overall Study|Adverse Event|1|||
155430817|NCT04996797|561002394|FG002|Overall Study|Adverse Event|0|||
155430818|NCT04996797|561002395|FG003|Overall Study|Adverse Event|1|||
155430819|NCT04996797|561002392|FG000|Overall Study|Lack of Efficacy|0|||
155430820|NCT04996797|561002393|FG001|Overall Study|Lack of Efficacy|2|||
155430821|NCT04996797|561002394|FG002|Overall Study|Lack of Efficacy|0|||
155373611|NCT01208103|560800172|FG000|Overall Study|Withdrawal by Subject|1|||
155373612|NCT00416195|560800175|FG000|Overall Study|Adverse Event|1|||
155373613|NCT00416195|560800176|FG001|Overall Study|Adverse Event|2|||
155373614|NCT00416195|560800175|FG000|Overall Study|Protocol Violation|1|||
155430822|NCT04996797|561002395|FG003|Overall Study|Lack of Efficacy|0|||
155649574|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
155649575|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
155373615|NCT00416195|560800176|FG001|Overall Study|Protocol Violation|1|||
155373616|NCT00416195|560800175|FG000|Overall Study|Other|0|||
155373617|NCT00416195|560800176|FG001|Overall Study|Other|1|||
155373618|NCT01606670|560800183|FG000|Overall Study|Adverse Event|6|||
155373619|NCT01606670|560800183|FG000|Overall Study|Lack of Efficacy|2|||
155373620|NCT01606670|560800183|FG000|Overall Study|Lost to Follow-up|3|||
155373621|NCT01606670|560800183|FG000|Overall Study|Withdrawal by Subject|3|||
155373622|NCT01606670|560800183|FG000|Overall Study|Other Reason|2|||
155373623|NCT03653208|560800186|FG000|Overall Study|Withdrawal by Subject|0|||
155373624|NCT03653208|560800187|FG001|Overall Study|Withdrawal by Subject|0|||
155373625|NCT03653208|560800188|FG002|Overall Study|Withdrawal by Subject|0|||
155373626|NCT03653208|560800189|FG003|Overall Study|Withdrawal by Subject|0|||
155373627|NCT03653208|560800190|FG004|Overall Study|Withdrawal by Subject|1|||
155373628|NCT03653208|560800191|FG005|Overall Study|Withdrawal by Subject|0|||
155373629|NCT03653208|560800192|FG006|Overall Study|Withdrawal by Subject|0|||
155373630|NCT03653208|560800193|FG007|Overall Study|Withdrawal by Subject|1|||
155373631|NCT03653208|560800194|FG008|Overall Study|Withdrawal by Subject|1|||
155373632|NCT00368927|560800195|FG000|Overall Study|Lost to Follow-up|2|||
155373633|NCT00368927|560800196|FG001|Overall Study|Lost to Follow-up|0|||
155373634|NCT00368927|560800195|FG000|Overall Study|Adverse Event|1|||
155373635|NCT00368927|560800196|FG001|Overall Study|Adverse Event|1|||
155373636|NCT00368927|560800195|FG000|Overall Study|Withdrawal by Subject|1|||
155373637|NCT00368927|560800196|FG001|Overall Study|Withdrawal by Subject|2|||
155373638|NCT00368927|560800195|FG000|Overall Study|Physician Decision|1|||
155373639|NCT00368927|560800196|FG001|Overall Study|Physician Decision|0|||
155373640|NCT01877239|560800197|FG000|Overall Study|Adverse Event|4|||
155373641|NCT01877239|560800197|FG000|Overall Study|Disease Remission|1|||
155373642|NCT01877239|560800197|FG000|Overall Study|Withdrawal by Subject|4|||
155373643|NCT01877239|560800197|FG000|Overall Study|Other|2|||
155373644|NCT01877239|560800197|FG000|Overall Study|Lack of Efficacy|4|||
155373645|NCT01877239|560800197|FG000|Overall Study|Data not available|35|||
155373646|NCT01989169|560800201|FG000|Period 2|Adverse Event|0|||
155373647|NCT01989169|560800202|FG001|Period 2|Adverse Event|1|||
155373648|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
155373649|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
155373650|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
155373651|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
155373652|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
155373653|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
155373654|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
155373655|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
155373656|NCT01114880|560800203|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
155373657|NCT01114880|560800204|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
155373658|NCT01114880|560800203|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
155373659|NCT01114880|560800204|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
155373660|NCT00283244|560800206|FG000|Overall Study|Adverse Event|0|||
155373661|NCT00283244|560800207|FG001|Overall Study|Adverse Event|8|||
155373662|NCT00283244|560800208|FG002|Overall Study|Adverse Event|11|||
155373663|NCT00283244|560800206|FG000|Overall Study|Death|4|||
155373664|NCT00283244|560800207|FG001|Overall Study|Death|3|||
155373665|NCT00283244|560800208|FG002|Overall Study|Death|2|||
155373666|NCT00283244|560800206|FG000|Overall Study|Lack of Efficacy|8|||
155373667|NCT00283244|560800207|FG001|Overall Study|Lack of Efficacy|32|||
155373668|NCT00283244|560800208|FG002|Overall Study|Lack of Efficacy|26|||
155373669|NCT00283244|560800206|FG000|Overall Study|Withdrawal by Subject|1|||
155373670|NCT00283244|560800207|FG001|Overall Study|Withdrawal by Subject|2|||
155373671|NCT00283244|560800208|FG002|Overall Study|Withdrawal by Subject|2|||
155373672|NCT00283244|560800206|FG000|Overall Study|Physician Decision|0|||
155373673|NCT00283244|560800207|FG001|Overall Study|Physician Decision|0|||
155373674|NCT00283244|560800208|FG002|Overall Study|Physician Decision|1|||
155373675|NCT00283244|560800206|FG000|Overall Study|Medical illness (other complicating dz)|4|||
155373676|NCT00283244|560800207|FG001|Overall Study|Medical illness (other complicating dz)|3|||
155373677|NCT00283244|560800208|FG002|Overall Study|Medical illness (other complicating dz)|6|||
155373678|NCT00283244|560800206|FG000|Overall Study|Clinical deterioration|1|||
155373679|NCT00283244|560800207|FG001|Overall Study|Clinical deterioration|3|||
155373680|NCT00283244|560800208|FG002|Overall Study|Clinical deterioration|3|||
155373681|NCT01585155|560800209|FG000|Overall Study|Adverse Event|1|||
155373682|NCT01585155|560800209|FG000|Overall Study|Lack of Efficacy|2|||
155373683|NCT01585155|560800209|FG000|Overall Study|Worsening ulcerative colitis|2|||
155373684|NCT02235311|560800210|FG000|Overall Study|Lost to Follow-up|0|||
155430823|NCT04996797|561002392|FG000|Overall Study|Prohibited Medication|0|||
155430824|NCT04996797|561002393|FG001|Overall Study|Prohibited Medication|1|||
155430825|NCT04996797|561002394|FG002|Overall Study|Prohibited Medication|0|||
155649576|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
155430826|NCT04996797|561002395|FG003|Overall Study|Prohibited Medication|0|||
155430827|NCT04996797|561002392|FG000|Overall Study|Ongoing|68|||
155430828|NCT04996797|561002393|FG001|Overall Study|Ongoing|60|||
155430829|NCT04996797|561002394|FG002|Overall Study|Ongoing|22|||
155430830|NCT04996797|561002395|FG003|Overall Study|Ongoing|20|||
155430831|NCT04996797|561002392|FG000|Overall Study|Withdrawal by Subject|0|||
155430832|NCT04996797|561002393|FG001|Overall Study|Withdrawal by Subject|2|||
155430833|NCT04996797|561002394|FG002|Overall Study|Withdrawal by Subject|0|||
155430834|NCT04996797|561002395|FG003|Overall Study|Withdrawal by Subject|0|||
155430835|NCT02793544|561002396|FG000|Overall Study|Death|10|||
155430836|NCT02793544|561002397|FG001|Overall Study|Death|8|||
155430837|NCT02793544|561002396|FG000|Overall Study|Lost to Follow-up|2|||
155430838|NCT02793544|561002397|FG001|Overall Study|Lost to Follow-up|0|||
155430839|NCT02793544|561002396|FG000|Overall Study|Withdrawal by Subject|1|||
155430840|NCT02793544|561002397|FG001|Overall Study|Withdrawal by Subject|0|||
155430841|NCT04091217|561002398|FG000|Overall Study|Lost to Follow-up|2|||
155430842|NCT02747004|561002399|FG000|Overall Study|Withdrawal by Subject|8|||
155430843|NCT02747004|561002400|FG001|Overall Study|Withdrawal by Subject|5|||
155430844|NCT02747004|561002401|FG002|Overall Study|Withdrawal by Subject|4|||
155430845|NCT02747004|561002399|FG000|Overall Study|Lost to Follow-up|1|||
155430846|NCT02747004|561002400|FG001|Overall Study|Lost to Follow-up|2|||
155430847|NCT02747004|561002401|FG002|Overall Study|Lost to Follow-up|2|||
155430848|NCT02747004|561002399|FG000|Overall Study|on study treatment/follow-up|48|||
155430849|NCT02747004|561002400|FG001|Overall Study|on study treatment/follow-up|42|||
155430850|NCT02747004|561002401|FG002|Overall Study|on study treatment/follow-up|41|||
155430851|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
155511082|NCT00982410|561297402|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
155511083|NCT00982410|561297403|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
155511084|NCT00982410|561297402|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
155511085|NCT00982410|561297403|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
155511086|NCT00982410|561297402|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
155511087|NCT00982410|561297403|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
155511088|NCT00982410|561297402|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
155511089|NCT00982410|561297403|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
155511090|NCT00982410|561297402|FG000|6-month Follow-up Assessment|participant no transportation|1|||
155511091|NCT00982410|561297403|FG001|6-month Follow-up Assessment|participant no transportation|0|||
155511092|NCT00982410|561297402|FG000|6-month Follow-up Assessment|incarceration|0|||
155511093|NCT00982410|561297403|FG001|6-month Follow-up Assessment|incarceration|2|||
155511094|NCT00982410|561297402|FG000|6-month Follow-up Assessment|patent surgery|0|||
155511095|NCT00982410|561297403|FG001|6-month Follow-up Assessment|patent surgery|1|||
155511096|NCT00982410|561297402|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
155511097|NCT00982410|561297403|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
155511098|NCT00982410|561297402|FG000|12-month Follow-up Assessment|Death|0|||
155511099|NCT00982410|561297403|FG001|12-month Follow-up Assessment|Death|2|||
155511100|NCT00982410|561297402|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
155511101|NCT00982410|561297403|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
155511102|NCT00982410|561297402|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
155511103|NCT00982410|561297403|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
155511104|NCT00982410|561297402|FG000|12-month Follow-up Assessment|incarceration|2|||
155511105|NCT00982410|561297403|FG001|12-month Follow-up Assessment|incarceration|1|||
155511106|NCT00982410|561297402|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
155511107|NCT00982410|561297403|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
155511108|NCT02034799|561297406|FG000|Overall Study|Withdrawal by Subject|0|||
155511109|NCT02034799|561297407|FG001|Overall Study|Withdrawal by Subject|2|||
155511110|NCT02034799|561297406|FG000|Overall Study|Lost to Follow-up|0|||
155511111|NCT02034799|561297407|FG001|Overall Study|Lost to Follow-up|1|||
155511112|NCT02034799|561297406|FG000|Overall Study|Death|2|||
155511113|NCT02034799|561297407|FG001|Overall Study|Death|1|||
155511114|NCT00671879|561297414|FG000|Overall Study|Withdrawal by Subject|0|||
155511115|NCT00671879|561297415|FG001|Overall Study|Withdrawal by Subject|4|||
155511116|NCT00671879|561297416|FG002|Overall Study|Withdrawal by Subject|6|||
155511117|NCT01628120|561297417|FG000|Overall Study|Withdrawal by Subject|7|||
155511118|NCT01628120|561297417|FG000|Overall Study|Adverse Event|12|||
155511119|NCT01628120|561297417|FG000|Overall Study|Lost to Follow-up|1|||
155511120|NCT01628120|561297417|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
155511121|NCT01628120|561297417|FG000|Overall Study|Non-compliant with Study Procedures|1|||
155511122|NCT01628120|561297417|FG000|Overall Study|Not Treated|3|||
155511123|NCT01628120|561297417|FG000|Overall Study|Sponsor Decision|5|||
155511124|NCT01628120|561297417|FG000|Overall Study|Switched Dialysis Method|2|||
155430852|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
155430853|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
155430854|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
155430855|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
155373685|NCT02235311|560800211|FG001|Overall Study|Lost to Follow-up|1|||
155373686|NCT02235311|560800210|FG000|Overall Study|Protocol Violation|0|||
155373687|NCT02235311|560800211|FG001|Overall Study|Protocol Violation|1|||
155649577|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
155649578|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
155649579|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
155649580|NCT00407030|561808302|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
155649581|NCT00407030|561808303|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
155649582|NCT00407030|561808304|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
155511125|NCT01628120|561297417|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
155511126|NCT01628120|561297417|FG000|Overall Study|Moved or Relocated|5|||
155511127|NCT01628120|561297417|FG000|Overall Study|Kidney Transplant|2|||
155511128|NCT01628120|561297417|FG000|Overall Study|Use of Standard of Care|1|||
155373688|NCT00658788|560800212|FG000|Overall Study|Adverse Event|11|||
155373689|NCT00658788|560800212|FG000|Overall Study|Withdrawal by Subject|13|||
155373690|NCT00658788|560800212|FG000|Overall Study|Lost to Follow-up|18|||
155373691|NCT00658788|560800212|FG000|Overall Study|Treatment Discontinuation|32|||
155373692|NCT03898167|560800213|FG000|Overall Study|Terminated phone call early|7|||
155373693|NCT03898167|560800214|FG001|Overall Study|Terminated phone call early|0|||
155373694|NCT03898167|560800215|FG002|Overall Study|Terminated phone call early|0|||
155373695|NCT03898167|560800213|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
155373696|NCT03898167|560800214|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
155373697|NCT03898167|560800215|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
155373698|NCT00091169|560801842|FG000|Overall Study|Disease progression|3|||
155373699|NCT00091169|560801843|FG001|Overall Study|Disease progression|1|||
155373700|NCT00091169|560801842|FG000|Overall Study|Adverse Event|11|||
155373701|NCT00091169|560801843|FG001|Overall Study|Adverse Event|17|||
155373702|NCT00091169|560801842|FG000|Overall Study|Death|4|||
155373703|NCT00091169|560801843|FG001|Overall Study|Death|1|||
155511129|NCT01927757|561297420|FG000|Overall Study|Withdrawal by Subject|14|||
155511130|NCT01927757|561297420|FG000|Overall Study|Lost to Follow-up|2|||
155511131|NCT01927757|561297420|FG000|Overall Study|Decision by Sponsor|2|||
155511132|NCT01927757|561297420|FG000|Overall Study|Other|1|||
155511133|NCT01927757|561297420|FG000|Overall Study|Ethical Reasons|4|||
155511134|NCT00444795|561297421|FG000|Overall Study|Not Treated|1|||
155511135|NCT00444795|561297421|FG000|Overall Study|Treated Prior to the Contract Date|2|||
155511136|NCT00988169|561297422|FG000|Overall Study|Withdrawal by Subject|1|||
155511137|NCT02637076|561297424|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
155511138|NCT02637076|561297425|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
155511139|NCT02637076|561297424|FG000|Overall Study|Withdrawal by Subject|0|||
155511140|NCT02637076|561297425|FG001|Overall Study|Withdrawal by Subject|4|||
155511141|NCT00130520|561297426|FG000|Overall Study|Adverse Event|11|||
155511142|NCT00130520|561297426|FG000|Overall Study|Death|1|||
155511143|NCT00130520|561297426|FG000|Overall Study|Physician Decision|1|||
155511144|NCT00130520|561297426|FG000|Overall Study|Withdrawal by Subject|1|||
155511145|NCT00130520|561297426|FG000|Overall Study|Disease Progression|23|||
155511146|NCT00130520|561297426|FG000|Overall Study|Protocol non-compliance|1|||
155511147|NCT00130520|561297426|FG000|Overall Study|Did not meet re-treatment criteria|1|||
155373704|NCT00091169|560801842|FG000|Overall Study|Withdrawal by Subject|10|||
155373705|NCT00091169|560801843|FG001|Overall Study|Withdrawal by Subject|13|||
155511148|NCT01464827|561297427|FG000|Overall Study|Adverse Event|0|||
155511149|NCT01464827|561297428|FG001|Overall Study|Adverse Event|0|||
155649583|NCT01452789|561808305|FG000|Overall Study|Withdrawal by Subject|3|||
155373706|NCT00091169|560801842|FG000|Overall Study|Other|3|||
155373707|NCT00091169|560801843|FG001|Overall Study|Other|4|||
155373708|NCT00091169|560801842|FG000|Overall Study|Not start protocol therapy|26|||
155373709|NCT00091169|560801843|FG001|Overall Study|Not start protocol therapy|17|||
155373710|NCT04410523|560801844|FG000|Overall Study|Study terminated by sponsor|1|||
155373711|NCT04410523|560801845|FG001|Overall Study|Study terminated by sponsor|3|||
155373712|NCT04410523|560801846|FG002|Overall Study|Study terminated by sponsor|2|||
155373713|NCT04410523|560801847|FG003|Overall Study|Study terminated by sponsor|6|||
155373714|NCT04410523|560801848|FG004|Overall Study|Study terminated by sponsor|3|||
155373715|NCT04410523|560801849|FG005|Overall Study|Study terminated by sponsor|4|||
155373716|NCT04410523|560801844|FG000|Overall Study|Adverse Event|1|||
155373717|NCT04410523|560801845|FG001|Overall Study|Adverse Event|0|||
155373718|NCT04410523|560801846|FG002|Overall Study|Adverse Event|0|||
155373719|NCT04410523|560801847|FG003|Overall Study|Adverse Event|0|||
155373720|NCT04410523|560801848|FG004|Overall Study|Adverse Event|0|||
155373721|NCT04410523|560801849|FG005|Overall Study|Adverse Event|2|||
155511150|NCT01464827|561297429|FG002|Overall Study|Adverse Event|0|||
155511151|NCT01464827|561297430|FG003|Overall Study|Adverse Event|0|||
155511152|NCT01464827|561297431|FG004|Overall Study|Adverse Event|0|||
155649584|NCT01452789|561808306|FG001|Overall Study|Withdrawal by Subject|2|||
155649585|NCT00066170|561808307|FG000|Overall Study|Adverse Event|2|||
155511153|NCT01464827|561297432|FG005|Overall Study|Adverse Event|0|||
155373722|NCT04410523|560801844|FG000|Overall Study|Lost to Follow-up|0|||
155511154|NCT01464827|561297433|FG006|Overall Study|Adverse Event|0|||
155511155|NCT01464827|561297434|FG007|Overall Study|Adverse Event|0|||
155373723|NCT04410523|560801845|FG001|Overall Study|Lost to Follow-up|1|||
155373724|NCT04410523|560801846|FG002|Overall Study|Lost to Follow-up|0|||
155373725|NCT04410523|560801847|FG003|Overall Study|Lost to Follow-up|0|||
155511156|NCT01464827|561297435|FG008|Overall Study|Adverse Event|0|||
155511157|NCT01464827|561297436|FG009|Overall Study|Adverse Event|0|||
155511158|NCT01464827|561297437|FG010|Overall Study|Adverse Event|0|||
155511159|NCT01464827|561297438|FG011|Overall Study|Adverse Event|0|||
155511160|NCT01464827|561297439|FG012|Overall Study|Adverse Event|1|||
155373726|NCT04410523|560801848|FG004|Overall Study|Lost to Follow-up|0|||
155373727|NCT04410523|560801849|FG005|Overall Study|Lost to Follow-up|0|||
155373728|NCT04410523|560801844|FG000|Overall Study|Physician Decision|0|||
155373729|NCT04410523|560801845|FG001|Overall Study|Physician Decision|1|||
155373730|NCT04410523|560801846|FG002|Overall Study|Physician Decision|0|||
155373731|NCT04410523|560801847|FG003|Overall Study|Physician Decision|0|||
155373732|NCT04410523|560801848|FG004|Overall Study|Physician Decision|0|||
155373733|NCT04410523|560801849|FG005|Overall Study|Physician Decision|0|||
155373734|NCT04410523|560801844|FG000|Overall Study|Pregnancy|0|||
155373735|NCT04410523|560801845|FG001|Overall Study|Pregnancy|0|||
155373736|NCT04410523|560801846|FG002|Overall Study|Pregnancy|0|||
155373737|NCT04410523|560801847|FG003|Overall Study|Pregnancy|0|||
155373738|NCT04410523|560801848|FG004|Overall Study|Pregnancy|0|||
155373739|NCT04410523|560801849|FG005|Overall Study|Pregnancy|1|||
155373740|NCT04410523|560801844|FG000|Overall Study|Protocol deviation|0|||
155373741|NCT04410523|560801845|FG001|Overall Study|Protocol deviation|0|||
155373742|NCT04410523|560801846|FG002|Overall Study|Protocol deviation|0|||
155373743|NCT04410523|560801847|FG003|Overall Study|Protocol deviation|0|||
155373744|NCT04410523|560801848|FG004|Overall Study|Protocol deviation|0|||
155373745|NCT04410523|560801849|FG005|Overall Study|Protocol deviation|2|||
155373746|NCT04410523|560801844|FG000|Overall Study|Subject decision|2|||
155373747|NCT04410523|560801845|FG001|Overall Study|Subject decision|0|||
155373748|NCT04410523|560801846|FG002|Overall Study|Subject decision|0|||
155373749|NCT04410523|560801847|FG003|Overall Study|Subject decision|1|||
155373750|NCT04410523|560801848|FG004|Overall Study|Subject decision|0|||
155373751|NCT04410523|560801849|FG005|Overall Study|Subject decision|1|||
155373752|NCT00490490|560801850|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
155373753|NCT00490490|560801850|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
155373754|NCT03207451|560801851|FG000|Overall Study|scheduling conflict|1|||
155373755|NCT03207451|560801852|FG001|Overall Study|scheduling conflict|0|||
155373756|NCT03207451|560801853|FG002|Overall Study|scheduling conflict|2|||
155373757|NCT03207451|560801854|FG003|Overall Study|scheduling conflict|2|||
155511161|NCT01464827|561297440|FG013|Overall Study|Adverse Event|0|||
155511162|NCT01464827|561297427|FG000|Overall Study|Withdrawal by Subject|1|||
155373758|NCT03207451|560801851|FG000|Overall Study|Adverse Event|0|||
155373759|NCT03207451|560801852|FG001|Overall Study|Adverse Event|0|||
155373760|NCT03207451|560801853|FG002|Overall Study|Adverse Event|0|||
155373761|NCT03207451|560801854|FG003|Overall Study|Adverse Event|1|||
155373762|NCT02040584|560801855|FG000|Overall Study|Adverse Event|13|||
155373763|NCT02040584|560801856|FG001|Overall Study|Adverse Event|6|||
155373764|NCT02040584|560801855|FG000|Overall Study|Protocol Violation|9|||
155373765|NCT02040584|560801856|FG001|Overall Study|Protocol Violation|11|||
155373766|NCT02040584|560801855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155373767|NCT02040584|560801856|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155373768|NCT02040584|560801855|FG000|Overall Study|Death|6|||
155373769|NCT02040584|560801856|FG001|Overall Study|Death|3|||
155373770|NCT02040584|560801855|FG000|Overall Study|Transplant rejection/retransplant|0|||
155373771|NCT02040584|560801856|FG001|Overall Study|Transplant rejection/retransplant|1|||
155373772|NCT02040584|560801855|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
155373773|NCT02040584|560801856|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
155373774|NCT00996476|560801857|FG000|Overall Study|Withdrawal by Subject|1|||
155373775|NCT00996476|560801858|FG001|Overall Study|Withdrawal by Subject|2|||
155373776|NCT00996476|560801859|FG002|Overall Study|Withdrawal by Subject|1|||
155373777|NCT00996476|560801860|FG003|Overall Study|Withdrawal by Subject|0|||
155373778|NCT00996476|560801861|FG004|Overall Study|Withdrawal by Subject|1|||
155373779|NCT00996476|560801857|FG000|Overall Study|Adverse Event|0|||
155373780|NCT00996476|560801858|FG001|Overall Study|Adverse Event|1|||
155373781|NCT00996476|560801859|FG002|Overall Study|Adverse Event|0|||
155373782|NCT00996476|560801860|FG003|Overall Study|Adverse Event|0|||
155373783|NCT00996476|560801861|FG004|Overall Study|Adverse Event|1|||
155430856|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
155430857|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
155430858|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
155430859|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
155430860|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
155430861|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
155430862|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155430863|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155430864|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155430865|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155430866|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
155430867|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
155430868|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
155430869|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
155430870|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
155430871|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Death|0|||
155430872|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Death|1|||
155430873|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Death|0|||
155430874|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Death|0|||
155430875|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Death|0|||
155430876|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
155430877|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
155430878|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
155430879|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
155430880|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
155430881|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
155430882|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
155430883|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
155430884|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
155430885|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
155430886|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
155430887|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
155430888|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
155430889|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
155430890|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
155430891|NCT05087030|561002402|FG000|Main Period (Week 0 to Week 52)|Other|1|||
155430892|NCT05087030|561002403|FG001|Main Period (Week 0 to Week 52)|Other|2|||
155430893|NCT05087030|561002404|FG002|Main Period (Week 0 to Week 52)|Other|0|||
155430894|NCT05087030|561002405|FG003|Main Period (Week 0 to Week 52)|Other|0|||
155430895|NCT05087030|561002406|FG004|Main Period (Week 0 to Week 52)|Other|0|||
155430896|NCT05087030|561002402|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155430897|NCT05087030|561002403|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155430898|NCT05087030|561002404|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155430899|NCT05087030|561002405|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155373784|NCT01802567|560801862|FG000|Overall Study|Withdrawal by Subject|2|||
155373785|NCT01802567|560801862|FG000|Overall Study|Physician Decision|1|||
155430900|NCT05087030|561002406|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
155373786|NCT01802567|560801862|FG000|Overall Study|Lack of Efficacy|7|||
155373787|NCT01802567|560801862|FG000|Overall Study|Consented but did not start therapy|7|||
155373788|NCT01802567|560801862|FG000|Overall Study|Protocol Violation|1|||
155373789|NCT01895101|560801863|FG000|Overall Study|OPCAB procedure|1|||
155373790|NCT01895101|560801864|FG001|Overall Study|OPCAB procedure|1|||
155373791|NCT01895101|560801865|FG002|Overall Study|OPCAB procedure|3|||
155373792|NCT01895101|560801863|FG000|Overall Study|Withdrawal by Subject|0|||
155373793|NCT01895101|560801864|FG001|Overall Study|Withdrawal by Subject|1|||
155373794|NCT01895101|560801865|FG002|Overall Study|Withdrawal by Subject|2|||
155373795|NCT01895101|560801863|FG000|Overall Study|another study, enrolled in other study|0|||
155373796|NCT01895101|560801864|FG001|Overall Study|another study, enrolled in other study|1|||
155373797|NCT01895101|560801865|FG002|Overall Study|another study, enrolled in other study|0|||
155373798|NCT01895101|560801863|FG000|Overall Study|Death|0|||
155373799|NCT01895101|560801864|FG001|Overall Study|Death|1|||
155373800|NCT01895101|560801865|FG002|Overall Study|Death|0|||
155373801|NCT01895101|560801863|FG000|Overall Study|coagulation disorder|0|||
155373802|NCT01895101|560801864|FG001|Overall Study|coagulation disorder|1|||
155373803|NCT01895101|560801865|FG002|Overall Study|coagulation disorder|0|||
155373804|NCT00436852|560801866|FG000|Overall Study|Death|23|||
155373805|NCT00436852|560801867|FG001|Overall Study|Death|34|||
155373806|NCT00436852|560801866|FG000|Overall Study|Lack of Efficacy|9|||
155373807|NCT00436852|560801867|FG001|Overall Study|Lack of Efficacy|7|||
155373808|NCT00436852|560801866|FG000|Overall Study|Withdrawal by Subject|2|||
155373809|NCT00436852|560801867|FG001|Overall Study|Withdrawal by Subject|4|||
155373810|NCT00436852|560801866|FG000|Overall Study|Ineligible|1|||
155373811|NCT00436852|560801867|FG001|Overall Study|Ineligible|0|||
155373812|NCT00370682|560801868|FG000|Overall Study|Moved from area|0|||
155373813|NCT00370682|560801869|FG001|Overall Study|Moved from area|2|||
155373814|NCT00370682|560801870|FG002|Overall Study|Moved from area|0|||
155373815|NCT00370682|560801868|FG000|Overall Study|Lost to Follow-up|0|||
155373816|NCT00370682|560801869|FG001|Overall Study|Lost to Follow-up|1|||
155373817|NCT00370682|560801870|FG002|Overall Study|Lost to Follow-up|1|||
155373818|NCT03167359|560801871|FG000|Overall Study|Physician Decision|1|||
155373819|NCT03167359|560801871|FG000|Overall Study|Lost to Follow-up|1|||
155373820|NCT03339583|560801872|FG000|First Intervention (14 Days)|Adverse Event|1|||
155373821|NCT03339583|560801873|FG001|First Intervention (14 Days)|Adverse Event|0|||
155373822|NCT03339583|560801872|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
155373823|NCT03339583|560801873|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
155373824|NCT03339583|560801872|FG000|Second Intervention (14 Days)|Adverse Event|0|||
155373825|NCT03339583|560801873|FG001|Second Intervention (14 Days)|Adverse Event|1|||
155373826|NCT03339583|560801872|FG000|Follow-up (14 Days)|Physician Decision|6|||
155373827|NCT03339583|560801873|FG001|Follow-up (14 Days)|Physician Decision|3|||
155373828|NCT00943852|560801874|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373829|NCT00943852|560801875|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373830|NCT00943852|560801876|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373831|NCT00943852|560801877|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
155373832|NCT00943852|560801878|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373833|NCT00943852|560801879|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373834|NCT00943852|560801880|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373835|NCT00943852|560801881|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373836|NCT00943852|560801882|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373837|NCT00943852|560801883|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373838|NCT00943852|560801874|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373839|NCT00943852|560801875|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373840|NCT00943852|560801876|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373841|NCT00943852|560801877|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373842|NCT00943852|560801878|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373843|NCT00943852|560801879|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
155373844|NCT00943852|560801880|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373845|NCT00943852|560801881|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373846|NCT00943852|560801882|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373847|NCT00943852|560801883|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373848|NCT00943852|560801874|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373849|NCT00943852|560801875|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373850|NCT00943852|560801876|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373851|NCT00943852|560801877|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373852|NCT00943852|560801878|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155649586|NCT00066170|561808308|FG001|Overall Study|Adverse Event|4|||
155373853|NCT00943852|560801879|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155430901|NCT04885257|561002407|FG000|Overall Study|Withdrawal by Subject|1|||
155373854|NCT00943852|560801880|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
155373855|NCT00943852|560801881|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373856|NCT00943852|560801882|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373857|NCT00943852|560801883|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373858|NCT00943852|560801874|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373859|NCT00943852|560801875|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373860|NCT00943852|560801876|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373861|NCT00943852|560801877|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373862|NCT00943852|560801878|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373863|NCT00943852|560801879|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373864|NCT00943852|560801880|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373865|NCT00943852|560801881|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
155373866|NCT00943852|560801882|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373867|NCT00943852|560801883|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373868|NCT00943852|560801874|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373869|NCT00943852|560801875|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373870|NCT00943852|560801876|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373871|NCT00943852|560801877|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373872|NCT00943852|560801878|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373873|NCT00943852|560801879|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373874|NCT00943852|560801880|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373875|NCT00943852|560801881|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373876|NCT00943852|560801882|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373877|NCT00943852|560801883|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373878|NCT02141620|560801884|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
155373879|NCT02141620|560801885|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
155373880|NCT00772330|560801886|FG000|Overall Study|Lost to Follow-up|3|||
155373881|NCT00734591|560801887|FG000|Screening for Prospective Period|Site did not participate|1604|||
155373882|NCT00734591|560801888|FG001|Screening for Prospective Period|Site did not participate|1488|||
155373883|NCT00734591|560801887|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
155373884|NCT00734591|560801888|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
155373885|NCT00734591|560801887|FG000|Prospective Period|Withdrawal by Subject|11|||
155373886|NCT00734591|560801888|FG001|Prospective Period|Withdrawal by Subject|9|||
155373887|NCT00734591|560801887|FG000|Prospective Period|Lost to Follow-up|37|||
155373888|NCT00734591|560801888|FG001|Prospective Period|Lost to Follow-up|33|||
155373889|NCT00734591|560801887|FG000|Prospective Period|Study Terminated|1|||
155373890|NCT00734591|560801888|FG001|Prospective Period|Study Terminated|0|||
155373891|NCT00734591|560801887|FG000|Prospective Period|Other|2|||
155373892|NCT00734591|560801888|FG001|Prospective Period|Other|2|||
155373893|NCT00730275|560801889|FG000|Overall Study|Withdrawal by Subject|0|||
155373894|NCT00730275|560801890|FG001|Overall Study|Withdrawal by Subject|0|||
155373895|NCT00730275|560801891|FG002|Overall Study|Withdrawal by Subject|0|||
155373896|NCT00730275|560801892|FG003|Overall Study|Withdrawal by Subject|1|||
155373897|NCT00356408|560801893|FG000|Overall Study|Adverse Event|9|||
155373898|NCT00356408|560801893|FG000|Overall Study|Lack of Efficacy|36|||
155373899|NCT00356408|560801893|FG000|Overall Study|Lost to Follow-up|2|||
155373900|NCT00356408|560801893|FG000|Overall Study|Withdrawal by Subject|6|||
155373901|NCT00356408|560801893|FG000|Overall Study|Other: Principal investigator discretion|3|||
155373902|NCT00356408|560801893|FG000|Overall Study|Other: Sponsor request|1|||
155373903|NCT00356408|560801893|FG000|Overall Study|Other: Azathioprine stopped|1|||
155373904|NCT00356408|560801893|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
155373905|NCT00356408|560801893|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
155373906|NCT05487586|560801894|FG000|Overall Study|Death|22|||
155373907|NCT05487586|560801894|FG000|Overall Study|Physician Decision|1|||
155373908|NCT05487586|560801894|FG000|Overall Study|Transfer to another hospital|4|||
155373909|NCT05487586|560801894|FG000|Overall Study|Other|1|||
155373910|NCT03921723|560801895|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
155430902|NCT04885257|561002408|FG001|Overall Study|Withdrawal by Subject|0|||
155430903|NCT04640766|561002409|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
155430904|NCT02597062|561002410|FG000|Overall Study|Ineligible|1|||
155430905|NCT00741819|561002411|FG000|Overall Study|Adverse Event|3|||
155430906|NCT00741819|561002411|FG000|Overall Study|Withdrawal by Subject|3|||
155430907|NCT00741819|561002411|FG000|Overall Study|Death|1|||
155511163|NCT01464827|561297428|FG001|Overall Study|Withdrawal by Subject|0|||
155511164|NCT01464827|561297429|FG002|Overall Study|Withdrawal by Subject|0|||
155511165|NCT01464827|561297430|FG003|Overall Study|Withdrawal by Subject|0|||
155373911|NCT03921723|560801895|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
155373912|NCT03015129|560801896|FG000|Overall Study|Death|2|||
155511166|NCT01464827|561297431|FG004|Overall Study|Withdrawal by Subject|1|||
155511167|NCT01464827|561297432|FG005|Overall Study|Withdrawal by Subject|0|||
155373913|NCT03015129|560801897|FG001|Overall Study|Death|2|||
155373914|NCT03015129|560801896|FG000|Overall Study|Lost to Follow-up|0|||
155373915|NCT03015129|560801897|FG001|Overall Study|Lost to Follow-up|1|||
155373916|NCT03015129|560801896|FG000|Overall Study|Progression of disease|38|||
155373917|NCT03015129|560801897|FG001|Overall Study|Progression of disease|33|||
155373918|NCT03015129|560801896|FG000|Overall Study|Adverse Event|0|||
155373919|NCT03015129|560801897|FG001|Overall Study|Adverse Event|4|||
155373920|NCT00939822|560801903|FG000|Overall Study|Lost to Follow-up|1|||
155373921|NCT00939822|560801904|FG001|Overall Study|Lost to Follow-up|0|||
155373922|NCT00939822|560801903|FG000|Overall Study|withdrew from study due to busy schedule|1|||
155373923|NCT00939822|560801904|FG001|Overall Study|withdrew from study due to busy schedule|1|||
155373924|NCT00939822|560801903|FG000|Overall Study|Mental health issues|0|||
155373925|NCT00939822|560801904|FG001|Overall Study|Mental health issues|2|||
155373926|NCT05032872|560801905|FG000|Overall Study|Adverse Event|1|||
155373927|NCT05032872|560801906|FG001|Overall Study|Adverse Event|0|||
155373928|NCT05032872|560801905|FG000|Overall Study|Lost to Follow-up|2|||
155373929|NCT05032872|560801906|FG001|Overall Study|Lost to Follow-up|4|||
155373930|NCT05032872|560801905|FG000|Overall Study|Withdrawal by Subject|4|||
155373931|NCT05032872|560801906|FG001|Overall Study|Withdrawal by Subject|3|||
155373932|NCT00406692|560801914|FG000|Overall Study|Withdrawal by Subject|4|||
155373933|NCT00406692|560801914|FG000|Overall Study|Physician Decision|1|||
155373934|NCT00406692|560801914|FG000|Overall Study|Adverse Event|1|||
155511168|NCT01464827|561297433|FG006|Overall Study|Withdrawal by Subject|0|||
155511169|NCT01464827|561297434|FG007|Overall Study|Withdrawal by Subject|1|||
155511170|NCT01464827|561297435|FG008|Overall Study|Withdrawal by Subject|0|||
155373935|NCT00406692|560801914|FG000|Overall Study|Lack of Efficacy|1|||
155373936|NCT00821587|560801915|FG000|Overall Study|Physician Decision|0|||
155373937|NCT00821587|560801916|FG001|Overall Study|Physician Decision|1|||
155511171|NCT01464827|561297436|FG009|Overall Study|Withdrawal by Subject|0|||
155511172|NCT01464827|561297437|FG010|Overall Study|Withdrawal by Subject|0|||
155511173|NCT01464827|561297438|FG011|Overall Study|Withdrawal by Subject|0|||
155511174|NCT01464827|561297439|FG012|Overall Study|Withdrawal by Subject|0|||
155511175|NCT01464827|561297440|FG013|Overall Study|Withdrawal by Subject|0|||
155511176|NCT01464827|561297427|FG000|Overall Study|Lost to Follow-up|0|||
155511177|NCT01464827|561297428|FG001|Overall Study|Lost to Follow-up|2|||
155373938|NCT04488770|560801917|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373939|NCT04488770|560801918|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373940|NCT04488770|560801919|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373941|NCT04488770|560801920|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
155373942|NCT04488770|560801921|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155511178|NCT01464827|561297429|FG002|Overall Study|Lost to Follow-up|0|||
155511179|NCT01464827|561297430|FG003|Overall Study|Lost to Follow-up|2|||
155511180|NCT01464827|561297431|FG004|Overall Study|Lost to Follow-up|3|||
155511181|NCT01464827|561297432|FG005|Overall Study|Lost to Follow-up|1|||
155511182|NCT01464827|561297433|FG006|Overall Study|Lost to Follow-up|2|||
155511183|NCT01464827|561297434|FG007|Overall Study|Lost to Follow-up|2|||
155511184|NCT01464827|561297435|FG008|Overall Study|Lost to Follow-up|0|||
155511185|NCT01464827|561297436|FG009|Overall Study|Lost to Follow-up|0|||
155511186|NCT01464827|561297437|FG010|Overall Study|Lost to Follow-up|0|||
155511187|NCT01464827|561297438|FG011|Overall Study|Lost to Follow-up|1|||
155511188|NCT01464827|561297439|FG012|Overall Study|Lost to Follow-up|0|||
155511189|NCT01464827|561297440|FG013|Overall Study|Lost to Follow-up|1|||
155511190|NCT01464827|561297427|FG000|Overall Study|Other|2|||
155511191|NCT01464827|561297428|FG001|Overall Study|Other|3|||
155511192|NCT01464827|561297429|FG002|Overall Study|Other|0|||
155511193|NCT01464827|561297430|FG003|Overall Study|Other|2|||
155511194|NCT01464827|561297431|FG004|Overall Study|Other|3|||
155511195|NCT01464827|561297432|FG005|Overall Study|Other|0|||
155511196|NCT01464827|561297433|FG006|Overall Study|Other|1|||
155511197|NCT01464827|561297434|FG007|Overall Study|Other|0|||
155511198|NCT01464827|561297435|FG008|Overall Study|Other|3|||
155511199|NCT01464827|561297436|FG009|Overall Study|Other|1|||
155511200|NCT01464827|561297437|FG010|Overall Study|Other|2|||
155511201|NCT01464827|561297438|FG011|Overall Study|Other|0|||
155511202|NCT01464827|561297439|FG012|Overall Study|Other|1|||
155511203|NCT01464827|561297440|FG013|Overall Study|Other|0|||
155511204|NCT01464827|561297427|FG000|Overall Study|Not Treated|0|||
155511205|NCT01464827|561297428|FG001|Overall Study|Not Treated|2|||
155511206|NCT01464827|561297429|FG002|Overall Study|Not Treated|0|||
155511207|NCT01464827|561297430|FG003|Overall Study|Not Treated|0|||
155511208|NCT01464827|561297431|FG004|Overall Study|Not Treated|1|||
155511209|NCT01464827|561297432|FG005|Overall Study|Not Treated|0|||
155511210|NCT01464827|561297433|FG006|Overall Study|Not Treated|1|||
155511211|NCT01464827|561297434|FG007|Overall Study|Not Treated|0|||
155511212|NCT01464827|561297435|FG008|Overall Study|Not Treated|0|||
155511213|NCT01464827|561297436|FG009|Overall Study|Not Treated|2|||
155511214|NCT01464827|561297437|FG010|Overall Study|Not Treated|0|||
155511215|NCT01464827|561297438|FG011|Overall Study|Not Treated|1|||
155511216|NCT01464827|561297439|FG012|Overall Study|Not Treated|0|||
155511217|NCT01464827|561297440|FG013|Overall Study|Not Treated|2|||
155511218|NCT00613574|561297441|FG000|Overall Study|Adverse Event|3|||
155511219|NCT00613574|561297441|FG000|Overall Study|Lost to Follow-up|2|||
155373943|NCT04488770|560801922|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373944|NCT04488770|560801923|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373945|NCT04488770|560801924|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373946|NCT04488770|560801925|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373947|NCT04488770|560801926|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155511220|NCT00613574|561297441|FG000|Overall Study|Other|1|||
155511221|NCT04604184|561297443|FG000|Overall Study|Adverse Event|5|||
155511222|NCT04604184|561297444|FG001|Overall Study|Adverse Event|5|||
155511223|NCT04604184|561297443|FG000|Overall Study|Death|2|||
155511224|NCT04604184|561297444|FG001|Overall Study|Death|1|||
155511225|NCT04604184|561297443|FG000|Overall Study|Withdrawal by Subject|1|||
155511226|NCT04604184|561297444|FG001|Overall Study|Withdrawal by Subject|3|||
155511227|NCT04604184|561297443|FG000|Overall Study|Not treated|2|||
155511228|NCT04604184|561297444|FG001|Overall Study|Not treated|2|||
155373948|NCT04488770|560801927|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373949|NCT04488770|560801928|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155511229|NCT04604184|561297443|FG000|Overall Study|Due to sponsor decision|9|||
155511230|NCT04604184|561297444|FG001|Overall Study|Due to sponsor decision|7|||
155511231|NCT04604184|561297443|FG000|Overall Study|Physician Decision|0|||
155511232|NCT04604184|561297444|FG001|Overall Study|Physician Decision|1|||
155511233|NCT04604184|561297443|FG000|Overall Study|Transfer to healthcare|1|||
155511234|NCT04604184|561297444|FG001|Overall Study|Transfer to healthcare|0|||
155511235|NCT00582036|561297445|FG000|Overall Study|Withdrawal by Subject|0|||
155511236|NCT00582036|561297446|FG001|Overall Study|Withdrawal by Subject|1|||
155511237|NCT02711956|561297447|FG000|Overall Study|Adverse Event|0|||
155511238|NCT02711956|561297448|FG001|Overall Study|Adverse Event|0|||
155511239|NCT02711956|561297449|FG002|Overall Study|Adverse Event|0|||
155373950|NCT04488770|560801929|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373951|NCT04488770|560801917|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
155373952|NCT04488770|560801918|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373953|NCT04488770|560801919|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373954|NCT04488770|560801920|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373955|NCT04488770|560801921|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373956|NCT04488770|560801922|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373957|NCT04488770|560801923|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373958|NCT04488770|560801924|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373959|NCT04488770|560801925|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373960|NCT04488770|560801926|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373961|NCT04488770|560801927|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373962|NCT04488770|560801928|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373963|NCT04488770|560801929|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373964|NCT04488770|560801917|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373965|NCT04488770|560801918|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373966|NCT04488770|560801919|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373967|NCT04488770|560801920|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373968|NCT04488770|560801921|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373969|NCT04488770|560801922|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155373970|NCT04488770|560801923|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155373971|NCT04488770|560801924|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373972|NCT04488770|560801925|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373973|NCT04488770|560801926|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373974|NCT04488770|560801927|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373975|NCT04488770|560801928|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373976|NCT04488770|560801929|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373977|NCT04488770|560801917|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373978|NCT04488770|560801918|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373979|NCT04488770|560801919|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373980|NCT04488770|560801920|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373981|NCT04488770|560801921|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
155373982|NCT04488770|560801922|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373983|NCT04488770|560801923|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373984|NCT04488770|560801924|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373985|NCT04488770|560801925|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373986|NCT04488770|560801926|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373987|NCT04488770|560801927|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373988|NCT04488770|560801928|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373989|NCT04488770|560801929|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373990|NCT03547739|560801930|FG000|Overall Study|Death|0|||
155373991|NCT03547739|560801931|FG001|Overall Study|Death|1|||
155373992|NCT03547739|560801932|FG002|Overall Study|Death|5|||
155373993|NCT03547739|560801930|FG000|Overall Study|Adverse Event|24|||
155373994|NCT03547739|560801931|FG001|Overall Study|Adverse Event|11|||
155373995|NCT03547739|560801932|FG002|Overall Study|Adverse Event|13|||
155373996|NCT03547739|560801930|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
155373997|NCT03547739|560801931|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
155373998|NCT03547739|560801932|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
155373999|NCT03547739|560801930|FG000|Overall Study|Lost to Follow-up|80|||
155374000|NCT03547739|560801931|FG001|Overall Study|Lost to Follow-up|84|||
155374001|NCT03547739|560801932|FG002|Overall Study|Lost to Follow-up|116|||
155374002|NCT01744392|560801937|FG000|Overall Study|Physician Decision|1|||
155374003|NCT01696955|560801941|FG000|Main Study|Protocol Violation|1|||
155374004|NCT01696955|560801942|FG001|Main Study|Protocol Violation|0|||
155374005|NCT01696955|560801941|FG000|Main Study|Withdrawal by Subject|1|||
155374006|NCT01696955|560801942|FG001|Main Study|Withdrawal by Subject|1|||
155374007|NCT00798590|560801949|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
155374008|NCT00798590|560801950|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
155374009|NCT01152814|560801953|FG000|Overall Study|Lost to Follow-up|2|||
155374010|NCT01280357|560801954|FG000|Overall Study|Excluded no internal monitoring|14|||
155374011|NCT01280357|560801954|FG000|Overall Study|IInsufficient data/No data supplied|12|||
155374012|NCT03284203|560801955|FG000|Overall Study|Lost to Follow-up|3|||
155374013|NCT00992225|560801956|FG000|Overall Study|Entry Criteria Not Met|8|||
155430908|NCT00741819|561002411|FG000|Overall Study|Disease progression|1|||
155430909|NCT00609622|561002414|FG000|Overall Study|Adverse Event|14|||
155430910|NCT00609622|561002415|FG001|Overall Study|Adverse Event|10|||
155374014|NCT00992225|560801956|FG000|Overall Study|Adverse Event|2|||
155374015|NCT03466073|560801957|FG000|Overall Study|Death|1|||
155374016|NCT03466073|560801958|FG001|Overall Study|Death|0|||
155374017|NCT03466073|560801959|FG002|Overall Study|Death|0|||
155374018|NCT03466073|560801960|FG003|Overall Study|Death|0|||
155374019|NCT03466073|560801961|FG004|Overall Study|Death|0|||
155374020|NCT03466073|560801962|FG005|Overall Study|Death|1|||
155374021|NCT00744757|560801963|FG000|Overall Study|Objective disease progression|7|||
155374022|NCT00744757|560801963|FG000|Overall Study|Physician Decision|5|||
155374023|NCT00744757|560801963|FG000|Overall Study|Withdrawal by Subject|1|||
155374024|NCT00744757|560801963|FG000|Overall Study|Death|6|||
155374025|NCT00744757|560801963|FG000|Overall Study|Adverse Event|2|||
155374026|NCT00532493|560801964|FG000|Overall Study|Death|1|||
155374027|NCT00532493|560801965|FG001|Overall Study|Death|1|||
155374028|NCT00532493|560801964|FG000|Overall Study|Lost to Follow-up|10|||
155374029|NCT00532493|560801965|FG001|Overall Study|Lost to Follow-up|7|||
155374030|NCT00532493|560801964|FG000|Overall Study|Withdrawal by Subject|7|||
155374031|NCT00532493|560801965|FG001|Overall Study|Withdrawal by Subject|9|||
155374032|NCT00532493|560801964|FG000|Overall Study|Physician Decision|1|||
155374033|NCT00532493|560801965|FG001|Overall Study|Physician Decision|6|||
155374034|NCT00532493|560801964|FG000|Overall Study|Adverse Event|6|||
155374035|NCT00532493|560801965|FG001|Overall Study|Adverse Event|5|||
155374036|NCT00532493|560801964|FG000|Overall Study|Protocol Deviation|1|||
155374037|NCT00532493|560801965|FG001|Overall Study|Protocol Deviation|0|||
155374038|NCT00532493|560801964|FG000|Overall Study|Subject Moved Away|3|||
155374039|NCT00532493|560801965|FG001|Overall Study|Subject Moved Away|1|||
155374040|NCT00532493|560801964|FG000|Overall Study|Contraindicative Medication|1|||
155374041|NCT00532493|560801965|FG001|Overall Study|Contraindicative Medication|0|||
155374042|NCT02045875|560801969|FG000|Overall Study|Lost to Follow-up|3|||
155374043|NCT02045875|560801970|FG001|Overall Study|Lost to Follow-up|0|||
155374044|NCT02045875|560801969|FG000|Overall Study|Withdrawal by Subject|4|||
155374045|NCT02045875|560801970|FG001|Overall Study|Withdrawal by Subject|3|||
155374046|NCT00775463|560803835|FG000|Overall Study|Withdrawal by Subject|0|||
155374047|NCT00775463|560803836|FG001|Overall Study|Withdrawal by Subject|1|||
155374048|NCT00775463|560803835|FG000|Overall Study|Adverse Event|7|||
155374049|NCT00775463|560803836|FG001|Overall Study|Adverse Event|9|||
155374050|NCT00775463|560803835|FG000|Overall Study|Protocol Violation|2|||
155374051|NCT00775463|560803836|FG001|Overall Study|Protocol Violation|2|||
155374052|NCT00775463|560803835|FG000|Overall Study|Lost to Follow-up|1|||
155374053|NCT00775463|560803836|FG001|Overall Study|Lost to Follow-up|0|||
155374054|NCT00775463|560803835|FG000|Overall Study|Lack of Efficacy|1|||
155374055|NCT00775463|560803836|FG001|Overall Study|Lack of Efficacy|1|||
155374056|NCT02980731|560803837|FG000|Overall Study|Death|63|||
155374057|NCT02980731|560803837|FG000|Overall Study|Withdrawal by Subject|6|||
155374058|NCT02980731|560803837|FG000|Overall Study|Lost to Follow-up|5|||
155374059|NCT02980731|560803837|FG000|Overall Study|Study terminated by Sponsor|4|||
155374060|NCT02980731|560803837|FG000|Overall Study|Completed survival follow-up period|65|||
155374061|NCT02980731|560803837|FG000|Overall Study|COVID-19 infection|1|||
155374062|NCT02980731|560803837|FG000|Overall Study|Other, not specified|66|||
155374063|NCT01789567|560803839|FG000|Overall Study|Death|6|||
155374064|NCT02731690|560803842|FG000|Overall Study|Adverse Event|1|||
155374065|NCT02731690|560803842|FG000|Overall Study|Withdrawal by Subject|3|||
155374066|NCT02731690|560803842|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
155374067|NCT00872989|560803843|FG000|Overall Study|Adverse Event|7|||
155374068|NCT00872989|560803844|FG001|Overall Study|Adverse Event|15|||
155374069|NCT00872989|560803843|FG000|Overall Study|Withdrawal by Subject|8|||
155374070|NCT00872989|560803844|FG001|Overall Study|Withdrawal by Subject|5|||
155374071|NCT00872989|560803843|FG000|Overall Study|Progression/relapse|47|||
155374072|NCT00872989|560803844|FG001|Overall Study|Progression/relapse|35|||
155374073|NCT00872989|560803843|FG000|Overall Study|Not protocol specified|3|||
155374074|NCT00872989|560803844|FG001|Overall Study|Not protocol specified|8|||
155374075|NCT03900416|560803850|FG000|Six Week Follow-up|Lost to Follow-up|1|||
155374076|NCT03900416|560803851|FG001|Six Week Follow-up|Lost to Follow-up|0|||
155374077|NCT03900416|560803850|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
155374078|NCT03900416|560803851|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
155374079|NCT03900416|560803850|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
155374080|NCT03900416|560803851|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
155374081|NCT03900416|560803850|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
155374082|NCT03900416|560803851|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
155374083|NCT03900416|560803850|FG000|Twelve Week Follow-up|Adverse Event|1|||
155374084|NCT03900416|560803851|FG001|Twelve Week Follow-up|Adverse Event|1|||
155374085|NCT03900416|560803850|FG000|Six Month Follow-up|Lost to Follow-up|4|||
155374086|NCT03900416|560803851|FG001|Six Month Follow-up|Lost to Follow-up|3|||
155374087|NCT03900416|560803850|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
155374088|NCT03900416|560803851|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
155374089|NCT00307684|560803852|FG000|Open Label Phase|Lack of Efficacy|0|||
155374090|NCT00307684|560803853|FG001|Open Label Phase|Lack of Efficacy|0|||
155374091|NCT00307684|560803854|FG002|Open Label Phase|Lack of Efficacy|3|||
155374092|NCT00307684|560803852|FG000|Open Label Phase|Adverse Event|0|||
155511240|NCT02711956|561297450|FG003|Overall Study|Adverse Event|1|||
155511241|NCT02711956|561297451|FG004|Overall Study|Adverse Event|2|||
155374093|NCT00307684|560803853|FG001|Open Label Phase|Adverse Event|0|||
155374094|NCT00307684|560803854|FG002|Open Label Phase|Adverse Event|16|||
155374095|NCT00307684|560803852|FG000|Open Label Phase|Withdrawal by Subject|0|||
155374096|NCT00307684|560803853|FG001|Open Label Phase|Withdrawal by Subject|0|||
155374097|NCT00307684|560803854|FG002|Open Label Phase|Withdrawal by Subject|15|||
155374098|NCT00307684|560803852|FG000|Open Label Phase|Lost to Follow-up|0|||
155374099|NCT00307684|560803853|FG001|Open Label Phase|Lost to Follow-up|0|||
155374100|NCT00307684|560803854|FG002|Open Label Phase|Lost to Follow-up|11|||
155374101|NCT00307684|560803852|FG000|Open Label Phase|non compliance|0|||
155374102|NCT00307684|560803853|FG001|Open Label Phase|non compliance|0|||
155374103|NCT00307684|560803854|FG002|Open Label Phase|non compliance|5|||
155374104|NCT00307684|560803852|FG000|Open Label Phase|other|0|||
155374105|NCT00307684|560803853|FG001|Open Label Phase|other|0|||
155374106|NCT00307684|560803854|FG002|Open Label Phase|other|6|||
155374107|NCT00307684|560803852|FG000|Double Blind Phase|Lack of Efficacy|2|||
155374108|NCT00307684|560803853|FG001|Double Blind Phase|Lack of Efficacy|5|||
155374109|NCT00307684|560803854|FG002|Double Blind Phase|Lack of Efficacy|0|||
155374110|NCT00224887|560803855|FG000|Overall Study|Pregnancy|6|||
155374111|NCT00224887|560803856|FG001|Overall Study|Pregnancy|6|||
155374112|NCT00338962|560803857|FG000|Overall Study|Lost to Follow-up|3|||
155374113|NCT00338962|560803858|FG001|Overall Study|Lost to Follow-up|3|||
155374114|NCT00338962|560803859|FG002|Overall Study|Lost to Follow-up|2|||
155374115|NCT00338962|560803860|FG003|Overall Study|Lost to Follow-up|3|||
155374116|NCT00338962|560803857|FG000|Overall Study|Withdrawal by Subject|1|||
155374117|NCT00338962|560803858|FG001|Overall Study|Withdrawal by Subject|0|||
155374118|NCT00338962|560803859|FG002|Overall Study|Withdrawal by Subject|0|||
155374119|NCT00338962|560803860|FG003|Overall Study|Withdrawal by Subject|0|||
155374120|NCT00338962|560803857|FG000|Overall Study|No Transportation|2|||
155374121|NCT00338962|560803858|FG001|Overall Study|No Transportation|0|||
155374122|NCT00338962|560803859|FG002|Overall Study|No Transportation|0|||
155374123|NCT00338962|560803860|FG003|Overall Study|No Transportation|0|||
155374124|NCT00338962|560803857|FG000|Overall Study|Time Constraint|2|||
155374125|NCT00338962|560803858|FG001|Overall Study|Time Constraint|0|||
155374126|NCT00338962|560803859|FG002|Overall Study|Time Constraint|0|||
155374127|NCT00338962|560803860|FG003|Overall Study|Time Constraint|0|||
155374128|NCT00338962|560803857|FG000|Overall Study|Moved|0|||
155374129|NCT00338962|560803858|FG001|Overall Study|Moved|1|||
155374130|NCT00338962|560803859|FG002|Overall Study|Moved|0|||
155374131|NCT00338962|560803860|FG003|Overall Study|Moved|0|||
155374132|NCT00338962|560803857|FG000|Overall Study|Adverse Event|0|||
155374133|NCT00338962|560803858|FG001|Overall Study|Adverse Event|0|||
155511242|NCT02711956|561297452|FG005|Overall Study|Adverse Event|0|||
155511243|NCT02711956|561297453|FG006|Overall Study|Adverse Event|0|||
155511244|NCT02711956|561297454|FG007|Overall Study|Adverse Event|1|||
155511245|NCT02711956|561297455|FG008|Overall Study|Adverse Event|1|||
155511246|NCT02711956|561297456|FG009|Overall Study|Adverse Event|1|||
155511247|NCT02711956|561297457|FG010|Overall Study|Adverse Event|1|||
155511248|NCT02711956|561297458|FG011|Overall Study|Adverse Event|0|||
155511249|NCT02711956|561297459|FG012|Overall Study|Adverse Event|0|||
155511250|NCT02711956|561297460|FG013|Overall Study|Adverse Event|0|||
155511251|NCT02711956|561297461|FG014|Overall Study|Adverse Event|2|||
155374134|NCT00338962|560803859|FG002|Overall Study|Adverse Event|2|||
155374135|NCT00338962|560803860|FG003|Overall Study|Adverse Event|0|||
155374136|NCT00338962|560803857|FG000|Overall Study|Poor Compliance|0|||
155374137|NCT00338962|560803858|FG001|Overall Study|Poor Compliance|0|||
155374138|NCT00338962|560803859|FG002|Overall Study|Poor Compliance|2|||
155374139|NCT00338962|560803860|FG003|Overall Study|Poor Compliance|0|||
155374140|NCT00910039|560803861|FG000|Overall Study|Physician Decision|1|||
155374141|NCT00635661|560803879|FG000|Overall Study|Withdrawal by Subject|4|||
155374142|NCT00403767|560803882|FG000|Overall Study|Adverse Event|993|||
155374143|NCT00403767|560803883|FG001|Overall Study|Adverse Event|919|||
155374144|NCT00403767|560803882|FG000|Overall Study|Non-compliant with study medication|134|||
155374145|NCT00403767|560803883|FG001|Overall Study|Non-compliant with study medication|164|||
155511252|NCT02711956|561297447|FG000|Overall Study|Physician Decision|0|||
155511253|NCT02711956|561297448|FG001|Overall Study|Physician Decision|0|||
155511254|NCT02711956|561297449|FG002|Overall Study|Physician Decision|0|||
155374146|NCT00403767|560803882|FG000|Overall Study|Consent withdrawn|671|||
155374147|NCT00403767|560803883|FG001|Overall Study|Consent withdrawn|673|||
155374148|NCT00403767|560803882|FG000|Overall Study|Investigator dec./not protocol-related|191|||
155374149|NCT00403767|560803883|FG001|Overall Study|Investigator dec./not protocol-related|178|||
155374150|NCT00403767|560803882|FG000|Overall Study|Lost to Follow-up|6|||
155511255|NCT02711956|561297450|FG003|Overall Study|Physician Decision|2|||
155511256|NCT02711956|561297451|FG004|Overall Study|Physician Decision|0|||
155374151|NCT00403767|560803883|FG001|Overall Study|Lost to Follow-up|8|||
155374152|NCT00403767|560803882|FG000|Overall Study|Protocol Violation|142|||
155374153|NCT00403767|560803883|FG001|Overall Study|Protocol Violation|124|||
155374154|NCT00403767|560803882|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
155374155|NCT00403767|560803883|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
155374156|NCT00403767|560803882|FG000|Overall Study|Study terminated by sponsor|82|||
155374157|NCT00403767|560803883|FG001|Overall Study|Study terminated by sponsor|69|||
155374158|NCT00403767|560803882|FG000|Overall Study|Missing/incomplete data|1|||
155374159|NCT00403767|560803883|FG001|Overall Study|Missing/incomplete data|1|||
155374160|NCT03192475|560803884|FG000|Overall Study|Death|0|||
155374161|NCT03192475|560803885|FG001|Overall Study|Death|1|||
155374162|NCT03192475|560803884|FG000|Overall Study|Lost to Follow-up|13|||
155374163|NCT03192475|560803885|FG001|Overall Study|Lost to Follow-up|8|||
155374164|NCT01641159|560803886|FG000|Overall Study|Lost to Follow-up|2|||
155374165|NCT01641159|560803887|FG001|Overall Study|Lost to Follow-up|1|||
155374166|NCT01641159|560803886|FG000|Overall Study|Withdrawal by Subject|0|||
155374167|NCT01641159|560803887|FG001|Overall Study|Withdrawal by Subject|1|||
155374168|NCT03980808|560803888|FG000|Overall Study|Lost to Follow-up|2|||
155374169|NCT03980808|560803889|FG001|Overall Study|Lost to Follow-up|2|||
155374170|NCT05330676|560803895|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
155374171|NCT05330676|560803896|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
155374172|NCT00436605|560803897|FG000|Overall Study|Protocol Violation|3|||
155374173|NCT02755818|560803898|FG000|Overall Study|Withdrawal by Subject|0|||
155374174|NCT02755818|560803899|FG001|Overall Study|Withdrawal by Subject|0|||
155374175|NCT02755818|560803900|FG002|Overall Study|Withdrawal by Subject|0|||
155374176|NCT02755818|560803901|FG003|Overall Study|Withdrawal by Subject|2|||
155374177|NCT02755818|560803898|FG000|Overall Study|withdrawal by PI|0|||
155374178|NCT02755818|560803899|FG001|Overall Study|withdrawal by PI|0|||
155374179|NCT02755818|560803900|FG002|Overall Study|withdrawal by PI|1|||
155374180|NCT02755818|560803901|FG003|Overall Study|withdrawal by PI|1|||
155374181|NCT03014011|560803902|FG000|First Intervention|Withdrawal by Subject|1|||
155374182|NCT03014011|560803903|FG001|First Intervention|Withdrawal by Subject|0|||
155374183|NCT03014011|560803902|FG000|Washout|Withdrawal by Subject|1|||
155374184|NCT03014011|560803903|FG001|Washout|Withdrawal by Subject|0|||
155374185|NCT00573859|560803906|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
155374186|NCT00573859|560803906|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
155374187|NCT02416453|560803907|FG000|Overall Study|Adverse Event|0|||
155374188|NCT02416453|560803908|FG001|Overall Study|Adverse Event|0|||
155374189|NCT02416453|560803909|FG002|Overall Study|Adverse Event|0|||
155374190|NCT02416453|560803910|FG003|Overall Study|Adverse Event|2|||
155374191|NCT02416453|560803911|FG004|Overall Study|Adverse Event|0|||
155374192|NCT02416453|560803912|FG005|Overall Study|Adverse Event|1|||
155374193|NCT02416453|560803913|FG006|Overall Study|Adverse Event|0|||
155374194|NCT02416453|560803914|FG007|Overall Study|Adverse Event|0|||
155511257|NCT02711956|561297452|FG005|Overall Study|Physician Decision|0|||
155511258|NCT02711956|561297453|FG006|Overall Study|Physician Decision|0|||
155511259|NCT02711956|561297454|FG007|Overall Study|Physician Decision|0|||
155511260|NCT02711956|561297455|FG008|Overall Study|Physician Decision|0|||
155511261|NCT02711956|561297456|FG009|Overall Study|Physician Decision|0|||
155511262|NCT02711956|561297457|FG010|Overall Study|Physician Decision|0|||
155374195|NCT02416453|560803915|FG008|Overall Study|Adverse Event|0|||
155374196|NCT02416453|560803916|FG009|Overall Study|Adverse Event|0|||
155374197|NCT02416453|560803917|FG010|Overall Study|Adverse Event|0|||
155374198|NCT02416453|560803907|FG000|Overall Study|Lost to Follow-up|1|||
155374199|NCT02416453|560803908|FG001|Overall Study|Lost to Follow-up|3|||
155374200|NCT02416453|560803909|FG002|Overall Study|Lost to Follow-up|0|||
155374201|NCT02416453|560803910|FG003|Overall Study|Lost to Follow-up|8|||
155374202|NCT02416453|560803911|FG004|Overall Study|Lost to Follow-up|0|||
155374203|NCT02416453|560803912|FG005|Overall Study|Lost to Follow-up|5|||
155374204|NCT02416453|560803913|FG006|Overall Study|Lost to Follow-up|1|||
155374205|NCT02416453|560803914|FG007|Overall Study|Lost to Follow-up|3|||
155374206|NCT02416453|560803915|FG008|Overall Study|Lost to Follow-up|1|||
155374207|NCT02416453|560803916|FG009|Overall Study|Lost to Follow-up|0|||
155374208|NCT02416453|560803917|FG010|Overall Study|Lost to Follow-up|0|||
155374209|NCT02416453|560803907|FG000|Overall Study|Physician Decision|0|||
155374210|NCT02416453|560803908|FG001|Overall Study|Physician Decision|0|||
155374211|NCT02416453|560803909|FG002|Overall Study|Physician Decision|0|||
155511263|NCT02711956|561297458|FG011|Overall Study|Physician Decision|0|||
155374212|NCT02416453|560803910|FG003|Overall Study|Physician Decision|0|||
155374213|NCT02416453|560803911|FG004|Overall Study|Physician Decision|0|||
155374214|NCT02416453|560803912|FG005|Overall Study|Physician Decision|1|||
155374215|NCT02416453|560803913|FG006|Overall Study|Physician Decision|1|||
155374216|NCT02416453|560803914|FG007|Overall Study|Physician Decision|1|||
155374217|NCT02416453|560803915|FG008|Overall Study|Physician Decision|0|||
155374218|NCT02416453|560803916|FG009|Overall Study|Physician Decision|0|||
155374219|NCT02416453|560803917|FG010|Overall Study|Physician Decision|0|||
155511264|NCT02711956|561297459|FG012|Overall Study|Physician Decision|0|||
155649587|NCT00066170|561808309|FG002|Overall Study|Adverse Event|1|||
155649588|NCT00066170|561808310|FG003|Overall Study|Adverse Event|7|||
155374220|NCT02416453|560803907|FG000|Overall Study|Withdrawal by Subject|2|||
155374221|NCT02416453|560803908|FG001|Overall Study|Withdrawal by Subject|0|||
155374222|NCT02416453|560803909|FG002|Overall Study|Withdrawal by Subject|0|||
155374223|NCT02416453|560803910|FG003|Overall Study|Withdrawal by Subject|5|||
155374224|NCT02416453|560803911|FG004|Overall Study|Withdrawal by Subject|1|||
155374225|NCT02416453|560803912|FG005|Overall Study|Withdrawal by Subject|8|||
155374226|NCT02416453|560803913|FG006|Overall Study|Withdrawal by Subject|0|||
155374227|NCT02416453|560803914|FG007|Overall Study|Withdrawal by Subject|8|||
155374228|NCT02416453|560803915|FG008|Overall Study|Withdrawal by Subject|4|||
155374229|NCT02416453|560803916|FG009|Overall Study|Withdrawal by Subject|0|||
155374230|NCT02416453|560803917|FG010|Overall Study|Withdrawal by Subject|0|||
155374231|NCT02416453|560803907|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374232|NCT02416453|560803908|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374233|NCT02416453|560803909|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
155374234|NCT02416453|560803910|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374235|NCT02416453|560803911|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374236|NCT02416453|560803912|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374237|NCT02416453|560803913|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374238|NCT02416453|560803914|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374239|NCT02416453|560803915|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374240|NCT02416453|560803916|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374241|NCT02416453|560803917|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374242|NCT02416453|560803907|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374243|NCT02416453|560803908|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374244|NCT02416453|560803909|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374245|NCT02416453|560803910|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374246|NCT02416453|560803911|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374247|NCT02416453|560803912|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
155374248|NCT02416453|560803913|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374249|NCT02416453|560803914|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374250|NCT02416453|560803915|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374251|NCT02416453|560803916|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374252|NCT02416453|560803917|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374253|NCT03223662|560803922|FG000|Overall Study|Physician Decision|1|||
155374254|NCT03223662|560803922|FG000|Overall Study|Study closure|1|||
155374255|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
155374256|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
155374257|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
155374258|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
155374259|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
155374260|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
155374261|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
155374262|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374263|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
155374264|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374265|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374266|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374267|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374268|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374269|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
155374270|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
155374271|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
155374272|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374273|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374274|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374275|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374276|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374277|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374278|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
155374279|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155649589|NCT00066170|561808307|FG000|Overall Study|Serious Adverse Event|0|||
155649590|NCT00066170|561808308|FG001|Overall Study|Serious Adverse Event|0|||
155374280|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374281|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374282|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374283|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Death|1|||
155649591|NCT00066170|561808309|FG002|Overall Study|Serious Adverse Event|1|||
155649592|NCT00066170|561808310|FG003|Overall Study|Serious Adverse Event|1|||
155511265|NCT02711956|561297460|FG013|Overall Study|Physician Decision|0|||
155511266|NCT02711956|561297461|FG014|Overall Study|Physician Decision|0|||
155511267|NCT02711956|561297447|FG000|Overall Study|Withdrawal by Subject|0|||
155511268|NCT02711956|561297448|FG001|Overall Study|Withdrawal by Subject|0|||
155511269|NCT02711956|561297449|FG002|Overall Study|Withdrawal by Subject|0|||
155511270|NCT02711956|561297450|FG003|Overall Study|Withdrawal by Subject|0|||
155511271|NCT02711956|561297451|FG004|Overall Study|Withdrawal by Subject|0|||
155511272|NCT02711956|561297452|FG005|Overall Study|Withdrawal by Subject|0|||
155511273|NCT02711956|561297453|FG006|Overall Study|Withdrawal by Subject|1|||
155511274|NCT02711956|561297454|FG007|Overall Study|Withdrawal by Subject|0|||
155511275|NCT02711956|561297455|FG008|Overall Study|Withdrawal by Subject|0|||
155511276|NCT02711956|561297456|FG009|Overall Study|Withdrawal by Subject|0|||
155511277|NCT02711956|561297457|FG010|Overall Study|Withdrawal by Subject|0|||
155511278|NCT02711956|561297458|FG011|Overall Study|Withdrawal by Subject|1|||
155511279|NCT02711956|561297459|FG012|Overall Study|Withdrawal by Subject|6|||
155511280|NCT02711956|561297460|FG013|Overall Study|Withdrawal by Subject|0|||
155511281|NCT02711956|561297461|FG014|Overall Study|Withdrawal by Subject|1|||
155511282|NCT02711956|561297447|FG000|Overall Study|Clinical progression|1|||
155511283|NCT02711956|561297448|FG001|Overall Study|Clinical progression|0|||
155511284|NCT02711956|561297449|FG002|Overall Study|Clinical progression|0|||
155511285|NCT02711956|561297450|FG003|Overall Study|Clinical progression|0|||
155511286|NCT02711956|561297451|FG004|Overall Study|Clinical progression|0|||
155511287|NCT02711956|561297452|FG005|Overall Study|Clinical progression|0|||
155511288|NCT02711956|561297453|FG006|Overall Study|Clinical progression|1|||
155511289|NCT02711956|561297454|FG007|Overall Study|Clinical progression|0|||
155511290|NCT02711956|561297455|FG008|Overall Study|Clinical progression|1|||
155511291|NCT02711956|561297456|FG009|Overall Study|Clinical progression|0|||
155511292|NCT02711956|561297457|FG010|Overall Study|Clinical progression|0|||
155511293|NCT02711956|561297458|FG011|Overall Study|Clinical progression|2|||
155511294|NCT02711956|561297459|FG012|Overall Study|Clinical progression|4|||
155511295|NCT02711956|561297460|FG013|Overall Study|Clinical progression|1|||
155511296|NCT02711956|561297461|FG014|Overall Study|Clinical progression|1|||
155511297|NCT02711956|561297447|FG000|Overall Study|Radiographic progression|1|||
155511298|NCT02711956|561297448|FG001|Overall Study|Radiographic progression|1|||
155511299|NCT02711956|561297449|FG002|Overall Study|Radiographic progression|2|||
155374284|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Death|1|||
155374285|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Death|0|||
155374286|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Death|0|||
155374287|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Death|0|||
155374288|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Death|0|||
155374289|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Death|0|||
155374290|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374291|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374292|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374293|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374294|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374295|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374296|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374297|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374298|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374299|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374300|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
155374301|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
155374302|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
155374303|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
155374304|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Death|0|||
155374305|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Death|0|||
155374306|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Death|0|||
155374307|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Death|1|||
155374308|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Death|0|||
155374309|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Death|1|||
155374310|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Death|1|||
155374311|NCT03541200|560803930|FG000|Overall Study|Adverse Event|19|||
155374312|NCT03541200|560803930|FG000|Overall Study|Death|1|||
155374313|NCT03541200|560803930|FG000|Overall Study|Lost to Follow-up|10|||
155511300|NCT02711956|561297450|FG003|Overall Study|Radiographic progression|0|||
155511301|NCT02711956|561297451|FG004|Overall Study|Radiographic progression|1|||
155374314|NCT03541200|560803930|FG000|Overall Study|Physician Decision|1|||
155511302|NCT02711956|561297452|FG005|Overall Study|Radiographic progression|0|||
155511303|NCT02711956|561297453|FG006|Overall Study|Radiographic progression|0|||
155374315|NCT03541200|560803930|FG000|Overall Study|Protocol Violation|51|||
155374316|NCT03541200|560803930|FG000|Overall Study|Withdrawal by Subject|23|||
155374317|NCT03541200|560803930|FG000|Overall Study|other|8|||
155374318|NCT03459443|560803931|FG000|Overall Study|Lack of Efficacy|3|||
155374319|NCT03459443|560803931|FG000|Overall Study|Adverse Event|1|||
155374320|NCT03459443|560803931|FG000|Overall Study|Sponsor's decision to close the study|18|||
155374321|NCT01276379|560803932|FG000|Overall Study|Screening failure|40|||
155374322|NCT01111240|560803933|FG000|Overall Study|Adverse Event|190|||
155374323|NCT01111240|560803933|FG000|Overall Study|Lack of Efficacy|545|||
155374324|NCT01111240|560803933|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
155430911|NCT00609622|561002414|FG000|Overall Study|Withdrawal by Subject|4|||
155430912|NCT00609622|561002415|FG001|Overall Study|Withdrawal by Subject|20|||
155430913|NCT00609622|561002414|FG000|Overall Study|Death|1|||
155430914|NCT00609622|561002415|FG001|Overall Study|Death|4|||
155374325|NCT01111240|560803933|FG000|Overall Study|Other|312|||
155374326|NCT00680992|560803939|FG000|Overall Study|Complete Resection (as per protocol)|25|||
155374327|NCT00680992|560803940|FG001|Overall Study|Complete Resection (as per protocol)|121|||
155374328|NCT00680992|560803941|FG002|Overall Study|Complete Resection (as per protocol)|0|||
155374329|NCT00680992|560803939|FG000|Overall Study|Administrative Decision|83|||
155374330|NCT00680992|560803940|FG001|Overall Study|Administrative Decision|42|||
155374331|NCT00680992|560803941|FG002|Overall Study|Administrative Decision|5|||
155374332|NCT00680992|560803939|FG000|Overall Study|End of Trial|32|||
155374333|NCT00680992|560803940|FG001|Overall Study|End of Trial|12|||
155374334|NCT00680992|560803941|FG002|Overall Study|End of Trial|3|||
155374335|NCT00680992|560803939|FG000|Overall Study|Withdrawal by Subject|33|||
155374336|NCT00680992|560803940|FG001|Overall Study|Withdrawal by Subject|11|||
155374337|NCT00680992|560803941|FG002|Overall Study|Withdrawal by Subject|1|||
155374338|NCT00680992|560803939|FG000|Overall Study|Adverse Event|21|||
155374339|NCT00680992|560803940|FG001|Overall Study|Adverse Event|19|||
155374340|NCT00680992|560803941|FG002|Overall Study|Adverse Event|1|||
155374341|NCT00680992|560803939|FG000|Overall Study|Other|19|||
155374342|NCT00680992|560803940|FG001|Overall Study|Other|14|||
155374343|NCT00680992|560803941|FG002|Overall Study|Other|1|||
155374344|NCT00680992|560803939|FG000|Overall Study|Disease Progression|21|||
155374345|NCT00680992|560803940|FG001|Overall Study|Disease Progression|9|||
155374346|NCT00680992|560803941|FG002|Overall Study|Disease Progression|0|||
155374347|NCT00680992|560803939|FG000|Overall Study|Lost to Follow-up|12|||
155374348|NCT00680992|560803940|FG001|Overall Study|Lost to Follow-up|14|||
155374349|NCT00680992|560803941|FG002|Overall Study|Lost to Follow-up|0|||
155374350|NCT00680992|560803939|FG000|Overall Study|Noncompliance|4|||
155374351|NCT00680992|560803940|FG001|Overall Study|Noncompliance|6|||
155374352|NCT00680992|560803941|FG002|Overall Study|Noncompliance|0|||
155374353|NCT00680992|560803939|FG000|Overall Study|Requirement for Alternative Therapy|8|||
155374354|NCT00680992|560803940|FG001|Overall Study|Requirement for Alternative Therapy|2|||
155374355|NCT00680992|560803941|FG002|Overall Study|Requirement for Alternative Therapy|0|||
155374356|NCT00680992|560803939|FG000|Overall Study|Pregnancy|5|||
155374357|NCT00680992|560803940|FG001|Overall Study|Pregnancy|0|||
155374358|NCT00680992|560803941|FG002|Overall Study|Pregnancy|1|||
155374359|NCT00680992|560803939|FG000|Overall Study|Death|5|||
155374360|NCT00680992|560803940|FG001|Overall Study|Death|1|||
155374361|NCT00680992|560803941|FG002|Overall Study|Death|0|||
155374362|NCT00680992|560803939|FG000|Overall Study|Ineligibility Determined|0|||
155374363|NCT00680992|560803940|FG001|Overall Study|Ineligibility Determined|1|||
155374364|NCT00680992|560803941|FG002|Overall Study|Ineligibility Determined|0|||
155374365|NCT02425904|560803944|FG000|Overall Study|Lost to Follow-up|1|||
155430915|NCT00609622|561002414|FG000|Overall Study|Protocol Violation|1|||
155430916|NCT00609622|561002415|FG001|Overall Study|Protocol Violation|1|||
155430917|NCT00609622|561002414|FG000|Overall Study|Objective progression or relapse|47|||
155374366|NCT02425904|560803945|FG001|Overall Study|Lost to Follow-up|0|||
155374367|NCT02425904|560803944|FG000|Overall Study|Withdrawal by Subject|2|||
155430918|NCT00609622|561002415|FG001|Overall Study|Objective progression or relapse|41|||
155374368|NCT02425904|560803945|FG001|Overall Study|Withdrawal by Subject|0|||
155374369|NCT02425904|560803944|FG000|Overall Study|Death|0|||
155374370|NCT02425904|560803945|FG001|Overall Study|Death|3|||
155374371|NCT05384938|560803946|FG000|Overall Study|Withdrawal by Subject|8|||
155374372|NCT05384938|560803946|FG000|Overall Study|Lost to Follow-up|6|||
155374373|NCT05384938|560803946|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
155374374|NCT02626455|560803947|FG000|Overall Study|Other|1|||
155511304|NCT02711956|561297454|FG007|Overall Study|Radiographic progression|0|||
155511305|NCT02711956|561297455|FG008|Overall Study|Radiographic progression|2|||
155511306|NCT02711956|561297456|FG009|Overall Study|Radiographic progression|1|||
155511307|NCT02711956|561297457|FG010|Overall Study|Radiographic progression|0|||
155511308|NCT02711956|561297458|FG011|Overall Study|Radiographic progression|5|||
155511309|NCT02711956|561297459|FG012|Overall Study|Radiographic progression|3|||
155511310|NCT02711956|561297460|FG013|Overall Study|Radiographic progression|0|||
155511311|NCT02711956|561297461|FG014|Overall Study|Radiographic progression|1|||
155511312|NCT02711956|561297447|FG000|Overall Study|PSA progression with clinical progression|0|||
155511313|NCT02711956|561297448|FG001|Overall Study|PSA progression with clinical progression|0|||
155511314|NCT02711956|561297449|FG002|Overall Study|PSA progression with clinical progression|0|||
155511315|NCT02711956|561297450|FG003|Overall Study|PSA progression with clinical progression|0|||
155511316|NCT02711956|561297451|FG004|Overall Study|PSA progression with clinical progression|1|||
155511317|NCT02711956|561297452|FG005|Overall Study|PSA progression with clinical progression|0|||
155511318|NCT02711956|561297453|FG006|Overall Study|PSA progression with clinical progression|0|||
155511319|NCT02711956|561297454|FG007|Overall Study|PSA progression with clinical progression|0|||
155511320|NCT02711956|561297455|FG008|Overall Study|PSA progression with clinical progression|0|||
155511321|NCT02711956|561297456|FG009|Overall Study|PSA progression with clinical progression|0|||
155511322|NCT02711956|561297457|FG010|Overall Study|PSA progression with clinical progression|0|||
155511323|NCT02711956|561297458|FG011|Overall Study|PSA progression with clinical progression|0|||
155511324|NCT02711956|561297459|FG012|Overall Study|PSA progression with clinical progression|1|||
155511325|NCT02711956|561297460|FG013|Overall Study|PSA progression with clinical progression|1|||
155511326|NCT02711956|561297461|FG014|Overall Study|PSA progression with clinical progression|0|||
155511327|NCT02711956|561297447|FG000|Overall Study|PSA progression with radiographic progression|0|||
155511328|NCT02711956|561297448|FG001|Overall Study|PSA progression with radiographic progression|1|||
155511329|NCT02711956|561297449|FG002|Overall Study|PSA progression with radiographic progression|0|||
155511330|NCT02711956|561297450|FG003|Overall Study|PSA progression with radiographic progression|0|||
155511331|NCT02711956|561297451|FG004|Overall Study|PSA progression with radiographic progression|0|||
155511332|NCT02711956|561297452|FG005|Overall Study|PSA progression with radiographic progression|2|||
155511333|NCT02711956|561297453|FG006|Overall Study|PSA progression with radiographic progression|2|||
155511334|NCT02711956|561297454|FG007|Overall Study|PSA progression with radiographic progression|1|||
155511335|NCT02711956|561297455|FG008|Overall Study|PSA progression with radiographic progression|0|||
155511336|NCT02711956|561297456|FG009|Overall Study|PSA progression with radiographic progression|1|||
155511337|NCT02711956|561297457|FG010|Overall Study|PSA progression with radiographic progression|0|||
155511338|NCT02711956|561297458|FG011|Overall Study|PSA progression with radiographic progression|1|||
155511339|NCT02711956|561297459|FG012|Overall Study|PSA progression with radiographic progression|2|||
155511340|NCT02711956|561297460|FG013|Overall Study|PSA progression with radiographic progression|3|||
155511341|NCT02711956|561297461|FG014|Overall Study|PSA progression with radiographic progression|3|||
155511342|NCT05487456|561297462|FG000|Overall Study|Withdrawal by Subject|0|||
155511343|NCT05487456|561297463|FG001|Overall Study|Withdrawal by Subject|0|||
155511344|NCT05487456|561297464|FG002|Overall Study|Withdrawal by Subject|1|||
155511345|NCT05487456|561297465|FG003|Overall Study|Withdrawal by Subject|0|||
155511346|NCT01625377|561297468|FG000|Overall Study|Death|1|||
155511347|NCT01625377|561297469|FG001|Overall Study|Death|1|||
155511348|NCT01625377|561297468|FG000|Overall Study|Administrative Problem|1|||
155511349|NCT01625377|561297469|FG001|Overall Study|Administrative Problem|1|||
155511350|NCT01625377|561297468|FG000|Overall Study|Protocol Violation|0|||
155511351|NCT01625377|561297469|FG001|Overall Study|Protocol Violation|3|||
155511352|NCT01625377|561297468|FG000|Overall Study|Adverse Event|3|||
155511353|NCT01625377|561297469|FG001|Overall Study|Adverse Event|16|||
155511354|NCT01625377|561297468|FG000|Overall Study|Graft loss|1|||
155511355|NCT01625377|561297469|FG001|Overall Study|Graft loss|0|||
155511356|NCT01625377|561297468|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155511357|NCT01625377|561297469|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155511358|NCT01625377|561297468|FG000|Overall Study|Abnormal laboratory values|1|||
155511359|NCT01625377|561297469|FG001|Overall Study|Abnormal laboratory values|0|||
155511360|NCT02043366|561297472|FG000|Overall Study|Lost to Follow-up|2|||
155511361|NCT02043366|561297473|FG001|Overall Study|Lost to Follow-up|2|||
155511362|NCT02043366|561297474|FG002|Overall Study|Lost to Follow-up|2|||
155511363|NCT02043366|561297475|FG003|Overall Study|Lost to Follow-up|2|||
155511364|NCT02043366|561297476|FG004|Overall Study|Lost to Follow-up|2|||
155649593|NCT00066170|561808307|FG000|Overall Study|Lost to Follow-up|0|||
155511365|NCT02043366|561297477|FG005|Overall Study|Lost to Follow-up|2|||
155511366|NCT03294538|561297480|FG000|Overall Study|Adverse Event|0|||
155649594|NCT00066170|561808308|FG001|Overall Study|Lost to Follow-up|1|||
155649595|NCT00066170|561808309|FG002|Overall Study|Lost to Follow-up|0|||
155511367|NCT03294538|561297481|FG001|Overall Study|Adverse Event|1|||
155511368|NCT03294538|561297482|FG002|Overall Study|Adverse Event|1|||
155511369|NCT03294538|561297480|FG000|Overall Study|Lost to Follow-up|1|||
155511370|NCT03294538|561297481|FG001|Overall Study|Lost to Follow-up|0|||
155511371|NCT03294538|561297482|FG002|Overall Study|Lost to Follow-up|0|||
155649596|NCT00066170|561808310|FG003|Overall Study|Lost to Follow-up|0|||
155511372|NCT03294538|561297480|FG000|Overall Study|Outside of Visit Window|4|||
155511373|NCT03294538|561297481|FG001|Overall Study|Outside of Visit Window|4|||
155511374|NCT03294538|561297482|FG002|Overall Study|Outside of Visit Window|1|||
155511375|NCT01489956|561297484|FG000|Overall Study|Lost to Follow-up|1|||
155511376|NCT01489956|561297485|FG001|Overall Study|Lost to Follow-up|0|||
155511377|NCT01489956|561297486|FG002|Overall Study|Lost to Follow-up|0|||
155511378|NCT01489956|561297484|FG000|Overall Study|Withdrawal by Subject|0|||
155511379|NCT01489956|561297485|FG001|Overall Study|Withdrawal by Subject|0|||
155511380|NCT01489956|561297486|FG002|Overall Study|Withdrawal by Subject|1|||
155511381|NCT01787825|561297488|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
155511382|NCT01787825|561297489|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
155511383|NCT01787825|561297488|FG000|Overall Study|Data Not Analyzable|5|||
155511384|NCT01787825|561297489|FG001|Overall Study|Data Not Analyzable|1|||
155511385|NCT01401478|561297505|FG000|Overall Study|Study drug not available|6|||
155511386|NCT01401478|561297505|FG000|Overall Study|Adverse Event|5|||
155511387|NCT01401478|561297505|FG000|Overall Study|Hyperphosphatemia|5|||
155511388|NCT01401478|561297505|FG000|Overall Study|Lost to Follow-up|5|||
155511389|NCT01401478|561297505|FG000|Overall Study|Kidney transplantation|3|||
155511390|NCT01401478|561297505|FG000|Overall Study|Withdrawal by Subject|3|||
155511391|NCT01401478|561297505|FG000|Overall Study|Blood samples not available|1|||
155511392|NCT01401478|561297505|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
155511393|NCT01401478|561297505|FG000|Overall Study|Low intact parathyroid hormone|1|||
155511394|NCT01401478|561297505|FG000|Overall Study|Serious adverse event|1|||
155511395|NCT01814137|561297506|FG000|Overall Study|Adverse Event|0|||
155511396|NCT01814137|561297507|FG001|Overall Study|Adverse Event|1|||
155511397|NCT01814137|561297506|FG000|Overall Study|Withdrawal by Subject|2|||
155511398|NCT01814137|561297507|FG001|Overall Study|Withdrawal by Subject|2|||
155511399|NCT01814137|561297506|FG000|Overall Study|Physician Decision|1|||
155511400|NCT01814137|561297507|FG001|Overall Study|Physician Decision|1|||
155511401|NCT01814137|561297506|FG000|Overall Study|Unclassified|2|||
155511402|NCT01814137|561297507|FG001|Overall Study|Unclassified|1|||
155511403|NCT01214603|561297508|FG000|Overall Study|Adverse Event|0|||
155511404|NCT01214603|561297509|FG001|Overall Study|Adverse Event|0|||
155511405|NCT01214603|561297510|FG002|Overall Study|Adverse Event|1|||
155511406|NCT01214603|561297508|FG000|Overall Study|Death|1|||
155511407|NCT01214603|561297509|FG001|Overall Study|Death|0|||
155511408|NCT01214603|561297510|FG002|Overall Study|Death|0|||
155511409|NCT01214603|561297508|FG000|Overall Study|Progressive Disease|4|||
155511410|NCT01214603|561297509|FG001|Overall Study|Progressive Disease|1|||
155511411|NCT01214603|561297510|FG002|Overall Study|Progressive Disease|3|||
155511412|NCT01507896|561297511|FG000|Overall Study|Withdrawal by Subject|1|||
155511413|NCT01507896|561297511|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
155511414|NCT00490061|561297512|FG000|Overall Study|Physician Decision|1|||
155511415|NCT01620983|561297527|FG000|Overall Study|Lost to Follow-up|8|||
155511416|NCT01620983|561297528|FG001|Overall Study|Lost to Follow-up|4|||
155511417|NCT01620983|561297529|FG002|Overall Study|Lost to Follow-up|9|||
155511418|NCT01620983|561297527|FG000|Overall Study|Withdrawal by Subject|6|||
155511419|NCT01620983|561297528|FG001|Overall Study|Withdrawal by Subject|8|||
155511420|NCT01620983|561297529|FG002|Overall Study|Withdrawal by Subject|1|||
155511421|NCT01620983|561297527|FG000|Overall Study|Death|2|||
155511422|NCT01620983|561297528|FG001|Overall Study|Death|0|||
155511423|NCT01620983|561297529|FG002|Overall Study|Death|0|||
155511424|NCT01620983|561297527|FG000|Overall Study|Physician Decision|3|||
155511425|NCT01620983|561297528|FG001|Overall Study|Physician Decision|10|||
155511426|NCT01620983|561297529|FG002|Overall Study|Physician Decision|5|||
155511427|NCT00798889|561297531|FG000|Overall Study|Adverse Event|53|||
155511428|NCT00798889|561297531|FG000|Overall Study|Protocol Violation|2|||
155511429|NCT00798889|561297531|FG000|Overall Study|Withdrawal by Subject|31|||
155511430|NCT00798889|561297531|FG000|Overall Study|Lost to Follow-up|1|||
155511431|NCT00798889|561297531|FG000|Overall Study|Lack of Efficacy|213|||
155511432|NCT00798889|561297531|FG000|Overall Study|Decision of Sponsor|11|||
155511433|NCT00798889|561297531|FG000|Overall Study|Enrolled, Not treated|3|||
155511434|NCT00617461|561297532|FG000|First Treatment Intervention Period|Adverse Event|2|||
155511435|NCT00617461|561297533|FG001|First Treatment Intervention Period|Adverse Event|0|||
155511436|NCT00617461|561297532|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
155649597|NCT00066170|561808307|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
155511437|NCT00617461|561297533|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
155511438|NCT00617461|561297532|FG000|First Treatment Intervention Period|Protocol Violation|2|||
155511439|NCT00617461|561297533|FG001|First Treatment Intervention Period|Protocol Violation|1|||
155511440|NCT00617461|561297532|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
155511441|NCT00617461|561297533|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
155511442|NCT00617461|561297532|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
155511443|NCT00617461|561297533|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
155511444|NCT00617461|561297532|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
155511445|NCT00617461|561297533|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
155511446|NCT00617461|561297532|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
155511447|NCT00617461|561297533|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
155511448|NCT00617461|561297532|FG000|Second Treatment Intervention Period|Adverse Event|0|||
155511449|NCT00617461|561297533|FG001|Second Treatment Intervention Period|Adverse Event|1|||
155511450|NCT00617461|561297532|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
155511451|NCT00617461|561297533|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
155511452|NCT00617461|561297532|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
155511453|NCT00617461|561297533|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
155511454|NCT00617461|561297532|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
155511455|NCT00617461|561297533|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
155511456|NCT01724359|561297534|FG000|Overall Study|Adverse Event|10|||
155511457|NCT01724359|561297534|FG000|Overall Study|Death|1|||
155511458|NCT01724359|561297534|FG000|Overall Study|Other|20|||
155511459|NCT05085964|561297535|FG000|Overall Study|Premature termination of study|21|||
155511460|NCT05085964|561297536|FG001|Overall Study|Premature termination of study|0|||
155511461|NCT00591253|561297541|FG000|Overall Study|Adverse Event|3|||
155511462|NCT00591253|561297542|FG001|Overall Study|Adverse Event|3|||
155374375|NCT02626455|560803948|FG001|Overall Study|Other|1|||
155374376|NCT02626455|560803949|FG002|Overall Study|Other|0|||
155374377|NCT02626455|560803950|FG003|Overall Study|Other|0|||
155374378|NCT02626455|560803951|FG004|Overall Study|Other|0|||
155511463|NCT00591253|561297543|FG002|Overall Study|Adverse Event|1|||
155511464|NCT00591253|561297541|FG000|Overall Study|Protocol Violation|2|||
155374379|NCT02626455|560803952|FG005|Overall Study|Other|17|||
155374380|NCT02626455|560803953|FG006|Overall Study|Other|23|||
155374381|NCT02626455|560803947|FG000|Overall Study|Withdrawal by Subject|1|||
155511465|NCT00591253|561297542|FG001|Overall Study|Protocol Violation|2|||
155511466|NCT00591253|561297543|FG002|Overall Study|Protocol Violation|2|||
155511467|NCT00591253|561297541|FG000|Overall Study|Lost to Follow-up|2|||
155511468|NCT00591253|561297542|FG001|Overall Study|Lost to Follow-up|4|||
155511469|NCT00591253|561297543|FG002|Overall Study|Lost to Follow-up|0|||
155511470|NCT00591253|561297541|FG000|Overall Study|Withdrawal by Subject|1|||
155511471|NCT00591253|561297542|FG001|Overall Study|Withdrawal by Subject|7|||
155511472|NCT00591253|561297543|FG002|Overall Study|Withdrawal by Subject|6|||
155511473|NCT00591253|561297541|FG000|Overall Study|Lack of Efficacy|1|||
155511474|NCT00591253|561297542|FG001|Overall Study|Lack of Efficacy|0|||
155511475|NCT00591253|561297543|FG002|Overall Study|Lack of Efficacy|3|||
155511476|NCT00591253|561297541|FG000|Overall Study|Other|5|||
155511477|NCT00591253|561297542|FG001|Overall Study|Other|5|||
155511478|NCT00591253|561297543|FG002|Overall Study|Other|3|||
155511479|NCT00252187|561297545|FG000|Overall Study|Adverse Event|3|||
155511480|NCT00252187|561297546|FG001|Overall Study|Adverse Event|1|||
155511481|NCT00252187|561297545|FG000|Overall Study|Withdrawal by Subject|1|||
155511482|NCT00252187|561297546|FG001|Overall Study|Withdrawal by Subject|0|||
155511483|NCT01875445|561297547|FG000|Overall Study|Lost to Follow-up|5|||
155511484|NCT01875445|561297548|FG001|Overall Study|Lost to Follow-up|0|||
155511485|NCT01875445|561297547|FG000|Overall Study|Withdrawal by Subject|2|||
155511486|NCT01875445|561297548|FG001|Overall Study|Withdrawal by Subject|0|||
155511487|NCT00593333|561297549|FG000|Overall Study|Lost to Follow-up|10|||
155511488|NCT00593333|561297550|FG001|Overall Study|Lost to Follow-up|11|||
155511489|NCT01738581|561297551|FG000|Overall Study|Lost to Follow-up|1|||
155511490|NCT01738581|561297552|FG001|Overall Study|Lost to Follow-up|0|||
155511491|NCT00210626|561297553|FG000|Overall Study|Adverse Event|1|||
155511492|NCT00210626|561297554|FG001|Overall Study|Adverse Event|2|||
155511493|NCT00210626|561297553|FG000|Overall Study|Protocol Violation|1|||
155511494|NCT00210626|561297554|FG001|Overall Study|Protocol Violation|5|||
155511495|NCT00210626|561297553|FG000|Overall Study|Lost to Follow-up|11|||
155511496|NCT00210626|561297554|FG001|Overall Study|Lost to Follow-up|11|||
155511497|NCT00210626|561297553|FG000|Overall Study|Death|1|||
155511498|NCT00210626|561297554|FG001|Overall Study|Death|0|||
155511499|NCT00210626|561297553|FG000|Overall Study|Withdrawal by Subject|29|||
155511500|NCT00210626|561297554|FG001|Overall Study|Withdrawal by Subject|20|||
155511501|NCT00210626|561297553|FG000|Overall Study|Physician Decision|0|||
155511502|NCT00210626|561297554|FG001|Overall Study|Physician Decision|2|||
155511503|NCT00210626|561297553|FG000|Overall Study|Sponser Request|1|||
155511504|NCT00210626|561297554|FG001|Overall Study|Sponser Request|0|||
155511505|NCT00210626|561297553|FG000|Overall Study|Other|4|||
155511506|NCT00210626|561297554|FG001|Overall Study|Other|5|||
155511507|NCT02191579|561297555|FG000|Treatment 1|Multiple Reasons Specified|27|||
155511508|NCT02191579|561297556|FG001|Treatment 1|Multiple Reasons Specified|58|||
155511509|NCT02191579|561297555|FG000|Treatment 2|Multiple Reasons Specified|0|||
155511510|NCT02191579|561297556|FG001|Treatment 2|Multiple Reasons Specified|25|||
155511511|NCT02862535|561297559|FG000|Overall Study|Death|7|||
155511512|NCT02862535|561297560|FG001|Overall Study|Death|3|||
155511513|NCT02862535|561297561|FG002|Overall Study|Death|2|||
155511514|NCT02862535|561297562|FG003|Overall Study|Death|5|||
155511515|NCT02862535|561297559|FG000|Overall Study|Study Terminated by Sponsor|1|||
155374382|NCT02626455|560803948|FG001|Overall Study|Withdrawal by Subject|0|||
155374383|NCT02626455|560803949|FG002|Overall Study|Withdrawal by Subject|0|||
155511516|NCT02862535|561297560|FG001|Overall Study|Study Terminated by Sponsor|3|||
155374384|NCT02626455|560803950|FG003|Overall Study|Withdrawal by Subject|0|||
155374385|NCT02626455|560803951|FG004|Overall Study|Withdrawal by Subject|0|||
155374386|NCT02626455|560803952|FG005|Overall Study|Withdrawal by Subject|10|||
155374387|NCT02626455|560803953|FG006|Overall Study|Withdrawal by Subject|6|||
155374388|NCT02626455|560803947|FG000|Overall Study|Physician Decision|0|||
155374389|NCT02626455|560803948|FG001|Overall Study|Physician Decision|2|||
155374390|NCT02626455|560803949|FG002|Overall Study|Physician Decision|2|||
155374391|NCT02626455|560803950|FG003|Overall Study|Physician Decision|2|||
155374392|NCT02626455|560803951|FG004|Overall Study|Physician Decision|1|||
155374393|NCT02626455|560803952|FG005|Overall Study|Physician Decision|10|||
155374394|NCT02626455|560803953|FG006|Overall Study|Physician Decision|3|||
155374395|NCT02626455|560803947|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374396|NCT02626455|560803948|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374397|NCT02626455|560803949|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374398|NCT02626455|560803950|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374399|NCT02626455|560803951|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374400|NCT02626455|560803952|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374401|NCT02626455|560803953|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
155374402|NCT02626455|560803947|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374403|NCT02626455|560803948|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374404|NCT02626455|560803949|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374405|NCT02626455|560803950|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374406|NCT02626455|560803951|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374407|NCT02626455|560803952|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374408|NCT02626455|560803953|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
155374409|NCT02626455|560803947|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374410|NCT02626455|560803948|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374411|NCT02626455|560803949|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374412|NCT02626455|560803950|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374413|NCT02626455|560803951|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374414|NCT02626455|560803952|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
155374415|NCT02626455|560803953|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
155374416|NCT02626455|560803947|FG000|Overall Study|Patient decision|0|||
155374417|NCT02626455|560803948|FG001|Overall Study|Patient decision|1|||
155374418|NCT02626455|560803949|FG002|Overall Study|Patient decision|0|||
155374419|NCT02626455|560803950|FG003|Overall Study|Patient decision|0|||
155374420|NCT02626455|560803951|FG004|Overall Study|Patient decision|1|||
155374421|NCT02626455|560803952|FG005|Overall Study|Patient decision|36|||
155374422|NCT02626455|560803953|FG006|Overall Study|Patient decision|22|||
155374423|NCT02626455|560803947|FG000|Overall Study|Protocol Violation|0|||
155374424|NCT02626455|560803948|FG001|Overall Study|Protocol Violation|0|||
155374425|NCT02626455|560803949|FG002|Overall Study|Protocol Violation|0|||
155374426|NCT02626455|560803950|FG003|Overall Study|Protocol Violation|0|||
155374427|NCT02626455|560803951|FG004|Overall Study|Protocol Violation|0|||
155374428|NCT02626455|560803952|FG005|Overall Study|Protocol Violation|0|||
155374429|NCT02626455|560803953|FG006|Overall Study|Protocol Violation|1|||
155374430|NCT02626455|560803947|FG000|Overall Study|Progressive disease - radiological progression|0|||
155374431|NCT02626455|560803948|FG001|Overall Study|Progressive disease - radiological progression|0|||
155374432|NCT02626455|560803949|FG002|Overall Study|Progressive disease - radiological progression|0|||
155374433|NCT02626455|560803950|FG003|Overall Study|Progressive disease - radiological progression|0|||
155374434|NCT02626455|560803951|FG004|Overall Study|Progressive disease - radiological progression|0|||
155374435|NCT02626455|560803952|FG005|Overall Study|Progressive disease - radiological progression|11|||
155374436|NCT02626455|560803953|FG006|Overall Study|Progressive disease - radiological progression|22|||
155374437|NCT02626455|560803947|FG000|Overall Study|Progressive disease - clinical progression|0|||
155374438|NCT02626455|560803948|FG001|Overall Study|Progressive disease - clinical progression|0|||
155374439|NCT02626455|560803949|FG002|Overall Study|Progressive disease - clinical progression|0|||
155374440|NCT02626455|560803950|FG003|Overall Study|Progressive disease - clinical progression|0|||
155374441|NCT02626455|560803951|FG004|Overall Study|Progressive disease - clinical progression|0|||
155374442|NCT02626455|560803952|FG005|Overall Study|Progressive disease - clinical progression|1|||
155374443|NCT02626455|560803953|FG006|Overall Study|Progressive disease - clinical progression|2|||
155374444|NCT02626455|560803947|FG000|Overall Study|Lost to Follow-up|0|||
155374445|NCT02626455|560803948|FG001|Overall Study|Lost to Follow-up|0|||
155374446|NCT02626455|560803949|FG002|Overall Study|Lost to Follow-up|0|||
155374447|NCT02626455|560803950|FG003|Overall Study|Lost to Follow-up|0|||
155374448|NCT02626455|560803951|FG004|Overall Study|Lost to Follow-up|0|||
155374449|NCT02626455|560803952|FG005|Overall Study|Lost to Follow-up|1|||
155374450|NCT02626455|560803953|FG006|Overall Study|Lost to Follow-up|0|||
155374451|NCT02626455|560803947|FG000|Overall Study|AE not associated with clinical disease progression|1|||
155374452|NCT02626455|560803948|FG001|Overall Study|AE not associated with clinical disease progression|1|||
155374453|NCT02626455|560803949|FG002|Overall Study|AE not associated with clinical disease progression|0|||
155374454|NCT02626455|560803950|FG003|Overall Study|AE not associated with clinical disease progression|2|||
155374455|NCT02626455|560803951|FG004|Overall Study|AE not associated with clinical disease progression|1|||
155374456|NCT02626455|560803952|FG005|Overall Study|AE not associated with clinical disease progression|65|||
155374457|NCT02626455|560803953|FG006|Overall Study|AE not associated with clinical disease progression|21|||
155374458|NCT02626455|560803947|FG000|Overall Study|AE associated with clinical disease progression|0|||
155374459|NCT02626455|560803948|FG001|Overall Study|AE associated with clinical disease progression|0|||
155374460|NCT02626455|560803949|FG002|Overall Study|AE associated with clinical disease progression|0|||
155374461|NCT02626455|560803950|FG003|Overall Study|AE associated with clinical disease progression|0|||
155374462|NCT02626455|560803951|FG004|Overall Study|AE associated with clinical disease progression|0|||
155374463|NCT02626455|560803952|FG005|Overall Study|AE associated with clinical disease progression|1|||
155374464|NCT02626455|560803953|FG006|Overall Study|AE associated with clinical disease progression|2|||
155374465|NCT02626455|560803947|FG000|Overall Study|Study intervention never administered|0|||
155374466|NCT02626455|560803948|FG001|Overall Study|Study intervention never administered|0|||
155374467|NCT02626455|560803949|FG002|Overall Study|Study intervention never administered|0|||
155374468|NCT02626455|560803950|FG003|Overall Study|Study intervention never administered|0|||
155374469|NCT02626455|560803951|FG004|Overall Study|Study intervention never administered|0|||
155374470|NCT02626455|560803952|FG005|Overall Study|Study intervention never administered|1|||
155374471|NCT02626455|560803953|FG006|Overall Study|Study intervention never administered|3|||
155374472|NCT05148962|560803954|FG000|Overall Study|Withdrawal by Subject|1|||
155374473|NCT05148962|560803955|FG001|Overall Study|Withdrawal by Subject|1|||
155374474|NCT05148962|560803956|FG002|Overall Study|Withdrawal by Subject|0|||
155374475|NCT05148962|560803957|FG003|Overall Study|Withdrawal by Subject|1|||
155374476|NCT05148962|560803958|FG004|Overall Study|Withdrawal by Subject|0|||
155374477|NCT05148962|560803954|FG000|Overall Study|Participant was early terminated per protocol|0|||
155374478|NCT05148962|560803955|FG001|Overall Study|Participant was early terminated per protocol|0|||
155374479|NCT05148962|560803956|FG002|Overall Study|Participant was early terminated per protocol|3|||
155374480|NCT05148962|560803957|FG003|Overall Study|Participant was early terminated per protocol|5|||
155374481|NCT05148962|560803958|FG004|Overall Study|Participant was early terminated per protocol|2|||
155374482|NCT05148962|560803954|FG000|Overall Study|Miscellaneous|0|||
155374483|NCT05148962|560803955|FG001|Overall Study|Miscellaneous|0|||
155374484|NCT05148962|560803956|FG002|Overall Study|Miscellaneous|0|||
155374485|NCT05148962|560803957|FG003|Overall Study|Miscellaneous|1|||
155374486|NCT05148962|560803958|FG004|Overall Study|Miscellaneous|0|||
155374487|NCT06665919|560803959|FG000|Overall Study|Withdrawal by Subject|4|||
155374488|NCT06665919|560803960|FG001|Overall Study|Withdrawal by Subject|4|||
155374489|NCT06665919|560803961|FG002|Overall Study|Withdrawal by Subject|4|||
155374490|NCT06665919|560803959|FG000|Overall Study|Non-compliance to Treatment|4|||
155374491|NCT06665919|560803960|FG001|Overall Study|Non-compliance to Treatment|1|||
155374492|NCT06665919|560803961|FG002|Overall Study|Non-compliance to Treatment|6|||
155374493|NCT06665919|560803959|FG000|Overall Study|Lost to Follow-up|3|||
155374494|NCT06665919|560803960|FG001|Overall Study|Lost to Follow-up|0|||
155374495|NCT06665919|560803961|FG002|Overall Study|Lost to Follow-up|2|||
155374496|NCT06665919|560803959|FG000|Overall Study|Physician Decision|4|||
155374497|NCT06665919|560803960|FG001|Overall Study|Physician Decision|0|||
155374498|NCT06665919|560803961|FG002|Overall Study|Physician Decision|1|||
155374499|NCT01144377|560803962|FG000|52 Week Treatment Period|Adverse Event|0|||
155374500|NCT01144377|560803963|FG001|52 Week Treatment Period|Adverse Event|0|||
155374501|NCT01144377|560803964|FG002|52 Week Treatment Period|Adverse Event|3|||
155374502|NCT01144377|560803965|FG003|52 Week Treatment Period|Adverse Event|2|||
155374503|NCT01144377|560803966|FG004|52 Week Treatment Period|Adverse Event|1|||
155374504|NCT01144377|560803962|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374505|NCT01144377|560803963|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374506|NCT01144377|560803964|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
155374507|NCT01144377|560803965|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
155374508|NCT01144377|560803966|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374509|NCT01144377|560803962|FG000|52 Week Treatment Period|Protocol Violation|0|||
155374510|NCT01144377|560803963|FG001|52 Week Treatment Period|Protocol Violation|0|||
155374511|NCT01144377|560803964|FG002|52 Week Treatment Period|Protocol Violation|0|||
155374512|NCT01144377|560803965|FG003|52 Week Treatment Period|Protocol Violation|0|||
155374513|NCT01144377|560803966|FG004|52 Week Treatment Period|Protocol Violation|1|||
155374514|NCT01144377|560803962|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
155374515|NCT01144377|560803963|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
155374516|NCT01144377|560803964|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
155374517|NCT01144377|560803965|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
155374518|NCT01144377|560803966|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
155374519|NCT01144377|560803962|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
155374520|NCT01144377|560803963|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
155374521|NCT01144377|560803964|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
155374522|NCT01144377|560803965|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
155374523|NCT01144377|560803966|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
155374524|NCT01144377|560803962|FG000|52 Week Treatment Period|Sponsor Decision|0|||
155374525|NCT01144377|560803963|FG001|52 Week Treatment Period|Sponsor Decision|0|||
155374526|NCT01144377|560803964|FG002|52 Week Treatment Period|Sponsor Decision|0|||
155374527|NCT01144377|560803965|FG003|52 Week Treatment Period|Sponsor Decision|0|||
155374528|NCT01144377|560803966|FG004|52 Week Treatment Period|Sponsor Decision|1|||
155374529|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374530|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
155374531|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374532|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374533|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
155374534|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374535|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374536|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374537|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374538|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
155374539|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
155511517|NCT02862535|561297561|FG002|Overall Study|Study Terminated by Sponsor|8|||
155511518|NCT02862535|561297562|FG003|Overall Study|Study Terminated by Sponsor|5|||
155511519|NCT02862535|561297559|FG000|Overall Study|Enrolled, not Treated|1|||
155511520|NCT02862535|561297560|FG001|Overall Study|Enrolled, not Treated|0|||
155511521|NCT02862535|561297561|FG002|Overall Study|Enrolled, not Treated|0|||
155374540|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374541|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374542|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374543|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374544|NCT01525238|560803967|FG000|Overall Study|Withdrawal by Subject|1|||
155430919|NCT00609622|561002414|FG000|Overall Study|Study terminated by sponsor|16|||
155511522|NCT02862535|561297562|FG003|Overall Study|Enrolled, not Treated|1|||
155430920|NCT00609622|561002415|FG001|Overall Study|Study terminated by sponsor|3|||
155511523|NCT01965652|561297565|FG000|Overall Study|Adverse Event|40|||
155511524|NCT01965652|561297566|FG001|Overall Study|Adverse Event|37|||
155511525|NCT01965652|561297565|FG000|Overall Study|Withdrawal by Subject|62|||
155511526|NCT01965652|561297566|FG001|Overall Study|Withdrawal by Subject|69|||
155511527|NCT01965652|561297565|FG000|Overall Study|Lost to Follow-up|53|||
155511528|NCT01965652|561297566|FG001|Overall Study|Lost to Follow-up|40|||
155511529|NCT01965652|561297565|FG000|Overall Study|Protocol Violation|34|||
155511530|NCT01965652|561297566|FG001|Overall Study|Protocol Violation|38|||
155511531|NCT01965652|561297565|FG000|Overall Study|Death|3|||
155511532|NCT01965652|561297566|FG001|Overall Study|Death|4|||
155511533|NCT01965652|561297565|FG000|Overall Study|Other - Miscellaneous|18|||
155511534|NCT01965652|561297566|FG001|Overall Study|Other - Miscellaneous|21|||
155511535|NCT01965652|561297565|FG000|Overall Study|Pregnancy|0|||
155511536|NCT01965652|561297566|FG001|Overall Study|Pregnancy|1|||
155511537|NCT01121900|561297567|FG000|First Intervention Period|Adverse Event|1|||
155511538|NCT01121900|561297568|FG001|First Intervention Period|Adverse Event|1|||
155511539|NCT01121900|561297567|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155511540|NCT01121900|561297568|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155511541|NCT03469271|561297569|FG000|Overall Study|Withdrawal by Subject|2|||
155511542|NCT03469271|561297570|FG001|Overall Study|Withdrawal by Subject|0|||
155511543|NCT03469271|561297571|FG002|Overall Study|Withdrawal by Subject|0|||
155374545|NCT01525238|560803968|FG001|Overall Study|Withdrawal by Subject|0|||
155374546|NCT01525238|560803969|FG002|Overall Study|Withdrawal by Subject|0|||
155374547|NCT01214642|560803970|FG000|Overall Study|Progressive Disease|3|||
155430921|NCT00609622|561002414|FG000|Overall Study|Other|7|||
155430922|NCT00609622|561002415|FG001|Overall Study|Other|14|||
155430923|NCT00609622|561002414|FG000|Overall Study|Global deterioration of health status|6|||
155430924|NCT00609622|561002415|FG001|Overall Study|Global deterioration of health status|2|||
155430925|NCT00686543|561002416|FG000|Overall Study|Adverse Event|9|||
155430926|NCT00686543|561002417|FG001|Overall Study|Adverse Event|1|||
155430927|NCT00686543|561002418|FG002|Overall Study|Adverse Event|3|||
155430928|NCT00686543|561002419|FG003|Overall Study|Adverse Event|2|||
155511544|NCT03469271|561297572|FG003|Overall Study|Withdrawal by Subject|1|||
155511545|NCT03760510|561297573|FG000|Overall Study|Not ventilated for 24 hours|105|||
155511546|NCT03760510|561297574|FG001|Overall Study|Not ventilated for 24 hours|97|||
155374548|NCT01214642|560803971|FG001|Overall Study|Progressive Disease|2|||
155374549|NCT01214642|560803972|FG002|Overall Study|Progressive Disease|3|||
155430929|NCT00686543|561002416|FG000|Overall Study|Withdrawal by Subject|2|||
155374550|NCT01214642|560803973|FG003|Overall Study|Progressive Disease|5|||
155374551|NCT01214642|560803974|FG004|Overall Study|Progressive Disease|5|||
155430930|NCT00686543|561002417|FG001|Overall Study|Withdrawal by Subject|0|||
155374552|NCT01214642|560803975|FG005|Overall Study|Progressive Disease|3|||
155374553|NCT01214642|560803976|FG006|Overall Study|Progressive Disease|5|||
155374554|NCT01214642|560803977|FG007|Overall Study|Progressive Disease|3|||
155374555|NCT01214642|560803978|FG008|Overall Study|Progressive Disease|10|||
155374556|NCT01214642|560803979|FG009|Overall Study|Progressive Disease|2|||
155374557|NCT01214642|560803980|FG010|Overall Study|Progressive Disease|1|||
155374558|NCT01214642|560803981|FG011|Overall Study|Progressive Disease|4|||
155374559|NCT01214642|560803970|FG000|Overall Study|Adverse Event|0|||
155374560|NCT01214642|560803971|FG001|Overall Study|Adverse Event|1|||
155374561|NCT01214642|560803972|FG002|Overall Study|Adverse Event|0|||
155374562|NCT01214642|560803973|FG003|Overall Study|Adverse Event|0|||
155374563|NCT01214642|560803974|FG004|Overall Study|Adverse Event|0|||
155374564|NCT01214642|560803975|FG005|Overall Study|Adverse Event|0|||
155374565|NCT01214642|560803976|FG006|Overall Study|Adverse Event|1|||
155374566|NCT01214642|560803977|FG007|Overall Study|Adverse Event|0|||
155374567|NCT01214642|560803978|FG008|Overall Study|Adverse Event|0|||
155374568|NCT01214642|560803979|FG009|Overall Study|Adverse Event|1|||
155374569|NCT01214642|560803980|FG010|Overall Study|Adverse Event|1|||
155374570|NCT01214642|560803981|FG011|Overall Study|Adverse Event|0|||
155374571|NCT01214642|560803970|FG000|Overall Study|Death|0|||
155374572|NCT01214642|560803971|FG001|Overall Study|Death|0|||
155374573|NCT01214642|560803972|FG002|Overall Study|Death|1|||
155374574|NCT01214642|560803973|FG003|Overall Study|Death|0|||
155374575|NCT01214642|560803974|FG004|Overall Study|Death|0|||
155374576|NCT01214642|560803975|FG005|Overall Study|Death|0|||
155374577|NCT01214642|560803976|FG006|Overall Study|Death|0|||
155374578|NCT01214642|560803977|FG007|Overall Study|Death|0|||
155374579|NCT01214642|560803978|FG008|Overall Study|Death|0|||
155374580|NCT01214642|560803979|FG009|Overall Study|Death|0|||
155374581|NCT01214642|560803980|FG010|Overall Study|Death|1|||
155374582|NCT01214642|560803981|FG011|Overall Study|Death|0|||
155374583|NCT01214642|560803970|FG000|Overall Study|Withdrawal by Subject|0|||
155374584|NCT01214642|560803971|FG001|Overall Study|Withdrawal by Subject|0|||
155374585|NCT01214642|560803972|FG002|Overall Study|Withdrawal by Subject|1|||
155374586|NCT01214642|560803973|FG003|Overall Study|Withdrawal by Subject|0|||
155374587|NCT01214642|560803974|FG004|Overall Study|Withdrawal by Subject|0|||
155374588|NCT01214642|560803975|FG005|Overall Study|Withdrawal by Subject|0|||
155374589|NCT01214642|560803976|FG006|Overall Study|Withdrawal by Subject|0|||
155374590|NCT01214642|560803977|FG007|Overall Study|Withdrawal by Subject|0|||
155374591|NCT01214642|560803978|FG008|Overall Study|Withdrawal by Subject|3|||
155374592|NCT01214642|560803979|FG009|Overall Study|Withdrawal by Subject|1|||
155374593|NCT01214642|560803980|FG010|Overall Study|Withdrawal by Subject|1|||
155374594|NCT01214642|560803981|FG011|Overall Study|Withdrawal by Subject|0|||
155374595|NCT01214642|560803970|FG000|Overall Study|Physician Decision|0|||
155374596|NCT01214642|560803971|FG001|Overall Study|Physician Decision|0|||
155374597|NCT01214642|560803972|FG002|Overall Study|Physician Decision|1|||
155374598|NCT01214642|560803973|FG003|Overall Study|Physician Decision|1|||
155374599|NCT01214642|560803974|FG004|Overall Study|Physician Decision|1|||
155374600|NCT01214642|560803975|FG005|Overall Study|Physician Decision|0|||
155374601|NCT01214642|560803976|FG006|Overall Study|Physician Decision|0|||
155374602|NCT01214642|560803977|FG007|Overall Study|Physician Decision|0|||
155374603|NCT01214642|560803978|FG008|Overall Study|Physician Decision|0|||
155374604|NCT01214642|560803979|FG009|Overall Study|Physician Decision|0|||
155374605|NCT01214642|560803980|FG010|Overall Study|Physician Decision|0|||
155374606|NCT01214642|560803981|FG011|Overall Study|Physician Decision|2|||
155374607|NCT04696653|560803982|FG000|Overall Study|left organization|18|||
155374608|NCT04696653|560803982|FG000|Overall Study|Lost to Follow-up|3|||
155374609|NCT02075476|560805317|FG000|Overall Study|Death|2|||
155374610|NCT02075476|560805318|FG001|Overall Study|Death|2|||
155374611|NCT02075476|560805317|FG000|Overall Study|Lost to Follow-up|1|||
155374612|NCT02075476|560805318|FG001|Overall Study|Lost to Follow-up|3|||
155374613|NCT02914275|560805321|FG000|Overall Study|Lost to Follow-up|84|||
155430931|NCT00686543|561002418|FG002|Overall Study|Withdrawal by Subject|0|||
155430932|NCT00686543|561002419|FG003|Overall Study|Withdrawal by Subject|0|||
155430933|NCT00686543|561002416|FG000|Overall Study|Protocol Violation|3|||
155430934|NCT00686543|561002417|FG001|Overall Study|Protocol Violation|0|||
155374614|NCT02914275|560805322|FG001|Overall Study|Lost to Follow-up|29|||
155374615|NCT02914275|560805321|FG000|Overall Study|Withdrawal by Subject|26|||
155374616|NCT02914275|560805322|FG001|Overall Study|Withdrawal by Subject|10|||
155374617|NCT02914275|560805321|FG000|Overall Study|Protocol Violation|1|||
155374618|NCT02914275|560805322|FG001|Overall Study|Protocol Violation|1|||
155374619|NCT02914275|560805321|FG000|Overall Study|Physician Decision|3|||
155374620|NCT02914275|560805322|FG001|Overall Study|Physician Decision|1|||
155374621|NCT02914275|560805321|FG000|Overall Study|Other|4|||
155374622|NCT02914275|560805322|FG001|Overall Study|Other|1|||
155374623|NCT02914275|560805321|FG000|Overall Study|Excluded due to invalid informed consent|3|||
155374624|NCT02914275|560805322|FG001|Overall Study|Excluded due to invalid informed consent|0|||
155374625|NCT03527550|560805325|FG000|Overall Study|Lost to Follow-up|4|||
155374626|NCT03527550|560805326|FG001|Overall Study|Lost to Follow-up|2|||
155430935|NCT00686543|561002418|FG002|Overall Study|Protocol Violation|2|||
155430936|NCT00686543|561002419|FG003|Overall Study|Protocol Violation|1|||
155430937|NCT01237951|561002420|FG000|Overall Study|Death|1|||
155430938|NCT01708057|561002421|FG000|Overall Study|Withdrawal due to study termination.|1|||
155430939|NCT01708057|561002422|FG001|Overall Study|Withdrawal due to study termination.|1|||
155430940|NCT01708057|561002423|FG002|Overall Study|Withdrawal due to study termination.|1|||
155430941|NCT00924703|561002426|FG000|Overall Study|Withdrawal by Subject|11|||
155430942|NCT00924703|561002426|FG000|Overall Study|Physician Decision|5|||
155430943|NCT00924703|561002426|FG000|Overall Study|Lost to Follow-up|3|||
155430944|NCT00924703|561002426|FG000|Overall Study|Adverse Event|2|||
155430945|NCT00924703|561002426|FG000|Overall Study|Withdrawal by Sponsor|1|||
155430946|NCT00666562|561002427|FG000|Overall Study|Withdrawal by Subject|0|||
155430947|NCT00666562|561002428|FG001|Overall Study|Withdrawal by Subject|1|||
155430948|NCT00666562|561002429|FG002|Overall Study|Withdrawal by Subject|0|||
155430949|NCT00666562|561002427|FG000|Overall Study|Concomitant Medication|0|||
155430950|NCT00666562|561002428|FG001|Overall Study|Concomitant Medication|1|||
155430951|NCT00666562|561002429|FG002|Overall Study|Concomitant Medication|0|||
155430952|NCT04906707|561002430|FG000|Overall Study|Withdrawal by Subject|2|||
155430953|NCT04906707|561002431|FG001|Overall Study|Withdrawal by Subject|0|||
155430954|NCT04906707|561002430|FG000|Overall Study|Withdrawal due to PI decision|1|||
155430955|NCT04906707|561002431|FG001|Overall Study|Withdrawal due to PI decision|0|||
155430956|NCT04906707|561002430|FG000|Overall Study|Lost to Follow-up|0|||
155430957|NCT04906707|561002431|FG001|Overall Study|Lost to Follow-up|1|||
155430958|NCT01976806|561002432|FG000|Overall Study|Lost to Follow-up|1|||
155430959|NCT01976806|561002433|FG001|Overall Study|Lost to Follow-up|4|||
155430960|NCT01976806|561002432|FG000|Overall Study|Adverse Event|1|||
155430961|NCT01976806|561002433|FG001|Overall Study|Adverse Event|1|||
155430962|NCT01976806|561002432|FG000|Overall Study|Withdrawal by Subject|1|||
155430963|NCT01976806|561002433|FG001|Overall Study|Withdrawal by Subject|1|||
155430964|NCT03929250|561002435|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
155430965|NCT03929250|561002436|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
155430966|NCT04429022|561002439|FG000|Overall Study|Protocol Violation|18|||
155430967|NCT04429022|561002440|FG001|Overall Study|Protocol Violation|1|||
155430968|NCT05262764|561002441|FG000|Overall Study|Case report form not collected|9|||
155430969|NCT05262764|561002441|FG000|Overall Study|No patient visits after entry|23|||
155430970|NCT05262764|561002441|FG000|Overall Study|Registration rule not followed|2|||
155430971|NCT05262764|561002441|FG000|Overall Study|Patient of non-chronic heart failure|1|||
155430972|NCT00075881|561003501|FG000|Overall Study|Lack of Efficacy|18|||
155430973|NCT00075881|561003501|FG000|Overall Study|Adverse Event|7|||
155430974|NCT00075881|561003501|FG000|Overall Study|Death|1|||
155430975|NCT00075881|561003501|FG000|Overall Study|Withdrawal by Subject|2|||
155430976|NCT00075881|561003501|FG000|Overall Study|Protocol Violation|4|||
155430977|NCT00075881|561003501|FG000|Overall Study|other complicating disease|3|||
155430978|NCT00075881|561003501|FG000|Overall Study|other|4|||
155430979|NCT00075881|561003501|FG000|Overall Study|missing data|2|||
155430980|NCT00075881|561003501|FG000|Overall Study|Ineligible|1|||
155430981|NCT00075881|561003501|FG000|Overall Study|never start protocol therapy|1|||
155430982|NCT02109029|561003504|FG000|Part B|Adverse Event|0|||
155430983|NCT02109029|561003505|FG001|Part B|Adverse Event|0|||
155430984|NCT02109029|561003506|FG002|Part B|Adverse Event|0|||
155430985|NCT02109029|561003507|FG003|Part B|Adverse Event|0|||
155430986|NCT02109029|561003508|FG004|Part B|Adverse Event|1|||
155430987|NCT02109029|561003509|FG005|Part B|Adverse Event|1|||
155430988|NCT03195894|561003510|FG000|Overall Study|"An example is Started other treatment."|4|||
155430989|NCT03195894|561003511|FG001|Overall Study|"An example is Started other treatment."|5|||
155430990|NCT03195894|561003510|FG000|Overall Study|Withdrawal by Subject|15|||
155430991|NCT03195894|561003511|FG001|Overall Study|Withdrawal by Subject|4|||
155430992|NCT03195894|561003510|FG000|Overall Study|Lost to Follow-up|14|||
155430993|NCT03195894|561003511|FG001|Overall Study|Lost to Follow-up|19|||
155430994|NCT00686205|561003515|FG000|Overall Study|Protocol Violation|127|||
155430995|NCT00686205|561003516|FG001|Overall Study|Protocol Violation|0|||
155430996|NCT00686205|561003515|FG000|Overall Study|Withdrawal by Subject|2|||
155430997|NCT00686205|561003516|FG001|Overall Study|Withdrawal by Subject|0|||
155430998|NCT00686205|561003515|FG000|Overall Study|Specimen handling procedure altered|5878|||
155430999|NCT00686205|561003516|FG001|Overall Study|Specimen handling procedure altered|0|||
155431000|NCT00686205|561003515|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
155431001|NCT00686205|561003516|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
155431002|NCT01217606|561003517|FG000|Initial Treatment Phase|Other Reasons|0|||
155431003|NCT01217606|561003518|FG001|Initial Treatment Phase|Other Reasons|2|||
155431004|NCT01217606|561003517|FG000|Initial Treatment Phase|Protocol Violation|3|||
155431005|NCT01217606|561003518|FG001|Initial Treatment Phase|Protocol Violation|2|||
155431006|NCT01217606|561003517|FG000|Initial Treatment Phase|Personal Reasons|0|||
155431007|NCT01217606|561003518|FG001|Initial Treatment Phase|Personal Reasons|2|||
155431008|NCT01217606|561003517|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
155431009|NCT01217606|561003518|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
155431010|NCT01217606|561003517|FG000|Initial Treatment Phase|Adverse Event|10|||
155511547|NCT03361956|561297575|FG000|Overall Study|Adverse Event|1|||
155511548|NCT03361956|561297576|FG001|Overall Study|Adverse Event|0|||
155511549|NCT03361956|561297577|FG002|Overall Study|Adverse Event|1|||
155511550|NCT03361956|561297578|FG003|Overall Study|Adverse Event|1|||
155511551|NCT03361956|561297579|FG004|Overall Study|Adverse Event|0|||
155511552|NCT03361956|561297575|FG000|Overall Study|Other|0|||
155511553|NCT03361956|561297576|FG001|Overall Study|Other|0|||
155511554|NCT03361956|561297577|FG002|Overall Study|Other|0|||
155511555|NCT03361956|561297578|FG003|Overall Study|Other|1|||
155511556|NCT03361956|561297579|FG004|Overall Study|Other|0|||
155511557|NCT03361956|561297575|FG000|Overall Study|Withdrawal by Subject|2|||
155511558|NCT03361956|561297576|FG001|Overall Study|Withdrawal by Subject|2|||
155511559|NCT03361956|561297577|FG002|Overall Study|Withdrawal by Subject|2|||
155511560|NCT03361956|561297578|FG003|Overall Study|Withdrawal by Subject|0|||
155511561|NCT03361956|561297579|FG004|Overall Study|Withdrawal by Subject|3|||
155511562|NCT03361956|561297575|FG000|Overall Study|Disease Relapse|0|||
155511563|NCT03361956|561297576|FG001|Overall Study|Disease Relapse|0|||
155511564|NCT03361956|561297577|FG002|Overall Study|Disease Relapse|1|||
155511565|NCT03361956|561297578|FG003|Overall Study|Disease Relapse|0|||
155511566|NCT03361956|561297579|FG004|Overall Study|Disease Relapse|0|||
155511567|NCT03361956|561297575|FG000|Overall Study|Physician Decision|0|||
155511568|NCT03361956|561297576|FG001|Overall Study|Physician Decision|2|||
155511569|NCT03361956|561297577|FG002|Overall Study|Physician Decision|0|||
155511570|NCT03361956|561297578|FG003|Overall Study|Physician Decision|1|||
155511571|NCT03361956|561297579|FG004|Overall Study|Physician Decision|0|||
155511572|NCT03361956|561297575|FG000|Overall Study|Lost to Follow-up|0|||
155511573|NCT03361956|561297576|FG001|Overall Study|Lost to Follow-up|0|||
155511574|NCT03361956|561297577|FG002|Overall Study|Lost to Follow-up|1|||
155511575|NCT03361956|561297578|FG003|Overall Study|Lost to Follow-up|1|||
155511576|NCT03361956|561297579|FG004|Overall Study|Lost to Follow-up|2|||
155511577|NCT04147715|561297581|FG000|Overall Study|Adverse Event|0|||
155511578|NCT04147715|561297582|FG001|Overall Study|Adverse Event|0|||
155511579|NCT04147715|561297583|FG002|Overall Study|Adverse Event|0|||
155511580|NCT04147715|561297584|FG003|Overall Study|Adverse Event|0|||
155511581|NCT04147715|561297585|FG004|Overall Study|Adverse Event|0|||
155511582|NCT04147715|561297586|FG005|Overall Study|Adverse Event|0|||
155511583|NCT04147715|561297587|FG006|Overall Study|Adverse Event|0|||
155511584|NCT04147715|561297588|FG007|Overall Study|Adverse Event|2|||
155511585|NCT04147715|561297589|FG008|Overall Study|Adverse Event|1|||
155511586|NCT04147715|561297590|FG009|Overall Study|Adverse Event|0|||
155511587|NCT04147715|561297591|FG010|Overall Study|Adverse Event|0|||
155511588|NCT04147715|561297592|FG011|Overall Study|Adverse Event|0|||
155511589|NCT02418910|561297594|FG000|Overall Study|Lost to Follow-up|3|||
155511590|NCT02418910|561297594|FG000|Overall Study|Withdrawal by Subject|4|||
155511591|NCT00895583|561297597|FG000|Overall Study|Adverse Event|28|||
155511592|NCT00895583|561297598|FG001|Overall Study|Adverse Event|4|||
155511593|NCT00895583|561297597|FG000|Overall Study|Death|2|||
155511594|NCT00895583|561297598|FG001|Overall Study|Death|1|||
155511595|NCT00895583|561297597|FG000|Overall Study|Physician Decision|3|||
155511596|NCT00895583|561297598|FG001|Overall Study|Physician Decision|1|||
155511597|NCT00895583|561297597|FG000|Overall Study|Lost to Follow-up|1|||
155511598|NCT00895583|561297598|FG001|Overall Study|Lost to Follow-up|3|||
155511599|NCT00895583|561297597|FG000|Overall Study|Protocol Violation|1|||
155511600|NCT00895583|561297598|FG001|Overall Study|Protocol Violation|0|||
155511601|NCT00895583|561297597|FG000|Overall Study|Withdrawal by Subject|4|||
155511602|NCT00895583|561297598|FG001|Overall Study|Withdrawal by Subject|2|||
155511603|NCT00895583|561297597|FG000|Overall Study|Lack of Efficacy|5|||
155511604|NCT00895583|561297598|FG001|Overall Study|Lack of Efficacy|0|||
155511605|NCT00895583|561297597|FG000|Overall Study|Other|0|||
155511606|NCT00895583|561297598|FG001|Overall Study|Other|1|||
155511607|NCT03016078|561297602|FG000|Overall Study|Protocol Violation|1|||
155511608|NCT03016078|561297602|FG000|Overall Study|Protocol Violation|1|||
155511609|NCT03381248|561299285|FG000|0-6 Months|Withdrawal by Subject|4|||
155511610|NCT03381248|561299286|FG001|0-6 Months|Withdrawal by Subject|1|||
155511611|NCT03381248|561299285|FG000|0-6 Months|Lost to Follow-up|3|||
155511612|NCT03381248|561299286|FG001|0-6 Months|Lost to Follow-up|2|||
155511613|NCT03381248|561299285|FG000|0-6 Months|Lack of Efficacy|1|||
155511614|NCT03381248|561299286|FG001|0-6 Months|Lack of Efficacy|0|||
155511615|NCT03381248|561299285|FG000|0-6 Months|Adverse Event|1|||
155511616|NCT03381248|561299286|FG001|0-6 Months|Adverse Event|0|||
155511617|NCT03381248|561299285|FG000|0-6 Months|Protocol Violation|2|||
155511618|NCT03381248|561299286|FG001|0-6 Months|Protocol Violation|1|||
155511619|NCT03381248|561299285|FG000|0-6 Months|Physician Decision|1|||
155511620|NCT03381248|561299286|FG001|0-6 Months|Physician Decision|0|||
155511621|NCT03381248|561299285|FG000|0-6 Months|Planning another procedure|1|||
155511622|NCT03381248|561299286|FG001|0-6 Months|Planning another procedure|2|||
155511623|NCT03381248|561299285|FG000|6-12 Months|Withdrawal by Subject|1|||
155511624|NCT03381248|561299286|FG001|6-12 Months|Withdrawal by Subject|3|||
155511625|NCT03381248|561299285|FG000|6-12 Months|Lost to Follow-up|0|||
155511626|NCT03381248|561299286|FG001|6-12 Months|Lost to Follow-up|2|||
155511627|NCT03381248|561299285|FG000|6-12 Months|Protocol Violation|3|||
155511628|NCT03381248|561299286|FG001|6-12 Months|Protocol Violation|2|||
155511629|NCT03381248|561299285|FG000|6-12 Months|Planning another procedure|6|||
155511630|NCT03381248|561299286|FG001|6-12 Months|Planning another procedure|2|||
155511631|NCT03381248|561299285|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
155511632|NCT03381248|561299286|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
155511633|NCT03381248|561299285|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
155511634|NCT03381248|561299286|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
155511635|NCT03381248|561299285|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
155511636|NCT03381248|561299286|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
155511637|NCT05188521|561299291|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
155511638|NCT05188521|561299292|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
155511639|NCT04582266|561299293|FG000|Overall Study|Lost to Follow-up|7|||
155511640|NCT04582266|561299294|FG001|Overall Study|Lost to Follow-up|5|||
155511641|NCT04582266|561299293|FG000|Overall Study|Withdrawal by Subject|1|||
155511642|NCT04582266|561299294|FG001|Overall Study|Withdrawal by Subject|0|||
155511643|NCT04582266|561299293|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
155511644|NCT04582266|561299294|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
155511645|NCT01341639|561299295|FG000|Infant Series|Protocol Violation|1|||
155511646|NCT01341639|561299296|FG001|Infant Series|Protocol Violation|0|||
155511647|NCT01341639|561299295|FG000|Infant Series|Not Vaccinated|0|||
155649598|NCT00066170|561808308|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
155649599|NCT00066170|561808309|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
155649600|NCT00066170|561808310|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
155649601|NCT00066170|561808307|FG000|Overall Study|Protocol Violation|3|||
155374627|NCT03527550|560805325|FG000|Overall Study|Withdrawal by Subject|4|||
155374628|NCT03527550|560805326|FG001|Overall Study|Withdrawal by Subject|1|||
155374629|NCT03527550|560805325|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
155374630|NCT03527550|560805326|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
155374631|NCT01659853|560805327|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
155374632|NCT01659853|560805328|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
155374633|NCT01659853|560805327|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
155374634|NCT01659853|560805328|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
155374635|NCT03053518|560805331|FG000|Overall Study|Withdrawal by Subject|3|||
155374636|NCT03053518|560805331|FG000|Overall Study|Lost to Follow-up|2|||
155374637|NCT03053518|560805331|FG000|Overall Study|Ineligible|5|||
155374638|NCT02683876|560805332|FG000|Overall Study|samples damaged during shipping|2|||
155374639|NCT02683876|560805333|FG001|Overall Study|samples damaged during shipping|0|||
155374640|NCT00488475|560805336|FG000|Overall Study|Other|1754|||
155374641|NCT02797080|560805340|FG000|Overall Study|Lost to Follow-up|1|||
155374642|NCT02797080|560805340|FG000|Overall Study|Withdrawal by Subject|1|||
155374643|NCT04035499|560805343|FG000|Overall Study|Death|2|||
155374644|NCT04035499|560805343|FG000|Overall Study|Withdrawal by Subject|1|||
155374645|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Adverse Event|1|||
155374646|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Adverse Event|1|||
155374647|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Adverse Event|2|||
155374648|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Adverse Event|5|||
155374649|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Adverse Event|0|||
155374650|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
155374651|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
155374652|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374653|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374654|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374655|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
155374656|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
155374657|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
155374658|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
155511648|NCT01341639|561299296|FG001|Infant Series|Not Vaccinated|1|||
155649602|NCT00066170|561808308|FG001|Overall Study|Protocol Violation|0|||
155374659|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
155374660|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374661|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374662|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374663|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
155374664|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155511649|NCT01341639|561299295|FG000|Infant Series|Adverse Event|0|||
155511650|NCT01341639|561299296|FG001|Infant Series|Adverse Event|5|||
155511651|NCT01341639|561299295|FG000|Infant Series|Withdrawal by Subject|11|||
155649603|NCT00066170|561808309|FG002|Overall Study|Protocol Violation|0|||
155374665|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
155374666|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
155374667|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
155649604|NCT00066170|561808310|FG003|Overall Study|Protocol Violation|0|||
155511652|NCT01341639|561299296|FG001|Infant Series|Withdrawal by Subject|8|||
155511653|NCT01341639|561299295|FG000|Infant Series|Lost to Follow-up|0|||
155511654|NCT01341639|561299296|FG001|Infant Series|Lost to Follow-up|2|||
155511655|NCT01341639|561299295|FG000|Infant Series|Site 0048 Participants|17|||
155511656|NCT01341639|561299296|FG001|Infant Series|Site 0048 Participants|16|||
155511657|NCT01341639|561299295|FG000|Interim Period|Withdrawal by Subject|6|||
155511658|NCT01341639|561299296|FG001|Interim Period|Withdrawal by Subject|7|||
155511659|NCT01341639|561299295|FG000|Interim Period|Lost to Follow-up|2|||
155511660|NCT01341639|561299296|FG001|Interim Period|Lost to Follow-up|0|||
155511661|NCT01341639|561299295|FG000|Interim Period|Physician Decision|0|||
155511662|NCT01341639|561299296|FG001|Interim Period|Physician Decision|1|||
155511663|NCT01341639|561299295|FG000|Interim Period|Protocol Violation|0|||
155511664|NCT01341639|561299296|FG001|Interim Period|Protocol Violation|1|||
155511665|NCT01341639|561299295|FG000|Post-Treatment|Withdrawal by Subject|0|||
155511666|NCT01341639|561299296|FG001|Post-Treatment|Withdrawal by Subject|1|||
155511667|NCT01341639|561299295|FG000|Post-Treatment|Adverse Event|0|||
155374668|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
155374669|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
155374670|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155374671|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
155374672|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
155374673|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155374674|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
155374675|NCT00951015|560805344|FG000|Open-label Phase|Adverse Event|0|||
155374676|NCT00951015|560805345|FG001|Open-label Phase|Adverse Event|0|||
155374677|NCT00951015|560805346|FG002|Open-label Phase|Adverse Event|0|||
155374678|NCT00951015|560805347|FG003|Open-label Phase|Adverse Event|0|||
155374679|NCT00951015|560805348|FG004|Open-label Phase|Adverse Event|3|||
155374680|NCT00951015|560805344|FG000|Open-label Phase|Lack of Efficacy|0|||
155374681|NCT00951015|560805345|FG001|Open-label Phase|Lack of Efficacy|0|||
155374682|NCT00951015|560805346|FG002|Open-label Phase|Lack of Efficacy|0|||
155374683|NCT00951015|560805347|FG003|Open-label Phase|Lack of Efficacy|0|||
155374684|NCT00951015|560805348|FG004|Open-label Phase|Lack of Efficacy|1|||
155374685|NCT00951015|560805344|FG000|Open-label Phase|Protocol Violation|0|||
155374686|NCT00951015|560805345|FG001|Open-label Phase|Protocol Violation|0|||
155374687|NCT00951015|560805346|FG002|Open-label Phase|Protocol Violation|0|||
155374688|NCT00951015|560805347|FG003|Open-label Phase|Protocol Violation|0|||
155374689|NCT00951015|560805348|FG004|Open-label Phase|Protocol Violation|12|||
155374690|NCT00951015|560805344|FG000|Open-label Phase|Lost to Follow-up|0|||
155374691|NCT00951015|560805345|FG001|Open-label Phase|Lost to Follow-up|0|||
155374692|NCT00951015|560805346|FG002|Open-label Phase|Lost to Follow-up|0|||
155374693|NCT00951015|560805347|FG003|Open-label Phase|Lost to Follow-up|0|||
155374694|NCT00951015|560805348|FG004|Open-label Phase|Lost to Follow-up|12|||
155374695|NCT00951015|560805344|FG000|Open-label Phase|Withdrawal by Subject|0|||
155374696|NCT00951015|560805345|FG001|Open-label Phase|Withdrawal by Subject|0|||
155374697|NCT00951015|560805346|FG002|Open-label Phase|Withdrawal by Subject|0|||
155374698|NCT00951015|560805347|FG003|Open-label Phase|Withdrawal by Subject|0|||
155374699|NCT00951015|560805348|FG004|Open-label Phase|Withdrawal by Subject|14|||
155374700|NCT00951015|560805344|FG000|Open-label Phase|Physician Decision|0|||
155374701|NCT00951015|560805345|FG001|Open-label Phase|Physician Decision|0|||
155374702|NCT00951015|560805346|FG002|Open-label Phase|Physician Decision|0|||
155374703|NCT00951015|560805347|FG003|Open-label Phase|Physician Decision|0|||
155374704|NCT00951015|560805348|FG004|Open-label Phase|Physician Decision|8|||
155374705|NCT03819634|560805350|FG000|Overall Study|Physician Decision|2|||
155374706|NCT00299494|560805351|FG000|Overall Study|Withdrawal by Subject|0|||
155374707|NCT00299494|560805352|FG001|Overall Study|Withdrawal by Subject|0|||
155374708|NCT00299494|560805353|FG002|Overall Study|Withdrawal by Subject|0|||
155374709|NCT00299494|560805354|FG003|Overall Study|Withdrawal by Subject|3|||
155374710|NCT00299494|560805355|FG004|Overall Study|Withdrawal by Subject|1|||
155374711|NCT00299494|560805356|FG005|Overall Study|Withdrawal by Subject|4|||
155374712|NCT00299494|560805351|FG000|Overall Study|Physician Decision|0|||
155374713|NCT00299494|560805352|FG001|Overall Study|Physician Decision|0|||
155374714|NCT00299494|560805353|FG002|Overall Study|Physician Decision|0|||
155374715|NCT00299494|560805354|FG003|Overall Study|Physician Decision|0|||
155374716|NCT00299494|560805355|FG004|Overall Study|Physician Decision|1|||
155374717|NCT00299494|560805356|FG005|Overall Study|Physician Decision|0|||
155511668|NCT01341639|561299296|FG001|Post-Treatment|Adverse Event|2|||
155511669|NCT02224456|561299297|FG000|Overall Study|Lack of Efficacy|1|||
155511670|NCT02224456|561299297|FG000|Overall Study|Lost to Follow-up|15|||
155374718|NCT00299494|560805351|FG000|Overall Study|Death|3|||
155374719|NCT00299494|560805352|FG001|Overall Study|Death|1|||
155374720|NCT00299494|560805353|FG002|Overall Study|Death|4|||
155374721|NCT00299494|560805354|FG003|Overall Study|Death|6|||
155374722|NCT00299494|560805355|FG004|Overall Study|Death|18|||
155374723|NCT00299494|560805356|FG005|Overall Study|Death|19|||
155374724|NCT00299494|560805351|FG000|Overall Study|Lost to Follow-up|0|||
155374725|NCT00299494|560805352|FG001|Overall Study|Lost to Follow-up|0|||
155511671|NCT02224456|561299297|FG000|Overall Study|Withdrawal by Subject|9|||
155374726|NCT00299494|560805353|FG002|Overall Study|Lost to Follow-up|0|||
155374727|NCT00299494|560805354|FG003|Overall Study|Lost to Follow-up|0|||
155374728|NCT00299494|560805355|FG004|Overall Study|Lost to Follow-up|3|||
155374729|NCT00299494|560805356|FG005|Overall Study|Lost to Follow-up|1|||
155374730|NCT00299494|560805351|FG000|Overall Study|Other - Unspecified|0|||
155374731|NCT00299494|560805352|FG001|Overall Study|Other - Unspecified|0|||
155374732|NCT00299494|560805353|FG002|Overall Study|Other - Unspecified|0|||
155374733|NCT00299494|560805354|FG003|Overall Study|Other - Unspecified|0|||
155374734|NCT00299494|560805355|FG004|Overall Study|Other - Unspecified|3|||
155374735|NCT00299494|560805356|FG005|Overall Study|Other - Unspecified|1|||
155374736|NCT00299494|560805351|FG000|Overall Study|Other - site closure|0|||
155374737|NCT00299494|560805352|FG001|Overall Study|Other - site closure|0|||
155374738|NCT00299494|560805353|FG002|Overall Study|Other - site closure|0|||
155374739|NCT00299494|560805354|FG003|Overall Study|Other - site closure|1|||
155374740|NCT00299494|560805355|FG004|Overall Study|Other - site closure|1|||
155374741|NCT00299494|560805356|FG005|Overall Study|Other - site closure|1|||
155374742|NCT01417104|560805360|FG000|Overall Study|Withdrawal by Subject|5|||
155374743|NCT01417104|560805361|FG001|Overall Study|Withdrawal by Subject|1|||
155374744|NCT01417104|560805360|FG000|Overall Study|Failure to make contact|0|||
155374745|NCT01417104|560805361|FG001|Overall Study|Failure to make contact|1|||
155374746|NCT01417104|560805360|FG000|Overall Study|Adverse Event|1|||
155374747|NCT01417104|560805361|FG001|Overall Study|Adverse Event|0|||
155374748|NCT01416389|560805362|FG000|Overall Study|Lost to Follow-up|1|||
155374749|NCT01416389|560805363|FG001|Overall Study|Lost to Follow-up|0|||
155374750|NCT01416389|560805362|FG000|Overall Study|Started New Therapy|2|||
155374751|NCT01416389|560805363|FG001|Overall Study|Started New Therapy|0|||
155374752|NCT01365481|560805364|FG000|Overall Study|Adverse Event|6|||
155374753|NCT01365481|560805365|FG001|Overall Study|Adverse Event|9|||
155374754|NCT01365481|560805366|FG002|Overall Study|Adverse Event|0|||
155374755|NCT01365481|560805367|FG003|Overall Study|Adverse Event|2|||
155374756|NCT01365481|560805364|FG000|Overall Study|Withdrawal by Subject|0|||
155374757|NCT01365481|560805365|FG001|Overall Study|Withdrawal by Subject|2|||
155374758|NCT01365481|560805366|FG002|Overall Study|Withdrawal by Subject|1|||
155374759|NCT01365481|560805367|FG003|Overall Study|Withdrawal by Subject|1|||
155374760|NCT01365481|560805364|FG000|Overall Study|Lost to Follow-up|1|||
155374761|NCT01365481|560805365|FG001|Overall Study|Lost to Follow-up|1|||
155431011|NCT01217606|561003518|FG001|Initial Treatment Phase|Adverse Event|6|||
155431012|NCT01217606|561003517|FG000|9-Month Masked Extension|Adverse Event|3|||
155431013|NCT01217606|561003518|FG001|9-Month Masked Extension|Adverse Event|6|||
155431014|NCT01217606|561003517|FG000|9-Month Masked Extension|Other Reasons|4|||
155431015|NCT01217606|561003518|FG001|9-Month Masked Extension|Other Reasons|4|||
155431016|NCT01217606|561003517|FG000|9-Month Masked Extension|Personal Reasons|2|||
155431017|NCT01217606|561003518|FG001|9-Month Masked Extension|Personal Reasons|1|||
155431018|NCT01217606|561003517|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
155431019|NCT01217606|561003518|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
155431020|NCT01217606|561003517|FG000|9-Month Masked Extension|Pregnancy|1|||
155431021|NCT01217606|561003518|FG001|9-Month Masked Extension|Pregnancy|0|||
155431022|NCT01217606|561003517|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
155431023|NCT01217606|561003518|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
155431024|NCT02966314|561003520|FG000|Overall Study|Lost to Follow-up|1|||
155431025|NCT02966314|561003521|FG001|Overall Study|Lost to Follow-up|0|||
155431026|NCT02725788|561003522|FG000|Overall Study|Lost to Follow-up|1|||
155431027|NCT02725788|561003523|FG001|Overall Study|Lost to Follow-up|1|||
155431028|NCT02725788|561003522|FG000|Overall Study|Protocol Violation|0|||
155431029|NCT02725788|561003523|FG001|Overall Study|Protocol Violation|1|||
155431030|NCT00828464|561003524|FG000|Overall Study|Withdrawal by Subject|1|||
155431031|NCT00474240|561003525|FG000|Overall Study|Withdrawal by Subject|1|||
155431032|NCT00474240|561003526|FG001|Overall Study|Withdrawal by Subject|1|||
155431033|NCT00474240|561003527|FG002|Overall Study|Withdrawal by Subject|0|||
155431034|NCT00474240|561003528|FG003|Overall Study|Withdrawal by Subject|2|||
155431035|NCT00474240|561003529|FG004|Overall Study|Withdrawal by Subject|3|||
155431036|NCT00474240|561003530|FG005|Overall Study|Withdrawal by Subject|1|||
155431037|NCT00474240|561003525|FG000|Overall Study|Adverse Event|0|||
155431038|NCT00474240|561003526|FG001|Overall Study|Adverse Event|0|||
155431039|NCT00474240|561003527|FG002|Overall Study|Adverse Event|9|||
155431040|NCT00474240|561003528|FG003|Overall Study|Adverse Event|14|||
155431041|NCT00474240|561003529|FG004|Overall Study|Adverse Event|5|||
155431042|NCT00474240|561003530|FG005|Overall Study|Adverse Event|16|||
155374762|NCT01365481|560805366|FG002|Overall Study|Lost to Follow-up|2|||
155431043|NCT00474240|561003525|FG000|Overall Study|Removed due to lab value|0|||
155431044|NCT00474240|561003526|FG001|Overall Study|Removed due to lab value|0|||
155431045|NCT00474240|561003527|FG002|Overall Study|Removed due to lab value|0|||
155431046|NCT00474240|561003528|FG003|Overall Study|Removed due to lab value|0|||
155431047|NCT00474240|561003529|FG004|Overall Study|Removed due to lab value|0|||
155374763|NCT01365481|560805367|FG003|Overall Study|Lost to Follow-up|3|||
155374764|NCT01365481|560805364|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155374765|NCT01365481|560805365|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155374766|NCT01365481|560805366|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155374767|NCT01365481|560805367|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155374768|NCT01365481|560805364|FG000|Overall Study|Administrative problems|0|||
155374769|NCT01365481|560805365|FG001|Overall Study|Administrative problems|1|||
155374770|NCT01365481|560805366|FG002|Overall Study|Administrative problems|0|||
155374771|NCT01365481|560805367|FG003|Overall Study|Administrative problems|0|||
155374772|NCT01365481|560805364|FG000|Overall Study|Protocol deviation|0|||
155374773|NCT01365481|560805365|FG001|Overall Study|Protocol deviation|1|||
155374774|NCT01365481|560805366|FG002|Overall Study|Protocol deviation|0|||
155374775|NCT01365481|560805367|FG003|Overall Study|Protocol deviation|1|||
155374776|NCT01365481|560805364|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155374777|NCT01365481|560805365|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155374778|NCT01365481|560805366|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
155374779|NCT01365481|560805367|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155374780|NCT00757627|560805368|FG000|Overall Study|Adverse Event|15|||
155374781|NCT00757627|560805368|FG000|Overall Study|Lack of Efficacy|10|||
155374782|NCT00757627|560805368|FG000|Overall Study|Lost to Follow-up|28|||
155374783|NCT00757627|560805368|FG000|Overall Study|Withdrawal by Subject|27|||
155511672|NCT02224456|561299297|FG000|Overall Study|Physician Decision|3|||
155511673|NCT02224456|561299297|FG000|Overall Study|Death|2|||
155511674|NCT02224456|561299297|FG000|Overall Study|Pregnancy|4|||
155511675|NCT02224456|561299297|FG000|Overall Study|Protocol Violation|1|||
155511676|NCT02224456|561299297|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
155511677|NCT01241461|561299298|FG000|Overall Study|Progressive Disease|3|||
155511678|NCT01241461|561299299|FG001|Overall Study|Progressive Disease|6|||
155511679|NCT01379781|561299303|FG000|Overall Study|Lost to Follow-up|11|||
155511680|NCT01379781|561299304|FG001|Overall Study|Lost to Follow-up|8|||
155511681|NCT02247479|561299305|FG000|Overall Study|Adverse Event|8|||
155511682|NCT02247479|561299306|FG001|Overall Study|Adverse Event|9|||
155511683|NCT02247479|561299307|FG002|Overall Study|Adverse Event|8|||
155511684|NCT02247479|561299305|FG000|Overall Study|Death|5|||
155374784|NCT00757627|560805368|FG000|Overall Study|Other|1|||
155374785|NCT00958841|560805371|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155374786|NCT00958841|560805371|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155374787|NCT00958841|560805371|FG000|Overall Study|Administrative problems|1|||
155374788|NCT00958841|560805371|FG000|Overall Study|Adverse Event|8|||
155374789|NCT00958841|560805371|FG000|Overall Study|New cancer therapy|5|||
155374790|NCT00958841|560805371|FG000|Overall Study|Withdrawal by Subject|1|||
155374791|NCT00958841|560805371|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
155374792|NCT00958841|560805371|FG000|Overall Study|Completed M6/did not enter extension|27|||
155374793|NCT00958841|560805371|FG000|Overall Study|Discontinued prior to M*|28|||
155374794|NCT00858364|560805372|FG000|Overall Study|Administrative Decision|3|||
155374795|NCT00858364|560805373|FG001|Overall Study|Administrative Decision|2|||
155374796|NCT00858364|560805372|FG000|Overall Study|Adverse Event|5|||
155374797|NCT00858364|560805373|FG001|Overall Study|Adverse Event|2|||
155431048|NCT00474240|561003530|FG005|Overall Study|Removed due to lab value|1|||
155431049|NCT03812510|561003533|FG000|Overall Study|Lost to Follow-up|39|||
155431050|NCT03812510|561003533|FG000|Overall Study|Withdrawal by Subject|42|||
155431051|NCT03812510|561003533|FG000|Overall Study|Physician Decision|2|||
155431052|NCT03812510|561003533|FG000|Overall Study|Study Terminated by Sponsor|9|||
155431053|NCT03812510|561003533|FG000|Overall Study|Did Not Start Study Medication|55|||
155431054|NCT03812510|561003533|FG000|Overall Study|Adverse Event|5|||
155431055|NCT03075839|561003534|FG000|Overall Study|Lost to Follow-up|4|||
155431056|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
155431057|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
155431058|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
155431059|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
155431060|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
155431061|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
155431062|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Personal issues|2|||
155431063|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Personal issues|0|||
155431064|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Personal issues|0|||
155431065|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Too busy|7|||
155431066|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Too busy|1|||
155431067|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Too busy|0|||
155431068|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Pain|2|||
155431069|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Pain|0|||
155431070|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Pain|0|||
155431071|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Moved|1|||
155431072|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Moved|0|||
155431073|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Moved|0|||
155431074|NCT00594399|561003535|FG000|Initial 3 Month Counseling|Family illness|1|||
155431075|NCT00594399|561003536|FG001|Initial 3 Month Counseling|Family illness|0|||
155431076|NCT00594399|561003537|FG002|Initial 3 Month Counseling|Family illness|0|||
155511685|NCT02247479|561299306|FG001|Overall Study|Death|4|||
155511686|NCT02247479|561299307|FG002|Overall Study|Death|6|||
155374798|NCT00858364|560805372|FG000|Overall Study|Withdrawal by Subject|44|||
155431077|NCT00594399|561003535|FG000|Rerandomization Arm 1 Only|Death|2|||
155511687|NCT02247479|561299305|FG000|Overall Study|Lost to Follow-up|3|||
155511688|NCT02247479|561299306|FG001|Overall Study|Lost to Follow-up|3|||
155649605|NCT00066170|561808307|FG000|Overall Study|Other|1|||
155374799|NCT00858364|560805373|FG001|Overall Study|Withdrawal by Subject|118|||
155431078|NCT00594399|561003536|FG001|Rerandomization Arm 1 Only|Death|1|||
155431079|NCT00594399|561003537|FG002|Rerandomization Arm 1 Only|Death|0|||
155374800|NCT00858364|560805372|FG000|Overall Study|Ineligibility Determined|1|||
155374801|NCT00858364|560805373|FG001|Overall Study|Ineligibility Determined|10|||
155511689|NCT02247479|561299307|FG002|Overall Study|Lost to Follow-up|1|||
155511690|NCT02247479|561299305|FG000|Overall Study|Non-compliance|0|||
155511691|NCT02247479|561299306|FG001|Overall Study|Non-compliance|0|||
155511692|NCT02247479|561299307|FG002|Overall Study|Non-compliance|1|||
155511693|NCT02247479|561299305|FG000|Overall Study|Withdrawal by Subject|25|||
155511694|NCT02247479|561299306|FG001|Overall Study|Withdrawal by Subject|29|||
155511695|NCT02247479|561299307|FG002|Overall Study|Withdrawal by Subject|24|||
155511696|NCT02247479|561299305|FG000|Overall Study|Study Terminated by Sponsor|98|||
155511697|NCT02247479|561299306|FG001|Overall Study|Study Terminated by Sponsor|88|||
155374802|NCT00858364|560805372|FG000|Overall Study|Lost to Follow-up|24|||
155374803|NCT00858364|560805373|FG001|Overall Study|Lost to Follow-up|54|||
155374804|NCT00858364|560805372|FG000|Overall Study|Noncompliance|3|||
155374805|NCT00858364|560805373|FG001|Overall Study|Noncompliance|4|||
155374806|NCT00858364|560805372|FG000|Overall Study|Protocol Deviation|0|||
155374807|NCT00858364|560805373|FG001|Overall Study|Protocol Deviation|2|||
155374808|NCT00858364|560805372|FG000|Overall Study|Other|9|||
155374809|NCT00858364|560805373|FG001|Overall Study|Other|17|||
155374810|NCT00858364|560805372|FG000|Overall Study|Missing|1|||
155374811|NCT00858364|560805373|FG001|Overall Study|Missing|1|||
155374812|NCT00858364|560805372|FG000|Overall Study|Still on-study|114|||
155374813|NCT00858364|560805373|FG001|Overall Study|Still on-study|247|||
155374814|NCT00688870|560805378|FG000|Infant Series|Parent or legal guardian request|4|||
155374815|NCT00688870|560805379|FG001|Infant Series|Parent or legal guardian request|0|||
155374816|NCT03682302|560805382|FG000|Overall Study|Lost to Follow-up|1|||
155374817|NCT03682302|560805383|FG001|Overall Study|Lost to Follow-up|2|||
155374818|NCT03682302|560805384|FG002|Overall Study|Lost to Follow-up|0|||
155374819|NCT03682302|560805385|FG003|Overall Study|Lost to Follow-up|1|||
155374820|NCT03682302|560805382|FG000|Overall Study|Study drug was not administered|0|||
155374821|NCT03682302|560805383|FG001|Overall Study|Study drug was not administered|0|||
155374822|NCT03682302|560805384|FG002|Overall Study|Study drug was not administered|1|||
155374823|NCT03682302|560805385|FG003|Overall Study|Study drug was not administered|1|||
155374824|NCT01489891|560805387|FG000|Overall Study|Endoscopy failure|1|||
155374825|NCT01489891|560805388|FG001|Overall Study|Endoscopy failure|0|||
155374826|NCT00948766|560805391|FG000|Core Study|Adverse Event|73|||
155431080|NCT00594399|561003535|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
155431081|NCT00594399|561003536|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
155431082|NCT00594399|561003537|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
155431083|NCT00659438|561003538|FG000|Overall Study|Withdrawal by Subject|2|||
155431084|NCT00659438|561003539|FG001|Overall Study|Withdrawal by Subject|2|||
155431085|NCT00659438|561003538|FG000|Overall Study|Death|11|||
155431086|NCT00659438|561003539|FG001|Overall Study|Death|6|||
155431087|NCT00659438|561003538|FG000|Overall Study|Lost to Follow-up|1|||
155431088|NCT00659438|561003539|FG001|Overall Study|Lost to Follow-up|0|||
155431089|NCT02469246|561003541|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
155431090|NCT02469246|561003542|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
155431091|NCT02469246|561003541|FG000|Double-Blind Phase|Adverse Event|12|||
155431092|NCT02469246|561003542|FG001|Double-Blind Phase|Adverse Event|9|||
155431093|NCT02469246|561003541|FG000|Double-Blind Phase|Death|2|||
155431094|NCT02469246|561003542|FG001|Double-Blind Phase|Death|0|||
155431095|NCT02469246|561003541|FG000|Double-Blind Phase|Lack of Efficacy|2|||
155431096|NCT02469246|561003542|FG001|Double-Blind Phase|Lack of Efficacy|1|||
155431097|NCT02469246|561003541|FG000|Double-Blind Phase|Investigator's Discretion|8|||
155431098|NCT02469246|561003542|FG001|Double-Blind Phase|Investigator's Discretion|8|||
155431099|NCT02469246|561003541|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
155511698|NCT02247479|561299307|FG002|Overall Study|Study Terminated by Sponsor|94|||
155511699|NCT02247479|561299305|FG000|Overall Study|Physician Decision|1|||
155511700|NCT02247479|561299306|FG001|Overall Study|Physician Decision|0|||
155511701|NCT02247479|561299307|FG002|Overall Study|Physician Decision|2|||
155511702|NCT02247479|561299305|FG000|Overall Study|Unspecified Reason|2|||
155511703|NCT02247479|561299306|FG001|Overall Study|Unspecified Reason|5|||
155511704|NCT02247479|561299307|FG002|Overall Study|Unspecified Reason|2|||
155511705|NCT02497391|561299310|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
155511706|NCT02497391|561299311|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
155511707|NCT02497391|561299312|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
155511708|NCT02497391|561299313|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
155511709|NCT02497391|561299314|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
155511710|NCT02497391|561299315|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
155511711|NCT02497391|561299310|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
155511712|NCT02497391|561299311|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
155511713|NCT02497391|561299312|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
155511714|NCT02497391|561299313|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
155511715|NCT02497391|561299314|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
155511716|NCT02497391|561299315|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
155511717|NCT02497391|561299310|FG000|Period 3 (14 Days)|Adverse Event|0|||
155374827|NCT00948766|560805392|FG001|Core Study|Adverse Event|51|||
155374828|NCT00948766|560805391|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
155431100|NCT02469246|561003542|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155431101|NCT02469246|561003541|FG000|Double-Blind Phase|Protocol Violation|1|||
155431102|NCT02469246|561003542|FG001|Double-Blind Phase|Protocol Violation|1|||
155374829|NCT00948766|560805392|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
155649606|NCT00066170|561808308|FG001|Overall Study|Other|5|||
155649607|NCT00066170|561808309|FG002|Overall Study|Other|2|||
155649608|NCT00066170|561808310|FG003|Overall Study|Other|0|||
155511718|NCT02497391|561299311|FG001|Period 3 (14 Days)|Adverse Event|1|||
155511719|NCT02497391|561299312|FG002|Period 3 (14 Days)|Adverse Event|0|||
155511720|NCT02497391|561299313|FG003|Period 3 (14 Days)|Adverse Event|0|||
155374830|NCT00948766|560805391|FG000|Core Study|Patient Withdrew Consent|27|||
155374831|NCT00948766|560805392|FG001|Core Study|Patient Withdrew Consent|46|||
155374832|NCT00948766|560805391|FG000|Core Study|Lost to Follow-up|3|||
155374833|NCT00948766|560805392|FG001|Core Study|Lost to Follow-up|2|||
155374834|NCT00948766|560805391|FG000|Core Study|Administrative Problems|2|||
155374835|NCT00948766|560805392|FG001|Core Study|Administrative Problems|2|||
155374836|NCT00948766|560805391|FG000|Core Study|Death|1|||
155374837|NCT00948766|560805392|FG001|Core Study|Death|1|||
155374838|NCT00948766|560805391|FG000|Core Study|Protocol Deviation|8|||
155374839|NCT00948766|560805392|FG001|Core Study|Protocol Deviation|10|||
155374840|NCT00948766|560805391|FG000|Extension Study|Adverse Event|43|||
155374841|NCT00948766|560805392|FG001|Extension Study|Adverse Event|0|||
155374842|NCT00948766|560805391|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
155374843|NCT00948766|560805392|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
155374844|NCT00948766|560805391|FG000|Extension Study|Study Drug No Longer Required|1|||
155374845|NCT00948766|560805392|FG001|Extension Study|Study Drug No Longer Required|0|||
155374846|NCT00948766|560805391|FG000|Extension Study|Patient Withdrew Consent|32|||
155374847|NCT00948766|560805392|FG001|Extension Study|Patient Withdrew Consent|0|||
155374848|NCT00948766|560805391|FG000|Extension Study|Lost to Follow-up|8|||
155374849|NCT00948766|560805392|FG001|Extension Study|Lost to Follow-up|0|||
155374850|NCT00948766|560805391|FG000|Extension Study|Administrative Problems|1|||
155374851|NCT00948766|560805392|FG001|Extension Study|Administrative Problems|0|||
155374852|NCT00948766|560805391|FG000|Extension Study|Death|4|||
155374853|NCT00948766|560805392|FG001|Extension Study|Death|0|||
155374854|NCT01769326|560805393|FG000|Overall Study|Lost to Follow-up|1|||
155374855|NCT01769326|560805394|FG001|Overall Study|Lost to Follow-up|2|||
155374856|NCT01769326|560805395|FG002|Overall Study|Lost to Follow-up|0|||
155374857|NCT01769326|560805396|FG003|Overall Study|Lost to Follow-up|0|||
155374858|NCT01769326|560805393|FG000|Overall Study|unrelated injry|1|||
155374859|NCT01769326|560805394|FG001|Overall Study|unrelated injry|1|||
155374860|NCT01769326|560805395|FG002|Overall Study|unrelated injry|0|||
155374861|NCT01769326|560805396|FG003|Overall Study|unrelated injry|0|||
155374862|NCT01769326|560805393|FG000|Overall Study|got a job|0|||
155374863|NCT01769326|560805394|FG001|Overall Study|got a job|1|||
155374864|NCT01769326|560805395|FG002|Overall Study|got a job|0|||
155374865|NCT01769326|560805396|FG003|Overall Study|got a job|0|||
155374866|NCT01769326|560805393|FG000|Overall Study|Got sick and could not complete study|0|||
155374867|NCT01769326|560805394|FG001|Overall Study|Got sick and could not complete study|0|||
155374868|NCT01769326|560805395|FG002|Overall Study|Got sick and could not complete study|1|||
155374869|NCT01769326|560805396|FG003|Overall Study|Got sick and could not complete study|0|||
155374870|NCT01036438|560805397|FG000|Overall Study|Adverse Event|7|||
155374871|NCT01036438|560805398|FG001|Overall Study|Adverse Event|8|||
155374872|NCT01036438|560805397|FG000|Overall Study|Death|0|||
155374873|NCT01036438|560805398|FG001|Overall Study|Death|1|||
155374874|NCT01036438|560805397|FG000|Overall Study|No effect of study treatment|3|||
155374875|NCT01036438|560805398|FG001|Overall Study|No effect of study treatment|1|||
155374876|NCT00888927|560805399|FG000|Overall Study|Adverse Event|0|||
155511721|NCT02497391|561299314|FG004|Period 3 (14 Days)|Adverse Event|0|||
155511722|NCT02497391|561299315|FG005|Period 3 (14 Days)|Adverse Event|0|||
155511723|NCT02497391|561299310|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
155511724|NCT02497391|561299311|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
155649609|NCT03722030|561808311|FG000|Overall Study|Withdrawal by Subject|1|||
155511725|NCT02497391|561299312|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
155511726|NCT02497391|561299313|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
155511727|NCT02497391|561299314|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
155511728|NCT02497391|561299315|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
155511729|NCT02497391|561299310|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
155511730|NCT02497391|561299311|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
155511731|NCT02497391|561299312|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
155511732|NCT02497391|561299313|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
155374877|NCT00888927|560805400|FG001|Overall Study|Adverse Event|0|||
155374878|NCT00888927|560805401|FG002|Overall Study|Adverse Event|0|||
155374879|NCT00888927|560805402|FG003|Overall Study|Adverse Event|1|||
155374880|NCT00888927|560805399|FG000|Overall Study|Withdrawal of consent|0|||
155374881|NCT00888927|560805400|FG001|Overall Study|Withdrawal of consent|0|||
155374882|NCT00888927|560805401|FG002|Overall Study|Withdrawal of consent|0|||
155374883|NCT00888927|560805402|FG003|Overall Study|Withdrawal of consent|1|||
155374884|NCT02153073|560805403|FG000|Overall Study|Case Report Forms Uncollected|230|||
155374885|NCT02153073|560805403|FG000|Overall Study|Protocol Deviation|68|||
155374886|NCT03189745|560805404|FG000|Overall Study|Conflict in work schedule of participant|1|||
155511733|NCT02497391|561299314|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
155649610|NCT03722030|561808312|FG001|Overall Study|Withdrawal by Subject|0|||
155374887|NCT03189745|560805405|FG001|Overall Study|Conflict in work schedule of participant|1|||
155374888|NCT03702231|560805406|FG000|Overall Study|Withdrawal by Subject|1|||
155374889|NCT03702231|560805407|FG001|Overall Study|Withdrawal by Subject|0|||
155374890|NCT03702231|560805408|FG002|Overall Study|Withdrawal by Subject|0|||
155374891|NCT03702231|560805406|FG000|Overall Study|Protocol Violation|0|||
155374892|NCT03702231|560805407|FG001|Overall Study|Protocol Violation|0|||
155374893|NCT03702231|560805408|FG002|Overall Study|Protocol Violation|1|||
155374894|NCT03702231|560805406|FG000|Overall Study|Change in CLL Treatment|0|||
155374895|NCT03702231|560805407|FG001|Overall Study|Change in CLL Treatment|0|||
155374896|NCT03702231|560805408|FG002|Overall Study|Change in CLL Treatment|1|||
155374897|NCT03702231|560805406|FG000|Overall Study|COVID Pandemic|1|||
155374898|NCT03702231|560805407|FG001|Overall Study|COVID Pandemic|4|||
155374899|NCT03702231|560805408|FG002|Overall Study|COVID Pandemic|1|||
155374900|NCT03702231|560805406|FG000|Overall Study|Non-compliance|0|||
155374901|NCT03702231|560805407|FG001|Overall Study|Non-compliance|0|||
155374902|NCT03702231|560805408|FG002|Overall Study|Non-compliance|1|||
155374903|NCT02729831|560805410|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
155649611|NCT00754559|561808317|FG000|Overall Study|Adverse Event|15|||
155649612|NCT00754559|561808317|FG000|Overall Study|Protocol Violation|11|||
155649613|NCT00754559|561808317|FG000|Overall Study|Lack of Efficacy|10|||
155649614|NCT00754559|561808317|FG000|Overall Study|Lost to Follow-up|2|||
155649615|NCT00754559|561808317|FG000|Overall Study|Administrative reason|1|||
155649616|NCT00754559|561808317|FG000|Overall Study|Other|5|||
155649617|NCT00754559|561808317|FG000|Overall Study|Withdrawal by Subject|3|||
155649618|NCT00345592|561808318|FG000|Overall Study|Death|14|||
155649619|NCT00345592|561808319|FG001|Overall Study|Death|16|||
155649620|NCT00345592|561808318|FG000|Overall Study|Withdrawal by Subject|11|||
155649621|NCT00345592|561808319|FG001|Overall Study|Withdrawal by Subject|8|||
155649622|NCT01663987|561808321|FG000|Overall Study|Adverse Event|7|||
155649623|NCT01663987|561808322|FG001|Overall Study|Adverse Event|2|||
155649624|NCT01663987|561808321|FG000|Overall Study|Lost to Follow-up|1|||
155649625|NCT01663987|561808322|FG001|Overall Study|Lost to Follow-up|1|||
155374904|NCT02729831|560805411|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
155649626|NCT01663987|561808321|FG000|Overall Study|Withdrawal by Subject|2|||
155649627|NCT01663987|561808322|FG001|Overall Study|Withdrawal by Subject|3|||
155649628|NCT01663987|561808321|FG000|Overall Study|Other reason not defined above|3|||
155649629|NCT01663987|561808322|FG001|Overall Study|Other reason not defined above|0|||
155649630|NCT04000724|561808326|FG000|Overall Study|Withdrawal by Subject|5|||
155649631|NCT04000724|561808327|FG001|Overall Study|Withdrawal by Subject|3|||
155649632|NCT04000724|561808328|FG002|Overall Study|Withdrawal by Subject|4|||
155649633|NCT04000724|561808326|FG000|Overall Study|Lost to Follow-up|11|||
155374905|NCT02729831|560805412|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
155374906|NCT02729831|560805413|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
155374907|NCT02729831|560805410|FG000|1 Week Post-visit|Lost to Follow-up|43|||
155374908|NCT02729831|560805411|FG001|1 Week Post-visit|Lost to Follow-up|40|||
155374909|NCT02729831|560805412|FG002|1 Week Post-visit|Lost to Follow-up|38|||
155374910|NCT02729831|560805413|FG003|1 Week Post-visit|Lost to Follow-up|36|||
155374911|NCT02729831|560805410|FG000|6 Month Follow-up|Lost to Follow-up|54|||
155374912|NCT02729831|560805411|FG001|6 Month Follow-up|Lost to Follow-up|51|||
155374913|NCT02729831|560805412|FG002|6 Month Follow-up|Lost to Follow-up|48|||
155374914|NCT02729831|560805413|FG003|6 Month Follow-up|Lost to Follow-up|42|||
155374915|NCT02729831|560805410|FG000|6 Month Follow-up|Death|1|||
155374916|NCT02729831|560805411|FG001|6 Month Follow-up|Death|3|||
155374917|NCT02729831|560805412|FG002|6 Month Follow-up|Death|0|||
155374918|NCT02729831|560805413|FG003|6 Month Follow-up|Death|1|||
155374919|NCT00864253|560805414|FG000|Overall Study|Adverse Event|56|||
155374920|NCT00864253|560805415|FG001|Overall Study|Adverse Event|11|||
155374921|NCT00864253|560805414|FG000|Overall Study|Unrelated Adverse Event|3|||
155374922|NCT00864253|560805415|FG001|Overall Study|Unrelated Adverse Event|1|||
155374923|NCT00864253|560805414|FG000|Overall Study|Physician Decision|11|||
155374924|NCT00864253|560805415|FG001|Overall Study|Physician Decision|15|||
155374925|NCT00864253|560805414|FG000|Overall Study|Protocol Violation|0|||
155374926|NCT00864253|560805415|FG001|Overall Study|Protocol Violation|2|||
155374927|NCT00864253|560805414|FG000|Overall Study|Lost to Follow-up|1|||
155374928|NCT00864253|560805415|FG001|Overall Study|Lost to Follow-up|1|||
155374929|NCT00864253|560805414|FG000|Overall Study|Withdrawal by Subject|18|||
155374930|NCT00864253|560805415|FG001|Overall Study|Withdrawal by Subject|18|||
155374931|NCT00864253|560805414|FG000|Overall Study|Death|1|||
155374932|NCT00864253|560805415|FG001|Overall Study|Death|0|||
155649634|NCT04000724|561808327|FG001|Overall Study|Lost to Follow-up|7|||
155649635|NCT04000724|561808328|FG002|Overall Study|Lost to Follow-up|13|||
155649636|NCT00455455|561808329|FG000|Washout|Withdrawal by Subject|0|||
155649637|NCT00455455|561808330|FG001|Washout|Withdrawal by Subject|1|||
155649638|NCT00455455|561808329|FG000|Washout|Withdrawal by Subject|1|||
155649639|NCT00455455|561808330|FG001|Washout|Withdrawal by Subject|0|||
155511734|NCT02497391|561299315|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
155511735|NCT01664052|561299316|FG000|Phase 1|No device placement|6|||
155374933|NCT00864253|560805414|FG000|Overall Study|Ongoing|2|||
155374934|NCT00864253|560805415|FG001|Overall Study|Ongoing|3|||
155374935|NCT00864253|560805414|FG000|Overall Study|Untreated|7|||
155374936|NCT00864253|560805415|FG001|Overall Study|Untreated|7|||
155374937|NCT01747551|560805417|FG000|Overall Study|Progressive Disease|24|||
155374938|NCT01747551|560805418|FG001|Overall Study|Progressive Disease|17|||
155374939|NCT01747551|560805417|FG000|Overall Study|Death|3|||
155374940|NCT01747551|560805418|FG001|Overall Study|Death|1|||
155374941|NCT01747551|560805417|FG000|Overall Study|Adverse Event|7|||
155374942|NCT01747551|560805418|FG001|Overall Study|Adverse Event|1|||
155374943|NCT01747551|560805417|FG000|Overall Study|Prolonged Treatment Delay|2|||
155374944|NCT01747551|560805418|FG001|Overall Study|Prolonged Treatment Delay|0|||
155374945|NCT01747551|560805417|FG000|Overall Study|Withdrawal by Subject|3|||
155374946|NCT01747551|560805418|FG001|Overall Study|Withdrawal by Subject|1|||
155374947|NCT01747551|560805417|FG000|Overall Study|Physician Decision|2|||
155374948|NCT01747551|560805418|FG001|Overall Study|Physician Decision|1|||
155374949|NCT01747551|560805417|FG000|Overall Study|Other|2|||
155374950|NCT01747551|560805418|FG001|Overall Study|Other|0|||
155511736|NCT01664052|561299317|FG001|Phase 1|No device placement|0|||
155511737|NCT01664052|561299316|FG000|Phase 1|No HSG 1 hr post placement|1|||
155511738|NCT01664052|561299317|FG001|Phase 1|No HSG 1 hr post placement|0|||
155511739|NCT01664052|561299316|FG000|Phase 2|No device placement|0|||
155511740|NCT01664052|561299317|FG001|Phase 2|No device placement|4|||
155511741|NCT03740698|561299318|FG000|Overall Study|Physician Decision|0|||
155511742|NCT03740698|561299319|FG001|Overall Study|Physician Decision|1|||
155511743|NCT03740698|561299320|FG002|Overall Study|Physician Decision|1|||
155511744|NCT05216978|561299330|FG000|Overall Study|Withdrawal by Subject|3|||
155374951|NCT01607476|560805419|FG000|Overall Study|Withdrawal by Subject|1|||
155374952|NCT01607476|560805420|FG001|Overall Study|Withdrawal by Subject|0|||
155511745|NCT05216978|561299330|FG000|Overall Study|Lost to Follow-up|5|||
155511746|NCT00658320|561299332|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
155511747|NCT00658320|561299333|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
155511748|NCT00658320|561299332|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
155511749|NCT00658320|561299333|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
155511750|NCT00658320|561299332|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
155511751|NCT00658320|561299333|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
155511752|NCT00658320|561299332|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
155511753|NCT00658320|561299333|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
155511754|NCT02410252|561299341|FG000|Overall Study|Withdrawal by Subject|4|||
155511755|NCT02410252|561299341|FG000|Overall Study|Physician Decision|2|||
155374953|NCT01607476|560805421|FG002|Overall Study|Withdrawal by Subject|1|||
155511756|NCT01007916|561299349|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
155511757|NCT01007916|561299350|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
155511758|NCT01007916|561299349|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
155511759|NCT01007916|561299350|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
155511760|NCT01162499|561299351|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
155511761|NCT01162499|561299352|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
155511762|NCT02058628|561299353|FG000|Overall Study|Adverse Event|1|||
155511763|NCT02058628|561299354|FG001|Overall Study|Adverse Event|0|||
155511764|NCT02058628|561299353|FG000|Overall Study|Withdrawal by Subject|2|||
155511765|NCT02058628|561299354|FG001|Overall Study|Withdrawal by Subject|2|||
155511766|NCT02058628|561299353|FG000|Overall Study|Lost to Follow-up|2|||
155511767|NCT02058628|561299354|FG001|Overall Study|Lost to Follow-up|4|||
155511768|NCT02058628|561299353|FG000|Overall Study|Not in time schedule|0|||
155511769|NCT02058628|561299354|FG001|Overall Study|Not in time schedule|1|||
155511770|NCT02058628|561299353|FG000|Overall Study|The visit date was not in timeline|0|||
155511771|NCT02058628|561299354|FG001|Overall Study|The visit date was not in timeline|1|||
155511772|NCT02058628|561299353|FG000|Overall Study|A lot of time for study for participant|1|||
155511773|NCT02058628|561299354|FG001|Overall Study|A lot of time for study for participant|0|||
155511774|NCT02058628|561299353|FG000|Overall Study|Non compliance|1|||
155511775|NCT02058628|561299354|FG001|Overall Study|Non compliance|0|||
155511776|NCT00704418|561299355|FG000|Overall Study|Withdrawal by Subject|2|||
155511777|NCT00704418|561299356|FG001|Overall Study|Withdrawal by Subject|0|||
155511778|NCT00704418|561299355|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
155511779|NCT00704418|561299356|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
155511780|NCT02710071|561299357|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
155374954|NCT01607476|560805419|FG000|Overall Study|Lost to Follow-up|0|||
155374955|NCT01607476|560805420|FG001|Overall Study|Lost to Follow-up|0|||
155374956|NCT01607476|560805421|FG002|Overall Study|Lost to Follow-up|2|||
155374957|NCT04445987|560805422|FG000|Overall Study|Adverse Event|0|||
155374958|NCT04445987|560805423|FG001|Overall Study|Adverse Event|0|||
155374959|NCT04445987|560805424|FG002|Overall Study|Adverse Event|1|||
155374960|NCT04445987|560805425|FG003|Overall Study|Adverse Event|0|||
155374961|NCT04445987|560805426|FG004|Overall Study|Adverse Event|4|||
155374962|NCT04445987|560805427|FG005|Overall Study|Adverse Event|0|||
155374963|NCT04445987|560805422|FG000|Overall Study|Lost to Follow-up|4|||
155374964|NCT04445987|560805423|FG001|Overall Study|Lost to Follow-up|3|||
155374965|NCT04445987|560805424|FG002|Overall Study|Lost to Follow-up|1|||
155374966|NCT04445987|560805425|FG003|Overall Study|Lost to Follow-up|1|||
155374967|NCT04445987|560805426|FG004|Overall Study|Lost to Follow-up|29|||
155374968|NCT04445987|560805427|FG005|Overall Study|Lost to Follow-up|0|||
155374969|NCT04445987|560805422|FG000|Overall Study|Physician Decision|0|||
155374970|NCT04445987|560805423|FG001|Overall Study|Physician Decision|0|||
155374971|NCT04445987|560805424|FG002|Overall Study|Physician Decision|0|||
155374972|NCT04445987|560805425|FG003|Overall Study|Physician Decision|0|||
155374973|NCT04445987|560805426|FG004|Overall Study|Physician Decision|1|||
155374974|NCT04445987|560805427|FG005|Overall Study|Physician Decision|0|||
155374975|NCT04445987|560805422|FG000|Overall Study|Protocol Violation|1|||
155374976|NCT04445987|560805423|FG001|Overall Study|Protocol Violation|0|||
155374977|NCT04445987|560805424|FG002|Overall Study|Protocol Violation|0|||
155374978|NCT04445987|560805425|FG003|Overall Study|Protocol Violation|0|||
155374979|NCT04445987|560805426|FG004|Overall Study|Protocol Violation|2|||
155374980|NCT04445987|560805427|FG005|Overall Study|Protocol Violation|0|||
155374981|NCT04445987|560805422|FG000|Overall Study|Withdrawal by Subject|4|||
155374982|NCT04445987|560805423|FG001|Overall Study|Withdrawal by Subject|0|||
155374983|NCT04445987|560805424|FG002|Overall Study|Withdrawal by Subject|1|||
155374984|NCT04445987|560805425|FG003|Overall Study|Withdrawal by Subject|0|||
155374985|NCT04445987|560805426|FG004|Overall Study|Withdrawal by Subject|18|||
155374986|NCT04445987|560805427|FG005|Overall Study|Withdrawal by Subject|1|||
155374987|NCT04445987|560805422|FG000|Overall Study|Other reason|0|||
155374988|NCT04445987|560805423|FG001|Overall Study|Other reason|0|||
155374989|NCT04445987|560805424|FG002|Overall Study|Other reason|1|||
155374990|NCT04445987|560805425|FG003|Overall Study|Other reason|0|||
155374991|NCT04445987|560805426|FG004|Overall Study|Other reason|2|||
155374992|NCT04445987|560805427|FG005|Overall Study|Other reason|0|||
155374993|NCT01609062|560805428|FG000|Extension Phase|Terminated by Sponsor|14|||
155374994|NCT01609062|560805429|FG001|Extension Phase|Terminated by Sponsor|9|||
155374995|NCT01609062|560805428|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
155374996|NCT01609062|560805429|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
155374997|NCT01609062|560805428|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
155374998|NCT01609062|560805429|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
155374999|NCT03772587|560805430|FG000|Overall Study|COVID-19|0|||
155375000|NCT03772587|560805431|FG001|Overall Study|COVID-19|0|||
155375001|NCT03772587|560805432|FG002|Overall Study|COVID-19|1|||
155375002|NCT03772587|560805433|FG003|Overall Study|COVID-19|1|||
155375003|NCT03772587|560805434|FG004|Overall Study|COVID-19|0|||
155375004|NCT03772587|560805430|FG000|Overall Study|Withdrawal by Subject|1|||
155375005|NCT03772587|560805431|FG001|Overall Study|Withdrawal by Subject|0|||
155375006|NCT03772587|560805432|FG002|Overall Study|Withdrawal by Subject|0|||
155375007|NCT03772587|560805433|FG003|Overall Study|Withdrawal by Subject|0|||
155375008|NCT03772587|560805434|FG004|Overall Study|Withdrawal by Subject|0|||
155431103|NCT02469246|561003541|FG000|Double-Blind Phase|Withdrew Consent|25|||
155431104|NCT02469246|561003542|FG001|Double-Blind Phase|Withdrew Consent|25|||
155431105|NCT02469246|561003541|FG000|Double-Blind Phase|Lost to Follow-up|9|||
155431106|NCT02469246|561003542|FG001|Double-Blind Phase|Lost to Follow-up|5|||
155431107|NCT00922935|561003546|FG000|Overall Study|Protocol Violation|0|||
155431108|NCT00922935|561003547|FG001|Overall Study|Protocol Violation|3|||
155431109|NCT00922935|561003548|FG002|Overall Study|Protocol Violation|0|||
155431110|NCT00922935|561003546|FG000|Overall Study|Physician Decision|1|||
155431111|NCT00922935|561003547|FG001|Overall Study|Physician Decision|1|||
155431112|NCT00922935|561003548|FG002|Overall Study|Physician Decision|0|||
155431113|NCT00922935|561003546|FG000|Overall Study|Lost to Follow-up|0|||
155431114|NCT00922935|561003547|FG001|Overall Study|Lost to Follow-up|1|||
155431115|NCT00922935|561003548|FG002|Overall Study|Lost to Follow-up|0|||
155431116|NCT01491945|561003549|FG000|Overall Study|Death|30|||
155431117|NCT01491945|561003549|FG000|Overall Study|Withdrwan/LTF|16|||
155431118|NCT01491945|561003549|FG000|Overall Study|Conversion|4|||
155431119|NCT01491945|561003549|FG000|Overall Study|Missed Visit|1|||
155431120|NCT02201940|561003550|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
155431121|NCT02201940|561003551|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
155431122|NCT02201940|561003550|FG000|Overall Study|Lack of Efficacy|2|||
155431123|NCT02201940|561003551|FG001|Overall Study|Lack of Efficacy|113|||
155431124|NCT02201940|561003550|FG000|Overall Study|Lost to Follow-up|5|||
155375009|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
155375010|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
155375011|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
155375012|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
155375013|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
155431125|NCT02201940|561003551|FG001|Overall Study|Lost to Follow-up|0|||
155375014|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
155375015|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
155375016|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
155511781|NCT02710071|561299358|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
155511782|NCT02710071|561299357|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
155375017|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
155375018|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
155375019|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
155375020|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
155375021|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
155375022|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
155375023|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
155375024|NCT03842358|560805440|FG000|Overall Study|Poor DOT probe contact with breast|2|||
155375025|NCT03842358|560805440|FG000|Overall Study|DOT system problem|1|||
155375026|NCT03842358|560805440|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
155375027|NCT03842358|560805440|FG000|Overall Study|No biopsy after physician review|4|||
155375028|NCT03842358|560805440|FG000|Overall Study|Patient withdrew|2|||
155375029|NCT01200290|560805441|FG000|Treatment Period|Adverse Event|1|||
155375030|NCT01200290|560805441|FG000|Post-Treatment Follow-Up Period|Death|2|||
155375031|NCT00607724|560805443|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
155375032|NCT00607724|560805444|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
155511783|NCT02710071|561299358|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
155511784|NCT01238848|561299360|FG000|Overall Study|Physician Decision|13|||
155511785|NCT01238848|561299361|FG001|Overall Study|Physician Decision|5|||
155511786|NCT00782509|561299362|FG000|Overall Study|Adverse Event|20|||
155511787|NCT00782509|561299363|FG001|Overall Study|Adverse Event|10|||
155511788|NCT00782509|561299364|FG002|Overall Study|Adverse Event|20|||
155511789|NCT00782509|561299362|FG000|Overall Study|Lost to Follow-up|1|||
155511790|NCT00782509|561299363|FG001|Overall Study|Lost to Follow-up|2|||
155375033|NCT00607724|560805445|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
155375034|NCT00607724|560805446|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375035|NCT00607724|560805447|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375036|NCT00607724|560805448|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375037|NCT00607724|560805449|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375038|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
155375039|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
155375040|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
155375041|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
155375042|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
155375043|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
155375044|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
155375045|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375046|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375047|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375048|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
155375049|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
155375050|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
155375051|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
155375052|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
155375053|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
155375054|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
155375055|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
155375056|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
155375057|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
155375058|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
155375059|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375060|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375061|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375062|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
155375063|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375064|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375065|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375066|NCT00151281|560805450|FG000|Overall Study|Not evaluable|3|||
155375067|NCT04349631|560805451|FG000|Overall Study|Lost to Follow-up|3|||
155375068|NCT04349631|560805451|FG000|Overall Study|Withdrawal by Subject|7|||
155375069|NCT03037931|560807348|FG000|Overall Study|Death|354|||
155375070|NCT03037931|560807349|FG001|Overall Study|Death|367|||
155375071|NCT03037931|560807348|FG000|Overall Study|Lost to Follow-up|7|||
155375072|NCT03037931|560807349|FG001|Overall Study|Lost to Follow-up|4|||
155511791|NCT00782509|561299364|FG002|Overall Study|Lost to Follow-up|3|||
155375073|NCT03037931|560807348|FG000|Overall Study|Withdrawal by Subject|48|||
155375074|NCT03037931|560807349|FG001|Overall Study|Withdrawal by Subject|41|||
155375075|NCT02407990|560807350|FG000|Overall Study|Death|2|||
155375076|NCT02407990|560807351|FG001|Overall Study|Death|22|||
155375077|NCT02407990|560807352|FG002|Overall Study|Death|23|||
155375078|NCT02407990|560807353|FG003|Overall Study|Death|7|||
155375079|NCT02407990|560807354|FG004|Overall Study|Death|17|||
155375080|NCT02407990|560807355|FG005|Overall Study|Death|16|||
155375081|NCT02407990|560807356|FG006|Overall Study|Death|10|||
155375082|NCT02407990|560807357|FG007|Overall Study|Death|248|||
155375083|NCT02407990|560807350|FG000|Overall Study|Lost to Follow-up|0|||
155375084|NCT02407990|560807351|FG001|Overall Study|Lost to Follow-up|1|||
155375085|NCT02407990|560807352|FG002|Overall Study|Lost to Follow-up|0|||
155375086|NCT02407990|560807353|FG003|Overall Study|Lost to Follow-up|0|||
155375087|NCT02407990|560807354|FG004|Overall Study|Lost to Follow-up|0|||
155375088|NCT02407990|560807355|FG005|Overall Study|Lost to Follow-up|0|||
155375089|NCT02407990|560807356|FG006|Overall Study|Lost to Follow-up|0|||
155375090|NCT02407990|560807357|FG007|Overall Study|Lost to Follow-up|17|||
155375091|NCT02407990|560807350|FG000|Overall Study|Progressive Disease|0|||
155375092|NCT02407990|560807351|FG001|Overall Study|Progressive Disease|0|||
155375093|NCT02407990|560807352|FG002|Overall Study|Progressive Disease|0|||
155375094|NCT02407990|560807353|FG003|Overall Study|Progressive Disease|0|||
155375095|NCT02407990|560807354|FG004|Overall Study|Progressive Disease|0|||
155375096|NCT02407990|560807355|FG005|Overall Study|Progressive Disease|0|||
155375097|NCT02407990|560807356|FG006|Overall Study|Progressive Disease|0|||
155375098|NCT02407990|560807357|FG007|Overall Study|Progressive Disease|1|||
155375099|NCT02407990|560807350|FG000|Overall Study|Withdrawal by Subject|0|||
155375100|NCT02407990|560807351|FG001|Overall Study|Withdrawal by Subject|0|||
155375101|NCT02407990|560807352|FG002|Overall Study|Withdrawal by Subject|0|||
155511792|NCT00782509|561299362|FG000|Overall Study|Withdrawal by Subject|3|||
155511793|NCT00782509|561299363|FG001|Overall Study|Withdrawal by Subject|5|||
155511794|NCT00782509|561299364|FG002|Overall Study|Withdrawal by Subject|8|||
155649640|NCT01370538|561808331|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
155649641|NCT01370538|561808332|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
155649642|NCT01370538|561808331|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155649643|NCT01370538|561808332|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155649644|NCT01370538|561808331|FG000|Overall Study|Adverse Event|1|||
155649645|NCT01370538|561808332|FG001|Overall Study|Adverse Event|0|||
155649646|NCT01370538|561808331|FG000|Overall Study|Protocol Violation|8|||
155649647|NCT01370538|561808332|FG001|Overall Study|Protocol Violation|5|||
155649648|NCT01370538|561808331|FG000|Overall Study|Development of study specific withdrawal|1|||
155649649|NCT01370538|561808332|FG001|Overall Study|Development of study specific withdrawal|1|||
155649650|NCT01370538|561808331|FG000|Overall Study|Lost to follow up|6|||
155649651|NCT01370538|561808332|FG001|Overall Study|Lost to follow up|10|||
155511795|NCT00782509|561299362|FG000|Overall Study|Non compliance with protocol|2|||
155511796|NCT00782509|561299363|FG001|Overall Study|Non compliance with protocol|0|||
155511797|NCT00782509|561299364|FG002|Overall Study|Non compliance with protocol|0|||
155511798|NCT00782509|561299362|FG000|Overall Study|Other reasons not stated above|5|||
155649652|NCT01084135|561808333|FG000|20 Week|Physician Decision|0|||
155649653|NCT01084135|561808334|FG001|20 Week|Physician Decision|1|||
155649654|NCT02366130|561808335|FG000|Overall Study|Withdrawal by Subject|3|||
155649655|NCT02366130|561808335|FG000|Overall Study|Ineligible|6|||
155649656|NCT01065766|561808336|FG000|Overall Study|Assessed before the contracted date|1|||
155649657|NCT01065766|561808336|FG000|Overall Study|Contraindication to administration|6|||
155649658|NCT01065766|561808336|FG000|Overall Study|Violated dosage/administration|25|||
155649659|NCT02945046|561808341|FG000|Overall Study|Adverse Event|1|||
155649660|NCT02945046|561808342|FG001|Overall Study|Adverse Event|0|||
155649661|NCT02945046|561808343|FG002|Overall Study|Adverse Event|2|||
155511799|NCT00782509|561299363|FG001|Overall Study|Other reasons not stated above|2|||
155511800|NCT00782509|561299364|FG002|Overall Study|Other reasons not stated above|3|||
155511801|NCT00782509|561299362|FG000|Overall Study|Lack of Efficacy|10|||
155511802|NCT00782509|561299363|FG001|Overall Study|Lack of Efficacy|5|||
155511803|NCT00782509|561299364|FG002|Overall Study|Lack of Efficacy|2|||
155511804|NCT03222141|561299365|FG000|Overall Study|Death|15|||
155511805|NCT03222141|561299365|FG000|Overall Study|Lost to Follow-up|3|||
155511806|NCT01418352|561299368|FG000|Overall Study|Lost to Follow-up|2|||
155511807|NCT01418352|561299369|FG001|Overall Study|Lost to Follow-up|0|||
155511808|NCT01418352|561299370|FG002|Overall Study|Lost to Follow-up|0|||
155511809|NCT01418352|561299371|FG003|Overall Study|Lost to Follow-up|0|||
155511810|NCT01418352|561299368|FG000|Overall Study|Adverse Event|0|||
155511811|NCT01418352|561299369|FG001|Overall Study|Adverse Event|1|||
155511812|NCT01418352|561299370|FG002|Overall Study|Adverse Event|0|||
155511813|NCT01418352|561299371|FG003|Overall Study|Adverse Event|0|||
155511814|NCT01418352|561299368|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
155511815|NCT01418352|561299369|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
155511816|NCT01418352|561299370|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
155511817|NCT01418352|561299371|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
155511818|NCT01418352|561299368|FG000|Overall Study|Subject Withdrew Consent|0|||
155511819|NCT01418352|561299369|FG001|Overall Study|Subject Withdrew Consent|1|||
155511820|NCT01418352|561299370|FG002|Overall Study|Subject Withdrew Consent|2|||
155511821|NCT01418352|561299371|FG003|Overall Study|Subject Withdrew Consent|1|||
155511822|NCT01418352|561299368|FG000|Overall Study|Protocol Deviation|0|||
155511823|NCT01418352|561299369|FG001|Overall Study|Protocol Deviation|0|||
155511824|NCT01418352|561299370|FG002|Overall Study|Protocol Deviation|1|||
155511825|NCT01418352|561299371|FG003|Overall Study|Protocol Deviation|0|||
155511826|NCT01418352|561299368|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
155511827|NCT01418352|561299369|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
155511828|NCT01418352|561299370|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
155511829|NCT01418352|561299371|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
155511830|NCT00585351|561299372|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
155511831|NCT00585351|561299373|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
155511832|NCT00585351|561299374|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
155511833|NCT00585351|561299375|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
155649662|NCT02945046|561808341|FG000|Overall Study|Withdrawal by Subject|3|||
155511834|NCT00585351|561299376|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
155511835|NCT00585351|561299377|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
155511836|NCT00585351|561299378|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
155511837|NCT00585351|561299379|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
155511838|NCT00585351|561299372|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
155649663|NCT02945046|561808342|FG001|Overall Study|Withdrawal by Subject|3|||
155649664|NCT02945046|561808343|FG002|Overall Study|Withdrawal by Subject|3|||
155649665|NCT02945046|561808341|FG000|Overall Study|Protocol Violation|2|||
155649666|NCT02945046|561808342|FG001|Overall Study|Protocol Violation|3|||
155375102|NCT02407990|560807353|FG003|Overall Study|Withdrawal by Subject|0|||
155375103|NCT02407990|560807354|FG004|Overall Study|Withdrawal by Subject|1|||
155375104|NCT02407990|560807355|FG005|Overall Study|Withdrawal by Subject|0|||
155375105|NCT02407990|560807356|FG006|Overall Study|Withdrawal by Subject|0|||
155375106|NCT02407990|560807357|FG007|Overall Study|Withdrawal by Subject|30|||
155375107|NCT02407990|560807350|FG000|Overall Study|Study Terminated by Sponsor|1|||
155375108|NCT02407990|560807351|FG001|Overall Study|Study Terminated by Sponsor|3|||
155375109|NCT02407990|560807352|FG002|Overall Study|Study Terminated by Sponsor|3|||
155375110|NCT02407990|560807353|FG003|Overall Study|Study Terminated by Sponsor|0|||
155375111|NCT02407990|560807354|FG004|Overall Study|Study Terminated by Sponsor|3|||
155375112|NCT02407990|560807355|FG005|Overall Study|Study Terminated by Sponsor|4|||
155375113|NCT02407990|560807356|FG006|Overall Study|Study Terminated by Sponsor|3|||
155375114|NCT02407990|560807357|FG007|Overall Study|Study Terminated by Sponsor|37|||
155375115|NCT02407990|560807350|FG000|Overall Study|Logistics|0|||
155375116|NCT02407990|560807351|FG001|Overall Study|Logistics|0|||
155375117|NCT02407990|560807352|FG002|Overall Study|Logistics|0|||
155375118|NCT02407990|560807353|FG003|Overall Study|Logistics|0|||
155375119|NCT02407990|560807354|FG004|Overall Study|Logistics|0|||
155375120|NCT02407990|560807355|FG005|Overall Study|Logistics|0|||
155375121|NCT02407990|560807356|FG006|Overall Study|Logistics|0|||
155375122|NCT02407990|560807357|FG007|Overall Study|Logistics|1|||
155375123|NCT02407990|560807350|FG000|Overall Study|Rolled into long-term extension study|0|||
155375124|NCT02407990|560807351|FG001|Overall Study|Rolled into long-term extension study|0|||
155375125|NCT02407990|560807352|FG002|Overall Study|Rolled into long-term extension study|0|||
155375126|NCT02407990|560807353|FG003|Overall Study|Rolled into long-term extension study|0|||
155375127|NCT02407990|560807354|FG004|Overall Study|Rolled into long-term extension study|0|||
155375128|NCT02407990|560807355|FG005|Overall Study|Rolled into long-term extension study|0|||
155375129|NCT02407990|560807356|FG006|Overall Study|Rolled into long-term extension study|0|||
155375130|NCT02407990|560807357|FG007|Overall Study|Rolled into long-term extension study|1|||
155375131|NCT01238900|560807358|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
155375132|NCT01238900|560807358|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
155375133|NCT01198756|560807359|FG000|Overall Study|Adverse Event|0|||
155375134|NCT01198756|560807360|FG001|Overall Study|Adverse Event|0|||
155375135|NCT01198756|560807361|FG002|Overall Study|Adverse Event|0|||
155375136|NCT01198756|560807362|FG003|Overall Study|Adverse Event|1|||
155375137|NCT01198756|560807359|FG000|Overall Study|Protocol Violation|0|||
155375138|NCT01198756|560807360|FG001|Overall Study|Protocol Violation|0|||
155375139|NCT01198756|560807361|FG002|Overall Study|Protocol Violation|0|||
155375140|NCT01198756|560807362|FG003|Overall Study|Protocol Violation|2|||
155375141|NCT01198756|560807359|FG000|Overall Study|Withdrawal by Subject|9|||
155375142|NCT01198756|560807360|FG001|Overall Study|Withdrawal by Subject|4|||
155375143|NCT01198756|560807361|FG002|Overall Study|Withdrawal by Subject|7|||
155375144|NCT01198756|560807362|FG003|Overall Study|Withdrawal by Subject|5|||
155375145|NCT01198756|560807359|FG000|Overall Study|Lost to Follow-up|29|||
155375146|NCT01198756|560807360|FG001|Overall Study|Lost to Follow-up|36|||
155375147|NCT01198756|560807361|FG002|Overall Study|Lost to Follow-up|23|||
155375148|NCT01198756|560807362|FG003|Overall Study|Lost to Follow-up|18|||
155375149|NCT02915302|560807363|FG000|Overall Study|Adverse Event|3|||
155375150|NCT02915302|560807364|FG001|Overall Study|Adverse Event|0|||
155375151|NCT02915302|560807363|FG000|Overall Study|Protocol Violation|20|||
155375152|NCT02915302|560807364|FG001|Overall Study|Protocol Violation|27|||
155375153|NCT02915302|560807363|FG000|Overall Study|Lost to Follow-up|19|||
155375154|NCT02915302|560807364|FG001|Overall Study|Lost to Follow-up|22|||
155375155|NCT02915302|560807363|FG000|Overall Study|Withdrawal by Subject|22|||
155375156|NCT02915302|560807364|FG001|Overall Study|Withdrawal by Subject|29|||
155375157|NCT02915302|560807363|FG000|Overall Study|Other|1|||
155375158|NCT02915302|560807364|FG001|Overall Study|Other|0|||
155375159|NCT04343872|560807367|FG000|Overall Study|Lost to Follow-up|6|||
155375160|NCT04343872|560807368|FG001|Overall Study|Lost to Follow-up|3|||
155375161|NCT02134977|560807369|FG000|Overall Study|Protocol Deviation|102|||
155375162|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Adverse Event|6|||
155375163|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Adverse Event|6|||
155375164|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Death|1|||
155375165|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Death|1|||
155375166|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155375167|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155375168|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
155375169|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
155375170|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Physician Decision|1|||
155375171|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Physician Decision|4|||
155375172|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Various reasons|5|||
155375173|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Various reasons|3|||
155375174|NCT03828747|560807370|FG000|Open-Label Extension|Adverse Event|9|||
155375175|NCT03828747|560807371|FG001|Open-Label Extension|Adverse Event|7|||
155375176|NCT03828747|560807370|FG000|Open-Label Extension|Death|0|||
155375177|NCT03828747|560807371|FG001|Open-Label Extension|Death|2|||
155375178|NCT03828747|560807370|FG000|Open-Label Extension|Lost to Follow-up|4|||
155375179|NCT03828747|560807371|FG001|Open-Label Extension|Lost to Follow-up|0|||
155375180|NCT03828747|560807370|FG000|Open-Label Extension|Withdrawal by Subject|31|||
155375181|NCT03828747|560807371|FG001|Open-Label Extension|Withdrawal by Subject|30|||
155375182|NCT03828747|560807370|FG000|Open-Label Extension|Various reasons|4|||
155375183|NCT03828747|560807371|FG001|Open-Label Extension|Various reasons|4|||
155375184|NCT03828747|560807370|FG000|Open-Label Extension|Physician Decision|6|||
155375185|NCT03828747|560807371|FG001|Open-Label Extension|Physician Decision|2|||
155375186|NCT03646656|560807372|FG000|Overall Study|Lost to Follow-up|1|||
155375187|NCT03646656|560807373|FG001|Overall Study|Lost to Follow-up|0|||
155375188|NCT03646656|560807372|FG000|Overall Study|Withdrawal by Subject|2|||
155375189|NCT03646656|560807373|FG001|Overall Study|Withdrawal by Subject|0|||
155375190|NCT03651622|560807376|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
155375191|NCT03651622|560807377|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
155375192|NCT03651622|560807378|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
155375193|NCT03651622|560807376|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
155375194|NCT03651622|560807377|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
155375195|NCT03651622|560807378|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
155375196|NCT03651622|560807376|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
155375197|NCT03651622|560807377|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
155375198|NCT03651622|560807378|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
155375199|NCT03651622|560807376|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
155375200|NCT03651622|560807377|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
155375201|NCT03651622|560807378|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
155375202|NCT03651622|560807376|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
155375203|NCT03651622|560807377|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
155375204|NCT03651622|560807378|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
155375205|NCT01519089|560807379|FG000|Overall Study|Adverse Event|4|||
155375206|NCT01519089|560807380|FG001|Overall Study|Adverse Event|4|||
155375207|NCT01519089|560807379|FG000|Overall Study|Lack of Efficacy|0|||
155375208|NCT01519089|560807380|FG001|Overall Study|Lack of Efficacy|2|||
155375209|NCT01519089|560807379|FG000|Overall Study|Lost to Follow-up|1|||
155375210|NCT01519089|560807380|FG001|Overall Study|Lost to Follow-up|0|||
155375211|NCT01519089|560807379|FG000|Overall Study|Withdrawal by Subject|0|||
155375212|NCT01519089|560807380|FG001|Overall Study|Withdrawal by Subject|2|||
155375213|NCT01519089|560807379|FG000|Overall Study|Other|2|||
155375214|NCT01519089|560807380|FG001|Overall Study|Other|6|||
155375215|NCT01519089|560807379|FG000|Overall Study|Not received study drug|0|||
155375216|NCT01519089|560807380|FG001|Overall Study|Not received study drug|1|||
155375217|NCT00127205|560807381|FG000|Overall Study|Adverse Event|228|||
155375218|NCT00127205|560807382|FG001|Overall Study|Adverse Event|387|||
155375219|NCT00127205|560807383|FG002|Overall Study|Adverse Event|273|||
155375220|NCT00127205|560807381|FG000|Overall Study|Death|8|||
155375221|NCT00127205|560807382|FG001|Overall Study|Death|6|||
155375222|NCT00127205|560807383|FG002|Overall Study|Death|5|||
155375223|NCT00127205|560807381|FG000|Overall Study|Withdrawal by Subject|318|||
155375224|NCT00127205|560807382|FG001|Overall Study|Withdrawal by Subject|310|||
155375225|NCT00127205|560807383|FG002|Overall Study|Withdrawal by Subject|172|||
155375226|NCT00127205|560807381|FG000|Overall Study|Other-non protocol specified|142|||
155375227|NCT00127205|560807382|FG001|Overall Study|Other-non protocol specified|129|||
155375228|NCT00127205|560807383|FG002|Overall Study|Other-non protocol specified|77|||
155375229|NCT00127205|560807381|FG000|Overall Study|Data not reported|6|||
155375230|NCT00127205|560807382|FG001|Overall Study|Data not reported|10|||
155375231|NCT00127205|560807383|FG002|Overall Study|Data not reported|1|||
155375232|NCT00127205|560807381|FG000|Overall Study|Progression|127|||
155375233|NCT00127205|560807382|FG001|Overall Study|Progression|131|||
155375234|NCT00127205|560807383|FG002|Overall Study|Progression|84|||
155375235|NCT03377699|560807384|FG000|Overall Study|Withdrawal by Subject|2|||
155375236|NCT03377699|560807385|FG001|Overall Study|Withdrawal by Subject|9|||
155375237|NCT03377699|560807384|FG000|Overall Study|Lost to Follow-up|1|||
155375238|NCT03377699|560807385|FG001|Overall Study|Lost to Follow-up|1|||
155375239|NCT03377699|560807384|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
155375240|NCT03377699|560807385|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
155431126|NCT02201940|561003550|FG000|Overall Study|Withdrew Consent|2|||
155511839|NCT00585351|561299373|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
155511840|NCT00585351|561299374|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
155511841|NCT00585351|561299375|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
155511842|NCT00585351|561299376|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
155511843|NCT00585351|561299377|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
155511844|NCT00585351|561299378|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
155511845|NCT00585351|561299379|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
155511846|NCT00585351|561299372|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
155511847|NCT00585351|561299373|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
155511848|NCT00585351|561299374|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
155649667|NCT02945046|561808343|FG002|Overall Study|Protocol Violation|2|||
155511849|NCT00585351|561299375|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
155511850|NCT00585351|561299376|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
155511851|NCT00585351|561299377|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
155511852|NCT00585351|561299378|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
155511853|NCT00585351|561299379|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
155511854|NCT00585351|561299372|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
155511855|NCT00585351|561299373|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
155511856|NCT00585351|561299374|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155649668|NCT02945046|561808341|FG000|Overall Study|Lost to Follow-up|1|||
155649669|NCT02945046|561808342|FG001|Overall Study|Lost to Follow-up|1|||
155649670|NCT02945046|561808343|FG002|Overall Study|Lost to Follow-up|0|||
155649671|NCT02945046|561808341|FG000|Overall Study|Lack of Efficacy|1|||
155649672|NCT02945046|561808342|FG001|Overall Study|Lack of Efficacy|2|||
155511857|NCT00585351|561299375|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155511858|NCT00585351|561299376|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155511859|NCT00585351|561299377|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155511860|NCT00585351|561299378|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155511861|NCT00585351|561299379|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155511862|NCT00585351|561299372|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155511863|NCT00585351|561299373|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155511864|NCT00585351|561299374|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155511865|NCT00585351|561299375|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155511866|NCT00585351|561299376|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155511867|NCT00585351|561299377|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155649673|NCT02945046|561808343|FG002|Overall Study|Lack of Efficacy|1|||
155375241|NCT03377699|560807384|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
155375242|NCT03377699|560807385|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
155375243|NCT03377699|560807384|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
155511868|NCT00585351|561299378|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
155649674|NCT02945046|561808341|FG000|Overall Study|Other than specified|5|||
155649675|NCT02945046|561808342|FG001|Overall Study|Other than specified|4|||
155511869|NCT00585351|561299379|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
155511870|NCT00585351|561299372|FG000|Enrollment Period (Intervention)|Death|0|||
155511871|NCT00585351|561299373|FG001|Enrollment Period (Intervention)|Death|0|||
155511872|NCT00585351|561299374|FG002|Enrollment Period (Intervention)|Death|0|||
155511873|NCT00585351|561299375|FG003|Enrollment Period (Intervention)|Death|0|||
155511874|NCT00585351|561299376|FG004|Enrollment Period (Intervention)|Death|1|||
155511875|NCT00585351|561299377|FG005|Enrollment Period (Intervention)|Death|0|||
155511876|NCT00585351|561299378|FG006|Enrollment Period (Intervention)|Death|1|||
155511877|NCT00585351|561299379|FG007|Enrollment Period (Intervention)|Death|0|||
155511878|NCT00585351|561299372|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155511879|NCT00585351|561299373|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155511880|NCT00585351|561299374|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155511881|NCT00585351|561299375|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155375244|NCT03377699|560807385|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
155375245|NCT03377699|560807384|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
155375246|NCT03377699|560807385|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
155375247|NCT02580305|560807386|FG000|Overall Study|Adverse Event|15|||
155375248|NCT02580305|560807387|FG001|Overall Study|Adverse Event|19|||
155375249|NCT02580305|560807388|FG002|Overall Study|Adverse Event|10|||
155375250|NCT02580305|560807386|FG000|Overall Study|Lack of Efficacy|5|||
155375251|NCT02580305|560807387|FG001|Overall Study|Lack of Efficacy|0|||
155375252|NCT02580305|560807388|FG002|Overall Study|Lack of Efficacy|2|||
155375253|NCT02580305|560807386|FG000|Overall Study|Protocol Violation|4|||
155375254|NCT02580305|560807387|FG001|Overall Study|Protocol Violation|9|||
155375255|NCT02580305|560807388|FG002|Overall Study|Protocol Violation|6|||
155375256|NCT02580305|560807386|FG000|Overall Study|Lost to Follow-up|4|||
155375257|NCT02580305|560807387|FG001|Overall Study|Lost to Follow-up|4|||
155375258|NCT02580305|560807388|FG002|Overall Study|Lost to Follow-up|2|||
155375259|NCT02580305|560807386|FG000|Overall Study|Withdrawal by Subject|11|||
155375260|NCT02580305|560807387|FG001|Overall Study|Withdrawal by Subject|9|||
155375261|NCT02580305|560807388|FG002|Overall Study|Withdrawal by Subject|7|||
155375262|NCT02580305|560807386|FG000|Overall Study|Randomized in error and never treated|4|||
155375263|NCT02580305|560807387|FG001|Overall Study|Randomized in error and never treated|8|||
155375264|NCT02580305|560807388|FG002|Overall Study|Randomized in error and never treated|5|||
155375265|NCT03582943|560807389|FG000|Allocated to Groups|Withdrawal by Subject|1|||
155375266|NCT03582943|560807390|FG001|Allocated to Groups|Withdrawal by Subject|1|||
155375267|NCT03582943|560807389|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
155375268|NCT03582943|560807390|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
155375269|NCT03582943|560807389|FG000|Analyzed|Protocol Violation|4|||
155375270|NCT03582943|560807390|FG001|Analyzed|Protocol Violation|1|||
155375271|NCT01177800|560807395|FG000|Overall Study|Adverse Event|9|||
155375272|NCT01177800|560807396|FG001|Overall Study|Adverse Event|3|||
155375273|NCT01177800|560807395|FG000|Overall Study|Protocol Violation|0|||
155375274|NCT01177800|560807396|FG001|Overall Study|Protocol Violation|1|||
155375275|NCT01177800|560807395|FG000|Overall Study|Physician Decision|1|||
155375276|NCT01177800|560807396|FG001|Overall Study|Physician Decision|0|||
155375277|NCT01177800|560807395|FG000|Overall Study|Withdrawal of informed consent|0|||
155375278|NCT01177800|560807396|FG001|Overall Study|Withdrawal of informed consent|1|||
155375279|NCT02071290|560807397|FG000|Overall Study|Death|1|||
155375280|NCT02071290|560807398|FG001|Overall Study|Death|0|||
155375281|NCT02071290|560807397|FG000|Overall Study|Withdrawal by Subject|0|||
155375282|NCT02071290|560807398|FG001|Overall Study|Withdrawal by Subject|1|||
155375283|NCT02071290|560807397|FG000|Overall Study|Protocol Violation|3|||
155375284|NCT02071290|560807398|FG001|Overall Study|Protocol Violation|5|||
155375285|NCT02071290|560807397|FG000|Overall Study|Physician Decision|0|||
155375286|NCT02071290|560807398|FG001|Overall Study|Physician Decision|1|||
155375287|NCT05560243|560807403|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
155375288|NCT01232738|560807404|FG000|Overall Study|Death|3|||
155375289|NCT01232738|560807404|FG000|Overall Study|Physician Decision|2|||
155375290|NCT01232738|560807404|FG000|Overall Study|Lost to Follow-up|1|||
155375291|NCT01232738|560807404|FG000|Overall Study|Withdrawal by Subject|2|||
155375292|NCT01232738|560807404|FG000|Overall Study|Adverse Event|5|||
155375293|NCT03231800|560807409|FG000|Overall Study|Lost to Follow-up|0|||
155375294|NCT03231800|560807410|FG001|Overall Study|Lost to Follow-up|2|||
155375295|NCT03231800|560807409|FG000|Overall Study|Protocol Violation|1|||
155375296|NCT03231800|560807410|FG001|Overall Study|Protocol Violation|1|||
155375297|NCT03231800|560807409|FG000|Overall Study|reason not provided|2|||
155375298|NCT03231800|560807410|FG001|Overall Study|reason not provided|0|||
155375299|NCT00859222|560807411|FG000|Overall Study|Adverse Event|2|||
155375300|NCT00859222|560807412|FG001|Overall Study|Adverse Event|3|||
155375301|NCT00859222|560807413|FG002|Overall Study|Adverse Event|6|||
155375302|NCT00859222|560807414|FG003|Overall Study|Adverse Event|24|||
155375303|NCT00859222|560807415|FG004|Overall Study|Adverse Event|15|||
155375304|NCT00859222|560807411|FG000|Overall Study|DLT|1|||
155375305|NCT00859222|560807412|FG001|Overall Study|DLT|0|||
155375306|NCT00859222|560807413|FG002|Overall Study|DLT|0|||
155375307|NCT00859222|560807414|FG003|Overall Study|DLT|0|||
155375308|NCT00859222|560807415|FG004|Overall Study|DLT|0|||
155375309|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
155375310|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
155375311|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
155375312|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
155375313|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
155375314|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
155375315|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
155375316|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
155375317|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
155375318|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
155431127|NCT02201940|561003551|FG001|Overall Study|Withdrew Consent|1|||
155431128|NCT02201940|561003550|FG000|Overall Study|Investigator's Discretion|1|||
155431129|NCT02201940|561003551|FG001|Overall Study|Investigator's Discretion|1|||
155431130|NCT02201940|561003550|FG000|Overall Study|Death|1|||
155431131|NCT02201940|561003551|FG001|Overall Study|Death|0|||
155431132|NCT02201940|561003550|FG000|Overall Study|Adverse Event|0|||
155431133|NCT02201940|561003551|FG001|Overall Study|Adverse Event|1|||
155431134|NCT02700451|561003552|FG000|Overall Study|Protocol Violation|2|||
155431135|NCT02700451|561003553|FG001|Overall Study|Protocol Violation|2|||
155431136|NCT02700451|561003554|FG002|Overall Study|Protocol Violation|3|||
155431137|NCT02700451|561003552|FG000|Overall Study|Discontinued intervention|14|||
155431138|NCT02700451|561003553|FG001|Overall Study|Discontinued intervention|15|||
155431139|NCT02700451|561003554|FG002|Overall Study|Discontinued intervention|14|||
155431140|NCT00404092|561003556|FG000|Overall Study|Death|1|||
155431141|NCT00404092|561003557|FG001|Overall Study|Death|0|||
155431142|NCT00404092|561003558|FG002|Overall Study|Death|0|||
155431143|NCT00404092|561003559|FG003|Overall Study|Death|0|||
155431144|NCT00404092|561003556|FG000|Overall Study|Adverse Event|0|||
155431145|NCT00404092|561003557|FG001|Overall Study|Adverse Event|0|||
155375319|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
155375320|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
155375321|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
155375322|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
155431146|NCT00404092|561003558|FG002|Overall Study|Adverse Event|1|||
155431147|NCT00404092|561003559|FG003|Overall Study|Adverse Event|0|||
155431148|NCT01511445|561003560|FG000|Overall Study|Lost to Follow-up|3|||
155375323|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
155375324|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
155375325|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
155431149|NCT01511445|561003561|FG001|Overall Study|Lost to Follow-up|1|||
155431150|NCT01511445|561003560|FG000|Overall Study|Protocol Violation|1|||
155375326|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
155375327|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
155375328|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
155375329|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
155375330|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
155375331|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
155375332|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
155375333|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
155375334|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
155375335|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
155375336|NCT01941719|560807429|FG000|Overall Study|Lost to Follow-up|20|||
155375337|NCT01941719|560807430|FG001|Overall Study|Lost to Follow-up|19|||
155375338|NCT02535091|560807433|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
155375339|NCT02535091|560807434|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
155375340|NCT02535091|560807435|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
155375341|NCT02535091|560807433|FG000|Overall Study|Withdrawal by Subject|14|||
155375342|NCT02535091|560807434|FG001|Overall Study|Withdrawal by Subject|5|||
155375343|NCT02535091|560807435|FG002|Overall Study|Withdrawal by Subject|121|||
155375344|NCT02535091|560807433|FG000|Overall Study|Adverse Event|9|||
155375345|NCT02535091|560807434|FG001|Overall Study|Adverse Event|4|||
155375346|NCT02535091|560807435|FG002|Overall Study|Adverse Event|170|||
155375347|NCT02535091|560807433|FG000|Overall Study|Other|4|||
155375348|NCT02535091|560807434|FG001|Overall Study|Other|3|||
155375349|NCT02535091|560807435|FG002|Overall Study|Other|81|||
155375350|NCT02535091|560807433|FG000|Overall Study|Lost to Follow-up|0|||
155375351|NCT02535091|560807434|FG001|Overall Study|Lost to Follow-up|1|||
155375352|NCT02535091|560807435|FG002|Overall Study|Lost to Follow-up|19|||
155375353|NCT02535091|560807433|FG000|Overall Study|Protocol Violation|0|||
155375354|NCT02535091|560807434|FG001|Overall Study|Protocol Violation|1|||
155375355|NCT02535091|560807435|FG002|Overall Study|Protocol Violation|11|||
155375356|NCT02535091|560807433|FG000|Overall Study|Pregnancy|0|||
155375357|NCT02535091|560807434|FG001|Overall Study|Pregnancy|0|||
155375358|NCT02535091|560807435|FG002|Overall Study|Pregnancy|7|||
155375359|NCT01259089|560807445|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375360|NCT01259089|560807446|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375361|NCT01259089|560807447|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375362|NCT01259089|560807448|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375363|NCT01259089|560807449|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375364|NCT01259089|560807450|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
155375365|NCT01259089|560807445|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
155375366|NCT01259089|560807446|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
155375367|NCT01259089|560807447|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
155375368|NCT01259089|560807448|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
155375369|NCT01259089|560807449|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
155375370|NCT01259089|560807450|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
155375371|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375372|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375373|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375374|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375375|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375376|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
155375377|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375378|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375379|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375380|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375381|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
155375382|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
155431151|NCT01511445|561003561|FG001|Overall Study|Protocol Violation|3|||
155431152|NCT01511445|561003560|FG000|Overall Study|Protocol Violation|1|||
155431153|NCT01511445|561003561|FG001|Overall Study|Protocol Violation|0|||
155431154|NCT02344576|561003565|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
155431155|NCT02344576|561003566|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
155431156|NCT02344576|561003567|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
155431157|NCT02344576|561003568|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
155431158|NCT02344576|561003565|FG000|1-Month Follow-Up|Death|13|||
155431159|NCT02344576|561003566|FG001|1-Month Follow-Up|Death|8|||
155431160|NCT02344576|561003567|FG002|1-Month Follow-Up|Death|0|||
155375383|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
155375384|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
155431161|NCT02344576|561003568|FG003|1-Month Follow-Up|Death|0|||
155431162|NCT02344576|561003565|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
155375385|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
155375386|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
155375387|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
155375388|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
155375389|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
155375390|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375391|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375392|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375393|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375394|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375395|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375396|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375397|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375398|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375399|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
155375400|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
155375401|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375402|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375403|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375404|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375405|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
155375406|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
155375407|NCT01259089|560807445|FG000|Survival Follow up for Two Years|Death|3|||
155375408|NCT01259089|560807446|FG001|Survival Follow up for Two Years|Death|2|||
155375409|NCT01259089|560807447|FG002|Survival Follow up for Two Years|Death|2|||
155375410|NCT01259089|560807448|FG003|Survival Follow up for Two Years|Death|3|||
155375411|NCT01259089|560807449|FG004|Survival Follow up for Two Years|Death|6|||
155375412|NCT01259089|560807450|FG005|Survival Follow up for Two Years|Death|13|||
155375413|NCT01259089|560807445|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375414|NCT01259089|560807446|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375415|NCT01259089|560807447|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375416|NCT01259089|560807448|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375417|NCT01259089|560807449|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375418|NCT01259089|560807450|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
155375419|NCT01259089|560807445|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375420|NCT01259089|560807446|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375421|NCT01259089|560807447|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375422|NCT01259089|560807448|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375423|NCT01259089|560807449|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375424|NCT01259089|560807450|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
155375425|NCT00548262|560807451|FG000|Overall Study|Death|21|||
155375426|NCT00548262|560807451|FG000|Overall Study|Adverse Event|2|||
155375427|NCT00548262|560807451|FG000|Overall Study|Lack of Efficacy|4|||
155375428|NCT00548262|560807451|FG000|Overall Study|Lost to Follow-up|1|||
155375429|NCT00548262|560807451|FG000|Overall Study|Other|3|||
155375430|NCT00548262|560807451|FG000|Overall Study|Withdrawal by Subject|1|||
155375431|NCT01712659|560807452|FG000|Dose Escalation|Physician Decision|0|||
155375432|NCT01712659|560807453|FG001|Dose Escalation|Physician Decision|1|||
155375433|NCT01712659|560807454|FG002|Dose Escalation|Physician Decision|0|||
155375434|NCT01712659|560807455|FG003|Dose Escalation|Physician Decision|0|||
155375435|NCT01712659|560807456|FG004|Dose Escalation|Physician Decision|0|||
155375436|NCT01712659|560807452|FG000|Dose Escalation|Unable to take study drug|0|||
155375437|NCT01712659|560807453|FG001|Dose Escalation|Unable to take study drug|1|||
155375438|NCT01712659|560807454|FG002|Dose Escalation|Unable to take study drug|0|||
155375439|NCT01712659|560807455|FG003|Dose Escalation|Unable to take study drug|0|||
155375440|NCT01712659|560807456|FG004|Dose Escalation|Unable to take study drug|0|||
155375441|NCT01712659|560807452|FG000|Dose Expansion|Early disease progression|1|||
155375442|NCT01712659|560807453|FG001|Dose Expansion|Early disease progression|0|||
155375443|NCT01712659|560807454|FG002|Dose Expansion|Early disease progression|0|||
155375444|NCT01712659|560807455|FG003|Dose Expansion|Early disease progression|0|||
155375445|NCT01712659|560807456|FG004|Dose Expansion|Early disease progression|0|||
155375446|NCT01712659|560807452|FG000|Dose Expansion|Physician Decision|1|||
155375447|NCT01712659|560807453|FG001|Dose Expansion|Physician Decision|0|||
155375448|NCT01712659|560807454|FG002|Dose Expansion|Physician Decision|0|||
155375449|NCT01712659|560807455|FG003|Dose Expansion|Physician Decision|0|||
155375450|NCT01712659|560807456|FG004|Dose Expansion|Physician Decision|0|||
155375451|NCT01278173|560807460|FG000|Overall Study|Lack of Efficacy|13|||
155375452|NCT01278173|560807460|FG000|Overall Study|Adverse Event|8|||
155375453|NCT01278173|560807460|FG000|Overall Study|Administrative or other reason|4|||
155375454|NCT01278173|560807460|FG000|Overall Study|Protocol Violation|1|||
155511882|NCT00585351|561299376|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
155511883|NCT00585351|561299377|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
155511884|NCT00585351|561299378|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155511885|NCT00585351|561299379|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155511886|NCT01821625|561299380|FG000|Overall Study|Withdrawal by Subject|2|||
155511887|NCT01821625|561299380|FG000|Overall Study|Lack of Efficacy|2|||
155511888|NCT01821625|561299380|FG000|Overall Study|Adverse Event|1|||
155511889|NCT01821625|561299380|FG000|Overall Study|Medical contraindication|1|||
155511890|NCT00457665|561299386|FG000|12 Months|Drug allergy|1|||
155511891|NCT00457665|561299387|FG001|12 Months|Drug allergy|1|||
155511892|NCT00457665|561299386|FG000|12 Months|High HIV viral load|5|||
155511893|NCT00457665|561299387|FG001|12 Months|High HIV viral load|1|||
155511894|NCT00457665|561299386|FG000|12 Months|Lipodystrophy|2|||
155511895|NCT00457665|561299387|FG001|12 Months|Lipodystrophy|0|||
155511896|NCT00457665|561299386|FG000|12 Months|Withdrawal by Subject|0|||
155511897|NCT00457665|561299387|FG001|12 Months|Withdrawal by Subject|2|||
155511898|NCT00457665|561299386|FG000|12 Months|Abnormal Liver function tests|0|||
155511899|NCT00457665|561299387|FG001|12 Months|Abnormal Liver function tests|5|||
155511900|NCT00457665|561299386|FG000|24 Months|Withdrawal by Subject|3|||
155511901|NCT00457665|561299387|FG001|24 Months|Withdrawal by Subject|2|||
155511902|NCT00457665|561299386|FG000|24 Months|Lipodystrophy|1|||
155511903|NCT00457665|561299387|FG001|24 Months|Lipodystrophy|1|||
155511904|NCT00457665|561299386|FG000|24 Months|Abnormal liver function tests|1|||
155511905|NCT00457665|561299387|FG001|24 Months|Abnormal liver function tests|5|||
155511906|NCT00446654|561299388|FG000|Overall Study|Withdrawal by Subject|1|||
155511907|NCT00446654|561299389|FG001|Overall Study|Withdrawal by Subject|0|||
155511908|NCT00446654|561299388|FG000|Overall Study|Adverse Event|1|||
155511909|NCT00446654|561299389|FG001|Overall Study|Adverse Event|0|||
155511910|NCT02535000|561299390|FG000|Overall Study|Cancellation of surgery.|1|||
155511911|NCT02535000|561299391|FG001|Overall Study|Cancellation of surgery.|2|||
155511912|NCT01620489|561299395|FG000|Overall Study|Adverse Event|17|||
155511913|NCT01620489|561299396|FG001|Overall Study|Adverse Event|4|||
155511914|NCT01620489|561299395|FG000|Overall Study|Protocol Violation|0|||
155511915|NCT01620489|561299396|FG001|Overall Study|Protocol Violation|3|||
155511916|NCT01620489|561299395|FG000|Overall Study|Withdrawal Criteria|17|||
155511917|NCT01620489|561299396|FG001|Overall Study|Withdrawal Criteria|25|||
155511918|NCT01620489|561299395|FG000|Overall Study|Unclassified|1|||
155511919|NCT01620489|561299396|FG001|Overall Study|Unclassified|2|||
155511920|NCT01328054|561299399|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
155511921|NCT01328054|561299400|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
155511922|NCT01328054|561299399|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
155511923|NCT01328054|561299400|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
155511924|NCT01328054|561299399|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
155511925|NCT01328054|561299400|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
155511926|NCT00871728|561299401|FG000|Overall Study|Adverse Event|1|||
155511927|NCT00871728|561299401|FG000|Overall Study|Protocol Violation|7|||
155511928|NCT00871728|561299401|FG000|Overall Study|Lost to Follow-up|2|||
155511929|NCT00871728|561299401|FG000|Overall Study|Failed to Visit Hospital|4|||
155511930|NCT00871728|561299401|FG000|Overall Study|Participant Non-compliance|1|||
155511931|NCT00871728|561299401|FG000|Overall Study|Withdrawal of Informed Consent|5|||
155511932|NCT02472977|561299408|FG000|Overall Study|Disease progression|4|||
155511933|NCT02472977|561299409|FG001|Overall Study|Disease progression|25|||
155511934|NCT02472977|561299410|FG002|Overall Study|Disease progression|6|||
155511935|NCT02472977|561299408|FG000|Overall Study|Withdrawal by Subject|0|||
155511936|NCT02472977|561299409|FG001|Overall Study|Withdrawal by Subject|1|||
155511937|NCT02472977|561299410|FG002|Overall Study|Withdrawal by Subject|0|||
155511938|NCT02472977|561299408|FG000|Overall Study|Study drug toxicity|2|||
155511939|NCT02472977|561299409|FG001|Overall Study|Study drug toxicity|0|||
155511940|NCT02472977|561299410|FG002|Overall Study|Study drug toxicity|2|||
155511941|NCT02472977|561299408|FG000|Overall Study|Subject request to discontinue treatment|0|||
155511942|NCT02472977|561299409|FG001|Overall Study|Subject request to discontinue treatment|1|||
155511943|NCT02472977|561299410|FG002|Overall Study|Subject request to discontinue treatment|0|||
155511944|NCT02668302|561299414|FG000|Overall Study|Withdrawal by Subject|1|||
155511945|NCT02668302|561299415|FG001|Overall Study|Withdrawal by Subject|0|||
155649676|NCT02945046|561808343|FG002|Overall Study|Other than specified|7|||
155649677|NCT01608308|561808345|FG000|Overall Study|pretreatment medical and billing reasons|0|||
155649678|NCT01608308|561808346|FG001|Overall Study|pretreatment medical and billing reasons|2|||
155649679|NCT00032487|561808367|FG000|Overall Study|Withdrawal by Subject|67|||
155649680|NCT00032487|561808368|FG001|Overall Study|Withdrawal by Subject|43|||
155649681|NCT00032487|561808367|FG000|Overall Study|Adverse Event|3|||
155649682|NCT00032487|561808368|FG001|Overall Study|Adverse Event|7|||
155649683|NCT00032487|561808367|FG000|Overall Study|Lost to Follow-up|57|||
155649684|NCT00032487|561808368|FG001|Overall Study|Lost to Follow-up|58|||
155649685|NCT00032487|561808367|FG000|Overall Study|Had other reason|12|||
155649686|NCT00032487|561808368|FG001|Overall Study|Had other reason|12|||
155649687|NCT01117350|561808379|FG000|Comparative Period|Not Treated|5|||
155649688|NCT01117350|561808380|FG001|Comparative Period|Not Treated|8|||
155649689|NCT01117350|561808379|FG000|Comparative Period|Adverse Event|6|||
155649690|NCT01117350|561808380|FG001|Comparative Period|Adverse Event|33|||
155649691|NCT01117350|561808379|FG000|Comparative Period|Lost to Follow-up|11|||
155649692|NCT01117350|561808380|FG001|Comparative Period|Lost to Follow-up|7|||
155649693|NCT01117350|561808379|FG000|Comparative Period|Withdrawal by Subject|9|||
155649694|NCT01117350|561808380|FG001|Comparative Period|Withdrawal by Subject|13|||
155649695|NCT01117350|561808379|FG000|Comparative Period|Protocol Violation|8|||
155649696|NCT01117350|561808380|FG001|Comparative Period|Protocol Violation|12|||
155649697|NCT01117350|561808379|FG000|Comparative Period|Lack of Efficacy|1|||
155649698|NCT01117350|561808380|FG001|Comparative Period|Lack of Efficacy|0|||
155649699|NCT01117350|561808379|FG000|Comparative Period|Physician Decision|0|||
155649700|NCT01117350|561808380|FG001|Comparative Period|Physician Decision|1|||
155375455|NCT01278173|560807460|FG000|Overall Study|Withdrawal by Subject|1|||
155375456|NCT02091206|560807462|FG000|Treatment Period|Adverse Event|0|||
155375457|NCT02091206|560807463|FG001|Treatment Period|Adverse Event|1|||
155375458|NCT02091206|560807464|FG002|Treatment Period|Adverse Event|0|||
155375459|NCT02091206|560807465|FG003|Treatment Period|Adverse Event|0|||
155375460|NCT02091206|560807462|FG000|Treatment Period|Met withdrawal criteria|0|||
155375461|NCT02091206|560807463|FG001|Treatment Period|Met withdrawal criteria|0|||
155375462|NCT02091206|560807464|FG002|Treatment Period|Met withdrawal criteria|1|||
155375463|NCT02091206|560807465|FG003|Treatment Period|Met withdrawal criteria|0|||
155375464|NCT02091206|560807462|FG000|Taper Period|Participant refused study drug|1|||
155511946|NCT03775681|561299416|FG000|Overall Study|Physician Decision|3|||
155375465|NCT02091206|560807463|FG001|Taper Period|Participant refused study drug|0|||
155375466|NCT02091206|560807464|FG002|Taper Period|Participant refused study drug|0|||
155375467|NCT02091206|560807465|FG003|Taper Period|Participant refused study drug|1|||
155375468|NCT02091206|560807462|FG000|Taper Period|Lost to Follow-up|0|||
155375469|NCT02091206|560807463|FG001|Taper Period|Lost to Follow-up|0|||
155375470|NCT02091206|560807464|FG002|Taper Period|Lost to Follow-up|0|||
155649701|NCT01117350|561808379|FG000|Comparative Period|Move to another city/country|2|||
155649702|NCT01117350|561808380|FG001|Comparative Period|Move to another city/country|1|||
155649703|NCT01117350|561808379|FG000|Extension Period|Not included in extension, not treated|0|||
155649704|NCT01117350|561808380|FG001|Extension Period|Not included in extension, not treated|50|||
155649705|NCT01117350|561808379|FG000|Extension Period|Adverse Event|0|||
155649706|NCT01117350|561808380|FG001|Extension Period|Adverse Event|2|||
155649707|NCT01117350|561808379|FG000|Extension Period|Protocol Violation|0|||
155649708|NCT01117350|561808380|FG001|Extension Period|Protocol Violation|2|||
155649709|NCT01117350|561808379|FG000|Extension Period|Lost to Follow-up|0|||
155649710|NCT01117350|561808380|FG001|Extension Period|Lost to Follow-up|2|||
155649711|NCT01117350|561808379|FG000|Extension Period|Withdrawal by Subject|0|||
155649712|NCT01117350|561808380|FG001|Extension Period|Withdrawal by Subject|3|||
155649713|NCT01117350|561808379|FG000|Extension Period|Lack of Efficacy|0|||
155649714|NCT01117350|561808380|FG001|Extension Period|Lack of Efficacy|2|||
155649715|NCT01117350|561808379|FG000|Extension Period|Inclusion criteria not respected|0|||
155649716|NCT01117350|561808380|FG001|Extension Period|Inclusion criteria not respected|1|||
155431163|NCT02344576|561003566|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
155431164|NCT02344576|561003567|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
155431165|NCT02344576|561003568|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
155431166|NCT02344576|561003565|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
155431167|NCT02344576|561003566|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
155431168|NCT02344576|561003567|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
155431169|NCT02344576|561003568|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
155431170|NCT02344576|561003565|FG000|6-Month Follow-Up|Death|14|||
155431171|NCT02344576|561003566|FG001|6-Month Follow-Up|Death|14|||
155431172|NCT02344576|561003567|FG002|6-Month Follow-Up|Death|0|||
155431173|NCT02344576|561003568|FG003|6-Month Follow-Up|Death|0|||
155431174|NCT02344576|561003565|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
155431175|NCT02344576|561003566|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
155431176|NCT02344576|561003567|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
155431177|NCT02344576|561003568|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
155431178|NCT02344576|561003565|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
155431179|NCT02344576|561003566|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
155431180|NCT02344576|561003567|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
155431181|NCT02344576|561003568|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
155431182|NCT02337387|561003570|FG000|Overall Study|Adverse Event|0|||
155431183|NCT02337387|561003571|FG001|Overall Study|Adverse Event|1|||
155431184|NCT02337387|561003572|FG002|Overall Study|Adverse Event|0|||
155431185|NCT02337387|561003573|FG003|Overall Study|Adverse Event|0|||
155431186|NCT02337387|561003570|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
155431187|NCT02337387|561003571|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
155431188|NCT02337387|561003572|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
155431189|NCT02337387|561003573|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
155431190|NCT02853760|561003574|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
155431191|NCT02853760|561003575|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
155431192|NCT02853760|561003576|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
155431193|NCT02853760|561003577|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
155431194|NCT02853760|561003578|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
155431195|NCT02853760|561003579|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
155431196|NCT01624142|561003580|FG000|Overall Study|Withdrawal by Subject|14|||
155431197|NCT01624142|561003581|FG001|Overall Study|Withdrawal by Subject|4|||
155431198|NCT01624142|561003580|FG000|Overall Study|Death|3|||
155431199|NCT01624142|561003581|FG001|Overall Study|Death|6|||
155431200|NCT01624142|561003580|FG000|Overall Study|Study Closure|12|||
155431201|NCT01624142|561003581|FG001|Overall Study|Study Closure|6|||
155431202|NCT01624142|561003580|FG000|Overall Study|Lost to Follow-up|2|||
155431203|NCT01624142|561003581|FG001|Overall Study|Lost to Follow-up|0|||
155431204|NCT01624142|561003580|FG000|Overall Study|Other|1|||
155431205|NCT01624142|561003581|FG001|Overall Study|Other|0|||
155431206|NCT04826900|561003582|FG000|Overall Study|Family factor|1|||
155431207|NCT04826900|561003583|FG001|Overall Study|Family factor|1|||
155431208|NCT03372941|561003584|FG000|Overall Study|Lost to Follow-up|2|||
155431209|NCT03372941|561003585|FG001|Overall Study|Lost to Follow-up|4|||
155431210|NCT01053429|561003586|FG000|Overall Study|Adverse Event|64|||
155431211|NCT01053429|561003586|FG000|Overall Study|Other|309|||
155649717|NCT01117350|561808379|FG000|Extension Period|Prohibited medication|0|||
155431212|NCT00752986|561003587|FG000|Overall Study|Withdrawal by Subject|2|||
155431213|NCT00752986|561003588|FG001|Overall Study|Withdrawal by Subject|1|||
155431214|NCT00752986|561003589|FG002|Overall Study|Withdrawal by Subject|2|||
155431215|NCT00752986|561003587|FG000|Overall Study|Protocol Violation|3|||
155431216|NCT00752986|561003588|FG001|Overall Study|Protocol Violation|0|||
155431217|NCT00752986|561003589|FG002|Overall Study|Protocol Violation|0|||
155431218|NCT01697345|561003590|FG000|Overall Study|Withdrawal by Subject|1|||
155431219|NCT02382133|561003591|FG000|Overall Study|Death|22|||
155431220|NCT02382133|561003591|FG000|Overall Study|transfer out of ICU|4|||
155649718|NCT01117350|561808380|FG001|Extension Period|Prohibited medication|1|||
155375471|NCT02091206|560807465|FG003|Taper Period|Lost to Follow-up|1|||
155375472|NCT00293059|560807466|FG000|Overall Study|Adverse Event|12|||
155375473|NCT00293059|560807467|FG001|Overall Study|Adverse Event|4|||
155375474|NCT00293059|560807466|FG000|Overall Study|Lack of Efficacy|2|||
155375475|NCT00293059|560807467|FG001|Overall Study|Lack of Efficacy|0|||
155375476|NCT00293059|560807466|FG000|Overall Study|Lost to Follow-up|2|||
155375477|NCT00293059|560807467|FG001|Overall Study|Lost to Follow-up|3|||
155375478|NCT00293059|560807466|FG000|Overall Study|Pregnancy|1|||
155375479|NCT00293059|560807467|FG001|Overall Study|Pregnancy|1|||
155375480|NCT00293059|560807466|FG000|Overall Study|Protocol Violation|2|||
155375481|NCT00293059|560807467|FG001|Overall Study|Protocol Violation|0|||
155375482|NCT00293059|560807466|FG000|Overall Study|Withdrawal by Subject|11|||
155375483|NCT00293059|560807467|FG001|Overall Study|Withdrawal by Subject|5|||
155375484|NCT00293059|560807466|FG000|Overall Study|Participant moved out of state|1|||
155375485|NCT00293059|560807467|FG001|Overall Study|Participant moved out of state|0|||
155375486|NCT00293059|560807466|FG000|Overall Study|Participant stopped study drug|1|||
155375487|NCT00293059|560807467|FG001|Overall Study|Participant stopped study drug|0|||
155375488|NCT00293059|560807466|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
155375489|NCT00293059|560807467|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
155375490|NCT00293059|560807466|FG000|Overall Study|missing|3|||
155375491|NCT00293059|560807467|FG001|Overall Study|missing|5|||
155375492|NCT02297139|560807470|FG000|Overall Study|Disease progression|0|||
155375493|NCT02297139|560807471|FG001|Overall Study|Disease progression|1|||
155375494|NCT02297139|560807470|FG000|Overall Study|Study drug toxicity|0|||
155375495|NCT02297139|560807471|FG001|Overall Study|Study drug toxicity|4|||
155375496|NCT02297139|560807470|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155375497|NCT02297139|560807471|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155375498|NCT02297139|560807470|FG000|Overall Study|Maximum clinical benefit|1|||
155375499|NCT02297139|560807471|FG001|Overall Study|Maximum clinical benefit|0|||
155375500|NCT02297139|560807470|FG000|Overall Study|Administrative reason by sponsor|0|||
155375501|NCT02297139|560807471|FG001|Overall Study|Administrative reason by sponsor|2|||
155375502|NCT02297139|560807470|FG000|Overall Study|Other reasons|0|||
155375503|NCT02297139|560807471|FG001|Overall Study|Other reasons|8|||
155375504|NCT05051462|560807477|FG000|Overall Study|Lost to Follow-up|1|||
155375505|NCT05051462|560807478|FG001|Overall Study|Lost to Follow-up|8|||
155375506|NCT05051462|560807477|FG000|Overall Study|Withdrawal by Subject|1|||
155375507|NCT05051462|560807478|FG001|Overall Study|Withdrawal by Subject|0|||
155375508|NCT05051462|560807477|FG000|Overall Study|Protocol Violation|0|||
155375509|NCT05051462|560807478|FG001|Overall Study|Protocol Violation|2|||
155375510|NCT05597787|560807479|FG000|Overall Study|Withdrawal by Subject|0|||
155375511|NCT05597787|560807480|FG001|Overall Study|Withdrawal by Subject|0|||
155375512|NCT05597787|560807481|FG002|Overall Study|Withdrawal by Subject|1|||
155375513|NCT01241604|560807482|FG000|Screening Period|Screen Failure|3|||
155375514|NCT01241604|560807483|FG001|Screening Period|Screen Failure|0|||
155375515|NCT01241604|560807484|FG002|Screening Period|Screen Failure|0|||
155375516|NCT01593787|560807485|FG000|Overall Study|Adverse Event|1|||
155375517|NCT01593787|560807486|FG001|Overall Study|Adverse Event|0|||
155375518|NCT01593787|560807487|FG002|Overall Study|Adverse Event|0|||
155375519|NCT01133418|560807490|FG000|Overall Study|Lost to Follow-up|5|||
155375520|NCT01133418|560807491|FG001|Overall Study|Lost to Follow-up|6|||
155375521|NCT04150068|560807497|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
155375522|NCT04150068|560807498|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
155375523|NCT04150068|560807499|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
155375524|NCT04150068|560807497|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
155375525|NCT04150068|560807498|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
155375526|NCT04150068|560807499|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
155649719|NCT02487199|561808386|FG000|Overall Study|Withdrew Consent|0|||
155649720|NCT02487199|561808387|FG001|Overall Study|Withdrew Consent|1|||
155649721|NCT00394472|561810118|FG000|Overall Study|Protocol Violation|1|||
155649722|NCT00394472|561810119|FG001|Overall Study|Protocol Violation|3|||
155649723|NCT00394472|561810118|FG000|Overall Study|incorrect enrolment|4|||
155649724|NCT00394472|561810119|FG001|Overall Study|incorrect enrolment|2|||
155649725|NCT00394472|561810118|FG000|Overall Study|Adverse Event|4|||
155375527|NCT05316701|560807500|FG000|Overall Study|Adverse Event|0|||
155375528|NCT05316701|560807501|FG001|Overall Study|Adverse Event|1|||
155375529|NCT05316701|560807500|FG000|Overall Study|Death|3|||
155375530|NCT05316701|560807501|FG001|Overall Study|Death|9|||
155375531|NCT05316701|560807500|FG000|Overall Study|Lost to Follow-up|1|||
155375532|NCT05316701|560807501|FG001|Overall Study|Lost to Follow-up|0|||
155375533|NCT05316701|560807500|FG000|Overall Study|Physician Decision|1|||
155375534|NCT05316701|560807501|FG001|Overall Study|Physician Decision|4|||
155375535|NCT05316701|560807500|FG000|Overall Study|Withdrawal by Subject|3|||
155375536|NCT05316701|560807501|FG001|Overall Study|Withdrawal by Subject|5|||
155375537|NCT05316701|560807500|FG000|Overall Study|Progression/Relapse|14|||
155375538|NCT05316701|560807501|FG001|Overall Study|Progression/Relapse|9|||
155375539|NCT05316701|560807500|FG000|Overall Study|Received Standard of Care|1|||
155649726|NCT00394472|561810119|FG001|Overall Study|Adverse Event|2|||
155375540|NCT05316701|560807501|FG001|Overall Study|Received Standard of Care|0|||
155375541|NCT05316701|560807500|FG000|Overall Study|Ongoing|70|||
155375542|NCT05316701|560807501|FG001|Overall Study|Ongoing|64|||
155375543|NCT01946529|560807502|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
155375544|NCT01946529|560807503|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
155375545|NCT01946529|560807504|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
155375546|NCT01946529|560807502|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
155375547|NCT01946529|560807503|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
155375548|NCT01946529|560807504|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
155375549|NCT04679935|560807505|FG000|Overall Study|Death|0|||
155375550|NCT04679935|560807506|FG001|Overall Study|Death|1|||
155375551|NCT04362189|560807507|FG000|Overall Study|Lost to Follow-up|0|||
155375552|NCT04362189|560807508|FG001|Overall Study|Lost to Follow-up|1|||
155375553|NCT04362189|560807507|FG000|Overall Study|Withdrawal by Subject|1|||
155375554|NCT04362189|560807508|FG001|Overall Study|Withdrawal by Subject|0|||
155375555|NCT04362189|560807507|FG000|Overall Study|FDA Clinical Hold|7|||
155375556|NCT04362189|560807508|FG001|Overall Study|FDA Clinical Hold|2|||
155375557|NCT04362189|560807507|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
155375558|NCT04362189|560807508|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
155375559|NCT04362189|560807507|FG000|Overall Study|Adverse Event|0|||
155375560|NCT04362189|560807508|FG001|Overall Study|Adverse Event|2|||
155375561|NCT04362189|560807507|FG000|Overall Study|Death|4|||
155375562|NCT04362189|560807508|FG001|Overall Study|Death|1|||
155375563|NCT02111681|560807509|FG000|Overall Study|Death|5|||
155375564|NCT02111681|560807509|FG000|Overall Study|Lack of Efficacy|2|||
155375565|NCT02111681|560807509|FG000|Overall Study|Progression of disease|4|||
155375566|NCT00923260|560809126|FG000|Overall Study|Lost to Follow-up|1|||
155375567|NCT00923260|560809127|FG001|Overall Study|Lost to Follow-up|1|||
155375568|NCT03241927|560809128|FG000|Overall Study|study terminated|1|||
155375569|NCT03241927|560809129|FG001|Overall Study|study terminated|0|||
155375570|NCT01850446|560809130|FG000|Overall Study|Lack of Efficacy|1|||
155375571|NCT01850446|560809131|FG001|Overall Study|Lack of Efficacy|0|||
155375572|NCT01850446|560809130|FG000|Overall Study|Withdrawal by Subject|4|||
155375573|NCT01850446|560809131|FG001|Overall Study|Withdrawal by Subject|0|||
155375574|NCT01850446|560809130|FG000|Overall Study|Protocol Violation|0|||
155375575|NCT01850446|560809131|FG001|Overall Study|Protocol Violation|2|||
155375576|NCT00591721|560809132|FG000|Overall Study|Withdrawal by Subject|10|||
155375577|NCT00591721|560809133|FG001|Overall Study|Withdrawal by Subject|10|||
155375578|NCT00591721|560809132|FG000|Overall Study|Lost to Follow-up|1|||
155375579|NCT00591721|560809133|FG001|Overall Study|Lost to Follow-up|4|||
155375580|NCT00591721|560809132|FG000|Overall Study|Intervention not received|10|||
155649727|NCT00394472|561810118|FG000|Overall Study|Withdrawal by Subject|0|||
155375581|NCT00591721|560809133|FG001|Overall Study|Intervention not received|8|||
155375582|NCT03507777|560809134|FG000|Overall Study|Lost to Follow-up|5|||
155375583|NCT03507777|560809135|FG001|Overall Study|Lost to Follow-up|7|||
155375584|NCT03507777|560809134|FG000|Overall Study|Withdrawal by Subject|6|||
155375585|NCT03507777|560809135|FG001|Overall Study|Withdrawal by Subject|11|||
155375586|NCT03507777|560809134|FG000|Overall Study|Death|30|||
155375587|NCT03507777|560809135|FG001|Overall Study|Death|44|||
155375588|NCT03507777|560809134|FG000|Overall Study|Other Reasons|3|||
155375589|NCT03507777|560809135|FG001|Overall Study|Other Reasons|8|||
155375590|NCT01879722|560809136|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155375591|NCT01879722|560809137|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155375592|NCT01879722|560809138|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155375593|NCT01879722|560809139|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155375594|NCT01879722|560809140|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
155375595|NCT01879722|560809141|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155375596|NCT01879722|560809142|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
155375597|NCT01879722|560809143|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
155375598|NCT01879722|560809144|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
155375599|NCT01879722|560809145|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
155375600|NCT01879722|560809136|FG000|Overall Study|Voluntary Withdrawal|0|||
155375601|NCT01879722|560809137|FG001|Overall Study|Voluntary Withdrawal|0|||
155375602|NCT01879722|560809138|FG002|Overall Study|Voluntary Withdrawal|0|||
155375603|NCT01879722|560809139|FG003|Overall Study|Voluntary Withdrawal|0|||
155375604|NCT01879722|560809140|FG004|Overall Study|Voluntary Withdrawal|0|||
155375605|NCT01879722|560809141|FG005|Overall Study|Voluntary Withdrawal|0|||
155375606|NCT01879722|560809142|FG006|Overall Study|Voluntary Withdrawal|0|||
155375607|NCT01879722|560809143|FG007|Overall Study|Voluntary Withdrawal|0|||
155375608|NCT01879722|560809144|FG008|Overall Study|Voluntary Withdrawal|1|||
155375609|NCT01879722|560809145|FG009|Overall Study|Voluntary Withdrawal|0|||
155375610|NCT00774930|560809153|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
155375611|NCT00774930|560809154|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
155375612|NCT00774930|560809153|FG000|DB Phase|Adverse Event|1|||
155375613|NCT00774930|560809154|FG001|DB Phase|Adverse Event|2|||
155375614|NCT00774930|560809153|FG000|DB Phase|Subject Decision|1|||
155375615|NCT00774930|560809154|FG001|DB Phase|Subject Decision|5|||
155375616|NCT00774930|560809153|FG000|DB Phase|Sponsor Decision|0|||
155375617|NCT00774930|560809154|FG001|DB Phase|Sponsor Decision|1|||
155375618|NCT00774930|560809153|FG000|DB Phase|Disease Progression|1|||
155375619|NCT00774930|560809154|FG001|DB Phase|Disease Progression|1|||
155375620|NCT00774930|560809153|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
155375621|NCT00774930|560809154|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
155375622|NCT00774930|560809153|FG000|IOL Phase|Adverse Event|1|||
155375623|NCT00774930|560809154|FG001|IOL Phase|Adverse Event|1|||
155375624|NCT00774930|560809153|FG000|IOL Phase|Subject Decision|4|||
155375625|NCT00774930|560809154|FG001|IOL Phase|Subject Decision|3|||
155375626|NCT00774930|560809153|FG000|IOL Phase|Physician Decision|3|||
155511947|NCT03558997|561299417|FG000|Overall Study|Adverse Event|0|||
155511948|NCT03558997|561299418|FG001|Overall Study|Adverse Event|2|||
155511949|NCT03558997|561299419|FG002|Overall Study|Adverse Event|5|||
155511950|NCT03558997|561299420|FG003|Overall Study|Adverse Event|1|||
155511951|NCT03558997|561299417|FG000|Overall Study|Physician Decision|0|||
155511952|NCT03558997|561299418|FG001|Overall Study|Physician Decision|0|||
155511953|NCT03558997|561299419|FG002|Overall Study|Physician Decision|1|||
155511954|NCT03558997|561299420|FG003|Overall Study|Physician Decision|0|||
155511955|NCT03558997|561299417|FG000|Overall Study|Withdrawal by Subject|1|||
155511956|NCT03558997|561299418|FG001|Overall Study|Withdrawal by Subject|0|||
155511957|NCT03558997|561299419|FG002|Overall Study|Withdrawal by Subject|1|||
155511958|NCT03558997|561299420|FG003|Overall Study|Withdrawal by Subject|1|||
155511959|NCT03558997|561299417|FG000|Overall Study|Lost to Follow-up|0|||
155511960|NCT03558997|561299418|FG001|Overall Study|Lost to Follow-up|0|||
155649728|NCT00394472|561810119|FG001|Overall Study|Withdrawal by Subject|2|||
155649729|NCT00394472|561810118|FG000|Overall Study|Physician Decision|0|||
155649730|NCT00394472|561810119|FG001|Overall Study|Physician Decision|1|||
155375627|NCT00774930|560809154|FG001|IOL Phase|Physician Decision|2|||
155511961|NCT03558997|561299419|FG002|Overall Study|Lost to Follow-up|1|||
155375628|NCT00774930|560809153|FG000|IOL Phase|Sponsor Decision|1|||
155375629|NCT00774930|560809154|FG001|IOL Phase|Sponsor Decision|0|||
155375630|NCT00774930|560809153|FG000|IOL Phase|Disease Progression|2|||
155375631|NCT00774930|560809154|FG001|IOL Phase|Disease Progression|1|||
155375632|NCT00774930|560809153|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
155375633|NCT00774930|560809154|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
155375634|NCT00774930|560809153|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
155375635|NCT00774930|560809154|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
155375636|NCT00774930|560809153|FG000|IOL Phase|Other|1|||
155511962|NCT03558997|561299420|FG003|Overall Study|Lost to Follow-up|0|||
155511963|NCT00616928|561299421|FG000|Overall Study|Adverse Event|6|||
155649731|NCT00394472|561810118|FG000|Overall Study|Lost to Follow-up|0|||
155375637|NCT00774930|560809154|FG001|IOL Phase|Other|0|||
155375638|NCT00774930|560809153|FG000|IOL Phase|Brain radiation|0|||
155375639|NCT00774930|560809154|FG001|IOL Phase|Brain radiation|1|||
155375640|NCT00774930|560809153|FG000|LTOLE Phase|Adverse Event|7|||
155375641|NCT00774930|560809154|FG001|LTOLE Phase|Adverse Event|3|||
155375642|NCT00774930|560809153|FG000|LTOLE Phase|Subject decision|0|||
155375643|NCT00774930|560809154|FG001|LTOLE Phase|Subject decision|5|||
155375644|NCT00774930|560809153|FG000|LTOLE Phase|Physician Decision|4|||
155375645|NCT00774930|560809154|FG001|LTOLE Phase|Physician Decision|1|||
155375646|NCT00774930|560809153|FG000|LTOLE Phase|Sponsor decision|2|||
155375647|NCT00774930|560809154|FG001|LTOLE Phase|Sponsor decision|1|||
155375648|NCT00774930|560809153|FG000|LTOLE Phase|Disease Progression|2|||
155375649|NCT00774930|560809154|FG001|LTOLE Phase|Disease Progression|5|||
155375650|NCT00774930|560809153|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
155375651|NCT00774930|560809154|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
155375652|NCT00774930|560809153|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
155375653|NCT00774930|560809154|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
155375654|NCT01153321|560809155|FG000|Overall Study|Development of study withdrawal criteria|0|||
155375655|NCT01153321|560809156|FG001|Overall Study|Development of study withdrawal criteria|1|||
155375656|NCT01153321|560809155|FG000|Overall Study|Withdrawal by Subject|0|||
155375657|NCT01153321|560809156|FG001|Overall Study|Withdrawal by Subject|1|||
155375658|NCT01153321|560809155|FG000|Overall Study|Adverse Event|1|||
155375659|NCT01153321|560809156|FG001|Overall Study|Adverse Event|1|||
155375660|NCT04032613|560809157|FG000|Overall Study|Did not complete post-program assessment|5|||
155375661|NCT04032613|560809158|FG001|Overall Study|Did not complete post-program assessment|2|||
155375662|NCT00424385|560809159|FG000|Cohort 0|Withdrawal by Subject|5|||
155375663|NCT00424385|560809159|FG000|Cohort 0|Physician Decision|1|||
155375664|NCT00424385|560809159|FG000|Cohort 1|Withdrawal by Subject|1|||
155375665|NCT00964886|560809164|FG000|Overall Study|Lost to Follow-up|2|||
155375666|NCT00964886|560809165|FG001|Overall Study|Lost to Follow-up|2|||
155375667|NCT00964886|560809166|FG002|Overall Study|Lost to Follow-up|6|||
155375668|NCT00964886|560809167|FG003|Overall Study|Lost to Follow-up|4|||
155375669|NCT00964886|560809164|FG000|Overall Study|Withdrawal by Subject|6|||
155375670|NCT00964886|560809165|FG001|Overall Study|Withdrawal by Subject|2|||
155375671|NCT00964886|560809166|FG002|Overall Study|Withdrawal by Subject|5|||
155375672|NCT00964886|560809167|FG003|Overall Study|Withdrawal by Subject|3|||
155375673|NCT00964886|560809164|FG000|Overall Study|Adverse Event|3|||
155375674|NCT00964886|560809165|FG001|Overall Study|Adverse Event|1|||
155375675|NCT00964886|560809166|FG002|Overall Study|Adverse Event|5|||
155375676|NCT00964886|560809167|FG003|Overall Study|Adverse Event|2|||
155375677|NCT00964886|560809164|FG000|Overall Study|Protocol Violation|0|||
155375678|NCT00964886|560809165|FG001|Overall Study|Protocol Violation|2|||
155375679|NCT00964886|560809166|FG002|Overall Study|Protocol Violation|0|||
155375680|NCT00964886|560809167|FG003|Overall Study|Protocol Violation|0|||
155375681|NCT05870228|560809169|FG000|Overall Study|Lost to Follow-up|2|||
155375682|NCT05870228|560809170|FG001|Overall Study|Lost to Follow-up|0|||
155375683|NCT05870228|560809169|FG000|Overall Study|Withdrawal by Subject|1|||
155375684|NCT05870228|560809170|FG001|Overall Study|Withdrawal by Subject|0|||
155375685|NCT04075994|560809172|FG000|Overall Study|Withdrawal by Subject|8|||
155375686|NCT04075994|560809173|FG001|Overall Study|Withdrawal by Subject|9|||
155375687|NCT04075994|560809172|FG000|Overall Study|Adverse Event|2|||
155375688|NCT04075994|560809173|FG001|Overall Study|Adverse Event|2|||
155375689|NCT04075994|560809172|FG000|Overall Study|Investigator withdrew|3|||
155375690|NCT04075994|560809173|FG001|Overall Study|Investigator withdrew|1|||
155375691|NCT00252577|560809178|FG000|Overall Study|Lost to Follow-up|20|||
155375692|NCT01125514|560809180|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
155375693|NCT01125514|560809180|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
155375694|NCT01125514|560809180|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
155375695|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
155375696|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
155375697|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
155375698|NCT01655693|560809181|FG000|Overall Study|Progression of Disease|92|||
155375699|NCT01655693|560809182|FG001|Overall Study|Progression of Disease|76|||
155375700|NCT01655693|560809183|FG002|Overall Study|Progression of Disease|58|||
155375701|NCT01655693|560809181|FG000|Overall Study|Death|8|||
155375702|NCT01655693|560809182|FG001|Overall Study|Death|9|||
155375703|NCT01655693|560809183|FG002|Overall Study|Death|12|||
155375704|NCT01655693|560809181|FG000|Overall Study|Serious Adverse Event|3|||
155375705|NCT01655693|560809182|FG001|Overall Study|Serious Adverse Event|15|||
155375706|NCT01655693|560809183|FG002|Overall Study|Serious Adverse Event|11|||
155375707|NCT01655693|560809181|FG000|Overall Study|Withdrawal by Subject|3|||
155375708|NCT01655693|560809182|FG001|Overall Study|Withdrawal by Subject|2|||
155375709|NCT01655693|560809183|FG002|Overall Study|Withdrawal by Subject|20|||
155375710|NCT01655693|560809181|FG000|Overall Study|Adverse Event|3|||
155375711|NCT01655693|560809182|FG001|Overall Study|Adverse Event|11|||
155375712|NCT01655693|560809183|FG002|Overall Study|Adverse Event|3|||
155375713|NCT01655693|560809181|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
155375714|NCT01655693|560809182|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
155375715|NCT01655693|560809183|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
155375716|NCT01655693|560809181|FG000|Overall Study|Non-Compliance|0|||
155375717|NCT01655693|560809182|FG001|Overall Study|Non-Compliance|0|||
155375718|NCT01655693|560809183|FG002|Overall Study|Non-Compliance|7|||
155375719|NCT01655693|560809181|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
155375720|NCT01655693|560809182|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
155375721|NCT01655693|560809183|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
155375722|NCT01655693|560809181|FG000|Overall Study|Protocol Violation|1|||
155375723|NCT01655693|560809182|FG001|Overall Study|Protocol Violation|0|||
155375724|NCT01655693|560809183|FG002|Overall Study|Protocol Violation|3|||
155375725|NCT01655693|560809181|FG000|Overall Study|Lost to Follow-up|1|||
155375726|NCT01655693|560809182|FG001|Overall Study|Lost to Follow-up|0|||
155375727|NCT01655693|560809183|FG002|Overall Study|Lost to Follow-up|1|||
155375728|NCT01655693|560809181|FG000|Overall Study|Screening Failure|1|||
155375729|NCT01655693|560809182|FG001|Overall Study|Screening Failure|0|||
155375730|NCT01655693|560809183|FG002|Overall Study|Screening Failure|0|||
155375731|NCT01655693|560809181|FG000|Overall Study|Other|8|||
155375732|NCT01655693|560809182|FG001|Overall Study|Other|6|||
155375733|NCT01655693|560809183|FG002|Overall Study|Other|15|||
155375734|NCT00929110|560809186|FG000|Overall Study|Adverse Event|40|||
155375735|NCT00929110|560809187|FG001|Overall Study|Adverse Event|29|||
155375736|NCT00929110|560809188|FG002|Overall Study|Adverse Event|18|||
155375737|NCT00929110|560809186|FG000|Overall Study|Subject withdrew consent|40|||
155375738|NCT00929110|560809187|FG001|Overall Study|Subject withdrew consent|23|||
155375739|NCT00929110|560809188|FG002|Overall Study|Subject withdrew consent|26|||
155375740|NCT00929110|560809186|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
155375741|NCT00929110|560809187|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
155375742|NCT00929110|560809188|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155375743|NCT00929110|560809186|FG000|Overall Study|Lost to Follow-up|7|||
155375744|NCT00929110|560809187|FG001|Overall Study|Lost to Follow-up|7|||
155375745|NCT00929110|560809188|FG002|Overall Study|Lost to Follow-up|3|||
155375746|NCT00929110|560809186|FG000|Overall Study|Protocol deviation|5|||
155375747|NCT00929110|560809187|FG001|Overall Study|Protocol deviation|2|||
155375748|NCT00929110|560809188|FG002|Overall Study|Protocol deviation|4|||
155375749|NCT00929110|560809186|FG000|Overall Study|Administrative problems|4|||
155375750|NCT00929110|560809187|FG001|Overall Study|Administrative problems|1|||
155375751|NCT00929110|560809188|FG002|Overall Study|Administrative problems|2|||
155375752|NCT00929110|560809186|FG000|Overall Study|Death|2|||
155375753|NCT00929110|560809187|FG001|Overall Study|Death|2|||
155375754|NCT00929110|560809188|FG002|Overall Study|Death|2|||
155375755|NCT00929110|560809186|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155375756|NCT00929110|560809187|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155375757|NCT00929110|560809188|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155375758|NCT00929110|560809186|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155375759|NCT00929110|560809187|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155375760|NCT00929110|560809188|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155375761|NCT00929110|560809186|FG000|Overall Study|Patient inability to use the device|0|||
155511964|NCT00616928|561299422|FG001|Overall Study|Adverse Event|3|||
155511965|NCT00616928|561299423|FG002|Overall Study|Adverse Event|2|||
155511966|NCT00616928|561299424|FG003|Overall Study|Adverse Event|2|||
155511967|NCT00616928|561299421|FG000|Overall Study|Other|51|||
155511968|NCT00616928|561299422|FG001|Overall Study|Other|8|||
155511969|NCT00616928|561299423|FG002|Overall Study|Other|15|||
155511970|NCT00616928|561299424|FG003|Overall Study|Other|5|||
155511971|NCT00616928|561299421|FG000|Overall Study|Lost to Follow-up|5|||
155511972|NCT00616928|561299422|FG001|Overall Study|Lost to Follow-up|7|||
155375762|NCT00929110|560809187|FG001|Overall Study|Patient inability to use the device|1|||
155375763|NCT00929110|560809188|FG002|Overall Study|Patient inability to use the device|0|||
155375764|NCT01163292|560809192|FG000|Overall Study|Lack of Efficacy|9|||
155375765|NCT01163292|560809193|FG001|Overall Study|Lack of Efficacy|0|||
155375766|NCT01163292|560809192|FG000|Overall Study|Adverse Event|6|||
155375767|NCT01163292|560809193|FG001|Overall Study|Adverse Event|0|||
155375768|NCT01163292|560809192|FG000|Overall Study|Initiation of biological therapy|0|||
155375769|NCT01163292|560809193|FG001|Overall Study|Initiation of biological therapy|15|||
155375770|NCT01163292|560809192|FG000|Overall Study|Sufficient response to adalimumab|8|||
155375771|NCT01163292|560809193|FG001|Overall Study|Sufficient response to adalimumab|0|||
155511973|NCT00616928|561299423|FG002|Overall Study|Lost to Follow-up|0|||
155511974|NCT00616928|561299424|FG003|Overall Study|Lost to Follow-up|0|||
155375772|NCT01163292|560809192|FG000|Overall Study|Refusal to receive adalimumab|7|||
155375773|NCT01163292|560809193|FG001|Overall Study|Refusal to receive adalimumab|0|||
155375774|NCT01163292|560809192|FG000|Overall Study|Economic reasons|6|||
155375775|NCT01163292|560809193|FG001|Overall Study|Economic reasons|0|||
155375776|NCT01163292|560809192|FG000|Overall Study|No further visits|5|||
155375777|NCT01163292|560809193|FG001|Overall Study|No further visits|7|||
155375778|NCT02643472|560809194|FG000|Overall Study|Death|2|||
155375779|NCT02643472|560809195|FG001|Overall Study|Death|5|||
155375780|NCT02643472|560809194|FG000|Overall Study|Withdrawal by Subject|3|||
155375781|NCT02643472|560809195|FG001|Overall Study|Withdrawal by Subject|2|||
155375782|NCT02643472|560809194|FG000|Overall Study|Protocol Violation|0|||
155375783|NCT02643472|560809195|FG001|Overall Study|Protocol Violation|1|||
155375784|NCT02643472|560809194|FG000|Overall Study|Lost to Follow-up|22|||
155375785|NCT02643472|560809195|FG001|Overall Study|Lost to Follow-up|26|||
155375786|NCT01258595|560809196|FG000|Overall Study|Lost to Follow-up|1|||
155375787|NCT01258595|560809197|FG001|Overall Study|Lost to Follow-up|0|||
155375788|NCT01258595|560809196|FG000|Overall Study|Withdrawal by Subject|0|||
155375789|NCT01258595|560809197|FG001|Overall Study|Withdrawal by Subject|1|||
155375790|NCT01215188|560809198|FG000|Overall Study|Lost to Follow-up|22|||
155375791|NCT01215188|560809199|FG001|Overall Study|Lost to Follow-up|22|||
155375792|NCT01215188|560809200|FG002|Overall Study|Lost to Follow-up|16|||
155375793|NCT01215188|560809198|FG000|Overall Study|Adverse Event|1|||
155375794|NCT01215188|560809199|FG001|Overall Study|Adverse Event|1|||
155375795|NCT01215188|560809200|FG002|Overall Study|Adverse Event|3|||
155375796|NCT01215188|560809198|FG000|Overall Study|Physician Decision|2|||
155375797|NCT01215188|560809199|FG001|Overall Study|Physician Decision|1|||
155375798|NCT01215188|560809200|FG002|Overall Study|Physician Decision|0|||
155375799|NCT01215188|560809198|FG000|Overall Study|Lack of Efficacy|0|||
155375800|NCT01215188|560809199|FG001|Overall Study|Lack of Efficacy|0|||
155375801|NCT01215188|560809200|FG002|Overall Study|Lack of Efficacy|1|||
155375802|NCT01215188|560809198|FG000|Overall Study|Protocol Violation|1|||
155375803|NCT01215188|560809199|FG001|Overall Study|Protocol Violation|1|||
155375804|NCT01215188|560809200|FG002|Overall Study|Protocol Violation|1|||
155375805|NCT01215188|560809198|FG000|Overall Study|Withdrawal by Subject|32|||
155375806|NCT01215188|560809199|FG001|Overall Study|Withdrawal by Subject|34|||
155375807|NCT01215188|560809200|FG002|Overall Study|Withdrawal by Subject|31|||
155375808|NCT01012414|560809201|FG000|Overall Study|Withdrawal by Subject|2|||
155375809|NCT01012414|560809201|FG000|Overall Study|Lost to Follow-up|1|||
155375810|NCT01012414|560809201|FG000|Overall Study|Trial was stopped before completed|7|||
155375811|NCT02601300|560809202|FG000|Induction Phase|Lack of Efficacy|2|||
155375812|NCT02601300|560809202|FG000|Induction Phase|Protocol Violation|1|||
155375813|NCT02601300|560809202|FG000|Extension Phase|Withdrawal by Subject|3|||
155375814|NCT02601300|560809202|FG000|Extension Phase|Adverse Event|4|||
155375815|NCT02601300|560809202|FG000|Extension Phase|Lack of Efficacy|10|||
155375816|NCT02310100|560809203|FG000|Overall Study|Physician Decision|3|||
155375817|NCT02310100|560809203|FG000|Overall Study|Withdrawal by Subject|10|||
155375818|NCT02310100|560809203|FG000|Overall Study|Enrollment closure|1|||
155375819|NCT02310100|560809203|FG000|Overall Study|Unapproved ablation operator|1|||
155375820|NCT02310100|560809203|FG000|Overall Study|Visit compliance|1|||
155375821|NCT02310100|560809203|FG000|Overall Study|Lost to Follow-up|2|||
155375822|NCT01127763|560809207|FG000|Overall Study|Adverse Event|2|||
155375823|NCT01127763|560809207|FG000|Overall Study|Withdrawal by Subject|1|||
155375824|NCT01127763|560809207|FG000|Overall Study|Physician Decision|2|||
155375825|NCT00528931|560809208|FG000|Overall Study|Lost to Follow-up|1|||
155431221|NCT02382133|561003591|FG000|Overall Study|Physician Decision|2|||
155431222|NCT02382133|561003591|FG000|Overall Study|arterial catheter loss|4|||
155431223|NCT02382133|561003591|FG000|Overall Study|pressure injury both sites|1|||
155431224|NCT03972488|561003595|FG000|Overall Study|Progressive disease|42|||
155431225|NCT03972488|561003596|FG001|Overall Study|Progressive disease|44|||
155431226|NCT03972488|561003595|FG000|Overall Study|Physician Decision|13|||
155431227|NCT03972488|561003596|FG001|Overall Study|Physician Decision|7|||
155431228|NCT03972488|561003595|FG000|Overall Study|Adverse Event|8|||
155431229|NCT03972488|561003596|FG001|Overall Study|Adverse Event|1|||
155431230|NCT03972488|561003595|FG000|Overall Study|Death|4|||
155375826|NCT03122223|560809213|FG000|Overall Study|Withdrawal by Subject|2|||
155375827|NCT03122223|560809214|FG001|Overall Study|Withdrawal by Subject|2|||
155375828|NCT03122223|560809215|FG002|Overall Study|Withdrawal by Subject|1|||
155375829|NCT03122223|560809216|FG003|Overall Study|Withdrawal by Subject|0|||
155431231|NCT03972488|561003596|FG001|Overall Study|Death|4|||
155431232|NCT03972488|561003595|FG000|Overall Study|Withdrawal by Subject|3|||
155431233|NCT03972488|561003596|FG001|Overall Study|Withdrawal by Subject|4|||
155375830|NCT03122223|560809213|FG000|Overall Study|Lost to Follow-up|0|||
155375831|NCT03122223|560809214|FG001|Overall Study|Lost to Follow-up|2|||
155375832|NCT03122223|560809215|FG002|Overall Study|Lost to Follow-up|2|||
155375833|NCT03122223|560809216|FG003|Overall Study|Lost to Follow-up|0|||
155375834|NCT03122223|560809213|FG000|Overall Study|Participant unable to adhere|1|||
155511975|NCT04535583|561299438|FG000|Overall Study|Lost to Follow-up|1|||
155511976|NCT04535583|561299438|FG000|Overall Study|Physician Decision|1|||
155511977|NCT04535583|561299438|FG000|Overall Study|Withdrawal by Subject|1|||
155511978|NCT01078090|561299439|FG000|Overall Study|Lost to Follow-up|2363|||
155511979|NCT01078090|561299439|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
155511980|NCT01078090|561299439|FG000|Overall Study|Lack of Efficacy|1193|||
155511981|NCT01078090|561299439|FG000|Overall Study|ADR and lack of efficacy|61|||
155511982|NCT01078090|561299439|FG000|Overall Study|Other|523|||
155511983|NCT01748890|561299441|FG000|Overall Study|Insufficient recruitment for analysis|4|||
155375835|NCT03122223|560809214|FG001|Overall Study|Participant unable to adhere|1|||
155375836|NCT03122223|560809215|FG002|Overall Study|Participant unable to adhere|1|||
155375837|NCT03122223|560809216|FG003|Overall Study|Participant unable to adhere|0|||
155375838|NCT01151410|560809219|FG000|Overall Study|Withdrawal by Subject|3|||
155375839|NCT01151410|560809220|FG001|Overall Study|Withdrawal by Subject|5|||
155375840|NCT01151410|560809219|FG000|Overall Study|Lost to Follow-up|3|||
155375841|NCT01151410|560809220|FG001|Overall Study|Lost to Follow-up|4|||
155375842|NCT01151410|560809219|FG000|Overall Study|Adverse Event|1|||
155375843|NCT01151410|560809220|FG001|Overall Study|Adverse Event|2|||
155375844|NCT01151410|560809219|FG000|Overall Study|Protocol deviation|2|||
155375845|NCT01151410|560809220|FG001|Overall Study|Protocol deviation|1|||
155511984|NCT02669264|561299442|FG000|Overall Study|Death|5|||
155511985|NCT02669264|561299443|FG001|Overall Study|Death|5|||
155511986|NCT02669264|561299444|FG002|Overall Study|Death|3|||
155511987|NCT02669264|561299445|FG003|Overall Study|Death|3|||
155511988|NCT02669264|561299446|FG004|Overall Study|Death|3|||
155375846|NCT01151410|560809219|FG000|Overall Study|Administrative problems|1|||
155375847|NCT01151410|560809220|FG001|Overall Study|Administrative problems|1|||
155375848|NCT01151410|560809219|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155375849|NCT01151410|560809220|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155375850|NCT01151410|560809219|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155375851|NCT01151410|560809220|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155375852|NCT01253018|560809221|FG000|Overall Study|Lost to Follow-up|1|||
155375853|NCT01253018|560809222|FG001|Overall Study|Lost to Follow-up|1|||
155375854|NCT01253018|560809221|FG000|Overall Study|Robot Repair Issues|2|||
155375855|NCT01253018|560809222|FG001|Overall Study|Robot Repair Issues|0|||
155375856|NCT01253018|560809221|FG000|Overall Study|Withdrawal by Subject|1|||
155375857|NCT01253018|560809222|FG001|Overall Study|Withdrawal by Subject|1|||
155375858|NCT00291642|560809224|FG000|Overall Study|Adverse Event|1|||
155375859|NCT00291642|560809225|FG001|Overall Study|Adverse Event|0|||
155375860|NCT00291642|560809226|FG002|Overall Study|Adverse Event|1|||
155375861|NCT00291642|560809227|FG003|Overall Study|Adverse Event|0|||
155375862|NCT00291642|560809228|FG004|Overall Study|Adverse Event|1|||
155375863|NCT00291642|560809224|FG000|Overall Study|Patient missed visit|0|||
155375864|NCT00291642|560809225|FG001|Overall Study|Patient missed visit|0|||
155375865|NCT00291642|560809226|FG002|Overall Study|Patient missed visit|1|||
155375866|NCT00291642|560809227|FG003|Overall Study|Patient missed visit|0|||
155375867|NCT00291642|560809228|FG004|Overall Study|Patient missed visit|0|||
155375868|NCT00291642|560809224|FG000|Overall Study|Intake of prohibited medication|1|||
155375869|NCT00291642|560809225|FG001|Overall Study|Intake of prohibited medication|0|||
155375870|NCT00291642|560809226|FG002|Overall Study|Intake of prohibited medication|0|||
155375871|NCT00291642|560809227|FG003|Overall Study|Intake of prohibited medication|0|||
155375872|NCT00291642|560809228|FG004|Overall Study|Intake of prohibited medication|0|||
155375873|NCT01820585|560809229|FG000|Overall Study|Adverse Event|9|||
155375874|NCT01820585|560809230|FG001|Overall Study|Adverse Event|13|||
155431234|NCT03972488|561003595|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
155431235|NCT03972488|561003596|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
155431236|NCT00045032|561003605|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
155431237|NCT00045032|561003606|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
155431238|NCT00045032|561003607|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
155431239|NCT00045032|561003605|FG000|Overall Study|Death|22|||
155431240|NCT00045032|561003606|FG001|Overall Study|Death|24|||
155431241|NCT00045032|561003607|FG002|Overall Study|Death|17|||
155431242|NCT00045032|561003605|FG000|Overall Study|Insufficient Therapeutic Response|542|||
155431243|NCT00045032|561003606|FG001|Overall Study|Insufficient Therapeutic Response|437|||
155431244|NCT00045032|561003607|FG002|Overall Study|Insufficient Therapeutic Response|445|||
155431245|NCT00045032|561003605|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
155431246|NCT00045032|561003606|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
155431247|NCT00045032|561003607|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
155511989|NCT02669264|561299447|FG005|Overall Study|Death|6|||
155511990|NCT02669264|561299448|FG006|Overall Study|Death|3|||
155511991|NCT02669264|561299442|FG000|Overall Study|Withdrawal by Subject|0|||
155649732|NCT00394472|561810119|FG001|Overall Study|Lost to Follow-up|1|||
155375875|NCT01820585|560809231|FG002|Overall Study|Adverse Event|23|||
155375876|NCT01820585|560809232|FG003|Overall Study|Adverse Event|34|||
155375877|NCT01820585|560809229|FG000|Overall Study|Lack of Efficacy|9|||
155375878|NCT01820585|560809230|FG001|Overall Study|Lack of Efficacy|7|||
155375879|NCT01820585|560809231|FG002|Overall Study|Lack of Efficacy|5|||
155375880|NCT01820585|560809232|FG003|Overall Study|Lack of Efficacy|1|||
155375881|NCT01820585|560809229|FG000|Overall Study|Withdrawal by Subject|3|||
155375882|NCT01820585|560809230|FG001|Overall Study|Withdrawal by Subject|7|||
155375883|NCT01820585|560809231|FG002|Overall Study|Withdrawal by Subject|3|||
155375884|NCT01820585|560809232|FG003|Overall Study|Withdrawal by Subject|8|||
155375885|NCT01820585|560809229|FG000|Overall Study|Lost to Follow-up|3|||
155375886|NCT01820585|560809230|FG001|Overall Study|Lost to Follow-up|3|||
155375887|NCT01820585|560809231|FG002|Overall Study|Lost to Follow-up|0|||
155375888|NCT01820585|560809232|FG003|Overall Study|Lost to Follow-up|3|||
155375889|NCT01820585|560809229|FG000|Overall Study|Protocol Violation|3|||
155375890|NCT01820585|560809230|FG001|Overall Study|Protocol Violation|1|||
155375891|NCT01820585|560809231|FG002|Overall Study|Protocol Violation|1|||
155375892|NCT01820585|560809232|FG003|Overall Study|Protocol Violation|1|||
155375893|NCT01820585|560809229|FG000|Overall Study|Subject non-compliance|0|||
155375894|NCT01820585|560809230|FG001|Overall Study|Subject non-compliance|0|||
155375895|NCT01820585|560809231|FG002|Overall Study|Subject non-compliance|1|||
155375896|NCT01820585|560809232|FG003|Overall Study|Subject non-compliance|2|||
155375897|NCT01820585|560809229|FG000|Overall Study|at sponsor request|0|||
155375898|NCT01820585|560809230|FG001|Overall Study|at sponsor request|0|||
155375899|NCT01820585|560809231|FG002|Overall Study|at sponsor request|1|||
155375900|NCT01820585|560809232|FG003|Overall Study|at sponsor request|0|||
155375901|NCT01820585|560809229|FG000|Overall Study|Pregnancy|0|||
155375902|NCT01820585|560809230|FG001|Overall Study|Pregnancy|1|||
155375903|NCT01820585|560809231|FG002|Overall Study|Pregnancy|0|||
155375904|NCT01820585|560809232|FG003|Overall Study|Pregnancy|0|||
155375905|NCT02285153|560809233|FG000|Overall Study|Adverse Event|1|||
155375906|NCT02285153|560809234|FG001|Overall Study|Adverse Event|0|||
155375907|NCT03590366|560809239|FG000|Overall Study|Adverse Event|0|||
155375908|NCT03590366|560809240|FG001|Overall Study|Adverse Event|3|||
155375909|NCT03590366|560809239|FG000|Overall Study|Lost to Follow-up|3|||
155375910|NCT03590366|560809240|FG001|Overall Study|Lost to Follow-up|3|||
155375911|NCT03590366|560809239|FG000|Overall Study|Withdrawal by Subject|0|||
155375912|NCT03590366|560809240|FG001|Overall Study|Withdrawal by Subject|2|||
155375913|NCT01413503|560809244|FG000|Overall Study|Lost to Follow-up|1|||
155375914|NCT02001064|560809246|FG000|Overall Study|Withdrawal by Subject|2|||
155375915|NCT02001064|560809247|FG001|Overall Study|Withdrawal by Subject|1|||
155375916|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155375917|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155375918|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
155375919|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
155375920|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
155375921|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
155375922|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
155375923|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
155375924|NCT00969709|560810864|FG000|Overall Study|Adverse Event|3|||
155375925|NCT00969709|560810865|FG001|Overall Study|Adverse Event|13|||
155375926|NCT00969709|560810866|FG002|Overall Study|Adverse Event|26|||
155375927|NCT00969709|560810867|FG003|Overall Study|Adverse Event|12|||
155375928|NCT00969709|560810864|FG000|Overall Study|Lack of Efficacy|7|||
155375929|NCT00969709|560810865|FG001|Overall Study|Lack of Efficacy|4|||
155375930|NCT00969709|560810866|FG002|Overall Study|Lack of Efficacy|1|||
155375931|NCT00969709|560810867|FG003|Overall Study|Lack of Efficacy|3|||
155375932|NCT00969709|560810864|FG000|Overall Study|Protocol Violation|9|||
155375933|NCT00969709|560810865|FG001|Overall Study|Protocol Violation|5|||
155375934|NCT00969709|560810866|FG002|Overall Study|Protocol Violation|9|||
155375935|NCT00969709|560810867|FG003|Overall Study|Protocol Violation|10|||
155375936|NCT00969709|560810864|FG000|Overall Study|Withdrawal by Subject|9|||
155431248|NCT00045032|561003605|FG000|Overall Study|Other Protocol Violation|2|||
155431249|NCT00045032|561003606|FG001|Overall Study|Other Protocol Violation|0|||
155431250|NCT00045032|561003607|FG002|Overall Study|Other Protocol Violation|1|||
155431251|NCT00045032|561003605|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
155375937|NCT00969709|560810865|FG001|Overall Study|Withdrawal by Subject|12|||
155375938|NCT00969709|560810866|FG002|Overall Study|Withdrawal by Subject|11|||
155375939|NCT00969709|560810867|FG003|Overall Study|Withdrawal by Subject|23|||
155431252|NCT00045032|561003606|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
155375940|NCT00969709|560810864|FG000|Overall Study|Lost to Follow-up|10|||
155375941|NCT00969709|560810865|FG001|Overall Study|Lost to Follow-up|14|||
155375942|NCT00969709|560810866|FG002|Overall Study|Lost to Follow-up|8|||
155375943|NCT00969709|560810867|FG003|Overall Study|Lost to Follow-up|15|||
155375944|NCT00969709|560810864|FG000|Overall Study|Other reasons|0|||
155375945|NCT00969709|560810865|FG001|Overall Study|Other reasons|0|||
155375946|NCT00969709|560810866|FG002|Overall Study|Other reasons|3|||
155375947|NCT00969709|560810867|FG003|Overall Study|Other reasons|0|||
155375948|NCT03695237|560810868|FG000|Overall Study|Withdrawal by Subject|1|||
155375949|NCT03695237|560810869|FG001|Overall Study|Withdrawal by Subject|3|||
155375950|NCT03695237|560810868|FG000|Overall Study|Lost to Follow-up|1|||
155375951|NCT03695237|560810869|FG001|Overall Study|Lost to Follow-up|2|||
155375952|NCT03695237|560810868|FG000|Overall Study|Other, Not Specified|8|||
155375953|NCT03695237|560810869|FG001|Overall Study|Other, Not Specified|2|||
155375954|NCT00055601|560810870|FG000|Overall Study|Protocol Violation|1|||
155375955|NCT00055601|560810871|FG001|Overall Study|Protocol Violation|1|||
155375956|NCT00055601|560810870|FG000|Overall Study|No protocol treatment received|1|||
155375957|NCT00055601|560810871|FG001|Overall Study|No protocol treatment received|1|||
155375958|NCT02217332|560810878|FG000|Overall Study|Adverse Event|3|||
155375959|NCT02217332|560810878|FG000|Overall Study|Dose interruption >1 month|1|||
155375960|NCT02217332|560810878|FG000|Overall Study|Protocol Violation (eligibility)|1|||
155375961|NCT02217332|560810878|FG000|Overall Study|Withdrawal by Subject|1|||
155375962|NCT02217332|560810878|FG000|Overall Study|Lost to Follow-up|1|||
155375963|NCT03725085|560810882|FG000|Overall Study|Lost to Follow-up|2|||
155375964|NCT02704754|560810883|FG000|Overall Study|Lost to Follow-up|1|||
155375965|NCT02704754|560810884|FG001|Overall Study|Lost to Follow-up|1|||
155375966|NCT02704754|560810883|FG000|Overall Study|Lack of Efficacy|1|||
155375967|NCT02704754|560810884|FG001|Overall Study|Lack of Efficacy|0|||
155375968|NCT02704754|560810883|FG000|Overall Study|Withdrawal by Subject|1|||
155375969|NCT02704754|560810884|FG001|Overall Study|Withdrawal by Subject|0|||
155375970|NCT03809429|560810890|FG000|Overall Study|Withdrawal by Subject|7|||
155375971|NCT03809429|560810891|FG001|Overall Study|Withdrawal by Subject|3|||
155431253|NCT00045032|561003607|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
155431254|NCT00045032|561003605|FG000|Overall Study|Failure to Return|57|||
155431255|NCT00045032|561003606|FG001|Overall Study|Failure to Return|62|||
155431256|NCT00045032|561003607|FG002|Overall Study|Failure to Return|61|||
155431257|NCT00045032|561003605|FG000|Overall Study|Other|93|||
155431258|NCT00045032|561003606|FG001|Overall Study|Other|84|||
155431259|NCT00045032|561003607|FG002|Overall Study|Other|105|||
155431260|NCT02582658|561003608|FG000|Overall Study|Failure to Return|10|||
155431261|NCT02582658|561003608|FG000|Overall Study|Insufficient Virological Response|2|||
155431262|NCT02582658|561003608|FG000|Overall Study|Withdrawn Consent|1|||
155431263|NCT02582658|561003608|FG000|Overall Study|Death|1|||
155431264|NCT02582658|561003608|FG000|Overall Study|Not further specified|11|||
155431265|NCT02581995|561003609|FG000|Overall Study|Unspecified other|3|||
155431266|NCT02581995|561003609|FG000|Overall Study|Adverse Event|6|||
155431267|NCT02581995|561003609|FG000|Overall Study|Lost to Follow-up|5|||
155431268|NCT02581995|561003609|FG000|Overall Study|Withdrawal by participant|12|||
155431269|NCT02581995|561003609|FG000|Overall Study|Physician Decision|1|||
155431270|NCT02581995|561003609|FG000|Overall Study|Death|4|||
155431271|NCT03277196|561003611|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
155431272|NCT03277196|561003611|FG000|Overall Study|Lost to Follow-up|3|||
155431273|NCT03277196|561003611|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
155431274|NCT03277196|561003611|FG000|Overall Study|Other|2|||
155431275|NCT06119191|561003612|FG000|Overall Study|Adverse Event|0|||
155431276|NCT06119191|561003613|FG001|Overall Study|Adverse Event|1|||
155431277|NCT06119191|561003612|FG000|Overall Study|Protocol Violation|1|||
155431278|NCT06119191|561003613|FG001|Overall Study|Protocol Violation|0|||
155431279|NCT00374556|561005043|FG000|Overall Study|Lost to Follow-up|1|||
155431280|NCT00374556|561005044|FG001|Overall Study|Lost to Follow-up|0|||
155431281|NCT00374556|561005043|FG000|Overall Study|Removed at baseline due to medical cond|0|||
155431282|NCT00374556|561005044|FG001|Overall Study|Removed at baseline due to medical cond|1|||
155431283|NCT00473694|561005045|FG000|Overall Study|Adverse Event|0|||
155431284|NCT00473694|561005046|FG001|Overall Study|Adverse Event|1|||
155431285|NCT00473694|561005047|FG002|Overall Study|Adverse Event|0|||
155431286|NCT00473694|561005048|FG003|Overall Study|Adverse Event|0|||
155431287|NCT00473694|561005045|FG000|Overall Study|Participants did not receive treatment|11|||
155431288|NCT00473694|561005046|FG001|Overall Study|Participants did not receive treatment|3|||
155431289|NCT00473694|561005047|FG002|Overall Study|Participants did not receive treatment|5|||
155431290|NCT00473694|561005048|FG003|Overall Study|Participants did not receive treatment|6|||
155431291|NCT00473694|561005045|FG000|Overall Study|Lost to Follow-up|0|||
155431292|NCT00473694|561005046|FG001|Overall Study|Lost to Follow-up|0|||
155431293|NCT00473694|561005047|FG002|Overall Study|Lost to Follow-up|0|||
155375972|NCT03809429|560810890|FG000|Overall Study|Adverse Event|6|||
155375973|NCT03809429|560810891|FG001|Overall Study|Adverse Event|9|||
155431294|NCT00473694|561005048|FG003|Overall Study|Lost to Follow-up|1|||
155431295|NCT03874234|561005051|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431296|NCT03874234|561005052|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431297|NCT03874234|561005053|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431298|NCT03874234|561005054|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
155431299|NCT03874234|561005055|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155375974|NCT03809429|560810890|FG000|Overall Study|COVID-19|3|||
155431300|NCT03874234|561005056|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155649733|NCT01654250|561810120|FG000|Overall Study|Lost to Follow-up|1|||
155375975|NCT03809429|560810891|FG001|Overall Study|COVID-19|1|||
155375976|NCT03809429|560810890|FG000|Overall Study|Participant was discontinued by investigator|12|||
155375977|NCT03809429|560810891|FG001|Overall Study|Participant was discontinued by investigator|7|||
155375978|NCT02245737|560810895|FG000|Overall Study|Adverse Event|23|||
155375979|NCT02245737|560810896|FG001|Overall Study|Adverse Event|26|||
155375980|NCT02245737|560810897|FG002|Overall Study|Adverse Event|33|||
155375981|NCT02245737|560810895|FG000|Overall Study|Condition Worsened|9|||
155375982|NCT02245737|560810896|FG001|Overall Study|Condition Worsened|10|||
155375983|NCT02245737|560810897|FG002|Overall Study|Condition Worsened|9|||
155375984|NCT02245737|560810895|FG000|Overall Study|Death|2|||
155375985|NCT02245737|560810896|FG001|Overall Study|Death|4|||
155375986|NCT02245737|560810897|FG002|Overall Study|Death|4|||
155375987|NCT02245737|560810895|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
155375988|NCT02245737|560810896|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
155375989|NCT02245737|560810897|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
155375990|NCT02245737|560810895|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
155375991|NCT02245737|560810896|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
155375992|NCT02245737|560810897|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
155375993|NCT02245737|560810895|FG000|Overall Study|Lost to Follow-up|2|||
155375994|NCT02245737|560810896|FG001|Overall Study|Lost to Follow-up|5|||
155375995|NCT02245737|560810897|FG002|Overall Study|Lost to Follow-up|4|||
155375996|NCT02245737|560810895|FG000|Overall Study|Other-determined by Investigator|9|||
155375997|NCT02245737|560810896|FG001|Overall Study|Other-determined by Investigator|10|||
155375998|NCT02245737|560810897|FG002|Overall Study|Other-determined by Investigator|10|||
155375999|NCT02245737|560810895|FG000|Overall Study|Physician Decision|6|||
155376000|NCT02245737|560810896|FG001|Overall Study|Physician Decision|3|||
155376001|NCT02245737|560810897|FG002|Overall Study|Physician Decision|6|||
155376002|NCT02245737|560810895|FG000|Overall Study|Protocol Violation|3|||
155376003|NCT02245737|560810896|FG001|Overall Study|Protocol Violation|2|||
155376004|NCT02245737|560810897|FG002|Overall Study|Protocol Violation|3|||
155376005|NCT02245737|560810895|FG000|Overall Study|Withdrawal by Subject|40|||
155376006|NCT02245737|560810896|FG001|Overall Study|Withdrawal by Subject|41|||
155376007|NCT02245737|560810897|FG002|Overall Study|Withdrawal by Subject|44|||
155376008|NCT02245737|560810895|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
155376009|NCT02245737|560810896|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
155376010|NCT02245737|560810897|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
155376011|NCT02245737|560810895|FG000|Overall Study|Sponsor Decision|445|||
155376012|NCT02245737|560810896|FG001|Overall Study|Sponsor Decision|430|||
155376013|NCT02245737|560810897|FG002|Overall Study|Sponsor Decision|432|||
155376014|NCT00836745|560810901|FG000|Overall Study|Death|2|||
155376015|NCT00836745|560810901|FG000|Overall Study|Lost to Follow-up|10|||
155376016|NCT00836745|560810901|FG000|Overall Study|Adverse Event|3|||
155376017|NCT00836745|560810901|FG000|Overall Study|Objective progression or relapse|4|||
155376018|NCT00836745|560810901|FG000|Overall Study|Other|2|||
155376019|NCT02366468|560810903|FG000|Overall Study|Adverse Event|2|||
155376020|NCT02366468|560810904|FG001|Overall Study|Adverse Event|0|||
155376021|NCT02366468|560810903|FG000|Overall Study|Withdrawal by Subject|1|||
155376022|NCT02366468|560810904|FG001|Overall Study|Withdrawal by Subject|5|||
155376023|NCT02366468|560810903|FG000|Overall Study|Lost to Follow-up|2|||
155376024|NCT02366468|560810904|FG001|Overall Study|Lost to Follow-up|0|||
155376025|NCT02366468|560810903|FG000|Overall Study|Death|1|||
155376026|NCT02366468|560810904|FG001|Overall Study|Death|2|||
155376027|NCT02366468|560810903|FG000|Overall Study|Other|0|||
155376028|NCT02366468|560810904|FG001|Overall Study|Other|2|||
155376029|NCT00446043|560810905|FG000|Overall Study|Adverse Event|9|||
155376030|NCT00446043|560810905|FG000|Overall Study|Withdrawal by Subject|70|||
155376031|NCT00446043|560810905|FG000|Overall Study|Protocol Violation|2|||
155376032|NCT00446043|560810905|FG000|Overall Study|Lost to Follow-up|42|||
155376033|NCT00446043|560810905|FG000|Overall Study|Pregnancy|2|||
155376034|NCT05540717|560810908|FG000|Overall Study|Lost to Follow-up|2|||
155376035|NCT05540717|560810909|FG001|Overall Study|Lost to Follow-up|5|||
155376036|NCT05540717|560810908|FG000|Overall Study|Withdrawal by Subject|6|||
155376037|NCT05540717|560810909|FG001|Overall Study|Withdrawal by Subject|6|||
155376038|NCT05540717|560810908|FG000|Overall Study|Sponsor request|1|||
155376039|NCT05540717|560810909|FG001|Overall Study|Sponsor request|0|||
155431301|NCT03874234|561005057|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431302|NCT03874234|561005058|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431303|NCT03874234|561005059|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431304|NCT03874234|561005060|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431305|NCT03874234|561005061|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431306|NCT03874234|561005062|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431307|NCT03874234|561005063|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
155431308|NCT03874234|561005051|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
155649734|NCT01654250|561810121|FG001|Overall Study|Lost to Follow-up|0|||
155649735|NCT02004275|561810122|FG000|Phase 1|Ineligible|0|||
155649736|NCT02004275|561810123|FG001|Phase 1|Ineligible|0|||
155649737|NCT02004275|561810124|FG002|Phase 1|Ineligible|0|||
155649738|NCT02004275|561810125|FG003|Phase 1|Ineligible|1|||
155649739|NCT02004275|561810126|FG004|Phase 1|Ineligible|1|||
155649740|NCT02004275|561810127|FG005|Phase 1|Ineligible|0|||
155649741|NCT02004275|561810122|FG000|Phase 1|Protocol Violation|0|||
155649742|NCT02004275|561810123|FG001|Phase 1|Protocol Violation|0|||
155649743|NCT02004275|561810124|FG002|Phase 1|Protocol Violation|0|||
155649744|NCT02004275|561810125|FG003|Phase 1|Protocol Violation|1|||
155649745|NCT02004275|561810126|FG004|Phase 1|Protocol Violation|0|||
155649746|NCT02004275|561810127|FG005|Phase 1|Protocol Violation|5|||
155649747|NCT02004275|561810122|FG000|Phase 2 Part 1|Ineligible|6|||
155649748|NCT02004275|561810123|FG001|Phase 2 Part 1|Ineligible|9|||
155649749|NCT02004275|561810124|FG002|Phase 2 Part 1|Ineligible|0|||
155649750|NCT02004275|561810125|FG003|Phase 2 Part 1|Ineligible|0|||
155649751|NCT02004275|561810126|FG004|Phase 2 Part 1|Ineligible|0|||
155649752|NCT02004275|561810127|FG005|Phase 2 Part 1|Ineligible|0|||
155649753|NCT02004275|561810122|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
155649754|NCT02004275|561810123|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
155649755|NCT02004275|561810124|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
155649756|NCT02004275|561810125|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
155649757|NCT02004275|561810126|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
155649758|NCT02004275|561810127|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
155649759|NCT00458705|561810128|FG000|Overall Study|Adverse Event|4|||
155649760|NCT00458705|561810128|FG000|Overall Study|Not Treated|1|||
155511992|NCT02669264|561299443|FG001|Overall Study|Withdrawal by Subject|1|||
155511993|NCT02669264|561299444|FG002|Overall Study|Withdrawal by Subject|0|||
155511994|NCT02669264|561299445|FG003|Overall Study|Withdrawal by Subject|0|||
155511995|NCT02669264|561299446|FG004|Overall Study|Withdrawal by Subject|1|||
155511996|NCT02669264|561299447|FG005|Overall Study|Withdrawal by Subject|0|||
155511997|NCT02669264|561299448|FG006|Overall Study|Withdrawal by Subject|0|||
155511998|NCT02669264|561299442|FG000|Overall Study|Lost to Follow-up|0|||
155511999|NCT02669264|561299443|FG001|Overall Study|Lost to Follow-up|0|||
155512000|NCT02669264|561299444|FG002|Overall Study|Lost to Follow-up|0|||
155512001|NCT02669264|561299445|FG003|Overall Study|Lost to Follow-up|0|||
155649761|NCT00378560|561810132|FG000|Overall Study|Adverse Event|1|||
155649762|NCT00378560|561810133|FG001|Overall Study|Adverse Event|0|||
155649763|NCT00378560|561810132|FG000|Overall Study|Lost to Follow-up|24|||
155649764|NCT00378560|561810133|FG001|Overall Study|Lost to Follow-up|29|||
155649765|NCT00378560|561810132|FG000|Overall Study|Protocol Violation|2|||
155649766|NCT00378560|561810133|FG001|Overall Study|Protocol Violation|0|||
155649767|NCT00378560|561810132|FG000|Overall Study|Withdrawal by Subject|17|||
155649768|NCT00378560|561810133|FG001|Overall Study|Withdrawal by Subject|21|||
155649769|NCT00378560|561810132|FG000|Overall Study|Moved|4|||
155649770|NCT00378560|561810133|FG001|Overall Study|Moved|3|||
155649771|NCT00378560|561810132|FG000|Overall Study|Pregnancy|7|||
155649772|NCT00378560|561810133|FG001|Overall Study|Pregnancy|5|||
155649773|NCT00378560|561810132|FG000|Overall Study|Laboratory test values abnormal|1|||
155376040|NCT05540717|560810908|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
155376041|NCT05540717|560810909|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
155376042|NCT05540717|560810908|FG000|Overall Study|Other|0|||
155376043|NCT05540717|560810909|FG001|Overall Study|Other|1|||
155376044|NCT00037830|560810910|FG000|Overall Study|Adverse Event|2|||
155376045|NCT00037830|560810911|FG001|Overall Study|Adverse Event|0|||
155376046|NCT00037830|560810912|FG002|Overall Study|Adverse Event|0|||
155376047|NCT00037830|560810910|FG000|Overall Study|Withdrawal by Subject|4|||
155376048|NCT00037830|560810911|FG001|Overall Study|Withdrawal by Subject|5|||
155512002|NCT02669264|561299446|FG004|Overall Study|Lost to Follow-up|1|||
155376049|NCT00037830|560810912|FG002|Overall Study|Withdrawal by Subject|1|||
155512003|NCT02669264|561299447|FG005|Overall Study|Lost to Follow-up|0|||
155512004|NCT02669264|561299448|FG006|Overall Study|Lost to Follow-up|0|||
155512005|NCT02669264|561299442|FG000|Overall Study|Miscellaneous|0|||
155649774|NCT00378560|561810133|FG001|Overall Study|Laboratory test values abnormal|0|||
155649775|NCT02070380|561810134|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
155649776|NCT02070380|561810135|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
155512006|NCT02669264|561299443|FG001|Overall Study|Miscellaneous|0|||
155512007|NCT02669264|561299444|FG002|Overall Study|Miscellaneous|0|||
155512008|NCT02669264|561299445|FG003|Overall Study|Miscellaneous|0|||
155649777|NCT02070380|561810136|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
155649778|NCT02070380|561810137|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
155649779|NCT02070380|561810134|FG000|Second Injection|Image sets missing or technically inadeq|0|||
155649780|NCT02070380|561810135|FG001|Second Injection|Image sets missing or technically inadeq|1|||
155649781|NCT02070380|561810136|FG002|Second Injection|Image sets missing or technically inadeq|0|||
155649782|NCT02070380|561810137|FG003|Second Injection|Image sets missing or technically inadeq|0|||
155649783|NCT02070380|561810134|FG000|Second Injection|Protocol Violation|0|||
155376050|NCT00037830|560810910|FG000|Overall Study|Protocol Violation|2|||
155376051|NCT00037830|560810911|FG001|Overall Study|Protocol Violation|2|||
155376052|NCT00037830|560810912|FG002|Overall Study|Protocol Violation|0|||
155376053|NCT00037830|560810910|FG000|Overall Study|Unrelated Medical Problem|2|||
155376054|NCT00037830|560810911|FG001|Overall Study|Unrelated Medical Problem|0|||
155376055|NCT00037830|560810912|FG002|Overall Study|Unrelated Medical Problem|0|||
155376056|NCT01327495|560810913|FG000|Overall Study|Adverse Event|2|||
155376057|NCT01327495|560810914|FG001|Overall Study|Adverse Event|1|||
155376058|NCT01327495|560810915|FG002|Overall Study|Adverse Event|1|||
155376059|NCT01327495|560810916|FG003|Overall Study|Adverse Event|0|||
155376060|NCT01327495|560810917|FG004|Overall Study|Adverse Event|0|||
155376061|NCT01327495|560810918|FG005|Overall Study|Adverse Event|2|||
155376062|NCT01327495|560810913|FG000|Overall Study|Withdrawal by Subject|0|||
155376063|NCT01327495|560810914|FG001|Overall Study|Withdrawal by Subject|1|||
155376064|NCT01327495|560810915|FG002|Overall Study|Withdrawal by Subject|1|||
155376065|NCT01327495|560810916|FG003|Overall Study|Withdrawal by Subject|0|||
155376066|NCT01327495|560810917|FG004|Overall Study|Withdrawal by Subject|1|||
155376067|NCT01327495|560810918|FG005|Overall Study|Withdrawal by Subject|0|||
155376068|NCT01327495|560810913|FG000|Overall Study|Physician Decision|0|||
155376069|NCT01327495|560810914|FG001|Overall Study|Physician Decision|0|||
155376070|NCT01327495|560810915|FG002|Overall Study|Physician Decision|0|||
155376071|NCT01327495|560810916|FG003|Overall Study|Physician Decision|0|||
155376072|NCT01327495|560810917|FG004|Overall Study|Physician Decision|2|||
155376073|NCT01327495|560810918|FG005|Overall Study|Physician Decision|0|||
155376074|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
155376075|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376076|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376077|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376078|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376079|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
155376080|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376081|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376082|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376083|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376084|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
155376085|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376086|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376087|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376088|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376089|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
155376090|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376091|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376092|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376093|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376094|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
155376095|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376096|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376097|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376098|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376099|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
155376100|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376101|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376102|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376103|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376104|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
155376105|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376106|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376107|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376108|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376109|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
155376110|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376111|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376112|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376113|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376114|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
155376115|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376116|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155512009|NCT02669264|561299446|FG004|Overall Study|Miscellaneous|0|||
155512010|NCT02669264|561299447|FG005|Overall Study|Miscellaneous|0|||
155376117|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376118|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376119|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376120|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
155376121|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376122|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376123|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376124|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376125|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
155376126|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376127|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376128|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376129|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376130|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
155376131|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376132|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376133|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376134|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376135|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
155376136|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376137|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376138|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376139|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376140|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
155376141|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376142|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376143|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376144|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376145|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
155376146|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376147|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376148|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376149|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376150|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
155376151|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376152|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376153|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376154|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376155|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
155376156|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376157|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376158|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155649784|NCT02070380|561810135|FG001|Second Injection|Protocol Violation|1|||
155512011|NCT02669264|561299448|FG006|Overall Study|Miscellaneous|2|||
155512012|NCT03529955|561299449|FG000|Overall Study|Adverse Event|1|||
155512013|NCT03529955|561299449|FG000|Overall Study|Lack of Efficacy|1|||
155376159|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376160|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
155376161|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376162|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376163|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376164|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376165|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
155376166|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376167|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376168|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376169|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376170|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376171|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
155376172|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
155376173|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376174|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
155649785|NCT02070380|561810136|FG002|Second Injection|Protocol Violation|1|||
155649786|NCT02070380|561810137|FG003|Second Injection|Protocol Violation|5|||
155649787|NCT01682603|561810148|FG000|Overall Study|Lost to Follow-up|3|||
155649788|NCT01791205|561810149|FG000|Phase II|Lack of Efficacy|6|||
155649789|NCT01791205|561810150|FG001|Phase II|Lack of Efficacy|0|||
155649790|NCT01791205|561810149|FG000|Phase II|Adverse Event|2|||
155649791|NCT01791205|561810150|FG001|Phase II|Adverse Event|0|||
155649792|NCT01791205|561810149|FG000|Phase II|Safety|1|||
155649793|NCT01791205|561810150|FG001|Phase II|Safety|0|||
155649794|NCT01791205|561810149|FG000|Phase II|Lost to Follow-up|1|||
155649795|NCT01791205|561810150|FG001|Phase II|Lost to Follow-up|0|||
155649796|NCT01791205|561810149|FG000|Phase II|Remission of disease|1|||
155649797|NCT01791205|561810150|FG001|Phase II|Remission of disease|0|||
155649798|NCT01791205|561810149|FG000|Phase II|Physician's decision|1|||
155649799|NCT01791205|561810150|FG001|Phase II|Physician's decision|0|||
155649800|NCT03071965|561810161|FG000|Overall Study|Adverse Event|0|||
155649801|NCT03071965|561810162|FG001|Overall Study|Adverse Event|0|||
155649802|NCT03071965|561810163|FG002|Overall Study|Adverse Event|1|||
155649803|NCT03071965|561810164|FG003|Overall Study|Adverse Event|0|||
155649804|NCT03071965|561810161|FG000|Overall Study|Death|0|||
155649805|NCT03071965|561810162|FG001|Overall Study|Death|0|||
155649806|NCT03071965|561810163|FG002|Overall Study|Death|1|||
155649807|NCT03071965|561810164|FG003|Overall Study|Death|1|||
155649808|NCT03071965|561810161|FG000|Overall Study|COVID-19|0|||
155649809|NCT03071965|561810162|FG001|Overall Study|COVID-19|1|||
155649810|NCT03071965|561810163|FG002|Overall Study|COVID-19|0|||
155649811|NCT03071965|561810164|FG003|Overall Study|COVID-19|1|||
155649812|NCT03071965|561810161|FG000|Overall Study|Other Health Reason|0|||
155649813|NCT03071965|561810162|FG001|Overall Study|Other Health Reason|0|||
155649814|NCT03071965|561810163|FG002|Overall Study|Other Health Reason|0|||
155649815|NCT03071965|561810164|FG003|Overall Study|Other Health Reason|1|||
155649816|NCT04829214|561810165|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
155649817|NCT04829214|561810166|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
155649818|NCT04829214|561810165|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
155649819|NCT04829214|561810166|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
155649820|NCT06399471|561810167|FG000|Overall Study|Withdrawal by Subject|1|||
155649821|NCT04034056|561810168|FG000|Overall Study|Withdrawal by Subject|2|||
155649822|NCT04034056|561810168|FG000|Overall Study|Reason Not Specified|13|||
155649823|NCT04034056|561810168|FG000|Overall Study|Adverse Event|56|||
155649824|NCT04135352|561810170|FG000|Overall Study|Not treated-randomization error|0|||
155649825|NCT04135352|561810171|FG001|Overall Study|Not treated-randomization error|0|||
155649826|NCT04135352|561810172|FG002|Overall Study|Not treated-randomization error|1|||
155649827|NCT04135352|561810173|FG003|Overall Study|Not treated-randomization error|0|||
155649828|NCT04135352|561810174|FG004|Overall Study|Not treated-randomization error|0|||
155649829|NCT04135352|561810175|FG005|Overall Study|Not treated-randomization error|0|||
155649830|NCT04135352|561810176|FG006|Overall Study|Not treated-randomization error|0|||
155649831|NCT04135352|561810177|FG007|Overall Study|Not treated-randomization error|0|||
155649832|NCT04135352|561810170|FG000|Overall Study|Withdrawal by Subject|0|||
155649833|NCT04135352|561810171|FG001|Overall Study|Withdrawal by Subject|0|||
155649834|NCT04135352|561810172|FG002|Overall Study|Withdrawal by Subject|2|||
155649835|NCT04135352|561810173|FG003|Overall Study|Withdrawal by Subject|0|||
155649836|NCT04135352|561810174|FG004|Overall Study|Withdrawal by Subject|0|||
155649837|NCT04135352|561810175|FG005|Overall Study|Withdrawal by Subject|0|||
155649838|NCT04135352|561810176|FG006|Overall Study|Withdrawal by Subject|0|||
155649839|NCT04135352|561810177|FG007|Overall Study|Withdrawal by Subject|0|||
155649840|NCT04135352|561810170|FG000|Overall Study|Sponsor Decision|0|||
155649841|NCT04135352|561810171|FG001|Overall Study|Sponsor Decision|0|||
155649842|NCT04135352|561810172|FG002|Overall Study|Sponsor Decision|2|||
155649843|NCT04135352|561810173|FG003|Overall Study|Sponsor Decision|5|||
155512014|NCT04128696|561299450|FG000|Overall Study|Lost to Follow-up|3|||
155512015|NCT04128696|561299451|FG001|Overall Study|Lost to Follow-up|7|||
155512016|NCT04128696|561299450|FG000|Overall Study|Withdrawal by Subject|12|||
155512017|NCT04128696|561299451|FG001|Overall Study|Withdrawal by Subject|11|||
155512018|NCT04128696|561299450|FG000|Overall Study|Study Closed/Terminated|26|||
155512019|NCT04128696|561299451|FG001|Overall Study|Study Closed/Terminated|38|||
155512020|NCT04128696|561299450|FG000|Overall Study|Physician Decision|2|||
155649844|NCT04135352|561810174|FG004|Overall Study|Sponsor Decision|1|||
155649845|NCT04135352|561810175|FG005|Overall Study|Sponsor Decision|4|||
155512021|NCT04128696|561299451|FG001|Overall Study|Physician Decision|3|||
155512022|NCT03507439|561299452|FG000|Overall Study|Other|2|||
155512023|NCT03507439|561299453|FG001|Overall Study|Other|1|||
155512024|NCT03507439|561299452|FG000|Overall Study|Withdrawal by Subject|1|||
155649846|NCT04135352|561810176|FG006|Overall Study|Sponsor Decision|0|||
155649847|NCT04135352|561810177|FG007|Overall Study|Sponsor Decision|0|||
155649848|NCT04135352|561810170|FG000|Overall Study|Physician Decision|0|||
155649849|NCT04135352|561810171|FG001|Overall Study|Physician Decision|0|||
155649850|NCT04135352|561810172|FG002|Overall Study|Physician Decision|1|||
155649851|NCT04135352|561810173|FG003|Overall Study|Physician Decision|0|||
155649852|NCT04135352|561810174|FG004|Overall Study|Physician Decision|1|||
155649853|NCT04135352|561810175|FG005|Overall Study|Physician Decision|0|||
155431309|NCT03874234|561005052|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431310|NCT03874234|561005053|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431311|NCT03874234|561005054|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431312|NCT03874234|561005055|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431313|NCT03874234|561005056|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431314|NCT03874234|561005057|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431315|NCT03874234|561005058|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431316|NCT03874234|561005059|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431317|NCT03874234|561005060|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431318|NCT03874234|561005061|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431319|NCT03874234|561005062|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431320|NCT03874234|561005063|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
155431321|NCT03874234|561005051|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431322|NCT03874234|561005052|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431323|NCT03874234|561005053|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431324|NCT03874234|561005054|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
155431325|NCT03874234|561005055|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431326|NCT03874234|561005056|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431327|NCT03874234|561005057|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431328|NCT03874234|561005058|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431329|NCT03874234|561005059|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431330|NCT03874234|561005060|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431331|NCT03874234|561005061|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431332|NCT03874234|561005062|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431333|NCT03874234|561005063|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
155431334|NCT03874234|561005051|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431335|NCT03874234|561005052|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431336|NCT03874234|561005053|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431337|NCT03874234|561005054|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431338|NCT03874234|561005055|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
155431339|NCT03874234|561005056|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431340|NCT03874234|561005057|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431341|NCT03874234|561005058|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431342|NCT03874234|561005059|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431343|NCT03874234|561005060|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431344|NCT03874234|561005061|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431345|NCT03874234|561005062|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431346|NCT03874234|561005063|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
155431347|NCT03874234|561005051|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431348|NCT03874234|561005052|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431349|NCT03874234|561005053|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431350|NCT03874234|561005054|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431351|NCT03874234|561005055|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431352|NCT03874234|561005056|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431353|NCT03874234|561005057|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431354|NCT03874234|561005058|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
155431355|NCT03874234|561005059|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431356|NCT03874234|561005060|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431357|NCT03874234|561005061|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431358|NCT03874234|561005062|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431359|NCT03874234|561005063|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
155431360|NCT03874234|561005051|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431361|NCT03874234|561005052|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431362|NCT03874234|561005053|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431363|NCT03874234|561005054|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431364|NCT03874234|561005055|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
155431365|NCT03874234|561005056|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
155431366|NCT03874234|561005057|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431367|NCT03874234|561005058|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431368|NCT03874234|561005059|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431369|NCT03874234|561005060|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431370|NCT03874234|561005061|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431371|NCT03874234|561005062|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431372|NCT03874234|561005063|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
155431373|NCT03874234|561005051|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155376175|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
155376176|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
155376177|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
155376178|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
155376179|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376180|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376181|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
155376182|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
155376183|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376184|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376185|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376186|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
155376187|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
155376188|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376189|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376190|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376191|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
155376192|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
155376193|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376194|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376195|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376196|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376197|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
155376198|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376199|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376200|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376201|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376202|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
155376203|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376204|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376205|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376206|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
155376207|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
155376208|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376209|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376210|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376211|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
155376212|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376213|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376214|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376215|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376216|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
155376217|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376218|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376219|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376220|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376221|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376222|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376223|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
155376224|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
155376225|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
155376226|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
155376227|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
155376228|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
155376229|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376230|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376231|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376232|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155431374|NCT03874234|561005052|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431375|NCT03874234|561005053|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431376|NCT03874234|561005054|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431377|NCT03874234|561005055|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431378|NCT03874234|561005056|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431379|NCT03874234|561005057|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
155431380|NCT03874234|561005058|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155376233|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
155376234|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376235|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376236|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376237|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376238|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
155376239|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376240|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376241|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376242|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376243|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
155376244|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376245|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376246|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376247|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376248|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
155376249|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376250|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376251|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376252|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376253|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
155376254|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376255|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376256|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376257|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376258|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
155376259|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376260|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376261|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376262|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376263|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
155376264|NCT02057523|560810931|FG000|Overall Study|Withdrawal by Subject|1|||
155376265|NCT02057523|560810931|FG000|Overall Study|Lack of Efficacy|1|||
155376266|NCT00941070|560810933|FG000|Overall Study|Patient non-compliant|1|||
155376267|NCT03174431|560810934|FG000|Overall Study|Withdrawal by Subject|14|||
155376268|NCT03174431|560810935|FG001|Overall Study|Withdrawal by Subject|11|||
155376269|NCT03174431|560810934|FG000|Overall Study|alternative treatment|2|||
155376270|NCT03174431|560810935|FG001|Overall Study|alternative treatment|0|||
155376271|NCT03174431|560810934|FG000|Overall Study|Lost to Follow-up|1|||
155376272|NCT03174431|560810935|FG001|Overall Study|Lost to Follow-up|5|||
155376273|NCT03500159|560810936|FG000|Overall Study|Study Terminated|2|||
155376274|NCT03500159|560810937|FG001|Overall Study|Study Terminated|1|||
155376275|NCT00560066|560810940|FG000|Overall Study|Death|2|||
155376276|NCT00560066|560810941|FG001|Overall Study|Death|1|||
155376277|NCT00560066|560810940|FG000|Overall Study|Withdrawal by Subject|0|||
155376278|NCT00560066|560810941|FG001|Overall Study|Withdrawal by Subject|3|||
155376279|NCT00560066|560810940|FG000|Overall Study|Lost to Follow-up|4|||
155376280|NCT00560066|560810941|FG001|Overall Study|Lost to Follow-up|10|||
155376281|NCT00560066|560810940|FG000|Overall Study|Protocol Violation|0|||
155376282|NCT00560066|560810941|FG001|Overall Study|Protocol Violation|1|||
155376283|NCT00560066|560810940|FG000|Overall Study|Administrative reason|0|||
155376284|NCT00560066|560810941|FG001|Overall Study|Administrative reason|5|||
155376285|NCT00560066|560810940|FG000|Overall Study|Missing primary reason|0|||
155376286|NCT00560066|560810941|FG001|Overall Study|Missing primary reason|2|||
155376287|NCT00506441|560810942|FG000|Period 1; Open-label Period|Adverse Event|21|||
155376288|NCT00506441|560810943|FG001|Period 1; Open-label Period|Adverse Event|0|||
155376289|NCT00506441|560810942|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
155376290|NCT00506441|560810943|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
155376291|NCT00506441|560810942|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
155376292|NCT00506441|560810943|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
155376293|NCT00506441|560810942|FG000|Period 1; Open-label Period|Physician Decision|5|||
155512025|NCT03507439|561299453|FG001|Overall Study|Withdrawal by Subject|0|||
155512026|NCT03507439|561299452|FG000|Overall Study|Death|1|||
155512027|NCT03507439|561299453|FG001|Overall Study|Death|1|||
155512028|NCT03433001|561301146|FG000|Overall Study|Lack of Efficacy|109|||
155512029|NCT03433001|561301146|FG000|Overall Study|Adverse Event|69|||
155512030|NCT03433001|561301146|FG000|Overall Study|Withdrawal by Subject|10|||
155512031|NCT03433001|561301146|FG000|Overall Study|Death|12|||
155376294|NCT00506441|560810943|FG001|Period 1; Open-label Period|Physician Decision|0|||
155376295|NCT00506441|560810942|FG000|Period 1; Open-label Period|Protocol Violation|9|||
155512032|NCT03433001|561301146|FG000|Overall Study|Lost to Follow-up|4|||
155649854|NCT04135352|561810176|FG006|Overall Study|Physician Decision|0|||
155649855|NCT04135352|561810177|FG007|Overall Study|Physician Decision|0|||
155649856|NCT04135352|561810170|FG000|Overall Study|Death|3|||
155649857|NCT04135352|561810171|FG001|Overall Study|Death|4|||
155649858|NCT04135352|561810172|FG002|Overall Study|Death|7|||
155649859|NCT04135352|561810173|FG003|Overall Study|Death|0|||
155649860|NCT04135352|561810174|FG004|Overall Study|Death|3|||
155649861|NCT04135352|561810175|FG005|Overall Study|Death|1|||
155649862|NCT04135352|561810176|FG006|Overall Study|Death|0|||
155649863|NCT04135352|561810177|FG007|Overall Study|Death|0|||
155649864|NCT00609973|561810178|FG000|Overall Study|Adverse Event|2|||
155649865|NCT00609973|561810179|FG001|Overall Study|Adverse Event|1|||
155649866|NCT00609973|561810178|FG000|Overall Study|Protocol Violation|4|||
155376296|NCT00506441|560810943|FG001|Period 1; Open-label Period|Protocol Violation|0|||
155376297|NCT00506441|560810942|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
155376298|NCT00506441|560810943|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
155376299|NCT00506441|560810942|FG000|Period 1; Open-label Period|Other Reasons|13|||
155376300|NCT00506441|560810943|FG001|Period 1; Open-label Period|Other Reasons|0|||
155376301|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Adverse Event|0|||
155376302|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Adverse Event|1|||
155376303|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
155376304|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
155376305|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Physician Decision|1|||
155376306|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Physician Decision|1|||
155376307|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
155376308|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
155376309|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Other Reason|1|||
155376310|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Other Reason|1|||
155376311|NCT00735475|560810944|FG000|Overall Study|Adverse Event|0|||
155376312|NCT00735475|560810945|FG001|Overall Study|Adverse Event|1|||
155376313|NCT00735475|560810944|FG000|Overall Study|Death|1|||
155376314|NCT00735475|560810945|FG001|Overall Study|Death|1|||
155376315|NCT00735475|560810944|FG000|Overall Study|Lost to Follow-up|3|||
155376316|NCT00735475|560810945|FG001|Overall Study|Lost to Follow-up|3|||
155376317|NCT00735475|560810944|FG000|Overall Study|Physician Decision|0|||
155376318|NCT00735475|560810945|FG001|Overall Study|Physician Decision|1|||
155376319|NCT00735475|560810944|FG000|Overall Study|Withdrawal by Subject|4|||
155376320|NCT00735475|560810945|FG001|Overall Study|Withdrawal by Subject|5|||
155376321|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
155376322|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
155376323|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
155376324|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
155376325|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
155376326|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
155376327|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
155376328|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
155376329|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
155376330|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376331|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376332|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376333|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
155376334|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376335|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376336|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376337|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
155376338|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
155376339|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
155376340|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
155376341|NCT02544451|560810948|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
155376342|NCT02544451|560810949|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
155376343|NCT02544451|560810950|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
155649867|NCT00609973|561810179|FG001|Overall Study|Protocol Violation|3|||
155376344|NCT02544451|560810951|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
155376345|NCT00844532|560810953|FG000|Overall Study|Death|16|||
155649868|NCT00609973|561810178|FG000|Overall Study|Lost to Follow-up|2|||
155376346|NCT00844532|560810953|FG000|Overall Study|Withdrawal by Subject|16|||
155376347|NCT00844532|560810953|FG000|Overall Study|Lost to Follow-up|7|||
155376348|NCT05086276|560810954|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
155649869|NCT00609973|561810179|FG001|Overall Study|Lost to Follow-up|1|||
155649870|NCT00609973|561810178|FG000|Overall Study|Withdrawal by Subject|0|||
155649871|NCT00609973|561810179|FG001|Overall Study|Withdrawal by Subject|1|||
155376349|NCT05086276|560810955|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
155376350|NCT03592745|560810956|FG000|Overall Study|Adverse Event|0|||
155376351|NCT03592745|560810957|FG001|Overall Study|Adverse Event|2|||
155376352|NCT03592745|560810956|FG000|Overall Study|Lost to Follow-up|2|||
155376353|NCT03592745|560810957|FG001|Overall Study|Lost to Follow-up|0|||
155376354|NCT03592745|560810956|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
155376355|NCT03592745|560810957|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
155376356|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
155376357|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
155376358|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
155376359|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Death|7|||
155376360|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
155376361|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
155376362|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
155376363|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Death|5|||
155376364|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
155376365|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
155376366|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
155376367|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
155376368|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Death|3|||
155376369|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
155376370|NCT00738894|560810959|FG000|Overall Study|Lost to Follow-up|23|||
155376371|NCT00738894|560810960|FG001|Overall Study|Lost to Follow-up|13|||
155376372|NCT00738894|560810959|FG000|Overall Study|Withdrawal by Subject|10|||
155376373|NCT00738894|560810960|FG001|Overall Study|Withdrawal by Subject|15|||
155376374|NCT00738894|560810959|FG000|Overall Study|Physician Decision|4|||
155376375|NCT00738894|560810960|FG001|Overall Study|Physician Decision|5|||
155376376|NCT00738894|560810959|FG000|Overall Study|Death|2|||
155376377|NCT00738894|560810960|FG001|Overall Study|Death|0|||
155376378|NCT05017103|560810961|FG000|Overall Study|Death|2|||
155376379|NCT02656329|560810962|FG000|Overall Study|Lost to Follow-up|2|||
155376380|NCT02656329|560810963|FG001|Overall Study|Lost to Follow-up|3|||
155376381|NCT02656329|560810962|FG000|Overall Study|Withdrawal by Subject|7|||
155376382|NCT02656329|560810963|FG001|Overall Study|Withdrawal by Subject|6|||
155376383|NCT02656329|560810962|FG000|Overall Study|Study termination by Sponsor|150|||
155376384|NCT02656329|560810963|FG001|Overall Study|Study termination by Sponsor|142|||
155376385|NCT02656329|560810962|FG000|Overall Study|Other than specified above|5|||
155376386|NCT02656329|560810963|FG001|Overall Study|Other than specified above|6|||
155376387|NCT01081665|560810965|FG000|Overall Study|Death|41|||
155376388|NCT01081665|560810965|FG000|Overall Study|Lost to Follow-up|18|||
155376389|NCT01081665|560810965|FG000|Overall Study|Withdrawal by Subject|17|||
155376390|NCT01081665|560810965|FG000|Overall Study|Change of dialysis unit|10|||
155376391|NCT01081665|560810965|FG000|Overall Study|Regulation of iPTH|5|||
155376392|NCT01081665|560810965|FG000|Overall Study|Change in renal replacement therapy|2|||
155376393|NCT01081665|560810965|FG000|Overall Study|Adverse Event|1|||
155376394|NCT01081665|560810965|FG000|Overall Study|Lack of Efficacy|1|||
155376395|NCT02546921|560810976|FG000|Overall Study|Adverse Event|0|||
155376396|NCT02546921|560810977|FG001|Overall Study|Adverse Event|5|||
155376397|NCT02546921|560810978|FG002|Overall Study|Adverse Event|2|||
155376398|NCT02546921|560810979|FG003|Overall Study|Adverse Event|0|||
155376399|NCT02546921|560810980|FG004|Overall Study|Adverse Event|0|||
155376400|NCT02546921|560810981|FG005|Overall Study|Adverse Event|0|||
155376401|NCT02546921|560810982|FG006|Overall Study|Adverse Event|0|||
155376402|NCT02546921|560810976|FG000|Overall Study|Evidence of Disease Progression|1|||
155376403|NCT02546921|560810977|FG001|Overall Study|Evidence of Disease Progression|0|||
155376404|NCT02546921|560810978|FG002|Overall Study|Evidence of Disease Progression|0|||
155376405|NCT02546921|560810979|FG003|Overall Study|Evidence of Disease Progression|0|||
155512033|NCT03433001|561301146|FG000|Overall Study|Other|25|||
155512034|NCT01299038|561301152|FG000|Overall Study|Withdrawal by Subject|1|||
155512035|NCT01299038|561301153|FG001|Overall Study|Withdrawal by Subject|0|||
155376406|NCT02546921|560810980|FG004|Overall Study|Evidence of Disease Progression|1|||
155376407|NCT02546921|560810981|FG005|Overall Study|Evidence of Disease Progression|0|||
155376408|NCT02546921|560810982|FG006|Overall Study|Evidence of Disease Progression|0|||
155376409|NCT02546921|560810976|FG000|Overall Study|Patient Choice|0|||
155376410|NCT02546921|560810977|FG001|Overall Study|Patient Choice|1|||
155512036|NCT00322556|561301158|FG000|Overall Study|Adverse Event|1|||
155512037|NCT00322556|561301158|FG000|Overall Study|Withdrawal by Subject|1|||
155512038|NCT00322556|561301158|FG000|Overall Study|Lost to Follow-up|3|||
155376411|NCT02546921|560810978|FG002|Overall Study|Patient Choice|0|||
155376412|NCT02546921|560810979|FG003|Overall Study|Patient Choice|0|||
155376413|NCT02546921|560810980|FG004|Overall Study|Patient Choice|0|||
155376414|NCT02546921|560810981|FG005|Overall Study|Patient Choice|1|||
155376415|NCT02546921|560810982|FG006|Overall Study|Patient Choice|0|||
155376416|NCT01373151|560810983|FG000|Period 1|Lack of Efficacy|3|||
155376417|NCT01373151|560810984|FG001|Period 1|Lack of Efficacy|0|||
155376418|NCT01373151|560810985|FG002|Period 1|Lack of Efficacy|0|||
155376419|NCT01373151|560810986|FG003|Period 1|Lack of Efficacy|0|||
155376420|NCT01373151|560810987|FG004|Period 1|Lack of Efficacy|1|||
155376421|NCT01373151|560810988|FG005|Period 1|Lack of Efficacy|0|||
155376422|NCT01373151|560810989|FG006|Period 1|Lack of Efficacy|0|||
155376423|NCT01373151|560810983|FG000|Period 1|Adverse Event|0|||
155376424|NCT01373151|560810984|FG001|Period 1|Adverse Event|0|||
155376425|NCT01373151|560810985|FG002|Period 1|Adverse Event|1|||
155376426|NCT01373151|560810986|FG003|Period 1|Adverse Event|0|||
155376427|NCT01373151|560810987|FG004|Period 1|Adverse Event|4|||
155376428|NCT01373151|560810988|FG005|Period 1|Adverse Event|3|||
155376429|NCT01373151|560810989|FG006|Period 1|Adverse Event|0|||
155512039|NCT00322556|561301158|FG000|Overall Study|Other Reason|7|||
155512040|NCT02040428|561301159|FG000|Overall Study|Death|4|||
155512041|NCT02040428|561301160|FG001|Overall Study|Death|3|||
155512042|NCT02040428|561301159|FG000|Overall Study|Withdrawal by Subject|1|||
155512043|NCT02040428|561301160|FG001|Overall Study|Withdrawal by Subject|1|||
155512044|NCT00832078|561301161|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
155512045|NCT00832078|561301162|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
155512046|NCT00832078|561301161|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
155512047|NCT00832078|561301162|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
155512048|NCT02961920|561301163|FG000|Overall Study|did not achive stydy protocol schedule|1|||
155512049|NCT02961920|561301164|FG001|Overall Study|did not achive stydy protocol schedule|1|||
155512050|NCT01452529|561301165|FG000|Run-in Period|Adverse Event|96|||
155512051|NCT01452529|561301166|FG001|Run-in Period|Adverse Event|0|||
155512052|NCT01452529|561301167|FG002|Run-in Period|Adverse Event|0|||
155512053|NCT01452529|561301165|FG000|Run-in Period|Withdrawal by Subject|49|||
155512054|NCT01452529|561301166|FG001|Run-in Period|Withdrawal by Subject|0|||
155512055|NCT01452529|561301167|FG002|Run-in Period|Withdrawal by Subject|0|||
155512056|NCT01452529|561301165|FG000|Run-in Period|Lost to Follow-up|19|||
155512057|NCT01452529|561301166|FG001|Run-in Period|Lost to Follow-up|0|||
155512058|NCT01452529|561301167|FG002|Run-in Period|Lost to Follow-up|0|||
155512059|NCT01452529|561301165|FG000|Run-in Period|Lack of Efficacy|46|||
155512060|NCT01452529|561301166|FG001|Run-in Period|Lack of Efficacy|0|||
155512061|NCT01452529|561301167|FG002|Run-in Period|Lack of Efficacy|0|||
155512062|NCT01452529|561301165|FG000|Run-in Period|Confirmed or suspected diversion|23|||
155512063|NCT01452529|561301166|FG001|Run-in Period|Confirmed or suspected diversion|0|||
155512064|NCT01452529|561301167|FG002|Run-in Period|Confirmed or suspected diversion|0|||
155512065|NCT01452529|561301165|FG000|Run-in Period|Administrative|21|||
155512066|NCT01452529|561301166|FG001|Run-in Period|Administrative|0|||
155512067|NCT01452529|561301167|FG002|Run-in Period|Administrative|0|||
155512068|NCT01452529|561301165|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
155512069|NCT01452529|561301166|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
155512070|NCT01452529|561301167|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
155512071|NCT01452529|561301165|FG000|Double-blind (DB) Period|Adverse Event|0|||
155376430|NCT01373151|560810983|FG000|Period 1|Withdrawal by Subject|2|||
155376431|NCT01373151|560810984|FG001|Period 1|Withdrawal by Subject|0|||
155376432|NCT01373151|560810985|FG002|Period 1|Withdrawal by Subject|3|||
155376433|NCT01373151|560810986|FG003|Period 1|Withdrawal by Subject|1|||
155512072|NCT01452529|561301166|FG001|Double-blind (DB) Period|Adverse Event|18|||
155512073|NCT01452529|561301167|FG002|Double-blind (DB) Period|Adverse Event|11|||
155512074|NCT01452529|561301165|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
155512075|NCT01452529|561301166|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
155512076|NCT01452529|561301167|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
155512077|NCT01452529|561301165|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
155512078|NCT01452529|561301166|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
155512079|NCT01452529|561301167|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
155512080|NCT01452529|561301165|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
155512081|NCT01452529|561301166|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
155512082|NCT01452529|561301167|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
155512083|NCT01452529|561301165|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
155512084|NCT01452529|561301166|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
155376434|NCT01373151|560810987|FG004|Period 1|Withdrawal by Subject|0|||
155376435|NCT01373151|560810988|FG005|Period 1|Withdrawal by Subject|1|||
155512085|NCT01452529|561301167|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
155512086|NCT01452529|561301165|FG000|Double-blind (DB) Period|Administrative|0|||
155512087|NCT01452529|561301166|FG001|Double-blind (DB) Period|Administrative|11|||
155512088|NCT01452529|561301167|FG002|Double-blind (DB) Period|Administrative|7|||
155512089|NCT03551730|561301168|FG000|Overall Study|Adverse Event|1|||
155376436|NCT01373151|560810989|FG006|Period 1|Withdrawal by Subject|0|||
155512090|NCT03551730|561301169|FG001|Overall Study|Adverse Event|0|||
155512091|NCT03551730|561301170|FG002|Overall Study|Adverse Event|0|||
155512092|NCT03551730|561301171|FG003|Overall Study|Adverse Event|0|||
155512093|NCT04527471|561301174|FG000|Overall Study|Adverse Event|1|||
155376437|NCT01373151|560810983|FG000|Period 2|Lack of Efficacy|9|||
155376438|NCT01373151|560810984|FG001|Period 2|Lack of Efficacy|0|||
155376439|NCT01373151|560810985|FG002|Period 2|Lack of Efficacy|0|||
155376440|NCT01373151|560810986|FG003|Period 2|Lack of Efficacy|1|||
155376441|NCT01373151|560810987|FG004|Period 2|Lack of Efficacy|2|||
155376442|NCT01373151|560810988|FG005|Period 2|Lack of Efficacy|0|||
155376443|NCT01373151|560810989|FG006|Period 2|Lack of Efficacy|3|||
155376444|NCT01373151|560810983|FG000|Period 2|Adverse Event|0|||
155376445|NCT01373151|560810984|FG001|Period 2|Adverse Event|0|||
155376446|NCT01373151|560810985|FG002|Period 2|Adverse Event|3|||
155376447|NCT01373151|560810986|FG003|Period 2|Adverse Event|3|||
155376448|NCT01373151|560810987|FG004|Period 2|Adverse Event|0|||
155376449|NCT01373151|560810988|FG005|Period 2|Adverse Event|0|||
155376450|NCT01373151|560810989|FG006|Period 2|Adverse Event|1|||
155376451|NCT01373151|560810983|FG000|Period 2|subject request to discontinue|0|||
155376452|NCT01373151|560810984|FG001|Period 2|subject request to discontinue|1|||
155376453|NCT01373151|560810985|FG002|Period 2|subject request to discontinue|0|||
155376454|NCT01373151|560810986|FG003|Period 2|subject request to discontinue|0|||
155376455|NCT01373151|560810987|FG004|Period 2|subject request to discontinue|0|||
155376456|NCT01373151|560810988|FG005|Period 2|subject request to discontinue|0|||
155376457|NCT01373151|560810989|FG006|Period 2|subject request to discontinue|0|||
155376458|NCT01373151|560810983|FG000|Period 2|Withdrawal by Subject|0|||
155376459|NCT01373151|560810984|FG001|Period 2|Withdrawal by Subject|0|||
155376460|NCT01373151|560810985|FG002|Period 2|Withdrawal by Subject|0|||
155376461|NCT01373151|560810986|FG003|Period 2|Withdrawal by Subject|1|||
155376462|NCT01373151|560810987|FG004|Period 2|Withdrawal by Subject|0|||
155376463|NCT01373151|560810988|FG005|Period 2|Withdrawal by Subject|0|||
155376464|NCT01373151|560810989|FG006|Period 2|Withdrawal by Subject|0|||
155376465|NCT01373151|560810983|FG000|Period 2|Other|0|||
155376466|NCT01373151|560810984|FG001|Period 2|Other|0|||
155376467|NCT01373151|560810985|FG002|Period 2|Other|1|||
155376468|NCT01373151|560810986|FG003|Period 2|Other|0|||
155376469|NCT01373151|560810987|FG004|Period 2|Other|0|||
155376470|NCT01373151|560810988|FG005|Period 2|Other|0|||
155376471|NCT01373151|560810989|FG006|Period 2|Other|1|||
155376472|NCT03026075|560810993|FG000|Overall Study|Physician Decision|1|||
155376473|NCT03381339|560810994|FG000|Overall Study|Protocol Violation|4|||
155376474|NCT03381339|560810995|FG001|Overall Study|Protocol Violation|3|||
155376475|NCT03381339|560810994|FG000|Overall Study|Lost to Follow-up|0|||
155376476|NCT03381339|560810995|FG001|Overall Study|Lost to Follow-up|1|||
155376477|NCT01468181|560810996|FG000|Overall Study|Adverse Event|8|||
155376478|NCT01468181|560810997|FG001|Overall Study|Adverse Event|1|||
155376479|NCT01468181|560810998|FG002|Overall Study|Adverse Event|6|||
155376480|NCT01468181|560810999|FG003|Overall Study|Adverse Event|2|||
155376481|NCT01468181|560811000|FG004|Overall Study|Adverse Event|2|||
155376482|NCT01468181|560810996|FG000|Overall Study|Protocol Violation|2|||
155376483|NCT01468181|560810997|FG001|Overall Study|Protocol Violation|0|||
155376484|NCT01468181|560810998|FG002|Overall Study|Protocol Violation|1|||
155376485|NCT01468181|560810999|FG003|Overall Study|Protocol Violation|0|||
155376486|NCT01468181|560811000|FG004|Overall Study|Protocol Violation|1|||
155376487|NCT01468181|560810996|FG000|Overall Study|Physician Decision|0|||
155376488|NCT01468181|560810997|FG001|Overall Study|Physician Decision|0|||
155376489|NCT01468181|560810998|FG002|Overall Study|Physician Decision|0|||
155376490|NCT01468181|560810999|FG003|Overall Study|Physician Decision|1|||
155376491|NCT01468181|560811000|FG004|Overall Study|Physician Decision|1|||
155376492|NCT01468181|560810996|FG000|Overall Study|Lost to Follow-up|0|||
155649872|NCT01362270|561810180|FG000|Overall Study|Withdrawal by Subject|1|||
155649873|NCT01362270|561810181|FG001|Overall Study|Withdrawal by Subject|0|||
155376493|NCT01468181|560810997|FG001|Overall Study|Lost to Follow-up|0|||
155376494|NCT01468181|560810998|FG002|Overall Study|Lost to Follow-up|1|||
155376495|NCT01468181|560810999|FG003|Overall Study|Lost to Follow-up|0|||
155376496|NCT01468181|560811000|FG004|Overall Study|Lost to Follow-up|1|||
155376497|NCT01468181|560810996|FG000|Overall Study|Withdrawal by Subject|0|||
155376498|NCT01468181|560810997|FG001|Overall Study|Withdrawal by Subject|1|||
155376499|NCT01468181|560810998|FG002|Overall Study|Withdrawal by Subject|0|||
155376500|NCT01468181|560810999|FG003|Overall Study|Withdrawal by Subject|0|||
155376501|NCT01468181|560811000|FG004|Overall Study|Withdrawal by Subject|0|||
155376502|NCT00513305|560811001|FG000|Overall Study|Adverse Event|6|||
155376503|NCT00513305|560811002|FG001|Overall Study|Adverse Event|2|||
155649874|NCT01362270|561810180|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
155649875|NCT01362270|561810181|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
155376504|NCT00513305|560811001|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
155649876|NCT01362270|561810180|FG000|Overall Study|Met excl. criteria before 1st session|1|||
155376505|NCT00513305|560811002|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
155376506|NCT00513305|560811001|FG000|Overall Study|Lack of Efficacy|8|||
155376507|NCT00513305|560811002|FG001|Overall Study|Lack of Efficacy|13|||
155376508|NCT00513305|560811001|FG000|Overall Study|Withdrawal by Subject|1|||
155376509|NCT00513305|560811002|FG001|Overall Study|Withdrawal by Subject|2|||
155376510|NCT00513305|560811001|FG000|Overall Study|Disease progression|8|||
155376511|NCT00513305|560811002|FG001|Overall Study|Disease progression|5|||
155376512|NCT00513305|560811001|FG000|Overall Study|Eligible for stem cell transplant|1|||
155376513|NCT00513305|560811002|FG001|Overall Study|Eligible for stem cell transplant|0|||
155376514|NCT00513305|560811001|FG000|Overall Study|Hematologic counts did not recover|1|||
155376515|NCT00513305|560811002|FG001|Overall Study|Hematologic counts did not recover|0|||
155376516|NCT00513305|560811001|FG000|Overall Study|Physician Decision|1|||
155376517|NCT00513305|560811002|FG001|Overall Study|Physician Decision|0|||
155376518|NCT00513305|560811001|FG000|Overall Study|Persistent hypocellularity|0|||
155376519|NCT00513305|560811002|FG001|Overall Study|Persistent hypocellularity|1|||
155376520|NCT00513305|560811001|FG000|Overall Study|Sponsor Decision|0|||
155376521|NCT00513305|560811002|FG001|Overall Study|Sponsor Decision|2|||
155376522|NCT02101385|560811010|FG000|Study Treatment|Disease Progression|9|||
155376523|NCT02101385|560811011|FG001|Study Treatment|Disease Progression|3|||
155376524|NCT02101385|560811010|FG000|Study Treatment|Alternative therapy|0|||
155376525|NCT02101385|560811011|FG001|Study Treatment|Alternative therapy|1|||
155376526|NCT02101385|560811010|FG000|Study Treatment|No treatment, per protocol criteria|0|||
155512094|NCT04527471|561301175|FG001|Overall Study|Adverse Event|0|||
155512095|NCT04527471|561301174|FG000|Overall Study|Lost to Follow-up|1|||
155512096|NCT04527471|561301175|FG001|Overall Study|Lost to Follow-up|0|||
155512097|NCT01165996|561301181|FG000|Overall Study|Death|1|||
155512098|NCT01165996|561301181|FG000|Overall Study|Physician Decision|1|||
155512099|NCT00096265|561301182|FG000|Overall Study|Ineligible|1|||
155512100|NCT00096265|561301183|FG001|Overall Study|Ineligible|0|||
155512101|NCT00096265|561301184|FG002|Overall Study|Ineligible|0|||
155512102|NCT01506323|561301185|FG000|Overall Study|Lost to Follow-up|5|||
155512103|NCT01506323|561301186|FG001|Overall Study|Lost to Follow-up|4|||
155512104|NCT01506323|561301185|FG000|Overall Study|Withdrawal by Subject|4|||
155512105|NCT01506323|561301186|FG001|Overall Study|Withdrawal by Subject|4|||
155512106|NCT01506323|561301185|FG000|Overall Study|Lack of Efficacy|1|||
155512107|NCT01506323|561301186|FG001|Overall Study|Lack of Efficacy|3|||
155512108|NCT01506323|561301185|FG000|Overall Study|Moved out of area|5|||
155512109|NCT01506323|561301186|FG001|Overall Study|Moved out of area|2|||
155512110|NCT01506323|561301185|FG000|Overall Study|Schedule or Transportation conflict|8|||
155512111|NCT01506323|561301186|FG001|Overall Study|Schedule or Transportation conflict|0|||
155512112|NCT01506323|561301185|FG000|Overall Study|Started another treatment|1|||
155512113|NCT01506323|561301186|FG001|Overall Study|Started another treatment|0|||
155512114|NCT02232074|561301187|FG000|Overall Study|Withdrawal by Subject|5|||
155512115|NCT02232074|561301188|FG001|Overall Study|Withdrawal by Subject|3|||
155512116|NCT02232074|561301187|FG000|Overall Study|No legal concerns at baseline|36|||
155512117|NCT02232074|561301188|FG001|Overall Study|No legal concerns at baseline|41|||
155512118|NCT02232074|561301187|FG000|Overall Study|deemed ineligible|0|||
155512119|NCT02232074|561301188|FG001|Overall Study|deemed ineligible|1|||
155512120|NCT04081337|561301190|FG000|Overall Study|Adverse Event|0|||
155512121|NCT04081337|561301191|FG001|Overall Study|Adverse Event|1|||
155512122|NCT04081337|561301190|FG000|Overall Study|Withdrawal by Subject|2|||
155512123|NCT04081337|561301191|FG001|Overall Study|Withdrawal by Subject|0|||
155512124|NCT04081337|561301190|FG000|Overall Study|Physician Decision|1|||
155376527|NCT02101385|560811011|FG001|Study Treatment|No treatment, per protocol criteria|4|||
155376528|NCT02101385|560811010|FG000|Study Treatment|Patient Non compliance|0|||
155376529|NCT02101385|560811011|FG001|Study Treatment|Patient Non compliance|2|||
155376530|NCT02101385|560811010|FG000|Study Treatment|Withdrawal by Subject|5|||
155376531|NCT02101385|560811011|FG001|Study Treatment|Withdrawal by Subject|2|||
155376532|NCT02101385|560811010|FG000|Study Treatment|screen failure|1|||
155376533|NCT02101385|560811011|FG001|Study Treatment|screen failure|0|||
155376534|NCT02101385|560811010|FG000|Study Treatment|AE/Side Effects/Complications|8|||
155376535|NCT02101385|560811011|FG001|Study Treatment|AE/Side Effects/Complications|0|||
155376536|NCT02101385|560811010|FG000|Study Treatment|Lost to Follow-up|1|||
155376537|NCT02101385|560811011|FG001|Study Treatment|Lost to Follow-up|0|||
155376538|NCT02101385|560811010|FG000|Study Treatment|Disease Progression before treatment|1|||
155376539|NCT02101385|560811011|FG001|Study Treatment|Disease Progression before treatment|0|||
155376540|NCT02101385|560811010|FG000|Study Treatment|Death|1|||
155376541|NCT02101385|560811011|FG001|Study Treatment|Death|0|||
155376542|NCT02101385|560811010|FG000|Follow up|Lost to Follow-up|4|||
155376543|NCT02101385|560811011|FG001|Follow up|Lost to Follow-up|9|||
155376544|NCT02101385|560811010|FG000|Follow up|Refused to follow up|5|||
155376545|NCT02101385|560811011|FG001|Follow up|Refused to follow up|4|||
155376546|NCT02101385|560811010|FG000|Follow up|Death|21|||
155376547|NCT02101385|560811011|FG001|Follow up|Death|39|||
155376548|NCT02101385|560811010|FG000|Follow up|study completed|33|||
155376549|NCT02101385|560811011|FG001|Follow up|study completed|52|||
155376550|NCT02101385|560811010|FG000|Follow up|screen failure|2|||
155512125|NCT04081337|561301191|FG001|Overall Study|Physician Decision|2|||
155512126|NCT04081337|561301190|FG000|Overall Study|Lost to Follow-up|1|||
155512127|NCT04081337|561301191|FG001|Overall Study|Lost to Follow-up|0|||
155512128|NCT01579474|561301192|FG000|Overall Study|Adverse Event|1|||
155376551|NCT02101385|560811011|FG001|Follow up|screen failure|0|||
155376552|NCT02101385|560811010|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
155376553|NCT02101385|560811011|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
155376554|NCT02101385|560811010|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
155376555|NCT02101385|560811011|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
155512129|NCT01579474|561301193|FG001|Overall Study|Adverse Event|13|||
155512130|NCT01579474|561301194|FG002|Overall Study|Adverse Event|2|||
155512131|NCT01579474|561301195|FG003|Overall Study|Adverse Event|0|||
155512132|NCT01579474|561301196|FG004|Overall Study|Adverse Event|0|||
155512133|NCT01579474|561301197|FG005|Overall Study|Adverse Event|1|||
155512134|NCT01579474|561301192|FG000|Overall Study|Lack of Efficacy|1|||
155512135|NCT01579474|561301193|FG001|Overall Study|Lack of Efficacy|0|||
155512136|NCT01579474|561301194|FG002|Overall Study|Lack of Efficacy|0|||
155512137|NCT01579474|561301195|FG003|Overall Study|Lack of Efficacy|0|||
155512138|NCT01579474|561301196|FG004|Overall Study|Lack of Efficacy|1|||
155512139|NCT01579474|561301197|FG005|Overall Study|Lack of Efficacy|0|||
155512140|NCT01579474|561301192|FG000|Overall Study|Withdrawal by Subject|1|||
155512141|NCT01579474|561301193|FG001|Overall Study|Withdrawal by Subject|0|||
155512142|NCT01579474|561301194|FG002|Overall Study|Withdrawal by Subject|0|||
155512143|NCT01579474|561301195|FG003|Overall Study|Withdrawal by Subject|0|||
155512144|NCT01579474|561301196|FG004|Overall Study|Withdrawal by Subject|0|||
155512145|NCT01579474|561301197|FG005|Overall Study|Withdrawal by Subject|0|||
155512146|NCT02295774|561301199|FG000|Overall Study|Physician Decision|1|||
155512147|NCT02295774|561301199|FG000|Overall Study|Withdrawal by Subject|2|||
155512148|NCT01075763|561301200|FG000|Overall Study|Lost to Follow-up|2|||
155512149|NCT01075763|561301201|FG001|Overall Study|Lost to Follow-up|1|||
155512150|NCT01075763|561301200|FG000|Overall Study|Lack of Efficacy|0|||
155512151|NCT01075763|561301201|FG001|Overall Study|Lack of Efficacy|1|||
155512152|NCT01075763|561301200|FG000|Overall Study|Withdrawal by Subject|2|||
155512153|NCT01075763|561301201|FG001|Overall Study|Withdrawal by Subject|2|||
155512154|NCT00586521|561301202|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
155512155|NCT03083483|561301206|FG000|Overall Study|Adverse Event|1|||
155512156|NCT03083483|561301207|FG001|Overall Study|Adverse Event|1|||
155512157|NCT03083483|561301208|FG002|Overall Study|Adverse Event|1|||
155512158|NCT03083483|561301206|FG000|Overall Study|Lost to Follow-up|2|||
155512159|NCT03083483|561301207|FG001|Overall Study|Lost to Follow-up|1|||
155512160|NCT03083483|561301208|FG002|Overall Study|Lost to Follow-up|1|||
155512161|NCT03083483|561301206|FG000|Overall Study|technological issues|1|||
155512162|NCT03083483|561301207|FG001|Overall Study|technological issues|0|||
155512163|NCT03083483|561301208|FG002|Overall Study|technological issues|1|||
155512164|NCT00449072|561301216|FG000|Overall Study|Adverse Event|3|||
155512165|NCT00449072|561301217|FG001|Overall Study|Adverse Event|1|||
155512166|NCT00449072|561301216|FG000|Overall Study|Protocol Violation|14|||
155512167|NCT00449072|561301217|FG001|Overall Study|Protocol Violation|12|||
155512168|NCT00449072|561301216|FG000|Overall Study|Lost to Follow-up|5|||
155512169|NCT00449072|561301217|FG001|Overall Study|Lost to Follow-up|7|||
155512170|NCT00449072|561301216|FG000|Overall Study|Withdrawal by Subject|11|||
155512171|NCT00449072|561301217|FG001|Overall Study|Withdrawal by Subject|8|||
155512172|NCT00449072|561301216|FG000|Overall Study|Lack of Efficacy|1|||
155512173|NCT00449072|561301217|FG001|Overall Study|Lack of Efficacy|1|||
155512174|NCT00449072|561301216|FG000|Overall Study|Physician Decision|1|||
155512175|NCT00449072|561301217|FG001|Overall Study|Physician Decision|0|||
155512176|NCT00449072|561301216|FG000|Overall Study|Not treated|0|||
155512177|NCT00449072|561301217|FG001|Overall Study|Not treated|1|||
155512178|NCT00449072|561301216|FG000|Overall Study|Excluded medication|0|||
155512179|NCT00449072|561301217|FG001|Overall Study|Excluded medication|2|||
155512180|NCT00449072|561301216|FG000|Overall Study|Non-compliance|2|||
155512181|NCT00449072|561301217|FG001|Overall Study|Non-compliance|5|||
155512182|NCT00449072|561301216|FG000|Overall Study|Sponsor decision|1|||
155512183|NCT00449072|561301217|FG001|Overall Study|Sponsor decision|3|||
155512184|NCT00449072|561301216|FG000|Overall Study|Relocation|3|||
155512185|NCT00449072|561301217|FG001|Overall Study|Relocation|2|||
155512186|NCT02623959|561301218|FG000|Overall Study|Progression|0|||
155512187|NCT02623959|561301219|FG001|Overall Study|Progression|1|||
155512188|NCT00989261|561301220|FG000|Overall Study|Still in follow up|12|||
155512189|NCT00989261|561301221|FG001|Overall Study|Still in follow up|21|||
155512190|NCT00989261|561301220|FG000|Overall Study|Withdrawal by Subject|0|||
155512191|NCT00989261|561301221|FG001|Overall Study|Withdrawal by Subject|1|||
155512192|NCT00989261|561301220|FG000|Overall Study|Lost to Follow-up|3|||
155512193|NCT00989261|561301221|FG001|Overall Study|Lost to Follow-up|0|||
155512194|NCT00441584|561301226|FG000|Overall Study|Lack of Efficacy|79|||
155512195|NCT00441584|561301226|FG000|Overall Study|Withdrawal by Subject|8|||
155512196|NCT00441584|561301226|FG000|Overall Study|Adverse Event|6|||
155512197|NCT00441584|561301226|FG000|Overall Study|Protocol Violation|5|||
155512198|NCT00441584|561301226|FG000|Overall Study|Lost to Follow-up|4|||
155512199|NCT00441584|561301226|FG000|Overall Study|Failure to meet eligibility criteria|3|||
155512200|NCT00368966|561301227|FG000|Infant Series|Withdrawal by Subject|11|||
155512201|NCT00368966|561301228|FG001|Infant Series|Withdrawal by Subject|6|||
155512202|NCT00368966|561301227|FG000|Infant Series|Protocol Violation|2|||
155512203|NCT00368966|561301228|FG001|Infant Series|Protocol Violation|1|||
155512204|NCT00368966|561301227|FG000|Infant Series|Lost to Follow-up|2|||
155512205|NCT00368966|561301228|FG001|Infant Series|Lost to Follow-up|0|||
155512206|NCT00368966|561301227|FG000|Infant Series|Randomization error|0|||
155512207|NCT00368966|561301228|FG001|Infant Series|Randomization error|1|||
155512208|NCT00368966|561301227|FG000|Infant Series|Failed to meet eligibility criteria|0|||
155512209|NCT00368966|561301228|FG001|Infant Series|Failed to meet eligibility criteria|1|||
155512210|NCT00368966|561301227|FG000|Infant Series|Adverse Event|0|||
155512211|NCT00368966|561301228|FG001|Infant Series|Adverse Event|1|||
155512212|NCT00368966|561301227|FG000|Infant Series|Failed to return|1|||
155512213|NCT00368966|561301228|FG001|Infant Series|Failed to return|0|||
155512214|NCT00368966|561301227|FG000|After Infant|Failed to return|3|||
155512215|NCT00368966|561301228|FG001|After Infant|Failed to return|1|||
155512216|NCT00368966|561301227|FG000|After Infant|Adverse Event|1|||
155512217|NCT00368966|561301228|FG001|After Infant|Adverse Event|2|||
155512218|NCT00368966|561301227|FG000|After Infant|Withdrawal by Subject|1|||
155376556|NCT02101385|560811010|FG000|Follow up|Withdrawal by Subject|2|||
155376557|NCT02101385|560811011|FG001|Follow up|Withdrawal by Subject|2|||
155376558|NCT02101385|560811010|FG000|Follow up|PI requested closure of site|0|||
155376559|NCT02101385|560811011|FG001|Follow up|PI requested closure of site|5|||
155376560|NCT02516332|560812680|FG000|Overall Study|Withdrawal by Subject|2|||
155376561|NCT02516332|560812681|FG001|Overall Study|Withdrawal by Subject|1|||
155376562|NCT02516332|560812682|FG002|Overall Study|Withdrawal by Subject|2|||
155376563|NCT03573583|560812685|FG000|Overall Study|Lost to Follow-up|1|||
155376564|NCT03573583|560812686|FG001|Overall Study|Lost to Follow-up|0|||
155376565|NCT03573583|560812685|FG000|Overall Study|Withdrawal by Subject|1|||
155376566|NCT03573583|560812686|FG001|Overall Study|Withdrawal by Subject|1|||
155376567|NCT01658150|560812689|FG000|Overall Study|Withdrawal by Subject|1|||
155376568|NCT04187989|560812690|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
155376569|NCT04187989|560812691|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
155376570|NCT04187989|560812690|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
155376571|NCT04187989|560812691|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
155512219|NCT00368966|561301228|FG001|After Infant|Withdrawal by Subject|1|||
155512220|NCT00368966|561301227|FG000|After Infant|Death|1|||
155512221|NCT00368966|561301228|FG001|After Infant|Death|0|||
155512222|NCT00368966|561301227|FG000|After Infant|Lost to Follow-up|0|||
155512223|NCT00368966|561301228|FG001|After Infant|Lost to Follow-up|1|||
155512224|NCT00368966|561301227|FG000|Toddler Dose|Withdrawal by Subject|1|||
155512225|NCT00368966|561301228|FG001|Toddler Dose|Withdrawal by Subject|1|||
155512226|NCT00368966|561301227|FG000|Toddler Dose|Lost to Follow-up|0|||
155512227|NCT00368966|561301228|FG001|Toddler Dose|Lost to Follow-up|2|||
155512228|NCT01694485|561301231|FG000|Overall Study|Withdrawal by Subject|20|||
155512229|NCT01694485|561301232|FG001|Overall Study|Withdrawal by Subject|6|||
155512230|NCT01694485|561301233|FG002|Overall Study|Withdrawal by Subject|7|||
155512231|NCT01694485|561301234|FG003|Overall Study|Withdrawal by Subject|25|||
155512232|NCT01694485|561301235|FG004|Overall Study|Withdrawal by Subject|18|||
155512233|NCT01694485|561301231|FG000|Overall Study|Sponsor Decision|3|||
155376576|NCT01144052|560812694|FG000|Overall Study|Withdrawal by Subject|1|||
155376577|NCT01144052|560812695|FG001|Overall Study|Withdrawal by Subject|1|||
155376578|NCT03836716|560812699|FG000|Overall Study|Adverse Event|3|||
155376579|NCT03836716|560812699|FG000|Overall Study|Death|22|||
155376580|NCT03836716|560812699|FG000|Overall Study|Withdrawal by Subject|8|||
155376581|NCT03836716|560812699|FG000|Overall Study|Study terminated by sponsor|87|||
155376582|NCT01983254|560812700|FG000|Overall Study|Death|6|||
155376583|NCT01983254|560812701|FG001|Overall Study|Death|6|||
155376584|NCT01983254|560812700|FG000|Overall Study|Lost to Follow-up|17|||
155376585|NCT01983254|560812701|FG001|Overall Study|Lost to Follow-up|16|||
155376586|NCT01983254|560812700|FG000|Overall Study|too ill|11|||
155376587|NCT01983254|560812701|FG001|Overall Study|too ill|8|||
155376588|NCT01631227|560812707|FG000|Overall Study|withdrawn consent|27|||
155376589|NCT01631227|560812708|FG001|Overall Study|withdrawn consent|21|||
155376590|NCT01631227|560812707|FG000|Overall Study|Adverse Event|1|||
155376591|NCT01631227|560812708|FG001|Overall Study|Adverse Event|0|||
155376592|NCT01631227|560812707|FG000|Overall Study|administrative|2|||
155376593|NCT01631227|560812708|FG001|Overall Study|administrative|1|||
155376594|NCT00766363|560812709|FG000|Overall Study|Withdrawal by Subject|1|||
155376595|NCT00766363|560812710|FG001|Overall Study|Withdrawal by Subject|0|||
155376596|NCT00766363|560812711|FG002|Overall Study|Withdrawal by Subject|0|||
155376597|NCT00766363|560812712|FG003|Overall Study|Withdrawal by Subject|0|||
155376598|NCT00766363|560812709|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
155376599|NCT00766363|560812710|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
155376600|NCT00766363|560812711|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
155376601|NCT00766363|560812712|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
155376602|NCT03020576|560812713|FG000|Overall Study|Withdrawal by Subject|1|||
155376603|NCT03020576|560812714|FG001|Overall Study|Withdrawal by Subject|2|||
155376604|NCT03292432|560812715|FG000|Overall Study|Lost to Follow-up|11|||
155376605|NCT03292432|560812716|FG001|Overall Study|Lost to Follow-up|8|||
155376606|NCT03292432|560812715|FG000|Overall Study|Death|2|||
155376607|NCT03292432|560812716|FG001|Overall Study|Death|1|||
155376608|NCT03292432|560812715|FG000|Overall Study|Withdrawal by Subject|1|||
155376609|NCT03292432|560812716|FG001|Overall Study|Withdrawal by Subject|2|||
155376610|NCT03292432|560812715|FG000|Overall Study|Site closed before any data collected|1|||
155376611|NCT03292432|560812716|FG001|Overall Study|Site closed before any data collected|0|||
155376612|NCT01498679|560812717|FG000|Overall Study|Adverse Event|1|||
155376613|NCT01498679|560812718|FG001|Overall Study|Adverse Event|4|||
155376614|NCT01498679|560812717|FG000|Overall Study|Lack of Efficacy|72|||
155376615|NCT01498679|560812718|FG001|Overall Study|Lack of Efficacy|12|||
155376616|NCT01498679|560812717|FG000|Overall Study|Protocol Violation|4|||
155376617|NCT01498679|560812718|FG001|Overall Study|Protocol Violation|0|||
155376618|NCT01498679|560812717|FG000|Overall Study|Physician Decision|0|||
155376619|NCT01498679|560812718|FG001|Overall Study|Physician Decision|2|||
155376620|NCT01498679|560812717|FG000|Overall Study|Withdrawal by Subject|12|||
155376621|NCT01498679|560812718|FG001|Overall Study|Withdrawal by Subject|4|||
155376622|NCT01871805|560812720|FG000|Phase I|Death|7|||
155376623|NCT01871805|560812721|FG001|Phase I|Death|4|||
155376624|NCT01871805|560812722|FG002|Phase I|Death|6|||
155376625|NCT01871805|560812723|FG003|Phase I|Death|2|||
155376626|NCT01871805|560812724|FG004|Phase I|Death|9|||
155376627|NCT01871805|560812725|FG005|Phase I|Death|0|||
155376628|NCT01871805|560812720|FG000|Phase I|Alive in Survival Follow-up|0|||
155376629|NCT01871805|560812721|FG001|Phase I|Alive in Survival Follow-up|2|||
155376630|NCT01871805|560812722|FG002|Phase I|Alive in Survival Follow-up|4|||
155376631|NCT01871805|560812723|FG003|Phase I|Alive in Survival Follow-up|5|||
155376632|NCT01871805|560812724|FG004|Phase I|Alive in Survival Follow-up|4|||
155376633|NCT01871805|560812725|FG005|Phase I|Alive in Survival Follow-up|0|||
155376634|NCT01871805|560812720|FG000|Phase I|Lost to Follow-up|0|||
155376635|NCT01871805|560812721|FG001|Phase I|Lost to Follow-up|1|||
155376636|NCT01871805|560812722|FG002|Phase I|Lost to Follow-up|3|||
155376637|NCT01871805|560812723|FG003|Phase I|Lost to Follow-up|0|||
155376638|NCT01871805|560812724|FG004|Phase I|Lost to Follow-up|0|||
155376639|NCT01871805|560812725|FG005|Phase I|Lost to Follow-up|0|||
155376640|NCT01871805|560812720|FG000|Phase II|Death|0|||
155376641|NCT01871805|560812721|FG001|Phase II|Death|0|||
155376642|NCT01871805|560812722|FG002|Phase II|Death|0|||
155376643|NCT01871805|560812723|FG003|Phase II|Death|0|||
155376644|NCT01871805|560812724|FG004|Phase II|Death|0|||
155376645|NCT01871805|560812725|FG005|Phase II|Death|45|||
155376646|NCT01871805|560812720|FG000|Phase II|Alive in Survival Follow-up|0|||
155376647|NCT01871805|560812721|FG001|Phase II|Alive in Survival Follow-up|0|||
155376648|NCT01871805|560812722|FG002|Phase II|Alive in Survival Follow-up|0|||
155376649|NCT01871805|560812723|FG003|Phase II|Alive in Survival Follow-up|0|||
155376650|NCT01871805|560812724|FG004|Phase II|Alive in Survival Follow-up|0|||
155376651|NCT01871805|560812725|FG005|Phase II|Alive in Survival Follow-up|29|||
155376652|NCT01871805|560812720|FG000|Phase II|Lost to Follow-up|0|||
155512234|NCT01694485|561301232|FG001|Overall Study|Sponsor Decision|0|||
155649877|NCT01362270|561810181|FG001|Overall Study|Met excl. criteria before 1st session|1|||
155649878|NCT01691482|561810184|FG000|Treatment Period 2|Adverse Event|0|||
155649879|NCT01691482|561810185|FG001|Treatment Period 2|Adverse Event|1|||
155649880|NCT01691482|561810184|FG000|Treatment Period 2|Protocol Violation|1|||
155649881|NCT01691482|561810185|FG001|Treatment Period 2|Protocol Violation|1|||
155649882|NCT01392495|561810186|FG000|Overall Study|Death|3|||
155649883|NCT01392495|561810186|FG000|Overall Study|Administrative problems|8|||
155649884|NCT01392495|561810186|FG000|Overall Study|Withdrawal by Subject|2|||
155649885|NCT01392495|561810186|FG000|Overall Study|Adverse Event|3|||
155649886|NCT02571244|561810187|FG000|Overall Study|Lost to Follow-up|0|||
155649887|NCT02571244|561810188|FG001|Overall Study|Lost to Follow-up|1|||
155649888|NCT02571244|561810187|FG000|Overall Study|Unable to reach out post discharge|3|||
155649889|NCT02571244|561810188|FG001|Overall Study|Unable to reach out post discharge|0|||
155649890|NCT01696214|561810189|FG000|Overall Study|Lost to Follow-up|1|||
155649891|NCT01696214|561810190|FG001|Overall Study|Lost to Follow-up|0|||
155649892|NCT01696214|561810191|FG002|Overall Study|Lost to Follow-up|0|||
155649893|NCT01696214|561810192|FG003|Overall Study|Lost to Follow-up|0|||
155649894|NCT02134028|561810193|FG000|Overall Study|Lack of Efficacy|1|||
155649895|NCT02134028|561810194|FG001|Overall Study|Lack of Efficacy|0|||
155649896|NCT02134028|561810195|FG002|Overall Study|Lack of Efficacy|3|||
155649897|NCT02134028|561810196|FG003|Overall Study|Lack of Efficacy|2|||
155649898|NCT02134028|561810197|FG004|Overall Study|Lack of Efficacy|1|||
155649899|NCT02134028|561810198|FG005|Overall Study|Lack of Efficacy|2|||
155649900|NCT02134028|561810199|FG006|Overall Study|Lack of Efficacy|1|||
155649901|NCT02134028|561810200|FG007|Overall Study|Lack of Efficacy|0|||
155376653|NCT01871805|560812721|FG001|Phase II|Lost to Follow-up|0|||
155376654|NCT01871805|560812722|FG002|Phase II|Lost to Follow-up|0|||
155376655|NCT01871805|560812723|FG003|Phase II|Lost to Follow-up|0|||
155376656|NCT01871805|560812724|FG004|Phase II|Lost to Follow-up|0|||
155376657|NCT01871805|560812725|FG005|Phase II|Lost to Follow-up|13|||
155376658|NCT03484273|560812734|FG000|Overall Study|Equipment Malfunction|1|||
155376659|NCT03484273|560812734|FG000|Overall Study|Data excluded from analysis|1|||
155376660|NCT00468104|560812740|FG000|First Intervention|Protocol Violation|2|||
155376661|NCT00468104|560812741|FG001|First Intervention|Protocol Violation|1|||
155376662|NCT00468104|560812740|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
155376663|NCT00468104|560812741|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
155376664|NCT00468104|560812740|FG000|First Intervention|died within 3 weeks|1|||
155376665|NCT00468104|560812741|FG001|First Intervention|died within 3 weeks|0|||
155376666|NCT00468104|560812740|FG000|First Intervention|malposition/blocked chest tube tube|2|||
155376667|NCT00468104|560812741|FG001|First Intervention|malposition/blocked chest tube tube|0|||
155376668|NCT00468104|560812740|FG000|First Intervention|large lung mass with minimal effusion|1|||
155376669|NCT00468104|560812741|FG001|First Intervention|large lung mass with minimal effusion|0|||
155376670|NCT00468104|560812740|FG000|First Intervention|associated prolonged pneumothorax|1|||
155376671|NCT00468104|560812741|FG001|First Intervention|associated prolonged pneumothorax|0|||
155376672|NCT00468104|560812740|FG000|First Intervention|trapped lung|1|||
155376673|NCT00468104|560812741|FG001|First Intervention|trapped lung|0|||
155376674|NCT00468104|560812740|FG000|Second Intervention|Withdrawal by Subject|5|||
155376675|NCT00468104|560812741|FG001|Second Intervention|Withdrawal by Subject|2|||
155376676|NCT00468104|560812740|FG000|Second Intervention|discarded for malposition of chest tube|0|||
155376677|NCT00468104|560812741|FG001|Second Intervention|discarded for malposition of chest tube|2|||
155376678|NCT01263665|560812742|FG000|Overall Study|Withdrew Consent|1|||
155376679|NCT01263665|560812742|FG000|Overall Study|Lost to Follow-up|3|||
155376680|NCT01263665|560812742|FG000|Overall Study|Death|2|||
155376681|NCT01263665|560812742|FG000|Overall Study|Amputation above the ankle|1|||
155376682|NCT01263665|560812742|FG000|Overall Study|Surgical Bypass|2|||
155376683|NCT02706899|560812747|FG000|Overall Study|Withdrawal by Subject|1|||
155376684|NCT02706899|560812748|FG001|Overall Study|Withdrawal by Subject|0|||
155376685|NCT02706899|560812747|FG000|Overall Study|Death|8|||
155376686|NCT02706899|560812748|FG001|Overall Study|Death|0|||
155376687|NCT02706899|560812747|FG000|Overall Study|Study Termination by Sponsor|4|||
155376688|NCT02706899|560812748|FG001|Overall Study|Study Termination by Sponsor|6|||
155376689|NCT00324675|560812749|FG000|Overall Study|Adverse Event|1|||
155376690|NCT00324675|560812750|FG001|Overall Study|Adverse Event|0|||
155376691|NCT00381615|560812751|FG000|Overall Study|Withdrawal by Subject|1|||
155376692|NCT00381615|560812752|FG001|Overall Study|Withdrawal by Subject|3|||
155376693|NCT00381615|560812753|FG002|Overall Study|Withdrawal by Subject|0|||
155376694|NCT00381615|560812754|FG003|Overall Study|Withdrawal by Subject|1|||
155649902|NCT02134028|561810193|FG000|Overall Study|Poor compliance to protocol|1|||
155376695|NCT00381615|560812751|FG000|Overall Study|Lost to Follow-up|3|||
155649903|NCT02134028|561810194|FG001|Overall Study|Poor compliance to protocol|1|||
155376696|NCT00381615|560812752|FG001|Overall Study|Lost to Follow-up|2|||
155376697|NCT00381615|560812753|FG002|Overall Study|Lost to Follow-up|0|||
155376698|NCT00381615|560812754|FG003|Overall Study|Lost to Follow-up|1|||
155376699|NCT00381615|560812751|FG000|Overall Study|Protocol Violation|0|||
155376700|NCT00381615|560812752|FG001|Overall Study|Protocol Violation|0|||
155649904|NCT02134028|561810195|FG002|Overall Study|Poor compliance to protocol|3|||
155512235|NCT01694485|561301233|FG002|Overall Study|Sponsor Decision|0|||
155512236|NCT01694485|561301234|FG003|Overall Study|Sponsor Decision|2|||
155376701|NCT00381615|560812753|FG002|Overall Study|Protocol Violation|1|||
155376702|NCT00381615|560812754|FG003|Overall Study|Protocol Violation|0|||
155376703|NCT04811131|560812766|FG000|Overall Study|Adverse Event|0|||
155376704|NCT04811131|560812767|FG001|Overall Study|Adverse Event|0|||
155376705|NCT04811131|560812768|FG002|Overall Study|Adverse Event|1|||
155376706|NCT04811131|560812769|FG003|Overall Study|Adverse Event|0|||
155376707|NCT04811131|560812766|FG000|Overall Study|Lack of Efficacy|0|||
155376708|NCT04811131|560812767|FG001|Overall Study|Lack of Efficacy|0|||
155376709|NCT04811131|560812768|FG002|Overall Study|Lack of Efficacy|0|||
155376710|NCT04811131|560812769|FG003|Overall Study|Lack of Efficacy|1|||
155376711|NCT04811131|560812766|FG000|Overall Study|Lost to Follow-up|0|||
155376712|NCT04811131|560812767|FG001|Overall Study|Lost to Follow-up|1|||
155376713|NCT04811131|560812768|FG002|Overall Study|Lost to Follow-up|0|||
155376714|NCT04811131|560812769|FG003|Overall Study|Lost to Follow-up|0|||
155376715|NCT04811131|560812766|FG000|Overall Study|Sponsor request|31|||
155376716|NCT04811131|560812767|FG001|Overall Study|Sponsor request|35|||
155376717|NCT04811131|560812768|FG002|Overall Study|Sponsor request|27|||
155376718|NCT04811131|560812769|FG003|Overall Study|Sponsor request|10|||
155376719|NCT04811131|560812766|FG000|Overall Study|Withdrawal by Subject|3|||
155376720|NCT04811131|560812767|FG001|Overall Study|Withdrawal by Subject|1|||
155376721|NCT04811131|560812768|FG002|Overall Study|Withdrawal by Subject|3|||
155376722|NCT04811131|560812769|FG003|Overall Study|Withdrawal by Subject|1|||
155376723|NCT03181789|560812773|FG000|Overall Study|Withdrawal by Subject|0|||
155376724|NCT03181789|560812774|FG001|Overall Study|Withdrawal by Subject|1|||
155376725|NCT03181789|560812775|FG002|Overall Study|Withdrawal by Subject|1|||
155376726|NCT03181789|560812776|FG003|Overall Study|Withdrawal by Subject|0|||
155376727|NCT03181789|560812773|FG000|Overall Study|Lost to Follow-up|7|||
155376728|NCT03181789|560812774|FG001|Overall Study|Lost to Follow-up|1|||
155376729|NCT03181789|560812775|FG002|Overall Study|Lost to Follow-up|0|||
155376730|NCT03181789|560812776|FG003|Overall Study|Lost to Follow-up|0|||
155376731|NCT03181789|560812773|FG000|Overall Study|Participant unable to adhere to visit|0|||
155376732|NCT03181789|560812774|FG001|Overall Study|Participant unable to adhere to visit|1|||
155376733|NCT03181789|560812775|FG002|Overall Study|Participant unable to adhere to visit|0|||
155376734|NCT03181789|560812776|FG003|Overall Study|Participant unable to adhere to visit|0|||
155376735|NCT01131182|560812777|FG000|Overall Study|Withdrawal by Subject|1|||
155376736|NCT01131182|560812778|FG001|Overall Study|Withdrawal by Subject|1|||
155376737|NCT01131182|560812777|FG000|Overall Study|Lost to Follow-up|14|||
155376738|NCT01131182|560812778|FG001|Overall Study|Lost to Follow-up|15|||
155376739|NCT01131182|560812777|FG000|Overall Study|Other Reason|1|||
155376740|NCT01131182|560812778|FG001|Overall Study|Other Reason|0|||
155376741|NCT03001076|560812779|FG000|Overall Study|Withdrawal by patient|2|||
155376742|NCT03001076|560812780|FG001|Overall Study|Withdrawal by patient|0|||
155376743|NCT03001076|560812779|FG000|Overall Study|Other|1|||
155376744|NCT03001076|560812780|FG001|Overall Study|Other|0|||
155376745|NCT03001076|560812779|FG000|Overall Study|Adverse Event|3|||
155376746|NCT03001076|560812780|FG001|Overall Study|Adverse Event|3|||
155376747|NCT03001076|560812779|FG000|Overall Study|Sponsor decision|1|||
155376748|NCT03001076|560812780|FG001|Overall Study|Sponsor decision|0|||
155376749|NCT03001076|560812779|FG000|Overall Study|Lost to Follow-up|0|||
155376750|NCT03001076|560812780|FG001|Overall Study|Lost to Follow-up|2|||
155431381|NCT03874234|561005059|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431382|NCT03874234|561005060|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431383|NCT03874234|561005061|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431384|NCT03874234|561005062|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431385|NCT03874234|561005063|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155431386|NCT03874234|561005051|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431387|NCT03874234|561005052|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431388|NCT03874234|561005053|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431389|NCT03874234|561005054|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431390|NCT03874234|561005055|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
155512237|NCT01694485|561301235|FG004|Overall Study|Sponsor Decision|0|||
155512238|NCT01694485|561301231|FG000|Overall Study|Lost to Follow-up|9|||
155649905|NCT02134028|561810196|FG003|Overall Study|Poor compliance to protocol|7|||
155649906|NCT02134028|561810197|FG004|Overall Study|Poor compliance to protocol|1|||
155376751|NCT04602221|560812781|FG000|Overall Study|Discontinuation of trial treatment|0|||
155376752|NCT04602221|560812782|FG001|Overall Study|Discontinuation of trial treatment|0|||
155376753|NCT04602221|560812783|FG002|Overall Study|Discontinuation of trial treatment|1|||
155376754|NCT04602221|560812784|FG003|Overall Study|Discontinuation of trial treatment|0|||
155376755|NCT04602221|560812785|FG004|Overall Study|Discontinuation of trial treatment|0|||
155376756|NCT04602221|560812786|FG005|Overall Study|Discontinuation of trial treatment|0|||
155376757|NCT04602221|560812787|FG006|Overall Study|Discontinuation of trial treatment|0|||
155376758|NCT04602221|560812788|FG007|Overall Study|Discontinuation of trial treatment|0|||
155512239|NCT01694485|561301232|FG001|Overall Study|Lost to Follow-up|1|||
155376759|NCT04602221|560812789|FG008|Overall Study|Discontinuation of trial treatment|0|||
155376760|NCT04602221|560812790|FG009|Overall Study|Discontinuation of trial treatment|0|||
155376761|NCT04602221|560812791|FG010|Overall Study|Discontinuation of trial treatment|0|||
155376762|NCT04602221|560812792|FG011|Overall Study|Discontinuation of trial treatment|0|||
155376763|NCT04602221|560812793|FG012|Overall Study|Discontinuation of trial treatment|0|||
155376764|NCT04602221|560812794|FG013|Overall Study|Discontinuation of trial treatment|0|||
155376765|NCT04602221|560812795|FG014|Overall Study|Discontinuation of trial treatment|0|||
155376766|NCT04602221|560812796|FG015|Overall Study|Discontinuation of trial treatment|0|||
155376767|NCT04602221|560812797|FG016|Overall Study|Discontinuation of trial treatment|0|||
155376768|NCT04602221|560812798|FG017|Overall Study|Discontinuation of trial treatment|0|||
155376769|NCT04602221|560812781|FG000|Overall Study|Other than listed|0|||
155376770|NCT04602221|560812782|FG001|Overall Study|Other than listed|0|||
155376771|NCT04602221|560812783|FG002|Overall Study|Other than listed|0|||
155376772|NCT04602221|560812784|FG003|Overall Study|Other than listed|0|||
155376773|NCT04602221|560812785|FG004|Overall Study|Other than listed|0|||
155376774|NCT04602221|560812786|FG005|Overall Study|Other than listed|0|||
155376775|NCT04602221|560812787|FG006|Overall Study|Other than listed|0|||
155376776|NCT04602221|560812788|FG007|Overall Study|Other than listed|0|||
155376777|NCT04602221|560812789|FG008|Overall Study|Other than listed|0|||
155376778|NCT04602221|560812790|FG009|Overall Study|Other than listed|0|||
155376779|NCT04602221|560812791|FG010|Overall Study|Other than listed|0|||
155376780|NCT04602221|560812792|FG011|Overall Study|Other than listed|0|||
155376781|NCT04602221|560812793|FG012|Overall Study|Other than listed|0|||
155376782|NCT04602221|560812794|FG013|Overall Study|Other than listed|0|||
155376783|NCT04602221|560812795|FG014|Overall Study|Other than listed|0|||
155376784|NCT04602221|560812796|FG015|Overall Study|Other than listed|1|||
155376785|NCT04602221|560812797|FG016|Overall Study|Other than listed|0|||
155376786|NCT04602221|560812798|FG017|Overall Study|Other than listed|1|||
155376787|NCT04602221|560812781|FG000|Overall Study|Withdrawal by Subject|0|||
155376788|NCT04602221|560812782|FG001|Overall Study|Withdrawal by Subject|0|||
155376789|NCT04602221|560812783|FG002|Overall Study|Withdrawal by Subject|0|||
155376790|NCT04602221|560812784|FG003|Overall Study|Withdrawal by Subject|0|||
155376791|NCT04602221|560812785|FG004|Overall Study|Withdrawal by Subject|0|||
155376792|NCT04602221|560812786|FG005|Overall Study|Withdrawal by Subject|0|||
155376793|NCT04602221|560812787|FG006|Overall Study|Withdrawal by Subject|0|||
155431391|NCT03874234|561005056|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431392|NCT03874234|561005057|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431393|NCT03874234|561005058|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431394|NCT03874234|561005059|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431395|NCT03874234|561005060|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431396|NCT03874234|561005061|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431397|NCT03874234|561005062|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431398|NCT03874234|561005063|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155431399|NCT01896232|561005069|FG000|Overall Study|Death|6|||
155431400|NCT01896232|561005070|FG001|Overall Study|Death|10|||
155431401|NCT01896232|561005069|FG000|Overall Study|Withdrawal by Subject|32|||
155431402|NCT01896232|561005070|FG001|Overall Study|Withdrawal by Subject|31|||
155431403|NCT01896232|561005069|FG000|Overall Study|Sponsor Decision|2|||
155431404|NCT01896232|561005070|FG001|Overall Study|Sponsor Decision|0|||
155431405|NCT01896232|561005069|FG000|Overall Study|Lost to Follow-up|9|||
155431406|NCT01896232|561005070|FG001|Overall Study|Lost to Follow-up|12|||
155431407|NCT00486902|561005080|FG000|Overall Study|Withdrawal by Subject|1|||
155431408|NCT00486902|561005081|FG001|Overall Study|Withdrawal by Subject|2|||
155431409|NCT00486902|561005080|FG000|Overall Study|decision for postpartum tubal ligation|3|||
155431410|NCT00486902|561005081|FG001|Overall Study|decision for postpartum tubal ligation|1|||
155431411|NCT00486902|561005080|FG000|Overall Study|spinal anesthetic protocal violation|1|||
155431412|NCT00486902|561005081|FG001|Overall Study|spinal anesthetic protocal violation|1|||
155431413|NCT00486902|561005080|FG000|Overall Study|Did not meet inclusion criteria|1|||
155431414|NCT00486902|561005081|FG001|Overall Study|Did not meet inclusion criteria|0|||
155431415|NCT00486902|561005080|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
155431416|NCT00486902|561005081|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
155431417|NCT04178590|561005084|FG000|Overall Study|Pregnancy|1|||
155431418|NCT04178590|561005084|FG000|Overall Study|Lost to Follow-up|1|||
155376794|NCT04602221|560812788|FG007|Overall Study|Withdrawal by Subject|0|||
155376795|NCT04602221|560812789|FG008|Overall Study|Withdrawal by Subject|0|||
155376796|NCT04602221|560812790|FG009|Overall Study|Withdrawal by Subject|0|||
155376797|NCT04602221|560812791|FG010|Overall Study|Withdrawal by Subject|0|||
155376798|NCT04602221|560812792|FG011|Overall Study|Withdrawal by Subject|0|||
155376799|NCT04602221|560812793|FG012|Overall Study|Withdrawal by Subject|1|||
155376800|NCT04602221|560812794|FG013|Overall Study|Withdrawal by Subject|0|||
155376801|NCT04602221|560812795|FG014|Overall Study|Withdrawal by Subject|0|||
155376802|NCT04602221|560812796|FG015|Overall Study|Withdrawal by Subject|0|||
155376803|NCT04602221|560812797|FG016|Overall Study|Withdrawal by Subject|0|||
155431419|NCT04723537|561005085|FG000|Overall Study|Withdrawal by Subject|3|||
155376804|NCT04602221|560812798|FG017|Overall Study|Withdrawal by Subject|0|||
155376805|NCT04602221|560812781|FG000|Overall Study|Lost to Follow-up|0|||
155376806|NCT04602221|560812782|FG001|Overall Study|Lost to Follow-up|0|||
155376807|NCT04602221|560812783|FG002|Overall Study|Lost to Follow-up|0|||
155376808|NCT04602221|560812784|FG003|Overall Study|Lost to Follow-up|0|||
155376809|NCT04602221|560812785|FG004|Overall Study|Lost to Follow-up|0|||
155376810|NCT04602221|560812786|FG005|Overall Study|Lost to Follow-up|1|||
155376811|NCT04602221|560812787|FG006|Overall Study|Lost to Follow-up|0|||
155512240|NCT01694485|561301233|FG002|Overall Study|Lost to Follow-up|6|||
155376812|NCT04602221|560812788|FG007|Overall Study|Lost to Follow-up|0|||
155376813|NCT04602221|560812789|FG008|Overall Study|Lost to Follow-up|0|||
155376814|NCT04602221|560812790|FG009|Overall Study|Lost to Follow-up|0|||
155376815|NCT04602221|560812791|FG010|Overall Study|Lost to Follow-up|0|||
155376816|NCT04602221|560812792|FG011|Overall Study|Lost to Follow-up|0|||
155376817|NCT04602221|560812793|FG012|Overall Study|Lost to Follow-up|0|||
155376818|NCT04602221|560812794|FG013|Overall Study|Lost to Follow-up|0|||
155376819|NCT04602221|560812795|FG014|Overall Study|Lost to Follow-up|0|||
155376820|NCT04602221|560812796|FG015|Overall Study|Lost to Follow-up|0|||
155376821|NCT04602221|560812797|FG016|Overall Study|Lost to Follow-up|0|||
155376822|NCT04602221|560812798|FG017|Overall Study|Lost to Follow-up|0|||
155376823|NCT02576587|560812799|FG000|Baseline|Equipment failure|0|||
155376824|NCT02576587|560812800|FG001|Baseline|Equipment failure|1|||
155376825|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
155376826|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
155376827|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
155376828|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
155376829|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
155376830|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
155376831|NCT01080716|560812801|FG000|Part 1|Physician Decision|1|||
155376832|NCT01080716|560812802|FG001|Part 1|Physician Decision|0|||
155376833|NCT01080716|560812803|FG002|Part 1|Physician Decision|0|||
155376834|NCT01080716|560812804|FG003|Part 1|Physician Decision|0|||
155376835|NCT01056718|560812805|FG000|Overall Study|Withdrawal by Subject|2|||
155376836|NCT01056718|560812805|FG000|Overall Study|Ischemia on baseline stress test|1|||
155376837|NCT00777088|560812806|FG000|Overall Study|PED Treatment not attempted|1|||
155376838|NCT01139580|560812807|FG000|Overall Study|Adverse Event|5|||
155376839|NCT01139580|560812808|FG001|Overall Study|Adverse Event|4|||
155376840|NCT01139580|560812807|FG000|Overall Study|Lost to Follow-up|9|||
155376841|NCT01139580|560812808|FG001|Overall Study|Lost to Follow-up|1|||
155376842|NCT01139580|560812807|FG000|Overall Study|Lack of Efficacy|0|||
155376843|NCT01139580|560812808|FG001|Overall Study|Lack of Efficacy|2|||
155376844|NCT01139580|560812807|FG000|Overall Study|Withdrawal by Subject|6|||
155376845|NCT01139580|560812808|FG001|Overall Study|Withdrawal by Subject|9|||
155376846|NCT01139580|560812807|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
155376847|NCT01139580|560812808|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
155376848|NCT01139580|560812807|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
155376849|NCT01139580|560812808|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
155376850|NCT01139580|560812807|FG000|Overall Study|Misrandomized|1|||
155376851|NCT01139580|560812808|FG001|Overall Study|Misrandomized|0|||
155376852|NCT01139580|560812807|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
155376853|NCT01139580|560812808|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
155376854|NCT01139580|560812807|FG000|Overall Study|Participant Randomization in Error|0|||
155376855|NCT01139580|560812808|FG001|Overall Study|Participant Randomization in Error|1|||
155376856|NCT03117998|560812814|FG000|Overall Study|Adverse Event|1|||
155376857|NCT03117998|560812815|FG001|Overall Study|Adverse Event|0|||
155376858|NCT03117998|560812816|FG002|Overall Study|Adverse Event|0|||
155512241|NCT01694485|561301234|FG003|Overall Study|Lost to Follow-up|10|||
155512242|NCT01694485|561301235|FG004|Overall Study|Lost to Follow-up|7|||
155512243|NCT01694485|561301231|FG000|Overall Study|Death|1|||
155512244|NCT01694485|561301232|FG001|Overall Study|Death|0|||
155512245|NCT01694485|561301233|FG002|Overall Study|Death|0|||
155512246|NCT01694485|561301234|FG003|Overall Study|Death|1|||
155512247|NCT01694485|561301235|FG004|Overall Study|Death|0|||
155512248|NCT02907203|561301236|FG000|Overall Study|Death|1|||
155512249|NCT02907203|561301236|FG000|Overall Study|Lost to Follow-up|3|||
155376859|NCT03117998|560812817|FG003|Overall Study|Adverse Event|0|||
155376860|NCT03117998|560812818|FG004|Overall Study|Adverse Event|0|||
155376861|NCT03117998|560812819|FG005|Overall Study|Adverse Event|0|||
155376862|NCT03117998|560812814|FG000|Overall Study|Withdrawal by Subject|0|||
155376863|NCT03117998|560812815|FG001|Overall Study|Withdrawal by Subject|0|||
155376864|NCT03117998|560812816|FG002|Overall Study|Withdrawal by Subject|2|||
155376865|NCT03117998|560812817|FG003|Overall Study|Withdrawal by Subject|3|||
155376866|NCT03117998|560812818|FG004|Overall Study|Withdrawal by Subject|3|||
155512250|NCT02907203|561301236|FG000|Overall Study|Withdrawal by Subject|3|||
155512251|NCT02907203|561301236|FG000|Overall Study|Surgical bypass|1|||
155512252|NCT00619619|561301237|FG000|Overall Study|Physician Decision|0|||
155512253|NCT00619619|561301238|FG001|Overall Study|Physician Decision|0|||
155376867|NCT03117998|560812819|FG005|Overall Study|Withdrawal by Subject|0|||
155376868|NCT03117998|560812814|FG000|Overall Study|Physician Decision|0|||
155376869|NCT03117998|560812815|FG001|Overall Study|Physician Decision|1|||
155376870|NCT03117998|560812816|FG002|Overall Study|Physician Decision|1|||
155376871|NCT03117998|560812817|FG003|Overall Study|Physician Decision|0|||
155376872|NCT03117998|560812818|FG004|Overall Study|Physician Decision|0|||
155376873|NCT03117998|560812819|FG005|Overall Study|Physician Decision|0|||
155376874|NCT03117998|560812814|FG000|Overall Study|Lost to Follow-up|0|||
155376875|NCT03117998|560812815|FG001|Overall Study|Lost to Follow-up|0|||
155376876|NCT03117998|560812816|FG002|Overall Study|Lost to Follow-up|0|||
155376877|NCT03117998|560812817|FG003|Overall Study|Lost to Follow-up|1|||
155376878|NCT03117998|560812818|FG004|Overall Study|Lost to Follow-up|4|||
155376879|NCT03117998|560812819|FG005|Overall Study|Lost to Follow-up|0|||
155376880|NCT03117998|560812814|FG000|Overall Study|Subject noncompliance|0|||
155376881|NCT03117998|560812815|FG001|Overall Study|Subject noncompliance|0|||
155376882|NCT03117998|560812816|FG002|Overall Study|Subject noncompliance|1|||
155376883|NCT03117998|560812817|FG003|Overall Study|Subject noncompliance|0|||
155376884|NCT03117998|560812818|FG004|Overall Study|Subject noncompliance|0|||
155376885|NCT03117998|560812819|FG005|Overall Study|Subject noncompliance|2|||
155376886|NCT03117998|560812814|FG000|Overall Study|Protocol Violation|0|||
155376887|NCT03117998|560812815|FG001|Overall Study|Protocol Violation|0|||
155376888|NCT03117998|560812816|FG002|Overall Study|Protocol Violation|0|||
155376889|NCT03117998|560812817|FG003|Overall Study|Protocol Violation|0|||
155376890|NCT03117998|560812818|FG004|Overall Study|Protocol Violation|0|||
155376891|NCT03117998|560812819|FG005|Overall Study|Protocol Violation|1|||
155376892|NCT00545753|560812824|FG000|Overall Study|Withdrawal by Subject|0|||
155376893|NCT00545753|560812825|FG001|Overall Study|Withdrawal by Subject|1|||
155376894|NCT00545753|560812826|FG002|Overall Study|Withdrawal by Subject|10|||
155376895|NCT00545753|560812824|FG000|Overall Study|Lost to Follow-up|13|||
155376896|NCT00545753|560812825|FG001|Overall Study|Lost to Follow-up|3|||
155376897|NCT00545753|560812826|FG002|Overall Study|Lost to Follow-up|12|||
155376898|NCT00545753|560812824|FG000|Overall Study|Protocol Violation|3|||
155376899|NCT00545753|560812825|FG001|Overall Study|Protocol Violation|1|||
155376900|NCT00545753|560812826|FG002|Overall Study|Protocol Violation|4|||
155376901|NCT01011153|560812828|FG000|Overall Study|Less than 78 cases completed|8|||
155376902|NCT01011153|560812829|FG001|Overall Study|Less than 78 cases completed|11|||
155376903|NCT01011153|560812830|FG002|Overall Study|Less than 78 cases completed|9|||
155376904|NCT03014479|560812831|FG000|Overall Study|Adverse Event|0|||
155376905|NCT03014479|560812832|FG001|Overall Study|Adverse Event|1|||
155376906|NCT03014479|560812831|FG000|Overall Study|Voluntary Withdrawal|0|||
155376907|NCT03014479|560812832|FG001|Overall Study|Voluntary Withdrawal|2|||
155376908|NCT03014479|560812831|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
155376909|NCT03014479|560812832|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
155376910|NCT01081132|560812835|FG000|Overall Study|Lack of Efficacy|25|||
155376911|NCT01081132|560812836|FG001|Overall Study|Lack of Efficacy|9|||
155376912|NCT01081132|560812835|FG000|Overall Study|Withdrawal by Subject|13|||
155376913|NCT01081132|560812836|FG001|Overall Study|Withdrawal by Subject|16|||
155376914|NCT01081132|560812835|FG000|Overall Study|Lost to Follow-up|4|||
155376915|NCT01081132|560812836|FG001|Overall Study|Lost to Follow-up|11|||
155376916|NCT01081132|560812835|FG000|Overall Study|Adverse Event|3|||
155376917|NCT01081132|560812836|FG001|Overall Study|Adverse Event|9|||
155376918|NCT01081132|560812835|FG000|Overall Study|Non Compliance|4|||
155376919|NCT01081132|560812836|FG001|Overall Study|Non Compliance|2|||
155376920|NCT01081132|560812835|FG000|Overall Study|Lack Of Compliance|0|||
155376921|NCT01081132|560812836|FG001|Overall Study|Lack Of Compliance|1|||
155376922|NCT01081132|560812835|FG000|Overall Study|Missed Visits|1|||
155376923|NCT01081132|560812836|FG001|Overall Study|Missed Visits|1|||
155376924|NCT01081132|560812835|FG000|Overall Study|Stopped Taking Meds|2|||
155376925|NCT01081132|560812836|FG001|Overall Study|Stopped Taking Meds|0|||
155376926|NCT01081132|560812835|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
155376927|NCT01081132|560812836|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
155376928|NCT01081132|560812835|FG000|Overall Study|Declined Taper Phase|0|||
155376929|NCT01081132|560812836|FG001|Overall Study|Declined Taper Phase|1|||
155376930|NCT01081132|560812835|FG000|Overall Study|Protocol Violation|3|||
155376931|NCT01081132|560812836|FG001|Overall Study|Protocol Violation|1|||
155376932|NCT02489968|560812839|FG000|Open-label Treatment Period|Adverse Event|14|||
155376933|NCT02489968|560812840|FG001|Open-label Treatment Period|Adverse Event|7|||
155376934|NCT02489968|560812841|FG002|Open-label Treatment Period|Adverse Event|0|||
155376935|NCT02489968|560812842|FG003|Open-label Treatment Period|Adverse Event|0|||
155376936|NCT02489968|560812843|FG004|Open-label Treatment Period|Adverse Event|0|||
155376937|NCT02489968|560812844|FG005|Open-label Treatment Period|Adverse Event|0|||
155376938|NCT02489968|560812839|FG000|Open-label Treatment Period|Protocol Violation|2|||
155376939|NCT02489968|560812840|FG001|Open-label Treatment Period|Protocol Violation|2|||
155376940|NCT02489968|560812841|FG002|Open-label Treatment Period|Protocol Violation|0|||
155376941|NCT02489968|560812842|FG003|Open-label Treatment Period|Protocol Violation|0|||
155376942|NCT02489968|560812843|FG004|Open-label Treatment Period|Protocol Violation|0|||
155376943|NCT02489968|560812844|FG005|Open-label Treatment Period|Protocol Violation|0|||
155376944|NCT02489968|560812839|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155376945|NCT02489968|560812840|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
155376946|NCT02489968|560812841|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155376947|NCT02489968|560812842|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155376948|NCT02489968|560812843|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
155376949|NCT02489968|560812844|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
155376950|NCT02489968|560812839|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
155376951|NCT02489968|560812840|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
155376952|NCT02489968|560812841|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155376953|NCT02489968|560812842|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
155376954|NCT02489968|560812843|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
155376955|NCT02489968|560812844|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
155376956|NCT02489968|560812839|FG000|Open-label Treatment Period|Other than specified above|204|||
155376957|NCT02489968|560812840|FG001|Open-label Treatment Period|Other than specified above|189|||
155376958|NCT02489968|560812841|FG002|Open-label Treatment Period|Other than specified above|0|||
155376959|NCT02489968|560812842|FG003|Open-label Treatment Period|Other than specified above|0|||
155376960|NCT02489968|560812843|FG004|Open-label Treatment Period|Other than specified above|0|||
155431420|NCT04723537|561005086|FG001|Overall Study|Withdrawal by Subject|0|||
155431421|NCT04723537|561005087|FG002|Overall Study|Withdrawal by Subject|0|||
155431422|NCT04723537|561005085|FG000|Overall Study|Physician Decision|0|||
155431423|NCT04723537|561005086|FG001|Overall Study|Physician Decision|0|||
155431424|NCT04723537|561005087|FG002|Overall Study|Physician Decision|1|||
155431425|NCT04723537|561005085|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
155431426|NCT04723537|561005086|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
155431427|NCT04723537|561005087|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
155431428|NCT02432807|561005088|FG000|Overall Study|Adverse Event|0|||
155431429|NCT02432807|561005089|FG001|Overall Study|Adverse Event|2|||
155431430|NCT02432807|561005088|FG000|Overall Study|Lost to Follow-up|1|||
155431431|NCT02432807|561005089|FG001|Overall Study|Lost to Follow-up|0|||
155431432|NCT02432807|561005088|FG000|Overall Study|Withdrawal by Subject|1|||
155431433|NCT02432807|561005089|FG001|Overall Study|Withdrawal by Subject|1|||
155431434|NCT02432807|561005088|FG000|Overall Study|Other|1|||
155431435|NCT02432807|561005089|FG001|Overall Study|Other|1|||
155431436|NCT02210780|561005091|FG000|Overall Study|Adverse Event|0|||
155431437|NCT02210780|561005092|FG001|Overall Study|Adverse Event|5|||
155431438|NCT02210780|561005091|FG000|Overall Study|Lost to Follow-up|2|||
155431439|NCT02210780|561005092|FG001|Overall Study|Lost to Follow-up|1|||
155431440|NCT02210780|561005091|FG000|Overall Study|Withdrawal by Subject|1|||
155431441|NCT02210780|561005092|FG001|Overall Study|Withdrawal by Subject|1|||
155431442|NCT02210780|561005091|FG000|Overall Study|Physician Decision|1|||
155431443|NCT02210780|561005092|FG001|Overall Study|Physician Decision|0|||
155431444|NCT02210780|561005091|FG000|Overall Study|Protocol Violation|1|||
155431445|NCT02210780|561005092|FG001|Overall Study|Protocol Violation|0|||
155431446|NCT02210780|561005091|FG000|Overall Study|Other than specified above|0|||
155431447|NCT02210780|561005092|FG001|Overall Study|Other than specified above|1|||
155431448|NCT00942409|561005093|FG000|Overall Study|Lack of Efficacy|1|||
155431449|NCT00942409|561005093|FG000|Overall Study|study drug unavailable|2|||
155431450|NCT01697215|561005096|FG000|Overall Study|Physician Decision|5|||
155431451|NCT01697215|561005096|FG000|Overall Study|Malfunction|9|||
155431452|NCT01697215|561005096|FG000|Overall Study|CXR not available|9|||
155431453|NCT01929083|561005097|FG000|Intervention 1|Lost to Follow-up|2|||
155431454|NCT01929083|561005098|FG001|Intervention 1|Lost to Follow-up|0|||
155431455|NCT01929083|561005097|FG000|Intervention 1|Nonadherent to study medications|1|||
155431456|NCT01929083|561005098|FG001|Intervention 1|Nonadherent to study medications|0|||
155431457|NCT01929083|561005097|FG000|Intervention 2|Adverse Event|0|||
155431458|NCT01929083|561005098|FG001|Intervention 2|Adverse Event|1|||
155431459|NCT02599402|561005099|FG000|Overall Study|Disease progression|153|||
155431460|NCT02599402|561005099|FG000|Overall Study|Study drug toxicity|201|||
155431461|NCT02599402|561005099|FG000|Overall Study|Death|26|||
155431462|NCT02599402|561005099|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
155431463|NCT02599402|561005099|FG000|Overall Study|Participant request to discontinue study treatment|13|||
155431464|NCT02599402|561005099|FG000|Overall Study|Participant withdrew consent|5|||
155431465|NCT02599402|561005099|FG000|Overall Study|Lost to Follow-up|1|||
155431466|NCT02599402|561005099|FG000|Overall Study|Maximum Clinical Benefit|7|||
155431467|NCT02599402|561005099|FG000|Overall Study|Poor/non-compliance|1|||
155431468|NCT02599402|561005099|FG000|Overall Study|Pregnancy|1|||
155431469|NCT02599402|561005099|FG000|Overall Study|Participant no longer met study criteria|7|||
155431470|NCT02599402|561005099|FG000|Overall Study|Other Reasons|95|||
155431471|NCT02945657|561005100|FG000|Overall Study|Adverse Event|1|||
155512254|NCT00619619|561301239|FG002|Overall Study|Physician Decision|1|||
155512255|NCT00619619|561301240|FG003|Overall Study|Physician Decision|0|||
155512256|NCT00619619|561301241|FG004|Overall Study|Physician Decision|0|||
155512257|NCT00619619|561301242|FG005|Overall Study|Physician Decision|0|||
155512258|NCT00619619|561301243|FG006|Overall Study|Physician Decision|0|||
155512259|NCT00619619|561301244|FG007|Overall Study|Physician Decision|0|||
155512260|NCT00619619|561301237|FG000|Overall Study|Protocol Violation|0|||
155512261|NCT00619619|561301238|FG001|Overall Study|Protocol Violation|0|||
155512262|NCT00619619|561301239|FG002|Overall Study|Protocol Violation|0|||
155512263|NCT00619619|561301240|FG003|Overall Study|Protocol Violation|1|||
155512264|NCT00619619|561301241|FG004|Overall Study|Protocol Violation|0|||
155512265|NCT00619619|561301242|FG005|Overall Study|Protocol Violation|0|||
155512266|NCT00619619|561301243|FG006|Overall Study|Protocol Violation|1|||
155512267|NCT00619619|561301244|FG007|Overall Study|Protocol Violation|1|||
155512268|NCT00619619|561301237|FG000|Overall Study|Adverse Event|0|||
155512269|NCT00619619|561301238|FG001|Overall Study|Adverse Event|0|||
155512270|NCT00619619|561301239|FG002|Overall Study|Adverse Event|0|||
155512271|NCT00619619|561301240|FG003|Overall Study|Adverse Event|0|||
155512272|NCT00619619|561301241|FG004|Overall Study|Adverse Event|2|||
155512273|NCT00619619|561301242|FG005|Overall Study|Adverse Event|0|||
155512274|NCT00619619|561301243|FG006|Overall Study|Adverse Event|0|||
155512275|NCT00619619|561301244|FG007|Overall Study|Adverse Event|2|||
155512276|NCT01689974|561301245|FG000|Overall Study|Termination of Study|5|||
155512277|NCT01689974|561301246|FG001|Overall Study|Termination of Study|5|||
155512278|NCT01388647|561301249|FG000|Overall Study|Adverse Event|1|||
155512279|NCT01388647|561301250|FG001|Overall Study|Adverse Event|2|||
155512280|NCT01006707|561301251|FG000|Study Session 1|Lost to Follow-up|2|||
155512281|NCT01006707|561301252|FG001|Study Session 1|Lost to Follow-up|0|||
155512282|NCT01006707|561301253|FG002|Study Session 1|Lost to Follow-up|0|||
155512283|NCT01006707|561301251|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
155512284|NCT01006707|561301252|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
155512285|NCT01006707|561301253|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
155512286|NCT00952484|561301254|FG000|Overall Study|Withdrawal by Subject|0|||
155512287|NCT00952484|561301255|FG001|Overall Study|Withdrawal by Subject|1|||
155512288|NCT00952484|561301256|FG002|Overall Study|Withdrawal by Subject|0|||
155512289|NCT00192296|561301258|FG000|Overall Study|Withdrawal by Subject|0|||
155512290|NCT00192296|561301259|FG001|Overall Study|Withdrawal by Subject|1|||
155512291|NCT00192296|561301260|FG002|Overall Study|Withdrawal by Subject|0|||
155512292|NCT00192296|561301261|FG003|Overall Study|Withdrawal by Subject|0|||
155512293|NCT00696709|561301267|FG000|Overall Study|Withdrawal by Subject|1|||
155512294|NCT00696709|561301268|FG001|Overall Study|Withdrawal by Subject|2|||
155512295|NCT00696709|561301269|FG002|Overall Study|Withdrawal by Subject|1|||
155512296|NCT00696709|561301270|FG003|Overall Study|Withdrawal by Subject|4|||
155512297|NCT00696709|561301271|FG004|Overall Study|Withdrawal by Subject|3|||
155512298|NCT00696709|561301267|FG000|Overall Study|Protocol Violation|1|||
155512299|NCT00696709|561301268|FG001|Overall Study|Protocol Violation|0|||
155512300|NCT00696709|561301269|FG002|Overall Study|Protocol Violation|0|||
155512301|NCT00696709|561301270|FG003|Overall Study|Protocol Violation|0|||
155512302|NCT00696709|561301271|FG004|Overall Study|Protocol Violation|0|||
155512303|NCT00696709|561301267|FG000|Overall Study|Lost to Follow-up|1|||
155512304|NCT00696709|561301268|FG001|Overall Study|Lost to Follow-up|1|||
155512305|NCT00696709|561301269|FG002|Overall Study|Lost to Follow-up|0|||
155512306|NCT00696709|561301270|FG003|Overall Study|Lost to Follow-up|0|||
155512307|NCT00696709|561301271|FG004|Overall Study|Lost to Follow-up|0|||
155512308|NCT00696709|561301267|FG000|Overall Study|Adverse Event|0|||
155512309|NCT00696709|561301268|FG001|Overall Study|Adverse Event|0|||
155512310|NCT00696709|561301269|FG002|Overall Study|Adverse Event|0|||
155512311|NCT00696709|561301270|FG003|Overall Study|Adverse Event|1|||
155512312|NCT00696709|561301271|FG004|Overall Study|Adverse Event|0|||
155512313|NCT00321711|561301275|FG000|Part A|Adverse Event|3|||
155512314|NCT00321711|561301276|FG001|Part A|Adverse Event|3|||
155512315|NCT00321711|561301277|FG002|Part A|Adverse Event|2|||
155512316|NCT00321711|561301278|FG003|Part A|Adverse Event|0|||
155512317|NCT00321711|561301279|FG004|Part A|Adverse Event|0|||
155512318|NCT00321711|561301275|FG000|Part A|Withdrawal by Subject|1|||
155512319|NCT00321711|561301276|FG001|Part A|Withdrawal by Subject|1|||
155649907|NCT02134028|561810198|FG005|Overall Study|Poor compliance to protocol|1|||
155649908|NCT02134028|561810199|FG006|Overall Study|Poor compliance to protocol|0|||
155512320|NCT00321711|561301277|FG002|Part A|Withdrawal by Subject|1|||
155512321|NCT00321711|561301278|FG003|Part A|Withdrawal by Subject|0|||
155512322|NCT00321711|561301279|FG004|Part A|Withdrawal by Subject|0|||
155512323|NCT00321711|561301275|FG000|Part A|Disease progression|0|||
155512324|NCT00321711|561301276|FG001|Part A|Disease progression|1|||
155512325|NCT00321711|561301277|FG002|Part A|Disease progression|0|||
155512326|NCT00321711|561301278|FG003|Part A|Disease progression|0|||
155512327|NCT00321711|561301279|FG004|Part A|Disease progression|0|||
155512328|NCT00321711|561301275|FG000|Part A|Requirement for alternative therapy|0|||
155512329|NCT00321711|561301276|FG001|Part A|Requirement for alternative therapy|2|||
155512330|NCT00321711|561301277|FG002|Part A|Requirement for alternative therapy|1|||
155376961|NCT02489968|560812844|FG005|Open-label Treatment Period|Other than specified above|0|||
155376962|NCT02489968|560812839|FG000|Double-blind Treatment Period|Adverse Event|0|||
155376963|NCT02489968|560812840|FG001|Double-blind Treatment Period|Adverse Event|0|||
155376964|NCT02489968|560812841|FG002|Double-blind Treatment Period|Adverse Event|2|||
155376965|NCT02489968|560812842|FG003|Double-blind Treatment Period|Adverse Event|6|||
155376966|NCT02489968|560812843|FG004|Double-blind Treatment Period|Adverse Event|4|||
155376967|NCT02489968|560812844|FG005|Double-blind Treatment Period|Adverse Event|5|||
155376968|NCT02489968|560812839|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155376969|NCT02489968|560812840|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155376970|NCT02489968|560812841|FG002|Double-blind Treatment Period|Protocol Violation|0|||
155376971|NCT02489968|560812842|FG003|Double-blind Treatment Period|Protocol Violation|0|||
155376972|NCT02489968|560812843|FG004|Double-blind Treatment Period|Protocol Violation|1|||
155376973|NCT02489968|560812844|FG005|Double-blind Treatment Period|Protocol Violation|1|||
155376974|NCT02489968|560812839|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376975|NCT02489968|560812840|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376976|NCT02489968|560812841|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376977|NCT02489968|560812842|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
155376978|NCT02489968|560812843|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376979|NCT02489968|560812844|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
155376980|NCT02489968|560812839|FG000|Double-blind Treatment Period|Other than specified above|0|||
155376981|NCT02489968|560812840|FG001|Double-blind Treatment Period|Other than specified above|0|||
155376982|NCT02489968|560812841|FG002|Double-blind Treatment Period|Other than specified above|0|||
155376983|NCT02489968|560812842|FG003|Double-blind Treatment Period|Other than specified above|0|||
155376984|NCT02489968|560812843|FG004|Double-blind Treatment Period|Other than specified above|1|||
155376985|NCT02489968|560812844|FG005|Double-blind Treatment Period|Other than specified above|0|||
155376986|NCT03738423|560812845|FG000|Overall Study|Withdrawal by Subject|9|||
155376987|NCT03738423|560812846|FG001|Overall Study|Withdrawal by Subject|12|||
155376988|NCT03738423|560812847|FG002|Overall Study|Withdrawal by Subject|9|||
155376989|NCT03738423|560812848|FG003|Overall Study|Withdrawal by Subject|12|||
155376990|NCT03738423|560812849|FG004|Overall Study|Withdrawal by Subject|10|||
155376991|NCT03738423|560812845|FG000|Overall Study|Lack of Efficacy|3|||
155376992|NCT03738423|560812846|FG001|Overall Study|Lack of Efficacy|1|||
155376993|NCT03738423|560812847|FG002|Overall Study|Lack of Efficacy|1|||
155376994|NCT03738423|560812848|FG003|Overall Study|Lack of Efficacy|1|||
155376995|NCT03738423|560812849|FG004|Overall Study|Lack of Efficacy|2|||
155376996|NCT03738423|560812845|FG000|Overall Study|Lost to Follow-up|1|||
155376997|NCT03738423|560812846|FG001|Overall Study|Lost to Follow-up|0|||
155376998|NCT03738423|560812847|FG002|Overall Study|Lost to Follow-up|1|||
155376999|NCT03738423|560812848|FG003|Overall Study|Lost to Follow-up|1|||
155377000|NCT03738423|560812849|FG004|Overall Study|Lost to Follow-up|0|||
155377001|NCT03738423|560812845|FG000|Overall Study|Protocol Violation|1|||
155377002|NCT03738423|560812846|FG001|Overall Study|Protocol Violation|0|||
155377003|NCT03738423|560812847|FG002|Overall Study|Protocol Violation|0|||
155377004|NCT03738423|560812848|FG003|Overall Study|Protocol Violation|0|||
155377005|NCT03738423|560812849|FG004|Overall Study|Protocol Violation|1|||
155377006|NCT03738423|560812845|FG000|Overall Study|Physician Decision|0|||
155377007|NCT03738423|560812846|FG001|Overall Study|Physician Decision|0|||
155377008|NCT03738423|560812847|FG002|Overall Study|Physician Decision|1|||
155377009|NCT03738423|560812848|FG003|Overall Study|Physician Decision|0|||
155377010|NCT03738423|560812849|FG004|Overall Study|Physician Decision|1|||
155377011|NCT03738423|560812845|FG000|Overall Study|Death|0|||
155377012|NCT03738423|560812846|FG001|Overall Study|Death|0|||
155377013|NCT03738423|560812847|FG002|Overall Study|Death|0|||
155377014|NCT03738423|560812848|FG003|Overall Study|Death|0|||
155377015|NCT03738423|560812849|FG004|Overall Study|Death|1|||
155377016|NCT03738423|560812845|FG000|Overall Study|Randomized but never treated|0|||
155377017|NCT03738423|560812846|FG001|Overall Study|Randomized but never treated|0|||
155377018|NCT03738423|560812847|FG002|Overall Study|Randomized but never treated|1|||
155377019|NCT03738423|560812848|FG003|Overall Study|Randomized but never treated|1|||
155377020|NCT03738423|560812849|FG004|Overall Study|Randomized but never treated|0|||
155377021|NCT03981861|560812855|FG000|Overall Study|Withdrawal by Subject|3|||
155377022|NCT03973931|560812856|FG000|Overall Study|Lost to Follow-up|47|||
155377023|NCT03973931|560812857|FG001|Overall Study|Lost to Follow-up|63|||
155377024|NCT03973931|560812858|FG002|Overall Study|Lost to Follow-up|51|||
155377025|NCT03973931|560812859|FG003|Overall Study|Lost to Follow-up|54|||
155377026|NCT03973931|560812856|FG000|Overall Study|opted out|6|||
155377027|NCT03973931|560812857|FG001|Overall Study|opted out|5|||
155377028|NCT03973931|560812858|FG002|Overall Study|opted out|5|||
155377029|NCT03973931|560812859|FG003|Overall Study|opted out|1|||
155377030|NCT01022112|560812860|FG000|Overall Study|Adverse Event|1|||
155377031|NCT01022112|560812861|FG001|Overall Study|Adverse Event|2|||
155377032|NCT01022112|560812862|FG002|Overall Study|Adverse Event|0|||
155377033|NCT01022112|560812863|FG003|Overall Study|Adverse Event|1|||
155377034|NCT01022112|560812864|FG004|Overall Study|Adverse Event|0|||
155377035|NCT01022112|560812860|FG000|Overall Study|Lack of Efficacy|1|||
155377036|NCT01022112|560812861|FG001|Overall Study|Lack of Efficacy|0|||
155377037|NCT01022112|560812862|FG002|Overall Study|Lack of Efficacy|0|||
155377038|NCT01022112|560812863|FG003|Overall Study|Lack of Efficacy|0|||
155377039|NCT01022112|560812864|FG004|Overall Study|Lack of Efficacy|1|||
155377040|NCT01022112|560812860|FG000|Overall Study|Physician Decision|0|||
155377041|NCT01022112|560812861|FG001|Overall Study|Physician Decision|0|||
155377042|NCT01022112|560812862|FG002|Overall Study|Physician Decision|1|||
155377043|NCT01022112|560812863|FG003|Overall Study|Physician Decision|0|||
155377044|NCT01022112|560812864|FG004|Overall Study|Physician Decision|1|||
155377045|NCT01022112|560812860|FG000|Overall Study|Withdrawal by Subject|0|||
155377046|NCT01022112|560812861|FG001|Overall Study|Withdrawal by Subject|1|||
155377047|NCT01022112|560812862|FG002|Overall Study|Withdrawal by Subject|2|||
155377048|NCT01022112|560812863|FG003|Overall Study|Withdrawal by Subject|2|||
155377049|NCT01022112|560812864|FG004|Overall Study|Withdrawal by Subject|1|||
155377050|NCT01022112|560812860|FG000|Overall Study|Fasting plasma glucose level increased|1|||
155377051|NCT01022112|560812861|FG001|Overall Study|Fasting plasma glucose level increased|0|||
155377052|NCT01022112|560812862|FG002|Overall Study|Fasting plasma glucose level increased|0|||
155377053|NCT01022112|560812863|FG003|Overall Study|Fasting plasma glucose level increased|0|||
155377054|NCT01022112|560812864|FG004|Overall Study|Fasting plasma glucose level increased|7|||
155377055|NCT03541174|560814357|FG000|Part 1 Double-Blind|Adverse Event|6|||
155377056|NCT03541174|560814358|FG001|Part 1 Double-Blind|Adverse Event|5|||
155377057|NCT03541174|560814359|FG002|Part 1 Double-Blind|Adverse Event|2|||
155377058|NCT03541174|560814360|FG003|Part 1 Double-Blind|Adverse Event|0|||
155377059|NCT03541174|560814361|FG004|Part 1 Double-Blind|Adverse Event|0|||
155377060|NCT03541174|560814362|FG005|Part 1 Double-Blind|Adverse Event|0|||
155377061|NCT03541174|560814357|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
155377062|NCT03541174|560814358|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
155377063|NCT03541174|560814359|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
155377064|NCT03541174|560814360|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377065|NCT03541174|560814361|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377066|NCT03541174|560814362|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377067|NCT03541174|560814357|FG000|Part 1 Double-Blind|Other reasons|3|||
155377068|NCT03541174|560814358|FG001|Part 1 Double-Blind|Other reasons|2|||
155377069|NCT03541174|560814359|FG002|Part 1 Double-Blind|Other reasons|3|||
155377070|NCT03541174|560814360|FG003|Part 1 Double-Blind|Other reasons|0|||
155377071|NCT03541174|560814361|FG004|Part 1 Double-Blind|Other reasons|0|||
155377072|NCT03541174|560814362|FG005|Part 1 Double-Blind|Other reasons|0|||
155377073|NCT03541174|560814357|FG000|Part 2 Single-Blind|Adverse Event|0|||
155377074|NCT03541174|560814358|FG001|Part 2 Single-Blind|Adverse Event|0|||
155377075|NCT03541174|560814359|FG002|Part 2 Single-Blind|Adverse Event|0|||
155377076|NCT03541174|560814360|FG003|Part 2 Single-Blind|Adverse Event|25|||
155377077|NCT03541174|560814361|FG004|Part 2 Single-Blind|Adverse Event|0|||
155377078|NCT03541174|560814362|FG005|Part 2 Single-Blind|Adverse Event|0|||
155377079|NCT03541174|560814357|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
155377080|NCT03541174|560814358|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
155377081|NCT03541174|560814359|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
155377082|NCT03541174|560814360|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
155377083|NCT03541174|560814361|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
155377084|NCT03541174|560814362|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
155377085|NCT03541174|560814357|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377086|NCT03541174|560814358|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377087|NCT03541174|560814359|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377088|NCT03541174|560814360|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
155377089|NCT03541174|560814361|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
155431472|NCT02945657|561005100|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
155431473|NCT00087438|561005107|FG000|Overall Study|Ineligible / No protocol treatment|4|||
155431474|NCT01486264|561005108|FG000|Overall Study|Death|1|||
155431475|NCT01486264|561005109|FG001|Overall Study|Death|1|||
155431476|NCT01486264|561005108|FG000|Overall Study|Adverse Event|3|||
155431477|NCT01486264|561005109|FG001|Overall Study|Adverse Event|3|||
155431478|NCT01486264|561005108|FG000|Overall Study|Lack of Efficacy|6|||
155431479|NCT01486264|561005109|FG001|Overall Study|Lack of Efficacy|10|||
155431480|NCT01486264|561005108|FG000|Overall Study|Withdrawal by Subject|7|||
155431481|NCT01486264|561005109|FG001|Overall Study|Withdrawal by Subject|18|||
155431482|NCT01486264|561005108|FG000|Overall Study|Physician Decision|1|||
155431483|NCT01486264|561005109|FG001|Overall Study|Physician Decision|1|||
155377090|NCT03541174|560814362|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
155431484|NCT01486264|561005108|FG000|Overall Study|Protocol Violation|3|||
155431485|NCT01486264|561005109|FG001|Overall Study|Protocol Violation|0|||
155377091|NCT03541174|560814357|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
155377092|NCT03541174|560814358|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
155377093|NCT03541174|560814359|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
155377094|NCT03541174|560814360|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
155377095|NCT03541174|560814361|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
155431486|NCT01486264|561005108|FG000|Overall Study|Lost to Follow-up|3|||
155431487|NCT01486264|561005109|FG001|Overall Study|Lost to Follow-up|2|||
155377096|NCT03541174|560814362|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
155377097|NCT03541174|560814357|FG000|Part 2 Single-Blind|Death|0|||
155377098|NCT03541174|560814358|FG001|Part 2 Single-Blind|Death|0|||
155377099|NCT03541174|560814359|FG002|Part 2 Single-Blind|Death|0|||
155377100|NCT03541174|560814360|FG003|Part 2 Single-Blind|Death|5|||
155377101|NCT03541174|560814361|FG004|Part 2 Single-Blind|Death|0|||
155377102|NCT03541174|560814362|FG005|Part 2 Single-Blind|Death|0|||
155377103|NCT03541174|560814357|FG000|Part 2 Single-Blind|Pregnancy|0|||
155377104|NCT03541174|560814358|FG001|Part 2 Single-Blind|Pregnancy|0|||
155377105|NCT03541174|560814359|FG002|Part 2 Single-Blind|Pregnancy|0|||
155377106|NCT03541174|560814360|FG003|Part 2 Single-Blind|Pregnancy|1|||
155377107|NCT03541174|560814361|FG004|Part 2 Single-Blind|Pregnancy|0|||
155377108|NCT03541174|560814362|FG005|Part 2 Single-Blind|Pregnancy|0|||
155377109|NCT03541174|560814357|FG000|Part 2 Single-Blind|Other reasons|0|||
155377110|NCT03541174|560814358|FG001|Part 2 Single-Blind|Other reasons|0|||
155377111|NCT03541174|560814359|FG002|Part 2 Single-Blind|Other reasons|0|||
155377112|NCT03541174|560814360|FG003|Part 2 Single-Blind|Other reasons|32|||
155377113|NCT03541174|560814361|FG004|Part 2 Single-Blind|Other reasons|0|||
155377114|NCT03541174|560814362|FG005|Part 2 Single-Blind|Other reasons|0|||
155377115|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377116|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377117|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377118|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377119|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
155377120|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
155377121|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377122|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377123|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377124|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377125|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
155377126|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
155377127|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377128|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377129|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377130|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377131|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377132|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
155377133|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377134|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377135|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377136|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377137|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
155377138|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
155377139|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377140|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377141|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377142|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377143|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
155377144|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377145|NCT00275262|560814363|FG000|Overall Study|Adverse Event|2|||
155377146|NCT00275262|560814364|FG001|Overall Study|Adverse Event|0|||
155377147|NCT00275262|560814363|FG000|Overall Study|Disease progression|2|||
155377148|NCT00275262|560814364|FG001|Overall Study|Disease progression|5|||
155377149|NCT00275262|560814363|FG000|Overall Study|Lost to Follow-up|0|||
155377150|NCT00275262|560814364|FG001|Overall Study|Lost to Follow-up|2|||
155377151|NCT00275262|560814363|FG000|Overall Study|Protocol Violation|0|||
155377152|NCT00275262|560814364|FG001|Overall Study|Protocol Violation|2|||
155377153|NCT00275262|560814363|FG000|Overall Study|Death|1|||
155377154|NCT00275262|560814364|FG001|Overall Study|Death|0|||
155377155|NCT00275262|560814363|FG000|Overall Study|Started Chemotherapy|1|||
155377156|NCT00275262|560814364|FG001|Overall Study|Started Chemotherapy|0|||
155377157|NCT02594163|560814367|FG000|Treatment Period|Progressive disease|2|||
155377158|NCT02594163|560814368|FG001|Treatment Period|Progressive disease|3|||
155377159|NCT02594163|560814367|FG000|Treatment Period|Adverse Event|1|||
155377160|NCT02594163|560814368|FG001|Treatment Period|Adverse Event|5|||
155377161|NCT02594163|560814367|FG000|Treatment Period|Physician Decision|1|||
155377162|NCT02594163|560814368|FG001|Treatment Period|Physician Decision|3|||
155377163|NCT02594163|560814367|FG000|Treatment Period|Study termination by sponsor|2|||
155377164|NCT02594163|560814368|FG001|Treatment Period|Study termination by sponsor|1|||
155377165|NCT02594163|560814367|FG000|Treatment Period|Other, Non-AE|1|||
155377166|NCT02594163|560814368|FG001|Treatment Period|Other, Non-AE|0|||
155431488|NCT01486264|561005108|FG000|Overall Study|Other|5|||
155431489|NCT01486264|561005109|FG001|Overall Study|Other|11|||
155431490|NCT01486264|561005108|FG000|Overall Study|Not treated|0|||
155377167|NCT02594163|560814367|FG000|Follow-up Period|Withdrawal by Subject|0|||
155377168|NCT02594163|560814368|FG001|Follow-up Period|Withdrawal by Subject|1|||
155377169|NCT02594163|560814367|FG000|Follow-up Period|Study Termination by Sponsor|6|||
155377170|NCT02594163|560814368|FG001|Follow-up Period|Study Termination by Sponsor|4|||
155377171|NCT02594163|560814367|FG000|Follow-up Period|Lost to Follow-up|1|||
155377172|NCT02594163|560814368|FG001|Follow-up Period|Lost to Follow-up|0|||
155377173|NCT02594163|560814367|FG000|Follow-up Period|Death|2|||
155377174|NCT02594163|560814368|FG001|Follow-up Period|Death|5|||
155377175|NCT02594163|560814367|FG000|Follow-up Period|Adverse Event|0|||
155377176|NCT02594163|560814368|FG001|Follow-up Period|Adverse Event|1|||
155377177|NCT02594163|560814367|FG000|Follow-up Period|Progressive Disease|2|||
155377178|NCT02594163|560814368|FG001|Follow-up Period|Progressive Disease|0|||
155377179|NCT02594163|560814367|FG000|Follow-up Period|Physician Decision|0|||
155377180|NCT02594163|560814368|FG001|Follow-up Period|Physician Decision|1|||
155377181|NCT01342341|560814369|FG000|Overall Study|Lost to Follow-up|4|||
155377182|NCT01342341|560814370|FG001|Overall Study|Lost to Follow-up|4|||
155377183|NCT02738203|560814373|FG000|Overall Study|Failed IUD Insertion|2|||
155377184|NCT02738203|560814374|FG001|Overall Study|Failed IUD Insertion|2|||
155377185|NCT02738203|560814373|FG000|Overall Study|Protocol Violation|0|||
155377186|NCT02738203|560814374|FG001|Overall Study|Protocol Violation|1|||
155377187|NCT05087979|560814375|FG000|Overall Study|Converted to general anesthesia|1|||
155377188|NCT05087979|560814376|FG001|Overall Study|Converted to general anesthesia|0|||
155377189|NCT02680002|560814382|FG000|Overall Study|Lost to Follow-up|5|||
155377190|NCT02680002|560814383|FG001|Overall Study|Lost to Follow-up|1|||
155377191|NCT02680002|560814384|FG002|Overall Study|Lost to Follow-up|4|||
155377192|NCT02680002|560814385|FG003|Overall Study|Lost to Follow-up|2|||
155377193|NCT02680002|560814386|FG004|Overall Study|Lost to Follow-up|0|||
155377194|NCT02680002|560814387|FG005|Overall Study|Lost to Follow-up|2|||
155377195|NCT02680002|560814382|FG000|Overall Study|Physician Decision|5|||
155377196|NCT02680002|560814383|FG001|Overall Study|Physician Decision|1|||
155377197|NCT02680002|560814384|FG002|Overall Study|Physician Decision|1|||
155377198|NCT02680002|560814385|FG003|Overall Study|Physician Decision|1|||
155377199|NCT02680002|560814386|FG004|Overall Study|Physician Decision|1|||
155377200|NCT02680002|560814387|FG005|Overall Study|Physician Decision|1|||
155377201|NCT02680002|560814382|FG000|Overall Study|Protocol Violation|1|||
155377202|NCT02680002|560814383|FG001|Overall Study|Protocol Violation|0|||
155377203|NCT02680002|560814384|FG002|Overall Study|Protocol Violation|1|||
155377204|NCT02680002|560814385|FG003|Overall Study|Protocol Violation|0|||
155377205|NCT02680002|560814386|FG004|Overall Study|Protocol Violation|1|||
155377206|NCT02680002|560814387|FG005|Overall Study|Protocol Violation|2|||
155377207|NCT02680002|560814382|FG000|Overall Study|Withdrawal by Subject|0|||
155377208|NCT02680002|560814383|FG001|Overall Study|Withdrawal by Subject|0|||
155377209|NCT02680002|560814384|FG002|Overall Study|Withdrawal by Subject|1|||
155377210|NCT02680002|560814385|FG003|Overall Study|Withdrawal by Subject|0|||
155377211|NCT02680002|560814386|FG004|Overall Study|Withdrawal by Subject|2|||
155377212|NCT02680002|560814387|FG005|Overall Study|Withdrawal by Subject|2|||
155377213|NCT02680002|560814382|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
155377214|NCT02680002|560814383|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
155377215|NCT02680002|560814384|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
155377216|NCT02680002|560814385|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
155377217|NCT02680002|560814386|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
155377218|NCT02680002|560814387|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
155377219|NCT02680002|560814382|FG000|Overall Study|Other|0|||
155377220|NCT02680002|560814383|FG001|Overall Study|Other|1|||
155377221|NCT02680002|560814384|FG002|Overall Study|Other|0|||
155377222|NCT02680002|560814385|FG003|Overall Study|Other|0|||
155377223|NCT02680002|560814386|FG004|Overall Study|Other|1|||
155377224|NCT02680002|560814387|FG005|Overall Study|Other|0|||
155377225|NCT02680002|560814382|FG000|Overall Study|Adverse Event|0|||
155377226|NCT02680002|560814383|FG001|Overall Study|Adverse Event|0|||
155377227|NCT02680002|560814384|FG002|Overall Study|Adverse Event|0|||
155377228|NCT02680002|560814385|FG003|Overall Study|Adverse Event|0|||
155377229|NCT02680002|560814386|FG004|Overall Study|Adverse Event|1|||
155377230|NCT02680002|560814387|FG005|Overall Study|Adverse Event|2|||
155377231|NCT00705679|560814388|FG000|Overall Study|Adverse Event|1|||
155377232|NCT00705679|560814389|FG001|Overall Study|Adverse Event|1|||
155377233|NCT00705679|560814390|FG002|Overall Study|Adverse Event|0|||
155377234|NCT00705679|560814391|FG003|Overall Study|Adverse Event|0|||
155377235|NCT00705679|560814392|FG004|Overall Study|Adverse Event|0|||
155377236|NCT00705679|560814388|FG000|Overall Study|Death|0|||
155377237|NCT00705679|560814389|FG001|Overall Study|Death|0|||
155377238|NCT00705679|560814390|FG002|Overall Study|Death|3|||
155377239|NCT00705679|560814391|FG003|Overall Study|Death|2|||
155377240|NCT00705679|560814392|FG004|Overall Study|Death|1|||
155377241|NCT00705679|560814388|FG000|Overall Study|Lost to Follow-up|32|||
155377242|NCT00705679|560814389|FG001|Overall Study|Lost to Follow-up|60|||
155377243|NCT00705679|560814390|FG002|Overall Study|Lost to Follow-up|44|||
155377244|NCT00705679|560814391|FG003|Overall Study|Lost to Follow-up|30|||
155377245|NCT00705679|560814392|FG004|Overall Study|Lost to Follow-up|35|||
155377246|NCT00705679|560814388|FG000|Overall Study|Physician Decision|0|||
155377247|NCT00705679|560814389|FG001|Overall Study|Physician Decision|1|||
155649909|NCT02134028|561810200|FG007|Overall Study|Poor compliance to protocol|0|||
155649910|NCT02134028|561810193|FG000|Overall Study|Other unspecified|4|||
155649911|NCT02134028|561810194|FG001|Overall Study|Other unspecified|22|||
155649912|NCT02134028|561810195|FG002|Overall Study|Other unspecified|33|||
155649913|NCT02134028|561810196|FG003|Overall Study|Other unspecified|64|||
155649914|NCT02134028|561810197|FG004|Overall Study|Other unspecified|8|||
155649915|NCT02134028|561810198|FG005|Overall Study|Other unspecified|6|||
155649916|NCT02134028|561810199|FG006|Overall Study|Other unspecified|2|||
155649917|NCT02134028|561810200|FG007|Overall Study|Other unspecified|1|||
155512331|NCT00321711|561301278|FG003|Part A|Requirement for alternative therapy|0|||
155512332|NCT00321711|561301279|FG004|Part A|Requirement for alternative therapy|0|||
155512333|NCT00321711|561301275|FG000|Part A|Physician Decision|0|||
155512334|NCT00321711|561301276|FG001|Part A|Physician Decision|1|||
155512335|NCT00321711|561301277|FG002|Part A|Physician Decision|3|||
155512336|NCT00321711|561301278|FG003|Part A|Physician Decision|0|||
155512337|NCT00321711|561301279|FG004|Part A|Physician Decision|0|||
155512338|NCT00321711|561301275|FG000|Part A|Other|1|||
155512339|NCT00321711|561301276|FG001|Part A|Other|2|||
155512340|NCT00321711|561301277|FG002|Part A|Other|3|||
155512341|NCT00321711|561301278|FG003|Part A|Other|0|||
155512342|NCT00321711|561301279|FG004|Part A|Other|0|||
155377248|NCT00705679|560814390|FG002|Overall Study|Physician Decision|0|||
155377249|NCT00705679|560814391|FG003|Overall Study|Physician Decision|1|||
155377250|NCT00705679|560814392|FG004|Overall Study|Physician Decision|0|||
155377251|NCT00705679|560814388|FG000|Overall Study|Withdrawal by Subject|32|||
155377252|NCT00705679|560814389|FG001|Overall Study|Withdrawal by Subject|77|||
155377253|NCT00705679|560814390|FG002|Overall Study|Withdrawal by Subject|68|||
155377254|NCT00705679|560814391|FG003|Overall Study|Withdrawal by Subject|47|||
155377255|NCT00705679|560814392|FG004|Overall Study|Withdrawal by Subject|33|||
155377256|NCT03527173|560814393|FG000|Overall Study|Lost to Follow-up|4|||
155377257|NCT03527173|560814394|FG001|Overall Study|Lost to Follow-up|2|||
155377258|NCT03527173|560814393|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
155377259|NCT03527173|560814394|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
155377260|NCT03527173|560814393|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155377261|NCT03527173|560814394|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
155377262|NCT03527173|560814393|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155377263|NCT03527173|560814394|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155377264|NCT00423943|560814397|FG000|Overall Study|Withdrawal by Subject|3|||
155377265|NCT00423943|560814398|FG001|Overall Study|Withdrawal by Subject|1|||
155377266|NCT03730480|560814399|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
155377267|NCT01248780|560814400|FG000|Overall Study|Lack of Efficacy|2|||
155377268|NCT01248780|560814401|FG001|Overall Study|Lack of Efficacy|0|||
155377269|NCT01248780|560814400|FG000|Overall Study|Lost to Follow-up|0|||
155512343|NCT00321711|561301275|FG000|Part A|Protocol deviation|0|||
155512344|NCT00321711|561301276|FG001|Part A|Protocol deviation|0|||
155512345|NCT00321711|561301277|FG002|Part A|Protocol deviation|1|||
155512346|NCT00321711|561301278|FG003|Part A|Protocol deviation|0|||
155512347|NCT00321711|561301279|FG004|Part A|Protocol deviation|0|||
155512348|NCT00321711|561301275|FG000|Part B|Noncompliance|0|||
155512349|NCT00321711|561301276|FG001|Part B|Noncompliance|0|||
155512350|NCT00321711|561301277|FG002|Part B|Noncompliance|0|||
155377270|NCT01248780|560814401|FG001|Overall Study|Lost to Follow-up|1|||
155377271|NCT01248780|560814400|FG000|Overall Study|Death|0|||
155377272|NCT01248780|560814401|FG001|Overall Study|Death|1|||
155377273|NCT01248780|560814400|FG000|Overall Study|Adverse Event|2|||
155377274|NCT01248780|560814401|FG001|Overall Study|Adverse Event|7|||
155377275|NCT01248780|560814400|FG000|Overall Study|Protocol Violation|1|||
155377276|NCT01248780|560814401|FG001|Overall Study|Protocol Violation|1|||
155377277|NCT01248780|560814400|FG000|Overall Study|Withdrawal by Subject|4|||
155377278|NCT01248780|560814401|FG001|Overall Study|Withdrawal by Subject|4|||
155377279|NCT01248780|560814400|FG000|Overall Study|Not treated|0|||
155377280|NCT01248780|560814401|FG001|Overall Study|Not treated|1|||
155377281|NCT04097301|560814402|FG000|Overall Study|Death|1|||
155377282|NCT04097301|560814402|FG000|Overall Study|Withdrawal by Subject|1|||
155377283|NCT04097301|560814402|FG000|Overall Study|Screening Failure|5|||
155377284|NCT01227577|560814403|FG000|Overall Study|Protocol deviation|3|||
155377285|NCT01227577|560814403|FG000|Overall Study|Death|3|||
155377286|NCT01227577|560814403|FG000|Overall Study|Administrative problems|2|||
155377287|NCT01227577|560814403|FG000|Overall Study|Lost to Follow-up|1|||
155377288|NCT01227577|560814403|FG000|Overall Study|Withdrawal by Subject|4|||
155512351|NCT00321711|561301278|FG003|Part B|Noncompliance|0|||
155512352|NCT00321711|561301279|FG004|Part B|Noncompliance|1|||
155512353|NCT00321711|561301275|FG000|Part B|Adverse Event|0|||
155512354|NCT00321711|561301276|FG001|Part B|Adverse Event|0|||
155512355|NCT00321711|561301277|FG002|Part B|Adverse Event|0|||
155512356|NCT00321711|561301278|FG003|Part B|Adverse Event|2|||
155512357|NCT00321711|561301279|FG004|Part B|Adverse Event|1|||
155512358|NCT00321711|561301275|FG000|Part B|Disease progression|0|||
155649918|NCT02134028|561810193|FG000|Overall Study|Adverse Event|3|||
155649919|NCT02134028|561810194|FG001|Overall Study|Adverse Event|19|||
155377289|NCT01227577|560814403|FG000|Overall Study|Lack of Efficacy|5|||
155377290|NCT01227577|560814403|FG000|Overall Study|Adverse Event|17|||
155377291|NCT00901186|560814404|FG000|Overall Study|Lack of Efficacy|0|||
155377292|NCT00901186|560814405|FG001|Overall Study|Lack of Efficacy|1|||
155377293|NCT00901186|560814404|FG000|Overall Study|Abnormal laboratory values|0|||
155377294|NCT00901186|560814405|FG001|Overall Study|Abnormal laboratory values|1|||
155377295|NCT00901186|560814404|FG000|Overall Study|Lost to Follow-up|2|||
155377296|NCT00901186|560814405|FG001|Overall Study|Lost to Follow-up|0|||
155377297|NCT00901186|560814404|FG000|Overall Study|Adverse Event|2|||
155377298|NCT00901186|560814405|FG001|Overall Study|Adverse Event|4|||
155377299|NCT00901186|560814404|FG000|Overall Study|Administration problems|0|||
155377300|NCT00901186|560814405|FG001|Overall Study|Administration problems|1|||
155377301|NCT00901186|560814404|FG000|Overall Study|Protocol deviations|5|||
155377302|NCT00901186|560814405|FG001|Overall Study|Protocol deviations|4|||
155377303|NCT00107120|560814406|FG000|Overall Study|Adverse Event|4|||
155377304|NCT00107120|560814407|FG001|Overall Study|Adverse Event|1|||
155377305|NCT00107120|560814406|FG000|Overall Study|Lack of Efficacy|5|||
155377306|NCT00107120|560814407|FG001|Overall Study|Lack of Efficacy|5|||
155377307|NCT00107120|560814406|FG000|Overall Study|Protocol Violation|3|||
155377308|NCT00107120|560814407|FG001|Overall Study|Protocol Violation|0|||
155377309|NCT00107120|560814406|FG000|Overall Study|Withdrawal by Subject|8|||
155377310|NCT00107120|560814407|FG001|Overall Study|Withdrawal by Subject|9|||
155377311|NCT00107120|560814406|FG000|Overall Study|Lost to Follow-up|8|||
155377312|NCT00107120|560814407|FG001|Overall Study|Lost to Follow-up|6|||
155377313|NCT00107120|560814406|FG000|Overall Study|Pregnancy|0|||
155377314|NCT00107120|560814407|FG001|Overall Study|Pregnancy|1|||
155377315|NCT00107120|560814406|FG000|Overall Study|moving away from site|1|||
155377316|NCT00107120|560814407|FG001|Overall Study|moving away from site|1|||
155377317|NCT00107120|560814406|FG000|Overall Study|death of parent|0|||
155377318|NCT00107120|560814407|FG001|Overall Study|death of parent|1|||
155377319|NCT01119105|560814408|FG000|Overall Study|Withdrawal by Subject|1|||
155377320|NCT01119105|560814409|FG001|Overall Study|Withdrawal by Subject|1|||
155377321|NCT01119105|560814410|FG002|Overall Study|Withdrawal by Subject|1|||
155377322|NCT01119105|560814408|FG000|Overall Study|Lost to Follow-up|0|||
155377323|NCT01119105|560814409|FG001|Overall Study|Lost to Follow-up|2|||
155377324|NCT01119105|560814410|FG002|Overall Study|Lost to Follow-up|5|||
155377325|NCT01119105|560814408|FG000|Overall Study|Adverse Event|1|||
155377326|NCT01119105|560814409|FG001|Overall Study|Adverse Event|0|||
155377327|NCT01119105|560814410|FG002|Overall Study|Adverse Event|1|||
155377328|NCT01119105|560814408|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
155377329|NCT01119105|560814409|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
155377330|NCT01119105|560814410|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
155377331|NCT01119105|560814408|FG000|Overall Study|Other|1|||
155377332|NCT01119105|560814409|FG001|Overall Study|Other|1|||
155377333|NCT01119105|560814410|FG002|Overall Study|Other|0|||
155377334|NCT01639495|560814411|FG000|Overall Study|Lost to Follow-up|6|||
155377335|NCT01639495|560814411|FG000|Overall Study|Consented but didn't have study catheter|4|||
155377336|NCT01639495|560814411|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
155377337|NCT01639495|560814411|FG000|Overall Study|No radiofrequency energy applied|2|||
155377338|NCT02383056|560814412|FG000|Overall Study|Adverse Event|1|||
155377339|NCT02383056|560814413|FG001|Overall Study|Adverse Event|0|||
155377340|NCT02383056|560814412|FG000|Overall Study|Lost to Follow-up|0|||
155377341|NCT02383056|560814413|FG001|Overall Study|Lost to Follow-up|2|||
155377342|NCT04214600|560814414|FG000|Overall Study|Lost to Follow-up|9|||
155377343|NCT04214600|560814415|FG001|Overall Study|Lost to Follow-up|14|||
155377344|NCT02935452|560814416|FG000|Overall Study|work and life commintment|3|||
155431491|NCT01486264|561005109|FG001|Overall Study|Not treated|1|||
155431492|NCT00283387|561005110|FG000|First Intervention|Subject non-compliant|1|||
155431493|NCT00283387|561005111|FG001|First Intervention|Subject non-compliant|1|||
155431494|NCT00283387|561005110|FG000|First Intervention|Withdrawal by Subject|0|||
155431495|NCT00283387|561005111|FG001|First Intervention|Withdrawal by Subject|1|||
155431496|NCT05340504|561005116|FG000|Overall Study|Withdrawal by Subject|1|||
155431497|NCT05340504|561005117|FG001|Overall Study|Withdrawal by Subject|0|||
155431498|NCT03068715|561005118|FG000|Overall Study|No longer met inclusion criteria|1|||
155431499|NCT03068715|561005119|FG001|Overall Study|No longer met inclusion criteria|0|||
155431500|NCT03584009|561005120|FG000|Overall Study|Death|25|||
155431501|NCT03584009|561005121|FG001|Overall Study|Death|18|||
155431502|NCT03584009|561005120|FG000|Overall Study|Lost to Follow-up|0|||
155431503|NCT03584009|561005121|FG001|Overall Study|Lost to Follow-up|1|||
155431504|NCT03584009|561005120|FG000|Overall Study|Physician Decision|1|||
155431505|NCT03584009|561005121|FG001|Overall Study|Physician Decision|1|||
155431506|NCT03584009|561005120|FG000|Overall Study|Study Terminated by Sponsor|22|||
155431507|NCT03584009|561005121|FG001|Overall Study|Study Terminated by Sponsor|30|||
155431508|NCT03584009|561005120|FG000|Overall Study|Withdrawal by Subject|3|||
155431509|NCT03584009|561005121|FG001|Overall Study|Withdrawal by Subject|2|||
155431510|NCT00768560|561005122|FG000|Intervention Set 1|Adverse Event|0|||
155377345|NCT02935452|560814417|FG001|Overall Study|work and life commintment|1|||
155377346|NCT01635920|560814419|FG000|Overall Study|Adverse Event|1|||
155377347|NCT01635920|560814420|FG001|Overall Study|Adverse Event|0|||
155377348|NCT01635920|560814419|FG000|Overall Study|Lost to Follow-up|0|||
155377349|NCT01635920|560814420|FG001|Overall Study|Lost to Follow-up|1|||
155377350|NCT01635920|560814419|FG000|Overall Study|Subject decision|2|||
155377351|NCT01635920|560814420|FG001|Overall Study|Subject decision|0|||
155377352|NCT01813929|560814421|FG000|Overall Study|Withdrawal by Subject|0|||
155377353|NCT01813929|560814422|FG001|Overall Study|Withdrawal by Subject|1|||
155377354|NCT01239043|560814427|FG000|Overall Study|Protocol Violation|2|||
155377355|NCT01239043|560814428|FG001|Overall Study|Protocol Violation|1|||
155377356|NCT02929329|560814429|FG000|Overall Study|Withdrawal by Subject|24|||
155377357|NCT02929329|560814430|FG001|Overall Study|Withdrawal by Subject|21|||
155377358|NCT02929329|560814429|FG000|Overall Study|Lost to Follow-up|26|||
155377359|NCT02929329|560814430|FG001|Overall Study|Lost to Follow-up|20|||
155377360|NCT02929329|560814429|FG000|Overall Study|Death|1054|||
155377361|NCT02929329|560814430|FG001|Overall Study|Death|1051|||
155377362|NCT02121301|560814431|FG000|Overall Study|Protocol Violation|1|||
155377363|NCT02121301|560814432|FG001|Overall Study|Protocol Violation|4|||
155377364|NCT02121301|560814433|FG002|Overall Study|Protocol Violation|1|||
155377365|NCT00434213|560814441|FG000|Overall Study|Adverse Event|12|||
155377366|NCT00434213|560814441|FG000|Overall Study|Lack of Efficacy|9|||
155377367|NCT00434213|560814441|FG000|Overall Study|Lost to Follow-up|14|||
155377368|NCT00434213|560814441|FG000|Overall Study|Withdrawal by Subject|7|||
155377369|NCT00434213|560814441|FG000|Overall Study|Protocol Violation|3|||
155377370|NCT00434213|560814441|FG000|Overall Study|Unable to comply with study visit window|2|||
155377371|NCT00434213|560814441|FG000|Overall Study|Application site reaction|1|||
155377372|NCT00434213|560814441|FG000|Overall Study|Non-compliant to study schedule|1|||
155377373|NCT04988867|560814442|FG000|Overall Study|Study terminated by Sponsor|12|||
155377374|NCT04988867|560814442|FG000|Overall Study|Adverse Event|2|||
155377375|NCT04988867|560814442|FG000|Overall Study|Study drug noncompliance|1|||
155377376|NCT01699503|560814443|FG000|Overall Study|Death|31|||
155377377|NCT01699503|560814444|FG001|Overall Study|Death|40|||
155377378|NCT01699503|560814443|FG000|Overall Study|Withdrawal by Subject|65|||
155377379|NCT01699503|560814444|FG001|Overall Study|Withdrawal by Subject|57|||
155377380|NCT01699503|560814443|FG000|Overall Study|Lost to Follow-up|121|||
155377381|NCT01699503|560814444|FG001|Overall Study|Lost to Follow-up|117|||
155377382|NCT01699503|560814443|FG000|Overall Study|Excluded due to quality|783|||
155377383|NCT01699503|560814444|FG001|Overall Study|Excluded due to quality|791|||
155377384|NCT01639560|560814445|FG000|Overall Study|Withdrawal by Subject|9|||
155377385|NCT01639560|560814446|FG001|Overall Study|Withdrawal by Subject|14|||
155377386|NCT01639560|560814445|FG000|Overall Study|Lack of Efficacy|1|||
155377387|NCT01639560|560814446|FG001|Overall Study|Lack of Efficacy|2|||
155377388|NCT01639560|560814445|FG000|Overall Study|Lost to Follow-up|9|||
155377389|NCT01639560|560814446|FG001|Overall Study|Lost to Follow-up|11|||
155377390|NCT01639560|560814445|FG000|Overall Study|Adverse Event|0|||
155377391|NCT01639560|560814446|FG001|Overall Study|Adverse Event|2|||
155377392|NCT00911937|560814447|FG000|Overall Study|Death|1|||
155377393|NCT00911937|560814448|FG001|Overall Study|Death|0|||
155377394|NCT00911937|560814447|FG000|Overall Study|Lost to Follow-up|8|||
155377395|NCT00911937|560814448|FG001|Overall Study|Lost to Follow-up|5|||
155377396|NCT00911937|560814447|FG000|Overall Study|Withdrawal by Subject|10|||
155377397|NCT00911937|560814448|FG001|Overall Study|Withdrawal by Subject|7|||
155377398|NCT00911937|560814447|FG000|Overall Study|Withdrawn due to pregnancy|1|||
155377399|NCT00911937|560814448|FG001|Overall Study|Withdrawn due to pregnancy|0|||
155377400|NCT00911937|560814447|FG000|Overall Study|Adverse Event|11|||
155377401|NCT00911937|560814448|FG001|Overall Study|Adverse Event|25|||
155512359|NCT00321711|561301276|FG001|Part B|Disease progression|0|||
155512360|NCT00321711|561301277|FG002|Part B|Disease progression|0|||
155512361|NCT00321711|561301278|FG003|Part B|Disease progression|1|||
155512362|NCT00321711|561301279|FG004|Part B|Disease progression|0|||
155512363|NCT00321711|561301275|FG000|Part B|Physician Decision|0|||
155512364|NCT00321711|561301276|FG001|Part B|Physician Decision|0|||
155377402|NCT00911937|560814447|FG000|Overall Study|Lack of Efficacy|11|||
155377403|NCT00911937|560814448|FG001|Overall Study|Lack of Efficacy|6|||
155377404|NCT00911937|560814447|FG000|Overall Study|Did not meet inclusion criteria|9|||
155377405|NCT00911937|560814448|FG001|Overall Study|Did not meet inclusion criteria|11|||
155377406|NCT00911937|560814447|FG000|Overall Study|Protocol Violation|14|||
155377407|NCT00911937|560814448|FG001|Overall Study|Protocol Violation|23|||
155377408|NCT00911937|560814447|FG000|Overall Study|Randomized but not treated|13|||
155377409|NCT00911937|560814448|FG001|Overall Study|Randomized but not treated|13|||
155377410|NCT00911937|560814447|FG000|Overall Study|Other|9|||
155377411|NCT00911937|560814448|FG001|Overall Study|Other|5|||
155377412|NCT00633880|560814451|FG000|Open Label Titration|Lack of Efficacy|1|||
155377413|NCT00633880|560814452|FG001|Open Label Titration|Lack of Efficacy|0|||
155377414|NCT00633880|560814453|FG002|Open Label Titration|Lack of Efficacy|0|||
155377415|NCT00633880|560814451|FG000|Open Label Titration|Adverse Event|13|||
155377416|NCT00633880|560814452|FG001|Open Label Titration|Adverse Event|0|||
155512365|NCT00321711|561301277|FG002|Part B|Physician Decision|0|||
155377417|NCT00633880|560814453|FG002|Open Label Titration|Adverse Event|0|||
155377418|NCT00633880|560814451|FG000|Open Label Titration|Treatment Failure|55|||
155377419|NCT00633880|560814452|FG001|Open Label Titration|Treatment Failure|0|||
155377420|NCT00633880|560814453|FG002|Open Label Titration|Treatment Failure|0|||
155377421|NCT00633880|560814451|FG000|Open Label Titration|Protocol Violation|6|||
155377422|NCT00633880|560814452|FG001|Open Label Titration|Protocol Violation|0|||
155377423|NCT00633880|560814453|FG002|Open Label Titration|Protocol Violation|0|||
155377424|NCT00633880|560814451|FG000|Open Label Titration|Physician Decision|1|||
155377425|NCT00633880|560814452|FG001|Open Label Titration|Physician Decision|0|||
155377426|NCT00633880|560814453|FG002|Open Label Titration|Physician Decision|0|||
155377427|NCT00633880|560814451|FG000|Open Label Titration|Withdrawal by Subject|4|||
155377428|NCT00633880|560814452|FG001|Open Label Titration|Withdrawal by Subject|0|||
155377429|NCT00633880|560814453|FG002|Open Label Titration|Withdrawal by Subject|0|||
155377430|NCT00700778|560814454|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
155377431|NCT04927247|560814456|FG000|Overall Study|Other|2|||
155377432|NCT04927247|560814457|FG001|Overall Study|Other|1|||
155377433|NCT04927247|560814456|FG000|Overall Study|Physician Decision|0|||
155377434|NCT04927247|560814457|FG001|Overall Study|Physician Decision|1|||
155377435|NCT04927247|560814456|FG000|Overall Study|Adverse Event|1|||
155377436|NCT04927247|560814457|FG001|Overall Study|Adverse Event|0|||
155377437|NCT00350103|560814458|FG000|Overall Study|Adverse Event|12|||
155377438|NCT00350103|560814459|FG001|Overall Study|Adverse Event|29|||
155377439|NCT00350103|560814460|FG002|Overall Study|Adverse Event|17|||
155377440|NCT00350103|560814458|FG000|Overall Study|Lack of Efficacy|5|||
155377441|NCT00350103|560814459|FG001|Overall Study|Lack of Efficacy|1|||
155377442|NCT00350103|560814460|FG002|Overall Study|Lack of Efficacy|3|||
155377443|NCT00350103|560814458|FG000|Overall Study|Withdrawal by Subject|6|||
155377444|NCT00350103|560814459|FG001|Overall Study|Withdrawal by Subject|6|||
155377445|NCT00350103|560814460|FG002|Overall Study|Withdrawal by Subject|8|||
155377446|NCT00350103|560814458|FG000|Overall Study|Protocol Violation|0|||
155377447|NCT00350103|560814459|FG001|Overall Study|Protocol Violation|0|||
155377448|NCT00350103|560814460|FG002|Overall Study|Protocol Violation|1|||
155377449|NCT00350103|560814458|FG000|Overall Study|Unsatisfactory Compliance|2|||
155377450|NCT00350103|560814459|FG001|Overall Study|Unsatisfactory Compliance|2|||
155377451|NCT00350103|560814460|FG002|Overall Study|Unsatisfactory Compliance|1|||
155377452|NCT00350103|560814458|FG000|Overall Study|Investigator´s decision|1|||
155377453|NCT00350103|560814459|FG001|Overall Study|Investigator´s decision|1|||
155377454|NCT00350103|560814460|FG002|Overall Study|Investigator´s decision|0|||
155377455|NCT00350103|560814458|FG000|Overall Study|Exclusion criteria met|0|||
155377456|NCT00350103|560814459|FG001|Overall Study|Exclusion criteria met|0|||
155377457|NCT00350103|560814460|FG002|Overall Study|Exclusion criteria met|1|||
155377458|NCT00350103|560814458|FG000|Overall Study|Patient relocated|0|||
155377459|NCT00350103|560814459|FG001|Overall Study|Patient relocated|0|||
155377460|NCT00350103|560814460|FG002|Overall Study|Patient relocated|1|||
155377461|NCT00350103|560814458|FG000|Overall Study|Need for prohibited medication|1|||
155377462|NCT00350103|560814459|FG001|Overall Study|Need for prohibited medication|0|||
155377463|NCT00350103|560814460|FG002|Overall Study|Need for prohibited medication|0|||
155377464|NCT00350103|560814458|FG000|Overall Study|Personal reasons|0|||
155377465|NCT00350103|560814459|FG001|Overall Study|Personal reasons|0|||
155377466|NCT00350103|560814460|FG002|Overall Study|Personal reasons|1|||
155377467|NCT00350103|560814458|FG000|Overall Study|Patient stopped feeling pain|1|||
155377468|NCT00350103|560814459|FG001|Overall Study|Patient stopped feeling pain|0|||
155431511|NCT00768560|561005123|FG001|Intervention Set 1|Adverse Event|1|||
155431512|NCT00768560|561005124|FG002|Intervention Set 1|Adverse Event|0|||
155431513|NCT00768560|561005125|FG003|Intervention Set 1|Adverse Event|0|||
155431514|NCT00768560|561005126|FG004|Intervention Set 1|Adverse Event|0|||
155431515|NCT00768560|561005127|FG005|Intervention Set 1|Adverse Event|0|||
155431516|NCT00117312|561005128|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
155431517|NCT00117312|561005129|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
155512366|NCT00321711|561301278|FG003|Part B|Physician Decision|1|||
155512367|NCT00321711|561301279|FG004|Part B|Physician Decision|2|||
155512368|NCT00321711|561301275|FG000|Part B|Death|0|||
155512369|NCT00321711|561301276|FG001|Part B|Death|0|||
155377469|NCT00350103|560814460|FG002|Overall Study|Patient stopped feeling pain|0|||
155377470|NCT00350103|560814458|FG000|Overall Study|PR greater than 250ms|0|||
155377471|NCT00350103|560814459|FG001|Overall Study|PR greater than 250ms|0|||
155377472|NCT00350103|560814460|FG002|Overall Study|PR greater than 250ms|1|||
155431518|NCT00117312|561005130|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
155431519|NCT00117312|561005131|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
155377473|NCT00350103|560814458|FG000|Overall Study|Wrong calculation of QT interval|0|||
155377474|NCT00350103|560814459|FG001|Overall Study|Wrong calculation of QT interval|0|||
155377475|NCT00350103|560814460|FG002|Overall Study|Wrong calculation of QT interval|1|||
155377476|NCT00350103|560814458|FG000|Overall Study|Sponsor mistake|1|||
155377477|NCT00350103|560814459|FG001|Overall Study|Sponsor mistake|0|||
155431520|NCT00117312|561005128|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
155512370|NCT00321711|561301277|FG002|Part B|Death|0|||
155377478|NCT00350103|560814460|FG002|Overall Study|Sponsor mistake|0|||
155377479|NCT00350103|560814458|FG000|Overall Study|Randomization mistake|0|||
155377480|NCT00350103|560814459|FG001|Overall Study|Randomization mistake|1|||
155377481|NCT00350103|560814460|FG002|Overall Study|Randomization mistake|1|||
155377482|NCT00350103|560814458|FG000|Overall Study|Sponsor´s decision|0|||
155377483|NCT00350103|560814459|FG001|Overall Study|Sponsor´s decision|1|||
155377484|NCT00350103|560814460|FG002|Overall Study|Sponsor´s decision|0|||
155377485|NCT00350103|560814458|FG000|Overall Study|Lost, Reason unknown|1|||
155377486|NCT00350103|560814459|FG001|Overall Study|Lost, Reason unknown|1|||
155377487|NCT00350103|560814460|FG002|Overall Study|Lost, Reason unknown|0|||
155377488|NCT02842151|560814461|FG000|Overall Study|Adverse Event|1|||
155377489|NCT02842151|560814461|FG000|Overall Study|Subject moved too far away|1|||
155377490|NCT02559895|560814462|FG000|Overall Study|Adverse Event|3|||
155377491|NCT02559895|560814463|FG001|Overall Study|Adverse Event|3|||
155377492|NCT02559895|560814464|FG002|Overall Study|Adverse Event|2|||
155377493|NCT02559895|560814465|FG003|Overall Study|Adverse Event|1|||
155377494|NCT02559895|560814462|FG000|Overall Study|Lack of Efficacy|2|||
155377495|NCT02559895|560814463|FG001|Overall Study|Lack of Efficacy|3|||
155377496|NCT02559895|560814464|FG002|Overall Study|Lack of Efficacy|2|||
155377497|NCT02559895|560814465|FG003|Overall Study|Lack of Efficacy|8|||
155377498|NCT02559895|560814462|FG000|Overall Study|Lost to Follow-up|22|||
155377499|NCT02559895|560814463|FG001|Overall Study|Lost to Follow-up|16|||
155377500|NCT02559895|560814464|FG002|Overall Study|Lost to Follow-up|12|||
155377501|NCT02559895|560814465|FG003|Overall Study|Lost to Follow-up|17|||
155377502|NCT02559895|560814462|FG000|Overall Study|Physician Decision|1|||
155377503|NCT02559895|560814463|FG001|Overall Study|Physician Decision|1|||
155377504|NCT02559895|560814464|FG002|Overall Study|Physician Decision|3|||
155377505|NCT02559895|560814465|FG003|Overall Study|Physician Decision|0|||
155377506|NCT02559895|560814462|FG000|Overall Study|Withdrawal by Subject|16|||
155377507|NCT02559895|560814463|FG001|Overall Study|Withdrawal by Subject|9|||
155377508|NCT02559895|560814464|FG002|Overall Study|Withdrawal by Subject|20|||
155377509|NCT02559895|560814465|FG003|Overall Study|Withdrawal by Subject|9|||
155377510|NCT02559895|560814462|FG000|Overall Study|Study Burden|10|||
155377511|NCT02559895|560814463|FG001|Overall Study|Study Burden|16|||
155377512|NCT02559895|560814464|FG002|Overall Study|Study Burden|12|||
155377513|NCT02559895|560814465|FG003|Overall Study|Study Burden|22|||
155377514|NCT02559895|560814462|FG000|Overall Study|Other|1|||
155377515|NCT02559895|560814463|FG001|Overall Study|Other|5|||
155377516|NCT02559895|560814464|FG002|Overall Study|Other|3|||
155377517|NCT02559895|560814465|FG003|Overall Study|Other|3|||
155377518|NCT00320528|560814466|FG000|Study Period II|Adverse Event|3|||
155377519|NCT00320528|560814467|FG001|Study Period II|Adverse Event|4|||
155377520|NCT00320528|560814468|FG002|Study Period II|Adverse Event|8|||
155377521|NCT00320528|560814466|FG000|Study Period II|Parent/Caregiver Decision|8|||
155377522|NCT00320528|560814467|FG001|Study Period II|Parent/Caregiver Decision|3|||
155377523|NCT00320528|560814468|FG002|Study Period II|Parent/Caregiver Decision|11|||
155377524|NCT00320528|560814466|FG000|Study Period II|Withdrawal by Subject|0|||
155377525|NCT00320528|560814467|FG001|Study Period II|Withdrawal by Subject|1|||
155377526|NCT00320528|560814468|FG002|Study Period II|Withdrawal by Subject|1|||
155377527|NCT00320528|560814466|FG000|Study Period II|Entry Criteria Exclusion|0|||
155377528|NCT00320528|560814467|FG001|Study Period II|Entry Criteria Exclusion|2|||
155377529|NCT00320528|560814468|FG002|Study Period II|Entry Criteria Exclusion|2|||
155377530|NCT00320528|560814466|FG000|Study Period III|Adverse Event|1|||
155377531|NCT00320528|560814467|FG001|Study Period III|Adverse Event|0|||
155377532|NCT00320528|560814468|FG002|Study Period III|Adverse Event|0|||
155377533|NCT00320528|560814466|FG000|Study Period III|Lost to Follow-up|1|||
155377534|NCT00320528|560814467|FG001|Study Period III|Lost to Follow-up|0|||
155377535|NCT00320528|560814468|FG002|Study Period III|Lost to Follow-up|0|||
155431521|NCT00117312|561005129|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
155431522|NCT00117312|561005130|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
155431523|NCT00117312|561005131|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
155431524|NCT00117312|561005128|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
155377536|NCT00320528|560814466|FG000|Study Period III|Withdrawal by Subject|1|||
155377537|NCT00320528|560814467|FG001|Study Period III|Withdrawal by Subject|1|||
155377538|NCT00320528|560814468|FG002|Study Period III|Withdrawal by Subject|2|||
155377539|NCT00320528|560814466|FG000|Study Period III|Lack of Efficacy|2|||
155377540|NCT00320528|560814467|FG001|Study Period III|Lack of Efficacy|0|||
155431525|NCT00117312|561005129|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
155431526|NCT00117312|561005130|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
155431527|NCT00117312|561005131|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
155377541|NCT00320528|560814468|FG002|Study Period III|Lack of Efficacy|0|||
155377542|NCT00320528|560814466|FG000|Study Period III|Parent/Caregiver Decision|14|||
155377543|NCT00320528|560814467|FG001|Study Period III|Parent/Caregiver Decision|3|||
155377544|NCT00320528|560814468|FG002|Study Period III|Parent/Caregiver Decision|11|||
155377545|NCT00320528|560814466|FG000|Study Period III|Protocol Violation|0|||
155377546|NCT00320528|560814467|FG001|Study Period III|Protocol Violation|1|||
155377547|NCT00320528|560814468|FG002|Study Period III|Protocol Violation|0|||
155377548|NCT00320528|560814466|FG000|Study Period III|Physician Decision|0|||
155377549|NCT00320528|560814467|FG001|Study Period III|Physician Decision|1|||
155377550|NCT00320528|560814468|FG002|Study Period III|Physician Decision|2|||
155377551|NCT00320528|560814466|FG000|Study Period III|Sponsor Decision|0|||
155377552|NCT00320528|560814467|FG001|Study Period III|Sponsor Decision|0|||
155377553|NCT00320528|560814468|FG002|Study Period III|Sponsor Decision|1|||
155377554|NCT00320528|560814466|FG000|Study Period III|Atomoxetine Commercially Available|68|||
155377555|NCT00320528|560814467|FG001|Study Period III|Atomoxetine Commercially Available|25|||
155377556|NCT00320528|560814468|FG002|Study Period III|Atomoxetine Commercially Available|90|||
155377557|NCT04828837|560814469|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
155377558|NCT04828837|560814470|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
155377559|NCT04828837|560814469|FG000|Overall Study|Lost to Follow-up|2|||
155377560|NCT04828837|560814470|FG001|Overall Study|Lost to Follow-up|6|||
155377561|NCT04828837|560814469|FG000|Overall Study|Lack of Efficacy|1|||
155377562|NCT04828837|560814470|FG001|Overall Study|Lack of Efficacy|0|||
155377563|NCT04828837|560814469|FG000|Overall Study|Admitted due to pneumothorax.|1|||
155377564|NCT04828837|560814470|FG001|Overall Study|Admitted due to pneumothorax.|0|||
155377565|NCT04828837|560814469|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
155377566|NCT04828837|560814470|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
155377567|NCT01397422|560814471|FG000|Overall Study|Adverse Event|0|||
155377568|NCT01397422|560814472|FG001|Overall Study|Adverse Event|3|||
155377569|NCT01397422|560814473|FG002|Overall Study|Adverse Event|3|||
155377570|NCT01397422|560814474|FG003|Overall Study|Adverse Event|8|||
155377571|NCT01397422|560814471|FG000|Overall Study|Withdrawal by Subject|1|||
155377572|NCT01397422|560814472|FG001|Overall Study|Withdrawal by Subject|0|||
155377573|NCT01397422|560814473|FG002|Overall Study|Withdrawal by Subject|0|||
155377574|NCT01397422|560814474|FG003|Overall Study|Withdrawal by Subject|0|||
155377575|NCT01397422|560814471|FG000|Overall Study|Increased bradykinesia related to PD|1|||
155377576|NCT01397422|560814472|FG001|Overall Study|Increased bradykinesia related to PD|0|||
155377577|NCT01397422|560814473|FG002|Overall Study|Increased bradykinesia related to PD|0|||
155377578|NCT01397422|560814474|FG003|Overall Study|Increased bradykinesia related to PD|0|||
155377579|NCT00760474|560814475|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
155377580|NCT00760474|560814476|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
155377581|NCT00760474|560814475|FG000|Placebo Washout Period|Other|0|||
155377582|NCT00760474|560814476|FG001|Placebo Washout Period|Other|1|||
155377583|NCT00760474|560814475|FG000|Period 2 (P2)|Lost to Follow-up|1|||
155377584|NCT00760474|560814476|FG001|Period 2 (P2)|Lost to Follow-up|0|||
155377585|NCT00760474|560814475|FG000|Period 2 (P2)|Adverse Event|0|||
155377586|NCT00760474|560814476|FG001|Period 2 (P2)|Adverse Event|1|||
155377587|NCT04664400|560814477|FG000|Overall Study|Withdrawal by Subject|2|||
155377588|NCT01262027|560814478|FG000|Overall Study|Adverse Event|1|||
155377589|NCT01262027|560814478|FG000|Overall Study|Withdrawal by Subject|3|||
155377590|NCT01262027|560814478|FG000|Overall Study|Protocol Violation|1|||
155377591|NCT01905150|560814492|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
155377592|NCT01905150|560814493|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
155377593|NCT01758900|560814500|FG000|Overall Study|difficulty for further intubation|7|||
155377594|NCT01758900|560814501|FG001|Overall Study|difficulty for further intubation|8|||
155377595|NCT03762200|560814503|FG000|Overall Study|Death|2|||
155377596|NCT04577001|560814504|FG000|Overall Study|Subject became ineligible|0|||
155377597|NCT04577001|560814505|FG001|Overall Study|Subject became ineligible|1|||
155377598|NCT01865747|560814508|FG000|Overall Study (ITT)|Adverse Event|32|||
155377599|NCT01865747|560814509|FG001|Overall Study (ITT)|Adverse Event|31|||
155377600|NCT01865747|560814508|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
155377601|NCT01865747|560814509|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
155377602|NCT01865747|560814508|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
155431528|NCT00117312|561005128|FG000|Overall Study|Other|0|||
155431529|NCT00117312|561005129|FG001|Overall Study|Other|1|||
155431530|NCT00117312|561005130|FG002|Overall Study|Other|3|||
155431531|NCT00117312|561005131|FG003|Overall Study|Other|1|||
155431532|NCT00117312|561005128|FG000|Overall Study|Patient choice|0|||
155431533|NCT00117312|561005129|FG001|Overall Study|Patient choice|0|||
155377603|NCT01865747|560814509|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
155377604|NCT01865747|560814508|FG000|Overall Study (ITT)|Protocol Violation|1|||
155377605|NCT01865747|560814509|FG001|Overall Study (ITT)|Protocol Violation|1|||
155377606|NCT01865747|560814508|FG000|Overall Study (ITT)|Physician Decision|5|||
155377607|NCT01865747|560814509|FG001|Overall Study (ITT)|Physician Decision|2|||
155377608|NCT01865747|560814508|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
155431534|NCT00117312|561005130|FG002|Overall Study|Patient choice|2|||
155377609|NCT01865747|560814509|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
155431535|NCT00117312|561005131|FG003|Overall Study|Patient choice|1|||
155649920|NCT02134028|561810195|FG002|Overall Study|Adverse Event|13|||
155649921|NCT02134028|561810196|FG003|Overall Study|Adverse Event|32|||
155377610|NCT01865747|560814508|FG000|Overall Study (ITT)|Sponsor Decision|0|||
155377611|NCT01865747|560814509|FG001|Overall Study (ITT)|Sponsor Decision|1|||
155377612|NCT01865747|560814508|FG000|Overall Study (ITT)|Progressive Disease|122|||
155377613|NCT01865747|560814509|FG001|Overall Study (ITT)|Progressive Disease|158|||
155377614|NCT01865747|560814508|FG000|Overall Study (ITT)|Reason Not Provided|0|||
155377615|NCT01865747|560814509|FG001|Overall Study (ITT)|Reason Not Provided|1|||
155377616|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
155377617|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
155377618|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
155377619|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
155377620|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
155377621|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
155377622|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
155377623|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
155377624|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
155377625|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
155377626|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
155377627|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
155377628|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
155377629|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
155377630|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Other|0|||
155377631|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Other|1|||
155377632|NCT00611975|560814512|FG000|Overall Study|Withdrawal by Subject|3|||
155377633|NCT00611975|560814513|FG001|Overall Study|Withdrawal by Subject|7|||
155377634|NCT00611975|560814512|FG000|Overall Study|Pregnancy|2|||
155377635|NCT00611975|560814513|FG001|Overall Study|Pregnancy|1|||
155377636|NCT04625413|560814514|FG000|Overall Study|Hospice|2|||
155377637|NCT04625413|560814514|FG000|Overall Study|Distress|1|||
155377638|NCT04625413|560814514|FG000|Overall Study|Not feeling well|1|||
155377639|NCT05618912|560814515|FG000|Overall Study|Lost to Follow-up|14|||
155377640|NCT05618912|560814516|FG001|Overall Study|Lost to Follow-up|19|||
155377641|NCT00432666|560815742|FG000|Main Period|Adverse Event|1|||
155377642|NCT00432666|560815743|FG001|Main Period|Adverse Event|1|||
155377643|NCT00432666|560815742|FG000|Main Period|Consent Withdrawn|1|||
155377644|NCT00432666|560815743|FG001|Main Period|Consent Withdrawn|0|||
155377645|NCT00432666|560815742|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
155377646|NCT00432666|560815743|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
155377647|NCT00432666|560815742|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
155377648|NCT00432666|560815743|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
155377649|NCT00432666|560815742|FG000|Open-Label Extension Period|Adverse Event|5|||
155377650|NCT00432666|560815743|FG001|Open-Label Extension Period|Adverse Event|0|||
155377651|NCT00432666|560815742|FG000|Open-Label Extension Period|Consent withdrawn|10|||
155377652|NCT00432666|560815743|FG001|Open-Label Extension Period|Consent withdrawn|0|||
155377653|NCT00432666|560815742|FG000|Open-Label Extension Period|Physician Decision|3|||
155377654|NCT00432666|560815743|FG001|Open-Label Extension Period|Physician Decision|0|||
155377655|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
155377656|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
155377657|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
155377658|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
155377659|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
155377660|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
155377661|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
155377662|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
155377663|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
155377664|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
155377665|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
155377666|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
155377667|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
155377668|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
155377669|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
155377670|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
155377671|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
155377672|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
155377673|NCT01506453|560815746|FG000|Overall Study|Withdrawal prior to treatment|0|||
155377674|NCT01506453|560815747|FG001|Overall Study|Withdrawal prior to treatment|2|||
155377675|NCT00605215|560815750|FG000|Overall Study|Death|0|||
155377676|NCT00605215|560815751|FG001|Overall Study|Death|0|||
155377677|NCT00605215|560815752|FG002|Overall Study|Death|1|||
155377678|NCT00605215|560815750|FG000|Overall Study|Adverse Event|19|||
155377679|NCT00605215|560815751|FG001|Overall Study|Adverse Event|21|||
155377680|NCT00605215|560815752|FG002|Overall Study|Adverse Event|26|||
155377681|NCT00605215|560815750|FG000|Overall Study|Refusal to sign the re-consent form|8|||
155377682|NCT00605215|560815751|FG001|Overall Study|Refusal to sign the re-consent form|3|||
155377683|NCT00605215|560815752|FG002|Overall Study|Refusal to sign the re-consent form|3|||
155377684|NCT00605215|560815750|FG000|Overall Study|Withdrawal by Subject|39|||
155377685|NCT00605215|560815751|FG001|Overall Study|Withdrawal by Subject|37|||
155377686|NCT00605215|560815752|FG002|Overall Study|Withdrawal by Subject|27|||
155377687|NCT00605215|560815750|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
155377688|NCT00605215|560815751|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
155377689|NCT00605215|560815752|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
155377690|NCT00605215|560815750|FG000|Overall Study|Protocol Violation|3|||
155377691|NCT00605215|560815751|FG001|Overall Study|Protocol Violation|4|||
155377692|NCT00605215|560815752|FG002|Overall Study|Protocol Violation|1|||
155377693|NCT00605215|560815750|FG000|Overall Study|Pregnancy|8|||
155377694|NCT00605215|560815751|FG001|Overall Study|Pregnancy|5|||
155377695|NCT00605215|560815752|FG002|Overall Study|Pregnancy|4|||
155377696|NCT00605215|560815750|FG000|Overall Study|Lost to Follow-up|8|||
155377697|NCT00605215|560815751|FG001|Overall Study|Lost to Follow-up|5|||
155377698|NCT00605215|560815752|FG002|Overall Study|Lost to Follow-up|2|||
155377699|NCT00605215|560815750|FG000|Overall Study|Other than specified|0|||
155377700|NCT00605215|560815751|FG001|Overall Study|Other than specified|2|||
155377701|NCT00605215|560815752|FG002|Overall Study|Other than specified|1|||
155377702|NCT04058366|560815753|FG000|Overall Study|Adverse Event|14|||
155377703|NCT04058366|560815753|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
155377704|NCT04058366|560815753|FG000|Overall Study|Commercial drug is available for participants|6|||
155377705|NCT04058366|560815753|FG000|Overall Study|Death|1|||
155377706|NCT04058366|560815753|FG000|Overall Study|Other non-compliance|2|||
155377707|NCT04058366|560815753|FG000|Overall Study|Other|6|||
155377708|NCT01302067|560815756|FG000|Overall Study|Death|0|||
155377709|NCT01302067|560815757|FG001|Overall Study|Death|0|||
155377710|NCT01302067|560815758|FG002|Overall Study|Death|1|||
155377711|NCT01302067|560815756|FG000|Overall Study|Physician Decision|9|||
155377712|NCT01302067|560815757|FG001|Overall Study|Physician Decision|5|||
155377713|NCT01302067|560815758|FG002|Overall Study|Physician Decision|14|||
155377714|NCT01302067|560815756|FG000|Overall Study|Lack of Efficacy|8|||
155377715|NCT01302067|560815757|FG001|Overall Study|Lack of Efficacy|4|||
155377716|NCT01302067|560815758|FG002|Overall Study|Lack of Efficacy|2|||
155377717|NCT01302067|560815756|FG000|Overall Study|Lost to Follow-up|9|||
155377718|NCT01302067|560815757|FG001|Overall Study|Lost to Follow-up|4|||
155377719|NCT01302067|560815758|FG002|Overall Study|Lost to Follow-up|15|||
155377720|NCT01302067|560815756|FG000|Overall Study|Withdrawal by Subject|13|||
155377721|NCT01302067|560815757|FG001|Overall Study|Withdrawal by Subject|6|||
155377722|NCT01302067|560815758|FG002|Overall Study|Withdrawal by Subject|10|||
155377723|NCT01302067|560815756|FG000|Overall Study|Other|1|||
155377724|NCT01302067|560815757|FG001|Overall Study|Other|1|||
155377725|NCT01302067|560815758|FG002|Overall Study|Other|3|||
155377726|NCT01302067|560815756|FG000|Overall Study|Protocol Violation|11|||
155377727|NCT01302067|560815757|FG001|Overall Study|Protocol Violation|0|||
155377728|NCT01302067|560815758|FG002|Overall Study|Protocol Violation|8|||
155377729|NCT01302067|560815756|FG000|Overall Study|Adverse Event|27|||
155377730|NCT01302067|560815757|FG001|Overall Study|Adverse Event|14|||
155377731|NCT01302067|560815758|FG002|Overall Study|Adverse Event|45|||
155377732|NCT01076192|560815759|FG000|Overall Study|Other|197|||
155377733|NCT01034176|560815760|FG000|Overall Study|Physician Decision|2|||
155377734|NCT01034176|560815761|FG001|Overall Study|Physician Decision|0|||
155377735|NCT01034176|560815760|FG000|Overall Study|Withdrawal by Subject|0|||
155377736|NCT01034176|560815761|FG001|Overall Study|Withdrawal by Subject|1|||
155377737|NCT01034176|560815760|FG000|Overall Study|Lost to Follow-up|0|||
155377738|NCT01034176|560815761|FG001|Overall Study|Lost to Follow-up|1|||
155377739|NCT00266227|560815762|FG000|Initial Treatment|Adverse Event|0|||
155377740|NCT00266227|560815763|FG001|Initial Treatment|Adverse Event|0|||
155377741|NCT00266227|560815764|FG002|Initial Treatment|Adverse Event|13|||
155377742|NCT00266227|560815762|FG000|Initial Treatment|Lost to Follow-up|0|||
155431536|NCT00117312|561005128|FG000|Overall Study|Adverse Event|0|||
155431537|NCT00117312|561005129|FG001|Overall Study|Adverse Event|2|||
155431538|NCT00117312|561005130|FG002|Overall Study|Adverse Event|0|||
155431539|NCT00117312|561005131|FG003|Overall Study|Adverse Event|0|||
155431540|NCT00117312|561005128|FG000|Overall Study|Protocol Violation|0|||
155431541|NCT00117312|561005129|FG001|Overall Study|Protocol Violation|1|||
155431542|NCT00117312|561005130|FG002|Overall Study|Protocol Violation|3|||
155431543|NCT00117312|561005131|FG003|Overall Study|Protocol Violation|0|||
155377743|NCT00266227|560815763|FG001|Initial Treatment|Lost to Follow-up|0|||
155377744|NCT00266227|560815764|FG002|Initial Treatment|Lost to Follow-up|6|||
155377745|NCT00266227|560815762|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
155377746|NCT00266227|560815763|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
155377747|NCT00266227|560815764|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
155377748|NCT00266227|560815762|FG000|Initial Treatment|Physician decision to withdraw|0|||
155377749|NCT00266227|560815763|FG001|Initial Treatment|Physician decision to withdraw|0|||
155431544|NCT00117312|561005128|FG000|Overall Study|PSA decrease <=50%|0|||
155431545|NCT00117312|561005129|FG001|Overall Study|PSA decrease <=50%|2|||
155377750|NCT00266227|560815764|FG002|Initial Treatment|Physician decision to withdraw|12|||
155377751|NCT00266227|560815762|FG000|Initial Treatment|Pregnancy|0|||
155377752|NCT00266227|560815763|FG001|Initial Treatment|Pregnancy|0|||
155377753|NCT00266227|560815764|FG002|Initial Treatment|Pregnancy|1|||
155377754|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Death|1|||
155377755|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Death|0|||
155377756|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Death|0|||
155377757|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
155377758|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
155377759|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
155377760|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
155377761|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
155377762|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
155377763|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
155377764|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
155377765|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
155377766|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
155377767|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
155377768|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
155377769|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
155377770|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
155377771|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
155377772|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Death|1|||
155377773|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Death|1|||
155377774|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Death|0|||
155377775|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
155377776|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
155377777|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
155377778|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
155377779|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
155377780|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
155377781|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
155377782|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
155377783|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
155377784|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
155377785|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
155377786|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
155377787|NCT01290315|560815766|FG000|Overall Study|Adverse Event|0|||
155377788|NCT01290315|560815767|FG001|Overall Study|Adverse Event|0|||
155377789|NCT01290315|560815768|FG002|Overall Study|Adverse Event|0|||
155377790|NCT01290315|560815769|FG003|Overall Study|Adverse Event|3|||
155377791|NCT01290315|560815766|FG000|Overall Study|Selection criteria/compliance|2|||
155377792|NCT01290315|560815767|FG001|Overall Study|Selection criteria/compliance|1|||
155377793|NCT01290315|560815768|FG002|Overall Study|Selection criteria/compliance|0|||
155377794|NCT01290315|560815769|FG003|Overall Study|Selection criteria/compliance|2|||
155377795|NCT01290315|560815766|FG000|Overall Study|Lost to Follow-up|0|||
155377796|NCT01290315|560815767|FG001|Overall Study|Lost to Follow-up|1|||
155377797|NCT01290315|560815768|FG002|Overall Study|Lost to Follow-up|0|||
155377798|NCT01290315|560815769|FG003|Overall Study|Lost to Follow-up|0|||
155377799|NCT01290315|560815766|FG000|Overall Study|Withdrawal by Subject|1|||
155377800|NCT01290315|560815767|FG001|Overall Study|Withdrawal by Subject|1|||
155377801|NCT01290315|560815768|FG002|Overall Study|Withdrawal by Subject|0|||
155377802|NCT01290315|560815769|FG003|Overall Study|Withdrawal by Subject|0|||
155377803|NCT00896051|560815773|FG000|Overall Study|Adverse Event|2|||
155377804|NCT00896051|560815774|FG001|Overall Study|Adverse Event|1|||
155512371|NCT00321711|561301278|FG003|Part B|Death|2|||
155377805|NCT00896051|560815773|FG000|Overall Study|Lost to Follow-up|3|||
155377806|NCT00896051|560815774|FG001|Overall Study|Lost to Follow-up|2|||
155377807|NCT00896051|560815773|FG000|Overall Study|Withdrawal by Subject|3|||
155377808|NCT00896051|560815774|FG001|Overall Study|Withdrawal by Subject|2|||
155377809|NCT00896051|560815773|FG000|Overall Study|Subject noncompliant|1|||
155377810|NCT00896051|560815774|FG001|Overall Study|Subject noncompliant|3|||
155377811|NCT00896051|560815773|FG000|Overall Study|Other|1|||
155377812|NCT00896051|560815774|FG001|Overall Study|Other|1|||
155377813|NCT00194987|560815775|FG000|Overall Study|Withdrawal by Subject|0|||
155377814|NCT00194987|560815776|FG001|Overall Study|Withdrawal by Subject|3|||
155377815|NCT01664598|560815777|FG000|Overall Study|Sponsor Decision|1|||
155377816|NCT01664598|560815777|FG000|Overall Study|Withdrawal of Informed Consent|4|||
155377817|NCT01664598|560815777|FG000|Overall Study|Adverse Event|1|||
155512372|NCT00321711|561301279|FG004|Part B|Death|1|||
155377818|NCT02342743|560815778|FG000|Baseline Period|Withdrawal by Subject|3|||
155377819|NCT02342743|560815778|FG000|Baseline Period|Lost to Follow-up|2|||
155377820|NCT02342743|560815778|FG000|Baseline Period|Change in prophylactic medication|3|||
155377821|NCT02342743|560815778|FG000|Baseline Period|Screening failure regarding baseline|7|||
155377822|NCT02342743|560815778|FG000|Treatment Period|Withdrawal by Subject|2|||
155377823|NCT02342743|560815778|FG000|Treatment Period|Lost to Follow-up|8|||
155377824|NCT02342743|560815778|FG000|Treatment Period|Change in prophylactic medication|1|||
155377825|NCT03602066|560815779|FG000|Overall Study|Withdrawal by Subject|2|||
155377826|NCT03602066|560815780|FG001|Overall Study|Withdrawal by Subject|0|||
155377827|NCT03602066|560815779|FG000|Overall Study|Physician Decision|1|||
155377828|NCT03602066|560815780|FG001|Overall Study|Physician Decision|0|||
155377829|NCT00092495|560815781|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
155377830|NCT00092495|560815782|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
155377831|NCT00092495|560815783|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155377832|NCT00092495|560815784|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
155377833|NCT00092495|560815785|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155377834|NCT00092495|560815781|FG000|Base Study Vaccination Period|Extended|0|||
155377835|NCT00092495|560815782|FG001|Base Study Vaccination Period|Extended|0|||
155377836|NCT00092495|560815783|FG002|Base Study Vaccination Period|Extended|0|||
155377837|NCT00092495|560815784|FG003|Base Study Vaccination Period|Extended|1|||
155377838|NCT00092495|560815785|FG004|Base Study Vaccination Period|Extended|0|||
155377839|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Clinical AE|1|||
155377840|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Clinical AE|0|||
155377841|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Clinical AE|1|||
155377842|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Clinical AE|2|||
155377843|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Clinical AE|0|||
155377844|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Other reasons|1|||
155377845|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Other reasons|0|||
155377846|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Other reasons|0|||
155377847|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Other reasons|1|||
155377848|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Other reasons|0|||
155377849|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Pregnancy|0|||
155377850|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Pregnancy|2|||
155377851|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Pregnancy|5|||
155377852|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Pregnancy|7|||
155377853|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Pregnancy|0|||
155377854|NCT00092495|560815781|FG000|Base Study Vaccination Period|Adverse Event|1|||
155377855|NCT00092495|560815782|FG001|Base Study Vaccination Period|Adverse Event|0|||
155377856|NCT00092495|560815783|FG002|Base Study Vaccination Period|Adverse Event|0|||
155377857|NCT00092495|560815784|FG003|Base Study Vaccination Period|Adverse Event|3|||
155377858|NCT00092495|560815785|FG004|Base Study Vaccination Period|Adverse Event|0|||
155377859|NCT00092495|560815781|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
155377860|NCT00092495|560815782|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
155377861|NCT00092495|560815783|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
155377862|NCT00092495|560815784|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
155377863|NCT00092495|560815785|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155377864|NCT00092495|560815781|FG000|Base Study Vaccination Period|Moved|3|||
155377865|NCT00092495|560815782|FG001|Base Study Vaccination Period|Moved|1|||
155377866|NCT00092495|560815783|FG002|Base Study Vaccination Period|Moved|2|||
155377867|NCT00092495|560815784|FG003|Base Study Vaccination Period|Moved|2|||
155377868|NCT00092495|560815785|FG004|Base Study Vaccination Period|Moved|0|||
155377869|NCT00092495|560815781|FG000|Base Study Vaccination Period|Other|1|||
155377870|NCT00092495|560815782|FG001|Base Study Vaccination Period|Other|1|||
155377871|NCT00092495|560815783|FG002|Base Study Vaccination Period|Other|0|||
155377872|NCT00092495|560815784|FG003|Base Study Vaccination Period|Other|2|||
155377873|NCT00092495|560815785|FG004|Base Study Vaccination Period|Other|0|||
155377874|NCT00092495|560815781|FG000|Base Study Vaccination Period|Pregnancy|2|||
155377875|NCT00092495|560815782|FG001|Base Study Vaccination Period|Pregnancy|0|||
155377876|NCT00092495|560815783|FG002|Base Study Vaccination Period|Pregnancy|0|||
155431546|NCT00117312|561005130|FG002|Overall Study|PSA decrease <=50%|2|||
155431547|NCT00117312|561005131|FG003|Overall Study|PSA decrease <=50%|4|||
155431548|NCT00117312|561005128|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
155377877|NCT00092495|560815784|FG003|Base Study Vaccination Period|Pregnancy|0|||
155377878|NCT00092495|560815785|FG004|Base Study Vaccination Period|Pregnancy|0|||
155377879|NCT00092495|560815781|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377880|NCT00092495|560815782|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377881|NCT00092495|560815783|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377882|NCT00092495|560815784|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
155377883|NCT00092495|560815785|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
155377884|NCT00092495|560815781|FG000|Base Study Vaccination Period|Protocol Violation|1|||
155377885|NCT00092495|560815782|FG001|Base Study Vaccination Period|Protocol Violation|0|||
155377886|NCT00092495|560815783|FG002|Base Study Vaccination Period|Protocol Violation|0|||
155431549|NCT00117312|561005129|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
155431550|NCT00117312|561005130|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
155431551|NCT00117312|561005131|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
155377887|NCT00092495|560815784|FG003|Base Study Vaccination Period|Protocol Violation|0|||
155377888|NCT00092495|560815785|FG004|Base Study Vaccination Period|Protocol Violation|0|||
155377889|NCT00092495|560815781|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
155377890|NCT00092495|560815782|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
155377891|NCT00092495|560815783|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
155377892|NCT00092495|560815784|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
155377893|NCT00092495|560815785|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155377894|NCT00092495|560815781|FG000|Base Study Follow-up Period|Extended|0|||
155377895|NCT00092495|560815782|FG001|Base Study Follow-up Period|Extended|0|||
155377896|NCT00092495|560815783|FG002|Base Study Follow-up Period|Extended|1|||
155377897|NCT00092495|560815784|FG003|Base Study Follow-up Period|Extended|2|||
155377898|NCT00092495|560815785|FG004|Base Study Follow-up Period|Extended|0|||
155377899|NCT00092495|560815781|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
155377900|NCT00092495|560815782|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
155377901|NCT00092495|560815783|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
155377902|NCT00092495|560815784|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
155377903|NCT00092495|560815785|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
155377904|NCT00092495|560815781|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
155377905|NCT00092495|560815782|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377906|NCT00092495|560815783|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377907|NCT00092495|560815784|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377908|NCT00092495|560815785|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377909|NCT03212989|560815798|FG000|Overall Study|Physician Decision|8|||
155377910|NCT01236534|560815801|FG000|Overall Study|Adverse Event|3|||
155377911|NCT01236534|560815802|FG001|Overall Study|Adverse Event|0|||
155377912|NCT01844687|560815805|FG000|Visit 1|Protocol Violation|3|||
155377913|NCT01844687|560815805|FG000|Visit 1|Lost to Follow-up|5|||
155377914|NCT01844687|560815805|FG000|Visit 2|Withdrawal by Subject|1|||
155377915|NCT01844687|560815805|FG000|Visit 2|Protocol Violation|1|||
155377916|NCT01844687|560815805|FG000|Visit 3|Lost to Follow-up|1|||
155377917|NCT01844687|560815805|FG000|Visit 3|Withdrawal by Subject|3|||
155377918|NCT01844687|560815805|FG000|Visit 3|child care problems|1|||
155377919|NCT01844687|560815805|FG000|Visit 4|Pregnancy|1|||
155377920|NCT01844687|560815805|FG000|Visit 4|Lost to Follow-up|1|||
155377921|NCT01844687|560815805|FG000|Visit 4|Withdrawal by Subject|2|||
155377922|NCT04638920|560815814|FG000|Overall Study|Withdrawal by Subject|5|||
155377923|NCT03775434|560815815|FG000|Overall Study|Adverse Event|2|||
155377924|NCT03775434|560815815|FG000|Overall Study|Withdrawal by Subject|1|||
155377925|NCT01435616|560815816|FG000|Overall Study|Adverse Event|39|||
155377926|NCT01435616|560815817|FG001|Overall Study|Adverse Event|21|||
155377927|NCT01435616|560815816|FG000|Overall Study|Death|7|||
155377928|NCT01435616|560815817|FG001|Overall Study|Death|2|||
155377929|NCT01435616|560815816|FG000|Overall Study|Lost to Follow-up|22|||
155377930|NCT01435616|560815817|FG001|Overall Study|Lost to Follow-up|13|||
155377931|NCT01435616|560815816|FG000|Overall Study|Protocol Violation|16|||
155431552|NCT00117312|561005128|FG000|Overall Study|Hepatic abnormality|0|||
155431553|NCT00117312|561005129|FG001|Overall Study|Hepatic abnormality|1|||
155431554|NCT00117312|561005130|FG002|Overall Study|Hepatic abnormality|0|||
155431555|NCT00117312|561005131|FG003|Overall Study|Hepatic abnormality|1|||
155431556|NCT00117312|561005128|FG000|Overall Study|Withdrawal by Subject|0|||
155431557|NCT00117312|561005129|FG001|Overall Study|Withdrawal by Subject|2|||
155431558|NCT00117312|561005130|FG002|Overall Study|Withdrawal by Subject|0|||
155431559|NCT00117312|561005131|FG003|Overall Study|Withdrawal by Subject|0|||
155431560|NCT01535235|561005133|FG000|Overall Study|Adverse Event|1|||
155431561|NCT01535235|561005134|FG001|Overall Study|Adverse Event|0|||
155431562|NCT00509106|561005136|FG000|Overall Study|Adverse Event|3|||
155431563|NCT00509106|561005137|FG001|Overall Study|Adverse Event|2|||
155431564|NCT00509106|561005136|FG000|Overall Study|Noncompliance|0|||
155431565|NCT00509106|561005137|FG001|Overall Study|Noncompliance|1|||
155431566|NCT00509106|561005136|FG000|Overall Study|At the request of sponsor/investigator|1|||
155431567|NCT00509106|561005137|FG001|Overall Study|At the request of sponsor/investigator|2|||
155431568|NCT00509106|561005136|FG000|Overall Study|Withdrew consent|4|||
155377932|NCT01435616|560815817|FG001|Overall Study|Protocol Violation|13|||
155377933|NCT01435616|560815816|FG000|Overall Study|Withdrawal by Subject|66|||
155377934|NCT01435616|560815817|FG001|Overall Study|Withdrawal by Subject|24|||
155431569|NCT00509106|561005137|FG001|Overall Study|Withdrew consent|8|||
155431570|NCT00509106|561005136|FG000|Overall Study|Lost to Follow-up|16|||
155431571|NCT00509106|561005137|FG001|Overall Study|Lost to Follow-up|10|||
155431572|NCT00509106|561005136|FG000|Overall Study|Other|1|||
155431573|NCT00509106|561005137|FG001|Overall Study|Other|0|||
155377935|NCT01435616|560815816|FG000|Overall Study|Physician Decision|20|||
155377936|NCT01435616|560815817|FG001|Overall Study|Physician Decision|7|||
155377937|NCT01435616|560815816|FG000|Overall Study|Sponsor Decision|1|||
155377938|NCT01435616|560815817|FG001|Overall Study|Sponsor Decision|0|||
155377939|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Death|1|||
155377940|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Death|1|||
155431574|NCT00509106|561005136|FG000|Overall Study|Death|6|||
155377941|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
155377942|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
155377943|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
155377944|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
155377945|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
155377946|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
155377947|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
155377948|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
155377949|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
155377950|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
155377951|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
155377952|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
155377953|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
155377954|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
155377955|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Death|0|||
155377956|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Death|2|||
155377957|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
155377958|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
155377959|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
155377960|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
155649922|NCT02134028|561810197|FG004|Overall Study|Adverse Event|4|||
155649923|NCT02134028|561810198|FG005|Overall Study|Adverse Event|5|||
155377961|NCT00438672|560815821|FG000|Overall Study|Lost to Follow-up|7|||
155377962|NCT00438672|560815822|FG001|Overall Study|Lost to Follow-up|9|||
155377963|NCT04540887|560815828|FG000|Overall Study|Withdrawal by Subject|2|||
155377964|NCT01394978|560815834|FG000|Overall Study|Withdrawal by Subject|2|||
155377965|NCT01394978|560815835|FG001|Overall Study|Withdrawal by Subject|4|||
155377966|NCT01394978|560815834|FG000|Overall Study|Lost to Follow-up|13|||
155377967|NCT01394978|560815835|FG001|Overall Study|Lost to Follow-up|20|||
155377968|NCT01394978|560815834|FG000|Overall Study|Death|6|||
155377969|NCT01394978|560815835|FG001|Overall Study|Death|7|||
155377970|NCT03562975|560815836|FG000|Overall Study|Death|1|||
155377971|NCT03562975|560815836|FG000|Overall Study|Lost to Follow-up|1|||
155377972|NCT03562975|560815836|FG000|Overall Study|Withdrawal by Subject|1|||
155377973|NCT00552929|560815837|FG000|Overall Study|Lost to Follow-up|0|||
155377974|NCT00552929|560815838|FG001|Overall Study|Lost to Follow-up|0|||
155377975|NCT00552929|560815839|FG002|Overall Study|Lost to Follow-up|0|||
155377976|NCT00552929|560815840|FG003|Overall Study|Lost to Follow-up|0|||
155377977|NCT00552929|560815841|FG004|Overall Study|Lost to Follow-up|0|||
155377978|NCT00552929|560815842|FG005|Overall Study|Lost to Follow-up|0|||
155377979|NCT00552929|560815843|FG006|Overall Study|Lost to Follow-up|0|||
155377980|NCT00552929|560815844|FG007|Overall Study|Lost to Follow-up|0|||
155377981|NCT00552929|560815845|FG008|Overall Study|Lost to Follow-up|1|||
155377982|NCT00552929|560815846|FG009|Overall Study|Lost to Follow-up|0|||
155377983|NCT00552929|560815837|FG000|Overall Study|Not Eligible|0|||
155377984|NCT00552929|560815838|FG001|Overall Study|Not Eligible|0|||
155377985|NCT00552929|560815839|FG002|Overall Study|Not Eligible|0|||
155377986|NCT00552929|560815840|FG003|Overall Study|Not Eligible|0|||
155377987|NCT00552929|560815841|FG004|Overall Study|Not Eligible|0|||
155431575|NCT00509106|561005137|FG001|Overall Study|Death|6|||
155431576|NCT01051739|561005140|FG000|Overall Study|Death|3|||
155431577|NCT01051739|561005141|FG001|Overall Study|Death|3|||
155431578|NCT01051739|561005140|FG000|Overall Study|Withdrawal by Subject|25|||
155431579|NCT01051739|561005141|FG001|Overall Study|Withdrawal by Subject|10|||
155431580|NCT03830281|561005142|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
155431581|NCT03830281|561005143|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
155431582|NCT03830281|561005142|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
155431583|NCT03830281|561005143|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
155431584|NCT03830281|561005142|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
155431585|NCT03830281|561005143|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
155431586|NCT03830281|561005142|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
155431587|NCT03830281|561005143|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
155649924|NCT02134028|561810199|FG006|Overall Study|Adverse Event|1|||
155377988|NCT00552929|560815842|FG005|Overall Study|Not Eligible|1|||
155431588|NCT03830281|561005142|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
155512373|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
155377989|NCT00552929|560815843|FG006|Overall Study|Not Eligible|0|||
155377990|NCT00552929|560815844|FG007|Overall Study|Not Eligible|0|||
155377991|NCT00552929|560815845|FG008|Overall Study|Not Eligible|0|||
155377992|NCT00552929|560815846|FG009|Overall Study|Not Eligible|0|||
155377993|NCT01147536|560815847|FG000|Overall Study|Administrative study close|2|||
155377994|NCT01147536|560815847|FG000|Overall Study|Death|1|||
155431589|NCT03830281|561005143|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
155649925|NCT02134028|561810200|FG007|Overall Study|Adverse Event|2|||
155377995|NCT02592876|560815850|FG000|Overall Study|Withdrawal by Subject|3|||
155377996|NCT02592876|560815851|FG001|Overall Study|Withdrawal by Subject|3|||
155377997|NCT02592876|560815850|FG000|Overall Study|Study Termination by Sponsor|32|||
155377998|NCT02592876|560815851|FG001|Overall Study|Study Termination by Sponsor|27|||
155377999|NCT02592876|560815850|FG000|Overall Study|Lost to Follow-up|0|||
155378000|NCT02592876|560815851|FG001|Overall Study|Lost to Follow-up|1|||
155378001|NCT02592876|560815850|FG000|Overall Study|Death|6|||
155378002|NCT02592876|560815851|FG001|Overall Study|Death|9|||
155378003|NCT01305200|560815852|FG000|Overall Study|Physician Decision|4|||
155378004|NCT01305200|560815853|FG001|Overall Study|Physician Decision|6|||
155378005|NCT01305200|560815854|FG002|Overall Study|Physician Decision|1|||
155378006|NCT01305200|560815852|FG000|Overall Study|Withdrawal by Subject|24|||
155378007|NCT01305200|560815853|FG001|Overall Study|Withdrawal by Subject|21|||
155378008|NCT01305200|560815854|FG002|Overall Study|Withdrawal by Subject|1|||
155378009|NCT01305200|560815852|FG000|Overall Study|Ineligible|1|||
155378010|NCT01305200|560815853|FG001|Overall Study|Ineligible|2|||
155378011|NCT01305200|560815854|FG002|Overall Study|Ineligible|1|||
155378012|NCT01305200|560815852|FG000|Overall Study|Death|0|||
155378013|NCT01305200|560815853|FG001|Overall Study|Death|2|||
155378014|NCT01305200|560815854|FG002|Overall Study|Death|0|||
155378015|NCT00925353|560815855|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
155378016|NCT03647488|560818170|FG000|Overall Study|Progressive disease|10|||
155378017|NCT03647488|560818171|FG001|Overall Study|Progressive disease|0|||
155378018|NCT03647488|560818172|FG002|Overall Study|Progressive disease|0|||
155378019|NCT03647488|560818170|FG000|Overall Study|Adverse Event|5|||
155378020|NCT03647488|560818171|FG001|Overall Study|Adverse Event|0|||
155378021|NCT03647488|560818172|FG002|Overall Study|Adverse Event|0|||
155378022|NCT03647488|560818170|FG000|Overall Study|Clinical progression|2|||
155378023|NCT03647488|560818171|FG001|Overall Study|Clinical progression|0|||
155378024|NCT03647488|560818172|FG002|Overall Study|Clinical progression|0|||
155378025|NCT03647488|560818170|FG000|Overall Study|Participant refused to take investigational product|1|||
155378026|NCT03647488|560818171|FG001|Overall Study|Participant refused to take investigational product|0|||
155378027|NCT03647488|560818172|FG002|Overall Study|Participant refused to take investigational product|0|||
155378028|NCT00812331|560818173|FG000|Overall Study|Adverse Event|1|||
155378029|NCT00812331|560818174|FG001|Overall Study|Adverse Event|0|||
155378030|NCT00812331|560818175|FG002|Overall Study|Adverse Event|0|||
155378031|NCT00812331|560818176|FG003|Overall Study|Adverse Event|0|||
155378032|NCT00812331|560818177|FG004|Overall Study|Adverse Event|0|||
155512374|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
155512375|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
155512376|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
155512377|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
155512378|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
155512379|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
155512380|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
155512381|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
155512382|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
155512383|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
155378049|NCT03694275|560818186|FG000|Overall Study|Adverse Event|0|||
155378050|NCT03694275|560818187|FG001|Overall Study|Adverse Event|1|||
155378051|NCT03694275|560818186|FG000|Overall Study|Reason not Specified|0|||
155378052|NCT03694275|560818187|FG001|Overall Study|Reason not Specified|1|||
155378053|NCT02502799|560818188|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378054|NCT02502799|560818189|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378055|NCT02502799|560818190|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378056|NCT02502799|560818191|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
155378057|NCT02502799|560818188|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378058|NCT02502799|560818189|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378059|NCT02502799|560818190|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378060|NCT02502799|560818191|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
155378061|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
155378062|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
155378063|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
155378064|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
155378065|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
155378066|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
155378067|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
155378068|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
155378069|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
155378070|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
155378071|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
155378072|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
155378073|NCT00153062|560818192|FG000|Overall Study|Death|360|||
155378074|NCT00153062|560818193|FG001|Overall Study|Death|352|||
155378075|NCT00153062|560818194|FG002|Overall Study|Death|369|||
155378076|NCT00153062|560818195|FG003|Overall Study|Death|365|||
155378077|NCT00153062|560818192|FG000|Overall Study|Withdrawal by Subject|14|||
155378078|NCT00153062|560818193|FG001|Overall Study|Withdrawal by Subject|30|||
155378079|NCT00153062|560818194|FG002|Overall Study|Withdrawal by Subject|27|||
155378080|NCT00153062|560818195|FG003|Overall Study|Withdrawal by Subject|28|||
155378081|NCT00153062|560818192|FG000|Overall Study|Lost to Follow-up|12|||
155378082|NCT00153062|560818193|FG001|Overall Study|Lost to Follow-up|20|||
155378083|NCT00153062|560818194|FG002|Overall Study|Lost to Follow-up|15|||
155378084|NCT00153062|560818195|FG003|Overall Study|Lost to Follow-up|16|||
155378085|NCT00153062|560818192|FG000|Overall Study|Adverse Event|0|||
155378086|NCT00153062|560818193|FG001|Overall Study|Adverse Event|1|||
155378087|NCT00153062|560818194|FG002|Overall Study|Adverse Event|1|||
155378088|NCT00153062|560818195|FG003|Overall Study|Adverse Event|0|||
155378089|NCT00153062|560818192|FG000|Overall Study|Protocol Violation|0|||
155378090|NCT00153062|560818193|FG001|Overall Study|Protocol Violation|2|||
155378091|NCT00153062|560818194|FG002|Overall Study|Protocol Violation|1|||
155378092|NCT00153062|560818195|FG003|Overall Study|Protocol Violation|1|||
155378093|NCT00153062|560818192|FG000|Overall Study|No disposition data available|1|||
155378094|NCT00153062|560818193|FG001|Overall Study|No disposition data available|1|||
155378095|NCT00153062|560818194|FG002|Overall Study|No disposition data available|1|||
155378096|NCT00153062|560818195|FG003|Overall Study|No disposition data available|1|||
155378097|NCT00153062|560818192|FG000|Overall Study|Other|0|||
155378098|NCT00153062|560818193|FG001|Overall Study|Other|0|||
155378099|NCT00153062|560818194|FG002|Overall Study|Other|1|||
155378100|NCT00153062|560818195|FG003|Overall Study|Other|0|||
155378101|NCT01589237|560818208|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
155378102|NCT01589237|560818209|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
155378103|NCT01589237|560818210|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
155378104|NCT01589237|560818211|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
155378105|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378106|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
155378107|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378108|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378109|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
155378110|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
155378111|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
155378112|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
155378113|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378114|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378115|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378116|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
155378117|NCT00117845|560818212|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
155378118|NCT01022268|560818213|FG000|Overall Study|Withdrawal by Subject|1|||
155378119|NCT01022268|560818214|FG001|Overall Study|Withdrawal by Subject|0|||
155378120|NCT01022268|560818213|FG000|Overall Study|Withdrawal by Subject|1|||
155378121|NCT01022268|560818214|FG001|Overall Study|Withdrawal by Subject|0|||
155378122|NCT00734097|560818215|FG000|Screening|Protocol Violation|12|||
155378123|NCT00734097|560818215|FG000|Screening|Withdrawal by Subject|5|||
155378124|NCT00734097|560818215|FG000|Screening|Lost to Follow-up|2|||
155378125|NCT00734097|560818215|FG000|Screening|Unconfirmed pregnancy|1|||
155378126|NCT00734097|560818215|FG000|Open Label|Lost to Follow-up|7|||
155431590|NCT03830281|561005142|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
155431591|NCT03830281|561005143|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
155431592|NCT03830281|561005142|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
155649926|NCT01370642|561810205|FG000|Overall Study|Adverse Event|2|||
155378127|NCT00734097|560818215|FG000|Open Label|Withdrawal by Subject|5|||
155378128|NCT00734097|560818215|FG000|Open Label|Protocol Violation|4|||
155378129|NCT02233543|560818218|FG000|Period 1|Withdrawal by Subject|1|||
155378130|NCT02233543|560818219|FG001|Period 1|Withdrawal by Subject|0|||
155431593|NCT03830281|561005143|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
155431594|NCT03830281|561005142|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
155431595|NCT03830281|561005143|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
155431596|NCT03830281|561005142|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
155431597|NCT03830281|561005143|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
155431598|NCT00201851|561005144|FG000|Overall Study|Lost to Follow-up|2|||
155431599|NCT00201851|561005145|FG001|Overall Study|Lost to Follow-up|1|||
155431600|NCT00201851|561005146|FG002|Overall Study|Lost to Follow-up|0|||
155378131|NCT02233543|560818218|FG000|Period 1|Participants required other treatment.|2|||
155378132|NCT02233543|560818219|FG001|Period 1|Participants required other treatment.|3|||
155378133|NCT02233543|560818218|FG000|Period 2|Adverse Event|1|||
155378134|NCT02233543|560818219|FG001|Period 2|Adverse Event|0|||
155378135|NCT02233543|560818218|FG000|Period 2|Participant required other treatment.|0|||
155378136|NCT02233543|560818219|FG001|Period 2|Participant required other treatment.|1|||
155378137|NCT02233543|560818218|FG000|Period 2|COPD exacerbation|1|||
155378138|NCT02233543|560818219|FG001|Period 2|COPD exacerbation|0|||
155378139|NCT00603304|560818220|FG000|Overall Study|Lost to Follow-up|5|||
155431601|NCT00201851|561005144|FG000|Overall Study|Ineligible post enrollment|6|||
155431602|NCT00201851|561005145|FG001|Overall Study|Ineligible post enrollment|1|||
155431603|NCT00201851|561005146|FG002|Overall Study|Ineligible post enrollment|1|||
155431604|NCT00074958|561005148|FG000|Overall Study|Adverse Event|1|||
155431605|NCT02690701|561005152|FG000|Treatment Period 1|Adverse Event|2|||
155431606|NCT02690701|561005153|FG001|Treatment Period 1|Adverse Event|2|||
155431607|NCT02690701|561005152|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155431608|NCT02690701|561005153|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155431609|NCT02690701|561005152|FG000|Treatment Period 2|Adverse Event|2|||
155431610|NCT02690701|561005153|FG001|Treatment Period 2|Adverse Event|0|||
155431611|NCT02690701|561005152|FG000|Treatment Period 2|Lack of Efficacy|1|||
155431612|NCT02690701|561005153|FG001|Treatment Period 2|Lack of Efficacy|0|||
155431613|NCT02690701|561005152|FG000|Treatment Period 2|Lost to Follow-up|0|||
155431614|NCT02690701|561005153|FG001|Treatment Period 2|Lost to Follow-up|2|||
155431615|NCT02690701|561005152|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155431616|NCT02690701|561005153|FG001|Treatment Period 2|Withdrawal by Subject|2|||
155431617|NCT02690701|561005152|FG000|Treatment Period 2|Protocol Violation|0|||
155431618|NCT02690701|561005153|FG001|Treatment Period 2|Protocol Violation|1|||
155431619|NCT01856114|561005154|FG000|Overall Study|Withdrawal by Subject|1|||
155431620|NCT01856114|561005155|FG001|Overall Study|Withdrawal by Subject|0|||
155431621|NCT01856114|561005154|FG000|Overall Study|Adverse Event|1|||
155431622|NCT01856114|561005155|FG001|Overall Study|Adverse Event|0|||
155431623|NCT01642212|561005156|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
155431624|NCT01642212|561005157|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
155431625|NCT01642212|561005158|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
155431626|NCT01642212|561005159|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
155431627|NCT01642212|561005160|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
155431628|NCT01642212|561005156|FG000|Double-blind Treatment|Other|0|||
155431629|NCT01642212|561005157|FG001|Double-blind Treatment|Other|2|||
155431630|NCT01642212|561005158|FG002|Double-blind Treatment|Other|1|||
155431631|NCT01642212|561005159|FG003|Double-blind Treatment|Other|0|||
155431632|NCT01642212|561005160|FG004|Double-blind Treatment|Other|0|||
155431633|NCT01642212|561005156|FG000|Double-blind Treatment|Non-compliance|0|||
155431634|NCT01642212|561005157|FG001|Double-blind Treatment|Non-compliance|1|||
155431635|NCT01642212|561005158|FG002|Double-blind Treatment|Non-compliance|0|||
155431636|NCT01642212|561005159|FG003|Double-blind Treatment|Non-compliance|0|||
155431637|NCT01642212|561005160|FG004|Double-blind Treatment|Non-compliance|0|||
155431638|NCT01642212|561005156|FG000|Double-blind Treatment|Adverse Event|0|||
155431639|NCT01642212|561005157|FG001|Double-blind Treatment|Adverse Event|0|||
155431640|NCT01642212|561005158|FG002|Double-blind Treatment|Adverse Event|1|||
155431641|NCT01642212|561005159|FG003|Double-blind Treatment|Adverse Event|0|||
155378140|NCT00603304|560818221|FG001|Overall Study|Lost to Follow-up|7|||
155431642|NCT01642212|561005160|FG004|Double-blind Treatment|Adverse Event|0|||
155431643|NCT01642212|561005156|FG000|Open-label Extension|Adverse Event|0|||
155431644|NCT01642212|561005157|FG001|Open-label Extension|Adverse Event|0|||
155431645|NCT01642212|561005158|FG002|Open-label Extension|Adverse Event|0|||
155378141|NCT00603304|560818220|FG000|Overall Study|Withdrawal by Subject|8|||
155378142|NCT00603304|560818221|FG001|Overall Study|Withdrawal by Subject|5|||
155431646|NCT01642212|561005159|FG003|Open-label Extension|Adverse Event|3|||
155431647|NCT01642212|561005160|FG004|Open-label Extension|Adverse Event|0|||
155649927|NCT01370642|561810206|FG001|Overall Study|Adverse Event|1|||
155431648|NCT01642212|561005156|FG000|Open-label Extension|Sponsor Decision|0|||
155431649|NCT01642212|561005157|FG001|Open-label Extension|Sponsor Decision|0|||
155649928|NCT01370642|561810207|FG002|Overall Study|Adverse Event|1|||
155649929|NCT01370642|561810205|FG000|Overall Study|Detectable HCV RNA|0|||
155649930|NCT01370642|561810206|FG001|Overall Study|Detectable HCV RNA|0|||
155649931|NCT01370642|561810207|FG002|Overall Study|Detectable HCV RNA|22|||
155649932|NCT01370642|561810205|FG000|Overall Study|Lost to Follow-up|0|||
155649933|NCT01370642|561810206|FG001|Overall Study|Lost to Follow-up|0|||
155649934|NCT01370642|561810207|FG002|Overall Study|Lost to Follow-up|1|||
155649935|NCT01370642|561810205|FG000|Overall Study|Physician Decision|4|||
155649936|NCT01370642|561810206|FG001|Overall Study|Physician Decision|1|||
155649937|NCT01370642|561810207|FG002|Overall Study|Physician Decision|2|||
155649938|NCT01370642|561810205|FG000|Overall Study|Withdrawal by Subject|2|||
155649939|NCT01370642|561810206|FG001|Overall Study|Withdrawal by Subject|4|||
155649940|NCT01370642|561810207|FG002|Overall Study|Withdrawal by Subject|3|||
155649941|NCT00987935|561810214|FG000|Overall Study|Progressive disease|3|||
155649942|NCT00987935|561810215|FG001|Overall Study|Progressive disease|2|||
155649943|NCT00987935|561810216|FG002|Overall Study|Progressive disease|3|||
155649944|NCT00987935|561810217|FG003|Overall Study|Progressive disease|2|||
155649945|NCT00987935|561810218|FG004|Overall Study|Progressive disease|5|||
155649946|NCT00987935|561810219|FG005|Overall Study|Progressive disease|3|||
155649947|NCT00987935|561810220|FG006|Overall Study|Progressive disease|9|||
155649948|NCT00987935|561810221|FG007|Overall Study|Progressive disease|48|||
155649949|NCT00987935|561810222|FG008|Overall Study|Progressive disease|23|||
155649950|NCT00987935|561810214|FG000|Overall Study|Adverse Event|0|||
155649951|NCT00987935|561810215|FG001|Overall Study|Adverse Event|1|||
155649952|NCT00987935|561810216|FG002|Overall Study|Adverse Event|0|||
155649953|NCT00987935|561810217|FG003|Overall Study|Adverse Event|1|||
155649954|NCT00987935|561810218|FG004|Overall Study|Adverse Event|1|||
155649955|NCT00987935|561810219|FG005|Overall Study|Adverse Event|0|||
155649956|NCT00987935|561810220|FG006|Overall Study|Adverse Event|2|||
155649957|NCT00987935|561810221|FG007|Overall Study|Adverse Event|10|||
155649958|NCT00987935|561810222|FG008|Overall Study|Adverse Event|6|||
155649959|NCT00987935|561810214|FG000|Overall Study|Refused to continue taking trial med.|1|||
155649960|NCT00987935|561810215|FG001|Overall Study|Refused to continue taking trial med.|0|||
155649961|NCT00987935|561810216|FG002|Overall Study|Refused to continue taking trial med.|0|||
155649962|NCT00987935|561810217|FG003|Overall Study|Refused to continue taking trial med.|0|||
155649963|NCT00987935|561810218|FG004|Overall Study|Refused to continue taking trial med.|1|||
155649964|NCT00987935|561810219|FG005|Overall Study|Refused to continue taking trial med.|0|||
155649965|NCT00987935|561810220|FG006|Overall Study|Refused to continue taking trial med.|4|||
155649966|NCT00987935|561810221|FG007|Overall Study|Refused to continue taking trial med.|4|||
155649967|NCT00987935|561810222|FG008|Overall Study|Refused to continue taking trial med.|2|||
155649968|NCT00987935|561810214|FG000|Overall Study|Reason other than those specified above|0|||
155649969|NCT00987935|561810215|FG001|Overall Study|Reason other than those specified above|0|||
155649970|NCT00987935|561810216|FG002|Overall Study|Reason other than those specified above|0|||
155649971|NCT00987935|561810217|FG003|Overall Study|Reason other than those specified above|0|||
155649972|NCT00987935|561810218|FG004|Overall Study|Reason other than those specified above|0|||
155649973|NCT00987935|561810219|FG005|Overall Study|Reason other than those specified above|0|||
155649974|NCT00987935|561810220|FG006|Overall Study|Reason other than those specified above|0|||
155649975|NCT00987935|561810221|FG007|Overall Study|Reason other than those specified above|0|||
155649976|NCT00987935|561810222|FG008|Overall Study|Reason other than those specified above|1|||
155649977|NCT01089543|561810223|FG000|Overall Study|Withdrawal by Subject|2|||
155649978|NCT01089543|561810224|FG001|Overall Study|Withdrawal by Subject|3|||
155431650|NCT01642212|561005158|FG002|Open-label Extension|Sponsor Decision|0|||
155431651|NCT01642212|561005159|FG003|Open-label Extension|Sponsor Decision|7|||
155431652|NCT01642212|561005160|FG004|Open-label Extension|Sponsor Decision|4|||
155431653|NCT01642212|561005156|FG000|Open-label Extension|Consent Withdrawn|0|||
155431654|NCT01642212|561005157|FG001|Open-label Extension|Consent Withdrawn|0|||
155431655|NCT01642212|561005158|FG002|Open-label Extension|Consent Withdrawn|0|||
155431656|NCT01642212|561005159|FG003|Open-label Extension|Consent Withdrawn|0|||
155431657|NCT01642212|561005160|FG004|Open-label Extension|Consent Withdrawn|2|||
155431658|NCT01642212|561005156|FG000|Open-label Extension|Lost to Follow-up|0|||
155431659|NCT01642212|561005157|FG001|Open-label Extension|Lost to Follow-up|0|||
155431660|NCT01642212|561005158|FG002|Open-label Extension|Lost to Follow-up|0|||
155431661|NCT01642212|561005159|FG003|Open-label Extension|Lost to Follow-up|0|||
155431662|NCT01642212|561005160|FG004|Open-label Extension|Lost to Follow-up|1|||
155431663|NCT01642212|561005156|FG000|Open-label Extension|Other|0|||
155649979|NCT01089543|561810225|FG002|Overall Study|Withdrawal by Subject|3|||
155649980|NCT01089543|561810226|FG003|Overall Study|Withdrawal by Subject|1|||
155649981|NCT01089543|561810223|FG000|Overall Study|Physician Decision|1|||
155649982|NCT01089543|561810224|FG001|Overall Study|Physician Decision|0|||
155649983|NCT01089543|561810225|FG002|Overall Study|Physician Decision|0|||
155649984|NCT01089543|561810226|FG003|Overall Study|Physician Decision|1|||
155649985|NCT01089543|561810223|FG000|Overall Study|Adverse Event|0|||
155649986|NCT01089543|561810224|FG001|Overall Study|Adverse Event|1|||
155378143|NCT00603304|560818220|FG000|Overall Study|Protocol Violation|1|||
155378144|NCT00603304|560818221|FG001|Overall Study|Protocol Violation|0|||
155378145|NCT00603304|560818220|FG000|Overall Study|Adverse Event|4|||
155378146|NCT00603304|560818221|FG001|Overall Study|Adverse Event|2|||
155378147|NCT00603304|560818220|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
155378148|NCT00603304|560818221|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
155378149|NCT00603304|560818220|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
155378150|NCT00603304|560818221|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
155378151|NCT00603304|560818220|FG000|Overall Study|Exclusionary Medication|2|||
155378152|NCT00603304|560818221|FG001|Overall Study|Exclusionary Medication|3|||
155378153|NCT00603304|560818220|FG000|Overall Study|Non-Compliant|0|||
155378154|NCT00603304|560818221|FG001|Overall Study|Non-Compliant|1|||
155378155|NCT00603304|560818220|FG000|Overall Study|Moved Away|0|||
155378156|NCT00603304|560818221|FG001|Overall Study|Moved Away|2|||
155378157|NCT00603304|560818220|FG000|Overall Study|Other|2|||
155378158|NCT00603304|560818221|FG001|Overall Study|Other|0|||
155378159|NCT00603304|560818220|FG000|Overall Study|Patient Decision|2|||
155378160|NCT00603304|560818221|FG001|Overall Study|Patient Decision|0|||
155378161|NCT01775475|560818222|FG000|Overall Study|Death|3|||
155378162|NCT01775475|560818223|FG001|Overall Study|Death|3|||
155378163|NCT00007345|560818230|FG000|Overall Study|Refused further treatment|0|||
155378164|NCT00007345|560818231|FG001|Overall Study|Refused further treatment|7|||
155378165|NCT00007345|560818230|FG000|Overall Study|Switched to alternative treatment|0|||
155378166|NCT00007345|560818231|FG001|Overall Study|Switched to alternative treatment|3|||
155378167|NCT00007345|560818230|FG000|Overall Study|Intercurrent illness|1|||
155378168|NCT00007345|560818231|FG001|Overall Study|Intercurrent illness|0|||
155378169|NCT00007345|560818230|FG000|Overall Study|Death on study|1|||
155378170|NCT00007345|560818231|FG001|Overall Study|Death on study|1|||
155378171|NCT04433585|560818232|FG000|Overall Study|Withdrawal by Subject|15|||
155378172|NCT04433585|560818233|FG001|Overall Study|Withdrawal by Subject|3|||
155378173|NCT04433585|560818234|FG002|Overall Study|Withdrawal by Subject|15|||
155378174|NCT04433585|560818235|FG003|Overall Study|Withdrawal by Subject|6|||
155378175|NCT04433585|560818232|FG000|Overall Study|Adverse Event|10|||
155378176|NCT04433585|560818233|FG001|Overall Study|Adverse Event|4|||
155378177|NCT04433585|560818234|FG002|Overall Study|Adverse Event|1|||
155378178|NCT04433585|560818235|FG003|Overall Study|Adverse Event|0|||
155378179|NCT04433585|560818232|FG000|Overall Study|Due to the conflict in Ukraine|2|||
155378180|NCT04433585|560818233|FG001|Overall Study|Due to the conflict in Ukraine|1|||
155378181|NCT04433585|560818234|FG002|Overall Study|Due to the conflict in Ukraine|1|||
155378182|NCT04433585|560818235|FG003|Overall Study|Due to the conflict in Ukraine|2|||
155378183|NCT04433585|560818232|FG000|Overall Study|Physician Decision|1|||
155378184|NCT04433585|560818233|FG001|Overall Study|Physician Decision|2|||
155378185|NCT04433585|560818234|FG002|Overall Study|Physician Decision|0|||
155378186|NCT04433585|560818235|FG003|Overall Study|Physician Decision|0|||
155378187|NCT04433585|560818232|FG000|Overall Study|Lost to Follow-up|1|||
155378188|NCT04433585|560818233|FG001|Overall Study|Lost to Follow-up|1|||
155378189|NCT04433585|560818234|FG002|Overall Study|Lost to Follow-up|1|||
155378190|NCT04433585|560818235|FG003|Overall Study|Lost to Follow-up|0|||
155378191|NCT04433585|560818232|FG000|Overall Study|Lack of Efficacy|0|||
155378192|NCT04433585|560818233|FG001|Overall Study|Lack of Efficacy|1|||
155378193|NCT04433585|560818234|FG002|Overall Study|Lack of Efficacy|1|||
155512384|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
155512385|NCT01227668|561301280|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
155378194|NCT04433585|560818235|FG003|Overall Study|Lack of Efficacy|1|||
155378195|NCT04433585|560818232|FG000|Overall Study|Death|0|||
155378196|NCT04433585|560818233|FG001|Overall Study|Death|1|||
155378197|NCT04433585|560818234|FG002|Overall Study|Death|0|||
155378198|NCT04433585|560818235|FG003|Overall Study|Death|0|||
155378199|NCT02074553|560818236|FG000|Intervention Period 1|Family Emergency|0|||
155378200|NCT02074553|560818237|FG001|Intervention Period 1|Family Emergency|0|||
155378201|NCT02074553|560818238|FG002|Intervention Period 1|Family Emergency|0|||
155378202|NCT02074553|560818239|FG003|Intervention Period 1|Family Emergency|1|||
155512386|NCT01227668|561301281|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
155512387|NCT01227668|561301280|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
155378203|NCT02074553|560818240|FG004|Intervention Period 1|Family Emergency|0|||
155378204|NCT02074553|560818241|FG005|Intervention Period 1|Family Emergency|0|||
155378205|NCT02074553|560818242|FG006|Intervention Period 1|Family Emergency|0|||
155378206|NCT02074553|560818243|FG007|Intervention Period 1|Family Emergency|0|||
155378207|NCT02074553|560818236|FG000|Washout Period 1|Adverse Event|1|||
155378208|NCT02074553|560818237|FG001|Washout Period 1|Adverse Event|0|||
155378209|NCT02074553|560818238|FG002|Washout Period 1|Adverse Event|0|||
155378210|NCT02074553|560818239|FG003|Washout Period 1|Adverse Event|0|||
155378211|NCT02074553|560818240|FG004|Washout Period 1|Adverse Event|0|||
155378212|NCT02074553|560818241|FG005|Washout Period 1|Adverse Event|0|||
155378213|NCT02074553|560818242|FG006|Washout Period 1|Adverse Event|0|||
155378214|NCT02074553|560818243|FG007|Washout Period 1|Adverse Event|0|||
155378215|NCT02074553|560818236|FG000|Washout Period 1|Physician Decision|0|||
155378216|NCT02074553|560818237|FG001|Washout Period 1|Physician Decision|0|||
155512388|NCT01227668|561301281|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
155512389|NCT01227668|561301280|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
155512390|NCT01227668|561301281|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
155512391|NCT01227668|561301280|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
155512392|NCT01227668|561301281|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
155512393|NCT01227668|561301280|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
155512394|NCT01227668|561301281|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
155378217|NCT02074553|560818238|FG002|Washout Period 1|Physician Decision|0|||
155378218|NCT02074553|560818239|FG003|Washout Period 1|Physician Decision|1|||
155378219|NCT02074553|560818240|FG004|Washout Period 1|Physician Decision|0|||
155378220|NCT02074553|560818241|FG005|Washout Period 1|Physician Decision|0|||
155378221|NCT02074553|560818242|FG006|Washout Period 1|Physician Decision|0|||
155378222|NCT02074553|560818243|FG007|Washout Period 1|Physician Decision|0|||
155378223|NCT02074553|560818236|FG000|Washout Period 1|Other|0|||
155378224|NCT02074553|560818237|FG001|Washout Period 1|Other|0|||
155378225|NCT02074553|560818238|FG002|Washout Period 1|Other|0|||
155378226|NCT02074553|560818239|FG003|Washout Period 1|Other|0|||
155378227|NCT02074553|560818240|FG004|Washout Period 1|Other|0|||
155512395|NCT01227668|561301280|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
155512396|NCT01227668|561301281|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
155512397|NCT01261325|561301285|FG000|Overall Study|Lack of Efficacy|1|||
155512398|NCT01261325|561301286|FG001|Overall Study|Lack of Efficacy|1|||
155378228|NCT02074553|560818241|FG005|Washout Period 1|Other|1|||
155378229|NCT02074553|560818242|FG006|Washout Period 1|Other|0|||
155378230|NCT02074553|560818243|FG007|Washout Period 1|Other|0|||
155378231|NCT02074553|560818236|FG000|Washout Period 2|Adverse Event|0|||
155378232|NCT02074553|560818237|FG001|Washout Period 2|Adverse Event|0|||
155378233|NCT02074553|560818238|FG002|Washout Period 2|Adverse Event|0|||
155378234|NCT02074553|560818239|FG003|Washout Period 2|Adverse Event|0|||
155378235|NCT02074553|560818240|FG004|Washout Period 2|Adverse Event|0|||
155378236|NCT02074553|560818241|FG005|Washout Period 2|Adverse Event|0|||
155378237|NCT02074553|560818242|FG006|Washout Period 2|Adverse Event|1|||
155378238|NCT02074553|560818243|FG007|Washout Period 2|Adverse Event|0|||
155378239|NCT02074553|560818236|FG000|Washout Period 2|Physician Decision|0|||
155378240|NCT02074553|560818237|FG001|Washout Period 2|Physician Decision|0|||
155378241|NCT02074553|560818238|FG002|Washout Period 2|Physician Decision|0|||
155378242|NCT02074553|560818239|FG003|Washout Period 2|Physician Decision|0|||
155378243|NCT02074553|560818240|FG004|Washout Period 2|Physician Decision|0|||
155512399|NCT01261325|561301287|FG002|Overall Study|Lack of Efficacy|0|||
155512400|NCT01261325|561301285|FG000|Overall Study|Withdrawal by Subject|2|||
155512401|NCT01261325|561301286|FG001|Overall Study|Withdrawal by Subject|2|||
155512402|NCT01261325|561301287|FG002|Overall Study|Withdrawal by Subject|4|||
155512403|NCT01261325|561301285|FG000|Overall Study|SAE, non-fatal|1|||
155512404|NCT01261325|561301286|FG001|Overall Study|SAE, non-fatal|5|||
155512405|NCT01261325|561301287|FG002|Overall Study|SAE, non-fatal|1|||
155512406|NCT01261325|561301285|FG000|Overall Study|AE, non-serious non-fatal|9|||
155512407|NCT01261325|561301286|FG001|Overall Study|AE, non-serious non-fatal|15|||
155512408|NCT01261325|561301287|FG002|Overall Study|AE, non-serious non-fatal|13|||
155512409|NCT01261325|561301285|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155512410|NCT01261325|561301286|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155512411|NCT01261325|561301287|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155512412|NCT01261325|561301285|FG000|Overall Study|Non Compliance|2|||
155512413|NCT01261325|561301286|FG001|Overall Study|Non Compliance|0|||
155512414|NCT01261325|561301287|FG002|Overall Study|Non Compliance|0|||
155512415|NCT01261325|561301285|FG000|Overall Study|Patient Randomized by Mistake|0|||
155512416|NCT01261325|561301286|FG001|Overall Study|Patient Randomized by Mistake|1|||
155512417|NCT01261325|561301287|FG002|Overall Study|Patient Randomized by Mistake|0|||
155512418|NCT01261325|561301285|FG000|Overall Study|Erroneously Randomized|1|||
155378244|NCT02074553|560818241|FG005|Washout Period 2|Physician Decision|1|||
155378245|NCT02074553|560818242|FG006|Washout Period 2|Physician Decision|0|||
155378246|NCT02074553|560818243|FG007|Washout Period 2|Physician Decision|0|||
155378247|NCT02074553|560818236|FG000|Washout Period 2|Lost to Follow-up|0|||
155378248|NCT02074553|560818237|FG001|Washout Period 2|Lost to Follow-up|0|||
155378249|NCT02074553|560818238|FG002|Washout Period 2|Lost to Follow-up|1|||
155378250|NCT02074553|560818239|FG003|Washout Period 2|Lost to Follow-up|0|||
155378251|NCT02074553|560818240|FG004|Washout Period 2|Lost to Follow-up|0|||
155378252|NCT02074553|560818241|FG005|Washout Period 2|Lost to Follow-up|0|||
155512419|NCT01261325|561301286|FG001|Overall Study|Erroneously Randomized|0|||
155512420|NCT01261325|561301287|FG002|Overall Study|Erroneously Randomized|0|||
155512421|NCT01261325|561301285|FG000|Overall Study|Screen Failure|1|||
155512422|NCT01261325|561301286|FG001|Overall Study|Screen Failure|0|||
155378253|NCT02074553|560818242|FG006|Washout Period 2|Lost to Follow-up|0|||
155378254|NCT02074553|560818243|FG007|Washout Period 2|Lost to Follow-up|0|||
155378255|NCT02074553|560818236|FG000|Washout Period 3|Physician Decision|0|||
155378256|NCT02074553|560818237|FG001|Washout Period 3|Physician Decision|0|||
155378257|NCT02074553|560818238|FG002|Washout Period 3|Physician Decision|0|||
155378258|NCT02074553|560818239|FG003|Washout Period 3|Physician Decision|0|||
155378259|NCT02074553|560818240|FG004|Washout Period 3|Physician Decision|0|||
155378260|NCT02074553|560818241|FG005|Washout Period 3|Physician Decision|0|||
155378261|NCT02074553|560818242|FG006|Washout Period 3|Physician Decision|0|||
155378262|NCT02074553|560818243|FG007|Washout Period 3|Physician Decision|1|||
155378263|NCT00686725|560818244|FG000|Overall Study|Adverse Event|1|||
155378264|NCT00686725|560818245|FG001|Overall Study|Adverse Event|1|||
155378265|NCT00686725|560818244|FG000|Overall Study|Progressive Disease|17|||
155378266|NCT00686725|560818245|FG001|Overall Study|Progressive Disease|23|||
155378267|NCT00686725|560818244|FG000|Overall Study|Lost to Follow-up|7|||
155378268|NCT00686725|560818245|FG001|Overall Study|Lost to Follow-up|5|||
155378269|NCT00686725|560818244|FG000|Overall Study|Death|6|||
155378270|NCT00686725|560818245|FG001|Overall Study|Death|3|||
155378271|NCT00686725|560818244|FG000|Overall Study|Withdrawal by Subject|13|||
155378272|NCT00686725|560818245|FG001|Overall Study|Withdrawal by Subject|4|||
155378273|NCT00686725|560818244|FG000|Overall Study|Protocol Violation|1|||
155512423|NCT01261325|561301287|FG002|Overall Study|Screen Failure|0|||
155512424|NCT01261325|561301285|FG000|Overall Study|Randomized in Error|0|||
155512425|NCT01261325|561301286|FG001|Overall Study|Randomized in Error|0|||
155378274|NCT00686725|560818245|FG001|Overall Study|Protocol Violation|3|||
155378275|NCT00686725|560818244|FG000|Overall Study|Other|1|||
155378276|NCT00686725|560818245|FG001|Overall Study|Other|3|||
155378277|NCT04875676|560818246|FG000|Overall Study|Lost to Follow-up|1|||
155378278|NCT04875676|560818247|FG001|Overall Study|Lost to Follow-up|0|||
155378279|NCT04875676|560818248|FG002|Overall Study|Lost to Follow-up|0|||
155378280|NCT03103763|560818253|FG000|Overall Study|Death|15|||
155378281|NCT03103763|560818254|FG001|Overall Study|Death|5|||
155378282|NCT03103763|560818255|FG002|Overall Study|Death|5|||
155378283|NCT03103763|560818253|FG000|Overall Study|Withdrawal by Subject|0|||
155378284|NCT03103763|560818254|FG001|Overall Study|Withdrawal by Subject|3|||
155378285|NCT03103763|560818255|FG002|Overall Study|Withdrawal by Subject|2|||
155378286|NCT00938470|560818256|FG000|Overall Study|Disease Progression|3|||
155378287|NCT00938470|560818257|FG001|Overall Study|Disease Progression|0|||
155378288|NCT00938470|560818256|FG000|Overall Study|Alternate Treatment|1|||
155378289|NCT00938470|560818257|FG001|Overall Study|Alternate Treatment|0|||
155378290|NCT00938470|560818256|FG000|Overall Study|Death|3|||
155378291|NCT00938470|560818257|FG001|Overall Study|Death|2|||
155378292|NCT00938470|560818256|FG000|Overall Study|Other Reason|0|||
155378293|NCT00938470|560818257|FG001|Overall Study|Other Reason|1|||
155378294|NCT03245151|560818258|FG000|Overall Study|Withdrawal by Subject|2|||
155378295|NCT03245151|560818259|FG001|Overall Study|Withdrawal by Subject|0|||
155378296|NCT03245151|560818260|FG002|Overall Study|Withdrawal by Subject|0|||
155378297|NCT03245151|560818261|FG003|Overall Study|Withdrawal by Subject|2|||
155378298|NCT03245151|560818262|FG004|Overall Study|Withdrawal by Subject|1|||
155378299|NCT03245151|560818258|FG000|Overall Study|Death|3|||
155378300|NCT03245151|560818259|FG001|Overall Study|Death|14|||
155378301|NCT03245151|560818260|FG002|Overall Study|Death|9|||
155378302|NCT03245151|560818261|FG003|Overall Study|Death|16|||
155378303|NCT03245151|560818262|FG004|Overall Study|Death|7|||
155378304|NCT03245151|560818258|FG000|Overall Study|Sponsor's decision|0|||
155378305|NCT03245151|560818259|FG001|Overall Study|Sponsor's decision|1|||
155378306|NCT03245151|560818260|FG002|Overall Study|Sponsor's decision|0|||
155378307|NCT03245151|560818261|FG003|Overall Study|Sponsor's decision|0|||
155378308|NCT03245151|560818262|FG004|Overall Study|Sponsor's decision|0|||
155378309|NCT01970345|560818263|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378310|NCT01970345|560818264|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378311|NCT01970345|560818263|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
155378312|NCT01970345|560818264|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378313|NCT01346475|560818265|FG000|First Intervention|Lost to Follow-up|4|||
155378314|NCT01346475|560818266|FG001|First Intervention|Lost to Follow-up|3|||
155512426|NCT01261325|561301287|FG002|Overall Study|Randomized in Error|1|||
155378315|NCT01552603|560818267|FG000|Overall Study|Physician Decision|1|||
155378316|NCT00618618|560818268|FG000|Overall Study|Patient Request|0|||
155378317|NCT00618618|560818269|FG001|Overall Study|Patient Request|0|||
155378318|NCT00618618|560818270|FG002|Overall Study|Patient Request|2|||
155378319|NCT00618618|560818271|FG003|Overall Study|Patient Request|0|||
155378320|NCT00618618|560818268|FG000|Overall Study|Inability to Complete Study Procedures|0|||
155378321|NCT00618618|560818269|FG001|Overall Study|Inability to Complete Study Procedures|1|||
155378322|NCT00618618|560818270|FG002|Overall Study|Inability to Complete Study Procedures|0|||
155378323|NCT00618618|560818271|FG003|Overall Study|Inability to Complete Study Procedures|0|||
155378324|NCT00618618|560818268|FG000|Overall Study|Lost to Follow-up|3|||
155378325|NCT00618618|560818269|FG001|Overall Study|Lost to Follow-up|0|||
155512427|NCT01261325|561301285|FG000|Overall Study|Protocol Violation|0|||
155512428|NCT01261325|561301286|FG001|Overall Study|Protocol Violation|3|||
155378326|NCT00618618|560818270|FG002|Overall Study|Lost to Follow-up|0|||
155378327|NCT00618618|560818271|FG003|Overall Study|Lost to Follow-up|1|||
155378328|NCT00618618|560818268|FG000|Overall Study|Non-compliance|1|||
155378329|NCT00618618|560818269|FG001|Overall Study|Non-compliance|1|||
155378330|NCT00618618|560818270|FG002|Overall Study|Non-compliance|0|||
155378331|NCT00618618|560818271|FG003|Overall Study|Non-compliance|0|||
155378332|NCT00618618|560818268|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
155378333|NCT00618618|560818269|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
155378334|NCT00618618|560818270|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
155378335|NCT00618618|560818271|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
155378336|NCT00618618|560818268|FG000|Overall Study|Death|0|||
155378337|NCT00618618|560818269|FG001|Overall Study|Death|1|||
155378338|NCT00618618|560818270|FG002|Overall Study|Death|0|||
155378339|NCT00618618|560818271|FG003|Overall Study|Death|0|||
155378340|NCT00621777|560818275|FG000|Open Phase|Adverse Event|20|||
155378341|NCT00621777|560818276|FG001|Open Phase|Adverse Event|0|||
155378342|NCT00621777|560818275|FG000|Open Phase|Did not abstain during open phase|56|||
155378343|NCT00621777|560818276|FG001|Open Phase|Did not abstain during open phase|0|||
155378344|NCT00621777|560818275|FG000|Open Phase|Withdrawal by Subject|17|||
155378345|NCT00621777|560818276|FG001|Open Phase|Withdrawal by Subject|0|||
155378346|NCT00621777|560818275|FG000|Open Phase|administrative|13|||
155378347|NCT00621777|560818276|FG001|Open Phase|administrative|0|||
155378348|NCT00621777|560818275|FG000|Open Phase|Lost to Follow-up|10|||
155378349|NCT00621777|560818276|FG001|Open Phase|Lost to Follow-up|0|||
155378350|NCT00621777|560818275|FG000|Randomized Phase|Adverse Event|3|||
155378351|NCT00621777|560818276|FG001|Randomized Phase|Adverse Event|3|||
155378352|NCT00621777|560818275|FG000|Randomized Phase|Lost to Follow-up|3|||
155378353|NCT00621777|560818276|FG001|Randomized Phase|Lost to Follow-up|3|||
155378354|NCT00621777|560818275|FG000|Randomized Phase|Withdrawal by Subject|1|||
155378355|NCT00621777|560818276|FG001|Randomized Phase|Withdrawal by Subject|9|||
155378356|NCT00621777|560818275|FG000|Randomized Phase|administrative|0|||
155378357|NCT00621777|560818276|FG001|Randomized Phase|administrative|3|||
155378358|NCT00621777|560818275|FG000|Randomized Phase|Death|0|||
155378359|NCT00621777|560818276|FG001|Randomized Phase|Death|1|||
155378360|NCT04797650|560818279|FG000|Overall Study|Reason Not Specified|5|||
155378361|NCT04797650|560818280|FG001|Overall Study|Reason Not Specified|12|||
155378362|NCT04797650|560818281|FG002|Overall Study|Reason Not Specified|5|||
155378363|NCT04797650|560818279|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
155378364|NCT04797650|560818280|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
155378365|NCT04797650|560818281|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
155378366|NCT04797650|560818279|FG000|Overall Study|Lack of Efficacy|1|||
155378367|NCT04797650|560818280|FG001|Overall Study|Lack of Efficacy|0|||
155378368|NCT04797650|560818281|FG002|Overall Study|Lack of Efficacy|1|||
155378369|NCT04797650|560818279|FG000|Overall Study|Non-compliance with Study Drug|0|||
155378370|NCT04797650|560818280|FG001|Overall Study|Non-compliance with Study Drug|0|||
155378371|NCT04797650|560818281|FG002|Overall Study|Non-compliance with Study Drug|2|||
155378372|NCT04797650|560818279|FG000|Overall Study|Lost to Follow-up|4|||
155378373|NCT04797650|560818280|FG001|Overall Study|Lost to Follow-up|6|||
155378374|NCT04797650|560818281|FG002|Overall Study|Lost to Follow-up|1|||
155378375|NCT00309959|560818284|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
155378376|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Death|0|||
155378377|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Death|0|||
155378378|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Death|1|||
155378379|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Death|0|||
155378380|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Death|0|||
155378381|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Death|0|||
155378382|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Death|0|||
155378383|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Death|0|||
155378384|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Death|0|||
155378385|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Death|0|||
155378386|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Death|0|||
155378387|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Death|0|||
155378388|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Death|0|||
155378389|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Death|0|||
155378390|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378391|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378392|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
155431664|NCT01642212|561005157|FG001|Open-label Extension|Other|0|||
155649987|NCT01089543|561810225|FG002|Overall Study|Adverse Event|0|||
155649988|NCT01089543|561810226|FG003|Overall Study|Adverse Event|0|||
155649989|NCT00309244|561810227|FG000|Overall Study|Adverse Event|29|||
155649990|NCT00309244|561810228|FG001|Overall Study|Adverse Event|12|||
155649991|NCT00309244|561810227|FG000|Overall Study|Lost to Follow-up|6|||
155649992|NCT00309244|561810228|FG001|Overall Study|Lost to Follow-up|22|||
155649993|NCT00309244|561810227|FG000|Overall Study|Physician Decision|5|||
155649994|NCT00309244|561810228|FG001|Overall Study|Physician Decision|8|||
155649995|NCT00309244|561810227|FG000|Overall Study|Protocol Violation|6|||
155649996|NCT00309244|561810228|FG001|Overall Study|Protocol Violation|3|||
155649997|NCT00309244|561810227|FG000|Overall Study|Withdrawal by Subject|50|||
155649998|NCT00309244|561810228|FG001|Overall Study|Withdrawal by Subject|32|||
155649999|NCT00309244|561810227|FG000|Overall Study|Various|7|||
155650000|NCT00309244|561810228|FG001|Overall Study|Various|7|||
155650001|NCT00309244|561810227|FG000|Overall Study|Randomized but not dosed|11|||
155650002|NCT00309244|561810228|FG001|Overall Study|Randomized but not dosed|12|||
155650003|NCT00309244|561810227|FG000|Overall Study|Death|4|||
155650004|NCT00309244|561810228|FG001|Overall Study|Death|1|||
155650005|NCT03438656|561810229|FG000|Overall Study|Lost to Follow-up|2|||
155650006|NCT03335566|561810230|FG000|Overall Study|Adverse Event|0|||
155650007|NCT03335566|561810231|FG001|Overall Study|Adverse Event|1|||
155650008|NCT03335566|561810230|FG000|Overall Study|Lost to Follow-up|1|||
155650009|NCT03335566|561810231|FG001|Overall Study|Lost to Follow-up|0|||
155650010|NCT03335566|561810230|FG000|Overall Study|Technical Problems|1|||
155650011|NCT03335566|561810231|FG001|Overall Study|Technical Problems|0|||
155650012|NCT03335566|561810230|FG000|Overall Study|Protocol Violation|1|||
155650013|NCT03335566|561810231|FG001|Overall Study|Protocol Violation|0|||
155378393|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378394|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378395|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378396|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378397|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378398|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378399|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378400|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378401|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378402|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378403|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378404|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
155378405|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
155378406|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
155378407|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
155378408|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378409|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378410|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378411|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378412|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378413|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378414|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378415|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378416|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378417|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378418|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378419|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155431665|NCT01642212|561005158|FG002|Open-label Extension|Other|0|||
155431666|NCT01642212|561005159|FG003|Open-label Extension|Other|0|||
155431667|NCT01642212|561005160|FG004|Open-label Extension|Other|1|||
155431668|NCT03430310|561005161|FG000|Overall Study|Protocol Violation|2|||
155431669|NCT03430310|561005162|FG001|Overall Study|Protocol Violation|0|||
155431670|NCT03430310|561005161|FG000|Overall Study|Withdrawal by Subject|3|||
155431671|NCT03430310|561005162|FG001|Overall Study|Withdrawal by Subject|2|||
155431672|NCT03430310|561005161|FG000|Overall Study|COVID shutdown March 2020|0|||
155431673|NCT03430310|561005162|FG001|Overall Study|COVID shutdown March 2020|1|||
155431674|NCT01446809|561005163|FG000|Overall Study|Adverse Event|0|||
155431675|NCT01446809|561005164|FG001|Overall Study|Adverse Event|0|||
155431676|NCT01446809|561005165|FG002|Overall Study|Adverse Event|1|||
155431677|NCT01446809|561005163|FG000|Overall Study|Failure to complete study procedures|0|||
155431678|NCT01446809|561005164|FG001|Overall Study|Failure to complete study procedures|0|||
155431679|NCT01446809|561005165|FG002|Overall Study|Failure to complete study procedures|1|||
155431680|NCT01331161|561005166|FG000|Overall Study|Physician Decision|1|||
155431681|NCT01331161|561005167|FG001|Overall Study|Physician Decision|0|||
155650014|NCT03335566|561810230|FG000|Overall Study|Other than specified above|1|||
155650015|NCT03335566|561810231|FG001|Overall Study|Other than specified above|2|||
155650016|NCT04223687|561810232|FG000|Overall Study|Missing primary outcome|1|||
155650017|NCT04223687|561810233|FG001|Overall Study|Missing primary outcome|0|||
155512429|NCT01261325|561301287|FG002|Overall Study|Protocol Violation|1|||
155512430|NCT01261325|561301285|FG000|Overall Study|Lost to Follow-up|0|||
155512431|NCT01261325|561301286|FG001|Overall Study|Lost to Follow-up|1|||
155512432|NCT01261325|561301287|FG002|Overall Study|Lost to Follow-up|3|||
155512433|NCT01261325|561301285|FG000|Overall Study|AE, serious fatal|0|||
155512434|NCT01261325|561301286|FG001|Overall Study|AE, serious fatal|0|||
155512435|NCT01261325|561301287|FG002|Overall Study|AE, serious fatal|2|||
155512436|NCT02330081|561301292|FG000|Overall Study|Adverse Event|1|||
155512437|NCT02330081|561301292|FG000|Overall Study|Donation did not meet criteria|1|||
155512438|NCT02330081|561301292|FG000|Overall Study|Protocol Violation|6|||
155512439|NCT02277769|561301293|FG000|Overall Study|Protocol Violation|3|||
155512440|NCT02277769|561301294|FG001|Overall Study|Protocol Violation|3|||
155512441|NCT02277769|561301295|FG002|Overall Study|Protocol Violation|5|||
155512442|NCT02277769|561301293|FG000|Overall Study|Lack of Efficacy|17|||
155512443|NCT02277769|561301294|FG001|Overall Study|Lack of Efficacy|0|||
155512444|NCT02277769|561301295|FG002|Overall Study|Lack of Efficacy|4|||
155512445|NCT02277769|561301293|FG000|Overall Study|Adverse Event|14|||
155512446|NCT02277769|561301294|FG001|Overall Study|Adverse Event|2|||
155512447|NCT02277769|561301295|FG002|Overall Study|Adverse Event|4|||
155512448|NCT02277769|561301293|FG000|Overall Study|Other than specified above|12|||
155512449|NCT02277769|561301294|FG001|Overall Study|Other than specified above|8|||
155512450|NCT02277769|561301295|FG002|Overall Study|Other than specified above|5|||
155512451|NCT01626885|561301296|FG000|Overall Study|Adverse Event|8|||
155512452|NCT01626885|561301296|FG000|Overall Study|Withdrawal by Subject|4|||
155512453|NCT00526890|561301297|FG000|Overall Study|Adverse Event|2|||
155512454|NCT01688037|561301298|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
155378420|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378421|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378422|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378423|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378424|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378425|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378426|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378427|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378428|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378429|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378430|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378431|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378432|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Other|0|||
155378433|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Other|0|||
155378434|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Other|2|||
155378435|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Other|0|||
155378436|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Other|0|||
155378437|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Other|0|||
155378438|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Other|0|||
155378439|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Other|0|||
155378440|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Other|0|||
155378441|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Other|0|||
155378442|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Other|0|||
155378443|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Other|0|||
155431682|NCT01331161|561005166|FG000|Overall Study|Lost to Follow-up|0|||
155431683|NCT01331161|561005167|FG001|Overall Study|Lost to Follow-up|1|||
155431684|NCT01331161|561005166|FG000|Overall Study|Pregnancy|0|||
155431685|NCT01331161|561005167|FG001|Overall Study|Pregnancy|1|||
155431686|NCT04909463|561007686|FG000|Overall Study|Withdrawal by Subject|0|||
155431687|NCT04909463|561007687|FG001|Overall Study|Withdrawal by Subject|1|||
155431688|NCT04909463|561007688|FG002|Overall Study|Withdrawal by Subject|0|||
155431689|NCT04909463|561007689|FG003|Overall Study|Withdrawal by Subject|0|||
155431690|NCT04909463|561007686|FG000|Overall Study|Lost to Follow-up|2|||
155431691|NCT04909463|561007687|FG001|Overall Study|Lost to Follow-up|1|||
155431692|NCT04909463|561007688|FG002|Overall Study|Lost to Follow-up|1|||
155431693|NCT04909463|561007689|FG003|Overall Study|Lost to Follow-up|0|||
155431694|NCT01614457|561007698|FG000|Overall Study|Non-Compliance|1|||
155431695|NCT01614457|561007699|FG001|Overall Study|Non-Compliance|0|||
155431696|NCT01614457|561007698|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
155431697|NCT01614457|561007699|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
155431698|NCT03518840|561007700|FG000|Overall Study|Lost to Follow-up|6|||
155431699|NCT02468193|561007703|FG000|Overall Study|Adverse Event|4|||
155431700|NCT02468193|561007703|FG000|Overall Study|Subject/ Guardian decision|2|||
155512455|NCT01688037|561301299|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
155512456|NCT01688037|561301300|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
155512457|NCT01688037|561301298|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
155512458|NCT01688037|561301299|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
155512459|NCT01688037|561301300|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
155512460|NCT01688037|561301298|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
155378444|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Other|0|||
155378445|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Other|0|||
155378446|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378447|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378448|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378449|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378450|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
155378451|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378452|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
155378453|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
155378454|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378455|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378456|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378457|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378458|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378459|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378460|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378461|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378462|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378463|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378464|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
155378465|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378466|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
155378467|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
155378468|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378469|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378470|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378471|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378472|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378473|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378474|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378475|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378476|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378477|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378478|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
155378479|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378480|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378481|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378482|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378483|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378484|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378485|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378486|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378487|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378488|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155431701|NCT00742781|561007704|FG000|Overall Study|Withdrawal by Subject|3|||
155431702|NCT01416181|561007705|FG000|Part 1|Other|10|||
155431703|NCT01416181|561007706|FG001|Part 1|Other|24|||
155431704|NCT01416181|561007705|FG000|Part 1|Death|0|||
155431705|NCT01416181|561007706|FG001|Part 1|Death|1|||
155431706|NCT01416181|561007705|FG000|Part 1|Investigator Decision|7|||
155431707|NCT01416181|561007706|FG001|Part 1|Investigator Decision|6|||
155431708|NCT01416181|561007705|FG000|Part 1|Withdrawal by Subject|74|||
155431709|NCT01416181|561007706|FG001|Part 1|Withdrawal by Subject|48|||
155431710|NCT01416181|561007705|FG000|Part 1|Lack of Efficacy|16|||
155431711|NCT01416181|561007706|FG001|Part 1|Lack of Efficacy|8|||
155431712|NCT01416181|561007705|FG000|Part 1|Lost to Follow-up|1|||
155431713|NCT01416181|561007706|FG001|Part 1|Lost to Follow-up|1|||
155431714|NCT01416181|561007705|FG000|Part 1|Adverse Event|15|||
155431715|NCT01416181|561007706|FG001|Part 1|Adverse Event|18|||
155431716|NCT01416181|561007705|FG000|Part 1|Ongoing in Follow-Up|14|||
155378489|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378490|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155431717|NCT01416181|561007706|FG001|Part 1|Ongoing in Follow-Up|8|||
155431718|NCT01416181|561007705|FG000|Part 2|Adverse Event|11|||
155431719|NCT01416181|561007706|FG001|Part 2|Adverse Event|4|||
155431720|NCT01416181|561007705|FG000|Part 2|Other|234|||
155431721|NCT01416181|561007706|FG001|Part 2|Other|267|||
155431722|NCT01416181|561007705|FG000|Part 2|Investigator Decision|6|||
155431723|NCT01416181|561007706|FG001|Part 2|Investigator Decision|7|||
155431724|NCT01416181|561007705|FG000|Part 2|Withdrawal by Subject|14|||
155431725|NCT01416181|561007706|FG001|Part 2|Withdrawal by Subject|5|||
155431726|NCT01416181|561007705|FG000|Part 2|Lack of Efficacy|4|||
155431727|NCT01416181|561007706|FG001|Part 2|Lack of Efficacy|1|||
155431728|NCT01416181|561007705|FG000|Part 2|Lost to Follow-up|2|||
155431729|NCT01416181|561007706|FG001|Part 2|Lost to Follow-up|2|||
155431730|NCT03816995|561007709|FG000|Overall Study|Withdrawal by Subject|3|||
155431731|NCT03816995|561007710|FG001|Overall Study|Withdrawal by Subject|1|||
155431732|NCT03816995|561007709|FG000|Overall Study|Cancelled Surgery|8|||
155431733|NCT03816995|561007710|FG001|Overall Study|Cancelled Surgery|12|||
155431734|NCT03816995|561007709|FG000|Overall Study|No wound protector used|11|||
155431735|NCT03816995|561007710|FG001|Overall Study|No wound protector used|17|||
155431736|NCT03816995|561007709|FG000|Overall Study|Protocol Violation|2|||
155431737|NCT03816995|561007710|FG001|Overall Study|Protocol Violation|3|||
155431738|NCT00541307|561007711|FG000|Overall Study|Death|5|||
155431739|NCT00541307|561007711|FG000|Overall Study|Physician Decision|3|||
155431740|NCT00541307|561007711|FG000|Overall Study|Withdrawal by Subject|6|||
155431741|NCT00541307|561007711|FG000|Overall Study|Lost to Follow-up|4|||
155431742|NCT00541307|561007711|FG000|Overall Study|Subject returned early (outside window)|1|||
155431743|NCT00541307|561007711|FG000|Overall Study|Surgical Bypass|5|||
155431744|NCT01485614|561007718|FG000|Randomization|Not Treated|1|||
155431745|NCT01485614|561007719|FG001|Randomization|Not Treated|0|||
155431746|NCT01485614|561007720|FG002|Randomization|Not Treated|0|||
155431747|NCT01485614|561007721|FG003|Randomization|Not Treated|0|||
155431748|NCT01485614|561007718|FG000|Weeks 0-20|Lost to Follow-up|2|||
155431749|NCT01485614|561007719|FG001|Weeks 0-20|Lost to Follow-up|0|||
155431750|NCT01485614|561007720|FG002|Weeks 0-20|Lost to Follow-up|0|||
155431751|NCT01485614|561007721|FG003|Weeks 0-20|Lost to Follow-up|0|||
155431752|NCT01485614|561007718|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
155431753|NCT01485614|561007719|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
155431754|NCT01485614|561007720|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
155431755|NCT01485614|561007721|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
155431756|NCT01485614|561007718|FG000|Weeks 0-20|Withdrawal by Subject|3|||
155431757|NCT01485614|561007719|FG001|Weeks 0-20|Withdrawal by Subject|2|||
155431758|NCT01485614|561007720|FG002|Weeks 0-20|Withdrawal by Subject|1|||
155650018|NCT04128228|561810237|FG000|Overall Study|Withdrawal by Subject|3|||
155650019|NCT04128228|561810238|FG001|Overall Study|Withdrawal by Subject|3|||
155650020|NCT04128228|561810239|FG002|Overall Study|Withdrawal by Subject|0|||
155431759|NCT01485614|561007721|FG003|Weeks 0-20|Withdrawal by Subject|0|||
155431760|NCT01485614|561007718|FG000|Weeks 20-54|Lost to Follow-up|4|||
155431761|NCT01485614|561007719|FG001|Weeks 20-54|Lost to Follow-up|3|||
155431762|NCT01485614|561007720|FG002|Weeks 20-54|Lost to Follow-up|1|||
155431763|NCT01485614|561007721|FG003|Weeks 20-54|Lost to Follow-up|0|||
155431764|NCT01485614|561007718|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
155431765|NCT01485614|561007719|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
155431766|NCT01485614|561007720|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
155431767|NCT01485614|561007721|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
155431768|NCT01485614|561007718|FG000|Weeks 20-54|Withdrawal by Subject|5|||
155431769|NCT01485614|561007719|FG001|Weeks 20-54|Withdrawal by Subject|3|||
155431770|NCT01485614|561007720|FG002|Weeks 20-54|Withdrawal by Subject|0|||
155431771|NCT01485614|561007721|FG003|Weeks 20-54|Withdrawal by Subject|0|||
155431772|NCT00733902|561007722|FG000|Overall Study|Death|0|||
155431773|NCT00733902|561007723|FG001|Overall Study|Death|0|||
155431774|NCT00733902|561007724|FG002|Overall Study|Death|0|||
155431775|NCT00733902|561007725|FG003|Overall Study|Death|1|||
155431776|NCT00733902|561007722|FG000|Overall Study|Adverse Event|3|||
155431777|NCT00733902|561007723|FG001|Overall Study|Adverse Event|4|||
155431778|NCT00733902|561007724|FG002|Overall Study|Adverse Event|7|||
155431779|NCT00733902|561007725|FG003|Overall Study|Adverse Event|11|||
155431780|NCT00733902|561007722|FG000|Overall Study|Lack of Efficacy|56|||
155431781|NCT00733902|561007723|FG001|Overall Study|Lack of Efficacy|21|||
155431782|NCT00733902|561007724|FG002|Overall Study|Lack of Efficacy|34|||
155431783|NCT00733902|561007725|FG003|Overall Study|Lack of Efficacy|23|||
155431784|NCT00733902|561007722|FG000|Overall Study|Protocol Violation|4|||
155650021|NCT04128228|561810240|FG003|Overall Study|Withdrawal by Subject|0|||
155431785|NCT00733902|561007723|FG001|Overall Study|Protocol Violation|6|||
155431786|NCT00733902|561007724|FG002|Overall Study|Protocol Violation|3|||
155431787|NCT00733902|561007725|FG003|Overall Study|Protocol Violation|3|||
155431788|NCT00733902|561007722|FG000|Overall Study|Withdrawal by Subject|10|||
155431789|NCT00733902|561007723|FG001|Overall Study|Withdrawal by Subject|5|||
155431790|NCT00733902|561007724|FG002|Overall Study|Withdrawal by Subject|4|||
155650022|NCT04128228|561810237|FG000|Overall Study|noncompliance|2|||
155431791|NCT00733902|561007725|FG003|Overall Study|Withdrawal by Subject|16|||
155431792|NCT00733902|561007722|FG000|Overall Study|Entered extension study|89|||
155431793|NCT00733902|561007723|FG001|Overall Study|Entered extension study|124|||
155431794|NCT00733902|561007724|FG002|Overall Study|Entered extension study|111|||
155431795|NCT00733902|561007725|FG003|Overall Study|Entered extension study|109|||
155431796|NCT00733902|561007722|FG000|Overall Study|Randomized but not treated|2|||
155650023|NCT04128228|561810238|FG001|Overall Study|noncompliance|2|||
155650024|NCT04128228|561810239|FG002|Overall Study|noncompliance|0|||
155431797|NCT00733902|561007723|FG001|Overall Study|Randomized but not treated|2|||
155431798|NCT00733902|561007724|FG002|Overall Study|Randomized but not treated|2|||
155378491|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378492|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
155378493|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
155378494|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
155378495|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
155378496|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378497|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378498|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378499|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378500|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378501|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378502|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378503|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378504|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378505|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378506|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
155378507|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378508|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
155378509|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378510|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378511|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378512|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378513|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378514|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378515|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378516|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378517|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378518|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378519|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155431799|NCT00733902|561007725|FG003|Overall Study|Randomized but not treated|1|||
155431800|NCT01503021|561007730|FG000|Overall Study|Adverse Event|7|||
155431801|NCT01503021|561007731|FG001|Overall Study|Adverse Event|6|||
155431802|NCT01503021|561007730|FG000|Overall Study|Death|0|||
155431803|NCT01503021|561007731|FG001|Overall Study|Death|2|||
155431804|NCT01503021|561007730|FG000|Overall Study|Lost to Follow-up|2|||
155431805|NCT01503021|561007731|FG001|Overall Study|Lost to Follow-up|0|||
155431806|NCT01503021|561007730|FG000|Overall Study|Physician Decision|3|||
155431807|NCT01503021|561007731|FG001|Overall Study|Physician Decision|0|||
155431808|NCT01503021|561007730|FG000|Overall Study|Protocol Violation|1|||
155431809|NCT01503021|561007731|FG001|Overall Study|Protocol Violation|3|||
155431810|NCT01503021|561007730|FG000|Overall Study|Withdrawal by Subject|9|||
155431811|NCT01503021|561007731|FG001|Overall Study|Withdrawal by Subject|8|||
155431812|NCT01503021|561007730|FG000|Overall Study|Moved, received transplant, etc.|5|||
155431813|NCT01503021|561007731|FG001|Overall Study|Moved, received transplant, etc.|7|||
155431814|NCT03941548|561007732|FG000|Overall Study|Adverse Event|0|||
155431815|NCT03941548|561007733|FG001|Overall Study|Adverse Event|1|||
155431816|NCT03941548|561007732|FG000|Overall Study|Lost to Follow-up|0|||
155431817|NCT03941548|561007733|FG001|Overall Study|Lost to Follow-up|1|||
155431818|NCT03941548|561007732|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
155431819|NCT03941548|561007733|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
155431820|NCT01242111|561007735|FG000|Overall Study|Adverse Event|1|||
155431821|NCT01242111|561007735|FG000|Overall Study|Withdrawal by Subject|1|||
155431822|NCT01242111|561007735|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
155431823|NCT00870688|561007736|FG000|Overall Study|Lost to Follow-up|2|||
155431824|NCT00870688|561007736|FG000|Overall Study|Death, Unrelated|1|||
155431825|NCT00870688|561007736|FG000|Overall Study|Granules in the Stools|1|||
155431826|NCT02015819|561007737|FG000|Overall Study|Rickham catheter was misaligned|0|||
155431827|NCT02015819|561007738|FG001|Overall Study|Rickham catheter was misaligned|0|||
155431828|NCT02015819|561007739|FG002|Overall Study|Rickham catheter was misaligned|0|||
155431829|NCT02015819|561007740|FG003|Overall Study|Rickham catheter was misaligned|1|||
155431830|NCT00728416|561007753|FG000|Overall Study|Adverse Event|1|||
155431831|NCT00728416|561007754|FG001|Overall Study|Adverse Event|1|||
155431832|NCT00728416|561007753|FG000|Overall Study|Treatment Failure|0|||
155431833|NCT00728416|561007754|FG001|Overall Study|Treatment Failure|1|||
155431834|NCT00728416|561007753|FG000|Overall Study|Withdrawal by Subject|1|||
155431835|NCT00728416|561007754|FG001|Overall Study|Withdrawal by Subject|0|||
155431836|NCT04112914|561007755|FG000|Overall Study|Lost to Follow-up|13|||
155431837|NCT04112914|561007756|FG001|Overall Study|Lost to Follow-up|9|||
155431838|NCT04112914|561007755|FG000|Overall Study|Withdrawal by Subject|1|||
155431839|NCT04112914|561007756|FG001|Overall Study|Withdrawal by Subject|0|||
155431840|NCT01120626|561007757|FG000|Overall Study|Withdrawal by Subject|1|||
155431841|NCT01120626|561007758|FG001|Overall Study|Withdrawal by Subject|0|||
155431842|NCT02635204|561007759|FG000|Overall Study|Adverse Event|1|||
155378520|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378521|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378522|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
155378523|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378524|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378525|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378526|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378527|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378528|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378529|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155431843|NCT02635204|561007760|FG001|Overall Study|Adverse Event|0|||
155431844|NCT02635204|561007759|FG000|Overall Study|Lost to Follow-up|1|||
155431845|NCT02635204|561007760|FG001|Overall Study|Lost to Follow-up|1|||
155431846|NCT05421754|561007765|FG000|Overall Study|Technical issue with sensor|1|||
155431847|NCT03527043|561007766|FG000|Overall Study|Withdrawal by Subject|1|||
155431848|NCT03527043|561007767|FG001|Overall Study|Withdrawal by Subject|0|||
155431849|NCT01772134|561007773|FG000|Overall Study|Adverse Event|6|||
155431850|NCT01772134|561007774|FG001|Overall Study|Adverse Event|5|||
155431851|NCT01772134|561007775|FG002|Overall Study|Adverse Event|10|||
155431852|NCT01772134|561007773|FG000|Overall Study|Withdrew Consent|3|||
155431853|NCT01772134|561007774|FG001|Overall Study|Withdrew Consent|1|||
155431854|NCT01772134|561007775|FG002|Overall Study|Withdrew Consent|5|||
155431855|NCT01772134|561007773|FG000|Overall Study|Lost to Follow-up|2|||
155431856|NCT01772134|561007774|FG001|Overall Study|Lost to Follow-up|0|||
155431857|NCT01772134|561007775|FG002|Overall Study|Lost to Follow-up|0|||
155431858|NCT01772134|561007773|FG000|Overall Study|Protocol Deviation|4|||
155431859|NCT01772134|561007774|FG001|Overall Study|Protocol Deviation|3|||
155431860|NCT01772134|561007775|FG002|Overall Study|Protocol Deviation|3|||
155431861|NCT01772134|561007773|FG000|Overall Study|Lack of Efficacy|11|||
155431862|NCT01772134|561007774|FG001|Overall Study|Lack of Efficacy|5|||
155431863|NCT01772134|561007775|FG002|Overall Study|Lack of Efficacy|3|||
155431864|NCT01772134|561007773|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
155431865|NCT01772134|561007774|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
155431866|NCT01772134|561007775|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
155431867|NCT01772134|561007773|FG000|Overall Study|Randomized Study Medication Not Received|2|||
155431868|NCT01772134|561007774|FG001|Overall Study|Randomized Study Medication Not Received|0|||
155431869|NCT01772134|561007775|FG002|Overall Study|Randomized Study Medication Not Received|1|||
155431870|NCT00636818|561007776|FG000|Overall Study|Adverse Event|1|||
155431871|NCT00636818|561007776|FG000|Overall Study|Lost to Follow-up|2|||
155431872|NCT00636818|561007776|FG000|Overall Study|Entry Criteria Exclusion|3|||
155431873|NCT00636818|561007776|FG000|Overall Study|Protocol Violation|1|||
155431874|NCT00636818|561007776|FG000|Overall Study|Withdrawal by Subject|4|||
155431875|NCT01023789|561007779|FG000|3 - Year Visit|Death|29|||
155431876|NCT01023789|561007779|FG000|3 - Year Visit|Withdrawal of consent|1|||
155431877|NCT01023789|561007779|FG000|3 - Year Visit|Lost to Follow-up|13|||
155431878|NCT02115308|561007787|FG000|Overall Study|Safety Screening|2|||
155431879|NCT02115308|561007788|FG001|Overall Study|Safety Screening|2|||
155431880|NCT01442181|561007796|FG000|Overall Study|patient refused surgery|1|||
155431881|NCT01442181|561007797|FG001|Overall Study|patient refused surgery|0|||
155431882|NCT01442181|561007796|FG000|Overall Study|no insurance for surgery|1|||
155431883|NCT01442181|561007797|FG001|Overall Study|no insurance for surgery|0|||
155431884|NCT01442181|561007796|FG000|Overall Study|low ejection factor|0|||
155431885|NCT01442181|561007797|FG001|Overall Study|low ejection factor|1|||
155431886|NCT01442181|561007796|FG000|Overall Study|Lost to Follow-up|1|||
155431887|NCT01442181|561007797|FG001|Overall Study|Lost to Follow-up|1|||
155431888|NCT01442181|561007796|FG000|Overall Study|patient in an additional study|1|||
155431889|NCT01442181|561007797|FG001|Overall Study|patient in an additional study|0|||
155431890|NCT01442181|561007796|FG000|Overall Study|atrial fibrillation not noted|0|||
155431891|NCT01442181|561007797|FG001|Overall Study|atrial fibrillation not noted|1|||
155431892|NCT00749203|561007798|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
155431893|NCT00749203|561007799|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
155431894|NCT00749203|561007798|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
155431895|NCT00749203|561007799|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
155431896|NCT00749203|561007798|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
155431897|NCT00749203|561007799|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
155431898|NCT00749203|561007798|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
155431899|NCT00749203|561007799|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
155431900|NCT00749203|561007798|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
155431901|NCT00749203|561007799|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
155431902|NCT00749203|561007798|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
155431903|NCT00749203|561007799|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
155431904|NCT02034123|561007800|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431905|NCT02034123|561007801|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155378530|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
155378531|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
155378532|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
155378533|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
155378534|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
155378535|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
155378536|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
155378537|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
155378538|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
155378539|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
155378540|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
155378541|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
155378542|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
155378543|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
155378544|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378545|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378546|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378547|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378548|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378549|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378550|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378551|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378552|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378553|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378554|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378555|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378556|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
155378557|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378558|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378559|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378560|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378561|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378562|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378563|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378564|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378565|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378566|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378567|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378568|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378569|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
155378570|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378571|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378572|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378573|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378574|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378575|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378576|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378577|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378578|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378579|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378580|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378581|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
155378582|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378583|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378584|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378585|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378586|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
155378587|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
155378588|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
155378589|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
155378590|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
155378591|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
155378592|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
155378593|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
155378594|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
155650025|NCT04128228|561810240|FG003|Overall Study|noncompliance|0|||
155512461|NCT01688037|561301299|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
155512462|NCT01688037|561301300|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
155512463|NCT01688037|561301298|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
155512464|NCT01688037|561301299|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
155378595|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
155378596|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
155378597|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
155378598|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
155378599|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
155378600|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378601|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378602|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378603|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378604|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378605|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378606|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378607|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378608|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378609|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378610|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378611|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378612|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
155378613|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378614|NCT00006011|560818300|FG000|Overall Study|Disease progression|13|||
155378615|NCT00006011|560818301|FG001|Overall Study|Disease progression|6|||
155378616|NCT00006011|560818302|FG002|Overall Study|Disease progression|26|||
155378617|NCT00006011|560818300|FG000|Overall Study|Refused further treatment|15|||
155378618|NCT00006011|560818301|FG001|Overall Study|Refused further treatment|13|||
155378619|NCT00006011|560818302|FG002|Overall Study|Refused further treatment|26|||
155378620|NCT00006011|560818300|FG000|Overall Study|Adverse Event|15|||
155378621|NCT00006011|560818301|FG001|Overall Study|Adverse Event|39|||
155378622|NCT00006011|560818302|FG002|Overall Study|Adverse Event|5|||
155378623|NCT00006011|560818300|FG000|Overall Study|Death|0|||
155378624|NCT00006011|560818301|FG001|Overall Study|Death|1|||
155378625|NCT00006011|560818302|FG002|Overall Study|Death|2|||
155378626|NCT00006011|560818300|FG000|Overall Study|Other|4|||
155378627|NCT00006011|560818301|FG001|Overall Study|Other|2|||
155378628|NCT00006011|560818302|FG002|Overall Study|Other|5|||
155378629|NCT00006011|560818300|FG000|Overall Study|Ineligible|18|||
155378630|NCT00006011|560818301|FG001|Overall Study|Ineligible|16|||
155378631|NCT00006011|560818302|FG002|Overall Study|Ineligible|9|||
155378632|NCT01097707|560818308|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155378633|NCT01097707|560818309|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155378634|NCT01097707|560818310|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378635|NCT01097707|560818311|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378636|NCT01097707|560818312|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378637|NCT01097707|560818308|FG000|Overall Study|Adverse Event|4|||
155378638|NCT01097707|560818309|FG001|Overall Study|Adverse Event|2|||
155378639|NCT01097707|560818310|FG002|Overall Study|Adverse Event|3|||
155378640|NCT01097707|560818311|FG003|Overall Study|Adverse Event|1|||
155378641|NCT01097707|560818312|FG004|Overall Study|Adverse Event|3|||
155378642|NCT01097707|560818308|FG000|Overall Study|Entry Criteria Not Met|2|||
155378643|NCT01097707|560818309|FG001|Overall Study|Entry Criteria Not Met|1|||
155378644|NCT01097707|560818310|FG002|Overall Study|Entry Criteria Not Met|1|||
155378645|NCT01097707|560818311|FG003|Overall Study|Entry Criteria Not Met|0|||
155378646|NCT01097707|560818312|FG004|Overall Study|Entry Criteria Not Met|1|||
155378647|NCT01097707|560818308|FG000|Overall Study|Lack of Efficacy|1|||
155378648|NCT01097707|560818309|FG001|Overall Study|Lack of Efficacy|0|||
155378649|NCT01097707|560818310|FG002|Overall Study|Lack of Efficacy|0|||
155378650|NCT01097707|560818311|FG003|Overall Study|Lack of Efficacy|1|||
155378651|NCT01097707|560818312|FG004|Overall Study|Lack of Efficacy|0|||
155378652|NCT01097707|560818308|FG000|Overall Study|Lost to Follow-up|1|||
155378653|NCT01097707|560818309|FG001|Overall Study|Lost to Follow-up|1|||
155378654|NCT01097707|560818310|FG002|Overall Study|Lost to Follow-up|2|||
155378655|NCT01097707|560818311|FG003|Overall Study|Lost to Follow-up|0|||
155378656|NCT01097707|560818312|FG004|Overall Study|Lost to Follow-up|3|||
155378657|NCT01097707|560818308|FG000|Overall Study|Protocol Violation|2|||
155378658|NCT01097707|560818309|FG001|Overall Study|Protocol Violation|2|||
155378659|NCT01097707|560818310|FG002|Overall Study|Protocol Violation|3|||
155512465|NCT01688037|561301300|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
155512466|NCT01688037|561301298|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
155378660|NCT01097707|560818311|FG003|Overall Study|Protocol Violation|2|||
155378661|NCT01097707|560818312|FG004|Overall Study|Protocol Violation|2|||
155378662|NCT01097707|560818308|FG000|Overall Study|Sponsor Decision|31|||
155378663|NCT01097707|560818309|FG001|Overall Study|Sponsor Decision|31|||
155378664|NCT01097707|560818310|FG002|Overall Study|Sponsor Decision|34|||
155378665|NCT01097707|560818311|FG003|Overall Study|Sponsor Decision|35|||
155378666|NCT01097707|560818312|FG004|Overall Study|Sponsor Decision|36|||
155378667|NCT01097707|560818308|FG000|Overall Study|Withdrawal by Subject|3|||
155378668|NCT01097707|560818309|FG001|Overall Study|Withdrawal by Subject|6|||
155378669|NCT01097707|560818310|FG002|Overall Study|Withdrawal by Subject|1|||
155378670|NCT01097707|560818311|FG003|Overall Study|Withdrawal by Subject|4|||
155378671|NCT01097707|560818312|FG004|Overall Study|Withdrawal by Subject|3|||
155378672|NCT01097707|560818308|FG000|Overall Study|Reason unknown|0|||
155378673|NCT01097707|560818309|FG001|Overall Study|Reason unknown|0|||
155378674|NCT01097707|560818310|FG002|Overall Study|Reason unknown|0|||
155378675|NCT01097707|560818311|FG003|Overall Study|Reason unknown|0|||
155378676|NCT01097707|560818312|FG004|Overall Study|Reason unknown|1|||
155378677|NCT00158860|560818319|FG000|Overall Study|Adverse Event|3|||
155378678|NCT00158860|560818320|FG001|Overall Study|Adverse Event|6|||
155378679|NCT00158860|560818319|FG000|Overall Study|Lost to Follow-up|11|||
155378680|NCT00158860|560818320|FG001|Overall Study|Lost to Follow-up|17|||
155378681|NCT00158860|560818319|FG000|Overall Study|Protocol Violation|8|||
155378682|NCT00158860|560818320|FG001|Overall Study|Protocol Violation|23|||
155378683|NCT00158860|560818319|FG000|Overall Study|Withdrawal by Subject|7|||
155378684|NCT00158860|560818320|FG001|Overall Study|Withdrawal by Subject|17|||
155378685|NCT00158860|560818319|FG000|Overall Study|MOVING OUT OF STATE|1|||
155378686|NCT00158860|560818320|FG001|Overall Study|MOVING OUT OF STATE|0|||
155378687|NCT00158860|560818319|FG000|Overall Study|Pregnancy|3|||
155378688|NCT00158860|560818320|FG001|Overall Study|Pregnancy|3|||
155378689|NCT00158860|560818319|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
155378690|NCT00158860|560818320|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
155378691|NCT00158860|560818319|FG000|Overall Study|SPONSOR REQUEST|0|||
155378692|NCT00158860|560818320|FG001|Overall Study|SPONSOR REQUEST|1|||
155378693|NCT00158860|560818319|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
155378694|NCT00158860|560818320|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
155378695|NCT00158860|560818319|FG000|Overall Study|Closed per sponsor|0|||
155378696|NCT00158860|560818320|FG001|Overall Study|Closed per sponsor|1|||
155378697|NCT03047395|560818321|FG000|Overall Study|Adverse Event|142|||
155378698|NCT03047395|560818321|FG000|Overall Study|Withdrawal by Subject|155|||
155378699|NCT03047395|560818321|FG000|Overall Study|Lost to Follow-up|144|||
155378700|NCT03047395|560818321|FG000|Overall Study|COVID-19 Infection|2|||
155378701|NCT03047395|560818321|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
155378702|NCT03047395|560818321|FG000|Overall Study|Other, Not Specified|117|||
155378703|NCT01157676|560818327|FG000|Randomization|Death|1|||
155378704|NCT01157676|560818328|FG001|Randomization|Death|1|||
155378705|NCT01157676|560818327|FG000|Randomization|unresectable|2|||
155378706|NCT01157676|560818328|FG001|Randomization|unresectable|3|||
155378707|NCT01157676|560818327|FG000|Randomization|Withdrawal by Subject|17|||
155378708|NCT01157676|560818328|FG001|Randomization|Withdrawal by Subject|13|||
155378709|NCT01157676|560818327|FG000|Randomization|Physician Decision|1|||
155378710|NCT01157676|560818328|FG001|Randomization|Physician Decision|0|||
155378711|NCT01157676|560818327|FG000|Surgery|underwent open cystectomy|0|||
155378712|NCT01157676|560818328|FG001|Surgery|underwent open cystectomy|4|||
155378713|NCT01157676|560818327|FG000|Surgery|converted to open procedure|0|||
155378714|NCT01157676|560818328|FG001|Surgery|converted to open procedure|5|||
155378715|NCT01157676|560818327|FG000|Surgery|underwent robotic cystectomy|1|||
155378716|NCT01157676|560818328|FG001|Surgery|underwent robotic cystectomy|0|||
155378717|NCT00682890|560818329|FG000|Overall Study|Lost to Follow-up|1|||
155378718|NCT00682890|560818330|FG001|Overall Study|Lost to Follow-up|1|||
155378719|NCT00682890|560818329|FG000|Overall Study|subject moved away|0|||
155378720|NCT00682890|560818330|FG001|Overall Study|subject moved away|1|||
155378721|NCT00682890|560818329|FG000|Overall Study|heavy menstrual bleeding|1|||
155378722|NCT00682890|560818330|FG001|Overall Study|heavy menstrual bleeding|0|||
155378723|NCT02595073|560818333|FG000|Overall Study|Progressive Disease|0|||
155378724|NCT02595073|560818334|FG001|Overall Study|Progressive Disease|1|||
155378725|NCT02595073|560818333|FG000|Overall Study|Protocol Violation|2|||
155378726|NCT02595073|560818334|FG001|Overall Study|Protocol Violation|0|||
155378727|NCT04860297|560818337|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
155378728|NCT04860297|560818338|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
155378729|NCT04860297|560818339|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
155378730|NCT04860297|560818340|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
155378731|NCT04860297|560818341|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
155378732|NCT04860297|560818342|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
155378733|NCT04860297|560818343|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
155650026|NCT03163264|561810241|FG000|Overall Study|Withdrawal by Subject|13|||
155378734|NCT04860297|560818344|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
155378735|NCT04860297|560818337|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
155378736|NCT04860297|560818338|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
155378737|NCT04860297|560818339|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
155650027|NCT03163264|561810242|FG001|Overall Study|Withdrawal by Subject|3|||
155650028|NCT03163264|561810243|FG002|Overall Study|Withdrawal by Subject|4|||
155378738|NCT04860297|560818340|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
155378739|NCT04860297|560818341|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
155378740|NCT04860297|560818342|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
155378741|NCT04860297|560818343|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
155378742|NCT04860297|560818344|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
155378743|NCT04860297|560818337|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
155378744|NCT04860297|560818338|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
155378745|NCT04860297|560818339|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
155378746|NCT04860297|560818340|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
155378747|NCT04860297|560818341|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
155378748|NCT04860297|560818342|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
155378749|NCT04860297|560818343|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
155378750|NCT04860297|560818344|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
155378751|NCT04860297|560818337|FG000|Part B (Booster Dose)|Other Than Specified|0|||
155378752|NCT04860297|560818338|FG001|Part B (Booster Dose)|Other Than Specified|0|||
155378753|NCT04860297|560818339|FG002|Part B (Booster Dose)|Other Than Specified|0|||
155378754|NCT04860297|560818340|FG003|Part B (Booster Dose)|Other Than Specified|0|||
155378755|NCT04860297|560818341|FG004|Part B (Booster Dose)|Other Than Specified|0|||
155378756|NCT04860297|560818342|FG005|Part B (Booster Dose)|Other Than Specified|1|||
155378757|NCT04860297|560818343|FG006|Part B (Booster Dose)|Other Than Specified|1|||
155378758|NCT04860297|560818344|FG007|Part B (Booster Dose)|Other Than Specified|0|||
155378759|NCT04860297|560818337|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378760|NCT04860297|560818338|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378761|NCT04860297|560818339|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378762|NCT04860297|560818340|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378763|NCT04860297|560818341|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378764|NCT04860297|560818342|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
155378765|NCT04860297|560818343|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378766|NCT04860297|560818344|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
155378767|NCT04860297|560818337|FG000|Part B (Booster Dose)|Death|0|||
155378768|NCT04860297|560818338|FG001|Part B (Booster Dose)|Death|0|||
155378769|NCT04860297|560818339|FG002|Part B (Booster Dose)|Death|0|||
155378770|NCT04860297|560818340|FG003|Part B (Booster Dose)|Death|0|||
155378771|NCT04860297|560818341|FG004|Part B (Booster Dose)|Death|1|||
155378772|NCT04860297|560818342|FG005|Part B (Booster Dose)|Death|2|||
155378773|NCT04860297|560818343|FG006|Part B (Booster Dose)|Death|1|||
155378774|NCT04860297|560818344|FG007|Part B (Booster Dose)|Death|0|||
155378775|NCT04860297|560818337|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
155378776|NCT04860297|560818338|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
155378777|NCT04860297|560818339|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
155378778|NCT04860297|560818340|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
155378779|NCT04860297|560818341|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
155378780|NCT04860297|560818342|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
155378781|NCT04860297|560818343|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
155378782|NCT04860297|560818344|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
155378783|NCT00620282|560818353|FG000|Overall Study|Adverse Event|0|||
155378784|NCT00620282|560818354|FG001|Overall Study|Adverse Event|1|||
155378785|NCT00620282|560818355|FG002|Overall Study|Adverse Event|0|||
155378786|NCT00620282|560818353|FG000|Overall Study|Arterial line unable to be placed|0|||
155378787|NCT00620282|560818354|FG001|Overall Study|Arterial line unable to be placed|0|||
155378788|NCT00620282|560818355|FG002|Overall Study|Arterial line unable to be placed|1|||
155378789|NCT00620282|560818353|FG000|Overall Study|Withdrawal by Subject|0|||
155378790|NCT00620282|560818354|FG001|Overall Study|Withdrawal by Subject|1|||
155378791|NCT00620282|560818355|FG002|Overall Study|Withdrawal by Subject|0|||
155378792|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
155378793|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
155378794|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
155378795|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
155431906|NCT02034123|561007802|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431907|NCT02034123|561007803|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155378796|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
155378797|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
155378798|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
155378799|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
155378800|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
155378801|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
155378802|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
155378803|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
155378804|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
155378805|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
155431908|NCT02034123|561007804|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
155378806|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
155431909|NCT02034123|561007805|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431910|NCT02034123|561007806|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431911|NCT02034123|561007807|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
155431912|NCT02034123|561007808|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
155431913|NCT02034123|561007809|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431914|NCT02034123|561007810|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431915|NCT02034123|561007811|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431916|NCT02034123|561007812|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431917|NCT02034123|561007813|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431918|NCT02034123|561007814|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431919|NCT02034123|561007815|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431920|NCT02034123|561007816|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431921|NCT02034123|561007817|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155431922|NCT02034123|561007800|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431923|NCT02034123|561007801|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431924|NCT02034123|561007802|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431925|NCT02034123|561007803|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
155431926|NCT02034123|561007804|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431927|NCT02034123|561007805|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431928|NCT02034123|561007806|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431929|NCT02034123|561007807|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431930|NCT02034123|561007808|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431931|NCT02034123|561007809|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431932|NCT02034123|561007810|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431933|NCT02034123|561007811|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431934|NCT02034123|561007812|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431935|NCT02034123|561007813|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431936|NCT02034123|561007814|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431937|NCT02034123|561007815|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431938|NCT02034123|561007816|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431939|NCT02034123|561007817|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155431940|NCT02034123|561007800|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431941|NCT02034123|561007801|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431942|NCT02034123|561007802|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431943|NCT02034123|561007803|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431944|NCT02034123|561007804|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431945|NCT02034123|561007805|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431946|NCT02034123|561007806|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431947|NCT02034123|561007807|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431948|NCT02034123|561007808|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
155431949|NCT02034123|561007809|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431950|NCT02034123|561007810|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431951|NCT02034123|561007811|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431952|NCT02034123|561007812|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431953|NCT02034123|561007813|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431954|NCT02034123|561007814|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431955|NCT02034123|561007815|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431956|NCT02034123|561007816|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431957|NCT02034123|561007817|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155431958|NCT02034123|561007800|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431959|NCT02034123|561007801|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431960|NCT02034123|561007802|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431961|NCT02034123|561007803|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
155431962|NCT02034123|561007804|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
155431963|NCT02034123|561007805|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431964|NCT02034123|561007806|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431965|NCT02034123|561007807|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431966|NCT02034123|561007808|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431967|NCT02034123|561007809|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155650029|NCT03163264|561810244|FG003|Overall Study|Withdrawal by Subject|2|||
155650030|NCT03163264|561810241|FG000|Overall Study|Lost to Follow-up|17|||
155650031|NCT03163264|561810242|FG001|Overall Study|Lost to Follow-up|20|||
155650032|NCT03163264|561810243|FG002|Overall Study|Lost to Follow-up|0|||
155378807|NCT02217475|560818356|FG000|Discontinued After Period 1|Adverse Event|1|||
155378808|NCT02217475|560818357|FG001|Discontinued After Period 1|Adverse Event|2|||
155378809|NCT02217475|560818358|FG002|Discontinued After Period 1|Adverse Event|0|||
155378810|NCT02217475|560818356|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
155378811|NCT02217475|560818357|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
155378812|NCT02217475|560818358|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
155378813|NCT02217475|560818356|FG000|Discontinued After Period 1|Physician Decision|0|||
155378814|NCT02217475|560818357|FG001|Discontinued After Period 1|Physician Decision|0|||
155378815|NCT02217475|560818358|FG002|Discontinued After Period 1|Physician Decision|1|||
155378816|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
155378817|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
155378818|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
155378819|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
155378820|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
155378821|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
155378822|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
155378823|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
155378824|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
155378825|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
155378826|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
155378827|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
155378828|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
155378829|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
155378830|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
155378831|NCT04738292|560818363|FG000|Overall Study|Death|1|||
155378832|NCT02971761|560818364|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
155378833|NCT02442336|560818365|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
155378834|NCT02442336|560818365|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
155378835|NCT02442336|560818365|FG000|Overall Study|Lost to Follow-up|11|||
155378836|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
155378837|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
155378838|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
155378839|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
155378840|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
155378841|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
155378842|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
155378843|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
155378844|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
155378845|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
155378846|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
155378847|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
155378848|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
155378849|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
155378850|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
155378851|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
155378852|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
155378853|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
155378854|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
155378855|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
155378856|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
155378857|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
155378858|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
155378859|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
155378860|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
155378861|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
155378862|NCT01237587|560818368|FG000|Taper Phase|Adverse Event|0|||
155378863|NCT01237587|560818369|FG001|Taper Phase|Adverse Event|2|||
155378864|NCT01237587|560818368|FG000|Taper Phase|Protocol Violation|2|||
155378865|NCT01237587|560818369|FG001|Taper Phase|Protocol Violation|0|||
155378866|NCT01237587|560818368|FG000|Taper Phase|Lack of Efficacy|2|||
155378867|NCT01237587|560818369|FG001|Taper Phase|Lack of Efficacy|5|||
155378868|NCT01237587|560818368|FG000|Taper Phase|Parent/Guardian Decision|0|||
155431968|NCT02034123|561007810|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431969|NCT02034123|561007811|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431970|NCT02034123|561007812|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155378869|NCT01237587|560818369|FG001|Taper Phase|Parent/Guardian Decision|2|||
155378870|NCT01237587|560818368|FG000|Taper Phase|Sponsor Decision|1|||
155378871|NCT01237587|560818369|FG001|Taper Phase|Sponsor Decision|0|||
155378872|NCT01237587|560818368|FG000|Taper Phase|Withdrawal by Subject|0|||
155378873|NCT01237587|560818369|FG001|Taper Phase|Withdrawal by Subject|1|||
155378874|NCT01011387|560818370|FG000|Overall Study|Withdrawal by Subject|3|||
155378875|NCT01011387|560818370|FG000|Overall Study|Adverse Event|2|||
155378876|NCT01011387|560818370|FG000|Overall Study|Protocol Violation|1|||
155378877|NCT01285609|560818371|FG000|Randomized|Progressive Disease|41|||
155378878|NCT01285609|560818372|FG001|Randomized|Progressive Disease|61|||
155378879|NCT01285609|560818371|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
155378880|NCT01285609|560818372|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
155378881|NCT01285609|560818371|FG000|Randomized|Study Drug Toxicity|13|||
155378882|NCT01285609|560818372|FG001|Randomized|Study Drug Toxicity|14|||
155378883|NCT01285609|560818371|FG000|Randomized|Death|5|||
155378884|NCT01285609|560818372|FG001|Randomized|Death|7|||
155378885|NCT01285609|560818371|FG000|Randomized|Withdrawal by Subject|8|||
155378886|NCT01285609|560818372|FG001|Randomized|Withdrawal by Subject|11|||
155378887|NCT01285609|560818371|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
155378888|NCT01285609|560818372|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
155378889|NCT01285609|560818371|FG000|Randomized|Undisclosed Reasons|1|||
155378890|NCT01285609|560818372|FG001|Randomized|Undisclosed Reasons|0|||
155378891|NCT01285609|560818371|FG000|Randomized|Randomized but not Treated|4|||
155378892|NCT01285609|560818372|FG001|Randomized|Randomized but not Treated|4|||
155378893|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
155378894|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
155378895|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
155378896|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
155378897|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
155378898|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
155378899|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
155378900|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
155378901|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Death|11|||
155378902|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Death|3|||
155378903|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
155378904|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
155378905|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Not Reported|0|||
155378906|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Not Reported|2|||
155378907|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
155378908|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
155378909|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
155378910|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
155378911|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
155378912|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
155378913|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
155378914|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
155378915|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
155378916|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
155378917|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
155378918|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
155378919|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
155378920|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
155378921|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
155378922|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
155378923|NCT01285609|560818371|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
155378924|NCT01285609|560818372|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
155378925|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
155512467|NCT01688037|561301299|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
155512468|NCT01688037|561301300|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
155378926|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
155378927|NCT01142115|560818373|FG000|First Intervention|Lack of Efficacy|1|||
155378928|NCT01142115|560818374|FG001|First Intervention|Lack of Efficacy|1|||
155378929|NCT01142115|560818373|FG000|First Intervention|Adverse Event|1|||
155378930|NCT01142115|560818374|FG001|First Intervention|Adverse Event|0|||
155378931|NCT03208036|560818375|FG000|Baseline Assessment|Withdrawal by Subject|1|||
155378932|NCT03208036|560818376|FG001|Baseline Assessment|Withdrawal by Subject|1|||
155378933|NCT03208036|560818375|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
155378934|NCT03208036|560818376|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
155378935|NCT03208036|560818375|FG000|Intervention|Withdrawal by Subject|3|||
155378936|NCT03208036|560818376|FG001|Intervention|Withdrawal by Subject|2|||
155378937|NCT03208036|560818375|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
155378938|NCT03208036|560818376|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
155378939|NCT01879553|560818377|FG000|Overall Study|Withdrawal by Subject|1|||
155378940|NCT01879553|560818378|FG001|Overall Study|Withdrawal by Subject|0|||
155378941|NCT02019667|560818379|FG000|First Intervention (6 Months)|Adverse Event|0|||
155378942|NCT02019667|560818380|FG001|First Intervention (6 Months)|Adverse Event|1|||
155378943|NCT02019667|560818379|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
155378944|NCT02019667|560818380|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
155378945|NCT02019667|560818379|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
155378946|NCT02019667|560818380|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
155378947|NCT02432196|560818381|FG000|Overall Study|Exit - did not receive study device|1|||
155378948|NCT02432196|560818381|FG000|Overall Study|Death|2|||
155378949|NCT02432196|560818381|FG000|Overall Study|Reoperation|3|||
155378950|NCT05038163|560818383|FG000|Stage 1|Did not complete survey|374|||
155378951|NCT05038163|560818384|FG001|Stage 1|Did not complete survey|0|||
155378952|NCT05038163|560818385|FG002|Stage 1|Did not complete survey|0|||
155378953|NCT05038163|560818386|FG003|Stage 1|Did not complete survey|0|||
155378954|NCT05038163|560818387|FG004|Stage 1|Did not complete survey|0|||
155378955|NCT05038163|560818388|FG005|Stage 1|Did not complete survey|0|||
155378956|NCT05038163|560818383|FG000|Stage 2|Did not complete Stage 2 survey|0|||
155378957|NCT05038163|560818384|FG001|Stage 2|Did not complete Stage 2 survey|29|||
155378958|NCT05038163|560818385|FG002|Stage 2|Did not complete Stage 2 survey|30|||
155378959|NCT05038163|560818386|FG003|Stage 2|Did not complete Stage 2 survey|24|||
155378960|NCT05038163|560818387|FG004|Stage 2|Did not complete Stage 2 survey|21|||
155378961|NCT05038163|560818388|FG005|Stage 2|Did not complete Stage 2 survey|100|||
155378962|NCT05453201|560818389|FG000|Overall Study|Withdrawal by Subject|1|||
155378963|NCT01934790|560818390|FG000|Treatment|Adverse Event|3|||
155378964|NCT01934790|560818390|FG000|Treatment|Clinical progression|6|||
155378965|NCT01934790|560818390|FG000|Treatment|Radiological progression|4|||
155378966|NCT01934790|560818390|FG000|Treatment|Withdrawal by Subject|2|||
155378967|NCT01934790|560818390|FG000|Treatment|Study drug never administered|1|||
155378968|NCT01934790|560818390|FG000|Active Follow up|Death|20|||
155378969|NCT01934790|560818390|FG000|Active Follow up|Physician Decision|2|||
155378970|NCT01934790|560818390|FG000|Active Follow up|Progressive disease|1|||
155378971|NCT01934790|560818390|FG000|Active Follow up|Other reason|1|||
155378972|NCT00935818|560818391|FG000|Overall Study|Withdrawal by Subject|45|||
155378973|NCT00935818|560818392|FG001|Overall Study|Withdrawal by Subject|50|||
155378974|NCT00935818|560818391|FG000|Overall Study|Lost to Follow-up|40|||
155378975|NCT00935818|560818392|FG001|Overall Study|Lost to Follow-up|42|||
155378976|NCT00935818|560818391|FG000|Overall Study|Adverse Event|6|||
155378977|NCT00935818|560818392|FG001|Overall Study|Adverse Event|7|||
155378978|NCT00935818|560818391|FG000|Overall Study|Physician Decision|0|||
155378979|NCT00935818|560818392|FG001|Overall Study|Physician Decision|1|||
155378980|NCT00867308|560818393|FG000|Overall Study|Death|1|||
155378981|NCT00867308|560818394|FG001|Overall Study|Death|0|||
155378982|NCT00867308|560818393|FG000|Overall Study|Adverse Event|1|||
155378983|NCT00867308|560818394|FG001|Overall Study|Adverse Event|4|||
155378984|NCT00867308|560818393|FG000|Overall Study|Lack of Efficacy|6|||
155378985|NCT00867308|560818394|FG001|Overall Study|Lack of Efficacy|12|||
155378986|NCT00867308|560818393|FG000|Overall Study|Withdrawal by Subject|1|||
155378987|NCT00867308|560818394|FG001|Overall Study|Withdrawal by Subject|2|||
155378988|NCT00604825|560818395|FG000|Overall Study|Adverse Event|2|||
155378989|NCT00604825|560818396|FG001|Overall Study|Adverse Event|6|||
155378990|NCT00604825|560818397|FG002|Overall Study|Adverse Event|7|||
155378991|NCT00604825|560818398|FG003|Overall Study|Adverse Event|4|||
155378992|NCT00604825|560818395|FG000|Overall Study|Lost to Follow-up|0|||
155378993|NCT00604825|560818396|FG001|Overall Study|Lost to Follow-up|3|||
155378994|NCT00604825|560818397|FG002|Overall Study|Lost to Follow-up|1|||
155378995|NCT00604825|560818398|FG003|Overall Study|Lost to Follow-up|0|||
155378996|NCT00604825|560818395|FG000|Overall Study|Protocol Violation|0|||
155378997|NCT00604825|560818396|FG001|Overall Study|Protocol Violation|1|||
155431971|NCT02034123|561007813|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431972|NCT02034123|561007814|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431973|NCT02034123|561007815|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155378998|NCT00604825|560818397|FG002|Overall Study|Protocol Violation|0|||
155378999|NCT00604825|560818398|FG003|Overall Study|Protocol Violation|0|||
155379000|NCT00604825|560818395|FG000|Overall Study|Withdrawal by Subject|4|||
155379001|NCT00604825|560818396|FG001|Overall Study|Withdrawal by Subject|3|||
155379002|NCT00604825|560818397|FG002|Overall Study|Withdrawal by Subject|5|||
155379003|NCT00604825|560818398|FG003|Overall Study|Withdrawal by Subject|5|||
155379004|NCT00604825|560818395|FG000|Overall Study|Lack of Efficacy|3|||
155379005|NCT00604825|560818396|FG001|Overall Study|Lack of Efficacy|2|||
155379006|NCT00604825|560818397|FG002|Overall Study|Lack of Efficacy|1|||
155379007|NCT00604825|560818398|FG003|Overall Study|Lack of Efficacy|0|||
155379008|NCT00604825|560818395|FG000|Overall Study|Did not meet eligibility criteria|0|||
155379009|NCT00604825|560818396|FG001|Overall Study|Did not meet eligibility criteria|0|||
155379010|NCT00604825|560818397|FG002|Overall Study|Did not meet eligibility criteria|2|||
155379011|NCT00604825|560818398|FG003|Overall Study|Did not meet eligibility criteria|0|||
155379012|NCT00604825|560818395|FG000|Overall Study|Physician Decision|0|||
155379013|NCT00604825|560818396|FG001|Overall Study|Physician Decision|0|||
155379014|NCT00604825|560818397|FG002|Overall Study|Physician Decision|0|||
155379015|NCT00604825|560818398|FG003|Overall Study|Physician Decision|1|||
155379016|NCT00604825|560818395|FG000|Overall Study|Exclusion criterion met|0|||
155379017|NCT00604825|560818396|FG001|Overall Study|Exclusion criterion met|0|||
155379018|NCT00604825|560818397|FG002|Overall Study|Exclusion criterion met|0|||
155379019|NCT00604825|560818398|FG003|Overall Study|Exclusion criterion met|1|||
155379020|NCT03465904|560818399|FG000|Overall Study|Withdrawal by Subject|9|||
155379021|NCT03465904|560818400|FG001|Overall Study|Withdrawal by Subject|5|||
155379022|NCT03465904|560818399|FG000|Overall Study|Lost to Follow-up|11|||
155379023|NCT03465904|560818400|FG001|Overall Study|Lost to Follow-up|9|||
155379024|NCT03465904|560818399|FG000|Overall Study|Protocol Violation|20|||
155379025|NCT03465904|560818400|FG001|Overall Study|Protocol Violation|15|||
155379026|NCT00616902|560820308|FG000|Overall Study|Termination of study|6|||
155379027|NCT00616902|560820309|FG001|Overall Study|Termination of study|6|||
155379028|NCT03207009|560820310|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
155379029|NCT02924428|560820311|FG000|Overall Study|Adverse Event|1|||
155379030|NCT02924428|560820312|FG001|Overall Study|Adverse Event|0|||
155379031|NCT02924428|560820311|FG000|Overall Study|Physician Decision|1|||
155379032|NCT02924428|560820312|FG001|Overall Study|Physician Decision|0|||
155379033|NCT02924428|560820311|FG000|Overall Study|Lost to Follow-up|2|||
155379034|NCT02924428|560820312|FG001|Overall Study|Lost to Follow-up|4|||
155379035|NCT02924428|560820311|FG000|Overall Study|Pregnancy|0|||
155379036|NCT02924428|560820312|FG001|Overall Study|Pregnancy|1|||
155379037|NCT01877837|560820313|FG000|Overall Study|Lost to Follow-up|1|||
155379038|NCT01877837|560820313|FG000|Overall Study|Ineligible|4|||
155379039|NCT00645801|560820314|FG000|Overall Study|unclear if patient took all the medication.|1|||
155379040|NCT00645801|560820315|FG001|Overall Study|unclear if patient took all the medication.|0|||
155379041|NCT00645801|560820314|FG000|Overall Study|Lost to Follow-up|19|||
155379042|NCT00645801|560820315|FG001|Overall Study|Lost to Follow-up|15|||
155379043|NCT00759915|560820316|FG000|Overall Study|Withdrawal by Subject|1|||
155379044|NCT00759915|560820317|FG001|Overall Study|Withdrawal by Subject|0|||
155379045|NCT00759915|560820316|FG000|Overall Study|Adverse Event|0|||
155379046|NCT00759915|560820317|FG001|Overall Study|Adverse Event|1|||
155379047|NCT00932113|560820320|FG000|Overall Study|Lost to Follow-up|1|||
155379048|NCT00932113|560820321|FG001|Overall Study|Lost to Follow-up|0|||
155379049|NCT01773291|560820324|FG000|Overall Study|Protocol Violation|1|||
155379050|NCT01773291|560820325|FG001|Overall Study|Protocol Violation|0|||
155379051|NCT01773291|560820326|FG002|Overall Study|Protocol Violation|0|||
155379052|NCT01773291|560820324|FG000|Overall Study|Withdrawal by Subject|0|||
155379053|NCT01773291|560820325|FG001|Overall Study|Withdrawal by Subject|0|||
155379054|NCT01773291|560820326|FG002|Overall Study|Withdrawal by Subject|1|||
155379055|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
155379056|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
155379057|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
155379058|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
155379059|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
155379060|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
155379061|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
155379062|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
155379063|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
155379064|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
155379065|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
155379066|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
155379067|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
155379068|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
155650033|NCT03163264|561810244|FG003|Overall Study|Lost to Follow-up|0|||
155650034|NCT03163264|561810241|FG000|Overall Study|Death|0|||
155650035|NCT03163264|561810242|FG001|Overall Study|Death|2|||
155650036|NCT03163264|561810243|FG002|Overall Study|Death|0|||
155650037|NCT03163264|561810244|FG003|Overall Study|Death|0|||
155650038|NCT04648241|561810245|FG000|Overall Study|Lost to Follow-up|1|||
155650039|NCT04648241|561810246|FG001|Overall Study|Lost to Follow-up|0|||
155379069|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
155379070|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
155379071|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
155379072|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
155379073|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
155379074|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
155512469|NCT01688037|561301298|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
155650040|NCT02057666|561810247|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
155650041|NCT02057666|561810248|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
155379075|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
155379076|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
155379077|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
155379078|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
155379079|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
155379080|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
155379081|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
155379082|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
155379083|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
155379084|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
155379085|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
155379086|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
155379087|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
155379088|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
155379089|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
155379090|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
155379091|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
155379092|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
155379093|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
155379094|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
155379095|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
155379096|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
155379097|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
155379098|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
155379099|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
155379100|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
155379101|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
155379102|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
155379103|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
155379104|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
155379105|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
155379106|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
155512470|NCT01688037|561301299|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
155512471|NCT01688037|561301300|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
155512472|NCT01688037|561301298|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
155512473|NCT01688037|561301299|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
155512474|NCT01688037|561301300|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
155512475|NCT01688037|561301298|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
155512476|NCT01688037|561301299|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
155512477|NCT01688037|561301300|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
155512478|NCT01688037|561301298|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
155512479|NCT01688037|561301299|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
155512480|NCT01688037|561301300|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
155512481|NCT01688037|561301298|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
155512482|NCT01688037|561301299|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
155512483|NCT01688037|561301300|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
155512484|NCT03035227|561301301|FG000|Overall Study|study stopped due to PI leaving institut|1|||
155512485|NCT03035227|561301302|FG001|Overall Study|study stopped due to PI leaving institut|1|||
155512486|NCT02100956|561301303|FG000|At Least One Week Between Injections|Adverse Event|0|||
155512487|NCT02100956|561301304|FG001|At Least One Week Between Injections|Adverse Event|1|||
155512488|NCT02220907|561301305|FG000|Overall Study|Adverse Event|7|||
155512489|NCT02220907|561301305|FG000|Overall Study|Physician Decision|1|||
155512490|NCT02220907|561301305|FG000|Overall Study|Withdrawal by Subject|2|||
155512491|NCT02220907|561301305|FG000|Overall Study|Conflict with the stopping criteria|1|||
155512492|NCT01098240|561301310|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
155512493|NCT01098240|561301311|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
155650042|NCT02057666|561810247|FG000|Double Blind Treatment Period|Poor tolerability|7|||
155512494|NCT01098240|561301312|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
155512495|NCT01098240|561301310|FG000|Open-Label Phase|Protocol Violation|4|||
155512496|NCT01098240|561301311|FG001|Open-Label Phase|Protocol Violation|0|||
155512497|NCT01098240|561301312|FG002|Open-Label Phase|Protocol Violation|0|||
155512498|NCT01098240|561301310|FG000|Open-Label Phase|Lost to Follow-up|13|||
155512499|NCT01098240|561301311|FG001|Open-Label Phase|Lost to Follow-up|0|||
155512500|NCT01098240|561301312|FG002|Open-Label Phase|Lost to Follow-up|0|||
155431974|NCT02034123|561007816|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431975|NCT02034123|561007817|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
155431976|NCT00246259|561007818|FG000|Overall Study|Other|3|||
155431977|NCT00246259|561007819|FG001|Overall Study|Other|3|||
155431978|NCT00246259|561007818|FG000|Overall Study|Not stable by Week 18|2|||
155431979|NCT00246259|561007819|FG001|Overall Study|Not stable by Week 18|1|||
155431980|NCT00246259|561007818|FG000|Overall Study|Participant non-compliant|4|||
155431981|NCT00246259|561007819|FG001|Overall Study|Participant non-compliant|9|||
155379107|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
155379108|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
155379109|NCT01403610|560820330|FG000|Overall Study|Withdrawal by Subject|2|||
155379110|NCT01403610|560820331|FG001|Overall Study|Withdrawal by Subject|0|||
155379111|NCT01403610|560820332|FG002|Overall Study|Withdrawal by Subject|0|||
155379112|NCT01403610|560820333|FG003|Overall Study|Withdrawal by Subject|0|||
155379113|NCT01403610|560820330|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
155379114|NCT01403610|560820331|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
155379115|NCT01403610|560820332|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
155379116|NCT01403610|560820333|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
155379117|NCT00203476|560820334|FG000|Overall Study|Lost to Follow-up|1|||
155379118|NCT00203476|560820335|FG001|Overall Study|Lost to Follow-up|0|||
155379119|NCT00203476|560820336|FG002|Overall Study|Lost to Follow-up|0|||
155379120|NCT00203476|560820334|FG000|Overall Study|Withdrawal by Subject|0|||
155379121|NCT00203476|560820335|FG001|Overall Study|Withdrawal by Subject|1|||
155379122|NCT00203476|560820336|FG002|Overall Study|Withdrawal by Subject|0|||
155379123|NCT01190514|560820337|FG000|First Intervention (Period 1)|Adverse Event|1|||
155379124|NCT01190514|560820338|FG001|First Intervention (Period 1)|Adverse Event|0|||
155379125|NCT01190514|560820339|FG002|First Intervention (Period 1)|Adverse Event|0|||
155379126|NCT01190514|560820340|FG003|First Intervention (Period 1)|Adverse Event|0|||
155379127|NCT01190514|560820337|FG000|Third Intervention (Period 3)|Adverse Event|1|||
155379128|NCT01190514|560820338|FG001|Third Intervention (Period 3)|Adverse Event|0|||
155379129|NCT01190514|560820339|FG002|Third Intervention (Period 3)|Adverse Event|0|||
155379130|NCT01190514|560820340|FG003|Third Intervention (Period 3)|Adverse Event|0|||
155379131|NCT00512317|560820342|FG000|Overall Study|Insufficient clinical response|36|||
155379132|NCT00512317|560820342|FG000|Overall Study|Withdrawal by Subject|23|||
155379133|NCT00512317|560820342|FG000|Overall Study|Sponsor closure of study|21|||
155379134|NCT00512317|560820342|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
155379135|NCT00512317|560820342|FG000|Overall Study|Adverse Event|13|||
155379136|NCT00512317|560820342|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
155379137|NCT00512317|560820342|FG000|Overall Study|Lost to Follow-up|2|||
155379138|NCT00512317|560820342|FG000|Overall Study|Other|2|||
155379139|NCT01491672|560820343|FG000|Overall Study|Lost to Follow-up|0|||
155379140|NCT01491672|560820344|FG001|Overall Study|Lost to Follow-up|4|||
155379141|NCT01491672|560820345|FG002|Overall Study|Lost to Follow-up|1|||
155379142|NCT01491672|560820343|FG000|Overall Study|Withdrawal by Subject|6|||
155379143|NCT01491672|560820344|FG001|Overall Study|Withdrawal by Subject|7|||
155379144|NCT01491672|560820345|FG002|Overall Study|Withdrawal by Subject|0|||
155379145|NCT01491672|560820343|FG000|Overall Study|Adverse Event|8|||
155379146|NCT01491672|560820344|FG001|Overall Study|Adverse Event|10|||
155379147|NCT01491672|560820345|FG002|Overall Study|Adverse Event|4|||
155379148|NCT01491672|560820343|FG000|Overall Study|Disease progression|42|||
155379149|NCT01491672|560820344|FG001|Overall Study|Disease progression|34|||
155431982|NCT00246259|561007818|FG000|Overall Study|Lack of Efficacy|2|||
155431983|NCT00246259|561007819|FG001|Overall Study|Lack of Efficacy|2|||
155431984|NCT00246259|561007818|FG000|Overall Study|Investigator withdrew participant|2|||
155431985|NCT00246259|561007819|FG001|Overall Study|Investigator withdrew participant|0|||
155431986|NCT00246259|561007818|FG000|Overall Study|Adverse Event|5|||
155431987|NCT00246259|561007819|FG001|Overall Study|Adverse Event|0|||
155431988|NCT00246259|561007818|FG000|Overall Study|Lost to Follow-up|3|||
155431989|NCT00246259|561007819|FG001|Overall Study|Lost to Follow-up|4|||
155431990|NCT00246259|561007818|FG000|Overall Study|Withdrawal by Subject|5|||
155431991|NCT00246259|561007819|FG001|Overall Study|Withdrawal by Subject|1|||
155431992|NCT00246259|561007818|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
155431993|NCT00246259|561007819|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
155379150|NCT01491672|560820345|FG002|Overall Study|Disease progression|6|||
155379151|NCT01491672|560820343|FG000|Overall Study|Protocol deviation|0|||
155431994|NCT03133767|561007820|FG000|Overall Study|Lost to Follow-up|38|||
155431995|NCT03133767|561007821|FG001|Overall Study|Lost to Follow-up|24|||
155431996|NCT03133767|561007820|FG000|Overall Study|Protocol Violation|0|||
155379152|NCT01491672|560820344|FG001|Overall Study|Protocol deviation|1|||
155379153|NCT01491672|560820345|FG002|Overall Study|Protocol deviation|0|||
155379154|NCT01491672|560820343|FG000|Overall Study|Death|0|||
155379155|NCT01491672|560820344|FG001|Overall Study|Death|4|||
155379156|NCT01491672|560820345|FG002|Overall Study|Death|0|||
155379157|NCT03241225|560820348|FG000|Overall Study|Lost to Follow-up|2|||
155379158|NCT03241225|560820349|FG001|Overall Study|Lost to Follow-up|1|||
155379159|NCT03241225|560820348|FG000|Overall Study|Protocol Violation|4|||
155379160|NCT03241225|560820349|FG001|Overall Study|Protocol Violation|1|||
155379161|NCT03241225|560820348|FG000|Overall Study|Withdrawal by Subject|1|||
155379162|NCT03241225|560820349|FG001|Overall Study|Withdrawal by Subject|0|||
155379163|NCT00852540|560820350|FG000|Overall Study|Adverse Event|10|||
155379164|NCT00852540|560820351|FG001|Overall Study|Adverse Event|3|||
155379165|NCT00852540|560820350|FG000|Overall Study|Lack of Efficacy|15|||
155379166|NCT00852540|560820351|FG001|Overall Study|Lack of Efficacy|3|||
155379167|NCT00852540|560820350|FG000|Overall Study|Protocol Violation|1|||
155379168|NCT00852540|560820351|FG001|Overall Study|Protocol Violation|2|||
155379169|NCT00852540|560820350|FG000|Overall Study|Lost to Follow-up|2|||
155379170|NCT00852540|560820351|FG001|Overall Study|Lost to Follow-up|3|||
155379171|NCT00852540|560820350|FG000|Overall Study|Investigator Discretion|2|||
155379172|NCT00852540|560820351|FG001|Overall Study|Investigator Discretion|3|||
155379173|NCT00852540|560820350|FG000|Overall Study|Withdrawal by Subject|3|||
155379174|NCT00852540|560820351|FG001|Overall Study|Withdrawal by Subject|1|||
155379175|NCT00852540|560820350|FG000|Overall Study|Did Not Receive Study Drug|3|||
155379176|NCT00852540|560820351|FG001|Overall Study|Did Not Receive Study Drug|3|||
155379177|NCT03064035|560820355|FG000|Overall Study|Did not receive allocated intervention|4|||
155379178|NCT03064035|560820356|FG001|Overall Study|Did not receive allocated intervention|2|||
155379179|NCT03064035|560820355|FG000|Overall Study|Lost to Follow-up|1|||
155379180|NCT03064035|560820356|FG001|Overall Study|Lost to Follow-up|1|||
155379181|NCT01253304|560820359|FG000|Overall Study|Adverse Event|0|||
155379182|NCT01253304|560820360|FG001|Overall Study|Adverse Event|0|||
155379183|NCT01253304|560820361|FG002|Overall Study|Adverse Event|0|||
155379184|NCT01253304|560820362|FG003|Overall Study|Adverse Event|1|||
155379185|NCT01004848|560820364|FG000|Overall Study|Lost to Follow-up|55|||
155379186|NCT01004848|560820365|FG001|Overall Study|Lost to Follow-up|45|||
155379187|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
155379188|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379189|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379190|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379191|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379192|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379193|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
155379194|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379195|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379196|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379197|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379198|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379199|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
155379200|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379201|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379202|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379203|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379204|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379205|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
155379206|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379207|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379208|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379209|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379210|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379211|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
155379212|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379213|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379214|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379215|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379216|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379217|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
155379218|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379219|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379220|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379221|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379222|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155431997|NCT03133767|561007821|FG001|Overall Study|Protocol Violation|1|||
155431998|NCT04233424|561007822|FG000|Overall Study|Death|15|||
155379223|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
155379224|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379225|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379226|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379227|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379228|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379229|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
155379230|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379231|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379232|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379233|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379234|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379235|NCT01160289|560820366|FG000|Post-Randomization Period|Adverse Event|0|||
155379236|NCT01160289|560820367|FG001|Post-Randomization Period|Adverse Event|4|||
155379237|NCT01160289|560820368|FG002|Post-Randomization Period|Adverse Event|4|||
155379238|NCT01160289|560820369|FG003|Post-Randomization Period|Adverse Event|2|||
155379239|NCT01160289|560820370|FG004|Post-Randomization Period|Adverse Event|0|||
155379240|NCT01160289|560820371|FG005|Post-Randomization Period|Adverse Event|0|||
155379241|NCT01160289|560820366|FG000|Post-Randomization Period|Death|0|||
155379242|NCT01160289|560820367|FG001|Post-Randomization Period|Death|0|||
155379243|NCT01160289|560820368|FG002|Post-Randomization Period|Death|0|||
155379244|NCT01160289|560820369|FG003|Post-Randomization Period|Death|1|||
155379245|NCT01160289|560820370|FG004|Post-Randomization Period|Death|0|||
155379246|NCT01160289|560820371|FG005|Post-Randomization Period|Death|0|||
155379247|NCT01160289|560820366|FG000|Post-Randomization Period|Lack of Efficacy|0|||
155379248|NCT01160289|560820367|FG001|Post-Randomization Period|Lack of Efficacy|1|||
155379249|NCT01160289|560820368|FG002|Post-Randomization Period|Lack of Efficacy|0|||
155379250|NCT01160289|560820369|FG003|Post-Randomization Period|Lack of Efficacy|3|||
155379251|NCT01160289|560820370|FG004|Post-Randomization Period|Lack of Efficacy|0|||
155379252|NCT01160289|560820371|FG005|Post-Randomization Period|Lack of Efficacy|0|||
155379253|NCT01160289|560820366|FG000|Post-Randomization Period|Lost to Follow-up|0|||
155379254|NCT01160289|560820367|FG001|Post-Randomization Period|Lost to Follow-up|3|||
155379255|NCT01160289|560820368|FG002|Post-Randomization Period|Lost to Follow-up|2|||
155379256|NCT01160289|560820369|FG003|Post-Randomization Period|Lost to Follow-up|5|||
155379257|NCT01160289|560820370|FG004|Post-Randomization Period|Lost to Follow-up|3|||
155379258|NCT01160289|560820371|FG005|Post-Randomization Period|Lost to Follow-up|4|||
155379259|NCT01160289|560820366|FG000|Post-Randomization Period|Physician Decision|0|||
155379260|NCT01160289|560820367|FG001|Post-Randomization Period|Physician Decision|0|||
155379261|NCT01160289|560820368|FG002|Post-Randomization Period|Physician Decision|1|||
155379262|NCT01160289|560820369|FG003|Post-Randomization Period|Physician Decision|0|||
155379263|NCT01160289|560820370|FG004|Post-Randomization Period|Physician Decision|0|||
155379264|NCT01160289|560820371|FG005|Post-Randomization Period|Physician Decision|0|||
155379265|NCT01160289|560820366|FG000|Post-Randomization Period|Protocol Violation|0|||
155379266|NCT01160289|560820367|FG001|Post-Randomization Period|Protocol Violation|4|||
155379267|NCT01160289|560820368|FG002|Post-Randomization Period|Protocol Violation|2|||
155379268|NCT01160289|560820369|FG003|Post-Randomization Period|Protocol Violation|0|||
155379269|NCT01160289|560820370|FG004|Post-Randomization Period|Protocol Violation|1|||
155379270|NCT01160289|560820371|FG005|Post-Randomization Period|Protocol Violation|3|||
155379271|NCT01160289|560820366|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
155379272|NCT01160289|560820367|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
155379273|NCT01160289|560820368|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
155379274|NCT01160289|560820369|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
155379275|NCT01160289|560820370|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
155379276|NCT01160289|560820371|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
155379277|NCT01160289|560820366|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
155379278|NCT01160289|560820367|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
155379279|NCT01160289|560820368|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
155379280|NCT01160289|560820369|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
155379281|NCT01160289|560820370|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
155379282|NCT01160289|560820371|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
155379283|NCT01160289|560820366|FG000|Post-Randomization Period|Sponsor Decision|0|||
155379284|NCT01160289|560820367|FG001|Post-Randomization Period|Sponsor Decision|1|||
155379285|NCT01160289|560820368|FG002|Post-Randomization Period|Sponsor Decision|0|||
155431999|NCT04233424|561007823|FG001|Overall Study|Death|16|||
155432000|NCT04233424|561007822|FG000|Overall Study|Withdrawal by Subject|2|||
155432001|NCT04233424|561007823|FG001|Overall Study|Withdrawal by Subject|8|||
155379286|NCT01160289|560820369|FG003|Post-Randomization Period|Sponsor Decision|0|||
155379287|NCT01160289|560820370|FG004|Post-Randomization Period|Sponsor Decision|0|||
155379288|NCT01160289|560820371|FG005|Post-Randomization Period|Sponsor Decision|0|||
155379289|NCT01156792|560820376|FG000|Overall Study|Adverse Event|1|||
155379290|NCT01156792|560820376|FG000|Overall Study|Lack of Efficacy|36|||
155379291|NCT01156792|560820376|FG000|Overall Study|Protocol Violation|6|||
155379292|NCT01156792|560820376|FG000|Overall Study|Lost to Follow-up|3|||
155379293|NCT01156792|560820376|FG000|Overall Study|Physician Decision|3|||
155379294|NCT01156792|560820376|FG000|Overall Study|Withdrawal by Subject|9|||
155379295|NCT01156792|560820376|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
155379296|NCT00768079|560820377|FG000|Overall Study|Lost to Follow-up|2|||
155379297|NCT00768079|560820378|FG001|Overall Study|Lost to Follow-up|0|||
155379298|NCT00768079|560820379|FG002|Overall Study|Lost to Follow-up|4|||
155379299|NCT00768079|560820377|FG000|Overall Study|Participant incarcerated|0|||
155379300|NCT00768079|560820378|FG001|Overall Study|Participant incarcerated|1|||
155379301|NCT00768079|560820379|FG002|Overall Study|Participant incarcerated|0|||
155379302|NCT00564889|560820382|FG000|Overall Study|Death|7|||
155379303|NCT00564889|560820382|FG000|Overall Study|Adverse Event|12|||
155379304|NCT00564889|560820382|FG000|Overall Study|Alternative treatment|3|||
155379305|NCT00564889|560820382|FG000|Overall Study|Disease progression|3|||
155379306|NCT00564889|560820382|FG000|Overall Study|Other, not specified|4|||
155379307|NCT00141219|560820384|FG000|Overall Study|Protocol violations|5|||
155379308|NCT00141219|560820385|FG001|Overall Study|Protocol violations|4|||
155379309|NCT00141219|560820384|FG000|Overall Study|Adverse Event|8|||
155379310|NCT00141219|560820385|FG001|Overall Study|Adverse Event|6|||
155379311|NCT00141219|560820384|FG000|Overall Study|Lack of Efficacy|5|||
155379312|NCT00141219|560820385|FG001|Overall Study|Lack of Efficacy|4|||
155379313|NCT00141219|560820384|FG000|Overall Study|Withdrawal by Subject|6|||
155379314|NCT00141219|560820385|FG001|Overall Study|Withdrawal by Subject|2|||
155379315|NCT01577745|560820387|FG000|Overall Study|Withdrawal by Subject|0|||
155379316|NCT01577745|560820388|FG001|Overall Study|Withdrawal by Subject|1|||
155379317|NCT01577745|560820389|FG002|Overall Study|Withdrawal by Subject|0|||
155379318|NCT01577745|560820390|FG003|Overall Study|Withdrawal by Subject|3|||
155379319|NCT01577745|560820391|FG004|Overall Study|Withdrawal by Subject|2|||
155379320|NCT01577745|560820392|FG005|Overall Study|Withdrawal by Subject|0|||
155379321|NCT01577745|560820387|FG000|Overall Study|Death|3|||
155379322|NCT01577745|560820388|FG001|Overall Study|Death|2|||
155379323|NCT01577745|560820389|FG002|Overall Study|Death|2|||
155379324|NCT01577745|560820390|FG003|Overall Study|Death|1|||
155379325|NCT01577745|560820391|FG004|Overall Study|Death|1|||
155379326|NCT01577745|560820392|FG005|Overall Study|Death|3|||
155379327|NCT01577745|560820387|FG000|Overall Study|Physician Decision|0|||
155379328|NCT01577745|560820388|FG001|Overall Study|Physician Decision|0|||
155379329|NCT01577745|560820389|FG002|Overall Study|Physician Decision|0|||
155379330|NCT01577745|560820390|FG003|Overall Study|Physician Decision|1|||
155379331|NCT01577745|560820391|FG004|Overall Study|Physician Decision|1|||
155379332|NCT01577745|560820392|FG005|Overall Study|Physician Decision|0|||
155379333|NCT01577745|560820387|FG000|Overall Study|Lost to Follow-up|0|||
155379334|NCT01577745|560820388|FG001|Overall Study|Lost to Follow-up|0|||
155379335|NCT01577745|560820389|FG002|Overall Study|Lost to Follow-up|0|||
155379336|NCT01577745|560820390|FG003|Overall Study|Lost to Follow-up|0|||
155379337|NCT01577745|560820391|FG004|Overall Study|Lost to Follow-up|0|||
155379338|NCT01577745|560820392|FG005|Overall Study|Lost to Follow-up|1|||
155379339|NCT01577745|560820387|FG000|Overall Study|Alternative Therapy|0|||
155379340|NCT01577745|560820388|FG001|Overall Study|Alternative Therapy|0|||
155379341|NCT01577745|560820389|FG002|Overall Study|Alternative Therapy|0|||
155379342|NCT01577745|560820390|FG003|Overall Study|Alternative Therapy|1|||
155379343|NCT01577745|560820391|FG004|Overall Study|Alternative Therapy|1|||
155379344|NCT01577745|560820392|FG005|Overall Study|Alternative Therapy|0|||
155379345|NCT01324440|560820395|FG000|Overall Study|Subject moved|0|||
155379346|NCT01324440|560820396|FG001|Overall Study|Subject moved|1|||
155379347|NCT02884908|560820397|FG000|Overall Study|Lost to Follow-up|13|||
155379348|NCT02884908|560820398|FG001|Overall Study|Lost to Follow-up|18|||
155379349|NCT01801735|560820402|FG000|Overall Study|Adverse Event|79|||
155379350|NCT01801735|560820402|FG000|Overall Study|Lack of Efficacy|28|||
155379351|NCT01801735|560820402|FG000|Overall Study|Withdrawal by Subject|27|||
155379352|NCT01801735|560820402|FG000|Overall Study|Protocol Violation|25|||
155379353|NCT01801735|560820402|FG000|Overall Study|Lost to Follow-up|15|||
155379354|NCT01801735|560820402|FG000|Overall Study|Non-compliance with Trial Drug|13|||
155379355|NCT01801735|560820402|FG000|Overall Study|Physician Decision|3|||
155379356|NCT01801735|560820402|FG000|Overall Study|Death|1|||
155379357|NCT01801735|560820402|FG000|Overall Study|Other, including site closure|19|||
155379358|NCT01293487|560820404|FG000|Overall Study|Lost to Follow-up|0|||
155379359|NCT01293487|560820405|FG001|Overall Study|Lost to Follow-up|0|||
155379360|NCT01293487|560820406|FG002|Overall Study|Lost to Follow-up|0|||
155379361|NCT01293487|560820407|FG003|Overall Study|Lost to Follow-up|1|||
155379362|NCT01293487|560820408|FG004|Overall Study|Lost to Follow-up|0|||
155379363|NCT01293487|560820409|FG005|Overall Study|Lost to Follow-up|0|||
155379364|NCT01293487|560820410|FG006|Overall Study|Lost to Follow-up|0|||
155379365|NCT01293487|560820411|FG007|Overall Study|Lost to Follow-up|0|||
155379366|NCT01293487|560820404|FG000|Overall Study|Withdrawal by Subject|0|||
155379367|NCT01293487|560820405|FG001|Overall Study|Withdrawal by Subject|0|||
155379368|NCT01293487|560820406|FG002|Overall Study|Withdrawal by Subject|0|||
155379369|NCT01293487|560820407|FG003|Overall Study|Withdrawal by Subject|0|||
155379370|NCT01293487|560820408|FG004|Overall Study|Withdrawal by Subject|0|||
155379371|NCT01293487|560820409|FG005|Overall Study|Withdrawal by Subject|0|||
155379372|NCT01293487|560820410|FG006|Overall Study|Withdrawal by Subject|0|||
155379373|NCT01293487|560820411|FG007|Overall Study|Withdrawal by Subject|2|||
155379374|NCT02703259|560820413|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
155379375|NCT02703259|560820414|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
155379376|NCT02703259|560820413|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
155379377|NCT02703259|560820414|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
155379378|NCT02703259|560820413|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
155379379|NCT02703259|560820414|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
155379380|NCT00287690|560820415|FG000|Overall Study|Protocol Violation|20|||
155379381|NCT00287690|560820416|FG001|Overall Study|Protocol Violation|26|||
155379382|NCT01146782|560820417|FG000|Screening Cohort|Screen Failure|187|||
155379383|NCT01146782|560820417|FG000|Screening Cohort|Lost to Follow-up|4|||
155379384|NCT01146782|560820417|FG000|Screening Cohort|Physician Decision|1|||
155379385|NCT01146782|560820417|FG000|Screening Cohort|Withdrawal by Subject|29|||
155379386|NCT01146782|560820417|FG000|Safety Cohort|Screen Failure|61|||
155379387|NCT01146782|560820417|FG000|Safety Cohort|Withdrawal by Subject|4|||
155379388|NCT01146782|560820417|FG000|Safety Cohort|Control AHI <5|4|||
155379389|NCT01146782|560820417|FG000|Safety Cohort|TST <4 hrs|14|||
155379390|NCT01146782|560820417|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
155379391|NCT01146782|560820417|FG000|Primary Endpoint Cohort|Physician Decision|1|||
155379392|NCT02414932|560820418|FG000|Overall Study|Withdrawal by Subject|2|||
155379393|NCT02414932|560820419|FG001|Overall Study|Withdrawal by Subject|3|||
155379394|NCT02414932|560820418|FG000|Overall Study|Adverse Event|1|||
155379395|NCT02414932|560820419|FG001|Overall Study|Adverse Event|0|||
155379396|NCT00470366|560820420|FG000|Overall Study|Adverse Event|3|||
155379397|NCT00470366|560820420|FG000|Overall Study|Poor compliance|1|||
155379398|NCT01021215|560820421|FG000|Overall Study|Lost to Follow-up|3|||
155379399|NCT01021215|560820422|FG001|Overall Study|Lost to Follow-up|0|||
155379400|NCT01688830|560820423|FG000|Overall Study|Lost to Follow-up|0|||
155512501|NCT01098240|561301310|FG000|Open-Label Phase|Other|19|||
155512502|NCT01098240|561301311|FG001|Open-Label Phase|Other|0|||
155512503|NCT01098240|561301312|FG002|Open-Label Phase|Other|0|||
155512504|NCT01098240|561301310|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
155512505|NCT01098240|561301311|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155512506|NCT01098240|561301312|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155512507|NCT01098240|561301310|FG000|Open-Label Phase|Pregnancy|1|||
155512508|NCT01098240|561301311|FG001|Open-Label Phase|Pregnancy|0|||
155512509|NCT01098240|561301312|FG002|Open-Label Phase|Pregnancy|0|||
155512510|NCT01098240|561301310|FG000|Open-Label Phase|Withdrawal by Subject|9|||
155512511|NCT01098240|561301311|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155512512|NCT01098240|561301312|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155512513|NCT01098240|561301310|FG000|Open-Label Phase|Adverse Event|12|||
155512514|NCT01098240|561301311|FG001|Open-Label Phase|Adverse Event|0|||
155512515|NCT01098240|561301312|FG002|Open-Label Phase|Adverse Event|0|||
155512516|NCT01098240|561301310|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
155512517|NCT01098240|561301311|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
155512518|NCT01098240|561301312|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
155512519|NCT01098240|561301310|FG000|Double-Blind Phase|Protocol Violation|0|||
155379401|NCT01688830|560820424|FG001|Overall Study|Lost to Follow-up|0|||
155379402|NCT01688830|560820425|FG002|Overall Study|Lost to Follow-up|0|||
155379403|NCT01688830|560820426|FG003|Overall Study|Lost to Follow-up|0|||
155512520|NCT01098240|561301311|FG001|Double-Blind Phase|Protocol Violation|2|||
155512521|NCT01098240|561301312|FG002|Double-Blind Phase|Protocol Violation|4|||
155512522|NCT01098240|561301310|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155379404|NCT01688830|560820427|FG004|Overall Study|Lost to Follow-up|0|||
155379405|NCT01688830|560820428|FG005|Overall Study|Lost to Follow-up|0|||
155379406|NCT01688830|560820429|FG006|Overall Study|Lost to Follow-up|0|||
155379407|NCT01688830|560820430|FG007|Overall Study|Lost to Follow-up|0|||
155379408|NCT01688830|560820431|FG008|Overall Study|Lost to Follow-up|0|||
155379409|NCT01688830|560820432|FG009|Overall Study|Lost to Follow-up|0|||
155379410|NCT01688830|560820433|FG010|Overall Study|Lost to Follow-up|1|||
155512523|NCT01098240|561301311|FG001|Double-Blind Phase|Lost to Follow-up|2|||
155512524|NCT01098240|561301312|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155512525|NCT01098240|561301310|FG000|Double-Blind Phase|Other|0|||
155512526|NCT01098240|561301311|FG001|Double-Blind Phase|Other|2|||
155512527|NCT01098240|561301312|FG002|Double-Blind Phase|Other|2|||
155512528|NCT01098240|561301310|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
155512529|NCT01098240|561301311|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
155512530|NCT01098240|561301312|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
155512531|NCT01098240|561301310|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
155379411|NCT01688830|560820434|FG011|Overall Study|Lost to Follow-up|0|||
155379412|NCT01688830|560820435|FG012|Overall Study|Lost to Follow-up|0|||
155432002|NCT04233424|561007822|FG000|Overall Study|Physician Decision|1|||
155432003|NCT04233424|561007823|FG001|Overall Study|Physician Decision|3|||
155432004|NCT04233424|561007822|FG000|Overall Study|Protocol Violation|3|||
155432005|NCT04233424|561007823|FG001|Overall Study|Protocol Violation|1|||
155432006|NCT04233424|561007822|FG000|Overall Study|Lost to Follow-up|1|||
155432007|NCT04233424|561007823|FG001|Overall Study|Lost to Follow-up|3|||
155432008|NCT04233424|561007822|FG000|Overall Study|subject refuse to visit site|2|||
155432009|NCT04233424|561007823|FG001|Overall Study|subject refuse to visit site|0|||
155432010|NCT02698189|561007824|FG000|Overall Study|Physician Decision|3|||
155432011|NCT02698189|561007825|FG001|Overall Study|Physician Decision|0|||
155432012|NCT02698189|561007824|FG000|Overall Study|Progressive disease|0|||
155432013|NCT02698189|561007825|FG001|Overall Study|Progressive disease|5|||
155432014|NCT02698189|561007824|FG000|Overall Study|Study terminated by sponsor|0|||
155432015|NCT02698189|561007825|FG001|Overall Study|Study terminated by sponsor|1|||
155432016|NCT02240706|561007826|FG000|Overall Study|Lack of Efficacy|2|||
155432017|NCT02240706|561007827|FG001|Overall Study|Lack of Efficacy|2|||
155432018|NCT02240706|561007828|FG002|Overall Study|Lack of Efficacy|2|||
155432019|NCT02240706|561007829|FG003|Overall Study|Lack of Efficacy|2|||
155432020|NCT02240706|561007830|FG004|Overall Study|Lack of Efficacy|5|||
155432021|NCT02240706|561007831|FG005|Overall Study|Lack of Efficacy|0|||
155432022|NCT02240706|561007832|FG006|Overall Study|Lack of Efficacy|0|||
155432023|NCT02240706|561007826|FG000|Overall Study|Adverse Event|1|||
155432024|NCT02240706|561007827|FG001|Overall Study|Adverse Event|0|||
155432025|NCT02240706|561007828|FG002|Overall Study|Adverse Event|1|||
155432026|NCT02240706|561007829|FG003|Overall Study|Adverse Event|0|||
155432027|NCT02240706|561007830|FG004|Overall Study|Adverse Event|2|||
155432028|NCT02240706|561007831|FG005|Overall Study|Adverse Event|0|||
155432029|NCT02240706|561007832|FG006|Overall Study|Adverse Event|0|||
155432030|NCT02240706|561007826|FG000|Overall Study|Progressive disease|0|||
155432031|NCT02240706|561007827|FG001|Overall Study|Progressive disease|0|||
155432032|NCT02240706|561007828|FG002|Overall Study|Progressive disease|0|||
155432033|NCT02240706|561007829|FG003|Overall Study|Progressive disease|0|||
155432034|NCT02240706|561007830|FG004|Overall Study|Progressive disease|1|||
155432035|NCT02240706|561007831|FG005|Overall Study|Progressive disease|0|||
155432036|NCT02240706|561007832|FG006|Overall Study|Progressive disease|0|||
155432037|NCT02240706|561007826|FG000|Overall Study|Dose limiting toxicity|0|||
155432038|NCT02240706|561007827|FG001|Overall Study|Dose limiting toxicity|0|||
155432039|NCT02240706|561007828|FG002|Overall Study|Dose limiting toxicity|0|||
155432040|NCT02240706|561007829|FG003|Overall Study|Dose limiting toxicity|0|||
155432041|NCT02240706|561007830|FG004|Overall Study|Dose limiting toxicity|1|||
155432042|NCT02240706|561007831|FG005|Overall Study|Dose limiting toxicity|0|||
155432043|NCT02240706|561007832|FG006|Overall Study|Dose limiting toxicity|0|||
155432044|NCT02240706|561007826|FG000|Overall Study|Refused to continue taking medication|0|||
155432045|NCT02240706|561007827|FG001|Overall Study|Refused to continue taking medication|1|||
155432046|NCT02240706|561007828|FG002|Overall Study|Refused to continue taking medication|3|||
155432047|NCT02240706|561007829|FG003|Overall Study|Refused to continue taking medication|1|||
155432048|NCT02240706|561007830|FG004|Overall Study|Refused to continue taking medication|2|||
155432049|NCT02240706|561007831|FG005|Overall Study|Refused to continue taking medication|0|||
155432050|NCT02240706|561007832|FG006|Overall Study|Refused to continue taking medication|0|||
155432051|NCT02240706|561007826|FG000|Overall Study|Insurance billing concerns|0|||
155432052|NCT02240706|561007827|FG001|Overall Study|Insurance billing concerns|0|||
155432053|NCT02240706|561007828|FG002|Overall Study|Insurance billing concerns|0|||
155432054|NCT02240706|561007829|FG003|Overall Study|Insurance billing concerns|1|||
155432055|NCT02240706|561007830|FG004|Overall Study|Insurance billing concerns|0|||
155432056|NCT02240706|561007831|FG005|Overall Study|Insurance billing concerns|0|||
155432057|NCT02240706|561007832|FG006|Overall Study|Insurance billing concerns|0|||
155432058|NCT03301857|561007833|FG000|Overall Study|Death|0|||
155432059|NCT03301857|561007834|FG001|Overall Study|Death|2|||
155432060|NCT03301857|561007833|FG000|Overall Study|Lost to Follow-up|4|||
155432061|NCT03301857|561007834|FG001|Overall Study|Lost to Follow-up|2|||
155432062|NCT03301857|561007833|FG000|Overall Study|Decision by Sponsor|6|||
155432063|NCT03301857|561007834|FG001|Overall Study|Decision by Sponsor|0|||
155432064|NCT03301857|561007833|FG000|Overall Study|Withdrawal by Subject|12|||
155432065|NCT03301857|561007834|FG001|Overall Study|Withdrawal by Subject|4|||
155432066|NCT05502289|561007852|FG000|Period 1|Out Of Window|1|||
155432067|NCT05502289|561007853|FG001|Period 1|Out Of Window|0|||
155432068|NCT01564784|561007861|FG000|Overall Study|Other|1|||
155432069|NCT01564784|561007862|FG001|Overall Study|Other|0|||
155432070|NCT01564784|561007861|FG000|Overall Study|Subject refused further follow-up|1|||
155432071|NCT01564784|561007862|FG001|Overall Study|Subject refused further follow-up|6|||
155432072|NCT01564784|561007861|FG000|Overall Study|Lost to Follow-up|1|||
155432073|NCT01564784|561007862|FG001|Overall Study|Lost to Follow-up|1|||
155432074|NCT01564784|561007861|FG000|Overall Study|Death|131|||
155432075|NCT01564784|561007862|FG001|Overall Study|Death|126|||
155432076|NCT05300087|561007863|FG000|Overall Study|Withdrawal by Subject|0|||
155432077|NCT05300087|561007864|FG001|Overall Study|Withdrawal by Subject|1|||
155432078|NCT01126580|561007865|FG000|Overall Study|Adverse Event|14|||
155432079|NCT01126580|561007866|FG001|Overall Study|Adverse Event|8|||
155512532|NCT01098240|561301311|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
155512533|NCT01098240|561301312|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
155512534|NCT01098240|561301310|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155512535|NCT01098240|561301311|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
155512536|NCT01098240|561301312|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
155512537|NCT01098240|561301310|FG000|Double-Blind Phase|Adverse Event|0|||
155512538|NCT01098240|561301311|FG001|Double-Blind Phase|Adverse Event|3|||
155512539|NCT01098240|561301312|FG002|Double-Blind Phase|Adverse Event|3|||
155512540|NCT03280537|561301313|FG000|Overall Study|Withdrawal by Subject|2|||
155512541|NCT03280537|561301314|FG001|Overall Study|Withdrawal by Subject|4|||
155512542|NCT01588106|561301315|FG000|Overall Study|Withdrawal by Subject|5|||
155512543|NCT01588106|561301316|FG001|Overall Study|Withdrawal by Subject|4|||
155512544|NCT03083132|561301317|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
155512545|NCT03083132|561301318|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
155512546|NCT03083132|561301317|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
155512547|NCT03083132|561301318|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
155512548|NCT03083132|561301317|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
155512549|NCT03083132|561301318|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
155512550|NCT02995837|561301319|FG000|Overall Study|Lost to Follow-up|9|||
155512551|NCT02995837|561301320|FG001|Overall Study|Lost to Follow-up|8|||
155512552|NCT03118739|561301321|FG000|Overall Study|Physician Decision|0|||
155512553|NCT03118739|561301322|FG001|Overall Study|Physician Decision|1|||
155512554|NCT03118739|561301321|FG000|Overall Study|Withdrawal by Subject|5|||
155512555|NCT03118739|561301322|FG001|Overall Study|Withdrawal by Subject|3|||
155512556|NCT03118739|561301321|FG000|Overall Study|Lost to Follow-up|2|||
155512557|NCT03118739|561301322|FG001|Overall Study|Lost to Follow-up|0|||
155512558|NCT01859702|561301323|FG000|Overall Study|Protocol deviation|3|||
155512559|NCT01859702|561301323|FG000|Overall Study|Adverse Event|2|||
155512560|NCT01893138|561301324|FG000|Double-Blind Period|Withdrawal by Subject|1|||
155512561|NCT01893138|561301325|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155512562|NCT01893138|561301324|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
155512563|NCT01893138|561301325|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
155512564|NCT01893138|561301324|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
155512565|NCT01893138|561301325|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
155512566|NCT01893138|561301324|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
155512567|NCT01893138|561301325|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
155512568|NCT01893138|561301324|FG000|Open Label - Unblinded Period|Adverse Event|1|||
155512569|NCT01893138|561301325|FG001|Open Label - Unblinded Period|Adverse Event|0|||
155512570|NCT01326026|561301326|FG000|Overall Study|Adverse Event|4|||
155512571|NCT01326026|561301327|FG001|Overall Study|Adverse Event|3|||
155512572|NCT01326026|561301326|FG000|Overall Study|Withdrawal Criteria|5|||
155512573|NCT01326026|561301327|FG001|Overall Study|Withdrawal Criteria|7|||
155512574|NCT01326026|561301326|FG000|Overall Study|Other|3|||
155512575|NCT01326026|561301327|FG001|Overall Study|Other|3|||
155512576|NCT04317053|561301331|FG000|Overall Study|Withdrawn (screen failure)|4|||
155512577|NCT04317053|561301332|FG001|Overall Study|Withdrawn (screen failure)|2|||
155512578|NCT00289458|561301333|FG000|Overall Study|Death|1|||
155512579|NCT00289458|561301334|FG001|Overall Study|Death|0|||
155512580|NCT00289458|561301335|FG002|Overall Study|Death|0|||
155512581|NCT00289458|561301333|FG000|Overall Study|Physician Decision|3|||
155512582|NCT00289458|561301334|FG001|Overall Study|Physician Decision|4|||
155512583|NCT00289458|561301335|FG002|Overall Study|Physician Decision|2|||
155512584|NCT00289458|561301333|FG000|Overall Study|Withdrawal by Subject|2|||
155512585|NCT00289458|561301334|FG001|Overall Study|Withdrawal by Subject|2|||
155512586|NCT00289458|561301335|FG002|Overall Study|Withdrawal by Subject|4|||
155512587|NCT04274192|561301336|FG000|Overall Study|Protocol Violation|1|||
155512588|NCT04274192|561301337|FG001|Overall Study|Protocol Violation|0|||
155512589|NCT00874757|561301338|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
155512590|NCT01132118|561302621|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
155512591|NCT01132118|561302622|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
155512592|NCT01132118|561302621|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155512593|NCT01132118|561302622|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
155512594|NCT01132118|561302621|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
155512595|NCT01132118|561302622|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
155512596|NCT00313703|561302624|FG000|Overall Study|Lost to Follow-up|11|||
155512597|NCT00313703|561302625|FG001|Overall Study|Lost to Follow-up|2|||
155512598|NCT00313703|561302626|FG002|Overall Study|Lost to Follow-up|5|||
155512599|NCT00313703|561302627|FG003|Overall Study|Lost to Follow-up|12|||
155512600|NCT01060670|561302628|FG000|Run In|screen failure|0|||
155512601|NCT01060670|561302629|FG001|Run In|screen failure|238|||
155512602|NCT00094302|561302630|FG000|Overall Study|Lost to Follow-up|43|||
155512603|NCT00094302|561302631|FG001|Overall Study|Lost to Follow-up|41|||
155512604|NCT00094302|561302630|FG000|Overall Study|Physician Decision|5|||
155379413|NCT01688830|560820436|FG013|Overall Study|Lost to Follow-up|0|||
155379414|NCT01688830|560820437|FG014|Overall Study|Lost to Follow-up|0|||
155379415|NCT01688830|560820438|FG015|Overall Study|Lost to Follow-up|0|||
155379416|NCT01688830|560820439|FG016|Overall Study|Lost to Follow-up|0|||
155379417|NCT01688830|560820440|FG017|Overall Study|Lost to Follow-up|0|||
155379418|NCT01688830|560820441|FG018|Overall Study|Lost to Follow-up|0|||
155379419|NCT01688830|560820442|FG019|Overall Study|Lost to Follow-up|0|||
155379420|NCT01688830|560820443|FG020|Overall Study|Lost to Follow-up|0|||
155379421|NCT04822597|560820444|FG000|Overall Study|Withdrawal by Subject|0|||
155379422|NCT04822597|560820445|FG001|Overall Study|Withdrawal by Subject|1|||
155379423|NCT04822597|560820446|FG002|Overall Study|Withdrawal by Subject|1|||
155379424|NCT04822597|560820447|FG003|Overall Study|Withdrawal by Subject|0|||
155379425|NCT04822597|560820444|FG000|Overall Study|Physician Decision|0|||
155379426|NCT04822597|560820445|FG001|Overall Study|Physician Decision|0|||
155379427|NCT04822597|560820446|FG002|Overall Study|Physician Decision|1|||
155379428|NCT04822597|560820447|FG003|Overall Study|Physician Decision|1|||
155379429|NCT04822597|560820444|FG000|Overall Study|Subject withdrawn after enrollment|0|||
155379430|NCT04822597|560820445|FG001|Overall Study|Subject withdrawn after enrollment|1|||
155379431|NCT04822597|560820446|FG002|Overall Study|Subject withdrawn after enrollment|0|||
155379432|NCT04822597|560820447|FG003|Overall Study|Subject withdrawn after enrollment|1|||
155379433|NCT04822597|560820444|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
155379434|NCT04822597|560820445|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379435|NCT04822597|560820446|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379436|NCT04822597|560820447|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379437|NCT00591851|560820448|FG000|Overall Study|Withdrawal by Subject|3|||
155379438|NCT00591851|560820448|FG000|Overall Study|Adverse Event|2|||
155379439|NCT00591851|560820448|FG000|Overall Study|Progressive Disease|1|||
155379440|NCT02217501|560820454|FG000|Overall Study|Death|3|||
155379441|NCT02217501|560820455|FG001|Overall Study|Death|4|||
155379442|NCT01942785|560820459|FG000|Overall Study|Adverse Event|2|||
155379443|NCT01942785|560820459|FG000|Overall Study|Withdrawal by Subject|1|||
155379444|NCT01942785|560820459|FG000|Overall Study|Protocol Violation|1|||
155432080|NCT01126580|561007867|FG002|Overall Study|Adverse Event|12|||
155432081|NCT01126580|561007865|FG000|Overall Study|Withdrawal by Subject|11|||
155432082|NCT01126580|561007866|FG001|Overall Study|Withdrawal by Subject|19|||
155432083|NCT01126580|561007867|FG002|Overall Study|Withdrawal by Subject|14|||
155432084|NCT01126580|561007865|FG000|Overall Study|Sponsor Decision|5|||
155432085|NCT01126580|561007866|FG001|Overall Study|Sponsor Decision|4|||
155432086|NCT01126580|561007867|FG002|Overall Study|Sponsor Decision|7|||
155432087|NCT01126580|561007865|FG000|Overall Study|Physician Decision|1|||
155432088|NCT01126580|561007866|FG001|Overall Study|Physician Decision|1|||
155432089|NCT01126580|561007867|FG002|Overall Study|Physician Decision|2|||
155432090|NCT01126580|561007865|FG000|Overall Study|Entry Criteria Not Met|1|||
155432091|NCT01126580|561007866|FG001|Overall Study|Entry Criteria Not Met|1|||
155432092|NCT01126580|561007867|FG002|Overall Study|Entry Criteria Not Met|2|||
155432093|NCT01126580|561007865|FG000|Overall Study|Lack of Efficacy|2|||
155432094|NCT01126580|561007866|FG001|Overall Study|Lack of Efficacy|3|||
155432095|NCT01126580|561007867|FG002|Overall Study|Lack of Efficacy|4|||
155432096|NCT01126580|561007865|FG000|Overall Study|Protocol Violation|0|||
155432097|NCT01126580|561007866|FG001|Overall Study|Protocol Violation|1|||
155432098|NCT01126580|561007867|FG002|Overall Study|Protocol Violation|2|||
155432099|NCT01126580|561007865|FG000|Overall Study|Lost to Follow-up|15|||
155432100|NCT01126580|561007866|FG001|Overall Study|Lost to Follow-up|13|||
155432101|NCT01126580|561007867|FG002|Overall Study|Lost to Follow-up|9|||
155432102|NCT01126580|561007865|FG000|Overall Study|Treatment Non-compliance|0|||
155432103|NCT01126580|561007866|FG001|Overall Study|Treatment Non-compliance|2|||
155432104|NCT01126580|561007867|FG002|Overall Study|Treatment Non-compliance|3|||
155432105|NCT01731002|561007877|FG000|Overall Study|Adverse Event|0|||
155432106|NCT01731002|561007878|FG001|Overall Study|Adverse Event|2|||
155432107|NCT01731002|561007879|FG002|Overall Study|Adverse Event|2|||
155432108|NCT01731002|561007877|FG000|Overall Study|Non-Compliant|0|||
155432109|NCT01731002|561007878|FG001|Overall Study|Non-Compliant|1|||
155432110|NCT01731002|561007879|FG002|Overall Study|Non-Compliant|0|||
155432111|NCT01731002|561007877|FG000|Overall Study|Lost to Follow-up|1|||
155432112|NCT01731002|561007878|FG001|Overall Study|Lost to Follow-up|0|||
155432113|NCT01731002|561007879|FG002|Overall Study|Lost to Follow-up|0|||
155650043|NCT02057666|561810248|FG001|Double Blind Treatment Period|Poor tolerability|2|||
155432114|NCT01731002|561007877|FG000|Overall Study|Test Agent Discontinuation|0|||
155432115|NCT01731002|561007878|FG001|Overall Study|Test Agent Discontinuation|1|||
155432116|NCT01731002|561007879|FG002|Overall Study|Test Agent Discontinuation|0|||
155432117|NCT01731002|561007877|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
155432118|NCT01731002|561007878|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
155432119|NCT01731002|561007879|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
155432120|NCT01731002|561007877|FG000|Overall Study|Elevated IOP|1|||
155432121|NCT01731002|561007878|FG001|Overall Study|Elevated IOP|0|||
155432122|NCT01731002|561007879|FG002|Overall Study|Elevated IOP|0|||
155432123|NCT01731002|561007877|FG000|Overall Study|Inappropriate use of study medications|0|||
155432124|NCT01731002|561007878|FG001|Overall Study|Inappropriate use of study medications|0|||
155432125|NCT01731002|561007879|FG002|Overall Study|Inappropriate use of study medications|1|||
155432126|NCT00947349|561007882|FG000|Triple Treatment Combination Period|Adverse Event|0|||
155432127|NCT00947349|561007883|FG001|Triple Treatment Combination Period|Adverse Event|1|||
155432128|NCT00947349|561007884|FG002|Triple Treatment Combination Period|Adverse Event|0|||
155432129|NCT00947349|561007885|FG003|Triple Treatment Combination Period|Adverse Event|0|||
155432130|NCT00947349|561007882|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
155432131|NCT00947349|561007883|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
155432132|NCT00947349|561007884|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
155432133|NCT00947349|561007885|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
155432134|NCT00947349|561007882|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
155432135|NCT00947349|561007883|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
155432136|NCT00947349|561007884|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
155432137|NCT00947349|561007885|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
155432138|NCT00947349|561007882|FG000|Overall Study Standard of Care|Other|0|||
155432139|NCT00947349|561007883|FG001|Overall Study Standard of Care|Other|0|||
155432140|NCT00947349|561007884|FG002|Overall Study Standard of Care|Other|0|||
155432141|NCT00947349|561007885|FG003|Overall Study Standard of Care|Other|1|||
155432142|NCT00538681|561007886|FG000|Overall Study|Progressive Disease|7|||
155432143|NCT00538681|561007887|FG001|Overall Study|Progressive Disease|0|||
155432144|NCT00538681|561007888|FG002|Overall Study|Progressive Disease|1|||
155432145|NCT00538681|561007889|FG003|Overall Study|Progressive Disease|0|||
155432146|NCT00538681|561007886|FG000|Overall Study|Sponsor Decision|1|||
155432147|NCT00538681|561007887|FG001|Overall Study|Sponsor Decision|3|||
155432148|NCT00538681|561007888|FG002|Overall Study|Sponsor Decision|8|||
155432149|NCT00538681|561007889|FG003|Overall Study|Sponsor Decision|9|||
155432150|NCT00538681|561007886|FG000|Overall Study|Adverse Event|1|||
155432151|NCT00538681|561007887|FG001|Overall Study|Adverse Event|1|||
155432152|NCT00538681|561007888|FG002|Overall Study|Adverse Event|1|||
155432153|NCT00538681|561007889|FG003|Overall Study|Adverse Event|0|||
155432154|NCT00538681|561007886|FG000|Overall Study|Death|0|||
155432155|NCT00538681|561007887|FG001|Overall Study|Death|0|||
155432156|NCT00538681|561007888|FG002|Overall Study|Death|1|||
155432157|NCT00538681|561007889|FG003|Overall Study|Death|1|||
155432158|NCT00538681|561007886|FG000|Overall Study|Investigator Decision|0|||
155432159|NCT00538681|561007887|FG001|Overall Study|Investigator Decision|0|||
155432160|NCT00538681|561007888|FG002|Overall Study|Investigator Decision|0|||
155432161|NCT00538681|561007889|FG003|Overall Study|Investigator Decision|1|||
155432162|NCT02770807|561007891|FG000|Overall Study|Adverse Event|3|||
155432163|NCT02770807|561007892|FG001|Overall Study|Adverse Event|3|||
155432164|NCT02770807|561007893|FG002|Overall Study|Adverse Event|1|||
155432165|NCT02770807|561007891|FG000|Overall Study|Withdrawal by Subject|7|||
155432166|NCT02770807|561007892|FG001|Overall Study|Withdrawal by Subject|3|||
155432167|NCT02770807|561007893|FG002|Overall Study|Withdrawal by Subject|4|||
155432168|NCT02770807|561007891|FG000|Overall Study|Other|0|||
155432169|NCT02770807|561007892|FG001|Overall Study|Other|1|||
155432170|NCT02770807|561007893|FG002|Overall Study|Other|0|||
155432171|NCT02770807|561007891|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
155432172|NCT02770807|561007892|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
155432173|NCT02770807|561007893|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
155432174|NCT02770807|561007891|FG000|Overall Study|Physician Decision|0|||
155432175|NCT02770807|561007892|FG001|Overall Study|Physician Decision|0|||
155432176|NCT02770807|561007893|FG002|Overall Study|Physician Decision|1|||
155432177|NCT00222105|561007896|FG000|Overall Study|Removed due to wrong diagnosis|1|||
155432178|NCT00222105|561007896|FG000|Overall Study|Withdrawal by Subject|1|||
155432179|NCT00222105|561007896|FG000|Overall Study|Adverse Event|8|||
155432180|NCT00222105|561007896|FG000|Overall Study|Treatment delays|2|||
155432181|NCT00222105|561007896|FG000|Overall Study|Death|2|||
155432182|NCT00853632|561009827|FG000|Overall Study|Death|88|||
155432183|NCT00853632|561009827|FG000|Overall Study|Withdrawal by Subject|45|||
155432184|NCT00853632|561009827|FG000|Overall Study|Lost to Follow-up|30|||
155432185|NCT00853632|561009827|FG000|Overall Study|Reoperation/Explant|17|||
155432186|NCT00853632|561009827|FG000|Overall Study|Exit with other reason|22|||
155432187|NCT03528681|561009830|FG000|Open-Label Phase|Physician Decision|2|||
155432188|NCT03528681|561009831|FG001|Open-Label Phase|Physician Decision|0|||
155432189|NCT03528681|561009832|FG002|Open-Label Phase|Physician Decision|0|||
155432190|NCT03528681|561009833|FG003|Open-Label Phase|Physician Decision|0|||
155432191|NCT03528681|561009830|FG000|Open-Label Phase|Withdrawal by Subject|8|||
155432192|NCT03528681|561009831|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155432193|NCT03528681|561009832|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155432194|NCT03528681|561009833|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155432195|NCT03528681|561009830|FG000|Open-Label Phase|(Not collected)|4|||
155432196|NCT03528681|561009831|FG001|Open-Label Phase|(Not collected)|0|||
155512605|NCT00094302|561302631|FG001|Overall Study|Physician Decision|8|||
155512606|NCT00094302|561302630|FG000|Overall Study|Withdrawal by Subject|103|||
155512607|NCT00094302|561302631|FG001|Overall Study|Withdrawal by Subject|111|||
155512608|NCT00094302|561302630|FG000|Overall Study|Death|266|||
155512609|NCT00094302|561302631|FG001|Overall Study|Death|246|||
155512610|NCT01469364|561302641|FG000|Overall Study|Adverse Event|1|||
155512611|NCT01469364|561302641|FG000|Overall Study|Withdrawal by Subject|1|||
155512612|NCT00958256|561302647|FG000|Overall Study|Adverse Event|3|||
155512613|NCT05431153|561302649|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155512614|NCT05431153|561302650|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155512615|NCT05431153|561302651|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155512616|NCT05431153|561302652|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155512617|NCT05431153|561302653|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
155512618|NCT05431153|561302654|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155512619|NCT00576901|561302659|FG000|Overall Study|Withdrawal by Subject|1|||
155512620|NCT00576901|561302659|FG000|Overall Study|Disease course|1|||
155512621|NCT00576901|561302659|FG000|Overall Study|Protocol Violation|1|||
155512622|NCT01259869|561302660|FG000|Overall Study|Duplicated registration|1|||
155512623|NCT00220701|561302662|FG000|Overall Study|Lost to Follow-up|5|||
155512624|NCT00220701|561302663|FG001|Overall Study|Lost to Follow-up|4|||
155512625|NCT00634907|561302669|FG000|Overall Study|Withdrawal by Subject|3|||
155512626|NCT00634907|561302670|FG001|Overall Study|Withdrawal by Subject|0|||
155512627|NCT00634907|561302669|FG000|Overall Study|Physician Decision|3|||
155512628|NCT00634907|561302670|FG001|Overall Study|Physician Decision|9|||
155512629|NCT00634907|561302669|FG000|Overall Study|Withdrawal by Subject|11|||
155512630|NCT00634907|561302670|FG001|Overall Study|Withdrawal by Subject|8|||
155512631|NCT04041570|561302673|FG000|Overall Study|Moved from Area|0|||
155512632|NCT04041570|561302674|FG001|Overall Study|Moved from Area|2|||
155512633|NCT01338636|561302675|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
155512634|NCT02385526|561302676|FG000|Overall Study|Withdrawal by Subject|0|||
155512635|NCT02385526|561302677|FG001|Overall Study|Withdrawal by Subject|2|||
155512636|NCT02385526|561302678|FG002|Overall Study|Withdrawal by Subject|0|||
155512637|NCT02385526|561302676|FG000|Overall Study|Lost to Follow-up|0|||
155512638|NCT02385526|561302677|FG001|Overall Study|Lost to Follow-up|1|||
155512639|NCT02385526|561302678|FG002|Overall Study|Lost to Follow-up|0|||
155512640|NCT02385526|561302676|FG000|Overall Study|Physician Decision|1|||
155512641|NCT02385526|561302677|FG001|Overall Study|Physician Decision|0|||
155512642|NCT02385526|561302678|FG002|Overall Study|Physician Decision|0|||
155512643|NCT02385526|561302676|FG000|Overall Study|Protocol Violation|1|||
155512644|NCT02385526|561302677|FG001|Overall Study|Protocol Violation|0|||
155512645|NCT02385526|561302678|FG002|Overall Study|Protocol Violation|0|||
155512646|NCT03532009|561302681|FG000|Overall Study|Other|1|||
155512647|NCT03532009|561302682|FG001|Overall Study|Other|1|||
155512648|NCT03532009|561302681|FG000|Overall Study|Death|1|||
155512649|NCT03532009|561302682|FG001|Overall Study|Death|1|||
155512650|NCT03532009|561302681|FG000|Overall Study|Withdrawal by Patient|0|||
155512651|NCT03532009|561302682|FG001|Overall Study|Withdrawal by Patient|2|||
155512652|NCT02866175|561302683|FG000|Overall Study|Adverse Event|56|||
155512653|NCT02866175|561302684|FG001|Overall Study|Adverse Event|54|||
155512654|NCT02866175|561302683|FG000|Overall Study|Withdrawal by Subject|31|||
155512655|NCT02866175|561302684|FG001|Overall Study|Withdrawal by Subject|52|||
155512656|NCT02866175|561302683|FG000|Overall Study|Death|30|||
155512657|NCT02866175|561302684|FG001|Overall Study|Death|23|||
155512658|NCT02866175|561302683|FG000|Overall Study|Other|7|||
155512659|NCT02866175|561302684|FG001|Overall Study|Other|14|||
155512660|NCT02866175|561302683|FG000|Overall Study|Progressive disease|1|||
155512661|NCT02866175|561302684|FG001|Overall Study|Progressive disease|1|||
155512662|NCT02866175|561302683|FG000|Overall Study|Lost to Follow-up|2|||
155512663|NCT02866175|561302684|FG001|Overall Study|Lost to Follow-up|0|||
155512664|NCT02866175|561302683|FG000|Overall Study|Lack of Efficacy|0|||
155512665|NCT02866175|561302684|FG001|Overall Study|Lack of Efficacy|1|||
155512666|NCT02866175|561302683|FG000|Overall Study|Physician Decision|3|||
155512667|NCT02866175|561302684|FG001|Overall Study|Physician Decision|15|||
155512668|NCT02866175|561302683|FG000|Overall Study|Did not receive treatment|5|||
155512669|NCT02866175|561302684|FG001|Overall Study|Did not receive treatment|15|||
155512670|NCT00681863|561302690|FG000|Overall Study|Adverse Event|1|||
155512671|NCT00681863|561302690|FG000|Overall Study|Lost to Follow-up|2|||
155512672|NCT00681863|561302690|FG000|Overall Study|Lack of Efficacy|2|||
155512673|NCT00681863|561302690|FG000|Overall Study|Other|18|||
155512674|NCT01333033|561302691|FG000|Overall Study|Ineligible|0|||
155512675|NCT01333033|561302692|FG001|Overall Study|Ineligible|0|||
155512676|NCT01333033|561302693|FG002|Overall Study|Ineligible|0|||
155512677|NCT01333033|561302694|FG003|Overall Study|Ineligible|0|||
155512678|NCT01333033|561302695|FG004|Overall Study|Ineligible|6|||
155512679|NCT01333033|561302696|FG005|Overall Study|Ineligible|8|||
155512680|NCT01333033|561302691|FG000|Overall Study|Withdrawal by Subject|0|||
155512681|NCT01333033|561302692|FG001|Overall Study|Withdrawal by Subject|0|||
155512682|NCT01333033|561302693|FG002|Overall Study|Withdrawal by Subject|0|||
155512683|NCT01333033|561302694|FG003|Overall Study|Withdrawal by Subject|0|||
155512684|NCT01333033|561302695|FG004|Overall Study|Withdrawal by Subject|4|||
155432197|NCT03528681|561009832|FG002|Open-Label Phase|(Not collected)|0|||
155432198|NCT03528681|561009833|FG003|Open-Label Phase|(Not collected)|0|||
155432199|NCT03528681|561009830|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
155432200|NCT03528681|561009831|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
155432201|NCT03528681|561009832|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
155432202|NCT03528681|561009833|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
155432203|NCT03528681|561009830|FG000|Randomized Treatment Phase|Physician Decision|0|||
155432204|NCT03528681|561009831|FG001|Randomized Treatment Phase|Physician Decision|5|||
155432205|NCT03528681|561009832|FG002|Randomized Treatment Phase|Physician Decision|1|||
155432206|NCT03528681|561009833|FG003|Randomized Treatment Phase|Physician Decision|2|||
155432207|NCT03528681|561009830|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
155432208|NCT03528681|561009831|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
155432209|NCT03528681|561009832|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
155432210|NCT03528681|561009833|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
155432211|NCT03528681|561009830|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
155432212|NCT03528681|561009831|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
155432213|NCT03528681|561009832|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
155432214|NCT03528681|561009833|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
155432215|NCT03528681|561009830|FG000|Randomized Treatment Phase|(Not collected)|0|||
155432216|NCT03528681|561009831|FG001|Randomized Treatment Phase|(Not collected)|4|||
155432217|NCT03528681|561009832|FG002|Randomized Treatment Phase|(Not collected)|6|||
155432218|NCT03528681|561009833|FG003|Randomized Treatment Phase|(Not collected)|5|||
155432219|NCT02017444|561009838|FG000|Overall Study|Physician Decision|1|||
155432220|NCT02017444|561009839|FG001|Overall Study|Physician Decision|0|||
155432221|NCT02017444|561009838|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
155432222|NCT02017444|561009839|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
155432223|NCT02342171|561009842|FG000|Overall Study|Death|4|||
155432224|NCT02342171|561009843|FG001|Overall Study|Death|87|||
155432225|NCT02342171|561009842|FG000|Overall Study|Received favipiravir|10|||
155432226|NCT02342171|561009843|FG001|Overall Study|Received favipiravir|0|||
155432227|NCT02342171|561009842|FG000|Overall Study|Missing cycle treshold value|1|||
155432228|NCT02342171|561009843|FG001|Overall Study|Missing cycle treshold value|0|||
155432229|NCT02342171|561009842|FG000|Overall Study|Unknown outcome|0|||
155432230|NCT02342171|561009843|FG001|Overall Study|Unknown outcome|1|||
155432231|NCT02342171|561009842|FG000|Overall Study|Missing age data|0|||
155432232|NCT02342171|561009843|FG001|Overall Study|Missing age data|1|||
155432233|NCT00886821|561009848|FG000|Stage 2|Adverse Event|0|||
155432234|NCT00886821|561009849|FG001|Stage 2|Adverse Event|0|||
155432235|NCT00886821|561009850|FG002|Stage 2|Adverse Event|0|||
155432236|NCT00886821|561009851|FG003|Stage 2|Adverse Event|0|||
155432237|NCT00886821|561009852|FG004|Stage 2|Adverse Event|0|||
155432238|NCT00886821|561009853|FG005|Stage 2|Adverse Event|0|||
155432239|NCT00886821|561009854|FG006|Stage 2|Adverse Event|0|||
155432240|NCT00886821|561009855|FG007|Stage 2|Adverse Event|0|||
155432241|NCT00886821|561009856|FG008|Stage 2|Adverse Event|0|||
155432242|NCT00886821|561009857|FG009|Stage 2|Adverse Event|0|||
155432243|NCT00886821|561009858|FG010|Stage 2|Adverse Event|0|||
155432244|NCT00886821|561009859|FG011|Stage 2|Adverse Event|1|||
155432245|NCT00886821|561009860|FG012|Stage 2|Adverse Event|3|||
155432246|NCT00886821|561009861|FG013|Stage 2|Adverse Event|0|||
155432247|NCT00886821|561009848|FG000|Stage 2|Lost to Follow-up|0|||
155432248|NCT00886821|561009849|FG001|Stage 2|Lost to Follow-up|0|||
155432249|NCT00886821|561009850|FG002|Stage 2|Lost to Follow-up|0|||
155432250|NCT00886821|561009851|FG003|Stage 2|Lost to Follow-up|0|||
155432251|NCT00886821|561009852|FG004|Stage 2|Lost to Follow-up|0|||
155432252|NCT00886821|561009853|FG005|Stage 2|Lost to Follow-up|0|||
155432253|NCT00886821|561009854|FG006|Stage 2|Lost to Follow-up|0|||
155432254|NCT00886821|561009855|FG007|Stage 2|Lost to Follow-up|0|||
155432255|NCT00886821|561009856|FG008|Stage 2|Lost to Follow-up|0|||
155432256|NCT00886821|561009857|FG009|Stage 2|Lost to Follow-up|0|||
155432257|NCT00886821|561009858|FG010|Stage 2|Lost to Follow-up|0|||
155432258|NCT00886821|561009859|FG011|Stage 2|Lost to Follow-up|0|||
155432259|NCT00886821|561009860|FG012|Stage 2|Lost to Follow-up|2|||
155432260|NCT00886821|561009861|FG013|Stage 2|Lost to Follow-up|1|||
155432261|NCT04645797|561009862|FG000|Overall Study|Disease Progression|3|||
155432262|NCT04645797|561009863|FG001|Overall Study|Disease Progression|3|||
155432263|NCT04645797|561009864|FG002|Overall Study|Disease Progression|1|||
155432264|NCT04645797|561009865|FG003|Overall Study|Disease Progression|0|||
155432265|NCT04645797|561009866|FG004|Overall Study|Disease Progression|0|||
155432266|NCT04645797|561009867|FG005|Overall Study|Disease Progression|0|||
155432267|NCT04645797|561009868|FG006|Overall Study|Disease Progression|0|||
155432268|NCT04645797|561009862|FG000|Overall Study|Death|3|||
155432269|NCT04645797|561009863|FG001|Overall Study|Death|1|||
155432270|NCT04645797|561009864|FG002|Overall Study|Death|0|||
155432271|NCT04645797|561009865|FG003|Overall Study|Death|0|||
155432272|NCT04645797|561009866|FG004|Overall Study|Death|0|||
155432273|NCT04645797|561009867|FG005|Overall Study|Death|0|||
155432274|NCT04645797|561009868|FG006|Overall Study|Death|0|||
155432275|NCT03596164|561009869|FG000|Overall Study|Adverse Event|0|||
155432276|NCT03596164|561009870|FG001|Overall Study|Adverse Event|1|||
155432277|NCT03596164|561009869|FG000|Overall Study|Death|1|||
155432278|NCT03596164|561009870|FG001|Overall Study|Death|0|||
155432279|NCT00389207|561009871|FG000|Overall Study|Adverse Event|26|||
155432280|NCT00389207|561009872|FG001|Overall Study|Adverse Event|32|||
155432281|NCT00389207|561009873|FG002|Overall Study|Adverse Event|10|||
155432282|NCT00389207|561009871|FG000|Overall Study|Protocol Violation|3|||
155432283|NCT00389207|561009872|FG001|Overall Study|Protocol Violation|1|||
155432284|NCT00389207|561009873|FG002|Overall Study|Protocol Violation|4|||
155432285|NCT00389207|561009871|FG000|Overall Study|Lost to Follow-up|12|||
155432286|NCT00389207|561009872|FG001|Overall Study|Lost to Follow-up|9|||
155432287|NCT00389207|561009873|FG002|Overall Study|Lost to Follow-up|7|||
155432288|NCT00389207|561009871|FG000|Overall Study|Withdrawal by Subject|5|||
155432289|NCT00389207|561009872|FG001|Overall Study|Withdrawal by Subject|7|||
155432290|NCT00389207|561009873|FG002|Overall Study|Withdrawal by Subject|11|||
155432291|NCT00389207|561009871|FG000|Overall Study|Other|17|||
155432292|NCT00389207|561009872|FG001|Overall Study|Other|23|||
155432293|NCT00389207|561009873|FG002|Overall Study|Other|9|||
155432294|NCT02500550|561009879|FG000|Overall Study|Death|7|||
155432295|NCT03293680|561009880|FG000|Overall Study|Death|1|||
155432296|NCT03293680|561009880|FG000|Overall Study|Did not meet inclusion criteria|8|||
155432297|NCT02604264|561009882|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
155432298|NCT02604264|561009883|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
155432299|NCT03192904|561009884|FG000|Overall Study|Physician Decision|3|||
155432300|NCT03192904|561009885|FG001|Overall Study|Physician Decision|1|||
155432301|NCT03192904|561009884|FG000|Overall Study|Lost to Follow-up|0|||
155432302|NCT03192904|561009885|FG001|Overall Study|Lost to Follow-up|1|||
155432303|NCT00424398|561009886|FG000|Overall Study|Withdrawal by Subject|2|||
155432304|NCT00424398|561009887|FG001|Overall Study|Withdrawal by Subject|1|||
155432305|NCT00424398|561009888|FG002|Overall Study|Withdrawal by Subject|0|||
155432306|NCT00424398|561009886|FG000|Overall Study|Subject met exclusion criteria|1|||
155432307|NCT00424398|561009887|FG001|Overall Study|Subject met exclusion criteria|0|||
155432308|NCT00424398|561009888|FG002|Overall Study|Subject met exclusion criteria|0|||
155432309|NCT01309737|561009892|FG000|Week 0 to 16|Death|1|||
155432310|NCT01309737|561009893|FG001|Week 0 to 16|Death|0|||
155432311|NCT01309737|561009894|FG002|Week 0 to 16|Death|1|||
155432312|NCT01309737|561009895|FG003|Week 0 to 16|Death|0|||
155432313|NCT01309737|561009896|FG004|Week 0 to 16|Death|0|||
155432314|NCT01309737|561009892|FG000|Week 0 to 16|Adverse Event|11|||
155432315|NCT01309737|561009893|FG001|Week 0 to 16|Adverse Event|10|||
155432316|NCT01309737|561009894|FG002|Week 0 to 16|Adverse Event|5|||
155432317|NCT01309737|561009895|FG003|Week 0 to 16|Adverse Event|0|||
155432318|NCT01309737|561009896|FG004|Week 0 to 16|Adverse Event|0|||
155432319|NCT01309737|561009892|FG000|Week 0 to 16|Lack of Efficacy|15|||
155432320|NCT01309737|561009893|FG001|Week 0 to 16|Lack of Efficacy|2|||
155432321|NCT01309737|561009894|FG002|Week 0 to 16|Lack of Efficacy|24|||
155432322|NCT01309737|561009895|FG003|Week 0 to 16|Lack of Efficacy|0|||
155432323|NCT01309737|561009896|FG004|Week 0 to 16|Lack of Efficacy|0|||
155432324|NCT01309737|561009892|FG000|Week 0 to 16|Lost to Follow-up|7|||
155432325|NCT01309737|561009893|FG001|Week 0 to 16|Lost to Follow-up|8|||
155432326|NCT01309737|561009894|FG002|Week 0 to 16|Lost to Follow-up|3|||
155432327|NCT01309737|561009895|FG003|Week 0 to 16|Lost to Follow-up|0|||
155432328|NCT01309737|561009896|FG004|Week 0 to 16|Lost to Follow-up|0|||
155432329|NCT01309737|561009892|FG000|Week 0 to 16|Withdrawal by Subject|7|||
155432330|NCT01309737|561009893|FG001|Week 0 to 16|Withdrawal by Subject|6|||
155432331|NCT01309737|561009894|FG002|Week 0 to 16|Withdrawal by Subject|7|||
155432332|NCT01309737|561009895|FG003|Week 0 to 16|Withdrawal by Subject|0|||
155432333|NCT01309737|561009896|FG004|Week 0 to 16|Withdrawal by Subject|0|||
155432334|NCT01309737|561009892|FG000|Week 0 to 16|Other|10|||
155432335|NCT01309737|561009893|FG001|Week 0 to 16|Other|14|||
155432336|NCT01309737|561009894|FG002|Week 0 to 16|Other|4|||
155432337|NCT01309737|561009895|FG003|Week 0 to 16|Other|0|||
155432338|NCT01309737|561009896|FG004|Week 0 to 16|Other|0|||
155432339|NCT01309737|561009892|FG000|Week 0 to 16|Randomized, but not treated|1|||
155432340|NCT01309737|561009893|FG001|Week 0 to 16|Randomized, but not treated|0|||
155432341|NCT01309737|561009894|FG002|Week 0 to 16|Randomized, but not treated|0|||
155432342|NCT01309737|561009895|FG003|Week 0 to 16|Randomized, but not treated|0|||
155432343|NCT01309737|561009896|FG004|Week 0 to 16|Randomized, but not treated|0|||
155432344|NCT01309737|561009892|FG000|Week 16 to 52|Death|0|||
155432345|NCT01309737|561009893|FG001|Week 16 to 52|Death|0|||
155432346|NCT01309737|561009894|FG002|Week 16 to 52|Death|0|||
155432347|NCT01309737|561009895|FG003|Week 16 to 52|Death|0|||
155432348|NCT01309737|561009896|FG004|Week 16 to 52|Death|1|||
155432349|NCT01309737|561009892|FG000|Week 16 to 52|Adverse Event|7|||
155432350|NCT01309737|561009893|FG001|Week 16 to 52|Adverse Event|7|||
155432351|NCT01309737|561009894|FG002|Week 16 to 52|Adverse Event|0|||
155432352|NCT01309737|561009895|FG003|Week 16 to 52|Adverse Event|6|||
155432353|NCT01309737|561009896|FG004|Week 16 to 52|Adverse Event|5|||
155432354|NCT01309737|561009892|FG000|Week 16 to 52|Lack of Efficacy|107|||
155432355|NCT01309737|561009893|FG001|Week 16 to 52|Lack of Efficacy|76|||
155650044|NCT02057666|561810247|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
155432356|NCT01309737|561009894|FG002|Week 16 to 52|Lack of Efficacy|0|||
155432357|NCT01309737|561009895|FG003|Week 16 to 52|Lack of Efficacy|25|||
155432358|NCT01309737|561009896|FG004|Week 16 to 52|Lack of Efficacy|21|||
155432359|NCT01309737|561009892|FG000|Week 16 to 52|Lost to Follow-up|4|||
155432360|NCT01309737|561009893|FG001|Week 16 to 52|Lost to Follow-up|2|||
155432361|NCT01309737|561009894|FG002|Week 16 to 52|Lost to Follow-up|0|||
155432362|NCT01309737|561009895|FG003|Week 16 to 52|Lost to Follow-up|1|||
155432363|NCT01309737|561009896|FG004|Week 16 to 52|Lost to Follow-up|4|||
155432364|NCT01309737|561009892|FG000|Week 16 to 52|Withdrawal by Subject|5|||
155432365|NCT01309737|561009893|FG001|Week 16 to 52|Withdrawal by Subject|6|||
155432366|NCT01309737|561009894|FG002|Week 16 to 52|Withdrawal by Subject|0|||
155432367|NCT01309737|561009895|FG003|Week 16 to 52|Withdrawal by Subject|0|||
155432368|NCT01309737|561009896|FG004|Week 16 to 52|Withdrawal by Subject|2|||
155432369|NCT01309737|561009892|FG000|Week 16 to 52|Other|10|||
155432370|NCT01309737|561009893|FG001|Week 16 to 52|Other|12|||
155432371|NCT01309737|561009894|FG002|Week 16 to 52|Other|0|||
155432372|NCT01309737|561009895|FG003|Week 16 to 52|Other|2|||
155432373|NCT01309737|561009896|FG004|Week 16 to 52|Other|0|||
155432374|NCT00709202|561009897|FG000|Overall Study|Withdrawal by Subject|6|||
155432375|NCT00709202|561009898|FG001|Overall Study|Withdrawal by Subject|6|||
155432376|NCT00855439|561009899|FG000|Overall Study|Withdrawal by Subject|2|||
155432377|NCT00855439|561009900|FG001|Overall Study|Withdrawal by Subject|0|||
155432378|NCT00855439|561009899|FG000|Overall Study|Pregnancy|1|||
155432379|NCT00855439|561009900|FG001|Overall Study|Pregnancy|0|||
155432380|NCT02272790|561009904|FG000|Overall Study|Physician Decision|0|||
155432381|NCT02272790|561009905|FG001|Overall Study|Physician Decision|1|||
155432382|NCT02272790|561009906|FG002|Overall Study|Physician Decision|0|||
155432383|NCT02272790|561009907|FG003|Overall Study|Physician Decision|0|||
155432384|NCT02272790|561009908|FG004|Overall Study|Physician Decision|0|||
155432385|NCT02272790|561009909|FG005|Overall Study|Physician Decision|0|||
155432386|NCT01076179|561009910|FG000|Overall Study|Withdrawal by Subject|1|||
155432387|NCT03459040|561009911|FG000|Overall Study|Death|8|||
155432388|NCT03459040|561009911|FG000|Overall Study|Withdrawal by Subject|1|||
155432389|NCT00986349|561009912|FG000|Overall Study|Unsuccessful implant procedure|3|||
155432390|NCT00986349|561009912|FG000|Overall Study|Adverse Event|2|||
155432391|NCT00986349|561009912|FG000|Overall Study|Physician Decision|1|||
155432392|NCT00986349|561009912|FG000|Overall Study|device migration|1|||
155432393|NCT02299934|561009913|FG000|Overall Study|Termination of study|13|||
155432394|NCT01273818|561009914|FG000|Overall Study|Physician Decision|13|||
155432395|NCT01273818|561009915|FG001|Overall Study|Physician Decision|2|||
155432396|NCT01273818|561009916|FG002|Overall Study|Physician Decision|9|||
155432397|NCT03815175|561009917|FG000|Overall Study|Subject Lost to Follow-up|6|||
155432398|NCT03815175|561009917|FG000|Overall Study|Subject Withdrew Consent|48|||
155432399|NCT03815175|561009917|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
155432400|NCT03815175|561009917|FG000|Overall Study|Death|86|||
155432401|NCT03815175|561009917|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
155432402|NCT03815175|561009917|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
155432403|NCT03815175|561009917|FG000|Overall Study|Other Status Change Reason|1|||
155432404|NCT03815175|561009917|FG000|Overall Study|Missed Visit|12|||
155432405|NCT03577990|561009918|FG000|Overall Study|Lost to Follow-up|4|||
155432406|NCT03577990|561009919|FG001|Overall Study|Lost to Follow-up|6|||
155432407|NCT03577990|561009918|FG000|Overall Study|Withdrawal by Subject|4|||
155432408|NCT03577990|561009919|FG001|Overall Study|Withdrawal by Subject|7|||
155432409|NCT03934684|561009924|FG000|Overall Study|Participants continuing in study|11|||
155432410|NCT03934684|561009925|FG001|Overall Study|Participants continuing in study|4|||
155432411|NCT03934684|561009924|FG000|Overall Study|Discontinuation of carfilzomib|20|||
155432412|NCT03934684|561009925|FG001|Overall Study|Discontinuation of carfilzomib|30|||
155432413|NCT03934684|561009924|FG000|Overall Study|Death|2|||
155432414|NCT03934684|561009925|FG001|Overall Study|Death|2|||
155432415|NCT03934684|561009924|FG000|Overall Study|Lost to Follow-up|2|||
155432416|NCT03934684|561009925|FG001|Overall Study|Lost to Follow-up|5|||
155432417|NCT03934684|561009924|FG000|Overall Study|Withdrawal by Subject|7|||
155432418|NCT03934684|561009925|FG001|Overall Study|Withdrawal by Subject|8|||
155432419|NCT00488631|561009926|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
155432420|NCT00488631|561009927|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
155432421|NCT00488631|561009928|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
155432422|NCT00488631|561009929|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
155432423|NCT00488631|561009930|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
155432424|NCT00488631|561009931|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
155432425|NCT00488631|561009932|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
155432426|NCT00488631|561009933|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
155432427|NCT00488631|561009934|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
155432428|NCT00488631|561009935|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
155512685|NCT01333033|561302696|FG005|Overall Study|Withdrawal by Subject|2|||
155512686|NCT01333033|561302691|FG000|Overall Study|PET inevaluable|0|||
155512687|NCT01333033|561302692|FG001|Overall Study|PET inevaluable|0|||
155512688|NCT01333033|561302693|FG002|Overall Study|PET inevaluable|0|||
155512689|NCT01333033|561302694|FG003|Overall Study|PET inevaluable|0|||
155512690|NCT01333033|561302695|FG004|Overall Study|PET inevaluable|2|||
155432429|NCT00488631|561009926|FG000|Double Blind Period (Week 0-54)|Death|0|||
155432430|NCT00488631|561009927|FG001|Double Blind Period (Week 0-54)|Death|0|||
155432431|NCT00488631|561009928|FG002|Double Blind Period (Week 0-54)|Death|0|||
155432432|NCT00488631|561009929|FG003|Double Blind Period (Week 0-54)|Death|0|||
155432433|NCT00488631|561009930|FG004|Double Blind Period (Week 0-54)|Death|0|||
155432434|NCT00488631|561009931|FG005|Double Blind Period (Week 0-54)|Death|1|||
155432435|NCT00488631|561009932|FG006|Double Blind Period (Week 0-54)|Death|0|||
155432436|NCT00488631|561009933|FG007|Double Blind Period (Week 0-54)|Death|0|||
155432437|NCT00488631|561009934|FG008|Double Blind Period (Week 0-54)|Death|0|||
155432438|NCT00488631|561009935|FG009|Double Blind Period (Week 0-54)|Death|0|||
155432439|NCT00488631|561009926|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
155432440|NCT00488631|561009927|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
155432441|NCT00488631|561009928|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
155432442|NCT00488631|561009929|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
155432443|NCT00488631|561009930|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
155432444|NCT00488631|561009931|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
155432445|NCT00488631|561009932|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
155512691|NCT01333033|561302696|FG005|Overall Study|PET inevaluable|4|||
155512692|NCT01333033|561302691|FG000|Overall Study|Adverse Event|0|||
155512693|NCT01333033|561302692|FG001|Overall Study|Adverse Event|0|||
155512694|NCT01333033|561302693|FG002|Overall Study|Adverse Event|0|||
155512695|NCT01333033|561302694|FG003|Overall Study|Adverse Event|0|||
155512696|NCT01333033|561302695|FG004|Overall Study|Adverse Event|2|||
155512697|NCT01333033|561302696|FG005|Overall Study|Adverse Event|1|||
155512698|NCT01333033|561302691|FG000|Overall Study|Progression|0|||
155512699|NCT01333033|561302692|FG001|Overall Study|Progression|0|||
155512700|NCT01333033|561302693|FG002|Overall Study|Progression|0|||
155512701|NCT01333033|561302694|FG003|Overall Study|Progression|0|||
155512702|NCT01333033|561302695|FG004|Overall Study|Progression|0|||
155512703|NCT01333033|561302696|FG005|Overall Study|Progression|1|||
155512704|NCT01333033|561302691|FG000|Overall Study|MD Decision|0|||
155512705|NCT01333033|561302692|FG001|Overall Study|MD Decision|0|||
155512706|NCT01333033|561302693|FG002|Overall Study|MD Decision|0|||
155512707|NCT01333033|561302694|FG003|Overall Study|MD Decision|0|||
155512708|NCT01333033|561302695|FG004|Overall Study|MD Decision|0|||
155512709|NCT01333033|561302696|FG005|Overall Study|MD Decision|2|||
155512710|NCT02750306|561302697|FG000|Overall Study|Withdrawal by Subject|5|||
155512711|NCT02750306|561302698|FG001|Overall Study|Withdrawal by Subject|2|||
155512712|NCT02750306|561302697|FG000|Overall Study|Protocol Violation|1|||
155512713|NCT02750306|561302698|FG001|Overall Study|Protocol Violation|0|||
155512714|NCT00760383|561302699|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
155512715|NCT00760383|561302700|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
155512716|NCT01842958|561302702|FG000|Overall Study|Lost to Follow-up|1|||
155512717|NCT01842958|561302703|FG001|Overall Study|Lost to Follow-up|1|||
155512718|NCT03361423|561302704|FG000|Overall Study|Withdrawal by Subject|4|||
155512719|NCT03361423|561302705|FG001|Overall Study|Withdrawal by Subject|3|||
155432446|NCT00488631|561009933|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
155432447|NCT00488631|561009934|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
155512720|NCT03361423|561302704|FG000|Overall Study|Did not treat|19|||
155512721|NCT03361423|561302705|FG001|Overall Study|Did not treat|18|||
155512722|NCT03361423|561302704|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
155512723|NCT03361423|561302705|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
155512724|NCT03361423|561302704|FG000|Overall Study|Missing data|4|||
155512725|NCT03361423|561302705|FG001|Overall Study|Missing data|1|||
155512726|NCT00818623|561302706|FG000|Overall Study|Adverse Event|1|||
155512727|NCT00818623|561302707|FG001|Overall Study|Adverse Event|0|||
155512728|NCT00818623|561302708|FG002|Overall Study|Adverse Event|1|||
155512729|NCT00818623|561302709|FG003|Overall Study|Adverse Event|0|||
155512730|NCT00818623|561302710|FG004|Overall Study|Adverse Event|0|||
155512731|NCT00818623|561302711|FG005|Overall Study|Adverse Event|1|||
155512732|NCT00818623|561302712|FG006|Overall Study|Adverse Event|0|||
155512733|NCT00818623|561302713|FG007|Overall Study|Adverse Event|0|||
155512734|NCT00818623|561302706|FG000|Overall Study|Bad prostate specific antigen response|0|||
155512735|NCT00818623|561302707|FG001|Overall Study|Bad prostate specific antigen response|3|||
155512736|NCT00818623|561302708|FG002|Overall Study|Bad prostate specific antigen response|2|||
155512737|NCT00818623|561302709|FG003|Overall Study|Bad prostate specific antigen response|5|||
155512738|NCT00818623|561302710|FG004|Overall Study|Bad prostate specific antigen response|0|||
155512739|NCT00818623|561302711|FG005|Overall Study|Bad prostate specific antigen response|1|||
155512740|NCT00818623|561302712|FG006|Overall Study|Bad prostate specific antigen response|0|||
155512741|NCT00818623|561302713|FG007|Overall Study|Bad prostate specific antigen response|0|||
155512742|NCT00818623|561302706|FG000|Overall Study|Withdrawal by Subject|0|||
155432448|NCT00488631|561009935|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
155432449|NCT00488631|561009926|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
155432450|NCT00488631|561009927|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
155432451|NCT00488631|561009928|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
155512743|NCT00818623|561302707|FG001|Overall Study|Withdrawal by Subject|1|||
155512744|NCT00818623|561302708|FG002|Overall Study|Withdrawal by Subject|1|||
155512745|NCT00818623|561302709|FG003|Overall Study|Withdrawal by Subject|0|||
155512746|NCT00818623|561302710|FG004|Overall Study|Withdrawal by Subject|0|||
155512747|NCT00818623|561302711|FG005|Overall Study|Withdrawal by Subject|1|||
155512748|NCT00818623|561302712|FG006|Overall Study|Withdrawal by Subject|1|||
155512749|NCT00818623|561302713|FG007|Overall Study|Withdrawal by Subject|1|||
155512750|NCT00818623|561302706|FG000|Overall Study|Protocol Violation|1|||
155512751|NCT00818623|561302707|FG001|Overall Study|Protocol Violation|0|||
155512752|NCT00818623|561302708|FG002|Overall Study|Protocol Violation|0|||
155512753|NCT00818623|561302709|FG003|Overall Study|Protocol Violation|0|||
155512754|NCT00818623|561302710|FG004|Overall Study|Protocol Violation|1|||
155512755|NCT00818623|561302711|FG005|Overall Study|Protocol Violation|0|||
155512756|NCT00818623|561302712|FG006|Overall Study|Protocol Violation|1|||
155512757|NCT00818623|561302713|FG007|Overall Study|Protocol Violation|0|||
155512758|NCT00818623|561302706|FG000|Overall Study|Need of additional treatment|0|||
155512759|NCT00818623|561302707|FG001|Overall Study|Need of additional treatment|0|||
155512760|NCT00818623|561302708|FG002|Overall Study|Need of additional treatment|0|||
155512761|NCT00818623|561302709|FG003|Overall Study|Need of additional treatment|0|||
155512762|NCT00818623|561302710|FG004|Overall Study|Need of additional treatment|1|||
155512763|NCT00818623|561302711|FG005|Overall Study|Need of additional treatment|0|||
155512764|NCT00818623|561302712|FG006|Overall Study|Need of additional treatment|0|||
155512765|NCT00818623|561302713|FG007|Overall Study|Need of additional treatment|0|||
155432452|NCT00488631|561009929|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
155432453|NCT00488631|561009930|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
155432454|NCT00488631|561009931|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
155432455|NCT00488631|561009932|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
155432456|NCT00488631|561009933|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
155432457|NCT00488631|561009934|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
155432458|NCT00488631|561009935|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
155432459|NCT00488631|561009926|FG000|Double Blind Period (Week 0-54)|Other|6|||
155432460|NCT00488631|561009927|FG001|Double Blind Period (Week 0-54)|Other|12|||
155432461|NCT00488631|561009928|FG002|Double Blind Period (Week 0-54)|Other|10|||
155432462|NCT00488631|561009929|FG003|Double Blind Period (Week 0-54)|Other|11|||
155432463|NCT00488631|561009930|FG004|Double Blind Period (Week 0-54)|Other|14|||
155432464|NCT00488631|561009931|FG005|Double Blind Period (Week 0-54)|Other|34|||
155432465|NCT00488631|561009932|FG006|Double Blind Period (Week 0-54)|Other|0|||
155432466|NCT00488631|561009933|FG007|Double Blind Period (Week 0-54)|Other|0|||
155432467|NCT00488631|561009934|FG008|Double Blind Period (Week 0-54)|Other|0|||
155432468|NCT00488631|561009935|FG009|Double Blind Period (Week 0-54)|Other|0|||
155432469|NCT00488631|561009926|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432470|NCT00488631|561009927|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432471|NCT00488631|561009928|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432472|NCT00488631|561009929|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432473|NCT00488631|561009930|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432474|NCT00488631|561009931|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432475|NCT00488631|561009932|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
155432476|NCT00488631|561009933|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
155432477|NCT00488631|561009934|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
155512766|NCT00818623|561302706|FG000|Overall Study|Lack of trial drug at site|0|||
155432478|NCT00488631|561009935|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
155432479|NCT00488631|561009926|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
155432480|NCT00488631|561009927|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
155432481|NCT00488631|561009928|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
155432482|NCT00488631|561009929|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
155512767|NCT00818623|561302707|FG001|Overall Study|Lack of trial drug at site|0|||
155512768|NCT00818623|561302708|FG002|Overall Study|Lack of trial drug at site|0|||
155512769|NCT00818623|561302709|FG003|Overall Study|Lack of trial drug at site|0|||
155432483|NCT00488631|561009930|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
155512770|NCT00818623|561302710|FG004|Overall Study|Lack of trial drug at site|2|||
155512771|NCT00818623|561302711|FG005|Overall Study|Lack of trial drug at site|0|||
155432484|NCT00488631|561009931|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
155432485|NCT00488631|561009932|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
155512772|NCT00818623|561302712|FG006|Overall Study|Lack of trial drug at site|1|||
155512773|NCT00818623|561302713|FG007|Overall Study|Lack of trial drug at site|0|||
155432486|NCT00488631|561009933|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
155432487|NCT00488631|561009934|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
155432488|NCT00488631|561009935|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
155432489|NCT00488631|561009926|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432490|NCT00488631|561009927|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432491|NCT00488631|561009928|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432492|NCT00488631|561009929|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432493|NCT00488631|561009930|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432494|NCT00488631|561009931|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
155432495|NCT00488631|561009932|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
155432496|NCT00488631|561009933|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
155432497|NCT00488631|561009934|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
155432498|NCT00488631|561009935|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
155432499|NCT00488631|561009926|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432500|NCT00488631|561009927|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432501|NCT00488631|561009928|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432502|NCT00488631|561009929|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432503|NCT00488631|561009930|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432504|NCT00488631|561009931|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432505|NCT00488631|561009932|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
155432506|NCT00488631|561009933|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432507|NCT00488631|561009934|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
155432508|NCT00488631|561009935|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
155432509|NCT00488631|561009926|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432510|NCT00488631|561009927|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432511|NCT00488631|561009928|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432512|NCT00488631|561009929|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432513|NCT00488631|561009930|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432514|NCT00488631|561009931|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432515|NCT00488631|561009932|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
155432516|NCT00488631|561009933|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
155432517|NCT00488631|561009934|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
155432518|NCT00488631|561009935|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
155432519|NCT01073943|561009936|FG000|Overall Study|Withdrawal by Subject|8|||
155432520|NCT01073943|561009937|FG001|Overall Study|Withdrawal by Subject|2|||
155432521|NCT01073943|561009936|FG000|Overall Study|Protocol Violation|2|||
155432522|NCT01073943|561009937|FG001|Overall Study|Protocol Violation|1|||
155432523|NCT01073943|561009936|FG000|Overall Study|Adverse Event|1|||
155432524|NCT01073943|561009937|FG001|Overall Study|Adverse Event|1|||
155432525|NCT01073943|561009936|FG000|Overall Study|Lost to Follow-up|0|||
155432526|NCT01073943|561009937|FG001|Overall Study|Lost to Follow-up|2|||
155432527|NCT01073943|561009936|FG000|Overall Study|Power outage; colonoscopy not done|1|||
155432528|NCT01073943|561009937|FG001|Overall Study|Power outage; colonoscopy not done|0|||
155432529|NCT01073943|561009936|FG000|Overall Study|Subject forgot|0|||
155432530|NCT01073943|561009937|FG001|Overall Study|Subject forgot|1|||
155432531|NCT01073943|561009936|FG000|Overall Study|Unable to return for follow-up|0|||
155432532|NCT01073943|561009937|FG001|Overall Study|Unable to return for follow-up|1|||
155432533|NCT01073943|561009936|FG000|Overall Study|Could not tolerate prep|1|||
155432534|NCT01073943|561009937|FG001|Overall Study|Could not tolerate prep|0|||
155432535|NCT00761215|561009943|FG000|Overall Study|Randomized but didn't receive drug|1|||
155432536|NCT00761215|561009944|FG001|Overall Study|Randomized but didn't receive drug|1|||
155432537|NCT00761215|561009945|FG002|Overall Study|Randomized but didn't receive drug|2|||
155432538|NCT00761215|561009943|FG000|Overall Study|Lost to Follow-up|6|||
155432539|NCT00761215|561009944|FG001|Overall Study|Lost to Follow-up|3|||
155432540|NCT00761215|561009945|FG002|Overall Study|Lost to Follow-up|6|||
155432541|NCT00761215|561009943|FG000|Overall Study|Withdrawal by Subject|1|||
155432542|NCT00761215|561009944|FG001|Overall Study|Withdrawal by Subject|0|||
155432543|NCT00761215|561009945|FG002|Overall Study|Withdrawal by Subject|0|||
155432544|NCT00761215|561009943|FG000|Overall Study|Bacteremia|1|||
155432545|NCT00761215|561009944|FG001|Overall Study|Bacteremia|0|||
155432546|NCT00761215|561009945|FG002|Overall Study|Bacteremia|0|||
155432547|NCT05662332|561009946|FG000|Overall Study|Death|3|||
155432548|NCT05662332|561009947|FG001|Overall Study|Death|3|||
155432549|NCT05662332|561009946|FG000|Overall Study|Lost to Follow-up|3|||
155432550|NCT05662332|561009947|FG001|Overall Study|Lost to Follow-up|8|||
155432551|NCT05662332|561009946|FG000|Overall Study|Physician Decision|1|||
155432552|NCT05662332|561009947|FG001|Overall Study|Physician Decision|2|||
155432553|NCT05662332|561009946|FG000|Overall Study|Protocol Deviation|2|||
155432554|NCT05662332|561009947|FG001|Overall Study|Protocol Deviation|1|||
155432555|NCT05662332|561009946|FG000|Overall Study|Withdrawal by Subject|14|||
155432556|NCT05662332|561009947|FG001|Overall Study|Withdrawal by Subject|14|||
155432557|NCT05662332|561009946|FG000|Overall Study|Assigned Treatment by Mistake|5|||
155432558|NCT05662332|561009947|FG001|Overall Study|Assigned Treatment by Mistake|7|||
155432559|NCT05662332|561009946|FG000|Overall Study|Non-compliance with study drug|4|||
155432560|NCT05662332|561009947|FG001|Overall Study|Non-compliance with study drug|1|||
155432561|NCT05662332|561009946|FG000|Overall Study|Due to Bariatric surgery|1|||
155432562|NCT05662332|561009947|FG001|Overall Study|Due to Bariatric surgery|0|||
155432563|NCT05662332|561009946|FG000|Overall Study|Subject Moving out of State|0|||
155432564|NCT05662332|561009947|FG001|Overall Study|Subject Moving out of State|1|||
155432565|NCT05662332|561009946|FG000|Overall Study|Subject Missed the Schedule|1|||
155432566|NCT05662332|561009947|FG001|Overall Study|Subject Missed the Schedule|0|||
155432567|NCT05662332|561009946|FG000|Overall Study|The Patient Moved to Another City|1|||
155432568|NCT05662332|561009947|FG001|Overall Study|The Patient Moved to Another City|0|||
155432569|NCT00667277|561009948|FG000|Overall Study|Withdrawal by Subject|2|||
155432570|NCT03248128|561009949|FG000|Overall Study|Lost to Follow-up|1|||
155432571|NCT03248128|561009950|FG001|Overall Study|Lost to Follow-up|0|||
155432572|NCT03248128|561009949|FG000|Overall Study|Withdrawal by Subject|16|||
155432573|NCT03248128|561009950|FG001|Overall Study|Withdrawal by Subject|14|||
155432574|NCT03248128|561009949|FG000|Overall Study|Site Closed|4|||
155432575|NCT03248128|561009950|FG001|Overall Study|Site Closed|3|||
155432576|NCT03248128|561009949|FG000|Overall Study|Randomized, but did not receive treatment|1|||
155432577|NCT03248128|561009950|FG001|Overall Study|Randomized, but did not receive treatment|3|||
155432578|NCT01914679|561009951|FG000|Overall Study|Lack of Efficacy|1|||
155432579|NCT01914679|561009951|FG000|Overall Study|Sponsor terminated study|4|||
155432580|NCT04321343|561009960|FG000|Overall Study|Adverse Event|0|||
155432581|NCT04321343|561009961|FG001|Overall Study|Adverse Event|0|||
155432582|NCT04321343|561009962|FG002|Overall Study|Adverse Event|1|||
155432583|NCT04321343|561009963|FG003|Overall Study|Adverse Event|0|||
155432584|NCT04321343|561009960|FG000|Overall Study|Death|0|||
155432585|NCT04321343|561009961|FG001|Overall Study|Death|0|||
155432586|NCT04321343|561009962|FG002|Overall Study|Death|0|||
155432587|NCT04321343|561009963|FG003|Overall Study|Death|1|||
155432588|NCT04321343|561009960|FG000|Overall Study|Pregnancy|1|||
155432589|NCT04321343|561009961|FG001|Overall Study|Pregnancy|0|||
155432590|NCT04321343|561009962|FG002|Overall Study|Pregnancy|0|||
155432591|NCT04321343|561009963|FG003|Overall Study|Pregnancy|0|||
155432592|NCT04321343|561009960|FG000|Overall Study|Protocol Violation|1|||
155432593|NCT04321343|561009961|FG001|Overall Study|Protocol Violation|1|||
155432594|NCT04321343|561009962|FG002|Overall Study|Protocol Violation|1|||
155432595|NCT04321343|561009963|FG003|Overall Study|Protocol Violation|1|||
155432596|NCT04321343|561009960|FG000|Overall Study|Withdrawal by Subject|0|||
155432597|NCT04321343|561009961|FG001|Overall Study|Withdrawal by Subject|6|||
155432598|NCT04321343|561009962|FG002|Overall Study|Withdrawal by Subject|0|||
155432599|NCT04321343|561009963|FG003|Overall Study|Withdrawal by Subject|2|||
155432600|NCT04321343|561009960|FG000|Overall Study|Lost to Follow-up|2|||
155432601|NCT04321343|561009961|FG001|Overall Study|Lost to Follow-up|2|||
155432602|NCT04321343|561009962|FG002|Overall Study|Lost to Follow-up|1|||
155432603|NCT04321343|561009963|FG003|Overall Study|Lost to Follow-up|3|||
155432604|NCT01682044|561009964|FG000|Overall Study|Death|1|||
155432605|NCT01682044|561009964|FG000|Overall Study|Progression|3|||
155432606|NCT01084252|561011997|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432607|NCT01084252|561011998|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432608|NCT01084252|561011999|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432609|NCT01084252|561012000|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432610|NCT01084252|561012001|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432611|NCT01084252|561012002|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432612|NCT01084252|561012003|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432613|NCT01084252|561012004|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432614|NCT01084252|561012005|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432615|NCT01084252|561012006|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432616|NCT01084252|561012007|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432617|NCT01084252|561012008|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432618|NCT01084252|561012009|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
155432619|NCT01084252|561012010|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
155432620|NCT04364854|561012011|FG000|Overall Study|Withdrawal by Subject|1|||
155432621|NCT04364854|561012012|FG001|Overall Study|Withdrawal by Subject|0|||
155432622|NCT04364854|561012013|FG002|Overall Study|Withdrawal by Subject|1|||
155432623|NCT04364854|561012014|FG003|Overall Study|Withdrawal by Subject|3|||
155432624|NCT04364854|561012011|FG000|Overall Study|Death|1|||
155432625|NCT04364854|561012012|FG001|Overall Study|Death|0|||
155432626|NCT04364854|561012013|FG002|Overall Study|Death|0|||
155432627|NCT04364854|561012014|FG003|Overall Study|Death|0|||
155432628|NCT04364854|561012011|FG000|Overall Study|Lost to Follow-up|0|||
155432629|NCT04364854|561012012|FG001|Overall Study|Lost to Follow-up|0|||
155432630|NCT04364854|561012013|FG002|Overall Study|Lost to Follow-up|0|||
155432631|NCT04364854|561012014|FG003|Overall Study|Lost to Follow-up|1|||
155432632|NCT04493619|561012016|FG000|Overall Study|Death|4|||
155432633|NCT04493619|561012017|FG001|Overall Study|Death|3|||
155432634|NCT04493619|561012018|FG002|Overall Study|Death|3|||
155432635|NCT04493619|561012019|FG003|Overall Study|Death|4|||
155432636|NCT04493619|561012016|FG000|Overall Study|Study discontinued early|10|||
155432637|NCT04493619|561012017|FG001|Overall Study|Study discontinued early|0|||
155432638|NCT04493619|561012018|FG002|Overall Study|Study discontinued early|4|||
155432639|NCT04493619|561012019|FG003|Overall Study|Study discontinued early|8|||
155432640|NCT04493619|561012016|FG000|Overall Study|Lost to Follow-up|0|||
155432641|NCT04493619|561012017|FG001|Overall Study|Lost to Follow-up|0|||
155432642|NCT04493619|561012018|FG002|Overall Study|Lost to Follow-up|0|||
155432643|NCT04493619|561012019|FG003|Overall Study|Lost to Follow-up|1|||
155432644|NCT03368859|561012021|FG000|Overall Study|Withdrew Consent|5|||
155432645|NCT03368859|561012022|FG001|Overall Study|Withdrew Consent|4|||
155432646|NCT03368859|561012021|FG000|Overall Study|Death|12|||
155432647|NCT03368859|561012022|FG001|Overall Study|Death|6|||
155432648|NCT03368859|561012021|FG000|Overall Study|Study terminated by Sponsor|18|||
155432649|NCT03368859|561012022|FG001|Overall Study|Study terminated by Sponsor|23|||
155432650|NCT03368859|561012021|FG000|Overall Study|Other|1|||
155432651|NCT03368859|561012022|FG001|Overall Study|Other|1|||
155432652|NCT02559505|561012023|FG000|Overall Study|Lost to Follow-up|23|||
155432653|NCT02559505|561012024|FG001|Overall Study|Lost to Follow-up|20|||
155432654|NCT02559505|561012023|FG000|Overall Study|Withdrawal by Subject|4|||
155432655|NCT02559505|561012024|FG001|Overall Study|Withdrawal by Subject|2|||
155432656|NCT03523585|561012025|FG000|Overall Study|Progressive Disease|174|||
155432657|NCT03523585|561012026|FG001|Overall Study|Progressive Disease|64|||
155432658|NCT03523585|561012027|FG002|Overall Study|Progressive Disease|77|||
155432659|NCT03523585|561012025|FG000|Overall Study|Adverse Event|74|||
155432660|NCT03523585|561012026|FG001|Overall Study|Adverse Event|5|||
155432661|NCT03523585|561012027|FG002|Overall Study|Adverse Event|9|||
155432662|NCT03523585|561012025|FG000|Overall Study|Withdrawal by Subject|30|||
155432663|NCT03523585|561012026|FG001|Overall Study|Withdrawal by Subject|11|||
155432664|NCT03523585|561012027|FG002|Overall Study|Withdrawal by Subject|6|||
155432665|NCT03523585|561012025|FG000|Overall Study|Clinical Progression|23|||
155432666|NCT03523585|561012026|FG001|Overall Study|Clinical Progression|5|||
155432667|NCT03523585|561012027|FG002|Overall Study|Clinical Progression|10|||
155432668|NCT03523585|561012025|FG000|Overall Study|Death|4|||
155432669|NCT03523585|561012026|FG001|Overall Study|Death|0|||
155432670|NCT03523585|561012027|FG002|Overall Study|Death|1|||
155432671|NCT03523585|561012025|FG000|Overall Study|Physician Decision|2|||
155432672|NCT03523585|561012026|FG001|Overall Study|Physician Decision|1|||
155432673|NCT03523585|561012027|FG002|Overall Study|Physician Decision|0|||
155432674|NCT03523585|561012025|FG000|Overall Study|Lost to Follow-up|1|||
155432675|NCT03523585|561012026|FG001|Overall Study|Lost to Follow-up|0|||
155432676|NCT03523585|561012027|FG002|Overall Study|Lost to Follow-up|0|||
155432677|NCT03523585|561012025|FG000|Overall Study|Miscellaneous|1|||
155432678|NCT03523585|561012026|FG001|Overall Study|Miscellaneous|0|||
155432679|NCT03523585|561012027|FG002|Overall Study|Miscellaneous|0|||
155432680|NCT03523585|561012025|FG000|Overall Study|Protocol Deviation|1|||
155432681|NCT03523585|561012026|FG001|Overall Study|Protocol Deviation|0|||
155432682|NCT03523585|561012027|FG002|Overall Study|Protocol Deviation|1|||
155432683|NCT03523585|561012025|FG000|Overall Study|Randomized But Not Treated|2|||
155432684|NCT03523585|561012026|FG001|Overall Study|Randomized But Not Treated|4|||
155432685|NCT03523585|561012027|FG002|Overall Study|Randomized But Not Treated|3|||
155432686|NCT00698516|561012028|FG000|Overall Study|Study Termination|2|||
155432687|NCT00698516|561012028|FG000|Overall Study|Withdrawal by Subject|3|||
155432688|NCT05882890|561012029|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
155432689|NCT04331899|561012040|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
155432690|NCT04331899|561012041|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
155432691|NCT01062399|561012044|FG000|Overall Study|Protocol Violation|0|||
155432692|NCT01062399|561012045|FG001|Overall Study|Protocol Violation|1|||
155432693|NCT01062399|561012046|FG002|Overall Study|Protocol Violation|0|||
155512774|NCT00818623|561302706|FG000|Overall Study|Disease progression|0|||
155432694|NCT01062399|561012047|FG003|Overall Study|Protocol Violation|6|||
155432695|NCT01062399|561012048|FG004|Overall Study|Protocol Violation|4|||
155432696|NCT02424539|561012049|FG000|Overall Study|Adverse Event|0|||
155432697|NCT02424539|561012050|FG001|Overall Study|Adverse Event|0|||
155432698|NCT02424539|561012051|FG002|Overall Study|Adverse Event|1|||
155432699|NCT02424539|561012049|FG000|Overall Study|Physician Decision|0|||
155432700|NCT02424539|561012050|FG001|Overall Study|Physician Decision|0|||
155432701|NCT02424539|561012051|FG002|Overall Study|Physician Decision|1|||
155432702|NCT02424539|561012049|FG000|Overall Study|Withdrawal by Subject|3|||
155432703|NCT02424539|561012050|FG001|Overall Study|Withdrawal by Subject|1|||
155432704|NCT02424539|561012051|FG002|Overall Study|Withdrawal by Subject|0|||
155432705|NCT02424539|561012049|FG000|Overall Study|Other: Reached stopping criteria|11|||
155432706|NCT02424539|561012050|FG001|Overall Study|Other: Reached stopping criteria|7|||
155432707|NCT02424539|561012051|FG002|Overall Study|Other: Reached stopping criteria|6|||
155432708|NCT00719810|561012052|FG000|Overall Study|Adverse Event|0|||
155432709|NCT00719810|561012053|FG001|Overall Study|Adverse Event|2|||
155432710|NCT00719810|561012054|FG002|Overall Study|Adverse Event|3|||
155432711|NCT00719810|561012052|FG000|Overall Study|Lost to Follow-up|2|||
155432712|NCT00719810|561012053|FG001|Overall Study|Lost to Follow-up|0|||
155432713|NCT00719810|561012054|FG002|Overall Study|Lost to Follow-up|3|||
155432714|NCT00719810|561012052|FG000|Overall Study|Physician Decision|0|||
155432715|NCT00719810|561012053|FG001|Overall Study|Physician Decision|1|||
155432716|NCT00719810|561012054|FG002|Overall Study|Physician Decision|0|||
155432717|NCT00719810|561012052|FG000|Overall Study|Withdrawal by Subject|1|||
155432718|NCT00719810|561012053|FG001|Overall Study|Withdrawal by Subject|1|||
155432719|NCT00719810|561012054|FG002|Overall Study|Withdrawal by Subject|2|||
155432720|NCT04893265|561012077|FG000|Overall Study|Withdrawal by Subject|2|||
155432721|NCT04893265|561012078|FG001|Overall Study|Withdrawal by Subject|5|||
155432722|NCT04893265|561012077|FG000|Overall Study|Lost to Follow-up|0|||
155432723|NCT04893265|561012078|FG001|Overall Study|Lost to Follow-up|4|||
155432724|NCT02465034|561012079|FG000|Overall Study|Withdrawal by Subject|1|||
155432725|NCT02465034|561012080|FG001|Overall Study|Withdrawal by Subject|1|||
155432726|NCT02465034|561012079|FG000|Overall Study|Screen fail|2|||
155432727|NCT02465034|561012080|FG001|Overall Study|Screen fail|0|||
155432728|NCT02465034|561012079|FG000|Overall Study|Could not be scheduled for study visit|0|||
155432729|NCT02465034|561012080|FG001|Overall Study|Could not be scheduled for study visit|5|||
155432730|NCT00573131|561012081|FG000|Overall Study|Withdrawal by Subject|10|||
155432731|NCT00573131|561012082|FG001|Overall Study|Withdrawal by Subject|8|||
155432732|NCT02401256|561012087|FG000|Overall Study|Adverse Event|5|||
155432733|NCT02401256|561012087|FG000|Overall Study|Withdrawal by Subject|12|||
155432734|NCT03090191|561012088|FG000|Overall Study|Adverse Event|90|||
155432735|NCT03090191|561012089|FG001|Overall Study|Adverse Event|72|||
155432736|NCT03090191|561012088|FG000|Overall Study|Death|365|||
155432737|NCT03090191|561012089|FG001|Overall Study|Death|358|||
155432738|NCT03090191|561012088|FG000|Overall Study|Lost to Follow-up|382|||
155432739|NCT03090191|561012089|FG001|Overall Study|Lost to Follow-up|394|||
155432740|NCT03090191|561012088|FG000|Overall Study|Physician Decision|77|||
155432741|NCT03090191|561012089|FG001|Overall Study|Physician Decision|66|||
155432742|NCT03090191|561012088|FG000|Overall Study|Protocol Violation|43|||
155432743|NCT03090191|561012089|FG001|Overall Study|Protocol Violation|52|||
155432744|NCT03090191|561012088|FG000|Overall Study|Withdrawal by Subject|2160|||
155432745|NCT03090191|561012089|FG001|Overall Study|Withdrawal by Subject|2133|||
155432746|NCT03090191|561012088|FG000|Overall Study|Site terminated|7|||
155432747|NCT03090191|561012089|FG001|Overall Study|Site terminated|8|||
155432748|NCT03090191|561012088|FG000|Overall Study|Other|66|||
155432749|NCT03090191|561012089|FG001|Overall Study|Other|60|||
155432750|NCT03090191|561012088|FG000|Overall Study|Withdrawn before any study vaccination|43|||
155432751|NCT03090191|561012089|FG001|Overall Study|Withdrawn before any study vaccination|52|||
155432752|NCT00893789|561012091|FG000|Overall Study|Withdrawal by Subject|3|||
155512775|NCT00818623|561302707|FG001|Overall Study|Disease progression|0|||
155512776|NCT00818623|561302708|FG002|Overall Study|Disease progression|0|||
155512777|NCT00818623|561302709|FG003|Overall Study|Disease progression|0|||
155512778|NCT00818623|561302710|FG004|Overall Study|Disease progression|0|||
155512779|NCT00818623|561302711|FG005|Overall Study|Disease progression|0|||
155512780|NCT00818623|561302712|FG006|Overall Study|Disease progression|1|||
155512781|NCT00818623|561302713|FG007|Overall Study|Disease progression|0|||
155512782|NCT04317781|561302714|FG000|Overall Study|Adverse Event|1|||
155512783|NCT04317781|561302714|FG000|Overall Study|Disease relapse|1|||
155512784|NCT04317781|561302714|FG000|Overall Study|Withdrawal by Subject|1|||
155512785|NCT02087059|561302715|FG000|Overall Study|Disease Progression|1|||
155512786|NCT02087059|561302715|FG000|Overall Study|Adverse Event|5|||
155512787|NCT02087059|561302715|FG000|Overall Study|Lost to Follow-up|1|||
155512788|NCT01851590|561302717|FG000|Overall Study|Withdrawal by Subject|0|||
155512789|NCT01851590|561302718|FG001|Overall Study|Withdrawal by Subject|0|||
155512790|NCT01851590|561302719|FG002|Overall Study|Withdrawal by Subject|1|||
155512791|NCT01851590|561302717|FG000|Overall Study|Adverse Event|0|||
155512792|NCT01851590|561302718|FG001|Overall Study|Adverse Event|0|||
155512793|NCT01851590|561302719|FG002|Overall Study|Adverse Event|2|||
155432753|NCT00893789|561012092|FG001|Overall Study|Withdrawal by Subject|1|||
155432754|NCT00893789|561012093|FG002|Overall Study|Withdrawal by Subject|3|||
155432755|NCT00893789|561012094|FG003|Overall Study|Withdrawal by Subject|1|||
155432756|NCT00893789|561012091|FG000|Overall Study|Noncompliance With Study Drug|1|||
155432757|NCT00893789|561012092|FG001|Overall Study|Noncompliance With Study Drug|0|||
155432758|NCT00893789|561012093|FG002|Overall Study|Noncompliance With Study Drug|1|||
155512794|NCT01851590|561302717|FG000|Overall Study|Lack of Efficacy|0|||
155512795|NCT01851590|561302718|FG001|Overall Study|Lack of Efficacy|1|||
155432759|NCT00893789|561012094|FG003|Overall Study|Noncompliance With Study Drug|2|||
155432760|NCT00893789|561012091|FG000|Overall Study|Noncompliance With Study Procedures|1|||
155432761|NCT00893789|561012092|FG001|Overall Study|Noncompliance With Study Procedures|0|||
155512796|NCT01851590|561302719|FG002|Overall Study|Lack of Efficacy|0|||
155512797|NCT00310856|561302720|FG000|Overall Study|Withdrawal by Subject|2|||
155512798|NCT00310856|561302721|FG001|Overall Study|Withdrawal by Subject|2|||
155432762|NCT00893789|561012093|FG002|Overall Study|Noncompliance With Study Procedures|0|||
155432763|NCT00893789|561012094|FG003|Overall Study|Noncompliance With Study Procedures|0|||
155432764|NCT00893789|561012091|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
155432765|NCT00893789|561012092|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
155432766|NCT00893789|561012093|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
155432767|NCT00893789|561012094|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
155432768|NCT00893789|561012091|FG000|Overall Study|Adverse Event|0|||
155432769|NCT00893789|561012092|FG001|Overall Study|Adverse Event|2|||
155432770|NCT00893789|561012093|FG002|Overall Study|Adverse Event|1|||
155432771|NCT00893789|561012094|FG003|Overall Study|Adverse Event|5|||
155432772|NCT00893789|561012091|FG000|Overall Study|Protocol Violation|0|||
155432773|NCT00893789|561012092|FG001|Overall Study|Protocol Violation|1|||
155432774|NCT00893789|561012093|FG002|Overall Study|Protocol Violation|1|||
155432775|NCT00893789|561012094|FG003|Overall Study|Protocol Violation|4|||
155432776|NCT00893789|561012091|FG000|Overall Study|Lost to Follow-up|0|||
155432777|NCT00893789|561012092|FG001|Overall Study|Lost to Follow-up|0|||
155432778|NCT00893789|561012093|FG002|Overall Study|Lost to Follow-up|0|||
155432779|NCT00893789|561012094|FG003|Overall Study|Lost to Follow-up|1|||
155432780|NCT02024464|561012095|FG000|Overall Study|Discontinued|5|||
155432781|NCT02024464|561012096|FG001|Overall Study|Discontinued|4|||
155432782|NCT02024464|561012095|FG000|Overall Study|Missed Visits|1|||
155432783|NCT02024464|561012096|FG001|Overall Study|Missed Visits|0|||
155432784|NCT02024464|561012095|FG000|Overall Study|Lost to Follow-up|4|||
155432785|NCT02024464|561012096|FG001|Overall Study|Lost to Follow-up|7|||
155432786|NCT01845025|561012101|FG000|Overall Study|Adverse Event|6|||
155432787|NCT01845025|561012102|FG001|Overall Study|Adverse Event|3|||
155432788|NCT01845025|561012101|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155432789|NCT01845025|561012102|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155432790|NCT01845025|561012101|FG000|Overall Study|Withdrawal by Subject|48|||
155432791|NCT01845025|561012102|FG001|Overall Study|Withdrawal by Subject|44|||
155432792|NCT01845025|561012101|FG000|Overall Study|Lost to Follow-up|13|||
155432793|NCT01845025|561012102|FG001|Overall Study|Lost to Follow-up|13|||
155432794|NCT01845025|561012101|FG000|Overall Study|Administrative problems|8|||
155432795|NCT01845025|561012102|FG001|Overall Study|Administrative problems|8|||
155432796|NCT01845025|561012101|FG000|Overall Study|Death|2|||
155432797|NCT01845025|561012102|FG001|Overall Study|Death|0|||
155432798|NCT01845025|561012101|FG000|Overall Study|Protocol deviation|3|||
155432799|NCT01845025|561012102|FG001|Overall Study|Protocol deviation|6|||
155432800|NCT01845025|561012101|FG000|Overall Study|Missing|1|||
155432801|NCT01845025|561012102|FG001|Overall Study|Missing|1|||
155432802|NCT01931865|561012111|FG000|Overall Study|Lost to Follow-up|2|||
155432803|NCT01931865|561012111|FG000|Overall Study|Withdrawal by Subject|2|||
155432804|NCT01121406|561012112|FG000|Overall Study|Progressive disease RECIST|44|||
155432805|NCT01121406|561012113|FG001|Overall Study|Progressive disease RECIST|28|||
155432806|NCT01121406|561012112|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
155432807|NCT01121406|561012113|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
155432808|NCT01121406|561012112|FG000|Overall Study|Other AE|3|||
155432809|NCT01121406|561012113|FG001|Overall Study|Other AE|10|||
155432810|NCT01121406|561012112|FG000|Overall Study|Non-compliant with protocol|0|||
155432811|NCT01121406|561012113|FG001|Overall Study|Non-compliant with protocol|2|||
155432812|NCT01121406|561012112|FG000|Overall Study|Lost to Follow-up|0|||
155432813|NCT01121406|561012113|FG001|Overall Study|Lost to Follow-up|1|||
155432814|NCT01121406|561012112|FG000|Overall Study|Refused continuation of study med.|1|||
155432815|NCT01121406|561012113|FG001|Overall Study|Refused continuation of study med.|2|||
155432816|NCT01121406|561012112|FG000|Overall Study|Reason other than specified above|2|||
155432817|NCT01121406|561012113|FG001|Overall Study|Reason other than specified above|6|||
155432818|NCT01121406|561012112|FG000|Overall Study|Not treated|1|||
155432819|NCT01121406|561012113|FG001|Overall Study|Not treated|0|||
155432820|NCT00504257|561012114|FG000|Overall Study|Withdrawal by Subject|2|||
155432821|NCT00504257|561012114|FG000|Overall Study|ineligible histology|2|||
155432822|NCT02750410|561012115|FG000|Double-Blind Treatment Period|Adverse Event|2|||
155512799|NCT00310856|561302722|FG002|Overall Study|Withdrawal by Subject|2|||
155512800|NCT00310856|561302720|FG000|Overall Study|Lost to Follow-up|1|||
155512801|NCT00310856|561302721|FG001|Overall Study|Lost to Follow-up|2|||
155512802|NCT00310856|561302722|FG002|Overall Study|Lost to Follow-up|6|||
155512803|NCT00310856|561302720|FG000|Overall Study|Inappropriate enrollment|1|||
155432823|NCT02750410|561012116|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155432824|NCT02750410|561012115|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155432825|NCT02750410|561012116|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155432826|NCT02750410|561012115|FG000|Open-Label Extension Period|Adverse Event|5|||
155432827|NCT02750410|561012116|FG001|Open-Label Extension Period|Adverse Event|3|||
155432828|NCT02750410|561012115|FG000|Open-Label Extension Period|Protocol Violation|0|||
155432829|NCT02750410|561012116|FG001|Open-Label Extension Period|Protocol Violation|1|||
155432830|NCT02750410|561012115|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
155432831|NCT02750410|561012116|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
155512804|NCT00310856|561302721|FG001|Overall Study|Inappropriate enrollment|1|||
155432832|NCT01531725|561012121|FG000|Overall Study|Protocol Violation|5|||
155432833|NCT03215277|561012122|FG000|Overall Study|Adverse Event|2|||
155432834|NCT03215277|561012123|FG001|Overall Study|Adverse Event|3|||
155432835|NCT03215277|561012122|FG000|Overall Study|Death|1|||
155432836|NCT03215277|561012123|FG001|Overall Study|Death|0|||
155432837|NCT03215277|561012122|FG000|Overall Study|Lost to Follow-up|0|||
155432838|NCT03215277|561012123|FG001|Overall Study|Lost to Follow-up|1|||
155432839|NCT03215277|561012122|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
155432840|NCT03215277|561012123|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
155432841|NCT00500071|561012125|FG000|Screening and Washout Phase|Protocol Violation|1|||
155432842|NCT00500071|561012125|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
155432843|NCT00500071|561012125|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
155432844|NCT00500071|561012125|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
155432845|NCT00500071|561012125|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
155432846|NCT00500071|561012125|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
155432847|NCT00500071|561012125|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
155432848|NCT00356915|561012129|FG000|Overall Study|Non compliance|1|||
155432849|NCT00356915|561012130|FG001|Overall Study|Non compliance|2|||
155432850|NCT00356915|561012131|FG002|Overall Study|Non compliance|1|||
155432851|NCT00356915|561012129|FG000|Overall Study|Protocol Violation|2|||
155432852|NCT00356915|561012130|FG001|Overall Study|Protocol Violation|3|||
155432853|NCT00356915|561012131|FG002|Overall Study|Protocol Violation|2|||
155432854|NCT00356915|561012129|FG000|Overall Study|Withdrawal by Subject|14|||
155432855|NCT00356915|561012130|FG001|Overall Study|Withdrawal by Subject|14|||
155432856|NCT00356915|561012131|FG002|Overall Study|Withdrawal by Subject|10|||
155432857|NCT00356915|561012129|FG000|Overall Study|Lack of Efficacy|0|||
155432858|NCT00356915|561012130|FG001|Overall Study|Lack of Efficacy|0|||
155432859|NCT00356915|561012131|FG002|Overall Study|Lack of Efficacy|3|||
155432860|NCT00356915|561012129|FG000|Overall Study|Lost to Follow-up|27|||
155432861|NCT00356915|561012130|FG001|Overall Study|Lost to Follow-up|34|||
155432862|NCT00356915|561012131|FG002|Overall Study|Lost to Follow-up|14|||
155432863|NCT00356915|561012129|FG000|Overall Study|Administrative Decision|0|||
155432864|NCT00356915|561012130|FG001|Overall Study|Administrative Decision|0|||
155432865|NCT00356915|561012131|FG002|Overall Study|Administrative Decision|1|||
155432866|NCT00356915|561012129|FG000|Overall Study|Physician Decision|0|||
155432867|NCT00356915|561012130|FG001|Overall Study|Physician Decision|2|||
155432868|NCT00356915|561012131|FG002|Overall Study|Physician Decision|0|||
155432869|NCT00356915|561012129|FG000|Overall Study|Adverse Event|21|||
155432870|NCT00356915|561012130|FG001|Overall Study|Adverse Event|31|||
155432871|NCT00356915|561012131|FG002|Overall Study|Adverse Event|8|||
155432872|NCT00356915|561012129|FG000|Overall Study|Miscellaneous reasons|11|||
155432873|NCT00356915|561012130|FG001|Overall Study|Miscellaneous reasons|8|||
155432874|NCT00356915|561012131|FG002|Overall Study|Miscellaneous reasons|3|||
155432875|NCT02580058|561012140|FG000|Overall Study|Adverse Event|16|||
155432876|NCT02580058|561012141|FG001|Overall Study|Adverse Event|30|||
155432877|NCT02580058|561012142|FG002|Overall Study|Adverse Event|20|||
155432878|NCT02580058|561012140|FG000|Overall Study|Death|4|||
155432879|NCT02580058|561012141|FG001|Overall Study|Death|4|||
155432880|NCT02580058|561012142|FG002|Overall Study|Death|5|||
155432881|NCT02580058|561012140|FG000|Overall Study|Physician Decision|1|||
155432882|NCT02580058|561012141|FG001|Overall Study|Physician Decision|3|||
155512805|NCT00310856|561302722|FG002|Overall Study|Inappropriate enrollment|0|||
155432883|NCT02580058|561012142|FG002|Overall Study|Physician Decision|11|||
155432884|NCT02580058|561012140|FG000|Overall Study|Other|5|||
155432885|NCT02580058|561012141|FG001|Overall Study|Other|1|||
155432886|NCT02580058|561012142|FG002|Overall Study|Other|3|||
155432887|NCT02580058|561012140|FG000|Overall Study|Withdrawal by Subject|4|||
155432888|NCT02580058|561012141|FG001|Overall Study|Withdrawal by Subject|7|||
155432889|NCT02580058|561012142|FG002|Overall Study|Withdrawal by Subject|31|||
155512806|NCT00310856|561302720|FG000|Overall Study|Unable to classify|1|||
155512807|NCT00310856|561302721|FG001|Overall Study|Unable to classify|0|||
155432890|NCT02580058|561012140|FG000|Overall Study|Global Deterioration of Health Status|19|||
155432891|NCT02580058|561012141|FG001|Overall Study|Global Deterioration of Health Status|18|||
155432892|NCT02580058|561012142|FG002|Overall Study|Global Deterioration of Health Status|24|||
155432893|NCT02580058|561012140|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
155432894|NCT02580058|561012141|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155432895|NCT02580058|561012142|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
155432896|NCT02580058|561012140|FG000|Overall Study|Progressive Disease|137|||
155432897|NCT02580058|561012141|FG001|Overall Study|Progressive Disease|125|||
155432898|NCT02580058|561012142|FG002|Overall Study|Progressive Disease|94|||
155432899|NCT02580058|561012140|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155432900|NCT02580058|561012141|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155432901|NCT02580058|561012142|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155432902|NCT02333227|561012143|FG000|Overall Study|Lost to Follow-up|137|||
155432903|NCT02333227|561012144|FG001|Overall Study|Lost to Follow-up|106|||
155432904|NCT02333227|561012143|FG000|Overall Study|Pregnancy Interrupted|42|||
155432905|NCT02333227|561012144|FG001|Overall Study|Pregnancy Interrupted|89|||
155432906|NCT02333227|561012143|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
155432907|NCT02333227|561012144|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
155432908|NCT04375878|561012147|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
155432909|NCT04375878|561012148|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
155432910|NCT04375878|561012149|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
155432911|NCT04375878|561012150|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
155432912|NCT04375878|561012151|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
155432913|NCT04375878|561012152|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
155432914|NCT04375878|561012147|FG000|Crossover First and Second Interventions|Adverse Event|0|||
155432915|NCT04375878|561012148|FG001|Crossover First and Second Interventions|Adverse Event|0|||
155432916|NCT04375878|561012149|FG002|Crossover First and Second Interventions|Adverse Event|1|||
155432917|NCT04375878|561012150|FG003|Crossover First and Second Interventions|Adverse Event|0|||
155432918|NCT04375878|561012151|FG004|Crossover First and Second Interventions|Adverse Event|0|||
155432919|NCT04375878|561012152|FG005|Crossover First and Second Interventions|Adverse Event|0|||
155432920|NCT04375878|561012147|FG000|Extension Phase|Withdrawal by Subject|0|||
155432921|NCT04375878|561012148|FG001|Extension Phase|Withdrawal by Subject|0|||
155432922|NCT04375878|561012149|FG002|Extension Phase|Withdrawal by Subject|0|||
155432923|NCT04375878|561012150|FG003|Extension Phase|Withdrawal by Subject|0|||
155432924|NCT04375878|561012151|FG004|Extension Phase|Withdrawal by Subject|1|||
155432925|NCT04375878|561012152|FG005|Extension Phase|Withdrawal by Subject|0|||
155432926|NCT03022461|561012153|FG000|Overall Study|Death|3|||
155432927|NCT01982630|561012154|FG000|Overall Study|Adverse Event|2|||
155432928|NCT01982630|561012155|FG001|Overall Study|Adverse Event|0|||
155432929|NCT01982630|561012156|FG002|Overall Study|Adverse Event|1|||
155432930|NCT01982630|561012157|FG003|Overall Study|Adverse Event|0|||
155432931|NCT01982630|561012158|FG004|Overall Study|Adverse Event|1|||
155432932|NCT01982630|561012159|FG005|Overall Study|Adverse Event|2|||
155432933|NCT01982630|561012160|FG006|Overall Study|Adverse Event|1|||
155432934|NCT01982630|561012161|FG007|Overall Study|Adverse Event|0|||
155432935|NCT01982630|561012154|FG000|Overall Study|Physician Decision|1|||
155432936|NCT01982630|561012155|FG001|Overall Study|Physician Decision|0|||
155432937|NCT01982630|561012156|FG002|Overall Study|Physician Decision|2|||
155432938|NCT01982630|561012157|FG003|Overall Study|Physician Decision|1|||
155432939|NCT01982630|561012158|FG004|Overall Study|Physician Decision|2|||
155432940|NCT01982630|561012159|FG005|Overall Study|Physician Decision|0|||
155432941|NCT01982630|561012160|FG006|Overall Study|Physician Decision|0|||
155432942|NCT01982630|561012161|FG007|Overall Study|Physician Decision|0|||
155432943|NCT01982630|561012154|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432944|NCT01982630|561012155|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432945|NCT01982630|561012156|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
155432946|NCT01982630|561012157|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432947|NCT01982630|561012158|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432948|NCT01982630|561012159|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432949|NCT01982630|561012160|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432950|NCT01982630|561012161|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
155432951|NCT01982630|561012154|FG000|Overall Study|Withdrawal by Subject|0|||
155432952|NCT01982630|561012155|FG001|Overall Study|Withdrawal by Subject|0|||
155432953|NCT01982630|561012156|FG002|Overall Study|Withdrawal by Subject|0|||
155432954|NCT01982630|561012157|FG003|Overall Study|Withdrawal by Subject|0|||
155432955|NCT01982630|561012158|FG004|Overall Study|Withdrawal by Subject|0|||
155432956|NCT01982630|561012159|FG005|Overall Study|Withdrawal by Subject|1|||
155432957|NCT01982630|561012160|FG006|Overall Study|Withdrawal by Subject|0|||
155432958|NCT01982630|561012161|FG007|Overall Study|Withdrawal by Subject|0|||
155432959|NCT00561353|561012162|FG000|Overall Study|Subject reached a virologic endpoint|2|||
155432960|NCT00561353|561012163|FG001|Overall Study|Subject reached a virologic endpoint|1|||
155432961|NCT00561353|561012164|FG002|Overall Study|Subject reached a virologic endpoint|1|||
155432962|NCT00561353|561012165|FG003|Overall Study|Subject reached a virologic endpoint|4|||
155432963|NCT00561353|561012166|FG004|Overall Study|Subject reached a virologic endpoint|1|||
155432964|NCT00561353|561012167|FG005|Overall Study|Subject reached a virologic endpoint|3|||
155432965|NCT00561353|561012168|FG006|Overall Study|Subject reached a virologic endpoint|4|||
155432966|NCT00561353|561012169|FG007|Overall Study|Subject reached a virologic endpoint|4|||
155650045|NCT02057666|561810248|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
155650046|NCT02057666|561810247|FG000|Double Blind Treatment Period|Physician Decision|1|||
155650047|NCT02057666|561810248|FG001|Double Blind Treatment Period|Physician Decision|0|||
155650048|NCT02057666|561810247|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
155650049|NCT02057666|561810248|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
155650050|NCT02057666|561810247|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
155650051|NCT02057666|561810248|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
155650052|NCT02057666|561810247|FG000|Double Blind Treatment Period|Sponsor's request|70|||
155650053|NCT02057666|561810248|FG001|Double Blind Treatment Period|Sponsor's request|34|||
155650054|NCT02057666|561810247|FG000|Open-Label Treatment Period|Poor tolerability|0|||
155650055|NCT02057666|561810248|FG001|Open-Label Treatment Period|Poor tolerability|1|||
155650056|NCT02057666|561810247|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
155650057|NCT02057666|561810248|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
155650058|NCT02057666|561810247|FG000|Open-Label Treatment Period|Sponsor's request|0|||
155650059|NCT02057666|561810248|FG001|Open-Label Treatment Period|Sponsor's request|4|||
155650060|NCT05661734|561810249|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
155650061|NCT05661734|561810249|FG000|Overall Study|Lost to Follow-up|13|||
155650062|NCT05661734|561810249|FG000|Overall Study|Enrolled but not dosed|2|||
155650063|NCT02489045|561810250|FG000|Overall Study|unable to collect usable data|53|||
155650064|NCT02489045|561810250|FG000|Follow-up|Lost to Follow-up|10|||
155650065|NCT01108055|561810259|FG000|Overall Study|Ineligible|11|||
155650066|NCT01108055|561810259|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
155650067|NCT03339453|561810260|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
155650068|NCT03339453|561810261|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
155650069|NCT00236197|561810266|FG000|Overall Study|Withdrawal by Subject|3|||
155650070|NCT00236197|561810267|FG001|Overall Study|Withdrawal by Subject|2|||
155650071|NCT00236197|561810266|FG000|Overall Study|Lost to Follow-up|1|||
155650072|NCT00236197|561810267|FG001|Overall Study|Lost to Follow-up|5|||
155650073|NCT00236197|561810266|FG000|Overall Study|Protocol Violation|0|||
155650074|NCT00236197|561810267|FG001|Overall Study|Protocol Violation|3|||
155650075|NCT00236197|561810266|FG000|Overall Study|Medication non-compliance|1|||
155650076|NCT00236197|561810267|FG001|Overall Study|Medication non-compliance|2|||
155650077|NCT00236197|561810266|FG000|Overall Study|Other|0|||
155650078|NCT00236197|561810267|FG001|Overall Study|Other|2|||
155650079|NCT03760666|561810270|FG000|Overall Study|Adverse Event|2|||
155650080|NCT03760666|561810271|FG001|Overall Study|Adverse Event|4|||
155650081|NCT03760666|561810272|FG002|Overall Study|Adverse Event|1|||
155650082|NCT03760666|561810270|FG000|Overall Study|AML Disease Progression|3|||
155650083|NCT03760666|561810271|FG001|Overall Study|AML Disease Progression|3|||
155650084|NCT03760666|561810272|FG002|Overall Study|AML Disease Progression|0|||
155650085|NCT03760666|561810270|FG000|Overall Study|Physician Decision|0|||
155432967|NCT00561353|561012170|FG008|Overall Study|Subject reached a virologic endpoint|5|||
155432968|NCT00561353|561012171|FG009|Overall Study|Subject reached a virologic endpoint|0|||
155432969|NCT00561353|561012162|FG000|Overall Study|Subject ineligible to continue the trial|0|||
155432970|NCT00561353|561012163|FG001|Overall Study|Subject ineligible to continue the trial|0|||
155432971|NCT00561353|561012164|FG002|Overall Study|Subject ineligible to continue the trial|0|||
155432972|NCT00561353|561012165|FG003|Overall Study|Subject ineligible to continue the trial|0|||
155432973|NCT00561353|561012166|FG004|Overall Study|Subject ineligible to continue the trial|0|||
155432974|NCT00561353|561012167|FG005|Overall Study|Subject ineligible to continue the trial|1|||
155432975|NCT00561353|561012168|FG006|Overall Study|Subject ineligible to continue the trial|1|||
155432976|NCT00561353|561012169|FG007|Overall Study|Subject ineligible to continue the trial|0|||
155432977|NCT00561353|561012170|FG008|Overall Study|Subject ineligible to continue the trial|2|||
155432978|NCT00561353|561012171|FG009|Overall Study|Subject ineligible to continue the trial|1|||
155432979|NCT00561353|561012162|FG000|Overall Study|Other|1|||
155432980|NCT00561353|561012163|FG001|Overall Study|Other|0|||
155432981|NCT00561353|561012164|FG002|Overall Study|Other|1|||
155432982|NCT00561353|561012165|FG003|Overall Study|Other|0|||
155432983|NCT00561353|561012166|FG004|Overall Study|Other|0|||
155432984|NCT00561353|561012167|FG005|Overall Study|Other|2|||
155432985|NCT00561353|561012168|FG006|Overall Study|Other|0|||
155432986|NCT00561353|561012169|FG007|Overall Study|Other|0|||
155432987|NCT00561353|561012170|FG008|Overall Study|Other|0|||
155432988|NCT00561353|561012171|FG009|Overall Study|Other|0|||
155432989|NCT00561353|561012162|FG000|Overall Study|Adverse Event|0|||
155432990|NCT00561353|561012163|FG001|Overall Study|Adverse Event|0|||
155432991|NCT00561353|561012164|FG002|Overall Study|Adverse Event|0|||
155432992|NCT00561353|561012165|FG003|Overall Study|Adverse Event|2|||
155432993|NCT00561353|561012166|FG004|Overall Study|Adverse Event|0|||
155432994|NCT00561353|561012167|FG005|Overall Study|Adverse Event|0|||
155432995|NCT00561353|561012168|FG006|Overall Study|Adverse Event|1|||
155432996|NCT00561353|561012169|FG007|Overall Study|Adverse Event|0|||
155650086|NCT03760666|561810271|FG001|Overall Study|Physician Decision|3|||
155650087|NCT03760666|561810272|FG002|Overall Study|Physician Decision|0|||
155650088|NCT03760666|561810270|FG000|Overall Study|Withdrawal by Subject|0|||
155432997|NCT00561353|561012170|FG008|Overall Study|Adverse Event|0|||
155432998|NCT00561353|561012171|FG009|Overall Study|Adverse Event|1|||
155432999|NCT00561353|561012162|FG000|Overall Study|Lost to Follow-up|2|||
155433000|NCT00561353|561012163|FG001|Overall Study|Lost to Follow-up|0|||
155433001|NCT00561353|561012164|FG002|Overall Study|Lost to Follow-up|1|||
155433002|NCT00561353|561012165|FG003|Overall Study|Lost to Follow-up|0|||
155433003|NCT00561353|561012166|FG004|Overall Study|Lost to Follow-up|0|||
155433004|NCT00561353|561012167|FG005|Overall Study|Lost to Follow-up|0|||
155433005|NCT00561353|561012168|FG006|Overall Study|Lost to Follow-up|0|||
155433006|NCT00561353|561012169|FG007|Overall Study|Lost to Follow-up|0|||
155433007|NCT00561353|561012170|FG008|Overall Study|Lost to Follow-up|0|||
155433008|NCT00561353|561012171|FG009|Overall Study|Lost to Follow-up|0|||
155433009|NCT00561353|561012162|FG000|Overall Study|Withdrawal by Subject|0|||
155433010|NCT00561353|561012163|FG001|Overall Study|Withdrawal by Subject|2|||
155433011|NCT00561353|561012164|FG002|Overall Study|Withdrawal by Subject|0|||
155433012|NCT00561353|561012165|FG003|Overall Study|Withdrawal by Subject|0|||
155433013|NCT00561353|561012166|FG004|Overall Study|Withdrawal by Subject|0|||
155433014|NCT00561353|561012167|FG005|Overall Study|Withdrawal by Subject|0|||
155433015|NCT00561353|561012168|FG006|Overall Study|Withdrawal by Subject|0|||
155433016|NCT00561353|561012169|FG007|Overall Study|Withdrawal by Subject|0|||
155433017|NCT00561353|561012170|FG008|Overall Study|Withdrawal by Subject|0|||
155433018|NCT00561353|561012171|FG009|Overall Study|Withdrawal by Subject|0|||
155512808|NCT00310856|561302722|FG002|Overall Study|Unable to classify|0|||
155512809|NCT02843074|561302723|FG000|Overall Study|Withdrawal by Subject|5|||
155512810|NCT02843074|561302723|FG000|Overall Study|Progressive disease|1|||
155512811|NCT02843074|561302723|FG000|Overall Study|Physician Decision|1|||
155512812|NCT02843074|561302723|FG000|Overall Study|Lost to Follow-up|1|||
155512813|NCT02843074|561302723|FG000|Overall Study|Death|9|||
155512814|NCT01564758|561302724|FG000|Overall Study|Death|8|||
155512815|NCT01564758|561302724|FG000|Overall Study|Adverse Event|3|||
155512816|NCT01564758|561302724|FG000|Overall Study|Other|3|||
155512817|NCT01186978|561302725|FG000|Overall Study|Withdrawal by Subject|1|||
155512818|NCT01306253|561302726|FG000|Overall Study|Lost to Follow-up|1|||
155512819|NCT01306253|561302727|FG001|Overall Study|Lost to Follow-up|1|||
155512820|NCT00543439|561302728|FG000|Period 1|Adverse Event|0|||
155512821|NCT00543439|561302729|FG001|Period 1|Adverse Event|2|||
155512822|NCT00543439|561302730|FG002|Period 1|Adverse Event|1|||
155512823|NCT00543439|561302728|FG000|Period 1|Withdrawal by Subject|1|||
155512824|NCT00543439|561302729|FG001|Period 1|Withdrawal by Subject|1|||
155512825|NCT00543439|561302730|FG002|Period 1|Withdrawal by Subject|0|||
155512826|NCT00543439|561302728|FG000|Period 1|Physician Decision|0|||
155512827|NCT00543439|561302729|FG001|Period 1|Physician Decision|0|||
155433019|NCT00256295|561012172|FG000|Overall Study|Withdrawal by Subject|3|||
155433020|NCT00256295|561012172|FG000|Overall Study|Death|1|||
155433021|NCT05369806|561012176|FG000|Overall Study|Lost to Follow-up|1|||
155433022|NCT00628355|561012177|FG000|Overall Study|Withdrawal by Subject|1|||
155433023|NCT00628355|561012178|FG001|Overall Study|Withdrawal by Subject|1|||
155433024|NCT00140855|561012179|FG000|Overall Study|Progressive disease|2|||
155433025|NCT03542682|561012181|FG000|Overall Study|COVID-19 Protocol|0|||
155433026|NCT03542682|561012182|FG001|Overall Study|COVID-19 Protocol|1|||
155433027|NCT01097044|561012188|FG000|Overall Study|Withdrawal by Subject|4|||
155433028|NCT01097044|561012189|FG001|Overall Study|Withdrawal by Subject|4|||
155433029|NCT01097044|561012188|FG000|Overall Study|Lost to Follow-up|1|||
155433030|NCT01097044|561012189|FG001|Overall Study|Lost to Follow-up|0|||
155433031|NCT01097044|561012188|FG000|Overall Study|Withdrawal by Sponsor|0|||
155433032|NCT01097044|561012189|FG001|Overall Study|Withdrawal by Sponsor|1|||
155433033|NCT04865731|561012193|FG000|Overall Study|Physician Decision|2|||
155433034|NCT04865731|561012194|FG001|Overall Study|Physician Decision|1|||
155433035|NCT04865731|561012193|FG000|Overall Study|Adverse Event|1|||
155433036|NCT04865731|561012194|FG001|Overall Study|Adverse Event|0|||
155512828|NCT00543439|561302730|FG002|Period 1|Physician Decision|1|||
155512829|NCT00543439|561302728|FG000|Period 2|Protocol Violation|1|||
155433037|NCT04865731|561012193|FG000|Overall Study|Withdrawal by Subject|0|||
155433038|NCT04865731|561012194|FG001|Overall Study|Withdrawal by Subject|1|||
155433039|NCT00875420|561014102|FG000|Overall Study|Adverse Event|0|||
155433040|NCT00875420|561014103|FG001|Overall Study|Adverse Event|1|||
155512830|NCT00543439|561302729|FG001|Period 2|Protocol Violation|0|||
155433041|NCT00875420|561014104|FG002|Overall Study|Adverse Event|1|||
155433042|NCT00875420|561014105|FG003|Overall Study|Adverse Event|0|||
155433043|NCT00875420|561014106|FG004|Overall Study|Adverse Event|0|||
155433044|NCT00875420|561014102|FG000|Overall Study|Inability to complete study procedures|1|||
155433045|NCT00875420|561014103|FG001|Overall Study|Inability to complete study procedures|0|||
155433046|NCT00875420|561014104|FG002|Overall Study|Inability to complete study procedures|1|||
155433047|NCT00875420|561014105|FG003|Overall Study|Inability to complete study procedures|1|||
155512831|NCT00543439|561302730|FG002|Period 2|Protocol Violation|1|||
155433048|NCT00875420|561014106|FG004|Overall Study|Inability to complete study procedures|1|||
155512832|NCT00543439|561302728|FG000|Period 2|Adverse Event|0|||
155512833|NCT00543439|561302729|FG001|Period 2|Adverse Event|1|||
155512834|NCT00543439|561302730|FG002|Period 2|Adverse Event|1|||
155433049|NCT00875420|561014102|FG000|Overall Study|Lost to Follow-up|1|||
155433050|NCT00875420|561014103|FG001|Overall Study|Lost to Follow-up|0|||
155512835|NCT01709383|561302735|FG000|Overall Study|Lost to Follow-up|1|||
155512836|NCT01709383|561302736|FG001|Overall Study|Lost to Follow-up|0|||
155433051|NCT00875420|561014104|FG002|Overall Study|Lost to Follow-up|0|||
155433052|NCT00875420|561014105|FG003|Overall Study|Lost to Follow-up|0|||
155433053|NCT00875420|561014106|FG004|Overall Study|Lost to Follow-up|0|||
155433054|NCT00875420|561014102|FG000|Overall Study|Personal reason|0|||
155433055|NCT00875420|561014103|FG001|Overall Study|Personal reason|0|||
155433056|NCT00875420|561014104|FG002|Overall Study|Personal reason|0|||
155433057|NCT00875420|561014105|FG003|Overall Study|Personal reason|0|||
155433058|NCT00875420|561014106|FG004|Overall Study|Personal reason|1|||
155433059|NCT00875420|561014102|FG000|Overall Study|Prohibited medication|0|||
155433060|NCT00875420|561014103|FG001|Overall Study|Prohibited medication|0|||
155433061|NCT00875420|561014104|FG002|Overall Study|Prohibited medication|0|||
155433062|NCT00875420|561014105|FG003|Overall Study|Prohibited medication|1|||
155433063|NCT00875420|561014106|FG004|Overall Study|Prohibited medication|0|||
155433064|NCT00875420|561014102|FG000|Overall Study|Sponsor decision|0|||
155433065|NCT00875420|561014103|FG001|Overall Study|Sponsor decision|1|||
155433066|NCT00875420|561014104|FG002|Overall Study|Sponsor decision|0|||
155433067|NCT00875420|561014105|FG003|Overall Study|Sponsor decision|0|||
155433068|NCT00875420|561014106|FG004|Overall Study|Sponsor decision|0|||
155433069|NCT00875420|561014102|FG000|Overall Study|Withdrawal by Subject|0|||
155433070|NCT00875420|561014103|FG001|Overall Study|Withdrawal by Subject|0|||
155512837|NCT03264066|561302737|FG000|Overall Study|Adverse Event|1|||
155512838|NCT03264066|561302738|FG001|Overall Study|Adverse Event|1|||
155512839|NCT03264066|561302739|FG002|Overall Study|Adverse Event|0|||
155512840|NCT03264066|561302740|FG003|Overall Study|Adverse Event|0|||
155512841|NCT03264066|561302741|FG004|Overall Study|Adverse Event|0|||
155512842|NCT03264066|561302742|FG005|Overall Study|Adverse Event|0|||
155512843|NCT03264066|561302737|FG000|Overall Study|Death|12|||
155512844|NCT03264066|561302738|FG001|Overall Study|Death|12|||
155512845|NCT03264066|561302739|FG002|Overall Study|Death|8|||
155512846|NCT03264066|561302740|FG003|Overall Study|Death|10|||
155433071|NCT00875420|561014104|FG002|Overall Study|Withdrawal by Subject|1|||
155433072|NCT00875420|561014105|FG003|Overall Study|Withdrawal by Subject|0|||
155433073|NCT00875420|561014106|FG004|Overall Study|Withdrawal by Subject|0|||
155433074|NCT00914628|561014107|FG000|Overall Study|Death|35|||
155433075|NCT00914628|561014108|FG001|Overall Study|Death|17|||
155433076|NCT00914628|561014107|FG000|Overall Study|Medical decision|4|||
155512847|NCT03264066|561302741|FG004|Overall Study|Death|6|||
155512848|NCT03264066|561302742|FG005|Overall Study|Death|1|||
155512849|NCT03264066|561302737|FG000|Overall Study|Lost to Follow-up|1|||
155512850|NCT03264066|561302738|FG001|Overall Study|Lost to Follow-up|0|||
155512851|NCT03264066|561302739|FG002|Overall Study|Lost to Follow-up|0|||
155512852|NCT03264066|561302740|FG003|Overall Study|Lost to Follow-up|0|||
155512853|NCT03264066|561302741|FG004|Overall Study|Lost to Follow-up|0|||
155512854|NCT03264066|561302742|FG005|Overall Study|Lost to Follow-up|0|||
155512855|NCT03264066|561302737|FG000|Overall Study|Progressive Disease|0|||
155512856|NCT03264066|561302738|FG001|Overall Study|Progressive Disease|2|||
155512857|NCT03264066|561302739|FG002|Overall Study|Progressive Disease|1|||
155512858|NCT03264066|561302740|FG003|Overall Study|Progressive Disease|0|||
155512859|NCT03264066|561302741|FG004|Overall Study|Progressive Disease|0|||
155433077|NCT00914628|561014108|FG001|Overall Study|Medical decision|0|||
155433078|NCT00914628|561014107|FG000|Overall Study|Protocol Violation|1|||
155433079|NCT00914628|561014108|FG001|Overall Study|Protocol Violation|0|||
155433080|NCT00914628|561014107|FG000|Overall Study|Lack of Efficacy|1|||
155433081|NCT00914628|561014108|FG001|Overall Study|Lack of Efficacy|0|||
155433082|NCT00914628|561014107|FG000|Overall Study|non-randomized|1|||
155433083|NCT00914628|561014108|FG001|Overall Study|non-randomized|0|||
155433084|NCT00914628|561014107|FG000|Overall Study|Relapse|1|||
155433085|NCT00914628|561014108|FG001|Overall Study|Relapse|2|||
155433086|NCT00914628|561014107|FG000|Overall Study|Study terminated by Sponsor|14|||
155433087|NCT00914628|561014108|FG001|Overall Study|Study terminated by Sponsor|8|||
155433088|NCT00914628|561014107|FG000|Overall Study|Patients who did not receive a single dose|7|||
155433089|NCT00914628|561014108|FG001|Overall Study|Patients who did not receive a single dose|1|||
155433090|NCT03716726|561014109|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
155433091|NCT03716726|561014110|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
155433092|NCT03716726|561014109|FG000|12 Months Followup|Lost to Follow-up|10|||
155433093|NCT03716726|561014110|FG001|12 Months Followup|Lost to Follow-up|17|||
155512860|NCT03264066|561302742|FG005|Overall Study|Progressive Disease|0|||
155512861|NCT03264066|561302737|FG000|Overall Study|Study Terminated by Sponsor|5|||
155512862|NCT03264066|561302738|FG001|Overall Study|Study Terminated by Sponsor|5|||
155512863|NCT03264066|561302739|FG002|Overall Study|Study Terminated by Sponsor|8|||
155512864|NCT03264066|561302740|FG003|Overall Study|Study Terminated by Sponsor|5|||
155433094|NCT02579603|561014111|FG000|Overall Study|Not treated|1|||
155433095|NCT02579603|561014112|FG001|Overall Study|Not treated|0|||
155433096|NCT02579603|561014111|FG000|Overall Study|Adverse Event|2|||
155512865|NCT03264066|561302741|FG004|Overall Study|Study Terminated by Sponsor|1|||
155650089|NCT03760666|561810271|FG001|Overall Study|Withdrawal by Subject|1|||
155650090|NCT03760666|561810272|FG002|Overall Study|Withdrawal by Subject|0|||
155650091|NCT01800058|561810277|FG000|Overall Study|Lost to Follow-up|1|||
155650092|NCT06868667|561810278|FG000|Overall Study|Death|0|||
155650093|NCT06868667|561810279|FG001|Overall Study|Death|4|||
155433097|NCT02579603|561014112|FG001|Overall Study|Adverse Event|2|||
155433098|NCT02579603|561014111|FG000|Overall Study|Other than stated|1|||
155433099|NCT02579603|561014112|FG001|Overall Study|Other than stated|0|||
155433100|NCT00942162|561014113|FG000|Overall Study|Death|45|||
155433101|NCT00942162|561014114|FG001|Overall Study|Death|35|||
155433102|NCT00942162|561014115|FG002|Overall Study|Death|0|||
155433103|NCT00942162|561014113|FG000|Overall Study|Withdrawal by Subject|7|||
155433104|NCT00942162|561014114|FG001|Overall Study|Withdrawal by Subject|2|||
155650094|NCT06868667|561810278|FG000|Overall Study|Lost to Follow-up|0|||
155650095|NCT06868667|561810279|FG001|Overall Study|Lost to Follow-up|1|||
155650096|NCT06868667|561810278|FG000|Overall Study|Withdrawal by Subject|1|||
155650097|NCT06868667|561810279|FG001|Overall Study|Withdrawal by Subject|0|||
155650098|NCT06868667|561810278|FG000|Overall Study|Ongoing|9|||
155650099|NCT06868667|561810279|FG001|Overall Study|Ongoing|9|||
155650100|NCT00286455|561810283|FG000|Overall Study|Hyperglycemia rescue|19|||
155650101|NCT00286455|561810284|FG001|Overall Study|Hyperglycemia rescue|13|||
155650102|NCT00286455|561810285|FG002|Overall Study|Hyperglycemia rescue|10|||
155650103|NCT00286455|561810283|FG000|Overall Study|Adverse Event|1|||
155650104|NCT00286455|561810284|FG001|Overall Study|Adverse Event|3|||
155650105|NCT00286455|561810285|FG002|Overall Study|Adverse Event|2|||
155650106|NCT00286455|561810283|FG000|Overall Study|Lost to Follow-up|0|||
155650107|NCT00286455|561810284|FG001|Overall Study|Lost to Follow-up|3|||
155650108|NCT00286455|561810285|FG002|Overall Study|Lost to Follow-up|3|||
155650109|NCT00286455|561810283|FG000|Overall Study|Physician Decision|3|||
155650110|NCT00286455|561810284|FG001|Overall Study|Physician Decision|0|||
155650111|NCT00286455|561810285|FG002|Overall Study|Physician Decision|2|||
155650112|NCT00286455|561810283|FG000|Overall Study|Protocol Violation|1|||
155650113|NCT00286455|561810284|FG001|Overall Study|Protocol Violation|1|||
155433105|NCT00942162|561014115|FG002|Overall Study|Withdrawal by Subject|0|||
155433106|NCT00942162|561014113|FG000|Overall Study|Lost to Follow-up|4|||
155650114|NCT00286455|561810285|FG002|Overall Study|Protocol Violation|0|||
155650115|NCT00286455|561810283|FG000|Overall Study|Participant Non-compliance|1|||
155650116|NCT00286455|561810284|FG001|Overall Study|Participant Non-compliance|0|||
155650117|NCT00286455|561810285|FG002|Overall Study|Participant Non-compliance|0|||
155650118|NCT00286455|561810283|FG000|Overall Study|Withdrawal by Subject|0|||
155650119|NCT00286455|561810284|FG001|Overall Study|Withdrawal by Subject|8|||
155433107|NCT00942162|561014114|FG001|Overall Study|Lost to Follow-up|0|||
155433108|NCT00942162|561014115|FG002|Overall Study|Lost to Follow-up|0|||
155433109|NCT00942162|561014113|FG000|Overall Study|Other|14|||
155433110|NCT00942162|561014114|FG001|Overall Study|Other|13|||
155433111|NCT00942162|561014115|FG002|Overall Study|Other|2|||
155433112|NCT01006356|561014119|FG000|Overall Study|Adverse Event|6|||
155433113|NCT01006356|561014119|FG000|Overall Study|Physician Decision|1|||
155433114|NCT01006356|561014119|FG000|Overall Study|Paticipants did not cooperate|6|||
155433115|NCT01006356|561014119|FG000|Overall Study|Withdrawal by Subject|1|||
155433116|NCT01006356|561014119|FG000|Overall Study|Choice by participants|2|||
155433117|NCT01006356|561014119|FG000|Overall Study|Protocol Violation|3|||
155433118|NCT01006356|561014119|FG000|Overall Study|Other|23|||
155433119|NCT01756157|561014123|FG000|First Intervention Period|Withdrawal by Subject|1|||
155433120|NCT01756157|561014124|FG001|First Intervention Period|Withdrawal by Subject|0|||
155433121|NCT01756157|561014123|FG000|First Intervention Period|Lost to Follow-up|0|||
155433122|NCT01756157|561014124|FG001|First Intervention Period|Lost to Follow-up|2|||
155433123|NCT02799381|561014127|FG000|Overall Study|Withdrew consent|3|||
155433124|NCT02799381|561014128|FG001|Overall Study|Withdrew consent|2|||
155433125|NCT02799381|561014127|FG000|Overall Study|Adverse Event|0|||
155433126|NCT02799381|561014128|FG001|Overall Study|Adverse Event|1|||
155433127|NCT02799381|561014127|FG000|Overall Study|Participant did not take any study drug|1|||
155433128|NCT02799381|561014128|FG001|Overall Study|Participant did not take any study drug|0|||
155433129|NCT02698410|561014129|FG000|Overall Study|Adverse Event|2|||
155433130|NCT02698410|561014129|FG000|Overall Study|Withdrawal by Subject|1|||
155433131|NCT02698410|561014129|FG000|Overall Study|Other|1|||
155433132|NCT03952130|561014130|FG000|Overall Study|Adverse Event|0|||
155433133|NCT03952130|561014131|FG001|Overall Study|Adverse Event|1|||
155433134|NCT03952130|561014130|FG000|Overall Study|Lost to Follow-up|1|||
155433135|NCT03952130|561014131|FG001|Overall Study|Lost to Follow-up|0|||
155433136|NCT03952130|561014130|FG000|Overall Study|Withdrawal by Subject|1|||
155433137|NCT03952130|561014131|FG001|Overall Study|Withdrawal by Subject|5|||
155433138|NCT01713348|561014132|FG000|Overall Study|Withdrawal by Subject|3|||
155433139|NCT01713348|561014133|FG001|Overall Study|Withdrawal by Subject|2|||
155650120|NCT00286455|561810285|FG002|Overall Study|Withdrawal by Subject|7|||
155650121|NCT02562040|561812375|FG000|Overall Study|Lost to Follow-up|20|||
155650122|NCT02562040|561812376|FG001|Overall Study|Lost to Follow-up|28|||
155650123|NCT02562040|561812375|FG000|Overall Study|Withdrawal by Subject|8|||
155650124|NCT02562040|561812376|FG001|Overall Study|Withdrawal by Subject|7|||
155650125|NCT02562040|561812375|FG000|Overall Study|Adverse Event|1|||
155650126|NCT02562040|561812376|FG001|Overall Study|Adverse Event|0|||
155650127|NCT00368849|561812380|FG000|Overall Study|Withdrawal by Subject|0|||
155650128|NCT00368849|561812381|FG001|Overall Study|Withdrawal by Subject|1|||
155650129|NCT00368849|561812380|FG000|Overall Study|Physician Decision|0|||
155650130|NCT00368849|561812381|FG001|Overall Study|Physician Decision|1|||
155650131|NCT01902303|561812383|FG000|Overall Study|Adverse Event|0|||
155650132|NCT01902303|561812384|FG001|Overall Study|Adverse Event|1|||
155650133|NCT01902303|561812383|FG000|Overall Study|Lost to Follow-up|0|||
155650134|NCT01902303|561812384|FG001|Overall Study|Lost to Follow-up|1|||
155650135|NCT01902303|561812383|FG000|Overall Study|Protocol Violation|2|||
155650136|NCT01902303|561812384|FG001|Overall Study|Protocol Violation|2|||
155650137|NCT01902303|561812383|FG000|Overall Study|subject lost investigational product|0|||
155650138|NCT01902303|561812384|FG001|Overall Study|subject lost investigational product|1|||
155650139|NCT01902303|561812383|FG000|Overall Study|Did not develop a cold sore|21|||
155650140|NCT01902303|561812384|FG001|Overall Study|Did not develop a cold sore|19|||
155650141|NCT01699685|561812385|FG000|Period 1|Adverse Event|1|||
155650142|NCT01699685|561812386|FG001|Period 1|Adverse Event|1|||
155650143|NCT01699685|561812385|FG000|Period 1|Medical or ethical, noncompliance|2|||
155650144|NCT01699685|561812386|FG001|Period 1|Medical or ethical, noncompliance|0|||
155433140|NCT01713348|561014134|FG002|Overall Study|Withdrawal by Subject|2|||
155433141|NCT01713348|561014135|FG003|Overall Study|Withdrawal by Subject|0|||
155433142|NCT01713348|561014132|FG000|Overall Study|Lost to Follow-up|1|||
155433143|NCT01713348|561014133|FG001|Overall Study|Lost to Follow-up|0|||
155433144|NCT01713348|561014134|FG002|Overall Study|Lost to Follow-up|0|||
155433145|NCT01713348|561014135|FG003|Overall Study|Lost to Follow-up|0|||
155433146|NCT02638012|561014136|FG000|Overall Study|Lost to Follow-up|1|||
155433147|NCT00621023|561014138|FG000|Overall Study|Death|5|||
155433148|NCT00621023|561014138|FG000|Overall Study|Follow up discontinued|1|||
155433149|NCT03199911|561014145|FG000|Overall Study|Lost to Follow-up|5|||
155433150|NCT03199911|561014146|FG001|Overall Study|Lost to Follow-up|5|||
155433151|NCT03199911|561014145|FG000|Overall Study|Did not proceed with surgery|2|||
155433152|NCT03199911|561014146|FG001|Overall Study|Did not proceed with surgery|1|||
155433153|NCT01324830|561014152|FG000|Overall Study|Progressive Disease|3|||
155433154|NCT01324830|561014153|FG001|Overall Study|Progressive Disease|2|||
155433155|NCT01324830|561014154|FG002|Overall Study|Progressive Disease|3|||
155433156|NCT01324830|561014155|FG003|Overall Study|Progressive Disease|3|||
155433157|NCT01324830|561014156|FG004|Overall Study|Progressive Disease|6|||
155433158|NCT01324830|561014157|FG005|Overall Study|Progressive Disease|6|||
155433159|NCT01324830|561014158|FG006|Overall Study|Progressive Disease|3|||
155433160|NCT01324830|561014159|FG007|Overall Study|Progressive Disease|3|||
155433161|NCT01324830|561014160|FG008|Overall Study|Progressive Disease|3|||
155433162|NCT01324830|561014161|FG009|Overall Study|Progressive Disease|6|||
155433163|NCT01324830|561014162|FG010|Overall Study|Progressive Disease|2|||
155433164|NCT01324830|561014163|FG011|Overall Study|Progressive Disease|1|||
155433165|NCT01324830|561014164|FG012|Overall Study|Progressive Disease|1|||
155433166|NCT01324830|561014165|FG013|Overall Study|Progressive Disease|1|||
155433167|NCT01324830|561014166|FG014|Overall Study|Progressive Disease|1|||
155433168|NCT01324830|561014167|FG015|Overall Study|Progressive Disease|3|||
155433169|NCT01324830|561014168|FG016|Overall Study|Progressive Disease|2|||
155433170|NCT01324830|561014169|FG017|Overall Study|Progressive Disease|3|||
155433171|NCT01324830|561014170|FG018|Overall Study|Progressive Disease|4|||
155433172|NCT01324830|561014152|FG000|Overall Study|Dose limiting toxicity|0|||
155433173|NCT01324830|561014153|FG001|Overall Study|Dose limiting toxicity|0|||
155433174|NCT01324830|561014154|FG002|Overall Study|Dose limiting toxicity|0|||
155433175|NCT01324830|561014155|FG003|Overall Study|Dose limiting toxicity|0|||
155433176|NCT01324830|561014156|FG004|Overall Study|Dose limiting toxicity|1|||
155433177|NCT01324830|561014157|FG005|Overall Study|Dose limiting toxicity|0|||
155433178|NCT01324830|561014158|FG006|Overall Study|Dose limiting toxicity|0|||
155433179|NCT01324830|561014159|FG007|Overall Study|Dose limiting toxicity|0|||
155433180|NCT01324830|561014160|FG008|Overall Study|Dose limiting toxicity|0|||
155433181|NCT01324830|561014161|FG009|Overall Study|Dose limiting toxicity|0|||
155433182|NCT01324830|561014162|FG010|Overall Study|Dose limiting toxicity|0|||
155433183|NCT01324830|561014163|FG011|Overall Study|Dose limiting toxicity|0|||
155433184|NCT01324830|561014164|FG012|Overall Study|Dose limiting toxicity|0|||
155433185|NCT01324830|561014165|FG013|Overall Study|Dose limiting toxicity|0|||
155433186|NCT01324830|561014166|FG014|Overall Study|Dose limiting toxicity|0|||
155433187|NCT01324830|561014167|FG015|Overall Study|Dose limiting toxicity|0|||
155433188|NCT01324830|561014168|FG016|Overall Study|Dose limiting toxicity|1|||
155433189|NCT01324830|561014169|FG017|Overall Study|Dose limiting toxicity|1|||
155433190|NCT01324830|561014170|FG018|Overall Study|Dose limiting toxicity|1|||
155433191|NCT01324830|561014152|FG000|Overall Study|Reason not mentioned above|0|||
155433192|NCT01324830|561014153|FG001|Overall Study|Reason not mentioned above|0|||
155433193|NCT01324830|561014154|FG002|Overall Study|Reason not mentioned above|0|||
155433194|NCT01324830|561014155|FG003|Overall Study|Reason not mentioned above|0|||
155433195|NCT01324830|561014156|FG004|Overall Study|Reason not mentioned above|0|||
155433196|NCT01324830|561014157|FG005|Overall Study|Reason not mentioned above|0|||
155433197|NCT01324830|561014158|FG006|Overall Study|Reason not mentioned above|0|||
155433198|NCT01324830|561014159|FG007|Overall Study|Reason not mentioned above|0|||
155433199|NCT01324830|561014160|FG008|Overall Study|Reason not mentioned above|0|||
155433200|NCT01324830|561014161|FG009|Overall Study|Reason not mentioned above|0|||
155433201|NCT01324830|561014162|FG010|Overall Study|Reason not mentioned above|0|||
155433202|NCT01324830|561014163|FG011|Overall Study|Reason not mentioned above|0|||
155433203|NCT01324830|561014164|FG012|Overall Study|Reason not mentioned above|0|||
155433204|NCT01324830|561014165|FG013|Overall Study|Reason not mentioned above|0|||
155433205|NCT01324830|561014166|FG014|Overall Study|Reason not mentioned above|0|||
155433206|NCT01324830|561014167|FG015|Overall Study|Reason not mentioned above|0|||
155433207|NCT01324830|561014168|FG016|Overall Study|Reason not mentioned above|0|||
155433208|NCT01324830|561014169|FG017|Overall Study|Reason not mentioned above|1|||
155433209|NCT01324830|561014170|FG018|Overall Study|Reason not mentioned above|0|||
155433210|NCT01324830|561014152|FG000|Overall Study|Adverse Event, serious fatal|0|||
155433211|NCT01324830|561014153|FG001|Overall Study|Adverse Event, serious fatal|1|||
155433212|NCT01324830|561014154|FG002|Overall Study|Adverse Event, serious fatal|0|||
155433213|NCT01324830|561014155|FG003|Overall Study|Adverse Event, serious fatal|0|||
155433214|NCT01324830|561014156|FG004|Overall Study|Adverse Event, serious fatal|0|||
155433215|NCT01324830|561014157|FG005|Overall Study|Adverse Event, serious fatal|0|||
155433216|NCT01324830|561014158|FG006|Overall Study|Adverse Event, serious fatal|0|||
155433217|NCT01324830|561014159|FG007|Overall Study|Adverse Event, serious fatal|0|||
155433218|NCT01324830|561014160|FG008|Overall Study|Adverse Event, serious fatal|0|||
155433219|NCT01324830|561014161|FG009|Overall Study|Adverse Event, serious fatal|0|||
155433220|NCT01324830|561014162|FG010|Overall Study|Adverse Event, serious fatal|0|||
155433221|NCT01324830|561014163|FG011|Overall Study|Adverse Event, serious fatal|0|||
155433222|NCT01324830|561014164|FG012|Overall Study|Adverse Event, serious fatal|0|||
155433223|NCT01324830|561014165|FG013|Overall Study|Adverse Event, serious fatal|0|||
155433224|NCT01324830|561014166|FG014|Overall Study|Adverse Event, serious fatal|0|||
155433225|NCT01324830|561014167|FG015|Overall Study|Adverse Event, serious fatal|0|||
155433226|NCT01324830|561014168|FG016|Overall Study|Adverse Event, serious fatal|0|||
155433227|NCT01324830|561014169|FG017|Overall Study|Adverse Event, serious fatal|0|||
155433228|NCT01324830|561014170|FG018|Overall Study|Adverse Event, serious fatal|0|||
155433229|NCT01324830|561014152|FG000|Overall Study|Adverse Event, non-fatal|0|||
155433230|NCT01324830|561014153|FG001|Overall Study|Adverse Event, non-fatal|0|||
155433231|NCT01324830|561014154|FG002|Overall Study|Adverse Event, non-fatal|0|||
155433232|NCT01324830|561014155|FG003|Overall Study|Adverse Event, non-fatal|0|||
155433233|NCT01324830|561014156|FG004|Overall Study|Adverse Event, non-fatal|0|||
155433234|NCT01324830|561014157|FG005|Overall Study|Adverse Event, non-fatal|0|||
155433235|NCT01324830|561014158|FG006|Overall Study|Adverse Event, non-fatal|0|||
155433236|NCT01324830|561014159|FG007|Overall Study|Adverse Event, non-fatal|0|||
155433237|NCT01324830|561014160|FG008|Overall Study|Adverse Event, non-fatal|2|||
155433238|NCT01324830|561014161|FG009|Overall Study|Adverse Event, non-fatal|0|||
155433239|NCT01324830|561014162|FG010|Overall Study|Adverse Event, non-fatal|1|||
155433240|NCT01324830|561014163|FG011|Overall Study|Adverse Event, non-fatal|0|||
155433241|NCT01324830|561014164|FG012|Overall Study|Adverse Event, non-fatal|0|||
155433242|NCT01324830|561014165|FG013|Overall Study|Adverse Event, non-fatal|0|||
155433243|NCT01324830|561014166|FG014|Overall Study|Adverse Event, non-fatal|0|||
155433244|NCT01324830|561014167|FG015|Overall Study|Adverse Event, non-fatal|0|||
155433245|NCT01324830|561014168|FG016|Overall Study|Adverse Event, non-fatal|0|||
155433246|NCT01324830|561014169|FG017|Overall Study|Adverse Event, non-fatal|1|||
155433247|NCT01324830|561014170|FG018|Overall Study|Adverse Event, non-fatal|0|||
155433248|NCT01324830|561014152|FG000|Overall Study|Withdrawal by Subject|0|||
155433249|NCT01324830|561014153|FG001|Overall Study|Withdrawal by Subject|0|||
155433250|NCT01324830|561014154|FG002|Overall Study|Withdrawal by Subject|0|||
155433251|NCT01324830|561014155|FG003|Overall Study|Withdrawal by Subject|0|||
155433252|NCT01324830|561014156|FG004|Overall Study|Withdrawal by Subject|0|||
155433253|NCT01324830|561014157|FG005|Overall Study|Withdrawal by Subject|1|||
155433254|NCT01324830|561014158|FG006|Overall Study|Withdrawal by Subject|0|||
155433255|NCT01324830|561014159|FG007|Overall Study|Withdrawal by Subject|0|||
155433256|NCT01324830|561014160|FG008|Overall Study|Withdrawal by Subject|0|||
155433257|NCT01324830|561014161|FG009|Overall Study|Withdrawal by Subject|0|||
155433258|NCT01324830|561014162|FG010|Overall Study|Withdrawal by Subject|1|||
155433259|NCT01324830|561014163|FG011|Overall Study|Withdrawal by Subject|0|||
155433260|NCT01324830|561014164|FG012|Overall Study|Withdrawal by Subject|0|||
155433261|NCT01324830|561014165|FG013|Overall Study|Withdrawal by Subject|0|||
155433262|NCT01324830|561014166|FG014|Overall Study|Withdrawal by Subject|0|||
155433263|NCT01324830|561014167|FG015|Overall Study|Withdrawal by Subject|0|||
155433264|NCT01324830|561014168|FG016|Overall Study|Withdrawal by Subject|0|||
155433265|NCT01324830|561014169|FG017|Overall Study|Withdrawal by Subject|0|||
155433266|NCT01324830|561014170|FG018|Overall Study|Withdrawal by Subject|1|||
155433267|NCT01973283|561014171|FG000|Overall Study|Lost to Follow-up|4|||
155433268|NCT00817414|561014172|FG000|Overall Study|Adverse Event|1|||
155650145|NCT01699685|561812385|FG000|Period 1|Other|0|||
155650146|NCT01699685|561812386|FG001|Period 1|Other|1|||
155650147|NCT01699685|561812385|FG000|Period 1|Patient request|0|||
155650148|NCT01699685|561812386|FG001|Period 1|Patient request|1|||
155650149|NCT01699685|561812385|FG000|Period 2|Lost to Follow-up|1|||
155650150|NCT01699685|561812386|FG001|Period 2|Lost to Follow-up|0|||
155650151|NCT03635996|561812387|FG000|Overall Study|Study terminated by Sponsor|94|||
155650152|NCT03635996|561812387|FG000|Overall Study|Withdrawal by Subject|20|||
155650153|NCT03635996|561812387|FG000|Overall Study|Ablation|26|||
155650154|NCT03635996|561812387|FG000|Overall Study|Adverse Event|7|||
155650155|NCT03635996|561812387|FG000|Overall Study|Physician Decision|3|||
155650156|NCT03635996|561812387|FG000|Overall Study|Prohibited medication|5|||
155650157|NCT03635996|561812387|FG000|Overall Study|Did not meet eligibility criteria|5|||
155650158|NCT03635996|561812387|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
155433269|NCT00817414|561014173|FG001|Overall Study|Adverse Event|1|||
155433270|NCT00817414|561014174|FG002|Overall Study|Adverse Event|1|||
155433271|NCT00817414|561014175|FG003|Overall Study|Adverse Event|0|||
155433272|NCT00817414|561014176|FG004|Overall Study|Adverse Event|0|||
155650159|NCT03635996|561812387|FG000|Overall Study|Protocol Violation|1|||
155650160|NCT03635996|561812387|FG000|Overall Study|Lost to Follow-up|1|||
155650161|NCT00004228|561812390|FG000|Overall Study|Adverse Event|0|||
155433273|NCT00817414|561014172|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
155433274|NCT00817414|561014173|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
155433275|NCT00817414|561014174|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
155433276|NCT00817414|561014175|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
155433277|NCT00817414|561014176|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
155433278|NCT00817414|561014172|FG000|Overall Study|Withdrawal by Subject|1|||
155433279|NCT00817414|561014173|FG001|Overall Study|Withdrawal by Subject|1|||
155433280|NCT00817414|561014174|FG002|Overall Study|Withdrawal by Subject|0|||
155650162|NCT00004228|561812391|FG001|Overall Study|Adverse Event|1|||
155650163|NCT00004228|561812392|FG002|Overall Study|Adverse Event|0|||
155650164|NCT00004228|561812393|FG003|Overall Study|Adverse Event|0|||
155433281|NCT00817414|561014175|FG003|Overall Study|Withdrawal by Subject|0|||
155433282|NCT00817414|561014176|FG004|Overall Study|Withdrawal by Subject|0|||
155433283|NCT00817414|561014172|FG000|Overall Study|Lost to Follow-up|0|||
155433284|NCT00817414|561014173|FG001|Overall Study|Lost to Follow-up|0|||
155433285|NCT00817414|561014174|FG002|Overall Study|Lost to Follow-up|1|||
155433286|NCT00817414|561014175|FG003|Overall Study|Lost to Follow-up|1|||
155433287|NCT00817414|561014176|FG004|Overall Study|Lost to Follow-up|1|||
155433288|NCT00817414|561014172|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
155433289|NCT00817414|561014173|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
155433290|NCT00817414|561014174|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
155433291|NCT00817414|561014175|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
155433292|NCT00817414|561014176|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
155433293|NCT00817414|561014172|FG000|Overall Study|Protocol Violation|0|||
155433294|NCT00817414|561014173|FG001|Overall Study|Protocol Violation|0|||
155433295|NCT00817414|561014174|FG002|Overall Study|Protocol Violation|0|||
155433296|NCT00817414|561014175|FG003|Overall Study|Protocol Violation|0|||
155433297|NCT00817414|561014176|FG004|Overall Study|Protocol Violation|1|||
155433298|NCT00886938|561014177|FG000|Overall Study|Adverse Event|1|||
155433299|NCT00886938|561014177|FG000|Overall Study|Withdrawal by Subject|1|||
155433300|NCT03872180|561014182|FG000|Overall Study|Adverse Event|4|||
155433301|NCT03872180|561014182|FG000|Overall Study|Lack of Efficacy|2|||
155433302|NCT00947154|561014183|FG000|Overall Study|Lost to Follow-up|1|||
155433303|NCT00900796|561014186|FG000|Phase 1|Lacked sufficient information|4|||
155433304|NCT00900796|561014186|FG000|Phase 1|Missing information at Week 16|7|||
155433305|NCT00900796|561014186|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
155433306|NCT00900796|561014186|FG000|Phase 2|Lost to Follow-up|5|||
155433307|NCT02586805|561014191|FG000|Overall Study|Withdrawal by Subject|3|||
155433308|NCT02586805|561014192|FG001|Overall Study|Withdrawal by Subject|1|||
155433309|NCT02586805|561014193|FG002|Overall Study|Withdrawal by Subject|1|||
155433310|NCT02586805|561014194|FG003|Overall Study|Withdrawal by Subject|2|||
155433311|NCT02586805|561014191|FG000|Overall Study|Adverse Event|2|||
155433312|NCT02586805|561014192|FG001|Overall Study|Adverse Event|0|||
155650165|NCT00004228|561812394|FG004|Overall Study|Adverse Event|1|||
155650166|NCT00004228|561812395|FG005|Overall Study|Adverse Event|0|||
155650167|NCT00004228|561812396|FG006|Overall Study|Adverse Event|0|||
155650168|NCT00004228|561812390|FG000|Overall Study|Death|0|||
155433313|NCT02586805|561014193|FG002|Overall Study|Adverse Event|1|||
155433314|NCT02586805|561014194|FG003|Overall Study|Adverse Event|0|||
155433315|NCT02586805|561014191|FG000|Overall Study|Lost to Follow-up|0|||
155433316|NCT02586805|561014192|FG001|Overall Study|Lost to Follow-up|0|||
155433317|NCT02586805|561014193|FG002|Overall Study|Lost to Follow-up|1|||
155433318|NCT02586805|561014194|FG003|Overall Study|Lost to Follow-up|0|||
155433319|NCT02586805|561014191|FG000|Overall Study|Physician Decision|1|||
155650169|NCT00004228|561812391|FG001|Overall Study|Death|1|||
155433320|NCT02586805|561014192|FG001|Overall Study|Physician Decision|0|||
155433321|NCT02586805|561014193|FG002|Overall Study|Physician Decision|0|||
155433322|NCT02586805|561014194|FG003|Overall Study|Physician Decision|0|||
155433323|NCT01859403|561014195|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
155433324|NCT01859403|561014196|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
155433325|NCT01859403|561014195|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
155433326|NCT01859403|561014196|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
155433327|NCT01859403|561014195|FG000|Primary Endpoint Measure|Physician Decision|0|||
155433328|NCT01859403|561014196|FG001|Primary Endpoint Measure|Physician Decision|1|||
155433329|NCT01859403|561014195|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
155433330|NCT01859403|561014196|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
155433331|NCT01157117|561014197|FG000|Overall Study|Dosing Symptoms|0|||
155433332|NCT01157117|561014198|FG001|Overall Study|Dosing Symptoms|4|||
155433333|NCT01157117|561014199|FG002|Overall Study|Dosing Symptoms|0|||
155433334|NCT01157117|561014197|FG000|Overall Study|Withdrawal by Subject|4|||
155433335|NCT01157117|561014198|FG001|Overall Study|Withdrawal by Subject|1|||
155433336|NCT01157117|561014199|FG002|Overall Study|Withdrawal by Subject|1|||
155433337|NCT01157117|561014197|FG000|Overall Study|Lack of Efficacy|1|||
155433338|NCT01157117|561014198|FG001|Overall Study|Lack of Efficacy|1|||
155433339|NCT01157117|561014199|FG002|Overall Study|Lack of Efficacy|0|||
155433340|NCT01157117|561014197|FG000|Overall Study|Lost to Follow-up|0|||
155433341|NCT01157117|561014198|FG001|Overall Study|Lost to Follow-up|0|||
155433342|NCT01157117|561014199|FG002|Overall Study|Lost to Follow-up|1|||
155433343|NCT01157117|561014197|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
155433344|NCT01157117|561014198|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
155433345|NCT01157117|561014199|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
155433346|NCT00811252|561014200|FG000|Overall Study|Adverse Event|6|||
155433347|NCT00811252|561014201|FG001|Overall Study|Adverse Event|10|||
155433348|NCT00811252|561014202|FG002|Overall Study|Adverse Event|15|||
155433349|NCT00811252|561014200|FG000|Overall Study|Lack of Efficacy|7|||
155433350|NCT00811252|561014201|FG001|Overall Study|Lack of Efficacy|2|||
155433351|NCT00811252|561014202|FG002|Overall Study|Lack of Efficacy|0|||
155433352|NCT00811252|561014200|FG000|Overall Study|Protocol Violation|3|||
155433353|NCT00811252|561014201|FG001|Overall Study|Protocol Violation|3|||
155433354|NCT00811252|561014202|FG002|Overall Study|Protocol Violation|2|||
155433355|NCT00811252|561014200|FG000|Overall Study|Withdrawal of Consent|1|||
155433356|NCT00811252|561014201|FG001|Overall Study|Withdrawal of Consent|2|||
155433357|NCT00811252|561014202|FG002|Overall Study|Withdrawal of Consent|2|||
155433358|NCT00811252|561014200|FG000|Overall Study|Lost to Follow-up|0|||
155433359|NCT00811252|561014201|FG001|Overall Study|Lost to Follow-up|0|||
155433360|NCT00811252|561014202|FG002|Overall Study|Lost to Follow-up|2|||
155433361|NCT00811252|561014200|FG000|Overall Study|Administrative or Other Reasons|0|||
155433362|NCT00811252|561014201|FG001|Overall Study|Administrative or Other Reasons|3|||
155433363|NCT00811252|561014202|FG002|Overall Study|Administrative or Other Reasons|2|||
155433364|NCT00813748|561014204|FG000|Skin Test Substudy|Physician Decision|0|||
155433365|NCT00813748|561014205|FG001|Skin Test Substudy|Physician Decision|1|||
155433366|NCT01829048|561014208|FG000|Overall Study|Withdrawal by Subject|0|||
155433367|NCT01829048|561014209|FG001|Overall Study|Withdrawal by Subject|0|||
155433368|NCT01829048|561014210|FG002|Overall Study|Withdrawal by Subject|0|||
155433369|NCT01829048|561014211|FG003|Overall Study|Withdrawal by Subject|2|||
155433370|NCT01829048|561014212|FG004|Overall Study|Withdrawal by Subject|0|||
155433371|NCT00892437|561014213|FG000|Randomized Phase|Randomized but not treated|6|||
155433372|NCT00892437|561014214|FG001|Randomized Phase|Randomized but not treated|0|||
155433373|NCT00892437|561014213|FG000|Randomized Phase|Adverse Event|2|||
155433374|NCT00892437|561014214|FG001|Randomized Phase|Adverse Event|2|||
155433375|NCT00892437|561014213|FG000|Randomized Phase|Lost to Follow-up|1|||
155433376|NCT00892437|561014214|FG001|Randomized Phase|Lost to Follow-up|3|||
155433377|NCT00892437|561014213|FG000|Randomized Phase|Investigator's Discretion|1|||
155433378|NCT00892437|561014214|FG001|Randomized Phase|Investigator's Discretion|0|||
155433379|NCT00892437|561014213|FG000|Randomized Phase|Withdrew Consent|1|||
155433380|NCT00892437|561014214|FG001|Randomized Phase|Withdrew Consent|0|||
155433381|NCT00892437|561014213|FG000|Open-Label Extension Phase|Adverse Event|4|||
155433382|NCT00892437|561014214|FG001|Open-Label Extension Phase|Adverse Event|2|||
155433383|NCT00892437|561014213|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
155433384|NCT00892437|561014214|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
155433385|NCT00892437|561014213|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
155433386|NCT00892437|561014214|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
155433387|NCT00892437|561014213|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
155433388|NCT00892437|561014214|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
155433389|NCT00892437|561014213|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
155433390|NCT00892437|561014214|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
155433391|NCT03185130|561014216|FG000|Overall Study|Withdrawal by Subject|0|||
155433392|NCT03185130|561014217|FG001|Overall Study|Withdrawal by Subject|2|||
155433393|NCT02286960|561014218|FG000|Overall Study|Lost to Follow-up|3|||
155433394|NCT02286960|561014219|FG001|Overall Study|Lost to Follow-up|3|||
155512866|NCT03264066|561302742|FG005|Overall Study|Study Terminated by Sponsor|2|||
155512867|NCT03264066|561302737|FG000|Overall Study|Withdrawal by Subject|1|||
155512868|NCT03264066|561302738|FG001|Overall Study|Withdrawal by Subject|0|||
155512869|NCT03264066|561302739|FG002|Overall Study|Withdrawal by Subject|0|||
155512870|NCT03264066|561302740|FG003|Overall Study|Withdrawal by Subject|5|||
155512871|NCT03264066|561302741|FG004|Overall Study|Withdrawal by Subject|0|||
155512872|NCT03264066|561302742|FG005|Overall Study|Withdrawal by Subject|0|||
155433395|NCT02504541|561014221|FG000|Overall Study|Adverse Event|4|||
155433396|NCT02504541|561014221|FG000|Overall Study|Withdrawal by Subject|4|||
155433397|NCT02504541|561014221|FG000|Overall Study|Lost to Follow-up|1|||
155433398|NCT02504541|561014221|FG000|Overall Study|Met Stopping Criteria|1|||
155433399|NCT02504541|561014221|FG000|Overall Study|Protocol Violation|2|||
155433400|NCT02504541|561014221|FG000|Overall Study|Termination by Sponsor|1|||
155433401|NCT02504541|561014221|FG000|Overall Study|Other|2|||
155433402|NCT02504541|561014221|FG000|Overall Study|Multiple|5|||
155433403|NCT02317510|561014235|FG000|Overall Study|Adverse Event|0|||
155433404|NCT02317510|561014236|FG001|Overall Study|Adverse Event|1|||
155433405|NCT00472303|561014237|FG000|Titration Phase|Adverse Event|22|||
155433406|NCT00472303|561014238|FG001|Titration Phase|Adverse Event|12|||
155433407|NCT00472303|561014239|FG002|Titration Phase|Adverse Event|0|||
155433408|NCT00472303|561014237|FG000|Titration Phase|Death|4|||
155433409|NCT00472303|561014238|FG001|Titration Phase|Death|2|||
155433410|NCT00472303|561014239|FG002|Titration Phase|Death|0|||
155433411|NCT00472303|561014237|FG000|Titration Phase|Lack of Efficacy|10|||
155433412|NCT00472303|561014238|FG001|Titration Phase|Lack of Efficacy|0|||
155433413|NCT00472303|561014239|FG002|Titration Phase|Lack of Efficacy|0|||
155433414|NCT00472303|561014237|FG000|Titration Phase|Withdrawal by Subject|16|||
155433415|NCT00472303|561014238|FG001|Titration Phase|Withdrawal by Subject|13|||
155433416|NCT00472303|561014239|FG002|Titration Phase|Withdrawal by Subject|0|||
155433417|NCT00472303|561014237|FG000|Titration Phase|Trial Medication non-compliant|4|||
155433418|NCT00472303|561014238|FG001|Titration Phase|Trial Medication non-compliant|1|||
155433419|NCT00472303|561014239|FG002|Titration Phase|Trial Medication non-compliant|0|||
155433420|NCT00472303|561014237|FG000|Titration Phase|Other|3|||
155512873|NCT01484028|561302743|FG000|Period 1|Lost to Follow-up|0|||
155512874|NCT01484028|561302744|FG001|Period 1|Lost to Follow-up|1|||
155512875|NCT01484028|561302745|FG002|Period 1|Lost to Follow-up|0|||
155512876|NCT01484028|561302746|FG003|Period 1|Lost to Follow-up|0|||
155512877|NCT01484028|561302743|FG000|Period 1|Non-Compliance to Protocol|0|||
155512878|NCT01484028|561302744|FG001|Period 1|Non-Compliance to Protocol|1|||
155512879|NCT01484028|561302745|FG002|Period 1|Non-Compliance to Protocol|0|||
155512880|NCT01484028|561302746|FG003|Period 1|Non-Compliance to Protocol|1|||
155512881|NCT01484028|561302743|FG000|Period 1|Lens Discomfort|0|||
155512882|NCT01484028|561302744|FG001|Period 1|Lens Discomfort|1|||
155512883|NCT01484028|561302745|FG002|Period 1|Lens Discomfort|0|||
155512884|NCT01484028|561302746|FG003|Period 1|Lens Discomfort|0|||
155512885|NCT01193517|561302762|FG000|Overall Study|Early Progression|1|||
155512886|NCT01193517|561302763|FG001|Overall Study|Early Progression|0|||
155512887|NCT01193517|561302764|FG002|Overall Study|Early Progression|0|||
155512888|NCT04014959|561304288|FG000|Baseline MRI and Assessments|Physician Decision|2|||
155512889|NCT04014959|561304288|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
155512890|NCT04014959|561304288|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
155512891|NCT02004847|561304290|FG000|Overall Study|Protocol Violation|1|||
155512892|NCT02004847|561304291|FG001|Overall Study|Protocol Violation|1|||
155512893|NCT00759148|561304292|FG000|Overall Study|Adverse Event|1|||
155512894|NCT00759148|561304293|FG001|Overall Study|Adverse Event|6|||
155512895|NCT00759148|561304292|FG000|Overall Study|Withdrawal by Subject|3|||
155512896|NCT00759148|561304293|FG001|Overall Study|Withdrawal by Subject|7|||
155512897|NCT00759148|561304292|FG000|Overall Study|Lost to Follow-up|3|||
155512898|NCT00759148|561304293|FG001|Overall Study|Lost to Follow-up|9|||
155512899|NCT00759148|561304292|FG000|Overall Study|Treatment Failure|6|||
155512900|NCT00759148|561304293|FG001|Overall Study|Treatment Failure|10|||
155512901|NCT00759148|561304292|FG000|Overall Study|Reason not given|1|||
155512902|NCT00759148|561304293|FG001|Overall Study|Reason not given|0|||
155512903|NCT01644890|561304294|FG000|Overall Study|Adverse Event|7|||
155512904|NCT01644890|561304295|FG001|Overall Study|Adverse Event|20|||
155512905|NCT01644890|561304294|FG000|Overall Study|Death|1|||
155512906|NCT01644890|561304295|FG001|Overall Study|Death|3|||
155512907|NCT01644890|561304294|FG000|Overall Study|Physician Decision|3|||
155512908|NCT01644890|561304295|FG001|Overall Study|Physician Decision|9|||
155512909|NCT01644890|561304294|FG000|Overall Study|Protocol Violation|6|||
155433421|NCT00472303|561014238|FG001|Titration Phase|Other|1|||
155433422|NCT00472303|561014239|FG002|Titration Phase|Other|0|||
155433423|NCT00472303|561014237|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
155433424|NCT00472303|561014238|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
155433425|NCT00472303|561014239|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
155433426|NCT00472303|561014237|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
155433427|NCT00472303|561014238|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
155512910|NCT01644890|561304295|FG001|Overall Study|Protocol Violation|7|||
155512911|NCT01644890|561304294|FG000|Overall Study|Withdrawal by Subject|19|||
155433428|NCT00472303|561014239|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
155433429|NCT00472303|561014237|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
155433430|NCT00472303|561014238|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
155433431|NCT00472303|561014239|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
155433432|NCT00472303|561014237|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
155433433|NCT00472303|561014238|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
155433434|NCT00472303|561014239|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
155433435|NCT00472303|561014237|FG000|Discontinuations After Titration Phase|Other|5|||
155512912|NCT01644890|561304295|FG001|Overall Study|Withdrawal by Subject|27|||
155512913|NCT01644890|561304294|FG000|Overall Study|Progression Disease|160|||
155512914|NCT01644890|561304295|FG001|Overall Study|Progression Disease|131|||
155512915|NCT01644890|561304294|FG000|Overall Study|Clinical Progression|6|||
155512916|NCT01644890|561304295|FG001|Overall Study|Clinical Progression|6|||
155512917|NCT01644890|561304294|FG000|Overall Study|> 28 days since last dose of study drug|6|||
155512918|NCT01644890|561304295|FG001|Overall Study|> 28 days since last dose of study drug|3|||
155512919|NCT01644890|561304294|FG000|Overall Study|Other|8|||
155512920|NCT01644890|561304295|FG001|Overall Study|Other|9|||
155512921|NCT03031899|561304298|FG000|Overall Study|Protocol Violation|1|||
155512922|NCT03031899|561304298|FG000|Overall Study|lesion disappeared after stopping habit|1|||
155512923|NCT03705351|561304299|FG000|Overall Study|Study termination|3|||
155512924|NCT03705351|561304299|FG000|Overall Study|Death|1|||
155433436|NCT00472303|561014238|FG001|Discontinuations After Titration Phase|Other|0|||
155433437|NCT00472303|561014239|FG002|Discontinuations After Titration Phase|Other|0|||
155433438|NCT00472303|561014237|FG000|Maintenance Phase|Adverse Event|5|||
155433439|NCT00472303|561014238|FG001|Maintenance Phase|Adverse Event|6|||
155512925|NCT03705351|561304299|FG000|Overall Study|Lack of Efficacy|2|||
155433440|NCT00472303|561014239|FG002|Maintenance Phase|Adverse Event|6|||
155433441|NCT00472303|561014237|FG000|Maintenance Phase|Death|3|||
155433442|NCT00472303|561014238|FG001|Maintenance Phase|Death|0|||
155433443|NCT00472303|561014239|FG002|Maintenance Phase|Death|2|||
155433444|NCT00472303|561014237|FG000|Maintenance Phase|Lack of Efficacy|2|||
155433445|NCT00472303|561014238|FG001|Maintenance Phase|Lack of Efficacy|2|||
155433446|NCT00472303|561014239|FG002|Maintenance Phase|Lack of Efficacy|4|||
155433447|NCT00472303|561014237|FG000|Maintenance Phase|Withdrawal by Subject|6|||
155433448|NCT00472303|561014238|FG001|Maintenance Phase|Withdrawal by Subject|7|||
155433449|NCT00472303|561014239|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155433450|NCT00472303|561014237|FG000|Maintenance Phase|Trial medication non-compliant|0|||
155433451|NCT00472303|561014238|FG001|Maintenance Phase|Trial medication non-compliant|0|||
155433452|NCT00472303|561014239|FG002|Maintenance Phase|Trial medication non-compliant|1|||
155433453|NCT00472303|561014237|FG000|Maintenance Phase|Resolution of pain|0|||
155433454|NCT00472303|561014238|FG001|Maintenance Phase|Resolution of pain|0|||
155433455|NCT00472303|561014239|FG002|Maintenance Phase|Resolution of pain|1|||
155433456|NCT00472303|561014237|FG000|Maintenance Phase|Other|1|||
155433457|NCT00472303|561014238|FG001|Maintenance Phase|Other|1|||
155433458|NCT00472303|561014239|FG002|Maintenance Phase|Other|0|||
155433459|NCT01122927|561014240|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
155433460|NCT01122927|561014241|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
155433461|NCT01122927|561014240|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
155433462|NCT01122927|561014241|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155433463|NCT01122927|561014240|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
155433464|NCT01122927|561014241|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
155433465|NCT01122927|561014240|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
155433466|NCT01122927|561014241|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155433467|NCT01122927|561014240|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
155433468|NCT01122927|561014241|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
155433469|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
155433470|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
155433471|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
155433472|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
155433473|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
155433474|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
155433475|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
155433476|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
155512926|NCT03705351|561304299|FG000|Overall Study|Withdrawal by Subject|1|||
155512927|NCT00633152|561304302|FG000|Overall Study|Adverse Event|1|||
155512928|NCT00633152|561304303|FG001|Overall Study|Adverse Event|0|||
155433477|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
155433478|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
155433479|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
155433480|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
155433481|NCT01122927|561014240|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
155650170|NCT00004228|561812392|FG002|Overall Study|Death|2|||
155433482|NCT01122927|561014241|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
155650171|NCT00004228|561812393|FG003|Overall Study|Death|0|||
155650172|NCT00004228|561812394|FG004|Overall Study|Death|1|||
155650173|NCT00004228|561812395|FG005|Overall Study|Death|0|||
155650174|NCT00004228|561812396|FG006|Overall Study|Death|0|||
155650175|NCT00004228|561812390|FG000|Overall Study|Lack of Efficacy|1|||
155650176|NCT00004228|561812391|FG001|Overall Study|Lack of Efficacy|6|||
155650177|NCT00004228|561812392|FG002|Overall Study|Lack of Efficacy|5|||
155650178|NCT00004228|561812393|FG003|Overall Study|Lack of Efficacy|3|||
155650179|NCT00004228|561812394|FG004|Overall Study|Lack of Efficacy|9|||
155650180|NCT00004228|561812395|FG005|Overall Study|Lack of Efficacy|8|||
155650181|NCT00004228|561812396|FG006|Overall Study|Lack of Efficacy|4|||
155650182|NCT00004228|561812390|FG000|Overall Study|Lost to Follow-up|0|||
155650183|NCT00004228|561812391|FG001|Overall Study|Lost to Follow-up|0|||
155650184|NCT00004228|561812392|FG002|Overall Study|Lost to Follow-up|1|||
155650185|NCT00004228|561812393|FG003|Overall Study|Lost to Follow-up|0|||
155650186|NCT00004228|561812394|FG004|Overall Study|Lost to Follow-up|0|||
155650187|NCT00004228|561812395|FG005|Overall Study|Lost to Follow-up|0|||
155650188|NCT00004228|561812396|FG006|Overall Study|Lost to Follow-up|0|||
155650189|NCT00004228|561812390|FG000|Overall Study|Physician Decision|1|||
155650190|NCT00004228|561812391|FG001|Overall Study|Physician Decision|0|||
155650191|NCT00004228|561812392|FG002|Overall Study|Physician Decision|3|||
155650192|NCT00004228|561812393|FG003|Overall Study|Physician Decision|2|||
155650193|NCT00004228|561812394|FG004|Overall Study|Physician Decision|1|||
155650194|NCT00004228|561812395|FG005|Overall Study|Physician Decision|1|||
155650195|NCT00004228|561812396|FG006|Overall Study|Physician Decision|1|||
155650196|NCT00004228|561812390|FG000|Overall Study|Protocol Violation|0|||
155650197|NCT00004228|561812391|FG001|Overall Study|Protocol Violation|5|||
155650198|NCT00004228|561812392|FG002|Overall Study|Protocol Violation|2|||
155650199|NCT00004228|561812393|FG003|Overall Study|Protocol Violation|1|||
155650200|NCT00004228|561812394|FG004|Overall Study|Protocol Violation|1|||
155650201|NCT00004228|561812395|FG005|Overall Study|Protocol Violation|2|||
155650202|NCT00004228|561812396|FG006|Overall Study|Protocol Violation|0|||
155650203|NCT00004228|561812390|FG000|Overall Study|Withdrawal by Subject|3|||
155650204|NCT00004228|561812391|FG001|Overall Study|Withdrawal by Subject|0|||
155650205|NCT00004228|561812392|FG002|Overall Study|Withdrawal by Subject|1|||
155650206|NCT00004228|561812393|FG003|Overall Study|Withdrawal by Subject|0|||
155650207|NCT00004228|561812394|FG004|Overall Study|Withdrawal by Subject|2|||
155650208|NCT00004228|561812395|FG005|Overall Study|Withdrawal by Subject|1|||
155650209|NCT00004228|561812396|FG006|Overall Study|Withdrawal by Subject|2|||
155650210|NCT00004228|561812390|FG000|Overall Study|Other|0|||
155650211|NCT00004228|561812391|FG001|Overall Study|Other|0|||
155650212|NCT00004228|561812392|FG002|Overall Study|Other|1|||
155650213|NCT00004228|561812393|FG003|Overall Study|Other|0|||
155650214|NCT00004228|561812394|FG004|Overall Study|Other|0|||
155433483|NCT03427073|561014249|FG000|Overall Study|Disease Progression|1|||
155433484|NCT03427073|561014250|FG001|Overall Study|Disease Progression|1|||
155650215|NCT00004228|561812395|FG005|Overall Study|Other|0|||
155650216|NCT00004228|561812396|FG006|Overall Study|Other|0|||
155433485|NCT03427073|561014251|FG002|Overall Study|Disease Progression|1|||
155433486|NCT03427073|561014252|FG003|Overall Study|Disease Progression|3|||
155433487|NCT03427073|561014253|FG004|Overall Study|Disease Progression|3|||
155433488|NCT03427073|561014254|FG005|Overall Study|Disease Progression|4|||
155433489|NCT03427073|561014255|FG006|Overall Study|Disease Progression|2|||
155433490|NCT03427073|561014256|FG007|Overall Study|Disease Progression|3|||
155433491|NCT03427073|561014249|FG000|Overall Study|Physician Decision|0|||
155433492|NCT03427073|561014250|FG001|Overall Study|Physician Decision|0|||
155433493|NCT03427073|561014251|FG002|Overall Study|Physician Decision|0|||
155433494|NCT03427073|561014252|FG003|Overall Study|Physician Decision|0|||
155433495|NCT03427073|561014253|FG004|Overall Study|Physician Decision|0|||
155433496|NCT03427073|561014254|FG005|Overall Study|Physician Decision|0|||
155433497|NCT03427073|561014255|FG006|Overall Study|Physician Decision|1|||
155433498|NCT03427073|561014256|FG007|Overall Study|Physician Decision|1|||
155433499|NCT01244737|561014257|FG000|Overall Study|Physician Decision|2|||
155433500|NCT01244737|561014258|FG001|Overall Study|Physician Decision|18|||
155433501|NCT01244737|561014259|FG002|Overall Study|Physician Decision|5|||
155650217|NCT00004228|561812390|FG000|Overall Study|ineligible|4|||
155650218|NCT00004228|561812391|FG001|Overall Study|ineligible|2|||
155650219|NCT00004228|561812392|FG002|Overall Study|ineligible|4|||
155650220|NCT00004228|561812393|FG003|Overall Study|ineligible|1|||
155650221|NCT00004228|561812394|FG004|Overall Study|ineligible|1|||
155433502|NCT01244737|561014257|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
155433503|NCT01244737|561014258|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
155433504|NCT01244737|561014259|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
155433505|NCT01244737|561014257|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
155650222|NCT00004228|561812395|FG005|Overall Study|ineligible|2|||
155650223|NCT00004228|561812396|FG006|Overall Study|ineligible|5|||
155650224|NCT01013870|561812400|FG000|Overall Study|Lost to Follow-up|1|||
155650225|NCT01013870|561812401|FG001|Overall Study|Lost to Follow-up|3|||
155650226|NCT00090402|561812402|FG000|Overall Study|Death|1|||
155650227|NCT00090402|561812403|FG001|Overall Study|Death|1|||
155650228|NCT00090402|561812404|FG002|Overall Study|Death|0|||
155650229|NCT00090402|561812402|FG000|Overall Study|subject moved|0|||
155650230|NCT00090402|561812403|FG001|Overall Study|subject moved|1|||
155650231|NCT00090402|561812404|FG002|Overall Study|subject moved|0|||
155650232|NCT00090402|561812402|FG000|Overall Study|stopped taking study medication|1|||
155650233|NCT00090402|561812403|FG001|Overall Study|stopped taking study medication|0|||
155650234|NCT00090402|561812404|FG002|Overall Study|stopped taking study medication|1|||
155650235|NCT00862277|561812409|FG000|Overall Study|Protocol Violation|1|||
155650236|NCT00862277|561812410|FG001|Overall Study|Protocol Violation|2|||
155650237|NCT00862277|561812411|FG002|Overall Study|Protocol Violation|5|||
155650238|NCT02168439|561812412|FG000|Overall Study|Protocol Violation|0|||
155650239|NCT02168439|561812413|FG001|Overall Study|Protocol Violation|2|||
155650240|NCT01292473|561812414|FG000|Overall Study|Adverse Event|1|||
155650241|NCT01292473|561812415|FG001|Overall Study|Adverse Event|0|||
155650242|NCT01292473|561812416|FG002|Overall Study|Adverse Event|1|||
155650243|NCT01292473|561812417|FG003|Overall Study|Adverse Event|1|||
155650244|NCT01292473|561812414|FG000|Overall Study|Lost to Follow-up|1|||
155650245|NCT01292473|561812415|FG001|Overall Study|Lost to Follow-up|1|||
155650246|NCT01292473|561812416|FG002|Overall Study|Lost to Follow-up|2|||
155650247|NCT01292473|561812417|FG003|Overall Study|Lost to Follow-up|2|||
155650248|NCT01292473|561812414|FG000|Overall Study|Withdrawal by Subject|3|||
155650249|NCT01292473|561812415|FG001|Overall Study|Withdrawal by Subject|4|||
155650250|NCT01292473|561812416|FG002|Overall Study|Withdrawal by Subject|3|||
155650251|NCT01292473|561812417|FG003|Overall Study|Withdrawal by Subject|3|||
155650252|NCT01292473|561812414|FG000|Overall Study|Physician Decision|0|||
155650253|NCT01292473|561812415|FG001|Overall Study|Physician Decision|1|||
155650254|NCT01292473|561812416|FG002|Overall Study|Physician Decision|0|||
155650255|NCT01292473|561812417|FG003|Overall Study|Physician Decision|0|||
155650256|NCT01292473|561812414|FG000|Overall Study|Disease Progression|0|||
155650257|NCT01292473|561812415|FG001|Overall Study|Disease Progression|1|||
155650258|NCT01292473|561812416|FG002|Overall Study|Disease Progression|3|||
155650259|NCT01292473|561812417|FG003|Overall Study|Disease Progression|6|||
155650260|NCT04432298|561812418|FG000|Overall Study|Other than specified|1|||
155650261|NCT04432298|561812419|FG001|Overall Study|Other than specified|0|||
155650262|NCT04432298|561812418|FG000|Overall Study|Lost to Follow-up|0|||
155650263|NCT04432298|561812419|FG001|Overall Study|Lost to Follow-up|1|||
155650264|NCT04432298|561812418|FG000|Overall Study|Death|3|||
155650265|NCT04432298|561812419|FG001|Overall Study|Death|2|||
155650266|NCT04432298|561812418|FG000|Overall Study|Withdrawal by Subject|2|||
155650267|NCT04432298|561812419|FG001|Overall Study|Withdrawal by Subject|0|||
155650268|NCT02451007|561812420|FG000|Overall Study|Withdrawal by Subject|4|||
155650269|NCT02451007|561812420|FG000|Overall Study|Adverse Event|1|||
155650270|NCT02451007|561812420|FG000|Overall Study|Disease Progression|2|||
155650271|NCT01716559|561812421|FG000|Overall Study|Adverse Event|11|||
155650272|NCT01716559|561812421|FG000|Overall Study|Death|21|||
155650273|NCT01716559|561812421|FG000|Overall Study|Withdrawal by Subject|4|||
155650274|NCT01716559|561812421|FG000|Overall Study|Other withdrawal reason|75|||
155650275|NCT00348374|561812422|FG000|Overall Study|Adverse Event|1|||
155650276|NCT00348374|561812423|FG001|Overall Study|Adverse Event|4|||
155650277|NCT00348374|561812422|FG000|Overall Study|Lost to Follow-up|1|||
155650278|NCT00348374|561812423|FG001|Overall Study|Lost to Follow-up|3|||
155650279|NCT00348374|561812422|FG000|Overall Study|Withdrawal by Subject|5|||
155650280|NCT00348374|561812423|FG001|Overall Study|Withdrawal by Subject|5|||
155650281|NCT00348374|561812422|FG000|Overall Study|Other|11|||
155650282|NCT00348374|561812423|FG001|Overall Study|Other|12|||
155650283|NCT00348374|561812422|FG000|Overall Study|ongoing at date of cutoff|1|||
155650284|NCT00348374|561812423|FG001|Overall Study|ongoing at date of cutoff|1|||
155650285|NCT00348374|561812422|FG000|Overall Study|randomized but did not receive treatment|0|||
155650286|NCT00348374|561812423|FG001|Overall Study|randomized but did not receive treatment|7|||
155650287|NCT02180672|561812432|FG000|Overall Study|Lost to Follow-up|5|||
155650288|NCT02180672|561812433|FG001|Overall Study|Lost to Follow-up|7|||
155650293|NCT01697501|561812439|FG000|Overall Study|Protocol Violation|2|||
155650294|NCT02242903|561812440|FG000|Overall Study|Withdrawal by Subject|1|||
155650295|NCT02242903|561812441|FG001|Overall Study|Withdrawal by Subject|0|||
155650296|NCT02242903|561812442|FG002|Overall Study|Withdrawal by Subject|0|||
155650297|NCT02242903|561812443|FG003|Overall Study|Withdrawal by Subject|0|||
155650298|NCT02242903|561812444|FG004|Overall Study|Withdrawal by Subject|0|||
155650299|NCT02242903|561812445|FG005|Overall Study|Withdrawal by Subject|0|||
155650300|NCT02242903|561812446|FG006|Overall Study|Withdrawal by Subject|0|||
155512929|NCT00633152|561304302|FG000|Overall Study|Randomized, did not receive study drug|5|||
155512930|NCT00633152|561304303|FG001|Overall Study|Randomized, did not receive study drug|2|||
155512931|NCT00633152|561304302|FG000|Overall Study|Withdrawal by Subject|1|||
155512932|NCT00633152|561304303|FG001|Overall Study|Withdrawal by Subject|1|||
155512933|NCT00633152|561304302|FG000|Overall Study|Lost to Follow-up|4|||
155512934|NCT00633152|561304303|FG001|Overall Study|Lost to Follow-up|1|||
155512935|NCT00633152|561304302|FG000|Overall Study|Miscellaneous Other|3|||
155512936|NCT00633152|561304303|FG001|Overall Study|Miscellaneous Other|2|||
155512937|NCT02180061|561304304|FG000|Overall Study|Adverse Event|4|||
155512938|NCT02180061|561304305|FG001|Overall Study|Adverse Event|2|||
155512939|NCT02180061|561304304|FG000|Overall Study|Clinical Progression|5|||
155512940|NCT02180061|561304305|FG001|Overall Study|Clinical Progression|1|||
155512941|NCT02180061|561304304|FG000|Overall Study|Progressive Disease|15|||
155512942|NCT02180061|561304305|FG001|Overall Study|Progressive Disease|5|||
155512943|NCT02180061|561304304|FG000|Overall Study|Physician Decision|1|||
155512944|NCT02180061|561304305|FG001|Overall Study|Physician Decision|0|||
155512945|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
155512946|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
155512947|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
155512948|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
155512949|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
155512950|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
155512951|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
155512952|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
155512953|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
155512954|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
155512955|NCT00056160|561304308|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
155512956|NCT00056160|561304309|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
155512957|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
155512958|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
155512959|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
155512960|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
155512961|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
155512962|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
155512963|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
155512964|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
155512965|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
155512966|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
155512967|NCT00056160|561304308|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
155512968|NCT00056160|561304309|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
155512969|NCT00056160|561304308|FG000|Final Follow-up|Transferred into expanded access study.|3|||
155512970|NCT00056160|561304309|FG001|Final Follow-up|Transferred into expanded access study.|0|||
155512971|NCT00056160|561304308|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
155512972|NCT00056160|561304309|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
155512973|NCT00056160|561304308|FG000|Final Follow-up|Adverse Event|1|||
155512974|NCT00056160|561304309|FG001|Final Follow-up|Adverse Event|0|||
155512975|NCT01590433|561304313|FG000|Overall Study|Lost to Follow-up|20|||
155512976|NCT01590433|561304314|FG001|Overall Study|Lost to Follow-up|8|||
155512977|NCT01590433|561304313|FG000|Overall Study|Withdrawal by Subject|21|||
155512978|NCT01590433|561304314|FG001|Overall Study|Withdrawal by Subject|11|||
155512979|NCT01590433|561304313|FG000|Overall Study|Adverse Event|11|||
155512980|NCT01590433|561304314|FG001|Overall Study|Adverse Event|3|||
155512981|NCT00555009|561304315|FG000|Overall Study|Withdrawal by Subject|0|||
155512982|NCT00555009|561304316|FG001|Overall Study|Withdrawal by Subject|1|||
155512983|NCT00555009|561304315|FG000|Overall Study|Terminated by Sponsor|2|||
155512984|NCT00555009|561304316|FG001|Overall Study|Terminated by Sponsor|5|||
155512985|NCT03731182|561304325|FG000|Overall Study|Lost to Follow-up|2|||
155512986|NCT03731182|561304326|FG001|Overall Study|Lost to Follow-up|0|||
155512987|NCT03731182|561304325|FG000|Overall Study|Physician Decision|1|||
155512988|NCT03731182|561304326|FG001|Overall Study|Physician Decision|0|||
155512989|NCT03731182|561304325|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
155512990|NCT03731182|561304326|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155512991|NCT01751412|561304327|FG000|Overall Study|Disease Progression Before Treatment|1|||
155512992|NCT03734237|561304330|FG000|Overall Study|Lost to Follow-up|1|||
155512993|NCT03734237|561304331|FG001|Overall Study|Lost to Follow-up|3|||
155512994|NCT03734237|561304332|FG002|Overall Study|Lost to Follow-up|0|||
155512995|NCT03734237|561304330|FG000|Overall Study|Withdrawal by Subject|7|||
155512996|NCT03734237|561304331|FG001|Overall Study|Withdrawal by Subject|9|||
155512997|NCT03734237|561304332|FG002|Overall Study|Withdrawal by Subject|10|||
155512998|NCT01844583|561304333|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
155512999|NCT01844583|561304334|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
155513000|NCT02207621|561304335|FG000|Overall Study|Adverse Event|71|||
155513001|NCT02207621|561304336|FG001|Overall Study|Adverse Event|15|||
155433506|NCT01244737|561014258|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
155433507|NCT01244737|561014259|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
155433508|NCT01244737|561014257|FG000|Overall Study|MIB immunopathology results not available|3|||
155433509|NCT01244737|561014258|FG001|Overall Study|MIB immunopathology results not available|2|||
155433510|NCT01244737|561014259|FG002|Overall Study|MIB immunopathology results not available|0|||
155433511|NCT01244737|561014257|FG000|Overall Study|PET data failure|0|||
155433512|NCT01244737|561014258|FG001|Overall Study|PET data failure|1|||
155433513|NCT01244737|561014259|FG002|Overall Study|PET data failure|0|||
155433514|NCT01244737|561014257|FG000|Overall Study|Withdrawal by Subject|0|||
155433515|NCT01244737|561014258|FG001|Overall Study|Withdrawal by Subject|0|||
155433516|NCT01244737|561014259|FG002|Overall Study|Withdrawal by Subject|1|||
155433517|NCT02835495|561014262|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
155433518|NCT02835495|561014263|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
155433519|NCT02835495|561014262|FG000|Overall Study|Declined in-person follow-up visit|4|||
155433520|NCT02835495|561014263|FG001|Overall Study|Declined in-person follow-up visit|2|||
155433521|NCT02371629|561014265|FG000|Overall Study|Patient decision|14|||
155433522|NCT02371629|561014266|FG001|Overall Study|Patient decision|10|||
155433523|NCT02371629|561014265|FG000|Overall Study|Adverse Event|8|||
155433524|NCT02371629|561014266|FG001|Overall Study|Adverse Event|8|||
155433525|NCT02371629|561014265|FG000|Overall Study|Physician Decision|2|||
155433526|NCT02371629|561014266|FG001|Overall Study|Physician Decision|3|||
155433527|NCT02371629|561014265|FG000|Overall Study|Death|1|||
155433528|NCT02371629|561014266|FG001|Overall Study|Death|1|||
155433529|NCT02371629|561014265|FG000|Overall Study|Noncompliance with study treatment|1|||
155433530|NCT02371629|561014266|FG001|Overall Study|Noncompliance with study treatment|0|||
155433531|NCT02371629|561014265|FG000|Overall Study|Lack of Efficacy|0|||
155433532|NCT02371629|561014266|FG001|Overall Study|Lack of Efficacy|2|||
155433533|NCT02371629|561014265|FG000|Overall Study|Protocol deviation|0|||
155433534|NCT02371629|561014266|FG001|Overall Study|Protocol deviation|1|||
155433535|NCT03486314|561014267|FG000|Part A|Adverse Event|1|||
155433536|NCT03486314|561014268|FG001|Part A|Adverse Event|0|||
155433537|NCT03486314|561014269|FG002|Part A|Adverse Event|0|||
155433538|NCT03486314|561014267|FG000|Part A|Symptomatic Deterioration|2|||
155433539|NCT03486314|561014268|FG001|Part A|Symptomatic Deterioration|0|||
155433540|NCT03486314|561014269|FG002|Part A|Symptomatic Deterioration|0|||
155433541|NCT00542828|561014274|FG000|Overall Study|Physician Decision|1|||
155433542|NCT00542828|561014274|FG000|Overall Study|Need for Prohibited Treatment|3|||
155433543|NCT00542828|561014274|FG000|Overall Study|Study Prematurely Discontinued|7|||
155433544|NCT00542828|561014274|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
155433545|NCT01364467|561014275|FG000|Overall Study|Lost to Follow-up|1|||
155433546|NCT01364467|561014276|FG001|Overall Study|Lost to Follow-up|2|||
155433547|NCT01634243|561014277|FG000|Overall Study|Adverse Event|5|||
155433548|NCT01634243|561014278|FG001|Overall Study|Adverse Event|5|||
155433549|NCT01634243|561014277|FG000|Overall Study|Lack of Efficacy|1|||
155433550|NCT01634243|561014278|FG001|Overall Study|Lack of Efficacy|0|||
155433551|NCT04283461|561014279|FG000|Overall Study|Enrolled in separate trial|0|||
155433552|NCT04283461|561014280|FG001|Overall Study|Enrolled in separate trial|0|||
155433553|NCT04283461|561014281|FG002|Overall Study|Enrolled in separate trial|8|||
155433554|NCT04283461|561014282|FG003|Overall Study|Enrolled in separate trial|13|||
155433555|NCT04283461|561014283|FG004|Overall Study|Enrolled in separate trial|12|||
155433556|NCT04283461|561014284|FG005|Overall Study|Enrolled in separate trial|0|||
155433557|NCT04283461|561014285|FG006|Overall Study|Enrolled in separate trial|0|||
155433558|NCT04283461|561014286|FG007|Overall Study|Enrolled in separate trial|8|||
155433559|NCT04283461|561014287|FG008|Overall Study|Enrolled in separate trial|0|||
155433560|NCT04283461|561014288|FG009|Overall Study|Enrolled in separate trial|0|||
155433561|NCT04283461|561014289|FG010|Overall Study|Enrolled in separate trial|0|||
155433562|NCT04283461|561014290|FG011|Overall Study|Enrolled in separate trial|7|||
155433563|NCT04283461|561014291|FG012|Overall Study|Enrolled in separate trial|0|||
155433564|NCT05490771|561014292|FG000|Overall Study|Disease progression|18|||
155433565|NCT05490771|561014292|FG000|Overall Study|Adverse Event|3|||
155433566|NCT05490771|561014292|FG000|Overall Study|Other complicating disease|1|||
155433567|NCT05490771|561014292|FG000|Overall Study|Withdrawal by Subject|3|||
155433568|NCT05490771|561014292|FG000|Overall Study|Physician Decision|1|||
155433569|NCT05490771|561014292|FG000|Overall Study|Still on treatment|2|||
155433570|NCT05490771|561014292|FG000|Overall Study|Never start protocol therapy|5|||
155433571|NCT05490771|561014292|FG000|Overall Study|Ineligible|2|||
155433572|NCT00816036|561014295|FG000|Overall Study|Death|47|||
155433573|NCT00816036|561014296|FG001|Overall Study|Death|28|||
155433574|NCT00816036|561014295|FG000|Overall Study|Lost to Follow-up|75|||
155433575|NCT00816036|561014296|FG001|Overall Study|Lost to Follow-up|57|||
155433576|NCT00816036|561014295|FG000|Overall Study|Withdrawal by Subject|54|||
155513002|NCT02207621|561304337|FG002|Overall Study|Adverse Event|132|||
155513003|NCT02207621|561304335|FG000|Overall Study|Withdrawal by Subject|9|||
155513004|NCT02207621|561304336|FG001|Overall Study|Withdrawal by Subject|9|||
155513005|NCT02207621|561304337|FG002|Overall Study|Withdrawal by Subject|13|||
155513006|NCT02207621|561304335|FG000|Overall Study|Non-Compliant|3|||
155513007|NCT02207621|561304336|FG001|Overall Study|Non-Compliant|3|||
155513008|NCT02207621|561304337|FG002|Overall Study|Non-Compliant|1|||
155513009|NCT02207621|561304335|FG000|Overall Study|Lost to Follow-up|1|||
155513010|NCT02207621|561304336|FG001|Overall Study|Lost to Follow-up|0|||
155513011|NCT02207621|561304337|FG002|Overall Study|Lost to Follow-up|3|||
155513012|NCT02207621|561304335|FG000|Overall Study|Lack of Efficacy|10|||
155513013|NCT02207621|561304336|FG001|Overall Study|Lack of Efficacy|2|||
155513014|NCT02207621|561304337|FG002|Overall Study|Lack of Efficacy|4|||
155513015|NCT02207621|561304335|FG000|Overall Study|Disallowed Concurrent Medication|2|||
155513016|NCT02207621|561304336|FG001|Overall Study|Disallowed Concurrent Medication|5|||
155513017|NCT02207621|561304337|FG002|Overall Study|Disallowed Concurrent Medication|2|||
155513018|NCT02207621|561304335|FG000|Overall Study|Physician Decision|1|||
155433577|NCT00816036|561014296|FG001|Overall Study|Withdrawal by Subject|23|||
155433578|NCT00004980|561014297|FG000|Overall Study|Withdrawal by Subject|1|||
155433579|NCT00004980|561014298|FG001|Overall Study|Withdrawal by Subject|0|||
155433580|NCT00004980|561014297|FG000|Overall Study|memory difficulties|1|||
155513019|NCT02207621|561304336|FG001|Overall Study|Physician Decision|2|||
155433581|NCT00004980|561014298|FG001|Overall Study|memory difficulties|1|||
155433582|NCT00004980|561014297|FG000|Overall Study|Physician Decision|0|||
155433583|NCT00004980|561014298|FG001|Overall Study|Physician Decision|1|||
155433584|NCT01299025|561014299|FG000|Overall Study|Withdrawal by Subject|2|||
155433585|NCT01299025|561014300|FG001|Overall Study|Withdrawal by Subject|1|||
155433586|NCT01299025|561014299|FG000|Overall Study|Lost to Follow-up|1|||
155433587|NCT01299025|561014300|FG001|Overall Study|Lost to Follow-up|0|||
155433588|NCT01624194|561014301|FG000|Overall Study|Lost to Follow-up|1|||
155433589|NCT01624194|561014302|FG001|Overall Study|Lost to Follow-up|0|||
155433590|NCT01624194|561014301|FG000|Overall Study|Withdrawal by Subject|1|||
155433591|NCT01624194|561014302|FG001|Overall Study|Withdrawal by Subject|0|||
155513020|NCT02207621|561304337|FG002|Overall Study|Physician Decision|2|||
155513021|NCT02207621|561304335|FG000|Overall Study|Protocol Violation|4|||
155513022|NCT02207621|561304336|FG001|Overall Study|Protocol Violation|10|||
155513023|NCT02207621|561304337|FG002|Overall Study|Protocol Violation|6|||
155513024|NCT02207621|561304335|FG000|Overall Study|Death|2|||
155513025|NCT02207621|561304336|FG001|Overall Study|Death|0|||
155513026|NCT02207621|561304337|FG002|Overall Study|Death|0|||
155513027|NCT02207621|561304335|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
155513028|NCT02207621|561304336|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
155513029|NCT02207621|561304337|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
155513030|NCT03036579|561304340|FG000|2 Years|Lost to Follow-up|1|||
155513031|NCT03036579|561304341|FG001|2 Years|Lost to Follow-up|0|||
155513032|NCT03036579|561304340|FG000|3 Years|Lost to Follow-up|0|||
155513033|NCT03036579|561304341|FG001|3 Years|Lost to Follow-up|1|||
155513034|NCT02398188|561304346|FG000|Overall Study|Adverse Event|2|||
155513035|NCT02398188|561304347|FG001|Overall Study|Adverse Event|3|||
155513036|NCT02398188|561304346|FG000|Overall Study|Lost to Follow-up|5|||
155513037|NCT02398188|561304347|FG001|Overall Study|Lost to Follow-up|0|||
155513038|NCT02398188|561304346|FG000|Overall Study|Non-compliance|4|||
155513039|NCT02398188|561304347|FG001|Overall Study|Non-compliance|4|||
155513040|NCT02398188|561304346|FG000|Overall Study|Protocol Violation|6|||
155513041|NCT02398188|561304347|FG001|Overall Study|Protocol Violation|10|||
155513042|NCT02398188|561304346|FG000|Overall Study|Sponsor Decision|2|||
155513043|NCT02398188|561304347|FG001|Overall Study|Sponsor Decision|1|||
155513044|NCT02398188|561304346|FG000|Overall Study|Pregnancy|1|||
155513045|NCT02398188|561304347|FG001|Overall Study|Pregnancy|0|||
155513046|NCT02398188|561304346|FG000|Overall Study|Withdrawal by Subject|7|||
155513047|NCT02398188|561304347|FG001|Overall Study|Withdrawal by Subject|16|||
155513048|NCT03209570|561304348|FG000|Overall Study|Death|1|||
155513049|NCT03209570|561304349|FG001|Overall Study|Death|0|||
155513050|NCT03209570|561304348|FG000|Overall Study|Incomplete Data|8|||
155513051|NCT03209570|561304349|FG001|Overall Study|Incomplete Data|10|||
155513052|NCT03209570|561304348|FG000|Overall Study|Protocol Violation|1|||
155513053|NCT03209570|561304349|FG001|Overall Study|Protocol Violation|0|||
155513054|NCT03209570|561304348|FG000|Overall Study|Withdrawal by Subject|0|||
155513055|NCT03209570|561304349|FG001|Overall Study|Withdrawal by Subject|3|||
155513056|NCT00755326|561304351|FG000|Overall Study|Lost to Follow-up|2|||
155513057|NCT00755326|561304352|FG001|Overall Study|Lost to Follow-up|3|||
155513058|NCT01829477|561304356|FG000|Overall Study|Study Terminated by Sponsor|15|||
155433592|NCT03212261|561014303|FG000|Overall Study|Became ineligible d/t tech|2|||
155433593|NCT03212261|561014303|FG000|Overall Study|Tech Trouble- No first study visit|1|||
155433594|NCT03212261|561014303|FG000|Overall Study|Lost to Follow-up|7|||
155513059|NCT01829477|561304357|FG001|Overall Study|Study Terminated by Sponsor|15|||
155433595|NCT03212261|561014303|FG000|Overall Study|Family Emergency|1|||
155433596|NCT03212261|561014303|FG000|Overall Study|Too busy/ No time|5|||
155433597|NCT05480514|561014304|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
155433598|NCT05480514|561014305|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
155433599|NCT05480514|561014304|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
155433600|NCT05480514|561014305|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
155433601|NCT05480514|561014304|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155433602|NCT05480514|561014305|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
155433603|NCT05480514|561014304|FG000|Period 1|Covid-19 Related|1|||
155433604|NCT05480514|561014305|FG001|Period 1|Covid-19 Related|0|||
155433605|NCT05480514|561014304|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
155433606|NCT05480514|561014305|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
155433607|NCT05738486|561015847|FG000|Overall Study|Continuing Study|194|||
155433608|NCT05738486|561015848|FG001|Overall Study|Continuing Study|196|||
155433609|NCT05738486|561015849|FG002|Overall Study|Continuing Study|193|||
155433610|NCT05738486|561015850|FG003|Overall Study|Continuing Study|191|||
155433611|NCT05738486|561015847|FG000|Overall Study|Withdrawal by Subject|8|||
155433612|NCT05738486|561015848|FG001|Overall Study|Withdrawal by Subject|5|||
155433613|NCT05738486|561015849|FG002|Overall Study|Withdrawal by Subject|7|||
155433614|NCT05738486|561015850|FG003|Overall Study|Withdrawal by Subject|13|||
155433615|NCT05738486|561015847|FG000|Overall Study|Adverse Event|4|||
155433616|NCT05738486|561015848|FG001|Overall Study|Adverse Event|6|||
155433617|NCT05738486|561015849|FG002|Overall Study|Adverse Event|4|||
155433618|NCT05738486|561015850|FG003|Overall Study|Adverse Event|5|||
155433619|NCT05738486|561015847|FG000|Overall Study|Physician Decision|0|||
155433620|NCT05738486|561015848|FG001|Overall Study|Physician Decision|2|||
155433621|NCT05738486|561015849|FG002|Overall Study|Physician Decision|4|||
155433622|NCT05738486|561015850|FG003|Overall Study|Physician Decision|1|||
155433623|NCT05738486|561015847|FG000|Overall Study|Lost to Follow-up|1|||
155433624|NCT05738486|561015848|FG001|Overall Study|Lost to Follow-up|1|||
155433625|NCT05738486|561015849|FG002|Overall Study|Lost to Follow-up|2|||
155433626|NCT05738486|561015850|FG003|Overall Study|Lost to Follow-up|1|||
155433627|NCT05738486|561015847|FG000|Overall Study|Participant was Non-ambulatory|0|||
155433628|NCT05738486|561015848|FG001|Overall Study|Participant was Non-ambulatory|0|||
155433629|NCT05738486|561015849|FG002|Overall Study|Participant was Non-ambulatory|1|||
155433630|NCT05738486|561015850|FG003|Overall Study|Participant was Non-ambulatory|0|||
155433631|NCT05738486|561015847|FG000|Overall Study|Participant had Poor Venous Access|0|||
155433632|NCT05738486|561015848|FG001|Overall Study|Participant had Poor Venous Access|0|||
155433633|NCT05738486|561015849|FG002|Overall Study|Participant had Poor Venous Access|0|||
155433634|NCT05738486|561015850|FG003|Overall Study|Participant had Poor Venous Access|1|||
155433635|NCT05738486|561015847|FG000|Overall Study|Assigned Treatment by Mistake|0|||
155433636|NCT05738486|561015848|FG001|Overall Study|Assigned Treatment by Mistake|0|||
155433637|NCT05738486|561015849|FG002|Overall Study|Assigned Treatment by Mistake|0|||
155433638|NCT05738486|561015850|FG003|Overall Study|Assigned Treatment by Mistake|1|||
155433639|NCT05738486|561015847|FG000|Overall Study|Death|0|||
155433640|NCT05738486|561015848|FG001|Overall Study|Death|0|||
155433641|NCT05738486|561015849|FG002|Overall Study|Death|1|||
155433642|NCT05738486|561015850|FG003|Overall Study|Death|0|||
155433643|NCT05738486|561015847|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
155433644|NCT05738486|561015848|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
155433645|NCT05738486|561015849|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
155433646|NCT05738486|561015850|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
155433647|NCT03395210|561015851|FG000|Overall Study|Other|0|||
155433648|NCT03395210|561015852|FG001|Overall Study|Other|0|||
155433649|NCT03395210|561015853|FG002|Overall Study|Other|0|||
155433650|NCT03395210|561015854|FG003|Overall Study|Other|0|||
155433651|NCT03395210|561015855|FG004|Overall Study|Other|1|||
155433652|NCT03395210|561015851|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
155433653|NCT03395210|561015852|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
155433654|NCT03395210|561015853|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
155433655|NCT03395210|561015854|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
155433656|NCT03395210|561015855|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
155433657|NCT03395210|561015851|FG000|Overall Study|Adverse Event|1|||
155433658|NCT03395210|561015852|FG001|Overall Study|Adverse Event|0|||
155433659|NCT03395210|561015853|FG002|Overall Study|Adverse Event|2|||
155433660|NCT03395210|561015854|FG003|Overall Study|Adverse Event|4|||
155433661|NCT03395210|561015855|FG004|Overall Study|Adverse Event|3|||
155433662|NCT03395210|561015851|FG000|Overall Study|Need of Rescue Medication|1|||
155650301|NCT00779909|561812453|FG000|Overall Study|Lost to Follow-up|1|||
155433663|NCT03395210|561015852|FG001|Overall Study|Need of Rescue Medication|0|||
155433664|NCT03395210|561015853|FG002|Overall Study|Need of Rescue Medication|1|||
155433665|NCT03395210|561015854|FG003|Overall Study|Need of Rescue Medication|4|||
155433666|NCT03395210|561015855|FG004|Overall Study|Need of Rescue Medication|0|||
155433667|NCT03395210|561015851|FG000|Overall Study|Lack of Response|0|||
155513060|NCT01829477|561304356|FG000|Overall Study|Withdrawal by Subject|1|||
155513061|NCT01829477|561304357|FG001|Overall Study|Withdrawal by Subject|0|||
155513062|NCT03465891|561304358|FG000|Overall Study|Withdrawal by Subject|0|||
155513063|NCT03465891|561304359|FG001|Overall Study|Withdrawal by Subject|1|||
155513064|NCT03465891|561304358|FG000|Overall Study|Disease progression|1|||
155513065|NCT03465891|561304359|FG001|Overall Study|Disease progression|0|||
155513066|NCT02737306|561304361|FG000|Overall Study|Adverse Event|3|||
155513067|NCT02737306|561304362|FG001|Overall Study|Adverse Event|0|||
155513068|NCT02737306|561304361|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
155513069|NCT02737306|561304362|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
155513070|NCT01336894|561304363|FG000|Follow-up|Study terminated prematurely|2|||
155513071|NCT01336894|561304364|FG001|Follow-up|Study terminated prematurely|7|||
155513072|NCT05034731|561304365|FG000|Overall Study|Screen fail|1|||
155513073|NCT05034731|561304366|FG001|Overall Study|Screen fail|1|||
155513074|NCT03937466|561304367|FG000|Overall Study|not eligbile after the 2-week diary|9|||
155513075|NCT03937466|561304367|FG000|Overall Study|never returned their diary|6|||
155513076|NCT03937466|561304367|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
155513077|NCT03937466|561304367|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
155513078|NCT00622908|561304368|FG000|Overall Study|Protocol Violation|1|||
155513079|NCT00622908|561304369|FG001|Overall Study|Protocol Violation|0|||
155513080|NCT00622908|561304368|FG000|Overall Study|Adverse Event|0|||
155513081|NCT00622908|561304369|FG001|Overall Study|Adverse Event|1|||
155513082|NCT00622908|561304368|FG000|Overall Study|Lack of Efficacy|1|||
155513083|NCT00622908|561304369|FG001|Overall Study|Lack of Efficacy|7|||
155513084|NCT00622908|561304368|FG000|Overall Study|Lost to Follow-up|1|||
155513085|NCT00622908|561304369|FG001|Overall Study|Lost to Follow-up|0|||
155513086|NCT00622908|561304368|FG000|Overall Study|Refusal|0|||
155513087|NCT00622908|561304369|FG001|Overall Study|Refusal|1|||
155513088|NCT00622908|561304368|FG000|Overall Study|Termination by study sponser|0|||
155513089|NCT00622908|561304369|FG001|Overall Study|Termination by study sponser|1|||
155513090|NCT00299156|561304372|FG000|Period 2 (Randomized)|Screen Failure|0|||
155513091|NCT00299156|561304373|FG001|Period 2 (Randomized)|Screen Failure|1|||
155513092|NCT00299156|561304374|FG002|Period 2 (Randomized)|Screen Failure|0|||
155513093|NCT01725451|561304375|FG000|Period 1|Withdrawal by Subject|1|||
155513094|NCT01725451|561304376|FG001|Period 1|Withdrawal by Subject|0|||
155513095|NCT01725451|561304377|FG002|Period 1|Withdrawal by Subject|0|||
155513096|NCT01725451|561304378|FG003|Period 1|Withdrawal by Subject|0|||
155650302|NCT00779909|561812454|FG001|Overall Study|Lost to Follow-up|0|||
155650303|NCT00779909|561812455|FG002|Overall Study|Lost to Follow-up|0|||
155650304|NCT00779909|561812456|FG003|Overall Study|Lost to Follow-up|1|||
155513097|NCT01725451|561304375|FG000|Washout From Period 3|Protocol Violation|0|||
155513098|NCT01725451|561304376|FG001|Washout From Period 3|Protocol Violation|0|||
155650305|NCT00779909|561812453|FG000|Overall Study|Withdrawal by Subject|0|||
155650306|NCT00779909|561812454|FG001|Overall Study|Withdrawal by Subject|1|||
155513099|NCT01725451|561304377|FG002|Washout From Period 3|Protocol Violation|1|||
155513100|NCT01725451|561304378|FG003|Washout From Period 3|Protocol Violation|0|||
155513101|NCT01725451|561304375|FG000|Washout From Period 3|Adverse Event|0|||
155513102|NCT01725451|561304376|FG001|Washout From Period 3|Adverse Event|1|||
155513103|NCT01725451|561304377|FG002|Washout From Period 3|Adverse Event|0|||
155513104|NCT01725451|561304378|FG003|Washout From Period 3|Adverse Event|0|||
155513105|NCT01725451|561304375|FG000|Period 4|Adverse Event|0|||
155513106|NCT01725451|561304376|FG001|Period 4|Adverse Event|0|||
155513107|NCT01725451|561304377|FG002|Period 4|Adverse Event|1|||
155513108|NCT01725451|561304378|FG003|Period 4|Adverse Event|0|||
155513109|NCT00358826|561304382|FG000|Core Study|Adverse Event|1|||
155513110|NCT00358826|561304383|FG001|Core Study|Adverse Event|3|||
155513111|NCT00358826|561304384|FG002|Core Study|Adverse Event|1|||
155513112|NCT00358826|561304385|FG003|Core Study|Adverse Event|1|||
155513113|NCT00358826|561304386|FG004|Core Study|Adverse Event|0|||
155513114|NCT00358826|561304387|FG005|Core Study|Adverse Event|0|||
155513115|NCT00358826|561304388|FG006|Core Study|Adverse Event|0|||
155513116|NCT00358826|561304389|FG007|Core Study|Adverse Event|0|||
155513117|NCT00358826|561304382|FG000|Core Study|Withdrawal by Subject|2|||
155513118|NCT00358826|561304383|FG001|Core Study|Withdrawal by Subject|2|||
155513119|NCT00358826|561304384|FG002|Core Study|Withdrawal by Subject|0|||
155513120|NCT00358826|561304385|FG003|Core Study|Withdrawal by Subject|0|||
155513121|NCT00358826|561304386|FG004|Core Study|Withdrawal by Subject|0|||
155513122|NCT00358826|561304387|FG005|Core Study|Withdrawal by Subject|0|||
155513123|NCT00358826|561304388|FG006|Core Study|Withdrawal by Subject|0|||
155513124|NCT00358826|561304389|FG007|Core Study|Withdrawal by Subject|0|||
155513125|NCT00358826|561304382|FG000|Core Study|Lost to Follow-up|0|||
155513126|NCT00358826|561304383|FG001|Core Study|Lost to Follow-up|0|||
155513127|NCT00358826|561304384|FG002|Core Study|Lost to Follow-up|0|||
155650307|NCT00779909|561812455|FG002|Overall Study|Withdrawal by Subject|0|||
155650308|NCT00779909|561812456|FG003|Overall Study|Withdrawal by Subject|0|||
155650309|NCT00337194|561812457|FG000|Overall Study|Adverse Event|5|||
155650310|NCT00337194|561812458|FG001|Overall Study|Adverse Event|1|||
155513128|NCT00358826|561304385|FG003|Core Study|Lost to Follow-up|1|||
155513129|NCT00358826|561304386|FG004|Core Study|Lost to Follow-up|0|||
155433668|NCT03395210|561015852|FG001|Overall Study|Lack of Response|0|||
155433669|NCT03395210|561015853|FG002|Overall Study|Lack of Response|0|||
155433670|NCT03395210|561015854|FG003|Overall Study|Lack of Response|5|||
155513130|NCT00358826|561304387|FG005|Core Study|Lost to Follow-up|0|||
155513131|NCT00358826|561304388|FG006|Core Study|Lost to Follow-up|0|||
155513132|NCT00358826|561304389|FG007|Core Study|Lost to Follow-up|0|||
155433671|NCT03395210|561015855|FG004|Overall Study|Lack of Response|5|||
155433672|NCT03395210|561015851|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
155433673|NCT03395210|561015852|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
155433674|NCT03395210|561015853|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
155433675|NCT03395210|561015854|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
155433676|NCT03395210|561015855|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
155433677|NCT03395210|561015851|FG000|Overall Study|Participant Decision|1|||
155433678|NCT03395210|561015852|FG001|Overall Study|Participant Decision|1|||
155433679|NCT03395210|561015853|FG002|Overall Study|Participant Decision|0|||
155433680|NCT03395210|561015854|FG003|Overall Study|Participant Decision|4|||
155433681|NCT03395210|561015855|FG004|Overall Study|Participant Decision|0|||
155433682|NCT03395210|561015851|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
155433683|NCT03395210|561015852|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
155433684|NCT03395210|561015853|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
155433685|NCT03395210|561015854|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
155433686|NCT03395210|561015855|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
155433687|NCT01672892|561015856|FG000|Overall Study|Protocol Violation|7|||
155433688|NCT01672892|561015857|FG001|Overall Study|Protocol Violation|3|||
155433689|NCT02128490|561015866|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155433690|NCT02128490|561015867|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155433691|NCT02128490|561015868|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155433692|NCT02128490|561015869|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155433693|NCT02128490|561015870|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155433694|NCT02128490|561015866|FG000|Overall Study|Major Protocol Deviation|1|||
155433695|NCT02128490|561015867|FG001|Overall Study|Major Protocol Deviation|2|||
155433696|NCT02128490|561015868|FG002|Overall Study|Major Protocol Deviation|0|||
155433697|NCT02128490|561015869|FG003|Overall Study|Major Protocol Deviation|2|||
155433698|NCT02128490|561015870|FG004|Overall Study|Major Protocol Deviation|2|||
155433699|NCT02128490|561015866|FG000|Overall Study|Lost to Follow-up|0|||
155433700|NCT02128490|561015867|FG001|Overall Study|Lost to Follow-up|0|||
155433701|NCT02128490|561015868|FG002|Overall Study|Lost to Follow-up|1|||
155513133|NCT00358826|561304382|FG000|Core Study|Physician Decision|0|||
155513134|NCT00358826|561304383|FG001|Core Study|Physician Decision|0|||
155513135|NCT00358826|561304384|FG002|Core Study|Physician Decision|1|||
155513136|NCT00358826|561304385|FG003|Core Study|Physician Decision|0|||
155513137|NCT00358826|561304386|FG004|Core Study|Physician Decision|0|||
155513138|NCT00358826|561304387|FG005|Core Study|Physician Decision|0|||
155433702|NCT02128490|561015869|FG003|Overall Study|Lost to Follow-up|1|||
155433703|NCT02128490|561015870|FG004|Overall Study|Lost to Follow-up|1|||
155650311|NCT00337194|561812457|FG000|Overall Study|Death|2|||
155513139|NCT00358826|561304388|FG006|Core Study|Physician Decision|0|||
155513140|NCT00358826|561304389|FG007|Core Study|Physician Decision|0|||
155433704|NCT02128490|561015866|FG000|Overall Study|Voluntary Withdrawal|3|||
155433705|NCT02128490|561015867|FG001|Overall Study|Voluntary Withdrawal|3|||
155433706|NCT02128490|561015868|FG002|Overall Study|Voluntary Withdrawal|1|||
155433707|NCT02128490|561015869|FG003|Overall Study|Voluntary Withdrawal|1|||
155433708|NCT02128490|561015870|FG004|Overall Study|Voluntary Withdrawal|2|||
155433709|NCT02128490|561015866|FG000|Overall Study|Lack of Efficacy|0|||
155433710|NCT02128490|561015867|FG001|Overall Study|Lack of Efficacy|1|||
155433711|NCT02128490|561015868|FG002|Overall Study|Lack of Efficacy|0|||
155433712|NCT02128490|561015869|FG003|Overall Study|Lack of Efficacy|0|||
155433713|NCT02128490|561015870|FG004|Overall Study|Lack of Efficacy|0|||
155433714|NCT02128490|561015866|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
155433715|NCT02128490|561015867|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
155433716|NCT02128490|561015868|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
155433717|NCT02128490|561015869|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
155433718|NCT02128490|561015870|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
155433719|NCT02128490|561015866|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155433720|NCT02128490|561015867|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155433721|NCT02128490|561015868|FG002|Overall Study|Other Miscellaneous Reasons|2|||
155433722|NCT02128490|561015869|FG003|Overall Study|Other Miscellaneous Reasons|1|||
155433723|NCT02128490|561015870|FG004|Overall Study|Other Miscellaneous Reasons|1|||
155433724|NCT02243176|561015871|FG000|Overall Study|Other reason|1|||
155433725|NCT02243176|561015872|FG001|Overall Study|Other reason|2|||
155433726|NCT02243176|561015871|FG000|Overall Study|protocol specified withdrawal critera|1|||
155433727|NCT02243176|561015872|FG001|Overall Study|protocol specified withdrawal critera|3|||
155433728|NCT02243176|561015871|FG000|Overall Study|Protocol Violation|2|||
155433729|NCT02243176|561015872|FG001|Overall Study|Protocol Violation|1|||
155433730|NCT02243176|561015871|FG000|Overall Study|Withdrawal by Subject|8|||
155433731|NCT02243176|561015872|FG001|Overall Study|Withdrawal by Subject|7|||
155433732|NCT02243176|561015871|FG000|Overall Study|Adverse Event|2|||
155433733|NCT02243176|561015872|FG001|Overall Study|Adverse Event|2|||
155433734|NCT03311126|561015874|FG000|Induction|Death|1|||
155433735|NCT03311126|561015874|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
155433736|NCT03113500|561015875|FG000|Overall Study|Withdrawal by Subject|1|||
155433737|NCT02517515|561015878|FG000|Overall Study|Adverse Event|0|||
155433738|NCT02517515|561015879|FG001|Overall Study|Adverse Event|1|||
155433739|NCT02517515|561015878|FG000|Overall Study|Withdrew Consent|0|||
155433740|NCT02517515|561015879|FG001|Overall Study|Withdrew Consent|1|||
155433741|NCT02517515|561015878|FG000|Overall Study|Lost to Follow-up|1|||
155433742|NCT02517515|561015879|FG001|Overall Study|Lost to Follow-up|0|||
155433743|NCT02517515|561015878|FG000|Overall Study|Other|1|||
155433744|NCT02517515|561015879|FG001|Overall Study|Other|0|||
155433745|NCT00469079|561015880|FG000|Overall Study|Lack of Efficacy|3|||
155433746|NCT00469079|561015881|FG001|Overall Study|Lack of Efficacy|8|||
155433747|NCT00469079|561015882|FG002|Overall Study|Lack of Efficacy|5|||
155433748|NCT00469079|561015880|FG000|Overall Study|Adverse Event|1|||
155433749|NCT00469079|561015881|FG001|Overall Study|Adverse Event|3|||
155433750|NCT00469079|561015882|FG002|Overall Study|Adverse Event|2|||
155433751|NCT00469079|561015880|FG000|Overall Study|Lost to Follow-up|4|||
155433752|NCT00469079|561015881|FG001|Overall Study|Lost to Follow-up|8|||
155433753|NCT00469079|561015882|FG002|Overall Study|Lost to Follow-up|10|||
155433754|NCT00469079|561015880|FG000|Overall Study|Withdrawal by Subject|1|||
155513141|NCT00358826|561304382|FG000|MDCT Substudy|Adverse Event|0|||
155650312|NCT00337194|561812458|FG001|Overall Study|Death|0|||
155433755|NCT00469079|561015881|FG001|Overall Study|Withdrawal by Subject|2|||
155433756|NCT00469079|561015882|FG002|Overall Study|Withdrawal by Subject|2|||
155433757|NCT00469079|561015880|FG000|Overall Study|Ineligible|0|||
155433758|NCT00469079|561015881|FG001|Overall Study|Ineligible|1|||
155433759|NCT00469079|561015882|FG002|Overall Study|Ineligible|0|||
155433760|NCT02981472|561015883|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
155433761|NCT02981472|561015884|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
155433762|NCT02981472|561015883|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155433763|NCT02981472|561015884|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155433764|NCT02981472|561015883|FG000|Treatment Period|Adverse Event|6|||
155433765|NCT02981472|561015884|FG001|Treatment Period|Adverse Event|1|||
155433766|NCT02981472|561015883|FG000|Treatment Period|Participant withdrew consent|1|||
155433767|NCT02981472|561015884|FG001|Treatment Period|Participant withdrew consent|0|||
155433768|NCT02981472|561015883|FG000|Treatment Period|Lost to Follow-up|0|||
155433769|NCT02981472|561015884|FG001|Treatment Period|Lost to Follow-up|1|||
155433770|NCT02874794|561015889|FG000|Overall Study|Physician Decision|3|||
155433771|NCT02874794|561015890|FG001|Overall Study|Physician Decision|2|||
155433772|NCT02874794|561015889|FG000|Overall Study|Withdrawal by Subject|2|||
155433773|NCT02874794|561015890|FG001|Overall Study|Withdrawal by Subject|8|||
155433774|NCT02874794|561015889|FG000|Overall Study|Death|2|||
155433775|NCT02874794|561015890|FG001|Overall Study|Death|1|||
155433776|NCT01473004|561015891|FG000|Overall Study|Incomplete Lobar Treatment|1|||
155433777|NCT01473004|561015892|FG001|Overall Study|Incomplete Lobar Treatment|0|||
155433778|NCT00613314|561015896|FG000|Overall Study|Adverse Event|5|||
155433779|NCT00613314|561015896|FG000|Overall Study|Protocol Violation|14|||
155433780|NCT00613314|561015896|FG000|Overall Study|Lost to Follow-up|46|||
155433781|NCT00613314|561015896|FG000|Overall Study|Other reason not defined above|90|||
155433782|NCT01584024|561015897|FG000|Overall Study|Lost to Follow-up|10|||
155433783|NCT01584024|561015897|FG000|Overall Study|Withdrawal by Subject|3|||
155433784|NCT04419506|561015900|FG000|Overall Study|Adverse Event|0|||
155433785|NCT04419506|561015901|FG001|Overall Study|Adverse Event|10|||
155433786|NCT04419506|561015902|FG002|Overall Study|Adverse Event|0|||
155433787|NCT04419506|561015903|FG003|Overall Study|Adverse Event|3|||
155433788|NCT04419506|561015900|FG000|Overall Study|Withdrawal by Subject|0|||
155433789|NCT04419506|561015901|FG001|Overall Study|Withdrawal by Subject|0|||
155433790|NCT04419506|561015902|FG002|Overall Study|Withdrawal by Subject|0|||
155433791|NCT04419506|561015903|FG003|Overall Study|Withdrawal by Subject|1|||
155433792|NCT04419506|561015900|FG000|Overall Study|poor-compliance|0|||
155433793|NCT04419506|561015901|FG001|Overall Study|poor-compliance|0|||
155433794|NCT04419506|561015902|FG002|Overall Study|poor-compliance|0|||
155433795|NCT04419506|561015903|FG003|Overall Study|poor-compliance|1|||
155433796|NCT00345605|561015904|FG000|Arm 1|Adverse Event|0|||
155433797|NCT00345605|561015905|FG001|Arm 1|Adverse Event|1|||
155433798|NCT00345605|561015904|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
155433799|NCT00345605|561015905|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
155433800|NCT01126619|561015910|FG000|Overall Study|Not eligible for the study|2|||
155433801|NCT01126619|561015910|FG000|Overall Study|Investigator decision|4|||
155433802|NCT01126619|561015910|FG000|Overall Study|Serious adverse event|1|||
155433803|NCT01126619|561015910|FG000|Overall Study|Withdrawal by Subject|9|||
155433804|NCT01126619|561015910|FG000|Overall Study|Non-compliance|1|||
155513142|NCT00358826|561304383|FG001|MDCT Substudy|Adverse Event|0|||
155513143|NCT00358826|561304384|FG002|MDCT Substudy|Adverse Event|0|||
155513144|NCT00358826|561304385|FG003|MDCT Substudy|Adverse Event|0|||
155513145|NCT00358826|561304386|FG004|MDCT Substudy|Adverse Event|1|||
155513146|NCT00358826|561304387|FG005|MDCT Substudy|Adverse Event|0|||
155513147|NCT00358826|561304388|FG006|MDCT Substudy|Adverse Event|0|||
155513148|NCT00358826|561304389|FG007|MDCT Substudy|Adverse Event|0|||
155513149|NCT00358826|561304382|FG000|MDCT Substudy|Lost to Follow-up|0|||
155513150|NCT00358826|561304383|FG001|MDCT Substudy|Lost to Follow-up|0|||
155513151|NCT00358826|561304384|FG002|MDCT Substudy|Lost to Follow-up|0|||
155513152|NCT00358826|561304385|FG003|MDCT Substudy|Lost to Follow-up|0|||
155513153|NCT00358826|561304386|FG004|MDCT Substudy|Lost to Follow-up|0|||
155513154|NCT00358826|561304387|FG005|MDCT Substudy|Lost to Follow-up|1|||
155513155|NCT00358826|561304388|FG006|MDCT Substudy|Lost to Follow-up|0|||
155513156|NCT00358826|561304389|FG007|MDCT Substudy|Lost to Follow-up|0|||
155513157|NCT00358826|561304382|FG000|MDCT Substudy|Withdrawal by Subject|0|||
155513158|NCT00358826|561304383|FG001|MDCT Substudy|Withdrawal by Subject|0|||
155513159|NCT00358826|561304384|FG002|MDCT Substudy|Withdrawal by Subject|0|||
155513160|NCT00358826|561304385|FG003|MDCT Substudy|Withdrawal by Subject|0|||
155513161|NCT00358826|561304386|FG004|MDCT Substudy|Withdrawal by Subject|0|||
155513162|NCT00358826|561304387|FG005|MDCT Substudy|Withdrawal by Subject|1|||
155513163|NCT00358826|561304388|FG006|MDCT Substudy|Withdrawal by Subject|0|||
155513164|NCT00358826|561304389|FG007|MDCT Substudy|Withdrawal by Subject|0|||
155513165|NCT00903383|561304393|FG000|Overall Study|Adverse Event|1|||
155433805|NCT04876391|561015911|FG000|Overall Study|Withdrawal by Subject|1|||
155433806|NCT04876391|561015912|FG001|Overall Study|Withdrawal by Subject|10|||
155433807|NCT04876391|561015911|FG000|Overall Study|Lost to Follow-up|2|||
155433808|NCT04876391|561015912|FG001|Overall Study|Lost to Follow-up|4|||
155650313|NCT00337194|561812457|FG000|Overall Study|Withdrawal by Subject|1|||
155650314|NCT00337194|561812458|FG001|Overall Study|Withdrawal by Subject|0|||
155433809|NCT04876391|561015911|FG000|Overall Study|Lack of Efficacy|0|||
155433810|NCT04876391|561015912|FG001|Overall Study|Lack of Efficacy|2|||
155433811|NCT04876391|561015911|FG000|Overall Study|Adverse Event|3|||
155433812|NCT04876391|561015912|FG001|Overall Study|Adverse Event|1|||
155433813|NCT04876391|561015911|FG000|Overall Study|Patient non-compliance|0|||
155433814|NCT04876391|561015912|FG001|Overall Study|Patient non-compliance|1|||
155433815|NCT04876391|561015911|FG000|Overall Study|Personal reasons|0|||
155433816|NCT04876391|561015912|FG001|Overall Study|Personal reasons|1|||
155433817|NCT04876391|561015911|FG000|Overall Study|Withdrawn as per protocol|2|||
155433818|NCT04876391|561015912|FG001|Overall Study|Withdrawn as per protocol|2|||
155433819|NCT03293030|561015913|FG000|Overall Study|Withdrawal by Subject|3|||
155433820|NCT04899271|561015914|FG000|Overall Study|Lost to Follow-up|1|||
155433821|NCT04899271|561015915|FG001|Overall Study|Lost to Follow-up|0|||
155433822|NCT04899271|561015914|FG000|Overall Study|Subject request/consent withdrawal|2|||
155433823|NCT04899271|561015915|FG001|Overall Study|Subject request/consent withdrawal|0|||
155433824|NCT02318602|561015917|FG000|Overall Study|Adverse Event|0|||
155433825|NCT02318602|561015918|FG001|Overall Study|Adverse Event|1|||
155433826|NCT02318602|561015919|FG002|Overall Study|Adverse Event|1|||
155433827|NCT02318602|561015917|FG000|Overall Study|Withdrawal by Subject|0|||
155433828|NCT02318602|561015918|FG001|Overall Study|Withdrawal by Subject|3|||
155433829|NCT02318602|561015919|FG002|Overall Study|Withdrawal by Subject|0|||
155433830|NCT02318602|561015917|FG000|Overall Study|Death|1|||
155433831|NCT02318602|561015918|FG001|Overall Study|Death|0|||
155433832|NCT02318602|561015919|FG002|Overall Study|Death|0|||
155433833|NCT02318602|561015917|FG000|Overall Study|Guardian decision to withdraw|0|||
155433834|NCT02318602|561015918|FG001|Overall Study|Guardian decision to withdraw|0|||
155433835|NCT02318602|561015919|FG002|Overall Study|Guardian decision to withdraw|1|||
155433836|NCT00095303|561015920|FG000|Main Study|Lost to Follow-up|91|||
155433837|NCT00095303|561015921|FG001|Main Study|Lost to Follow-up|87|||
155433838|NCT00095303|561015920|FG000|Follow Up Study|Lost to Follow-up|59|||
155433839|NCT00095303|561015921|FG001|Follow Up Study|Lost to Follow-up|58|||
155433840|NCT03228186|561015924|FG000|Overall Study|Patient never started treatment|1|||
155433841|NCT03953118|561015927|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
155433842|NCT03953118|561015928|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
155433843|NCT00258154|561015929|FG000|Overall Study|Adverse Event|1|||
155433844|NCT00258154|561015930|FG001|Overall Study|Adverse Event|0|||
155433845|NCT00258154|561015929|FG000|Overall Study|Lost to Follow-up|0|||
155433846|NCT00258154|561015930|FG001|Overall Study|Lost to Follow-up|1|||
155433847|NCT00258154|561015929|FG000|Overall Study|Protocol Violation|2|||
155433848|NCT00258154|561015930|FG001|Overall Study|Protocol Violation|1|||
155433849|NCT00258154|561015929|FG000|Overall Study|Withdrawal by Subject|3|||
155433850|NCT00258154|561015930|FG001|Overall Study|Withdrawal by Subject|4|||
155433851|NCT00258154|561015929|FG000|Overall Study|Patient Moved|3|||
155433852|NCT00258154|561015930|FG001|Overall Study|Patient Moved|1|||
155433853|NCT05139030|561015936|FG000|Overall Study|Withdrawal by Subject|1|||
155433854|NCT05139030|561015937|FG001|Overall Study|Withdrawal by Subject|3|||
155433855|NCT05139030|561015936|FG000|Overall Study|Adverse Event|0|||
155433856|NCT05139030|561015937|FG001|Overall Study|Adverse Event|1|||
155433857|NCT05139030|561015936|FG000|Overall Study|Failure to meet continuation criteria|0|||
155433858|NCT05139030|561015937|FG001|Overall Study|Failure to meet continuation criteria|1|||
155433859|NCT02502864|561015942|FG000|Overall Study|Withdrawal by Subject|1|||
155433860|NCT03772327|561015943|FG000|Overall Study|Lost to Follow-up|3|||
155433861|NCT03772327|561015944|FG001|Overall Study|Lost to Follow-up|4|||
155433862|NCT03772327|561015943|FG000|Overall Study|Withdrawal by Subject|2|||
155433863|NCT03772327|561015944|FG001|Overall Study|Withdrawal by Subject|3|||
155433864|NCT00613626|561015948|FG000|Overall Study|Ineligible|0|||
155433865|NCT00613626|561015949|FG001|Overall Study|Ineligible|1|||
155433866|NCT00613626|561015950|FG002|Overall Study|Ineligible|0|||
155433867|NCT00820040|561015956|FG000|Overall Study|Death|1|||
155433868|NCT00820040|561015956|FG000|Overall Study|Sponsor terminated study|1|||
155433869|NCT00820040|561015956|FG000|Overall Study|Screen failure|1|||
155433870|NCT01259466|561015961|FG000|Overall Study|Withdrawal by Subject|1|||
155433871|NCT01259466|561015962|FG001|Overall Study|Withdrawal by Subject|9|||
155433872|NCT01824602|561015967|FG000|Overall Study|Withdrawal by Subject|0|||
155433873|NCT01824602|561015968|FG001|Overall Study|Withdrawal by Subject|0|||
155433874|NCT01824602|561015969|FG002|Overall Study|Withdrawal by Subject|1|||
155433875|NCT01824602|561015970|FG003|Overall Study|Withdrawal by Subject|2|||
155433876|NCT01824602|561015967|FG000|Overall Study|Patient non-compliance|0|||
155433877|NCT01824602|561015968|FG001|Overall Study|Patient non-compliance|0|||
155433878|NCT01824602|561015969|FG002|Overall Study|Patient non-compliance|1|||
155433879|NCT01824602|561015970|FG003|Overall Study|Patient non-compliance|0|||
155433880|NCT01824602|561015967|FG000|Overall Study|Adverse Event|1|||
155433881|NCT01824602|561015968|FG001|Overall Study|Adverse Event|0|||
155433882|NCT01824602|561015969|FG002|Overall Study|Adverse Event|2|||
155433883|NCT01824602|561015970|FG003|Overall Study|Adverse Event|2|||
155433884|NCT01824602|561015967|FG000|Overall Study|Treatment failure|0|||
155433885|NCT01824602|561015968|FG001|Overall Study|Treatment failure|0|||
155433886|NCT01824602|561015969|FG002|Overall Study|Treatment failure|0|||
155433887|NCT01824602|561015970|FG003|Overall Study|Treatment failure|1|||
155433888|NCT00184054|561015971|FG000|Overall Study|Adverse Event|1|||
155433889|NCT02296840|561015972|FG000|Overall Study|Adverse Event|1|||
155433890|NCT02296840|561015973|FG001|Overall Study|Adverse Event|1|||
155433891|NCT02296840|561015972|FG000|Overall Study|Protocol Violation|2|||
155433892|NCT02296840|561015973|FG001|Overall Study|Protocol Violation|1|||
155433893|NCT02296840|561015972|FG000|Overall Study|Lost to Follow-up|6|||
155433894|NCT02296840|561015973|FG001|Overall Study|Lost to Follow-up|17|||
155650315|NCT00337194|561812457|FG000|Overall Study|Disease progression|1|||
155650316|NCT00337194|561812458|FG001|Overall Study|Disease progression|2|||
155433895|NCT02485717|561015974|FG000|Overall Study|Lost to Follow-up|6|||
155433896|NCT02485717|561015975|FG001|Overall Study|Lost to Follow-up|0|||
155433897|NCT02485717|561015976|FG002|Overall Study|Lost to Follow-up|0|||
155433898|NCT02485717|561015974|FG000|Overall Study|Withdrawal by Subject|0|||
155433899|NCT02485717|561015975|FG001|Overall Study|Withdrawal by Subject|0|||
155433900|NCT02485717|561015976|FG002|Overall Study|Withdrawal by Subject|1|||
155433901|NCT02485717|561015974|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
155433902|NCT02485717|561015975|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
155433903|NCT02485717|561015976|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
155433904|NCT02485717|561015974|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
155433905|NCT02485717|561015975|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
155433906|NCT02485717|561015976|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
155433907|NCT02827877|561015977|FG000|Overall Study|Withdrawal by Subject|1|||
155433908|NCT00814710|561015980|FG000|Overall Study|Adverse Event|1|||
155433909|NCT00814710|561015981|FG001|Overall Study|Adverse Event|0|||
155433910|NCT00814710|561015980|FG000|Overall Study|Lost to Follow-up|7|||
155433911|NCT00814710|561015981|FG001|Overall Study|Lost to Follow-up|3|||
155433912|NCT03885284|561015982|FG000|Overall Study|Disease Progression|1|||
155433913|NCT03885284|561015983|FG001|Overall Study|Disease Progression|3|||
155433914|NCT03885284|561015982|FG000|Overall Study|Physician Decision|0|||
155433915|NCT03885284|561015983|FG001|Overall Study|Physician Decision|1|||
155433916|NCT00002850|561015986|FG000|Overall Study|Death|4|||
155433917|NCT00002850|561015987|FG001|Overall Study|Death|1|||
155433918|NCT00002850|561015988|FG002|Overall Study|Death|3|||
155433919|NCT00002850|561015986|FG000|Overall Study|Protocol Violation|1|||
155433920|NCT00002850|561015987|FG001|Overall Study|Protocol Violation|0|||
155433921|NCT00002850|561015988|FG002|Overall Study|Protocol Violation|1|||
155433922|NCT00002850|561015986|FG000|Overall Study|Withdrawal by Subject|0|||
155433923|NCT00002850|561015987|FG001|Overall Study|Withdrawal by Subject|1|||
155433924|NCT00002850|561015988|FG002|Overall Study|Withdrawal by Subject|0|||
155433925|NCT01450540|561015989|FG000|Overall Study|Withdrawal by Subject|19|||
155433926|NCT01450540|561015990|FG001|Overall Study|Withdrawal by Subject|13|||
155433927|NCT01450540|561015989|FG000|Overall Study|protocol deviation|3|||
155433928|NCT01450540|561015990|FG001|Overall Study|protocol deviation|23|||
155433929|NCT02452359|561015991|FG000|Overall Study|Adverse Event|1|||
155433930|NCT02452359|561015991|FG000|Overall Study|Lost to Follow-up|15|||
155433931|NCT02452359|561015991|FG000|Overall Study|Pregnancy|1|||
155433932|NCT02452359|561015991|FG000|Overall Study|Withdrawal by Subject|4|||
155650317|NCT00337194|561812457|FG000|Overall Study|Subsequent non-protocol therapy|3|||
155650318|NCT00337194|561812458|FG001|Overall Study|Subsequent non-protocol therapy|1|||
155650319|NCT01896986|561812459|FG000|Overall Study|samples lost|14|||
155650320|NCT01896986|561812460|FG001|Overall Study|samples lost|23|||
155650321|NCT03757715|561812463|FG000|Overall Study|Lost to Follow-up|4|||
155650322|NCT03757715|561812464|FG001|Overall Study|Lost to Follow-up|9|||
155650323|NCT03757715|561812463|FG000|Overall Study|Withdrawal by Subject|1|||
155650324|NCT03757715|561812464|FG001|Overall Study|Withdrawal by Subject|1|||
155650325|NCT00281580|561812465|FG000|Overall Study|Adverse Event|2|||
155650326|NCT00281580|561812466|FG001|Overall Study|Adverse Event|0|||
155650327|NCT00281580|561812467|FG002|Overall Study|Adverse Event|2|||
155650328|NCT00281580|561812468|FG003|Overall Study|Adverse Event|4|||
155650329|NCT00281580|561812469|FG004|Overall Study|Adverse Event|1|||
155650330|NCT00281580|561812470|FG005|Overall Study|Adverse Event|0|||
155650331|NCT00281580|561812471|FG006|Overall Study|Adverse Event|1|||
155650332|NCT00281580|561812472|FG007|Overall Study|Adverse Event|0|||
155650333|NCT00281580|561812473|FG008|Overall Study|Adverse Event|1|||
155650334|NCT00281580|561812474|FG009|Overall Study|Adverse Event|6|||
155650335|NCT00281580|561812475|FG010|Overall Study|Adverse Event|0|||
155650336|NCT00281580|561812476|FG011|Overall Study|Adverse Event|5|||
155650337|NCT00281580|561812477|FG012|Overall Study|Adverse Event|8|||
155650338|NCT00281580|561812478|FG013|Overall Study|Adverse Event|2|||
155650339|NCT00281580|561812479|FG014|Overall Study|Adverse Event|3|||
155650340|NCT00281580|561812480|FG015|Overall Study|Adverse Event|3|||
155650341|NCT00281580|561812465|FG000|Overall Study|Protocol Violation|0|||
155650342|NCT00281580|561812466|FG001|Overall Study|Protocol Violation|0|||
155650343|NCT00281580|561812467|FG002|Overall Study|Protocol Violation|1|||
155650344|NCT00281580|561812468|FG003|Overall Study|Protocol Violation|1|||
155650345|NCT00281580|561812469|FG004|Overall Study|Protocol Violation|0|||
155650346|NCT00281580|561812470|FG005|Overall Study|Protocol Violation|0|||
155433933|NCT01887210|561015995|FG000|Overall Study|Withdrawal by Subject|1|||
155433934|NCT01887210|561015996|FG001|Overall Study|Withdrawal by Subject|3|||
155650347|NCT00281580|561812471|FG006|Overall Study|Protocol Violation|1|||
155650348|NCT00281580|561812472|FG007|Overall Study|Protocol Violation|0|||
155650349|NCT00281580|561812473|FG008|Overall Study|Protocol Violation|2|||
155650350|NCT00281580|561812474|FG009|Overall Study|Protocol Violation|0|||
155650351|NCT00281580|561812475|FG010|Overall Study|Protocol Violation|1|||
155650352|NCT00281580|561812476|FG011|Overall Study|Protocol Violation|2|||
155650353|NCT00281580|561812477|FG012|Overall Study|Protocol Violation|0|||
155650354|NCT00281580|561812478|FG013|Overall Study|Protocol Violation|1|||
155650355|NCT00281580|561812479|FG014|Overall Study|Protocol Violation|1|||
155650356|NCT00281580|561812480|FG015|Overall Study|Protocol Violation|3|||
155650357|NCT00281580|561812465|FG000|Overall Study|Withdrawal by Subject|3|||
155650358|NCT00281580|561812466|FG001|Overall Study|Withdrawal by Subject|0|||
155650359|NCT00281580|561812467|FG002|Overall Study|Withdrawal by Subject|1|||
155650360|NCT00281580|561812468|FG003|Overall Study|Withdrawal by Subject|1|||
155650361|NCT00281580|561812469|FG004|Overall Study|Withdrawal by Subject|1|||
155650362|NCT00281580|561812470|FG005|Overall Study|Withdrawal by Subject|2|||
155650363|NCT00281580|561812471|FG006|Overall Study|Withdrawal by Subject|2|||
155650364|NCT00281580|561812472|FG007|Overall Study|Withdrawal by Subject|0|||
155650365|NCT00281580|561812473|FG008|Overall Study|Withdrawal by Subject|1|||
155433935|NCT01887210|561015995|FG000|Overall Study|Lost to Follow-up|0|||
155433936|NCT01887210|561015996|FG001|Overall Study|Lost to Follow-up|1|||
155433937|NCT00840463|561015997|FG000|Overall Study|Adverse Event|1|||
155433938|NCT00840463|561015998|FG001|Overall Study|Adverse Event|0|||
155433939|NCT03414359|561015999|FG000|Overall Study|Lack of Efficacy|1|||
155433940|NCT03414359|561016000|FG001|Overall Study|Lack of Efficacy|1|||
155433941|NCT03414359|561015999|FG000|Overall Study|Protocol Violation|0|||
155433942|NCT03414359|561016000|FG001|Overall Study|Protocol Violation|1|||
155433943|NCT03439345|561017231|FG000|Overall Study|Lost to Follow-up|0|||
155433944|NCT03439345|561017232|FG001|Overall Study|Lost to Follow-up|1|||
155433945|NCT03439345|561017231|FG000|Overall Study|Consent withdrawn|0|||
155433946|NCT03439345|561017232|FG001|Overall Study|Consent withdrawn|1|||
155433947|NCT05405166|561017233|FG000|Overall Study|Death|49|||
155433948|NCT05405166|561017234|FG001|Overall Study|Death|50|||
155433949|NCT05405166|561017233|FG000|Overall Study|Withdrawal by Subject|10|||
155433950|NCT05405166|561017234|FG001|Overall Study|Withdrawal by Subject|3|||
155433951|NCT05405166|561017233|FG000|Overall Study|Ongoing at the time of PCD|209|||
155433952|NCT05405166|561017234|FG001|Overall Study|Ongoing at the time of PCD|210|||
155433953|NCT01386385|561017235|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
155433954|NCT01386385|561017236|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433955|NCT01386385|561017237|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433956|NCT01386385|561017238|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433957|NCT01386385|561017239|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433958|NCT01386385|561017240|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433959|NCT01386385|561017241|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433960|NCT01386385|561017242|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
155433961|NCT01386385|561017235|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
155433962|NCT01386385|561017236|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433963|NCT01386385|561017237|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433964|NCT01386385|561017238|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433965|NCT01386385|561017239|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433966|NCT01386385|561017240|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433967|NCT01386385|561017241|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433968|NCT01386385|561017242|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
155433969|NCT01386385|561017235|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433970|NCT01386385|561017236|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433971|NCT01386385|561017237|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
155433972|NCT01386385|561017238|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433973|NCT01386385|561017239|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433974|NCT01386385|561017240|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433975|NCT01386385|561017241|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433976|NCT01386385|561017242|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
155433977|NCT01386385|561017235|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433978|NCT01386385|561017236|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433979|NCT01386385|561017237|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433980|NCT01386385|561017238|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433981|NCT01386385|561017239|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
155433982|NCT01386385|561017240|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433983|NCT01386385|561017241|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155433984|NCT01386385|561017242|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
155650366|NCT00281580|561812474|FG009|Overall Study|Withdrawal by Subject|4|||
155650367|NCT00281580|561812475|FG010|Overall Study|Withdrawal by Subject|1|||
155650368|NCT00281580|561812476|FG011|Overall Study|Withdrawal by Subject|1|||
155650369|NCT00281580|561812477|FG012|Overall Study|Withdrawal by Subject|2|||
155650370|NCT00281580|561812478|FG013|Overall Study|Withdrawal by Subject|2|||
155650371|NCT00281580|561812479|FG014|Overall Study|Withdrawal by Subject|1|||
155650372|NCT00281580|561812480|FG015|Overall Study|Withdrawal by Subject|5|||
155650373|NCT00281580|561812465|FG000|Overall Study|Lack of Efficacy|2|||
155650374|NCT00281580|561812466|FG001|Overall Study|Lack of Efficacy|1|||
155650375|NCT00281580|561812467|FG002|Overall Study|Lack of Efficacy|1|||
155650376|NCT00281580|561812468|FG003|Overall Study|Lack of Efficacy|6|||
155650377|NCT00281580|561812469|FG004|Overall Study|Lack of Efficacy|2|||
155650378|NCT00281580|561812470|FG005|Overall Study|Lack of Efficacy|0|||
155650379|NCT00281580|561812471|FG006|Overall Study|Lack of Efficacy|0|||
155650380|NCT00281580|561812472|FG007|Overall Study|Lack of Efficacy|0|||
155650381|NCT00281580|561812473|FG008|Overall Study|Lack of Efficacy|0|||
155650382|NCT00281580|561812474|FG009|Overall Study|Lack of Efficacy|0|||
155650383|NCT00281580|561812475|FG010|Overall Study|Lack of Efficacy|0|||
155650384|NCT00281580|561812476|FG011|Overall Study|Lack of Efficacy|1|||
155650385|NCT00281580|561812477|FG012|Overall Study|Lack of Efficacy|0|||
155650386|NCT00281580|561812478|FG013|Overall Study|Lack of Efficacy|2|||
155650387|NCT00281580|561812479|FG014|Overall Study|Lack of Efficacy|1|||
155650388|NCT00281580|561812480|FG015|Overall Study|Lack of Efficacy|0|||
155650389|NCT00281580|561812465|FG000|Overall Study|Lost to Follow-up|0|||
155650390|NCT00281580|561812466|FG001|Overall Study|Lost to Follow-up|0|||
155650391|NCT00281580|561812467|FG002|Overall Study|Lost to Follow-up|0|||
155650392|NCT00281580|561812468|FG003|Overall Study|Lost to Follow-up|3|||
155650393|NCT00281580|561812469|FG004|Overall Study|Lost to Follow-up|0|||
155650394|NCT00281580|561812470|FG005|Overall Study|Lost to Follow-up|1|||
155650395|NCT00281580|561812471|FG006|Overall Study|Lost to Follow-up|0|||
155650396|NCT00281580|561812472|FG007|Overall Study|Lost to Follow-up|1|||
155650397|NCT00281580|561812473|FG008|Overall Study|Lost to Follow-up|2|||
155650398|NCT00281580|561812474|FG009|Overall Study|Lost to Follow-up|1|||
155650399|NCT00281580|561812475|FG010|Overall Study|Lost to Follow-up|1|||
155650400|NCT00281580|561812476|FG011|Overall Study|Lost to Follow-up|0|||
155650401|NCT00281580|561812477|FG012|Overall Study|Lost to Follow-up|1|||
155650402|NCT00281580|561812478|FG013|Overall Study|Lost to Follow-up|0|||
155650403|NCT00281580|561812479|FG014|Overall Study|Lost to Follow-up|0|||
155650404|NCT00281580|561812480|FG015|Overall Study|Lost to Follow-up|0|||
155650405|NCT00281580|561812465|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
155650406|NCT00281580|561812466|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
155650407|NCT00281580|561812467|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
155650408|NCT00281580|561812468|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
155650409|NCT00281580|561812469|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
155650410|NCT00281580|561812470|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
155650411|NCT00281580|561812471|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
155650412|NCT00281580|561812472|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
155650413|NCT00281580|561812473|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
155650414|NCT00281580|561812474|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
155650415|NCT00281580|561812475|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
155433985|NCT01386385|561017235|FG000|Phase II Concurrent CRT|Adverse Event|0|||
155433986|NCT01386385|561017236|FG001|Phase II Concurrent CRT|Adverse Event|0|||
155433987|NCT01386385|561017237|FG002|Phase II Concurrent CRT|Adverse Event|0|||
155433988|NCT01386385|561017238|FG003|Phase II Concurrent CRT|Adverse Event|0|||
155433989|NCT01386385|561017239|FG004|Phase II Concurrent CRT|Adverse Event|0|||
155433990|NCT01386385|561017240|FG005|Phase II Concurrent CRT|Adverse Event|0|||
155433991|NCT01386385|561017241|FG006|Phase II Concurrent CRT|Adverse Event|3|||
155433992|NCT01386385|561017242|FG007|Phase II Concurrent CRT|Adverse Event|3|||
155433993|NCT01386385|561017235|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155650416|NCT00281580|561812476|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
155650417|NCT00281580|561812477|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
155650418|NCT00281580|561812478|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
155650419|NCT00281580|561812479|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
155650420|NCT00281580|561812480|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
155433994|NCT01386385|561017236|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155433995|NCT01386385|561017237|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155650421|NCT00276380|561812484|FG000|Overall Study|Adverse Event|5|||
155433996|NCT01386385|561017238|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155433997|NCT01386385|561017239|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155433998|NCT01386385|561017240|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155433999|NCT01386385|561017241|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
155434000|NCT01386385|561017242|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
155434001|NCT01386385|561017235|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
155434002|NCT01386385|561017236|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
155434003|NCT01386385|561017237|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
155434004|NCT01386385|561017238|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
155650422|NCT00276380|561812485|FG001|Overall Study|Adverse Event|3|||
155650423|NCT00276380|561812484|FG000|Overall Study|Lost to Follow-up|1|||
155650424|NCT00276380|561812485|FG001|Overall Study|Lost to Follow-up|1|||
155650425|NCT00276380|561812484|FG000|Overall Study|Withdrawal by Subject|3|||
155650426|NCT00276380|561812485|FG001|Overall Study|Withdrawal by Subject|6|||
155650427|NCT00276380|561812484|FG000|Overall Study|Death|5|||
155650428|NCT00276380|561812485|FG001|Overall Study|Death|3|||
155650429|NCT00276380|561812484|FG000|Overall Study|Abnormal aPPT Levels|0|||
155650430|NCT00276380|561812485|FG001|Overall Study|Abnormal aPPT Levels|1|||
155650431|NCT01651208|561812490|FG000|Overall Study|Lost to Follow-up|14|||
155650432|NCT01651208|561812491|FG001|Overall Study|Lost to Follow-up|16|||
155650433|NCT02067156|561812492|FG000|Overall Study|Lost to Follow-up|4|||
155650434|NCT03596983|561812493|FG000|Overall Study|Withdrawal by Subject|3|||
155513166|NCT00903383|561304394|FG001|Overall Study|Adverse Event|2|||
155513167|NCT00903383|561304395|FG002|Overall Study|Adverse Event|3|||
155513168|NCT00903383|561304396|FG003|Overall Study|Adverse Event|1|||
155513169|NCT00903383|561304393|FG000|Overall Study|Physician Decision|1|||
155513170|NCT00903383|561304394|FG001|Overall Study|Physician Decision|2|||
155513171|NCT00903383|561304395|FG002|Overall Study|Physician Decision|0|||
155513172|NCT00903383|561304396|FG003|Overall Study|Physician Decision|0|||
155513173|NCT00903383|561304393|FG000|Overall Study|Lost to Follow-up|0|||
155513174|NCT00903383|561304394|FG001|Overall Study|Lost to Follow-up|0|||
155513175|NCT00903383|561304395|FG002|Overall Study|Lost to Follow-up|0|||
155513176|NCT00903383|561304396|FG003|Overall Study|Lost to Follow-up|1|||
155513177|NCT00903383|561304393|FG000|Overall Study|Decision of Sponsor|1|||
155513178|NCT00903383|561304394|FG001|Overall Study|Decision of Sponsor|0|||
155513179|NCT00903383|561304395|FG002|Overall Study|Decision of Sponsor|0|||
155513180|NCT00903383|561304396|FG003|Overall Study|Decision of Sponsor|0|||
155513181|NCT00903383|561304393|FG000|Overall Study|Withdrawal by Subject|4|||
155513182|NCT00903383|561304394|FG001|Overall Study|Withdrawal by Subject|1|||
155513183|NCT00903383|561304395|FG002|Overall Study|Withdrawal by Subject|0|||
155513184|NCT00903383|561304396|FG003|Overall Study|Withdrawal by Subject|2|||
155513185|NCT00903383|561304393|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
155513186|NCT00903383|561304394|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
155513187|NCT00903383|561304395|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
155513188|NCT00903383|561304396|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
155513189|NCT00903383|561304393|FG000|Overall Study|Patient Decision|0|||
155513190|NCT00903383|561304394|FG001|Overall Study|Patient Decision|0|||
155513191|NCT00903383|561304395|FG002|Overall Study|Patient Decision|0|||
155513192|NCT00903383|561304396|FG003|Overall Study|Patient Decision|1|||
155513193|NCT02015793|561304401|FG000|Overall Study|Adverse Event|3|||
155513194|NCT02015793|561304402|FG001|Overall Study|Adverse Event|3|||
155513195|NCT02015793|561304401|FG000|Overall Study|Withdrawal by Subject|1|||
155434005|NCT01386385|561017239|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
155434006|NCT01386385|561017240|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
155434007|NCT01386385|561017241|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
155434008|NCT01386385|561017242|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
155434009|NCT01386385|561017235|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434010|NCT01386385|561017236|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434011|NCT01386385|561017237|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434012|NCT01386385|561017238|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434013|NCT01386385|561017239|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434014|NCT01386385|561017240|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434015|NCT01386385|561017241|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
155434016|NCT01386385|561017242|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155434017|NCT01386385|561017235|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434018|NCT01386385|561017236|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434019|NCT01386385|561017237|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434020|NCT01386385|561017238|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434021|NCT01386385|561017239|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434022|NCT01386385|561017240|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
155434023|NCT01386385|561017241|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
155434024|NCT01386385|561017242|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
155434025|NCT03746080|561017244|FG000|Overall Study|In follow up|2|||
155434026|NCT03746080|561017244|FG000|Overall Study|Death|15|||
155434027|NCT01348919|561017248|FG000|Overall Study|Adverse Event|3|||
155434028|NCT01348919|561017249|FG001|Overall Study|Adverse Event|1|||
155434029|NCT01348919|561017250|FG002|Overall Study|Adverse Event|0|||
155434030|NCT01348919|561017248|FG000|Overall Study|Withdrawal by Subject|0|||
155434031|NCT01348919|561017249|FG001|Overall Study|Withdrawal by Subject|1|||
155434032|NCT01348919|561017250|FG002|Overall Study|Withdrawal by Subject|0|||
155434033|NCT01348919|561017248|FG000|Overall Study|Disease progression|0|||
155434034|NCT01348919|561017249|FG001|Overall Study|Disease progression|1|||
155434035|NCT01348919|561017250|FG002|Overall Study|Disease progression|1|||
155434036|NCT06400238|561017253|FG000|Overall Study|Started Protocol Therapy|2|||
155434037|NCT06400238|561017253|FG000|Overall Study|Adverse Event|1|||
155434038|NCT06400238|561017253|FG000|Overall Study|Death|1|||
155434039|NCT06400238|561017253|FG000|Overall Study|Disease Progression|27|||
155434040|NCT06400238|561017253|FG000|Overall Study|Withdrawal by Subject|2|||
155434041|NCT06400238|561017253|FG000|Overall Study|Physician Decision|2|||
155434042|NCT01009463|561017258|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
155434043|NCT01009463|561017259|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155434044|NCT01009463|561017260|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155434045|NCT01009463|561017261|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155434046|NCT01009463|561017262|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
155434047|NCT01009463|561017258|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
155434048|NCT01009463|561017259|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
155434049|NCT01009463|561017260|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
155434050|NCT01009463|561017261|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
155434051|NCT01009463|561017262|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
155434052|NCT01009463|561017258|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
155434053|NCT01009463|561017259|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155434054|NCT01009463|561017260|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155434055|NCT01009463|561017261|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155434056|NCT01009463|561017262|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
155434057|NCT01009463|561017258|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
155434058|NCT01009463|561017259|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
155434059|NCT01009463|561017260|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
155434060|NCT01009463|561017261|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
155434061|NCT01009463|561017262|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
155434062|NCT01009463|561017258|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
155434063|NCT01009463|561017259|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155434064|NCT01009463|561017260|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155434065|NCT01009463|561017261|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155434066|NCT01009463|561017262|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
155434067|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
155434068|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
155434069|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
155434070|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
155434071|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
155434072|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155513196|NCT02015793|561304402|FG001|Overall Study|Withdrawal by Subject|1|||
155513197|NCT00320593|561304403|FG000|Overall Study|Lost to Follow-up|3|||
155513198|NCT00320593|561304404|FG001|Overall Study|Lost to Follow-up|0|||
155513199|NCT00320593|561304403|FG000|Overall Study|Moved to another state|1|||
155513200|NCT00320593|561304404|FG001|Overall Study|Moved to another state|0|||
155513201|NCT00320593|561304403|FG000|Overall Study|Withdrawal by Subject|2|||
155513202|NCT00320593|561304404|FG001|Overall Study|Withdrawal by Subject|1|||
155513203|NCT00320593|561304403|FG000|Overall Study|Withdrawal by clinical center|1|||
155513204|NCT00320593|561304404|FG001|Overall Study|Withdrawal by clinical center|0|||
155434073|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
155434074|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
155434075|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
155434076|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
155434077|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
155434078|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
155513205|NCT00283686|561304405|FG000|Overall Study|Death|1|||
155513206|NCT00283686|561304406|FG001|Overall Study|Death|1|||
155434079|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
155513207|NCT00283686|561304407|FG002|Overall Study|Death|1|||
155434080|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
155434081|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
155434082|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
155434083|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
155434084|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
155434085|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
155434086|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
155434087|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155434088|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
155434089|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
155434090|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
155434091|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
155434092|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155434093|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
155434094|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155434095|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
155434096|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
155434097|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155434098|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
155434099|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
155434100|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
155434101|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
155434102|NCT01009463|561017258|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
155434103|NCT01009463|561017259|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
155434104|NCT01009463|561017260|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
155434105|NCT01009463|561017261|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
155434106|NCT01009463|561017262|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
155434107|NCT04430348|561017265|FG000|Overall Study|Death|3|||
155434108|NCT04430348|561017266|FG001|Overall Study|Death|2|||
155434109|NCT04430348|561017267|FG002|Overall Study|Death|2|||
155434110|NCT04430348|561017268|FG003|Overall Study|Death|2|||
155434111|NCT04430348|561017269|FG004|Overall Study|Death|2|||
155434112|NCT04430348|561017270|FG005|Overall Study|Death|3|||
155434113|NCT04430348|561017265|FG000|Overall Study|Lost to Follow-up|0|||
155434114|NCT04430348|561017266|FG001|Overall Study|Lost to Follow-up|0|||
155434115|NCT04430348|561017267|FG002|Overall Study|Lost to Follow-up|0|||
155434116|NCT04430348|561017268|FG003|Overall Study|Lost to Follow-up|1|||
155434117|NCT04430348|561017269|FG004|Overall Study|Lost to Follow-up|0|||
155434118|NCT04430348|561017270|FG005|Overall Study|Lost to Follow-up|0|||
155513208|NCT00283686|561304408|FG003|Overall Study|Death|0|||
155513209|NCT00283686|561304405|FG000|Overall Study|Lost to Follow-up|21|||
155650435|NCT00736476|561812494|FG000|Overall Study|Adverse Event|1|||
155650436|NCT00736476|561812495|FG001|Overall Study|Adverse Event|0|||
155434119|NCT04430348|561017265|FG000|Overall Study|Adverse Event|0|||
155650437|NCT01796470|561812497|FG000|Overall Study|Adverse Event|4|||
155434120|NCT04430348|561017266|FG001|Overall Study|Adverse Event|0|||
155434121|NCT04430348|561017267|FG002|Overall Study|Adverse Event|0|||
155434122|NCT04430348|561017268|FG003|Overall Study|Adverse Event|0|||
155434123|NCT04430348|561017269|FG004|Overall Study|Adverse Event|0|||
155434124|NCT04430348|561017270|FG005|Overall Study|Adverse Event|1|||
155434125|NCT04430348|561017265|FG000|Overall Study|Withdrawal by Subject|0|||
155434126|NCT04430348|561017266|FG001|Overall Study|Withdrawal by Subject|1|||
155434127|NCT04430348|561017267|FG002|Overall Study|Withdrawal by Subject|0|||
155434128|NCT04430348|561017268|FG003|Overall Study|Withdrawal by Subject|0|||
155434129|NCT04430348|561017269|FG004|Overall Study|Withdrawal by Subject|0|||
155434130|NCT04430348|561017270|FG005|Overall Study|Withdrawal by Subject|1|||
155434131|NCT04430348|561017265|FG000|Overall Study|Study Terminated by Sponsor|0|||
155434132|NCT04430348|561017266|FG001|Overall Study|Study Terminated by Sponsor|0|||
155434133|NCT04430348|561017267|FG002|Overall Study|Study Terminated by Sponsor|2|||
155434134|NCT04430348|561017268|FG003|Overall Study|Study Terminated by Sponsor|0|||
155434135|NCT04430348|561017269|FG004|Overall Study|Study Terminated by Sponsor|1|||
155434136|NCT04430348|561017270|FG005|Overall Study|Study Terminated by Sponsor|1|||
155434137|NCT03839524|561017275|FG000|Overall Study|Adverse Event|1|||
155434138|NCT04329949|561017280|FG000|Overall Study|Death|36|||
155434139|NCT04329949|561017280|FG000|Overall Study|Withdrawal by Subject|4|||
155434140|NCT04329949|561017280|FG000|Overall Study|Termination of study by sponsor|3|||
155434141|NCT02037919|561017281|FG000|Overall Study|Lost to Follow-up|30|||
155434142|NCT02037919|561017282|FG001|Overall Study|Lost to Follow-up|45|||
155434143|NCT00917384|561017285|FG000|Overall Study|Lost to Follow-up|4|||
155434144|NCT00917384|561017286|FG001|Overall Study|Lost to Follow-up|2|||
155434145|NCT00917384|561017285|FG000|Overall Study|Withdrawal by Subject|10|||
155434146|NCT00917384|561017286|FG001|Overall Study|Withdrawal by Subject|2|||
155434147|NCT03717922|561017289|FG000|Overall Study|Lost to Follow-up|2|||
155434148|NCT03717922|561017290|FG001|Overall Study|Lost to Follow-up|2|||
155434149|NCT01458340|561017291|FG000|Overall Study|Adverse Event|5|||
155434150|NCT01458340|561017292|FG001|Overall Study|Adverse Event|4|||
155434151|NCT01458340|561017293|FG002|Overall Study|Adverse Event|2|||
155434152|NCT01458340|561017291|FG000|Overall Study|Lost to Follow-up|3|||
155434153|NCT01458340|561017292|FG001|Overall Study|Lost to Follow-up|3|||
155650438|NCT01796470|561812498|FG001|Overall Study|Adverse Event|2|||
155650439|NCT01796470|561812499|FG002|Overall Study|Adverse Event|2|||
155650440|NCT01796470|561812500|FG003|Overall Study|Adverse Event|1|||
155650441|NCT01796470|561812501|FG004|Overall Study|Adverse Event|3|||
155650442|NCT01796470|561812497|FG000|Overall Study|Death|2|||
155650443|NCT01796470|561812498|FG001|Overall Study|Death|0|||
155650444|NCT01796470|561812499|FG002|Overall Study|Death|0|||
155650445|NCT01796470|561812500|FG003|Overall Study|Death|0|||
155650446|NCT01796470|561812501|FG004|Overall Study|Death|1|||
155650447|NCT01796470|561812497|FG000|Overall Study|Initiated New Therapy|9|||
155650448|NCT01796470|561812498|FG001|Overall Study|Initiated New Therapy|0|||
155650449|NCT01796470|561812499|FG002|Overall Study|Initiated New Therapy|0|||
155650450|NCT01796470|561812500|FG003|Overall Study|Initiated New Therapy|0|||
155650451|NCT01796470|561812501|FG004|Overall Study|Initiated New Therapy|2|||
155650452|NCT01796470|561812497|FG000|Overall Study|Lost to Follow-up|0|||
155650453|NCT01796470|561812498|FG001|Overall Study|Lost to Follow-up|1|||
155650454|NCT01796470|561812499|FG002|Overall Study|Lost to Follow-up|0|||
155650455|NCT01796470|561812500|FG003|Overall Study|Lost to Follow-up|0|||
155650456|NCT01796470|561812501|FG004|Overall Study|Lost to Follow-up|0|||
155650457|NCT01796470|561812497|FG000|Overall Study|Physician Decision|5|||
155650458|NCT01796470|561812498|FG001|Overall Study|Physician Decision|4|||
155650459|NCT01796470|561812499|FG002|Overall Study|Physician Decision|1|||
155650460|NCT01796470|561812500|FG003|Overall Study|Physician Decision|0|||
155650461|NCT01796470|561812501|FG004|Overall Study|Physician Decision|1|||
155434154|NCT01458340|561017293|FG002|Overall Study|Lost to Follow-up|10|||
155434155|NCT01458340|561017291|FG000|Overall Study|Miscellaneous|0|||
155434156|NCT01458340|561017292|FG001|Overall Study|Miscellaneous|1|||
155434157|NCT01458340|561017293|FG002|Overall Study|Miscellaneous|0|||
155434158|NCT01458340|561017291|FG000|Overall Study|Physician Decision|1|||
155434159|NCT01458340|561017292|FG001|Overall Study|Physician Decision|1|||
155434160|NCT01458340|561017293|FG002|Overall Study|Physician Decision|2|||
155434161|NCT01458340|561017291|FG000|Overall Study|Protocol Violation|6|||
155434162|NCT01458340|561017292|FG001|Overall Study|Protocol Violation|6|||
155434163|NCT01458340|561017293|FG002|Overall Study|Protocol Violation|5|||
155434164|NCT01458340|561017291|FG000|Overall Study|Withdrawal by Subject|12|||
155434165|NCT01458340|561017292|FG001|Overall Study|Withdrawal by Subject|6|||
155434166|NCT01458340|561017293|FG002|Overall Study|Withdrawal by Subject|4|||
155434167|NCT03126227|561017294|FG000|Overall Study|Adverse Event|43|||
155434168|NCT03126227|561017295|FG001|Overall Study|Adverse Event|4|||
155434169|NCT03126227|561017294|FG000|Overall Study|Death|0|||
155434170|NCT03126227|561017295|FG001|Overall Study|Death|1|||
155434171|NCT03126227|561017294|FG000|Overall Study|Lost to Follow-up|0|||
155434172|NCT03126227|561017295|FG001|Overall Study|Lost to Follow-up|1|||
155434173|NCT03126227|561017294|FG000|Overall Study|Physician Decision|2|||
155434174|NCT03126227|561017295|FG001|Overall Study|Physician Decision|0|||
155434175|NCT03126227|561017294|FG000|Overall Study|Protocol Violation|1|||
155434176|NCT03126227|561017295|FG001|Overall Study|Protocol Violation|0|||
155434177|NCT03126227|561017294|FG000|Overall Study|Withdrawal by Subject|19|||
155434178|NCT03126227|561017295|FG001|Overall Study|Withdrawal by Subject|3|||
155513210|NCT00283686|561304406|FG001|Overall Study|Lost to Follow-up|31|||
155650462|NCT01796470|561812497|FG000|Overall Study|Progressive Disease|7|||
155434179|NCT03126227|561017294|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
155434180|NCT03126227|561017295|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
155434181|NCT03126227|561017294|FG000|Overall Study|Lack of dosing compliance|2|||
155434182|NCT03126227|561017295|FG001|Overall Study|Lack of dosing compliance|0|||
155434183|NCT03126227|561017294|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
155434184|NCT03126227|561017295|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
155434185|NCT03126227|561017294|FG000|Overall Study|Scheduling conflict|1|||
155434186|NCT03126227|561017295|FG001|Overall Study|Scheduling conflict|0|||
155434187|NCT01021007|561017298|FG000|Overall Study|Lost to Follow-up|1|||
155434188|NCT01021007|561017299|FG001|Overall Study|Lost to Follow-up|1|||
155434189|NCT01021007|561017298|FG000|Overall Study|Adverse Event|1|||
155434190|NCT01021007|561017299|FG001|Overall Study|Adverse Event|3|||
155434191|NCT01575548|561017300|FG000|Overall Study|Adverse Event|15|||
155434192|NCT01575548|561017301|FG001|Overall Study|Adverse Event|2|||
155434193|NCT01575548|561017300|FG000|Overall Study|Disease progression|12|||
155434194|NCT01575548|561017301|FG001|Overall Study|Disease progression|25|||
155434195|NCT01575548|561017300|FG000|Overall Study|Death|1|||
155434196|NCT01575548|561017301|FG001|Overall Study|Death|0|||
155513211|NCT00283686|561304407|FG002|Overall Study|Lost to Follow-up|26|||
155434197|NCT01575548|561017300|FG000|Overall Study|Other complicating disease|1|||
155434198|NCT01575548|561017301|FG001|Overall Study|Other complicating disease|0|||
155434199|NCT01575548|561017300|FG000|Overall Study|Withdrawal by Subject|7|||
155434200|NCT01575548|561017301|FG001|Overall Study|Withdrawal by Subject|3|||
155434201|NCT01575548|561017300|FG000|Overall Study|Noncompliance|1|||
155434202|NCT01575548|561017301|FG001|Overall Study|Noncompliance|0|||
155434203|NCT01575548|561017300|FG000|Overall Study|Anticipated surgery|0|||
155434204|NCT01575548|561017301|FG001|Overall Study|Anticipated surgery|1|||
155434205|NCT01575548|561017300|FG000|Overall Study|Never started protocol therapy|3|||
155434206|NCT01575548|561017301|FG001|Overall Study|Never started protocol therapy|2|||
155434207|NCT00693706|561017305|FG000|Overall Study|Protocol Violation|0|||
155434208|NCT00693706|561017306|FG001|Overall Study|Protocol Violation|1|||
155434209|NCT00730236|561017310|FG000|Overall Study|Adverse Event|4|||
155434210|NCT00730236|561017310|FG000|Overall Study|Withdrawal by Subject|1|||
155434211|NCT00730236|561017310|FG000|Overall Study|Non-compliance|1|||
155434212|NCT00465569|561017312|FG000|Overall Study|persistent eczema during dose escalation|1|||
155434213|NCT00465569|561017313|FG001|Overall Study|persistent eczema during dose escalation|0|||
155434214|NCT02388776|561017314|FG000|Overall Study|Death|1|||
155434215|NCT02388776|561017314|FG000|Overall Study|Lost to Follow-up|1|||
155434216|NCT03826914|561017315|FG000|Overall Study|Withdrawal by Subject|1|||
155434217|NCT03826914|561017316|FG001|Overall Study|Withdrawal by Subject|1|||
155434218|NCT00104871|561017319|FG000|Overall Study|Not evaluable|1|||
155434219|NCT00519532|561017322|FG000|Overall Study|Adverse Event|11|||
155434220|NCT00519532|561017322|FG000|Overall Study|Withdrawal by Subject|5|||
155434221|NCT00519532|561017322|FG000|Overall Study|Lost to Follow-up|2|||
155434222|NCT02932267|561017327|FG000|Overall Study|Withdrawal by Subject|3|||
155434223|NCT02932267|561017327|FG000|Overall Study|Lost to Follow-up|4|||
155434224|NCT02932267|561017327|FG000|Overall Study|Pregnancy|1|||
155434225|NCT04090164|561017328|FG000|Overall Study|incomplete data on file|245|||
155434226|NCT04090164|561017329|FG001|Overall Study|incomplete data on file|0|||
155434227|NCT00957372|561017340|FG000|PART I|Lost to Follow-up|0|||
155434228|NCT00957372|561017341|FG001|PART I|Lost to Follow-up|0|||
155434229|NCT00957372|561017342|FG002|PART I|Lost to Follow-up|1|||
155434230|NCT00957372|561017343|FG003|PART I|Lost to Follow-up|0|||
155434231|NCT00957372|561017340|FG000|PART II|Withdrawal by Subject|0|||
155434232|NCT00957372|561017341|FG001|PART II|Withdrawal by Subject|0|||
155434233|NCT00957372|561017342|FG002|PART II|Withdrawal by Subject|0|||
155434234|NCT00957372|561017343|FG003|PART II|Withdrawal by Subject|8|||
155434235|NCT00957372|561017340|FG000|PART II|Physician Decision|0|||
155434236|NCT00957372|561017341|FG001|PART II|Physician Decision|0|||
155434237|NCT00957372|561017342|FG002|PART II|Physician Decision|0|||
155434238|NCT00957372|561017343|FG003|PART II|Physician Decision|1|||
155434239|NCT00957372|561017340|FG000|PART II|Pregnancy|0|||
155434240|NCT00957372|561017341|FG001|PART II|Pregnancy|0|||
155513212|NCT00283686|561304408|FG003|Overall Study|Lost to Follow-up|20|||
155434241|NCT00957372|561017342|FG002|PART II|Pregnancy|0|||
155434242|NCT00957372|561017343|FG003|PART II|Pregnancy|1|||
155434243|NCT00957372|561017340|FG000|PART II|Not Know|0|||
155434244|NCT00957372|561017341|FG001|PART II|Not Know|0|||
155513213|NCT00283686|561304405|FG000|Overall Study|Less than full participation|7|||
155434245|NCT00957372|561017342|FG002|PART II|Not Know|0|||
155434246|NCT00957372|561017343|FG003|PART II|Not Know|20|||
155434247|NCT00957372|561017340|FG000|PART II|Adverse Event|0|||
155434248|NCT00957372|561017341|FG001|PART II|Adverse Event|0|||
155434249|NCT00957372|561017342|FG002|PART II|Adverse Event|0|||
155434250|NCT00957372|561017343|FG003|PART II|Adverse Event|10|||
155434251|NCT00957372|561017340|FG000|PART II|Patient non-compliance|0|||
155434252|NCT00957372|561017341|FG001|PART II|Patient non-compliance|0|||
155434253|NCT00957372|561017342|FG002|PART II|Patient non-compliance|0|||
155434254|NCT00957372|561017343|FG003|PART II|Patient non-compliance|4|||
155434255|NCT01444391|561017346|FG000|Overall Study|Death|1|||
155434256|NCT00630032|561017347|FG000|Overall Study|Death|55|||
155434257|NCT00630032|561017348|FG001|Overall Study|Death|49|||
155434258|NCT00630032|561017347|FG000|Overall Study|Withdrawal by Subject|3|||
155434259|NCT00630032|561017348|FG001|Overall Study|Withdrawal by Subject|2|||
155434260|NCT00630032|561017347|FG000|Overall Study|Lost to Follow-up|18|||
155434261|NCT00630032|561017348|FG001|Overall Study|Lost to Follow-up|31|||
155434262|NCT00630032|561017347|FG000|Overall Study|Protocol Violation|1|||
155434263|NCT00630032|561017348|FG001|Overall Study|Protocol Violation|0|||
155434264|NCT00630032|561017347|FG000|Overall Study|Patient has moved|1|||
155434265|NCT00630032|561017348|FG001|Overall Study|Patient has moved|1|||
155434266|NCT00630032|561017347|FG000|Overall Study|Disease progression|1|||
155434267|NCT00630032|561017348|FG001|Overall Study|Disease progression|1|||
155434268|NCT00630032|561017347|FG000|Overall Study|End of monitoring in US centers|11|||
155434269|NCT00630032|561017348|FG001|Overall Study|End of monitoring in US centers|11|||
155434270|NCT02332915|561017349|FG000|Overall Study|Moved out of region|3|||
155434271|NCT02332915|561017350|FG001|Overall Study|Moved out of region|0|||
155434272|NCT02332915|561017349|FG000|Overall Study|Unrelated illness|1|||
155434273|NCT02332915|561017350|FG001|Overall Study|Unrelated illness|1|||
155434274|NCT02332915|561017349|FG000|Overall Study|Travel distance prohibitive|0|||
155434275|NCT02332915|561017350|FG001|Overall Study|Travel distance prohibitive|1|||
155434276|NCT02332915|561017349|FG000|Overall Study|did not meet inclusion criteria|2|||
155434277|NCT02332915|561017350|FG001|Overall Study|did not meet inclusion criteria|4|||
155434278|NCT01901328|561017351|FG000|Overall Study|Lost to Follow-up|1|||
155434279|NCT01901328|561017352|FG001|Overall Study|Lost to Follow-up|0|||
155434280|NCT01901328|561017351|FG000|Overall Study|Physician Decision|0|||
155513214|NCT00283686|561304406|FG001|Overall Study|Less than full participation|9|||
155513215|NCT00283686|561304407|FG002|Overall Study|Less than full participation|6|||
155434281|NCT01901328|561017352|FG001|Overall Study|Physician Decision|1|||
155434282|NCT01901328|561017351|FG000|Overall Study|Protocol Violation|1|||
155434283|NCT01901328|561017352|FG001|Overall Study|Protocol Violation|1|||
155434284|NCT01901328|561017351|FG000|Overall Study|Study Terminated by Sponsor|19|||
155434285|NCT01901328|561017352|FG001|Overall Study|Study Terminated by Sponsor|16|||
155434286|NCT01901328|561017351|FG000|Overall Study|Withdrawal by Subject|1|||
155434287|NCT01901328|561017352|FG001|Overall Study|Withdrawal by Subject|2|||
155434288|NCT01901328|561017351|FG000|Overall Study|Lack of Efficacy|0|||
155434289|NCT01901328|561017352|FG001|Overall Study|Lack of Efficacy|1|||
155434290|NCT02462889|561017353|FG000|Overall Study|Withdrawal by Subject|2|||
155434291|NCT02462889|561017354|FG001|Overall Study|Withdrawal by Subject|6|||
155434292|NCT02462889|561017353|FG000|Overall Study|Death|1|||
155434293|NCT02462889|561017354|FG001|Overall Study|Death|5|||
155434294|NCT03232073|561017357|FG000|Overall Study|Death|1|||
155434295|NCT03232073|561017358|FG001|Overall Study|Death|0|||
155434296|NCT03232073|561017357|FG000|Overall Study|Adverse Event|7|||
155434297|NCT03232073|561017358|FG001|Overall Study|Adverse Event|12|||
155434298|NCT03232073|561017357|FG000|Overall Study|Lost to Follow-up|6|||
155434299|NCT03232073|561017358|FG001|Overall Study|Lost to Follow-up|6|||
155434300|NCT03232073|561017357|FG000|Overall Study|Lack of Efficacy|10|||
155434301|NCT03232073|561017358|FG001|Overall Study|Lack of Efficacy|8|||
155434302|NCT03232073|561017357|FG000|Overall Study|Physician Decision|9|||
155434303|NCT03232073|561017358|FG001|Overall Study|Physician Decision|2|||
155434304|NCT03232073|561017357|FG000|Overall Study|Withdrawal by Subject|54|||
155434305|NCT03232073|561017358|FG001|Overall Study|Withdrawal by Subject|39|||
155434306|NCT02032875|561017359|FG000|Treatment Period|Adverse Event|1|||
155434307|NCT02032875|561017360|FG001|Treatment Period|Adverse Event|0|||
155434308|NCT02032875|561017359|FG000|Treatment Period|Liver transplant, No extension needed|0|||
155434309|NCT02032875|561017360|FG001|Treatment Period|Liver transplant, No extension needed|1|||
155434310|NCT02032875|561017359|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
155434311|NCT02032875|561017360|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
155434312|NCT02032875|561017359|FG000|Follow-up Period|Death|0|||
155434313|NCT02032875|561017360|FG001|Follow-up Period|Death|1|||
155434314|NCT02032875|561017359|FG000|Follow-up Period|Virologic Relapse|3|||
155434315|NCT02032875|561017360|FG001|Follow-up Period|Virologic Relapse|10|||
155434316|NCT03191786|561017365|FG000|Overall Study|Death|236|||
155434317|NCT03191786|561017366|FG001|Overall Study|Death|127|||
155434318|NCT03191786|561017365|FG000|Overall Study|Lost to Follow-up|9|||
155434319|NCT03191786|561017366|FG001|Overall Study|Lost to Follow-up|3|||
155434320|NCT03191786|561017365|FG000|Overall Study|Physician Decision|1|||
155434321|NCT03191786|561017366|FG001|Overall Study|Physician Decision|0|||
155434322|NCT03191786|561017365|FG000|Overall Study|Moved to Post Trial Access Program|30|||
155434323|NCT03191786|561017366|FG001|Overall Study|Moved to Post Trial Access Program|5|||
155434324|NCT03191786|561017365|FG000|Overall Study|Withdrawal by Subject|26|||
155434325|NCT03191786|561017366|FG001|Overall Study|Withdrawal by Subject|16|||
155434326|NCT05847881|561017367|FG000|Overall Study|Principal Investigator Decision|8|||
155434327|NCT05847881|561017367|FG000|Overall Study|Withdrawal by Subject|2|||
155434328|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
155434329|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
155434330|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
155434331|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
155513216|NCT00283686|561304408|FG003|Overall Study|Less than full participation|12|||
155513217|NCT01076166|561304409|FG000|Overall Study|Adverse Event|3|||
155434332|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
155434333|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
155434334|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
155434335|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
155434336|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
155434337|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
155434338|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
155434339|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
155434340|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
155434341|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
155434342|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
155434343|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
155434344|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
155434345|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
155434346|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Death|0|||
155434347|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Death|1|||
155434348|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Death|0|||
155434349|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
155434350|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
155434351|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
155434352|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
155434353|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
155434354|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
155434355|NCT00430781|561019215|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
155434356|NCT00430781|561019216|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
155434357|NCT00430781|561019217|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
155434358|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
155434359|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
155434360|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
155434361|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
155434362|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
155434363|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
155434364|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
155434365|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
155434366|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
155434367|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
155434368|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
155434369|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
155434370|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Other|0|||
155434371|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Other|1|||
155434372|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Other|0|||
155434373|NCT00430781|561019215|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
155434374|NCT00430781|561019216|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
155434375|NCT00430781|561019217|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
155434376|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
155434377|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
155434378|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
155434379|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
155434380|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
155434381|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
155434382|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
155434383|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
155434384|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
155434385|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
155434386|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
155434387|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
155434388|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
155434389|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
155434390|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
155434391|NCT00430781|561019215|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
155434392|NCT00430781|561019216|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
155434393|NCT00430781|561019217|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
155434394|NCT05408858|561019218|FG000|Overall Study|no longer met eligibility criteria|1|||
155434395|NCT01451515|561019226|FG000|Overall Study|Death|0|||
155434396|NCT01451515|561019227|FG001|Overall Study|Death|1|||
155434397|NCT01451515|561019228|FG002|Overall Study|Death|0|||
155434398|NCT01451515|561019226|FG000|Overall Study|Withdrawal by Subject|0|||
155434399|NCT01451515|561019227|FG001|Overall Study|Withdrawal by Subject|1|||
155434400|NCT01451515|561019228|FG002|Overall Study|Withdrawal by Subject|0|||
155434401|NCT01451515|561019226|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
155434402|NCT01451515|561019227|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
155434403|NCT01451515|561019228|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
155434404|NCT01451515|561019226|FG000|Overall Study|Relapse (except CNS)|1|||
155434405|NCT01451515|561019227|FG001|Overall Study|Relapse (except CNS)|1|||
155434406|NCT01451515|561019228|FG002|Overall Study|Relapse (except CNS)|0|||
155434407|NCT03230097|561019234|FG000|Overall Study|Adverse Event|2|||
155434408|NCT03230097|561019235|FG001|Overall Study|Adverse Event|1|||
155650463|NCT01796470|561812498|FG001|Overall Study|Progressive Disease|7|||
155434409|NCT03230097|561019234|FG000|Overall Study|non-compliance|0|||
155434410|NCT03230097|561019235|FG001|Overall Study|non-compliance|1|||
155434411|NCT03230097|561019234|FG000|Overall Study|Lost to Follow-up|2|||
155434412|NCT03230097|561019235|FG001|Overall Study|Lost to Follow-up|4|||
155513218|NCT01076166|561304409|FG000|Overall Study|Symptoms improved/resolved|6|||
155513219|NCT01211769|561304412|FG000|Overall Study|Lost to Follow-up|7|||
155513220|NCT01211769|561304413|FG001|Overall Study|Lost to Follow-up|9|||
155513221|NCT01211769|561304414|FG002|Overall Study|Lost to Follow-up|5|||
155513222|NCT01211769|561304415|FG003|Overall Study|Lost to Follow-up|9|||
155513223|NCT01211769|561304412|FG000|Overall Study|Physician Decision|2|||
155513224|NCT01211769|561304413|FG001|Overall Study|Physician Decision|0|||
155513225|NCT01211769|561304414|FG002|Overall Study|Physician Decision|2|||
155513226|NCT01211769|561304415|FG003|Overall Study|Physician Decision|1|||
155513227|NCT01211769|561304412|FG000|Overall Study|Adverse Event|0|||
155513228|NCT01211769|561304413|FG001|Overall Study|Adverse Event|1|||
155513229|NCT01211769|561304414|FG002|Overall Study|Adverse Event|1|||
155513230|NCT01211769|561304415|FG003|Overall Study|Adverse Event|1|||
155513231|NCT00947427|561304416|FG000|Overall Study|Withdrawal by Subject|1|||
155513232|NCT00947427|561304417|FG001|Overall Study|Withdrawal by Subject|3|||
155434413|NCT03230097|561019234|FG000|Overall Study|Withdrawal by Subject|7|||
155434414|NCT03230097|561019235|FG001|Overall Study|Withdrawal by Subject|3|||
155434415|NCT03230097|561019234|FG000|Overall Study|Trial termination|4|||
155434416|NCT03230097|561019235|FG001|Overall Study|Trial termination|5|||
155434417|NCT03230097|561019234|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
155434418|NCT03230097|561019235|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
155434419|NCT03230097|561019234|FG000|Overall Study|outcome event|0|||
155434420|NCT03230097|561019235|FG001|Overall Study|outcome event|1|||
155434421|NCT01702805|561019242|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
155434422|NCT01702805|561019243|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
155434423|NCT01702805|561019242|FG000|Overall Study|Incomplete Follow-up|18|||
155434424|NCT01702805|561019243|FG001|Overall Study|Incomplete Follow-up|15|||
155434425|NCT01702805|561019242|FG000|Overall Study|Vital Status Assessment Only|40|||
155434426|NCT01702805|561019243|FG001|Overall Study|Vital Status Assessment Only|39|||
155434427|NCT01702805|561019242|FG000|Overall Study|Lost to Follow-up|5|||
155434428|NCT01702805|561019243|FG001|Overall Study|Lost to Follow-up|5|||
155434429|NCT00635102|561019244|FG000|Overall Study|Withdrawal by Subject|7|||
155434430|NCT00635102|561019245|FG001|Overall Study|Withdrawal by Subject|8|||
155434431|NCT00440401|561019247|FG000|Overall Study|Adverse Event|2|||
155434432|NCT00440401|561019248|FG001|Overall Study|Adverse Event|1|||
155434433|NCT00440401|561019247|FG000|Overall Study|Other|2|||
155434434|NCT00440401|561019248|FG001|Overall Study|Other|5|||
155434435|NCT01925703|561019249|FG000|Overall Study|Physician Decision|1|||
155434436|NCT01925703|561019249|FG000|Overall Study|Lost to Follow-up|2|||
155434437|NCT01925703|561019249|FG000|Overall Study|Discharge prior to full iron repletion|1|||
155434438|NCT01238120|561019251|FG000|Overall Study|Withdrawal by Subject|4|||
155434439|NCT01238120|561019252|FG001|Overall Study|Withdrawal by Subject|1|||
155434440|NCT01238120|561019253|FG002|Overall Study|Withdrawal by Subject|2|||
155434441|NCT01238120|561019254|FG003|Overall Study|Withdrawal by Subject|5|||
155434442|NCT01238120|561019251|FG000|Overall Study|Lost to Follow-up|2|||
155434443|NCT01238120|561019252|FG001|Overall Study|Lost to Follow-up|0|||
155434444|NCT01238120|561019253|FG002|Overall Study|Lost to Follow-up|1|||
155434445|NCT01238120|561019254|FG003|Overall Study|Lost to Follow-up|1|||
155434446|NCT01238120|561019251|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
155434447|NCT01238120|561019252|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
155434448|NCT01238120|561019253|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
155434449|NCT01238120|561019254|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
155434450|NCT00881205|561019255|FG000|Overall Study|Adverse Event|8|||
155434451|NCT00881205|561019256|FG001|Overall Study|Adverse Event|3|||
155434452|NCT00881205|561019255|FG000|Overall Study|Withdrawal by Subject|1|||
155434453|NCT00881205|561019256|FG001|Overall Study|Withdrawal by Subject|2|||
155434454|NCT00881205|561019255|FG000|Overall Study|Lost to Follow-up|0|||
155434455|NCT00881205|561019256|FG001|Overall Study|Lost to Follow-up|1|||
155434456|NCT00881205|561019255|FG000|Overall Study|Administrative problems|1|||
155434457|NCT00881205|561019256|FG001|Overall Study|Administrative problems|1|||
155434458|NCT00881205|561019255|FG000|Overall Study|Condition no longer requires drug|1|||
155434459|NCT00881205|561019256|FG001|Overall Study|Condition no longer requires drug|0|||
155434460|NCT02498652|561019259|FG000|Overall Study|Protocol Violation|0|||
155434461|NCT02498652|561019260|FG001|Overall Study|Protocol Violation|1|||
155513233|NCT00947427|561304416|FG000|Overall Study|Protocol Violation|0|||
155513234|NCT00947427|561304417|FG001|Overall Study|Protocol Violation|1|||
155513235|NCT02115256|561304420|FG000|Overall Study|Withdrawal by Subject|0|||
155513236|NCT02115256|561304421|FG001|Overall Study|Withdrawal by Subject|1|||
155513237|NCT00146770|561304422|FG000|Overall Study|Adverse Event|2|||
155434462|NCT01193335|561019261|FG000|After Infant Series|Lost to Follow-up|1|||
155434463|NCT01193335|561019262|FG001|After Infant Series|Lost to Follow-up|2|||
155434464|NCT01193335|561019261|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
155434465|NCT01193335|561019262|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
155434466|NCT01193335|561019261|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
155434467|NCT01193335|561019262|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
155434468|NCT01193335|561019261|FG000|1-Year Follow-up|Lost to Follow-up|4|||
155434469|NCT01193335|561019262|FG001|1-Year Follow-up|Lost to Follow-up|0|||
155434470|NCT01193335|561019261|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
155434471|NCT01193335|561019262|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
155434472|NCT01193335|561019261|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
155434473|NCT01193335|561019262|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
155434474|NCT01733329|561019263|FG000|Overall Study|Protocol Violation|1|||
155434475|NCT01733329|561019264|FG001|Overall Study|Protocol Violation|1|||
155434476|NCT01733329|561019263|FG000|Overall Study|Uterine artery injury|1|||
155434477|NCT01733329|561019264|FG001|Overall Study|Uterine artery injury|0|||
155434478|NCT01985321|561019270|FG000|Overall Study|Protocol Violation|4|||
155434479|NCT01985321|561019271|FG001|Overall Study|Protocol Violation|3|||
155434480|NCT01985321|561019270|FG000|Overall Study|Withdrawal by Subject|1|||
155434481|NCT01985321|561019271|FG001|Overall Study|Withdrawal by Subject|0|||
155434482|NCT01985321|561019270|FG000|Overall Study|Lost to Follow-up|5|||
155434483|NCT01985321|561019271|FG001|Overall Study|Lost to Follow-up|2|||
155434484|NCT01985321|561019270|FG000|Overall Study|Subject treated wrong type of sore|1|||
155434485|NCT01985321|561019271|FG001|Overall Study|Subject treated wrong type of sore|0|||
155434486|NCT00482001|561019272|FG000|Overall Study|Protocol Violation|1|||
155434487|NCT00482001|561019273|FG001|Overall Study|Protocol Violation|1|||
155434488|NCT04786210|561019274|FG000|Overall Study|Lost to Follow-up|2|||
155434489|NCT04786210|561019274|FG000|Overall Study|Withdrawal by Subject|4|||
155434490|NCT04334148|561019277|FG000|Overall Study|positive nasal swab at baseline|0|||
155434491|NCT04334148|561019278|FG001|Overall Study|positive nasal swab at baseline|1|||
155434492|NCT00498173|561019279|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
155434493|NCT00498173|561019280|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
155434494|NCT00498173|561019281|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
155434495|NCT04246047|561019282|FG000|Overall Study|Death|50|||
155434496|NCT04246047|561019283|FG001|Overall Study|Death|77|||
155434497|NCT04246047|561019282|FG000|Overall Study|Lost to Follow-up|1|||
155434498|NCT04246047|561019283|FG001|Overall Study|Lost to Follow-up|3|||
155434499|NCT04246047|561019282|FG000|Overall Study|Physician Decision|4|||
155434500|NCT04246047|561019283|FG001|Overall Study|Physician Decision|10|||
155434501|NCT04246047|561019282|FG000|Overall Study|Withdrawal by Subject|19|||
155434502|NCT04246047|561019283|FG001|Overall Study|Withdrawal by Subject|26|||
155434503|NCT04246047|561019282|FG000|Overall Study|Ongoing|169|||
155434504|NCT04246047|561019283|FG001|Overall Study|Ongoing|135|||
155434505|NCT04689828|561019284|FG000|Overall Study|Subject decision|5|||
155434506|NCT04689828|561019285|FG001|Overall Study|Subject decision|5|||
155434507|NCT04689828|561019284|FG000|Overall Study|Adverse Event|12|||
155434508|NCT04689828|561019285|FG001|Overall Study|Adverse Event|12|||
155434509|NCT04689828|561019284|FG000|Overall Study|Physician Decision|24|||
155434510|NCT04689828|561019285|FG001|Overall Study|Physician Decision|32|||
155434511|NCT04689828|561019284|FG000|Overall Study|Progressive disease|54|||
155434512|NCT04689828|561019285|FG001|Overall Study|Progressive disease|173|||
155434513|NCT04689828|561019284|FG000|Overall Study|Death|0|||
155434514|NCT04689828|561019285|FG001|Overall Study|Death|1|||
155434515|NCT04689828|561019284|FG000|Overall Study|Lost to Follow-up|1|||
155434516|NCT04689828|561019285|FG001|Overall Study|Lost to Follow-up|0|||
155434517|NCT04689828|561019284|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
155434518|NCT04689828|561019285|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
155434519|NCT04689828|561019284|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
155434520|NCT04689828|561019285|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
155434521|NCT04689828|561019284|FG000|Overall Study|Participants not treated|7|||
155434522|NCT04689828|561019285|FG001|Overall Study|Participants not treated|2|||
155434523|NCT04332419|561019292|FG000|Overall Study|Withdrawal by Subject|1|||
155434524|NCT02493751|561019293|FG000|Overall Study|Withdrawal by Subject|2|||
155434525|NCT02493751|561019294|FG001|Overall Study|Withdrawal by Subject|8|||
155434526|NCT02493751|561019293|FG000|Overall Study|Death|6|||
155650464|NCT01796470|561812499|FG002|Overall Study|Progressive Disease|3|||
155434527|NCT02493751|561019294|FG001|Overall Study|Death|13|||
155434528|NCT02493751|561019293|FG000|Overall Study|Lost to Follow-up|2|||
155434529|NCT02493751|561019294|FG001|Overall Study|Lost to Follow-up|3|||
155434530|NCT02493751|561019293|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
155434531|NCT02493751|561019294|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
155434532|NCT00519623|561019295|FG000|Overall Study|Adverse Event|1|||
155434533|NCT03819140|561019298|FG000|Overall Study|Lost to Follow-up|1|||
155434534|NCT03819140|561019299|FG001|Overall Study|Lost to Follow-up|2|||
155434535|NCT03819140|561019298|FG000|Overall Study|Withdrawal by Subject|3|||
155434536|NCT03819140|561019299|FG001|Overall Study|Withdrawal by Subject|2|||
155434537|NCT03819140|561019298|FG000|Overall Study|Adverse Event|0|||
155434538|NCT03819140|561019299|FG001|Overall Study|Adverse Event|1|||
155434539|NCT03819140|561019298|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
155434540|NCT03819140|561019299|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
155434541|NCT03819140|561019298|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
155434542|NCT03819140|561019299|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
155434543|NCT02192359|561019300|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
155434544|NCT02192359|561019301|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
155434545|NCT02192359|561019302|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
155434546|NCT02192359|561019303|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
155434547|NCT02192359|561019300|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
155434548|NCT02192359|561019301|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
155434549|NCT02192359|561019302|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
155434550|NCT02192359|561019303|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
155434551|NCT02192359|561019300|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
155434552|NCT02192359|561019301|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
155434553|NCT02192359|561019302|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
155434554|NCT02192359|561019303|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
155434555|NCT00457639|561019304|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
155434556|NCT00457639|561019305|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
155434557|NCT00457639|561019304|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
155434558|NCT00457639|561019305|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
155434559|NCT00457639|561019304|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
155434560|NCT00457639|561019305|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
155434561|NCT02117687|561019306|FG000|Overall Study|Lost to Follow-up|0|||
155434562|NCT02117687|561019307|FG001|Overall Study|Lost to Follow-up|1|||
155434563|NCT02117687|561019306|FG000|Overall Study|Adverse Event|0|||
155434564|NCT02117687|561019307|FG001|Overall Study|Adverse Event|2|||
155434565|NCT02117687|561019306|FG000|Overall Study|Other Reasons|1|||
155434566|NCT02117687|561019307|FG001|Overall Study|Other Reasons|1|||
155434567|NCT01687673|561019319|FG000|Overall Study|Physician Decision|1|||
155513238|NCT00146770|561304423|FG001|Overall Study|Adverse Event|0|||
155513239|NCT00146770|561304422|FG000|Overall Study|Pregnancy|1|||
155513240|NCT00146770|561304423|FG001|Overall Study|Pregnancy|0|||
155513241|NCT00146770|561304422|FG000|Overall Study|Withdrawal by Subject|2|||
155513242|NCT00146770|561304423|FG001|Overall Study|Withdrawal by Subject|0|||
155513243|NCT02427607|561304424|FG000|Overall Study|Withdrawal by Subject|1|||
155513244|NCT02826603|561304425|FG000|Overall Study|Adverse Event|17|||
155513245|NCT02826603|561304426|FG001|Overall Study|Adverse Event|9|||
155434568|NCT02234622|561019320|FG000|Overall Study|Withdrawal by Subject|16|||
155434569|NCT02234622|561019321|FG001|Overall Study|Withdrawal by Subject|22|||
155434570|NCT02234622|561019320|FG000|Overall Study|Lost to Follow-up|27|||
155434571|NCT02234622|561019321|FG001|Overall Study|Lost to Follow-up|14|||
155434572|NCT03476239|561019322|FG000|Overall Study|Withdrawal by Subject|10|||
155434573|NCT03476239|561019322|FG000|Overall Study|Death|80|||
155434574|NCT03476239|561019322|FG000|Overall Study|Lost to Follow-up|8|||
155434575|NCT00618956|561019323|FG000|Overall Study|Adverse Event|10|||
155434576|NCT00618956|561019324|FG001|Overall Study|Adverse Event|34|||
155513246|NCT02826603|561304425|FG000|Overall Study|Lack of Efficacy|4|||
155513247|NCT02826603|561304426|FG001|Overall Study|Lack of Efficacy|9|||
155513248|NCT02826603|561304425|FG000|Overall Study|Lost to Follow-up|13|||
155650465|NCT01796470|561812500|FG003|Overall Study|Progressive Disease|2|||
155650466|NCT01796470|561812501|FG004|Overall Study|Progressive Disease|0|||
155650467|NCT01796470|561812497|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
155650468|NCT01796470|561812498|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
155650469|NCT01796470|561812499|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
155650470|NCT01796470|561812500|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
155650471|NCT01796470|561812501|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
155650472|NCT01796470|561812497|FG000|Overall Study|Withdrawal by Subject|7|||
155650473|NCT01796470|561812498|FG001|Overall Study|Withdrawal by Subject|0|||
155650474|NCT01796470|561812499|FG002|Overall Study|Withdrawal by Subject|0|||
155650475|NCT01796470|561812500|FG003|Overall Study|Withdrawal by Subject|0|||
155650476|NCT01796470|561812501|FG004|Overall Study|Withdrawal by Subject|1|||
155650477|NCT00147537|561812502|FG000|Phase 1b|Death|0|||
155650478|NCT00147537|561812503|FG001|Phase 1b|Death|1|||
155650479|NCT00147537|561812504|FG002|Phase 1b|Death|2|||
155650480|NCT00147537|561812505|FG003|Phase 1b|Death|1|||
155650481|NCT00147537|561812506|FG004|Phase 1b|Death|2|||
155650482|NCT00147537|561812507|FG005|Phase 1b|Death|2|||
155650483|NCT00147537|561812508|FG006|Phase 1b|Death|1|||
155650484|NCT00147537|561812509|FG007|Phase 1b|Death|3|||
155650485|NCT00147537|561812510|FG008|Phase 1b|Death|9|||
155650486|NCT00147537|561812511|FG009|Phase 1b|Death|0|||
155650487|NCT00147537|561812512|FG010|Phase 1b|Death|0|||
155650488|NCT00147537|561812502|FG000|Phase 1b|Lost to Follow-up|2|||
155650489|NCT00147537|561812503|FG001|Phase 1b|Lost to Follow-up|1|||
155650490|NCT00147537|561812504|FG002|Phase 1b|Lost to Follow-up|0|||
155650491|NCT00147537|561812505|FG003|Phase 1b|Lost to Follow-up|0|||
155650492|NCT00147537|561812506|FG004|Phase 1b|Lost to Follow-up|0|||
155650493|NCT00147537|561812507|FG005|Phase 1b|Lost to Follow-up|0|||
155650494|NCT00147537|561812508|FG006|Phase 1b|Lost to Follow-up|2|||
155650495|NCT00147537|561812509|FG007|Phase 1b|Lost to Follow-up|0|||
155650496|NCT00147537|561812510|FG008|Phase 1b|Lost to Follow-up|1|||
155650497|NCT00147537|561812511|FG009|Phase 1b|Lost to Follow-up|0|||
155650498|NCT00147537|561812512|FG010|Phase 1b|Lost to Follow-up|0|||
155650499|NCT00147537|561812502|FG000|Phase 1b|Other|0|||
155650500|NCT00147537|561812503|FG001|Phase 1b|Other|0|||
155650501|NCT00147537|561812504|FG002|Phase 1b|Other|2|||
155650502|NCT00147537|561812505|FG003|Phase 1b|Other|1|||
155650503|NCT00147537|561812506|FG004|Phase 1b|Other|1|||
155650504|NCT00147537|561812507|FG005|Phase 1b|Other|1|||
155650505|NCT00147537|561812508|FG006|Phase 1b|Other|14|||
155650506|NCT00147537|561812509|FG007|Phase 1b|Other|4|||
155650507|NCT00147537|561812510|FG008|Phase 1b|Other|4|||
155650508|NCT00147537|561812511|FG009|Phase 1b|Other|0|||
155434577|NCT00618956|561019323|FG000|Overall Study|Lack of Efficacy|2|||
155434578|NCT00618956|561019324|FG001|Overall Study|Lack of Efficacy|1|||
155434579|NCT00618956|561019323|FG000|Overall Study|Withdrawal by Subject|5|||
155434580|NCT00618956|561019324|FG001|Overall Study|Withdrawal by Subject|7|||
155434581|NCT00618956|561019323|FG000|Overall Study|Lost to Follow-up|4|||
155434582|NCT00618956|561019324|FG001|Overall Study|Lost to Follow-up|5|||
155434583|NCT00618956|561019323|FG000|Overall Study|Protocol Violation|2|||
155434584|NCT00618956|561019324|FG001|Overall Study|Protocol Violation|2|||
155434585|NCT00618956|561019323|FG000|Overall Study|did not meet criteria, non-compliance|2|||
155434586|NCT00618956|561019324|FG001|Overall Study|did not meet criteria, non-compliance|1|||
155434587|NCT03598777|561019325|FG000|Overall Study|Study Terminated by Sponsor|3|||
155434588|NCT03598777|561019326|FG001|Overall Study|Study Terminated by Sponsor|0|||
155434589|NCT03598777|561019327|FG002|Overall Study|Study Terminated by Sponsor|0|||
155434590|NCT03598777|561019328|FG003|Overall Study|Study Terminated by Sponsor|0|||
155434591|NCT03598777|561019329|FG004|Overall Study|Study Terminated by Sponsor|15|||
155434592|NCT03598777|561019325|FG000|Overall Study|Withdrawal by Subject|1|||
155434593|NCT03598777|561019326|FG001|Overall Study|Withdrawal by Subject|1|||
155434594|NCT03598777|561019327|FG002|Overall Study|Withdrawal by Subject|0|||
155434595|NCT03598777|561019328|FG003|Overall Study|Withdrawal by Subject|0|||
155650509|NCT00147537|561812512|FG010|Phase 1b|Other|0|||
155650510|NCT00147537|561812502|FG000|Phase 1b|Withdrawal by Subject|0|||
155650511|NCT00147537|561812503|FG001|Phase 1b|Withdrawal by Subject|0|||
155650512|NCT00147537|561812504|FG002|Phase 1b|Withdrawal by Subject|0|||
155650513|NCT00147537|561812505|FG003|Phase 1b|Withdrawal by Subject|0|||
155650514|NCT00147537|561812506|FG004|Phase 1b|Withdrawal by Subject|0|||
155434596|NCT03598777|561019329|FG004|Overall Study|Withdrawal by Subject|0|||
155434597|NCT03598777|561019325|FG000|Overall Study|Adverse Event|1|||
155434598|NCT03598777|561019326|FG001|Overall Study|Adverse Event|0|||
155434599|NCT03598777|561019327|FG002|Overall Study|Adverse Event|0|||
155434600|NCT03598777|561019328|FG003|Overall Study|Adverse Event|0|||
155650515|NCT00147537|561812507|FG005|Phase 1b|Withdrawal by Subject|0|||
155650516|NCT00147537|561812508|FG006|Phase 1b|Withdrawal by Subject|0|||
155650517|NCT00147537|561812509|FG007|Phase 1b|Withdrawal by Subject|0|||
155650518|NCT00147537|561812510|FG008|Phase 1b|Withdrawal by Subject|2|||
155434601|NCT03598777|561019329|FG004|Overall Study|Adverse Event|0|||
155434602|NCT03598777|561019325|FG000|Overall Study|Lost to Follow-up|1|||
155434603|NCT03598777|561019326|FG001|Overall Study|Lost to Follow-up|0|||
155434604|NCT03598777|561019327|FG002|Overall Study|Lost to Follow-up|0|||
155434605|NCT03598777|561019328|FG003|Overall Study|Lost to Follow-up|0|||
155434606|NCT03598777|561019329|FG004|Overall Study|Lost to Follow-up|0|||
155434607|NCT02006576|561019330|FG000|Overall Study|Withdrawal by Subject|4|||
155434608|NCT02006576|561019331|FG001|Overall Study|Withdrawal by Subject|6|||
155434609|NCT02006576|561019332|FG002|Overall Study|Withdrawal by Subject|2|||
155434610|NCT02006576|561019330|FG000|Overall Study|Death|0|||
155434611|NCT02006576|561019331|FG001|Overall Study|Death|0|||
155434612|NCT02006576|561019332|FG002|Overall Study|Death|1|||
155434613|NCT02006576|561019330|FG000|Overall Study|Lost to Follow-up|1|||
155434614|NCT02006576|561019331|FG001|Overall Study|Lost to Follow-up|0|||
155434615|NCT02006576|561019332|FG002|Overall Study|Lost to Follow-up|1|||
155434616|NCT02006576|561019330|FG000|Overall Study|Screen Failure, too sick, other|13|||
155434617|NCT02006576|561019331|FG001|Overall Study|Screen Failure, too sick, other|1|||
155434618|NCT02006576|561019332|FG002|Overall Study|Screen Failure, too sick, other|13|||
155434619|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
155434620|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
155434621|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
155434622|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
155434623|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
155434624|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155434625|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155434626|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155434627|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155434628|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
155434629|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
155434630|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
155434631|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
155434632|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
155434633|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
155434634|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
155434635|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
155434636|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
155434637|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
155434638|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
155434639|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
155434640|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
155434641|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
155434642|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
155434643|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
155434644|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
155434645|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
155434646|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
155434647|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
155434648|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
155434649|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
155434650|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
155434651|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
155434652|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
155434653|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
155434654|NCT00785577|561019333|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
155434655|NCT00785577|561019334|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
155434656|NCT00785577|561019335|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
155434657|NCT00785577|561019336|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
155434658|NCT00785577|561019337|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
155434659|NCT00785577|561019333|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
155434660|NCT00785577|561019334|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
155434661|NCT00785577|561019335|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
155434662|NCT00785577|561019336|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
155434663|NCT00785577|561019337|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
155434664|NCT00785577|561019333|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
155434665|NCT00785577|561019334|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
155434666|NCT00785577|561019335|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
155434667|NCT00785577|561019336|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
155434668|NCT00785577|561019337|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
155434669|NCT01650805|561019342|FG000|Overall Study|Withdrawal by Subject|1|||
155434670|NCT01650805|561019343|FG001|Overall Study|Withdrawal by Subject|0|||
155434671|NCT02515669|561019344|FG000|228 Week Open-Label Phase|Other|0|||
155434672|NCT02515669|561019345|FG001|228 Week Open-Label Phase|Other|0|||
155434673|NCT02515669|561019346|FG002|228 Week Open-Label Phase|Other|1|||
155434674|NCT02515669|561019347|FG003|228 Week Open-Label Phase|Other|4|||
155434675|NCT02515669|561019344|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
155434676|NCT02515669|561019345|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
155434677|NCT02515669|561019346|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
155434678|NCT02515669|561019347|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
155434679|NCT02515669|561019344|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
155434680|NCT02515669|561019345|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
155434681|NCT02515669|561019346|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
155434682|NCT02515669|561019347|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
155434683|NCT02515669|561019344|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
155434684|NCT02515669|561019345|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
155434685|NCT02515669|561019346|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
155434686|NCT02515669|561019347|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
155434687|NCT02515669|561019344|FG000|228 Week Open-Label Phase|Missing|0|||
155434688|NCT02515669|561019345|FG001|228 Week Open-Label Phase|Missing|2|||
155434689|NCT02515669|561019346|FG002|228 Week Open-Label Phase|Missing|2|||
155650519|NCT00147537|561812511|FG009|Phase 1b|Withdrawal by Subject|0|||
155650520|NCT00147537|561812512|FG010|Phase 1b|Withdrawal by Subject|0|||
155434690|NCT02515669|561019347|FG003|228 Week Open-Label Phase|Missing|2|||
155434691|NCT03750838|561019348|FG000|Overall Study|Lost to Follow-up|10|||
155434692|NCT03750838|561019349|FG001|Overall Study|Lost to Follow-up|6|||
155434693|NCT04070378|561019355|FG000|Overall Study|Withdrawal by Subject|2|||
155434694|NCT04070378|561019355|FG000|Overall Study|Screen Failure|6|||
155434695|NCT04070378|561019355|FG000|Overall Study|Physician Decision|1|||
155434696|NCT04070378|561019355|FG000|Overall Study|Adverse Event|1|||
155434697|NCT05781542|561020702|FG000|Overall Study|Lost to Follow-up|1|||
155434698|NCT05781542|561020703|FG001|Overall Study|Lost to Follow-up|0|||
155434699|NCT05781542|561020704|FG002|Overall Study|Lost to Follow-up|1|||
155434700|NCT01843374|561020709|FG000|Overall Study|Death|155|||
155434701|NCT01843374|561020710|FG001|Overall Study|Death|313|||
155434702|NCT01843374|561020709|FG000|Overall Study|Withdrawal by Subject|14|||
155434703|NCT01843374|561020710|FG001|Overall Study|Withdrawal by Subject|20|||
155434704|NCT01843374|561020709|FG000|Overall Study|Withdrawing due to Other reason|20|||
155434705|NCT01843374|561020710|FG001|Overall Study|Withdrawing due to Other reason|46|||
155434706|NCT01826214|561020711|FG000|Overall Study|Adverse Event|7|||
155434707|NCT01826214|561020712|FG001|Overall Study|Adverse Event|6|||
155434708|NCT01826214|561020711|FG000|Overall Study|Death|3|||
155434709|NCT01826214|561020712|FG001|Overall Study|Death|1|||
155434710|NCT01826214|561020711|FG000|Overall Study|Lost to Follow-up|1|||
155434711|NCT01826214|561020712|FG001|Overall Study|Lost to Follow-up|0|||
155434712|NCT01826214|561020711|FG000|Overall Study|Physician Decision|0|||
155434713|NCT01826214|561020712|FG001|Overall Study|Physician Decision|2|||
155434714|NCT01826214|561020711|FG000|Overall Study|Progressive disease|22|||
155434715|NCT01826214|561020712|FG001|Overall Study|Progressive disease|21|||
155434716|NCT01826214|561020711|FG000|Overall Study|Study terminated by Sponsor|0|||
155434717|NCT01826214|561020712|FG001|Overall Study|Study terminated by Sponsor|1|||
155434718|NCT01826214|561020711|FG000|Overall Study|Subject/guardian decision|2|||
155434719|NCT01826214|561020712|FG001|Overall Study|Subject/guardian decision|3|||
155434720|NCT00955110|561020713|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
155434721|NCT00955110|561020713|FG000|Treatment Phase|Adverse Event|2|||
155434722|NCT00955110|561020713|FG000|Treatment Phase|Administrative reasons|2|||
155434723|NCT00955110|561020713|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
155434724|NCT00955110|561020713|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
155434725|NCT03704051|561020718|FG000|Overall Study|Withdrawal by Subject|4|||
155434726|NCT03704051|561020719|FG001|Overall Study|Withdrawal by Subject|0|||
155434727|NCT01981187|561020728|FG000|Overall Study|Participant/guardian decision|2|||
155434728|NCT01981187|561020728|FG000|Overall Study|Physician Decision|1|||
155434729|NCT01981187|561020728|FG000|Overall Study|Disease progression|2|||
155434730|NCT01981187|561020728|FG000|Overall Study|Adverse Event|7|||
155434731|NCT01362322|561020729|FG000|Overall Study|Withdrawal by Subject|3|||
155434732|NCT01362322|561020730|FG001|Overall Study|Withdrawal by Subject|1|||
155434733|NCT01362322|561020729|FG000|Overall Study|Lost to Follow-up|2|||
155434734|NCT01362322|561020730|FG001|Overall Study|Lost to Follow-up|6|||
155434735|NCT01943539|561020731|FG000|Overall Study|Non-compliance with at-home intervention|4|||
155434736|NCT01943539|561020732|FG001|Overall Study|Non-compliance with at-home intervention|0|||
155434737|NCT02158533|561020737|FG000|Stage 1|Adverse Event|6|||
155434738|NCT02158533|561020738|FG001|Stage 1|Adverse Event|4|||
155434739|NCT02158533|561020739|FG002|Stage 1|Adverse Event|7|||
155434740|NCT02158533|561020740|FG003|Stage 1|Adverse Event|0|||
155434741|NCT02158533|561020741|FG004|Stage 1|Adverse Event|0|||
155434742|NCT02158533|561020742|FG005|Stage 1|Adverse Event|0|||
155434743|NCT02158533|561020737|FG000|Stage 1|Withdrawal by Subject|3|||
155434744|NCT02158533|561020738|FG001|Stage 1|Withdrawal by Subject|2|||
155434745|NCT02158533|561020739|FG002|Stage 1|Withdrawal by Subject|1|||
155434746|NCT02158533|561020740|FG003|Stage 1|Withdrawal by Subject|0|||
155434747|NCT02158533|561020741|FG004|Stage 1|Withdrawal by Subject|0|||
155434748|NCT02158533|561020742|FG005|Stage 1|Withdrawal by Subject|0|||
155434749|NCT02158533|561020737|FG000|Stage 1|Lack of Efficacy|1|||
155434750|NCT02158533|561020738|FG001|Stage 1|Lack of Efficacy|0|||
155434751|NCT02158533|561020739|FG002|Stage 1|Lack of Efficacy|0|||
155434752|NCT02158533|561020740|FG003|Stage 1|Lack of Efficacy|0|||
155434753|NCT02158533|561020741|FG004|Stage 1|Lack of Efficacy|0|||
155434754|NCT02158533|561020742|FG005|Stage 1|Lack of Efficacy|0|||
155434755|NCT02158533|561020737|FG000|Stage 1|Lost to Follow-up|3|||
155434756|NCT02158533|561020738|FG001|Stage 1|Lost to Follow-up|1|||
155434757|NCT02158533|561020739|FG002|Stage 1|Lost to Follow-up|0|||
155434758|NCT02158533|561020740|FG003|Stage 1|Lost to Follow-up|0|||
155434759|NCT02158533|561020741|FG004|Stage 1|Lost to Follow-up|0|||
155434760|NCT02158533|561020742|FG005|Stage 1|Lost to Follow-up|0|||
155650521|NCT00147537|561812502|FG000|Phase 1b|Randomized but not treated|0|||
155434761|NCT02158533|561020737|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
155434762|NCT02158533|561020738|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
155434763|NCT02158533|561020739|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
155434764|NCT02158533|561020740|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
155434765|NCT02158533|561020741|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
155434766|NCT02158533|561020742|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
155434767|NCT02158533|561020737|FG000|Stage 1|Non-compliance with study visits|1|||
155434768|NCT02158533|561020738|FG001|Stage 1|Non-compliance with study visits|0|||
155434769|NCT02158533|561020739|FG002|Stage 1|Non-compliance with study visits|0|||
155434770|NCT02158533|561020740|FG003|Stage 1|Non-compliance with study visits|0|||
155434771|NCT02158533|561020741|FG004|Stage 1|Non-compliance with study visits|0|||
155434772|NCT02158533|561020742|FG005|Stage 1|Non-compliance with study visits|0|||
155434773|NCT02158533|561020737|FG000|Stage 2|Adverse Event|0|||
155434774|NCT02158533|561020738|FG001|Stage 2|Adverse Event|0|||
155434775|NCT02158533|561020739|FG002|Stage 2|Adverse Event|0|||
155434776|NCT02158533|561020740|FG003|Stage 2|Adverse Event|0|||
155434777|NCT02158533|561020741|FG004|Stage 2|Adverse Event|0|||
155434778|NCT02158533|561020742|FG005|Stage 2|Adverse Event|1|||
155434779|NCT02158533|561020737|FG000|Stage 2|Lack of Efficacy|0|||
155434780|NCT02158533|561020738|FG001|Stage 2|Lack of Efficacy|0|||
155434781|NCT02158533|561020739|FG002|Stage 2|Lack of Efficacy|0|||
155434782|NCT02158533|561020740|FG003|Stage 2|Lack of Efficacy|0|||
155434783|NCT02158533|561020741|FG004|Stage 2|Lack of Efficacy|1|||
155434784|NCT02158533|561020742|FG005|Stage 2|Lack of Efficacy|0|||
155434785|NCT02158533|561020737|FG000|Stage 2|Lost to Follow-up|0|||
155434786|NCT02158533|561020738|FG001|Stage 2|Lost to Follow-up|0|||
155434787|NCT02158533|561020739|FG002|Stage 2|Lost to Follow-up|0|||
155434788|NCT02158533|561020740|FG003|Stage 2|Lost to Follow-up|1|||
155434789|NCT02158533|561020741|FG004|Stage 2|Lost to Follow-up|1|||
155434790|NCT02158533|561020742|FG005|Stage 2|Lost to Follow-up|2|||
155434791|NCT02158533|561020737|FG000|Stage 2|Withdrawal by Subject|0|||
155434792|NCT02158533|561020738|FG001|Stage 2|Withdrawal by Subject|0|||
155434793|NCT02158533|561020739|FG002|Stage 2|Withdrawal by Subject|0|||
155434794|NCT02158533|561020740|FG003|Stage 2|Withdrawal by Subject|0|||
155434795|NCT02158533|561020741|FG004|Stage 2|Withdrawal by Subject|1|||
155434796|NCT02158533|561020742|FG005|Stage 2|Withdrawal by Subject|2|||
155434797|NCT02158533|561020737|FG000|Stage 2|Physician Decision|0|||
155434798|NCT02158533|561020738|FG001|Stage 2|Physician Decision|0|||
155434799|NCT02158533|561020739|FG002|Stage 2|Physician Decision|0|||
155434800|NCT02158533|561020740|FG003|Stage 2|Physician Decision|0|||
155434801|NCT02158533|561020741|FG004|Stage 2|Physician Decision|1|||
155434802|NCT02158533|561020742|FG005|Stage 2|Physician Decision|0|||
155434803|NCT02158533|561020737|FG000|Stage 2|Pregnancy|0|||
155434804|NCT02158533|561020738|FG001|Stage 2|Pregnancy|0|||
155434805|NCT02158533|561020739|FG002|Stage 2|Pregnancy|0|||
155434806|NCT02158533|561020740|FG003|Stage 2|Pregnancy|1|||
155434807|NCT02158533|561020741|FG004|Stage 2|Pregnancy|0|||
155434808|NCT02158533|561020742|FG005|Stage 2|Pregnancy|0|||
155434809|NCT02158533|561020737|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
155434810|NCT02158533|561020738|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
155434811|NCT02158533|561020739|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
155434812|NCT02158533|561020740|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
155434813|NCT02158533|561020741|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
155434814|NCT02158533|561020742|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
155434815|NCT02158533|561020737|FG000|Stage 2|Non-adherence with study visits|0|||
155434816|NCT02158533|561020738|FG001|Stage 2|Non-adherence with study visits|0|||
155434817|NCT02158533|561020739|FG002|Stage 2|Non-adherence with study visits|0|||
155434818|NCT02158533|561020740|FG003|Stage 2|Non-adherence with study visits|0|||
155434819|NCT02158533|561020741|FG004|Stage 2|Non-adherence with study visits|0|||
155434820|NCT02158533|561020742|FG005|Stage 2|Non-adherence with study visits|1|||
155434821|NCT00384956|561020743|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
155434822|NCT00174941|561020747|FG000|Overall Study|Adverse Event|1|||
155434823|NCT00174941|561020748|FG001|Overall Study|Adverse Event|10|||
155434824|NCT00174941|561020749|FG002|Overall Study|Adverse Event|2|||
155434825|NCT00174941|561020750|FG003|Overall Study|Adverse Event|13|||
155434826|NCT00174941|561020747|FG000|Overall Study|Protocol Violation|0|||
155434827|NCT00174941|561020748|FG001|Overall Study|Protocol Violation|1|||
155434828|NCT00174941|561020749|FG002|Overall Study|Protocol Violation|0|||
155434829|NCT00174941|561020750|FG003|Overall Study|Protocol Violation|1|||
155434830|NCT00174941|561020747|FG000|Overall Study|Lost to Follow-up|0|||
155434831|NCT00174941|561020748|FG001|Overall Study|Lost to Follow-up|3|||
155434832|NCT00174941|561020749|FG002|Overall Study|Lost to Follow-up|2|||
155434833|NCT00174941|561020750|FG003|Overall Study|Lost to Follow-up|5|||
155434834|NCT00174941|561020747|FG000|Overall Study|Personal Reason(s)|0|||
155434835|NCT00174941|561020748|FG001|Overall Study|Personal Reason(s)|14|||
155434836|NCT00174941|561020749|FG002|Overall Study|Personal Reason(s)|8|||
155434837|NCT00174941|561020750|FG003|Overall Study|Personal Reason(s)|22|||
155434838|NCT00174941|561020747|FG000|Overall Study|Gout Flare|0|||
155434839|NCT00174941|561020748|FG001|Overall Study|Gout Flare|4|||
155434840|NCT00174941|561020749|FG002|Overall Study|Gout Flare|4|||
155434841|NCT00174941|561020750|FG003|Overall Study|Gout Flare|8|||
155434842|NCT00174941|561020747|FG000|Overall Study|Reason Not Specified|1|||
155434843|NCT00174941|561020748|FG001|Overall Study|Reason Not Specified|6|||
155434844|NCT00174941|561020749|FG002|Overall Study|Reason Not Specified|2|||
155434845|NCT00174941|561020750|FG003|Overall Study|Reason Not Specified|9|||
155434846|NCT01588197|561020763|FG000|Overall Study|Lack of Efficacy|0|||
155434847|NCT01588197|561020764|FG001|Overall Study|Lack of Efficacy|1|||
155434848|NCT01588197|561020763|FG000|Overall Study|No MRI|1|||
155434849|NCT01588197|561020764|FG001|Overall Study|No MRI|0|||
155434850|NCT01938625|561020771|FG000|Overall Study|Withdrawal by Subject|0|||
155434851|NCT01938625|561020772|FG001|Overall Study|Withdrawal by Subject|1|||
155434852|NCT01938625|561020771|FG000|Overall Study|Adverse Event|0|||
155434853|NCT01938625|561020772|FG001|Overall Study|Adverse Event|1|||
155434854|NCT01937312|561020773|FG000|Overall Study|Adverse Event|10|||
155434855|NCT01937312|561020774|FG001|Overall Study|Adverse Event|1|||
155434856|NCT01937312|561020773|FG000|Overall Study|Lack of Efficacy|0|||
155434857|NCT01937312|561020774|FG001|Overall Study|Lack of Efficacy|1|||
155434858|NCT01937312|561020773|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
155434859|NCT01937312|561020774|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
155434860|NCT00091793|561020775|FG000|Overall Study|Adverse Event|1|||
155434861|NCT00091793|561020776|FG001|Overall Study|Adverse Event|2|||
155434862|NCT00091793|561020775|FG000|Overall Study|Withdrawal by Subject|10|||
155434863|NCT00091793|561020776|FG001|Overall Study|Withdrawal by Subject|15|||
155434864|NCT00091793|561020775|FG000|Overall Study|Ineligibility determined|2|||
155434865|NCT00091793|561020776|FG001|Overall Study|Ineligibility determined|0|||
155434866|NCT00091793|561020775|FG000|Overall Study|Lost to Follow-up|7|||
155434867|NCT00091793|561020776|FG001|Overall Study|Lost to Follow-up|5|||
155434868|NCT00091793|561020775|FG000|Overall Study|Noncompliance|2|||
155434869|NCT00091793|561020776|FG001|Overall Study|Noncompliance|0|||
155434870|NCT00091793|561020775|FG000|Overall Study|Other|2|||
155434871|NCT00091793|561020776|FG001|Overall Study|Other|0|||
155434872|NCT05309083|561020777|FG000|Overall Study|Withdrawal by Subject|2|||
155434873|NCT01184989|561020779|FG000|Overall Study|Adverse Event|11|||
155434874|NCT01184989|561020779|FG000|Overall Study|Withdrawal by Subject|1|||
155434875|NCT05370157|561020782|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
155434876|NCT05370157|561020783|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
155434877|NCT05370157|561020782|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
155434878|NCT05370157|561020783|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
155434879|NCT01508676|561020784|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
155434880|NCT01508676|561020785|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
155434881|NCT01508676|561020784|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
155434882|NCT01508676|561020785|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
155434883|NCT01508676|561020784|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
155434884|NCT01508676|561020785|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
155434885|NCT01508676|561020784|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
155434886|NCT01508676|561020785|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
155434887|NCT01508676|561020784|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
155434888|NCT01508676|561020785|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
155434889|NCT06129487|561020787|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
155434890|NCT06129487|561020788|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
155434891|NCT00587223|561020798|FG000|Overall Study|Adverse Event|1|||
155434892|NCT00195351|561020799|FG000|Overall Study|Lost to Follow-up|9|||
155434893|NCT00195351|561020800|FG001|Overall Study|Lost to Follow-up|9|||
155434894|NCT00195351|561020799|FG000|Overall Study|Withdrawal by Subject|6|||
155434895|NCT00195351|561020800|FG001|Overall Study|Withdrawal by Subject|3|||
155434896|NCT00195351|561020799|FG000|Overall Study|Protocol Deviation|3|||
155434897|NCT00195351|561020800|FG001|Overall Study|Protocol Deviation|2|||
155434898|NCT00195351|561020799|FG000|Overall Study|Death|3|||
155434899|NCT00195351|561020800|FG001|Overall Study|Death|1|||
155434900|NCT00195351|561020799|FG000|Overall Study|Lack of Efficacy|0|||
155434901|NCT00195351|561020800|FG001|Overall Study|Lack of Efficacy|1|||
155434902|NCT02111369|561020801|FG000|Overall Study|Lost to Follow-up|2|||
155434903|NCT02111369|561020801|FG000|Overall Study|Withdrawal by Subject|1|||
155434904|NCT00828451|561020806|FG000|Overall Study|Death|2|||
155434905|NCT00828451|561020806|FG000|Overall Study|Lack of intravenous line|7|||
155434906|NCT00828451|561020806|FG000|Overall Study|Withdrawal by Subject|1|||
155434907|NCT00828451|561020806|FG000|Overall Study|Deterioration in clinical status|1|||
155434908|NCT00095121|561020812|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
155434909|NCT00095121|561020813|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
155434910|NCT00095121|561020812|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
155434911|NCT00095121|561020813|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
155434912|NCT04358458|561020819|FG000|Overall Study|Death|1|||
155434913|NCT04358458|561020820|FG001|Overall Study|Death|1|||
155434914|NCT04358458|561020821|FG002|Overall Study|Death|3|||
155434915|NCT04358458|561020822|FG003|Overall Study|Death|8|||
155434916|NCT04358458|561020823|FG004|Overall Study|Death|1|||
155434917|NCT04358458|561020824|FG005|Overall Study|Death|6|||
155434918|NCT04358458|561020825|FG006|Overall Study|Death|2|||
155434919|NCT04358458|561020826|FG007|Overall Study|Death|3|||
155434920|NCT04358458|561020819|FG000|Overall Study|Lost to Follow-up|0|||
155434921|NCT04358458|561020820|FG001|Overall Study|Lost to Follow-up|0|||
155434922|NCT04358458|561020821|FG002|Overall Study|Lost to Follow-up|0|||
155434923|NCT04358458|561020822|FG003|Overall Study|Lost to Follow-up|0|||
155434924|NCT04358458|561020823|FG004|Overall Study|Lost to Follow-up|0|||
155434925|NCT04358458|561020824|FG005|Overall Study|Lost to Follow-up|0|||
155434926|NCT04358458|561020825|FG006|Overall Study|Lost to Follow-up|0|||
155434927|NCT04358458|561020826|FG007|Overall Study|Lost to Follow-up|1|||
155434928|NCT04358458|561020819|FG000|Overall Study|Site is closing study participation|0|||
155434929|NCT04358458|561020820|FG001|Overall Study|Site is closing study participation|0|||
155434930|NCT04358458|561020821|FG002|Overall Study|Site is closing study participation|0|||
155434931|NCT04358458|561020822|FG003|Overall Study|Site is closing study participation|1|||
155434932|NCT04358458|561020823|FG004|Overall Study|Site is closing study participation|0|||
155434933|NCT04358458|561020824|FG005|Overall Study|Site is closing study participation|0|||
155434934|NCT04358458|561020825|FG006|Overall Study|Site is closing study participation|0|||
155434935|NCT04358458|561020826|FG007|Overall Study|Site is closing study participation|0|||
155434936|NCT04358458|561020819|FG000|Overall Study|Sponsor request|2|||
155434937|NCT04358458|561020820|FG001|Overall Study|Sponsor request|3|||
155434938|NCT04358458|561020821|FG002|Overall Study|Sponsor request|3|||
155434939|NCT04358458|561020822|FG003|Overall Study|Sponsor request|0|||
155434940|NCT04358458|561020823|FG004|Overall Study|Sponsor request|2|||
155434941|NCT04358458|561020824|FG005|Overall Study|Sponsor request|3|||
155434942|NCT04358458|561020825|FG006|Overall Study|Sponsor request|1|||
155434943|NCT04358458|561020826|FG007|Overall Study|Sponsor request|1|||
155434944|NCT04358458|561020819|FG000|Overall Study|Withdrawal by Subject|0|||
155434945|NCT04358458|561020820|FG001|Overall Study|Withdrawal by Subject|0|||
155434946|NCT04358458|561020821|FG002|Overall Study|Withdrawal by Subject|1|||
155434947|NCT04358458|561020822|FG003|Overall Study|Withdrawal by Subject|1|||
155434948|NCT04358458|561020823|FG004|Overall Study|Withdrawal by Subject|0|||
155434949|NCT04358458|561020824|FG005|Overall Study|Withdrawal by Subject|1|||
155434950|NCT04358458|561020825|FG006|Overall Study|Withdrawal by Subject|0|||
155434951|NCT04358458|561020826|FG007|Overall Study|Withdrawal by Subject|1|||
155434952|NCT04636177|561020827|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
155434953|NCT04636177|561020828|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
155434954|NCT04636177|561020827|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
155434955|NCT04636177|561020828|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
155434956|NCT04636177|561020827|FG000|Single-arm portion|Withdrawal by Subject|1|||
155434957|NCT04636177|561020828|FG001|Single-arm portion|Withdrawal by Subject|0|||
155434958|NCT04636177|561020827|FG000|Single-arm portion|Adverse Event|1|||
155434959|NCT04636177|561020828|FG001|Single-arm portion|Adverse Event|0|||
155434960|NCT02495077|561022841|FG000|Overall Study|Adverse Event|0|||
155434961|NCT02495077|561022842|FG001|Overall Study|Adverse Event|1|||
155434962|NCT02495077|561022843|FG002|Overall Study|Adverse Event|1|||
155434963|NCT02495077|561022844|FG003|Overall Study|Adverse Event|0|||
155434964|NCT02495077|561022841|FG000|Overall Study|Death|3|||
155434965|NCT02495077|561022842|FG001|Overall Study|Death|5|||
155434966|NCT02495077|561022843|FG002|Overall Study|Death|0|||
155434967|NCT02495077|561022844|FG003|Overall Study|Death|0|||
155434968|NCT02495077|561022841|FG000|Overall Study|Lost to Follow-up|6|||
155434969|NCT02495077|561022842|FG001|Overall Study|Lost to Follow-up|4|||
155434970|NCT02495077|561022843|FG002|Overall Study|Lost to Follow-up|0|||
155434971|NCT02495077|561022844|FG003|Overall Study|Lost to Follow-up|0|||
155434972|NCT02495077|561022841|FG000|Overall Study|Physician Decision|2|||
155434973|NCT02495077|561022842|FG001|Overall Study|Physician Decision|1|||
155434974|NCT02495077|561022843|FG002|Overall Study|Physician Decision|4|||
155434975|NCT02495077|561022844|FG003|Overall Study|Physician Decision|0|||
155434976|NCT02495077|561022841|FG000|Overall Study|Protocol Violation|0|||
155434977|NCT02495077|561022842|FG001|Overall Study|Protocol Violation|1|||
155434978|NCT02495077|561022843|FG002|Overall Study|Protocol Violation|0|||
155434979|NCT02495077|561022844|FG003|Overall Study|Protocol Violation|0|||
155434980|NCT02495077|561022841|FG000|Overall Study|Screen Failure|0|||
155434981|NCT02495077|561022842|FG001|Overall Study|Screen Failure|0|||
155434982|NCT02495077|561022843|FG002|Overall Study|Screen Failure|0|||
155434983|NCT02495077|561022844|FG003|Overall Study|Screen Failure|48|||
155434984|NCT02495077|561022841|FG000|Overall Study|Withdrawal by Subject|7|||
155434985|NCT02495077|561022842|FG001|Overall Study|Withdrawal by Subject|7|||
155434986|NCT02495077|561022843|FG002|Overall Study|Withdrawal by Subject|7|||
155434987|NCT02495077|561022844|FG003|Overall Study|Withdrawal by Subject|0|||
155434988|NCT02495077|561022841|FG000|Overall Study|Covid-19 research restrictions|1|||
155434989|NCT02495077|561022842|FG001|Overall Study|Covid-19 research restrictions|0|||
155434990|NCT02495077|561022843|FG002|Overall Study|Covid-19 research restrictions|0|||
155434991|NCT02495077|561022844|FG003|Overall Study|Covid-19 research restrictions|0|||
155434992|NCT02495077|561022841|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
155434993|NCT02495077|561022842|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
155434994|NCT02495077|561022843|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
155434995|NCT02495077|561022844|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
155434996|NCT02495077|561022841|FG000|Overall Study|Incarcerated|0|||
155434997|NCT02495077|561022842|FG001|Overall Study|Incarcerated|1|||
155434998|NCT02495077|561022843|FG002|Overall Study|Incarcerated|0|||
155434999|NCT02495077|561022844|FG003|Overall Study|Incarcerated|0|||
155435000|NCT02495077|561022841|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
155435001|NCT02495077|561022842|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
155435002|NCT02495077|561022843|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
155435003|NCT02495077|561022844|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
155435004|NCT02495077|561022841|FG000|Overall Study|Timing of transplant and randomization|0|||
155435005|NCT02495077|561022842|FG001|Overall Study|Timing of transplant and randomization|0|||
155435006|NCT02495077|561022843|FG002|Overall Study|Timing of transplant and randomization|5|||
155435007|NCT02495077|561022844|FG003|Overall Study|Timing of transplant and randomization|0|||
155435008|NCT02742649|561022845|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
155435009|NCT02742649|561022846|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
155435010|NCT02742649|561022847|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
155435011|NCT02742649|561022848|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
155435012|NCT02742649|561022849|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
155435013|NCT02742649|561022845|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155435014|NCT02742649|561022846|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155435015|NCT02742649|561022847|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155435016|NCT02742649|561022848|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155435017|NCT02742649|561022849|FG004|Double-Blind Treatment Period|Adverse Event|0|||
155435018|NCT02742649|561022845|FG000|Open-Label Period|Lost to Follow-up|0|||
155435019|NCT02742649|561022846|FG001|Open-Label Period|Lost to Follow-up|0|||
155435020|NCT02742649|561022847|FG002|Open-Label Period|Lost to Follow-up|0|||
155435021|NCT02742649|561022848|FG003|Open-Label Period|Lost to Follow-up|0|||
155435022|NCT02742649|561022849|FG004|Open-Label Period|Lost to Follow-up|1|||
155435023|NCT03167619|561022853|FG000|Overall Study|Death|11|||
155435024|NCT03167619|561022854|FG001|Overall Study|Death|8|||
155435025|NCT03167619|561022853|FG000|Overall Study|Withdrawal by Subject|1|||
155435026|NCT03167619|561022854|FG001|Overall Study|Withdrawal by Subject|2|||
155435027|NCT03167619|561022853|FG000|Overall Study|Physician Decision|0|||
155435028|NCT03167619|561022854|FG001|Overall Study|Physician Decision|1|||
155435029|NCT02082184|561022856|FG000|Overall Study|Adverse Event|1|||
155435030|NCT02082184|561022857|FG001|Overall Study|Adverse Event|0|||
155435031|NCT02082184|561022856|FG000|Overall Study|Medical diagnosis|1|||
155435032|NCT02082184|561022857|FG001|Overall Study|Medical diagnosis|2|||
155435033|NCT02082184|561022856|FG000|Overall Study|Device associated symptoms|5|||
155435034|NCT02082184|561022857|FG001|Overall Study|Device associated symptoms|0|||
155435035|NCT02082184|561022856|FG000|Overall Study|Withdrawal by Subject|3|||
155435036|NCT02082184|561022857|FG001|Overall Study|Withdrawal by Subject|2|||
155435037|NCT02082184|561022856|FG000|Overall Study|Protocol Violation|0|||
155435038|NCT02082184|561022857|FG001|Overall Study|Protocol Violation|6|||
155435039|NCT02082184|561022856|FG000|Overall Study|Lost to Follow-up|0|||
155435040|NCT02082184|561022857|FG001|Overall Study|Lost to Follow-up|2|||
155435041|NCT02082184|561022856|FG000|Overall Study|Subject non-compliance|0|||
155435042|NCT02082184|561022857|FG001|Overall Study|Subject non-compliance|1|||
155435043|NCT02413398|561022860|FG000|Overall Study|Lost to Follow-up|2|||
155435044|NCT02413398|561022861|FG001|Overall Study|Lost to Follow-up|4|||
155435045|NCT02413398|561022860|FG000|Overall Study|Withdrawal by Subject|1|||
155435046|NCT02413398|561022861|FG001|Overall Study|Withdrawal by Subject|1|||
155435047|NCT02413398|561022860|FG000|Overall Study|Other Eligibility criteria|1|||
155435048|NCT02413398|561022861|FG001|Overall Study|Other Eligibility criteria|2|||
155435049|NCT00537940|561022864|FG000|Overall Study|Adverse Event|20|||
155435050|NCT00537940|561022865|FG001|Overall Study|Adverse Event|19|||
155435051|NCT00537940|561022864|FG000|Overall Study|Lack of Efficacy|8|||
155435052|NCT00537940|561022865|FG001|Overall Study|Lack of Efficacy|16|||
155435053|NCT00537940|561022864|FG000|Overall Study|Lost to Follow-up|23|||
155435054|NCT00537940|561022865|FG001|Overall Study|Lost to Follow-up|29|||
155435055|NCT00537940|561022864|FG000|Overall Study|Withdrawal by Subject|113|||
155435056|NCT00537940|561022865|FG001|Overall Study|Withdrawal by Subject|95|||
155435057|NCT00537940|561022864|FG000|Overall Study|Protocol Violation|6|||
155435058|NCT00537940|561022865|FG001|Overall Study|Protocol Violation|4|||
155435059|NCT00537940|561022864|FG000|Overall Study|Pregnancy|1|||
155435060|NCT00537940|561022865|FG001|Overall Study|Pregnancy|1|||
155435061|NCT00537940|561022864|FG000|Overall Study|Study terminated by sponsor|2|||
155435062|NCT00537940|561022865|FG001|Overall Study|Study terminated by sponsor|3|||
155435063|NCT00537940|561022864|FG000|Overall Study|Other|10|||
155435064|NCT00537940|561022865|FG001|Overall Study|Other|12|||
155435065|NCT03715465|561022867|FG000|Overall Study|Withdrawal by Subject|1|||
155435066|NCT03715465|561022868|FG001|Overall Study|Withdrawal by Subject|2|||
155435067|NCT01389128|561022873|FG000|Overall Study|Fetal distress|1|||
155435068|NCT01389128|561022874|FG001|Overall Study|Fetal distress|0|||
155435069|NCT01389128|561022873|FG000|Overall Study|Cervix dilation stop|1|||
155435070|NCT01389128|561022874|FG001|Overall Study|Cervix dilation stop|2|||
155435071|NCT01389128|561022873|FG000|Overall Study|Rapid labor evolution|3|||
155435072|NCT01389128|561022874|FG001|Overall Study|Rapid labor evolution|2|||
155435073|NCT01389128|561022873|FG000|Overall Study|Intolerance to procedure|0|||
155435074|NCT01389128|561022874|FG001|Overall Study|Intolerance to procedure|2|||
155435075|NCT00756002|561022875|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
155435076|NCT00756002|561022876|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
155435077|NCT00756002|561022875|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155435078|NCT00756002|561022876|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155435079|NCT00756002|561022875|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
155435080|NCT00756002|561022876|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
155435081|NCT00756002|561022875|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
155435082|NCT00756002|561022876|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
155435083|NCT00756002|561022875|FG000|Double-Blind Treatment Period|Other|2|||
155435084|NCT00756002|561022876|FG001|Double-Blind Treatment Period|Other|2|||
155435085|NCT04329923|561022877|FG000|Overall Study|Withdrawal by Subject|1|||
155435086|NCT04329923|561022878|FG001|Overall Study|Withdrawal by Subject|4|||
155435087|NCT04329923|561022879|FG002|Overall Study|Withdrawal by Subject|1|||
155435088|NCT04329923|561022880|FG003|Overall Study|Withdrawal by Subject|1|||
155435089|NCT04329923|561022881|FG004|Overall Study|Withdrawal by Subject|1|||
155435090|NCT04329923|561022882|FG005|Overall Study|Withdrawal by Subject|1|||
155435091|NCT04329923|561022877|FG000|Overall Study|early termination of study|0|||
155435092|NCT04329923|561022878|FG001|Overall Study|early termination of study|0|||
155435093|NCT04329923|561022879|FG002|Overall Study|early termination of study|0|||
155435094|NCT04329923|561022880|FG003|Overall Study|early termination of study|0|||
155435095|NCT04329923|561022881|FG004|Overall Study|early termination of study|1|||
155435096|NCT04329923|561022882|FG005|Overall Study|early termination of study|2|||
155435097|NCT04329923|561022877|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
155435098|NCT04329923|561022878|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
155435099|NCT04329923|561022879|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
155435100|NCT04329923|561022880|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
155435101|NCT04329923|561022881|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
155435102|NCT04329923|561022882|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
155435103|NCT03334214|561022883|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155435104|NCT03334214|561022884|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155435105|NCT03334214|561022883|FG000|Overall Study|Withdrawal by Subject|0|||
155435106|NCT03334214|561022884|FG001|Overall Study|Withdrawal by Subject|1|||
155435107|NCT03334214|561022883|FG000|Overall Study|Other|1|||
155435108|NCT03334214|561022884|FG001|Overall Study|Other|0|||
155435109|NCT00550238|561022892|FG000|Overall Study|Adverse Event|88|||
155435110|NCT00550238|561022892|FG000|Overall Study|Death|34|||
155435111|NCT00550238|561022892|FG000|Overall Study|Disease progression|46|||
155435112|NCT00550238|561022892|FG000|Overall Study|Withdrawal by Subject|167|||
155435113|NCT00550238|561022892|FG000|Overall Study|Physician Decision|31|||
155435114|NCT00550238|561022892|FG000|Overall Study|Patient noncompliance|25|||
155435115|NCT00550238|561022892|FG000|Overall Study|Lost to Follow-up|13|||
155435116|NCT00550238|561022892|FG000|Overall Study|Sponsor decision|55|||
155435117|NCT01486238|561022894|FG000|Overall Study|Death|0|||
155435118|NCT01486238|561022895|FG001|Overall Study|Death|2|||
155435119|NCT01486238|561022894|FG000|Overall Study|Withdrawal by Subject|2|||
155435120|NCT01486238|561022895|FG001|Overall Study|Withdrawal by Subject|1|||
155435121|NCT01486238|561022894|FG000|Overall Study|Lost to Follow-up|0|||
155435122|NCT01486238|561022895|FG001|Overall Study|Lost to Follow-up|3|||
155435123|NCT01050062|561022896|FG000|Overall Study|Adverse Event|75|||
155435124|NCT01050062|561022897|FG001|Overall Study|Adverse Event|22|||
155435125|NCT01050062|561022896|FG000|Overall Study|Lost to Follow-up|83|||
155435126|NCT01050062|561022897|FG001|Overall Study|Lost to Follow-up|35|||
155435127|NCT01050062|561022896|FG000|Overall Study|Lack of Efficacy|22|||
155435128|NCT01050062|561022897|FG001|Overall Study|Lack of Efficacy|35|||
155435129|NCT01050062|561022896|FG000|Overall Study|Physician Decision|74|||
155435130|NCT01050062|561022897|FG001|Overall Study|Physician Decision|9|||
155435131|NCT01050062|561022896|FG000|Overall Study|Others|17|||
155435132|NCT01050062|561022897|FG001|Overall Study|Others|11|||
155435133|NCT01570491|561022899|FG000|Overall Study|Lost to Follow-up|3|||
155435134|NCT01570491|561022900|FG001|Overall Study|Lost to Follow-up|1|||
155435135|NCT01570491|561022899|FG000|Overall Study|treatment: not given or discontinued|2|||
155435136|NCT01570491|561022900|FG001|Overall Study|treatment: not given or discontinued|0|||
155435137|NCT00754390|561022904|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
155435138|NCT00754390|561022904|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
155435139|NCT00754390|561022904|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
155435140|NCT00754390|561022904|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
155435141|NCT00847613|561022905|FG000|Overall Study|Ongoing at cut-off date|250|||
155435142|NCT00847613|561022906|FG001|Overall Study|Ongoing at cut-off date|265|||
155435143|NCT00847613|561022907|FG002|Overall Study|Ongoing at cut-off date|64|||
155435144|NCT00847613|561022908|FG003|Overall Study|Ongoing at cut-off date|64|||
155435145|NCT00847613|561022905|FG000|Overall Study|Death|1|||
155435146|NCT00847613|561022906|FG001|Overall Study|Death|1|||
155435147|NCT00847613|561022907|FG002|Overall Study|Death|0|||
155435148|NCT00847613|561022908|FG003|Overall Study|Death|0|||
155435149|NCT00847613|561022905|FG000|Overall Study|Adverse Event|36|||
155435150|NCT00847613|561022906|FG001|Overall Study|Adverse Event|26|||
155435151|NCT00847613|561022907|FG002|Overall Study|Adverse Event|5|||
155435152|NCT00847613|561022908|FG003|Overall Study|Adverse Event|6|||
155435153|NCT00847613|561022905|FG000|Overall Study|Lack of Efficacy|7|||
155435154|NCT00847613|561022906|FG001|Overall Study|Lack of Efficacy|3|||
155435155|NCT00847613|561022907|FG002|Overall Study|Lack of Efficacy|3|||
155435156|NCT00847613|561022908|FG003|Overall Study|Lack of Efficacy|1|||
155435157|NCT00847613|561022905|FG000|Overall Study|Study terminated by Sponsor|1|||
155435158|NCT00847613|561022906|FG001|Overall Study|Study terminated by Sponsor|0|||
155435159|NCT00847613|561022907|FG002|Overall Study|Study terminated by Sponsor|2|||
155435160|NCT00847613|561022908|FG003|Overall Study|Study terminated by Sponsor|1|||
155435161|NCT00847613|561022905|FG000|Overall Study|Lost to Follow-up|5|||
155435162|NCT00847613|561022906|FG001|Overall Study|Lost to Follow-up|0|||
155513249|NCT02826603|561304426|FG001|Overall Study|Lost to Follow-up|12|||
155435163|NCT00847613|561022907|FG002|Overall Study|Lost to Follow-up|0|||
155435164|NCT00847613|561022908|FG003|Overall Study|Lost to Follow-up|3|||
155435165|NCT00847613|561022905|FG000|Overall Study|Protocol Violation|6|||
155435166|NCT00847613|561022906|FG001|Overall Study|Protocol Violation|6|||
155435167|NCT00847613|561022907|FG002|Overall Study|Protocol Violation|3|||
155435168|NCT00847613|561022908|FG003|Overall Study|Protocol Violation|1|||
155435169|NCT00847613|561022905|FG000|Overall Study|Pregnancy|1|||
155435170|NCT00847613|561022906|FG001|Overall Study|Pregnancy|1|||
155435171|NCT00847613|561022907|FG002|Overall Study|Pregnancy|0|||
155435172|NCT00847613|561022908|FG003|Overall Study|Pregnancy|0|||
155435173|NCT00847613|561022905|FG000|Overall Study|Site closure|1|||
155435174|NCT00847613|561022906|FG001|Overall Study|Site closure|0|||
155435175|NCT00847613|561022907|FG002|Overall Study|Site closure|0|||
155435176|NCT00847613|561022908|FG003|Overall Study|Site closure|1|||
155435177|NCT00847613|561022905|FG000|Overall Study|Withdrawal by Subject|8|||
155435178|NCT00847613|561022906|FG001|Overall Study|Withdrawal by Subject|11|||
155435179|NCT00847613|561022907|FG002|Overall Study|Withdrawal by Subject|2|||
155435180|NCT00847613|561022908|FG003|Overall Study|Withdrawal by Subject|2|||
155435181|NCT00847613|561022905|FG000|Overall Study|Participant moved|4|||
155435182|NCT00847613|561022906|FG001|Overall Study|Participant moved|1|||
155435183|NCT00847613|561022907|FG002|Overall Study|Participant moved|0|||
155435184|NCT00847613|561022908|FG003|Overall Study|Participant moved|0|||
155435185|NCT00847613|561022905|FG000|Overall Study|Sponsor request|0|||
155435186|NCT00847613|561022906|FG001|Overall Study|Sponsor request|1|||
155435187|NCT00847613|561022907|FG002|Overall Study|Sponsor request|0|||
155435188|NCT00847613|561022908|FG003|Overall Study|Sponsor request|0|||
155435189|NCT00847613|561022905|FG000|Overall Study|Randomized, but not treated|0|||
155435190|NCT00847613|561022906|FG001|Overall Study|Randomized, but not treated|3|||
155435191|NCT00847613|561022907|FG002|Overall Study|Randomized, but not treated|0|||
155435192|NCT00847613|561022908|FG003|Overall Study|Randomized, but not treated|0|||
155435193|NCT00847613|561022905|FG000|Overall Study|Other|1|||
155435194|NCT00847613|561022906|FG001|Overall Study|Other|1|||
155435195|NCT00847613|561022907|FG002|Overall Study|Other|2|||
155435196|NCT00847613|561022908|FG003|Overall Study|Other|0|||
155435197|NCT00845429|561022909|FG000|Overall Study|Protocol Violation|5|||
155435198|NCT00845429|561022910|FG001|Overall Study|Protocol Violation|4|||
155435199|NCT00845429|561022911|FG002|Overall Study|Protocol Violation|7|||
155513250|NCT02826603|561304425|FG000|Overall Study|Noncompliance with treatment|0|||
155513251|NCT02826603|561304426|FG001|Overall Study|Noncompliance with treatment|2|||
155513252|NCT02826603|561304425|FG000|Overall Study|Physician Decision|1|||
155513253|NCT02826603|561304426|FG001|Overall Study|Physician Decision|7|||
155513254|NCT02826603|561304425|FG000|Overall Study|Pregnancy|1|||
155513255|NCT02826603|561304426|FG001|Overall Study|Pregnancy|2|||
155513256|NCT02826603|561304425|FG000|Overall Study|Protocol Violation|3|||
155435200|NCT00845429|561022909|FG000|Overall Study|Lost to Follow-up|7|||
155435201|NCT00845429|561022910|FG001|Overall Study|Lost to Follow-up|9|||
155435202|NCT00845429|561022911|FG002|Overall Study|Lost to Follow-up|10|||
155513257|NCT02826603|561304426|FG001|Overall Study|Protocol Violation|3|||
155513258|NCT02826603|561304425|FG000|Overall Study|Withdrawal by Subject|20|||
155513259|NCT02826603|561304426|FG001|Overall Study|Withdrawal by Subject|19|||
155513260|NCT02826603|561304425|FG000|Overall Study|Death|2|||
155513261|NCT02826603|561304426|FG001|Overall Study|Death|0|||
155513262|NCT02826603|561304425|FG000|Overall Study|New therapy for study indication|0|||
155513263|NCT02826603|561304426|FG001|Overall Study|New therapy for study indication|1|||
155513264|NCT00905489|561304427|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
155435203|NCT00845429|561022909|FG000|Overall Study|Withdrawal by Subject|2|||
155435204|NCT00845429|561022910|FG001|Overall Study|Withdrawal by Subject|2|||
155435205|NCT00845429|561022911|FG002|Overall Study|Withdrawal by Subject|2|||
155435206|NCT00845429|561022909|FG000|Overall Study|Serious adverse event|0|||
155435207|NCT00845429|561022910|FG001|Overall Study|Serious adverse event|0|||
155435208|NCT00845429|561022911|FG002|Overall Study|Serious adverse event|1|||
155435209|NCT01480180|561022914|FG000|Main Phase|Withdrawal criteria|12|||
155513265|NCT00905489|561304427|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
155513266|NCT00905489|561304427|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
155513267|NCT00583596|561304428|FG000|Overall Study|Lost to Follow-up|110|||
155435210|NCT01480180|561022915|FG001|Main Phase|Withdrawal criteria|1|||
155435211|NCT01480180|561022916|FG002|Main Phase|Withdrawal criteria|0|||
155435212|NCT01480180|561022917|FG003|Main Phase|Withdrawal criteria|0|||
155435213|NCT01480180|561022918|FG004|Main Phase|Withdrawal criteria|0|||
155435214|NCT01480180|561022919|FG005|Main Phase|Withdrawal criteria|0|||
155435215|NCT01480180|561022914|FG000|Main Phase|Lack of Efficacy|1|||
155435216|NCT01480180|561022915|FG001|Main Phase|Lack of Efficacy|0|||
155435217|NCT01480180|561022916|FG002|Main Phase|Lack of Efficacy|0|||
155435218|NCT01480180|561022917|FG003|Main Phase|Lack of Efficacy|0|||
155435219|NCT01480180|561022918|FG004|Main Phase|Lack of Efficacy|0|||
155435220|NCT01480180|561022919|FG005|Main Phase|Lack of Efficacy|0|||
155435221|NCT01480180|561022914|FG000|Main Phase|Non-compliance|3|||
155435222|NCT01480180|561022915|FG001|Main Phase|Non-compliance|0|||
155435223|NCT01480180|561022916|FG002|Main Phase|Non-compliance|0|||
155435224|NCT01480180|561022917|FG003|Main Phase|Non-compliance|0|||
155435225|NCT01480180|561022918|FG004|Main Phase|Non-compliance|0|||
155435226|NCT01480180|561022919|FG005|Main Phase|Non-compliance|0|||
155435227|NCT01480180|561022914|FG000|Main Phase|Unclassified|3|||
155435228|NCT01480180|561022915|FG001|Main Phase|Unclassified|0|||
155435229|NCT01480180|561022916|FG002|Main Phase|Unclassified|0|||
155435230|NCT01480180|561022917|FG003|Main Phase|Unclassified|0|||
155435231|NCT01480180|561022918|FG004|Main Phase|Unclassified|0|||
155435232|NCT01480180|561022919|FG005|Main Phase|Unclassified|0|||
155435233|NCT01480180|561022914|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
155435234|NCT01480180|561022915|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
155435235|NCT01480180|561022916|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
155435236|NCT01480180|561022917|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
155435237|NCT01480180|561022918|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
155435238|NCT01480180|561022919|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
155435239|NCT01480180|561022914|FG000|Extension Phase, Part 1|Unclassified|0|||
155435240|NCT01480180|561022915|FG001|Extension Phase, Part 1|Unclassified|0|||
155435241|NCT01480180|561022916|FG002|Extension Phase, Part 1|Unclassified|1|||
155435242|NCT01480180|561022917|FG003|Extension Phase, Part 1|Unclassified|0|||
155435243|NCT01480180|561022918|FG004|Extension Phase, Part 1|Unclassified|0|||
155435244|NCT01480180|561022919|FG005|Extension Phase, Part 1|Unclassified|0|||
155435245|NCT01480180|561022914|FG000|Extension Phase, Part 1|Adverse Event|0|||
155435246|NCT01480180|561022915|FG001|Extension Phase, Part 1|Adverse Event|0|||
155435247|NCT01480180|561022916|FG002|Extension Phase, Part 1|Adverse Event|4|||
155435248|NCT01480180|561022917|FG003|Extension Phase, Part 1|Adverse Event|1|||
155435249|NCT01480180|561022918|FG004|Extension Phase, Part 1|Adverse Event|0|||
155435250|NCT01480180|561022919|FG005|Extension Phase, Part 1|Adverse Event|0|||
155435251|NCT01480180|561022914|FG000|Extension Phase, Part 1|Change of treatment|0|||
155435252|NCT01480180|561022915|FG001|Extension Phase, Part 1|Change of treatment|0|||
155435253|NCT01480180|561022916|FG002|Extension Phase, Part 1|Change of treatment|0|||
155435254|NCT01480180|561022917|FG003|Extension Phase, Part 1|Change of treatment|9|||
155435255|NCT01480180|561022918|FG004|Extension Phase, Part 1|Change of treatment|0|||
155435256|NCT01480180|561022919|FG005|Extension Phase, Part 1|Change of treatment|0|||
155435257|NCT01480180|561022914|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
155435258|NCT01480180|561022915|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
155435259|NCT01480180|561022916|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
155435260|NCT01480180|561022917|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
155435261|NCT01480180|561022918|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
155435262|NCT01480180|561022919|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
155435263|NCT01480180|561022914|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
155435264|NCT01480180|561022915|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
155435265|NCT01480180|561022916|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
155435266|NCT01480180|561022917|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
155435267|NCT01480180|561022918|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
155435268|NCT01480180|561022919|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
155435269|NCT01480180|561022914|FG000|Extension Phase, Part 2|Unclassified|0|||
155435270|NCT01480180|561022915|FG001|Extension Phase, Part 2|Unclassified|0|||
155435271|NCT01480180|561022916|FG002|Extension Phase, Part 2|Unclassified|3|||
155435272|NCT01480180|561022917|FG003|Extension Phase, Part 2|Unclassified|1|||
155435273|NCT01480180|561022918|FG004|Extension Phase, Part 2|Unclassified|1|||
155435274|NCT01480180|561022919|FG005|Extension Phase, Part 2|Unclassified|0|||
155435275|NCT04222725|561022920|FG000|Overall Study|Adverse Event|0|||
155435276|NCT04222725|561022921|FG001|Overall Study|Adverse Event|1|||
155435277|NCT04222725|561022922|FG002|Overall Study|Adverse Event|0|||
155435278|NCT04222725|561022923|FG003|Overall Study|Adverse Event|0|||
155435279|NCT00658333|561022924|FG000|Overall Study|Adverse Event|2|||
155435280|NCT00658333|561022925|FG001|Overall Study|Adverse Event|1|||
155435281|NCT03519178|561022926|FG000|PF-06873600 Treatment|Adverse Event|0|||
155435282|NCT03519178|561022927|FG001|PF-06873600 Treatment|Adverse Event|0|||
155435283|NCT03519178|561022928|FG002|PF-06873600 Treatment|Adverse Event|0|||
155435284|NCT03519178|561022929|FG003|PF-06873600 Treatment|Adverse Event|0|||
155435285|NCT03519178|561022930|FG004|PF-06873600 Treatment|Adverse Event|0|||
155435286|NCT03519178|561022931|FG005|PF-06873600 Treatment|Adverse Event|0|||
155435287|NCT03519178|561022932|FG006|PF-06873600 Treatment|Adverse Event|0|||
155435288|NCT03519178|561022933|FG007|PF-06873600 Treatment|Adverse Event|2|||
155435289|NCT03519178|561022934|FG008|PF-06873600 Treatment|Adverse Event|1|||
155650522|NCT00147537|561812503|FG001|Phase 1b|Randomized but not treated|0|||
155650523|NCT00147537|561812504|FG002|Phase 1b|Randomized but not treated|0|||
155435290|NCT03519178|561022935|FG009|PF-06873600 Treatment|Adverse Event|0|||
155435291|NCT03519178|561022936|FG010|PF-06873600 Treatment|Adverse Event|0|||
155435292|NCT03519178|561022937|FG011|PF-06873600 Treatment|Adverse Event|0|||
155435293|NCT03519178|561022938|FG012|PF-06873600 Treatment|Adverse Event|1|||
155435294|NCT03519178|561022939|FG013|PF-06873600 Treatment|Adverse Event|3|||
155435295|NCT03519178|561022940|FG014|PF-06873600 Treatment|Adverse Event|2|||
155435296|NCT03519178|561022926|FG000|PF-06873600 Treatment|Death|0|||
155435297|NCT03519178|561022927|FG001|PF-06873600 Treatment|Death|0|||
155435298|NCT03519178|561022928|FG002|PF-06873600 Treatment|Death|0|||
155435299|NCT03519178|561022929|FG003|PF-06873600 Treatment|Death|0|||
155435300|NCT03519178|561022930|FG004|PF-06873600 Treatment|Death|0|||
155435301|NCT03519178|561022931|FG005|PF-06873600 Treatment|Death|0|||
155435302|NCT03519178|561022932|FG006|PF-06873600 Treatment|Death|0|||
155435303|NCT03519178|561022933|FG007|PF-06873600 Treatment|Death|0|||
155435304|NCT03519178|561022934|FG008|PF-06873600 Treatment|Death|1|||
155435305|NCT03519178|561022935|FG009|PF-06873600 Treatment|Death|1|||
155435306|NCT03519178|561022936|FG010|PF-06873600 Treatment|Death|0|||
155435307|NCT03519178|561022937|FG011|PF-06873600 Treatment|Death|0|||
155435308|NCT03519178|561022938|FG012|PF-06873600 Treatment|Death|0|||
155435309|NCT03519178|561022939|FG013|PF-06873600 Treatment|Death|0|||
155435310|NCT03519178|561022940|FG014|PF-06873600 Treatment|Death|1|||
155435311|NCT03519178|561022926|FG000|PF-06873600 Treatment|Physician Decision|0|||
155435312|NCT03519178|561022927|FG001|PF-06873600 Treatment|Physician Decision|0|||
155435313|NCT03519178|561022928|FG002|PF-06873600 Treatment|Physician Decision|0|||
155435314|NCT03519178|561022929|FG003|PF-06873600 Treatment|Physician Decision|0|||
155435315|NCT03519178|561022930|FG004|PF-06873600 Treatment|Physician Decision|0|||
155435316|NCT03519178|561022931|FG005|PF-06873600 Treatment|Physician Decision|0|||
155435317|NCT03519178|561022932|FG006|PF-06873600 Treatment|Physician Decision|0|||
155435318|NCT03519178|561022933|FG007|PF-06873600 Treatment|Physician Decision|1|||
155435319|NCT03519178|561022934|FG008|PF-06873600 Treatment|Physician Decision|0|||
155435320|NCT03519178|561022935|FG009|PF-06873600 Treatment|Physician Decision|0|||
155435321|NCT03519178|561022936|FG010|PF-06873600 Treatment|Physician Decision|1|||
155435322|NCT03519178|561022937|FG011|PF-06873600 Treatment|Physician Decision|0|||
155435323|NCT03519178|561022938|FG012|PF-06873600 Treatment|Physician Decision|0|||
155435324|NCT03519178|561022939|FG013|PF-06873600 Treatment|Physician Decision|4|||
155435325|NCT03519178|561022940|FG014|PF-06873600 Treatment|Physician Decision|1|||
155435326|NCT03519178|561022926|FG000|PF-06873600 Treatment|Progressive disease|1|||
155435327|NCT03519178|561022927|FG001|PF-06873600 Treatment|Progressive disease|1|||
155435328|NCT03519178|561022928|FG002|PF-06873600 Treatment|Progressive disease|1|||
155435329|NCT03519178|561022929|FG003|PF-06873600 Treatment|Progressive disease|1|||
155435330|NCT03519178|561022930|FG004|PF-06873600 Treatment|Progressive disease|6|||
155435331|NCT03519178|561022931|FG005|PF-06873600 Treatment|Progressive disease|7|||
155435332|NCT03519178|561022932|FG006|PF-06873600 Treatment|Progressive disease|3|||
155435333|NCT03519178|561022933|FG007|PF-06873600 Treatment|Progressive disease|7|||
155435334|NCT03519178|561022934|FG008|PF-06873600 Treatment|Progressive disease|3|||
155435335|NCT03519178|561022935|FG009|PF-06873600 Treatment|Progressive disease|5|||
155435336|NCT03519178|561022936|FG010|PF-06873600 Treatment|Progressive disease|4|||
155435337|NCT03519178|561022937|FG011|PF-06873600 Treatment|Progressive disease|3|||
155435338|NCT03519178|561022938|FG012|PF-06873600 Treatment|Progressive disease|4|||
155435339|NCT03519178|561022939|FG013|PF-06873600 Treatment|Progressive disease|28|||
155435340|NCT03519178|561022940|FG014|PF-06873600 Treatment|Progressive disease|8|||
155435341|NCT03519178|561022926|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435342|NCT03519178|561022927|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435343|NCT03519178|561022928|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
155435344|NCT03519178|561022929|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435345|NCT03519178|561022930|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
155435346|NCT03519178|561022931|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435347|NCT03519178|561022932|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435348|NCT03519178|561022933|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
155435349|NCT03519178|561022934|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
155435350|NCT03519178|561022935|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
155435351|NCT03519178|561022936|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
155435352|NCT03519178|561022937|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
155435353|NCT03519178|561022938|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
155435354|NCT03519178|561022939|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
155435355|NCT03519178|561022940|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
155435356|NCT03519178|561022926|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
155435357|NCT03519178|561022927|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
155435358|NCT03519178|561022928|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
155650524|NCT00147537|561812505|FG003|Phase 1b|Randomized but not treated|0|||
155435359|NCT03519178|561022929|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
155435360|NCT03519178|561022930|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
155435361|NCT03519178|561022931|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
155435362|NCT03519178|561022932|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
155435363|NCT03519178|561022933|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
155435364|NCT03519178|561022934|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
155435365|NCT03519178|561022935|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
155435366|NCT03519178|561022936|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
155435367|NCT03519178|561022937|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
155435368|NCT03519178|561022938|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
155435369|NCT03519178|561022939|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
155435370|NCT03519178|561022940|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
155435371|NCT03519178|561022926|FG000|PF-06873600 Treatment|Refused further treatment|0|||
155435372|NCT03519178|561022927|FG001|PF-06873600 Treatment|Refused further treatment|1|||
155435373|NCT03519178|561022928|FG002|PF-06873600 Treatment|Refused further treatment|0|||
155435374|NCT03519178|561022929|FG003|PF-06873600 Treatment|Refused further treatment|0|||
155435375|NCT03519178|561022930|FG004|PF-06873600 Treatment|Refused further treatment|1|||
155650525|NCT00147537|561812506|FG004|Phase 1b|Randomized but not treated|0|||
155650526|NCT00147537|561812507|FG005|Phase 1b|Randomized but not treated|0|||
155650527|NCT00147537|561812508|FG006|Phase 1b|Randomized but not treated|1|||
155435376|NCT03519178|561022931|FG005|PF-06873600 Treatment|Refused further treatment|0|||
155435377|NCT03519178|561022932|FG006|PF-06873600 Treatment|Refused further treatment|0|||
155435378|NCT03519178|561022933|FG007|PF-06873600 Treatment|Refused further treatment|0|||
155435379|NCT03519178|561022934|FG008|PF-06873600 Treatment|Refused further treatment|0|||
155435380|NCT03519178|561022935|FG009|PF-06873600 Treatment|Refused further treatment|0|||
155435381|NCT03519178|561022936|FG010|PF-06873600 Treatment|Refused further treatment|0|||
155435382|NCT03519178|561022937|FG011|PF-06873600 Treatment|Refused further treatment|0|||
155435383|NCT03519178|561022938|FG012|PF-06873600 Treatment|Refused further treatment|0|||
155435384|NCT03519178|561022939|FG013|PF-06873600 Treatment|Refused further treatment|0|||
155435385|NCT03519178|561022940|FG014|PF-06873600 Treatment|Refused further treatment|1|||
155435386|NCT03519178|561022926|FG000|PF-06873600 Treatment|Other|0|||
155435387|NCT03519178|561022927|FG001|PF-06873600 Treatment|Other|0|||
155435388|NCT03519178|561022928|FG002|PF-06873600 Treatment|Other|0|||
155435389|NCT03519178|561022929|FG003|PF-06873600 Treatment|Other|0|||
155435390|NCT03519178|561022930|FG004|PF-06873600 Treatment|Other|0|||
155435391|NCT03519178|561022931|FG005|PF-06873600 Treatment|Other|0|||
155435392|NCT03519178|561022932|FG006|PF-06873600 Treatment|Other|0|||
155435393|NCT03519178|561022933|FG007|PF-06873600 Treatment|Other|0|||
155435394|NCT03519178|561022934|FG008|PF-06873600 Treatment|Other|1|||
155435395|NCT03519178|561022935|FG009|PF-06873600 Treatment|Other|0|||
155435396|NCT03519178|561022936|FG010|PF-06873600 Treatment|Other|0|||
155435397|NCT03519178|561022937|FG011|PF-06873600 Treatment|Other|0|||
155435398|NCT03519178|561022938|FG012|PF-06873600 Treatment|Other|0|||
155435399|NCT03519178|561022939|FG013|PF-06873600 Treatment|Other|1|||
155435400|NCT03519178|561022940|FG014|PF-06873600 Treatment|Other|3|||
155435401|NCT03519178|561022926|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
155435402|NCT03519178|561022927|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
155435403|NCT03519178|561022928|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
155435404|NCT03519178|561022929|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
155435405|NCT03519178|561022930|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
155435406|NCT03519178|561022931|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
155435407|NCT03519178|561022932|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
155435408|NCT03519178|561022933|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
155435409|NCT03519178|561022934|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
155435410|NCT03519178|561022935|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
155435411|NCT03519178|561022936|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
155435412|NCT03519178|561022937|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
155435413|NCT03519178|561022938|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
155435414|NCT03519178|561022939|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
155435415|NCT03519178|561022940|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
155435416|NCT03519178|561022926|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435417|NCT03519178|561022927|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435418|NCT03519178|561022928|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435419|NCT03519178|561022929|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435420|NCT03519178|561022930|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435421|NCT03519178|561022931|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435422|NCT03519178|561022932|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435423|NCT03519178|561022933|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435424|NCT03519178|561022934|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435425|NCT03519178|561022935|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435426|NCT03519178|561022936|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435427|NCT03519178|561022937|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
155513268|NCT00583596|561304428|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
155513269|NCT00583596|561304428|FG000|Overall Study|Death|2|||
155513270|NCT00583596|561304428|FG000|Overall Study|Withdrawal by Subject|6|||
155513271|NCT00583596|561304428|FG000|Overall Study|Lost to Follow-up|94|||
155513272|NCT00583596|561304428|FG000|Overall Study|Data not complete|1|||
155513273|NCT00583596|561304428|FG000|Overall Study|Not consented|15|||
155513274|NCT00583596|561304428|FG000|Overall Study|Outside f-up window|26|||
155513275|NCT01533428|561304431|FG000|Overall Study|Adverse Event|0|||
155513276|NCT01533428|561304432|FG001|Overall Study|Adverse Event|1|||
155513277|NCT01533428|561304431|FG000|Overall Study|Lost to Follow-up|2|||
155513278|NCT01533428|561304432|FG001|Overall Study|Lost to Follow-up|1|||
155513279|NCT01533428|561304431|FG000|Overall Study|Withdrawal by Subject|7|||
155513280|NCT01533428|561304432|FG001|Overall Study|Withdrawal by Subject|6|||
155513281|NCT00859469|561304434|FG000|Overall Study|Adverse Event|2|||
155513282|NCT00859469|561304434|FG000|Overall Study|Lack of Efficacy|9|||
155513283|NCT00859469|561304434|FG000|Overall Study|Withdrawal by Subject|1|||
155513284|NCT00859469|561304434|FG000|Overall Study|Death|16|||
155435428|NCT03519178|561022938|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
155435429|NCT03519178|561022939|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
155435430|NCT03519178|561022940|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
155435431|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Adverse Event|0|||
155435432|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Adverse Event|0|||
155435433|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Adverse Event|0|||
155435434|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Adverse Event|0|||
155435435|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Adverse Event|0|||
155435436|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Adverse Event|0|||
155435437|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Adverse Event|0|||
155435438|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Adverse Event|0|||
155435439|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Adverse Event|0|||
155435440|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Adverse Event|0|||
155435441|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Adverse Event|0|||
155435442|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Adverse Event|0|||
155435443|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Adverse Event|0|||
155435444|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Adverse Event|1|||
155435445|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Adverse Event|0|||
155435446|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Death|0|||
155435447|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Death|0|||
155435448|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Death|0|||
155435449|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Death|0|||
155435450|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Death|0|||
155435451|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Death|0|||
155435452|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Death|0|||
155435453|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Death|0|||
155435454|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Death|0|||
155435455|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Death|1|||
155435456|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Death|0|||
155435457|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Death|0|||
155435458|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Death|0|||
155435459|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Death|0|||
155435460|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Death|1|||
155435461|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435462|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435463|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435464|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435465|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435466|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435467|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435468|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
155513285|NCT02102490|561304438|FG000|Overall Study|Death|6|||
155435469|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435470|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435471|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435472|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435473|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435474|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
155435475|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
155435476|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Physician Decision|0|||
155435477|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Physician Decision|0|||
155435478|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Physician Decision|0|||
155435479|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Physician Decision|0|||
155435480|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Physician Decision|0|||
155435481|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Physician Decision|0|||
155513286|NCT02102490|561304438|FG000|Overall Study|Lost to Follow-up|1|||
155513287|NCT00095199|561304441|FG000|Overall Study|Adverse Event|40|||
155513288|NCT00095199|561304442|FG001|Overall Study|Adverse Event|22|||
155513289|NCT00095199|561304443|FG002|Overall Study|Adverse Event|26|||
155513290|NCT00095199|561304444|FG003|Overall Study|Adverse Event|11|||
155435482|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Physician Decision|0|||
155435483|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Physician Decision|0|||
155435484|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Physician Decision|0|||
155435485|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Physician Decision|0|||
155435486|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Physician Decision|0|||
155435487|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Physician Decision|0|||
155435488|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Physician Decision|0|||
155435489|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Physician Decision|4|||
155435490|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Physician Decision|2|||
155435491|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Progressive disease|0|||
155435492|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Progressive disease|0|||
155435493|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Progressive disease|0|||
155435494|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Progressive disease|0|||
155435495|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Progressive disease|0|||
155435496|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Progressive disease|0|||
155435497|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Progressive disease|0|||
155435498|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Progressive disease|0|||
155435499|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Progressive disease|0|||
155650528|NCT00147537|561812509|FG007|Phase 1b|Randomized but not treated|0|||
155435500|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Progressive disease|5|||
155435501|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Progressive disease|0|||
155435502|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Progressive disease|0|||
155435503|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Progressive disease|0|||
155435504|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Progressive disease|30|||
155435505|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Progressive disease|8|||
155435506|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435507|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435508|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435509|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435510|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435511|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435512|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435513|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435514|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435515|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435516|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155650529|NCT00147537|561812510|FG008|Phase 1b|Randomized but not treated|1|||
155435517|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435518|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
155435519|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
155435520|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
155435521|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155513291|NCT00095199|561304441|FG000|Overall Study|Progressive disease|213|||
155513292|NCT00095199|561304442|FG001|Overall Study|Progressive disease|179|||
155513293|NCT00095199|561304443|FG002|Overall Study|Progressive disease|105|||
155513294|NCT00095199|561304444|FG003|Overall Study|Progressive disease|98|||
155513295|NCT00095199|561304441|FG000|Overall Study|Death|10|||
155513296|NCT00095199|561304442|FG001|Overall Study|Death|6|||
155513297|NCT00095199|561304443|FG002|Overall Study|Death|11|||
155513298|NCT00095199|561304444|FG003|Overall Study|Death|9|||
155513299|NCT00095199|561304441|FG000|Overall Study|Withdrawal by Subject|21|||
155513300|NCT00095199|561304442|FG001|Overall Study|Withdrawal by Subject|16|||
155513301|NCT00095199|561304443|FG002|Overall Study|Withdrawal by Subject|13|||
155513302|NCT00095199|561304444|FG003|Overall Study|Withdrawal by Subject|22|||
155513303|NCT00095199|561304441|FG000|Overall Study|Protocol Violation|4|||
155513304|NCT00095199|561304442|FG001|Overall Study|Protocol Violation|4|||
155513305|NCT00095199|561304443|FG002|Overall Study|Protocol Violation|2|||
155513306|NCT00095199|561304444|FG003|Overall Study|Protocol Violation|0|||
155513307|NCT00095199|561304441|FG000|Overall Study|Liver function test results elevated|0|||
155513308|NCT00095199|561304442|FG001|Overall Study|Liver function test results elevated|0|||
155513309|NCT00095199|561304443|FG002|Overall Study|Liver function test results elevated|1|||
155513310|NCT00095199|561304444|FG003|Overall Study|Liver function test results elevated|1|||
155513311|NCT00095199|561304441|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
155513312|NCT00095199|561304442|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
155513313|NCT00095199|561304443|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
155513314|NCT00095199|561304444|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
155513315|NCT00095199|561304441|FG000|Overall Study|Physician Decision|5|||
155513316|NCT00095199|561304442|FG001|Overall Study|Physician Decision|6|||
155513317|NCT00095199|561304443|FG002|Overall Study|Physician Decision|1|||
155513318|NCT00095199|561304444|FG003|Overall Study|Physician Decision|1|||
155650530|NCT00147537|561812511|FG009|Phase 1b|Randomized but not treated|0|||
155435522|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435523|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435524|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435525|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435526|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435527|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435528|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435529|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435530|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
155435531|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435532|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435533|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
155435534|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
155435535|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
155435536|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435537|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435538|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435539|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435540|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435541|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435542|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435543|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435544|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435545|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
155435546|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435547|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435548|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435549|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
155435550|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
155435551|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
155513319|NCT00095199|561304441|FG000|Overall Study|Not eligible|1|||
155513320|NCT00095199|561304442|FG001|Overall Study|Not eligible|7|||
155513321|NCT00095199|561304443|FG002|Overall Study|Not eligible|0|||
155513322|NCT00095199|561304444|FG003|Overall Study|Not eligible|1|||
155513323|NCT00095199|561304441|FG000|Overall Study|Started Palliative Radiotherapy|1|||
155513324|NCT00095199|561304442|FG001|Overall Study|Started Palliative Radiotherapy|0|||
155513325|NCT00095199|561304443|FG002|Overall Study|Started Palliative Radiotherapy|0|||
155435552|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
155435553|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
155435554|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
155435555|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
155435556|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
155435557|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
155435558|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
155435559|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
155435560|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
155435561|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
155435562|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
155435563|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
155435564|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
155435565|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
155435566|NCT03519178|561022926|FG000|Fulvestrant. Treatment|Other|0|||
155435567|NCT03519178|561022927|FG001|Fulvestrant. Treatment|Other|0|||
155435568|NCT03519178|561022928|FG002|Fulvestrant. Treatment|Other|0|||
155435569|NCT03519178|561022929|FG003|Fulvestrant. Treatment|Other|0|||
155435570|NCT03519178|561022930|FG004|Fulvestrant. Treatment|Other|0|||
155435571|NCT03519178|561022931|FG005|Fulvestrant. Treatment|Other|0|||
155435572|NCT03519178|561022932|FG006|Fulvestrant. Treatment|Other|0|||
155435573|NCT03519178|561022933|FG007|Fulvestrant. Treatment|Other|0|||
155435574|NCT03519178|561022934|FG008|Fulvestrant. Treatment|Other|0|||
155435575|NCT03519178|561022935|FG009|Fulvestrant. Treatment|Other|0|||
155435576|NCT03519178|561022936|FG010|Fulvestrant. Treatment|Other|0|||
155435577|NCT03519178|561022937|FG011|Fulvestrant. Treatment|Other|0|||
155435578|NCT03519178|561022938|FG012|Fulvestrant. Treatment|Other|0|||
155435579|NCT03519178|561022939|FG013|Fulvestrant. Treatment|Other|1|||
155435580|NCT03519178|561022940|FG014|Fulvestrant. Treatment|Other|3|||
155435581|NCT03519178|561022926|FG000|Letrozole Treatment|Physician Decision|0|||
155435582|NCT03519178|561022927|FG001|Letrozole Treatment|Physician Decision|0|||
155435583|NCT03519178|561022928|FG002|Letrozole Treatment|Physician Decision|0|||
155435584|NCT03519178|561022929|FG003|Letrozole Treatment|Physician Decision|0|||
155435585|NCT03519178|561022930|FG004|Letrozole Treatment|Physician Decision|0|||
155435586|NCT03519178|561022931|FG005|Letrozole Treatment|Physician Decision|0|||
155435587|NCT03519178|561022932|FG006|Letrozole Treatment|Physician Decision|0|||
155435588|NCT03519178|561022933|FG007|Letrozole Treatment|Physician Decision|0|||
155435589|NCT03519178|561022934|FG008|Letrozole Treatment|Physician Decision|0|||
155435590|NCT03519178|561022935|FG009|Letrozole Treatment|Physician Decision|0|||
155435591|NCT03519178|561022936|FG010|Letrozole Treatment|Physician Decision|1|||
155435592|NCT03519178|561022937|FG011|Letrozole Treatment|Physician Decision|0|||
155435593|NCT03519178|561022938|FG012|Letrozole Treatment|Physician Decision|0|||
155435594|NCT03519178|561022939|FG013|Letrozole Treatment|Physician Decision|0|||
155435595|NCT03519178|561022940|FG014|Letrozole Treatment|Physician Decision|0|||
155435596|NCT03519178|561022926|FG000|Letrozole Treatment|Progressive disease|0|||
155435597|NCT03519178|561022927|FG001|Letrozole Treatment|Progressive disease|0|||
155435598|NCT03519178|561022928|FG002|Letrozole Treatment|Progressive disease|0|||
155435599|NCT03519178|561022929|FG003|Letrozole Treatment|Progressive disease|0|||
155435600|NCT03519178|561022930|FG004|Letrozole Treatment|Progressive disease|0|||
155435601|NCT03519178|561022931|FG005|Letrozole Treatment|Progressive disease|0|||
155435602|NCT03519178|561022932|FG006|Letrozole Treatment|Progressive disease|0|||
155435603|NCT03519178|561022933|FG007|Letrozole Treatment|Progressive disease|0|||
155435604|NCT03519178|561022934|FG008|Letrozole Treatment|Progressive disease|0|||
155435605|NCT03519178|561022935|FG009|Letrozole Treatment|Progressive disease|0|||
155435606|NCT03519178|561022936|FG010|Letrozole Treatment|Progressive disease|4|||
155435607|NCT03519178|561022937|FG011|Letrozole Treatment|Progressive disease|0|||
155435608|NCT03519178|561022938|FG012|Letrozole Treatment|Progressive disease|0|||
155435609|NCT03519178|561022939|FG013|Letrozole Treatment|Progressive disease|0|||
155435610|NCT03519178|561022940|FG014|Letrozole Treatment|Progressive disease|0|||
155435611|NCT03519178|561022926|FG000|Letrozole Treatment|Global deterioration of health status|0|||
155435612|NCT03519178|561022927|FG001|Letrozole Treatment|Global deterioration of health status|0|||
155435613|NCT03519178|561022928|FG002|Letrozole Treatment|Global deterioration of health status|0|||
155435614|NCT03519178|561022929|FG003|Letrozole Treatment|Global deterioration of health status|0|||
155435615|NCT03519178|561022930|FG004|Letrozole Treatment|Global deterioration of health status|0|||
155435616|NCT03519178|561022931|FG005|Letrozole Treatment|Global deterioration of health status|0|||
155435617|NCT03519178|561022932|FG006|Letrozole Treatment|Global deterioration of health status|0|||
155435618|NCT03519178|561022933|FG007|Letrozole Treatment|Global deterioration of health status|0|||
155435619|NCT03519178|561022934|FG008|Letrozole Treatment|Global deterioration of health status|0|||
155435620|NCT03519178|561022935|FG009|Letrozole Treatment|Global deterioration of health status|0|||
155435621|NCT03519178|561022936|FG010|Letrozole Treatment|Global deterioration of health status|2|||
155435622|NCT03519178|561022937|FG011|Letrozole Treatment|Global deterioration of health status|0|||
155435623|NCT03519178|561022938|FG012|Letrozole Treatment|Global deterioration of health status|0|||
155435624|NCT03519178|561022939|FG013|Letrozole Treatment|Global deterioration of health status|0|||
155513326|NCT00095199|561304444|FG003|Overall Study|Started Palliative Radiotherapy|0|||
155513327|NCT00095199|561304441|FG000|Overall Study|Started radiotherapy regimen|0|||
155513328|NCT00095199|561304442|FG001|Overall Study|Started radiotherapy regimen|1|||
155513329|NCT00095199|561304443|FG002|Overall Study|Started radiotherapy regimen|0|||
155513330|NCT00095199|561304444|FG003|Overall Study|Started radiotherapy regimen|0|||
155513331|NCT00095199|561304441|FG000|Overall Study|Primary tumor removed in other surgery|0|||
155513332|NCT00095199|561304442|FG001|Overall Study|Primary tumor removed in other surgery|1|||
155513333|NCT00095199|561304443|FG002|Overall Study|Primary tumor removed in other surgery|0|||
155513334|NCT00095199|561304444|FG003|Overall Study|Primary tumor removed in other surgery|0|||
155513335|NCT00095199|561304441|FG000|Overall Study|Data inadvertently lost by site|1|||
155513336|NCT00095199|561304442|FG001|Overall Study|Data inadvertently lost by site|0|||
155513337|NCT00095199|561304443|FG002|Overall Study|Data inadvertently lost by site|0|||
155513338|NCT00095199|561304444|FG003|Overall Study|Data inadvertently lost by site|0|||
155513339|NCT01890707|561304479|FG000|Overall Study|Lost to Follow-up|1|||
155513340|NCT01890707|561304480|FG001|Overall Study|Lost to Follow-up|1|||
155513341|NCT00669955|561304481|FG000|Overall Study|Adverse Event|3|||
155513342|NCT00669955|561304482|FG001|Overall Study|Adverse Event|5|||
155513343|NCT00669955|561304481|FG000|Overall Study|Death|0|||
155513344|NCT00669955|561304482|FG001|Overall Study|Death|1|||
155513345|NCT00669955|561304481|FG000|Overall Study|Withdrawal by Subject|2|||
155513346|NCT00669955|561304482|FG001|Overall Study|Withdrawal by Subject|3|||
155513347|NCT00669955|561304481|FG000|Overall Study|Lost to Follow-up|5|||
155435625|NCT03519178|561022940|FG014|Letrozole Treatment|Global deterioration of health status|0|||
155435626|NCT03519178|561022926|FG000|Follow-Up|Death|0|||
155435627|NCT03519178|561022927|FG001|Follow-Up|Death|0|||
155435628|NCT03519178|561022928|FG002|Follow-Up|Death|0|||
155435629|NCT03519178|561022929|FG003|Follow-Up|Death|0|||
155435630|NCT03519178|561022930|FG004|Follow-Up|Death|0|||
155435631|NCT03519178|561022931|FG005|Follow-Up|Death|0|||
155435632|NCT03519178|561022932|FG006|Follow-Up|Death|0|||
155435633|NCT03519178|561022933|FG007|Follow-Up|Death|0|||
155435634|NCT03519178|561022934|FG008|Follow-Up|Death|3|||
155435635|NCT03519178|561022935|FG009|Follow-Up|Death|1|||
155435636|NCT03519178|561022936|FG010|Follow-Up|Death|0|||
155435637|NCT03519178|561022937|FG011|Follow-Up|Death|0|||
155435638|NCT03519178|561022938|FG012|Follow-Up|Death|2|||
155435639|NCT03519178|561022939|FG013|Follow-Up|Death|0|||
155435640|NCT03519178|561022940|FG014|Follow-Up|Death|0|||
155435641|NCT03519178|561022926|FG000|Follow-Up|Lost to Follow-up|0|||
155435642|NCT03519178|561022927|FG001|Follow-Up|Lost to Follow-up|0|||
155513348|NCT00669955|561304482|FG001|Overall Study|Lost to Follow-up|7|||
155513349|NCT00669955|561304481|FG000|Overall Study|Protocol Violation|2|||
155513350|NCT00669955|561304482|FG001|Overall Study|Protocol Violation|7|||
155513351|NCT00669955|561304481|FG000|Overall Study|Investigator Sponsor Judgement|0|||
155513352|NCT00669955|561304482|FG001|Overall Study|Investigator Sponsor Judgement|1|||
155513353|NCT00669955|561304481|FG000|Overall Study|not compliant with study drug/visit|2|||
155513354|NCT00669955|561304482|FG001|Overall Study|not compliant with study drug/visit|3|||
155513355|NCT00385541|561304484|FG000|Overall Study|severe pain, clinician requested unblind|0|||
155513356|NCT00385541|561304485|FG001|Overall Study|severe pain, clinician requested unblind|1|||
155513357|NCT01073020|561306196|FG000|Overall Study|Withdrawal by Subject|6|||
155513358|NCT01073020|561306197|FG001|Overall Study|Withdrawal by Subject|4|||
155513359|NCT01073020|561306198|FG002|Overall Study|Withdrawal by Subject|1|||
155513360|NCT01073020|561306199|FG003|Overall Study|Withdrawal by Subject|2|||
155513361|NCT01073020|561306196|FG000|Overall Study|Physician Decision|1|||
155513362|NCT01073020|561306197|FG001|Overall Study|Physician Decision|0|||
155513363|NCT01073020|561306198|FG002|Overall Study|Physician Decision|2|||
155513364|NCT01073020|561306199|FG003|Overall Study|Physician Decision|0|||
155513365|NCT01073020|561306196|FG000|Overall Study|Death|0|||
155513366|NCT01073020|561306197|FG001|Overall Study|Death|1|||
155513367|NCT01073020|561306198|FG002|Overall Study|Death|0|||
155513368|NCT01073020|561306199|FG003|Overall Study|Death|0|||
155513369|NCT00836927|561306202|FG000|Overall Study|Progressive disease|2|||
155513370|NCT00836927|561306203|FG001|Overall Study|Progressive disease|0|||
155513371|NCT00836927|561306204|FG002|Overall Study|Progressive disease|0|||
155650531|NCT00147537|561812512|FG010|Phase 1b|Randomized but not treated|0|||
155435643|NCT03519178|561022928|FG002|Follow-Up|Lost to Follow-up|0|||
155435644|NCT03519178|561022929|FG003|Follow-Up|Lost to Follow-up|0|||
155435645|NCT03519178|561022930|FG004|Follow-Up|Lost to Follow-up|0|||
155435646|NCT03519178|561022931|FG005|Follow-Up|Lost to Follow-up|3|||
155435647|NCT03519178|561022932|FG006|Follow-Up|Lost to Follow-up|1|||
155435648|NCT03519178|561022933|FG007|Follow-Up|Lost to Follow-up|4|||
155435649|NCT03519178|561022934|FG008|Follow-Up|Lost to Follow-up|1|||
155513372|NCT00836927|561306205|FG003|Overall Study|Progressive disease|1|||
155513373|NCT00836927|561306206|FG004|Overall Study|Progressive disease|1|||
155513374|NCT00836927|561306202|FG000|Overall Study|Withdrawal by Subject|1|||
155513375|NCT00836927|561306203|FG001|Overall Study|Withdrawal by Subject|0|||
155513376|NCT00836927|561306204|FG002|Overall Study|Withdrawal by Subject|0|||
155513377|NCT00836927|561306205|FG003|Overall Study|Withdrawal by Subject|0|||
155513378|NCT00836927|561306206|FG004|Overall Study|Withdrawal by Subject|0|||
155650532|NCT00147537|561812502|FG000|Phase 2|Death|0|||
155513379|NCT00614055|561306208|FG000|Overall Study|Adverse Event|1|||
155513380|NCT00614055|561306209|FG001|Overall Study|Adverse Event|0|||
155513381|NCT00614055|561306210|FG002|Overall Study|Adverse Event|0|||
155513382|NCT00614055|561306208|FG000|Overall Study|Protocol Violation|2|||
155513383|NCT00614055|561306209|FG001|Overall Study|Protocol Violation|2|||
155513384|NCT00614055|561306210|FG002|Overall Study|Protocol Violation|1|||
155513385|NCT00614055|561306208|FG000|Overall Study|Lack of Efficacy|0|||
155513386|NCT00614055|561306209|FG001|Overall Study|Lack of Efficacy|0|||
155513387|NCT00614055|561306210|FG002|Overall Study|Lack of Efficacy|2|||
155513388|NCT00614055|561306208|FG000|Overall Study|Unclassified|1|||
155513389|NCT00614055|561306209|FG001|Overall Study|Unclassified|4|||
155513390|NCT00614055|561306210|FG002|Overall Study|Unclassified|2|||
155513391|NCT02637557|561306221|FG000|Overall Study|Adverse Event|3|||
155513392|NCT02637557|561306222|FG001|Overall Study|Adverse Event|1|||
155513393|NCT02637557|561306223|FG002|Overall Study|Adverse Event|3|||
155513394|NCT02637557|561306224|FG003|Overall Study|Adverse Event|3|||
155513395|NCT02637557|561306221|FG000|Overall Study|Lost to Follow-up|1|||
155513396|NCT02637557|561306222|FG001|Overall Study|Lost to Follow-up|1|||
155513397|NCT02637557|561306223|FG002|Overall Study|Lost to Follow-up|0|||
155513398|NCT02637557|561306224|FG003|Overall Study|Lost to Follow-up|1|||
155513399|NCT02637557|561306221|FG000|Overall Study|Physician Decision|1|||
155513400|NCT02637557|561306222|FG001|Overall Study|Physician Decision|0|||
155513401|NCT02637557|561306223|FG002|Overall Study|Physician Decision|0|||
155513402|NCT02637557|561306224|FG003|Overall Study|Physician Decision|0|||
155513403|NCT02637557|561306221|FG000|Overall Study|Protocol Violation|2|||
155513404|NCT02637557|561306222|FG001|Overall Study|Protocol Violation|0|||
155513405|NCT02637557|561306223|FG002|Overall Study|Protocol Violation|2|||
155513406|NCT02637557|561306224|FG003|Overall Study|Protocol Violation|1|||
155513407|NCT02637557|561306221|FG000|Overall Study|Withdrawal by Subject|1|||
155513408|NCT02637557|561306222|FG001|Overall Study|Withdrawal by Subject|3|||
155513409|NCT02637557|561306223|FG002|Overall Study|Withdrawal by Subject|4|||
155513410|NCT02637557|561306224|FG003|Overall Study|Withdrawal by Subject|2|||
155513411|NCT02006706|561306225|FG000|Overall Study|Lost to Follow-up|1|||
155513412|NCT01673009|561306226|FG000|Overall Study|Physician Decision|5|||
155513413|NCT01673009|561306226|FG000|Overall Study|Withdrawal by Subject|8|||
155513414|NCT04161144|561306227|FG000|Overall Study|Withdrawal by Subject|0|||
155513415|NCT04161144|561306228|FG001|Overall Study|Withdrawal by Subject|1|||
155513416|NCT04161144|561306227|FG000|Overall Study|Protocol Violation|1|||
155513417|NCT04161144|561306228|FG001|Overall Study|Protocol Violation|0|||
155513418|NCT02848599|561306232|FG000|Overall Study|Protocol Violation|7|||
155513419|NCT02848599|561306233|FG001|Overall Study|Protocol Violation|9|||
155513420|NCT04828161|561306234|FG000|Overall Study|Withdrawal by Subject|0|||
155513421|NCT04828161|561306235|FG001|Overall Study|Withdrawal by Subject|3|||
155513422|NCT04828161|561306236|FG002|Overall Study|Withdrawal by Subject|3|||
155513423|NCT04828161|561306237|FG003|Overall Study|Withdrawal by Subject|4|||
155513424|NCT04828161|561306234|FG000|Overall Study|Lost to Follow-up|1|||
155513425|NCT04828161|561306235|FG001|Overall Study|Lost to Follow-up|4|||
155513426|NCT04828161|561306236|FG002|Overall Study|Lost to Follow-up|2|||
155513427|NCT04828161|561306237|FG003|Overall Study|Lost to Follow-up|2|||
155513428|NCT04828161|561306234|FG000|Overall Study|Other|2|||
155513429|NCT04828161|561306235|FG001|Overall Study|Other|0|||
155513430|NCT04828161|561306236|FG002|Overall Study|Other|2|||
155513431|NCT04828161|561306237|FG003|Overall Study|Other|0|||
155513432|NCT04828161|561306234|FG000|Overall Study|Death|0|||
155513433|NCT04828161|561306235|FG001|Overall Study|Death|0|||
155435650|NCT03519178|561022935|FG009|Follow-Up|Lost to Follow-up|0|||
155435651|NCT03519178|561022936|FG010|Follow-Up|Lost to Follow-up|0|||
155435652|NCT03519178|561022937|FG011|Follow-Up|Lost to Follow-up|0|||
155435653|NCT03519178|561022938|FG012|Follow-Up|Lost to Follow-up|0|||
155435654|NCT03519178|561022939|FG013|Follow-Up|Lost to Follow-up|0|||
155435655|NCT03519178|561022940|FG014|Follow-Up|Lost to Follow-up|0|||
155435656|NCT03519178|561022926|FG000|Follow-Up|Withdrawal by Subject|1|||
155435657|NCT03519178|561022927|FG001|Follow-Up|Withdrawal by Subject|2|||
155435658|NCT03519178|561022928|FG002|Follow-Up|Withdrawal by Subject|2|||
155435659|NCT03519178|561022929|FG003|Follow-Up|Withdrawal by Subject|3|||
155435660|NCT03519178|561022930|FG004|Follow-Up|Withdrawal by Subject|5|||
155513434|NCT04828161|561306236|FG002|Overall Study|Death|0|||
155435661|NCT03519178|561022931|FG005|Follow-Up|Withdrawal by Subject|1|||
155513435|NCT04828161|561306237|FG003|Overall Study|Death|2|||
155513436|NCT02352337|561306238|FG000|Overall Study|Patients never treated|4|||
155513437|NCT02352337|561306239|FG001|Overall Study|Patients never treated|1|||
155513438|NCT02352337|561306240|FG002|Overall Study|Patients never treated|2|||
155435662|NCT03519178|561022932|FG006|Follow-Up|Withdrawal by Subject|2|||
155513439|NCT02458638|561306243|FG000|Overall Study|Death|309|||
155513440|NCT02458638|561306243|FG000|Overall Study|End of Cohort/End of Study|67|||
155513441|NCT02458638|561306243|FG000|Overall Study|Lost to Follow-up|31|||
155513442|NCT02458638|561306243|FG000|Overall Study|Other Reasons|4|||
155513443|NCT02458638|561306243|FG000|Overall Study|Physician Decision|1|||
155513444|NCT02458638|561306243|FG000|Overall Study|Withdrawal by Subject|47|||
155513445|NCT00135707|561306253|FG000|Overall Study|Lost to Follow-up|94|||
155513446|NCT00135707|561306254|FG001|Overall Study|Lost to Follow-up|89|||
155513447|NCT00135707|561306253|FG000|Overall Study|Withdrawal by Subject|0|||
155513448|NCT00135707|561306254|FG001|Overall Study|Withdrawal by Subject|1|||
155513449|NCT00135707|561306253|FG000|Overall Study|Institutional review board request|1|||
155513450|NCT00135707|561306254|FG001|Overall Study|Institutional review board request|0|||
155513451|NCT01612000|561306262|FG000|Overall Study|Lost to Follow-up|6|||
155513452|NCT01612000|561306263|FG001|Overall Study|Lost to Follow-up|4|||
155513453|NCT01612000|561306264|FG002|Overall Study|Lost to Follow-up|4|||
155513454|NCT01612000|561306265|FG003|Overall Study|Lost to Follow-up|8|||
155513455|NCT01612000|561306262|FG000|Overall Study|Physician Decision|0|||
155513456|NCT01612000|561306263|FG001|Overall Study|Physician Decision|0|||
155513457|NCT01612000|561306264|FG002|Overall Study|Physician Decision|1|||
155513458|NCT01612000|561306265|FG003|Overall Study|Physician Decision|0|||
155513459|NCT01612000|561306262|FG000|Overall Study|Withdrawal by Subject|3|||
155513460|NCT01612000|561306263|FG001|Overall Study|Withdrawal by Subject|1|||
155513461|NCT01612000|561306264|FG002|Overall Study|Withdrawal by Subject|2|||
155513462|NCT01612000|561306265|FG003|Overall Study|Withdrawal by Subject|2|||
155513463|NCT02173704|561306266|FG000|Overall Study|Adverse Event|1|||
155513464|NCT02173704|561306267|FG001|Overall Study|Adverse Event|0|||
155513465|NCT02173704|561306266|FG000|Overall Study|Lost to Follow-up|1|||
155513466|NCT02173704|561306267|FG001|Overall Study|Lost to Follow-up|0|||
155513467|NCT02173704|561306266|FG000|Overall Study|Other|1|||
155513468|NCT02173704|561306267|FG001|Overall Study|Other|0|||
155513469|NCT02173704|561306266|FG000|Overall Study|Protocol Violation|1|||
155513470|NCT02173704|561306267|FG001|Overall Study|Protocol Violation|0|||
155513471|NCT02173704|561306266|FG000|Overall Study|Withdrawal by Subject|9|||
155513472|NCT02173704|561306267|FG001|Overall Study|Withdrawal by Subject|4|||
155513473|NCT01180244|561306278|FG000|Overall Study|Lack of Efficacy|0|||
155513474|NCT01180244|561306279|FG001|Overall Study|Lack of Efficacy|7|||
155513475|NCT01180244|561306278|FG000|Overall Study|Physician Decision|3|||
155513476|NCT01180244|561306279|FG001|Overall Study|Physician Decision|0|||
155435663|NCT03519178|561022933|FG007|Follow-Up|Withdrawal by Subject|6|||
155435664|NCT03519178|561022934|FG008|Follow-Up|Withdrawal by Subject|5|||
155435665|NCT03519178|561022935|FG009|Follow-Up|Withdrawal by Subject|2|||
155435666|NCT03519178|561022936|FG010|Follow-Up|Withdrawal by Subject|3|||
155435667|NCT03519178|561022937|FG011|Follow-Up|Withdrawal by Subject|5|||
155435668|NCT03519178|561022938|FG012|Follow-Up|Withdrawal by Subject|2|||
155435669|NCT03519178|561022939|FG013|Follow-Up|Withdrawal by Subject|0|||
155435670|NCT03519178|561022940|FG014|Follow-Up|Withdrawal by Subject|0|||
155435671|NCT03519178|561022926|FG000|Follow-Up|Other|0|||
155435672|NCT03519178|561022927|FG001|Follow-Up|Other|0|||
155435673|NCT03519178|561022928|FG002|Follow-Up|Other|0|||
155435674|NCT03519178|561022929|FG003|Follow-Up|Other|0|||
155435675|NCT03519178|561022930|FG004|Follow-Up|Other|0|||
155435676|NCT03519178|561022931|FG005|Follow-Up|Other|0|||
155435677|NCT03519178|561022932|FG006|Follow-Up|Other|0|||
155435678|NCT03519178|561022933|FG007|Follow-Up|Other|1|||
155435679|NCT03519178|561022934|FG008|Follow-Up|Other|0|||
155435680|NCT03519178|561022935|FG009|Follow-Up|Other|0|||
155435681|NCT03519178|561022936|FG010|Follow-Up|Other|0|||
155435682|NCT03519178|561022937|FG011|Follow-Up|Other|0|||
155435683|NCT03519178|561022938|FG012|Follow-Up|Other|0|||
155435684|NCT03519178|561022939|FG013|Follow-Up|Other|0|||
155435685|NCT03519178|561022940|FG014|Follow-Up|Other|0|||
155435686|NCT03519178|561022926|FG000|Long-term Follow-up|Death|0|||
155435687|NCT03519178|561022927|FG001|Long-term Follow-up|Death|0|||
155435688|NCT03519178|561022928|FG002|Long-term Follow-up|Death|0|||
155513477|NCT01180244|561306278|FG000|Overall Study|Adverse Event|1|||
155513478|NCT01180244|561306279|FG001|Overall Study|Adverse Event|0|||
155435689|NCT03519178|561022929|FG003|Long-term Follow-up|Death|0|||
155435690|NCT03519178|561022930|FG004|Long-term Follow-up|Death|0|||
155435691|NCT03519178|561022931|FG005|Long-term Follow-up|Death|0|||
155435692|NCT03519178|561022932|FG006|Long-term Follow-up|Death|0|||
155435693|NCT03519178|561022933|FG007|Long-term Follow-up|Death|0|||
155435694|NCT03519178|561022934|FG008|Long-term Follow-up|Death|0|||
155435695|NCT03519178|561022935|FG009|Long-term Follow-up|Death|0|||
155435696|NCT03519178|561022936|FG010|Long-term Follow-up|Death|0|||
155513479|NCT01180244|561306278|FG000|Overall Study|Withdrawal by Subject|0|||
155513480|NCT01180244|561306279|FG001|Overall Study|Withdrawal by Subject|1|||
155513481|NCT01180244|561306278|FG000|Overall Study|Protocol Violation|1|||
155435697|NCT03519178|561022937|FG011|Long-term Follow-up|Death|0|||
155435698|NCT03519178|561022938|FG012|Long-term Follow-up|Death|0|||
155435699|NCT03519178|561022939|FG013|Long-term Follow-up|Death|4|||
155435700|NCT03519178|561022940|FG014|Long-term Follow-up|Death|4|||
155435701|NCT03519178|561022926|FG000|Long-term Follow-up|Lost to Follow-up|0|||
155435702|NCT03519178|561022927|FG001|Long-term Follow-up|Lost to Follow-up|0|||
155435703|NCT03519178|561022928|FG002|Long-term Follow-up|Lost to Follow-up|0|||
155435704|NCT03519178|561022929|FG003|Long-term Follow-up|Lost to Follow-up|0|||
155435705|NCT03519178|561022930|FG004|Long-term Follow-up|Lost to Follow-up|0|||
155435706|NCT03519178|561022931|FG005|Long-term Follow-up|Lost to Follow-up|0|||
155435707|NCT03519178|561022932|FG006|Long-term Follow-up|Lost to Follow-up|0|||
155435708|NCT03519178|561022933|FG007|Long-term Follow-up|Lost to Follow-up|0|||
155435709|NCT03519178|561022934|FG008|Long-term Follow-up|Lost to Follow-up|0|||
155435710|NCT03519178|561022935|FG009|Long-term Follow-up|Lost to Follow-up|0|||
155435711|NCT03519178|561022936|FG010|Long-term Follow-up|Lost to Follow-up|0|||
155435712|NCT03519178|561022937|FG011|Long-term Follow-up|Lost to Follow-up|0|||
155435713|NCT03519178|561022938|FG012|Long-term Follow-up|Lost to Follow-up|0|||
155435714|NCT03519178|561022939|FG013|Long-term Follow-up|Lost to Follow-up|1|||
155435715|NCT03519178|561022940|FG014|Long-term Follow-up|Lost to Follow-up|1|||
155435716|NCT03519178|561022926|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
155435717|NCT03519178|561022927|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
155435718|NCT03519178|561022928|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
155435719|NCT03519178|561022929|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
155435720|NCT03519178|561022930|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
155435721|NCT03519178|561022931|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
155435722|NCT03519178|561022932|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
155435723|NCT03519178|561022933|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
155435724|NCT03519178|561022934|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
155435725|NCT03519178|561022935|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
155435726|NCT03519178|561022936|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
155435727|NCT03519178|561022937|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
155435728|NCT03519178|561022938|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
155435729|NCT03519178|561022939|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
155435730|NCT03519178|561022940|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
155435731|NCT03519178|561022926|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
155435732|NCT03519178|561022927|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
155435733|NCT03519178|561022928|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
155435734|NCT03519178|561022929|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
155435735|NCT03519178|561022930|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
155435736|NCT03519178|561022931|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
155435737|NCT03519178|561022932|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
155435738|NCT03519178|561022933|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
155435739|NCT03519178|561022934|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
155435740|NCT03519178|561022935|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
155435741|NCT03519178|561022936|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
155435742|NCT03519178|561022937|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
155435743|NCT03519178|561022938|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
155435744|NCT03519178|561022939|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
155435745|NCT03519178|561022940|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
155435746|NCT03519178|561022926|FG000|Long-term Follow-up|Other|0|||
155435747|NCT03519178|561022927|FG001|Long-term Follow-up|Other|0|||
155435748|NCT03519178|561022928|FG002|Long-term Follow-up|Other|0|||
155435749|NCT03519178|561022929|FG003|Long-term Follow-up|Other|0|||
155435750|NCT03519178|561022930|FG004|Long-term Follow-up|Other|0|||
155435751|NCT03519178|561022931|FG005|Long-term Follow-up|Other|0|||
155435752|NCT03519178|561022932|FG006|Long-term Follow-up|Other|0|||
155435753|NCT03519178|561022933|FG007|Long-term Follow-up|Other|0|||
155435754|NCT03519178|561022934|FG008|Long-term Follow-up|Other|0|||
155435755|NCT03519178|561022935|FG009|Long-term Follow-up|Other|0|||
155435756|NCT03519178|561022936|FG010|Long-term Follow-up|Other|0|||
155435757|NCT03519178|561022937|FG011|Long-term Follow-up|Other|0|||
155435758|NCT03519178|561022938|FG012|Long-term Follow-up|Other|0|||
155435759|NCT03519178|561022939|FG013|Long-term Follow-up|Other|0|||
155435760|NCT03519178|561022940|FG014|Long-term Follow-up|Other|1|||
155435761|NCT03519178|561022926|FG000|Long-term Follow-up|Global deterioration of health status|0|||
155513482|NCT01180244|561306279|FG001|Overall Study|Protocol Violation|0|||
155435762|NCT03519178|561022927|FG001|Long-term Follow-up|Global deterioration of health status|0|||
155513483|NCT01180244|561306278|FG000|Overall Study|Lost to Follow-up|1|||
155513484|NCT01180244|561306279|FG001|Overall Study|Lost to Follow-up|0|||
155513485|NCT00620763|561306282|FG000|Period: First Intervention|Withdrawal by Subject|0|||
155435763|NCT03519178|561022928|FG002|Long-term Follow-up|Global deterioration of health status|0|||
155650533|NCT00147537|561812503|FG001|Phase 2|Death|0|||
155435764|NCT03519178|561022929|FG003|Long-term Follow-up|Global deterioration of health status|0|||
155650534|NCT00147537|561812504|FG002|Phase 2|Death|0|||
155513486|NCT00620763|561306283|FG001|Period: First Intervention|Withdrawal by Subject|2|||
155513487|NCT00620763|561306282|FG000|Period: First Intervention|Protocol Violation|0|||
155513488|NCT00620763|561306283|FG001|Period: First Intervention|Protocol Violation|3|||
155513489|NCT00620763|561306282|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
155513490|NCT00620763|561306283|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
155513491|NCT01595009|561306284|FG000|Core|Patients completed per protocol|85|||
155513492|NCT01595009|561306285|FG001|Core|Patients completed per protocol|44|||
155513493|NCT01595009|561306286|FG002|Core|Patients completed per protocol|0|||
155513494|NCT01595009|561306287|FG003|Core|Patients completed per protocol|0|||
155513495|NCT01595009|561306284|FG000|Core|Adverse Event|19|||
155513496|NCT01595009|561306285|FG001|Core|Adverse Event|23|||
155513497|NCT01595009|561306286|FG002|Core|Adverse Event|0|||
155513498|NCT01595009|561306287|FG003|Core|Adverse Event|0|||
155513499|NCT01595009|561306284|FG000|Core|Disease progression|14|||
155513500|NCT01595009|561306285|FG001|Core|Disease progression|26|||
155513501|NCT01595009|561306286|FG002|Core|Disease progression|0|||
155513502|NCT01595009|561306287|FG003|Core|Disease progression|0|||
155513503|NCT01595009|561306284|FG000|Core|Withdrawal by Subject|4|||
155513504|NCT01595009|561306285|FG001|Core|Withdrawal by Subject|17|||
155513505|NCT01595009|561306286|FG002|Core|Withdrawal by Subject|0|||
155513506|NCT01595009|561306287|FG003|Core|Withdrawal by Subject|0|||
155513507|NCT01595009|561306284|FG000|Core|Death|3|||
155513508|NCT01595009|561306285|FG001|Core|Death|6|||
155513509|NCT01595009|561306286|FG002|Core|Death|0|||
155513510|NCT01595009|561306287|FG003|Core|Death|0|||
155513511|NCT01595009|561306284|FG000|Core|Lost to Follow-up|1|||
155513512|NCT01595009|561306285|FG001|Core|Lost to Follow-up|2|||
155513513|NCT01595009|561306286|FG002|Core|Lost to Follow-up|0|||
155513514|NCT01595009|561306287|FG003|Core|Lost to Follow-up|0|||
155513515|NCT01595009|561306284|FG000|Core|Protocol deviation|0|||
155513516|NCT01595009|561306285|FG001|Core|Protocol deviation|1|||
155513517|NCT01595009|561306286|FG002|Core|Protocol deviation|0|||
155513518|NCT01595009|561306287|FG003|Core|Protocol deviation|0|||
155513519|NCT01595009|561306284|FG000|Core|Administrative problems|0|||
155513520|NCT01595009|561306285|FG001|Core|Administrative problems|1|||
155513521|NCT01595009|561306286|FG002|Core|Administrative problems|0|||
155513522|NCT01595009|561306287|FG003|Core|Administrative problems|0|||
155513523|NCT01595009|561306284|FG000|Extension|Administrative problems|0|||
155513524|NCT01595009|561306285|FG001|Extension|Administrative problems|0|||
155513525|NCT01595009|561306286|FG002|Extension|Administrative problems|0|||
155513526|NCT01595009|561306287|FG003|Extension|Administrative problems|1|||
155513527|NCT01595009|561306284|FG000|Extension|Patients completed per protocol|0|||
155513528|NCT01595009|561306285|FG001|Extension|Patients completed per protocol|0|||
155513529|NCT01595009|561306286|FG002|Extension|Patients completed per protocol|0|||
155513530|NCT01595009|561306287|FG003|Extension|Patients completed per protocol|2|||
155513531|NCT01595009|561306284|FG000|Extension|Disease progression|0|||
155513532|NCT01595009|561306285|FG001|Extension|Disease progression|0|||
155513533|NCT01595009|561306286|FG002|Extension|Disease progression|4|||
155513534|NCT01595009|561306287|FG003|Extension|Disease progression|7|||
155513535|NCT01595009|561306284|FG000|Extension|Adverse Event|0|||
155513536|NCT01595009|561306285|FG001|Extension|Adverse Event|0|||
155513537|NCT01595009|561306286|FG002|Extension|Adverse Event|0|||
155513538|NCT01595009|561306287|FG003|Extension|Adverse Event|1|||
155513539|NCT04956666|561306288|FG000|Overall Study|Adverse Event|18|||
155513540|NCT04956666|561306288|FG000|Overall Study|Physician Decision|5|||
155513541|NCT00729859|561306289|FG000|Overall Study|Adverse Event|0|||
155513542|NCT00729859|561306290|FG001|Overall Study|Adverse Event|1|||
155513543|NCT00729859|561306291|FG002|Overall Study|Adverse Event|0|||
155650535|NCT00147537|561812505|FG003|Phase 2|Death|0|||
155650536|NCT00147537|561812506|FG004|Phase 2|Death|0|||
155513544|NCT00729859|561306289|FG000|Overall Study|Withdrawal by Subject|0|||
155513545|NCT00729859|561306290|FG001|Overall Study|Withdrawal by Subject|1|||
155513546|NCT00729859|561306291|FG002|Overall Study|Withdrawal by Subject|0|||
155513547|NCT02623829|561306299|FG000|Overall Study|Lost to Follow-up|1|||
155513548|NCT02623829|561306300|FG001|Overall Study|Lost to Follow-up|1|||
155650537|NCT00147537|561812507|FG005|Phase 2|Death|0|||
155513549|NCT00662025|561306301|FG000|Overall Study|Objective progression or relapse|51|||
155513550|NCT00662025|561306301|FG000|Overall Study|Adverse Event|7|||
155513551|NCT00662025|561306301|FG000|Overall Study|Withdrawal by Subject|1|||
155513552|NCT00662025|561306301|FG000|Overall Study|Results of other clinical study|2|||
155513553|NCT00662025|561306301|FG000|Overall Study|Target lesion cannot be evaluated|1|||
155513554|NCT00662025|561306301|FG000|Overall Study|Domestic circumstances|1|||
155513555|NCT00384033|561306311|FG000|Overall Study|Adverse Event|10|||
155513556|NCT00384033|561306312|FG001|Overall Study|Adverse Event|8|||
155513557|NCT00384033|561306313|FG002|Overall Study|Adverse Event|11|||
155513558|NCT00384033|561306314|FG003|Overall Study|Adverse Event|20|||
155650538|NCT00147537|561812508|FG006|Phase 2|Death|0|||
155513559|NCT00384033|561306311|FG000|Overall Study|Failed to return|1|||
155513560|NCT00384033|561306312|FG001|Overall Study|Failed to return|3|||
155513561|NCT00384033|561306313|FG002|Overall Study|Failed to return|2|||
155513562|NCT00384033|561306314|FG003|Overall Study|Failed to return|2|||
155513563|NCT00384033|561306311|FG000|Overall Study|Physician Decision|1|||
155513564|NCT00384033|561306312|FG001|Overall Study|Physician Decision|0|||
155513565|NCT00384033|561306313|FG002|Overall Study|Physician Decision|0|||
155513566|NCT00384033|561306314|FG003|Overall Study|Physician Decision|0|||
155513567|NCT00384033|561306311|FG000|Overall Study|Lost to Follow-up|6|||
155513568|NCT00384033|561306312|FG001|Overall Study|Lost to Follow-up|12|||
155650539|NCT00147537|561812509|FG007|Phase 2|Death|0|||
155513569|NCT00384033|561306313|FG002|Overall Study|Lost to Follow-up|7|||
155513570|NCT00384033|561306314|FG003|Overall Study|Lost to Follow-up|7|||
155513571|NCT00384033|561306311|FG000|Overall Study|Other|2|||
155513572|NCT00384033|561306312|FG001|Overall Study|Other|0|||
155513573|NCT00384033|561306313|FG002|Overall Study|Other|0|||
155650540|NCT00147537|561812510|FG008|Phase 2|Death|0|||
155513574|NCT00384033|561306314|FG003|Overall Study|Other|0|||
155513575|NCT00384033|561306311|FG000|Overall Study|Protocol Violation|5|||
155513576|NCT00384033|561306312|FG001|Overall Study|Protocol Violation|0|||
155513577|NCT00384033|561306313|FG002|Overall Study|Protocol Violation|5|||
155513578|NCT00384033|561306314|FG003|Overall Study|Protocol Violation|6|||
155513579|NCT00384033|561306311|FG000|Overall Study|Withdrawal by Subject|6|||
155513580|NCT00384033|561306312|FG001|Overall Study|Withdrawal by Subject|2|||
155513581|NCT00384033|561306313|FG002|Overall Study|Withdrawal by Subject|5|||
155513582|NCT00384033|561306314|FG003|Overall Study|Withdrawal by Subject|2|||
155513583|NCT00384033|561306311|FG000|Overall Study|Lack of Efficacy|7|||
155513584|NCT00384033|561306312|FG001|Overall Study|Lack of Efficacy|3|||
155513585|NCT00384033|561306313|FG002|Overall Study|Lack of Efficacy|3|||
155513586|NCT00384033|561306314|FG003|Overall Study|Lack of Efficacy|1|||
155513587|NCT00384033|561306311|FG000|Overall Study|Randomized but not treated|3|||
155513588|NCT00384033|561306312|FG001|Overall Study|Randomized but not treated|7|||
155513589|NCT00384033|561306313|FG002|Overall Study|Randomized but not treated|10|||
155513590|NCT00384033|561306314|FG003|Overall Study|Randomized but not treated|2|||
155513591|NCT02162758|561306318|FG000|Overall Study|Study termination|0|||
155513592|NCT02162758|561306319|FG001|Overall Study|Study termination|1|||
155513593|NCT01166568|561306325|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
155513594|NCT01166568|561306326|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
155513595|NCT01166568|561306327|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
155513596|NCT01166568|561306325|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
155513597|NCT01166568|561306326|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
155513598|NCT01166568|561306327|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
155513599|NCT01166568|561306325|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
155513600|NCT01166568|561306326|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
155513601|NCT01166568|561306327|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
155513602|NCT01716754|561306328|FG000|Overall Study|Death|0|||
155513603|NCT01716754|561306329|FG001|Overall Study|Death|0|||
155513604|NCT01716754|561306330|FG002|Overall Study|Death|0|||
155513605|NCT01716754|561306331|FG003|Overall Study|Death|1|||
155513606|NCT01716754|561306328|FG000|Overall Study|Protocol deviation|0|||
155513607|NCT01716754|561306329|FG001|Overall Study|Protocol deviation|2|||
155513608|NCT01716754|561306330|FG002|Overall Study|Protocol deviation|7|||
155513609|NCT01716754|561306331|FG003|Overall Study|Protocol deviation|2|||
155513610|NCT01716754|561306328|FG000|Overall Study|Non-compliance with study treatment|0|||
155513611|NCT01716754|561306329|FG001|Overall Study|Non-compliance with study treatment|0|||
155513612|NCT01716754|561306330|FG002|Overall Study|Non-compliance with study treatment|1|||
155513613|NCT01716754|561306331|FG003|Overall Study|Non-compliance with study treatment|0|||
155513614|NCT01716754|561306328|FG000|Overall Study|Physician Decision|1|||
155513615|NCT01716754|561306329|FG001|Overall Study|Physician Decision|0|||
155513616|NCT01716754|561306330|FG002|Overall Study|Physician Decision|0|||
155513617|NCT01716754|561306331|FG003|Overall Study|Physician Decision|0|||
155513618|NCT01716754|561306328|FG000|Overall Study|Lost to Follow-up|1|||
155513619|NCT01716754|561306329|FG001|Overall Study|Lost to Follow-up|0|||
155513620|NCT01716754|561306330|FG002|Overall Study|Lost to Follow-up|0|||
155513621|NCT01716754|561306331|FG003|Overall Study|Lost to Follow-up|1|||
155513622|NCT01716754|561306328|FG000|Overall Study|Adverse Event|4|||
155513623|NCT01716754|561306329|FG001|Overall Study|Adverse Event|2|||
155513624|NCT01716754|561306330|FG002|Overall Study|Adverse Event|2|||
155513625|NCT01716754|561306331|FG003|Overall Study|Adverse Event|1|||
155513626|NCT01716754|561306328|FG000|Overall Study|Withdrawal by Subject|5|||
155513627|NCT01716754|561306329|FG001|Overall Study|Withdrawal by Subject|0|||
155513628|NCT01716754|561306330|FG002|Overall Study|Withdrawal by Subject|4|||
155513629|NCT01716754|561306331|FG003|Overall Study|Withdrawal by Subject|3|||
155513630|NCT02110706|561306349|FG000|Overall Study|Adverse Event|2|||
155513631|NCT02110706|561306350|FG001|Overall Study|Adverse Event|3|||
155513632|NCT02110706|561306349|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
155513633|NCT02110706|561306350|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
155513634|NCT01348542|561306356|FG000|Overall Study|Withdrawal by Subject|3|||
155513635|NCT01348542|561306357|FG001|Overall Study|Withdrawal by Subject|0|||
155513636|NCT01789320|561306364|FG000|Overall Study|Re-enrolled into study|1|||
155513637|NCT01789320|561306364|FG000|Overall Study|Lost to Follow-up|1|||
155513638|NCT00656019|561306369|FG000|Overall Study|Not Eligible|10|||
155513639|NCT00656019|561306370|FG001|Overall Study|Not Eligible|0|||
155513640|NCT00656019|561306371|FG002|Overall Study|Not Eligible|0|||
155513641|NCT00656019|561306372|FG003|Overall Study|Not Eligible|0|||
155513642|NCT00656019|561306369|FG000|Overall Study|Withdrawal by Subject|2|||
155513643|NCT00656019|561306370|FG001|Overall Study|Withdrawal by Subject|0|||
155513644|NCT00656019|561306371|FG002|Overall Study|Withdrawal by Subject|0|||
155513645|NCT00656019|561306372|FG003|Overall Study|Withdrawal by Subject|0|||
155650541|NCT00147537|561812511|FG009|Phase 2|Death|85|||
155513646|NCT00656019|561306369|FG000|Overall Study|Lost to Follow-up|2|||
155513647|NCT00656019|561306370|FG001|Overall Study|Lost to Follow-up|1|||
155513648|NCT00656019|561306371|FG002|Overall Study|Lost to Follow-up|0|||
155650542|NCT00147537|561812512|FG010|Phase 2|Death|31|||
155513649|NCT00656019|561306372|FG003|Overall Study|Lost to Follow-up|0|||
155513650|NCT01309919|561306383|FG000|Overall Study|Did not receive a postpartum IUD|17|||
155513651|NCT01309919|561306384|FG001|Overall Study|Did not receive a postpartum IUD|48|||
155513652|NCT03896490|561306385|FG000|Overall Study|Withdrawal by Subject|1|||
155513653|NCT03896490|561306386|FG001|Overall Study|Withdrawal by Subject|1|||
155513654|NCT03329027|561308106|FG000|Overall Study|Lost to Follow-up|1|||
155650543|NCT00147537|561812502|FG000|Phase 2|Lost to Follow-up|0|||
155513655|NCT03329027|561308107|FG001|Overall Study|Lost to Follow-up|0|||
155513656|NCT03329027|561308108|FG002|Overall Study|Lost to Follow-up|1|||
155513657|NCT03329027|561308106|FG000|Overall Study|Protocol Violation|9|||
155513658|NCT03329027|561308107|FG001|Overall Study|Protocol Violation|5|||
155513659|NCT03329027|561308108|FG002|Overall Study|Protocol Violation|7|||
155513660|NCT02761980|561308109|FG000|Overall Study|Adverse Event|4|||
155513661|NCT02761980|561308110|FG001|Overall Study|Adverse Event|6|||
155513662|NCT02761980|561308111|FG002|Overall Study|Adverse Event|5|||
155513663|NCT02761980|561308112|FG003|Overall Study|Adverse Event|6|||
155513664|NCT02761980|561308109|FG000|Overall Study|Withdrawal by Subject|0|||
155513665|NCT02761980|561308110|FG001|Overall Study|Withdrawal by Subject|1|||
155513666|NCT02761980|561308111|FG002|Overall Study|Withdrawal by Subject|0|||
155513667|NCT02761980|561308112|FG003|Overall Study|Withdrawal by Subject|0|||
155513668|NCT02761980|561308109|FG000|Overall Study|Other|0|||
155513669|NCT02761980|561308110|FG001|Overall Study|Other|0|||
155513670|NCT02761980|561308111|FG002|Overall Study|Other|1|||
155513671|NCT02761980|561308112|FG003|Overall Study|Other|0|||
155513672|NCT00101582|561308119|FG000|Overall Study|Ineligibility determined|0|||
155513673|NCT00101582|561308120|FG001|Overall Study|Ineligibility determined|1|||
155513674|NCT00101582|561308119|FG000|Overall Study|Adverse Event|1|||
155513675|NCT00101582|561308120|FG001|Overall Study|Adverse Event|4|||
155513676|NCT00101582|561308119|FG000|Overall Study|Withdrawal by Subject|6|||
155513677|NCT00101582|561308120|FG001|Overall Study|Withdrawal by Subject|4|||
155513678|NCT00101582|561308119|FG000|Overall Study|Physician Decision|1|||
155513679|NCT00101582|561308120|FG001|Overall Study|Physician Decision|0|||
155513680|NCT00101582|561308119|FG000|Overall Study|Death|3|||
155513681|NCT00101582|561308120|FG001|Overall Study|Death|5|||
155513682|NCT00101582|561308119|FG000|Overall Study|Other|0|||
155513683|NCT00101582|561308120|FG001|Overall Study|Other|1|||
155513684|NCT01907087|561308121|FG000|Overall Study|Withdrawal by Subject|1|||
155513685|NCT01919190|561308123|FG000|Overall Study|Intra-op findings, etc.|3|||
155513686|NCT01919190|561308124|FG001|Overall Study|Intra-op findings, etc.|0|||
155513687|NCT01767597|561308125|FG000|Overall Study|Incomplete intervention|3|||
155513688|NCT01767597|561308126|FG001|Overall Study|Incomplete intervention|1|||
155513689|NCT01767597|561308125|FG000|Overall Study|Withdrawal by Subject|1|||
155513690|NCT01767597|561308126|FG001|Overall Study|Withdrawal by Subject|0|||
155513691|NCT03355742|561308127|FG000|Overall Study|Lost to Follow-up|4|||
155513692|NCT03355742|561308127|FG000|Overall Study|Withdrawal by Subject|29|||
155513693|NCT03355742|561308127|FG000|Overall Study|Physician Decision|6|||
155513694|NCT03355742|561308127|FG000|Overall Study|Death|55|||
155513695|NCT03355742|561308127|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
155513696|NCT04820842|561308130|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155513697|NCT04820842|561308131|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
155513698|NCT04820842|561308132|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
155513699|NCT04820842|561308133|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155513700|NCT04820842|561308134|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155513701|NCT04820842|561308135|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155513702|NCT04820842|561308136|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155513703|NCT04820842|561308130|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
155513704|NCT04820842|561308131|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
155513705|NCT04820842|561308132|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
155513706|NCT04820842|561308133|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513707|NCT04820842|561308134|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513708|NCT04820842|561308135|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513709|NCT04820842|561308136|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513710|NCT04820842|561308130|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155513711|NCT04820842|561308131|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
155513712|NCT04820842|561308132|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155513713|NCT04820842|561308133|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155513714|NCT04820842|561308134|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155513715|NCT04820842|561308135|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155650544|NCT00147537|561812503|FG001|Phase 2|Lost to Follow-up|0|||
155513716|NCT04820842|561308136|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155513717|NCT04820842|561308130|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513718|NCT04820842|561308131|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513719|NCT04820842|561308132|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513720|NCT04820842|561308133|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
155513721|NCT04820842|561308134|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513722|NCT04820842|561308135|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
155513723|NCT04820842|561308136|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
155513724|NCT01691508|561308137|FG000|Overall Study|Adverse Event|3|||
155513725|NCT01691508|561308138|FG001|Overall Study|Adverse Event|3|||
155513726|NCT01691508|561308137|FG000|Overall Study|Withdrawal by Subject|1|||
155513727|NCT01691508|561308138|FG001|Overall Study|Withdrawal by Subject|0|||
155513728|NCT01296932|561308139|FG000|Overall Study|Dose limiting toxicity|0|||
155513729|NCT01296932|561308140|FG001|Overall Study|Dose limiting toxicity|0|||
155513730|NCT01296932|561308141|FG002|Overall Study|Dose limiting toxicity|0|||
155513731|NCT01296932|561308142|FG003|Overall Study|Dose limiting toxicity|0|||
155513732|NCT01296932|561308143|FG004|Overall Study|Dose limiting toxicity|0|||
155513733|NCT01296932|561308144|FG005|Overall Study|Dose limiting toxicity|0|||
155513734|NCT01296932|561308145|FG006|Overall Study|Dose limiting toxicity|1|||
155513735|NCT01296932|561308146|FG007|Overall Study|Dose limiting toxicity|0|||
155513736|NCT01296932|561308147|FG008|Overall Study|Dose limiting toxicity|1|||
155513737|NCT01296932|561308139|FG000|Overall Study|Progressive disease|2|||
155513738|NCT01296932|561308140|FG001|Overall Study|Progressive disease|0|||
155513739|NCT01296932|561308141|FG002|Overall Study|Progressive disease|1|||
155513740|NCT01296932|561308142|FG003|Overall Study|Progressive disease|1|||
155513741|NCT01296932|561308143|FG004|Overall Study|Progressive disease|2|||
155513742|NCT01296932|561308144|FG005|Overall Study|Progressive disease|3|||
155513743|NCT01296932|561308145|FG006|Overall Study|Progressive disease|1|||
155513744|NCT01296932|561308146|FG007|Overall Study|Progressive disease|0|||
155513745|NCT01296932|561308147|FG008|Overall Study|Progressive disease|0|||
155513746|NCT01296932|561308139|FG000|Overall Study|Withdrawal by Subject|0|||
155513747|NCT01296932|561308140|FG001|Overall Study|Withdrawal by Subject|0|||
155513748|NCT01296932|561308141|FG002|Overall Study|Withdrawal by Subject|1|||
155513749|NCT01296932|561308142|FG003|Overall Study|Withdrawal by Subject|1|||
155513750|NCT01296932|561308143|FG004|Overall Study|Withdrawal by Subject|0|||
155513751|NCT01296932|561308144|FG005|Overall Study|Withdrawal by Subject|0|||
155513752|NCT01296932|561308145|FG006|Overall Study|Withdrawal by Subject|3|||
155513753|NCT01296932|561308146|FG007|Overall Study|Withdrawal by Subject|0|||
155513754|NCT01296932|561308147|FG008|Overall Study|Withdrawal by Subject|0|||
155513755|NCT01296932|561308139|FG000|Overall Study|Adverse Event|1|||
155513756|NCT01296932|561308140|FG001|Overall Study|Adverse Event|1|||
155513757|NCT01296932|561308141|FG002|Overall Study|Adverse Event|1|||
155513758|NCT01296932|561308142|FG003|Overall Study|Adverse Event|2|||
155513759|NCT01296932|561308143|FG004|Overall Study|Adverse Event|1|||
155513760|NCT01296932|561308144|FG005|Overall Study|Adverse Event|0|||
155513761|NCT01296932|561308145|FG006|Overall Study|Adverse Event|0|||
155513762|NCT01296932|561308146|FG007|Overall Study|Adverse Event|0|||
155513763|NCT01296932|561308147|FG008|Overall Study|Adverse Event|1|||
155513764|NCT01296932|561308139|FG000|Overall Study|Investigator decision|0|||
155513765|NCT01296932|561308140|FG001|Overall Study|Investigator decision|1|||
155513766|NCT01296932|561308141|FG002|Overall Study|Investigator decision|0|||
155513767|NCT01296932|561308142|FG003|Overall Study|Investigator decision|1|||
155513768|NCT01296932|561308143|FG004|Overall Study|Investigator decision|0|||
155513769|NCT01296932|561308144|FG005|Overall Study|Investigator decision|0|||
155513770|NCT01296932|561308145|FG006|Overall Study|Investigator decision|1|||
155513771|NCT01296932|561308146|FG007|Overall Study|Investigator decision|0|||
155513772|NCT01296932|561308147|FG008|Overall Study|Investigator decision|1|||
155513773|NCT01296932|561308139|FG000|Overall Study|No clinical benefit anymore|0|||
155513774|NCT01296932|561308140|FG001|Overall Study|No clinical benefit anymore|1|||
155513775|NCT01296932|561308141|FG002|Overall Study|No clinical benefit anymore|0|||
155513776|NCT01296932|561308142|FG003|Overall Study|No clinical benefit anymore|0|||
155513777|NCT01296932|561308143|FG004|Overall Study|No clinical benefit anymore|0|||
155513778|NCT01296932|561308144|FG005|Overall Study|No clinical benefit anymore|0|||
155513779|NCT01296932|561308145|FG006|Overall Study|No clinical benefit anymore|0|||
155513780|NCT01296932|561308146|FG007|Overall Study|No clinical benefit anymore|0|||
155513781|NCT01296932|561308147|FG008|Overall Study|No clinical benefit anymore|0|||
155513782|NCT01296932|561308139|FG000|Overall Study|Physician Decision|0|||
155513783|NCT01296932|561308140|FG001|Overall Study|Physician Decision|0|||
155513784|NCT01296932|561308141|FG002|Overall Study|Physician Decision|1|||
155513785|NCT01296932|561308142|FG003|Overall Study|Physician Decision|0|||
155513786|NCT01296932|561308143|FG004|Overall Study|Physician Decision|0|||
155513787|NCT01296932|561308144|FG005|Overall Study|Physician Decision|0|||
155513788|NCT01296932|561308145|FG006|Overall Study|Physician Decision|0|||
155513789|NCT01296932|561308146|FG007|Overall Study|Physician Decision|0|||
155513790|NCT01296932|561308147|FG008|Overall Study|Physician Decision|0|||
155513791|NCT01296932|561308139|FG000|Overall Study|IV problems, administration not possible|0|||
155513792|NCT01296932|561308140|FG001|Overall Study|IV problems, administration not possible|0|||
155513793|NCT01296932|561308141|FG002|Overall Study|IV problems, administration not possible|1|||
155513794|NCT01296932|561308142|FG003|Overall Study|IV problems, administration not possible|0|||
155513795|NCT01296932|561308143|FG004|Overall Study|IV problems, administration not possible|0|||
155513796|NCT01296932|561308144|FG005|Overall Study|IV problems, administration not possible|0|||
155513797|NCT01296932|561308145|FG006|Overall Study|IV problems, administration not possible|0|||
155513798|NCT01296932|561308146|FG007|Overall Study|IV problems, administration not possible|0|||
155513799|NCT01296932|561308147|FG008|Overall Study|IV problems, administration not possible|0|||
155513800|NCT01296932|561308139|FG000|Overall Study|per protocol|0|||
155513801|NCT01296932|561308140|FG001|Overall Study|per protocol|0|||
155513802|NCT01296932|561308141|FG002|Overall Study|per protocol|1|||
155513803|NCT01296932|561308142|FG003|Overall Study|per protocol|1|||
155513804|NCT01296932|561308143|FG004|Overall Study|per protocol|0|||
155513805|NCT01296932|561308144|FG005|Overall Study|per protocol|0|||
155513806|NCT01296932|561308145|FG006|Overall Study|per protocol|0|||
155513807|NCT01296932|561308146|FG007|Overall Study|per protocol|0|||
155513808|NCT01296932|561308147|FG008|Overall Study|per protocol|0|||
155513809|NCT01296932|561308139|FG000|Overall Study|Low benefit and too many side effects|0|||
155513810|NCT01296932|561308140|FG001|Overall Study|Low benefit and too many side effects|0|||
155513811|NCT01296932|561308141|FG002|Overall Study|Low benefit and too many side effects|0|||
155513812|NCT01296932|561308142|FG003|Overall Study|Low benefit and too many side effects|0|||
155513813|NCT01296932|561308143|FG004|Overall Study|Low benefit and too many side effects|0|||
155513814|NCT01296932|561308144|FG005|Overall Study|Low benefit and too many side effects|0|||
155513815|NCT01296932|561308145|FG006|Overall Study|Low benefit and too many side effects|0|||
155513816|NCT01296932|561308146|FG007|Overall Study|Low benefit and too many side effects|1|||
155513817|NCT01296932|561308147|FG008|Overall Study|Low benefit and too many side effects|0|||
155513818|NCT01296932|561308139|FG000|Overall Study|No adequate treatment response|0|||
155513819|NCT01296932|561308140|FG001|Overall Study|No adequate treatment response|0|||
155513820|NCT01296932|561308141|FG002|Overall Study|No adequate treatment response|0|||
155513821|NCT01296932|561308142|FG003|Overall Study|No adequate treatment response|0|||
155513822|NCT01296932|561308143|FG004|Overall Study|No adequate treatment response|0|||
155513823|NCT01296932|561308144|FG005|Overall Study|No adequate treatment response|0|||
155513824|NCT01296932|561308145|FG006|Overall Study|No adequate treatment response|0|||
155513825|NCT01296932|561308146|FG007|Overall Study|No adequate treatment response|1|||
155513826|NCT01296932|561308147|FG008|Overall Study|No adequate treatment response|0|||
155513827|NCT01296932|561308139|FG000|Overall Study|Dosage already reduced, AE still present|0|||
155513828|NCT01296932|561308140|FG001|Overall Study|Dosage already reduced, AE still present|0|||
155513829|NCT01296932|561308141|FG002|Overall Study|Dosage already reduced, AE still present|0|||
155513830|NCT01296932|561308142|FG003|Overall Study|Dosage already reduced, AE still present|0|||
155513831|NCT01296932|561308143|FG004|Overall Study|Dosage already reduced, AE still present|0|||
155513832|NCT01296932|561308144|FG005|Overall Study|Dosage already reduced, AE still present|0|||
155513833|NCT01296932|561308145|FG006|Overall Study|Dosage already reduced, AE still present|0|||
155513834|NCT01296932|561308146|FG007|Overall Study|Dosage already reduced, AE still present|0|||
155513835|NCT01296932|561308147|FG008|Overall Study|Dosage already reduced, AE still present|1|||
155513836|NCT03093454|561308150|FG000|Overall Study|Withdrawal by Subject|1|||
155513837|NCT03093454|561308151|FG001|Overall Study|Withdrawal by Subject|1|||
155513838|NCT03093454|561308150|FG000|Overall Study|Scheduling conflict|3|||
155435765|NCT03519178|561022930|FG004|Long-term Follow-up|Global deterioration of health status|0|||
155435766|NCT03519178|561022931|FG005|Long-term Follow-up|Global deterioration of health status|0|||
155435767|NCT03519178|561022932|FG006|Long-term Follow-up|Global deterioration of health status|0|||
155435768|NCT03519178|561022933|FG007|Long-term Follow-up|Global deterioration of health status|0|||
155435769|NCT03519178|561022934|FG008|Long-term Follow-up|Global deterioration of health status|0|||
155435770|NCT03519178|561022935|FG009|Long-term Follow-up|Global deterioration of health status|0|||
155435771|NCT03519178|561022936|FG010|Long-term Follow-up|Global deterioration of health status|0|||
155435772|NCT03519178|561022937|FG011|Long-term Follow-up|Global deterioration of health status|0|||
155435773|NCT03519178|561022938|FG012|Long-term Follow-up|Global deterioration of health status|0|||
155435774|NCT03519178|561022939|FG013|Long-term Follow-up|Global deterioration of health status|1|||
155435775|NCT03519178|561022940|FG014|Long-term Follow-up|Global deterioration of health status|0|||
155435776|NCT03256539|561022943|FG000|Overall Study|Withdrawal by Subject|0|||
155435777|NCT03256539|561022944|FG001|Overall Study|Withdrawal by Subject|3|||
155435778|NCT03256539|561022943|FG000|Overall Study|Unexpected closure of study components|8|||
155435779|NCT03256539|561022944|FG001|Overall Study|Unexpected closure of study components|4|||
155435780|NCT05755438|561022947|FG000|12-week DBVC Period|Adverse Event|4|||
155435781|NCT05755438|561022948|FG001|12-week DBVC Period|Adverse Event|1|||
155435782|NCT05755438|561022947|FG000|12-week DBVC Period|Physician Decision|1|||
155435783|NCT05755438|561022948|FG001|12-week DBVC Period|Physician Decision|1|||
155435784|NCT05755438|561022947|FG000|12-week DBVC Period|Protocol Violation|4|||
155435785|NCT05755438|561022948|FG001|12-week DBVC Period|Protocol Violation|2|||
155435786|NCT05755438|561022947|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
155435787|NCT05755438|561022948|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
155435788|NCT05755438|561022947|FG000|12-week DBVC Period|Sponsor Decision|1|||
155435789|NCT05755438|561022948|FG001|12-week DBVC Period|Sponsor Decision|0|||
155435790|NCT05755438|561022947|FG000|40-week OLE Period|Adverse Event|0|||
155435791|NCT05755438|561022948|FG001|40-week OLE Period|Adverse Event|2|||
155435792|NCT05755438|561022947|FG000|40-week OLE Period|Lack of Efficacy|1|||
155435793|NCT05755438|561022948|FG001|40-week OLE Period|Lack of Efficacy|1|||
155435794|NCT05755438|561022947|FG000|40-week OLE Period|Lost to Follow-up|1|||
155435795|NCT05755438|561022948|FG001|40-week OLE Period|Lost to Follow-up|0|||
155435796|NCT05755438|561022947|FG000|40-week OLE Period|Physician Decision|1|||
155435797|NCT05755438|561022948|FG001|40-week OLE Period|Physician Decision|1|||
155435798|NCT05755438|561022947|FG000|40-week OLE Period|Protocol Violation|1|||
155435799|NCT05755438|561022948|FG001|40-week OLE Period|Protocol Violation|1|||
155435800|NCT05755438|561022947|FG000|40-week OLE Period|Withdrawal by Subject|6|||
155435801|NCT05755438|561022948|FG001|40-week OLE Period|Withdrawal by Subject|6|||
155435802|NCT05755438|561022947|FG000|40-week OLE Period|Sponsor Decision|3|||
155435803|NCT05755438|561022948|FG001|40-week OLE Period|Sponsor Decision|0|||
155435804|NCT05755438|561022947|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
155435805|NCT05755438|561022948|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
155435806|NCT05755438|561022947|FG000|40-week OLE Period|Ongoing|46|||
155435807|NCT05755438|561022948|FG001|40-week OLE Period|Ongoing|58|||
155435808|NCT03914300|561022950|FG000|Overall Study|Adverse Event|1|||
155435809|NCT00624338|561022959|FG000|Overall Study|Adverse Event|14|||
155435810|NCT00624338|561022960|FG001|Overall Study|Adverse Event|14|||
155435811|NCT00624338|561022961|FG002|Overall Study|Adverse Event|18|||
155435812|NCT00624338|561022959|FG000|Overall Study|Lost to Follow-up|1|||
155435813|NCT00624338|561022960|FG001|Overall Study|Lost to Follow-up|0|||
155513839|NCT03093454|561308151|FG001|Overall Study|Scheduling conflict|1|||
155513840|NCT03093454|561308150|FG000|Overall Study|Physician Decision|2|||
155650645|NCT02006654|561812521|FG000|Overall Study|Withdrawal by Subject|14|||
155650646|NCT02006654|561812522|FG001|Overall Study|Withdrawal by Subject|12|||
155650647|NCT02006654|561812521|FG000|Overall Study|Protocol Violation|5|||
155650648|NCT02006654|561812522|FG001|Overall Study|Protocol Violation|8|||
155650649|NCT02006654|561812521|FG000|Overall Study|Lost to Follow-up|1|||
155650650|NCT02006654|561812522|FG001|Overall Study|Lost to Follow-up|0|||
155650651|NCT02006654|561812521|FG000|Overall Study|patient's will|2|||
155650652|NCT02006654|561812522|FG001|Overall Study|patient's will|1|||
155650653|NCT02006654|561812521|FG000|Overall Study|insufficient compliance|1|||
155650654|NCT02006654|561812522|FG001|Overall Study|insufficient compliance|0|||
155650655|NCT02006654|561812521|FG000|Overall Study|worsening cognitive condition|0|||
155650656|NCT02006654|561812522|FG001|Overall Study|worsening cognitive condition|1|||
155650657|NCT02006654|561812521|FG000|Overall Study|faecal incontinence|0|||
155650658|NCT02006654|561812522|FG001|Overall Study|faecal incontinence|1|||
155650659|NCT02006654|561812521|FG000|Overall Study|mood disorder|0|||
155436256|NCT00923091|561024574|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
155436257|NCT00923091|561024575|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
155650660|NCT02006654|561812522|FG001|Overall Study|mood disorder|1|||
155650661|NCT02006654|561812521|FG000|Overall Study|disallowed medication|1|||
155436258|NCT00923091|561024576|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
155436259|NCT00923091|561024577|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
155436260|NCT00923091|561024578|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
155436261|NCT00923091|561024579|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
155436262|NCT00923091|561024580|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
155436263|NCT00923091|561024581|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
155436264|NCT00923091|561024582|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
155436265|NCT00923091|561024583|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
155436266|NCT00923091|561024571|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436267|NCT00923091|561024572|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436268|NCT00923091|561024573|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436269|NCT00923091|561024574|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436270|NCT00923091|561024575|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155514025|NCT01626859|561308228|FG001|Overall Study|Withdrawal by Subject|4|||
155514026|NCT01626859|561308229|FG002|Overall Study|Withdrawal by Subject|2|||
155514027|NCT01620177|561308230|FG000|Overall Study|Failure at Screening Visit|43|||
155514028|NCT01620177|561308230|FG000|Overall Study|Withdrawal by Subject|26|||
155514029|NCT01620177|561308230|FG000|Overall Study|Lost to Follow-up|7|||
155514030|NCT01620177|561308230|FG000|Overall Study|Physician Decision|2|||
155514031|NCT01620177|561308230|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
155514032|NCT00814320|561308235|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
155514033|NCT00814320|561308236|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
155514034|NCT00814320|561308235|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
155514035|NCT00814320|561308236|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
155514036|NCT00814320|561308235|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
155514037|NCT00814320|561308236|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
155514038|NCT00814320|561308235|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
155514039|NCT00814320|561308236|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
155514040|NCT00814320|561308235|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
155514041|NCT00814320|561308236|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
155514042|NCT00814320|561308235|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
155514043|NCT00814320|561308236|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
155514044|NCT00814320|561308235|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
155514045|NCT00814320|561308236|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
155514046|NCT00814320|561308235|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
155514047|NCT00814320|561308236|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
155514048|NCT00814320|561308235|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
155514049|NCT00814320|561308236|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
155650662|NCT02006654|561812522|FG001|Overall Study|disallowed medication|0|||
155514050|NCT00814320|561308235|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
155650663|NCT02006654|561812521|FG000|Overall Study|moving out of state|0|||
155650664|NCT02006654|561812522|FG001|Overall Study|moving out of state|1|||
155650665|NCT01905267|561812525|FG000|Overall Study|Physician Decision|2|||
155650666|NCT01905267|561812526|FG001|Overall Study|Physician Decision|2|||
155650667|NCT02294019|561812527|FG000|Overall Study|Adverse Event|2|||
155650668|NCT02294019|561812527|FG000|Overall Study|Protocol Violation|68|||
155650669|NCT02294019|561812527|FG000|Overall Study|Lost to Follow-up|31|||
155650670|NCT02294019|561812527|FG000|Overall Study|Other|1|||
155650671|NCT02294019|561812527|FG000|Overall Study|Withdrawal by Subject|1|||
155650672|NCT01189227|561812529|FG000|Overall Study|Study terminated due to low accrual|6|||
155650673|NCT01189227|561812530|FG001|Overall Study|Study terminated due to low accrual|3|||
155650674|NCT02991859|561812533|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650675|NCT02991859|561812534|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
155436271|NCT00923091|561024576|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
155436272|NCT00923091|561024577|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436273|NCT00923091|561024578|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436274|NCT00923091|561024579|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436275|NCT00923091|561024580|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436276|NCT00923091|561024581|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436277|NCT00923091|561024582|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436278|NCT00923091|561024583|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
155436279|NCT00923091|561024571|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436280|NCT00923091|561024572|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
155436281|NCT00923091|561024573|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436282|NCT00923091|561024574|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
155436283|NCT00923091|561024575|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436284|NCT00923091|561024576|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
155436285|NCT00923091|561024577|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436286|NCT00923091|561024578|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436287|NCT00923091|561024579|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436288|NCT00923091|561024580|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436289|NCT00923091|561024581|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436290|NCT00923091|561024582|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436291|NCT00923091|561024583|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
155436292|NCT00923091|561024571|FG000|Period III (Single-Blind)|Adverse Event|5|||
155436293|NCT00923091|561024572|FG001|Period III (Single-Blind)|Adverse Event|0|||
155436294|NCT00923091|561024573|FG002|Period III (Single-Blind)|Adverse Event|0|||
155436295|NCT00923091|561024574|FG003|Period III (Single-Blind)|Adverse Event|0|||
155436296|NCT00923091|561024575|FG004|Period III (Single-Blind)|Adverse Event|0|||
155436297|NCT00923091|561024576|FG005|Period III (Single-Blind)|Adverse Event|0|||
155436298|NCT00923091|561024577|FG006|Period III (Single-Blind)|Adverse Event|0|||
155436299|NCT00923091|561024578|FG007|Period III (Single-Blind)|Adverse Event|0|||
155436300|NCT00923091|561024579|FG008|Period III (Single-Blind)|Adverse Event|0|||
155436301|NCT00923091|561024580|FG009|Period III (Single-Blind)|Adverse Event|0|||
155436302|NCT00923091|561024581|FG010|Period III (Single-Blind)|Adverse Event|0|||
155436303|NCT00923091|561024582|FG011|Period III (Single-Blind)|Adverse Event|0|||
155436304|NCT00923091|561024583|FG012|Period III (Single-Blind)|Adverse Event|0|||
155436305|NCT00923091|561024571|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
155436306|NCT00923091|561024572|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436307|NCT00923091|561024573|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436308|NCT00923091|561024574|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436309|NCT00923091|561024575|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436310|NCT00923091|561024576|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436311|NCT00923091|561024577|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436312|NCT00923091|561024578|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436313|NCT00923091|561024579|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436314|NCT00923091|561024580|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436315|NCT00923091|561024581|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436316|NCT00923091|561024582|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436317|NCT00923091|561024583|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
155436318|NCT00923091|561024571|FG000|Period III (Single-Blind)|Protocol Violation|3|||
155650676|NCT02991859|561812535|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155436319|NCT00923091|561024572|FG001|Period III (Single-Blind)|Protocol Violation|0|||
155650677|NCT02991859|561812536|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650678|NCT02991859|561812537|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
155650679|NCT02991859|561812538|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650680|NCT02991859|561812539|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650681|NCT02991859|561812540|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650682|NCT02991859|561812541|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650683|NCT02991859|561812542|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650684|NCT02991859|561812543|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650685|NCT02991859|561812544|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650686|NCT02991859|561812545|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650687|NCT02991859|561812546|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650688|NCT02991859|561812547|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650689|NCT02991859|561812548|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155514051|NCT00814320|561308236|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
155514052|NCT00491504|561308237|FG000|Overall Study|Adverse Event|0|||
155514053|NCT00491504|561308238|FG001|Overall Study|Adverse Event|1|||
155514054|NCT00491504|561308239|FG002|Overall Study|Adverse Event|0|||
155514055|NCT00491504|561308240|FG003|Overall Study|Adverse Event|0|||
155514056|NCT00491504|561308237|FG000|Overall Study|Withdrawal by Subject|0|||
155514057|NCT00491504|561308238|FG001|Overall Study|Withdrawal by Subject|0|||
155514058|NCT00491504|561308239|FG002|Overall Study|Withdrawal by Subject|1|||
155650690|NCT02991859|561812549|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155650691|NCT02991859|561812533|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650692|NCT02991859|561812534|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650693|NCT02991859|561812535|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650694|NCT02991859|561812536|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650695|NCT02991859|561812537|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650696|NCT02991859|561812538|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650697|NCT02991859|561812539|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650698|NCT02991859|561812540|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650699|NCT02991859|561812541|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650700|NCT02991859|561812542|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650701|NCT02991859|561812543|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650702|NCT02991859|561812544|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650703|NCT02991859|561812545|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
155650704|NCT02991859|561812546|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
155650705|NCT02991859|561812547|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650706|NCT02991859|561812548|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650707|NCT02991859|561812549|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155650708|NCT02991859|561812533|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650709|NCT02991859|561812534|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650710|NCT02991859|561812535|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650711|NCT02991859|561812536|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650712|NCT02991859|561812537|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650713|NCT02991859|561812538|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
155650714|NCT02991859|561812539|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650715|NCT02991859|561812540|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650716|NCT02991859|561812541|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650717|NCT02991859|561812542|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650718|NCT02991859|561812543|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650719|NCT02991859|561812544|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650720|NCT02991859|561812545|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650721|NCT02991859|561812546|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650722|NCT02991859|561812547|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650723|NCT02991859|561812548|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650724|NCT02991859|561812549|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155650725|NCT02991859|561812533|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650726|NCT02991859|561812534|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650727|NCT02991859|561812535|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650728|NCT02991859|561812536|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650729|NCT02991859|561812537|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650730|NCT02991859|561812538|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650731|NCT02991859|561812539|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650732|NCT02991859|561812540|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650733|NCT02991859|561812541|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155436320|NCT00923091|561024573|FG002|Period III (Single-Blind)|Protocol Violation|0|||
155436321|NCT00923091|561024574|FG003|Period III (Single-Blind)|Protocol Violation|0|||
155436322|NCT00923091|561024575|FG004|Period III (Single-Blind)|Protocol Violation|0|||
155436323|NCT00923091|561024576|FG005|Period III (Single-Blind)|Protocol Violation|0|||
155436324|NCT00923091|561024577|FG006|Period III (Single-Blind)|Protocol Violation|0|||
155436325|NCT00923091|561024578|FG007|Period III (Single-Blind)|Protocol Violation|0|||
155436326|NCT00923091|561024579|FG008|Period III (Single-Blind)|Protocol Violation|0|||
155436327|NCT00923091|561024580|FG009|Period III (Single-Blind)|Protocol Violation|0|||
155436328|NCT00923091|561024581|FG010|Period III (Single-Blind)|Protocol Violation|0|||
155436329|NCT00923091|561024582|FG011|Period III (Single-Blind)|Protocol Violation|0|||
155436330|NCT00923091|561024583|FG012|Period III (Single-Blind)|Protocol Violation|0|||
155436331|NCT00923091|561024571|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
155436332|NCT00923091|561024572|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
155436333|NCT00923091|561024573|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
155436334|NCT00923091|561024574|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
155650734|NCT02991859|561812542|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
155650735|NCT02991859|561812543|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650736|NCT02991859|561812544|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650737|NCT02991859|561812545|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650738|NCT02991859|561812546|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650739|NCT02991859|561812547|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650740|NCT02991859|561812548|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650741|NCT02991859|561812549|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155650742|NCT02991859|561812533|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650743|NCT02991859|561812534|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650744|NCT02991859|561812535|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650745|NCT02991859|561812536|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650746|NCT02991859|561812537|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650747|NCT02991859|561812538|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650748|NCT02991859|561812539|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650749|NCT02991859|561812540|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650750|NCT02991859|561812541|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
155650751|NCT02991859|561812542|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650752|NCT02991859|561812543|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650753|NCT02991859|561812544|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650754|NCT02991859|561812545|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155514059|NCT00491504|561308240|FG003|Overall Study|Withdrawal by Subject|2|||
155514060|NCT00491504|561308237|FG000|Overall Study|Protocol Violation|0|||
155514061|NCT00491504|561308238|FG001|Overall Study|Protocol Violation|0|||
155514062|NCT00491504|561308239|FG002|Overall Study|Protocol Violation|3|||
155514063|NCT00491504|561308240|FG003|Overall Study|Protocol Violation|2|||
155514064|NCT02789111|561308241|FG000|Overall Study|Withdrawal by Subject|1|||
155514065|NCT02789111|561308242|FG001|Overall Study|Withdrawal by Subject|4|||
155514066|NCT03271528|561308244|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
155514067|NCT03271528|561308245|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
155514068|NCT03271528|561308244|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
155514069|NCT03271528|561308245|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
155436335|NCT00923091|561024575|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
155436336|NCT00923091|561024576|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
155436337|NCT00923091|561024577|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
155436338|NCT00923091|561024578|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
155436339|NCT00923091|561024579|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
155436340|NCT00923091|561024580|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
155436341|NCT00923091|561024581|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
155436342|NCT00923091|561024582|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
155436343|NCT00923091|561024583|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
155436344|NCT00923091|561024571|FG000|Period IV (Double-Blind)|Adverse Event|2|||
155436345|NCT00923091|561024572|FG001|Period IV (Double-Blind)|Adverse Event|0|||
155436346|NCT00923091|561024573|FG002|Period IV (Double-Blind)|Adverse Event|0|||
155436347|NCT00923091|561024574|FG003|Period IV (Double-Blind)|Adverse Event|0|||
155436348|NCT00923091|561024575|FG004|Period IV (Double-Blind)|Adverse Event|0|||
155436349|NCT00923091|561024576|FG005|Period IV (Double-Blind)|Adverse Event|0|||
155436350|NCT00923091|561024577|FG006|Period IV (Double-Blind)|Adverse Event|0|||
155436351|NCT00923091|561024578|FG007|Period IV (Double-Blind)|Adverse Event|0|||
155436352|NCT00923091|561024579|FG008|Period IV (Double-Blind)|Adverse Event|0|||
155436353|NCT00923091|561024580|FG009|Period IV (Double-Blind)|Adverse Event|0|||
155436354|NCT00923091|561024581|FG010|Period IV (Double-Blind)|Adverse Event|0|||
155436355|NCT00923091|561024582|FG011|Period IV (Double-Blind)|Adverse Event|0|||
155436356|NCT00923091|561024583|FG012|Period IV (Double-Blind)|Adverse Event|0|||
155436357|NCT00923091|561024571|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436358|NCT00923091|561024572|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
155436359|NCT00923091|561024573|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436360|NCT00923091|561024574|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436361|NCT00923091|561024575|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436362|NCT00923091|561024576|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436363|NCT00923091|561024577|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436364|NCT00923091|561024578|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436365|NCT00923091|561024579|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436366|NCT00923091|561024580|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436367|NCT00923091|561024581|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155514070|NCT03271528|561308244|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
155436368|NCT00923091|561024582|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436369|NCT00923091|561024583|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
155436370|NCT00923091|561024571|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
155436371|NCT00923091|561024572|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
155650755|NCT02991859|561812546|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650756|NCT02991859|561812547|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650757|NCT02991859|561812548|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650758|NCT02991859|561812549|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155650759|NCT01016015|561812550|FG000|Overall Study|Not Treated|3|||
155650760|NCT01016015|561812550|FG000|Overall Study|Withdrawal by Subject|1|||
155650761|NCT01016015|561812550|FG000|Overall Study|Adverse Event|15|||
155650762|NCT02774278|561812551|FG000|Overall Study|Lack of Efficacy|199|||
155650763|NCT02774278|561812551|FG000|Overall Study|Death|29|||
155650764|NCT02774278|561812551|FG000|Overall Study|Adverse event/intercurrent illness|16|||
155650765|NCT02774278|561812551|FG000|Overall Study|Refused treatment/did not cooperate|9|||
155650766|NCT02774278|561812551|FG000|Overall Study|Administrative reasons|6|||
155650767|NCT02774278|561812551|FG000|Overall Study|Withdrawal by Subject|3|||
155650768|NCT02774278|561812551|FG000|Overall Study|Protocol Violation|2|||
155650769|NCT00930176|561812555|FG000|Overall Study|Death|1|||
155650770|NCT00362609|561812556|FG000|Overall Study|Withdrawal by Subject|0|||
155650771|NCT00362609|561812557|FG001|Overall Study|Withdrawal by Subject|1|||
155650772|NCT00362609|561812556|FG000|Overall Study|Protocol Violation|0|||
155650773|NCT00362609|561812557|FG001|Overall Study|Protocol Violation|1|||
155650774|NCT05330429|561812558|FG000|Overall Study|Study Terminated by Sponsor|4|||
155650775|NCT05330429|561812559|FG001|Overall Study|Study Terminated by Sponsor|33|||
155650776|NCT05330429|561812560|FG002|Overall Study|Study Terminated by Sponsor|12|||
155650777|NCT05330429|561812558|FG000|Overall Study|Death|5|||
155650778|NCT05330429|561812559|FG001|Overall Study|Death|2|||
155650779|NCT05330429|561812560|FG002|Overall Study|Death|4|||
155650780|NCT05330429|561812558|FG000|Overall Study|Withdrew Consent|0|||
155650781|NCT05330429|561812559|FG001|Overall Study|Withdrew Consent|5|||
155650782|NCT05330429|561812560|FG002|Overall Study|Withdrew Consent|4|||
155650783|NCT05330429|561812558|FG000|Overall Study|Investigator's Discretion|0|||
155650784|NCT05330429|561812559|FG001|Overall Study|Investigator's Discretion|1|||
155650785|NCT05330429|561812560|FG002|Overall Study|Investigator's Discretion|3|||
155650786|NCT05330429|561812558|FG000|Overall Study|Subject Decision|1|||
155650787|NCT05330429|561812559|FG001|Overall Study|Subject Decision|2|||
155650788|NCT05330429|561812560|FG002|Overall Study|Subject Decision|0|||
155650789|NCT05330429|561812558|FG000|Overall Study|Lost to Follow-up|0|||
155650790|NCT05330429|561812559|FG001|Overall Study|Lost to Follow-up|1|||
155650791|NCT05330429|561812560|FG002|Overall Study|Lost to Follow-up|0|||
155650792|NCT06097273|561812561|FG000|Overall Study|Death|2|||
155650793|NCT06097273|561812562|FG001|Overall Study|Death|1|||
155650794|NCT06097273|561812563|FG002|Overall Study|Death|2|||
155650795|NCT06097273|561812564|FG003|Overall Study|Death|2|||
155650796|NCT06097273|561812561|FG000|Overall Study|Lost to Follow-up|27|||
155650797|NCT06097273|561812562|FG001|Overall Study|Lost to Follow-up|18|||
155650798|NCT06097273|561812563|FG002|Overall Study|Lost to Follow-up|36|||
155650799|NCT06097273|561812564|FG003|Overall Study|Lost to Follow-up|31|||
155650800|NCT06097273|561812561|FG000|Overall Study|Physician Decision|0|||
155650801|NCT06097273|561812562|FG001|Overall Study|Physician Decision|1|||
155650802|NCT06097273|561812563|FG002|Overall Study|Physician Decision|0|||
155650803|NCT06097273|561812564|FG003|Overall Study|Physician Decision|3|||
155650804|NCT06097273|561812561|FG000|Overall Study|Protocol Violation|1|||
155650805|NCT06097273|561812562|FG001|Overall Study|Protocol Violation|1|||
155650806|NCT06097273|561812563|FG002|Overall Study|Protocol Violation|2|||
155650807|NCT06097273|561812564|FG003|Overall Study|Protocol Violation|1|||
155650808|NCT06097273|561812561|FG000|Overall Study|Withdrawal by Subject|14|||
155650809|NCT06097273|561812562|FG001|Overall Study|Withdrawal by Subject|11|||
155650810|NCT06097273|561812563|FG002|Overall Study|Withdrawal by Subject|14|||
155650811|NCT06097273|561812564|FG003|Overall Study|Withdrawal by Subject|15|||
155650812|NCT06097273|561812561|FG000|Overall Study|Other Than Specified|7|||
155650813|NCT06097273|561812562|FG001|Overall Study|Other Than Specified|3|||
155650814|NCT06097273|561812563|FG002|Overall Study|Other Than Specified|11|||
155650815|NCT06097273|561812564|FG003|Overall Study|Other Than Specified|6|||
155650816|NCT01251965|561814473|FG000|Overall Study|Participant/physician decision|1|||
155650817|NCT01251965|561814474|FG001|Overall Study|Participant/physician decision|2|||
155650818|NCT01251965|561814475|FG002|Overall Study|Participant/physician decision|0|||
155650819|NCT01251965|561814473|FG000|Overall Study|Death|0|||
155650820|NCT01251965|561814474|FG001|Overall Study|Death|0|||
155650821|NCT01251965|561814475|FG002|Overall Study|Death|11|||
155650822|NCT01027754|561814476|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
155650823|NCT01027754|561814477|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
155650824|NCT01027754|561814476|FG000|Overall Study|Withdrawal by Subject|0|||
155650825|NCT01027754|561814477|FG001|Overall Study|Withdrawal by Subject|5|||
155650826|NCT02529488|561814478|FG000|Overall Study|Adverse Event|1|||
155650827|NCT02529488|561814478|FG000|Overall Study|Death|3|||
155650828|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
155650829|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155650830|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155650831|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155650832|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155650833|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
155650834|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155650835|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
155650836|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155650837|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
155650838|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155650839|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155650840|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155650841|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155436372|NCT00923091|561024573|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
155436373|NCT00923091|561024574|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
155436374|NCT00923091|561024575|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
155436375|NCT00923091|561024576|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
155436376|NCT00923091|561024577|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
155436377|NCT00923091|561024578|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
155436378|NCT00923091|561024579|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
155436379|NCT00923091|561024580|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
155436380|NCT00923091|561024581|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
155436381|NCT00923091|561024582|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
155436382|NCT00923091|561024583|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
155436383|NCT00923091|561024571|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436384|NCT00923091|561024572|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436385|NCT00923091|561024573|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
155650842|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
155650843|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650844|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650845|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650846|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650847|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650848|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155650849|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
155650850|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155650851|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155650852|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155650853|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155650854|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
155650855|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155650856|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650857|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
155650858|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650859|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650860|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650861|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650862|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155650863|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155650864|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155650865|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155650866|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155650867|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155650868|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
155650869|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
155650870|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155650871|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155650872|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155650873|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155650874|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155650875|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155650876|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155650877|NCT01557244|561814479|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
155650878|NCT01557244|561814480|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155650879|NCT01557244|561814481|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
155650880|NCT01557244|561814482|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155650881|NCT01557244|561814483|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155650882|NCT01557244|561814484|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155650883|NCT01557244|561814485|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155650884|NCT01557244|561814479|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155650885|NCT01557244|561814480|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155650886|NCT01557244|561814481|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155650887|NCT01557244|561814482|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155650888|NCT01557244|561814483|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155650889|NCT01557244|561814484|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155650890|NCT01557244|561814485|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155650891|NCT01557244|561814479|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
155650892|NCT01557244|561814480|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
155650893|NCT01557244|561814481|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155650894|NCT01557244|561814482|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155650895|NCT01557244|561814483|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155650896|NCT01557244|561814484|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155650897|NCT01557244|561814485|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155650898|NCT01557244|561814479|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155650899|NCT01557244|561814480|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155650900|NCT01557244|561814481|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155436386|NCT00923091|561024574|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436387|NCT00923091|561024575|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436388|NCT00923091|561024576|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436389|NCT00923091|561024577|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436390|NCT00923091|561024578|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436391|NCT00923091|561024579|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
155436392|NCT00923091|561024580|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436393|NCT00923091|561024581|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436394|NCT00923091|561024582|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
155436395|NCT00923091|561024583|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
155436396|NCT00923091|561024571|FG000|Period V (Double -Blind)|Protocol Violation|0|||
155436397|NCT00923091|561024572|FG001|Period V (Double -Blind)|Protocol Violation|0|||
155436398|NCT00923091|561024573|FG002|Period V (Double -Blind)|Protocol Violation|0|||
155436399|NCT00923091|561024574|FG003|Period V (Double -Blind)|Protocol Violation|0|||
155436400|NCT00923091|561024575|FG004|Period V (Double -Blind)|Protocol Violation|0|||
155436401|NCT00923091|561024576|FG005|Period V (Double -Blind)|Protocol Violation|0|||
155436402|NCT00923091|561024577|FG006|Period V (Double -Blind)|Protocol Violation|0|||
155436403|NCT00923091|561024578|FG007|Period V (Double -Blind)|Protocol Violation|0|||
155436404|NCT00923091|561024579|FG008|Period V (Double -Blind)|Protocol Violation|0|||
155436405|NCT00923091|561024580|FG009|Period V (Double -Blind)|Protocol Violation|0|||
155436406|NCT00923091|561024581|FG010|Period V (Double -Blind)|Protocol Violation|0|||
155436407|NCT00923091|561024582|FG011|Period V (Double -Blind)|Protocol Violation|0|||
155436408|NCT00923091|561024583|FG012|Period V (Double -Blind)|Protocol Violation|1|||
155436409|NCT00923091|561024571|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
155436410|NCT00923091|561024572|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
155436411|NCT00923091|561024573|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
155436412|NCT00923091|561024574|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
155514071|NCT03271528|561308245|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
155514072|NCT03271528|561308244|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
155514073|NCT03271528|561308245|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
155514074|NCT03271528|561308244|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
155514075|NCT03271528|561308245|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
155514076|NCT03271528|561308244|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
155514077|NCT03271528|561308245|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
155514078|NCT03271528|561308244|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
155514079|NCT03271528|561308245|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
155514080|NCT01618305|561308247|FG000|Overall Study|Death|0|||
155650901|NCT01557244|561814482|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
155650902|NCT01557244|561814483|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155650903|NCT01557244|561814484|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155650904|NCT01557244|561814485|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155650905|NCT01557244|561814479|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
155650906|NCT01557244|561814480|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
155650907|NCT01557244|561814481|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155650908|NCT01557244|561814482|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155650909|NCT01557244|561814483|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155650910|NCT01557244|561814484|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155650911|NCT01557244|561814485|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155650912|NCT01313676|561814486|FG000|Overall Study|Adverse Event|395|||
155650913|NCT01313676|561814487|FG001|Overall Study|Adverse Event|365|||
155650914|NCT01313676|561814488|FG002|Overall Study|Adverse Event|372|||
155650915|NCT01313676|561814489|FG003|Overall Study|Adverse Event|333|||
155650916|NCT01313676|561814486|FG000|Overall Study|Lack of Efficacy|98|||
155650917|NCT01313676|561814487|FG001|Overall Study|Lack of Efficacy|90|||
155650918|NCT01313676|561814488|FG002|Overall Study|Lack of Efficacy|65|||
155650919|NCT01313676|561814489|FG003|Overall Study|Lack of Efficacy|46|||
155650920|NCT01313676|561814486|FG000|Overall Study|Protocol Violation|37|||
155650921|NCT01313676|561814487|FG001|Overall Study|Protocol Violation|44|||
155650922|NCT01313676|561814488|FG002|Overall Study|Protocol Violation|46|||
155650923|NCT01313676|561814489|FG003|Overall Study|Protocol Violation|44|||
155650924|NCT01313676|561814486|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
155650925|NCT01313676|561814487|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
155650926|NCT01313676|561814488|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
155650927|NCT01313676|561814489|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
155650928|NCT01313676|561814486|FG000|Overall Study|Study Closed/terminated|7|||
155650929|NCT01313676|561814487|FG001|Overall Study|Study Closed/terminated|6|||
155650930|NCT01313676|561814488|FG002|Overall Study|Study Closed/terminated|9|||
155650931|NCT01313676|561814489|FG003|Overall Study|Study Closed/terminated|9|||
155650932|NCT01313676|561814486|FG000|Overall Study|Lost to Follow-up|0|||
155650933|NCT01313676|561814487|FG001|Overall Study|Lost to Follow-up|0|||
155650934|NCT01313676|561814488|FG002|Overall Study|Lost to Follow-up|1|||
155650935|NCT01313676|561814489|FG003|Overall Study|Lost to Follow-up|0|||
155650936|NCT01313676|561814486|FG000|Overall Study|Physician Decision|53|||
155436413|NCT00923091|561024575|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
155436414|NCT00923091|561024576|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
155436415|NCT00923091|561024577|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
155650937|NCT01313676|561814487|FG001|Overall Study|Physician Decision|64|||
155650938|NCT01313676|561814488|FG002|Overall Study|Physician Decision|62|||
155436416|NCT00923091|561024578|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
155436417|NCT00923091|561024579|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
155436418|NCT00923091|561024580|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
155436419|NCT00923091|561024581|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
155436420|NCT00923091|561024582|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
155436421|NCT00923091|561024583|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
155436422|NCT00923091|561024571|FG000|Period VI (Open-Label)|Adverse Event|17|||
155436423|NCT00923091|561024572|FG001|Period VI (Open-Label)|Adverse Event|0|||
155436424|NCT00923091|561024573|FG002|Period VI (Open-Label)|Adverse Event|4|||
155436425|NCT00923091|561024574|FG003|Period VI (Open-Label)|Adverse Event|1|||
155436426|NCT00923091|561024575|FG004|Period VI (Open-Label)|Adverse Event|1|||
155436427|NCT00923091|561024576|FG005|Period VI (Open-Label)|Adverse Event|0|||
155436428|NCT00923091|561024577|FG006|Period VI (Open-Label)|Adverse Event|0|||
155436429|NCT00923091|561024578|FG007|Period VI (Open-Label)|Adverse Event|0|||
155436430|NCT00923091|561024579|FG008|Period VI (Open-Label)|Adverse Event|0|||
155514081|NCT01618305|561308248|FG001|Overall Study|Death|1|||
155514082|NCT01618305|561308247|FG000|Overall Study|Lost to Follow-up|11|||
155514083|NCT01618305|561308248|FG001|Overall Study|Lost to Follow-up|7|||
155514084|NCT01618305|561308247|FG000|Overall Study|Protocol Violation|1|||
155514085|NCT01618305|561308248|FG001|Overall Study|Protocol Violation|0|||
155514086|NCT01618305|561308247|FG000|Overall Study|Withdrawal by Subject|3|||
155514087|NCT01618305|561308248|FG001|Overall Study|Withdrawal by Subject|2|||
155514088|NCT01960816|561308249|FG000|Overall Study|Lost to Follow-up|1|||
155514089|NCT01736553|561308268|FG000|Overall Study|Death|12|||
155514090|NCT01736553|561308269|FG001|Overall Study|Death|0|||
155514091|NCT01736553|561308268|FG000|Overall Study|Withdrawal by Subject|5|||
155514092|NCT01736553|561308269|FG001|Overall Study|Withdrawal by Subject|2|||
155514093|NCT01736553|561308268|FG000|Overall Study|Lost to Follow-up|2|||
155514094|NCT01736553|561308269|FG001|Overall Study|Lost to Follow-up|2|||
155514095|NCT01896297|561308272|FG000|Overall Study|Died in post treatment phase|1|||
155514096|NCT00003782|561308273|FG000|Overall Study|No follow up data|30|||
155514097|NCT00003782|561308274|FG001|Overall Study|No follow up data|31|||
155650939|NCT01313676|561814489|FG003|Overall Study|Physician Decision|48|||
155650940|NCT01313676|561814486|FG000|Overall Study|Decision by Participant or Proxy|643|||
155650941|NCT01313676|561814487|FG001|Overall Study|Decision by Participant or Proxy|527|||
155650942|NCT01313676|561814488|FG002|Overall Study|Decision by Participant or Proxy|515|||
155650943|NCT01313676|561814489|FG003|Overall Study|Decision by Participant or Proxy|492|||
155650944|NCT01313676|561814486|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
155650945|NCT01313676|561814487|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
155650946|NCT01313676|561814488|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
155650947|NCT01313676|561814489|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
155650948|NCT01313676|561814486|FG000|Overall Study|Investigator Site Closed|12|||
155650949|NCT01313676|561814487|FG001|Overall Study|Investigator Site Closed|11|||
155650950|NCT01313676|561814488|FG002|Overall Study|Investigator Site Closed|15|||
155650951|NCT01313676|561814489|FG003|Overall Study|Investigator Site Closed|10|||
155650952|NCT01313676|561814486|FG000|Overall Study|Missing|1|||
155650953|NCT01313676|561814487|FG001|Overall Study|Missing|1|||
155650954|NCT01313676|561814488|FG002|Overall Study|Missing|1|||
155650955|NCT01313676|561814489|FG003|Overall Study|Missing|0|||
155650956|NCT02821000|561814490|FG000|Overall Study|Death|89|||
155650957|NCT02821000|561814490|FG000|Overall Study|Sponsor Decision|12|||
155650958|NCT02821000|561814490|FG000|Overall Study|Withdrawal by Subject|2|||
155650959|NCT05058456|561814491|FG000|Overall Study|Death|1|||
155650960|NCT05058456|561814491|FG000|Overall Study|End of Study data not yet due for release|34|||
155650961|NCT02933151|561814492|FG000|Overall Study|Lost to Follow-up|19|||
155650962|NCT02933151|561814493|FG001|Overall Study|Lost to Follow-up|18|||
155650963|NCT02933151|561814492|FG000|Overall Study|Death|1732|||
155650964|NCT02933151|561814493|FG001|Overall Study|Death|1827|||
155650965|NCT02933151|561814492|FG000|Overall Study|Transplant|210|||
155650966|NCT02933151|561814493|FG001|Overall Study|Transplant|278|||
155436431|NCT00923091|561024580|FG009|Period VI (Open-Label)|Adverse Event|0|||
155650967|NCT02933151|561814492|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
155650968|NCT02933151|561814493|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
155436432|NCT00923091|561024581|FG010|Period VI (Open-Label)|Adverse Event|0|||
155436433|NCT00923091|561024582|FG011|Period VI (Open-Label)|Adverse Event|0|||
155514098|NCT00003782|561308275|FG002|Overall Study|No follow up data|26|||
155514099|NCT00929708|561308277|FG000|Overall Study|Protocol Violation|2|||
155514100|NCT00929708|561308278|FG001|Overall Study|Protocol Violation|1|||
155514101|NCT00929708|561308279|FG002|Overall Study|Protocol Violation|1|||
155650969|NCT02933151|561814492|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
155650970|NCT02933151|561814493|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
155650971|NCT02933151|561814492|FG000|Overall Study|Recovered Kidney Function|47|||
155650972|NCT02933151|561814493|FG001|Overall Study|Recovered Kidney Function|29|||
155650973|NCT01832038|561814494|FG000|Overall Study|Death|5|||
155650974|NCT01832038|561814494|FG000|Overall Study|Adverse Event|50|||
155650975|NCT01832038|561814494|FG000|Overall Study|Lack of Efficacy|81|||
155650976|NCT01832038|561814494|FG000|Overall Study|Protocol Violation|7|||
155436434|NCT00923091|561024583|FG012|Period VI (Open-Label)|Adverse Event|0|||
155436435|NCT00923091|561024571|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
155436436|NCT00923091|561024572|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
155436437|NCT00923091|561024573|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
155436438|NCT00923091|561024574|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436439|NCT00923091|561024575|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
155436440|NCT00923091|561024576|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436441|NCT00923091|561024577|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436442|NCT00923091|561024578|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436443|NCT00923091|561024579|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436444|NCT00923091|561024580|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436445|NCT00923091|561024581|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436446|NCT00923091|561024582|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436447|NCT00923091|561024583|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
155436448|NCT00923091|561024571|FG000|Period VI (Open-Label)|Protocol Violation|6|||
155436449|NCT00923091|561024572|FG001|Period VI (Open-Label)|Protocol Violation|1|||
155514102|NCT00929708|561308280|FG003|Overall Study|Protocol Violation|1|||
155436450|NCT00923091|561024573|FG002|Period VI (Open-Label)|Protocol Violation|3|||
155436451|NCT00923091|561024574|FG003|Period VI (Open-Label)|Protocol Violation|1|||
155436452|NCT00923091|561024575|FG004|Period VI (Open-Label)|Protocol Violation|4|||
155436453|NCT00923091|561024576|FG005|Period VI (Open-Label)|Protocol Violation|0|||
155436454|NCT00923091|561024577|FG006|Period VI (Open-Label)|Protocol Violation|0|||
155436455|NCT00923091|561024578|FG007|Period VI (Open-Label)|Protocol Violation|0|||
155436456|NCT00923091|561024579|FG008|Period VI (Open-Label)|Protocol Violation|0|||
155436457|NCT00923091|561024580|FG009|Period VI (Open-Label)|Protocol Violation|0|||
155436458|NCT00923091|561024581|FG010|Period VI (Open-Label)|Protocol Violation|0|||
155436459|NCT00923091|561024582|FG011|Period VI (Open-Label)|Protocol Violation|0|||
155436460|NCT00923091|561024583|FG012|Period VI (Open-Label)|Protocol Violation|0|||
155436461|NCT00923091|561024571|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
155436462|NCT00923091|561024572|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
155650977|NCT01832038|561814494|FG000|Overall Study|Lost to Follow-up|10|||
155436463|NCT00923091|561024573|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
155436464|NCT00923091|561024574|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
155436465|NCT00923091|561024575|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
155514103|NCT00929708|561308281|FG004|Overall Study|Protocol Violation|1|||
155514104|NCT00929708|561308277|FG000|Overall Study|Withdrawal by Subject|2|||
155514105|NCT00929708|561308278|FG001|Overall Study|Withdrawal by Subject|0|||
155514106|NCT00929708|561308279|FG002|Overall Study|Withdrawal by Subject|0|||
155514107|NCT00929708|561308280|FG003|Overall Study|Withdrawal by Subject|2|||
155514108|NCT00929708|561308281|FG004|Overall Study|Withdrawal by Subject|1|||
155514109|NCT00929708|561308277|FG000|Overall Study|Adverse Event|0|||
155514110|NCT00929708|561308278|FG001|Overall Study|Adverse Event|0|||
155514111|NCT00929708|561308279|FG002|Overall Study|Adverse Event|0|||
155514112|NCT00929708|561308280|FG003|Overall Study|Adverse Event|0|||
155514113|NCT00929708|561308281|FG004|Overall Study|Adverse Event|3|||
155514114|NCT00929708|561308277|FG000|Overall Study|Physician Decision|0|||
155436466|NCT00923091|561024576|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
155436467|NCT00923091|561024577|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
155436468|NCT00923091|561024578|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
155436469|NCT00923091|561024579|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
155436470|NCT00923091|561024580|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
155436471|NCT00923091|561024581|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
155436472|NCT00923091|561024582|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
155436473|NCT00923091|561024583|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
155436474|NCT00923091|561024571|FG000|Period VI (Open-Label)|Other Reason|0|||
155436475|NCT00923091|561024572|FG001|Period VI (Open-Label)|Other Reason|0|||
155436476|NCT00923091|561024573|FG002|Period VI (Open-Label)|Other Reason|0|||
155436477|NCT00923091|561024574|FG003|Period VI (Open-Label)|Other Reason|1|||
155436478|NCT00923091|561024575|FG004|Period VI (Open-Label)|Other Reason|1|||
155436479|NCT00923091|561024576|FG005|Period VI (Open-Label)|Other Reason|0|||
155436480|NCT00923091|561024577|FG006|Period VI (Open-Label)|Other Reason|0|||
155436481|NCT00923091|561024578|FG007|Period VI (Open-Label)|Other Reason|0|||
155436482|NCT00923091|561024579|FG008|Period VI (Open-Label)|Other Reason|0|||
155436483|NCT00923091|561024580|FG009|Period VI (Open-Label)|Other Reason|0|||
155436484|NCT00923091|561024581|FG010|Period VI (Open-Label)|Other Reason|0|||
155436485|NCT00923091|561024582|FG011|Period VI (Open-Label)|Other Reason|0|||
155436486|NCT00923091|561024583|FG012|Period VI (Open-Label)|Other Reason|0|||
155436487|NCT03237845|561024587|FG000|Overall Study|Adverse Event|0|||
155436488|NCT03237845|561024588|FG001|Overall Study|Adverse Event|1|||
155436489|NCT03237845|561024587|FG000|Overall Study|Lost to Follow-up|13|||
155436490|NCT03237845|561024588|FG001|Overall Study|Lost to Follow-up|10|||
155436491|NCT03237845|561024587|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
155436492|NCT03237845|561024588|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
155436493|NCT03237845|561024587|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
155436494|NCT03237845|561024588|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
155436495|NCT03237845|561024587|FG000|Overall Study|Physician Decision|1|||
155436496|NCT03237845|561024588|FG001|Overall Study|Physician Decision|2|||
155436497|NCT03237845|561024587|FG000|Overall Study|Pregnancy|1|||
155436498|NCT03237845|561024588|FG001|Overall Study|Pregnancy|0|||
155436499|NCT03237845|561024587|FG000|Overall Study|Protocol Deviation|0|||
155436500|NCT03237845|561024588|FG001|Overall Study|Protocol Deviation|1|||
155436501|NCT03237845|561024587|FG000|Overall Study|Technical Problems|8|||
155436502|NCT03237845|561024588|FG001|Overall Study|Technical Problems|1|||
155436503|NCT03237845|561024587|FG000|Overall Study|Withdrawal by Subject|3|||
155436504|NCT03237845|561024588|FG001|Overall Study|Withdrawal by Subject|3|||
155436505|NCT03237845|561024587|FG000|Overall Study|Other Reasons|4|||
155436506|NCT03237845|561024588|FG001|Overall Study|Other Reasons|0|||
155436507|NCT01221233|561024589|FG000|Overall Study|Withdrawal by Subject|3|||
155436508|NCT01221233|561024590|FG001|Overall Study|Withdrawal by Subject|1|||
155436509|NCT02460822|561024595|FG000|Overall Study|Withdrawal by Subject|1|||
155436510|NCT00971321|561024596|FG000|Up to Month 7|Withdrawal by Subject|1|||
155436511|NCT00971321|561024597|FG001|Up to Month 7|Withdrawal by Subject|0|||
155436512|NCT00971321|561024596|FG000|Up to Month 7|Migrated/moved from study area|3|||
155436513|NCT00971321|561024597|FG001|Up to Month 7|Migrated/moved from study area|2|||
155436514|NCT00971321|561024596|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
155436515|NCT00971321|561024597|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
155436516|NCT00971321|561024596|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
155436517|NCT00971321|561024597|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
155436518|NCT00971321|561024596|FG000|Up to Month 11-12|Lost to Follow-up|1|||
155436519|NCT00971321|561024597|FG001|Up to Month 11-12|Lost to Follow-up|0|||
155436520|NCT02782715|561024598|FG000|Overall Study|Withdrawal by Subject|1|||
155436521|NCT01662999|561024602|FG000|Period 3|Withdrawal by Subject|0|||
155436522|NCT01662999|561024603|FG001|Period 3|Withdrawal by Subject|1|||
155436523|NCT01662999|561024604|FG002|Period 3|Withdrawal by Subject|0|||
155436524|NCT01662999|561024605|FG003|Period 3|Withdrawal by Subject|0|||
155436525|NCT01662999|561024606|FG004|Period 3|Withdrawal by Subject|0|||
155436526|NCT01662999|561024607|FG005|Period 3|Withdrawal by Subject|0|||
155436527|NCT01933672|561024610|FG000|Metformin Run-in Period|Adverse Event|1|||
155436528|NCT01933672|561024611|FG001|Metformin Run-in Period|Adverse Event|0|||
155436529|NCT01933672|561024612|FG002|Metformin Run-in Period|Adverse Event|0|||
155436530|NCT01933672|561024613|FG003|Metformin Run-in Period|Adverse Event|0|||
155436531|NCT01933672|561024614|FG004|Metformin Run-in Period|Adverse Event|0|||
155436532|NCT01933672|561024615|FG005|Metformin Run-in Period|Adverse Event|0|||
155436533|NCT01933672|561024616|FG006|Metformin Run-in Period|Adverse Event|0|||
155436534|NCT01933672|561024610|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
155436535|NCT01933672|561024611|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155436536|NCT01933672|561024612|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155436537|NCT01933672|561024613|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155436538|NCT01933672|561024614|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155436539|NCT01933672|561024615|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155514115|NCT00929708|561308278|FG001|Overall Study|Physician Decision|2|||
155436540|NCT01933672|561024616|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
155436541|NCT01933672|561024610|FG000|Metformin Run-in Period|Other|5|||
155436542|NCT01933672|561024611|FG001|Metformin Run-in Period|Other|0|||
155436543|NCT01933672|561024612|FG002|Metformin Run-in Period|Other|0|||
155436544|NCT01933672|561024613|FG003|Metformin Run-in Period|Other|0|||
155436545|NCT01933672|561024614|FG004|Metformin Run-in Period|Other|0|||
155436546|NCT01933672|561024615|FG005|Metformin Run-in Period|Other|0|||
155436547|NCT01933672|561024616|FG006|Metformin Run-in Period|Other|0|||
155436548|NCT01933672|561024610|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436549|NCT01933672|561024611|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436550|NCT01933672|561024612|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436551|NCT01933672|561024613|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436552|NCT01933672|561024614|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
155436553|NCT01933672|561024615|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436554|NCT01933672|561024616|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436555|NCT01933672|561024610|FG000|First Intervention Period (12-16 Days)|Other|0|||
155436556|NCT01933672|561024611|FG001|First Intervention Period (12-16 Days)|Other|0|||
155436557|NCT01933672|561024612|FG002|First Intervention Period (12-16 Days)|Other|1|||
155436558|NCT01933672|561024613|FG003|First Intervention Period (12-16 Days)|Other|0|||
155436559|NCT01933672|561024614|FG004|First Intervention Period (12-16 Days)|Other|0|||
155436560|NCT01933672|561024615|FG005|First Intervention Period (12-16 Days)|Other|1|||
155436561|NCT01933672|561024616|FG006|First Intervention Period (12-16 Days)|Other|0|||
155436562|NCT01933672|561024610|FG000|Second Intervention Period (12-16 Days)|Other|0|||
155436563|NCT01933672|561024611|FG001|Second Intervention Period (12-16 Days)|Other|1|||
155436564|NCT01933672|561024612|FG002|Second Intervention Period (12-16 Days)|Other|1|||
155436565|NCT01933672|561024613|FG003|Second Intervention Period (12-16 Days)|Other|0|||
155436566|NCT01933672|561024614|FG004|Second Intervention Period (12-16 Days)|Other|0|||
155436567|NCT01933672|561024615|FG005|Second Intervention Period (12-16 Days)|Other|0|||
155436568|NCT01933672|561024616|FG006|Second Intervention Period (12-16 Days)|Other|0|||
155436569|NCT01933672|561024610|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436570|NCT01933672|561024611|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436571|NCT01933672|561024612|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436572|NCT01933672|561024613|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
155436573|NCT01933672|561024614|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436574|NCT01933672|561024615|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436575|NCT01933672|561024616|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155436576|NCT01933672|561024610|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436577|NCT01933672|561024611|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
155436578|NCT01933672|561024612|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436579|NCT01933672|561024613|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436580|NCT01933672|561024614|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436581|NCT01933672|561024615|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436582|NCT01933672|561024616|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155436583|NCT05165394|561026255|FG000|Overall Study|Withdrawal by Subject|5|||
155436584|NCT05165394|561026256|FG001|Overall Study|Withdrawal by Subject|1|||
155436585|NCT05165394|561026255|FG000|Overall Study|Lost to Follow-up|1|||
155436586|NCT05165394|561026256|FG001|Overall Study|Lost to Follow-up|2|||
155436587|NCT05165394|561026255|FG000|Overall Study|Other Than Specified|0|||
155436588|NCT05165394|561026256|FG001|Overall Study|Other Than Specified|1|||
155436589|NCT00001259|561026259|FG000|Study 2|Adverse Event|0|||
155436590|NCT00001259|561026260|FG001|Study 2|Adverse Event|0|||
155436591|NCT00001259|561026261|FG002|Study 2|Adverse Event|0|||
155436592|NCT00001259|561026262|FG003|Study 2|Adverse Event|0|||
155436593|NCT00001259|561026263|FG004|Study 2|Adverse Event|2|||
155436594|NCT00001259|561026264|FG005|Study 2|Adverse Event|0|||
155436595|NCT00001259|561026265|FG006|Study 2|Adverse Event|0|||
155436596|NCT03705494|561026266|FG000|Overall Study|Lost to Follow-up|2|||
155436597|NCT03705494|561026267|FG001|Overall Study|Lost to Follow-up|1|||
155436598|NCT03705494|561026266|FG000|Overall Study|Withdrawal by Subject|5|||
155514116|NCT00929708|561308279|FG002|Overall Study|Physician Decision|2|||
155514117|NCT00929708|561308280|FG003|Overall Study|Physician Decision|2|||
155514118|NCT00929708|561308281|FG004|Overall Study|Physician Decision|1|||
155514119|NCT00929708|561308277|FG000|Overall Study|Lost to Follow-up|0|||
155514120|NCT00929708|561308278|FG001|Overall Study|Lost to Follow-up|0|||
155514121|NCT00929708|561308279|FG002|Overall Study|Lost to Follow-up|0|||
155514122|NCT00929708|561308280|FG003|Overall Study|Lost to Follow-up|1|||
155650978|NCT01832038|561814494|FG000|Overall Study|Withdrawal by Subject|49|||
155436599|NCT03705494|561026267|FG001|Overall Study|Withdrawal by Subject|2|||
155436600|NCT01582282|561026268|FG000|Overall Study|Adverse Event|1|||
155436601|NCT01582282|561026269|FG001|Overall Study|Adverse Event|1|||
155436602|NCT01582282|561026270|FG002|Overall Study|Adverse Event|0|||
155436603|NCT01582282|561026268|FG000|Overall Study|Lost to Follow-up|1|||
155436604|NCT01582282|561026269|FG001|Overall Study|Lost to Follow-up|0|||
155514123|NCT00929708|561308281|FG004|Overall Study|Lost to Follow-up|0|||
155514124|NCT02154529|561308282|FG000|Overall Study|Death|1|||
155514125|NCT02154529|561308283|FG001|Overall Study|Death|1|||
155514126|NCT02154529|561308284|FG002|Overall Study|Death|5|||
155514127|NCT02154529|561308285|FG003|Overall Study|Death|1|||
155514128|NCT02154529|561308282|FG000|Overall Study|Termination of study by sponsor|2|||
155514129|NCT02154529|561308283|FG001|Overall Study|Termination of study by sponsor|2|||
155514130|NCT02154529|561308284|FG002|Overall Study|Termination of study by sponsor|3|||
155514131|NCT02154529|561308285|FG003|Overall Study|Termination of study by sponsor|1|||
155514132|NCT02154529|561308282|FG000|Overall Study|Lost to Follow-up|1|||
155514133|NCT02154529|561308283|FG001|Overall Study|Lost to Follow-up|0|||
155514134|NCT02154529|561308284|FG002|Overall Study|Lost to Follow-up|0|||
155514135|NCT02154529|561308285|FG003|Overall Study|Lost to Follow-up|0|||
155514136|NCT02146430|561310212|FG000|Overall Study|Protocol Violation|5|||
155514137|NCT02146430|561310213|FG001|Overall Study|Protocol Violation|4|||
155514138|NCT02146430|561310214|FG002|Overall Study|Protocol Violation|8|||
155514139|NCT02146430|561310215|FG003|Overall Study|Protocol Violation|6|||
155514140|NCT02146430|561310212|FG000|Overall Study|Lack of Efficacy|13|||
155514141|NCT02146430|561310213|FG001|Overall Study|Lack of Efficacy|11|||
155514142|NCT02146430|561310214|FG002|Overall Study|Lack of Efficacy|8|||
155514143|NCT02146430|561310215|FG003|Overall Study|Lack of Efficacy|5|||
155514144|NCT02146430|561310212|FG000|Overall Study|Adverse Event|20|||
155514145|NCT02146430|561310213|FG001|Overall Study|Adverse Event|40|||
155514146|NCT02146430|561310214|FG002|Overall Study|Adverse Event|32|||
155514147|NCT02146430|561310215|FG003|Overall Study|Adverse Event|49|||
155514148|NCT02146430|561310212|FG000|Overall Study|Reason missing or not reported|2|||
155514149|NCT02146430|561310213|FG001|Overall Study|Reason missing or not reported|3|||
155514150|NCT02146430|561310214|FG002|Overall Study|Reason missing or not reported|4|||
155514151|NCT02146430|561310215|FG003|Overall Study|Reason missing or not reported|5|||
155514152|NCT02146430|561310212|FG000|Overall Study|Withdrawal by Subject|27|||
155514153|NCT02146430|561310213|FG001|Overall Study|Withdrawal by Subject|29|||
155514154|NCT02146430|561310214|FG002|Overall Study|Withdrawal by Subject|30|||
155514155|NCT02146430|561310215|FG003|Overall Study|Withdrawal by Subject|34|||
155514156|NCT03312530|561310216|FG000|Overall Study|Death|5|||
155514157|NCT03312530|561310217|FG001|Overall Study|Death|5|||
155514158|NCT03312530|561310218|FG002|Overall Study|Death|4|||
155514159|NCT03312530|561310219|FG003|Overall Study|Death|10|||
155514160|NCT03312530|561310220|FG004|Overall Study|Death|8|||
155514161|NCT03312530|561310216|FG000|Overall Study|Lost to Follow-up|0|||
155514162|NCT03312530|561310217|FG001|Overall Study|Lost to Follow-up|0|||
155514163|NCT03312530|561310218|FG002|Overall Study|Lost to Follow-up|0|||
155514164|NCT03312530|561310219|FG003|Overall Study|Lost to Follow-up|1|||
155514165|NCT03312530|561310220|FG004|Overall Study|Lost to Follow-up|0|||
155514166|NCT03312530|561310216|FG000|Overall Study|Participant in another sponsor study.|0|||
155514167|NCT03312530|561310217|FG001|Overall Study|Participant in another sponsor study.|0|||
155514168|NCT03312530|561310218|FG002|Overall Study|Participant in another sponsor study.|0|||
155514169|NCT03312530|561310219|FG003|Overall Study|Participant in another sponsor study.|1|||
155514170|NCT03312530|561310220|FG004|Overall Study|Participant in another sponsor study.|0|||
155514171|NCT03312530|561310216|FG000|Overall Study|Study terminated by sponsor|1|||
155514172|NCT03312530|561310217|FG001|Overall Study|Study terminated by sponsor|0|||
155514173|NCT03312530|561310218|FG002|Overall Study|Study terminated by sponsor|2|||
155514174|NCT03312530|561310219|FG003|Overall Study|Study terminated by sponsor|3|||
155514175|NCT03312530|561310220|FG004|Overall Study|Study terminated by sponsor|7|||
155514176|NCT03312530|561310216|FG000|Overall Study|Withdrawal by Subject|0|||
155514177|NCT03312530|561310217|FG001|Overall Study|Withdrawal by Subject|1|||
155514178|NCT03312530|561310218|FG002|Overall Study|Withdrawal by Subject|0|||
155514179|NCT03312530|561310219|FG003|Overall Study|Withdrawal by Subject|0|||
155514180|NCT03312530|561310220|FG004|Overall Study|Withdrawal by Subject|0|||
155514181|NCT03312530|561310216|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
155514182|NCT03312530|561310217|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
155514183|NCT03312530|561310218|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
155514184|NCT03312530|561310219|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
155514185|NCT03312530|561310220|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
155514186|NCT03093324|561310221|FG000|Overall Study|Adverse Event|4|||
155514187|NCT03093324|561310222|FG001|Overall Study|Adverse Event|15|||
155514188|NCT03093324|561310221|FG000|Overall Study|Lost to Follow-up|1|||
155514189|NCT03093324|561310222|FG001|Overall Study|Lost to Follow-up|0|||
155514190|NCT03093324|561310221|FG000|Overall Study|Protocol Deviation|2|||
155514191|NCT03093324|561310222|FG001|Overall Study|Protocol Deviation|2|||
155514192|NCT03093324|561310221|FG000|Overall Study|Withdrawal by Subject|2|||
155514193|NCT03093324|561310222|FG001|Overall Study|Withdrawal by Subject|2|||
155514194|NCT04583579|561310224|FG000|Overall Study|Lost to Follow-up|4|||
155514195|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
155514196|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
155514197|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
155514198|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
155514199|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
155514200|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
155514201|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
155514202|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
155514203|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
155514204|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
155514205|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
155514206|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
155514207|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
155514208|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
155514209|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
155514210|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
155514211|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
155514212|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
155514213|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
155514214|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
155514215|NCT04700449|561310227|FG000|Stage 1: Double-Blind Period|Other|0|||
155514216|NCT04700449|561310228|FG001|Stage 1: Double-Blind Period|Other|0|||
155514217|NCT04700449|561310229|FG002|Stage 1: Double-Blind Period|Other|1|||
155514218|NCT04700449|561310230|FG003|Stage 1: Double-Blind Period|Other|0|||
155514219|NCT04700449|561310227|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
155514220|NCT04700449|561310228|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
155514221|NCT04700449|561310229|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
155514222|NCT04700449|561310230|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
155514223|NCT04700449|561310227|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
155514224|NCT04700449|561310228|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
155514225|NCT04700449|561310229|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
155514226|NCT04700449|561310230|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
155514227|NCT04700449|561310227|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
155514228|NCT04700449|561310228|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
155514229|NCT04700449|561310229|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
155514230|NCT04700449|561310230|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
155514231|NCT04700449|561310227|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
155514232|NCT04700449|561310228|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
155514233|NCT04700449|561310229|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
155514234|NCT04700449|561310230|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
155514235|NCT04700449|561310227|FG000|Stage 2 Sub-study 1|Other|1|||
155514236|NCT04700449|561310228|FG001|Stage 2 Sub-study 1|Other|2|||
155514237|NCT04700449|561310229|FG002|Stage 2 Sub-study 1|Other|0|||
155436605|NCT01582282|561026270|FG002|Overall Study|Lost to Follow-up|0|||
155436606|NCT01582282|561026268|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
155436607|NCT01582282|561026269|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
155436608|NCT01582282|561026270|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
155436609|NCT03937986|561026272|FG000|Overall Study|COVID-19 Pandemic|1|||
155436610|NCT02839746|561026274|FG000|Overall Study|Not met selection criteria|12|||
155436611|NCT02089737|561026275|FG000|Overall Study|Survey form not completed|5|||
155650979|NCT01832038|561814494|FG000|Overall Study|Visit non-compliance|2|||
155650980|NCT01832038|561814494|FG000|Overall Study|Subject refused to return visit|2|||
155650981|NCT01832038|561814494|FG000|Overall Study|Not convenient to come back to site|2|||
155650982|NCT01832038|561814494|FG000|Overall Study|Participant was asked to quit|5|||
155650983|NCT01832038|561814494|FG000|Overall Study|Back home|1|||
155650984|NCT01832038|561814494|FG000|Overall Study|Pregnancy|1|||
155650985|NCT01832038|561814494|FG000|Overall Study|Low compliance|3|||
155650986|NCT01832038|561814494|FG000|Overall Study|Prohibit procedure|2|||
155650987|NCT01832038|561814494|FG000|Overall Study|Not possible to visit the hospital|1|||
155650988|NCT01832038|561814494|FG000|Overall Study|Changes of implementation system|3|||
155650989|NCT01832038|561814494|FG000|Overall Study|Plan to pregnancy|7|||
155650990|NCT01832038|561814494|FG000|Overall Study|Bad mood and has suicidal thought|1|||
155650991|NCT01832038|561814494|FG000|Overall Study|Prohibited concomitant medication|1|||
155650992|NCT01832038|561814494|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
155650993|NCT01832038|561814494|FG000|Overall Study|Subject considered the efficacy was poor|1|||
155650994|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
155650995|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
155650996|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
155650997|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
155650998|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
155650999|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
155651000|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
155651001|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
155651002|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155651003|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155436612|NCT02089737|561026275|FG000|Overall Study|Not treated|1|||
155436613|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
155436614|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
155514238|NCT04700449|561310230|FG003|Stage 2 Sub-study 1|Other|0|||
155514239|NCT04700449|561310227|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
155514240|NCT04700449|561310228|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
155514241|NCT04700449|561310229|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
155651004|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155651005|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
155436615|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
155436616|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
155436617|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
155436618|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
155436619|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
155436620|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
155436621|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
155436622|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
155436623|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
155436624|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
155436625|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
155436626|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
155436627|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
155436628|NCT01330381|561026276|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
155436629|NCT01330381|561026277|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
155436630|NCT01330381|561026278|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
155436631|NCT01330381|561026276|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
155436632|NCT01330381|561026277|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
155436633|NCT01330381|561026278|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
155436634|NCT01330381|561026276|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
155436635|NCT01330381|561026277|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
155436636|NCT01330381|561026278|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
155436637|NCT01330381|561026276|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
155436638|NCT01330381|561026277|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
155436639|NCT01330381|561026278|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
155436640|NCT01330381|561026276|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
155436641|NCT01330381|561026277|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
155436642|NCT01330381|561026278|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
155436643|NCT01272180|561026284|FG000|Overall Study|Adverse Event|0|||
155436644|NCT01272180|561026285|FG001|Overall Study|Adverse Event|0|||
155436645|NCT01272180|561026286|FG002|Overall Study|Adverse Event|1|||
155436646|NCT01272180|561026287|FG003|Overall Study|Adverse Event|0|||
155436647|NCT01272180|561026284|FG000|Overall Study|Withdrawal by Subject|2|||
155436648|NCT01272180|561026285|FG001|Overall Study|Withdrawal by Subject|6|||
155436649|NCT01272180|561026286|FG002|Overall Study|Withdrawal by Subject|3|||
155436650|NCT01272180|561026287|FG003|Overall Study|Withdrawal by Subject|2|||
155436651|NCT01272180|561026284|FG000|Overall Study|Lost to Follow-up|15|||
155436652|NCT01272180|561026285|FG001|Overall Study|Lost to Follow-up|14|||
155436653|NCT01272180|561026286|FG002|Overall Study|Lost to Follow-up|8|||
155436654|NCT01272180|561026287|FG003|Overall Study|Lost to Follow-up|10|||
155436655|NCT01272180|561026284|FG000|Overall Study|Inappropriate enrollment|0|||
155436656|NCT01272180|561026285|FG001|Overall Study|Inappropriate enrollment|0|||
155436657|NCT01272180|561026286|FG002|Overall Study|Inappropriate enrollment|1|||
155436658|NCT01272180|561026287|FG003|Overall Study|Inappropriate enrollment|1|||
155436659|NCT01272180|561026284|FG000|Overall Study|Protocol Violation|0|||
155436660|NCT01272180|561026285|FG001|Overall Study|Protocol Violation|1|||
155436661|NCT01272180|561026286|FG002|Overall Study|Protocol Violation|0|||
155436662|NCT01272180|561026287|FG003|Overall Study|Protocol Violation|1|||
155436663|NCT03351244|561026288|FG000|Overall Study|Adverse Event|7|||
155436664|NCT03351244|561026289|FG001|Overall Study|Adverse Event|11|||
155436665|NCT03351244|561026290|FG002|Overall Study|Adverse Event|12|||
155436666|NCT03351244|561026288|FG000|Overall Study|Investigator's decision|0|||
155436667|NCT03351244|561026289|FG001|Overall Study|Investigator's decision|0|||
155436668|NCT03351244|561026290|FG002|Overall Study|Investigator's decision|2|||
155436669|NCT03351244|561026288|FG000|Overall Study|System error|0|||
155436670|NCT03351244|561026289|FG001|Overall Study|System error|0|||
155436671|NCT03351244|561026290|FG002|Overall Study|System error|2|||
155436672|NCT03351244|561026288|FG000|Overall Study|COVID-19 restrictions|3|||
155436673|NCT03351244|561026289|FG001|Overall Study|COVID-19 restrictions|0|||
155436674|NCT03351244|561026290|FG002|Overall Study|COVID-19 restrictions|1|||
155436675|NCT03351244|561026288|FG000|Overall Study|Non-compliance|2|||
155436676|NCT03351244|561026289|FG001|Overall Study|Non-compliance|5|||
155436677|NCT03351244|561026290|FG002|Overall Study|Non-compliance|0|||
155436678|NCT03351244|561026288|FG000|Overall Study|Withdrawal by Subject|11|||
155436679|NCT03351244|561026289|FG001|Overall Study|Withdrawal by Subject|16|||
155436680|NCT03351244|561026290|FG002|Overall Study|Withdrawal by Subject|13|||
155436681|NCT03351244|561026288|FG000|Overall Study|Lost to Follow-up|2|||
155436682|NCT03351244|561026289|FG001|Overall Study|Lost to Follow-up|6|||
155436683|NCT03351244|561026290|FG002|Overall Study|Lost to Follow-up|4|||
155436684|NCT03351244|561026288|FG000|Overall Study|Protocol Violation|2|||
155436685|NCT03351244|561026289|FG001|Overall Study|Protocol Violation|2|||
155436686|NCT03351244|561026290|FG002|Overall Study|Protocol Violation|0|||
155436687|NCT01844076|561026295|FG000|Overall Study|Adverse Event|1|||
155436688|NCT01844076|561026296|FG001|Overall Study|Adverse Event|0|||
155436689|NCT01844076|561026297|FG002|Overall Study|Adverse Event|0|||
155651006|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
155651007|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
155651008|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
155651009|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
155651010|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
155436690|NCT01844076|561026298|FG003|Overall Study|Adverse Event|0|||
155436691|NCT01844076|561026295|FG000|Overall Study|Withdrawal by Subject|1|||
155436692|NCT01844076|561026296|FG001|Overall Study|Withdrawal by Subject|0|||
155436693|NCT01844076|561026297|FG002|Overall Study|Withdrawal by Subject|0|||
155436694|NCT01844076|561026298|FG003|Overall Study|Withdrawal by Subject|0|||
155436695|NCT00308620|561026306|FG000|Overall Study|Death|1|||
155436696|NCT00308620|561026307|FG001|Overall Study|Death|1|||
155436697|NCT00308620|561026308|FG002|Overall Study|Death|0|||
155436698|NCT00308620|561026306|FG000|Overall Study|Lost to Follow-up|0|||
155436699|NCT00308620|561026307|FG001|Overall Study|Lost to Follow-up|0|||
155436700|NCT00308620|561026308|FG002|Overall Study|Lost to Follow-up|1|||
155436701|NCT01025336|561026312|FG000|Overall Study|Protocol Violation|0|||
155436702|NCT01025336|561026313|FG001|Overall Study|Protocol Violation|0|||
155436703|NCT01025336|561026314|FG002|Overall Study|Protocol Violation|0|||
155436704|NCT01025336|561026315|FG003|Overall Study|Protocol Violation|2|||
155436705|NCT01025336|561026316|FG004|Overall Study|Protocol Violation|0|||
155436706|NCT01165229|561026317|FG000|Overall Study|Serious Adverse Event|456|||
155436707|NCT01165229|561026318|FG001|Overall Study|Serious Adverse Event|487|||
155436708|NCT01165229|561026317|FG000|Overall Study|Non-Serious Adverse Event|47|||
155436709|NCT01165229|561026318|FG001|Overall Study|Non-Serious Adverse Event|15|||
155436710|NCT01165229|561026317|FG000|Overall Study|Protocol Violation|6|||
155436711|NCT01165229|561026318|FG001|Overall Study|Protocol Violation|8|||
155436712|NCT01165229|561026317|FG000|Overall Study|Withdrawal by Subject|387|||
155436713|NCT01165229|561026318|FG001|Overall Study|Withdrawal by Subject|396|||
155436714|NCT01165229|561026317|FG000|Overall Study|Migrated/moved from study area|51|||
155436715|NCT01165229|561026318|FG001|Overall Study|Migrated/moved from study area|46|||
155436716|NCT01165229|561026317|FG000|Overall Study|Lost to Follow-up|123|||
155436717|NCT01165229|561026318|FG001|Overall Study|Lost to Follow-up|133|||
155436718|NCT01165229|561026317|FG000|Overall Study|Suspected HZ Episode|2|||
155436719|NCT01165229|561026318|FG001|Overall Study|Suspected HZ Episode|2|||
155436720|NCT01165229|561026317|FG000|Overall Study|No reason from the subject|108|||
155436721|NCT01165229|561026318|FG001|Overall Study|No reason from the subject|102|||
155436722|NCT01165229|561026317|FG000|Overall Study|Unknown completion status|0|||
155436723|NCT01165229|561026318|FG001|Overall Study|Unknown completion status|1|||
155436724|NCT00474253|561026319|FG000|Overall Study|Withdrew consent|2|||
155436725|NCT00474253|561026320|FG001|Overall Study|Withdrew consent|0|||
155436726|NCT00474253|561026319|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
155436727|NCT00474253|561026320|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
155436728|NCT00474253|561026319|FG000|Overall Study|Lost to Follow-up|1|||
155436729|NCT00474253|561026320|FG001|Overall Study|Lost to Follow-up|0|||
155436730|NCT00474253|561026319|FG000|Overall Study|Discharged prior to study completion|0|||
155436731|NCT00474253|561026320|FG001|Overall Study|Discharged prior to study completion|1|||
155436732|NCT01512368|561026323|FG000|Overall Study|Protocol Violation|3|||
155436733|NCT02532543|561026324|FG000|Overall Study|Lost to Follow-up|0|||
155436734|NCT02532543|561026325|FG001|Overall Study|Lost to Follow-up|0|||
155436735|NCT02532543|561026326|FG002|Overall Study|Lost to Follow-up|1|||
155436736|NCT02532543|561026327|FG003|Overall Study|Lost to Follow-up|0|||
155436737|NCT01319929|561026330|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
155436738|NCT01319929|561026331|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
155436739|NCT01319929|561026330|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
155436740|NCT01319929|561026331|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
155436741|NCT01319929|561026330|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
155436742|NCT01319929|561026331|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
155436743|NCT01319929|561026330|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
155436744|NCT01319929|561026331|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
155436745|NCT01319929|561026330|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
155436746|NCT01319929|561026331|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
155436747|NCT01645280|561026333|FG000|Overall Study|Death|0|||
155436748|NCT01645280|561026334|FG001|Overall Study|Death|1|||
155436749|NCT01645280|561026335|FG002|Overall Study|Death|0|||
155651011|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
155651012|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
155651013|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
155651014|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
155651015|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
155436750|NCT01645280|561026336|FG003|Overall Study|Death|0|||
155436751|NCT01645280|561026337|FG004|Overall Study|Death|0|||
155436752|NCT01645280|561026333|FG000|Overall Study|Withdrawal by Subject|4|||
155436753|NCT01645280|561026334|FG001|Overall Study|Withdrawal by Subject|0|||
155436754|NCT01645280|561026335|FG002|Overall Study|Withdrawal by Subject|2|||
155436755|NCT01645280|561026336|FG003|Overall Study|Withdrawal by Subject|4|||
155436756|NCT01645280|561026337|FG004|Overall Study|Withdrawal by Subject|5|||
155436757|NCT01645280|561026333|FG000|Overall Study|Lost to Follow-up|0|||
155436758|NCT01645280|561026334|FG001|Overall Study|Lost to Follow-up|0|||
155436759|NCT01645280|561026335|FG002|Overall Study|Lost to Follow-up|0|||
155436760|NCT01645280|561026336|FG003|Overall Study|Lost to Follow-up|2|||
155651016|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
155651017|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
155651018|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
155651019|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155651020|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155651021|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155651022|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
155651023|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
155651024|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
155651025|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
155651026|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
155651027|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
155651028|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
155651029|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
155651030|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155651031|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155651032|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155651033|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
155651034|NCT02596893|561814495|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
155651035|NCT02596893|561814496|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
155651036|NCT02596893|561814497|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
155651037|NCT02596893|561814498|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
155651038|NCT03280615|561814499|FG000|Overall Study|Lost to Follow-up|1|||
155651039|NCT03280615|561814500|FG001|Overall Study|Lost to Follow-up|2|||
155651040|NCT03280615|561814499|FG000|Overall Study|Adverse Event|1|||
155651041|NCT03280615|561814500|FG001|Overall Study|Adverse Event|1|||
155651042|NCT03280615|561814499|FG000|Overall Study|Withdrawal by Subject|2|||
155651043|NCT03280615|561814500|FG001|Overall Study|Withdrawal by Subject|2|||
155651044|NCT02457546|561814504|FG000|Overall Study|Other reasons|4|||
155651045|NCT02457546|561814505|FG001|Overall Study|Other reasons|1|||
155651046|NCT02457546|561814504|FG000|Overall Study|Refused to complete study/procedures|1|||
155651047|NCT02457546|561814505|FG001|Overall Study|Refused to complete study/procedures|1|||
155651048|NCT02457546|561814504|FG000|Overall Study|Lost to Follow-up|4|||
155651049|NCT02457546|561814505|FG001|Overall Study|Lost to Follow-up|1|||
155651050|NCT02457546|561814504|FG000|Overall Study|Adverse Event|0|||
155651051|NCT02457546|561814505|FG001|Overall Study|Adverse Event|1|||
155651052|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
155651053|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
155651054|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
155651055|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
155651056|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
155651057|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
155436761|NCT01645280|561026337|FG004|Overall Study|Lost to Follow-up|1|||
155651058|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
155651059|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
155651060|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
155651061|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
155436762|NCT01645280|561026333|FG000|Overall Study|Other|1|||
155436763|NCT01645280|561026334|FG001|Overall Study|Other|1|||
155436764|NCT01645280|561026335|FG002|Overall Study|Other|2|||
155436765|NCT01645280|561026336|FG003|Overall Study|Other|0|||
155436766|NCT01645280|561026337|FG004|Overall Study|Other|0|||
155436767|NCT01645280|561026333|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
155436768|NCT01645280|561026334|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
155436769|NCT01645280|561026335|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
155436770|NCT01645280|561026336|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
155651062|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
155651063|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
155651064|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
155651065|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
155651066|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
155651067|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
155651068|NCT01755156|561814515|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
155651069|NCT01755156|561814516|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
155651070|NCT01755156|561814515|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
155651071|NCT01755156|561814516|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
155651072|NCT01755156|561814515|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
155436771|NCT01645280|561026337|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
155436772|NCT03368404|561026351|FG000|Overall Study|Adverse Event|2|||
155436773|NCT03368404|561026352|FG001|Overall Study|Adverse Event|1|||
155436774|NCT03368404|561026351|FG000|Overall Study|Withdrawal by Subject|1|||
155436775|NCT03368404|561026352|FG001|Overall Study|Withdrawal by Subject|1|||
155436776|NCT01751646|561026358|FG000|Overall Study|Lost to Follow-up|5|||
155436777|NCT01751646|561026359|FG001|Overall Study|Lost to Follow-up|1|||
155436778|NCT01751646|561026358|FG000|Overall Study|Withdrawal by Subject|0|||
155436779|NCT01751646|561026359|FG001|Overall Study|Withdrawal by Subject|4|||
155436780|NCT01751646|561026358|FG000|Overall Study|Starting hormone therapy|1|||
155436781|NCT01751646|561026359|FG001|Overall Study|Starting hormone therapy|0|||
155436782|NCT01751646|561026358|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
155436783|NCT01751646|561026359|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
155436784|NCT01751646|561026358|FG000|Overall Study|Inadvertent enrollment|1|||
155436785|NCT01751646|561026359|FG001|Overall Study|Inadvertent enrollment|1|||
155436786|NCT01751646|561026358|FG000|Overall Study|Moved out of the area|1|||
155436787|NCT01751646|561026359|FG001|Overall Study|Moved out of the area|5|||
155436788|NCT01751646|561026358|FG000|Overall Study|Inability to attend required visits|0|||
155436789|NCT01751646|561026359|FG001|Overall Study|Inability to attend required visits|1|||
155436790|NCT01751646|561026358|FG000|Overall Study|Off study due to multiple obligations|0|||
155436791|NCT01751646|561026359|FG001|Overall Study|Off study due to multiple obligations|1|||
155651073|NCT01755156|561814516|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
155651074|NCT01052428|561814517|FG000|Overall Study|Death|1|||
155651075|NCT01052428|561814518|FG001|Overall Study|Death|0|||
155651076|NCT01052428|561814517|FG000|Overall Study|Withdrawal by Subject|0|||
155651077|NCT01052428|561814518|FG001|Overall Study|Withdrawal by Subject|1|||
155651078|NCT00871000|561814519|FG000|Overall Study|Withdrawal by Subject|1|||
155651079|NCT00871000|561814520|FG001|Overall Study|Withdrawal by Subject|0|||
155651080|NCT01061710|561814524|FG000|Overall Study|Protocol Violation|14|||
155651081|NCT02771145|561814528|FG000|Overall Study|Adverse Event|3|||
155651082|NCT02771145|561814528|FG000|Overall Study|Lost to Follow-up|1|||
155651083|NCT03473301|561814532|FG000|Overall Study|Protocol Violation|4|||
155651084|NCT03473301|561814533|FG001|Overall Study|Protocol Violation|0|||
155651085|NCT03473301|561814534|FG002|Overall Study|Protocol Violation|0|||
155651086|NCT03473301|561814532|FG000|Overall Study|Withdrawal by Subject|0|||
155651087|NCT03473301|561814533|FG001|Overall Study|Withdrawal by Subject|1|||
155651088|NCT03473301|561814534|FG002|Overall Study|Withdrawal by Subject|0|||
155436792|NCT01751646|561026358|FG000|Overall Study|Fails to comply with study requirements|0|||
155436793|NCT01751646|561026359|FG001|Overall Study|Fails to comply with study requirements|1|||
155436794|NCT01751646|561026358|FG000|Overall Study|Childcare issues|1|||
155436795|NCT01751646|561026359|FG001|Overall Study|Childcare issues|1|||
155436796|NCT02190591|561026360|FG000|Overall Study|Withdrawal by Subject|1|||
155436797|NCT02190591|561026361|FG001|Overall Study|Withdrawal by Subject|8|||
155436798|NCT02190591|561026360|FG000|Overall Study|Protocol Violation|1|||
155436799|NCT02190591|561026361|FG001|Overall Study|Protocol Violation|0|||
155436800|NCT02190591|561026360|FG000|Overall Study|did not use peanut ball as instructed|0|||
155651089|NCT03473301|561814532|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
155436801|NCT02190591|561026361|FG001|Overall Study|did not use peanut ball as instructed|2|||
155651090|NCT03473301|561814533|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
155651091|NCT03473301|561814534|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
155651092|NCT05287685|561814535|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
155436802|NCT02190591|561026360|FG000|Overall Study|face presentation so she was ineligible|0|||
155436803|NCT02190591|561026361|FG001|Overall Study|face presentation so she was ineligible|1|||
155436804|NCT00857246|561026362|FG000|Induction Regimen|Adverse Event|1|||
155436805|NCT00857246|561026362|FG000|Induction Regimen|disease-related complications|1|||
155436806|NCT00857246|561026362|FG000|Induction Regimen|Withdrawal by Subject|1|||
155436807|NCT00857246|561026362|FG000|Surgery (Curative)|disease progression|6|||
155436808|NCT00857246|561026362|FG000|ChemoRT|Withdrawal by Subject|1|||
155436809|NCT00857246|561026362|FG000|ChemoRT|Adverse Event|2|||
155436810|NCT02426086|561026363|FG000|Overall Study|Death|33|||
155436811|NCT02426086|561026364|FG001|Overall Study|Death|36|||
155436812|NCT02426086|561026363|FG000|Overall Study|Lost to Follow-up|2|||
155436813|NCT02426086|561026364|FG001|Overall Study|Lost to Follow-up|0|||
155436814|NCT02426086|561026363|FG000|Overall Study|Study Terminated by Sponsor|5|||
155436815|NCT02426086|561026364|FG001|Overall Study|Study Terminated by Sponsor|14|||
155436816|NCT02426086|561026363|FG000|Overall Study|Withdrawal by Subject|8|||
155436817|NCT02426086|561026364|FG001|Overall Study|Withdrawal by Subject|9|||
155436818|NCT04542291|561026365|FG000|Overall Study|Adverse Event|1|||
155436819|NCT04542291|561026365|FG000|Overall Study|Physician Decision|2|||
155436820|NCT00524303|561026366|FG000|Overall Study|Lost to Follow-up|6|||
155436821|NCT00524303|561026367|FG001|Overall Study|Lost to Follow-up|0|||
155436822|NCT00524303|561026368|FG002|Overall Study|Lost to Follow-up|3|||
155436823|NCT00524303|561026366|FG000|Overall Study|Protocol Violation|0|||
155436824|NCT00524303|561026367|FG001|Overall Study|Protocol Violation|1|||
155436825|NCT00524303|561026368|FG002|Overall Study|Protocol Violation|1|||
155436826|NCT00524303|561026366|FG000|Overall Study|Withdrawal by Subject|3|||
155436827|NCT00524303|561026367|FG001|Overall Study|Withdrawal by Subject|0|||
155436828|NCT00524303|561026368|FG002|Overall Study|Withdrawal by Subject|4|||
155436829|NCT00524303|561026366|FG000|Overall Study|Death|0|||
155436830|NCT00524303|561026367|FG001|Overall Study|Death|2|||
155436831|NCT00524303|561026368|FG002|Overall Study|Death|3|||
155436832|NCT00524303|561026366|FG000|Overall Study|Adverse Event|1|||
155436833|NCT00524303|561026367|FG001|Overall Study|Adverse Event|2|||
155436834|NCT00524303|561026368|FG002|Overall Study|Adverse Event|3|||
155436835|NCT00524303|561026366|FG000|Overall Study|Did not Complete Study Dosing|1|||
155436836|NCT00524303|561026367|FG001|Overall Study|Did not Complete Study Dosing|0|||
155436837|NCT00524303|561026368|FG002|Overall Study|Did not Complete Study Dosing|0|||
155436838|NCT00524303|561026366|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
155436839|NCT00524303|561026367|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
155436840|NCT00524303|561026368|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
155436841|NCT00524303|561026366|FG000|Overall Study|Disease Progression|0|||
155436842|NCT00524303|561026367|FG001|Overall Study|Disease Progression|4|||
155436843|NCT00524303|561026368|FG002|Overall Study|Disease Progression|1|||
155436844|NCT00524303|561026366|FG000|Overall Study|Disease Recurrence|0|||
155436845|NCT00524303|561026367|FG001|Overall Study|Disease Recurrence|1|||
155436846|NCT00524303|561026368|FG002|Overall Study|Disease Recurrence|0|||
155436847|NCT00524303|561026366|FG000|Overall Study|Sponsor Request|0|||
155436848|NCT00524303|561026367|FG001|Overall Study|Sponsor Request|0|||
155436849|NCT00524303|561026368|FG002|Overall Study|Sponsor Request|1|||
155436850|NCT00524303|561026366|FG000|Overall Study|Physician Decision|0|||
155436851|NCT00524303|561026367|FG001|Overall Study|Physician Decision|0|||
155436852|NCT00524303|561026368|FG002|Overall Study|Physician Decision|1|||
155436853|NCT00524303|561026366|FG000|Overall Study|Completed 5 years|0|||
155436854|NCT00524303|561026367|FG001|Overall Study|Completed 5 years|0|||
155436855|NCT00524303|561026368|FG002|Overall Study|Completed 5 years|1|||
155436856|NCT03478683|561026369|FG000|Overall Study|Adverse Event|5|||
155436857|NCT03478683|561026370|FG001|Overall Study|Adverse Event|3|||
155436858|NCT03478683|561026369|FG000|Overall Study|Lost to Follow-up|0|||
155436859|NCT03478683|561026370|FG001|Overall Study|Lost to Follow-up|5|||
155436860|NCT03478683|561026369|FG000|Overall Study|Physician Decision|1|||
155436861|NCT03478683|561026370|FG001|Overall Study|Physician Decision|3|||
155436862|NCT03478683|561026369|FG000|Overall Study|Withdrawal by Subject|7|||
155436863|NCT03478683|561026370|FG001|Overall Study|Withdrawal by Subject|7|||
155436864|NCT01607892|561026375|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
155436865|NCT01607892|561026376|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
155436866|NCT01607892|561026377|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
155436867|NCT01607892|561026378|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
155436868|NCT01607892|561026379|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
155436869|NCT01607892|561026375|FG000|Overall Study|Death|4|||
155436870|NCT01607892|561026376|FG001|Overall Study|Death|2|||
155436871|NCT01607892|561026377|FG002|Overall Study|Death|8|||
155436872|NCT01607892|561026378|FG003|Overall Study|Death|10|||
155436873|NCT01607892|561026379|FG004|Overall Study|Death|3|||
155436874|NCT01607892|561026375|FG000|Overall Study|Investigator discretion|2|||
155436875|NCT01607892|561026376|FG001|Overall Study|Investigator discretion|4|||
155436876|NCT01607892|561026377|FG002|Overall Study|Investigator discretion|4|||
155436877|NCT01607892|561026378|FG003|Overall Study|Investigator discretion|8|||
155436878|NCT01607892|561026379|FG004|Overall Study|Investigator discretion|0|||
155436879|NCT01607892|561026375|FG000|Overall Study|Other treatments became available|1|||
155436880|NCT01607892|561026376|FG001|Overall Study|Other treatments became available|1|||
155436881|NCT01607892|561026377|FG002|Overall Study|Other treatments became available|0|||
155436882|NCT01607892|561026378|FG003|Overall Study|Other treatments became available|0|||
155436883|NCT01607892|561026379|FG004|Overall Study|Other treatments became available|2|||
155436884|NCT01607892|561026375|FG000|Overall Study|Intercurrent illness|1|||
155436885|NCT01607892|561026376|FG001|Overall Study|Intercurrent illness|0|||
155436886|NCT01607892|561026377|FG002|Overall Study|Intercurrent illness|0|||
155436887|NCT01607892|561026378|FG003|Overall Study|Intercurrent illness|3|||
155436888|NCT01607892|561026379|FG004|Overall Study|Intercurrent illness|0|||
155436889|NCT01607892|561026375|FG000|Overall Study|Non-Compliance with study procedures|0|||
155436890|NCT01607892|561026376|FG001|Overall Study|Non-Compliance with study procedures|0|||
155436891|NCT01607892|561026377|FG002|Overall Study|Non-Compliance with study procedures|1|||
155436892|NCT01607892|561026378|FG003|Overall Study|Non-Compliance with study procedures|0|||
155436893|NCT01607892|561026379|FG004|Overall Study|Non-Compliance with study procedures|0|||
155436894|NCT01607892|561026375|FG000|Overall Study|Consent withdrawn by participant|9|||
155436895|NCT01607892|561026376|FG001|Overall Study|Consent withdrawn by participant|4|||
155436896|NCT01607892|561026377|FG002|Overall Study|Consent withdrawn by participant|24|||
155436897|NCT01607892|561026378|FG003|Overall Study|Consent withdrawn by participant|14|||
155436898|NCT01607892|561026379|FG004|Overall Study|Consent withdrawn by participant|4|||
155436899|NCT01607892|561026375|FG000|Overall Study|Disease progression|38|||
155436900|NCT01607892|561026376|FG001|Overall Study|Disease progression|13|||
155436901|NCT01607892|561026377|FG002|Overall Study|Disease progression|37|||
155436902|NCT01607892|561026378|FG003|Overall Study|Disease progression|57|||
155436903|NCT01607892|561026379|FG004|Overall Study|Disease progression|9|||
155436904|NCT01607892|561026375|FG000|Overall Study|Incidence or severity of Adverse events|3|||
155436905|NCT01607892|561026376|FG001|Overall Study|Incidence or severity of Adverse events|3|||
155436906|NCT01607892|561026377|FG002|Overall Study|Incidence or severity of Adverse events|7|||
155436907|NCT01607892|561026378|FG003|Overall Study|Incidence or severity of Adverse events|2|||
155436908|NCT01607892|561026379|FG004|Overall Study|Incidence or severity of Adverse events|6|||
155436909|NCT03022422|561026382|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
155436910|NCT03022422|561026383|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
155436911|NCT03022422|561026384|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
155436912|NCT03022422|561026385|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
155436913|NCT03022422|561026386|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
155436914|NCT03022422|561026387|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
155436915|NCT01287117|561026388|FG000|Overall Study|Adverse Event|2|||
155436916|NCT01287117|561026389|FG001|Overall Study|Adverse Event|1|||
155436917|NCT01287117|561026390|FG002|Overall Study|Adverse Event|1|||
155436918|NCT01287117|561026391|FG003|Overall Study|Adverse Event|1|||
155436919|NCT01287117|561026388|FG000|Overall Study|Lost to Follow-up|1|||
155436920|NCT01287117|561026389|FG001|Overall Study|Lost to Follow-up|1|||
155436921|NCT01287117|561026390|FG002|Overall Study|Lost to Follow-up|0|||
155436922|NCT01287117|561026391|FG003|Overall Study|Lost to Follow-up|0|||
155436923|NCT01287117|561026388|FG000|Overall Study|Physician Decision|0|||
155436924|NCT01287117|561026389|FG001|Overall Study|Physician Decision|1|||
155436925|NCT01287117|561026390|FG002|Overall Study|Physician Decision|1|||
155514242|NCT04700449|561310230|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
155436926|NCT01287117|561026391|FG003|Overall Study|Physician Decision|1|||
155436927|NCT01287117|561026388|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
155436928|NCT01287117|561026389|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
155436929|NCT01287117|561026390|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
155436930|NCT01287117|561026391|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
155436931|NCT01287117|561026388|FG000|Overall Study|Disease Progression|10|||
155436932|NCT01287117|561026389|FG001|Overall Study|Disease Progression|5|||
155436933|NCT01287117|561026390|FG002|Overall Study|Disease Progression|6|||
155436934|NCT01287117|561026391|FG003|Overall Study|Disease Progression|5|||
155436935|NCT01769404|561026397|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
155436936|NCT01769404|561026398|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
155436937|NCT01769404|561026397|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155436938|NCT01769404|561026398|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155436939|NCT01769404|561026397|FG000|Treatment Period 1|Sponsor decision|1|||
155436940|NCT01769404|561026398|FG001|Treatment Period 1|Sponsor decision|0|||
155436941|NCT01769404|561026397|FG000|Treatment Period 2|Sponsor decision|7|||
155436942|NCT01769404|561026398|FG001|Treatment Period 2|Sponsor decision|0|||
155436943|NCT02277444|561026410|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
155436944|NCT02277444|561026410|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
155436945|NCT02277444|561026410|FG000|Treatment Period (Week 0-52)|Other|1|||
155436946|NCT02277444|561026410|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
155436947|NCT02277444|561026410|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
155436948|NCT02277444|561026410|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
155436949|NCT02277444|561026410|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
155436950|NCT02277444|561026410|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
155436951|NCT02277444|561026410|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
155436952|NCT05278104|561026411|FG000|Overall Study|Not treated|1|||
155436953|NCT05278104|561026412|FG001|Overall Study|Not treated|0|||
155436954|NCT05278104|561026411|FG000|Overall Study|Adverse Event|2|||
155436955|NCT05278104|561026412|FG001|Overall Study|Adverse Event|1|||
155436956|NCT05278104|561026411|FG000|Overall Study|Exclusion criteria not met|1|||
155436957|NCT05278104|561026412|FG001|Overall Study|Exclusion criteria not met|0|||
155491123|NCT01023815|561223475|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
155491124|NCT01023815|561223476|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
155491125|NCT01023815|561223477|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
155491126|NCT01023815|561223474|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
155491127|NCT01023815|561223475|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
155491128|NCT01023815|561223476|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
155491129|NCT01023815|561223477|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
155491130|NCT01023815|561223474|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
155491131|NCT01023815|561223475|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
155491132|NCT01023815|561223476|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
155651093|NCT05287685|561814536|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
155491133|NCT01023815|561223477|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
155491134|NCT01023815|561223474|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
155491135|NCT01023815|561223475|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
155491136|NCT01023815|561223476|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
155436958|NCT05635838|561028633|FG000|16-Week DBVC Period|Adverse Event|2|||
155436959|NCT05635838|561028634|FG001|16-Week DBVC Period|Adverse Event|0|||
155436960|NCT05635838|561028635|FG002|16-Week DBVC Period|Adverse Event|0|||
155436961|NCT05635838|561028636|FG003|16-Week DBVC Period|Adverse Event|0|||
155436962|NCT05635838|561028633|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
155436963|NCT05635838|561028634|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
155514243|NCT04700449|561310227|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
155436964|NCT05635838|561028635|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
155436965|NCT05635838|561028636|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
155436966|NCT05635838|561028633|FG000|16-Week DBVC Period|Physician Decision|0|||
155436967|NCT05635838|561028634|FG001|16-Week DBVC Period|Physician Decision|1|||
155436968|NCT05635838|561028635|FG002|16-Week DBVC Period|Physician Decision|0|||
155436969|NCT05635838|561028636|FG003|16-Week DBVC Period|Physician Decision|0|||
155436970|NCT05635838|561028633|FG000|16-Week DBVC Period|Protocol Violation|1|||
155436971|NCT05635838|561028634|FG001|16-Week DBVC Period|Protocol Violation|0|||
155436972|NCT05635838|561028635|FG002|16-Week DBVC Period|Protocol Violation|0|||
155436973|NCT05635838|561028636|FG003|16-Week DBVC Period|Protocol Violation|0|||
155436974|NCT05635838|561028633|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
155436975|NCT05635838|561028634|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
155436976|NCT05635838|561028635|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
155436977|NCT05635838|561028636|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
155436978|NCT05635838|561028633|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
155436979|NCT05635838|561028634|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
155436980|NCT05635838|561028635|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
155436981|NCT05635838|561028636|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
155436982|NCT05635838|561028633|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
155436983|NCT05635838|561028634|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
155436984|NCT05635838|561028635|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
155436985|NCT05635838|561028636|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
155436986|NCT05635838|561028633|FG000|16-Week OLE Period|Adverse Event|0|||
155436987|NCT05635838|561028634|FG001|16-Week OLE Period|Adverse Event|0|||
155436988|NCT05635838|561028635|FG002|16-Week OLE Period|Adverse Event|0|||
155436989|NCT05635838|561028636|FG003|16-Week OLE Period|Adverse Event|2|||
155436990|NCT05635838|561028633|FG000|16-Week OLE Period|Lost to Follow-up|0|||
155436991|NCT05635838|561028634|FG001|16-Week OLE Period|Lost to Follow-up|0|||
155436992|NCT05635838|561028635|FG002|16-Week OLE Period|Lost to Follow-up|1|||
155436993|NCT05635838|561028636|FG003|16-Week OLE Period|Lost to Follow-up|3|||
155436994|NCT05635838|561028633|FG000|16-Week OLE Period|Physician Decision|0|||
155436995|NCT05635838|561028634|FG001|16-Week OLE Period|Physician Decision|0|||
155436996|NCT05635838|561028635|FG002|16-Week OLE Period|Physician Decision|0|||
155436997|NCT05635838|561028636|FG003|16-Week OLE Period|Physician Decision|1|||
155436998|NCT05635838|561028633|FG000|16-Week OLE Period|Protocol Violation|0|||
155436999|NCT05635838|561028634|FG001|16-Week OLE Period|Protocol Violation|0|||
155437000|NCT05635838|561028635|FG002|16-Week OLE Period|Protocol Violation|1|||
155437001|NCT05635838|561028636|FG003|16-Week OLE Period|Protocol Violation|1|||
155437002|NCT05635838|561028633|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
155437003|NCT05635838|561028634|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
155437004|NCT05635838|561028635|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
155437005|NCT05635838|561028636|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
155437006|NCT05635838|561028633|FG000|16-Week OLE Period|Pregnancy|0|||
155437007|NCT05635838|561028634|FG001|16-Week OLE Period|Pregnancy|0|||
155437008|NCT05635838|561028635|FG002|16-Week OLE Period|Pregnancy|1|||
155437009|NCT05635838|561028636|FG003|16-Week OLE Period|Pregnancy|0|||
155437010|NCT02031146|561028638|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
155437011|NCT02031146|561028639|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
155437012|NCT02031146|561028640|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
155437013|NCT02031146|561028641|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
155437014|NCT02031146|561028642|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
155437015|NCT02031146|561028643|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
155437016|NCT02031146|561028644|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
155437017|NCT02629393|561028645|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
155437018|NCT02629393|561028645|FG000|Overall Study|Physician Decision|1|||
155437019|NCT00744055|561028646|FG000|Overall Study|Withdrawal by Subject|6|||
155437020|NCT00744055|561028647|FG001|Overall Study|Withdrawal by Subject|9|||
155437021|NCT00744055|561028646|FG000|Overall Study|Lack of Efficacy|0|||
155437022|NCT00744055|561028647|FG001|Overall Study|Lack of Efficacy|1|||
155437023|NCT00744055|561028646|FG000|Overall Study|Physician Decision|0|||
155437024|NCT00744055|561028647|FG001|Overall Study|Physician Decision|2|||
155514244|NCT04700449|561310228|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
155514245|NCT04700449|561310229|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
155514246|NCT04700449|561310230|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
155514247|NCT04700449|561310227|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
155514248|NCT04700449|561310228|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
155514249|NCT04700449|561310229|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
155514250|NCT04700449|561310230|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
155514251|NCT04700449|561310227|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
155437025|NCT00744055|561028646|FG000|Overall Study|Protocol Violation|1|||
155437026|NCT00744055|561028647|FG001|Overall Study|Protocol Violation|1|||
155437027|NCT00744055|561028646|FG000|Overall Study|Lost to Follow-up|0|||
155514252|NCT04700449|561310228|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
155437028|NCT00744055|561028647|FG001|Overall Study|Lost to Follow-up|1|||
155514253|NCT04700449|561310229|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
155437029|NCT02413255|561028650|FG000|Overall Study|Voluntary Withdrawal|0|||
155437030|NCT02413255|561028651|FG001|Overall Study|Voluntary Withdrawal|0|||
155437031|NCT02413255|561028652|FG002|Overall Study|Voluntary Withdrawal|0|||
155437032|NCT02413255|561028653|FG003|Overall Study|Voluntary Withdrawal|0|||
155437033|NCT02413255|561028654|FG004|Overall Study|Voluntary Withdrawal|0|||
155437034|NCT02413255|561028655|FG005|Overall Study|Voluntary Withdrawal|0|||
155437035|NCT02413255|561028656|FG006|Overall Study|Voluntary Withdrawal|0|||
155437036|NCT02413255|561028657|FG007|Overall Study|Voluntary Withdrawal|0|||
155437037|NCT02413255|561028658|FG008|Overall Study|Voluntary Withdrawal|0|||
155437038|NCT02413255|561028659|FG009|Overall Study|Voluntary Withdrawal|0|||
155437039|NCT02413255|561028660|FG010|Overall Study|Voluntary Withdrawal|0|||
155437040|NCT02413255|561028661|FG011|Overall Study|Voluntary Withdrawal|0|||
155437041|NCT02413255|561028662|FG012|Overall Study|Voluntary Withdrawal|0|||
155437042|NCT02413255|561028663|FG013|Overall Study|Voluntary Withdrawal|0|||
155437043|NCT02413255|561028664|FG014|Overall Study|Voluntary Withdrawal|1|||
155437044|NCT02413255|561028665|FG015|Overall Study|Voluntary Withdrawal|0|||
155437045|NCT02413255|561028666|FG016|Overall Study|Voluntary Withdrawal|0|||
155437046|NCT02760602|561028669|FG000|Overall Study|Withdrawal by Subject|1|||
155437047|NCT02760602|561028670|FG001|Overall Study|Withdrawal by Subject|0|||
155437048|NCT02760602|561028669|FG000|Overall Study|Terminated by sponsor|12|||
155437049|NCT02760602|561028670|FG001|Overall Study|Terminated by sponsor|13|||
155437050|NCT03056287|561028671|FG000|Overall Study|Withdrawal by Subject|0|||
155437051|NCT03056287|561028672|FG001|Overall Study|Withdrawal by Subject|1|||
155437052|NCT03056287|561028673|FG002|Overall Study|Withdrawal by Subject|0|||
155437053|NCT03056287|561028674|FG003|Overall Study|Withdrawal by Subject|0|||
155437054|NCT03056287|561028671|FG000|Overall Study|move out of area|0|||
155437055|NCT03056287|561028672|FG001|Overall Study|move out of area|0|||
155437056|NCT03056287|561028673|FG002|Overall Study|move out of area|1|||
155437057|NCT03056287|561028674|FG003|Overall Study|move out of area|1|||
155437058|NCT02424149|561028676|FG000|Overall Study|surgery cancelled|2|||
155437059|NCT02424149|561028677|FG001|Overall Study|surgery cancelled|0|||
155437060|NCT02424149|561028676|FG000|Overall Study|Withdrawal by Subject|0|||
155437061|NCT02424149|561028677|FG001|Overall Study|Withdrawal by Subject|1|||
155437062|NCT01357239|561028682|FG000|Stratum: All Patients|Adverse Event|0|||
155437063|NCT01357239|561028683|FG001|Stratum: All Patients|Adverse Event|0|||
155437064|NCT01357239|561028684|FG002|Stratum: All Patients|Adverse Event|1|||
155437065|NCT01357239|561028685|FG003|Stratum: All Patients|Adverse Event|1|||
155437066|NCT01357239|561028682|FG000|Stratum: All Patients|Subject withdrew consent|0|||
155437067|NCT01357239|561028683|FG001|Stratum: All Patients|Subject withdrew consent|0|||
155437068|NCT01357239|561028684|FG002|Stratum: All Patients|Subject withdrew consent|1|||
155437069|NCT01357239|561028685|FG003|Stratum: All Patients|Subject withdrew consent|1|||
155437070|NCT01357239|561028682|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
155437071|NCT01357239|561028683|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
155437072|NCT01357239|561028684|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
155437073|NCT01357239|561028685|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
155437074|NCT01357239|561028682|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
155437075|NCT01357239|561028683|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
155437076|NCT01357239|561028684|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
155437077|NCT01357239|561028685|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
155437078|NCT01357239|561028682|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
155437079|NCT01357239|561028683|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
155437080|NCT01357239|561028684|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
155437081|NCT01357239|561028685|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
155437082|NCT00852930|561028693|FG000|Overall Study|Withdrawal by Subject|1|||
155437083|NCT00852930|561028694|FG001|Overall Study|Withdrawal by Subject|1|||
155437084|NCT00852930|561028695|FG002|Overall Study|Withdrawal by Subject|1|||
155437085|NCT00852930|561028693|FG000|Overall Study|Physician Decision|0|||
155437086|NCT00852930|561028694|FG001|Overall Study|Physician Decision|0|||
155437087|NCT00852930|561028695|FG002|Overall Study|Physician Decision|1|||
155437088|NCT00779038|561028696|FG000|Overall Study|Study Prematurely Terminated|13|||
155437089|NCT05372315|561028697|FG000|Overall Study|Withdrawal by Subject|1|||
155437090|NCT05372315|561028698|FG001|Overall Study|Withdrawal by Subject|0|||
155437091|NCT00328198|561028699|FG000|Treatment|Adverse Event|21|||
155437092|NCT00328198|561028699|FG000|Treatment|Death|1|||
155437093|NCT00328198|561028699|FG000|Treatment|Physician Decision|5|||
155437094|NCT00328198|561028699|FG000|Treatment|Withdrawal by Subject|5|||
155437095|NCT00328198|561028699|FG000|Treatment|Evidence of disease progression|2|||
155437096|NCT00328198|561028699|FG000|Treatment|Non-compliance|1|||
155437097|NCT00328198|561028699|FG000|Treatment|Confirmed complete response, MRD -|3|||
155437098|NCT00328198|561028699|FG000|Follow-up|Lost to Follow-up|4|||
155437099|NCT00328198|561028699|FG000|Follow-up|Death|31|||
155437100|NCT00650585|561028700|FG000|Overall Study|Lost to Follow-up|505|||
155437101|NCT00650585|561028701|FG001|Overall Study|Lost to Follow-up|482|||
155437102|NCT00650585|561028700|FG000|Overall Study|No parental consent|935|||
155437103|NCT00650585|561028701|FG001|Overall Study|No parental consent|866|||
155437104|NCT00650585|561028700|FG000|Overall Study|Excluded/ruled ineligible|357|||
155437105|NCT00650585|561028701|FG001|Overall Study|Excluded/ruled ineligible|129|||
155437106|NCT02640612|561028702|FG000|Overall Study|Adverse Event|6|||
155437107|NCT02640612|561028703|FG001|Overall Study|Adverse Event|7|||
155437108|NCT02640612|561028704|FG002|Overall Study|Adverse Event|2|||
155437109|NCT02640612|561028702|FG000|Overall Study|Death|1|||
155437110|NCT02640612|561028703|FG001|Overall Study|Death|0|||
155437111|NCT02640612|561028704|FG002|Overall Study|Death|0|||
155437112|NCT02640612|561028702|FG000|Overall Study|Withdrawal by Subject|10|||
155437113|NCT02640612|561028703|FG001|Overall Study|Withdrawal by Subject|3|||
155437114|NCT02640612|561028704|FG002|Overall Study|Withdrawal by Subject|3|||
155437115|NCT02640612|561028702|FG000|Overall Study|Lost to Follow-up|4|||
155437116|NCT02640612|561028703|FG001|Overall Study|Lost to Follow-up|1|||
155437117|NCT02640612|561028704|FG002|Overall Study|Lost to Follow-up|1|||
155437118|NCT02640612|561028702|FG000|Overall Study|Protocol Violation|0|||
155437119|NCT02640612|561028703|FG001|Overall Study|Protocol Violation|2|||
155437120|NCT02640612|561028704|FG002|Overall Study|Protocol Violation|0|||
155437121|NCT02640612|561028702|FG000|Overall Study|Lack of Efficacy|1|||
155651094|NCT05287685|561814535|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
155651095|NCT05287685|561814536|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
155651096|NCT05529173|561814537|FG000|Overall Study|Physician Decision|3|||
155651097|NCT05529173|561814538|FG001|Overall Study|Physician Decision|6|||
155651098|NCT05529173|561814537|FG000|Overall Study|Sample shipment delay more than one day|4|||
155651099|NCT05529173|561814538|FG001|Overall Study|Sample shipment delay more than one day|0|||
155651100|NCT00835549|561814541|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
155651101|NCT00835549|561814542|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155651102|NCT03760081|561814556|FG000|Overall Study|Miscellaneous|0|||
155651103|NCT03760081|561814557|FG001|Overall Study|Miscellaneous|1|||
155651104|NCT03760081|561814556|FG000|Overall Study|Progressive Disease|5|||
155651105|NCT03760081|561814557|FG001|Overall Study|Progressive Disease|10|||
155651106|NCT03760081|561814556|FG000|Overall Study|Death|1|||
155651107|NCT03760081|561814557|FG001|Overall Study|Death|1|||
155651108|NCT00986102|561814558|FG000|Overall Study|Lost to Follow-up|0|||
155651109|NCT00986102|561814559|FG001|Overall Study|Lost to Follow-up|1|||
155651110|NCT00986102|561814560|FG002|Overall Study|Lost to Follow-up|0|||
155651111|NCT00986102|561814561|FG003|Overall Study|Lost to Follow-up|1|||
155651112|NCT00986102|561814558|FG000|Overall Study|Withdrawal by Subject|1|||
155651113|NCT00986102|561814559|FG001|Overall Study|Withdrawal by Subject|1|||
155651114|NCT00986102|561814560|FG002|Overall Study|Withdrawal by Subject|0|||
155651115|NCT00986102|561814561|FG003|Overall Study|Withdrawal by Subject|0|||
155651116|NCT04008069|561814562|FG000|Open-Label Period|Adverse Event|1|||
155651117|NCT04008069|561814563|FG001|Open-Label Period|Adverse Event|0|||
155651118|NCT04008069|561814564|FG002|Open-Label Period|Adverse Event|0|||
155651119|NCT04008069|561814562|FG000|Open-Label Period|Lack of Efficacy|4|||
155651120|NCT04008069|561814563|FG001|Open-Label Period|Lack of Efficacy|0|||
155651121|NCT04008069|561814564|FG002|Open-Label Period|Lack of Efficacy|0|||
155651122|NCT04008069|561814562|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
155651123|NCT04008069|561814563|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
155651124|NCT04008069|561814564|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
155651125|NCT04008069|561814562|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
155651126|NCT04008069|561814563|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
155437122|NCT02640612|561028703|FG001|Overall Study|Lack of Efficacy|1|||
155437123|NCT02640612|561028704|FG002|Overall Study|Lack of Efficacy|0|||
155437124|NCT03865407|561028722|FG000|Overall Study|Adverse Event|1|||
155437125|NCT03865407|561028723|FG001|Overall Study|Adverse Event|0|||
155437126|NCT03865407|561028722|FG000|Overall Study|Withdrawal by Subject|1|||
155437127|NCT03865407|561028723|FG001|Overall Study|Withdrawal by Subject|0|||
155437128|NCT03865407|561028722|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
155437129|NCT03865407|561028723|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
155437130|NCT02117050|561028724|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
155437131|NCT00546819|561028730|FG000|Overall Study|Adverse Event|2|||
155437132|NCT00546819|561028731|FG001|Overall Study|Adverse Event|3|||
155437133|NCT00546819|561028730|FG000|Overall Study|Lost to Follow-up|2|||
155437134|NCT00546819|561028731|FG001|Overall Study|Lost to Follow-up|1|||
155437135|NCT00546819|561028730|FG000|Overall Study|Withdrawal by Subject|4|||
155437136|NCT00546819|561028731|FG001|Overall Study|Withdrawal by Subject|2|||
155437137|NCT03849560|561028732|FG000|Overall Study|Withdrawal by Subject|1|||
155437138|NCT03849560|561028733|FG001|Overall Study|Withdrawal by Subject|0|||
155437139|NCT03849560|561028734|FG002|Overall Study|Withdrawal by Subject|0|||
155437140|NCT01254344|561028739|FG000|Overall Study|Adverse Event|2|||
155437141|NCT01254344|561028740|FG001|Overall Study|Adverse Event|5|||
155437142|NCT01254344|561028739|FG000|Overall Study|Physician Decision|7|||
155437143|NCT01254344|561028740|FG001|Overall Study|Physician Decision|4|||
155437144|NCT01254344|561028739|FG000|Overall Study|Protocol Violation|1|||
155437145|NCT01254344|561028740|FG001|Overall Study|Protocol Violation|4|||
155437146|NCT01254344|561028739|FG000|Overall Study|Withdrawal by Subject|3|||
155437147|NCT01254344|561028740|FG001|Overall Study|Withdrawal by Subject|6|||
155437148|NCT00467649|561028741|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
155437149|NCT00467649|561028742|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
155437150|NCT00467649|561028743|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
155437151|NCT00467649|561028744|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
155437152|NCT00467649|561028745|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
155437153|NCT00467649|561028746|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
155437154|NCT00467649|561028741|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
155437155|NCT00467649|561028742|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
155437156|NCT00467649|561028743|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
155437157|NCT00467649|561028744|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
155437158|NCT00467649|561028745|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
155651127|NCT04008069|561814564|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
155651128|NCT02314247|561814571|FG000|Overall Study|Adverse Event|2|||
155651129|NCT02314247|561814572|FG001|Overall Study|Adverse Event|1|||
155651130|NCT02314247|561814573|FG002|Overall Study|Adverse Event|0|||
155437159|NCT00467649|561028746|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
155437160|NCT00467649|561028741|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
155437161|NCT00467649|561028742|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
155437162|NCT00467649|561028743|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
155437163|NCT00467649|561028744|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
155437164|NCT00467649|561028745|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
155437165|NCT00467649|561028746|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
155437166|NCT00467649|561028741|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
155437167|NCT00467649|561028742|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
155437168|NCT00467649|561028743|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
155437169|NCT00467649|561028744|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
155437170|NCT00467649|561028745|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
155437171|NCT00467649|561028746|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
155437172|NCT00467649|561028741|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
155437173|NCT00467649|561028742|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
155437174|NCT00467649|561028743|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
155437175|NCT00467649|561028744|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
155437176|NCT00467649|561028745|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
155437177|NCT00467649|561028746|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
155437178|NCT00467649|561028741|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155437179|NCT00467649|561028742|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155437180|NCT00467649|561028743|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155437181|NCT00467649|561028744|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
155437182|NCT00467649|561028745|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155437183|NCT00467649|561028746|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155437184|NCT00467649|561028741|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155437185|NCT00467649|561028742|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155437186|NCT00467649|561028743|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155651131|NCT02314247|561814571|FG000|Overall Study|Withdrawal by Subject|1|||
155437187|NCT00467649|561028744|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155437188|NCT00467649|561028745|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155437189|NCT00467649|561028746|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
155437190|NCT01633060|561028747|FG000|Randomization Phase|Protocol deviation|1|||
155437191|NCT01633060|561028748|FG001|Randomization Phase|Protocol deviation|2|||
155437192|NCT01633060|561028747|FG000|Randomization Phase|Technical problem|0|||
155437193|NCT01633060|561028748|FG001|Randomization Phase|Technical problem|1|||
155437194|NCT01633060|561028747|FG000|Treatment Phase|Adverse Event|24|||
155437195|NCT01633060|561028748|FG001|Treatment Phase|Adverse Event|3|||
155437196|NCT01633060|561028747|FG000|Treatment Phase|Lost to Follow-up|1|||
155437197|NCT01633060|561028748|FG001|Treatment Phase|Lost to Follow-up|0|||
155437198|NCT01633060|561028747|FG000|Treatment Phase|Physician Decision|16|||
155437199|NCT01633060|561028748|FG001|Treatment Phase|Physician Decision|7|||
155437200|NCT01633060|561028747|FG000|Treatment Phase|Progressive Disease|210|||
155437201|NCT01633060|561028748|FG001|Treatment Phase|Progressive Disease|120|||
155437202|NCT01633060|561028747|FG000|Treatment Phase|Protocol Deviation|1|||
155437203|NCT01633060|561028748|FG001|Treatment Phase|Protocol Deviation|0|||
155437204|NCT01633060|561028747|FG000|Treatment Phase|Study Terminated by sponsor|7|||
155437205|NCT01633060|561028748|FG001|Treatment Phase|Study Terminated by sponsor|3|||
155437206|NCT01633060|561028747|FG000|Treatment Phase|Subject/guardian decision|25|||
155437207|NCT01633060|561028748|FG001|Treatment Phase|Subject/guardian decision|4|||
155437208|NCT01633060|561028747|FG000|Treatment Phase|Death|4|||
155437209|NCT01633060|561028748|FG001|Treatment Phase|Death|3|||
155437210|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
155437211|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155437212|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
155437213|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
155437214|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
155651132|NCT02314247|561814572|FG001|Overall Study|Withdrawal by Subject|3|||
155651133|NCT02314247|561814573|FG002|Overall Study|Withdrawal by Subject|1|||
155651134|NCT02314247|561814571|FG000|Overall Study|Progression of Disease|6|||
155651135|NCT02314247|561814572|FG001|Overall Study|Progression of Disease|2|||
155651136|NCT02314247|561814573|FG002|Overall Study|Progression of Disease|0|||
155651137|NCT01953354|561814574|FG000|Overall Study|Withdrawal by Subject|0|||
155651138|NCT01953354|561814575|FG001|Overall Study|Withdrawal by Subject|1|||
155651139|NCT01953354|561814574|FG000|Overall Study|Decision of Sponsor|0|||
155651140|NCT01953354|561814575|FG001|Overall Study|Decision of Sponsor|1|||
155651141|NCT01953354|561814574|FG000|Overall Study|Disease Exacerbation|1|||
155651142|NCT01953354|561814575|FG001|Overall Study|Disease Exacerbation|0|||
155651143|NCT01570192|561814576|FG000|Overall Study|no qualifying organism|6|||
155651144|NCT01570192|561814577|FG001|Overall Study|no qualifying organism|12|||
155651145|NCT01570192|561814576|FG000|Overall Study|changed to palliative care|1|||
155651146|NCT01570192|561814577|FG001|Overall Study|changed to palliative care|0|||
155651147|NCT01570192|561814576|FG000|Overall Study|Physician Decision|0|||
155651148|NCT01570192|561814577|FG001|Overall Study|Physician Decision|1|||
155651149|NCT02965976|561814578|FG000|Overall Study|Withdrawal by Subject|2|||
155651150|NCT02965976|561814579|FG001|Overall Study|Withdrawal by Subject|0|||
155651151|NCT00806026|561814580|FG000|Overall Study|Death|0|||
155651152|NCT00806026|561814581|FG001|Overall Study|Death|0|||
155651153|NCT00806026|561814582|FG002|Overall Study|Death|0|||
155651154|NCT00806026|561814583|FG003|Overall Study|Death|1|||
155651155|NCT00806026|561814584|FG004|Overall Study|Death|0|||
155651156|NCT00806026|561814585|FG005|Overall Study|Death|0|||
155651157|NCT00806026|561814580|FG000|Overall Study|Did not meet entrance criteria|4|||
155651158|NCT00806026|561814581|FG001|Overall Study|Did not meet entrance criteria|1|||
155651159|NCT00806026|561814582|FG002|Overall Study|Did not meet entrance criteria|2|||
155651160|NCT00806026|561814583|FG003|Overall Study|Did not meet entrance criteria|1|||
155651161|NCT00806026|561814584|FG004|Overall Study|Did not meet entrance criteria|0|||
155651162|NCT00806026|561814585|FG005|Overall Study|Did not meet entrance criteria|0|||
155651163|NCT00806026|561814580|FG000|Overall Study|Lack of Efficacy|5|||
155651164|NCT00806026|561814581|FG001|Overall Study|Lack of Efficacy|18|||
155651165|NCT00806026|561814582|FG002|Overall Study|Lack of Efficacy|13|||
155651166|NCT00806026|561814583|FG003|Overall Study|Lack of Efficacy|4|||
155651167|NCT00806026|561814584|FG004|Overall Study|Lack of Efficacy|8|||
155651168|NCT00806026|561814585|FG005|Overall Study|Lack of Efficacy|7|||
155651169|NCT00806026|561814580|FG000|Overall Study|Lost to Follow-up|8|||
155651170|NCT00806026|561814581|FG001|Overall Study|Lost to Follow-up|15|||
155651171|NCT00806026|561814582|FG002|Overall Study|Lost to Follow-up|8|||
155651172|NCT00806026|561814583|FG003|Overall Study|Lost to Follow-up|2|||
155651173|NCT00806026|561814584|FG004|Overall Study|Lost to Follow-up|6|||
155651174|NCT00806026|561814585|FG005|Overall Study|Lost to Follow-up|6|||
155651175|NCT00806026|561814580|FG000|Overall Study|Withdrawal by Subject|14|||
155651176|NCT00806026|561814581|FG001|Overall Study|Withdrawal by Subject|17|||
155651177|NCT00806026|561814582|FG002|Overall Study|Withdrawal by Subject|9|||
155437215|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
155437216|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
155437217|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
155437218|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
155437219|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
155437220|NCT01633060|561028747|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
155437221|NCT01633060|561028748|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
155437222|NCT03233048|561028751|FG000|Overall Study|Withdrawal by Subject|1|||
155437223|NCT00491530|561028752|FG000|Overall Study|Adverse Event|6|||
155437224|NCT00491530|561028753|FG001|Overall Study|Adverse Event|1|||
155437225|NCT00491530|561028754|FG002|Overall Study|Adverse Event|2|||
155437226|NCT00491530|561028752|FG000|Overall Study|Withdrawal by Subject|3|||
155437227|NCT00491530|561028753|FG001|Overall Study|Withdrawal by Subject|0|||
155437228|NCT00491530|561028754|FG002|Overall Study|Withdrawal by Subject|0|||
155437229|NCT00491530|561028752|FG000|Overall Study|Lost to Follow-up|3|||
155437230|NCT00491530|561028753|FG001|Overall Study|Lost to Follow-up|2|||
155437231|NCT00491530|561028754|FG002|Overall Study|Lost to Follow-up|2|||
155437232|NCT00491530|561028752|FG000|Overall Study|Lack of Efficacy|0|||
155437233|NCT00491530|561028753|FG001|Overall Study|Lack of Efficacy|1|||
155437234|NCT00491530|561028754|FG002|Overall Study|Lack of Efficacy|0|||
155437235|NCT00491530|561028752|FG000|Overall Study|Investigator Discretion|0|||
155437236|NCT00491530|561028753|FG001|Overall Study|Investigator Discretion|1|||
155437237|NCT00491530|561028754|FG002|Overall Study|Investigator Discretion|0|||
155437238|NCT00491530|561028752|FG000|Overall Study|Patient Request|0|||
155437239|NCT00491530|561028753|FG001|Overall Study|Patient Request|1|||
155437240|NCT00491530|561028754|FG002|Overall Study|Patient Request|0|||
155437241|NCT00491530|561028752|FG000|Overall Study|Use of Prohibited Medication|0|||
155437242|NCT00491530|561028753|FG001|Overall Study|Use of Prohibited Medication|0|||
155437243|NCT00491530|561028754|FG002|Overall Study|Use of Prohibited Medication|1|||
155437244|NCT01856673|561028755|FG000|Overall Study|Withdrawal by Subject|44|||
155437245|NCT01856673|561028756|FG001|Overall Study|Withdrawal by Subject|50|||
155514254|NCT04700449|561310230|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
155514255|NCT04700449|561310227|FG000|Stage 2 Sub-study 2|Other|0|||
155514256|NCT04700449|561310228|FG001|Stage 2 Sub-study 2|Other|0|||
155437246|NCT01856673|561028757|FG002|Overall Study|Withdrawal by Subject|33|||
155437247|NCT01856673|561028755|FG000|Overall Study|Lost to Follow-up|31|||
155437248|NCT01856673|561028756|FG001|Overall Study|Lost to Follow-up|34|||
155437249|NCT01856673|561028757|FG002|Overall Study|Lost to Follow-up|0|||
155437250|NCT01856673|561028755|FG000|Overall Study|Unknown reasons|9|||
155437251|NCT01856673|561028756|FG001|Overall Study|Unknown reasons|0|||
155437252|NCT01856673|561028757|FG002|Overall Study|Unknown reasons|0|||
155437253|NCT01856673|561028755|FG000|Overall Study|Psychologist decision|1|||
155437254|NCT01856673|561028756|FG001|Overall Study|Psychologist decision|0|||
155437255|NCT01856673|561028757|FG002|Overall Study|Psychologist decision|0|||
155437256|NCT01856673|561028755|FG000|Overall Study|Paperwork errors|8|||
155437257|NCT01856673|561028756|FG001|Overall Study|Paperwork errors|0|||
155437258|NCT01856673|561028757|FG002|Overall Study|Paperwork errors|0|||
155437259|NCT01856673|561028755|FG000|Overall Study|Death|1|||
155437260|NCT01856673|561028756|FG001|Overall Study|Death|1|||
155437261|NCT01856673|561028757|FG002|Overall Study|Death|0|||
155437262|NCT01856673|561028755|FG000|Overall Study|Protocol Violation|1|||
155437263|NCT01856673|561028756|FG001|Overall Study|Protocol Violation|0|||
155437264|NCT01856673|561028757|FG002|Overall Study|Protocol Violation|1|||
155514257|NCT04700449|561310229|FG002|Stage 2 Sub-study 2|Other|0|||
155514258|NCT04700449|561310230|FG003|Stage 2 Sub-study 2|Other|5|||
155514259|NCT00356200|561310231|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
155514260|NCT00356200|561310232|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
155514261|NCT00356200|561310231|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
155514262|NCT00356200|561310232|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
155514263|NCT01000337|561310233|FG000|Overall Study|Lost to Follow-up|4|||
155514264|NCT01000337|561310234|FG001|Overall Study|Lost to Follow-up|3|||
155514265|NCT02909673|561310235|FG000|Overall Study|Did not meet inclusion criteria|129|||
155514266|NCT02909673|561310236|FG001|Overall Study|Did not meet inclusion criteria|29|||
155514267|NCT02909673|561310235|FG000|Overall Study|Surveys lost by scanner|95|||
155514268|NCT02909673|561310236|FG001|Overall Study|Surveys lost by scanner|2|||
155514269|NCT02909673|561310235|FG000|Overall Study|Tracking info missing|0|||
155514270|NCT02909673|561310236|FG001|Overall Study|Tracking info missing|5|||
155514271|NCT02752776|561310237|FG000|Overall Study|Adverse Event|15|||
155514272|NCT02752776|561310238|FG001|Overall Study|Adverse Event|23|||
155514273|NCT02752776|561310239|FG002|Overall Study|Adverse Event|11|||
155514274|NCT02752776|561310237|FG000|Overall Study|Lack of Efficacy|2|||
155514275|NCT02752776|561310238|FG001|Overall Study|Lack of Efficacy|6|||
155514276|NCT02752776|561310239|FG002|Overall Study|Lack of Efficacy|14|||
155514277|NCT02752776|561310237|FG000|Overall Study|Lost to Follow-up|11|||
155514278|NCT02752776|561310238|FG001|Overall Study|Lost to Follow-up|12|||
155514279|NCT02752776|561310239|FG002|Overall Study|Lost to Follow-up|4|||
155514280|NCT02752776|561310237|FG000|Overall Study|Non-compliance with study treatment|0|||
155514281|NCT02752776|561310238|FG001|Overall Study|Non-compliance with study treatment|0|||
155514282|NCT02752776|561310239|FG002|Overall Study|Non-compliance with study treatment|1|||
155514283|NCT02752776|561310237|FG000|Overall Study|Physician Decision|2|||
155514284|NCT02752776|561310238|FG001|Overall Study|Physician Decision|6|||
155514285|NCT02752776|561310239|FG002|Overall Study|Physician Decision|2|||
155514286|NCT02752776|561310237|FG000|Overall Study|Pregnancy|1|||
155514287|NCT02752776|561310238|FG001|Overall Study|Pregnancy|6|||
155514288|NCT02752776|561310239|FG002|Overall Study|Pregnancy|3|||
155514289|NCT02752776|561310237|FG000|Overall Study|Protocol Violation|10|||
155514290|NCT02752776|561310238|FG001|Overall Study|Protocol Violation|13|||
155514291|NCT02752776|561310239|FG002|Overall Study|Protocol Violation|6|||
155514292|NCT02752776|561310237|FG000|Overall Study|Subject/guardian decision|8|||
155514293|NCT02752776|561310238|FG001|Overall Study|Subject/guardian decision|6|||
155514294|NCT02752776|561310239|FG002|Overall Study|Subject/guardian decision|4|||
155514295|NCT02752776|561310237|FG000|Overall Study|Death|0|||
155514296|NCT02752776|561310238|FG001|Overall Study|Death|0|||
155514297|NCT02752776|561310239|FG002|Overall Study|Death|1|||
155514298|NCT02752776|561310237|FG000|Overall Study|Withdrawal by Subject|3|||
155514299|NCT02752776|561310238|FG001|Overall Study|Withdrawal by Subject|4|||
155514300|NCT02752776|561310239|FG002|Overall Study|Withdrawal by Subject|2|||
155514301|NCT01816477|561310240|FG000|Overall Study|Withdrawal by Subject|13|||
155514302|NCT01816477|561310241|FG001|Overall Study|Withdrawal by Subject|1|||
155514303|NCT01816477|561310240|FG000|Overall Study|Unable to tolerate catheter placement|3|||
155514304|NCT01816477|561310241|FG001|Overall Study|Unable to tolerate catheter placement|0|||
155437265|NCT03240081|561028758|FG000|Overall Study|Withdrawal by Subject|0|||
155437266|NCT03240081|561028759|FG001|Overall Study|Withdrawal by Subject|2|||
155437267|NCT03240081|561028758|FG000|Overall Study|Lost to Follow-up|0|||
155514305|NCT04471935|561310242|FG000|Overall Study|Withdrawal by Subject|1|||
155514306|NCT04471935|561310242|FG000|Overall Study|Deemed ineligible to participate|1|||
155514307|NCT01399736|561310243|FG000|Overall Study|Withdrawal by Subject|4|||
155514308|NCT01399736|561310244|FG001|Overall Study|Withdrawal by Subject|2|||
155437268|NCT03240081|561028759|FG001|Overall Study|Lost to Follow-up|1|||
155437269|NCT00883753|561028760|FG000|Overall Study|Adverse Event|37|||
155437270|NCT00883753|561028760|FG000|Overall Study|Death|2|||
155437271|NCT00883753|561028760|FG000|Overall Study|Insufficient therapeutic response|16|||
155514309|NCT01399736|561310243|FG000|Overall Study|Lost to Follow-up|0|||
155437272|NCT00883753|561028760|FG000|Overall Study|Lost to Follow-up|4|||
155437273|NCT00883753|561028760|FG000|Overall Study|Violation of selection criteria at entry|7|||
155437274|NCT00883753|561028760|FG000|Overall Study|Protocol Violation|2|||
155437275|NCT00883753|561028760|FG000|Overall Study|Refused treatment|4|||
155437276|NCT00883753|561028760|FG000|Overall Study|Withdrew consent|10|||
155437277|NCT00883753|561028760|FG000|Overall Study|Investigator's decision|17|||
155437278|NCT00883753|561028760|FG000|Overall Study|Administrative/Other|8|||
155437279|NCT02859415|561028761|FG000|Overall Study|Physician Decision|1|||
155437280|NCT02859415|561028762|FG001|Overall Study|Physician Decision|0|||
155437281|NCT02859415|561028761|FG000|Overall Study|Off treatment due to cardiac event|0|||
155437282|NCT02859415|561028762|FG001|Overall Study|Off treatment due to cardiac event|1|||
155437283|NCT01396525|561028765|FG000|Overall Study|Withdrawal by Subject|8|||
155437284|NCT01396525|561028765|FG000|Overall Study|Death|14|||
155437285|NCT01396525|561028765|FG000|Overall Study|Lost to Follow-up|4|||
155437286|NCT03114969|561028766|FG000|Overall Study|Lost to Follow-up|0|||
155437287|NCT03114969|561028767|FG001|Overall Study|Lost to Follow-up|0|||
155437288|NCT03114969|561028768|FG002|Overall Study|Lost to Follow-up|3|||
155437289|NCT03114969|561028769|FG003|Overall Study|Lost to Follow-up|2|||
155437290|NCT03114969|561028770|FG004|Overall Study|Lost to Follow-up|0|||
155437291|NCT03114969|561028771|FG005|Overall Study|Lost to Follow-up|0|||
155437292|NCT03114969|561028772|FG006|Overall Study|Lost to Follow-up|0|||
155437293|NCT03114969|561028773|FG007|Overall Study|Lost to Follow-up|0|||
155437294|NCT03114969|561028774|FG008|Overall Study|Lost to Follow-up|0|||
155437295|NCT03114969|561028766|FG000|Overall Study|Adverse Event|0|||
155437296|NCT03114969|561028767|FG001|Overall Study|Adverse Event|0|||
155437297|NCT03114969|561028768|FG002|Overall Study|Adverse Event|1|||
155437298|NCT03114969|561028769|FG003|Overall Study|Adverse Event|0|||
155437299|NCT03114969|561028770|FG004|Overall Study|Adverse Event|0|||
155437300|NCT03114969|561028771|FG005|Overall Study|Adverse Event|1|||
155437301|NCT03114969|561028772|FG006|Overall Study|Adverse Event|1|||
155437302|NCT03114969|561028773|FG007|Overall Study|Adverse Event|0|||
155437303|NCT03114969|561028774|FG008|Overall Study|Adverse Event|2|||
155437304|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Adverse Event|12|||
155437305|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Adverse Event|3|||
155437306|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Adverse Event|4|||
155437307|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Adverse Event|2|||
155437308|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
155437309|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
155437310|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
155437311|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
155437312|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
155437313|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
155437314|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
155437315|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
155437316|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
155437317|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
155437318|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
155437319|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
155437320|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
155437321|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
155437322|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
155437323|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
155437324|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
155437325|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
155437326|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
155437327|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
155437328|NCT02436239|561028778|FG000|Open-Lable Treatment Period|Other Reason|1|||
155437329|NCT02436239|561028779|FG001|Open-Lable Treatment Period|Other Reason|1|||
155437330|NCT02436239|561028780|FG002|Open-Lable Treatment Period|Other Reason|0|||
155437331|NCT02436239|561028781|FG003|Open-Lable Treatment Period|Other Reason|0|||
155437332|NCT02436239|561028778|FG000|Down-Taper Period|Withdrawal by Subject|4|||
155437333|NCT02436239|561028779|FG001|Down-Taper Period|Withdrawal by Subject|4|||
155437334|NCT02436239|561028780|FG002|Down-Taper Period|Withdrawal by Subject|1|||
155437335|NCT02436239|561028781|FG003|Down-Taper Period|Withdrawal by Subject|2|||
155437336|NCT02168946|561028782|FG000|Overall Study|Adverse Event|8|||
155437337|NCT02168946|561028783|FG001|Overall Study|Adverse Event|5|||
155437338|NCT02168946|561028782|FG000|Overall Study|Lost to Follow-up|3|||
155437339|NCT02168946|561028783|FG001|Overall Study|Lost to Follow-up|0|||
155437340|NCT02168946|561028782|FG000|Overall Study|Subject unable to come back for visits|1|||
155437341|NCT02168946|561028783|FG001|Overall Study|Subject unable to come back for visits|0|||
155437342|NCT01450137|561028791|FG000|Up to Week 12|Adverse Event|2|||
155437343|NCT01450137|561028792|FG001|Up to Week 12|Adverse Event|1|||
155437344|NCT01450137|561028791|FG000|Up to Week 12|Withdrawal by Subject|0|||
155437345|NCT01450137|561028792|FG001|Up to Week 12|Withdrawal by Subject|2|||
155437346|NCT01450137|561028791|FG000|Week 12 to Study End|Death|0|||
155437347|NCT01450137|561028792|FG001|Week 12 to Study End|Death|1|||
155437348|NCT01450137|561028791|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
155437349|NCT01450137|561028792|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
155437350|NCT01926886|561028793|FG000|Overall Study|Administrative/other|1|||
155437351|NCT01926886|561028794|FG001|Overall Study|Administrative/other|0|||
155437352|NCT01926886|561028793|FG000|Overall Study|Adverse event/intercurrent illness|4|||
155437353|NCT01926886|561028794|FG001|Overall Study|Adverse event/intercurrent illness|0|||
155437354|NCT01926886|561028793|FG000|Overall Study|Disease progression/recurrence|4|||
155437355|NCT01926886|561028794|FG001|Overall Study|Disease progression/recurrence|0|||
155437356|NCT01926886|561028793|FG000|Overall Study|Withdrawal by Subject|15|||
155437357|NCT01926886|561028794|FG001|Overall Study|Withdrawal by Subject|0|||
155437358|NCT01926886|561028793|FG000|Overall Study|Failure to return|3|||
155437359|NCT01926886|561028794|FG001|Overall Study|Failure to return|0|||
155437360|NCT01926886|561028793|FG000|Overall Study|Recurrence of disease|1|||
155437361|NCT01926886|561028794|FG001|Overall Study|Recurrence of disease|0|||
155437362|NCT01926886|561028793|FG000|Overall Study|Progression of disease|2|||
155437363|NCT01926886|561028794|FG001|Overall Study|Progression of disease|0|||
155437364|NCT01926886|561028793|FG000|Overall Study|Death|1|||
155437365|NCT01926886|561028794|FG001|Overall Study|Death|0|||
155437366|NCT01926886|561028793|FG000|Overall Study|Did not cooperate|1|||
155437367|NCT01926886|561028794|FG001|Overall Study|Did not cooperate|0|||
155437368|NCT04458857|561028798|FG000|Overall Study|Adverse Event|0|||
155437369|NCT04458857|561028799|FG001|Overall Study|Adverse Event|1|||
155437370|NCT04458857|561028800|FG002|Overall Study|Adverse Event|0|||
155437371|NCT04458857|561028798|FG000|Overall Study|Withdrawal by Subject|2|||
155437372|NCT04458857|561028799|FG001|Overall Study|Withdrawal by Subject|0|||
155437373|NCT04458857|561028800|FG002|Overall Study|Withdrawal by Subject|0|||
155437374|NCT04458857|561028798|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155437375|NCT04458857|561028799|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155437376|NCT04458857|561028800|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155437377|NCT04458857|561028798|FG000|Overall Study|Non-compliance with study drug|0|||
155437378|NCT04458857|561028799|FG001|Overall Study|Non-compliance with study drug|1|||
155514310|NCT01399736|561310244|FG001|Overall Study|Lost to Follow-up|2|||
155514311|NCT03335371|561310245|FG000|Overall Study|Lost to Follow-up|0|||
155514312|NCT03335371|561310246|FG001|Overall Study|Lost to Follow-up|0|||
155514313|NCT03335371|561310247|FG002|Overall Study|Lost to Follow-up|0|||
155514314|NCT03335371|561310248|FG003|Overall Study|Lost to Follow-up|0|||
155514315|NCT03335371|561310249|FG004|Overall Study|Lost to Follow-up|1|||
155514316|NCT03335371|561310245|FG000|Overall Study|Withdrawal by Subject|0|||
155514317|NCT03335371|561310246|FG001|Overall Study|Withdrawal by Subject|0|||
155514318|NCT03335371|561310247|FG002|Overall Study|Withdrawal by Subject|0|||
155514319|NCT03335371|561310248|FG003|Overall Study|Withdrawal by Subject|0|||
155514320|NCT03335371|561310249|FG004|Overall Study|Withdrawal by Subject|1|||
155514321|NCT03335371|561310245|FG000|Overall Study|Randomization Error|0|||
155514322|NCT03335371|561310246|FG001|Overall Study|Randomization Error|0|||
155514323|NCT03335371|561310247|FG002|Overall Study|Randomization Error|1|||
155514324|NCT03335371|561310248|FG003|Overall Study|Randomization Error|0|||
155514325|NCT03335371|561310249|FG004|Overall Study|Randomization Error|0|||
155514326|NCT04128007|561310250|FG000|Overall Study|Withdrawal by Subject|9|||
155514327|NCT04128007|561310251|FG001|Overall Study|Withdrawal by Subject|6|||
155651178|NCT00806026|561814583|FG003|Overall Study|Withdrawal by Subject|2|||
155651179|NCT00806026|561814584|FG004|Overall Study|Withdrawal by Subject|5|||
155651180|NCT00806026|561814585|FG005|Overall Study|Withdrawal by Subject|3|||
155437379|NCT04458857|561028800|FG002|Overall Study|Non-compliance with study drug|0|||
155437380|NCT04458857|561028798|FG000|Overall Study|Lost to Follow-up|4|||
155437381|NCT04458857|561028799|FG001|Overall Study|Lost to Follow-up|1|||
155437382|NCT04458857|561028800|FG002|Overall Study|Lost to Follow-up|0|||
155437383|NCT02986373|561028801|FG000|Overall Study|Adverse Event|4|||
155437384|NCT02986373|561028801|FG000|Overall Study|Lost to Follow-up|1|||
155437385|NCT02986373|561028801|FG000|Overall Study|Withdrawal by Subject|10|||
155437386|NCT02986373|561028801|FG000|Overall Study|Other|24|||
155437387|NCT04800315|561028802|FG000|Randomization|Did not receive study treatment|1|||
155437388|NCT04800315|561028803|FG001|Randomization|Did not receive study treatment|0|||
155437389|NCT04800315|561028804|FG002|Randomization|Did not receive study treatment|0|||
155437390|NCT04800315|561028805|FG003|Randomization|Did not receive study treatment|0|||
155437391|NCT04800315|561028802|FG000|Treatment Period|Adverse Event|4|||
155437392|NCT04800315|561028803|FG001|Treatment Period|Adverse Event|2|||
155437393|NCT04800315|561028804|FG002|Treatment Period|Adverse Event|1|||
155437394|NCT04800315|561028805|FG003|Treatment Period|Adverse Event|2|||
155437395|NCT04800315|561028802|FG000|Treatment Period|Lack of Efficacy|1|||
155437396|NCT04800315|561028803|FG001|Treatment Period|Lack of Efficacy|0|||
155437397|NCT04800315|561028804|FG002|Treatment Period|Lack of Efficacy|0|||
155437398|NCT04800315|561028805|FG003|Treatment Period|Lack of Efficacy|3|||
155437399|NCT04800315|561028802|FG000|Treatment Period|Lost to Follow-up|0|||
155437400|NCT04800315|561028803|FG001|Treatment Period|Lost to Follow-up|1|||
155437401|NCT04800315|561028804|FG002|Treatment Period|Lost to Follow-up|2|||
155437402|NCT04800315|561028805|FG003|Treatment Period|Lost to Follow-up|2|||
155437403|NCT04800315|561028802|FG000|Treatment Period|Withdrawal by participant|0|||
155437404|NCT04800315|561028803|FG001|Treatment Period|Withdrawal by participant|0|||
155514328|NCT04128007|561310250|FG000|Overall Study|Protocol Violation|1|||
155514329|NCT04128007|561310251|FG001|Overall Study|Protocol Violation|0|||
155514330|NCT04128007|561310250|FG000|Overall Study|Lost to Follow-up|8|||
155651181|NCT00806026|561814580|FG000|Overall Study|Other|3|||
155651182|NCT00806026|561814581|FG001|Overall Study|Other|6|||
155437405|NCT04800315|561028804|FG002|Treatment Period|Withdrawal by participant|0|||
155437406|NCT04800315|561028805|FG003|Treatment Period|Withdrawal by participant|4|||
155437407|NCT04800315|561028802|FG000|Treatment Period|Other Reasons|0|||
155651183|NCT00806026|561814582|FG002|Overall Study|Other|8|||
155437408|NCT04800315|561028803|FG001|Treatment Period|Other Reasons|2|||
155437409|NCT04800315|561028804|FG002|Treatment Period|Other Reasons|0|||
155437410|NCT04800315|561028805|FG003|Treatment Period|Other Reasons|1|||
155514331|NCT04128007|561310251|FG001|Overall Study|Lost to Follow-up|7|||
155437411|NCT00753922|561028806|FG000|Overall Study|Lost to Follow-up|155|||
155437412|NCT00753922|561028807|FG001|Overall Study|Lost to Follow-up|24|||
155514332|NCT04128007|561310250|FG000|Overall Study|Adverse Event|5|||
155437413|NCT00753922|561028808|FG002|Overall Study|Lost to Follow-up|28|||
155437414|NCT00753922|561028809|FG003|Overall Study|Lost to Follow-up|5|||
155437415|NCT00753922|561028806|FG000|Overall Study|Withdrawal by Subject|9|||
155437416|NCT00753922|561028807|FG001|Overall Study|Withdrawal by Subject|11|||
155437417|NCT00753922|561028808|FG002|Overall Study|Withdrawal by Subject|4|||
155437418|NCT00753922|561028809|FG003|Overall Study|Withdrawal by Subject|2|||
155437419|NCT00753922|561028806|FG000|Overall Study|Patient Non-compliance|55|||
155437420|NCT00753922|561028807|FG001|Overall Study|Patient Non-compliance|22|||
155437421|NCT00753922|561028808|FG002|Overall Study|Patient Non-compliance|14|||
155437422|NCT00753922|561028809|FG003|Overall Study|Patient Non-compliance|11|||
155437423|NCT00753922|561028806|FG000|Overall Study|Patients Not Completing Visit|11|||
155437424|NCT00753922|561028807|FG001|Overall Study|Patients Not Completing Visit|0|||
155437425|NCT00753922|561028808|FG002|Overall Study|Patients Not Completing Visit|1|||
155437426|NCT00753922|561028809|FG003|Overall Study|Patients Not Completing Visit|0|||
155437427|NCT00753922|561028806|FG000|Overall Study|Death|2|||
155437428|NCT00753922|561028807|FG001|Overall Study|Death|23|||
155437429|NCT00753922|561028808|FG002|Overall Study|Death|2|||
155437430|NCT00753922|561028809|FG003|Overall Study|Death|1|||
155437431|NCT00753922|561028806|FG000|Overall Study|Discontinuation Due to Explantation|14|||
155437432|NCT00753922|561028807|FG001|Overall Study|Discontinuation Due to Explantation|14|||
155437433|NCT00753922|561028808|FG002|Overall Study|Discontinuation Due to Explantation|14|||
155437434|NCT00753922|561028809|FG003|Overall Study|Discontinuation Due to Explantation|4|||
155437435|NCT00196937|561028810|FG000|Overall Study|Serious Adverse Event|1|||
155437436|NCT00196937|561028811|FG001|Overall Study|Serious Adverse Event|0|||
155437437|NCT00196937|561028812|FG002|Overall Study|Serious Adverse Event|0|||
155437438|NCT00196937|561028810|FG000|Overall Study|Non-serious adverse event|1|||
155437439|NCT00196937|561028811|FG001|Overall Study|Non-serious adverse event|1|||
155437440|NCT00196937|561028812|FG002|Overall Study|Non-serious adverse event|1|||
155437441|NCT00196937|561028810|FG000|Overall Study|Withdrawal by Subject|0|||
155437442|NCT00196937|561028811|FG001|Overall Study|Withdrawal by Subject|0|||
155437443|NCT00196937|561028812|FG002|Overall Study|Withdrawal by Subject|2|||
155437444|NCT00196937|561028810|FG000|Overall Study|Lost to Follow-up|4|||
155437445|NCT00196937|561028811|FG001|Overall Study|Lost to Follow-up|3|||
155437446|NCT00196937|561028812|FG002|Overall Study|Lost to Follow-up|3|||
155437447|NCT00196937|561028810|FG000|Overall Study|Other|3|||
155437448|NCT00196937|561028811|FG001|Overall Study|Other|1|||
155437449|NCT00196937|561028812|FG002|Overall Study|Other|1|||
155437450|NCT02983292|561028820|FG000|Overall Study|Participant unwell & cannot travel|2|||
155437451|NCT02983292|561028820|FG000|Overall Study|Lost to Follow-up|3|||
155437452|NCT02983292|561028820|FG000|Overall Study|Participant withdrew consent|2|||
155437453|NCT02983292|561028820|FG000|Overall Study|Revision|7|||
155437454|NCT02983292|561028820|FG000|Overall Study|Death|1|||
155437455|NCT02983292|561028820|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
155437456|NCT02983292|561028820|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
155437457|NCT02983292|561028820|FG000|Overall Study|Participant relocation|1|||
155437458|NCT04725682|561028821|FG000|Overall Study|Withdrawal by Subject|7|||
155437459|NCT04725682|561028822|FG001|Overall Study|Withdrawal by Subject|5|||
155437460|NCT04725682|561028821|FG000|Overall Study|Failed to comply with the requirements|2|||
155437461|NCT04725682|561028822|FG001|Overall Study|Failed to comply with the requirements|1|||
155437462|NCT04725682|561028821|FG000|Overall Study|Adverse Event|1|||
155437463|NCT04725682|561028822|FG001|Overall Study|Adverse Event|1|||
155437464|NCT04725682|561028821|FG000|Overall Study|Death|0|||
155437465|NCT04725682|561028822|FG001|Overall Study|Death|1|||
155437466|NCT00964795|561028823|FG000|Overall Study|Withdrawal by Subject|79|||
155437467|NCT00964795|561028823|FG000|Overall Study|Adverse Event|12|||
155437468|NCT00964795|561028823|FG000|Overall Study|Death|14|||
155437469|NCT00964795|561028823|FG000|Overall Study|Lost to Follow-up|7|||
155437470|NCT00964795|561028823|FG000|Overall Study|Termination of Study by Sponsor|169|||
155437471|NCT00964795|561028823|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
155437472|NCT00964795|561028823|FG000|Overall Study|Other|23|||
155437473|NCT02453841|561028828|FG000|Overall Study|Protocol Violation|1|||
155514333|NCT04128007|561310251|FG001|Overall Study|Adverse Event|2|||
155437474|NCT02453841|561028828|FG000|Overall Study|Unable to obtain blood samples|2|||
155437475|NCT00586690|561028829|FG000|Overall Study|Death|2|||
155437476|NCT00586690|561028830|FG001|Overall Study|Death|0|||
155437477|NCT00586690|561028829|FG000|Overall Study|Disease Progression|10|||
155437478|NCT00586690|561028830|FG001|Overall Study|Disease Progression|0|||
155437479|NCT00586690|561028829|FG000|Overall Study|Adverse Event|1|||
155437480|NCT00586690|561028830|FG001|Overall Study|Adverse Event|0|||
155437481|NCT00586690|561028829|FG000|Overall Study|Lack of Efficacy|2|||
155437482|NCT00586690|561028830|FG001|Overall Study|Lack of Efficacy|0|||
155437483|NCT00586690|561028829|FG000|Overall Study|Lab can't accommodate|1|||
155437484|NCT00586690|561028830|FG001|Overall Study|Lab can't accommodate|0|||
155437485|NCT01151137|561028833|FG000|Overall Study|Death|15|||
155437486|NCT01151137|561028834|FG001|Overall Study|Death|27|||
155437487|NCT01151137|561028833|FG000|Overall Study|Lost to Follow-up|1|||
155437488|NCT01151137|561028834|FG001|Overall Study|Lost to Follow-up|1|||
155437489|NCT00072189|561028835|FG000|Overall Study|Withdrawal by Subject|1|||
155437490|NCT02973815|561028836|FG000|Post Intervention|Death|1|||
155437491|NCT02973815|561028837|FG001|Post Intervention|Death|0|||
155437492|NCT02973815|561028836|FG000|Post Intervention|Lost to Follow-up|7|||
155437493|NCT02973815|561028837|FG001|Post Intervention|Lost to Follow-up|24|||
155437494|NCT02973815|561028836|FG000|Follow-up|Lost to Follow-up|2|||
155437495|NCT02973815|561028837|FG001|Follow-up|Lost to Follow-up|0|||
155437496|NCT02273973|561028839|FG000|Overall Study|Adverse Event|4|||
155437497|NCT02273973|561028840|FG001|Overall Study|Adverse Event|0|||
155437498|NCT02273973|561028839|FG000|Overall Study|Withdrawal by Subject|2|||
155437499|NCT02273973|561028840|FG001|Overall Study|Withdrawal by Subject|3|||
155437500|NCT02273973|561028839|FG000|Overall Study|Death|1|||
155437501|NCT02273973|561028840|FG001|Overall Study|Death|0|||
155437502|NCT02273973|561028839|FG000|Overall Study|Non-compliance|1|||
155437503|NCT02273973|561028840|FG001|Overall Study|Non-compliance|0|||
155437504|NCT02273973|561028839|FG000|Overall Study|Protocol Violation|1|||
155437505|NCT02273973|561028840|FG001|Overall Study|Protocol Violation|0|||
155437506|NCT02273973|561028839|FG000|Overall Study|Progression of disease|0|||
155437507|NCT02273973|561028840|FG001|Overall Study|Progression of disease|2|||
155437508|NCT02273973|561028839|FG000|Overall Study|Lost to Follow-up|0|||
155437509|NCT02273973|561028840|FG001|Overall Study|Lost to Follow-up|1|||
155437510|NCT02273973|561028839|FG000|Overall Study|Physician Decision|0|||
155437511|NCT02273973|561028840|FG001|Overall Study|Physician Decision|1|||
155437512|NCT02273973|561028839|FG000|Overall Study|Reason not specified|0|||
155437513|NCT02273973|561028840|FG001|Overall Study|Reason not specified|1|||
155437514|NCT02606877|561028847|FG000|Overall Study|Adverse Event|3|||
155437515|NCT02606877|561028848|FG001|Overall Study|Adverse Event|0|||
155437516|NCT02606877|561028847|FG000|Overall Study|Non-compliance with protocol|0|||
155437517|NCT02606877|561028848|FG001|Overall Study|Non-compliance with protocol|1|||
155437518|NCT02606877|561028847|FG000|Overall Study|Other than listed above|1|||
155437519|NCT02606877|561028848|FG001|Overall Study|Other than listed above|0|||
155437520|NCT00778999|561028849|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
155437521|NCT00778999|561028850|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
155437522|NCT00778999|561028849|FG000|Overall Study|Did not receive recFSH|14|||
155437523|NCT00778999|561028850|FG001|Overall Study|Did not receive recFSH|20|||
155437524|NCT02032524|561028851|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
155437525|NCT02032524|561028852|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
155437526|NCT02032524|561028853|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
155437527|NCT02032524|561028854|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
155437528|NCT02032524|561028855|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
155437529|NCT02032524|561028856|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
155437530|NCT02032524|561028851|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
155437531|NCT02032524|561028852|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
155437532|NCT02032524|561028853|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
155437533|NCT02032524|561028854|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
155437534|NCT02032524|561028855|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
155437535|NCT02032524|561028856|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
155437536|NCT02032524|561028851|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
155437537|NCT02032524|561028852|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
155437538|NCT02032524|561028853|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
155437539|NCT02032524|561028854|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
155437540|NCT02032524|561028855|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
155437541|NCT02032524|561028856|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
155437542|NCT02032524|561028851|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
155437543|NCT02032524|561028852|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
155437544|NCT02032524|561028853|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
155437545|NCT02032524|561028854|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
155437546|NCT02032524|561028855|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
155437547|NCT02032524|561028856|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
155437548|NCT02032524|561028851|FG000|Period 2: LTS13769 Study|Other|0|||
155437549|NCT02032524|561028852|FG001|Period 2: LTS13769 Study|Other|0|||
155437550|NCT02032524|561028853|FG002|Period 2: LTS13769 Study|Other|0|||
155437551|NCT02032524|561028854|FG003|Period 2: LTS13769 Study|Other|0|||
155437552|NCT02032524|561028855|FG004|Period 2: LTS13769 Study|Other|0|||
155437553|NCT02032524|561028856|FG005|Period 2: LTS13769 Study|Other|1|||
155437554|NCT04513158|561028857|FG000|Overall Study|Screen Failure|1|||
155437555|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
155437556|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
155437557|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
155437558|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
155437559|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
155437560|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155437561|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155437562|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155437563|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
155437564|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
155437565|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
155437566|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
155437567|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
155437568|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
155437569|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
155437570|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
155437571|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
155437572|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155437573|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155437574|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
155437575|NCT01894516|561030575|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155437576|NCT01894516|561030576|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
155437577|NCT01894516|561030577|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
155437578|NCT01894516|561030578|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155437579|NCT01894516|561030575|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
155437580|NCT01894516|561030576|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
155437581|NCT01894516|561030577|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
155437582|NCT01894516|561030578|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
155437583|NCT01894516|561030575|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155437584|NCT01894516|561030576|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155437585|NCT01894516|561030577|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
155437586|NCT01894516|561030578|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155437587|NCT02452970|561030583|FG000|Overall Study|Adverse Event|1|||
155437588|NCT01266148|561030584|FG000|Overall Study|Adverse Event|2|||
155437589|NCT01266148|561030585|FG001|Overall Study|Adverse Event|0|||
155437590|NCT01266148|561030584|FG000|Overall Study|Ongoing rejection|1|||
155437591|NCT01266148|561030585|FG001|Overall Study|Ongoing rejection|0|||
155437592|NCT01266148|561030584|FG000|Overall Study|2 2R rejections|1|||
155437593|NCT01266148|561030585|FG001|Overall Study|2 2R rejections|0|||
155437594|NCT01266148|561030584|FG000|Overall Study|Death|2|||
155437595|NCT01266148|561030585|FG001|Overall Study|Death|3|||
155437596|NCT01266148|561030584|FG000|Overall Study|missing mGFR value + AE|1|||
155437597|NCT01266148|561030585|FG001|Overall Study|missing mGFR value + AE|0|||
155437598|NCT01853228|561030588|FG000|Phase 1|Lack of Efficacy|8|||
155437599|NCT01853228|561030589|FG001|Phase 1|Lack of Efficacy|0|||
155437600|NCT01853228|561030588|FG000|Phase 1|Other|1|||
155437601|NCT01853228|561030589|FG001|Phase 1|Other|0|||
155437602|NCT01853228|561030588|FG000|Phase 2|Physician Decision|0|||
155437603|NCT01853228|561030589|FG001|Phase 2|Physician Decision|1|||
155437604|NCT01853228|561030588|FG000|Phase 2|Proceed To Transplant|0|||
155437605|NCT01853228|561030589|FG001|Phase 2|Proceed To Transplant|3|||
155437606|NCT01853228|561030588|FG000|Phase 2|Lack of Efficacy|0|||
155437607|NCT01853228|561030589|FG001|Phase 2|Lack of Efficacy|4|||
155437608|NCT01269125|561030591|FG000|Overall Study|Adverse Event|3|||
155437609|NCT01269125|561030592|FG001|Overall Study|Adverse Event|5|||
155437610|NCT01269125|561030593|FG002|Overall Study|Adverse Event|0|||
155437611|NCT01269125|561030591|FG000|Overall Study|Lost to Follow-up|4|||
155437612|NCT01269125|561030592|FG001|Overall Study|Lost to Follow-up|0|||
155437613|NCT01269125|561030593|FG002|Overall Study|Lost to Follow-up|0|||
155514334|NCT04128007|561310250|FG000|Overall Study|Not reported|0|||
155437614|NCT01040832|561030594|FG000|Overall Study|Adverse Event|4|||
155437615|NCT01040832|561030595|FG001|Overall Study|Adverse Event|5|||
155437616|NCT01040832|561030594|FG000|Overall Study|Death|4|||
155437617|NCT01040832|561030595|FG001|Overall Study|Death|6|||
155437618|NCT01040832|561030594|FG000|Overall Study|Withdrawal by Subject|2|||
155437619|NCT01040832|561030595|FG001|Overall Study|Withdrawal by Subject|3|||
155437620|NCT01040832|561030594|FG000|Overall Study|Progressive disease|32|||
155437621|NCT01040832|561030595|FG001|Overall Study|Progressive disease|17|||
155437622|NCT01040832|561030594|FG000|Overall Study|Symptomatic deterioration|2|||
155437623|NCT01040832|561030595|FG001|Overall Study|Symptomatic deterioration|5|||
155437624|NCT01040832|561030594|FG000|Overall Study|Other|2|||
155437625|NCT01040832|561030595|FG001|Overall Study|Other|1|||
155437626|NCT01300286|561030596|FG000|Overall Study|did not get dosed|1|||
155437627|NCT03635190|561030597|FG000|Overall Study|Lost to Follow-up|4|||
155437628|NCT03635190|561030597|FG000|Overall Study|Death|3|||
155437629|NCT03635190|561030597|FG000|Overall Study|Withdrawal by Subject|1|||
155437630|NCT03635190|561030597|FG000|Overall Study|Patient moved and did not return for follow up|1|||
155437631|NCT02767570|561030600|FG000|Overall Study|Lost to Follow-up|3|||
155437632|NCT02767570|561030601|FG001|Overall Study|Lost to Follow-up|0|||
155437633|NCT02767570|561030600|FG000|Overall Study|COVID shutdown|2|||
155437634|NCT02767570|561030601|FG001|Overall Study|COVID shutdown|5|||
155437635|NCT02767570|561030600|FG000|Overall Study|Increased pain|2|||
155437636|NCT02767570|561030601|FG001|Overall Study|Increased pain|0|||
155437637|NCT02767570|561030600|FG000|Overall Study|Withdrawal by Subject|1|||
155437638|NCT02767570|561030601|FG001|Overall Study|Withdrawal by Subject|3|||
155437639|NCT02767570|561030600|FG000|Overall Study|Unrelated medical issue|1|||
155437640|NCT02767570|561030601|FG001|Overall Study|Unrelated medical issue|1|||
155437641|NCT02767570|561030600|FG000|Overall Study|Received intra-articular injection|0|||
155437642|NCT02767570|561030601|FG001|Overall Study|Received intra-articular injection|1|||
155437643|NCT00417612|561030602|FG000|Overall Study|Errant diagnosis|0|||
155437644|NCT00417612|561030603|FG001|Overall Study|Errant diagnosis|1|||
155437645|NCT00417612|561030602|FG000|Overall Study|Adverse Event|2|||
155437646|NCT00417612|561030603|FG001|Overall Study|Adverse Event|0|||
155437647|NCT00417612|561030602|FG000|Overall Study|Protocol Violation|0|||
155437648|NCT00417612|561030603|FG001|Overall Study|Protocol Violation|2|||
155437649|NCT00417612|561030602|FG000|Overall Study|Lost to Follow-up|1|||
155437650|NCT00417612|561030603|FG001|Overall Study|Lost to Follow-up|0|||
155437651|NCT01712438|561030606|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
155437652|NCT01712438|561030606|FG000|Overall Study|Ongoing ITI treatment|6|||
155437653|NCT01712438|561030606|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
155437654|NCT01712438|561030606|FG000|Overall Study|Prematurely Discontinued|25|||
155437655|NCT04426630|561030607|FG000|Overall Study|Death|4|||
155437656|NCT04426630|561030607|FG000|Overall Study|Lost to Follow-up|2|||
155437657|NCT02786537|561030608|FG000|As Randomized|Adverse Event|0|||
155437658|NCT02786537|561030609|FG001|As Randomized|Adverse Event|11|||
155437659|NCT02786537|561030610|FG002|As Randomized|Adverse Event|0|||
155437660|NCT02786537|561030611|FG003|As Randomized|Adverse Event|4|||
155437661|NCT02786537|561030612|FG004|As Randomized|Adverse Event|6|||
155437662|NCT02786537|561030613|FG005|As Randomized|Adverse Event|2|||
155437663|NCT02786537|561030608|FG000|As Randomized|Lack of Efficacy|0|||
155437664|NCT02786537|561030609|FG001|As Randomized|Lack of Efficacy|0|||
155437665|NCT02786537|561030610|FG002|As Randomized|Lack of Efficacy|0|||
155437666|NCT02786537|561030611|FG003|As Randomized|Lack of Efficacy|1|||
155514335|NCT04128007|561310251|FG001|Overall Study|Not reported|2|||
155514336|NCT00638157|561310254|FG000|Overall Study|Adverse Event|0|||
155514337|NCT00638157|561310255|FG001|Overall Study|Adverse Event|1|||
155514338|NCT00638157|561310254|FG000|Overall Study|Clinical (symptomatic) failure|1|||
155514339|NCT00638157|561310255|FG001|Overall Study|Clinical (symptomatic) failure|1|||
155514340|NCT00638157|561310254|FG000|Overall Study|Microbiological failure|1|||
155514341|NCT00638157|561310255|FG001|Overall Study|Microbiological failure|0|||
155514342|NCT00638157|561310254|FG000|Overall Study|Lost to Follow-up|1|||
155514343|NCT00638157|561310255|FG001|Overall Study|Lost to Follow-up|0|||
155514344|NCT00638157|561310254|FG000|Overall Study|Physician Decision|1|||
155437667|NCT02786537|561030612|FG004|As Randomized|Lack of Efficacy|0|||
155437668|NCT02786537|561030613|FG005|As Randomized|Lack of Efficacy|0|||
155437669|NCT02786537|561030608|FG000|As Randomized|Withdrawal by Subject|1|||
155437670|NCT02786537|561030609|FG001|As Randomized|Withdrawal by Subject|2|||
155437671|NCT02786537|561030610|FG002|As Randomized|Withdrawal by Subject|0|||
155437672|NCT02786537|561030611|FG003|As Randomized|Withdrawal by Subject|1|||
155437673|NCT02786537|561030612|FG004|As Randomized|Withdrawal by Subject|1|||
155437674|NCT02786537|561030613|FG005|As Randomized|Withdrawal by Subject|0|||
155651184|NCT00806026|561814583|FG003|Overall Study|Other|2|||
155437675|NCT02786537|561030608|FG000|As Randomized|Death|0|||
155437676|NCT02786537|561030609|FG001|As Randomized|Death|2|||
155437677|NCT02786537|561030610|FG002|As Randomized|Death|0|||
155437678|NCT02786537|561030611|FG003|As Randomized|Death|3|||
155437679|NCT02786537|561030612|FG004|As Randomized|Death|1|||
155437680|NCT02786537|561030613|FG005|As Randomized|Death|0|||
155437681|NCT02786537|561030608|FG000|As Randomized|Non-compliance with study drug|1|||
155437682|NCT02786537|561030609|FG001|As Randomized|Non-compliance with study drug|11|||
155437683|NCT02786537|561030610|FG002|As Randomized|Non-compliance with study drug|0|||
155437684|NCT02786537|561030611|FG003|As Randomized|Non-compliance with study drug|1|||
155437685|NCT02786537|561030612|FG004|As Randomized|Non-compliance with study drug|0|||
155437686|NCT02786537|561030613|FG005|As Randomized|Non-compliance with study drug|1|||
155437687|NCT02786537|561030608|FG000|As Randomized|Lost to treatment follow-up|4|||
155437688|NCT02786537|561030609|FG001|As Randomized|Lost to treatment follow-up|32|||
155437689|NCT02786537|561030610|FG002|As Randomized|Lost to treatment follow-up|0|||
155437690|NCT02786537|561030611|FG003|As Randomized|Lost to treatment follow-up|24|||
155437691|NCT02786537|561030612|FG004|As Randomized|Lost to treatment follow-up|4|||
155437692|NCT02786537|561030613|FG005|As Randomized|Lost to treatment follow-up|4|||
155437693|NCT02786537|561030608|FG000|As Randomized|Incarceration|0|||
155437694|NCT02786537|561030609|FG001|As Randomized|Incarceration|1|||
155437695|NCT02786537|561030610|FG002|As Randomized|Incarceration|0|||
155437696|NCT02786537|561030611|FG003|As Randomized|Incarceration|0|||
155437697|NCT02786537|561030612|FG004|As Randomized|Incarceration|0|||
155437698|NCT02786537|561030613|FG005|As Randomized|Incarceration|0|||
155437699|NCT02786537|561030608|FG000|As Randomized|Opiate Dependency Relapse|0|||
155437700|NCT02786537|561030609|FG001|As Randomized|Opiate Dependency Relapse|1|||
155437701|NCT02786537|561030610|FG002|As Randomized|Opiate Dependency Relapse|0|||
155437702|NCT02786537|561030611|FG003|As Randomized|Opiate Dependency Relapse|0|||
155437703|NCT02786537|561030612|FG004|As Randomized|Opiate Dependency Relapse|0|||
155437704|NCT02786537|561030613|FG005|As Randomized|Opiate Dependency Relapse|0|||
155437705|NCT02786537|561030608|FG000|As Randomized|HCV drugs stolen from pt|0|||
155437706|NCT02786537|561030609|FG001|As Randomized|HCV drugs stolen from pt|1|||
155437707|NCT02786537|561030610|FG002|As Randomized|HCV drugs stolen from pt|0|||
155437708|NCT02786537|561030611|FG003|As Randomized|HCV drugs stolen from pt|0|||
155437709|NCT02786537|561030612|FG004|As Randomized|HCV drugs stolen from pt|0|||
155437710|NCT02786537|561030613|FG005|As Randomized|HCV drugs stolen from pt|0|||
155437711|NCT02786537|561030608|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
155437712|NCT02786537|561030609|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
155437713|NCT02786537|561030610|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
155437714|NCT02786537|561030611|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
155437715|NCT02786537|561030612|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
155437716|NCT02786537|561030613|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
155437717|NCT02786537|561030608|FG000|As Randomized|Subject lost insurance|0|||
155437718|NCT02786537|561030609|FG001|As Randomized|Subject lost insurance|0|||
155437719|NCT02786537|561030610|FG002|As Randomized|Subject lost insurance|0|||
155437720|NCT02786537|561030611|FG003|As Randomized|Subject lost insurance|1|||
155437721|NCT02786537|561030612|FG004|As Randomized|Subject lost insurance|0|||
155437722|NCT02786537|561030613|FG005|As Randomized|Subject lost insurance|0|||
155437723|NCT02786537|561030608|FG000|As Treated|Adverse Event|0|||
155437724|NCT02786537|561030609|FG001|As Treated|Adverse Event|11|||
155437725|NCT02786537|561030610|FG002|As Treated|Adverse Event|0|||
155437726|NCT02786537|561030611|FG003|As Treated|Adverse Event|4|||
155437727|NCT02786537|561030612|FG004|As Treated|Adverse Event|6|||
155437728|NCT02786537|561030613|FG005|As Treated|Adverse Event|2|||
155437729|NCT02786537|561030608|FG000|As Treated|Death|0|||
155437730|NCT02786537|561030609|FG001|As Treated|Death|2|||
155651185|NCT00806026|561814584|FG004|Overall Study|Other|0|||
155651186|NCT00806026|561814585|FG005|Overall Study|Other|4|||
155651187|NCT00806026|561814580|FG000|Overall Study|Protocol Violation|6|||
155651188|NCT00806026|561814581|FG001|Overall Study|Protocol Violation|9|||
155651189|NCT00806026|561814582|FG002|Overall Study|Protocol Violation|9|||
155651190|NCT00806026|561814583|FG003|Overall Study|Protocol Violation|0|||
155651191|NCT00806026|561814584|FG004|Overall Study|Protocol Violation|2|||
155651192|NCT00806026|561814585|FG005|Overall Study|Protocol Violation|3|||
155651193|NCT00806026|561814580|FG000|Overall Study|Adverse Event|52|||
155651194|NCT00806026|561814581|FG001|Overall Study|Adverse Event|35|||
155651195|NCT00806026|561814582|FG002|Overall Study|Adverse Event|44|||
155651196|NCT00806026|561814583|FG003|Overall Study|Adverse Event|17|||
155651197|NCT00806026|561814584|FG004|Overall Study|Adverse Event|9|||
155651198|NCT00806026|561814585|FG005|Overall Study|Adverse Event|9|||
155651199|NCT00819832|561814586|FG000|Overall Study|Sponsor Termination of Study|3|||
155651200|NCT00819832|561814587|FG001|Overall Study|Sponsor Termination of Study|0|||
155437731|NCT02786537|561030610|FG002|As Treated|Death|0|||
155651201|NCT00819832|561814588|FG002|Overall Study|Sponsor Termination of Study|0|||
155437732|NCT02786537|561030611|FG003|As Treated|Death|3|||
155437733|NCT02786537|561030612|FG004|As Treated|Death|1|||
155437734|NCT02786537|561030613|FG005|As Treated|Death|0|||
155437735|NCT02786537|561030608|FG000|As Treated|Lack of Efficacy|0|||
155437736|NCT02786537|561030609|FG001|As Treated|Lack of Efficacy|0|||
155437737|NCT02786537|561030610|FG002|As Treated|Lack of Efficacy|0|||
155651202|NCT00819832|561814589|FG003|Overall Study|Sponsor Termination of Study|0|||
155437738|NCT02786537|561030611|FG003|As Treated|Lack of Efficacy|1|||
155437739|NCT02786537|561030612|FG004|As Treated|Lack of Efficacy|0|||
155437740|NCT02786537|561030613|FG005|As Treated|Lack of Efficacy|0|||
155437741|NCT02786537|561030608|FG000|As Treated|Lost to Follow-up|4|||
155437742|NCT02786537|561030609|FG001|As Treated|Lost to Follow-up|32|||
155437743|NCT02786537|561030610|FG002|As Treated|Lost to Follow-up|0|||
155437744|NCT02786537|561030611|FG003|As Treated|Lost to Follow-up|25|||
155437745|NCT02786537|561030612|FG004|As Treated|Lost to Follow-up|4|||
155437746|NCT02786537|561030613|FG005|As Treated|Lost to Follow-up|4|||
155437747|NCT02786537|561030608|FG000|As Treated|Non-compliance with study drug|1|||
155437748|NCT02786537|561030609|FG001|As Treated|Non-compliance with study drug|11|||
155437749|NCT02786537|561030610|FG002|As Treated|Non-compliance with study drug|0|||
155437750|NCT02786537|561030611|FG003|As Treated|Non-compliance with study drug|1|||
155437751|NCT02786537|561030612|FG004|As Treated|Non-compliance with study drug|0|||
155437752|NCT02786537|561030613|FG005|As Treated|Non-compliance with study drug|1|||
155437753|NCT02786537|561030608|FG000|As Treated|Lost insurance|0|||
155437754|NCT02786537|561030609|FG001|As Treated|Lost insurance|0|||
155437755|NCT02786537|561030610|FG002|As Treated|Lost insurance|0|||
155437756|NCT02786537|561030611|FG003|As Treated|Lost insurance|1|||
155437757|NCT02786537|561030612|FG004|As Treated|Lost insurance|0|||
155437758|NCT02786537|561030613|FG005|As Treated|Lost insurance|0|||
155437759|NCT02786537|561030608|FG000|As Treated|Withdrawal by Subject|1|||
155437760|NCT02786537|561030609|FG001|As Treated|Withdrawal by Subject|2|||
155437761|NCT02786537|561030610|FG002|As Treated|Withdrawal by Subject|0|||
155437762|NCT02786537|561030611|FG003|As Treated|Withdrawal by Subject|0|||
155437763|NCT02786537|561030612|FG004|As Treated|Withdrawal by Subject|1|||
155437764|NCT02786537|561030613|FG005|As Treated|Withdrawal by Subject|0|||
155437765|NCT02786537|561030608|FG000|As Treated|Incarceration|0|||
155437766|NCT02786537|561030609|FG001|As Treated|Incarceration|1|||
155437767|NCT02786537|561030610|FG002|As Treated|Incarceration|0|||
155437768|NCT02786537|561030611|FG003|As Treated|Incarceration|0|||
155437769|NCT02786537|561030612|FG004|As Treated|Incarceration|0|||
155437770|NCT02786537|561030613|FG005|As Treated|Incarceration|0|||
155437771|NCT02786537|561030608|FG000|As Treated|Opiate dependency relapse|0|||
155437772|NCT02786537|561030609|FG001|As Treated|Opiate dependency relapse|1|||
155437773|NCT02786537|561030610|FG002|As Treated|Opiate dependency relapse|0|||
155437774|NCT02786537|561030611|FG003|As Treated|Opiate dependency relapse|0|||
155437775|NCT02786537|561030612|FG004|As Treated|Opiate dependency relapse|0|||
155437776|NCT02786537|561030613|FG005|As Treated|Opiate dependency relapse|0|||
155437777|NCT02786537|561030608|FG000|As Treated|Drugs stolen from patient|0|||
155437778|NCT02786537|561030609|FG001|As Treated|Drugs stolen from patient|1|||
155437779|NCT02786537|561030610|FG002|As Treated|Drugs stolen from patient|0|||
155514345|NCT00638157|561310255|FG001|Overall Study|Physician Decision|0|||
155514346|NCT00638157|561310254|FG000|Overall Study|Other|1|||
155514347|NCT00638157|561310255|FG001|Overall Study|Other|2|||
155437780|NCT02786537|561030611|FG003|As Treated|Drugs stolen from patient|0|||
155437781|NCT02786537|561030612|FG004|As Treated|Drugs stolen from patient|0|||
155437782|NCT02786537|561030613|FG005|As Treated|Drugs stolen from patient|0|||
155437783|NCT02786537|561030608|FG000|As Treated|Advised to stop tx after loss of meds|0|||
155437784|NCT02786537|561030609|FG001|As Treated|Advised to stop tx after loss of meds|1|||
155437785|NCT02786537|561030610|FG002|As Treated|Advised to stop tx after loss of meds|0|||
155437786|NCT02786537|561030611|FG003|As Treated|Advised to stop tx after loss of meds|0|||
155437787|NCT02786537|561030612|FG004|As Treated|Advised to stop tx after loss of meds|0|||
155514348|NCT00638157|561310254|FG000|Overall Study|Randomized, not treated|2|||
155514349|NCT00638157|561310255|FG001|Overall Study|Randomized, not treated|0|||
155514350|NCT00437281|561310256|FG000|Overall Study|Adverse Event|0|||
155514351|NCT00437281|561310257|FG001|Overall Study|Adverse Event|0|||
155514352|NCT00437281|561310258|FG002|Overall Study|Adverse Event|0|||
155514353|NCT00437281|561310259|FG003|Overall Study|Adverse Event|1|||
155514354|NCT00437281|561310260|FG004|Overall Study|Adverse Event|0|||
155514355|NCT00437281|561310261|FG005|Overall Study|Adverse Event|1|||
155514356|NCT00437281|561310262|FG006|Overall Study|Adverse Event|0|||
155514357|NCT00437281|561310263|FG007|Overall Study|Adverse Event|0|||
155514358|NCT00437281|561310264|FG008|Overall Study|Adverse Event|0|||
155514359|NCT00437281|561310265|FG009|Overall Study|Adverse Event|1|||
155514360|NCT00437281|561310266|FG010|Overall Study|Adverse Event|0|||
155514361|NCT00437281|561310267|FG011|Overall Study|Adverse Event|0|||
155514362|NCT00437281|561310268|FG012|Overall Study|Adverse Event|0|||
155514363|NCT00437281|561310269|FG013|Overall Study|Adverse Event|1|||
155514364|NCT00437281|561310270|FG014|Overall Study|Adverse Event|1|||
155514365|NCT00437281|561310271|FG015|Overall Study|Adverse Event|0|||
155437788|NCT02786537|561030613|FG005|As Treated|Advised to stop tx after loss of meds|0|||
155437789|NCT03216265|561030614|FG000|Overall Study|Adverse Event|2|||
155437790|NCT03216265|561030615|FG001|Overall Study|Adverse Event|0|||
155437791|NCT03216265|561030616|FG002|Overall Study|Adverse Event|2|||
155437792|NCT03216265|561030614|FG000|Overall Study|Lost to Follow-up|0|||
155437793|NCT03216265|561030615|FG001|Overall Study|Lost to Follow-up|1|||
155437794|NCT03216265|561030616|FG002|Overall Study|Lost to Follow-up|0|||
155437795|NCT03216265|561030614|FG000|Overall Study|Withdrawal by Subject|0|||
155437796|NCT03216265|561030615|FG001|Overall Study|Withdrawal by Subject|0|||
155437797|NCT03216265|561030616|FG002|Overall Study|Withdrawal by Subject|1|||
155437798|NCT01306058|561030617|FG000|Overall Study|Death|1|||
155437799|NCT01306058|561030617|FG000|Overall Study|Enrolled but did not get treatment|1|||
155437800|NCT01539837|561030618|FG000|Overall Study|reduce neutrophil level|0|||
155437801|NCT01539837|561030619|FG001|Overall Study|reduce neutrophil level|1|||
155437802|NCT01539837|561030620|FG002|Overall Study|reduce neutrophil level|1|||
155437803|NCT01539837|561030618|FG000|Overall Study|bad compliance|0|||
155437804|NCT01539837|561030619|FG001|Overall Study|bad compliance|0|||
155437805|NCT01539837|561030620|FG002|Overall Study|bad compliance|1|||
155437806|NCT00849693|561030621|FG000|Acute Treatment Phase|Adverse Event|12|||
155437807|NCT00849693|561030622|FG001|Acute Treatment Phase|Adverse Event|7|||
155437808|NCT00849693|561030623|FG002|Acute Treatment Phase|Adverse Event|6|||
155437809|NCT00849693|561030624|FG003|Acute Treatment Phase|Adverse Event|4|||
155437810|NCT00849693|561030621|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
155514366|NCT00437281|561310272|FG016|Overall Study|Adverse Event|0|||
155514367|NCT00437281|561310273|FG017|Overall Study|Adverse Event|0|||
155514368|NCT00437281|561310274|FG018|Overall Study|Adverse Event|1|||
155514369|NCT00437281|561310275|FG019|Overall Study|Adverse Event|0|||
155514370|NCT00437281|561310256|FG000|Overall Study|Lost to Follow-up|0|||
155514371|NCT00437281|561310257|FG001|Overall Study|Lost to Follow-up|0|||
155514372|NCT00437281|561310258|FG002|Overall Study|Lost to Follow-up|0|||
155514373|NCT00437281|561310259|FG003|Overall Study|Lost to Follow-up|0|||
155514374|NCT00437281|561310260|FG004|Overall Study|Lost to Follow-up|0|||
155514375|NCT00437281|561310261|FG005|Overall Study|Lost to Follow-up|0|||
155514376|NCT00437281|561310262|FG006|Overall Study|Lost to Follow-up|0|||
155514377|NCT00437281|561310263|FG007|Overall Study|Lost to Follow-up|0|||
155514378|NCT00437281|561310264|FG008|Overall Study|Lost to Follow-up|0|||
155514379|NCT00437281|561310265|FG009|Overall Study|Lost to Follow-up|0|||
155514380|NCT00437281|561310266|FG010|Overall Study|Lost to Follow-up|0|||
155514381|NCT00437281|561310267|FG011|Overall Study|Lost to Follow-up|0|||
155514382|NCT00437281|561310268|FG012|Overall Study|Lost to Follow-up|0|||
155514383|NCT00437281|561310269|FG013|Overall Study|Lost to Follow-up|0|||
155514384|NCT00437281|561310270|FG014|Overall Study|Lost to Follow-up|0|||
155514385|NCT00437281|561310271|FG015|Overall Study|Lost to Follow-up|0|||
155514386|NCT00437281|561310272|FG016|Overall Study|Lost to Follow-up|0|||
155514387|NCT00437281|561310273|FG017|Overall Study|Lost to Follow-up|0|||
155514388|NCT00437281|561310274|FG018|Overall Study|Lost to Follow-up|0|||
155514389|NCT00437281|561310275|FG019|Overall Study|Lost to Follow-up|1|||
155514390|NCT00876733|561310278|FG000|Overall Study|Adverse Event|34|||
155514391|NCT00876733|561310279|FG001|Overall Study|Adverse Event|20|||
155514392|NCT00876733|561310280|FG002|Overall Study|Adverse Event|10|||
155514393|NCT00876733|561310281|FG003|Overall Study|Adverse Event|3|||
155437811|NCT00849693|561030622|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
155437812|NCT00849693|561030623|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
155437813|NCT00849693|561030624|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
155437814|NCT00849693|561030621|FG000|Acute Treatment Phase|Protocol Violation|1|||
155437815|NCT00849693|561030622|FG001|Acute Treatment Phase|Protocol Violation|5|||
155437816|NCT00849693|561030623|FG002|Acute Treatment Phase|Protocol Violation|2|||
155514394|NCT00876733|561310278|FG000|Overall Study|Lack of Efficacy|17|||
155514395|NCT00876733|561310279|FG001|Overall Study|Lack of Efficacy|9|||
155514396|NCT00876733|561310280|FG002|Overall Study|Lack of Efficacy|10|||
155437817|NCT00849693|561030624|FG003|Acute Treatment Phase|Protocol Violation|6|||
155437818|NCT00849693|561030621|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
155437819|NCT00849693|561030622|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
155437820|NCT00849693|561030623|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
155437821|NCT00849693|561030624|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
155437822|NCT00849693|561030621|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
155437823|NCT00849693|561030622|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
155437824|NCT00849693|561030623|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
155437825|NCT00849693|561030624|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
155437826|NCT00849693|561030621|FG000|Acute Treatment Phase|Physician Decision|2|||
155437827|NCT00849693|561030622|FG001|Acute Treatment Phase|Physician Decision|1|||
155437828|NCT00849693|561030623|FG002|Acute Treatment Phase|Physician Decision|2|||
155437829|NCT00849693|561030624|FG003|Acute Treatment Phase|Physician Decision|1|||
155437830|NCT00849693|561030621|FG000|Acute Treatment Phase|Sponsor decision|0|||
155437831|NCT00849693|561030622|FG001|Acute Treatment Phase|Sponsor decision|0|||
155437832|NCT00849693|561030623|FG002|Acute Treatment Phase|Sponsor decision|1|||
155437833|NCT00849693|561030624|FG003|Acute Treatment Phase|Sponsor decision|0|||
155437834|NCT00849693|561030621|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
155437835|NCT00849693|561030622|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
155437836|NCT00849693|561030623|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
155437837|NCT00849693|561030624|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
155437838|NCT00849693|561030621|FG000|Extension Phase|Adverse Event|4|||
155437839|NCT00849693|561030622|FG001|Extension Phase|Adverse Event|6|||
155437840|NCT00849693|561030623|FG002|Extension Phase|Adverse Event|3|||
155437841|NCT00849693|561030624|FG003|Extension Phase|Adverse Event|7|||
155437842|NCT00849693|561030621|FG000|Extension Phase|Lost to Follow-up|7|||
155437843|NCT00849693|561030622|FG001|Extension Phase|Lost to Follow-up|5|||
155437844|NCT00849693|561030623|FG002|Extension Phase|Lost to Follow-up|6|||
155437845|NCT00849693|561030624|FG003|Extension Phase|Lost to Follow-up|6|||
155437846|NCT00849693|561030621|FG000|Extension Phase|Protocol Violation|0|||
155437847|NCT00849693|561030622|FG001|Extension Phase|Protocol Violation|3|||
155437848|NCT00849693|561030623|FG002|Extension Phase|Protocol Violation|2|||
155437849|NCT00849693|561030624|FG003|Extension Phase|Protocol Violation|3|||
155437850|NCT00849693|561030621|FG000|Extension Phase|Withdrawal by Subject|6|||
155437851|NCT00849693|561030622|FG001|Extension Phase|Withdrawal by Subject|9|||
155437852|NCT00849693|561030623|FG002|Extension Phase|Withdrawal by Subject|10|||
155437853|NCT00849693|561030624|FG003|Extension Phase|Withdrawal by Subject|15|||
155437854|NCT00849693|561030621|FG000|Extension Phase|Parent or caregiver decision|9|||
155437855|NCT00849693|561030622|FG001|Extension Phase|Parent or caregiver decision|4|||
155437856|NCT00849693|561030623|FG002|Extension Phase|Parent or caregiver decision|10|||
155437857|NCT00849693|561030624|FG003|Extension Phase|Parent or caregiver decision|5|||
155437858|NCT00849693|561030621|FG000|Extension Phase|Physician Decision|1|||
155437859|NCT00849693|561030622|FG001|Extension Phase|Physician Decision|1|||
155437860|NCT00849693|561030623|FG002|Extension Phase|Physician Decision|2|||
155437861|NCT00849693|561030624|FG003|Extension Phase|Physician Decision|0|||
155437862|NCT00849693|561030621|FG000|Extension Phase|Sponsor decision|1|||
155437863|NCT00849693|561030622|FG001|Extension Phase|Sponsor decision|0|||
155437864|NCT00849693|561030623|FG002|Extension Phase|Sponsor decision|0|||
155437865|NCT00849693|561030624|FG003|Extension Phase|Sponsor decision|1|||
155437866|NCT00849693|561030621|FG000|Extension Phase|Lack of Efficacy|2|||
155437867|NCT00849693|561030622|FG001|Extension Phase|Lack of Efficacy|2|||
155437868|NCT00849693|561030623|FG002|Extension Phase|Lack of Efficacy|2|||
155437869|NCT00849693|561030624|FG003|Extension Phase|Lack of Efficacy|1|||
155437870|NCT01978912|561030625|FG000|Overall Study|Adverse Event|0|||
155437871|NCT01978912|561030626|FG001|Overall Study|Adverse Event|1|||
155437872|NCT01978912|561030627|FG002|Overall Study|Adverse Event|0|||
155437873|NCT01978912|561030628|FG003|Overall Study|Adverse Event|0|||
155437874|NCT01978912|561030625|FG000|Overall Study|Lost to Follow-up|1|||
155437875|NCT01978912|561030626|FG001|Overall Study|Lost to Follow-up|1|||
155437876|NCT01978912|561030627|FG002|Overall Study|Lost to Follow-up|0|||
155437877|NCT01978912|561030628|FG003|Overall Study|Lost to Follow-up|1|||
155437878|NCT01978912|561030625|FG000|Overall Study|Withdrawal by Subject|1|||
155437879|NCT01978912|561030626|FG001|Overall Study|Withdrawal by Subject|0|||
155437880|NCT01978912|561030627|FG002|Overall Study|Withdrawal by Subject|2|||
155437881|NCT01978912|561030628|FG003|Overall Study|Withdrawal by Subject|2|||
155437882|NCT01978912|561030625|FG000|Overall Study|Lumbar Surgery|1|||
155437883|NCT01978912|561030626|FG001|Overall Study|Lumbar Surgery|0|||
155437884|NCT01978912|561030627|FG002|Overall Study|Lumbar Surgery|1|||
155437885|NCT01978912|561030628|FG003|Overall Study|Lumbar Surgery|0|||
155437886|NCT01978912|561030625|FG000|Overall Study|Intradiscal Steroid Injection|0|||
155437887|NCT01978912|561030626|FG001|Overall Study|Intradiscal Steroid Injection|1|||
155437888|NCT01978912|561030627|FG002|Overall Study|Intradiscal Steroid Injection|0|||
155437889|NCT01978912|561030628|FG003|Overall Study|Intradiscal Steroid Injection|0|||
155437890|NCT00224107|561030629|FG000|Overall Study|Adverse Event|20|||
155437891|NCT00224107|561030630|FG001|Overall Study|Adverse Event|6|||
155437892|NCT00224107|561030629|FG000|Overall Study|Protocol Violation|2|||
155437893|NCT00224107|561030630|FG001|Overall Study|Protocol Violation|3|||
155437894|NCT00224107|561030629|FG000|Overall Study|Withdrawal by Subject|1|||
155437895|NCT00224107|561030630|FG001|Overall Study|Withdrawal by Subject|4|||
155437896|NCT00224107|561030629|FG000|Overall Study|Lack of Efficacy|2|||
155437897|NCT00224107|561030630|FG001|Overall Study|Lack of Efficacy|0|||
155437898|NCT00224107|561030629|FG000|Overall Study|Lost to Follow-up|4|||
155437899|NCT00224107|561030630|FG001|Overall Study|Lost to Follow-up|0|||
155437900|NCT00224107|561030629|FG000|Overall Study|Physician Decision|1|||
155437901|NCT00224107|561030630|FG001|Overall Study|Physician Decision|0|||
155437902|NCT00224107|561030629|FG000|Overall Study|Other|1|||
155437903|NCT00224107|561030630|FG001|Overall Study|Other|1|||
155437904|NCT01408537|561030631|FG000|Overall Study|Withdrawal by Subject|2|||
155437905|NCT01408537|561030631|FG000|Overall Study|Protocol Violation|3|||
155437906|NCT01408537|561030631|FG000|Overall Study|Lost to Follow-up|3|||
155437907|NCT05523362|561030632|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
155437908|NCT05523362|561030632|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
155437909|NCT05523362|561030632|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
155437910|NCT05523362|561030632|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
155437911|NCT01183858|561030635|FG000|Overall Study|Death not related to Progressive Disease|5|||
155437912|NCT01183858|561030636|FG001|Overall Study|Death not related to Progressive Disease|6|||
155437913|NCT01183858|561030635|FG000|Overall Study|Adverse Event|14|||
155437914|NCT01183858|561030636|FG001|Overall Study|Adverse Event|11|||
155437915|NCT01183858|561030635|FG000|Overall Study|Investigator's Decision|0|||
155437916|NCT01183858|561030636|FG001|Overall Study|Investigator's Decision|3|||
155437917|NCT01183858|561030635|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155437918|NCT01183858|561030636|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155437919|NCT01183858|561030635|FG000|Overall Study|Refused Treatment|1|||
155437920|NCT01183858|561030636|FG001|Overall Study|Refused Treatment|4|||
155437921|NCT01183858|561030635|FG000|Overall Study|Withdrew Consent|4|||
155437922|NCT01183858|561030636|FG001|Overall Study|Withdrew Consent|4|||
155437923|NCT01183858|561030635|FG000|Overall Study|Discontinued Smoking|3|||
155437924|NCT01183858|561030636|FG001|Overall Study|Discontinued Smoking|1|||
155437925|NCT01183858|561030635|FG000|Overall Study|Protocol Violation|1|||
155437926|NCT01183858|561030636|FG001|Overall Study|Protocol Violation|0|||
155437927|NCT01183858|561030635|FG000|Overall Study|Administrative/Other|6|||
155437928|NCT01183858|561030636|FG001|Overall Study|Administrative/Other|6|||
155437929|NCT01183858|561030635|FG000|Overall Study|Progressive Disease|112|||
155437930|NCT01183858|561030636|FG001|Overall Study|Progressive Disease|115|||
155437931|NCT01183858|561030635|FG000|Overall Study|Death related to Progressive Disease|4|||
155437932|NCT01183858|561030636|FG001|Overall Study|Death related to Progressive Disease|5|||
155437933|NCT01183858|561030635|FG000|Overall Study|Lost to Follow-up|1|||
155437934|NCT01183858|561030636|FG001|Overall Study|Lost to Follow-up|1|||
155437935|NCT00098345|561030637|FG000|Overall Study|Adverse Event|7|||
155437936|NCT00098345|561030637|FG000|Overall Study|Withdrawal by Subject|2|||
155437937|NCT00098345|561030637|FG000|Overall Study|progression|4|||
155437938|NCT03707977|561030638|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
155437939|NCT03707977|561030639|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
155437940|NCT03707977|561030640|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
155437941|NCT03707977|561030638|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
155437942|NCT03707977|561030639|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
155437943|NCT03707977|561030640|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
155437944|NCT03842709|561030641|FG000|Overall Study|Withdrawal by Subject|3|||
155437945|NCT03842709|561030642|FG001|Overall Study|Withdrawal by Subject|3|||
155437946|NCT03842709|561030641|FG000|Overall Study|Lost to Follow-up|1|||
155437947|NCT03842709|561030642|FG001|Overall Study|Lost to Follow-up|0|||
155437948|NCT00641147|561030643|FG000|Completed 4 Months.|Physician Decision|1|||
155437949|NCT00641147|561030644|FG001|Completed 4 Months.|Physician Decision|0|||
155437950|NCT00641147|561030643|FG000|Completed 4 Months.|Adverse Event|1|||
155437951|NCT00641147|561030644|FG001|Completed 4 Months.|Adverse Event|0|||
155437952|NCT00641147|561030643|FG000|Completed 8 Months.|Physician Decision|2|||
155437953|NCT00641147|561030644|FG001|Completed 8 Months.|Physician Decision|1|||
155437954|NCT00641147|561030643|FG000|Completed 8 Months.|non compliance|1|||
155437955|NCT00641147|561030644|FG001|Completed 8 Months.|non compliance|0|||
155514397|NCT00876733|561310281|FG003|Overall Study|Lack of Efficacy|1|||
155437956|NCT00641147|561030643|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
155437957|NCT00641147|561030644|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
155437958|NCT00641147|561030643|FG000|Completed 12 Months.|Physician Decision|1|||
155437959|NCT00641147|561030644|FG001|Completed 12 Months.|Physician Decision|1|||
155437960|NCT00641147|561030643|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
155437961|NCT00641147|561030644|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
155514398|NCT00876733|561310278|FG000|Overall Study|Lost to Follow-up|26|||
155437962|NCT00641147|561030643|FG000|Completed 16 Months.|Physician Decision|1|||
155437963|NCT00641147|561030644|FG001|Completed 16 Months.|Physician Decision|0|||
155437964|NCT00641147|561030643|FG000|Completed 16 Months.|Lost to Follow-up|1|||
155437965|NCT00641147|561030644|FG001|Completed 16 Months.|Lost to Follow-up|0|||
155437966|NCT00791128|561030645|FG000|Overall Study|Adverse Event|4|||
155437967|NCT00791128|561030645|FG000|Overall Study|Device migration|2|||
155437968|NCT00791128|561030645|FG000|Overall Study|non-compliance by subject|2|||
155437969|NCT00791128|561030645|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
155437970|NCT00984659|561030646|FG000|2-week Run-in Period|Adverse Event|8|||
155514399|NCT00876733|561310279|FG001|Overall Study|Lost to Follow-up|10|||
155514400|NCT00876733|561310280|FG002|Overall Study|Lost to Follow-up|3|||
155514401|NCT00876733|561310281|FG003|Overall Study|Lost to Follow-up|2|||
155514402|NCT00876733|561310278|FG000|Overall Study|Data not available|14|||
155514403|NCT00876733|561310279|FG001|Overall Study|Data not available|3|||
155514404|NCT00876733|561310280|FG002|Overall Study|Data not available|7|||
155514405|NCT00876733|561310281|FG003|Overall Study|Data not available|1|||
155514406|NCT03521999|561310282|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
155514407|NCT03521999|561310283|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
155514408|NCT03521999|561310282|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
155514409|NCT03521999|561310283|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
155514410|NCT03521999|561310282|FG000|Completed 3 Month Follow up|Death|0|||
155437971|NCT00984659|561030647|FG001|2-week Run-in Period|Adverse Event|0|||
155437972|NCT00984659|561030648|FG002|2-week Run-in Period|Adverse Event|0|||
155437973|NCT00984659|561030649|FG003|2-week Run-in Period|Adverse Event|0|||
155514411|NCT03521999|561310283|FG001|Completed 3 Month Follow up|Death|1|||
155437974|NCT00984659|561030646|FG000|2-week Run-in Period|Protocol Violation|5|||
155437975|NCT00984659|561030647|FG001|2-week Run-in Period|Protocol Violation|0|||
155437976|NCT00984659|561030648|FG002|2-week Run-in Period|Protocol Violation|0|||
155437977|NCT00984659|561030649|FG003|2-week Run-in Period|Protocol Violation|0|||
155437978|NCT00984659|561030646|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
155437979|NCT00984659|561030647|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
155437980|NCT00984659|561030648|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
155437981|NCT00984659|561030649|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
155437982|NCT00984659|561030646|FG000|2-week Run-in Period|Lost to Follow-up|3|||
155437983|NCT00984659|561030647|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155437984|NCT00984659|561030648|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155437985|NCT00984659|561030649|FG003|2-week Run-in Period|Lost to Follow-up|0|||
155437986|NCT00984659|561030646|FG000|2-week Run-in Period|Physician Decision|10|||
155437987|NCT00984659|561030647|FG001|2-week Run-in Period|Physician Decision|0|||
155437988|NCT00984659|561030648|FG002|2-week Run-in Period|Physician Decision|0|||
155437989|NCT00984659|561030649|FG003|2-week Run-in Period|Physician Decision|0|||
155437990|NCT00984659|561030646|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
155437991|NCT00984659|561030647|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155437992|NCT00984659|561030648|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155437993|NCT00984659|561030649|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
155437994|NCT00984659|561030646|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
155437995|NCT00984659|561030647|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155437996|NCT00984659|561030648|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155437997|NCT00984659|561030649|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155437998|NCT00984659|561030646|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
155437999|NCT00984659|561030647|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
155438000|NCT00984659|561030648|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
155438001|NCT00984659|561030649|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
155438002|NCT00984659|561030646|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
155438003|NCT00984659|561030647|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
155438004|NCT00984659|561030648|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
155438005|NCT00984659|561030649|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
155438006|NCT00984659|561030646|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
155438007|NCT00984659|561030647|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
155651203|NCT00819832|561814590|FG004|Overall Study|Sponsor Termination of Study|0|||
155438008|NCT00984659|561030648|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
155438009|NCT00984659|561030649|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
155438010|NCT00984659|561030646|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
155438011|NCT00984659|561030647|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
155438012|NCT00984659|561030648|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
155438013|NCT00984659|561030649|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
155438014|NCT00984659|561030646|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155438015|NCT00984659|561030647|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
155438016|NCT00984659|561030648|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
155438017|NCT00984659|561030649|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
155438018|NCT01720667|561030653|FG000|Overall Study|Adverse Event|1|||
155438019|NCT01720667|561030654|FG001|Overall Study|Adverse Event|1|||
155438020|NCT01720667|561030653|FG000|Overall Study|Withdrawal by Subject|3|||
155438021|NCT01720667|561030654|FG001|Overall Study|Withdrawal by Subject|0|||
155438022|NCT03472534|561030655|FG000|Overall Study|Withdrawal by Subject|9|||
155438023|NCT03472534|561030655|FG000|Overall Study|Adverse Event|2|||
155438024|NCT02614794|561030656|FG000|Overall Study|Death|258|||
155438025|NCT02614794|561030657|FG001|Overall Study|Death|151|||
155438026|NCT02614794|561030656|FG000|Overall Study|Study closure by Sponsor|119|||
155438027|NCT02614794|561030657|FG001|Overall Study|Study closure by Sponsor|45|||
155438028|NCT02614794|561030656|FG000|Overall Study|Withdrawal by Subject|24|||
155438029|NCT02614794|561030657|FG001|Overall Study|Withdrawal by Subject|5|||
155438030|NCT02614794|561030656|FG000|Overall Study|Lost to Follow-up|7|||
155438031|NCT02614794|561030657|FG001|Overall Study|Lost to Follow-up|0|||
155438032|NCT02614794|561030656|FG000|Overall Study|Physician Decision|1|||
155438033|NCT02614794|561030657|FG001|Overall Study|Physician Decision|1|||
155438034|NCT02614794|561030656|FG000|Overall Study|Hospital closure|1|||
155438035|NCT02614794|561030657|FG001|Overall Study|Hospital closure|0|||
155438036|NCT00234104|561030658|FG000|Overall Study|Adverse Event|4|||
155438037|NCT00234104|561030659|FG001|Overall Study|Adverse Event|0|||
155438038|NCT00234104|561030660|FG002|Overall Study|Adverse Event|3|||
155438039|NCT00234104|561030661|FG003|Overall Study|Adverse Event|5|||
155438040|NCT00234104|561030658|FG000|Overall Study|Protocol Violation|0|||
155438041|NCT00234104|561030659|FG001|Overall Study|Protocol Violation|0|||
155438042|NCT00234104|561030660|FG002|Overall Study|Protocol Violation|0|||
155438043|NCT00234104|561030661|FG003|Overall Study|Protocol Violation|1|||
155438044|NCT00234104|561030658|FG000|Overall Study|Physician Decision|0|||
155438045|NCT00234104|561030659|FG001|Overall Study|Physician Decision|1|||
155438046|NCT00234104|561030660|FG002|Overall Study|Physician Decision|2|||
155438047|NCT00234104|561030661|FG003|Overall Study|Physician Decision|2|||
155438048|NCT02052960|561030663|FG000|Overall Study|Adverse Event|19|||
155438049|NCT02052960|561030664|FG001|Overall Study|Adverse Event|17|||
155438050|NCT02052960|561030663|FG000|Overall Study|Protocol Violation|4|||
155438051|NCT02052960|561030664|FG001|Overall Study|Protocol Violation|3|||
155438052|NCT02052960|561030663|FG000|Overall Study|Withdrawal by Subject|6|||
155438053|NCT02052960|561030664|FG001|Overall Study|Withdrawal by Subject|11|||
155438054|NCT02052960|561030663|FG000|Overall Study|Other|25|||
155438055|NCT02052960|561030664|FG001|Overall Study|Other|15|||
155438056|NCT04045613|561030665|FG000|Overall Study|Adverse Event|2|||
155438057|NCT04045613|561030666|FG001|Overall Study|Adverse Event|2|||
155438058|NCT04045613|561030667|FG002|Overall Study|Adverse Event|1|||
155438059|NCT04045613|561030668|FG003|Overall Study|Adverse Event|1|||
155438060|NCT04045613|561030669|FG004|Overall Study|Adverse Event|0|||
155438061|NCT04045613|561030670|FG005|Overall Study|Adverse Event|0|||
155438062|NCT04045613|561030671|FG006|Overall Study|Adverse Event|1|||
155438063|NCT04045613|561030665|FG000|Overall Study|Withdrawal by Subject|0|||
155438064|NCT04045613|561030666|FG001|Overall Study|Withdrawal by Subject|5|||
155438065|NCT04045613|561030667|FG002|Overall Study|Withdrawal by Subject|0|||
155438066|NCT04045613|561030668|FG003|Overall Study|Withdrawal by Subject|0|||
155438067|NCT04045613|561030669|FG004|Overall Study|Withdrawal by Subject|0|||
155438068|NCT04045613|561030670|FG005|Overall Study|Withdrawal by Subject|1|||
155438069|NCT04045613|561030671|FG006|Overall Study|Withdrawal by Subject|0|||
155438070|NCT04045613|561030665|FG000|Overall Study|Physician Decision|2|||
155438071|NCT04045613|561030666|FG001|Overall Study|Physician Decision|0|||
155438072|NCT04045613|561030667|FG002|Overall Study|Physician Decision|0|||
155438073|NCT04045613|561030668|FG003|Overall Study|Physician Decision|0|||
155438074|NCT04045613|561030669|FG004|Overall Study|Physician Decision|1|||
155438075|NCT04045613|561030670|FG005|Overall Study|Physician Decision|0|||
155438076|NCT04045613|561030671|FG006|Overall Study|Physician Decision|0|||
155438077|NCT04045613|561030665|FG000|Overall Study|Death|3|||
155438078|NCT04045613|561030666|FG001|Overall Study|Death|0|||
155438079|NCT04045613|561030667|FG002|Overall Study|Death|0|||
155438080|NCT04045613|561030668|FG003|Overall Study|Death|0|||
155438081|NCT04045613|561030669|FG004|Overall Study|Death|0|||
155438082|NCT04045613|561030670|FG005|Overall Study|Death|0|||
155438083|NCT04045613|561030671|FG006|Overall Study|Death|1|||
155438084|NCT04045613|561030665|FG000|Overall Study|Other reasons|0|||
155438085|NCT04045613|561030666|FG001|Overall Study|Other reasons|1|||
155438086|NCT04045613|561030667|FG002|Overall Study|Other reasons|0|||
155438087|NCT04045613|561030668|FG003|Overall Study|Other reasons|0|||
155438088|NCT04045613|561030669|FG004|Overall Study|Other reasons|0|||
155438089|NCT04045613|561030670|FG005|Overall Study|Other reasons|0|||
155438090|NCT04045613|561030671|FG006|Overall Study|Other reasons|1|||
155438091|NCT04045613|561030665|FG000|Overall Study|Progressive disease: Clinical progression|1|||
155438092|NCT04045613|561030666|FG001|Overall Study|Progressive disease: Clinical progression|0|||
155438093|NCT04045613|561030667|FG002|Overall Study|Progressive disease: Clinical progression|3|||
155438094|NCT04045613|561030668|FG003|Overall Study|Progressive disease: Clinical progression|1|||
155438095|NCT04045613|561030669|FG004|Overall Study|Progressive disease: Clinical progression|1|||
155438096|NCT04045613|561030670|FG005|Overall Study|Progressive disease: Clinical progression|3|||
155438097|NCT04045613|561030671|FG006|Overall Study|Progressive disease: Clinical progression|3|||
155438098|NCT04045613|561030665|FG000|Overall Study|Progressive disease: Radiological progression|24|||
155438099|NCT04045613|561030666|FG001|Overall Study|Progressive disease: Radiological progression|6|||
155438100|NCT04045613|561030667|FG002|Overall Study|Progressive disease: Radiological progression|8|||
155438101|NCT04045613|561030668|FG003|Overall Study|Progressive disease: Radiological progression|0|||
155438102|NCT04045613|561030669|FG004|Overall Study|Progressive disease: Radiological progression|6|||
155438103|NCT04045613|561030670|FG005|Overall Study|Progressive disease: Radiological progression|6|||
155438104|NCT04045613|561030671|FG006|Overall Study|Progressive disease: Radiological progression|11|||
155438105|NCT03633331|561030682|FG000|Overall Study|Withdrawal by Subject|1|||
155438106|NCT00949650|561030683|FG000|Overall Study|Progressive disease|188|||
155438107|NCT00949650|561030684|FG001|Overall Study|Progressive disease|19|||
155438108|NCT00949650|561030683|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
155438109|NCT00949650|561030684|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
155438110|NCT00949650|561030683|FG000|Overall Study|Other Adverse Event (AE)|28|||
155438111|NCT00949650|561030684|FG001|Overall Study|Other Adverse Event (AE)|17|||
155438112|NCT00949650|561030683|FG000|Overall Study|Protocol Violation|1|||
155438113|NCT00949650|561030684|FG001|Overall Study|Protocol Violation|4|||
155438114|NCT00949650|561030683|FG000|Overall Study|Refusal to continue medication|7|||
155438115|NCT00949650|561030684|FG001|Overall Study|Refusal to continue medication|11|||
155438116|NCT00949650|561030683|FG000|Overall Study|Not treated|1|||
155438117|NCT00949650|561030684|FG001|Overall Study|Not treated|4|||
155438118|NCT00949650|561030683|FG000|Overall Study|Other not specified above|5|||
155438119|NCT00949650|561030684|FG001|Overall Study|Other not specified above|0|||
155438120|NCT03671369|561030687|FG000|Overall Study|Other|1|||
155438121|NCT03671369|561030687|FG000|Overall Study|Withdrawal by Subject|289|||
155438122|NCT03671369|561030687|FG000|Overall Study|Not willing to be vaccinated|1|||
155438123|NCT01743027|561030692|FG000|Overall Study|Adverse Event|2|||
155438124|NCT01743027|561030693|FG001|Overall Study|Adverse Event|0|||
155438125|NCT01743027|561030694|FG002|Overall Study|Adverse Event|0|||
155438126|NCT01743027|561030695|FG003|Overall Study|Adverse Event|0|||
155438127|NCT01743027|561030692|FG000|Overall Study|Lost to Follow-up|0|||
155438128|NCT01743027|561030693|FG001|Overall Study|Lost to Follow-up|0|||
155438129|NCT01743027|561030694|FG002|Overall Study|Lost to Follow-up|2|||
155438130|NCT01743027|561030695|FG003|Overall Study|Lost to Follow-up|0|||
155438131|NCT01743027|561030692|FG000|Overall Study|Progressive Disease|1|||
155438132|NCT01743027|561030693|FG001|Overall Study|Progressive Disease|4|||
155438133|NCT01743027|561030694|FG002|Overall Study|Progressive Disease|3|||
155438134|NCT01743027|561030695|FG003|Overall Study|Progressive Disease|0|||
155438135|NCT01743027|561030692|FG000|Overall Study|Protocol Violation|1|||
155438136|NCT01743027|561030693|FG001|Overall Study|Protocol Violation|1|||
155438137|NCT01743027|561030694|FG002|Overall Study|Protocol Violation|1|||
155438138|NCT01743027|561030695|FG003|Overall Study|Protocol Violation|0|||
155438139|NCT01743027|561030692|FG000|Overall Study|Withdrawal by Subject|1|||
155438140|NCT01743027|561030693|FG001|Overall Study|Withdrawal by Subject|0|||
155438141|NCT01743027|561030694|FG002|Overall Study|Withdrawal by Subject|3|||
155438142|NCT01743027|561030695|FG003|Overall Study|Withdrawal by Subject|1|||
155438143|NCT00450866|561030696|FG000|Overall Study|Adverse Event|0|||
155438144|NCT00450866|561030697|FG001|Overall Study|Adverse Event|1|||
155438145|NCT00450866|561030696|FG000|Overall Study|Withdrawal by Subject|5|||
155438146|NCT00450866|561030697|FG001|Overall Study|Withdrawal by Subject|2|||
155438147|NCT00450866|561030696|FG000|Overall Study|Death|1|||
155438148|NCT00450866|561030697|FG001|Overall Study|Death|0|||
155438149|NCT00450866|561030696|FG000|Overall Study|Physician Decision|1|||
155438150|NCT00450866|561030697|FG001|Overall Study|Physician Decision|0|||
155438151|NCT01753518|561030698|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
155438152|NCT01753518|561030699|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
155438153|NCT01753518|561030698|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
155438154|NCT01753518|561030699|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
155438155|NCT01753518|561030698|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
155438156|NCT01753518|561030699|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
155438157|NCT01753518|561030698|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
155438158|NCT01753518|561030699|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
155438159|NCT01971476|561030700|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
155438160|NCT01971476|561030701|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
155438161|NCT01971476|561030702|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
155438162|NCT01971476|561030700|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
155438163|NCT01971476|561030701|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
155438164|NCT01971476|561030702|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
155438165|NCT01971476|561030700|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
155438166|NCT01971476|561030701|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
155438167|NCT01971476|561030702|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
155438168|NCT00138151|561030703|FG000|Overall Study|Withdrawal by Subject|3|||
155438169|NCT00138151|561030703|FG000|Overall Study|Physician Decision|1|||
155438170|NCT04925570|561030706|FG000|Overall Study|Protocol Violation|24|||
155438171|NCT04925570|561030707|FG001|Overall Study|Protocol Violation|30|||
155514412|NCT03521999|561310282|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
155514413|NCT03521999|561310283|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
155514414|NCT05476679|561310286|FG000|Overall Study|Withdrawal by Subject|0|||
155514415|NCT05476679|561310287|FG001|Overall Study|Withdrawal by Subject|0|||
155514416|NCT05476679|561310288|FG002|Overall Study|Withdrawal by Subject|0|||
155514417|NCT05476679|561310289|FG003|Overall Study|Withdrawal by Subject|1|||
155438172|NCT04925570|561030706|FG000|Overall Study|Withdrawal by Subject|0|||
155438173|NCT04925570|561030707|FG001|Overall Study|Withdrawal by Subject|2|||
155438174|NCT02675517|561030708|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
155514418|NCT05476679|561310290|FG004|Overall Study|Withdrawal by Subject|0|||
155438175|NCT02675517|561030708|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
155438176|NCT03249350|561030711|FG000|Overall Study|Participant did not initiate treatment|5|||
155438177|NCT03249350|561030712|FG001|Overall Study|Participant did not initiate treatment|8|||
155438178|NCT02111811|561030713|FG000|Treatment Phase|Lost to Follow-up|22|||
155438179|NCT02111811|561030714|FG001|Treatment Phase|Lost to Follow-up|18|||
155438180|NCT02111811|561030713|FG000|Treatment Phase|Death|2|||
155438181|NCT02111811|561030714|FG001|Treatment Phase|Death|0|||
155438182|NCT02111811|561030713|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
155438183|NCT02111811|561030714|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
155438184|NCT02111811|561030713|FG000|Follow up Period (Aim 2)|Death|2|||
155438185|NCT02111811|561030714|FG001|Follow up Period (Aim 2)|Death|0|||
155438186|NCT03443024|561030717|FG000|Overall Study|Adverse Event|2|||
155438187|NCT03443024|561030718|FG001|Overall Study|Adverse Event|4|||
155438188|NCT03443024|561030719|FG002|Overall Study|Adverse Event|3|||
155438189|NCT03443024|561030720|FG003|Overall Study|Adverse Event|1|||
155438190|NCT03443024|561030717|FG000|Overall Study|Lost to Follow-up|9|||
155438191|NCT03443024|561030718|FG001|Overall Study|Lost to Follow-up|9|||
155438192|NCT03443024|561030719|FG002|Overall Study|Lost to Follow-up|7|||
155438193|NCT03443024|561030720|FG003|Overall Study|Lost to Follow-up|5|||
155438194|NCT03443024|561030717|FG000|Overall Study|Withdrawal by Subject|8|||
155438195|NCT03443024|561030718|FG001|Overall Study|Withdrawal by Subject|15|||
155438196|NCT03443024|561030719|FG002|Overall Study|Withdrawal by Subject|9|||
155438197|NCT03443024|561030720|FG003|Overall Study|Withdrawal by Subject|23|||
155438198|NCT03443024|561030717|FG000|Overall Study|Physician Decision|1|||
155438199|NCT03443024|561030718|FG001|Overall Study|Physician Decision|2|||
155438200|NCT03443024|561030719|FG002|Overall Study|Physician Decision|0|||
155438201|NCT03443024|561030720|FG003|Overall Study|Physician Decision|1|||
155438202|NCT03443024|561030717|FG000|Overall Study|Sponsor Decision|1|||
155438203|NCT03443024|561030718|FG001|Overall Study|Sponsor Decision|1|||
155438204|NCT03443024|561030719|FG002|Overall Study|Sponsor Decision|0|||
155438205|NCT03443024|561030720|FG003|Overall Study|Sponsor Decision|0|||
155438206|NCT03443024|561030717|FG000|Overall Study|Protocol Deviation|0|||
155438207|NCT03443024|561030718|FG001|Overall Study|Protocol Deviation|0|||
155438208|NCT03443024|561030719|FG002|Overall Study|Protocol Deviation|0|||
155438209|NCT03443024|561030720|FG003|Overall Study|Protocol Deviation|2|||
155438210|NCT00149825|561030721|FG000|Overall Study|Intolerance to medication side effects|1|||
155438211|NCT00149825|561030722|FG001|Overall Study|Intolerance to medication side effects|2|||
155438212|NCT00149825|561030721|FG000|Overall Study|Time commitments|2|||
155438213|NCT00149825|561030722|FG001|Overall Study|Time commitments|1|||
155438214|NCT00149825|561030721|FG000|Overall Study|Not liking insomnia therapy|1|||
155438215|NCT00149825|561030722|FG001|Overall Study|Not liking insomnia therapy|0|||
155438216|NCT00149825|561030721|FG000|Overall Study|Other|1|||
155438217|NCT00149825|561030722|FG001|Overall Study|Other|0|||
155438218|NCT05897853|561030723|FG000|Overall Study|Lost to Follow-up|2|||
155438219|NCT05897853|561030724|FG001|Overall Study|Lost to Follow-up|0|||
155438220|NCT05897853|561030723|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
155438221|NCT05897853|561030724|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
155438222|NCT03851510|561030725|FG000|Overall Study|Screen Fail|1|||
155438223|NCT03851510|561030725|FG000|Overall Study|Adverse Event|1|||
155438224|NCT03851510|561030725|FG000|Overall Study|Withdrawal by Subject|1|||
155438225|NCT00970294|561030728|FG000|Overall Study|Physician Decision|4|||
155438226|NCT00970294|561030728|FG000|Overall Study|Withdrawal by Subject|1|||
155438227|NCT01333189|561030729|FG000|Overall Study|Time constraints|1|||
155438228|NCT01333189|561030730|FG001|Overall Study|Time constraints|0|||
155438229|NCT01333189|561030729|FG000|Overall Study|Adverse Event|1|||
155438230|NCT01333189|561030730|FG001|Overall Study|Adverse Event|0|||
155438231|NCT01333189|561030729|FG000|Overall Study|Transportation difficulties|0|||
155438232|NCT01333189|561030730|FG001|Overall Study|Transportation difficulties|1|||
155438233|NCT01333189|561030729|FG000|Overall Study|Moved from region|0|||
155438234|NCT01333189|561030730|FG001|Overall Study|Moved from region|1|||
155438235|NCT01739595|561030731|FG000|Overall Study|Adverse Event|3|||
155438236|NCT01739595|561030732|FG001|Overall Study|Adverse Event|0|||
155438237|NCT01739595|561030733|FG002|Overall Study|Adverse Event|0|||
155438238|NCT01739595|561030731|FG000|Overall Study|Lost to Follow-up|2|||
155438239|NCT01739595|561030732|FG001|Overall Study|Lost to Follow-up|0|||
155438240|NCT01739595|561030733|FG002|Overall Study|Lost to Follow-up|0|||
155438241|NCT01739595|561030731|FG000|Overall Study|Withdrawal by Subject|2|||
155438242|NCT01739595|561030732|FG001|Overall Study|Withdrawal by Subject|1|||
155438243|NCT01739595|561030733|FG002|Overall Study|Withdrawal by Subject|2|||
155438244|NCT01739595|561030731|FG000|Overall Study|Eligibility issue|3|||
155438245|NCT01739595|561030732|FG001|Overall Study|Eligibility issue|0|||
155438246|NCT01739595|561030733|FG002|Overall Study|Eligibility issue|0|||
155438247|NCT01739595|561030731|FG000|Overall Study|Protocol Violation|1|||
155438248|NCT01739595|561030732|FG001|Overall Study|Protocol Violation|0|||
155438249|NCT01739595|561030733|FG002|Overall Study|Protocol Violation|0|||
155438250|NCT01739595|561030731|FG000|Overall Study|Lab assessment|1|||
155438251|NCT01739595|561030732|FG001|Overall Study|Lab assessment|0|||
155438252|NCT01739595|561030733|FG002|Overall Study|Lab assessment|0|||
155438253|NCT01739595|561030731|FG000|Overall Study|Drug discrepancy|1|||
155438254|NCT01739595|561030732|FG001|Overall Study|Drug discrepancy|0|||
155438255|NCT01739595|561030733|FG002|Overall Study|Drug discrepancy|0|||
155438256|NCT02104180|561030734|FG000|Overall Study|Protocol Violation|1|||
155438257|NCT02104180|561030735|FG001|Overall Study|Protocol Violation|0|||
155438258|NCT00793585|561030736|FG000|Overall Study|Adverse Event|1|||
155438259|NCT00793585|561030737|FG001|Overall Study|Adverse Event|1|||
155438260|NCT00793585|561030736|FG000|Overall Study|Protocol Violation|1|||
155438261|NCT00793585|561030737|FG001|Overall Study|Protocol Violation|2|||
155438262|NCT00035815|561030738|FG000|Overall Study|Withdrawal by Subject|17|||
155438263|NCT00035815|561030739|FG001|Overall Study|Withdrawal by Subject|11|||
155438264|NCT04952389|561030741|FG000|Overall Study|Withdrawal by Subject|8|||
155438265|NCT04952389|561030742|FG001|Overall Study|Withdrawal by Subject|4|||
155438266|NCT04075604|561031660|FG000|Overall Study|Adverse Event|0|||
155438267|NCT04075604|561031661|FG001|Overall Study|Adverse Event|0|||
155438268|NCT04075604|561031662|FG002|Overall Study|Adverse Event|3|||
155438269|NCT04075604|561031660|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155438270|NCT04075604|561031661|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155438271|NCT04075604|561031662|FG002|Overall Study|Participant request to discontinue study treatment|1|||
155438272|NCT04075604|561031660|FG000|Overall Study|Participant withdrew consent|0|||
155438273|NCT04075604|561031661|FG001|Overall Study|Participant withdrew consent|0|||
155438274|NCT04075604|561031662|FG002|Overall Study|Participant withdrew consent|1|||
155438275|NCT04075604|561031660|FG000|Overall Study|Other reasons|1|||
155438276|NCT04075604|561031661|FG001|Overall Study|Other reasons|0|||
155438277|NCT04075604|561031662|FG002|Overall Study|Other reasons|0|||
155438278|NCT04075604|561031660|FG000|Overall Study|Disease progression|0|||
155438279|NCT04075604|561031661|FG001|Overall Study|Disease progression|1|||
155438280|NCT04075604|561031662|FG002|Overall Study|Disease progression|0|||
155438281|NCT04075604|561031660|FG000|Overall Study|Study drug toxicity|0|||
155438282|NCT04075604|561031661|FG001|Overall Study|Study drug toxicity|5|||
155438283|NCT04075604|561031662|FG002|Overall Study|Study drug toxicity|1|||
155438284|NCT02717546|561031673|FG000|Overall Study|Lost to Follow-up|12|||
155438285|NCT01009294|561031674|FG000|Overall Study|Study discontinued by Sponsor|6|||
155438286|NCT00414440|561031677|FG000|Core Period|Withdrawal by Subject|70|||
155438287|NCT00414440|561031678|FG001|Core Period|Withdrawal by Subject|32|||
155438288|NCT00414440|561031677|FG000|Extension Period|Lost to Follow-up|44|||
155438289|NCT00414440|561031678|FG001|Extension Period|Lost to Follow-up|52|||
155438290|NCT00414440|561031677|FG000|Extension Period|Did not consent to continue follow up|61|||
155438291|NCT00414440|561031678|FG001|Extension Period|Did not consent to continue follow up|54|||
155438292|NCT00414440|561031677|FG000|Extension Period|Other|1|||
155438293|NCT00414440|561031678|FG001|Extension Period|Other|1|||
155438294|NCT00414440|561031677|FG000|Extension Period|Administrative|16|||
155438295|NCT00414440|561031678|FG001|Extension Period|Administrative|16|||
155438296|NCT00414440|561031677|FG000|Extension Period|Death|1|||
155438297|NCT00414440|561031678|FG001|Extension Period|Death|2|||
155438298|NCT00414440|561031677|FG000|Extension Period|Withdrawal by Subject|9|||
155438299|NCT00414440|561031678|FG001|Extension Period|Withdrawal by Subject|7|||
155438300|NCT00414440|561031677|FG000|Extension Period|Not included in follow up period|18|||
155438301|NCT00414440|561031678|FG001|Extension Period|Not included in follow up period|8|||
155438302|NCT04382651|561031679|FG000|Overall Study|Death|26|||
155438303|NCT04382651|561031680|FG001|Overall Study|Death|23|||
155438304|NCT04382651|561031679|FG000|Overall Study|Lost to Follow-up|3|||
155438305|NCT04382651|561031680|FG001|Overall Study|Lost to Follow-up|4|||
155438306|NCT04382651|561031679|FG000|Overall Study|Withdrawal by Subject|2|||
155438307|NCT04382651|561031680|FG001|Overall Study|Withdrawal by Subject|0|||
155438308|NCT04382651|561031679|FG000|Overall Study|Physician Decision|0|||
155438309|NCT04382651|561031680|FG001|Overall Study|Physician Decision|1|||
155438310|NCT01507545|561031681|FG000|Overall Study|Withdrawal by Subject|6|||
155438311|NCT01507545|561031682|FG001|Overall Study|Withdrawal by Subject|2|||
155438312|NCT01507545|561031681|FG000|Overall Study|Lost to Follow-up|1|||
155438313|NCT01507545|561031682|FG001|Overall Study|Lost to Follow-up|0|||
155438314|NCT01507545|561031681|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
155438315|NCT01507545|561031682|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
155438316|NCT01507545|561031681|FG000|Overall Study|Progressive disease|60|||
155438317|NCT01507545|561031682|FG001|Overall Study|Progressive disease|27|||
155438318|NCT01507545|561031681|FG000|Overall Study|Other|6|||
155438319|NCT01507545|561031682|FG001|Overall Study|Other|4|||
155438320|NCT00790296|561031684|FG000|Overall Study|Did not meet study eligibility criteria|1|||
155438321|NCT00790296|561031685|FG001|Overall Study|Did not meet study eligibility criteria|1|||
155438322|NCT00790296|561031684|FG000|Overall Study|Adverse Event|0|||
155438323|NCT00790296|561031685|FG001|Overall Study|Adverse Event|1|||
155438324|NCT02612077|561031686|FG000|Overall Study|Adverse Event|3|||
155514419|NCT05476679|561310286|FG000|Overall Study|Lost to Follow-up|0|||
155438325|NCT02612077|561031686|FG000|Overall Study|Withdrawal by Subject|9|||
155514420|NCT05476679|561310287|FG001|Overall Study|Lost to Follow-up|0|||
155438326|NCT02612077|561031686|FG000|Overall Study|Protocol Violation|28|||
155438327|NCT02612077|561031686|FG000|Overall Study|Lost to Follow-up|20|||
155438328|NCT02612077|561031686|FG000|Overall Study|Death|377|||
155438329|NCT02612077|561031686|FG000|Overall Study|Moved or Changed Medical Team|23|||
155438330|NCT02612077|561031686|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
155438331|NCT02612077|561031686|FG000|Overall Study|Disease Progression|3|||
155438332|NCT02612077|561031686|FG000|Overall Study|Unknown reason|2|||
155438333|NCT00940342|561031687|FG000|Overall Study|Adverse Event|0|||
155438334|NCT00940342|561031688|FG001|Overall Study|Adverse Event|2|||
155438335|NCT00940342|561031689|FG002|Overall Study|Adverse Event|1|||
155438336|NCT01716169|561031691|FG000|Overall Study|Adverse Event|1|||
155438337|NCT01716169|561031691|FG000|Overall Study|Lost to Follow-up|1|||
155438338|NCT01716169|561031691|FG000|Overall Study|Withdrawal by Subject|1|||
155438339|NCT01716169|561031691|FG000|Overall Study|inconsistent dressing application|1|||
155438340|NCT00553787|561031692|FG000|Overall Study|Adverse Event|34|||
155438341|NCT00553787|561031693|FG001|Overall Study|Adverse Event|21|||
155438342|NCT00553787|561031694|FG002|Overall Study|Adverse Event|67|||
155438343|NCT00553787|561031692|FG000|Overall Study|Lost to Follow-up|132|||
155438344|NCT00553787|561031693|FG001|Overall Study|Lost to Follow-up|44|||
155438345|NCT00553787|561031694|FG002|Overall Study|Lost to Follow-up|78|||
155438346|NCT00553787|561031692|FG000|Overall Study|Withdrawal by Subject|151|||
155438347|NCT00553787|561031693|FG001|Overall Study|Withdrawal by Subject|40|||
155438348|NCT00553787|561031694|FG002|Overall Study|Withdrawal by Subject|83|||
155438349|NCT00553787|561031692|FG000|Overall Study|Lack of Efficacy|31|||
155438350|NCT00553787|561031693|FG001|Overall Study|Lack of Efficacy|1|||
155438351|NCT00553787|561031694|FG002|Overall Study|Lack of Efficacy|3|||
155438352|NCT00553787|561031692|FG000|Overall Study|Pregnancy|0|||
155438353|NCT00553787|561031693|FG001|Overall Study|Pregnancy|1|||
155438354|NCT00553787|561031694|FG002|Overall Study|Pregnancy|2|||
155438355|NCT00553787|561031692|FG000|Overall Study|non compliance|4|||
155438356|NCT00553787|561031693|FG001|Overall Study|non compliance|0|||
155438357|NCT00553787|561031694|FG002|Overall Study|non compliance|11|||
155438358|NCT00553787|561031692|FG000|Overall Study|Requirement for restricted medication|8|||
155438359|NCT00553787|561031693|FG001|Overall Study|Requirement for restricted medication|7|||
155438360|NCT00553787|561031694|FG002|Overall Study|Requirement for restricted medication|5|||
155438361|NCT00553787|561031692|FG000|Overall Study|Other|18|||
155438362|NCT00553787|561031693|FG001|Overall Study|Other|10|||
155438363|NCT00553787|561031694|FG002|Overall Study|Other|13|||
155438364|NCT01088412|561031695|FG000|Overall Study|Adverse Event|38|||
155438365|NCT01088412|561031696|FG001|Overall Study|Adverse Event|0|||
155438366|NCT01088412|561031697|FG002|Overall Study|Adverse Event|0|||
155438367|NCT01088412|561031695|FG000|Overall Study|Death|42|||
155438368|NCT01088412|561031696|FG001|Overall Study|Death|6|||
155438369|NCT01088412|561031697|FG002|Overall Study|Death|0|||
155438370|NCT01088412|561031695|FG000|Overall Study|Other Reason per Case Report Form|2089|||
155438371|NCT01088412|561031696|FG001|Overall Study|Other Reason per Case Report Form|103|||
155438372|NCT01088412|561031697|FG002|Overall Study|Other Reason per Case Report Form|9|||
155438373|NCT01088412|561031695|FG000|Overall Study|Withdrawal by Subject|1761|||
155438374|NCT01088412|561031696|FG001|Overall Study|Withdrawal by Subject|25|||
155438375|NCT01088412|561031697|FG002|Overall Study|Withdrawal by Subject|1|||
155438376|NCT01088412|561031695|FG000|Overall Study|Received Another GH Product|79|||
155438377|NCT01088412|561031696|FG001|Overall Study|Received Another GH Product|0|||
155438378|NCT01088412|561031697|FG002|Overall Study|Received Another GH Product|0|||
155438379|NCT01088412|561031695|FG000|Overall Study|Participant Moved|601|||
155438380|NCT01088412|561031696|FG001|Overall Study|Participant Moved|21|||
155438381|NCT01088412|561031697|FG002|Overall Study|Participant Moved|2|||
155438382|NCT01088412|561031695|FG000|Overall Study|Physician Decision|1041|||
155438383|NCT01088412|561031696|FG001|Overall Study|Physician Decision|8|||
155438384|NCT01088412|561031697|FG002|Overall Study|Physician Decision|4|||
155438385|NCT01088412|561031695|FG000|Overall Study|Sponsor Decision|4467|||
155438386|NCT01088412|561031696|FG001|Overall Study|Sponsor Decision|79|||
155438387|NCT01088412|561031697|FG002|Overall Study|Sponsor Decision|23|||
155438388|NCT01088412|561031695|FG000|Overall Study|Third Party Required to Change Brand|487|||
155438389|NCT01088412|561031696|FG001|Overall Study|Third Party Required to Change Brand|0|||
155438390|NCT01088412|561031697|FG002|Overall Study|Third Party Required to Change Brand|0|||
155438391|NCT01088412|561031695|FG000|Overall Study|Lost to Follow-up|3052|||
155438392|NCT01088412|561031696|FG001|Overall Study|Lost to Follow-up|130|||
155438393|NCT01088412|561031697|FG002|Overall Study|Lost to Follow-up|11|||
155438394|NCT01088412|561031695|FG000|Overall Study|Study Summary Not Completed|4360|||
155438395|NCT01088412|561031696|FG001|Overall Study|Study Summary Not Completed|64|||
155438396|NCT01088412|561031697|FG002|Overall Study|Study Summary Not Completed|22|||
155438397|NCT00793104|561031698|FG000|Overall Study|Lost to Follow-up|1|||
155438398|NCT05121103|561031701|FG000|Overall Study|Progressive disease|2|||
155438399|NCT05121103|561031702|FG001|Overall Study|Progressive disease|1|||
155438400|NCT05121103|561031703|FG002|Overall Study|Progressive disease|6|||
155438401|NCT05121103|561031701|FG000|Overall Study|Physician Decision|2|||
155438402|NCT05121103|561031702|FG001|Overall Study|Physician Decision|1|||
155438403|NCT05121103|561031703|FG002|Overall Study|Physician Decision|0|||
155438404|NCT05121103|561031701|FG000|Overall Study|Withdrawal by Subject|0|||
155438405|NCT05121103|561031702|FG001|Overall Study|Withdrawal by Subject|1|||
155438406|NCT05121103|561031703|FG002|Overall Study|Withdrawal by Subject|0|||
155438407|NCT03494725|561031706|FG000|Overall Study|Withdrawal by Subject|0|||
155438408|NCT03494725|561031707|FG001|Overall Study|Withdrawal by Subject|2|||
155438409|NCT03494725|561031706|FG000|Overall Study|Antibiotic use|1|||
155438410|NCT03494725|561031707|FG001|Overall Study|Antibiotic use|0|||
155438411|NCT02619253|561031708|FG000|Overall Study|Adverse Event|0|||
155438412|NCT02619253|561031709|FG001|Overall Study|Adverse Event|0|||
155438413|NCT02619253|561031710|FG002|Overall Study|Adverse Event|1|||
155438414|NCT02619253|561031711|FG003|Overall Study|Adverse Event|1|||
155438415|NCT02619253|561031712|FG004|Overall Study|Adverse Event|3|||
155438416|NCT02619253|561031708|FG000|Overall Study|Alternative Therapy|0|||
155438417|NCT02619253|561031709|FG001|Overall Study|Alternative Therapy|0|||
155438418|NCT02619253|561031710|FG002|Overall Study|Alternative Therapy|1|||
155438419|NCT02619253|561031711|FG003|Overall Study|Alternative Therapy|0|||
155438420|NCT02619253|561031712|FG004|Overall Study|Alternative Therapy|0|||
155438421|NCT02619253|561031708|FG000|Overall Study|Death|0|||
155438422|NCT02619253|561031709|FG001|Overall Study|Death|0|||
155438423|NCT02619253|561031710|FG002|Overall Study|Death|0|||
155438424|NCT02619253|561031711|FG003|Overall Study|Death|1|||
155438425|NCT02619253|561031712|FG004|Overall Study|Death|0|||
155438426|NCT02619253|561031708|FG000|Overall Study|Disease Progression|4|||
155438427|NCT02619253|561031709|FG001|Overall Study|Disease Progression|2|||
155438428|NCT02619253|561031710|FG002|Overall Study|Disease Progression|8|||
155438429|NCT02619253|561031711|FG003|Overall Study|Disease Progression|9|||
155438430|NCT02619253|561031712|FG004|Overall Study|Disease Progression|10|||
155438431|NCT02619253|561031708|FG000|Overall Study|Needed a disqualifying therapy|0|||
155438432|NCT02619253|561031709|FG001|Overall Study|Needed a disqualifying therapy|0|||
155438433|NCT02619253|561031710|FG002|Overall Study|Needed a disqualifying therapy|1|||
155438434|NCT02619253|561031711|FG003|Overall Study|Needed a disqualifying therapy|0|||
155438435|NCT02619253|561031712|FG004|Overall Study|Needed a disqualifying therapy|0|||
155438436|NCT02619253|561031708|FG000|Overall Study|Transferred to hospice|0|||
155438437|NCT02619253|561031709|FG001|Overall Study|Transferred to hospice|0|||
155438438|NCT02619253|561031710|FG002|Overall Study|Transferred to hospice|1|||
155438439|NCT02619253|561031711|FG003|Overall Study|Transferred to hospice|0|||
155438440|NCT02619253|561031712|FG004|Overall Study|Transferred to hospice|0|||
155438441|NCT02619253|561031708|FG000|Overall Study|Physician Decision|0|||
155438442|NCT02619253|561031709|FG001|Overall Study|Physician Decision|1|||
155438443|NCT02619253|561031710|FG002|Overall Study|Physician Decision|2|||
155438444|NCT02619253|561031711|FG003|Overall Study|Physician Decision|3|||
155438445|NCT02619253|561031712|FG004|Overall Study|Physician Decision|0|||
155438446|NCT02619253|561031708|FG000|Overall Study|Withdrawal by Subject|0|||
155438447|NCT02619253|561031709|FG001|Overall Study|Withdrawal by Subject|1|||
155438448|NCT02619253|561031710|FG002|Overall Study|Withdrawal by Subject|0|||
155438449|NCT02619253|561031711|FG003|Overall Study|Withdrawal by Subject|0|||
155438450|NCT02619253|561031712|FG004|Overall Study|Withdrawal by Subject|2|||
155438451|NCT00514449|561031713|FG000|Overall Study|Withdrawal by Subject|1|||
155438452|NCT00514449|561031714|FG001|Overall Study|Withdrawal by Subject|2|||
155438453|NCT00514449|561031713|FG000|Overall Study|Protocol Violation|1|||
155438454|NCT00514449|561031714|FG001|Overall Study|Protocol Violation|2|||
155438455|NCT00514449|561031713|FG000|Overall Study|Lost to Follow-up|1|||
155514421|NCT05476679|561310288|FG002|Overall Study|Lost to Follow-up|0|||
155514422|NCT05476679|561310289|FG003|Overall Study|Lost to Follow-up|1|||
155514423|NCT05476679|561310290|FG004|Overall Study|Lost to Follow-up|0|||
155514424|NCT03402893|561310291|FG000|Overall Study|Withdrawal by Subject|1|||
155514425|NCT00686036|561310294|FG000|Overall Study|Adverse Event|3|||
155514426|NCT00686036|561310295|FG001|Overall Study|Adverse Event|0|||
155514427|NCT00686036|561310294|FG000|Overall Study|Withdrawal by Subject|3|||
155514428|NCT00686036|561310295|FG001|Overall Study|Withdrawal by Subject|1|||
155651204|NCT00819832|561814591|FG005|Overall Study|Sponsor Termination of Study|0|||
155651205|NCT01063881|561814595|FG000|Overall Study|Adverse Event|12|||
155651206|NCT01063881|561814596|FG001|Overall Study|Adverse Event|2|||
155438456|NCT00514449|561031714|FG001|Overall Study|Lost to Follow-up|0|||
155438457|NCT00301067|561031722|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
155514429|NCT00686036|561310294|FG000|Overall Study|Study terminated by AstraZeneca|2|||
155514430|NCT00686036|561310295|FG001|Overall Study|Study terminated by AstraZeneca|1|||
155438458|NCT00301067|561031723|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
155438459|NCT00301067|561031724|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
155438460|NCT00301067|561031725|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
155438461|NCT00301067|561031722|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
155514431|NCT00686036|561310294|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
155514432|NCT00686036|561310295|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
155438462|NCT00301067|561031723|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
155438463|NCT00301067|561031724|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
155438464|NCT00301067|561031725|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
155438465|NCT00301067|561031722|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
155438466|NCT00301067|561031723|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
155438467|NCT00301067|561031724|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
155438468|NCT00301067|561031725|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
155438469|NCT00301067|561031722|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
155438470|NCT00301067|561031723|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
155438471|NCT00301067|561031724|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
155438472|NCT00301067|561031725|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
155438473|NCT00301067|561031722|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
155438474|NCT00301067|561031723|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
155438475|NCT00301067|561031724|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
155438476|NCT00301067|561031725|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
155438477|NCT00301067|561031722|FG000|Follow up Until Death|Alive at last data cut point|1|||
155438478|NCT00301067|561031723|FG001|Follow up Until Death|Alive at last data cut point|0|||
155438479|NCT00301067|561031724|FG002|Follow up Until Death|Alive at last data cut point|0|||
155438480|NCT00301067|561031725|FG003|Follow up Until Death|Alive at last data cut point|1|||
155438481|NCT01359982|561031726|FG000|Overall Study|Adverse Event|2|||
155438482|NCT01359982|561031727|FG001|Overall Study|Adverse Event|0|||
155438483|NCT01359982|561031728|FG002|Overall Study|Adverse Event|0|||
155438484|NCT01359982|561031729|FG003|Overall Study|Adverse Event|1|||
155438485|NCT01359982|561031730|FG004|Overall Study|Adverse Event|0|||
155438486|NCT01359982|561031731|FG005|Overall Study|Adverse Event|0|||
155438487|NCT01359982|561031726|FG000|Overall Study|Death|1|||
155438488|NCT01359982|561031727|FG001|Overall Study|Death|0|||
155438489|NCT01359982|561031728|FG002|Overall Study|Death|0|||
155438490|NCT01359982|561031729|FG003|Overall Study|Death|0|||
155438491|NCT01359982|561031730|FG004|Overall Study|Death|0|||
155438492|NCT01359982|561031731|FG005|Overall Study|Death|0|||
155438493|NCT05593432|561031732|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
155438494|NCT05593432|561031733|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
155438495|NCT05593432|561031734|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
155438496|NCT05593432|561031735|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
155438497|NCT05593432|561031732|FG000|16-Week OLE Period|Lack of Efficacy|0|||
155438498|NCT05593432|561031733|FG001|16-Week OLE Period|Lack of Efficacy|0|||
155438499|NCT05593432|561031734|FG002|16-Week OLE Period|Lack of Efficacy|0|||
155438500|NCT05593432|561031735|FG003|16-Week OLE Period|Lack of Efficacy|1|||
155438501|NCT05593432|561031732|FG000|16-Week OLE Period|Lost to Follow-up|0|||
155438502|NCT05593432|561031733|FG001|16-Week OLE Period|Lost to Follow-up|0|||
155438503|NCT05593432|561031734|FG002|16-Week OLE Period|Lost to Follow-up|1|||
155438504|NCT05593432|561031735|FG003|16-Week OLE Period|Lost to Follow-up|2|||
155438505|NCT05593432|561031732|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
155438506|NCT05593432|561031733|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
155438507|NCT05593432|561031734|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
155438508|NCT05593432|561031735|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
155438509|NCT02609399|561031740|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
155438510|NCT02609399|561031741|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
155438511|NCT02609399|561031740|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
155438512|NCT02609399|561031741|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
155438513|NCT02609399|561031740|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
155438514|NCT02609399|561031741|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
155438515|NCT00069121|561031742|FG000|Overall Study|Death|286|||
155438516|NCT00069121|561031743|FG001|Overall Study|Death|242|||
155438517|NCT00069121|561031742|FG000|Overall Study|Withdrawal by Subject|18|||
155438518|NCT00069121|561031743|FG001|Overall Study|Withdrawal by Subject|20|||
155438519|NCT00069121|561031742|FG000|Overall Study|Lost to Follow-up|63|||
155438520|NCT00069121|561031743|FG001|Overall Study|Lost to Follow-up|63|||
155438521|NCT00306891|561031744|FG000|Part A|Withdrawal by Subject|1|||
155438522|NCT00306891|561031745|FG001|Part A|Withdrawal by Subject|1|||
155438523|NCT00306891|561031746|FG002|Part A|Withdrawal by Subject|0|||
155438524|NCT00306891|561031747|FG003|Part A|Withdrawal by Subject|0|||
155438525|NCT00306891|561031744|FG000|Part A|Condition under investigation worsened|2|||
155438526|NCT00306891|561031745|FG001|Part A|Condition under investigation worsened|2|||
155438527|NCT00306891|561031746|FG002|Part A|Condition under investigation worsened|0|||
155438528|NCT00306891|561031747|FG003|Part A|Condition under investigation worsened|0|||
155438529|NCT00306891|561031744|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
155438530|NCT00306891|561031745|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
155438531|NCT00306891|561031746|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
155438532|NCT00306891|561031747|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
155438533|NCT00306891|561031744|FG000|Part A|Partial bowel obstruction|1|||
155438534|NCT00306891|561031745|FG001|Part A|Partial bowel obstruction|0|||
155438535|NCT00306891|561031746|FG002|Part A|Partial bowel obstruction|0|||
155438536|NCT00306891|561031747|FG003|Part A|Partial bowel obstruction|0|||
155438537|NCT00306891|561031744|FG000|Part A|Reaccumul. of ascites following drainage|0|||
155438538|NCT00306891|561031745|FG001|Part A|Reaccumul. of ascites following drainage|1|||
155438539|NCT00306891|561031746|FG002|Part A|Reaccumul. of ascites following drainage|0|||
155438540|NCT00306891|561031747|FG003|Part A|Reaccumul. of ascites following drainage|0|||
155438541|NCT00306891|561031744|FG000|Part A|Suspicion of second malignancy|0|||
155438542|NCT00306891|561031745|FG001|Part A|Suspicion of second malignancy|1|||
155438543|NCT00306891|561031746|FG002|Part A|Suspicion of second malignancy|0|||
155438544|NCT00306891|561031747|FG003|Part A|Suspicion of second malignancy|0|||
155438545|NCT00306891|561031744|FG000|Part A|QTC interval outwith elig. criteria|1|||
155438546|NCT00306891|561031745|FG001|Part A|QTC interval outwith elig. criteria|0|||
155438547|NCT00306891|561031746|FG002|Part A|QTC interval outwith elig. criteria|0|||
155438548|NCT00306891|561031747|FG003|Part A|QTC interval outwith elig. criteria|0|||
155438549|NCT00306891|561031744|FG000|Part B|Death|0|||
155438550|NCT00306891|561031745|FG001|Part B|Death|0|||
155438551|NCT00306891|561031746|FG002|Part B|Death|1|||
155438552|NCT00306891|561031747|FG003|Part B|Death|2|||
155438553|NCT00306891|561031744|FG000|Part B|Adverse Event|0|||
155438554|NCT00306891|561031745|FG001|Part B|Adverse Event|0|||
155438555|NCT00306891|561031746|FG002|Part B|Adverse Event|5|||
155438556|NCT00306891|561031747|FG003|Part B|Adverse Event|5|||
155438557|NCT00306891|561031744|FG000|Part B|Withdrawal by Subject|0|||
155438558|NCT00306891|561031745|FG001|Part B|Withdrawal by Subject|0|||
155438559|NCT00306891|561031746|FG002|Part B|Withdrawal by Subject|3|||
155438560|NCT00306891|561031747|FG003|Part B|Withdrawal by Subject|1|||
155438561|NCT00306891|561031744|FG000|Part B|Condition under investigation worsened|0|||
155438562|NCT00306891|561031745|FG001|Part B|Condition under investigation worsened|0|||
155438563|NCT00306891|561031746|FG002|Part B|Condition under investigation worsened|2|||
155438564|NCT00306891|561031747|FG003|Part B|Condition under investigation worsened|8|||
155438565|NCT00306891|561031744|FG000|Part B|Development of study specific disc crit.|0|||
155438566|NCT00306891|561031745|FG001|Part B|Development of study specific disc crit.|0|||
155438567|NCT00306891|561031746|FG002|Part B|Development of study specific disc crit.|0|||
155438568|NCT00306891|561031747|FG003|Part B|Development of study specific disc crit.|1|||
155438569|NCT00206518|561031749|FG000|Overall Study|Lack of Efficacy|6|||
155438570|NCT00206518|561031750|FG001|Overall Study|Lack of Efficacy|4|||
155438571|NCT00206518|561031749|FG000|Overall Study|Adverse Event|2|||
155438572|NCT00206518|561031750|FG001|Overall Study|Adverse Event|1|||
155438573|NCT00206518|561031749|FG000|Overall Study|Physician Decision|1|||
155438574|NCT00206518|561031750|FG001|Overall Study|Physician Decision|0|||
155438575|NCT00206518|561031749|FG000|Overall Study|Protocol Violation|1|||
155438576|NCT00206518|561031750|FG001|Overall Study|Protocol Violation|1|||
155438577|NCT02335450|561031751|FG000|Overall Study|Pregnancy|1|||
155438578|NCT02613572|561031752|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
155438579|NCT02613572|561031753|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
155438580|NCT02613572|561031754|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
155438581|NCT02613572|561031752|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
155438582|NCT02613572|561031753|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
155438583|NCT02613572|561031754|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
155438584|NCT00231478|561031756|FG000|Overall Study|Protocol Violation|3|||
155438585|NCT00231478|561031757|FG001|Overall Study|Protocol Violation|2|||
155438586|NCT00231478|561031756|FG000|Overall Study|Refused Treatment|1|||
155438587|NCT00231478|561031757|FG001|Overall Study|Refused Treatment|1|||
155438588|NCT00231478|561031756|FG000|Overall Study|Withdrawal by Subject|1|||
155438589|NCT00231478|561031757|FG001|Overall Study|Withdrawal by Subject|0|||
155438590|NCT00231478|561031756|FG000|Overall Study|Adverse Event|0|||
155514433|NCT00686036|561310294|FG000|Overall Study|Other reasons not identified|0|||
155514434|NCT00686036|561310295|FG001|Overall Study|Other reasons not identified|4|||
155438591|NCT00231478|561031757|FG001|Overall Study|Adverse Event|1|||
155438592|NCT00231478|561031756|FG000|Overall Study|Administrative|3|||
155438593|NCT00231478|561031757|FG001|Overall Study|Administrative|2|||
155438594|NCT00853905|561031758|FG000|Overall Study|Lost to Follow-up|1|||
155514435|NCT01937364|561310296|FG000|Overall Study|Adverse Event|2|||
155514436|NCT01937364|561310297|FG001|Overall Study|Adverse Event|1|||
155651207|NCT01063881|561814597|FG002|Overall Study|Adverse Event|0|||
155438595|NCT00853905|561031759|FG001|Overall Study|Lost to Follow-up|3|||
155438596|NCT00853905|561031758|FG000|Overall Study|Withdrawal by Subject|0|||
155438597|NCT00853905|561031759|FG001|Overall Study|Withdrawal by Subject|1|||
155438598|NCT00853905|561031758|FG000|Overall Study|never had surgery|1|||
155438599|NCT00853905|561031759|FG001|Overall Study|never had surgery|0|||
155438600|NCT04538950|561031760|FG000|Overall Study|Pulmonary Issues|2|||
155438601|NCT04538950|561031760|FG000|Overall Study|illness|2|||
155438602|NCT00847561|561031761|FG000|Overall Study|Withdrawal by Subject|4|||
155438603|NCT00847561|561031762|FG001|Overall Study|Withdrawal by Subject|3|||
155438604|NCT00847561|561031761|FG000|Overall Study|Unable to schedule|9|||
155438605|NCT00847561|561031762|FG001|Overall Study|Unable to schedule|1|||
155438606|NCT00393458|561031764|FG000|Overall Study|Adverse Event|35|||
155438607|NCT00393458|561031765|FG001|Overall Study|Adverse Event|24|||
155438608|NCT00393458|561031766|FG002|Overall Study|Adverse Event|40|||
155438609|NCT00393458|561031767|FG003|Overall Study|Adverse Event|35|||
155438610|NCT00393458|561031764|FG000|Overall Study|Subject withdrew consent|27|||
155438611|NCT00393458|561031765|FG001|Overall Study|Subject withdrew consent|40|||
155438612|NCT00393458|561031766|FG002|Overall Study|Subject withdrew consent|33|||
155438613|NCT00393458|561031767|FG003|Overall Study|Subject withdrew consent|50|||
155438614|NCT00393458|561031764|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
155438615|NCT00393458|561031765|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
155438616|NCT00393458|561031766|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
155438617|NCT00393458|561031767|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
155438618|NCT00393458|561031764|FG000|Overall Study|Protocol deviation|11|||
155438619|NCT00393458|561031765|FG001|Overall Study|Protocol deviation|11|||
155438620|NCT00393458|561031766|FG002|Overall Study|Protocol deviation|11|||
155438621|NCT00393458|561031767|FG003|Overall Study|Protocol deviation|10|||
155438622|NCT00393458|561031764|FG000|Overall Study|Administrative problems|7|||
155438623|NCT00393458|561031765|FG001|Overall Study|Administrative problems|8|||
155438624|NCT00393458|561031766|FG002|Overall Study|Administrative problems|5|||
155438625|NCT00393458|561031767|FG003|Overall Study|Administrative problems|2|||
155438626|NCT00393458|561031764|FG000|Overall Study|Lost to Follow-up|5|||
155438627|NCT00393458|561031765|FG001|Overall Study|Lost to Follow-up|6|||
155438628|NCT00393458|561031766|FG002|Overall Study|Lost to Follow-up|5|||
155438629|NCT00393458|561031767|FG003|Overall Study|Lost to Follow-up|3|||
155438630|NCT00393458|561031764|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155438631|NCT00393458|561031765|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155438632|NCT00393458|561031766|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155438633|NCT00393458|561031767|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155438634|NCT00393458|561031764|FG000|Overall Study|Death|1|||
155438635|NCT00393458|561031765|FG001|Overall Study|Death|1|||
155438636|NCT00393458|561031766|FG002|Overall Study|Death|5|||
155438637|NCT00393458|561031767|FG003|Overall Study|Death|5|||
155438638|NCT00393458|561031764|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155438639|NCT00393458|561031765|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155438640|NCT00393458|561031766|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155438641|NCT00393458|561031767|FG003|Overall Study|Abnormal test procedure result(s)|2|||
155438642|NCT00393458|561031764|FG000|Overall Study|Subject no longer requires study drug|0|||
155438643|NCT00393458|561031765|FG001|Overall Study|Subject no longer requires study drug|1|||
155438644|NCT00393458|561031766|FG002|Overall Study|Subject no longer requires study drug|0|||
155438645|NCT00393458|561031767|FG003|Overall Study|Subject no longer requires study drug|0|||
155438646|NCT02100657|561033488|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
155438647|NCT02100657|561033489|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
155438648|NCT02100657|561033490|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
155438649|NCT02100657|561033488|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
155438650|NCT02100657|561033489|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
155438651|NCT02100657|561033490|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
155438652|NCT02100657|561033488|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
155438653|NCT02100657|561033489|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
155438654|NCT02100657|561033490|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
155438655|NCT02100657|561033488|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
155438656|NCT02100657|561033489|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
155438657|NCT02100657|561033490|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
155438658|NCT02100657|561033488|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
155438659|NCT02100657|561033489|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
155438660|NCT02100657|561033490|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
155438661|NCT02100657|561033488|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
155438662|NCT02100657|561033489|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
155438663|NCT02100657|561033490|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
155438664|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
155438665|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
155651208|NCT01063881|561814595|FG000|Overall Study|Lost to Follow-up|13|||
155438666|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
155438667|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Death|0|||
155438668|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Death|0|||
155438669|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Death|1|||
155438670|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
155438671|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
155438672|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
155438673|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
155438674|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
155438675|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
155438676|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
155438677|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
155438678|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
155438679|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
155438680|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
155438681|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
155438682|NCT02100657|561033488|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
155438683|NCT02100657|561033489|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
155438684|NCT02100657|561033490|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
155438685|NCT01543490|561033492|FG000|Overall Study|Adverse Event|4|||
155438686|NCT01543490|561033493|FG001|Overall Study|Adverse Event|0|||
155438687|NCT01543490|561033492|FG000|Overall Study|Physician Decision|1|||
155438688|NCT01543490|561033493|FG001|Overall Study|Physician Decision|0|||
155438689|NCT01543490|561033492|FG000|Overall Study|Lack of Efficacy|3|||
155438690|NCT01543490|561033493|FG001|Overall Study|Lack of Efficacy|3|||
155438691|NCT01543490|561033492|FG000|Overall Study|Lost to Follow-up|5|||
155438692|NCT01543490|561033493|FG001|Overall Study|Lost to Follow-up|0|||
155438693|NCT01543490|561033492|FG000|Overall Study|Withdrawal by Subject|2|||
155438694|NCT01543490|561033493|FG001|Overall Study|Withdrawal by Subject|0|||
155438695|NCT01543490|561033492|FG000|Overall Study|Other-Various Administrative Reasons|1|||
155438696|NCT01543490|561033493|FG001|Overall Study|Other-Various Administrative Reasons|2|||
155438697|NCT04168645|561033494|FG000|Overall Study|Lost to Follow-up|23|||
155438698|NCT04168645|561033495|FG001|Overall Study|Lost to Follow-up|28|||
155438699|NCT04168645|561033496|FG002|Overall Study|Lost to Follow-up|15|||
155438700|NCT04168645|561033497|FG003|Overall Study|Lost to Follow-up|12|||
155438701|NCT04168645|561033494|FG000|Overall Study|Death|1|||
155438702|NCT04168645|561033495|FG001|Overall Study|Death|1|||
155438703|NCT04168645|561033496|FG002|Overall Study|Death|0|||
155438704|NCT04168645|561033497|FG003|Overall Study|Death|0|||
155438705|NCT04168645|561033494|FG000|Overall Study|Withdrawal by Subject|5|||
155438706|NCT04168645|561033495|FG001|Overall Study|Withdrawal by Subject|2|||
155438707|NCT04168645|561033496|FG002|Overall Study|Withdrawal by Subject|2|||
155438708|NCT04168645|561033497|FG003|Overall Study|Withdrawal by Subject|2|||
155438709|NCT04168645|561033494|FG000|Overall Study|Administrative Withdrawal|3|||
155438710|NCT04168645|561033495|FG001|Overall Study|Administrative Withdrawal|1|||
155438711|NCT04168645|561033496|FG002|Overall Study|Administrative Withdrawal|1|||
155438712|NCT04168645|561033497|FG003|Overall Study|Administrative Withdrawal|3|||
155438713|NCT03692910|561033500|FG000|Overall Study|Lost to Follow-up|4|||
155438714|NCT03692910|561033501|FG001|Overall Study|Lost to Follow-up|0|||
155438715|NCT03692910|561033502|FG002|Overall Study|Lost to Follow-up|0|||
155438716|NCT03692910|561033500|FG000|Overall Study|Withdrawal by Subject|2|||
155438717|NCT03692910|561033501|FG001|Overall Study|Withdrawal by Subject|0|||
155438718|NCT03692910|561033502|FG002|Overall Study|Withdrawal by Subject|0|||
155438719|NCT00151411|561033503|FG000|Overall Study|Lost to Follow-up|15|||
155438720|NCT00151411|561033504|FG001|Overall Study|Lost to Follow-up|19|||
155438721|NCT00151411|561033503|FG000|Overall Study|Withdrawal by Subject|12|||
155438722|NCT00151411|561033504|FG001|Overall Study|Withdrawal by Subject|20|||
155438723|NCT00151411|561033503|FG000|Overall Study|Adverse Event|6|||
155438724|NCT00151411|561033504|FG001|Overall Study|Adverse Event|0|||
155438725|NCT00151411|561033503|FG000|Overall Study|Pregnancy|0|||
155438726|NCT00151411|561033504|FG001|Overall Study|Pregnancy|4|||
155438727|NCT01283581|561033505|FG000|Overall Study|Lost to Follow-up|8|||
155438728|NCT01283581|561033506|FG001|Overall Study|Lost to Follow-up|6|||
155438729|NCT01283581|561033507|FG002|Overall Study|Lost to Follow-up|8|||
155438730|NCT01283581|561033505|FG000|Overall Study|Withdrawal by Subject|2|||
155438731|NCT01283581|561033506|FG001|Overall Study|Withdrawal by Subject|5|||
155438732|NCT01283581|561033507|FG002|Overall Study|Withdrawal by Subject|2|||
155438733|NCT01283581|561033505|FG000|Overall Study|Adverse Event|1|||
155438734|NCT01283581|561033506|FG001|Overall Study|Adverse Event|1|||
155438735|NCT01283581|561033507|FG002|Overall Study|Adverse Event|4|||
155438736|NCT01283581|561033505|FG000|Overall Study|Physician Decision|0|||
155438737|NCT01283581|561033506|FG001|Overall Study|Physician Decision|1|||
155438738|NCT01283581|561033507|FG002|Overall Study|Physician Decision|2|||
155438739|NCT01283581|561033505|FG000|Overall Study|Protocol Violation|0|||
155438740|NCT01283581|561033506|FG001|Overall Study|Protocol Violation|1|||
155438741|NCT01283581|561033507|FG002|Overall Study|Protocol Violation|2|||
155438742|NCT01283581|561033505|FG000|Overall Study|Noncompliance|1|||
155438743|NCT01283581|561033506|FG001|Overall Study|Noncompliance|0|||
155438744|NCT01283581|561033507|FG002|Overall Study|Noncompliance|0|||
155438745|NCT01283581|561033505|FG000|Overall Study|Investigator unblinded|0|||
155438746|NCT01283581|561033506|FG001|Overall Study|Investigator unblinded|0|||
155438747|NCT01283581|561033507|FG002|Overall Study|Investigator unblinded|1|||
155438748|NCT01283581|561033505|FG000|Overall Study|"Early termination"|0|||
155438749|NCT01283581|561033506|FG001|Overall Study|"Early termination"|0|||
155438750|NCT01283581|561033507|FG002|Overall Study|"Early termination"|1|||
155438751|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
155438752|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
155438753|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
155438754|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
155438755|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
155438756|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
155438757|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
155438758|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
155438759|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
155438760|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
155438761|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
155438762|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
155438763|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
155438764|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
155438765|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
155438766|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
155438767|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
155438768|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
155438769|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
155438770|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
155438771|NCT01259492|561033508|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
155438772|NCT01259492|561033509|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
155438773|NCT01259492|561033510|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
155438774|NCT01259492|561033511|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
155438775|NCT01259492|561033508|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
155438776|NCT01259492|561033509|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
155438777|NCT01259492|561033510|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
155438778|NCT01259492|561033511|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
155438779|NCT01259492|561033508|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
155438780|NCT01259492|561033509|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
155438781|NCT01259492|561033510|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
155438782|NCT01259492|561033511|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
155438783|NCT01259492|561033508|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
155438784|NCT01259492|561033509|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
155438785|NCT01259492|561033510|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
155438786|NCT01259492|561033511|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
155438787|NCT01259492|561033508|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
155438788|NCT01259492|561033509|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
155438789|NCT01259492|561033510|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
155438790|NCT01259492|561033511|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
155438791|NCT01259492|561033508|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
155438792|NCT01259492|561033509|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
155438793|NCT01259492|561033510|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
155438794|NCT01259492|561033511|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
155514437|NCT00467584|561310298|FG000|Overall Study|Withdrawal by Subject|4|||
155514438|NCT00467584|561310299|FG001|Overall Study|Withdrawal by Subject|5|||
155438795|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
155438796|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
155438797|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
155438798|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
155438799|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
155438800|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
155438801|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
155438802|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
155438803|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
155438804|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
155438805|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
155438806|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
155438807|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
155438808|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
155438809|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
155438810|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
155438811|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
155438812|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
155438813|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
155438814|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
155438815|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
155438816|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
155438817|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
155438818|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
155438819|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
155438820|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
155438821|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
155438822|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
155438823|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
155438824|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
155438825|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
155438826|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
155438827|NCT01259492|561033508|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
155438828|NCT01259492|561033509|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
155438829|NCT01259492|561033510|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
155438830|NCT01259492|561033511|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
155438831|NCT00089843|561033512|FG000|Overall Study|Withdrawal by Subject|1|||
155438832|NCT00089843|561033513|FG001|Overall Study|Withdrawal by Subject|4|||
155438833|NCT00089843|561033514|FG002|Overall Study|Withdrawal by Subject|5|||
155438834|NCT00089843|561033515|FG003|Overall Study|Withdrawal by Subject|6|||
155438835|NCT00089843|561033512|FG000|Overall Study|Physician Decision|1|||
155438836|NCT00089843|561033513|FG001|Overall Study|Physician Decision|0|||
155438837|NCT00089843|561033514|FG002|Overall Study|Physician Decision|0|||
155438838|NCT00089843|561033515|FG003|Overall Study|Physician Decision|1|||
155438839|NCT03846947|561033516|FG000|Overall Study|technical issues with imaging sequence|2|||
155438840|NCT03060577|561033517|FG000|Overall Study|Withdrawal by Subject|25|||
155438841|NCT03060577|561033518|FG001|Overall Study|Withdrawal by Subject|5|||
155438842|NCT03060577|561033517|FG000|Overall Study|Physician Decision|4|||
155438843|NCT03060577|561033518|FG001|Overall Study|Physician Decision|3|||
155438844|NCT03060577|561033517|FG000|Overall Study|Lost to Follow-up|3|||
155438845|NCT03060577|561033518|FG001|Overall Study|Lost to Follow-up|0|||
155438846|NCT03060577|561033517|FG000|Overall Study|Death|7|||
155438847|NCT03060577|561033518|FG001|Overall Study|Death|1|||
155438848|NCT03060577|561033517|FG000|Overall Study|Adverse Event|9|||
155438849|NCT03060577|561033518|FG001|Overall Study|Adverse Event|1|||
155438850|NCT03060577|561033517|FG000|Overall Study|Inclusion/Exclusion|1|||
155438851|NCT03060577|561033518|FG001|Overall Study|Inclusion/Exclusion|0|||
155438852|NCT03060577|561033517|FG000|Overall Study|Other|8|||
155438853|NCT03060577|561033518|FG001|Overall Study|Other|2|||
155438854|NCT02584634|561033521|FG000|Overall Study|Adverse Event|3|||
155438855|NCT02584634|561033522|FG001|Overall Study|Adverse Event|5|||
155438856|NCT02584634|561033521|FG000|Overall Study|Death|0|||
155514439|NCT00467584|561310300|FG002|Overall Study|Withdrawal by Subject|1|||
155438857|NCT02584634|561033522|FG001|Overall Study|Death|1|||
155514440|NCT02482571|561310301|FG000|Overall Study|Adverse Event|1|||
155438858|NCT02584634|561033521|FG000|Overall Study|Lost to Follow-up|0|||
155438859|NCT02584634|561033522|FG001|Overall Study|Lost to Follow-up|1|||
155438860|NCT02584634|561033521|FG000|Overall Study|Physician Decision|1|||
155438861|NCT02584634|561033522|FG001|Overall Study|Physician Decision|2|||
155438862|NCT02584634|561033521|FG000|Overall Study|Progressive disease|7|||
155438863|NCT02584634|561033522|FG001|Overall Study|Progressive disease|15|||
155438864|NCT02584634|561033521|FG000|Overall Study|Withdrawal by Subject|1|||
155438865|NCT02584634|561033522|FG001|Overall Study|Withdrawal by Subject|1|||
155438866|NCT02584634|561033521|FG000|Overall Study|Other|0|||
155438867|NCT02584634|561033522|FG001|Overall Study|Other|6|||
155438868|NCT01295905|561033524|FG000|Overall Study|Did not meet inclusion criteria|1|||
155438869|NCT01295905|561033525|FG001|Overall Study|Did not meet inclusion criteria|0|||
155438870|NCT01295905|561033524|FG000|Overall Study|Met exclusion criteria|1|||
155438871|NCT01295905|561033525|FG001|Overall Study|Met exclusion criteria|0|||
155438872|NCT03069690|561033526|FG000|Pregnancy Intervention|Pregnancy loss|9|||
155438873|NCT03069690|561033527|FG001|Pregnancy Intervention|Pregnancy loss|4|||
155438874|NCT03069690|561033528|FG002|Pregnancy Intervention|Pregnancy loss|0|||
155438875|NCT03069690|561033529|FG003|Pregnancy Intervention|Pregnancy loss|0|||
155438876|NCT03069690|561033530|FG004|Pregnancy Intervention|Pregnancy loss|0|||
155438877|NCT03069690|561033531|FG005|Pregnancy Intervention|Pregnancy loss|0|||
155438878|NCT03069690|561033526|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
155438879|NCT03069690|561033527|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
155438880|NCT03069690|561033528|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
155438881|NCT03069690|561033529|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
155438882|NCT03069690|561033530|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
155438883|NCT03069690|561033531|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
155438884|NCT03069690|561033526|FG000|Postpartum Intervention|Lost to Follow-up|0|||
155438885|NCT03069690|561033527|FG001|Postpartum Intervention|Lost to Follow-up|0|||
155438886|NCT03069690|561033528|FG002|Postpartum Intervention|Lost to Follow-up|5|||
155438887|NCT03069690|561033529|FG003|Postpartum Intervention|Lost to Follow-up|5|||
155438888|NCT03069690|561033530|FG004|Postpartum Intervention|Lost to Follow-up|2|||
155438889|NCT03069690|561033531|FG005|Postpartum Intervention|Lost to Follow-up|4|||
155438890|NCT02564120|561033532|FG000|Overall Study|Did not return release forms|160|||
155438891|NCT02564120|561033532|FG000|Overall Study|Death|58|||
155438892|NCT02564120|561033532|FG000|Overall Study|Withdrawal by Subject|204|||
155438893|NCT02564120|561033532|FG000|Overall Study|Other medical condition|24|||
155438894|NCT01629667|561033533|FG000|Overall Study|Lost to Follow-up|0|||
155438895|NCT01629667|561033534|FG001|Overall Study|Lost to Follow-up|1|||
155438896|NCT01629667|561033535|FG002|Overall Study|Lost to Follow-up|1|||
155438897|NCT01629667|561033533|FG000|Overall Study|Withdrawal by Subject|31|||
155438898|NCT01629667|561033534|FG001|Overall Study|Withdrawal by Subject|20|||
155438899|NCT01629667|561033535|FG002|Overall Study|Withdrawal by Subject|28|||
155438900|NCT01629667|561033533|FG000|Overall Study|Death|1|||
155438901|NCT01629667|561033534|FG001|Overall Study|Death|5|||
155438902|NCT01629667|561033535|FG002|Overall Study|Death|3|||
155438903|NCT01629667|561033533|FG000|Overall Study|Randomized, not treated|2|||
155438904|NCT01629667|561033534|FG001|Overall Study|Randomized, not treated|1|||
155438905|NCT01629667|561033535|FG002|Overall Study|Randomized, not treated|0|||
155438906|NCT01629667|561033533|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
155438907|NCT01629667|561033534|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
155438908|NCT01629667|561033535|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
155438909|NCT01629667|561033533|FG000|Overall Study|Requiring lung transplant|2|||
155438910|NCT01629667|561033534|FG001|Overall Study|Requiring lung transplant|1|||
155438911|NCT01629667|561033535|FG002|Overall Study|Requiring lung transplant|3|||
155438912|NCT01629667|561033533|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
155438913|NCT01629667|561033534|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
155438914|NCT01629667|561033535|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
155438915|NCT01629667|561033533|FG000|Overall Study|Started other medicine|1|||
155438916|NCT01629667|561033534|FG001|Overall Study|Started other medicine|0|||
155438917|NCT01629667|561033535|FG002|Overall Study|Started other medicine|1|||
155438918|NCT01629667|561033533|FG000|Overall Study|Site error in safety follow-up|0|||
155438919|NCT01629667|561033534|FG001|Overall Study|Site error in safety follow-up|0|||
155438920|NCT01629667|561033535|FG002|Overall Study|Site error in safety follow-up|1|||
155438921|NCT01629667|561033533|FG000|Overall Study|Enrolled in another clinical study|0|||
155438922|NCT01629667|561033534|FG001|Overall Study|Enrolled in another clinical study|1|||
155438923|NCT01629667|561033535|FG002|Overall Study|Enrolled in another clinical study|0|||
155438924|NCT01629667|561033533|FG000|Overall Study|Code break|1|||
155438925|NCT01629667|561033534|FG001|Overall Study|Code break|0|||
155438926|NCT01629667|561033535|FG002|Overall Study|Code break|0|||
155438927|NCT00891657|561033536|FG000|Overall Study|Withdrawal by Subject|1|||
155438928|NCT00891657|561033537|FG001|Overall Study|Withdrawal by Subject|1|||
155438929|NCT03455543|561033541|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
155438930|NCT03455543|561033542|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
155438931|NCT03455543|561033543|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
155438932|NCT03455543|561033541|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
155438933|NCT03455543|561033542|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
155438934|NCT03455543|561033543|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
155438935|NCT03455543|561033541|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
155438936|NCT03455543|561033542|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
155438937|NCT03455543|561033543|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
155438938|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
155438939|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
155438940|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
155438941|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
155438942|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
155438943|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
155438944|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
155438945|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
155438946|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
155438947|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
155438948|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
155438949|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
155438950|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
155438951|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
155438952|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
155438953|NCT03455543|561033541|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
155438954|NCT03455543|561033542|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
155438955|NCT03455543|561033543|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
155438956|NCT00909090|561033547|FG000|Overall Study|Lost to Follow-up|17|||
155438957|NCT00909090|561033548|FG001|Overall Study|Lost to Follow-up|17|||
155438958|NCT02926573|561033550|FG000|Overall Study|Nausea|1|||
155438959|NCT02926573|561033551|FG001|Overall Study|Nausea|0|||
155438960|NCT02926573|561033550|FG000|Overall Study|Remain intubated|2|||
155438961|NCT02926573|561033551|FG001|Overall Study|Remain intubated|2|||
155438962|NCT02926573|561033550|FG000|Overall Study|Change in surgery plan|3|||
155438963|NCT02926573|561033551|FG001|Overall Study|Change in surgery plan|1|||
155438964|NCT02926573|561033550|FG000|Overall Study|Change to outpatient status|5|||
155438965|NCT02926573|561033551|FG001|Overall Study|Change to outpatient status|1|||
155438966|NCT02926573|561033550|FG000|Overall Study|Withdrawal by Subject|0|||
155438967|NCT02926573|561033551|FG001|Overall Study|Withdrawal by Subject|2|||
155514441|NCT02482571|561310301|FG000|Overall Study|Scanner or Respiract failure|3|||
155438968|NCT02926573|561033550|FG000|Overall Study|Return to operating room|0|||
155438969|NCT02926573|561033551|FG001|Overall Study|Return to operating room|2|||
155438970|NCT02926573|561033550|FG000|Overall Study|Delirium|0|||
155438971|NCT02926573|561033551|FG001|Overall Study|Delirium|1|||
155438972|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
155438973|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
155438974|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155438975|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
155438976|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155438977|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155438978|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
155438979|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
155438980|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155438981|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
155438982|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155438983|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155438984|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
155438985|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
155438986|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
155438987|NCT00611455|561033554|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
155438988|NCT00611455|561033555|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
155438989|NCT00611455|561033556|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
155438990|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155438991|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
155438992|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155438993|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155438994|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
155438995|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155438996|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155438997|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
155438998|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155438999|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155439000|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
155439001|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155439002|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155439003|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
155439004|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155439005|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
155439006|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
155439007|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
155439008|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155439009|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
155439010|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155439011|NCT00611455|561033554|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155439012|NCT00611455|561033555|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
155439013|NCT00611455|561033556|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155439014|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
155439015|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
155439016|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
155439017|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
155439018|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
155439019|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
155439020|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
155439021|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
155439022|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
155439023|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
155439024|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
155439025|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
155439026|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
155439027|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
155439028|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
155439029|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
155439030|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
155439031|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
155439032|NCT00611455|561033554|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
155439033|NCT00611455|561033555|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
155439034|NCT00611455|561033556|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
155439035|NCT04601272|561033557|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
155439036|NCT04601272|561033558|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
155439037|NCT04601272|561033559|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
155439038|NCT00942708|561033561|FG000|Overall Study|Withdrawal by Subject|1|||
155439039|NCT00995371|561033562|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
155439040|NCT00995371|561033563|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
155439041|NCT00673673|561033564|FG000|Overall Study|Progressive disease|27|||
155439042|NCT00673673|561033564|FG000|Overall Study|Adverse Event|4|||
155439043|NCT00673673|561033564|FG000|Overall Study|Withdrawal by Subject|3|||
155439044|NCT00673673|561033564|FG000|Overall Study|Investigators' discretion|2|||
155439045|NCT04579393|561033577|FG000|Overall Study|Withdrawal by Subject|2|||
155439046|NCT04579393|561033578|FG001|Overall Study|Withdrawal by Subject|2|||
155439047|NCT04579393|561033577|FG000|Overall Study|Death|1|||
155439048|NCT04579393|561033578|FG001|Overall Study|Death|3|||
155439049|NCT01282814|561033579|FG000|First Intervention|Emesis During Dosing Interval|0|||
155439050|NCT01282814|561033580|FG001|First Intervention|Emesis During Dosing Interval|3|||
155439051|NCT01282814|561033579|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
155439052|NCT01282814|561033580|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155439053|NCT01524289|561033581|FG000|Overall Study|Lost to Follow-up|0|||
155439054|NCT01524289|561033582|FG001|Overall Study|Lost to Follow-up|1|||
155439055|NCT01524289|561033581|FG000|Overall Study|Physician Decision|1|||
155439056|NCT01524289|561033582|FG001|Overall Study|Physician Decision|0|||
155439057|NCT01524289|561033581|FG000|Overall Study|Protocol Violation|5|||
155439058|NCT01524289|561033582|FG001|Overall Study|Protocol Violation|1|||
155439059|NCT01524289|561033581|FG000|Overall Study|Withdrawal by Subject|11|||
155439060|NCT01524289|561033582|FG001|Overall Study|Withdrawal by Subject|7|||
155439061|NCT01524289|561033581|FG000|Overall Study|Adverse Event|12|||
155439062|NCT01524289|561033582|FG001|Overall Study|Adverse Event|5|||
155439063|NCT01524289|561033581|FG000|Overall Study|Did not take study medication|1|||
155439064|NCT01524289|561033582|FG001|Overall Study|Did not take study medication|0|||
155439065|NCT02704429|561033583|FG000|Part A: 24 Weeks|Adverse Event|3|||
155439066|NCT02704429|561033584|FG001|Part A: 24 Weeks|Adverse Event|0|||
155439067|NCT02704429|561033583|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
155439068|NCT02704429|561033584|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
155439069|NCT02519231|561033585|FG000|Overall Study|Lost to Follow-up|2|||
155439070|NCT02519231|561033586|FG001|Overall Study|Lost to Follow-up|5|||
155439071|NCT02519231|561033585|FG000|Overall Study|Withdrawal by Subject|0|||
155439072|NCT02519231|561033586|FG001|Overall Study|Withdrawal by Subject|1|||
155439073|NCT00104104|561033588|FG000|Overall Study|Adverse Event|8|||
155439074|NCT00104104|561033589|FG001|Overall Study|Adverse Event|8|||
155439075|NCT00104104|561033588|FG000|Overall Study|Abnormal laboratory value(s)|20|||
155439076|NCT00104104|561033589|FG001|Overall Study|Abnormal laboratory value(s)|14|||
155439077|NCT00104104|561033588|FG000|Overall Study|Lack of Efficacy|0|||
155439078|NCT00104104|561033589|FG001|Overall Study|Lack of Efficacy|3|||
155514442|NCT02482571|561310301|FG000|Overall Study|Withdrawal by Subject|4|||
155514443|NCT00926289|561310305|FG000|Overall Study|Adverse Event|9|||
155514444|NCT00926289|561310306|FG001|Overall Study|Adverse Event|11|||
155514445|NCT00926289|561310305|FG000|Overall Study|Protocol Violation|8|||
155514446|NCT00926289|561310306|FG001|Overall Study|Protocol Violation|12|||
155439079|NCT00104104|561033588|FG000|Overall Study|Condition no longer requires study drug|7|||
155439080|NCT00104104|561033589|FG001|Overall Study|Condition no longer requires study drug|4|||
155439081|NCT00104104|561033588|FG000|Overall Study|Protocol Violation|5|||
155439082|NCT00104104|561033589|FG001|Overall Study|Protocol Violation|2|||
155439083|NCT00104104|561033588|FG000|Overall Study|Withdrawal by Subject|11|||
155439084|NCT00104104|561033589|FG001|Overall Study|Withdrawal by Subject|15|||
155439085|NCT00104104|561033588|FG000|Overall Study|Lost to Follow-up|3|||
155514447|NCT00926289|561310305|FG000|Overall Study|Lost to Follow-up|3|||
155514448|NCT00926289|561310306|FG001|Overall Study|Lost to Follow-up|6|||
155439086|NCT00104104|561033589|FG001|Overall Study|Lost to Follow-up|7|||
155514449|NCT00926289|561310305|FG000|Overall Study|Withdrawal by Subject|4|||
155439087|NCT00104104|561033588|FG000|Overall Study|Administrative problems|12|||
155439088|NCT00104104|561033589|FG001|Overall Study|Administrative problems|13|||
155439089|NCT00104104|561033588|FG000|Overall Study|Death|9|||
155439090|NCT00104104|561033589|FG001|Overall Study|Death|6|||
155439091|NCT00447421|561033590|FG000|Overall Study|Lack of Efficacy|1|||
155439092|NCT00447421|561033590|FG000|Overall Study|Adverse Event|3|||
155439093|NCT00447421|561033590|FG000|Overall Study|Sponsor Decision|2|||
155439094|NCT01707147|561033591|FG000|Overall Study|Administered Trajenta prior to contract|5|||
155439095|NCT01707147|561033591|FG000|Overall Study|Patients who have not taken Trajenta|1|||
155439096|NCT01707147|561033591|FG000|Overall Study|Follow-up failure|17|||
155439097|NCT01707147|561033591|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
155439098|NCT02725177|561033593|FG000|Overall Study|Physician Decision|4|||
155439099|NCT02725177|561033593|FG000|Overall Study|Adverse Event|1|||
155439100|NCT01326962|561033596|FG000|Overall Study|Adverse Event|1|||
155439101|NCT01326962|561033596|FG000|Overall Study|Withdrawal by Subject|1|||
155439102|NCT01326962|561033596|FG000|Overall Study|Lost to Follow-up|3|||
155439103|NCT01326962|561033596|FG000|Overall Study|Other|2|||
155439104|NCT02053246|561033597|FG000|Overall Study|Withdrawal by Subject|3|||
155439105|NCT02053246|561033597|FG000|Overall Study|Physician Decision|1|||
155439106|NCT02707757|561033598|FG000|Overall Study|Protocol Violation|3|||
155439107|NCT02707757|561033599|FG001|Overall Study|Protocol Violation|2|||
155439108|NCT02707757|561033598|FG000|Overall Study|Withdrawal by Subject|2|||
155439109|NCT02707757|561033599|FG001|Overall Study|Withdrawal by Subject|0|||
155439110|NCT02707757|561033598|FG000|Overall Study|Death|0|||
155439111|NCT02707757|561033599|FG001|Overall Study|Death|1|||
155439112|NCT02707757|561033598|FG000|Overall Study|Adverse Event|6|||
155439113|NCT02707757|561033599|FG001|Overall Study|Adverse Event|4|||
155439114|NCT02707757|561033598|FG000|Overall Study|Renal transplant/elective operation|1|||
155439115|NCT02707757|561033599|FG001|Overall Study|Renal transplant/elective operation|5|||
155439116|NCT01056523|561033600|FG000|Overall Study|Death|1|||
155439117|NCT01056523|561033601|FG001|Overall Study|Death|0|||
155439118|NCT01056523|561033602|FG002|Overall Study|Death|2|||
155439119|NCT01056523|561033603|FG003|Overall Study|Death|3|||
155439120|NCT01056523|561033604|FG004|Overall Study|Death|0|||
155439121|NCT01056523|561033605|FG005|Overall Study|Death|0|||
155439122|NCT01056523|561033606|FG006|Overall Study|Death|1|||
155439123|NCT03429556|561033607|FG000|Overall Study|Lost to Follow-up|0|||
155439124|NCT03429556|561033608|FG001|Overall Study|Lost to Follow-up|1|||
155439125|NCT03429556|561033609|FG002|Overall Study|Lost to Follow-up|0|||
155439126|NCT03429556|561033610|FG003|Overall Study|Lost to Follow-up|0|||
155439127|NCT01863758|561033618|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
155439128|NCT01863758|561033618|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
155439129|NCT02369510|561033619|FG000|Overall Study|Spilled Medication|1|||
155439130|NCT02369510|561033620|FG001|Overall Study|Spilled Medication|2|||
155439131|NCT02369510|561033621|FG002|Overall Study|Spilled Medication|1|||
155439132|NCT02369510|561033619|FG000|Overall Study|Epidural Activation|1|||
155439133|NCT02369510|561033620|FG001|Overall Study|Epidural Activation|1|||
155439134|NCT02369510|561033621|FG002|Overall Study|Epidural Activation|5|||
155439135|NCT04285723|561033629|FG000|Overall Study|Subject decision|1|||
155439136|NCT04285723|561033630|FG001|Overall Study|Subject decision|2|||
155439137|NCT04285723|561033629|FG000|Overall Study|Physician Decision|1|||
155439138|NCT04285723|561033630|FG001|Overall Study|Physician Decision|0|||
155439139|NCT04285723|561033629|FG000|Overall Study|No efficiency|1|||
155439140|NCT04285723|561033630|FG001|Overall Study|No efficiency|0|||
155439141|NCT03067311|561033631|FG000|Overall Study|Lost to Follow-up|1|||
155439142|NCT03067311|561033632|FG001|Overall Study|Lost to Follow-up|1|||
155439143|NCT03067311|561033631|FG000|Overall Study|Moved away|1|||
155439144|NCT03067311|561033632|FG001|Overall Study|Moved away|1|||
155439145|NCT01089725|561033636|FG000|Overall Study|Adverse Event|1|||
155439146|NCT01089725|561033637|FG001|Overall Study|Adverse Event|1|||
155439147|NCT01089725|561033638|FG002|Overall Study|Adverse Event|0|||
155439148|NCT01089725|561033639|FG003|Overall Study|Adverse Event|0|||
155439149|NCT01089725|561033640|FG004|Overall Study|Adverse Event|2|||
155439150|NCT01089725|561033636|FG000|Overall Study|Lack of Efficacy|4|||
155439151|NCT01089725|561033637|FG001|Overall Study|Lack of Efficacy|3|||
155439152|NCT01089725|561033638|FG002|Overall Study|Lack of Efficacy|1|||
155439153|NCT01089725|561033639|FG003|Overall Study|Lack of Efficacy|0|||
155439154|NCT01089725|561033640|FG004|Overall Study|Lack of Efficacy|4|||
155439155|NCT01089725|561033636|FG000|Overall Study|Lost to Follow-up|2|||
155439156|NCT01089725|561033637|FG001|Overall Study|Lost to Follow-up|2|||
155439157|NCT01089725|561033638|FG002|Overall Study|Lost to Follow-up|0|||
155439158|NCT01089725|561033639|FG003|Overall Study|Lost to Follow-up|3|||
155439159|NCT01089725|561033640|FG004|Overall Study|Lost to Follow-up|0|||
155439160|NCT01089725|561033636|FG000|Overall Study|Protocol Violation|0|||
155439161|NCT01089725|561033637|FG001|Overall Study|Protocol Violation|0|||
155439162|NCT01089725|561033638|FG002|Overall Study|Protocol Violation|1|||
155439163|NCT01089725|561033639|FG003|Overall Study|Protocol Violation|1|||
155439164|NCT01089725|561033640|FG004|Overall Study|Protocol Violation|0|||
155439165|NCT01089725|561033636|FG000|Overall Study|Withdrawal by Subject|5|||
155439166|NCT01089725|561033637|FG001|Overall Study|Withdrawal by Subject|5|||
155439167|NCT01089725|561033638|FG002|Overall Study|Withdrawal by Subject|4|||
155439168|NCT01089725|561033639|FG003|Overall Study|Withdrawal by Subject|5|||
155439169|NCT01089725|561033640|FG004|Overall Study|Withdrawal by Subject|4|||
155439170|NCT01089725|561033636|FG000|Overall Study|Study Terminated by Sponsor|51|||
155439171|NCT01089725|561033637|FG001|Overall Study|Study Terminated by Sponsor|56|||
155439172|NCT01089725|561033638|FG002|Overall Study|Study Terminated by Sponsor|53|||
155439173|NCT01089725|561033639|FG003|Overall Study|Study Terminated by Sponsor|68|||
155439174|NCT01089725|561033640|FG004|Overall Study|Study Terminated by Sponsor|68|||
155439175|NCT01089725|561033636|FG000|Overall Study|Randomized, but not treated|0|||
155439176|NCT01089725|561033637|FG001|Overall Study|Randomized, but not treated|1|||
155651209|NCT01063881|561814596|FG001|Overall Study|Lost to Follow-up|7|||
155651210|NCT01063881|561814597|FG002|Overall Study|Lost to Follow-up|1|||
155514450|NCT00926289|561310306|FG001|Overall Study|Withdrawal by Subject|4|||
155439177|NCT01089725|561033638|FG002|Overall Study|Randomized, but not treated|2|||
155439178|NCT01089725|561033639|FG003|Overall Study|Randomized, but not treated|1|||
155439179|NCT01089725|561033640|FG004|Overall Study|Randomized, but not treated|2|||
155439180|NCT01089725|561033636|FG000|Overall Study|Other|3|||
155439181|NCT01089725|561033637|FG001|Overall Study|Other|0|||
155439182|NCT01089725|561033638|FG002|Overall Study|Other|0|||
155439183|NCT01089725|561033639|FG003|Overall Study|Other|1|||
155439184|NCT01089725|561033640|FG004|Overall Study|Other|0|||
155439185|NCT01486316|561034772|FG000|Overall Study|Device explanted with/without re-implant|3|||
155439186|NCT01486316|561034773|FG001|Overall Study|Device explanted with/without re-implant|2|||
155439187|NCT01486316|561034774|FG002|Overall Study|Device explanted with/without re-implant|0|||
155651211|NCT01063881|561814595|FG000|Overall Study|Withdrawal by Subject|25|||
155439188|NCT01486316|561034775|FG003|Overall Study|Device explanted with/without re-implant|2|||
155651212|NCT01063881|561814596|FG001|Overall Study|Withdrawal by Subject|1|||
155514451|NCT00926289|561310305|FG000|Overall Study|Other|1|||
155514452|NCT00926289|561310306|FG001|Overall Study|Other|3|||
155514453|NCT01498484|561310307|FG000|Overall Study|Death|6|||
155514454|NCT01498484|561310308|FG001|Overall Study|Death|3|||
155514455|NCT01498484|561310309|FG002|Overall Study|Death|1|||
155514456|NCT01498484|561310310|FG003|Overall Study|Death|1|||
155514457|NCT01498484|561310311|FG004|Overall Study|Death|0|||
155514458|NCT01498484|561310312|FG005|Overall Study|Death|0|||
155514459|NCT01498484|561310313|FG006|Overall Study|Death|10|||
155514460|NCT01498484|561310314|FG007|Overall Study|Death|1|||
155514461|NCT01498484|561310315|FG008|Overall Study|Death|0|||
155514462|NCT01498484|561310307|FG000|Overall Study|Physician Decision|3|||
155514463|NCT01498484|561310308|FG001|Overall Study|Physician Decision|2|||
155514464|NCT01498484|561310309|FG002|Overall Study|Physician Decision|1|||
155514465|NCT01498484|561310310|FG003|Overall Study|Physician Decision|1|||
155514466|NCT01498484|561310311|FG004|Overall Study|Physician Decision|0|||
155514467|NCT01498484|561310312|FG005|Overall Study|Physician Decision|0|||
155514468|NCT01498484|561310313|FG006|Overall Study|Physician Decision|8|||
155514469|NCT01498484|561310314|FG007|Overall Study|Physician Decision|13|||
155514470|NCT01498484|561310315|FG008|Overall Study|Physician Decision|1|||
155514471|NCT01498484|561310307|FG000|Overall Study|Adverse Event|0|||
155514472|NCT01498484|561310308|FG001|Overall Study|Adverse Event|0|||
155514473|NCT01498484|561310309|FG002|Overall Study|Adverse Event|0|||
155514474|NCT01498484|561310310|FG003|Overall Study|Adverse Event|0|||
155514475|NCT01498484|561310311|FG004|Overall Study|Adverse Event|0|||
155514476|NCT01498484|561310312|FG005|Overall Study|Adverse Event|1|||
155514477|NCT01498484|561310313|FG006|Overall Study|Adverse Event|0|||
155514478|NCT01498484|561310314|FG007|Overall Study|Adverse Event|0|||
155514479|NCT01498484|561310315|FG008|Overall Study|Adverse Event|0|||
155514480|NCT01498484|561310307|FG000|Overall Study|Withdrawal by Subject|0|||
155514481|NCT01498484|561310308|FG001|Overall Study|Withdrawal by Subject|0|||
155514482|NCT01498484|561310309|FG002|Overall Study|Withdrawal by Subject|0|||
155514483|NCT01498484|561310310|FG003|Overall Study|Withdrawal by Subject|1|||
155514484|NCT01498484|561310311|FG004|Overall Study|Withdrawal by Subject|0|||
155514485|NCT01498484|561310312|FG005|Overall Study|Withdrawal by Subject|0|||
155514486|NCT01498484|561310313|FG006|Overall Study|Withdrawal by Subject|1|||
155514487|NCT01498484|561310314|FG007|Overall Study|Withdrawal by Subject|0|||
155514488|NCT01498484|561310315|FG008|Overall Study|Withdrawal by Subject|0|||
155514489|NCT01498484|561310307|FG000|Overall Study|Other|5|||
155514490|NCT01498484|561310308|FG001|Overall Study|Other|2|||
155514491|NCT01498484|561310309|FG002|Overall Study|Other|0|||
155514492|NCT01498484|561310310|FG003|Overall Study|Other|0|||
155514493|NCT01498484|561310311|FG004|Overall Study|Other|1|||
155514494|NCT01498484|561310312|FG005|Overall Study|Other|0|||
155514495|NCT01498484|561310313|FG006|Overall Study|Other|3|||
155514496|NCT01498484|561310314|FG007|Overall Study|Other|0|||
155514497|NCT01498484|561310315|FG008|Overall Study|Other|1|||
155514498|NCT04104646|561310316|FG000|Overall Study|Withdrawal by Subject|1|||
155514499|NCT04104646|561310317|FG001|Overall Study|Withdrawal by Subject|1|||
155514500|NCT04104646|561310316|FG000|Overall Study|Lost to Follow-up|1|||
155514501|NCT04104646|561310317|FG001|Overall Study|Lost to Follow-up|0|||
155514502|NCT04104646|561310316|FG000|Overall Study|Physician Decision|2|||
155514503|NCT04104646|561310317|FG001|Overall Study|Physician Decision|0|||
155514504|NCT00319956|561310318|FG000|Overall Study|Death|20|||
155514505|NCT00319956|561310319|FG001|Overall Study|Death|24|||
155514506|NCT01199601|561310320|FG000|Overall Study|Lost to Follow-up|47|||
155514507|NCT01199601|561310321|FG001|Overall Study|Lost to Follow-up|66|||
155514508|NCT01199601|561310320|FG000|Overall Study|Withdrawal by Subject|15|||
155514509|NCT01199601|561310321|FG001|Overall Study|Withdrawal by Subject|3|||
155514510|NCT01199601|561310320|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
155514511|NCT01199601|561310321|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
155514512|NCT00753714|561310322|FG000|Overall Study|Lack of Efficacy|21|||
155514513|NCT00753714|561310323|FG001|Overall Study|Lack of Efficacy|34|||
155514514|NCT00753714|561310322|FG000|Overall Study|Adverse Event|26|||
155514515|NCT00753714|561310323|FG001|Overall Study|Adverse Event|18|||
155514516|NCT00753714|561310322|FG000|Overall Study|Protocol Violation|1|||
155514517|NCT00753714|561310323|FG001|Overall Study|Protocol Violation|0|||
155514518|NCT00753714|561310322|FG000|Overall Study|Lost to Follow-up|0|||
155514519|NCT00753714|561310323|FG001|Overall Study|Lost to Follow-up|1|||
155514520|NCT00753714|561310322|FG000|Overall Study|Withdrawal by Subject|2|||
155514521|NCT00753714|561310323|FG001|Overall Study|Withdrawal by Subject|1|||
155514522|NCT00753714|561310322|FG000|Overall Study|Death|3|||
155514523|NCT00753714|561310323|FG001|Overall Study|Death|3|||
155514524|NCT00753714|561310322|FG000|Overall Study|Other|7|||
155514525|NCT00753714|561310323|FG001|Overall Study|Other|5|||
155514526|NCT02607800|561310324|FG000|Overall Study|Lost to Follow-up|7|||
155514527|NCT02607800|561310325|FG001|Overall Study|Lost to Follow-up|10|||
155514528|NCT02607800|561310324|FG000|Overall Study|Withdrew Consent|2|||
155514529|NCT02607800|561310325|FG001|Overall Study|Withdrew Consent|0|||
155514530|NCT02607800|561310324|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
155514531|NCT02607800|561310325|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
155439189|NCT01486316|561034772|FG000|Overall Study|Not meeting eligibility criteria|0|||
155439190|NCT01486316|561034773|FG001|Overall Study|Not meeting eligibility criteria|0|||
155439191|NCT01486316|561034774|FG002|Overall Study|Not meeting eligibility criteria|1|||
155651213|NCT01063881|561814597|FG002|Overall Study|Withdrawal by Subject|0|||
155439192|NCT01486316|561034775|FG003|Overall Study|Not meeting eligibility criteria|0|||
155439193|NCT01486316|561034772|FG000|Overall Study|Withdrawal by Subject|1|||
155439194|NCT01486316|561034773|FG001|Overall Study|Withdrawal by Subject|0|||
155439195|NCT01486316|561034774|FG002|Overall Study|Withdrawal by Subject|3|||
155439196|NCT01486316|561034775|FG003|Overall Study|Withdrawal by Subject|0|||
155439197|NCT01486316|561034772|FG000|Overall Study|Physician Decision|0|||
155439198|NCT01486316|561034773|FG001|Overall Study|Physician Decision|0|||
155439199|NCT01486316|561034774|FG002|Overall Study|Physician Decision|1|||
155439200|NCT01486316|561034775|FG003|Overall Study|Physician Decision|0|||
155439201|NCT01486316|561034772|FG000|Overall Study|Death|0|||
155439202|NCT01486316|561034773|FG001|Overall Study|Death|1|||
155439203|NCT01486316|561034774|FG002|Overall Study|Death|0|||
155439204|NCT01486316|561034775|FG003|Overall Study|Death|0|||
155439205|NCT03191396|561034776|FG000|Overall Study|Lost to Follow-up|0|||
155439206|NCT03191396|561034777|FG001|Overall Study|Lost to Follow-up|3|||
155439207|NCT03191396|561034776|FG000|Overall Study|Withdrawal by Subject|3|||
155439208|NCT03191396|561034777|FG001|Overall Study|Withdrawal by Subject|2|||
155439209|NCT05094154|561034778|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
155439210|NCT05094154|561034779|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
155439211|NCT05094154|561034778|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
155439212|NCT05094154|561034779|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
155439213|NCT00893113|561034786|FG000|Overall Study|Lost to Follow-up|4|||
155439214|NCT00893113|561034787|FG001|Overall Study|Lost to Follow-up|8|||
155439215|NCT00893113|561034786|FG000|Overall Study|Early Termination|1|||
155439216|NCT00893113|561034787|FG001|Overall Study|Early Termination|1|||
155439217|NCT00893113|561034786|FG000|Overall Study|Withdrew Consent|8|||
155439218|NCT00893113|561034787|FG001|Overall Study|Withdrew Consent|7|||
155439219|NCT02531035|561034790|FG000|Overall Study|Death|0|||
155439220|NCT02531035|561034791|FG001|Overall Study|Death|1|||
155439221|NCT02531035|561034790|FG000|Overall Study|Protocol Violation|1|||
155439222|NCT02531035|561034791|FG001|Overall Study|Protocol Violation|1|||
155439223|NCT02531035|561034790|FG000|Overall Study|Noncompliance with study drug|8|||
155439224|NCT02531035|561034791|FG001|Overall Study|Noncompliance with study drug|3|||
155439225|NCT02531035|561034790|FG000|Overall Study|Physician Decision|1|||
155439226|NCT02531035|561034791|FG001|Overall Study|Physician Decision|0|||
155439227|NCT02531035|561034790|FG000|Overall Study|Adverse Event|16|||
155439228|NCT02531035|561034791|FG001|Overall Study|Adverse Event|45|||
155439229|NCT02531035|561034790|FG000|Overall Study|Other|3|||
155439230|NCT02531035|561034791|FG001|Overall Study|Other|2|||
155439231|NCT02531035|561034790|FG000|Overall Study|Withdrawal by Subject|42|||
155439232|NCT02531035|561034791|FG001|Overall Study|Withdrawal by Subject|32|||
155439233|NCT02531035|561034790|FG000|Overall Study|Lost to Follow-up|8|||
155439234|NCT02531035|561034791|FG001|Overall Study|Lost to Follow-up|10|||
155439235|NCT02531035|561034790|FG000|Overall Study|Randomized, not treated|2|||
155439236|NCT02531035|561034791|FG001|Overall Study|Randomized, not treated|1|||
155439237|NCT01240811|561034798|FG000|Overall Study|Physician Decision|0|||
155439238|NCT01240811|561034799|FG001|Overall Study|Physician Decision|1|||
155439239|NCT01240811|561034800|FG002|Overall Study|Physician Decision|0|||
155439240|NCT01240811|561034798|FG000|Overall Study|Withdrawal by Subject|0|||
155439241|NCT01240811|561034799|FG001|Overall Study|Withdrawal by Subject|0|||
155439242|NCT01240811|561034800|FG002|Overall Study|Withdrawal by Subject|1|||
155439243|NCT02400346|561034814|FG000|Overall Study|Adverse Event|24|||
155439244|NCT02400346|561034814|FG000|Overall Study|Lack of Efficacy|9|||
155439245|NCT02400346|561034814|FG000|Overall Study|Non-compliance with IMP|1|||
155439246|NCT02400346|561034814|FG000|Overall Study|Withdrawal by Subject|7|||
155439247|NCT02400346|561034814|FG000|Overall Study|Administrative or other reason(s)|2|||
155439248|NCT02400346|561034814|FG000|Overall Study|Lost to Follow-up|1|||
155439249|NCT02114203|561034815|FG000|Overall Study|Adverse Event|0|||
155439250|NCT02114203|561034816|FG001|Overall Study|Adverse Event|1|||
155439251|NCT02114203|561034817|FG002|Overall Study|Adverse Event|0|||
155439252|NCT02114203|561034815|FG000|Overall Study|Withdrawal by Subject|0|||
155439253|NCT02114203|561034816|FG001|Overall Study|Withdrawal by Subject|1|||
155439254|NCT02114203|561034817|FG002|Overall Study|Withdrawal by Subject|0|||
155439255|NCT01518699|561034818|FG000|Period 2|Protocol Violation|1|||
155514532|NCT03387098|561310326|FG000|Overall Study|progressive disease|1|||
155514533|NCT03387098|561310326|FG000|Overall Study|Withdrawal by Subject|2|||
155514534|NCT03387098|561310326|FG000|Overall Study|study terminated by sponsor|1|||
155651214|NCT01063881|561814595|FG000|Overall Study|Reason for not completed not specified|5|||
155514535|NCT02974153|561310327|FG000|Overall Study|Adverse Event|6|||
155514536|NCT02974153|561310328|FG001|Overall Study|Adverse Event|0|||
155514537|NCT02974153|561310329|FG002|Overall Study|Adverse Event|1|||
155514538|NCT02974153|561310327|FG000|Overall Study|Lack of Efficacy|6|||
155514539|NCT02974153|561310328|FG001|Overall Study|Lack of Efficacy|5|||
155514540|NCT02974153|561310329|FG002|Overall Study|Lack of Efficacy|10|||
155514541|NCT02974153|561310327|FG000|Overall Study|Lost to Follow-up|9|||
155514542|NCT02974153|561310328|FG001|Overall Study|Lost to Follow-up|10|||
155514543|NCT02974153|561310329|FG002|Overall Study|Lost to Follow-up|17|||
155514544|NCT02974153|561310327|FG000|Overall Study|Physician Decision|0|||
155514545|NCT02974153|561310328|FG001|Overall Study|Physician Decision|2|||
155514546|NCT02974153|561310329|FG002|Overall Study|Physician Decision|1|||
155514547|NCT02974153|561310327|FG000|Overall Study|Withdrawal by Subject|9|||
155514548|NCT02974153|561310328|FG001|Overall Study|Withdrawal by Subject|16|||
155514549|NCT02974153|561310329|FG002|Overall Study|Withdrawal by Subject|11|||
155514550|NCT02974153|561310327|FG000|Overall Study|Study Burden|8|||
155514551|NCT02974153|561310328|FG001|Overall Study|Study Burden|7|||
155514552|NCT02974153|561310329|FG002|Overall Study|Study Burden|3|||
155514553|NCT02974153|561310327|FG000|Overall Study|Other|14|||
155514554|NCT02974153|561310328|FG001|Overall Study|Other|8|||
155514555|NCT02974153|561310329|FG002|Overall Study|Other|7|||
155514556|NCT01202747|561310330|FG000|Overall Study|Withdrawal by Subject|1|||
155439256|NCT01518699|561034819|FG001|Period 2|Protocol Violation|1|||
155439257|NCT01518699|561034820|FG002|Period 2|Protocol Violation|0|||
155439258|NCT01518699|561034821|FG003|Period 2|Protocol Violation|0|||
155439259|NCT01518699|561034822|FG004|Period 2|Protocol Violation|0|||
155439260|NCT01518699|561034823|FG005|Period 2|Protocol Violation|0|||
155439261|NCT01518699|561034818|FG000|Period 2|Lost to Follow-up|0|||
155439262|NCT01518699|561034819|FG001|Period 2|Lost to Follow-up|1|||
155439263|NCT01518699|561034820|FG002|Period 2|Lost to Follow-up|0|||
155439264|NCT01518699|561034821|FG003|Period 2|Lost to Follow-up|0|||
155439265|NCT01518699|561034822|FG004|Period 2|Lost to Follow-up|0|||
155439266|NCT01518699|561034823|FG005|Period 2|Lost to Follow-up|0|||
155439267|NCT01518699|561034818|FG000|Period 2|Adverse Event|1|||
155439268|NCT01518699|561034819|FG001|Period 2|Adverse Event|0|||
155439269|NCT01518699|561034820|FG002|Period 2|Adverse Event|0|||
155439270|NCT01518699|561034821|FG003|Period 2|Adverse Event|0|||
155439271|NCT01518699|561034822|FG004|Period 2|Adverse Event|0|||
155439272|NCT01518699|561034823|FG005|Period 2|Adverse Event|0|||
155439273|NCT00486226|561034828|FG000|Overall Study|Death|3|||
155439274|NCT00486226|561034828|FG000|Overall Study|Adverse Event|1|||
155439275|NCT00486226|561034828|FG000|Overall Study|Withdrawal by Subject|1|||
155514557|NCT01446913|561310331|FG000|Overall Study|Significant illness|1|||
155514558|NCT01446913|561310332|FG001|Overall Study|Significant illness|1|||
155514559|NCT01446913|561310333|FG002|Overall Study|Significant illness|1|||
155514560|NCT01446913|561310331|FG000|Overall Study|Withdrawal by Subject|5|||
155514561|NCT01446913|561310332|FG001|Overall Study|Withdrawal by Subject|3|||
155514562|NCT01446913|561310333|FG002|Overall Study|Withdrawal by Subject|5|||
155514563|NCT01446913|561310331|FG000|Overall Study|Physician Decision|0|||
155514564|NCT01446913|561310332|FG001|Overall Study|Physician Decision|0|||
155514565|NCT01446913|561310333|FG002|Overall Study|Physician Decision|2|||
155651215|NCT01063881|561814596|FG001|Overall Study|Reason for not completed not specified|1|||
155651216|NCT01063881|561814597|FG002|Overall Study|Reason for not completed not specified|0|||
155651217|NCT01340170|561814598|FG000|Overall Study|Lost to Follow-up|2|||
155514566|NCT01446913|561310331|FG000|Overall Study|Lost to Follow-up|3|||
155514567|NCT01446913|561310332|FG001|Overall Study|Lost to Follow-up|5|||
155651218|NCT01340170|561814599|FG001|Overall Study|Lost to Follow-up|4|||
155439276|NCT00486226|561034828|FG000|Overall Study|Lost to Follow-up|8|||
155439277|NCT01981122|561034830|FG000|Overall Study|Withdrawal by Subject|0|||
155439278|NCT01981122|561034831|FG001|Overall Study|Withdrawal by Subject|2|||
155439279|NCT01981122|561034830|FG000|Overall Study|Protocol Violation|0|||
155439280|NCT01981122|561034831|FG001|Overall Study|Protocol Violation|1|||
155439281|NCT01981122|561034830|FG000|Overall Study|Lost to Follow-up|0|||
155439282|NCT01981122|561034831|FG001|Overall Study|Lost to Follow-up|1|||
155439283|NCT01981122|561034830|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
155439284|NCT01981122|561034831|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
155439285|NCT01981122|561034830|FG000|Overall Study|Death|14|||
155439286|NCT01981122|561034831|FG001|Overall Study|Death|15|||
155439287|NCT00283712|561034833|FG000|Overall Study|Death|0|||
155439288|NCT00283712|561034834|FG001|Overall Study|Death|1|||
155439289|NCT02046564|561034839|FG000|Overall Study|Adverse Event|6|||
155439290|NCT02046564|561034840|FG001|Overall Study|Adverse Event|3|||
155439291|NCT02046564|561034839|FG000|Overall Study|Physician Decision|0|||
155439292|NCT02046564|561034840|FG001|Overall Study|Physician Decision|1|||
155439293|NCT02046564|561034839|FG000|Overall Study|Protocol Violation|3|||
155439294|NCT02046564|561034840|FG001|Overall Study|Protocol Violation|1|||
155439295|NCT02046564|561034839|FG000|Overall Study|Withdrawal by Subject|4|||
155439296|NCT02046564|561034840|FG001|Overall Study|Withdrawal by Subject|10|||
155439297|NCT02046564|561034839|FG000|Overall Study|Subject met withdrawal criteria|2|||
155439298|NCT02046564|561034840|FG001|Overall Study|Subject met withdrawal criteria|5|||
155439299|NCT02747043|561034841|FG000|Overall Study|Other|1|||
155439300|NCT02747043|561034842|FG001|Overall Study|Other|1|||
155439301|NCT02747043|561034841|FG000|Overall Study|Adverse Event|3|||
155439302|NCT02747043|561034842|FG001|Overall Study|Adverse Event|1|||
155439303|NCT02747043|561034841|FG000|Overall Study|Withdrawal by Subject|1|||
155439304|NCT02747043|561034842|FG001|Overall Study|Withdrawal by Subject|1|||
155439305|NCT02747043|561034841|FG000|Overall Study|Physician Decision|1|||
155439306|NCT02747043|561034842|FG001|Overall Study|Physician Decision|1|||
155439307|NCT02747043|561034841|FG000|Overall Study|Protocol Violation|0|||
155439308|NCT02747043|561034842|FG001|Overall Study|Protocol Violation|1|||
155439309|NCT02747043|561034841|FG000|Overall Study|Disease progression|4|||
155439310|NCT02747043|561034842|FG001|Overall Study|Disease progression|0|||
155439311|NCT00553059|561034844|FG000|Overall Study|Deemed ineligible|1|||
155439312|NCT00553059|561034845|FG001|Overall Study|Deemed ineligible|1|||
155439313|NCT00553059|561034844|FG000|Overall Study|Drug supply not available|0|||
155439314|NCT00553059|561034845|FG001|Overall Study|Drug supply not available|1|||
155439315|NCT00670111|561034851|FG000|Enrollment to One Month|Testing Failure|0|||
155439316|NCT00670111|561034852|FG001|Enrollment to One Month|Testing Failure|0|||
155439317|NCT00670111|561034853|FG002|Enrollment to One Month|Testing Failure|13|||
155514568|NCT01446913|561310333|FG002|Overall Study|Lost to Follow-up|3|||
155514569|NCT02521948|561310334|FG000|Overall Study|Adverse Event|2|||
155514570|NCT02521948|561310334|FG000|Overall Study|Death|4|||
155514571|NCT02521948|561310334|FG000|Overall Study|Lost to Follow-up|1|||
155514572|NCT02521948|561310334|FG000|Overall Study|Did not attend one or both follow-ups|6|||
155514573|NCT00423800|561310335|FG000|Overall Study|Protocol Violation|0|||
155514574|NCT00423800|561310336|FG001|Overall Study|Protocol Violation|1|||
155514575|NCT02292238|561310337|FG000|Overall Study|Protocol Violation|1|||
155514576|NCT02292238|561310338|FG001|Overall Study|Protocol Violation|2|||
155514577|NCT02292238|561310337|FG000|Overall Study|Withdrawal by Subject|2|||
155514578|NCT02292238|561310338|FG001|Overall Study|Withdrawal by Subject|1|||
155514579|NCT02292238|561310337|FG000|Overall Study|Lost to Follow-up|1|||
155514580|NCT02292238|561310338|FG001|Overall Study|Lost to Follow-up|0|||
155514581|NCT02292238|561310337|FG000|Overall Study|Physician Decision|0|||
155514582|NCT02292238|561310338|FG001|Overall Study|Physician Decision|1|||
155514583|NCT04000009|561310339|FG000|Overall Study|Adverse Event|13|||
155514584|NCT04000009|561310339|FG000|Overall Study|Lack of Efficacy|7|||
155514585|NCT04000009|561310339|FG000|Overall Study|Lost to Follow-up|8|||
155514586|NCT04000009|561310339|FG000|Overall Study|Noncompliance with study drug|4|||
155514587|NCT04000009|561310339|FG000|Overall Study|Physician Decision|1|||
155514588|NCT04000009|561310339|FG000|Overall Study|Use of prohibited medication|3|||
155514589|NCT04000009|561310339|FG000|Overall Study|Pregnancy|1|||
155514590|NCT04000009|561310339|FG000|Overall Study|Withdrawal by Subject|22|||
155514591|NCT04000009|561310339|FG000|Overall Study|Study terminated by sponsor|98|||
155514592|NCT04000009|561310339|FG000|Overall Study|Not further specified|8|||
155514593|NCT01754259|561310342|FG000|Overall Study|Withdrawal by Subject|2|||
155514594|NCT01754259|561310343|FG001|Overall Study|Withdrawal by Subject|4|||
155514595|NCT01754259|561310342|FG000|Overall Study|Adverse Event|3|||
155514596|NCT01754259|561310343|FG001|Overall Study|Adverse Event|1|||
155514597|NCT01754259|561310342|FG000|Overall Study|Lost to Follow-up|0|||
155514598|NCT01754259|561310343|FG001|Overall Study|Lost to Follow-up|1|||
155514599|NCT00619385|561310344|FG000|Overall Study|Adverse Event|0|||
155514600|NCT00619385|561310345|FG001|Overall Study|Adverse Event|0|||
155514601|NCT00619385|561310346|FG002|Overall Study|Adverse Event|3|||
155514602|NCT00619385|561310344|FG000|Overall Study|Other|1|||
155514603|NCT00619385|561310345|FG001|Overall Study|Other|2|||
155514604|NCT00619385|561310346|FG002|Overall Study|Other|1|||
155514605|NCT02041702|561310349|FG000|Overall Study|Lost to Follow-up|1|||
155514606|NCT02041702|561310350|FG001|Overall Study|Lost to Follow-up|6|||
155514607|NCT02041702|561310349|FG000|Overall Study|Death|4|||
155514608|NCT02041702|561310350|FG001|Overall Study|Death|0|||
155514609|NCT02041702|561310349|FG000|Overall Study|Withdrawal by Subject|4|||
155514610|NCT02041702|561310350|FG001|Overall Study|Withdrawal by Subject|3|||
155514611|NCT02041702|561310349|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
155514612|NCT02041702|561310350|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
155514613|NCT02041702|561310349|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
155514614|NCT02041702|561310350|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
155514615|NCT00203307|561310351|FG000|First Intervention|Adverse Event|2|||
155514616|NCT00203307|561310352|FG001|First Intervention|Adverse Event|0|||
155514617|NCT03730103|561310353|FG000|Overall Study|Did not meet inclusion criteria|0|||
155514618|NCT03730103|561310354|FG001|Overall Study|Did not meet inclusion criteria|5|||
155514619|NCT01488578|561310355|FG000|Overall Study|Protocol Violation|1836|||
155514620|NCT02308111|561310356|FG000|Overall Study|Adverse Event|31|||
155514621|NCT02308111|561310357|FG001|Overall Study|Adverse Event|19|||
155514622|NCT02308111|561310356|FG000|Overall Study|Death|9|||
155514623|NCT02308111|561310357|FG001|Overall Study|Death|6|||
155514624|NCT02308111|561310356|FG000|Overall Study|Lost to Follow-up|2|||
155514625|NCT02308111|561310357|FG001|Overall Study|Lost to Follow-up|7|||
155514626|NCT02308111|561310356|FG000|Overall Study|Physician Decision|6|||
155514627|NCT02308111|561310357|FG001|Overall Study|Physician Decision|17|||
155514628|NCT02308111|561310356|FG000|Overall Study|Protocol Violation|0|||
155651219|NCT01340170|561814600|FG002|Overall Study|Lost to Follow-up|0|||
155514629|NCT02308111|561310357|FG001|Overall Study|Protocol Violation|1|||
155514630|NCT02308111|561310356|FG000|Overall Study|Withdrawal by Subject|28|||
155514631|NCT02308111|561310357|FG001|Overall Study|Withdrawal by Subject|38|||
155514632|NCT02308111|561310356|FG000|Overall Study|Study Terminated by Sponsor|72|||
155514633|NCT02308111|561310357|FG001|Overall Study|Study Terminated by Sponsor|61|||
155514634|NCT02308111|561310356|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
155514635|NCT02308111|561310357|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
155514636|NCT02308111|561310356|FG000|Overall Study|Site Closure|3|||
155514637|NCT02308111|561310357|FG001|Overall Study|Site Closure|3|||
155514638|NCT02308111|561310356|FG000|Overall Study|Non-compliance with Study Drug|3|||
155514639|NCT02308111|561310357|FG001|Overall Study|Non-compliance with Study Drug|1|||
155514640|NCT02308111|561310356|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
155514641|NCT02308111|561310357|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
155514642|NCT02308111|561310356|FG000|Overall Study|Liver Transplant|3|||
155514643|NCT02308111|561310357|FG001|Overall Study|Liver Transplant|3|||
155514644|NCT02308111|561310356|FG000|Overall Study|Liver Transplant Waitlist|2|||
155651220|NCT01340170|561814598|FG000|Overall Study|Implant failure|1|||
155651221|NCT01340170|561814599|FG001|Overall Study|Implant failure|3|||
155651222|NCT01340170|561814600|FG002|Overall Study|Implant failure|0|||
155651223|NCT01248468|561814601|FG000|Overall Study|Administrative problem|1|||
155651224|NCT01248468|561814602|FG001|Overall Study|Administrative problem|0|||
155651225|NCT01248468|561814603|FG002|Overall Study|Administrative problem|0|||
155651226|NCT01248468|561814601|FG000|Overall Study|Lost to Follow-up|9|||
155514645|NCT02308111|561310357|FG001|Overall Study|Liver Transplant Waitlist|2|||
155514646|NCT02308111|561310356|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
155514647|NCT02308111|561310357|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
155514648|NCT00717756|561310358|FG000|Overall Study|Withdrawal by Subject|1|||
155514649|NCT01873859|561310363|FG000|Overall Study|Withdrawal by Subject|0|||
155514650|NCT01873859|561310364|FG001|Overall Study|Withdrawal by Subject|4|||
155514651|NCT01364870|561310365|FG000|Overall Study|Withdrawal by Subject|13|||
155514652|NCT01364870|561310366|FG001|Overall Study|Withdrawal by Subject|24|||
155514653|NCT01364870|561310367|FG002|Overall Study|Withdrawal by Subject|10|||
155514654|NCT01364870|561310365|FG000|Overall Study|Adverse Event|8|||
155514655|NCT01364870|561310366|FG001|Overall Study|Adverse Event|6|||
155514656|NCT01364870|561310367|FG002|Overall Study|Adverse Event|4|||
155514657|NCT01364870|561310365|FG000|Overall Study|Protocol Violation|1|||
155514658|NCT01364870|561310366|FG001|Overall Study|Protocol Violation|0|||
155514659|NCT01364870|561310367|FG002|Overall Study|Protocol Violation|0|||
155514660|NCT03977584|561310368|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
155514661|NCT03977584|561310369|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
155514662|NCT03977584|561310370|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
155514663|NCT00745251|561310374|FG000|Overall Study|Adverse Event|1|||
155514664|NCT00745251|561310375|FG001|Overall Study|Adverse Event|2|||
155514665|NCT00745251|561310374|FG000|Overall Study|Withdrawal by Subject|1|||
155514666|NCT00745251|561310375|FG001|Overall Study|Withdrawal by Subject|1|||
155514667|NCT03850509|561310376|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
155514668|NCT03850509|561310377|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
155514669|NCT02666430|561310378|FG000|Period 1|Lost to Follow-up|1|||
155514670|NCT02666430|561310379|FG001|Period 1|Lost to Follow-up|0|||
155514671|NCT02666430|561310378|FG000|Period 1|Adverse Event|0|||
155514672|NCT02666430|561310379|FG001|Period 1|Adverse Event|1|||
155514673|NCT02666430|561310378|FG000|Period 2|Withdrawal by Subject|1|||
155514674|NCT02666430|561310379|FG001|Period 2|Withdrawal by Subject|4|||
155514675|NCT02666430|561310378|FG000|Period 3|Lost to Follow-up|1|||
155514676|NCT02666430|561310379|FG001|Period 3|Lost to Follow-up|0|||
155514677|NCT03828461|561310380|FG000|Overall Study|Lost to Follow-up|1|||
155514678|NCT03828461|561310380|FG000|Overall Study|Withdrawal by Subject|3|||
155514679|NCT01565083|561310381|FG000|Overall Study|Withdrawal by Subject|6|||
155514680|NCT01565083|561310382|FG001|Overall Study|Withdrawal by Subject|4|||
155514681|NCT01565083|561310381|FG000|Overall Study|Lost to Follow-up|2|||
155514682|NCT01565083|561310382|FG001|Overall Study|Lost to Follow-up|7|||
155514683|NCT01565083|561310381|FG000|Overall Study|Death|22|||
155514684|NCT01565083|561310382|FG001|Overall Study|Death|23|||
155514685|NCT01565083|561310381|FG000|Overall Study|Other|3|||
155514686|NCT01565083|561310382|FG001|Overall Study|Other|5|||
155514687|NCT01118728|561310383|FG000|Overall Study|Adverse Event|17|||
155514688|NCT01118728|561310383|FG000|Overall Study|Lack of Efficacy|27|||
155514689|NCT01118728|561310383|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
155514690|NCT01118728|561310383|FG000|Overall Study|Withdrawal by Subject|3|||
155514691|NCT01118728|561310383|FG000|Overall Study|Lost to Follow-up|4|||
155514692|NCT03495869|561310393|FG000|Overall Study|Lost to Follow-up|4|||
155514693|NCT03495869|561310394|FG001|Overall Study|Lost to Follow-up|17|||
155514694|NCT03495869|561310395|FG002|Overall Study|Lost to Follow-up|8|||
155514695|NCT03495869|561310396|FG003|Overall Study|Lost to Follow-up|14|||
155514696|NCT03495869|561310393|FG000|Overall Study|Withdrawal by Subject|0|||
155514697|NCT03495869|561310394|FG001|Overall Study|Withdrawal by Subject|3|||
155514698|NCT03495869|561310395|FG002|Overall Study|Withdrawal by Subject|0|||
155514699|NCT03495869|561310396|FG003|Overall Study|Withdrawal by Subject|3|||
155514700|NCT03495869|561310393|FG000|Overall Study|Dropped from study|0|||
155514701|NCT03495869|561310394|FG001|Overall Study|Dropped from study|7|||
155651227|NCT01248468|561814602|FG001|Overall Study|Lost to Follow-up|12|||
155651228|NCT01248468|561814603|FG002|Overall Study|Lost to Follow-up|4|||
155651229|NCT01248468|561814601|FG000|Overall Study|Pregnancy|1|||
155514702|NCT03495869|561310395|FG002|Overall Study|Dropped from study|2|||
155514703|NCT03495869|561310396|FG003|Overall Study|Dropped from study|4|||
155514704|NCT04680052|561311500|FG000|Overall Study|Ongoing|244|||
155514705|NCT04680052|561311501|FG001|Overall Study|Ongoing|229|||
155514706|NCT04680052|561311502|FG002|Overall Study|Ongoing|39|||
155514707|NCT04680052|561311503|FG003|Overall Study|Ongoing|46|||
155514708|NCT04680052|561311500|FG000|Overall Study|Death|15|||
155514709|NCT04680052|561311501|FG001|Overall Study|Death|22|||
155514710|NCT04680052|561311502|FG002|Overall Study|Death|7|||
155514711|NCT04680052|561311503|FG003|Overall Study|Death|1|||
155514712|NCT04680052|561311500|FG000|Overall Study|Lost to Follow-up|3|||
155514713|NCT04680052|561311501|FG001|Overall Study|Lost to Follow-up|2|||
155514714|NCT04680052|561311502|FG002|Overall Study|Lost to Follow-up|0|||
155514715|NCT04680052|561311503|FG003|Overall Study|Lost to Follow-up|1|||
155514716|NCT04680052|561311500|FG000|Overall Study|Withdrawal by Subject|11|||
155514717|NCT04680052|561311501|FG001|Overall Study|Withdrawal by Subject|19|||
155514718|NCT04680052|561311502|FG002|Overall Study|Withdrawal by Subject|7|||
155651230|NCT01248468|561814602|FG001|Overall Study|Pregnancy|0|||
155651231|NCT01248468|561814603|FG002|Overall Study|Pregnancy|0|||
155514719|NCT04680052|561311503|FG003|Overall Study|Withdrawal by Subject|5|||
155514720|NCT04680052|561311500|FG000|Overall Study|Missing|0|||
155439318|NCT00670111|561034851|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
155439319|NCT00670111|561034852|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
155439320|NCT00670111|561034853|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
155439321|NCT00670111|561034851|FG000|Enrollment to One Month|Physician Decision|1|||
155439322|NCT00670111|561034852|FG001|Enrollment to One Month|Physician Decision|0|||
155439323|NCT00670111|561034853|FG002|Enrollment to One Month|Physician Decision|0|||
155439324|NCT01749735|561034854|FG000|Overall Study|Withdrawal by Subject|1|||
155439325|NCT01749735|561034855|FG001|Overall Study|Withdrawal by Subject|0|||
155439326|NCT01873742|561034856|FG000|Overall Study|Lost to Follow-up|68|||
155439327|NCT01873742|561034857|FG001|Overall Study|Lost to Follow-up|76|||
155439328|NCT02498821|561034858|FG000|Overall Study|Screen failure|3|||
155439329|NCT02498821|561034859|FG001|Overall Study|Screen failure|5|||
155439330|NCT01457339|561034866|FG000|Period 3 (100 mg)|Adverse Event|0|||
155439331|NCT01457339|561034867|FG001|Period 3 (100 mg)|Adverse Event|1|||
155439332|NCT01457339|561034866|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
155439333|NCT01457339|561034867|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
155439334|NCT01457339|561034866|FG000|Period 6 (250 mg)|Family Emergency|1|||
155439335|NCT01457339|561034867|FG001|Period 6 (250 mg)|Family Emergency|0|||
155439336|NCT01457339|561034866|FG000|Period 6 (250 mg)|Personal appointment|0|||
155439337|NCT01457339|561034867|FG001|Period 6 (250 mg)|Personal appointment|1|||
155439338|NCT01164501|561034869|FG000|Overall Study|Not treated|2|||
155439339|NCT01164501|561034870|FG001|Overall Study|Not treated|0|||
155439340|NCT01164501|561034871|FG002|Overall Study|Not treated|1|||
155439341|NCT01164501|561034869|FG000|Overall Study|Adverse Event|18|||
155439342|NCT01164501|561034870|FG001|Overall Study|Adverse Event|4|||
155439343|NCT01164501|561034871|FG002|Overall Study|Adverse Event|21|||
155439344|NCT01164501|561034869|FG000|Overall Study|Lack of Efficacy|0|||
155439345|NCT01164501|561034870|FG001|Overall Study|Lack of Efficacy|0|||
155439346|NCT01164501|561034871|FG002|Overall Study|Lack of Efficacy|1|||
155439347|NCT01164501|561034869|FG000|Overall Study|Non compliant with protocol|1|||
155439348|NCT01164501|561034870|FG001|Overall Study|Non compliant with protocol|1|||
155439349|NCT01164501|561034871|FG002|Overall Study|Non compliant with protocol|4|||
155439350|NCT01164501|561034869|FG000|Overall Study|Lost to Follow-up|3|||
155439351|NCT01164501|561034870|FG001|Overall Study|Lost to Follow-up|0|||
155439352|NCT01164501|561034871|FG002|Overall Study|Lost to Follow-up|3|||
155439353|NCT01164501|561034869|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
155439354|NCT01164501|561034870|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
155514721|NCT04680052|561311501|FG001|Overall Study|Missing|1|||
155439355|NCT01164501|561034871|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
155651232|NCT01248468|561814601|FG000|Overall Study|Withdrawal by Subject|4|||
155651233|NCT01248468|561814602|FG001|Overall Study|Withdrawal by Subject|2|||
155439356|NCT01164501|561034869|FG000|Overall Study|Other reason not defined above|9|||
155439357|NCT01164501|561034870|FG001|Overall Study|Other reason not defined above|1|||
155439358|NCT01164501|561034871|FG002|Overall Study|Other reason not defined above|4|||
155439359|NCT01845077|561034872|FG000|Washout Period|Lost to Follow-up|0|||
155439360|NCT01845077|561034873|FG001|Washout Period|Lost to Follow-up|1|||
155439361|NCT01845077|561034874|FG002|Washout Period|Lost to Follow-up|0|||
155439362|NCT01845077|561034875|FG003|Washout Period|Lost to Follow-up|1|||
155439363|NCT01845077|561034876|FG004|Washout Period|Lost to Follow-up|0|||
155439364|NCT01845077|561034877|FG005|Washout Period|Lost to Follow-up|1|||
155439365|NCT01845077|561034872|FG000|Washout Period|Adverse Event|1|||
155439366|NCT01845077|561034873|FG001|Washout Period|Adverse Event|0|||
155439367|NCT01845077|561034874|FG002|Washout Period|Adverse Event|0|||
155439368|NCT01845077|561034875|FG003|Washout Period|Adverse Event|0|||
155439369|NCT01845077|561034876|FG004|Washout Period|Adverse Event|0|||
155439370|NCT01845077|561034877|FG005|Washout Period|Adverse Event|0|||
155439371|NCT01845077|561034872|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
155439372|NCT01845077|561034873|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
155439373|NCT01845077|561034874|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
155439374|NCT01845077|561034875|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
155439375|NCT01845077|561034876|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
155439376|NCT01845077|561034877|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
155439377|NCT01845077|561034872|FG000|Washout Period|Protocol Violation|0|||
155439378|NCT01845077|561034873|FG001|Washout Period|Protocol Violation|0|||
155439379|NCT01845077|561034874|FG002|Washout Period|Protocol Violation|0|||
155439380|NCT01845077|561034875|FG003|Washout Period|Protocol Violation|1|||
155439381|NCT01845077|561034876|FG004|Washout Period|Protocol Violation|1|||
155439382|NCT01845077|561034877|FG005|Washout Period|Protocol Violation|0|||
155439383|NCT00312377|561034879|FG000|Overall Study|Death|403|||
155439384|NCT00312377|561034880|FG001|Overall Study|Death|418|||
155439385|NCT00312377|561034879|FG000|Overall Study|Withdrawal by Subject|23|||
155439386|NCT00312377|561034880|FG001|Overall Study|Withdrawal by Subject|30|||
155439387|NCT00312377|561034879|FG000|Overall Study|Lost to Follow-up|9|||
155439388|NCT00312377|561034880|FG001|Overall Study|Lost to Follow-up|12|||
155439389|NCT00312377|561034879|FG000|Overall Study|Non-compliance|0|||
155439390|NCT00312377|561034880|FG001|Overall Study|Non-compliance|2|||
155439391|NCT00312377|561034879|FG000|Overall Study|Randomised but never received treatment|6|||
155439392|NCT00312377|561034880|FG001|Overall Study|Randomised but never received treatment|6|||
155514722|NCT04680052|561311502|FG002|Overall Study|Missing|0|||
155514723|NCT04680052|561311503|FG003|Overall Study|Missing|0|||
155651234|NCT01248468|561814603|FG002|Overall Study|Withdrawal by Subject|0|||
155514724|NCT04680052|561311500|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
155514725|NCT04680052|561311501|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
155514726|NCT04680052|561311502|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
155514727|NCT04680052|561311503|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
155514728|NCT04680052|561311500|FG000|Overall Study|Physician Decision|0|||
155514729|NCT04680052|561311501|FG001|Overall Study|Physician Decision|1|||
155514730|NCT04680052|561311502|FG002|Overall Study|Physician Decision|0|||
155514731|NCT04680052|561311503|FG003|Overall Study|Physician Decision|0|||
155651235|NCT02191397|561814604|FG000|Overall Study|Adverse Event|28|||
155651236|NCT02191397|561814605|FG001|Overall Study|Adverse Event|17|||
155651237|NCT02191397|561814604|FG000|Overall Study|Lack of Efficacy|10|||
155651238|NCT02191397|561814605|FG001|Overall Study|Lack of Efficacy|5|||
155651239|NCT02191397|561814604|FG000|Overall Study|Protocol Violation|0|||
155651240|NCT02191397|561814605|FG001|Overall Study|Protocol Violation|3|||
155651241|NCT02191397|561814604|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
155651242|NCT02191397|561814605|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
155651243|NCT02191397|561814604|FG000|Overall Study|Lost to Follow-up|10|||
155439393|NCT00312377|561034879|FG000|Overall Study|Discontinue treatment survival follow up|202|||
155439394|NCT00312377|561034880|FG001|Overall Study|Discontinue treatment survival follow up|200|||
155439395|NCT00312377|561034879|FG000|Overall Study|Site ended participation in study|1|||
155439396|NCT00312377|561034880|FG001|Overall Study|Site ended participation in study|0|||
155439397|NCT05258058|561034881|FG000|Overall Study|Withdrawal by Subject|2|||
155439398|NCT00408681|561034884|FG000|Overall Study|Lack of Efficacy|2|||
155439399|NCT00408681|561034884|FG000|Overall Study|Adverse Event|7|||
155439400|NCT02209597|561034887|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
155651244|NCT02191397|561814605|FG001|Overall Study|Lost to Follow-up|11|||
155651245|NCT02191397|561814604|FG000|Overall Study|Physician Decision|8|||
155651246|NCT02191397|561814605|FG001|Overall Study|Physician Decision|3|||
155651247|NCT02191397|561814604|FG000|Overall Study|Withdrawal by Subject|22|||
155651248|NCT02191397|561814605|FG001|Overall Study|Withdrawal by Subject|27|||
155651249|NCT00472641|561814610|FG000|Overall Study|Lack of Efficacy|3|||
155651250|NCT00472641|561814610|FG000|Overall Study|Adverse Event|3|||
155651251|NCT00472641|561814610|FG000|Overall Study|Lost to Follow-up|1|||
155651252|NCT03888482|561814611|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
155651253|NCT03888482|561814612|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
155651254|NCT03888482|561814611|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
155651255|NCT03888482|561814612|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
155651256|NCT05652140|561814615|FG000|Overall Study|Lost to Follow-up|7|||
155651257|NCT05652140|561814616|FG001|Overall Study|Lost to Follow-up|16|||
155651258|NCT05652140|561814617|FG002|Overall Study|Lost to Follow-up|22|||
155651259|NCT05652140|561814618|FG003|Overall Study|Lost to Follow-up|31|||
155651260|NCT00968968|561814621|FG000|Overall Study|Study closed/terminated|10|||
155651261|NCT00968968|561814622|FG001|Overall Study|Study closed/terminated|10|||
155651262|NCT00968968|561814621|FG000|Overall Study|Protocol defined stopping criteria|3|||
155651263|NCT00968968|561814622|FG001|Overall Study|Protocol defined stopping criteria|1|||
155651264|NCT00968968|561814621|FG000|Overall Study|Withdrawal by Subject|2|||
155651265|NCT00968968|561814622|FG001|Overall Study|Withdrawal by Subject|0|||
155651266|NCT00968968|561814621|FG000|Overall Study|Physician Decision|1|||
155651267|NCT00968968|561814622|FG001|Overall Study|Physician Decision|2|||
155651268|NCT00968968|561814621|FG000|Overall Study|Lost to Follow-up|0|||
155651269|NCT00968968|561814622|FG001|Overall Study|Lost to Follow-up|1|||
155651270|NCT04401293|561814623|FG000|Overall Study|Withdrawal by Subject|1|||
155651271|NCT04401293|561814624|FG001|Overall Study|Withdrawal by Subject|3|||
155651272|NCT03679884|561814625|FG000|Overall Study|Other|12|||
155651273|NCT03679884|561814626|FG001|Overall Study|Other|12|||
155651274|NCT03679884|561814627|FG002|Overall Study|Other|12|||
155651275|NCT03679884|561814628|FG003|Overall Study|Other|7|||
155651276|NCT03679884|561814629|FG004|Overall Study|Other|8|||
155651277|NCT03679884|561814625|FG000|Overall Study|Lack of Efficacy|15|||
155651278|NCT03679884|561814626|FG001|Overall Study|Lack of Efficacy|29|||
155651279|NCT03679884|561814627|FG002|Overall Study|Lack of Efficacy|13|||
155651280|NCT03679884|561814628|FG003|Overall Study|Lack of Efficacy|29|||
155651281|NCT03679884|561814629|FG004|Overall Study|Lack of Efficacy|10|||
155651282|NCT03679884|561814625|FG000|Overall Study|Death|1|||
155651283|NCT03679884|561814626|FG001|Overall Study|Death|0|||
155651284|NCT03679884|561814627|FG002|Overall Study|Death|0|||
155651285|NCT03679884|561814628|FG003|Overall Study|Death|0|||
155651286|NCT03679884|561814629|FG004|Overall Study|Death|0|||
155651287|NCT03679884|561814625|FG000|Overall Study|Adverse Event|2|||
155651288|NCT03679884|561814626|FG001|Overall Study|Adverse Event|10|||
155651289|NCT03679884|561814627|FG002|Overall Study|Adverse Event|9|||
155651290|NCT03679884|561814628|FG003|Overall Study|Adverse Event|6|||
155651291|NCT03679884|561814629|FG004|Overall Study|Adverse Event|6|||
155651292|NCT03679884|561814625|FG000|Overall Study|Withdrawal by Subject|12|||
155651293|NCT03679884|561814626|FG001|Overall Study|Withdrawal by Subject|23|||
155651294|NCT03679884|561814627|FG002|Overall Study|Withdrawal by Subject|8|||
155514732|NCT05342753|561311509|FG000|Overall Study|Withdrawal by Subject|6|||
155514733|NCT05342753|561311509|FG000|Overall Study|Lost to Follow-up|1|||
155514734|NCT02489318|561311510|FG000|Randomized|Withdrawal by Subject|0|||
155514735|NCT02489318|561311511|FG001|Randomized|Withdrawal by Subject|1|||
155514736|NCT02489318|561311510|FG000|Treated|Adverse Event|19|||
155514737|NCT02489318|561311511|FG001|Treated|Adverse Event|62|||
155514738|NCT02489318|561311510|FG000|Treated|Death|13|||
155514739|NCT02489318|561311511|FG001|Treated|Death|11|||
155514740|NCT02489318|561311510|FG000|Treated|Physician Decision|4|||
155514741|NCT02489318|561311511|FG001|Treated|Physician Decision|6|||
155514742|NCT02489318|561311510|FG000|Treated|Protocol Violation|1|||
155514743|NCT02489318|561311511|FG001|Treated|Protocol Violation|2|||
155514744|NCT02489318|561311510|FG000|Treated|Withdrawal by Subject|37|||
155514745|NCT02489318|561311511|FG001|Treated|Withdrawal by Subject|36|||
155514746|NCT02489318|561311510|FG000|Treated|Other: Progressive Disease|245|||
155514747|NCT02489318|561311511|FG001|Treated|Other: Progressive Disease|138|||
155514748|NCT02489318|561311510|FG000|Treated|Other|0|||
155514749|NCT02489318|561311511|FG001|Treated|Other|2|||
155514750|NCT02489318|561311510|FG000|Treated|Ongoing|0|||
155514751|NCT02489318|561311511|FG001|Treated|Ongoing|267|||
155514752|NCT05218655|561311512|FG000|Overall Study|Adverse Event|6|||
155514753|NCT05218655|561311512|FG000|Overall Study|Sponsor's decision|85|||
155514754|NCT05218655|561311512|FG000|Overall Study|Death|1|||
155514755|NCT05218655|561311512|FG000|Overall Study|Lost to Follow-up|3|||
155514756|NCT05218655|561311512|FG000|Overall Study|Withdrawal by Subject|3|||
155514757|NCT05218655|561311512|FG000|Overall Study|Other than specified|3|||
155651295|NCT03679884|561814628|FG003|Overall Study|Withdrawal by Subject|8|||
155514758|NCT03901963|561311513|FG000|Overall Study|Lost to Follow-up|1|||
155514759|NCT03901963|561311514|FG001|Overall Study|Lost to Follow-up|1|||
155514760|NCT03901963|561311513|FG000|Overall Study|Physician Decision|1|||
155514761|NCT03901963|561311514|FG001|Overall Study|Physician Decision|2|||
155514762|NCT03901963|561311513|FG000|Overall Study|Protocol Violation|1|||
155514763|NCT03901963|561311514|FG001|Overall Study|Protocol Violation|1|||
155651296|NCT03679884|561814629|FG004|Overall Study|Withdrawal by Subject|9|||
155439401|NCT02209597|561034887|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
155439402|NCT02209597|561034887|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
155439403|NCT02209597|561034887|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
155439404|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Adverse Event|37|||
155439405|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Adverse Event|0|||
155439406|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Adverse Event|0|||
155439407|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Adverse Event|0|||
155439408|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Death|2|||
155439409|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Death|0|||
155439410|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Death|0|||
155439411|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Death|0|||
155439412|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
155439413|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
155439414|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
155439415|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
155439416|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
155439417|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
155439418|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
155439419|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
155439420|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
155439421|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
155439422|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
155439423|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
155439424|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
155439425|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
155439426|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
155439427|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
155439428|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Physician Decision|4|||
155439429|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Physician Decision|0|||
155439430|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Physician Decision|0|||
155439431|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Physician Decision|0|||
155439432|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Pregnancy|1|||
155439433|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Pregnancy|0|||
155439434|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Pregnancy|0|||
155439435|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Pregnancy|0|||
155514764|NCT03901963|561311513|FG000|Overall Study|Withdrawal by Subject|4|||
155439436|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
155439437|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
155439438|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
155439439|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
155439440|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
155439441|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
155439442|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
155439443|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
155439444|NCT01855789|561034891|FG000|1) Baseline up to Week 24|Other|4|||
155439445|NCT01855789|561034892|FG001|1) Baseline up to Week 24|Other|0|||
155439446|NCT01855789|561034893|FG002|1) Baseline up to Week 24|Other|0|||
155439447|NCT01855789|561034894|FG003|1) Baseline up to Week 24|Other|0|||
155439448|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
155439449|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
155439450|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
155651297|NCT03679884|561814625|FG000|Overall Study|Lost to Follow-up|1|||
155651298|NCT03679884|561814626|FG001|Overall Study|Lost to Follow-up|4|||
155651299|NCT03679884|561814627|FG002|Overall Study|Lost to Follow-up|2|||
155439451|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
155439452|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
155439453|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
155439454|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
155439455|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
155439456|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
155439457|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
155439458|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
155439459|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
155439460|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
155439461|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
155439462|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
155439463|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
155439464|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
155439465|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
155439466|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
155439467|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
155439468|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
155439469|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
155439470|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
155439471|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
155439472|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
155439473|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
155439474|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
155439475|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
155439476|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
155439477|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
155439478|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
155439479|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
155439480|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
155439481|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
155439482|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
155439483|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
155439484|NCT01855789|561034891|FG000|2) Week 24 up to End of Study|Other|0|||
155439485|NCT01855789|561034892|FG001|2) Week 24 up to End of Study|Other|0|||
155439486|NCT01855789|561034893|FG002|2) Week 24 up to End of Study|Other|0|||
155439487|NCT01855789|561034894|FG003|2) Week 24 up to End of Study|Other|1|||
155439488|NCT02050048|561034895|FG000|Overall Study|Lost to Follow-up|0|||
155439489|NCT02050048|561034896|FG001|Overall Study|Lost to Follow-up|1|||
155439490|NCT02050048|561034895|FG000|Overall Study|Death|1|||
155439491|NCT02050048|561034896|FG001|Overall Study|Death|0|||
155439492|NCT02050048|561034895|FG000|Overall Study|Ineligible after ERCP|4|||
155439493|NCT02050048|561034896|FG001|Overall Study|Ineligible after ERCP|1|||
155439494|NCT02903511|561034902|FG000|Overall Study|Withdrawal by Subject|1|||
155439495|NCT02903511|561034903|FG001|Overall Study|Withdrawal by Subject|0|||
155439496|NCT02903511|561034902|FG000|Overall Study|Lost to Follow-up|3|||
155439497|NCT02903511|561034903|FG001|Overall Study|Lost to Follow-up|2|||
155439498|NCT02699515|561036763|FG000|Overall Study|Death|3|||
155439499|NCT02699515|561036764|FG001|Overall Study|Death|3|||
155439500|NCT02699515|561036765|FG002|Overall Study|Death|3|||
155439501|NCT02699515|561036766|FG003|Overall Study|Death|23|||
155439502|NCT02699515|561036767|FG004|Overall Study|Death|22|||
155439503|NCT02699515|561036768|FG005|Overall Study|Death|23|||
155439504|NCT02699515|561036769|FG006|Overall Study|Death|3|||
155439505|NCT02699515|561036770|FG007|Overall Study|Death|5|||
155439506|NCT02699515|561036763|FG000|Overall Study|Withdrawal by Subject|0|||
155439507|NCT02699515|561036764|FG001|Overall Study|Withdrawal by Subject|0|||
155439508|NCT02699515|561036765|FG002|Overall Study|Withdrawal by Subject|3|||
155439509|NCT02699515|561036766|FG003|Overall Study|Withdrawal by Subject|1|||
155439510|NCT02699515|561036767|FG004|Overall Study|Withdrawal by Subject|5|||
155439511|NCT02699515|561036768|FG005|Overall Study|Withdrawal by Subject|3|||
155439512|NCT02699515|561036769|FG006|Overall Study|Withdrawal by Subject|0|||
155439513|NCT02699515|561036770|FG007|Overall Study|Withdrawal by Subject|1|||
155439514|NCT02699515|561036763|FG000|Overall Study|Other|1|||
155439515|NCT02699515|561036764|FG001|Overall Study|Other|0|||
155439516|NCT02699515|561036765|FG002|Overall Study|Other|1|||
155439517|NCT02699515|561036766|FG003|Overall Study|Other|6|||
155439518|NCT02699515|561036767|FG004|Overall Study|Other|4|||
155439519|NCT02699515|561036768|FG005|Overall Study|Other|3|||
155439520|NCT02699515|561036769|FG006|Overall Study|Other|0|||
155439521|NCT02699515|561036770|FG007|Overall Study|Other|0|||
155439522|NCT05243550|561036771|FG000|Overall Study|Ongoing in the Study|171|||
155439523|NCT05243550|561036771|FG000|Overall Study|Withdrawal by Subject|10|||
155439524|NCT05243550|561036771|FG000|Overall Study|Lost to Follow-up|7|||
155439525|NCT05243550|561036771|FG000|Overall Study|Adverse Event|3|||
155439526|NCT05243550|561036771|FG000|Overall Study|Noncompliance|1|||
155439527|NCT05243550|561036771|FG000|Overall Study|Physician Decision|1|||
155439528|NCT05243550|561036771|FG000|Overall Study|Other Reason|4|||
155439529|NCT00375934|561036781|FG000|Overall Study|Adverse Event|1|||
155439530|NCT00375934|561036782|FG001|Overall Study|Adverse Event|1|||
155439531|NCT00375934|561036781|FG000|Overall Study|Withdrawal by Subject|2|||
155439532|NCT00375934|561036782|FG001|Overall Study|Withdrawal by Subject|2|||
155439533|NCT00375934|561036781|FG000|Overall Study|Lack of Efficacy|0|||
155439534|NCT00375934|561036782|FG001|Overall Study|Lack of Efficacy|2|||
155439535|NCT00375934|561036781|FG000|Overall Study|Physician Decision|0|||
155439536|NCT00375934|561036782|FG001|Overall Study|Physician Decision|1|||
155439537|NCT00500149|561036792|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
155439538|NCT00500149|561036793|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
155439539|NCT00500149|561036792|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
155439540|NCT00500149|561036793|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
155439541|NCT00500149|561036792|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
155514765|NCT03901963|561311514|FG001|Overall Study|Withdrawal by Subject|11|||
155439542|NCT00500149|561036793|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
155439543|NCT00500149|561036792|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
155439544|NCT00500149|561036793|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
155439545|NCT00500149|561036792|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
155439546|NCT00500149|561036793|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
155514766|NCT03901963|561311513|FG000|Overall Study|Ongoing|84|||
155439547|NCT00500149|561036792|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
155439548|NCT00500149|561036793|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
155439549|NCT00500149|561036792|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
155439550|NCT00500149|561036793|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
155439551|NCT01988012|561036796|FG000|Overall Study|Adverse Event|5|||
155439552|NCT01988012|561036796|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155439553|NCT01988012|561036796|FG000|Overall Study|Patient Withdrawal of Consent|4|||
155439554|NCT01988012|561036796|FG000|Overall Study|Lost to Follow-up|1|||
155439555|NCT01988012|561036796|FG000|Overall Study|Physician Decision|1|||
155439556|NCT01988012|561036796|FG000|Overall Study|Protocol Violation|1|||
155514767|NCT03901963|561311514|FG001|Overall Study|Ongoing|73|||
155514768|NCT03901963|561311513|FG000|Overall Study|Randomized but not treated|3|||
155514769|NCT03901963|561311514|FG001|Overall Study|Randomized but not treated|3|||
155514770|NCT02854436|561311515|FG000|Overall Study|Adverse Event|1|||
155514771|NCT02854436|561311515|FG000|Overall Study|Death|208|||
155514772|NCT02854436|561311515|FG000|Overall Study|Lost to Follow-up|5|||
155514773|NCT02854436|561311515|FG000|Overall Study|Withdrawal by Subject|24|||
155514774|NCT02854436|561311515|FG000|Overall Study|Other|45|||
155514775|NCT02854436|561311515|FG000|Overall Study|Physician Decision|6|||
155514776|NCT05014204|561311516|FG000|Overall Study|Withdrawal by Subject|1|||
155514777|NCT05014204|561311516|FG000|Overall Study|Physician Decision|1|||
155514778|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
155514779|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
155514780|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514781|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514782|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514783|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
155514784|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
155514785|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514786|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514787|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514788|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514789|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514790|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514791|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
155514792|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514793|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514794|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514795|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514796|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514797|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
155514798|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
155514799|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514800|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514801|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514802|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514803|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514804|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514805|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
155514806|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
155514807|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514808|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514809|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514810|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514811|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514812|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
155514813|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514814|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155439557|NCT00521339|561036797|FG000|Treatment Phase|Adverse Event|2|||
155514815|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514816|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514817|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155514818|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155651300|NCT03679884|561814628|FG003|Overall Study|Lost to Follow-up|0|||
155651301|NCT03679884|561814629|FG004|Overall Study|Lost to Follow-up|3|||
155651302|NCT01026038|561814630|FG000|Overall Study|Lost to Follow-up|1|||
155514819|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
155651303|NCT01026038|561814631|FG001|Overall Study|Lost to Follow-up|1|||
155651304|NCT01026038|561814632|FG002|Overall Study|Lost to Follow-up|0|||
155439558|NCT00521339|561036798|FG001|Treatment Phase|Adverse Event|0|||
155439559|NCT00521339|561036799|FG002|Treatment Phase|Adverse Event|0|||
155439560|NCT00521339|561036797|FG000|Treatment Phase|Intolerability to study drug|2|||
155439561|NCT00521339|561036798|FG001|Treatment Phase|Intolerability to study drug|0|||
155439562|NCT00521339|561036799|FG002|Treatment Phase|Intolerability to study drug|0|||
155439563|NCT00521339|561036797|FG000|Treatment Phase|Lack of Efficacy|3|||
155439564|NCT00521339|561036798|FG001|Treatment Phase|Lack of Efficacy|0|||
155439565|NCT00521339|561036799|FG002|Treatment Phase|Lack of Efficacy|0|||
155439566|NCT00521339|561036797|FG000|Treatment Phase|Withdrawal by Subject|3|||
155439567|NCT00521339|561036798|FG001|Treatment Phase|Withdrawal by Subject|0|||
155439568|NCT00521339|561036799|FG002|Treatment Phase|Withdrawal by Subject|0|||
155439569|NCT00521339|561036797|FG000|Treatment Phase|Lost to Follow-up|1|||
155439570|NCT00521339|561036798|FG001|Treatment Phase|Lost to Follow-up|0|||
155439571|NCT00521339|561036799|FG002|Treatment Phase|Lost to Follow-up|0|||
155439572|NCT00521339|561036797|FG000|Treatment Phase|Protocol Violation|1|||
155439573|NCT00521339|561036798|FG001|Treatment Phase|Protocol Violation|0|||
155439574|NCT00521339|561036799|FG002|Treatment Phase|Protocol Violation|0|||
155439575|NCT00521339|561036797|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
155439576|NCT00521339|561036798|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
155439577|NCT00521339|561036799|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
155439578|NCT00521339|561036797|FG000|Treatment Extension Phase|Death|0|||
155439579|NCT00521339|561036798|FG001|Treatment Extension Phase|Death|0|||
155439580|NCT00521339|561036799|FG002|Treatment Extension Phase|Death|1|||
155439581|NCT01058369|561036800|FG000|Overall Study|Adverse Event|1|||
155439582|NCT01058369|561036800|FG000|Overall Study|Early termination study|1|||
155439583|NCT03314519|561036801|FG000|Overall Study|Protocol Violation|3|||
155439584|NCT03314519|561036802|FG001|Overall Study|Protocol Violation|2|||
155439585|NCT01157169|561036805|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
155439586|NCT01157169|561036806|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
155439587|NCT01157169|561036805|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
155439588|NCT01157169|561036806|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
155439589|NCT00663858|561036809|FG000|Overall Study|Adverse Event|9|||
155439590|NCT00663858|561036810|FG001|Overall Study|Adverse Event|1|||
155439591|NCT00663858|561036811|FG002|Overall Study|Adverse Event|6|||
155439592|NCT00663858|561036809|FG000|Overall Study|Lack of Efficacy|5|||
155439593|NCT00663858|561036810|FG001|Overall Study|Lack of Efficacy|1|||
155439594|NCT00663858|561036811|FG002|Overall Study|Lack of Efficacy|3|||
155439595|NCT00663858|561036809|FG000|Overall Study|Withdrawal by Subject|7|||
155439596|NCT00663858|561036810|FG001|Overall Study|Withdrawal by Subject|3|||
155439597|NCT00663858|561036811|FG002|Overall Study|Withdrawal by Subject|3|||
155439598|NCT00663858|561036809|FG000|Overall Study|Protocol Violation|5|||
155439599|NCT00663858|561036810|FG001|Overall Study|Protocol Violation|3|||
155439600|NCT00663858|561036811|FG002|Overall Study|Protocol Violation|4|||
155439601|NCT00663858|561036809|FG000|Overall Study|Other|8|||
155439602|NCT00663858|561036810|FG001|Overall Study|Other|2|||
155439603|NCT00663858|561036811|FG002|Overall Study|Other|4|||
155439604|NCT02940886|561036812|FG000|Overall Study|Adverse Event|7|||
155439605|NCT02940886|561036813|FG001|Overall Study|Adverse Event|3|||
155439606|NCT02940886|561036812|FG000|Overall Study|Protocol Violation|0|||
155439607|NCT02940886|561036813|FG001|Overall Study|Protocol Violation|2|||
155439608|NCT02940886|561036812|FG000|Overall Study|Withdrawal by Subject|28|||
155439609|NCT02940886|561036813|FG001|Overall Study|Withdrawal by Subject|20|||
155439610|NCT02940886|561036812|FG000|Overall Study|Death|1|||
155439611|NCT02940886|561036813|FG001|Overall Study|Death|0|||
155439612|NCT02940886|561036812|FG000|Overall Study|Lack of Efficacy|1|||
155439613|NCT02940886|561036813|FG001|Overall Study|Lack of Efficacy|0|||
155439614|NCT02940886|561036812|FG000|Overall Study|Lost to Follow-up|49|||
155439615|NCT02940886|561036813|FG001|Overall Study|Lost to Follow-up|21|||
155439616|NCT02940886|561036812|FG000|Overall Study|Physician Decision|9|||
155439617|NCT02940886|561036813|FG001|Overall Study|Physician Decision|4|||
155439618|NCT02940886|561036812|FG000|Overall Study|Sponsor decision|0|||
155439619|NCT02940886|561036813|FG001|Overall Study|Sponsor decision|1|||
155439620|NCT02940886|561036812|FG000|Overall Study|No treatment|7|||
155439621|NCT02940886|561036813|FG001|Overall Study|No treatment|2|||
155439622|NCT02940886|561036812|FG000|Overall Study|Enrolment error|0|||
155439623|NCT02940886|561036813|FG001|Overall Study|Enrolment error|1|||
155439624|NCT03042611|561036814|FG000|Core Phase|Withdrawal by Subject|13|||
155439625|NCT03042611|561036815|FG001|Core Phase|Withdrawal by Subject|4|||
155439626|NCT03042611|561036816|FG002|Core Phase|Withdrawal by Subject|0|||
155439627|NCT03042611|561036817|FG003|Core Phase|Withdrawal by Subject|0|||
155439628|NCT03042611|561036814|FG000|Core Phase|Death|232|||
155439629|NCT03042611|561036815|FG001|Core Phase|Death|110|||
155439630|NCT03042611|561036816|FG002|Core Phase|Death|0|||
155439631|NCT03042611|561036817|FG003|Core Phase|Death|0|||
155439632|NCT03042611|561036814|FG000|Core Phase|Lost to Follow-up|4|||
155439633|NCT03042611|561036815|FG001|Core Phase|Lost to Follow-up|7|||
155439634|NCT03042611|561036816|FG002|Core Phase|Lost to Follow-up|0|||
155439635|NCT03042611|561036817|FG003|Core Phase|Lost to Follow-up|0|||
155439636|NCT03042611|561036814|FG000|Core Phase|Physician Decision|7|||
155439637|NCT03042611|561036815|FG001|Core Phase|Physician Decision|2|||
155439638|NCT03042611|561036816|FG002|Core Phase|Physician Decision|0|||
155439639|NCT03042611|561036817|FG003|Core Phase|Physician Decision|0|||
155439640|NCT03042611|561036814|FG000|Core Phase|Study Closed|0|||
155439641|NCT03042611|561036815|FG001|Core Phase|Study Closed|1|||
155439642|NCT03042611|561036816|FG002|Core Phase|Study Closed|0|||
155439643|NCT03042611|561036817|FG003|Core Phase|Study Closed|0|||
155439644|NCT03042611|561036814|FG000|Extension Phase|Death|0|||
155439645|NCT03042611|561036815|FG001|Extension Phase|Death|0|||
155439646|NCT03042611|561036816|FG002|Extension Phase|Death|34|||
155439647|NCT03042611|561036817|FG003|Extension Phase|Death|16|||
155439648|NCT03042611|561036814|FG000|Extension Phase|Lost to Follow-up|0|||
155439649|NCT03042611|561036815|FG001|Extension Phase|Lost to Follow-up|0|||
155439650|NCT03042611|561036816|FG002|Extension Phase|Lost to Follow-up|1|||
155439651|NCT03042611|561036817|FG003|Extension Phase|Lost to Follow-up|1|||
155439652|NCT03042611|561036814|FG000|Extension Phase|Study Closed|0|||
155439653|NCT03042611|561036815|FG001|Extension Phase|Study Closed|0|||
155439654|NCT03042611|561036816|FG002|Extension Phase|Study Closed|17|||
155439655|NCT03042611|561036817|FG003|Extension Phase|Study Closed|11|||
155439656|NCT01277289|561036819|FG000|Overall Study|fragile vein|1|||
155439657|NCT01277289|561036820|FG001|Overall Study|fragile vein|0|||
155439658|NCT01277289|561036819|FG000|Overall Study|Physician Decision|1|||
155439659|NCT01277289|561036820|FG001|Overall Study|Physician Decision|0|||
155439660|NCT01277289|561036819|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
155439661|NCT01277289|561036820|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
155439662|NCT01277289|561036819|FG000|Overall Study|Protocol Violation|1|||
155439663|NCT01277289|561036820|FG001|Overall Study|Protocol Violation|1|||
155439664|NCT01277289|561036819|FG000|Overall Study|Adverse Event|2|||
155439665|NCT01277289|561036820|FG001|Overall Study|Adverse Event|1|||
155439666|NCT01277289|561036819|FG000|Overall Study|consent withdrawn|1|||
155439667|NCT01277289|561036820|FG001|Overall Study|consent withdrawn|1|||
155439668|NCT01277289|561036819|FG000|Overall Study|premature closure of the study|4|||
155439669|NCT01277289|561036820|FG001|Overall Study|premature closure of the study|2|||
155439670|NCT00084682|561036825|FG000|Overall Study|Withdrawal by Subject|1|||
155439671|NCT00474630|561036830|FG000|Overall Study|Adverse Event|98|||
155439672|NCT00474630|561036831|FG001|Overall Study|Adverse Event|26|||
155439673|NCT00474630|561036830|FG000|Overall Study|Lost to Follow-up|22|||
155439674|NCT00474630|561036831|FG001|Overall Study|Lost to Follow-up|15|||
155439675|NCT00474630|561036830|FG000|Overall Study|Withdrawal by Subject|21|||
155439676|NCT00474630|561036831|FG001|Overall Study|Withdrawal by Subject|15|||
155439677|NCT00474630|561036830|FG000|Overall Study|Protocol Violation|3|||
155439678|NCT00474630|561036831|FG001|Overall Study|Protocol Violation|4|||
155439679|NCT00474630|561036830|FG000|Overall Study|Lack of Efficacy|5|||
155439680|NCT00474630|561036831|FG001|Overall Study|Lack of Efficacy|6|||
155439681|NCT00474630|561036830|FG000|Overall Study|Drug noncompliance, other|11|||
155439682|NCT00474630|561036831|FG001|Overall Study|Drug noncompliance, other|4|||
155439683|NCT03088605|561036832|FG000|Overall Study|Withdrawal by Subject|1|||
155439684|NCT03088605|561036833|FG001|Overall Study|Withdrawal by Subject|0|||
155439685|NCT03666143|561036838|FG000|Overall Study|Death|158|||
155439686|NCT03666143|561036838|FG000|Overall Study|Sponsor Decision|31|||
155439687|NCT03666143|561036838|FG000|Overall Study|Withdrawal by Subject|11|||
155439688|NCT03666143|561036838|FG000|Overall Study|Lost to Follow-up|5|||
155439689|NCT03666143|561036838|FG000|Overall Study|Physician Decision|1|||
155439690|NCT03666143|561036838|FG000|Overall Study|Rolled into extension study|9|||
155439691|NCT03666143|561036838|FG000|Overall Study|Progressive Disease|1|||
155439692|NCT01103349|561036839|FG000|Overall Study|Adverse Event|8|||
155439693|NCT01103349|561036840|FG001|Overall Study|Adverse Event|5|||
155439694|NCT01103349|561036841|FG002|Overall Study|Adverse Event|3|||
155439695|NCT01103349|561036839|FG000|Overall Study|Consent withdrawn|1|||
155439696|NCT01103349|561036840|FG001|Overall Study|Consent withdrawn|0|||
155439697|NCT01103349|561036841|FG002|Overall Study|Consent withdrawn|0|||
155439698|NCT01103349|561036839|FG000|Overall Study|Incorrectly included in the trial|1|||
155439699|NCT01103349|561036840|FG001|Overall Study|Incorrectly included in the trial|0|||
155439700|NCT01103349|561036841|FG002|Overall Study|Incorrectly included in the trial|0|||
155439701|NCT01103349|561036839|FG000|Overall Study|Withdrawal by Subject|1|||
155439702|NCT01103349|561036840|FG001|Overall Study|Withdrawal by Subject|1|||
155439703|NCT01103349|561036841|FG002|Overall Study|Withdrawal by Subject|0|||
155439704|NCT01103349|561036839|FG000|Overall Study|did not want to take trial medication|0|||
155439705|NCT01103349|561036840|FG001|Overall Study|did not want to take trial medication|1|||
155439706|NCT01103349|561036841|FG002|Overall Study|did not want to take trial medication|0|||
155439707|NCT01103349|561036839|FG000|Overall Study|forgot to take medication|0|||
155439708|NCT01103349|561036840|FG001|Overall Study|forgot to take medication|0|||
155439709|NCT01103349|561036841|FG002|Overall Study|forgot to take medication|1|||
155439710|NCT02397655|561036843|FG000|Overall Study|data not completed|1301|||
155439711|NCT01736683|561036844|FG000|Overall Study|Disease Relapse|0|||
155439712|NCT01736683|561036845|FG001|Overall Study|Disease Relapse|0|||
155439713|NCT01736683|561036846|FG002|Overall Study|Disease Relapse|2|||
155439714|NCT01736683|561036847|FG003|Overall Study|Disease Relapse|1|||
155439715|NCT01736683|561036848|FG004|Overall Study|Disease Relapse|0|||
155439716|NCT01736683|561036844|FG000|Overall Study|Adverse Event|0|||
155439717|NCT01736683|561036845|FG001|Overall Study|Adverse Event|2|||
155439718|NCT01736683|561036846|FG002|Overall Study|Adverse Event|2|||
155439719|NCT01736683|561036847|FG003|Overall Study|Adverse Event|3|||
155439720|NCT01736683|561036848|FG004|Overall Study|Adverse Event|2|||
155439721|NCT01736683|561036844|FG000|Overall Study|Withdrawal by Subject|0|||
155439722|NCT01736683|561036845|FG001|Overall Study|Withdrawal by Subject|0|||
155439723|NCT01736683|561036846|FG002|Overall Study|Withdrawal by Subject|3|||
155439724|NCT01736683|561036847|FG003|Overall Study|Withdrawal by Subject|1|||
155439725|NCT01736683|561036848|FG004|Overall Study|Withdrawal by Subject|1|||
155439726|NCT01736683|561036844|FG000|Overall Study|Lack of Therapeutic Effect|7|||
155439727|NCT01736683|561036845|FG001|Overall Study|Lack of Therapeutic Effect|4|||
155439728|NCT01736683|561036846|FG002|Overall Study|Lack of Therapeutic Effect|13|||
155439729|NCT01736683|561036847|FG003|Overall Study|Lack of Therapeutic Effect|20|||
155439730|NCT01736683|561036848|FG004|Overall Study|Lack of Therapeutic Effect|1|||
155439731|NCT01736683|561036844|FG000|Overall Study|Progressive Disease|0|||
155439732|NCT01736683|561036845|FG001|Overall Study|Progressive Disease|0|||
155439733|NCT01736683|561036846|FG002|Overall Study|Progressive Disease|0|||
155439734|NCT01736683|561036847|FG003|Overall Study|Progressive Disease|1|||
155439735|NCT01736683|561036848|FG004|Overall Study|Progressive Disease|0|||
155439736|NCT01736683|561036844|FG000|Overall Study|Other|0|||
155439737|NCT01736683|561036845|FG001|Overall Study|Other|0|||
155439738|NCT01736683|561036846|FG002|Overall Study|Other|1|||
155439739|NCT01736683|561036847|FG003|Overall Study|Other|9|||
155439740|NCT01736683|561036848|FG004|Overall Study|Other|1|||
155439741|NCT01966731|561036855|FG000|Overall Study|Death|2|||
155439742|NCT01966731|561036855|FG000|Overall Study|Lost to Follow-up|1|||
155439743|NCT01966731|561036855|FG000|Overall Study|Physician Decision|2|||
155439744|NCT01966731|561036855|FG000|Overall Study|Follow up is not complete|600|||
155439745|NCT01966731|561036855|FG000|Overall Study|Screening Failure|29|||
155439746|NCT01966731|561036855|FG000|Overall Study|Found to be ineligible|1|||
155439747|NCT03952650|561036856|FG000|Overall Study|TRAVEL|0|||
155439748|NCT03952650|561036857|FG001|Overall Study|TRAVEL|4|||
155439749|NCT03952650|561036858|FG002|Overall Study|TRAVEL|0|||
155439750|NCT03952650|561036859|FG003|Overall Study|TRAVEL|4|||
155439751|NCT03952650|561036860|FG004|Overall Study|TRAVEL|0|||
155439752|NCT03952650|561036861|FG005|Overall Study|TRAVEL|3|||
155439753|NCT03952650|561036862|FG006|Overall Study|TRAVEL|2|||
155439754|NCT03952650|561036856|FG000|Overall Study|Withdrawal by Subject|0|||
155439755|NCT03952650|561036857|FG001|Overall Study|Withdrawal by Subject|2|||
155439756|NCT03952650|561036858|FG002|Overall Study|Withdrawal by Subject|0|||
155439757|NCT03952650|561036859|FG003|Overall Study|Withdrawal by Subject|3|||
155439758|NCT03952650|561036860|FG004|Overall Study|Withdrawal by Subject|0|||
155439759|NCT03952650|561036861|FG005|Overall Study|Withdrawal by Subject|1|||
155439760|NCT03952650|561036862|FG006|Overall Study|Withdrawal by Subject|1|||
155439761|NCT03952650|561036856|FG000|Overall Study|Lost to Follow-up|0|||
155439762|NCT03952650|561036857|FG001|Overall Study|Lost to Follow-up|1|||
155439763|NCT03952650|561036858|FG002|Overall Study|Lost to Follow-up|0|||
155439764|NCT03952650|561036859|FG003|Overall Study|Lost to Follow-up|0|||
155439765|NCT03952650|561036860|FG004|Overall Study|Lost to Follow-up|0|||
155439766|NCT03952650|561036861|FG005|Overall Study|Lost to Follow-up|1|||
155439767|NCT03952650|561036862|FG006|Overall Study|Lost to Follow-up|1|||
155514820|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514821|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514822|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514823|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155651305|NCT00480025|561814636|FG000|Overall Study|Protocol Violation|12|||
155439768|NCT03952650|561036856|FG000|Overall Study|Received wrong vaccine and travelled|0|||
155439769|NCT03952650|561036857|FG001|Overall Study|Received wrong vaccine and travelled|0|||
155439770|NCT03952650|561036858|FG002|Overall Study|Received wrong vaccine and travelled|0|||
155439771|NCT03952650|561036859|FG003|Overall Study|Received wrong vaccine and travelled|0|||
155439772|NCT03952650|561036860|FG004|Overall Study|Received wrong vaccine and travelled|0|||
155439773|NCT03952650|561036861|FG005|Overall Study|Received wrong vaccine and travelled|1|||
155439774|NCT03952650|561036862|FG006|Overall Study|Received wrong vaccine and travelled|0|||
155439775|NCT03952650|561036856|FG000|Overall Study|Unable to make study visit|0|||
155439776|NCT03952650|561036857|FG001|Overall Study|Unable to make study visit|0|||
155439777|NCT03952650|561036858|FG002|Overall Study|Unable to make study visit|0|||
155439778|NCT03952650|561036859|FG003|Overall Study|Unable to make study visit|0|||
155439779|NCT03952650|561036860|FG004|Overall Study|Unable to make study visit|0|||
155439780|NCT03952650|561036861|FG005|Overall Study|Unable to make study visit|1|||
155439781|NCT03952650|561036862|FG006|Overall Study|Unable to make study visit|0|||
155439782|NCT00592683|561036863|FG000|Overall Study|Found ineligible|0|||
155439783|NCT00592683|561036864|FG001|Overall Study|Found ineligible|1|||
155439784|NCT00592683|561036863|FG000|Overall Study|Withdrawal by Subject|1|||
155439785|NCT00592683|561036864|FG001|Overall Study|Withdrawal by Subject|0|||
155439786|NCT00592683|561036863|FG000|Overall Study|Adverse Event|0|||
155514824|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514825|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
155514826|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
155514827|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514828|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514829|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514830|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514831|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514832|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514833|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155514834|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514835|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514836|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514837|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514838|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514839|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514840|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
155514841|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514842|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514843|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514844|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155439787|NCT00592683|561036864|FG001|Overall Study|Adverse Event|2|||
155439788|NCT00592683|561036863|FG000|Overall Study|Protocol Violation|1|||
155439789|NCT00592683|561036864|FG001|Overall Study|Protocol Violation|0|||
155439790|NCT00592683|561036863|FG000|Overall Study|Study drug expired|1|||
155439791|NCT00592683|561036864|FG001|Overall Study|Study drug expired|0|||
155439792|NCT00592683|561036863|FG000|Overall Study|Other|1|||
155439793|NCT00592683|561036864|FG001|Overall Study|Other|0|||
155439794|NCT00592683|561036863|FG000|Overall Study|Lost to Follow-up|0|||
155439795|NCT00592683|561036864|FG001|Overall Study|Lost to Follow-up|1|||
155439796|NCT00201201|561036865|FG000|Overall Study|Death|0|||
155439797|NCT00201201|561036866|FG001|Overall Study|Death|2|||
155439798|NCT00201201|561036865|FG000|Overall Study|Withdrawal by Subject|5|||
155439799|NCT00201201|561036866|FG001|Overall Study|Withdrawal by Subject|5|||
155439800|NCT00545818|561036867|FG000|Overall Study|Protocol Violation|1|||
155439801|NCT00545818|561036868|FG001|Overall Study|Protocol Violation|0|||
155439802|NCT00545818|561036867|FG000|Overall Study|Adverse Event|1|||
155439803|NCT00545818|561036868|FG001|Overall Study|Adverse Event|1|||
155439804|NCT00545818|561036867|FG000|Overall Study|Lost to Follow-up|1|||
155439805|NCT00545818|561036868|FG001|Overall Study|Lost to Follow-up|6|||
155439806|NCT02623361|561036869|FG000|Overall Study|Protocol Violation|0|||
155439807|NCT02623361|561036870|FG001|Overall Study|Protocol Violation|1|||
155439808|NCT02623361|561036869|FG000|Overall Study|Withdrawal by Subject|0|||
155439809|NCT02623361|561036870|FG001|Overall Study|Withdrawal by Subject|1|||
155439810|NCT02441803|561036872|FG000|Overall Study|Physician Decision|0|||
155439811|NCT02441803|561036873|FG001|Overall Study|Physician Decision|2|||
155439812|NCT02441803|561036874|FG002|Overall Study|Physician Decision|2|||
155439813|NCT00537823|561036878|FG000|Overall Study|Adverse Event|2|||
155439814|NCT00537823|561036879|FG001|Overall Study|Adverse Event|0|||
155439815|NCT02873221|561036880|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
155439816|NCT02873221|561036881|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
155439817|NCT02873221|561036882|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
155514845|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514846|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514847|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155514848|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
155514849|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
155439818|NCT02873221|561036880|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
155439819|NCT02873221|561036881|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
155439820|NCT02873221|561036882|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
155439821|NCT02873221|561036880|FG000|Treatment Period|Protocol Violation|2|||
155439822|NCT02873221|561036881|FG001|Treatment Period|Protocol Violation|5|||
155439823|NCT02873221|561036882|FG002|Treatment Period|Protocol Violation|8|||
155439824|NCT02873221|561036880|FG000|Treatment Period|Pregnancy|4|||
155439825|NCT02873221|561036881|FG001|Treatment Period|Pregnancy|6|||
155514850|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
155514851|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514852|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155439826|NCT02873221|561036882|FG002|Treatment Period|Pregnancy|3|||
155439827|NCT02873221|561036880|FG000|Treatment Period|Lack of Qualifying Event|0|||
155439828|NCT02873221|561036881|FG001|Treatment Period|Lack of Qualifying Event|3|||
155439829|NCT02873221|561036882|FG002|Treatment Period|Lack of Qualifying Event|1|||
155439830|NCT02873221|561036880|FG000|Treatment Period|Withdrawal of Consent|52|||
155439831|NCT02873221|561036881|FG001|Treatment Period|Withdrawal of Consent|51|||
155439832|NCT02873221|561036882|FG002|Treatment Period|Withdrawal of Consent|41|||
155439833|NCT02873221|561036880|FG000|Treatment Period|Lack of Efficacy|0|||
155439834|NCT02873221|561036881|FG001|Treatment Period|Lack of Efficacy|17|||
155439835|NCT02873221|561036882|FG002|Treatment Period|Lack of Efficacy|12|||
155439836|NCT02873221|561036880|FG000|Treatment Period|Adverse Event|4|||
155439837|NCT02873221|561036881|FG001|Treatment Period|Adverse Event|9|||
155439838|NCT02873221|561036882|FG002|Treatment Period|Adverse Event|11|||
155439839|NCT02873221|561036880|FG000|Treatment Period|Lost to Follow-up|26|||
155439840|NCT02873221|561036881|FG001|Treatment Period|Lost to Follow-up|30|||
155439841|NCT02873221|561036882|FG002|Treatment Period|Lost to Follow-up|26|||
155439842|NCT02873221|561036880|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155439843|NCT02873221|561036881|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
155439844|NCT02873221|561036882|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155439845|NCT02873221|561036880|FG000|Safety Follow-up Period|Protocol Violation|0|||
155439846|NCT02873221|561036881|FG001|Safety Follow-up Period|Protocol Violation|0|||
155439847|NCT02873221|561036882|FG002|Safety Follow-up Period|Protocol Violation|1|||
155439848|NCT02873221|561036880|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
155439849|NCT02873221|561036881|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
155439850|NCT02873221|561036882|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
155439851|NCT02873221|561036880|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
155439852|NCT02873221|561036881|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
155439853|NCT02873221|561036882|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
155439854|NCT01325493|561036883|FG000|Overall Study|Protocol Violation|0|||
155439855|NCT01325493|561036884|FG001|Overall Study|Protocol Violation|1|||
155439856|NCT01325493|561036883|FG000|Overall Study|loss of neuromonitoring signals|0|||
155439857|NCT01325493|561036884|FG001|Overall Study|loss of neuromonitoring signals|2|||
155439858|NCT01325493|561036883|FG000|Overall Study|Allergy|1|||
155439859|NCT01325493|561036884|FG001|Overall Study|Allergy|0|||
155439860|NCT02240628|561036885|FG000|Overall Study|Physician Decision|6|||
155439861|NCT02240628|561036886|FG001|Overall Study|Physician Decision|5|||
155439862|NCT02732912|561036887|FG000|Overall Study|Discharged before night|2|||
155439863|NCT02732912|561036888|FG001|Overall Study|Discharged before night|6|||
155439864|NCT02732912|561036887|FG000|Overall Study|Incomplete completion of questionnaire|2|||
155439865|NCT02732912|561036888|FG001|Overall Study|Incomplete completion of questionnaire|3|||
155439866|NCT02732912|561036887|FG000|Overall Study|No outcome; discharged or refused|6|||
155439867|NCT02732912|561036888|FG001|Overall Study|No outcome; discharged or refused|9|||
155439868|NCT02285010|561036889|FG000|Overall Study|not abdominal hysterectomy|2|||
155439869|NCT02285010|561036890|FG001|Overall Study|not abdominal hysterectomy|0|||
155439870|NCT02285010|561036889|FG000|Overall Study|Not spinal anesthesia|3|||
155439871|NCT02285010|561036890|FG001|Overall Study|Not spinal anesthesia|1|||
155439872|NCT01208181|561036893|FG000|Part 1|Withdrawal by Subject|11|||
155439873|NCT01208181|561036894|FG001|Part 1|Withdrawal by Subject|10|||
155439874|NCT01208181|561036895|FG002|Part 1|Withdrawal by Subject|0|||
155439875|NCT01208181|561036896|FG003|Part 1|Withdrawal by Subject|0|||
155439876|NCT01208181|561036897|FG004|Part 1|Withdrawal by Subject|0|||
155439877|NCT01208181|561036893|FG000|Part 1|Technical problem|5|||
155439878|NCT01208181|561036894|FG001|Part 1|Technical problem|0|||
155439879|NCT01208181|561036895|FG002|Part 1|Technical problem|0|||
155439880|NCT01208181|561036896|FG003|Part 1|Technical problem|0|||
155439881|NCT01208181|561036897|FG004|Part 1|Technical problem|0|||
155439882|NCT01208181|561036893|FG000|Part 1|Protocol Violation|10|||
155439883|NCT01208181|561036894|FG001|Part 1|Protocol Violation|5|||
155439884|NCT01208181|561036895|FG002|Part 1|Protocol Violation|0|||
155439885|NCT01208181|561036896|FG003|Part 1|Protocol Violation|0|||
155439886|NCT01208181|561036897|FG004|Part 1|Protocol Violation|0|||
155439887|NCT01208181|561036893|FG000|Part 1|Physician Decision|4|||
155439888|NCT01208181|561036894|FG001|Part 1|Physician Decision|0|||
155439889|NCT01208181|561036895|FG002|Part 1|Physician Decision|0|||
155439890|NCT01208181|561036896|FG003|Part 1|Physician Decision|0|||
155439891|NCT01208181|561036897|FG004|Part 1|Physician Decision|0|||
155439892|NCT01208181|561036893|FG000|Part 1|Non-compliance with study drug|1|||
155439893|NCT01208181|561036894|FG001|Part 1|Non-compliance with study drug|1|||
155439894|NCT01208181|561036895|FG002|Part 1|Non-compliance with study drug|0|||
155439895|NCT01208181|561036896|FG003|Part 1|Non-compliance with study drug|0|||
155439896|NCT01208181|561036897|FG004|Part 1|Non-compliance with study drug|0|||
155439897|NCT01208181|561036893|FG000|Part 1|Lost to Follow-up|5|||
155439898|NCT01208181|561036894|FG001|Part 1|Lost to Follow-up|3|||
155439899|NCT01208181|561036895|FG002|Part 1|Lost to Follow-up|0|||
155439900|NCT01208181|561036896|FG003|Part 1|Lost to Follow-up|0|||
155439901|NCT01208181|561036897|FG004|Part 1|Lost to Follow-up|1|||
155439902|NCT01208181|561036893|FG000|Part 1|Lack of Efficacy|37|||
155439903|NCT01208181|561036894|FG001|Part 1|Lack of Efficacy|12|||
155439904|NCT01208181|561036895|FG002|Part 1|Lack of Efficacy|0|||
155439905|NCT01208181|561036896|FG003|Part 1|Lack of Efficacy|0|||
155439906|NCT01208181|561036897|FG004|Part 1|Lack of Efficacy|17|||
155439907|NCT01208181|561036893|FG000|Part 1|Adverse Event|26|||
155439908|NCT01208181|561036894|FG001|Part 1|Adverse Event|24|||
155439909|NCT01208181|561036895|FG002|Part 1|Adverse Event|0|||
155439910|NCT01208181|561036896|FG003|Part 1|Adverse Event|0|||
155439911|NCT01208181|561036897|FG004|Part 1|Adverse Event|4|||
155439912|NCT01208181|561036893|FG000|Part 2|Adverse Event|0|||
155439913|NCT01208181|561036894|FG001|Part 2|Adverse Event|0|||
155439914|NCT01208181|561036895|FG002|Part 2|Adverse Event|6|||
155439915|NCT01208181|561036896|FG003|Part 2|Adverse Event|7|||
155439916|NCT01208181|561036897|FG004|Part 2|Adverse Event|0|||
155439917|NCT01208181|561036893|FG000|Part 2|Withdrawal by Subject|0|||
155439918|NCT01208181|561036894|FG001|Part 2|Withdrawal by Subject|0|||
155439919|NCT01208181|561036895|FG002|Part 2|Withdrawal by Subject|1|||
155439920|NCT01208181|561036896|FG003|Part 2|Withdrawal by Subject|1|||
155439921|NCT01208181|561036897|FG004|Part 2|Withdrawal by Subject|0|||
155439922|NCT01208181|561036893|FG000|Part 2|Protocol Violation|0|||
155439923|NCT01208181|561036894|FG001|Part 2|Protocol Violation|0|||
155439924|NCT01208181|561036895|FG002|Part 2|Protocol Violation|1|||
155439925|NCT01208181|561036896|FG003|Part 2|Protocol Violation|0|||
155439926|NCT01208181|561036897|FG004|Part 2|Protocol Violation|0|||
155439927|NCT01208181|561036893|FG000|Part 2|Physician Decision|0|||
155439928|NCT01208181|561036894|FG001|Part 2|Physician Decision|0|||
155439929|NCT01208181|561036895|FG002|Part 2|Physician Decision|1|||
155439930|NCT01208181|561036896|FG003|Part 2|Physician Decision|2|||
155439931|NCT01208181|561036897|FG004|Part 2|Physician Decision|0|||
155439932|NCT01208181|561036893|FG000|Part 2|Non-compliance with study drug|0|||
155439933|NCT01208181|561036894|FG001|Part 2|Non-compliance with study drug|0|||
155439934|NCT01208181|561036895|FG002|Part 2|Non-compliance with study drug|1|||
155439935|NCT01208181|561036896|FG003|Part 2|Non-compliance with study drug|1|||
155439936|NCT01208181|561036897|FG004|Part 2|Non-compliance with study drug|0|||
155439937|NCT01208181|561036893|FG000|Part 2|Lost to Follow-up|0|||
155439938|NCT01208181|561036894|FG001|Part 2|Lost to Follow-up|0|||
155439939|NCT01208181|561036895|FG002|Part 2|Lost to Follow-up|1|||
155439940|NCT01208181|561036896|FG003|Part 2|Lost to Follow-up|2|||
155439941|NCT01208181|561036897|FG004|Part 2|Lost to Follow-up|0|||
155439942|NCT01208181|561036893|FG000|Part 2|Lack of Efficacy|0|||
155439943|NCT01208181|561036894|FG001|Part 2|Lack of Efficacy|0|||
155439944|NCT01208181|561036895|FG002|Part 2|Lack of Efficacy|5|||
155439945|NCT01208181|561036896|FG003|Part 2|Lack of Efficacy|7|||
155439946|NCT01208181|561036897|FG004|Part 2|Lack of Efficacy|0|||
155439947|NCT01096667|561036900|FG000|Overall Study|Lost to Follow-up|1|||
155439948|NCT01096667|561036901|FG001|Overall Study|Lost to Follow-up|1|||
155439949|NCT01096667|561036902|FG002|Overall Study|Lost to Follow-up|1|||
155439950|NCT01096667|561036903|FG003|Overall Study|Lost to Follow-up|0|||
155439951|NCT01096667|561036904|FG004|Overall Study|Lost to Follow-up|0|||
155439952|NCT01096667|561036900|FG000|Overall Study|Withdrawal by Subject|1|||
155439953|NCT01096667|561036901|FG001|Overall Study|Withdrawal by Subject|0|||
155439954|NCT01096667|561036902|FG002|Overall Study|Withdrawal by Subject|0|||
155439955|NCT01096667|561036903|FG003|Overall Study|Withdrawal by Subject|1|||
155439956|NCT01096667|561036904|FG004|Overall Study|Withdrawal by Subject|0|||
155439957|NCT01096667|561036900|FG000|Overall Study|Reason not available|0|||
155514853|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
155514854|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
155439958|NCT01096667|561036901|FG001|Overall Study|Reason not available|1|||
155439959|NCT01096667|561036902|FG002|Overall Study|Reason not available|1|||
155651306|NCT00480025|561814637|FG001|Overall Study|Protocol Violation|7|||
155439960|NCT01096667|561036903|FG003|Overall Study|Reason not available|1|||
155439961|NCT01096667|561036904|FG004|Overall Study|Reason not available|0|||
155439962|NCT01096667|561036900|FG000|Overall Study|Protocol Violation|0|||
155439963|NCT01096667|561036901|FG001|Overall Study|Protocol Violation|0|||
155439964|NCT01096667|561036902|FG002|Overall Study|Protocol Violation|0|||
155439965|NCT01096667|561036903|FG003|Overall Study|Protocol Violation|1|||
155439966|NCT01096667|561036904|FG004|Overall Study|Protocol Violation|0|||
155439967|NCT01096667|561036900|FG000|Overall Study|Not treated|1|||
155439968|NCT01096667|561036901|FG001|Overall Study|Not treated|0|||
155439969|NCT01096667|561036902|FG002|Overall Study|Not treated|0|||
155439970|NCT01096667|561036903|FG003|Overall Study|Not treated|0|||
155439971|NCT01096667|561036904|FG004|Overall Study|Not treated|0|||
155439972|NCT00394914|561036907|FG000|Treatment Period|Adverse Event|0|||
155439973|NCT00394914|561036908|FG001|Treatment Period|Adverse Event|3|||
155439974|NCT00394914|561036909|FG002|Treatment Period|Adverse Event|1|||
155439975|NCT00394914|561036907|FG000|Treatment Period|Lost to Follow-up|0|||
155514855|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514856|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514857|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514858|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514859|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514860|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514861|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
155514862|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514863|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
155514864|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514865|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514866|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514867|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
155514868|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514869|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514870|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514871|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514872|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514873|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514874|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514875|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155514876|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
155514877|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514878|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514879|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514880|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514881|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
155514882|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514883|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514884|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514885|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514886|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514887|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514888|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155514889|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
155439976|NCT00394914|561036908|FG001|Treatment Period|Lost to Follow-up|1|||
155439977|NCT00394914|561036909|FG002|Treatment Period|Lost to Follow-up|0|||
155439978|NCT00394914|561036907|FG000|Treatment Period|Withdrawal by Subject|0|||
155439979|NCT00394914|561036908|FG001|Treatment Period|Withdrawal by Subject|2|||
155439980|NCT00394914|561036909|FG002|Treatment Period|Withdrawal by Subject|2|||
155439981|NCT00394914|561036907|FG000|Treatment Period|Noncompliance with protocol|0|||
155439982|NCT00394914|561036908|FG001|Treatment Period|Noncompliance with protocol|3|||
155439983|NCT00394914|561036909|FG002|Treatment Period|Noncompliance with protocol|2|||
155439984|NCT00394914|561036907|FG000|Treatment Period|Did not meet protocol eligibility|0|||
155439985|NCT00394914|561036908|FG001|Treatment Period|Did not meet protocol eligibility|1|||
155439986|NCT00394914|561036909|FG002|Treatment Period|Did not meet protocol eligibility|1|||
155439987|NCT02179398|561036917|FG000|Overall Study|Lack of obligatory data|3|||
155439988|NCT02179398|561036918|FG001|Overall Study|Lack of obligatory data|3|||
155439989|NCT02179398|561036917|FG000|Overall Study|Lost to Follow-up|0|||
155439990|NCT02179398|561036918|FG001|Overall Study|Lost to Follow-up|1|||
155439991|NCT01787591|561036926|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
155439992|NCT01787591|561036927|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
155439993|NCT01787591|561036928|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
155439994|NCT01787591|561036929|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
155439995|NCT02489630|561036932|FG000|Overall Study|Oversedation|1|||
155439996|NCT02489630|561036933|FG001|Overall Study|Oversedation|1|||
155439997|NCT02489630|561036932|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
155439998|NCT02489630|561036933|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
155439999|NCT00815308|561036934|FG000|Overall Study|Adverse Event|4|||
155440000|NCT00815308|561036934|FG000|Overall Study|Withdrawal by Subject|0|||
155440001|NCT00815308|561036934|FG000|Overall Study|Protocol Violation|6|||
155440002|NCT00377299|561036935|FG000|Overall Study|Lost to Follow-up|14|||
155440003|NCT00377299|561036936|FG001|Overall Study|Lost to Follow-up|19|||
155440004|NCT00377299|561036935|FG000|Overall Study|Adverse Event|0|||
155514890|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155651307|NCT00480025|561814636|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
155440005|NCT00377299|561036936|FG001|Overall Study|Adverse Event|1|||
155440006|NCT00377299|561036935|FG000|Overall Study|Withdrawal by Subject|5|||
155440007|NCT00377299|561036936|FG001|Overall Study|Withdrawal by Subject|4|||
155440008|NCT04799782|561036937|FG000|Washout|Physician Decision|2|||
155440009|NCT04799782|561036938|FG001|Washout|Physician Decision|0|||
155440010|NCT04799782|561036937|FG000|Washout|Withdrawal by Subject|0|||
155440011|NCT04799782|561036938|FG001|Washout|Withdrawal by Subject|2|||
155440012|NCT04799782|561036937|FG000|Washout|Lost to Follow-up|0|||
155440013|NCT04799782|561036938|FG001|Washout|Lost to Follow-up|1|||
155440014|NCT01589094|561036941|FG000|Overall Study|Did not receive treatment|2|||
155440015|NCT02975349|561036942|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155440016|NCT02975349|561036943|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155440017|NCT02975349|561036944|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155440018|NCT02975349|561036945|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155440019|NCT02975349|561036946|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155440020|NCT02975349|561036947|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155514891|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155651308|NCT00480025|561814637|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
155651309|NCT00480025|561814636|FG000|Overall Study|Disease Progression / Recurrence|449|||
155651310|NCT00480025|561814637|FG001|Overall Study|Disease Progression / Recurrence|224|||
155651311|NCT00480025|561814636|FG000|Overall Study|Adverse Event|44|||
155651312|NCT00480025|561814637|FG001|Overall Study|Adverse Event|12|||
155651313|NCT00480025|561814636|FG000|Overall Study|Other|70|||
155651314|NCT00480025|561814637|FG001|Overall Study|Other|29|||
155651315|NCT00480025|561814636|FG000|Overall Study|SAE including intercurrent illness|76|||
155514892|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514893|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
155514894|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
155514895|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514896|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514897|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
155514898|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
155514899|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514900|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514901|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514902|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514903|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
155514904|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514905|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155651316|NCT00480025|561814637|FG001|Overall Study|SAE including intercurrent illness|42|||
155651317|NCT00682435|561814638|FG000|Overall Study|Insufficient data|5|||
155651318|NCT00682435|561814638|FG000|Overall Study|Erroneously enrolled twice|2|||
155514906|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514907|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514908|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514909|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514910|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155651319|NCT01064622|561814640|FG000|Randomized Phase II|Withdrawal by Subject|2|||
155651320|NCT01064622|561814641|FG001|Randomized Phase II|Withdrawal by Subject|2|||
155651321|NCT01064622|561814640|FG000|Randomized Phase II|Protocol Violation|0|||
155440021|NCT02975349|561036948|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155440022|NCT02975349|561036942|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155440023|NCT02975349|561036943|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440024|NCT02975349|561036944|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440025|NCT02975349|561036945|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440026|NCT02975349|561036946|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440027|NCT02975349|561036947|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440028|NCT02975349|561036948|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155440029|NCT02975349|561036942|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
155440030|NCT02975349|561036943|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
155440031|NCT02975349|561036944|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
155440032|NCT02975349|561036945|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
155440033|NCT02975349|561036946|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
155440034|NCT02975349|561036947|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
155440035|NCT02975349|561036948|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
155440036|NCT02975349|561036942|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
155440037|NCT02975349|561036943|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
155440038|NCT02975349|561036944|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
155440039|NCT02975349|561036945|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
155440040|NCT02975349|561036946|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
155440041|NCT02975349|561036947|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
155440042|NCT02975349|561036948|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
155440043|NCT02975349|561036942|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
155440044|NCT02975349|561036943|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
155440045|NCT02975349|561036944|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
155440046|NCT02975349|561036945|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
155440047|NCT02975349|561036946|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
155440048|NCT02975349|561036947|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
155440049|NCT02975349|561036948|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
155440050|NCT02975349|561036942|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440051|NCT02975349|561036943|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440052|NCT02975349|561036944|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440053|NCT02975349|561036945|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
155440054|NCT02975349|561036946|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440055|NCT02975349|561036947|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440056|NCT02975349|561036948|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
155440057|NCT02975349|561036942|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440058|NCT02975349|561036943|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
155440059|NCT02975349|561036944|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440060|NCT02975349|561036945|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440061|NCT02975349|561036946|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440062|NCT02975349|561036947|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440063|NCT02975349|561036948|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
155440064|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
155440065|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
155440066|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
155440067|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
155440068|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
155440069|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
155440070|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
155440071|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440072|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440073|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440074|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440075|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
155440076|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440077|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
155440078|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
155440079|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
155440080|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
155440081|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
155440082|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
155440083|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
155440084|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
155440085|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
155440086|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
155440087|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
155440088|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
155440089|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
155440090|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
155440091|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
155440092|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
155440093|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
155440094|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
155440095|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
155440096|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
155440097|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
155440098|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
155440099|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
155440100|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
155440101|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
155440102|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
155440103|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
155440104|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
155440105|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
155440106|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
155440107|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
155440108|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
155440109|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
155440110|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
155440111|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
155440112|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
155440113|NCT02975349|561036942|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
155440114|NCT02975349|561036943|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
155440115|NCT02975349|561036944|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
155440116|NCT02975349|561036945|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
155440117|NCT02975349|561036946|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
155440118|NCT02975349|561036947|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
155440119|NCT02975349|561036948|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
155440120|NCT00969618|561036954|FG000|Overall Study|Adverse Event|29|||
155440121|NCT00969618|561036954|FG000|Overall Study|Entry Criteria Not Met|3|||
155440122|NCT00969618|561036954|FG000|Overall Study|Lack of Efficacy|2|||
155440123|NCT00969618|561036954|FG000|Overall Study|Lost to Follow-up|7|||
155440124|NCT00969618|561036954|FG000|Overall Study|Physician Decision|1|||
155440125|NCT00969618|561036954|FG000|Overall Study|Protocol Violation|9|||
155440126|NCT00969618|561036954|FG000|Overall Study|Withdrawal by Subject|27|||
155440127|NCT00907738|561036957|FG000|Overall Study|Adverse Event|2|||
155440128|NCT00907738|561036958|FG001|Overall Study|Adverse Event|0|||
155440129|NCT00907738|561036959|FG002|Overall Study|Adverse Event|1|||
155514911|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
155514912|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
155514913|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514914|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514915|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514916|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155440130|NCT00907738|561036960|FG003|Overall Study|Adverse Event|0|||
155440131|NCT00907738|561036961|FG004|Overall Study|Adverse Event|0|||
155440132|NCT00907738|561036957|FG000|Overall Study|not specified or withdrew consent|3|||
155440133|NCT00907738|561036958|FG001|Overall Study|not specified or withdrew consent|0|||
155440134|NCT00907738|561036959|FG002|Overall Study|not specified or withdrew consent|0|||
155440135|NCT00907738|561036960|FG003|Overall Study|not specified or withdrew consent|0|||
155440136|NCT00907738|561036961|FG004|Overall Study|not specified or withdrew consent|0|||
155440137|NCT00907738|561036957|FG000|Overall Study|Disease progression|8|||
155440138|NCT00907738|561036958|FG001|Overall Study|Disease progression|1|||
155440139|NCT00907738|561036959|FG002|Overall Study|Disease progression|6|||
155440140|NCT00907738|561036960|FG003|Overall Study|Disease progression|4|||
155440141|NCT00907738|561036961|FG004|Overall Study|Disease progression|2|||
155440142|NCT05363293|561036962|FG000|Overall Study|Withdrawal by Subject|1|||
155440143|NCT05363293|561036963|FG001|Overall Study|Withdrawal by Subject|0|||
155440144|NCT05363293|561036964|FG002|Overall Study|Withdrawal by Subject|0|||
155440145|NCT05363293|561036965|FG003|Overall Study|Withdrawal by Subject|0|||
155440146|NCT05363293|561036966|FG004|Overall Study|Withdrawal by Subject|0|||
155440147|NCT05363293|561036967|FG005|Overall Study|Withdrawal by Subject|0|||
155440148|NCT05363293|561036968|FG006|Overall Study|Withdrawal by Subject|0|||
155440149|NCT05363293|561036969|FG007|Overall Study|Withdrawal by Subject|0|||
155440150|NCT05363293|561036970|FG008|Overall Study|Withdrawal by Subject|0|||
155440151|NCT05363293|561036971|FG009|Overall Study|Withdrawal by Subject|0|||
155440152|NCT04773041|561036972|FG000|Overall Study|Unable to data match|1|||
155440153|NCT04773041|561036973|FG001|Overall Study|Unable to data match|0|||
155440154|NCT04773041|561036974|FG002|Overall Study|Unable to data match|0|||
155440155|NCT03270085|561038709|FG000|Overall Study|Withdrawal by Subject|1|||
155440156|NCT03270085|561038710|FG001|Overall Study|Withdrawal by Subject|0|||
155440157|NCT03825042|561038711|FG000|Overall Study|Adverse Event|1|||
155440158|NCT03825042|561038712|FG001|Overall Study|Adverse Event|0|||
155440159|NCT03825042|561038711|FG000|Overall Study|Withdrawal by Subject|1|||
155440160|NCT03825042|561038712|FG001|Overall Study|Withdrawal by Subject|0|||
155440161|NCT01158534|561038719|FG000|Overall Study|Withdrawal by Subject|1|||
155440162|NCT01158534|561038719|FG000|Overall Study|Death|1|||
155440163|NCT01158534|561038719|FG000|Overall Study|Other|1|||
155440164|NCT01666444|561038724|FG000|Overall Study|Did not initiate treatment|2|||
155440165|NCT01666444|561038725|FG001|Overall Study|Did not initiate treatment|1|||
155440166|NCT00950690|561038726|FG000|Overall Study|Death|4|||
155440167|NCT00950690|561038726|FG000|Overall Study|Adverse Event|15|||
155440168|NCT00950690|561038726|FG000|Overall Study|Lack of Efficacy|22|||
155440169|NCT00950690|561038726|FG000|Overall Study|Lost to Follow-up|40|||
155440170|NCT00950690|561038726|FG000|Overall Study|Other|163|||
155440171|NCT01713036|561038727|FG000|Overall Study|Death|1|||
155440172|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
155440173|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
155440174|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
155514917|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
155514918|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155651322|NCT01064622|561814641|FG001|Randomized Phase II|Protocol Violation|1|||
155440175|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
155440176|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
155440177|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
155440178|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
155440179|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
155651323|NCT04359680|561816174|FG000|Overall Study|Withdrawal by Subject|29|||
155514919|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514920|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514921|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514922|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514923|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514924|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514925|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514926|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
155514927|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514928|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514929|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514930|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514931|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155514932|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514933|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155440180|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
155440181|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
155440182|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
155440183|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
155440184|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
155440185|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
155440186|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
155440187|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
155440188|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
155440189|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
155440190|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
155440191|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
155440192|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
155440193|NCT00092547|561038728|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
155440194|NCT00092547|561038729|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
155440195|NCT00092547|561038730|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
155440196|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
155440197|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
155440198|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
155440199|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
155440200|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
155440201|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
155440202|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
155440203|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
155440204|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
155440205|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
155440206|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
155440207|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
155440208|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
155440209|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
155440210|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
155440211|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
155440212|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
155440213|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
155440214|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
155440215|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
155440216|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
155440217|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
155440218|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
155440219|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
155440220|NCT00092547|561038728|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
155440221|NCT00092547|561038729|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
155440222|NCT00092547|561038730|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
155440223|NCT00092547|561038728|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
155440224|NCT00092547|561038729|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
155440225|NCT00092547|561038730|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
155440226|NCT00092547|561038728|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
155440227|NCT00092547|561038729|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
155440228|NCT00092547|561038730|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
155440229|NCT00092547|561038728|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
155440230|NCT00092547|561038729|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
155440231|NCT00092547|561038730|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
155440232|NCT00092547|561038728|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
155440233|NCT00092547|561038729|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
155440234|NCT00092547|561038730|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
155440235|NCT01166659|561038731|FG000|Overall Study|Subject Decision|8|||
155440236|NCT01166659|561038731|FG000|Overall Study|Investigator Decision|2|||
155440237|NCT01166659|561038731|FG000|Overall Study|Death|1|||
155440238|NCT01166659|561038731|FG000|Overall Study|Lost to Follow-up|1|||
155440239|NCT01166659|561038731|FG000|Overall Study|Study Closed at Site|1|||
155440240|NCT00634543|561038735|FG000|Overall Study|Other|1|||
155440241|NCT00634543|561038736|FG001|Overall Study|Other|2|||
155440242|NCT00634543|561038735|FG000|Overall Study|Protocol Violation|3|||
155440243|NCT00634543|561038736|FG001|Overall Study|Protocol Violation|3|||
155440244|NCT00634543|561038735|FG000|Overall Study|Adverse Event|11|||
155440245|NCT00634543|561038736|FG001|Overall Study|Adverse Event|11|||
155440246|NCT00634543|561038735|FG000|Overall Study|Withdrawal by Subject|4|||
155440247|NCT00634543|561038736|FG001|Overall Study|Withdrawal by Subject|4|||
155440248|NCT00634543|561038735|FG000|Overall Study|Lost to Follow-up|0|||
155440249|NCT00634543|561038736|FG001|Overall Study|Lost to Follow-up|1|||
155440250|NCT03515538|561038739|FG000|Overall Study|Lack of Efficacy|2|||
155440251|NCT03515538|561038740|FG001|Overall Study|Lack of Efficacy|0|||
155440252|NCT03515538|561038741|FG002|Overall Study|Lack of Efficacy|2|||
155440253|NCT03515538|561038742|FG003|Overall Study|Lack of Efficacy|0|||
155440254|NCT03515538|561038739|FG000|Overall Study|Death|0|||
155440255|NCT03515538|561038740|FG001|Overall Study|Death|0|||
155440256|NCT03515538|561038741|FG002|Overall Study|Death|1|||
155440257|NCT03515538|561038742|FG003|Overall Study|Death|0|||
155440258|NCT03515538|561038739|FG000|Overall Study|Protocol Violation|0|||
155440259|NCT03515538|561038740|FG001|Overall Study|Protocol Violation|0|||
155440260|NCT03515538|561038741|FG002|Overall Study|Protocol Violation|0|||
155440261|NCT03515538|561038742|FG003|Overall Study|Protocol Violation|1|||
155440262|NCT03515538|561038739|FG000|Overall Study|Screen failure (baseline dropout)|0|||
155440263|NCT03515538|561038740|FG001|Overall Study|Screen failure (baseline dropout)|1|||
155440264|NCT03515538|561038741|FG002|Overall Study|Screen failure (baseline dropout)|0|||
155440265|NCT03515538|561038742|FG003|Overall Study|Screen failure (baseline dropout)|0|||
155440266|NCT03515538|561038739|FG000|Overall Study|Withdrawal by Subject|2|||
155440267|NCT03515538|561038740|FG001|Overall Study|Withdrawal by Subject|2|||
155440268|NCT03515538|561038741|FG002|Overall Study|Withdrawal by Subject|1|||
155440269|NCT03515538|561038742|FG003|Overall Study|Withdrawal by Subject|3|||
155440270|NCT03515538|561038739|FG000|Overall Study|Physician Decision|1|||
155440271|NCT03515538|561038740|FG001|Overall Study|Physician Decision|0|||
155440272|NCT03515538|561038741|FG002|Overall Study|Physician Decision|0|||
155440273|NCT03515538|561038742|FG003|Overall Study|Physician Decision|1|||
155440274|NCT00915005|561038751|FG000|Overall Study|Withdrawal by Subject|4|||
155440275|NCT00915005|561038752|FG001|Overall Study|Withdrawal by Subject|4|||
155440276|NCT00915005|561038751|FG000|Overall Study|Patient preferred protons therapy|6|||
155440277|NCT00915005|561038752|FG001|Overall Study|Patient preferred protons therapy|0|||
155440278|NCT00915005|561038751|FG000|Overall Study|Insurance denial|3|||
155514934|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514935|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
155651324|NCT04359680|561816175|FG001|Overall Study|Withdrawal by Subject|24|||
155440279|NCT00915005|561038752|FG001|Overall Study|Insurance denial|15|||
155440280|NCT00090285|561038755|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
155440281|NCT00090285|561038756|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
155440282|NCT00090285|561038757|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155440283|NCT00090285|561038758|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155514936|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514937|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514938|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514939|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514940|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155440284|NCT00090285|561038759|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155440285|NCT00090285|561038760|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155440286|NCT00090285|561038755|FG000|Base Study Vaccination Period|Adverse Event|2|||
155440287|NCT00090285|561038756|FG001|Base Study Vaccination Period|Adverse Event|4|||
155440288|NCT00090285|561038757|FG002|Base Study Vaccination Period|Adverse Event|0|||
155440289|NCT00090285|561038758|FG003|Base Study Vaccination Period|Adverse Event|0|||
155440290|NCT00090285|561038759|FG004|Base Study Vaccination Period|Adverse Event|0|||
155440291|NCT00090285|561038760|FG005|Base Study Vaccination Period|Adverse Event|0|||
155440292|NCT00090285|561038755|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
155440293|NCT00090285|561038756|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
155440294|NCT00090285|561038757|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
155440295|NCT00090285|561038758|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
155440296|NCT00090285|561038759|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155440297|NCT00090285|561038760|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
155440298|NCT00090285|561038755|FG000|Base Study Vaccination Period|Protocol Violation|2|||
155440299|NCT00090285|561038756|FG001|Base Study Vaccination Period|Protocol Violation|3|||
155440300|NCT00090285|561038757|FG002|Base Study Vaccination Period|Protocol Violation|0|||
155440301|NCT00090285|561038758|FG003|Base Study Vaccination Period|Protocol Violation|0|||
155440302|NCT00090285|561038759|FG004|Base Study Vaccination Period|Protocol Violation|0|||
155440303|NCT00090285|561038760|FG005|Base Study Vaccination Period|Protocol Violation|0|||
155440304|NCT00090285|561038755|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
155440305|NCT00090285|561038756|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
155440306|NCT00090285|561038757|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
155440307|NCT00090285|561038758|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
155440308|NCT00090285|561038759|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155440309|NCT00090285|561038760|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
155440310|NCT00090285|561038755|FG000|Base Study Vaccination Period|Uncooperative|2|||
155440311|NCT00090285|561038756|FG001|Base Study Vaccination Period|Uncooperative|2|||
155440312|NCT00090285|561038757|FG002|Base Study Vaccination Period|Uncooperative|0|||
155440313|NCT00090285|561038758|FG003|Base Study Vaccination Period|Uncooperative|0|||
155440314|NCT00090285|561038759|FG004|Base Study Vaccination Period|Uncooperative|0|||
155440315|NCT00090285|561038760|FG005|Base Study Vaccination Period|Uncooperative|0|||
155440316|NCT00090285|561038755|FG000|Base Study Vaccination Period|Moved|20|||
155440317|NCT00090285|561038756|FG001|Base Study Vaccination Period|Moved|21|||
155440318|NCT00090285|561038757|FG002|Base Study Vaccination Period|Moved|0|||
155440319|NCT00090285|561038758|FG003|Base Study Vaccination Period|Moved|0|||
155440320|NCT00090285|561038759|FG004|Base Study Vaccination Period|Moved|0|||
155440321|NCT00090285|561038760|FG005|Base Study Vaccination Period|Moved|0|||
155440322|NCT00090285|561038755|FG000|Base Study Vaccination Period|Site Terminated|1|||
155440323|NCT00090285|561038756|FG001|Base Study Vaccination Period|Site Terminated|0|||
155440324|NCT00090285|561038757|FG002|Base Study Vaccination Period|Site Terminated|0|||
155440325|NCT00090285|561038758|FG003|Base Study Vaccination Period|Site Terminated|0|||
155440326|NCT00090285|561038759|FG004|Base Study Vaccination Period|Site Terminated|0|||
155440327|NCT00090285|561038760|FG005|Base Study Vaccination Period|Site Terminated|0|||
155440328|NCT00090285|561038755|FG000|Base Study Vaccination Period|Other|2|||
155440329|NCT00090285|561038756|FG001|Base Study Vaccination Period|Other|2|||
155440330|NCT00090285|561038757|FG002|Base Study Vaccination Period|Other|0|||
155440331|NCT00090285|561038758|FG003|Base Study Vaccination Period|Other|0|||
155440332|NCT00090285|561038759|FG004|Base Study Vaccination Period|Other|0|||
155440333|NCT00090285|561038760|FG005|Base Study Vaccination Period|Other|0|||
155440334|NCT00090285|561038755|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
155440335|NCT00090285|561038756|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
155440336|NCT00090285|561038757|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
155440337|NCT00090285|561038758|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
155440338|NCT00090285|561038759|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
155440339|NCT00090285|561038760|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
155440340|NCT00090285|561038755|FG000|Base Study Vaccination Period|HIV positive|1|||
155440341|NCT00090285|561038756|FG001|Base Study Vaccination Period|HIV positive|1|||
155440342|NCT00090285|561038757|FG002|Base Study Vaccination Period|HIV positive|0|||
155440343|NCT00090285|561038758|FG003|Base Study Vaccination Period|HIV positive|0|||
155440344|NCT00090285|561038759|FG004|Base Study Vaccination Period|HIV positive|0|||
155440345|NCT00090285|561038760|FG005|Base Study Vaccination Period|HIV positive|0|||
155440346|NCT00090285|561038755|FG000|Base Study Follow-up Period|Adverse Event|3|||
155440347|NCT00090285|561038756|FG001|Base Study Follow-up Period|Adverse Event|10|||
155440348|NCT00090285|561038757|FG002|Base Study Follow-up Period|Adverse Event|0|||
155440349|NCT00090285|561038758|FG003|Base Study Follow-up Period|Adverse Event|0|||
155440350|NCT00090285|561038759|FG004|Base Study Follow-up Period|Adverse Event|0|||
155651325|NCT04359680|561816174|FG000|Overall Study|Adverse Event|6|||
155651326|NCT04359680|561816175|FG001|Overall Study|Adverse Event|2|||
155651327|NCT04359680|561816174|FG000|Overall Study|Lost to Follow-up|56|||
155440351|NCT00090285|561038760|FG005|Base Study Follow-up Period|Adverse Event|0|||
155440352|NCT00090285|561038755|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
155440353|NCT00090285|561038756|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
155440354|NCT00090285|561038757|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
155440355|NCT00090285|561038758|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
155440356|NCT00090285|561038759|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
155440357|NCT00090285|561038760|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
155440358|NCT00090285|561038755|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
155440359|NCT00090285|561038756|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
155440360|NCT00090285|561038757|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
155440361|NCT00090285|561038758|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
155440362|NCT00090285|561038759|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
155440363|NCT00090285|561038760|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
155440364|NCT00090285|561038755|FG000|Base Study Follow-up Period|Moved|41|||
155440365|NCT00090285|561038756|FG001|Base Study Follow-up Period|Moved|36|||
155440366|NCT00090285|561038757|FG002|Base Study Follow-up Period|Moved|0|||
155440367|NCT00090285|561038758|FG003|Base Study Follow-up Period|Moved|0|||
155440368|NCT00090285|561038759|FG004|Base Study Follow-up Period|Moved|0|||
155440369|NCT00090285|561038760|FG005|Base Study Follow-up Period|Moved|0|||
155440370|NCT00090285|561038755|FG000|Base Study Follow-up Period|Other|2|||
155440371|NCT00090285|561038756|FG001|Base Study Follow-up Period|Other|0|||
155440372|NCT00090285|561038757|FG002|Base Study Follow-up Period|Other|0|||
155440373|NCT00090285|561038758|FG003|Base Study Follow-up Period|Other|0|||
155440374|NCT00090285|561038759|FG004|Base Study Follow-up Period|Other|0|||
155440375|NCT00090285|561038760|FG005|Base Study Follow-up Period|Other|0|||
155440376|NCT00090285|561038755|FG000|Base Study Follow-up Period|Protocol Violation|1|||
155440377|NCT00090285|561038756|FG001|Base Study Follow-up Period|Protocol Violation|0|||
155440378|NCT00090285|561038757|FG002|Base Study Follow-up Period|Protocol Violation|0|||
155440379|NCT00090285|561038758|FG003|Base Study Follow-up Period|Protocol Violation|0|||
155440380|NCT00090285|561038759|FG004|Base Study Follow-up Period|Protocol Violation|0|||
155440381|NCT00090285|561038760|FG005|Base Study Follow-up Period|Protocol Violation|0|||
155440382|NCT00090285|561038755|FG000|Base Study Follow-up Period|Uncooperative|3|||
155440383|NCT00090285|561038756|FG001|Base Study Follow-up Period|Uncooperative|4|||
155440384|NCT00090285|561038757|FG002|Base Study Follow-up Period|Uncooperative|0|||
155440385|NCT00090285|561038758|FG003|Base Study Follow-up Period|Uncooperative|0|||
155440386|NCT00090285|561038759|FG004|Base Study Follow-up Period|Uncooperative|0|||
155440387|NCT00090285|561038760|FG005|Base Study Follow-up Period|Uncooperative|0|||
155440388|NCT00090285|561038755|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
155440389|NCT00090285|561038756|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
155440390|NCT00090285|561038757|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
155440391|NCT00090285|561038758|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
155440392|NCT00090285|561038759|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
155440393|NCT00090285|561038760|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
155440394|NCT00090285|561038755|FG000|Extension 1|Adverse Event|0|||
155440395|NCT00090285|561038756|FG001|Extension 1|Adverse Event|0|||
155440396|NCT00090285|561038757|FG002|Extension 1|Adverse Event|2|||
155440397|NCT00090285|561038758|FG003|Extension 1|Adverse Event|0|||
155440398|NCT00090285|561038759|FG004|Extension 1|Adverse Event|0|||
155440399|NCT00090285|561038760|FG005|Extension 1|Adverse Event|0|||
155440400|NCT00090285|561038755|FG000|Extension 1|Lost to Follow-up|0|||
155440401|NCT00090285|561038756|FG001|Extension 1|Lost to Follow-up|0|||
155440402|NCT00090285|561038757|FG002|Extension 1|Lost to Follow-up|35|||
155440403|NCT00090285|561038758|FG003|Extension 1|Lost to Follow-up|0|||
155440404|NCT00090285|561038759|FG004|Extension 1|Lost to Follow-up|0|||
155440405|NCT00090285|561038760|FG005|Extension 1|Lost to Follow-up|0|||
155440406|NCT00090285|561038755|FG000|Extension 1|Withdrawal by Subject|0|||
155440407|NCT00090285|561038756|FG001|Extension 1|Withdrawal by Subject|0|||
155440408|NCT00090285|561038757|FG002|Extension 1|Withdrawal by Subject|13|||
155440409|NCT00090285|561038758|FG003|Extension 1|Withdrawal by Subject|1|||
155440410|NCT00090285|561038759|FG004|Extension 1|Withdrawal by Subject|0|||
155440411|NCT00090285|561038760|FG005|Extension 1|Withdrawal by Subject|0|||
155440412|NCT00090285|561038755|FG000|Extension 1|Other|0|||
155440413|NCT00090285|561038756|FG001|Extension 1|Other|0|||
155440414|NCT00090285|561038757|FG002|Extension 1|Other|4|||
155440415|NCT00090285|561038758|FG003|Extension 1|Other|0|||
155440416|NCT00090285|561038759|FG004|Extension 1|Other|0|||
155440417|NCT00090285|561038760|FG005|Extension 1|Other|0|||
155440418|NCT00090285|561038755|FG000|Extension 1|Moved|0|||
155440419|NCT00090285|561038756|FG001|Extension 1|Moved|0|||
155440420|NCT00090285|561038757|FG002|Extension 1|Moved|3|||
155440421|NCT00090285|561038758|FG003|Extension 1|Moved|0|||
155440422|NCT00090285|561038759|FG004|Extension 1|Moved|0|||
155440423|NCT00090285|561038760|FG005|Extension 1|Moved|0|||
155440424|NCT00090285|561038755|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
155440425|NCT00090285|561038756|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
155440426|NCT00090285|561038757|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
155440427|NCT00090285|561038758|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
155440428|NCT00090285|561038759|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
155440429|NCT00090285|561038760|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
155440430|NCT00090285|561038755|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155440431|NCT00090285|561038756|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155440432|NCT00090285|561038757|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155440433|NCT00090285|561038758|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155440434|NCT00090285|561038759|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
155440435|NCT00090285|561038760|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
155440436|NCT00090285|561038755|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155440437|NCT00090285|561038756|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155440438|NCT00090285|561038757|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155440439|NCT00090285|561038758|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155440440|NCT00090285|561038759|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
155440441|NCT00090285|561038760|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
155440442|NCT00090285|561038755|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
155440443|NCT00090285|561038756|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
155440444|NCT00090285|561038757|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
155514941|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514942|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514943|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514944|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155440445|NCT00090285|561038758|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
155440446|NCT00090285|561038759|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
155440447|NCT00090285|561038760|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
155440448|NCT01936649|561038761|FG000|Overall Study|Withdrawal by Subject|4|||
155440449|NCT01936649|561038761|FG000|Overall Study|Physician Decision|2|||
155440450|NCT01936649|561038761|FG000|Overall Study|Protocol Violation|2|||
155440451|NCT01936649|561038761|FG000|Overall Study|Other than specified above|5|||
155440452|NCT00631488|561038766|FG000|Overall Study|Adverse Event|1|||
155440453|NCT00631488|561038767|FG001|Overall Study|Adverse Event|0|||
155440454|NCT00631488|561038768|FG002|Overall Study|Adverse Event|0|||
155440455|NCT00631488|561038766|FG000|Overall Study|Lost to Follow-up|2|||
155440456|NCT00631488|561038767|FG001|Overall Study|Lost to Follow-up|2|||
155440457|NCT00631488|561038768|FG002|Overall Study|Lost to Follow-up|0|||
155440458|NCT00631488|561038766|FG000|Overall Study|Physician Decision|1|||
155440459|NCT00631488|561038767|FG001|Overall Study|Physician Decision|0|||
155440460|NCT00631488|561038768|FG002|Overall Study|Physician Decision|1|||
155440461|NCT00631488|561038766|FG000|Overall Study|Protocol Violation|0|||
155440462|NCT00631488|561038767|FG001|Overall Study|Protocol Violation|0|||
155440463|NCT00631488|561038768|FG002|Overall Study|Protocol Violation|1|||
155440464|NCT03648476|561038769|FG000|Overall Study|Withdrawal by Subject|2|||
155440465|NCT03648476|561038770|FG001|Overall Study|Withdrawal by Subject|1|||
155440466|NCT02855411|561038776|FG000|Overall Study|Study terminated by sponsor|21|||
155440467|NCT02855411|561038776|FG000|Overall Study|Does not meet entrance criteria|14|||
155440468|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
155440469|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
155440470|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
155440471|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155440472|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155440473|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155440474|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155440475|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
155440476|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
155440477|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
155440478|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
155440479|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155440480|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155440481|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155440482|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155440483|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
155440484|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
155440485|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
155440486|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
155440487|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155440488|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155440489|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155440490|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155440491|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
155440492|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
155440493|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
155651328|NCT04359680|561816175|FG001|Overall Study|Lost to Follow-up|59|||
155651329|NCT04359680|561816174|FG000|Overall Study|Protocol Violation|3|||
155651330|NCT04359680|561816175|FG001|Overall Study|Protocol Violation|5|||
155651331|NCT04359680|561816174|FG000|Overall Study|Physician Decision|1|||
155651332|NCT04359680|561816175|FG001|Overall Study|Physician Decision|1|||
155651333|NCT04359680|561816174|FG000|Overall Study|Sponsor Decision|0|||
155651334|NCT04359680|561816175|FG001|Overall Study|Sponsor Decision|1|||
155651335|NCT03810365|561816176|FG000|Overall Study|Lost to Follow-up|2|||
155651336|NCT03810365|561816177|FG001|Overall Study|Lost to Follow-up|2|||
155651337|NCT03810365|561816176|FG000|Overall Study|Withdrawal by Subject|4|||
155440494|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440495|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440496|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440497|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440498|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440499|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
155440500|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
155440501|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
155440502|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
155440503|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155440504|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155440505|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155440506|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155440507|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
155440508|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
155440509|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
155440510|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440511|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440512|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440513|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440514|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440515|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
155440516|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
155440517|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
155440518|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440519|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440520|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440521|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440522|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440523|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
155440524|NCT01097616|561038779|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440525|NCT01097616|561038780|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155514945|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
155514946|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514947|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514948|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514949|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514950|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514951|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514952|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514953|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
155514954|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
155514955|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514956|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514957|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514958|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514959|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
155514960|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514961|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514962|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514963|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514964|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514965|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514966|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514967|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
155514968|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514969|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514970|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514971|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514972|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514973|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155514974|NCT04033445|561311517|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514975|NCT04033445|561311518|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514976|NCT04033445|561311519|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514977|NCT04033445|561311520|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155440526|NCT01097616|561038781|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
155440527|NCT01097616|561038782|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440528|NCT01097616|561038783|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440529|NCT01097616|561038784|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440530|NCT01097616|561038785|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440531|NCT01097616|561038786|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155440532|NCT01097616|561038779|FG000|Optional DB EXT Phase|Adverse Event|0|||
155440533|NCT01097616|561038780|FG001|Optional DB EXT Phase|Adverse Event|7|||
155440534|NCT01097616|561038781|FG002|Optional DB EXT Phase|Adverse Event|2|||
155440535|NCT01097616|561038782|FG003|Optional DB EXT Phase|Adverse Event|0|||
155440536|NCT01097616|561038783|FG004|Optional DB EXT Phase|Adverse Event|0|||
155440537|NCT01097616|561038784|FG005|Optional DB EXT Phase|Adverse Event|0|||
155440538|NCT01097616|561038785|FG006|Optional DB EXT Phase|Adverse Event|0|||
155440539|NCT01097616|561038786|FG007|Optional DB EXT Phase|Adverse Event|0|||
155440540|NCT01097616|561038779|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
155440541|NCT01097616|561038780|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
155440542|NCT01097616|561038781|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
155440543|NCT01097616|561038782|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
155440544|NCT01097616|561038783|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
155440545|NCT01097616|561038784|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
155440546|NCT01097616|561038785|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
155440547|NCT01097616|561038786|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
155440548|NCT01097616|561038779|FG000|Optional DB EXT Phase|Protocol Violation|0|||
155440549|NCT01097616|561038780|FG001|Optional DB EXT Phase|Protocol Violation|2|||
155440550|NCT01097616|561038781|FG002|Optional DB EXT Phase|Protocol Violation|3|||
155440551|NCT01097616|561038782|FG003|Optional DB EXT Phase|Protocol Violation|0|||
155440552|NCT01097616|561038783|FG004|Optional DB EXT Phase|Protocol Violation|0|||
155440553|NCT01097616|561038784|FG005|Optional DB EXT Phase|Protocol Violation|0|||
155440554|NCT01097616|561038785|FG006|Optional DB EXT Phase|Protocol Violation|0|||
155440555|NCT01097616|561038786|FG007|Optional DB EXT Phase|Protocol Violation|0|||
155514978|NCT04033445|561311521|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155440556|NCT01097616|561038779|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
155440557|NCT01097616|561038780|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
155440558|NCT01097616|561038781|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
155514979|NCT04033445|561311522|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514980|NCT04033445|561311523|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514981|NCT04033445|561311524|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
155514982|NCT04033445|561311525|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514983|NCT04033445|561311526|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514984|NCT04033445|561311527|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514985|NCT04033445|561311528|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514986|NCT04033445|561311529|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514987|NCT04033445|561311530|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
155514988|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514989|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514990|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514991|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514992|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514993|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514994|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514995|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514996|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
155514997|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
155514998|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
155514999|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
155515000|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
155515001|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
155515002|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515003|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515004|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515005|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515006|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515007|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515008|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515009|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515010|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
155515011|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
155515012|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
155515013|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
155515014|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
155515015|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
155515016|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515017|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515018|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515019|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515020|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515021|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515022|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515023|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515024|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515025|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515026|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
155515027|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
155651338|NCT03810365|561816177|FG001|Overall Study|Withdrawal by Subject|5|||
155651339|NCT02255279|561816178|FG000|Overall Study|Lost to Follow-up|2|||
155651340|NCT02255279|561816179|FG001|Overall Study|Lost to Follow-up|2|||
155651341|NCT02255279|561816178|FG000|Overall Study|Protocol Violation|0|||
155440559|NCT01097616|561038782|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
155440560|NCT01097616|561038783|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
155440561|NCT01097616|561038784|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
155440562|NCT01097616|561038785|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
155440563|NCT01097616|561038786|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
155440564|NCT01097616|561038779|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
155440565|NCT01097616|561038780|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
155440566|NCT01097616|561038781|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
155651342|NCT02255279|561816179|FG001|Overall Study|Protocol Violation|1|||
155440567|NCT01097616|561038782|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
155440568|NCT01097616|561038783|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
155440569|NCT01097616|561038784|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
155440570|NCT01097616|561038785|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
155440571|NCT01097616|561038786|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
155440572|NCT01097616|561038779|FG000|Optional DB EXT Phase|Physician Decision|1|||
155440573|NCT01097616|561038780|FG001|Optional DB EXT Phase|Physician Decision|0|||
155440574|NCT01097616|561038781|FG002|Optional DB EXT Phase|Physician Decision|0|||
155440575|NCT01097616|561038782|FG003|Optional DB EXT Phase|Physician Decision|0|||
155440576|NCT01097616|561038783|FG004|Optional DB EXT Phase|Physician Decision|0|||
155440577|NCT01097616|561038784|FG005|Optional DB EXT Phase|Physician Decision|0|||
155440578|NCT01097616|561038785|FG006|Optional DB EXT Phase|Physician Decision|0|||
155440579|NCT01097616|561038786|FG007|Optional DB EXT Phase|Physician Decision|0|||
155440580|NCT01097616|561038779|FG000|DB RO Phase|Adverse Event|0|||
155440581|NCT01097616|561038780|FG001|DB RO Phase|Adverse Event|0|||
155440582|NCT01097616|561038781|FG002|DB RO Phase|Adverse Event|0|||
155440583|NCT01097616|561038782|FG003|DB RO Phase|Adverse Event|0|||
155440584|NCT01097616|561038783|FG004|DB RO Phase|Adverse Event|0|||
155440585|NCT01097616|561038784|FG005|DB RO Phase|Adverse Event|0|||
155440586|NCT01097616|561038785|FG006|DB RO Phase|Adverse Event|1|||
155440587|NCT01097616|561038786|FG007|DB RO Phase|Adverse Event|0|||
155440588|NCT01097616|561038779|FG000|DB RO Phase|Withdrawal by Subject|0|||
155440589|NCT01097616|561038780|FG001|DB RO Phase|Withdrawal by Subject|0|||
155440590|NCT01097616|561038781|FG002|DB RO Phase|Withdrawal by Subject|0|||
155440591|NCT01097616|561038782|FG003|DB RO Phase|Withdrawal by Subject|0|||
155515028|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
155515029|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
155515030|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515031|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515032|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515033|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515034|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515035|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515036|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515037|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515038|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515039|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155515040|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
155515041|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
155515042|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
155515043|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
155515044|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515045|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515046|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515047|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515048|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515049|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515050|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515051|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515052|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
155515053|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
155515054|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
155515055|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
155515056|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
155515057|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
155515058|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515059|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515060|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515061|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515062|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515063|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155440592|NCT01097616|561038783|FG004|DB RO Phase|Withdrawal by Subject|0|||
155440593|NCT01097616|561038784|FG005|DB RO Phase|Withdrawal by Subject|1|||
155440594|NCT01097616|561038785|FG006|DB RO Phase|Withdrawal by Subject|0|||
155440595|NCT01097616|561038786|FG007|DB RO Phase|Withdrawal by Subject|0|||
155440596|NCT01097616|561038779|FG000|DB RO Phase|Lost to Follow-up|0|||
155440597|NCT01097616|561038780|FG001|DB RO Phase|Lost to Follow-up|0|||
155440598|NCT01097616|561038781|FG002|DB RO Phase|Lost to Follow-up|0|||
155440599|NCT01097616|561038782|FG003|DB RO Phase|Lost to Follow-up|1|||
155440600|NCT01097616|561038783|FG004|DB RO Phase|Lost to Follow-up|1|||
155440601|NCT01097616|561038784|FG005|DB RO Phase|Lost to Follow-up|0|||
155440602|NCT01097616|561038785|FG006|DB RO Phase|Lost to Follow-up|0|||
155440603|NCT01097616|561038786|FG007|DB RO Phase|Lost to Follow-up|1|||
155440604|NCT01097616|561038779|FG000|DB RO Phase|Not Treated in RO|0|||
155440605|NCT01097616|561038780|FG001|DB RO Phase|Not Treated in RO|0|||
155440606|NCT01097616|561038781|FG002|DB RO Phase|Not Treated in RO|0|||
155440607|NCT01097616|561038782|FG003|DB RO Phase|Not Treated in RO|0|||
155440608|NCT01097616|561038783|FG004|DB RO Phase|Not Treated in RO|0|||
155440609|NCT01097616|561038784|FG005|DB RO Phase|Not Treated in RO|1|||
155440610|NCT01097616|561038785|FG006|DB RO Phase|Not Treated in RO|0|||
155440611|NCT01097616|561038786|FG007|DB RO Phase|Not Treated in RO|0|||
155440612|NCT00130208|561038791|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
155440613|NCT00130208|561038792|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
155440614|NCT00130208|561038791|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
155440615|NCT00130208|561038792|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
155440616|NCT00130208|561038791|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
155440617|NCT00130208|561038792|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
155440618|NCT00130208|561038791|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
155440619|NCT00130208|561038792|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
155440620|NCT00130208|561038791|FG000|Maintenance Period (26 Weeks)|Other|1|||
155440621|NCT00130208|561038792|FG001|Maintenance Period (26 Weeks)|Other|1|||
155440622|NCT00130208|561038791|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
155440623|NCT00130208|561038792|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
155440624|NCT00130208|561038791|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
155440625|NCT00130208|561038792|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
155440626|NCT00130208|561038791|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
155440627|NCT00130208|561038792|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
155440628|NCT00130208|561038791|FG000|Washout Period (8 Weeks)|Other|1|||
155440629|NCT00130208|561038792|FG001|Washout Period (8 Weeks)|Other|1|||
155440630|NCT04655586|561038795|FG000|Overall Study|Physician Decision|1|||
155440631|NCT04655586|561038796|FG001|Overall Study|Physician Decision|3|||
155440632|NCT04655586|561038797|FG002|Overall Study|Physician Decision|4|||
155440633|NCT04655586|561038795|FG000|Overall Study|Withdrawal by Subject|1|||
155440634|NCT04655586|561038796|FG001|Overall Study|Withdrawal by Subject|3|||
155440635|NCT04655586|561038797|FG002|Overall Study|Withdrawal by Subject|1|||
155440636|NCT00117338|561038804|FG000|Overall Study|Adverse Event|0|||
155440637|NCT00117338|561038805|FG001|Overall Study|Adverse Event|1|||
155440638|NCT00117338|561038804|FG000|Overall Study|Protocol Violation|3|||
155440639|NCT00117338|561038805|FG001|Overall Study|Protocol Violation|2|||
155440640|NCT00117338|561038804|FG000|Overall Study|Withdrawal by Subject|1|||
155440641|NCT00117338|561038805|FG001|Overall Study|Withdrawal by Subject|0|||
155440642|NCT00117338|561038804|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
155440643|NCT00117338|561038805|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
155515064|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515065|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155651343|NCT02255279|561816178|FG000|Overall Study|Withdrawal by Subject|3|||
155440644|NCT00117338|561038804|FG000|Overall Study|Lack of Efficacy|0|||
155440645|NCT00117338|561038805|FG001|Overall Study|Lack of Efficacy|1|||
155440646|NCT04734873|561038806|FG000|Overall Study|Lost to Follow-up|1|||
155440647|NCT04734873|561038807|FG001|Overall Study|Lost to Follow-up|3|||
155440648|NCT04734873|561038808|FG002|Overall Study|Lost to Follow-up|2|||
155440649|NCT04734873|561038806|FG000|Overall Study|Randomized but not dosed|1|||
155440650|NCT04734873|561038807|FG001|Overall Study|Randomized but not dosed|0|||
155440651|NCT04734873|561038808|FG002|Overall Study|Randomized but not dosed|1|||
155440652|NCT01342640|561038810|FG000|Overall Study|Adverse Event|3|||
155440653|NCT01342640|561038810|FG000|Overall Study|Protocol Violation|16|||
155440654|NCT01342640|561038810|FG000|Overall Study|Lost to Follow-up|21|||
155440655|NCT01342640|561038810|FG000|Overall Study|Other|1|||
155440656|NCT02616029|561038811|FG000|Overall Study|Adverse Event|1|||
155440657|NCT02616029|561038812|FG001|Overall Study|Adverse Event|0|||
155440658|NCT02616029|561038811|FG000|Overall Study|Death|0|||
155440659|NCT02616029|561038812|FG001|Overall Study|Death|1|||
155440660|NCT02616029|561038811|FG000|Overall Study|Protocol Violation|1|||
155440661|NCT02616029|561038812|FG001|Overall Study|Protocol Violation|0|||
155440662|NCT02616029|561038811|FG000|Overall Study|Withdrew Consent|1|||
155440663|NCT02616029|561038812|FG001|Overall Study|Withdrew Consent|0|||
155440664|NCT02616029|561038811|FG000|Overall Study|Enrolled and Never Treated|1|||
155440665|NCT02616029|561038812|FG001|Overall Study|Enrolled and Never Treated|1|||
155440666|NCT00609609|561038813|FG000|Overall Study|Withdrawal by Subject|2|||
155440667|NCT00609609|561038814|FG001|Overall Study|Withdrawal by Subject|0|||
155440668|NCT00609609|561038813|FG000|Overall Study|Progression|4|||
155440669|NCT00609609|561038814|FG001|Overall Study|Progression|2|||
155440670|NCT03988751|561038817|FG000|Overall Study|Withdrawal by Subject|1|||
155440671|NCT03988751|561038818|FG001|Overall Study|Withdrawal by Subject|0|||
155440672|NCT03988751|561038817|FG000|Overall Study|Protocol Violation|0|||
155440673|NCT03988751|561038818|FG001|Overall Study|Protocol Violation|1|||
155440674|NCT00844883|561038819|FG000|Overall Study|Bridged to liver transplant|3|||
155440675|NCT00844883|561038819|FG000|Overall Study|Bridged to resection|1|||
155440676|NCT03065530|561038824|FG000|Overall Study|Lack of Efficacy|1|||
155440677|NCT03065530|561038825|FG001|Overall Study|Lack of Efficacy|1|||
155440678|NCT03065530|561038826|FG002|Overall Study|Lack of Efficacy|0|||
155440679|NCT03065530|561038827|FG003|Overall Study|Lack of Efficacy|1|||
155440680|NCT03065530|561038824|FG000|Overall Study|Protocol Violation|1|||
155440681|NCT03065530|561038825|FG001|Overall Study|Protocol Violation|0|||
155440682|NCT03065530|561038826|FG002|Overall Study|Protocol Violation|1|||
155440683|NCT03065530|561038827|FG003|Overall Study|Protocol Violation|1|||
155440684|NCT00479466|561038830|FG000|Overall Study|Adverse Event|5|||
155440685|NCT00479466|561038831|FG001|Overall Study|Adverse Event|1|||
155440686|NCT00479466|561038832|FG002|Overall Study|Adverse Event|0|||
155440687|NCT00479466|561038833|FG003|Overall Study|Adverse Event|1|||
155440688|NCT00479466|561038834|FG004|Overall Study|Adverse Event|2|||
155440689|NCT00479466|561038835|FG005|Overall Study|Adverse Event|0|||
155440690|NCT00479466|561038830|FG000|Overall Study|Hyperglycemia|0|||
155440691|NCT00479466|561038831|FG001|Overall Study|Hyperglycemia|0|||
155440692|NCT00479466|561038832|FG002|Overall Study|Hyperglycemia|0|||
155440693|NCT00479466|561038833|FG003|Overall Study|Hyperglycemia|0|||
155440694|NCT00479466|561038834|FG004|Overall Study|Hyperglycemia|0|||
155440695|NCT00479466|561038835|FG005|Overall Study|Hyperglycemia|1|||
155440696|NCT00479466|561038830|FG000|Overall Study|Lack of Efficacy|2|||
155440697|NCT00479466|561038831|FG001|Overall Study|Lack of Efficacy|0|||
155440698|NCT00479466|561038832|FG002|Overall Study|Lack of Efficacy|1|||
155440699|NCT00479466|561038833|FG003|Overall Study|Lack of Efficacy|0|||
155440700|NCT00479466|561038834|FG004|Overall Study|Lack of Efficacy|0|||
155440701|NCT00479466|561038835|FG005|Overall Study|Lack of Efficacy|0|||
155440702|NCT00479466|561038830|FG000|Overall Study|Lost to Follow-up|0|||
155440703|NCT00479466|561038831|FG001|Overall Study|Lost to Follow-up|1|||
155440704|NCT00479466|561038832|FG002|Overall Study|Lost to Follow-up|1|||
155440705|NCT00479466|561038833|FG003|Overall Study|Lost to Follow-up|0|||
155440706|NCT00479466|561038834|FG004|Overall Study|Lost to Follow-up|2|||
155440707|NCT00479466|561038835|FG005|Overall Study|Lost to Follow-up|2|||
155440708|NCT00479466|561038830|FG000|Overall Study|Physician Decision|2|||
155440709|NCT00479466|561038831|FG001|Overall Study|Physician Decision|1|||
155440710|NCT00479466|561038832|FG002|Overall Study|Physician Decision|1|||
155440711|NCT00479466|561038833|FG003|Overall Study|Physician Decision|0|||
155440712|NCT00479466|561038834|FG004|Overall Study|Physician Decision|0|||
155440713|NCT00479466|561038835|FG005|Overall Study|Physician Decision|0|||
155440714|NCT00479466|561038830|FG000|Overall Study|Pregnancy|0|||
155606761|NCT01420679|561649555|FG000|Overall Study|Investigator Decision|1|||
155440715|NCT00479466|561038831|FG001|Overall Study|Pregnancy|0|||
155606762|NCT01420679|561649556|FG001|Overall Study|Investigator Decision|2|||
155606763|NCT01420679|561649555|FG000|Overall Study|Sponsor Decision|3|||
155606764|NCT01420679|561649556|FG001|Overall Study|Sponsor Decision|3|||
155606765|NCT01420679|561649555|FG000|Overall Study|Other|1|||
155606766|NCT01420679|561649556|FG001|Overall Study|Other|0|||
155606767|NCT00412217|561649557|FG000|Overall Study|Insufficient Data Available|8|||
155606768|NCT00412217|561649558|FG001|Overall Study|Insufficient Data Available|3|||
155606769|NCT00412217|561649557|FG000|Overall Study|Death|5|||
155606770|NCT00412217|561649558|FG001|Overall Study|Death|4|||
155606771|NCT00412217|561649557|FG000|Overall Study|Disease Progression|2|||
155606772|NCT00412217|561649558|FG001|Overall Study|Disease Progression|3|||
155606773|NCT00412217|561649557|FG000|Overall Study|Investigator Decision|1|||
155606774|NCT00412217|561649558|FG001|Overall Study|Investigator Decision|0|||
155440716|NCT00479466|561038832|FG002|Overall Study|Pregnancy|0|||
155440717|NCT00479466|561038833|FG003|Overall Study|Pregnancy|0|||
155440718|NCT00479466|561038834|FG004|Overall Study|Pregnancy|1|||
155440719|NCT00479466|561038835|FG005|Overall Study|Pregnancy|0|||
155440720|NCT00479466|561038830|FG000|Overall Study|Protocol Violation|1|||
155440721|NCT00479466|561038831|FG001|Overall Study|Protocol Violation|0|||
155440722|NCT00479466|561038832|FG002|Overall Study|Protocol Violation|0|||
155440723|NCT00479466|561038833|FG003|Overall Study|Protocol Violation|0|||
155440724|NCT00479466|561038834|FG004|Overall Study|Protocol Violation|0|||
155440725|NCT00479466|561038835|FG005|Overall Study|Protocol Violation|0|||
155440726|NCT00479466|561038830|FG000|Overall Study|Withdrawal by Subject|3|||
155440727|NCT00479466|561038831|FG001|Overall Study|Withdrawal by Subject|5|||
155440728|NCT00479466|561038832|FG002|Overall Study|Withdrawal by Subject|0|||
155440729|NCT00479466|561038833|FG003|Overall Study|Withdrawal by Subject|2|||
155440730|NCT00479466|561038834|FG004|Overall Study|Withdrawal by Subject|3|||
155440731|NCT00479466|561038835|FG005|Overall Study|Withdrawal by Subject|1|||
155440732|NCT02927171|561038836|FG000|Overall Study|Lost to Follow-up|0|||
155440733|NCT02927171|561038837|FG001|Overall Study|Lost to Follow-up|1|||
155440734|NCT04530825|561038842|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
155440735|NCT04530825|561038843|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
155440736|NCT04530825|561038844|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
155440737|NCT04530825|561038845|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
155440738|NCT04530825|561038842|FG000|Overall Study|Did not complete follow-up|3|||
155440739|NCT04530825|561038843|FG001|Overall Study|Did not complete follow-up|0|||
155440740|NCT04530825|561038844|FG002|Overall Study|Did not complete follow-up|0|||
155440741|NCT04530825|561038845|FG003|Overall Study|Did not complete follow-up|0|||
155440742|NCT04101422|561038847|FG000|Overall Study|Ineligible|1|||
155440743|NCT04101422|561038848|FG001|Overall Study|Ineligible|0|||
155440744|NCT04101422|561038849|FG002|Overall Study|Ineligible|9|||
155440745|NCT04101422|561038850|FG003|Overall Study|Ineligible|0|||
155440746|NCT04101422|561038847|FG000|Overall Study|Withdrawal by Subject|0|||
155440747|NCT04101422|561038848|FG001|Overall Study|Withdrawal by Subject|0|||
155440748|NCT04101422|561038849|FG002|Overall Study|Withdrawal by Subject|1|||
155440749|NCT04101422|561038850|FG003|Overall Study|Withdrawal by Subject|0|||
155440750|NCT04101422|561038847|FG000|Overall Study|Not attending to the stimuli|0|||
155440751|NCT04101422|561038848|FG001|Overall Study|Not attending to the stimuli|0|||
155440752|NCT04101422|561038849|FG002|Overall Study|Not attending to the stimuli|4|||
155440753|NCT04101422|561038850|FG003|Overall Study|Not attending to the stimuli|0|||
155440754|NCT04101422|561038847|FG000|Overall Study|Did not download app|0|||
155440755|NCT04101422|561038848|FG001|Overall Study|Did not download app|0|||
155515066|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515067|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515068|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515069|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515070|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155515071|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
155515072|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515073|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515074|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515075|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
155440756|NCT04101422|561038849|FG002|Overall Study|Did not download app|0|||
155440757|NCT04101422|561038850|FG003|Overall Study|Did not download app|17|||
155440758|NCT04101422|561038847|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
155440759|NCT04101422|561038848|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
155440760|NCT04101422|561038849|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
155440761|NCT04101422|561038850|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
155440762|NCT00850499|561038851|FG000|Overall Study|Adverse Event|3|||
155440763|NCT00850499|561038852|FG001|Overall Study|Adverse Event|1|||
155440764|NCT00850499|561038851|FG000|Overall Study|Lack of Efficacy|0|||
155440765|NCT00850499|561038852|FG001|Overall Study|Lack of Efficacy|1|||
155440766|NCT00552305|561038853|FG000|Overall Study|Adverse Event|43|||
155440767|NCT00552305|561038853|FG000|Overall Study|Lack of Efficacy|120|||
155440768|NCT00552305|561038853|FG000|Overall Study|Lost to Follow-up|4|||
155440769|NCT00552305|561038853|FG000|Overall Study|Protocol Violation|3|||
155515076|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515077|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
155651344|NCT02255279|561816179|FG001|Overall Study|Withdrawal by Subject|6|||
155440770|NCT00552305|561038853|FG000|Overall Study|Withdrawal by Subject|44|||
155651345|NCT00107614|561816180|FG000|Overall Study|Physician Decision|10|||
155651346|NCT00107614|561816180|FG000|Overall Study|Death|2|||
155440771|NCT00552305|561038853|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
155440772|NCT00552305|561038853|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
155515078|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
155440773|NCT00552305|561038853|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
155440774|NCT00552305|561038853|FG000|Overall Study|Unsatisfactory compliance|11|||
155440775|NCT00552305|561038853|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
155440776|NCT00552305|561038853|FG000|Overall Study|AE/Other: prohibited drug required|1|||
155440777|NCT00552305|561038853|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
155440778|NCT00552305|561038853|FG000|Overall Study|Other: Site closed|4|||
155440779|NCT00552305|561038853|FG000|Overall Study|Other: Personal problems|1|||
155440780|NCT00552305|561038853|FG000|Overall Study|Other: Unable to attend visits|1|||
155440781|NCT00552305|561038853|FG000|Overall Study|Other: Subject underwent surgery|4|||
155440782|NCT00552305|561038853|FG000|Overall Study|Other: Subject became pregnant|1|||
155440783|NCT00552305|561038853|FG000|Overall Study|Other: Health problems, not drug related|1|||
155440784|NCT00552305|561038853|FG000|Overall Study|Other: Subject moved from area|2|||
155440785|NCT00552305|561038853|FG000|Overall Study|Other: Subject incarcerated|1|||
155440786|NCT00552305|561038853|FG000|Overall Study|Other: Subject went to rehab|1|||
155440787|NCT00718861|561038854|FG000|Overall Study|Withdrawal by Subject|15|||
155440788|NCT00718861|561038855|FG001|Overall Study|Withdrawal by Subject|10|||
155440789|NCT00718861|561038854|FG000|Overall Study|Adverse Event|2|||
155440790|NCT00718861|561038855|FG001|Overall Study|Adverse Event|1|||
155440791|NCT00718861|561038854|FG000|Overall Study|Lost to Follow-up|2|||
155440792|NCT00718861|561038855|FG001|Overall Study|Lost to Follow-up|1|||
155440793|NCT00718861|561038854|FG000|Overall Study|Administrative Problems|1|||
155440794|NCT00718861|561038855|FG001|Overall Study|Administrative Problems|1|||
155440795|NCT00718861|561038854|FG000|Overall Study|Death|1|||
155440796|NCT00718861|561038855|FG001|Overall Study|Death|5|||
155440797|NCT01703819|561038856|FG000|Overall Study|Adverse Event|0|||
155440798|NCT01703819|561038857|FG001|Overall Study|Adverse Event|1|||
155440799|NCT01703819|561038856|FG000|Overall Study|Withdrawal by Subject|0|||
155440800|NCT01703819|561038857|FG001|Overall Study|Withdrawal by Subject|1|||
155440801|NCT01302041|561038858|FG000|Overall Study|Death|5|||
155440802|NCT01302041|561038858|FG000|Overall Study|Withdrawal by Subject|4|||
155440803|NCT01302041|561038858|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
155440804|NCT01302041|561038858|FG000|Overall Study|Other-Miscellaneous Reason|2|||
155440805|NCT02234583|561038863|FG000|Overall Study|Adverse Event|172|||
155440806|NCT02234583|561038864|FG001|Overall Study|Adverse Event|156|||
155440807|NCT02234583|561038863|FG000|Overall Study|Withdrawal by Subject|109|||
155440808|NCT02234583|561038864|FG001|Overall Study|Withdrawal by Subject|157|||
155440809|NCT02234583|561038863|FG000|Overall Study|Lost to Follow-up|0|||
155440810|NCT02234583|561038864|FG001|Overall Study|Lost to Follow-up|1|||
155440811|NCT02234583|561038863|FG000|Overall Study|Lack of Efficacy|58|||
155440812|NCT02234583|561038864|FG001|Overall Study|Lack of Efficacy|103|||
155440813|NCT02234583|561038863|FG000|Overall Study|Protocol Violation|35|||
155440814|NCT02234583|561038864|FG001|Overall Study|Protocol Violation|42|||
155440815|NCT02234583|561038863|FG000|Overall Study|Other|39|||
155440816|NCT02234583|561038864|FG001|Overall Study|Other|97|||
155440817|NCT01849250|561038865|FG000|Overall Study|Withdrawal by Subject|1|||
155440818|NCT01849250|561038866|FG001|Overall Study|Withdrawal by Subject|0|||
155440819|NCT01849250|561038865|FG000|Overall Study|Not Evaluable|5|||
155440820|NCT01849250|561038866|FG001|Overall Study|Not Evaluable|3|||
155440821|NCT01849250|561038865|FG000|Overall Study|Screen Failure|1|||
155440822|NCT01849250|561038866|FG001|Overall Study|Screen Failure|0|||
155440823|NCT04504032|561038869|FG000|Overall Study|Adverse Event|1|||
155440824|NCT04504032|561038870|FG001|Overall Study|Adverse Event|2|||
155440825|NCT04504032|561038869|FG000|Overall Study|Lost to Follow-up|6|||
155440826|NCT04504032|561038870|FG001|Overall Study|Lost to Follow-up|9|||
155440827|NCT04504032|561038869|FG000|Overall Study|Protocol Violation|2|||
155440828|NCT04504032|561038870|FG001|Overall Study|Protocol Violation|0|||
155440829|NCT04504032|561038869|FG000|Overall Study|Study terminated by sponsor|1|||
155440830|NCT04504032|561038870|FG001|Overall Study|Study terminated by sponsor|2|||
155440831|NCT04504032|561038869|FG000|Overall Study|Withdrawal by Subject|9|||
155440832|NCT04504032|561038870|FG001|Overall Study|Withdrawal by Subject|11|||
155440833|NCT04504032|561038869|FG000|Overall Study|Disease progression prior to dosing|15|||
155440834|NCT04504032|561038870|FG001|Overall Study|Disease progression prior to dosing|3|||
155440835|NCT04504032|561038869|FG000|Overall Study|Drug supply issues|1|||
155440836|NCT04504032|561038870|FG001|Overall Study|Drug supply issues|1|||
155440837|NCT04504032|561038869|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
155440838|NCT04504032|561038870|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
155440839|NCT00771030|561038871|FG000|Overall Study|Adverse Event|0|||
155440840|NCT00771030|561038872|FG001|Overall Study|Adverse Event|1|||
155440841|NCT00771030|561038873|FG002|Overall Study|Adverse Event|0|||
155440842|NCT00771030|561038874|FG003|Overall Study|Adverse Event|0|||
155440843|NCT00771030|561038875|FG004|Overall Study|Adverse Event|0|||
155440844|NCT00771030|561038876|FG005|Overall Study|Adverse Event|0|||
155440845|NCT00771030|561038877|FG006|Overall Study|Adverse Event|0|||
155440846|NCT01174784|561038878|FG000|Overall Study|Screen fails|4|||
155440847|NCT00465738|561038881|FG000|Overall Study|Lost to Follow-up|2|||
155440848|NCT00465738|561038882|FG001|Overall Study|Lost to Follow-up|0|||
155440849|NCT00465738|561038881|FG000|Overall Study|Adverse Event|0|||
155440850|NCT00465738|561038882|FG001|Overall Study|Adverse Event|1|||
155440851|NCT00465738|561038881|FG000|Overall Study|Withdrawal by Subject|2|||
155440852|NCT00465738|561038882|FG001|Overall Study|Withdrawal by Subject|0|||
155440853|NCT00465738|561038881|FG000|Overall Study|Other|2|||
155440854|NCT00465738|561038882|FG001|Overall Study|Other|5|||
155440855|NCT01318902|561038885|FG000|Overall Study|Symptomatic Deterioration|0|||
155440856|NCT01318902|561038886|FG001|Overall Study|Symptomatic Deterioration|1|||
155440857|NCT01318902|561038887|FG002|Overall Study|Symptomatic Deterioration|1|||
155440858|NCT01318902|561038888|FG003|Overall Study|Symptomatic Deterioration|2|||
155440859|NCT01318902|561038885|FG000|Overall Study|Withdrawal by Patient|0|||
155440860|NCT01318902|561038886|FG001|Overall Study|Withdrawal by Patient|1|||
155440861|NCT01318902|561038887|FG002|Overall Study|Withdrawal by Patient|0|||
155440862|NCT01318902|561038888|FG003|Overall Study|Withdrawal by Patient|3|||
155440863|NCT01318902|561038885|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
155440864|NCT01318902|561038886|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155440865|NCT01318902|561038887|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155440866|NCT01318902|561038888|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
155440867|NCT01318902|561038885|FG000|Overall Study|Adverse Event|0|||
155440868|NCT01318902|561038886|FG001|Overall Study|Adverse Event|1|||
155440869|NCT01318902|561038887|FG002|Overall Study|Adverse Event|0|||
155440870|NCT01318902|561038888|FG003|Overall Study|Adverse Event|0|||
155440871|NCT01318902|561038885|FG000|Overall Study|Terminated by Sponsor|0|||
155440872|NCT01318902|561038886|FG001|Overall Study|Terminated by Sponsor|0|||
155440873|NCT01318902|561038887|FG002|Overall Study|Terminated by Sponsor|1|||
155440874|NCT01318902|561038888|FG003|Overall Study|Terminated by Sponsor|0|||
155440875|NCT04003155|561041375|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
155440876|NCT04003155|561041376|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
155440877|NCT04003155|561041377|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
155440878|NCT04003155|561041378|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
155440879|NCT04003155|561041379|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
155440880|NCT04003155|561041375|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
155440881|NCT04003155|561041376|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
155440882|NCT04003155|561041377|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
155440883|NCT04003155|561041378|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
155440884|NCT04003155|561041379|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
155440885|NCT04003155|561041375|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
155440886|NCT04003155|561041376|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
155440887|NCT04003155|561041377|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
155440888|NCT04003155|561041378|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
155440889|NCT04003155|561041379|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
155440890|NCT04003155|561041375|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
155440891|NCT04003155|561041376|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
155440892|NCT04003155|561041377|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
155440893|NCT04003155|561041378|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
155440894|NCT04003155|561041379|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
155440895|NCT04003155|561041375|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
155440896|NCT04003155|561041376|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
155440897|NCT04003155|561041377|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
155440898|NCT04003155|561041378|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
155440899|NCT04003155|561041379|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
155440900|NCT04003155|561041375|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
155440901|NCT04003155|561041376|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
155440902|NCT04003155|561041377|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
155440903|NCT04003155|561041378|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
155440904|NCT04003155|561041379|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
155440905|NCT04003155|561041375|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
155440906|NCT04003155|561041376|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
155440907|NCT04003155|561041377|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
155440908|NCT04003155|561041378|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
155440909|NCT04003155|561041379|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
155440910|NCT04003155|561041375|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
155440911|NCT04003155|561041376|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
155440912|NCT04003155|561041377|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
155440913|NCT04003155|561041378|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
155440914|NCT04003155|561041379|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
155440915|NCT04003155|561041375|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
155440916|NCT04003155|561041376|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
155440917|NCT04003155|561041377|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
155440918|NCT04003155|561041378|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
155440919|NCT04003155|561041379|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
155440920|NCT01912872|561041380|FG000|Overall Study|Lost to Follow-up|2|||
155440921|NCT01912872|561041381|FG001|Overall Study|Lost to Follow-up|3|||
155440922|NCT01912872|561041382|FG002|Overall Study|Lost to Follow-up|5|||
155440923|NCT01912872|561041383|FG003|Overall Study|Lost to Follow-up|5|||
155440924|NCT01912872|561041380|FG000|Overall Study|Other unspecified|3|||
155440925|NCT01912872|561041381|FG001|Overall Study|Other unspecified|1|||
155440926|NCT01912872|561041382|FG002|Overall Study|Other unspecified|3|||
155440927|NCT01912872|561041383|FG003|Overall Study|Other unspecified|0|||
155440928|NCT01912872|561041380|FG000|Overall Study|Informed consent withdrawn|0|||
155440929|NCT01912872|561041381|FG001|Overall Study|Informed consent withdrawn|0|||
155440930|NCT01912872|561041382|FG002|Overall Study|Informed consent withdrawn|1|||
155440931|NCT01912872|561041383|FG003|Overall Study|Informed consent withdrawn|1|||
155440932|NCT01912872|561041380|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
155440933|NCT01912872|561041381|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
155440934|NCT01912872|561041382|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
155440935|NCT01912872|561041383|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
155440936|NCT01912872|561041380|FG000|Overall Study|Protocol Violation|0|||
155440937|NCT01912872|561041381|FG001|Overall Study|Protocol Violation|0|||
155440938|NCT01912872|561041382|FG002|Overall Study|Protocol Violation|1|||
155440939|NCT01912872|561041383|FG003|Overall Study|Protocol Violation|0|||
155440940|NCT01912872|561041380|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155440941|NCT01912872|561041381|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155440942|NCT01912872|561041382|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155440943|NCT01912872|561041383|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155440944|NCT01912872|561041380|FG000|Overall Study|Withdrawal of study medication|0|||
155440945|NCT01912872|561041381|FG001|Overall Study|Withdrawal of study medication|0|||
155440946|NCT01912872|561041382|FG002|Overall Study|Withdrawal of study medication|0|||
155440947|NCT01912872|561041383|FG003|Overall Study|Withdrawal of study medication|2|||
155440948|NCT01912872|561041380|FG000|Overall Study|Missing|0|||
155440949|NCT01912872|561041381|FG001|Overall Study|Missing|0|||
155440950|NCT01912872|561041382|FG002|Overall Study|Missing|0|||
155440951|NCT01912872|561041383|FG003|Overall Study|Missing|1|||
155440952|NCT00592358|561041388|FG000|Overall Study|Withdrawal by Subject|2|||
155440953|NCT00592358|561041388|FG000|Overall Study|Adverse Event|1|||
155440954|NCT00592358|561041388|FG000|Overall Study|Lack of Efficacy|2|||
155440955|NCT00592358|561041388|FG000|Overall Study|Inability to swallow pills|1|||
155440956|NCT04760314|561041391|FG000|Induction Period|Withdrawal by Subject|0|||
155440957|NCT04760314|561041392|FG001|Induction Period|Withdrawal by Subject|1|||
155440958|NCT04760314|561041393|FG002|Induction Period|Withdrawal by Subject|1|||
155440959|NCT04760314|561041394|FG003|Induction Period|Withdrawal by Subject|0|||
155440960|NCT04760314|561041395|FG004|Induction Period|Withdrawal by Subject|0|||
155440961|NCT04760314|561041396|FG005|Induction Period|Withdrawal by Subject|0|||
155440962|NCT04760314|561041397|FG006|Induction Period|Withdrawal by Subject|0|||
155440963|NCT04760314|561041398|FG007|Induction Period|Withdrawal by Subject|0|||
155440964|NCT04760314|561041399|FG008|Induction Period|Withdrawal by Subject|0|||
155440965|NCT04760314|561041400|FG009|Induction Period|Withdrawal by Subject|0|||
155440966|NCT04760314|561041401|FG010|Induction Period|Withdrawal by Subject|0|||
155440967|NCT04760314|561041391|FG000|Induction Period|Adverse Event|0|||
155440968|NCT04760314|561041392|FG001|Induction Period|Adverse Event|0|||
155440969|NCT04760314|561041393|FG002|Induction Period|Adverse Event|2|||
155440970|NCT04760314|561041394|FG003|Induction Period|Adverse Event|0|||
155440971|NCT04760314|561041395|FG004|Induction Period|Adverse Event|0|||
155440972|NCT04760314|561041396|FG005|Induction Period|Adverse Event|0|||
155440973|NCT04760314|561041397|FG006|Induction Period|Adverse Event|0|||
155440974|NCT04760314|561041398|FG007|Induction Period|Adverse Event|0|||
155440975|NCT04760314|561041399|FG008|Induction Period|Adverse Event|0|||
155440976|NCT04760314|561041400|FG009|Induction Period|Adverse Event|0|||
155440977|NCT04760314|561041401|FG010|Induction Period|Adverse Event|0|||
155440978|NCT04760314|561041391|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440979|NCT04760314|561041392|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440980|NCT04760314|561041393|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440981|NCT04760314|561041394|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
155440982|NCT04760314|561041395|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
155440983|NCT04760314|561041396|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
155440984|NCT04760314|561041397|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
155440985|NCT04760314|561041398|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440986|NCT04760314|561041399|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440987|NCT04760314|561041400|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440988|NCT04760314|561041401|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
155440989|NCT04760314|561041391|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440990|NCT04760314|561041392|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440991|NCT04760314|561041393|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440992|NCT04760314|561041394|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
155440993|NCT04760314|561041395|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440994|NCT04760314|561041396|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
155440995|NCT04760314|561041397|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
155440996|NCT04760314|561041398|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440997|NCT04760314|561041399|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440998|NCT04760314|561041400|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155440999|NCT04760314|561041401|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
155441000|NCT04760314|561041391|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441001|NCT04760314|561041392|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441002|NCT04760314|561041393|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441003|NCT04760314|561041394|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441004|NCT04760314|561041395|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
155441005|NCT04760314|561041396|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441006|NCT04760314|561041397|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441007|NCT04760314|561041398|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441008|NCT04760314|561041399|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441009|NCT04760314|561041400|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441010|NCT04760314|561041401|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
155441011|NCT04760314|561041391|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
155441012|NCT04760314|561041392|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
155441013|NCT04760314|561041393|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
155441014|NCT04760314|561041394|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
155441015|NCT04760314|561041395|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
155441016|NCT04760314|561041396|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
155515079|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515080|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
155515081|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
155515082|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
155515083|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
155515084|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
155515085|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
155515086|NCT04033445|561311517|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515087|NCT04033445|561311518|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515088|NCT04033445|561311519|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515089|NCT04033445|561311520|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515090|NCT04033445|561311521|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515091|NCT04033445|561311522|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515092|NCT04033445|561311523|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515093|NCT04033445|561311524|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515094|NCT04033445|561311525|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515095|NCT04033445|561311526|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
155515096|NCT04033445|561311527|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155515097|NCT04033445|561311528|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
155515098|NCT04033445|561311529|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
155515099|NCT04033445|561311530|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
155441017|NCT04760314|561041397|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
155441018|NCT04760314|561041398|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
155441019|NCT04760314|561041399|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
155441020|NCT04760314|561041400|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
155441021|NCT04760314|561041401|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
155441022|NCT04760314|561041391|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441023|NCT04760314|561041392|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441024|NCT04760314|561041393|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441025|NCT04760314|561041394|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441026|NCT04760314|561041395|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441027|NCT04760314|561041396|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441028|NCT04760314|561041397|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441029|NCT04760314|561041398|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
155441030|NCT04760314|561041399|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155441031|NCT04760314|561041400|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
155441032|NCT04760314|561041401|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
155441033|NCT04760314|561041391|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441034|NCT04760314|561041392|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441035|NCT04760314|561041393|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441036|NCT04760314|561041394|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441037|NCT04760314|561041395|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441038|NCT04760314|561041396|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441039|NCT04760314|561041397|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441040|NCT04760314|561041398|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
155441041|NCT04760314|561041399|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
155441042|NCT04760314|561041400|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
155441043|NCT04760314|561041401|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155441044|NCT04760314|561041391|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441045|NCT04760314|561041392|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441046|NCT04760314|561041393|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441047|NCT04760314|561041394|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441048|NCT04760314|561041395|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441049|NCT04760314|561041396|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155515100|NCT02985957|561311531|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515101|NCT02985957|561311532|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515102|NCT02985957|561311533|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515103|NCT02985957|561311534|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515104|NCT02985957|561311535|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155515105|NCT02985957|561311536|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515106|NCT02985957|561311537|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155515107|NCT02985957|561311531|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
155515108|NCT02985957|561311532|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155441050|NCT04760314|561041397|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441051|NCT04760314|561041398|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
155441052|NCT04760314|561041399|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441053|NCT04760314|561041400|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441054|NCT04760314|561041401|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155441055|NCT04760314|561041391|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441056|NCT04760314|561041392|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441057|NCT04760314|561041393|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441058|NCT04760314|561041394|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441059|NCT04760314|561041395|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441060|NCT04760314|561041396|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441061|NCT04760314|561041397|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441062|NCT04760314|561041398|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441063|NCT04760314|561041399|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
155441064|NCT04760314|561041400|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
155441065|NCT04760314|561041401|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
155441066|NCT01013883|561041407|FG000|Overall Study|Lost to Follow-up|2|||
155441067|NCT01013883|561041408|FG001|Overall Study|Lost to Follow-up|2|||
155441068|NCT01371838|561041409|FG000|Overall Study|Withdrawal by Subject|27|||
155441069|NCT01371838|561041410|FG001|Overall Study|Withdrawal by Subject|33|||
155441070|NCT01371838|561041409|FG000|Overall Study|Lost to Follow-up|10|||
155441071|NCT01371838|561041410|FG001|Overall Study|Lost to Follow-up|20|||
155441072|NCT01371838|561041409|FG000|Overall Study|Death|3|||
155441073|NCT01371838|561041410|FG001|Overall Study|Death|4|||
155441074|NCT01371838|561041409|FG000|Overall Study|Protocol Violation|3|||
155441075|NCT01371838|561041410|FG001|Overall Study|Protocol Violation|0|||
155441076|NCT01371838|561041409|FG000|Overall Study|Investigator Decision|3|||
155441077|NCT01371838|561041410|FG001|Overall Study|Investigator Decision|8|||
155441078|NCT01371838|561041409|FG000|Overall Study|Last follow-up visit not conducted|2|||
155441079|NCT01371838|561041410|FG001|Overall Study|Last follow-up visit not conducted|0|||
155441080|NCT01371838|561041409|FG000|Overall Study|Lack of therapeutic response|0|||
155441081|NCT01371838|561041410|FG001|Overall Study|Lack of therapeutic response|1|||
155441082|NCT01371838|561041409|FG000|Overall Study|Surgery|1|||
155441083|NCT01371838|561041410|FG001|Overall Study|Surgery|0|||
155441084|NCT00641043|561041415|FG000|Overall Study|Adverse Event|6|||
155441085|NCT00641043|561041416|FG001|Overall Study|Adverse Event|4|||
155441086|NCT00641043|561041415|FG000|Overall Study|Protocol Violation|2|||
155441087|NCT00641043|561041416|FG001|Overall Study|Protocol Violation|3|||
155441088|NCT00641043|561041415|FG000|Overall Study|Lost to Follow-up|3|||
155441089|NCT00641043|561041416|FG001|Overall Study|Lost to Follow-up|2|||
155441090|NCT00641043|561041415|FG000|Overall Study|Withdrawal by Subject|4|||
155441091|NCT00641043|561041416|FG001|Overall Study|Withdrawal by Subject|4|||
155441092|NCT00641043|561041415|FG000|Overall Study|Other incl. lack of efficacy|4|||
155441093|NCT00641043|561041416|FG001|Overall Study|Other incl. lack of efficacy|2|||
155441094|NCT04275310|561041419|FG000|Overall Study|Non-randomized due to running out of funding|4|||
155441095|NCT04275310|561041420|FG001|Overall Study|Non-randomized due to running out of funding|0|||
155441096|NCT02345161|561041423|FG000|Overall Study|Withdrawal by Subject|25|||
155441097|NCT02345161|561041424|FG001|Overall Study|Withdrawal by Subject|33|||
155441098|NCT02345161|561041423|FG000|Overall Study|Adverse Event|16|||
155441099|NCT02345161|561041424|FG001|Overall Study|Adverse Event|19|||
155441100|NCT02345161|561041423|FG000|Overall Study|Physician Decision|4|||
155441101|NCT02345161|561041424|FG001|Overall Study|Physician Decision|4|||
155441102|NCT02345161|561041423|FG000|Overall Study|Lost to Follow-up|0|||
155441103|NCT02345161|561041424|FG001|Overall Study|Lost to Follow-up|1|||
155441104|NCT02225223|561041425|FG000|Overall Study|Death|10|||
155441105|NCT02225223|561041426|FG001|Overall Study|Death|1|||
155441106|NCT02225223|561041425|FG000|Overall Study|Lost to Follow-up|5|||
155441107|NCT02225223|561041426|FG001|Overall Study|Lost to Follow-up|0|||
155441108|NCT02225223|561041425|FG000|Overall Study|Other|1|||
155441109|NCT02225223|561041426|FG001|Overall Study|Other|2|||
155441110|NCT02225223|561041425|FG000|Overall Study|Physician Decision|1|||
155441111|NCT02225223|561041426|FG001|Overall Study|Physician Decision|0|||
155441112|NCT02225223|561041425|FG000|Overall Study|Withdrawal by Subject|2|||
155441113|NCT02225223|561041426|FG001|Overall Study|Withdrawal by Subject|2|||
155441114|NCT01650779|561041427|FG000|Overall Study|Withdrawal by Subject|1|||
155515109|NCT02985957|561311533|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
155515110|NCT02985957|561311534|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
155515111|NCT02985957|561311535|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
155441115|NCT03567291|561041428|FG000|Period I|Adverse Event|14|||
155441116|NCT03567291|561041429|FG001|Period I|Adverse Event|0|||
155441117|NCT03567291|561041430|FG002|Period I|Adverse Event|0|||
155441118|NCT03567291|561041431|FG003|Period I|Adverse Event|0|||
155441119|NCT03567291|561041428|FG000|Period I|Protocol Violation|1|||
155441120|NCT03567291|561041429|FG001|Period I|Protocol Violation|0|||
155515112|NCT02985957|561311536|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
155515113|NCT02985957|561311537|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
155441121|NCT03567291|561041430|FG002|Period I|Protocol Violation|0|||
155441122|NCT03567291|561041431|FG003|Period I|Protocol Violation|0|||
155441123|NCT03567291|561041428|FG000|Period I|Withdrawal by Subject|23|||
155441124|NCT03567291|561041429|FG001|Period I|Withdrawal by Subject|0|||
155441125|NCT03567291|561041430|FG002|Period I|Withdrawal by Subject|0|||
155441126|NCT03567291|561041431|FG003|Period I|Withdrawal by Subject|0|||
155441127|NCT03567291|561041428|FG000|Period I|Lost to Follow-up|2|||
155441128|NCT03567291|561041429|FG001|Period I|Lost to Follow-up|0|||
155441129|NCT03567291|561041430|FG002|Period I|Lost to Follow-up|0|||
155441130|NCT03567291|561041431|FG003|Period I|Lost to Follow-up|0|||
155441131|NCT03567291|561041428|FG000|Period I|Terminated by sponsor|44|||
155441132|NCT03567291|561041429|FG001|Period I|Terminated by sponsor|0|||
155441133|NCT03567291|561041430|FG002|Period I|Terminated by sponsor|0|||
155441134|NCT03567291|561041431|FG003|Period I|Terminated by sponsor|0|||
155441135|NCT03567291|561041428|FG000|Period I|Missing or unknown|7|||
155441136|NCT03567291|561041429|FG001|Period I|Missing or unknown|0|||
155441137|NCT03567291|561041430|FG002|Period I|Missing or unknown|0|||
155441138|NCT03567291|561041431|FG003|Period I|Missing or unknown|0|||
155441139|NCT03567291|561041428|FG000|Period II|Adverse Event|0|||
155441140|NCT03567291|561041429|FG001|Period II|Adverse Event|1|||
155441141|NCT03567291|561041430|FG002|Period II|Adverse Event|0|||
155441142|NCT03567291|561041431|FG003|Period II|Adverse Event|0|||
155441143|NCT03567291|561041428|FG000|Period II|Missing or unknown|0|||
155441144|NCT03567291|561041429|FG001|Period II|Missing or unknown|2|||
155441145|NCT03567291|561041430|FG002|Period II|Missing or unknown|1|||
155441146|NCT03567291|561041431|FG003|Period II|Missing or unknown|0|||
155441147|NCT03567291|561041428|FG000|Period III|Adverse Event|0|||
155441148|NCT03567291|561041429|FG001|Period III|Adverse Event|0|||
155441149|NCT03567291|561041430|FG002|Period III|Adverse Event|0|||
155441150|NCT03567291|561041431|FG003|Period III|Adverse Event|4|||
155441151|NCT03567291|561041428|FG000|Period III|Withdrawal by Subject|0|||
155441152|NCT03567291|561041429|FG001|Period III|Withdrawal by Subject|0|||
155441153|NCT03567291|561041430|FG002|Period III|Withdrawal by Subject|0|||
155441154|NCT03567291|561041431|FG003|Period III|Withdrawal by Subject|4|||
155441155|NCT03567291|561041428|FG000|Period III|Lost to Follow-up|0|||
155441156|NCT03567291|561041429|FG001|Period III|Lost to Follow-up|0|||
155441157|NCT03567291|561041430|FG002|Period III|Lost to Follow-up|0|||
155441158|NCT03567291|561041431|FG003|Period III|Lost to Follow-up|1|||
155441159|NCT03567291|561041428|FG000|Period III|Terminated by sponsor|0|||
155441160|NCT03567291|561041429|FG001|Period III|Terminated by sponsor|0|||
155441161|NCT03567291|561041430|FG002|Period III|Terminated by sponsor|0|||
155441162|NCT03567291|561041431|FG003|Period III|Terminated by sponsor|68|||
155441163|NCT03567291|561041428|FG000|Period III|Missing or unknown|0|||
155441164|NCT03567291|561041429|FG001|Period III|Missing or unknown|0|||
155441165|NCT03567291|561041430|FG002|Period III|Missing or unknown|0|||
155441166|NCT03567291|561041431|FG003|Period III|Missing or unknown|8|||
155441167|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
155441168|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
155515114|NCT02985957|561311531|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155515115|NCT02985957|561311532|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155515116|NCT02985957|561311533|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155515117|NCT02985957|561311534|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155651347|NCT01897896|561816184|FG000|Overall Study|Death|1|||
155441169|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
155441170|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
155441171|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
155441172|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
155441173|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
155441174|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
155441175|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
155441176|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
155441177|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
155441178|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
155441179|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
155441180|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
155441181|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
155441182|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
155441183|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
155441184|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
155441185|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
155441186|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
155441187|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
155441188|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
155441189|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
155441190|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
155441191|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
155441192|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
155441193|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
155441194|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
155441195|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
155441196|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
155441197|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
155441198|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
155441199|NCT00958568|561041432|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
155441200|NCT00958568|561041433|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
155441201|NCT00958568|561041434|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
155441202|NCT00958568|561041435|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
155441203|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
155441204|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
155441205|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
155441206|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
155441207|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
155441208|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
155441209|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
155441210|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
155441211|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
155441212|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
155441213|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
155441214|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
155441215|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
155441216|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
155441217|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
155441218|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
155441219|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
155441220|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
155441221|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
155441222|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
155441223|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
155441224|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
155441225|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
155441226|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
155441227|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
155441228|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
155441229|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
155441230|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
155441231|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
155441232|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
155441233|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
155441234|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
155441235|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
155441236|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
155441237|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
155441238|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
155441239|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
155441240|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
155441241|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
155441242|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
155441243|NCT00958568|561041432|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
155441244|NCT00958568|561041433|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
155651348|NCT01897896|561816185|FG001|Overall Study|Death|0|||
155441245|NCT00958568|561041434|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
155441246|NCT00958568|561041435|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
155441247|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
155441248|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
155441249|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
155441250|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
155441251|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
155441252|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
155441253|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
155441254|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
155441255|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
155441256|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
155441257|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
155441258|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
155441259|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
155441260|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
155441261|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
155441262|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
155441263|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
155441264|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
155441265|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
155441266|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
155441267|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
155441268|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
155441269|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
155441270|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
155441271|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
155441272|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
155441273|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
155441274|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
155441275|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
155441276|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
155441277|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
155441278|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
155441279|NCT00958568|561041432|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
155441280|NCT00958568|561041433|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
155441281|NCT00958568|561041434|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
155441282|NCT00958568|561041435|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
155441283|NCT00972244|561041436|FG000|Overall Study|Incorrect Enrolment|1|||
155441284|NCT00972244|561041437|FG001|Overall Study|Incorrect Enrolment|0|||
155441285|NCT00972244|561041438|FG002|Overall Study|Incorrect Enrolment|0|||
155441286|NCT00972244|561041439|FG003|Overall Study|Incorrect Enrolment|0|||
155441287|NCT00972244|561041440|FG004|Overall Study|Incorrect Enrolment|0|||
155441288|NCT00972244|561041436|FG000|Overall Study|Adverse Event|0|||
155441289|NCT00972244|561041437|FG001|Overall Study|Adverse Event|1|||
155441290|NCT00972244|561041438|FG002|Overall Study|Adverse Event|1|||
155441291|NCT00972244|561041439|FG003|Overall Study|Adverse Event|0|||
155441292|NCT00972244|561041440|FG004|Overall Study|Adverse Event|0|||
155441293|NCT00972244|561041436|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
155441294|NCT00972244|561041437|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
155441295|NCT00972244|561041438|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
155441296|NCT00972244|561041439|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
155441297|NCT00972244|561041440|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
155441298|NCT00972244|561041436|FG000|Overall Study|Withdrawal by Subject|1|||
155441299|NCT00972244|561041437|FG001|Overall Study|Withdrawal by Subject|2|||
155441300|NCT00972244|561041438|FG002|Overall Study|Withdrawal by Subject|1|||
155441301|NCT00972244|561041439|FG003|Overall Study|Withdrawal by Subject|0|||
155441302|NCT00972244|561041440|FG004|Overall Study|Withdrawal by Subject|1|||
155441303|NCT00972244|561041436|FG000|Overall Study|Safety|0|||
155441304|NCT00972244|561041437|FG001|Overall Study|Safety|0|||
155441305|NCT00972244|561041438|FG002|Overall Study|Safety|0|||
155441306|NCT00972244|561041439|FG003|Overall Study|Safety|0|||
155441307|NCT00972244|561041440|FG004|Overall Study|Safety|1|||
155441308|NCT00972244|561041436|FG000|Overall Study|Death|1|||
155441309|NCT00972244|561041437|FG001|Overall Study|Death|0|||
155441310|NCT00972244|561041438|FG002|Overall Study|Death|0|||
155441311|NCT00972244|561041439|FG003|Overall Study|Death|0|||
155441312|NCT00972244|561041440|FG004|Overall Study|Death|0|||
155441313|NCT00972244|561041436|FG000|Overall Study|Various|0|||
155441314|NCT00972244|561041437|FG001|Overall Study|Various|0|||
155441315|NCT00972244|561041438|FG002|Overall Study|Various|0|||
155441316|NCT00972244|561041439|FG003|Overall Study|Various|0|||
155441317|NCT00972244|561041440|FG004|Overall Study|Various|2|||
155441318|NCT00907478|561041442|FG000|Overall Study|Ineligibility determined|0|||
155441319|NCT00907478|561041443|FG001|Overall Study|Ineligibility determined|0|||
155441320|NCT00907478|561041444|FG002|Overall Study|Ineligibility determined|1|||
155441321|NCT00907478|561041442|FG000|Overall Study|Noncompliance|0|||
155441322|NCT00907478|561041443|FG001|Overall Study|Noncompliance|0|||
155441323|NCT00907478|561041444|FG002|Overall Study|Noncompliance|1|||
155441324|NCT00907478|561041442|FG000|Overall Study|Adverse Event|3|||
155441325|NCT00907478|561041443|FG001|Overall Study|Adverse Event|1|||
155441326|NCT00907478|561041444|FG002|Overall Study|Adverse Event|2|||
155441327|NCT00907478|561041442|FG000|Overall Study|Withdrawal by Subject|8|||
155441328|NCT00907478|561041443|FG001|Overall Study|Withdrawal by Subject|9|||
155441329|NCT00907478|561041444|FG002|Overall Study|Withdrawal by Subject|6|||
155441330|NCT00907478|561041442|FG000|Overall Study|Requirement for alternative therapy|1|||
155441331|NCT00907478|561041443|FG001|Overall Study|Requirement for alternative therapy|2|||
155441332|NCT00907478|561041444|FG002|Overall Study|Requirement for alternative therapy|3|||
155441333|NCT00907478|561041442|FG000|Overall Study|Physician Decision|2|||
155441334|NCT00907478|561041443|FG001|Overall Study|Physician Decision|0|||
155441335|NCT00907478|561041444|FG002|Overall Study|Physician Decision|3|||
155441336|NCT00907478|561041442|FG000|Overall Study|Death|4|||
155441337|NCT00907478|561041443|FG001|Overall Study|Death|2|||
155441338|NCT00907478|561041444|FG002|Overall Study|Death|1|||
155441339|NCT00907478|561041442|FG000|Overall Study|Protocol-specified criteria|5|||
155441340|NCT00907478|561041443|FG001|Overall Study|Protocol-specified criteria|2|||
155441341|NCT00907478|561041444|FG002|Overall Study|Protocol-specified criteria|3|||
155441342|NCT00907478|561041442|FG000|Overall Study|Pregnancy|0|||
155441343|NCT00907478|561041443|FG001|Overall Study|Pregnancy|1|||
155441344|NCT00907478|561041444|FG002|Overall Study|Pregnancy|1|||
155441345|NCT00907478|561041442|FG000|Overall Study|Lost to Follow-up|1|||
155441346|NCT00907478|561041443|FG001|Overall Study|Lost to Follow-up|0|||
155441347|NCT00907478|561041444|FG002|Overall Study|Lost to Follow-up|0|||
155441348|NCT00907478|561041442|FG000|Overall Study|Other|3|||
155441349|NCT00907478|561041443|FG001|Overall Study|Other|0|||
155441350|NCT00907478|561041444|FG002|Overall Study|Other|1|||
155441351|NCT03554005|561041453|FG000|Overall Study|Not in participant's best interest|0|||
155441352|NCT03554005|561041454|FG001|Overall Study|Not in participant's best interest|0|||
155441353|NCT03554005|561041455|FG002|Overall Study|Not in participant's best interest|0|||
155441354|NCT03554005|561041456|FG003|Overall Study|Not in participant's best interest|0|||
155441355|NCT03554005|561041457|FG004|Overall Study|Not in participant's best interest|0|||
155441356|NCT03554005|561041458|FG005|Overall Study|Not in participant's best interest|1|||
155441357|NCT03554005|561041453|FG000|Overall Study|Disease Progression|1|||
155441358|NCT03554005|561041454|FG001|Overall Study|Disease Progression|1|||
155441359|NCT03554005|561041455|FG002|Overall Study|Disease Progression|1|||
155441360|NCT03554005|561041456|FG003|Overall Study|Disease Progression|1|||
155441361|NCT03554005|561041457|FG004|Overall Study|Disease Progression|5|||
155441362|NCT03554005|561041458|FG005|Overall Study|Disease Progression|6|||
155441363|NCT03554005|561041453|FG000|Overall Study|Adverse Event|0|||
155441364|NCT03554005|561041454|FG001|Overall Study|Adverse Event|0|||
155441365|NCT03554005|561041455|FG002|Overall Study|Adverse Event|0|||
155441366|NCT03554005|561041456|FG003|Overall Study|Adverse Event|0|||
155441367|NCT03554005|561041457|FG004|Overall Study|Adverse Event|0|||
155441368|NCT03554005|561041458|FG005|Overall Study|Adverse Event|3|||
155441369|NCT03554005|561041453|FG000|Overall Study|Physician Decision|0|||
155441370|NCT03554005|561041454|FG001|Overall Study|Physician Decision|0|||
155441371|NCT03554005|561041455|FG002|Overall Study|Physician Decision|0|||
155441372|NCT03554005|561041456|FG003|Overall Study|Physician Decision|0|||
155441373|NCT03554005|561041457|FG004|Overall Study|Physician Decision|1|||
155441374|NCT03554005|561041458|FG005|Overall Study|Physician Decision|0|||
155441375|NCT03554005|561041453|FG000|Overall Study|Other|0|||
155441376|NCT03554005|561041454|FG001|Overall Study|Other|0|||
155441377|NCT03554005|561041455|FG002|Overall Study|Other|0|||
155441378|NCT03554005|561041456|FG003|Overall Study|Other|0|||
155441379|NCT03554005|561041457|FG004|Overall Study|Other|0|||
155441380|NCT03554005|561041458|FG005|Overall Study|Other|1|||
155441381|NCT02639182|561041462|FG000|Overall Study|Disease Progression|50|||
155441382|NCT02639182|561041463|FG001|Overall Study|Disease Progression|49|||
155441383|NCT02639182|561041462|FG000|Overall Study|Adverse Event|7|||
155441384|NCT02639182|561041463|FG001|Overall Study|Adverse Event|5|||
155441385|NCT02639182|561041462|FG000|Overall Study|Physician Decision|3|||
155441386|NCT02639182|561041463|FG001|Overall Study|Physician Decision|3|||
155441387|NCT02639182|561041462|FG000|Overall Study|Withdrew Consent|5|||
155441388|NCT02639182|561041463|FG001|Overall Study|Withdrew Consent|4|||
155441389|NCT02639182|561041462|FG000|Overall Study|Lost to Follow-up|0|||
155441390|NCT02639182|561041463|FG001|Overall Study|Lost to Follow-up|1|||
155441391|NCT02639182|561041462|FG000|Overall Study|Study Closure|1|||
155441392|NCT02639182|561041463|FG001|Overall Study|Study Closure|2|||
155441393|NCT02639182|561041462|FG000|Overall Study|Sponsor Ended Study|0|||
155441394|NCT02639182|561041463|FG001|Overall Study|Sponsor Ended Study|1|||
155441395|NCT02639182|561041462|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
155441396|NCT02639182|561041463|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
155441397|NCT00907881|561041464|FG000|Overall Study|Lost to Follow-up|59|||
155441398|NCT00907881|561041464|FG000|Overall Study|Noncompliance|5|||
155441399|NCT00907881|561041464|FG000|Overall Study|Withdrawal by Subject|5|||
155441400|NCT00907881|561041464|FG000|Overall Study|Protocol Violation|1|||
155441401|NCT00907881|561041464|FG000|Overall Study|Missing discontinuation information|15|||
155441402|NCT02546856|561041467|FG000|4 Months Evaluation|Death|2|||
155441403|NCT02546856|561041468|FG001|4 Months Evaluation|Death|3|||
155441404|NCT02546856|561041467|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
155441405|NCT02546856|561041468|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
155441406|NCT02546856|561041467|FG000|4 Months Evaluation|Lost to Follow-up|3|||
155441407|NCT02546856|561041468|FG001|4 Months Evaluation|Lost to Follow-up|3|||
155441408|NCT02546856|561041467|FG000|4 Months Evaluation|Physician Decision|3|||
155441409|NCT02546856|561041468|FG001|4 Months Evaluation|Physician Decision|0|||
155441410|NCT02546856|561041467|FG000|4 Months Evaluation|Working or living abroad|5|||
155441411|NCT02546856|561041468|FG001|4 Months Evaluation|Working or living abroad|1|||
155441412|NCT02546856|561041467|FG000|4 Months Evaluation|reasons not due to titration|4|||
155441413|NCT02546856|561041468|FG001|4 Months Evaluation|reasons not due to titration|1|||
155441414|NCT02546856|561041467|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
155441415|NCT02546856|561041468|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
155441416|NCT02546856|561041467|FG000|6 Months Evaluation|Death|1|||
155441417|NCT02546856|561041468|FG001|6 Months Evaluation|Death|1|||
155441418|NCT02546856|561041467|FG000|6 Months Evaluation|Lost to Follow-up|1|||
155441419|NCT02546856|561041468|FG001|6 Months Evaluation|Lost to Follow-up|1|||
155441420|NCT02546856|561041467|FG000|6 Months Evaluation|Working or living abroad|6|||
155441421|NCT02546856|561041468|FG001|6 Months Evaluation|Working or living abroad|4|||
155441422|NCT02546856|561041467|FG000|6 Months Evaluation|reasons not due to titration|0|||
155441423|NCT02546856|561041468|FG001|6 Months Evaluation|reasons not due to titration|1|||
155441424|NCT03268746|561041472|FG000|Overall Study|Withdrawal by Subject|1|||
155441425|NCT00589472|561041473|FG000|Overall Study|Adverse Event|1|||
155441426|NCT01372878|561041474|FG000|Overall Study|Withdrawal by Subject|63|||
155441427|NCT01372878|561041474|FG000|Overall Study|Protocol Violation|17|||
155441428|NCT01372878|561041474|FG000|Overall Study|incomplete study procedure|104|||
155441429|NCT01380093|561041475|FG000|Naloxone Challenge Phase|Screen failures|21|||
155441430|NCT01380093|561041476|FG001|Naloxone Challenge Phase|Screen failures|0|||
155441431|NCT01380093|561041477|FG002|Naloxone Challenge Phase|Screen failures|0|||
155515118|NCT02985957|561311535|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155515119|NCT02985957|561311536|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155441432|NCT01380093|561041478|FG003|Naloxone Challenge Phase|Screen failures|0|||
155441433|NCT01380093|561041479|FG004|Naloxone Challenge Phase|Screen failures|0|||
155441434|NCT01380093|561041480|FG005|Naloxone Challenge Phase|Screen failures|0|||
155441435|NCT01380093|561041481|FG006|Naloxone Challenge Phase|Screen failures|0|||
155441436|NCT01380093|561041482|FG007|Naloxone Challenge Phase|Screen failures|0|||
155441437|NCT01380093|561041483|FG008|Naloxone Challenge Phase|Screen failures|0|||
155441438|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441439|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
155441440|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441441|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441442|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441443|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441444|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441445|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441446|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155441447|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441448|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
155441449|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
155441450|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441451|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441452|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441453|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441454|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441455|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155441456|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441457|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
155441458|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441459|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441460|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441461|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441462|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441463|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441464|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155441465|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441466|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
155441467|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
155441468|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441469|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441470|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441471|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441472|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441473|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
155441474|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441475|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
155441476|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
155441477|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441478|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441479|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441480|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441481|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441482|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
155441483|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441484|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441485|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
155441486|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441487|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441488|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441489|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441490|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441491|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
155441492|NCT01380093|561041475|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441493|NCT01380093|561041476|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441494|NCT01380093|561041477|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
155441495|NCT01380093|561041478|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441496|NCT01380093|561041479|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441497|NCT01380093|561041480|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441498|NCT01380093|561041481|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441499|NCT01380093|561041482|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441500|NCT01380093|561041483|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
155441501|NCT01380093|561041475|FG000|Treatment Phase: Second Intervention|Other|0|||
155441502|NCT01380093|561041476|FG001|Treatment Phase: Second Intervention|Other|0|||
155441503|NCT01380093|561041477|FG002|Treatment Phase: Second Intervention|Other|0|||
155441504|NCT01380093|561041478|FG003|Treatment Phase: Second Intervention|Other|1|||
155441505|NCT01380093|561041479|FG004|Treatment Phase: Second Intervention|Other|0|||
155441506|NCT01380093|561041480|FG005|Treatment Phase: Second Intervention|Other|0|||
155441507|NCT01380093|561041481|FG006|Treatment Phase: Second Intervention|Other|0|||
155441508|NCT01380093|561041482|FG007|Treatment Phase: Second Intervention|Other|0|||
155441509|NCT01380093|561041483|FG008|Treatment Phase: Second Intervention|Other|0|||
155441510|NCT01380093|561041475|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
155441511|NCT01380093|561041476|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
155441512|NCT01380093|561041477|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
155441513|NCT01380093|561041478|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
155441514|NCT01380093|561041479|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
155441515|NCT01380093|561041480|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
155441516|NCT01380093|561041481|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
155441517|NCT01380093|561041482|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
155441518|NCT01380093|561041483|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
155441519|NCT01380093|561041475|FG000|Treatment Phase: Third Intervention|Other|0|||
155441520|NCT01380093|561041476|FG001|Treatment Phase: Third Intervention|Other|0|||
155441521|NCT01380093|561041477|FG002|Treatment Phase: Third Intervention|Other|0|||
155441522|NCT01380093|561041478|FG003|Treatment Phase: Third Intervention|Other|0|||
155441523|NCT01380093|561041479|FG004|Treatment Phase: Third Intervention|Other|0|||
155441524|NCT01380093|561041480|FG005|Treatment Phase: Third Intervention|Other|0|||
155441525|NCT01380093|561041481|FG006|Treatment Phase: Third Intervention|Other|0|||
155441526|NCT01380093|561041482|FG007|Treatment Phase: Third Intervention|Other|0|||
155441527|NCT01380093|561041483|FG008|Treatment Phase: Third Intervention|Other|1|||
155441528|NCT00546351|561041484|FG000|Overall Study|Adverse Event|76|||
155441529|NCT00546351|561041484|FG000|Overall Study|Lack of Efficacy|15|||
155441530|NCT00546351|561041484|FG000|Overall Study|Withdrawal by Subject|109|||
155441531|NCT00546351|561041484|FG000|Overall Study|Lost to Follow-up|9|||
155441532|NCT00546351|561041484|FG000|Overall Study|Protocol Deviation|1|||
155441533|NCT00546351|561041484|FG000|Overall Study|Unsatisfactory compliance|9|||
155441534|NCT00546351|561041484|FG000|Overall Study|Other reasons for premature termination|17|||
155441535|NCT04230486|561041494|FG000|Overall Study|Screen Failure|1|||
155441536|NCT01839188|561041495|FG000|Overall Study|Withdrawal by Subject|1|||
155441537|NCT04983901|561041496|FG000|Overall Study|Death|1|||
155441538|NCT04983901|561041497|FG001|Overall Study|Death|4|||
155441539|NCT04983901|561041496|FG000|Overall Study|Lost to Follow-up|3|||
155441540|NCT04983901|561041497|FG001|Overall Study|Lost to Follow-up|0|||
155441541|NCT04983901|561041496|FG000|Overall Study|Protocol Violation|1|||
155441542|NCT04983901|561041497|FG001|Overall Study|Protocol Violation|0|||
155441543|NCT04983901|561041496|FG000|Overall Study|Withdrawal by Subject|1|||
155441544|NCT04983901|561041497|FG001|Overall Study|Withdrawal by Subject|2|||
155441545|NCT02805907|561041498|FG000|Overall Study|Lost to Follow-up|3|||
155441546|NCT02805907|561041499|FG001|Overall Study|Lost to Follow-up|3|||
155441547|NCT01022853|561041506|FG000|Overall Study|Progressive disease|2|||
155441548|NCT01022853|561041507|FG001|Overall Study|Progressive disease|3|||
155441549|NCT01022853|561041508|FG002|Overall Study|Progressive disease|11|||
155441550|NCT01022853|561041509|FG003|Overall Study|Progressive disease|7|||
155441551|NCT01022853|561041510|FG004|Overall Study|Progressive disease|1|||
155441552|NCT01022853|561041506|FG000|Overall Study|Dose-limiting toxicity|0|||
155441553|NCT01022853|561041507|FG001|Overall Study|Dose-limiting toxicity|0|||
155441554|NCT01022853|561041508|FG002|Overall Study|Dose-limiting toxicity|0|||
155441555|NCT01022853|561041509|FG003|Overall Study|Dose-limiting toxicity|0|||
155441556|NCT01022853|561041510|FG004|Overall Study|Dose-limiting toxicity|1|||
155441557|NCT01022853|561041506|FG000|Overall Study|Withdrawal by Subject|0|||
155441558|NCT01022853|561041507|FG001|Overall Study|Withdrawal by Subject|1|||
155441559|NCT01022853|561041508|FG002|Overall Study|Withdrawal by Subject|1|||
155441560|NCT01022853|561041509|FG003|Overall Study|Withdrawal by Subject|1|||
155441561|NCT01022853|561041510|FG004|Overall Study|Withdrawal by Subject|0|||
155441562|NCT01022853|561041506|FG000|Overall Study|Other not stated above|1|||
155441563|NCT01022853|561041507|FG001|Overall Study|Other not stated above|0|||
155441564|NCT01022853|561041508|FG002|Overall Study|Other not stated above|1|||
155441565|NCT01022853|561041509|FG003|Overall Study|Other not stated above|0|||
155441566|NCT01022853|561041510|FG004|Overall Study|Other not stated above|0|||
155441567|NCT00532883|561041511|FG000|Overall Study|Adverse Event|1|||
155441568|NCT00532883|561041512|FG001|Overall Study|Adverse Event|0|||
155441569|NCT00532883|561041513|FG002|Overall Study|Adverse Event|0|||
155441570|NCT00532883|561041514|FG003|Overall Study|Adverse Event|1|||
155441571|NCT00532883|561041511|FG000|Overall Study|Lost to Follow-up|1|||
155441572|NCT00532883|561041512|FG001|Overall Study|Lost to Follow-up|1|||
155441573|NCT00532883|561041513|FG002|Overall Study|Lost to Follow-up|1|||
155441574|NCT00532883|561041514|FG003|Overall Study|Lost to Follow-up|0|||
155441575|NCT00532883|561041511|FG000|Overall Study|Withdrawal by Subject|0|||
155441576|NCT00532883|561041512|FG001|Overall Study|Withdrawal by Subject|1|||
155441577|NCT00532883|561041513|FG002|Overall Study|Withdrawal by Subject|1|||
155441578|NCT00532883|561041514|FG003|Overall Study|Withdrawal by Subject|0|||
155441579|NCT00532883|561041511|FG000|Overall Study|Subject was Nonadherent|0|||
155441580|NCT00532883|561041512|FG001|Overall Study|Subject was Nonadherent|1|||
155441581|NCT00532883|561041513|FG002|Overall Study|Subject was Nonadherent|1|||
155441582|NCT00532883|561041514|FG003|Overall Study|Subject was Nonadherent|0|||
155515120|NCT02985957|561311537|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
155515121|NCT02985957|561311531|FG000|Treatment Period|Death|0|||
155515122|NCT02985957|561311532|FG001|Treatment Period|Death|0|||
155515123|NCT02985957|561311533|FG002|Treatment Period|Death|0|||
155515124|NCT02985957|561311534|FG003|Treatment Period|Death|0|||
155515125|NCT02985957|561311535|FG004|Treatment Period|Death|1|||
155515126|NCT02985957|561311536|FG005|Treatment Period|Death|0|||
155515127|NCT02985957|561311537|FG006|Treatment Period|Death|0|||
155515128|NCT02985957|561311531|FG000|Treatment Period|Participant withdrew consent|0|||
155515129|NCT02985957|561311532|FG001|Treatment Period|Participant withdrew consent|0|||
155515130|NCT02985957|561311533|FG002|Treatment Period|Participant withdrew consent|0|||
155515131|NCT02985957|561311534|FG003|Treatment Period|Participant withdrew consent|1|||
155515132|NCT02985957|561311535|FG004|Treatment Period|Participant withdrew consent|3|||
155515133|NCT02985957|561311536|FG005|Treatment Period|Participant withdrew consent|0|||
155515134|NCT02985957|561311537|FG006|Treatment Period|Participant withdrew consent|1|||
155515135|NCT02985957|561311531|FG000|Treatment Period|Lost to Follow-up|0|||
155515136|NCT02985957|561311532|FG001|Treatment Period|Lost to Follow-up|0|||
155515137|NCT02985957|561311533|FG002|Treatment Period|Lost to Follow-up|0|||
155515138|NCT02985957|561311534|FG003|Treatment Period|Lost to Follow-up|0|||
155515139|NCT02985957|561311535|FG004|Treatment Period|Lost to Follow-up|1|||
155515140|NCT02985957|561311536|FG005|Treatment Period|Lost to Follow-up|0|||
155515141|NCT02985957|561311537|FG006|Treatment Period|Lost to Follow-up|0|||
155515142|NCT02985957|561311531|FG000|Treatment Period|Other reasons|0|||
155515143|NCT02985957|561311532|FG001|Treatment Period|Other reasons|0|||
155515144|NCT02985957|561311533|FG002|Treatment Period|Other reasons|1|||
155515145|NCT02985957|561311534|FG003|Treatment Period|Other reasons|3|||
155515146|NCT02985957|561311535|FG004|Treatment Period|Other reasons|5|||
155515147|NCT02985957|561311536|FG005|Treatment Period|Other reasons|0|||
155515148|NCT02985957|561311537|FG006|Treatment Period|Other reasons|1|||
155441583|NCT00532883|561041511|FG000|Overall Study|Early Study Termination|4|||
155441584|NCT00532883|561041512|FG001|Overall Study|Early Study Termination|4|||
155441585|NCT00532883|561041513|FG002|Overall Study|Early Study Termination|1|||
155515149|NCT02985957|561311531|FG000|Treatment Period|Not reported|0|||
155441586|NCT00532883|561041514|FG003|Overall Study|Early Study Termination|4|||
155441587|NCT01214434|561041517|FG000|Overall Study|Withdrawal by Subject|1|||
155441588|NCT01214434|561041518|FG001|Overall Study|Withdrawal by Subject|0|||
155441589|NCT01214434|561041517|FG000|Overall Study|Lost to Follow-up|2|||
155441590|NCT01214434|561041518|FG001|Overall Study|Lost to Follow-up|2|||
155441591|NCT01214434|561041517|FG000|Overall Study|Site error|1|||
155441592|NCT01214434|561041518|FG001|Overall Study|Site error|0|||
155441593|NCT02075255|561041520|FG000|Overall Study|Study specific withdrawal criteria|0|||
155441594|NCT02075255|561041521|FG001|Overall Study|Study specific withdrawal criteria|1|||
155441595|NCT02075255|561041522|FG002|Overall Study|Study specific withdrawal criteria|1|||
155441596|NCT02075255|561041520|FG000|Overall Study|Withdrawal by Subject|4|||
155441597|NCT02075255|561041521|FG001|Overall Study|Withdrawal by Subject|1|||
155441598|NCT02075255|561041522|FG002|Overall Study|Withdrawal by Subject|0|||
155441599|NCT02075255|561041520|FG000|Overall Study|Lost to Follow-up|0|||
155441600|NCT02075255|561041521|FG001|Overall Study|Lost to Follow-up|0|||
155441601|NCT02075255|561041522|FG002|Overall Study|Lost to Follow-up|1|||
155441602|NCT02075255|561041520|FG000|Overall Study|Adverse Event|0|||
155441603|NCT02075255|561041521|FG001|Overall Study|Adverse Event|0|||
155441604|NCT02075255|561041522|FG002|Overall Study|Adverse Event|1|||
155441605|NCT02075255|561041520|FG000|Overall Study|Death|0|||
155441606|NCT02075255|561041521|FG001|Overall Study|Death|2|||
155441607|NCT02075255|561041522|FG002|Overall Study|Death|0|||
155441608|NCT03792750|561041523|FG000|Overall Study|Death|3|||
155441609|NCT01651052|561041524|FG000|Overall Study|Death|21|||
155441610|NCT01651052|561041524|FG000|Overall Study|Explant|1|||
155441611|NCT01651052|561041524|FG000|Overall Study|Withdrawal by Subject|1|||
155441612|NCT01651052|561041524|FG000|Overall Study|Lost to Follow-up|3|||
155441613|NCT03503773|561041525|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
155441614|NCT03503773|561041526|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
155441615|NCT03503773|561041525|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
155441616|NCT03503773|561041526|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
155441617|NCT03503773|561041525|FG000|Overall Study|Not completing the primary ABPM|3|||
155441618|NCT03503773|561041526|FG001|Overall Study|Not completing the primary ABPM|1|||
155441619|NCT03503773|561041525|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155441620|NCT03503773|561041526|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155441621|NCT00425438|561041530|FG000|Overall Study|Termination by Sponsor|25|||
155441622|NCT00425438|561041531|FG001|Overall Study|Termination by Sponsor|27|||
155441623|NCT02902809|561041532|FG000|Overall Study|Discontinuation of asthma program|28|||
155441624|NCT00532259|561041533|FG000|Overall Study|Withdrawal by Subject|2|||
155441625|NCT00532259|561041533|FG000|Overall Study|Adverse Event|1|||
155441626|NCT00532259|561041533|FG000|Overall Study|Death|1|||
155441627|NCT00532259|561041533|FG000|Overall Study|Lack of Efficacy|21|||
155441628|NCT00532259|561041533|FG000|Overall Study|Lost to Follow-up|3|||
155441629|NCT00532259|561041533|FG000|Overall Study|Physician Decision|3|||
155441630|NCT00532259|561041533|FG000|Overall Study|Protocol Violation|1|||
155441631|NCT01188798|561041534|FG000|Overall Study|Death|0|||
155441632|NCT01188798|561041535|FG001|Overall Study|Death|1|||
155441633|NCT01188798|561041534|FG000|Overall Study|Required additional transplant|1|||
155441634|NCT01188798|561041535|FG001|Overall Study|Required additional transplant|1|||
155441635|NCT01188798|561041534|FG000|Overall Study|Protocol closure|1|||
155441636|NCT01188798|561041535|FG001|Overall Study|Protocol closure|1|||
155441637|NCT02795767|561041536|FG000|Overall Study|Received Commercial Emicizumab|1|||
155441638|NCT02795767|561041537|FG001|Overall Study|Received Commercial Emicizumab|0|||
155441639|NCT02795767|561041538|FG002|Overall Study|Received Commercial Emicizumab|0|||
155441640|NCT03964415|561041539|FG000|Overall Study|Sponsor's decision|1563|||
155441641|NCT03964415|561041540|FG001|Overall Study|Sponsor's decision|1528|||
155441642|NCT03964415|561041539|FG000|Overall Study|Lost to Follow-up|139|||
155515150|NCT02985957|561311532|FG001|Treatment Period|Not reported|2|||
155515151|NCT02985957|561311533|FG002|Treatment Period|Not reported|2|||
155441643|NCT03964415|561041540|FG001|Overall Study|Lost to Follow-up|146|||
155441644|NCT03964415|561041539|FG000|Overall Study|Withdrawal by Subject|68|||
155441645|NCT03964415|561041540|FG001|Overall Study|Withdrawal by Subject|72|||
155441646|NCT03964415|561041539|FG000|Overall Study|Physician Decision|34|||
155441647|NCT03964415|561041540|FG001|Overall Study|Physician Decision|48|||
155441648|NCT03964415|561041539|FG000|Overall Study|Adverse Event|3|||
155441649|NCT03964415|561041540|FG001|Overall Study|Adverse Event|0|||
155515152|NCT02985957|561311534|FG003|Treatment Period|Not reported|5|||
155441650|NCT03964415|561041539|FG000|Overall Study|Death|4|||
155441651|NCT03964415|561041540|FG001|Overall Study|Death|6|||
155441652|NCT03964415|561041539|FG000|Overall Study|Protocol Violation|1|||
155441653|NCT03964415|561041540|FG001|Overall Study|Protocol Violation|4|||
155441654|NCT03964415|561041539|FG000|Overall Study|Other|35|||
155441655|NCT03964415|561041540|FG001|Overall Study|Other|38|||
155441656|NCT03964415|561041539|FG000|Overall Study|Randomized but not treated|6|||
155441657|NCT03964415|561041540|FG001|Overall Study|Randomized but not treated|7|||
155441658|NCT01097330|561041545|FG000|Overall Study|Study terminated early|7|||
155441659|NCT01097330|561041546|FG001|Overall Study|Study terminated early|5|||
155441660|NCT04983940|561041547|FG000|Overall Study|Lost to Follow-up|14|||
155441661|NCT04983940|561041547|FG000|Overall Study|Lack of Efficacy|2|||
155441662|NCT04156646|561041553|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
155441663|NCT04156646|561041554|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
155441664|NCT05270694|561042864|FG000|Overall Study|Death|1|||
155441665|NCT05270694|561042864|FG000|Overall Study|Medical issues impacted ability to participate|2|||
155441666|NCT05270694|561042864|FG000|Overall Study|Lost to Follow-up|3|||
155441667|NCT05270694|561042864|FG000|Overall Study|Withdrawal by Subject|3|||
155441668|NCT02345434|561042871|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
155441669|NCT02345434|561042872|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
155441670|NCT02064439|561042873|FG000|Overall Study|Adverse Event|51|||
155441671|NCT02064439|561042874|FG001|Overall Study|Adverse Event|47|||
155441672|NCT02064439|561042875|FG002|Overall Study|Adverse Event|46|||
155441673|NCT02064439|561042873|FG000|Overall Study|Death|0|||
155441674|NCT02064439|561042874|FG001|Overall Study|Death|2|||
155441675|NCT02064439|561042875|FG002|Overall Study|Death|3|||
155441676|NCT02064439|561042873|FG000|Overall Study|Withdrawal by Subject|29|||
155441677|NCT02064439|561042874|FG001|Overall Study|Withdrawal by Subject|18|||
155441678|NCT02064439|561042875|FG002|Overall Study|Withdrawal by Subject|26|||
155441679|NCT02064439|561042873|FG000|Overall Study|Protocol Violation|3|||
155441680|NCT02064439|561042874|FG001|Overall Study|Protocol Violation|5|||
155441681|NCT02064439|561042875|FG002|Overall Study|Protocol Violation|3|||
155441682|NCT02064439|561042873|FG000|Overall Study|Lost to Follow-up|1|||
155441683|NCT02064439|561042874|FG001|Overall Study|Lost to Follow-up|3|||
155441684|NCT02064439|561042875|FG002|Overall Study|Lost to Follow-up|4|||
155441685|NCT02064439|561042873|FG000|Overall Study|Non-compliance with study medication|21|||
155441686|NCT02064439|561042874|FG001|Overall Study|Non-compliance with study medication|19|||
155441687|NCT02064439|561042875|FG002|Overall Study|Non-compliance with study medication|23|||
155441688|NCT02064439|561042873|FG000|Overall Study|Physician Decision|0|||
155441689|NCT02064439|561042874|FG001|Overall Study|Physician Decision|1|||
155441690|NCT02064439|561042875|FG002|Overall Study|Physician Decision|1|||
155441691|NCT02064439|561042873|FG000|Overall Study|Logistical difficulties|6|||
155441692|NCT02064439|561042874|FG001|Overall Study|Logistical difficulties|5|||
155441693|NCT02064439|561042875|FG002|Overall Study|Logistical difficulties|2|||
155441694|NCT02064439|561042873|FG000|Overall Study|Efficacy outcome reached|18|||
155441695|NCT02064439|561042874|FG001|Overall Study|Efficacy outcome reached|16|||
155441696|NCT02064439|561042875|FG002|Overall Study|Efficacy outcome reached|57|||
155441697|NCT02064439|561042873|FG000|Overall Study|Safety outcome reached|12|||
155441698|NCT02064439|561042874|FG001|Overall Study|Safety outcome reached|20|||
155441699|NCT02064439|561042875|FG002|Overall Study|Safety outcome reached|10|||
155441700|NCT02064439|561042873|FG000|Overall Study|Other|2|||
155441701|NCT02064439|561042874|FG001|Overall Study|Other|2|||
155441702|NCT02064439|561042875|FG002|Overall Study|Other|7|||
155441703|NCT02433288|561042876|FG000|Overall Study|Severe non-compliance to protocol|13|||
155441704|NCT02433288|561042877|FG001|Overall Study|Severe non-compliance to protocol|7|||
155441705|NCT02433288|561042876|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
155441706|NCT02433288|561042877|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
155441707|NCT02433288|561042876|FG000|Overall Study|Withdrawal by Subject|101|||
155441708|NCT02433288|561042877|FG001|Overall Study|Withdrawal by Subject|99|||
155441709|NCT02433288|561042876|FG000|Overall Study|Lost to Follow-up|2|||
155441710|NCT02433288|561042877|FG001|Overall Study|Lost to Follow-up|14|||
155441711|NCT02433288|561042876|FG000|Overall Study|Death|0|||
155441712|NCT02433288|561042877|FG001|Overall Study|Death|3|||
155441713|NCT00858702|561042880|FG000|Overall Study|Lack of Efficacy|1|||
155441714|NCT00858702|561042881|FG001|Overall Study|Lack of Efficacy|0|||
155441715|NCT00858702|561042880|FG000|Overall Study|Protocol Violation|1|||
155441716|NCT00858702|561042881|FG001|Overall Study|Protocol Violation|1|||
155441717|NCT00858702|561042880|FG000|Overall Study|Other|2|||
155441718|NCT00858702|561042881|FG001|Overall Study|Other|1|||
155441719|NCT00858702|561042880|FG000|Overall Study|Withdrawal by Subject|1|||
155441720|NCT00858702|561042881|FG001|Overall Study|Withdrawal by Subject|0|||
155441721|NCT00367640|561042882|FG000|Overall Study|Adverse Event|3|||
155441722|NCT00367640|561042883|FG001|Overall Study|Adverse Event|6|||
155441723|NCT00367640|561042884|FG002|Overall Study|Adverse Event|8|||
155441724|NCT00367640|561042885|FG003|Overall Study|Adverse Event|0|||
155441725|NCT00367640|561042882|FG000|Overall Study|Withdrawal by Subject|8|||
155441726|NCT00367640|561042883|FG001|Overall Study|Withdrawal by Subject|11|||
155441727|NCT00367640|561042884|FG002|Overall Study|Withdrawal by Subject|8|||
155441728|NCT00367640|561042885|FG003|Overall Study|Withdrawal by Subject|6|||
155441729|NCT00367640|561042882|FG000|Overall Study|Any other reason not above-mentioned|7|||
155441730|NCT00367640|561042883|FG001|Overall Study|Any other reason not above-mentioned|5|||
155441731|NCT00367640|561042884|FG002|Overall Study|Any other reason not above-mentioned|3|||
155441732|NCT00367640|561042885|FG003|Overall Study|Any other reason not above-mentioned|4|||
155441733|NCT02417233|561042886|FG000|Overall Study|Death|4|||
155441734|NCT02417233|561042887|FG001|Overall Study|Death|10|||
155441735|NCT02417233|561042888|FG002|Overall Study|Death|14|||
155441736|NCT02417233|561042886|FG000|Overall Study|Lost to Follow-up|27|||
155441737|NCT02417233|561042887|FG001|Overall Study|Lost to Follow-up|39|||
155441738|NCT02417233|561042888|FG002|Overall Study|Lost to Follow-up|34|||
155441739|NCT02417233|561042886|FG000|Overall Study|Protocol Violation|2|||
155441740|NCT02417233|561042887|FG001|Overall Study|Protocol Violation|0|||
155441741|NCT02417233|561042888|FG002|Overall Study|Protocol Violation|2|||
155441742|NCT02417233|561042886|FG000|Overall Study|Withdrawal by Subject|2|||
155441743|NCT02417233|561042887|FG001|Overall Study|Withdrawal by Subject|1|||
155441744|NCT02417233|561042888|FG002|Overall Study|Withdrawal by Subject|8|||
155441745|NCT02417233|561042886|FG000|Overall Study|Relocation out of study area|1|||
155441746|NCT02417233|561042887|FG001|Overall Study|Relocation out of study area|0|||
155441747|NCT02417233|561042888|FG002|Overall Study|Relocation out of study area|1|||
155441748|NCT02417233|561042886|FG000|Overall Study|Mentally unstable|0|||
155441749|NCT02417233|561042887|FG001|Overall Study|Mentally unstable|1|||
155441750|NCT02417233|561042888|FG002|Overall Study|Mentally unstable|0|||
155441751|NCT01063751|561042890|FG000|Overall Study|Censored from analyses|42|||
155441752|NCT01063751|561042890|FG000|Overall Study|Withdrawal by Subject|34|||
155441753|NCT01063751|561042890|FG000|Overall Study|Lost to Follow-up|30|||
155441754|NCT01063751|561042890|FG000|Overall Study|Death|13|||
155441755|NCT01063751|561042890|FG000|Overall Study|Sponsored Terminated Study|60|||
155441756|NCT01063751|561042890|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
155441757|NCT01063751|561042890|FG000|Overall Study|Investigator site closed|10|||
155441758|NCT01063751|561042890|FG000|Overall Study|Revision|6|||
155441759|NCT01063751|561042890|FG000|Overall Study|Physician Decision|4|||
155441760|NCT01671488|561042911|FG000|Overall Study|Withdrawal by Subject|1|||
155441761|NCT02416908|561042912|FG000|Dose Escalation Phase|Adverse Event|0|||
155441762|NCT02416908|561042913|FG001|Dose Escalation Phase|Adverse Event|0|||
155441763|NCT02416908|561042914|FG002|Dose Escalation Phase|Adverse Event|3|||
155441764|NCT02416908|561042915|FG003|Dose Escalation Phase|Adverse Event|0|||
155515153|NCT02985957|561311535|FG004|Treatment Period|Not reported|0|||
155441765|NCT02416908|561042912|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155441766|NCT02416908|561042913|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155441767|NCT02416908|561042914|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
155441768|NCT02416908|561042915|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155441769|NCT03799718|561042916|FG000|Overall Study|Adverse Event|2|||
155441770|NCT03662334|561042923|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
155441771|NCT03662334|561042924|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
155441772|NCT01478347|561042934|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
155441773|NCT01478347|561042934|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
155441774|NCT01478347|561042934|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
155441775|NCT01645930|561042935|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
155441776|NCT01645930|561042935|FG000|Overall Study|Progressive Disease|12|||
155441777|NCT01645930|561042935|FG000|Overall Study|Adverse Event|4|||
155441778|NCT01645930|561042935|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
155441779|NCT01645930|561042935|FG000|Overall Study|Withdrawal by Participant|2|||
155441780|NCT01645930|561042935|FG000|Overall Study|Reason not Defined|1|||
155441781|NCT01748760|561042936|FG000|Overall Study|Withdrawal by Subject|1|||
155441782|NCT01748760|561042937|FG001|Overall Study|Withdrawal by Subject|1|||
155441783|NCT01748760|561042936|FG000|Overall Study|Lost to Follow-up|5|||
155441784|NCT01748760|561042937|FG001|Overall Study|Lost to Follow-up|1|||
155441785|NCT03245814|561042938|FG000|Overall Study|Lost to Follow-up|5|||
155441786|NCT03245814|561042939|FG001|Overall Study|Lost to Follow-up|8|||
155441787|NCT03245814|561042938|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
155441788|NCT03245814|561042939|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
155441789|NCT02263365|561042944|FG000|Overall Study|Physician Decision|22|||
155441790|NCT02263365|561042945|FG001|Overall Study|Physician Decision|18|||
155441791|NCT00510692|561042946|FG000|Overall Study|Adverse Event|1|||
155441792|NCT00510692|561042947|FG001|Overall Study|Adverse Event|3|||
155441793|NCT00510692|561042946|FG000|Overall Study|Withdrawal by Subject|1|||
155441794|NCT00510692|561042947|FG001|Overall Study|Withdrawal by Subject|0|||
155441795|NCT00945191|561042948|FG000|Overall Study|Did not achieve a complete response|18|||
155441796|NCT00945191|561042948|FG000|Overall Study|Participant relocated to another state|1|||
155441797|NCT00945191|561042948|FG000|Overall Study|Disease progression|3|||
155441798|NCT00945191|561042948|FG000|Overall Study|Serious adverse event or adverse event|1|||
155441799|NCT00945191|561042948|FG000|Overall Study|Investigator's discretion|1|||
155441800|NCT02116972|561042949|FG000|Overall Study|Adverse Event|4|||
155441801|NCT02116972|561042950|FG001|Overall Study|Adverse Event|4|||
155441802|NCT02116972|561042951|FG002|Overall Study|Adverse Event|1|||
155441803|NCT02116972|561042949|FG000|Overall Study|Withdrawal by Subject|1|||
155441804|NCT02116972|561042950|FG001|Overall Study|Withdrawal by Subject|1|||
155441805|NCT02116972|561042951|FG002|Overall Study|Withdrawal by Subject|5|||
155441806|NCT02116972|561042949|FG000|Overall Study|Protocol Violation|1|||
155441807|NCT02116972|561042950|FG001|Overall Study|Protocol Violation|0|||
155441808|NCT02116972|561042951|FG002|Overall Study|Protocol Violation|1|||
155441809|NCT02116972|561042949|FG000|Overall Study|Lost to Follow-up|4|||
155441810|NCT02116972|561042950|FG001|Overall Study|Lost to Follow-up|3|||
155441811|NCT02116972|561042951|FG002|Overall Study|Lost to Follow-up|1|||
155441812|NCT02116972|561042949|FG000|Overall Study|Lack of Efficacy|6|||
155441813|NCT02116972|561042950|FG001|Overall Study|Lack of Efficacy|6|||
155441814|NCT02116972|561042951|FG002|Overall Study|Lack of Efficacy|5|||
155441815|NCT02116972|561042949|FG000|Overall Study|scheduling conflicts and relocation|3|||
155441816|NCT02116972|561042950|FG001|Overall Study|scheduling conflicts and relocation|3|||
155441817|NCT02116972|561042951|FG002|Overall Study|scheduling conflicts and relocation|6|||
155441818|NCT00784784|561042952|FG000|Overall Study|Withdrawal by Subject|2|||
155441819|NCT00784784|561042953|FG001|Overall Study|Withdrawal by Subject|2|||
155441820|NCT01879618|561042956|FG000|Overall Study|Does not meet entrance criteria|1|||
155441821|NCT01879618|561042956|FG000|Overall Study|Withdrawal by Subject|1|||
155441822|NCT01879618|561042956|FG000|Overall Study|Surgery;changed schedule; not available|8|||
155441823|NCT01879618|561042956|FG000|Overall Study|Protocol Violation|6|||
155441824|NCT01879618|561042956|FG000|Overall Study|Adverse Event|5|||
155441825|NCT00872898|561042961|FG000|Part Two - Double Blind|Adverse Event|4|||
155441826|NCT00872898|561042962|FG001|Part Two - Double Blind|Adverse Event|3|||
155441827|NCT00872898|561042961|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
155441828|NCT00872898|561042962|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
155441829|NCT00872898|561042961|FG000|Part Two - Double Blind|Protocol Violation|1|||
155441830|NCT00872898|561042962|FG001|Part Two - Double Blind|Protocol Violation|0|||
155441831|NCT00872898|561042961|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
155441832|NCT00872898|561042962|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
155441833|NCT00872898|561042961|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
155441834|NCT00872898|561042962|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
155441835|NCT00872898|561042961|FG000|Part Two - Double Blind|Other reasons|2|||
155441836|NCT00872898|561042962|FG001|Part Two - Double Blind|Other reasons|0|||
155441837|NCT01004146|561042963|FG000|Overall Study|Withdrawal by Subject|4|||
155441838|NCT01004146|561042964|FG001|Overall Study|Withdrawal by Subject|5|||
155441839|NCT00863928|561042969|FG000|Overall Study|Protocol Violation|26|||
155441840|NCT00863928|561042970|FG001|Overall Study|Protocol Violation|0|||
155441841|NCT00863928|561042969|FG000|Overall Study|Withdrawal by Subject|3|||
155441842|NCT00863928|561042970|FG001|Overall Study|Withdrawal by Subject|0|||
155441843|NCT00863928|561042969|FG000|Overall Study|surgery cancellation|4|||
155441844|NCT00863928|561042970|FG001|Overall Study|surgery cancellation|0|||
155441845|NCT00863928|561042969|FG000|Overall Study|medication allergy|3|||
155441846|NCT00863928|561042970|FG001|Overall Study|medication allergy|0|||
155441847|NCT01001494|561042975|FG000|Overall Study|Adverse Event|8|||
155441848|NCT01001494|561042976|FG001|Overall Study|Adverse Event|4|||
155441849|NCT01001494|561042977|FG002|Overall Study|Adverse Event|6|||
155441850|NCT01001494|561042975|FG000|Overall Study|Protocol Violation|0|||
155441851|NCT01001494|561042976|FG001|Overall Study|Protocol Violation|1|||
155441852|NCT01001494|561042977|FG002|Overall Study|Protocol Violation|1|||
155441853|NCT01001494|561042975|FG000|Overall Study|Lost to Follow-up|2|||
155441854|NCT01001494|561042976|FG001|Overall Study|Lost to Follow-up|0|||
155441855|NCT01001494|561042977|FG002|Overall Study|Lost to Follow-up|1|||
155441856|NCT01001494|561042975|FG000|Overall Study|Withdrawal by Subject|9|||
155441857|NCT01001494|561042976|FG001|Overall Study|Withdrawal by Subject|7|||
155441858|NCT01001494|561042977|FG002|Overall Study|Withdrawal by Subject|17|||
155441859|NCT01001494|561042975|FG000|Overall Study|COPD exacerbation|3|||
155441860|NCT01001494|561042976|FG001|Overall Study|COPD exacerbation|4|||
155441861|NCT01001494|561042977|FG002|Overall Study|COPD exacerbation|5|||
155441862|NCT01001494|561042975|FG000|Overall Study|Lack of Efficacy|2|||
155441863|NCT01001494|561042976|FG001|Overall Study|Lack of Efficacy|0|||
155441864|NCT01001494|561042977|FG002|Overall Study|Lack of Efficacy|8|||
155441865|NCT01001494|561042975|FG000|Overall Study|Other|0|||
155441866|NCT01001494|561042976|FG001|Overall Study|Other|1|||
155441867|NCT01001494|561042977|FG002|Overall Study|Other|3|||
155441868|NCT02795156|561042979|FG000|Overall Study|Progressive Disease|22|||
155441869|NCT02795156|561042980|FG001|Overall Study|Progressive Disease|7|||
155441870|NCT02795156|561042981|FG002|Overall Study|Progressive Disease|34|||
155441871|NCT02795156|561042982|FG003|Overall Study|Progressive Disease|7|||
155441872|NCT02795156|561042979|FG000|Overall Study|Adverse Event|13|||
155441873|NCT02795156|561042980|FG001|Overall Study|Adverse Event|2|||
155441874|NCT02795156|561042981|FG002|Overall Study|Adverse Event|3|||
155441875|NCT02795156|561042982|FG003|Overall Study|Adverse Event|2|||
155441876|NCT02795156|561042979|FG000|Overall Study|Death|1|||
155441877|NCT02795156|561042980|FG001|Overall Study|Death|1|||
155441878|NCT02795156|561042981|FG002|Overall Study|Death|1|||
155441879|NCT02795156|561042982|FG003|Overall Study|Death|0|||
155441880|NCT02795156|561042979|FG000|Overall Study|Physician Decision|1|||
155441881|NCT02795156|561042980|FG001|Overall Study|Physician Decision|0|||
155441882|NCT02795156|561042981|FG002|Overall Study|Physician Decision|1|||
155441883|NCT02795156|561042982|FG003|Overall Study|Physician Decision|0|||
155441884|NCT02795156|561042979|FG000|Overall Study|Withdrawal by Subject|2|||
155441885|NCT02795156|561042980|FG001|Overall Study|Withdrawal by Subject|0|||
155441886|NCT02795156|561042981|FG002|Overall Study|Withdrawal by Subject|3|||
155441887|NCT02795156|561042982|FG003|Overall Study|Withdrawal by Subject|0|||
155441888|NCT00734929|561042986|FG000|Overall Study|Lost to Follow-up|1|||
155441889|NCT00734929|561042987|FG001|Overall Study|Lost to Follow-up|2|||
155441890|NCT00734929|561042986|FG000|Overall Study|No intervention/ screen fail|5|||
155441891|NCT00734929|561042987|FG001|Overall Study|No intervention/ screen fail|3|||
155441892|NCT02961764|561042991|FG000|Overall Study|Protocol Violation|0|||
155441893|NCT02961764|561042992|FG001|Overall Study|Protocol Violation|1|||
155441894|NCT02961764|561042991|FG000|Overall Study|Death|2|||
155441895|NCT02961764|561042992|FG001|Overall Study|Death|0|||
155441896|NCT02961764|561042991|FG000|Overall Study|Lost to Follow-up|35|||
155441897|NCT02961764|561042992|FG001|Overall Study|Lost to Follow-up|24|||
155441898|NCT02961764|561042991|FG000|Overall Study|Withdrawal by Subject|2|||
155441899|NCT02961764|561042992|FG001|Overall Study|Withdrawal by Subject|0|||
155441900|NCT01903434|561043000|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
155441901|NCT01903434|561043001|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
155441902|NCT01903434|561043000|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
155441903|NCT01903434|561043001|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
155441904|NCT04267562|561044366|FG000|Assessed for Eligibility|Screen Failure|64|||
155441905|NCT04267562|561044366|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
155441906|NCT04267562|561044366|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
155441907|NCT04267562|561044366|FG000|Assessed for Eligibility|Site closure|6|||
155441908|NCT04267562|561044366|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
155441909|NCT04267562|561044366|FG000|Assessed for Eligibility|Physician Decision|1|||
155441910|NCT04267562|561044366|FG000|Month 24|Elective hysterectomy|1|||
155441911|NCT04267562|561044366|FG000|Month 24|Lost to Follow-up|1|||
155441912|NCT04267562|561044366|FG000|Month 36|Elective hysterectomy|2|||
155441913|NCT04267562|561044366|FG000|Month 36|Lost to Follow-up|3|||
155441914|NCT00128206|561044370|FG000|Overall Study|Lost to Follow-up|137|||
155441915|NCT00128206|561044371|FG001|Overall Study|Lost to Follow-up|118|||
155441916|NCT00128206|561044370|FG000|Overall Study|Adverse Event|0|||
155441917|NCT00128206|561044371|FG001|Overall Study|Adverse Event|2|||
155441918|NCT03032068|561044380|FG000|Overall Study|Adverse Event|1|||
155441919|NCT01597622|561044381|FG000|Overall Study|Adverse Event|7|||
155441920|NCT01597622|561044381|FG000|Overall Study|Lack of Efficacy|3|||
155441921|NCT01597622|561044381|FG000|Overall Study|Protocol Violation|1|||
155441922|NCT01597622|561044381|FG000|Overall Study|Lost to Follow-up|1|||
155441923|NCT01597622|561044381|FG000|Overall Study|Investigator Discretion|5|||
155441924|NCT01597622|561044381|FG000|Overall Study|Withdrawal by Subject|20|||
155441925|NCT01597622|561044381|FG000|Overall Study|Death|1|||
155441926|NCT00408421|561044382|FG000|Treatment Initial Randomization|Adverse Event|5|||
155441927|NCT00408421|561044383|FG001|Treatment Initial Randomization|Adverse Event|9|||
155441928|NCT00408421|561044384|FG002|Treatment Initial Randomization|Adverse Event|0|||
155441929|NCT00408421|561044382|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
155441930|NCT00408421|561044383|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
155441931|NCT00408421|561044384|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
155441932|NCT00408421|561044382|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
155441933|NCT00408421|561044383|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
155651349|NCT01897896|561816184|FG000|Overall Study|Adverse Event|11|||
155651350|NCT01897896|561816185|FG001|Overall Study|Adverse Event|1|||
155441934|NCT00408421|561044384|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
155441935|NCT00408421|561044382|FG000|Treatment Initial Randomization|Physician Decision|1|||
155441936|NCT00408421|561044383|FG001|Treatment Initial Randomization|Physician Decision|0|||
155441937|NCT00408421|561044384|FG002|Treatment Initial Randomization|Physician Decision|0|||
155441938|NCT00408421|561044382|FG000|Treatment Initial Randomization|Protocol Violation|0|||
155441939|NCT00408421|561044383|FG001|Treatment Initial Randomization|Protocol Violation|1|||
155441940|NCT00408421|561044384|FG002|Treatment Initial Randomization|Protocol Violation|0|||
155441941|NCT00408421|561044382|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
155441942|NCT00408421|561044383|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
155441943|NCT00408421|561044384|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
155441944|NCT00408421|561044382|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
155441945|NCT00408421|561044383|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
155441946|NCT00408421|561044384|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
155441947|NCT00408421|561044382|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
155441948|NCT00408421|561044383|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
155651351|NCT01897896|561816184|FG000|Overall Study|Lost to Follow-up|1|||
155651352|NCT01897896|561816185|FG001|Overall Study|Lost to Follow-up|0|||
155515154|NCT02985957|561311536|FG005|Treatment Period|Not reported|0|||
155441949|NCT00408421|561044384|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
155441950|NCT00408421|561044382|FG000|Treatment Re-Randomization|Adverse Event|2|||
155441951|NCT00408421|561044383|FG001|Treatment Re-Randomization|Adverse Event|2|||
155441952|NCT00408421|561044384|FG002|Treatment Re-Randomization|Adverse Event|4|||
155441953|NCT00408421|561044382|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
155441954|NCT00408421|561044383|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
155441955|NCT00408421|561044384|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
155441956|NCT00408421|561044382|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
155441957|NCT00408421|561044383|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
155441958|NCT00408421|561044384|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
155441959|NCT00408421|561044382|FG000|Treatment Re-Randomization|Physician Decision|1|||
155441960|NCT00408421|561044383|FG001|Treatment Re-Randomization|Physician Decision|3|||
155441961|NCT00408421|561044384|FG002|Treatment Re-Randomization|Physician Decision|0|||
155441962|NCT00408421|561044382|FG000|Treatment Re-Randomization|Protocol Violation|1|||
155441963|NCT00408421|561044383|FG001|Treatment Re-Randomization|Protocol Violation|1|||
155441964|NCT00408421|561044384|FG002|Treatment Re-Randomization|Protocol Violation|0|||
155441965|NCT00408421|561044382|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
155441966|NCT00408421|561044383|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
155441967|NCT00408421|561044384|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
155441968|NCT03132805|561044387|FG000|Overall Study|Lost to Follow-up|142|||
155441969|NCT03132805|561044388|FG001|Overall Study|Lost to Follow-up|141|||
155441970|NCT03132805|561044389|FG002|Overall Study|Lost to Follow-up|113|||
155441971|NCT03009539|561044390|FG000|Overall Study|Lost to Follow-up|132|||
155441972|NCT03009539|561044391|FG001|Overall Study|Lost to Follow-up|113|||
155441973|NCT03009539|561044392|FG002|Overall Study|Lost to Follow-up|132|||
155441974|NCT03009539|561044393|FG003|Overall Study|Lost to Follow-up|113|||
155441975|NCT03151148|561044394|FG000|Overall Study|Lost to Follow-up|1|||
155441976|NCT03151148|561044395|FG001|Overall Study|Lost to Follow-up|0|||
155441977|NCT03151148|561044394|FG000|Overall Study|Withdrawal by Subject|1|||
155441978|NCT03151148|561044395|FG001|Overall Study|Withdrawal by Subject|0|||
155441979|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
155441980|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
155441981|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
155441982|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
155441983|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
155441984|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
155441985|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
155441986|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
155441987|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
155441988|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
155441989|NCT00710034|561044396|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
155441990|NCT00710034|561044397|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
155441991|NCT00710034|561044396|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
155441992|NCT00710034|561044397|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
155441993|NCT00710034|561044396|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
155441994|NCT00710034|561044397|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
155441995|NCT00710034|561044396|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
155441996|NCT00710034|561044397|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
155441997|NCT00710034|561044396|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
155441998|NCT00710034|561044397|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
155441999|NCT00710034|561044396|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
155442000|NCT00710034|561044397|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
155442001|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
155442002|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
155442003|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
155442004|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
155442005|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Death|8|||
155442006|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Death|3|||
155442007|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
155442008|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
155442009|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
155442010|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
155442011|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
155442012|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
155442013|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
155442014|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
155442015|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
155442016|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
155442017|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
155442018|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
155442019|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
155442020|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
155442021|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
155442022|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
155442023|NCT00494871|561044398|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
155442024|NCT00494871|561044399|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
155442025|NCT00494871|561044398|FG000|Follow-up (FU) Period|Adverse Event|1|||
155442026|NCT00494871|561044399|FG001|Follow-up (FU) Period|Adverse Event|1|||
155442027|NCT00494871|561044398|FG000|Follow-up (FU) Period|Death|13|||
155442028|NCT00494871|561044399|FG001|Follow-up (FU) Period|Death|12|||
155442029|NCT00494871|561044398|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
155442030|NCT00494871|561044399|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
155442031|NCT00494871|561044398|FG000|Follow-up (FU) Period|Physician Decision|0|||
155442032|NCT00494871|561044399|FG001|Follow-up (FU) Period|Physician Decision|1|||
155442033|NCT00494871|561044398|FG000|Follow-up (FU) Period|Protocol Violation|1|||
155442034|NCT00494871|561044399|FG001|Follow-up (FU) Period|Protocol Violation|0|||
155442035|NCT00494871|561044398|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
155442036|NCT00494871|561044399|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
155442037|NCT00494871|561044398|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
155442038|NCT00494871|561044399|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
155442039|NCT03238248|561044402|FG000|Overall Study|Death|5|||
155442040|NCT03238248|561044402|FG000|Overall Study|Withdrawal by Subject|7|||
155442041|NCT03238248|561044402|FG000|Overall Study|Participant proceeding to transplant|10|||
155442042|NCT03238248|561044402|FG000|Overall Study|Lack of Efficacy|4|||
155442043|NCT03238248|561044402|FG000|Overall Study|Physician Decision|3|||
155442044|NCT03238248|561044402|FG000|Overall Study|Transitioning to another study|1|||
155442045|NCT03238248|561044402|FG000|Overall Study|No longer benefiting|1|||
155442046|NCT03238248|561044402|FG000|Overall Study|Other complicating disease|1|||
155442047|NCT03238248|561044402|FG000|Overall Study|Adverse Event|5|||
155442048|NCT03238248|561044402|FG000|Overall Study|Disease progression|26|||
155442049|NCT03238248|561044402|FG000|Overall Study|N/A participant is still on treatment|1|||
155442050|NCT03238248|561044402|FG000|Overall Study|Decline in condition|1|||
155442051|NCT03238248|561044402|FG000|Overall Study|Alternative therapy|2|||
155515155|NCT02985957|561311537|FG006|Treatment Period|Not reported|0|||
155442052|NCT02241512|561044409|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
155442053|NCT02241512|561044410|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
155442054|NCT02385123|561044415|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
155442055|NCT04498910|561044416|FG000|Overall Study|Lost to Follow-up|0|||
155442056|NCT04498910|561044417|FG001|Overall Study|Lost to Follow-up|1|||
155442057|NCT04498910|561044416|FG000|Overall Study|Withdrawal by Subject|2|||
155442058|NCT04498910|561044417|FG001|Overall Study|Withdrawal by Subject|1|||
155442059|NCT04498910|561044416|FG000|Overall Study|Adverse Event|1|||
155442060|NCT04498910|561044417|FG001|Overall Study|Adverse Event|0|||
155442061|NCT03215264|561044419|FG000|Dose Level 2|Adverse Event|0|||
155442062|NCT03215264|561044420|FG001|Dose Level 2|Adverse Event|1|||
155442063|NCT03215264|561044421|FG002|Dose Level 2|Adverse Event|0|||
155442064|NCT03215264|561044419|FG000|Dose Level 3|Withdrawal by Subject|0|||
155442065|NCT03215264|561044420|FG001|Dose Level 3|Withdrawal by Subject|0|||
155442066|NCT03215264|561044421|FG002|Dose Level 3|Withdrawal by Subject|1|||
155442067|NCT02145156|561044422|FG000|Overall Study|No match to vaccination records|60|||
155442068|NCT02145156|561044423|FG001|Overall Study|No match to vaccination records|52|||
155442069|NCT02145156|561044424|FG002|Overall Study|No match to vaccination records|41|||
155442070|NCT01740440|561044425|FG000|Overall Study|Lost to Follow-up|3|||
155442071|NCT03408873|561044429|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
155442072|NCT03408873|561044429|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
155442073|NCT03408873|561044429|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
155442074|NCT03408873|561044429|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
155442075|NCT03408873|561044429|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
155442076|NCT03408873|561044429|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
155442077|NCT01264965|561044430|FG000|Overall Study|Withdrawal by Subject|10|||
155442078|NCT00406315|561044432|FG000|Overall Study|Death|1|||
155442079|NCT00406315|561044432|FG000|Overall Study|Adverse Event|39|||
155442080|NCT00406315|561044432|FG000|Overall Study|Laboratory Abnormality|4|||
155442081|NCT00406315|561044432|FG000|Overall Study|Lack of Efficacy|13|||
155442082|NCT00406315|561044432|FG000|Overall Study|Other|33|||
155442083|NCT00406315|561044432|FG000|Overall Study|Lost to Follow-up|21|||
155442084|NCT00406315|561044432|FG000|Overall Study|Withdrawal by Subject|30|||
155442085|NCT01469013|561044434|FG000|Part A (Treatment Period)|Adverse Event|1|||
155442086|NCT01469013|561044435|FG001|Part A (Treatment Period)|Adverse Event|0|||
155442087|NCT01469013|561044436|FG002|Part A (Treatment Period)|Adverse Event|0|||
155442088|NCT01469013|561044437|FG003|Part A (Treatment Period)|Adverse Event|0|||
155442089|NCT01469013|561044438|FG004|Part A (Treatment Period)|Adverse Event|1|||
155442090|NCT01469013|561044439|FG005|Part A (Treatment Period)|Adverse Event|0|||
155442091|NCT01469013|561044440|FG006|Part A (Treatment Period)|Adverse Event|0|||
155442092|NCT01469013|561044441|FG007|Part A (Treatment Period)|Adverse Event|0|||
155442093|NCT01469013|561044442|FG008|Part A (Treatment Period)|Adverse Event|0|||
155442094|NCT01469013|561044443|FG009|Part A (Treatment Period)|Adverse Event|0|||
155442095|NCT01469013|561044444|FG010|Part A (Treatment Period)|Adverse Event|0|||
155442096|NCT01469013|561044445|FG011|Part A (Treatment Period)|Adverse Event|0|||
155442097|NCT01469013|561044446|FG012|Part A (Treatment Period)|Adverse Event|0|||
155442098|NCT01469013|561044434|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442099|NCT01469013|561044435|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442100|NCT01469013|561044436|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
155442101|NCT01469013|561044437|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442102|NCT01469013|561044438|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442103|NCT01469013|561044439|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442104|NCT01469013|561044440|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442105|NCT01469013|561044441|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442106|NCT01469013|561044442|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442107|NCT01469013|561044443|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442108|NCT01469013|561044444|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442109|NCT01469013|561044445|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442110|NCT01469013|561044446|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
155442111|NCT01469013|561044434|FG000|Part B (Extension Period)|Adverse Event|0|||
155442112|NCT01469013|561044435|FG001|Part B (Extension Period)|Adverse Event|0|||
155442113|NCT01469013|561044436|FG002|Part B (Extension Period)|Adverse Event|0|||
155442114|NCT01469013|561044437|FG003|Part B (Extension Period)|Adverse Event|0|||
155442115|NCT01469013|561044438|FG004|Part B (Extension Period)|Adverse Event|0|||
155442116|NCT01469013|561044439|FG005|Part B (Extension Period)|Adverse Event|2|||
155442117|NCT01469013|561044440|FG006|Part B (Extension Period)|Adverse Event|5|||
155442118|NCT01469013|561044441|FG007|Part B (Extension Period)|Adverse Event|5|||
155442119|NCT01469013|561044442|FG008|Part B (Extension Period)|Adverse Event|3|||
155442120|NCT01469013|561044443|FG009|Part B (Extension Period)|Adverse Event|3|||
155442121|NCT01469013|561044444|FG010|Part B (Extension Period)|Adverse Event|1|||
155442122|NCT01469013|561044445|FG011|Part B (Extension Period)|Adverse Event|6|||
155442123|NCT01469013|561044446|FG012|Part B (Extension Period)|Adverse Event|3|||
155442124|NCT01469013|561044434|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
155442125|NCT01469013|561044435|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
155442126|NCT01469013|561044436|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
155442127|NCT01469013|561044437|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
155442128|NCT01469013|561044438|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
155442129|NCT01469013|561044439|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
155442130|NCT01469013|561044440|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
155442131|NCT01469013|561044441|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
155442132|NCT01469013|561044442|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
155442133|NCT01469013|561044443|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
155442134|NCT01469013|561044444|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
155442135|NCT01469013|561044445|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
155442136|NCT01469013|561044446|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
155442137|NCT05232097|561044447|FG000|Overall Study|Physician Decision|1|||
155442138|NCT01172288|561044450|FG000|Overall Study|Adverse Event|1|||
155442139|NCT01172288|561044451|FG001|Overall Study|Adverse Event|0|||
155442140|NCT01172288|561044450|FG000|Overall Study|Protocol Violation|0|||
155442141|NCT01172288|561044451|FG001|Overall Study|Protocol Violation|1|||
155442142|NCT01327339|561044452|FG000|Overall Study|Protocol Violation|8|||
155442143|NCT00871858|561044453|FG000|Overall Study|Protocol Violation|3|||
155442144|NCT00871858|561044454|FG001|Overall Study|Protocol Violation|4|||
155442145|NCT00871858|561044453|FG000|Overall Study|Adverse Event|1|||
155442146|NCT00871858|561044454|FG001|Overall Study|Adverse Event|1|||
155442147|NCT00871858|561044453|FG000|Overall Study|Withdrawal by Subject|1|||
155442148|NCT00871858|561044454|FG001|Overall Study|Withdrawal by Subject|1|||
155442149|NCT00871858|561044453|FG000|Overall Study|Lost to Follow-up|0|||
155442150|NCT00871858|561044454|FG001|Overall Study|Lost to Follow-up|1|||
155442151|NCT00700752|561044455|FG000|First Intervention|Withdrawal by Subject|0|||
155442152|NCT00700752|561044456|FG001|First Intervention|Withdrawal by Subject|2|||
155442153|NCT01302769|561044457|FG000|Overall Study|Lost to Follow-up|1|||
155442154|NCT01302769|561044458|FG001|Overall Study|Lost to Follow-up|1|||
155442155|NCT01734993|561044462|FG000|Overall Study|Adverse Event|1|||
155442156|NCT01734993|561044462|FG000|Overall Study|Lack of Efficacy|1|||
155442157|NCT01426386|561044463|FG000|Overall Study|Adverse Event|0|||
155442158|NCT01426386|561044464|FG001|Overall Study|Adverse Event|1|||
155442159|NCT01426386|561044465|FG002|Overall Study|Adverse Event|0|||
155442160|NCT01426386|561044466|FG003|Overall Study|Adverse Event|0|||
155442161|NCT01426386|561044467|FG004|Overall Study|Adverse Event|0|||
155442162|NCT01426386|561044468|FG005|Overall Study|Adverse Event|0|||
155442163|NCT01426386|561044463|FG000|Overall Study|Did not attend scheduled visit|1|||
155442164|NCT01426386|561044464|FG001|Overall Study|Did not attend scheduled visit|4|||
155442165|NCT01426386|561044465|FG002|Overall Study|Did not attend scheduled visit|0|||
155442166|NCT01426386|561044466|FG003|Overall Study|Did not attend scheduled visit|0|||
155442167|NCT01426386|561044467|FG004|Overall Study|Did not attend scheduled visit|2|||
155442168|NCT01426386|561044468|FG005|Overall Study|Did not attend scheduled visit|1|||
155442169|NCT01426386|561044463|FG000|Overall Study|Poor response|2|||
155442170|NCT01426386|561044464|FG001|Overall Study|Poor response|1|||
155442171|NCT01426386|561044465|FG002|Overall Study|Poor response|2|||
155442172|NCT01426386|561044466|FG003|Overall Study|Poor response|0|||
155442173|NCT01426386|561044467|FG004|Overall Study|Poor response|1|||
155442174|NCT01426386|561044468|FG005|Overall Study|Poor response|0|||
155442175|NCT01426386|561044463|FG000|Overall Study|Personal reasons|0|||
155442176|NCT01426386|561044464|FG001|Overall Study|Personal reasons|0|||
155442177|NCT01426386|561044465|FG002|Overall Study|Personal reasons|0|||
155442178|NCT01426386|561044466|FG003|Overall Study|Personal reasons|0|||
155442179|NCT01426386|561044467|FG004|Overall Study|Personal reasons|1|||
155442180|NCT01426386|561044468|FG005|Overall Study|Personal reasons|0|||
155442181|NCT01797432|561044471|FG000|Overall Study|Lost to Follow-up|1|||
155442182|NCT01797432|561044471|FG000|Overall Study|Adverse Event|1|||
155442183|NCT01797432|561044471|FG000|Overall Study|Withdrawal by Subject|1|||
155442184|NCT01797432|561044471|FG000|Overall Study|lived too far from study site|1|||
155442185|NCT02792777|561044472|FG000|Overall Study|Withdrawal by Subject|2|||
155442186|NCT02792777|561044473|FG001|Overall Study|Withdrawal by Subject|0|||
155442187|NCT02792777|561044472|FG000|Overall Study|Recording malfunction|2|||
155442188|NCT02792777|561044473|FG001|Overall Study|Recording malfunction|0|||
155442189|NCT02792777|561044472|FG000|Overall Study|Later determined to be ineligible|2|||
155442190|NCT02792777|561044473|FG001|Overall Study|Later determined to be ineligible|0|||
155442191|NCT02792777|561044472|FG000|Overall Study|Participant interviewed twice|1|||
155442192|NCT02792777|561044473|FG001|Overall Study|Participant interviewed twice|0|||
155442193|NCT00638846|561044474|FG000|Overall Study|Adverse Event|0|||
155442194|NCT00638846|561044475|FG001|Overall Study|Adverse Event|1|||
155442195|NCT00638846|561044474|FG000|Overall Study|Lost to Follow-up|3|||
155442196|NCT00638846|561044475|FG001|Overall Study|Lost to Follow-up|2|||
155442197|NCT00638846|561044474|FG000|Overall Study|lens issue|1|||
155442198|NCT00638846|561044475|FG001|Overall Study|lens issue|3|||
155442199|NCT03176966|561044479|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
155442200|NCT03176966|561044480|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
155442201|NCT03176966|561044479|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
155442202|NCT03176966|561044480|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
155442203|NCT03176966|561044479|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
155442204|NCT03176966|561044480|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
155442205|NCT03176966|561044479|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
155442206|NCT03176966|561044480|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
155442207|NCT03176966|561044479|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
155442208|NCT03176966|561044480|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
155442209|NCT03176966|561044479|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
155442210|NCT03176966|561044480|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
155442211|NCT03176966|561044479|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
155442212|NCT03176966|561044480|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
155442213|NCT01507246|561044481|FG000|Overall Study|Required different surgical procedures|2|||
155442214|NCT01507246|561044482|FG001|Overall Study|Required different surgical procedures|1|||
155442215|NCT03103750|561044483|FG000|Overall Study|Adverse Event|1|||
155442216|NCT03103750|561044484|FG001|Overall Study|Adverse Event|0|||
155442217|NCT03103750|561044483|FG000|Overall Study|Lost to Follow-up|1|||
155442218|NCT03103750|561044484|FG001|Overall Study|Lost to Follow-up|0|||
155442219|NCT03103750|561044483|FG000|Overall Study|PET Equipment Related|2|||
155442220|NCT03103750|561044484|FG001|Overall Study|PET Equipment Related|2|||
155442221|NCT01663740|561044486|FG000|Overall Study|Lost to Follow-up|1|||
155442222|NCT01663740|561044487|FG001|Overall Study|Lost to Follow-up|4|||
155442223|NCT01663740|561044486|FG000|Overall Study|Other|9|||
155442224|NCT01663740|561044487|FG001|Overall Study|Other|2|||
155442225|NCT01663740|561044486|FG000|Overall Study|Inclusion/Exclusion not met|1|||
155442226|NCT01663740|561044487|FG001|Overall Study|Inclusion/Exclusion not met|0|||
155442227|NCT01663740|561044486|FG000|Overall Study|Death|0|||
155442228|NCT01663740|561044487|FG001|Overall Study|Death|1|||
155442229|NCT01663740|561044486|FG000|Overall Study|Withdrawal by Subject|2|||
155442230|NCT01663740|561044487|FG001|Overall Study|Withdrawal by Subject|1|||
155442231|NCT01663740|561044486|FG000|Overall Study|No end of study status|3|||
155442232|NCT01663740|561044487|FG001|Overall Study|No end of study status|0|||
155442233|NCT03575468|561044490|FG000|Overall Study|Withdrawal by Subject|3|||
155442234|NCT03575468|561044491|FG001|Overall Study|Withdrawal by Subject|0|||
155442235|NCT03575468|561044490|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
155442236|NCT03575468|561044491|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
155442237|NCT03575468|561044490|FG000|Overall Study|Lost to Follow-up|13|||
155442238|NCT03575468|561044491|FG001|Overall Study|Lost to Follow-up|17|||
155651353|NCT01897896|561816184|FG000|Overall Study|Non-compliance with study drug dosing|1|||
155442239|NCT00404768|561044492|FG000|Part A and B|Withdrawn due to labor progression|1|||
155442240|NCT00404768|561044493|FG001|Part A and B|Withdrawn due to labor progression|0|||
155442241|NCT00404768|561044494|FG002|Part A and B|Withdrawn due to labor progression|0|||
155442242|NCT00404768|561044495|FG003|Part A and B|Withdrawn due to labor progression|0|||
155442243|NCT00404768|561044492|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
155442244|NCT00404768|561044493|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
155442245|NCT00404768|561044494|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
155442246|NCT00404768|561044495|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
155442247|NCT00404768|561044492|FG000|Part C|Adverse Event|0|||
155442248|NCT00404768|561044493|FG001|Part C|Adverse Event|0|||
155442249|NCT00404768|561044494|FG002|Part C|Adverse Event|0|||
155442250|NCT00404768|561044495|FG003|Part C|Adverse Event|3|||
155442251|NCT00404768|561044492|FG000|Part C|Lost to Follow-up|0|||
155442252|NCT00404768|561044493|FG001|Part C|Lost to Follow-up|0|||
155442253|NCT00404768|561044494|FG002|Part C|Lost to Follow-up|3|||
155442254|NCT00404768|561044495|FG003|Part C|Lost to Follow-up|1|||
155442255|NCT00404768|561044492|FG000|Part C|Withdrawal by Subject|0|||
155442256|NCT00404768|561044493|FG001|Part C|Withdrawal by Subject|0|||
155442257|NCT00404768|561044494|FG002|Part C|Withdrawal by Subject|2|||
155442258|NCT00404768|561044495|FG003|Part C|Withdrawal by Subject|1|||
155442259|NCT00404768|561044492|FG000|Part C|Early withdrawal from study medication|0|||
155442260|NCT00404768|561044493|FG001|Part C|Early withdrawal from study medication|0|||
155442261|NCT00404768|561044494|FG002|Part C|Early withdrawal from study medication|1|||
155442262|NCT00404768|561044495|FG003|Part C|Early withdrawal from study medication|0|||
155442263|NCT00404768|561044492|FG000|Part C|Participant did not respond to therapy|0|||
155442264|NCT00404768|561044493|FG001|Part C|Participant did not respond to therapy|0|||
155442265|NCT00404768|561044494|FG002|Part C|Participant did not respond to therapy|1|||
155442266|NCT00404768|561044495|FG003|Part C|Participant did not respond to therapy|1|||
155442267|NCT00404768|561044492|FG000|Part C|Physician withdrew the study medication|0|||
155442268|NCT00404768|561044493|FG001|Part C|Physician withdrew the study medication|0|||
155442269|NCT00404768|561044494|FG002|Part C|Physician withdrew the study medication|1|||
155442270|NCT00404768|561044495|FG003|Part C|Physician withdrew the study medication|0|||
155442271|NCT00404768|561044492|FG000|Part C|Participant delivered baby|0|||
155442272|NCT00404768|561044493|FG001|Part C|Participant delivered baby|0|||
155442273|NCT00404768|561044494|FG002|Part C|Participant delivered baby|0|||
155442274|NCT00404768|561044495|FG003|Part C|Participant delivered baby|1|||
155442275|NCT00404768|561044492|FG000|Part C|Unsatisfactory uterine response to IP|0|||
155442276|NCT00404768|561044493|FG001|Part C|Unsatisfactory uterine response to IP|0|||
155442277|NCT00404768|561044494|FG002|Part C|Unsatisfactory uterine response to IP|0|||
155442278|NCT00404768|561044495|FG003|Part C|Unsatisfactory uterine response to IP|1|||
155442279|NCT00404768|561044492|FG000|Part C|Active labor|0|||
155442280|NCT00404768|561044493|FG001|Part C|Active labor|0|||
155442281|NCT00404768|561044494|FG002|Part C|Active labor|0|||
155442282|NCT00404768|561044495|FG003|Part C|Active labor|1|||
155442283|NCT00404768|561044492|FG000|Part C|Lack of Efficacy|0|||
155442284|NCT00404768|561044493|FG001|Part C|Lack of Efficacy|0|||
155442285|NCT00404768|561044494|FG002|Part C|Lack of Efficacy|0|||
155442286|NCT00404768|561044495|FG003|Part C|Lack of Efficacy|2|||
155442287|NCT00404768|561044492|FG000|Part C|Treatment failure|0|||
155442288|NCT00404768|561044493|FG001|Part C|Treatment failure|0|||
155442289|NCT00404768|561044494|FG002|Part C|Treatment failure|0|||
155442290|NCT00404768|561044495|FG003|Part C|Treatment failure|1|||
155442291|NCT00404768|561044492|FG000|Part C|Investigator discretion|0|||
155442292|NCT00404768|561044493|FG001|Part C|Investigator discretion|0|||
155442293|NCT00404768|561044494|FG002|Part C|Investigator discretion|0|||
155442294|NCT00404768|561044495|FG003|Part C|Investigator discretion|1|||
155442295|NCT00404768|561044492|FG000|Part C|Researcher suspended study medication|0|||
155442296|NCT00404768|561044493|FG001|Part C|Researcher suspended study medication|0|||
155442297|NCT00404768|561044494|FG002|Part C|Researcher suspended study medication|0|||
155442298|NCT00404768|561044495|FG003|Part C|Researcher suspended study medication|1|||
155442299|NCT01522651|561044496|FG000|Overall Study|Adverse Event|3|||
155442300|NCT01522651|561044497|FG001|Overall Study|Adverse Event|4|||
155442301|NCT01522651|561044498|FG002|Overall Study|Adverse Event|4|||
155442302|NCT01522651|561044499|FG003|Overall Study|Adverse Event|5|||
155442303|NCT01522651|561044500|FG004|Overall Study|Adverse Event|4|||
155442304|NCT01522651|561044496|FG000|Overall Study|Cardioversion|1|||
155442305|NCT01522651|561044497|FG001|Overall Study|Cardioversion|0|||
155442306|NCT01522651|561044498|FG002|Overall Study|Cardioversion|0|||
155442307|NCT01522651|561044499|FG003|Overall Study|Cardioversion|0|||
155442308|NCT01522651|561044500|FG004|Overall Study|Cardioversion|0|||
155442309|NCT01522651|561044496|FG000|Overall Study|Device Malfunction|0|||
155442310|NCT01522651|561044497|FG001|Overall Study|Device Malfunction|1|||
155442311|NCT01522651|561044498|FG002|Overall Study|Device Malfunction|0|||
155442312|NCT01522651|561044499|FG003|Overall Study|Device Malfunction|0|||
155442313|NCT01522651|561044500|FG004|Overall Study|Device Malfunction|0|||
155442314|NCT01522651|561044496|FG000|Overall Study|Investigator's Discretion|0|||
155442315|NCT01522651|561044497|FG001|Overall Study|Investigator's Discretion|1|||
155442316|NCT01522651|561044498|FG002|Overall Study|Investigator's Discretion|0|||
155442317|NCT01522651|561044499|FG003|Overall Study|Investigator's Discretion|0|||
155442318|NCT01522651|561044500|FG004|Overall Study|Investigator's Discretion|0|||
155442319|NCT01522651|561044496|FG000|Overall Study|Protocol Violation|3|||
155515156|NCT02985957|561311531|FG000|Treatment Period|Maximum clinical benefit|0|||
155442320|NCT01522651|561044497|FG001|Overall Study|Protocol Violation|0|||
155515157|NCT02985957|561311532|FG001|Treatment Period|Maximum clinical benefit|0|||
155442321|NCT01522651|561044498|FG002|Overall Study|Protocol Violation|0|||
155442322|NCT01522651|561044499|FG003|Overall Study|Protocol Violation|0|||
155442323|NCT01522651|561044500|FG004|Overall Study|Protocol Violation|0|||
155442324|NCT01522651|561044496|FG000|Overall Study|Reason Not Specified|0|||
155442325|NCT01522651|561044497|FG001|Overall Study|Reason Not Specified|0|||
155442326|NCT01522651|561044498|FG002|Overall Study|Reason Not Specified|0|||
155442327|NCT01522651|561044499|FG003|Overall Study|Reason Not Specified|1|||
155442328|NCT01522651|561044500|FG004|Overall Study|Reason Not Specified|0|||
155442329|NCT01522651|561044496|FG000|Overall Study|Participant Non-Compliance|1|||
155442330|NCT01522651|561044497|FG001|Overall Study|Participant Non-Compliance|0|||
155442331|NCT01522651|561044498|FG002|Overall Study|Participant Non-Compliance|0|||
155442332|NCT01522651|561044499|FG003|Overall Study|Participant Non-Compliance|0|||
155442333|NCT01522651|561044500|FG004|Overall Study|Participant Non-Compliance|0|||
155442334|NCT01522651|561044496|FG000|Overall Study|Withdrew Consent|1|||
155442335|NCT01522651|561044497|FG001|Overall Study|Withdrew Consent|1|||
155442336|NCT01522651|561044498|FG002|Overall Study|Withdrew Consent|0|||
155442337|NCT01522651|561044499|FG003|Overall Study|Withdrew Consent|1|||
155442338|NCT01522651|561044500|FG004|Overall Study|Withdrew Consent|1|||
155442339|NCT01522651|561044496|FG000|Overall Study|Randomized but Never Treated|0|||
155442340|NCT01522651|561044497|FG001|Overall Study|Randomized but Never Treated|1|||
155442341|NCT01522651|561044498|FG002|Overall Study|Randomized but Never Treated|0|||
155442342|NCT01522651|561044499|FG003|Overall Study|Randomized but Never Treated|1|||
155442343|NCT01522651|561044500|FG004|Overall Study|Randomized but Never Treated|1|||
155442344|NCT02658656|561044501|FG000|Screening|Failed eligibility criteria|0|||
155442345|NCT02658656|561044502|FG001|Screening|Failed eligibility criteria|0|||
155442346|NCT02658656|561044503|FG002|Screening|Failed eligibility criteria|263|||
155442347|NCT02658656|561044501|FG000|Randomization|Withdrawal by Subject|8|||
155442348|NCT02658656|561044502|FG001|Randomization|Withdrawal by Subject|7|||
155442349|NCT02658656|561044503|FG002|Randomization|Withdrawal by Subject|0|||
155442350|NCT02658656|561044501|FG000|Randomization|Lost to Follow-up|1|||
155442351|NCT02658656|561044502|FG001|Randomization|Lost to Follow-up|3|||
155442352|NCT02658656|561044503|FG002|Randomization|Lost to Follow-up|0|||
155442353|NCT02658656|561044501|FG000|Randomization|Adverse Event|4|||
155442354|NCT02658656|561044502|FG001|Randomization|Adverse Event|0|||
155442355|NCT02658656|561044503|FG002|Randomization|Adverse Event|0|||
155442356|NCT02658656|561044501|FG000|Randomization|Administrative Termination|3|||
155442357|NCT02658656|561044502|FG001|Randomization|Administrative Termination|1|||
155442358|NCT02658656|561044503|FG002|Randomization|Administrative Termination|0|||
155442359|NCT02658656|561044501|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
155442360|NCT02658656|561044502|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
155442361|NCT02658656|561044503|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
155442362|NCT02658656|561044501|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
155442363|NCT02658656|561044502|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
155442364|NCT02658656|561044503|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
155442365|NCT02658656|561044501|FG000|Randomization|Not eligible for Randomization|1|||
155442366|NCT02658656|561044502|FG001|Randomization|Not eligible for Randomization|0|||
155442367|NCT02658656|561044503|FG002|Randomization|Not eligible for Randomization|0|||
155442368|NCT02658656|561044501|FG000|Randomization|Protocol Violation|1|||
155442369|NCT02658656|561044502|FG001|Randomization|Protocol Violation|0|||
155442370|NCT02658656|561044503|FG002|Randomization|Protocol Violation|0|||
155442371|NCT01118143|561044504|FG000|Overall Study|Withdrawal by Subject|2|||
155442372|NCT01118143|561044505|FG001|Overall Study|Withdrawal by Subject|5|||
155442373|NCT02112448|561044506|FG000|Overall Study|lab values precluding use of ketorolac|2|||
155442374|NCT02112448|561044507|FG001|Overall Study|lab values precluding use of ketorolac|2|||
155442375|NCT02112448|561044506|FG000|Overall Study|Protocol Violation|1|||
155442376|NCT02112448|561044507|FG001|Overall Study|Protocol Violation|2|||
155442377|NCT02112448|561044506|FG000|Overall Study|Physician Decision|4|||
155442378|NCT02112448|561044507|FG001|Overall Study|Physician Decision|6|||
155442379|NCT02112448|561044506|FG000|Overall Study|required heparin so could not use ketoro|1|||
155442380|NCT02112448|561044507|FG001|Overall Study|required heparin so could not use ketoro|0|||
155442381|NCT03918642|561046133|FG000|Overall Study|Lost to Follow-up|12|||
155442382|NCT03918642|561046134|FG001|Overall Study|Lost to Follow-up|10|||
155442383|NCT01115569|561046137|FG000|Conversion/Titration Phase|Adverse Event|59|||
155442384|NCT01115569|561046138|FG001|Conversion/Titration Phase|Adverse Event|0|||
155442385|NCT01115569|561046137|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
155442386|NCT01115569|561046138|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
155442387|NCT01115569|561046137|FG000|Conversion/Titration Phase|Physician Decision|5|||
155442388|NCT01115569|561046138|FG001|Conversion/Titration Phase|Physician Decision|0|||
155442389|NCT01115569|561046137|FG000|Conversion/Titration Phase|Protocol Violation|68|||
155442390|NCT01115569|561046138|FG001|Conversion/Titration Phase|Protocol Violation|0|||
155442391|NCT01115569|561046137|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
155442392|NCT01115569|561046138|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
155442393|NCT01115569|561046137|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
155442394|NCT01115569|561046138|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
155515158|NCT02985957|561311533|FG002|Treatment Period|Maximum clinical benefit|1|||
155442395|NCT01115569|561046137|FG000|Maintenance Phase|Adverse Event|0|||
155515159|NCT02985957|561311534|FG003|Treatment Period|Maximum clinical benefit|1|||
155515160|NCT02985957|561311535|FG004|Treatment Period|Maximum clinical benefit|0|||
155442396|NCT01115569|561046138|FG001|Maintenance Phase|Adverse Event|43|||
155442397|NCT01115569|561046137|FG000|Maintenance Phase|Lost to Follow-up|0|||
155442398|NCT01115569|561046138|FG001|Maintenance Phase|Lost to Follow-up|8|||
155442399|NCT01115569|561046137|FG000|Maintenance Phase|Physician Decision|0|||
155442400|NCT01115569|561046138|FG001|Maintenance Phase|Physician Decision|3|||
155442401|NCT01115569|561046137|FG000|Maintenance Phase|Protocol Violation|0|||
155442402|NCT01115569|561046138|FG001|Maintenance Phase|Protocol Violation|9|||
155442403|NCT01115569|561046137|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155442404|NCT01115569|561046138|FG001|Maintenance Phase|Withdrawal by Subject|27|||
155442405|NCT01115569|561046137|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
155442406|NCT01115569|561046138|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
155442407|NCT01115569|561046137|FG000|Maintenance Phase|Administrative|0|||
155442408|NCT01115569|561046138|FG001|Maintenance Phase|Administrative|1|||
155442409|NCT01070303|561046140|FG000|Overall Study|Adverse Event|39|||
155442410|NCT01070303|561046140|FG000|Overall Study|Withdrawal by Subject|20|||
155442411|NCT01070303|561046140|FG000|Overall Study|Lost to Follow-up|9|||
155442412|NCT01070303|561046140|FG000|Overall Study|Protocol Violation|0|||
155442413|NCT01070303|561046140|FG000|Overall Study|Lack of Efficacy|2|||
155442414|NCT01070303|561046140|FG000|Overall Study|Administrative Reason|1|||
155442415|NCT01070303|561046140|FG000|Overall Study|Other|18|||
155442416|NCT00859898|561046142|FG000|Overall Study|Lack of Efficacy|0|||
155442417|NCT00859898|561046143|FG001|Overall Study|Lack of Efficacy|1|||
155442418|NCT00859898|561046144|FG002|Overall Study|Lack of Efficacy|1|||
155442419|NCT00859898|561046142|FG000|Overall Study|Adverse Event|4|||
155442420|NCT00859898|561046143|FG001|Overall Study|Adverse Event|9|||
155442421|NCT00859898|561046144|FG002|Overall Study|Adverse Event|8|||
155442422|NCT00859898|561046142|FG000|Overall Study|Withdrawal by Subject|11|||
155442423|NCT00859898|561046143|FG001|Overall Study|Withdrawal by Subject|8|||
155442424|NCT00859898|561046144|FG002|Overall Study|Withdrawal by Subject|11|||
155442425|NCT00859898|561046142|FG000|Overall Study|Death|0|||
155442426|NCT00859898|561046143|FG001|Overall Study|Death|0|||
155442427|NCT00859898|561046144|FG002|Overall Study|Death|1|||
155442428|NCT00859898|561046142|FG000|Overall Study|Lost to Follow-up|10|||
155442429|NCT00859898|561046143|FG001|Overall Study|Lost to Follow-up|11|||
155442430|NCT00859898|561046144|FG002|Overall Study|Lost to Follow-up|5|||
155442431|NCT00859898|561046142|FG000|Overall Study|poor/non-compliance|2|||
155442432|NCT00859898|561046143|FG001|Overall Study|poor/non-compliance|0|||
155442433|NCT00859898|561046144|FG002|Overall Study|poor/non-compliance|0|||
155442434|NCT00859898|561046142|FG000|Overall Study|No longer meets criteria|0|||
155442435|NCT00859898|561046143|FG001|Overall Study|No longer meets criteria|1|||
155442436|NCT00859898|561046144|FG002|Overall Study|No longer meets criteria|0|||
155442437|NCT00859898|561046142|FG000|Overall Study|non-specified|1|||
155442438|NCT00859898|561046143|FG001|Overall Study|non-specified|1|||
155442439|NCT00859898|561046144|FG002|Overall Study|non-specified|1|||
155442440|NCT03350750|561046147|FG000|Overall Study|Death|1|||
155442441|NCT03350750|561046148|FG001|Overall Study|Death|1|||
155442442|NCT02202031|561046151|FG000|Overall Study|Lost to Follow-up|1|||
155442443|NCT02202031|561046152|FG001|Overall Study|Lost to Follow-up|0|||
155442444|NCT02202031|561046151|FG000|Overall Study|Too Busy|1|||
155442445|NCT02202031|561046152|FG001|Overall Study|Too Busy|3|||
155442446|NCT02202031|561046151|FG000|Overall Study|Illness/Medical Reason|0|||
155442447|NCT02202031|561046152|FG001|Overall Study|Illness/Medical Reason|2|||
155442448|NCT02202031|561046151|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
155442449|NCT02202031|561046152|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
155442450|NCT02184143|561046153|FG000|Overall Study|Withdrawal by Subject|4|||
155442451|NCT02184143|561046154|FG001|Overall Study|Withdrawal by Subject|4|||
155442452|NCT02184143|561046153|FG000|Overall Study|Lost to Follow-up|5|||
155442453|NCT02184143|561046154|FG001|Overall Study|Lost to Follow-up|3|||
155442454|NCT02184143|561046153|FG000|Overall Study|Death|1|||
155442455|NCT02184143|561046154|FG001|Overall Study|Death|0|||
155442456|NCT00321984|561046156|FG000|Overall Study|Adverse Event|9|||
155442457|NCT00321984|561046157|FG001|Overall Study|Adverse Event|6|||
155442458|NCT00321984|561046158|FG002|Overall Study|Adverse Event|8|||
155442459|NCT00321984|561046156|FG000|Overall Study|Protocol Violation|0|||
155442460|NCT00321984|561046157|FG001|Overall Study|Protocol Violation|1|||
155442461|NCT00321984|561046158|FG002|Overall Study|Protocol Violation|1|||
155442462|NCT00321984|561046156|FG000|Overall Study|Lost to Follow-up|2|||
155442463|NCT00321984|561046157|FG001|Overall Study|Lost to Follow-up|4|||
155442464|NCT00321984|561046158|FG002|Overall Study|Lost to Follow-up|2|||
155442465|NCT00321984|561046156|FG000|Overall Study|Withdrawal by Subject|8|||
155442466|NCT00321984|561046157|FG001|Overall Study|Withdrawal by Subject|6|||
155442467|NCT00321984|561046158|FG002|Overall Study|Withdrawal by Subject|5|||
155442468|NCT00321984|561046156|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
155442469|NCT00321984|561046157|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
155442470|NCT00321984|561046158|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
155442471|NCT00321984|561046156|FG000|Overall Study|Lack of Efficacy|3|||
155442472|NCT00321984|561046157|FG001|Overall Study|Lack of Efficacy|1|||
155442473|NCT00321984|561046158|FG002|Overall Study|Lack of Efficacy|3|||
155442474|NCT00321984|561046156|FG000|Overall Study|Noncompliant|0|||
155442475|NCT00321984|561046157|FG001|Overall Study|Noncompliant|0|||
155442476|NCT00321984|561046158|FG002|Overall Study|Noncompliant|2|||
155442477|NCT00321984|561046156|FG000|Overall Study|Pregnancy|0|||
155442478|NCT00321984|561046157|FG001|Overall Study|Pregnancy|1|||
155442479|NCT00321984|561046158|FG002|Overall Study|Pregnancy|0|||
155442480|NCT00321984|561046156|FG000|Overall Study|Per Subject Request|1|||
155442481|NCT00321984|561046157|FG001|Overall Study|Per Subject Request|0|||
155442482|NCT00321984|561046158|FG002|Overall Study|Per Subject Request|0|||
155442483|NCT00321984|561046156|FG000|Overall Study|Per Investigator Request|1|||
155442484|NCT00321984|561046157|FG001|Overall Study|Per Investigator Request|0|||
155442485|NCT00321984|561046158|FG002|Overall Study|Per Investigator Request|0|||
155442486|NCT00321984|561046156|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
155442487|NCT00321984|561046157|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
155442488|NCT00321984|561046158|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
155442489|NCT02214186|561046161|FG000|Overall Study|Lost to Follow-up|1|||
155442490|NCT02214186|561046162|FG001|Overall Study|Lost to Follow-up|1|||
155442491|NCT02214186|561046161|FG000|Overall Study|Protocol Violation|1|||
155442492|NCT02214186|561046162|FG001|Overall Study|Protocol Violation|1|||
155442493|NCT01525849|561046163|FG000|Overall Study|Lost to Follow-up|3|||
155442494|NCT01525849|561046164|FG001|Overall Study|Lost to Follow-up|2|||
155442495|NCT01525849|561046163|FG000|Overall Study|Withdrawal by Subject|1|||
155442496|NCT01525849|561046164|FG001|Overall Study|Withdrawal by Subject|9|||
155442497|NCT01525849|561046163|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
155442498|NCT01525849|561046164|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
155442499|NCT01525849|561046163|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
155442500|NCT01525849|561046164|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
155442501|NCT00611130|561046175|FG000|Overall Study|Lost to Follow-up|25|||
155442502|NCT00611130|561046176|FG001|Overall Study|Lost to Follow-up|29|||
155442503|NCT00611130|561046175|FG000|Overall Study|Protocol noncompliance|7|||
155442504|NCT00611130|561046176|FG001|Overall Study|Protocol noncompliance|6|||
155442505|NCT00611130|561046175|FG000|Overall Study|Withdrawal by Subject|6|||
155442506|NCT00611130|561046176|FG001|Overall Study|Withdrawal by Subject|5|||
155442507|NCT00611130|561046175|FG000|Overall Study|Other|5|||
155442508|NCT00611130|561046176|FG001|Overall Study|Other|4|||
155442509|NCT00611130|561046175|FG000|Overall Study|Incarceration|3|||
155442510|NCT00611130|561046176|FG001|Overall Study|Incarceration|2|||
155442511|NCT00611130|561046175|FG000|Overall Study|Administrative|1|||
155442512|NCT00611130|561046176|FG001|Overall Study|Administrative|1|||
155442513|NCT00611130|561046175|FG000|Overall Study|Adverse Event|1|||
155442514|NCT00611130|561046176|FG001|Overall Study|Adverse Event|0|||
155442515|NCT00611130|561046175|FG000|Overall Study|Death|1|||
155442516|NCT00611130|561046176|FG001|Overall Study|Death|0|||
155442517|NCT03303339|561046178|FG000|Overall Study|Death|2|||
155442518|NCT03303339|561046179|FG001|Overall Study|Death|2|||
155515161|NCT02985957|561311536|FG005|Treatment Period|Maximum clinical benefit|0|||
155515162|NCT02985957|561311537|FG006|Treatment Period|Maximum clinical benefit|2|||
155442519|NCT03303339|561046180|FG002|Overall Study|Death|2|||
155442520|NCT03303339|561046181|FG003|Overall Study|Death|1|||
155442521|NCT03303339|561046182|FG004|Overall Study|Death|4|||
155442522|NCT03303339|561046183|FG005|Overall Study|Death|2|||
155442523|NCT03303339|561046184|FG006|Overall Study|Death|2|||
155442524|NCT03303339|561046185|FG007|Overall Study|Death|2|||
155442525|NCT03303339|561046186|FG008|Overall Study|Death|3|||
155442526|NCT03303339|561046187|FG009|Overall Study|Death|3|||
155442527|NCT03303339|561046188|FG010|Overall Study|Death|4|||
155442528|NCT03303339|561046189|FG011|Overall Study|Death|24|||
155442529|NCT03303339|561046178|FG000|Overall Study|Study Terminated by Sponsor|0|||
155442530|NCT03303339|561046179|FG001|Overall Study|Study Terminated by Sponsor|0|||
155442531|NCT03303339|561046180|FG002|Overall Study|Study Terminated by Sponsor|0|||
155442532|NCT03303339|561046181|FG003|Overall Study|Study Terminated by Sponsor|0|||
155442533|NCT03303339|561046182|FG004|Overall Study|Study Terminated by Sponsor|0|||
155442534|NCT03303339|561046183|FG005|Overall Study|Study Terminated by Sponsor|0|||
155442535|NCT03303339|561046184|FG006|Overall Study|Study Terminated by Sponsor|0|||
155442536|NCT03303339|561046185|FG007|Overall Study|Study Terminated by Sponsor|0|||
155442537|NCT03303339|561046186|FG008|Overall Study|Study Terminated by Sponsor|1|||
155442538|NCT03303339|561046187|FG009|Overall Study|Study Terminated by Sponsor|0|||
155442539|NCT03303339|561046188|FG010|Overall Study|Study Terminated by Sponsor|1|||
155442540|NCT03303339|561046189|FG011|Overall Study|Study Terminated by Sponsor|1|||
155442541|NCT03303339|561046178|FG000|Overall Study|Withdrawal by Subject|1|||
155442542|NCT03303339|561046179|FG001|Overall Study|Withdrawal by Subject|0|||
155442543|NCT03303339|561046180|FG002|Overall Study|Withdrawal by Subject|0|||
155442544|NCT03303339|561046181|FG003|Overall Study|Withdrawal by Subject|0|||
155442545|NCT03303339|561046182|FG004|Overall Study|Withdrawal by Subject|0|||
155442546|NCT03303339|561046183|FG005|Overall Study|Withdrawal by Subject|1|||
155442547|NCT03303339|561046184|FG006|Overall Study|Withdrawal by Subject|1|||
155442548|NCT03303339|561046185|FG007|Overall Study|Withdrawal by Subject|0|||
155442549|NCT03303339|561046186|FG008|Overall Study|Withdrawal by Subject|0|||
155442550|NCT03303339|561046187|FG009|Overall Study|Withdrawal by Subject|0|||
155442551|NCT03303339|561046188|FG010|Overall Study|Withdrawal by Subject|0|||
155442552|NCT03303339|561046189|FG011|Overall Study|Withdrawal by Subject|2|||
155442553|NCT03303339|561046178|FG000|Overall Study|Physician Decision|0|||
155442554|NCT03303339|561046179|FG001|Overall Study|Physician Decision|0|||
155442555|NCT03303339|561046180|FG002|Overall Study|Physician Decision|0|||
155442556|NCT03303339|561046181|FG003|Overall Study|Physician Decision|0|||
155442557|NCT03303339|561046182|FG004|Overall Study|Physician Decision|1|||
155442558|NCT03303339|561046183|FG005|Overall Study|Physician Decision|0|||
155442559|NCT03303339|561046184|FG006|Overall Study|Physician Decision|0|||
155442560|NCT03303339|561046185|FG007|Overall Study|Physician Decision|0|||
155442561|NCT03303339|561046186|FG008|Overall Study|Physician Decision|0|||
155442562|NCT03303339|561046187|FG009|Overall Study|Physician Decision|0|||
155442563|NCT03303339|561046188|FG010|Overall Study|Physician Decision|0|||
155442564|NCT03303339|561046189|FG011|Overall Study|Physician Decision|0|||
155442565|NCT03303339|561046178|FG000|Overall Study|Safety/Non-compliance|0|||
155442566|NCT03303339|561046179|FG001|Overall Study|Safety/Non-compliance|0|||
155442567|NCT03303339|561046180|FG002|Overall Study|Safety/Non-compliance|0|||
155442568|NCT03303339|561046181|FG003|Overall Study|Safety/Non-compliance|0|||
155442569|NCT03303339|561046182|FG004|Overall Study|Safety/Non-compliance|0|||
155442570|NCT03303339|561046183|FG005|Overall Study|Safety/Non-compliance|0|||
155442571|NCT03303339|561046184|FG006|Overall Study|Safety/Non-compliance|0|||
155442572|NCT03303339|561046185|FG007|Overall Study|Safety/Non-compliance|0|||
155442573|NCT03303339|561046186|FG008|Overall Study|Safety/Non-compliance|0|||
155442574|NCT03303339|561046187|FG009|Overall Study|Safety/Non-compliance|0|||
155442575|NCT03303339|561046188|FG010|Overall Study|Safety/Non-compliance|0|||
155442576|NCT03303339|561046189|FG011|Overall Study|Safety/Non-compliance|1|||
155442577|NCT03694522|561046190|FG000|Overall Study|Withdrawal by Subject|8|||
155442578|NCT03694522|561046191|FG001|Overall Study|Withdrawal by Subject|10|||
155442579|NCT03694522|561046190|FG000|Overall Study|Physician Decision|53|||
155442580|NCT03694522|561046191|FG001|Overall Study|Physician Decision|54|||
155442581|NCT03694522|561046190|FG000|Overall Study|Other|1|||
155442582|NCT03694522|561046191|FG001|Overall Study|Other|1|||
155651354|NCT01897896|561816185|FG001|Overall Study|Non-compliance with study drug dosing|1|||
155442583|NCT03694522|561046190|FG000|Overall Study|Lost to Follow-up|0|||
155442584|NCT03694522|561046191|FG001|Overall Study|Lost to Follow-up|1|||
155442585|NCT02760407|561046192|FG000|Overall Study|Death|2|||
155442586|NCT02760407|561046193|FG001|Overall Study|Death|3|||
155442587|NCT02760407|561046194|FG002|Overall Study|Death|1|||
155442588|NCT02760407|561046195|FG003|Overall Study|Death|1|||
155651355|NCT01897896|561816184|FG000|Overall Study|Withdrawal by Subject|7|||
155442589|NCT02760407|561046192|FG000|Overall Study|Lost to Follow-up|1|||
155442590|NCT02760407|561046193|FG001|Overall Study|Lost to Follow-up|7|||
155442591|NCT02760407|561046194|FG002|Overall Study|Lost to Follow-up|4|||
155442592|NCT02760407|561046195|FG003|Overall Study|Lost to Follow-up|6|||
155442593|NCT02760407|561046192|FG000|Overall Study|Withdrawal by Subject|25|||
155442594|NCT02760407|561046193|FG001|Overall Study|Withdrawal by Subject|31|||
155442595|NCT02760407|561046194|FG002|Overall Study|Withdrawal by Subject|37|||
155442596|NCT02760407|561046195|FG003|Overall Study|Withdrawal by Subject|25|||
155442597|NCT02760407|561046192|FG000|Overall Study|Violation of Eligibility criteria|0|||
155442598|NCT02760407|561046193|FG001|Overall Study|Violation of Eligibility criteria|0|||
155442599|NCT02760407|561046194|FG002|Overall Study|Violation of Eligibility criteria|1|||
155442600|NCT02760407|561046195|FG003|Overall Study|Violation of Eligibility criteria|1|||
155442601|NCT02760407|561046192|FG000|Overall Study|Personal reasons|0|||
155442602|NCT02760407|561046193|FG001|Overall Study|Personal reasons|0|||
155442603|NCT02760407|561046194|FG002|Overall Study|Personal reasons|0|||
155442604|NCT02760407|561046195|FG003|Overall Study|Personal reasons|1|||
155442605|NCT02760407|561046192|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
155442606|NCT02760407|561046193|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
155442607|NCT02760407|561046194|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
155442608|NCT02760407|561046195|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
155442609|NCT02760407|561046192|FG000|Overall Study|Use of prohibited Medication|0|||
155442610|NCT02760407|561046193|FG001|Overall Study|Use of prohibited Medication|0|||
155442611|NCT02760407|561046194|FG002|Overall Study|Use of prohibited Medication|1|||
155442612|NCT02760407|561046195|FG003|Overall Study|Use of prohibited Medication|0|||
155442613|NCT02760407|561046192|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
155442614|NCT02760407|561046193|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
155442615|NCT02760407|561046194|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
155442616|NCT02760407|561046195|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
155442617|NCT02760407|561046192|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
155442618|NCT02760407|561046193|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
155442619|NCT02760407|561046194|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
155442620|NCT02760407|561046195|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
155442621|NCT02760407|561046192|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
155442622|NCT02760407|561046193|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
155442623|NCT02760407|561046194|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
155442624|NCT02760407|561046195|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
155442625|NCT02760407|561046192|FG000|Overall Study|Inadequately Enrolled|0|||
155442626|NCT02760407|561046193|FG001|Overall Study|Inadequately Enrolled|0|||
155442627|NCT02760407|561046194|FG002|Overall Study|Inadequately Enrolled|0|||
155442628|NCT02760407|561046195|FG003|Overall Study|Inadequately Enrolled|1|||
155442629|NCT02760407|561046192|FG000|Overall Study|Withdrawal By PI's Decision|0|||
155442630|NCT02760407|561046193|FG001|Overall Study|Withdrawal By PI's Decision|1|||
155442631|NCT02760407|561046194|FG002|Overall Study|Withdrawal By PI's Decision|0|||
155442632|NCT02760407|561046195|FG003|Overall Study|Withdrawal By PI's Decision|0|||
155442633|NCT02760407|561046192|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
155442634|NCT02760407|561046193|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
155442635|NCT02760407|561046194|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
155442636|NCT02760407|561046195|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
155442637|NCT02760407|561046192|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
155442638|NCT02760407|561046193|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
155442639|NCT02760407|561046194|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
155442640|NCT02760407|561046195|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
155442641|NCT02760407|561046192|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
155442642|NCT02760407|561046193|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
155442643|NCT02760407|561046194|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
155442644|NCT02760407|561046195|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
155442645|NCT02760407|561046192|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
155442646|NCT02760407|561046193|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
155442647|NCT02760407|561046194|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
155442648|NCT02760407|561046195|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
155442649|NCT02760407|561046192|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
155442650|NCT02760407|561046193|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
155442651|NCT02760407|561046194|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
155442652|NCT02760407|561046195|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
155442653|NCT02760407|561046192|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
155442654|NCT02760407|561046193|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
155442655|NCT02760407|561046194|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
155442656|NCT02760407|561046195|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
155442657|NCT02760407|561046192|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
155442658|NCT02760407|561046193|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
155442659|NCT02760407|561046194|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
155442660|NCT02760407|561046195|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
155442661|NCT02760407|561046192|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
155442662|NCT02760407|561046193|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
155442663|NCT02760407|561046194|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
155442664|NCT02760407|561046195|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
155442665|NCT02760407|561046192|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
155442666|NCT02760407|561046193|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
155442667|NCT02760407|561046194|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
155442668|NCT02760407|561046195|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
155442669|NCT02522377|561046196|FG000|Overall Study|Withdrawal by Subject|1|||
155442670|NCT02522377|561046197|FG001|Overall Study|Withdrawal by Subject|0|||
155442671|NCT02522377|561046196|FG000|Overall Study|Remission Achieved|3|||
155442672|NCT02522377|561046197|FG001|Overall Study|Remission Achieved|0|||
155442673|NCT01158950|561046198|FG000|1st Intervention (1 Day)|Physician Decision|1|||
155442674|NCT01158950|561046199|FG001|1st Intervention (1 Day)|Physician Decision|2|||
155515163|NCT02985957|561311531|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
155515164|NCT02985957|561311532|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
155442675|NCT02137772|561046202|FG000|Overall Study|Adverse Event|6|||
155442676|NCT02137772|561046203|FG001|Overall Study|Adverse Event|3|||
155442677|NCT02137772|561046202|FG000|Overall Study|Death|71|||
155442678|NCT02137772|561046203|FG001|Overall Study|Death|44|||
155442679|NCT02137772|561046202|FG000|Overall Study|Lost to Follow-up|8|||
155442680|NCT02137772|561046203|FG001|Overall Study|Lost to Follow-up|4|||
155442681|NCT02137772|561046202|FG000|Overall Study|Physician Decision|15|||
155442682|NCT02137772|561046203|FG001|Overall Study|Physician Decision|5|||
155442683|NCT02137772|561046202|FG000|Overall Study|Withdrawal by Subject|28|||
155442684|NCT02137772|561046203|FG001|Overall Study|Withdrawal by Subject|17|||
155442685|NCT02137772|561046202|FG000|Overall Study|Non-compliance with study drug|1|||
155442686|NCT02137772|561046203|FG001|Overall Study|Non-compliance with study drug|0|||
155442687|NCT02137772|561046202|FG000|Overall Study|Not treated|3|||
155442688|NCT02137772|561046203|FG001|Overall Study|Not treated|2|||
155442689|NCT01844700|561046204|FG000|Overall Study|Lack of Efficacy|1|||
155442690|NCT01844700|561046205|FG001|Overall Study|Lack of Efficacy|0|||
155442691|NCT01844700|561046204|FG000|Overall Study|refused medication switch|1|||
155442692|NCT01844700|561046205|FG001|Overall Study|refused medication switch|0|||
155442693|NCT01844700|561046204|FG000|Overall Study|Withdrawal by Subject|1|||
155442694|NCT01844700|561046205|FG001|Overall Study|Withdrawal by Subject|0|||
155442695|NCT01844700|561046204|FG000|Overall Study|stopped taking meds|0|||
155442696|NCT01844700|561046205|FG001|Overall Study|stopped taking meds|1|||
155442697|NCT03290300|561046206|FG000|Overall Study|Lost to Follow-up|3|||
155442698|NCT00864227|561046207|FG000|Overall Study|Withdrawal by Subject|1|||
155442699|NCT00864227|561046207|FG000|Overall Study|Disease Relapse/Progression|3|||
155442700|NCT02124798|561046208|FG000|Overall Study|Adverse Event|3|||
155442701|NCT02124798|561046208|FG000|Overall Study|Lost to Follow-up|1|||
155442702|NCT00487279|561046216|FG000|Overall Study|Death|1|||
155442703|NCT00487279|561046217|FG001|Overall Study|Death|0|||
155442704|NCT00487279|561046216|FG000|Overall Study|Withdrawal by Subject|0|||
155442705|NCT00487279|561046217|FG001|Overall Study|Withdrawal by Subject|2|||
155442706|NCT02746679|561046218|FG000|Overall Study|Lost to Follow-up|4|||
155442707|NCT02746679|561046219|FG001|Overall Study|Lost to Follow-up|6|||
155442708|NCT00501852|561046220|FG000|Overall Study|Adverse Event|3|||
155442709|NCT00501852|561046220|FG000|Overall Study|Withdrawal by Subject|2|||
155442710|NCT01171521|561046223|FG000|Overall Study|Lost to Follow-up|5|||
155442711|NCT01171521|561046223|FG000|Overall Study|screen failure|1|||
155442712|NCT01416610|561046225|FG000|Overall Study|Adverse Event|4|||
155442713|NCT01416610|561046225|FG000|Overall Study|Adverse Event -Patient decision|3|||
155442714|NCT01416610|561046225|FG000|Overall Study|Lack of Efficacy|4|||
155442715|NCT01416610|561046225|FG000|Overall Study|No reason given|5|||
155442716|NCT01416610|561046225|FG000|Overall Study|Withdrawal by Subject|13|||
155442717|NCT01416610|561046225|FG000|Overall Study|Lost to Follow-up|7|||
155442718|NCT01416610|561046225|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
155442719|NCT01520922|561046226|FG000|Treatment Phase|Physician Decision|2|||
155442720|NCT01520922|561046227|FG001|Treatment Phase|Physician Decision|1|||
155442721|NCT01520922|561046226|FG000|Treatment Phase|Progression|0|||
155442722|NCT01520922|561046227|FG001|Treatment Phase|Progression|2|||
155442723|NCT01520922|561046226|FG000|Treatment Phase|Adverse Event|3|||
155442724|NCT01520922|561046227|FG001|Treatment Phase|Adverse Event|5|||
155442725|NCT01520922|561046226|FG000|Follow up|Lost to Follow-up|0|||
155442726|NCT01520922|561046227|FG001|Follow up|Lost to Follow-up|1|||
155442727|NCT01520922|561046226|FG000|Survival Follow-up|Withdrawal by Subject|1|||
155442728|NCT01520922|561046227|FG001|Survival Follow-up|Withdrawal by Subject|0|||
155442729|NCT01696877|561046230|FG000|Overall Study|Adverse Event|0|||
155442730|NCT01696877|561046231|FG001|Overall Study|Adverse Event|1|||
155442731|NCT01422304|561046234|FG000|Overall Study|Adverse Event|0|||
155442732|NCT01422304|561046235|FG001|Overall Study|Adverse Event|1|||
155442733|NCT01422304|561046234|FG000|Overall Study|Lost to Follow-up|14|||
155442734|NCT01422304|561046235|FG001|Overall Study|Lost to Follow-up|20|||
155442735|NCT01422304|561046234|FG000|Overall Study|Never Entered Follow-up|2|||
155442736|NCT01422304|561046235|FG001|Overall Study|Never Entered Follow-up|1|||
155442737|NCT01422304|561046234|FG000|Overall Study|Protocol Violation|1|||
155442738|NCT01422304|561046235|FG001|Overall Study|Protocol Violation|0|||
155442739|NCT01422304|561046234|FG000|Overall Study|Withdrawal by Subject|4|||
155442740|NCT01422304|561046235|FG001|Overall Study|Withdrawal by Subject|2|||
155442741|NCT01422304|561046234|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
155442742|NCT01422304|561046235|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
155442743|NCT01422304|561046234|FG000|Overall Study|Not Treated|3|||
155442744|NCT01422304|561046235|FG001|Overall Study|Not Treated|11|||
155442745|NCT00469014|561046238|FG000|Initial Phase Randomization|Disease Progression|0|||
155442746|NCT00469014|561046239|FG001|Initial Phase Randomization|Disease Progression|1|||
155442747|NCT00469014|561046240|FG002|Initial Phase Randomization|Disease Progression|1|||
155442748|NCT00469014|561046241|FG003|Initial Phase Randomization|Disease Progression|0|||
155442749|NCT00469014|561046238|FG000|Initial Phase Randomization|No Response|1|||
155442750|NCT00469014|561046239|FG001|Initial Phase Randomization|No Response|0|||
155442751|NCT00469014|561046240|FG002|Initial Phase Randomization|No Response|0|||
155442752|NCT00469014|561046241|FG003|Initial Phase Randomization|No Response|1|||
155442753|NCT00469014|561046238|FG000|Adaptive Randomization|Not Evaluable|1|||
155442754|NCT00469014|561046239|FG001|Adaptive Randomization|Not Evaluable|0|||
155442755|NCT00469014|561046240|FG002|Adaptive Randomization|Not Evaluable|0|||
155442756|NCT00469014|561046241|FG003|Adaptive Randomization|Not Evaluable|1|||
155442757|NCT00469014|561046238|FG000|Adaptive Randomization|No Response|0|||
155442758|NCT00469014|561046239|FG001|Adaptive Randomization|No Response|1|||
155442759|NCT00469014|561046240|FG002|Adaptive Randomization|No Response|0|||
155442760|NCT00469014|561046241|FG003|Adaptive Randomization|No Response|0|||
155442761|NCT00469014|561046238|FG000|Adaptive Randomization|Death|0|||
155442762|NCT00469014|561046239|FG001|Adaptive Randomization|Death|0|||
155442763|NCT00469014|561046240|FG002|Adaptive Randomization|Death|1|||
155442764|NCT00469014|561046241|FG003|Adaptive Randomization|Death|0|||
155442765|NCT03461289|561046245|FG000|Overall Study|Death|1|||
155442766|NCT00866294|561046246|FG000|Overall Study|Adverse Event|12|||
155442767|NCT00866294|561046247|FG001|Overall Study|Adverse Event|13|||
155442768|NCT00866294|561046248|FG002|Overall Study|Adverse Event|9|||
155442769|NCT00866294|561046246|FG000|Overall Study|Lack of Efficacy|7|||
155442770|NCT00866294|561046247|FG001|Overall Study|Lack of Efficacy|1|||
155442771|NCT00866294|561046248|FG002|Overall Study|Lack of Efficacy|0|||
155442772|NCT00866294|561046246|FG000|Overall Study|Protocol Violation|2|||
155442773|NCT00866294|561046247|FG001|Overall Study|Protocol Violation|0|||
155442774|NCT00866294|561046248|FG002|Overall Study|Protocol Violation|0|||
155442775|NCT00866294|561046246|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
155442776|NCT00866294|561046247|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155442777|NCT00866294|561046248|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155442778|NCT00866294|561046246|FG000|Overall Study|Lost to Follow-up|1|||
155442779|NCT00866294|561046247|FG001|Overall Study|Lost to Follow-up|3|||
155442780|NCT00866294|561046248|FG002|Overall Study|Lost to Follow-up|0|||
155442781|NCT00866294|561046246|FG000|Overall Study|Physician Decision|6|||
155442782|NCT00866294|561046247|FG001|Overall Study|Physician Decision|2|||
155442783|NCT00866294|561046248|FG002|Overall Study|Physician Decision|1|||
155442784|NCT03241173|561046249|FG000|Overall Study|Death|3|||
155442785|NCT03241173|561046250|FG001|Overall Study|Death|2|||
155442786|NCT03241173|561046251|FG002|Overall Study|Death|4|||
155442787|NCT03241173|561046252|FG003|Overall Study|Death|4|||
155442788|NCT03241173|561046253|FG004|Overall Study|Death|2|||
155442789|NCT03241173|561046254|FG005|Overall Study|Death|2|||
155442790|NCT03241173|561046255|FG006|Overall Study|Death|3|||
155442791|NCT03241173|561046256|FG007|Overall Study|Death|1|||
155442792|NCT03241173|561046257|FG008|Overall Study|Death|0|||
155442793|NCT03241173|561046258|FG009|Overall Study|Death|5|||
155442794|NCT03241173|561046259|FG010|Overall Study|Death|4|||
155442795|NCT03241173|561046260|FG011|Overall Study|Death|3|||
155442796|NCT03241173|561046261|FG012|Overall Study|Death|0|||
155442797|NCT03241173|561046262|FG013|Overall Study|Death|0|||
155442798|NCT03241173|561046263|FG014|Overall Study|Death|0|||
155442799|NCT03241173|561046249|FG000|Overall Study|Withdrawal by Subject|0|||
155442800|NCT03241173|561046250|FG001|Overall Study|Withdrawal by Subject|0|||
155442801|NCT03241173|561046251|FG002|Overall Study|Withdrawal by Subject|1|||
155442802|NCT03241173|561046252|FG003|Overall Study|Withdrawal by Subject|0|||
155442803|NCT03241173|561046253|FG004|Overall Study|Withdrawal by Subject|0|||
155442804|NCT03241173|561046254|FG005|Overall Study|Withdrawal by Subject|1|||
155442805|NCT03241173|561046255|FG006|Overall Study|Withdrawal by Subject|0|||
155442806|NCT03241173|561046256|FG007|Overall Study|Withdrawal by Subject|0|||
155442807|NCT03241173|561046257|FG008|Overall Study|Withdrawal by Subject|0|||
155442808|NCT03241173|561046258|FG009|Overall Study|Withdrawal by Subject|0|||
155442809|NCT03241173|561046259|FG010|Overall Study|Withdrawal by Subject|0|||
155442810|NCT03241173|561046260|FG011|Overall Study|Withdrawal by Subject|0|||
155442811|NCT03241173|561046261|FG012|Overall Study|Withdrawal by Subject|0|||
155442812|NCT03241173|561046262|FG013|Overall Study|Withdrawal by Subject|0|||
155442813|NCT03241173|561046263|FG014|Overall Study|Withdrawal by Subject|0|||
155442814|NCT03241173|561046249|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
155442815|NCT03241173|561046250|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
155442816|NCT03241173|561046251|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442817|NCT03241173|561046252|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
155442818|NCT03241173|561046253|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
155442819|NCT03241173|561046254|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
155442820|NCT03241173|561046255|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
155442821|NCT03241173|561046256|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
155442822|NCT03241173|561046257|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442823|NCT03241173|561046258|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442824|NCT03241173|561046259|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
155442825|NCT03241173|561046260|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
155442826|NCT03241173|561046261|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442827|NCT03241173|561046262|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442828|NCT03241173|561046263|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
155442829|NCT03241173|561046249|FG000|Overall Study|Lost to Follow-up|0|||
155442830|NCT03241173|561046250|FG001|Overall Study|Lost to Follow-up|0|||
155442831|NCT03241173|561046251|FG002|Overall Study|Lost to Follow-up|0|||
155442832|NCT03241173|561046252|FG003|Overall Study|Lost to Follow-up|0|||
155442833|NCT03241173|561046253|FG004|Overall Study|Lost to Follow-up|1|||
155442834|NCT03241173|561046254|FG005|Overall Study|Lost to Follow-up|0|||
155442835|NCT03241173|561046255|FG006|Overall Study|Lost to Follow-up|0|||
155442836|NCT03241173|561046256|FG007|Overall Study|Lost to Follow-up|0|||
155442837|NCT03241173|561046257|FG008|Overall Study|Lost to Follow-up|0|||
155442838|NCT03241173|561046258|FG009|Overall Study|Lost to Follow-up|1|||
155442839|NCT03241173|561046259|FG010|Overall Study|Lost to Follow-up|0|||
155442840|NCT03241173|561046260|FG011|Overall Study|Lost to Follow-up|0|||
155442841|NCT03241173|561046261|FG012|Overall Study|Lost to Follow-up|0|||
155442842|NCT03241173|561046262|FG013|Overall Study|Lost to Follow-up|0|||
155442843|NCT03241173|561046263|FG014|Overall Study|Lost to Follow-up|0|||
155442844|NCT00515463|561046264|FG000|Overall Study|Physician Decision|4|||
155442845|NCT00515463|561046265|FG001|Overall Study|Physician Decision|2|||
155442846|NCT00515463|561046264|FG000|Overall Study|Adverse Event|1|||
155442847|NCT00515463|561046265|FG001|Overall Study|Adverse Event|2|||
155442848|NCT00515463|561046264|FG000|Overall Study|Withdrawal by Subject|3|||
155442849|NCT00515463|561046265|FG001|Overall Study|Withdrawal by Subject|4|||
155442850|NCT00515463|561046264|FG000|Overall Study|Lost to Follow-up|6|||
155442851|NCT00515463|561046265|FG001|Overall Study|Lost to Follow-up|5|||
155442852|NCT00515463|561046264|FG000|Overall Study|Other|0|||
155442853|NCT00515463|561046265|FG001|Overall Study|Other|1|||
155442854|NCT00916721|561046266|FG000|Overall Study|Lost to Follow-up|0|||
155442855|NCT00916721|561046267|FG001|Overall Study|Lost to Follow-up|1|||
155442856|NCT00916721|561046266|FG000|Overall Study|Adverse Event|6|||
155442857|NCT00916721|561046267|FG001|Overall Study|Adverse Event|3|||
155442858|NCT00916721|561046266|FG000|Overall Study|Withdrawal by Subject|2|||
155442859|NCT00916721|561046267|FG001|Overall Study|Withdrawal by Subject|2|||
155442860|NCT00916721|561046266|FG000|Overall Study|Protocol Violation|2|||
155442861|NCT00916721|561046267|FG001|Overall Study|Protocol Violation|4|||
155442862|NCT01469052|561046270|FG000|Overall Study|Adverse Event|2|||
155442863|NCT01469052|561046271|FG001|Overall Study|Adverse Event|3|||
155442864|NCT01469052|561046272|FG002|Overall Study|Adverse Event|0|||
155442865|NCT01469052|561046273|FG003|Overall Study|Adverse Event|2|||
155442866|NCT01469052|561046274|FG004|Overall Study|Adverse Event|0|||
155442867|NCT01469052|561046275|FG005|Overall Study|Adverse Event|1|||
155442868|NCT01469052|561046270|FG000|Overall Study|Progressive disease|3|||
155442869|NCT01469052|561046271|FG001|Overall Study|Progressive disease|0|||
155442870|NCT01469052|561046272|FG002|Overall Study|Progressive disease|5|||
155442871|NCT01469052|561046273|FG003|Overall Study|Progressive disease|3|||
155442872|NCT01469052|561046274|FG004|Overall Study|Progressive disease|7|||
155442873|NCT01469052|561046275|FG005|Overall Study|Progressive disease|2|||
155442874|NCT01469052|561046270|FG000|Overall Study|Lack of Efficacy|0|||
155442875|NCT01469052|561046271|FG001|Overall Study|Lack of Efficacy|0|||
155442876|NCT01469052|561046272|FG002|Overall Study|Lack of Efficacy|0|||
155442877|NCT01469052|561046273|FG003|Overall Study|Lack of Efficacy|0|||
155442878|NCT01469052|561046274|FG004|Overall Study|Lack of Efficacy|0|||
155442879|NCT01469052|561046275|FG005|Overall Study|Lack of Efficacy|2|||
155442880|NCT01469052|561046270|FG000|Overall Study|Moved to rollover protocol|1|||
155442881|NCT01469052|561046271|FG001|Overall Study|Moved to rollover protocol|0|||
155442882|NCT01469052|561046272|FG002|Overall Study|Moved to rollover protocol|1|||
155442883|NCT01469052|561046273|FG003|Overall Study|Moved to rollover protocol|0|||
155442884|NCT01469052|561046274|FG004|Overall Study|Moved to rollover protocol|0|||
155442885|NCT01469052|561046275|FG005|Overall Study|Moved to rollover protocol|1|||
155442886|NCT01469052|561046270|FG000|Overall Study|Other|0|||
155442887|NCT01469052|561046271|FG001|Overall Study|Other|1|||
155442888|NCT01469052|561046272|FG002|Overall Study|Other|0|||
155442889|NCT01469052|561046273|FG003|Overall Study|Other|0|||
155442890|NCT01469052|561046274|FG004|Overall Study|Other|1|||
155442891|NCT01469052|561046275|FG005|Overall Study|Other|0|||
155442892|NCT03648996|561046277|FG000|Overall Study|Withdrawal by Subject|0|||
155442893|NCT03648996|561046278|FG001|Overall Study|Withdrawal by Subject|2|||
155442894|NCT03648996|561046279|FG002|Overall Study|Withdrawal by Subject|2|||
155442895|NCT03648996|561046277|FG000|Overall Study|Physician Decision|2|||
155442896|NCT03648996|561046278|FG001|Overall Study|Physician Decision|0|||
155442897|NCT03648996|561046279|FG002|Overall Study|Physician Decision|0|||
155442898|NCT02749370|561046281|FG000|Overall Study|Withdrawal by Subject|11|||
155442899|NCT02749370|561046281|FG000|Overall Study|Lost to Follow-up|3|||
155442900|NCT01519427|561046285|FG000|Overall Study|disease progression|2|||
155442901|NCT03894904|561046286|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
155442902|NCT03894904|561046287|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
155442903|NCT03894904|561046286|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
155442904|NCT03894904|561046287|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
155442905|NCT00633139|561046295|FG000|Overall Study|Non compliance|0|||
155442906|NCT00633139|561046296|FG001|Overall Study|Non compliance|0|||
155442907|NCT00633139|561046297|FG002|Overall Study|Non compliance|1|||
155442908|NCT00633139|561046295|FG000|Overall Study|Withdrawal by Subject|0|||
155442909|NCT00633139|561046296|FG001|Overall Study|Withdrawal by Subject|1|||
155442910|NCT00633139|561046297|FG002|Overall Study|Withdrawal by Subject|0|||
155442911|NCT02160977|561046298|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
155442912|NCT02160977|561046299|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
155442913|NCT02160977|561046298|FG000|Three Months After Surgery|Lost to Follow-up|0|||
155442914|NCT02160977|561046299|FG001|Three Months After Surgery|Lost to Follow-up|2|||
155442915|NCT02160977|561046298|FG000|Six Months After Surgery|Lost to Follow-up|2|||
155442916|NCT02160977|561046299|FG001|Six Months After Surgery|Lost to Follow-up|1|||
155442917|NCT02269319|561046300|FG000|Overall Study|Lost to Follow-up|4|||
155442918|NCT02269319|561046301|FG001|Overall Study|Lost to Follow-up|3|||
155442919|NCT02269319|561046300|FG000|Overall Study|Adverse Event|0|||
155442920|NCT02269319|561046301|FG001|Overall Study|Adverse Event|1|||
155442921|NCT02269319|561046300|FG000|Overall Study|Instructions not followed|1|||
155442922|NCT02269319|561046301|FG001|Overall Study|Instructions not followed|0|||
155442923|NCT04543955|561048064|FG000|Overall Study|Company cancelled study|1|||
155442924|NCT04543955|561048065|FG001|Overall Study|Company cancelled study|0|||
155442925|NCT01614769|561048066|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
155442926|NCT01614769|561048067|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
155442927|NCT01614769|561048068|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
155442928|NCT01614769|561048069|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
155442929|NCT01614769|561048070|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
155442930|NCT01614769|561048071|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
155442931|NCT01614769|561048066|FG000|Period 1|Protocol Violation|0|||
155442932|NCT01614769|561048067|FG001|Period 1|Protocol Violation|0|||
155442933|NCT01614769|561048068|FG002|Period 1|Protocol Violation|0|||
155442934|NCT01614769|561048069|FG003|Period 1|Protocol Violation|1|||
155442935|NCT01614769|561048070|FG004|Period 1|Protocol Violation|0|||
155442936|NCT01614769|561048071|FG005|Period 1|Protocol Violation|0|||
155442937|NCT01614769|561048066|FG000|Period 1|Withdrawal by Subject|1|||
155442938|NCT01614769|561048067|FG001|Period 1|Withdrawal by Subject|0|||
155442939|NCT01614769|561048068|FG002|Period 1|Withdrawal by Subject|0|||
155442940|NCT01614769|561048069|FG003|Period 1|Withdrawal by Subject|0|||
155442941|NCT01614769|561048070|FG004|Period 1|Withdrawal by Subject|0|||
155442942|NCT01614769|561048071|FG005|Period 1|Withdrawal by Subject|0|||
155442943|NCT01614769|561048066|FG000|Period 3|Withdrawal by Subject|0|||
155442944|NCT01614769|561048067|FG001|Period 3|Withdrawal by Subject|0|||
155442945|NCT01614769|561048068|FG002|Period 3|Withdrawal by Subject|1|||
155442946|NCT01614769|561048069|FG003|Period 3|Withdrawal by Subject|0|||
155442947|NCT01614769|561048070|FG004|Period 3|Withdrawal by Subject|0|||
155442948|NCT01614769|561048071|FG005|Period 3|Withdrawal by Subject|0|||
155442949|NCT02115815|561048072|FG000|Overall Study|Withdrawal by Subject|2|||
155442950|NCT02115815|561048073|FG001|Overall Study|Withdrawal by Subject|0|||
155442951|NCT02115815|561048074|FG002|Overall Study|Withdrawal by Subject|0|||
155442952|NCT02115815|561048075|FG003|Overall Study|Withdrawal by Subject|0|||
155442953|NCT02115815|561048076|FG004|Overall Study|Withdrawal by Subject|0|||
155442954|NCT02115815|561048077|FG005|Overall Study|Withdrawal by Subject|0|||
155442955|NCT02115815|561048078|FG006|Overall Study|Withdrawal by Subject|0|||
155442956|NCT02115815|561048072|FG000|Overall Study|Not enough drug to dose participant|0|||
155442957|NCT02115815|561048073|FG001|Overall Study|Not enough drug to dose participant|0|||
155442958|NCT02115815|561048074|FG002|Overall Study|Not enough drug to dose participant|0|||
155442959|NCT02115815|561048075|FG003|Overall Study|Not enough drug to dose participant|0|||
155442960|NCT02115815|561048076|FG004|Overall Study|Not enough drug to dose participant|0|||
155442961|NCT02115815|561048077|FG005|Overall Study|Not enough drug to dose participant|1|||
155442962|NCT02115815|561048078|FG006|Overall Study|Not enough drug to dose participant|0|||
155442963|NCT02115815|561048072|FG000|Overall Study|Missed appointment, randomized in error|0|||
155442964|NCT02115815|561048073|FG001|Overall Study|Missed appointment, randomized in error|0|||
155442965|NCT02115815|561048074|FG002|Overall Study|Missed appointment, randomized in error|0|||
155442966|NCT02115815|561048075|FG003|Overall Study|Missed appointment, randomized in error|0|||
155442967|NCT02115815|561048076|FG004|Overall Study|Missed appointment, randomized in error|0|||
155442968|NCT02115815|561048077|FG005|Overall Study|Missed appointment, randomized in error|1|||
155442969|NCT02115815|561048078|FG006|Overall Study|Missed appointment, randomized in error|0|||
155442970|NCT01228071|561048079|FG000|Overall Study|Protocol Violation|1|||
155442971|NCT01228071|561048079|FG000|Overall Study|Withdrawal by Subject|1|||
155442972|NCT01989546|561048080|FG000|Overall Study|Clinical Progression|1|||
155442973|NCT01989546|561048080|FG000|Overall Study|Disease progression on study|8|||
155442974|NCT02819310|561048083|FG000|Overall Study|Withdrawal by Subject|37|||
155442975|NCT02819310|561048083|FG000|Overall Study|Lost to Follow-up|16|||
155442976|NCT02819310|561048083|FG000|Overall Study|Adverse Event|13|||
155442977|NCT02819310|561048083|FG000|Overall Study|Lack of Efficacy|5|||
155442978|NCT02819310|561048083|FG000|Overall Study|Physician Decision|8|||
155442979|NCT02819310|561048083|FG000|Overall Study|Protocol Violation|30|||
155442980|NCT01793051|561048088|FG000|Overall Study|Withdrawal by Subject|6|||
155442981|NCT01793051|561048089|FG001|Overall Study|Withdrawal by Subject|4|||
155442982|NCT01793051|561048088|FG000|Overall Study|Adverse Event|0|||
155442983|NCT01793051|561048089|FG001|Overall Study|Adverse Event|2|||
155442984|NCT01793051|561048088|FG000|Overall Study|Too ill to continue|1|||
155442985|NCT01793051|561048089|FG001|Overall Study|Too ill to continue|0|||
155442986|NCT01793051|561048088|FG000|Overall Study|Switched chemo|1|||
155442987|NCT01793051|561048089|FG001|Overall Study|Switched chemo|1|||
155442988|NCT01793051|561048088|FG000|Overall Study|Lack of compliance|1|||
155442989|NCT01793051|561048089|FG001|Overall Study|Lack of compliance|0|||
155442990|NCT01793051|561048088|FG000|Overall Study|Requested to be removed from the study|1|||
155442991|NCT01793051|561048089|FG001|Overall Study|Requested to be removed from the study|1|||
155442992|NCT00059215|561048092|FG000|Overall Study|Adverse Event|5|||
155442993|NCT00059215|561048093|FG001|Overall Study|Adverse Event|5|||
155442994|NCT00059215|561048094|FG002|Overall Study|Adverse Event|9|||
155442995|NCT00059215|561048095|FG003|Overall Study|Adverse Event|9|||
155515165|NCT02985957|561311533|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
155442996|NCT00059215|561048092|FG000|Overall Study|Death|0|||
155442997|NCT00059215|561048093|FG001|Overall Study|Death|0|||
155442998|NCT00059215|561048094|FG002|Overall Study|Death|3|||
155442999|NCT00059215|561048095|FG003|Overall Study|Death|0|||
155443000|NCT00059215|561048092|FG000|Overall Study|Lost to Follow-up|1|||
155443001|NCT00059215|561048093|FG001|Overall Study|Lost to Follow-up|2|||
155443002|NCT00059215|561048094|FG002|Overall Study|Lost to Follow-up|0|||
155443003|NCT00059215|561048095|FG003|Overall Study|Lost to Follow-up|0|||
155443004|NCT00059215|561048092|FG000|Overall Study|Withdrawal by Subject|4|||
155443005|NCT00059215|561048093|FG001|Overall Study|Withdrawal by Subject|4|||
155443006|NCT00059215|561048094|FG002|Overall Study|Withdrawal by Subject|1|||
155443007|NCT00059215|561048095|FG003|Overall Study|Withdrawal by Subject|3|||
155443008|NCT00059215|561048092|FG000|Overall Study|Protocol Violation|1|||
155443009|NCT00059215|561048093|FG001|Overall Study|Protocol Violation|0|||
155443010|NCT00059215|561048094|FG002|Overall Study|Protocol Violation|1|||
155443011|NCT00059215|561048095|FG003|Overall Study|Protocol Violation|0|||
155443012|NCT00059215|561048092|FG000|Overall Study|Protocol entry criteria not met|1|||
155443013|NCT00059215|561048093|FG001|Overall Study|Protocol entry criteria not met|1|||
155443014|NCT00059215|561048094|FG002|Overall Study|Protocol entry criteria not met|0|||
155443015|NCT00059215|561048095|FG003|Overall Study|Protocol entry criteria not met|2|||
155443016|NCT00059215|561048092|FG000|Overall Study|Physician Decision|1|||
155443017|NCT00059215|561048093|FG001|Overall Study|Physician Decision|2|||
155443018|NCT00059215|561048094|FG002|Overall Study|Physician Decision|1|||
155443019|NCT00059215|561048095|FG003|Overall Study|Physician Decision|1|||
155443020|NCT04439838|561048096|FG000|Overall Study|Withdrawal by Subject|0|||
155443021|NCT04439838|561048097|FG001|Overall Study|Withdrawal by Subject|0|||
155443022|NCT04439838|561048098|FG002|Overall Study|Withdrawal by Subject|0|||
155443023|NCT04439838|561048099|FG003|Overall Study|Withdrawal by Subject|0|||
155443024|NCT04439838|561048100|FG004|Overall Study|Withdrawal by Subject|0|||
155443025|NCT04439838|561048101|FG005|Overall Study|Withdrawal by Subject|0|||
155443026|NCT04439838|561048102|FG006|Overall Study|Withdrawal by Subject|0|||
155443027|NCT04439838|561048103|FG007|Overall Study|Withdrawal by Subject|0|||
155443028|NCT04439838|561048104|FG008|Overall Study|Withdrawal by Subject|1|||
155443029|NCT01958671|561048109|FG000|Overall Study|Adverse Event|1|||
155443030|NCT01958671|561048110|FG001|Overall Study|Adverse Event|1|||
155443031|NCT01958671|561048111|FG002|Overall Study|Adverse Event|5|||
155443032|NCT01958671|561048109|FG000|Overall Study|Death|1|||
155443033|NCT01958671|561048110|FG001|Overall Study|Death|0|||
155443034|NCT01958671|561048111|FG002|Overall Study|Death|0|||
155443035|NCT01958671|561048109|FG000|Overall Study|Excluded medication|0|||
155443036|NCT01958671|561048110|FG001|Overall Study|Excluded medication|0|||
155443037|NCT01958671|561048111|FG002|Overall Study|Excluded medication|1|||
155443038|NCT01958671|561048109|FG000|Overall Study|Hyperglycemia|0|||
155443039|NCT01958671|561048110|FG001|Overall Study|Hyperglycemia|0|||
155443040|NCT01958671|561048111|FG002|Overall Study|Hyperglycemia|2|||
155443041|NCT01958671|561048109|FG000|Overall Study|Lost to Follow-up|7|||
155443042|NCT01958671|561048110|FG001|Overall Study|Lost to Follow-up|11|||
155443043|NCT01958671|561048111|FG002|Overall Study|Lost to Follow-up|7|||
155443044|NCT01958671|561048109|FG000|Overall Study|Non-compliance with study drug|1|||
155443045|NCT01958671|561048110|FG001|Overall Study|Non-compliance with study drug|1|||
155443046|NCT01958671|561048111|FG002|Overall Study|Non-compliance with study drug|1|||
155443047|NCT01958671|561048109|FG000|Overall Study|Pregnancy|0|||
155443048|NCT01958671|561048110|FG001|Overall Study|Pregnancy|0|||
155443049|NCT01958671|561048111|FG002|Overall Study|Pregnancy|1|||
155443050|NCT01958671|561048109|FG000|Overall Study|Protocol Violation|0|||
155443051|NCT01958671|561048110|FG001|Overall Study|Protocol Violation|1|||
155443052|NCT01958671|561048111|FG002|Overall Study|Protocol Violation|0|||
155443053|NCT01958671|561048109|FG000|Overall Study|Study site terminated by sponsor|1|||
155443054|NCT01958671|561048110|FG001|Overall Study|Study site terminated by sponsor|0|||
155443055|NCT01958671|561048111|FG002|Overall Study|Study site terminated by sponsor|1|||
155443056|NCT01958671|561048109|FG000|Overall Study|Participant moved|0|||
155443057|NCT01958671|561048110|FG001|Overall Study|Participant moved|0|||
155443058|NCT01958671|561048111|FG002|Overall Study|Participant moved|1|||
155443059|NCT01958671|561048109|FG000|Overall Study|Withdrawal by Subject|8|||
155443060|NCT01958671|561048110|FG001|Overall Study|Withdrawal by Subject|10|||
155443061|NCT01958671|561048111|FG002|Overall Study|Withdrawal by Subject|13|||
155443062|NCT02778867|561048112|FG000|Phase 1|Withdrawal by Subject|2|||
155443063|NCT02778867|561048113|FG001|Phase 1|Withdrawal by Subject|3|||
155443064|NCT02778867|561048114|FG002|Phase 1|Withdrawal by Subject|0|||
155443065|NCT02778867|561048115|FG003|Phase 1|Withdrawal by Subject|0|||
155443066|NCT02778867|561048112|FG000|Phase 2|Withdrawal by Subject|0|||
155443067|NCT02778867|561048113|FG001|Phase 2|Withdrawal by Subject|0|||
155443068|NCT02778867|561048114|FG002|Phase 2|Withdrawal by Subject|1|||
155443069|NCT02778867|561048115|FG003|Phase 2|Withdrawal by Subject|0|||
155443070|NCT02778867|561048112|FG000|Phase 2|Physician Decision|0|||
155515166|NCT02985957|561311534|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
155515167|NCT02985957|561311535|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
155443071|NCT02778867|561048113|FG001|Phase 2|Physician Decision|0|||
155443072|NCT02778867|561048114|FG002|Phase 2|Physician Decision|0|||
155443073|NCT02778867|561048115|FG003|Phase 2|Physician Decision|1|||
155443074|NCT02778867|561048112|FG000|Phase 2|Adverse Event|0|||
155443075|NCT02778867|561048113|FG001|Phase 2|Adverse Event|0|||
155443076|NCT02778867|561048114|FG002|Phase 2|Adverse Event|0|||
155443077|NCT02778867|561048115|FG003|Phase 2|Adverse Event|1|||
155515168|NCT02985957|561311536|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
155515169|NCT02985957|561311537|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
155515170|NCT02985957|561311531|FG000|Treatment Period|Study drug toxicity|1|||
155515171|NCT02985957|561311532|FG001|Treatment Period|Study drug toxicity|23|||
155515172|NCT02985957|561311533|FG002|Treatment Period|Study drug toxicity|20|||
155443078|NCT02948777|561048116|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
155443079|NCT03242928|561048118|FG000|Overall Study|Adverse Event|2|||
155443080|NCT03242928|561048119|FG001|Overall Study|Adverse Event|1|||
155443081|NCT03242928|561048118|FG000|Overall Study|Lost to Follow-up|2|||
155443082|NCT03242928|561048119|FG001|Overall Study|Lost to Follow-up|0|||
155443083|NCT03242928|561048118|FG000|Overall Study|Physician Decision|0|||
155443084|NCT03242928|561048119|FG001|Overall Study|Physician Decision|1|||
155443085|NCT03242928|561048118|FG000|Overall Study|Withdrawal by Subject|5|||
155443086|NCT03242928|561048119|FG001|Overall Study|Withdrawal by Subject|3|||
155443087|NCT00960440|561048120|FG000|Overall Study|Death|0|||
155443088|NCT00960440|561048121|FG001|Overall Study|Death|0|||
155443089|NCT00960440|561048122|FG002|Overall Study|Death|0|||
155443090|NCT00960440|561048123|FG003|Overall Study|Death|1|||
155443091|NCT00960440|561048120|FG000|Overall Study|Adverse Event|12|||
155443092|NCT00960440|561048121|FG001|Overall Study|Adverse Event|12|||
155443093|NCT00960440|561048122|FG002|Overall Study|Adverse Event|4|||
155443094|NCT00960440|561048123|FG003|Overall Study|Adverse Event|4|||
155443095|NCT00960440|561048120|FG000|Overall Study|Lack of Efficacy|2|||
155443096|NCT00960440|561048121|FG001|Overall Study|Lack of Efficacy|5|||
155443097|NCT00960440|561048122|FG002|Overall Study|Lack of Efficacy|3|||
155443098|NCT00960440|561048123|FG003|Overall Study|Lack of Efficacy|8|||
155443099|NCT00960440|561048120|FG000|Overall Study|Protocol Violation|2|||
155443100|NCT00960440|561048121|FG001|Overall Study|Protocol Violation|8|||
155443101|NCT00960440|561048122|FG002|Overall Study|Protocol Violation|3|||
155443102|NCT00960440|561048123|FG003|Overall Study|Protocol Violation|4|||
155443103|NCT00960440|561048120|FG000|Overall Study|Withdrawal by Subject|9|||
155443104|NCT00960440|561048121|FG001|Overall Study|Withdrawal by Subject|5|||
155443105|NCT00960440|561048122|FG002|Overall Study|Withdrawal by Subject|2|||
155515173|NCT02985957|561311534|FG003|Treatment Period|Study drug toxicity|12|||
155515174|NCT02985957|561311535|FG004|Treatment Period|Study drug toxicity|20|||
155515175|NCT02985957|561311536|FG005|Treatment Period|Study drug toxicity|3|||
155515176|NCT02985957|561311537|FG006|Treatment Period|Study drug toxicity|5|||
155515177|NCT02985957|561311531|FG000|Treatment Period|Disease progression|0|||
155515178|NCT02985957|561311532|FG001|Treatment Period|Disease progression|16|||
155515179|NCT02985957|561311533|FG002|Treatment Period|Disease progression|20|||
155515180|NCT02985957|561311534|FG003|Treatment Period|Disease progression|40|||
155515181|NCT02985957|561311535|FG004|Treatment Period|Disease progression|29|||
155515182|NCT02985957|561311536|FG005|Treatment Period|Disease progression|11|||
155515183|NCT02985957|561311537|FG006|Treatment Period|Disease progression|28|||
155443106|NCT00960440|561048123|FG003|Overall Study|Withdrawal by Subject|1|||
155443107|NCT00960440|561048120|FG000|Overall Study|Other|1|||
155443108|NCT00960440|561048121|FG001|Overall Study|Other|1|||
155443109|NCT00960440|561048122|FG002|Overall Study|Other|1|||
155443110|NCT00960440|561048123|FG003|Overall Study|Other|0|||
155443111|NCT03504774|561048127|FG000|Overall Study|Adverse Event|2|||
155515184|NCT02985957|561311531|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
155443112|NCT03504774|561048128|FG001|Overall Study|Adverse Event|0|||
155443113|NCT03504774|561048127|FG000|Overall Study|Lost to Follow-up|0|||
155443114|NCT03504774|561048128|FG001|Overall Study|Lost to Follow-up|1|||
155443115|NCT03504774|561048127|FG000|Overall Study|Protocol Violation|11|||
155443116|NCT03504774|561048128|FG001|Overall Study|Protocol Violation|3|||
155443117|NCT03504774|561048127|FG000|Overall Study|failed wk 52 DBPCFC|1|||
155443118|NCT03504774|561048128|FG001|Overall Study|failed wk 52 DBPCFC|0|||
155443119|NCT00625365|561048129|FG000|Overall Study|Withdrawal by Subject|1|||
155443120|NCT00625365|561048129|FG000|Overall Study|No IV access|5|||
155443121|NCT00625365|561048129|FG000|Overall Study|VSD|1|||
155443122|NCT01781429|561048130|FG000|Overall Study|Death|0|||
155443123|NCT01781429|561048131|FG001|Overall Study|Death|0|||
155443124|NCT01781429|561048132|FG002|Overall Study|Death|0|||
155443125|NCT01781429|561048133|FG003|Overall Study|Death|0|||
155443126|NCT01781429|561048134|FG004|Overall Study|Death|0|||
155443127|NCT01781429|561048135|FG005|Overall Study|Death|0|||
155443128|NCT01781429|561048136|FG006|Overall Study|Death|0|||
155443129|NCT01781429|561048137|FG007|Overall Study|Death|0|||
155443130|NCT01781429|561048138|FG008|Overall Study|Death|0|||
155443131|NCT01781429|561048139|FG009|Overall Study|Death|1|||
155443132|NCT01781429|561048140|FG010|Overall Study|Death|0|||
155443133|NCT01781429|561048141|FG011|Overall Study|Death|0|||
155443134|NCT01781429|561048142|FG012|Overall Study|Death|1|||
155443135|NCT01781429|561048143|FG013|Overall Study|Death|0|||
155443136|NCT01781429|561048144|FG014|Overall Study|Death|1|||
155443137|NCT01781429|561048145|FG015|Overall Study|Death|0|||
155443138|NCT01781429|561048130|FG000|Overall Study|Withdrawal by Subject|0|||
155443139|NCT01781429|561048131|FG001|Overall Study|Withdrawal by Subject|0|||
155443140|NCT01781429|561048132|FG002|Overall Study|Withdrawal by Subject|0|||
155443141|NCT01781429|561048133|FG003|Overall Study|Withdrawal by Subject|0|||
155443142|NCT01781429|561048134|FG004|Overall Study|Withdrawal by Subject|0|||
155443143|NCT01781429|561048135|FG005|Overall Study|Withdrawal by Subject|0|||
155443144|NCT01781429|561048136|FG006|Overall Study|Withdrawal by Subject|0|||
155443145|NCT01781429|561048137|FG007|Overall Study|Withdrawal by Subject|0|||
155443146|NCT01781429|561048138|FG008|Overall Study|Withdrawal by Subject|1|||
155443147|NCT01781429|561048139|FG009|Overall Study|Withdrawal by Subject|3|||
155443148|NCT01781429|561048140|FG010|Overall Study|Withdrawal by Subject|1|||
155443149|NCT01781429|561048141|FG011|Overall Study|Withdrawal by Subject|1|||
155443150|NCT01781429|561048142|FG012|Overall Study|Withdrawal by Subject|5|||
155443151|NCT01781429|561048143|FG013|Overall Study|Withdrawal by Subject|2|||
155443152|NCT01781429|561048144|FG014|Overall Study|Withdrawal by Subject|3|||
155443153|NCT01781429|561048145|FG015|Overall Study|Withdrawal by Subject|0|||
155443154|NCT01781429|561048130|FG000|Overall Study|Disease Progression|1|||
155443155|NCT01781429|561048131|FG001|Overall Study|Disease Progression|0|||
155443156|NCT01781429|561048132|FG002|Overall Study|Disease Progression|1|||
155443157|NCT01781429|561048133|FG003|Overall Study|Disease Progression|1|||
155443158|NCT01781429|561048134|FG004|Overall Study|Disease Progression|1|||
155443159|NCT01781429|561048135|FG005|Overall Study|Disease Progression|4|||
155443160|NCT01781429|561048136|FG006|Overall Study|Disease Progression|7|||
155443161|NCT01781429|561048137|FG007|Overall Study|Disease Progression|4|||
155443162|NCT01781429|561048138|FG008|Overall Study|Disease Progression|6|||
155443163|NCT01781429|561048139|FG009|Overall Study|Disease Progression|15|||
155443164|NCT01781429|561048140|FG010|Overall Study|Disease Progression|15|||
155443165|NCT01781429|561048141|FG011|Overall Study|Disease Progression|15|||
155443166|NCT01781429|561048142|FG012|Overall Study|Disease Progression|15|||
155443167|NCT01781429|561048143|FG013|Overall Study|Disease Progression|4|||
155443168|NCT01781429|561048144|FG014|Overall Study|Disease Progression|11|||
155443169|NCT01781429|561048145|FG015|Overall Study|Disease Progression|0|||
155443170|NCT01781429|561048130|FG000|Overall Study|Unacceptable Toxicity|0|||
155443171|NCT01781429|561048131|FG001|Overall Study|Unacceptable Toxicity|0|||
155443172|NCT01781429|561048132|FG002|Overall Study|Unacceptable Toxicity|0|||
155443173|NCT01781429|561048133|FG003|Overall Study|Unacceptable Toxicity|0|||
155443174|NCT01781429|561048134|FG004|Overall Study|Unacceptable Toxicity|0|||
155443175|NCT01781429|561048135|FG005|Overall Study|Unacceptable Toxicity|0|||
155443176|NCT01781429|561048136|FG006|Overall Study|Unacceptable Toxicity|0|||
155443177|NCT01781429|561048137|FG007|Overall Study|Unacceptable Toxicity|0|||
155443178|NCT01781429|561048138|FG008|Overall Study|Unacceptable Toxicity|0|||
155443179|NCT01781429|561048139|FG009|Overall Study|Unacceptable Toxicity|0|||
155443180|NCT01781429|561048140|FG010|Overall Study|Unacceptable Toxicity|0|||
155443181|NCT01781429|561048141|FG011|Overall Study|Unacceptable Toxicity|2|||
155443182|NCT01781429|561048142|FG012|Overall Study|Unacceptable Toxicity|0|||
155443183|NCT01781429|561048143|FG013|Overall Study|Unacceptable Toxicity|0|||
155443184|NCT01781429|561048144|FG014|Overall Study|Unacceptable Toxicity|0|||
155443185|NCT01781429|561048145|FG015|Overall Study|Unacceptable Toxicity|0|||
155443186|NCT01781429|561048130|FG000|Overall Study|Patient Condition Changed|0|||
155443187|NCT01781429|561048131|FG001|Overall Study|Patient Condition Changed|0|||
155443188|NCT01781429|561048132|FG002|Overall Study|Patient Condition Changed|0|||
155443189|NCT01781429|561048133|FG003|Overall Study|Patient Condition Changed|0|||
155443190|NCT01781429|561048134|FG004|Overall Study|Patient Condition Changed|0|||
155443191|NCT01781429|561048135|FG005|Overall Study|Patient Condition Changed|0|||
155443192|NCT01781429|561048136|FG006|Overall Study|Patient Condition Changed|0|||
155443193|NCT01781429|561048137|FG007|Overall Study|Patient Condition Changed|0|||
155443194|NCT01781429|561048138|FG008|Overall Study|Patient Condition Changed|0|||
155443195|NCT01781429|561048139|FG009|Overall Study|Patient Condition Changed|4|||
155443196|NCT01781429|561048140|FG010|Overall Study|Patient Condition Changed|0|||
155443197|NCT01781429|561048141|FG011|Overall Study|Patient Condition Changed|1|||
155443198|NCT01781429|561048142|FG012|Overall Study|Patient Condition Changed|0|||
155443199|NCT01781429|561048143|FG013|Overall Study|Patient Condition Changed|1|||
155443200|NCT01781429|561048144|FG014|Overall Study|Patient Condition Changed|0|||
155443201|NCT01781429|561048145|FG015|Overall Study|Patient Condition Changed|0|||
155443202|NCT01781429|561048130|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
155443203|NCT01781429|561048131|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
155443204|NCT01781429|561048132|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
155443205|NCT01781429|561048133|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
155443206|NCT01781429|561048134|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
155443207|NCT01781429|561048135|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
155443208|NCT01781429|561048136|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
155443209|NCT01781429|561048137|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
155443210|NCT01781429|561048138|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
155443211|NCT01781429|561048139|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
155443212|NCT01781429|561048140|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
155443213|NCT01781429|561048141|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
155443214|NCT01781429|561048142|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
155443215|NCT01781429|561048143|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
155443216|NCT01781429|561048144|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
155443217|NCT01781429|561048145|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
155443218|NCT01781429|561048130|FG000|Overall Study|Enrolled, but not treated|0|||
155443219|NCT01781429|561048131|FG001|Overall Study|Enrolled, but not treated|0|||
155443220|NCT01781429|561048132|FG002|Overall Study|Enrolled, but not treated|0|||
155443221|NCT01781429|561048133|FG003|Overall Study|Enrolled, but not treated|0|||
155443222|NCT01781429|561048134|FG004|Overall Study|Enrolled, but not treated|0|||
155443223|NCT01781429|561048135|FG005|Overall Study|Enrolled, but not treated|0|||
155443224|NCT01781429|561048136|FG006|Overall Study|Enrolled, but not treated|0|||
155443225|NCT01781429|561048137|FG007|Overall Study|Enrolled, but not treated|0|||
155443226|NCT01781429|561048138|FG008|Overall Study|Enrolled, but not treated|0|||
155443227|NCT01781429|561048139|FG009|Overall Study|Enrolled, but not treated|0|||
155443228|NCT01781429|561048140|FG010|Overall Study|Enrolled, but not treated|1|||
155443229|NCT01781429|561048141|FG011|Overall Study|Enrolled, but not treated|0|||
155443230|NCT01781429|561048142|FG012|Overall Study|Enrolled, but not treated|0|||
155443231|NCT01781429|561048143|FG013|Overall Study|Enrolled, but not treated|0|||
155443232|NCT01781429|561048144|FG014|Overall Study|Enrolled, but not treated|0|||
155443233|NCT01781429|561048145|FG015|Overall Study|Enrolled, but not treated|0|||
155443234|NCT01703286|561048147|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
155443235|NCT01703286|561048148|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
155443236|NCT01703286|561048149|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
155443237|NCT01703286|561048150|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
155443238|NCT01703286|561048151|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
155443239|NCT01703286|561048152|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
155443240|NCT01703286|561048147|FG000|Period 2 Including Washout|Adverse Event|0|||
155443241|NCT01703286|561048148|FG001|Period 2 Including Washout|Adverse Event|0|||
155443242|NCT01703286|561048149|FG002|Period 2 Including Washout|Adverse Event|0|||
155443243|NCT01703286|561048150|FG003|Period 2 Including Washout|Adverse Event|1|||
155443244|NCT01703286|561048151|FG004|Period 2 Including Washout|Adverse Event|0|||
155443245|NCT01703286|561048152|FG005|Period 2 Including Washout|Adverse Event|0|||
155443246|NCT00931892|561048153|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
155443247|NCT00931892|561048154|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
155443248|NCT02207530|561048157|FG000|Overall Study|Worsening condition under investigation|78|||
155443249|NCT02207530|561048157|FG000|Overall Study|Patient decision to stop study treatment|5|||
155443250|NCT02207530|561048157|FG000|Overall Study|Adverse Event|8|||
155443251|NCT06094296|561048160|FG000|Overall Study|Progressive Disease|1|||
155443252|NCT06094296|561048161|FG001|Overall Study|Progressive Disease|0|||
155443253|NCT06094296|561048162|FG002|Overall Study|Progressive Disease|0|||
155443254|NCT06094296|561048163|FG003|Overall Study|Progressive Disease|0|||
155443255|NCT00986258|561048164|FG000|Observation Period|Not eligible to be dosed|11|||
155443256|NCT00986258|561048164|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
155443257|NCT00986258|561048164|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
155443258|NCT00986258|561048164|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
155443259|NCT00986258|561048164|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
155443260|NCT00986258|561048164|FG000|Titration and Optimal Dose Period|Other|1|||
155443261|NCT00986258|561048164|FG000|Maintenance Period|Adverse Event|5|||
155443262|NCT00986258|561048164|FG000|Maintenance Period|Lack of Efficacy|2|||
155443263|NCT00986258|561048164|FG000|Maintenance Period|Withdrawal by Subject|2|||
155443264|NCT03332667|561048165|FG000|Overall Study|Adverse Event|0|||
155443265|NCT03332667|561048166|FG001|Overall Study|Adverse Event|0|||
155443266|NCT03332667|561048167|FG002|Overall Study|Adverse Event|2|||
155443267|NCT03332667|561048168|FG003|Overall Study|Adverse Event|1|||
155443268|NCT03332667|561048165|FG000|Overall Study|Withdrawal by Subject|2|||
155443269|NCT03332667|561048166|FG001|Overall Study|Withdrawal by Subject|1|||
155443270|NCT03332667|561048167|FG002|Overall Study|Withdrawal by Subject|5|||
155443271|NCT03332667|561048168|FG003|Overall Study|Withdrawal by Subject|1|||
155443272|NCT03332667|561048165|FG000|Overall Study|Disease Progression or Relapse|2|||
155443273|NCT03332667|561048166|FG001|Overall Study|Disease Progression or Relapse|1|||
155443274|NCT03332667|561048167|FG002|Overall Study|Disease Progression or Relapse|3|||
155443275|NCT03332667|561048168|FG003|Overall Study|Disease Progression or Relapse|0|||
155443276|NCT03332667|561048165|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
155443277|NCT03332667|561048166|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
155443278|NCT03332667|561048167|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
155443279|NCT03332667|561048168|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
155443280|NCT03332667|561048165|FG000|Overall Study|No Treatment Received|0|||
155443281|NCT03332667|561048166|FG001|Overall Study|No Treatment Received|0|||
155443282|NCT03332667|561048167|FG002|Overall Study|No Treatment Received|1|||
155443283|NCT03332667|561048168|FG003|Overall Study|No Treatment Received|0|||
155443284|NCT01035606|561048169|FG000|Overall Study|change in health, job demands,family|3|||
155443285|NCT01035606|561048170|FG001|Overall Study|change in health, job demands,family|3|||
155443286|NCT01035606|561048171|FG002|Overall Study|change in health, job demands,family|4|||
155443287|NCT01809262|561048172|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443288|NCT01809262|561048173|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443289|NCT01809262|561048174|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443290|NCT01809262|561048175|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443291|NCT01809262|561048176|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
155443292|NCT01809262|561048177|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443293|NCT01809262|561048178|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443294|NCT01809262|561048179|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443295|NCT01809262|561048180|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443296|NCT01809262|561048181|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
155443297|NCT01809262|561048172|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443298|NCT01809262|561048173|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
155443299|NCT01809262|561048174|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443300|NCT01809262|561048175|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443301|NCT01809262|561048176|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443302|NCT01809262|561048177|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443303|NCT01809262|561048178|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443304|NCT01809262|561048179|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443305|NCT01809262|561048180|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443306|NCT01809262|561048181|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
155443307|NCT01505491|561048182|FG000|Overall Study|Other reason not listed|1|||
155443308|NCT01505491|561048183|FG001|Overall Study|Other reason not listed|0|||
155443309|NCT01505491|561048184|FG002|Overall Study|Other reason not listed|0|||
155443310|NCT01505491|561048182|FG000|Overall Study|Withdrawal by Subject|1|||
155443311|NCT01505491|561048183|FG001|Overall Study|Withdrawal by Subject|1|||
155443312|NCT01505491|561048184|FG002|Overall Study|Withdrawal by Subject|4|||
155443313|NCT01505491|561048182|FG000|Overall Study|Lost to Follow-up|0|||
155443314|NCT01505491|561048183|FG001|Overall Study|Lost to Follow-up|0|||
155443315|NCT01505491|561048184|FG002|Overall Study|Lost to Follow-up|1|||
155443316|NCT01797783|561048188|FG000|Overall Study|Adverse Event|1|||
155443317|NCT01797783|561048189|FG001|Overall Study|Adverse Event|1|||
155443318|NCT01797783|561048188|FG000|Overall Study|Withdrawal by Subject|1|||
155515185|NCT02985957|561311532|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
155443319|NCT01797783|561048189|FG001|Overall Study|Withdrawal by Subject|0|||
155443320|NCT00431847|561048193|FG000|Overall Study|completion of less than two study visits|6|||
155515186|NCT02985957|561311533|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
155515187|NCT02985957|561311534|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
155515188|NCT02985957|561311535|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
155443321|NCT00431847|561048194|FG001|Overall Study|completion of less than two study visits|3|||
155443322|NCT00431847|561048195|FG002|Overall Study|completion of less than two study visits|4|||
155443323|NCT00431847|561048196|FG003|Overall Study|completion of less than two study visits|14|||
155443324|NCT00431847|561048197|FG004|Overall Study|completion of less than two study visits|0|||
155443325|NCT00431847|561048193|FG000|Overall Study|Protocol Violation|0|||
155443326|NCT00431847|561048194|FG001|Overall Study|Protocol Violation|0|||
155443327|NCT00431847|561048195|FG002|Overall Study|Protocol Violation|0|||
155443328|NCT00431847|561048196|FG003|Overall Study|Protocol Violation|0|||
155443329|NCT00431847|561048197|FG004|Overall Study|Protocol Violation|1|||
155443330|NCT00339183|561048198|FG000|Overall Study|Adverse Event|5|||
155443331|NCT00339183|561048199|FG001|Overall Study|Adverse Event|3|||
155443332|NCT00339183|561048198|FG000|Overall Study|Withdrawal by Subject|16|||
155443333|NCT00339183|561048199|FG001|Overall Study|Withdrawal by Subject|19|||
155443334|NCT00339183|561048198|FG000|Overall Study|Physician Decision|2|||
155443335|NCT00339183|561048199|FG001|Overall Study|Physician Decision|4|||
155443336|NCT00339183|561048198|FG000|Overall Study|Lost to Follow-up|17|||
155443337|NCT00339183|561048199|FG001|Overall Study|Lost to Follow-up|17|||
155443338|NCT00339183|561048198|FG000|Overall Study|Protocol-specified criteria|12|||
155443339|NCT00339183|561048199|FG001|Overall Study|Protocol-specified criteria|8|||
155443340|NCT00339183|561048198|FG000|Overall Study|Missing reason|3|||
155443341|NCT00339183|561048199|FG001|Overall Study|Missing reason|1|||
155443342|NCT00339183|561048198|FG000|Overall Study|Other|46|||
155443343|NCT00339183|561048199|FG001|Overall Study|Other|40|||
155443344|NCT00339183|561048198|FG000|Overall Study|Ongoing|20|||
155443345|NCT00339183|561048199|FG001|Overall Study|Ongoing|13|||
155443346|NCT00446446|561048200|FG000|Overall Study|Death|10|||
155443347|NCT00446446|561048200|FG000|Overall Study|Withdrawal by Subject|6|||
155443348|NCT00446446|561048200|FG000|Overall Study|Other|4|||
155443349|NCT00446446|561048200|FG000|Overall Study|Disease Progession|2|||
155443350|NCT00446446|561048200|FG000|Overall Study|Adverse Event|1|||
155443351|NCT00446446|561048200|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
155443352|NCT02142894|561048201|FG000|Overall Study|Protocol Violation|8|||
155443353|NCT01024465|561048207|FG000|Overall Study|Adverse Event|2|||
155443354|NCT01024465|561048207|FG000|Overall Study|Physician Decision|1|||
155443355|NCT03078608|561048210|FG000|Overall Study|Death|1|||
155443356|NCT03078608|561048211|FG001|Overall Study|Death|2|||
155443357|NCT03078608|561048212|FG002|Overall Study|Death|0|||
155443358|NCT03078608|561048213|FG003|Overall Study|Death|0|||
155443359|NCT03078608|561048210|FG000|Overall Study|Withdrawal by Subject|8|||
155443360|NCT03078608|561048211|FG001|Overall Study|Withdrawal by Subject|1|||
155443361|NCT03078608|561048212|FG002|Overall Study|Withdrawal by Subject|0|||
155443362|NCT03078608|561048213|FG003|Overall Study|Withdrawal by Subject|0|||
155443363|NCT03078608|561048210|FG000|Overall Study|Lost to Follow-up|5|||
155443364|NCT03078608|561048211|FG001|Overall Study|Lost to Follow-up|8|||
155443365|NCT03078608|561048212|FG002|Overall Study|Lost to Follow-up|4|||
155443366|NCT03078608|561048213|FG003|Overall Study|Lost to Follow-up|1|||
155443367|NCT00723840|561048214|FG000|Overall Study|Lost to Follow-up|2|||
155443368|NCT00723840|561048214|FG000|Overall Study|Failure to return|18|||
155443369|NCT00723840|561048214|FG000|Overall Study|Withdrawal by Subject|55|||
155443370|NCT00723840|561048214|FG000|Overall Study|Serious Adverse Events|3|||
155443371|NCT00723840|561048214|FG000|Overall Study|Other Medical Event|2|||
155443372|NCT00723840|561048214|FG000|Overall Study|Unspecified reason|2|||
155443373|NCT01137435|561048215|FG000|Overall Study|Lost to Follow-up|24|||
155443374|NCT01137435|561048215|FG000|Overall Study|Off label usage|4|||
155443375|NCT00492921|561048216|FG000|Overall Study|Death|1|||
155443376|NCT00492921|561048217|FG001|Overall Study|Death|0|||
155443377|NCT00492921|561048218|FG002|Overall Study|Death|1|||
155443378|NCT00652093|561048219|FG000|Overall Study|Withdrawal by Subject|0|||
155443379|NCT00652093|561048220|FG001|Overall Study|Withdrawal by Subject|0|||
155443380|NCT00652093|561048221|FG002|Overall Study|Withdrawal by Subject|1|||
155443381|NCT00652093|561048222|FG003|Overall Study|Withdrawal by Subject|0|||
155443382|NCT00652093|561048223|FG004|Overall Study|Withdrawal by Subject|1|||
155443383|NCT00652093|561048224|FG005|Overall Study|Withdrawal by Subject|0|||
155443384|NCT00652093|561048219|FG000|Overall Study|Physician Decision|0|||
155443385|NCT00652093|561048220|FG001|Overall Study|Physician Decision|0|||
155443386|NCT00652093|561048221|FG002|Overall Study|Physician Decision|0|||
155443387|NCT00652093|561048222|FG003|Overall Study|Physician Decision|0|||
155443388|NCT00652093|561048223|FG004|Overall Study|Physician Decision|1|||
155443389|NCT00652093|561048224|FG005|Overall Study|Physician Decision|0|||
155443390|NCT00564629|561048227|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
155443391|NCT00564629|561048228|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
155443392|NCT03117049|561048235|FG000|Overall Study|Continued the follow-up period|109|||
155443393|NCT03117049|561048236|FG001|Overall Study|Continued the follow-up period|129|||
155443394|NCT03117049|561048235|FG000|Overall Study|Died|82|||
155443395|NCT03117049|561048236|FG001|Overall Study|Died|93|||
155443396|NCT03117049|561048235|FG000|Overall Study|Consent withdrawal|7|||
155443397|NCT03117049|561048236|FG001|Overall Study|Consent withdrawal|6|||
155443398|NCT03117049|561048235|FG000|Overall Study|Missing contact|3|||
155443399|NCT03117049|561048236|FG001|Overall Study|Missing contact|3|||
155443400|NCT00651118|561048237|FG000|Overall Study|Adverse Event|4|||
155443401|NCT00651118|561048238|FG001|Overall Study|Adverse Event|0|||
155443402|NCT00651118|561048239|FG002|Overall Study|Adverse Event|1|||
155443403|NCT00651118|561048240|FG003|Overall Study|Adverse Event|1|||
155443404|NCT00651118|561048237|FG000|Overall Study|Protocol Violation|2|||
155443405|NCT00651118|561048238|FG001|Overall Study|Protocol Violation|2|||
155443406|NCT00651118|561048239|FG002|Overall Study|Protocol Violation|6|||
155443407|NCT00651118|561048240|FG003|Overall Study|Protocol Violation|2|||
155443408|NCT00651118|561048237|FG000|Overall Study|Lost to Follow-up|2|||
155443409|NCT00651118|561048238|FG001|Overall Study|Lost to Follow-up|0|||
155443410|NCT00651118|561048239|FG002|Overall Study|Lost to Follow-up|1|||
155443411|NCT00651118|561048240|FG003|Overall Study|Lost to Follow-up|2|||
155443412|NCT00651118|561048237|FG000|Overall Study|administrative|1|||
155443413|NCT00651118|561048238|FG001|Overall Study|administrative|4|||
155443414|NCT00651118|561048239|FG002|Overall Study|administrative|2|||
155443415|NCT00651118|561048240|FG003|Overall Study|administrative|1|||
155443416|NCT00651118|561048237|FG000|Overall Study|Withdrawal by Subject|0|||
155443417|NCT00651118|561048238|FG001|Overall Study|Withdrawal by Subject|1|||
155443418|NCT00651118|561048239|FG002|Overall Study|Withdrawal by Subject|1|||
155443419|NCT00651118|561048240|FG003|Overall Study|Withdrawal by Subject|1|||
155443420|NCT00839098|561048241|FG000|Overall Study|Withdrawal by Subject|2|||
155443421|NCT00839098|561048242|FG001|Overall Study|Withdrawal by Subject|1|||
155443422|NCT00839098|561048243|FG002|Overall Study|Withdrawal by Subject|7|||
155443423|NCT00365976|561048244|FG000|Overall Study|Withdrawal by Subject|1|||
155443424|NCT00365976|561048245|FG001|Overall Study|Withdrawal by Subject|5|||
155443425|NCT02190435|561048246|FG000|Overall Study|First 12 patients were lead-ins|12|||
155443426|NCT02190435|561048247|FG001|Overall Study|First 12 patients were lead-ins|0|||
155443427|NCT02190435|561048246|FG000|Overall Study|3 consented screen fails|3|||
155443428|NCT02190435|561048247|FG001|Overall Study|3 consented screen fails|0|||
155443429|NCT02399475|561048256|FG000|Overall Study|Physician Decision|1|||
155443430|NCT02399475|561048257|FG001|Overall Study|Physician Decision|0|||
155443431|NCT02260193|561048258|FG000|Overall Study|Lack of Efficacy|0|||
155443432|NCT02260193|561048259|FG001|Overall Study|Lack of Efficacy|1|||
155443433|NCT02260193|561048260|FG002|Overall Study|Lack of Efficacy|6|||
155443434|NCT02260193|561048258|FG000|Overall Study|Adverse Event|3|||
155443435|NCT02260193|561048259|FG001|Overall Study|Adverse Event|4|||
155443436|NCT02260193|561048260|FG002|Overall Study|Adverse Event|1|||
155443437|NCT02260193|561048258|FG000|Overall Study|Protocol Violation|0|||
155443438|NCT02260193|561048259|FG001|Overall Study|Protocol Violation|4|||
155443439|NCT02260193|561048260|FG002|Overall Study|Protocol Violation|0|||
155443440|NCT02260193|561048258|FG000|Overall Study|Withdrawal by Subject|3|||
155443441|NCT02260193|561048259|FG001|Overall Study|Withdrawal by Subject|0|||
155443442|NCT02260193|561048260|FG002|Overall Study|Withdrawal by Subject|2|||
155443443|NCT02260193|561048258|FG000|Overall Study|Kidney Transplantation|0|||
155443444|NCT02260193|561048259|FG001|Overall Study|Kidney Transplantation|0|||
155443445|NCT02260193|561048260|FG002|Overall Study|Kidney Transplantation|1|||
155443446|NCT01780389|561048261|FG000|Overall Study|Adverse Event|1|||
155443447|NCT00935220|561048262|FG000|Overall Study|Adverse Event|1|||
155443448|NCT00935220|561048262|FG000|Overall Study|Other reason (not specified)|1|||
155443449|NCT03625986|561049982|FG000|Randomization Period|Lost to Follow-up|7|||
155443450|NCT03625986|561049983|FG001|Randomization Period|Lost to Follow-up|12|||
155443451|NCT03625986|561049982|FG000|Randomization Period|Withdrawal by Subject|10|||
155443452|NCT03625986|561049983|FG001|Randomization Period|Withdrawal by Subject|6|||
155443453|NCT01850563|561049984|FG000|Overall Study|Not eligible|3|||
155443454|NCT01850563|561049985|FG001|Overall Study|Not eligible|0|||
155443455|NCT04359823|561049986|FG000|Overall Study|Lost to Follow-up|0|||
155443456|NCT04359823|561049987|FG001|Overall Study|Lost to Follow-up|1|||
155443457|NCT04359823|561049986|FG000|Overall Study|Withdrawal by Subject|0|||
155443458|NCT04359823|561049987|FG001|Overall Study|Withdrawal by Subject|1|||
155443459|NCT02078713|561049988|FG000|Overall Study|Lost to Follow-up|49|||
155443460|NCT02078713|561049989|FG001|Overall Study|Lost to Follow-up|55|||
155443461|NCT02078713|561049990|FG002|Overall Study|Lost to Follow-up|0|||
155443462|NCT02078713|561049991|FG003|Overall Study|Lost to Follow-up|0|||
155443463|NCT02078713|561049988|FG000|Overall Study|Pregnant at baseline|3|||
155443464|NCT02078713|561049989|FG001|Overall Study|Pregnant at baseline|5|||
155443465|NCT02078713|561049990|FG002|Overall Study|Pregnant at baseline|0|||
155443466|NCT02078713|561049991|FG003|Overall Study|Pregnant at baseline|0|||
155443467|NCT02078713|561049988|FG000|Overall Study|Enrolled twice|0|||
155443468|NCT02078713|561049989|FG001|Overall Study|Enrolled twice|1|||
155443469|NCT02078713|561049990|FG002|Overall Study|Enrolled twice|0|||
155443470|NCT02078713|561049991|FG003|Overall Study|Enrolled twice|0|||
155443471|NCT04494633|561050002|FG000|Overall Study|Lost to Follow-up|5|||
155443472|NCT04494633|561050003|FG001|Overall Study|Lost to Follow-up|3|||
155443473|NCT04494633|561050002|FG000|Overall Study|Protocol Violation|1|||
155443474|NCT04494633|561050003|FG001|Overall Study|Protocol Violation|1|||
155443475|NCT01254604|561050004|FG000|Overall Study|Lost to Follow-up|1|||
155443476|NCT01254604|561050005|FG001|Overall Study|Lost to Follow-up|1|||
155443477|NCT01254604|561050004|FG000|Overall Study|Protocol Violation|2|||
155443478|NCT01254604|561050005|FG001|Overall Study|Protocol Violation|2|||
155443479|NCT01254604|561050004|FG000|Overall Study|Withdrawal by Subject|2|||
155443480|NCT01254604|561050005|FG001|Overall Study|Withdrawal by Subject|4|||
155443481|NCT01254604|561050004|FG000|Overall Study|Adverse Event|3|||
155443482|NCT01254604|561050005|FG001|Overall Study|Adverse Event|2|||
155443483|NCT03074162|561050006|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
155443484|NCT03074162|561050007|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
155443485|NCT03074162|561050008|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
155443486|NCT03074162|561050009|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
155443487|NCT03074162|561050010|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
155443488|NCT03074162|561050011|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
155443489|NCT03074162|561050006|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
155443490|NCT03074162|561050007|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
155443491|NCT03074162|561050008|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
155443492|NCT03074162|561050009|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
155443493|NCT03074162|561050010|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
155443494|NCT03074162|561050011|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
155443495|NCT03074162|561050006|FG000|Period 3|Withdrawal by Subject|1|||
155443496|NCT03074162|561050007|FG001|Period 3|Withdrawal by Subject|0|||
155443497|NCT03074162|561050008|FG002|Period 3|Withdrawal by Subject|0|||
155443498|NCT03074162|561050009|FG003|Period 3|Withdrawal by Subject|0|||
155443499|NCT03074162|561050010|FG004|Period 3|Withdrawal by Subject|1|||
155443500|NCT03074162|561050011|FG005|Period 3|Withdrawal by Subject|0|||
155443501|NCT02421120|561050017|FG000|Overall Study|Adverse Event|1|||
155443502|NCT00273858|561050019|FG000|Overall Study|Not completed 24 month observation time|334|||
155443503|NCT00273858|561050019|FG000|Overall Study|Lost to Follow-up|101|||
155443504|NCT00273858|561050019|FG000|Overall Study|Withdrawal by Subject|21|||
155443505|NCT00273858|561050019|FG000|Overall Study|Adverse Event|81|||
155443506|NCT01070550|561050025|FG000|Overall Study|Adverse Event|43|||
155443507|NCT01070550|561050026|FG001|Overall Study|Adverse Event|1|||
155443508|NCT01070550|561050027|FG002|Overall Study|Adverse Event|3|||
155443509|NCT01070550|561050028|FG003|Overall Study|Adverse Event|0|||
155443510|NCT01070550|561050029|FG004|Overall Study|Adverse Event|0|||
155443511|NCT01070550|561050030|FG005|Overall Study|Adverse Event|0|||
155443512|NCT01070550|561050025|FG000|Overall Study|Death|20|||
155443513|NCT01070550|561050026|FG001|Overall Study|Death|4|||
155443514|NCT01070550|561050027|FG002|Overall Study|Death|3|||
155443515|NCT01070550|561050028|FG003|Overall Study|Death|0|||
155443516|NCT01070550|561050029|FG004|Overall Study|Death|0|||
155443517|NCT01070550|561050030|FG005|Overall Study|Death|0|||
155443518|NCT01070550|561050025|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
155443519|NCT01070550|561050026|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155443520|NCT01070550|561050027|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155443521|NCT01070550|561050028|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155443522|NCT01070550|561050029|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155443523|NCT01070550|561050030|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155443524|NCT01070550|561050025|FG000|Overall Study|Early termination|3|||
155443525|NCT01070550|561050026|FG001|Overall Study|Early termination|0|||
155443526|NCT01070550|561050027|FG002|Overall Study|Early termination|0|||
155443527|NCT01070550|561050028|FG003|Overall Study|Early termination|0|||
155443528|NCT01070550|561050029|FG004|Overall Study|Early termination|0|||
155443529|NCT01070550|561050030|FG005|Overall Study|Early termination|0|||
155443530|NCT01070550|561050025|FG000|Overall Study|Failed to return|450|||
155443531|NCT01070550|561050026|FG001|Overall Study|Failed to return|33|||
155443532|NCT01070550|561050027|FG002|Overall Study|Failed to return|144|||
155443533|NCT01070550|561050028|FG003|Overall Study|Failed to return|40|||
155443534|NCT01070550|561050029|FG004|Overall Study|Failed to return|1|||
155443535|NCT01070550|561050030|FG005|Overall Study|Failed to return|2|||
155443536|NCT01070550|561050025|FG000|Overall Study|Incomplete treatment|2|||
155443537|NCT01070550|561050026|FG001|Overall Study|Incomplete treatment|0|||
155443538|NCT01070550|561050027|FG002|Overall Study|Incomplete treatment|0|||
155443539|NCT01070550|561050028|FG003|Overall Study|Incomplete treatment|0|||
155443540|NCT01070550|561050029|FG004|Overall Study|Incomplete treatment|0|||
155443541|NCT01070550|561050030|FG005|Overall Study|Incomplete treatment|0|||
155443542|NCT01070550|561050025|FG000|Overall Study|Lab test not done|22|||
155443543|NCT01070550|561050026|FG001|Overall Study|Lab test not done|3|||
155443544|NCT01070550|561050027|FG002|Overall Study|Lab test not done|4|||
155443545|NCT01070550|561050028|FG003|Overall Study|Lab test not done|1|||
155443546|NCT01070550|561050029|FG004|Overall Study|Lab test not done|0|||
155443547|NCT01070550|561050030|FG005|Overall Study|Lab test not done|1|||
155443548|NCT01070550|561050025|FG000|Overall Study|Lack of Efficacy|65|||
155443549|NCT01070550|561050026|FG001|Overall Study|Lack of Efficacy|1|||
155443550|NCT01070550|561050027|FG002|Overall Study|Lack of Efficacy|5|||
155443551|NCT01070550|561050028|FG003|Overall Study|Lack of Efficacy|5|||
155443552|NCT01070550|561050029|FG004|Overall Study|Lack of Efficacy|0|||
155443553|NCT01070550|561050030|FG005|Overall Study|Lack of Efficacy|1|||
155443554|NCT01070550|561050025|FG000|Overall Study|Miscellaneous|12|||
155443555|NCT01070550|561050026|FG001|Overall Study|Miscellaneous|2|||
155443556|NCT01070550|561050027|FG002|Overall Study|Miscellaneous|3|||
155443557|NCT01070550|561050028|FG003|Overall Study|Miscellaneous|1|||
155443558|NCT01070550|561050029|FG004|Overall Study|Miscellaneous|0|||
155443559|NCT01070550|561050030|FG005|Overall Study|Miscellaneous|0|||
155443560|NCT01070550|561050025|FG000|Overall Study|New treatment started|3|||
155443561|NCT01070550|561050026|FG001|Overall Study|New treatment started|1|||
155443562|NCT01070550|561050027|FG002|Overall Study|New treatment started|0|||
155443563|NCT01070550|561050028|FG003|Overall Study|New treatment started|2|||
155443564|NCT01070550|561050029|FG004|Overall Study|New treatment started|0|||
155443565|NCT01070550|561050030|FG005|Overall Study|New treatment started|0|||
155443566|NCT01070550|561050025|FG000|Overall Study|Non-responders|493|||
155443567|NCT01070550|561050026|FG001|Overall Study|Non-responders|4|||
155443568|NCT01070550|561050027|FG002|Overall Study|Non-responders|21|||
155443569|NCT01070550|561050028|FG003|Overall Study|Non-responders|20|||
155443570|NCT01070550|561050029|FG004|Overall Study|Non-responders|0|||
155443571|NCT01070550|561050030|FG005|Overall Study|Non-responders|2|||
155443572|NCT01070550|561050025|FG000|Overall Study|Not categorized|33|||
155443573|NCT01070550|561050026|FG001|Overall Study|Not categorized|2|||
155443574|NCT01070550|561050027|FG002|Overall Study|Not categorized|6|||
155443575|NCT01070550|561050028|FG003|Overall Study|Not categorized|1|||
155443576|NCT01070550|561050029|FG004|Overall Study|Not categorized|0|||
155443577|NCT01070550|561050030|FG005|Overall Study|Not categorized|1|||
155443578|NCT01070550|561050025|FG000|Overall Study|Protocol Violation|15|||
155443579|NCT01070550|561050026|FG001|Overall Study|Protocol Violation|1|||
155443580|NCT01070550|561050027|FG002|Overall Study|Protocol Violation|1|||
155443581|NCT01070550|561050028|FG003|Overall Study|Protocol Violation|1|||
155443582|NCT01070550|561050029|FG004|Overall Study|Protocol Violation|0|||
155443583|NCT01070550|561050030|FG005|Overall Study|Protocol Violation|0|||
155443584|NCT01070550|561050025|FG000|Overall Study|Relapse|44|||
155443585|NCT01070550|561050026|FG001|Overall Study|Relapse|5|||
155443586|NCT01070550|561050027|FG002|Overall Study|Relapse|14|||
155443587|NCT01070550|561050028|FG003|Overall Study|Relapse|4|||
155443588|NCT01070550|561050029|FG004|Overall Study|Relapse|0|||
155443589|NCT01070550|561050030|FG005|Overall Study|Relapse|0|||
155443590|NCT01070550|561050025|FG000|Overall Study|Result not available|3|||
155443591|NCT01070550|561050026|FG001|Overall Study|Result not available|1|||
155443592|NCT01070550|561050027|FG002|Overall Study|Result not available|3|||
155443593|NCT01070550|561050028|FG003|Overall Study|Result not available|0|||
155443594|NCT01070550|561050029|FG004|Overall Study|Result not available|0|||
155443595|NCT01070550|561050030|FG005|Overall Study|Result not available|0|||
155443596|NCT01070550|561050025|FG000|Overall Study|Screen failure|1|||
155443597|NCT01070550|561050026|FG001|Overall Study|Screen failure|0|||
155443598|NCT01070550|561050027|FG002|Overall Study|Screen failure|0|||
155443599|NCT01070550|561050028|FG003|Overall Study|Screen failure|0|||
155443600|NCT01070550|561050029|FG004|Overall Study|Screen failure|0|||
155443601|NCT01070550|561050030|FG005|Overall Study|Screen failure|0|||
155443602|NCT01070550|561050025|FG000|Overall Study|Sponsor decision|1|||
155443603|NCT01070550|561050026|FG001|Overall Study|Sponsor decision|0|||
155443604|NCT01070550|561050027|FG002|Overall Study|Sponsor decision|0|||
155443605|NCT01070550|561050028|FG003|Overall Study|Sponsor decision|0|||
155443606|NCT01070550|561050029|FG004|Overall Study|Sponsor decision|0|||
155443607|NCT01070550|561050030|FG005|Overall Study|Sponsor decision|0|||
155443608|NCT01070550|561050025|FG000|Overall Study|Treatment duration shortened|1|||
155443609|NCT01070550|561050026|FG001|Overall Study|Treatment duration shortened|0|||
155443610|NCT01070550|561050027|FG002|Overall Study|Treatment duration shortened|0|||
155443611|NCT01070550|561050028|FG003|Overall Study|Treatment duration shortened|0|||
155443612|NCT01070550|561050029|FG004|Overall Study|Treatment duration shortened|0|||
155443613|NCT01070550|561050030|FG005|Overall Study|Treatment duration shortened|0|||
155443614|NCT01070550|561050025|FG000|Overall Study|Treatment interrupted|7|||
155443615|NCT01070550|561050026|FG001|Overall Study|Treatment interrupted|0|||
155443616|NCT01070550|561050027|FG002|Overall Study|Treatment interrupted|1|||
155443617|NCT01070550|561050028|FG003|Overall Study|Treatment interrupted|1|||
155443618|NCT01070550|561050029|FG004|Overall Study|Treatment interrupted|0|||
155443619|NCT01070550|561050030|FG005|Overall Study|Treatment interrupted|0|||
155443620|NCT01070550|561050025|FG000|Overall Study|Treatment not started|14|||
155443621|NCT01070550|561050026|FG001|Overall Study|Treatment not started|2|||
155443622|NCT01070550|561050027|FG002|Overall Study|Treatment not started|4|||
155443623|NCT01070550|561050028|FG003|Overall Study|Treatment not started|0|||
155443624|NCT01070550|561050029|FG004|Overall Study|Treatment not started|0|||
155443625|NCT01070550|561050030|FG005|Overall Study|Treatment not started|0|||
155443626|NCT01070550|561050025|FG000|Overall Study|Treatment restarted|0|||
155443627|NCT01070550|561050026|FG001|Overall Study|Treatment restarted|1|||
155443628|NCT01070550|561050027|FG002|Overall Study|Treatment restarted|0|||
155443629|NCT01070550|561050028|FG003|Overall Study|Treatment restarted|0|||
155443630|NCT01070550|561050029|FG004|Overall Study|Treatment restarted|0|||
155443631|NCT01070550|561050030|FG005|Overall Study|Treatment restarted|0|||
155443632|NCT01070550|561050025|FG000|Overall Study|Treatment stopped|3|||
155443633|NCT01070550|561050026|FG001|Overall Study|Treatment stopped|0|||
155443634|NCT01070550|561050027|FG002|Overall Study|Treatment stopped|0|||
155443635|NCT01070550|561050028|FG003|Overall Study|Treatment stopped|0|||
155443636|NCT01070550|561050029|FG004|Overall Study|Treatment stopped|0|||
155443637|NCT01070550|561050030|FG005|Overall Study|Treatment stopped|0|||
155443638|NCT01070550|561050025|FG000|Overall Study|Treatment unavailable|1|||
155443639|NCT01070550|561050026|FG001|Overall Study|Treatment unavailable|0|||
155443640|NCT01070550|561050027|FG002|Overall Study|Treatment unavailable|0|||
155443641|NCT01070550|561050028|FG003|Overall Study|Treatment unavailable|0|||
155443642|NCT01070550|561050029|FG004|Overall Study|Treatment unavailable|0|||
155443643|NCT01070550|561050030|FG005|Overall Study|Treatment unavailable|0|||
155443644|NCT01070550|561050025|FG000|Overall Study|Treatment was stopped early|7|||
155443645|NCT01070550|561050026|FG001|Overall Study|Treatment was stopped early|0|||
155443646|NCT01070550|561050027|FG002|Overall Study|Treatment was stopped early|0|||
155443647|NCT01070550|561050028|FG003|Overall Study|Treatment was stopped early|0|||
155443648|NCT01070550|561050029|FG004|Overall Study|Treatment was stopped early|0|||
155443649|NCT01070550|561050030|FG005|Overall Study|Treatment was stopped early|0|||
155443650|NCT01070550|561050025|FG000|Overall Study|Other|5|||
155443651|NCT01070550|561050026|FG001|Overall Study|Other|0|||
155443652|NCT01070550|561050027|FG002|Overall Study|Other|0|||
155443653|NCT01070550|561050028|FG003|Overall Study|Other|1|||
155443654|NCT01070550|561050029|FG004|Overall Study|Other|0|||
155443655|NCT01070550|561050030|FG005|Overall Study|Other|0|||
155443656|NCT01070550|561050025|FG000|Overall Study|Withdrawal by Subject|35|||
155443657|NCT01070550|561050026|FG001|Overall Study|Withdrawal by Subject|0|||
155443658|NCT01070550|561050027|FG002|Overall Study|Withdrawal by Subject|3|||
155443659|NCT01070550|561050028|FG003|Overall Study|Withdrawal by Subject|0|||
155443660|NCT01070550|561050029|FG004|Overall Study|Withdrawal by Subject|0|||
155443661|NCT01070550|561050030|FG005|Overall Study|Withdrawal by Subject|0|||
155443662|NCT00305006|561050031|FG000|Overall Study|Withdrawal by Subject|1|||
155443663|NCT00305006|561050032|FG001|Overall Study|Withdrawal by Subject|0|||
155443664|NCT00305006|561050031|FG000|Overall Study|Failure to complete pretest|0|||
155443665|NCT00305006|561050032|FG001|Overall Study|Failure to complete pretest|1|||
155443666|NCT04964063|561050033|FG000|Overall Study|Adverse Event|4|||
155443667|NCT04964063|561050033|FG000|Overall Study|Lost to Follow-up|47|||
155443668|NCT04964063|561050033|FG000|Overall Study|Withdrawal by Subject|5|||
155443669|NCT04964063|561050033|FG000|Overall Study|Baseline Tasks Expired|41|||
155443670|NCT04964063|561050033|FG000|Overall Study|Participant withdrawn in error|1|||
155443671|NCT01849848|561050036|FG000|Overall Study|Physician Decision|1|||
155443672|NCT01849848|561050036|FG000|Overall Study|Progression of the primary disease|3|||
155443673|NCT01702363|561050037|FG000|Overall Study|Adverse Event|14|||
155443674|NCT01702363|561050037|FG000|Overall Study|Lack of Efficacy|4|||
155443675|NCT01702363|561050037|FG000|Overall Study|Withdrawal by Subject|2|||
155443676|NCT01312428|561050038|FG000|Overall Study|Study Termination|3|||
155443677|NCT01312428|561050039|FG001|Overall Study|Study Termination|4|||
155443678|NCT00793819|561050045|FG000|Overall Study|Adverse Event|8|||
155443679|NCT00793819|561050046|FG001|Overall Study|Adverse Event|4|||
155443680|NCT00793819|561050045|FG000|Overall Study|Lack of Efficacy|1|||
155443681|NCT00793819|561050046|FG001|Overall Study|Lack of Efficacy|1|||
155443682|NCT00793819|561050045|FG000|Overall Study|Withdrawal by Subject|4|||
155443683|NCT00793819|561050046|FG001|Overall Study|Withdrawal by Subject|3|||
155443684|NCT00793819|561050045|FG000|Overall Study|Lost to Follow-up|1|||
155443685|NCT00793819|561050046|FG001|Overall Study|Lost to Follow-up|1|||
155443686|NCT05100199|561050056|FG000|Overall Study|Lost to Follow-up|5|||
155443687|NCT05100199|561050057|FG001|Overall Study|Lost to Follow-up|8|||
155443688|NCT05100199|561050058|FG002|Overall Study|Lost to Follow-up|3|||
155443689|NCT05100199|561050059|FG003|Overall Study|Lost to Follow-up|6|||
155443690|NCT05100199|561050056|FG000|Overall Study|Withdrawal by Subject|3|||
155443691|NCT05100199|561050057|FG001|Overall Study|Withdrawal by Subject|3|||
155443692|NCT05100199|561050058|FG002|Overall Study|Withdrawal by Subject|9|||
155443693|NCT05100199|561050059|FG003|Overall Study|Withdrawal by Subject|7|||
155443694|NCT05100199|561050056|FG000|Overall Study|Other|0|||
155443695|NCT05100199|561050057|FG001|Overall Study|Other|0|||
155443696|NCT05100199|561050058|FG002|Overall Study|Other|1|||
155443697|NCT05100199|561050059|FG003|Overall Study|Other|1|||
155443698|NCT02853331|561050060|FG000|Overall Study|Death|59|||
155443699|NCT02853331|561050061|FG001|Overall Study|Death|95|||
155443700|NCT02853331|561050060|FG000|Overall Study|Withdrawal by Subject|5|||
155651356|NCT01897896|561816185|FG001|Overall Study|Withdrawal by Subject|1|||
155651357|NCT01897896|561816184|FG000|Overall Study|Require drug that interfere with study|1|||
155651358|NCT01897896|561816185|FG001|Overall Study|Require drug that interfere with study|4|||
155651359|NCT01897896|561816184|FG000|Overall Study|Protocol Violation|1|||
155651360|NCT01897896|561816185|FG001|Overall Study|Protocol Violation|1|||
155651361|NCT01897896|561816184|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
155651362|NCT01897896|561816185|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
155651363|NCT01897896|561816184|FG000|Overall Study|Caregiver can no longer participate|0|||
155651364|NCT01897896|561816185|FG001|Overall Study|Caregiver can no longer participate|2|||
155651365|NCT01897896|561816184|FG000|Overall Study|Other than specified|2|||
155651366|NCT01897896|561816185|FG001|Overall Study|Other than specified|1|||
155651367|NCT00432991|561816186|FG000|Overall Study|Protocol Violation|7|||
155651368|NCT00432991|561816187|FG001|Overall Study|Protocol Violation|12|||
155443701|NCT02853331|561050061|FG001|Overall Study|Withdrawal by Subject|9|||
155443702|NCT02853331|561050060|FG000|Overall Study|Ongoing in study|368|||
155443703|NCT02853331|561050061|FG001|Overall Study|Ongoing in study|325|||
155443704|NCT01455428|561050062|FG000|Overall Study|Protocol Violation|2|||
155443705|NCT01455428|561050063|FG001|Overall Study|Protocol Violation|1|||
155443706|NCT01455428|561050062|FG000|Overall Study|Adverse Event|6|||
155443707|NCT01455428|561050063|FG001|Overall Study|Adverse Event|2|||
155443708|NCT01455428|561050062|FG000|Overall Study|Lost to Follow-up|1|||
155443709|NCT01455428|561050063|FG001|Overall Study|Lost to Follow-up|1|||
155443710|NCT01455428|561050062|FG000|Overall Study|Withdrawal by Subject|2|||
155443711|NCT01455428|561050063|FG001|Overall Study|Withdrawal by Subject|5|||
155443712|NCT01455428|561050062|FG000|Overall Study|Did not meet entrance criteria|0|||
155443713|NCT01455428|561050063|FG001|Overall Study|Did not meet entrance criteria|2|||
155443714|NCT01455428|561050062|FG000|Overall Study|Insufficient clinical response|0|||
155443715|NCT01455428|561050063|FG001|Overall Study|Insufficient clinical response|2|||
155443716|NCT01455428|561050062|FG000|Overall Study|Did not receive treatment|1|||
155443717|NCT01455428|561050063|FG001|Overall Study|Did not receive treatment|1|||
155443718|NCT01455428|561050062|FG000|Overall Study|Other|2|||
155443719|NCT01455428|561050063|FG001|Overall Study|Other|4|||
155443720|NCT00257192|561050067|FG000|Overall Study|Adverse Event|21|||
155443721|NCT00257192|561050068|FG001|Overall Study|Adverse Event|10|||
155443722|NCT00257192|561050067|FG000|Overall Study|Laboratory abnormality|1|||
155443723|NCT00257192|561050068|FG001|Overall Study|Laboratory abnormality|1|||
155443724|NCT00257192|561050067|FG000|Overall Study|Lost to Follow-up|3|||
155443725|NCT00257192|561050068|FG001|Overall Study|Lost to Follow-up|3|||
155443726|NCT00257192|561050067|FG000|Overall Study|Insufficient clinical response|18|||
155443727|NCT00257192|561050068|FG001|Overall Study|Insufficient clinical response|18|||
155443728|NCT00257192|561050067|FG000|Overall Study|Withdrawal by Subject|14|||
155443729|NCT00257192|561050068|FG001|Overall Study|Withdrawal by Subject|2|||
155443730|NCT00257192|561050067|FG000|Overall Study|Randomized but not treated|0|||
155443731|NCT00257192|561050068|FG001|Overall Study|Randomized but not treated|1|||
155443732|NCT00257192|561050067|FG000|Overall Study|Study terminated by sponsor|1|||
155443733|NCT00257192|561050068|FG001|Overall Study|Study terminated by sponsor|0|||
155443734|NCT00257192|561050067|FG000|Overall Study|Miscellaneous|0|||
155443735|NCT00257192|561050068|FG001|Overall Study|Miscellaneous|4|||
155443736|NCT02062151|561050071|FG000|Overall Study|screen failure|1|||
155443737|NCT01161524|561050073|FG000|Core Study (23 Weeks)|Adverse Event|3|||
155443738|NCT01161524|561050074|FG001|Core Study (23 Weeks)|Adverse Event|0|||
155443739|NCT01161524|561050075|FG002|Core Study (23 Weeks)|Adverse Event|0|||
155443740|NCT01161524|561050073|FG000|Core Study (23 Weeks)|Other|1|||
155443741|NCT01161524|561050074|FG001|Core Study (23 Weeks)|Other|0|||
155443742|NCT01161524|561050075|FG002|Core Study (23 Weeks)|Other|0|||
155443743|NCT01161524|561050073|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
155443744|NCT01161524|561050074|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
155443745|NCT01161524|561050075|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
155443746|NCT01161524|561050073|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
155443747|NCT01161524|561050074|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
155443748|NCT01161524|561050075|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
155651369|NCT00363467|561816188|FG000|Overall Study|Physician Decision|1|||
155651370|NCT05069415|561816189|FG000|Overall Study|Withdrawal by Subject|2|||
155443749|NCT01161524|561050073|FG000|Core Study (23 Weeks)|Subject Choice|3|||
155443750|NCT01161524|561050074|FG001|Core Study (23 Weeks)|Subject Choice|2|||
155443751|NCT01161524|561050075|FG002|Core Study (23 Weeks)|Subject Choice|0|||
155443752|NCT01161524|561050073|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
155651371|NCT05069415|561816190|FG001|Overall Study|Withdrawal by Subject|0|||
155443753|NCT01161524|561050074|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
155443754|NCT01161524|561050075|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
155443755|NCT01161524|561050073|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
155443756|NCT01161524|561050074|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
155443757|NCT01161524|561050075|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
155443758|NCT01161524|561050073|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
155443759|NCT01161524|561050074|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
155443760|NCT01161524|561050075|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
155443761|NCT01161524|561050073|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
155443762|NCT01161524|561050074|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
155443763|NCT01161524|561050075|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
155443764|NCT01161524|561050073|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
155443765|NCT01161524|561050074|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
155443766|NCT01161524|561050075|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
155443767|NCT01618656|561050078|FG000|Overall Study|Withdrawal by Subject|7|||
155443768|NCT01618656|561050079|FG001|Overall Study|Withdrawal by Subject|3|||
155443769|NCT01618656|561050078|FG000|Overall Study|Physician Decision|1|||
155443770|NCT01618656|561050079|FG001|Overall Study|Physician Decision|1|||
155443771|NCT01899144|561050080|FG000|Treatment Period 2|Other|1|||
155443772|NCT01899144|561050080|FG000|Treatment Period 3|Other|2|||
155443773|NCT01899144|561050080|FG000|Treatment Period 5|Other|1|||
155443774|NCT02119104|561050082|FG000|Overall Study|Protocol Violation|16|||
155443775|NCT00081289|561050085|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
155443776|NCT00081289|561050086|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
155443777|NCT00081289|561050085|FG000|Overall Study|Ineligible / no protocol treatment|3|||
155443778|NCT00081289|561050086|FG001|Overall Study|Ineligible / no protocol treatment|4|||
155443779|NCT01952015|561050089|FG000|Induction|Protocol Violation|1|||
155443780|NCT01952015|561050089|FG000|Maintenance|Adverse Event|2|||
155443781|NCT01952015|561050089|FG000|Treatment Period 3|Physician Decision|9|||
155443782|NCT02239094|561050090|FG000|Overall Study|Withdrawal by Subject|1|||
155443783|NCT02239094|561050090|FG000|Overall Study|Remitted before started|1|||
155443784|NCT02508701|561050093|FG000|Overall Study|Lost to Follow-up|9|||
155443785|NCT02508701|561050094|FG001|Overall Study|Lost to Follow-up|5|||
155443786|NCT02508701|561050095|FG002|Overall Study|Lost to Follow-up|5|||
155443787|NCT02508701|561050096|FG003|Overall Study|Lost to Follow-up|3|||
155443788|NCT00530712|561050101|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
155443789|NCT00530712|561050101|FG000|30 Day Follow-up Visit|Missed Visit|5|||
155443790|NCT00530712|561050101|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
155443791|NCT00530712|561050101|FG000|6 Month Follow-up Visit|Missed Visit|3|||
155443792|NCT00530712|561050101|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
155443793|NCT00530712|561050101|FG000|6 Month Follow-up Visit|Death|2|||
155443794|NCT00530712|561050101|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
155443795|NCT00530712|561050101|FG000|12 Month Follow-up Visit|Missed Visit|3|||
155443796|NCT00530712|561050101|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
155443797|NCT00530712|561050101|FG000|12 Month Follow-up Visit|Death|9|||
155443798|NCT03242759|561050104|FG000|Overall Study|Adverse Event|5|||
155443799|NCT03242759|561050105|FG001|Overall Study|Adverse Event|1|||
155443800|NCT03242759|561050104|FG000|Overall Study|Withdrawal by Subject|4|||
155443801|NCT03242759|561050105|FG001|Overall Study|Withdrawal by Subject|3|||
155443802|NCT03242759|561050104|FG000|Overall Study|Lost to Follow-up|3|||
155443803|NCT03242759|561050105|FG001|Overall Study|Lost to Follow-up|1|||
155443804|NCT03242759|561050104|FG000|Overall Study|Administrative problems|1|||
155443805|NCT03242759|561050105|FG001|Overall Study|Administrative problems|1|||
155443806|NCT03242759|561050104|FG000|Overall Study|Death|22|||
155443807|NCT03242759|561050105|FG001|Overall Study|Death|0|||
155443808|NCT03242759|561050104|FG000|Overall Study|Change visit schedule|0|||
155443809|NCT03242759|561050105|FG001|Overall Study|Change visit schedule|1|||
155443810|NCT01095250|561050106|FG000|Overall Study|administrative reasons|8|||
155443811|NCT01095250|561050107|FG001|Overall Study|administrative reasons|10|||
155443812|NCT01095250|561050108|FG002|Overall Study|administrative reasons|7|||
155443813|NCT01095250|561050109|FG003|Overall Study|administrative reasons|5|||
155443814|NCT01095250|561050106|FG000|Overall Study|Withdrawal by Subject|0|||
155443815|NCT01095250|561050107|FG001|Overall Study|Withdrawal by Subject|0|||
155443816|NCT01095250|561050108|FG002|Overall Study|Withdrawal by Subject|1|||
155443817|NCT01095250|561050109|FG003|Overall Study|Withdrawal by Subject|0|||
155443818|NCT01000064|561050110|FG000|Overall Study|Withdrawal by Subject|1|||
155443819|NCT01000064|561050111|FG001|Overall Study|Withdrawal by Subject|1|||
155443820|NCT02518620|561050112|FG000|Overall Study|Adverse Event|23|||
155443821|NCT02518620|561050113|FG001|Overall Study|Adverse Event|11|||
155443822|NCT02518620|561050112|FG000|Overall Study|Lack of Efficacy|2|||
155443823|NCT02518620|561050113|FG001|Overall Study|Lack of Efficacy|0|||
155443824|NCT02518620|561050112|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155443825|NCT02518620|561050113|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155443826|NCT02518620|561050112|FG000|Overall Study|Physician Decision|1|||
155443827|NCT02518620|561050113|FG001|Overall Study|Physician Decision|1|||
155443828|NCT02518620|561050112|FG000|Overall Study|Sponsor's Decision|0|||
155443829|NCT02518620|561050113|FG001|Overall Study|Sponsor's Decision|3|||
155443830|NCT02518620|561050112|FG000|Overall Study|Lost to Follow-up|1|||
155443831|NCT02518620|561050113|FG001|Overall Study|Lost to Follow-up|1|||
155443832|NCT02518620|561050112|FG000|Overall Study|Withdrawal by Subject|17|||
155443833|NCT02518620|561050113|FG001|Overall Study|Withdrawal by Subject|9|||
155443834|NCT02518620|561050112|FG000|Overall Study|Death|1|||
155443835|NCT02518620|561050113|FG001|Overall Study|Death|0|||
155443836|NCT02518620|561050112|FG000|Overall Study|Pregnancy Wish|3|||
155443837|NCT02518620|561050113|FG001|Overall Study|Pregnancy Wish|0|||
155443838|NCT02518620|561050112|FG000|Overall Study|Pregnancy|1|||
155651372|NCT05069415|561816189|FG000|Overall Study|Adverse Event|2|||
155443839|NCT02518620|561050113|FG001|Overall Study|Pregnancy|0|||
155443840|NCT02518620|561050112|FG000|Overall Study|Relocation|2|||
155443841|NCT02518620|561050113|FG001|Overall Study|Relocation|1|||
155443842|NCT00798967|561050114|FG000|Overall Study|Adverse Event|2|||
155443843|NCT00798967|561050115|FG001|Overall Study|Adverse Event|3|||
155443844|NCT00798967|561050114|FG000|Overall Study|Withdrawal by Subject|0|||
155443845|NCT00798967|561050115|FG001|Overall Study|Withdrawal by Subject|1|||
155443846|NCT00798967|561050114|FG000|Overall Study|Physician Decision|1|||
155443847|NCT00798967|561050115|FG001|Overall Study|Physician Decision|0|||
155443848|NCT00798967|561050114|FG000|Overall Study|Randomized in error by site|1|||
155443849|NCT00798967|561050115|FG001|Overall Study|Randomized in error by site|0|||
155443850|NCT01415440|561050120|FG000|Overall Study|Lost to Follow-up|0|||
155443851|NCT01415440|561050121|FG001|Overall Study|Lost to Follow-up|1|||
155443852|NCT01415440|561050122|FG002|Overall Study|Lost to Follow-up|2|||
155443853|NCT01415440|561050120|FG000|Overall Study|Physician Decision|3|||
155443854|NCT01415440|561050121|FG001|Overall Study|Physician Decision|0|||
155443855|NCT01415440|561050122|FG002|Overall Study|Physician Decision|0|||
155443856|NCT01415440|561050120|FG000|Overall Study|Withdrawal by Subject|1|||
155443857|NCT01415440|561050121|FG001|Overall Study|Withdrawal by Subject|0|||
155443858|NCT01415440|561050122|FG002|Overall Study|Withdrawal by Subject|0|||
155443859|NCT00336492|561050125|FG000|Overall Study|Adverse Event|4|||
155443860|NCT00336492|561050126|FG001|Overall Study|Adverse Event|3|||
155443861|NCT00336492|561050127|FG002|Overall Study|Adverse Event|6|||
155443862|NCT00336492|561050125|FG000|Overall Study|Lack of Efficacy|6|||
155651373|NCT05069415|561816190|FG001|Overall Study|Adverse Event|0|||
155443863|NCT00336492|561050126|FG001|Overall Study|Lack of Efficacy|1|||
155443864|NCT00336492|561050127|FG002|Overall Study|Lack of Efficacy|4|||
155443865|NCT00336492|561050125|FG000|Overall Study|Other|5|||
155443866|NCT00336492|561050126|FG001|Overall Study|Other|0|||
155443867|NCT00336492|561050127|FG002|Overall Study|Other|1|||
155443868|NCT01781026|561050130|FG000|Overall Study|Lack of Efficacy|2|||
155443869|NCT03141307|561050131|FG000|In-Hospital|Withdrawal by Subject|0|||
155443870|NCT03141307|561050132|FG001|In-Hospital|Withdrawal by Subject|2|||
155443871|NCT03141307|561050131|FG000|In-Hospital|Protocol Violation|4|||
155651374|NCT00101400|561816193|FG000|Survival Follow-Up|Alive|7|||
155651375|NCT03160573|561816194|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
155651376|NCT03160573|561816195|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
155651377|NCT03160573|561816196|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
155443872|NCT03141307|561050132|FG001|In-Hospital|Protocol Violation|0|||
155443873|NCT03141307|561050131|FG000|Follow-Up|Lost to Follow-up|97|||
155443874|NCT03141307|561050132|FG001|Follow-Up|Lost to Follow-up|54|||
155443875|NCT03090737|561050133|FG000|Overall Study|Other reasons|1|||
155443876|NCT03090737|561050133|FG000|Overall Study|Completed treatment as per protocol|17|||
155443877|NCT03090737|561050133|FG000|Overall Study|Maximum clinical benefit|2|||
155443878|NCT03090737|561050133|FG000|Overall Study|Adverse event unrelated to study drug|7|||
155443879|NCT03090737|561050133|FG000|Overall Study|Study drug toxicity|4|||
155443880|NCT03090737|561050133|FG000|Overall Study|Disease progression|98|||
155651378|NCT03160573|561816197|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
155443881|NCT00227877|561050134|FG000|Pre-visit Assessment|Technical difficulties|7|||
155443882|NCT00227877|561050135|FG001|Pre-visit Assessment|Technical difficulties|3|||
155443883|NCT00227877|561050136|FG002|Pre-visit Assessment|Technical difficulties|0|||
155443884|NCT00227877|561050137|FG003|Pre-visit Assessment|Technical difficulties|0|||
155443885|NCT00227877|561050134|FG000|Post-visit Checklist|Lost to Follow-up|24|||
155443886|NCT00227877|561050135|FG001|Post-visit Checklist|Lost to Follow-up|13|||
155443887|NCT00227877|561050136|FG002|Post-visit Checklist|Lost to Follow-up|1|||
155443888|NCT00227877|561050137|FG003|Post-visit Checklist|Lost to Follow-up|0|||
155443889|NCT00227877|561050134|FG000|3-months Follow-up|Completed late|135|||
155443890|NCT00227877|561050135|FG001|3-months Follow-up|Completed late|128|||
155443891|NCT00227877|561050136|FG002|3-months Follow-up|Completed late|34|||
155443892|NCT00227877|561050137|FG003|3-months Follow-up|Completed late|8|||
155443893|NCT00227877|561050134|FG000|3-months Follow-up|Lost to Follow-up|178|||
155443894|NCT00227877|561050135|FG001|3-months Follow-up|Lost to Follow-up|139|||
155443895|NCT00227877|561050136|FG002|3-months Follow-up|Lost to Follow-up|18|||
155443896|NCT00227877|561050137|FG003|3-months Follow-up|Lost to Follow-up|13|||
155443897|NCT00227877|561050134|FG000|12-months Follow-up|Completed late|78|||
155443898|NCT00227877|561050135|FG001|12-months Follow-up|Completed late|74|||
155443899|NCT00227877|561050136|FG002|12-months Follow-up|Completed late|1|||
155443900|NCT00227877|561050137|FG003|12-months Follow-up|Completed late|0|||
155443901|NCT00227877|561050134|FG000|12-months Follow-up|Lost to Follow-up|232|||
155443902|NCT00227877|561050135|FG001|12-months Follow-up|Lost to Follow-up|189|||
155443903|NCT00227877|561050136|FG002|12-months Follow-up|Lost to Follow-up|30|||
155443904|NCT00227877|561050137|FG003|12-months Follow-up|Lost to Follow-up|26|||
155443905|NCT03596177|561050142|FG000|Single Blind Period|Withdrawal by Subject|1|||
155443906|NCT03596177|561050143|FG001|Single Blind Period|Withdrawal by Subject|1|||
155443907|NCT03596177|561050142|FG000|Single Blind Period|Other|1|||
155443908|NCT03596177|561050143|FG001|Single Blind Period|Other|0|||
155443909|NCT03596177|561050142|FG000|Double Blind Period|Withdrawal by Subject|0|||
155443910|NCT03596177|561050143|FG001|Double Blind Period|Withdrawal by Subject|1|||
155443911|NCT03596177|561050142|FG000|Double Blind Period|Other|0|||
155443912|NCT03596177|561050143|FG001|Double Blind Period|Other|4|||
155443913|NCT03596177|561050142|FG000|Double Blind Period|Death during safety follow-up|0|||
155443914|NCT03596177|561050143|FG001|Double Blind Period|Death during safety follow-up|1|||
155443915|NCT02522481|561050146|FG000|Overall Study|discontinued|1|||
155443916|NCT02522481|561050146|FG000|Overall Study|Not dosed|2|||
155443917|NCT04400318|561051796|FG000|Overall Study|Adverse Event|1|||
155443918|NCT04400318|561051797|FG001|Overall Study|Adverse Event|0|||
155443919|NCT04400318|561051796|FG000|Overall Study|Withdrawal by Subject|1|||
155443920|NCT04400318|561051797|FG001|Overall Study|Withdrawal by Subject|1|||
155443921|NCT04400318|561051796|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
155443922|NCT04400318|561051797|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
155443923|NCT00165646|561051798|FG000|Overall Study|Adverse Event|1|||
155443924|NCT00165646|561051799|FG001|Overall Study|Adverse Event|1|||
155443925|NCT00165646|561051800|FG002|Overall Study|Adverse Event|1|||
155443926|NCT00165646|561051798|FG000|Overall Study|Lack of Efficacy|1|||
155443927|NCT00165646|561051799|FG001|Overall Study|Lack of Efficacy|2|||
155443928|NCT00165646|561051800|FG002|Overall Study|Lack of Efficacy|0|||
155443929|NCT00165646|561051798|FG000|Overall Study|Withdrawal by Subject|0|||
155443930|NCT00165646|561051799|FG001|Overall Study|Withdrawal by Subject|2|||
155443931|NCT00165646|561051800|FG002|Overall Study|Withdrawal by Subject|1|||
155443932|NCT00165646|561051798|FG000|Overall Study|Physician Decision|2|||
155443933|NCT00165646|561051799|FG001|Overall Study|Physician Decision|0|||
155443934|NCT00165646|561051800|FG002|Overall Study|Physician Decision|2|||
155443935|NCT00165646|561051798|FG000|Overall Study|Protocol Violation|1|||
155443936|NCT00165646|561051799|FG001|Overall Study|Protocol Violation|0|||
155443937|NCT00165646|561051800|FG002|Overall Study|Protocol Violation|0|||
155443938|NCT01790438|561051801|FG000|Overall Study|Adverse Event|3|||
155443939|NCT01790438|561051802|FG001|Overall Study|Adverse Event|2|||
155443940|NCT01790438|561051801|FG000|Overall Study|Death|4|||
155443941|NCT01790438|561051802|FG001|Overall Study|Death|0|||
155651379|NCT00382863|561816202|FG000|Overall Study|Death|9|||
155651380|NCT00382863|561816203|FG001|Overall Study|Death|9|||
155651381|NCT00382863|561816202|FG000|Overall Study|Lost to Follow-up|1|||
155443942|NCT01790438|561051801|FG000|Overall Study|Lost to Follow-up|5|||
155443943|NCT01790438|561051802|FG001|Overall Study|Lost to Follow-up|2|||
155443944|NCT01790438|561051801|FG000|Overall Study|Withdrawal by Subject|13|||
155443945|NCT01790438|561051802|FG001|Overall Study|Withdrawal by Subject|2|||
155443946|NCT01790438|561051801|FG000|Overall Study|Physician Decision|3|||
155443947|NCT01790438|561051802|FG001|Overall Study|Physician Decision|1|||
155443948|NCT01790438|561051801|FG000|Overall Study|Sponsor Decision|0|||
155651382|NCT00382863|561816203|FG001|Overall Study|Lost to Follow-up|2|||
155651383|NCT00382863|561816202|FG000|Overall Study|Withdrawal by Subject|5|||
155651384|NCT00382863|561816203|FG001|Overall Study|Withdrawal by Subject|25|||
155443949|NCT01790438|561051802|FG001|Overall Study|Sponsor Decision|3|||
155443950|NCT01790438|561051801|FG000|Overall Study|Protocol Required Discontinuation|7|||
155443951|NCT01790438|561051802|FG001|Overall Study|Protocol Required Discontinuation|1|||
155443952|NCT02433210|561051805|FG000|Overall Study|Physician Decision|1|||
155443953|NCT02433210|561051806|FG001|Overall Study|Physician Decision|0|||
155443954|NCT02433210|561051807|FG002|Overall Study|Physician Decision|0|||
155443955|NCT04907539|561051808|FG000|Overall Study|Consent withdrawn|1|||
155443956|NCT04907539|561051809|FG001|Overall Study|Consent withdrawn|0|||
155443957|NCT04907539|561051808|FG000|Overall Study|Death|14|||
155443958|NCT04907539|561051809|FG001|Overall Study|Death|3|||
155443959|NCT01701583|561051810|FG000|Overall Study|Withdrawal by Subject|2|||
155443960|NCT01701583|561051811|FG001|Overall Study|Withdrawal by Subject|0|||
155443961|NCT05070429|561051812|FG000|Overall Study|Death|0|||
155443962|NCT05070429|561051813|FG001|Overall Study|Death|4|||
155443963|NCT05070429|561051812|FG000|Overall Study|Withdrawal by Subject|2|||
155443964|NCT05070429|561051813|FG001|Overall Study|Withdrawal by Subject|1|||
155443965|NCT05070429|561051812|FG000|Overall Study|Other|15|||
155443966|NCT05070429|561051813|FG001|Overall Study|Other|5|||
155443967|NCT02311478|561051814|FG000|Overall Study|Withdrawal by Subject|1|||
155443968|NCT02311478|561051814|FG000|Overall Study|Lost to Follow-up|5|||
155443969|NCT02311478|561051814|FG000|Overall Study|Failed IUD Insertion|1|||
155443970|NCT03276936|561051815|FG000|Overall Study|Adverse Event|4|||
155443971|NCT03276936|561051816|FG001|Overall Study|Adverse Event|2|||
155443972|NCT03276936|561051815|FG000|Overall Study|Lost to Follow-up|16|||
155443973|NCT03276936|561051816|FG001|Overall Study|Lost to Follow-up|13|||
155443974|NCT03276936|561051815|FG000|Overall Study|Withdrawal by Subject|30|||
155443975|NCT03276936|561051816|FG001|Overall Study|Withdrawal by Subject|20|||
155443976|NCT03276936|561051815|FG000|Overall Study|Not mentioned|6|||
155443977|NCT03276936|561051816|FG001|Overall Study|Not mentioned|3|||
155443978|NCT03041116|561051817|FG000|Double-blind|Death|0|||
155443979|NCT03041116|561051818|FG001|Double-blind|Death|2|||
155443980|NCT03041116|561051817|FG000|Double-blind|Withdrawal by Subject|0|||
155443981|NCT03041116|561051818|FG001|Double-blind|Withdrawal by Subject|4|||
155443982|NCT03041116|561051817|FG000|Open-label|Death|1|||
155443983|NCT03041116|561051818|FG001|Open-label|Death|0|||
155443984|NCT03041116|561051817|FG000|Open-label|Termination of the study by Sponsor|39|||
155443985|NCT03041116|561051818|FG001|Open-label|Termination of the study by Sponsor|37|||
155443986|NCT03041116|561051817|FG000|Open-label|Withdrawal by Subject|1|||
155443987|NCT03041116|561051818|FG001|Open-label|Withdrawal by Subject|0|||
155443988|NCT00943319|561051819|FG000|Overall Study|Death|1|||
155443989|NCT02043301|561051820|FG000|Overall Study|Discontinued|0|||
155443990|NCT02043301|561051821|FG001|Overall Study|Discontinued|1|||
155443991|NCT02043301|561051822|FG002|Overall Study|Discontinued|0|||
155443992|NCT01798134|561051823|FG000|Overall Study|Lost to Follow-up|1|||
155443993|NCT01798134|561051823|FG000|Overall Study|Withdrawal by Subject|3|||
155443994|NCT01798134|561051823|FG000|Overall Study|Death|2|||
155443995|NCT01798134|561051823|FG000|Overall Study|Adverse Event|3|||
155443996|NCT01798134|561051823|FG000|Overall Study|Physician Decision|3|||
155443997|NCT01798134|561051823|FG000|Overall Study|Liver transplant/surgery|4|||
155443998|NCT02653976|561051824|FG000|Overall Study|Withdrawal by Subject|5|||
155443999|NCT02653976|561051824|FG000|Overall Study|Death|4|||
155444000|NCT02023164|561051825|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
155444001|NCT02023164|561051826|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
155444002|NCT02436577|561051827|FG000|Overall Study|Protocol Deviation|0|||
155444003|NCT02436577|561051828|FG001|Overall Study|Protocol Deviation|1|||
155444004|NCT02436577|561051829|FG002|Overall Study|Protocol Deviation|0|||
155444005|NCT02436577|561051830|FG003|Overall Study|Protocol Deviation|0|||
155444006|NCT02436577|561051831|FG004|Overall Study|Protocol Deviation|0|||
155444007|NCT02436577|561051832|FG005|Overall Study|Protocol Deviation|0|||
155444008|NCT03703375|561051833|FG000|Randomization Period|Withdrawal by Subject|0|||
155444009|NCT03703375|561051834|FG001|Randomization Period|Withdrawal by Subject|0|||
155444010|NCT03703375|561051835|FG002|Randomization Period|Withdrawal by Subject|0|||
155444011|NCT03703375|561051836|FG003|Randomization Period|Withdrawal by Subject|1|||
155444012|NCT03703375|561051833|FG000|Randomization Period|Completed safety run-in treatment|7|||
155444013|NCT03703375|561051834|FG001|Randomization Period|Completed safety run-in treatment|0|||
155444014|NCT03703375|561051835|FG002|Randomization Period|Completed safety run-in treatment|0|||
155444015|NCT03703375|561051836|FG003|Randomization Period|Completed safety run-in treatment|0|||
155444016|NCT03703375|561051833|FG000|Treatment Period|Other Reasons|0|||
155444017|NCT03703375|561051834|FG001|Treatment Period|Other Reasons|1|||
155444018|NCT03703375|561051835|FG002|Treatment Period|Other Reasons|0|||
155444019|NCT03703375|561051836|FG003|Treatment Period|Other Reasons|3|||
155444020|NCT03703375|561051833|FG000|Treatment Period|Consent Withdrawal|0|||
155444021|NCT03703375|561051834|FG001|Treatment Period|Consent Withdrawal|0|||
155444022|NCT03703375|561051835|FG002|Treatment Period|Consent Withdrawal|0|||
155444023|NCT03703375|561051836|FG003|Treatment Period|Consent Withdrawal|1|||
155444024|NCT03703375|561051833|FG000|Treatment Period|Death|1|||
155444025|NCT03703375|561051834|FG001|Treatment Period|Death|0|||
155444026|NCT03703375|561051835|FG002|Treatment Period|Death|1|||
155444027|NCT03703375|561051836|FG003|Treatment Period|Death|2|||
155444028|NCT03703375|561051833|FG000|Treatment Period|Toxicity of Study Treatment|2|||
155444029|NCT03703375|561051834|FG001|Treatment Period|Toxicity of Study Treatment|0|||
155444030|NCT03703375|561051835|FG002|Treatment Period|Toxicity of Study Treatment|4|||
155444031|NCT03703375|561051836|FG003|Treatment Period|Toxicity of Study Treatment|1|||
155444032|NCT03703375|561051833|FG000|Treatment Period|Progression|32|||
155444033|NCT03703375|561051834|FG001|Treatment Period|Progression|1|||
155444034|NCT03703375|561051835|FG002|Treatment Period|Progression|7|||
155444035|NCT03703375|561051836|FG003|Treatment Period|Progression|11|||
155444036|NCT03703375|561051833|FG000|Treatment Period|Completed treatment|7|||
155444037|NCT03703375|561051834|FG001|Treatment Period|Completed treatment|2|||
155515189|NCT02985957|561311536|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
155515190|NCT02985957|561311537|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
155515191|NCT02985957|561311531|FG000|Treatment Period|Poor/Non-Compliance|0|||
155515192|NCT02985957|561311532|FG001|Treatment Period|Poor/Non-Compliance|0|||
155515193|NCT02985957|561311533|FG002|Treatment Period|Poor/Non-Compliance|0|||
155515194|NCT02985957|561311534|FG003|Treatment Period|Poor/Non-Compliance|0|||
155515195|NCT02985957|561311535|FG004|Treatment Period|Poor/Non-Compliance|1|||
155515196|NCT02985957|561311536|FG005|Treatment Period|Poor/Non-Compliance|1|||
155515197|NCT02985957|561311537|FG006|Treatment Period|Poor/Non-Compliance|0|||
155515198|NCT05845645|561311538|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515199|NCT05845645|561311539|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515200|NCT05845645|561311540|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
155515201|NCT05845645|561311541|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515202|NCT05845645|561311542|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515203|NCT05845645|561311543|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515204|NCT05845645|561311544|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515205|NCT05845645|561311545|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515206|NCT05845645|561311546|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515207|NCT05845645|561311547|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515208|NCT05845645|561311548|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515209|NCT05845645|561311549|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
155515210|NCT05845645|561311538|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515211|NCT05845645|561311539|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515212|NCT05845645|561311540|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515213|NCT05845645|561311541|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515214|NCT05845645|561311542|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515215|NCT05845645|561311543|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515216|NCT05845645|561311544|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515217|NCT05845645|561311545|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515218|NCT05845645|561311546|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515219|NCT05845645|561311547|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
155515220|NCT05845645|561311548|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515221|NCT05845645|561311549|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
155515222|NCT03748641|561311553|FG000|Overall Study|Ongoing|155|||
155515223|NCT03748641|561311554|FG001|Overall Study|Ongoing|148|||
155515224|NCT03748641|561311555|FG002|Overall Study|Ongoing|66|||
155515225|NCT03748641|561311556|FG003|Overall Study|Ongoing|79|||
155515226|NCT03748641|561311557|FG004|Overall Study|Ongoing|84|||
155515227|NCT03748641|561311553|FG000|Overall Study|Death|54|||
155515228|NCT03748641|561311554|FG001|Overall Study|Death|59|||
155515229|NCT03748641|561311555|FG002|Overall Study|Death|51|||
155515230|NCT03748641|561311556|FG003|Overall Study|Death|42|||
155515231|NCT03748641|561311557|FG004|Overall Study|Death|9|||
155515232|NCT03748641|561311553|FG000|Overall Study|Lost to Follow-up|0|||
155515233|NCT03748641|561311554|FG001|Overall Study|Lost to Follow-up|2|||
155515234|NCT03748641|561311555|FG002|Overall Study|Lost to Follow-up|1|||
155515235|NCT03748641|561311556|FG003|Overall Study|Lost to Follow-up|0|||
155515236|NCT03748641|561311557|FG004|Overall Study|Lost to Follow-up|0|||
155515237|NCT03748641|561311553|FG000|Overall Study|Withdrawal by Subject|3|||
155444038|NCT03703375|561051835|FG002|Treatment Period|Completed treatment|0|||
155444039|NCT03703375|561051836|FG003|Treatment Period|Completed treatment|0|||
155444040|NCT01675011|561051837|FG000|Overall Study|Trial terminated by Sponsor|3|||
155444041|NCT01675011|561051838|FG001|Overall Study|Trial terminated by Sponsor|1|||
155444042|NCT00615290|561051839|FG000|Overall Study|Adverse Event|2|||
155444043|NCT00615290|561051839|FG000|Overall Study|Lost to Follow-up|3|||
155444044|NCT00615290|561051839|FG000|Overall Study|Withdrawal by Subject|1|||
155444045|NCT00615290|561051839|FG000|Overall Study|Other|2|||
155444046|NCT02849990|561051840|FG000|Overall Study|Adverse Event|1|||
155444047|NCT02849990|561051840|FG000|Overall Study|Withdrawal by Subject|1|||
155444048|NCT01252134|561051841|FG000|Period 1, 8 Hours|Personal Reasons|0|||
155444049|NCT01252134|561051842|FG001|Period 1, 8 Hours|Personal Reasons|1|||
155444050|NCT01252134|561051843|FG002|Period 1, 8 Hours|Personal Reasons|1|||
155444051|NCT01252134|561051844|FG003|Period 1, 8 Hours|Personal Reasons|0|||
155444052|NCT01252134|561051845|FG004|Period 1, 8 Hours|Personal Reasons|0|||
155444053|NCT01252134|561051846|FG005|Period 1, 8 Hours|Personal Reasons|0|||
155444054|NCT02678741|561051848|FG000|Overall Study|Death|4|||
155444055|NCT02678741|561051848|FG000|Overall Study|Withdrawal by Subject|1|||
155444056|NCT02678741|561051848|FG000|Overall Study|ineligible|3|||
155444057|NCT02678741|561051848|FG000|Overall Study|Not RECIST Measurable|2|||
155444058|NCT02678741|561051848|FG000|Overall Study|Lack of Efficacy|10|||
155444059|NCT01795898|561051849|FG000|Overall Study|Adverse Event|27|||
155444060|NCT01795898|561051849|FG000|Overall Study|Lost to Follow-up|20|||
155444061|NCT01795898|561051849|FG000|Overall Study|Withdrawal of consent|6|||
155444062|NCT01795898|561051849|FG000|Overall Study|Diagnosed with metastasis|1|||
155444063|NCT01795898|561051849|FG000|Overall Study|No pain|1|||
155444064|NCT01795898|561051849|FG000|Overall Study|Death|1|||
155444065|NCT01795898|561051849|FG000|Overall Study|Withdrew consent & had adverse events|3|||
155444066|NCT01795898|561051849|FG000|Overall Study|Physician Decision|1|||
155444067|NCT00372190|561051862|FG000|Overall Study|Lost to Follow-up|3|||
155444068|NCT00372190|561051863|FG001|Overall Study|Lost to Follow-up|1|||
155444069|NCT00623467|561051864|FG000|Overall Study|Lost to Follow-up|1|||
155444070|NCT00623467|561051864|FG000|Overall Study|Protocol Violation|4|||
155444071|NCT00623467|561051864|FG000|Overall Study|Withdrawal by Subject|2|||
155444072|NCT02606045|561051879|FG000|Overall Study|Study closed before treament could begin|1|||
155444073|NCT02606045|561051880|FG001|Overall Study|Study closed before treament could begin|2|||
155444074|NCT03952468|561051881|FG000|Overall Study|Death|0|||
155444075|NCT03952468|561051882|FG001|Overall Study|Death|1|||
155444076|NCT03952468|561051881|FG000|Overall Study|Adverse Event|0|||
155444077|NCT03952468|561051882|FG001|Overall Study|Adverse Event|1|||
155444078|NCT03952468|561051881|FG000|Overall Study|Physician Decision|1|||
155444079|NCT03952468|561051882|FG001|Overall Study|Physician Decision|0|||
155444080|NCT03952468|561051881|FG000|Overall Study|Lost to Follow-up|3|||
155444081|NCT03952468|561051882|FG001|Overall Study|Lost to Follow-up|4|||
155444082|NCT03952468|561051881|FG000|Overall Study|Withdrawal by Subject|2|||
155444083|NCT03952468|561051882|FG001|Overall Study|Withdrawal by Subject|1|||
155444084|NCT01996319|561051883|FG000|Overall Study|Protocol Violation|1|||
155444085|NCT01996319|561051884|FG001|Overall Study|Protocol Violation|0|||
155444086|NCT01996319|561051883|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
155444087|NCT01996319|561051884|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
155444088|NCT01996319|561051883|FG000|Overall Study|Adverse Event|2|||
155444089|NCT01996319|561051884|FG001|Overall Study|Adverse Event|2|||
155444090|NCT01671085|561051886|FG000|Overall Study|Withdrawal by Subject|1|||
155444091|NCT01671085|561051887|FG001|Overall Study|Withdrawal by Subject|0|||
155444092|NCT00637273|561051888|FG000|Overall Study|Adverse Event|11|||
155444093|NCT00637273|561051889|FG001|Overall Study|Adverse Event|5|||
155444094|NCT00637273|561051890|FG002|Overall Study|Adverse Event|7|||
155444095|NCT00637273|561051888|FG000|Overall Study|Lost to Follow-up|8|||
155444096|NCT00637273|561051889|FG001|Overall Study|Lost to Follow-up|9|||
155444097|NCT00637273|561051890|FG002|Overall Study|Lost to Follow-up|13|||
155444098|NCT00637273|561051888|FG000|Overall Study|Protocol Violation|2|||
155444099|NCT00637273|561051889|FG001|Overall Study|Protocol Violation|4|||
155444100|NCT00637273|561051890|FG002|Overall Study|Protocol Violation|1|||
155444101|NCT00637273|561051888|FG000|Overall Study|Withdrawal of Consent|18|||
155444102|NCT00637273|561051889|FG001|Overall Study|Withdrawal of Consent|6|||
155444103|NCT00637273|561051890|FG002|Overall Study|Withdrawal of Consent|18|||
155444104|NCT00637273|561051888|FG000|Overall Study|Investigator Decision|1|||
155444105|NCT00637273|561051889|FG001|Overall Study|Investigator Decision|3|||
155444106|NCT00637273|561051890|FG002|Overall Study|Investigator Decision|1|||
155444107|NCT00637273|561051888|FG000|Overall Study|Administrative|2|||
155444108|NCT00637273|561051889|FG001|Overall Study|Administrative|0|||
155444109|NCT00637273|561051890|FG002|Overall Study|Administrative|0|||
155444110|NCT00637273|561051888|FG000|Overall Study|Loss of Glucose Control|1|||
155444111|NCT00637273|561051889|FG001|Overall Study|Loss of Glucose Control|1|||
155444112|NCT00637273|561051890|FG002|Overall Study|Loss of Glucose Control|1|||
155444113|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
155444114|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
155444115|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155444116|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155444117|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155444118|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155444119|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155444120|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
155444121|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
155444122|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
155444123|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
155444124|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
155444125|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
155444126|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
155444127|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
155444128|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
155444129|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
155444130|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
155444131|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
155444132|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
155444133|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
155444134|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Other|0|||
155444135|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Other|1|||
155444136|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Other|0|||
155444137|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Other|0|||
155444138|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Other|0|||
155444139|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Other|0|||
155444140|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Other|0|||
155444141|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
155444142|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
155444143|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
155444144|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
155444145|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
155444146|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
155444147|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
155444148|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
155444149|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
155444150|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
155651385|NCT03400787|561816204|FG000|Overall Study|Lost to Follow-up|1|||
155651386|NCT03400787|561816205|FG001|Overall Study|Lost to Follow-up|0|||
155651387|NCT03400787|561816204|FG000|Overall Study|Death|1|||
155651388|NCT03400787|561816205|FG001|Overall Study|Death|0|||
155651389|NCT03400787|561816204|FG000|Overall Study|Protocol Violation|0|||
155651390|NCT03400787|561816205|FG001|Overall Study|Protocol Violation|2|||
155651391|NCT03400787|561816204|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
155444151|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
155444152|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
155444153|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
155444154|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
155444155|NCT00365716|561051891|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
155444156|NCT00365716|561051892|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
155444157|NCT00365716|561051893|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
155444158|NCT00365716|561051894|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
155444159|NCT00365716|561051895|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
155444160|NCT00365716|561051896|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
155444161|NCT00365716|561051897|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
155444162|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
155444163|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
155444164|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
155444165|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
155444166|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
155444167|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
155651392|NCT03400787|561816205|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
155444168|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
155444169|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
155651393|NCT00449787|561816210|FG000|Overall Study|Lost to Follow-up|10|||
155515238|NCT03748641|561311554|FG001|Overall Study|Withdrawal by Subject|2|||
155515239|NCT03748641|561311555|FG002|Overall Study|Withdrawal by Subject|5|||
155515240|NCT03748641|561311556|FG003|Overall Study|Withdrawal by Subject|3|||
155515241|NCT03748641|561311557|FG004|Overall Study|Withdrawal by Subject|2|||
155444170|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
155444171|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
155444172|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
155444173|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
155444174|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
155444175|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
155444176|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
155444177|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
155444178|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
155444179|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
155444180|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
155444181|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
155444182|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
155444183|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
155444184|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
155444185|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
155444186|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
155444187|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
155444188|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
155444189|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
155444190|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
155444191|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
155444192|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
155444193|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
155444194|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
155444195|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
155444196|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
155444197|NCT00365716|561051891|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
155444198|NCT00365716|561051892|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
155444199|NCT00365716|561051893|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
155444200|NCT00365716|561051894|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
155444201|NCT00365716|561051895|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
155444202|NCT00365716|561051896|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
155444203|NCT00365716|561051897|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
155444204|NCT00365716|561051891|FG000|Extension 1|Lost to Follow-up|0|||
155444205|NCT00365716|561051892|FG001|Extension 1|Lost to Follow-up|0|||
155444206|NCT00365716|561051893|FG002|Extension 1|Lost to Follow-up|0|||
155444207|NCT00365716|561051894|FG003|Extension 1|Lost to Follow-up|0|||
155444208|NCT00365716|561051895|FG004|Extension 1|Lost to Follow-up|0|||
155444209|NCT00365716|561051896|FG005|Extension 1|Lost to Follow-up|1|||
155444210|NCT00365716|561051897|FG006|Extension 1|Lost to Follow-up|0|||
155444211|NCT00365716|561051891|FG000|Extension 1|Other|0|||
155444212|NCT00365716|561051892|FG001|Extension 1|Other|0|||
155444213|NCT00365716|561051893|FG002|Extension 1|Other|0|||
155444214|NCT00365716|561051894|FG003|Extension 1|Other|0|||
155444215|NCT00365716|561051895|FG004|Extension 1|Other|0|||
155444216|NCT00365716|561051896|FG005|Extension 1|Other|9|||
155444217|NCT00365716|561051897|FG006|Extension 1|Other|0|||
155444218|NCT00365716|561051891|FG000|Extension 1|Moved|0|||
155515242|NCT02549495|561311558|FG000|Overall Study|Death|2|||
155515243|NCT02549495|561311558|FG000|Overall Study|Withdrawal by Subject|5|||
155515244|NCT02549495|561311558|FG000|Overall Study|Physician Decision|22|||
155515245|NCT02549495|561311558|FG000|Overall Study|Lost to Follow-up|6|||
155515246|NCT02549495|561311558|FG000|Overall Study|Protocol Violation|6|||
155651394|NCT00449787|561816211|FG001|Overall Study|Lost to Follow-up|8|||
155651395|NCT00449787|561816210|FG000|Overall Study|Did not require medication|95|||
155515247|NCT03495986|561311559|FG000|Overall Study|Physician Decision|1|||
155515248|NCT03495986|561311560|FG001|Overall Study|Physician Decision|0|||
155515249|NCT03495986|561311559|FG000|Overall Study|Withdrawal by Subject|1|||
155515250|NCT03495986|561311560|FG001|Overall Study|Withdrawal by Subject|1|||
155444219|NCT00365716|561051892|FG001|Extension 1|Moved|0|||
155444220|NCT00365716|561051893|FG002|Extension 1|Moved|0|||
155444221|NCT00365716|561051894|FG003|Extension 1|Moved|0|||
155515251|NCT03495986|561311559|FG000|Overall Study|Withdrawal by Subject|1|||
155515252|NCT03495986|561311560|FG001|Overall Study|Withdrawal by Subject|0|||
155444222|NCT00365716|561051895|FG004|Extension 1|Moved|0|||
155444223|NCT00365716|561051896|FG005|Extension 1|Moved|4|||
155444224|NCT00365716|561051897|FG006|Extension 1|Moved|0|||
155444225|NCT00365716|561051891|FG000|Extension 1|Withdrawal by Subject|0|||
155444226|NCT00365716|561051892|FG001|Extension 1|Withdrawal by Subject|0|||
155444227|NCT00365716|561051893|FG002|Extension 1|Withdrawal by Subject|0|||
155444228|NCT00365716|561051894|FG003|Extension 1|Withdrawal by Subject|0|||
155444229|NCT00365716|561051895|FG004|Extension 1|Withdrawal by Subject|0|||
155444230|NCT00365716|561051896|FG005|Extension 1|Withdrawal by Subject|3|||
155444231|NCT00365716|561051897|FG006|Extension 1|Withdrawal by Subject|0|||
155444232|NCT00365716|561051891|FG000|Extension 1|Pregnancy|0|||
155444233|NCT00365716|561051892|FG001|Extension 1|Pregnancy|0|||
155444234|NCT00365716|561051893|FG002|Extension 1|Pregnancy|0|||
155444235|NCT00365716|561051894|FG003|Extension 1|Pregnancy|0|||
155444236|NCT00365716|561051895|FG004|Extension 1|Pregnancy|0|||
155444237|NCT00365716|561051896|FG005|Extension 1|Pregnancy|4|||
155444238|NCT00365716|561051897|FG006|Extension 1|Pregnancy|0|||
155444239|NCT00365716|561051891|FG000|Extension 1|Protocol Violation|0|||
155444240|NCT00365716|561051892|FG001|Extension 1|Protocol Violation|0|||
155444241|NCT00365716|561051893|FG002|Extension 1|Protocol Violation|0|||
155444242|NCT00365716|561051894|FG003|Extension 1|Protocol Violation|0|||
155444243|NCT00365716|561051895|FG004|Extension 1|Protocol Violation|0|||
155444244|NCT00365716|561051896|FG005|Extension 1|Protocol Violation|1|||
155444245|NCT00365716|561051897|FG006|Extension 1|Protocol Violation|0|||
155444246|NCT00365716|561051891|FG000|Extension 2|Lost to Follow-up|0|||
155444247|NCT00365716|561051892|FG001|Extension 2|Lost to Follow-up|0|||
155444248|NCT00365716|561051893|FG002|Extension 2|Lost to Follow-up|0|||
155444249|NCT00365716|561051894|FG003|Extension 2|Lost to Follow-up|0|||
155444250|NCT00365716|561051895|FG004|Extension 2|Lost to Follow-up|0|||
155444251|NCT00365716|561051896|FG005|Extension 2|Lost to Follow-up|0|||
155444252|NCT00365716|561051897|FG006|Extension 2|Lost to Follow-up|2|||
155444253|NCT00365716|561051891|FG000|Extension 2|Other|0|||
155444254|NCT00365716|561051892|FG001|Extension 2|Other|0|||
155444255|NCT00365716|561051893|FG002|Extension 2|Other|0|||
155444256|NCT00365716|561051894|FG003|Extension 2|Other|0|||
155444257|NCT00365716|561051895|FG004|Extension 2|Other|0|||
155444258|NCT00365716|561051896|FG005|Extension 2|Other|0|||
155444259|NCT00365716|561051897|FG006|Extension 2|Other|3|||
155444260|NCT00365716|561051891|FG000|Extension 2|Withdrawal by Subject|0|||
155444261|NCT00365716|561051892|FG001|Extension 2|Withdrawal by Subject|0|||
155444262|NCT00365716|561051893|FG002|Extension 2|Withdrawal by Subject|0|||
155444263|NCT00365716|561051894|FG003|Extension 2|Withdrawal by Subject|0|||
155444264|NCT00365716|561051895|FG004|Extension 2|Withdrawal by Subject|0|||
155444265|NCT00365716|561051896|FG005|Extension 2|Withdrawal by Subject|0|||
155444266|NCT00365716|561051897|FG006|Extension 2|Withdrawal by Subject|5|||
155444267|NCT03649321|561051899|FG000|Overall Study|Withdrawal by Subject|1|||
155444268|NCT03649321|561051900|FG001|Overall Study|Withdrawal by Subject|0|||
155444269|NCT03649321|561051899|FG000|Overall Study|Death|1|||
155444270|NCT03649321|561051900|FG001|Overall Study|Death|0|||
155444271|NCT00002663|561051901|FG000|Overall Study|Death|4|||
155444272|NCT00002663|561051902|FG001|Overall Study|Death|1|||
155444273|NCT00002663|561051903|FG002|Overall Study|Death|1|||
155444274|NCT00002663|561051904|FG003|Overall Study|Death|0|||
155444275|NCT00002663|561051905|FG004|Overall Study|Death|0|||
155444276|NCT00002663|561051906|FG005|Overall Study|Death|13|||
155444277|NCT00002663|561051907|FG006|Overall Study|Death|0|||
155444278|NCT00002663|561051908|FG007|Overall Study|Death|1|||
155444279|NCT00002663|561051909|FG008|Overall Study|Death|1|||
155444280|NCT00002663|561051910|FG009|Overall Study|Death|1|||
155444281|NCT00002663|561051901|FG000|Overall Study|Lost to Follow-up|3|||
155444282|NCT00002663|561051902|FG001|Overall Study|Lost to Follow-up|0|||
155444283|NCT00002663|561051903|FG002|Overall Study|Lost to Follow-up|0|||
155444284|NCT00002663|561051904|FG003|Overall Study|Lost to Follow-up|1|||
155444285|NCT00002663|561051905|FG004|Overall Study|Lost to Follow-up|0|||
155444286|NCT00002663|561051906|FG005|Overall Study|Lost to Follow-up|1|||
155444287|NCT00002663|561051907|FG006|Overall Study|Lost to Follow-up|0|||
155444288|NCT00002663|561051908|FG007|Overall Study|Lost to Follow-up|0|||
155444289|NCT00002663|561051909|FG008|Overall Study|Lost to Follow-up|0|||
155444290|NCT00002663|561051910|FG009|Overall Study|Lost to Follow-up|0|||
155444291|NCT00002663|561051901|FG000|Overall Study|Other|0|||
155444292|NCT00002663|561051902|FG001|Overall Study|Other|1|||
155444293|NCT00002663|561051903|FG002|Overall Study|Other|0|||
155444294|NCT00002663|561051904|FG003|Overall Study|Other|0|||
155444295|NCT00002663|561051905|FG004|Overall Study|Other|0|||
155444296|NCT00002663|561051906|FG005|Overall Study|Other|1|||
155444297|NCT00002663|561051907|FG006|Overall Study|Other|1|||
155444298|NCT00002663|561051908|FG007|Overall Study|Other|0|||
155444299|NCT00002663|561051909|FG008|Overall Study|Other|0|||
155444300|NCT00002663|561051910|FG009|Overall Study|Other|0|||
155444301|NCT00002663|561051901|FG000|Overall Study|Physician Decision|0|||
155444302|NCT00002663|561051902|FG001|Overall Study|Physician Decision|0|||
155444303|NCT00002663|561051903|FG002|Overall Study|Physician Decision|0|||
155444304|NCT00002663|561051904|FG003|Overall Study|Physician Decision|0|||
155444305|NCT00002663|561051905|FG004|Overall Study|Physician Decision|1|||
155444306|NCT00002663|561051906|FG005|Overall Study|Physician Decision|0|||
155444307|NCT00002663|561051907|FG006|Overall Study|Physician Decision|0|||
155444308|NCT00002663|561051908|FG007|Overall Study|Physician Decision|0|||
155444309|NCT00002663|561051909|FG008|Overall Study|Physician Decision|1|||
155444310|NCT00002663|561051910|FG009|Overall Study|Physician Decision|1|||
155444311|NCT00002663|561051901|FG000|Overall Study|Adverse Event|0|||
155444312|NCT00002663|561051902|FG001|Overall Study|Adverse Event|0|||
155444313|NCT00002663|561051903|FG002|Overall Study|Adverse Event|0|||
155444314|NCT00002663|561051904|FG003|Overall Study|Adverse Event|1|||
155444315|NCT00002663|561051905|FG004|Overall Study|Adverse Event|0|||
155444316|NCT00002663|561051906|FG005|Overall Study|Adverse Event|0|||
155444317|NCT00002663|561051907|FG006|Overall Study|Adverse Event|0|||
155444318|NCT00002663|561051908|FG007|Overall Study|Adverse Event|1|||
155444319|NCT00002663|561051909|FG008|Overall Study|Adverse Event|0|||
155444320|NCT00002663|561051910|FG009|Overall Study|Adverse Event|0|||
155444321|NCT00751101|561051911|FG000|Overall Study|Withdrawal by Subject|1|||
155444322|NCT00751101|561051912|FG001|Overall Study|Withdrawal by Subject|0|||
155444323|NCT00751101|561051911|FG000|Overall Study|No HFS / Never Started Patch/|0|||
155444324|NCT00751101|561051912|FG001|Overall Study|No HFS / Never Started Patch/|4|||
155444325|NCT00751101|561051911|FG000|Overall Study|Never began capecitabine|1|||
155444326|NCT00751101|561051912|FG001|Overall Study|Never began capecitabine|0|||
155444327|NCT00751101|561051911|FG000|Overall Study|Physician Decision|0|||
155444328|NCT00751101|561051912|FG001|Overall Study|Physician Decision|1|||
155444329|NCT01905397|561051913|FG000|Overall Study|Death|0|||
155444330|NCT01905397|561051914|FG001|Overall Study|Death|1|||
155444331|NCT01905397|561051913|FG000|Overall Study|Withdrawal by Subject|2|||
155444332|NCT01905397|561051914|FG001|Overall Study|Withdrawal by Subject|0|||
155444333|NCT01905397|561051913|FG000|Overall Study|Surgery canceled/aborted|9|||
155444334|NCT01905397|561051914|FG001|Overall Study|Surgery canceled/aborted|5|||
155444335|NCT01905397|561051913|FG000|Overall Study|Incision < 7 cm|2|||
155444336|NCT01905397|561051914|FG001|Overall Study|Incision < 7 cm|0|||
155444337|NCT01905397|561051913|FG000|Overall Study|Wrong treatment|1|||
155444338|NCT01905397|561051914|FG001|Overall Study|Wrong treatment|1|||
155444339|NCT01905397|561051913|FG000|Overall Study|Device not applied|3|||
155444340|NCT01905397|561051914|FG001|Overall Study|Device not applied|0|||
155444341|NCT01905397|561051913|FG000|Overall Study|Dressing not applied in operating room|1|||
155444342|NCT01905397|561051914|FG001|Overall Study|Dressing not applied in operating room|0|||
155444343|NCT01905397|561051913|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
155444344|NCT01905397|561051914|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
155444345|NCT01921270|561051918|FG000|Overall Study|Withdrawal by Subject|1|||
155444346|NCT00844428|561051919|FG000|Screening Period|Screen Failure|3|||
155444347|NCT00844428|561051919|FG000|Extension Treatment Period|Death|1|||
155444348|NCT00844428|561051919|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
155444349|NCT00789477|561051920|FG000|Overall Study|Withdrawal by Subject|2|||
155444350|NCT00789477|561051921|FG001|Overall Study|Withdrawal by Subject|1|||
155444351|NCT00789477|561051922|FG002|Overall Study|Withdrawal by Subject|3|||
155444352|NCT00789477|561051923|FG003|Overall Study|Withdrawal by Subject|2|||
155444353|NCT00789477|561051924|FG004|Overall Study|Withdrawal by Subject|3|||
155444354|NCT00789477|561051920|FG000|Overall Study|Protocol Violation|1|||
155444355|NCT00789477|561051921|FG001|Overall Study|Protocol Violation|0|||
155444356|NCT00789477|561051922|FG002|Overall Study|Protocol Violation|0|||
155444357|NCT00789477|561051923|FG003|Overall Study|Protocol Violation|1|||
155444358|NCT00789477|561051924|FG004|Overall Study|Protocol Violation|0|||
155444359|NCT00789477|561051920|FG000|Overall Study|Adverse Event|3|||
155444360|NCT00789477|561051921|FG001|Overall Study|Adverse Event|3|||
155444361|NCT00789477|561051922|FG002|Overall Study|Adverse Event|1|||
155444362|NCT00789477|561051923|FG003|Overall Study|Adverse Event|0|||
155444363|NCT00789477|561051924|FG004|Overall Study|Adverse Event|0|||
155444364|NCT00789477|561051920|FG000|Overall Study|Death|1|||
155444365|NCT00789477|561051921|FG001|Overall Study|Death|1|||
155444366|NCT00789477|561051922|FG002|Overall Study|Death|2|||
155444367|NCT00789477|561051923|FG003|Overall Study|Death|2|||
155444368|NCT00789477|561051924|FG004|Overall Study|Death|0|||
155444369|NCT00789477|561051920|FG000|Overall Study|Lost to Follow-up|0|||
155444370|NCT00789477|561051921|FG001|Overall Study|Lost to Follow-up|1|||
155444371|NCT00789477|561051922|FG002|Overall Study|Lost to Follow-up|4|||
155444372|NCT00789477|561051923|FG003|Overall Study|Lost to Follow-up|2|||
155444373|NCT00789477|561051924|FG004|Overall Study|Lost to Follow-up|4|||
155444374|NCT00789477|561051920|FG000|Overall Study|Lack of Efficacy|2|||
155444375|NCT00789477|561051921|FG001|Overall Study|Lack of Efficacy|0|||
155444376|NCT00789477|561051922|FG002|Overall Study|Lack of Efficacy|0|||
155444377|NCT00789477|561051923|FG003|Overall Study|Lack of Efficacy|0|||
155444378|NCT00789477|561051924|FG004|Overall Study|Lack of Efficacy|0|||
155444379|NCT00789477|561051920|FG000|Overall Study|Other|2|||
155444380|NCT00789477|561051921|FG001|Overall Study|Other|0|||
155444381|NCT00789477|561051922|FG002|Overall Study|Other|1|||
155444382|NCT00789477|561051923|FG003|Overall Study|Other|3|||
155444383|NCT00789477|561051924|FG004|Overall Study|Other|0|||
155444384|NCT00455858|561051925|FG000|Overall Study|Lost to Follow-up|2|||
155444385|NCT00455858|561051925|FG000|Overall Study|Protocol Violation|1|||
155444386|NCT00455858|561051925|FG000|Overall Study|Lack of Efficacy|1|||
155444387|NCT00455858|561051925|FG000|Overall Study|Well controlled FPG without insulin|1|||
155444388|NCT00455858|561051925|FG000|Overall Study|Withdrawal|1|||
155444389|NCT01927562|561051926|FG000|Overall Study|Lost to Follow-up|30|||
155444390|NCT01927562|561051926|FG000|Overall Study|Withdrawal by Subject|3|||
155444391|NCT01927562|561051926|FG000|Overall Study|Physician Decision|5|||
155444392|NCT00642616|561051927|FG000|Overall Study|Adverse Event|2|||
155444393|NCT00642616|561051928|FG001|Overall Study|Adverse Event|0|||
155444394|NCT00642616|561051929|FG002|Overall Study|Adverse Event|1|||
155444395|NCT00642616|561051930|FG003|Overall Study|Adverse Event|0|||
155444396|NCT00642616|561051927|FG000|Overall Study|Study Terminated by Sponsor|7|||
155444397|NCT00642616|561051928|FG001|Overall Study|Study Terminated by Sponsor|6|||
155444398|NCT00642616|561051929|FG002|Overall Study|Study Terminated by Sponsor|4|||
155444399|NCT00642616|561051930|FG003|Overall Study|Study Terminated by Sponsor|5|||
155444400|NCT00642616|561051927|FG000|Overall Study|Withdrawal by Subject|0|||
155444401|NCT00642616|561051928|FG001|Overall Study|Withdrawal by Subject|1|||
155444402|NCT00642616|561051929|FG002|Overall Study|Withdrawal by Subject|1|||
155444403|NCT00642616|561051930|FG003|Overall Study|Withdrawal by Subject|1|||
155444404|NCT00642616|561051927|FG000|Overall Study|Protocol Violation|0|||
155444405|NCT00642616|561051928|FG001|Overall Study|Protocol Violation|0|||
155444406|NCT00642616|561051929|FG002|Overall Study|Protocol Violation|2|||
155444407|NCT00642616|561051930|FG003|Overall Study|Protocol Violation|0|||
155444408|NCT00642616|561051927|FG000|Overall Study|Physician Decision|0|||
155444409|NCT00642616|561051928|FG001|Overall Study|Physician Decision|0|||
155444410|NCT00642616|561051929|FG002|Overall Study|Physician Decision|1|||
155444411|NCT00642616|561051930|FG003|Overall Study|Physician Decision|1|||
155444412|NCT00399802|561051931|FG000|Overall Study|Adverse Event|0|||
155444413|NCT00399802|561051932|FG001|Overall Study|Adverse Event|2|||
155444414|NCT00399802|561051931|FG000|Overall Study|Participant discontinued by mistake|0|||
155444415|NCT00399802|561051932|FG001|Overall Study|Participant discontinued by mistake|1|||
155444416|NCT00542815|561051933|FG000|Overall Study|Adverse Event|19|||
155444417|NCT00542815|561051934|FG001|Overall Study|Adverse Event|6|||
155444418|NCT00542815|561051935|FG002|Overall Study|Adverse Event|9|||
155444419|NCT00542815|561051933|FG000|Overall Study|Death|10|||
155444420|NCT00542815|561051934|FG001|Overall Study|Death|7|||
155444421|NCT00542815|561051935|FG002|Overall Study|Death|3|||
155444422|NCT00542815|561051933|FG000|Overall Study|Lack of Efficacy|9|||
155444423|NCT00542815|561051934|FG001|Overall Study|Lack of Efficacy|2|||
155444424|NCT00542815|561051935|FG002|Overall Study|Lack of Efficacy|0|||
155444425|NCT00542815|561051933|FG000|Overall Study|Physician Decision|2|||
155444426|NCT00542815|561051934|FG001|Overall Study|Physician Decision|1|||
155444427|NCT00542815|561051935|FG002|Overall Study|Physician Decision|0|||
155444428|NCT00542815|561051933|FG000|Overall Study|Protocol Violation|1|||
155444429|NCT00542815|561051934|FG001|Overall Study|Protocol Violation|1|||
155444430|NCT00542815|561051935|FG002|Overall Study|Protocol Violation|2|||
155444431|NCT00542815|561051933|FG000|Overall Study|Withdrawal by Subject|41|||
155444432|NCT00542815|561051934|FG001|Overall Study|Withdrawal by Subject|5|||
155444433|NCT00542815|561051935|FG002|Overall Study|Withdrawal by Subject|8|||
155444434|NCT00542815|561051933|FG000|Overall Study|Other reasons|24|||
155444435|NCT00542815|561051934|FG001|Overall Study|Other reasons|10|||
155444436|NCT00542815|561051935|FG002|Overall Study|Other reasons|10|||
155444437|NCT04172831|561051936|FG000|Overall Study|Adverse Event|21|||
155444438|NCT04172831|561051937|FG001|Overall Study|Adverse Event|9|||
155444439|NCT04172831|561051936|FG000|Overall Study|Lack of Efficacy|2|||
155444440|NCT04172831|561051937|FG001|Overall Study|Lack of Efficacy|8|||
155444441|NCT04172831|561051936|FG000|Overall Study|Physician Decision|0|||
155444442|NCT04172831|561051937|FG001|Overall Study|Physician Decision|1|||
155444443|NCT04172831|561051936|FG000|Overall Study|Withdrawal by Subject|12|||
155515253|NCT02365597|561311561|FG000|Overall Study|Lost to Follow-up|0|||
155444444|NCT04172831|561051937|FG001|Overall Study|Withdrawal by Subject|11|||
155444445|NCT04172831|561051936|FG000|Overall Study|Lost to Follow-up|4|||
155444446|NCT04172831|561051937|FG001|Overall Study|Lost to Follow-up|9|||
155444447|NCT04172831|561051936|FG000|Overall Study|COVID-19 related crisis|3|||
155444448|NCT04172831|561051937|FG001|Overall Study|COVID-19 related crisis|3|||
155444449|NCT04172831|561051936|FG000|Overall Study|Subject non-compliance|1|||
155444450|NCT04172831|561051937|FG001|Overall Study|Subject non-compliance|1|||
155444451|NCT04172831|561051936|FG000|Overall Study|Family emergency|1|||
155444452|NCT04172831|561051937|FG001|Overall Study|Family emergency|0|||
155444453|NCT01041573|561051938|FG000|Overall Study|Withdrawal by Subject|2|||
155444454|NCT01041573|561051939|FG001|Overall Study|Withdrawal by Subject|5|||
155444455|NCT01041573|561051940|FG002|Overall Study|Withdrawal by Subject|2|||
155444456|NCT01041573|561051941|FG003|Overall Study|Withdrawal by Subject|0|||
155444457|NCT01041573|561051938|FG000|Overall Study|Death|1|||
155444458|NCT01041573|561051939|FG001|Overall Study|Death|0|||
155444459|NCT01041573|561051940|FG002|Overall Study|Death|0|||
155651396|NCT00449787|561816211|FG001|Overall Study|Did not require medication|92|||
155651397|NCT02595437|561816213|FG000|Triferic Via IV|Withdrawal by Subject|1|||
155651398|NCT03574389|561816215|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
155651399|NCT03574389|561816216|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
155444460|NCT01041573|561051941|FG003|Overall Study|Death|0|||
155444461|NCT01041573|561051938|FG000|Overall Study|Lost to Follow-up|0|||
155444462|NCT01041573|561051939|FG001|Overall Study|Lost to Follow-up|1|||
155444463|NCT01041573|561051940|FG002|Overall Study|Lost to Follow-up|2|||
155444464|NCT01041573|561051941|FG003|Overall Study|Lost to Follow-up|1|||
155444465|NCT01041573|561051938|FG000|Overall Study|Adverse Event|0|||
155444466|NCT01041573|561051939|FG001|Overall Study|Adverse Event|2|||
155444467|NCT01041573|561051940|FG002|Overall Study|Adverse Event|0|||
155444468|NCT01041573|561051941|FG003|Overall Study|Adverse Event|0|||
155444469|NCT01041573|561051938|FG000|Overall Study|relocation|1|||
155444470|NCT01041573|561051939|FG001|Overall Study|relocation|4|||
155444471|NCT01041573|561051940|FG002|Overall Study|relocation|3|||
155444472|NCT01041573|561051941|FG003|Overall Study|relocation|1|||
155444473|NCT01041573|561051938|FG000|Overall Study|further blood extraction|0|||
155444474|NCT01041573|561051939|FG001|Overall Study|further blood extraction|1|||
155444475|NCT01041573|561051940|FG002|Overall Study|further blood extraction|0|||
155444476|NCT01041573|561051941|FG003|Overall Study|further blood extraction|0|||
155444477|NCT01041573|561051938|FG000|Overall Study|positive to anti-HCV|1|||
155444478|NCT01041573|561051939|FG001|Overall Study|positive to anti-HCV|0|||
155444479|NCT01041573|561051940|FG002|Overall Study|positive to anti-HCV|0|||
155444480|NCT01041573|561051941|FG003|Overall Study|positive to anti-HCV|0|||
155444481|NCT02955186|561051942|FG000|Overall Study|Withdrawal by Subject|6|||
155444482|NCT02955186|561051943|FG001|Overall Study|Withdrawal by Subject|2|||
155444483|NCT02955186|561051942|FG000|Overall Study|Protocol Violation|1|||
155444484|NCT02955186|561051943|FG001|Overall Study|Protocol Violation|0|||
155444485|NCT01276847|561051946|FG000|Overall Study|Withdrawal by Subject|1|||
155444486|NCT01276847|561051947|FG001|Overall Study|Withdrawal by Subject|0|||
155444487|NCT01276847|561051948|FG002|Overall Study|Withdrawal by Subject|0|||
155444488|NCT02021812|561051952|FG000|Overall Study|Death|8|||
155444489|NCT02021812|561051952|FG000|Overall Study|Withdrawal by Subject|3|||
155444490|NCT02021812|561051952|FG000|Overall Study|Lost to Follow-up|2|||
155444491|NCT02021812|561051952|FG000|Overall Study|Refuse to return, COVD 19|2|||
155444492|NCT02698423|561051953|FG000|Overall Study|Lost to Follow-up|19|||
155444493|NCT02698423|561051954|FG001|Overall Study|Lost to Follow-up|24|||
155444494|NCT01651260|561051957|FG000|Overall Study|unable to apply product|3|||
155444495|NCT00064662|561051958|FG000|Overall Study|Death|1|||
155444496|NCT00064662|561051959|FG001|Overall Study|Death|1|||
155444497|NCT00064662|561051958|FG000|Overall Study|Lost to Follow-up|57|||
155444498|NCT00064662|561051959|FG001|Overall Study|Lost to Follow-up|44|||
155444499|NCT00064662|561051958|FG000|Overall Study|Withdrawal by Subject|14|||
155444500|NCT00064662|561051959|FG001|Overall Study|Withdrawal by Subject|14|||
155444501|NCT00064662|561051958|FG000|Overall Study|Administratively withdrawn|2|||
155444502|NCT00064662|561051959|FG001|Overall Study|Administratively withdrawn|2|||
155444503|NCT01963117|561051962|FG000|Overall Study|Death|1|||
155444504|NCT03844633|561051963|FG000|1 Week FU|Lost to Follow-up|0|||
155444505|NCT03844633|561051964|FG001|1 Week FU|Lost to Follow-up|1|||
155444506|NCT03844633|561051965|FG002|1 Week FU|Lost to Follow-up|4|||
155444507|NCT03844633|561051963|FG000|12-month Follow-up|Lost to Follow-up|7|||
155444508|NCT03844633|561051964|FG001|12-month Follow-up|Lost to Follow-up|5|||
155444509|NCT03844633|561051965|FG002|12-month Follow-up|Lost to Follow-up|8|||
155444510|NCT04083222|561051967|FG000|Overall Study|Voluntary Withdrawal|0|||
155444511|NCT04083222|561051968|FG001|Overall Study|Voluntary Withdrawal|1|||
155444512|NCT04083222|561051967|FG000|Overall Study|Reason not Specified|0|||
155651400|NCT03574389|561816217|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
155651401|NCT03574389|561816218|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
155444513|NCT04083222|561051968|FG001|Overall Study|Reason not Specified|1|||
155444514|NCT03123939|561051973|FG000|Overall Study|Lack of Efficacy|6|||
155444515|NCT03123939|561051973|FG000|Overall Study|Death|5|||
155444516|NCT03123939|561051973|FG000|Overall Study|Physician Decision|2|||
155444517|NCT03123939|561051973|FG000|Overall Study|Subject/guardian decision|2|||
155444518|NCT03123939|561051973|FG000|Overall Study|Lost to Follow-up|1|||
155444519|NCT03123939|561051973|FG000|Overall Study|New therapy for study indication|1|||
155444520|NCT03123939|561051973|FG000|Overall Study|Protocol deviation|1|||
155444521|NCT03123939|561051973|FG000|Overall Study|Progressive disease|18|||
155444522|NCT03123939|561051973|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
155444523|NCT03123939|561051973|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
155444524|NCT01937130|561054284|FG000|Overall Study|Withdrawal by Subject|0|||
155444525|NCT01937130|561054285|FG001|Overall Study|Withdrawal by Subject|0|||
155444526|NCT01937130|561054286|FG002|Overall Study|Withdrawal by Subject|0|||
155444527|NCT01937130|561054287|FG003|Overall Study|Withdrawal by Subject|1|||
155444528|NCT01937130|561054284|FG000|Overall Study|Adverse Event|0|||
155444529|NCT01937130|561054285|FG001|Overall Study|Adverse Event|1|||
155444530|NCT01937130|561054286|FG002|Overall Study|Adverse Event|0|||
155444531|NCT01937130|561054287|FG003|Overall Study|Adverse Event|1|||
155444532|NCT01937130|561054284|FG000|Overall Study|Death|1|||
155444533|NCT01937130|561054285|FG001|Overall Study|Death|1|||
155444534|NCT01937130|561054286|FG002|Overall Study|Death|1|||
155444535|NCT01937130|561054287|FG003|Overall Study|Death|0|||
155444536|NCT01937130|561054284|FG000|Overall Study|Lost to Follow-up|2|||
155444537|NCT01937130|561054285|FG001|Overall Study|Lost to Follow-up|0|||
155444538|NCT01937130|561054286|FG002|Overall Study|Lost to Follow-up|2|||
155444539|NCT01937130|561054287|FG003|Overall Study|Lost to Follow-up|0|||
155444540|NCT01937130|561054284|FG000|Overall Study|Physician Decision|0|||
155444541|NCT01937130|561054285|FG001|Overall Study|Physician Decision|1|||
155444542|NCT01937130|561054286|FG002|Overall Study|Physician Decision|0|||
155444543|NCT01937130|561054287|FG003|Overall Study|Physician Decision|0|||
155444544|NCT01937130|561054284|FG000|Overall Study|Patients unable to swallow|0|||
155444545|NCT01937130|561054285|FG001|Overall Study|Patients unable to swallow|1|||
155444546|NCT01937130|561054286|FG002|Overall Study|Patients unable to swallow|0|||
155444547|NCT01937130|561054287|FG003|Overall Study|Patients unable to swallow|0|||
155444548|NCT01937130|561054284|FG000|Overall Study|Patient lost to FU due to death|2|||
155444549|NCT01937130|561054285|FG001|Overall Study|Patient lost to FU due to death|0|||
155444550|NCT01937130|561054286|FG002|Overall Study|Patient lost to FU due to death|0|||
155444551|NCT01937130|561054287|FG003|Overall Study|Patient lost to FU due to death|0|||
155444552|NCT04191967|561054288|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
155444553|NCT04191967|561054288|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
155444554|NCT01431144|561054289|FG000|Overall Study|Implant mobility and removal|2|||
155444555|NCT01431144|561054290|FG001|Overall Study|Implant mobility and removal|0|||
155444556|NCT00953043|561054296|FG000|Overall Study|Withdrawal by Subject|4|||
155444557|NCT00953043|561054297|FG001|Overall Study|Withdrawal by Subject|0|||
155444558|NCT00953043|561054296|FG000|Overall Study|Physician Decision|0|||
155444559|NCT00953043|561054297|FG001|Overall Study|Physician Decision|2|||
155444560|NCT02322892|561054299|FG000|Overall Study|Surgery cancelled|1|||
155444561|NCT02322892|561054300|FG001|Overall Study|Surgery cancelled|2|||
155444562|NCT02322892|561054299|FG000|Overall Study|Met exclusion criteria|0|||
155444563|NCT02322892|561054300|FG001|Overall Study|Met exclusion criteria|1|||
155444564|NCT02322892|561054299|FG000|Overall Study|Protocol Violation|1|||
155444565|NCT02322892|561054300|FG001|Overall Study|Protocol Violation|0|||
155444566|NCT00747617|561054301|FG000|Overall Study|Lost to Follow-up|3|||
155444567|NCT00747617|561054302|FG001|Overall Study|Lost to Follow-up|1|||
155444568|NCT03509207|561054303|FG000|Overall Study|Death|2|||
155444569|NCT02125331|561054304|FG000|Overall Study|Protocol Violation|1|||
155444570|NCT02125331|561054305|FG001|Overall Study|Protocol Violation|0|||
155444571|NCT02125331|561054304|FG000|Overall Study|technical problem|2|||
155444572|NCT02125331|561054305|FG001|Overall Study|technical problem|0|||
155444573|NCT02125331|561054304|FG000|Overall Study|screen failure|2|||
155444574|NCT02125331|561054305|FG001|Overall Study|screen failure|0|||
155444575|NCT01432262|561054306|FG000|Overall Study|Withdrawal by Subject|2|||
155444576|NCT01432262|561054307|FG001|Overall Study|Withdrawal by Subject|1|||
155444577|NCT04657016|561054308|FG000|Overall Study|Adverse Event|2|||
155444578|NCT04657016|561054309|FG001|Overall Study|Adverse Event|4|||
155444579|NCT04657016|561054308|FG000|Overall Study|Death|1|||
155444580|NCT04657016|561054309|FG001|Overall Study|Death|1|||
155444581|NCT04657016|561054308|FG000|Overall Study|Lost to Follow-up|24|||
155444582|NCT04657016|561054309|FG001|Overall Study|Lost to Follow-up|12|||
155444583|NCT04657016|561054308|FG000|Overall Study|Physician Decision|1|||
155651402|NCT03574389|561816219|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
155651403|NCT03574389|561816220|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
155651404|NCT03574389|561816221|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
155651405|NCT03574389|561816215|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
155651406|NCT03574389|561816216|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
155651407|NCT03574389|561816217|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
155651408|NCT03574389|561816218|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
155444584|NCT04657016|561054309|FG001|Overall Study|Physician Decision|2|||
155444585|NCT04657016|561054308|FG000|Overall Study|Pregnancy|2|||
155444586|NCT04657016|561054309|FG001|Overall Study|Pregnancy|2|||
155444587|NCT04657016|561054308|FG000|Overall Study|Protocol Deviation|1|||
155444588|NCT04657016|561054309|FG001|Overall Study|Protocol Deviation|0|||
155444589|NCT04657016|561054308|FG000|Overall Study|Withdrawal by Subject|28|||
155444590|NCT04657016|561054309|FG001|Overall Study|Withdrawal by Subject|14|||
155444591|NCT04657016|561054308|FG000|Overall Study|Other - as reported by the investigator|6|||
155444592|NCT04657016|561054309|FG001|Overall Study|Other - as reported by the investigator|0|||
155444593|NCT01104558|561054312|FG000|Overall Study|Protocol Violation|6|||
155444594|NCT01104558|561054312|FG000|Overall Study|Missing of primary efficacy assessment|10|||
155444595|NCT01104558|561054312|FG000|Overall Study|Missing of genetic analysis results|1|||
155444596|NCT00696657|561054313|FG000|Overall Study|Protocol Violation|0|||
155444597|NCT00696657|561054314|FG001|Overall Study|Protocol Violation|0|||
155444598|NCT00696657|561054315|FG002|Overall Study|Protocol Violation|0|||
155444599|NCT00696657|561054316|FG003|Overall Study|Protocol Violation|0|||
155444600|NCT00696657|561054317|FG004|Overall Study|Protocol Violation|0|||
155444601|NCT00696657|561054318|FG005|Overall Study|Protocol Violation|1|||
155444602|NCT00696657|561054319|FG006|Overall Study|Protocol Violation|0|||
155444603|NCT00696657|561054320|FG007|Overall Study|Protocol Violation|0|||
155444604|NCT00696657|561054321|FG008|Overall Study|Protocol Violation|1|||
155444605|NCT00696657|561054313|FG000|Overall Study|Lack of Efficacy|0|||
155444606|NCT00696657|561054314|FG001|Overall Study|Lack of Efficacy|1|||
155444607|NCT00696657|561054315|FG002|Overall Study|Lack of Efficacy|0|||
155444608|NCT00696657|561054316|FG003|Overall Study|Lack of Efficacy|0|||
155444609|NCT00696657|561054317|FG004|Overall Study|Lack of Efficacy|0|||
155444610|NCT00696657|561054318|FG005|Overall Study|Lack of Efficacy|0|||
155444611|NCT00696657|561054319|FG006|Overall Study|Lack of Efficacy|0|||
155444612|NCT00696657|561054320|FG007|Overall Study|Lack of Efficacy|0|||
155444613|NCT00696657|561054321|FG008|Overall Study|Lack of Efficacy|0|||
155444614|NCT00696657|561054313|FG000|Overall Study|Withdrawal criteria|1|||
155444615|NCT00696657|561054314|FG001|Overall Study|Withdrawal criteria|3|||
155444616|NCT00696657|561054315|FG002|Overall Study|Withdrawal criteria|2|||
155444617|NCT00696657|561054316|FG003|Overall Study|Withdrawal criteria|2|||
155444618|NCT00696657|561054317|FG004|Overall Study|Withdrawal criteria|0|||
155444619|NCT00696657|561054318|FG005|Overall Study|Withdrawal criteria|0|||
155444620|NCT00696657|561054319|FG006|Overall Study|Withdrawal criteria|1|||
155444621|NCT00696657|561054320|FG007|Overall Study|Withdrawal criteria|1|||
155444622|NCT00696657|561054321|FG008|Overall Study|Withdrawal criteria|2|||
155444623|NCT00696657|561054313|FG000|Overall Study|Unclassified|0|||
155444624|NCT00696657|561054314|FG001|Overall Study|Unclassified|1|||
155444625|NCT00696657|561054315|FG002|Overall Study|Unclassified|3|||
155444626|NCT00696657|561054316|FG003|Overall Study|Unclassified|2|||
155444627|NCT00696657|561054317|FG004|Overall Study|Unclassified|4|||
155444628|NCT00696657|561054318|FG005|Overall Study|Unclassified|2|||
155444629|NCT00696657|561054319|FG006|Overall Study|Unclassified|0|||
155444630|NCT00696657|561054320|FG007|Overall Study|Unclassified|0|||
155444631|NCT00696657|561054321|FG008|Overall Study|Unclassified|1|||
155444632|NCT00696657|561054313|FG000|Overall Study|Adverse Event|0|||
155444633|NCT00696657|561054314|FG001|Overall Study|Adverse Event|0|||
155444634|NCT00696657|561054315|FG002|Overall Study|Adverse Event|3|||
155444635|NCT00696657|561054316|FG003|Overall Study|Adverse Event|7|||
155444636|NCT00696657|561054317|FG004|Overall Study|Adverse Event|6|||
155444637|NCT00696657|561054318|FG005|Overall Study|Adverse Event|9|||
155444638|NCT00696657|561054319|FG006|Overall Study|Adverse Event|14|||
155444639|NCT00696657|561054320|FG007|Overall Study|Adverse Event|2|||
155444640|NCT00696657|561054321|FG008|Overall Study|Adverse Event|5|||
155444641|NCT00523341|561054325|FG000|Overall Study|Withdrawal by Subject|399|||
155444642|NCT00523341|561054326|FG001|Overall Study|Withdrawal by Subject|427|||
155444643|NCT00523341|561054325|FG000|Overall Study|Other|181|||
155444644|NCT00523341|561054326|FG001|Overall Study|Other|198|||
155444645|NCT00523341|561054325|FG000|Overall Study|Adverse Event|122|||
155444646|NCT00523341|561054326|FG001|Overall Study|Adverse Event|155|||
155444647|NCT00523341|561054325|FG000|Overall Study|Death|101|||
155444648|NCT00523341|561054326|FG001|Overall Study|Death|110|||
155444649|NCT00523341|561054325|FG000|Overall Study|Lost to Follow-up|73|||
155444650|NCT00523341|561054326|FG001|Overall Study|Lost to Follow-up|61|||
155444651|NCT00523341|561054325|FG000|Overall Study|Non-compliance|20|||
155444652|NCT00523341|561054326|FG001|Overall Study|Non-compliance|13|||
155444653|NCT00523341|561054325|FG000|Overall Study|Physician Decision|14|||
155444654|NCT00523341|561054326|FG001|Overall Study|Physician Decision|13|||
155515254|NCT02365597|561311562|FG001|Overall Study|Lost to Follow-up|1|||
155515255|NCT02365597|561311563|FG002|Overall Study|Lost to Follow-up|0|||
155515256|NCT02365597|561311564|FG003|Overall Study|Lost to Follow-up|1|||
155444655|NCT00523341|561054325|FG000|Overall Study|Requirement for Alternative Therapy|4|||
155444656|NCT00523341|561054326|FG001|Overall Study|Requirement for Alternative Therapy|14|||
155444657|NCT00523341|561054325|FG000|Overall Study|Protocol Deviation|6|||
155444658|NCT00523341|561054326|FG001|Overall Study|Protocol Deviation|5|||
155444659|NCT00523341|561054325|FG000|Overall Study|Ineligibility Determined|3|||
155444660|NCT00523341|561054326|FG001|Overall Study|Ineligibility Determined|4|||
155444661|NCT00523341|561054325|FG000|Overall Study|Disease Progression|1|||
155444662|NCT00523341|561054326|FG001|Overall Study|Disease Progression|0|||
155444663|NCT02601001|561054329|FG000|Dosing Period 2|Adverse Event|0|||
155444664|NCT02601001|561054330|FG001|Dosing Period 2|Adverse Event|0|||
155444665|NCT02601001|561054331|FG002|Dosing Period 2|Adverse Event|0|||
155444666|NCT02601001|561054332|FG003|Dosing Period 2|Adverse Event|0|||
155444667|NCT02601001|561054333|FG004|Dosing Period 2|Adverse Event|0|||
155444668|NCT02601001|561054334|FG005|Dosing Period 2|Adverse Event|0|||
155444669|NCT02601001|561054335|FG006|Dosing Period 2|Adverse Event|1|||
155444670|NCT01356602|561054336|FG000|Overall Study|Protocol Deviation|0|||
155515257|NCT02365597|561311561|FG000|Overall Study|Withdrawal by Subject|1|||
155444671|NCT01356602|561054337|FG001|Overall Study|Protocol Deviation|1|||
155444672|NCT01356602|561054338|FG002|Overall Study|Protocol Deviation|1|||
155444673|NCT01356602|561054336|FG000|Overall Study|Administrative Problems|1|||
155444674|NCT01356602|561054337|FG001|Overall Study|Administrative Problems|4|||
155444675|NCT01356602|561054338|FG002|Overall Study|Administrative Problems|5|||
155444676|NCT01356602|561054336|FG000|Overall Study|Lost to Follow-up|4|||
155444677|NCT01356602|561054337|FG001|Overall Study|Lost to Follow-up|5|||
155444678|NCT01356602|561054338|FG002|Overall Study|Lost to Follow-up|6|||
155444679|NCT01356602|561054336|FG000|Overall Study|Withdrawal by Subject|4|||
155444680|NCT01356602|561054337|FG001|Overall Study|Withdrawal by Subject|3|||
155444681|NCT01356602|561054338|FG002|Overall Study|Withdrawal by Subject|7|||
155444682|NCT01356602|561054336|FG000|Overall Study|Lack of Efficacy|0|||
155444683|NCT01356602|561054337|FG001|Overall Study|Lack of Efficacy|1|||
155444684|NCT01356602|561054338|FG002|Overall Study|Lack of Efficacy|4|||
155444685|NCT01356602|561054336|FG000|Overall Study|Adverse Event|0|||
155444686|NCT01356602|561054337|FG001|Overall Study|Adverse Event|1|||
155444687|NCT01356602|561054338|FG002|Overall Study|Adverse Event|1|||
155444688|NCT03123354|561054339|FG000|Overall Study|Physician Decision|6|||
155444689|NCT01931462|561054340|FG000|Overall Study|Withdrawal by Subject|1|||
155444690|NCT00366548|561054341|FG000|Infant Series|Adverse Event|1|||
155444691|NCT00366548|561054342|FG001|Infant Series|Adverse Event|3|||
155444692|NCT00366548|561054341|FG000|Infant Series|Protocol Violation|0|||
155444693|NCT00366548|561054342|FG001|Infant Series|Protocol Violation|1|||
155444694|NCT00366548|561054341|FG000|Infant Series|Withdrawal by Subject|3|||
155444695|NCT00366548|561054342|FG001|Infant Series|Withdrawal by Subject|1|||
155444696|NCT00366548|561054341|FG000|After Infant Series|Withdrawal by Subject|3|||
155444697|NCT00366548|561054342|FG001|After Infant Series|Withdrawal by Subject|1|||
155444698|NCT00366548|561054341|FG000|After Infant Series|Adverse Event|2|||
155444699|NCT00366548|561054342|FG001|After Infant Series|Adverse Event|0|||
155444700|NCT00366548|561054341|FG000|After Infant Series|Lost to Follow-up|1|||
155444701|NCT00366548|561054342|FG001|After Infant Series|Lost to Follow-up|0|||
155444702|NCT02531373|561054343|FG000|Overall Study|Lack of Efficacy|0|||
155444703|NCT02531373|561054344|FG001|Overall Study|Lack of Efficacy|0|||
155444704|NCT02531373|561054345|FG002|Overall Study|Lack of Efficacy|0|||
155444705|NCT02531373|561054346|FG003|Overall Study|Lack of Efficacy|0|||
155444706|NCT02531373|561054347|FG004|Overall Study|Lack of Efficacy|3|||
155444707|NCT02531373|561054348|FG005|Overall Study|Lack of Efficacy|2|||
155444708|NCT02531373|561054349|FG006|Overall Study|Lack of Efficacy|4|||
155444709|NCT02531373|561054350|FG007|Overall Study|Lack of Efficacy|8|||
155444710|NCT02531373|561054351|FG008|Overall Study|Lack of Efficacy|5|||
155444711|NCT02531373|561054343|FG000|Overall Study|Lost to Follow-up|0|||
155444712|NCT02531373|561054344|FG001|Overall Study|Lost to Follow-up|0|||
155444713|NCT02531373|561054345|FG002|Overall Study|Lost to Follow-up|0|||
155444714|NCT02531373|561054346|FG003|Overall Study|Lost to Follow-up|0|||
155444715|NCT02531373|561054347|FG004|Overall Study|Lost to Follow-up|0|||
155444716|NCT02531373|561054348|FG005|Overall Study|Lost to Follow-up|2|||
155444717|NCT02531373|561054349|FG006|Overall Study|Lost to Follow-up|2|||
155444718|NCT02531373|561054350|FG007|Overall Study|Lost to Follow-up|0|||
155444719|NCT02531373|561054351|FG008|Overall Study|Lost to Follow-up|0|||
155444720|NCT02531373|561054343|FG000|Overall Study|Physician Decision|0|||
155444721|NCT02531373|561054344|FG001|Overall Study|Physician Decision|0|||
155444722|NCT02531373|561054345|FG002|Overall Study|Physician Decision|0|||
155444723|NCT02531373|561054346|FG003|Overall Study|Physician Decision|0|||
155444724|NCT02531373|561054347|FG004|Overall Study|Physician Decision|2|||
155444725|NCT02531373|561054348|FG005|Overall Study|Physician Decision|1|||
155444726|NCT02531373|561054349|FG006|Overall Study|Physician Decision|0|||
155444727|NCT02531373|561054350|FG007|Overall Study|Physician Decision|0|||
155444728|NCT02531373|561054351|FG008|Overall Study|Physician Decision|0|||
155444729|NCT02531373|561054343|FG000|Overall Study|Protocol Violation|0|||
155444730|NCT02531373|561054344|FG001|Overall Study|Protocol Violation|0|||
155444731|NCT02531373|561054345|FG002|Overall Study|Protocol Violation|0|||
155444732|NCT02531373|561054346|FG003|Overall Study|Protocol Violation|0|||
155651409|NCT03574389|561816219|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
155444733|NCT02531373|561054347|FG004|Overall Study|Protocol Violation|0|||
155444734|NCT02531373|561054348|FG005|Overall Study|Protocol Violation|1|||
155444735|NCT02531373|561054349|FG006|Overall Study|Protocol Violation|1|||
155444736|NCT02531373|561054350|FG007|Overall Study|Protocol Violation|0|||
155444737|NCT02531373|561054351|FG008|Overall Study|Protocol Violation|1|||
155444738|NCT02531373|561054343|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155444739|NCT02531373|561054344|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155444740|NCT02531373|561054345|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155444741|NCT02531373|561054346|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155444742|NCT02531373|561054347|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155444743|NCT02531373|561054348|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
155444744|NCT02531373|561054349|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
155444745|NCT02531373|561054350|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
155444746|NCT02531373|561054351|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
155444747|NCT02531373|561054343|FG000|Overall Study|Withdrawal by Subject|0|||
155444748|NCT02531373|561054344|FG001|Overall Study|Withdrawal by Subject|0|||
155444749|NCT02531373|561054345|FG002|Overall Study|Withdrawal by Subject|0|||
155444750|NCT02531373|561054346|FG003|Overall Study|Withdrawal by Subject|0|||
155444751|NCT02531373|561054347|FG004|Overall Study|Withdrawal by Subject|3|||
155444752|NCT02531373|561054348|FG005|Overall Study|Withdrawal by Subject|0|||
155444753|NCT02531373|561054349|FG006|Overall Study|Withdrawal by Subject|0|||
155444754|NCT02531373|561054350|FG007|Overall Study|Withdrawal by Subject|0|||
155444755|NCT02531373|561054351|FG008|Overall Study|Withdrawal by Subject|0|||
155444756|NCT01623531|561054352|FG000|Overall Study|Death|1|||
155444757|NCT01623531|561054353|FG001|Overall Study|Death|0|||
155444758|NCT01623531|561054352|FG000|Overall Study|Protocol Violation|2|||
155444759|NCT01623531|561054353|FG001|Overall Study|Protocol Violation|1|||
155444760|NCT01623531|561054352|FG000|Overall Study|Missing data at primary outcome time poi|1|||
155444761|NCT01623531|561054353|FG001|Overall Study|Missing data at primary outcome time poi|1|||
155444762|NCT02834403|561054358|FG000|Overall Study|Physician Decision|2|||
155444763|NCT02834403|561054359|FG001|Overall Study|Physician Decision|1|||
155444764|NCT02834403|561054360|FG002|Overall Study|Physician Decision|2|||
155444765|NCT02834403|561054361|FG003|Overall Study|Physician Decision|1|||
155444766|NCT02834403|561054362|FG004|Overall Study|Physician Decision|1|||
155444767|NCT02834403|561054363|FG005|Overall Study|Physician Decision|2|||
155444768|NCT02834403|561054364|FG006|Overall Study|Physician Decision|12|||
155444769|NCT02834403|561054358|FG000|Overall Study|Adverse Event|0|||
155444770|NCT02834403|561054359|FG001|Overall Study|Adverse Event|0|||
155444771|NCT02834403|561054360|FG002|Overall Study|Adverse Event|0|||
155444772|NCT02834403|561054361|FG003|Overall Study|Adverse Event|0|||
155444773|NCT02834403|561054362|FG004|Overall Study|Adverse Event|1|||
155444774|NCT02834403|561054363|FG005|Overall Study|Adverse Event|1|||
155444775|NCT02834403|561054364|FG006|Overall Study|Adverse Event|3|||
155444776|NCT02834403|561054358|FG000|Overall Study|Withdrawal by Subject|0|||
155444777|NCT02834403|561054359|FG001|Overall Study|Withdrawal by Subject|1|||
155444778|NCT02834403|561054360|FG002|Overall Study|Withdrawal by Subject|0|||
155444779|NCT02834403|561054361|FG003|Overall Study|Withdrawal by Subject|0|||
155444780|NCT02834403|561054362|FG004|Overall Study|Withdrawal by Subject|1|||
155444781|NCT02834403|561054363|FG005|Overall Study|Withdrawal by Subject|0|||
155444782|NCT02834403|561054364|FG006|Overall Study|Withdrawal by Subject|0|||
155444783|NCT02834403|561054358|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
155444784|NCT02834403|561054359|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
155444785|NCT02834403|561054360|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
155444786|NCT02834403|561054361|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
155444787|NCT02834403|561054362|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
155444788|NCT02834403|561054363|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
155651410|NCT03574389|561816220|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
155651411|NCT03574389|561816221|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
155651412|NCT03574389|561816215|FG000|Vaccination Period|Other|6|||
155444789|NCT02834403|561054364|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
155444790|NCT04705597|561054365|FG000|Overall Study|Death|16|||
155444791|NCT04705597|561054366|FG001|Overall Study|Death|9|||
155444792|NCT04705597|561054365|FG000|Overall Study|Lost to Follow-up|1|||
155444793|NCT04705597|561054366|FG001|Overall Study|Lost to Follow-up|0|||
155444794|NCT04705597|561054365|FG000|Overall Study|Withdrawal by Subject|1|||
155444795|NCT04705597|561054366|FG001|Overall Study|Withdrawal by Subject|2|||
155444796|NCT00390780|561054367|FG000|Overall Study|Not completed|10|||
155444797|NCT00390780|561054368|FG001|Overall Study|Not completed|4|||
155444798|NCT00390780|561054367|FG000|Overall Study|Protocol Violation|6|||
155444799|NCT00390780|561054368|FG001|Overall Study|Protocol Violation|4|||
155444800|NCT00390780|561054367|FG000|Overall Study|Lost to Follow-up|3|||
155651413|NCT03574389|561816216|FG001|Vaccination Period|Other|0|||
155651414|NCT03574389|561816217|FG002|Vaccination Period|Other|0|||
155444801|NCT00390780|561054368|FG001|Overall Study|Lost to Follow-up|6|||
155651415|NCT03574389|561816218|FG003|Vaccination Period|Other|0|||
155651416|NCT03574389|561816219|FG004|Vaccination Period|Other|0|||
155651417|NCT03574389|561816220|FG005|Vaccination Period|Other|0|||
155651418|NCT03574389|561816221|FG006|Vaccination Period|Other|0|||
155444802|NCT00390780|561054367|FG000|Overall Study|Adverse Event|2|||
155444803|NCT00390780|561054368|FG001|Overall Study|Adverse Event|3|||
155444804|NCT00390780|561054367|FG000|Overall Study|Death|1|||
155444805|NCT00390780|561054368|FG001|Overall Study|Death|3|||
155444806|NCT00390780|561054367|FG000|Overall Study|Withdrawal by Subject|1|||
155444807|NCT00390780|561054368|FG001|Overall Study|Withdrawal by Subject|2|||
155444808|NCT00390780|561054367|FG000|Overall Study|Inclusion criteria not satisfied|0|||
155444809|NCT00390780|561054368|FG001|Overall Study|Inclusion criteria not satisfied|2|||
155444810|NCT00390780|561054367|FG000|Overall Study|Lost to follow up and other reasons|0|||
155444811|NCT00390780|561054368|FG001|Overall Study|Lost to follow up and other reasons|1|||
155651419|NCT03574389|561816215|FG000|Vaccination Period|Adverse Event|0|||
155444812|NCT00390780|561054367|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
155444813|NCT00390780|561054368|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
155651420|NCT03574389|561816216|FG001|Vaccination Period|Adverse Event|1|||
155444814|NCT00390780|561054367|FG000|Overall Study|SAE, death|0|||
155444815|NCT00390780|561054368|FG001|Overall Study|SAE, death|1|||
155444816|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
155444817|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
155444818|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
155444819|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
155444820|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
155444821|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
155444822|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
155444823|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
155444824|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
155444825|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
155444826|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
155444827|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
155444828|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
155444829|NCT02232516|561054369|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
155444830|NCT02232516|561054369|FG000|Survival Follow-up|Death|15|||
155444831|NCT02232516|561054369|FG000|Survival Follow-up|Withdrawal by Subject|3|||
155444832|NCT02232516|561054369|FG000|Survival Follow-up|Lost to Follow-up|1|||
155444833|NCT02232516|561054369|FG000|Survival Follow-up|Still in follow-up|5|||
155444834|NCT01585961|561054370|FG000|Overall Study|Death|6|||
155444835|NCT01585961|561054370|FG000|Overall Study|Physician Decision|1|||
155444836|NCT01585961|561054370|FG000|Overall Study|Decision to use non-study catheter|1|||
155444837|NCT01585961|561054370|FG000|Overall Study|Withdrawal by Subject|1|||
155444838|NCT01585961|561054370|FG000|Overall Study|Lost to Follow-up|23|||
155444839|NCT01585961|561054370|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
155444840|NCT01258348|561054371|FG000|Overall Study|Adverse Event|1|||
155444841|NCT01258348|561054372|FG001|Overall Study|Adverse Event|1|||
155444842|NCT01258348|561054373|FG002|Overall Study|Adverse Event|3|||
155444843|NCT01258348|561054374|FG003|Overall Study|Adverse Event|2|||
155444844|NCT01258348|561054375|FG004|Overall Study|Adverse Event|4|||
155444845|NCT01258348|561054371|FG000|Overall Study|Progressive Disease|0|||
155444846|NCT01258348|561054372|FG001|Overall Study|Progressive Disease|3|||
155444847|NCT01258348|561054373|FG002|Overall Study|Progressive Disease|0|||
155444848|NCT01258348|561054374|FG003|Overall Study|Progressive Disease|2|||
155444849|NCT01258348|561054375|FG004|Overall Study|Progressive Disease|2|||
155444850|NCT01258348|561054371|FG000|Overall Study|Physician Decision|0|||
155444851|NCT01258348|561054372|FG001|Overall Study|Physician Decision|0|||
155444852|NCT01258348|561054373|FG002|Overall Study|Physician Decision|0|||
155444853|NCT01258348|561054374|FG003|Overall Study|Physician Decision|2|||
155444854|NCT01258348|561054375|FG004|Overall Study|Physician Decision|0|||
155444855|NCT01258348|561054371|FG000|Overall Study|Withdrawal by Subject|0|||
155444856|NCT01258348|561054372|FG001|Overall Study|Withdrawal by Subject|1|||
155444857|NCT01258348|561054373|FG002|Overall Study|Withdrawal by Subject|0|||
155444858|NCT01258348|561054374|FG003|Overall Study|Withdrawal by Subject|0|||
155444859|NCT01258348|561054375|FG004|Overall Study|Withdrawal by Subject|0|||
155444860|NCT01120093|561054384|FG000|Treatment Period 1|Adverse Event|0|||
155444861|NCT01120093|561054385|FG001|Treatment Period 1|Adverse Event|0|||
155444862|NCT01120093|561054386|FG002|Treatment Period 1|Adverse Event|1|||
155444863|NCT01120093|561054387|FG003|Treatment Period 1|Adverse Event|0|||
155444864|NCT01120093|561054388|FG004|Treatment Period 1|Adverse Event|1|||
155444865|NCT01120093|561054384|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155444866|NCT01120093|561054385|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155444867|NCT01120093|561054386|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155444868|NCT01120093|561054387|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155444869|NCT01120093|561054388|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155444870|NCT01120093|561054384|FG000|Treatment Period 2|Adverse Event|0|||
155444871|NCT01120093|561054385|FG001|Treatment Period 2|Adverse Event|0|||
155444872|NCT01120093|561054386|FG002|Treatment Period 2|Adverse Event|0|||
155444873|NCT01120093|561054387|FG003|Treatment Period 2|Adverse Event|1|||
155444874|NCT01120093|561054388|FG004|Treatment Period 2|Adverse Event|0|||
155444875|NCT01120093|561054384|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155444876|NCT01120093|561054385|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155444877|NCT01120093|561054386|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155444878|NCT01120093|561054387|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155444879|NCT01120093|561054388|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155444880|NCT01120093|561054384|FG000|Treatment Period 3|Lack of Efficacy|0|||
155444881|NCT01120093|561054385|FG001|Treatment Period 3|Lack of Efficacy|0|||
155444882|NCT01120093|561054386|FG002|Treatment Period 3|Lack of Efficacy|0|||
155651421|NCT03574389|561816217|FG002|Vaccination Period|Adverse Event|0|||
155444883|NCT01120093|561054387|FG003|Treatment Period 3|Lack of Efficacy|1|||
155651422|NCT03574389|561816218|FG003|Vaccination Period|Adverse Event|0|||
155444884|NCT01120093|561054388|FG004|Treatment Period 3|Lack of Efficacy|0|||
155444885|NCT01120093|561054384|FG000|Treatment Period 3|Adverse Event|0|||
155444886|NCT01120093|561054385|FG001|Treatment Period 3|Adverse Event|0|||
155444887|NCT01120093|561054386|FG002|Treatment Period 3|Adverse Event|0|||
155444888|NCT01120093|561054387|FG003|Treatment Period 3|Adverse Event|0|||
155444889|NCT01120093|561054388|FG004|Treatment Period 3|Adverse Event|1|||
155444890|NCT01120093|561054384|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155444891|NCT01120093|561054385|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155444892|NCT01120093|561054386|FG002|Treatment Period 3|Withdrawal by Subject|1|||
155444893|NCT01120093|561054387|FG003|Treatment Period 3|Withdrawal by Subject|0|||
155444894|NCT01120093|561054388|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155444895|NCT01120093|561054384|FG000|Treatment Period 4|Adverse Event|1|||
155444896|NCT01120093|561054385|FG001|Treatment Period 4|Adverse Event|0|||
155444897|NCT01120093|561054386|FG002|Treatment Period 4|Adverse Event|0|||
155444898|NCT01120093|561054387|FG003|Treatment Period 4|Adverse Event|0|||
155444899|NCT01120093|561054388|FG004|Treatment Period 4|Adverse Event|0|||
155444900|NCT01120093|561054384|FG000|Treatment Period 5|Adverse Event|0|||
155444901|NCT01120093|561054385|FG001|Treatment Period 5|Adverse Event|1|||
155444902|NCT01120093|561054386|FG002|Treatment Period 5|Adverse Event|0|||
155444903|NCT01120093|561054387|FG003|Treatment Period 5|Adverse Event|1|||
155444904|NCT01120093|561054388|FG004|Treatment Period 5|Adverse Event|0|||
155444905|NCT00525148|561054393|FG000|Overall Study|Other Adverse Event|3|||
155444906|NCT00525148|561054394|FG001|Overall Study|Other Adverse Event|5|||
155444907|NCT00525148|561054395|FG002|Overall Study|Other Adverse Event|1|||
155444908|NCT00525148|561054396|FG003|Overall Study|Other Adverse Event|8|||
155444909|NCT00525148|561054393|FG000|Overall Study|Progressive disease|18|||
155444910|NCT00525148|561054394|FG001|Overall Study|Progressive disease|30|||
155444911|NCT00525148|561054395|FG002|Overall Study|Progressive disease|6|||
155444912|NCT00525148|561054396|FG003|Overall Study|Progressive disease|49|||
155444913|NCT00525148|561054393|FG000|Overall Study|Refused continuation of study medication|0|||
155444914|NCT00525148|561054394|FG001|Overall Study|Refused continuation of study medication|2|||
155444915|NCT00525148|561054395|FG002|Overall Study|Refused continuation of study medication|0|||
155444916|NCT00525148|561054396|FG003|Overall Study|Refused continuation of study medication|1|||
155444917|NCT00525148|561054393|FG000|Overall Study|Other than stated|2|||
155444918|NCT00525148|561054394|FG001|Overall Study|Other than stated|1|||
155444919|NCT00525148|561054395|FG002|Overall Study|Other than stated|0|||
155444920|NCT00525148|561054396|FG003|Overall Study|Other than stated|3|||
155444921|NCT00570739|561054397|FG000|Overall Study|Adverse Event|8|||
155444922|NCT00570739|561054398|FG001|Overall Study|Adverse Event|6|||
155444923|NCT00570739|561054399|FG002|Overall Study|Adverse Event|2|||
155444924|NCT00570739|561054400|FG003|Overall Study|Adverse Event|2|||
155444925|NCT00570739|561054397|FG000|Overall Study|Lost to Follow-up|4|||
155444926|NCT00570739|561054398|FG001|Overall Study|Lost to Follow-up|5|||
155444927|NCT00570739|561054399|FG002|Overall Study|Lost to Follow-up|4|||
155444928|NCT00570739|561054400|FG003|Overall Study|Lost to Follow-up|1|||
155444929|NCT00570739|561054397|FG000|Overall Study|Physician Decision|1|||
155444930|NCT00570739|561054398|FG001|Overall Study|Physician Decision|1|||
155444931|NCT00570739|561054399|FG002|Overall Study|Physician Decision|0|||
155444932|NCT00570739|561054400|FG003|Overall Study|Physician Decision|0|||
155444933|NCT00570739|561054397|FG000|Overall Study|Withdrawal by Subject|7|||
155444934|NCT00570739|561054398|FG001|Overall Study|Withdrawal by Subject|7|||
155444935|NCT00570739|561054399|FG002|Overall Study|Withdrawal by Subject|3|||
155444936|NCT00570739|561054400|FG003|Overall Study|Withdrawal by Subject|5|||
155444937|NCT00570739|561054397|FG000|Overall Study|Required restricted medication|0|||
155444938|NCT00570739|561054398|FG001|Overall Study|Required restricted medication|0|||
155444939|NCT00570739|561054399|FG002|Overall Study|Required restricted medication|1|||
155444940|NCT00570739|561054400|FG003|Overall Study|Required restricted medication|0|||
155444941|NCT00570739|561054397|FG000|Overall Study|Met discontinuation criteria|1|||
155444942|NCT00570739|561054398|FG001|Overall Study|Met discontinuation criteria|0|||
155444943|NCT00570739|561054399|FG002|Overall Study|Met discontinuation criteria|1|||
155444944|NCT00570739|561054400|FG003|Overall Study|Met discontinuation criteria|1|||
155444945|NCT00570739|561054397|FG000|Overall Study|Other|0|||
155444946|NCT00570739|561054398|FG001|Overall Study|Other|2|||
155444947|NCT00570739|561054399|FG002|Overall Study|Other|5|||
155444948|NCT00570739|561054400|FG003|Overall Study|Other|3|||
155444949|NCT02086565|561054402|FG000|Overall Study|Lost to Follow-up|9|||
155444950|NCT02086565|561054403|FG001|Overall Study|Lost to Follow-up|7|||
155444951|NCT02086565|561054402|FG000|Overall Study|Withdrawal by Subject|2|||
155444952|NCT02086565|561054403|FG001|Overall Study|Withdrawal by Subject|1|||
155444953|NCT02086565|561054402|FG000|Overall Study|Death|3|||
155444954|NCT02086565|561054403|FG001|Overall Study|Death|2|||
155444955|NCT02086565|561054402|FG000|Overall Study|withdrawn by research team|2|||
155444956|NCT02086565|561054403|FG001|Overall Study|withdrawn by research team|2|||
155444957|NCT00739297|561054404|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
155444958|NCT00739297|561054405|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
155444959|NCT00739297|561054406|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
155444960|NCT00739297|561054407|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
155444961|NCT00739297|561054408|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
155444962|NCT00739297|561054409|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
155444963|NCT00739297|561054410|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
155444964|NCT00739297|561054404|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
155444965|NCT00739297|561054405|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
155444966|NCT00739297|561054406|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
155444967|NCT00739297|561054407|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
155444968|NCT00739297|561054408|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
155444969|NCT00739297|561054409|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
155444970|NCT00739297|561054410|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
155444971|NCT01400971|561054411|FG000|Overall Study|Death|82|||
155444972|NCT01400971|561054411|FG000|Overall Study|Lost to Follow-up|196|||
155444973|NCT01400971|561054411|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
155444974|NCT01400971|561054411|FG000|Overall Study|Physician Decision|57|||
155444975|NCT01400971|561054411|FG000|Overall Study|Withdrawal by Subject|158|||
155444976|NCT01400971|561054411|FG000|Overall Study|Other|422|||
155444977|NCT02092389|561054416|FG000|Overall Study|Adverse Event|1|||
155444978|NCT02092389|561054416|FG000|Overall Study|Other|5|||
155444979|NCT01242020|561054417|FG000|Overall Study|Withdrawal by Subject|2|||
155444980|NCT01242020|561054418|FG001|Overall Study|Withdrawal by Subject|0|||
155444981|NCT01242020|561054417|FG000|Overall Study|Failed screening|1|||
155444982|NCT01242020|561054418|FG001|Overall Study|Failed screening|0|||
155444983|NCT02680847|561054419|FG000|Overall Study|Other|2|||
155444984|NCT02680847|561054420|FG001|Overall Study|Other|0|||
155444985|NCT02680847|561054421|FG002|Overall Study|Other|0|||
155444986|NCT02680847|561054419|FG000|Overall Study|No longer met eligibility criteria|2|||
155444987|NCT02680847|561054420|FG001|Overall Study|No longer met eligibility criteria|2|||
155444988|NCT02680847|561054421|FG002|Overall Study|No longer met eligibility criteria|0|||
155444989|NCT02680847|561054419|FG000|Overall Study|Unwilling to participate in study|1|||
155444990|NCT02680847|561054420|FG001|Overall Study|Unwilling to participate in study|1|||
155444991|NCT02680847|561054421|FG002|Overall Study|Unwilling to participate in study|0|||
155444992|NCT02680847|561054419|FG000|Overall Study|Lack of Efficacy|0|||
155444993|NCT02680847|561054420|FG001|Overall Study|Lack of Efficacy|0|||
155444994|NCT02680847|561054421|FG002|Overall Study|Lack of Efficacy|2|||
155444995|NCT02680847|561054419|FG000|Overall Study|Adverse Event|0|||
155444996|NCT02680847|561054420|FG001|Overall Study|Adverse Event|0|||
155444997|NCT02680847|561054421|FG002|Overall Study|Adverse Event|1|||
155444998|NCT01595646|561054427|FG000|Overall Study|Withdrawal by Subject|1|||
155444999|NCT01595646|561054428|FG001|Overall Study|Withdrawal by Subject|0|||
155445000|NCT01595646|561054429|FG002|Overall Study|Withdrawal by Subject|0|||
155445001|NCT00751881|561054435|FG000|Core Treatment Period|Not treated|1|||
155445002|NCT00751881|561054436|FG001|Core Treatment Period|Not treated|1|||
155445003|NCT00751881|561054437|FG002|Core Treatment Period|Not treated|2|||
155445004|NCT00751881|561054435|FG000|Core Treatment Period|Adverse Event|26|||
155445005|NCT00751881|561054436|FG001|Core Treatment Period|Adverse Event|54|||
155445006|NCT00751881|561054437|FG002|Core Treatment Period|Adverse Event|58|||
155445007|NCT00751881|561054435|FG000|Core Treatment Period|Lack of Efficacy|37|||
155445008|NCT00751881|561054436|FG001|Core Treatment Period|Lack of Efficacy|30|||
155445009|NCT00751881|561054437|FG002|Core Treatment Period|Lack of Efficacy|20|||
155445010|NCT00751881|561054435|FG000|Core Treatment Period|Poor compliance to protocol|15|||
155445011|NCT00751881|561054436|FG001|Core Treatment Period|Poor compliance to protocol|3|||
155445012|NCT00751881|561054437|FG002|Core Treatment Period|Poor compliance to protocol|4|||
155445013|NCT00751881|561054435|FG000|Core Treatment Period|Lost to Follow-up|6|||
155445014|NCT00751881|561054436|FG001|Core Treatment Period|Lost to Follow-up|4|||
155445015|NCT00751881|561054437|FG002|Core Treatment Period|Lost to Follow-up|3|||
155445016|NCT00751881|561054435|FG000|Core Treatment Period|Other: protocol deviation|3|||
155445017|NCT00751881|561054436|FG001|Core Treatment Period|Other: protocol deviation|3|||
155445018|NCT00751881|561054437|FG002|Core Treatment Period|Other: protocol deviation|7|||
155445019|NCT00751881|561054435|FG000|Core Treatment Period|Other: wish to parent|5|||
155445020|NCT00751881|561054436|FG001|Core Treatment Period|Other: wish to parent|7|||
155445021|NCT00751881|561054437|FG002|Core Treatment Period|Other: wish to parent|4|||
155445022|NCT00751881|561054435|FG000|Core Treatment Period|Other: personal/family constraints|6|||
155445023|NCT00751881|561054436|FG001|Core Treatment Period|Other: personal/family constraints|7|||
155445024|NCT00751881|561054437|FG002|Core Treatment Period|Other: personal/family constraints|10|||
155445025|NCT00751881|561054435|FG000|Core Treatment Period|Other: MS treatment change|6|||
155445026|NCT00751881|561054436|FG001|Core Treatment Period|Other: MS treatment change|4|||
155445027|NCT00751881|561054437|FG002|Core Treatment Period|Other: MS treatment change|4|||
155445028|NCT00751881|561054435|FG000|Core Treatment Period|Other: tolerability complaints|2|||
155445029|NCT00751881|561054436|FG001|Core Treatment Period|Other: tolerability complaints|0|||
155445030|NCT00751881|561054437|FG002|Core Treatment Period|Other: tolerability complaints|0|||
155445031|NCT00751881|561054435|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
155445032|NCT00751881|561054436|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
155445033|NCT00751881|561054437|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
155445034|NCT00751881|561054435|FG000|Extension Study Period|Adverse Event|18|||
155445035|NCT00751881|561054436|FG001|Extension Study Period|Adverse Event|20|||
155445036|NCT00751881|561054437|FG002|Extension Study Period|Adverse Event|21|||
155445037|NCT00751881|561054435|FG000|Extension Study Period|Lack of Efficacy|14|||
155445038|NCT00751881|561054436|FG001|Extension Study Period|Lack of Efficacy|10|||
155445039|NCT00751881|561054437|FG002|Extension Study Period|Lack of Efficacy|20|||
155445040|NCT00751881|561054435|FG000|Extension Study Period|Lost to Follow-up|4|||
155445041|NCT00751881|561054436|FG001|Extension Study Period|Lost to Follow-up|9|||
155445042|NCT00751881|561054437|FG002|Extension Study Period|Lost to Follow-up|6|||
155445043|NCT00751881|561054435|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
155445044|NCT00751881|561054436|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
155445045|NCT00751881|561054437|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
155445046|NCT00751881|561054435|FG000|Extension Study Period|Other than specified above|26|||
155445047|NCT00751881|561054436|FG001|Extension Study Period|Other than specified above|30|||
155445048|NCT00751881|561054437|FG002|Extension Study Period|Other than specified above|18|||
155445049|NCT04770155|561054438|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445050|NCT04770155|561054439|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445051|NCT04770155|561054440|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445052|NCT04770155|561054441|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445053|NCT04770155|561054442|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445054|NCT04770155|561054443|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445055|NCT04770155|561054444|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445056|NCT04770155|561054445|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
155445057|NCT01765764|561054446|FG000|Treatment Period|Adverse Event|1|||
155445058|NCT01765764|561054447|FG001|Treatment Period|Adverse Event|2|||
155445059|NCT01765764|561054448|FG002|Treatment Period|Adverse Event|1|||
155445060|NCT01765764|561054446|FG000|Treatment Period|Lost to Follow-up|0|||
155445061|NCT01765764|561054447|FG001|Treatment Period|Lost to Follow-up|3|||
155445062|NCT01765764|561054448|FG002|Treatment Period|Lost to Follow-up|2|||
155445063|NCT01765764|561054446|FG000|Treatment Period|Personal Reasons|1|||
155445064|NCT01765764|561054447|FG001|Treatment Period|Personal Reasons|2|||
155445065|NCT01765764|561054448|FG002|Treatment Period|Personal Reasons|1|||
155445066|NCT01765764|561054446|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
155445067|NCT01765764|561054447|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
155445068|NCT01765764|561054448|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
155445069|NCT01597193|561054450|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
155445070|NCT01597193|561054451|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
155445071|NCT01597193|561054452|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
155445072|NCT01597193|561054453|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
155445073|NCT01597193|561054454|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
155445074|NCT01597193|561054455|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
155445075|NCT01597193|561054456|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
155445076|NCT01597193|561054450|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
155445077|NCT01597193|561054451|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
155445078|NCT01597193|561054452|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
155445079|NCT01597193|561054453|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
155445080|NCT01597193|561054454|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
155445081|NCT01597193|561054455|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
155445082|NCT01597193|561054456|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
155445083|NCT01597193|561054450|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
155445084|NCT01597193|561054451|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
155445085|NCT01597193|561054452|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
155445086|NCT01597193|561054453|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
155445087|NCT01597193|561054454|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
155445088|NCT01597193|561054455|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
155651423|NCT03574389|561816219|FG004|Vaccination Period|Adverse Event|0|||
155651424|NCT03574389|561816220|FG005|Vaccination Period|Adverse Event|0|||
155651425|NCT03574389|561816221|FG006|Vaccination Period|Adverse Event|0|||
155651426|NCT03574389|561816215|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
155445089|NCT01597193|561054456|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
155445090|NCT01597193|561054450|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155651427|NCT03574389|561816216|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
155445091|NCT01597193|561054451|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155445092|NCT01597193|561054452|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155445093|NCT01597193|561054453|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155445094|NCT01597193|561054454|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155445095|NCT01597193|561054455|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
155445096|NCT01597193|561054456|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
155445097|NCT01597193|561054450|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
155445098|NCT01597193|561054451|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
155445099|NCT01597193|561054452|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
155445100|NCT01597193|561054453|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
155445101|NCT01597193|561054454|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
155445102|NCT01597193|561054455|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
155445103|NCT01597193|561054456|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
155445104|NCT01345786|561054465|FG000|Overall Study|Adverse Event|0|||
155445105|NCT01345786|561054466|FG001|Overall Study|Adverse Event|1|||
155445106|NCT01345786|561054467|FG002|Overall Study|Adverse Event|3|||
155445107|NCT01345786|561054468|FG003|Overall Study|Adverse Event|1|||
155445108|NCT01345786|561054465|FG000|Overall Study|Subject withdrew consent|2|||
155445109|NCT01345786|561054466|FG001|Overall Study|Subject withdrew consent|2|||
155445110|NCT01345786|561054467|FG002|Overall Study|Subject withdrew consent|1|||
155445111|NCT01345786|561054468|FG003|Overall Study|Subject withdrew consent|0|||
155445112|NCT01345786|561054465|FG000|Overall Study|Noncompliance with protocol|1|||
155445113|NCT01345786|561054466|FG001|Overall Study|Noncompliance with protocol|0|||
155445114|NCT01345786|561054467|FG002|Overall Study|Noncompliance with protocol|1|||
155445115|NCT01345786|561054468|FG003|Overall Study|Noncompliance with protocol|0|||
155445116|NCT01345786|561054465|FG000|Overall Study|Administrative|3|||
155445117|NCT01345786|561054466|FG001|Overall Study|Administrative|5|||
155445118|NCT01345786|561054467|FG002|Overall Study|Administrative|0|||
155445119|NCT01345786|561054468|FG003|Overall Study|Administrative|0|||
155445120|NCT01345786|561054465|FG000|Overall Study|Lost to Follow-up|0|||
155445121|NCT01345786|561054466|FG001|Overall Study|Lost to Follow-up|0|||
155445122|NCT01345786|561054467|FG002|Overall Study|Lost to Follow-up|0|||
155445123|NCT01345786|561054468|FG003|Overall Study|Lost to Follow-up|2|||
155445124|NCT01070784|561054469|FG000|Overall Study|Withdrawal by Subject|6|||
155445125|NCT01070784|561054470|FG001|Overall Study|Withdrawal by Subject|9|||
155445126|NCT01070784|561054469|FG000|Overall Study|Adverse Event|14|||
155445127|NCT01070784|561054470|FG001|Overall Study|Adverse Event|9|||
155445128|NCT01323673|561054471|FG000|Overall Study|Adverse Event|0|||
155445129|NCT01323673|561054472|FG001|Overall Study|Adverse Event|1|||
155445130|NCT01323673|561054471|FG000|Overall Study|Lost to Follow-up|0|||
155445131|NCT01323673|561054472|FG001|Overall Study|Lost to Follow-up|1|||
155445132|NCT01323673|561054471|FG000|Overall Study|Protocol Violation|1|||
155445133|NCT01323673|561054472|FG001|Overall Study|Protocol Violation|0|||
155445134|NCT01323673|561054471|FG000|Overall Study|Withdrawal by Subject|2|||
155445135|NCT01323673|561054472|FG001|Overall Study|Withdrawal by Subject|3|||
155445136|NCT02588248|561054476|FG000|Overall Study|Physician Decision|4|||
155445137|NCT02588248|561054477|FG001|Overall Study|Physician Decision|3|||
155445138|NCT01355068|561054478|FG000|First Intervention Period|Adverse Event|0|||
155445139|NCT01355068|561054479|FG001|First Intervention Period|Adverse Event|1|||
155445140|NCT01355068|561054478|FG000|First Intervention Period|Withdrawal by Subject|0|||
155445141|NCT01355068|561054479|FG001|First Intervention Period|Withdrawal by Subject|1|||
155445142|NCT04229446|561054480|FG000|Overall Study|Death|12|||
155445143|NCT04229446|561054481|FG001|Overall Study|Death|10|||
155445144|NCT04229446|561054480|FG000|Overall Study|Lost to Follow-up|5|||
155445145|NCT04229446|561054481|FG001|Overall Study|Lost to Follow-up|8|||
155445146|NCT00705224|561054482|FG000|Overall Study|Adverse Event|1|||
155445147|NCT00705224|561054482|FG000|Overall Study|Lack of Efficacy|2|||
155445148|NCT00705224|561054482|FG000|Overall Study|Withdrawal by Subject|3|||
155445149|NCT00705224|561054482|FG000|Overall Study|Lost to Follow-up|5|||
155445150|NCT03283163|561054483|FG000|Overall Study|Lost to Follow-up|1|||
155445151|NCT03283163|561054483|FG000|Overall Study|other life commitments|6|||
155445152|NCT03283163|561054483|FG000|Overall Study|COVID-19 institution wide halting|1|||
155445153|NCT03283163|561054483|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
155445154|NCT03283163|561054483|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
155445155|NCT02566525|561054484|FG000|Overall Study|Protocol Violation|3|||
155445156|NCT02566525|561054485|FG001|Overall Study|Protocol Violation|5|||
155445157|NCT03141086|561054486|FG000|Overall Study|Study Terminated By Sponsor|1|||
155445158|NCT03141086|561054487|FG001|Overall Study|Study Terminated By Sponsor|1|||
155445159|NCT03141086|561054486|FG000|Overall Study|Withdrawal by Subject|0|||
155445160|NCT03141086|561054487|FG001|Overall Study|Withdrawal by Subject|1|||
155445161|NCT03141086|561054486|FG000|Overall Study|Protocol Violation|0|||
155445162|NCT03141086|561054487|FG001|Overall Study|Protocol Violation|1|||
155445163|NCT03141086|561054486|FG000|Overall Study|Adverse Event|0|||
155445164|NCT03141086|561054487|FG001|Overall Study|Adverse Event|2|||
155445165|NCT01441440|561055869|FG000|Overall Study|Death|1|||
155445166|NCT01441440|561055870|FG001|Overall Study|Death|0|||
155445167|NCT01441440|561055871|FG002|Overall Study|Death|1|||
155445168|NCT01441440|561055869|FG000|Overall Study|Adverse Event|2|||
155445169|NCT01441440|561055870|FG001|Overall Study|Adverse Event|9|||
155445170|NCT01441440|561055871|FG002|Overall Study|Adverse Event|9|||
155445171|NCT01441440|561055869|FG000|Overall Study|Lost to Follow-up|0|||
155445172|NCT01441440|561055870|FG001|Overall Study|Lost to Follow-up|2|||
155445173|NCT01441440|561055871|FG002|Overall Study|Lost to Follow-up|1|||
155445174|NCT01441440|561055869|FG000|Overall Study|Withdrawal by Subject|11|||
155445175|NCT01441440|561055870|FG001|Overall Study|Withdrawal by Subject|9|||
155445176|NCT01441440|561055871|FG002|Overall Study|Withdrawal by Subject|9|||
155445177|NCT01441440|561055869|FG000|Overall Study|Pregnancy|1|||
155445178|NCT01441440|561055870|FG001|Overall Study|Pregnancy|0|||
155445179|NCT01441440|561055871|FG002|Overall Study|Pregnancy|0|||
155445180|NCT01441440|561055869|FG000|Overall Study|Lack of Efficacy|1|||
155445181|NCT01441440|561055870|FG001|Overall Study|Lack of Efficacy|0|||
155445182|NCT01441440|561055871|FG002|Overall Study|Lack of Efficacy|1|||
155445183|NCT01441440|561055869|FG000|Overall Study|Moving|0|||
155445184|NCT01441440|561055870|FG001|Overall Study|Moving|1|||
155445185|NCT01441440|561055871|FG002|Overall Study|Moving|1|||
155445186|NCT01441440|561055869|FG000|Overall Study|Work-related matter|0|||
155445187|NCT01441440|561055870|FG001|Overall Study|Work-related matter|1|||
155445188|NCT01441440|561055871|FG002|Overall Study|Work-related matter|0|||
155445189|NCT01441440|561055869|FG000|Overall Study|Difficllty in keeping the schedule|1|||
155445190|NCT01441440|561055870|FG001|Overall Study|Difficllty in keeping the schedule|1|||
155445191|NCT01441440|561055871|FG002|Overall Study|Difficllty in keeping the schedule|0|||
155445192|NCT01345123|561055872|FG000|Overall Study|participants no longer with health plan|79|||
155445193|NCT01345123|561055873|FG001|Overall Study|participants no longer with health plan|85|||
155445194|NCT01345123|561055874|FG002|Overall Study|participants no longer with health plan|88|||
155445195|NCT03097328|561055875|FG000|Overall Study|Still on Therapy|2|||
155445196|NCT03097328|561055875|FG000|Overall Study|Progressive Disease|29|||
155445197|NCT03097328|561055875|FG000|Overall Study|Adverse Event|4|||
155445198|NCT03097328|561055875|FG000|Overall Study|Withdrawal by Subject|1|||
155445199|NCT03097328|561055875|FG000|Overall Study|Physician Decision|1|||
155445200|NCT03097328|561055875|FG000|Overall Study|Patient Decision|1|||
155445201|NCT03097328|561055875|FG000|Overall Study|Ineligible for Study Drug|1|||
155445202|NCT00883558|561055876|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
155445203|NCT00883558|561055877|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
155445204|NCT00883558|561055878|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
155445205|NCT00883558|561055876|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
155445206|NCT00883558|561055877|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
155445207|NCT00883558|561055878|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
155445208|NCT00883558|561055876|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
155445209|NCT00883558|561055877|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
155445210|NCT00883558|561055878|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
155445211|NCT00883558|561055876|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
155445212|NCT00883558|561055877|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
155445213|NCT00883558|561055878|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
155445214|NCT00883558|561055876|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
155445215|NCT00883558|561055877|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
155445216|NCT00883558|561055878|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
155445217|NCT03650452|561055879|FG000|Overall Study|Physician Decision|1|||
155445218|NCT03650452|561055880|FG001|Overall Study|Physician Decision|0|||
155445219|NCT03650452|561055879|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
155445220|NCT03650452|561055880|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155445221|NCT03650452|561055879|FG000|Overall Study|Adverse Event|3|||
155445222|NCT03650452|561055880|FG001|Overall Study|Adverse Event|4|||
155445223|NCT03650452|561055879|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
155445224|NCT03650452|561055880|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
155445225|NCT03539458|561055882|FG000|Overall Study|Death|1|||
155445226|NCT01984346|561055884|FG000|Overall Study|Physician Decision|4|||
155445227|NCT01984346|561055885|FG001|Overall Study|Physician Decision|2|||
155445228|NCT01984346|561055884|FG000|Overall Study|Withdrawal by Subject|2|||
155445229|NCT01984346|561055885|FG001|Overall Study|Withdrawal by Subject|2|||
155445230|NCT01984346|561055884|FG000|Overall Study|Enrollment Closed|8|||
155651428|NCT03574389|561816217|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
155651429|NCT03574389|561816218|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
155651430|NCT03574389|561816219|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
155445231|NCT01984346|561055885|FG001|Overall Study|Enrollment Closed|1|||
155445232|NCT01984346|561055884|FG000|Overall Study|Insurance Coverage|1|||
155445233|NCT01984346|561055885|FG001|Overall Study|Insurance Coverage|0|||
155445234|NCT01984346|561055884|FG000|Overall Study|Intra-operative Exclusion|2|||
155445235|NCT01984346|561055885|FG001|Overall Study|Intra-operative Exclusion|0|||
155445236|NCT02042404|561055888|FG000|Overall Study|Death|1|||
155445237|NCT02042404|561055889|FG001|Overall Study|Death|0|||
155445238|NCT02042404|561055888|FG000|Overall Study|Unrelated Adverse Event|3|||
155445239|NCT02042404|561055889|FG001|Overall Study|Unrelated Adverse Event|0|||
155445240|NCT02042404|561055888|FG000|Overall Study|Inability to meet time requirements|1|||
155445241|NCT02042404|561055889|FG001|Overall Study|Inability to meet time requirements|0|||
155445242|NCT03100942|561055890|FG000|Randomized Treatment Period|Withdrew Consent|4|||
155445243|NCT03100942|561055891|FG001|Randomized Treatment Period|Withdrew Consent|5|||
155445244|NCT03100942|561055892|FG002|Randomized Treatment Period|Withdrew Consent|3|||
155445245|NCT03100942|561055893|FG003|Randomized Treatment Period|Withdrew Consent|3|||
155445246|NCT03100942|561055894|FG004|Randomized Treatment Period|Withdrew Consent|0|||
155445247|NCT03100942|561055895|FG005|Randomized Treatment Period|Withdrew Consent|0|||
155445248|NCT03100942|561055896|FG006|Randomized Treatment Period|Withdrew Consent|0|||
155445249|NCT03100942|561055890|FG000|Randomized Treatment Period|Adverse Event|5|||
155445250|NCT03100942|561055891|FG001|Randomized Treatment Period|Adverse Event|2|||
155445251|NCT03100942|561055892|FG002|Randomized Treatment Period|Adverse Event|1|||
155445252|NCT03100942|561055893|FG003|Randomized Treatment Period|Adverse Event|0|||
155445253|NCT03100942|561055894|FG004|Randomized Treatment Period|Adverse Event|0|||
155445254|NCT03100942|561055895|FG005|Randomized Treatment Period|Adverse Event|0|||
155445255|NCT03100942|561055896|FG006|Randomized Treatment Period|Adverse Event|0|||
155445256|NCT03100942|561055890|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
155445257|NCT03100942|561055891|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
155445258|NCT03100942|561055892|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
155445259|NCT03100942|561055893|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
155445260|NCT03100942|561055894|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
155445261|NCT03100942|561055895|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
155445262|NCT03100942|561055896|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
155445263|NCT03100942|561055890|FG000|Randomized Treatment Period|Protocol Violation|0|||
155445264|NCT03100942|561055891|FG001|Randomized Treatment Period|Protocol Violation|1|||
155445265|NCT03100942|561055892|FG002|Randomized Treatment Period|Protocol Violation|1|||
155445266|NCT03100942|561055893|FG003|Randomized Treatment Period|Protocol Violation|1|||
155445267|NCT03100942|561055894|FG004|Randomized Treatment Period|Protocol Violation|0|||
155445268|NCT03100942|561055895|FG005|Randomized Treatment Period|Protocol Violation|0|||
155445269|NCT03100942|561055896|FG006|Randomized Treatment Period|Protocol Violation|0|||
155445270|NCT03100942|561055890|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
155445271|NCT03100942|561055891|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
155445272|NCT03100942|561055892|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
155445273|NCT03100942|561055893|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
155445274|NCT03100942|561055894|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
155445275|NCT03100942|561055895|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
155445276|NCT03100942|561055896|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
155445277|NCT03100942|561055890|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
155445278|NCT03100942|561055891|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
155445279|NCT03100942|561055892|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
155445280|NCT03100942|561055893|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
155445281|NCT03100942|561055894|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
155445282|NCT03100942|561055895|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
155445283|NCT03100942|561055896|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
155445284|NCT03100942|561055890|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445285|NCT03100942|561055891|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445286|NCT03100942|561055892|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445287|NCT03100942|561055893|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445288|NCT03100942|561055894|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445289|NCT03100942|561055895|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
155445290|NCT03100942|561055896|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
155445291|NCT01876732|561055901|FG000|Overall Study|MMA was not over 800mg/dL|75|||
155445292|NCT00536731|561055902|FG000|Overall Study|Adverse Event|3|||
155445293|NCT00536731|561055903|FG001|Overall Study|Adverse Event|2|||
155651431|NCT03574389|561816220|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
155445294|NCT00536731|561055904|FG002|Overall Study|Adverse Event|3|||
155445295|NCT00536731|561055902|FG000|Overall Study|Withdrawal by Subject|0|||
155445296|NCT00536731|561055903|FG001|Overall Study|Withdrawal by Subject|2|||
155445297|NCT00536731|561055904|FG002|Overall Study|Withdrawal by Subject|0|||
155445298|NCT00536731|561055902|FG000|Overall Study|Intake of prohibited conc. medication|0|||
155445299|NCT00536731|561055903|FG001|Overall Study|Intake of prohibited conc. medication|0|||
155445300|NCT00536731|561055904|FG002|Overall Study|Intake of prohibited conc. medication|1|||
155445301|NCT00536731|561055902|FG000|Overall Study|Safety reasons|0|||
155445302|NCT00536731|561055903|FG001|Overall Study|Safety reasons|0|||
155445303|NCT00536731|561055904|FG002|Overall Study|Safety reasons|1|||
155445304|NCT00536731|561055902|FG000|Overall Study|Other|1|||
155445305|NCT00536731|561055903|FG001|Overall Study|Other|1|||
155445306|NCT00536731|561055904|FG002|Overall Study|Other|0|||
155445307|NCT00718419|561055905|FG000|Overall Study|Adverse Event|2|||
155445308|NCT00718419|561055906|FG001|Overall Study|Adverse Event|1|||
155445309|NCT00718419|561055905|FG000|Overall Study|Physician Decision|1|||
155445310|NCT00718419|561055906|FG001|Overall Study|Physician Decision|6|||
155445311|NCT00718419|561055905|FG000|Overall Study|Sponsor decision|0|||
155445312|NCT00718419|561055906|FG001|Overall Study|Sponsor decision|1|||
155445313|NCT00718419|561055905|FG000|Overall Study|Withdrawal by Subject|0|||
155445314|NCT00718419|561055906|FG001|Overall Study|Withdrawal by Subject|5|||
155445315|NCT00718419|561055905|FG000|Overall Study|Progressive Disease|7|||
155445316|NCT00718419|561055906|FG001|Overall Study|Progressive Disease|25|||
155445317|NCT00718419|561055905|FG000|Overall Study|Death Due to Progressive Disease|2|||
155445318|NCT00718419|561055906|FG001|Overall Study|Death Due to Progressive Disease|0|||
155445319|NCT00718419|561055905|FG000|Overall Study|Death Due to Study Drug Related|0|||
155445320|NCT00718419|561055906|FG001|Overall Study|Death Due to Study Drug Related|1|||
155445321|NCT00718419|561055905|FG000|Overall Study|Death Due to Adverse Events|1|||
155445322|NCT00718419|561055906|FG001|Overall Study|Death Due to Adverse Events|0|||
155445323|NCT01675531|561055909|FG000|Overall Study|Adverse Event|9|||
155445324|NCT01675531|561055909|FG000|Overall Study|Withdrawal by Subject|7|||
155445325|NCT01675531|561055909|FG000|Overall Study|Lack of Efficacy|1|||
155445326|NCT01675531|561055909|FG000|Overall Study|Protocol Violation|8|||
155445327|NCT04184622|561055910|FG000|Primary Treatment Period|Adverse Event|6|||
155445328|NCT04184622|561055911|FG001|Primary Treatment Period|Adverse Event|4|||
155445329|NCT04184622|561055912|FG002|Primary Treatment Period|Adverse Event|8|||
155445330|NCT04184622|561055913|FG003|Primary Treatment Period|Adverse Event|6|||
155445331|NCT04184622|561055910|FG000|Primary Treatment Period|Death|4|||
155445332|NCT04184622|561055911|FG001|Primary Treatment Period|Death|4|||
155445333|NCT04184622|561055912|FG002|Primary Treatment Period|Death|2|||
155445334|NCT04184622|561055913|FG003|Primary Treatment Period|Death|1|||
155445335|NCT04184622|561055910|FG000|Primary Treatment Period|Lost to Follow-up|41|||
155445336|NCT04184622|561055911|FG001|Primary Treatment Period|Lost to Follow-up|17|||
155445337|NCT04184622|561055912|FG002|Primary Treatment Period|Lost to Follow-up|15|||
155445338|NCT04184622|561055913|FG003|Primary Treatment Period|Lost to Follow-up|13|||
155445339|NCT04184622|561055910|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
155445340|NCT04184622|561055911|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
155445341|NCT04184622|561055912|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
155445342|NCT04184622|561055913|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
155445343|NCT04184622|561055910|FG000|Primary Treatment Period|Physician Decision|0|||
155445344|NCT04184622|561055911|FG001|Primary Treatment Period|Physician Decision|0|||
155445345|NCT04184622|561055912|FG002|Primary Treatment Period|Physician Decision|3|||
155445346|NCT04184622|561055913|FG003|Primary Treatment Period|Physician Decision|1|||
155445347|NCT04184622|561055910|FG000|Primary Treatment Period|Pregnancy|4|||
155445348|NCT04184622|561055911|FG001|Primary Treatment Period|Pregnancy|3|||
155445349|NCT04184622|561055912|FG002|Primary Treatment Period|Pregnancy|4|||
155445350|NCT04184622|561055913|FG003|Primary Treatment Period|Pregnancy|1|||
155445351|NCT04184622|561055910|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
155445352|NCT04184622|561055911|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
155445353|NCT04184622|561055912|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
155445354|NCT04184622|561055913|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
155445355|NCT04184622|561055910|FG000|Additional Treatment Period|Adverse Event|1|||
155445356|NCT04184622|561055911|FG001|Additional Treatment Period|Adverse Event|2|||
155445357|NCT04184622|561055912|FG002|Additional Treatment Period|Adverse Event|1|||
155445358|NCT04184622|561055913|FG003|Additional Treatment Period|Adverse Event|0|||
155445359|NCT04184622|561055910|FG000|Additional Treatment Period|Death|0|||
155445360|NCT04184622|561055911|FG001|Additional Treatment Period|Death|0|||
155445361|NCT04184622|561055912|FG002|Additional Treatment Period|Death|1|||
155445362|NCT04184622|561055913|FG003|Additional Treatment Period|Death|1|||
155445363|NCT04184622|561055910|FG000|Additional Treatment Period|Lost to Follow-up|6|||
155445364|NCT04184622|561055911|FG001|Additional Treatment Period|Lost to Follow-up|4|||
155445365|NCT04184622|561055912|FG002|Additional Treatment Period|Lost to Follow-up|8|||
155445366|NCT04184622|561055913|FG003|Additional Treatment Period|Lost to Follow-up|6|||
155445367|NCT04184622|561055910|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
155445368|NCT04184622|561055911|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
155445369|NCT04184622|561055912|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
155445370|NCT04184622|561055913|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
155445371|NCT04184622|561055910|FG000|Additional Treatment Period|Physician Decision|0|||
155445372|NCT04184622|561055911|FG001|Additional Treatment Period|Physician Decision|0|||
155445373|NCT04184622|561055912|FG002|Additional Treatment Period|Physician Decision|1|||
155445374|NCT04184622|561055913|FG003|Additional Treatment Period|Physician Decision|0|||
155445375|NCT04184622|561055910|FG000|Additional Treatment Period|Pregnancy|0|||
155445376|NCT04184622|561055911|FG001|Additional Treatment Period|Pregnancy|0|||
155445377|NCT04184622|561055912|FG002|Additional Treatment Period|Pregnancy|0|||
155445378|NCT04184622|561055913|FG003|Additional Treatment Period|Pregnancy|1|||
155445379|NCT04184622|561055910|FG000|Additional Treatment Period|Protocol deviation|0|||
155445380|NCT04184622|561055911|FG001|Additional Treatment Period|Protocol deviation|0|||
155445381|NCT04184622|561055912|FG002|Additional Treatment Period|Protocol deviation|1|||
155445382|NCT04184622|561055913|FG003|Additional Treatment Period|Protocol deviation|0|||
155445383|NCT04184622|561055910|FG000|Additional Treatment Period|Site closed|1|||
155445384|NCT04184622|561055911|FG001|Additional Treatment Period|Site closed|0|||
155445385|NCT04184622|561055912|FG002|Additional Treatment Period|Site closed|1|||
155445386|NCT04184622|561055913|FG003|Additional Treatment Period|Site closed|0|||
155445387|NCT04184622|561055910|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
155445388|NCT04184622|561055911|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
155445389|NCT04184622|561055912|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
155445390|NCT04184622|561055913|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
155445391|NCT04184622|561055910|FG000|Safety Follow-up Period|Adverse Event|6|||
155445392|NCT04184622|561055911|FG001|Safety Follow-up Period|Adverse Event|8|||
155445393|NCT04184622|561055912|FG002|Safety Follow-up Period|Adverse Event|9|||
155445394|NCT04184622|561055913|FG003|Safety Follow-up Period|Adverse Event|16|||
155445395|NCT04184622|561055910|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
155445396|NCT04184622|561055911|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
155445397|NCT04184622|561055912|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
155445398|NCT04184622|561055913|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
155445399|NCT04184622|561055910|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
155445400|NCT04184622|561055911|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
155445401|NCT04184622|561055912|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
155445402|NCT04184622|561055913|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
155445403|NCT04184622|561055910|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
155445404|NCT04184622|561055911|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
155445405|NCT04184622|561055912|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
155445406|NCT04184622|561055913|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
155445407|NCT04184622|561055910|FG000|Safety Follow-up Period|Physician Decision|1|||
155445408|NCT04184622|561055911|FG001|Safety Follow-up Period|Physician Decision|0|||
155445409|NCT04184622|561055912|FG002|Safety Follow-up Period|Physician Decision|0|||
155445410|NCT04184622|561055913|FG003|Safety Follow-up Period|Physician Decision|1|||
155445411|NCT04184622|561055910|FG000|Safety Follow-up Period|Pregnancy|1|||
155445412|NCT04184622|561055911|FG001|Safety Follow-up Period|Pregnancy|3|||
155445413|NCT04184622|561055912|FG002|Safety Follow-up Period|Pregnancy|0|||
155445414|NCT04184622|561055913|FG003|Safety Follow-up Period|Pregnancy|6|||
155445415|NCT04184622|561055910|FG000|Safety Follow-up Period|Protocol deviation|1|||
155445416|NCT04184622|561055911|FG001|Safety Follow-up Period|Protocol deviation|0|||
155445417|NCT04184622|561055912|FG002|Safety Follow-up Period|Protocol deviation|0|||
155445418|NCT04184622|561055913|FG003|Safety Follow-up Period|Protocol deviation|0|||
155445419|NCT04184622|561055910|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
155445420|NCT04184622|561055911|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
155445421|NCT04184622|561055912|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
155445422|NCT04184622|561055913|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
155445423|NCT02795988|561055914|FG000|Phase 1b|Withdrawal by Subject|0|||
155445424|NCT02795988|561055915|FG001|Phase 1b|Withdrawal by Subject|1|||
155445425|NCT02795988|561055916|FG002|Phase 1b|Withdrawal by Subject|0|||
155445426|NCT02795988|561055917|FG003|Phase 1b|Withdrawal by Subject|0|||
155445427|NCT02795988|561055918|FG004|Phase 1b|Withdrawal by Subject|0|||
155445428|NCT02795988|561055919|FG005|Phase 1b|Withdrawal by Subject|0|||
155445429|NCT02795988|561055920|FG006|Phase 1b|Withdrawal by Subject|0|||
155445430|NCT02795988|561055914|FG000|Phase 1b|Death|1|||
155445431|NCT02795988|561055915|FG001|Phase 1b|Death|2|||
155445432|NCT02795988|561055916|FG002|Phase 1b|Death|1|||
155445433|NCT02795988|561055917|FG003|Phase 1b|Death|0|||
155445434|NCT02795988|561055918|FG004|Phase 1b|Death|0|||
155445435|NCT02795988|561055919|FG005|Phase 1b|Death|0|||
155445436|NCT02795988|561055920|FG006|Phase 1b|Death|0|||
155445437|NCT02795988|561055914|FG000|Phase 1b|Physician Decision|0|||
155445438|NCT02795988|561055915|FG001|Phase 1b|Physician Decision|0|||
155445439|NCT02795988|561055916|FG002|Phase 1b|Physician Decision|1|||
155445440|NCT02795988|561055917|FG003|Phase 1b|Physician Decision|0|||
155445441|NCT02795988|561055918|FG004|Phase 1b|Physician Decision|0|||
155445442|NCT02795988|561055919|FG005|Phase 1b|Physician Decision|0|||
155445443|NCT02795988|561055920|FG006|Phase 1b|Physician Decision|0|||
155445444|NCT02795988|561055914|FG000|Phase 1b|Progressive Disease|2|||
155445445|NCT02795988|561055915|FG001|Phase 1b|Progressive Disease|2|||
155445446|NCT02795988|561055916|FG002|Phase 1b|Progressive Disease|0|||
155445447|NCT02795988|561055917|FG003|Phase 1b|Progressive Disease|0|||
155445448|NCT02795988|561055918|FG004|Phase 1b|Progressive Disease|0|||
155445449|NCT02795988|561055919|FG005|Phase 1b|Progressive Disease|0|||
155445450|NCT02795988|561055920|FG006|Phase 1b|Progressive Disease|0|||
155445451|NCT02795988|561055914|FG000|Phase 2|Withdrawal by Subject|0|||
155445452|NCT02795988|561055915|FG001|Phase 2|Withdrawal by Subject|0|||
155445453|NCT02795988|561055916|FG002|Phase 2|Withdrawal by Subject|0|||
155445454|NCT02795988|561055917|FG003|Phase 2|Withdrawal by Subject|1|||
155445455|NCT02795988|561055918|FG004|Phase 2|Withdrawal by Subject|0|||
155445456|NCT02795988|561055919|FG005|Phase 2|Withdrawal by Subject|0|||
155445457|NCT02795988|561055920|FG006|Phase 2|Withdrawal by Subject|0|||
155445458|NCT02795988|561055914|FG000|Phase 2|Death|0|||
155445459|NCT02795988|561055915|FG001|Phase 2|Death|0|||
155445460|NCT02795988|561055916|FG002|Phase 2|Death|0|||
155445461|NCT02795988|561055917|FG003|Phase 2|Death|17|||
155445462|NCT02795988|561055918|FG004|Phase 2|Death|17|||
155445463|NCT02795988|561055919|FG005|Phase 2|Death|0|||
155445464|NCT02795988|561055920|FG006|Phase 2|Death|0|||
155445465|NCT02795988|561055914|FG000|Phase 2|Other|0|||
155445466|NCT02795988|561055915|FG001|Phase 2|Other|0|||
155445467|NCT02795988|561055916|FG002|Phase 2|Other|0|||
155445468|NCT02795988|561055917|FG003|Phase 2|Other|1|||
155445469|NCT02795988|561055918|FG004|Phase 2|Other|0|||
155445470|NCT02795988|561055919|FG005|Phase 2|Other|0|||
155445471|NCT02795988|561055920|FG006|Phase 2|Other|0|||
155445472|NCT02795988|561055914|FG000|Phase 2 Extension|Death|0|||
155445473|NCT02795988|561055915|FG001|Phase 2 Extension|Death|0|||
155445474|NCT02795988|561055916|FG002|Phase 2 Extension|Death|0|||
155445475|NCT02795988|561055917|FG003|Phase 2 Extension|Death|0|||
155445476|NCT02795988|561055918|FG004|Phase 2 Extension|Death|0|||
155445477|NCT02795988|561055919|FG005|Phase 2 Extension|Death|5|||
155445478|NCT02795988|561055920|FG006|Phase 2 Extension|Death|6|||
155445479|NCT02795988|561055914|FG000|Phase 2 Extension|Other reasons|0|||
155445480|NCT02795988|561055915|FG001|Phase 2 Extension|Other reasons|0|||
155445481|NCT02795988|561055916|FG002|Phase 2 Extension|Other reasons|0|||
155445482|NCT02795988|561055917|FG003|Phase 2 Extension|Other reasons|0|||
155445483|NCT02795988|561055918|FG004|Phase 2 Extension|Other reasons|0|||
155445484|NCT02795988|561055919|FG005|Phase 2 Extension|Other reasons|2|||
155445485|NCT02795988|561055920|FG006|Phase 2 Extension|Other reasons|1|||
155445486|NCT02341014|561055921|FG000|Overall Study|Adverse Event|0|||
155445487|NCT02341014|561055922|FG001|Overall Study|Adverse Event|1|||
155445488|NCT02341014|561055923|FG002|Overall Study|Adverse Event|0|||
155445489|NCT02341014|561055924|FG003|Overall Study|Adverse Event|0|||
155445490|NCT02341014|561055925|FG004|Overall Study|Adverse Event|2|||
155445491|NCT00726323|561055926|FG000|Overall Study|Withdrawal by Subject|3|||
155445492|NCT00726323|561055927|FG001|Overall Study|Withdrawal by Subject|1|||
155445493|NCT00726323|561055926|FG000|Overall Study|Physician Decision|1|||
155445494|NCT00726323|561055927|FG001|Overall Study|Physician Decision|0|||
155445495|NCT00726323|561055926|FG000|Overall Study|Progressive disease|23|||
155445496|NCT00726323|561055927|FG001|Overall Study|Progressive disease|16|||
155445497|NCT00726323|561055926|FG000|Overall Study|Clinical progression|0|||
155445498|NCT00726323|561055927|FG001|Overall Study|Clinical progression|3|||
155445499|NCT00726323|561055926|FG000|Overall Study|Adverse Event|9|||
155445500|NCT00726323|561055927|FG001|Overall Study|Adverse Event|9|||
155445501|NCT00726323|561055926|FG000|Overall Study|Death|1|||
155445502|NCT00726323|561055927|FG001|Overall Study|Death|0|||
155445503|NCT00726323|561055926|FG000|Overall Study|Participant wished to discontinue|0|||
155445504|NCT00726323|561055927|FG001|Overall Study|Participant wished to discontinue|1|||
155445505|NCT00726323|561055926|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
155445506|NCT00726323|561055927|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
155445507|NCT05058664|561055928|FG000|Overall Study|No follow-up data provided|4|||
155445508|NCT05058664|561055929|FG001|Overall Study|No follow-up data provided|0|||
155445509|NCT05058664|561055930|FG002|Overall Study|No follow-up data provided|2|||
155445510|NCT05058664|561055928|FG000|Overall Study|Withdrawal by Subject|0|||
155445511|NCT05058664|561055929|FG001|Overall Study|Withdrawal by Subject|0|||
155445512|NCT05058664|561055930|FG002|Overall Study|Withdrawal by Subject|1|||
155445513|NCT01617681|561055932|FG000|Period 1 Double Blind|Adverse Event|2|||
155445514|NCT01617681|561055933|FG001|Period 1 Double Blind|Adverse Event|0|||
155445515|NCT01617681|561055934|FG002|Period 1 Double Blind|Adverse Event|0|||
155445516|NCT01617681|561055935|FG003|Period 1 Double Blind|Adverse Event|2|||
155445517|NCT01617681|561055936|FG004|Period 1 Double Blind|Adverse Event|0|||
155445518|NCT01617681|561055932|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
155445519|NCT01617681|561055933|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
155445520|NCT01617681|561055934|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
155445521|NCT01617681|561055935|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
155445522|NCT01617681|561055936|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
155445523|NCT01617681|561055932|FG000|Period 2 Open Label|Adverse Event|0|||
155445524|NCT01617681|561055933|FG001|Period 2 Open Label|Adverse Event|0|||
155445525|NCT01617681|561055934|FG002|Period 2 Open Label|Adverse Event|0|||
155445526|NCT01617681|561055935|FG003|Period 2 Open Label|Adverse Event|0|||
155445527|NCT01617681|561055936|FG004|Period 2 Open Label|Adverse Event|3|||
155445528|NCT01617681|561055932|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
155445529|NCT01617681|561055933|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
155445530|NCT01617681|561055934|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
155445531|NCT01617681|561055935|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
155445532|NCT01617681|561055936|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
155445533|NCT00316303|561055941|FG000|Overall Study|Lost to Follow-up|11|||
155445534|NCT00316303|561055942|FG001|Overall Study|Lost to Follow-up|16|||
155445535|NCT03838367|561055943|FG000|Overall Study|Early termination of study|3|||
155445536|NCT03838367|561055944|FG001|Overall Study|Early termination of study|4|||
155445537|NCT03838367|561055945|FG002|Overall Study|Early termination of study|3|||
155445538|NCT03838367|561055946|FG003|Overall Study|Early termination of study|0|||
155445539|NCT03015610|561055947|FG000|Overall Study|Lost to Follow-up|1|||
155445540|NCT03015610|561055948|FG001|Overall Study|Lost to Follow-up|5|||
155445541|NCT02375698|561055952|FG000|Overall Study|Withdrawal by Subject|0|||
155445542|NCT02375698|561055953|FG001|Overall Study|Withdrawal by Subject|2|||
155445543|NCT02375698|561055952|FG000|Overall Study|Physician Decision|2|||
155445544|NCT02375698|561055953|FG001|Overall Study|Physician Decision|0|||
155445545|NCT01632878|561055954|FG000|Screening|Physician Decision|268|||
155445546|NCT01632878|561055954|FG000|Treatment|Lost to Follow-up|41|||
155445547|NCT01632878|561055954|FG000|Treatment|Withdrawal by Subject|36|||
155445548|NCT01632878|561055954|FG000|Treatment|Physician Decision|34|||
155445549|NCT01632878|561055954|FG000|Treatment|missing information|4|||
155445550|NCT01632878|561055954|FG000|Treatment|no information on study completion|43|||
155445551|NCT03634072|561055955|FG000|Overall Study|Early termination of overall study|1|||
155445552|NCT03634072|561055956|FG001|Overall Study|Early termination of overall study|0|||
155445553|NCT03184701|561055959|FG000|Overall Study|Death|3|||
155445554|NCT03184701|561055959|FG000|Overall Study|Physician Decision|3|||
155445555|NCT03184701|561055959|FG000|Overall Study|Withdrawal by Subject|6|||
155445556|NCT03184701|561055959|FG000|Overall Study|Lost to Follow-up|5|||
155445557|NCT01259297|561055960|FG000|Double Blind Randomized Period|Death|1|||
155445558|NCT01259297|561055961|FG001|Double Blind Randomized Period|Death|1|||
155445559|NCT01259297|561055962|FG002|Double Blind Randomized Period|Death|1|||
155445560|NCT01259297|561055963|FG003|Double Blind Randomized Period|Death|2|||
155445561|NCT01259297|561055964|FG004|Double Blind Randomized Period|Death|1|||
155445562|NCT01259297|561055965|FG005|Double Blind Randomized Period|Death|5|||
155445563|NCT01259297|561055966|FG006|Double Blind Randomized Period|Death|2|||
155445564|NCT01259297|561055967|FG007|Double Blind Randomized Period|Death|1|||
155445565|NCT01259297|561055960|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
155445566|NCT01259297|561055961|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
155445567|NCT01259297|561055962|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
155445568|NCT01259297|561055963|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
155445569|NCT01259297|561055964|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
155445570|NCT01259297|561055965|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
155445571|NCT01259297|561055966|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
155445572|NCT01259297|561055967|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
155445573|NCT01259297|561055960|FG000|Double Blind Randomized Period|Other reasons|0|||
155445574|NCT01259297|561055961|FG001|Double Blind Randomized Period|Other reasons|1|||
155445575|NCT01259297|561055962|FG002|Double Blind Randomized Period|Other reasons|0|||
155445576|NCT01259297|561055963|FG003|Double Blind Randomized Period|Other reasons|0|||
155445577|NCT01259297|561055964|FG004|Double Blind Randomized Period|Other reasons|1|||
155445578|NCT01259297|561055965|FG005|Double Blind Randomized Period|Other reasons|2|||
155445579|NCT01259297|561055966|FG006|Double Blind Randomized Period|Other reasons|3|||
155445580|NCT01259297|561055967|FG007|Double Blind Randomized Period|Other reasons|1|||
155445581|NCT00504166|561055971|FG000|Overall Study|Adverse Event|1|||
155445582|NCT00504166|561055972|FG001|Overall Study|Adverse Event|4|||
155445583|NCT00504166|561055971|FG000|Overall Study|Withdrawal by Subject|3|||
155651432|NCT03574389|561816221|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
155445584|NCT00504166|561055972|FG001|Overall Study|Withdrawal by Subject|6|||
155445585|NCT00504166|561055971|FG000|Overall Study|Physician Decision|1|||
155445586|NCT00504166|561055972|FG001|Overall Study|Physician Decision|1|||
155445587|NCT00504166|561055971|FG000|Overall Study|Lost to Follow-up|1|||
155445588|NCT00504166|561055972|FG001|Overall Study|Lost to Follow-up|3|||
155445589|NCT01096550|561055973|FG000|Overall Study|discontinued site|10|||
155445590|NCT01096550|561055974|FG001|Overall Study|discontinued site|11|||
155445591|NCT01096550|561055973|FG000|Overall Study|non-regular treatment track at clinic|1|||
155445592|NCT01096550|561055974|FG001|Overall Study|non-regular treatment track at clinic|1|||
155445593|NCT01096550|561055973|FG000|Overall Study|clinic readmission|1|||
155445594|NCT01096550|561055974|FG001|Overall Study|clinic readmission|1|||
155445595|NCT01096550|561055973|FG000|Overall Study|Withdrawal by Subject|0|||
155445596|NCT01096550|561055974|FG001|Overall Study|Withdrawal by Subject|1|||
155445597|NCT01096550|561055973|FG000|Overall Study|non-African American participant|13|||
155445598|NCT01096550|561055974|FG001|Overall Study|non-African American participant|6|||
155445599|NCT01096550|561055973|FG000|Overall Study|Lost to Follow-up|12|||
155445600|NCT01096550|561055974|FG001|Overall Study|Lost to Follow-up|9|||
155445601|NCT01555463|561055975|FG000|Treatment|Adverse Event|6|||
155445602|NCT01555463|561055976|FG001|Treatment|Adverse Event|12|||
155445603|NCT01555463|561055975|FG000|Treatment|Withdrawal by Subject|24|||
155445604|NCT01555463|561055976|FG001|Treatment|Withdrawal by Subject|36|||
155445605|NCT01555463|561055975|FG000|Treatment|Lost to Follow-up|28|||
155445606|NCT01555463|561055976|FG001|Treatment|Lost to Follow-up|23|||
155445607|NCT01555463|561055975|FG000|Treatment|Protocol Violation|4|||
155445608|NCT01555463|561055976|FG001|Treatment|Protocol Violation|5|||
155445609|NCT01555463|561055975|FG000|Treatment|Other reason|2|||
155445610|NCT01555463|561055976|FG001|Treatment|Other reason|3|||
155445611|NCT01555463|561055975|FG000|Follow up|Adverse Event|2|||
155445612|NCT01555463|561055976|FG001|Follow up|Adverse Event|5|||
155445613|NCT01555463|561055975|FG000|Follow up|Death|0|||
155445614|NCT01555463|561055976|FG001|Follow up|Death|1|||
155445615|NCT01555463|561055975|FG000|Follow up|Withdrawal by Subject|22|||
155445616|NCT01555463|561055976|FG001|Follow up|Withdrawal by Subject|22|||
155445617|NCT01555463|561055975|FG000|Follow up|Lost to Follow-up|9|||
155445618|NCT01555463|561055976|FG001|Follow up|Lost to Follow-up|10|||
155445619|NCT01555463|561055975|FG000|Follow up|Protocol Violation|2|||
155445620|NCT01555463|561055976|FG001|Follow up|Protocol Violation|4|||
155445621|NCT01555463|561055975|FG000|Follow up|Other reason|3|||
155445622|NCT01555463|561055976|FG001|Follow up|Other reason|3|||
155445623|NCT01165203|561055977|FG000|Active Phase|Serious Adverse Event|1|||
155445624|NCT01165203|561055978|FG001|Active Phase|Serious Adverse Event|0|||
155445625|NCT01165203|561055977|FG000|Active Phase|Withdrawal by Subject|2|||
155445626|NCT01165203|561055978|FG001|Active Phase|Withdrawal by Subject|1|||
155445627|NCT01165203|561055977|FG000|Active Phase|Migrated/moved from study area|0|||
155445628|NCT01165203|561055978|FG001|Active Phase|Migrated/moved from study area|1|||
155445629|NCT01165203|561055977|FG000|Active Phase|Lost to Follow-up|2|||
155445630|NCT01165203|561055978|FG001|Active Phase|Lost to Follow-up|0|||
155445631|NCT01165203|561055977|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
155445632|NCT01165203|561055978|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
155445633|NCT01165203|561055977|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
155445634|NCT01165203|561055978|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
155445635|NCT01165203|561055977|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
155445636|NCT01165203|561055978|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
155445637|NCT01165203|561055977|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
155445638|NCT01165203|561055978|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
155445639|NCT01165203|561055977|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
155445640|NCT01165203|561055978|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
155445641|NCT02815397|561055982|FG000|Overall Study|Physician Decision|2|||
155445642|NCT00085540|561055983|FG000|Overall Study|Withdrawal by Subject|0|||
155445643|NCT00085540|561055984|FG001|Overall Study|Withdrawal by Subject|1|||
155445644|NCT00085540|561055983|FG000|Overall Study|Protocol Violation|0|||
155445645|NCT00085540|561055984|FG001|Overall Study|Protocol Violation|1|||
155445646|NCT01605396|561055987|FG000|Overall Study|Adverse Event|5|||
155445647|NCT01605396|561055988|FG001|Overall Study|Adverse Event|3|||
155445648|NCT01605396|561055987|FG000|Overall Study|Lost to Follow-up|1|||
155445649|NCT01605396|561055988|FG001|Overall Study|Lost to Follow-up|0|||
155445650|NCT01605396|561055987|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155445651|NCT01605396|561055988|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155445652|NCT01605396|561055987|FG000|Overall Study|Physician Decision|2|||
155445653|NCT01605396|561055988|FG001|Overall Study|Physician Decision|2|||
155445654|NCT01605396|561055987|FG000|Overall Study|Progressive Disease|23|||
155445655|NCT01605396|561055988|FG001|Overall Study|Progressive Disease|27|||
155445656|NCT01605396|561055987|FG000|Overall Study|Withdrawal by Subject|4|||
155445657|NCT01605396|561055988|FG001|Overall Study|Withdrawal by Subject|2|||
155445658|NCT01605396|561055987|FG000|Overall Study|Transfer Off Study|4|||
155445659|NCT01605396|561055988|FG001|Overall Study|Transfer Off Study|5|||
155445660|NCT04598165|561055989|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
155445661|NCT04598165|561055990|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
155445662|NCT04598165|561055989|FG000|Completed 6-week Follow-up|Death|2|||
155445663|NCT04598165|561055990|FG001|Completed 6-week Follow-up|Death|1|||
155445664|NCT04598165|561055989|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
155445665|NCT04598165|561055990|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
155445666|NCT04598165|561055989|FG000|Completed 6-week Follow-up|Ineligible|4|||
155445667|NCT04598165|561055990|FG001|Completed 6-week Follow-up|Ineligible|3|||
155445668|NCT04598165|561055989|FG000|Completed 6-week Follow-up|Partner refusal|0|||
155445669|NCT04598165|561055990|FG001|Completed 6-week Follow-up|Partner refusal|1|||
155445670|NCT04598165|561055989|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
155445671|NCT04598165|561055990|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
155445672|NCT00426751|561055993|FG000|Overall Study|Adverse Event|8|||
155445673|NCT00426751|561055994|FG001|Overall Study|Adverse Event|1|||
155445674|NCT00426751|561055993|FG000|Overall Study|Lost to Follow-up|7|||
155445675|NCT00426751|561055994|FG001|Overall Study|Lost to Follow-up|6|||
155445676|NCT00426751|561055993|FG000|Overall Study|Consent Withdrawn|0|||
155445677|NCT00426751|561055994|FG001|Overall Study|Consent Withdrawn|1|||
155445678|NCT00426751|561055993|FG000|Overall Study|Other Reasons|7|||
155445679|NCT00426751|561055994|FG001|Overall Study|Other Reasons|12|||
155445680|NCT04238663|561055995|FG000|Overall Study|Lost to Follow-up|0|||
155445681|NCT04238663|561055996|FG001|Overall Study|Lost to Follow-up|1|||
155445682|NCT04238663|561055997|FG002|Overall Study|Lost to Follow-up|0|||
155445683|NCT00337467|561055998|FG000|Overall Study|Adverse Event|3|||
155445684|NCT00337467|561055998|FG000|Overall Study|Subject Withdrew Consent|2|||
155445685|NCT00337467|561055998|FG000|Overall Study|Pregnancy|1|||
155445686|NCT00337467|561055998|FG000|Overall Study|Lost to Follow-up|2|||
155445687|NCT00337467|561055998|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
155445688|NCT04430582|561056002|FG000|Overall Study|Found to meet exclusionary criteria|1|||
155445689|NCT04430582|561056003|FG001|Overall Study|Found to meet exclusionary criteria|0|||
155445690|NCT04430582|561056002|FG000|Overall Study|Withdrawal by Subject|0|||
155445691|NCT04430582|561056003|FG001|Overall Study|Withdrawal by Subject|1|||
155445692|NCT03607682|561056004|FG000|Overall Study|Withdrawal by Subject|1|||
155445693|NCT03607682|561056004|FG000|Overall Study|Disease progression|1|||
155445694|NCT01770353|561056005|FG000|Overall Study|Progressive disease|2|||
155445695|NCT01770353|561056006|FG001|Overall Study|Progressive disease|1|||
155445696|NCT01770353|561056005|FG000|Overall Study|Adverse Event|0|||
155445697|NCT01770353|561056006|FG001|Overall Study|Adverse Event|1|||
155445698|NCT01770353|561056005|FG000|Overall Study|Protocol Violation|1|||
155445699|NCT01770353|561056006|FG001|Overall Study|Protocol Violation|0|||
155445700|NCT01770353|561056005|FG000|Overall Study|Physician Decision|0|||
155445701|NCT01770353|561056006|FG001|Overall Study|Physician Decision|3|||
155445702|NCT01770353|561056005|FG000|Overall Study|Clinical deterioration|3|||
155445703|NCT01770353|561056006|FG001|Overall Study|Clinical deterioration|6|||
155445704|NCT01770353|561056005|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
155445705|NCT01770353|561056006|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
155445706|NCT00620321|561057671|FG000|Overall Study|Adverse Event|1|||
155445707|NCT00620321|561057672|FG001|Overall Study|Adverse Event|1|||
155445708|NCT00620321|561057671|FG000|Overall Study|Death|1|||
155445709|NCT00620321|561057672|FG001|Overall Study|Death|1|||
155445710|NCT00620321|561057671|FG000|Overall Study|Physician Decision|0|||
155445711|NCT00620321|561057672|FG001|Overall Study|Physician Decision|7|||
155445712|NCT00620321|561057671|FG000|Overall Study|Progressive Disease|5|||
155445713|NCT00620321|561057672|FG001|Overall Study|Progressive Disease|5|||
155445714|NCT00620321|561057671|FG000|Overall Study|Sponsor Decision|0|||
155445715|NCT00620321|561057672|FG001|Overall Study|Sponsor Decision|1|||
155445716|NCT00620321|561057671|FG000|Overall Study|Withdrawal by Subject|1|||
155445717|NCT00620321|561057672|FG001|Overall Study|Withdrawal by Subject|1|||
155445718|NCT02410902|561057676|FG000|Overall Study|Adverse Event|2|||
155445719|NCT02410902|561057677|FG001|Overall Study|Adverse Event|3|||
155445720|NCT02410902|561057676|FG000|Overall Study|Lost to Follow-up|4|||
155445721|NCT02410902|561057677|FG001|Overall Study|Lost to Follow-up|1|||
155445722|NCT02410902|561057676|FG000|Overall Study|Protocol Violation|1|||
155445723|NCT02410902|561057677|FG001|Overall Study|Protocol Violation|4|||
155445724|NCT02410902|561057676|FG000|Overall Study|Withdrawal by Subject|6|||
155445725|NCT02410902|561057677|FG001|Overall Study|Withdrawal by Subject|8|||
155445726|NCT02410902|561057676|FG000|Overall Study|Non-Compliance|8|||
155445727|NCT02410902|561057677|FG001|Overall Study|Non-Compliance|2|||
155445728|NCT02279524|561057678|FG000|Overall Study|Withdrawal by Subject|3|||
155445729|NCT02279524|561057679|FG001|Overall Study|Withdrawal by Subject|6|||
155445730|NCT02279524|561057680|FG002|Overall Study|Withdrawal by Subject|3|||
155445731|NCT02279524|561057678|FG000|Overall Study|Adverse Event|4|||
155445732|NCT02279524|561057679|FG001|Overall Study|Adverse Event|3|||
155445733|NCT02279524|561057680|FG002|Overall Study|Adverse Event|2|||
155445734|NCT02279524|561057678|FG000|Overall Study|Lost to Follow-up|1|||
155445735|NCT02279524|561057679|FG001|Overall Study|Lost to Follow-up|1|||
155445736|NCT02279524|561057680|FG002|Overall Study|Lost to Follow-up|0|||
155445737|NCT02279524|561057678|FG000|Overall Study|Disallowed medication|1|||
155445738|NCT02279524|561057679|FG001|Overall Study|Disallowed medication|1|||
155445739|NCT02279524|561057680|FG002|Overall Study|Disallowed medication|2|||
155445740|NCT02279524|561057678|FG000|Overall Study|Bariatric surgery|1|||
155445741|NCT02279524|561057679|FG001|Overall Study|Bariatric surgery|0|||
155445742|NCT02279524|561057680|FG002|Overall Study|Bariatric surgery|0|||
155445743|NCT01746732|561057681|FG000|Lead-In Period|Withdrawal by Subject|1|||
155445744|NCT01746732|561057682|FG001|Lead-In Period|Withdrawal by Subject|0|||
155445745|NCT01746732|561057683|FG002|Lead-In Period|Withdrawal by Subject|0|||
155445746|NCT01746732|561057681|FG000|Period 1|Physician Decision|0|||
155445747|NCT01746732|561057682|FG001|Period 1|Physician Decision|1|||
155445748|NCT01746732|561057683|FG002|Period 1|Physician Decision|0|||
155445749|NCT01746732|561057681|FG000|Period 2|Withdrawal by Subject|0|||
155445750|NCT01746732|561057682|FG001|Period 2|Withdrawal by Subject|0|||
155445751|NCT01746732|561057683|FG002|Period 2|Withdrawal by Subject|2|||
155445752|NCT01746732|561057681|FG000|Period 2|Adverse Event|0|||
155445753|NCT01746732|561057682|FG001|Period 2|Adverse Event|0|||
155445754|NCT01746732|561057683|FG002|Period 2|Adverse Event|1|||
155445755|NCT01746732|561057681|FG000|Period 2|Lost to Follow-up|0|||
155445756|NCT01746732|561057682|FG001|Period 2|Lost to Follow-up|0|||
155445757|NCT01746732|561057683|FG002|Period 2|Lost to Follow-up|1|||
155445758|NCT02817555|561057684|FG000|Overall Study|Death|1|||
155445759|NCT02817555|561057685|FG001|Overall Study|Death|3|||
155445760|NCT02817555|561057684|FG000|Overall Study|moved away|1|||
155445761|NCT02817555|561057685|FG001|Overall Study|moved away|0|||
155445762|NCT02817555|561057684|FG000|Overall Study|transplant|1|||
155445763|NCT02817555|561057685|FG001|Overall Study|transplant|1|||
155445764|NCT02817555|561057684|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
155445765|NCT02817555|561057685|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
155445766|NCT00137436|561057686|FG000|Overall Study|Adverse Event|13|||
155445767|NCT00137436|561057686|FG000|Overall Study|Death|2|||
155445768|NCT00137436|561057686|FG000|Overall Study|Lack of Efficacy|17|||
155445769|NCT00137436|561057686|FG000|Overall Study|Withdrawal by Subject|6|||
155445770|NCT00137436|561057686|FG000|Overall Study|Other|5|||
155445771|NCT00701727|561057687|FG000|First Treatment Period|Adverse Event|0|||
155445772|NCT00701727|561057688|FG001|First Treatment Period|Adverse Event|0|||
155445773|NCT00701727|561057687|FG000|First Treatment Period|Withdrawal by Subject|1|||
155445774|NCT00701727|561057688|FG001|First Treatment Period|Withdrawal by Subject|0|||
155445775|NCT00701727|561057687|FG000|First Treatment Period|sponsor decision|0|||
155445776|NCT00701727|561057688|FG001|First Treatment Period|sponsor decision|1|||
155445777|NCT00701727|561057687|FG000|First Treatment Period|Lost to Follow-up|0|||
155445778|NCT00701727|561057688|FG001|First Treatment Period|Lost to Follow-up|1|||
155445779|NCT00701727|561057687|FG000|Second Treatment Period|Withdrawal by Subject|2|||
155445780|NCT00701727|561057688|FG001|Second Treatment Period|Withdrawal by Subject|0|||
155445781|NCT00912015|561057689|FG000|Overall Study|Lack of Efficacy|1|||
155445782|NCT00912015|561057690|FG001|Overall Study|Lack of Efficacy|0|||
155445783|NCT00912015|561057691|FG002|Overall Study|Lack of Efficacy|0|||
155445784|NCT00912015|561057692|FG003|Overall Study|Lack of Efficacy|0|||
155445785|NCT00912015|561057689|FG000|Overall Study|Withdrawal by Subject|8|||
155445786|NCT00912015|561057690|FG001|Overall Study|Withdrawal by Subject|8|||
155445787|NCT00912015|561057691|FG002|Overall Study|Withdrawal by Subject|3|||
155445788|NCT00912015|561057692|FG003|Overall Study|Withdrawal by Subject|0|||
155445789|NCT00912015|561057689|FG000|Overall Study|Protocol Violation|1|||
155445790|NCT00912015|561057690|FG001|Overall Study|Protocol Violation|0|||
155445791|NCT00912015|561057691|FG002|Overall Study|Protocol Violation|0|||
155445792|NCT00912015|561057692|FG003|Overall Study|Protocol Violation|1|||
155445793|NCT00912015|561057689|FG000|Overall Study|Adverse Event|6|||
155445794|NCT00912015|561057690|FG001|Overall Study|Adverse Event|0|||
155445795|NCT00912015|561057691|FG002|Overall Study|Adverse Event|0|||
155445796|NCT00912015|561057692|FG003|Overall Study|Adverse Event|1|||
155445797|NCT05137041|561057695|FG000|Overall Study|Lost to Follow-up|1|||
155445798|NCT05137041|561057696|FG001|Overall Study|Lost to Follow-up|1|||
155445799|NCT05137041|561057695|FG000|Overall Study|Withdrawal by Subject|0|||
155445800|NCT05137041|561057696|FG001|Overall Study|Withdrawal by Subject|2|||
155445801|NCT05137041|561057695|FG000|Overall Study|Reason not Specified|0|||
155445802|NCT05137041|561057696|FG001|Overall Study|Reason not Specified|1|||
155445803|NCT02090114|561057697|FG000|Overall Study|Withdrawal by Subject|3|||
155445804|NCT02090114|561057698|FG001|Overall Study|Withdrawal by Subject|6|||
155445805|NCT02090114|561057699|FG002|Overall Study|Withdrawal by Subject|2|||
155445806|NCT02090114|561057700|FG003|Overall Study|Withdrawal by Subject|1|||
155445807|NCT02090114|561057697|FG000|Overall Study|Physician Decision|5|||
155445808|NCT02090114|561057698|FG001|Overall Study|Physician Decision|0|||
155445809|NCT02090114|561057699|FG002|Overall Study|Physician Decision|1|||
155445810|NCT02090114|561057700|FG003|Overall Study|Physician Decision|1|||
155445811|NCT02090114|561057697|FG000|Overall Study|Adverse Event|1|||
155445812|NCT02090114|561057698|FG001|Overall Study|Adverse Event|2|||
155445813|NCT02090114|561057699|FG002|Overall Study|Adverse Event|2|||
155445814|NCT02090114|561057700|FG003|Overall Study|Adverse Event|0|||
155445815|NCT02090114|561057697|FG000|Overall Study|Progressive Disease|20|||
155445816|NCT02090114|561057698|FG001|Overall Study|Progressive Disease|21|||
155445817|NCT02090114|561057699|FG002|Overall Study|Progressive Disease|23|||
155445818|NCT02090114|561057700|FG003|Overall Study|Progressive Disease|6|||
155445819|NCT02090114|561057697|FG000|Overall Study|Death|1|||
155445820|NCT02090114|561057698|FG001|Overall Study|Death|0|||
155445821|NCT02090114|561057699|FG002|Overall Study|Death|1|||
155445822|NCT02090114|561057700|FG003|Overall Study|Death|0|||
155445823|NCT00392171|561057701|FG000|Overall Study|Did not meet inclusion criteria|4|||
155445824|NCT00392171|561057701|FG000|Overall Study|Disease progression|101|||
155445825|NCT01605071|561057702|FG000|Overall Study|Withdrawal by Subject|3|||
155445826|NCT01605071|561057703|FG001|Overall Study|Withdrawal by Subject|2|||
155445827|NCT00051558|561057707|FG000|Overall Study|Adverse Event|30|||
155445828|NCT00051558|561057708|FG001|Overall Study|Adverse Event|18|||
155445829|NCT00051558|561057707|FG000|Overall Study|Withdrawal by Subject|29|||
155445830|NCT00051558|561057708|FG001|Overall Study|Withdrawal by Subject|42|||
155445831|NCT00051558|561057707|FG000|Overall Study|Death|9|||
155445832|NCT00051558|561057708|FG001|Overall Study|Death|15|||
155445833|NCT00051558|561057707|FG000|Overall Study|Lost to Follow-up|4|||
155445834|NCT00051558|561057708|FG001|Overall Study|Lost to Follow-up|13|||
155445835|NCT00051558|561057707|FG000|Overall Study|Protocol Violation|3|||
155445836|NCT00051558|561057708|FG001|Overall Study|Protocol Violation|4|||
155445837|NCT00051558|561057707|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
155445838|NCT00051558|561057708|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
155445839|NCT00051558|561057707|FG000|Overall Study|Sponsor Decision|6|||
155445840|NCT00051558|561057708|FG001|Overall Study|Sponsor Decision|1|||
155445841|NCT00051558|561057707|FG000|Overall Study|Other|2|||
155445842|NCT00051558|561057708|FG001|Overall Study|Other|1|||
155445843|NCT00051558|561057707|FG000|Overall Study|Significant Lab Value|2|||
155445844|NCT00051558|561057708|FG001|Overall Study|Significant Lab Value|0|||
155445845|NCT00051558|561057707|FG000|Overall Study|Physician Decision|5|||
155445846|NCT00051558|561057708|FG001|Overall Study|Physician Decision|0|||
155445847|NCT01881620|561057710|FG000|Overall Study|Protocol Violation|4|||
155445848|NCT02163993|561057711|FG000|Treatment Period|Adverse Event|0|||
155445849|NCT02163993|561057712|FG001|Treatment Period|Adverse Event|1|||
155445850|NCT02163993|561057713|FG002|Treatment Period|Adverse Event|0|||
155445851|NCT02163993|561057714|FG003|Treatment Period|Adverse Event|0|||
155445852|NCT02163993|561057715|FG004|Treatment Period|Adverse Event|1|||
155445853|NCT02163993|561057711|FG000|Treatment Period|Lost to Follow-up|2|||
155445854|NCT02163993|561057712|FG001|Treatment Period|Lost to Follow-up|3|||
155445855|NCT02163993|561057713|FG002|Treatment Period|Lost to Follow-up|1|||
155445856|NCT02163993|561057714|FG003|Treatment Period|Lost to Follow-up|3|||
155445857|NCT02163993|561057715|FG004|Treatment Period|Lost to Follow-up|1|||
155445858|NCT02163993|561057711|FG000|Treatment Period|Physician Decision|1|||
155445859|NCT02163993|561057712|FG001|Treatment Period|Physician Decision|0|||
155445860|NCT02163993|561057713|FG002|Treatment Period|Physician Decision|0|||
155445861|NCT02163993|561057714|FG003|Treatment Period|Physician Decision|0|||
155445862|NCT02163993|561057715|FG004|Treatment Period|Physician Decision|0|||
155445863|NCT02163993|561057711|FG000|Treatment Period|Protocol Violation|2|||
155445864|NCT02163993|561057712|FG001|Treatment Period|Protocol Violation|1|||
155445865|NCT02163993|561057713|FG002|Treatment Period|Protocol Violation|0|||
155445866|NCT02163993|561057714|FG003|Treatment Period|Protocol Violation|1|||
155445867|NCT02163993|561057715|FG004|Treatment Period|Protocol Violation|2|||
155445868|NCT02163993|561057711|FG000|Treatment Period|Withdrawal by Subject|6|||
155445869|NCT02163993|561057712|FG001|Treatment Period|Withdrawal by Subject|4|||
155445870|NCT02163993|561057713|FG002|Treatment Period|Withdrawal by Subject|1|||
155445871|NCT02163993|561057714|FG003|Treatment Period|Withdrawal by Subject|4|||
155445872|NCT02163993|561057715|FG004|Treatment Period|Withdrawal by Subject|1|||
155445873|NCT02163993|561057711|FG000|Treatment Period|Not treated|1|||
155445874|NCT02163993|561057712|FG001|Treatment Period|Not treated|0|||
155445875|NCT02163993|561057713|FG002|Treatment Period|Not treated|0|||
155445876|NCT02163993|561057714|FG003|Treatment Period|Not treated|1|||
155445877|NCT02163993|561057715|FG004|Treatment Period|Not treated|2|||
155445878|NCT02163993|561057711|FG000|Post-treatment Period|Adverse Event|0|||
155445879|NCT02163993|561057712|FG001|Post-treatment Period|Adverse Event|0|||
155445880|NCT02163993|561057713|FG002|Post-treatment Period|Adverse Event|1|||
155445881|NCT02163993|561057714|FG003|Post-treatment Period|Adverse Event|0|||
155445882|NCT02163993|561057715|FG004|Post-treatment Period|Adverse Event|0|||
155445883|NCT02163993|561057711|FG000|Post-treatment Period|Lost to Follow-up|2|||
155445884|NCT02163993|561057712|FG001|Post-treatment Period|Lost to Follow-up|2|||
155445885|NCT02163993|561057713|FG002|Post-treatment Period|Lost to Follow-up|3|||
155445886|NCT02163993|561057714|FG003|Post-treatment Period|Lost to Follow-up|1|||
155445887|NCT02163993|561057715|FG004|Post-treatment Period|Lost to Follow-up|0|||
155445888|NCT02163993|561057711|FG000|Post-treatment Period|Protocol Violation|0|||
155445889|NCT02163993|561057712|FG001|Post-treatment Period|Protocol Violation|0|||
155445890|NCT02163993|561057713|FG002|Post-treatment Period|Protocol Violation|0|||
155445891|NCT02163993|561057714|FG003|Post-treatment Period|Protocol Violation|0|||
155445892|NCT02163993|561057715|FG004|Post-treatment Period|Protocol Violation|1|||
155445893|NCT02163993|561057711|FG000|Post-treatment Period|Withdrawal by Subject|2|||
155445894|NCT02163993|561057712|FG001|Post-treatment Period|Withdrawal by Subject|4|||
155445895|NCT02163993|561057713|FG002|Post-treatment Period|Withdrawal by Subject|0|||
155445896|NCT02163993|561057714|FG003|Post-treatment Period|Withdrawal by Subject|1|||
155445897|NCT02163993|561057715|FG004|Post-treatment Period|Withdrawal by Subject|2|||
155445898|NCT00414310|561057716|FG000|Overall Study|Not treated|1|||
155445899|NCT00414310|561057717|FG001|Overall Study|Not treated|0|||
155445900|NCT01808118|561057718|FG000|Period 1|Adverse Event|15|||
155445901|NCT01808118|561057719|FG001|Period 1|Adverse Event|0|||
155445902|NCT01808118|561057720|FG002|Period 1|Adverse Event|0|||
155445903|NCT01808118|561057718|FG000|Period 1|Withdrew consent|24|||
155445904|NCT01808118|561057719|FG001|Period 1|Withdrew consent|0|||
155445905|NCT01808118|561057720|FG002|Period 1|Withdrew consent|0|||
155445906|NCT01808118|561057718|FG000|Period 1|Lost to Follow-up|9|||
155445907|NCT01808118|561057719|FG001|Period 1|Lost to Follow-up|0|||
155445908|NCT01808118|561057720|FG002|Period 1|Lost to Follow-up|0|||
155445909|NCT01808118|561057718|FG000|Period 1|Did not meet criteria for remission|303|||
155445910|NCT01808118|561057719|FG001|Period 1|Did not meet criteria for remission|0|||
155445911|NCT01808118|561057720|FG002|Period 1|Did not meet criteria for remission|0|||
155445912|NCT01808118|561057718|FG000|Period 1|Enrolled in error|7|||
155445913|NCT01808118|561057719|FG001|Period 1|Enrolled in error|0|||
155651433|NCT02094885|561816225|FG000|Overall Study|Death|1|||
155651434|NCT02094885|561816226|FG001|Overall Study|Death|5|||
155651435|NCT02094885|561816225|FG000|Overall Study|Withdrawn due to age|1|||
155651436|NCT02094885|561816226|FG001|Overall Study|Withdrawn due to age|0|||
155445914|NCT01808118|561057720|FG002|Period 1|Enrolled in error|0|||
155445915|NCT01808118|561057718|FG000|Period 1|Did not meet inclusion criteria|3|||
155651437|NCT02003898|561816227|FG000|Overall Study|Death|3|||
155651438|NCT02003898|561816227|FG000|Overall Study|Lost to Follow-up|12|||
155651439|NCT02003898|561816227|FG000|Overall Study|Withdrawal by Subject|52|||
155651440|NCT05166902|561816228|FG000|First Intervention|Lost to Follow-up|0|||
155651441|NCT05166902|561816229|FG001|First Intervention|Lost to Follow-up|1|||
155651442|NCT03436420|561816230|FG000|Overall Study|Lack of Efficacy|3|||
155651443|NCT01903720|561816231|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
155651444|NCT01903720|561816231|FG000|Overall Study|Adverse Event|1|||
155651445|NCT01903720|561816231|FG000|Overall Study|Rescinding of informed consent|2|||
155651446|NCT01903720|561816231|FG000|Overall Study|Lost to Follow-up|2|||
155651447|NCT01903720|561816231|FG000|Overall Study|Treatment with alternative drug|1|||
155651448|NCT00159874|561816232|FG000|Overall Study|Adverse Event|2|||
155651449|NCT00159874|561816233|FG001|Overall Study|Adverse Event|2|||
155651450|NCT00159874|561816234|FG002|Overall Study|Adverse Event|5|||
155445916|NCT01808118|561057719|FG001|Period 1|Did not meet inclusion criteria|0|||
155445917|NCT01808118|561057720|FG002|Period 1|Did not meet inclusion criteria|0|||
155445918|NCT01808118|561057718|FG000|Period 1|Non-conformance with inclusion criteria|3|||
155445919|NCT01808118|561057719|FG001|Period 1|Non-conformance with inclusion criteria|0|||
155445920|NCT01808118|561057720|FG002|Period 1|Non-conformance with inclusion criteria|0|||
155445921|NCT01808118|561057718|FG000|Period 1|Investigator decision: site closure|2|||
155445922|NCT01808118|561057719|FG001|Period 1|Investigator decision: site closure|0|||
155651451|NCT00159874|561816235|FG003|Overall Study|Adverse Event|1|||
155651452|NCT00159874|561816236|FG004|Overall Study|Adverse Event|1|||
155651453|NCT00159874|561816237|FG005|Overall Study|Adverse Event|2|||
155651454|NCT00159874|561816238|FG006|Overall Study|Adverse Event|0|||
155651455|NCT00159874|561816232|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
155445923|NCT01808118|561057720|FG002|Period 1|Investigator decision: site closure|0|||
155445924|NCT01808118|561057718|FG000|Period 1|Non-compliance per sponsor|1|||
155445925|NCT01808118|561057719|FG001|Period 1|Non-compliance per sponsor|0|||
155445926|NCT01808118|561057720|FG002|Period 1|Non-compliance per sponsor|0|||
155445927|NCT01808118|561057718|FG000|Period 1|Lack of Efficacy|1|||
155445928|NCT01808118|561057719|FG001|Period 1|Lack of Efficacy|0|||
155445929|NCT01808118|561057720|FG002|Period 1|Lack of Efficacy|0|||
155445930|NCT01808118|561057718|FG000|Period 2|Adverse Event|0|||
155445931|NCT01808118|561057719|FG001|Period 2|Adverse Event|4|||
155445932|NCT01808118|561057720|FG002|Period 2|Adverse Event|0|||
155651456|NCT00159874|561816233|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
155651457|NCT00159874|561816234|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
155515258|NCT02365597|561311562|FG001|Overall Study|Withdrawal by Subject|8|||
155651458|NCT00159874|561816235|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
155445933|NCT01808118|561057718|FG000|Period 2|Withdrew consent|0|||
155445934|NCT01808118|561057719|FG001|Period 2|Withdrew consent|7|||
155445935|NCT01808118|561057720|FG002|Period 2|Withdrew consent|6|||
155445936|NCT01808118|561057718|FG000|Period 2|Lost to Follow-up|0|||
155445937|NCT01808118|561057719|FG001|Period 2|Lost to Follow-up|0|||
155445938|NCT01808118|561057720|FG002|Period 2|Lost to Follow-up|2|||
155445939|NCT01808118|561057718|FG000|Period 2|Investigator no longer conducting trials|0|||
155445940|NCT01808118|561057719|FG001|Period 2|Investigator no longer conducting trials|1|||
155445941|NCT01808118|561057720|FG002|Period 2|Investigator no longer conducting trials|0|||
155445942|NCT01808118|561057718|FG000|Period 2|Switched to other therapy|0|||
155445943|NCT01808118|561057719|FG001|Period 2|Switched to other therapy|1|||
155445944|NCT01808118|561057720|FG002|Period 2|Switched to other therapy|0|||
155445945|NCT01993329|561057724|FG000|Period 2|Adverse Event|0|||
155445946|NCT01993329|561057725|FG001|Period 2|Adverse Event|0|||
155445947|NCT01993329|561057726|FG002|Period 2|Adverse Event|0|||
155445948|NCT01993329|561057727|FG003|Period 2|Adverse Event|0|||
155445949|NCT01993329|561057728|FG004|Period 2|Adverse Event|0|||
155445950|NCT01993329|561057729|FG005|Period 2|Adverse Event|1|||
155445951|NCT01993329|561057724|FG000|Wash-out|Personal reasons|0|||
155445952|NCT01993329|561057725|FG001|Wash-out|Personal reasons|1|||
155445953|NCT01993329|561057726|FG002|Wash-out|Personal reasons|0|||
155445954|NCT01993329|561057727|FG003|Wash-out|Personal reasons|0|||
155445955|NCT01993329|561057728|FG004|Wash-out|Personal reasons|0|||
155445956|NCT01993329|561057729|FG005|Wash-out|Personal reasons|0|||
155445957|NCT00109733|561057734|FG000|Overall Study|Protocol Violation|0|||
155445958|NCT00109733|561057735|FG001|Overall Study|Protocol Violation|1|||
155445959|NCT00109733|561057734|FG000|Overall Study|Stopped taking study drug|1|||
155445960|NCT00109733|561057735|FG001|Overall Study|Stopped taking study drug|1|||
155445961|NCT00109733|561057734|FG000|Overall Study|Non-compliant|0|||
155445962|NCT00109733|561057735|FG001|Overall Study|Non-compliant|1|||
155445963|NCT00109733|561057734|FG000|Overall Study|Could not commit time for study|1|||
155445964|NCT00109733|561057735|FG001|Overall Study|Could not commit time for study|1|||
155445965|NCT00879814|561057747|FG000|Overall Study|Adverse Event|0|||
155445966|NCT00879814|561057748|FG001|Overall Study|Adverse Event|1|||
155445967|NCT00879814|561057749|FG002|Overall Study|Adverse Event|0|||
155445968|NCT00879814|561057750|FG003|Overall Study|Adverse Event|0|||
155445969|NCT00879814|561057747|FG000|Overall Study|Lost to Follow-up|1|||
155445970|NCT00879814|561057748|FG001|Overall Study|Lost to Follow-up|0|||
155445971|NCT00879814|561057749|FG002|Overall Study|Lost to Follow-up|0|||
155445972|NCT00879814|561057750|FG003|Overall Study|Lost to Follow-up|2|||
155445973|NCT00879814|561057747|FG000|Overall Study|Participant Failed to Return|0|||
155445974|NCT00879814|561057748|FG001|Overall Study|Participant Failed to Return|0|||
155445975|NCT00879814|561057749|FG002|Overall Study|Participant Failed to Return|0|||
155445976|NCT00879814|561057750|FG003|Overall Study|Participant Failed to Return|1|||
155445977|NCT00879814|561057747|FG000|Overall Study|Withdrawal by Subject|3|||
155445978|NCT00879814|561057748|FG001|Overall Study|Withdrawal by Subject|1|||
155445979|NCT00879814|561057749|FG002|Overall Study|Withdrawal by Subject|1|||
155445980|NCT00879814|561057750|FG003|Overall Study|Withdrawal by Subject|2|||
155445981|NCT00879814|561057747|FG000|Overall Study|Physician Decision|0|||
155445982|NCT00879814|561057748|FG001|Overall Study|Physician Decision|0|||
155445983|NCT00879814|561057749|FG002|Overall Study|Physician Decision|1|||
155445984|NCT00879814|561057750|FG003|Overall Study|Physician Decision|0|||
155445985|NCT00879814|561057747|FG000|Overall Study|Other|0|||
155445986|NCT00879814|561057748|FG001|Overall Study|Other|0|||
155651459|NCT00159874|561816236|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
155651460|NCT00159874|561816237|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
155651461|NCT00159874|561816238|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
155445987|NCT00879814|561057749|FG002|Overall Study|Other|1|||
155445988|NCT00879814|561057750|FG003|Overall Study|Other|0|||
155445989|NCT00630812|561057751|FG000|Randomisation to First Dose|Adverse Event|1|||
155445990|NCT00630812|561057752|FG001|Randomisation to First Dose|Adverse Event|1|||
155445991|NCT00630812|561057751|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
155445992|NCT00630812|561057752|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
155445993|NCT00630812|561057751|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
155445994|NCT00630812|561057752|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
155445995|NCT00630812|561057751|FG000|Randomisation to First Dose|Protocol Violation|4|||
155445996|NCT00630812|561057752|FG001|Randomisation to First Dose|Protocol Violation|1|||
155445997|NCT00630812|561057751|FG000|Double Blind Treatment Period|Adverse Event|13|||
155445998|NCT00630812|561057752|FG001|Double Blind Treatment Period|Adverse Event|5|||
155445999|NCT00630812|561057751|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
155446000|NCT00630812|561057752|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155446001|NCT00630812|561057751|FG000|Double Blind Treatment Period|Physician Decision|2|||
155446002|NCT00630812|561057752|FG001|Double Blind Treatment Period|Physician Decision|1|||
155446003|NCT00630812|561057751|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155446004|NCT00630812|561057752|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155446005|NCT00630812|561057751|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
155446006|NCT00630812|561057752|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
155446007|NCT00630812|561057751|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
155446008|NCT00630812|561057752|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
155446009|NCT00630812|561057751|FG000|Double Blind Treatment Period|Non-compliance|0|||
155446010|NCT00630812|561057752|FG001|Double Blind Treatment Period|Non-compliance|1|||
155446011|NCT00972478|561057753|FG000|Overall Study|Adverse Event|3|||
155446012|NCT00972478|561057754|FG001|Overall Study|Adverse Event|16|||
155446013|NCT00972478|561057753|FG000|Overall Study|Withdrawal by Subject|1|||
155446014|NCT00972478|561057754|FG001|Overall Study|Withdrawal by Subject|8|||
155446015|NCT00972478|561057753|FG000|Overall Study|Progression/Relapse|0|||
155446016|NCT00972478|561057754|FG001|Overall Study|Progression/Relapse|2|||
155446017|NCT00972478|561057753|FG000|Overall Study|Death|0|||
155446018|NCT00972478|561057754|FG001|Overall Study|Death|2|||
155446019|NCT00972478|561057753|FG000|Overall Study|Not protocol specified|1|||
155446020|NCT00972478|561057754|FG001|Overall Study|Not protocol specified|1|||
155446021|NCT00972478|561057753|FG000|Overall Study|Ineligible|1|||
155446022|NCT00972478|561057754|FG001|Overall Study|Ineligible|7|||
155446023|NCT00972478|561057753|FG000|Overall Study|Not start protocol treatment|1|||
155446024|NCT00972478|561057754|FG001|Overall Study|Not start protocol treatment|2|||
155446025|NCT02561000|561057755|FG000|Overall Study|Withdrawal by Subject|2|||
155446026|NCT02561000|561057756|FG001|Overall Study|Withdrawal by Subject|3|||
155446027|NCT02561000|561057757|FG002|Overall Study|Withdrawal by Subject|0|||
155446028|NCT02561000|561057755|FG000|Overall Study|Adverse Event|0|||
155446029|NCT02561000|561057756|FG001|Overall Study|Adverse Event|1|||
155446030|NCT02561000|561057757|FG002|Overall Study|Adverse Event|0|||
155446031|NCT01234402|561057758|FG000|Overall Study|Lost to Follow-up|0|||
155446032|NCT01234402|561057759|FG001|Overall Study|Lost to Follow-up|1|||
155446033|NCT01234402|561057760|FG002|Overall Study|Lost to Follow-up|3|||
155446034|NCT01234402|561057758|FG000|Overall Study|Withdrawal by Subject|1|||
155446035|NCT01234402|561057759|FG001|Overall Study|Withdrawal by Subject|3|||
155446036|NCT01234402|561057760|FG002|Overall Study|Withdrawal by Subject|4|||
155446037|NCT01234402|561057758|FG000|Overall Study|Never treated: Death|0|||
155446038|NCT01234402|561057759|FG001|Overall Study|Never treated: Death|0|||
155446039|NCT01234402|561057760|FG002|Overall Study|Never treated: Death|1|||
155446040|NCT01234402|561057758|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
155446041|NCT01234402|561057759|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
155446042|NCT01234402|561057760|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
155446043|NCT01234402|561057758|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
155446044|NCT01234402|561057759|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
155446045|NCT01234402|561057760|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
155446046|NCT02280291|561057762|FG000|Overall Study|Lost to Follow-up|2|||
155446047|NCT02280291|561057763|FG001|Overall Study|Lost to Follow-up|1|||
155446048|NCT02280291|561057764|FG002|Overall Study|Lost to Follow-up|3|||
155446049|NCT02280291|561057765|FG003|Overall Study|Lost to Follow-up|8|||
155446050|NCT02280291|561057762|FG000|Overall Study|Protocol Violation|1|||
155446051|NCT02280291|561057763|FG001|Overall Study|Protocol Violation|0|||
155446052|NCT02280291|561057764|FG002|Overall Study|Protocol Violation|0|||
155446053|NCT02280291|561057765|FG003|Overall Study|Protocol Violation|0|||
155446054|NCT02280291|561057762|FG000|Overall Study|Other|1|||
155446055|NCT02280291|561057763|FG001|Overall Study|Other|1|||
155446056|NCT02280291|561057764|FG002|Overall Study|Other|0|||
155446057|NCT02280291|561057765|FG003|Overall Study|Other|0|||
155446058|NCT00506077|561057767|FG000|Treatment Period 1|Adverse Event|2|||
155446059|NCT00506077|561057768|FG001|Treatment Period 1|Adverse Event|1|||
155446060|NCT00506077|561057767|FG000|Treatment Period 1|Lost to Follow-up|0|||
155446061|NCT00506077|561057768|FG001|Treatment Period 1|Lost to Follow-up|2|||
155446062|NCT00506077|561057767|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155446063|NCT00506077|561057768|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155446064|NCT00506077|561057767|FG000|Treatment Period 2|Adverse Event|0|||
155446065|NCT00506077|561057768|FG001|Treatment Period 2|Adverse Event|1|||
155446066|NCT00506077|561057767|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155446067|NCT00506077|561057768|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155446068|NCT02918266|561057769|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
155446069|NCT02918266|561057770|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446070|NCT02918266|561057771|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446071|NCT02918266|561057772|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446072|NCT02918266|561057773|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446073|NCT02918266|561057774|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446074|NCT02918266|561057775|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
155446075|NCT02918266|561057776|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446076|NCT02918266|561057777|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
155446077|NCT02918266|561057778|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446078|NCT02918266|561057779|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
155446079|NCT01293032|561057780|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
155446080|NCT01293032|561057781|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
155446081|NCT01293032|561057782|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
155446082|NCT01293032|561057783|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
155446083|NCT01293032|561057780|FG000|Treatment|Adverse Event|0|||
155446084|NCT01293032|561057781|FG001|Treatment|Adverse Event|0|||
155446085|NCT01293032|561057782|FG002|Treatment|Adverse Event|1|||
155446086|NCT01293032|561057783|FG003|Treatment|Adverse Event|1|||
155446087|NCT01293032|561057780|FG000|Treatment|Withdrawal by Subject|2|||
155446088|NCT01293032|561057781|FG001|Treatment|Withdrawal by Subject|4|||
155446089|NCT01293032|561057782|FG002|Treatment|Withdrawal by Subject|0|||
155446090|NCT01293032|561057783|FG003|Treatment|Withdrawal by Subject|0|||
155446091|NCT01293032|561057780|FG000|Treatment|Disease Progression, relapse|0|||
155446092|NCT01293032|561057781|FG001|Treatment|Disease Progression, relapse|1|||
155446093|NCT01293032|561057782|FG002|Treatment|Disease Progression, relapse|0|||
155446094|NCT01293032|561057783|FG003|Treatment|Disease Progression, relapse|0|||
155446095|NCT01106534|561057786|FG000|Overall Study|Withdrawal by Subject|18|||
155446096|NCT01106534|561057786|FG000|Overall Study|Lost to Follow-up|2|||
155446097|NCT01106534|561057786|FG000|Overall Study|Death|16|||
155446098|NCT01106534|561057786|FG000|Overall Study|Physician Decision|1|||
155446099|NCT01603641|561057792|FG000|Overall Study|Did not Receive Treatment|3|||
155446100|NCT01603641|561057792|FG000|Overall Study|Adverse Event|1|||
155446101|NCT01603641|561057792|FG000|Overall Study|Lack of Efficacy|1|||
155446102|NCT01603641|561057792|FG000|Overall Study|Lost to Follow-up|6|||
155446103|NCT01603641|561057792|FG000|Overall Study|Personal Reasons|18|||
155446104|NCT01603641|561057792|FG000|Overall Study|Other Miscellaneous Reasons|6|||
155446105|NCT00114972|561057793|FG000|Overall Study|Withdrawal by Subject|40|||
155446106|NCT00114972|561057794|FG001|Overall Study|Withdrawal by Subject|7|||
155446107|NCT00114972|561057793|FG000|Overall Study|Lost to Follow-up|8|||
155446108|NCT00114972|561057794|FG001|Overall Study|Lost to Follow-up|5|||
155446109|NCT00358917|561057795|FG000|Overall Study|Adverse Event|14|||
155446110|NCT00358917|561057796|FG001|Overall Study|Adverse Event|21|||
155446111|NCT00358917|561057795|FG000|Overall Study|Withdrawal by Subject|5|||
155446112|NCT00358917|561057796|FG001|Overall Study|Withdrawal by Subject|7|||
155446113|NCT00358917|561057795|FG000|Overall Study|Lost to Follow-up|20|||
155446114|NCT00358917|561057796|FG001|Overall Study|Lost to Follow-up|17|||
155446115|NCT00358917|561057795|FG000|Overall Study|Noncompliance|12|||
155446116|NCT00358917|561057796|FG001|Overall Study|Noncompliance|11|||
155446117|NCT00358917|561057795|FG000|Overall Study|Death|2|||
155446118|NCT00358917|561057796|FG001|Overall Study|Death|3|||
155446119|NCT00358917|561057795|FG000|Overall Study|Virologic failure|11|||
155446120|NCT00358917|561057796|FG001|Overall Study|Virologic failure|8|||
155446121|NCT00358917|561057795|FG000|Overall Study|Unable to Continue Participation|2|||
155446122|NCT00358917|561057796|FG001|Overall Study|Unable to Continue Participation|2|||
155446123|NCT00772967|561057805|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
155446124|NCT00772967|561057806|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
155446125|NCT00772967|561057807|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
155446126|NCT00772967|561057808|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
155446127|NCT00772967|561057809|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
155446128|NCT00772967|561057810|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
155446129|NCT00772967|561057805|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
155446130|NCT00772967|561057806|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
155446131|NCT00772967|561057807|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
155446132|NCT00772967|561057808|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
155446133|NCT00772967|561057809|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
155446134|NCT00772967|561057810|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
155446135|NCT00772967|561057805|FG000|Crossover Treatment 3|Adverse Event|0|||
155446136|NCT00772967|561057806|FG001|Crossover Treatment 3|Adverse Event|0|||
155446137|NCT00772967|561057807|FG002|Crossover Treatment 3|Adverse Event|0|||
155446138|NCT00772967|561057808|FG003|Crossover Treatment 3|Adverse Event|0|||
155446139|NCT00772967|561057809|FG004|Crossover Treatment 3|Adverse Event|1|||
155446140|NCT00772967|561057810|FG005|Crossover Treatment 3|Adverse Event|0|||
155446141|NCT02144220|561057811|FG000|Overall Study|technology incompatibility|9|||
155446142|NCT02144220|561057811|FG000|Overall Study|Lack of Efficacy|4|||
155446143|NCT02144220|561057811|FG000|Overall Study|Physician Decision|3|||
155446144|NCT02144220|561057811|FG000|Overall Study|Withdrawal by Subject|2|||
155446145|NCT02144220|561057811|FG000|Overall Study|Protocol Violation|1|||
155446146|NCT01558089|561057812|FG000|Overall Study|Adverse Event|1|||
155446147|NCT01558089|561057812|FG000|Overall Study|Lack of Efficacy|1|||
155446148|NCT01558089|561057812|FG000|Overall Study|Lost to Follow-up|5|||
155446149|NCT01558089|561057812|FG000|Overall Study|Withdrawal by Subject|6|||
155446150|NCT00053846|561057813|FG000|Overall Study|Changed mind|8|||
155446151|NCT00053846|561057814|FG001|Overall Study|Changed mind|13|||
155446152|NCT00053846|561057813|FG000|Overall Study|Became too ill|8|||
155446153|NCT00053846|561057814|FG001|Overall Study|Became too ill|7|||
155446154|NCT00053846|561057813|FG000|Overall Study|Expired|5|||
155446155|NCT00053846|561057814|FG001|Overall Study|Expired|0|||
155446156|NCT00053846|561057813|FG000|Overall Study|Became ineligible|3|||
155446157|NCT00053846|561057814|FG001|Overall Study|Became ineligible|1|||
155446158|NCT00053846|561057813|FG000|Overall Study|Did not return data|1|||
155446159|NCT00053846|561057814|FG001|Overall Study|Did not return data|2|||
155446160|NCT00053846|561057813|FG000|Overall Study|Quit due to side effects|1|||
155446161|NCT00053846|561057814|FG001|Overall Study|Quit due to side effects|3|||
155446162|NCT00053846|561057813|FG000|Overall Study|Pills too large|0|||
155446163|NCT00053846|561057814|FG001|Overall Study|Pills too large|1|||
155446164|NCT00592501|561057815|FG000|Overall Study|Withdrawal by Subject|1|||
155446165|NCT00592501|561057815|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
155446166|NCT02229864|561057816|FG000|Overall Study|Death|2|||
155446167|NCT02229864|561057816|FG000|Overall Study|Lost to Follow-up|1|||
155446168|NCT02650284|561057819|FG000|Overall Study|Lost to Follow-up|3|||
155446169|NCT02650284|561057820|FG001|Overall Study|Lost to Follow-up|3|||
155446170|NCT02650284|561057819|FG000|Overall Study|Consent incorrectly taken|0|||
155446171|NCT02650284|561057820|FG001|Overall Study|Consent incorrectly taken|1|||
155446172|NCT02807454|561057827|FG000|Overall Study|Adverse Event|1|||
155446173|NCT02807454|561057828|FG001|Overall Study|Adverse Event|0|||
155446174|NCT02807454|561057827|FG000|Overall Study|Withdrawal by Subject|0|||
155446175|NCT02807454|561057828|FG001|Overall Study|Withdrawal by Subject|1|||
155446176|NCT02807454|561057827|FG000|Overall Study|Progressive Disease|30|||
155446177|NCT02807454|561057828|FG001|Overall Study|Progressive Disease|3|||
155446178|NCT02807454|561057827|FG000|Overall Study|Other Reasons|1|||
155446179|NCT02807454|561057828|FG001|Overall Study|Other Reasons|1|||
155446180|NCT02275026|561057829|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
155446181|NCT02275026|561057829|FG000|Overall Study|Withdrawal by Subject|4|||
155446182|NCT02275026|561057829|FG000|Overall Study|Ineligible due to medical history|13|||
155446183|NCT02275026|561057829|FG000|Overall Study|MRI malfunction precluded testing|1|||
155446184|NCT02275026|561057829|FG000|Overall Study|Ineligible after MRI findings|1|||
155446185|NCT02275026|561057829|FG000|Overall Study|Lost to Follow-up|2|||
155446186|NCT02275026|561057829|FG000|Overall Study|Scanner failure|1|||
155446187|NCT05468086|561057832|FG000|Overall Study|Withdrawal by Subject|3|||
155446188|NCT05468086|561057832|FG000|Overall Study|Subject was found ineligible after consent|1|||
155446189|NCT00374907|561057833|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
155446190|NCT00374907|561057834|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
155446191|NCT00374907|561057833|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
155446192|NCT00374907|561057834|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
155446193|NCT00374907|561057833|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
155446194|NCT00374907|561057834|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
155446195|NCT00374907|561057833|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
155446196|NCT00374907|561057834|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
155446197|NCT00374907|561057833|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
155446198|NCT00374907|561057834|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
155446199|NCT01200511|561057842|FG000|Overall Study|Lost to Follow-up|3|||
155446200|NCT01200511|561057842|FG000|Overall Study|Withdrawal by Subject|1|||
155446201|NCT01200511|561057842|FG000|Overall Study|Adverse Event|1|||
155446202|NCT03382899|561057843|FG000|Overall Study|Ineligibility Determined|0|||
155446203|NCT03382899|561057844|FG001|Overall Study|Ineligibility Determined|1|||
155446204|NCT03382899|561057843|FG000|Overall Study|Lost to Follow-up|0|||
155446205|NCT03382899|561057844|FG001|Overall Study|Lost to Follow-up|1|||
155446206|NCT03382899|561057843|FG000|Overall Study|Sponsor's decision|31|||
155446207|NCT03382899|561057844|FG001|Overall Study|Sponsor's decision|28|||
155446208|NCT03382899|561057843|FG000|Overall Study|Withdrawal by Subject|0|||
155446209|NCT03382899|561057844|FG001|Overall Study|Withdrawal by Subject|5|||
155446210|NCT02504892|561057846|FG000|Overall Study|Adverse event-pneumonitis|2|||
155446211|NCT00524745|561057847|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
155446212|NCT00524745|561057848|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
155446213|NCT00524745|561057849|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
155446214|NCT00524745|561057850|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
155446215|NCT00576693|561057851|FG000|Overall Study|Lost to Follow-up|7|||
155446216|NCT00576693|561057852|FG001|Overall Study|Lost to Follow-up|11|||
155446217|NCT00576693|561057851|FG000|Overall Study|Withdrawal by Subject|3|||
155446218|NCT00576693|561057852|FG001|Overall Study|Withdrawal by Subject|13|||
155446219|NCT01413178|561057853|FG000|Overall Study|Toxicity|1|||
155446220|NCT01413178|561057854|FG001|Overall Study|Toxicity|0|||
155446221|NCT01413178|561057853|FG000|Overall Study|Ineligible|0|||
155446222|NCT01413178|561057854|FG001|Overall Study|Ineligible|2|||
155446223|NCT00540449|561057855|FG000|Overall Study|Adverse Event|12|||
155446224|NCT00540449|561057856|FG001|Overall Study|Adverse Event|32|||
155446225|NCT00540449|561057855|FG000|Overall Study|Sponsor's Decision|1|||
155446226|NCT00540449|561057856|FG001|Overall Study|Sponsor's Decision|1|||
155446227|NCT00540449|561057855|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
155446228|NCT00540449|561057856|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
155446229|NCT00540449|561057855|FG000|Overall Study|Lost to Follow-up|19|||
155446230|NCT00540449|561057856|FG001|Overall Study|Lost to Follow-up|17|||
155446231|NCT00540449|561057855|FG000|Overall Study|Subject Non-Compliant|7|||
155446232|NCT00540449|561057856|FG001|Overall Study|Subject Non-Compliant|5|||
155446233|NCT00540449|561057855|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
155446234|NCT00540449|561057856|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
155446235|NCT00540449|561057855|FG000|Overall Study|Withdrawal by Subject|10|||
155446236|NCT00540449|561057856|FG001|Overall Study|Withdrawal by Subject|10|||
155446237|NCT00540449|561057855|FG000|Overall Study|Other|1|||
155446238|NCT00540449|561057856|FG001|Overall Study|Other|4|||
155446239|NCT00376688|561057857|FG000|Overall Study|Adverse Event|3|||
155446240|NCT00376688|561057857|FG000|Overall Study|Death|1|||
155446241|NCT05128162|561057858|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
155446242|NCT05128162|561057858|FG000|Overall Study|Physician Decision|1|||
155446243|NCT02985450|561058773|FG000|Overall Study|Lost to Follow-up|7|||
155446244|NCT00069576|561058774|FG000|Original Trial|Lost to Follow-up|25|||
155446245|NCT00069576|561058775|FG001|Original Trial|Lost to Follow-up|33|||
155446246|NCT00069576|561058774|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
155446247|NCT00069576|561058775|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
155446248|NCT00905307|561058776|FG000|Overall Study|Switched to Open Label Rescue|7|||
155446249|NCT00905307|561058777|FG001|Overall Study|Switched to Open Label Rescue|17|||
155446250|NCT00905307|561058778|FG002|Overall Study|Switched to Open Label Rescue|11|||
155446251|NCT00905307|561058779|FG003|Overall Study|Switched to Open Label Rescue|11|||
155446252|NCT00905307|561058780|FG004|Overall Study|Switched to Open Label Rescue|4|||
155446253|NCT00905307|561058781|FG005|Overall Study|Switched to Open Label Rescue|15|||
155446254|NCT00905307|561058776|FG000|Overall Study|Lost to Follow-up|0|||
155446255|NCT00905307|561058777|FG001|Overall Study|Lost to Follow-up|0|||
155446256|NCT00905307|561058778|FG002|Overall Study|Lost to Follow-up|0|||
155446257|NCT00905307|561058779|FG003|Overall Study|Lost to Follow-up|0|||
155446258|NCT00905307|561058780|FG004|Overall Study|Lost to Follow-up|1|||
155446259|NCT00905307|561058781|FG005|Overall Study|Lost to Follow-up|1|||
155446260|NCT00905307|561058776|FG000|Overall Study|Adverse Event|3|||
155446261|NCT00905307|561058777|FG001|Overall Study|Adverse Event|4|||
155446262|NCT00905307|561058778|FG002|Overall Study|Adverse Event|5|||
155446263|NCT00905307|561058779|FG003|Overall Study|Adverse Event|11|||
155446264|NCT00905307|561058780|FG004|Overall Study|Adverse Event|3|||
155446265|NCT00905307|561058781|FG005|Overall Study|Adverse Event|5|||
155446266|NCT00905307|561058776|FG000|Overall Study|Withdrawal by Subject|5|||
155446267|NCT00905307|561058777|FG001|Overall Study|Withdrawal by Subject|13|||
155446268|NCT00905307|561058778|FG002|Overall Study|Withdrawal by Subject|15|||
155446269|NCT00905307|561058779|FG003|Overall Study|Withdrawal by Subject|11|||
155446270|NCT00905307|561058780|FG004|Overall Study|Withdrawal by Subject|4|||
155446271|NCT00905307|561058781|FG005|Overall Study|Withdrawal by Subject|13|||
155446272|NCT00905307|561058776|FG000|Overall Study|Protocol Violation|1|||
155446273|NCT00905307|561058777|FG001|Overall Study|Protocol Violation|0|||
155446274|NCT00905307|561058778|FG002|Overall Study|Protocol Violation|1|||
155446275|NCT00905307|561058779|FG003|Overall Study|Protocol Violation|0|||
155446276|NCT00905307|561058780|FG004|Overall Study|Protocol Violation|0|||
155446277|NCT00905307|561058781|FG005|Overall Study|Protocol Violation|0|||
155446278|NCT00905307|561058776|FG000|Overall Study|Lack of Efficacy|6|||
155446279|NCT00905307|561058777|FG001|Overall Study|Lack of Efficacy|3|||
155446280|NCT00905307|561058778|FG002|Overall Study|Lack of Efficacy|5|||
155446281|NCT00905307|561058779|FG003|Overall Study|Lack of Efficacy|4|||
155446282|NCT00905307|561058780|FG004|Overall Study|Lack of Efficacy|4|||
155446283|NCT00905307|561058781|FG005|Overall Study|Lack of Efficacy|8|||
155446284|NCT05590793|561058782|FG000|Overall Study|Withdrawal by Subject|6|||
155446285|NCT05590793|561058782|FG000|Overall Study|Physician Decision|1|||
155446286|NCT04060667|561058783|FG000|Overall Study|Lost to Follow-up|75|||
155446287|NCT04060667|561058784|FG001|Overall Study|Lost to Follow-up|10|||
155446288|NCT04488822|561058785|FG000|Overall Study|Adverse Event|8|||
155446289|NCT04488822|561058785|FG000|Overall Study|Withdrawal by Subject|1|||
155446290|NCT03406104|561058786|FG000|Overall Study|Lost to Follow-up|2|||
155446291|NCT03406104|561058786|FG000|Overall Study|Withdrawal by Subject|2|||
155446292|NCT03406104|561058786|FG000|Overall Study|due to Covid patient did not want to travel|1|||
155446293|NCT03406104|561058786|FG000|Overall Study|Death|2|||
155446294|NCT02890329|561058795|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
155446295|NCT02890329|561058796|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
155446296|NCT02890329|561058797|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
155446297|NCT02890329|561058798|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
155446298|NCT02890329|561058799|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
155446299|NCT02890329|561058800|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
155446300|NCT02890329|561058795|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
155446301|NCT02890329|561058796|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
155446302|NCT02890329|561058797|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
155446303|NCT02890329|561058798|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
155446304|NCT02890329|561058799|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
155446305|NCT02890329|561058800|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
155446306|NCT02890329|561058795|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
155446307|NCT02890329|561058796|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
155446308|NCT02890329|561058797|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
155446309|NCT02890329|561058798|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
155446310|NCT02890329|561058799|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
155446311|NCT02890329|561058800|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
155446312|NCT02890329|561058795|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
155446313|NCT02890329|561058796|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
155446314|NCT02890329|561058797|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
155446315|NCT02890329|561058798|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
155515259|NCT02365597|561311563|FG002|Overall Study|Withdrawal by Subject|5|||
155515260|NCT02365597|561311564|FG003|Overall Study|Withdrawal by Subject|1|||
155515261|NCT02365597|561311561|FG000|Overall Study|Sponsor's decision|1|||
155515262|NCT02365597|561311562|FG001|Overall Study|Sponsor's decision|3|||
155515263|NCT02365597|561311563|FG002|Overall Study|Sponsor's decision|13|||
155446316|NCT02890329|561058799|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
155446317|NCT02890329|561058800|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
155446318|NCT01035255|561058802|FG000|Overall Study|Death|724|||
155446319|NCT01035255|561058803|FG001|Overall Study|Death|844|||
155446320|NCT01035255|561058802|FG000|Overall Study|Lost to Follow-up|2|||
155446321|NCT01035255|561058803|FG001|Overall Study|Lost to Follow-up|5|||
155446322|NCT01035255|561058802|FG000|Overall Study|patient's request|15|||
155446323|NCT01035255|561058803|FG001|Overall Study|patient's request|13|||
155446324|NCT00231062|561058808|FG000|Overall Study|Physician Decision|6|||
155446325|NCT03321929|561058809|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
155515264|NCT02365597|561311564|FG003|Overall Study|Sponsor's decision|0|||
155446326|NCT00616239|561058810|FG000|Overall Study|Withdrawal by Subject|2|||
155446327|NCT02873715|561058811|FG000|Overall Study|Lost to Follow-up|84|||
155446328|NCT02873715|561058812|FG001|Overall Study|Lost to Follow-up|94|||
155446329|NCT02873715|561058811|FG000|Overall Study|Withdrawal by Subject|7|||
155446330|NCT02873715|561058812|FG001|Overall Study|Withdrawal by Subject|26|||
155446331|NCT00590681|561058813|FG000|Overall Study|Withdrawal by Subject|7|||
155446332|NCT00590681|561058813|FG000|Overall Study|Adverse Event|8|||
155446333|NCT00590681|561058813|FG000|Overall Study|Death|3|||
155446334|NCT00590681|561058813|FG000|Overall Study|Lost to Follow-up|1|||
155446335|NCT00590681|561058813|FG000|Overall Study|disease progression|1|||
155446336|NCT00933335|561058816|FG000|Overall Study|Lost to Follow-up|1|||
155515265|NCT02365597|561311561|FG000|Overall Study|Other|0|||
155515266|NCT02365597|561311562|FG001|Overall Study|Other|4|||
155515267|NCT02365597|561311563|FG002|Overall Study|Other|0|||
155515268|NCT02365597|561311564|FG003|Overall Study|Other|0|||
155515269|NCT02365597|561311561|FG000|Overall Study|Enrolled but not treated|0|||
155515270|NCT02365597|561311562|FG001|Overall Study|Enrolled but not treated|1|||
155515271|NCT02365597|561311563|FG002|Overall Study|Enrolled but not treated|1|||
155515272|NCT02365597|561311564|FG003|Overall Study|Enrolled but not treated|0|||
155515273|NCT02365597|561311561|FG000|Overall Study|Ongoing|0|||
155515274|NCT02365597|561311562|FG001|Overall Study|Ongoing|0|||
155515275|NCT02365597|561311563|FG002|Overall Study|Ongoing|0|||
155515276|NCT02365597|561311564|FG003|Overall Study|Ongoing|17|||
155515277|NCT04309474|561311565|FG000|Overall Study|Randomized but not treated|0|||
155446337|NCT00933335|561058817|FG001|Overall Study|Lost to Follow-up|3|||
155446338|NCT00933335|561058816|FG000|Overall Study|Withdrawal by Subject|0|||
155446339|NCT00933335|561058817|FG001|Overall Study|Withdrawal by Subject|1|||
155446340|NCT00933335|561058816|FG000|Overall Study|Progressive Disease|0|||
155446341|NCT00933335|561058817|FG001|Overall Study|Progressive Disease|11|||
155446342|NCT00933335|561058816|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
155446343|NCT00933335|561058817|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
155446344|NCT00933335|561058816|FG000|Overall Study|Co-morbid Illness|1|||
155446345|NCT00933335|561058817|FG001|Overall Study|Co-morbid Illness|0|||
155446346|NCT03880227|561058818|FG000|First Visit|Withdrawal by Subject|1|||
155446347|NCT03880227|561058819|FG001|First Visit|Withdrawal by Subject|0|||
155446348|NCT03880227|561058820|FG002|First Visit|Withdrawal by Subject|0|||
155446349|NCT03880227|561058821|FG003|First Visit|Withdrawal by Subject|0|||
155446350|NCT03880227|561058818|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
155446351|NCT03880227|561058819|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
155446352|NCT03880227|561058820|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
155446353|NCT03880227|561058821|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
155446354|NCT03880227|561058818|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
155446355|NCT03880227|561058819|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
155446356|NCT03880227|561058820|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
155446357|NCT03880227|561058821|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
155446358|NCT03880227|561058818|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
155446359|NCT03880227|561058819|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
155446360|NCT03880227|561058820|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
155446361|NCT03880227|561058821|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
155446362|NCT04590937|561058822|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
155446363|NCT01929044|561058823|FG000|Overall Study|Adverse Event|1|||
155446364|NCT01929044|561058824|FG001|Overall Study|Adverse Event|0|||
155446365|NCT01929044|561058823|FG000|Overall Study|Protocol Violation|9|||
155446366|NCT01929044|561058824|FG001|Overall Study|Protocol Violation|14|||
155446367|NCT01929044|561058823|FG000|Overall Study|Not Treated|1|||
155446368|NCT01929044|561058824|FG001|Overall Study|Not Treated|3|||
155446369|NCT02084134|561058827|FG000|Overall Study|Protocol Violation|4|||
155446370|NCT02084134|561058828|FG001|Overall Study|Protocol Violation|2|||
155446371|NCT02084134|561058827|FG000|Overall Study|Death|0|||
155446372|NCT02084134|561058828|FG001|Overall Study|Death|1|||
155446373|NCT04333433|561058829|FG000|Overall Study|Withdrawal by Subject|6|||
155446374|NCT04333433|561058830|FG001|Overall Study|Withdrawal by Subject|3|||
155446375|NCT04333433|561058829|FG000|Overall Study|Death|3|||
155446376|NCT04333433|561058830|FG001|Overall Study|Death|0|||
155446377|NCT04333433|561058829|FG000|Overall Study|Lost to Follow-up|6|||
155446378|NCT04333433|561058830|FG001|Overall Study|Lost to Follow-up|1|||
155515278|NCT04309474|561311566|FG001|Overall Study|Randomized but not treated|2|||
155515279|NCT04309474|561311565|FG000|Overall Study|Adverse Event|4|||
155446379|NCT04333433|561058829|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
155515280|NCT04309474|561311566|FG001|Overall Study|Adverse Event|1|||
155515281|NCT04309474|561311565|FG000|Overall Study|Withdrawal by Subject|6|||
155446380|NCT04333433|561058830|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
155446381|NCT02026271|561058831|FG000|Overall Study|Adverse Event|2|||
155446382|NCT02026271|561058832|FG001|Overall Study|Adverse Event|3|||
155446383|NCT02026271|561058833|FG002|Overall Study|Adverse Event|2|||
155446384|NCT02026271|561058834|FG003|Overall Study|Adverse Event|3|||
155446385|NCT02026271|561058835|FG004|Overall Study|Adverse Event|0|||
155446386|NCT02026271|561058831|FG000|Overall Study|Withdrawal by Subject|0|||
155446387|NCT02026271|561058832|FG001|Overall Study|Withdrawal by Subject|0|||
155446388|NCT02026271|561058833|FG002|Overall Study|Withdrawal by Subject|0|||
155446389|NCT02026271|561058834|FG003|Overall Study|Withdrawal by Subject|0|||
155446390|NCT02026271|561058835|FG004|Overall Study|Withdrawal by Subject|1|||
155446391|NCT00878072|561058836|FG000|Overall Study|Withdrew consent|2|||
155446392|NCT03288779|561058837|FG000|Overall Study|Withdrawal by Subject|3|||
155446393|NCT00237796|561058838|FG000|Overall Study|Baseline and one other ILSS required|10|||
155446394|NCT00237796|561058839|FG001|Overall Study|Baseline and one other ILSS required|5|||
155446395|NCT00968253|561058840|FG000|Overall Study|Death|0|||
155446396|NCT00968253|561058841|FG001|Overall Study|Death|0|||
155446397|NCT00968253|561058842|FG002|Overall Study|Death|2|||
155446398|NCT00968253|561058840|FG000|Overall Study|Withdrawal by Subject|0|||
155446399|NCT00968253|561058841|FG001|Overall Study|Withdrawal by Subject|0|||
155446400|NCT00968253|561058842|FG002|Overall Study|Withdrawal by Subject|1|||
155446401|NCT00968253|561058840|FG000|Overall Study|Disease Progression|0|||
155446402|NCT00968253|561058841|FG001|Overall Study|Disease Progression|3|||
155446403|NCT00968253|561058842|FG002|Overall Study|Disease Progression|3|||
155446404|NCT00968253|561058840|FG000|Overall Study|Adverse Event|0|||
155446405|NCT00968253|561058841|FG001|Overall Study|Adverse Event|0|||
155446406|NCT00968253|561058842|FG002|Overall Study|Adverse Event|1|||
155446407|NCT01721408|561058843|FG000|Overall Study|Adverse Event|6|||
155446408|NCT01721408|561058844|FG001|Overall Study|Adverse Event|1|||
155446409|NCT01721408|561058843|FG000|Overall Study|Death|1|||
155446410|NCT01721408|561058844|FG001|Overall Study|Death|0|||
155446411|NCT01721408|561058843|FG000|Overall Study|Insufficient clinical response|15|||
155446412|NCT01721408|561058844|FG001|Overall Study|Insufficient clinical response|6|||
155446413|NCT01721408|561058843|FG000|Overall Study|No longer willing to participate study|9|||
155446414|NCT01721408|561058844|FG001|Overall Study|No longer willing to participate study|10|||
155446415|NCT01721408|561058843|FG000|Overall Study|Protocol Violation|0|||
155446416|NCT01721408|561058844|FG001|Overall Study|Protocol Violation|2|||
155446417|NCT01721408|561058843|FG000|Overall Study|Other|3|||
155446418|NCT01721408|561058844|FG001|Overall Study|Other|3|||
155446419|NCT01721408|561058843|FG000|Overall Study|Lost to Follow-up|1|||
155446420|NCT01721408|561058844|FG001|Overall Study|Lost to Follow-up|2|||
155446421|NCT01721408|561058843|FG000|Overall Study|Does not meet entrance criteria|1|||
155446422|NCT01721408|561058844|FG001|Overall Study|Does not meet entrance criteria|0|||
155446423|NCT04160468|561058847|FG000|Overall Study|Lost to Follow-up|19|||
155446424|NCT04160468|561058848|FG001|Overall Study|Lost to Follow-up|4|||
155446425|NCT04160468|561058847|FG000|Overall Study|Randomized but not dosed|6|||
155446426|NCT04160468|561058848|FG001|Overall Study|Randomized but not dosed|0|||
155446427|NCT04160468|561058847|FG000|Overall Study|Withdrawal by Subject|4|||
155446428|NCT04160468|561058848|FG001|Overall Study|Withdrawal by Subject|1|||
155446429|NCT04160468|561058847|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
155446430|NCT04160468|561058848|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
155446431|NCT04160468|561058847|FG000|Overall Study|Participant incarcerated|1|||
155446432|NCT04160468|561058848|FG001|Overall Study|Participant incarcerated|0|||
155446433|NCT01187901|561058849|FG000|Overall Study|Protocol Violation|1|||
155446434|NCT01187901|561058850|FG001|Overall Study|Protocol Violation|0|||
155446435|NCT01187901|561058849|FG000|Overall Study|Lost to Follow-up|1|||
155446436|NCT01187901|561058850|FG001|Overall Study|Lost to Follow-up|2|||
155446437|NCT01187901|561058849|FG000|Overall Study|Unrelated Health Reasons|1|||
155446438|NCT01187901|561058850|FG001|Overall Study|Unrelated Health Reasons|2|||
155446439|NCT01187901|561058849|FG000|Overall Study|Suspected Allergic Reaction|1|||
155446440|NCT01187901|561058850|FG001|Overall Study|Suspected Allergic Reaction|1|||
155446441|NCT01187901|561058849|FG000|Overall Study|Adverse Event|3|||
155446442|NCT01187901|561058850|FG001|Overall Study|Adverse Event|0|||
155446443|NCT01187901|561058849|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
155446444|NCT01187901|561058850|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
155446445|NCT01187901|561058849|FG000|Overall Study|Pregnancy|0|||
155446446|NCT01187901|561058850|FG001|Overall Study|Pregnancy|2|||
155446447|NCT03987620|561058851|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
155446448|NCT03987620|561058852|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
155446449|NCT03987620|561058851|FG000|Overall Study|Adverse Event|3|||
155446450|NCT03987620|561058852|FG001|Overall Study|Adverse Event|0|||
155446451|NCT03987620|561058851|FG000|Overall Study|Lost to Follow-up|1|||
155446452|NCT03987620|561058852|FG001|Overall Study|Lost to Follow-up|2|||
155446453|NCT03987620|561058851|FG000|Overall Study|Physician Decision|0|||
155446454|NCT03987620|561058852|FG001|Overall Study|Physician Decision|1|||
155446455|NCT03987620|561058851|FG000|Overall Study|Pregnancy|1|||
155446456|NCT03987620|561058852|FG001|Overall Study|Pregnancy|0|||
155446457|NCT03987620|561058851|FG000|Overall Study|Withdrawal by Subject|7|||
155446458|NCT03987620|561058852|FG001|Overall Study|Withdrawal by Subject|1|||
155446459|NCT03987620|561058851|FG000|Overall Study|Other|2|||
155446460|NCT03987620|561058852|FG001|Overall Study|Other|5|||
155446461|NCT02149836|561058853|FG000|Overall Study|Withdrawal by Subject|1|||
155446462|NCT00370149|561058860|FG000|Overall Study|Physician Decision|16|||
155446463|NCT00370149|561058861|FG001|Overall Study|Physician Decision|16|||
155446464|NCT00370149|561058860|FG000|Overall Study|Protocol Violation|1|||
155446465|NCT00370149|561058861|FG001|Overall Study|Protocol Violation|0|||
155446466|NCT00370149|561058860|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
155446467|NCT00370149|561058861|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
155446468|NCT00370149|561058860|FG000|Overall Study|Pre-existing infection|0|||
155446469|NCT00370149|561058861|FG001|Overall Study|Pre-existing infection|1|||
155446470|NCT00370149|561058860|FG000|Overall Study|Antibiotic coated dressing placed|0|||
155446471|NCT00370149|561058861|FG001|Overall Study|Antibiotic coated dressing placed|1|||
155446472|NCT01096446|561060443|FG000|Overall Study|Death|1|||
155446473|NCT01096446|561060444|FG001|Overall Study|Death|0|||
155446474|NCT01096446|561060443|FG000|Overall Study|Protocol Violation|2|||
155446475|NCT01096446|561060444|FG001|Overall Study|Protocol Violation|0|||
155446476|NCT01043185|561060445|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
155446477|NCT01043185|561060446|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
155446478|NCT01043185|561060447|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
155446479|NCT01043185|561060448|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
155446480|NCT01043185|561060449|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
155446481|NCT01043185|561060450|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
155446482|NCT01043185|561060451|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
155446483|NCT01043185|561060452|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
155446484|NCT01043185|561060453|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
155446485|NCT01043185|561060454|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
155446486|NCT03488472|561060455|FG000|Overall Study|disease progression additional mets|1|||
155446487|NCT00028002|561060456|FG000|Overall Study|Withdrawal by Subject|3|||
155446488|NCT00028002|561060456|FG000|Overall Study|Ineligible|8|||
155446489|NCT02750800|561060463|FG000|Overall Study|Adverse Event|18|||
155446490|NCT02750800|561060463|FG000|Overall Study|Lost to Follow-up|12|||
155446491|NCT02750800|561060463|FG000|Overall Study|Investigator decision|53|||
155446492|NCT02750800|561060463|FG000|Overall Study|Patient request|12|||
155446493|NCT02750800|561060463|FG000|Overall Study|Other, not specified|3|||
155446494|NCT03430245|561060481|FG000|Overall Study|Withdrawal by Subject|6|||
155446495|NCT03430245|561060481|FG000|Overall Study|Lost to Follow-up|1|||
155446496|NCT05628181|561060482|FG000|Overall Study|Death|2|||
155446497|NCT05628181|561060483|FG001|Overall Study|Death|4|||
155446498|NCT05628181|561060484|FG002|Overall Study|Death|0|||
155446499|NCT04742907|561060491|FG000|Overall Study|Adverse Event|1|||
155446500|NCT04742907|561060492|FG001|Overall Study|Adverse Event|0|||
155446501|NCT04742907|561060493|FG002|Overall Study|Adverse Event|1|||
155446502|NCT04742907|561060491|FG000|Overall Study|Lost to Follow-up|3|||
155446503|NCT04742907|561060492|FG001|Overall Study|Lost to Follow-up|3|||
155446504|NCT04742907|561060493|FG002|Overall Study|Lost to Follow-up|2|||
155446505|NCT04742907|561060491|FG000|Overall Study|Physician Decision|0|||
155446506|NCT04742907|561060492|FG001|Overall Study|Physician Decision|1|||
155446507|NCT04742907|561060493|FG002|Overall Study|Physician Decision|0|||
155446508|NCT04742907|561060491|FG000|Overall Study|Protocol Violation|1|||
155446509|NCT04742907|561060492|FG001|Overall Study|Protocol Violation|1|||
155446510|NCT04742907|561060493|FG002|Overall Study|Protocol Violation|1|||
155446511|NCT04742907|561060491|FG000|Overall Study|Withdrawal by Subject|5|||
155446512|NCT04742907|561060492|FG001|Overall Study|Withdrawal by Subject|6|||
155446513|NCT04742907|561060493|FG002|Overall Study|Withdrawal by Subject|4|||
155446514|NCT04742907|561060491|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
155446515|NCT04742907|561060492|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
155446516|NCT04742907|561060493|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
155446517|NCT04742907|561060491|FG000|Overall Study|Did Not Receive the Study Drug|2|||
155446518|NCT04742907|561060492|FG001|Overall Study|Did Not Receive the Study Drug|4|||
155446519|NCT04742907|561060493|FG002|Overall Study|Did Not Receive the Study Drug|4|||
155446520|NCT01428063|561060494|FG000|Overall Study|Lack of Efficacy|8|||
155446521|NCT01428063|561060495|FG001|Overall Study|Lack of Efficacy|4|||
155446522|NCT01428063|561060496|FG002|Overall Study|Lack of Efficacy|1|||
155446523|NCT01428063|561060494|FG000|Overall Study|Adverse Event|2|||
155446524|NCT01428063|561060495|FG001|Overall Study|Adverse Event|3|||
155446525|NCT01428063|561060496|FG002|Overall Study|Adverse Event|0|||
155446526|NCT01428063|561060494|FG000|Overall Study|Lost to Follow-up|0|||
155446527|NCT01428063|561060495|FG001|Overall Study|Lost to Follow-up|2|||
155446528|NCT01428063|561060496|FG002|Overall Study|Lost to Follow-up|0|||
155446529|NCT01428063|561060494|FG000|Overall Study|No longer meets study criteria|0|||
155446530|NCT01428063|561060495|FG001|Overall Study|No longer meets study criteria|1|||
155446531|NCT01428063|561060496|FG002|Overall Study|No longer meets study criteria|0|||
155446532|NCT05761444|561060497|FG000|Overall Study|Protocol Violation|2|||
155446533|NCT05761444|561060498|FG001|Overall Study|Protocol Violation|1|||
155446534|NCT05761444|561060497|FG000|Overall Study|Adverse Event|2|||
155446535|NCT05761444|561060498|FG001|Overall Study|Adverse Event|2|||
155446536|NCT05761444|561060497|FG000|Overall Study|Withdrawal by Subject|3|||
155446537|NCT05761444|561060498|FG001|Overall Study|Withdrawal by Subject|2|||
155446538|NCT05761444|561060497|FG000|Overall Study|Other|1|||
155446539|NCT05761444|561060498|FG001|Overall Study|Other|0|||
155446540|NCT03508622|561060499|FG000|Overall Study|Protocol Violation|1|||
155446541|NCT03508622|561060500|FG001|Overall Study|Protocol Violation|0|||
155446542|NCT03508622|561060499|FG000|Overall Study|Withdrawal by Subject|1|||
155446543|NCT03508622|561060500|FG001|Overall Study|Withdrawal by Subject|0|||
155446544|NCT03508622|561060499|FG000|Overall Study|Lost to Follow-up|16|||
155446545|NCT03508622|561060500|FG001|Overall Study|Lost to Follow-up|0|||
155446546|NCT03508622|561060499|FG000|Overall Study|Incomplete data|0|||
155446547|NCT03508622|561060500|FG001|Overall Study|Incomplete data|24|||
155446548|NCT03196505|561060503|FG000|Overall Study|Physician Decision|26|||
155446549|NCT03196505|561060504|FG001|Overall Study|Physician Decision|26|||
155446550|NCT01005719|561060505|FG000|Period 1|Adverse Event|0|||
155446551|NCT01005719|561060506|FG001|Period 1|Adverse Event|0|||
155446552|NCT01005719|561060507|FG002|Period 1|Adverse Event|0|||
155446553|NCT01005719|561060508|FG003|Period 1|Adverse Event|1|||
155446554|NCT01005719|561060509|FG004|Period 1|Adverse Event|0|||
155446555|NCT01005719|561060510|FG005|Period 1|Adverse Event|0|||
155446556|NCT01005719|561060505|FG000|Period 1|Delay in completing study procedures|0|||
155446557|NCT01005719|561060506|FG001|Period 1|Delay in completing study procedures|0|||
155446558|NCT01005719|561060507|FG002|Period 1|Delay in completing study procedures|0|||
155446559|NCT01005719|561060508|FG003|Period 1|Delay in completing study procedures|0|||
155446560|NCT01005719|561060509|FG004|Period 1|Delay in completing study procedures|0|||
155515282|NCT04309474|561311566|FG001|Overall Study|Withdrawal by Subject|9|||
155515283|NCT04309474|561311565|FG000|Overall Study|Lost to Follow-up|1|||
155515284|NCT04309474|561311566|FG001|Overall Study|Lost to Follow-up|2|||
155515285|NCT04309474|561311565|FG000|Overall Study|Not disclosed|10|||
155446561|NCT01005719|561060510|FG005|Period 1|Delay in completing study procedures|1|||
155446562|NCT01005719|561060505|FG000|Period 2|Adverse Event|0|||
155446563|NCT01005719|561060506|FG001|Period 2|Adverse Event|0|||
155446564|NCT01005719|561060507|FG002|Period 2|Adverse Event|0|||
155446565|NCT01005719|561060508|FG003|Period 2|Adverse Event|0|||
155446566|NCT01005719|561060509|FG004|Period 2|Adverse Event|1|||
155515286|NCT04309474|561311566|FG001|Overall Study|Not disclosed|6|||
155515287|NCT04670068|561311567|FG000|Overall Study|Progressive Disease|1|||
155446567|NCT01005719|561060510|FG005|Period 2|Adverse Event|1|||
155446568|NCT01753076|561060511|FG000|Overall Study|Adverse Event|17|||
155446569|NCT01753076|561060512|FG001|Overall Study|Adverse Event|18|||
155446570|NCT01753076|561060511|FG000|Overall Study|Lack of Efficacy|3|||
155446571|NCT01753076|561060512|FG001|Overall Study|Lack of Efficacy|1|||
155446572|NCT01753076|561060511|FG000|Overall Study|Lost to Follow-up|2|||
155446573|NCT01753076|561060512|FG001|Overall Study|Lost to Follow-up|1|||
155446574|NCT01753076|561060511|FG000|Overall Study|Physician Decision|4|||
155446575|NCT01753076|561060512|FG001|Overall Study|Physician Decision|2|||
155446576|NCT01753076|561060511|FG000|Overall Study|Withdrawal by Subject|14|||
155446577|NCT01753076|561060512|FG001|Overall Study|Withdrawal by Subject|24|||
155446578|NCT01753076|561060511|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
155446579|NCT01753076|561060512|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
155446580|NCT02575079|561060513|FG000|Overall Study|Death|3|||
155446581|NCT02575079|561060514|FG001|Overall Study|Death|0|||
155446582|NCT02575079|561060513|FG000|Overall Study|Withdrawal by Subject|3|||
155446583|NCT02575079|561060514|FG001|Overall Study|Withdrawal by Subject|0|||
155446584|NCT01259856|561060515|FG000|Overall Study|Adverse Event|12|||
155446585|NCT01259856|561060516|FG001|Overall Study|Adverse Event|9|||
155446586|NCT01259856|561060515|FG000|Overall Study|Death|0|||
155446587|NCT01259856|561060516|FG001|Overall Study|Death|1|||
155446588|NCT01259856|561060515|FG000|Overall Study|Lack of Efficacy|3|||
155446589|NCT01259856|561060516|FG001|Overall Study|Lack of Efficacy|1|||
155446590|NCT01259856|561060515|FG000|Overall Study|Lost to Follow-up|1|||
155446591|NCT01259856|561060516|FG001|Overall Study|Lost to Follow-up|1|||
155446592|NCT01259856|561060515|FG000|Overall Study|Physician Decision|2|||
155446593|NCT01259856|561060516|FG001|Overall Study|Physician Decision|1|||
155446594|NCT01259856|561060515|FG000|Overall Study|Withdrawal by Subject|9|||
155446595|NCT01259856|561060516|FG001|Overall Study|Withdrawal by Subject|10|||
155446596|NCT01259856|561060515|FG000|Overall Study|Treatment never started|0|||
155446597|NCT01259856|561060516|FG001|Overall Study|Treatment never started|6|||
155446598|NCT01259856|561060515|FG000|Overall Study|Study closure by sponsor|40|||
155446599|NCT01259856|561060516|FG001|Overall Study|Study closure by sponsor|41|||
155446600|NCT01259856|561060515|FG000|Overall Study|Patient developed other disease|0|||
155446601|NCT01259856|561060516|FG001|Overall Study|Patient developed other disease|1|||
155446602|NCT01259856|561060515|FG000|Overall Study|Transfer to another study|0|||
155446603|NCT01259856|561060516|FG001|Overall Study|Transfer to another study|1|||
155446604|NCT01259856|561060515|FG000|Overall Study|Unknown/missing|2|||
155446605|NCT01259856|561060516|FG001|Overall Study|Unknown/missing|2|||
155446606|NCT00788775|561060519|FG000|Overall Study|Progressive Disease|8|||
155446607|NCT00788775|561060520|FG001|Overall Study|Progressive Disease|6|||
155446608|NCT00788775|561060519|FG000|Overall Study|Withdrawal by Subject|0|||
155446609|NCT00788775|561060520|FG001|Overall Study|Withdrawal by Subject|2|||
155446610|NCT00788775|561060519|FG000|Overall Study|Patient Non-Compliance|1|||
155446611|NCT00788775|561060520|FG001|Overall Study|Patient Non-Compliance|0|||
155446612|NCT00788775|561060519|FG000|Overall Study|Patient's measurable disease resected.|1|||
155446613|NCT00788775|561060520|FG001|Overall Study|Patient's measurable disease resected.|0|||
155446614|NCT01757704|561060523|FG000|Overall Study|Protocol Violation|1|||
155446615|NCT01757704|561060524|FG001|Overall Study|Protocol Violation|3|||
155446616|NCT00938327|561060525|FG000|Overall Study|Adverse Event|2|||
155446617|NCT00938327|561060525|FG000|Overall Study|Protocol Violation|1|||
155446618|NCT00938327|561060525|FG000|Overall Study|Withdrawal by Subject|4|||
155446619|NCT00938327|561060525|FG000|Overall Study|Lost to Follow-up|37|||
155446620|NCT00938327|561060525|FG000|Overall Study|2nd dose received outside of the study|7|||
155446621|NCT00938327|561060525|FG000|Overall Study|Vaccine not received as out of stock|9|||
155446622|NCT00803244|561060528|FG000|Overall Study|Adverse Event|1|||
155446623|NCT00803244|561060529|FG001|Overall Study|Adverse Event|2|||
155446624|NCT00803244|561060528|FG000|Overall Study|Withdrawal by Subject|2|||
155446625|NCT00803244|561060529|FG001|Overall Study|Withdrawal by Subject|3|||
155446626|NCT00803244|561060528|FG000|Overall Study|Any other reason not above-mentioned|4|||
155446627|NCT00803244|561060529|FG001|Overall Study|Any other reason not above-mentioned|10|||
155446628|NCT00443430|561060538|FG000|Overall Study|Lack of Efficacy|3|||
155446629|NCT00443430|561060539|FG001|Overall Study|Lack of Efficacy|3|||
155446630|NCT00443430|561060538|FG000|Overall Study|Adverse Event|1|||
155446631|NCT00443430|561060539|FG001|Overall Study|Adverse Event|1|||
155446632|NCT01635933|561060540|FG000|Overall Study|Adverse Event|1|||
155446633|NCT01635933|561060541|FG001|Overall Study|Adverse Event|0|||
155446634|NCT01635933|561060540|FG000|Overall Study|Lost to Follow-up|0|||
155446635|NCT01635933|561060541|FG001|Overall Study|Lost to Follow-up|5|||
155446636|NCT01635933|561060540|FG000|Overall Study|Subject decision|1|||
155446637|NCT01635933|561060541|FG001|Overall Study|Subject decision|1|||
155446638|NCT01635933|561060540|FG000|Overall Study|Noncompliance|0|||
155446639|NCT01635933|561060541|FG001|Overall Study|Noncompliance|1|||
155446640|NCT01635933|561060540|FG000|Overall Study|No longer had transportation|0|||
155446641|NCT01635933|561060541|FG001|Overall Study|No longer had transportation|1|||
155446642|NCT01544595|561060544|FG000|Status at Week 68|Adverse Event|3|||
155446643|NCT01544595|561060545|FG001|Status at Week 68|Adverse Event|2|||
155446644|NCT01544595|561060546|FG002|Status at Week 68|Adverse Event|1|||
155446645|NCT01544595|561060547|FG003|Status at Week 68|Adverse Event|0|||
155446646|NCT01544595|561060548|FG004|Status at Week 68|Adverse Event|0|||
155446647|NCT01544595|561060549|FG005|Status at Week 68|Adverse Event|0|||
155446648|NCT01544595|561060544|FG000|Status at Week 68|Lack of Efficacy|1|||
155446649|NCT01544595|561060545|FG001|Status at Week 68|Lack of Efficacy|0|||
155446650|NCT01544595|561060546|FG002|Status at Week 68|Lack of Efficacy|0|||
155446651|NCT01544595|561060547|FG003|Status at Week 68|Lack of Efficacy|0|||
155446652|NCT01544595|561060548|FG004|Status at Week 68|Lack of Efficacy|0|||
155446653|NCT01544595|561060549|FG005|Status at Week 68|Lack of Efficacy|0|||
155446654|NCT01544595|561060544|FG000|Status at Week 68|Lost to Follow-up|1|||
155446655|NCT01544595|561060545|FG001|Status at Week 68|Lost to Follow-up|1|||
155446656|NCT01544595|561060546|FG002|Status at Week 68|Lost to Follow-up|0|||
155446657|NCT01544595|561060547|FG003|Status at Week 68|Lost to Follow-up|0|||
155446658|NCT01544595|561060548|FG004|Status at Week 68|Lost to Follow-up|0|||
155446659|NCT01544595|561060549|FG005|Status at Week 68|Lost to Follow-up|0|||
155446660|NCT01544595|561060544|FG000|Status at Week 68|Non-compliance with study treatment|1|||
155446661|NCT01544595|561060545|FG001|Status at Week 68|Non-compliance with study treatment|0|||
155446662|NCT01544595|561060546|FG002|Status at Week 68|Non-compliance with study treatment|0|||
155446663|NCT01544595|561060547|FG003|Status at Week 68|Non-compliance with study treatment|1|||
155446664|NCT01544595|561060548|FG004|Status at Week 68|Non-compliance with study treatment|0|||
155446665|NCT01544595|561060549|FG005|Status at Week 68|Non-compliance with study treatment|0|||
155446666|NCT01544595|561060544|FG000|Status at Week 68|Protocol Violation|2|||
155446667|NCT01544595|561060545|FG001|Status at Week 68|Protocol Violation|0|||
155446668|NCT01544595|561060546|FG002|Status at Week 68|Protocol Violation|1|||
155446669|NCT01544595|561060547|FG003|Status at Week 68|Protocol Violation|1|||
155446670|NCT01544595|561060548|FG004|Status at Week 68|Protocol Violation|0|||
155446671|NCT01544595|561060549|FG005|Status at Week 68|Protocol Violation|0|||
155446672|NCT01544595|561060544|FG000|Status at Week 68|Technical problems|1|||
155446673|NCT01544595|561060545|FG001|Status at Week 68|Technical problems|0|||
155446674|NCT01544595|561060546|FG002|Status at Week 68|Technical problems|0|||
155446675|NCT01544595|561060547|FG003|Status at Week 68|Technical problems|1|||
155446676|NCT01544595|561060548|FG004|Status at Week 68|Technical problems|0|||
155446677|NCT01544595|561060549|FG005|Status at Week 68|Technical problems|0|||
155446678|NCT01544595|561060544|FG000|Status at Week 68|Withdrawal by Subject|0|||
155446679|NCT01544595|561060545|FG001|Status at Week 68|Withdrawal by Subject|1|||
155446680|NCT01544595|561060546|FG002|Status at Week 68|Withdrawal by Subject|1|||
155446681|NCT01544595|561060547|FG003|Status at Week 68|Withdrawal by Subject|2|||
155446682|NCT01544595|561060548|FG004|Status at Week 68|Withdrawal by Subject|0|||
155446683|NCT01544595|561060549|FG005|Status at Week 68|Withdrawal by Subject|0|||
155446684|NCT01544595|561060544|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
155446685|NCT01544595|561060545|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
155651462|NCT00159874|561816232|FG000|Overall Study|Lack of Efficacy|2|||
155446686|NCT01544595|561060546|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
155446687|NCT01544595|561060547|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
155446688|NCT01544595|561060548|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
155446689|NCT01544595|561060549|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
155446690|NCT01544595|561060544|FG000|Status at Week 156|Withdrawal by Subject|9|||
155446691|NCT01544595|561060545|FG001|Status at Week 156|Withdrawal by Subject|10|||
155446692|NCT01544595|561060546|FG002|Status at Week 156|Withdrawal by Subject|4|||
155446693|NCT01544595|561060547|FG003|Status at Week 156|Withdrawal by Subject|9|||
155446694|NCT01544595|561060548|FG004|Status at Week 156|Withdrawal by Subject|20|||
155446695|NCT01544595|561060549|FG005|Status at Week 156|Withdrawal by Subject|6|||
155446696|NCT01544595|561060544|FG000|Status at Week 156|Adverse Event|9|||
155446697|NCT01544595|561060545|FG001|Status at Week 156|Adverse Event|11|||
155446698|NCT01544595|561060546|FG002|Status at Week 156|Adverse Event|1|||
155446699|NCT01544595|561060547|FG003|Status at Week 156|Adverse Event|3|||
155446700|NCT01544595|561060548|FG004|Status at Week 156|Adverse Event|4|||
155446701|NCT01544595|561060549|FG005|Status at Week 156|Adverse Event|2|||
155446702|NCT01544595|561060544|FG000|Status at Week 156|Lost to Follow-up|4|||
155446703|NCT01544595|561060545|FG001|Status at Week 156|Lost to Follow-up|4|||
155446704|NCT01544595|561060546|FG002|Status at Week 156|Lost to Follow-up|0|||
155446705|NCT01544595|561060547|FG003|Status at Week 156|Lost to Follow-up|1|||
155446706|NCT01544595|561060548|FG004|Status at Week 156|Lost to Follow-up|4|||
155446707|NCT01544595|561060549|FG005|Status at Week 156|Lost to Follow-up|1|||
155446708|NCT01544595|561060544|FG000|Status at Week 156|Non-compliance with study treatement|0|||
155446709|NCT01544595|561060545|FG001|Status at Week 156|Non-compliance with study treatement|1|||
155446710|NCT01544595|561060546|FG002|Status at Week 156|Non-compliance with study treatement|0|||
155446711|NCT01544595|561060547|FG003|Status at Week 156|Non-compliance with study treatement|1|||
155446712|NCT01544595|561060548|FG004|Status at Week 156|Non-compliance with study treatement|0|||
155446713|NCT01544595|561060549|FG005|Status at Week 156|Non-compliance with study treatement|1|||
155446714|NCT01544595|561060544|FG000|Status at Week 156|Physician Decision|0|||
155446715|NCT01544595|561060545|FG001|Status at Week 156|Physician Decision|3|||
155446716|NCT01544595|561060546|FG002|Status at Week 156|Physician Decision|1|||
155446717|NCT01544595|561060547|FG003|Status at Week 156|Physician Decision|0|||
155446718|NCT01544595|561060548|FG004|Status at Week 156|Physician Decision|0|||
155446719|NCT01544595|561060549|FG005|Status at Week 156|Physician Decision|0|||
155446720|NCT01544595|561060544|FG000|Status at Week 156|Pregnancy|2|||
155446721|NCT01544595|561060545|FG001|Status at Week 156|Pregnancy|3|||
155446722|NCT01544595|561060546|FG002|Status at Week 156|Pregnancy|0|||
155446723|NCT01544595|561060547|FG003|Status at Week 156|Pregnancy|0|||
155446724|NCT01544595|561060548|FG004|Status at Week 156|Pregnancy|0|||
155446725|NCT01544595|561060549|FG005|Status at Week 156|Pregnancy|0|||
155446726|NCT01544595|561060544|FG000|Status at Week 156|Protocol Violation|3|||
155446727|NCT01544595|561060545|FG001|Status at Week 156|Protocol Violation|1|||
155446728|NCT01544595|561060546|FG002|Status at Week 156|Protocol Violation|2|||
155446729|NCT01544595|561060547|FG003|Status at Week 156|Protocol Violation|2|||
155446730|NCT01544595|561060548|FG004|Status at Week 156|Protocol Violation|0|||
155446731|NCT01544595|561060549|FG005|Status at Week 156|Protocol Violation|0|||
155446732|NCT01544595|561060544|FG000|Status at Week 156|Technical problems|3|||
155446733|NCT01544595|561060545|FG001|Status at Week 156|Technical problems|1|||
155446734|NCT01544595|561060546|FG002|Status at Week 156|Technical problems|0|||
155446735|NCT01544595|561060547|FG003|Status at Week 156|Technical problems|1|||
155446736|NCT01544595|561060548|FG004|Status at Week 156|Technical problems|0|||
155446737|NCT01544595|561060549|FG005|Status at Week 156|Technical problems|0|||
155446738|NCT01544595|561060544|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
155446739|NCT01544595|561060545|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
155446740|NCT01544595|561060546|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
155446741|NCT01544595|561060547|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
155446742|NCT01544595|561060548|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
155515288|NCT04670068|561311568|FG001|Overall Study|Progressive Disease|1|||
155446743|NCT01544595|561060549|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
155446744|NCT01544595|561060544|FG000|Status at Week 156|Lack of Efficacy|1|||
155446745|NCT01544595|561060545|FG001|Status at Week 156|Lack of Efficacy|0|||
155446746|NCT01544595|561060546|FG002|Status at Week 156|Lack of Efficacy|1|||
155446747|NCT01544595|561060547|FG003|Status at Week 156|Lack of Efficacy|4|||
155515289|NCT04670068|561311567|FG000|Overall Study|Withdrawal by Subject|1|||
155651463|NCT00159874|561816233|FG001|Overall Study|Lack of Efficacy|0|||
155651464|NCT00159874|561816234|FG002|Overall Study|Lack of Efficacy|1|||
155651465|NCT00159874|561816235|FG003|Overall Study|Lack of Efficacy|1|||
155651466|NCT00159874|561816236|FG004|Overall Study|Lack of Efficacy|0|||
155651467|NCT00159874|561816237|FG005|Overall Study|Lack of Efficacy|3|||
155446748|NCT01544595|561060548|FG004|Status at Week 156|Lack of Efficacy|10|||
155446749|NCT01544595|561060549|FG005|Status at Week 156|Lack of Efficacy|5|||
155446750|NCT01108809|561060550|FG000|Overall Study|Adverse Event|3|||
155446751|NCT01108809|561060550|FG000|Overall Study|Lost to Follow-up|1|||
155446752|NCT02379923|561060562|FG000|Overall Study|Death|5|||
155446753|NCT03643432|561060563|FG000|Overall Study|Lost to Follow-up|1|||
155446754|NCT03643432|561060564|FG001|Overall Study|Lost to Follow-up|0|||
155446755|NCT00804193|561060565|FG000|Overall Study|Lack of baseline fungus|32|||
155446756|NCT00804193|561060566|FG001|Overall Study|Lack of baseline fungus|31|||
155446757|NCT00804193|561060567|FG002|Overall Study|Lack of baseline fungus|19|||
155446758|NCT00804193|561060565|FG000|Overall Study|Adverse Event|0|||
155446759|NCT00804193|561060566|FG001|Overall Study|Adverse Event|0|||
155446760|NCT00804193|561060567|FG002|Overall Study|Adverse Event|2|||
155446761|NCT00804193|561060565|FG000|Overall Study|Lack of Efficacy|1|||
155446762|NCT00804193|561060566|FG001|Overall Study|Lack of Efficacy|1|||
155446763|NCT00804193|561060567|FG002|Overall Study|Lack of Efficacy|3|||
155446764|NCT00804193|561060565|FG000|Overall Study|Protocol Violation|0|||
155446765|NCT00804193|561060566|FG001|Overall Study|Protocol Violation|8|||
155446766|NCT00804193|561060567|FG002|Overall Study|Protocol Violation|2|||
155446767|NCT00804193|561060565|FG000|Overall Study|Lost to Follow-up|3|||
155446768|NCT00804193|561060566|FG001|Overall Study|Lost to Follow-up|3|||
155446769|NCT00804193|561060567|FG002|Overall Study|Lost to Follow-up|4|||
155446770|NCT00804193|561060565|FG000|Overall Study|Withdrawal by Subject|3|||
155446771|NCT00804193|561060566|FG001|Overall Study|Withdrawal by Subject|1|||
155446772|NCT00804193|561060567|FG002|Overall Study|Withdrawal by Subject|2|||
155446773|NCT01193348|561060570|FG000|Screening Period|Screen Failure|5|||
155446774|NCT01193348|561060570|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
155446775|NCT01193348|561060570|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
155446776|NCT01193348|561060570|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
155446777|NCT01193348|561060570|FG000|Extension Treatment Period|Physician Decision|1|||
155446778|NCT01193348|561060570|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
155446779|NCT02928406|561060571|FG000|Overall Study|Death|780|||
155446780|NCT02928406|561060571|FG000|Overall Study|Progressive disease|3|||
155446781|NCT02928406|561060571|FG000|Overall Study|Lost to Follow-up|49|||
155446782|NCT02928406|561060571|FG000|Overall Study|Non-compliance|2|||
155446783|NCT02928406|561060571|FG000|Overall Study|Withdrawal by Subject|40|||
155446784|NCT02928406|561060571|FG000|Overall Study|Study terminated by sponsor|57|||
155446785|NCT02928406|561060571|FG000|Overall Study|Physician Decision|1|||
155446786|NCT02928406|561060571|FG000|Overall Study|Various reasons|72|||
155446787|NCT01745393|561060572|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
155651468|NCT00159874|561816238|FG006|Overall Study|Lack of Efficacy|0|||
155651469|NCT00159874|561816232|FG000|Overall Study|Lost to Follow-up|1|||
155651470|NCT00159874|561816233|FG001|Overall Study|Lost to Follow-up|0|||
155446788|NCT01745393|561060573|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
155446789|NCT01745393|561060572|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
155446790|NCT01745393|561060573|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
155446791|NCT01745393|561060572|FG000|12-month Follow-up|Lost to Follow-up|6|||
155446792|NCT01745393|561060573|FG001|12-month Follow-up|Lost to Follow-up|5|||
155446793|NCT00905021|561060574|FG000|Overall Study|Adverse Event|2|||
155446794|NCT00786838|561060575|FG000|Overall Study|Physician Decision|4|||
155446795|NCT00786838|561060575|FG000|Overall Study|Death|4|||
155651471|NCT00159874|561816234|FG002|Overall Study|Lost to Follow-up|3|||
155446796|NCT00786838|561060575|FG000|Overall Study|Adverse Event|6|||
155446797|NCT00786838|561060575|FG000|Overall Study|Progressive disease|31|||
155446798|NCT00786838|561060575|FG000|Overall Study|Withdrawal by Subject|4|||
155446799|NCT04937816|561060576|FG000|Overall Study|Study drug stopped, reason missing|5|||
155446800|NCT04937816|561060577|FG001|Overall Study|Study drug stopped, reason missing|3|||
155446801|NCT04937816|561060578|FG002|Overall Study|Study drug stopped, reason missing|4|||
155446802|NCT04937816|561060579|FG003|Overall Study|Study drug stopped, reason missing|6|||
155446803|NCT04937816|561060580|FG004|Overall Study|Study drug stopped, reason missing|1|||
155446804|NCT04937816|561060581|FG005|Overall Study|Study drug stopped, reason missing|0|||
155446805|NCT04937816|561060582|FG006|Overall Study|Study drug stopped, reason missing|0|||
155446806|NCT04937816|561060576|FG000|Overall Study|Other than stated below|173|||
155446807|NCT04937816|561060577|FG001|Overall Study|Other than stated below|143|||
155446808|NCT04937816|561060578|FG002|Overall Study|Other than stated below|125|||
155446809|NCT04937816|561060579|FG003|Overall Study|Other than stated below|44|||
155446810|NCT04937816|561060580|FG004|Overall Study|Other than stated below|45|||
155651472|NCT00159874|561816235|FG003|Overall Study|Lost to Follow-up|0|||
155446811|NCT04937816|561060581|FG005|Overall Study|Other than stated below|28|||
155446812|NCT04937816|561060582|FG006|Overall Study|Other than stated below|31|||
155446813|NCT04937816|561060576|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
155446814|NCT04937816|561060577|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
155446815|NCT04937816|561060578|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
155446816|NCT04937816|561060579|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
155446817|NCT04937816|561060580|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
155446818|NCT04937816|561060581|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
155446819|NCT04937816|561060582|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
155446820|NCT04937816|561060576|FG000|Overall Study|Lost to Follow-up|15|||
155446821|NCT04937816|561060577|FG001|Overall Study|Lost to Follow-up|9|||
155446822|NCT04937816|561060578|FG002|Overall Study|Lost to Follow-up|6|||
155446823|NCT04937816|561060579|FG003|Overall Study|Lost to Follow-up|6|||
155446824|NCT04937816|561060580|FG004|Overall Study|Lost to Follow-up|16|||
155446825|NCT04937816|561060581|FG005|Overall Study|Lost to Follow-up|11|||
155446826|NCT04937816|561060582|FG006|Overall Study|Lost to Follow-up|17|||
155446827|NCT04937816|561060576|FG000|Overall Study|Protocol Violation|15|||
155446828|NCT04937816|561060577|FG001|Overall Study|Protocol Violation|15|||
155446829|NCT04937816|561060578|FG002|Overall Study|Protocol Violation|12|||
155446830|NCT04937816|561060579|FG003|Overall Study|Protocol Violation|30|||
155446831|NCT04937816|561060580|FG004|Overall Study|Protocol Violation|24|||
155446832|NCT04937816|561060581|FG005|Overall Study|Protocol Violation|5|||
155446833|NCT04937816|561060582|FG006|Overall Study|Protocol Violation|5|||
155446834|NCT04937816|561060576|FG000|Overall Study|Adverse Event|303|||
155446835|NCT04937816|561060577|FG001|Overall Study|Adverse Event|267|||
155446836|NCT04937816|561060578|FG002|Overall Study|Adverse Event|273|||
155515290|NCT04670068|561311568|FG001|Overall Study|Withdrawal by Subject|0|||
155446837|NCT04937816|561060579|FG003|Overall Study|Adverse Event|553|||
155446838|NCT04937816|561060580|FG004|Overall Study|Adverse Event|575|||
155446839|NCT04937816|561060581|FG005|Overall Study|Adverse Event|343|||
155446840|NCT04937816|561060582|FG006|Overall Study|Adverse Event|337|||
155446841|NCT04937816|561060576|FG000|Overall Study|Not treated|4|||
155446842|NCT04937816|561060577|FG001|Overall Study|Not treated|2|||
155446843|NCT04937816|561060578|FG002|Overall Study|Not treated|2|||
155446844|NCT04937816|561060579|FG003|Overall Study|Not treated|2|||
155446845|NCT04937816|561060580|FG004|Overall Study|Not treated|1|||
155446846|NCT04937816|561060581|FG005|Overall Study|Not treated|4|||
155446847|NCT04937816|561060582|FG006|Overall Study|Not treated|0|||
155446848|NCT02488759|561060584|FG000|Overall Study|Disease progression|73|||
155446849|NCT02488759|561060585|FG001|Overall Study|Disease progression|111|||
155446850|NCT02488759|561060586|FG002|Overall Study|Disease progression|62|||
155446851|NCT02488759|561060587|FG003|Overall Study|Disease progression|7|||
155446852|NCT02488759|561060588|FG004|Overall Study|Disease progression|4|||
155446853|NCT02488759|561060589|FG005|Overall Study|Disease progression|2|||
155446854|NCT02488759|561060584|FG000|Overall Study|Study drug toxicity|11|||
155446855|NCT02488759|561060585|FG001|Overall Study|Study drug toxicity|33|||
155446856|NCT02488759|561060586|FG002|Overall Study|Study drug toxicity|31|||
155446857|NCT02488759|561060587|FG003|Overall Study|Study drug toxicity|0|||
155446858|NCT02488759|561060588|FG004|Overall Study|Study drug toxicity|0|||
155446859|NCT02488759|561060589|FG005|Overall Study|Study drug toxicity|2|||
155446860|NCT02488759|561060584|FG000|Overall Study|Adverse event unrelated to study drug|9|||
155446861|NCT02488759|561060585|FG001|Overall Study|Adverse event unrelated to study drug|11|||
155446862|NCT02488759|561060586|FG002|Overall Study|Adverse event unrelated to study drug|7|||
155446863|NCT02488759|561060587|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155446864|NCT02488759|561060588|FG004|Overall Study|Adverse event unrelated to study drug|1|||
155446865|NCT02488759|561060589|FG005|Overall Study|Adverse event unrelated to study drug|0|||
155446866|NCT02488759|561060584|FG000|Overall Study|Participant request to discontinue study treatment|6|||
155446867|NCT02488759|561060585|FG001|Overall Study|Participant request to discontinue study treatment|8|||
155446868|NCT02488759|561060586|FG002|Overall Study|Participant request to discontinue study treatment|4|||
155446869|NCT02488759|561060587|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155446870|NCT02488759|561060588|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155446871|NCT02488759|561060589|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155446872|NCT02488759|561060584|FG000|Overall Study|Withdrawal by Subject|4|||
155515291|NCT04684524|561311569|FG000|Overall Study|Other|2|||
155515292|NCT04684524|561311570|FG001|Overall Study|Other|0|||
155515293|NCT04684524|561311569|FG000|Overall Study|Withdrawal by Subject|5|||
155446873|NCT02488759|561060585|FG001|Overall Study|Withdrawal by Subject|0|||
155446874|NCT02488759|561060586|FG002|Overall Study|Withdrawal by Subject|3|||
155446875|NCT02488759|561060587|FG003|Overall Study|Withdrawal by Subject|0|||
155446876|NCT02488759|561060588|FG004|Overall Study|Withdrawal by Subject|0|||
155446877|NCT02488759|561060589|FG005|Overall Study|Withdrawal by Subject|2|||
155515294|NCT04684524|561311570|FG001|Overall Study|Withdrawal by Subject|3|||
155651473|NCT00159874|561816236|FG004|Overall Study|Lost to Follow-up|1|||
155446878|NCT02488759|561060584|FG000|Overall Study|Lost to Follow-up|0|||
155446879|NCT02488759|561060585|FG001|Overall Study|Lost to Follow-up|0|||
155446880|NCT02488759|561060586|FG002|Overall Study|Lost to Follow-up|2|||
155446881|NCT02488759|561060587|FG003|Overall Study|Lost to Follow-up|0|||
155446882|NCT02488759|561060588|FG004|Overall Study|Lost to Follow-up|0|||
155446883|NCT02488759|561060589|FG005|Overall Study|Lost to Follow-up|0|||
155446884|NCT02488759|561060584|FG000|Overall Study|Maximum clinical benefit|3|||
155446885|NCT02488759|561060585|FG001|Overall Study|Maximum clinical benefit|0|||
155446886|NCT02488759|561060586|FG002|Overall Study|Maximum clinical benefit|1|||
155446887|NCT02488759|561060587|FG003|Overall Study|Maximum clinical benefit|0|||
155446888|NCT02488759|561060588|FG004|Overall Study|Maximum clinical benefit|0|||
155446889|NCT02488759|561060589|FG005|Overall Study|Maximum clinical benefit|0|||
155446890|NCT02488759|561060584|FG000|Overall Study|Other reasons|7|||
155446891|NCT02488759|561060585|FG001|Overall Study|Other reasons|32|||
155446892|NCT02488759|561060586|FG002|Overall Study|Other reasons|23|||
155446893|NCT02488759|561060587|FG003|Overall Study|Other reasons|1|||
155446894|NCT02488759|561060588|FG004|Overall Study|Other reasons|1|||
155446895|NCT02488759|561060589|FG005|Overall Study|Other reasons|1|||
155446896|NCT03860844|561060590|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
155446897|NCT03860844|561060591|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
155446898|NCT03860844|561060592|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
155446899|NCT03860844|561060590|FG000|Overall Study|Progressive disease|5|||
155446900|NCT03860844|561060591|FG001|Overall Study|Progressive disease|3|||
155446901|NCT03860844|561060592|FG002|Overall Study|Progressive disease|4|||
155446902|NCT03860844|561060590|FG000|Overall Study|Other, Not related to COVID-19|0|||
155446903|NCT03860844|561060591|FG001|Overall Study|Other, Not related to COVID-19|1|||
155446904|NCT03860844|561060592|FG002|Overall Study|Other, Not related to COVID-19|0|||
155446905|NCT01678807|561060598|FG000|Overall Study|Adverse Event|4|||
155446906|NCT01678807|561060599|FG001|Overall Study|Adverse Event|4|||
155446907|NCT01678807|561060600|FG002|Overall Study|Adverse Event|0|||
155446908|NCT01678807|561060598|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
155446909|NCT01678807|561060599|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
155446910|NCT01678807|561060600|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
155446911|NCT02574312|561060601|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
155446912|NCT02574312|561060602|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
155446913|NCT05306873|561062026|FG000|Stage 2|Study stopped|1|||
155446914|NCT05306873|561062027|FG001|Stage 2|Study stopped|1|||
155446915|NCT05306873|561062028|FG002|Stage 2|Study stopped|0|||
155446916|NCT05306873|561062029|FG003|Stage 2|Study stopped|0|||
155446917|NCT05306873|561062026|FG000|Stage 2|Stage 2 Treatment Failure|2|||
155446918|NCT05306873|561062027|FG001|Stage 2|Stage 2 Treatment Failure|3|||
155446919|NCT05306873|561062028|FG002|Stage 2|Stage 2 Treatment Failure|0|||
155446920|NCT05306873|561062029|FG003|Stage 2|Stage 2 Treatment Failure|0|||
155446921|NCT05306873|561062026|FG000|Stage 2|Logistical issues due to participant moving|1|||
155446922|NCT05306873|561062027|FG001|Stage 2|Logistical issues due to participant moving|0|||
155446923|NCT05306873|561062028|FG002|Stage 2|Logistical issues due to participant moving|0|||
155446924|NCT05306873|561062029|FG003|Stage 2|Logistical issues due to participant moving|0|||
155446925|NCT05306873|561062026|FG000|Stage 3|Stage 3 Treatment Failure|0|||
155446926|NCT05306873|561062027|FG001|Stage 3|Stage 3 Treatment Failure|0|||
155446927|NCT05306873|561062028|FG002|Stage 3|Stage 3 Treatment Failure|0|||
155446928|NCT05306873|561062029|FG003|Stage 3|Stage 3 Treatment Failure|1|||
155446929|NCT05306873|561062026|FG000|Stage 3|Study Stopped|0|||
155446930|NCT05306873|561062027|FG001|Stage 3|Study Stopped|0|||
155446931|NCT05306873|561062028|FG002|Stage 3|Study Stopped|1|||
155446932|NCT05306873|561062029|FG003|Stage 3|Study Stopped|0|||
155446933|NCT04920084|561062035|FG000|Overall Study|Adverse Event|1|||
155446934|NCT04920084|561062035|FG000|Overall Study|Lost to Follow-up|2|||
155446935|NCT04920084|561062035|FG000|Overall Study|Withdrawal by Subject|2|||
155446936|NCT00074412|561062036|FG000|Overall Study|Death|30|||
155446937|NCT00074412|561062037|FG001|Overall Study|Death|26|||
155446938|NCT00074412|561062036|FG000|Overall Study|Lost to Follow-up|52|||
155446939|NCT00074412|561062037|FG001|Overall Study|Lost to Follow-up|58|||
155651474|NCT00159874|561816237|FG005|Overall Study|Lost to Follow-up|2|||
155651475|NCT00159874|561816238|FG006|Overall Study|Lost to Follow-up|1|||
155446940|NCT00418834|561062040|FG000|Overall Study|Adverse Event|16|||
155446941|NCT00418834|561062041|FG001|Overall Study|Adverse Event|9|||
155446942|NCT00418834|561062040|FG000|Overall Study|Lost to Follow-up|0|||
155446943|NCT00418834|561062041|FG001|Overall Study|Lost to Follow-up|1|||
155446944|NCT00418834|561062040|FG000|Overall Study|Protocol Violation|4|||
155515295|NCT04684524|561311569|FG000|Overall Study|Adverse Event|1|||
155515296|NCT04684524|561311570|FG001|Overall Study|Adverse Event|1|||
155446945|NCT00418834|561062041|FG001|Overall Study|Protocol Violation|3|||
155446946|NCT00418834|561062040|FG000|Overall Study|Withdrawal by Subject|3|||
155446947|NCT00418834|561062041|FG001|Overall Study|Withdrawal by Subject|7|||
155446948|NCT01755195|561062044|FG000|Overall Study|Participant noncompliance|2|||
155446949|NCT01755195|561062044|FG000|Overall Study|Switched to alternative treatment|4|||
155446950|NCT01755195|561062044|FG000|Overall Study|Withdrawal by Subject|1|||
155446951|NCT01755195|561062044|FG000|Overall Study|Participant refused to start treatment|1|||
155446952|NCT01755195|561062044|FG000|Overall Study|Participant has been consented for another trial|1|||
155515297|NCT04182204|561311574|FG000|Safety Run-in|Lost to Follow-up|1|||
155446953|NCT01755195|561062044|FG000|Overall Study|Refused further treatment|3|||
155446954|NCT01755195|561062044|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
155446955|NCT05113953|561062045|FG000|Overall Study|Adverse Event|5|||
155446956|NCT05113953|561062046|FG001|Overall Study|Adverse Event|0|||
155446957|NCT05113953|561062047|FG002|Overall Study|Adverse Event|3|||
155446958|NCT05113953|561062045|FG000|Overall Study|Lost to Follow-up|3|||
155446959|NCT05113953|561062046|FG001|Overall Study|Lost to Follow-up|4|||
155446960|NCT05113953|561062047|FG002|Overall Study|Lost to Follow-up|2|||
155446961|NCT05113953|561062045|FG000|Overall Study|Non-compliance with Study Drug|1|||
155446962|NCT05113953|561062046|FG001|Overall Study|Non-compliance with Study Drug|0|||
155446963|NCT05113953|561062047|FG002|Overall Study|Non-compliance with Study Drug|0|||
155446964|NCT05113953|561062045|FG000|Overall Study|Withdrawal by Subject|2|||
155446965|NCT05113953|561062046|FG001|Overall Study|Withdrawal by Subject|6|||
155446966|NCT05113953|561062047|FG002|Overall Study|Withdrawal by Subject|4|||
155446967|NCT05113953|561062045|FG000|Overall Study|Reason not Specified|2|||
155446968|NCT05113953|561062046|FG001|Overall Study|Reason not Specified|0|||
155446969|NCT05113953|561062047|FG002|Overall Study|Reason not Specified|0|||
155446970|NCT03470922|561062053|FG000|Overall Study|Death|107|||
155446971|NCT03470922|561062054|FG001|Overall Study|Death|118|||
155446972|NCT03470922|561062053|FG000|Overall Study|Lost to Follow-up|5|||
155446973|NCT03470922|561062054|FG001|Overall Study|Lost to Follow-up|5|||
155446974|NCT03470922|561062053|FG000|Overall Study|Participant Withdrew Consent|4|||
155446975|NCT03470922|561062054|FG001|Overall Study|Participant Withdrew Consent|9|||
155446976|NCT03470922|561062053|FG000|Overall Study|Other reasons|1|||
155446977|NCT03470922|561062054|FG001|Overall Study|Other reasons|0|||
155446978|NCT03470922|561062053|FG000|Overall Study|Not reported|1|||
155446979|NCT03470922|561062054|FG001|Overall Study|Not reported|0|||
155446980|NCT02340819|561062055|FG000|Overall Study|Adverse Event|1|||
155446981|NCT02340819|561062055|FG000|Overall Study|Withdrawal by Subject|2|||
155446982|NCT02340819|561062055|FG000|Overall Study|Discontinued with other reason|1|||
155446983|NCT02626819|561062056|FG000|Overall Study|Lost to Follow-up|3|||
155446984|NCT02626819|561062057|FG001|Overall Study|Lost to Follow-up|2|||
155446985|NCT02626819|561062056|FG000|Overall Study|Withdrawal by Subject|1|||
155446986|NCT02626819|561062057|FG001|Overall Study|Withdrawal by Subject|0|||
155446987|NCT02626819|561062056|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
155446988|NCT02626819|561062057|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
155446989|NCT02361762|561062058|FG000|Overall Study|Withdrawal by Subject|0|||
155446990|NCT02361762|561062059|FG001|Overall Study|Withdrawal by Subject|1|||
155446991|NCT02361762|561062058|FG000|Overall Study|Lost to Follow-up|0|||
155446992|NCT02361762|561062059|FG001|Overall Study|Lost to Follow-up|1|||
155446993|NCT00502307|561062062|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
155446994|NCT00502307|561062063|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
155446995|NCT00502307|561062064|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
155446996|NCT00502307|561062062|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
155446997|NCT00502307|561062063|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
155446998|NCT00502307|561062064|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
155446999|NCT00502307|561062062|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
155447000|NCT00502307|561062063|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
155447001|NCT00502307|561062064|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
155447002|NCT00502307|561062062|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
155447003|NCT00502307|561062063|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
155447004|NCT00502307|561062064|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
155447005|NCT00502307|561062062|FG000|Maintenance Period|Progressive disease|80|||
155447006|NCT00502307|561062063|FG001|Maintenance Period|Progressive disease|0|||
155447007|NCT00502307|561062064|FG002|Maintenance Period|Progressive disease|0|||
155447008|NCT00502307|561062062|FG000|Maintenance Period|Discontinued due to other reasons|68|||
155447009|NCT00502307|561062063|FG001|Maintenance Period|Discontinued due to other reasons|0|||
155447010|NCT00502307|561062064|FG002|Maintenance Period|Discontinued due to other reasons|0|||
155447011|NCT04467164|561062067|FG000|Washout (1 Week)|Lost to Follow-up|2|||
155447012|NCT04467164|561062068|FG001|Washout (1 Week)|Lost to Follow-up|0|||
155447013|NCT02750813|561062069|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
155447014|NCT02750813|561062070|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
155447015|NCT02750813|561062069|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
155447016|NCT02750813|561062070|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
155447017|NCT01998581|561062071|FG000|Overall Study|Refused repeat treatment|20|||
155447018|NCT01998581|561062072|FG001|Overall Study|Refused repeat treatment|4|||
155447019|NCT01998581|561062071|FG000|Overall Study|Protocol Violation|1|||
155447020|NCT01998581|561062072|FG001|Overall Study|Protocol Violation|0|||
155447021|NCT01998581|561062071|FG000|Overall Study|Withdrawal by Subject|8|||
155447022|NCT01998581|561062072|FG001|Overall Study|Withdrawal by Subject|1|||
155447023|NCT01998581|561062071|FG000|Overall Study|Lost to Follow-up|12|||
155447024|NCT01998581|561062072|FG001|Overall Study|Lost to Follow-up|4|||
155447025|NCT01998581|561062071|FG000|Overall Study|Adverse Event|1|||
155447026|NCT01998581|561062072|FG001|Overall Study|Adverse Event|1|||
155447027|NCT01998581|561062071|FG000|Overall Study|Other reasons|3|||
155447028|NCT01998581|561062072|FG001|Overall Study|Other reasons|2|||
155447029|NCT01998581|561062071|FG000|Overall Study|Randomized but withdrew before treatment|1|||
155447030|NCT01998581|561062072|FG001|Overall Study|Randomized but withdrew before treatment|0|||
155447031|NCT02273050|561062075|FG000|Overall Study|Adverse Event|4|||
155447032|NCT02273050|561062076|FG001|Overall Study|Adverse Event|3|||
155447033|NCT02273050|561062077|FG002|Overall Study|Adverse Event|3|||
155447034|NCT02273050|561062075|FG000|Overall Study|Death|0|||
155447035|NCT02273050|561062076|FG001|Overall Study|Death|0|||
155447036|NCT02273050|561062077|FG002|Overall Study|Death|1|||
155447037|NCT02273050|561062075|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
155447038|NCT02273050|561062076|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
155447039|NCT02273050|561062077|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
155447040|NCT02273050|561062075|FG000|Overall Study|Lack of Efficacy|0|||
155447041|NCT02273050|561062076|FG001|Overall Study|Lack of Efficacy|1|||
155447042|NCT02273050|561062077|FG002|Overall Study|Lack of Efficacy|1|||
155447043|NCT02273050|561062075|FG000|Overall Study|Withdrawal by Subject|17|||
155447044|NCT02273050|561062076|FG001|Overall Study|Withdrawal by Subject|14|||
155447045|NCT02273050|561062077|FG002|Overall Study|Withdrawal by Subject|16|||
155447046|NCT02273050|561062075|FG000|Overall Study|Lost to Follow-up|0|||
155447047|NCT02273050|561062076|FG001|Overall Study|Lost to Follow-up|2|||
155447048|NCT02273050|561062077|FG002|Overall Study|Lost to Follow-up|3|||
155447049|NCT02273050|561062075|FG000|Overall Study|Protocol Violation|3|||
155447050|NCT02273050|561062076|FG001|Overall Study|Protocol Violation|1|||
155447051|NCT02273050|561062077|FG002|Overall Study|Protocol Violation|4|||
155447052|NCT02273752|561062078|FG000|Overall Study|Trial was terminated early|2|||
155447053|NCT00903032|561062079|FG000|Overall Study|Withdrawal by Subject|5|||
155447054|NCT00903032|561062080|FG001|Overall Study|Withdrawal by Subject|3|||
155447055|NCT00903032|561062079|FG000|Overall Study|Lost to Follow-up|2|||
155447056|NCT00903032|561062080|FG001|Overall Study|Lost to Follow-up|2|||
155447057|NCT01429792|561062081|FG000|Overall Study|Other Reasons|67|||
155447058|NCT01429792|561062081|FG000|Overall Study|Unknown Disposition|94|||
155447059|NCT01429792|561062081|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
155447060|NCT01429792|561062081|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
155447061|NCT01429792|561062081|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
155447062|NCT01429792|561062081|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
155447063|NCT01429792|561062081|FG000|Overall Study|Withdrawal by Subject|70|||
155447064|NCT01429792|561062081|FG000|Overall Study|Lost to Follow-up|88|||
155447065|NCT04346628|561062084|FG000|Overall Study|Lost to Follow-up|4|||
155447066|NCT04346628|561062085|FG001|Overall Study|Lost to Follow-up|4|||
155447067|NCT04346628|561062084|FG000|Overall Study|Withdrew (had personal reasons)|2|||
155447068|NCT04346628|561062085|FG001|Overall Study|Withdrew (had personal reasons)|5|||
155447069|NCT04346628|561062084|FG000|Overall Study|Withdrew (medication intolerant)|0|||
155447070|NCT04346628|561062085|FG001|Overall Study|Withdrew (medication intolerant)|3|||
155447071|NCT04346628|561062084|FG000|Overall Study|Withdrew (declined intervention)|0|||
155447072|NCT04346628|561062085|FG001|Overall Study|Withdrew (declined intervention)|1|||
155447073|NCT01763905|561062086|FG000|Overall Study|Withdrawal by Subject|1|||
155447074|NCT01763905|561062087|FG001|Overall Study|Withdrawal by Subject|1|||
155447075|NCT01763905|561062088|FG002|Overall Study|Withdrawal by Subject|0|||
155447076|NCT01763905|561062089|FG003|Overall Study|Withdrawal by Subject|1|||
155447077|NCT01763905|561062086|FG000|Overall Study|Decision by sponsor|5|||
155447078|NCT01763905|561062087|FG001|Overall Study|Decision by sponsor|0|||
155447079|NCT01763905|561062088|FG002|Overall Study|Decision by sponsor|8|||
155447080|NCT01763905|561062089|FG003|Overall Study|Decision by sponsor|0|||
155447081|NCT01763905|561062086|FG000|Overall Study|Lost to Follow-up|0|||
155447082|NCT01763905|561062087|FG001|Overall Study|Lost to Follow-up|0|||
155447083|NCT01763905|561062088|FG002|Overall Study|Lost to Follow-up|1|||
155447084|NCT01763905|561062089|FG003|Overall Study|Lost to Follow-up|0|||
155447085|NCT02324842|561062090|FG000|Overall Study|Lost to Follow-up|1|||
155447086|NCT02324842|561062091|FG001|Overall Study|Lost to Follow-up|1|||
155447087|NCT02324842|561062092|FG002|Overall Study|Lost to Follow-up|2|||
155651476|NCT00159874|561816232|FG000|Overall Study|Other|8|||
155447088|NCT01263691|561062097|FG000|Overall Study|Lost to Follow-up|1|||
155447089|NCT01263691|561062098|FG001|Overall Study|Lost to Follow-up|0|||
155447090|NCT01263691|561062099|FG002|Overall Study|Lost to Follow-up|1|||
155651477|NCT00159874|561816233|FG001|Overall Study|Other|8|||
155651478|NCT00159874|561816234|FG002|Overall Study|Other|8|||
155651479|NCT00159874|561816235|FG003|Overall Study|Other|0|||
155651480|NCT00159874|561816236|FG004|Overall Study|Other|2|||
155651481|NCT00159874|561816237|FG005|Overall Study|Other|1|||
155651482|NCT00159874|561816238|FG006|Overall Study|Other|3|||
155651483|NCT00159874|561816232|FG000|Overall Study|Protocol Violation|0|||
155651484|NCT00159874|561816233|FG001|Overall Study|Protocol Violation|5|||
155651485|NCT00159874|561816234|FG002|Overall Study|Protocol Violation|2|||
155651486|NCT00159874|561816235|FG003|Overall Study|Protocol Violation|0|||
155651487|NCT00159874|561816236|FG004|Overall Study|Protocol Violation|0|||
155651488|NCT00159874|561816237|FG005|Overall Study|Protocol Violation|0|||
155651489|NCT00159874|561816238|FG006|Overall Study|Protocol Violation|0|||
155651490|NCT00159874|561816232|FG000|Overall Study|Death|3|||
155651491|NCT00159874|561816233|FG001|Overall Study|Death|8|||
155651492|NCT00159874|561816234|FG002|Overall Study|Death|15|||
155651493|NCT00159874|561816235|FG003|Overall Study|Death|0|||
155651494|NCT00159874|561816236|FG004|Overall Study|Death|1|||
155651495|NCT00159874|561816237|FG005|Overall Study|Death|2|||
155651496|NCT00159874|561816238|FG006|Overall Study|Death|0|||
155651497|NCT00159874|561816232|FG000|Overall Study|Withdrawal by Subject|2|||
155651498|NCT00159874|561816233|FG001|Overall Study|Withdrawal by Subject|6|||
155651499|NCT00159874|561816234|FG002|Overall Study|Withdrawal by Subject|8|||
155651500|NCT00159874|561816235|FG003|Overall Study|Withdrawal by Subject|4|||
155651501|NCT00159874|561816236|FG004|Overall Study|Withdrawal by Subject|3|||
155651502|NCT00159874|561816237|FG005|Overall Study|Withdrawal by Subject|2|||
155651503|NCT00159874|561816238|FG006|Overall Study|Withdrawal by Subject|1|||
155447091|NCT01263691|561062100|FG003|Overall Study|Lost to Follow-up|1|||
155447092|NCT01263691|561062101|FG004|Overall Study|Lost to Follow-up|0|||
155447093|NCT01263691|561062102|FG005|Overall Study|Lost to Follow-up|0|||
155447094|NCT01263691|561062097|FG000|Overall Study|Withdrawal by Subject|1|||
155447095|NCT01263691|561062098|FG001|Overall Study|Withdrawal by Subject|0|||
155447096|NCT01263691|561062099|FG002|Overall Study|Withdrawal by Subject|0|||
155447097|NCT01263691|561062100|FG003|Overall Study|Withdrawal by Subject|0|||
155447098|NCT01263691|561062101|FG004|Overall Study|Withdrawal by Subject|0|||
155447099|NCT01263691|561062102|FG005|Overall Study|Withdrawal by Subject|0|||
155447100|NCT01263691|561062097|FG000|Overall Study|Adverse Event|1|||
155447101|NCT01263691|561062098|FG001|Overall Study|Adverse Event|0|||
155447102|NCT01263691|561062099|FG002|Overall Study|Adverse Event|0|||
155447103|NCT01263691|561062100|FG003|Overall Study|Adverse Event|0|||
155447104|NCT01263691|561062101|FG004|Overall Study|Adverse Event|0|||
155447105|NCT01263691|561062102|FG005|Overall Study|Adverse Event|0|||
155447106|NCT01202227|561062103|FG000|Overall Study|Adverse Event|16|||
155447107|NCT01202227|561062103|FG000|Overall Study|Withdrawal by Subject|2|||
155447108|NCT01202227|561062103|FG000|Overall Study|Lack of Efficacy|1|||
155447109|NCT00643487|561062104|FG000|Overall Study|Technical difficulty|3|||
155447110|NCT01894477|561062105|FG000|Overall Study|Protocol Violation|0|||
155447111|NCT01894477|561062106|FG001|Overall Study|Protocol Violation|1|||
155447112|NCT01894477|561062105|FG000|Overall Study|protocol changed due SC changed to cord|0|||
155447113|NCT01894477|561062106|FG001|Overall Study|protocol changed due SC changed to cord|1|||
155447114|NCT00850759|561062109|FG000|Overall Study|Lost to Follow-up|7|||
155447115|NCT00850759|561062110|FG001|Overall Study|Lost to Follow-up|5|||
155651504|NCT00159874|561816232|FG000|Overall Study|Pregnancy|1|||
155651505|NCT00159874|561816233|FG001|Overall Study|Pregnancy|1|||
155651506|NCT00159874|561816234|FG002|Overall Study|Pregnancy|0|||
155651507|NCT00159874|561816235|FG003|Overall Study|Pregnancy|0|||
155651508|NCT00159874|561816236|FG004|Overall Study|Pregnancy|0|||
155651509|NCT00159874|561816237|FG005|Overall Study|Pregnancy|0|||
155651510|NCT00159874|561816238|FG006|Overall Study|Pregnancy|0|||
155651511|NCT01104870|561816239|FG000|Overall Study|Adverse Event|1|||
155651512|NCT01104870|561816240|FG001|Overall Study|Adverse Event|1|||
155651513|NCT01104870|561816241|FG002|Overall Study|Adverse Event|0|||
155447116|NCT00850759|561062111|FG002|Overall Study|Lost to Follow-up|5|||
155447117|NCT00850759|561062112|FG003|Overall Study|Lost to Follow-up|3|||
155447118|NCT02389816|561062113|FG000|Overall Study|Randomized but Not Treated|1|||
155447119|NCT02389816|561062114|FG001|Overall Study|Randomized but Not Treated|0|||
155651514|NCT01104870|561816239|FG000|Overall Study|Death|0|||
155651515|NCT01104870|561816240|FG001|Overall Study|Death|0|||
155651516|NCT01104870|561816241|FG002|Overall Study|Death|1|||
155651517|NCT01104870|561816239|FG000|Overall Study|Withdrawal by Subject|0|||
155651518|NCT01104870|561816240|FG001|Overall Study|Withdrawal by Subject|0|||
155651519|NCT01104870|561816241|FG002|Overall Study|Withdrawal by Subject|1|||
155447120|NCT02389816|561062115|FG002|Overall Study|Randomized but Not Treated|0|||
155651520|NCT02150863|561816242|FG000|Overall Study|Lost to Follow-up|0|||
155651521|NCT02150863|561816243|FG001|Overall Study|Lost to Follow-up|1|||
155447121|NCT02389816|561062113|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
155447122|NCT02389816|561062114|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
155651522|NCT02150863|561816244|FG002|Overall Study|Lost to Follow-up|0|||
155651523|NCT01853280|561816245|FG000|Overall Study|Lack of Efficacy|2|||
155651524|NCT01853280|561816246|FG001|Overall Study|Lack of Efficacy|2|||
155651525|NCT01853280|561816245|FG000|Overall Study|Lost to Follow-up|0|||
155447123|NCT02389816|561062115|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
155447124|NCT02389816|561062113|FG000|Overall Study|Major Protocol Deviation|1|||
155447125|NCT02389816|561062114|FG001|Overall Study|Major Protocol Deviation|0|||
155447126|NCT02389816|561062115|FG002|Overall Study|Major Protocol Deviation|0|||
155447127|NCT02389816|561062113|FG000|Overall Study|Lost to Follow-up|1|||
155447128|NCT02389816|561062114|FG001|Overall Study|Lost to Follow-up|0|||
155447129|NCT02389816|561062115|FG002|Overall Study|Lost to Follow-up|0|||
155447130|NCT02389816|561062113|FG000|Overall Study|Withdrawal of Consent|6|||
155447131|NCT02389816|561062114|FG001|Overall Study|Withdrawal of Consent|4|||
155447132|NCT02389816|561062115|FG002|Overall Study|Withdrawal of Consent|4|||
155447133|NCT02389816|561062113|FG000|Overall Study|Lack of Efficacy|1|||
155447134|NCT02389816|561062114|FG001|Overall Study|Lack of Efficacy|0|||
155447135|NCT02389816|561062115|FG002|Overall Study|Lack of Efficacy|0|||
155447136|NCT02389816|561062113|FG000|Overall Study|Non Compliance with Study Drug|1|||
155447137|NCT02389816|561062114|FG001|Overall Study|Non Compliance with Study Drug|1|||
155447138|NCT02389816|561062115|FG002|Overall Study|Non Compliance with Study Drug|1|||
155447139|NCT02389816|561062113|FG000|Overall Study|Reason not Specified|0|||
155447140|NCT02389816|561062114|FG001|Overall Study|Reason not Specified|2|||
155447141|NCT02389816|561062115|FG002|Overall Study|Reason not Specified|0|||
155447142|NCT00578864|561062116|FG000|Overall Study|Death|1|||
155447143|NCT00578864|561062117|FG001|Overall Study|Death|0|||
155447144|NCT01253044|561062118|FG000|Overall Study|Lost to Follow-up|38|||
155447145|NCT01253044|561062119|FG001|Overall Study|Lost to Follow-up|29|||
155447146|NCT01087528|561062120|FG000|Overall Study|Withdrawal by Subject|1|||
155447147|NCT01087528|561062120|FG000|Overall Study|Incomplete CE procedure|6|||
155447148|NCT03116399|561062121|FG000|Overall Study|Death|8|||
155447149|NCT03116399|561062122|FG001|Overall Study|Death|3|||
155447150|NCT03116399|561062121|FG000|Overall Study|Lost to Follow-up|7|||
155447151|NCT03116399|561062122|FG001|Overall Study|Lost to Follow-up|11|||
155447152|NCT03116399|561062121|FG000|Overall Study|Investigator Decision|1|||
155447153|NCT03116399|561062122|FG001|Overall Study|Investigator Decision|1|||
155447154|NCT03116399|561062121|FG000|Overall Study|Withdrawal by Subject|24|||
155447155|NCT03116399|561062122|FG001|Overall Study|Withdrawal by Subject|9|||
155447156|NCT02868216|561062124|FG000|Overall Study|Death|0|||
155447157|NCT02868216|561062125|FG001|Overall Study|Death|1|||
155447158|NCT02868216|561062124|FG000|Overall Study|coronary artery bypass|1|||
155447159|NCT02868216|561062125|FG001|Overall Study|coronary artery bypass|0|||
155447160|NCT02868216|561062124|FG000|Overall Study|Withdrawal by Subject|7|||
155447161|NCT02868216|561062125|FG001|Overall Study|Withdrawal by Subject|5|||
155447162|NCT00987623|561062126|FG000|Overall Study|Lost to Follow-up|2|||
155447163|NCT00987623|561062127|FG001|Overall Study|Lost to Follow-up|1|||
155447164|NCT00987623|561062126|FG000|Overall Study|Time/job conflict|2|||
155447165|NCT00987623|561062127|FG001|Overall Study|Time/job conflict|0|||
155447166|NCT00987623|561062126|FG000|Overall Study|Discomfort|1|||
155447167|NCT00987623|561062127|FG001|Overall Study|Discomfort|0|||
155447168|NCT00987623|561062126|FG000|Overall Study|Biomicroscopy|0|||
155447169|NCT00987623|561062127|FG001|Overall Study|Biomicroscopy|1|||
155447170|NCT00987623|561062126|FG000|Overall Study|Influenza|0|||
155447171|NCT00987623|561062127|FG001|Overall Study|Influenza|1|||
155447172|NCT00752609|561062128|FG000|Overall Study|Adverse Event|2|||
155447173|NCT00752609|561062129|FG001|Overall Study|Adverse Event|2|||
155447174|NCT00752609|561062128|FG000|Overall Study|Withdrawal by Subject|3|||
155447175|NCT00752609|561062129|FG001|Overall Study|Withdrawal by Subject|0|||
155447176|NCT00752609|561062128|FG000|Overall Study|Physician Decision|1|||
155447177|NCT00752609|561062129|FG001|Overall Study|Physician Decision|0|||
155447178|NCT00752609|561062128|FG000|Overall Study|Death|1|||
155447179|NCT00752609|561062129|FG001|Overall Study|Death|0|||
155447180|NCT00752609|561062128|FG000|Overall Study|Met exclusion criteria|1|||
155447181|NCT00752609|561062129|FG001|Overall Study|Met exclusion criteria|0|||
155447182|NCT00752609|561062128|FG000|Overall Study|Received Aranesp in error|1|||
155447183|NCT00752609|561062129|FG001|Overall Study|Received Aranesp in error|0|||
155447184|NCT05114590|561062130|FG000|Overall Study|Adverse Event|1|||
155447185|NCT05114590|561062130|FG000|Overall Study|Investigator decision|1|||
155447186|NCT05114590|561062130|FG000|Overall Study|Lost to Follow-up|5|||
155447187|NCT05114590|561062130|FG000|Overall Study|Withdrawal by Subject|5|||
155447188|NCT05114590|561062130|FG000|Overall Study|Other|2|||
155447189|NCT01425190|561062131|FG000|Overall Study|Full dose not consumed.|1|||
155447190|NCT01425190|561062132|FG001|Overall Study|Full dose not consumed.|0|||
155447191|NCT01425190|561062133|FG002|Overall Study|Full dose not consumed.|0|||
155447192|NCT00195260|561062134|FG000|Part 1: Dose Escalation|Adverse Event|0|||
155447193|NCT00195260|561062135|FG001|Part 1: Dose Escalation|Adverse Event|1|||
155447194|NCT00195260|561062136|FG002|Part 1: Dose Escalation|Adverse Event|0|||
155447195|NCT00195260|561062137|FG003|Part 1: Dose Escalation|Adverse Event|1|||
155447196|NCT00195260|561062138|FG004|Part 1: Dose Escalation|Adverse Event|1|||
155447197|NCT00195260|561062139|FG005|Part 1: Dose Escalation|Adverse Event|0|||
155447198|NCT00195260|561062140|FG006|Part 1: Dose Escalation|Adverse Event|3|||
155447199|NCT00195260|561062141|FG007|Part 1: Dose Escalation|Adverse Event|0|||
155447200|NCT00195260|561062142|FG008|Part 1: Dose Escalation|Adverse Event|0|||
155447201|NCT00195260|561062143|FG009|Part 1: Dose Escalation|Adverse Event|0|||
155447202|NCT00195260|561062144|FG010|Part 1: Dose Escalation|Adverse Event|0|||
155447203|NCT00195260|561062134|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447204|NCT00195260|561062135|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447205|NCT00195260|561062136|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447206|NCT00195260|561062137|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447207|NCT00195260|561062138|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155447208|NCT00195260|561062139|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447209|NCT00195260|561062140|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447210|NCT00195260|561062141|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155447211|NCT00195260|561062142|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447212|NCT00195260|561062143|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447213|NCT00195260|561062144|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155447214|NCT00195260|561062134|FG000|Part 1: Dose Escalation|Death|0|||
155447215|NCT00195260|561062135|FG001|Part 1: Dose Escalation|Death|0|||
155447216|NCT00195260|561062136|FG002|Part 1: Dose Escalation|Death|0|||
155447217|NCT00195260|561062137|FG003|Part 1: Dose Escalation|Death|0|||
155447218|NCT00195260|561062138|FG004|Part 1: Dose Escalation|Death|0|||
155447219|NCT00195260|561062139|FG005|Part 1: Dose Escalation|Death|0|||
155651526|NCT01853280|561816246|FG001|Overall Study|Lost to Follow-up|1|||
155447220|NCT00195260|561062140|FG006|Part 1: Dose Escalation|Death|0|||
155447221|NCT00195260|561062141|FG007|Part 1: Dose Escalation|Death|1|||
155447222|NCT00195260|561062142|FG008|Part 1: Dose Escalation|Death|0|||
155447223|NCT00195260|561062143|FG009|Part 1: Dose Escalation|Death|0|||
155447224|NCT00195260|561062144|FG010|Part 1: Dose Escalation|Death|0|||
155447225|NCT00195260|561062134|FG000|Part 1: Dose Escalation|Disease Progression|3|||
155447226|NCT00195260|561062135|FG001|Part 1: Dose Escalation|Disease Progression|2|||
155447227|NCT00195260|561062136|FG002|Part 1: Dose Escalation|Disease Progression|5|||
155447228|NCT00195260|561062137|FG003|Part 1: Dose Escalation|Disease Progression|6|||
155447229|NCT00195260|561062138|FG004|Part 1: Dose Escalation|Disease Progression|4|||
155447230|NCT00195260|561062139|FG005|Part 1: Dose Escalation|Disease Progression|6|||
155447231|NCT00195260|561062140|FG006|Part 1: Dose Escalation|Disease Progression|7|||
155447232|NCT00195260|561062141|FG007|Part 1: Dose Escalation|Disease Progression|4|||
155447233|NCT00195260|561062142|FG008|Part 1: Dose Escalation|Disease Progression|0|||
155447234|NCT00195260|561062143|FG009|Part 1: Dose Escalation|Disease Progression|0|||
155447235|NCT00195260|561062144|FG010|Part 1: Dose Escalation|Disease Progression|0|||
155447236|NCT00195260|561062134|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
155447237|NCT00195260|561062135|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
155447238|NCT00195260|561062136|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
155447239|NCT00195260|561062137|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447240|NCT00195260|561062138|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447241|NCT00195260|561062139|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
155447242|NCT00195260|561062140|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447243|NCT00195260|561062141|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447244|NCT00195260|561062142|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447245|NCT00195260|561062143|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447246|NCT00195260|561062144|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
155447247|NCT00195260|561062134|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447248|NCT00195260|561062135|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447249|NCT00195260|561062136|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447250|NCT00195260|561062137|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447251|NCT00195260|561062138|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447252|NCT00195260|561062139|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447253|NCT00195260|561062140|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447254|NCT00195260|561062141|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
155447255|NCT00195260|561062142|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
155447256|NCT00195260|561062143|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
155447257|NCT00195260|561062144|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
155447258|NCT00195260|561062134|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447259|NCT00195260|561062135|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447260|NCT00195260|561062136|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447261|NCT00195260|561062137|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447262|NCT00195260|561062138|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447263|NCT00195260|561062139|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447264|NCT00195260|561062140|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447265|NCT00195260|561062141|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
155447266|NCT00195260|561062142|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
155447267|NCT00195260|561062143|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
155447268|NCT00195260|561062144|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
155447269|NCT00195260|561062134|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447270|NCT00195260|561062135|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447271|NCT00195260|561062136|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447272|NCT00195260|561062137|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447273|NCT00195260|561062138|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447274|NCT00195260|561062139|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447275|NCT00195260|561062140|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447276|NCT00195260|561062141|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
155447277|NCT00195260|561062142|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
155447278|NCT00195260|561062143|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
155447279|NCT00195260|561062144|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
155447280|NCT00195260|561062134|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447281|NCT00195260|561062135|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447282|NCT00195260|561062136|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447283|NCT00195260|561062137|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447284|NCT00195260|561062138|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447285|NCT00195260|561062139|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447286|NCT00195260|561062140|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447287|NCT00195260|561062141|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
155447288|NCT00195260|561062142|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
155447289|NCT00195260|561062143|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
155447290|NCT00195260|561062144|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
155447291|NCT02749721|561062145|FG000|Screening|Withdrawal by Subject|1|||
155447292|NCT02749721|561062145|FG000|Screening|Lost to Follow-up|2|||
155447293|NCT02749721|561062145|FG000|Screening|Protocol Violation|3|||
155447294|NCT02749721|561062145|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
155447295|NCT02749721|561062145|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
155447296|NCT01379534|561062146|FG000|Treatment Phase|Withdrawal by Subject|2|||
155447297|NCT01379534|561062147|FG001|Treatment Phase|Withdrawal by Subject|2|||
155447298|NCT01379534|561062146|FG000|Treatment Phase|Progressive disease|13|||
155447299|NCT01379534|561062147|FG001|Treatment Phase|Progressive disease|22|||
155447300|NCT01379534|561062146|FG000|Treatment Phase|Adverse Event|7|||
155447301|NCT01379534|561062147|FG001|Treatment Phase|Adverse Event|7|||
155447302|NCT01379534|561062146|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
155447303|NCT01379534|561062147|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
155447304|NCT01379534|561062146|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
155447305|NCT01379534|561062147|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
155447306|NCT01379534|561062146|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
155447307|NCT01379534|561062147|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
155447308|NCT01379534|561062146|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
155447309|NCT01379534|561062147|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
155447310|NCT02691247|561062148|FG000|Overall Study|Withdrawal by Subject|1|||
155447311|NCT02691247|561062149|FG001|Overall Study|Withdrawal by Subject|2|||
155515298|NCT04182204|561311575|FG001|Safety Run-in|Lost to Follow-up|0|||
155651527|NCT01853280|561816245|FG000|Overall Study|Physician Decision|0|||
155651528|NCT01853280|561816246|FG001|Overall Study|Physician Decision|1|||
155447312|NCT02691247|561062150|FG002|Overall Study|Withdrawal by Subject|2|||
155447313|NCT02691247|561062148|FG000|Overall Study|Lost to Follow-up|2|||
155447314|NCT02691247|561062149|FG001|Overall Study|Lost to Follow-up|0|||
155447315|NCT02691247|561062150|FG002|Overall Study|Lost to Follow-up|1|||
155447316|NCT01519245|561062151|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
155515299|NCT04182204|561311576|FG002|Safety Run-in|Lost to Follow-up|0|||
155447317|NCT01519245|561062152|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
155447318|NCT02582749|561062153|FG000|Overall Study|Study terminated by funder|5|||
155447319|NCT02582749|561062154|FG001|Overall Study|Study terminated by funder|10|||
155447320|NCT02582749|561062153|FG000|Overall Study|Withdrawal by Subject|0|||
155447321|NCT02582749|561062154|FG001|Overall Study|Withdrawal by Subject|1|||
155447322|NCT02213198|561062155|FG000|Baseline|No show for intake|7|||
155447323|NCT02213198|561062156|FG001|Baseline|No show for intake|9|||
155447324|NCT02213198|561062155|FG000|Baseline|Withdrawal by Subject|34|||
155447325|NCT02213198|561062156|FG001|Baseline|Withdrawal by Subject|11|||
155447326|NCT02213198|561062155|FG000|Baseline|transferred out of clinic|7|||
155447327|NCT02213198|561062156|FG001|Baseline|transferred out of clinic|9|||
155447328|NCT02213198|561062155|FG000|Baseline|Lost to Follow-up|40|||
155447329|NCT02213198|561062156|FG001|Baseline|Lost to Follow-up|21|||
155447330|NCT02213198|561062155|FG000|Baseline|incarcerated,violent|0|||
155447331|NCT02213198|561062156|FG001|Baseline|incarcerated,violent|1|||
155447332|NCT02213198|561062155|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
155447333|NCT02213198|561062156|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
155447334|NCT02213198|561062155|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
155447335|NCT02213198|561062156|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
155447336|NCT02213198|561062155|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
155447337|NCT02213198|561062156|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
155447338|NCT02213198|561062155|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
155447339|NCT02213198|561062156|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
155447340|NCT02213198|561062155|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
155447341|NCT02213198|561062156|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
155447342|NCT02213198|561062155|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
155447343|NCT02213198|561062156|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
155447344|NCT01518192|561062157|FG000|Overall Study|Lost to Follow-up|29|||
155447345|NCT01518192|561062158|FG001|Overall Study|Lost to Follow-up|26|||
155447346|NCT01518192|561062159|FG002|Overall Study|Lost to Follow-up|35|||
155447347|NCT00001262|561062160|FG000|Overall Study|Death|10|||
155447348|NCT00001262|561062161|FG001|Overall Study|Death|11|||
155447349|NCT00001262|561062162|FG002|Overall Study|Death|0|||
155447350|NCT00001262|561062160|FG000|Overall Study|Withdrawal by Subject|0|||
155447351|NCT00001262|561062161|FG001|Overall Study|Withdrawal by Subject|3|||
155447352|NCT00001262|561062162|FG002|Overall Study|Withdrawal by Subject|0|||
155447353|NCT00783705|561062163|FG000|Overall Study|Adverse Event|2|||
155447354|NCT00783705|561062164|FG001|Overall Study|Adverse Event|0|||
155447355|NCT00783705|561062163|FG000|Overall Study|Withdrawal by Subject|3|||
155447356|NCT00783705|561062164|FG001|Overall Study|Withdrawal by Subject|2|||
155447357|NCT00783705|561062163|FG000|Overall Study|Lost to Follow-up|1|||
155447358|NCT00783705|561062164|FG001|Overall Study|Lost to Follow-up|3|||
155447359|NCT01987986|561062165|FG000|Overall Study|Lost to Follow-up|1|||
155447360|NCT01987986|561062166|FG001|Overall Study|Lost to Follow-up|0|||
155447361|NCT01987986|561062167|FG002|Overall Study|Lost to Follow-up|0|||
155447362|NCT01987986|561062168|FG003|Overall Study|Lost to Follow-up|0|||
155447363|NCT01987986|561062165|FG000|Overall Study|Adverse Event|1|||
155447364|NCT01987986|561062166|FG001|Overall Study|Adverse Event|0|||
155447365|NCT01987986|561062167|FG002|Overall Study|Adverse Event|2|||
155447366|NCT01987986|561062168|FG003|Overall Study|Adverse Event|0|||
155447367|NCT01617434|561062169|FG000|Overall Study|Adverse Event|12|||
155447368|NCT01617434|561062170|FG001|Overall Study|Adverse Event|3|||
155447369|NCT01617434|561062169|FG000|Overall Study|Protocol Violation|8|||
155447370|NCT01617434|561062170|FG001|Overall Study|Protocol Violation|7|||
155447371|NCT01617434|561062169|FG000|Overall Study|Withdrawal Criteria|12|||
155447372|NCT01617434|561062170|FG001|Overall Study|Withdrawal Criteria|37|||
155447373|NCT01617434|561062169|FG000|Overall Study|Unclassified|3|||
155447374|NCT01617434|561062170|FG001|Overall Study|Unclassified|4|||
155447375|NCT01402284|561062174|FG000|Overall Study|Withdrawal consent|2|||
155447376|NCT01402284|561062174|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
155447377|NCT01402284|561062174|FG000|Overall Study|Physician Decision|1|||
155447378|NCT01402284|561062174|FG000|Overall Study|Disease progression on study|10|||
155447379|NCT04038255|561063841|FG000|Overall Study|Lost to Follow-up|0|||
155447380|NCT04038255|561063842|FG001|Overall Study|Lost to Follow-up|9|||
155447381|NCT04038255|561063843|FG002|Overall Study|Lost to Follow-up|5|||
155447382|NCT04038255|561063841|FG000|Overall Study|Withdrawal by Subject|0|||
155447383|NCT04038255|561063842|FG001|Overall Study|Withdrawal by Subject|0|||
155447384|NCT04038255|561063843|FG002|Overall Study|Withdrawal by Subject|1|||
155447385|NCT05183867|561063844|FG000|Overall Study|Withdrawal by Subject|3|||
155447386|NCT05183867|561063845|FG001|Overall Study|Withdrawal by Subject|2|||
155447387|NCT05183867|561063846|FG002|Overall Study|Withdrawal by Subject|0|||
155447388|NCT04491877|561063847|FG000|Overall Study|Protocol Deviation|1|||
155447389|NCT04491877|561063848|FG001|Overall Study|Protocol Deviation|0|||
155447390|NCT04491877|561063849|FG002|Overall Study|Protocol Deviation|2|||
155447391|NCT04491877|561063850|FG003|Overall Study|Protocol Deviation|0|||
155447392|NCT04491877|561063851|FG004|Overall Study|Protocol Deviation|0|||
155447393|NCT04491877|561063852|FG005|Overall Study|Protocol Deviation|0|||
155447394|NCT04491877|561063853|FG006|Overall Study|Protocol Deviation|1|||
155447395|NCT04491877|561063854|FG007|Overall Study|Protocol Deviation|1|||
155447396|NCT04491877|561063855|FG008|Overall Study|Protocol Deviation|0|||
155447397|NCT04491877|561063847|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155447398|NCT04491877|561063848|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155447399|NCT04491877|561063849|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155447400|NCT04491877|561063850|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
155447401|NCT04491877|561063851|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155447402|NCT04491877|561063852|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
155447403|NCT04491877|561063853|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
155447404|NCT04491877|561063854|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
155447405|NCT04491877|561063855|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
155447406|NCT04491877|561063847|FG000|Overall Study|Lost to Follow-up|0|||
155447407|NCT04491877|561063848|FG001|Overall Study|Lost to Follow-up|2|||
155447408|NCT04491877|561063849|FG002|Overall Study|Lost to Follow-up|0|||
155447409|NCT04491877|561063850|FG003|Overall Study|Lost to Follow-up|0|||
155447410|NCT04491877|561063851|FG004|Overall Study|Lost to Follow-up|0|||
155447411|NCT04491877|561063852|FG005|Overall Study|Lost to Follow-up|0|||
155447412|NCT04491877|561063853|FG006|Overall Study|Lost to Follow-up|2|||
155447413|NCT04491877|561063854|FG007|Overall Study|Lost to Follow-up|1|||
155447414|NCT04491877|561063855|FG008|Overall Study|Lost to Follow-up|1|||
155447415|NCT02614287|561063856|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
155447416|NCT02614287|561063857|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
155447417|NCT02614287|561063856|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
155447418|NCT02614287|561063857|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
155447419|NCT02614287|561063856|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
155447420|NCT02614287|561063857|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
155447421|NCT02614287|561063856|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
155447422|NCT02614287|561063857|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
155447423|NCT02614287|561063856|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
155447424|NCT02614287|561063857|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
155447425|NCT02614287|561063856|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
155447426|NCT02614287|561063857|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
155447427|NCT02614287|561063856|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
155447428|NCT02614287|561063857|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
155447429|NCT02614287|561063856|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
155447430|NCT02614287|561063857|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
155447431|NCT00441441|561063860|FG000|Overall Study|Adverse Event|2|||
155447432|NCT00441441|561063861|FG001|Overall Study|Adverse Event|1|||
155447433|NCT00441441|561063860|FG000|Overall Study|Protocol Violation|4|||
155447434|NCT00441441|561063861|FG001|Overall Study|Protocol Violation|6|||
155447435|NCT00441441|561063860|FG000|Overall Study|Exacerbation of asthma|1|||
155447436|NCT00441441|561063861|FG001|Overall Study|Exacerbation of asthma|2|||
155447437|NCT00441441|561063860|FG000|Overall Study|Withdrawal by Subject|1|||
155447438|NCT00441441|561063861|FG001|Overall Study|Withdrawal by Subject|2|||
155447439|NCT00441441|561063860|FG000|Overall Study|Other|3|||
155447440|NCT00441441|561063861|FG001|Overall Study|Other|3|||
155651529|NCT01853280|561816245|FG000|Overall Study|Withdrawal by Subject|0|||
155651530|NCT01853280|561816246|FG001|Overall Study|Withdrawal by Subject|1|||
155651531|NCT01853280|561816245|FG000|Overall Study|Ineligible|0|||
155651532|NCT01853280|561816246|FG001|Overall Study|Ineligible|1|||
155447441|NCT05619172|561063865|FG000|Safety Cohort 1|Death|7|||
155447442|NCT05619172|561063866|FG001|Safety Cohort 1|Death|0|||
155447443|NCT05619172|561063865|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
155447444|NCT05619172|561063866|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
155651533|NCT00104884|561816247|FG000|Overall Study|Disease progression|4|||
155651534|NCT03654326|561816248|FG000|Overall Study|Withdrawal by Subject|5|||
155651535|NCT03654326|561816249|FG001|Overall Study|Withdrawal by Subject|3|||
155651536|NCT03654326|561816248|FG000|Overall Study|Physician Decision|0|||
155651537|NCT03654326|561816249|FG001|Overall Study|Physician Decision|1|||
155447445|NCT05619172|561063865|FG000|Safety Cohort 2|Death|0|||
155447446|NCT05619172|561063866|FG001|Safety Cohort 2|Death|1|||
155447447|NCT05619172|561063865|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
155447448|NCT05619172|561063866|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
155651538|NCT03654326|561816248|FG000|Overall Study|Unable to adhere to study schedule|0|||
155651539|NCT03654326|561816249|FG001|Overall Study|Unable to adhere to study schedule|1|||
155651540|NCT03654326|561816248|FG000|Overall Study|Lost to Follow-up|1|||
155447461|NCT03165721|561063869|FG000|Overall Study|Refused further treatment|3|||
155447462|NCT03165721|561063870|FG001|Overall Study|Refused further treatment|0|||
155447463|NCT03165721|561063871|FG002|Overall Study|Refused further treatment|0|||
155447464|NCT03165721|561063869|FG000|Overall Study|Physician Decision|1|||
155447465|NCT03165721|561063870|FG001|Overall Study|Physician Decision|0|||
155447466|NCT03165721|561063871|FG002|Overall Study|Physician Decision|0|||
155447467|NCT01457118|561063873|FG000|Overall Study|Adverse Event|1|||
155447468|NCT01457118|561063874|FG001|Overall Study|Adverse Event|0|||
155447469|NCT01457118|561063875|FG002|Overall Study|Adverse Event|0|||
155447470|NCT01457118|561063876|FG003|Overall Study|Adverse Event|1|||
155447471|NCT01457118|561063873|FG000|Overall Study|Clinical Progression|0|||
155447472|NCT01457118|561063874|FG001|Overall Study|Clinical Progression|1|||
155447473|NCT01457118|561063875|FG002|Overall Study|Clinical Progression|0|||
155447474|NCT01457118|561063876|FG003|Overall Study|Clinical Progression|1|||
155447475|NCT01457118|561063873|FG000|Overall Study|Physician Decision|2|||
155447476|NCT01457118|561063874|FG001|Overall Study|Physician Decision|0|||
155447477|NCT01457118|561063875|FG002|Overall Study|Physician Decision|0|||
155447478|NCT01457118|561063876|FG003|Overall Study|Physician Decision|0|||
155447479|NCT01457118|561063873|FG000|Overall Study|Progressive Disease by RECIST|12|||
155447480|NCT01457118|561063874|FG001|Overall Study|Progressive Disease by RECIST|3|||
155447481|NCT01457118|561063875|FG002|Overall Study|Progressive Disease by RECIST|1|||
155447482|NCT01457118|561063876|FG003|Overall Study|Progressive Disease by RECIST|0|||
155447483|NCT01457118|561063873|FG000|Overall Study|Withdrawal by Subject|5|||
155447484|NCT01457118|561063874|FG001|Overall Study|Withdrawal by Subject|0|||
155447485|NCT01457118|561063875|FG002|Overall Study|Withdrawal by Subject|0|||
155447486|NCT01457118|561063876|FG003|Overall Study|Withdrawal by Subject|0|||
155447487|NCT03298412|561063877|FG000|Run-in Period|Other, Not Specified|1|||
155447488|NCT03298412|561063877|FG000|Run-in Period|Disease Progression|1|||
155447489|NCT03298412|561063877|FG000|Run-in Period|Ineligibility Determined|1|||
155447490|NCT03298412|561063877|FG000|Run-in Period|Decision by Sponsor|6|||
155447491|NCT03456713|561063878|FG000|Overall Study|Lost to Follow-up|1|||
155447492|NCT03456713|561063879|FG001|Overall Study|Lost to Follow-up|0|||
155447493|NCT03456713|561063880|FG002|Overall Study|Lost to Follow-up|0|||
155447494|NCT03456713|561063881|FG003|Overall Study|Lost to Follow-up|0|||
155447495|NCT03656926|561063882|FG000|Overall Study|Adverse Event|5|||
155447496|NCT03656926|561063883|FG001|Overall Study|Adverse Event|4|||
155447497|NCT03656926|561063882|FG000|Overall Study|Withdrawal by Subject|7|||
155447498|NCT03656926|561063883|FG001|Overall Study|Withdrawal by Subject|2|||
155447499|NCT03656926|561063882|FG000|Overall Study|Screen fail after randomization|1|||
155447500|NCT03656926|561063883|FG001|Overall Study|Screen fail after randomization|0|||
155447501|NCT03656926|561063882|FG000|Overall Study|PI decision due to patient condition|1|||
155447502|NCT03656926|561063883|FG001|Overall Study|PI decision due to patient condition|0|||
155447503|NCT03656926|561063882|FG000|Overall Study|Patient unresponsiveness|1|||
155447504|NCT03656926|561063883|FG001|Overall Study|Patient unresponsiveness|0|||
155447505|NCT00069095|561063884|FG000|Primary Treatment Phase|Ongoing|0|||
155447506|NCT00069095|561063885|FG001|Primary Treatment Phase|Ongoing|0|||
155447507|NCT00069095|561063886|FG002|Primary Treatment Phase|Ongoing|5|||
155447508|NCT00069095|561063887|FG003|Primary Treatment Phase|Ongoing|7|||
155447509|NCT00069095|561063888|FG004|Primary Treatment Phase|Ongoing|7|||
155447510|NCT00069095|561063889|FG005|Primary Treatment Phase|Ongoing|4|||
155447511|NCT00069095|561063884|FG000|Primary Treatment Phase|Admin/Other|29|||
155651541|NCT03654326|561816249|FG001|Overall Study|Lost to Follow-up|1|||
155447512|NCT00069095|561063885|FG001|Primary Treatment Phase|Admin/Other|38|||
155447513|NCT00069095|561063886|FG002|Primary Treatment Phase|Admin/Other|31|||
155447514|NCT00069095|561063887|FG003|Primary Treatment Phase|Admin/Other|45|||
155447515|NCT00069095|561063888|FG004|Primary Treatment Phase|Admin/Other|48|||
155447516|NCT00069095|561063889|FG005|Primary Treatment Phase|Admin/Other|42|||
155447517|NCT00069095|561063884|FG000|Primary Treatment Phase|Adverse Event|99|||
155447518|NCT00069095|561063885|FG001|Primary Treatment Phase|Adverse Event|92|||
155447519|NCT00069095|561063886|FG002|Primary Treatment Phase|Adverse Event|71|||
155447520|NCT00069095|561063887|FG003|Primary Treatment Phase|Adverse Event|72|||
155447521|NCT00069095|561063888|FG004|Primary Treatment Phase|Adverse Event|109|||
155447522|NCT00069095|561063889|FG005|Primary Treatment Phase|Adverse Event|101|||
155447523|NCT00069095|561063884|FG000|Primary Treatment Phase|Death|14|||
155447524|NCT00069095|561063885|FG001|Primary Treatment Phase|Death|8|||
155447525|NCT00069095|561063886|FG002|Primary Treatment Phase|Death|2|||
155447526|NCT00069095|561063887|FG003|Primary Treatment Phase|Death|5|||
155447527|NCT00069095|561063888|FG004|Primary Treatment Phase|Death|8|||
155447528|NCT00069095|561063889|FG005|Primary Treatment Phase|Death|8|||
155447529|NCT00069095|561063884|FG000|Primary Treatment Phase|Failure to return|5|||
155447530|NCT00069095|561063885|FG001|Primary Treatment Phase|Failure to return|5|||
155447531|NCT00069095|561063886|FG002|Primary Treatment Phase|Failure to return|0|||
155447532|NCT00069095|561063887|FG003|Primary Treatment Phase|Failure to return|0|||
155447533|NCT00069095|561063888|FG004|Primary Treatment Phase|Failure to return|0|||
155447534|NCT00069095|561063889|FG005|Primary Treatment Phase|Failure to return|2|||
155447535|NCT00069095|561063884|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
155447536|NCT00069095|561063885|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
155447537|NCT00069095|561063886|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
155447538|NCT00069095|561063887|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
155447539|NCT00069095|561063888|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
155447540|NCT00069095|561063889|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
155447541|NCT00069095|561063884|FG000|Primary Treatment Phase|Refused treatment|15|||
155447542|NCT00069095|561063885|FG001|Primary Treatment Phase|Refused treatment|26|||
155447543|NCT00069095|561063886|FG002|Primary Treatment Phase|Refused treatment|17|||
155447544|NCT00069095|561063887|FG003|Primary Treatment Phase|Refused treatment|31|||
155447545|NCT00069095|561063888|FG004|Primary Treatment Phase|Refused treatment|24|||
155447546|NCT00069095|561063889|FG005|Primary Treatment Phase|Refused treatment|27|||
155447547|NCT00069095|561063884|FG000|Primary Treatment Phase|Withdrew|2|||
155447548|NCT00069095|561063885|FG001|Primary Treatment Phase|Withdrew|3|||
155447549|NCT00069095|561063886|FG002|Primary Treatment Phase|Withdrew|8|||
155447550|NCT00069095|561063887|FG003|Primary Treatment Phase|Withdrew|2|||
155447551|NCT00069095|561063888|FG004|Primary Treatment Phase|Withdrew|4|||
155447552|NCT00069095|561063889|FG005|Primary Treatment Phase|Withdrew|9|||
155447553|NCT00069095|561063884|FG000|Primary Treatment Phase|Other Violation|0|||
155447554|NCT00069095|561063885|FG001|Primary Treatment Phase|Other Violation|1|||
155447555|NCT00069095|561063886|FG002|Primary Treatment Phase|Other Violation|1|||
155447556|NCT00069095|561063887|FG003|Primary Treatment Phase|Other Violation|1|||
155447557|NCT00069095|561063888|FG004|Primary Treatment Phase|Other Violation|0|||
155447558|NCT00069095|561063889|FG005|Primary Treatment Phase|Other Violation|1|||
155447559|NCT00069095|561063884|FG000|Primary Treatment Phase|Violation criteria|0|||
155447560|NCT00069095|561063885|FG001|Primary Treatment Phase|Violation criteria|2|||
155447561|NCT00069095|561063886|FG002|Primary Treatment Phase|Violation criteria|4|||
155447562|NCT00069095|561063887|FG003|Primary Treatment Phase|Violation criteria|3|||
155447563|NCT00069095|561063888|FG004|Primary Treatment Phase|Violation criteria|1|||
155447564|NCT00069095|561063889|FG005|Primary Treatment Phase|Violation criteria|5|||
155447565|NCT00069095|561063884|FG000|Post-study Treatment Phase|Missing reason|1|||
155447566|NCT00069095|561063885|FG001|Post-study Treatment Phase|Missing reason|3|||
155447567|NCT00069095|561063886|FG002|Post-study Treatment Phase|Missing reason|12|||
155447568|NCT00069095|561063887|FG003|Post-study Treatment Phase|Missing reason|8|||
155447569|NCT00069095|561063888|FG004|Post-study Treatment Phase|Missing reason|18|||
155447570|NCT00069095|561063889|FG005|Post-study Treatment Phase|Missing reason|17|||
155447571|NCT00069095|561063884|FG000|Post-study Treatment Phase|Adverse Event|2|||
155447572|NCT00069095|561063885|FG001|Post-study Treatment Phase|Adverse Event|3|||
155447573|NCT00069095|561063886|FG002|Post-study Treatment Phase|Adverse Event|1|||
155447574|NCT00069095|561063887|FG003|Post-study Treatment Phase|Adverse Event|0|||
155447575|NCT00069095|561063888|FG004|Post-study Treatment Phase|Adverse Event|5|||
155447576|NCT00069095|561063889|FG005|Post-study Treatment Phase|Adverse Event|1|||
155447577|NCT00069095|561063884|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
155447578|NCT00069095|561063885|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
155447579|NCT00069095|561063886|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
155447580|NCT00069095|561063887|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
155447581|NCT00069095|561063888|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
155447582|NCT00069095|561063889|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
155447583|NCT00069095|561063884|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
155447584|NCT00069095|561063885|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
155447585|NCT00069095|561063886|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
155447586|NCT00069095|561063887|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
155447587|NCT00069095|561063888|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
155447588|NCT00069095|561063889|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
155447589|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
155447590|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
155447591|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
155447592|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
155447593|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
155447594|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
155447595|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant had complete response|1|||
155447596|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant had complete response|1|||
155447597|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant had complete response|0|||
155447598|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant had complete response|0|||
155447599|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant had complete response|0|||
155447600|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant had complete response|0|||
155447601|NCT00069095|561063884|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
155447602|NCT00069095|561063885|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
155447603|NCT00069095|561063886|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
155447604|NCT00069095|561063887|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
155447605|NCT00069095|561063888|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
155447606|NCT00069095|561063889|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
155447607|NCT00069095|561063884|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
155447608|NCT00069095|561063885|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
155447609|NCT00069095|561063886|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
155447610|NCT00069095|561063887|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
155447611|NCT00069095|561063888|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
155447612|NCT00069095|561063889|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
155447613|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
155447614|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
155447615|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
155447616|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
155447617|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
155447618|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
155447619|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
155447620|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
155447621|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
155447622|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
155447623|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
155447624|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
155447625|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
155447626|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
155447627|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
155447628|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
155447629|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
155447630|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
155447631|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
155447632|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
155447633|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
155447634|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
155447635|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
155447636|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
155447637|NCT00069095|561063884|FG000|Post-study Treatment Phase|Surgery|0|||
155447638|NCT00069095|561063885|FG001|Post-study Treatment Phase|Surgery|0|||
155447639|NCT00069095|561063886|FG002|Post-study Treatment Phase|Surgery|0|||
155447640|NCT00069095|561063887|FG003|Post-study Treatment Phase|Surgery|1|||
155447641|NCT00069095|561063888|FG004|Post-study Treatment Phase|Surgery|1|||
155447642|NCT00069095|561063889|FG005|Post-study Treatment Phase|Surgery|0|||
155447643|NCT00069095|561063884|FG000|Post-study Treatment Phase|Death|0|||
155447644|NCT00069095|561063885|FG001|Post-study Treatment Phase|Death|0|||
155447645|NCT00069095|561063886|FG002|Post-study Treatment Phase|Death|0|||
155447646|NCT00069095|561063887|FG003|Post-study Treatment Phase|Death|0|||
155447647|NCT00069095|561063888|FG004|Post-study Treatment Phase|Death|1|||
155447648|NCT00069095|561063889|FG005|Post-study Treatment Phase|Death|0|||
155447649|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
155447650|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
155447651|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
155447652|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
155447653|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
155447654|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
155447655|NCT00069095|561063884|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
155447656|NCT00069095|561063885|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
155447657|NCT00069095|561063886|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
155447658|NCT00069095|561063887|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
155447659|NCT00069095|561063888|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
155447660|NCT00069095|561063889|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
155447661|NCT00069095|561063884|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
155447662|NCT00069095|561063885|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
155447663|NCT00069095|561063886|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
155447664|NCT00069095|561063887|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
155447665|NCT00069095|561063888|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
155447666|NCT00069095|561063889|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
155447667|NCT00069095|561063884|FG000|Post-study Treatment Phase|Investigator decision|0|||
155447668|NCT00069095|561063885|FG001|Post-study Treatment Phase|Investigator decision|0|||
155447669|NCT00069095|561063886|FG002|Post-study Treatment Phase|Investigator decision|0|||
155447670|NCT00069095|561063887|FG003|Post-study Treatment Phase|Investigator decision|0|||
155447671|NCT00069095|561063888|FG004|Post-study Treatment Phase|Investigator decision|0|||
155447672|NCT00069095|561063889|FG005|Post-study Treatment Phase|Investigator decision|1|||
155447673|NCT00069095|561063884|FG000|Follow-up Phase|Death|174|||
155447674|NCT00069095|561063885|FG001|Follow-up Phase|Death|206|||
155447675|NCT00069095|561063886|FG002|Follow-up Phase|Death|120|||
155447676|NCT00069095|561063887|FG003|Follow-up Phase|Death|112|||
155447677|NCT00069095|561063888|FG004|Follow-up Phase|Death|92|||
155447678|NCT00069095|561063889|FG005|Follow-up Phase|Death|101|||
155447679|NCT05610176|561063890|FG000|Overall Study|Death|6|||
155515300|NCT04182204|561311574|FG000|Safety Run-in|Withdrawal by Subject|2|||
155447680|NCT01217190|561063902|FG000|Second Dosing|Withdrawal by Subject|0|||
155447681|NCT01217190|561063903|FG001|Second Dosing|Withdrawal by Subject|2|||
155447682|NCT01594476|561063904|FG000|Overall Study|Protocol Violation|1|||
155447683|NCT01594476|561063905|FG001|Overall Study|Protocol Violation|3|||
155447684|NCT03161678|561063910|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
155447685|NCT03161678|561063911|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
155447686|NCT03161678|561063912|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155447687|NCT03161678|561063913|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
155447688|NCT03161678|561063914|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
155447689|NCT03161678|561063915|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155447690|NCT03161678|561063910|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
155447691|NCT03161678|561063911|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
155447692|NCT03161678|561063912|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
155447693|NCT03161678|561063913|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
155447694|NCT03161678|561063914|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
155447695|NCT03161678|561063915|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
155447696|NCT03161678|561063910|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
155447697|NCT03161678|561063911|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
155447698|NCT03161678|561063912|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
155447699|NCT03161678|561063913|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
155447700|NCT03161678|561063914|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
155447701|NCT03161678|561063915|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
155447702|NCT03161678|561063910|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
155447703|NCT03161678|561063911|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
155447704|NCT03161678|561063912|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
155447705|NCT03161678|561063913|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
155447706|NCT03161678|561063914|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
155447707|NCT03161678|561063915|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
155447708|NCT02552355|561063916|FG000|Overall Study|Adverse Event|0|||
155447709|NCT02552355|561063917|FG001|Overall Study|Adverse Event|2|||
155447710|NCT02552355|561063918|FG002|Overall Study|Adverse Event|2|||
155447711|NCT02552355|561063919|FG003|Overall Study|Adverse Event|0|||
155447712|NCT02552355|561063916|FG000|Overall Study|Withdrawal by Subject|0|||
155447713|NCT02552355|561063917|FG001|Overall Study|Withdrawal by Subject|0|||
155447714|NCT02552355|561063918|FG002|Overall Study|Withdrawal by Subject|0|||
155447715|NCT02552355|561063919|FG003|Overall Study|Withdrawal by Subject|1|||
155447716|NCT00850460|561063922|FG000|Overall Study|Lost to Follow-up|4|||
155447717|NCT00850460|561063923|FG001|Overall Study|Lost to Follow-up|4|||
155447718|NCT03007953|561063926|FG000|Overall Study|Withdrawal by Subject|5|||
155447719|NCT03007953|561063927|FG001|Overall Study|Withdrawal by Subject|2|||
155447720|NCT03007953|561063926|FG000|Overall Study|Death|5|||
155447721|NCT03007953|561063927|FG001|Overall Study|Death|7|||
155447722|NCT03007953|561063926|FG000|Overall Study|Lost to Follow-up|3|||
155447723|NCT03007953|561063927|FG001|Overall Study|Lost to Follow-up|2|||
155447724|NCT03007953|561063926|FG000|Overall Study|Enrolled in Hospice|3|||
155447725|NCT03007953|561063927|FG001|Overall Study|Enrolled in Hospice|2|||
155447726|NCT01052012|561063928|FG000|Overall Study|Not treated|2|||
155447727|NCT01052012|561063929|FG001|Overall Study|Not treated|5|||
155447728|NCT01052012|561063930|FG002|Overall Study|Not treated|0|||
155447729|NCT01052012|561063931|FG003|Overall Study|Not treated|0|||
155447730|NCT01052012|561063932|FG004|Overall Study|Not treated|11|||
155447731|NCT01052012|561063933|FG005|Overall Study|Not treated|8|||
155447732|NCT01052012|561063928|FG000|Overall Study|Adverse Event|1|||
155447733|NCT01052012|561063929|FG001|Overall Study|Adverse Event|0|||
155447734|NCT01052012|561063930|FG002|Overall Study|Adverse Event|0|||
155447735|NCT01052012|561063931|FG003|Overall Study|Adverse Event|1|||
155447736|NCT01052012|561063932|FG004|Overall Study|Adverse Event|0|||
155447737|NCT01052012|561063933|FG005|Overall Study|Adverse Event|0|||
155447738|NCT01052012|561063928|FG000|Overall Study|Lost to Follow-up|0|||
155447739|NCT01052012|561063929|FG001|Overall Study|Lost to Follow-up|0|||
155447740|NCT01052012|561063930|FG002|Overall Study|Lost to Follow-up|0|||
155447741|NCT01052012|561063931|FG003|Overall Study|Lost to Follow-up|0|||
155447742|NCT01052012|561063932|FG004|Overall Study|Lost to Follow-up|1|||
155447743|NCT01052012|561063933|FG005|Overall Study|Lost to Follow-up|0|||
155447744|NCT01052012|561063928|FG000|Overall Study|Withdrawal by Subject|1|||
155447745|NCT01052012|561063929|FG001|Overall Study|Withdrawal by Subject|1|||
155447746|NCT01052012|561063930|FG002|Overall Study|Withdrawal by Subject|0|||
155447747|NCT01052012|561063931|FG003|Overall Study|Withdrawal by Subject|0|||
155447748|NCT01052012|561063932|FG004|Overall Study|Withdrawal by Subject|3|||
155447749|NCT01052012|561063933|FG005|Overall Study|Withdrawal by Subject|1|||
155447750|NCT01052012|561063928|FG000|Overall Study|Physician Decision|0|||
155447751|NCT01052012|561063929|FG001|Overall Study|Physician Decision|0|||
155447752|NCT01052012|561063930|FG002|Overall Study|Physician Decision|0|||
155447753|NCT01052012|561063931|FG003|Overall Study|Physician Decision|0|||
155447754|NCT01052012|561063932|FG004|Overall Study|Physician Decision|0|||
155447755|NCT01052012|561063933|FG005|Overall Study|Physician Decision|1|||
155447756|NCT01052012|561063928|FG000|Overall Study|Other|0|||
155447757|NCT01052012|561063929|FG001|Overall Study|Other|0|||
155447758|NCT01052012|561063930|FG002|Overall Study|Other|0|||
155447759|NCT01052012|561063931|FG003|Overall Study|Other|0|||
155447760|NCT01052012|561063932|FG004|Overall Study|Other|1|||
155447761|NCT01052012|561063933|FG005|Overall Study|Other|0|||
155447762|NCT02224846|561063934|FG000|Period 1 (Month 3)|Adverse Event|2|||
155447763|NCT02224846|561063935|FG001|Period 1 (Month 3)|Adverse Event|1|||
155447764|NCT02224846|561063934|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
155447765|NCT02224846|561063935|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
155447766|NCT02224846|561063934|FG000|Period 1 (Month 3)|Protocol Violation|4|||
155447767|NCT02224846|561063935|FG001|Period 1 (Month 3)|Protocol Violation|8|||
155447768|NCT02224846|561063934|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
155447769|NCT02224846|561063935|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
155447770|NCT02224846|561063934|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
155447771|NCT02224846|561063935|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
155447772|NCT02224846|561063934|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
155447773|NCT02224846|561063935|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
155447774|NCT02224846|561063934|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
155447775|NCT02224846|561063935|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
155447776|NCT02224846|561063934|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
155447777|NCT02224846|561063935|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
155447778|NCT02224846|561063934|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
155447779|NCT02224846|561063935|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
155447780|NCT02224846|561063934|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
155447781|NCT02224846|561063935|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
155447782|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
155447783|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
155447784|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
155447785|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
155447786|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
155447787|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
155447788|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
155447789|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
155447790|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
155447791|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
155447792|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
155447793|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
155447794|NCT02224846|561063934|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
155447795|NCT02224846|561063935|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
155447796|NCT03196297|561063939|FG000|Main Period|Withdrawal by Subject|4|||
155447797|NCT03196297|561063939|FG000|Extension Period|Withdrawal by Subject|1|||
155447798|NCT03196297|561063939|FG000|Extension Period|Lack of Efficacy|2|||
155447799|NCT02538666|561063940|FG000|Pre-Treatment|Disease progression|1|||
155447800|NCT02538666|561063941|FG001|Pre-Treatment|Disease progression|0|||
155447801|NCT02538666|561063942|FG002|Pre-Treatment|Disease progression|0|||
155447802|NCT02538666|561063940|FG000|Pre-Treatment|no longer meets study criteria|1|||
155447803|NCT02538666|561063941|FG001|Pre-Treatment|no longer meets study criteria|0|||
155447804|NCT02538666|561063942|FG002|Pre-Treatment|no longer meets study criteria|0|||
155447805|NCT02538666|561063940|FG000|Pre-Treatment|Withdrew Consent|0|||
155447806|NCT02538666|561063941|FG001|Pre-Treatment|Withdrew Consent|1|||
155447807|NCT02538666|561063942|FG002|Pre-Treatment|Withdrew Consent|1|||
155447808|NCT02538666|561063940|FG000|Treatment|Disease progression|270|||
155447809|NCT02538666|561063941|FG001|Treatment|Disease progression|227|||
155447810|NCT02538666|561063942|FG002|Treatment|Disease progression|165|||
155447811|NCT02538666|561063940|FG000|Treatment|Study drug toxicity|1|||
155447812|NCT02538666|561063941|FG001|Treatment|Study drug toxicity|29|||
155447813|NCT02538666|561063942|FG002|Treatment|Study drug toxicity|92|||
155447814|NCT02538666|561063940|FG000|Treatment|Death|0|||
155447815|NCT02538666|561063941|FG001|Treatment|Death|2|||
155447816|NCT02538666|561063942|FG002|Treatment|Death|3|||
155447817|NCT02538666|561063940|FG000|Treatment|Adverse event unrelated to study drug|8|||
155447818|NCT02538666|561063941|FG001|Treatment|Adverse event unrelated to study drug|10|||
155447819|NCT02538666|561063942|FG002|Treatment|Adverse event unrelated to study drug|15|||
155447820|NCT02538666|561063940|FG000|Treatment|Participant request to discontinue study treatment|3|||
155447821|NCT02538666|561063941|FG001|Treatment|Participant request to discontinue study treatment|6|||
155447822|NCT02538666|561063942|FG002|Treatment|Participant request to discontinue study treatment|11|||
155447823|NCT02538666|561063940|FG000|Treatment|Participant withdrew consent|2|||
155447824|NCT02538666|561063941|FG001|Treatment|Participant withdrew consent|5|||
155447825|NCT02538666|561063942|FG002|Treatment|Participant withdrew consent|3|||
155447826|NCT02538666|561063940|FG000|Treatment|Lost to Follow-up|0|||
155447827|NCT02538666|561063941|FG001|Treatment|Lost to Follow-up|1|||
155447828|NCT02538666|561063942|FG002|Treatment|Lost to Follow-up|1|||
155447829|NCT02538666|561063940|FG000|Treatment|Maximum clinical benefit|4|||
155447830|NCT02538666|561063941|FG001|Treatment|Maximum clinical benefit|3|||
155447831|NCT02538666|561063942|FG002|Treatment|Maximum clinical benefit|4|||
155447832|NCT02538666|561063940|FG000|Treatment|Poor/non-compliance|0|||
155447833|NCT02538666|561063941|FG001|Treatment|Poor/non-compliance|1|||
155447834|NCT02538666|561063942|FG002|Treatment|Poor/non-compliance|0|||
155447835|NCT02538666|561063940|FG000|Treatment|Participant no longer meets study criteria|0|||
155447836|NCT02538666|561063941|FG001|Treatment|Participant no longer meets study criteria|2|||
155447837|NCT02538666|561063942|FG002|Treatment|Participant no longer meets study criteria|0|||
155447838|NCT02538666|561063940|FG000|Treatment|Administrative reason by sponsor|0|||
155447839|NCT02538666|561063941|FG001|Treatment|Administrative reason by sponsor|0|||
155447840|NCT02538666|561063942|FG002|Treatment|Administrative reason by sponsor|1|||
155447841|NCT02538666|561063940|FG000|Treatment|Other reasons|8|||
155447842|NCT02538666|561063941|FG001|Treatment|Other reasons|15|||
155447843|NCT02538666|561063942|FG002|Treatment|Other reasons|5|||
155447844|NCT02538666|561063940|FG000|Treatment|Not reported|2|||
155447845|NCT02538666|561063941|FG001|Treatment|Not reported|2|||
155447846|NCT02538666|561063942|FG002|Treatment|Not reported|2|||
155447847|NCT00320385|561063947|FG000|Overall Study|Lost to Follow-up|7|||
155447848|NCT00320385|561063948|FG001|Overall Study|Lost to Follow-up|10|||
155447849|NCT00320385|561063947|FG000|Overall Study|Withdrawal by Subject|6|||
155447850|NCT00320385|561063948|FG001|Overall Study|Withdrawal by Subject|7|||
155447851|NCT00320385|561063947|FG000|Overall Study|Sponsor Terminated Study|2|||
155447852|NCT00320385|561063948|FG001|Overall Study|Sponsor Terminated Study|1|||
155447853|NCT00320385|561063947|FG000|Overall Study|Investigator Decision|0|||
155447854|NCT00320385|561063948|FG001|Overall Study|Investigator Decision|1|||
155447855|NCT00320385|561063947|FG000|Overall Study|Death|1|||
155447856|NCT00320385|561063948|FG001|Overall Study|Death|2|||
155447857|NCT00320385|561063947|FG000|Overall Study|Serious Adverse Event|1|||
155447858|NCT00320385|561063948|FG001|Overall Study|Serious Adverse Event|0|||
155447859|NCT00320385|561063947|FG000|Overall Study|Withdrew Consent|1|||
155447860|NCT00320385|561063948|FG001|Overall Study|Withdrew Consent|0|||
155447861|NCT00320385|561063947|FG000|Overall Study|Adverse Event|0|||
155447862|NCT00320385|561063948|FG001|Overall Study|Adverse Event|1|||
155447863|NCT04370028|561063949|FG000|Overall Study|Withdrawal by Subject|695|||
155447864|NCT04370028|561063949|FG000|Overall Study|Protocol Violation|9|||
155447865|NCT04370028|561063949|FG000|Overall Study|Adverse Event|3|||
155447866|NCT00748540|561063957|FG000|Overall Study|Physician Decision|1|||
155447867|NCT04743635|561063958|FG000|Overall Study|Lost to Follow-up|2|||
155447868|NCT04743635|561063959|FG001|Overall Study|Lost to Follow-up|0|||
155447869|NCT01954121|561063961|FG000|Overall Study|Lack of Efficacy|94|||
155447870|NCT01954121|561063962|FG001|Overall Study|Lack of Efficacy|41|||
155447871|NCT01954121|561063961|FG000|Overall Study|Protocol Violation|0|||
155447872|NCT01954121|561063962|FG001|Overall Study|Protocol Violation|2|||
155447873|NCT01954121|561063961|FG000|Overall Study|Lost to Follow-up|5|||
155447874|NCT01954121|561063962|FG001|Overall Study|Lost to Follow-up|6|||
155447875|NCT01954121|561063961|FG000|Overall Study|Withdrawal by Subject|18|||
155447876|NCT01954121|561063962|FG001|Overall Study|Withdrawal by Subject|12|||
155447877|NCT01954121|561063961|FG000|Overall Study|Pregnancy|1|||
155447878|NCT01954121|561063962|FG001|Overall Study|Pregnancy|1|||
155447879|NCT01954121|561063961|FG000|Overall Study|AE, serious fatal|1|||
155447880|NCT01954121|561063962|FG001|Overall Study|AE, serious fatal|0|||
155447881|NCT01954121|561063961|FG000|Overall Study|AE, non-serious non-fatal|5|||
155447882|NCT01954121|561063962|FG001|Overall Study|AE, non-serious non-fatal|22|||
155447883|NCT01954121|561063961|FG000|Overall Study|SAE, non-fatal|1|||
155447884|NCT01954121|561063962|FG001|Overall Study|SAE, non-fatal|4|||
155447885|NCT01954121|561063961|FG000|Overall Study|Non-compliant with study procedures|1|||
155447886|NCT01954121|561063962|FG001|Overall Study|Non-compliant with study procedures|0|||
155447887|NCT01954121|561063961|FG000|Overall Study|Non-compliant patient|1|||
155447888|NCT01954121|561063962|FG001|Overall Study|Non-compliant patient|1|||
155447889|NCT01954121|561063961|FG000|Overall Study|Subject did not follow instructions|0|||
155447890|NCT01954121|561063962|FG001|Overall Study|Subject did not follow instructions|2|||
155447891|NCT00872170|561063963|FG000|Overall Study|Adverse Event|1|||
155447892|NCT00872170|561063964|FG001|Overall Study|Adverse Event|0|||
155447893|NCT00601523|561063965|FG000|Overall Study|Adverse Event|42|||
155447894|NCT00601523|561063966|FG001|Overall Study|Adverse Event|14|||
155447895|NCT00601523|561063965|FG000|Overall Study|Lack of Efficacy|3|||
155447896|NCT00601523|561063966|FG001|Overall Study|Lack of Efficacy|0|||
155447897|NCT00601523|561063965|FG000|Overall Study|Protocol Violation|5|||
155447898|NCT00601523|561063966|FG001|Overall Study|Protocol Violation|1|||
155515301|NCT04182204|561311575|FG001|Safety Run-in|Withdrawal by Subject|0|||
155515302|NCT04182204|561311576|FG002|Safety Run-in|Withdrawal by Subject|0|||
155515303|NCT04182204|561311574|FG000|Safety Run-in|Death|7|||
155515304|NCT04182204|561311575|FG001|Safety Run-in|Death|0|||
155515305|NCT04182204|561311576|FG002|Safety Run-in|Death|0|||
155515306|NCT04182204|561311574|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
155515307|NCT04182204|561311575|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
155515308|NCT04182204|561311576|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
155515309|NCT04182204|561311574|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
155651542|NCT00835042|561816250|FG000|First Intervention|Withdrawal by Subject|3|||
155447899|NCT00601523|561063965|FG000|Overall Study|Lost to Follow-up|0|||
155447900|NCT00601523|561063966|FG001|Overall Study|Lost to Follow-up|1|||
155447901|NCT00601523|561063965|FG000|Overall Study|Withdrawal by Subject|18|||
155447902|NCT00601523|561063966|FG001|Overall Study|Withdrawal by Subject|9|||
155447903|NCT00601523|561063965|FG000|Overall Study|Other|9|||
155447904|NCT00601523|561063966|FG001|Overall Study|Other|1|||
155515310|NCT04182204|561311575|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
155515311|NCT04182204|561311576|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
155651543|NCT00835042|561816251|FG001|First Intervention|Withdrawal by Subject|0|||
155447905|NCT04072146|561063967|FG000|Overall Study|Adverse Event|0|||
155447906|NCT04072146|561063968|FG001|Overall Study|Adverse Event|1|||
155447907|NCT00540436|561063972|FG000|First 12-Week Treatment Period|Adverse Event|1|||
155447908|NCT00540436|561063972|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
155447909|NCT00540436|561063972|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
155447910|NCT00540436|561063972|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
155515312|NCT04182204|561311574|FG000|Randomized Controlled Trial|Death|0|||
155515313|NCT04182204|561311575|FG001|Randomized Controlled Trial|Death|83|||
155515314|NCT04182204|561311576|FG002|Randomized Controlled Trial|Death|66|||
155515315|NCT05876091|561311577|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
155515316|NCT03466411|561311578|FG000|Overall Study|Lost to Follow-up|0|||
155515317|NCT03466411|561311579|FG001|Overall Study|Lost to Follow-up|1|||
155515318|NCT03466411|561311580|FG002|Overall Study|Lost to Follow-up|1|||
155447911|NCT01064648|561063973|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
155447912|NCT01064648|561063974|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
155447913|NCT01064648|561063975|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
155447914|NCT01064648|561063976|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
155447915|NCT01064648|561063973|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
155447916|NCT01064648|561063974|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
155447917|NCT01064648|561063975|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
155447918|NCT01064648|561063976|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
155447919|NCT01064648|561063973|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
155447920|NCT01064648|561063974|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
155447921|NCT01064648|561063975|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
155447922|NCT01064648|561063976|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
155447923|NCT01064648|561063973|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
155447924|NCT01064648|561063974|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
155447925|NCT01064648|561063975|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
155447926|NCT01064648|561063976|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
155447927|NCT01064648|561063973|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
155447928|NCT01064648|561063974|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
155447929|NCT01064648|561063975|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
155447930|NCT01064648|561063976|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
155447931|NCT01064648|561063973|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
155447932|NCT01064648|561063974|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
155447933|NCT01064648|561063975|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
155447934|NCT01064648|561063976|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
155447935|NCT01064648|561063973|FG000|Phase II|Adverse Event|0|||
155447936|NCT01064648|561063974|FG001|Phase II|Adverse Event|0|||
155447937|NCT01064648|561063975|FG002|Phase II|Adverse Event|15|||
155447938|NCT01064648|561063976|FG003|Phase II|Adverse Event|8|||
155447939|NCT01064648|561063973|FG000|Phase II|Death|0|||
155447940|NCT01064648|561063974|FG001|Phase II|Death|0|||
155447941|NCT01064648|561063975|FG002|Phase II|Death|4|||
155515319|NCT03466411|561311581|FG003|Overall Study|Lost to Follow-up|0|||
155515320|NCT03466411|561311582|FG004|Overall Study|Lost to Follow-up|0|||
155515321|NCT03466411|561311583|FG005|Overall Study|Lost to Follow-up|0|||
155651544|NCT00835042|561816250|FG000|First Intervention|Adverse Event|1|||
155447942|NCT01064648|561063976|FG003|Phase II|Death|5|||
155447943|NCT01064648|561063973|FG000|Phase II|Withdrawal by Subject|0|||
155447944|NCT01064648|561063974|FG001|Phase II|Withdrawal by Subject|0|||
155447945|NCT01064648|561063975|FG002|Phase II|Withdrawal by Subject|2|||
155447946|NCT01064648|561063976|FG003|Phase II|Withdrawal by Subject|5|||
155447947|NCT01064648|561063973|FG000|Phase II|Progression|0|||
155447948|NCT01064648|561063974|FG001|Phase II|Progression|0|||
155447949|NCT01064648|561063975|FG002|Phase II|Progression|21|||
155515322|NCT03466411|561311584|FG006|Overall Study|Lost to Follow-up|1|||
155515323|NCT03466411|561311585|FG007|Overall Study|Lost to Follow-up|1|||
155515324|NCT03466411|561311586|FG008|Overall Study|Lost to Follow-up|0|||
155515325|NCT03466411|561311587|FG009|Overall Study|Lost to Follow-up|1|||
155447950|NCT01064648|561063976|FG003|Phase II|Progression|27|||
155447951|NCT01064648|561063973|FG000|Phase II|Non-protocol specified|0|||
155447952|NCT01064648|561063974|FG001|Phase II|Non-protocol specified|0|||
155447953|NCT01064648|561063975|FG002|Phase II|Non-protocol specified|5|||
155447954|NCT01064648|561063976|FG003|Phase II|Non-protocol specified|3|||
155447955|NCT01064648|561063973|FG000|Phase II|Under Review|0|||
155447956|NCT01064648|561063974|FG001|Phase II|Under Review|0|||
155447957|NCT01064648|561063975|FG002|Phase II|Under Review|2|||
155447958|NCT01064648|561063976|FG003|Phase II|Under Review|0|||
155447959|NCT05281523|561063977|FG000|Overall Study|Adverse Event|1|||
155447960|NCT05281523|561063978|FG001|Overall Study|Adverse Event|1|||
155447961|NCT05281523|561063977|FG000|Overall Study|Physician Decision|1|||
155447962|NCT05281523|561063978|FG001|Overall Study|Physician Decision|1|||
155447963|NCT05281523|561063977|FG000|Overall Study|Withdrawal by Subject|5|||
155447964|NCT05281523|561063978|FG001|Overall Study|Withdrawal by Subject|15|||
155447965|NCT05281523|561063977|FG000|Overall Study|GCP violations|3|||
155447966|NCT05281523|561063978|FG001|Overall Study|GCP violations|4|||
155447967|NCT05513391|561063979|FG000|Overall Study|Adverse Event|1|||
155447968|NCT05513391|561063980|FG001|Overall Study|Adverse Event|0|||
155447969|NCT05513391|561063979|FG000|Overall Study|Protocol Deviation|0|||
155447970|NCT05513391|561063980|FG001|Overall Study|Protocol Deviation|1|||
155447971|NCT05513391|561063979|FG000|Overall Study|Withdrawal by Subject|3|||
155447972|NCT05513391|561063980|FG001|Overall Study|Withdrawal by Subject|1|||
155447973|NCT05513391|561063979|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155447974|NCT05513391|561063980|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155447975|NCT05513391|561063979|FG000|Overall Study|Lost to Follow-up|0|||
155447976|NCT05513391|561063980|FG001|Overall Study|Lost to Follow-up|2|||
155447977|NCT02429427|561063981|FG000|Overall Study|Adverse Event|220|||
155447978|NCT02429427|561063982|FG001|Overall Study|Adverse Event|92|||
155447979|NCT02429427|561063981|FG000|Overall Study|Protocol Violation|10|||
155447980|NCT02429427|561063982|FG001|Overall Study|Protocol Violation|6|||
155447981|NCT02429427|561063981|FG000|Overall Study|Lost to Follow-up|15|||
155447982|NCT02429427|561063982|FG001|Overall Study|Lost to Follow-up|6|||
155447983|NCT02429427|561063981|FG000|Overall Study|Withdrawal by Subject|64|||
155447984|NCT02429427|561063982|FG001|Overall Study|Withdrawal by Subject|34|||
155447985|NCT02429427|561063981|FG000|Overall Study|Other|62|||
155447986|NCT02429427|561063982|FG001|Overall Study|Other|41|||
155447987|NCT00719732|561063983|FG000|Overall Study|Lost to Follow-up|20|||
155447988|NCT00719732|561063983|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
155447989|NCT00719732|561063983|FG000|Overall Study|Illness not associated with device|1|||
155447990|NCT00436215|561063984|FG000|Overall Study|Refused further treatment|3|||
155447991|NCT00436215|561063984|FG000|Overall Study|Small bowel obstruction|1|||
155447992|NCT03364335|561065557|FG000|Overall Study|Adverse Event|3|||
155447993|NCT03364335|561065558|FG001|Overall Study|Adverse Event|4|||
155447994|NCT03364335|561065559|FG002|Overall Study|Adverse Event|1|||
155447995|NCT03364335|561065560|FG003|Overall Study|Adverse Event|2|||
155447996|NCT03364335|561065561|FG004|Overall Study|Adverse Event|0|||
155447997|NCT03364335|561065557|FG000|Overall Study|Lost to Follow-up|7|||
155447998|NCT03364335|561065558|FG001|Overall Study|Lost to Follow-up|7|||
155447999|NCT03364335|561065559|FG002|Overall Study|Lost to Follow-up|10|||
155448000|NCT03364335|561065560|FG003|Overall Study|Lost to Follow-up|11|||
155448001|NCT03364335|561065561|FG004|Overall Study|Lost to Follow-up|11|||
155448002|NCT00492856|561065562|FG000|Induction|Adverse Event|2|||
155448003|NCT00492856|561065563|FG001|Induction|Adverse Event|0|||
155448004|NCT00492856|561065564|FG002|Induction|Adverse Event|0|||
155448005|NCT00492856|561065565|FG003|Induction|Adverse Event|0|||
155448006|NCT00492856|561065562|FG000|Induction|Withdrawal by Subject|1|||
155448007|NCT00492856|561065563|FG001|Induction|Withdrawal by Subject|0|||
155448008|NCT00492856|561065564|FG002|Induction|Withdrawal by Subject|0|||
155448009|NCT00492856|561065565|FG003|Induction|Withdrawal by Subject|0|||
155448010|NCT00492856|561065562|FG000|Induction|Death|3|||
155448011|NCT00492856|561065563|FG001|Induction|Death|0|||
155448012|NCT00492856|561065564|FG002|Induction|Death|0|||
155515326|NCT03466411|561311588|FG010|Overall Study|Lost to Follow-up|1|||
155515327|NCT03466411|561311589|FG011|Overall Study|Lost to Follow-up|1|||
155651545|NCT00835042|561816251|FG001|First Intervention|Adverse Event|2|||
155448013|NCT00492856|561065565|FG003|Induction|Death|0|||
155448014|NCT00492856|561065562|FG000|Consolidation|Adverse Event|6|||
155448015|NCT00492856|561065563|FG001|Consolidation|Adverse Event|0|||
155448016|NCT00492856|561065564|FG002|Consolidation|Adverse Event|0|||
155448017|NCT00492856|561065565|FG003|Consolidation|Adverse Event|0|||
155448018|NCT00492856|561065562|FG000|Consolidation|Not protocol specified|2|||
155448019|NCT00492856|561065563|FG001|Consolidation|Not protocol specified|0|||
155448020|NCT00492856|561065564|FG002|Consolidation|Not protocol specified|0|||
155448021|NCT00492856|561065565|FG003|Consolidation|Not protocol specified|0|||
155448022|NCT00492856|561065562|FG000|Consolidation|Lost to Follow-up|1|||
155448023|NCT00492856|561065563|FG001|Consolidation|Lost to Follow-up|0|||
155448024|NCT00492856|561065564|FG002|Consolidation|Lost to Follow-up|0|||
155448025|NCT00492856|561065565|FG003|Consolidation|Lost to Follow-up|0|||
155448026|NCT00492856|561065562|FG000|Post-consolidation|Adverse Event|0|||
155448027|NCT00492856|561065563|FG001|Post-consolidation|Adverse Event|4|||
155448028|NCT00492856|561065564|FG002|Post-consolidation|Adverse Event|0|||
155448029|NCT00492856|561065565|FG003|Post-consolidation|Adverse Event|1|||
155515328|NCT03466411|561311590|FG012|Overall Study|Lost to Follow-up|0|||
155448030|NCT00492856|561065562|FG000|Post-consolidation|Withdrawal by Subject|0|||
155448031|NCT00492856|561065563|FG001|Post-consolidation|Withdrawal by Subject|4|||
155448032|NCT00492856|561065564|FG002|Post-consolidation|Withdrawal by Subject|0|||
155448033|NCT00492856|561065565|FG003|Post-consolidation|Withdrawal by Subject|0|||
155448034|NCT00492856|561065562|FG000|Post-consolidation|Death|0|||
155448035|NCT00492856|561065563|FG001|Post-consolidation|Death|1|||
155448036|NCT00492856|561065564|FG002|Post-consolidation|Death|0|||
155448037|NCT00492856|561065565|FG003|Post-consolidation|Death|0|||
155448038|NCT00492856|561065562|FG000|Post-consolidation|Not protocol specified|0|||
155448039|NCT00492856|561065563|FG001|Post-consolidation|Not protocol specified|1|||
155448040|NCT00492856|561065564|FG002|Post-consolidation|Not protocol specified|0|||
155448041|NCT00492856|561065565|FG003|Post-consolidation|Not protocol specified|0|||
155448042|NCT00492856|561065562|FG000|Post-consolidation|Lost to Follow-up|0|||
155448043|NCT00492856|561065563|FG001|Post-consolidation|Lost to Follow-up|2|||
155448044|NCT00492856|561065564|FG002|Post-consolidation|Lost to Follow-up|0|||
155448045|NCT00492856|561065565|FG003|Post-consolidation|Lost to Follow-up|0|||
155448046|NCT00492856|561065562|FG000|Post-consolidation|Observation Arm|0|||
155448047|NCT00492856|561065563|FG001|Post-consolidation|Observation Arm|0|||
155448048|NCT00492856|561065564|FG002|Post-consolidation|Observation Arm|27|||
155448049|NCT00492856|561065565|FG003|Post-consolidation|Observation Arm|0|||
155448050|NCT01520324|561065568|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
155448051|NCT00948818|561065570|FG000|Overall Study|Adverse Event|10|||
155448052|NCT00948818|561065571|FG001|Overall Study|Adverse Event|32|||
155448053|NCT00948818|561065570|FG000|Overall Study|Protocol Violation|9|||
155448054|NCT00948818|561065571|FG001|Overall Study|Protocol Violation|10|||
155448055|NCT00948818|561065570|FG000|Overall Study|Withdrawal by Subject|25|||
155448056|NCT00948818|561065571|FG001|Overall Study|Withdrawal by Subject|25|||
155448057|NCT00948818|561065570|FG000|Overall Study|Lost to Follow-up|10|||
155448058|NCT00948818|561065571|FG001|Overall Study|Lost to Follow-up|17|||
155448059|NCT00948818|561065570|FG000|Overall Study|Lack of Efficacy|4|||
155448060|NCT00948818|561065571|FG001|Overall Study|Lack of Efficacy|5|||
155448061|NCT00948818|561065570|FG000|Overall Study|Other Reason|4|||
155448062|NCT00948818|561065571|FG001|Overall Study|Other Reason|5|||
155448063|NCT00745368|561065572|FG000|Overall Study|Unable to provide sample|3|||
155448064|NCT02364947|561065573|FG000|Overall Study|Withdrawal by Subject|10|||
155448065|NCT02364947|561065574|FG001|Overall Study|Withdrawal by Subject|8|||
155448066|NCT02364947|561065575|FG002|Overall Study|Withdrawal by Subject|9|||
155448067|NCT02364947|561065573|FG000|Overall Study|Adverse Event|45|||
155448068|NCT02364947|561065574|FG001|Overall Study|Adverse Event|33|||
155448069|NCT02364947|561065575|FG002|Overall Study|Adverse Event|11|||
155448070|NCT02364947|561065573|FG000|Overall Study|Protocol Violation|1|||
155448071|NCT02364947|561065574|FG001|Overall Study|Protocol Violation|1|||
155448072|NCT02364947|561065575|FG002|Overall Study|Protocol Violation|1|||
155448073|NCT02364947|561065573|FG000|Overall Study|Physician Decision|3|||
155448074|NCT02364947|561065574|FG001|Overall Study|Physician Decision|2|||
155448075|NCT02364947|561065575|FG002|Overall Study|Physician Decision|5|||
155448076|NCT02364947|561065573|FG000|Overall Study|Death|0|||
155448077|NCT02364947|561065574|FG001|Overall Study|Death|1|||
155448078|NCT02364947|561065575|FG002|Overall Study|Death|0|||
155448079|NCT00853489|561065576|FG000|Overall Study|Lost to Follow-up|5|||
155448080|NCT00853489|561065577|FG001|Overall Study|Lost to Follow-up|2|||
155448081|NCT02326467|561065578|FG000|Overall Study|Withdrawal by Subject|1|||
155448082|NCT00434512|561065579|FG000|Overall Study|Migrated/moved from study area|0|||
155448083|NCT00434512|561065580|FG001|Overall Study|Migrated/moved from study area|0|||
155448084|NCT00434512|561065581|FG002|Overall Study|Migrated/moved from study area|0|||
155448085|NCT00434512|561065582|FG003|Overall Study|Migrated/moved from study area|1|||
155448086|NCT00434512|561065583|FG004|Overall Study|Migrated/moved from study area|1|||
155448087|NCT00434512|561065584|FG005|Overall Study|Migrated/moved from study area|1|||
155448088|NCT00434512|561065579|FG000|Overall Study|Other|0|||
155448089|NCT00434512|561065580|FG001|Overall Study|Other|1|||
155448090|NCT00434512|561065581|FG002|Overall Study|Other|0|||
155448091|NCT00434512|561065582|FG003|Overall Study|Other|0|||
155448092|NCT00434512|561065583|FG004|Overall Study|Other|0|||
155515329|NCT03466411|561311578|FG000|Overall Study|Withdrawal by Subject|14|||
155448093|NCT00434512|561065584|FG005|Overall Study|Other|0|||
155448094|NCT01251276|561065588|FG000|Overall Study|Protocol Violation|1|||
155448095|NCT01251276|561065589|FG001|Overall Study|Protocol Violation|0|||
155448096|NCT01251276|561065588|FG000|Overall Study|Lost to Follow-up|0|||
155448097|NCT01251276|561065589|FG001|Overall Study|Lost to Follow-up|1|||
155448098|NCT02245568|561065590|FG000|Overall Study|Study terminated by Sponsor|346|||
155448099|NCT02245568|561065590|FG000|Overall Study|Adverse Event|144|||
155448100|NCT02245568|561065590|FG000|Overall Study|Lack of Efficacy|98|||
155448101|NCT02245568|561065590|FG000|Overall Study|Withdrawal by Caregiver|85|||
155448102|NCT02245568|561065590|FG000|Overall Study|Withdrawal by Subject|77|||
155448103|NCT02245568|561065590|FG000|Overall Study|Withdrawal by Legal Representative|31|||
155448104|NCT02245568|561065590|FG000|Overall Study|Missing (Site closure)|16|||
155448105|NCT02245568|561065590|FG000|Overall Study|Physician Decision|14|||
155448106|NCT02245568|561065590|FG000|Overall Study|Non-compliance with study drug|11|||
155448107|NCT02245568|561065590|FG000|Overall Study|Death|9|||
155448108|NCT02245568|561065590|FG000|Overall Study|Blue staining|6|||
155448109|NCT02245568|561065590|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
155448110|NCT02245568|561065590|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
155448111|NCT02245568|561065590|FG000|Overall Study|Lost to Follow-up|5|||
155448112|NCT01725152|561065594|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
155448113|NCT01725152|561065595|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
155448114|NCT01725152|561065594|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
155448115|NCT01725152|561065595|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
155448116|NCT01725152|561065594|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
155448117|NCT01725152|561065595|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
155448118|NCT01725152|561065594|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
155448119|NCT01725152|561065595|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
155448120|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
155448121|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155448122|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155448123|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155448124|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155448125|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
155448126|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155448127|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155448128|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155448129|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155448130|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
155448131|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155448132|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155448133|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155448134|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155448135|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
155448136|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
155448137|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
155448138|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
155448139|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
155448140|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
155448141|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
155448142|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
155448143|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
155448144|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
155448145|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
155448146|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155448147|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155448148|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155448149|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155448150|NCT01111539|561065598|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
155448151|NCT01111539|561065599|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
155448152|NCT01111539|561065600|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
155448153|NCT01111539|561065601|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
155448154|NCT01111539|561065602|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
155448155|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155448156|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155448157|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
155448158|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155448159|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
155448160|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155448161|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155448162|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
155448163|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155448164|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
155448165|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
155448166|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
155448167|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
155448168|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155448169|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155515330|NCT03466411|561311579|FG001|Overall Study|Withdrawal by Subject|7|||
155515331|NCT03466411|561311580|FG002|Overall Study|Withdrawal by Subject|8|||
155515332|NCT03466411|561311581|FG003|Overall Study|Withdrawal by Subject|4|||
155515333|NCT03466411|561311582|FG004|Overall Study|Withdrawal by Subject|6|||
155448170|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
155448171|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
155448172|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
155448173|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
155448174|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
155448175|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
155448176|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
155448177|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
155448178|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
155448179|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
155448180|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
155448181|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
155448182|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
155448183|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
155448184|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
155448185|NCT01111539|561065598|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155448186|NCT01111539|561065599|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155448187|NCT01111539|561065600|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155448188|NCT01111539|561065601|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155448189|NCT01111539|561065602|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
155448190|NCT03580382|561065607|FG000|Overall Study|Early Termination of Study|0|||
155448191|NCT03580382|561065608|FG001|Overall Study|Early Termination of Study|3|||
155448192|NCT02808312|561065609|FG000|Overall Study|Enrolled but Never Treated|0|||
155448193|NCT02808312|561065610|FG001|Overall Study|Enrolled but Never Treated|0|||
155448194|NCT02808312|561065611|FG002|Overall Study|Enrolled but Never Treated|1|||
155448195|NCT02808312|561065612|FG003|Overall Study|Enrolled but Never Treated|0|||
155448196|NCT02808312|561065613|FG004|Overall Study|Enrolled but Never Treated|0|||
155448197|NCT03628417|561065614|FG000|Overall Study|Death|1|||
155448198|NCT03628417|561065615|FG001|Overall Study|Death|1|||
155448199|NCT02420223|561065616|FG000|Overall Study|Adverse Event|1|||
155448200|NCT02420223|561065617|FG001|Overall Study|Adverse Event|0|||
155448201|NCT02420223|561065616|FG000|Overall Study|Physician Decision|0|||
155448202|NCT02420223|561065617|FG001|Overall Study|Physician Decision|2|||
155448203|NCT01826422|561065618|FG000|Overall Study|Withdrawal by Subject|1|||
155448204|NCT01826422|561065619|FG001|Overall Study|Withdrawal by Subject|3|||
155448205|NCT00769704|561065623|FG000|Overall Study|Lost to Follow-up|3|||
155448206|NCT00769704|561065624|FG001|Overall Study|Lost to Follow-up|2|||
155448207|NCT00769704|561065623|FG000|Overall Study|Death|95|||
155448208|NCT00769704|561065624|FG001|Overall Study|Death|190|||
155448209|NCT00769704|561065623|FG000|Overall Study|Withdrawal by Subject|12|||
155448210|NCT00769704|561065624|FG001|Overall Study|Withdrawal by Subject|5|||
155448211|NCT00769704|561065623|FG000|Overall Study|Other|1|||
155448212|NCT00769704|561065624|FG001|Overall Study|Other|2|||
155448213|NCT00450372|561065625|FG000|Overall Study|Physician Decision|1|||
155448214|NCT05131451|561065626|FG000|Overall Study|Protocol Violation|1|||
155448215|NCT05131451|561065627|FG001|Overall Study|Protocol Violation|0|||
155448216|NCT01856595|561065634|FG000|Overall Study|Withdrawal by Subject|0|||
155448217|NCT01856595|561065635|FG001|Overall Study|Withdrawal by Subject|1|||
155448218|NCT01856595|561065636|FG002|Overall Study|Withdrawal by Subject|0|||
155448219|NCT01856595|561065637|FG003|Overall Study|Withdrawal by Subject|0|||
155448220|NCT01856595|561065638|FG004|Overall Study|Withdrawal by Subject|0|||
155448221|NCT01856595|561065639|FG005|Overall Study|Withdrawal by Subject|0|||
155448222|NCT01856595|561065640|FG006|Overall Study|Withdrawal by Subject|1|||
155448223|NCT01856595|561065641|FG007|Overall Study|Withdrawal by Subject|0|||
155448224|NCT01856595|561065642|FG008|Overall Study|Withdrawal by Subject|0|||
155448225|NCT04426825|561065644|FG000|Overall Study|Death|17|||
155448226|NCT04426825|561065644|FG000|Overall Study|Lost to Follow-up|1|||
155448227|NCT04426825|561065644|FG000|Overall Study|Study terminated by sponsor|5|||
155448228|NCT01863849|561065652|FG000|Overall Study|Lost to Follow-up|1|||
155448229|NCT01863849|561065653|FG001|Overall Study|Lost to Follow-up|0|||
155448230|NCT01727713|561065661|FG000|Overall Study|Lost to Follow-up|5|||
155448231|NCT01727713|561065661|FG000|Overall Study|Adverse Event|10|||
155448232|NCT01727713|561065661|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
155448233|NCT01727713|561065661|FG000|Overall Study|Withdrawal by Subject|13|||
155448234|NCT01727713|561065661|FG000|Overall Study|Protocol Deviation|2|||
155448235|NCT00532948|561065662|FG000|Overall Study|Protocol Violation|1|||
155448236|NCT00532948|561065663|FG001|Overall Study|Protocol Violation|0|||
155448237|NCT00532948|561065664|FG002|Overall Study|Protocol Violation|0|||
155448238|NCT00532948|561065662|FG000|Overall Study|Death|3|||
155448239|NCT00532948|561065663|FG001|Overall Study|Death|3|||
155651546|NCT00835042|561816250|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
155448240|NCT00532948|561065664|FG002|Overall Study|Death|4|||
155651547|NCT00835042|561816251|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
155448241|NCT00532948|561065662|FG000|Overall Study|Violation of selection criteria at entry|0|||
155448242|NCT00532948|561065663|FG001|Overall Study|Violation of selection criteria at entry|1|||
155448243|NCT00532948|561065664|FG002|Overall Study|Violation of selection criteria at entry|0|||
155448244|NCT00532948|561065662|FG000|Overall Study|Failure to return|0|||
155448245|NCT00532948|561065663|FG001|Overall Study|Failure to return|1|||
155448246|NCT00532948|561065664|FG002|Overall Study|Failure to return|0|||
155448247|NCT01842308|561065666|FG000|Overall Study|Withdrawal by Subject|0|||
155448248|NCT01842308|561065667|FG001|Overall Study|Withdrawal by Subject|0|||
155448249|NCT01842308|561065668|FG002|Overall Study|Withdrawal by Subject|0|||
155448250|NCT01842308|561065669|FG003|Overall Study|Withdrawal by Subject|0|||
155448251|NCT01842308|561065670|FG004|Overall Study|Withdrawal by Subject|1|||
155448252|NCT03885726|561065672|FG000|Overall Study|Staffing issues/lost interest|1|||
155448253|NCT03885726|561065672|FG000|Overall Study|Early discharge from hospital|3|||
155448254|NCT02702193|561065673|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
155448255|NCT02702193|561065674|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
155448256|NCT02702193|561065673|FG000|4 Month Follow up|Withdrawal by Subject|1|||
155448257|NCT02702193|561065674|FG001|4 Month Follow up|Withdrawal by Subject|0|||
155448258|NCT02702193|561065673|FG000|4 Month Follow up|Lost to Follow-up|17|||
155448259|NCT02702193|561065674|FG001|4 Month Follow up|Lost to Follow-up|18|||
155448260|NCT02702193|561065673|FG000|8 Month Follow up|Withdrawal by Subject|1|||
155448261|NCT02702193|561065674|FG001|8 Month Follow up|Withdrawal by Subject|0|||
155448262|NCT02702193|561065673|FG000|8 Month Follow up|Lost to Follow-up|14|||
155448263|NCT02702193|561065674|FG001|8 Month Follow up|Lost to Follow-up|18|||
155448264|NCT02702193|561065673|FG000|12 Month Follow up|Withdrawal by Subject|1|||
155448265|NCT02702193|561065674|FG001|12 Month Follow up|Withdrawal by Subject|0|||
155448266|NCT02702193|561065673|FG000|12 Month Follow up|Lost to Follow-up|16|||
155448267|NCT02702193|561065674|FG001|12 Month Follow up|Lost to Follow-up|18|||
155448268|NCT05692154|561065676|FG000|Overall Study|Adverse Event|0|||
155448269|NCT05692154|561065677|FG001|Overall Study|Adverse Event|1|||
155448270|NCT01912729|561065680|FG000|Overall Study|Withdrawal by Subject|0|||
155448271|NCT01912729|561065681|FG001|Overall Study|Withdrawal by Subject|1|||
155448272|NCT05513053|561065689|FG000|Overall Study|Lost to Follow-up|9|||
155448273|NCT05513053|561065690|FG001|Overall Study|Lost to Follow-up|11|||
155448274|NCT05513053|561065689|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155448275|NCT05513053|561065690|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155448276|NCT05513053|561065689|FG000|Overall Study|Withdrawal by Subject|2|||
155448277|NCT05513053|561065690|FG001|Overall Study|Withdrawal by Subject|9|||
155448278|NCT05513053|561065689|FG000|Overall Study|Protocol Violation|6|||
155448279|NCT05513053|561065690|FG001|Overall Study|Protocol Violation|3|||
155448280|NCT05513053|561065689|FG000|Overall Study|Adverse Event|0|||
155448281|NCT05513053|561065690|FG001|Overall Study|Adverse Event|2|||
155448282|NCT00683475|561067347|FG000|Overall Study|Withdrawal by Subject|1|||
155448283|NCT00683475|561067348|FG001|Overall Study|Withdrawal by Subject|0|||
155448284|NCT00683475|561067347|FG000|Overall Study|Never Treated: Adverse Event|2|||
155448285|NCT00683475|561067348|FG001|Overall Study|Never Treated: Adverse Event|3|||
155448286|NCT00683475|561067347|FG000|Overall Study|Never Treated: Progressive Disease|1|||
155448287|NCT00683475|561067348|FG001|Overall Study|Never Treated: Progressive Disease|0|||
155448288|NCT01953328|561067349|FG000|Overall Study|Withdrawal by Subject|0|||
155448289|NCT01953328|561067350|FG001|Overall Study|Withdrawal by Subject|0|||
155448290|NCT01953328|561067351|FG002|Overall Study|Withdrawal by Subject|0|||
155448291|NCT01953328|561067352|FG003|Overall Study|Withdrawal by Subject|0|||
155448292|NCT01953328|561067353|FG004|Overall Study|Withdrawal by Subject|1|||
155448293|NCT01953328|561067354|FG005|Overall Study|Withdrawal by Subject|0|||
155448294|NCT01953328|561067355|FG006|Overall Study|Withdrawal by Subject|0|||
155448295|NCT01953328|561067356|FG007|Overall Study|Withdrawal by Subject|0|||
155448296|NCT01953328|561067349|FG000|Overall Study|Lost to Follow-up|0|||
155448297|NCT01953328|561067350|FG001|Overall Study|Lost to Follow-up|0|||
155448298|NCT01953328|561067351|FG002|Overall Study|Lost to Follow-up|0|||
155448299|NCT01953328|561067352|FG003|Overall Study|Lost to Follow-up|0|||
155448300|NCT01953328|561067353|FG004|Overall Study|Lost to Follow-up|1|||
155448301|NCT01953328|561067354|FG005|Overall Study|Lost to Follow-up|0|||
155515334|NCT03466411|561311583|FG005|Overall Study|Withdrawal by Subject|3|||
155515335|NCT03466411|561311584|FG006|Overall Study|Withdrawal by Subject|6|||
155448302|NCT01953328|561067355|FG006|Overall Study|Lost to Follow-up|0|||
155448303|NCT01953328|561067356|FG007|Overall Study|Lost to Follow-up|0|||
155448304|NCT02429258|561067359|FG000|Overall Study|Withdrawal by Subject|2|||
155448305|NCT02429258|561067360|FG001|Overall Study|Withdrawal by Subject|0|||
155448306|NCT02429258|561067359|FG000|Overall Study|Protocol Violation|0|||
155448307|NCT02429258|561067360|FG001|Overall Study|Protocol Violation|1|||
155448308|NCT03987919|561067362|FG000|Overall Study|Adverse Event|1|||
155515336|NCT03466411|561311585|FG007|Overall Study|Withdrawal by Subject|9|||
155448309|NCT03987919|561067363|FG001|Overall Study|Adverse Event|4|||
155515337|NCT03466411|561311586|FG008|Overall Study|Withdrawal by Subject|6|||
155448310|NCT03987919|561067364|FG002|Overall Study|Adverse Event|1|||
155448311|NCT03987919|561067365|FG003|Overall Study|Adverse Event|3|||
155448312|NCT03987919|561067362|FG000|Overall Study|Death|4|||
155448313|NCT03987919|561067363|FG001|Overall Study|Death|4|||
155448314|NCT03987919|561067364|FG002|Overall Study|Death|4|||
155448315|NCT03987919|561067365|FG003|Overall Study|Death|1|||
155448316|NCT03987919|561067362|FG000|Overall Study|Lost to Follow-up|5|||
155448317|NCT03987919|561067363|FG001|Overall Study|Lost to Follow-up|6|||
155448318|NCT03987919|561067364|FG002|Overall Study|Lost to Follow-up|8|||
155448319|NCT03987919|561067365|FG003|Overall Study|Lost to Follow-up|12|||
155448320|NCT03987919|561067362|FG000|Overall Study|Physician Decision|0|||
155448321|NCT03987919|561067363|FG001|Overall Study|Physician Decision|2|||
155448322|NCT03987919|561067364|FG002|Overall Study|Physician Decision|0|||
155448323|NCT03987919|561067365|FG003|Overall Study|Physician Decision|4|||
155448324|NCT03987919|561067362|FG000|Overall Study|Pregnancy|1|||
155448325|NCT03987919|561067363|FG001|Overall Study|Pregnancy|0|||
155448326|NCT03987919|561067364|FG002|Overall Study|Pregnancy|1|||
155448327|NCT03987919|561067365|FG003|Overall Study|Pregnancy|1|||
155448328|NCT03987919|561067362|FG000|Overall Study|Protocol Violation|0|||
155448329|NCT03987919|561067363|FG001|Overall Study|Protocol Violation|1|||
155448330|NCT03987919|561067364|FG002|Overall Study|Protocol Violation|0|||
155448331|NCT03987919|561067365|FG003|Overall Study|Protocol Violation|0|||
155448332|NCT03987919|561067362|FG000|Overall Study|Site terminated by Sponsor|0|||
155448333|NCT03987919|561067363|FG001|Overall Study|Site terminated by Sponsor|0|||
155448334|NCT03987919|561067364|FG002|Overall Study|Site terminated by Sponsor|0|||
155448335|NCT03987919|561067365|FG003|Overall Study|Site terminated by Sponsor|1|||
155448336|NCT03987919|561067362|FG000|Overall Study|Withdrawal by Subject|7|||
155448337|NCT03987919|561067363|FG001|Overall Study|Withdrawal by Subject|7|||
155448338|NCT03987919|561067364|FG002|Overall Study|Withdrawal by Subject|8|||
155448339|NCT03987919|561067365|FG003|Overall Study|Withdrawal by Subject|4|||
155448340|NCT03987919|561067362|FG000|Overall Study|Other - as reported by the investigator|1|||
155448341|NCT03987919|561067363|FG001|Overall Study|Other - as reported by the investigator|3|||
155448342|NCT03987919|561067364|FG002|Overall Study|Other - as reported by the investigator|2|||
155448343|NCT03987919|561067365|FG003|Overall Study|Other - as reported by the investigator|0|||
155448344|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
155448345|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
155448346|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
155448347|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155448348|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155448349|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155448350|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155448351|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155448352|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
155448353|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
155448354|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
155448355|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155448356|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155448357|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155448358|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155448359|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155448360|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
155448361|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448362|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448363|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448364|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448365|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448366|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448367|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
155448368|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
155448369|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448370|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448371|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448372|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155515338|NCT03466411|561311587|FG009|Overall Study|Withdrawal by Subject|11|||
155515339|NCT03466411|561311588|FG010|Overall Study|Withdrawal by Subject|14|||
155448373|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448374|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448375|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
155448376|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
155448377|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
155448378|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
155448379|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
155448380|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
155448381|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
155448382|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
155448383|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
155448384|NCT03725202|561067366|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448385|NCT03725202|561067367|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448386|NCT03725202|561067368|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
155448387|NCT03725202|561067369|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448388|NCT03725202|561067370|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448389|NCT03725202|561067371|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448390|NCT03725202|561067372|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448391|NCT03725202|561067373|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
155448392|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
155448393|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
155448394|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
155448395|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
155448396|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
155448397|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
155448398|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
155448399|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
155448400|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
155448401|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
155448402|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
155448403|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
155448404|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
155448405|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
155448406|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
155448407|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
155448408|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
155448409|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
155448410|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
155448411|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
155448412|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
155448413|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
155448414|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
155448415|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
155448416|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448417|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448418|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448419|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448420|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448421|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448422|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
155448423|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
155448424|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448425|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448426|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448427|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448428|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448429|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
155448430|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448431|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
155448432|NCT03725202|561067366|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
155448433|NCT03725202|561067367|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
155448434|NCT03725202|561067368|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
155448435|NCT03725202|561067369|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
155448436|NCT03725202|561067370|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
155448437|NCT03725202|561067371|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
155515340|NCT03466411|561311589|FG011|Overall Study|Withdrawal by Subject|12|||
155515341|NCT03466411|561311590|FG012|Overall Study|Withdrawal by Subject|7|||
155515342|NCT03466411|561311578|FG000|Overall Study|Other|1|||
155515343|NCT03466411|561311579|FG001|Overall Study|Other|1|||
155515344|NCT03466411|561311580|FG002|Overall Study|Other|0|||
155515345|NCT03466411|561311581|FG003|Overall Study|Other|1|||
155515346|NCT03466411|561311582|FG004|Overall Study|Other|2|||
155448438|NCT03725202|561067372|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
155448439|NCT03725202|561067373|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
155448440|NCT01328249|561067376|FG000|Overall Study|Adverse Event|3|||
155448441|NCT01328249|561067377|FG001|Overall Study|Adverse Event|0|||
155448442|NCT01328249|561067376|FG000|Overall Study|Disease progression|1|||
155448443|NCT01328249|561067377|FG001|Overall Study|Disease progression|0|||
155448444|NCT01328249|561067376|FG000|Overall Study|Withdrawal by Subject|1|||
155448445|NCT01328249|561067377|FG001|Overall Study|Withdrawal by Subject|1|||
155448446|NCT01328249|561067376|FG000|Overall Study|Moved before end of treatment visit|1|||
155448447|NCT01328249|561067377|FG001|Overall Study|Moved before end of treatment visit|0|||
155448448|NCT01328249|561067376|FG000|Overall Study|Subject choice|1|||
155448449|NCT01328249|561067377|FG001|Overall Study|Subject choice|1|||
155448450|NCT01328249|561067376|FG000|Overall Study|Protocol Violation|0|||
155448451|NCT01328249|561067377|FG001|Overall Study|Protocol Violation|1|||
155448452|NCT00748553|561067378|FG000|Overall Study|Adverse Event|0|||
155448453|NCT00748553|561067379|FG001|Overall Study|Adverse Event|1|||
155448454|NCT00748553|561067378|FG000|Overall Study|disease progression|2|||
155448455|NCT00748553|561067379|FG001|Overall Study|disease progression|0|||
155448456|NCT00748553|561067378|FG000|Overall Study|noncompliance|1|||
155448457|NCT00748553|561067379|FG001|Overall Study|noncompliance|0|||
155448458|NCT02330549|561067380|FG000|Overall Study|Adverse Event|1|||
155448459|NCT02330549|561067381|FG001|Overall Study|Adverse Event|0|||
155448460|NCT02330549|561067380|FG000|Overall Study|Subject withdrew consent|2|||
155448461|NCT02330549|561067381|FG001|Overall Study|Subject withdrew consent|1|||
155448462|NCT02330549|561067380|FG000|Overall Study|Failure to meet randomization criteria|1|||
155448463|NCT02330549|561067381|FG001|Overall Study|Failure to meet randomization criteria|0|||
155448464|NCT00495495|561067382|FG000|Overall Study|Protocol Violation|99|||
155448465|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
155448466|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
155448467|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
155448468|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
155448469|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
155448470|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
155448471|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
155448472|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155448473|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
155448474|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
155448475|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
155448476|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
155448477|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
155448478|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
155448479|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
155448480|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
155448481|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
155448482|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
155448483|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
155448484|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
155448485|NCT00423085|561067388|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
155448486|NCT00423085|561067389|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
155448487|NCT00423085|561067390|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
155448488|NCT00423085|561067391|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
155448489|NCT00423085|561067388|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
155448490|NCT00423085|561067389|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
155448491|NCT00423085|561067390|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
155448492|NCT00423085|561067391|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
155448493|NCT00423085|561067388|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
155448494|NCT00423085|561067389|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
155448495|NCT00423085|561067390|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
155448496|NCT00423085|561067391|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
155448497|NCT00423085|561067388|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
155448498|NCT00423085|561067389|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
155448499|NCT00423085|561067390|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
155448500|NCT00423085|561067391|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
155448501|NCT00423085|561067388|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
155448502|NCT00423085|561067389|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
155448503|NCT00423085|561067390|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
155448504|NCT00423085|561067391|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
155448505|NCT00423085|561067388|FG000|52-Week Open-Label Extension Phase|Death|0|||
155448506|NCT00423085|561067389|FG001|52-Week Open-Label Extension Phase|Death|0|||
155448507|NCT00423085|561067390|FG002|52-Week Open-Label Extension Phase|Death|0|||
155448508|NCT00423085|561067391|FG003|52-Week Open-Label Extension Phase|Death|2|||
155448509|NCT02702518|561067392|FG000|Overall Study|Lost to Follow-up|3|||
155448510|NCT02702518|561067393|FG001|Overall Study|Lost to Follow-up|4|||
155448511|NCT03331666|561067394|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
155448512|NCT03331666|561067395|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
155448513|NCT05525975|561067396|FG000|Overall Study|Surgery cancellation|4|||
155448514|NCT05525975|561067397|FG001|Overall Study|Surgery cancellation|5|||
155448515|NCT05525975|561067396|FG000|Overall Study|didn't fill prescription|1|||
155448516|NCT05525975|561067397|FG001|Overall Study|didn't fill prescription|0|||
155448517|NCT05525975|561067396|FG000|Overall Study|Withdrawal by Subject|0|||
155448518|NCT05525975|561067397|FG001|Overall Study|Withdrawal by Subject|3|||
155448519|NCT01051986|561067399|FG000|Overall Study|Death|1|||
155448520|NCT01051986|561067400|FG001|Overall Study|Death|0|||
155448521|NCT01051986|561067399|FG000|Overall Study|Withdrawal by Subject|2|||
155448522|NCT01051986|561067400|FG001|Overall Study|Withdrawal by Subject|1|||
155448523|NCT01051986|561067399|FG000|Overall Study|Protocol Violation|2|||
155448524|NCT01051986|561067400|FG001|Overall Study|Protocol Violation|3|||
155448525|NCT00262080|561067401|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
155448526|NCT00262080|561067402|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155448527|NCT00262080|561067403|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
155448528|NCT00262080|561067401|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
155448529|NCT00262080|561067402|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
155448530|NCT00262080|561067403|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
155448531|NCT00262080|561067401|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
155448532|NCT00262080|561067402|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
155448533|NCT00262080|561067403|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
155448534|NCT00262080|561067401|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
155448535|NCT00262080|561067402|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
155448536|NCT00262080|561067403|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
155448537|NCT00262080|561067401|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
155448538|NCT00262080|561067402|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
155448539|NCT00262080|561067403|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
155448540|NCT00262080|561067401|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
155448541|NCT00262080|561067402|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
155448542|NCT00262080|561067403|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
155448543|NCT02044159|561067405|FG000|Overall Study|Consent declined (deferred consent)|2|||
155448544|NCT02044159|561067406|FG001|Overall Study|Consent declined (deferred consent)|4|||
155448545|NCT02044159|561067405|FG000|Overall Study|No longer eligible, drug not given|1|||
155448546|NCT02044159|561067406|FG001|Overall Study|No longer eligible, drug not given|0|||
155448547|NCT02044159|561067405|FG000|Overall Study|Nurse declined to give study drug|1|||
155448548|NCT02044159|561067406|FG001|Overall Study|Nurse declined to give study drug|0|||
155448549|NCT01361009|561067407|FG000|Overall Study|Protocol Violation|116|||
155448550|NCT04009096|561067408|FG000|Overall Study|Withdrawal by Subject|0|||
155448551|NCT04009096|561067409|FG001|Overall Study|Withdrawal by Subject|7|||
155448552|NCT04009096|561067410|FG002|Overall Study|Withdrawal by Subject|0|||
155448553|NCT04009096|561067408|FG000|Overall Study|Physician Decision|0|||
155448554|NCT04009096|561067409|FG001|Overall Study|Physician Decision|1|||
155448555|NCT04009096|561067410|FG002|Overall Study|Physician Decision|0|||
155448556|NCT04263142|561067411|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
155448557|NCT04263142|561067412|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
155448558|NCT04263142|561067413|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
155448559|NCT04263142|561067414|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
155448560|NCT04263142|561067415|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
155448561|NCT04263142|561067411|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
155448562|NCT04263142|561067412|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
155448563|NCT04263142|561067413|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
155448564|NCT04263142|561067414|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
155448565|NCT04263142|561067415|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
155448566|NCT03010423|561067419|FG000|Overall Study|Study termination|8|||
155448567|NCT01597557|561067420|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
155448568|NCT01597557|561067421|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
155448569|NCT00115349|561067424|FG000|Overall Study|Study closed due to low enrollment.|11|||
155651548|NCT02662582|561816252|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
155448570|NCT00115349|561067425|FG001|Overall Study|Study closed due to low enrollment.|9|||
155448571|NCT04402008|561067428|FG000|Overall Study|Adverse Event|0|||
155448572|NCT04402008|561067429|FG001|Overall Study|Adverse Event|0|||
155448573|NCT04402008|561067430|FG002|Overall Study|Adverse Event|0|||
155448574|NCT04402008|561067431|FG003|Overall Study|Adverse Event|1|||
155515347|NCT03466411|561311583|FG005|Overall Study|Other|0|||
155448575|NCT04402008|561067432|FG004|Overall Study|Adverse Event|0|||
155515348|NCT03466411|561311584|FG006|Overall Study|Other|0|||
155448576|NCT04402008|561067433|FG005|Overall Study|Adverse Event|0|||
155448577|NCT04402008|561067434|FG006|Overall Study|Adverse Event|0|||
155448578|NCT04402008|561067428|FG000|Overall Study|Disease Progression|3|||
155448579|NCT04402008|561067429|FG001|Overall Study|Disease Progression|2|||
155448580|NCT04402008|561067430|FG002|Overall Study|Disease Progression|3|||
155448581|NCT04402008|561067431|FG003|Overall Study|Disease Progression|3|||
155448582|NCT04402008|561067432|FG004|Overall Study|Disease Progression|4|||
155448583|NCT04402008|561067433|FG005|Overall Study|Disease Progression|3|||
155448584|NCT04402008|561067434|FG006|Overall Study|Disease Progression|10|||
155448585|NCT04402008|561067428|FG000|Overall Study|Withdrawal by Subject|0|||
155448586|NCT04402008|561067429|FG001|Overall Study|Withdrawal by Subject|1|||
155448587|NCT04402008|561067430|FG002|Overall Study|Withdrawal by Subject|0|||
155448588|NCT04402008|561067431|FG003|Overall Study|Withdrawal by Subject|0|||
155448589|NCT04402008|561067432|FG004|Overall Study|Withdrawal by Subject|1|||
155448590|NCT04402008|561067433|FG005|Overall Study|Withdrawal by Subject|0|||
155448591|NCT04402008|561067434|FG006|Overall Study|Withdrawal by Subject|0|||
155448592|NCT04402008|561067428|FG000|Overall Study|Sponsor Decision|0|||
155448593|NCT04402008|561067429|FG001|Overall Study|Sponsor Decision|0|||
155448594|NCT04402008|561067430|FG002|Overall Study|Sponsor Decision|0|||
155448595|NCT04402008|561067431|FG003|Overall Study|Sponsor Decision|0|||
155448596|NCT04402008|561067432|FG004|Overall Study|Sponsor Decision|0|||
155448597|NCT04402008|561067433|FG005|Overall Study|Sponsor Decision|0|||
155448598|NCT04402008|561067434|FG006|Overall Study|Sponsor Decision|3|||
155448599|NCT04402008|561067428|FG000|Overall Study|Death|0|||
155448600|NCT04402008|561067429|FG001|Overall Study|Death|0|||
155448601|NCT04402008|561067430|FG002|Overall Study|Death|0|||
155448602|NCT04402008|561067431|FG003|Overall Study|Death|0|||
155448603|NCT04402008|561067432|FG004|Overall Study|Death|1|||
155448604|NCT04402008|561067433|FG005|Overall Study|Death|0|||
155448605|NCT04402008|561067434|FG006|Overall Study|Death|2|||
155448606|NCT04402008|561067428|FG000|Overall Study|Other|0|||
155448607|NCT04402008|561067429|FG001|Overall Study|Other|0|||
155448608|NCT04402008|561067430|FG002|Overall Study|Other|0|||
155448609|NCT04402008|561067431|FG003|Overall Study|Other|0|||
155448610|NCT04402008|561067432|FG004|Overall Study|Other|0|||
155448611|NCT04402008|561067433|FG005|Overall Study|Other|0|||
155448612|NCT04402008|561067434|FG006|Overall Study|Other|5|||
155448613|NCT01533935|561067436|FG000|Overall Study|Adverse Event|5|||
155448614|NCT01533935|561067437|FG001|Overall Study|Adverse Event|7|||
155448615|NCT01533935|561067438|FG002|Overall Study|Adverse Event|1|||
155448616|NCT01533935|561067439|FG003|Overall Study|Adverse Event|5|||
155448617|NCT01533935|561067440|FG004|Overall Study|Adverse Event|3|||
155448618|NCT01533935|561067436|FG000|Overall Study|Protocol Violation|0|||
155448619|NCT01533935|561067437|FG001|Overall Study|Protocol Violation|2|||
155448620|NCT01533935|561067438|FG002|Overall Study|Protocol Violation|0|||
155448621|NCT01533935|561067439|FG003|Overall Study|Protocol Violation|0|||
155448622|NCT01533935|561067440|FG004|Overall Study|Protocol Violation|0|||
155448623|NCT01533935|561067436|FG000|Overall Study|Lost to Follow-up|0|||
155448624|NCT01533935|561067437|FG001|Overall Study|Lost to Follow-up|0|||
155448625|NCT01533935|561067438|FG002|Overall Study|Lost to Follow-up|1|||
155448626|NCT01533935|561067439|FG003|Overall Study|Lost to Follow-up|0|||
155448627|NCT01533935|561067440|FG004|Overall Study|Lost to Follow-up|0|||
155448628|NCT01533935|561067436|FG000|Overall Study|Withdrawal by Subject|0|||
155448629|NCT01533935|561067437|FG001|Overall Study|Withdrawal by Subject|4|||
155448630|NCT01533935|561067438|FG002|Overall Study|Withdrawal by Subject|5|||
155448631|NCT01533935|561067439|FG003|Overall Study|Withdrawal by Subject|2|||
155448632|NCT01533935|561067440|FG004|Overall Study|Withdrawal by Subject|4|||
155448633|NCT01533935|561067436|FG000|Overall Study|Other reason not defined above|1|||
155448634|NCT01533935|561067437|FG001|Overall Study|Other reason not defined above|0|||
155448635|NCT01533935|561067438|FG002|Overall Study|Other reason not defined above|1|||
155448636|NCT01533935|561067439|FG003|Overall Study|Other reason not defined above|0|||
155448637|NCT01533935|561067440|FG004|Overall Study|Other reason not defined above|1|||
155448638|NCT05132569|561067441|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
155448639|NCT05132569|561067442|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
155448640|NCT05132569|561067441|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
155448641|NCT05132569|561067442|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
155448642|NCT05132569|561067441|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
155448643|NCT05132569|561067442|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
155448644|NCT01554956|561067443|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
155448645|NCT01554956|561067444|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
155448646|NCT01554956|561067445|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
155448647|NCT01554956|561067443|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
155448648|NCT01554956|561067444|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
155448649|NCT01554956|561067445|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
155448650|NCT01554956|561067443|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
155491137|NCT01023815|561223477|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
155491138|NCT01023815|561223474|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
155448651|NCT01554956|561067444|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
155448652|NCT01554956|561067445|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
155448653|NCT00913978|561067446|FG000|Overall Study|Surgeon choice|1|||
155448654|NCT00913978|561067447|FG001|Overall Study|Surgeon choice|3|||
155448655|NCT04716933|561067448|FG000|Overall Study|Sponsor Decision|36|||
155448656|NCT04716933|561067449|FG001|Overall Study|Sponsor Decision|33|||
155448657|NCT04716933|561067448|FG000|Overall Study|Death|65|||
155448658|NCT04716933|561067449|FG001|Overall Study|Death|67|||
155448659|NCT00740779|561067455|FG000|Overall Study|Adverse Event|4|||
155448660|NCT00740779|561067456|FG001|Overall Study|Adverse Event|6|||
155448661|NCT00740779|561067457|FG002|Overall Study|Adverse Event|3|||
155448662|NCT00740779|561067455|FG000|Overall Study|Protocol Violation|1|||
155448663|NCT00740779|561067456|FG001|Overall Study|Protocol Violation|1|||
155448664|NCT00740779|561067457|FG002|Overall Study|Protocol Violation|1|||
155448665|NCT00740779|561067455|FG000|Overall Study|Lack of Efficacy|0|||
155448666|NCT00740779|561067456|FG001|Overall Study|Lack of Efficacy|0|||
155448667|NCT00740779|561067457|FG002|Overall Study|Lack of Efficacy|2|||
155448668|NCT00740779|561067455|FG000|Overall Study|Withdrawal by Subject|2|||
155448669|NCT00740779|561067456|FG001|Overall Study|Withdrawal by Subject|4|||
155448670|NCT00740779|561067457|FG002|Overall Study|Withdrawal by Subject|2|||
155448671|NCT00740779|561067455|FG000|Overall Study|Lost to Follow-up|2|||
155448672|NCT00740779|561067456|FG001|Overall Study|Lost to Follow-up|3|||
155448673|NCT00740779|561067457|FG002|Overall Study|Lost to Follow-up|5|||
155448674|NCT00988559|561067458|FG000|Overall Study|Withdrawal by Subject|1|||
155448675|NCT00988559|561067459|FG001|Overall Study|Withdrawal by Subject|1|||
155448676|NCT00988559|561067460|FG002|Overall Study|Withdrawal by Subject|0|||
155448677|NCT00988559|561067461|FG003|Overall Study|Withdrawal by Subject|1|||
155448678|NCT00988559|561067458|FG000|Overall Study|Pregnancy|0|||
155448679|NCT00988559|561067459|FG001|Overall Study|Pregnancy|1|||
155448680|NCT00988559|561067460|FG002|Overall Study|Pregnancy|1|||
155448681|NCT00988559|561067461|FG003|Overall Study|Pregnancy|0|||
155448682|NCT00988559|561067458|FG000|Overall Study|Lost to Follow-up|0|||
155448683|NCT00988559|561067459|FG001|Overall Study|Lost to Follow-up|0|||
155448684|NCT00988559|561067460|FG002|Overall Study|Lost to Follow-up|1|||
155448685|NCT00988559|561067461|FG003|Overall Study|Lost to Follow-up|0|||
155448686|NCT05372575|561067462|FG000|Overall Study|Protocol Violation|7|||
155448687|NCT05372575|561067463|FG001|Overall Study|Protocol Violation|16|||
155448688|NCT00829166|561067464|FG000|Overall Study|Death|305|||
155448689|NCT00829166|561067465|FG001|Overall Study|Death|333|||
155448690|NCT00829166|561067464|FG000|Overall Study|Lost to Follow-up|5|||
155448691|NCT00829166|561067465|FG001|Overall Study|Lost to Follow-up|4|||
155448692|NCT00829166|561067464|FG000|Overall Study|Physician's Decision|4|||
155448693|NCT00829166|561067465|FG001|Overall Study|Physician's Decision|3|||
155448694|NCT00829166|561067464|FG000|Overall Study|Subject's Decision|41|||
155448695|NCT00829166|561067465|FG001|Overall Study|Subject's Decision|55|||
155448696|NCT00829166|561067464|FG000|Overall Study|Sponsor's Decision|137|||
155448697|NCT00829166|561067465|FG001|Overall Study|Sponsor's Decision|98|||
155448698|NCT00829166|561067464|FG000|Overall Study|Reason Not Specified|3|||
155448699|NCT00829166|561067465|FG001|Overall Study|Reason Not Specified|3|||
155448700|NCT03510663|561067466|FG000|Overall Study|Withdrawal by Subject|0|||
155448701|NCT03510663|561067467|FG001|Overall Study|Withdrawal by Subject|1|||
155448702|NCT03510663|561067468|FG002|Overall Study|Withdrawal by Subject|0|||
155448703|NCT03510663|561067469|FG003|Overall Study|Withdrawal by Subject|0|||
155448704|NCT03510663|561067470|FG004|Overall Study|Withdrawal by Subject|0|||
155448705|NCT03510663|561067471|FG005|Overall Study|Withdrawal by Subject|0|||
155448706|NCT03510663|561067472|FG006|Overall Study|Withdrawal by Subject|0|||
155448707|NCT03510663|561067473|FG007|Overall Study|Withdrawal by Subject|0|||
155448708|NCT01465178|561067479|FG000|Overall Study|Withdrawal by Subject|1|||
155448709|NCT01465178|561067480|FG001|Overall Study|Withdrawal by Subject|0|||
155448710|NCT03342469|561067481|FG000|Overall Study|Withdrawal by Subject|0|||
155448711|NCT03342469|561067482|FG001|Overall Study|Withdrawal by Subject|1|||
155448712|NCT03342469|561067483|FG002|Overall Study|Withdrawal by Subject|0|||
155448713|NCT03342469|561067484|FG003|Overall Study|Withdrawal by Subject|0|||
155448714|NCT02426658|561067488|FG000|Overall Study|Withdrawal by Subject|1|||
155515349|NCT03466411|561311585|FG007|Overall Study|Other|0|||
155448715|NCT02426658|561067488|FG000|Overall Study|Patient expired before treatment|2|||
155448716|NCT01204658|561067493|FG000|Primary Phase|Adverse Event|0|||
155448717|NCT01204658|561067494|FG001|Primary Phase|Adverse Event|0|||
155448718|NCT01204658|561067495|FG002|Primary Phase|Adverse Event|1|||
155448719|NCT01204658|561067496|FG003|Primary Phase|Adverse Event|0|||
155448720|NCT04594239|561067497|FG000|Overall Study|Withdrawal by Subject|3|||
155448721|NCT04594239|561067498|FG001|Overall Study|Withdrawal by Subject|4|||
155448722|NCT04594239|561067499|FG002|Overall Study|Withdrawal by Subject|2|||
155448723|NCT04594239|561067500|FG003|Overall Study|Withdrawal by Subject|4|||
155448724|NCT04594239|561067497|FG000|Overall Study|Lost to Follow-up|8|||
155448725|NCT04594239|561067498|FG001|Overall Study|Lost to Follow-up|5|||
155448726|NCT04594239|561067499|FG002|Overall Study|Lost to Follow-up|4|||
155448727|NCT04594239|561067500|FG003|Overall Study|Lost to Follow-up|6|||
155448728|NCT04594239|561067497|FG000|Overall Study|Subject relocated|0|||
155448729|NCT04594239|561067498|FG001|Overall Study|Subject relocated|0|||
155448730|NCT04594239|561067499|FG002|Overall Study|Subject relocated|0|||
155448731|NCT04594239|561067500|FG003|Overall Study|Subject relocated|1|||
155448732|NCT00309777|561067513|FG000|Overall Study|Adverse Event|13|||
155448733|NCT00309777|561067514|FG001|Overall Study|Adverse Event|2|||
155448734|NCT00309777|561067515|FG002|Overall Study|Adverse Event|8|||
155448735|NCT00309777|561067516|FG003|Overall Study|Adverse Event|1|||
155448736|NCT00309777|561067513|FG000|Overall Study|Protocol Violation|4|||
155448737|NCT00309777|561067514|FG001|Overall Study|Protocol Violation|1|||
155448738|NCT00309777|561067515|FG002|Overall Study|Protocol Violation|3|||
155448739|NCT00309777|561067516|FG003|Overall Study|Protocol Violation|1|||
155448740|NCT00309777|561067513|FG000|Overall Study|Withdrawal by Subject|6|||
155448741|NCT00309777|561067514|FG001|Overall Study|Withdrawal by Subject|5|||
155448742|NCT00309777|561067515|FG002|Overall Study|Withdrawal by Subject|7|||
155448743|NCT00309777|561067516|FG003|Overall Study|Withdrawal by Subject|2|||
155448744|NCT00309777|561067513|FG000|Overall Study|Lost to Follow-up|0|||
155448745|NCT00309777|561067514|FG001|Overall Study|Lost to Follow-up|0|||
155448746|NCT00309777|561067515|FG002|Overall Study|Lost to Follow-up|1|||
155448747|NCT00309777|561067516|FG003|Overall Study|Lost to Follow-up|0|||
155448748|NCT00309777|561067513|FG000|Overall Study|Death|0|||
155448749|NCT00309777|561067514|FG001|Overall Study|Death|1|||
155448750|NCT00309777|561067515|FG002|Overall Study|Death|0|||
155448751|NCT00309777|561067516|FG003|Overall Study|Death|0|||
155448752|NCT00520676|561069020|FG000|Overall Study|Death|84|||
155448753|NCT00520676|561069021|FG001|Overall Study|Death|81|||
155448754|NCT00520676|561069020|FG000|Overall Study|Lost to Follow-up|6|||
155448755|NCT00520676|561069021|FG001|Overall Study|Lost to Follow-up|10|||
155448756|NCT00520676|561069020|FG000|Overall Study|Physician Decision|4|||
155448757|NCT00520676|561069021|FG001|Overall Study|Physician Decision|1|||
155448758|NCT00520676|561069020|FG000|Overall Study|Withdrawal by Subject|7|||
155448759|NCT00520676|561069021|FG001|Overall Study|Withdrawal by Subject|11|||
155448760|NCT03484923|561069024|FG000|Overall Study|Adverse Event|3|||
155448761|NCT03484923|561069025|FG001|Overall Study|Adverse Event|3|||
155448762|NCT03484923|561069026|FG002|Overall Study|Adverse Event|5|||
155448763|NCT03484923|561069027|FG003|Overall Study|Adverse Event|11|||
155448764|NCT03484923|561069028|FG004|Overall Study|Adverse Event|1|||
155448765|NCT03484923|561069024|FG000|Overall Study|Death|2|||
155448766|NCT03484923|561069025|FG001|Overall Study|Death|2|||
155448767|NCT03484923|561069026|FG002|Overall Study|Death|3|||
155448768|NCT03484923|561069027|FG003|Overall Study|Death|0|||
155448769|NCT03484923|561069028|FG004|Overall Study|Death|1|||
155448770|NCT03484923|561069024|FG000|Overall Study|Physician Decision|6|||
155448771|NCT03484923|561069025|FG001|Overall Study|Physician Decision|7|||
155448772|NCT03484923|561069026|FG002|Overall Study|Physician Decision|6|||
155448773|NCT03484923|561069027|FG003|Overall Study|Physician Decision|3|||
155448774|NCT03484923|561069028|FG004|Overall Study|Physician Decision|2|||
155448775|NCT03484923|561069024|FG000|Overall Study|Progressive disease|33|||
155448776|NCT03484923|561069025|FG001|Overall Study|Progressive disease|28|||
155448777|NCT03484923|561069026|FG002|Overall Study|Progressive disease|26|||
155448778|NCT03484923|561069027|FG003|Overall Study|Progressive disease|30|||
155448779|NCT03484923|561069028|FG004|Overall Study|Progressive disease|16|||
155448780|NCT03484923|561069024|FG000|Overall Study|Subject Decision|1|||
155448781|NCT03484923|561069025|FG001|Overall Study|Subject Decision|3|||
155448782|NCT03484923|561069026|FG002|Overall Study|Subject Decision|3|||
155448783|NCT03484923|561069027|FG003|Overall Study|Subject Decision|0|||
155448784|NCT03484923|561069028|FG004|Overall Study|Subject Decision|1|||
155448785|NCT03439748|561069029|FG000|Overall Study|Withdrawal by Subject|11|||
155448786|NCT03439748|561069030|FG001|Overall Study|Withdrawal by Subject|17|||
155448787|NCT01028651|561069035|FG000|Overall Study|Death|2|||
155448788|NCT01028651|561069035|FG000|Overall Study|Adverse Event|1|||
155448789|NCT06150573|561069036|FG000|Overall Study|Did not meet study criteria|1|||
155448790|NCT06150573|561069037|FG001|Overall Study|Did not meet study criteria|0|||
155448791|NCT06150573|561069036|FG000|Overall Study|Adverse Event|1|||
155448792|NCT06150573|561069037|FG001|Overall Study|Adverse Event|0|||
155448793|NCT06150573|561069036|FG000|Overall Study|Lost to Follow-up|0|||
155448794|NCT06150573|561069037|FG001|Overall Study|Lost to Follow-up|1|||
155448795|NCT06150573|561069036|FG000|Overall Study|Protocol Violation|0|||
155448796|NCT06150573|561069037|FG001|Overall Study|Protocol Violation|1|||
155448797|NCT06150573|561069036|FG000|Overall Study|Withdrawal by Subject|2|||
155448798|NCT06150573|561069037|FG001|Overall Study|Withdrawal by Subject|0|||
155448799|NCT00210158|561069038|FG000|Overall Study|Protocol Violation|0|||
155515350|NCT03466411|561311586|FG008|Overall Study|Other|0|||
155515351|NCT03466411|561311587|FG009|Overall Study|Other|1|||
155448800|NCT00210158|561069039|FG001|Overall Study|Protocol Violation|2|||
155448801|NCT01327651|561069040|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
155448802|NCT01327651|561069041|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
155448803|NCT01327651|561069042|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
155448804|NCT01327651|561069043|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
155448805|NCT01327651|561069044|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
155448806|NCT01327651|561069045|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
155448807|NCT01327651|561069046|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
155448808|NCT01327651|561069047|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
155448809|NCT01327651|561069048|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
155448810|NCT01327651|561069040|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
155448811|NCT01327651|561069041|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448812|NCT01327651|561069042|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448813|NCT01327651|561069043|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448814|NCT01327651|561069044|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448815|NCT01327651|561069045|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448816|NCT01327651|561069046|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448817|NCT01327651|561069047|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448818|NCT01327651|561069048|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
155448819|NCT01327651|561069040|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
155448820|NCT01327651|561069041|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
155448821|NCT01327651|561069042|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
155448822|NCT01327651|561069043|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
155448823|NCT01327651|561069044|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
155448824|NCT01327651|561069045|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
155448825|NCT01327651|561069046|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
155448826|NCT01327651|561069047|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
155448827|NCT01327651|561069048|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
155448828|NCT01327651|561069040|FG000|Post Study Follow-up|Lost to Follow-up|0|||
155448829|NCT01327651|561069041|FG001|Post Study Follow-up|Lost to Follow-up|1|||
155448830|NCT01327651|561069042|FG002|Post Study Follow-up|Lost to Follow-up|1|||
155448831|NCT01327651|561069043|FG003|Post Study Follow-up|Lost to Follow-up|0|||
155448832|NCT01327651|561069044|FG004|Post Study Follow-up|Lost to Follow-up|0|||
155448833|NCT01327651|561069045|FG005|Post Study Follow-up|Lost to Follow-up|0|||
155448834|NCT01327651|561069046|FG006|Post Study Follow-up|Lost to Follow-up|4|||
155448835|NCT01327651|561069047|FG007|Post Study Follow-up|Lost to Follow-up|1|||
155448836|NCT01327651|561069048|FG008|Post Study Follow-up|Lost to Follow-up|2|||
155448837|NCT03249792|561069049|FG000|Arms 1, 2, and 4|Death|1|||
155448838|NCT03249792|561069050|FG001|Arms 1, 2, and 4|Death|1|||
155448839|NCT03249792|561069051|FG002|Arms 1, 2, and 4|Death|0|||
155448840|NCT03249792|561069052|FG003|Arms 1, 2, and 4|Death|2|||
155448841|NCT03249792|561069053|FG004|Arms 1, 2, and 4|Death|3|||
155448842|NCT03249792|561069054|FG005|Arms 1, 2, and 4|Death|2|||
155448843|NCT03249792|561069055|FG006|Arms 1, 2, and 4|Death|2|||
155448844|NCT03249792|561069056|FG007|Arms 1, 2, and 4|Death|4|||
155448845|NCT03249792|561069057|FG008|Arms 1, 2, and 4|Death|2|||
155448846|NCT03249792|561069058|FG009|Arms 1, 2, and 4|Death|1|||
155448847|NCT03249792|561069059|FG010|Arms 1, 2, and 4|Death|7|||
155448848|NCT03249792|561069060|FG011|Arms 1, 2, and 4|Death|7|||
155448849|NCT03249792|561069061|FG012|Arms 1, 2, and 4|Death|12|||
155448850|NCT03249792|561069062|FG013|Arms 1, 2, and 4|Death|7|||
155448851|NCT03249792|561069063|FG014|Arms 1, 2, and 4|Death|0|||
155448852|NCT03249792|561069064|FG015|Arms 1, 2, and 4|Death|4|||
155448853|NCT03249792|561069065|FG016|Arms 1, 2, and 4|Death|4|||
155448854|NCT03249792|561069066|FG017|Arms 1, 2, and 4|Death|12|||
155448855|NCT03249792|561069067|FG018|Arms 1, 2, and 4|Death|6|||
155448856|NCT03249792|561069068|FG019|Arms 1, 2, and 4|Death|4|||
155448857|NCT03249792|561069069|FG020|Arms 1, 2, and 4|Death|2|||
155448858|NCT03249792|561069070|FG021|Arms 1, 2, and 4|Death|3|||
155448859|NCT03249792|561069071|FG022|Arms 1, 2, and 4|Death|1|||
155448860|NCT03249792|561069072|FG023|Arms 1, 2, and 4|Death|1|||
155448861|NCT03249792|561069073|FG024|Arms 1, 2, and 4|Death|4|||
155448862|NCT03249792|561069074|FG025|Arms 1, 2, and 4|Death|0|||
155448863|NCT03249792|561069075|FG026|Arms 1, 2, and 4|Death|0|||
155448864|NCT03249792|561069076|FG027|Arms 1, 2, and 4|Death|0|||
155448865|NCT03249792|561069077|FG028|Arms 1, 2, and 4|Death|0|||
155448866|NCT03249792|561069078|FG029|Arms 1, 2, and 4|Death|0|||
155448867|NCT03249792|561069079|FG030|Arms 1, 2, and 4|Death|0|||
155448868|NCT03249792|561069080|FG031|Arms 1, 2, and 4|Death|0|||
155448869|NCT03249792|561069081|FG032|Arms 1, 2, and 4|Death|0|||
155448870|NCT03249792|561069049|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448871|NCT03249792|561069050|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448872|NCT03249792|561069051|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448873|NCT03249792|561069052|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448874|NCT03249792|561069053|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448875|NCT03249792|561069054|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448876|NCT03249792|561069055|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
155448877|NCT03249792|561069056|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448878|NCT03249792|561069057|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
155448879|NCT03249792|561069058|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448880|NCT03249792|561069059|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
155448881|NCT03249792|561069060|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
155448882|NCT03249792|561069061|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
155448883|NCT03249792|561069062|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
155448884|NCT03249792|561069063|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448885|NCT03249792|561069064|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448886|NCT03249792|561069065|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
155448887|NCT03249792|561069066|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448888|NCT03249792|561069067|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448889|NCT03249792|561069068|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448890|NCT03249792|561069069|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448891|NCT03249792|561069070|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448892|NCT03249792|561069071|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448893|NCT03249792|561069072|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
155448894|NCT03249792|561069073|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448895|NCT03249792|561069074|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448896|NCT03249792|561069075|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448897|NCT03249792|561069076|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448898|NCT03249792|561069077|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448899|NCT03249792|561069078|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448900|NCT03249792|561069079|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448901|NCT03249792|561069080|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448902|NCT03249792|561069081|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
155448903|NCT03249792|561069049|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
155448904|NCT03249792|561069050|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
155448905|NCT03249792|561069051|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
155448906|NCT03249792|561069052|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
155448907|NCT03249792|561069053|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
155448908|NCT03249792|561069054|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
155448909|NCT03249792|561069055|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
155448910|NCT03249792|561069056|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
155448911|NCT03249792|561069057|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
155448912|NCT03249792|561069058|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
155448913|NCT03249792|561069059|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
155448914|NCT03249792|561069060|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
155448915|NCT03249792|561069061|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
155448916|NCT03249792|561069062|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
155448917|NCT03249792|561069063|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
155448918|NCT03249792|561069064|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
155448919|NCT03249792|561069065|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
155448920|NCT03249792|561069066|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
155448921|NCT03249792|561069067|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
155448922|NCT03249792|561069068|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
155448923|NCT03249792|561069069|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
155448924|NCT03249792|561069070|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
155448925|NCT03249792|561069071|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
155448926|NCT03249792|561069072|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
155448927|NCT03249792|561069073|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
155448928|NCT03249792|561069074|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
155448929|NCT03249792|561069075|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
155448930|NCT03249792|561069076|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
155448931|NCT03249792|561069077|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
155448932|NCT03249792|561069078|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
155448933|NCT03249792|561069079|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
155448934|NCT03249792|561069080|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
155448935|NCT03249792|561069081|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
155448936|NCT03249792|561069049|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448937|NCT03249792|561069050|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448938|NCT03249792|561069051|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448939|NCT03249792|561069052|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448940|NCT03249792|561069053|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448941|NCT03249792|561069054|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448942|NCT03249792|561069055|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
155515352|NCT03466411|561311588|FG010|Overall Study|Other|2|||
155515353|NCT03466411|561311589|FG011|Overall Study|Other|0|||
155448943|NCT03249792|561069056|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448944|NCT03249792|561069057|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
155448945|NCT03249792|561069058|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
155515354|NCT03466411|561311590|FG012|Overall Study|Other|0|||
155448946|NCT03249792|561069059|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448947|NCT03249792|561069060|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448948|NCT03249792|561069061|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448949|NCT03249792|561069062|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448950|NCT03249792|561069063|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448951|NCT03249792|561069064|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448952|NCT03249792|561069065|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
155448953|NCT03249792|561069066|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
155448954|NCT03249792|561069067|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448955|NCT03249792|561069068|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
155448956|NCT03249792|561069069|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448957|NCT03249792|561069070|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448958|NCT03249792|561069071|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448959|NCT03249792|561069072|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448960|NCT03249792|561069073|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448961|NCT03249792|561069074|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448962|NCT03249792|561069075|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448963|NCT03249792|561069076|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448964|NCT03249792|561069077|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448965|NCT03249792|561069078|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448966|NCT03249792|561069079|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448967|NCT03249792|561069080|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448968|NCT03249792|561069081|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
155448969|NCT03249792|561069049|FG000|Switch Over Period|Withdrawal by Subject|0|||
155448970|NCT03249792|561069050|FG001|Switch Over Period|Withdrawal by Subject|0|||
155448971|NCT03249792|561069051|FG002|Switch Over Period|Withdrawal by Subject|0|||
155448972|NCT03249792|561069052|FG003|Switch Over Period|Withdrawal by Subject|0|||
155448973|NCT03249792|561069053|FG004|Switch Over Period|Withdrawal by Subject|0|||
155448974|NCT03249792|561069054|FG005|Switch Over Period|Withdrawal by Subject|0|||
155448975|NCT03249792|561069055|FG006|Switch Over Period|Withdrawal by Subject|0|||
155448976|NCT03249792|561069056|FG007|Switch Over Period|Withdrawal by Subject|0|||
155448977|NCT03249792|561069057|FG008|Switch Over Period|Withdrawal by Subject|0|||
155448978|NCT03249792|561069058|FG009|Switch Over Period|Withdrawal by Subject|0|||
155448979|NCT03249792|561069059|FG010|Switch Over Period|Withdrawal by Subject|0|||
155448980|NCT03249792|561069060|FG011|Switch Over Period|Withdrawal by Subject|0|||
155448981|NCT03249792|561069061|FG012|Switch Over Period|Withdrawal by Subject|0|||
155448982|NCT03249792|561069062|FG013|Switch Over Period|Withdrawal by Subject|0|||
155448983|NCT03249792|561069063|FG014|Switch Over Period|Withdrawal by Subject|0|||
155448984|NCT03249792|561069064|FG015|Switch Over Period|Withdrawal by Subject|0|||
155448985|NCT03249792|561069065|FG016|Switch Over Period|Withdrawal by Subject|0|||
155448986|NCT03249792|561069066|FG017|Switch Over Period|Withdrawal by Subject|0|||
155448987|NCT03249792|561069067|FG018|Switch Over Period|Withdrawal by Subject|0|||
155448988|NCT03249792|561069068|FG019|Switch Over Period|Withdrawal by Subject|0|||
155448989|NCT03249792|561069069|FG020|Switch Over Period|Withdrawal by Subject|0|||
155448990|NCT03249792|561069070|FG021|Switch Over Period|Withdrawal by Subject|0|||
155448991|NCT03249792|561069071|FG022|Switch Over Period|Withdrawal by Subject|0|||
155448992|NCT03249792|561069072|FG023|Switch Over Period|Withdrawal by Subject|0|||
155448993|NCT03249792|561069073|FG024|Switch Over Period|Withdrawal by Subject|0|||
155448994|NCT03249792|561069074|FG025|Switch Over Period|Withdrawal by Subject|0|||
155448995|NCT03249792|561069075|FG026|Switch Over Period|Withdrawal by Subject|0|||
155448996|NCT03249792|561069076|FG027|Switch Over Period|Withdrawal by Subject|0|||
155448997|NCT03249792|561069077|FG028|Switch Over Period|Withdrawal by Subject|0|||
155448998|NCT03249792|561069078|FG029|Switch Over Period|Withdrawal by Subject|0|||
155448999|NCT03249792|561069079|FG030|Switch Over Period|Withdrawal by Subject|0|||
155449000|NCT03249792|561069080|FG031|Switch Over Period|Withdrawal by Subject|1|||
155449001|NCT03249792|561069081|FG032|Switch Over Period|Withdrawal by Subject|0|||
155449002|NCT03249792|561069049|FG000|Switch Over Period|Progressive Disease|0|||
155449003|NCT03249792|561069050|FG001|Switch Over Period|Progressive Disease|0|||
155449004|NCT03249792|561069051|FG002|Switch Over Period|Progressive Disease|0|||
155449005|NCT03249792|561069052|FG003|Switch Over Period|Progressive Disease|0|||
155449006|NCT03249792|561069053|FG004|Switch Over Period|Progressive Disease|0|||
155449007|NCT03249792|561069054|FG005|Switch Over Period|Progressive Disease|0|||
155449008|NCT03249792|561069055|FG006|Switch Over Period|Progressive Disease|0|||
155449009|NCT03249792|561069056|FG007|Switch Over Period|Progressive Disease|0|||
155449010|NCT03249792|561069057|FG008|Switch Over Period|Progressive Disease|0|||
155449011|NCT03249792|561069058|FG009|Switch Over Period|Progressive Disease|0|||
155449012|NCT03249792|561069059|FG010|Switch Over Period|Progressive Disease|0|||
155449013|NCT03249792|561069060|FG011|Switch Over Period|Progressive Disease|0|||
155449014|NCT03249792|561069061|FG012|Switch Over Period|Progressive Disease|0|||
155449015|NCT03249792|561069062|FG013|Switch Over Period|Progressive Disease|0|||
155449016|NCT03249792|561069063|FG014|Switch Over Period|Progressive Disease|0|||
155449017|NCT03249792|561069064|FG015|Switch Over Period|Progressive Disease|0|||
155449018|NCT03249792|561069065|FG016|Switch Over Period|Progressive Disease|0|||
155449019|NCT03249792|561069066|FG017|Switch Over Period|Progressive Disease|0|||
155449020|NCT03249792|561069067|FG018|Switch Over Period|Progressive Disease|0|||
155449021|NCT03249792|561069068|FG019|Switch Over Period|Progressive Disease|0|||
155449022|NCT03249792|561069069|FG020|Switch Over Period|Progressive Disease|0|||
155449023|NCT03249792|561069070|FG021|Switch Over Period|Progressive Disease|0|||
155449024|NCT03249792|561069071|FG022|Switch Over Period|Progressive Disease|0|||
155449025|NCT03249792|561069072|FG023|Switch Over Period|Progressive Disease|0|||
155449026|NCT03249792|561069073|FG024|Switch Over Period|Progressive Disease|0|||
155449027|NCT03249792|561069074|FG025|Switch Over Period|Progressive Disease|0|||
155449028|NCT03249792|561069075|FG026|Switch Over Period|Progressive Disease|1|||
155449029|NCT03249792|561069076|FG027|Switch Over Period|Progressive Disease|0|||
155449030|NCT03249792|561069077|FG028|Switch Over Period|Progressive Disease|1|||
155449031|NCT03249792|561069078|FG029|Switch Over Period|Progressive Disease|2|||
155449032|NCT03249792|561069079|FG030|Switch Over Period|Progressive Disease|1|||
155449033|NCT03249792|561069080|FG031|Switch Over Period|Progressive Disease|0|||
155449034|NCT03249792|561069081|FG032|Switch Over Period|Progressive Disease|1|||
155449035|NCT03249792|561069049|FG000|Switch Over Period|Adverse Event|0|||
155449036|NCT03249792|561069050|FG001|Switch Over Period|Adverse Event|0|||
155449037|NCT03249792|561069051|FG002|Switch Over Period|Adverse Event|0|||
155449038|NCT03249792|561069052|FG003|Switch Over Period|Adverse Event|0|||
155449039|NCT03249792|561069053|FG004|Switch Over Period|Adverse Event|0|||
155449040|NCT03249792|561069054|FG005|Switch Over Period|Adverse Event|0|||
155449041|NCT03249792|561069055|FG006|Switch Over Period|Adverse Event|0|||
155449042|NCT03249792|561069056|FG007|Switch Over Period|Adverse Event|0|||
155449043|NCT03249792|561069057|FG008|Switch Over Period|Adverse Event|0|||
155449044|NCT03249792|561069058|FG009|Switch Over Period|Adverse Event|0|||
155449045|NCT03249792|561069059|FG010|Switch Over Period|Adverse Event|0|||
155449046|NCT03249792|561069060|FG011|Switch Over Period|Adverse Event|0|||
155449047|NCT03249792|561069061|FG012|Switch Over Period|Adverse Event|0|||
155449048|NCT03249792|561069062|FG013|Switch Over Period|Adverse Event|0|||
155449049|NCT03249792|561069063|FG014|Switch Over Period|Adverse Event|0|||
155449050|NCT03249792|561069064|FG015|Switch Over Period|Adverse Event|0|||
155449051|NCT03249792|561069065|FG016|Switch Over Period|Adverse Event|0|||
155449052|NCT03249792|561069066|FG017|Switch Over Period|Adverse Event|0|||
155449053|NCT03249792|561069067|FG018|Switch Over Period|Adverse Event|0|||
155449054|NCT03249792|561069068|FG019|Switch Over Period|Adverse Event|0|||
155449055|NCT03249792|561069069|FG020|Switch Over Period|Adverse Event|0|||
155449056|NCT03249792|561069070|FG021|Switch Over Period|Adverse Event|0|||
155449057|NCT03249792|561069071|FG022|Switch Over Period|Adverse Event|0|||
155449058|NCT03249792|561069072|FG023|Switch Over Period|Adverse Event|0|||
155449059|NCT03249792|561069073|FG024|Switch Over Period|Adverse Event|0|||
155449060|NCT03249792|561069074|FG025|Switch Over Period|Adverse Event|1|||
155449061|NCT03249792|561069075|FG026|Switch Over Period|Adverse Event|0|||
155449062|NCT03249792|561069076|FG027|Switch Over Period|Adverse Event|1|||
155449063|NCT03249792|561069077|FG028|Switch Over Period|Adverse Event|0|||
155449064|NCT03249792|561069078|FG029|Switch Over Period|Adverse Event|0|||
155449065|NCT03249792|561069079|FG030|Switch Over Period|Adverse Event|0|||
155449066|NCT03249792|561069080|FG031|Switch Over Period|Adverse Event|0|||
155449067|NCT03249792|561069081|FG032|Switch Over Period|Adverse Event|0|||
155449068|NCT02284906|561069084|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155449069|NCT02284906|561069085|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155449070|NCT02284906|561069086|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155449071|NCT02284906|561069084|FG000|Overall Study|Major Protocol Deviation|0|||
155449072|NCT02284906|561069085|FG001|Overall Study|Major Protocol Deviation|1|||
155449073|NCT02284906|561069086|FG002|Overall Study|Major Protocol Deviation|0|||
155449074|NCT02284906|561069084|FG000|Overall Study|Voluntary Withdrawal|2|||
155449075|NCT02284906|561069085|FG001|Overall Study|Voluntary Withdrawal|4|||
155449076|NCT02284906|561069086|FG002|Overall Study|Voluntary Withdrawal|5|||
155449077|NCT02284906|561069084|FG000|Overall Study|Study Termination|0|||
155449078|NCT02284906|561069085|FG001|Overall Study|Study Termination|11|||
155449079|NCT02284906|561069086|FG002|Overall Study|Study Termination|14|||
155449080|NCT02284906|561069084|FG000|Overall Study|Reason not Specified|1|||
155449081|NCT02284906|561069085|FG001|Overall Study|Reason not Specified|1|||
155449082|NCT02284906|561069086|FG002|Overall Study|Reason not Specified|0|||
155449083|NCT00995345|561069087|FG000|Overall Study|Withdrawal by Subject|4|||
155449084|NCT00995345|561069088|FG001|Overall Study|Withdrawal by Subject|2|||
155449085|NCT00995345|561069089|FG002|Overall Study|Withdrawal by Subject|1|||
155449086|NCT00995345|561069090|FG003|Overall Study|Withdrawal by Subject|3|||
155449087|NCT00995345|561069091|FG004|Overall Study|Withdrawal by Subject|1|||
155449088|NCT00995345|561069087|FG000|Overall Study|Adverse Event|3|||
155449089|NCT00995345|561069088|FG001|Overall Study|Adverse Event|1|||
155449090|NCT00995345|561069089|FG002|Overall Study|Adverse Event|2|||
155449091|NCT00995345|561069090|FG003|Overall Study|Adverse Event|0|||
155651549|NCT02662582|561816253|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
155651550|NCT02662582|561816252|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
155449092|NCT00995345|561069091|FG004|Overall Study|Adverse Event|1|||
155449093|NCT00995345|561069087|FG000|Overall Study|Lost to Follow-up|2|||
155449094|NCT00995345|561069088|FG001|Overall Study|Lost to Follow-up|2|||
155449095|NCT00995345|561069089|FG002|Overall Study|Lost to Follow-up|2|||
155449096|NCT00995345|561069090|FG003|Overall Study|Lost to Follow-up|1|||
155449097|NCT00995345|561069091|FG004|Overall Study|Lost to Follow-up|0|||
155449098|NCT00995345|561069087|FG000|Overall Study|all other reasons combined|2|||
155449099|NCT00995345|561069088|FG001|Overall Study|all other reasons combined|2|||
155449100|NCT00995345|561069089|FG002|Overall Study|all other reasons combined|2|||
155449101|NCT00995345|561069090|FG003|Overall Study|all other reasons combined|1|||
155449102|NCT00995345|561069091|FG004|Overall Study|all other reasons combined|3|||
155449103|NCT01201798|561069097|FG000|Overall Study|Adverse Event|2|||
155449104|NCT01201798|561069098|FG001|Overall Study|Adverse Event|0|||
155449105|NCT01201798|561069097|FG000|Overall Study|Lost to Follow-up|3|||
155449106|NCT01201798|561069098|FG001|Overall Study|Lost to Follow-up|5|||
155449107|NCT01201798|561069097|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
155449108|NCT01201798|561069098|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
155449109|NCT01201798|561069097|FG000|Overall Study|Noncompliance|1|||
155449110|NCT01201798|561069098|FG001|Overall Study|Noncompliance|0|||
155449111|NCT01201798|561069097|FG000|Overall Study|Protocol Violation|1|||
155449112|NCT01201798|561069098|FG001|Overall Study|Protocol Violation|1|||
155449113|NCT01201798|561069097|FG000|Overall Study|Treatment Failure|1|||
155449114|NCT01201798|561069098|FG001|Overall Study|Treatment Failure|8|||
155449115|NCT02509598|561069099|FG000|Overall Study|Withdrawal by Subject|1|||
155449116|NCT03521687|561069101|FG000|Overall Study|Adverse Event|4|||
155449117|NCT03521687|561069101|FG000|Overall Study|Physician Decision|1|||
155449118|NCT05122650|561069108|FG000|Overall Study|Adverse Event|4|||
155449119|NCT05122650|561069109|FG001|Overall Study|Adverse Event|16|||
155449120|NCT05122650|561069110|FG002|Overall Study|Adverse Event|11|||
155449121|NCT05122650|561069111|FG003|Overall Study|Adverse Event|12|||
155449122|NCT05122650|561069108|FG000|Overall Study|Lack of Efficacy|0|||
155449123|NCT05122650|561069109|FG001|Overall Study|Lack of Efficacy|1|||
155449124|NCT05122650|561069110|FG002|Overall Study|Lack of Efficacy|1|||
155449125|NCT05122650|561069111|FG003|Overall Study|Lack of Efficacy|2|||
155449126|NCT05122650|561069108|FG000|Overall Study|Lost to Follow-up|1|||
155449127|NCT05122650|561069109|FG001|Overall Study|Lost to Follow-up|1|||
155449128|NCT05122650|561069110|FG002|Overall Study|Lost to Follow-up|3|||
155449129|NCT05122650|561069111|FG003|Overall Study|Lost to Follow-up|0|||
155449130|NCT05122650|561069108|FG000|Overall Study|Non-compliance with study intervention|0|||
155449131|NCT05122650|561069109|FG001|Overall Study|Non-compliance with study intervention|0|||
155449132|NCT05122650|561069110|FG002|Overall Study|Non-compliance with study intervention|0|||
155449133|NCT05122650|561069111|FG003|Overall Study|Non-compliance with study intervention|2|||
155449134|NCT05122650|561069108|FG000|Overall Study|Protocol Violation|0|||
155449135|NCT05122650|561069109|FG001|Overall Study|Protocol Violation|1|||
155449136|NCT05122650|561069110|FG002|Overall Study|Protocol Violation|0|||
155449137|NCT05122650|561069111|FG003|Overall Study|Protocol Violation|1|||
155449138|NCT05122650|561069108|FG000|Overall Study|Randomized by mistake|0|||
155449139|NCT05122650|561069109|FG001|Overall Study|Randomized by mistake|0|||
155449140|NCT05122650|561069110|FG002|Overall Study|Randomized by mistake|3|||
155449141|NCT05122650|561069111|FG003|Overall Study|Randomized by mistake|2|||
155449142|NCT05122650|561069108|FG000|Overall Study|Sponsor request|0|||
155449143|NCT05122650|561069109|FG001|Overall Study|Sponsor request|1|||
155449144|NCT05122650|561069110|FG002|Overall Study|Sponsor request|1|||
155449145|NCT05122650|561069111|FG003|Overall Study|Sponsor request|2|||
155449146|NCT05122650|561069108|FG000|Overall Study|Withdrawal by Subject|3|||
155449147|NCT05122650|561069109|FG001|Overall Study|Withdrawal by Subject|7|||
155449148|NCT05122650|561069110|FG002|Overall Study|Withdrawal by Subject|4|||
155449149|NCT05122650|561069111|FG003|Overall Study|Withdrawal by Subject|8|||
155449150|NCT05122650|561069108|FG000|Overall Study|Other|5|||
155449151|NCT05122650|561069109|FG001|Overall Study|Other|0|||
155449152|NCT05122650|561069110|FG002|Overall Study|Other|0|||
155449153|NCT05122650|561069111|FG003|Overall Study|Other|0|||
155449154|NCT03609359|561069114|FG000|Overall Study|Progression of primary disease (PD)|25|||
155449155|NCT03609359|561069114|FG000|Overall Study|Patient's refusal|1|||
155449156|NCT03609359|561069114|FG000|Overall Study|Physician Decision|1|||
155449157|NCT03609359|561069114|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
155449158|NCT04285346|561069116|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
155449159|NCT04285346|561069117|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
155449160|NCT04285346|561069116|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
155449161|NCT04285346|561069117|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155449162|NCT04285346|561069116|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
155449163|NCT04285346|561069117|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155449164|NCT01975272|561069120|FG000|Overall Study|Excluded after protocol amendment|1|||
155449165|NCT01975272|561069121|FG001|Overall Study|Excluded after protocol amendment|1|||
155449166|NCT01975272|561069122|FG002|Overall Study|Excluded after protocol amendment|2|||
155449167|NCT00610935|561069123|FG000|Overall Study|Lost to Follow-up|0|||
155449168|NCT00610935|561069124|FG001|Overall Study|Lost to Follow-up|1|||
155449169|NCT00610935|561069123|FG000|Overall Study|Withdrawal by Subject|0|||
155651551|NCT02662582|561816253|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
155449170|NCT00610935|561069124|FG001|Overall Study|Withdrawal by Subject|2|||
155449171|NCT00610935|561069123|FG000|Overall Study|Sponsor Discontinuation|1|||
155449172|NCT00610935|561069124|FG001|Overall Study|Sponsor Discontinuation|0|||
155449173|NCT02399813|561069130|FG000|Overall Study|Progressive Disease-Radiographic|2|||
155449174|NCT02399813|561069130|FG000|Overall Study|Death|20|||
155449175|NCT02399813|561069130|FG000|Overall Study|Withdrawal by Subject|3|||
155449176|NCT02399813|561069130|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
155449177|NCT02399813|561069130|FG000|Overall Study|Lost to Follow-up|2|||
155449178|NCT02399813|561069130|FG000|Overall Study|Other than specified|5|||
155449179|NCT03280550|561069131|FG000|Overall Study|Withdrawal by Subject|2|||
155449180|NCT03280550|561069132|FG001|Overall Study|Withdrawal by Subject|2|||
155449181|NCT03280550|561069131|FG000|Overall Study|Physician Decision|0|||
155449182|NCT03280550|561069132|FG001|Overall Study|Physician Decision|1|||
155449183|NCT03345836|561069135|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
155449184|NCT03345836|561069136|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
155449185|NCT03345836|561069137|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
155449186|NCT03345836|561069138|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
155449187|NCT03345836|561069139|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
155449188|NCT03345836|561069140|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
155449189|NCT03345836|561069135|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
155449190|NCT03345836|561069136|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
155449191|NCT03345836|561069137|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
155449192|NCT03345836|561069138|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
155449193|NCT03345836|561069139|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
155449194|NCT03345836|561069140|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
155449195|NCT03345836|561069135|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
155449196|NCT03345836|561069136|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
155449197|NCT03345836|561069137|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
155449198|NCT03345836|561069138|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
155449199|NCT03345836|561069139|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
155449200|NCT03345836|561069140|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
155449201|NCT03345836|561069135|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
155449202|NCT03345836|561069136|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
155449203|NCT03345836|561069137|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
155449204|NCT03345836|561069138|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
155449205|NCT03345836|561069139|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
155449206|NCT03345836|561069140|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
155449207|NCT03345836|561069135|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
155449208|NCT03345836|561069136|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
155449209|NCT03345836|561069137|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
155449210|NCT03345836|561069138|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
155449211|NCT03345836|561069139|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
155449212|NCT03345836|561069140|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
155449213|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
155449214|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
155449215|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
155449216|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
155449217|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
155449218|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
155449219|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
155449220|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
155449221|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
155449222|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
155449223|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
155449224|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
155449225|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
155449226|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
155449227|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
155449228|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
155449229|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
155449230|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
155449231|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
155449232|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
155449233|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
155449234|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
155449235|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
155449236|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
155449237|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
155449238|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
155449239|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
155449240|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
155449241|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
155449242|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
155449243|NCT03345836|561069135|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
155449244|NCT03345836|561069136|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
155449245|NCT03345836|561069137|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
155449246|NCT03345836|561069138|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
155449247|NCT03345836|561069139|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
155449248|NCT03345836|561069140|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
155449249|NCT00222729|561069141|FG000|Overall Study|Adverse Event|3|||
155449250|NCT01915849|561069144|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
155449251|NCT01915849|561069145|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
155449252|NCT01915849|561069146|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
155449253|NCT01915849|561069147|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
155449254|NCT01915849|561069144|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
155449255|NCT01915849|561069145|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155449256|NCT01915849|561069146|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155449257|NCT01915849|561069147|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155449258|NCT02775864|561069148|FG000|Overall Study|Data ended end of 2010|1764|||
155449259|NCT02775864|561069149|FG001|Overall Study|Data ended end of 2010|2880|||
155449260|NCT02775864|561069150|FG002|Overall Study|Data ended end of 2010|1140|||
155449261|NCT02775864|561069151|FG003|Overall Study|Data ended end of 2010|1194|||
155449262|NCT02775864|561069148|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
155449263|NCT02775864|561069149|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
155449264|NCT02775864|561069150|FG002|Overall Study|Medicaid eligibility discontinued|720|||
155449265|NCT02775864|561069151|FG003|Overall Study|Medicaid eligibility discontinued|890|||
155449266|NCT03552549|561069155|FG000|Overall Study|Disease progression|25|||
155449267|NCT03552549|561069156|FG001|Overall Study|Disease progression|17|||
155449268|NCT03552549|561069155|FG000|Overall Study|Adverse event in first 12 months|12|||
155449269|NCT03552549|561069156|FG001|Overall Study|Adverse event in first 12 months|8|||
155449270|NCT03552549|561069155|FG000|Overall Study|Withdrawal by Subject|7|||
155449271|NCT03552549|561069156|FG001|Overall Study|Withdrawal by Subject|7|||
155449272|NCT03552549|561069155|FG000|Overall Study|Unknown (no reason provided)|4|||
155449273|NCT03552549|561069156|FG001|Overall Study|Unknown (no reason provided)|2|||
155449274|NCT03552549|561069155|FG000|Overall Study|Not in participant's best interest|2|||
155449275|NCT03552549|561069156|FG001|Overall Study|Not in participant's best interest|1|||
155449276|NCT03552549|561069155|FG000|Overall Study|Did not complete study treatment|2|||
155449277|NCT03552549|561069156|FG001|Overall Study|Did not complete study treatment|3|||
155449278|NCT03552549|561069155|FG000|Overall Study|Did not meet eligibility criteria|1|||
155449279|NCT03552549|561069156|FG001|Overall Study|Did not meet eligibility criteria|0|||
155449280|NCT03552549|561069155|FG000|Overall Study|Administrative|0|||
155449281|NCT03552549|561069156|FG001|Overall Study|Administrative|14|||
155449282|NCT02761993|561069157|FG000|Overall Study|Adverse Event|0|||
155449283|NCT02761993|561069158|FG001|Overall Study|Adverse Event|2|||
155449284|NCT02761993|561069159|FG002|Overall Study|Adverse Event|0|||
155449285|NCT02761993|561069157|FG000|Overall Study|Lost to Follow-up|1|||
155449286|NCT02761993|561069158|FG001|Overall Study|Lost to Follow-up|3|||
155449287|NCT02761993|561069159|FG002|Overall Study|Lost to Follow-up|2|||
155449288|NCT02761993|561069157|FG000|Overall Study|Withdrawal by Subject|1|||
155449289|NCT02761993|561069158|FG001|Overall Study|Withdrawal by Subject|1|||
155449290|NCT02761993|561069159|FG002|Overall Study|Withdrawal by Subject|2|||
155449291|NCT02993224|561069162|FG000|Core Phase - Period 1|Adverse Event|4|||
155449292|NCT02993224|561069162|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
155449293|NCT02993224|561069162|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
155449294|NCT02993224|561069162|FG000|Core Phase- Period 2|Adverse Event|1|||
155449295|NCT02993224|561069162|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
155449296|NCT02993224|561069162|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
155449297|NCT02993224|561069162|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
155449298|NCT02993224|561069162|FG000|Extension Phase|Adverse Event|3|||
155449299|NCT02993224|561069162|FG000|Extension Phase|Withdrawal by Subject|3|||
155449300|NCT02993224|561069162|FG000|Extension Phase|Lost to Follow-up|2|||
155449301|NCT02993224|561069162|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
155449302|NCT01921257|561069165|FG000|Overall Study|Adverse Event|1|||
155449303|NCT01921257|561069165|FG000|Overall Study|Protocol Violation|1|||
155449304|NCT01921257|561069165|FG000|Overall Study|Withdrawal by Subject|1|||
155449305|NCT05515601|561069166|FG000|Overall Study|Withdrawal by Subject|1|||
155449306|NCT05515601|561069167|FG001|Overall Study|Withdrawal by Subject|3|||
155449307|NCT05515601|561069168|FG002|Overall Study|Withdrawal by Subject|2|||
155651552|NCT02662582|561816252|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
155449308|NCT05515601|561069169|FG003|Overall Study|Withdrawal by Subject|1|||
155449309|NCT05515601|561069170|FG004|Overall Study|Withdrawal by Subject|1|||
155449310|NCT05515601|561069171|FG005|Overall Study|Withdrawal by Subject|1|||
155449311|NCT05515601|561069166|FG000|Overall Study|Lost to Follow-up|0|||
155449312|NCT05515601|561069167|FG001|Overall Study|Lost to Follow-up|0|||
155449313|NCT05515601|561069168|FG002|Overall Study|Lost to Follow-up|0|||
155449314|NCT05515601|561069169|FG003|Overall Study|Lost to Follow-up|0|||
155449315|NCT05515601|561069170|FG004|Overall Study|Lost to Follow-up|1|||
155449316|NCT05515601|561069171|FG005|Overall Study|Lost to Follow-up|0|||
155449317|NCT00364845|561069172|FG000|Overall Study|Adverse Event|1|||
155449318|NCT00364845|561069173|FG001|Overall Study|Adverse Event|0|||
155449319|NCT00364845|561069172|FG000|Overall Study|Withdrawal by Subject|2|||
155449320|NCT00364845|561069173|FG001|Overall Study|Withdrawal by Subject|1|||
155449321|NCT00364845|561069172|FG000|Overall Study|Physician Decision|8|||
155449322|NCT00364845|561069173|FG001|Overall Study|Physician Decision|8|||
155449323|NCT00364845|561069172|FG000|Overall Study|Lost to Follow-up|0|||
155449324|NCT00364845|561069173|FG001|Overall Study|Lost to Follow-up|1|||
155449325|NCT00364845|561069172|FG000|Overall Study|Death|0|||
155449326|NCT00364845|561069173|FG001|Overall Study|Death|1|||
155449327|NCT01423617|561069174|FG000|Overall Study|Lost to Follow-up|0|||
155449328|NCT01423617|561069175|FG001|Overall Study|Lost to Follow-up|1|||
155449329|NCT01515306|561069176|FG000|Overall Study|Adverse Event|3|||
155449330|NCT01515306|561069177|FG001|Overall Study|Adverse Event|2|||
155449331|NCT01515306|561069176|FG000|Overall Study|Progressive Disease|19|||
155449332|NCT01515306|561069177|FG001|Overall Study|Progressive Disease|9|||
155449333|NCT01515306|561069176|FG000|Overall Study|Withdrawal by Subject|1|||
155449334|NCT01515306|561069177|FG001|Overall Study|Withdrawal by Subject|2|||
155449335|NCT01515306|561069176|FG000|Overall Study|Physician Decision|1|||
155449336|NCT01515306|561069177|FG001|Overall Study|Physician Decision|1|||
155449337|NCT00634244|561069178|FG000|Overall Study|Never started treatment|0|||
155449338|NCT00634244|561069179|FG001|Overall Study|Never started treatment|1|||
155449339|NCT00634244|561069180|FG002|Overall Study|Never started treatment|0|||
155449340|NCT00634244|561069178|FG000|Overall Study|Death|1|||
155449341|NCT00634244|561069179|FG001|Overall Study|Death|6|||
155449342|NCT00634244|561069180|FG002|Overall Study|Death|0|||
155449343|NCT00634244|561069178|FG000|Overall Study|Adverse Event|0|||
155449344|NCT00634244|561069179|FG001|Overall Study|Adverse Event|2|||
155449345|NCT00634244|561069180|FG002|Overall Study|Adverse Event|0|||
155449346|NCT00634244|561069178|FG000|Overall Study|Withdrawal by Subject|0|||
155449347|NCT00634244|561069179|FG001|Overall Study|Withdrawal by Subject|1|||
155449348|NCT00634244|561069180|FG002|Overall Study|Withdrawal by Subject|0|||
155449349|NCT00634244|561069178|FG000|Overall Study|Physician Decision|0|||
155449350|NCT00634244|561069179|FG001|Overall Study|Physician Decision|1|||
155449351|NCT00634244|561069180|FG002|Overall Study|Physician Decision|0|||
155449352|NCT00634244|561069178|FG000|Overall Study|Disease progression/relapse|0|||
155449353|NCT00634244|561069179|FG001|Overall Study|Disease progression/relapse|1|||
155449354|NCT00634244|561069180|FG002|Overall Study|Disease progression/relapse|0|||
155449355|NCT00634244|561069178|FG000|Overall Study|Other complicating disease|0|||
155449356|NCT00634244|561069179|FG001|Overall Study|Other complicating disease|1|||
155449357|NCT00634244|561069180|FG002|Overall Study|Other complicating disease|0|||
155449358|NCT04737031|561069186|FG000|Overall Study|Patients who did not have a treatment visit|0|||
155449359|NCT04737031|561069187|FG001|Overall Study|Patients who did not have a treatment visit|31|||
155449360|NCT04737031|561069188|FG002|Overall Study|Patients who did not have a treatment visit|93|||
155449361|NCT04737031|561069189|FG003|Overall Study|Patients who did not have a treatment visit|227|||
155449362|NCT03453151|561069190|FG000|Overall Study|Withdrawal by Subject|1|||
155449363|NCT03453151|561069190|FG000|Overall Study|Physician Decision|3|||
155449364|NCT02678780|561069195|FG000|Overall Study|Adverse Event|11|||
155449365|NCT02678780|561069196|FG001|Overall Study|Adverse Event|14|||
155449366|NCT02678780|561069195|FG000|Overall Study|Withdrawal by Subject|2|||
155449367|NCT02678780|561069196|FG001|Overall Study|Withdrawal by Subject|1|||
155449368|NCT02678780|561069195|FG000|Overall Study|Sponsor discontinuation|7|||
155449369|NCT02678780|561069196|FG001|Overall Study|Sponsor discontinuation|4|||
155449370|NCT02678780|561069195|FG000|Overall Study|Death|1|||
155449371|NCT02678780|561069196|FG001|Overall Study|Death|1|||
155449372|NCT02678780|561069195|FG000|Overall Study|Other|6|||
155449373|NCT02678780|561069196|FG001|Overall Study|Other|8|||
155449374|NCT03229759|561069197|FG000|Overall Study|Screen Failure|30|||
155449375|NCT03050359|561070652|FG000|Overall Study|Randomized But Not Treated|2|||
155449376|NCT03050359|561070653|FG001|Overall Study|Randomized But Not Treated|0|||
155449377|NCT03050359|561070652|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
155449378|NCT03050359|561070653|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
155449379|NCT03050359|561070652|FG000|Overall Study|Significant Protocol Deviation|2|||
155449380|NCT03050359|561070653|FG001|Overall Study|Significant Protocol Deviation|3|||
155515355|NCT03466411|561311578|FG000|Overall Study|Randomized but not Treated|0|||
155449381|NCT03050359|561070652|FG000|Overall Study|Lost to Follow-up|2|||
155449382|NCT03050359|561070653|FG001|Overall Study|Lost to Follow-up|1|||
155449383|NCT03050359|561070652|FG000|Overall Study|Voluntary Withdrawal|4|||
155449384|NCT03050359|561070653|FG001|Overall Study|Voluntary Withdrawal|6|||
155449385|NCT03050359|561070652|FG000|Overall Study|Pregnancy|1|||
155449386|NCT03050359|561070653|FG001|Overall Study|Pregnancy|0|||
155449387|NCT03050359|561070652|FG000|Overall Study|Reason Not Specified|1|||
155449388|NCT03050359|561070653|FG001|Overall Study|Reason Not Specified|0|||
155449389|NCT02020031|561070654|FG000|Overall Study|Physician Decision|1|||
155449390|NCT02020031|561070655|FG001|Overall Study|Physician Decision|1|||
155449391|NCT00755846|561070658|FG000|Overall Study|Adverse Event|0|||
155449392|NCT00755846|561070659|FG001|Overall Study|Adverse Event|0|||
155449393|NCT00755846|561070660|FG002|Overall Study|Adverse Event|0|||
155449394|NCT00755846|561070661|FG003|Overall Study|Adverse Event|1|||
155449395|NCT00755846|561070662|FG004|Overall Study|Adverse Event|3|||
155449396|NCT00755846|561070663|FG005|Overall Study|Adverse Event|2|||
155449397|NCT00755846|561070658|FG000|Overall Study|Protocol Violation|1|||
155449398|NCT00755846|561070659|FG001|Overall Study|Protocol Violation|1|||
155449399|NCT00755846|561070660|FG002|Overall Study|Protocol Violation|1|||
155449400|NCT00755846|561070661|FG003|Overall Study|Protocol Violation|1|||
155449401|NCT00755846|561070662|FG004|Overall Study|Protocol Violation|1|||
155449402|NCT00755846|561070663|FG005|Overall Study|Protocol Violation|1|||
155449403|NCT00755846|561070658|FG000|Overall Study|Lost to Follow-up|0|||
155449404|NCT00755846|561070659|FG001|Overall Study|Lost to Follow-up|2|||
155449405|NCT00755846|561070660|FG002|Overall Study|Lost to Follow-up|1|||
155449406|NCT00755846|561070661|FG003|Overall Study|Lost to Follow-up|0|||
155449407|NCT00755846|561070662|FG004|Overall Study|Lost to Follow-up|4|||
155449408|NCT00755846|561070663|FG005|Overall Study|Lost to Follow-up|2|||
155449409|NCT00755846|561070658|FG000|Overall Study|Withdrawal by Subject|2|||
155449410|NCT00755846|561070659|FG001|Overall Study|Withdrawal by Subject|3|||
155449411|NCT00755846|561070660|FG002|Overall Study|Withdrawal by Subject|5|||
155449412|NCT00755846|561070661|FG003|Overall Study|Withdrawal by Subject|2|||
155449413|NCT00755846|561070662|FG004|Overall Study|Withdrawal by Subject|0|||
155449414|NCT00755846|561070663|FG005|Overall Study|Withdrawal by Subject|1|||
155651553|NCT02662582|561816253|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
155651554|NCT02662582|561816252|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155651555|NCT02662582|561816253|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155651556|NCT00511199|561816255|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
155651557|NCT00511199|561816256|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
155651558|NCT00511199|561816255|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
155651559|NCT00511199|561816256|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
155651560|NCT00511199|561816255|FG000|Overall Study|Withdrawal of Informed Consent|19|||
155651561|NCT00511199|561816256|FG001|Overall Study|Withdrawal of Informed Consent|4|||
155651562|NCT00511199|561816255|FG000|Overall Study|Pregnancy|6|||
155651563|NCT00511199|561816256|FG001|Overall Study|Pregnancy|3|||
155651564|NCT00511199|561816255|FG000|Overall Study|Pregnancy Wish|16|||
155651565|NCT00511199|561816256|FG001|Overall Study|Pregnancy Wish|8|||
155651566|NCT00511199|561816255|FG000|Overall Study|Lost to Follow-up|40|||
155651567|NCT00511199|561816256|FG001|Overall Study|Lost to Follow-up|17|||
155651568|NCT00511199|561816255|FG000|Overall Study|Other Reason|78|||
155651569|NCT00511199|561816256|FG001|Overall Study|Other Reason|37|||
155651570|NCT00489359|561816257|FG000|Overall Study|Death|0|||
155651571|NCT00489359|561816258|FG001|Overall Study|Death|2|||
155651572|NCT00489359|561816257|FG000|Overall Study|Progressive Disease|5|||
155651573|NCT00489359|561816258|FG001|Overall Study|Progressive Disease|6|||
155651574|NCT00489359|561816257|FG000|Overall Study|Lost to Follow-up|1|||
155651575|NCT00489359|561816258|FG001|Overall Study|Lost to Follow-up|0|||
155651576|NCT00489359|561816257|FG000|Overall Study|Withdrawal by Subject|1|||
155651577|NCT00489359|561816258|FG001|Overall Study|Withdrawal by Subject|5|||
155651578|NCT00489359|561816257|FG000|Overall Study|Adverse Event|0|||
155651579|NCT00489359|561816258|FG001|Overall Study|Adverse Event|16|||
155449415|NCT00755846|561070658|FG000|Overall Study|Hyperglycemic Rescue|21|||
155449416|NCT00755846|561070659|FG001|Overall Study|Hyperglycemic Rescue|7|||
155449417|NCT00755846|561070660|FG002|Overall Study|Hyperglycemic Rescue|5|||
155449418|NCT00755846|561070661|FG003|Overall Study|Hyperglycemic Rescue|8|||
155449419|NCT00755846|561070662|FG004|Overall Study|Hyperglycemic Rescue|8|||
155449420|NCT00755846|561070663|FG005|Overall Study|Hyperglycemic Rescue|7|||
155449421|NCT00755846|561070658|FG000|Overall Study|Physician Decision|1|||
155449422|NCT00755846|561070659|FG001|Overall Study|Physician Decision|3|||
155449423|NCT00755846|561070660|FG002|Overall Study|Physician Decision|0|||
155449424|NCT00755846|561070661|FG003|Overall Study|Physician Decision|1|||
155449425|NCT00755846|561070662|FG004|Overall Study|Physician Decision|0|||
155651580|NCT03180138|561816259|FG000|Overall Study|Mobile-phone could not be verified|2|||
155651581|NCT03180138|561816260|FG001|Overall Study|Mobile-phone could not be verified|13|||
155651582|NCT03180138|561816261|FG002|Overall Study|Mobile-phone could not be verified|15|||
155651583|NCT03180138|561816259|FG000|Overall Study|No prior immunization records|17|||
155651584|NCT03180138|561816260|FG001|Overall Study|No prior immunization records|0|||
155651585|NCT03180138|561816261|FG002|Overall Study|No prior immunization records|6|||
155651586|NCT03180138|561816259|FG000|Overall Study|Found to be >24 mon after randomization|3|||
155651587|NCT03180138|561816260|FG001|Overall Study|Found to be >24 mon after randomization|0|||
155449426|NCT00755846|561070663|FG005|Overall Study|Physician Decision|1|||
155449427|NCT00755846|561070658|FG000|Overall Study|Administrative Error|0|||
155449428|NCT00755846|561070659|FG001|Overall Study|Administrative Error|1|||
155449429|NCT00755846|561070660|FG002|Overall Study|Administrative Error|0|||
155651588|NCT03180138|561816261|FG002|Overall Study|Found to be >24 mon after randomization|3|||
155651589|NCT01260311|561816263|FG000|Overall Study|Adverse Event|11|||
155651590|NCT01260311|561816263|FG000|Overall Study|Lack of Efficacy|4|||
155449430|NCT00755846|561070661|FG003|Overall Study|Administrative Error|0|||
155449431|NCT00755846|561070662|FG004|Overall Study|Administrative Error|0|||
155449432|NCT00755846|561070663|FG005|Overall Study|Administrative Error|0|||
155449433|NCT00755846|561070658|FG000|Overall Study|Participant Non-compliance|0|||
155449434|NCT00755846|561070659|FG001|Overall Study|Participant Non-compliance|0|||
155449435|NCT00755846|561070660|FG002|Overall Study|Participant Non-compliance|0|||
155449436|NCT00755846|561070661|FG003|Overall Study|Participant Non-compliance|0|||
155449437|NCT00755846|561070662|FG004|Overall Study|Participant Non-compliance|1|||
155449438|NCT00755846|561070663|FG005|Overall Study|Participant Non-compliance|0|||
155449439|NCT01830543|561070664|FG000|Overall Study|Subject Decision|19|||
155449440|NCT01830543|561070665|FG001|Overall Study|Subject Decision|21|||
155449441|NCT01830543|561070666|FG002|Overall Study|Subject Decision|57|||
155449442|NCT01830543|561070664|FG000|Overall Study|Adverse Event|91|||
155449443|NCT01830543|561070665|FG001|Overall Study|Adverse Event|77|||
155449444|NCT01830543|561070666|FG002|Overall Study|Adverse Event|76|||
155449445|NCT01830543|561070664|FG000|Overall Study|Death|20|||
155449446|NCT01830543|561070665|FG001|Overall Study|Death|22|||
155449447|NCT01830543|561070666|FG002|Overall Study|Death|22|||
155449448|NCT01830543|561070664|FG000|Overall Study|Protocol Violation|3|||
155449449|NCT01830543|561070665|FG001|Overall Study|Protocol Violation|7|||
155449450|NCT01830543|561070666|FG002|Overall Study|Protocol Violation|7|||
155449451|NCT01830543|561070664|FG000|Overall Study|Physician Decision|11|||
155449452|NCT01830543|561070665|FG001|Overall Study|Physician Decision|5|||
155449453|NCT01830543|561070666|FG002|Overall Study|Physician Decision|12|||
155449454|NCT01830543|561070664|FG000|Overall Study|Withdrawal by consent|3|||
155449455|NCT01830543|561070665|FG001|Overall Study|Withdrawal by consent|3|||
155449456|NCT01830543|561070666|FG002|Overall Study|Withdrawal by consent|3|||
155449457|NCT01830543|561070664|FG000|Overall Study|Other|12|||
155449458|NCT01830543|561070665|FG001|Overall Study|Other|17|||
155449459|NCT01830543|561070666|FG002|Overall Study|Other|37|||
155449460|NCT01030458|561070673|FG000|Overall Study|Lost to Follow-up|9|||
155449461|NCT01030458|561070674|FG001|Overall Study|Lost to Follow-up|10|||
155449462|NCT01030458|561070673|FG000|Overall Study|Withdrawal by Subject|2|||
155449463|NCT01030458|561070674|FG001|Overall Study|Withdrawal by Subject|3|||
155449464|NCT01030458|561070673|FG000|Overall Study|Logistical reasons|9|||
155449465|NCT01030458|561070674|FG001|Overall Study|Logistical reasons|5|||
155449466|NCT01030458|561070673|FG000|Overall Study|Moved or changed job|6|||
155449467|NCT01030458|561070674|FG001|Overall Study|Moved or changed job|13|||
155449468|NCT01030458|561070673|FG000|Overall Study|Side effect of medication|1|||
155449469|NCT01030458|561070674|FG001|Overall Study|Side effect of medication|1|||
155449470|NCT05631548|561070681|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
155449471|NCT05631548|561070682|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
155449472|NCT01592409|561070683|FG000|Overall Study|Withdrawal by Subject|0|||
155449473|NCT01592409|561070684|FG001|Overall Study|Withdrawal by Subject|1|||
155449474|NCT02935634|561070685|FG000|Randomization|Participant withdrew consent|0|||
155449475|NCT02935634|561070686|FG001|Randomization|Participant withdrew consent|1|||
155449476|NCT02935634|561070687|FG002|Randomization|Participant withdrew consent|0|||
155449477|NCT02935634|561070688|FG003|Randomization|Participant withdrew consent|0|||
155449478|NCT02935634|561070689|FG004|Randomization|Participant withdrew consent|0|||
155449479|NCT02935634|561070690|FG005|Randomization|Participant withdrew consent|0|||
155449480|NCT02935634|561070685|FG000|Randomization|Death|2|||
155449481|NCT02935634|561070686|FG001|Randomization|Death|1|||
155449482|NCT02935634|561070687|FG002|Randomization|Death|1|||
155449483|NCT02935634|561070688|FG003|Randomization|Death|0|||
155449484|NCT02935634|561070689|FG004|Randomization|Death|0|||
155449485|NCT02935634|561070690|FG005|Randomization|Death|0|||
155449486|NCT02935634|561070685|FG000|Randomization|Other reasons|0|||
155449487|NCT02935634|561070686|FG001|Randomization|Other reasons|2|||
155449488|NCT02935634|561070687|FG002|Randomization|Other reasons|2|||
155449489|NCT02935634|561070688|FG003|Randomization|Other reasons|0|||
155449490|NCT02935634|561070689|FG004|Randomization|Other reasons|0|||
155449491|NCT02935634|561070690|FG005|Randomization|Other reasons|0|||
155449492|NCT02935634|561070685|FG000|Treatment: Track 1|Disease progression|15|||
155449493|NCT02935634|561070686|FG001|Treatment: Track 1|Disease progression|17|||
155449494|NCT02935634|561070687|FG002|Treatment: Track 1|Disease progression|28|||
155449495|NCT02935634|561070688|FG003|Treatment: Track 1|Disease progression|4|||
155651591|NCT01260311|561816263|FG000|Overall Study|Lost to Follow-up|25|||
155449496|NCT02935634|561070689|FG004|Treatment: Track 1|Disease progression|6|||
155449497|NCT02935634|561070690|FG005|Treatment: Track 1|Disease progression|2|||
155449498|NCT02935634|561070685|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
155449499|NCT02935634|561070686|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
155449500|NCT02935634|561070687|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
155449501|NCT02935634|561070688|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
155449502|NCT02935634|561070689|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
155449503|NCT02935634|561070690|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
155449504|NCT02935634|561070685|FG000|Treatment: Track 1|Lost to Follow-up|1|||
155449505|NCT02935634|561070686|FG001|Treatment: Track 1|Lost to Follow-up|0|||
155449506|NCT02935634|561070687|FG002|Treatment: Track 1|Lost to Follow-up|0|||
155449507|NCT02935634|561070688|FG003|Treatment: Track 1|Lost to Follow-up|0|||
155449508|NCT02935634|561070689|FG004|Treatment: Track 1|Lost to Follow-up|0|||
155449509|NCT02935634|561070690|FG005|Treatment: Track 1|Lost to Follow-up|0|||
155449510|NCT02935634|561070685|FG000|Treatment: Track 1|Study drug toxicity|2|||
155449511|NCT02935634|561070686|FG001|Treatment: Track 1|Study drug toxicity|1|||
155449512|NCT02935634|561070687|FG002|Treatment: Track 1|Study drug toxicity|3|||
155449513|NCT02935634|561070688|FG003|Treatment: Track 1|Study drug toxicity|0|||
155449514|NCT02935634|561070689|FG004|Treatment: Track 1|Study drug toxicity|0|||
155449515|NCT02935634|561070690|FG005|Treatment: Track 1|Study drug toxicity|1|||
155449516|NCT02935634|561070685|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
155449517|NCT02935634|561070686|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
155449518|NCT02935634|561070687|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
155449519|NCT02935634|561070688|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
155449520|NCT02935634|561070689|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
155449521|NCT02935634|561070690|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
155449522|NCT02935634|561070685|FG000|Treatment: Track 1|Participant withdrew consent|2|||
155449523|NCT02935634|561070686|FG001|Treatment: Track 1|Participant withdrew consent|0|||
155449524|NCT02935634|561070687|FG002|Treatment: Track 1|Participant withdrew consent|1|||
155449525|NCT02935634|561070688|FG003|Treatment: Track 1|Participant withdrew consent|0|||
155449526|NCT02935634|561070689|FG004|Treatment: Track 1|Participant withdrew consent|1|||
155449527|NCT02935634|561070690|FG005|Treatment: Track 1|Participant withdrew consent|0|||
155449528|NCT02935634|561070685|FG000|Treatment: Track 1|Other reasons|0|||
155449529|NCT02935634|561070686|FG001|Treatment: Track 1|Other reasons|0|||
155449530|NCT02935634|561070687|FG002|Treatment: Track 1|Other reasons|2|||
155449531|NCT02935634|561070688|FG003|Treatment: Track 1|Other reasons|0|||
155449532|NCT02935634|561070689|FG004|Treatment: Track 1|Other reasons|0|||
155449533|NCT02935634|561070690|FG005|Treatment: Track 1|Other reasons|0|||
155449534|NCT02935634|561070685|FG000|Treatment: Track 2|Disease progression|13|||
155449535|NCT02935634|561070686|FG001|Treatment: Track 2|Disease progression|26|||
155449536|NCT02935634|561070687|FG002|Treatment: Track 2|Disease progression|20|||
155449537|NCT02935634|561070688|FG003|Treatment: Track 2|Disease progression|5|||
155449538|NCT02935634|561070689|FG004|Treatment: Track 2|Disease progression|1|||
155449539|NCT02935634|561070690|FG005|Treatment: Track 2|Disease progression|4|||
155449540|NCT02935634|561070685|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
155449541|NCT02935634|561070686|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
155449542|NCT02935634|561070687|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
155449543|NCT02935634|561070688|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
155449544|NCT02935634|561070689|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
155449545|NCT02935634|561070690|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
155449546|NCT02935634|561070685|FG000|Treatment: Track 2|Study drug toxicity|7|||
155449547|NCT02935634|561070686|FG001|Treatment: Track 2|Study drug toxicity|3|||
155449548|NCT02935634|561070687|FG002|Treatment: Track 2|Study drug toxicity|0|||
155449549|NCT02935634|561070688|FG003|Treatment: Track 2|Study drug toxicity|0|||
155449550|NCT02935634|561070689|FG004|Treatment: Track 2|Study drug toxicity|0|||
155449551|NCT02935634|561070690|FG005|Treatment: Track 2|Study drug toxicity|0|||
155449552|NCT02935634|561070685|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
155449553|NCT02935634|561070686|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
155449554|NCT02935634|561070687|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
155449555|NCT02935634|561070688|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
155449556|NCT02935634|561070689|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
155449557|NCT02935634|561070690|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
155449558|NCT02935634|561070685|FG000|Treatment: Track 2|Participant withdrew consent|0|||
155449559|NCT02935634|561070686|FG001|Treatment: Track 2|Participant withdrew consent|1|||
155449560|NCT02935634|561070687|FG002|Treatment: Track 2|Participant withdrew consent|1|||
155449561|NCT02935634|561070688|FG003|Treatment: Track 2|Participant withdrew consent|0|||
155449562|NCT02935634|561070689|FG004|Treatment: Track 2|Participant withdrew consent|1|||
155515356|NCT03466411|561311579|FG001|Overall Study|Randomized but not Treated|0|||
155449563|NCT02935634|561070690|FG005|Treatment: Track 2|Participant withdrew consent|0|||
155449564|NCT04056455|561070698|FG000|Overall Study|Adverse Event|1|||
155515357|NCT03466411|561311580|FG002|Overall Study|Randomized but not Treated|0|||
155515358|NCT03466411|561311581|FG003|Overall Study|Randomized but not Treated|0|||
155449565|NCT04056455|561070699|FG001|Overall Study|Adverse Event|0|||
155449566|NCT04891770|561070703|FG000|Overall Study|Withdrew consent|1|||
155449567|NCT04891770|561070704|FG001|Overall Study|Withdrew consent|3|||
155449568|NCT04891770|561070705|FG002|Overall Study|Withdrew consent|0|||
155449569|NCT04891770|561070703|FG000|Overall Study|Enrolled but never treated|0|||
155449570|NCT04891770|561070704|FG001|Overall Study|Enrolled but never treated|0|||
155449571|NCT04891770|561070705|FG002|Overall Study|Enrolled but never treated|1|||
155449572|NCT04891770|561070703|FG000|Overall Study|Investigator's discretion|0|||
155449573|NCT04891770|561070704|FG001|Overall Study|Investigator's discretion|1|||
155449574|NCT04891770|561070705|FG002|Overall Study|Investigator's discretion|0|||
155449575|NCT00830037|561070709|FG000|Overall Study|Withdrawal by Subject|2|||
155449576|NCT00830037|561070710|FG001|Overall Study|Withdrawal by Subject|3|||
155449577|NCT00830037|561070709|FG000|Overall Study|Lost to Follow-up|1|||
155449578|NCT00830037|561070710|FG001|Overall Study|Lost to Follow-up|2|||
155449579|NCT00830037|561070709|FG000|Overall Study|Active when terminated by DSMB|15|||
155449580|NCT00830037|561070710|FG001|Overall Study|Active when terminated by DSMB|14|||
155449581|NCT01401010|561070713|FG000|Overall Study|Could not interpret assay results|1|||
155449582|NCT01401010|561070714|FG001|Overall Study|Could not interpret assay results|0|||
155449583|NCT01952834|561070715|FG000|Overall Study|Adverse Event|1|||
155449584|NCT05091060|561070725|FG000|Overall Study|Lost to Follow-up|1|||
155449585|NCT01318083|561070726|FG000|Overall Study|Adverse Event|4|||
155449586|NCT01318083|561070727|FG001|Overall Study|Adverse Event|1|||
155449587|NCT01318083|561070728|FG002|Overall Study|Adverse Event|2|||
155449588|NCT01318083|561070726|FG000|Overall Study|Withdrawal by Subject|1|||
155449589|NCT01318083|561070727|FG001|Overall Study|Withdrawal by Subject|0|||
155449590|NCT01318083|561070728|FG002|Overall Study|Withdrawal by Subject|2|||
155449591|NCT01318083|561070726|FG000|Overall Study|Lack of Efficacy|0|||
155449592|NCT01318083|561070727|FG001|Overall Study|Lack of Efficacy|0|||
155449593|NCT01318083|561070728|FG002|Overall Study|Lack of Efficacy|1|||
155449594|NCT01318083|561070726|FG000|Overall Study|Treatment Complications|1|||
155449595|NCT01318083|561070727|FG001|Overall Study|Treatment Complications|0|||
155449596|NCT01318083|561070728|FG002|Overall Study|Treatment Complications|0|||
155449597|NCT01318083|561070726|FG000|Overall Study|Lack of Study Medication Compliance|0|||
155449598|NCT01318083|561070727|FG001|Overall Study|Lack of Study Medication Compliance|1|||
155449599|NCT01318083|561070728|FG002|Overall Study|Lack of Study Medication Compliance|0|||
155449600|NCT02028338|561070729|FG000|Overall Study|Withdrawal by Subject|3|||
155449601|NCT02028338|561070730|FG001|Overall Study|Withdrawal by Subject|1|||
155449602|NCT02028338|561070729|FG000|Overall Study|Unable to contact participant|1|||
155449603|NCT02028338|561070730|FG001|Overall Study|Unable to contact participant|0|||
155449604|NCT00256867|561070735|FG000|Overall Study|Adverse Event|0|||
155449605|NCT00256867|561070736|FG001|Overall Study|Adverse Event|1|||
155449606|NCT00256867|561070737|FG002|Overall Study|Adverse Event|1|||
155449607|NCT00256867|561070738|FG003|Overall Study|Adverse Event|1|||
155449608|NCT00256867|561070739|FG004|Overall Study|Adverse Event|2|||
155449609|NCT00256867|561070740|FG005|Overall Study|Adverse Event|2|||
155449610|NCT00256867|561070741|FG006|Overall Study|Adverse Event|1|||
155449611|NCT00256867|561070742|FG007|Overall Study|Adverse Event|4|||
155449612|NCT00256867|561070735|FG000|Overall Study|Lost to Follow-up|2|||
155449613|NCT00256867|561070736|FG001|Overall Study|Lost to Follow-up|2|||
155449614|NCT00256867|561070737|FG002|Overall Study|Lost to Follow-up|2|||
155449615|NCT00256867|561070738|FG003|Overall Study|Lost to Follow-up|3|||
155449616|NCT00256867|561070739|FG004|Overall Study|Lost to Follow-up|2|||
155449617|NCT00256867|561070740|FG005|Overall Study|Lost to Follow-up|0|||
155449618|NCT00256867|561070741|FG006|Overall Study|Lost to Follow-up|1|||
155449619|NCT00256867|561070742|FG007|Overall Study|Lost to Follow-up|2|||
155449620|NCT00256867|561070735|FG000|Overall Study|Protocol Violation|0|||
155449621|NCT00256867|561070736|FG001|Overall Study|Protocol Violation|0|||
155449622|NCT00256867|561070737|FG002|Overall Study|Protocol Violation|0|||
155449623|NCT00256867|561070738|FG003|Overall Study|Protocol Violation|1|||
155449624|NCT00256867|561070739|FG004|Overall Study|Protocol Violation|0|||
155449625|NCT00256867|561070740|FG005|Overall Study|Protocol Violation|1|||
155449626|NCT00256867|561070741|FG006|Overall Study|Protocol Violation|0|||
155449627|NCT00256867|561070742|FG007|Overall Study|Protocol Violation|1|||
155449628|NCT00256867|561070735|FG000|Overall Study|Withdrawal by Subject|0|||
155449629|NCT00256867|561070736|FG001|Overall Study|Withdrawal by Subject|0|||
155449630|NCT00256867|561070737|FG002|Overall Study|Withdrawal by Subject|1|||
155449631|NCT00256867|561070738|FG003|Overall Study|Withdrawal by Subject|1|||
155449632|NCT00256867|561070739|FG004|Overall Study|Withdrawal by Subject|2|||
155449633|NCT00256867|561070740|FG005|Overall Study|Withdrawal by Subject|2|||
155449634|NCT00256867|561070741|FG006|Overall Study|Withdrawal by Subject|3|||
155449635|NCT00256867|561070742|FG007|Overall Study|Withdrawal by Subject|2|||
155449636|NCT00256867|561070735|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449637|NCT00256867|561070736|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
155449638|NCT00256867|561070737|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449639|NCT00256867|561070738|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449640|NCT00256867|561070739|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449641|NCT00256867|561070740|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449642|NCT00256867|561070741|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449643|NCT00256867|561070742|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
155449644|NCT00256867|561070735|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449645|NCT00256867|561070736|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449646|NCT00256867|561070737|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449647|NCT00256867|561070738|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449648|NCT00256867|561070739|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449649|NCT00256867|561070740|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449650|NCT00256867|561070741|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
155449651|NCT00256867|561070742|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
155449652|NCT00256867|561070735|FG000|Overall Study|Investigator's Decision|0|||
155449653|NCT00256867|561070736|FG001|Overall Study|Investigator's Decision|0|||
155449654|NCT00256867|561070737|FG002|Overall Study|Investigator's Decision|0|||
155449655|NCT00256867|561070738|FG003|Overall Study|Investigator's Decision|0|||
155449656|NCT00256867|561070739|FG004|Overall Study|Investigator's Decision|1|||
155449657|NCT00256867|561070740|FG005|Overall Study|Investigator's Decision|0|||
155449658|NCT00256867|561070741|FG006|Overall Study|Investigator's Decision|0|||
155449659|NCT00256867|561070742|FG007|Overall Study|Investigator's Decision|0|||
155449660|NCT00256867|561070735|FG000|Overall Study|Non-compliance with study medication|0|||
155449661|NCT00256867|561070736|FG001|Overall Study|Non-compliance with study medication|0|||
155449662|NCT00256867|561070737|FG002|Overall Study|Non-compliance with study medication|0|||
155449663|NCT00256867|561070738|FG003|Overall Study|Non-compliance with study medication|0|||
155449664|NCT00256867|561070739|FG004|Overall Study|Non-compliance with study medication|0|||
155449665|NCT00256867|561070740|FG005|Overall Study|Non-compliance with study medication|0|||
155449666|NCT00256867|561070741|FG006|Overall Study|Non-compliance with study medication|0|||
155449667|NCT00256867|561070742|FG007|Overall Study|Non-compliance with study medication|1|||
155449668|NCT00256867|561070735|FG000|Overall Study|Participant travelled Overseas|0|||
155449669|NCT00256867|561070736|FG001|Overall Study|Participant travelled Overseas|1|||
155449670|NCT00256867|561070737|FG002|Overall Study|Participant travelled Overseas|0|||
155449671|NCT00256867|561070738|FG003|Overall Study|Participant travelled Overseas|0|||
155449672|NCT00256867|561070739|FG004|Overall Study|Participant travelled Overseas|0|||
155449673|NCT00256867|561070740|FG005|Overall Study|Participant travelled Overseas|0|||
155449674|NCT00256867|561070741|FG006|Overall Study|Participant travelled Overseas|0|||
155449675|NCT00256867|561070742|FG007|Overall Study|Participant travelled Overseas|0|||
155449676|NCT00256867|561070735|FG000|Overall Study|Participant out of assessment window|0|||
155449677|NCT00256867|561070736|FG001|Overall Study|Participant out of assessment window|0|||
155449678|NCT00256867|561070737|FG002|Overall Study|Participant out of assessment window|1|||
155449679|NCT00256867|561070738|FG003|Overall Study|Participant out of assessment window|0|||
155449680|NCT00256867|561070739|FG004|Overall Study|Participant out of assessment window|0|||
155449681|NCT00256867|561070740|FG005|Overall Study|Participant out of assessment window|0|||
155449682|NCT00256867|561070741|FG006|Overall Study|Participant out of assessment window|0|||
155449683|NCT00256867|561070742|FG007|Overall Study|Participant out of assessment window|0|||
155449684|NCT00256867|561070735|FG000|Overall Study|Withdrawal by participant|0|||
155449685|NCT00256867|561070736|FG001|Overall Study|Withdrawal by participant|0|||
155449686|NCT00256867|561070737|FG002|Overall Study|Withdrawal by participant|0|||
155449687|NCT00256867|561070738|FG003|Overall Study|Withdrawal by participant|0|||
155449688|NCT00256867|561070739|FG004|Overall Study|Withdrawal by participant|0|||
155449689|NCT00256867|561070740|FG005|Overall Study|Withdrawal by participant|1|||
155449690|NCT00256867|561070741|FG006|Overall Study|Withdrawal by participant|0|||
155449691|NCT00256867|561070742|FG007|Overall Study|Withdrawal by participant|0|||
155449692|NCT01930799|561070746|FG000|Overall Study|Withdrawal by Subject|3|||
155449693|NCT01930799|561070746|FG000|Overall Study|Lost to Follow-up|5|||
155449694|NCT00875017|561070749|FG000|First Intervention|Withdrawal by Subject|1|||
155449695|NCT00875017|561070750|FG001|First Intervention|Withdrawal by Subject|0|||
155449696|NCT00875017|561070751|FG002|First Intervention|Withdrawal by Subject|1|||
155449697|NCT00875017|561070752|FG003|First Intervention|Withdrawal by Subject|0|||
155449698|NCT00875017|561070753|FG004|First Intervention|Withdrawal by Subject|0|||
155449699|NCT00875017|561070754|FG005|First Intervention|Withdrawal by Subject|0|||
155449700|NCT00875017|561070749|FG000|First Intervention|Adverse Event|0|||
155449701|NCT00875017|561070750|FG001|First Intervention|Adverse Event|0|||
155449702|NCT00875017|561070751|FG002|First Intervention|Adverse Event|0|||
155449703|NCT00875017|561070752|FG003|First Intervention|Adverse Event|1|||
155449704|NCT00875017|561070753|FG004|First Intervention|Adverse Event|0|||
155449705|NCT00875017|561070754|FG005|First Intervention|Adverse Event|0|||
155449706|NCT00875017|561070749|FG000|First Intervention|Problems collecting rectal effluent|1|||
155449707|NCT00875017|561070750|FG001|First Intervention|Problems collecting rectal effluent|0|||
155449708|NCT00875017|561070751|FG002|First Intervention|Problems collecting rectal effluent|0|||
155449709|NCT00875017|561070752|FG003|First Intervention|Problems collecting rectal effluent|0|||
155449710|NCT00875017|561070753|FG004|First Intervention|Problems collecting rectal effluent|0|||
155449711|NCT00875017|561070754|FG005|First Intervention|Problems collecting rectal effluent|0|||
155449712|NCT00875017|561070749|FG000|First Intervention|Intolerance to nasogastric tube|0|||
155449713|NCT00875017|561070750|FG001|First Intervention|Intolerance to nasogastric tube|0|||
155449714|NCT00875017|561070751|FG002|First Intervention|Intolerance to nasogastric tube|0|||
155449715|NCT00875017|561070752|FG003|First Intervention|Intolerance to nasogastric tube|0|||
155449716|NCT00875017|561070753|FG004|First Intervention|Intolerance to nasogastric tube|1|||
155449717|NCT00875017|561070754|FG005|First Intervention|Intolerance to nasogastric tube|0|||
155449718|NCT00875017|561070749|FG000|Washout|Problem collecting rectal effluent|0|||
155449719|NCT00875017|561070750|FG001|Washout|Problem collecting rectal effluent|0|||
155449720|NCT00875017|561070751|FG002|Washout|Problem collecting rectal effluent|1|||
155449721|NCT00875017|561070752|FG003|Washout|Problem collecting rectal effluent|0|||
155449722|NCT00875017|561070753|FG004|Washout|Problem collecting rectal effluent|0|||
155449723|NCT00875017|561070754|FG005|Washout|Problem collecting rectal effluent|0|||
155449724|NCT00875017|561070749|FG000|Second Intervention|Adverse Event|0|||
155449725|NCT00875017|561070750|FG001|Second Intervention|Adverse Event|0|||
155449726|NCT00875017|561070751|FG002|Second Intervention|Adverse Event|0|||
155449727|NCT00875017|561070752|FG003|Second Intervention|Adverse Event|1|||
155449728|NCT00875017|561070753|FG004|Second Intervention|Adverse Event|0|||
155449729|NCT00875017|561070754|FG005|Second Intervention|Adverse Event|0|||
155449730|NCT00875017|561070749|FG000|Washout|Problems collecting rectal effluent|0|||
155449731|NCT00875017|561070750|FG001|Washout|Problems collecting rectal effluent|1|||
155449732|NCT00875017|561070751|FG002|Washout|Problems collecting rectal effluent|0|||
155449733|NCT00875017|561070752|FG003|Washout|Problems collecting rectal effluent|0|||
155449734|NCT00875017|561070753|FG004|Washout|Problems collecting rectal effluent|0|||
155449735|NCT00875017|561070754|FG005|Washout|Problems collecting rectal effluent|0|||
155449736|NCT00875017|561070749|FG000|Third Intervention|Adverse Event|0|||
155449737|NCT00875017|561070750|FG001|Third Intervention|Adverse Event|1|||
155449738|NCT00875017|561070751|FG002|Third Intervention|Adverse Event|1|||
155449739|NCT00875017|561070752|FG003|Third Intervention|Adverse Event|0|||
155449740|NCT00875017|561070753|FG004|Third Intervention|Adverse Event|0|||
155449741|NCT00875017|561070754|FG005|Third Intervention|Adverse Event|0|||
155449742|NCT00875017|561070749|FG000|Washout|Withdrawal by Subject|0|||
155449743|NCT00875017|561070750|FG001|Washout|Withdrawal by Subject|0|||
155449744|NCT00875017|561070751|FG002|Washout|Withdrawal by Subject|0|||
155449745|NCT00875017|561070752|FG003|Washout|Withdrawal by Subject|0|||
155449746|NCT00875017|561070753|FG004|Washout|Withdrawal by Subject|1|||
155449747|NCT00875017|561070754|FG005|Washout|Withdrawal by Subject|0|||
155449748|NCT00875017|561070749|FG000|Fourth Intervention|Inability to comply with fasting|0|||
155449749|NCT00875017|561070750|FG001|Fourth Intervention|Inability to comply with fasting|0|||
155449750|NCT00875017|561070751|FG002|Fourth Intervention|Inability to comply with fasting|0|||
155449751|NCT00875017|561070752|FG003|Fourth Intervention|Inability to comply with fasting|0|||
155449752|NCT00875017|561070753|FG004|Fourth Intervention|Inability to comply with fasting|0|||
155449753|NCT00875017|561070754|FG005|Fourth Intervention|Inability to comply with fasting|1|||
155449754|NCT02689219|561070755|FG000|Overall Study|Death|1|||
155449755|NCT02689219|561070756|FG001|Overall Study|Death|1|||
155449756|NCT02689219|561070755|FG000|Overall Study|Disease Progression|10|||
155449757|NCT02689219|561070756|FG001|Overall Study|Disease Progression|6|||
155449758|NCT01477892|561070757|FG000|Overall Study|Withdrawal by Subject|0|||
155449759|NCT01477892|561070758|FG001|Overall Study|Withdrawal by Subject|2|||
155449760|NCT03255291|561070765|FG000|Overall Study|Determined to be ineligible|10|||
155449761|NCT03255291|561070766|FG001|Overall Study|Determined to be ineligible|12|||
155449762|NCT03255291|561070767|FG002|Overall Study|Determined to be ineligible|6|||
155449763|NCT03255291|561070768|FG003|Overall Study|Determined to be ineligible|6|||
155449764|NCT03255291|561070769|FG004|Overall Study|Determined to be ineligible|5|||
155449765|NCT03255291|561070770|FG005|Overall Study|Determined to be ineligible|10|||
155449766|NCT03255291|561070765|FG000|Overall Study|Baseline data collection issues|3|||
155449767|NCT03255291|561070766|FG001|Overall Study|Baseline data collection issues|0|||
155449768|NCT03255291|561070767|FG002|Overall Study|Baseline data collection issues|0|||
155449769|NCT03255291|561070768|FG003|Overall Study|Baseline data collection issues|0|||
155449770|NCT03255291|561070769|FG004|Overall Study|Baseline data collection issues|2|||
155449771|NCT03255291|561070770|FG005|Overall Study|Baseline data collection issues|0|||
155449772|NCT03591146|561070773|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
155449773|NCT03591146|561070774|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
155449774|NCT03591146|561070775|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
155449775|NCT03591146|561070776|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
155449776|NCT03591146|561070777|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
155449777|NCT03591146|561070773|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
155449778|NCT03591146|561070774|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
155449779|NCT03591146|561070775|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
155449780|NCT03591146|561070776|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
155449781|NCT03591146|561070777|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
155449782|NCT03591146|561070773|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
155449783|NCT03591146|561070774|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
155449784|NCT03591146|561070775|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
155449785|NCT03591146|561070776|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
155449786|NCT03591146|561070777|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
155449787|NCT03591146|561070773|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
155449788|NCT03591146|561070774|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
155449789|NCT03591146|561070775|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
155449790|NCT03591146|561070776|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
155449791|NCT03591146|561070777|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
155449792|NCT04369430|561070780|FG000|Overall Study|Adverse Event|2|||
155449793|NCT04369430|561070781|FG001|Overall Study|Adverse Event|3|||
155449794|NCT04369430|561070780|FG000|Overall Study|Death|1|||
155449795|NCT04369430|561070781|FG001|Overall Study|Death|0|||
155449796|NCT04369430|561070780|FG000|Overall Study|Withdrawal by Subject|4|||
155449797|NCT04369430|561070781|FG001|Overall Study|Withdrawal by Subject|3|||
155449798|NCT04369430|561070780|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
155449799|NCT04369430|561070781|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
155449800|NCT04369430|561070780|FG000|Overall Study|Lost to Follow-up|0|||
155449801|NCT04369430|561070781|FG001|Overall Study|Lost to Follow-up|1|||
155449802|NCT00142519|561070784|FG000|Overall Study|Not Treated|7|||
155449803|NCT00142519|561070785|FG001|Overall Study|Not Treated|9|||
155449804|NCT00142519|561070784|FG000|Overall Study|Protocol Violation|1|||
155449805|NCT00142519|561070785|FG001|Overall Study|Protocol Violation|0|||
155449806|NCT00142519|561070784|FG000|Overall Study|Withdrawal by Subject|10|||
155449807|NCT00142519|561070785|FG001|Overall Study|Withdrawal by Subject|7|||
155449808|NCT01468909|561070786|FG000|Overall Study|Never Treated|2|||
155449809|NCT01468909|561070787|FG001|Overall Study|Never Treated|2|||
155449810|NCT01511419|561070791|FG000|Dose 2|Physician Decision|1|||
155449811|NCT01511419|561070792|FG001|Dose 2|Physician Decision|0|||
155449812|NCT00937768|561070793|FG000|Overall Study|Refused Further Treatment|3|||
155449813|NCT00937768|561070794|FG001|Overall Study|Refused Further Treatment|2|||
155449814|NCT00937768|561070793|FG000|Overall Study|Disease Progression|1|||
155449815|NCT00937768|561070794|FG001|Overall Study|Disease Progression|1|||
155449816|NCT00937768|561070793|FG000|Overall Study|Alternate Treatment|0|||
155449817|NCT00937768|561070794|FG001|Overall Study|Alternate Treatment|1|||
155449818|NCT00937768|561070793|FG000|Overall Study|No Further Funding|4|||
155449819|NCT00937768|561070794|FG001|Overall Study|No Further Funding|4|||
155449820|NCT01687413|561070799|FG000|Overall Study|Withdrawal by Subject|0|||
155449821|NCT01687413|561070800|FG001|Overall Study|Withdrawal by Subject|2|||
155449822|NCT01687413|561070799|FG000|Overall Study|Not eligible|0|||
155449823|NCT01687413|561070800|FG001|Overall Study|Not eligible|2|||
155449824|NCT01687413|561070799|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
155449825|NCT01687413|561070800|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
155449826|NCT04973228|561070801|FG000|Overall Study|Adverse Event|2|||
155449827|NCT04973228|561070802|FG001|Overall Study|Adverse Event|3|||
155449828|NCT04973228|561070801|FG000|Overall Study|Lack of Efficacy|1|||
155449829|NCT04973228|561070802|FG001|Overall Study|Lack of Efficacy|3|||
155449830|NCT04973228|561070801|FG000|Overall Study|Lost to Follow-up|12|||
155449831|NCT04973228|561070802|FG001|Overall Study|Lost to Follow-up|4|||
155449832|NCT04973228|561070801|FG000|Overall Study|Withdrawal by Subject|11|||
155449833|NCT04973228|561070802|FG001|Overall Study|Withdrawal by Subject|4|||
155449834|NCT04973228|561070801|FG000|Overall Study|Did not tolerate application|1|||
155449835|NCT04973228|561070802|FG001|Overall Study|Did not tolerate application|0|||
155449836|NCT04973228|561070801|FG000|Overall Study|Wanted to early terminate and use own product|0|||
155449837|NCT04973228|561070802|FG001|Overall Study|Wanted to early terminate and use own product|1|||
155449838|NCT04973228|561070801|FG000|Overall Study|Missed visits due to new work schedule|1|||
155449839|NCT04973228|561070802|FG001|Overall Study|Missed visits due to new work schedule|0|||
155449840|NCT00091390|561070807|FG000|Overall Study|Protocol Violation|1|||
155515359|NCT03466411|561311582|FG004|Overall Study|Randomized but not Treated|0|||
155449841|NCT00091390|561070807|FG000|Overall Study|No protocol treatment|3|||
155449842|NCT00406640|561070808|FG000|Acute Phase|Adverse Event|18|||
155449843|NCT00406640|561070809|FG001|Acute Phase|Adverse Event|13|||
155449844|NCT00406640|561070808|FG000|Acute Phase|Failed to Return|5|||
155515360|NCT03466411|561311583|FG005|Overall Study|Randomized but not Treated|0|||
155449845|NCT00406640|561070809|FG001|Acute Phase|Failed to Return|1|||
155449846|NCT00406640|561070808|FG000|Acute Phase|Physician Decision|0|||
155449847|NCT00406640|561070809|FG001|Acute Phase|Physician Decision|1|||
155449848|NCT00406640|561070808|FG000|Acute Phase|Lost to Follow-up|7|||
155449849|NCT00406640|561070809|FG001|Acute Phase|Lost to Follow-up|4|||
155449850|NCT00406640|561070808|FG000|Acute Phase|Protocol deviation|4|||
155449851|NCT00406640|561070809|FG001|Acute Phase|Protocol deviation|10|||
155449852|NCT00406640|561070808|FG000|Acute Phase|Protocol Violation|3|||
155449853|NCT00406640|561070809|FG001|Acute Phase|Protocol Violation|2|||
155449854|NCT00406640|561070808|FG000|Acute Phase|Withdrawal by Subject|11|||
155449855|NCT00406640|561070809|FG001|Acute Phase|Withdrawal by Subject|9|||
155449856|NCT00406640|561070808|FG000|Acute Phase|Lack of Efficacy|3|||
155449857|NCT00406640|561070809|FG001|Acute Phase|Lack of Efficacy|3|||
155449858|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
155449859|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
155449860|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Death|1|||
155449861|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Death|0|||
155449862|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
155449863|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
155449864|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
155449865|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
155449866|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
155449867|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
155449868|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|non-compliance|7|||
155449869|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|non-compliance|5|||
155449870|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
155449871|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
155449872|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
155449873|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
155449874|NCT00406640|561070808|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
155449875|NCT00406640|561070809|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
155449876|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
155449877|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
155449878|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
155449879|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
155449880|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
155449881|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
155449882|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
155449883|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
155449884|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
155449885|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
155449886|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
155449887|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
155449888|NCT00406640|561070808|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
155449889|NCT00406640|561070809|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
155449890|NCT02723604|561073281|FG000|Overall Study|ineligible|1|||
155449891|NCT02723604|561073281|FG000|Overall Study|never received treatment|1|||
155449892|NCT02669862|561073282|FG000|Overall Study|Lost to Follow-up|0|||
155449893|NCT02669862|561073283|FG001|Overall Study|Lost to Follow-up|2|||
155449894|NCT02669862|561073284|FG002|Overall Study|Lost to Follow-up|1|||
155449895|NCT02669862|561073282|FG000|Overall Study|Withdrawal by Subject|2|||
155449896|NCT02669862|561073283|FG001|Overall Study|Withdrawal by Subject|2|||
155449897|NCT02669862|561073284|FG002|Overall Study|Withdrawal by Subject|3|||
155449898|NCT02669862|561073282|FG000|Overall Study|moved|0|||
155449899|NCT02669862|561073283|FG001|Overall Study|moved|1|||
155449900|NCT02669862|561073284|FG002|Overall Study|moved|0|||
155449901|NCT02669862|561073282|FG000|Overall Study|Protocol Violation|0|||
155449902|NCT02669862|561073283|FG001|Overall Study|Protocol Violation|0|||
155449903|NCT02669862|561073284|FG002|Overall Study|Protocol Violation|1|||
155449904|NCT00311181|561073285|FG000|Overall Study|Final DFTs were not obtained|96|||
155449905|NCT02294318|561073286|FG000|Overall Study|Worsening of drinking|3|||
155449906|NCT02294318|561073287|FG001|Overall Study|Worsening of drinking|0|||
155449907|NCT02294318|561073286|FG000|Overall Study|Not exposed to intervention|0|||
155449908|NCT02294318|561073287|FG001|Overall Study|Not exposed to intervention|2|||
155449909|NCT00506948|561073292|FG000|Overall Study|Death|4|||
155449910|NCT00506948|561073292|FG000|Overall Study|Adverse Event|5|||
155449911|NCT00506948|561073292|FG000|Overall Study|Physician Decision|1|||
155449912|NCT02395653|561073293|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
155449913|NCT02395653|561073293|FG000|Overall Study|Consent Withdrawn at Screening|1|||
155449914|NCT02395653|561073293|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
155449915|NCT02395653|561073293|FG000|Overall Study|Investigator Decision at Screening|1|||
155449916|NCT02395653|561073293|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
155449917|NCT02395653|561073293|FG000|Overall Study|Withdrawal by Subject|1|||
155449918|NCT02395653|561073293|FG000|Overall Study|Lost to Follow-up|1|||
155449919|NCT01194804|561073294|FG000|Overall Study|Withdrawal by Subject|1|||
155449920|NCT02670915|561073295|FG000|Overall Study|Withdrawal by Subject|0|||
155449921|NCT02670915|561073296|FG001|Overall Study|Withdrawal by Subject|1|||
155449922|NCT02670915|561073297|FG002|Overall Study|Withdrawal by Subject|4|||
155449923|NCT02670915|561073295|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155449924|NCT02670915|561073296|FG001|Overall Study|Withdrawal by parent/guardian|4|||
155449925|NCT02670915|561073297|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155449926|NCT02670915|561073295|FG000|Overall Study|Unclassified|0|||
155449927|NCT02670915|561073296|FG001|Overall Study|Unclassified|3|||
155449928|NCT02670915|561073297|FG002|Overall Study|Unclassified|0|||
155449929|NCT00818207|561073298|FG000|Overall Study|Adverse Event|6|||
155449930|NCT00818207|561073299|FG001|Overall Study|Adverse Event|0|||
155449931|NCT00818207|561073298|FG000|Overall Study|Lost to Follow-up|160|||
155449932|NCT00818207|561073299|FG001|Overall Study|Lost to Follow-up|146|||
155449933|NCT00818207|561073298|FG000|Overall Study|Multiple reasons|11|||
155449934|NCT00818207|561073299|FG001|Overall Study|Multiple reasons|12|||
155449935|NCT00818207|561073298|FG000|Overall Study|Withdrawal by Subject|42|||
155449936|NCT00818207|561073299|FG001|Overall Study|Withdrawal by Subject|104|||
155449937|NCT00818207|561073298|FG000|Overall Study|Death|3|||
155449938|NCT00818207|561073299|FG001|Overall Study|Death|5|||
155449939|NCT02616185|561073300|FG000|Overall Study|Death|0|||
155449940|NCT02616185|561073301|FG001|Overall Study|Death|0|||
155449941|NCT02616185|561073302|FG002|Overall Study|Death|0|||
155449942|NCT02616185|561073303|FG003|Overall Study|Death|1|||
155449943|NCT02616185|561073304|FG004|Overall Study|Death|2|||
155449944|NCT02616185|561073305|FG005|Overall Study|Death|0|||
155449945|NCT02616185|561073306|FG006|Overall Study|Death|0|||
155449946|NCT02616185|561073307|FG007|Overall Study|Death|2|||
155449947|NCT02616185|561073308|FG008|Overall Study|Death|1|||
155449948|NCT02616185|561073300|FG000|Overall Study|Study terminated by sponsor|0|||
155449949|NCT02616185|561073301|FG001|Overall Study|Study terminated by sponsor|0|||
155449950|NCT02616185|561073302|FG002|Overall Study|Study terminated by sponsor|1|||
155449951|NCT02616185|561073303|FG003|Overall Study|Study terminated by sponsor|0|||
155449952|NCT02616185|561073304|FG004|Overall Study|Study terminated by sponsor|0|||
155449953|NCT02616185|561073305|FG005|Overall Study|Study terminated by sponsor|0|||
155449954|NCT02616185|561073306|FG006|Overall Study|Study terminated by sponsor|5|||
155449955|NCT02616185|561073307|FG007|Overall Study|Study terminated by sponsor|2|||
155449956|NCT02616185|561073308|FG008|Overall Study|Study terminated by sponsor|0|||
155449957|NCT02616185|561073300|FG000|Overall Study|Participant refused further follow-up|1|||
155449958|NCT02616185|561073301|FG001|Overall Study|Participant refused further follow-up|1|||
155449959|NCT02616185|561073302|FG002|Overall Study|Participant refused further follow-up|2|||
155449960|NCT02616185|561073303|FG003|Overall Study|Participant refused further follow-up|3|||
155449961|NCT02616185|561073304|FG004|Overall Study|Participant refused further follow-up|4|||
155449962|NCT02616185|561073305|FG005|Overall Study|Participant refused further follow-up|0|||
155449963|NCT02616185|561073306|FG006|Overall Study|Participant refused further follow-up|3|||
155449964|NCT02616185|561073307|FG007|Overall Study|Participant refused further follow-up|4|||
155449965|NCT02616185|561073308|FG008|Overall Study|Participant refused further follow-up|3|||
155449966|NCT02616185|561073300|FG000|Overall Study|Not reported|0|||
155449967|NCT02616185|561073301|FG001|Overall Study|Not reported|0|||
155449968|NCT02616185|561073302|FG002|Overall Study|Not reported|0|||
155449969|NCT02616185|561073303|FG003|Overall Study|Not reported|1|||
155449970|NCT02616185|561073304|FG004|Overall Study|Not reported|3|||
155449971|NCT02616185|561073305|FG005|Overall Study|Not reported|1|||
155449972|NCT02616185|561073306|FG006|Overall Study|Not reported|0|||
155449973|NCT02616185|561073307|FG007|Overall Study|Not reported|5|||
155449974|NCT02616185|561073308|FG008|Overall Study|Not reported|2|||
155449975|NCT03621943|561073309|FG000|First Randomized Intervention|Lost to Follow-up|51|||
155449976|NCT03621943|561073310|FG001|First Randomized Intervention|Lost to Follow-up|54|||
155449977|NCT03621943|561073309|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
155449978|NCT03621943|561073310|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
155449979|NCT03621943|561073309|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
155449980|NCT03621943|561073310|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
155449981|NCT03621943|561073309|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
155449982|NCT03621943|561073310|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
155449983|NCT01215734|561073311|FG000|Overall Study|Death|0|||
155651592|NCT01260311|561816263|FG000|Overall Study|Withdrawal by Subject|6|||
155449984|NCT01215734|561073312|FG001|Overall Study|Death|1|||
155449985|NCT00315705|561073313|FG000|Phase 1|Refused further treatment|1|||
155449986|NCT00315705|561073313|FG000|Phase 1|Failure to achieve response|8|||
155449987|NCT00315705|561073313|FG000|Phase 1|Disease relapse|4|||
155449988|NCT00315705|561073313|FG000|Phase 1|Scheduled for transplant|9|||
155449989|NCT00315705|561073313|FG000|Phase 1|Death|3|||
155449990|NCT00315705|561073313|FG000|Phase 2|Physician Decision|4|||
155651593|NCT01260311|561816263|FG000|Overall Study|Financial Constraints|77|||
155449991|NCT00315705|561073313|FG000|Phase 2|Adverse Event|1|||
155449992|NCT00315705|561073313|FG000|Phase 2|Failure to achieve response|3|||
155449993|NCT00315705|561073313|FG000|Phase 2|Disease relapse|1|||
155651594|NCT01260311|561816263|FG000|Overall Study|Gone to Province|2|||
155449994|NCT00315705|561073313|FG000|Phase 2|Scheduled for transplant|8|||
155449995|NCT00315705|561073313|FG000|Phase 2|Other|1|||
155449996|NCT00315705|561073313|FG000|Phase 2|Death|7|||
155449997|NCT01346371|561073314|FG000|Overall Study|Lost to Follow-up|2|||
155449998|NCT01346371|561073315|FG001|Overall Study|Lost to Follow-up|0|||
155449999|NCT00833248|561073322|FG000|Overall Study|Adverse Event|3|||
155450000|NCT00833248|561073323|FG001|Overall Study|Adverse Event|0|||
155450001|NCT00833248|561073322|FG000|Overall Study|Protocol Violation|1|||
155450002|NCT00833248|561073323|FG001|Overall Study|Protocol Violation|2|||
155450003|NCT00833248|561073322|FG000|Overall Study|Withdrawal by Subject|0|||
155450004|NCT00833248|561073323|FG001|Overall Study|Withdrawal by Subject|1|||
155450005|NCT00839423|561073324|FG000|Overall Study|Adverse Event|4|||
155450006|NCT00839423|561073325|FG001|Overall Study|Adverse Event|3|||
155450007|NCT00839423|561073326|FG002|Overall Study|Adverse Event|7|||
155450008|NCT00839423|561073327|FG003|Overall Study|Adverse Event|16|||
155450009|NCT00839423|561073324|FG000|Overall Study|Lack of Efficacy|6|||
155450010|NCT00839423|561073325|FG001|Overall Study|Lack of Efficacy|6|||
155450011|NCT00839423|561073326|FG002|Overall Study|Lack of Efficacy|3|||
155450012|NCT00839423|561073327|FG003|Overall Study|Lack of Efficacy|2|||
155450013|NCT00839423|561073324|FG000|Overall Study|Non-compliance|0|||
155450014|NCT00839423|561073325|FG001|Overall Study|Non-compliance|0|||
155450015|NCT00839423|561073326|FG002|Overall Study|Non-compliance|0|||
155450016|NCT00839423|561073327|FG003|Overall Study|Non-compliance|1|||
155450017|NCT00839423|561073324|FG000|Overall Study|Protocol Violation|0|||
155450018|NCT00839423|561073325|FG001|Overall Study|Protocol Violation|1|||
155450019|NCT00839423|561073326|FG002|Overall Study|Protocol Violation|2|||
155450020|NCT00839423|561073327|FG003|Overall Study|Protocol Violation|0|||
155450021|NCT00839423|561073324|FG000|Overall Study|Withdrawal of consent|4|||
155450022|NCT00839423|561073325|FG001|Overall Study|Withdrawal of consent|0|||
155450023|NCT00839423|561073326|FG002|Overall Study|Withdrawal of consent|4|||
155450024|NCT00839423|561073327|FG003|Overall Study|Withdrawal of consent|1|||
155450025|NCT00839423|561073324|FG000|Overall Study|Lost to Follow-up|1|||
155450026|NCT00839423|561073325|FG001|Overall Study|Lost to Follow-up|0|||
155450027|NCT00839423|561073326|FG002|Overall Study|Lost to Follow-up|1|||
155450028|NCT00839423|561073327|FG003|Overall Study|Lost to Follow-up|0|||
155450029|NCT00839423|561073324|FG000|Overall Study|Administrative or other reasons|3|||
155450030|NCT00839423|561073325|FG001|Overall Study|Administrative or other reasons|0|||
155450031|NCT00839423|561073326|FG002|Overall Study|Administrative or other reasons|1|||
155450032|NCT00839423|561073327|FG003|Overall Study|Administrative or other reasons|0|||
155450033|NCT01071096|561073328|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
155450034|NCT01071096|561073329|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
155450035|NCT02585999|561073330|FG000|Overall Study|Lost to Follow-up|1|||
155450036|NCT02585999|561073330|FG000|Overall Study|Protocol Violation|1|||
155450037|NCT01332019|561073331|FG000|Overall Study|Was Not Dosed|1|||
155450038|NCT01332019|561073332|FG001|Overall Study|Was Not Dosed|0|||
155450039|NCT01332019|561073331|FG000|Overall Study|Other|16|||
155450040|NCT01332019|561073332|FG001|Overall Study|Other|18|||
155651595|NCT01260311|561816263|FG000|Overall Study|Medication Stopped|1|||
155450041|NCT01332019|561073331|FG000|Overall Study|Death|2|||
155450042|NCT01332019|561073332|FG001|Overall Study|Death|1|||
155450043|NCT01332019|561073331|FG000|Overall Study|Physician Decision|4|||
155450044|NCT01332019|561073332|FG001|Overall Study|Physician Decision|3|||
155450045|NCT01332019|561073331|FG000|Overall Study|Withdrawal by Subject|73|||
155450046|NCT01332019|561073332|FG001|Overall Study|Withdrawal by Subject|71|||
155651596|NCT01260311|561816263|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
155450047|NCT01332019|561073331|FG000|Overall Study|Lost to Follow-up|4|||
155450048|NCT01332019|561073332|FG001|Overall Study|Lost to Follow-up|7|||
155450049|NCT01332019|561073331|FG000|Overall Study|Adverse Event|13|||
155450050|NCT01332019|561073332|FG001|Overall Study|Adverse Event|22|||
155450051|NCT01369849|561073335|FG000|Overall Study|Ineligible prior to treatment|0|||
155450052|NCT01369849|561073336|FG001|Overall Study|Ineligible prior to treatment|0|||
155515361|NCT03466411|561311584|FG006|Overall Study|Randomized but not Treated|1|||
155651597|NCT01903733|561816264|FG000|Overall Study|Death|23|||
155450053|NCT01369849|561073337|FG002|Overall Study|Ineligible prior to treatment|1|||
155450054|NCT01369849|561073335|FG000|Overall Study|Ineligible after receiving treatment|0|||
155450055|NCT01369849|561073336|FG001|Overall Study|Ineligible after receiving treatment|1|||
155450056|NCT01369849|561073337|FG002|Overall Study|Ineligible after receiving treatment|0|||
155450057|NCT00871377|561073338|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155450058|NCT00871377|561073339|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155450059|NCT00871377|561073340|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
155450060|NCT00871377|561073341|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155450061|NCT00871377|561073342|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155450062|NCT00871377|561073343|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155450063|NCT00871377|561073338|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
155450064|NCT00871377|561073339|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
155450065|NCT00871377|561073340|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
155450066|NCT00871377|561073341|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
155450067|NCT00871377|561073342|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
155450068|NCT00871377|561073343|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
155450069|NCT00871377|561073338|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
155450070|NCT00871377|561073339|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450071|NCT00871377|561073340|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450072|NCT00871377|561073341|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450073|NCT00871377|561073342|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450074|NCT00871377|561073343|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450075|NCT00871377|561073338|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450076|NCT00871377|561073339|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450077|NCT00871377|561073340|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450078|NCT00871377|561073341|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450079|NCT00871377|561073342|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
155450080|NCT00871377|561073343|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
155450081|NCT00871377|561073338|FG000|Third Intervention (10 Weeks)|Death|0|||
155450082|NCT00871377|561073339|FG001|Third Intervention (10 Weeks)|Death|0|||
155450083|NCT00871377|561073340|FG002|Third Intervention (10 Weeks)|Death|0|||
155450084|NCT00871377|561073341|FG003|Third Intervention (10 Weeks)|Death|1|||
155450085|NCT00871377|561073342|FG004|Third Intervention (10 Weeks)|Death|0|||
155450086|NCT00871377|561073343|FG005|Third Intervention (10 Weeks)|Death|0|||
155450087|NCT04281030|561073344|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
155450088|NCT04281030|561073345|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
155450089|NCT04281030|561073344|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
155450090|NCT04281030|561073345|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
155450091|NCT00288860|561073350|FG000|Overall Study|Did not complete intake|4|||
155450092|NCT00288860|561073351|FG001|Overall Study|Did not complete intake|8|||
155450093|NCT00288860|561073350|FG000|Overall Study|Death|4|||
155450094|NCT00288860|561073351|FG001|Overall Study|Death|3|||
155450095|NCT00288860|561073350|FG000|Overall Study|Withdrawal by Subject|20|||
155450096|NCT00288860|561073351|FG001|Overall Study|Withdrawal by Subject|15|||
155450097|NCT00288860|561073350|FG000|Overall Study|Lost to Follow-up|74|||
155450098|NCT00288860|561073351|FG001|Overall Study|Lost to Follow-up|71|||
155450099|NCT05142332|561073352|FG000|Overall Study|Withdrawal by Subject|0|||
155450100|NCT05142332|561073353|FG001|Overall Study|Withdrawal by Subject|1|||
155450101|NCT05142332|561073354|FG002|Overall Study|Withdrawal by Subject|2|||
155450102|NCT05142332|561073355|FG003|Overall Study|Withdrawal by Subject|0|||
155450103|NCT05142332|561073356|FG004|Overall Study|Withdrawal by Subject|0|||
155450104|NCT05142332|561073357|FG005|Overall Study|Withdrawal by Subject|2|||
155450105|NCT05142332|561073358|FG006|Overall Study|Withdrawal by Subject|6|||
155450106|NCT05142332|561073352|FG000|Overall Study|Left ED|3|||
155450107|NCT05142332|561073353|FG001|Overall Study|Left ED|0|||
155450108|NCT05142332|561073354|FG002|Overall Study|Left ED|4|||
155450109|NCT05142332|561073355|FG003|Overall Study|Left ED|6|||
155450110|NCT05142332|561073356|FG004|Overall Study|Left ED|1|||
155450111|NCT05142332|561073357|FG005|Overall Study|Left ED|2|||
155651598|NCT01903733|561816265|FG001|Overall Study|Death|54|||
155651599|NCT01903733|561816266|FG002|Overall Study|Death|30|||
155651600|NCT01903733|561816267|FG003|Overall Study|Death|98|||
155651601|NCT01903733|561816264|FG000|Overall Study|Participant refused further follow-up|35|||
155450112|NCT05142332|561073358|FG006|Overall Study|Left ED|6|||
155450113|NCT05142332|561073352|FG000|Overall Study|Physician Decision|0|||
155450114|NCT05142332|561073353|FG001|Overall Study|Physician Decision|0|||
155450115|NCT05142332|561073354|FG002|Overall Study|Physician Decision|2|||
155450116|NCT05142332|561073355|FG003|Overall Study|Physician Decision|1|||
155651602|NCT01903733|561816265|FG001|Overall Study|Participant refused further follow-up|38|||
155651603|NCT01903733|561816266|FG002|Overall Study|Participant refused further follow-up|13|||
155450117|NCT05142332|561073356|FG004|Overall Study|Physician Decision|0|||
155450118|NCT05142332|561073357|FG005|Overall Study|Physician Decision|0|||
155450119|NCT05142332|561073358|FG006|Overall Study|Physician Decision|3|||
155450120|NCT05142332|561073352|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
155450121|NCT05142332|561073353|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
155450122|NCT05142332|561073354|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
155450123|NCT05142332|561073355|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
155450124|NCT05142332|561073356|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
155450125|NCT05142332|561073357|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
155450126|NCT05142332|561073358|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
155450127|NCT02116660|561073359|FG000|Overall Study|Deteriorating renal function|0|||
155450128|NCT02116660|561073360|FG001|Overall Study|Deteriorating renal function|1|||
155450129|NCT02116660|561073359|FG000|Overall Study|Adverse Event|1|||
155450130|NCT02116660|561073360|FG001|Overall Study|Adverse Event|1|||
155450131|NCT02116660|561073359|FG000|Overall Study|Withdrawal by Subject|0|||
155450132|NCT02116660|561073360|FG001|Overall Study|Withdrawal by Subject|2|||
155450133|NCT02116660|561073359|FG000|Overall Study|Organization reason|1|||
155450134|NCT02116660|561073360|FG001|Overall Study|Organization reason|0|||
155450135|NCT01718509|561073361|FG000|Overall Study|Lost to Follow-up|18|||
155450136|NCT01718509|561073362|FG001|Overall Study|Lost to Follow-up|15|||
155450137|NCT01718509|561073361|FG000|Overall Study|Withdrawal by Subject|7|||
155450138|NCT01718509|561073362|FG001|Overall Study|Withdrawal by Subject|13|||
155450139|NCT01718509|561073361|FG000|Overall Study|Adverse Event|5|||
155450140|NCT01718509|561073362|FG001|Overall Study|Adverse Event|7|||
155450141|NCT01718509|561073361|FG000|Overall Study|Other|13|||
155450142|NCT01718509|561073362|FG001|Overall Study|Other|11|||
155450143|NCT01718509|561073361|FG000|Overall Study|Protocol Violation|4|||
155450144|NCT01718509|561073362|FG001|Overall Study|Protocol Violation|2|||
155450145|NCT01718509|561073361|FG000|Overall Study|Lack of Efficacy|1|||
155450146|NCT01718509|561073362|FG001|Overall Study|Lack of Efficacy|0|||
155450147|NCT00411788|561073365|FG000|Overall Study|Protocol Violation|1|||
155450148|NCT00411788|561073365|FG000|Overall Study|Adverse Event|1|||
155450149|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
155450150|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
155450151|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
155450152|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
155450153|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
155450154|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
155450155|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
155450156|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
155450157|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
155450158|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
155450159|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
155450160|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
155450161|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
155450162|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
155450163|NCT00848549|561073366|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
155450164|NCT00848549|561073367|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
155450165|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
155450166|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
155450167|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
155450168|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
155450169|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
155450170|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
155450171|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
155450172|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
155450173|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
155450174|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
155450175|NCT00848549|561073366|FG000|E2090-E044-314 (Extension Study)|Other|5|||
155450176|NCT00848549|561073367|FG001|E2090-E044-314 (Extension Study)|Other|6|||
155450177|NCT02561299|561073368|FG000|Overall Study|Death|2|||
155450178|NCT02561299|561073369|FG001|Overall Study|Death|4|||
155450179|NCT02561299|561073368|FG000|Overall Study|Lost to Follow-up|1|||
155450180|NCT02561299|561073369|FG001|Overall Study|Lost to Follow-up|0|||
155450181|NCT02561299|561073368|FG000|Overall Study|Withdrawal by Subject|2|||
155450182|NCT02561299|561073369|FG001|Overall Study|Withdrawal by Subject|2|||
155450183|NCT00390416|561073370|FG000|Overall Study|Withdrawal by Subject|1|||
155450184|NCT00390416|561073370|FG000|Overall Study|Not treated|3|||
155450185|NCT01219959|561073373|FG000|Overall Study|Adverse Event|6|||
155450186|NCT01219959|561073374|FG001|Overall Study|Adverse Event|14|||
155450187|NCT01219959|561073373|FG000|Overall Study|Physician Decision|0|||
155651604|NCT01903733|561816267|FG003|Overall Study|Participant refused further follow-up|9|||
155651605|NCT01903733|561816264|FG000|Overall Study|Lost to Follow-up|18|||
155450188|NCT01219959|561073374|FG001|Overall Study|Physician Decision|4|||
155450189|NCT01219959|561073373|FG000|Overall Study|Withdrawal by Subject|0|||
155450190|NCT01219959|561073374|FG001|Overall Study|Withdrawal by Subject|2|||
155450191|NCT01219959|561073373|FG000|Overall Study|Renal Transplantation|0|||
155450192|NCT01219959|561073374|FG001|Overall Study|Renal Transplantation|3|||
155450193|NCT01219959|561073373|FG000|Overall Study|Other|1|||
155450194|NCT01219959|561073374|FG001|Overall Study|Other|0|||
155450195|NCT01728584|561073375|FG000|Overall Study|Adverse Event|1|||
155450196|NCT01728584|561073376|FG001|Overall Study|Adverse Event|0|||
155450197|NCT01728584|561073377|FG002|Overall Study|Adverse Event|0|||
155450198|NCT01728584|561073378|FG003|Overall Study|Adverse Event|0|||
155450199|NCT01728584|561073375|FG000|Overall Study|Physician Decision|4|||
155450200|NCT01728584|561073376|FG001|Overall Study|Physician Decision|0|||
155450201|NCT01728584|561073377|FG002|Overall Study|Physician Decision|1|||
155450202|NCT01728584|561073378|FG003|Overall Study|Physician Decision|0|||
155450203|NCT01728584|561073375|FG000|Overall Study|Withdrawal by Subject|1|||
155450204|NCT01728584|561073376|FG001|Overall Study|Withdrawal by Subject|0|||
155450205|NCT01728584|561073377|FG002|Overall Study|Withdrawal by Subject|0|||
155450206|NCT01728584|561073378|FG003|Overall Study|Withdrawal by Subject|0|||
155450207|NCT01728584|561073375|FG000|Overall Study|Screen failure|1|||
155450208|NCT01728584|561073376|FG001|Overall Study|Screen failure|0|||
155450209|NCT01728584|561073377|FG002|Overall Study|Screen failure|0|||
155450210|NCT01728584|561073378|FG003|Overall Study|Screen failure|0|||
155450211|NCT01728584|561073375|FG000|Overall Study|Other reason (not specified)|1|||
155450212|NCT01728584|561073376|FG001|Overall Study|Other reason (not specified)|0|||
155450213|NCT01728584|561073377|FG002|Overall Study|Other reason (not specified)|0|||
155450214|NCT01728584|561073378|FG003|Overall Study|Other reason (not specified)|1|||
155450215|NCT01409031|561073384|FG000|Overall Study|transferred to other hosp|1|||
155450216|NCT01409031|561073385|FG001|Overall Study|transferred to other hosp|0|||
155450217|NCT00471536|561073390|FG000|Overall Study|Withdrawal by Subject|1|||
155450218|NCT02651194|561073391|FG000|Overall Study|Lost to Follow-up|3|||
155450219|NCT02651194|561073391|FG000|Overall Study|Other|2|||
155450220|NCT01980706|561073394|FG000|Overall Study|Withdrawal by Subject|9|||
155450221|NCT01980706|561073395|FG001|Overall Study|Withdrawal by Subject|6|||
155450222|NCT01980706|561073396|FG002|Overall Study|Withdrawal by Subject|2|||
155450223|NCT01980706|561073394|FG000|Overall Study|Adverse Event|1|||
155450224|NCT01980706|561073395|FG001|Overall Study|Adverse Event|2|||
155450225|NCT01980706|561073396|FG002|Overall Study|Adverse Event|5|||
155450226|NCT01980706|561073394|FG000|Overall Study|Lost to Follow-up|3|||
155450227|NCT01980706|561073395|FG001|Overall Study|Lost to Follow-up|4|||
155450228|NCT01980706|561073396|FG002|Overall Study|Lost to Follow-up|3|||
155450229|NCT01980706|561073394|FG000|Overall Study|miscellaneous|4|||
155450230|NCT01980706|561073395|FG001|Overall Study|miscellaneous|5|||
155450231|NCT01980706|561073396|FG002|Overall Study|miscellaneous|3|||
155450232|NCT02546674|561073397|FG000|Overall Study|Adverse Event|19|||
155450233|NCT02546674|561073397|FG000|Overall Study|Death|1|||
155450234|NCT02546674|561073397|FG000|Overall Study|Lost to Follow-up|1|||
155450235|NCT02546674|561073397|FG000|Overall Study|Physician Decision|13|||
155450236|NCT02546674|561073397|FG000|Overall Study|Pregnancy|1|||
155450237|NCT02546674|561073397|FG000|Overall Study|Progressive Disease|2|||
155450238|NCT02546674|561073397|FG000|Overall Study|Protocol Deviation|2|||
155450239|NCT02546674|561073397|FG000|Overall Study|Subject/Guardian Decision|6|||
155450240|NCT02546674|561073397|FG000|Overall Study|Withdrawal of Informed Consent|3|||
155450241|NCT01094730|561073400|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
155450242|NCT01094730|561073401|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
155450243|NCT01094730|561073400|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
155450244|NCT01094730|561073401|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
155450245|NCT01094730|561073400|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
155450246|NCT01094730|561073401|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
155450247|NCT01094730|561073400|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
155450248|NCT01094730|561073401|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
155450249|NCT01094730|561073400|FG000|Period 2 (14 Days)|Protocol Violation|2|||
155450250|NCT01094730|561073401|FG001|Period 2 (14 Days)|Protocol Violation|0|||
155450251|NCT01094730|561073400|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
155450252|NCT01094730|561073401|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
155450253|NCT01094730|561073400|FG000|Period 2 (14 Days)|Adverse Event|0|||
155450254|NCT01094730|561073401|FG001|Period 2 (14 Days)|Adverse Event|1|||
155450255|NCT01094730|561073400|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
155450256|NCT01094730|561073401|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
155515362|NCT03466411|561311585|FG007|Overall Study|Randomized but not Treated|0|||
155450257|NCT01864018|561073404|FG000|Overall Study|Ineligible|3|||
155450258|NCT01864018|561073405|FG001|Overall Study|Ineligible|1|||
155450259|NCT02512068|561073407|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
155450260|NCT02512068|561073408|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
155450261|NCT02512068|561073407|FG000|Overall Study|Major Protocol Deviation|1|||
155450262|NCT02512068|561073408|FG001|Overall Study|Major Protocol Deviation|0|||
155450263|NCT02512068|561073407|FG000|Overall Study|Voluntary Withdrawal|0|||
155450264|NCT02512068|561073408|FG001|Overall Study|Voluntary Withdrawal|1|||
155450265|NCT02512068|561073407|FG000|Overall Study|Lack of Efficacy|0|||
155450266|NCT02512068|561073408|FG001|Overall Study|Lack of Efficacy|1|||
155450267|NCT02512068|561073407|FG000|Overall Study|Reason Not Specified|3|||
155450268|NCT02512068|561073408|FG001|Overall Study|Reason Not Specified|5|||
155450269|NCT01798706|561073409|FG000|Overall Study|Adverse Event|15|||
155450270|NCT01798706|561073410|FG001|Overall Study|Adverse Event|10|||
155450271|NCT01798706|561073409|FG000|Overall Study|Lack of Efficacy|0|||
155450272|NCT01798706|561073410|FG001|Overall Study|Lack of Efficacy|2|||
155450273|NCT01798706|561073409|FG000|Overall Study|Poor compliance to protocol|1|||
155450274|NCT01798706|561073410|FG001|Overall Study|Poor compliance to protocol|0|||
155450275|NCT01798706|561073409|FG000|Overall Study|Other than specified above|5|||
155450276|NCT01798706|561073410|FG001|Overall Study|Other than specified above|9|||
155450277|NCT05896761|561073411|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
155450278|NCT05896761|561073412|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
155450279|NCT05896761|561073411|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
155450280|NCT05896761|561073412|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
155450281|NCT02739594|561073417|FG000|Overall Study|Undesired Event|3|||
155450282|NCT02739594|561073418|FG001|Overall Study|Undesired Event|4|||
155450283|NCT02739594|561073417|FG000|Overall Study|Violation of Eligibility Criteria|1|||
155450284|NCT02739594|561073418|FG001|Overall Study|Violation of Eligibility Criteria|2|||
155450285|NCT02739594|561073417|FG000|Overall Study|Protocol Violation|5|||
155450286|NCT02739594|561073418|FG001|Overall Study|Protocol Violation|6|||
155450287|NCT02739594|561073417|FG000|Overall Study|Death|4|||
155450288|NCT02739594|561073418|FG001|Overall Study|Death|2|||
155450289|NCT02739594|561073417|FG000|Overall Study|Renal Insufficiency|4|||
155450290|NCT02739594|561073418|FG001|Overall Study|Renal Insufficiency|6|||
155450291|NCT02739594|561073417|FG000|Overall Study|Administrative Reasons|1|||
155450292|NCT02739594|561073418|FG001|Overall Study|Administrative Reasons|3|||
155450293|NCT02739594|561073417|FG000|Overall Study|Withdrawal by Subject|1|||
155450294|NCT02739594|561073418|FG001|Overall Study|Withdrawal by Subject|1|||
155450295|NCT02739594|561073417|FG000|Overall Study|Lost to Follow-up|0|||
155450296|NCT02739594|561073418|FG001|Overall Study|Lost to Follow-up|1|||
155450297|NCT02739594|561073417|FG000|Overall Study|Elevated Serum Creatinine|0|||
155450298|NCT02739594|561073418|FG001|Overall Study|Elevated Serum Creatinine|1|||
155450299|NCT02739594|561073417|FG000|Overall Study|Other|6|||
155450300|NCT02739594|561073418|FG001|Overall Study|Other|2|||
155450301|NCT00527111|561073419|FG000|Overall Study|Adverse Event|14|||
155450302|NCT00527111|561073420|FG001|Overall Study|Adverse Event|13|||
155450303|NCT00527111|561073419|FG000|Overall Study|Death|0|||
155450304|NCT00527111|561073420|FG001|Overall Study|Death|1|||
155450305|NCT00527111|561073419|FG000|Overall Study|Investigator Request|2|||
155450306|NCT00527111|561073420|FG001|Overall Study|Investigator Request|1|||
155450307|NCT00527111|561073419|FG000|Overall Study|Patient Request|2|||
155450308|NCT00527111|561073420|FG001|Overall Study|Patient Request|5|||
155450309|NCT00527111|561073419|FG000|Overall Study|Other|2|||
155450310|NCT00527111|561073420|FG001|Overall Study|Other|2|||
155450311|NCT00952289|561073423|FG000|All Participants|Death|9|||
155450312|NCT00952289|561073424|FG001|All Participants|Death|9|||
155450313|NCT00952289|561073423|FG000|All Participants|Adverse Event|8|||
155450314|NCT00952289|561073424|FG001|All Participants|Adverse Event|8|||
155450315|NCT00952289|561073423|FG000|All Participants|Disease progression|3|||
155450316|NCT00952289|561073424|FG001|All Participants|Disease progression|12|||
155450317|NCT00952289|561073423|FG000|All Participants|Withdrawal by Subject|1|||
155450318|NCT00952289|561073424|FG001|All Participants|Withdrawal by Subject|10|||
155450319|NCT00952289|561073423|FG000|All Participants|Data lost during site relocation|0|||
155450320|NCT00952289|561073424|FG001|All Participants|Data lost during site relocation|1|||
155450321|NCT00952289|561073423|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
155450322|NCT00952289|561073424|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
155450323|NCT00952289|561073423|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
155450324|NCT00952289|561073424|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
155450325|NCT00952289|561073423|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
155450326|NCT00952289|561073424|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
155450327|NCT00952289|561073423|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
155450328|NCT00952289|561073424|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
155450329|NCT00952289|561073423|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
155450330|NCT00952289|561073424|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
155450331|NCT03259334|561073425|FG000|Overall Study|Adverse Event|3|||
155450332|NCT03259334|561073426|FG001|Overall Study|Adverse Event|8|||
155450333|NCT03259334|561073427|FG002|Overall Study|Adverse Event|5|||
155450334|NCT03259334|561073425|FG000|Overall Study|Withdrawal by Subject|4|||
155450335|NCT03259334|561073426|FG001|Overall Study|Withdrawal by Subject|2|||
155450336|NCT03259334|561073427|FG002|Overall Study|Withdrawal by Subject|4|||
155450337|NCT03259334|561073425|FG000|Overall Study|Physician Decision|1|||
155450338|NCT03259334|561073426|FG001|Overall Study|Physician Decision|0|||
155450339|NCT03259334|561073427|FG002|Overall Study|Physician Decision|0|||
155450340|NCT03259334|561073425|FG000|Overall Study|Lost to Follow-up|0|||
155450341|NCT03259334|561073426|FG001|Overall Study|Lost to Follow-up|2|||
155450342|NCT03259334|561073427|FG002|Overall Study|Lost to Follow-up|1|||
155450343|NCT03259334|561073425|FG000|Overall Study|Protocol Deviation|0|||
155450344|NCT03259334|561073426|FG001|Overall Study|Protocol Deviation|3|||
155450345|NCT03259334|561073427|FG002|Overall Study|Protocol Deviation|2|||
155450346|NCT03259334|561073425|FG000|Overall Study|Lack of Efficacy|2|||
155450347|NCT03259334|561073426|FG001|Overall Study|Lack of Efficacy|0|||
155450348|NCT03259334|561073427|FG002|Overall Study|Lack of Efficacy|1|||
155450349|NCT03259334|561073425|FG000|Overall Study|Randomized but never treated|0|||
155450350|NCT03259334|561073426|FG001|Overall Study|Randomized but never treated|2|||
155450351|NCT03259334|561073427|FG002|Overall Study|Randomized but never treated|0|||
155450352|NCT00777491|561073428|FG000|Overall Study|Protocol Violation|0|||
155450353|NCT00777491|561073429|FG001|Overall Study|Protocol Violation|2|||
155450354|NCT00777491|561073428|FG000|Overall Study|Did not receive any protocol treatment|2|||
155450355|NCT00777491|561073429|FG001|Overall Study|Did not receive any protocol treatment|0|||
155450356|NCT01689207|561073430|FG000|Overall Study|Adverse Event|0|||
155450357|NCT01689207|561073431|FG001|Overall Study|Adverse Event|1|||
155450358|NCT01689207|561073432|FG002|Overall Study|Adverse Event|0|||
155450359|NCT01689207|561073433|FG003|Overall Study|Adverse Event|0|||
155450360|NCT01689207|561073434|FG004|Overall Study|Adverse Event|2|||
155450361|NCT01689207|561073435|FG005|Overall Study|Adverse Event|1|||
155450362|NCT01689207|561073436|FG006|Overall Study|Adverse Event|0|||
155450363|NCT01689207|561073437|FG007|Overall Study|Adverse Event|0|||
155450364|NCT01689207|561073438|FG008|Overall Study|Adverse Event|1|||
155450365|NCT01689207|561073439|FG009|Overall Study|Adverse Event|0|||
155450366|NCT01689207|561073440|FG010|Overall Study|Adverse Event|0|||
155450367|NCT01912768|561073441|FG000|Overall Study|Adverse Event|2|||
155450368|NCT01912768|561073442|FG001|Overall Study|Adverse Event|0|||
155450369|NCT01912768|561073441|FG000|Overall Study|Lost to Follow-up|2|||
155450370|NCT01912768|561073442|FG001|Overall Study|Lost to Follow-up|1|||
155450371|NCT01912768|561073441|FG000|Overall Study|Withdrawal by Subject|5|||
155450372|NCT01912768|561073442|FG001|Overall Study|Withdrawal by Subject|3|||
155450373|NCT01912768|561073441|FG000|Overall Study|Randomized in error|1|||
155450374|NCT01912768|561073442|FG001|Overall Study|Randomized in error|0|||
155450375|NCT00524316|561073443|FG000|Overall Study|Withdrawal by Subject|2|||
155450376|NCT00524316|561073443|FG000|Overall Study|Adverse Event|7|||
155450377|NCT00524316|561073443|FG000|Overall Study|Disease Progression|7|||
155450378|NCT01199263|561073444|FG000|Overall Study|Ineligible|0|||
155651606|NCT01903733|561816265|FG001|Overall Study|Lost to Follow-up|19|||
155450379|NCT01199263|561073445|FG001|Overall Study|Ineligible|2|||
155450380|NCT01199263|561073444|FG000|Overall Study|Never Treated|6|||
155450381|NCT01199263|561073445|FG001|Overall Study|Never Treated|0|||
155450382|NCT00488033|561073446|FG000|Overall Study|Withdrawal by Subject|1|||
155450383|NCT00488033|561073447|FG001|Overall Study|Withdrawal by Subject|0|||
155450384|NCT00444626|561073454|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
155450385|NCT00444626|561073454|FG000|Initial Treatment Period|Adverse Event|1|||
155450386|NCT00444626|561073454|FG000|Initial Treatment Period|Lost to Follow-up|9|||
155450387|NCT00008138|561073455|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
155450388|NCT00008138|561073455|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
155450389|NCT00008138|561073455|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
155450390|NCT00008138|561073455|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
155450391|NCT00008138|561073455|FG000|Interval Debulking|Withdrawal by Subject|2|||
155450392|NCT00008138|561073455|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
155450393|NCT00008138|561073455|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
155450394|NCT00008138|561073455|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
155450395|NCT01694420|561075527|FG000|Overall Study|Lost to Follow-up|3|||
155450396|NCT00762372|561075528|FG000|Overall Study|Adverse Event|1|||
155450397|NCT00762372|561075529|FG001|Overall Study|Adverse Event|0|||
155450398|NCT00762372|561075530|FG002|Overall Study|Adverse Event|0|||
155450399|NCT02494778|561075531|FG000|Overall Study|Death|3|||
155450400|NCT02494778|561075531|FG000|Overall Study|Other|173|||
155450401|NCT02494778|561075531|FG000|Overall Study|Lack of Efficacy|4|||
155450402|NCT02494778|561075531|FG000|Overall Study|Adverse Event|18|||
155450403|NCT02494778|561075531|FG000|Overall Study|Withdrawal by Subject|20|||
155450404|NCT02494778|561075531|FG000|Overall Study|Lost to Follow-up|2|||
155450405|NCT02494778|561075531|FG000|Overall Study|Noncompliant with study drug admin.|1|||
155450406|NCT01303380|561075532|FG000|Overall Study|Lack of compliance to study procedures|1|||
155450407|NCT00967226|561075533|FG000|Overall Study|Adverse Event|0|||
155450408|NCT00967226|561075534|FG001|Overall Study|Adverse Event|5|||
155450409|NCT00967226|561075533|FG000|Overall Study|Protocol Violation|2|||
155450410|NCT00967226|561075534|FG001|Overall Study|Protocol Violation|0|||
155450411|NCT00967226|561075533|FG000|Overall Study|Physician Decision|0|||
155450412|NCT00967226|561075534|FG001|Overall Study|Physician Decision|1|||
155450413|NCT02174861|561075535|FG000|Overall Study|Decision by sponsor|8|||
155450414|NCT02174861|561075535|FG000|Overall Study|Withdrawal by Subject|124|||
155450415|NCT02174861|561075535|FG000|Overall Study|Lost to Follow-up|26|||
155450416|NCT01716533|561075536|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
155450417|NCT01716533|561075537|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
155450418|NCT01716533|561075538|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
155450419|NCT01716533|561075539|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
155450420|NCT01716533|561075536|FG000|Overall Study|Withdrawal by Subject|0|||
155450421|NCT01716533|561075537|FG001|Overall Study|Withdrawal by Subject|0|||
155450422|NCT01716533|561075538|FG002|Overall Study|Withdrawal by Subject|0|||
155450423|NCT01716533|561075539|FG003|Overall Study|Withdrawal by Subject|5|||
155450424|NCT01716533|561075536|FG000|Overall Study|Death|0|||
155450425|NCT01716533|561075537|FG001|Overall Study|Death|0|||
155450426|NCT01716533|561075538|FG002|Overall Study|Death|0|||
155450427|NCT01716533|561075539|FG003|Overall Study|Death|2|||
155450428|NCT01716533|561075536|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
155450429|NCT01716533|561075537|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
155450430|NCT01716533|561075538|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
155450431|NCT01716533|561075539|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
155450432|NCT01670656|561075546|FG000|Overall Study|Non-compliance with study drug|0|||
155450433|NCT01670656|561075547|FG001|Overall Study|Non-compliance with study drug|0|||
155450434|NCT01670656|561075548|FG002|Overall Study|Non-compliance with study drug|3|||
155450435|NCT01670656|561075549|FG003|Overall Study|Non-compliance with study drug|0|||
155450436|NCT01670656|561075550|FG004|Overall Study|Non-compliance with study drug|1|||
155450437|NCT01670656|561075546|FG000|Overall Study|Pregnancy|0|||
155450438|NCT01670656|561075547|FG001|Overall Study|Pregnancy|0|||
155450439|NCT01670656|561075548|FG002|Overall Study|Pregnancy|0|||
155515363|NCT03466411|561311586|FG008|Overall Study|Randomized but not Treated|0|||
155515364|NCT03466411|561311587|FG009|Overall Study|Randomized but not Treated|0|||
155515365|NCT03466411|561311588|FG010|Overall Study|Randomized but not Treated|0|||
155515366|NCT03466411|561311589|FG011|Overall Study|Randomized but not Treated|0|||
155651607|NCT01903733|561816266|FG002|Overall Study|Lost to Follow-up|6|||
155450440|NCT01670656|561075549|FG003|Overall Study|Pregnancy|0|||
155651608|NCT01903733|561816267|FG003|Overall Study|Lost to Follow-up|9|||
155450441|NCT01670656|561075550|FG004|Overall Study|Pregnancy|1|||
155450442|NCT01670656|561075546|FG000|Overall Study|Withdrawal by Subject|1|||
155450443|NCT01670656|561075547|FG001|Overall Study|Withdrawal by Subject|1|||
155450444|NCT01670656|561075548|FG002|Overall Study|Withdrawal by Subject|0|||
155450445|NCT01670656|561075549|FG003|Overall Study|Withdrawal by Subject|0|||
155450446|NCT01670656|561075550|FG004|Overall Study|Withdrawal by Subject|0|||
155450447|NCT01670656|561075546|FG000|Overall Study|Non-compliance with protocol|0|||
155450448|NCT01670656|561075547|FG001|Overall Study|Non-compliance with protocol|3|||
155450449|NCT01670656|561075548|FG002|Overall Study|Non-compliance with protocol|1|||
155450450|NCT01670656|561075549|FG003|Overall Study|Non-compliance with protocol|1|||
155450451|NCT01670656|561075550|FG004|Overall Study|Non-compliance with protocol|2|||
155450452|NCT01670656|561075546|FG000|Overall Study|Adverse Event|2|||
155450453|NCT01670656|561075547|FG001|Overall Study|Adverse Event|2|||
155450454|NCT01670656|561075548|FG002|Overall Study|Adverse Event|2|||
155450455|NCT01670656|561075549|FG003|Overall Study|Adverse Event|3|||
155450456|NCT01670656|561075550|FG004|Overall Study|Adverse Event|3|||
155450457|NCT01670656|561075546|FG000|Overall Study|Subject withdrew consent|0|||
155450458|NCT01670656|561075547|FG001|Overall Study|Subject withdrew consent|1|||
155450459|NCT01670656|561075548|FG002|Overall Study|Subject withdrew consent|2|||
155450460|NCT01670656|561075549|FG003|Overall Study|Subject withdrew consent|1|||
155450461|NCT01670656|561075550|FG004|Overall Study|Subject withdrew consent|1|||
155450462|NCT01670656|561075546|FG000|Overall Study|Lost to Follow-up|0|||
155450463|NCT01670656|561075547|FG001|Overall Study|Lost to Follow-up|0|||
155450464|NCT01670656|561075548|FG002|Overall Study|Lost to Follow-up|0|||
155450465|NCT01670656|561075549|FG003|Overall Study|Lost to Follow-up|0|||
155450466|NCT01670656|561075550|FG004|Overall Study|Lost to Follow-up|3|||
155450467|NCT01670656|561075546|FG000|Overall Study|Subject moved|0|||
155450468|NCT01670656|561075547|FG001|Overall Study|Subject moved|0|||
155450469|NCT01670656|561075548|FG002|Overall Study|Subject moved|0|||
155450470|NCT01670656|561075549|FG003|Overall Study|Subject moved|1|||
155450471|NCT01670656|561075550|FG004|Overall Study|Subject moved|0|||
155450472|NCT00789958|561075551|FG000|Overall Study|Adverse Event|3|||
155450473|NCT00789958|561075551|FG000|Overall Study|Withdrawal by Subject|4|||
155450474|NCT00789958|561075551|FG000|Overall Study|Progression|3|||
155450475|NCT00789958|561075551|FG000|Overall Study|not protocol specified|1|||
155450476|NCT00789958|561075551|FG000|Overall Study|Not eligible/not analyzable|26|||
155450477|NCT02622724|561075552|FG000|Overall Study|Death|51|||
155450478|NCT02622724|561075553|FG001|Overall Study|Death|53|||
155450479|NCT02622724|561075552|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
155450480|NCT02622724|561075553|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
155450481|NCT02622724|561075552|FG000|Overall Study|Early termination of study|38|||
155450482|NCT02622724|561075553|FG001|Overall Study|Early termination of study|43|||
155450483|NCT00487084|561075554|FG000|Overall Study|Did not receive intervention|4|||
155450484|NCT00487084|561075555|FG001|Overall Study|Did not receive intervention|3|||
155450485|NCT00487084|561075556|FG002|Overall Study|Did not receive intervention|5|||
155450486|NCT00254293|561075557|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
155450487|NCT00254293|561075558|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
155450488|NCT00254293|561075559|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
155450489|NCT00254293|561075560|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
155450490|NCT00254293|561075561|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
155450491|NCT00254293|561075562|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
155450492|NCT00254293|561075563|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
155450493|NCT00254293|561075557|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450494|NCT00254293|561075558|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450495|NCT00254293|561075559|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
155450496|NCT00254293|561075560|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450497|NCT00254293|561075561|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450498|NCT00254293|561075562|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450499|NCT00254293|561075563|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
155450500|NCT00254293|561075557|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450501|NCT00254293|561075558|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450502|NCT00254293|561075559|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
155450503|NCT00254293|561075560|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450504|NCT00254293|561075561|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450505|NCT00254293|561075562|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450506|NCT00254293|561075563|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
155450507|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Death|0|||
155450508|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Death|0|||
155450509|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Death|1|||
155450510|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Death|0|||
155450511|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Death|0|||
155450512|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Death|0|||
155450513|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Death|0|||
155651609|NCT01903733|561816264|FG000|Overall Study|Other|10|||
155450514|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
155450515|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
155450516|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
155450517|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
155450518|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
155450519|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
155450520|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
155450521|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
155450522|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
155450523|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
155450524|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
155450525|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
155450526|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
155450527|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
155450528|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450529|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450530|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
155450531|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450532|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450533|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450534|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
155450535|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450536|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450537|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
155450538|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450539|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450540|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450541|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
155450542|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450543|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450544|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
155450545|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450546|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450547|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450548|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155450549|NCT00254293|561075557|FG000|LTE Open Label Variable SC Dosing|Other|0|||
155450550|NCT00254293|561075558|FG001|LTE Open Label Variable SC Dosing|Other|0|||
155450551|NCT00254293|561075559|FG002|LTE Open Label Variable SC Dosing|Other|2|||
155450552|NCT00254293|561075560|FG003|LTE Open Label Variable SC Dosing|Other|0|||
155450553|NCT00254293|561075561|FG004|LTE Open Label Variable SC Dosing|Other|0|||
155450554|NCT00254293|561075562|FG005|LTE Open Label Variable SC Dosing|Other|0|||
155450555|NCT00254293|561075563|FG006|LTE Open Label Variable SC Dosing|Other|0|||
155450556|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Death|0|||
155450557|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Death|0|||
155450558|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Death|0|||
155450559|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Death|0|||
155450560|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Death|0|||
155450561|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Death|0|||
155450562|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Death|3|||
155450563|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
155515367|NCT03466411|561311590|FG012|Overall Study|Randomized but not Treated|0|||
155515368|NCT03462719|561311591|FG000|Overall Study|Withdrawal by Subject|4|||
155515369|NCT03462719|561311592|FG001|Overall Study|Withdrawal by Subject|3|||
155515370|NCT03462719|561311591|FG000|Overall Study|Ongoing|87|||
155515371|NCT03462719|561311592|FG001|Overall Study|Ongoing|72|||
155515372|NCT02829918|561311593|FG000|Overall Study|Death|2|||
155515373|NCT02829918|561311593|FG000|Overall Study|Withdrawal by Subject|4|||
155515374|NCT02829918|561311593|FG000|Overall Study|Adverse Event|1|||
155515375|NCT02829918|561311593|FG000|Overall Study|Progression|1|||
155515376|NCT02257736|561311594|FG000|Overall Study|Progressive disease|365|||
155515377|NCT02257736|561311595|FG001|Overall Study|Progressive disease|327|||
155651610|NCT01903733|561816265|FG001|Overall Study|Other|15|||
155450564|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
155450565|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
155450566|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
155450567|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
155450568|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
155515378|NCT02257736|561311594|FG000|Overall Study|Adverse Event|45|||
155515379|NCT02257736|561311595|FG001|Overall Study|Adverse Event|56|||
155515380|NCT02257736|561311594|FG000|Overall Study|Withdrawal by Subject|21|||
155515381|NCT02257736|561311595|FG001|Overall Study|Withdrawal by Subject|38|||
155450569|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
155450570|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450571|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450572|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450573|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450574|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450575|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
155450576|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
155450577|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450578|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450579|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450580|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450581|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450582|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
155450583|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
155450584|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450585|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450586|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450587|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450588|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450589|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
155450590|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
155450591|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450592|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450593|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450594|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450595|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450596|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
155450597|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
155450598|NCT00254293|561075557|FG000|LTE Open Label Fixed Dosing|Other|0|||
155450599|NCT00254293|561075558|FG001|LTE Open Label Fixed Dosing|Other|0|||
155450600|NCT00254293|561075559|FG002|LTE Open Label Fixed Dosing|Other|0|||
155450601|NCT00254293|561075560|FG003|LTE Open Label Fixed Dosing|Other|0|||
155450602|NCT00254293|561075561|FG004|LTE Open Label Fixed Dosing|Other|0|||
155450603|NCT00254293|561075562|FG005|LTE Open Label Fixed Dosing|Other|0|||
155450604|NCT00254293|561075563|FG006|LTE Open Label Fixed Dosing|Other|1|||
155450605|NCT01575197|561075564|FG000|Overall Study|Migration out of study area|1|||
155450606|NCT01575197|561075565|FG001|Overall Study|Migration out of study area|5|||
155450607|NCT01575197|561075566|FG002|Overall Study|Migration out of study area|4|||
155450608|NCT01575197|561075564|FG000|Overall Study|SAE|0|||
155450609|NCT01575197|561075565|FG001|Overall Study|SAE|1|||
155450610|NCT01575197|561075566|FG002|Overall Study|SAE|0|||
155450611|NCT01575197|561075564|FG000|Overall Study|Lost to Follow-up|0|||
155450612|NCT01575197|561075565|FG001|Overall Study|Lost to Follow-up|1|||
155450613|NCT01575197|561075566|FG002|Overall Study|Lost to Follow-up|0|||
155450614|NCT01575197|561075564|FG000|Overall Study|Withdrawal by Subject|0|||
155450615|NCT01575197|561075565|FG001|Overall Study|Withdrawal by Subject|1|||
155450616|NCT01575197|561075566|FG002|Overall Study|Withdrawal by Subject|1|||
155450617|NCT01575197|561075564|FG000|Overall Study|Protocol Violation|2|||
155450618|NCT01575197|561075565|FG001|Overall Study|Protocol Violation|1|||
155450619|NCT01575197|561075566|FG002|Overall Study|Protocol Violation|1|||
155450620|NCT02709083|561075567|FG000|Overall Study|Original PI left institution|7|||
155450621|NCT00111475|561075568|FG000|Overall Study|Lost to Follow-up|0|||
155450622|NCT00111475|561075569|FG001|Overall Study|Lost to Follow-up|0|||
155450623|NCT00111475|561075570|FG002|Overall Study|Lost to Follow-up|0|||
155450624|NCT00111475|561075571|FG003|Overall Study|Lost to Follow-up|0|||
155450625|NCT00111475|561075572|FG004|Overall Study|Lost to Follow-up|0|||
155450626|NCT00111475|561075573|FG005|Overall Study|Lost to Follow-up|1|||
155450627|NCT00111475|561075574|FG006|Overall Study|Lost to Follow-up|0|||
155450628|NCT00111475|561075575|FG007|Overall Study|Lost to Follow-up|0|||
155450629|NCT00111475|561075576|FG008|Overall Study|Lost to Follow-up|0|||
155450630|NCT00111475|561075577|FG009|Overall Study|Lost to Follow-up|0|||
155450631|NCT03303092|561075578|FG000|Overall Study|Adverse Event|1|||
155450632|NCT03303092|561075579|FG001|Overall Study|Adverse Event|0|||
155450633|NCT03303092|561075580|FG002|Overall Study|Adverse Event|1|||
155450634|NCT03303092|561075578|FG000|Overall Study|Protocol Violation|1|||
155450635|NCT03303092|561075579|FG001|Overall Study|Protocol Violation|5|||
155450636|NCT03303092|561075580|FG002|Overall Study|Protocol Violation|1|||
155450637|NCT03303092|561075578|FG000|Overall Study|Withdrawal by Subject|1|||
155450638|NCT03303092|561075579|FG001|Overall Study|Withdrawal by Subject|1|||
155450639|NCT03303092|561075580|FG002|Overall Study|Withdrawal by Subject|3|||
155450640|NCT01995136|561075586|FG000|Overall Study|Change in residence|1|||
155450641|NCT01626352|561075590|FG000|Overall Study|Disease Progression|3|||
155450642|NCT01626352|561075590|FG000|Overall Study|Intercurrent Illness|2|||
155450643|NCT01626352|561075590|FG000|Overall Study|Death|2|||
155450644|NCT01626352|561075590|FG000|Overall Study|Withdrawal by Subject|1|||
155450645|NCT01626352|561075590|FG000|Overall Study|Non-Compliance|1|||
155450646|NCT01626352|561075590|FG000|Overall Study|Never Treated|1|||
155450647|NCT02681055|561075591|FG000|Weeks 5-12|Adverse Event|1|||
155450648|NCT03446651|561075596|FG000|Overall Study|Lost to Follow-up|4|||
155450649|NCT03446651|561075597|FG001|Overall Study|Lost to Follow-up|0|||
155450650|NCT03446651|561075596|FG000|Overall Study|Open Label Participants|5|||
155450651|NCT03446651|561075597|FG001|Overall Study|Open Label Participants|0|||
155450652|NCT00343291|561075598|FG000|Overall Study|Adverse Event|13|||
155450653|NCT00343291|561075599|FG001|Overall Study|Adverse Event|13|||
155450654|NCT00343291|561075598|FG000|Overall Study|Death|3|||
155450655|NCT00343291|561075599|FG001|Overall Study|Death|2|||
155450656|NCT00343291|561075598|FG000|Overall Study|Progressive disease|33|||
155450657|NCT00343291|561075599|FG001|Overall Study|Progressive disease|34|||
155450658|NCT00343291|561075598|FG000|Overall Study|Withdrawal by Subject|0|||
155450659|NCT00343291|561075599|FG001|Overall Study|Withdrawal by Subject|2|||
155450660|NCT00343291|561075598|FG000|Overall Study|Other|8|||
155450661|NCT00343291|561075599|FG001|Overall Study|Other|5|||
155450662|NCT00882999|561075604|FG000|Overall Study|Adverse Event|0|||
155450663|NCT00882999|561075605|FG001|Overall Study|Adverse Event|0|||
155450664|NCT00882999|561075606|FG002|Overall Study|Adverse Event|0|||
155450665|NCT00882999|561075607|FG003|Overall Study|Adverse Event|0|||
155450666|NCT00882999|561075608|FG004|Overall Study|Adverse Event|1|||
155450667|NCT00882999|561075609|FG005|Overall Study|Adverse Event|0|||
155450668|NCT00882999|561075610|FG006|Overall Study|Adverse Event|0|||
155450669|NCT00882999|561075604|FG000|Overall Study|Death|0|||
155450670|NCT00882999|561075605|FG001|Overall Study|Death|1|||
155450671|NCT00882999|561075606|FG002|Overall Study|Death|0|||
155450672|NCT00882999|561075607|FG003|Overall Study|Death|0|||
155450673|NCT00882999|561075608|FG004|Overall Study|Death|0|||
155450674|NCT00882999|561075609|FG005|Overall Study|Death|0|||
155450675|NCT00882999|561075610|FG006|Overall Study|Death|0|||
155450676|NCT00882999|561075604|FG000|Overall Study|Withdrawal by Subject|7|||
155450677|NCT00882999|561075605|FG001|Overall Study|Withdrawal by Subject|6|||
155450678|NCT00882999|561075606|FG002|Overall Study|Withdrawal by Subject|3|||
155450679|NCT00882999|561075607|FG003|Overall Study|Withdrawal by Subject|3|||
155450680|NCT00882999|561075608|FG004|Overall Study|Withdrawal by Subject|6|||
155450681|NCT00882999|561075609|FG005|Overall Study|Withdrawal by Subject|5|||
155450682|NCT00882999|561075610|FG006|Overall Study|Withdrawal by Subject|5|||
155450683|NCT00882999|561075604|FG000|Overall Study|Lost to Follow-up|0|||
155450684|NCT00882999|561075605|FG001|Overall Study|Lost to Follow-up|1|||
155450685|NCT00882999|561075606|FG002|Overall Study|Lost to Follow-up|1|||
155450686|NCT00882999|561075607|FG003|Overall Study|Lost to Follow-up|2|||
155450687|NCT00882999|561075608|FG004|Overall Study|Lost to Follow-up|1|||
155450688|NCT00882999|561075609|FG005|Overall Study|Lost to Follow-up|1|||
155450689|NCT00882999|561075610|FG006|Overall Study|Lost to Follow-up|2|||
155450690|NCT00882999|561075604|FG000|Overall Study|Physician Decision|1|||
155450691|NCT00882999|561075605|FG001|Overall Study|Physician Decision|0|||
155450692|NCT00882999|561075606|FG002|Overall Study|Physician Decision|0|||
155450693|NCT00882999|561075607|FG003|Overall Study|Physician Decision|0|||
155450694|NCT00882999|561075608|FG004|Overall Study|Physician Decision|0|||
155450695|NCT00882999|561075609|FG005|Overall Study|Physician Decision|1|||
155450696|NCT00882999|561075610|FG006|Overall Study|Physician Decision|1|||
155450697|NCT01757405|561075613|FG000|Overall Study|Lost to Follow-up|1|||
155450698|NCT01757405|561075614|FG001|Overall Study|Lost to Follow-up|1|||
155450699|NCT01757405|561075613|FG000|Overall Study|Withdrawal by Subject|0|||
155450700|NCT01757405|561075614|FG001|Overall Study|Withdrawal by Subject|1|||
155450701|NCT00082758|561075615|FG000|Overall Study|Adverse Event|0|||
155450702|NCT00082758|561075616|FG001|Overall Study|Adverse Event|2|||
155450703|NCT00082758|561075617|FG002|Overall Study|Adverse Event|0|||
155450704|NCT00082758|561075615|FG000|Overall Study|Lack of Efficacy|12|||
155515382|NCT02257736|561311594|FG000|Overall Study|Death|11|||
155515383|NCT02257736|561311595|FG001|Overall Study|Death|6|||
155450705|NCT00082758|561075616|FG001|Overall Study|Lack of Efficacy|13|||
155450706|NCT00082758|561075617|FG002|Overall Study|Lack of Efficacy|0|||
155450707|NCT00082758|561075615|FG000|Overall Study|Physician Decision|0|||
155450708|NCT00082758|561075616|FG001|Overall Study|Physician Decision|1|||
155450709|NCT00082758|561075617|FG002|Overall Study|Physician Decision|0|||
155450710|NCT00082758|561075615|FG000|Overall Study|Withdrawal by Subject|3|||
155450711|NCT00082758|561075616|FG001|Overall Study|Withdrawal by Subject|0|||
155450712|NCT00082758|561075617|FG002|Overall Study|Withdrawal by Subject|0|||
155450713|NCT00082758|561075615|FG000|Overall Study|Protocol Violation|0|||
155450714|NCT00082758|561075616|FG001|Overall Study|Protocol Violation|1|||
155450715|NCT00082758|561075617|FG002|Overall Study|Protocol Violation|0|||
155450716|NCT00238303|561075618|FG000|Overall Study|Withdrawal by Subject|11|||
155450717|NCT00238303|561075619|FG001|Overall Study|Withdrawal by Subject|1|||
155450718|NCT00238303|561075620|FG002|Overall Study|Withdrawal by Subject|2|||
155450719|NCT00238303|561075618|FG000|Overall Study|Death|1|||
155450720|NCT00238303|561075619|FG001|Overall Study|Death|0|||
155450721|NCT00238303|561075620|FG002|Overall Study|Death|1|||
155450722|NCT00238303|561075618|FG000|Overall Study|Other Medical Problems|2|||
155450723|NCT00238303|561075619|FG001|Overall Study|Other Medical Problems|0|||
155450724|NCT00238303|561075620|FG002|Overall Study|Other Medical Problems|2|||
155450725|NCT00238303|561075618|FG000|Overall Study|Poor tolerance of study treatment|1|||
155450726|NCT00238303|561075619|FG001|Overall Study|Poor tolerance of study treatment|0|||
155450727|NCT00238303|561075620|FG002|Overall Study|Poor tolerance of study treatment|1|||
155450728|NCT00238303|561075618|FG000|Overall Study|Adverse Event|0|||
155450729|NCT00238303|561075619|FG001|Overall Study|Adverse Event|1|||
155450730|NCT00238303|561075620|FG002|Overall Study|Adverse Event|3|||
155450731|NCT00937560|561075622|FG000|Initial Treatment|Death|6|||
155450732|NCT00937560|561075622|FG000|Initial Treatment|Withdraw consent|3|||
155450733|NCT00937560|561075622|FG000|Initial Treatment|Adverse Event|1|||
155450734|NCT00937560|561075622|FG000|Initial Treatment|Lost to Follow-up|1|||
155450735|NCT00937560|561075622|FG000|Initial Treatment|No end of study page|10|||
155450736|NCT00937560|561075622|FG000|Maintenance Treatment|Death|12|||
155450737|NCT00937560|561075622|FG000|Maintenance Treatment|Withdraw consent|5|||
155450738|NCT00937560|561075622|FG000|Maintenance Treatment|According to protocol|1|||
155450739|NCT05906732|561075623|FG000|Overall Study|Withdrawal by Subject|1|||
155450740|NCT05906732|561075624|FG001|Overall Study|Withdrawal by Subject|0|||
155450741|NCT05906732|561075625|FG002|Overall Study|Withdrawal by Subject|0|||
155450742|NCT05906732|561075626|FG003|Overall Study|Withdrawal by Subject|0|||
155450743|NCT05906732|561075623|FG000|Overall Study|Physician Decision|2|||
155450744|NCT05906732|561075624|FG001|Overall Study|Physician Decision|4|||
155450745|NCT05906732|561075625|FG002|Overall Study|Physician Decision|0|||
155450746|NCT05906732|561075626|FG003|Overall Study|Physician Decision|0|||
155450747|NCT01248130|561075627|FG000|Overall Study|Protocol Violation|1|||
155450748|NCT01248130|561075628|FG001|Overall Study|Protocol Violation|0|||
155450749|NCT01248130|561075627|FG000|Overall Study|Ineligible|1|||
155450750|NCT01248130|561075628|FG001|Overall Study|Ineligible|0|||
155450751|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
155450752|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
155450753|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
155450754|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
155450755|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
155450756|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
155450757|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450758|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
155450759|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
155450760|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
155450761|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
155450762|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
155450763|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
155450764|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
155450765|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450766|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450767|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450768|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450769|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450770|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450771|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450772|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450773|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
155450774|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
155450775|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
155450776|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
155450777|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
155450778|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
155450779|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
155450780|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
155450781|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
155450782|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
155450783|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450784|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450785|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
155515384|NCT02257736|561311594|FG000|Overall Study|Physician Decision|5|||
155450786|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
155450787|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
155450788|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450789|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450790|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450791|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450792|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450793|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450794|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450795|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450796|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155450797|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450798|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450799|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450800|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450801|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450802|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450803|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450804|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450805|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450806|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450807|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450808|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450809|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450810|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
155450811|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450812|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450813|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450814|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450815|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450816|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450817|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450818|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450819|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
155450820|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
155450821|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
155450822|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
155450823|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
155450824|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
155450825|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
155450826|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
155450827|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
155450828|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
155450829|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
155450830|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
155450831|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
155450832|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
155450833|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
155450834|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
155450835|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
155450836|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
155450837|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
155450838|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
155450839|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
155450840|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
155450841|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
155450842|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
155450843|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450844|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450845|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450846|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450847|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450848|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450849|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450850|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450851|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
155450852|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450853|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450854|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450855|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450856|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
155450857|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450858|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450859|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450860|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450861|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450862|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450863|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450864|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450865|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
155450866|NCT02052778|561075629|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450867|NCT02052778|561075630|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450868|NCT02052778|561075631|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450869|NCT02052778|561075632|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450870|NCT02052778|561075633|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450871|NCT02052778|561075634|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
155450872|NCT02052778|561075635|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450873|NCT02052778|561075636|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450874|NCT02052778|561075637|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450875|NCT02052778|561075638|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450876|NCT02052778|561075639|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450877|NCT02052778|561075640|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450878|NCT02052778|561075641|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
155450879|NCT02052778|561075642|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450880|NCT02052778|561075643|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450881|NCT02052778|561075644|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450882|NCT02052778|561075645|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450883|NCT02052778|561075646|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450884|NCT02052778|561075647|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450885|NCT02052778|561075648|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450886|NCT02052778|561075649|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450887|NCT02052778|561075650|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450888|NCT02052778|561075651|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
155450889|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450890|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450891|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450892|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450893|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450894|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450895|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450896|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450897|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450898|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450899|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450900|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450901|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450902|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450903|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
155515385|NCT02257736|561311595|FG001|Overall Study|Physician Decision|9|||
155450904|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
155450905|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
155450906|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
155450907|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
155450908|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
155450909|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
155450910|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
155450911|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
155450912|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450913|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450914|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450915|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450916|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450917|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450918|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450919|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450920|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450921|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450922|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450923|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450924|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450925|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450926|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
155450927|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
155450928|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450929|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
155450930|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
155450931|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
155450932|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
155450933|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
155450934|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
155450935|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450936|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450937|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450938|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450939|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450940|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450941|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450942|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450943|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450944|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450945|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450946|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450947|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450948|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450949|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
155450950|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
155450951|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
155450952|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450953|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
155450954|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
155450955|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450956|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450957|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
155450958|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450959|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450960|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450961|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155515386|NCT02257736|561311594|FG000|Overall Study|Non-Compliance with study drug|1|||
155651611|NCT01903733|561816266|FG002|Overall Study|Other|12|||
155651612|NCT01903733|561816267|FG003|Overall Study|Other|3|||
155651613|NCT01903733|561816264|FG000|Overall Study|Missing|2|||
155651614|NCT01903733|561816265|FG001|Overall Study|Missing|0|||
155450962|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450963|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450964|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450965|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450966|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450967|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450968|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450969|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450970|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450971|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155515387|NCT02257736|561311595|FG001|Overall Study|Non-Compliance with study drug|2|||
155515388|NCT02257736|561311594|FG000|Overall Study|Protocol Violation|1|||
155515389|NCT02257736|561311595|FG001|Overall Study|Protocol Violation|0|||
155515390|NCT02257736|561311594|FG000|Overall Study|Other|1|||
155515391|NCT02257736|561311595|FG001|Overall Study|Other|7|||
155515392|NCT02257736|561311594|FG000|Overall Study|Randomized, not treated|1|||
155515393|NCT02257736|561311595|FG001|Overall Study|Randomized, not treated|2|||
155515394|NCT05514119|561312100|FG000|Overall Study|Ineligible due to disease progression|1|||
155515395|NCT02396381|561312101|FG000|Overall Study|Adverse Event|3|||
155515396|NCT02396381|561312102|FG001|Overall Study|Adverse Event|2|||
155515397|NCT02396381|561312101|FG000|Overall Study|Withdrawal by Subject|33|||
155515398|NCT02396381|561312102|FG001|Overall Study|Withdrawal by Subject|24|||
155515399|NCT02396381|561312101|FG000|Overall Study|Lost to Follow-up|49|||
155515400|NCT02396381|561312102|FG001|Overall Study|Lost to Follow-up|31|||
155515401|NCT02396381|561312101|FG000|Overall Study|Protocol Violation|1|||
155515402|NCT02396381|561312102|FG001|Overall Study|Protocol Violation|0|||
155515403|NCT02396381|561312101|FG000|Overall Study|Site terminated by sponsor|7|||
155515404|NCT02396381|561312102|FG001|Overall Study|Site terminated by sponsor|8|||
155515405|NCT02396381|561312101|FG000|Overall Study|Physician Decision|5|||
155515406|NCT02396381|561312102|FG001|Overall Study|Physician Decision|5|||
155515407|NCT02396381|561312101|FG000|Overall Study|Pregnancy|2|||
155515408|NCT02396381|561312102|FG001|Overall Study|Pregnancy|0|||
155515409|NCT02396381|561312101|FG000|Overall Study|Non-compliance with study procedures|1|||
155515410|NCT02396381|561312102|FG001|Overall Study|Non-compliance with study procedures|0|||
155515411|NCT02396381|561312101|FG000|Overall Study|Moved out of town/state|1|||
155515412|NCT02396381|561312102|FG001|Overall Study|Moved out of town/state|3|||
155515413|NCT02396381|561312101|FG000|Overall Study|Could not complete visit|1|||
155515414|NCT02396381|561312102|FG001|Overall Study|Could not complete visit|0|||
155515415|NCT02396381|561312101|FG000|Overall Study|Possible conflict of interest|1|||
155515416|NCT02396381|561312102|FG001|Overall Study|Possible conflict of interest|0|||
155515417|NCT02396381|561312101|FG000|Overall Study|Randomization/Screening Error|3|||
155515418|NCT02396381|561312102|FG001|Overall Study|Randomization/Screening Error|1|||
155515419|NCT03500484|561312103|FG000|Overall Study|Adverse Event|2|||
155515420|NCT03500484|561312104|FG001|Overall Study|Adverse Event|0|||
155515421|NCT03500484|561312103|FG000|Overall Study|Physician Decision|1|||
155515422|NCT03500484|561312104|FG001|Overall Study|Physician Decision|0|||
155515423|NCT03500484|561312103|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
155515424|NCT03500484|561312104|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
155515425|NCT00948675|561312105|FG000|Overall Study|Lost to Follow-up|1|||
155515426|NCT00948675|561312106|FG001|Overall Study|Lost to Follow-up|0|||
155515427|NCT01654380|561312110|FG000|Part B, Period 1|Physician Decision|0|||
155515428|NCT01654380|561312111|FG001|Part B, Period 1|Physician Decision|0|||
155515429|NCT01654380|561312112|FG002|Part B, Period 1|Physician Decision|1|||
155515430|NCT01654380|561312113|FG003|Part B, Period 1|Physician Decision|0|||
155515431|NCT04471428|561312119|FG000|Overall Study|Withdrawal by Subject|29|||
155515432|NCT04471428|561312120|FG001|Overall Study|Withdrawal by Subject|4|||
155515433|NCT04471428|561312119|FG000|Overall Study|Physician Decision|0|||
155515434|NCT04471428|561312120|FG001|Overall Study|Physician Decision|1|||
155515435|NCT04471428|561312119|FG000|Overall Study|Reason Not Specified|0|||
155515436|NCT04471428|561312120|FG001|Overall Study|Reason Not Specified|2|||
155515437|NCT04471428|561312119|FG000|Overall Study|Death|131|||
155515438|NCT04471428|561312120|FG001|Overall Study|Death|147|||
155515439|NCT04471428|561312119|FG000|Overall Study|Lost to Follow-up|0|||
155515440|NCT04471428|561312120|FG001|Overall Study|Lost to Follow-up|3|||
155515441|NCT04471428|561312119|FG000|Overall Study|Study Terminated by Sponsor|20|||
155515442|NCT04471428|561312120|FG001|Overall Study|Study Terminated by Sponsor|29|||
155515443|NCT03290079|561312121|FG000|Overall Study|Death|2|||
155515444|NCT03390504|561312122|FG000|Overall Study|Lost to Follow-up|2|||
155515445|NCT03390504|561312123|FG001|Overall Study|Lost to Follow-up|4|||
155450972|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
155450973|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
155450974|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450975|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450976|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450977|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450978|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450979|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450980|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
155450981|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450982|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450983|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450984|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450985|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450986|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450987|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450988|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450989|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450990|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450991|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450992|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450993|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450994|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450995|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
155450996|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
155450997|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450998|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155450999|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155451000|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
155451001|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155451002|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155451003|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155451004|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
155451005|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
155451006|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
155451007|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
155451008|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
155451009|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
155451010|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
155451011|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
155451012|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
155451013|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
155451014|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
155451015|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
155451016|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
155451017|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
155451018|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
155451019|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
155451020|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
155451021|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
155451022|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
155451023|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
155451024|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
155451025|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
155451026|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
155451027|NCT02052778|561075629|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451028|NCT02052778|561075630|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451029|NCT02052778|561075631|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451030|NCT02052778|561075632|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451031|NCT02052778|561075633|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451032|NCT02052778|561075634|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155515446|NCT03390504|561312124|FG002|Overall Study|Lost to Follow-up|0|||
155451033|NCT02052778|561075635|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451034|NCT02052778|561075636|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451035|NCT02052778|561075637|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451036|NCT02052778|561075638|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451037|NCT02052778|561075639|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451038|NCT02052778|561075640|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451039|NCT02052778|561075641|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451040|NCT02052778|561075642|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451041|NCT02052778|561075643|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
155451042|NCT02052778|561075644|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
155451043|NCT02052778|561075645|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
155451044|NCT02052778|561075646|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451045|NCT02052778|561075647|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
155451046|NCT02052778|561075648|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451047|NCT02052778|561075649|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451048|NCT02052778|561075650|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451049|NCT02052778|561075651|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
155451050|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451051|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451052|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451053|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451054|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451055|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451056|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451057|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451058|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451059|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451060|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451061|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451062|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451063|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451064|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451065|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451066|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451067|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451068|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451069|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451070|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451071|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155451072|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
155451073|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451074|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451075|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451076|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451077|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451078|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451079|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451080|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451081|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451082|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451083|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451084|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451085|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451086|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451087|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451088|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451089|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451090|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155515447|NCT03390504|561312125|FG003|Overall Study|Lost to Follow-up|1|||
155451091|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155515448|NCT03390504|561312122|FG000|Overall Study|Withdrawal by Subject|3|||
155515449|NCT03390504|561312123|FG001|Overall Study|Withdrawal by Subject|15|||
155451092|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451093|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451094|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
155451095|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
155451096|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451097|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451098|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451099|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451100|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155515450|NCT03390504|561312124|FG002|Overall Study|Withdrawal by Subject|5|||
155515451|NCT03390504|561312125|FG003|Overall Study|Withdrawal by Subject|2|||
155515452|NCT03390504|561312122|FG000|Overall Study|Other|1|||
155515453|NCT03390504|561312123|FG001|Overall Study|Other|2|||
155515454|NCT03390504|561312124|FG002|Overall Study|Other|2|||
155515455|NCT03390504|561312125|FG003|Overall Study|Other|6|||
155515456|NCT03095352|561312126|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
155515457|NCT03095352|561312127|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
155515458|NCT02779855|561312128|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
155515459|NCT02779855|561312129|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
155515460|NCT02779855|561312130|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
155515461|NCT05431686|561312137|FG000|Overall Study|unable to schedule|10|||
155515462|NCT05328375|561313459|FG000|Overall Study|Withdrawal by Subject|0|||
155651615|NCT01903733|561816266|FG002|Overall Study|Missing|0|||
155651616|NCT01903733|561816267|FG003|Overall Study|Missing|0|||
155515463|NCT05328375|561313460|FG001|Overall Study|Withdrawal by Subject|1|||
155651617|NCT01903733|561816264|FG000|Overall Study|Investigator request|18|||
155651618|NCT01903733|561816265|FG001|Overall Study|Investigator request|0|||
155515464|NCT02178709|561313462|FG000|Overall Study|Adverse Event|5|||
155515465|NCT02178709|561313462|FG000|Overall Study|Death|2|||
155515466|NCT02178709|561313462|FG000|Overall Study|Withdrawal by Subject|2|||
155515467|NCT02178709|561313462|FG000|Overall Study|Physician Decision|2|||
155515468|NCT02178709|561313462|FG000|Overall Study|Disease Progression|5|||
155515469|NCT02946385|561313463|FG000|Overall Study|Lost to Follow-up|0|||
155515470|NCT02946385|561313464|FG001|Overall Study|Lost to Follow-up|0|||
155515471|NCT02946385|561313465|FG002|Overall Study|Lost to Follow-up|3|||
155515472|NCT02946385|561313466|FG003|Overall Study|Lost to Follow-up|0|||
155515473|NCT02946385|561313467|FG004|Overall Study|Lost to Follow-up|2|||
155515474|NCT02946385|561313468|FG005|Overall Study|Lost to Follow-up|1|||
155515475|NCT04849988|561313471|FG000|Overall Study|Lack of Efficacy|3|||
155515476|NCT04849988|561313472|FG001|Overall Study|Lack of Efficacy|4|||
155451101|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451102|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451103|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451104|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451105|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451106|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451107|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451108|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451109|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451110|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451111|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451112|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451113|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451114|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451115|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451116|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451117|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155451118|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
155451119|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451120|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451121|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451122|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451123|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451124|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451125|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451126|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451127|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451128|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451129|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451130|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155515477|NCT04849988|561313473|FG002|Overall Study|Lack of Efficacy|1|||
155515478|NCT04849988|561313474|FG003|Overall Study|Lack of Efficacy|4|||
155515479|NCT04849988|561313471|FG000|Overall Study|Other reasons|1|||
155515480|NCT04849988|561313472|FG001|Overall Study|Other reasons|2|||
155515481|NCT04849988|561313473|FG002|Overall Study|Other reasons|2|||
155515482|NCT04849988|561313474|FG003|Overall Study|Other reasons|1|||
155515483|NCT01893905|561313481|FG000|Overall Study|Withdrawal by Subject|1|||
155515484|NCT01893905|561313482|FG001|Overall Study|Withdrawal by Subject|0|||
155515485|NCT01893905|561313481|FG000|Overall Study|Adverse Event|9|||
155451131|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451132|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451133|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451134|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451135|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451136|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451137|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451138|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451139|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451140|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
155451141|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
155451142|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451143|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451144|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451145|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451146|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451147|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451148|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451149|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451150|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451151|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451152|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451153|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451154|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451155|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451156|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451157|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451158|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451159|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451160|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451161|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451162|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451163|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
155451164|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
155451165|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
155451166|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
155451167|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
155451168|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
155451169|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
155451170|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
155515486|NCT01893905|561313482|FG001|Overall Study|Adverse Event|3|||
155515487|NCT01893905|561313481|FG000|Overall Study|Lack of Efficacy|5|||
155515488|NCT01893905|561313482|FG001|Overall Study|Lack of Efficacy|7|||
155515489|NCT01893905|561313481|FG000|Overall Study|Lost to Follow-up|1|||
155515490|NCT01893905|561313482|FG001|Overall Study|Lost to Follow-up|0|||
155515491|NCT01893905|561313481|FG000|Overall Study|Protocol Violation|6|||
155515492|NCT01893905|561313482|FG001|Overall Study|Protocol Violation|1|||
155515493|NCT01893905|561313481|FG000|Overall Study|Lack of adherence to treatment|2|||
155515494|NCT01893905|561313482|FG001|Overall Study|Lack of adherence to treatment|0|||
155515495|NCT01893905|561313481|FG000|Overall Study|Other reason|1|||
155515496|NCT01893905|561313482|FG001|Overall Study|Other reason|3|||
155515497|NCT01768858|561313483|FG000|Overall Study|Lost to Follow-up|9|||
155451171|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
155515498|NCT01768858|561313483|FG000|Overall Study|Lack of Efficacy|8|||
155515499|NCT01768858|561313483|FG000|Overall Study|Serious Adverse Event|1|||
155451172|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
155451173|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
155515500|NCT01768858|561313483|FG000|Overall Study|Participant moved to Germany|1|||
155515501|NCT01768858|561313483|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
155515502|NCT01768858|561313483|FG000|Overall Study|Exanthema|1|||
155451174|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
155451175|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
155451176|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
155451177|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
155451178|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
155451179|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
155451180|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
155451181|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
155451182|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
155451183|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
155451184|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
155451185|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
155451186|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
155451187|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
155451188|NCT02052778|561075629|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451189|NCT02052778|561075630|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451190|NCT02052778|561075631|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451191|NCT02052778|561075632|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451192|NCT02052778|561075633|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451193|NCT02052778|561075634|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451194|NCT02052778|561075635|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451195|NCT02052778|561075636|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451196|NCT02052778|561075637|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451197|NCT02052778|561075638|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451198|NCT02052778|561075639|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451199|NCT02052778|561075640|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451200|NCT02052778|561075641|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451201|NCT02052778|561075642|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451202|NCT02052778|561075643|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451203|NCT02052778|561075644|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451204|NCT02052778|561075645|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451205|NCT02052778|561075646|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451206|NCT02052778|561075647|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451207|NCT02052778|561075648|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451208|NCT02052778|561075649|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451209|NCT02052778|561075650|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
155451210|NCT02052778|561075651|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
155451211|NCT01994226|561075658|FG000|Overall Study|Protocol Violation|13|||
155451212|NCT01994226|561075659|FG001|Overall Study|Protocol Violation|10|||
155451213|NCT01994226|561075658|FG000|Overall Study|Early Cessation of treatment|6|||
155451214|NCT01994226|561075659|FG001|Overall Study|Early Cessation of treatment|11|||
155451215|NCT02345252|561075665|FG000|Double-Blind Phase|Adverse Event|2|||
155451216|NCT02345252|561075666|FG001|Double-Blind Phase|Adverse Event|3|||
155451217|NCT02345252|561075665|FG000|Double-Blind Phase|Death|1|||
155451218|NCT02345252|561075666|FG001|Double-Blind Phase|Death|2|||
155451219|NCT02345252|561075665|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155451220|NCT02345252|561075666|FG001|Double-Blind Phase|Lack of Efficacy|0|||
155451221|NCT02345252|561075665|FG000|Double-Blind Phase|Investigator's Discretion|4|||
155451222|NCT02345252|561075666|FG001|Double-Blind Phase|Investigator's Discretion|6|||
155451223|NCT02345252|561075665|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155451224|NCT02345252|561075666|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
155451225|NCT02345252|561075665|FG000|Double-Blind Phase|Protocol Violation|2|||
155451226|NCT02345252|561075666|FG001|Double-Blind Phase|Protocol Violation|1|||
155451227|NCT02345252|561075665|FG000|Double-Blind Phase|Withdrew Consent|21|||
155451228|NCT02345252|561075666|FG001|Double-Blind Phase|Withdrew Consent|23|||
155451229|NCT02345252|561075665|FG000|Double-Blind Phase|Lost to Follow-up|8|||
155451230|NCT02345252|561075666|FG001|Double-Blind Phase|Lost to Follow-up|10|||
155451231|NCT02345252|561075665|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
155451232|NCT02345252|561075666|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
155451233|NCT02864940|561075667|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
155451234|NCT02864940|561075668|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
155451235|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
155451236|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451237|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451238|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451239|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451240|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451241|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451242|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451243|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155451244|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
155451245|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451246|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451247|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451248|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451249|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451250|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451251|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451252|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155451253|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
155451254|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451255|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451256|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451257|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451258|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451259|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451260|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451261|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155451262|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
155451263|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451264|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451265|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451266|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451267|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451268|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451269|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451270|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
155451271|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
155451272|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451273|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451274|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451275|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451276|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451277|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451278|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451279|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155451280|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
155451281|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451282|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451283|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451284|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451285|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451286|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451287|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451288|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155451289|NCT02175771|561075669|FG000|Run-In Period (Pre-assignment)|Other|8|||
155451290|NCT02175771|561075670|FG001|Run-In Period (Pre-assignment)|Other|0|||
155451291|NCT02175771|561075671|FG002|Run-In Period (Pre-assignment)|Other|0|||
155451292|NCT02175771|561075672|FG003|Run-In Period (Pre-assignment)|Other|0|||
155451293|NCT02175771|561075673|FG004|Run-In Period (Pre-assignment)|Other|0|||
155451294|NCT02175771|561075674|FG005|Run-In Period (Pre-assignment)|Other|0|||
155451295|NCT02175771|561075675|FG006|Run-In Period (Pre-assignment)|Other|0|||
155451296|NCT02175771|561075676|FG007|Run-In Period (Pre-assignment)|Other|0|||
155451297|NCT02175771|561075677|FG008|Run-In Period (Pre-assignment)|Other|0|||
155451298|NCT02175771|561075669|FG000|Treatment Period|Adverse Event|0|||
155451299|NCT02175771|561075670|FG001|Treatment Period|Adverse Event|2|||
155451300|NCT02175771|561075671|FG002|Treatment Period|Adverse Event|1|||
155451301|NCT02175771|561075672|FG003|Treatment Period|Adverse Event|1|||
155451302|NCT02175771|561075673|FG004|Treatment Period|Adverse Event|1|||
155451303|NCT02175771|561075674|FG005|Treatment Period|Adverse Event|3|||
155451304|NCT02175771|561075675|FG006|Treatment Period|Adverse Event|2|||
155451305|NCT02175771|561075676|FG007|Treatment Period|Adverse Event|0|||
155451306|NCT02175771|561075677|FG008|Treatment Period|Adverse Event|1|||
155451307|NCT02175771|561075669|FG000|Treatment Period|Withdrawal by Subject|0|||
155451308|NCT02175771|561075670|FG001|Treatment Period|Withdrawal by Subject|9|||
155451309|NCT02175771|561075671|FG002|Treatment Period|Withdrawal by Subject|3|||
155451310|NCT02175771|561075672|FG003|Treatment Period|Withdrawal by Subject|6|||
155451311|NCT02175771|561075673|FG004|Treatment Period|Withdrawal by Subject|2|||
155451312|NCT02175771|561075674|FG005|Treatment Period|Withdrawal by Subject|4|||
155451313|NCT02175771|561075675|FG006|Treatment Period|Withdrawal by Subject|2|||
155515503|NCT01768858|561313483|FG000|Overall Study|Withdrawal by Subject|1|||
155515504|NCT02742090|561313485|FG000|Overall Study|Adverse Event|10|||
155515505|NCT02742090|561313485|FG000|Overall Study|Death|3|||
155515506|NCT02742090|561313485|FG000|Overall Study|Disease Progression|25|||
155515507|NCT02742090|561313485|FG000|Overall Study|Investigator's Decision|1|||
155515508|NCT02742090|561313485|FG000|Overall Study|Lost to Follow-up|1|||
155515509|NCT02742090|561313485|FG000|Overall Study|Non-compliance with Study|1|||
155515510|NCT02742090|561313485|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
155515511|NCT02742090|561313485|FG000|Overall Study|Withdrawal by Subject|4|||
155451314|NCT02175771|561075676|FG007|Treatment Period|Withdrawal by Subject|9|||
155451315|NCT02175771|561075677|FG008|Treatment Period|Withdrawal by Subject|2|||
155451316|NCT02175771|561075669|FG000|Treatment Period|Noncompliance|0|||
155451317|NCT02175771|561075670|FG001|Treatment Period|Noncompliance|1|||
155451318|NCT02175771|561075671|FG002|Treatment Period|Noncompliance|2|||
155451319|NCT02175771|561075672|FG003|Treatment Period|Noncompliance|0|||
155451320|NCT02175771|561075673|FG004|Treatment Period|Noncompliance|0|||
155451321|NCT02175771|561075674|FG005|Treatment Period|Noncompliance|0|||
155451322|NCT02175771|561075675|FG006|Treatment Period|Noncompliance|0|||
155451323|NCT02175771|561075676|FG007|Treatment Period|Noncompliance|0|||
155451324|NCT02175771|561075677|FG008|Treatment Period|Noncompliance|1|||
155451325|NCT02175771|561075669|FG000|Treatment Period|Protocol Violation|0|||
155451326|NCT02175771|561075670|FG001|Treatment Period|Protocol Violation|0|||
155451327|NCT02175771|561075671|FG002|Treatment Period|Protocol Violation|0|||
155451328|NCT02175771|561075672|FG003|Treatment Period|Protocol Violation|0|||
155451329|NCT02175771|561075673|FG004|Treatment Period|Protocol Violation|0|||
155451330|NCT02175771|561075674|FG005|Treatment Period|Protocol Violation|0|||
155451331|NCT02175771|561075675|FG006|Treatment Period|Protocol Violation|0|||
155451332|NCT02175771|561075676|FG007|Treatment Period|Protocol Violation|1|||
155451333|NCT02175771|561075677|FG008|Treatment Period|Protocol Violation|0|||
155451334|NCT02175771|561075669|FG000|Treatment Period|Disease progression|0|||
155451335|NCT02175771|561075670|FG001|Treatment Period|Disease progression|0|||
155451336|NCT02175771|561075671|FG002|Treatment Period|Disease progression|0|||
155451337|NCT02175771|561075672|FG003|Treatment Period|Disease progression|0|||
155451338|NCT02175771|561075673|FG004|Treatment Period|Disease progression|0|||
155451339|NCT02175771|561075674|FG005|Treatment Period|Disease progression|0|||
155451340|NCT02175771|561075675|FG006|Treatment Period|Disease progression|0|||
155451341|NCT02175771|561075676|FG007|Treatment Period|Disease progression|2|||
155451342|NCT02175771|561075677|FG008|Treatment Period|Disease progression|0|||
155451343|NCT02175771|561075669|FG000|Treatment Period|Lost to Follow-up|0|||
155451344|NCT02175771|561075670|FG001|Treatment Period|Lost to Follow-up|3|||
155451345|NCT02175771|561075671|FG002|Treatment Period|Lost to Follow-up|1|||
155451346|NCT02175771|561075672|FG003|Treatment Period|Lost to Follow-up|3|||
155451347|NCT02175771|561075673|FG004|Treatment Period|Lost to Follow-up|1|||
155451348|NCT02175771|561075674|FG005|Treatment Period|Lost to Follow-up|2|||
155451349|NCT02175771|561075675|FG006|Treatment Period|Lost to Follow-up|1|||
155451350|NCT02175771|561075676|FG007|Treatment Period|Lost to Follow-up|2|||
155451351|NCT02175771|561075677|FG008|Treatment Period|Lost to Follow-up|2|||
155451352|NCT02175771|561075669|FG000|Treatment Period|Lack of Efficacy|0|||
155451353|NCT02175771|561075670|FG001|Treatment Period|Lack of Efficacy|0|||
155451354|NCT02175771|561075671|FG002|Treatment Period|Lack of Efficacy|0|||
155451355|NCT02175771|561075672|FG003|Treatment Period|Lack of Efficacy|0|||
155451356|NCT02175771|561075673|FG004|Treatment Period|Lack of Efficacy|0|||
155451357|NCT02175771|561075674|FG005|Treatment Period|Lack of Efficacy|1|||
155451358|NCT02175771|561075675|FG006|Treatment Period|Lack of Efficacy|0|||
155451359|NCT02175771|561075676|FG007|Treatment Period|Lack of Efficacy|1|||
155451360|NCT02175771|561075677|FG008|Treatment Period|Lack of Efficacy|0|||
155451361|NCT02175771|561075669|FG000|Treatment Period|Other|0|||
155451362|NCT02175771|561075670|FG001|Treatment Period|Other|1|||
155515512|NCT02742090|561313485|FG000|Overall Study|Reason Not Specified|1|||
155451363|NCT02175771|561075671|FG002|Treatment Period|Other|0|||
155451364|NCT02175771|561075672|FG003|Treatment Period|Other|3|||
155451365|NCT02175771|561075673|FG004|Treatment Period|Other|1|||
155451366|NCT02175771|561075674|FG005|Treatment Period|Other|0|||
155451367|NCT02175771|561075675|FG006|Treatment Period|Other|0|||
155451368|NCT02175771|561075676|FG007|Treatment Period|Other|2|||
155515513|NCT02192905|561313492|FG000|Overall Study|Lost to Follow-up|1|||
155451369|NCT02175771|561075677|FG008|Treatment Period|Other|0|||
155451370|NCT02232087|561075678|FG000|Overall Study|Withdrawal by Subject|2|||
155451371|NCT02232087|561075679|FG001|Overall Study|Withdrawal by Subject|0|||
155451372|NCT02232087|561075680|FG002|Overall Study|Withdrawal by Subject|0|||
155451373|NCT02232087|561075681|FG003|Overall Study|Withdrawal by Subject|0|||
155515514|NCT00862979|561313495|FG000|Overall Study|Adverse Event|6|||
155515515|NCT00862979|561313496|FG001|Overall Study|Adverse Event|3|||
155651619|NCT01903733|561816266|FG002|Overall Study|Investigator request|0|||
155451374|NCT02232087|561075682|FG004|Overall Study|Withdrawal by Subject|0|||
155451375|NCT02232087|561075683|FG005|Overall Study|Withdrawal by Subject|1|||
155451376|NCT02232087|561075678|FG000|Overall Study|poor inhalation technique|0|||
155451377|NCT02232087|561075679|FG001|Overall Study|poor inhalation technique|1|||
155451378|NCT02232087|561075680|FG002|Overall Study|poor inhalation technique|0|||
155451379|NCT02232087|561075681|FG003|Overall Study|poor inhalation technique|0|||
155451380|NCT02232087|561075682|FG004|Overall Study|poor inhalation technique|0|||
155451381|NCT02232087|561075683|FG005|Overall Study|poor inhalation technique|2|||
155451382|NCT02232087|561075678|FG000|Overall Study|protocol stop criteria|0|||
155451383|NCT02232087|561075679|FG001|Overall Study|protocol stop criteria|1|||
155451384|NCT02232087|561075680|FG002|Overall Study|protocol stop criteria|0|||
155451385|NCT02232087|561075681|FG003|Overall Study|protocol stop criteria|1|||
155451386|NCT02232087|561075682|FG004|Overall Study|protocol stop criteria|0|||
155451387|NCT02232087|561075683|FG005|Overall Study|protocol stop criteria|0|||
155451388|NCT02232087|561075678|FG000|Overall Study|Adverse Event|0|||
155451389|NCT02232087|561075679|FG001|Overall Study|Adverse Event|0|||
155451390|NCT02232087|561075680|FG002|Overall Study|Adverse Event|0|||
155451391|NCT02232087|561075681|FG003|Overall Study|Adverse Event|0|||
155451392|NCT02232087|561075682|FG004|Overall Study|Adverse Event|1|||
155451393|NCT02232087|561075683|FG005|Overall Study|Adverse Event|0|||
155451394|NCT01958125|561075684|FG000|Overall Study|Missing diary data|2|||
155451395|NCT01958125|561075685|FG001|Overall Study|Missing diary data|6|||
155451396|NCT01958125|561075684|FG000|Overall Study|No headache attacks|0|||
155451397|NCT01958125|561075685|FG001|Overall Study|No headache attacks|2|||
155451398|NCT04096326|561075686|FG000|Overall Study|Withdrawal by Subject|0|||
155451399|NCT04096326|561075687|FG001|Overall Study|Withdrawal by Subject|0|||
155451400|NCT04096326|561075688|FG002|Overall Study|Withdrawal by Subject|0|||
155451401|NCT04096326|561075689|FG003|Overall Study|Withdrawal by Subject|0|||
155451402|NCT04096326|561075690|FG004|Overall Study|Withdrawal by Subject|0|||
155451403|NCT04096326|561075691|FG005|Overall Study|Withdrawal by Subject|0|||
155451404|NCT04096326|561075692|FG006|Overall Study|Withdrawal by Subject|1|||
155451405|NCT04096326|561075693|FG007|Overall Study|Withdrawal by Subject|0|||
155451406|NCT04096326|561075694|FG008|Overall Study|Withdrawal by Subject|0|||
155451407|NCT04096326|561075695|FG009|Overall Study|Withdrawal by Subject|0|||
155451408|NCT04096326|561075686|FG000|Overall Study|Lost to Follow-up|0|||
155451409|NCT04096326|561075687|FG001|Overall Study|Lost to Follow-up|1|||
155451410|NCT04096326|561075688|FG002|Overall Study|Lost to Follow-up|0|||
155451411|NCT04096326|561075689|FG003|Overall Study|Lost to Follow-up|0|||
155451412|NCT04096326|561075690|FG004|Overall Study|Lost to Follow-up|0|||
155451413|NCT04096326|561075691|FG005|Overall Study|Lost to Follow-up|0|||
155451414|NCT04096326|561075692|FG006|Overall Study|Lost to Follow-up|0|||
155451415|NCT04096326|561075693|FG007|Overall Study|Lost to Follow-up|0|||
155451416|NCT04096326|561075694|FG008|Overall Study|Lost to Follow-up|0|||
155451417|NCT04096326|561075695|FG009|Overall Study|Lost to Follow-up|0|||
155451418|NCT04096326|561075686|FG000|Overall Study|COVID-19-related reasons|0|||
155451419|NCT04096326|561075687|FG001|Overall Study|COVID-19-related reasons|0|||
155451420|NCT04096326|561075688|FG002|Overall Study|COVID-19-related reasons|0|||
155451421|NCT04096326|561075689|FG003|Overall Study|COVID-19-related reasons|0|||
155451422|NCT04096326|561075690|FG004|Overall Study|COVID-19-related reasons|1|||
155451423|NCT04096326|561075691|FG005|Overall Study|COVID-19-related reasons|5|||
155451424|NCT04096326|561075692|FG006|Overall Study|COVID-19-related reasons|0|||
155451425|NCT04096326|561075693|FG007|Overall Study|COVID-19-related reasons|0|||
155515516|NCT00862979|561313495|FG000|Overall Study|Protocol Violation|0|||
155515517|NCT00862979|561313496|FG001|Overall Study|Protocol Violation|1|||
155515518|NCT00862979|561313495|FG000|Overall Study|Patient withdrew consent|2|||
155515519|NCT00862979|561313496|FG001|Overall Study|Patient withdrew consent|1|||
155515520|NCT00862979|561313495|FG000|Overall Study|Administrative problems|0|||
155515521|NCT00862979|561313496|FG001|Overall Study|Administrative problems|1|||
155515522|NCT00862979|561313495|FG000|Overall Study|Death|0|||
155515523|NCT00862979|561313496|FG001|Overall Study|Death|1|||
155515524|NCT02688400|561313498|FG000|Overall Study|Protocol Violation|2|||
155515525|NCT02688400|561313499|FG001|Overall Study|Protocol Violation|5|||
155515526|NCT02688400|561313498|FG000|Overall Study|Lack of Efficacy|7|||
155515527|NCT02688400|561313499|FG001|Overall Study|Lack of Efficacy|7|||
155515528|NCT02688400|561313498|FG000|Overall Study|Adverse Event|21|||
155451426|NCT04096326|561075694|FG008|Overall Study|COVID-19-related reasons|0|||
155451427|NCT04096326|561075695|FG009|Overall Study|COVID-19-related reasons|0|||
155451428|NCT04804033|561075696|FG000|Period 1: DBT Phase|Adverse Event|1|||
155451429|NCT04804033|561075697|FG001|Period 1: DBT Phase|Adverse Event|5|||
155451430|NCT04804033|561075698|FG002|Period 1: DBT Phase|Adverse Event|3|||
155451431|NCT04804033|561075699|FG003|Period 1: DBT Phase|Adverse Event|4|||
155451432|NCT04804033|561075696|FG000|Period 1: DBT Phase|Death|1|||
155451433|NCT04804033|561075697|FG001|Period 1: DBT Phase|Death|0|||
155515529|NCT02688400|561313499|FG001|Overall Study|Adverse Event|12|||
155451434|NCT04804033|561075698|FG002|Period 1: DBT Phase|Death|0|||
155451435|NCT04804033|561075699|FG003|Period 1: DBT Phase|Death|0|||
155451436|NCT04804033|561075696|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
155451437|NCT04804033|561075697|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
155451438|NCT04804033|561075698|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
155451439|NCT04804033|561075699|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
155451440|NCT04804033|561075696|FG000|Period 1: DBT Phase|Non-compliance|1|||
155451441|NCT04804033|561075697|FG001|Period 1: DBT Phase|Non-compliance|0|||
155451442|NCT04804033|561075698|FG002|Period 1: DBT Phase|Non-compliance|1|||
155451443|NCT04804033|561075699|FG003|Period 1: DBT Phase|Non-compliance|2|||
155451444|NCT04804033|561075696|FG000|Period 1: DBT Phase|Other|0|||
155451445|NCT04804033|561075697|FG001|Period 1: DBT Phase|Other|1|||
155451446|NCT04804033|561075698|FG002|Period 1: DBT Phase|Other|0|||
155451447|NCT04804033|561075699|FG003|Period 1: DBT Phase|Other|0|||
155451448|NCT04804033|561075696|FG000|Period 1: DBT Phase|Pregnancy|2|||
155451449|NCT04804033|561075697|FG001|Period 1: DBT Phase|Pregnancy|0|||
155451450|NCT04804033|561075698|FG002|Period 1: DBT Phase|Pregnancy|0|||
155451451|NCT04804033|561075699|FG003|Period 1: DBT Phase|Pregnancy|0|||
155451452|NCT04804033|561075696|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
155451453|NCT04804033|561075697|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
155451454|NCT04804033|561075698|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
155451455|NCT04804033|561075699|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
155451456|NCT04804033|561075696|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
155451457|NCT04804033|561075697|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
155451458|NCT04804033|561075698|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
155451459|NCT04804033|561075699|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
155451460|NCT04804033|561075696|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
155451461|NCT04804033|561075697|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
155451462|NCT04804033|561075698|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
155451463|NCT04804033|561075699|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
155451464|NCT04804033|561075696|FG000|Period 2: OLE Phase|Adverse Event|3|||
155451465|NCT04804033|561075697|FG001|Period 2: OLE Phase|Adverse Event|4|||
155451466|NCT04804033|561075698|FG002|Period 2: OLE Phase|Adverse Event|2|||
155451467|NCT04804033|561075699|FG003|Period 2: OLE Phase|Adverse Event|0|||
155451468|NCT04804033|561075696|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
155451469|NCT04804033|561075697|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
155451470|NCT04804033|561075698|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
155451471|NCT04804033|561075699|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
155451472|NCT04804033|561075696|FG000|Period 2: OLE Phase|Non-compliance|2|||
155451473|NCT04804033|561075697|FG001|Period 2: OLE Phase|Non-compliance|2|||
155451474|NCT04804033|561075698|FG002|Period 2: OLE Phase|Non-compliance|0|||
155451475|NCT04804033|561075699|FG003|Period 2: OLE Phase|Non-compliance|1|||
155451476|NCT04804033|561075696|FG000|Period 2: OLE Phase|Other|0|||
155451477|NCT04804033|561075697|FG001|Period 2: OLE Phase|Other|2|||
155451478|NCT04804033|561075698|FG002|Period 2: OLE Phase|Other|0|||
155451479|NCT04804033|561075699|FG003|Period 2: OLE Phase|Other|0|||
155451480|NCT04804033|561075696|FG000|Period 2: OLE Phase|Physician Decision|1|||
155451481|NCT04804033|561075697|FG001|Period 2: OLE Phase|Physician Decision|1|||
155451482|NCT04804033|561075698|FG002|Period 2: OLE Phase|Physician Decision|0|||
155451483|NCT04804033|561075699|FG003|Period 2: OLE Phase|Physician Decision|0|||
155451484|NCT04804033|561075696|FG000|Period 2: OLE Phase|Pregnancy|0|||
155451485|NCT04804033|561075697|FG001|Period 2: OLE Phase|Pregnancy|0|||
155451486|NCT04804033|561075698|FG002|Period 2: OLE Phase|Pregnancy|2|||
155451487|NCT04804033|561075699|FG003|Period 2: OLE Phase|Pregnancy|0|||
155451488|NCT04804033|561075696|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
155451489|NCT04804033|561075697|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
155451490|NCT04804033|561075698|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
155451491|NCT04804033|561075699|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
155451492|NCT04804033|561075696|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
155451493|NCT04804033|561075697|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
155451494|NCT04804033|561075698|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
155451495|NCT04804033|561075699|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
155451496|NCT04804033|561075696|FG000|Period 2: OLE Phase|Not reported|0|||
155451497|NCT04804033|561075697|FG001|Period 2: OLE Phase|Not reported|2|||
155451498|NCT04804033|561075698|FG002|Period 2: OLE Phase|Not reported|0|||
155451499|NCT04804033|561075699|FG003|Period 2: OLE Phase|Not reported|0|||
155515530|NCT02688400|561313498|FG000|Overall Study|Withdrawal by Subject|15|||
155451500|NCT04804033|561075696|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
155451501|NCT04804033|561075697|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
155451502|NCT04804033|561075698|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
155451503|NCT04804033|561075699|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
155451504|NCT04804033|561075696|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
155451505|NCT04804033|561075697|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
155515531|NCT02688400|561313499|FG001|Overall Study|Withdrawal by Subject|13|||
155451506|NCT04804033|561075698|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
155451507|NCT04804033|561075699|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
155451508|NCT04804033|561075696|FG000|Period 3: Follow-up Phase|Other|0|||
155451509|NCT04804033|561075697|FG001|Period 3: Follow-up Phase|Other|1|||
155451510|NCT04804033|561075698|FG002|Period 3: Follow-up Phase|Other|2|||
155451511|NCT04804033|561075699|FG003|Period 3: Follow-up Phase|Other|1|||
155451512|NCT04804033|561075696|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
155451513|NCT04804033|561075697|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
155451514|NCT04804033|561075698|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
155451515|NCT04804033|561075699|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
155451516|NCT04804033|561075696|FG000|Period 3: Follow-up Phase|Not reported|18|||
155451517|NCT04804033|561075697|FG001|Period 3: Follow-up Phase|Not reported|15|||
155451518|NCT04804033|561075698|FG002|Period 3: Follow-up Phase|Not reported|1|||
155451519|NCT04804033|561075699|FG003|Period 3: Follow-up Phase|Not reported|4|||
155451520|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
155451521|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
155451522|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
155451523|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
155451524|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
155451525|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
155451526|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
155451527|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
155451528|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
155451529|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
155451530|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
155451531|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
155451532|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
155451533|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
155451534|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
155451535|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
155451536|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
155451537|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155451538|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
155451539|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
155451540|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
155451541|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155451542|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155451543|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155451544|NCT01106625|561075702|FG000|Core Period: Baseline to Week 26|Other|8|||
155451545|NCT01106625|561075703|FG001|Core Period: Baseline to Week 26|Other|7|||
155451546|NCT01106625|561075704|FG002|Core Period: Baseline to Week 26|Other|4|||
155451547|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155451548|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155451549|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
155451550|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
155451551|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
155451552|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155451553|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155451554|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155451555|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
155451556|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155451557|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155451558|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155451559|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
155451560|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155451561|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155451562|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
155451563|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
155451564|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
155451565|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
155451566|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
155451567|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
155451568|NCT01106625|561075702|FG000|Extension Period: Week 26 to Week 52|Other|5|||
155451569|NCT01106625|561075703|FG001|Extension Period: Week 26 to Week 52|Other|5|||
155451570|NCT01106625|561075704|FG002|Extension Period: Week 26 to Week 52|Other|4|||
155451571|NCT02496585|561075705|FG000|Overall Study|Death|3|||
155451572|NCT02496585|561075706|FG001|Overall Study|Death|0|||
155651620|NCT01903733|561816267|FG003|Overall Study|Investigator request|0|||
155651621|NCT01714063|561816268|FG000|Overall Study|Equipment malfunction|2|||
155451573|NCT02496585|561075705|FG000|Overall Study|Lost to Follow-up|2|||
155451574|NCT02496585|561075706|FG001|Overall Study|Lost to Follow-up|0|||
155451575|NCT02496585|561075705|FG000|Overall Study|Withdrawal by Subject|1|||
155451576|NCT02496585|561075706|FG001|Overall Study|Withdrawal by Subject|2|||
155451577|NCT02496585|561075705|FG000|Overall Study|Progression of Malignancy|4|||
155451578|NCT02496585|561075706|FG001|Overall Study|Progression of Malignancy|1|||
155451579|NCT01276457|561075707|FG000|Core Study|Adverse Event|6|||
155451580|NCT01276457|561075708|FG001|Core Study|Adverse Event|3|||
155451581|NCT01276457|561075707|FG000|Core Study|Lost to Follow-up|1|||
155451582|NCT01276457|561075708|FG001|Core Study|Lost to Follow-up|2|||
155451583|NCT01276457|561075707|FG000|Core Study|Administrative problems|1|||
155451584|NCT01276457|561075708|FG001|Core Study|Administrative problems|1|||
155451585|NCT01276457|561075707|FG000|Core Study|Death|2|||
155451586|NCT01276457|561075708|FG001|Core Study|Death|2|||
155451587|NCT01276457|561075707|FG000|Core Study|Lack of Efficacy|3|||
155451588|NCT01276457|561075708|FG001|Core Study|Lack of Efficacy|12|||
155451589|NCT01276457|561075707|FG000|Extension Study|Lost to Follow-up|3|||
155451590|NCT01276457|561075708|FG001|Extension Study|Lost to Follow-up|0|||
155451591|NCT01276457|561075707|FG000|Extension Study|Death|0|||
155451592|NCT01276457|561075708|FG001|Extension Study|Death|1|||
155451593|NCT01276457|561075707|FG000|Extension Study|Lack of Efficacy|3|||
155451594|NCT01276457|561075708|FG001|Extension Study|Lack of Efficacy|1|||
155451595|NCT04360187|561075709|FG000|Double-Blind Treatment|Adverse Event|9|||
155451596|NCT04360187|561075710|FG001|Double-Blind Treatment|Adverse Event|11|||
155451597|NCT04360187|561075709|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
155451598|NCT04360187|561075710|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
155451599|NCT04360187|561075709|FG000|Double-Blind Treatment|Physician Decision|1|||
155451600|NCT04360187|561075710|FG001|Double-Blind Treatment|Physician Decision|0|||
155451601|NCT04360187|561075709|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
155451602|NCT04360187|561075710|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
155451603|NCT04360187|561075709|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
155451604|NCT04360187|561075710|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
155451605|NCT04360187|561075709|FG000|Follow-Up|Lost to Follow-up|1|||
155451606|NCT04360187|561075710|FG001|Follow-Up|Lost to Follow-up|0|||
155451607|NCT02203838|561075711|FG000|Overall Study|Lack of Efficacy|7|||
155451608|NCT02203838|561075712|FG001|Overall Study|Lack of Efficacy|0|||
155451609|NCT02203838|561075713|FG002|Overall Study|Lack of Efficacy|1|||
155451610|NCT02203838|561075714|FG003|Overall Study|Lack of Efficacy|1|||
155451611|NCT02203838|561075711|FG000|Overall Study|Adverse Event|46|||
155451612|NCT02203838|561075712|FG001|Overall Study|Adverse Event|6|||
155451613|NCT02203838|561075713|FG002|Overall Study|Adverse Event|3|||
155451614|NCT02203838|561075714|FG003|Overall Study|Adverse Event|2|||
155451615|NCT02203838|561075711|FG000|Overall Study|Lost to Follow-up|39|||
155451616|NCT02203838|561075712|FG001|Overall Study|Lost to Follow-up|3|||
155451617|NCT02203838|561075713|FG002|Overall Study|Lost to Follow-up|2|||
155451618|NCT02203838|561075714|FG003|Overall Study|Lost to Follow-up|1|||
155451619|NCT02203838|561075711|FG000|Overall Study|Protocol Violation|7|||
155451620|NCT02203838|561075712|FG001|Overall Study|Protocol Violation|3|||
155451621|NCT02203838|561075713|FG002|Overall Study|Protocol Violation|0|||
155451622|NCT02203838|561075714|FG003|Overall Study|Protocol Violation|0|||
155451623|NCT02203838|561075711|FG000|Overall Study|Withdrawal by Subject|83|||
155451624|NCT02203838|561075712|FG001|Overall Study|Withdrawal by Subject|10|||
155451625|NCT02203838|561075713|FG002|Overall Study|Withdrawal by Subject|8|||
155451626|NCT02203838|561075714|FG003|Overall Study|Withdrawal by Subject|11|||
155451627|NCT02203838|561075711|FG000|Overall Study|Physician Decision|27|||
155451628|NCT02203838|561075712|FG001|Overall Study|Physician Decision|0|||
155451629|NCT02203838|561075713|FG002|Overall Study|Physician Decision|2|||
155451630|NCT02203838|561075714|FG003|Overall Study|Physician Decision|3|||
155451631|NCT02203838|561075711|FG000|Overall Study|Other|1|||
155451632|NCT02203838|561075712|FG001|Overall Study|Other|0|||
155515532|NCT02688400|561313498|FG000|Overall Study|No study medication intake|1|||
155515533|NCT02688400|561313499|FG001|Overall Study|No study medication intake|4|||
155515534|NCT02688400|561313498|FG000|Overall Study|Lost to Follow-up|0|||
155515535|NCT02688400|561313499|FG001|Overall Study|Lost to Follow-up|3|||
155451633|NCT02203838|561075713|FG002|Overall Study|Other|0|||
155451634|NCT02203838|561075714|FG003|Overall Study|Other|0|||
155451635|NCT00496873|561075715|FG000|Overall Study|Ineligible|2|||
155451636|NCT00496873|561075715|FG000|Overall Study|Death|2|||
155451637|NCT00496873|561075715|FG000|Overall Study|Withdrawal by Subject|3|||
155515536|NCT01027143|561313500|FG000|Overall Study|Lost to Follow-up|9|||
155451638|NCT01842620|561075716|FG000|Period 1|Withdrawal by Subject|1|||
155451639|NCT01842620|561075717|FG001|Period 1|Withdrawal by Subject|0|||
155451640|NCT02435277|561075720|FG000|Overall Study|Adverse Event|1|||
155451641|NCT02435277|561075721|FG001|Overall Study|Adverse Event|1|||
155451642|NCT02435277|561075722|FG002|Overall Study|Adverse Event|0|||
155451643|NCT02435277|561075723|FG003|Overall Study|Adverse Event|0|||
155451644|NCT02435277|561075720|FG000|Overall Study|Withdrawal by Subject|1|||
155451645|NCT02435277|561075721|FG001|Overall Study|Withdrawal by Subject|0|||
155451646|NCT02435277|561075722|FG002|Overall Study|Withdrawal by Subject|0|||
155451647|NCT02435277|561075723|FG003|Overall Study|Withdrawal by Subject|0|||
155451648|NCT02635737|561075726|FG000|Overall Study|Protocol Violation|1|||
155451649|NCT00165841|561077530|FG000|Overall Study|Adverse Event|2|||
155451650|NCT00165841|561077531|FG001|Overall Study|Adverse Event|3|||
155451651|NCT00165841|561077530|FG000|Overall Study|Lack of Efficacy|6|||
155451652|NCT00165841|561077531|FG001|Overall Study|Lack of Efficacy|33|||
155451653|NCT00165841|561077530|FG000|Overall Study|Lost to Follow-up|4|||
155451654|NCT00165841|561077531|FG001|Overall Study|Lost to Follow-up|4|||
155451655|NCT00165841|561077530|FG000|Overall Study|Withdrawal by Subject|7|||
155451656|NCT00165841|561077531|FG001|Overall Study|Withdrawal by Subject|8|||
155451657|NCT00165841|561077530|FG000|Overall Study|Physician Decision|1|||
155451658|NCT00165841|561077531|FG001|Overall Study|Physician Decision|0|||
155451659|NCT00165841|561077530|FG000|Overall Study|Protocol Violation|6|||
155451660|NCT00165841|561077531|FG001|Overall Study|Protocol Violation|8|||
155451661|NCT00165841|561077530|FG000|Overall Study|Other|3|||
155451662|NCT00165841|561077531|FG001|Overall Study|Other|5|||
155451663|NCT00165841|561077530|FG000|Overall Study|Medication Noncompliance|1|||
155451664|NCT00165841|561077531|FG001|Overall Study|Medication Noncompliance|1|||
155451665|NCT01000727|561077532|FG000|Overall Study|Lost to Follow-up|41|||
155451666|NCT01000727|561077533|FG001|Overall Study|Lost to Follow-up|43|||
155451667|NCT01000727|561077532|FG000|Overall Study|Withdrawal by Subject|111|||
155451668|NCT01000727|561077533|FG001|Overall Study|Withdrawal by Subject|109|||
155451669|NCT01000727|561077532|FG000|Overall Study|Study closed/terminated|23|||
155451670|NCT01000727|561077533|FG001|Overall Study|Study closed/terminated|24|||
155451671|NCT01026389|561077537|FG000|Overall Study|Withdrawal by Subject|1|||
155451672|NCT01026389|561077538|FG001|Overall Study|Withdrawal by Subject|3|||
155451673|NCT01026389|561077537|FG000|Overall Study|change of treatment, patient moved|4|||
155451674|NCT01026389|561077538|FG001|Overall Study|change of treatment, patient moved|2|||
155451675|NCT01697267|561077539|FG000|Overall Study|Death|3|||
155451676|NCT01697267|561077540|FG001|Overall Study|Death|1|||
155451677|NCT01697267|561077539|FG000|Overall Study|Withdrawal by Subject|5|||
155451678|NCT01697267|561077540|FG001|Overall Study|Withdrawal by Subject|5|||
155451679|NCT01697267|561077539|FG000|Overall Study|Adverse Event|2|||
155451680|NCT01697267|561077540|FG001|Overall Study|Adverse Event|1|||
155451681|NCT01697267|561077539|FG000|Overall Study|Lost to Follow-up|2|||
155515537|NCT01027143|561313501|FG001|Overall Study|Lost to Follow-up|4|||
155515538|NCT00992407|561313504|FG000|Overall Study|Protocol Violation|2|||
155515539|NCT00992407|561313505|FG001|Overall Study|Protocol Violation|1|||
155515540|NCT00992407|561313504|FG000|Overall Study|Lost to Follow-up|3|||
155515541|NCT00992407|561313505|FG001|Overall Study|Lost to Follow-up|3|||
155515542|NCT00992407|561313504|FG000|Overall Study|Adverse Event|3|||
155515543|NCT00992407|561313505|FG001|Overall Study|Adverse Event|2|||
155515544|NCT00992407|561313504|FG000|Overall Study|protocol Violation & Adverse events|2|||
155515545|NCT00992407|561313505|FG001|Overall Study|protocol Violation & Adverse events|4|||
155515546|NCT00992407|561313504|FG000|Overall Study|Other|2|||
155515547|NCT00992407|561313505|FG001|Overall Study|Other|0|||
155515548|NCT00992407|561313504|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
155515549|NCT00992407|561313505|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
155515550|NCT00992407|561313504|FG000|Overall Study|Study medication not administered|17|||
155515551|NCT00992407|561313505|FG001|Overall Study|Study medication not administered|13|||
155515552|NCT03738332|561313506|FG000|Overall Study|Withdrawal by Subject|1|||
155515553|NCT01521559|561313507|FG000|Overall Study|Adverse Event|0|||
155515554|NCT01521559|561313508|FG001|Overall Study|Adverse Event|4|||
155515555|NCT01521559|561313507|FG000|Overall Study|Death|1|||
155451682|NCT01697267|561077540|FG001|Overall Study|Lost to Follow-up|4|||
155451683|NCT01697267|561077539|FG000|Overall Study|Physician Decision|2|||
155451684|NCT01697267|561077540|FG001|Overall Study|Physician Decision|4|||
155451685|NCT03544268|561077541|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
155451686|NCT03544268|561077542|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
155451687|NCT04410198|561077543|FG000|Overall Study|Death|10|||
155451688|NCT04410198|561077543|FG000|Overall Study|Withdrawal by Subject|7|||
155515556|NCT01521559|561313508|FG001|Overall Study|Death|0|||
155515557|NCT01521559|561313507|FG000|Overall Study|Withdrawal by Subject|9|||
155515558|NCT01521559|561313508|FG001|Overall Study|Withdrawal by Subject|11|||
155451689|NCT04410198|561077543|FG000|Overall Study|Transferred/Relocation|4|||
155451690|NCT04410198|561077543|FG000|Overall Study|Kidney Transplant|9|||
155451691|NCT04410198|561077543|FG000|Overall Study|Adverse Event|4|||
155451692|NCT04410198|561077543|FG000|Overall Study|Physician Decision|2|||
155515559|NCT01521559|561313507|FG000|Overall Study|Lost to Follow-up|3|||
155451693|NCT04410198|561077543|FG000|Overall Study|Other than specified|1|||
155451694|NCT02006667|561077544|FG000|Overall Study|Adverse Event|3|||
155451695|NCT02006667|561077544|FG000|Overall Study|Death|2|||
155451696|NCT02006667|561077544|FG000|Overall Study|Withdrawal by Subject|1|||
155451697|NCT02796391|561077547|FG000|Overall Study|Lost to Follow-up|2|||
155451698|NCT02796391|561077548|FG001|Overall Study|Lost to Follow-up|2|||
155451699|NCT02796391|561077549|FG002|Overall Study|Lost to Follow-up|13|||
155451700|NCT02796391|561077550|FG003|Overall Study|Lost to Follow-up|8|||
155451701|NCT02796391|561077551|FG004|Overall Study|Lost to Follow-up|14|||
155451702|NCT02796391|561077552|FG005|Overall Study|Lost to Follow-up|13|||
155451703|NCT02796391|561077547|FG000|Overall Study|COVID|0|||
155451704|NCT02796391|561077548|FG001|Overall Study|COVID|0|||
155451705|NCT02796391|561077549|FG002|Overall Study|COVID|5|||
155451706|NCT02796391|561077550|FG003|Overall Study|COVID|5|||
155451707|NCT02796391|561077551|FG004|Overall Study|COVID|2|||
155451708|NCT02796391|561077552|FG005|Overall Study|COVID|4|||
155451709|NCT02796391|561077547|FG000|Overall Study|Participant did not like study cigarettes|0|||
155451710|NCT02796391|561077548|FG001|Overall Study|Participant did not like study cigarettes|0|||
155451711|NCT02796391|561077549|FG002|Overall Study|Participant did not like study cigarettes|3|||
155451712|NCT02796391|561077550|FG003|Overall Study|Participant did not like study cigarettes|0|||
155451713|NCT02796391|561077551|FG004|Overall Study|Participant did not like study cigarettes|0|||
155451714|NCT02796391|561077552|FG005|Overall Study|Participant did not like study cigarettes|0|||
155451715|NCT02796391|561077547|FG000|Overall Study|Withdrawal by Subject|1|||
155451716|NCT02796391|561077548|FG001|Overall Study|Withdrawal by Subject|1|||
155451717|NCT02796391|561077549|FG002|Overall Study|Withdrawal by Subject|4|||
155451718|NCT02796391|561077550|FG003|Overall Study|Withdrawal by Subject|3|||
155451719|NCT02796391|561077551|FG004|Overall Study|Withdrawal by Subject|4|||
155451720|NCT02796391|561077552|FG005|Overall Study|Withdrawal by Subject|3|||
155451721|NCT02796391|561077547|FG000|Overall Study|Adverse Event|0|||
155451722|NCT02796391|561077548|FG001|Overall Study|Adverse Event|0|||
155451723|NCT02796391|561077549|FG002|Overall Study|Adverse Event|0|||
155451724|NCT02796391|561077550|FG003|Overall Study|Adverse Event|1|||
155451725|NCT02796391|561077551|FG004|Overall Study|Adverse Event|0|||
155451726|NCT02796391|561077552|FG005|Overall Study|Adverse Event|0|||
155451727|NCT02796391|561077547|FG000|Overall Study|Protocol Violation|0|||
155451728|NCT02796391|561077548|FG001|Overall Study|Protocol Violation|0|||
155451729|NCT02796391|561077549|FG002|Overall Study|Protocol Violation|0|||
155451730|NCT02796391|561077550|FG003|Overall Study|Protocol Violation|1|||
155451731|NCT02796391|561077551|FG004|Overall Study|Protocol Violation|0|||
155451732|NCT02796391|561077552|FG005|Overall Study|Protocol Violation|0|||
155451733|NCT02695524|561077553|FG000|Overall Study|Lost to Follow-up|3|||
155451734|NCT02695524|561077554|FG001|Overall Study|Lost to Follow-up|2|||
155451735|NCT02695524|561077553|FG000|Overall Study|Death|0|||
155451736|NCT02695524|561077554|FG001|Overall Study|Death|1|||
155451737|NCT00377611|561077555|FG000|Overall Study|Adverse Event|2|||
155451738|NCT00377611|561077556|FG001|Overall Study|Adverse Event|9|||
155451739|NCT00377611|561077555|FG000|Overall Study|Protocol Violation|2|||
155451740|NCT00377611|561077556|FG001|Overall Study|Protocol Violation|0|||
155451741|NCT00377611|561077555|FG000|Overall Study|Withdrawal by Subject|0|||
155451742|NCT00377611|561077556|FG001|Overall Study|Withdrawal by Subject|5|||
155451743|NCT00377611|561077555|FG000|Overall Study|Lost to Follow-up|18|||
155451744|NCT00377611|561077556|FG001|Overall Study|Lost to Follow-up|16|||
155451745|NCT00377611|561077555|FG000|Overall Study|Other|0|||
155451746|NCT00377611|561077556|FG001|Overall Study|Other|3|||
155451747|NCT00798655|561077562|FG000|Overall Study|Did not receive at least one dose of pan|2|||
155451748|NCT03712345|561077563|FG000|Overall Study|Failure to meet randomization criteria|0|||
155451749|NCT03712345|561077564|FG001|Overall Study|Failure to meet randomization criteria|0|||
155451750|NCT03712345|561077565|FG002|Overall Study|Failure to meet randomization criteria|1|||
155451751|NCT00960934|561077566|FG000|Overall Study|Adverse Event|2|||
155451752|NCT00960934|561077567|FG001|Overall Study|Adverse Event|3|||
155451753|NCT00960934|561077568|FG002|Overall Study|Adverse Event|3|||
155451754|NCT00960934|561077569|FG003|Overall Study|Adverse Event|2|||
155451755|NCT00960934|561077570|FG004|Overall Study|Adverse Event|4|||
155451756|NCT00960934|561077571|FG005|Overall Study|Adverse Event|3|||
155451757|NCT00960934|561077566|FG000|Overall Study|Lack of Efficacy|1|||
155451758|NCT00960934|561077567|FG001|Overall Study|Lack of Efficacy|0|||
155451759|NCT00960934|561077568|FG002|Overall Study|Lack of Efficacy|0|||
155451760|NCT00960934|561077569|FG003|Overall Study|Lack of Efficacy|0|||
155451761|NCT00960934|561077570|FG004|Overall Study|Lack of Efficacy|0|||
155451762|NCT00960934|561077571|FG005|Overall Study|Lack of Efficacy|0|||
155451763|NCT00960934|561077566|FG000|Overall Study|Lost to Follow-up|0|||
155451764|NCT00960934|561077567|FG001|Overall Study|Lost to Follow-up|1|||
155451765|NCT00960934|561077568|FG002|Overall Study|Lost to Follow-up|0|||
155451766|NCT00960934|561077569|FG003|Overall Study|Lost to Follow-up|0|||
155451767|NCT00960934|561077570|FG004|Overall Study|Lost to Follow-up|0|||
155451768|NCT00960934|561077571|FG005|Overall Study|Lost to Follow-up|0|||
155451769|NCT00960934|561077566|FG000|Overall Study|Other|2|||
155451770|NCT00960934|561077567|FG001|Overall Study|Other|1|||
155451771|NCT00960934|561077568|FG002|Overall Study|Other|5|||
155451772|NCT00960934|561077569|FG003|Overall Study|Other|4|||
155451773|NCT00960934|561077570|FG004|Overall Study|Other|2|||
155451774|NCT00960934|561077571|FG005|Overall Study|Other|2|||
155451775|NCT00960934|561077566|FG000|Overall Study|Physician Decision|0|||
155451776|NCT00960934|561077567|FG001|Overall Study|Physician Decision|1|||
155451777|NCT00960934|561077568|FG002|Overall Study|Physician Decision|0|||
155451778|NCT00960934|561077569|FG003|Overall Study|Physician Decision|0|||
155451779|NCT00960934|561077570|FG004|Overall Study|Physician Decision|0|||
155451780|NCT00960934|561077571|FG005|Overall Study|Physician Decision|0|||
155451781|NCT00960934|561077566|FG000|Overall Study|Progressive Disease|1|||
155451782|NCT00960934|561077567|FG001|Overall Study|Progressive Disease|1|||
155451783|NCT00960934|561077568|FG002|Overall Study|Progressive Disease|0|||
155451784|NCT00960934|561077569|FG003|Overall Study|Progressive Disease|0|||
155451785|NCT00960934|561077570|FG004|Overall Study|Progressive Disease|1|||
155451786|NCT00960934|561077571|FG005|Overall Study|Progressive Disease|1|||
155451787|NCT00960934|561077566|FG000|Overall Study|Protocol Violation|3|||
155451788|NCT00960934|561077567|FG001|Overall Study|Protocol Violation|4|||
155451789|NCT00960934|561077568|FG002|Overall Study|Protocol Violation|0|||
155451790|NCT00960934|561077569|FG003|Overall Study|Protocol Violation|3|||
155451791|NCT00960934|561077570|FG004|Overall Study|Protocol Violation|3|||
155451792|NCT00960934|561077571|FG005|Overall Study|Protocol Violation|2|||
155451793|NCT00960934|561077566|FG000|Overall Study|Withdrawal by Subject|5|||
155451794|NCT00960934|561077567|FG001|Overall Study|Withdrawal by Subject|6|||
155451795|NCT00960934|561077568|FG002|Overall Study|Withdrawal by Subject|4|||
155451796|NCT00960934|561077569|FG003|Overall Study|Withdrawal by Subject|5|||
155451797|NCT00960934|561077570|FG004|Overall Study|Withdrawal by Subject|5|||
155451798|NCT00960934|561077571|FG005|Overall Study|Withdrawal by Subject|7|||
155451799|NCT00960934|561077566|FG000|Overall Study|Study Terminated by Sponsor|50|||
155451800|NCT00960934|561077567|FG001|Overall Study|Study Terminated by Sponsor|46|||
155451801|NCT00960934|561077568|FG002|Overall Study|Study Terminated by Sponsor|52|||
155451802|NCT00960934|561077569|FG003|Overall Study|Study Terminated by Sponsor|50|||
155451803|NCT00960934|561077570|FG004|Overall Study|Study Terminated by Sponsor|49|||
155451804|NCT00960934|561077571|FG005|Overall Study|Study Terminated by Sponsor|49|||
155451805|NCT04348656|561077576|FG000|Overall Study|Withdrawal by Subject|2|||
155451806|NCT04348656|561077577|FG001|Overall Study|Withdrawal by Subject|0|||
155451807|NCT04348656|561077576|FG000|Overall Study|Lost to Follow-up|11|||
155451808|NCT04348656|561077577|FG001|Overall Study|Lost to Follow-up|6|||
155451809|NCT01395368|561077578|FG000|Overall Study|Physician Decision|14|||
155451810|NCT01395368|561077578|FG000|Overall Study|Withdrawal by Subject|2|||
155451811|NCT00310388|561077579|FG000|Primary Reporting Phase|Adverse Event|101|||
155451812|NCT00310388|561077580|FG001|Primary Reporting Phase|Adverse Event|0|||
155451813|NCT00310388|561077579|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
155451814|NCT00310388|561077580|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
155451815|NCT00310388|561077579|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
155451816|NCT00310388|561077580|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
155451817|NCT00310388|561077579|FG000|Primary Reporting Phase|Protocol Violation|10|||
155451818|NCT00310388|561077580|FG001|Primary Reporting Phase|Protocol Violation|0|||
155451819|NCT00310388|561077579|FG000|Primary Reporting Phase|Pregnancy|3|||
155451820|NCT00310388|561077580|FG001|Primary Reporting Phase|Pregnancy|0|||
155451821|NCT00310388|561077579|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
155451822|NCT00310388|561077580|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
155451823|NCT00310388|561077579|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
155451824|NCT00310388|561077580|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
155451825|NCT00310388|561077579|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
155451826|NCT00310388|561077580|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
155451827|NCT00310388|561077579|FG000|Primary Reporting Phase|Physician Decision|2|||
155451828|NCT00310388|561077580|FG001|Primary Reporting Phase|Physician Decision|0|||
155451829|NCT00310388|561077579|FG000|Primary Reporting Phase|Request of the sponsor|19|||
155451830|NCT00310388|561077580|FG001|Primary Reporting Phase|Request of the sponsor|0|||
155451831|NCT00310388|561077579|FG000|Primary Reporting Phase|Failed to return|8|||
155451832|NCT00310388|561077580|FG001|Primary Reporting Phase|Failed to return|0|||
155451833|NCT00310388|561077579|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
155451834|NCT00310388|561077580|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
155451835|NCT00310388|561077579|FG000|Primary Reporting Phase|Participant request|2|||
155451836|NCT00310388|561077580|FG001|Primary Reporting Phase|Participant request|0|||
155451837|NCT00310388|561077579|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
155451838|NCT00310388|561077580|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
155451839|NCT00310388|561077579|FG000|Primary Reporting Phase|Discontinuation of study|1|||
155451840|NCT00310388|561077580|FG001|Primary Reporting Phase|Discontinuation of study|0|||
155451841|NCT00310388|561077579|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
155451842|NCT00310388|561077580|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
155451843|NCT00310388|561077579|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
155451844|NCT00310388|561077580|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
155451845|NCT00310388|561077579|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
155451846|NCT00310388|561077580|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
155451847|NCT00310388|561077579|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
155451848|NCT00310388|561077580|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
155451849|NCT00310388|561077579|FG000|Primary Reporting Phase|Participant passed away|1|||
155451850|NCT00310388|561077580|FG001|Primary Reporting Phase|Participant passed away|0|||
155451851|NCT00310388|561077579|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
155451852|NCT00310388|561077580|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
155451853|NCT00310388|561077579|FG000|Primary Reporting Phase|Missing|1|||
155451854|NCT00310388|561077580|FG001|Primary Reporting Phase|Missing|0|||
155451855|NCT00310388|561077579|FG000|Primary Reporting Phase|Other|1|||
155651622|NCT02633527|561816269|FG000|Overall Study|Failed to meet eligibility|0|||
155651623|NCT02633527|561816270|FG001|Overall Study|Failed to meet eligibility|1|||
155451856|NCT00310388|561077580|FG001|Primary Reporting Phase|Other|0|||
155451857|NCT00310388|561077579|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
155451858|NCT00310388|561077580|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
155451859|NCT00310388|561077579|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
155451860|NCT00310388|561077580|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
155451861|NCT00310388|561077579|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
155451862|NCT00310388|561077580|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
155451863|NCT00310388|561077579|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
155451864|NCT00310388|561077580|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
155451865|NCT02179515|561077583|FG000|Overall Study|switched to alternative treatment|0|||
155451866|NCT02179515|561077584|FG001|Overall Study|switched to alternative treatment|1|||
155451867|NCT02179515|561077585|FG002|Overall Study|switched to alternative treatment|1|||
155451868|NCT02179515|561077583|FG000|Overall Study|Death|0|||
155451869|NCT02179515|561077584|FG001|Overall Study|Death|1|||
155451870|NCT02179515|561077585|FG002|Overall Study|Death|1|||
155451871|NCT02179515|561077583|FG000|Overall Study|refused further treatment|0|||
155451872|NCT02179515|561077584|FG001|Overall Study|refused further treatment|3|||
155451873|NCT02179515|561077585|FG002|Overall Study|refused further treatment|4|||
155451874|NCT02179515|561077583|FG000|Overall Study|Disease progression on study|2|||
155451875|NCT02179515|561077584|FG001|Overall Study|Disease progression on study|11|||
155451876|NCT02179515|561077585|FG002|Overall Study|Disease progression on study|8|||
155451877|NCT00782418|561077590|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
155451878|NCT00782418|561077591|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451879|NCT00782418|561077592|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451880|NCT00782418|561077593|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451881|NCT00782418|561077594|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451882|NCT00782418|561077595|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451883|NCT00782418|561077596|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
155451884|NCT00782418|561077590|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
155451885|NCT00782418|561077591|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
155451886|NCT00782418|561077592|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
155451887|NCT00782418|561077593|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
155451888|NCT00782418|561077594|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
155451889|NCT00782418|561077595|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
155451890|NCT00782418|561077596|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
155651624|NCT02633527|561816271|FG002|Overall Study|Failed to meet eligibility|1|||
155451891|NCT00501046|561077600|FG000|Overall Study|Adverse Event|21|||
155451892|NCT00501046|561077601|FG001|Overall Study|Adverse Event|25|||
155451893|NCT00501046|561077600|FG000|Overall Study|Death|23|||
155451894|NCT00501046|561077601|FG001|Overall Study|Death|30|||
155451895|NCT00501046|561077600|FG000|Overall Study|Lost to Follow-up|14|||
155451896|NCT00501046|561077601|FG001|Overall Study|Lost to Follow-up|13|||
155451897|NCT00501046|561077600|FG000|Overall Study|Physician Decision|7|||
155451898|NCT00501046|561077601|FG001|Overall Study|Physician Decision|2|||
155451899|NCT00501046|561077600|FG000|Overall Study|Pregnancy|0|||
155451900|NCT00501046|561077601|FG001|Overall Study|Pregnancy|3|||
155451901|NCT00501046|561077600|FG000|Overall Study|Protocol Violation|2|||
155451902|NCT00501046|561077601|FG001|Overall Study|Protocol Violation|1|||
155451903|NCT00501046|561077600|FG000|Overall Study|Withdrawal by Subject|84|||
155451904|NCT00501046|561077601|FG001|Overall Study|Withdrawal by Subject|83|||
155451905|NCT00501046|561077600|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
155451906|NCT00501046|561077601|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
155451907|NCT02488551|561077604|FG000|Overall Study|Lost to Follow-up|4|||
155451908|NCT02488551|561077605|FG001|Overall Study|Lost to Follow-up|7|||
155451909|NCT02488551|561077606|FG002|Overall Study|Lost to Follow-up|0|||
155451910|NCT02488551|561077607|FG003|Overall Study|Lost to Follow-up|0|||
155451911|NCT02488551|561077604|FG000|Overall Study|Military Deployment|1|||
155451912|NCT02488551|561077605|FG001|Overall Study|Military Deployment|1|||
155451913|NCT02488551|561077606|FG002|Overall Study|Military Deployment|0|||
155451914|NCT02488551|561077607|FG003|Overall Study|Military Deployment|0|||
155451915|NCT01188564|561077614|FG000|Double-blind Phase|randomized not treated|1|||
155451916|NCT01188564|561077615|FG001|Double-blind Phase|randomized not treated|0|||
155451917|NCT04171037|561077616|FG000|Overall Study|Lost to Follow-up|1|||
155451918|NCT04171037|561077617|FG001|Overall Study|Lost to Follow-up|0|||
155451919|NCT04171037|561077616|FG000|Overall Study|Physician Decision|3|||
155451920|NCT04171037|561077617|FG001|Overall Study|Physician Decision|3|||
155451921|NCT01934894|561077618|FG000|Overall Study|Adverse Event|1|||
155451922|NCT01934894|561077619|FG001|Overall Study|Adverse Event|2|||
155451923|NCT01934894|561077618|FG000|Overall Study|Death|2|||
155451924|NCT01934894|561077619|FG001|Overall Study|Death|0|||
155451925|NCT01934894|561077618|FG000|Overall Study|Withdrawal by Subject|0|||
155451926|NCT01934894|561077619|FG001|Overall Study|Withdrawal by Subject|1|||
155451927|NCT01934894|561077618|FG000|Overall Study|Progressive Disease|3|||
155451928|NCT01934894|561077619|FG001|Overall Study|Progressive Disease|2|||
155451929|NCT01954251|561077624|FG000|Overall Study|Adverse Event|5|||
155451930|NCT01954251|561077625|FG001|Overall Study|Adverse Event|7|||
155451931|NCT01954251|561077624|FG000|Overall Study|Lost to Follow-up|6|||
155451932|NCT01954251|561077625|FG001|Overall Study|Lost to Follow-up|6|||
155451933|NCT01954251|561077624|FG000|Overall Study|Withdrawal by Subject|2|||
155451934|NCT01954251|561077625|FG001|Overall Study|Withdrawal by Subject|6|||
155451935|NCT03364673|561077626|FG000|Overall Study|Withdrawal by Subject|2|||
155451936|NCT03364673|561077626|FG000|Overall Study|Injury unrelated to study|3|||
155451937|NCT02208024|561077627|FG000|Overall Study|Withdrawal by Subject|1|||
155451938|NCT02207556|561077628|FG000|Overall Study|Physician Decision|1|||
155451939|NCT02207556|561077629|FG001|Overall Study|Physician Decision|0|||
155451940|NCT02207556|561077628|FG000|Overall Study|Withdrawal by Subject|1|||
155451941|NCT02207556|561077629|FG001|Overall Study|Withdrawal by Subject|0|||
155451942|NCT02207556|561077628|FG000|Overall Study|Death|0|||
155451943|NCT02207556|561077629|FG001|Overall Study|Death|5|||
155451944|NCT03558555|561077630|FG000|Overall Study|Lost to Follow-up|2|||
155451945|NCT03558555|561077631|FG001|Overall Study|Lost to Follow-up|1|||
155451946|NCT00194025|561077632|FG000|Overall Study|Adverse Event|1|||
155451947|NCT00194025|561077632|FG000|Overall Study|non-adherence with study medication|4|||
155451948|NCT00511342|561077647|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
155451949|NCT00511342|561077648|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
155451950|NCT00511342|561077647|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
155451951|NCT00511342|561077648|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
155451952|NCT00511342|561077647|FG000|Overall Study|Pregnancy|0|||
155451953|NCT00511342|561077648|FG001|Overall Study|Pregnancy|1|||
155451954|NCT00511342|561077647|FG000|Overall Study|Pregnancy wish|0|||
155451955|NCT00511342|561077648|FG001|Overall Study|Pregnancy wish|1|||
155451956|NCT00511342|561077647|FG000|Overall Study|Lost to Follow-up|1|||
155451957|NCT00511342|561077648|FG001|Overall Study|Lost to Follow-up|5|||
155451958|NCT00511342|561077647|FG000|Overall Study|Other Reason|2|||
155451959|NCT00511342|561077648|FG001|Overall Study|Other Reason|2|||
155451960|NCT02432040|561077649|FG000|Overall Study|Lack of Efficacy|3|||
155451961|NCT02432040|561077650|FG001|Overall Study|Lack of Efficacy|0|||
155451962|NCT02432040|561077649|FG000|Overall Study|Lost to Follow-up|4|||
155451963|NCT02432040|561077650|FG001|Overall Study|Lost to Follow-up|5|||
155451964|NCT02432040|561077649|FG000|Overall Study|Physician Decision|1|||
155451965|NCT02432040|561077650|FG001|Overall Study|Physician Decision|1|||
155451966|NCT01100307|561077651|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
155451967|NCT01100307|561077652|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
155451968|NCT01100307|561077651|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
155451969|NCT01100307|561077652|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
155451970|NCT01100307|561077651|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
155451971|NCT01100307|561077652|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
155451972|NCT01100307|561077651|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
155451973|NCT01100307|561077652|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
155451974|NCT01100307|561077651|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
155451975|NCT01100307|561077652|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
155451976|NCT01100307|561077651|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
155451977|NCT01100307|561077652|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
155451978|NCT00997321|561077653|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
155451979|NCT00997321|561077654|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
155451980|NCT00608530|561077659|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
155451981|NCT00608530|561077660|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
155451982|NCT00608530|561077661|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
155451983|NCT00608530|561077662|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
155451984|NCT00608530|561077659|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
155451985|NCT00608530|561077660|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
155451986|NCT00608530|561077661|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
155451987|NCT00608530|561077662|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
155451988|NCT00608530|561077659|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
155451989|NCT00608530|561077660|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
155451990|NCT00608530|561077661|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
155451991|NCT00608530|561077662|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
155451992|NCT00608530|561077659|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
155451993|NCT00608530|561077660|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
155451994|NCT00608530|561077661|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
155451995|NCT00608530|561077662|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
155451996|NCT00608530|561077659|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
155451997|NCT00608530|561077660|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
155451998|NCT00608530|561077661|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
155451999|NCT00608530|561077662|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
155452000|NCT00608530|561077659|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
155452001|NCT00608530|561077660|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
155452002|NCT00608530|561077661|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
155452003|NCT00608530|561077662|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
155452004|NCT00077610|561077663|FG000|Overall Study|Adverse Event|9|||
155452005|NCT00077610|561077664|FG001|Overall Study|Adverse Event|7|||
155452006|NCT00077610|561077665|FG002|Overall Study|Adverse Event|1|||
155452007|NCT00077610|561077663|FG000|Overall Study|Lost to Follow-up|0|||
155515560|NCT01521559|561313508|FG001|Overall Study|Lost to Follow-up|1|||
155515561|NCT01521559|561313507|FG000|Overall Study|Protocol Violation|1|||
155515562|NCT01521559|561313508|FG001|Overall Study|Protocol Violation|0|||
155515563|NCT01521559|561313507|FG000|Overall Study|Other|1|||
155515564|NCT01521559|561313508|FG001|Overall Study|Other|2|||
155515565|NCT02336737|561313509|FG000|Overall Study|Withdrawal by Subject|5|||
155515566|NCT02336737|561313509|FG000|Overall Study|Physician Decision|8|||
155515567|NCT02228382|561313510|FG000|Overall Study|Death|5|||
155515568|NCT02228382|561313511|FG001|Overall Study|Death|7|||
155515569|NCT02228382|561313512|FG002|Overall Study|Death|5|||
155515570|NCT02228382|561313513|FG003|Overall Study|Death|0|||
155515571|NCT02228382|561313514|FG004|Overall Study|Death|2|||
155515572|NCT02228382|561313510|FG000|Overall Study|Participant refused further follow-up|0|||
155515573|NCT02228382|561313511|FG001|Overall Study|Participant refused further follow-up|0|||
155515574|NCT02228382|561313512|FG002|Overall Study|Participant refused further follow-up|1|||
155515575|NCT02228382|561313513|FG003|Overall Study|Participant refused further follow-up|0|||
155515576|NCT02228382|561313514|FG004|Overall Study|Participant refused further follow-up|0|||
155515577|NCT02228382|561313510|FG000|Overall Study|Study terminated by sponsor|3|||
155515578|NCT02228382|561313511|FG001|Overall Study|Study terminated by sponsor|5|||
155515579|NCT02228382|561313512|FG002|Overall Study|Study terminated by sponsor|7|||
155515580|NCT02228382|561313513|FG003|Overall Study|Study terminated by sponsor|0|||
155515581|NCT02228382|561313514|FG004|Overall Study|Study terminated by sponsor|0|||
155515582|NCT02228382|561313510|FG000|Overall Study|Lost to Follow-up|0|||
155515583|NCT02228382|561313511|FG001|Overall Study|Lost to Follow-up|0|||
155515584|NCT02228382|561313512|FG002|Overall Study|Lost to Follow-up|3|||
155515585|NCT02228382|561313513|FG003|Overall Study|Lost to Follow-up|1|||
155515586|NCT02228382|561313514|FG004|Overall Study|Lost to Follow-up|0|||
155515587|NCT02228382|561313510|FG000|Overall Study|Withdrawal by Subject|0|||
155515588|NCT02228382|561313511|FG001|Overall Study|Withdrawal by Subject|3|||
155515589|NCT02228382|561313512|FG002|Overall Study|Withdrawal by Subject|2|||
155452008|NCT00077610|561077664|FG001|Overall Study|Lost to Follow-up|1|||
155452009|NCT00077610|561077665|FG002|Overall Study|Lost to Follow-up|2|||
155515590|NCT02228382|561313513|FG003|Overall Study|Withdrawal by Subject|1|||
155515591|NCT02228382|561313514|FG004|Overall Study|Withdrawal by Subject|0|||
155515592|NCT02228382|561313510|FG000|Overall Study|Other|2|||
155515593|NCT02228382|561313511|FG001|Overall Study|Other|3|||
155515594|NCT02228382|561313512|FG002|Overall Study|Other|3|||
155515595|NCT02228382|561313513|FG003|Overall Study|Other|0|||
155452010|NCT00077610|561077663|FG000|Overall Study|Withdrawal by Subject|4|||
155452011|NCT00077610|561077664|FG001|Overall Study|Withdrawal by Subject|10|||
155452012|NCT00077610|561077665|FG002|Overall Study|Withdrawal by Subject|6|||
155452013|NCT00077610|561077663|FG000|Overall Study|Death|17|||
155452014|NCT00077610|561077664|FG001|Overall Study|Death|13|||
155452015|NCT00077610|561077665|FG002|Overall Study|Death|13|||
155452016|NCT00077610|561077663|FG000|Overall Study|Renal transplant|12|||
155452017|NCT00077610|561077664|FG001|Overall Study|Renal transplant|15|||
155452018|NCT00077610|561077665|FG002|Overall Study|Renal transplant|11|||
155452019|NCT00077610|561077663|FG000|Overall Study|Withdrew from dialysis care|5|||
155452020|NCT00077610|561077664|FG001|Overall Study|Withdrew from dialysis care|0|||
155452021|NCT00077610|561077665|FG002|Overall Study|Withdrew from dialysis care|3|||
155452022|NCT00077610|561077663|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155452023|NCT00077610|561077664|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155452024|NCT00077610|561077665|FG002|Overall Study|Insufficient Therapeutic Response|0|||
155452025|NCT00077610|561077663|FG000|Overall Study|Multiple blood transfusions|0|||
155452026|NCT00077610|561077664|FG001|Overall Study|Multiple blood transfusions|0|||
155452027|NCT00077610|561077665|FG002|Overall Study|Multiple blood transfusions|1|||
155452028|NCT00077610|561077663|FG000|Overall Study|Principal Investigator's decision|1|||
155452029|NCT00077610|561077664|FG001|Overall Study|Principal Investigator's decision|0|||
155452030|NCT00077610|561077665|FG002|Overall Study|Principal Investigator's decision|1|||
155452031|NCT00077610|561077663|FG000|Overall Study|Worsening of health condition|1|||
155452032|NCT00077610|561077664|FG001|Overall Study|Worsening of health condition|1|||
155452033|NCT00077610|561077665|FG002|Overall Study|Worsening of health condition|0|||
155452034|NCT00077610|561077663|FG000|Overall Study|Given Epogen in hospital|1|||
155452035|NCT00077610|561077664|FG001|Overall Study|Given Epogen in hospital|0|||
155452036|NCT00077610|561077665|FG002|Overall Study|Given Epogen in hospital|0|||
155452037|NCT00077610|561077663|FG000|Overall Study|Transferred to other unit|0|||
155452038|NCT00077610|561077664|FG001|Overall Study|Transferred to other unit|0|||
155452039|NCT00077610|561077665|FG002|Overall Study|Transferred to other unit|1|||
155452040|NCT00077610|561077663|FG000|Overall Study|Transferred to nursing home|0|||
155452041|NCT00077610|561077664|FG001|Overall Study|Transferred to nursing home|0|||
155452042|NCT00077610|561077665|FG002|Overall Study|Transferred to nursing home|1|||
155452043|NCT00077610|561077663|FG000|Overall Study|Transfer to satellite unit|1|||
155452044|NCT00077610|561077664|FG001|Overall Study|Transfer to satellite unit|0|||
155452045|NCT00077610|561077665|FG002|Overall Study|Transfer to satellite unit|0|||
155452046|NCT00077610|561077663|FG000|Overall Study|Transfer to other center for surgery|1|||
155452047|NCT00077610|561077664|FG001|Overall Study|Transfer to other center for surgery|0|||
155452048|NCT00077610|561077665|FG002|Overall Study|Transfer to other center for surgery|0|||
155452049|NCT00077610|561077663|FG000|Overall Study|Change in dialysis modality|1|||
155452050|NCT00077610|561077664|FG001|Overall Study|Change in dialysis modality|0|||
155452051|NCT00077610|561077665|FG002|Overall Study|Change in dialysis modality|0|||
155452052|NCT00077610|561077663|FG000|Overall Study|Relocation|0|||
155452053|NCT00077610|561077664|FG001|Overall Study|Relocation|8|||
155452054|NCT00077610|561077665|FG002|Overall Study|Relocation|5|||
155452055|NCT00077610|561077663|FG000|Overall Study|Financial issues|0|||
155452056|NCT00077610|561077664|FG001|Overall Study|Financial issues|1|||
155452057|NCT00077610|561077665|FG002|Overall Study|Financial issues|0|||
155452058|NCT00077610|561077663|FG000|Overall Study|Sponsors decision to withdraw|0|||
155452059|NCT00077610|561077664|FG001|Overall Study|Sponsors decision to withdraw|0|||
155452060|NCT00077610|561077665|FG002|Overall Study|Sponsors decision to withdraw|1|||
155452061|NCT04544709|561077668|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
155452062|NCT03135028|561077669|FG000|Overall Study|Death|6|||
155452063|NCT03135028|561077669|FG000|Overall Study|Study Terminated by Sponsor|2|||
155452064|NCT03135028|561077669|FG000|Overall Study|Withdrew Consent|1|||
155452065|NCT02065869|561077670|FG000|Overall Study|Death|7|||
155452066|NCT02065869|561077670|FG000|Overall Study|Disease relapse|16|||
155452067|NCT02065869|561077670|FG000|Overall Study|Lost to Follow-up|4|||
155452068|NCT02065869|561077670|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
155452069|NCT02065869|561077670|FG000|Overall Study|Withdrawal by Subject|1|||
155452070|NCT01814800|561077671|FG000|Overall Study|Adverse Event|2|||
155452071|NCT01814800|561077671|FG000|Overall Study|Pregnancy|1|||
155452072|NCT01814800|561077671|FG000|Overall Study|Sponsor decision|1|||
155452073|NCT01814800|561077671|FG000|Overall Study|Subject relocation|1|||
155452074|NCT02402218|561077672|FG000|Overall Study|Did not pickup study medication|12|||
155452075|NCT02402218|561077673|FG001|Overall Study|Did not pickup study medication|9|||
155452076|NCT02402218|561077674|FG002|Overall Study|Did not pickup study medication|13|||
155452077|NCT02402218|561077672|FG000|Overall Study|Lack of Efficacy|0|||
155452078|NCT02402218|561077673|FG001|Overall Study|Lack of Efficacy|1|||
155452079|NCT02402218|561077674|FG002|Overall Study|Lack of Efficacy|1|||
155452080|NCT02402218|561077672|FG000|Overall Study|Death|1|||
155452081|NCT02402218|561077673|FG001|Overall Study|Death|0|||
155452082|NCT02402218|561077674|FG002|Overall Study|Death|0|||
155452083|NCT02402218|561077672|FG000|Overall Study|Reinfection|0|||
155452084|NCT02402218|561077673|FG001|Overall Study|Reinfection|0|||
155452085|NCT02402218|561077674|FG002|Overall Study|Reinfection|1|||
155452086|NCT02402218|561077672|FG000|Overall Study|Adverse Event|0|||
155452087|NCT02402218|561077673|FG001|Overall Study|Adverse Event|2|||
155452088|NCT02402218|561077674|FG002|Overall Study|Adverse Event|1|||
155452089|NCT02402218|561077672|FG000|Overall Study|Withdrawal by Subject|1|||
155452090|NCT02402218|561077673|FG001|Overall Study|Withdrawal by Subject|1|||
155452091|NCT02402218|561077674|FG002|Overall Study|Withdrawal by Subject|1|||
155452092|NCT03827473|561077675|FG000|Overall Study|Withdrawal by Subject|1|||
155452093|NCT03827473|561077676|FG001|Overall Study|Withdrawal by Subject|0|||
155452094|NCT04436822|561077677|FG000|Overall Study|Physician Decision|2|||
155452095|NCT04436822|561077678|FG001|Overall Study|Physician Decision|0|||
155452096|NCT04436822|561077677|FG000|Overall Study|Sponsor request|1|||
155452097|NCT04436822|561077678|FG001|Overall Study|Sponsor request|0|||
155452098|NCT04436822|561077677|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155452099|NCT04436822|561077678|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155452100|NCT04436822|561077677|FG000|Overall Study|Unsuccessful procedure|0|||
155452101|NCT04436822|561077678|FG001|Overall Study|Unsuccessful procedure|1|||
155452102|NCT04436822|561077677|FG000|Overall Study|Withdrawal due to Covid-19|8|||
155452103|NCT04436822|561077678|FG001|Overall Study|Withdrawal due to Covid-19|1|||
155452104|NCT04436822|561077677|FG000|Overall Study|Withdrawal by Subject|1|||
155452105|NCT04436822|561077678|FG001|Overall Study|Withdrawal by Subject|0|||
155452106|NCT04436822|561077677|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
155452107|NCT04436822|561077678|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
155452108|NCT03807739|561077679|FG000|Overall Study|Adverse Event|1|||
155452109|NCT03807739|561077680|FG001|Overall Study|Adverse Event|0|||
155452110|NCT03807739|561077681|FG002|Overall Study|Adverse Event|0|||
155452111|NCT03807739|561077682|FG003|Overall Study|Adverse Event|0|||
155452112|NCT03807739|561077679|FG000|Overall Study|Withdrawal by Subject|1|||
155452113|NCT03807739|561077680|FG001|Overall Study|Withdrawal by Subject|0|||
155452114|NCT03807739|561077681|FG002|Overall Study|Withdrawal by Subject|0|||
155452115|NCT03807739|561077682|FG003|Overall Study|Withdrawal by Subject|0|||
155515596|NCT02228382|561313514|FG004|Overall Study|Other|0|||
155515597|NCT00275002|561313516|FG000|Overall Study|Death|1|||
155515598|NCT00275002|561313517|FG001|Overall Study|Death|0|||
155515599|NCT00275002|561313516|FG000|Overall Study|Disease progression|21|||
155515600|NCT00275002|561313517|FG001|Overall Study|Disease progression|15|||
155515601|NCT00275002|561313516|FG000|Overall Study|Adverse Event|0|||
155515602|NCT00275002|561313517|FG001|Overall Study|Adverse Event|1|||
155515603|NCT02918162|561313519|FG000|Overall Study|Withdrawal by Subject|1|||
155515604|NCT02918162|561313519|FG000|Overall Study|Omental Disease|1|||
155515605|NCT00395226|561313520|FG000|Overall Study|Adverse Event|4|||
155452116|NCT02371759|561077683|FG000|Overall Study|Protocol Violation|3|||
155452117|NCT02371759|561077684|FG001|Overall Study|Protocol Violation|1|||
155452118|NCT02371759|561077685|FG002|Overall Study|Protocol Violation|1|||
155452119|NCT02371759|561077686|FG003|Overall Study|Protocol Violation|0|||
155452120|NCT02371759|561077687|FG004|Overall Study|Protocol Violation|3|||
155452121|NCT02371759|561077688|FG005|Overall Study|Protocol Violation|1|||
155452122|NCT02371759|561077689|FG006|Overall Study|Protocol Violation|0|||
155452123|NCT02371759|561077690|FG007|Overall Study|Protocol Violation|3|||
155452124|NCT02371759|561077683|FG000|Overall Study|Withdrawal by Subject|0|||
155515606|NCT00395226|561313521|FG001|Overall Study|Adverse Event|3|||
155515607|NCT00395226|561313520|FG000|Overall Study|Withdrawal by Subject|0|||
155515608|NCT00395226|561313521|FG001|Overall Study|Withdrawal by Subject|1|||
155515609|NCT00395226|561313520|FG000|Overall Study|Lost to Follow-up|0|||
155515610|NCT00395226|561313521|FG001|Overall Study|Lost to Follow-up|1|||
155515611|NCT02655237|561313524|FG000|Overall Study|Adverse Event|10|||
155515612|NCT02655237|561313525|FG001|Overall Study|Adverse Event|7|||
155515613|NCT02655237|561313524|FG000|Overall Study|Protocol Deviation|2|||
155515614|NCT02655237|561313525|FG001|Overall Study|Protocol Deviation|0|||
155452125|NCT02371759|561077684|FG001|Overall Study|Withdrawal by Subject|0|||
155452126|NCT02371759|561077685|FG002|Overall Study|Withdrawal by Subject|0|||
155452127|NCT02371759|561077686|FG003|Overall Study|Withdrawal by Subject|0|||
155515615|NCT02655237|561313524|FG000|Overall Study|Withdrawal by Participant|1|||
155452128|NCT02371759|561077687|FG004|Overall Study|Withdrawal by Subject|0|||
155515616|NCT02655237|561313525|FG001|Overall Study|Withdrawal by Participant|2|||
155515617|NCT02655237|561313524|FG000|Overall Study|Lack of Efficacy|0|||
155515618|NCT02655237|561313525|FG001|Overall Study|Lack of Efficacy|1|||
155515619|NCT02655237|561313524|FG000|Overall Study|Recovery Leading to Surgery|2|||
155452129|NCT02371759|561077688|FG005|Overall Study|Withdrawal by Subject|0|||
155452130|NCT02371759|561077689|FG006|Overall Study|Withdrawal by Subject|0|||
155452131|NCT02371759|561077690|FG007|Overall Study|Withdrawal by Subject|1|||
155452132|NCT03375112|561077691|FG000|Overall Study|Withdrawal by Subject|3|||
155452133|NCT03375112|561077692|FG001|Overall Study|Withdrawal by Subject|0|||
155452134|NCT03599141|561077695|FG000|Overall Study|Lost to Follow-up|3|||
155452135|NCT03599141|561077696|FG001|Overall Study|Lost to Follow-up|1|||
155452136|NCT03136185|561077697|FG000|Overall Study|Adverse Event|0|||
155452137|NCT03136185|561077698|FG001|Overall Study|Adverse Event|1|||
155452138|NCT03136185|561077699|FG002|Overall Study|Adverse Event|3|||
155452139|NCT03136185|561077700|FG003|Overall Study|Adverse Event|1|||
155452140|NCT03136185|561077701|FG004|Overall Study|Adverse Event|2|||
155452141|NCT03136185|561077702|FG005|Overall Study|Adverse Event|2|||
155452142|NCT03136185|561077703|FG006|Overall Study|Adverse Event|5|||
155452143|NCT03136185|561077704|FG007|Overall Study|Adverse Event|1|||
155452144|NCT03136185|561077705|FG008|Overall Study|Adverse Event|1|||
155452145|NCT03136185|561077697|FG000|Overall Study|Death|0|||
155452146|NCT03136185|561077698|FG001|Overall Study|Death|0|||
155452147|NCT03136185|561077699|FG002|Overall Study|Death|0|||
155452148|NCT03136185|561077700|FG003|Overall Study|Death|1|||
155452149|NCT03136185|561077701|FG004|Overall Study|Death|1|||
155452150|NCT03136185|561077702|FG005|Overall Study|Death|0|||
155452151|NCT03136185|561077703|FG006|Overall Study|Death|1|||
155452152|NCT03136185|561077704|FG007|Overall Study|Death|0|||
155452153|NCT03136185|561077705|FG008|Overall Study|Death|0|||
155452154|NCT03136185|561077697|FG000|Overall Study|Physician Decision|3|||
155452155|NCT03136185|561077698|FG001|Overall Study|Physician Decision|1|||
155452156|NCT03136185|561077699|FG002|Overall Study|Physician Decision|1|||
155452157|NCT03136185|561077700|FG003|Overall Study|Physician Decision|2|||
155452158|NCT03136185|561077701|FG004|Overall Study|Physician Decision|1|||
155452159|NCT03136185|561077702|FG005|Overall Study|Physician Decision|2|||
155452160|NCT03136185|561077703|FG006|Overall Study|Physician Decision|1|||
155452161|NCT03136185|561077704|FG007|Overall Study|Physician Decision|0|||
155452162|NCT03136185|561077705|FG008|Overall Study|Physician Decision|1|||
155452163|NCT03136185|561077697|FG000|Overall Study|Protocol Defined Disease Progression|0|||
155452164|NCT03136185|561077698|FG001|Overall Study|Protocol Defined Disease Progression|0|||
155452165|NCT03136185|561077699|FG002|Overall Study|Protocol Defined Disease Progression|1|||
155452166|NCT03136185|561077700|FG003|Overall Study|Protocol Defined Disease Progression|0|||
155452167|NCT03136185|561077701|FG004|Overall Study|Protocol Defined Disease Progression|0|||
155452168|NCT03136185|561077702|FG005|Overall Study|Protocol Defined Disease Progression|1|||
155452169|NCT03136185|561077703|FG006|Overall Study|Protocol Defined Disease Progression|0|||
155452170|NCT03136185|561077704|FG007|Overall Study|Protocol Defined Disease Progression|1|||
155452171|NCT03136185|561077705|FG008|Overall Study|Protocol Defined Disease Progression|1|||
155452172|NCT03136185|561077697|FG000|Overall Study|Withdrawal by Subject|1|||
155452173|NCT03136185|561077698|FG001|Overall Study|Withdrawal by Subject|0|||
155452174|NCT03136185|561077699|FG002|Overall Study|Withdrawal by Subject|1|||
155452175|NCT03136185|561077700|FG003|Overall Study|Withdrawal by Subject|1|||
155452176|NCT03136185|561077701|FG004|Overall Study|Withdrawal by Subject|1|||
155452177|NCT03136185|561077702|FG005|Overall Study|Withdrawal by Subject|1|||
155452178|NCT03136185|561077703|FG006|Overall Study|Withdrawal by Subject|2|||
155452179|NCT03136185|561077704|FG007|Overall Study|Withdrawal by Subject|3|||
155452180|NCT03136185|561077705|FG008|Overall Study|Withdrawal by Subject|3|||
155452181|NCT03136185|561077697|FG000|Overall Study|Not Reported|4|||
155452182|NCT03136185|561077698|FG001|Overall Study|Not Reported|1|||
155452183|NCT03136185|561077699|FG002|Overall Study|Not Reported|0|||
155452184|NCT03136185|561077700|FG003|Overall Study|Not Reported|1|||
155452185|NCT03136185|561077701|FG004|Overall Study|Not Reported|0|||
155452186|NCT03136185|561077702|FG005|Overall Study|Not Reported|2|||
155452187|NCT03136185|561077703|FG006|Overall Study|Not Reported|1|||
155452188|NCT03136185|561077704|FG007|Overall Study|Not Reported|1|||
155452189|NCT03136185|561077705|FG008|Overall Study|Not Reported|0|||
155452190|NCT00303108|561077713|FG000|Overall Study|Adverse Event|5|||
155452191|NCT00303108|561077714|FG001|Overall Study|Adverse Event|6|||
155452192|NCT00303108|561077715|FG002|Overall Study|Adverse Event|7|||
155452193|NCT00303108|561077713|FG000|Overall Study|Patient Request|4|||
155651625|NCT02633527|561816272|FG003|Overall Study|Failed to meet eligibility|0|||
155452194|NCT00303108|561077714|FG001|Overall Study|Patient Request|2|||
155452195|NCT00303108|561077715|FG002|Overall Study|Patient Request|8|||
155452196|NCT00303108|561077713|FG000|Overall Study|Failed Entry|1|||
155452197|NCT00303108|561077714|FG001|Overall Study|Failed Entry|0|||
155452198|NCT00303108|561077715|FG002|Overall Study|Failed Entry|1|||
155452199|NCT00303108|561077713|FG000|Overall Study|ineligible|2|||
155452200|NCT00303108|561077714|FG001|Overall Study|ineligible|1|||
155452201|NCT00303108|561077715|FG002|Overall Study|ineligible|0|||
155452202|NCT00894413|561077716|FG000|Overall Study|Physician Decision|0|||
155452203|NCT00894413|561077717|FG001|Overall Study|Physician Decision|2|||
155452204|NCT00894413|561077716|FG000|Overall Study|Adverse Event|0|||
155452205|NCT00894413|561077717|FG001|Overall Study|Adverse Event|2|||
155452206|NCT00894413|561077716|FG000|Overall Study|Withdrawal by Subject|0|||
155452207|NCT00894413|561077717|FG001|Overall Study|Withdrawal by Subject|4|||
155452208|NCT02349789|561079249|FG000|Overall Study|Withdrawal by Subject|2|||
155452209|NCT00786032|561079252|FG000|Overall Study|Death|4|||
155452210|NCT00786032|561079252|FG000|Overall Study|Withdrawal by Subject|14|||
155452211|NCT00786032|561079252|FG000|Overall Study|Did not complete in the timeframe|6|||
155452212|NCT02457182|561079253|FG000|Overall Study|Lost to Follow-up|1|||
155452213|NCT02457182|561079254|FG001|Overall Study|Lost to Follow-up|0|||
155452214|NCT02397694|561079257|FG000|Double-Blinded Phase|Adverse Event|1|||
155452215|NCT02397694|561079258|FG001|Double-Blinded Phase|Adverse Event|0|||
155452216|NCT02397694|561079257|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
155452217|NCT02397694|561079258|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
155452218|NCT02397694|561079257|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
155452219|NCT02397694|561079258|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
155452220|NCT02397694|561079257|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
155452221|NCT02397694|561079258|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
155452222|NCT02397694|561079257|FG000|Open Label Extension Phase|Protocol Violation|1|||
155452223|NCT02397694|561079258|FG001|Open Label Extension Phase|Protocol Violation|0|||
155452224|NCT02397694|561079257|FG000|Open Label Extension Phase|Withdrew Consent|3|||
155452225|NCT02397694|561079258|FG001|Open Label Extension Phase|Withdrew Consent|1|||
155452226|NCT02397694|561079257|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
155452227|NCT02397694|561079258|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
155452228|NCT01116687|561079259|FG000|Overall Study|Withdrawal by Subject|4|||
155452229|NCT00424528|561079260|FG000|Overall Study|Adverse Event|2|||
155452230|NCT00424528|561079261|FG001|Overall Study|Adverse Event|1|||
155452231|NCT00424528|561079262|FG002|Overall Study|Adverse Event|2|||
155452232|NCT00424528|561079260|FG000|Overall Study|Protocol Violation|1|||
155452233|NCT00424528|561079261|FG001|Overall Study|Protocol Violation|1|||
155452234|NCT00424528|561079262|FG002|Overall Study|Protocol Violation|0|||
155452235|NCT00424528|561079260|FG000|Overall Study|Lost to Follow-up|0|||
155452236|NCT00424528|561079261|FG001|Overall Study|Lost to Follow-up|1|||
155452237|NCT00424528|561079262|FG002|Overall Study|Lost to Follow-up|0|||
155452238|NCT00424528|561079260|FG000|Overall Study|noncompliance with study requirements|2|||
155452239|NCT00424528|561079261|FG001|Overall Study|noncompliance with study requirements|1|||
155452240|NCT00424528|561079262|FG002|Overall Study|noncompliance with study requirements|2|||
155452241|NCT02115113|561079263|FG000|Participants in Run-in Period|Death|0|||
155452242|NCT02115113|561079264|FG001|Participants in Run-in Period|Death|0|||
155452243|NCT02115113|561079265|FG002|Participants in Run-in Period|Death|1|||
155452244|NCT02115113|561079263|FG000|Participants in Run-in Period|Administrative problems|0|||
155452245|NCT02115113|561079264|FG001|Participants in Run-in Period|Administrative problems|0|||
155452246|NCT02115113|561079265|FG002|Participants in Run-in Period|Administrative problems|1|||
155452247|NCT02115113|561079263|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
155452248|NCT02115113|561079264|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
155452249|NCT02115113|561079265|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
155452250|NCT02115113|561079263|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
155452251|NCT02115113|561079264|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
155452252|NCT02115113|561079265|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
155452253|NCT02115113|561079263|FG000|Participants Randomized|Lost to Follow-up|1|||
155452254|NCT02115113|561079264|FG001|Participants Randomized|Lost to Follow-up|0|||
155452255|NCT02115113|561079265|FG002|Participants Randomized|Lost to Follow-up|0|||
155452256|NCT02115113|561079263|FG000|Participants Randomized|Death|1|||
155452257|NCT02115113|561079264|FG001|Participants Randomized|Death|0|||
155452258|NCT02115113|561079265|FG002|Participants Randomized|Death|0|||
155452259|NCT01009983|561079266|FG000|Overall Study|necessary scans not completed|1|||
155452260|NCT00296725|561079271|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
155452261|NCT00296725|561079271|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
155452262|NCT00296725|561079271|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
155452263|NCT03196193|561079279|FG000|Overall Study|Adverse Event|1|||
155452264|NCT03196193|561079280|FG001|Overall Study|Adverse Event|0|||
155452265|NCT03196193|561079279|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
155452266|NCT03196193|561079280|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
155452267|NCT03583372|561079281|FG000|Overall Study|Withdrawal by Subject|6|||
155452268|NCT03583372|561079282|FG001|Overall Study|Withdrawal by Subject|11|||
155452269|NCT03583372|561079283|FG002|Overall Study|Withdrawal by Subject|7|||
155452270|NCT03583372|561079284|FG003|Overall Study|Withdrawal by Subject|8|||
155452271|NCT03583372|561079281|FG000|Overall Study|Lost to Follow-up|4|||
155452272|NCT03583372|561079282|FG001|Overall Study|Lost to Follow-up|6|||
155452273|NCT03583372|561079283|FG002|Overall Study|Lost to Follow-up|3|||
155452274|NCT03583372|561079284|FG003|Overall Study|Lost to Follow-up|2|||
155452275|NCT03583372|561079281|FG000|Overall Study|Adverse Event|1|||
155452276|NCT03583372|561079282|FG001|Overall Study|Adverse Event|3|||
155452277|NCT03583372|561079283|FG002|Overall Study|Adverse Event|4|||
155452278|NCT03583372|561079284|FG003|Overall Study|Adverse Event|4|||
155452279|NCT03583372|561079281|FG000|Overall Study|Physician Decision|0|||
155452280|NCT03583372|561079282|FG001|Overall Study|Physician Decision|1|||
155452281|NCT03583372|561079283|FG002|Overall Study|Physician Decision|1|||
155452282|NCT03583372|561079284|FG003|Overall Study|Physician Decision|1|||
155452283|NCT03583372|561079281|FG000|Overall Study|Lack of Efficacy|0|||
155452284|NCT03583372|561079282|FG001|Overall Study|Lack of Efficacy|1|||
155452285|NCT03583372|561079283|FG002|Overall Study|Lack of Efficacy|0|||
155452286|NCT03583372|561079284|FG003|Overall Study|Lack of Efficacy|1|||
155452287|NCT03583372|561079281|FG000|Overall Study|Death|1|||
155452288|NCT03583372|561079282|FG001|Overall Study|Death|0|||
155452289|NCT03583372|561079283|FG002|Overall Study|Death|0|||
155452290|NCT03583372|561079284|FG003|Overall Study|Death|0|||
155452291|NCT03583372|561079281|FG000|Overall Study|Protocol Violation|0|||
155452292|NCT03583372|561079282|FG001|Overall Study|Protocol Violation|1|||
155452293|NCT03583372|561079283|FG002|Overall Study|Protocol Violation|0|||
155452294|NCT03583372|561079284|FG003|Overall Study|Protocol Violation|0|||
155452295|NCT03583372|561079281|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
155452296|NCT03583372|561079282|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
155452297|NCT03583372|561079283|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
155452298|NCT03583372|561079284|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
155452299|NCT03583372|561079281|FG000|Overall Study|Did Not Receive Study Drug|0|||
155452300|NCT03583372|561079282|FG001|Overall Study|Did Not Receive Study Drug|1|||
155452301|NCT03583372|561079283|FG002|Overall Study|Did Not Receive Study Drug|0|||
155452302|NCT03583372|561079284|FG003|Overall Study|Did Not Receive Study Drug|0|||
155452303|NCT03583372|561079281|FG000|Overall Study|Captured as Other in the Database|1|||
155452304|NCT03583372|561079282|FG001|Overall Study|Captured as Other in the Database|2|||
155452305|NCT03583372|561079283|FG002|Overall Study|Captured as Other in the Database|4|||
155452306|NCT03583372|561079284|FG003|Overall Study|Captured as Other in the Database|1|||
155452307|NCT04831515|561079285|FG000|First Intervention|Adverse Event|0|||
155452308|NCT04831515|561079286|FG001|First Intervention|Adverse Event|1|||
155452309|NCT02338492|561079294|FG000|Overall Study|Death|32|||
155452310|NCT02338492|561079294|FG000|Overall Study|Adverse Event|3|||
155452311|NCT02338492|561079294|FG000|Overall Study|Lost to Follow-up|4|||
155452312|NCT02338492|561079294|FG000|Overall Study|Reason not captured above|6|||
155452313|NCT00756886|561079295|FG000|Overall Study|Lost to Follow-up|1|||
155452314|NCT00756886|561079296|FG001|Overall Study|Lost to Follow-up|0|||
155452315|NCT00756886|561079295|FG000|Overall Study|Adverse Event|0|||
155452316|NCT00756886|561079296|FG001|Overall Study|Adverse Event|3|||
155452317|NCT00756886|561079295|FG000|Overall Study|Lack of Efficacy|1|||
155452318|NCT00756886|561079296|FG001|Overall Study|Lack of Efficacy|0|||
155452319|NCT00756886|561079295|FG000|Overall Study|Ineligible|9|||
155452320|NCT00756886|561079296|FG001|Overall Study|Ineligible|4|||
155452321|NCT00174785|561079300|FG000|Overall Study|Adverse Event|293|||
155452322|NCT00174785|561079301|FG001|Overall Study|Adverse Event|191|||
155452323|NCT00174785|561079300|FG000|Overall Study|Protocol Violation|14|||
155452324|NCT00174785|561079301|FG001|Overall Study|Protocol Violation|14|||
155452325|NCT00174785|561079300|FG000|Overall Study|Withdrawal by Subject|173|||
155452326|NCT00174785|561079301|FG001|Overall Study|Withdrawal by Subject|175|||
155452327|NCT00174785|561079300|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
155452328|NCT00174785|561079301|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
155452329|NCT00174785|561079300|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
155452330|NCT00174785|561079301|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
155452331|NCT00174785|561079300|FG000|Overall Study|Other prohibited medication|5|||
155452332|NCT00174785|561079301|FG001|Overall Study|Other prohibited medication|3|||
155452333|NCT00174785|561079300|FG000|Overall Study|Family request|6|||
155452334|NCT00174785|561079301|FG001|Overall Study|Family request|8|||
155452335|NCT00174785|561079300|FG000|Overall Study|Not pre-specified/Not coded|56|||
155452336|NCT00174785|561079301|FG001|Overall Study|Not pre-specified/Not coded|70|||
155452337|NCT00120289|561079303|FG000|Overall Study|Death|96|||
155452338|NCT00120289|561079304|FG001|Overall Study|Death|82|||
155452339|NCT00120289|561079303|FG000|Overall Study|Lost to Follow-up|11|||
155452340|NCT00120289|561079304|FG001|Overall Study|Lost to Follow-up|14|||
155452341|NCT00120289|561079303|FG000|Overall Study|Withdrawal by Subject|14|||
155452342|NCT00120289|561079304|FG001|Overall Study|Withdrawal by Subject|13|||
155452343|NCT00779324|561079307|FG000|Overall Study|Lost to Follow-up|2|||
155452344|NCT00779324|561079308|FG001|Overall Study|Lost to Follow-up|1|||
155452345|NCT00779324|561079307|FG000|Overall Study|Withdrawal by Subject|4|||
155651626|NCT02633527|561816273|FG004|Overall Study|Failed to meet eligibility|1|||
155651627|NCT02633527|561816269|FG000|Overall Study|Adverse Event|0|||
155651628|NCT02633527|561816270|FG001|Overall Study|Adverse Event|4|||
155651629|NCT02633527|561816271|FG002|Overall Study|Adverse Event|3|||
155651630|NCT02633527|561816272|FG003|Overall Study|Adverse Event|1|||
155651631|NCT02633527|561816273|FG004|Overall Study|Adverse Event|5|||
155651632|NCT02633527|561816269|FG000|Overall Study|Lost to Follow-up|1|||
155651633|NCT02633527|561816270|FG001|Overall Study|Lost to Follow-up|2|||
155651634|NCT02633527|561816271|FG002|Overall Study|Lost to Follow-up|5|||
155651635|NCT02633527|561816272|FG003|Overall Study|Lost to Follow-up|5|||
155651636|NCT02633527|561816273|FG004|Overall Study|Lost to Follow-up|4|||
155651637|NCT02633527|561816269|FG000|Overall Study|Withdrawal by Subject|0|||
155651638|NCT02633527|561816270|FG001|Overall Study|Withdrawal by Subject|3|||
155651639|NCT02633527|561816271|FG002|Overall Study|Withdrawal by Subject|5|||
155651640|NCT02633527|561816272|FG003|Overall Study|Withdrawal by Subject|4|||
155651641|NCT02633527|561816273|FG004|Overall Study|Withdrawal by Subject|4|||
155651642|NCT02633527|561816269|FG000|Overall Study|Protocol Violation|0|||
155651643|NCT02633527|561816270|FG001|Overall Study|Protocol Violation|1|||
155651644|NCT02633527|561816271|FG002|Overall Study|Protocol Violation|1|||
155651645|NCT02633527|561816272|FG003|Overall Study|Protocol Violation|1|||
155651646|NCT02633527|561816273|FG004|Overall Study|Protocol Violation|1|||
155651647|NCT02633527|561816269|FG000|Overall Study|Physician Decision|0|||
155651648|NCT02633527|561816270|FG001|Overall Study|Physician Decision|0|||
155651649|NCT02633527|561816271|FG002|Overall Study|Physician Decision|0|||
155651650|NCT02633527|561816272|FG003|Overall Study|Physician Decision|0|||
155651651|NCT02633527|561816273|FG004|Overall Study|Physician Decision|1|||
155651652|NCT02633527|561816269|FG000|Overall Study|Administrative reason|1|||
155651653|NCT02633527|561816270|FG001|Overall Study|Administrative reason|0|||
155452346|NCT00779324|561079308|FG001|Overall Study|Withdrawal by Subject|2|||
155452347|NCT00779324|561079307|FG000|Overall Study|Missed visit|1|||
155452348|NCT00779324|561079308|FG001|Overall Study|Missed visit|1|||
155452349|NCT00543569|561079309|FG000|Overall Study|Death|2|||
155452350|NCT00543569|561079310|FG001|Overall Study|Death|2|||
155452351|NCT00543569|561079311|FG002|Overall Study|Death|3|||
155452352|NCT00543569|561079312|FG003|Overall Study|Death|1|||
155452353|NCT00543569|561079309|FG000|Overall Study|Lost to Follow-up|0|||
155452354|NCT00543569|561079310|FG001|Overall Study|Lost to Follow-up|0|||
155452355|NCT00543569|561079311|FG002|Overall Study|Lost to Follow-up|1|||
155452356|NCT00543569|561079312|FG003|Overall Study|Lost to Follow-up|1|||
155452357|NCT00543569|561079309|FG000|Overall Study|Miscellaneous Reasons|7|||
155452358|NCT00543569|561079310|FG001|Overall Study|Miscellaneous Reasons|3|||
155452359|NCT00543569|561079311|FG002|Overall Study|Miscellaneous Reasons|11|||
155452360|NCT00543569|561079312|FG003|Overall Study|Miscellaneous Reasons|4|||
155452361|NCT00543569|561079309|FG000|Overall Study|Randomized but never received study drug|3|||
155452362|NCT00543569|561079310|FG001|Overall Study|Randomized but never received study drug|3|||
155452363|NCT00543569|561079311|FG002|Overall Study|Randomized but never received study drug|5|||
155452364|NCT00543569|561079312|FG003|Overall Study|Randomized but never received study drug|3|||
155452365|NCT00862849|561079313|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
155452366|NCT00862849|561079314|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
155452367|NCT00862849|561079315|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
155452368|NCT00862849|561079316|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
155452369|NCT00862849|561079317|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
155452370|NCT00862849|561079318|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
155651654|NCT02633527|561816271|FG002|Overall Study|Administrative reason|0|||
155651655|NCT02633527|561816272|FG003|Overall Study|Administrative reason|1|||
155651656|NCT02633527|561816273|FG004|Overall Study|Administrative reason|0|||
155651657|NCT02633527|561816269|FG000|Overall Study|Multiple reasons|1|||
155452371|NCT00862849|561079313|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
155651658|NCT02633527|561816270|FG001|Overall Study|Multiple reasons|0|||
155452372|NCT00862849|561079314|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
155452373|NCT00862849|561079315|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
155452374|NCT00862849|561079316|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
155651659|NCT02633527|561816271|FG002|Overall Study|Multiple reasons|2|||
155651660|NCT02633527|561816272|FG003|Overall Study|Multiple reasons|2|||
155651661|NCT02633527|561816273|FG004|Overall Study|Multiple reasons|1|||
155651662|NCT03721107|561816274|FG000|Overall Study|Adverse Event|1|||
155651663|NCT03721107|561816275|FG001|Overall Study|Adverse Event|1|||
155452375|NCT00862849|561079317|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
155651664|NCT03721107|561816276|FG002|Overall Study|Adverse Event|6|||
155651665|NCT03721107|561816277|FG003|Overall Study|Adverse Event|5|||
155651666|NCT03721107|561816274|FG000|Overall Study|Lost to Follow-up|2|||
155452376|NCT00862849|561079318|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
155452377|NCT00305253|561079326|FG000|Overall Study|Withdrawal by Subject|0|||
155452378|NCT00305253|561079327|FG001|Overall Study|Withdrawal by Subject|1|||
155452379|NCT01357915|561079328|FG000|Overall Study|Lost to Follow-up|3|||
155452380|NCT01357915|561079329|FG001|Overall Study|Lost to Follow-up|0|||
155452381|NCT01153763|561079332|FG000|Overall Study|Study Closed|16|||
155452382|NCT01153763|561079332|FG000|Overall Study|Lost to Follow-up|1|||
155452383|NCT01153763|561079332|FG000|Overall Study|Physician Decision|2|||
155452384|NCT01153763|561079332|FG000|Overall Study|Withdrawal by Subject|2|||
155452385|NCT02841787|561079333|FG000|Overall Study|Lost to Follow-up|1|||
155452386|NCT02841787|561079334|FG001|Overall Study|Lost to Follow-up|0|||
155452387|NCT02841787|561079335|FG002|Overall Study|Lost to Follow-up|0|||
155452388|NCT02841787|561079333|FG000|Overall Study|Symptoms dropped below threshold|1|||
155452389|NCT02841787|561079334|FG001|Overall Study|Symptoms dropped below threshold|0|||
155452390|NCT02841787|561079335|FG002|Overall Study|Symptoms dropped below threshold|0|||
155452391|NCT02841787|561079333|FG000|Overall Study|Withdrawal by Subject|1|||
155452392|NCT02841787|561079334|FG001|Overall Study|Withdrawal by Subject|4|||
155452393|NCT02841787|561079335|FG002|Overall Study|Withdrawal by Subject|0|||
155452394|NCT01474746|561079336|FG000|Overall Study|Lost to Follow-up|1|||
155452395|NCT01474746|561079337|FG001|Overall Study|Lost to Follow-up|1|||
155452396|NCT01474746|561079336|FG000|Overall Study|Withdrawal by Subject|2|||
155452397|NCT01474746|561079337|FG001|Overall Study|Withdrawal by Subject|1|||
155452398|NCT01766336|561079341|FG000|Overall Study|Adverse Event|11|||
155452399|NCT01766336|561079342|FG001|Overall Study|Adverse Event|8|||
155452400|NCT01766336|561079341|FG000|Overall Study|Death|4|||
155452401|NCT01766336|561079342|FG001|Overall Study|Death|3|||
155452402|NCT01766336|561079341|FG000|Overall Study|Lost to Follow-up|1|||
155452403|NCT01766336|561079342|FG001|Overall Study|Lost to Follow-up|3|||
155452404|NCT01766336|561079341|FG000|Overall Study|Physician Decision|4|||
155452405|NCT01766336|561079342|FG001|Overall Study|Physician Decision|2|||
155452406|NCT01766336|561079341|FG000|Overall Study|Protocol Violation|0|||
155452407|NCT01766336|561079342|FG001|Overall Study|Protocol Violation|1|||
155452408|NCT01766336|561079341|FG000|Overall Study|Sponsor Decision|52|||
155452409|NCT01766336|561079342|FG001|Overall Study|Sponsor Decision|43|||
155452410|NCT01766336|561079341|FG000|Overall Study|Withdrawal by Subject|18|||
155452411|NCT01766336|561079342|FG001|Overall Study|Withdrawal by Subject|15|||
155452412|NCT03029650|561079343|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
155452413|NCT03029650|561079344|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
155452414|NCT03029650|561079343|FG000|Washout (1 Week)|Physician Decision|0|||
155452415|NCT03029650|561079344|FG001|Washout (1 Week)|Physician Decision|1|||
155452416|NCT05118386|561079353|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
155452417|NCT05118386|561079354|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
155452418|NCT05118386|561079355|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
155452419|NCT05118386|561079356|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
155452420|NCT05118386|561079357|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
155452421|NCT05118386|561079358|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
155452422|NCT05118386|561079353|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
155452423|NCT05118386|561079354|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
155452424|NCT05118386|561079355|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
155452425|NCT05118386|561079356|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
155452426|NCT05118386|561079357|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
155452427|NCT05118386|561079358|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
155452428|NCT00369668|561079359|FG000|Overall Study|Lack of Efficacy|4|||
155452429|NCT00369668|561079360|FG001|Overall Study|Lack of Efficacy|5|||
155452430|NCT00369668|561079361|FG002|Overall Study|Lack of Efficacy|7|||
155452431|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
155452432|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
155452433|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
155452434|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
155452435|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
155515620|NCT02655237|561313525|FG001|Overall Study|Recovery Leading to Surgery|1|||
155452436|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
155452437|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
155452438|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
155515621|NCT02655237|561313524|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
155651667|NCT03721107|561816275|FG001|Overall Study|Lost to Follow-up|0|||
155452439|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
155452440|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
155452441|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
155452442|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
155452443|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
155452444|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
155452445|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
155452446|NCT03855137|561079362|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
155452447|NCT03855137|561079363|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
155452448|NCT03855137|561079364|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
155452449|NCT03855137|561079362|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
155452450|NCT03855137|561079363|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
155452451|NCT03855137|561079364|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
155452452|NCT03855137|561079362|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
155452453|NCT03855137|561079363|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
155452454|NCT03855137|561079364|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
155452455|NCT03855137|561079362|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
155452456|NCT03855137|561079363|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
155452457|NCT03855137|561079364|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
155452458|NCT03855137|561079362|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
155452459|NCT03855137|561079363|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
155452460|NCT03855137|561079364|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
155452461|NCT02427477|561079367|FG000|Period 1|Adverse Event|1|||
155452462|NCT02427477|561079368|FG001|Period 1|Adverse Event|0|||
155452463|NCT01067508|561079369|FG000|Overall Study|Physician Decision|0|||
155452464|NCT01067508|561079370|FG001|Overall Study|Physician Decision|1|||
155452465|NCT01067508|561079369|FG000|Overall Study|Withdrawal by Subject|0|||
155452466|NCT01067508|561079370|FG001|Overall Study|Withdrawal by Subject|1|||
155452467|NCT03213626|561079371|FG000|Overall Study|Adverse Event|1|||
155452468|NCT03213626|561079371|FG000|Overall Study|Progressive Disease|6|||
155452469|NCT01005732|561079375|FG000|Overall Study|Lost to Follow-up|10|||
155452470|NCT01005732|561079375|FG000|Overall Study|Death|1|||
155452471|NCT01552928|561079376|FG000|Period 3|Adverse Event|0|||
155452472|NCT01552928|561079377|FG001|Period 3|Adverse Event|0|||
155452473|NCT01552928|561079378|FG002|Period 3|Adverse Event|1|||
155452474|NCT01552928|561079379|FG003|Period 3|Adverse Event|0|||
155452475|NCT00632463|561079381|FG000|Overall Study|Adverse Event|0|||
155452476|NCT00632463|561079382|FG001|Overall Study|Adverse Event|1|||
155452477|NCT00632463|561079383|FG002|Overall Study|Adverse Event|0|||
155452478|NCT02065622|561079384|FG000|Induction Study|Adverse Event|13|||
155452479|NCT02065622|561079385|FG001|Induction Study|Adverse Event|19|||
155452480|NCT02065622|561079386|FG002|Induction Study|Adverse Event|0|||
155452481|NCT02065622|561079387|FG003|Induction Study|Adverse Event|0|||
155452482|NCT02065622|561079388|FG004|Induction Study|Adverse Event|0|||
155452483|NCT02065622|561079384|FG000|Induction Study|Withdrawal by Subject|3|||
155452484|NCT02065622|561079385|FG001|Induction Study|Withdrawal by Subject|5|||
155452485|NCT02065622|561079386|FG002|Induction Study|Withdrawal by Subject|0|||
155452486|NCT02065622|561079387|FG003|Induction Study|Withdrawal by Subject|0|||
155452487|NCT02065622|561079388|FG004|Induction Study|Withdrawal by Subject|0|||
155452488|NCT02065622|561079384|FG000|Induction Study|Lost to Follow-up|1|||
155452489|NCT02065622|561079385|FG001|Induction Study|Lost to Follow-up|0|||
155452490|NCT02065622|561079386|FG002|Induction Study|Lost to Follow-up|0|||
155452491|NCT02065622|561079387|FG003|Induction Study|Lost to Follow-up|0|||
155452492|NCT02065622|561079388|FG004|Induction Study|Lost to Follow-up|0|||
155452493|NCT02065622|561079384|FG000|Induction Study|Lack of Efficacy|22|||
155452494|NCT02065622|561079385|FG001|Induction Study|Lack of Efficacy|27|||
155452495|NCT02065622|561079386|FG002|Induction Study|Lack of Efficacy|0|||
155452496|NCT02065622|561079387|FG003|Induction Study|Lack of Efficacy|0|||
155452497|NCT02065622|561079388|FG004|Induction Study|Lack of Efficacy|0|||
155452498|NCT02065622|561079384|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
155452499|NCT02065622|561079385|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
155452500|NCT02065622|561079386|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
155452501|NCT02065622|561079387|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
155452502|NCT02065622|561079388|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
155452503|NCT02065622|561079384|FG000|Induction Study|Subject Noncompliance|1|||
155452504|NCT02065622|561079385|FG001|Induction Study|Subject Noncompliance|1|||
155452505|NCT02065622|561079386|FG002|Induction Study|Subject Noncompliance|0|||
155452506|NCT02065622|561079387|FG003|Induction Study|Subject Noncompliance|0|||
155452507|NCT02065622|561079388|FG004|Induction Study|Subject Noncompliance|0|||
155452508|NCT02065622|561079384|FG000|Induction Study|Other, Not Specified|3|||
155452509|NCT02065622|561079385|FG001|Induction Study|Other, Not Specified|2|||
155452510|NCT02065622|561079386|FG002|Induction Study|Other, Not Specified|0|||
155452511|NCT02065622|561079387|FG003|Induction Study|Other, Not Specified|0|||
155452512|NCT02065622|561079388|FG004|Induction Study|Other, Not Specified|0|||
155452513|NCT02065622|561079384|FG000|Maintenance Study|Adverse Event|0|||
155452514|NCT02065622|561079385|FG001|Maintenance Study|Adverse Event|0|||
155452515|NCT02065622|561079386|FG002|Maintenance Study|Adverse Event|25|||
155452516|NCT02065622|561079387|FG003|Maintenance Study|Adverse Event|22|||
155452517|NCT02065622|561079388|FG004|Maintenance Study|Adverse Event|11|||
155452518|NCT02065622|561079384|FG000|Maintenance Study|Withdrawal by Subject|0|||
155452519|NCT02065622|561079385|FG001|Maintenance Study|Withdrawal by Subject|0|||
155452520|NCT02065622|561079386|FG002|Maintenance Study|Withdrawal by Subject|11|||
155452521|NCT02065622|561079387|FG003|Maintenance Study|Withdrawal by Subject|5|||
155452522|NCT02065622|561079388|FG004|Maintenance Study|Withdrawal by Subject|7|||
155452523|NCT02065622|561079384|FG000|Maintenance Study|Lost to Follow-up|0|||
155452524|NCT02065622|561079385|FG001|Maintenance Study|Lost to Follow-up|0|||
155452525|NCT02065622|561079386|FG002|Maintenance Study|Lost to Follow-up|4|||
155452526|NCT02065622|561079387|FG003|Maintenance Study|Lost to Follow-up|1|||
155452527|NCT02065622|561079388|FG004|Maintenance Study|Lost to Follow-up|1|||
155452528|NCT02065622|561079384|FG000|Maintenance Study|Lack of Efficacy|0|||
155452529|NCT02065622|561079385|FG001|Maintenance Study|Lack of Efficacy|0|||
155452530|NCT02065622|561079386|FG002|Maintenance Study|Lack of Efficacy|70|||
155452531|NCT02065622|561079387|FG003|Maintenance Study|Lack of Efficacy|55|||
155452532|NCT02065622|561079388|FG004|Maintenance Study|Lack of Efficacy|19|||
155452533|NCT02065622|561079384|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
155452534|NCT02065622|561079385|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
155452535|NCT02065622|561079386|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
155452536|NCT02065622|561079387|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
155452537|NCT02065622|561079388|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
155452538|NCT02065622|561079384|FG000|Maintenance Study|Subject Non-Compliance|0|||
155452539|NCT02065622|561079385|FG001|Maintenance Study|Subject Non-Compliance|0|||
155452540|NCT02065622|561079386|FG002|Maintenance Study|Subject Non-Compliance|1|||
155452541|NCT02065622|561079387|FG003|Maintenance Study|Subject Non-Compliance|3|||
155452542|NCT02065622|561079388|FG004|Maintenance Study|Subject Non-Compliance|2|||
155452543|NCT02065622|561079384|FG000|Maintenance Study|Other, Not Specified|0|||
155452544|NCT02065622|561079385|FG001|Maintenance Study|Other, Not Specified|0|||
155452545|NCT02065622|561079386|FG002|Maintenance Study|Other, Not Specified|6|||
155452546|NCT02065622|561079387|FG003|Maintenance Study|Other, Not Specified|14|||
155452547|NCT02065622|561079388|FG004|Maintenance Study|Other, Not Specified|2|||
155452548|NCT02065622|561079384|FG000|Maintenance Study|Unknown Reason|0|||
155452549|NCT02065622|561079385|FG001|Maintenance Study|Unknown Reason|0|||
155452550|NCT02065622|561079386|FG002|Maintenance Study|Unknown Reason|0|||
155452551|NCT02065622|561079387|FG003|Maintenance Study|Unknown Reason|1|||
155452552|NCT02065622|561079388|FG004|Maintenance Study|Unknown Reason|0|||
155452553|NCT00488618|561079401|FG000|Overall Study|Adverse Event|13|||
155452554|NCT00488618|561079402|FG001|Overall Study|Adverse Event|17|||
155452555|NCT00488618|561079401|FG000|Overall Study|Insufficient Therapeutic Response|18|||
155452556|NCT00488618|561079402|FG001|Overall Study|Insufficient Therapeutic Response|11|||
155452557|NCT00488618|561079401|FG000|Overall Study|Protocol Violation|0|||
155452558|NCT00488618|561079402|FG001|Overall Study|Protocol Violation|2|||
155452559|NCT00488618|561079401|FG000|Overall Study|Withdrawal of Consent|15|||
155452560|NCT00488618|561079402|FG001|Overall Study|Withdrawal of Consent|13|||
155452561|NCT00488618|561079401|FG000|Overall Study|Lost to Follow-up|1|||
155452562|NCT00488618|561079402|FG001|Overall Study|Lost to Follow-up|0|||
155452563|NCT00992446|561079403|FG000|Overall Study|Disease Progression|1|||
155452564|NCT00992446|561079403|FG000|Overall Study|Withdrawal by Subject|2|||
155452565|NCT00992446|561079403|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
155452566|NCT02922634|561080996|FG000|Overall Study|Withdrawal by Subject|5|||
155452567|NCT02922634|561080996|FG000|Overall Study|Did not have their surgery|5|||
155452568|NCT02625324|561080997|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
155452569|NCT02625324|561080997|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
155452570|NCT02625324|561080997|FG000|6-Month Follow-up Subject Accountability|Death|5|||
155452571|NCT02625324|561080997|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
155452572|NCT02625324|561080997|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
155452573|NCT02625324|561080997|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
155452574|NCT02625324|561080997|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
155452575|NCT02625324|561080997|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
155452576|NCT02625324|561080997|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
155452577|NCT02625324|561080997|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
155452578|NCT02625324|561080997|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
155452579|NCT02625324|561080997|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
155452580|NCT02625324|561080997|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
155452581|NCT02625324|561080997|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
155452582|NCT02625324|561080997|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155452583|NCT02625324|561080997|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
155452584|NCT02625324|561080997|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155452585|NCT00352755|561080998|FG000|Overall Study|Physician Decision|1|||
155452586|NCT00352755|561080998|FG000|Overall Study|Adverse Event|1|||
155452587|NCT00789191|561081000|FG000|Overall Study|Adverse Event|2|||
155452588|NCT00789191|561081001|FG001|Overall Study|Adverse Event|4|||
155452589|NCT00789191|561081000|FG000|Overall Study|Lack of Efficacy|0|||
155452590|NCT00789191|561081001|FG001|Overall Study|Lack of Efficacy|5|||
155452591|NCT00789191|561081000|FG000|Overall Study|Protocol Violation|5|||
155452592|NCT00789191|561081001|FG001|Overall Study|Protocol Violation|3|||
155452593|NCT00789191|561081000|FG000|Overall Study|Withdrawal Criteria|2|||
155452594|NCT00789191|561081001|FG001|Overall Study|Withdrawal Criteria|4|||
155452595|NCT00789191|561081000|FG000|Overall Study|Unclassified|5|||
155452596|NCT00789191|561081001|FG001|Overall Study|Unclassified|3|||
155452597|NCT03497429|561081003|FG000|Overall Study|Progressive disease|3|||
155452598|NCT03497429|561081004|FG001|Overall Study|Progressive disease|4|||
155452599|NCT03497429|561081003|FG000|Overall Study|Adverse Event|0|||
155452600|NCT03497429|561081004|FG001|Overall Study|Adverse Event|2|||
155452601|NCT03137121|561081007|FG000|Overall Study|Withdrawal by Subject|0|||
155452602|NCT03137121|561081008|FG001|Overall Study|Withdrawal by Subject|1|||
155452603|NCT00280150|561081012|FG000|Overall Study|Adverse Event|0|||
155452604|NCT00280150|561081013|FG001|Overall Study|Adverse Event|1|||
155452605|NCT00280150|561081014|FG002|Overall Study|Adverse Event|2|||
155452606|NCT00280150|561081015|FG003|Overall Study|Adverse Event|3|||
155452607|NCT00280150|561081012|FG000|Overall Study|Lack of Efficacy|0|||
155452608|NCT00280150|561081013|FG001|Overall Study|Lack of Efficacy|0|||
155452609|NCT00280150|561081014|FG002|Overall Study|Lack of Efficacy|0|||
155452610|NCT00280150|561081015|FG003|Overall Study|Lack of Efficacy|3|||
155452611|NCT00280150|561081012|FG000|Overall Study|Physician Decision|0|||
155452612|NCT00280150|561081013|FG001|Overall Study|Physician Decision|0|||
155452613|NCT00280150|561081014|FG002|Overall Study|Physician Decision|0|||
155452614|NCT00280150|561081015|FG003|Overall Study|Physician Decision|1|||
155452615|NCT00280150|561081012|FG000|Overall Study|Protocol Violation|0|||
155452616|NCT00280150|561081013|FG001|Overall Study|Protocol Violation|0|||
155452617|NCT00280150|561081014|FG002|Overall Study|Protocol Violation|0|||
155452618|NCT00280150|561081015|FG003|Overall Study|Protocol Violation|1|||
155452619|NCT00280150|561081012|FG000|Overall Study|Withdrawal by Subject|0|||
155452620|NCT00280150|561081013|FG001|Overall Study|Withdrawal by Subject|0|||
155452621|NCT00280150|561081014|FG002|Overall Study|Withdrawal by Subject|0|||
155452622|NCT00280150|561081015|FG003|Overall Study|Withdrawal by Subject|1|||
155452623|NCT00280150|561081012|FG000|Overall Study|Did not get consolidation therapy|3|||
155452624|NCT00280150|561081013|FG001|Overall Study|Did not get consolidation therapy|0|||
155452625|NCT00280150|561081014|FG002|Overall Study|Did not get consolidation therapy|3|||
155452626|NCT00280150|561081015|FG003|Overall Study|Did not get consolidation therapy|0|||
155452627|NCT00280150|561081012|FG000|Overall Study|Declining Performance Status|0|||
155452628|NCT00280150|561081013|FG001|Overall Study|Declining Performance Status|0|||
155452629|NCT00280150|561081014|FG002|Overall Study|Declining Performance Status|0|||
155452630|NCT00280150|561081015|FG003|Overall Study|Declining Performance Status|1|||
155452631|NCT02939937|561081022|FG000|Overall Study|Adverse Event|5|||
155452632|NCT02939937|561081023|FG001|Overall Study|Adverse Event|0|||
155452633|NCT02939937|561081022|FG000|Overall Study|Lost to Follow-up|1|||
155452634|NCT02939937|561081023|FG001|Overall Study|Lost to Follow-up|3|||
155515622|NCT02655237|561313525|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
155515623|NCT02655237|561313524|FG000|Overall Study|Randomized but Not Treated|1|||
155651668|NCT03721107|561816276|FG002|Overall Study|Lost to Follow-up|3|||
155651669|NCT03721107|561816277|FG003|Overall Study|Lost to Follow-up|0|||
155651670|NCT03721107|561816274|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155651671|NCT03721107|561816275|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155452635|NCT00568958|561081025|FG000|Allocation|Withdrawal by Subject|7|||
155452636|NCT00568958|561081026|FG001|Allocation|Withdrawal by Subject|3|||
155452637|NCT00568958|561081025|FG000|Allocation|Physician Decision|2|||
155452638|NCT00568958|561081026|FG001|Allocation|Physician Decision|0|||
155452639|NCT00568958|561081025|FG000|Follow-Up|Withdrawal by Subject|6|||
155452640|NCT00568958|561081026|FG001|Follow-Up|Withdrawal by Subject|6|||
155452641|NCT00568958|561081025|FG000|Follow-Up|Physician Decision|1|||
155452642|NCT00568958|561081026|FG001|Follow-Up|Physician Decision|1|||
155452643|NCT00568958|561081025|FG000|Follow-Up|Family Emergency|1|||
155452644|NCT00568958|561081026|FG001|Follow-Up|Family Emergency|0|||
155452645|NCT00568958|561081025|FG000|Follow-Up|Adverse Event|1|||
155452646|NCT00568958|561081026|FG001|Follow-Up|Adverse Event|0|||
155452647|NCT05254613|561081038|FG000|Overall Study|Lost to Follow-up|0|||
155452648|NCT05254613|561081039|FG001|Overall Study|Lost to Follow-up|0|||
155452649|NCT05254613|561081040|FG002|Overall Study|Lost to Follow-up|1|||
155452650|NCT02387372|561081041|FG000|Overall Study|Not Treated|1|||
155452651|NCT02387372|561081042|FG001|Overall Study|Not Treated|0|||
155452652|NCT01911845|561081044|FG000|Overall Study|Adverse Event|2|||
155452653|NCT01911845|561081044|FG000|Overall Study|Lost to Follow-up|1|||
155452654|NCT01911845|561081044|FG000|Overall Study|Other (not specified)|3|||
155452655|NCT01576016|561081045|FG000|Lead Safety|Death|132|||
155452656|NCT01576016|561081046|FG001|Lead Safety|Death|0|||
155452657|NCT01576016|561081045|FG000|Lead Safety|Withdrawal by Subject|81|||
155452658|NCT01576016|561081046|FG001|Lead Safety|Withdrawal by Subject|0|||
155452659|NCT01576016|561081045|FG000|Lead Safety|System Explanted without Replacement|24|||
155452660|NCT01576016|561081046|FG001|Lead Safety|System Explanted without Replacement|0|||
155452661|NCT01576016|561081045|FG000|Lead Safety|Physician Decision|14|||
155452662|NCT01576016|561081046|FG001|Lead Safety|Physician Decision|0|||
155452663|NCT01576016|561081045|FG000|Lead Safety|Lost to Follow-up|13|||
155452664|NCT01576016|561081046|FG001|Lead Safety|Lost to Follow-up|0|||
155452665|NCT01576016|561081045|FG000|Lead Safety|Unsuccessful implant|2|||
155452666|NCT01576016|561081046|FG001|Lead Safety|Unsuccessful implant|0|||
155452667|NCT01576016|561081045|FG000|Lead Safety|Sponsor request|1|||
155452668|NCT01576016|561081046|FG001|Lead Safety|Sponsor request|0|||
155452669|NCT01576016|561081045|FG000|Lead Safety|Device replaced with CRT-D|1|||
155452670|NCT01576016|561081046|FG001|Lead Safety|Device replaced with CRT-D|0|||
155452671|NCT01576016|561081045|FG000|Lead Safety|Patient on Palliative Care|1|||
155452672|NCT01576016|561081046|FG001|Lead Safety|Patient on Palliative Care|0|||
155452673|NCT01576016|561081045|FG000|Lead Safety|Patient noncompliance|1|||
155452674|NCT01576016|561081046|FG001|Lead Safety|Patient noncompliance|0|||
155452675|NCT01576016|561081045|FG000|Lead Safety|Too far from study site|1|||
155452676|NCT01576016|561081046|FG001|Lead Safety|Too far from study site|0|||
155452677|NCT01576016|561081045|FG000|Lead Safety|System deactivated|1|||
155452678|NCT01576016|561081046|FG001|Lead Safety|System deactivated|0|||
155452679|NCT01576016|561081045|FG000|Lead Safety|Patient no longer followed by study PI|1|||
155452680|NCT01576016|561081046|FG001|Lead Safety|Patient no longer followed by study PI|0|||
155452681|NCT01576016|561081045|FG000|MRI Safety|Withdrawal by Subject|0|||
155452682|NCT01576016|561081046|FG001|MRI Safety|Withdrawal by Subject|10|||
155452683|NCT01576016|561081045|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
155452684|NCT01576016|561081046|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
155452685|NCT01576016|561081045|FG000|MRI Safety|Has not yet completed MRI scan|0|||
155452686|NCT01576016|561081046|FG001|MRI Safety|Has not yet completed MRI scan|56|||
155452687|NCT01576016|561081045|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
155452688|NCT01576016|561081046|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
155452689|NCT01774344|561081047|FG000|Overall Study|Withdrawal by Subject|3|||
155452690|NCT01774344|561081048|FG001|Overall Study|Withdrawal by Subject|10|||
155452691|NCT01774344|561081047|FG000|Overall Study|Protocol Violation|0|||
155452692|NCT01774344|561081048|FG001|Overall Study|Protocol Violation|1|||
155452693|NCT01774344|561081047|FG000|Overall Study|Lost to Follow-up|4|||
155452694|NCT01774344|561081048|FG001|Overall Study|Lost to Follow-up|10|||
155452695|NCT01774344|561081047|FG000|Overall Study|End of survival follow-up not available|2|||
155452696|NCT01774344|561081048|FG001|Overall Study|End of survival follow-up not available|2|||
155452697|NCT01774344|561081047|FG000|Overall Study|Data collection finished|4|||
155452698|NCT01774344|561081048|FG001|Overall Study|Data collection finished|14|||
155452699|NCT01774344|561081047|FG000|Overall Study|Other|0|||
155452700|NCT01774344|561081048|FG001|Overall Study|Other|1|||
155452701|NCT01774344|561081047|FG000|Overall Study|Did not enter Survival Follow up|49|||
155452702|NCT01774344|561081048|FG001|Overall Study|Did not enter Survival Follow up|83|||
155452703|NCT00436566|561081061|FG000|Overall Study|Withdrawal by Subject|2|||
155452704|NCT00436566|561081061|FG000|Overall Study|Protocol Violation|1|||
155452705|NCT04507867|561081062|FG000|Overall Study|Death|7|||
155452706|NCT04507867|561081063|FG001|Overall Study|Death|1|||
155452707|NCT01860534|561081066|FG000|ROP #1|Needed treatment for ROP|0|||
155452708|NCT01860534|561081067|FG001|ROP #1|Needed treatment for ROP|1|||
155452709|NCT01860534|561081066|FG000|ROP #2|discharged prior to ROP #2|1|||
155452710|NCT01860534|561081067|FG001|ROP #2|discharged prior to ROP #2|0|||
155452711|NCT00502320|561081069|FG000|Overall Study|Lost to Follow-up|1|||
155452712|NCT00502320|561081070|FG001|Overall Study|Lost to Follow-up|1|||
155452713|NCT00502320|561081069|FG000|Overall Study|Withdrew Consent|1|||
155452714|NCT00502320|561081070|FG001|Overall Study|Withdrew Consent|0|||
155452715|NCT00502320|561081069|FG000|Overall Study|No longer met criteria|1|||
155452716|NCT00502320|561081070|FG001|Overall Study|No longer met criteria|0|||
155452717|NCT00502320|561081069|FG000|Overall Study|Screen Failure|0|||
155452718|NCT00502320|561081070|FG001|Overall Study|Screen Failure|1|||
155452719|NCT00502320|561081069|FG000|Overall Study|Adverse Event|3|||
155452720|NCT00502320|561081070|FG001|Overall Study|Adverse Event|5|||
155452721|NCT02124707|561081073|FG000|Overall Study|Adverse Event|5|||
155452722|NCT02124707|561081073|FG000|Overall Study|Physician Decision|1|||
155452723|NCT02124707|561081073|FG000|Overall Study|Death|1|||
155452724|NCT02196038|561081082|FG000|Overall Study|Death|16|||
155452725|NCT02196038|561081083|FG001|Overall Study|Death|21|||
155452726|NCT02196038|561081082|FG000|Overall Study|Withdrawal by Subject|0|||
155452727|NCT02196038|561081083|FG001|Overall Study|Withdrawal by Subject|1|||
155452728|NCT02196038|561081082|FG000|Overall Study|Lost to Follow-up|1|||
155452729|NCT02196038|561081083|FG001|Overall Study|Lost to Follow-up|0|||
155452730|NCT01151579|561081087|FG000|Overall Study|Physician Decision|3|||
155452731|NCT01151579|561081088|FG001|Overall Study|Physician Decision|1|||
155452732|NCT01151579|561081087|FG000|Overall Study|Withdrawal by Subject|3|||
155452733|NCT01151579|561081088|FG001|Overall Study|Withdrawal by Subject|2|||
155452734|NCT01151579|561081087|FG000|Overall Study|Not meet inclusion criteria|6|||
155452735|NCT01151579|561081088|FG001|Overall Study|Not meet inclusion criteria|4|||
155452736|NCT01098461|561081091|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
155452737|NCT01098461|561081092|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
155452738|NCT01098461|561081093|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
155452739|NCT01098461|561081094|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
155452740|NCT01098461|561081091|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
155452741|NCT01098461|561081092|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
155452742|NCT01098461|561081093|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
155452743|NCT01098461|561081094|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
155452744|NCT01098461|561081091|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
155452745|NCT01098461|561081092|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
155452746|NCT01098461|561081093|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
155452747|NCT01098461|561081094|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
155452748|NCT01098461|561081091|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
155452749|NCT01098461|561081092|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
155452750|NCT01098461|561081093|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
155452751|NCT01098461|561081094|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
155452752|NCT01098461|561081091|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
155452753|NCT01098461|561081092|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
155452754|NCT01098461|561081093|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
155452755|NCT01098461|561081094|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
155452756|NCT01098461|561081091|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
155452757|NCT01098461|561081092|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
155452758|NCT01098461|561081093|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
155452759|NCT01098461|561081094|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
155452760|NCT01098461|561081091|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
155452761|NCT01098461|561081092|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
155452762|NCT01098461|561081093|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
155452763|NCT01098461|561081094|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
155452764|NCT03491553|561081095|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
155452765|NCT03491553|561081096|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
155452766|NCT03491553|561081097|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
155452767|NCT03491553|561081098|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
155452768|NCT03491553|561081099|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
155452769|NCT03491553|561081100|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
155452770|NCT03491553|561081095|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
155452771|NCT03491553|561081096|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
155452772|NCT03491553|561081097|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
155452773|NCT03491553|561081098|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
155452774|NCT03491553|561081099|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
155452775|NCT03491553|561081100|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
155452776|NCT01606761|561081103|FG000|Prior to Week 24|Lost to Follow-up|0|||
155452777|NCT01606761|561081104|FG001|Prior to Week 24|Lost to Follow-up|3|||
155452778|NCT01606761|561081105|FG002|Prior to Week 24|Lost to Follow-up|2|||
155452779|NCT01606761|561081106|FG003|Prior to Week 24|Lost to Follow-up|0|||
155452780|NCT01606761|561081107|FG004|Prior to Week 24|Lost to Follow-up|0|||
155452781|NCT01606761|561081103|FG000|Prior to Week 24|Withdrawal by Subject|12|||
155452782|NCT01606761|561081104|FG001|Prior to Week 24|Withdrawal by Subject|10|||
155452783|NCT01606761|561081105|FG002|Prior to Week 24|Withdrawal by Subject|9|||
155452784|NCT01606761|561081106|FG003|Prior to Week 24|Withdrawal by Subject|0|||
155452785|NCT01606761|561081107|FG004|Prior to Week 24|Withdrawal by Subject|0|||
155452786|NCT01606761|561081103|FG000|Prior to Week 24|Adverse Event|11|||
155452787|NCT01606761|561081104|FG001|Prior to Week 24|Adverse Event|18|||
155452788|NCT01606761|561081105|FG002|Prior to Week 24|Adverse Event|22|||
155452789|NCT01606761|561081106|FG003|Prior to Week 24|Adverse Event|0|||
155452790|NCT01606761|561081107|FG004|Prior to Week 24|Adverse Event|0|||
155452791|NCT01606761|561081103|FG000|Prior to Week 24|Lack of Efficacy|15|||
155452792|NCT01606761|561081104|FG001|Prior to Week 24|Lack of Efficacy|14|||
155452793|NCT01606761|561081105|FG002|Prior to Week 24|Lack of Efficacy|8|||
155452794|NCT01606761|561081106|FG003|Prior to Week 24|Lack of Efficacy|0|||
155452795|NCT01606761|561081107|FG004|Prior to Week 24|Lack of Efficacy|0|||
155452796|NCT01606761|561081103|FG000|Prior to Week 24|Physician Decision|0|||
155452797|NCT01606761|561081104|FG001|Prior to Week 24|Physician Decision|3|||
155452798|NCT01606761|561081105|FG002|Prior to Week 24|Physician Decision|1|||
155452799|NCT01606761|561081106|FG003|Prior to Week 24|Physician Decision|0|||
155452800|NCT01606761|561081107|FG004|Prior to Week 24|Physician Decision|0|||
155452801|NCT01606761|561081103|FG000|Prior to Week 24|Other|4|||
155452802|NCT01606761|561081104|FG001|Prior to Week 24|Other|7|||
155452803|NCT01606761|561081105|FG002|Prior to Week 24|Other|5|||
155452804|NCT01606761|561081106|FG003|Prior to Week 24|Other|0|||
155452805|NCT01606761|561081107|FG004|Prior to Week 24|Other|0|||
155452806|NCT01606761|561081103|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
155452807|NCT01606761|561081104|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
155452808|NCT01606761|561081105|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
155452809|NCT01606761|561081106|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
155452810|NCT01606761|561081107|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
155452811|NCT01606761|561081103|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
155452812|NCT01606761|561081104|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
155452813|NCT01606761|561081105|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
155452814|NCT01606761|561081106|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
155452815|NCT01606761|561081107|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
155452816|NCT01606761|561081103|FG000|Week 24 to Week 52|Adverse Event|0|||
155452817|NCT01606761|561081104|FG001|Week 24 to Week 52|Adverse Event|11|||
155452818|NCT01606761|561081105|FG002|Week 24 to Week 52|Adverse Event|14|||
155452819|NCT01606761|561081106|FG003|Week 24 to Week 52|Adverse Event|3|||
155452820|NCT01606761|561081107|FG004|Week 24 to Week 52|Adverse Event|15|||
155452821|NCT01606761|561081103|FG000|Week 24 to Week 52|Death|0|||
155452822|NCT01606761|561081104|FG001|Week 24 to Week 52|Death|0|||
155452823|NCT01606761|561081105|FG002|Week 24 to Week 52|Death|2|||
155452824|NCT01606761|561081106|FG003|Week 24 to Week 52|Death|1|||
155452825|NCT01606761|561081107|FG004|Week 24 to Week 52|Death|0|||
155452826|NCT01606761|561081103|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
155452827|NCT01606761|561081104|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
155452828|NCT01606761|561081105|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
155452829|NCT01606761|561081106|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
155452830|NCT01606761|561081107|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
155452831|NCT01606761|561081103|FG000|Week 24 to Week 52|Physician Decision|0|||
155452832|NCT01606761|561081104|FG001|Week 24 to Week 52|Physician Decision|1|||
155452833|NCT01606761|561081105|FG002|Week 24 to Week 52|Physician Decision|1|||
155452834|NCT01606761|561081106|FG003|Week 24 to Week 52|Physician Decision|0|||
155452835|NCT01606761|561081107|FG004|Week 24 to Week 52|Physician Decision|0|||
155452836|NCT01606761|561081103|FG000|Week 24 to Week 52|Other|0|||
155452837|NCT01606761|561081104|FG001|Week 24 to Week 52|Other|1|||
155452838|NCT01606761|561081105|FG002|Week 24 to Week 52|Other|5|||
155452839|NCT01606761|561081106|FG003|Week 24 to Week 52|Other|2|||
155452840|NCT01606761|561081107|FG004|Week 24 to Week 52|Other|2|||
155452841|NCT01606761|561081103|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
155452842|NCT01606761|561081104|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
155452843|NCT01606761|561081105|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
155452844|NCT01606761|561081106|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
155452845|NCT01606761|561081107|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
155452846|NCT01606761|561081103|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
155452847|NCT01606761|561081104|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
155452848|NCT01606761|561081105|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
155452849|NCT01606761|561081106|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
155452850|NCT01606761|561081107|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
155452851|NCT01606761|561081103|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
155452852|NCT01606761|561081104|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
155452853|NCT01606761|561081105|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
155452854|NCT01606761|561081106|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
155452855|NCT01606761|561081107|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
155452856|NCT01606761|561081103|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
155452857|NCT01606761|561081104|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
155452858|NCT01606761|561081105|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
155452859|NCT01606761|561081106|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
155452860|NCT01606761|561081107|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
155452861|NCT05086289|561081108|FG000|Overall Study|Adverse Event|4|||
155452862|NCT05086289|561081109|FG001|Overall Study|Adverse Event|2|||
155452863|NCT05086289|561081108|FG000|Overall Study|Lost to Follow-up|2|||
155452864|NCT05086289|561081109|FG001|Overall Study|Lost to Follow-up|0|||
155452865|NCT05086289|561081108|FG000|Overall Study|Non-compliance with study drug|2|||
155452866|NCT05086289|561081109|FG001|Overall Study|Non-compliance with study drug|1|||
155452867|NCT05086289|561081108|FG000|Overall Study|Physician Decision|2|||
155452868|NCT05086289|561081109|FG001|Overall Study|Physician Decision|0|||
155452869|NCT05086289|561081108|FG000|Overall Study|Withdrawal by Subject|5|||
155452870|NCT05086289|561081109|FG001|Overall Study|Withdrawal by Subject|2|||
155452871|NCT00515008|561081115|FG000|Overall Study|Lost to Follow-up|1|||
155452872|NCT00515008|561081116|FG001|Overall Study|Lost to Follow-up|0|||
155452873|NCT00515008|561081115|FG000|Overall Study|Declined|0|||
155452874|NCT00515008|561081116|FG001|Overall Study|Declined|3|||
155452875|NCT00515008|561081115|FG000|Overall Study|Left the Boston Area|1|||
155452876|NCT00515008|561081116|FG001|Overall Study|Left the Boston Area|1|||
155452877|NCT00515008|561081115|FG000|Overall Study|Scheduling conflict|1|||
155452878|NCT00515008|561081116|FG001|Overall Study|Scheduling conflict|0|||
155452879|NCT03238235|561081117|FG000|Overall Study|Adverse Event|2|||
155452880|NCT03238235|561081118|FG001|Overall Study|Adverse Event|0|||
155452881|NCT03238235|561081117|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
155452882|NCT03238235|561081118|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
155452883|NCT03201198|561081129|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
155452884|NCT03201198|561081130|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
155452885|NCT03201198|561081129|FG000|Overall Study|Withdrawal by Subject|2|||
155452886|NCT03201198|561081130|FG001|Overall Study|Withdrawal by Subject|3|||
155452887|NCT00471445|561081131|FG000|Overall Study|Withdrawal by Subject|1|||
155452888|NCT00471445|561081132|FG001|Overall Study|Withdrawal by Subject|1|||
155452889|NCT00471445|561081131|FG000|Overall Study|Ineligible|1|||
155452890|NCT00471445|561081132|FG001|Overall Study|Ineligible|0|||
155452891|NCT00471445|561081131|FG000|Overall Study|Protocol Violation|0|||
155452892|NCT00471445|561081132|FG001|Overall Study|Protocol Violation|1|||
155452893|NCT04715230|561081138|FG000|Overall Study|Withdrawal by Subject|1|||
155452894|NCT04715230|561081139|FG001|Overall Study|Withdrawal by Subject|0|||
155452895|NCT04715230|561081140|FG002|Overall Study|Withdrawal by Subject|0|||
155452896|NCT04715230|561081138|FG000|Overall Study|Lost to Follow-up|0|||
155452897|NCT04715230|561081139|FG001|Overall Study|Lost to Follow-up|5|||
155452898|NCT04715230|561081140|FG002|Overall Study|Lost to Follow-up|1|||
155452899|NCT02596711|561081147|FG000|Overall Study|Lost to Follow-up|1|||
155452900|NCT02596711|561081148|FG001|Overall Study|Lost to Follow-up|2|||
155452901|NCT02596711|561081149|FG002|Overall Study|Lost to Follow-up|3|||
155452902|NCT00586924|561081150|FG000|Overall Study|Adverse event/serious adverse event|0|||
155452903|NCT00586924|561081151|FG001|Overall Study|Adverse event/serious adverse event|0|||
155452904|NCT00586924|561081152|FG002|Overall Study|Adverse event/serious adverse event|0|||
155452905|NCT00586924|561081153|FG003|Overall Study|Adverse event/serious adverse event|1|||
155452906|NCT00586924|561081154|FG004|Overall Study|Adverse event/serious adverse event|0|||
155452907|NCT00586924|561081155|FG005|Overall Study|Adverse event/serious adverse event|2|||
155452908|NCT00586924|561081150|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
155452909|NCT00586924|561081151|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
155452910|NCT00586924|561081152|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
155452911|NCT00586924|561081153|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
155452912|NCT00586924|561081154|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
155452913|NCT00586924|561081155|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
155452914|NCT00586924|561081150|FG000|Overall Study|Disease progression|0|||
155515624|NCT02655237|561313525|FG001|Overall Study|Randomized but Not Treated|0|||
155452915|NCT00586924|561081151|FG001|Overall Study|Disease progression|0|||
155452916|NCT00586924|561081152|FG002|Overall Study|Disease progression|0|||
155452917|NCT00586924|561081153|FG003|Overall Study|Disease progression|1|||
155452918|NCT00586924|561081154|FG004|Overall Study|Disease progression|1|||
155452919|NCT00586924|561081155|FG005|Overall Study|Disease progression|0|||
155452920|NCT00586924|561081150|FG000|Overall Study|Development of neutralizing antibodies|2|||
155452921|NCT00586924|561081151|FG001|Overall Study|Development of neutralizing antibodies|2|||
155452922|NCT00586924|561081152|FG002|Overall Study|Development of neutralizing antibodies|2|||
155515625|NCT03679741|561313526|FG000|Period 1|No longer meet eligibility criteria|1|||
155515626|NCT03679741|561313527|FG001|Period 1|No longer meet eligibility criteria|0|||
155515627|NCT03679741|561313526|FG000|Period 1|Lost to Follow-up|0|||
155515628|NCT03679741|561313527|FG001|Period 1|Lost to Follow-up|1|||
155515629|NCT03679741|561313526|FG000|Period 1|Adverse Event|1|||
155515630|NCT03679741|561313527|FG001|Period 1|Adverse Event|1|||
155515631|NCT03679741|561313526|FG000|Period 1|Withdrawal by Subject|0|||
155515632|NCT03679741|561313527|FG001|Period 1|Withdrawal by Subject|1|||
155515633|NCT03679741|561313526|FG000|Period 2|Adverse Event|2|||
155515634|NCT03679741|561313527|FG001|Period 2|Adverse Event|1|||
155515635|NCT03679741|561313526|FG000|Period 2|Withdrawal by Subject|1|||
155515636|NCT03679741|561313527|FG001|Period 2|Withdrawal by Subject|1|||
155515637|NCT02227862|561313531|FG000|Overall Study|Protocol Violation|7|||
155515638|NCT02227862|561313532|FG001|Overall Study|Protocol Violation|9|||
155515639|NCT02227862|561313531|FG000|Overall Study|Other|0|||
155515640|NCT02227862|561313532|FG001|Overall Study|Other|2|||
155515641|NCT02227862|561313531|FG000|Overall Study|Adverse Event|4|||
155515642|NCT02227862|561313532|FG001|Overall Study|Adverse Event|3|||
155651672|NCT03721107|561816276|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155452923|NCT00586924|561081153|FG003|Overall Study|Development of neutralizing antibodies|0|||
155452924|NCT00586924|561081154|FG004|Overall Study|Development of neutralizing antibodies|0|||
155452925|NCT00586924|561081155|FG005|Overall Study|Development of neutralizing antibodies|22|||
155452926|NCT00586924|561081150|FG000|Overall Study|Complete response|0|||
155452927|NCT00586924|561081151|FG001|Overall Study|Complete response|1|||
155452928|NCT00586924|561081152|FG002|Overall Study|Complete response|0|||
155452929|NCT00586924|561081153|FG003|Overall Study|Complete response|0|||
155452930|NCT00586924|561081154|FG004|Overall Study|Complete response|2|||
155452931|NCT00586924|561081155|FG005|Overall Study|Complete response|2|||
155452932|NCT00586924|561081150|FG000|Overall Study|Other|1|||
155452933|NCT00586924|561081151|FG001|Overall Study|Other|0|||
155452934|NCT00586924|561081152|FG002|Overall Study|Other|1|||
155452935|NCT00586924|561081153|FG003|Overall Study|Other|1|||
155452936|NCT00586924|561081154|FG004|Overall Study|Other|1|||
155452937|NCT00586924|561081155|FG005|Overall Study|Other|6|||
155452938|NCT01767194|561081157|FG000|Overall Study|Adverse Event|1|||
155452939|NCT01767194|561081158|FG001|Overall Study|Adverse Event|1|||
155452940|NCT01767194|561081157|FG000|Overall Study|Death|0|||
155452941|NCT01767194|561081158|FG001|Overall Study|Death|1|||
155452942|NCT01767194|561081157|FG000|Overall Study|Lack of Efficacy|12|||
155452943|NCT01767194|561081158|FG001|Overall Study|Lack of Efficacy|11|||
155452944|NCT01767194|561081157|FG000|Overall Study|Physician Decision|2|||
155452945|NCT01767194|561081158|FG001|Overall Study|Physician Decision|23|||
155452946|NCT01767194|561081157|FG000|Overall Study|Withdrawal by Subject|0|||
155452947|NCT01767194|561081158|FG001|Overall Study|Withdrawal by Subject|1|||
155452948|NCT01767194|561081157|FG000|Overall Study|Ineligible|1|||
155452949|NCT01767194|561081158|FG001|Overall Study|Ineligible|1|||
155452950|NCT01767194|561081157|FG000|Overall Study|Refusal by patient/parent|2|||
155452951|NCT01767194|561081158|FG001|Overall Study|Refusal by patient/parent|4|||
155452952|NCT01767194|561081157|FG000|Overall Study|Criteria not met on time for next cycle|0|||
155452953|NCT01767194|561081158|FG001|Overall Study|Criteria not met on time for next cycle|1|||
155452954|NCT01683071|561081162|FG000|Part 1|Lack of Efficacy|1|||
155452955|NCT01683071|561081163|FG001|Part 1|Lack of Efficacy|0|||
155452956|NCT01683071|561081164|FG002|Part 1|Lack of Efficacy|0|||
155452957|NCT01683071|561081165|FG003|Part 1|Lack of Efficacy|3|||
155452958|NCT01683071|561081166|FG004|Part 1|Lack of Efficacy|0|||
155452959|NCT01683071|561081167|FG005|Part 1|Lack of Efficacy|0|||
155452960|NCT01683071|561081162|FG000|Part 1|Withdrawal by Subject|1|||
155452961|NCT01683071|561081163|FG001|Part 1|Withdrawal by Subject|2|||
155452962|NCT01683071|561081164|FG002|Part 1|Withdrawal by Subject|2|||
155452963|NCT01683071|561081165|FG003|Part 1|Withdrawal by Subject|1|||
155452964|NCT01683071|561081166|FG004|Part 1|Withdrawal by Subject|0|||
155452965|NCT01683071|561081167|FG005|Part 1|Withdrawal by Subject|0|||
155515643|NCT02227862|561313531|FG000|Overall Study|Withdrawal by Subject|7|||
155515644|NCT02227862|561313532|FG001|Overall Study|Withdrawal by Subject|6|||
155452966|NCT01683071|561081162|FG000|Part 1|Surgery Cancelled|1|||
155452967|NCT01683071|561081163|FG001|Part 1|Surgery Cancelled|0|||
155452968|NCT01683071|561081164|FG002|Part 1|Surgery Cancelled|0|||
155452969|NCT01683071|561081165|FG003|Part 1|Surgery Cancelled|0|||
155452970|NCT01683071|561081166|FG004|Part 1|Surgery Cancelled|0|||
155452971|NCT01683071|561081167|FG005|Part 1|Surgery Cancelled|0|||
155452972|NCT01683071|561081162|FG000|Part 1|Did not receive study drug|1|||
155452973|NCT01683071|561081163|FG001|Part 1|Did not receive study drug|0|||
155452974|NCT01683071|561081164|FG002|Part 1|Did not receive study drug|0|||
155452975|NCT01683071|561081165|FG003|Part 1|Did not receive study drug|1|||
155452976|NCT01683071|561081166|FG004|Part 1|Did not receive study drug|0|||
155452977|NCT01683071|561081167|FG005|Part 1|Did not receive study drug|0|||
155515645|NCT02227862|561313531|FG000|Overall Study|Lost to Follow-up|1|||
155515646|NCT02227862|561313532|FG001|Overall Study|Lost to Follow-up|2|||
155515647|NCT00783796|561313533|FG000|Overall Study|Did not receive any stent|4|||
155515648|NCT00783796|561313533|FG000|Overall Study|Received non-XIENCE V stent|1|||
155452978|NCT01683071|561081162|FG000|Part 1|Early termination; met exclusion criteria|0|||
155452979|NCT01683071|561081163|FG001|Part 1|Early termination; met exclusion criteria|2|||
155452980|NCT01683071|561081164|FG002|Part 1|Early termination; met exclusion criteria|1|||
155452981|NCT01683071|561081165|FG003|Part 1|Early termination; met exclusion criteria|0|||
155452982|NCT01683071|561081166|FG004|Part 1|Early termination; met exclusion criteria|0|||
155452983|NCT01683071|561081167|FG005|Part 1|Early termination; met exclusion criteria|0|||
155452984|NCT01683071|561081162|FG000|Part 2|Lack of Efficacy|0|||
155452985|NCT01683071|561081163|FG001|Part 2|Lack of Efficacy|0|||
155452986|NCT01683071|561081164|FG002|Part 2|Lack of Efficacy|0|||
155452987|NCT01683071|561081165|FG003|Part 2|Lack of Efficacy|0|||
155452988|NCT01683071|561081166|FG004|Part 2|Lack of Efficacy|3|||
155452989|NCT01683071|561081167|FG005|Part 2|Lack of Efficacy|4|||
155452990|NCT01683071|561081162|FG000|Part 2|Lost to Follow-up|0|||
155452991|NCT01683071|561081163|FG001|Part 2|Lost to Follow-up|0|||
155452992|NCT01683071|561081164|FG002|Part 2|Lost to Follow-up|0|||
155452993|NCT01683071|561081165|FG003|Part 2|Lost to Follow-up|0|||
155452994|NCT01683071|561081166|FG004|Part 2|Lost to Follow-up|2|||
155452995|NCT01683071|561081167|FG005|Part 2|Lost to Follow-up|0|||
155452996|NCT01683071|561081162|FG000|Part 2|Withdrawal by Subject|0|||
155452997|NCT01683071|561081163|FG001|Part 2|Withdrawal by Subject|0|||
155452998|NCT01683071|561081164|FG002|Part 2|Withdrawal by Subject|0|||
155452999|NCT01683071|561081165|FG003|Part 2|Withdrawal by Subject|0|||
155453000|NCT01683071|561081166|FG004|Part 2|Withdrawal by Subject|3|||
155453001|NCT01683071|561081167|FG005|Part 2|Withdrawal by Subject|3|||
155453002|NCT01683071|561081162|FG000|Part 2|Surgery cancelled|0|||
155453003|NCT01683071|561081163|FG001|Part 2|Surgery cancelled|0|||
155453004|NCT01683071|561081164|FG002|Part 2|Surgery cancelled|0|||
155453005|NCT01683071|561081165|FG003|Part 2|Surgery cancelled|0|||
155453006|NCT01683071|561081166|FG004|Part 2|Surgery cancelled|4|||
155453007|NCT01683071|561081167|FG005|Part 2|Surgery cancelled|2|||
155453008|NCT01683071|561081162|FG000|Part 2|Did not receive study drug|0|||
155453009|NCT01683071|561081163|FG001|Part 2|Did not receive study drug|0|||
155453010|NCT01683071|561081164|FG002|Part 2|Did not receive study drug|0|||
155453011|NCT01683071|561081165|FG003|Part 2|Did not receive study drug|0|||
155453012|NCT01683071|561081166|FG004|Part 2|Did not receive study drug|2|||
155453013|NCT01683071|561081167|FG005|Part 2|Did not receive study drug|1|||
155453014|NCT01683071|561081162|FG000|Part 2|Met exclusion criterion|0|||
155453015|NCT01683071|561081163|FG001|Part 2|Met exclusion criterion|0|||
155453016|NCT01683071|561081164|FG002|Part 2|Met exclusion criterion|0|||
155453017|NCT01683071|561081165|FG003|Part 2|Met exclusion criterion|0|||
155453018|NCT01683071|561081166|FG004|Part 2|Met exclusion criterion|1|||
155453019|NCT01683071|561081167|FG005|Part 2|Met exclusion criterion|1|||
155453020|NCT01683071|561081162|FG000|Part 2|Protocol deviation|0|||
155453021|NCT01683071|561081163|FG001|Part 2|Protocol deviation|0|||
155453022|NCT01683071|561081164|FG002|Part 2|Protocol deviation|0|||
155453023|NCT01683071|561081165|FG003|Part 2|Protocol deviation|0|||
155453024|NCT01683071|561081166|FG004|Part 2|Protocol deviation|1|||
155453025|NCT01683071|561081167|FG005|Part 2|Protocol deviation|2|||
155453026|NCT01683071|561081162|FG000|Part 2|Withdrawal by investigator decision|0|||
155453027|NCT01683071|561081163|FG001|Part 2|Withdrawal by investigator decision|0|||
155453028|NCT01683071|561081164|FG002|Part 2|Withdrawal by investigator decision|0|||
155453029|NCT01683071|561081165|FG003|Part 2|Withdrawal by investigator decision|0|||
155453030|NCT01683071|561081166|FG004|Part 2|Withdrawal by investigator decision|1|||
155453031|NCT01683071|561081167|FG005|Part 2|Withdrawal by investigator decision|2|||
155453032|NCT00605722|561083315|FG000|Overall Study|Adverse Event|6|||
155453033|NCT00605722|561083315|FG000|Overall Study|Insufficient therapeutic response|44|||
155453034|NCT00605722|561083315|FG000|Overall Study|Failure to return|1|||
155453035|NCT00356863|561083318|FG000|Overall Study|Death|16|||
155453036|NCT00356863|561083319|FG001|Overall Study|Death|32|||
155453037|NCT00356863|561083318|FG000|Overall Study|Lost to Follow-up|76|||
155453038|NCT00356863|561083319|FG001|Overall Study|Lost to Follow-up|43|||
155453039|NCT00836277|561083320|FG000|Overall Study|Not evaluable for response|6|||
155453040|NCT02871401|561083322|FG000|Overall Study|Adverse Event|1|||
155453041|NCT02871401|561083323|FG001|Overall Study|Adverse Event|0|||
155453042|NCT03162055|561083324|FG000|Overall Study|Adverse Event|6|||
155453043|NCT03162055|561083325|FG001|Overall Study|Adverse Event|5|||
155453044|NCT03162055|561083324|FG000|Overall Study|Death|3|||
155453045|NCT03162055|561083325|FG001|Overall Study|Death|3|||
155453046|NCT03162055|561083324|FG000|Overall Study|Lost to Follow-up|0|||
155453047|NCT03162055|561083325|FG001|Overall Study|Lost to Follow-up|1|||
155453048|NCT03162055|561083324|FG000|Overall Study|Study-specific withdrawal criteria|22|||
155453049|NCT03162055|561083325|FG001|Overall Study|Study-specific withdrawal criteria|14|||
155453050|NCT03162055|561083324|FG000|Overall Study|Withdrawal by Subject|17|||
155453051|NCT03162055|561083325|FG001|Overall Study|Withdrawal by Subject|2|||
155453052|NCT03162055|561083324|FG000|Overall Study|Did not receive treatment|2|||
155453053|NCT03162055|561083325|FG001|Overall Study|Did not receive treatment|0|||
155453054|NCT03162055|561083324|FG000|Overall Study|Incorrect randomization|4|||
155453055|NCT03162055|561083325|FG001|Overall Study|Incorrect randomization|3|||
155453056|NCT03162055|561083324|FG000|Overall Study|Other|8|||
155453057|NCT03162055|561083325|FG001|Overall Study|Other|15|||
155453058|NCT00831441|561083329|FG000|Randomized|Death|82|||
155453059|NCT00831441|561083330|FG001|Randomized|Death|81|||
155453060|NCT00831441|561083329|FG000|Randomized|Adverse Event|248|||
155453061|NCT00831441|561083330|FG001|Randomized|Adverse Event|321|||
155453062|NCT00831441|561083329|FG000|Randomized|Emergency procedure|2|||
155453063|NCT00831441|561083330|FG001|Randomized|Emergency procedure|2|||
155453064|NCT00831441|561083329|FG000|Randomized|Elective procedure|26|||
155453065|NCT00831441|561083330|FG001|Randomized|Elective procedure|25|||
155453066|NCT00831441|561083329|FG000|Randomized|Physician Decision|26|||
155453067|NCT00831441|561083330|FG001|Randomized|Physician Decision|35|||
155453068|NCT00831441|561083329|FG000|Randomized|No longer met criteria|13|||
155453069|NCT00831441|561083330|FG001|Randomized|No longer met criteria|19|||
155453070|NCT00831441|561083329|FG000|Randomized|Withdrawal by Subject|178|||
155453071|NCT00831441|561083330|FG001|Randomized|Withdrawal by Subject|212|||
155453072|NCT00831441|561083329|FG000|Randomized|Lost to Follow-up|26|||
155453073|NCT00831441|561083330|FG001|Randomized|Lost to Follow-up|35|||
155453074|NCT00831441|561083329|FG000|Randomized|Administrative reason by sponsor|2780|||
155453075|NCT00831441|561083330|FG001|Randomized|Administrative reason by sponsor|2671|||
155453076|NCT00831441|561083329|FG000|Randomized|poor/non-compliance|30|||
155453077|NCT00831441|561083330|FG001|Randomized|poor/non-compliance|38|||
155453078|NCT00831441|561083329|FG000|Randomized|non-specified|276|||
155453079|NCT00831441|561083330|FG001|Randomized|non-specified|266|||
155453080|NCT00831441|561083329|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
155453081|NCT00831441|561083330|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
155453082|NCT00831441|561083329|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
155453083|NCT00831441|561083330|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
155453084|NCT00831441|561083329|FG000|Follow Up (30 Days)|Death|63|||
155453085|NCT00831441|561083330|FG001|Follow Up (30 Days)|Death|86|||
155453086|NCT00831441|561083329|FG000|Follow Up (30 Days)|non-specified|16|||
155453087|NCT00831441|561083330|FG001|Follow Up (30 Days)|non-specified|26|||
155453088|NCT00831441|561083329|FG000|Follow Up (30 Days)|missing end of study status|0|||
155453089|NCT00831441|561083330|FG001|Follow Up (30 Days)|missing end of study status|1|||
155453090|NCT00485589|561083333|FG000|Overall Study|Death|2|||
155453091|NCT00485589|561083334|FG001|Overall Study|Death|2|||
155453092|NCT00485589|561083335|FG002|Overall Study|Death|0|||
155453093|NCT00485589|561083333|FG000|Overall Study|Failure to return|6|||
155453094|NCT00485589|561083334|FG001|Overall Study|Failure to return|5|||
155453095|NCT00485589|561083335|FG002|Overall Study|Failure to return|1|||
155453096|NCT00485589|561083333|FG000|Overall Study|Protocol Violation|1|||
155453097|NCT00485589|561083334|FG001|Overall Study|Protocol Violation|0|||
155453098|NCT00485589|561083335|FG002|Overall Study|Protocol Violation|0|||
155453099|NCT00485589|561083333|FG000|Overall Study|Violation of selection criteria at entry|0|||
155453100|NCT00485589|561083334|FG001|Overall Study|Violation of selection criteria at entry|3|||
155453101|NCT00485589|561083335|FG002|Overall Study|Violation of selection criteria at entry|1|||
155453102|NCT00485589|561083333|FG000|Overall Study|Administrative/Other|1|||
155453103|NCT00485589|561083334|FG001|Overall Study|Administrative/Other|2|||
155453104|NCT00485589|561083335|FG002|Overall Study|Administrative/Other|1|||
155453105|NCT00485589|561083333|FG000|Overall Study|Insufficient therapeutic response|10|||
155453106|NCT00485589|561083334|FG001|Overall Study|Insufficient therapeutic response|3|||
155453107|NCT00485589|561083335|FG002|Overall Study|Insufficient therapeutic response|1|||
155453108|NCT00485589|561083333|FG000|Overall Study|Refused treatment/did not cooperate|1|||
155453109|NCT00485589|561083334|FG001|Overall Study|Refused treatment/did not cooperate|0|||
155453110|NCT00485589|561083335|FG002|Overall Study|Refused treatment/did not cooperate|2|||
155453111|NCT00485589|561083333|FG000|Overall Study|Withdrawal by Subject|3|||
155515649|NCT00783796|561313533|FG000|Overall Study|Received commercial XIENCE V stent|1|||
155515650|NCT01215942|561313537|FG000|Treatment Period|Adverse Event|15|||
155453112|NCT00485589|561083334|FG001|Overall Study|Withdrawal by Subject|2|||
155453113|NCT00485589|561083335|FG002|Overall Study|Withdrawal by Subject|2|||
155453114|NCT00485589|561083333|FG000|Overall Study|Adverse Event|3|||
155453115|NCT00485589|561083334|FG001|Overall Study|Adverse Event|3|||
155453116|NCT00485589|561083335|FG002|Overall Study|Adverse Event|10|||
155515651|NCT01215942|561313538|FG001|Treatment Period|Adverse Event|26|||
155515652|NCT01215942|561313537|FG000|Treatment Period|Death|2|||
155453117|NCT01944969|561083336|FG000|Overall Study|Adverse Event|1|||
155453118|NCT01944969|561083336|FG000|Overall Study|Lack of Efficacy|1|||
155453119|NCT01944969|561083336|FG000|Overall Study|Non-compliance with IMP|1|||
155453120|NCT01944969|561083336|FG000|Overall Study|Administrative or other reasons|23|||
155453121|NCT01104584|561083338|FG000|Overall Study|Study drug never administered|21|||
155453122|NCT01104584|561083338|FG000|Overall Study|Study prematurely discontinued|2|||
155515653|NCT01215942|561313538|FG001|Treatment Period|Death|4|||
155453123|NCT02370498|561083339|FG000|Overall Study|Adverse Event|10|||
155453124|NCT02370498|561083340|FG001|Overall Study|Adverse Event|8|||
155453125|NCT02370498|561083339|FG000|Overall Study|Death|263|||
155453126|NCT02370498|561083340|FG001|Overall Study|Death|265|||
155453127|NCT02370498|561083339|FG000|Overall Study|Protocol Violation|1|||
155453128|NCT02370498|561083340|FG001|Overall Study|Protocol Violation|2|||
155453129|NCT02370498|561083339|FG000|Overall Study|Withdrawal by Subject|7|||
155453130|NCT02370498|561083340|FG001|Overall Study|Withdrawal by Subject|12|||
155453131|NCT02370498|561083339|FG000|Overall Study|Sponsor's decision|15|||
155453132|NCT02370498|561083340|FG001|Overall Study|Sponsor's decision|9|||
155453133|NCT04017442|561083341|FG000|Overall Study|Withdrawal by Subject|0|||
155453134|NCT04017442|561083342|FG001|Overall Study|Withdrawal by Subject|3|||
155453135|NCT04017442|561083341|FG000|Overall Study|Lost to Follow-up|21|||
155453136|NCT04017442|561083342|FG001|Overall Study|Lost to Follow-up|19|||
155453137|NCT02586233|561083346|FG000|Overall Study|Randomized but did not receive treatment|0|||
155453138|NCT02586233|561083347|FG001|Overall Study|Randomized but did not receive treatment|1|||
155453139|NCT02586233|561083348|FG002|Overall Study|Randomized but did not receive treatment|0|||
155453140|NCT02586233|561083349|FG003|Overall Study|Randomized but did not receive treatment|0|||
155453141|NCT02586233|561083350|FG004|Overall Study|Randomized but did not receive treatment|0|||
155453142|NCT02586233|561083351|FG005|Overall Study|Randomized but did not receive treatment|2|||
155453143|NCT02586233|561083352|FG006|Overall Study|Randomized but did not receive treatment|2|||
155453144|NCT02586233|561083346|FG000|Overall Study|Death|0|||
155453145|NCT02586233|561083347|FG001|Overall Study|Death|1|||
155453146|NCT02586233|561083348|FG002|Overall Study|Death|0|||
155453147|NCT02586233|561083349|FG003|Overall Study|Death|0|||
155453148|NCT02586233|561083350|FG004|Overall Study|Death|2|||
155453149|NCT02586233|561083351|FG005|Overall Study|Death|0|||
155453150|NCT02586233|561083352|FG006|Overall Study|Death|0|||
155453151|NCT03225716|561083353|FG000|Overall Study|Withdrawal by Subject|2|||
155453152|NCT03225716|561083354|FG001|Overall Study|Withdrawal by Subject|2|||
155453153|NCT03225716|561083355|FG002|Overall Study|Withdrawal by Subject|0|||
155453154|NCT03225716|561083353|FG000|Overall Study|Lack of Efficacy|1|||
155453155|NCT03225716|561083354|FG001|Overall Study|Lack of Efficacy|0|||
155453156|NCT03225716|561083355|FG002|Overall Study|Lack of Efficacy|0|||
155453157|NCT03225716|561083353|FG000|Overall Study|Adverse Event|2|||
155453158|NCT03225716|561083354|FG001|Overall Study|Adverse Event|0|||
155453159|NCT03225716|561083355|FG002|Overall Study|Adverse Event|1|||
155453160|NCT03225716|561083353|FG000|Overall Study|Study early termination by Sponsor|0|||
155453161|NCT03225716|561083354|FG001|Overall Study|Study early termination by Sponsor|0|||
155453162|NCT03225716|561083355|FG002|Overall Study|Study early termination by Sponsor|2|||
155453163|NCT01205451|561083356|FG000|Overall Study|Lost to Follow-up|1|||
155453164|NCT01205451|561083357|FG001|Overall Study|Lost to Follow-up|1|||
155453165|NCT01205451|561083356|FG000|Overall Study|Withdrawal by Subject|5|||
155453166|NCT01205451|561083357|FG001|Overall Study|Withdrawal by Subject|9|||
155453167|NCT03421964|561083365|FG000|Overall Study|Lost to Follow-up|11|||
155453168|NCT03421964|561083366|FG001|Overall Study|Lost to Follow-up|21|||
155453169|NCT03421964|561083365|FG000|Overall Study|Withdrawal by Subject|9|||
155453170|NCT03421964|561083366|FG001|Overall Study|Withdrawal by Subject|3|||
155453171|NCT03421964|561083365|FG000|Overall Study|Incarcerated|1|||
155453172|NCT03421964|561083366|FG001|Overall Study|Incarcerated|0|||
155453173|NCT03421964|561083365|FG000|Overall Study|Inpt Treatment Facility|1|||
155453174|NCT03421964|561083366|FG001|Overall Study|Inpt Treatment Facility|1|||
155453175|NCT03421964|561083365|FG000|Overall Study|Virtual Platform Issues|1|||
155453176|NCT03421964|561083366|FG001|Overall Study|Virtual Platform Issues|1|||
155453177|NCT02938585|561083367|FG000|Overall Study|Withdrawal by parent or guardian|0|||
155515654|NCT01215942|561313537|FG000|Treatment Period|Lack of Efficacy|23|||
155453178|NCT02938585|561083368|FG001|Overall Study|Withdrawal by parent or guardian|1|||
155453179|NCT02938585|561083369|FG002|Overall Study|Withdrawal by parent or guardian|0|||
155453180|NCT02938585|561083370|FG003|Overall Study|Withdrawal by parent or guardian|0|||
155453181|NCT02938585|561083367|FG000|Overall Study|Withdrawal by Subject|0|||
155453182|NCT02938585|561083368|FG001|Overall Study|Withdrawal by Subject|0|||
155453183|NCT02938585|561083369|FG002|Overall Study|Withdrawal by Subject|0|||
155453184|NCT02938585|561083370|FG003|Overall Study|Withdrawal by Subject|5|||
155453185|NCT02106455|561083378|FG000|Overall Study|Case Report Form Uncollected|6|||
155453186|NCT02106455|561083378|FG000|Overall Study|Protocol Deviation|2|||
155453187|NCT00213980|561083379|FG000|Overall Study|Withdrawal by Subject|3|||
155453188|NCT00213980|561083380|FG001|Overall Study|Withdrawal by Subject|1|||
155453189|NCT00213980|561083379|FG000|Overall Study|Adverse Event|1|||
155453190|NCT00213980|561083380|FG001|Overall Study|Adverse Event|1|||
155453191|NCT00213980|561083379|FG000|Overall Study|Disease progression|0|||
155453192|NCT00213980|561083380|FG001|Overall Study|Disease progression|2|||
155453193|NCT00213980|561083379|FG000|Overall Study|Developed ovarian cancer|1|||
155453194|NCT00213980|561083380|FG001|Overall Study|Developed ovarian cancer|0|||
155453195|NCT00213980|561083379|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
155453196|NCT00213980|561083380|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
155453197|NCT03607838|561083381|FG000|Overall Study|Lack of Efficacy|14|||
155453198|NCT03607838|561083382|FG001|Overall Study|Lack of Efficacy|20|||
155453199|NCT03607838|561083381|FG000|Overall Study|Withdrawal by Subject|13|||
155453200|NCT03607838|561083382|FG001|Overall Study|Withdrawal by Subject|8|||
155453201|NCT03607838|561083381|FG000|Overall Study|Lost to Follow-up|6|||
155453202|NCT03607838|561083382|FG001|Overall Study|Lost to Follow-up|11|||
155453203|NCT03607838|561083381|FG000|Overall Study|Adverse Event|2|||
155453204|NCT03607838|561083382|FG001|Overall Study|Adverse Event|2|||
155453205|NCT03607838|561083381|FG000|Overall Study|Physician Decision|2|||
155453206|NCT03607838|561083382|FG001|Overall Study|Physician Decision|0|||
155453207|NCT03607838|561083381|FG000|Overall Study|Failure to meet randomization criteria|1|||
155453208|NCT03607838|561083382|FG001|Overall Study|Failure to meet randomization criteria|2|||
155453209|NCT03607838|561083381|FG000|Overall Study|Pregnancy|1|||
155453210|NCT03607838|561083382|FG001|Overall Study|Pregnancy|0|||
155453211|NCT03607838|561083381|FG000|Overall Study|Protocol Violation|1|||
155453212|NCT03607838|561083382|FG001|Overall Study|Protocol Violation|0|||
155453213|NCT03607838|561083381|FG000|Overall Study|Due to work|1|||
155453214|NCT03607838|561083382|FG001|Overall Study|Due to work|0|||
155453215|NCT03607838|561083381|FG000|Overall Study|Litigation|0|||
155453216|NCT03607838|561083382|FG001|Overall Study|Litigation|1|||
155453217|NCT03607838|561083381|FG000|Overall Study|Temperature excursion for study drug|0|||
155453218|NCT03607838|561083382|FG001|Overall Study|Temperature excursion for study drug|1|||
155453219|NCT03607838|561083381|FG000|Overall Study|Change of mind|0|||
155453220|NCT03607838|561083382|FG001|Overall Study|Change of mind|1|||
155453221|NCT02411201|561083383|FG000|Overall Study|Adverse Event|2|||
155453222|NCT02411201|561083383|FG000|Overall Study|Withdrawal by Subject|2|||
155453223|NCT02411201|561083383|FG000|Overall Study|Age group completed|2|||
155453224|NCT01260467|561083384|FG000|Overall Study|Withdrawal by Subject|2|||
155453225|NCT00798694|561083385|FG000|Overall Study|Lost to Follow-up|1|||
155453226|NCT00798694|561083386|FG001|Overall Study|Lost to Follow-up|1|||
155453227|NCT00798694|561083385|FG000|Overall Study|Physician Decision|1|||
155453228|NCT00798694|561083386|FG001|Overall Study|Physician Decision|0|||
155453229|NCT03364608|561083390|FG000|Overall Study|Withdrawal by Subject|4|||
155453230|NCT03364608|561083390|FG000|Overall Study|Protocol Violation|2|||
155453231|NCT03364608|561083390|FG000|Overall Study|Lost to Follow-up|2|||
155453232|NCT03888391|561083393|FG000|Overall Study|Lost to Follow-up|15|||
155453233|NCT02504268|561083396|FG000|Overall Study|Adverse Event|18|||
155453234|NCT02504268|561083397|FG001|Overall Study|Adverse Event|8|||
155453235|NCT02504268|561083398|FG002|Overall Study|Adverse Event|14|||
155453236|NCT02504268|561083399|FG003|Overall Study|Adverse Event|0|||
155453237|NCT02504268|561083400|FG004|Overall Study|Adverse Event|0|||
155453238|NCT02504268|561083401|FG005|Overall Study|Adverse Event|0|||
155453239|NCT02504268|561083402|FG006|Overall Study|Adverse Event|0|||
155453240|NCT02504268|561083403|FG007|Overall Study|Adverse Event|0|||
155453241|NCT02504268|561083404|FG008|Overall Study|Adverse Event|0|||
155453242|NCT02504268|561083396|FG000|Overall Study|Withdrawal of Consent|11|||
155453243|NCT02504268|561083397|FG001|Overall Study|Withdrawal of Consent|10|||
155453244|NCT02504268|561083398|FG002|Overall Study|Withdrawal of Consent|3|||
155453245|NCT02504268|561083399|FG003|Overall Study|Withdrawal of Consent|0|||
155453246|NCT02504268|561083400|FG004|Overall Study|Withdrawal of Consent|0|||
155453247|NCT02504268|561083401|FG005|Overall Study|Withdrawal of Consent|0|||
155453248|NCT02504268|561083402|FG006|Overall Study|Withdrawal of Consent|0|||
155453249|NCT02504268|561083403|FG007|Overall Study|Withdrawal of Consent|0|||
155453250|NCT02504268|561083404|FG008|Overall Study|Withdrawal of Consent|0|||
155453251|NCT02504268|561083396|FG000|Overall Study|Pregnancy|2|||
155453252|NCT02504268|561083397|FG001|Overall Study|Pregnancy|0|||
155453253|NCT02504268|561083398|FG002|Overall Study|Pregnancy|0|||
155453254|NCT02504268|561083399|FG003|Overall Study|Pregnancy|0|||
155453255|NCT02504268|561083400|FG004|Overall Study|Pregnancy|0|||
155453256|NCT02504268|561083401|FG005|Overall Study|Pregnancy|0|||
155453257|NCT02504268|561083402|FG006|Overall Study|Pregnancy|0|||
155453258|NCT02504268|561083403|FG007|Overall Study|Pregnancy|0|||
155453259|NCT02504268|561083404|FG008|Overall Study|Pregnancy|0|||
155453260|NCT02504268|561083396|FG000|Overall Study|Lost to Follow-up|3|||
155453261|NCT02504268|561083397|FG001|Overall Study|Lost to Follow-up|6|||
155453262|NCT02504268|561083398|FG002|Overall Study|Lost to Follow-up|4|||
155453263|NCT02504268|561083399|FG003|Overall Study|Lost to Follow-up|0|||
155453264|NCT02504268|561083400|FG004|Overall Study|Lost to Follow-up|0|||
155453265|NCT02504268|561083401|FG005|Overall Study|Lost to Follow-up|0|||
155453266|NCT02504268|561083402|FG006|Overall Study|Lost to Follow-up|0|||
155453267|NCT02504268|561083403|FG007|Overall Study|Lost to Follow-up|0|||
155453268|NCT02504268|561083404|FG008|Overall Study|Lost to Follow-up|0|||
155453269|NCT02504268|561083396|FG000|Overall Study|Death|1|||
155453270|NCT02504268|561083397|FG001|Overall Study|Death|1|||
155453271|NCT02504268|561083398|FG002|Overall Study|Death|0|||
155453272|NCT02504268|561083399|FG003|Overall Study|Death|0|||
155453273|NCT02504268|561083400|FG004|Overall Study|Death|0|||
155453274|NCT02504268|561083401|FG005|Overall Study|Death|0|||
155453275|NCT02504268|561083402|FG006|Overall Study|Death|0|||
155453276|NCT02504268|561083403|FG007|Overall Study|Death|0|||
155453277|NCT02504268|561083404|FG008|Overall Study|Death|0|||
155453278|NCT02504268|561083396|FG000|Overall Study|Subject Request to Discontinue|11|||
155453279|NCT02504268|561083397|FG001|Overall Study|Subject Request to Discontinue|3|||
155453280|NCT02504268|561083398|FG002|Overall Study|Subject Request to Discontinue|6|||
155453281|NCT02504268|561083399|FG003|Overall Study|Subject Request to Discontinue|0|||
155453282|NCT02504268|561083400|FG004|Overall Study|Subject Request to Discontinue|0|||
155453283|NCT02504268|561083401|FG005|Overall Study|Subject Request to Discontinue|0|||
155453284|NCT02504268|561083402|FG006|Overall Study|Subject Request to Discontinue|0|||
155453285|NCT02504268|561083403|FG007|Overall Study|Subject Request to Discontinue|0|||
155453286|NCT02504268|561083404|FG008|Overall Study|Subject Request to Discontinue|0|||
155453287|NCT02504268|561083396|FG000|Overall Study|No Longer Meets Study Criteria|2|||
155453288|NCT02504268|561083397|FG001|Overall Study|No Longer Meets Study Criteria|3|||
155453289|NCT02504268|561083398|FG002|Overall Study|No Longer Meets Study Criteria|0|||
155453290|NCT02504268|561083399|FG003|Overall Study|No Longer Meets Study Criteria|0|||
155453291|NCT02504268|561083400|FG004|Overall Study|No Longer Meets Study Criteria|0|||
155453292|NCT02504268|561083401|FG005|Overall Study|No Longer Meets Study Criteria|0|||
155453293|NCT02504268|561083402|FG006|Overall Study|No Longer Meets Study Criteria|0|||
155453294|NCT02504268|561083403|FG007|Overall Study|No Longer Meets Study Criteria|0|||
155453295|NCT02504268|561083404|FG008|Overall Study|No Longer Meets Study Criteria|0|||
155453296|NCT02504268|561083396|FG000|Overall Study|Lack of Efficacy|11|||
155453297|NCT02504268|561083397|FG001|Overall Study|Lack of Efficacy|35|||
155453298|NCT02504268|561083398|FG002|Overall Study|Lack of Efficacy|9|||
155453299|NCT02504268|561083399|FG003|Overall Study|Lack of Efficacy|0|||
155453300|NCT02504268|561083400|FG004|Overall Study|Lack of Efficacy|0|||
155453301|NCT02504268|561083401|FG005|Overall Study|Lack of Efficacy|0|||
155453302|NCT02504268|561083402|FG006|Overall Study|Lack of Efficacy|0|||
155453303|NCT02504268|561083403|FG007|Overall Study|Lack of Efficacy|0|||
155453304|NCT02504268|561083404|FG008|Overall Study|Lack of Efficacy|0|||
155453305|NCT02504268|561083396|FG000|Overall Study|Poor/Non-Compliance|3|||
155453306|NCT02504268|561083397|FG001|Overall Study|Poor/Non-Compliance|2|||
155453307|NCT02504268|561083398|FG002|Overall Study|Poor/Non-Compliance|3|||
155453308|NCT02504268|561083399|FG003|Overall Study|Poor/Non-Compliance|0|||
155453309|NCT02504268|561083400|FG004|Overall Study|Poor/Non-Compliance|0|||
155453310|NCT02504268|561083401|FG005|Overall Study|Poor/Non-Compliance|0|||
155453311|NCT02504268|561083402|FG006|Overall Study|Poor/Non-Compliance|0|||
155453312|NCT02504268|561083403|FG007|Overall Study|Poor/Non-Compliance|0|||
155453313|NCT02504268|561083404|FG008|Overall Study|Poor/Non-Compliance|0|||
155453314|NCT02504268|561083396|FG000|Overall Study|Not Disclosed|1|||
155453315|NCT02504268|561083397|FG001|Overall Study|Not Disclosed|0|||
155453316|NCT02504268|561083398|FG002|Overall Study|Not Disclosed|2|||
155453317|NCT02504268|561083399|FG003|Overall Study|Not Disclosed|0|||
155453318|NCT02504268|561083400|FG004|Overall Study|Not Disclosed|0|||
155453319|NCT02504268|561083401|FG005|Overall Study|Not Disclosed|0|||
155453320|NCT02504268|561083402|FG006|Overall Study|Not Disclosed|0|||
155453321|NCT02504268|561083403|FG007|Overall Study|Not Disclosed|0|||
155651673|NCT03721107|561816277|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
155651674|NCT03721107|561816274|FG000|Overall Study|Physician Decision|0|||
155453322|NCT02504268|561083404|FG008|Overall Study|Not Disclosed|0|||
155453323|NCT03025217|561083405|FG000|Overall Study|Pregnancy|1|||
155453324|NCT03025217|561083405|FG000|Overall Study|Lost to Follow-up|1|||
155453325|NCT03025217|561083405|FG000|Overall Study|Not eligible, poor English|2|||
155453326|NCT03654755|561083406|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
155651675|NCT03721107|561816275|FG001|Overall Study|Physician Decision|1|||
155453327|NCT03654755|561083407|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
155453328|NCT03654755|561083408|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
155453329|NCT03654755|561083406|FG000|Overall Study|Withdrawal by Subject|2|||
155453330|NCT03654755|561083407|FG001|Overall Study|Withdrawal by Subject|4|||
155453331|NCT03654755|561083408|FG002|Overall Study|Withdrawal by Subject|8|||
155453332|NCT03654755|561083406|FG000|Overall Study|Lost to Follow-up|1|||
155453333|NCT03654755|561083407|FG001|Overall Study|Lost to Follow-up|3|||
155453334|NCT03654755|561083408|FG002|Overall Study|Lost to Follow-up|7|||
155453335|NCT03654755|561083406|FG000|Overall Study|Physician Decision|0|||
155453336|NCT03654755|561083407|FG001|Overall Study|Physician Decision|1|||
155453337|NCT03654755|561083408|FG002|Overall Study|Physician Decision|0|||
155453338|NCT03654755|561083406|FG000|Overall Study|Adverse Event|0|||
155453339|NCT03654755|561083407|FG001|Overall Study|Adverse Event|0|||
155453340|NCT03654755|561083408|FG002|Overall Study|Adverse Event|4|||
155453341|NCT03654755|561083406|FG000|Overall Study|Lack of Efficacy|0|||
155453342|NCT03654755|561083407|FG001|Overall Study|Lack of Efficacy|0|||
155453343|NCT03654755|561083408|FG002|Overall Study|Lack of Efficacy|1|||
155453344|NCT00617409|561083411|FG000|Overall Study|Withdrawal by Subject|4|||
155453345|NCT00617409|561083412|FG001|Overall Study|Withdrawal by Subject|1|||
155453346|NCT00617409|561083413|FG002|Overall Study|Withdrawal by Subject|2|||
155453347|NCT00617409|561083411|FG000|Overall Study|Adverse Event|0|||
155453348|NCT00617409|561083412|FG001|Overall Study|Adverse Event|2|||
155453349|NCT00617409|561083413|FG002|Overall Study|Adverse Event|3|||
155453350|NCT00617409|561083411|FG000|Overall Study|Disease Progression|8|||
155453351|NCT00617409|561083412|FG001|Overall Study|Disease Progression|8|||
155453352|NCT00617409|561083413|FG002|Overall Study|Disease Progression|18|||
155453353|NCT00617409|561083411|FG000|Overall Study|Death|3|||
155453354|NCT00617409|561083412|FG001|Overall Study|Death|5|||
155453355|NCT00617409|561083413|FG002|Overall Study|Death|4|||
155453356|NCT00617409|561083411|FG000|Overall Study|Alternative Therapy|1|||
155453357|NCT00617409|561083412|FG001|Overall Study|Alternative Therapy|2|||
155453358|NCT00617409|561083413|FG002|Overall Study|Alternative Therapy|0|||
155453359|NCT03198754|561083417|FG000|Overall Study|Withdrawal by Subject|5|||
155453360|NCT03198754|561083418|FG001|Overall Study|Withdrawal by Subject|4|||
155453361|NCT03198754|561083417|FG000|Overall Study|Lost to Follow-up|4|||
155453362|NCT03198754|561083418|FG001|Overall Study|Lost to Follow-up|3|||
155453363|NCT03198754|561083417|FG000|Overall Study|Ineligible|2|||
155453364|NCT03198754|561083418|FG001|Overall Study|Ineligible|1|||
155453365|NCT03247413|561083424|FG000|Overall Study|Lost to Follow-up|28|||
155453366|NCT00668200|561083425|FG000|Overall Study|Withdrawal by Subject|2|||
155453367|NCT00668200|561083425|FG000|Overall Study|Lost to Follow-up|1|||
155453368|NCT01496430|561083426|FG000|Overall Study|Adverse Event|0|||
155453369|NCT01496430|561083427|FG001|Overall Study|Adverse Event|0|||
155453370|NCT01496430|561083428|FG002|Overall Study|Adverse Event|1|||
155453371|NCT01496430|561083426|FG000|Overall Study|Major Protocol Deviation|0|||
155453372|NCT01496430|561083427|FG001|Overall Study|Major Protocol Deviation|0|||
155453373|NCT01496430|561083428|FG002|Overall Study|Major Protocol Deviation|1|||
155453374|NCT01496430|561083426|FG000|Overall Study|Lost to Follow-up|2|||
155453375|NCT01496430|561083427|FG001|Overall Study|Lost to Follow-up|3|||
155453376|NCT01496430|561083428|FG002|Overall Study|Lost to Follow-up|1|||
155453377|NCT01496430|561083426|FG000|Overall Study|Voluntary Withdrawal|2|||
155453378|NCT01496430|561083427|FG001|Overall Study|Voluntary Withdrawal|1|||
155453379|NCT01496430|561083428|FG002|Overall Study|Voluntary Withdrawal|6|||
155453380|NCT01496430|561083426|FG000|Overall Study|Principal Investigator Discretion|0|||
155453381|NCT01496430|561083427|FG001|Overall Study|Principal Investigator Discretion|1|||
155453382|NCT01496430|561083428|FG002|Overall Study|Principal Investigator Discretion|1|||
155453383|NCT01496430|561083426|FG000|Overall Study|Other|2|||
155453384|NCT01496430|561083427|FG001|Overall Study|Other|0|||
155453385|NCT01496430|561083428|FG002|Overall Study|Other|0|||
155453386|NCT03806179|561083439|FG000|Overall Study|Progressive disease|0|||
155453387|NCT03806179|561083440|FG001|Overall Study|Progressive disease|2|||
155453388|NCT02662985|561083443|FG000|Treatment Period 1|Adverse Event|0|||
155453389|NCT02662985|561083444|FG001|Treatment Period 1|Adverse Event|2|||
155453390|NCT02662985|561083443|FG000|Treatment Period 1|Protocol Violation|0|||
155453391|NCT02662985|561083444|FG001|Treatment Period 1|Protocol Violation|1|||
155453392|NCT02662985|561083443|FG000|Treatment Period 1|Physician Decision|1|||
155453393|NCT02662985|561083444|FG001|Treatment Period 1|Physician Decision|0|||
155453394|NCT02662985|561083443|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155453395|NCT02662985|561083444|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155453396|NCT02662985|561083443|FG000|Treatment Period 2|Lack of Efficacy|0|||
155453397|NCT02662985|561083444|FG001|Treatment Period 2|Lack of Efficacy|1|||
155453398|NCT02662985|561083443|FG000|Treatment Period 2|Lost to Follow-up|1|||
155453399|NCT02662985|561083444|FG001|Treatment Period 2|Lost to Follow-up|0|||
155453400|NCT02662985|561083443|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
155453401|NCT02662985|561083444|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
155453402|NCT02662985|561083443|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
155453403|NCT02662985|561083444|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
155453404|NCT02662985|561083443|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
155453405|NCT02662985|561083444|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
155453406|NCT02662985|561083443|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
155453407|NCT02662985|561083444|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
155453408|NCT02662985|561083443|FG000|Treatment Period 3 (Extension Period)|Death|0|||
155453409|NCT02662985|561083444|FG001|Treatment Period 3 (Extension Period)|Death|1|||
155453410|NCT05373706|561083449|FG000|Overall Study|Lost to Follow-up|2|||
155453411|NCT05373706|561083450|FG001|Overall Study|Lost to Follow-up|2|||
155453412|NCT01486784|561083451|FG000|Overall Study|Withdrawal by Subject|0|||
155453413|NCT01486784|561083452|FG001|Overall Study|Withdrawal by Subject|0|||
155453414|NCT01486784|561083453|FG002|Overall Study|Withdrawal by Subject|1|||
155453415|NCT01486784|561083454|FG003|Overall Study|Withdrawal by Subject|0|||
155453416|NCT01486784|561083455|FG004|Overall Study|Withdrawal by Subject|1|||
155453417|NCT01486784|561083456|FG005|Overall Study|Withdrawal by Subject|2|||
155453418|NCT01486784|561083451|FG000|Overall Study|Subject did not meet entry criteria|0|||
155651676|NCT03721107|561816276|FG002|Overall Study|Physician Decision|0|||
155515655|NCT01215942|561313538|FG001|Treatment Period|Lack of Efficacy|62|||
155515656|NCT01215942|561313537|FG000|Treatment Period|Lost to Follow-up|3|||
155515657|NCT01215942|561313538|FG001|Treatment Period|Lost to Follow-up|4|||
155515658|NCT01215942|561313537|FG000|Treatment Period|Withdrawal by Subject|17|||
155515659|NCT01215942|561313538|FG001|Treatment Period|Withdrawal by Subject|40|||
155515660|NCT01215942|561313537|FG000|Treatment Period|Physician Decision|5|||
155515661|NCT01215942|561313538|FG001|Treatment Period|Physician Decision|5|||
155515662|NCT01215942|561313537|FG000|Treatment Period|Protocol Violation|0|||
155453419|NCT01486784|561083452|FG001|Overall Study|Subject did not meet entry criteria|0|||
155453420|NCT01486784|561083453|FG002|Overall Study|Subject did not meet entry criteria|0|||
155453421|NCT01486784|561083454|FG003|Overall Study|Subject did not meet entry criteria|0|||
155453422|NCT01486784|561083455|FG004|Overall Study|Subject did not meet entry criteria|1|||
155453423|NCT01486784|561083456|FG005|Overall Study|Subject did not meet entry criteria|0|||
155453424|NCT01486784|561083451|FG000|Overall Study|Death|0|||
155453425|NCT01486784|561083452|FG001|Overall Study|Death|0|||
155453426|NCT01486784|561083453|FG002|Overall Study|Death|0|||
155453427|NCT01486784|561083454|FG003|Overall Study|Death|0|||
155453428|NCT01486784|561083455|FG004|Overall Study|Death|0|||
155453429|NCT01486784|561083456|FG005|Overall Study|Death|1|||
155453430|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
155453431|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
155453432|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Death|2|||
155453433|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Death|1|||
155453434|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
155453435|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
155453436|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
155453437|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
155453438|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
155453439|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
155453440|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
155453441|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
155453442|NCT03633227|561083457|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
155453443|NCT03633227|561083458|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
155453444|NCT03633227|561083457|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
155453445|NCT03633227|561083458|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
155453446|NCT03633227|561083457|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
155453447|NCT03633227|561083458|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
155453448|NCT03633227|561083457|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
155453449|NCT03633227|561083458|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
155453450|NCT03633227|561083457|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
155453451|NCT03633227|561083458|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
155453452|NCT03633227|561083457|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
155453453|NCT03633227|561083458|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
155453454|NCT01479374|561083464|FG000|Overall Study|Adverse Event|2|||
155453455|NCT01479374|561083465|FG001|Overall Study|Adverse Event|1|||
155453456|NCT01479374|561083466|FG002|Overall Study|Adverse Event|0|||
155453457|NCT01479374|561083464|FG000|Overall Study|Lost to Follow-up|1|||
155453458|NCT01479374|561083465|FG001|Overall Study|Lost to Follow-up|2|||
155453459|NCT01479374|561083466|FG002|Overall Study|Lost to Follow-up|0|||
155453460|NCT01479374|561083464|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
155453461|NCT01479374|561083465|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
155453462|NCT01479374|561083466|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
155453463|NCT01479374|561083464|FG000|Overall Study|Other|0|||
155453464|NCT01479374|561083465|FG001|Overall Study|Other|4|||
155453465|NCT01479374|561083466|FG002|Overall Study|Other|5|||
155453466|NCT03628508|561083467|FG000|Overall Study|Lost to Follow-up|1|||
155453467|NCT01996748|561083468|FG000|Overall Study|Personal reason|1|||
155453468|NCT01996748|561083469|FG001|Overall Study|Personal reason|0|||
155453469|NCT01996748|561083468|FG000|Overall Study|Physician Decision|2|||
155453470|NCT01996748|561083469|FG001|Overall Study|Physician Decision|0|||
155453471|NCT01996748|561083468|FG000|Overall Study|Adverse Event|1|||
155453472|NCT01996748|561083469|FG001|Overall Study|Adverse Event|4|||
155453473|NCT01996748|561083468|FG000|Overall Study|Withdrawal by Subject|0|||
155453474|NCT01996748|561083469|FG001|Overall Study|Withdrawal by Subject|1|||
155515663|NCT01215942|561313538|FG001|Treatment Period|Protocol Violation|1|||
155453475|NCT01996748|561083468|FG000|Overall Study|Lost to Follow-up|4|||
155453476|NCT01996748|561083469|FG001|Overall Study|Lost to Follow-up|1|||
155453477|NCT00243230|561083470|FG000|Double-Blind Period|Adverse Event|0|||
155453478|NCT00243230|561083471|FG001|Double-Blind Period|Adverse Event|2|||
155453479|NCT00243230|561083472|FG002|Double-Blind Period|Adverse Event|2|||
155515664|NCT01215942|561313537|FG000|Treatment Period|Sponsor Decision|349|||
155515665|NCT01215942|561313538|FG001|Treatment Period|Sponsor Decision|530|||
155515666|NCT01215942|561313537|FG000|Post-Treatment Follow-Up Period|Death|0|||
155453480|NCT00243230|561083473|FG003|Double-Blind Period|Adverse Event|0|||
155453481|NCT00243230|561083470|FG000|Double-Blind Period|Withdrawal by Subject|1|||
155453482|NCT00243230|561083471|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155453483|NCT00243230|561083472|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155453484|NCT00243230|561083473|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155453485|NCT00243230|561083470|FG000|Double-Blind Period|Protocol Violation|0|||
155453486|NCT00243230|561083471|FG001|Double-Blind Period|Protocol Violation|0|||
155453487|NCT00243230|561083472|FG002|Double-Blind Period|Protocol Violation|1|||
155453488|NCT00243230|561083473|FG003|Double-Blind Period|Protocol Violation|0|||
155453489|NCT00243230|561083470|FG000|Double-Blind Period|Randomized but Not Treated|0|||
155453490|NCT00243230|561083471|FG001|Double-Blind Period|Randomized but Not Treated|0|||
155453491|NCT00243230|561083472|FG002|Double-Blind Period|Randomized but Not Treated|2|||
155453492|NCT00243230|561083473|FG003|Double-Blind Period|Randomized but Not Treated|0|||
155453493|NCT00243230|561083470|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
155453494|NCT00243230|561083471|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
155453495|NCT00243230|561083472|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
155453496|NCT00243230|561083473|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
155453497|NCT00243230|561083470|FG000|Open Label Period|Adverse Event|0|||
155453498|NCT00243230|561083471|FG001|Open Label Period|Adverse Event|0|||
155453499|NCT00243230|561083472|FG002|Open Label Period|Adverse Event|0|||
155453500|NCT00243230|561083473|FG003|Open Label Period|Adverse Event|2|||
155453501|NCT00243230|561083470|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
155453502|NCT00243230|561083471|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
155453503|NCT00243230|561083472|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
155453504|NCT00243230|561083473|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
155453505|NCT00243230|561083470|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
155453506|NCT00243230|561083471|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
155453507|NCT00243230|561083472|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
155453508|NCT00243230|561083473|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
155453509|NCT00243230|561083470|FG000|Open Label Period|Lost to Follow-up|0|||
155453510|NCT00243230|561083471|FG001|Open Label Period|Lost to Follow-up|0|||
155453511|NCT00243230|561083472|FG002|Open Label Period|Lost to Follow-up|0|||
155453512|NCT00243230|561083473|FG003|Open Label Period|Lost to Follow-up|2|||
155453513|NCT00243230|561083470|FG000|Open Label Period|Withdrawal by Subject|0|||
155453514|NCT00243230|561083471|FG001|Open Label Period|Withdrawal by Subject|0|||
155453515|NCT00243230|561083472|FG002|Open Label Period|Withdrawal by Subject|0|||
155453516|NCT00243230|561083473|FG003|Open Label Period|Withdrawal by Subject|2|||
155453517|NCT00243230|561083470|FG000|Open Label Period|Protocol Violation|0|||
155453518|NCT00243230|561083471|FG001|Open Label Period|Protocol Violation|0|||
155453519|NCT00243230|561083472|FG002|Open Label Period|Protocol Violation|0|||
155453520|NCT00243230|561083473|FG003|Open Label Period|Protocol Violation|2|||
155453521|NCT00243230|561083470|FG000|Open Label Period|Administrative Reason|0|||
155453522|NCT00243230|561083471|FG001|Open Label Period|Administrative Reason|0|||
155453523|NCT00243230|561083472|FG002|Open Label Period|Administrative Reason|0|||
155453524|NCT00243230|561083473|FG003|Open Label Period|Administrative Reason|63|||
155453525|NCT03011840|561083474|FG000|Overall Study|Not received PIL in post PIL phase|0|||
155453526|NCT03011840|561083475|FG001|Overall Study|Not received PIL in post PIL phase|21|||
155453527|NCT02112994|561083476|FG000|Overall Study|Progressive Disease|0|||
155453528|NCT02112994|561083477|FG001|Overall Study|Progressive Disease|0|||
155453529|NCT02112994|561083478|FG002|Overall Study|Progressive Disease|1|||
155453530|NCT02112994|561083476|FG000|Overall Study|Pregnancy|0|||
155453531|NCT02112994|561083477|FG001|Overall Study|Pregnancy|1|||
155453532|NCT02112994|561083478|FG002|Overall Study|Pregnancy|1|||
155453533|NCT02112994|561083476|FG000|Overall Study|Liver Transplant|0|||
155453534|NCT02112994|561083477|FG001|Overall Study|Liver Transplant|1|||
155453535|NCT02112994|561083478|FG002|Overall Study|Liver Transplant|0|||
155453536|NCT02112994|561083476|FG000|Overall Study|Withdrawal by Subject|0|||
155651677|NCT03721107|561816277|FG003|Overall Study|Physician Decision|0|||
155453537|NCT02112994|561083477|FG001|Overall Study|Withdrawal by Subject|0|||
155453538|NCT02112994|561083478|FG002|Overall Study|Withdrawal by Subject|1|||
155453539|NCT04031404|561084802|FG000|Baseline|Lost to Follow-up|0|||
155453540|NCT04031404|561084803|FG001|Baseline|Lost to Follow-up|1|||
155453541|NCT04031404|561084802|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
155453542|NCT04031404|561084803|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
155453543|NCT04031404|561084802|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
155453544|NCT04031404|561084803|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
155453545|NCT04031404|561084802|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
155453546|NCT04031404|561084803|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
155453547|NCT04031404|561084802|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
155453548|NCT04031404|561084803|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
155453549|NCT01993615|561084807|FG000|Overall Study|Death|1|||
155453550|NCT01993615|561084808|FG001|Overall Study|Death|0|||
155453551|NCT02282982|561084814|FG000|Overall Study|Lost to Follow-up|15|||
155453552|NCT02282982|561084814|FG000|Overall Study|Withdrew consent|2|||
155453553|NCT02282982|561084814|FG000|Overall Study|Death|4|||
155453554|NCT02282982|561084814|FG000|Overall Study|Lack of product|156|||
155453555|NCT02282982|561084814|FG000|Overall Study|Palivizumab is ended|11|||
155453556|NCT02282982|561084814|FG000|Overall Study|Other, not specified|18|||
155453557|NCT01354353|561084815|FG000|Overall Study|Adverse Event|1|||
155453558|NCT01354353|561084816|FG001|Overall Study|Adverse Event|0|||
155453559|NCT01354353|561084817|FG002|Overall Study|Adverse Event|0|||
155453560|NCT01354353|561084818|FG003|Overall Study|Adverse Event|4|||
155453561|NCT01354353|561084819|FG004|Overall Study|Adverse Event|0|||
155453562|NCT01354353|561084820|FG005|Overall Study|Adverse Event|5|||
155453563|NCT01354353|561084815|FG000|Overall Study|Entry Criteria Not Met|0|||
155453564|NCT01354353|561084816|FG001|Overall Study|Entry Criteria Not Met|0|||
155453565|NCT01354353|561084817|FG002|Overall Study|Entry Criteria Not Met|0|||
155453566|NCT01354353|561084818|FG003|Overall Study|Entry Criteria Not Met|1|||
155453567|NCT01354353|561084819|FG004|Overall Study|Entry Criteria Not Met|1|||
155453568|NCT01354353|561084820|FG005|Overall Study|Entry Criteria Not Met|0|||
155453569|NCT01354353|561084815|FG000|Overall Study|Physician Decision|0|||
155453570|NCT01354353|561084816|FG001|Overall Study|Physician Decision|1|||
155453571|NCT01354353|561084817|FG002|Overall Study|Physician Decision|1|||
155453572|NCT01354353|561084818|FG003|Overall Study|Physician Decision|0|||
155453573|NCT01354353|561084819|FG004|Overall Study|Physician Decision|0|||
155453574|NCT01354353|561084820|FG005|Overall Study|Physician Decision|0|||
155453575|NCT01354353|561084815|FG000|Overall Study|Withdrawal by Subject|2|||
155453576|NCT01354353|561084816|FG001|Overall Study|Withdrawal by Subject|0|||
155453577|NCT01354353|561084817|FG002|Overall Study|Withdrawal by Subject|1|||
155453578|NCT01354353|561084818|FG003|Overall Study|Withdrawal by Subject|0|||
155453579|NCT01354353|561084819|FG004|Overall Study|Withdrawal by Subject|0|||
155453580|NCT01354353|561084820|FG005|Overall Study|Withdrawal by Subject|1|||
155453581|NCT05674344|561084821|FG000|Overall Study|Screen Fail|21|||
155453582|NCT05674344|561084821|FG000|Overall Study|Incomplete study procedures|3|||
155453583|NCT00111917|561084822|FG000|Overall Study|Withdrawal by Subject|1|||
155453584|NCT00111917|561084823|FG001|Overall Study|Withdrawal by Subject|1|||
155453585|NCT01640925|561084824|FG000|Overall Study|Withdrawal by Subject|1|||
155453586|NCT01640925|561084825|FG001|Overall Study|Withdrawal by Subject|0|||
155453587|NCT01640925|561084824|FG000|Overall Study|Previously enrolled in this trial|13|||
155453588|NCT01640925|561084825|FG001|Overall Study|Previously enrolled in this trial|11|||
155453589|NCT02156492|561084826|FG000|Period 1|No Reason Given|0|||
155453590|NCT02156492|561084827|FG001|Period 1|No Reason Given|1|||
155453591|NCT02156492|561084828|FG002|Period 1|No Reason Given|0|||
155453592|NCT02156492|561084826|FG000|Period 3|Adverse Event|0|||
155453593|NCT02156492|561084827|FG001|Period 3|Adverse Event|1|||
155453594|NCT02156492|561084828|FG002|Period 3|Adverse Event|0|||
155453595|NCT02924688|561084837|FG000|Overall Study|Adverse Event|9|||
155453596|NCT02924688|561084838|FG001|Overall Study|Adverse Event|3|||
155453597|NCT02924688|561084839|FG002|Overall Study|Adverse Event|2|||
155453598|NCT02924688|561084840|FG003|Overall Study|Adverse Event|2|||
155453599|NCT02924688|561084841|FG004|Overall Study|Adverse Event|3|||
155453600|NCT02924688|561084842|FG005|Overall Study|Adverse Event|2|||
155453601|NCT02924688|561084837|FG000|Overall Study|Lack of Efficacy|2|||
155453602|NCT02924688|561084838|FG001|Overall Study|Lack of Efficacy|3|||
155453603|NCT02924688|561084839|FG002|Overall Study|Lack of Efficacy|4|||
155453604|NCT02924688|561084840|FG003|Overall Study|Lack of Efficacy|2|||
155453605|NCT02924688|561084841|FG004|Overall Study|Lack of Efficacy|1|||
155453606|NCT02924688|561084842|FG005|Overall Study|Lack of Efficacy|1|||
155453607|NCT02924688|561084837|FG000|Overall Study|Protocol Violation|3|||
155453608|NCT02924688|561084838|FG001|Overall Study|Protocol Violation|7|||
155453609|NCT02924688|561084839|FG002|Overall Study|Protocol Violation|5|||
155453610|NCT02924688|561084840|FG003|Overall Study|Protocol Violation|6|||
155453611|NCT02924688|561084841|FG004|Overall Study|Protocol Violation|2|||
155453612|NCT02924688|561084842|FG005|Overall Study|Protocol Violation|2|||
155453613|NCT02924688|561084837|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
155453614|NCT02924688|561084838|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
155453615|NCT02924688|561084839|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
155453616|NCT02924688|561084840|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
155453617|NCT02924688|561084841|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
155453618|NCT02924688|561084842|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
155453619|NCT02924688|561084837|FG000|Overall Study|Lost to Follow-up|2|||
155453620|NCT02924688|561084838|FG001|Overall Study|Lost to Follow-up|4|||
155453621|NCT02924688|561084839|FG002|Overall Study|Lost to Follow-up|2|||
155453622|NCT02924688|561084840|FG003|Overall Study|Lost to Follow-up|4|||
155453623|NCT02924688|561084841|FG004|Overall Study|Lost to Follow-up|2|||
155453624|NCT02924688|561084842|FG005|Overall Study|Lost to Follow-up|4|||
155453625|NCT02924688|561084837|FG000|Overall Study|Physician Decision|2|||
155453626|NCT02924688|561084838|FG001|Overall Study|Physician Decision|1|||
155453627|NCT02924688|561084839|FG002|Overall Study|Physician Decision|0|||
155453628|NCT02924688|561084840|FG003|Overall Study|Physician Decision|1|||
155453629|NCT02924688|561084841|FG004|Overall Study|Physician Decision|1|||
155453630|NCT02924688|561084842|FG005|Overall Study|Physician Decision|1|||
155453631|NCT02924688|561084837|FG000|Overall Study|Withdrawal by Subject|14|||
155453632|NCT02924688|561084838|FG001|Overall Study|Withdrawal by Subject|13|||
155453633|NCT02924688|561084839|FG002|Overall Study|Withdrawal by Subject|9|||
155453634|NCT02924688|561084840|FG003|Overall Study|Withdrawal by Subject|12|||
155453635|NCT02924688|561084841|FG004|Overall Study|Withdrawal by Subject|13|||
155453636|NCT02924688|561084842|FG005|Overall Study|Withdrawal by Subject|14|||
155453637|NCT03072719|561084845|FG000|Overall Study|Adverse Event|1|||
155453638|NCT03072719|561084846|FG001|Overall Study|Adverse Event|1|||
155453639|NCT00992784|561084853|FG000|Overall Study|Adverse Event|2|||
155453640|NCT00992784|561084854|FG001|Overall Study|Adverse Event|1|||
155453641|NCT00992784|561084855|FG002|Overall Study|Adverse Event|0|||
155453642|NCT00992784|561084853|FG000|Overall Study|Withdrawal by Subject|1|||
155453643|NCT00992784|561084854|FG001|Overall Study|Withdrawal by Subject|1|||
155453644|NCT00992784|561084855|FG002|Overall Study|Withdrawal by Subject|1|||
155453645|NCT00781599|561084856|FG000|Overall Study|Lost to Follow-up|7|||
155453646|NCT00781599|561084857|FG001|Overall Study|Lost to Follow-up|4|||
155453647|NCT01088438|561084858|FG000|Overall Study|Withdrawal by Subject|11|||
155453648|NCT01088438|561084859|FG001|Overall Study|Withdrawal by Subject|6|||
155453649|NCT01088438|561084858|FG000|Overall Study|Lost to Follow-up|18|||
155453650|NCT01088438|561084859|FG001|Overall Study|Lost to Follow-up|30|||
155453651|NCT01363713|561084860|FG000|Overall Study|Adverse Event|1|||
155453652|NCT01363713|561084860|FG000|Overall Study|Protocol Violation|3|||
155453653|NCT01363713|561084860|FG000|Overall Study|Withdrawal by Subject|2|||
155453654|NCT01199055|561084861|FG000|Overall Study|Death|0|||
155453655|NCT01199055|561084862|FG001|Overall Study|Death|1|||
155453656|NCT01199055|561084863|FG002|Overall Study|Death|0|||
155453657|NCT01199055|561084861|FG000|Overall Study|Physician Decision|0|||
155453658|NCT01199055|561084862|FG001|Overall Study|Physician Decision|1|||
155453659|NCT01199055|561084863|FG002|Overall Study|Physician Decision|1|||
155453660|NCT01199055|561084861|FG000|Overall Study|Progressive disease|2|||
155453661|NCT01199055|561084862|FG001|Overall Study|Progressive disease|1|||
155453662|NCT01199055|561084863|FG002|Overall Study|Progressive disease|2|||
155453663|NCT01199055|561084861|FG000|Overall Study|Withdrawal by Subject|0|||
155453664|NCT01199055|561084862|FG001|Overall Study|Withdrawal by Subject|0|||
155453665|NCT01199055|561084863|FG002|Overall Study|Withdrawal by Subject|1|||
155453666|NCT00424294|561084868|FG000|Overall Study|Adverse Event|4|||
155453667|NCT00424294|561084869|FG001|Overall Study|Adverse Event|10|||
155453668|NCT00424294|561084868|FG000|Overall Study|Lack of Efficacy|2|||
155453669|NCT00424294|561084869|FG001|Overall Study|Lack of Efficacy|1|||
155453670|NCT00424294|561084868|FG000|Overall Study|Withdrawal by Subject|1|||
155453671|NCT00424294|561084869|FG001|Overall Study|Withdrawal by Subject|2|||
155453672|NCT00424294|561084868|FG000|Overall Study|Other|0|||
155453673|NCT00424294|561084869|FG001|Overall Study|Other|2|||
155453674|NCT00424294|561084868|FG000|Overall Study|Randomized but not Treated|1|||
155453675|NCT00424294|561084869|FG001|Overall Study|Randomized but not Treated|0|||
155453676|NCT03337152|561084870|FG000|Overall Study|Physician Decision|1|||
155453677|NCT03337152|561084871|FG001|Overall Study|Physician Decision|0|||
155453678|NCT03337152|561084870|FG000|Overall Study|Lost to Follow-up|1|||
155453679|NCT03337152|561084871|FG001|Overall Study|Lost to Follow-up|3|||
155453680|NCT03337152|561084870|FG000|Overall Study|Adverse Event|3|||
155453681|NCT03337152|561084871|FG001|Overall Study|Adverse Event|1|||
155453682|NCT03337152|561084870|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
155453683|NCT03337152|561084871|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
155453684|NCT00718666|561084872|FG000|Booster Phase Year 5|No active participation request|0|||
155453685|NCT00718666|561084873|FG001|Booster Phase Year 5|No active participation request|0|||
155453686|NCT00718666|561084874|FG002|Booster Phase Year 5|No active participation request|1|||
155453687|NCT00718666|561084872|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
155453688|NCT00718666|561084873|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
155453689|NCT00718666|561084874|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
155453690|NCT00718666|561084872|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
155453691|NCT00718666|561084873|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
155453692|NCT00718666|561084874|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
155453693|NCT00718666|561084872|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
155453694|NCT00718666|561084873|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
155453695|NCT00718666|561084874|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
155453696|NCT00421343|561084875|FG000|Overall Study|Death|1|||
155453697|NCT00421343|561084875|FG000|Overall Study|Withdrawal by Subject|2|||
155453698|NCT00421343|561084875|FG000|Overall Study|Lost to Follow-up|3|||
155453699|NCT03471767|561084876|FG000|Overall Study|Withdrawal by Subject|3|||
155453700|NCT03471767|561084877|FG001|Overall Study|Withdrawal by Subject|1|||
155453701|NCT03471767|561084876|FG000|Overall Study|Adverse Event|1|||
155453702|NCT03471767|561084877|FG001|Overall Study|Adverse Event|0|||
155453703|NCT03471767|561084876|FG000|Overall Study|Lost to Follow-up|1|||
155453704|NCT03471767|561084877|FG001|Overall Study|Lost to Follow-up|0|||
155453705|NCT03471767|561084876|FG000|Overall Study|PI Withdrawal|1|||
155453706|NCT03471767|561084877|FG001|Overall Study|PI Withdrawal|3|||
155453707|NCT01952730|561084880|FG000|Overall Study|FDA shut down core lab used by study|1|||
155453708|NCT01019486|561084887|FG000|Overall Study|Withdrawal by Subject|1|||
155453709|NCT01019486|561084888|FG001|Overall Study|Withdrawal by Subject|1|||
155453710|NCT01019486|561084889|FG002|Overall Study|Withdrawal by Subject|1|||
155453711|NCT03442829|561084891|FG000|Overall Study|Scheduling clash|3|||
155453712|NCT03442829|561084892|FG001|Overall Study|Scheduling clash|1|||
155453713|NCT03442829|561084891|FG000|Overall Study|Illness unrelated to study|1|||
155453714|NCT03442829|561084892|FG001|Overall Study|Illness unrelated to study|1|||
155453715|NCT02605447|561084895|FG000|Overall Study|Death|66|||
155453716|NCT02605447|561084895|FG000|Overall Study|Physician Decision|1|||
155453717|NCT02605447|561084895|FG000|Overall Study|Lost to Follow-up|24|||
155453718|NCT02605447|561084895|FG000|Overall Study|Withdrawal by Subject|10|||
155453719|NCT02605447|561084895|FG000|Overall Study|Not disclosed|1|||
155453720|NCT02237157|561084896|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
155453721|NCT02237157|561084897|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
155453722|NCT02237157|561084898|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
155453723|NCT02237157|561084899|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
155453724|NCT02237157|561084896|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
155453725|NCT02237157|561084897|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
155453726|NCT02237157|561084898|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
155453727|NCT02237157|561084899|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
155453728|NCT02045212|561084901|FG000|Overall Study|Adverse Event|0|||
155453729|NCT02045212|561084902|FG001|Overall Study|Adverse Event|1|||
155453730|NCT02045212|561084901|FG000|Overall Study|Withdrawal by Subject|1|||
155453731|NCT02045212|561084902|FG001|Overall Study|Withdrawal by Subject|0|||
155453732|NCT02045212|561084901|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
155453733|NCT02045212|561084902|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
155453734|NCT03126539|561084904|FG000|Overall Study|Lost to Follow-up|1|||
155453735|NCT03126539|561084905|FG001|Overall Study|Lost to Follow-up|1|||
155453736|NCT03126539|561084906|FG002|Overall Study|Lost to Follow-up|1|||
155453737|NCT03126539|561084907|FG003|Overall Study|Lost to Follow-up|0|||
155453738|NCT03126539|561084908|FG004|Overall Study|Lost to Follow-up|0|||
155453739|NCT00926796|561084909|FG000|Overall Study|Did not receive randomized treatment|4|||
155453740|NCT00926796|561084910|FG001|Overall Study|Did not receive randomized treatment|7|||
155453741|NCT00926796|561084909|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
155453742|NCT00926796|561084910|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
155453743|NCT00926796|561084909|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
155453744|NCT00926796|561084910|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
155453745|NCT00926796|561084909|FG000|Overall Study|Adverse Event|7|||
155453746|NCT00926796|561084910|FG001|Overall Study|Adverse Event|14|||
155453747|NCT00926796|561084909|FG000|Overall Study|Lost to Follow-up|22|||
155453748|NCT00926796|561084910|FG001|Overall Study|Lost to Follow-up|13|||
155453749|NCT00926796|561084909|FG000|Overall Study|Protocol Violation|15|||
155453750|NCT00926796|561084910|FG001|Overall Study|Protocol Violation|11|||
155453751|NCT00926796|561084909|FG000|Overall Study|Withdrawal by Subject|1|||
155453752|NCT00926796|561084910|FG001|Overall Study|Withdrawal by Subject|0|||
155453753|NCT00946530|561084916|FG000|Overall Study|Withdrawal by Subject|0|||
155453754|NCT00946530|561084917|FG001|Overall Study|Withdrawal by Subject|3|||
155453755|NCT00946530|561084918|FG002|Overall Study|Withdrawal by Subject|0|||
155515667|NCT01215942|561313538|FG001|Post-Treatment Follow-Up Period|Death|1|||
155453756|NCT00946530|561084919|FG003|Overall Study|Withdrawal by Subject|3|||
155453757|NCT00946530|561084916|FG000|Overall Study|Physician Decision|1|||
155453758|NCT00946530|561084917|FG001|Overall Study|Physician Decision|1|||
155453759|NCT00946530|561084918|FG002|Overall Study|Physician Decision|1|||
155453760|NCT00946530|561084919|FG003|Overall Study|Physician Decision|1|||
155453761|NCT00115804|561084920|FG000|Overall Study|Adverse Event|2|||
155453762|NCT00621855|561084921|FG000|Overall Study|Adverse Event|32|||
155453763|NCT00621855|561084922|FG001|Overall Study|Adverse Event|31|||
155453764|NCT00621855|561084923|FG002|Overall Study|Adverse Event|48|||
155453765|NCT00621855|561084924|FG003|Overall Study|Adverse Event|34|||
155453766|NCT00621855|561084925|FG004|Overall Study|Adverse Event|31|||
155453767|NCT00621855|561084921|FG000|Overall Study|Lost to Follow-up|0|||
155453768|NCT00621855|561084922|FG001|Overall Study|Lost to Follow-up|1|||
155453769|NCT00621855|561084923|FG002|Overall Study|Lost to Follow-up|3|||
155453770|NCT00621855|561084924|FG003|Overall Study|Lost to Follow-up|4|||
155453771|NCT00621855|561084925|FG004|Overall Study|Lost to Follow-up|1|||
155453772|NCT00621855|561084921|FG000|Overall Study|Protocol Violation|16|||
155453773|NCT00621855|561084922|FG001|Overall Study|Protocol Violation|8|||
155453774|NCT00621855|561084923|FG002|Overall Study|Protocol Violation|6|||
155453775|NCT00621855|561084924|FG003|Overall Study|Protocol Violation|7|||
155453776|NCT00621855|561084925|FG004|Overall Study|Protocol Violation|8|||
155453777|NCT00621855|561084921|FG000|Overall Study|Withdrawal by Subject|16|||
155453778|NCT00621855|561084922|FG001|Overall Study|Withdrawal by Subject|11|||
155453779|NCT00621855|561084923|FG002|Overall Study|Withdrawal by Subject|13|||
155453780|NCT00621855|561084924|FG003|Overall Study|Withdrawal by Subject|13|||
155453781|NCT00621855|561084925|FG004|Overall Study|Withdrawal by Subject|9|||
155453782|NCT00621855|561084921|FG000|Overall Study|Other|9|||
155453783|NCT00621855|561084922|FG001|Overall Study|Other|7|||
155651678|NCT03721107|561816274|FG000|Overall Study|Pregnancy|0|||
155651679|NCT03721107|561816275|FG001|Overall Study|Pregnancy|0|||
155651680|NCT03721107|561816276|FG002|Overall Study|Pregnancy|1|||
155651681|NCT03721107|561816277|FG003|Overall Study|Pregnancy|0|||
155651682|NCT03721107|561816274|FG000|Overall Study|Withdrawal by Subject|1|||
155651683|NCT03721107|561816275|FG001|Overall Study|Withdrawal by Subject|1|||
155651684|NCT03721107|561816276|FG002|Overall Study|Withdrawal by Subject|5|||
155651685|NCT03721107|561816277|FG003|Overall Study|Withdrawal by Subject|5|||
155651686|NCT03721107|561816274|FG000|Overall Study|Other|1|||
155651687|NCT03721107|561816275|FG001|Overall Study|Other|0|||
155651688|NCT03721107|561816276|FG002|Overall Study|Other|0|||
155651689|NCT03721107|561816277|FG003|Overall Study|Other|1|||
155651690|NCT04818086|561816280|FG000|Overall Study|Physician Decision|1|||
155651691|NCT04818086|561816281|FG001|Overall Study|Physician Decision|0|||
155651692|NCT04818086|561816280|FG000|Overall Study|Withdrawal by Subject|0|||
155651693|NCT04818086|561816281|FG001|Overall Study|Withdrawal by Subject|1|||
155651694|NCT01835431|561816284|FG000|Overall Study|Adverse Event|1|||
155651695|NCT01835431|561816285|FG001|Overall Study|Adverse Event|0|||
155651696|NCT01835431|561816284|FG000|Overall Study|other|0|||
155651697|NCT01835431|561816285|FG001|Overall Study|other|2|||
155651698|NCT01835431|561816284|FG000|Overall Study|Withdrawal by Subject|6|||
155651699|NCT01835431|561816285|FG001|Overall Study|Withdrawal by Subject|10|||
155651700|NCT01835431|561816284|FG000|Overall Study|Protocol Violation|1|||
155651701|NCT01835431|561816285|FG001|Overall Study|Protocol Violation|0|||
155651702|NCT02792257|561816292|FG000|Overall Study|Lost to Follow-up|3|||
155651703|NCT02792257|561816293|FG001|Overall Study|Lost to Follow-up|4|||
155651704|NCT02792257|561816292|FG000|Overall Study|Allergy|0|||
155651705|NCT02792257|561816293|FG001|Overall Study|Allergy|1|||
155651706|NCT02792257|561816292|FG000|Overall Study|Protocol Violation|2|||
155651707|NCT02792257|561816293|FG001|Overall Study|Protocol Violation|0|||
155651708|NCT02792257|561816292|FG000|Overall Study|Excessive Agitation|0|||
155651709|NCT02792257|561816293|FG001|Overall Study|Excessive Agitation|1|||
155651710|NCT02792257|561816292|FG000|Overall Study|Not Feeling Well|0|||
155651711|NCT02792257|561816293|FG001|Overall Study|Not Feeling Well|1|||
155651712|NCT02946996|561816294|FG000|Overall Study|non-evaluable|3|||
155651713|NCT02946996|561816295|FG001|Overall Study|non-evaluable|6|||
155651714|NCT02946996|561816296|FG002|Overall Study|non-evaluable|5|||
155651715|NCT02151604|561816299|FG000|Overall Study|Lost to Follow-up|3|||
155651716|NCT02151604|561816299|FG000|Overall Study|Withdrawal by Subject|2|||
155651717|NCT02151604|561816299|FG000|Overall Study|Physician Decision|3|||
155453784|NCT00621855|561084923|FG002|Overall Study|Other|6|||
155651718|NCT02151604|561816299|FG000|Overall Study|Death|1|||
155651719|NCT02568254|561816300|FG000|Period 2|Adverse Event|0|||
155651720|NCT02568254|561816301|FG001|Period 2|Adverse Event|0|||
155651721|NCT02568254|561816302|FG002|Period 2|Adverse Event|1|||
155651722|NCT02568254|561816303|FG003|Period 2|Adverse Event|0|||
155453785|NCT00621855|561084924|FG003|Overall Study|Other|5|||
155453786|NCT00621855|561084925|FG004|Overall Study|Other|4|||
155453787|NCT00621855|561084921|FG000|Overall Study|Patients did not receive study drug|3|||
155453788|NCT00621855|561084922|FG001|Overall Study|Patients did not receive study drug|3|||
155651723|NCT02568254|561816304|FG004|Period 2|Adverse Event|0|||
155651724|NCT02568254|561816305|FG005|Period 2|Adverse Event|0|||
155651725|NCT02568254|561816300|FG000|Period 3|Unstatisfactory Lens fitting|0|||
155651726|NCT02568254|561816301|FG001|Period 3|Unstatisfactory Lens fitting|0|||
155651727|NCT02568254|561816302|FG002|Period 3|Unstatisfactory Lens fitting|0|||
155651728|NCT02568254|561816303|FG003|Period 3|Unstatisfactory Lens fitting|0|||
155651729|NCT02568254|561816304|FG004|Period 3|Unstatisfactory Lens fitting|1|||
155651730|NCT02568254|561816305|FG005|Period 3|Unstatisfactory Lens fitting|0|||
155651731|NCT00655746|561816306|FG000|Overall Study|Withdrawal by Subject|1|||
155453789|NCT00621855|561084923|FG002|Overall Study|Patients did not receive study drug|5|||
155453790|NCT00621855|561084924|FG003|Overall Study|Patients did not receive study drug|4|||
155453791|NCT00621855|561084925|FG004|Overall Study|Patients did not receive study drug|2|||
155453792|NCT03095521|561084926|FG000|Overall Study|Withdrawal by Subject|0|||
155453793|NCT03095521|561084927|FG001|Overall Study|Withdrawal by Subject|1|||
155453794|NCT03095521|561084926|FG000|Overall Study|Lost to Follow-up|0|||
155453795|NCT03095521|561084927|FG001|Overall Study|Lost to Follow-up|1|||
155453796|NCT00430521|561084930|FG000|Overall Study|Adverse Event|0|||
155453797|NCT00430521|561084931|FG001|Overall Study|Adverse Event|0|||
155453798|NCT00430521|561084932|FG002|Overall Study|Adverse Event|0|||
155453799|NCT00430521|561084933|FG003|Overall Study|Adverse Event|0|||
155453800|NCT00430521|561084934|FG004|Overall Study|Adverse Event|0|||
155453801|NCT00430521|561084935|FG005|Overall Study|Adverse Event|2|||
155453802|NCT00430521|561084936|FG006|Overall Study|Adverse Event|1|||
155453803|NCT00430521|561084937|FG007|Overall Study|Adverse Event|0|||
155453804|NCT00430521|561084930|FG000|Overall Study|Lost to Follow-up|7|||
155453805|NCT00430521|561084931|FG001|Overall Study|Lost to Follow-up|8|||
155453806|NCT00430521|561084932|FG002|Overall Study|Lost to Follow-up|3|||
155453807|NCT00430521|561084933|FG003|Overall Study|Lost to Follow-up|5|||
155453808|NCT00430521|561084934|FG004|Overall Study|Lost to Follow-up|5|||
155453809|NCT00430521|561084935|FG005|Overall Study|Lost to Follow-up|2|||
155453810|NCT00430521|561084936|FG006|Overall Study|Lost to Follow-up|8|||
155453811|NCT00430521|561084937|FG007|Overall Study|Lost to Follow-up|10|||
155453812|NCT00430521|561084930|FG000|Overall Study|Pregnancy|0|||
155453813|NCT00430521|561084931|FG001|Overall Study|Pregnancy|0|||
155453814|NCT00430521|561084932|FG002|Overall Study|Pregnancy|0|||
155453815|NCT00430521|561084933|FG003|Overall Study|Pregnancy|0|||
155453816|NCT00430521|561084934|FG004|Overall Study|Pregnancy|0|||
155453817|NCT00430521|561084935|FG005|Overall Study|Pregnancy|0|||
155453818|NCT00430521|561084936|FG006|Overall Study|Pregnancy|1|||
155453819|NCT00430521|561084937|FG007|Overall Study|Pregnancy|0|||
155453820|NCT00430521|561084930|FG000|Overall Study|Vaccine Expired|0|||
155453821|NCT00430521|561084931|FG001|Overall Study|Vaccine Expired|0|||
155453822|NCT00430521|561084932|FG002|Overall Study|Vaccine Expired|0|||
155453823|NCT00430521|561084933|FG003|Overall Study|Vaccine Expired|0|||
155453824|NCT00430521|561084934|FG004|Overall Study|Vaccine Expired|0|||
155453825|NCT00430521|561084935|FG005|Overall Study|Vaccine Expired|1|||
155453826|NCT00430521|561084936|FG006|Overall Study|Vaccine Expired|0|||
155453827|NCT00430521|561084937|FG007|Overall Study|Vaccine Expired|0|||
155453828|NCT00430521|561084930|FG000|Overall Study|Protocol Violation|1|||
155453829|NCT00430521|561084931|FG001|Overall Study|Protocol Violation|0|||
155453830|NCT00430521|561084932|FG002|Overall Study|Protocol Violation|0|||
155453831|NCT00430521|561084933|FG003|Overall Study|Protocol Violation|0|||
155453832|NCT00430521|561084934|FG004|Overall Study|Protocol Violation|0|||
155453833|NCT00430521|561084935|FG005|Overall Study|Protocol Violation|0|||
155453834|NCT00430521|561084936|FG006|Overall Study|Protocol Violation|0|||
155453835|NCT00430521|561084937|FG007|Overall Study|Protocol Violation|0|||
155453836|NCT00430521|561084930|FG000|Overall Study|Withdrawal by Subject|3|||
155453837|NCT00430521|561084931|FG001|Overall Study|Withdrawal by Subject|1|||
155453838|NCT00430521|561084932|FG002|Overall Study|Withdrawal by Subject|0|||
155453839|NCT00430521|561084933|FG003|Overall Study|Withdrawal by Subject|3|||
155453840|NCT00430521|561084934|FG004|Overall Study|Withdrawal by Subject|0|||
155453841|NCT00430521|561084935|FG005|Overall Study|Withdrawal by Subject|0|||
155453842|NCT00430521|561084936|FG006|Overall Study|Withdrawal by Subject|0|||
155453843|NCT00430521|561084937|FG007|Overall Study|Withdrawal by Subject|2|||
155453844|NCT02198651|561086791|FG000|Lead-in Period|Withdrew consent|13|||
155453845|NCT02198651|561086792|FG001|Lead-in Period|Withdrew consent|0|||
155453846|NCT02198651|561086793|FG002|Lead-in Period|Withdrew consent|0|||
155453847|NCT02198651|561086794|FG003|Lead-in Period|Withdrew consent|0|||
155453848|NCT02198651|561086795|FG004|Lead-in Period|Withdrew consent|0|||
155453849|NCT02198651|561086791|FG000|Lead-in Period|Adverse Event|2|||
155453850|NCT02198651|561086792|FG001|Lead-in Period|Adverse Event|0|||
155453851|NCT02198651|561086793|FG002|Lead-in Period|Adverse Event|0|||
155453852|NCT02198651|561086794|FG003|Lead-in Period|Adverse Event|0|||
155453853|NCT02198651|561086795|FG004|Lead-in Period|Adverse Event|0|||
155453854|NCT02198651|561086791|FG000|Lead-in Period|Other, not specified|22|||
155453855|NCT02198651|561086792|FG001|Lead-in Period|Other, not specified|0|||
155453856|NCT02198651|561086793|FG002|Lead-in Period|Other, not specified|0|||
155453857|NCT02198651|561086794|FG003|Lead-in Period|Other, not specified|0|||
155453858|NCT02198651|561086795|FG004|Lead-in Period|Other, not specified|0|||
155453859|NCT02198651|561086791|FG000|Double-blind Period|Withdrew consent|0|||
155453860|NCT02198651|561086792|FG001|Double-blind Period|Withdrew consent|4|||
155453861|NCT02198651|561086793|FG002|Double-blind Period|Withdrew consent|0|||
155453862|NCT02198651|561086794|FG003|Double-blind Period|Withdrew consent|0|||
155453863|NCT02198651|561086795|FG004|Double-blind Period|Withdrew consent|0|||
155453864|NCT02198651|561086791|FG000|Double-blind Period|Adverse Event|0|||
155453865|NCT02198651|561086792|FG001|Double-blind Period|Adverse Event|1|||
155453866|NCT02198651|561086793|FG002|Double-blind Period|Adverse Event|0|||
155453867|NCT02198651|561086794|FG003|Double-blind Period|Adverse Event|0|||
155453868|NCT02198651|561086795|FG004|Double-blind Period|Adverse Event|0|||
155453869|NCT02198651|561086791|FG000|Double-blind Period|Other, not specified|0|||
155453870|NCT02198651|561086792|FG001|Double-blind Period|Other, not specified|4|||
155453871|NCT02198651|561086793|FG002|Double-blind Period|Other, not specified|1|||
155453872|NCT02198651|561086794|FG003|Double-blind Period|Other, not specified|0|||
155453873|NCT02198651|561086795|FG004|Double-blind Period|Other, not specified|0|||
155453874|NCT02198651|561086791|FG000|Open-label Rescue Period|Withdrew consent|0|||
155453875|NCT02198651|561086792|FG001|Open-label Rescue Period|Withdrew consent|0|||
155453876|NCT02198651|561086793|FG002|Open-label Rescue Period|Withdrew consent|0|||
155453877|NCT02198651|561086794|FG003|Open-label Rescue Period|Withdrew consent|2|||
155453878|NCT02198651|561086795|FG004|Open-label Rescue Period|Withdrew consent|0|||
155453879|NCT02198651|561086791|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
155453880|NCT02198651|561086792|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
155453881|NCT02198651|561086793|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
155453882|NCT02198651|561086794|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
155453883|NCT02198651|561086795|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
155453884|NCT00333619|561086805|FG000|Overall Study|Death|12|||
155453885|NCT00333619|561086806|FG001|Overall Study|Death|6|||
155453886|NCT00333619|561086805|FG000|Overall Study|Withdrawal by Subject|6|||
155453887|NCT00333619|561086806|FG001|Overall Study|Withdrawal by Subject|1|||
155453888|NCT00333619|561086805|FG000|Overall Study|Lost to Follow-up|3|||
155453889|NCT00333619|561086806|FG001|Overall Study|Lost to Follow-up|3|||
155453890|NCT01120379|561086815|FG000|One Year Timepoint|Withdrawal by Subject|41|||
155453891|NCT01120379|561086815|FG000|One Year Timepoint|Lost to Follow-up|115|||
155453892|NCT01120379|561086815|FG000|One Year Timepoint|Death|108|||
155453893|NCT01120379|561086815|FG000|One Year Timepoint|Physician Decision|9|||
155453894|NCT01120379|561086815|FG000|One Year Timepoint|Any other reason for early termination|5|||
155453895|NCT01120379|561086815|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
155453896|NCT01120379|561086815|FG000|Two Year Timepoint|Lost to Follow-up|87|||
155453897|NCT01120379|561086815|FG000|Two Year Timepoint|Death|123|||
155453898|NCT01120379|561086815|FG000|Two Year Timepoint|Physician Decision|12|||
155453899|NCT01120379|561086815|FG000|Two Year Timepoint|Any other reason for early termination|4|||
155453900|NCT01120379|561086815|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
155453901|NCT01120379|561086815|FG000|Three Year Timepoint|Lost to Follow-up|43|||
155453902|NCT01120379|561086815|FG000|Three Year Timepoint|Death|120|||
155453903|NCT01120379|561086815|FG000|Three Year Timepoint|Physician Decision|9|||
155453904|NCT01120379|561086815|FG000|Three Year Timepoint|Any other reason for early termination|17|||
155453905|NCT01120379|561086815|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
155453906|NCT01120379|561086815|FG000|Four Year Timepoint|Lost to Follow-up|10|||
155453907|NCT01120379|561086815|FG000|Four Year Timepoint|Death|131|||
155453908|NCT01120379|561086815|FG000|Four Year Timepoint|Physician Decision|5|||
155453909|NCT01120379|561086815|FG000|Four Year Timepoint|Any other reason for early termination|217|||
155453910|NCT00848250|561086816|FG000|Overall Study|surgery was completed without cardiopulm|0|||
155453911|NCT00848250|561086817|FG001|Overall Study|surgery was completed without cardiopulm|1|||
155453912|NCT04032171|561086826|FG000|Overall Study|Study Termination|1|||
155453913|NCT04032171|561086827|FG001|Overall Study|Study Termination|0|||
155453914|NCT00642746|561086828|FG000|Overall Study|Patient unevaluable|1|||
155453915|NCT00642746|561086829|FG001|Overall Study|Patient unevaluable|0|||
155453916|NCT02108951|561086832|FG000|Overall Study|Lost to Follow-up|1|||
155453917|NCT02108951|561086832|FG000|Overall Study|Patient's/guardian's decision|1|||
155453918|NCT02108951|561086832|FG000|Overall Study|Study Terminated by Sponsor|14|||
155453919|NCT00678587|561086833|FG000|Overall Study|Adverse Event|3|||
155453920|NCT00678587|561086834|FG001|Overall Study|Adverse Event|3|||
155453921|NCT00678587|561086833|FG000|Overall Study|Lack of Efficacy|1|||
155453922|NCT00678587|561086834|FG001|Overall Study|Lack of Efficacy|0|||
155453923|NCT00678587|561086833|FG000|Overall Study|Protocol Violation|2|||
155453924|NCT00678587|561086834|FG001|Overall Study|Protocol Violation|1|||
155651732|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
155651733|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
155651734|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
155453925|NCT00678587|561086833|FG000|Overall Study|Study Closed/Terminated|1|||
155453926|NCT00678587|561086834|FG001|Overall Study|Study Closed/Terminated|0|||
155453927|NCT00678587|561086833|FG000|Overall Study|Lost to Follow-up|3|||
155453928|NCT00678587|561086834|FG001|Overall Study|Lost to Follow-up|5|||
155453929|NCT00678587|561086833|FG000|Overall Study|Investigator Discretion|2|||
155453930|NCT00678587|561086834|FG001|Overall Study|Investigator Discretion|6|||
155453931|NCT00678587|561086833|FG000|Overall Study|Withdrew Consent|8|||
155453932|NCT00678587|561086834|FG001|Overall Study|Withdrew Consent|3|||
155453933|NCT01514188|561086835|FG000|Overall Study|Adverse Event|3|||
155453934|NCT01514188|561086836|FG001|Overall Study|Adverse Event|5|||
155453935|NCT01514188|561086835|FG000|Overall Study|Withdrawal by Subject|2|||
155453936|NCT01514188|561086836|FG001|Overall Study|Withdrawal by Subject|4|||
155453937|NCT01514188|561086835|FG000|Overall Study|Protocol Violation|2|||
155453938|NCT01514188|561086836|FG001|Overall Study|Protocol Violation|4|||
155453939|NCT01514188|561086835|FG000|Overall Study|Physician Decision|0|||
155453940|NCT01514188|561086836|FG001|Overall Study|Physician Decision|2|||
155453941|NCT01514188|561086835|FG000|Overall Study|Disease Progression|13|||
155453942|NCT01514188|561086836|FG001|Overall Study|Disease Progression|14|||
155453943|NCT01514188|561086835|FG000|Overall Study|Death|1|||
155453944|NCT01514188|561086836|FG001|Overall Study|Death|3|||
155453945|NCT01514188|561086835|FG000|Overall Study|Other|2|||
155453946|NCT01514188|561086836|FG001|Overall Study|Other|1|||
155453947|NCT02932332|561086837|FG000|Overall Study|Withdrawal by Subject|1|||
155453948|NCT02932332|561086838|FG001|Overall Study|Withdrawal by Subject|1|||
155453949|NCT02932332|561086839|FG002|Overall Study|Withdrawal by Subject|0|||
155453950|NCT02932332|561086840|FG003|Overall Study|Withdrawal by Subject|1|||
155453951|NCT02932332|561086837|FG000|Overall Study|Chest pain|0|||
155453952|NCT02932332|561086838|FG001|Overall Study|Chest pain|0|||
155453953|NCT02932332|561086839|FG002|Overall Study|Chest pain|0|||
155453954|NCT02932332|561086840|FG003|Overall Study|Chest pain|1|||
155453955|NCT02932332|561086837|FG000|Overall Study|Not Dyspneic cough|1|||
155453956|NCT02932332|561086838|FG001|Overall Study|Not Dyspneic cough|2|||
155453957|NCT02932332|561086839|FG002|Overall Study|Not Dyspneic cough|1|||
155453958|NCT02932332|561086840|FG003|Overall Study|Not Dyspneic cough|0|||
155453959|NCT02493426|561086841|FG000|Overall Study|Withdrawal by Subject|0|||
155453960|NCT02493426|561086842|FG001|Overall Study|Withdrawal by Subject|1|||
155453961|NCT01069523|561086843|FG000|Overall Study|Withdrawal by Subject|4|||
155453962|NCT01069523|561086844|FG001|Overall Study|Withdrawal by Subject|7|||
155453963|NCT01875367|561086845|FG000|Overall Study|Not complete at least 2 questionaries|4|||
155453964|NCT01875367|561086846|FG001|Overall Study|Not complete at least 2 questionaries|2|||
155453965|NCT01875367|561086845|FG000|Overall Study|Not receive study treatment|1|||
155453966|NCT01875367|561086846|FG001|Overall Study|Not receive study treatment|0|||
155453967|NCT04533815|561086852|FG000|Overall Study|Adverse Event|2|||
155453968|NCT04533815|561086852|FG000|Overall Study|Site withdrew|5|||
155453969|NCT00488592|561086853|FG000|Overall Study|Withdrawal by Subject|1|||
155453970|NCT00488592|561086853|FG000|Overall Study|Disease progression|1|||
155453971|NCT00488592|561086853|FG000|Overall Study|Enrolled but not treated|1|||
155453972|NCT00441103|561086854|FG000|Overall Study|Adverse Event|2|||
155453973|NCT00441103|561086855|FG001|Overall Study|Adverse Event|1|||
155453974|NCT00441103|561086854|FG000|Overall Study|Death|1|||
155453975|NCT00441103|561086855|FG001|Overall Study|Death|0|||
155453976|NCT00441103|561086854|FG000|Overall Study|Disease Progression|2|||
155453977|NCT00441103|561086855|FG001|Overall Study|Disease Progression|0|||
155453978|NCT00441103|561086854|FG000|Overall Study|Lost to Follow-up|1|||
155453979|NCT00441103|561086855|FG001|Overall Study|Lost to Follow-up|0|||
155453980|NCT00441103|561086854|FG000|Overall Study|Protocol Violation|1|||
155651735|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Adverse Event|5|||
155453981|NCT00441103|561086855|FG001|Overall Study|Protocol Violation|0|||
155453982|NCT00441103|561086854|FG000|Overall Study|Participant unable to use Rebiject II|1|||
155453983|NCT00441103|561086855|FG001|Overall Study|Participant unable to use Rebiject II|0|||
155453984|NCT00441103|561086854|FG000|Overall Study|Participant refused MRI|1|||
155453985|NCT00441103|561086855|FG001|Overall Study|Participant refused MRI|0|||
155453986|NCT00441103|561086854|FG000|Overall Study|Inclusion criteria absent|1|||
155453987|NCT00441103|561086855|FG001|Overall Study|Inclusion criteria absent|0|||
155651736|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Adverse Event|1|||
155453988|NCT00441103|561086854|FG000|Overall Study|Non-compliant|0|||
155453989|NCT00441103|561086855|FG001|Overall Study|Non-compliant|1|||
155453990|NCT00441103|561086854|FG000|Overall Study|Participant decided to withdraw|1|||
155453991|NCT00441103|561086855|FG001|Overall Study|Participant decided to withdraw|0|||
155453992|NCT00441103|561086854|FG000|Overall Study|Participant's reason|0|||
155453993|NCT00441103|561086855|FG001|Overall Study|Participant's reason|1|||
155453994|NCT00441103|561086854|FG000|Overall Study|Participant decided to stop|0|||
155453995|NCT00441103|561086855|FG001|Overall Study|Participant decided to stop|1|||
155453996|NCT02951988|561086856|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
155453997|NCT02951988|561086857|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
155453998|NCT02951988|561086858|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
155453999|NCT02951988|561086859|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
155454000|NCT02951988|561086856|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
155454001|NCT02951988|561086857|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
155454002|NCT02951988|561086858|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
155454003|NCT02951988|561086859|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
155454004|NCT02951988|561086856|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
155454005|NCT02951988|561086857|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
155454006|NCT02951988|561086858|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
155454007|NCT02951988|561086859|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
155454008|NCT02951988|561086856|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
155454009|NCT02951988|561086857|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
155454010|NCT02951988|561086858|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
155454011|NCT02951988|561086859|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
155454012|NCT02951988|561086856|FG000|Open-Label Treatment Period|Protocol Violation|22|||
155454013|NCT02951988|561086857|FG001|Open-Label Treatment Period|Protocol Violation|0|||
155454014|NCT02951988|561086858|FG002|Open-Label Treatment Period|Protocol Violation|0|||
155454015|NCT02951988|561086859|FG003|Open-Label Treatment Period|Protocol Violation|0|||
155454016|NCT02951988|561086856|FG000|Open-Label Treatment Period|Pregnancy|2|||
155454017|NCT02951988|561086857|FG001|Open-Label Treatment Period|Pregnancy|0|||
155454018|NCT02951988|561086858|FG002|Open-Label Treatment Period|Pregnancy|0|||
155454019|NCT02951988|561086859|FG003|Open-Label Treatment Period|Pregnancy|0|||
155454020|NCT02951988|561086856|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
155454021|NCT02951988|561086857|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
155454022|NCT02951988|561086858|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
155454023|NCT02951988|561086859|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
155454024|NCT02951988|561086856|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
155454025|NCT02951988|561086857|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
155454026|NCT02951988|561086858|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
155454027|NCT02951988|561086859|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
155454028|NCT02951988|561086856|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
155454029|NCT02951988|561086857|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155454030|NCT02951988|561086858|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155454031|NCT02951988|561086859|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
155454032|NCT02951988|561086856|FG000|Open-Label Treatment Period|Adverse Event|45|||
155454033|NCT02951988|561086857|FG001|Open-Label Treatment Period|Adverse Event|0|||
155454034|NCT02951988|561086858|FG002|Open-Label Treatment Period|Adverse Event|0|||
155454035|NCT02951988|561086859|FG003|Open-Label Treatment Period|Adverse Event|0|||
155454036|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
155454037|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
155454038|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
155454039|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
155454040|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
155454041|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
155454042|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
155454043|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
155454044|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
155454045|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
155454046|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
155454047|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
155454048|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155454049|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
155454050|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
155454051|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
155454052|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Pregnancy|0|||
155454053|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Pregnancy|1|||
155454054|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Pregnancy|1|||
155454055|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Pregnancy|0|||
155454056|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155454057|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
155454058|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
155454059|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
155454060|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155454061|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
155454062|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
155515668|NCT01215942|561313537|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
155515669|NCT01215942|561313538|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
155515670|NCT01215942|561313537|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
155515671|NCT01215942|561313538|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
155515672|NCT01215942|561313537|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
155515673|NCT01215942|561313538|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
155515674|NCT01215942|561313537|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
155515675|NCT01215942|561313538|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
155515676|NCT03305055|561313539|FG000|Overall Study|Withdrawal by Subject|0|||
155515677|NCT03305055|561313540|FG001|Overall Study|Withdrawal by Subject|1|||
155515678|NCT03305055|561313539|FG000|Overall Study|Adverse Event|1|||
155515679|NCT03305055|561313540|FG001|Overall Study|Adverse Event|1|||
155515680|NCT00113490|561313541|FG000|Overall Study|Withdrawal by Subject|1|||
155515681|NCT00113490|561313542|FG001|Overall Study|Withdrawal by Subject|3|||
155515682|NCT00113490|561313541|FG000|Overall Study|Lost to Follow-up|1|||
155515683|NCT00113490|561313542|FG001|Overall Study|Lost to Follow-up|0|||
155515684|NCT00819247|561313543|FG000|Overall Study|Adverse Event|0|||
155515685|NCT00819247|561313544|FG001|Overall Study|Adverse Event|5|||
155515686|NCT00819247|561313545|FG002|Overall Study|Adverse Event|3|||
155515687|NCT00819247|561313543|FG000|Overall Study|Insufficient testosterone response|5|||
155515688|NCT00819247|561313544|FG001|Overall Study|Insufficient testosterone response|8|||
155515689|NCT00819247|561313545|FG002|Overall Study|Insufficient testosterone response|10|||
155515690|NCT00819247|561313543|FG000|Overall Study|Withdrawal by Subject|1|||
155515691|NCT00819247|561313544|FG001|Overall Study|Withdrawal by Subject|0|||
155515692|NCT00819247|561313545|FG002|Overall Study|Withdrawal by Subject|0|||
155515693|NCT00819247|561313543|FG000|Overall Study|Protocol Violation|1|||
155515694|NCT00819247|561313544|FG001|Overall Study|Protocol Violation|0|||
155515695|NCT00819247|561313545|FG002|Overall Study|Protocol Violation|1|||
155515696|NCT00819247|561313543|FG000|Overall Study|Mistakenly withdrawn|0|||
155515697|NCT00819247|561313544|FG001|Overall Study|Mistakenly withdrawn|1|||
155454063|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
155454064|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155454065|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Adverse Event|8|||
155454066|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Adverse Event|3|||
155454067|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Adverse Event|6|||
155454068|NCT02951988|561086856|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
155454069|NCT02951988|561086857|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
155454070|NCT02951988|561086858|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
155454071|NCT02951988|561086859|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
155454072|NCT05836818|561086860|FG000|Overall Study|Physician Decision|1|||
155454073|NCT05836818|561086861|FG001|Overall Study|Physician Decision|1|||
155454074|NCT05836818|561086862|FG002|Overall Study|Physician Decision|0|||
155454075|NCT05836818|561086860|FG000|Overall Study|Withdrawal by Subject|0|||
155454076|NCT05836818|561086861|FG001|Overall Study|Withdrawal by Subject|0|||
155454077|NCT05836818|561086862|FG002|Overall Study|Withdrawal by Subject|1|||
155454078|NCT05836818|561086860|FG000|Overall Study|Later found to be previously vaccinated|0|||
155454079|NCT05836818|561086861|FG001|Overall Study|Later found to be previously vaccinated|1|||
155454080|NCT05836818|561086862|FG002|Overall Study|Later found to be previously vaccinated|3|||
155454081|NCT05836818|561086860|FG000|Overall Study|Pregnancy|0|||
155454082|NCT05836818|561086861|FG001|Overall Study|Pregnancy|1|||
155454083|NCT05836818|561086862|FG002|Overall Study|Pregnancy|0|||
155454084|NCT05836818|561086860|FG000|Overall Study|Allergic to vaccines|0|||
155454085|NCT05836818|561086861|FG001|Overall Study|Allergic to vaccines|1|||
155454086|NCT05836818|561086862|FG002|Overall Study|Allergic to vaccines|0|||
155454087|NCT03738566|561086863|FG000|Initial Study Phase|Withdrawal by Subject|1|||
155454088|NCT03738566|561086864|FG001|Initial Study Phase|Withdrawal by Subject|1|||
155454089|NCT03738566|561086865|FG002|Initial Study Phase|Withdrawal by Subject|2|||
155515698|NCT00819247|561313545|FG002|Overall Study|Mistakenly withdrawn|0|||
155454090|NCT03738566|561086866|FG003|Initial Study Phase|Withdrawal by Subject|0|||
155454091|NCT03738566|561086863|FG000|Initial Study Phase|Death|0|||
155454092|NCT03738566|561086864|FG001|Initial Study Phase|Death|1|||
155454093|NCT03738566|561086865|FG002|Initial Study Phase|Death|0|||
155454094|NCT03738566|561086866|FG003|Initial Study Phase|Death|0|||
155515699|NCT00819247|561313543|FG000|Overall Study|Bad prostate-specific antigen response|3|||
155515700|NCT00819247|561313544|FG001|Overall Study|Bad prostate-specific antigen response|2|||
155515701|NCT00819247|561313545|FG002|Overall Study|Bad prostate-specific antigen response|0|||
155515702|NCT00819247|561313543|FG000|Overall Study|Other|1|||
155454095|NCT03738566|561086863|FG000|Initial Study Phase|Treatment failure|5|||
155454096|NCT03738566|561086864|FG001|Initial Study Phase|Treatment failure|0|||
155454097|NCT03738566|561086865|FG002|Initial Study Phase|Treatment failure|0|||
155454098|NCT03738566|561086866|FG003|Initial Study Phase|Treatment failure|0|||
155454099|NCT03738566|561086863|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
155454100|NCT03738566|561086864|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
155454101|NCT03738566|561086865|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
155454102|NCT03738566|561086866|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
155454103|NCT01627067|561086869|FG000|Overall Study|Screen Failure|1|||
155454104|NCT00516269|561086870|FG000|Overall Study|Adverse Event|2|||
155454105|NCT00516269|561086871|FG001|Overall Study|Adverse Event|1|||
155454106|NCT00516269|561086870|FG000|Overall Study|Lost to Follow-up|0|||
155454107|NCT00516269|561086871|FG001|Overall Study|Lost to Follow-up|1|||
155454108|NCT00516269|561086870|FG000|Overall Study|Protocol Violation|0|||
155454109|NCT00516269|561086871|FG001|Overall Study|Protocol Violation|1|||
155454110|NCT04570657|561086873|FG000|Overall Study|Adverse Event|0|||
155454111|NCT04570657|561086874|FG001|Overall Study|Adverse Event|0|||
155454112|NCT04570657|561086875|FG002|Overall Study|Adverse Event|1|||
155454113|NCT04570657|561086873|FG000|Overall Study|Lost to Follow-up|0|||
155515703|NCT00819247|561313544|FG001|Overall Study|Other|0|||
155515704|NCT00819247|561313545|FG002|Overall Study|Other|0|||
155454114|NCT04570657|561086874|FG001|Overall Study|Lost to Follow-up|0|||
155454115|NCT04570657|561086875|FG002|Overall Study|Lost to Follow-up|1|||
155454116|NCT04570657|561086873|FG000|Overall Study|Physician Decision|0|||
155454117|NCT04570657|561086874|FG001|Overall Study|Physician Decision|1|||
155454118|NCT04570657|561086875|FG002|Overall Study|Physician Decision|0|||
155454119|NCT04570657|561086873|FG000|Overall Study|Withdrawal by Subject|1|||
155454120|NCT04570657|561086874|FG001|Overall Study|Withdrawal by Subject|2|||
155454121|NCT04570657|561086875|FG002|Overall Study|Withdrawal by Subject|2|||
155454122|NCT01079962|561086876|FG000|Overall Study|Adverse Event|2|||
155454123|NCT01079962|561086877|FG001|Overall Study|Adverse Event|2|||
155454124|NCT01079962|561086876|FG000|Overall Study|Withdrawal by Subject|5|||
155454125|NCT01079962|561086877|FG001|Overall Study|Withdrawal by Subject|7|||
155454126|NCT01079962|561086876|FG000|Overall Study|Protocol Violation|2|||
155454127|NCT01079962|561086877|FG001|Overall Study|Protocol Violation|2|||
155454128|NCT01079962|561086876|FG000|Overall Study|No blood pressure (BP) control|3|||
155454129|NCT01079962|561086877|FG001|Overall Study|No blood pressure (BP) control|0|||
155454130|NCT01079962|561086876|FG000|Overall Study|Inclusion/exclusion criteria|1|||
155454131|NCT01079962|561086877|FG001|Overall Study|Inclusion/exclusion criteria|3|||
155454132|NCT01079962|561086876|FG000|Overall Study|Participant not returning for next visit|1|||
155454133|NCT01079962|561086877|FG001|Overall Study|Participant not returning for next visit|0|||
155454134|NCT01079962|561086876|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
155454135|NCT01079962|561086877|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
155454136|NCT01072539|561086878|FG000|Overall Study|Treated prior to the Site Initiation|1|||
155454137|NCT01072539|561086878|FG000|Overall Study|Protocol Violation|2|||
155454138|NCT01331239|561086879|FG000|Part II: Core Study|Adverse Event|0|||
155454139|NCT01331239|561086880|FG001|Part II: Core Study|Adverse Event|3|||
155454140|NCT01331239|561086881|FG002|Part II: Core Study|Adverse Event|0|||
155454141|NCT01331239|561086879|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
155454142|NCT01331239|561086880|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
155454143|NCT01331239|561086881|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
155454144|NCT01331239|561086879|FG000|Part II: Core Study|Withdrawal by Subject|0|||
155454145|NCT01331239|561086880|FG001|Part II: Core Study|Withdrawal by Subject|2|||
155454146|NCT01331239|561086881|FG002|Part II: Core Study|Withdrawal by Subject|0|||
155454147|NCT01331239|561086879|FG000|Part II: Core Study|Administrative problems|0|||
155454148|NCT01331239|561086880|FG001|Part II: Core Study|Administrative problems|1|||
155454149|NCT01331239|561086881|FG002|Part II: Core Study|Administrative problems|0|||
155515705|NCT02795104|561313546|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
155515706|NCT02795104|561313547|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
155515707|NCT02795104|561313548|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
155515708|NCT02795104|561313546|FG000|Overall Study|Withdrawal by Subject|0|||
155515709|NCT02795104|561313547|FG001|Overall Study|Withdrawal by Subject|2|||
155515710|NCT02795104|561313548|FG002|Overall Study|Withdrawal by Subject|0|||
155515711|NCT02795104|561313546|FG000|Overall Study|Lost to Follow-up|0|||
155515712|NCT02795104|561313547|FG001|Overall Study|Lost to Follow-up|0|||
155454150|NCT01008995|561086882|FG000|Controlled Period|Adverse Event|1|||
155454151|NCT01008995|561086883|FG001|Controlled Period|Adverse Event|2|||
155454152|NCT01008995|561086884|FG002|Controlled Period|Adverse Event|0|||
155454153|NCT01008995|561086885|FG003|Controlled Period|Adverse Event|0|||
155454154|NCT01008995|561086882|FG000|Controlled Period|Other|2|||
155454155|NCT01008995|561086883|FG001|Controlled Period|Other|1|||
155454156|NCT01008995|561086884|FG002|Controlled Period|Other|0|||
155454157|NCT01008995|561086885|FG003|Controlled Period|Other|0|||
155515713|NCT02795104|561313548|FG002|Overall Study|Lost to Follow-up|1|||
155515714|NCT04652453|561313550|FG000|Overall Study|Death|8|||
155515715|NCT04652453|561313551|FG001|Overall Study|Death|2|||
155515716|NCT04652453|561313552|FG002|Overall Study|Death|0|||
155515717|NCT04652453|561313550|FG000|Overall Study|Hospice|5|||
155515718|NCT04652453|561313551|FG001|Overall Study|Hospice|5|||
155515719|NCT04652453|561313552|FG002|Overall Study|Hospice|0|||
155515720|NCT04652453|561313550|FG000|Overall Study|Withdrawal by Subject|2|||
155454158|NCT01008995|561086882|FG000|After Controlled Period|Adverse Event|0|||
155454159|NCT01008995|561086883|FG001|After Controlled Period|Adverse Event|0|||
155454160|NCT01008995|561086884|FG002|After Controlled Period|Adverse Event|1|||
155454161|NCT01008995|561086885|FG003|After Controlled Period|Adverse Event|1|||
155454162|NCT01008995|561086882|FG000|After Controlled Period|Other|0|||
155454163|NCT01008995|561086883|FG001|After Controlled Period|Other|0|||
155454164|NCT01008995|561086884|FG002|After Controlled Period|Other|1|||
155454165|NCT01008995|561086885|FG003|After Controlled Period|Other|0|||
155454166|NCT04167306|561086886|FG000|Overall Study|Lost to Follow-up|2|||
155454167|NCT04167306|561086887|FG001|Overall Study|Lost to Follow-up|2|||
155454168|NCT04167306|561086888|FG002|Overall Study|Lost to Follow-up|5|||
155454169|NCT04167306|561086889|FG003|Overall Study|Lost to Follow-up|5|||
155454170|NCT04167306|561086886|FG000|Overall Study|Adverse Event|13|||
155454171|NCT04167306|561086887|FG001|Overall Study|Adverse Event|14|||
155454172|NCT04167306|561086888|FG002|Overall Study|Adverse Event|5|||
155454173|NCT04167306|561086889|FG003|Overall Study|Adverse Event|4|||
155454174|NCT04167306|561086886|FG000|Overall Study|Withdrawal by Subject|4|||
155454175|NCT04167306|561086887|FG001|Overall Study|Withdrawal by Subject|6|||
155454176|NCT04167306|561086888|FG002|Overall Study|Withdrawal by Subject|8|||
155454177|NCT04167306|561086889|FG003|Overall Study|Withdrawal by Subject|3|||
155454178|NCT04167306|561086886|FG000|Overall Study|covid|1|||
155454179|NCT04167306|561086887|FG001|Overall Study|covid|1|||
155454180|NCT04167306|561086888|FG002|Overall Study|covid|2|||
155454181|NCT04167306|561086889|FG003|Overall Study|covid|1|||
155454182|NCT04167306|561086886|FG000|Overall Study|concomitant medication|0|||
155454183|NCT04167306|561086887|FG001|Overall Study|concomitant medication|0|||
155454184|NCT04167306|561086888|FG002|Overall Study|concomitant medication|0|||
155454185|NCT04167306|561086889|FG003|Overall Study|concomitant medication|1|||
155454186|NCT04167306|561086886|FG000|Overall Study|Alcohol treatment|0|||
155454187|NCT04167306|561086887|FG001|Overall Study|Alcohol treatment|4|||
155454188|NCT04167306|561086888|FG002|Overall Study|Alcohol treatment|3|||
155454189|NCT04167306|561086889|FG003|Overall Study|Alcohol treatment|2|||
155454190|NCT04167306|561086886|FG000|Overall Study|non-compliance|0|||
155454191|NCT04167306|561086887|FG001|Overall Study|non-compliance|0|||
155454192|NCT04167306|561086888|FG002|Overall Study|non-compliance|1|||
155454193|NCT04167306|561086889|FG003|Overall Study|non-compliance|0|||
155454194|NCT04167306|561086886|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
155454195|NCT04167306|561086887|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
155454196|NCT04167306|561086888|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
155454197|NCT04167306|561086889|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
155454198|NCT03731364|561086892|FG000|Overall Study|Adverse Event|0|||
155454199|NCT03731364|561086893|FG001|Overall Study|Adverse Event|0|||
155454200|NCT03731364|561086894|FG002|Overall Study|Adverse Event|1|||
155454201|NCT03731364|561086895|FG003|Overall Study|Adverse Event|2|||
155454202|NCT03731364|561086896|FG004|Overall Study|Adverse Event|1|||
155454203|NCT01934192|561086899|FG000|Overall Study|Protocol Violation|0|||
155454204|NCT01934192|561086900|FG001|Overall Study|Protocol Violation|0|||
155454205|NCT01934192|561086901|FG002|Overall Study|Protocol Violation|0|||
155454206|NCT01934192|561086902|FG003|Overall Study|Protocol Violation|1|||
155454207|NCT01934192|561086899|FG000|Overall Study|Other: reached stopping criteria|6|||
155454208|NCT01934192|561086900|FG001|Overall Study|Other: reached stopping criteria|5|||
155454209|NCT01934192|561086901|FG002|Overall Study|Other: reached stopping criteria|1|||
155454210|NCT01934192|561086902|FG003|Overall Study|Other: reached stopping criteria|0|||
155454211|NCT01934192|561086899|FG000|Overall Study|Physician Decision|3|||
155454212|NCT01934192|561086900|FG001|Overall Study|Physician Decision|2|||
155454213|NCT01934192|561086901|FG002|Overall Study|Physician Decision|0|||
155454214|NCT01934192|561086902|FG003|Overall Study|Physician Decision|0|||
155454215|NCT01189435|561086903|FG000|Overall Study|Withdrawal by Subject|1|||
155454216|NCT01189435|561086903|FG000|Overall Study|Physician Decision|1|||
155454217|NCT00403559|561086904|FG000|Overall Study|Adverse Event|0|||
155454218|NCT00403559|561086905|FG001|Overall Study|Adverse Event|1|||
155454219|NCT00403559|561086904|FG000|Overall Study|Lost to Follow-up|3|||
155454220|NCT00403559|561086905|FG001|Overall Study|Lost to Follow-up|3|||
155454221|NCT00403559|561086904|FG000|Overall Study|Withdrawal by Subject|1|||
155454222|NCT00403559|561086905|FG001|Overall Study|Withdrawal by Subject|0|||
155515721|NCT04652453|561313551|FG001|Overall Study|Withdrawal by Subject|0|||
155454223|NCT00547378|561086906|FG000|Randomized Cohort|Withdrawal by Subject|7|||
155454224|NCT00547378|561086907|FG001|Randomized Cohort|Withdrawal by Subject|5|||
155454225|NCT00547378|561086908|FG002|Randomized Cohort|Withdrawal by Subject|0|||
155454226|NCT00547378|561086906|FG000|Randomized Cohort|Death|0|||
155454227|NCT00547378|561086907|FG001|Randomized Cohort|Death|1|||
155454228|NCT00547378|561086908|FG002|Randomized Cohort|Death|0|||
155454229|NCT00547378|561086906|FG000|Randomized Cohort|Lost to Follow-up|1|||
155454230|NCT00547378|561086907|FG001|Randomized Cohort|Lost to Follow-up|0|||
155454231|NCT00547378|561086908|FG002|Randomized Cohort|Lost to Follow-up|0|||
155454232|NCT00547378|561086906|FG000|Randomized Cohort|Adverse Event|1|||
155454233|NCT00547378|561086907|FG001|Randomized Cohort|Adverse Event|0|||
155454234|NCT00547378|561086908|FG002|Randomized Cohort|Adverse Event|0|||
155454235|NCT00547378|561086906|FG000|Randomized Cohort|Other reasons|2|||
155454236|NCT00547378|561086907|FG001|Randomized Cohort|Other reasons|0|||
155454237|NCT00547378|561086908|FG002|Randomized Cohort|Other reasons|0|||
155454238|NCT00547378|561086906|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
155454239|NCT00547378|561086907|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
155454240|NCT00547378|561086908|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
155454241|NCT00547378|561086906|FG000|All Implanted Cohort|Adverse Event|4|||
155454242|NCT00547378|561086907|FG001|All Implanted Cohort|Adverse Event|10|||
155454243|NCT00547378|561086908|FG002|All Implanted Cohort|Adverse Event|17|||
155454244|NCT00547378|561086906|FG000|All Implanted Cohort|Lost to Follow-up|0|||
155454245|NCT00547378|561086907|FG001|All Implanted Cohort|Lost to Follow-up|1|||
155454246|NCT00547378|561086908|FG002|All Implanted Cohort|Lost to Follow-up|14|||
155454247|NCT00547378|561086906|FG000|All Implanted Cohort|Death|3|||
155454248|NCT00547378|561086907|FG001|All Implanted Cohort|Death|1|||
155454249|NCT00547378|561086908|FG002|All Implanted Cohort|Death|4|||
155454250|NCT00547378|561086906|FG000|All Implanted Cohort|Physician Decision|0|||
155454251|NCT00547378|561086907|FG001|All Implanted Cohort|Physician Decision|2|||
155454252|NCT00547378|561086908|FG002|All Implanted Cohort|Physician Decision|6|||
155454253|NCT00547378|561086906|FG000|All Implanted Cohort|Site closure|2|||
155454254|NCT00547378|561086907|FG001|All Implanted Cohort|Site closure|0|||
155454255|NCT00547378|561086908|FG002|All Implanted Cohort|Site closure|1|||
155454256|NCT00547378|561086906|FG000|All Implanted Cohort|Other reasons|1|||
155454257|NCT00547378|561086907|FG001|All Implanted Cohort|Other reasons|0|||
155454258|NCT00547378|561086908|FG002|All Implanted Cohort|Other reasons|1|||
155454259|NCT04105244|561086909|FG000|Overall Study|Withdrawal by Subject|10|||
155454260|NCT04105244|561086910|FG001|Overall Study|Withdrawal by Subject|12|||
155454261|NCT04105244|561086909|FG000|Overall Study|Lost to Follow-up|20|||
155454262|NCT04105244|561086910|FG001|Overall Study|Lost to Follow-up|15|||
155454263|NCT04105244|561086909|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
155454264|NCT04105244|561086910|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
155454265|NCT04105244|561086909|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
155454266|NCT04105244|561086910|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
155454267|NCT02768194|561086911|FG000|Period 1|Adverse Event|0|||
155454268|NCT02768194|561086912|FG001|Period 1|Adverse Event|0|||
155454269|NCT02768194|561086913|FG002|Period 1|Adverse Event|0|||
155454270|NCT02768194|561086914|FG003|Period 1|Adverse Event|1|||
155454271|NCT02768194|561086915|FG004|Period 1|Adverse Event|0|||
155454272|NCT02768194|561086916|FG005|Period 1|Adverse Event|0|||
155454273|NCT02768194|561086911|FG000|Period 2|Other (Reason not specified)|1|||
155454274|NCT02768194|561086912|FG001|Period 2|Other (Reason not specified)|0|||
155454275|NCT02768194|561086913|FG002|Period 2|Other (Reason not specified)|0|||
155454276|NCT02768194|561086914|FG003|Period 2|Other (Reason not specified)|0|||
155454277|NCT02768194|561086915|FG004|Period 2|Other (Reason not specified)|0|||
155454278|NCT02768194|561086916|FG005|Period 2|Other (Reason not specified)|0|||
155454279|NCT02768194|561086911|FG000|Period 3|Other (Reason not specified)|0|||
155454280|NCT02768194|561086912|FG001|Period 3|Other (Reason not specified)|1|||
155454281|NCT02768194|561086913|FG002|Period 3|Other (Reason not specified)|0|||
155454282|NCT02768194|561086914|FG003|Period 3|Other (Reason not specified)|0|||
155454283|NCT02768194|561086915|FG004|Period 3|Other (Reason not specified)|0|||
155454284|NCT02768194|561086916|FG005|Period 3|Other (Reason not specified)|0|||
155454285|NCT04863014|561086917|FG000|Overall Study|Lost to Follow-up|3|||
155454286|NCT04863014|561086918|FG001|Overall Study|Lost to Follow-up|2|||
155454287|NCT04863014|561086917|FG000|Overall Study|Subject Decision|0|||
155454288|NCT04863014|561086918|FG001|Overall Study|Subject Decision|4|||
155454289|NCT04387136|561086919|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
155454290|NCT04387136|561086920|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
155454291|NCT01982773|561086921|FG000|Overall Study|Withdrawal by Subject|1|||
155454292|NCT01982773|561086922|FG001|Overall Study|Withdrawal by Subject|3|||
155454293|NCT01982773|561086921|FG000|Overall Study|Lost to Follow-up|7|||
155454294|NCT01982773|561086922|FG001|Overall Study|Lost to Follow-up|1|||
155454295|NCT01029886|561086925|FG000|Overall Study|Adverse Event|12|||
155454296|NCT01029886|561086926|FG001|Overall Study|Adverse Event|25|||
155454297|NCT01029886|561086925|FG000|Overall Study|Lost to Follow-up|1|||
155515722|NCT04652453|561313552|FG002|Overall Study|Withdrawal by Subject|0|||
155454298|NCT01029886|561086926|FG001|Overall Study|Lost to Follow-up|0|||
155454299|NCT01029886|561086925|FG000|Overall Study|Physician Decision|2|||
155454300|NCT01029886|561086926|FG001|Overall Study|Physician Decision|6|||
155454301|NCT01029886|561086925|FG000|Overall Study|Protocol Violation|17|||
155454302|NCT01029886|561086926|FG001|Overall Study|Protocol Violation|5|||
155454303|NCT01029886|561086925|FG000|Overall Study|Withdrawal by Subject|8|||
155454304|NCT01029886|561086926|FG001|Overall Study|Withdrawal by Subject|18|||
155454305|NCT01029886|561086925|FG000|Overall Study|Entry Criteria Not Met|13|||
155454306|NCT01029886|561086926|FG001|Overall Study|Entry Criteria Not Met|5|||
155454307|NCT01029886|561086925|FG000|Overall Study|Sponsor Decision|1|||
155454308|NCT01029886|561086926|FG001|Overall Study|Sponsor Decision|0|||
155454309|NCT01029886|561086925|FG000|Overall Study|Loss Glucose Control|7|||
155454310|NCT01029886|561086926|FG001|Overall Study|Loss Glucose Control|1|||
155454311|NCT03294681|561086927|FG000|Overall Study|Withdrawal by Subject|1|||
155454312|NCT03089216|561086928|FG000|Overall Study|Adverse Event|0|||
155454313|NCT03089216|561086929|FG001|Overall Study|Adverse Event|0|||
155454314|NCT03089216|561086930|FG002|Overall Study|Adverse Event|0|||
155454315|NCT03089216|561086931|FG003|Overall Study|Adverse Event|1|||
155454316|NCT00417976|561086934|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
155454317|NCT00417976|561086934|FG000|Overall Study|Treatment -related toxicity|2|||
155454318|NCT04501679|561086935|FG000|Overall Study|Pregnancy|0|||
155454319|NCT04501679|561086936|FG001|Overall Study|Pregnancy|1|||
155454320|NCT04501679|561086935|FG000|Overall Study|Adverse Event|4|||
155454321|NCT04501679|561086936|FG001|Overall Study|Adverse Event|2|||
155454322|NCT04501679|561086935|FG000|Overall Study|Withdrawal by Subject|2|||
155454323|NCT04501679|561086936|FG001|Overall Study|Withdrawal by Subject|0|||
155454324|NCT04501679|561086935|FG000|Overall Study|Physician Decision|1|||
155454325|NCT04501679|561086936|FG001|Overall Study|Physician Decision|0|||
155454326|NCT04501679|561086935|FG000|Overall Study|Lost to Follow-up|2|||
155454327|NCT04501679|561086936|FG001|Overall Study|Lost to Follow-up|0|||
155454328|NCT02121756|561086939|FG000|Overall Study|Adverse Event|3|||
155454329|NCT02121756|561086940|FG001|Overall Study|Adverse Event|0|||
155454330|NCT02121756|561086939|FG000|Overall Study|Protocol Violation|1|||
155454331|NCT02121756|561086940|FG001|Overall Study|Protocol Violation|1|||
155454332|NCT02121756|561086939|FG000|Overall Study|Physician Decision|2|||
155454333|NCT02121756|561086940|FG001|Overall Study|Physician Decision|1|||
155454334|NCT00751114|561086941|FG000|Overall Study|Adverse Event|2|||
155454335|NCT00751114|561086942|FG001|Overall Study|Adverse Event|4|||
155454336|NCT00751114|561086941|FG000|Overall Study|Protocol Violation|8|||
155454337|NCT00751114|561086942|FG001|Overall Study|Protocol Violation|9|||
155454338|NCT00751114|561086941|FG000|Overall Study|Withdrawal by Subject|9|||
155454339|NCT00751114|561086942|FG001|Overall Study|Withdrawal by Subject|4|||
155454340|NCT00751114|561086941|FG000|Overall Study|Lost to Follow-up|4|||
155454341|NCT00751114|561086942|FG001|Overall Study|Lost to Follow-up|7|||
155454342|NCT00751114|561086941|FG000|Overall Study|Lack of Efficacy|0|||
155454343|NCT00751114|561086942|FG001|Overall Study|Lack of Efficacy|7|||
155454344|NCT00751114|561086941|FG000|Overall Study|Not Treated|13|||
155454345|NCT00751114|561086942|FG001|Overall Study|Not Treated|1|||
155454346|NCT00751114|561086941|FG000|Overall Study|Out of country for 2 months|1|||
155454347|NCT00751114|561086942|FG001|Overall Study|Out of country for 2 months|0|||
155454348|NCT00751114|561086941|FG000|Overall Study|Move to another city|1|||
155454349|NCT00751114|561086942|FG001|Overall Study|Move to another city|0|||
155454350|NCT02358369|561086943|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
155454351|NCT02358369|561086944|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
155454352|NCT02358369|561086945|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
155454353|NCT02358369|561086946|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
155454354|NCT02358369|561086947|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
155454355|NCT02358369|561086943|FG000|Treatment Period A/B|Adverse Event|0|||
155454356|NCT02358369|561086944|FG001|Treatment Period A/B|Adverse Event|0|||
155454357|NCT02358369|561086945|FG002|Treatment Period A/B|Adverse Event|1|||
155454358|NCT02358369|561086946|FG003|Treatment Period A/B|Adverse Event|2|||
155454359|NCT02358369|561086947|FG004|Treatment Period A/B|Adverse Event|0|||
155454360|NCT02358369|561086943|FG000|Treatment Period A/B|Death|0|||
155454361|NCT02358369|561086944|FG001|Treatment Period A/B|Death|0|||
155454362|NCT02358369|561086945|FG002|Treatment Period A/B|Death|1|||
155454363|NCT02358369|561086946|FG003|Treatment Period A/B|Death|0|||
155454364|NCT02358369|561086947|FG004|Treatment Period A/B|Death|0|||
155454365|NCT02358369|561086943|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
155454366|NCT02358369|561086944|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
155454367|NCT02358369|561086945|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
155454368|NCT02358369|561086946|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
155454369|NCT02358369|561086947|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
155454370|NCT02358369|561086943|FG000|Treatment Period C|Adverse Event|0|||
155454371|NCT02358369|561086944|FG001|Treatment Period C|Adverse Event|0|||
155454372|NCT02358369|561086945|FG002|Treatment Period C|Adverse Event|0|||
155454373|NCT02358369|561086946|FG003|Treatment Period C|Adverse Event|0|||
155454374|NCT02358369|561086947|FG004|Treatment Period C|Adverse Event|7|||
155454375|NCT01536119|561086950|FG000|Overall Study|Lost to Follow-up|17|||
155454376|NCT01536119|561086951|FG001|Overall Study|Lost to Follow-up|14|||
155454377|NCT04191577|561086952|FG000|Overall Study|Withdrawal by Subject|2|||
155454378|NCT04191577|561086953|FG001|Overall Study|Withdrawal by Subject|2|||
155454379|NCT04191577|561086954|FG002|Overall Study|Withdrawal by Subject|1|||
155454380|NCT04191577|561086952|FG000|Overall Study|Physician Decision|1|||
155454381|NCT04191577|561086953|FG001|Overall Study|Physician Decision|1|||
155515723|NCT04543136|561313553|FG000|Overall Study|Withdrawal by Subject|0|||
155515724|NCT04543136|561313554|FG001|Overall Study|Withdrawal by Subject|1|||
155515725|NCT04543136|561313555|FG002|Overall Study|Withdrawal by Subject|0|||
155515726|NCT04543136|561313556|FG003|Overall Study|Withdrawal by Subject|1|||
155515727|NCT04543136|561313557|FG004|Overall Study|Withdrawal by Subject|0|||
155515728|NCT04543136|561313558|FG005|Overall Study|Withdrawal by Subject|0|||
155515729|NCT06331156|561313564|FG000|Overall Study|Adverse Event|1|||
155515730|NCT06331156|561313565|FG001|Overall Study|Adverse Event|0|||
155515731|NCT06331156|561313564|FG000|Overall Study|Lost to Follow-up|1|||
155515732|NCT06331156|561313565|FG001|Overall Study|Lost to Follow-up|0|||
155454382|NCT04191577|561086954|FG002|Overall Study|Physician Decision|0|||
155454383|NCT04191577|561086952|FG000|Overall Study|Adverse Event|0|||
155454384|NCT04191577|561086953|FG001|Overall Study|Adverse Event|0|||
155454385|NCT04191577|561086954|FG002|Overall Study|Adverse Event|1|||
155454386|NCT04191577|561086952|FG000|Overall Study|Death|0|||
155454387|NCT04191577|561086953|FG001|Overall Study|Death|0|||
155454388|NCT04191577|561086954|FG002|Overall Study|Death|1|||
155454389|NCT00448916|561086955|FG000|Overall Study|Adverse Event|2|||
155454390|NCT00448916|561086956|FG001|Overall Study|Adverse Event|2|||
155454391|NCT00448916|561086957|FG002|Overall Study|Adverse Event|3|||
155454392|NCT00448916|561086958|FG003|Overall Study|Adverse Event|2|||
155454393|NCT00448916|561086955|FG000|Overall Study|Lack of Efficacy|1|||
155454394|NCT00448916|561086956|FG001|Overall Study|Lack of Efficacy|0|||
155454395|NCT00448916|561086957|FG002|Overall Study|Lack of Efficacy|2|||
155454396|NCT00448916|561086958|FG003|Overall Study|Lack of Efficacy|1|||
155454397|NCT00448916|561086955|FG000|Overall Study|Withdrawal by Subject|3|||
155454398|NCT00448916|561086956|FG001|Overall Study|Withdrawal by Subject|3|||
155454399|NCT00448916|561086957|FG002|Overall Study|Withdrawal by Subject|1|||
155454400|NCT00448916|561086958|FG003|Overall Study|Withdrawal by Subject|1|||
155454401|NCT00448916|561086955|FG000|Overall Study|Other|1|||
155454402|NCT00448916|561086956|FG001|Overall Study|Other|0|||
155454403|NCT00448916|561086957|FG002|Overall Study|Other|0|||
155454404|NCT00448916|561086958|FG003|Overall Study|Other|0|||
155454405|NCT00448916|561086955|FG000|Overall Study|Lost to Follow-up|0|||
155454406|NCT00448916|561086956|FG001|Overall Study|Lost to Follow-up|1|||
155454407|NCT00448916|561086957|FG002|Overall Study|Lost to Follow-up|0|||
155454408|NCT00448916|561086958|FG003|Overall Study|Lost to Follow-up|1|||
155454409|NCT00448916|561086955|FG000|Overall Study|Protocol Violation|0|||
155454410|NCT00448916|561086956|FG001|Overall Study|Protocol Violation|0|||
155454411|NCT00448916|561086957|FG002|Overall Study|Protocol Violation|0|||
155454412|NCT00448916|561086958|FG003|Overall Study|Protocol Violation|1|||
155454413|NCT03655717|561086959|FG000|Overall Study|Withdrawal by Subject|4|||
155454414|NCT03655717|561086960|FG001|Overall Study|Withdrawal by Subject|8|||
155454415|NCT03655717|561086961|FG002|Overall Study|Withdrawal by Subject|1|||
155454416|NCT03655717|561086962|FG003|Overall Study|Withdrawal by Subject|0|||
155454417|NCT03655717|561086963|FG004|Overall Study|Withdrawal by Subject|0|||
155454418|NCT03655717|561086964|FG005|Overall Study|Withdrawal by Subject|1|||
155454419|NCT03655717|561086965|FG006|Overall Study|Withdrawal by Subject|3|||
155454420|NCT03655717|561086966|FG007|Overall Study|Withdrawal by Subject|1|||
155454421|NCT03655717|561086967|FG008|Overall Study|Withdrawal by Subject|2|||
155454422|NCT03655717|561086968|FG009|Overall Study|Withdrawal by Subject|0|||
155454423|NCT03655717|561086969|FG010|Overall Study|Withdrawal by Subject|0|||
155454424|NCT03655717|561086970|FG011|Overall Study|Withdrawal by Subject|1|||
155454425|NCT03655717|561086971|FG012|Overall Study|Withdrawal by Subject|0|||
155454426|NCT03655717|561086972|FG013|Overall Study|Withdrawal by Subject|3|||
155454427|NCT03655717|561086973|FG014|Overall Study|Withdrawal by Subject|0|||
155454428|NCT03655717|561086974|FG015|Overall Study|Withdrawal by Subject|1|||
155454429|NCT03655717|561086975|FG016|Overall Study|Withdrawal by Subject|0|||
155454430|NCT03655717|561086976|FG017|Overall Study|Withdrawal by Subject|0|||
155454431|NCT03655717|561086977|FG018|Overall Study|Withdrawal by Subject|1|||
155515733|NCT06331156|561313564|FG000|Overall Study|Migrated / Moved from the study area|4|||
155515734|NCT06331156|561313565|FG001|Overall Study|Migrated / Moved from the study area|3|||
155515735|NCT06331156|561313564|FG000|Overall Study|Other|7|||
155454432|NCT03655717|561086978|FG019|Overall Study|Withdrawal by Subject|0|||
155454433|NCT03655717|561086979|FG020|Overall Study|Withdrawal by Subject|0|||
155454434|NCT03655717|561086980|FG021|Overall Study|Withdrawal by Subject|1|||
155454435|NCT03655717|561086981|FG022|Overall Study|Withdrawal by Subject|2|||
155454436|NCT03655717|561086982|FG023|Overall Study|Withdrawal by Subject|1|||
155454437|NCT03655717|561086983|FG024|Overall Study|Withdrawal by Subject|1|||
155454438|NCT03655717|561086984|FG025|Overall Study|Withdrawal by Subject|0|||
155454439|NCT03655717|561086959|FG000|Overall Study|Physician Decision|3|||
155515736|NCT06331156|561313565|FG001|Overall Study|Other|0|||
155454440|NCT03655717|561086960|FG001|Overall Study|Physician Decision|3|||
155454441|NCT03655717|561086961|FG002|Overall Study|Physician Decision|0|||
155454442|NCT03655717|561086962|FG003|Overall Study|Physician Decision|0|||
155454443|NCT03655717|561086963|FG004|Overall Study|Physician Decision|0|||
155454444|NCT03655717|561086964|FG005|Overall Study|Physician Decision|0|||
155454445|NCT03655717|561086965|FG006|Overall Study|Physician Decision|0|||
155454446|NCT03655717|561086966|FG007|Overall Study|Physician Decision|0|||
155454447|NCT03655717|561086967|FG008|Overall Study|Physician Decision|0|||
155454448|NCT03655717|561086968|FG009|Overall Study|Physician Decision|1|||
155454449|NCT03655717|561086969|FG010|Overall Study|Physician Decision|0|||
155454450|NCT03655717|561086970|FG011|Overall Study|Physician Decision|0|||
155454451|NCT03655717|561086971|FG012|Overall Study|Physician Decision|0|||
155454452|NCT03655717|561086972|FG013|Overall Study|Physician Decision|0|||
155454453|NCT03655717|561086973|FG014|Overall Study|Physician Decision|0|||
155454454|NCT03655717|561086974|FG015|Overall Study|Physician Decision|0|||
155454455|NCT03655717|561086975|FG016|Overall Study|Physician Decision|0|||
155454456|NCT03655717|561086976|FG017|Overall Study|Physician Decision|0|||
155454457|NCT03655717|561086977|FG018|Overall Study|Physician Decision|0|||
155454458|NCT03655717|561086978|FG019|Overall Study|Physician Decision|1|||
155454459|NCT03655717|561086979|FG020|Overall Study|Physician Decision|0|||
155454460|NCT03655717|561086980|FG021|Overall Study|Physician Decision|0|||
155454461|NCT03655717|561086981|FG022|Overall Study|Physician Decision|0|||
155454462|NCT03655717|561086982|FG023|Overall Study|Physician Decision|1|||
155454463|NCT03655717|561086983|FG024|Overall Study|Physician Decision|0|||
155454464|NCT03655717|561086984|FG025|Overall Study|Physician Decision|0|||
155454465|NCT03655717|561086959|FG000|Overall Study|Lost to Follow-up|3|||
155454466|NCT03655717|561086960|FG001|Overall Study|Lost to Follow-up|1|||
155454467|NCT03655717|561086961|FG002|Overall Study|Lost to Follow-up|0|||
155454468|NCT03655717|561086962|FG003|Overall Study|Lost to Follow-up|1|||
155454469|NCT03655717|561086963|FG004|Overall Study|Lost to Follow-up|0|||
155454470|NCT03655717|561086964|FG005|Overall Study|Lost to Follow-up|1|||
155454471|NCT03655717|561086965|FG006|Overall Study|Lost to Follow-up|0|||
155454472|NCT03655717|561086966|FG007|Overall Study|Lost to Follow-up|0|||
155454473|NCT03655717|561086967|FG008|Overall Study|Lost to Follow-up|0|||
155454474|NCT03655717|561086968|FG009|Overall Study|Lost to Follow-up|0|||
155454475|NCT03655717|561086969|FG010|Overall Study|Lost to Follow-up|0|||
155454476|NCT03655717|561086970|FG011|Overall Study|Lost to Follow-up|1|||
155454477|NCT03655717|561086971|FG012|Overall Study|Lost to Follow-up|0|||
155454478|NCT03655717|561086972|FG013|Overall Study|Lost to Follow-up|0|||
155454479|NCT03655717|561086973|FG014|Overall Study|Lost to Follow-up|0|||
155454480|NCT03655717|561086974|FG015|Overall Study|Lost to Follow-up|0|||
155454481|NCT03655717|561086975|FG016|Overall Study|Lost to Follow-up|0|||
155454482|NCT03655717|561086976|FG017|Overall Study|Lost to Follow-up|0|||
155454483|NCT03655717|561086977|FG018|Overall Study|Lost to Follow-up|0|||
155454484|NCT03655717|561086978|FG019|Overall Study|Lost to Follow-up|0|||
155454485|NCT03655717|561086979|FG020|Overall Study|Lost to Follow-up|0|||
155454486|NCT03655717|561086980|FG021|Overall Study|Lost to Follow-up|0|||
155454487|NCT03655717|561086981|FG022|Overall Study|Lost to Follow-up|0|||
155454488|NCT03655717|561086982|FG023|Overall Study|Lost to Follow-up|0|||
155454489|NCT03655717|561086983|FG024|Overall Study|Lost to Follow-up|0|||
155651737|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Adverse Event|0|||
155454490|NCT03655717|561086984|FG025|Overall Study|Lost to Follow-up|0|||
155454491|NCT01185249|561086985|FG000|Overall Study|Patients discharged or change in status|42|||
155651738|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
155651739|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
155454492|NCT02365584|561086986|FG000|Overall Study|Adverse Event|2|||
155454493|NCT02365584|561086987|FG001|Overall Study|Adverse Event|2|||
155454494|NCT02365584|561086986|FG000|Overall Study|Withdrawal by Subject|1|||
155454495|NCT02365584|561086987|FG001|Overall Study|Withdrawal by Subject|0|||
155454496|NCT02365584|561086986|FG000|Overall Study|Disease Progression|9|||
155454497|NCT02365584|561086987|FG001|Overall Study|Disease Progression|12|||
155454498|NCT01973452|561086988|FG000|Overall Study|Lack of Efficacy|0|||
155454499|NCT01973452|561086989|FG001|Overall Study|Lack of Efficacy|1|||
155454500|NCT01973452|561086988|FG000|Overall Study|Lost to Follow-up|1|||
155454501|NCT01973452|561086989|FG001|Overall Study|Lost to Follow-up|0|||
155454502|NCT01973452|561086988|FG000|Overall Study|Withdrawal by Subject|10|||
155454503|NCT01973452|561086989|FG001|Overall Study|Withdrawal by Subject|9|||
155454504|NCT01973452|561086988|FG000|Overall Study|Ineligible|1|||
155454505|NCT01973452|561086989|FG001|Overall Study|Ineligible|1|||
155651740|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
155651741|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Death|8|||
155454506|NCT01973452|561086988|FG000|Overall Study|Surgery canceled by participant|5|||
155454507|NCT01973452|561086989|FG001|Overall Study|Surgery canceled by participant|3|||
155454508|NCT03521193|561086990|FG000|Overall Study|Withdrawal by Subject|8|||
155454509|NCT03521193|561086991|FG001|Overall Study|Withdrawal by Subject|0|||
155454510|NCT03521193|561086990|FG000|Overall Study|non compliant to ASA treatment|8|||
155454511|NCT03521193|561086991|FG001|Overall Study|non compliant to ASA treatment|0|||
155454512|NCT03675737|561086993|FG000|Overall Study|Death|593|||
155454513|NCT03675737|561086994|FG001|Overall Study|Death|660|||
155454514|NCT03675737|561086993|FG000|Overall Study|Lost to Follow-up|1|||
155454515|NCT03675737|561086994|FG001|Overall Study|Lost to Follow-up|5|||
155454516|NCT03675737|561086993|FG000|Overall Study|Physician Decision|1|||
155454517|NCT03675737|561086994|FG001|Overall Study|Physician Decision|0|||
155454518|NCT03675737|561086993|FG000|Overall Study|Withdrawal by Subject|14|||
155454519|NCT03675737|561086994|FG001|Overall Study|Withdrawal by Subject|12|||
155454520|NCT03675737|561086993|FG000|Overall Study|Ongoing in Study|181|||
155651742|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Death|24|||
155651743|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Death|0|||
155651744|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
155651745|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
155454521|NCT03675737|561086994|FG001|Overall Study|Ongoing in Study|112|||
155454522|NCT00369967|561088601|FG000|Overall Study|Lost to Follow-up|23|||
155454523|NCT00369967|561088602|FG001|Overall Study|Lost to Follow-up|12|||
155454524|NCT01708941|561088603|FG000|Overall Study|Adverse Event|4|||
155454525|NCT01708941|561088604|FG001|Overall Study|Adverse Event|6|||
155454526|NCT01708941|561088605|FG002|Overall Study|Adverse Event|1|||
155454527|NCT01708941|561088606|FG003|Overall Study|Adverse Event|0|||
155454528|NCT01708941|561088603|FG000|Overall Study|Death|1|||
155454529|NCT01708941|561088604|FG001|Overall Study|Death|1|||
155651746|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
155651747|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
155651748|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
155651749|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
155651750|NCT02931539|561816307|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
155651751|NCT02931539|561816308|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
155651752|NCT02931539|561816309|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
155651753|NCT02931539|561816307|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
155651754|NCT02931539|561816308|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
155651755|NCT02931539|561816309|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
155651756|NCT03178942|561816312|FG000|Overall Study|Withdrawal by Subject|2|||
155651757|NCT03178942|561816313|FG001|Overall Study|Withdrawal by Subject|0|||
155651758|NCT03178942|561816312|FG000|Overall Study|Lost to Follow-up|1|||
155651759|NCT03178942|561816313|FG001|Overall Study|Lost to Follow-up|2|||
155651760|NCT01197300|561818095|FG000|Overall Study|Lost to Follow-up|0|||
155651761|NCT01197300|561818096|FG001|Overall Study|Lost to Follow-up|1|||
155651762|NCT01197300|561818095|FG000|Overall Study|Protocol Violation|0|||
155651763|NCT01197300|561818096|FG001|Overall Study|Protocol Violation|1|||
155651764|NCT02113878|561818097|FG000|Overall Study|Adverse Event|1|||
155651765|NCT02113878|561818098|FG001|Overall Study|Adverse Event|0|||
155651766|NCT02113878|561818097|FG000|Overall Study|Withdrawal by Subject|1|||
155651767|NCT02113878|561818098|FG001|Overall Study|Withdrawal by Subject|0|||
155651768|NCT02113878|561818097|FG000|Overall Study|patient non-compliance|1|||
155651769|NCT02113878|561818098|FG001|Overall Study|patient non-compliance|0|||
155651770|NCT00530257|561818106|FG000|Overall Study|Lost to Follow-up|1|||
155651771|NCT05130281|561818110|FG000|Overall Study|Withdrawal by Subject|0|||
155651772|NCT05130281|561818111|FG001|Overall Study|Withdrawal by Subject|0|||
155454530|NCT01708941|561088605|FG002|Overall Study|Death|2|||
155454531|NCT01708941|561088606|FG003|Overall Study|Death|14|||
155454532|NCT01708941|561088603|FG000|Overall Study|Withdrawal by Subject|1|||
155454533|NCT01708941|561088604|FG001|Overall Study|Withdrawal by Subject|0|||
155454534|NCT01708941|561088605|FG002|Overall Study|Withdrawal by Subject|3|||
155454535|NCT01708941|561088606|FG003|Overall Study|Withdrawal by Subject|4|||
155454536|NCT01708941|561088603|FG000|Overall Study|Disease progression|9|||
155454537|NCT01708941|561088604|FG001|Overall Study|Disease progression|10|||
155454538|NCT01708941|561088605|FG002|Overall Study|Disease progression|8|||
155454539|NCT01708941|561088606|FG003|Overall Study|Disease progression|0|||
155651773|NCT05130281|561818112|FG002|Overall Study|Withdrawal by Subject|1|||
155454540|NCT01708941|561088603|FG000|Overall Study|Alternative therapy|0|||
155651774|NCT06844812|561818113|FG000|Overall Study|Lost to Follow-up|5|||
155651775|NCT06844812|561818113|FG000|Overall Study|stigmatization concerns|2|||
155651776|NCT06844812|561818113|FG000|Overall Study|medication refusal|2|||
155651777|NCT06844812|561818113|FG000|Overall Study|concerns about possible side effects|2|||
155651778|NCT06844812|561818113|FG000|Overall Study|wanting to seek another specialist opinion|2|||
155651779|NCT06844812|561818113|FG000|Overall Study|side effects (dizziness)|1|||
155651780|NCT03142451|561818142|FG000|Overall Study|Adverse Event|5|||
155651781|NCT03142451|561818143|FG001|Overall Study|Adverse Event|2|||
155651782|NCT03142451|561818142|FG000|Overall Study|Lost to Follow-up|25|||
155454541|NCT01708941|561088604|FG001|Overall Study|Alternative therapy|0|||
155454542|NCT01708941|561088605|FG002|Overall Study|Alternative therapy|2|||
155454543|NCT01708941|561088606|FG003|Overall Study|Alternative therapy|0|||
155454544|NCT01708941|561088603|FG000|Overall Study|Ineligible and never started treatment|1|||
155454545|NCT01708941|561088604|FG001|Overall Study|Ineligible and never started treatment|0|||
155454546|NCT01708941|561088605|FG002|Overall Study|Ineligible and never started treatment|1|||
155454547|NCT01708941|561088606|FG003|Overall Study|Ineligible and never started treatment|0|||
155454548|NCT01708941|561088603|FG000|Overall Study|Never started treatment|2|||
155454549|NCT01708941|561088604|FG001|Overall Study|Never started treatment|1|||
155454550|NCT01708941|561088605|FG002|Overall Study|Never started treatment|0|||
155454551|NCT01708941|561088606|FG003|Overall Study|Never started treatment|0|||
155454552|NCT01708941|561088603|FG000|Overall Study|Ineligible|0|||
155454553|NCT01708941|561088604|FG001|Overall Study|Ineligible|0|||
155454554|NCT01708941|561088605|FG002|Overall Study|Ineligible|2|||
155454555|NCT01708941|561088606|FG003|Overall Study|Ineligible|0|||
155454556|NCT02226146|561088607|FG000|Overall Study|Received rescue therapy|1|||
155454557|NCT02226146|561088607|FG000|Overall Study|Withdrawal by Subject|2|||
155454558|NCT05464836|561088608|FG000|Overall Study|Progression of Disease|1|||
155454559|NCT05464836|561088608|FG000|Overall Study|Physician Decision|1|||
155454560|NCT02883049|561088609|FG000|Induction|Adverse Event|52|||
155454561|NCT02883049|561088610|FG001|Induction|Adverse Event|2|||
155454562|NCT02883049|561088611|FG002|Induction|Adverse Event|0|||
155454563|NCT02883049|561088612|FG003|Induction|Adverse Event|0|||
155454564|NCT02883049|561088613|FG004|Induction|Adverse Event|0|||
155454565|NCT02883049|561088614|FG005|Induction|Adverse Event|0|||
155454566|NCT02883049|561088615|FG006|Induction|Adverse Event|0|||
155454567|NCT02883049|561088616|FG007|Induction|Adverse Event|0|||
155454568|NCT02883049|561088617|FG008|Induction|Adverse Event|0|||
155454569|NCT02883049|561088618|FG009|Induction|Adverse Event|0|||
155454570|NCT02883049|561088619|FG010|Induction|Adverse Event|0|||
155454571|NCT02883049|561088620|FG011|Induction|Adverse Event|0|||
155454572|NCT02883049|561088621|FG012|Induction|Adverse Event|0|||
155454573|NCT02883049|561088622|FG013|Induction|Adverse Event|0|||
155454574|NCT02883049|561088623|FG014|Induction|Adverse Event|0|||
155454575|NCT02883049|561088624|FG015|Induction|Adverse Event|0|||
155454576|NCT02883049|561088609|FG000|Induction|Death|76|||
155454577|NCT02883049|561088610|FG001|Induction|Death|8|||
155454578|NCT02883049|561088611|FG002|Induction|Death|0|||
155454579|NCT02883049|561088612|FG003|Induction|Death|0|||
155454580|NCT02883049|561088613|FG004|Induction|Death|0|||
155454581|NCT02883049|561088614|FG005|Induction|Death|0|||
155454582|NCT02883049|561088615|FG006|Induction|Death|0|||
155454583|NCT02883049|561088616|FG007|Induction|Death|0|||
155454584|NCT02883049|561088617|FG008|Induction|Death|0|||
155454585|NCT02883049|561088618|FG009|Induction|Death|0|||
155454586|NCT02883049|561088619|FG010|Induction|Death|0|||
155454587|NCT02883049|561088620|FG011|Induction|Death|0|||
155454588|NCT02883049|561088621|FG012|Induction|Death|0|||
155454589|NCT02883049|561088622|FG013|Induction|Death|0|||
155454590|NCT02883049|561088623|FG014|Induction|Death|0|||
155454591|NCT02883049|561088624|FG015|Induction|Death|0|||
155454592|NCT02883049|561088609|FG000|Induction|Lost to Follow-up|2|||
155454593|NCT02883049|561088610|FG001|Induction|Lost to Follow-up|0|||
155454594|NCT02883049|561088611|FG002|Induction|Lost to Follow-up|0|||
155454595|NCT02883049|561088612|FG003|Induction|Lost to Follow-up|0|||
155454596|NCT02883049|561088613|FG004|Induction|Lost to Follow-up|0|||
155454597|NCT02883049|561088614|FG005|Induction|Lost to Follow-up|0|||
155454598|NCT02883049|561088615|FG006|Induction|Lost to Follow-up|0|||
155454599|NCT02883049|561088616|FG007|Induction|Lost to Follow-up|0|||
155454600|NCT02883049|561088617|FG008|Induction|Lost to Follow-up|0|||
155454601|NCT02883049|561088618|FG009|Induction|Lost to Follow-up|0|||
155454602|NCT02883049|561088619|FG010|Induction|Lost to Follow-up|0|||
155454603|NCT02883049|561088620|FG011|Induction|Lost to Follow-up|0|||
155454604|NCT02883049|561088621|FG012|Induction|Lost to Follow-up|0|||
155454605|NCT02883049|561088622|FG013|Induction|Lost to Follow-up|0|||
155454606|NCT02883049|561088623|FG014|Induction|Lost to Follow-up|0|||
155454607|NCT02883049|561088624|FG015|Induction|Lost to Follow-up|0|||
155454608|NCT02883049|561088609|FG000|Induction|Physician Decision|1407|||
155454609|NCT02883049|561088610|FG001|Induction|Physician Decision|8|||
155454610|NCT02883049|561088611|FG002|Induction|Physician Decision|0|||
155454611|NCT02883049|561088612|FG003|Induction|Physician Decision|0|||
155515737|NCT06331156|561313564|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
155515738|NCT06331156|561313565|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
155454612|NCT02883049|561088613|FG004|Induction|Physician Decision|0|||
155454613|NCT02883049|561088614|FG005|Induction|Physician Decision|0|||
155454614|NCT02883049|561088615|FG006|Induction|Physician Decision|0|||
155515739|NCT02978326|561313570|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
155454615|NCT02883049|561088616|FG007|Induction|Physician Decision|0|||
155454616|NCT02883049|561088617|FG008|Induction|Physician Decision|0|||
155454617|NCT02883049|561088618|FG009|Induction|Physician Decision|0|||
155454618|NCT02883049|561088619|FG010|Induction|Physician Decision|0|||
155454619|NCT02883049|561088620|FG011|Induction|Physician Decision|0|||
155454620|NCT02883049|561088621|FG012|Induction|Physician Decision|0|||
155454621|NCT02883049|561088622|FG013|Induction|Physician Decision|0|||
155454622|NCT02883049|561088623|FG014|Induction|Physician Decision|0|||
155454623|NCT02883049|561088624|FG015|Induction|Physician Decision|0|||
155454624|NCT02883049|561088609|FG000|Induction|Protocol Violation|6|||
155454625|NCT02883049|561088610|FG001|Induction|Protocol Violation|0|||
155454626|NCT02883049|561088611|FG002|Induction|Protocol Violation|0|||
155454627|NCT02883049|561088612|FG003|Induction|Protocol Violation|0|||
155515740|NCT02978326|561313571|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
155454628|NCT02883049|561088613|FG004|Induction|Protocol Violation|0|||
155454629|NCT02883049|561088614|FG005|Induction|Protocol Violation|0|||
155454630|NCT02883049|561088615|FG006|Induction|Protocol Violation|0|||
155454631|NCT02883049|561088616|FG007|Induction|Protocol Violation|0|||
155454632|NCT02883049|561088617|FG008|Induction|Protocol Violation|0|||
155454633|NCT02883049|561088618|FG009|Induction|Protocol Violation|0|||
155454634|NCT02883049|561088619|FG010|Induction|Protocol Violation|0|||
155454635|NCT02883049|561088620|FG011|Induction|Protocol Violation|0|||
155454636|NCT02883049|561088621|FG012|Induction|Protocol Violation|0|||
155454637|NCT02883049|561088622|FG013|Induction|Protocol Violation|0|||
155454638|NCT02883049|561088623|FG014|Induction|Protocol Violation|0|||
155454639|NCT02883049|561088624|FG015|Induction|Protocol Violation|0|||
155454640|NCT02883049|561088609|FG000|Induction|Withdrawal by Subject|6|||
155454641|NCT02883049|561088610|FG001|Induction|Withdrawal by Subject|0|||
155454642|NCT02883049|561088611|FG002|Induction|Withdrawal by Subject|0|||
155454643|NCT02883049|561088612|FG003|Induction|Withdrawal by Subject|0|||
155454644|NCT02883049|561088613|FG004|Induction|Withdrawal by Subject|0|||
155454645|NCT02883049|561088614|FG005|Induction|Withdrawal by Subject|0|||
155454646|NCT02883049|561088615|FG006|Induction|Withdrawal by Subject|0|||
155454647|NCT02883049|561088616|FG007|Induction|Withdrawal by Subject|0|||
155454648|NCT02883049|561088617|FG008|Induction|Withdrawal by Subject|0|||
155454649|NCT02883049|561088618|FG009|Induction|Withdrawal by Subject|0|||
155454650|NCT02883049|561088619|FG010|Induction|Withdrawal by Subject|0|||
155454651|NCT02883049|561088620|FG011|Induction|Withdrawal by Subject|0|||
155454652|NCT02883049|561088621|FG012|Induction|Withdrawal by Subject|0|||
155454653|NCT02883049|561088622|FG013|Induction|Withdrawal by Subject|0|||
155454654|NCT02883049|561088623|FG014|Induction|Withdrawal by Subject|0|||
155454655|NCT02883049|561088624|FG015|Induction|Withdrawal by Subject|0|||
155454656|NCT02883049|561088609|FG000|Induction|Ineligible|35|||
155454657|NCT02883049|561088610|FG001|Induction|Ineligible|1|||
155454658|NCT02883049|561088611|FG002|Induction|Ineligible|0|||
155454659|NCT02883049|561088612|FG003|Induction|Ineligible|0|||
155454660|NCT02883049|561088613|FG004|Induction|Ineligible|0|||
155454661|NCT02883049|561088614|FG005|Induction|Ineligible|0|||
155454662|NCT02883049|561088615|FG006|Induction|Ineligible|0|||
155454663|NCT02883049|561088616|FG007|Induction|Ineligible|0|||
155454664|NCT02883049|561088617|FG008|Induction|Ineligible|0|||
155454665|NCT02883049|561088618|FG009|Induction|Ineligible|0|||
155454666|NCT02883049|561088619|FG010|Induction|Ineligible|0|||
155454667|NCT02883049|561088620|FG011|Induction|Ineligible|0|||
155454668|NCT02883049|561088621|FG012|Induction|Ineligible|0|||
155454669|NCT02883049|561088622|FG013|Induction|Ineligible|0|||
155454670|NCT02883049|561088623|FG014|Induction|Ineligible|0|||
155454671|NCT02883049|561088624|FG015|Induction|Ineligible|0|||
155454672|NCT02883049|561088609|FG000|Induction|Refusal of further protocol therapy|466|||
155454673|NCT02883049|561088610|FG001|Induction|Refusal of further protocol therapy|2|||
155454674|NCT02883049|561088611|FG002|Induction|Refusal of further protocol therapy|0|||
155454675|NCT02883049|561088612|FG003|Induction|Refusal of further protocol therapy|0|||
155454676|NCT02883049|561088613|FG004|Induction|Refusal of further protocol therapy|0|||
155454677|NCT02883049|561088614|FG005|Induction|Refusal of further protocol therapy|0|||
155454678|NCT02883049|561088615|FG006|Induction|Refusal of further protocol therapy|0|||
155454679|NCT02883049|561088616|FG007|Induction|Refusal of further protocol therapy|0|||
155454680|NCT02883049|561088617|FG008|Induction|Refusal of further protocol therapy|0|||
155454681|NCT02883049|561088618|FG009|Induction|Refusal of further protocol therapy|0|||
155454682|NCT02883049|561088619|FG010|Induction|Refusal of further protocol therapy|0|||
155454683|NCT02883049|561088620|FG011|Induction|Refusal of further protocol therapy|0|||
155454684|NCT02883049|561088621|FG012|Induction|Refusal of further protocol therapy|0|||
155454685|NCT02883049|561088622|FG013|Induction|Refusal of further protocol therapy|0|||
155454686|NCT02883049|561088623|FG014|Induction|Refusal of further protocol therapy|0|||
155454687|NCT02883049|561088624|FG015|Induction|Refusal of further protocol therapy|0|||
155454688|NCT02883049|561088609|FG000|Induction|Identified as Ph+ patients|279|||
155454689|NCT02883049|561088610|FG001|Induction|Identified as Ph+ patients|1|||
155515741|NCT02978326|561313572|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
155515742|NCT02978326|561313570|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
155515743|NCT02978326|561313571|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
155515744|NCT02978326|561313572|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
155454690|NCT02883049|561088611|FG002|Induction|Identified as Ph+ patients|0|||
155454691|NCT02883049|561088612|FG003|Induction|Identified as Ph+ patients|0|||
155454692|NCT02883049|561088613|FG004|Induction|Identified as Ph+ patients|0|||
155454693|NCT02883049|561088614|FG005|Induction|Identified as Ph+ patients|0|||
155454694|NCT02883049|561088615|FG006|Induction|Identified as Ph+ patients|0|||
155454695|NCT02883049|561088616|FG007|Induction|Identified as Ph+ patients|0|||
155454696|NCT02883049|561088617|FG008|Induction|Identified as Ph+ patients|0|||
155454697|NCT02883049|561088618|FG009|Induction|Identified as Ph+ patients|0|||
155454698|NCT02883049|561088619|FG010|Induction|Identified as Ph+ patients|0|||
155454699|NCT02883049|561088620|FG011|Induction|Identified as Ph+ patients|0|||
155454700|NCT02883049|561088621|FG012|Induction|Identified as Ph+ patients|0|||
155454701|NCT02883049|561088622|FG013|Induction|Identified as Ph+ patients|0|||
155454702|NCT02883049|561088623|FG014|Induction|Identified as Ph+ patients|0|||
155454703|NCT02883049|561088624|FG015|Induction|Identified as Ph+ patients|0|||
155454704|NCT02883049|561088609|FG000|Induction|M3 Marrow at Day29|8|||
155454705|NCT02883049|561088610|FG001|Induction|M3 Marrow at Day29|1|||
155454706|NCT02883049|561088611|FG002|Induction|M3 Marrow at Day29|0|||
155454707|NCT02883049|561088612|FG003|Induction|M3 Marrow at Day29|0|||
155454708|NCT02883049|561088613|FG004|Induction|M3 Marrow at Day29|0|||
155454709|NCT02883049|561088614|FG005|Induction|M3 Marrow at Day29|0|||
155454710|NCT02883049|561088615|FG006|Induction|M3 Marrow at Day29|0|||
155454711|NCT02883049|561088616|FG007|Induction|M3 Marrow at Day29|0|||
155454712|NCT02883049|561088617|FG008|Induction|M3 Marrow at Day29|0|||
155454713|NCT02883049|561088618|FG009|Induction|M3 Marrow at Day29|0|||
155454714|NCT02883049|561088619|FG010|Induction|M3 Marrow at Day29|0|||
155454715|NCT02883049|561088620|FG011|Induction|M3 Marrow at Day29|0|||
155454716|NCT02883049|561088621|FG012|Induction|M3 Marrow at Day29|0|||
155454717|NCT02883049|561088622|FG013|Induction|M3 Marrow at Day29|0|||
155454718|NCT02883049|561088623|FG014|Induction|M3 Marrow at Day29|0|||
155454719|NCT02883049|561088624|FG015|Induction|M3 Marrow at Day29|0|||
155454720|NCT02883049|561088609|FG000|Induction|Inevaluable|33|||
155454721|NCT02883049|561088610|FG001|Induction|Inevaluable|1|||
155454722|NCT02883049|561088611|FG002|Induction|Inevaluable|0|||
155454723|NCT02883049|561088612|FG003|Induction|Inevaluable|0|||
155454724|NCT02883049|561088613|FG004|Induction|Inevaluable|0|||
155454725|NCT02883049|561088614|FG005|Induction|Inevaluable|0|||
155454726|NCT02883049|561088615|FG006|Induction|Inevaluable|0|||
155454727|NCT02883049|561088616|FG007|Induction|Inevaluable|0|||
155454728|NCT02883049|561088617|FG008|Induction|Inevaluable|0|||
155454729|NCT02883049|561088618|FG009|Induction|Inevaluable|0|||
155454730|NCT02883049|561088619|FG010|Induction|Inevaluable|0|||
155454731|NCT02883049|561088620|FG011|Induction|Inevaluable|0|||
155454732|NCT02883049|561088621|FG012|Induction|Inevaluable|0|||
155454733|NCT02883049|561088622|FG013|Induction|Inevaluable|0|||
155454734|NCT02883049|561088623|FG014|Induction|Inevaluable|0|||
155454735|NCT02883049|561088624|FG015|Induction|Inevaluable|0|||
155454736|NCT02883049|561088609|FG000|Induction|Identified as VHR at end of Induction|244|||
155454737|NCT02883049|561088610|FG001|Induction|Identified as VHR at end of Induction|0|||
155454738|NCT02883049|561088611|FG002|Induction|Identified as VHR at end of Induction|0|||
155454739|NCT02883049|561088612|FG003|Induction|Identified as VHR at end of Induction|0|||
155454740|NCT02883049|561088613|FG004|Induction|Identified as VHR at end of Induction|0|||
155454741|NCT02883049|561088614|FG005|Induction|Identified as VHR at end of Induction|0|||
155454742|NCT02883049|561088615|FG006|Induction|Identified as VHR at end of Induction|0|||
155454743|NCT02883049|561088616|FG007|Induction|Identified as VHR at end of Induction|0|||
155454744|NCT02883049|561088617|FG008|Induction|Identified as VHR at end of Induction|0|||
155454745|NCT02883049|561088618|FG009|Induction|Identified as VHR at end of Induction|0|||
155454746|NCT02883049|561088619|FG010|Induction|Identified as VHR at end of Induction|0|||
155454747|NCT02883049|561088620|FG011|Induction|Identified as VHR at end of Induction|0|||
155454748|NCT02883049|561088621|FG012|Induction|Identified as VHR at end of Induction|0|||
155454749|NCT02883049|561088622|FG013|Induction|Identified as VHR at end of Induction|0|||
155454750|NCT02883049|561088623|FG014|Induction|Identified as VHR at end of Induction|0|||
155454751|NCT02883049|561088624|FG015|Induction|Identified as VHR at end of Induction|0|||
155454752|NCT02883049|561088609|FG000|Induction|Moved to another non-COG institution|3|||
155454753|NCT02883049|561088610|FG001|Induction|Moved to another non-COG institution|0|||
155454754|NCT02883049|561088611|FG002|Induction|Moved to another non-COG institution|0|||
155454755|NCT02883049|561088612|FG003|Induction|Moved to another non-COG institution|0|||
155454756|NCT02883049|561088613|FG004|Induction|Moved to another non-COG institution|0|||
155454757|NCT02883049|561088614|FG005|Induction|Moved to another non-COG institution|0|||
155454758|NCT02883049|561088615|FG006|Induction|Moved to another non-COG institution|0|||
155454759|NCT02883049|561088616|FG007|Induction|Moved to another non-COG institution|0|||
155454760|NCT02883049|561088617|FG008|Induction|Moved to another non-COG institution|0|||
155454761|NCT02883049|561088618|FG009|Induction|Moved to another non-COG institution|0|||
155454762|NCT02883049|561088619|FG010|Induction|Moved to another non-COG institution|0|||
155454763|NCT02883049|561088620|FG011|Induction|Moved to another non-COG institution|0|||
155454764|NCT02883049|561088621|FG012|Induction|Moved to another non-COG institution|0|||
155454765|NCT02883049|561088622|FG013|Induction|Moved to another non-COG institution|0|||
155454766|NCT02883049|561088623|FG014|Induction|Moved to another non-COG institution|0|||
155454767|NCT02883049|561088624|FG015|Induction|Moved to another non-COG institution|0|||
155454768|NCT02883049|561088609|FG000|Induction|Randomization closed|41|||
155454769|NCT02883049|561088610|FG001|Induction|Randomization closed|0|||
155454770|NCT02883049|561088611|FG002|Induction|Randomization closed|0|||
155454771|NCT02883049|561088612|FG003|Induction|Randomization closed|0|||
155454772|NCT02883049|561088613|FG004|Induction|Randomization closed|0|||
155454773|NCT02883049|561088614|FG005|Induction|Randomization closed|0|||
155454774|NCT02883049|561088615|FG006|Induction|Randomization closed|0|||
155454775|NCT02883049|561088616|FG007|Induction|Randomization closed|0|||
155454776|NCT02883049|561088617|FG008|Induction|Randomization closed|0|||
155454777|NCT02883049|561088618|FG009|Induction|Randomization closed|0|||
155454778|NCT02883049|561088619|FG010|Induction|Randomization closed|0|||
155454779|NCT02883049|561088620|FG011|Induction|Randomization closed|0|||
155454780|NCT02883049|561088621|FG012|Induction|Randomization closed|0|||
155454781|NCT02883049|561088622|FG013|Induction|Randomization closed|0|||
155454782|NCT02883049|561088623|FG014|Induction|Randomization closed|0|||
155454783|NCT02883049|561088624|FG015|Induction|Randomization closed|0|||
155454784|NCT02883049|561088609|FG000|Induction|MRD negative|36|||
155454785|NCT02883049|561088610|FG001|Induction|MRD negative|0|||
155454786|NCT02883049|561088611|FG002|Induction|MRD negative|0|||
155454787|NCT02883049|561088612|FG003|Induction|MRD negative|0|||
155454788|NCT02883049|561088613|FG004|Induction|MRD negative|0|||
155454789|NCT02883049|561088614|FG005|Induction|MRD negative|0|||
155454790|NCT02883049|561088615|FG006|Induction|MRD negative|0|||
155454791|NCT02883049|561088616|FG007|Induction|MRD negative|0|||
155454792|NCT02883049|561088617|FG008|Induction|MRD negative|0|||
155454793|NCT02883049|561088618|FG009|Induction|MRD negative|0|||
155454794|NCT02883049|561088619|FG010|Induction|MRD negative|0|||
155454795|NCT02883049|561088620|FG011|Induction|MRD negative|0|||
155454796|NCT02883049|561088621|FG012|Induction|MRD negative|0|||
155454797|NCT02883049|561088622|FG013|Induction|MRD negative|0|||
155454798|NCT02883049|561088623|FG014|Induction|MRD negative|0|||
155454799|NCT02883049|561088624|FG015|Induction|MRD negative|0|||
155454800|NCT02883049|561088609|FG000|Induction|Identified as HR patients|165|||
155454801|NCT02883049|561088610|FG001|Induction|Identified as HR patients|0|||
155454802|NCT02883049|561088611|FG002|Induction|Identified as HR patients|0|||
155454803|NCT02883049|561088612|FG003|Induction|Identified as HR patients|0|||
155454804|NCT02883049|561088613|FG004|Induction|Identified as HR patients|0|||
155454805|NCT02883049|561088614|FG005|Induction|Identified as HR patients|0|||
155454806|NCT02883049|561088615|FG006|Induction|Identified as HR patients|0|||
155454807|NCT02883049|561088616|FG007|Induction|Identified as HR patients|0|||
155454808|NCT02883049|561088617|FG008|Induction|Identified as HR patients|0|||
155454809|NCT02883049|561088618|FG009|Induction|Identified as HR patients|0|||
155454810|NCT02883049|561088619|FG010|Induction|Identified as HR patients|0|||
155454811|NCT02883049|561088620|FG011|Induction|Identified as HR patients|0|||
155454812|NCT02883049|561088621|FG012|Induction|Identified as HR patients|0|||
155454813|NCT02883049|561088622|FG013|Induction|Identified as HR patients|0|||
155454814|NCT02883049|561088623|FG014|Induction|Identified as HR patients|0|||
155454815|NCT02883049|561088624|FG015|Induction|Identified as HR patients|0|||
155454816|NCT02883049|561088609|FG000|Induction|Developed SMN|0|||
155454817|NCT02883049|561088610|FG001|Induction|Developed SMN|1|||
155454818|NCT02883049|561088611|FG002|Induction|Developed SMN|0|||
155454819|NCT02883049|561088612|FG003|Induction|Developed SMN|0|||
155454820|NCT02883049|561088613|FG004|Induction|Developed SMN|0|||
155454821|NCT02883049|561088614|FG005|Induction|Developed SMN|0|||
155454822|NCT02883049|561088615|FG006|Induction|Developed SMN|0|||
155454823|NCT02883049|561088616|FG007|Induction|Developed SMN|0|||
155454824|NCT02883049|561088617|FG008|Induction|Developed SMN|0|||
155454825|NCT02883049|561088618|FG009|Induction|Developed SMN|0|||
155454826|NCT02883049|561088619|FG010|Induction|Developed SMN|0|||
155454827|NCT02883049|561088620|FG011|Induction|Developed SMN|0|||
155454828|NCT02883049|561088621|FG012|Induction|Developed SMN|0|||
155454829|NCT02883049|561088622|FG013|Induction|Developed SMN|0|||
155454830|NCT02883049|561088623|FG014|Induction|Developed SMN|0|||
155454831|NCT02883049|561088624|FG015|Induction|Developed SMN|0|||
155454832|NCT02883049|561088609|FG000|Induction|Enrolled onto another COG study|72|||
155454833|NCT02883049|561088610|FG001|Induction|Enrolled onto another COG study|0|||
155454834|NCT02883049|561088611|FG002|Induction|Enrolled onto another COG study|0|||
155454835|NCT02883049|561088612|FG003|Induction|Enrolled onto another COG study|0|||
155454836|NCT02883049|561088613|FG004|Induction|Enrolled onto another COG study|0|||
155454837|NCT02883049|561088614|FG005|Induction|Enrolled onto another COG study|0|||
155454838|NCT02883049|561088615|FG006|Induction|Enrolled onto another COG study|0|||
155454839|NCT02883049|561088616|FG007|Induction|Enrolled onto another COG study|0|||
155454840|NCT02883049|561088617|FG008|Induction|Enrolled onto another COG study|0|||
155454841|NCT02883049|561088618|FG009|Induction|Enrolled onto another COG study|0|||
155454842|NCT02883049|561088619|FG010|Induction|Enrolled onto another COG study|0|||
155454843|NCT02883049|561088620|FG011|Induction|Enrolled onto another COG study|0|||
155454844|NCT02883049|561088621|FG012|Induction|Enrolled onto another COG study|0|||
155454845|NCT02883049|561088622|FG013|Induction|Enrolled onto another COG study|0|||
155651783|NCT03142451|561818143|FG001|Overall Study|Lost to Follow-up|8|||
155454846|NCT02883049|561088623|FG014|Induction|Enrolled onto another COG study|0|||
155454847|NCT02883049|561088624|FG015|Induction|Enrolled onto another COG study|0|||
155454848|NCT02883049|561088609|FG000|Induction|Incomplete induction data|17|||
155454849|NCT02883049|561088610|FG001|Induction|Incomplete induction data|0|||
155454850|NCT02883049|561088611|FG002|Induction|Incomplete induction data|0|||
155454851|NCT02883049|561088612|FG003|Induction|Incomplete induction data|0|||
155454852|NCT02883049|561088613|FG004|Induction|Incomplete induction data|0|||
155454853|NCT02883049|561088614|FG005|Induction|Incomplete induction data|0|||
155454854|NCT02883049|561088615|FG006|Induction|Incomplete induction data|0|||
155454855|NCT02883049|561088616|FG007|Induction|Incomplete induction data|0|||
155454856|NCT02883049|561088617|FG008|Induction|Incomplete induction data|0|||
155454857|NCT02883049|561088618|FG009|Induction|Incomplete induction data|0|||
155454858|NCT02883049|561088619|FG010|Induction|Incomplete induction data|0|||
155454859|NCT02883049|561088620|FG011|Induction|Incomplete induction data|0|||
155454860|NCT02883049|561088621|FG012|Induction|Incomplete induction data|0|||
155454861|NCT02883049|561088622|FG013|Induction|Incomplete induction data|0|||
155454862|NCT02883049|561088623|FG014|Induction|Incomplete induction data|0|||
155454863|NCT02883049|561088624|FG015|Induction|Incomplete induction data|0|||
155454864|NCT02883049|561088609|FG000|Post Induction|Adverse Event|0|||
155454865|NCT02883049|561088610|FG001|Post Induction|Adverse Event|0|||
155454866|NCT02883049|561088611|FG002|Post Induction|Adverse Event|0|||
155454867|NCT02883049|561088612|FG003|Post Induction|Adverse Event|7|||
155454868|NCT02883049|561088613|FG004|Post Induction|Adverse Event|8|||
155454869|NCT02883049|561088614|FG005|Post Induction|Adverse Event|3|||
155454870|NCT02883049|561088615|FG006|Post Induction|Adverse Event|4|||
155454871|NCT02883049|561088616|FG007|Post Induction|Adverse Event|5|||
155454872|NCT02883049|561088617|FG008|Post Induction|Adverse Event|6|||
155454873|NCT02883049|561088618|FG009|Post Induction|Adverse Event|7|||
155454874|NCT02883049|561088619|FG010|Post Induction|Adverse Event|2|||
155454875|NCT02883049|561088620|FG011|Post Induction|Adverse Event|2|||
155454876|NCT02883049|561088621|FG012|Post Induction|Adverse Event|0|||
155454877|NCT02883049|561088622|FG013|Post Induction|Adverse Event|0|||
155454878|NCT02883049|561088623|FG014|Post Induction|Adverse Event|5|||
155454879|NCT02883049|561088624|FG015|Post Induction|Adverse Event|2|||
155454880|NCT02883049|561088609|FG000|Post Induction|Death|0|||
155454881|NCT02883049|561088610|FG001|Post Induction|Death|0|||
155454882|NCT02883049|561088611|FG002|Post Induction|Death|0|||
155454883|NCT02883049|561088612|FG003|Post Induction|Death|9|||
155454884|NCT02883049|561088613|FG004|Post Induction|Death|9|||
155454885|NCT02883049|561088614|FG005|Post Induction|Death|0|||
155454886|NCT02883049|561088615|FG006|Post Induction|Death|1|||
155454887|NCT02883049|561088616|FG007|Post Induction|Death|6|||
155454888|NCT02883049|561088617|FG008|Post Induction|Death|5|||
155454889|NCT02883049|561088618|FG009|Post Induction|Death|3|||
155454890|NCT02883049|561088619|FG010|Post Induction|Death|1|||
155454891|NCT02883049|561088620|FG011|Post Induction|Death|0|||
155454892|NCT02883049|561088621|FG012|Post Induction|Death|1|||
155454893|NCT02883049|561088622|FG013|Post Induction|Death|1|||
155454894|NCT02883049|561088623|FG014|Post Induction|Death|10|||
155454895|NCT02883049|561088624|FG015|Post Induction|Death|2|||
155454896|NCT02883049|561088609|FG000|Post Induction|Lost to Follow-up|0|||
155454897|NCT02883049|561088610|FG001|Post Induction|Lost to Follow-up|0|||
155454898|NCT02883049|561088611|FG002|Post Induction|Lost to Follow-up|0|||
155454899|NCT02883049|561088612|FG003|Post Induction|Lost to Follow-up|0|||
155454900|NCT02883049|561088613|FG004|Post Induction|Lost to Follow-up|1|||
155454901|NCT02883049|561088614|FG005|Post Induction|Lost to Follow-up|1|||
155454902|NCT02883049|561088615|FG006|Post Induction|Lost to Follow-up|0|||
155454903|NCT02883049|561088616|FG007|Post Induction|Lost to Follow-up|0|||
155454904|NCT02883049|561088617|FG008|Post Induction|Lost to Follow-up|3|||
155454905|NCT02883049|561088618|FG009|Post Induction|Lost to Follow-up|0|||
155454906|NCT02883049|561088619|FG010|Post Induction|Lost to Follow-up|1|||
155454907|NCT02883049|561088620|FG011|Post Induction|Lost to Follow-up|0|||
155454908|NCT02883049|561088621|FG012|Post Induction|Lost to Follow-up|0|||
155454909|NCT02883049|561088622|FG013|Post Induction|Lost to Follow-up|0|||
155454910|NCT02883049|561088623|FG014|Post Induction|Lost to Follow-up|0|||
155454911|NCT02883049|561088624|FG015|Post Induction|Lost to Follow-up|0|||
155454912|NCT02883049|561088609|FG000|Post Induction|Physician Decision|0|||
155454913|NCT02883049|561088610|FG001|Post Induction|Physician Decision|0|||
155454914|NCT02883049|561088611|FG002|Post Induction|Physician Decision|0|||
155454915|NCT02883049|561088612|FG003|Post Induction|Physician Decision|27|||
155454916|NCT02883049|561088613|FG004|Post Induction|Physician Decision|27|||
155454917|NCT02883049|561088614|FG005|Post Induction|Physician Decision|23|||
155454918|NCT02883049|561088615|FG006|Post Induction|Physician Decision|30|||
155454919|NCT02883049|561088616|FG007|Post Induction|Physician Decision|56|||
155454920|NCT02883049|561088617|FG008|Post Induction|Physician Decision|85|||
155515745|NCT02978326|561313570|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
155454921|NCT02883049|561088618|FG009|Post Induction|Physician Decision|12|||
155454922|NCT02883049|561088619|FG010|Post Induction|Physician Decision|5|||
155454923|NCT02883049|561088620|FG011|Post Induction|Physician Decision|14|||
155454924|NCT02883049|561088621|FG012|Post Induction|Physician Decision|1|||
155454925|NCT02883049|561088622|FG013|Post Induction|Physician Decision|11|||
155454926|NCT02883049|561088623|FG014|Post Induction|Physician Decision|19|||
155454927|NCT02883049|561088624|FG015|Post Induction|Physician Decision|5|||
155454928|NCT02883049|561088609|FG000|Post Induction|Protocol Violation|0|||
155515746|NCT02978326|561313571|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
155515747|NCT02978326|561313572|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
155515748|NCT02978326|561313570|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
155515749|NCT02978326|561313571|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
155515750|NCT02978326|561313572|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
155454929|NCT02883049|561088610|FG001|Post Induction|Protocol Violation|0|||
155454930|NCT02883049|561088611|FG002|Post Induction|Protocol Violation|0|||
155454931|NCT02883049|561088612|FG003|Post Induction|Protocol Violation|0|||
155454932|NCT02883049|561088613|FG004|Post Induction|Protocol Violation|0|||
155454933|NCT02883049|561088614|FG005|Post Induction|Protocol Violation|0|||
155454934|NCT02883049|561088615|FG006|Post Induction|Protocol Violation|0|||
155454935|NCT02883049|561088616|FG007|Post Induction|Protocol Violation|1|||
155454936|NCT02883049|561088617|FG008|Post Induction|Protocol Violation|0|||
155454937|NCT02883049|561088618|FG009|Post Induction|Protocol Violation|0|||
155454938|NCT02883049|561088619|FG010|Post Induction|Protocol Violation|0|||
155454939|NCT02883049|561088620|FG011|Post Induction|Protocol Violation|0|||
155454940|NCT02883049|561088621|FG012|Post Induction|Protocol Violation|0|||
155454941|NCT02883049|561088622|FG013|Post Induction|Protocol Violation|0|||
155454942|NCT02883049|561088623|FG014|Post Induction|Protocol Violation|0|||
155454943|NCT02883049|561088624|FG015|Post Induction|Protocol Violation|0|||
155454944|NCT02883049|561088609|FG000|Post Induction|Withdrawal by Subject|0|||
155454945|NCT02883049|561088610|FG001|Post Induction|Withdrawal by Subject|0|||
155454946|NCT02883049|561088611|FG002|Post Induction|Withdrawal by Subject|0|||
155454947|NCT02883049|561088612|FG003|Post Induction|Withdrawal by Subject|5|||
155454948|NCT02883049|561088613|FG004|Post Induction|Withdrawal by Subject|2|||
155454949|NCT02883049|561088614|FG005|Post Induction|Withdrawal by Subject|1|||
155454950|NCT02883049|561088615|FG006|Post Induction|Withdrawal by Subject|0|||
155454951|NCT02883049|561088616|FG007|Post Induction|Withdrawal by Subject|0|||
155454952|NCT02883049|561088617|FG008|Post Induction|Withdrawal by Subject|2|||
155454953|NCT02883049|561088618|FG009|Post Induction|Withdrawal by Subject|0|||
155454954|NCT02883049|561088619|FG010|Post Induction|Withdrawal by Subject|1|||
155454955|NCT02883049|561088620|FG011|Post Induction|Withdrawal by Subject|1|||
155454956|NCT02883049|561088621|FG012|Post Induction|Withdrawal by Subject|0|||
155454957|NCT02883049|561088622|FG013|Post Induction|Withdrawal by Subject|0|||
155454958|NCT02883049|561088623|FG014|Post Induction|Withdrawal by Subject|1|||
155454959|NCT02883049|561088624|FG015|Post Induction|Withdrawal by Subject|0|||
155454960|NCT02883049|561088609|FG000|Post Induction|Ineligible|0|||
155454961|NCT02883049|561088610|FG001|Post Induction|Ineligible|0|||
155454962|NCT02883049|561088611|FG002|Post Induction|Ineligible|2|||
155454963|NCT02883049|561088612|FG003|Post Induction|Ineligible|0|||
155454964|NCT02883049|561088613|FG004|Post Induction|Ineligible|0|||
155454965|NCT02883049|561088614|FG005|Post Induction|Ineligible|0|||
155454966|NCT02883049|561088615|FG006|Post Induction|Ineligible|1|||
155454967|NCT02883049|561088616|FG007|Post Induction|Ineligible|0|||
155454968|NCT02883049|561088617|FG008|Post Induction|Ineligible|0|||
155454969|NCT02883049|561088618|FG009|Post Induction|Ineligible|0|||
155454970|NCT02883049|561088619|FG010|Post Induction|Ineligible|1|||
155454971|NCT02883049|561088620|FG011|Post Induction|Ineligible|0|||
155454972|NCT02883049|561088621|FG012|Post Induction|Ineligible|0|||
155454973|NCT02883049|561088622|FG013|Post Induction|Ineligible|0|||
155454974|NCT02883049|561088623|FG014|Post Induction|Ineligible|0|||
155454975|NCT02883049|561088624|FG015|Post Induction|Ineligible|1|||
155454976|NCT02883049|561088609|FG000|Post Induction|Refusal of further protocol therapy|0|||
155454977|NCT02883049|561088610|FG001|Post Induction|Refusal of further protocol therapy|0|||
155454978|NCT02883049|561088611|FG002|Post Induction|Refusal of further protocol therapy|0|||
155454979|NCT02883049|561088612|FG003|Post Induction|Refusal of further protocol therapy|11|||
155454980|NCT02883049|561088613|FG004|Post Induction|Refusal of further protocol therapy|15|||
155454981|NCT02883049|561088614|FG005|Post Induction|Refusal of further protocol therapy|9|||
155454982|NCT02883049|561088615|FG006|Post Induction|Refusal of further protocol therapy|13|||
155454983|NCT02883049|561088616|FG007|Post Induction|Refusal of further protocol therapy|5|||
155515751|NCT00601354|561313575|FG000|Overall Study|Lost to Follow-up|4|||
155454984|NCT02883049|561088617|FG008|Post Induction|Refusal of further protocol therapy|21|||
155515752|NCT00601354|561313576|FG001|Overall Study|Lost to Follow-up|5|||
155454985|NCT02883049|561088618|FG009|Post Induction|Refusal of further protocol therapy|7|||
155454986|NCT02883049|561088619|FG010|Post Induction|Refusal of further protocol therapy|0|||
155454987|NCT02883049|561088620|FG011|Post Induction|Refusal of further protocol therapy|7|||
155515753|NCT04799158|561313577|FG000|Run-In Period|Adverse Event|6|||
155454988|NCT02883049|561088621|FG012|Post Induction|Refusal of further protocol therapy|3|||
155454989|NCT02883049|561088622|FG013|Post Induction|Refusal of further protocol therapy|0|||
155454990|NCT02883049|561088623|FG014|Post Induction|Refusal of further protocol therapy|4|||
155454991|NCT02883049|561088624|FG015|Post Induction|Refusal of further protocol therapy|1|||
155454992|NCT02883049|561088609|FG000|Post Induction|Inevaluable|0|||
155454993|NCT02883049|561088610|FG001|Post Induction|Inevaluable|0|||
155515754|NCT04799158|561313578|FG001|Run-In Period|Adverse Event|0|||
155454994|NCT02883049|561088611|FG002|Post Induction|Inevaluable|0|||
155454995|NCT02883049|561088612|FG003|Post Induction|Inevaluable|1|||
155454996|NCT02883049|561088613|FG004|Post Induction|Inevaluable|1|||
155454997|NCT02883049|561088614|FG005|Post Induction|Inevaluable|2|||
155454998|NCT02883049|561088615|FG006|Post Induction|Inevaluable|7|||
155454999|NCT02883049|561088616|FG007|Post Induction|Inevaluable|6|||
155455000|NCT02883049|561088617|FG008|Post Induction|Inevaluable|4|||
155455001|NCT02883049|561088618|FG009|Post Induction|Inevaluable|4|||
155455002|NCT02883049|561088619|FG010|Post Induction|Inevaluable|1|||
155455003|NCT02883049|561088620|FG011|Post Induction|Inevaluable|1|||
155455004|NCT02883049|561088621|FG012|Post Induction|Inevaluable|2|||
155455005|NCT02883049|561088622|FG013|Post Induction|Inevaluable|0|||
155455006|NCT02883049|561088623|FG014|Post Induction|Inevaluable|0|||
155455007|NCT02883049|561088624|FG015|Post Induction|Inevaluable|1|||
155455008|NCT02883049|561088609|FG000|Post Induction|Moved to another non-COG institution|0|||
155455009|NCT02883049|561088610|FG001|Post Induction|Moved to another non-COG institution|0|||
155455010|NCT02883049|561088611|FG002|Post Induction|Moved to another non-COG institution|0|||
155455011|NCT02883049|561088612|FG003|Post Induction|Moved to another non-COG institution|0|||
155455012|NCT02883049|561088613|FG004|Post Induction|Moved to another non-COG institution|0|||
155455013|NCT02883049|561088614|FG005|Post Induction|Moved to another non-COG institution|0|||
155455014|NCT02883049|561088615|FG006|Post Induction|Moved to another non-COG institution|0|||
155455015|NCT02883049|561088616|FG007|Post Induction|Moved to another non-COG institution|2|||
155455016|NCT02883049|561088617|FG008|Post Induction|Moved to another non-COG institution|2|||
155455017|NCT02883049|561088618|FG009|Post Induction|Moved to another non-COG institution|0|||
155455018|NCT02883049|561088619|FG010|Post Induction|Moved to another non-COG institution|0|||
155455019|NCT02883049|561088620|FG011|Post Induction|Moved to another non-COG institution|1|||
155455020|NCT02883049|561088621|FG012|Post Induction|Moved to another non-COG institution|0|||
155455021|NCT02883049|561088622|FG013|Post Induction|Moved to another non-COG institution|0|||
155455022|NCT02883049|561088623|FG014|Post Induction|Moved to another non-COG institution|0|||
155455023|NCT02883049|561088624|FG015|Post Induction|Moved to another non-COG institution|0|||
155455024|NCT02883049|561088609|FG000|Post Induction|Randomization closed|0|||
155455025|NCT02883049|561088610|FG001|Post Induction|Randomization closed|0|||
155455026|NCT02883049|561088611|FG002|Post Induction|Randomization closed|0|||
155455027|NCT02883049|561088612|FG003|Post Induction|Randomization closed|0|||
155455028|NCT02883049|561088613|FG004|Post Induction|Randomization closed|0|||
155455029|NCT02883049|561088614|FG005|Post Induction|Randomization closed|0|||
155455030|NCT02883049|561088615|FG006|Post Induction|Randomization closed|0|||
155455031|NCT02883049|561088616|FG007|Post Induction|Randomization closed|20|||
155455032|NCT02883049|561088617|FG008|Post Induction|Randomization closed|0|||
155455033|NCT02883049|561088618|FG009|Post Induction|Randomization closed|0|||
155455034|NCT02883049|561088619|FG010|Post Induction|Randomization closed|0|||
155455035|NCT02883049|561088620|FG011|Post Induction|Randomization closed|0|||
155455036|NCT02883049|561088621|FG012|Post Induction|Randomization closed|0|||
155455037|NCT02883049|561088622|FG013|Post Induction|Randomization closed|0|||
155455038|NCT02883049|561088623|FG014|Post Induction|Randomization closed|0|||
155455039|NCT02883049|561088624|FG015|Post Induction|Randomization closed|0|||
155455040|NCT02883049|561088609|FG000|Post Induction|MRD negative|0|||
155455041|NCT02883049|561088610|FG001|Post Induction|MRD negative|0|||
155455042|NCT02883049|561088611|FG002|Post Induction|MRD negative|0|||
155455043|NCT02883049|561088612|FG003|Post Induction|MRD negative|0|||
155455044|NCT02883049|561088613|FG004|Post Induction|MRD negative|0|||
155455045|NCT02883049|561088614|FG005|Post Induction|MRD negative|0|||
155455046|NCT02883049|561088615|FG006|Post Induction|MRD negative|0|||
155455047|NCT02883049|561088616|FG007|Post Induction|MRD negative|11|||
155455048|NCT02883049|561088617|FG008|Post Induction|MRD negative|0|||
155455049|NCT02883049|561088618|FG009|Post Induction|MRD negative|0|||
155455050|NCT02883049|561088619|FG010|Post Induction|MRD negative|0|||
155455051|NCT02883049|561088620|FG011|Post Induction|MRD negative|0|||
155455052|NCT02883049|561088621|FG012|Post Induction|MRD negative|0|||
155455053|NCT02883049|561088622|FG013|Post Induction|MRD negative|0|||
155455054|NCT02883049|561088623|FG014|Post Induction|MRD negative|0|||
155455055|NCT02883049|561088624|FG015|Post Induction|MRD negative|0|||
155455056|NCT02883049|561088609|FG000|Post Induction|Developed SMN|0|||
155455057|NCT02883049|561088610|FG001|Post Induction|Developed SMN|0|||
155455058|NCT02883049|561088611|FG002|Post Induction|Developed SMN|0|||
155455059|NCT02883049|561088612|FG003|Post Induction|Developed SMN|0|||
155455060|NCT02883049|561088613|FG004|Post Induction|Developed SMN|1|||
155455061|NCT02883049|561088614|FG005|Post Induction|Developed SMN|0|||
155455062|NCT02883049|561088615|FG006|Post Induction|Developed SMN|1|||
155455063|NCT02883049|561088616|FG007|Post Induction|Developed SMN|0|||
155455064|NCT02883049|561088617|FG008|Post Induction|Developed SMN|0|||
155455065|NCT02883049|561088618|FG009|Post Induction|Developed SMN|0|||
155455066|NCT02883049|561088619|FG010|Post Induction|Developed SMN|1|||
155455067|NCT02883049|561088620|FG011|Post Induction|Developed SMN|1|||
155455068|NCT02883049|561088621|FG012|Post Induction|Developed SMN|0|||
155455069|NCT02883049|561088622|FG013|Post Induction|Developed SMN|0|||
155455070|NCT02883049|561088623|FG014|Post Induction|Developed SMN|1|||
155455071|NCT02883049|561088624|FG015|Post Induction|Developed SMN|0|||
155455072|NCT02883049|561088609|FG000|Post Induction|Enrolled onto another COG study|0|||
155455073|NCT02883049|561088610|FG001|Post Induction|Enrolled onto another COG study|0|||
155455074|NCT02883049|561088611|FG002|Post Induction|Enrolled onto another COG study|0|||
155455075|NCT02883049|561088612|FG003|Post Induction|Enrolled onto another COG study|1|||
155455076|NCT02883049|561088613|FG004|Post Induction|Enrolled onto another COG study|1|||
155455077|NCT02883049|561088614|FG005|Post Induction|Enrolled onto another COG study|0|||
155455078|NCT02883049|561088615|FG006|Post Induction|Enrolled onto another COG study|0|||
155455079|NCT02883049|561088616|FG007|Post Induction|Enrolled onto another COG study|4|||
155455080|NCT02883049|561088617|FG008|Post Induction|Enrolled onto another COG study|0|||
155455081|NCT02883049|561088618|FG009|Post Induction|Enrolled onto another COG study|0|||
155455082|NCT02883049|561088619|FG010|Post Induction|Enrolled onto another COG study|0|||
155455083|NCT02883049|561088620|FG011|Post Induction|Enrolled onto another COG study|2|||
155455084|NCT02883049|561088621|FG012|Post Induction|Enrolled onto another COG study|0|||
155455085|NCT02883049|561088622|FG013|Post Induction|Enrolled onto another COG study|1|||
155455086|NCT02883049|561088623|FG014|Post Induction|Enrolled onto another COG study|0|||
155455087|NCT02883049|561088624|FG015|Post Induction|Enrolled onto another COG study|0|||
155455088|NCT02883049|561088609|FG000|Post Induction|Recurrent leukemia|0|||
155455089|NCT02883049|561088610|FG001|Post Induction|Recurrent leukemia|0|||
155455090|NCT02883049|561088611|FG002|Post Induction|Recurrent leukemia|0|||
155455091|NCT02883049|561088612|FG003|Post Induction|Recurrent leukemia|17|||
155455092|NCT02883049|561088613|FG004|Post Induction|Recurrent leukemia|12|||
155455093|NCT02883049|561088614|FG005|Post Induction|Recurrent leukemia|4|||
155455094|NCT02883049|561088615|FG006|Post Induction|Recurrent leukemia|1|||
155455095|NCT02883049|561088616|FG007|Post Induction|Recurrent leukemia|13|||
155455096|NCT02883049|561088617|FG008|Post Induction|Recurrent leukemia|27|||
155455097|NCT02883049|561088618|FG009|Post Induction|Recurrent leukemia|5|||
155455098|NCT02883049|561088619|FG010|Post Induction|Recurrent leukemia|3|||
155455099|NCT02883049|561088620|FG011|Post Induction|Recurrent leukemia|12|||
155455100|NCT02883049|561088621|FG012|Post Induction|Recurrent leukemia|1|||
155455101|NCT02883049|561088622|FG013|Post Induction|Recurrent leukemia|1|||
155455102|NCT02883049|561088623|FG014|Post Induction|Recurrent leukemia|9|||
155455103|NCT02883049|561088624|FG015|Post Induction|Recurrent leukemia|3|||
155455104|NCT02883049|561088609|FG000|Post Induction|Induction Failure|0|||
155455105|NCT02883049|561088610|FG001|Post Induction|Induction Failure|0|||
155455106|NCT02883049|561088611|FG002|Post Induction|Induction Failure|0|||
155455107|NCT02883049|561088612|FG003|Post Induction|Induction Failure|0|||
155455108|NCT02883049|561088613|FG004|Post Induction|Induction Failure|0|||
155455109|NCT02883049|561088614|FG005|Post Induction|Induction Failure|0|||
155455110|NCT02883049|561088615|FG006|Post Induction|Induction Failure|0|||
155455111|NCT02883049|561088616|FG007|Post Induction|Induction Failure|2|||
155455112|NCT02883049|561088617|FG008|Post Induction|Induction Failure|2|||
155455113|NCT02883049|561088618|FG009|Post Induction|Induction Failure|0|||
155455114|NCT02883049|561088619|FG010|Post Induction|Induction Failure|0|||
155455115|NCT02883049|561088620|FG011|Post Induction|Induction Failure|0|||
155455116|NCT02883049|561088621|FG012|Post Induction|Induction Failure|0|||
155455117|NCT02883049|561088622|FG013|Post Induction|Induction Failure|2|||
155455118|NCT02883049|561088623|FG014|Post Induction|Induction Failure|0|||
155455119|NCT02883049|561088624|FG015|Post Induction|Induction Failure|0|||
155455120|NCT00229203|561088625|FG000|Overall Study|Progressive disease|18|||
155455121|NCT00229203|561088626|FG001|Overall Study|Progressive disease|9|||
155455122|NCT00229203|561088625|FG000|Overall Study|Toxicity|6|||
155455123|NCT00229203|561088626|FG001|Overall Study|Toxicity|1|||
155455124|NCT00229203|561088625|FG000|Overall Study|Death|4|||
155455125|NCT00229203|561088626|FG001|Overall Study|Death|2|||
155455126|NCT00229203|561088625|FG000|Overall Study|Other|3|||
155455127|NCT00229203|561088626|FG001|Overall Study|Other|3|||
155455128|NCT00229203|561088625|FG000|Overall Study|Withdrawal by Subject|1|||
155455129|NCT00229203|561088626|FG001|Overall Study|Withdrawal by Subject|4|||
155455130|NCT03457103|561088627|FG000|Overall Study|illness/hospitalization|4|||
155455131|NCT03457103|561088628|FG001|Overall Study|illness/hospitalization|2|||
155455132|NCT03457103|561088627|FG000|Overall Study|Lost to Follow-up|2|||
155455133|NCT03457103|561088628|FG001|Overall Study|Lost to Follow-up|1|||
155455134|NCT03457103|561088627|FG000|Overall Study|Withdrawal by Subject|1|||
155455135|NCT03457103|561088628|FG001|Overall Study|Withdrawal by Subject|2|||
155455136|NCT03457103|561088627|FG000|Overall Study|financial/ insurance issues|1|||
155455137|NCT03457103|561088628|FG001|Overall Study|financial/ insurance issues|1|||
155455138|NCT03004469|561088631|FG000|Overall Study|Adverse Event|6|||
155455139|NCT03004469|561088632|FG001|Overall Study|Adverse Event|4|||
155455140|NCT03004469|561088633|FG002|Overall Study|Adverse Event|6|||
155455141|NCT03004469|561088631|FG000|Overall Study|Lack of Efficacy|1|||
155455142|NCT03004469|561088632|FG001|Overall Study|Lack of Efficacy|0|||
155455143|NCT03004469|561088633|FG002|Overall Study|Lack of Efficacy|1|||
155455144|NCT03004469|561088631|FG000|Overall Study|Lost to Follow-up|23|||
155455145|NCT03004469|561088632|FG001|Overall Study|Lost to Follow-up|14|||
155455146|NCT03004469|561088633|FG002|Overall Study|Lost to Follow-up|6|||
155455147|NCT03004469|561088631|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155455148|NCT03004469|561088632|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155455149|NCT03004469|561088633|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155455150|NCT03004469|561088631|FG000|Overall Study|Protocol Violation|0|||
155455151|NCT03004469|561088632|FG001|Overall Study|Protocol Violation|0|||
155455152|NCT03004469|561088633|FG002|Overall Study|Protocol Violation|1|||
155455153|NCT03004469|561088631|FG000|Overall Study|Withdrawal by Subject|29|||
155455154|NCT03004469|561088632|FG001|Overall Study|Withdrawal by Subject|27|||
155455155|NCT03004469|561088633|FG002|Overall Study|Withdrawal by Subject|10|||
155455156|NCT03004469|561088631|FG000|Overall Study|Other unspecified reason|0|||
155455157|NCT03004469|561088632|FG001|Overall Study|Other unspecified reason|4|||
155455158|NCT03004469|561088633|FG002|Overall Study|Other unspecified reason|1|||
155455159|NCT01163253|561088634|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
155455160|NCT01163253|561088635|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
155455161|NCT01163253|561088634|FG000|Overall Study|Study Terminated by Sponsor|978|||
155455162|NCT01163253|561088635|FG001|Overall Study|Study Terminated by Sponsor|349|||
155455163|NCT01163253|561088634|FG000|Overall Study|Protocol Violation|43|||
155455164|NCT01163253|561088635|FG001|Overall Study|Protocol Violation|12|||
155455165|NCT01163253|561088634|FG000|Overall Study|Withdrawal by Subject|199|||
155455166|NCT01163253|561088635|FG001|Overall Study|Withdrawal by Subject|50|||
155455167|NCT01163253|561088634|FG000|Overall Study|Medication Error|1|||
155455168|NCT01163253|561088635|FG001|Overall Study|Medication Error|0|||
155455169|NCT01163253|561088634|FG000|Overall Study|Lost to Follow-up|125|||
155455170|NCT01163253|561088635|FG001|Overall Study|Lost to Follow-up|23|||
155455171|NCT01163253|561088634|FG000|Overall Study|Insufficient Clinical Response|423|||
155455172|NCT01163253|561088635|FG001|Overall Study|Insufficient Clinical Response|29|||
155455173|NCT01163253|561088634|FG000|Overall Study|Adverse Event|300|||
155455174|NCT01163253|561088635|FG001|Overall Study|Adverse Event|78|||
155455175|NCT01163253|561088634|FG000|Overall Study|Death|17|||
155455176|NCT01163253|561088635|FG001|Overall Study|Death|5|||
155455177|NCT01163253|561088634|FG000|Overall Study|Ongoing|13|||
155455178|NCT01163253|561088635|FG001|Overall Study|Ongoing|4|||
155455179|NCT01163253|561088634|FG000|Overall Study|Other Unspecified|170|||
155455180|NCT01163253|561088635|FG001|Overall Study|Other Unspecified|34|||
155455181|NCT01397552|561088636|FG000|Overall Study|Adverse Event|1|||
155455182|NCT01397552|561088637|FG001|Overall Study|Adverse Event|0|||
155455183|NCT01397552|561088636|FG000|Overall Study|Withdrawal by Subject|2|||
155455184|NCT01397552|561088637|FG001|Overall Study|Withdrawal by Subject|1|||
155455185|NCT00423735|561088638|FG000|Overall Study|Ineligible / No protocol treatment|8|||
155455186|NCT00423735|561088639|FG001|Overall Study|Ineligible / No protocol treatment|6|||
155455187|NCT00423735|561088640|FG002|Overall Study|Ineligible / No protocol treatment|0|||
155455188|NCT01089582|561088646|FG000|Overall Study|Death|2|||
155455189|NCT01089582|561088646|FG000|Overall Study|Adverse Event|15|||
155455190|NCT01089582|561088646|FG000|Overall Study|Lost to Follow-up|8|||
155455191|NCT01089582|561088646|FG000|Overall Study|Other|4|||
155455192|NCT01089582|561088646|FG000|Overall Study|Withdrawal by Subject|1|||
155455193|NCT02394808|561088647|FG000|Period 1|Unsatisfactory lens fitting|0|||
155455194|NCT02394808|561088648|FG001|Period 1|Unsatisfactory lens fitting|1|||
155455195|NCT02394808|561088647|FG000|Period 2|Lost to Follow-up|1|||
155455196|NCT02394808|561088648|FG001|Period 2|Lost to Follow-up|0|||
155455197|NCT00289185|561088649|FG000|Overall Study|Withdrawal by Subject|4|||
155455198|NCT00289185|561088650|FG001|Overall Study|Withdrawal by Subject|8|||
155455199|NCT00289185|561088649|FG000|Overall Study|Lost to Follow-up|23|||
155455200|NCT00289185|561088650|FG001|Overall Study|Lost to Follow-up|17|||
155455201|NCT00289185|561088649|FG000|Overall Study|Death|1|||
155455202|NCT00289185|561088650|FG001|Overall Study|Death|1|||
155455203|NCT01124448|561088653|FG000|Overall Study|Lost to Follow-up|0|||
155455204|NCT01124448|561088654|FG001|Overall Study|Lost to Follow-up|3|||
155455205|NCT01124448|561088653|FG000|Overall Study|Protocol Violation|2|||
155455206|NCT01124448|561088654|FG001|Overall Study|Protocol Violation|0|||
155455207|NCT05025787|561088655|FG000|Overall Study|Lack of Efficacy|0|||
155455208|NCT05025787|561088656|FG001|Overall Study|Lack of Efficacy|1|||
155455209|NCT05025787|561088655|FG000|Overall Study|Adverse Event|2|||
155455210|NCT05025787|561088656|FG001|Overall Study|Adverse Event|4|||
155455211|NCT05025787|561088655|FG000|Overall Study|Non compliance|0|||
155455212|NCT05025787|561088656|FG001|Overall Study|Non compliance|1|||
155455213|NCT05025787|561088655|FG000|Overall Study|Protocol Violation|3|||
155455214|NCT05025787|561088656|FG001|Overall Study|Protocol Violation|1|||
155455215|NCT05025787|561088655|FG000|Overall Study|Stopping criteria met|1|||
155455216|NCT05025787|561088656|FG001|Overall Study|Stopping criteria met|1|||
155455217|NCT05025787|561088655|FG000|Overall Study|Withdrawal by Subject|3|||
155455218|NCT05025787|561088656|FG001|Overall Study|Withdrawal by Subject|1|||
155455219|NCT00976950|561088657|FG000|Overall Study|Adverse Event|3|||
155455220|NCT00976950|561088657|FG000|Overall Study|Events with no relationship to Aptivus|3|||
155455221|NCT01025817|561088665|FG000|Completed Study Medication|Adverse Event|66|||
155455222|NCT01025817|561088666|FG001|Completed Study Medication|Adverse Event|39|||
155455223|NCT01025817|561088665|FG000|Completed Study Medication|Protocol Deviation|9|||
155455224|NCT01025817|561088666|FG001|Completed Study Medication|Protocol Deviation|8|||
155455225|NCT01025817|561088665|FG000|Completed Study Medication|Withdrawal by Subject|8|||
155455226|NCT01025817|561088666|FG001|Completed Study Medication|Withdrawal by Subject|9|||
155455227|NCT01025817|561088665|FG000|Completed Study Medication|Administrative problems|7|||
155455228|NCT01025817|561088666|FG001|Completed Study Medication|Administrative problems|5|||
155455229|NCT01025817|561088665|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
155455230|NCT01025817|561088666|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
155455231|NCT01025817|561088665|FG000|Completed Study Medication|Abnormal test procedure|4|||
155455232|NCT01025817|561088666|FG001|Completed Study Medication|Abnormal test procedure|0|||
155455233|NCT01025817|561088665|FG000|Completed Study Medication|Graft loss|2|||
155455234|NCT01025817|561088666|FG001|Completed Study Medication|Graft loss|5|||
155455235|NCT01025817|561088665|FG000|Completed Study Medication|Death|2|||
155455236|NCT01025817|561088666|FG001|Completed Study Medication|Death|2|||
155455237|NCT01025817|561088665|FG000|Completed Study Medication|Abnormal lab values|0|||
155455238|NCT01025817|561088666|FG001|Completed Study Medication|Abnormal lab values|2|||
155455239|NCT01025817|561088665|FG000|Completed Study Medication|Subject no longer required study drug|0|||
155455240|NCT01025817|561088666|FG001|Completed Study Medication|Subject no longer required study drug|1|||
155455241|NCT01025817|561088665|FG000|Completed Study Medication|Lost to Follow-up|0|||
155455242|NCT01025817|561088666|FG001|Completed Study Medication|Lost to Follow-up|1|||
155455243|NCT01025817|561088665|FG000|Completed Study|Withdrawal by Subject|8|||
155455244|NCT01025817|561088666|FG001|Completed Study|Withdrawal by Subject|16|||
155455245|NCT01025817|561088665|FG000|Completed Study|Death|6|||
155455246|NCT01025817|561088666|FG001|Completed Study|Death|5|||
155455247|NCT01025817|561088665|FG000|Completed Study|Missing|2|||
155455248|NCT01025817|561088666|FG001|Completed Study|Missing|0|||
155455249|NCT01025817|561088665|FG000|Completed Study|Lost to Follow-up|0|||
155455250|NCT01025817|561088666|FG001|Completed Study|Lost to Follow-up|1|||
155455251|NCT00807846|561088669|FG000|Overall Study|Adverse Event|5|||
155455252|NCT00807846|561088670|FG001|Overall Study|Adverse Event|0|||
155455253|NCT00807846|561088669|FG000|Overall Study|Lack of Efficacy|2|||
155455254|NCT00807846|561088670|FG001|Overall Study|Lack of Efficacy|0|||
155455255|NCT00807846|561088669|FG000|Overall Study|Protocol Violation|2|||
155455256|NCT00807846|561088670|FG001|Overall Study|Protocol Violation|1|||
155455257|NCT00807846|561088669|FG000|Overall Study|Withdrawal by Subject|2|||
155455258|NCT00807846|561088670|FG001|Overall Study|Withdrawal by Subject|1|||
155455259|NCT00807846|561088669|FG000|Overall Study|Other|1|||
155455260|NCT00807846|561088670|FG001|Overall Study|Other|2|||
155455261|NCT01081873|561088671|FG000|Overall Study|Death|86|||
155455262|NCT01081873|561088671|FG000|Overall Study|Withdrawal by Subject|10|||
155455263|NCT01081873|561088671|FG000|Overall Study|Lost to Follow-up|142|||
155455264|NCT01081873|561088671|FG000|Overall Study|Progression of prostate cancer|13|||
155455265|NCT01081873|561088671|FG000|Overall Study|Other|47|||
155455266|NCT01165021|561088673|FG000|Overall Study|Death|1|||
155455267|NCT02491073|561088674|FG000|Overall Study|screen failure|1|||
155455268|NCT02491073|561088675|FG001|Overall Study|screen failure|0|||
155455269|NCT03977727|561088676|FG000|Second Treatment|Lost to Follow-up|0|||
155455270|NCT03977727|561088677|FG001|Second Treatment|Lost to Follow-up|3|||
155455271|NCT01419665|561088678|FG000|Combination Treatment|Adverse Event|7|||
155455272|NCT01419665|561088679|FG001|Combination Treatment|Adverse Event|10|||
155455273|NCT01419665|561088678|FG000|Combination Treatment|Physician Decision|5|||
155455274|NCT01419665|561088679|FG001|Combination Treatment|Physician Decision|8|||
155455275|NCT01419665|561088678|FG000|Combination Treatment|Protocol Violation|6|||
155455276|NCT01419665|561088679|FG001|Combination Treatment|Protocol Violation|2|||
155455277|NCT01419665|561088678|FG000|Combination Treatment|disease progression|10|||
155455278|NCT01419665|561088679|FG001|Combination Treatment|disease progression|9|||
155455279|NCT01419665|561088678|FG000|Combination Treatment|Death|5|||
155455280|NCT01419665|561088679|FG001|Combination Treatment|Death|7|||
155455281|NCT01419665|561088678|FG000|Combination Treatment|administrative problems|0|||
155455282|NCT01419665|561088679|FG001|Combination Treatment|administrative problems|1|||
155455283|NCT01419665|561088678|FG000|Combination Treatment|Withdrawal by Subject|5|||
155455284|NCT01419665|561088679|FG001|Combination Treatment|Withdrawal by Subject|4|||
155455285|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
155455286|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
155455287|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
155455288|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
155455289|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
155455290|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
155455291|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
155455292|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
155455293|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
155455294|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
155455295|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
155455296|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
155515755|NCT04799158|561313579|FG002|Run-In Period|Adverse Event|0|||
155515756|NCT04799158|561313580|FG003|Run-In Period|Adverse Event|0|||
155515757|NCT04799158|561313581|FG004|Run-In Period|Adverse Event|0|||
155455297|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Death|1|||
155455298|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Death|2|||
155455299|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
155455300|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
155455301|NCT01419665|561088678|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
155455302|NCT01419665|561088679|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
155455303|NCT01419665|561088678|FG000|Open Label Phase|Death|1|||
155455304|NCT01419665|561088679|FG001|Open Label Phase|Death|0|||
155455305|NCT01419665|561088678|FG000|Open Label Phase|disease progression|0|||
155455306|NCT01419665|561088679|FG001|Open Label Phase|disease progression|1|||
155455307|NCT02683525|561088681|FG000|Overall Study|Lost to Follow-up|1|||
155455308|NCT02683525|561088681|FG000|Overall Study|Physician Decision|1|||
155455309|NCT02683525|561088681|FG000|Overall Study|Disease Progression|6|||
155455310|NCT03352414|561088685|FG000|Overall Study|Ineligible by operative criteria|12|||
155515758|NCT04799158|561313577|FG000|Run-In Period|Lost to Follow-up|4|||
155455311|NCT03352414|561088686|FG001|Overall Study|Ineligible by operative criteria|10|||
155455312|NCT01341652|561088687|FG000|Overall Study|Incorrect Random Assignment|0|||
155455313|NCT01341652|561088688|FG001|Overall Study|Incorrect Random Assignment|1|||
155455314|NCT01341652|561088687|FG000|Overall Study|ineligible; presence metastatic disease|0|||
155455315|NCT01341652|561088688|FG001|Overall Study|ineligible; presence metastatic disease|1|||
155455316|NCT02998554|561088692|FG000|Overall Study|Adverse Event|8|||
155455317|NCT02998554|561088693|FG001|Overall Study|Adverse Event|3|||
155455318|NCT02998554|561088692|FG000|Overall Study|Protocol deviation|1|||
155455319|NCT02998554|561088693|FG001|Overall Study|Protocol deviation|0|||
155455320|NCT02998554|561088692|FG000|Overall Study|Withdrawal by Subject|2|||
155455321|NCT02998554|561088693|FG001|Overall Study|Withdrawal by Subject|6|||
155455322|NCT02998554|561088692|FG000|Overall Study|Lost to Follow-up|0|||
155455323|NCT02998554|561088693|FG001|Overall Study|Lost to Follow-up|1|||
155455324|NCT02998554|561088692|FG000|Overall Study|Lack of Efficacy|0|||
155455325|NCT02998554|561088693|FG001|Overall Study|Lack of Efficacy|1|||
155455326|NCT02953782|561088694|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
155455327|NCT02953782|561088695|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
155455328|NCT02953782|561088696|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
155455329|NCT02953782|561088697|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
155455330|NCT02953782|561088698|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
155455331|NCT02953782|561088699|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
155455332|NCT02953782|561088700|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
155455333|NCT02953782|561088701|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
155455334|NCT02953782|561088694|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
155455335|NCT02953782|561088695|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
155455336|NCT02953782|561088696|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
155455337|NCT02953782|561088697|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
155455338|NCT02953782|561088698|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
155455339|NCT02953782|561088699|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
155455340|NCT02953782|561088700|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
155455341|NCT02953782|561088701|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
155455342|NCT02953782|561088694|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
155455343|NCT02953782|561088695|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
155455344|NCT02953782|561088696|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
155455345|NCT02953782|561088697|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
155455346|NCT02953782|561088698|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
155455347|NCT02953782|561088699|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
155455348|NCT02953782|561088700|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
155455349|NCT02953782|561088701|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
155455350|NCT02953782|561088694|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155455351|NCT02953782|561088695|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155455352|NCT02953782|561088696|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
155515759|NCT04799158|561313578|FG001|Run-In Period|Lost to Follow-up|0|||
155455353|NCT02953782|561088697|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
155455354|NCT02953782|561088698|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155455355|NCT02953782|561088699|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155455356|NCT02953782|561088700|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155515760|NCT04799158|561313579|FG002|Run-In Period|Lost to Follow-up|0|||
155455357|NCT02953782|561088701|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
155455358|NCT02953782|561088694|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
155455359|NCT02953782|561088695|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
155455360|NCT02953782|561088696|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
155455361|NCT02953782|561088697|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
155455362|NCT02953782|561088698|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
155455363|NCT02953782|561088699|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
155455364|NCT02953782|561088700|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
155455365|NCT02953782|561088701|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
155455366|NCT02953782|561088694|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
155455367|NCT02953782|561088695|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
155455368|NCT02953782|561088696|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
155455369|NCT02953782|561088697|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
155455370|NCT02953782|561088698|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
155455371|NCT02953782|561088699|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
155455372|NCT02953782|561088700|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
155455373|NCT02953782|561088701|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
155455374|NCT02953782|561088694|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
155455375|NCT02953782|561088695|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
155455376|NCT02953782|561088696|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
155455377|NCT02953782|561088697|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
155455378|NCT02953782|561088698|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
155455379|NCT02953782|561088699|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
155455380|NCT02953782|561088700|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
155455381|NCT02953782|561088701|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
155455382|NCT02953782|561088694|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455383|NCT02953782|561088695|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455384|NCT02953782|561088696|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155515761|NCT04799158|561313580|FG003|Run-In Period|Lost to Follow-up|0|||
155455385|NCT02953782|561088697|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455386|NCT02953782|561088698|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455387|NCT02953782|561088699|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455388|NCT02953782|561088700|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
155455389|NCT02953782|561088701|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
155455390|NCT01737840|561088702|FG000|Overall Study|Diagnosed with an other pathology|2|||
155455391|NCT01737840|561088703|FG001|Overall Study|Diagnosed with an other pathology|2|||
155455392|NCT03105700|561088706|FG000|Overall Study|screen fail|3|||
155455393|NCT03105700|561088706|FG000|Overall Study|Lost to Follow-up|4|||
155455394|NCT01449682|561088707|FG000|Overall Study|Death|0|||
155455395|NCT01449682|561088708|FG001|Overall Study|Death|1|||
155455396|NCT01449682|561088707|FG000|Overall Study|Adverse Event|1|||
155455397|NCT01449682|561088708|FG001|Overall Study|Adverse Event|0|||
155455398|NCT02720016|561088709|FG000|Overall Study|Separation of couple|6|||
155455399|NCT02720016|561088710|FG001|Overall Study|Separation of couple|8|||
155455400|NCT02720016|561088711|FG002|Overall Study|Separation of couple|2|||
155455401|NCT02720016|561088709|FG000|Overall Study|Withdrawal by Subject|6|||
155455402|NCT02720016|561088710|FG001|Overall Study|Withdrawal by Subject|6|||
155455403|NCT02720016|561088711|FG002|Overall Study|Withdrawal by Subject|4|||
155455404|NCT02720016|561088709|FG000|Overall Study|Scheduling issues|2|||
155455405|NCT02720016|561088710|FG001|Overall Study|Scheduling issues|4|||
155455406|NCT02720016|561088711|FG002|Overall Study|Scheduling issues|7|||
155455407|NCT02720016|561088709|FG000|Overall Study|Childcare|2|||
155515762|NCT04799158|561313581|FG004|Run-In Period|Lost to Follow-up|0|||
155515763|NCT04799158|561313577|FG000|Run-In Period|Significant Protocol Deviation|1|||
155515764|NCT04799158|561313578|FG001|Run-In Period|Significant Protocol Deviation|0|||
155515765|NCT04799158|561313579|FG002|Run-In Period|Significant Protocol Deviation|0|||
155455408|NCT02720016|561088710|FG001|Overall Study|Childcare|0|||
155455409|NCT02720016|561088711|FG002|Overall Study|Childcare|2|||
155455410|NCT02720016|561088709|FG000|Overall Study|Withdrawal by PI|2|||
155455411|NCT02720016|561088710|FG001|Overall Study|Withdrawal by PI|2|||
155455412|NCT02720016|561088711|FG002|Overall Study|Withdrawal by PI|0|||
155455413|NCT02720016|561088709|FG000|Overall Study|Moved away|2|||
155455414|NCT02720016|561088710|FG001|Overall Study|Moved away|0|||
155455415|NCT02720016|561088711|FG002|Overall Study|Moved away|0|||
155455416|NCT02720016|561088709|FG000|Overall Study|Not Primary Health Concern|0|||
155455417|NCT02720016|561088710|FG001|Overall Study|Not Primary Health Concern|0|||
155455418|NCT02720016|561088711|FG002|Overall Study|Not Primary Health Concern|2|||
155455419|NCT02720016|561088709|FG000|Overall Study|Transportation issues|0|||
155455420|NCT02720016|561088710|FG001|Overall Study|Transportation issues|0|||
155455421|NCT02720016|561088711|FG002|Overall Study|Transportation issues|1|||
155455422|NCT02720016|561088709|FG000|Overall Study|Other|0|||
155455423|NCT02720016|561088710|FG001|Overall Study|Other|0|||
155455424|NCT02720016|561088711|FG002|Overall Study|Other|2|||
155455425|NCT05319080|561088713|FG000|Overall Study|Withdrawal by Subject|2|||
155455426|NCT05319080|561088713|FG000|Overall Study|Physician Decision|4|||
155455427|NCT00406783|561088714|FG000|Overall Study|Adverse Event|4|||
155455428|NCT00406783|561088715|FG001|Overall Study|Adverse Event|4|||
155455429|NCT00406783|561088714|FG000|Overall Study|Treatment Failure|2|||
155455430|NCT00406783|561088715|FG001|Overall Study|Treatment Failure|3|||
155455431|NCT00406783|561088714|FG000|Overall Study|Lost to Follow-up|3|||
155455432|NCT00406783|561088715|FG001|Overall Study|Lost to Follow-up|0|||
155455433|NCT00406783|561088714|FG000|Overall Study|Withdrawal by Subject|1|||
155455434|NCT00406783|561088715|FG001|Overall Study|Withdrawal by Subject|4|||
155455435|NCT00406783|561088714|FG000|Overall Study|Protocol Violation|4|||
155455436|NCT00406783|561088715|FG001|Overall Study|Protocol Violation|4|||
155515766|NCT04799158|561313580|FG003|Run-In Period|Significant Protocol Deviation|0|||
155515767|NCT04799158|561313581|FG004|Run-In Period|Significant Protocol Deviation|0|||
155515768|NCT04799158|561313577|FG000|Run-In Period|Withdrawal by Subject|11|||
155455437|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
155455438|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
155455439|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
155455440|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
155455441|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
155455442|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
155455443|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
155455444|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155455445|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
155455446|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
155455447|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
155455448|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
155455449|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
155455450|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
155455451|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
155455452|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
155455453|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Missing|3|||
155455454|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Missing|1|||
155455455|NCT00838916|561088716|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
155455456|NCT00838916|561088717|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
155455457|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
155455458|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
155455459|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
155455460|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
155455461|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
155455462|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
155455463|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
155455464|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
155455465|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
155455466|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
155455467|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
155455468|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
155455469|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
155455470|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
155455471|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
155455472|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
155455473|NCT00838916|561088716|FG000|Follow-up Period (8 Weeks)|Missing|3|||
155455474|NCT00838916|561088717|FG001|Follow-up Period (8 Weeks)|Missing|0|||
155455475|NCT03488251|561088718|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
155515769|NCT04799158|561313578|FG001|Run-In Period|Withdrawal by Subject|0|||
155515770|NCT04799158|561313579|FG002|Run-In Period|Withdrawal by Subject|0|||
155455476|NCT03488251|561088719|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
155455477|NCT03488251|561088720|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
155455478|NCT03488251|561088721|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
155455479|NCT03488251|561088718|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
155455480|NCT03488251|561088719|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
155455481|NCT03488251|561088720|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
155455482|NCT03488251|561088721|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
155455483|NCT03488251|561088718|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
155455484|NCT03488251|561088719|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
155455485|NCT03488251|561088720|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
155455486|NCT03488251|561088721|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
155455487|NCT03488251|561088718|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
155455488|NCT03488251|561088719|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
155455489|NCT03488251|561088720|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
155455490|NCT03488251|561088721|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
155455491|NCT03488251|561088718|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
155455492|NCT03488251|561088719|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
155455493|NCT03488251|561088720|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
155455494|NCT03488251|561088721|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
155455495|NCT03600714|561088722|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
155455496|NCT01935336|561088723|FG000|Overall Study|Adverse Event|1|||
155455497|NCT01935336|561088724|FG001|Overall Study|Adverse Event|0|||
155455498|NCT01935336|561088725|FG002|Overall Study|Adverse Event|0|||
155455499|NCT01935336|561088726|FG003|Overall Study|Adverse Event|0|||
155455500|NCT01935336|561088723|FG000|Overall Study|Progressive disease|5|||
155455501|NCT01935336|561088724|FG001|Overall Study|Progressive disease|3|||
155455502|NCT01935336|561088725|FG002|Overall Study|Progressive disease|47|||
155455503|NCT01935336|561088726|FG003|Overall Study|Progressive disease|66|||
155455504|NCT01810042|561088727|FG000|Overall Study|Lost to Follow-up|10|||
155455505|NCT03707158|561088728|FG000|Midtreatment|Lost to Follow-up|16|||
155455506|NCT03707158|561088729|FG001|Midtreatment|Lost to Follow-up|7|||
155455507|NCT03707158|561088728|FG000|Midtreatment|Withdrawal by Subject|28|||
155455508|NCT03707158|561088729|FG001|Midtreatment|Withdrawal by Subject|19|||
155455509|NCT03707158|561088728|FG000|Posttreatment|Lost to Follow-up|0|||
155455510|NCT03707158|561088729|FG001|Posttreatment|Lost to Follow-up|5|||
155455511|NCT03707158|561088728|FG000|Follow-up|Lost to Follow-up|19|||
155455512|NCT03707158|561088729|FG001|Follow-up|Lost to Follow-up|18|||
155455513|NCT03707158|561088728|FG000|Follow-up|Withdrawal by Subject|13|||
155455514|NCT03707158|561088729|FG001|Follow-up|Withdrawal by Subject|6|||
155455515|NCT01454401|561088733|FG000|Overall Study|Death|1|||
155455516|NCT01454401|561088733|FG000|Overall Study|hospitalised|1|||
155455517|NCT01454401|561088733|FG000|Overall Study|osteomyelitis|2|||
155455518|NCT01454401|561088733|FG000|Overall Study|non-adherence|1|||
155455519|NCT01968187|561088734|FG000|Overall Study|Adverse Event|0|||
155455520|NCT01968187|561088735|FG001|Overall Study|Adverse Event|1|||
155455521|NCT01968187|561088734|FG000|Overall Study|Randomized but not treated|1|||
155455522|NCT01968187|561088735|FG001|Overall Study|Randomized but not treated|0|||
155455523|NCT05108805|561088740|FG000|Overall Study|T-cell expansion was not successful.|5|||
155455524|NCT03422133|561088743|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
155455525|NCT03422133|561088744|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
155455526|NCT01274338|561090606|FG000|Overall Study|Lack of Efficacy|72|||
155455527|NCT01274338|561090607|FG001|Overall Study|Lack of Efficacy|108|||
155455528|NCT01274338|561090608|FG002|Overall Study|Lack of Efficacy|116|||
155455529|NCT01274338|561090609|FG003|Overall Study|Lack of Efficacy|0|||
155455530|NCT01274338|561090610|FG004|Overall Study|Lack of Efficacy|0|||
155455531|NCT01274338|561090611|FG005|Overall Study|Lack of Efficacy|0|||
155455532|NCT01274338|561090606|FG000|Overall Study|Adverse Event|272|||
155455533|NCT01274338|561090607|FG001|Overall Study|Adverse Event|105|||
155455534|NCT01274338|561090608|FG002|Overall Study|Adverse Event|180|||
155455535|NCT01274338|561090609|FG003|Overall Study|Adverse Event|1|||
155455536|NCT01274338|561090610|FG004|Overall Study|Adverse Event|0|||
155455537|NCT01274338|561090611|FG005|Overall Study|Adverse Event|0|||
155455538|NCT01274338|561090606|FG000|Overall Study|Death|8|||
155455539|NCT01274338|561090607|FG001|Overall Study|Death|1|||
155455540|NCT01274338|561090608|FG002|Overall Study|Death|0|||
155455541|NCT01274338|561090609|FG003|Overall Study|Death|0|||
155455542|NCT01274338|561090610|FG004|Overall Study|Death|0|||
155455543|NCT01274338|561090611|FG005|Overall Study|Death|0|||
155455544|NCT01274338|561090606|FG000|Overall Study|Withdrawal by Subject|27|||
155455545|NCT01274338|561090607|FG001|Overall Study|Withdrawal by Subject|99|||
155455546|NCT01274338|561090608|FG002|Overall Study|Withdrawal by Subject|17|||
155455547|NCT01274338|561090609|FG003|Overall Study|Withdrawal by Subject|0|||
155455548|NCT01274338|561090610|FG004|Overall Study|Withdrawal by Subject|0|||
155455549|NCT01274338|561090611|FG005|Overall Study|Withdrawal by Subject|0|||
155455550|NCT01274338|561090606|FG000|Overall Study|Did not start treatment|8|||
155455551|NCT01274338|561090607|FG001|Overall Study|Did not start treatment|116|||
155455552|NCT01274338|561090608|FG002|Overall Study|Did not start treatment|7|||
155455553|NCT01274338|561090609|FG003|Overall Study|Did not start treatment|0|||
155455554|NCT01274338|561090610|FG004|Overall Study|Did not start treatment|0|||
155455555|NCT01274338|561090611|FG005|Overall Study|Did not start treatment|0|||
155455556|NCT01274338|561090606|FG000|Overall Study|Alternative therapy|0|||
155455557|NCT01274338|561090607|FG001|Overall Study|Alternative therapy|1|||
155455558|NCT01274338|561090608|FG002|Overall Study|Alternative therapy|0|||
155455559|NCT01274338|561090609|FG003|Overall Study|Alternative therapy|0|||
155455560|NCT01274338|561090610|FG004|Overall Study|Alternative therapy|0|||
155455561|NCT01274338|561090611|FG005|Overall Study|Alternative therapy|0|||
155455562|NCT01274338|561090606|FG000|Overall Study|Other complicating diseases|0|||
155455563|NCT01274338|561090607|FG001|Overall Study|Other complicating diseases|3|||
155455564|NCT01274338|561090608|FG002|Overall Study|Other complicating diseases|1|||
155455565|NCT01274338|561090609|FG003|Overall Study|Other complicating diseases|0|||
155455566|NCT01274338|561090610|FG004|Overall Study|Other complicating diseases|0|||
155455567|NCT01274338|561090611|FG005|Overall Study|Other complicating diseases|0|||
155455568|NCT01274338|561090606|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
155455569|NCT01274338|561090607|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
155455570|NCT01274338|561090608|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
155455571|NCT01274338|561090609|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
155455572|NCT01274338|561090610|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
155455573|NCT01274338|561090611|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
155455574|NCT01274338|561090606|FG000|Overall Study|Pregnancy|0|||
155455575|NCT01274338|561090607|FG001|Overall Study|Pregnancy|0|||
155455576|NCT01274338|561090608|FG002|Overall Study|Pregnancy|1|||
155455577|NCT01274338|561090609|FG003|Overall Study|Pregnancy|0|||
155455578|NCT01274338|561090610|FG004|Overall Study|Pregnancy|0|||
155455579|NCT01274338|561090611|FG005|Overall Study|Pregnancy|0|||
155455580|NCT01274338|561090606|FG000|Overall Study|Reason not reported|12|||
155455581|NCT01274338|561090607|FG001|Overall Study|Reason not reported|21|||
155455582|NCT01274338|561090608|FG002|Overall Study|Reason not reported|3|||
155455583|NCT01274338|561090609|FG003|Overall Study|Reason not reported|0|||
155455584|NCT01274338|561090610|FG004|Overall Study|Reason not reported|1|||
155455585|NCT01274338|561090611|FG005|Overall Study|Reason not reported|0|||
155455586|NCT01927744|561090612|FG000|Overall Study|Death|2|||
155455587|NCT01927744|561090613|FG001|Overall Study|Death|9|||
155455588|NCT03073213|561090614|FG000|Multiple Dose Period|Protocol Violation|0|||
155455589|NCT03073213|561090615|FG001|Multiple Dose Period|Protocol Violation|0|||
155455590|NCT03073213|561090616|FG002|Multiple Dose Period|Protocol Violation|1|||
155455591|NCT02064205|561090617|FG000|Overall Study|Withdrawal by Subject|1|||
155455592|NCT01522976|561090619|FG000|Overall Study|Ineligible|4|||
155455593|NCT01522976|561090620|FG001|Overall Study|Ineligible|0|||
155455594|NCT01522976|561090621|FG002|Overall Study|Ineligible|1|||
155455595|NCT01522976|561090619|FG000|Overall Study|Death|7|||
155455596|NCT01522976|561090620|FG001|Overall Study|Death|6|||
155455597|NCT01522976|561090621|FG002|Overall Study|Death|2|||
155455598|NCT01522976|561090619|FG000|Overall Study|Still on treatment|9|||
155455599|NCT01522976|561090620|FG001|Overall Study|Still on treatment|9|||
155455600|NCT01522976|561090621|FG002|Overall Study|Still on treatment|6|||
155455601|NCT01522976|561090619|FG000|Overall Study|Disease progression|28|||
155455602|NCT01522976|561090620|FG001|Overall Study|Disease progression|30|||
155455603|NCT01522976|561090621|FG002|Overall Study|Disease progression|25|||
155455604|NCT01522976|561090619|FG000|Overall Study|Adverse Event|17|||
155455605|NCT01522976|561090620|FG001|Overall Study|Adverse Event|7|||
155455606|NCT01522976|561090621|FG002|Overall Study|Adverse Event|18|||
155455607|NCT01522976|561090619|FG000|Overall Study|Refusal unrelated to adverse event|10|||
155455608|NCT01522976|561090620|FG001|Overall Study|Refusal unrelated to adverse event|13|||
155455609|NCT01522976|561090621|FG002|Overall Study|Refusal unrelated to adverse event|14|||
155455610|NCT01522976|561090619|FG000|Overall Study|Not protocol specified|22|||
155455611|NCT01522976|561090620|FG001|Overall Study|Not protocol specified|27|||
155455612|NCT01522976|561090621|FG002|Overall Study|Not protocol specified|27|||
155455613|NCT00579501|561090622|FG000|Overall Study|Death|1|||
155455614|NCT00579501|561090622|FG000|Overall Study|End of neoadjuvant therapy|25|||
155455615|NCT00579501|561090622|FG000|Overall Study|toxicity|1|||
155455616|NCT00579501|561090622|FG000|Overall Study|Secondary lesion|1|||
155455617|NCT00579501|561090622|FG000|Overall Study|Radiation therapy before surgery|1|||
155455618|NCT00190983|561090623|FG000|Overall Study|Inevaluable (never treated)|2|||
155455619|NCT02287402|561090624|FG000|Treatment Period|Adverse Event|17|||
155455620|NCT02287402|561090624|FG000|Treatment Period|Voluntary Withdrawal|10|||
155455621|NCT02287402|561090624|FG000|Follow-up|Lost to Follow-up|1|||
155455622|NCT02287402|561090624|FG000|Follow-up|Voluntary Withdrawal|2|||
155455623|NCT04069156|561090625|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
155455624|NCT04069156|561090626|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
155455625|NCT04069156|561090625|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
155455626|NCT04069156|561090626|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
155455627|NCT04069156|561090625|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
155455628|NCT04069156|561090626|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
155455629|NCT04069156|561090625|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
155455630|NCT04069156|561090626|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
155455631|NCT04247815|561090627|FG000|Overall Study|Adverse Event|1|||
155455632|NCT04247815|561090628|FG001|Overall Study|Adverse Event|0|||
155455633|NCT04247815|561090627|FG000|Overall Study|Withdrawal by Subject|1|||
155455634|NCT04247815|561090628|FG001|Overall Study|Withdrawal by Subject|0|||
155455635|NCT04247815|561090627|FG000|Overall Study|Protocol Violation|0|||
155455636|NCT04247815|561090628|FG001|Overall Study|Protocol Violation|1|||
155455637|NCT00209170|561090629|FG000|Overall Study|Adverse Event|0|||
155455638|NCT00209170|561090630|FG001|Overall Study|Adverse Event|1|||
155455639|NCT00209170|561090629|FG000|Overall Study|Withdrawal by Subject|2|||
155455640|NCT00209170|561090630|FG001|Overall Study|Withdrawal by Subject|1|||
155455641|NCT00209170|561090629|FG000|Overall Study|Lack of Efficacy|0|||
155455642|NCT00209170|561090630|FG001|Overall Study|Lack of Efficacy|1|||
155455643|NCT02108600|561090631|FG000|Overall Study|Withdrawal by Subject|2|||
155455644|NCT02108600|561090632|FG001|Overall Study|Withdrawal by Subject|0|||
155455645|NCT02108600|561090631|FG000|Overall Study|Lost to Follow-up|1|||
155455646|NCT02108600|561090632|FG001|Overall Study|Lost to Follow-up|1|||
155455647|NCT01295580|561090633|FG000|Overall Study|Protocol Violation|4|||
155455648|NCT01295580|561090634|FG001|Overall Study|Protocol Violation|2|||
155455649|NCT01295580|561090633|FG000|Overall Study|Withdrawal by Subject|1|||
155455650|NCT01295580|561090634|FG001|Overall Study|Withdrawal by Subject|4|||
155455651|NCT01295580|561090633|FG000|Overall Study|Adverse Event|2|||
155455652|NCT01295580|561090634|FG001|Overall Study|Adverse Event|1|||
155455653|NCT01295580|561090633|FG000|Overall Study|Lost to Follow-up|1|||
155455654|NCT01295580|561090634|FG001|Overall Study|Lost to Follow-up|0|||
155455655|NCT01295580|561090633|FG000|Overall Study|Lack of Efficacy|1|||
155455656|NCT01295580|561090634|FG001|Overall Study|Lack of Efficacy|0|||
155455657|NCT01295580|561090633|FG000|Overall Study|Other: inconvenience|1|||
155455658|NCT01295580|561090634|FG001|Overall Study|Other: inconvenience|0|||
155455659|NCT01295580|561090633|FG000|Overall Study|Other: family objection|0|||
155455660|NCT01295580|561090634|FG001|Overall Study|Other: family objection|1|||
155455661|NCT00089479|561090635|FG000|Overall Study|Death|108|||
155455662|NCT00089479|561090636|FG001|Overall Study|Death|75|||
155455663|NCT00089479|561090635|FG000|Overall Study|Withdrawal by Subject|86|||
155455664|NCT00089479|561090636|FG001|Overall Study|Withdrawal by Subject|107|||
155455665|NCT00089479|561090635|FG000|Overall Study|Lost to Follow-up|137|||
155455666|NCT00089479|561090636|FG001|Overall Study|Lost to Follow-up|107|||
155455667|NCT03943953|561090637|FG000|Trial of ITG 1|Lost to Follow-up|19|||
155455668|NCT03943953|561090638|FG001|Trial of ITG 1|Lost to Follow-up|1|||
155455669|NCT03943953|561090637|FG000|Trial of ITG 2|Lost to Follow-up|8|||
155455670|NCT03943953|561090638|FG001|Trial of ITG 2|Lost to Follow-up|0|||
155455671|NCT03943953|561090637|FG000|Trial of ITG 3|Lost to Follow-up|2|||
155455672|NCT03943953|561090638|FG001|Trial of ITG 3|Lost to Follow-up|0|||
155455673|NCT03943953|561090637|FG000|Trial of ITG 4|Lost to Follow-up|2|||
155455674|NCT03943953|561090638|FG001|Trial of ITG 4|Lost to Follow-up|0|||
155455675|NCT01742078|561090641|FG000|Overall Study|Withdrawal by Subject|0|||
155455676|NCT01742078|561090642|FG001|Overall Study|Withdrawal by Subject|0|||
155455677|NCT01742078|561090643|FG002|Overall Study|Withdrawal by Subject|0|||
155455678|NCT01742078|561090644|FG003|Overall Study|Withdrawal by Subject|1|||
155455679|NCT01742078|561090645|FG004|Overall Study|Withdrawal by Subject|0|||
155455680|NCT01742078|561090646|FG005|Overall Study|Withdrawal by Subject|0|||
155455681|NCT01742078|561090647|FG006|Overall Study|Withdrawal by Subject|0|||
155455682|NCT01742078|561090648|FG007|Overall Study|Withdrawal by Subject|0|||
155455683|NCT01742078|561090649|FG008|Overall Study|Withdrawal by Subject|0|||
155455684|NCT05600309|561090652|FG000|Overall Study|Death|41|||
155455685|NCT05600309|561090653|FG001|Overall Study|Death|38|||
155455686|NCT05600309|561090652|FG000|Overall Study|Sponsor Decision|9|||
155455687|NCT05600309|561090653|FG001|Overall Study|Sponsor Decision|6|||
155455688|NCT05822830|561090654|FG000|Overall Study|Adverse Event|6|||
155455689|NCT05822830|561090655|FG001|Overall Study|Adverse Event|6|||
155455690|NCT05822830|561090654|FG000|Overall Study|Assigned Treatment by Mistake|5|||
155455691|NCT05822830|561090655|FG001|Overall Study|Assigned Treatment by Mistake|3|||
155455692|NCT05822830|561090654|FG000|Overall Study|Lost to Follow-up|16|||
155455693|NCT05822830|561090655|FG001|Overall Study|Lost to Follow-up|18|||
155455694|NCT05822830|561090654|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155455695|NCT05822830|561090655|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155455696|NCT05822830|561090654|FG000|Overall Study|Participant was Out of the Country|0|||
155455697|NCT05822830|561090655|FG001|Overall Study|Participant was Out of the Country|1|||
155455698|NCT05822830|561090654|FG000|Overall Study|Pregnancy|1|||
155455699|NCT05822830|561090655|FG001|Overall Study|Pregnancy|2|||
155455700|NCT05822830|561090654|FG000|Overall Study|Withdrawal by Subject|27|||
155455701|NCT05822830|561090655|FG001|Overall Study|Withdrawal by Subject|26|||
155455702|NCT03368664|561090656|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
155455703|NCT03368664|561090656|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
155455704|NCT03368664|561090656|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
155455705|NCT03368664|561090656|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
155455706|NCT05441592|561090657|FG000|Overall Study|Lost to Follow-up|1|||
155455707|NCT05441592|561090658|FG001|Overall Study|Lost to Follow-up|5|||
155455708|NCT01021852|561090659|FG000|Treatment Period 1|Adverse Event|3|||
155455709|NCT01021852|561090660|FG001|Treatment Period 1|Adverse Event|1|||
155455710|NCT01021852|561090661|FG002|Treatment Period 1|Adverse Event|1|||
155455711|NCT01021852|561090662|FG003|Treatment Period 1|Adverse Event|0|||
155455712|NCT01021852|561090663|FG004|Treatment Period 1|Adverse Event|2|||
155455713|NCT01021852|561090664|FG005|Treatment Period 1|Adverse Event|2|||
155455714|NCT01021852|561090665|FG006|Treatment Period 1|Adverse Event|0|||
155455715|NCT01021852|561090666|FG007|Treatment Period 1|Adverse Event|0|||
155455716|NCT01021852|561090659|FG000|Treatment Period 1|Pregnancy|0|||
155455717|NCT01021852|561090660|FG001|Treatment Period 1|Pregnancy|0|||
155455718|NCT01021852|561090661|FG002|Treatment Period 1|Pregnancy|1|||
155455719|NCT01021852|561090662|FG003|Treatment Period 1|Pregnancy|0|||
155651784|NCT03142451|561818142|FG000|Overall Study|Participant request|24|||
155651785|NCT03142451|561818143|FG001|Overall Study|Participant request|12|||
155651786|NCT03142451|561818142|FG000|Overall Study|Protocol Violation|3|||
155651787|NCT03142451|561818143|FG001|Overall Study|Protocol Violation|1|||
155651788|NCT03142451|561818142|FG000|Overall Study|Other|1|||
155651789|NCT03142451|561818143|FG001|Overall Study|Other|1|||
155651790|NCT05333965|561818144|FG000|First Intervention|Adverse Event|0|||
155651791|NCT05333965|561818145|FG001|First Intervention|Adverse Event|1|||
155651792|NCT05333965|561818144|FG000|First Intervention|Withdrawal by Subject|0|||
155651793|NCT05333965|561818145|FG001|First Intervention|Withdrawal by Subject|1|||
155651794|NCT03048019|561818146|FG000|Overall Study|Adverse Event|1|||
155651795|NCT03048019|561818147|FG001|Overall Study|Adverse Event|0|||
155515771|NCT04799158|561313580|FG003|Run-In Period|Withdrawal by Subject|0|||
155515772|NCT04799158|561313581|FG004|Run-In Period|Withdrawal by Subject|0|||
155455720|NCT01021852|561090663|FG004|Treatment Period 1|Pregnancy|0|||
155455721|NCT01021852|561090664|FG005|Treatment Period 1|Pregnancy|0|||
155455722|NCT01021852|561090665|FG006|Treatment Period 1|Pregnancy|0|||
155455723|NCT01021852|561090666|FG007|Treatment Period 1|Pregnancy|0|||
155455724|NCT01021852|561090659|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155455725|NCT01021852|561090660|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155455726|NCT01021852|561090661|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155455727|NCT01021852|561090662|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155455728|NCT01021852|561090663|FG004|Treatment Period 1|Withdrawal by Subject|1|||
155455729|NCT01021852|561090664|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155455730|NCT01021852|561090665|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155455731|NCT01021852|561090666|FG007|Treatment Period 1|Withdrawal by Subject|1|||
155455732|NCT01021852|561090659|FG000|Treatment Period 1|Not Treated|0|||
155455733|NCT01021852|561090660|FG001|Treatment Period 1|Not Treated|0|||
155455734|NCT01021852|561090661|FG002|Treatment Period 1|Not Treated|0|||
155455735|NCT01021852|561090662|FG003|Treatment Period 1|Not Treated|2|||
155455736|NCT01021852|561090663|FG004|Treatment Period 1|Not Treated|0|||
155455737|NCT01021852|561090664|FG005|Treatment Period 1|Not Treated|0|||
155455738|NCT01021852|561090665|FG006|Treatment Period 1|Not Treated|0|||
155455739|NCT01021852|561090666|FG007|Treatment Period 1|Not Treated|0|||
155455740|NCT01021852|561090659|FG000|Washout Period-Placebo|Adverse Event|0|||
155455741|NCT01021852|561090660|FG001|Washout Period-Placebo|Adverse Event|0|||
155455742|NCT01021852|561090661|FG002|Washout Period-Placebo|Adverse Event|0|||
155455743|NCT01021852|561090662|FG003|Washout Period-Placebo|Adverse Event|1|||
155455744|NCT01021852|561090663|FG004|Washout Period-Placebo|Adverse Event|0|||
155455745|NCT01021852|561090664|FG005|Washout Period-Placebo|Adverse Event|1|||
155455746|NCT01021852|561090665|FG006|Washout Period-Placebo|Adverse Event|0|||
155455747|NCT01021852|561090666|FG007|Washout Period-Placebo|Adverse Event|0|||
155455748|NCT01021852|561090659|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
155515773|NCT04799158|561313577|FG000|Run-In Period|Miscellaneous|3|||
155515774|NCT04799158|561313578|FG001|Run-In Period|Miscellaneous|0|||
155455749|NCT01021852|561090660|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
155455750|NCT01021852|561090661|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
155455751|NCT01021852|561090662|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
155515775|NCT04799158|561313579|FG002|Run-In Period|Miscellaneous|0|||
155515776|NCT04799158|561313580|FG003|Run-In Period|Miscellaneous|0|||
155651796|NCT01730729|561818148|FG000|Overall Study|Adverse Event|1|||
155651797|NCT01730729|561818148|FG000|Overall Study|Death|1|||
155455752|NCT01021852|561090663|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
155515777|NCT04799158|561313581|FG004|Run-In Period|Miscellaneous|0|||
155515778|NCT04799158|561313577|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
155515779|NCT04799158|561313578|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
155515780|NCT04799158|561313579|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
155651798|NCT01730729|561818148|FG000|Overall Study|Progressive Disease|12|||
155651799|NCT00203242|561818151|FG000|Overall Study|Lost to Follow-up|1|||
155651800|NCT02837952|561818153|FG000|Overall Study|Adverse Event|0|||
155455753|NCT01021852|561090664|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
155455754|NCT01021852|561090665|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
155455755|NCT01021852|561090666|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
155455756|NCT01021852|561090659|FG000|Washout Period-Placebo|Protocol Violation|0|||
155455757|NCT01021852|561090660|FG001|Washout Period-Placebo|Protocol Violation|0|||
155455758|NCT01021852|561090661|FG002|Washout Period-Placebo|Protocol Violation|0|||
155515781|NCT04799158|561313580|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
155455759|NCT01021852|561090662|FG003|Washout Period-Placebo|Protocol Violation|0|||
155455760|NCT01021852|561090663|FG004|Washout Period-Placebo|Protocol Violation|0|||
155455761|NCT01021852|561090664|FG005|Washout Period-Placebo|Protocol Violation|0|||
155455762|NCT01021852|561090665|FG006|Washout Period-Placebo|Protocol Violation|1|||
155455763|NCT01021852|561090666|FG007|Washout Period-Placebo|Protocol Violation|0|||
155455764|NCT01021852|561090659|FG000|Washout Period-No Drug|Adverse Event|1|||
155455765|NCT01021852|561090660|FG001|Washout Period-No Drug|Adverse Event|0|||
155455766|NCT01021852|561090661|FG002|Washout Period-No Drug|Adverse Event|0|||
155455767|NCT01021852|561090662|FG003|Washout Period-No Drug|Adverse Event|0|||
155455768|NCT01021852|561090663|FG004|Washout Period-No Drug|Adverse Event|0|||
155455769|NCT01021852|561090664|FG005|Washout Period-No Drug|Adverse Event|1|||
155455770|NCT01021852|561090665|FG006|Washout Period-No Drug|Adverse Event|0|||
155455771|NCT01021852|561090666|FG007|Washout Period-No Drug|Adverse Event|0|||
155455772|NCT01021852|561090659|FG000|Treatment Period 2|Adverse Event|0|||
155455773|NCT01021852|561090660|FG001|Treatment Period 2|Adverse Event|1|||
155455774|NCT01021852|561090661|FG002|Treatment Period 2|Adverse Event|0|||
155455775|NCT01021852|561090662|FG003|Treatment Period 2|Adverse Event|0|||
155455776|NCT01021852|561090663|FG004|Treatment Period 2|Adverse Event|1|||
155455777|NCT01021852|561090664|FG005|Treatment Period 2|Adverse Event|0|||
155455778|NCT01021852|561090665|FG006|Treatment Period 2|Adverse Event|1|||
155455779|NCT01021852|561090666|FG007|Treatment Period 2|Adverse Event|0|||
155455780|NCT01021852|561090659|FG000|Treatment Period 2|Lack of Efficacy|0|||
155455781|NCT01021852|561090660|FG001|Treatment Period 2|Lack of Efficacy|0|||
155455782|NCT01021852|561090661|FG002|Treatment Period 2|Lack of Efficacy|0|||
155455783|NCT01021852|561090662|FG003|Treatment Period 2|Lack of Efficacy|0|||
155455784|NCT01021852|561090663|FG004|Treatment Period 2|Lack of Efficacy|0|||
155455785|NCT01021852|561090664|FG005|Treatment Period 2|Lack of Efficacy|1|||
155455786|NCT01021852|561090665|FG006|Treatment Period 2|Lack of Efficacy|0|||
155455787|NCT01021852|561090666|FG007|Treatment Period 2|Lack of Efficacy|0|||
155455788|NCT01021852|561090659|FG000|Treatment Period 2|Physician Decision|0|||
155455789|NCT01021852|561090660|FG001|Treatment Period 2|Physician Decision|0|||
155455790|NCT01021852|561090661|FG002|Treatment Period 2|Physician Decision|1|||
155455791|NCT01021852|561090662|FG003|Treatment Period 2|Physician Decision|0|||
155455792|NCT01021852|561090663|FG004|Treatment Period 2|Physician Decision|0|||
155455793|NCT01021852|561090664|FG005|Treatment Period 2|Physician Decision|0|||
155455794|NCT01021852|561090665|FG006|Treatment Period 2|Physician Decision|0|||
155455795|NCT01021852|561090666|FG007|Treatment Period 2|Physician Decision|0|||
155455796|NCT01021852|561090659|FG000|Treatment Period 2|Protocol Violation|0|||
155455797|NCT01021852|561090660|FG001|Treatment Period 2|Protocol Violation|0|||
155455798|NCT01021852|561090661|FG002|Treatment Period 2|Protocol Violation|0|||
155455799|NCT01021852|561090662|FG003|Treatment Period 2|Protocol Violation|0|||
155455800|NCT01021852|561090663|FG004|Treatment Period 2|Protocol Violation|1|||
155455801|NCT01021852|561090664|FG005|Treatment Period 2|Protocol Violation|0|||
155455802|NCT01021852|561090665|FG006|Treatment Period 2|Protocol Violation|1|||
155455803|NCT01021852|561090666|FG007|Treatment Period 2|Protocol Violation|0|||
155455804|NCT01021852|561090659|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155455805|NCT01021852|561090660|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155455806|NCT01021852|561090661|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155515782|NCT04799158|561313581|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
155515783|NCT04799158|561313577|FG000|On-Demand Treatment Period|Adverse Event|0|||
155515784|NCT04799158|561313578|FG001|On-Demand Treatment Period|Adverse Event|1|||
155455807|NCT01021852|561090662|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155455808|NCT01021852|561090663|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155455809|NCT01021852|561090664|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155455810|NCT01021852|561090665|FG006|Treatment Period 2|Withdrawal by Subject|1|||
155455811|NCT01021852|561090666|FG007|Treatment Period 2|Withdrawal by Subject|2|||
155455812|NCT01371981|561090667|FG000|Overall Study|Adverse Event|12|||
155455813|NCT01371981|561090668|FG001|Overall Study|Adverse Event|17|||
155455814|NCT01371981|561090669|FG002|Overall Study|Adverse Event|0|||
155455815|NCT01371981|561090670|FG003|Overall Study|Adverse Event|4|||
155515785|NCT04799158|561313579|FG002|On-Demand Treatment Period|Adverse Event|0|||
155455816|NCT01371981|561090671|FG004|Overall Study|Adverse Event|1|||
155455817|NCT01371981|561090672|FG005|Overall Study|Adverse Event|0|||
155455818|NCT01371981|561090667|FG000|Overall Study|Death|22|||
155455819|NCT01371981|561090668|FG001|Overall Study|Death|16|||
155455820|NCT01371981|561090669|FG002|Overall Study|Death|0|||
155455821|NCT01371981|561090670|FG003|Overall Study|Death|0|||
155455822|NCT01371981|561090671|FG004|Overall Study|Death|2|||
155455823|NCT01371981|561090672|FG005|Overall Study|Death|2|||
155455824|NCT01371981|561090667|FG000|Overall Study|Lack of Efficacy|69|||
155455825|NCT01371981|561090668|FG001|Overall Study|Lack of Efficacy|61|||
155455826|NCT01371981|561090669|FG002|Overall Study|Lack of Efficacy|4|||
155455827|NCT01371981|561090670|FG003|Overall Study|Lack of Efficacy|8|||
155455828|NCT01371981|561090671|FG004|Overall Study|Lack of Efficacy|5|||
155455829|NCT01371981|561090672|FG005|Overall Study|Lack of Efficacy|0|||
155455830|NCT01371981|561090667|FG000|Overall Study|Physician Decision|48|||
155455831|NCT01371981|561090668|FG001|Overall Study|Physician Decision|63|||
155455832|NCT01371981|561090669|FG002|Overall Study|Physician Decision|1|||
155455833|NCT01371981|561090670|FG003|Overall Study|Physician Decision|7|||
155455834|NCT01371981|561090671|FG004|Overall Study|Physician Decision|14|||
155455835|NCT01371981|561090672|FG005|Overall Study|Physician Decision|3|||
155455836|NCT01371981|561090667|FG000|Overall Study|Withdrawal by Subject|12|||
155455837|NCT01371981|561090668|FG001|Overall Study|Withdrawal by Subject|19|||
155455838|NCT01371981|561090669|FG002|Overall Study|Withdrawal by Subject|1|||
155455839|NCT01371981|561090670|FG003|Overall Study|Withdrawal by Subject|2|||
155455840|NCT01371981|561090671|FG004|Overall Study|Withdrawal by Subject|10|||
155455841|NCT01371981|561090672|FG005|Overall Study|Withdrawal by Subject|3|||
155455842|NCT01371981|561090667|FG000|Overall Study|Ineligible|19|||
155455843|NCT01371981|561090668|FG001|Overall Study|Ineligible|13|||
155455844|NCT01371981|561090669|FG002|Overall Study|Ineligible|0|||
155455845|NCT01371981|561090670|FG003|Overall Study|Ineligible|0|||
155455846|NCT01371981|561090671|FG004|Overall Study|Ineligible|0|||
155455847|NCT01371981|561090672|FG005|Overall Study|Ineligible|4|||
155455848|NCT01371981|561090667|FG000|Overall Study|Did not start treatment|2|||
155455849|NCT01371981|561090668|FG001|Overall Study|Did not start treatment|3|||
155455850|NCT01371981|561090669|FG002|Overall Study|Did not start treatment|0|||
155455851|NCT01371981|561090670|FG003|Overall Study|Did not start treatment|0|||
155455852|NCT01371981|561090671|FG004|Overall Study|Did not start treatment|0|||
155455853|NCT01371981|561090672|FG005|Overall Study|Did not start treatment|2|||
155455854|NCT01655823|561090673|FG000|Overall Study|Lost to Follow-up|0|||
155455855|NCT01655823|561090674|FG001|Overall Study|Lost to Follow-up|1|||
155455856|NCT01655823|561090675|FG002|Overall Study|Lost to Follow-up|0|||
155455857|NCT01655823|561090676|FG003|Overall Study|Lost to Follow-up|0|||
155455858|NCT01655823|561090677|FG004|Overall Study|Lost to Follow-up|1|||
155455859|NCT01655823|561090673|FG000|Overall Study|Withdrawal by Subject|0|||
155455860|NCT01655823|561090674|FG001|Overall Study|Withdrawal by Subject|1|||
155455861|NCT01655823|561090675|FG002|Overall Study|Withdrawal by Subject|0|||
155455862|NCT01655823|561090676|FG003|Overall Study|Withdrawal by Subject|1|||
155455863|NCT01655823|561090677|FG004|Overall Study|Withdrawal by Subject|0|||
155455864|NCT00603980|561090678|FG000|Study Qualification|Protocol Violation|3|||
155455865|NCT00603980|561090678|FG000|Study Qualification|Inconsistent data reporting|13|||
155455866|NCT00603980|561090678|FG000|Main Study|14th subject completed trial|1|||
155455867|NCT02632110|561090683|FG000|Overall Study|Withdrawal by Subject|1|||
155455868|NCT02632110|561090684|FG001|Overall Study|Withdrawal by Subject|1|||
155455869|NCT02632110|561090685|FG002|Overall Study|Withdrawal by Subject|0|||
155455870|NCT02632110|561090686|FG003|Overall Study|Withdrawal by Subject|0|||
155455871|NCT02632110|561090687|FG004|Overall Study|Withdrawal by Subject|1|||
155455872|NCT02632110|561090688|FG005|Overall Study|Withdrawal by Subject|1|||
155455873|NCT02632110|561090689|FG006|Overall Study|Withdrawal by Subject|3|||
155455874|NCT02632110|561090690|FG007|Overall Study|Withdrawal by Subject|3|||
155651801|NCT02837952|561818154|FG001|Overall Study|Adverse Event|1|||
155651802|NCT02837952|561818153|FG000|Overall Study|Withdrawal by Subject|4|||
155455875|NCT02632110|561090691|FG008|Overall Study|Withdrawal by Subject|1|||
155455876|NCT02632110|561090692|FG009|Overall Study|Withdrawal by Subject|1|||
155455877|NCT02618928|561090695|FG000|Overall Study|Failure to Return|28|||
155455878|NCT02618928|561090695|FG000|Overall Study|Insufficient Virological Response|1|||
155455879|NCT02618928|561090695|FG000|Overall Study|Withdrawal by Subject|2|||
155455880|NCT02618928|561090695|FG000|Overall Study|Death|3|||
155455881|NCT02618928|561090695|FG000|Overall Study|Other|11|||
155455882|NCT02618928|561090695|FG000|Overall Study|Missing|6|||
155455883|NCT02618928|561090695|FG000|Overall Study|Treatment Never Started|7|||
155455884|NCT02357849|561090699|FG000|Overall Study|Withdrawal by Subject|2|||
155455885|NCT02357849|561090700|FG001|Overall Study|Withdrawal by Subject|3|||
155455886|NCT00064350|561090714|FG000|Induction Treatment|Disease Progression|5|||
155455887|NCT00064350|561090715|FG001|Induction Treatment|Disease Progression|1|||
155455888|NCT00064350|561090716|FG002|Induction Treatment|Disease Progression|110|||
155455889|NCT00064350|561090714|FG000|Induction Treatment|Adverse Event|0|||
155455890|NCT00064350|561090715|FG001|Induction Treatment|Adverse Event|2|||
155455891|NCT00064350|561090716|FG002|Induction Treatment|Adverse Event|49|||
155651803|NCT02837952|561818154|FG001|Overall Study|Withdrawal by Subject|5|||
155455892|NCT00064350|561090714|FG000|Induction Treatment|Death|0|||
155455893|NCT00064350|561090715|FG001|Induction Treatment|Death|0|||
155455894|NCT00064350|561090716|FG002|Induction Treatment|Death|9|||
155455895|NCT00064350|561090714|FG000|Induction Treatment|Withdrawal by Subject|0|||
155651804|NCT02837952|561818153|FG000|Overall Study|Medication Error|1|||
155651805|NCT02837952|561818154|FG001|Overall Study|Medication Error|0|||
155651806|NCT01517178|561818155|FG000|Period 1|Adverse Event|1|||
155455896|NCT00064350|561090715|FG001|Induction Treatment|Withdrawal by Subject|0|||
155455897|NCT00064350|561090716|FG002|Induction Treatment|Withdrawal by Subject|21|||
155455898|NCT00064350|561090714|FG000|Induction Treatment|Ineligible or never started treatment|3|||
155455899|NCT00064350|561090715|FG001|Induction Treatment|Ineligible or never started treatment|6|||
155455900|NCT00064350|561090716|FG002|Induction Treatment|Ineligible or never started treatment|34|||
155455901|NCT00064350|561090714|FG000|Induction Treatment|Other|0|||
155455902|NCT00064350|561090715|FG001|Induction Treatment|Other|0|||
155455903|NCT00064350|561090716|FG002|Induction Treatment|Other|13|||
155455904|NCT00064350|561090714|FG000|Randomization|Adverse Event|8|||
155455905|NCT00064350|561090715|FG001|Randomization|Adverse Event|3|||
155455906|NCT00064350|561090716|FG002|Randomization|Adverse Event|0|||
155455907|NCT00064350|561090714|FG000|Randomization|Death|3|||
155455908|NCT00064350|561090715|FG001|Randomization|Death|0|||
155455909|NCT00064350|561090716|FG002|Randomization|Death|0|||
155455910|NCT00064350|561090714|FG000|Randomization|Withdrawal by Subject|1|||
155455911|NCT00064350|561090715|FG001|Randomization|Withdrawal by Subject|0|||
155455912|NCT00064350|561090716|FG002|Randomization|Withdrawal by Subject|0|||
155455913|NCT00064350|561090714|FG000|Randomization|Ineligible or never started treatment|9|||
155455914|NCT00064350|561090715|FG001|Randomization|Ineligible or never started treatment|15|||
155455915|NCT00064350|561090716|FG002|Randomization|Ineligible or never started treatment|0|||
155455916|NCT00064350|561090714|FG000|Randomization|Other|5|||
155455917|NCT00064350|561090715|FG001|Randomization|Other|0|||
155455918|NCT00064350|561090716|FG002|Randomization|Other|0|||
155455919|NCT00064350|561090714|FG000|Cross-Over|Adverse Event|0|||
155455920|NCT00064350|561090715|FG001|Cross-Over|Adverse Event|1|||
155455921|NCT00064350|561090716|FG002|Cross-Over|Adverse Event|0|||
155455922|NCT00064350|561090714|FG000|Cross-Over|Death|1|||
155455923|NCT00064350|561090715|FG001|Cross-Over|Death|3|||
155455924|NCT00064350|561090716|FG002|Cross-Over|Death|0|||
155455925|NCT00064350|561090714|FG000|Cross-Over|Withdrawal by Subject|2|||
155455926|NCT00064350|561090715|FG001|Cross-Over|Withdrawal by Subject|2|||
155455927|NCT00064350|561090716|FG002|Cross-Over|Withdrawal by Subject|0|||
155455928|NCT00064350|561090714|FG000|Cross-Over|Ineligible or never started treatment|3|||
155455929|NCT00064350|561090715|FG001|Cross-Over|Ineligible or never started treatment|6|||
155455930|NCT00064350|561090716|FG002|Cross-Over|Ineligible or never started treatment|0|||
155455931|NCT00064350|561090714|FG000|Cross-Over|Other|0|||
155455932|NCT00064350|561090715|FG001|Cross-Over|Other|2|||
155455933|NCT00064350|561090716|FG002|Cross-Over|Other|0|||
155455934|NCT01927419|561090717|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155455935|NCT01927419|561090718|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
155455936|NCT01927419|561090717|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
155455937|NCT01927419|561090718|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
155455938|NCT01927419|561090717|FG000|Treatment Period|Disease progression|17|||
155455939|NCT01927419|561090718|FG001|Treatment Period|Disease progression|20|||
155455940|NCT01927419|561090717|FG000|Treatment Period|Study drug toxicity|48|||
155455941|NCT01927419|561090718|FG001|Treatment Period|Study drug toxicity|10|||
155455942|NCT01927419|561090717|FG000|Treatment Period|Death|0|||
155455943|NCT01927419|561090718|FG001|Treatment Period|Death|1|||
155455944|NCT01927419|561090717|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
155455945|NCT01927419|561090718|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
155455946|NCT01927419|561090717|FG000|Treatment Period|Participant request to discontinue|12|||
155455947|NCT01927419|561090718|FG001|Treatment Period|Participant request to discontinue|4|||
155455948|NCT01927419|561090717|FG000|Treatment Period|Withdrawal by Subject|1|||
155455949|NCT01927419|561090718|FG001|Treatment Period|Withdrawal by Subject|1|||
155455950|NCT01927419|561090717|FG000|Treatment Period|Maximum Clinical Benefit|6|||
155455951|NCT01927419|561090718|FG001|Treatment Period|Maximum Clinical Benefit|2|||
155455952|NCT01927419|561090717|FG000|Treatment Period|Other reasons|3|||
155455953|NCT01927419|561090718|FG001|Treatment Period|Other reasons|4|||
155455954|NCT01927419|561090717|FG000|Treatment Period|Not Reported|1|||
155455955|NCT01927419|561090718|FG001|Treatment Period|Not Reported|1|||
155455956|NCT00115765|561090719|FG000|Overall Study|Withdrawal by Subject|22|||
155455957|NCT00115765|561090720|FG001|Overall Study|Withdrawal by Subject|53|||
155455958|NCT00115765|561090721|FG002|Overall Study|Withdrawal by Subject|76|||
155455959|NCT00115765|561090722|FG003|Overall Study|Withdrawal by Subject|15|||
155455960|NCT00115765|561090719|FG000|Overall Study|Physician Decision|4|||
155455961|NCT00115765|561090720|FG001|Overall Study|Physician Decision|15|||
155455962|NCT00115765|561090721|FG002|Overall Study|Physician Decision|18|||
155455963|NCT00115765|561090722|FG003|Overall Study|Physician Decision|13|||
155455964|NCT00115765|561090719|FG000|Overall Study|Lost to Follow-up|3|||
155455965|NCT00115765|561090720|FG001|Overall Study|Lost to Follow-up|20|||
155455966|NCT00115765|561090721|FG002|Overall Study|Lost to Follow-up|18|||
155455967|NCT00115765|561090722|FG003|Overall Study|Lost to Follow-up|1|||
155455968|NCT00115765|561090719|FG000|Overall Study|Other|6|||
155455969|NCT00115765|561090720|FG001|Overall Study|Other|12|||
155455970|NCT00115765|561090721|FG002|Overall Study|Other|9|||
155455971|NCT00115765|561090722|FG003|Overall Study|Other|2|||
155455972|NCT00995670|561090725|FG000|Overall Study|Failed arterial cannulation|1|||
155455973|NCT00995670|561090726|FG001|Overall Study|Failed arterial cannulation|0|||
155455974|NCT00995670|561090727|FG002|Overall Study|Failed arterial cannulation|3|||
155455975|NCT00675103|561090728|FG000|Overall Study|Lack of Efficacy|2|||
155455976|NCT00675103|561090728|FG000|Overall Study|Adverse Event|1|||
155455977|NCT00592553|561090731|FG000|Overall Study|Protocol Noncompliance|1|||
155455978|NCT00592553|561090732|FG001|Overall Study|Protocol Noncompliance|0|||
155455979|NCT00592553|561090733|FG002|Overall Study|Protocol Noncompliance|0|||
155455980|NCT01208038|561090736|FG000|Overall Study|Withdrawal by Subject|1|||
155455981|NCT02773238|561090737|FG000|Overall Study|Lack of Efficacy|4|||
155455982|NCT01877382|561090740|FG000|Dose Escalation|Progressive disease|2|||
155455983|NCT01877382|561090741|FG001|Dose Escalation|Progressive disease|0|||
155455984|NCT01877382|561090742|FG002|Dose Escalation|Progressive disease|1|||
155455985|NCT01877382|561090743|FG003|Dose Escalation|Progressive disease|6|||
155455986|NCT01877382|561090744|FG004|Dose Escalation|Progressive disease|1|||
155455987|NCT01877382|561090745|FG005|Dose Escalation|Progressive disease|0|||
155455988|NCT01877382|561090746|FG006|Dose Escalation|Progressive disease|3|||
155455989|NCT01877382|561090747|FG007|Dose Escalation|Progressive disease|10|||
155455990|NCT01877382|561090748|FG008|Dose Escalation|Progressive disease|4|||
155455991|NCT01877382|561090749|FG009|Dose Escalation|Progressive disease|2|||
155455992|NCT01877382|561090750|FG010|Dose Escalation|Progressive disease|3|||
155455993|NCT01877382|561090751|FG011|Dose Escalation|Progressive disease|3|||
155455994|NCT01877382|561090752|FG012|Dose Escalation|Progressive disease|13|||
155455995|NCT01877382|561090753|FG013|Dose Escalation|Progressive disease|1|||
155455996|NCT01877382|561090754|FG014|Dose Escalation|Progressive disease|0|||
155455997|NCT01877382|561090740|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155455998|NCT01877382|561090741|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155455999|NCT01877382|561090742|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456000|NCT01877382|561090743|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155456001|NCT01877382|561090744|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456002|NCT01877382|561090745|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456003|NCT01877382|561090746|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155456004|NCT01877382|561090747|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456005|NCT01877382|561090748|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456006|NCT01877382|561090749|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456007|NCT01877382|561090750|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456008|NCT01877382|561090751|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456009|NCT01877382|561090752|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456010|NCT01877382|561090753|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456011|NCT01877382|561090754|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456012|NCT01877382|561090740|FG000|Dose Escalation|Clinical progression|0|||
155456013|NCT01877382|561090741|FG001|Dose Escalation|Clinical progression|1|||
155456014|NCT01877382|561090742|FG002|Dose Escalation|Clinical progression|0|||
155515786|NCT04799158|561313580|FG003|On-Demand Treatment Period|Adverse Event|0|||
155515787|NCT04799158|561313581|FG004|On-Demand Treatment Period|Adverse Event|1|||
155456015|NCT01877382|561090743|FG003|Dose Escalation|Clinical progression|2|||
155456016|NCT01877382|561090744|FG004|Dose Escalation|Clinical progression|0|||
155456017|NCT01877382|561090745|FG005|Dose Escalation|Clinical progression|0|||
155456018|NCT01877382|561090746|FG006|Dose Escalation|Clinical progression|1|||
155456019|NCT01877382|561090747|FG007|Dose Escalation|Clinical progression|0|||
155456020|NCT01877382|561090748|FG008|Dose Escalation|Clinical progression|0|||
155456021|NCT01877382|561090749|FG009|Dose Escalation|Clinical progression|1|||
155515788|NCT04799158|561313577|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
155515789|NCT04799158|561313578|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
155515790|NCT04799158|561313579|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
155515791|NCT04799158|561313580|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
155515792|NCT04799158|561313581|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
155456022|NCT01877382|561090750|FG010|Dose Escalation|Clinical progression|0|||
155456023|NCT01877382|561090751|FG011|Dose Escalation|Clinical progression|0|||
155456024|NCT01877382|561090752|FG012|Dose Escalation|Clinical progression|2|||
155515793|NCT04799158|561313577|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
155515794|NCT04799158|561313578|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
155456025|NCT01877382|561090753|FG013|Dose Escalation|Clinical progression|1|||
155456026|NCT01877382|561090754|FG014|Dose Escalation|Clinical progression|0|||
155456027|NCT01877382|561090740|FG000|Dose Escalation|Adverse Event|0|||
155456028|NCT01877382|561090741|FG001|Dose Escalation|Adverse Event|0|||
155456029|NCT01877382|561090742|FG002|Dose Escalation|Adverse Event|0|||
155456030|NCT01877382|561090743|FG003|Dose Escalation|Adverse Event|4|||
155456031|NCT01877382|561090744|FG004|Dose Escalation|Adverse Event|1|||
155456032|NCT01877382|561090745|FG005|Dose Escalation|Adverse Event|2|||
155456033|NCT01877382|561090746|FG006|Dose Escalation|Adverse Event|1|||
155456034|NCT01877382|561090747|FG007|Dose Escalation|Adverse Event|2|||
155515795|NCT04799158|561313579|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
155515796|NCT04799158|561313580|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
155515797|NCT04799158|561313581|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
155456035|NCT01877382|561090748|FG008|Dose Escalation|Adverse Event|0|||
155456036|NCT01877382|561090749|FG009|Dose Escalation|Adverse Event|0|||
155456037|NCT01877382|561090750|FG010|Dose Escalation|Adverse Event|0|||
155456038|NCT01877382|561090751|FG011|Dose Escalation|Adverse Event|0|||
155456039|NCT01877382|561090752|FG012|Dose Escalation|Adverse Event|1|||
155456040|NCT01877382|561090753|FG013|Dose Escalation|Adverse Event|0|||
155456041|NCT01877382|561090754|FG014|Dose Escalation|Adverse Event|0|||
155456042|NCT01877382|561090740|FG000|Dose Escalation|Withdrawal by Subject|0|||
155456043|NCT01877382|561090741|FG001|Dose Escalation|Withdrawal by Subject|0|||
155456044|NCT01877382|561090742|FG002|Dose Escalation|Withdrawal by Subject|0|||
155456045|NCT01877382|561090743|FG003|Dose Escalation|Withdrawal by Subject|0|||
155456046|NCT01877382|561090744|FG004|Dose Escalation|Withdrawal by Subject|0|||
155456047|NCT01877382|561090745|FG005|Dose Escalation|Withdrawal by Subject|3|||
155456048|NCT01877382|561090746|FG006|Dose Escalation|Withdrawal by Subject|2|||
155456049|NCT01877382|561090747|FG007|Dose Escalation|Withdrawal by Subject|1|||
155456050|NCT01877382|561090748|FG008|Dose Escalation|Withdrawal by Subject|1|||
155456051|NCT01877382|561090749|FG009|Dose Escalation|Withdrawal by Subject|0|||
155456052|NCT01877382|561090750|FG010|Dose Escalation|Withdrawal by Subject|0|||
155456053|NCT01877382|561090751|FG011|Dose Escalation|Withdrawal by Subject|0|||
155456054|NCT01877382|561090752|FG012|Dose Escalation|Withdrawal by Subject|0|||
155456055|NCT01877382|561090753|FG013|Dose Escalation|Withdrawal by Subject|0|||
155456056|NCT01877382|561090754|FG014|Dose Escalation|Withdrawal by Subject|0|||
155456057|NCT01877382|561090740|FG000|Dose Escalation|Protocol Violation|0|||
155456058|NCT01877382|561090741|FG001|Dose Escalation|Protocol Violation|0|||
155456059|NCT01877382|561090742|FG002|Dose Escalation|Protocol Violation|0|||
155456060|NCT01877382|561090743|FG003|Dose Escalation|Protocol Violation|0|||
155456061|NCT01877382|561090744|FG004|Dose Escalation|Protocol Violation|0|||
155456062|NCT01877382|561090745|FG005|Dose Escalation|Protocol Violation|0|||
155456063|NCT01877382|561090746|FG006|Dose Escalation|Protocol Violation|1|||
155456064|NCT01877382|561090747|FG007|Dose Escalation|Protocol Violation|0|||
155456065|NCT01877382|561090748|FG008|Dose Escalation|Protocol Violation|0|||
155456066|NCT01877382|561090749|FG009|Dose Escalation|Protocol Violation|0|||
155456067|NCT01877382|561090750|FG010|Dose Escalation|Protocol Violation|0|||
155456068|NCT01877382|561090751|FG011|Dose Escalation|Protocol Violation|0|||
155456069|NCT01877382|561090752|FG012|Dose Escalation|Protocol Violation|0|||
155456070|NCT01877382|561090753|FG013|Dose Escalation|Protocol Violation|0|||
155456071|NCT01877382|561090754|FG014|Dose Escalation|Protocol Violation|0|||
155456072|NCT01877382|561090740|FG000|Dose Escalation|Study terminated by sponsor|0|||
155456073|NCT01877382|561090741|FG001|Dose Escalation|Study terminated by sponsor|0|||
155456074|NCT01877382|561090742|FG002|Dose Escalation|Study terminated by sponsor|0|||
155456075|NCT01877382|561090743|FG003|Dose Escalation|Study terminated by sponsor|0|||
155456076|NCT01877382|561090744|FG004|Dose Escalation|Study terminated by sponsor|0|||
155456077|NCT01877382|561090745|FG005|Dose Escalation|Study terminated by sponsor|0|||
155456078|NCT01877382|561090746|FG006|Dose Escalation|Study terminated by sponsor|0|||
155456079|NCT01877382|561090747|FG007|Dose Escalation|Study terminated by sponsor|1|||
155456080|NCT01877382|561090748|FG008|Dose Escalation|Study terminated by sponsor|1|||
155456081|NCT01877382|561090749|FG009|Dose Escalation|Study terminated by sponsor|0|||
155456082|NCT01877382|561090750|FG010|Dose Escalation|Study terminated by sponsor|0|||
155456083|NCT01877382|561090751|FG011|Dose Escalation|Study terminated by sponsor|0|||
155515798|NCT04799158|561313577|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
155515799|NCT04799158|561313578|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
155515800|NCT04799158|561313579|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
155515801|NCT04799158|561313580|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
155515802|NCT04799158|561313581|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
155456084|NCT01877382|561090752|FG012|Dose Escalation|Study terminated by sponsor|3|||
155456085|NCT01877382|561090753|FG013|Dose Escalation|Study terminated by sponsor|0|||
155456086|NCT01877382|561090754|FG014|Dose Escalation|Study terminated by sponsor|0|||
155456087|NCT01877382|561090740|FG000|Dose Escalation|Death|0|||
155456088|NCT01877382|561090741|FG001|Dose Escalation|Death|0|||
155456089|NCT01877382|561090742|FG002|Dose Escalation|Death|0|||
155456090|NCT01877382|561090743|FG003|Dose Escalation|Death|0|||
155456091|NCT01877382|561090744|FG004|Dose Escalation|Death|0|||
155456092|NCT01877382|561090745|FG005|Dose Escalation|Death|0|||
155456093|NCT01877382|561090746|FG006|Dose Escalation|Death|0|||
155456094|NCT01877382|561090747|FG007|Dose Escalation|Death|1|||
155456095|NCT01877382|561090748|FG008|Dose Escalation|Death|0|||
155456096|NCT01877382|561090749|FG009|Dose Escalation|Death|0|||
155456097|NCT01877382|561090750|FG010|Dose Escalation|Death|0|||
155456098|NCT01877382|561090751|FG011|Dose Escalation|Death|0|||
155456099|NCT01877382|561090752|FG012|Dose Escalation|Death|1|||
155456100|NCT01877382|561090753|FG013|Dose Escalation|Death|1|||
155456101|NCT01877382|561090754|FG014|Dose Escalation|Death|0|||
155456102|NCT01877382|561090740|FG000|Dose Expansion|Progressive disease|0|||
155456103|NCT01877382|561090741|FG001|Dose Expansion|Progressive disease|0|||
155456104|NCT01877382|561090742|FG002|Dose Expansion|Progressive disease|0|||
155456105|NCT01877382|561090743|FG003|Dose Expansion|Progressive disease|0|||
155456106|NCT01877382|561090744|FG004|Dose Expansion|Progressive disease|0|||
155456107|NCT01877382|561090745|FG005|Dose Expansion|Progressive disease|0|||
155456108|NCT01877382|561090746|FG006|Dose Expansion|Progressive disease|0|||
155456109|NCT01877382|561090747|FG007|Dose Expansion|Progressive disease|0|||
155456110|NCT01877382|561090748|FG008|Dose Expansion|Progressive disease|0|||
155456111|NCT01877382|561090749|FG009|Dose Expansion|Progressive disease|0|||
155456112|NCT01877382|561090750|FG010|Dose Expansion|Progressive disease|0|||
155456113|NCT01877382|561090751|FG011|Dose Expansion|Progressive disease|0|||
155456114|NCT01877382|561090752|FG012|Dose Expansion|Progressive disease|0|||
155456115|NCT01877382|561090753|FG013|Dose Expansion|Progressive disease|0|||
155456116|NCT01877382|561090754|FG014|Dose Expansion|Progressive disease|11|||
155456117|NCT01877382|561090740|FG000|Dose Expansion|Clinical progression|0|||
155456118|NCT01877382|561090741|FG001|Dose Expansion|Clinical progression|0|||
155456119|NCT01877382|561090742|FG002|Dose Expansion|Clinical progression|0|||
155456120|NCT01877382|561090743|FG003|Dose Expansion|Clinical progression|0|||
155456121|NCT01877382|561090744|FG004|Dose Expansion|Clinical progression|0|||
155456122|NCT01877382|561090745|FG005|Dose Expansion|Clinical progression|0|||
155456123|NCT01877382|561090746|FG006|Dose Expansion|Clinical progression|0|||
155456124|NCT01877382|561090747|FG007|Dose Expansion|Clinical progression|0|||
155456125|NCT01877382|561090748|FG008|Dose Expansion|Clinical progression|0|||
155456126|NCT01877382|561090749|FG009|Dose Expansion|Clinical progression|0|||
155456127|NCT01877382|561090750|FG010|Dose Expansion|Clinical progression|0|||
155456128|NCT01877382|561090751|FG011|Dose Expansion|Clinical progression|0|||
155456129|NCT01877382|561090752|FG012|Dose Expansion|Clinical progression|0|||
155456130|NCT01877382|561090753|FG013|Dose Expansion|Clinical progression|0|||
155456131|NCT01877382|561090754|FG014|Dose Expansion|Clinical progression|6|||
155456132|NCT01877382|561090740|FG000|Dose Expansion|Adverse Event|0|||
155456133|NCT01877382|561090741|FG001|Dose Expansion|Adverse Event|0|||
155456134|NCT01877382|561090742|FG002|Dose Expansion|Adverse Event|0|||
155456135|NCT01877382|561090743|FG003|Dose Expansion|Adverse Event|0|||
155456136|NCT01877382|561090744|FG004|Dose Expansion|Adverse Event|0|||
155456137|NCT01877382|561090745|FG005|Dose Expansion|Adverse Event|0|||
155456138|NCT01877382|561090746|FG006|Dose Expansion|Adverse Event|0|||
155456139|NCT01877382|561090747|FG007|Dose Expansion|Adverse Event|0|||
155456140|NCT01877382|561090748|FG008|Dose Expansion|Adverse Event|0|||
155456141|NCT01877382|561090749|FG009|Dose Expansion|Adverse Event|0|||
155456142|NCT01877382|561090750|FG010|Dose Expansion|Adverse Event|0|||
155456143|NCT01877382|561090751|FG011|Dose Expansion|Adverse Event|0|||
155456144|NCT01877382|561090752|FG012|Dose Expansion|Adverse Event|0|||
155456145|NCT01877382|561090753|FG013|Dose Expansion|Adverse Event|0|||
155456146|NCT01877382|561090754|FG014|Dose Expansion|Adverse Event|1|||
155456147|NCT01877382|561090740|FG000|Dose Expansion|Death|0|||
155456148|NCT01877382|561090741|FG001|Dose Expansion|Death|0|||
155456149|NCT01877382|561090742|FG002|Dose Expansion|Death|0|||
155456150|NCT01877382|561090743|FG003|Dose Expansion|Death|0|||
155456151|NCT01877382|561090744|FG004|Dose Expansion|Death|0|||
155456152|NCT01877382|561090745|FG005|Dose Expansion|Death|0|||
155456153|NCT01877382|561090746|FG006|Dose Expansion|Death|0|||
155456154|NCT01877382|561090747|FG007|Dose Expansion|Death|0|||
155456155|NCT01877382|561090748|FG008|Dose Expansion|Death|0|||
155456156|NCT01877382|561090749|FG009|Dose Expansion|Death|0|||
155515803|NCT04799158|561313577|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
155515804|NCT04799158|561313578|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
155515805|NCT04799158|561313579|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
155515806|NCT04799158|561313580|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
155515807|NCT04799158|561313581|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
155515808|NCT04799158|561313577|FG000|On-Demand Treatment Period|Miscellaneous|0|||
155456157|NCT01877382|561090750|FG010|Dose Expansion|Death|0|||
155456158|NCT01877382|561090751|FG011|Dose Expansion|Death|0|||
155456159|NCT01877382|561090752|FG012|Dose Expansion|Death|0|||
155456160|NCT01877382|561090753|FG013|Dose Expansion|Death|0|||
155456161|NCT01877382|561090754|FG014|Dose Expansion|Death|1|||
155456162|NCT01877382|561090740|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456163|NCT01877382|561090741|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456164|NCT01877382|561090742|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456165|NCT01877382|561090743|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456166|NCT01877382|561090744|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456167|NCT01877382|561090745|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456168|NCT01877382|561090746|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456169|NCT01877382|561090747|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456170|NCT01877382|561090748|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456171|NCT01877382|561090749|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155515809|NCT04799158|561313578|FG001|On-Demand Treatment Period|Miscellaneous|0|||
155456172|NCT01877382|561090750|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456173|NCT01877382|561090751|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456174|NCT01877382|561090752|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456175|NCT01877382|561090753|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155456176|NCT01877382|561090754|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155456177|NCT03829332|561090755|FG000|Overall Study|Death|225|||
155456178|NCT03829332|561090756|FG001|Overall Study|Death|230|||
155456179|NCT03829332|561090755|FG000|Overall Study|Lost to Follow-up|1|||
155456180|NCT03829332|561090756|FG001|Overall Study|Lost to Follow-up|3|||
155456181|NCT03829332|561090755|FG000|Overall Study|Physician Decision|1|||
155456182|NCT03829332|561090756|FG001|Overall Study|Physician Decision|0|||
155456183|NCT03829332|561090755|FG000|Overall Study|Sponsor Decision|71|||
155456184|NCT03829332|561090756|FG001|Overall Study|Sponsor Decision|72|||
155456185|NCT03829332|561090755|FG000|Overall Study|Withdrawal by Subject|11|||
155456186|NCT03829332|561090756|FG001|Overall Study|Withdrawal by Subject|9|||
155456187|NCT00479557|561090757|FG000|Overall Study|Death|0|||
155456188|NCT00479557|561090758|FG001|Overall Study|Death|0|||
155456189|NCT00479557|561090759|FG002|Overall Study|Death|0|||
155456190|NCT00479557|561090760|FG003|Overall Study|Death|0|||
155456191|NCT00479557|561090761|FG004|Overall Study|Death|0|||
155456192|NCT00479557|561090762|FG005|Overall Study|Death|1|||
155456193|NCT00479557|561090763|FG006|Overall Study|Death|0|||
155456194|NCT00479557|561090757|FG000|Overall Study|Lack of Efficacy|1|||
155456195|NCT00479557|561090758|FG001|Overall Study|Lack of Efficacy|0|||
155456196|NCT00479557|561090759|FG002|Overall Study|Lack of Efficacy|0|||
155456197|NCT00479557|561090760|FG003|Overall Study|Lack of Efficacy|0|||
155456198|NCT00479557|561090761|FG004|Overall Study|Lack of Efficacy|0|||
155456199|NCT00479557|561090762|FG005|Overall Study|Lack of Efficacy|0|||
155456200|NCT00479557|561090763|FG006|Overall Study|Lack of Efficacy|0|||
155456201|NCT00479557|561090757|FG000|Overall Study|Lost to Follow-up|0|||
155456202|NCT00479557|561090758|FG001|Overall Study|Lost to Follow-up|2|||
155456203|NCT00479557|561090759|FG002|Overall Study|Lost to Follow-up|0|||
155456204|NCT00479557|561090760|FG003|Overall Study|Lost to Follow-up|2|||
155456205|NCT00479557|561090761|FG004|Overall Study|Lost to Follow-up|0|||
155456206|NCT00479557|561090762|FG005|Overall Study|Lost to Follow-up|0|||
155456207|NCT00479557|561090763|FG006|Overall Study|Lost to Follow-up|0|||
155456208|NCT00479557|561090757|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155456209|NCT00479557|561090758|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155456210|NCT00479557|561090759|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
155456211|NCT00479557|561090760|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
155456212|NCT00479557|561090761|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155456213|NCT00479557|561090762|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155456214|NCT00479557|561090763|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155456215|NCT00479557|561090757|FG000|Overall Study|AE not related to Study Drug|1|||
155456216|NCT00479557|561090758|FG001|Overall Study|AE not related to Study Drug|3|||
155456217|NCT00479557|561090759|FG002|Overall Study|AE not related to Study Drug|0|||
155456218|NCT00479557|561090760|FG003|Overall Study|AE not related to Study Drug|0|||
155456219|NCT00479557|561090761|FG004|Overall Study|AE not related to Study Drug|2|||
155456220|NCT00479557|561090762|FG005|Overall Study|AE not related to Study Drug|2|||
155456221|NCT00479557|561090763|FG006|Overall Study|AE not related to Study Drug|1|||
155456222|NCT00479557|561090757|FG000|Overall Study|Caregiver Request|2|||
155456223|NCT00479557|561090758|FG001|Overall Study|Caregiver Request|2|||
155515810|NCT04799158|561313579|FG002|On-Demand Treatment Period|Miscellaneous|0|||
155456224|NCT00479557|561090759|FG002|Overall Study|Caregiver Request|2|||
155456225|NCT00479557|561090760|FG003|Overall Study|Caregiver Request|0|||
155456226|NCT00479557|561090761|FG004|Overall Study|Caregiver Request|1|||
155456227|NCT00479557|561090762|FG005|Overall Study|Caregiver Request|2|||
155456228|NCT00479557|561090763|FG006|Overall Study|Caregiver Request|0|||
155515811|NCT04799158|561313580|FG003|On-Demand Treatment Period|Miscellaneous|0|||
155456229|NCT00479557|561090757|FG000|Overall Study|Investigator Request|0|||
155456230|NCT00479557|561090758|FG001|Overall Study|Investigator Request|0|||
155456231|NCT00479557|561090759|FG002|Overall Study|Investigator Request|1|||
155456232|NCT00479557|561090760|FG003|Overall Study|Investigator Request|0|||
155456233|NCT00479557|561090761|FG004|Overall Study|Investigator Request|0|||
155456234|NCT00479557|561090762|FG005|Overall Study|Investigator Request|0|||
155456235|NCT00479557|561090763|FG006|Overall Study|Investigator Request|0|||
155456236|NCT00479557|561090757|FG000|Overall Study|Subject Request|3|||
155456237|NCT00479557|561090758|FG001|Overall Study|Subject Request|0|||
155456238|NCT00479557|561090759|FG002|Overall Study|Subject Request|1|||
155456239|NCT00479557|561090760|FG003|Overall Study|Subject Request|1|||
155456240|NCT00479557|561090761|FG004|Overall Study|Subject Request|1|||
155456241|NCT00479557|561090762|FG005|Overall Study|Subject Request|4|||
155456242|NCT00479557|561090763|FG006|Overall Study|Subject Request|1|||
155456243|NCT00479557|561090757|FG000|Overall Study|Other|2|||
155515812|NCT04799158|561313581|FG004|On-Demand Treatment Period|Miscellaneous|1|||
155456244|NCT00479557|561090758|FG001|Overall Study|Other|3|||
155456245|NCT00479557|561090759|FG002|Overall Study|Other|1|||
155456246|NCT00479557|561090760|FG003|Overall Study|Other|0|||
155456247|NCT00479557|561090761|FG004|Overall Study|Other|0|||
155456248|NCT00479557|561090762|FG005|Overall Study|Other|3|||
155456249|NCT00479557|561090763|FG006|Overall Study|Other|0|||
155456250|NCT01511107|561090764|FG000|Overall Study|Ineligible|3|||
155456251|NCT01511107|561090765|FG001|Overall Study|Ineligible|2|||
155456252|NCT01511107|561090764|FG000|Overall Study|Lost to Follow-up|10|||
155456253|NCT01511107|561090765|FG001|Overall Study|Lost to Follow-up|19|||
155456254|NCT01511107|561090764|FG000|Overall Study|Withdrawal by Subject|9|||
155456255|NCT01511107|561090765|FG001|Overall Study|Withdrawal by Subject|20|||
155456256|NCT02598661|561090766|FG000|Overall Study|Death|27|||
155456257|NCT02598661|561090767|FG001|Overall Study|Death|34|||
155456258|NCT02598661|561090768|FG002|Overall Study|Death|14|||
155456259|NCT02598661|561090769|FG003|Overall Study|Death|1|||
155456260|NCT02598661|561090770|FG004|Overall Study|Death|0|||
155456261|NCT02598661|561090766|FG000|Overall Study|Lost to Follow-up|2|||
155456262|NCT02598661|561090767|FG001|Overall Study|Lost to Follow-up|3|||
155456263|NCT02598661|561090768|FG002|Overall Study|Lost to Follow-up|2|||
155456264|NCT02598661|561090769|FG003|Overall Study|Lost to Follow-up|0|||
155456265|NCT02598661|561090770|FG004|Overall Study|Lost to Follow-up|0|||
155456266|NCT02598661|561090766|FG000|Overall Study|Withdrawal by Subject|13|||
155456267|NCT02598661|561090767|FG001|Overall Study|Withdrawal by Subject|24|||
155456268|NCT02598661|561090768|FG002|Overall Study|Withdrawal by Subject|14|||
155456269|NCT02598661|561090769|FG003|Overall Study|Withdrawal by Subject|1|||
155456270|NCT02598661|561090770|FG004|Overall Study|Withdrawal by Subject|1|||
155456271|NCT02598661|561090766|FG000|Overall Study|Adverse Event|0|||
155456272|NCT02598661|561090767|FG001|Overall Study|Adverse Event|0|||
155456273|NCT02598661|561090768|FG002|Overall Study|Adverse Event|1|||
155456274|NCT02598661|561090769|FG003|Overall Study|Adverse Event|0|||
155456275|NCT02598661|561090770|FG004|Overall Study|Adverse Event|0|||
155456276|NCT02598661|561090766|FG000|Overall Study|Randomized, Never Treated|0|||
155456277|NCT02598661|561090767|FG001|Overall Study|Randomized, Never Treated|0|||
155456278|NCT02598661|561090768|FG002|Overall Study|Randomized, Never Treated|0|||
155456279|NCT02598661|561090769|FG003|Overall Study|Randomized, Never Treated|0|||
155456280|NCT02598661|561090770|FG004|Overall Study|Randomized, Never Treated|1|||
155456281|NCT05195359|561092575|FG000|Overall Study|Lost to Follow-up|124|||
155456282|NCT05195359|561092576|FG001|Overall Study|Lost to Follow-up|34|||
155456283|NCT01146951|561092581|FG000|Overall Study|Adverse Event|4|||
155456284|NCT01146951|561092582|FG001|Overall Study|Adverse Event|1|||
155456285|NCT04092816|561092586|FG000|Overall Study|Lost to Follow-up|1|||
155456286|NCT04092816|561092587|FG001|Overall Study|Lost to Follow-up|2|||
155456287|NCT01747811|561092589|FG000|Overall Study|Lack of Efficacy|2|||
155456288|NCT01747811|561092590|FG001|Overall Study|Lack of Efficacy|4|||
155456289|NCT01617655|561092593|FG000|Overall Study|Adverse Event|2|||
155456290|NCT01617655|561092594|FG001|Overall Study|Adverse Event|3|||
155456291|NCT01617655|561092593|FG000|Overall Study|Poor compliance to protocol|1|||
155456292|NCT01617655|561092594|FG001|Overall Study|Poor compliance to protocol|4|||
155456293|NCT01617655|561092593|FG000|Overall Study|Participants moved|0|||
155456294|NCT01617655|561092594|FG001|Overall Study|Participants moved|4|||
155456295|NCT01617655|561092593|FG000|Overall Study|Consent withdrawn by participant|1|||
155456296|NCT01617655|561092594|FG001|Overall Study|Consent withdrawn by participant|1|||
155456297|NCT01617655|561092593|FG000|Overall Study|Last visit outside protocol visit window|1|||
155456298|NCT01617655|561092594|FG001|Overall Study|Last visit outside protocol visit window|10|||
155456299|NCT01617655|561092593|FG000|Overall Study|Site closure|3|||
155456300|NCT01617655|561092594|FG001|Overall Study|Site closure|5|||
155456301|NCT01617655|561092593|FG000|Overall Study|Other than specified above|1|||
155456302|NCT01617655|561092594|FG001|Overall Study|Other than specified above|2|||
155456303|NCT01175213|561092595|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
155456304|NCT01175213|561092596|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
155456305|NCT01175213|561092595|FG000|IGSC, 10%/rHuPH20|Death|1|||
155456306|NCT01175213|561092596|FG001|IGSC, 10%/rHuPH20|Death|0|||
155456307|NCT01175213|561092595|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
155456308|NCT01175213|561092596|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
155456309|NCT01175213|561092595|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
155456310|NCT01175213|561092596|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
155456311|NCT01175213|561092595|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
155456312|NCT01175213|561092596|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
155456313|NCT01175213|561092595|FG000|Safety Follow-up|Adverse Event|1|||
155456314|NCT01175213|561092596|FG001|Safety Follow-up|Adverse Event|0|||
155456315|NCT03057951|561092600|FG000|Overall Study|Adverse Event|553|||
155456316|NCT03057951|561092601|FG001|Overall Study|Adverse Event|575|||
155456317|NCT03057951|561092600|FG000|Overall Study|Protocol Violation|30|||
155456318|NCT03057951|561092601|FG001|Overall Study|Protocol Violation|24|||
155456319|NCT03057951|561092600|FG000|Overall Study|Lost to Follow-up|6|||
155456320|NCT03057951|561092601|FG001|Overall Study|Lost to Follow-up|16|||
155456321|NCT03057951|561092600|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
155456322|NCT03057951|561092601|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
155456323|NCT03057951|561092600|FG000|Overall Study|Study drug stopped, reason missing|6|||
155456324|NCT03057951|561092601|FG001|Overall Study|Study drug stopped, reason missing|1|||
155456325|NCT03057951|561092600|FG000|Overall Study|Medical advice|6|||
155456326|NCT03057951|561092601|FG001|Overall Study|Medical advice|2|||
155456327|NCT03057951|561092600|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
155456328|NCT03057951|561092601|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
155456329|NCT03057951|561092600|FG000|Overall Study|Investigator decision|2|||
155456330|NCT03057951|561092601|FG001|Overall Study|Investigator decision|0|||
155456331|NCT03057951|561092600|FG000|Overall Study|Patient decision|5|||
155456332|NCT03057951|561092601|FG001|Overall Study|Patient decision|2|||
155456333|NCT03057951|561092600|FG000|Overall Study|Not attending study visits|3|||
155456334|NCT03057951|561092601|FG001|Overall Study|Not attending study visits|0|||
155456335|NCT03057951|561092600|FG000|Overall Study|Patient moved away|3|||
155456336|NCT03057951|561092601|FG001|Overall Study|Patient moved away|4|||
155456337|NCT03057951|561092600|FG000|Overall Study|Other reason than stated above|23|||
155456338|NCT03057951|561092601|FG001|Overall Study|Other reason than stated above|29|||
155456339|NCT03057951|561092600|FG000|Overall Study|Not treated|2|||
155456340|NCT03057951|561092601|FG001|Overall Study|Not treated|1|||
155456341|NCT02700919|561092602|FG000|Overall Study|Physician Decision|1|||
155456342|NCT02700919|561092603|FG001|Overall Study|Physician Decision|0|||
155456343|NCT02700919|561092604|FG002|Overall Study|Physician Decision|0|||
155456344|NCT02700919|561092602|FG000|Overall Study|Protocol Violation|1|||
155456345|NCT02700919|561092603|FG001|Overall Study|Protocol Violation|0|||
155456346|NCT02700919|561092604|FG002|Overall Study|Protocol Violation|0|||
155456347|NCT02700919|561092602|FG000|Overall Study|Adverse Event|1|||
155456348|NCT02700919|561092603|FG001|Overall Study|Adverse Event|3|||
155456349|NCT02700919|561092604|FG002|Overall Study|Adverse Event|1|||
155456350|NCT02700919|561092602|FG000|Overall Study|Withdrawal by Subject|5|||
155456351|NCT02700919|561092603|FG001|Overall Study|Withdrawal by Subject|8|||
155456352|NCT02700919|561092604|FG002|Overall Study|Withdrawal by Subject|2|||
155456353|NCT02700919|561092602|FG000|Overall Study|Lost to Follow-up|2|||
155456354|NCT02700919|561092603|FG001|Overall Study|Lost to Follow-up|0|||
155456355|NCT02700919|561092604|FG002|Overall Study|Lost to Follow-up|0|||
155456356|NCT02700919|561092602|FG000|Overall Study|Other|2|||
155456357|NCT02700919|561092603|FG001|Overall Study|Other|1|||
155456358|NCT02700919|561092604|FG002|Overall Study|Other|1|||
155456359|NCT04393038|561092605|FG000|Overall Study|Adverse Event|11|||
155456360|NCT04393038|561092606|FG001|Overall Study|Adverse Event|2|||
155456361|NCT04393038|561092605|FG000|Overall Study|Protocol Violation|1|||
155456362|NCT04393038|561092606|FG001|Overall Study|Protocol Violation|0|||
155456363|NCT04393038|561092605|FG000|Overall Study|Death|6|||
155456364|NCT04393038|561092606|FG001|Overall Study|Death|4|||
155456365|NCT04393038|561092605|FG000|Overall Study|Withdrawal by Subject|24|||
155456366|NCT04393038|561092606|FG001|Overall Study|Withdrawal by Subject|8|||
155456367|NCT04393038|561092605|FG000|Overall Study|Lost to Follow-up|5|||
155456368|NCT04393038|561092606|FG001|Overall Study|Lost to Follow-up|4|||
155456369|NCT04393038|561092605|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
155456370|NCT04393038|561092606|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
155456371|NCT04393038|561092605|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
155456372|NCT04393038|561092606|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
155456373|NCT05168813|561092607|FG000|Part A (Open-label)|Lost to Follow-up|21|||
155456374|NCT05168813|561092608|FG001|Part A (Open-label)|Lost to Follow-up|39|||
155456375|NCT05168813|561092609|FG002|Part A (Open-label)|Lost to Follow-up|8|||
155456376|NCT05168813|561092610|FG003|Part A (Open-label)|Lost to Follow-up|26|||
155456377|NCT05168813|561092611|FG004|Part A (Open-label)|Lost to Follow-up|0|||
155456378|NCT05168813|561092612|FG005|Part A (Open-label)|Lost to Follow-up|0|||
155456379|NCT05168813|561092607|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
155456380|NCT05168813|561092608|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
155456381|NCT05168813|561092609|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
155456382|NCT05168813|561092610|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
155456383|NCT05168813|561092611|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
155456384|NCT05168813|561092612|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
155456385|NCT05168813|561092607|FG000|Part A (Open-label)|Death|23|||
155456386|NCT05168813|561092608|FG001|Part A (Open-label)|Death|28|||
155456387|NCT05168813|561092609|FG002|Part A (Open-label)|Death|1|||
155456388|NCT05168813|561092610|FG003|Part A (Open-label)|Death|9|||
155456389|NCT05168813|561092611|FG004|Part A (Open-label)|Death|0|||
155456390|NCT05168813|561092612|FG005|Part A (Open-label)|Death|0|||
155456391|NCT05168813|561092607|FG000|Part A (Open-label)|Physician Decision|0|||
155456392|NCT05168813|561092608|FG001|Part A (Open-label)|Physician Decision|1|||
155651807|NCT01517178|561818156|FG001|Period 1|Adverse Event|2|||
155456393|NCT05168813|561092609|FG002|Part A (Open-label)|Physician Decision|0|||
155456394|NCT05168813|561092610|FG003|Part A (Open-label)|Physician Decision|2|||
155456395|NCT05168813|561092611|FG004|Part A (Open-label)|Physician Decision|0|||
155456396|NCT05168813|561092612|FG005|Part A (Open-label)|Physician Decision|0|||
155456397|NCT05168813|561092607|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
155456398|NCT05168813|561092608|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
155456399|NCT05168813|561092609|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
155456400|NCT05168813|561092610|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
155456401|NCT05168813|561092611|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
155456402|NCT05168813|561092612|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
155456403|NCT05168813|561092607|FG000|Part A (Open-label)|Protocol Violation|0|||
155456404|NCT05168813|561092608|FG001|Part A (Open-label)|Protocol Violation|1|||
155456405|NCT05168813|561092609|FG002|Part A (Open-label)|Protocol Violation|0|||
155456406|NCT05168813|561092610|FG003|Part A (Open-label)|Protocol Violation|0|||
155456407|NCT05168813|561092611|FG004|Part A (Open-label)|Protocol Violation|0|||
155456408|NCT05168813|561092612|FG005|Part A (Open-label)|Protocol Violation|0|||
155456409|NCT05168813|561092607|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
155456410|NCT05168813|561092608|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
155456411|NCT05168813|561092609|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
155456412|NCT05168813|561092610|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
155456413|NCT05168813|561092611|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
155456414|NCT05168813|561092612|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
155456415|NCT05168813|561092607|FG000|Part A (Open-label)|Other|0|||
155456416|NCT05168813|561092608|FG001|Part A (Open-label)|Other|1|||
155456417|NCT05168813|561092609|FG002|Part A (Open-label)|Other|0|||
155456418|NCT05168813|561092610|FG003|Part A (Open-label)|Other|0|||
155456419|NCT05168813|561092611|FG004|Part A (Open-label)|Other|0|||
155456420|NCT05168813|561092612|FG005|Part A (Open-label)|Other|0|||
155456421|NCT05168813|561092607|FG000|Part B (Blinded)|Lost to Follow-up|0|||
155456422|NCT05168813|561092608|FG001|Part B (Blinded)|Lost to Follow-up|0|||
155456423|NCT05168813|561092609|FG002|Part B (Blinded)|Lost to Follow-up|0|||
155456424|NCT05168813|561092610|FG003|Part B (Blinded)|Lost to Follow-up|0|||
155456425|NCT05168813|561092611|FG004|Part B (Blinded)|Lost to Follow-up|219|||
155456426|NCT05168813|561092612|FG005|Part B (Blinded)|Lost to Follow-up|88|||
155456427|NCT05168813|561092607|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
155456428|NCT05168813|561092608|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
155456429|NCT05168813|561092609|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
155456430|NCT05168813|561092610|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
155456431|NCT05168813|561092611|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
155456432|NCT05168813|561092612|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
155456433|NCT05168813|561092607|FG000|Part B (Blinded)|Death|0|||
155456434|NCT05168813|561092608|FG001|Part B (Blinded)|Death|0|||
155456435|NCT05168813|561092609|FG002|Part B (Blinded)|Death|0|||
155456436|NCT05168813|561092610|FG003|Part B (Blinded)|Death|0|||
155456437|NCT05168813|561092611|FG004|Part B (Blinded)|Death|63|||
155456438|NCT05168813|561092612|FG005|Part B (Blinded)|Death|19|||
155456439|NCT05168813|561092607|FG000|Part B (Blinded)|Physician Decision|0|||
155456440|NCT05168813|561092608|FG001|Part B (Blinded)|Physician Decision|0|||
155456441|NCT05168813|561092609|FG002|Part B (Blinded)|Physician Decision|0|||
155456442|NCT05168813|561092610|FG003|Part B (Blinded)|Physician Decision|0|||
155456443|NCT05168813|561092611|FG004|Part B (Blinded)|Physician Decision|6|||
155456444|NCT05168813|561092612|FG005|Part B (Blinded)|Physician Decision|1|||
155456445|NCT05168813|561092607|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
155456446|NCT05168813|561092608|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
155456447|NCT05168813|561092609|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
155456448|NCT05168813|561092610|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
155456449|NCT05168813|561092611|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
155456450|NCT05168813|561092612|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
155456451|NCT05168813|561092607|FG000|Part B (Blinded)|Pregnancy|0|||
155456452|NCT05168813|561092608|FG001|Part B (Blinded)|Pregnancy|0|||
155456453|NCT05168813|561092609|FG002|Part B (Blinded)|Pregnancy|0|||
155456454|NCT05168813|561092610|FG003|Part B (Blinded)|Pregnancy|0|||
155456455|NCT05168813|561092611|FG004|Part B (Blinded)|Pregnancy|1|||
155456456|NCT05168813|561092612|FG005|Part B (Blinded)|Pregnancy|0|||
155456457|NCT05168813|561092607|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
155456458|NCT05168813|561092608|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
155456459|NCT05168813|561092609|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
155456460|NCT05168813|561092610|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
155456461|NCT05168813|561092611|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
155456462|NCT05168813|561092612|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
155456463|NCT05168813|561092607|FG000|Part B (Blinded)|Other|0|||
155456464|NCT05168813|561092608|FG001|Part B (Blinded)|Other|0|||
155456465|NCT05168813|561092609|FG002|Part B (Blinded)|Other|0|||
155456466|NCT05168813|561092610|FG003|Part B (Blinded)|Other|0|||
155456467|NCT05168813|561092611|FG004|Part B (Blinded)|Other|41|||
155456468|NCT05168813|561092612|FG005|Part B (Blinded)|Other|27|||
155456469|NCT02680587|561092616|FG000|Overall Study|Withdrawal by Subject|1|||
155456470|NCT02680587|561092617|FG001|Overall Study|Withdrawal by Subject|0|||
155456471|NCT00259740|561092619|FG000|Overall Study|Physician Decision|1|||
155456472|NCT00259740|561092620|FG001|Overall Study|Physician Decision|1|||
155456473|NCT00259740|561092619|FG000|Overall Study|Adverse Event|0|||
155456474|NCT00259740|561092620|FG001|Overall Study|Adverse Event|2|||
155456475|NCT00259740|561092619|FG000|Overall Study|Withdrawal by Subject|2|||
155456476|NCT00259740|561092620|FG001|Overall Study|Withdrawal by Subject|6|||
155456477|NCT00259740|561092619|FG000|Overall Study|Death|1|||
155456478|NCT00259740|561092620|FG001|Overall Study|Death|1|||
155456479|NCT00259740|561092619|FG000|Overall Study|Disease progression|19|||
155456480|NCT00259740|561092620|FG001|Overall Study|Disease progression|36|||
155456481|NCT00259740|561092619|FG000|Overall Study|Ongoing|17|||
155456482|NCT00259740|561092620|FG001|Overall Study|Ongoing|3|||
155456483|NCT00259740|561092619|FG000|Overall Study|Other|3|||
155456484|NCT00259740|561092620|FG001|Overall Study|Other|0|||
155456485|NCT00259740|561092619|FG000|Overall Study|Requirement for alternative therapy|0|||
155456486|NCT00259740|561092620|FG001|Overall Study|Requirement for alternative therapy|4|||
155456487|NCT02492997|561092621|FG000|Overall Study|Withdrawal by Subject|1|||
155456488|NCT02492997|561092622|FG001|Overall Study|Withdrawal by Subject|0|||
155456489|NCT02492997|561092621|FG000|Overall Study|Gained Weight|1|||
155456490|NCT02492997|561092622|FG001|Overall Study|Gained Weight|0|||
155456491|NCT02492997|561092621|FG000|Overall Study|Lost to Follow-up|0|||
155456492|NCT02492997|561092622|FG001|Overall Study|Lost to Follow-up|1|||
155456493|NCT01844830|561092627|FG000|Overall Study|Withdrawal by Subject|1|||
155456494|NCT01844830|561092628|FG001|Overall Study|Withdrawal by Subject|0|||
155456495|NCT04735393|561092634|FG000|Overall Study|Lost to Follow-up|46|||
155456496|NCT04735393|561092635|FG001|Overall Study|Lost to Follow-up|24|||
155456497|NCT04735393|561092634|FG000|Overall Study|Physician Decision|2|||
155456498|NCT04735393|561092635|FG001|Overall Study|Physician Decision|1|||
155456499|NCT04735393|561092634|FG000|Overall Study|Not Detailed|1|||
155456500|NCT04735393|561092635|FG001|Overall Study|Not Detailed|2|||
155456501|NCT04735393|561092634|FG000|Overall Study|Withdrawal by Subject|71|||
155456502|NCT04735393|561092635|FG001|Overall Study|Withdrawal by Subject|28|||
155456503|NCT04735393|561092634|FG000|Overall Study|Adverse Event|56|||
155456504|NCT04735393|561092635|FG001|Overall Study|Adverse Event|7|||
155456505|NCT04735393|561092634|FG000|Overall Study|Protocol Violation|6|||
155456506|NCT04735393|561092635|FG001|Overall Study|Protocol Violation|1|||
155456507|NCT04735393|561092634|FG000|Overall Study|Trial terminated by Sponsor|49|||
155456508|NCT04735393|561092635|FG001|Overall Study|Trial terminated by Sponsor|29|||
155456509|NCT02130427|561092636|FG000|Overall Study|Imaging results not interpretable|30|||
155456510|NCT03150095|561092643|FG000|Overall Study|Death|0|||
155456511|NCT03150095|561092644|FG001|Overall Study|Death|1|||
155456512|NCT03150095|561092643|FG000|Overall Study|Lost to Follow-up|1|||
155456513|NCT03150095|561092644|FG001|Overall Study|Lost to Follow-up|1|||
155456514|NCT03150095|561092643|FG000|Overall Study|Withdrawal by Subject|4|||
155456515|NCT03150095|561092644|FG001|Overall Study|Withdrawal by Subject|0|||
155456516|NCT03150095|561092643|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
155456517|NCT03150095|561092644|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
155651808|NCT01517178|561818155|FG000|Period 1|Lack of Efficacy|0|||
155456518|NCT04580394|561092656|FG000|First Intervention|Incorrectly Randomized|1|||
155456519|NCT04580394|561092656|FG000|First Intervention|Physician Decision|1|||
155456520|NCT04580394|561092656|FG000|First Intervention|Lost to Follow-up|1|||
155456521|NCT04580394|561092656|FG000|Washout (One Week)|Withdrawal by Subject|1|||
155456522|NCT04580394|561092656|FG000|Washout (One Week)|Adverse Event|1|||
155456523|NCT04580394|561092656|FG000|Washout (One Week)|Withdrawal by Subject|2|||
155456524|NCT04580394|561092656|FG000|Third Intervention|Adverse Event|1|||
155456525|NCT04580394|561092656|FG000|Third Intervention|Withdrawal by Subject|1|||
155456526|NCT04580394|561092656|FG000|Washout (One Week)|Withdrawal by Subject|2|||
155456527|NCT04397718|561092659|FG000|Overall Study|Death|7|||
155456528|NCT04397718|561092660|FG001|Overall Study|Death|11|||
155456529|NCT04397718|561092659|FG000|Overall Study|Lost to Follow-up|0|||
155456530|NCT04397718|561092660|FG001|Overall Study|Lost to Follow-up|4|||
155456531|NCT03589326|561092661|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
155456532|NCT03589326|561092662|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
155456533|NCT03589326|561092661|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
155456534|NCT03589326|561092662|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
155456535|NCT03589326|561092661|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
155456536|NCT03589326|561092662|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
155456537|NCT03589326|561092661|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
155456538|NCT03589326|561092662|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
155456539|NCT03589326|561092661|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
155456540|NCT03589326|561092662|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
155456541|NCT01029002|561092663|FG000|Overall Study|Lost to Follow-up|2|||
155456542|NCT01029002|561092664|FG001|Overall Study|Lost to Follow-up|4|||
155651809|NCT01517178|561818156|FG001|Period 1|Lack of Efficacy|1|||
155456543|NCT01096849|561092669|FG000|Overall Study|Consent Withdrawn|1|||
155456544|NCT01096849|561092670|FG001|Overall Study|Consent Withdrawn|4|||
155456545|NCT01096849|561092671|FG002|Overall Study|Consent Withdrawn|2|||
155456546|NCT01096849|561092669|FG000|Overall Study|Lack of Efficacy|0|||
155456547|NCT01096849|561092670|FG001|Overall Study|Lack of Efficacy|2|||
155456548|NCT01096849|561092671|FG002|Overall Study|Lack of Efficacy|0|||
155456549|NCT01096849|561092669|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
155456550|NCT01096849|561092670|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
155456551|NCT01096849|561092671|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
155456552|NCT01096849|561092669|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
155456553|NCT01096849|561092670|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
155456554|NCT01096849|561092671|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
155456555|NCT01096849|561092669|FG000|Overall Study|Administrative Reasons|0|||
155456556|NCT01096849|561092670|FG001|Overall Study|Administrative Reasons|1|||
155456557|NCT01096849|561092671|FG002|Overall Study|Administrative Reasons|2|||
155456558|NCT01096849|561092669|FG000|Overall Study|Lost to Follow-up|1|||
155456559|NCT01096849|561092670|FG001|Overall Study|Lost to Follow-up|3|||
155456560|NCT01096849|561092671|FG002|Overall Study|Lost to Follow-up|1|||
155456561|NCT04146467|561092677|FG000|Overall Study|Adverse Event|0|||
155456562|NCT04146467|561092678|FG001|Overall Study|Adverse Event|1|||
155456563|NCT04146467|561092677|FG000|Overall Study|Lost to Follow-up|0|||
155456564|NCT04146467|561092678|FG001|Overall Study|Lost to Follow-up|2|||
155456565|NCT02128763|561092679|FG000|Overall Study|Death|1|||
155456566|NCT02128763|561092680|FG001|Overall Study|Death|0|||
155456567|NCT02128763|561092679|FG000|Overall Study|Lost to Follow-up|19|||
155456568|NCT02128763|561092680|FG001|Overall Study|Lost to Follow-up|16|||
155456569|NCT01253421|561092681|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
155456570|NCT01253421|561092682|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
155456571|NCT01253421|561092683|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
155456572|NCT01253421|561092684|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
155456573|NCT01253421|561092685|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
155456574|NCT01253421|561092681|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
155456575|NCT01253421|561092682|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
155456576|NCT01253421|561092683|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
155456577|NCT01253421|561092684|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
155456578|NCT01253421|561092685|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
155456579|NCT01253421|561092681|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
155456580|NCT01253421|561092682|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
155456581|NCT01253421|561092683|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
155456582|NCT01253421|561092684|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
155456583|NCT01253421|561092685|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
155456584|NCT01253421|561092681|FG000|Assessment and Scheduling|Physician Decision|1|||
155456585|NCT01253421|561092682|FG001|Assessment and Scheduling|Physician Decision|0|||
155456586|NCT01253421|561092683|FG002|Assessment and Scheduling|Physician Decision|0|||
155456587|NCT01253421|561092684|FG003|Assessment and Scheduling|Physician Decision|0|||
155456588|NCT01253421|561092685|FG004|Assessment and Scheduling|Physician Decision|0|||
155456589|NCT01253421|561092681|FG000|Drug+Scanning Visit|Physician Decision|0|||
155456590|NCT01253421|561092682|FG001|Drug+Scanning Visit|Physician Decision|0|||
155456591|NCT01253421|561092683|FG002|Drug+Scanning Visit|Physician Decision|0|||
155456592|NCT01253421|561092684|FG003|Drug+Scanning Visit|Physician Decision|0|||
155456593|NCT01253421|561092685|FG004|Drug+Scanning Visit|Physician Decision|1|||
155456594|NCT01608724|561092687|FG000|Overall Study|Withdrawal by Subject|131|||
155456595|NCT01608724|561092687|FG000|Overall Study|Lost to Follow-up|41|||
155456596|NCT01608724|561092687|FG000|Overall Study|Study-specific discontinuation criteria|32|||
155456597|NCT01608724|561092687|FG000|Overall Study|Adverse Event|29|||
155456598|NCT01608724|561092687|FG000|Overall Study|Protocol Violation|6|||
155456599|NCT01608724|561092687|FG000|Overall Study|bood sugar too high, etc.|3|||
155456600|NCT01608724|561092687|FG000|Overall Study|Safety reasons|1|||
155456601|NCT04633473|561092688|FG000|Overall Study|Withdrawal by Subject|6|||
155456602|NCT00099359|561092690|FG000|Overall Study|Death|11|||
155456603|NCT00099359|561092691|FG001|Overall Study|Death|15|||
155456604|NCT00099359|561092692|FG002|Overall Study|Death|17|||
155456605|NCT00099359|561092690|FG000|Overall Study|Withdrawal by Subject|19|||
155456606|NCT00099359|561092691|FG001|Overall Study|Withdrawal by Subject|19|||
155456607|NCT00099359|561092692|FG002|Overall Study|Withdrawal by Subject|23|||
155456608|NCT00099359|561092690|FG000|Overall Study|Lost to Follow-up|15|||
155456609|NCT00099359|561092691|FG001|Overall Study|Lost to Follow-up|24|||
155456610|NCT00099359|561092692|FG002|Overall Study|Lost to Follow-up|24|||
155456611|NCT00099359|561092690|FG000|Overall Study|moved out of area|9|||
155456612|NCT00099359|561092691|FG001|Overall Study|moved out of area|7|||
155456613|NCT00099359|561092692|FG002|Overall Study|moved out of area|4|||
155456614|NCT01822691|561092693|FG000|Overall Study|Withdrawal by Subject|2|||
155456615|NCT01778127|561092696|FG000|Overall Study|Lost to Follow-up|5|||
155456616|NCT01778127|561092697|FG001|Overall Study|Lost to Follow-up|1|||
155456617|NCT01778127|561092698|FG002|Overall Study|Lost to Follow-up|2|||
155456618|NCT01778127|561092696|FG000|Overall Study|Withdrawal by Subject|3|||
155456619|NCT01778127|561092697|FG001|Overall Study|Withdrawal by Subject|1|||
155456620|NCT01778127|561092698|FG002|Overall Study|Withdrawal by Subject|4|||
155456621|NCT02104804|561092699|FG000|Overall Study|Did not take study medication|0|||
155456622|NCT02104804|561092700|FG001|Overall Study|Did not take study medication|1|||
155456623|NCT02104804|561092699|FG000|Overall Study|Study specific discontinuation criteria|6|||
155456624|NCT02104804|561092700|FG001|Overall Study|Study specific discontinuation criteria|1|||
155456625|NCT02104804|561092699|FG000|Overall Study|Other listed|2|||
155456626|NCT02104804|561092700|FG001|Overall Study|Other listed|1|||
155456627|NCT02104804|561092699|FG000|Overall Study|Protocol Violation|0|||
155456628|NCT02104804|561092700|FG001|Overall Study|Protocol Violation|1|||
155456629|NCT02104804|561092699|FG000|Overall Study|Adverse Event|4|||
155456630|NCT02104804|561092700|FG001|Overall Study|Adverse Event|3|||
155456631|NCT02104804|561092699|FG000|Overall Study|Withdrawal by Subject|4|||
155456632|NCT02104804|561092700|FG001|Overall Study|Withdrawal by Subject|12|||
155456633|NCT01348425|561092701|FG000|Overall Study|Imaging was not taken.|1|||
155456634|NCT01348425|561092702|FG001|Overall Study|Imaging was not taken.|1|||
155456635|NCT01968954|561092705|FG000|Overall Study|Adverse Event|6|||
155456636|NCT01968954|561092706|FG001|Overall Study|Adverse Event|3|||
155456637|NCT01968954|561092705|FG000|Overall Study|Death|1|||
155456638|NCT01968954|561092706|FG001|Overall Study|Death|2|||
155456639|NCT01968954|561092705|FG000|Overall Study|Lost to Follow-up|6|||
155456640|NCT01968954|561092706|FG001|Overall Study|Lost to Follow-up|4|||
155456641|NCT01968954|561092705|FG000|Overall Study|Withdrawal by Subject|20|||
155456642|NCT01968954|561092706|FG001|Overall Study|Withdrawal by Subject|23|||
155456643|NCT01968954|561092705|FG000|Overall Study|Other|7|||
155456644|NCT01968954|561092706|FG001|Overall Study|Other|8|||
155456645|NCT01968954|561092705|FG000|Overall Study|Protocol Violation|0|||
155456646|NCT01968954|561092706|FG001|Overall Study|Protocol Violation|1|||
155456647|NCT01968954|561092705|FG000|Overall Study|Did not met inclusion criteria|0|||
155456648|NCT01968954|561092706|FG001|Overall Study|Did not met inclusion criteria|2|||
155456649|NCT03260205|561092711|FG000|Overall Study|Adverse Event|2|||
155456650|NCT03260205|561092712|FG001|Overall Study|Adverse Event|0|||
155456651|NCT03260205|561092713|FG002|Overall Study|Adverse Event|2|||
155456652|NCT03260205|561092714|FG003|Overall Study|Adverse Event|2|||
155456653|NCT03260205|561092715|FG004|Overall Study|Adverse Event|4|||
155456654|NCT03260205|561092711|FG000|Overall Study|Lost to Follow-up|2|||
155456655|NCT03260205|561092712|FG001|Overall Study|Lost to Follow-up|2|||
155456656|NCT03260205|561092713|FG002|Overall Study|Lost to Follow-up|1|||
155456657|NCT03260205|561092714|FG003|Overall Study|Lost to Follow-up|1|||
155456658|NCT03260205|561092715|FG004|Overall Study|Lost to Follow-up|5|||
155456659|NCT03260205|561092711|FG000|Overall Study|Protocol Violation|0|||
155456660|NCT03260205|561092712|FG001|Overall Study|Protocol Violation|0|||
155456661|NCT03260205|561092713|FG002|Overall Study|Protocol Violation|2|||
155456662|NCT03260205|561092714|FG003|Overall Study|Protocol Violation|0|||
155456663|NCT03260205|561092715|FG004|Overall Study|Protocol Violation|1|||
155456664|NCT03260205|561092711|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
155456665|NCT03260205|561092712|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
155456666|NCT03260205|561092713|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
155456667|NCT03260205|561092714|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
155456668|NCT03260205|561092715|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
155456669|NCT03260205|561092711|FG000|Overall Study|Other: Unspecified|0|||
155456670|NCT03260205|561092712|FG001|Overall Study|Other: Unspecified|0|||
155456671|NCT03260205|561092713|FG002|Overall Study|Other: Unspecified|3|||
155515813|NCT00936975|561313582|FG000|Overall Study|Withdrawal by Subject|1|||
155515814|NCT00936975|561313582|FG000|Overall Study|Disease progression|3|||
155515815|NCT00936975|561313582|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
155651810|NCT01517178|561818155|FG000|Period 1|E.g. study termination|3|||
155456672|NCT03260205|561092714|FG003|Overall Study|Other: Unspecified|1|||
155456673|NCT03260205|561092715|FG004|Overall Study|Other: Unspecified|1|||
155456674|NCT03260205|561092711|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
155456675|NCT03260205|561092712|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
155456676|NCT03260205|561092713|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
155456677|NCT03260205|561092714|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
155456678|NCT03260205|561092715|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
155456679|NCT03423979|561092716|FG000|Overall Study|Death|5|||
155456680|NCT03423979|561092716|FG000|Overall Study|Adverse Event|4|||
155456681|NCT03423979|561092716|FG000|Overall Study|Withdrawal by Subject|3|||
155456682|NCT03423979|561092716|FG000|Overall Study|Lost to Follow-up|16|||
155456683|NCT00808249|561092717|FG000|Overall Study|Adverse Event|4|||
155456684|NCT00808249|561092718|FG001|Overall Study|Adverse Event|7|||
155456685|NCT00808249|561092719|FG002|Overall Study|Adverse Event|10|||
155456686|NCT00808249|561092720|FG003|Overall Study|Adverse Event|6|||
155456687|NCT00808249|561092717|FG000|Overall Study|Lost to Follow-up|2|||
155456688|NCT00808249|561092718|FG001|Overall Study|Lost to Follow-up|3|||
155456689|NCT00808249|561092719|FG002|Overall Study|Lost to Follow-up|3|||
155456690|NCT00808249|561092720|FG003|Overall Study|Lost to Follow-up|5|||
155456691|NCT00808249|561092717|FG000|Overall Study|Withdrawal by Subject|4|||
155456692|NCT00808249|561092718|FG001|Overall Study|Withdrawal by Subject|0|||
155456693|NCT00808249|561092719|FG002|Overall Study|Withdrawal by Subject|2|||
155456694|NCT00808249|561092720|FG003|Overall Study|Withdrawal by Subject|4|||
155456695|NCT00808249|561092717|FG000|Overall Study|Protocol Violation|3|||
155456696|NCT00808249|561092718|FG001|Overall Study|Protocol Violation|3|||
155456697|NCT00808249|561092719|FG002|Overall Study|Protocol Violation|3|||
155456698|NCT00808249|561092720|FG003|Overall Study|Protocol Violation|0|||
155456699|NCT00808249|561092717|FG000|Overall Study|Lack of Efficacy|1|||
155456700|NCT00808249|561092718|FG001|Overall Study|Lack of Efficacy|1|||
155456701|NCT00808249|561092719|FG002|Overall Study|Lack of Efficacy|0|||
155456702|NCT00808249|561092720|FG003|Overall Study|Lack of Efficacy|0|||
155456703|NCT00808249|561092717|FG000|Overall Study|study specific discontinuation criteria|1|||
155456704|NCT00808249|561092718|FG001|Overall Study|study specific discontinuation criteria|0|||
155456705|NCT00808249|561092719|FG002|Overall Study|study specific discontinuation criteria|1|||
155456706|NCT00808249|561092720|FG003|Overall Study|study specific discontinuation criteria|0|||
155456707|NCT00808249|561092717|FG000|Overall Study|All other reasons|2|||
155456708|NCT00808249|561092718|FG001|Overall Study|All other reasons|1|||
155456709|NCT00808249|561092719|FG002|Overall Study|All other reasons|3|||
155456710|NCT00808249|561092720|FG003|Overall Study|All other reasons|1|||
155456711|NCT04095286|561092721|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456712|NCT04095286|561092722|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
155456713|NCT04095286|561092723|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456714|NCT04095286|561092724|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456715|NCT04095286|561092725|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456716|NCT04095286|561092726|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456717|NCT04095286|561092721|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
155456718|NCT04095286|561092722|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
155456719|NCT04095286|561092723|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
155456720|NCT04095286|561092724|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
155456721|NCT04095286|561092725|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
155456722|NCT04095286|561092726|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
155456723|NCT04095286|561092721|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
155456724|NCT04095286|561092722|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
155456725|NCT04095286|561092723|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
155456726|NCT04095286|561092724|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
155456727|NCT04095286|561092725|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
155456728|NCT04095286|561092726|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
155456729|NCT04095286|561092721|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456730|NCT04095286|561092722|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456731|NCT04095286|561092723|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
155456732|NCT04095286|561092724|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456733|NCT04095286|561092725|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456734|NCT04095286|561092726|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
155456735|NCT04095286|561092721|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
155456736|NCT04095286|561092722|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
155456737|NCT04095286|561092723|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
155456738|NCT04095286|561092724|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
155456739|NCT04095286|561092725|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
155456740|NCT04095286|561092726|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
155456741|NCT02509494|561092727|FG000|Overall Study|Lost to Follow-up|8|||
155456742|NCT02509494|561092728|FG001|Overall Study|Lost to Follow-up|47|||
155651811|NCT01517178|561818156|FG001|Period 1|E.g. study termination|1|||
155456743|NCT02509494|561092729|FG002|Overall Study|Lost to Follow-up|19|||
155456744|NCT02509494|561092730|FG003|Overall Study|Lost to Follow-up|6|||
155456745|NCT02509494|561092731|FG004|Overall Study|Lost to Follow-up|3|||
155456746|NCT02509494|561092732|FG005|Overall Study|Lost to Follow-up|3|||
155456747|NCT02509494|561092733|FG006|Overall Study|Lost to Follow-up|1|||
155456748|NCT02509494|561092734|FG007|Overall Study|Lost to Follow-up|3|||
155456749|NCT02509494|561092735|FG008|Overall Study|Lost to Follow-up|1|||
155456750|NCT02509494|561092727|FG000|Overall Study|Physician Decision|2|||
155456751|NCT02509494|561092728|FG001|Overall Study|Physician Decision|1|||
155456752|NCT02509494|561092729|FG002|Overall Study|Physician Decision|0|||
155456753|NCT02509494|561092730|FG003|Overall Study|Physician Decision|0|||
155456754|NCT02509494|561092731|FG004|Overall Study|Physician Decision|0|||
155456755|NCT02509494|561092732|FG005|Overall Study|Physician Decision|0|||
155456756|NCT02509494|561092733|FG006|Overall Study|Physician Decision|0|||
155456757|NCT02509494|561092734|FG007|Overall Study|Physician Decision|0|||
155456758|NCT02509494|561092735|FG008|Overall Study|Physician Decision|0|||
155456759|NCT02509494|561092727|FG000|Overall Study|Withdrawal by Subject|4|||
155456760|NCT02509494|561092728|FG001|Overall Study|Withdrawal by Subject|17|||
155456761|NCT02509494|561092729|FG002|Overall Study|Withdrawal by Subject|7|||
155456762|NCT02509494|561092730|FG003|Overall Study|Withdrawal by Subject|5|||
155456763|NCT02509494|561092731|FG004|Overall Study|Withdrawal by Subject|0|||
155456764|NCT02509494|561092732|FG005|Overall Study|Withdrawal by Subject|6|||
155456765|NCT02509494|561092733|FG006|Overall Study|Withdrawal by Subject|1|||
155456766|NCT02509494|561092734|FG007|Overall Study|Withdrawal by Subject|2|||
155456767|NCT02509494|561092735|FG008|Overall Study|Withdrawal by Subject|1|||
155456768|NCT02509494|561092727|FG000|Overall Study|Death|0|||
155456769|NCT02509494|561092728|FG001|Overall Study|Death|1|||
155456770|NCT02509494|561092729|FG002|Overall Study|Death|0|||
155456771|NCT02509494|561092730|FG003|Overall Study|Death|0|||
155456772|NCT02509494|561092731|FG004|Overall Study|Death|1|||
155456773|NCT02509494|561092732|FG005|Overall Study|Death|0|||
155456774|NCT02509494|561092733|FG006|Overall Study|Death|0|||
155456775|NCT02509494|561092734|FG007|Overall Study|Death|1|||
155456776|NCT02509494|561092735|FG008|Overall Study|Death|0|||
155456777|NCT02509494|561092727|FG000|Overall Study|Other|0|||
155456778|NCT02509494|561092728|FG001|Overall Study|Other|4|||
155456779|NCT02509494|561092729|FG002|Overall Study|Other|5|||
155456780|NCT02509494|561092730|FG003|Overall Study|Other|0|||
155456781|NCT02509494|561092731|FG004|Overall Study|Other|0|||
155456782|NCT02509494|561092732|FG005|Overall Study|Other|0|||
155456783|NCT02509494|561092733|FG006|Overall Study|Other|0|||
155456784|NCT02509494|561092734|FG007|Overall Study|Other|0|||
155456785|NCT02509494|561092735|FG008|Overall Study|Other|0|||
155456786|NCT02509494|561092727|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155456787|NCT02509494|561092728|FG001|Overall Study|Non-Compliance With Study Drug|11|||
155456788|NCT02509494|561092729|FG002|Overall Study|Non-Compliance With Study Drug|7|||
155456789|NCT02509494|561092730|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155456790|NCT02509494|561092731|FG004|Overall Study|Non-Compliance With Study Drug|1|||
155456791|NCT02509494|561092732|FG005|Overall Study|Non-Compliance With Study Drug|2|||
155456792|NCT02509494|561092733|FG006|Overall Study|Non-Compliance With Study Drug|1|||
155456793|NCT02509494|561092734|FG007|Overall Study|Non-Compliance With Study Drug|1|||
155456794|NCT02509494|561092735|FG008|Overall Study|Non-Compliance With Study Drug|0|||
155456795|NCT05371912|561092736|FG000|Overall Study|Lost to Follow-up|3|||
155456796|NCT05371912|561092737|FG001|Overall Study|Lost to Follow-up|2|||
155456797|NCT04752189|561092738|FG000|Overall Study|Withdrawal by Subject|0|||
155456798|NCT04752189|561092739|FG001|Overall Study|Withdrawal by Subject|150|||
155456799|NCT04752189|561092738|FG000|Overall Study|Lost to Follow-up|261|||
155456800|NCT04752189|561092739|FG001|Overall Study|Lost to Follow-up|126|||
155456801|NCT00975195|561092740|FG000|Overall Study|Adverse Event|108|||
155456802|NCT00975195|561092741|FG001|Overall Study|Adverse Event|101|||
155456803|NCT00975195|561092740|FG000|Overall Study|Lack of Efficacy|6|||
155456804|NCT00975195|561092741|FG001|Overall Study|Lack of Efficacy|6|||
155456805|NCT00975195|561092740|FG000|Overall Study|Protocol Violation|27|||
155456806|NCT00975195|561092741|FG001|Overall Study|Protocol Violation|23|||
155456807|NCT00975195|561092740|FG000|Overall Study|Lost to Follow-up|9|||
155456808|NCT00975195|561092741|FG001|Overall Study|Lost to Follow-up|7|||
155456809|NCT00975195|561092740|FG000|Overall Study|Withdrawal by Subject|48|||
155456810|NCT00975195|561092741|FG001|Overall Study|Withdrawal by Subject|61|||
155456811|NCT00975195|561092740|FG000|Overall Study|Other reason not defined above|29|||
155456812|NCT00975195|561092741|FG001|Overall Study|Other reason not defined above|33|||
155456813|NCT00975195|561092740|FG000|Overall Study|Not treated|1|||
155456814|NCT00975195|561092741|FG001|Overall Study|Not treated|2|||
155456815|NCT03003403|561092746|FG000|Overall Study|Ineligible|8|||
155456816|NCT03003403|561092747|FG001|Overall Study|Ineligible|7|||
155456817|NCT03003403|561092746|FG000|Overall Study|Withdrawal by Subject|3|||
155456818|NCT03003403|561092747|FG001|Overall Study|Withdrawal by Subject|1|||
155456819|NCT02690207|561094018|FG000|Overall Study|Lost to Follow-up|48|||
155456820|NCT02690207|561094018|FG000|Overall Study|Withdrawal by Subject|46|||
155456821|NCT02690207|561094018|FG000|Overall Study|Protocol Violation|2|||
155456822|NCT02690207|561094018|FG000|Overall Study|Serious adverse event|110|||
155456823|NCT02690207|561094018|FG000|Overall Study|Non-serious Adverse Event|18|||
155456824|NCT02690207|561094018|FG000|Overall Study|Migrated/moved from study area|5|||
155456825|NCT02690207|561094018|FG000|Overall Study|Suspected HZ Episode|1|||
155456826|NCT02690207|561094018|FG000|Overall Study|Other reasons for withdrawal|23|||
155456827|NCT02862548|561094019|FG000|Randomized Phase (Up to Week 48)|Death|0|||
155456828|NCT02862548|561094020|FG001|Randomized Phase (Up to Week 48)|Death|1|||
155456829|NCT02862548|561094019|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
155456830|NCT02862548|561094020|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
155456831|NCT02862548|561094019|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
155515816|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
155515817|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
155515818|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Death|0|||
155515819|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Death|1|||
155515820|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
155515821|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
155515822|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
155515823|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
155515824|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
155456832|NCT02862548|561094020|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
155456833|NCT02862548|561094019|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
155456834|NCT02862548|561094020|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
155456835|NCT02475850|561094021|FG000|Overall Study|Death|155|||
155456836|NCT02475850|561094022|FG001|Overall Study|Death|141|||
155456837|NCT02475850|561094021|FG000|Overall Study|Lost to Follow-up|217|||
155456838|NCT02475850|561094022|FG001|Overall Study|Lost to Follow-up|188|||
155456839|NCT02475850|561094021|FG000|Overall Study|Withdrawal by Subject|221|||
155456840|NCT02475850|561094022|FG001|Overall Study|Withdrawal by Subject|155|||
155456841|NCT03434418|561094028|FG000|Overall Study|Disease Progression|11|||
155456842|NCT03434418|561094028|FG000|Overall Study|Adverse Event|2|||
155456843|NCT03434418|561094028|FG000|Overall Study|Physician Decision|1|||
155456844|NCT03434418|561094028|FG000|Overall Study|Decline in Performance Status (PS)|1|||
155456845|NCT02254551|561094033|FG000|Dose Escalation|Physician Decision|1|||
155456846|NCT02254551|561094033|FG000|Dose Escalation|Dose-limiting toxicity|2|||
155456847|NCT03569449|561094034|FG000|Overall Study|Lost to Follow-up|0|||
155456848|NCT03569449|561094035|FG001|Overall Study|Lost to Follow-up|1|||
155456849|NCT03569449|561094036|FG002|Overall Study|Lost to Follow-up|0|||
155456850|NCT03569449|561094037|FG003|Overall Study|Lost to Follow-up|2|||
155456851|NCT03569449|561094038|FG004|Overall Study|Lost to Follow-up|0|||
155456852|NCT03569449|561094039|FG005|Overall Study|Lost to Follow-up|0|||
155456853|NCT03569449|561094040|FG006|Overall Study|Lost to Follow-up|0|||
155456854|NCT03569449|561094041|FG007|Overall Study|Lost to Follow-up|0|||
155456855|NCT03569449|561094042|FG008|Overall Study|Lost to Follow-up|0|||
155456856|NCT03569449|561094043|FG009|Overall Study|Lost to Follow-up|0|||
155456857|NCT03569449|561094044|FG010|Overall Study|Lost to Follow-up|0|||
155456858|NCT03569449|561094045|FG011|Overall Study|Lost to Follow-up|0|||
155456859|NCT03569449|561094046|FG012|Overall Study|Lost to Follow-up|0|||
155456860|NCT03569449|561094047|FG013|Overall Study|Lost to Follow-up|0|||
155456861|NCT03569449|561094048|FG014|Overall Study|Lost to Follow-up|1|||
155456862|NCT03569449|561094049|FG015|Overall Study|Lost to Follow-up|0|||
155456863|NCT03569449|561094034|FG000|Overall Study|Withdrawal by Subject|0|||
155456864|NCT03569449|561094035|FG001|Overall Study|Withdrawal by Subject|1|||
155456865|NCT03569449|561094036|FG002|Overall Study|Withdrawal by Subject|0|||
155456866|NCT03569449|561094037|FG003|Overall Study|Withdrawal by Subject|0|||
155456867|NCT03569449|561094038|FG004|Overall Study|Withdrawal by Subject|1|||
155456868|NCT03569449|561094039|FG005|Overall Study|Withdrawal by Subject|0|||
155456869|NCT03569449|561094040|FG006|Overall Study|Withdrawal by Subject|0|||
155456870|NCT03569449|561094041|FG007|Overall Study|Withdrawal by Subject|0|||
155456871|NCT03569449|561094042|FG008|Overall Study|Withdrawal by Subject|0|||
155515825|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
155515826|NCT01656889|561313586|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
155515827|NCT01656889|561313587|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
155456872|NCT03569449|561094043|FG009|Overall Study|Withdrawal by Subject|0|||
155456873|NCT03569449|561094044|FG010|Overall Study|Withdrawal by Subject|0|||
155456874|NCT03569449|561094045|FG011|Overall Study|Withdrawal by Subject|0|||
155456875|NCT03569449|561094046|FG012|Overall Study|Withdrawal by Subject|0|||
155456876|NCT03569449|561094047|FG013|Overall Study|Withdrawal by Subject|0|||
155456877|NCT03569449|561094048|FG014|Overall Study|Withdrawal by Subject|0|||
155456878|NCT03569449|561094049|FG015|Overall Study|Withdrawal by Subject|0|||
155456879|NCT04124692|561094050|FG000|Overall Study|Medical reason|0|||
155456880|NCT04124692|561094051|FG001|Overall Study|Medical reason|1|||
155456881|NCT04124692|561094050|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
155456882|NCT04124692|561094051|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
155515828|NCT01656889|561313586|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
155515829|NCT01656889|561313587|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
155456883|NCT04124692|561094050|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
155456884|NCT04124692|561094051|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
155456885|NCT04124692|561094050|FG000|Overall Study|Lost to Follow-up|2|||
155456886|NCT04124692|561094051|FG001|Overall Study|Lost to Follow-up|4|||
155456887|NCT04124692|561094050|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
155456888|NCT04124692|561094051|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
155456889|NCT05279898|561094065|FG000|Overall Study|Withdrawal by Subject|1|||
155456890|NCT05279898|561094066|FG001|Overall Study|Withdrawal by Subject|0|||
155456891|NCT05279898|561094065|FG000|Overall Study|Physician Decision|1|||
155456892|NCT05279898|561094066|FG001|Overall Study|Physician Decision|1|||
155456893|NCT05136170|561094067|FG000|Overall Study|Withdrawal by Subject|2|||
155456894|NCT05136170|561094068|FG001|Overall Study|Withdrawal by Subject|2|||
155456895|NCT05136170|561094067|FG000|Overall Study|Can no longer make office visits|1|||
155456896|NCT05136170|561094068|FG001|Overall Study|Can no longer make office visits|0|||
155456897|NCT01754922|561094069|FG000|Overall Study|Adverse Event|0|||
155456898|NCT01754922|561094070|FG001|Overall Study|Adverse Event|1|||
155456899|NCT01207388|561094071|FG000|Overall Study|Death|67|||
155456900|NCT01207388|561094071|FG000|Overall Study|Withdrawal by Subject|1|||
155456901|NCT00571688|561094078|FG000|Overall Study|Lost to Follow-up|3|||
155456902|NCT00571688|561094079|FG001|Overall Study|Lost to Follow-up|6|||
155456903|NCT00571688|561094078|FG000|Overall Study|subject did not tolerate Consta|1|||
155456904|NCT00571688|561094079|FG001|Overall Study|subject did not tolerate Consta|0|||
155456905|NCT00571688|561094078|FG000|Overall Study|subject moved out of the area|1|||
155456906|NCT00571688|561094079|FG001|Overall Study|subject moved out of the area|0|||
155456907|NCT01194869|561094080|FG000|Overall Study|Disease Progression|2|||
155456908|NCT01194869|561094080|FG000|Overall Study|Toxicity|2|||
155456909|NCT01048853|561094081|FG000|Overall Study|Death|1|||
155456910|NCT01048853|561094082|FG001|Overall Study|Death|0|||
155456911|NCT01048853|561094083|FG002|Overall Study|Death|0|||
155456912|NCT01048853|561094081|FG000|Overall Study|Lost to Follow-up|1|||
155456913|NCT01048853|561094082|FG001|Overall Study|Lost to Follow-up|4|||
155456914|NCT01048853|561094083|FG002|Overall Study|Lost to Follow-up|0|||
155456915|NCT06964165|561094087|FG000|Overall Study|Death|4|||
155456916|NCT06964165|561094088|FG001|Overall Study|Death|4|||
155456917|NCT06964165|561094087|FG000|Overall Study|Physician Decision|1|||
155456918|NCT06964165|561094088|FG001|Overall Study|Physician Decision|1|||
155456919|NCT06964165|561094087|FG000|Overall Study|Withdrawal by Subject|0|||
155456920|NCT06964165|561094088|FG001|Overall Study|Withdrawal by Subject|2|||
155456921|NCT06964165|561094087|FG000|Overall Study|Study terminated by sponsor|12|||
155456922|NCT06964165|561094088|FG001|Overall Study|Study terminated by sponsor|10|||
155456923|NCT06964165|561094087|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
155456924|NCT06964165|561094088|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
155456925|NCT06964165|561094087|FG000|Overall Study|Participant removed due to non-compliance|0|||
155456926|NCT06964165|561094088|FG001|Overall Study|Participant removed due to non-compliance|1|||
155456927|NCT03224104|561094094|FG000|Overall Study|Lack of Efficacy|2|||
155456928|NCT03224104|561094095|FG001|Overall Study|Lack of Efficacy|6|||
155456929|NCT03224104|561094096|FG002|Overall Study|Lack of Efficacy|3|||
155456930|NCT03224104|561094097|FG003|Overall Study|Lack of Efficacy|4|||
155456931|NCT03224104|561094098|FG004|Overall Study|Lack of Efficacy|42|||
155456932|NCT03224104|561094094|FG000|Overall Study|Withdrawal by Subject|0|||
155456933|NCT03224104|561094095|FG001|Overall Study|Withdrawal by Subject|2|||
155456934|NCT03224104|561094096|FG002|Overall Study|Withdrawal by Subject|0|||
155456935|NCT03224104|561094097|FG003|Overall Study|Withdrawal by Subject|1|||
155456936|NCT03224104|561094098|FG004|Overall Study|Withdrawal by Subject|3|||
155456937|NCT03224104|561094094|FG000|Overall Study|Death|0|||
155456938|NCT03224104|561094095|FG001|Overall Study|Death|1|||
155456939|NCT03224104|561094096|FG002|Overall Study|Death|0|||
155456940|NCT03224104|561094097|FG003|Overall Study|Death|0|||
155456941|NCT03224104|561094098|FG004|Overall Study|Death|0|||
155456942|NCT03224104|561094094|FG000|Overall Study|Adverse Event|1|||
155456943|NCT03224104|561094095|FG001|Overall Study|Adverse Event|0|||
155456944|NCT03224104|561094096|FG002|Overall Study|Adverse Event|0|||
155456945|NCT03224104|561094097|FG003|Overall Study|Adverse Event|1|||
155456946|NCT03224104|561094098|FG004|Overall Study|Adverse Event|3|||
155456947|NCT03224104|561094094|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
155456948|NCT03224104|561094095|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
155456949|NCT03224104|561094096|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
155456950|NCT03224104|561094097|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
155456951|NCT03224104|561094098|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
155456952|NCT03224104|561094094|FG000|Overall Study|Treatment ongoing|0|||
155456953|NCT03224104|561094095|FG001|Overall Study|Treatment ongoing|0|||
155456954|NCT03224104|561094096|FG002|Overall Study|Treatment ongoing|0|||
155456955|NCT03224104|561094097|FG003|Overall Study|Treatment ongoing|0|||
155456956|NCT03224104|561094098|FG004|Overall Study|Treatment ongoing|1|||
155456957|NCT06087328|561094099|FG000|28-Day Treatment|Lost to Follow-up|7|||
155456958|NCT06087328|561094100|FG001|28-Day Treatment|Lost to Follow-up|3|||
155456959|NCT06087328|561094101|FG002|28-Day Treatment|Lost to Follow-up|4|||
155456960|NCT06087328|561094099|FG000|1-month Follow-up|Lost to Follow-up|0|||
155456961|NCT06087328|561094100|FG001|1-month Follow-up|Lost to Follow-up|1|||
155456962|NCT06087328|561094101|FG002|1-month Follow-up|Lost to Follow-up|1|||
155456963|NCT03201965|561094104|FG000|Overall Study|Death|5|||
155456964|NCT03201965|561094105|FG001|Overall Study|Death|65|||
155456965|NCT03201965|561094106|FG002|Overall Study|Death|47|||
155456966|NCT03201965|561094104|FG000|Overall Study|Lost to Follow-up|0|||
155456967|NCT03201965|561094105|FG001|Overall Study|Lost to Follow-up|6|||
155456968|NCT03201965|561094106|FG002|Overall Study|Lost to Follow-up|0|||
155456969|NCT03201965|561094104|FG000|Overall Study|Withdrawal by Subject|3|||
155456970|NCT03201965|561094105|FG001|Overall Study|Withdrawal by Subject|23|||
155456971|NCT03201965|561094106|FG002|Overall Study|Withdrawal by Subject|8|||
155456972|NCT03201965|561094104|FG000|Overall Study|Sponsor's Decision|20|||
155456973|NCT03201965|561094105|FG001|Overall Study|Sponsor's Decision|99|||
155456974|NCT03201965|561094106|FG002|Overall Study|Sponsor's Decision|140|||
155456975|NCT01153893|561094116|FG000|Overall Study|Adverse Event|1|||
155456976|NCT01153893|561094117|FG001|Overall Study|Adverse Event|0|||
155456977|NCT04799405|561094118|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
155456978|NCT00118482|561094119|FG000|Overall Study|Lost to Follow-up|7|||
155456979|NCT00118482|561094120|FG001|Overall Study|Lost to Follow-up|7|||
155456980|NCT00118482|561094119|FG000|Overall Study|Withdrawal by Subject|23|||
155456981|NCT00118482|561094120|FG001|Overall Study|Withdrawal by Subject|22|||
155456982|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
155456983|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
155456984|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
155456985|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
155456986|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
155456987|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
155456988|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
155456989|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
155456990|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
155456991|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
155456992|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
155456993|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
155456994|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
155456995|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
155456996|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
155456997|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
155651812|NCT01517178|561818155|FG000|Period 1|Withdrawal by Subject|0|||
155651813|NCT01517178|561818156|FG001|Period 1|Withdrawal by Subject|1|||
155651814|NCT01517178|561818155|FG000|Period 2|Adverse Event|1|||
155651815|NCT01517178|561818156|FG001|Period 2|Adverse Event|0|||
155651816|NCT01517178|561818155|FG000|Period 2|Withdrawal by Subject|3|||
155651817|NCT01517178|561818156|FG001|Period 2|Withdrawal by Subject|0|||
155651818|NCT01517178|561818155|FG000|Period 2|E.g. study termination|2|||
155651819|NCT01517178|561818156|FG001|Period 2|E.g. study termination|2|||
155456998|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
155651820|NCT01959919|561818157|FG000|Overall Study|Did not meet the eligibility criteria|2|||
155651821|NCT03439072|561818158|FG000|Overall Study|Withdrawal by Subject|2|||
155651822|NCT03439072|561818159|FG001|Overall Study|Withdrawal by Subject|3|||
155651823|NCT03439072|561818158|FG000|Overall Study|Physician Decision|0|||
155456999|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
155457000|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
155457001|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
155457002|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
155515830|NCT01656889|561313586|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
155651824|NCT03439072|561818159|FG001|Overall Study|Physician Decision|1|||
155651825|NCT03627468|561818160|FG000|Overall Study|Adverse Event|5|||
155651826|NCT03627468|561818161|FG001|Overall Study|Adverse Event|33|||
155651827|NCT03627468|561818160|FG000|Overall Study|Withdrawal by Subject|13|||
155651828|NCT03627468|561818161|FG001|Overall Study|Withdrawal by Subject|23|||
155651829|NCT03627468|561818160|FG000|Overall Study|Physician Decision|1|||
155651830|NCT03627468|561818161|FG001|Overall Study|Physician Decision|0|||
155651831|NCT03627468|561818160|FG000|Overall Study|Protocol Violation|0|||
155651832|NCT03627468|561818161|FG001|Overall Study|Protocol Violation|2|||
155651833|NCT03627468|561818160|FG000|Overall Study|Lost to Follow-up|10|||
155651834|NCT03627468|561818161|FG001|Overall Study|Lost to Follow-up|16|||
155651835|NCT03627468|561818160|FG000|Overall Study|Death|1|||
155651836|NCT03627468|561818161|FG001|Overall Study|Death|0|||
155457003|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
155457004|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
155457005|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
155457006|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
155457007|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
155457008|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
155457009|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
155457010|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
155457011|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
155457012|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
155457013|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
155457014|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
155457015|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
155457016|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
155457017|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
155457018|NCT01963208|561094121|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
155457019|NCT01963208|561094122|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
155457020|NCT01963208|561094123|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
155457021|NCT01963208|561094124|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
155457022|NCT01963208|561094125|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
155457023|NCT01963208|561094126|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
155457024|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
155457025|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
155457026|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
155457027|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
155457028|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
155457029|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
155457030|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
155457031|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
155457032|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
155457033|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
155457034|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
155457035|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
155457036|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
155457037|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
155457038|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
155457039|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
155457040|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
155457041|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
155457042|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
155457043|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
155457044|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
155457045|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
155457046|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
155457047|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
155457048|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
155457049|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
155457050|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
155457051|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
155457052|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
155457053|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
155457054|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
155457055|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
155457056|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
155651837|NCT03627468|561818160|FG000|Overall Study|Pregnancy|1|||
155651838|NCT03627468|561818161|FG001|Overall Study|Pregnancy|1|||
155651839|NCT03627468|561818160|FG000|Overall Study|Lack of Efficacy|0|||
155651840|NCT03627468|561818161|FG001|Overall Study|Lack of Efficacy|2|||
155651841|NCT03627468|561818160|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
155515831|NCT01656889|561313587|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
155515832|NCT01656889|561313586|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
155515833|NCT01656889|561313587|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
155515834|NCT01656889|561313586|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
155515835|NCT01656889|561313587|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
155457057|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
155457058|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
155457059|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
155457060|NCT01963208|561094121|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
155457061|NCT01963208|561094122|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
155457062|NCT01963208|561094123|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
155457063|NCT01963208|561094124|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
155457064|NCT01963208|561094125|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
155515836|NCT02486796|561313588|FG000|Overall Study|Withdrawal by Subject|1|||
155457065|NCT01963208|561094126|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
155457066|NCT00438399|561094127|FG000|Overall Study|Lost to Follow-up|2|||
155457067|NCT00438399|561094128|FG001|Overall Study|Lost to Follow-up|2|||
155457068|NCT00438399|561094129|FG002|Overall Study|Lost to Follow-up|1|||
155457069|NCT00438399|561094130|FG003|Overall Study|Lost to Follow-up|1|||
155457070|NCT00438399|561094131|FG004|Overall Study|Lost to Follow-up|1|||
155457071|NCT00438399|561094132|FG005|Overall Study|Lost to Follow-up|1|||
155457072|NCT00438399|561094127|FG000|Overall Study|Adverse Event|0|||
155457073|NCT00438399|561094128|FG001|Overall Study|Adverse Event|0|||
155457074|NCT00438399|561094129|FG002|Overall Study|Adverse Event|1|||
155457075|NCT00438399|561094130|FG003|Overall Study|Adverse Event|1|||
155457076|NCT00438399|561094131|FG004|Overall Study|Adverse Event|0|||
155457077|NCT00438399|561094132|FG005|Overall Study|Adverse Event|1|||
155457078|NCT00438399|561094127|FG000|Overall Study|Withdrawal by Subject|5|||
155457079|NCT00438399|561094128|FG001|Overall Study|Withdrawal by Subject|6|||
155457080|NCT00438399|561094129|FG002|Overall Study|Withdrawal by Subject|3|||
155457081|NCT00438399|561094130|FG003|Overall Study|Withdrawal by Subject|2|||
155457082|NCT00438399|561094131|FG004|Overall Study|Withdrawal by Subject|2|||
155457083|NCT00438399|561094132|FG005|Overall Study|Withdrawal by Subject|2|||
155457084|NCT00438399|561094127|FG000|Overall Study|Protocol Violation|0|||
155457085|NCT00438399|561094128|FG001|Overall Study|Protocol Violation|0|||
155457086|NCT00438399|561094129|FG002|Overall Study|Protocol Violation|1|||
155457087|NCT00438399|561094130|FG003|Overall Study|Protocol Violation|0|||
155457088|NCT00438399|561094131|FG004|Overall Study|Protocol Violation|0|||
155457089|NCT00438399|561094132|FG005|Overall Study|Protocol Violation|1|||
155457090|NCT00438399|561094127|FG000|Overall Study|Subje stopped study|0|||
155457091|NCT00438399|561094128|FG001|Overall Study|Subje stopped study|0|||
155457092|NCT00438399|561094129|FG002|Overall Study|Subje stopped study|1|||
155457093|NCT00438399|561094130|FG003|Overall Study|Subje stopped study|0|||
155457094|NCT00438399|561094131|FG004|Overall Study|Subje stopped study|0|||
155457095|NCT00438399|561094132|FG005|Overall Study|Subje stopped study|0|||
155457096|NCT00438399|561094127|FG000|Overall Study|Pregnancy|0|||
155457097|NCT00438399|561094128|FG001|Overall Study|Pregnancy|0|||
155457098|NCT00438399|561094129|FG002|Overall Study|Pregnancy|0|||
155457099|NCT00438399|561094130|FG003|Overall Study|Pregnancy|0|||
155457100|NCT00438399|561094131|FG004|Overall Study|Pregnancy|0|||
155457101|NCT00438399|561094132|FG005|Overall Study|Pregnancy|1|||
155457102|NCT00438399|561094127|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
155457103|NCT00438399|561094128|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
155457104|NCT00438399|561094129|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
155457105|NCT00438399|561094130|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
155457106|NCT00438399|561094131|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
155457107|NCT00438399|561094132|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
155457108|NCT05294211|561094136|FG000|Overall Study|Withdrawal by Subject|3|||
155515837|NCT02486796|561313589|FG001|Overall Study|Withdrawal by Subject|1|||
155515838|NCT02486796|561313588|FG000|Overall Study|Physician Decision|1|||
155515839|NCT02486796|561313589|FG001|Overall Study|Physician Decision|0|||
155515840|NCT00679783|561313590|FG000|Overall Study|Adverse Event|0|||
155651842|NCT03627468|561818161|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
155457109|NCT05294211|561094136|FG000|Overall Study|Physician Decision|2|||
155457110|NCT05294211|561094136|FG000|Overall Study|Progressed to active labor|1|||
155457111|NCT05294211|561094136|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
155457112|NCT05294211|561094136|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
155457113|NCT00012012|561094139|FG000|Overall Study|Protocol Violation|1|||
155457114|NCT00012012|561094140|FG001|Overall Study|Protocol Violation|1|||
155457115|NCT00012012|561094139|FG000|Overall Study|Withdrawal by Subject|0|||
155457116|NCT00012012|561094140|FG001|Overall Study|Withdrawal by Subject|2|||
155457117|NCT02159469|561094141|FG000|Overall Study|Missing Completion status|1|||
155457118|NCT02159469|561094141|FG000|Overall Study|Adverse Event|5|||
155457119|NCT02159469|561094141|FG000|Overall Study|Non-compliance|2|||
155515841|NCT00679783|561313591|FG001|Overall Study|Adverse Event|0|||
155457120|NCT02159469|561094141|FG000|Overall Study|Withdrawal by Subject|9|||
155457121|NCT02159469|561094141|FG000|Overall Study|Lost to Follow-up|1|||
155457122|NCT02159469|561094141|FG000|Overall Study|Sponsor's request|2|||
155457123|NCT02159469|561094141|FG000|Overall Study|Met Stopping Criteria|3|||
155457124|NCT02159469|561094141|FG000|Overall Study|Other|1|||
155457125|NCT02159469|561094141|FG000|Overall Study|Multiple|29|||
155457126|NCT02034474|561094142|FG000|Overall Study|Adverse Event|3|||
155457127|NCT02034474|561094143|FG001|Overall Study|Adverse Event|2|||
155457128|NCT02034474|561094142|FG000|Overall Study|Withdrawal by Subject|1|||
155457129|NCT02034474|561094143|FG001|Overall Study|Withdrawal by Subject|2|||
155457130|NCT01391819|561094144|FG000|Overall Study|Withdrawal by Subject|56|||
155457131|NCT01391819|561094144|FG000|Overall Study|Migrated/moved from study area|82|||
155457132|NCT01391819|561094144|FG000|Overall Study|Lost to Follow-up|252|||
155457133|NCT01391819|561094144|FG000|Overall Study|Death|3|||
155457134|NCT01391819|561094144|FG000|Overall Study|Other|9|||
155457135|NCT03730194|561094151|FG000|First Stage Treatment|Withdrawal by Subject|1|||
155457136|NCT03730194|561094152|FG001|First Stage Treatment|Withdrawal by Subject|1|||
155457137|NCT03730194|561094153|FG002|First Stage Treatment|Withdrawal by Subject|0|||
155457138|NCT03730194|561094154|FG003|First Stage Treatment|Withdrawal by Subject|0|||
155457139|NCT03730194|561094155|FG004|First Stage Treatment|Withdrawal by Subject|0|||
155457140|NCT03730194|561094156|FG005|First Stage Treatment|Withdrawal by Subject|0|||
155457141|NCT03730194|561094151|FG000|First Stage Treatment|Protocol Violation|3|||
155457142|NCT03730194|561094152|FG001|First Stage Treatment|Protocol Violation|3|||
155457143|NCT03730194|561094153|FG002|First Stage Treatment|Protocol Violation|0|||
155457144|NCT03730194|561094154|FG003|First Stage Treatment|Protocol Violation|0|||
155457145|NCT03730194|561094155|FG004|First Stage Treatment|Protocol Violation|0|||
155457146|NCT03730194|561094156|FG005|First Stage Treatment|Protocol Violation|0|||
155457147|NCT01244191|561094159|FG000|Overall Study|Progressive disease|295|||
155457148|NCT01244191|561094160|FG001|Overall Study|Progressive disease|350|||
155457149|NCT01244191|561094159|FG000|Overall Study|Clinical disease progression|54|||
155457150|NCT01244191|561094160|FG001|Overall Study|Clinical disease progression|36|||
155515842|NCT00679783|561313592|FG002|Overall Study|Adverse Event|0|||
155515843|NCT00679783|561313593|FG003|Overall Study|Adverse Event|3|||
155515844|NCT00679783|561313594|FG004|Overall Study|Adverse Event|0|||
155515845|NCT00679783|561313595|FG005|Overall Study|Adverse Event|0|||
155457151|NCT01244191|561094159|FG000|Overall Study|Adverse Event|65|||
155457152|NCT01244191|561094160|FG001|Overall Study|Adverse Event|48|||
155457153|NCT01244191|561094159|FG000|Overall Study|Death|22|||
155457154|NCT01244191|561094160|FG001|Overall Study|Death|29|||
155457155|NCT01244191|561094159|FG000|Overall Study|Lost to Follow-up|0|||
155457156|NCT01244191|561094160|FG001|Overall Study|Lost to Follow-up|2|||
155457157|NCT01244191|561094159|FG000|Overall Study|Protocol Violation|1|||
155457158|NCT01244191|561094160|FG001|Overall Study|Protocol Violation|2|||
155457159|NCT01244191|561094159|FG000|Overall Study|Withdrawal by Subject|31|||
155457160|NCT01244191|561094160|FG001|Overall Study|Withdrawal by Subject|23|||
155457161|NCT01244191|561094159|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
155457162|NCT01244191|561094160|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
155457163|NCT01752842|561094161|FG000|Overall Study|Adverse Event|3|||
155457164|NCT01752842|561094162|FG001|Overall Study|Adverse Event|0|||
155457165|NCT01752842|561094161|FG000|Overall Study|Withdrawal by Subject|0|||
155457166|NCT01752842|561094162|FG001|Overall Study|Withdrawal by Subject|2|||
155457167|NCT02164513|561094163|FG000|Overall Study|Adverse Event|162|||
155457168|NCT02164513|561094164|FG001|Overall Study|Adverse Event|180|||
155457169|NCT02164513|561094165|FG002|Overall Study|Adverse Event|111|||
155457170|NCT02164513|561094163|FG000|Overall Study|Other: Study Closed or terminated|5|||
155457171|NCT02164513|561094164|FG001|Overall Study|Other: Study Closed or terminated|2|||
155457172|NCT02164513|561094165|FG002|Overall Study|Other: Study Closed or terminated|4|||
155457173|NCT02164513|561094163|FG000|Overall Study|Lost to Follow-up|30|||
155515846|NCT00679783|561313596|FG006|Overall Study|Adverse Event|1|||
155457174|NCT02164513|561094164|FG001|Overall Study|Lost to Follow-up|36|||
155457175|NCT02164513|561094165|FG002|Overall Study|Lost to Follow-up|22|||
155457176|NCT02164513|561094163|FG000|Overall Study|Physician Decision|47|||
155457177|NCT02164513|561094164|FG001|Overall Study|Physician Decision|57|||
155457178|NCT02164513|561094165|FG002|Overall Study|Physician Decision|28|||
155457179|NCT02164513|561094163|FG000|Overall Study|Withdrawal by Subject|192|||
155457180|NCT02164513|561094164|FG001|Overall Study|Withdrawal by Subject|261|||
155457181|NCT02164513|561094165|FG002|Overall Study|Withdrawal by Subject|130|||
155515847|NCT00679783|561313590|FG000|Overall Study|Lack of Efficacy|0|||
155515848|NCT00679783|561313591|FG001|Overall Study|Lack of Efficacy|1|||
155515849|NCT00679783|561313592|FG002|Overall Study|Lack of Efficacy|0|||
155457182|NCT02164513|561094163|FG000|Overall Study|Other: Reason not provided by site|1|||
155457183|NCT02164513|561094164|FG001|Overall Study|Other: Reason not provided by site|0|||
155457184|NCT02164513|561094165|FG002|Overall Study|Other: Reason not provided by site|0|||
155457185|NCT05584202|561094166|FG000|Overall Study|Withdrawal of Consent|3|||
155457186|NCT05584202|561094167|FG001|Overall Study|Withdrawal of Consent|2|||
155457187|NCT05584202|561094166|FG000|Overall Study|Lost to Follow-up|2|||
155457188|NCT05584202|561094167|FG001|Overall Study|Lost to Follow-up|1|||
155457189|NCT05584202|561094166|FG000|Overall Study|Death|0|||
155457190|NCT05584202|561094167|FG001|Overall Study|Death|1|||
155457191|NCT05301322|561094168|FG000|Overall Study|Adverse Event|7|||
155457192|NCT05301322|561094169|FG001|Overall Study|Adverse Event|3|||
155457193|NCT05301322|561094168|FG000|Overall Study|Death|0|||
155457194|NCT05301322|561094169|FG001|Overall Study|Death|1|||
155457195|NCT05301322|561094168|FG000|Overall Study|Lost to Follow-up|2|||
155457196|NCT05301322|561094169|FG001|Overall Study|Lost to Follow-up|1|||
155457197|NCT05301322|561094168|FG000|Overall Study|Protocol Violation|3|||
155457198|NCT05301322|561094169|FG001|Overall Study|Protocol Violation|1|||
155457199|NCT05301322|561094168|FG000|Overall Study|Withdrawal by Subject|3|||
155457200|NCT05301322|561094169|FG001|Overall Study|Withdrawal by Subject|0|||
155457201|NCT05301322|561094168|FG000|Overall Study|Other|4|||
155457202|NCT05301322|561094169|FG001|Overall Study|Other|0|||
155457203|NCT05084053|561097111|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
155457204|NCT05084053|561097112|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
155457205|NCT05084053|561097113|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
155457206|NCT05084053|561097114|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
155457207|NCT05084053|561097111|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
155457208|NCT05084053|561097112|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
155457209|NCT05084053|561097113|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
155457210|NCT05084053|561097114|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
155457211|NCT05084053|561097111|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
155457212|NCT05084053|561097112|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
155457213|NCT05084053|561097113|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
155457214|NCT05084053|561097114|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
155457215|NCT02180724|561097115|FG000|Overall Study|Death|26|||
155457216|NCT02180724|561097116|FG001|Overall Study|Death|1|||
155457217|NCT02180724|561097115|FG000|Overall Study|Lost to Follow-up|3|||
155457218|NCT02180724|561097116|FG001|Overall Study|Lost to Follow-up|1|||
155457219|NCT02180724|561097115|FG000|Overall Study|Withdrawal by Subject|4|||
155457220|NCT02180724|561097116|FG001|Overall Study|Withdrawal by Subject|2|||
155457221|NCT02180724|561097115|FG000|Overall Study|PI Decision|5|||
155457222|NCT02180724|561097116|FG001|Overall Study|PI Decision|2|||
155457223|NCT02180724|561097115|FG000|Overall Study|Study terminated by sponsor|54|||
155457224|NCT02180724|561097116|FG001|Overall Study|Study terminated by sponsor|8|||
155457225|NCT00571519|561097117|FG000|Overall Study|Subject withdrew consent|0|||
155457226|NCT00571519|561097118|FG001|Overall Study|Subject withdrew consent|1|||
155457227|NCT00571519|561097119|FG002|Overall Study|Subject withdrew consent|0|||
155457228|NCT00571519|561097120|FG003|Overall Study|Subject withdrew consent|2|||
155457229|NCT00571519|561097121|FG004|Overall Study|Subject withdrew consent|1|||
155457230|NCT00571519|561097122|FG005|Overall Study|Subject withdrew consent|1|||
155457231|NCT00571519|561097123|FG006|Overall Study|Subject withdrew consent|2|||
155457232|NCT00571519|561097117|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
155457233|NCT00571519|561097118|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
155457234|NCT00571519|561097119|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
155457235|NCT00571519|561097120|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
155457236|NCT00571519|561097121|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
155457237|NCT00571519|561097122|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
155457238|NCT00571519|561097123|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
155457239|NCT00571519|561097117|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457240|NCT00571519|561097118|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
155457241|NCT00571519|561097119|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457242|NCT00571519|561097120|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457243|NCT00571519|561097121|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457244|NCT00571519|561097122|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457245|NCT00571519|561097123|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
155457246|NCT00571519|561097117|FG000|Overall Study|Termination of study by Sponsor|2|||
155457247|NCT00571519|561097118|FG001|Overall Study|Termination of study by Sponsor|7|||
155457248|NCT00571519|561097119|FG002|Overall Study|Termination of study by Sponsor|10|||
155457249|NCT00571519|561097120|FG003|Overall Study|Termination of study by Sponsor|24|||
155457250|NCT00571519|561097121|FG004|Overall Study|Termination of study by Sponsor|8|||
155457251|NCT00571519|561097122|FG005|Overall Study|Termination of study by Sponsor|9|||
155457252|NCT00571519|561097123|FG006|Overall Study|Termination of study by Sponsor|22|||
155457253|NCT00571519|561097117|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457254|NCT00571519|561097118|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457255|NCT00571519|561097119|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
155457256|NCT00571519|561097120|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457257|NCT00571519|561097121|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457258|NCT00571519|561097122|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457259|NCT00571519|561097123|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
155457260|NCT05458011|561097124|FG000|DB Period (12 Weeks)|Adverse Event|2|||
155457261|NCT05458011|561097125|FG001|DB Period (12 Weeks)|Adverse Event|1|||
155457262|NCT05458011|561097126|FG002|DB Period (12 Weeks)|Adverse Event|1|||
155457263|NCT05458011|561097124|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
155457264|NCT05458011|561097125|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
155457265|NCT05458011|561097126|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
155457266|NCT05458011|561097124|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
155457267|NCT05458011|561097125|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
155457268|NCT05458011|561097126|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
155457269|NCT05458011|561097124|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
155457270|NCT05458011|561097125|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
155457271|NCT05458011|561097126|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
155457272|NCT05458011|561097124|FG000|OL Period (12 Weeks)|Adverse Event|1|||
155457273|NCT05458011|561097125|FG001|OL Period (12 Weeks)|Adverse Event|2|||
155457274|NCT05458011|561097126|FG002|OL Period (12 Weeks)|Adverse Event|1|||
155457275|NCT05458011|561097124|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
155457276|NCT05458011|561097125|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
155457277|NCT05458011|561097126|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
155457278|NCT00574119|561097127|FG000|Overall Study|Adverse Event|1|||
155457279|NCT00574119|561097127|FG000|Overall Study|Protocol Violation|1|||
155457280|NCT00574119|561097127|FG000|Overall Study|Withdrawal by Subject|1|||
155457281|NCT00574119|561097127|FG000|Overall Study|Physician Decision|1|||
155457282|NCT04656418|561097131|FG000|Overall Study|Withdrawal by Subject|1|||
155457283|NCT04656418|561097132|FG001|Overall Study|Withdrawal by Subject|3|||
155457284|NCT03287245|561097133|FG000|Overall Study|Study terminated by sponsor|3|||
155457285|NCT03287245|561097134|FG001|Overall Study|Study terminated by sponsor|0|||
155457286|NCT03287245|561097135|FG002|Overall Study|Study terminated by sponsor|3|||
155457287|NCT03287245|561097136|FG003|Overall Study|Study terminated by sponsor|1|||
155457288|NCT03287245|561097133|FG000|Overall Study|Adverse Event|1|||
155457289|NCT03287245|561097134|FG001|Overall Study|Adverse Event|0|||
155457290|NCT03287245|561097135|FG002|Overall Study|Adverse Event|0|||
155457291|NCT03287245|561097136|FG003|Overall Study|Adverse Event|0|||
155457292|NCT03287245|561097133|FG000|Overall Study|Withdrawal by Subject|8|||
155457293|NCT03287245|561097134|FG001|Overall Study|Withdrawal by Subject|3|||
155457294|NCT03287245|561097135|FG002|Overall Study|Withdrawal by Subject|3|||
155457295|NCT03287245|561097136|FG003|Overall Study|Withdrawal by Subject|0|||
155457296|NCT03287245|561097133|FG000|Overall Study|Physician Decision|3|||
155457297|NCT03287245|561097134|FG001|Overall Study|Physician Decision|2|||
155457298|NCT03287245|561097135|FG002|Overall Study|Physician Decision|0|||
155457299|NCT03287245|561097136|FG003|Overall Study|Physician Decision|0|||
155457300|NCT02586077|561097137|FG000|Overall Study|Withdrawal by Subject|1|||
155457301|NCT02586077|561097137|FG000|Overall Study|Physician Decision|4|||
155457302|NCT02586077|561097137|FG000|Overall Study|Lost to Follow-up|3|||
155457303|NCT02701192|561097138|FG000|Overall Study|Protocol Violation|2|||
155457304|NCT02701192|561097138|FG000|Overall Study|Lost to Follow-up|4|||
155457305|NCT00880763|561097139|FG000|Extension Period (Part 2)|Adverse Event|0|||
155457306|NCT00880763|561097140|FG001|Extension Period (Part 2)|Adverse Event|0|||
155457307|NCT00880763|561097141|FG002|Extension Period (Part 2)|Adverse Event|1|||
155457308|NCT00880763|561097142|FG003|Extension Period (Part 2)|Adverse Event|1|||
155457309|NCT00880763|561097139|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
155457310|NCT00880763|561097140|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
155457311|NCT00880763|561097141|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
155457312|NCT00880763|561097142|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
155515850|NCT00679783|561313593|FG003|Overall Study|Lack of Efficacy|2|||
155651843|NCT01550965|561818165|FG000|Overall Study|Adverse Event|26|||
155651844|NCT01550965|561818165|FG000|Overall Study|Withdrawal by Subject|10|||
155457313|NCT00880763|561097139|FG000|Extension Period (Part 2)|Physician Decision|0|||
155457314|NCT00880763|561097140|FG001|Extension Period (Part 2)|Physician Decision|1|||
155457315|NCT00880763|561097141|FG002|Extension Period (Part 2)|Physician Decision|1|||
155457316|NCT00880763|561097142|FG003|Extension Period (Part 2)|Physician Decision|0|||
155457317|NCT00880763|561097139|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
155457318|NCT00880763|561097140|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
155457319|NCT00880763|561097141|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
155457320|NCT00880763|561097142|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
155457321|NCT00003476|561097144|FG000|Overall Study|Not evaluable|1|||
155457322|NCT00696436|561097145|FG000|Overall Study|Adverse Event|7|||
155457323|NCT00696436|561097146|FG001|Overall Study|Adverse Event|9|||
155457324|NCT00696436|561097147|FG002|Overall Study|Adverse Event|8|||
155651845|NCT01550965|561818165|FG000|Overall Study|Lost to Follow-up|2|||
155457325|NCT00696436|561097148|FG003|Overall Study|Adverse Event|6|||
155457326|NCT00696436|561097149|FG004|Overall Study|Adverse Event|4|||
155457327|NCT00696436|561097145|FG000|Overall Study|Protocol Violation|3|||
155457328|NCT00696436|561097146|FG001|Overall Study|Protocol Violation|2|||
155457329|NCT00696436|561097147|FG002|Overall Study|Protocol Violation|2|||
155651846|NCT01550965|561818165|FG000|Overall Study|Lack of Efficacy|59|||
155651847|NCT01550965|561818165|FG000|Overall Study|Other|13|||
155651848|NCT01347086|561818172|FG000|Overall Study|failed screening visit|0|||
155651849|NCT01347086|561818173|FG001|Overall Study|failed screening visit|0|||
155651850|NCT01347086|561818174|FG002|Overall Study|failed screening visit|1|||
155651851|NCT01347086|561818175|FG003|Overall Study|failed screening visit|0|||
155651852|NCT01347086|561818176|FG004|Overall Study|failed screening visit|0|||
155651853|NCT01347086|561818177|FG005|Overall Study|failed screening visit|0|||
155651854|NCT01347086|561818178|FG006|Overall Study|failed screening visit|1|||
155651855|NCT01347086|561818179|FG007|Overall Study|failed screening visit|1|||
155651856|NCT01347086|561818180|FG008|Overall Study|failed screening visit|0|||
155651857|NCT01347086|561818181|FG009|Overall Study|failed screening visit|1|||
155651858|NCT02624687|561818182|FG000|Overall Study|Withdrawal by Subject|1|||
155651859|NCT02624687|561818183|FG001|Overall Study|Withdrawal by Subject|1|||
155651860|NCT02624687|561818182|FG000|Overall Study|medical leave from work|0|||
155457330|NCT00696436|561097148|FG003|Overall Study|Protocol Violation|0|||
155457331|NCT00696436|561097149|FG004|Overall Study|Protocol Violation|1|||
155457332|NCT00696436|561097145|FG000|Overall Study|Lost to Follow-up|1|||
155457333|NCT00696436|561097146|FG001|Overall Study|Lost to Follow-up|6|||
155457334|NCT00696436|561097147|FG002|Overall Study|Lost to Follow-up|2|||
155457335|NCT00696436|561097148|FG003|Overall Study|Lost to Follow-up|4|||
155457336|NCT00696436|561097149|FG004|Overall Study|Lost to Follow-up|3|||
155457337|NCT00696436|561097145|FG000|Overall Study|Withdrawal by Subject|4|||
155457338|NCT00696436|561097146|FG001|Overall Study|Withdrawal by Subject|11|||
155457339|NCT00696436|561097147|FG002|Overall Study|Withdrawal by Subject|5|||
155457340|NCT00696436|561097148|FG003|Overall Study|Withdrawal by Subject|7|||
155457341|NCT00696436|561097149|FG004|Overall Study|Withdrawal by Subject|1|||
155457342|NCT00696436|561097145|FG000|Overall Study|Lack of Efficacy|3|||
155457343|NCT00696436|561097146|FG001|Overall Study|Lack of Efficacy|1|||
155457344|NCT00696436|561097147|FG002|Overall Study|Lack of Efficacy|5|||
155457345|NCT00696436|561097148|FG003|Overall Study|Lack of Efficacy|2|||
155457346|NCT00696436|561097149|FG004|Overall Study|Lack of Efficacy|4|||
155651861|NCT02624687|561818183|FG001|Overall Study|medical leave from work|1|||
155457347|NCT00696436|561097145|FG000|Overall Study|Participant Unavailability|2|||
155457348|NCT00696436|561097146|FG001|Overall Study|Participant Unavailability|0|||
155457349|NCT00696436|561097147|FG002|Overall Study|Participant Unavailability|2|||
155457350|NCT00696436|561097148|FG003|Overall Study|Participant Unavailability|1|||
155457351|NCT00696436|561097149|FG004|Overall Study|Participant Unavailability|0|||
155457352|NCT00696436|561097145|FG000|Overall Study|Administrative Error|2|||
155457353|NCT00696436|561097146|FG001|Overall Study|Administrative Error|0|||
155457354|NCT00696436|561097147|FG002|Overall Study|Administrative Error|2|||
155457355|NCT00696436|561097148|FG003|Overall Study|Administrative Error|0|||
155457356|NCT00696436|561097149|FG004|Overall Study|Administrative Error|0|||
155457357|NCT00696436|561097145|FG000|Overall Study|Participant Non-compliance|0|||
155457358|NCT00696436|561097146|FG001|Overall Study|Participant Non-compliance|0|||
155457359|NCT00696436|561097147|FG002|Overall Study|Participant Non-compliance|1|||
155457360|NCT00696436|561097148|FG003|Overall Study|Participant Non-compliance|2|||
155457361|NCT00696436|561097149|FG004|Overall Study|Participant Non-compliance|0|||
155457362|NCT00696436|561097145|FG000|Overall Study|Administrative Decision|1|||
155457363|NCT00696436|561097146|FG001|Overall Study|Administrative Decision|0|||
155457364|NCT00696436|561097147|FG002|Overall Study|Administrative Decision|0|||
155457365|NCT00696436|561097148|FG003|Overall Study|Administrative Decision|0|||
155457366|NCT00696436|561097149|FG004|Overall Study|Administrative Decision|0|||
155457367|NCT00696436|561097145|FG000|Overall Study|Missing|0|||
155457368|NCT00696436|561097146|FG001|Overall Study|Missing|1|||
155457369|NCT00696436|561097147|FG002|Overall Study|Missing|1|||
155457370|NCT00696436|561097148|FG003|Overall Study|Missing|0|||
155457371|NCT00696436|561097149|FG004|Overall Study|Missing|0|||
155457372|NCT03039738|561097153|FG000|Overall Study|Incomplete data sets|54|||
155457373|NCT03039738|561097154|FG001|Overall Study|Incomplete data sets|0|||
155457374|NCT00912340|561097155|FG000|Overall Study|Adverse Event|2|||
155457375|NCT00912340|561097156|FG001|Overall Study|Adverse Event|4|||
155457376|NCT00912340|561097157|FG002|Overall Study|Adverse Event|0|||
155457377|NCT00912340|561097155|FG000|Overall Study|Protocol revised to remove arm|0|||
155457378|NCT00912340|561097156|FG001|Overall Study|Protocol revised to remove arm|0|||
155457379|NCT00912340|561097157|FG002|Overall Study|Protocol revised to remove arm|4|||
155457380|NCT01517412|561097160|FG000|Overall Study|Adverse Event|10|||
155457381|NCT01517412|561097161|FG001|Overall Study|Adverse Event|11|||
155651862|NCT03111108|561818184|FG000|Overall Study|Death|0|||
155651863|NCT03111108|561818185|FG001|Overall Study|Death|1|||
155651864|NCT03111108|561818184|FG000|Overall Study|Withdrawal by Subject|1|||
155457382|NCT01517412|561097160|FG000|Overall Study|Lack of Efficacy|10|||
155457383|NCT01517412|561097161|FG001|Overall Study|Lack of Efficacy|5|||
155457384|NCT01517412|561097160|FG000|Overall Study|Poor compliance to protocol|8|||
155457385|NCT01517412|561097161|FG001|Overall Study|Poor compliance to protocol|3|||
155457386|NCT01517412|561097160|FG000|Overall Study|Other than specified above|8|||
155457387|NCT01517412|561097161|FG001|Overall Study|Other than specified above|5|||
155457388|NCT01253187|561097162|FG000|Period 2|Withdrawal by Subject|0|||
155457389|NCT01253187|561097163|FG001|Period 2|Withdrawal by Subject|0|||
155651865|NCT03111108|561818185|FG001|Overall Study|Withdrawal by Subject|0|||
155651866|NCT01514357|561818186|FG000|Overall Study|Screen failure|2|||
155651867|NCT01514357|561818187|FG001|Overall Study|Screen failure|0|||
155651868|NCT01514357|561818186|FG000|Overall Study|Withdrawal by Subject|2|||
155651869|NCT01514357|561818187|FG001|Overall Study|Withdrawal by Subject|0|||
155651870|NCT04893811|561818188|FG000|Vaccination Phase|Death|1|||
155651871|NCT04893811|561818189|FG001|Vaccination Phase|Death|0|||
155651872|NCT04893811|561818188|FG000|Vaccination Phase|Lost to Follow-up|1|||
155651873|NCT04893811|561818189|FG001|Vaccination Phase|Lost to Follow-up|1|||
155651874|NCT04893811|561818188|FG000|Vaccination Phase|Protocol Violation|2|||
155651875|NCT04893811|561818189|FG001|Vaccination Phase|Protocol Violation|0|||
155651876|NCT04893811|561818188|FG000|Vaccination Phase|Withdrawal by Subject|2|||
155651877|NCT04893811|561818189|FG001|Vaccination Phase|Withdrawal by Subject|1|||
155651878|NCT04893811|561818188|FG000|Vaccination Phase|Other|0|||
155651879|NCT04893811|561818189|FG001|Vaccination Phase|Other|1|||
155651880|NCT04893811|561818188|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
155651881|NCT04893811|561818189|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
155651882|NCT04893811|561818188|FG000|Follow-up Phase|Lost to Follow-up|0|||
155651883|NCT04893811|561818189|FG001|Follow-up Phase|Lost to Follow-up|1|||
155651884|NCT02739828|561818190|FG000|Overall Study|Adverse Event|1|||
155651885|NCT02739828|561818190|FG000|Overall Study|Lost to Follow-up|4|||
155651886|NCT04191733|561818198|FG000|Overall Study|Withdrawn due to study closure|13|||
155651887|NCT04191733|561818199|FG001|Overall Study|Withdrawn due to study closure|14|||
155651888|NCT04191733|561818198|FG000|Overall Study|Withdrawal by Subject|2|||
155651889|NCT04191733|561818199|FG001|Overall Study|Withdrawal by Subject|4|||
155651890|NCT04191733|561818198|FG000|Overall Study|Physician Decision|1|||
155651891|NCT04191733|561818199|FG001|Overall Study|Physician Decision|1|||
155651892|NCT04191733|561818198|FG000|Overall Study|Lost to Follow-up|5|||
155651893|NCT04191733|561818199|FG001|Overall Study|Lost to Follow-up|6|||
155651894|NCT04191733|561818198|FG000|Overall Study|Death|0|||
155651895|NCT04191733|561818199|FG001|Overall Study|Death|1|||
155651896|NCT02202577|561818200|FG000|Overall Study|Lost to Follow-up|6|||
155651897|NCT02202577|561818201|FG001|Overall Study|Lost to Follow-up|16|||
155651898|NCT02202577|561818200|FG000|Overall Study|Protocol Violation|7|||
155651899|NCT02202577|561818201|FG001|Overall Study|Protocol Violation|3|||
155651900|NCT03878602|561818202|FG000|Overall Study|cord blood donation|7|||
155651901|NCT03878602|561818203|FG001|Overall Study|cord blood donation|1|||
155651902|NCT03878602|561818202|FG000|Overall Study|incomplete data collection|2|||
155651903|NCT03878602|561818203|FG001|Overall Study|incomplete data collection|0|||
155651904|NCT02100644|561818204|FG000|LTG Escalation Phase|Adverse Event|9|||
155651905|NCT02100644|561818205|FG001|LTG Escalation Phase|Adverse Event|0|||
155651906|NCT02100644|561818206|FG002|LTG Escalation Phase|Adverse Event|0|||
155651907|NCT02100644|561818204|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
155651908|NCT02100644|561818205|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
155651909|NCT02100644|561818206|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
155651910|NCT02100644|561818204|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
155651911|NCT02100644|561818205|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
155651912|NCT02100644|561818206|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
155651913|NCT00478140|561818207|FG000|Overall Study|Clinical Disease Progression|1|||
155651914|NCT01898091|561818210|FG000|Overall Study|Lost to Follow-up|1|||
155651915|NCT01898091|561818211|FG001|Overall Study|Lost to Follow-up|1|||
155651916|NCT01898091|561818210|FG000|Overall Study|Withdrawal by Subject|1|||
155651917|NCT01898091|561818211|FG001|Overall Study|Withdrawal by Subject|5|||
155651918|NCT00563316|561818212|FG000|Overall Study|Adverse Event|2|||
155651919|NCT00563316|561818212|FG000|Overall Study|Physician Decision|1|||
155651920|NCT00563316|561818212|FG000|Overall Study|Lost to Follow-up|2|||
155651921|NCT00563316|561818212|FG000|Overall Study|Death|1|||
155651922|NCT00563316|561818212|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
155651923|NCT00563316|561818212|FG000|Overall Study|Other|1|||
155651924|NCT06048705|561818222|FG000|Overall Study|Physician Decision|1|||
155651925|NCT06048705|561818223|FG001|Overall Study|Physician Decision|0|||
155651926|NCT06048705|561818224|FG002|Overall Study|Physician Decision|0|||
155651927|NCT06048705|561818222|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
155651928|NCT06048705|561818223|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
155651929|NCT06048705|561818224|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
155651930|NCT06048705|561818222|FG000|Overall Study|Death prior to lymphodepletion|0|||
155651931|NCT06048705|561818223|FG001|Overall Study|Death prior to lymphodepletion|0|||
155651932|NCT06048705|561818224|FG002|Overall Study|Death prior to lymphodepletion|1|||
155651933|NCT02614066|561818225|FG000|Overall Study|Death|6|||
155651934|NCT02614066|561818226|FG001|Overall Study|Death|14|||
155651935|NCT02614066|561818227|FG002|Overall Study|Death|11|||
155651936|NCT02614066|561818228|FG003|Overall Study|Death|29|||
155457390|NCT01253187|561097164|FG002|Period 2|Withdrawal by Subject|0|||
155457391|NCT01253187|561097165|FG003|Period 2|Withdrawal by Subject|0|||
155457392|NCT01253187|561097166|FG004|Period 2|Withdrawal by Subject|1|||
155457393|NCT01253187|561097167|FG005|Period 2|Withdrawal by Subject|0|||
155457394|NCT01253187|561097162|FG000|Period 3|Pregnancy|1|||
155457395|NCT01253187|561097163|FG001|Period 3|Pregnancy|0|||
155457396|NCT01253187|561097164|FG002|Period 3|Pregnancy|0|||
155457397|NCT01253187|561097165|FG003|Period 3|Pregnancy|0|||
155457398|NCT01253187|561097166|FG004|Period 3|Pregnancy|0|||
155457399|NCT01253187|561097167|FG005|Period 3|Pregnancy|0|||
155457400|NCT01253187|561097162|FG000|Period 3|difficulty with blood sampling|0|||
155457401|NCT01253187|561097163|FG001|Period 3|difficulty with blood sampling|1|||
155457402|NCT01253187|561097164|FG002|Period 3|difficulty with blood sampling|0|||
155457403|NCT01253187|561097165|FG003|Period 3|difficulty with blood sampling|0|||
155457404|NCT01253187|561097166|FG004|Period 3|difficulty with blood sampling|0|||
155457405|NCT01253187|561097167|FG005|Period 3|difficulty with blood sampling|0|||
155457406|NCT01253187|561097162|FG000|Period 3|non-compliance|0|||
155457407|NCT01253187|561097163|FG001|Period 3|non-compliance|0|||
155457408|NCT01253187|561097164|FG002|Period 3|non-compliance|0|||
155457409|NCT01253187|561097165|FG003|Period 3|non-compliance|0|||
155457410|NCT01253187|561097166|FG004|Period 3|non-compliance|1|||
155457411|NCT01253187|561097167|FG005|Period 3|non-compliance|0|||
155457412|NCT01293006|561097171|FG000|Period 2|Lost to Follow-up|1|||
155457413|NCT01293006|561097172|FG001|Period 2|Lost to Follow-up|0|||
155457414|NCT01293006|561097173|FG002|Period 2|Lost to Follow-up|0|||
155457415|NCT01293006|561097174|FG003|Period 2|Lost to Follow-up|0|||
155457416|NCT01494987|561097175|FG000|Overall Study|Adverse Event|6|||
155457417|NCT01494987|561097176|FG001|Overall Study|Adverse Event|5|||
155457418|NCT01494987|561097175|FG000|Overall Study|Hyperglycemia|6|||
155457419|NCT01494987|561097176|FG001|Overall Study|Hyperglycemia|4|||
155457420|NCT01494987|561097175|FG000|Overall Study|Investigator's Discretion|1|||
155457421|NCT01494987|561097176|FG001|Overall Study|Investigator's Discretion|2|||
155457422|NCT01494987|561097175|FG000|Overall Study|Lost to Follow-up|1|||
155457423|NCT01494987|561097176|FG001|Overall Study|Lost to Follow-up|1|||
155457424|NCT01494987|561097175|FG000|Overall Study|Protocol Violation|3|||
155457425|NCT01494987|561097176|FG001|Overall Study|Protocol Violation|3|||
155457426|NCT01494987|561097175|FG000|Overall Study|Subject Non-Compliance|9|||
155457427|NCT01494987|561097176|FG001|Overall Study|Subject Non-Compliance|10|||
155457428|NCT01494987|561097175|FG000|Overall Study|Subject Withdrew Consent|2|||
155457429|NCT01494987|561097176|FG001|Overall Study|Subject Withdrew Consent|3|||
155457430|NCT00205699|561097180|FG000|Overall Study|Lost to Follow-up|1|||
155457431|NCT00205699|561097181|FG001|Overall Study|Lost to Follow-up|3|||
155457432|NCT00205699|561097182|FG002|Overall Study|Lost to Follow-up|5|||
155457433|NCT00205699|561097180|FG000|Overall Study|Adverse Event|1|||
155457434|NCT00205699|561097181|FG001|Overall Study|Adverse Event|0|||
155457435|NCT00205699|561097182|FG002|Overall Study|Adverse Event|0|||
155457436|NCT00205699|561097180|FG000|Overall Study|Withdrawal by Subject|1|||
155457437|NCT00205699|561097181|FG001|Overall Study|Withdrawal by Subject|2|||
155457438|NCT00205699|561097182|FG002|Overall Study|Withdrawal by Subject|1|||
155457439|NCT00205699|561097180|FG000|Overall Study|Lack of Efficacy|0|||
155457440|NCT00205699|561097181|FG001|Overall Study|Lack of Efficacy|1|||
155457441|NCT00205699|561097182|FG002|Overall Study|Lack of Efficacy|0|||
155457442|NCT01885078|561097183|FG000|Treatment Period|Adverse Event|52|||
155457443|NCT01885078|561097184|FG001|Treatment Period|Adverse Event|136|||
155457444|NCT01885078|561097185|FG002|Treatment Period|Adverse Event|30|||
155457445|NCT01885078|561097186|FG003|Treatment Period|Adverse Event|73|||
155651937|NCT02614066|561818225|FG000|Overall Study|Full consent withdrawn|0|||
155457446|NCT01885078|561097187|FG004|Treatment Period|Adverse Event|17|||
155457447|NCT01885078|561097188|FG005|Treatment Period|Adverse Event|72|||
155457448|NCT01885078|561097189|FG006|Treatment Period|Adverse Event|24|||
155457449|NCT01885078|561097190|FG007|Treatment Period|Adverse Event|5|||
155457450|NCT01885078|561097191|FG008|Treatment Period|Adverse Event|0|||
155457451|NCT01885078|561097192|FG009|Treatment Period|Adverse Event|0|||
155457452|NCT01885078|561097183|FG000|Treatment Period|Death|13|||
155457453|NCT01885078|561097184|FG001|Treatment Period|Death|33|||
155457454|NCT01885078|561097185|FG002|Treatment Period|Death|5|||
155457455|NCT01885078|561097186|FG003|Treatment Period|Death|9|||
155651938|NCT02614066|561818226|FG001|Overall Study|Full consent withdrawn|1|||
155457456|NCT01885078|561097187|FG004|Treatment Period|Death|2|||
155457457|NCT01885078|561097188|FG005|Treatment Period|Death|10|||
155457458|NCT01885078|561097189|FG006|Treatment Period|Death|3|||
155457459|NCT01885078|561097190|FG007|Treatment Period|Death|2|||
155651939|NCT02614066|561818227|FG002|Overall Study|Full consent withdrawn|0|||
155457460|NCT01885078|561097191|FG008|Treatment Period|Death|0|||
155457461|NCT01885078|561097192|FG009|Treatment Period|Death|0|||
155457462|NCT01885078|561097183|FG000|Treatment Period|Lack of Efficacy|12|||
155457463|NCT01885078|561097184|FG001|Treatment Period|Lack of Efficacy|33|||
155457464|NCT01885078|561097185|FG002|Treatment Period|Lack of Efficacy|10|||
155457465|NCT01885078|561097186|FG003|Treatment Period|Lack of Efficacy|23|||
155457466|NCT01885078|561097187|FG004|Treatment Period|Lack of Efficacy|24|||
155515851|NCT00679783|561313594|FG004|Overall Study|Lack of Efficacy|0|||
155515852|NCT00679783|561313595|FG005|Overall Study|Lack of Efficacy|0|||
155515853|NCT00679783|561313596|FG006|Overall Study|Lack of Efficacy|0|||
155457467|NCT01885078|561097188|FG005|Treatment Period|Lack of Efficacy|58|||
155457468|NCT01885078|561097189|FG006|Treatment Period|Lack of Efficacy|9|||
155457469|NCT01885078|561097190|FG007|Treatment Period|Lack of Efficacy|5|||
155457470|NCT01885078|561097191|FG008|Treatment Period|Lack of Efficacy|0|||
155457471|NCT01885078|561097192|FG009|Treatment Period|Lack of Efficacy|0|||
155457472|NCT01885078|561097183|FG000|Treatment Period|Lost to Follow-up|16|||
155457473|NCT01885078|561097184|FG001|Treatment Period|Lost to Follow-up|19|||
155457474|NCT01885078|561097185|FG002|Treatment Period|Lost to Follow-up|7|||
155457475|NCT01885078|561097186|FG003|Treatment Period|Lost to Follow-up|9|||
155457476|NCT01885078|561097187|FG004|Treatment Period|Lost to Follow-up|2|||
155457477|NCT01885078|561097188|FG005|Treatment Period|Lost to Follow-up|8|||
155457478|NCT01885078|561097189|FG006|Treatment Period|Lost to Follow-up|2|||
155457479|NCT01885078|561097190|FG007|Treatment Period|Lost to Follow-up|0|||
155457480|NCT01885078|561097191|FG008|Treatment Period|Lost to Follow-up|0|||
155457481|NCT01885078|561097192|FG009|Treatment Period|Lost to Follow-up|0|||
155457482|NCT01885078|561097183|FG000|Treatment Period|Physician Decision|19|||
155457483|NCT01885078|561097184|FG001|Treatment Period|Physician Decision|21|||
155457484|NCT01885078|561097185|FG002|Treatment Period|Physician Decision|5|||
155457485|NCT01885078|561097186|FG003|Treatment Period|Physician Decision|12|||
155457486|NCT01885078|561097187|FG004|Treatment Period|Physician Decision|9|||
155457487|NCT01885078|561097188|FG005|Treatment Period|Physician Decision|24|||
155457488|NCT01885078|561097189|FG006|Treatment Period|Physician Decision|4|||
155457489|NCT01885078|561097190|FG007|Treatment Period|Physician Decision|3|||
155457490|NCT01885078|561097191|FG008|Treatment Period|Physician Decision|0|||
155457491|NCT01885078|561097192|FG009|Treatment Period|Physician Decision|0|||
155457492|NCT01885078|561097183|FG000|Treatment Period|Protocol Violation|3|||
155457493|NCT01885078|561097184|FG001|Treatment Period|Protocol Violation|5|||
155457494|NCT01885078|561097185|FG002|Treatment Period|Protocol Violation|0|||
155457495|NCT01885078|561097186|FG003|Treatment Period|Protocol Violation|3|||
155457496|NCT01885078|561097187|FG004|Treatment Period|Protocol Violation|1|||
155457497|NCT01885078|561097188|FG005|Treatment Period|Protocol Violation|6|||
155457498|NCT01885078|561097189|FG006|Treatment Period|Protocol Violation|0|||
155457499|NCT01885078|561097190|FG007|Treatment Period|Protocol Violation|0|||
155457500|NCT01885078|561097191|FG008|Treatment Period|Protocol Violation|0|||
155457501|NCT01885078|561097192|FG009|Treatment Period|Protocol Violation|0|||
155457502|NCT01885078|561097183|FG000|Treatment Period|Sponsor Decision|245|||
155457503|NCT01885078|561097184|FG001|Treatment Period|Sponsor Decision|648|||
155457504|NCT01885078|561097185|FG002|Treatment Period|Sponsor Decision|49|||
155515854|NCT00679783|561313590|FG000|Overall Study|Withdrawal by Subject|0|||
155457505|NCT01885078|561097186|FG003|Treatment Period|Sponsor Decision|90|||
155515855|NCT00679783|561313591|FG001|Overall Study|Withdrawal by Subject|0|||
155515856|NCT00679783|561313592|FG002|Overall Study|Withdrawal by Subject|1|||
155515857|NCT00679783|561313593|FG003|Overall Study|Withdrawal by Subject|1|||
155515858|NCT00679783|561313594|FG004|Overall Study|Withdrawal by Subject|0|||
155515859|NCT00679783|561313595|FG005|Overall Study|Withdrawal by Subject|0|||
155457506|NCT01885078|561097187|FG004|Treatment Period|Sponsor Decision|20|||
155457507|NCT01885078|561097188|FG005|Treatment Period|Sponsor Decision|38|||
155457508|NCT01885078|561097189|FG006|Treatment Period|Sponsor Decision|162|||
155515860|NCT00679783|561313596|FG006|Overall Study|Withdrawal by Subject|0|||
155457509|NCT01885078|561097190|FG007|Treatment Period|Sponsor Decision|3|||
155457510|NCT01885078|561097191|FG008|Treatment Period|Sponsor Decision|0|||
155457511|NCT01885078|561097192|FG009|Treatment Period|Sponsor Decision|0|||
155457512|NCT01885078|561097183|FG000|Treatment Period|Withdrawal by Subject|72|||
155457513|NCT01885078|561097184|FG001|Treatment Period|Withdrawal by Subject|132|||
155457514|NCT01885078|561097185|FG002|Treatment Period|Withdrawal by Subject|25|||
155457515|NCT01885078|561097186|FG003|Treatment Period|Withdrawal by Subject|63|||
155457516|NCT01885078|561097187|FG004|Treatment Period|Withdrawal by Subject|15|||
155457517|NCT01885078|561097188|FG005|Treatment Period|Withdrawal by Subject|34|||
155457518|NCT01885078|561097189|FG006|Treatment Period|Withdrawal by Subject|17|||
155457519|NCT01885078|561097190|FG007|Treatment Period|Withdrawal by Subject|10|||
155457520|NCT01885078|561097191|FG008|Treatment Period|Withdrawal by Subject|0|||
155457521|NCT01885078|561097192|FG009|Treatment Period|Withdrawal by Subject|0|||
155457522|NCT01885078|561097183|FG000|Treatment Period|Other|0|||
155457523|NCT01885078|561097184|FG001|Treatment Period|Other|0|||
155457524|NCT01885078|561097185|FG002|Treatment Period|Other|0|||
155457525|NCT01885078|561097186|FG003|Treatment Period|Other|1|||
155457526|NCT01885078|561097187|FG004|Treatment Period|Other|0|||
155457527|NCT01885078|561097188|FG005|Treatment Period|Other|0|||
155457528|NCT01885078|561097189|FG006|Treatment Period|Other|0|||
155457529|NCT01885078|561097190|FG007|Treatment Period|Other|0|||
155457530|NCT01885078|561097191|FG008|Treatment Period|Other|0|||
155457531|NCT01885078|561097192|FG009|Treatment Period|Other|0|||
155457532|NCT01885078|561097183|FG000|Step-down Period|Sponsor Decision|0|||
155457533|NCT01885078|561097184|FG001|Step-down Period|Sponsor Decision|0|||
155457534|NCT01885078|561097185|FG002|Step-down Period|Sponsor Decision|0|||
155457535|NCT01885078|561097186|FG003|Step-down Period|Sponsor Decision|0|||
155457536|NCT01885078|561097187|FG004|Step-down Period|Sponsor Decision|0|||
155457537|NCT01885078|561097188|FG005|Step-down Period|Sponsor Decision|0|||
155457538|NCT01885078|561097189|FG006|Step-down Period|Sponsor Decision|0|||
155457539|NCT01885078|561097190|FG007|Step-down Period|Sponsor Decision|0|||
155457540|NCT01885078|561097191|FG008|Step-down Period|Sponsor Decision|1|||
155457541|NCT01885078|561097192|FG009|Step-down Period|Sponsor Decision|1|||
155457542|NCT01885078|561097183|FG000|Step-down Period|Adverse Event|0|||
155457543|NCT01885078|561097184|FG001|Step-down Period|Adverse Event|0|||
155457544|NCT01885078|561097185|FG002|Step-down Period|Adverse Event|0|||
155457545|NCT01885078|561097186|FG003|Step-down Period|Adverse Event|0|||
155457546|NCT01885078|561097187|FG004|Step-down Period|Adverse Event|0|||
155457547|NCT01885078|561097188|FG005|Step-down Period|Adverse Event|0|||
155457548|NCT01885078|561097189|FG006|Step-down Period|Adverse Event|0|||
155457549|NCT01885078|561097190|FG007|Step-down Period|Adverse Event|0|||
155457550|NCT01885078|561097191|FG008|Step-down Period|Adverse Event|29|||
155457551|NCT01885078|561097192|FG009|Step-down Period|Adverse Event|38|||
155515861|NCT00679783|561313590|FG000|Overall Study|Not Captured|0|||
155515862|NCT00679783|561313591|FG001|Overall Study|Not Captured|0|||
155515863|NCT00679783|561313592|FG002|Overall Study|Not Captured|0|||
155515864|NCT00679783|561313593|FG003|Overall Study|Not Captured|5|||
155515865|NCT00679783|561313594|FG004|Overall Study|Not Captured|0|||
155515866|NCT00679783|561313595|FG005|Overall Study|Not Captured|0|||
155515867|NCT00679783|561313596|FG006|Overall Study|Not Captured|0|||
155515868|NCT00679783|561313590|FG000|Overall Study|Ongoing at data cut-off|2|||
155515869|NCT00679783|561313591|FG001|Overall Study|Ongoing at data cut-off|2|||
155515870|NCT00679783|561313592|FG002|Overall Study|Ongoing at data cut-off|0|||
155515871|NCT00679783|561313593|FG003|Overall Study|Ongoing at data cut-off|9|||
155515872|NCT00679783|561313594|FG004|Overall Study|Ongoing at data cut-off|1|||
155515873|NCT00679783|561313595|FG005|Overall Study|Ongoing at data cut-off|0|||
155515874|NCT00679783|561313596|FG006|Overall Study|Ongoing at data cut-off|0|||
155515875|NCT02626949|561313597|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
155515876|NCT02626949|561313598|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
155515877|NCT02626949|561313597|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
155515878|NCT02626949|561313598|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
155515879|NCT02626949|561313597|FG000|Enrolled|Lost to Follow-up|7|||
155515880|NCT02626949|561313598|FG001|Enrolled|Lost to Follow-up|6|||
155515881|NCT02626949|561313597|FG000|Enrolled|Withdrawal by Subject|3|||
155515882|NCT02626949|561313598|FG001|Enrolled|Withdrawal by Subject|2|||
155457552|NCT01885078|561097183|FG000|Step-down Period|Withdrawal by Subject|0|||
155515883|NCT01463683|561313599|FG000|Overall Study|Adverse Event|2|||
155515884|NCT01463683|561313600|FG001|Overall Study|Adverse Event|0|||
155515885|NCT01463683|561313601|FG002|Overall Study|Adverse Event|0|||
155515886|NCT01463683|561313599|FG000|Overall Study|Lost to Follow-up|10|||
155457553|NCT01885078|561097184|FG001|Step-down Period|Withdrawal by Subject|0|||
155457554|NCT01885078|561097185|FG002|Step-down Period|Withdrawal by Subject|0|||
155457555|NCT01885078|561097186|FG003|Step-down Period|Withdrawal by Subject|0|||
155457556|NCT01885078|561097187|FG004|Step-down Period|Withdrawal by Subject|0|||
155457557|NCT01885078|561097188|FG005|Step-down Period|Withdrawal by Subject|0|||
155457558|NCT01885078|561097189|FG006|Step-down Period|Withdrawal by Subject|0|||
155457559|NCT01885078|561097190|FG007|Step-down Period|Withdrawal by Subject|0|||
155457560|NCT01885078|561097191|FG008|Step-down Period|Withdrawal by Subject|25|||
155457561|NCT01885078|561097192|FG009|Step-down Period|Withdrawal by Subject|15|||
155457562|NCT01885078|561097183|FG000|Step-down Period|Physician Decision|0|||
155457563|NCT01885078|561097184|FG001|Step-down Period|Physician Decision|0|||
155457564|NCT01885078|561097185|FG002|Step-down Period|Physician Decision|0|||
155457565|NCT01885078|561097186|FG003|Step-down Period|Physician Decision|0|||
155457566|NCT01885078|561097187|FG004|Step-down Period|Physician Decision|0|||
155457567|NCT01885078|561097188|FG005|Step-down Period|Physician Decision|0|||
155457568|NCT01885078|561097189|FG006|Step-down Period|Physician Decision|0|||
155457569|NCT01885078|561097190|FG007|Step-down Period|Physician Decision|0|||
155457570|NCT01885078|561097191|FG008|Step-down Period|Physician Decision|7|||
155457571|NCT01885078|561097192|FG009|Step-down Period|Physician Decision|2|||
155457572|NCT01885078|561097183|FG000|Step-down Period|Death|0|||
155457573|NCT01885078|561097184|FG001|Step-down Period|Death|0|||
155457574|NCT01885078|561097185|FG002|Step-down Period|Death|0|||
155457575|NCT01885078|561097186|FG003|Step-down Period|Death|0|||
155457576|NCT01885078|561097187|FG004|Step-down Period|Death|0|||
155457577|NCT01885078|561097188|FG005|Step-down Period|Death|0|||
155457578|NCT01885078|561097189|FG006|Step-down Period|Death|0|||
155457579|NCT01885078|561097190|FG007|Step-down Period|Death|0|||
155457580|NCT01885078|561097191|FG008|Step-down Period|Death|4|||
155457581|NCT01885078|561097192|FG009|Step-down Period|Death|3|||
155457582|NCT01885078|561097183|FG000|Step-down Period|Lost to Follow-up|0|||
155457583|NCT01885078|561097184|FG001|Step-down Period|Lost to Follow-up|0|||
155457584|NCT01885078|561097185|FG002|Step-down Period|Lost to Follow-up|0|||
155457585|NCT01885078|561097186|FG003|Step-down Period|Lost to Follow-up|0|||
155457586|NCT01885078|561097187|FG004|Step-down Period|Lost to Follow-up|0|||
155457587|NCT01885078|561097188|FG005|Step-down Period|Lost to Follow-up|0|||
155457588|NCT01885078|561097189|FG006|Step-down Period|Lost to Follow-up|0|||
155457589|NCT01885078|561097190|FG007|Step-down Period|Lost to Follow-up|0|||
155457590|NCT01885078|561097191|FG008|Step-down Period|Lost to Follow-up|1|||
155457591|NCT01885078|561097192|FG009|Step-down Period|Lost to Follow-up|1|||
155457592|NCT01885078|561097183|FG000|Step-down Period|Lack of Efficacy|0|||
155457593|NCT01885078|561097184|FG001|Step-down Period|Lack of Efficacy|0|||
155457594|NCT01885078|561097185|FG002|Step-down Period|Lack of Efficacy|0|||
155457595|NCT01885078|561097186|FG003|Step-down Period|Lack of Efficacy|0|||
155457596|NCT01885078|561097187|FG004|Step-down Period|Lack of Efficacy|0|||
155457597|NCT01885078|561097188|FG005|Step-down Period|Lack of Efficacy|0|||
155515887|NCT01463683|561313600|FG001|Overall Study|Lost to Follow-up|9|||
155515888|NCT01463683|561313601|FG002|Overall Study|Lost to Follow-up|7|||
155515889|NCT01463683|561313599|FG000|Overall Study|Physician Decision|0|||
155515890|NCT01463683|561313600|FG001|Overall Study|Physician Decision|3|||
155515891|NCT01463683|561313601|FG002|Overall Study|Physician Decision|1|||
155515892|NCT01463683|561313599|FG000|Overall Study|Pregnancy|2|||
155515893|NCT01463683|561313600|FG001|Overall Study|Pregnancy|2|||
155515894|NCT01463683|561313601|FG002|Overall Study|Pregnancy|1|||
155515895|NCT01463683|561313599|FG000|Overall Study|Withdrawal by Subject|5|||
155515896|NCT01463683|561313600|FG001|Overall Study|Withdrawal by Subject|17|||
155515897|NCT01463683|561313601|FG002|Overall Study|Withdrawal by Subject|2|||
155515898|NCT01691859|561315670|FG000|Overall Study|Adverse Event|19|||
155515899|NCT01691859|561315670|FG000|Overall Study|Lack of Efficacy|11|||
155515900|NCT01691859|561315670|FG000|Overall Study|Protocol Violation|4|||
155515901|NCT01691859|561315670|FG000|Overall Study|Product commercially available|221|||
155457598|NCT01885078|561097189|FG006|Step-down Period|Lack of Efficacy|0|||
155515902|NCT01691859|561315670|FG000|Overall Study|Study closed/terminated|50|||
155515903|NCT01691859|561315670|FG000|Overall Study|Lost to Follow-up|5|||
155515904|NCT01691859|561315670|FG000|Overall Study|Physician Decision|6|||
155457599|NCT01885078|561097190|FG007|Step-down Period|Lack of Efficacy|0|||
155457600|NCT01885078|561097191|FG008|Step-down Period|Lack of Efficacy|1|||
155457601|NCT01885078|561097192|FG009|Step-down Period|Lack of Efficacy|0|||
155457602|NCT01885078|561097183|FG000|Step-down Period|Protocol Violation|0|||
155457603|NCT01885078|561097184|FG001|Step-down Period|Protocol Violation|0|||
155457604|NCT01885078|561097185|FG002|Step-down Period|Protocol Violation|0|||
155457605|NCT01885078|561097186|FG003|Step-down Period|Protocol Violation|0|||
155457606|NCT01885078|561097187|FG004|Step-down Period|Protocol Violation|0|||
155457607|NCT01885078|561097188|FG005|Step-down Period|Protocol Violation|0|||
155457608|NCT01885078|561097189|FG006|Step-down Period|Protocol Violation|0|||
155457609|NCT01885078|561097190|FG007|Step-down Period|Protocol Violation|0|||
155457610|NCT01885078|561097191|FG008|Step-down Period|Protocol Violation|1|||
155457611|NCT01885078|561097192|FG009|Step-down Period|Protocol Violation|1|||
155457612|NCT01895452|561097193|FG000|Overall Study|Adverse Event|1|||
155457613|NCT01895452|561097194|FG001|Overall Study|Adverse Event|4|||
155457614|NCT01895452|561097193|FG000|Overall Study|Lost to Follow-up|1|||
155457615|NCT01895452|561097194|FG001|Overall Study|Lost to Follow-up|5|||
155457616|NCT01895452|561097193|FG000|Overall Study|Pregnancy|0|||
155457617|NCT01895452|561097194|FG001|Overall Study|Pregnancy|1|||
155515905|NCT01691859|561315670|FG000|Overall Study|Withdrawal by Subject|31|||
155515906|NCT00278200|561315671|FG000|Overall Study|Death|1|||
155515907|NCT00278200|561315672|FG001|Overall Study|Death|3|||
155515908|NCT00278200|561315671|FG000|Overall Study|Physician Decision|0|||
155515909|NCT00278200|561315672|FG001|Overall Study|Physician Decision|1|||
155515910|NCT03519256|561315680|FG000|Overall Study|Disease recurrence|4|||
155515911|NCT03519256|561315681|FG001|Overall Study|Disease recurrence|4|||
155515912|NCT03519256|561315682|FG002|Overall Study|Disease recurrence|5|||
155515913|NCT03519256|561315683|FG003|Overall Study|Disease recurrence|2|||
155515914|NCT03519256|561315680|FG000|Overall Study|Study drug toxicity|0|||
155515915|NCT03519256|561315681|FG001|Overall Study|Study drug toxicity|2|||
155515916|NCT03519256|561315682|FG002|Overall Study|Study drug toxicity|5|||
155515917|NCT03519256|561315683|FG003|Overall Study|Study drug toxicity|2|||
155515918|NCT03519256|561315680|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155515919|NCT03519256|561315681|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155515920|NCT03519256|561315682|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155515921|NCT03519256|561315683|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155515922|NCT03519256|561315680|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155515923|NCT03519256|561315681|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155515924|NCT03519256|561315682|FG002|Overall Study|Participant request to discontinue study treatment|0|||
155515925|NCT03519256|561315683|FG003|Overall Study|Participant request to discontinue study treatment|2|||
155515926|NCT03519256|561315680|FG000|Overall Study|Other reasons|0|||
155515927|NCT03519256|561315681|FG001|Overall Study|Other reasons|0|||
155515928|NCT03519256|561315682|FG002|Overall Study|Other reasons|2|||
155515929|NCT03519256|561315683|FG003|Overall Study|Other reasons|0|||
155515930|NCT03519256|561315680|FG000|Overall Study|Disease progression|6|||
155515931|NCT03519256|561315681|FG001|Overall Study|Disease progression|3|||
155515932|NCT03519256|561315682|FG002|Overall Study|Disease progression|2|||
155515933|NCT03519256|561315683|FG003|Overall Study|Disease progression|1|||
155515934|NCT03519256|561315680|FG000|Overall Study|Lost to Follow-up|0|||
155515935|NCT03519256|561315681|FG001|Overall Study|Lost to Follow-up|1|||
155515936|NCT03519256|561315682|FG002|Overall Study|Lost to Follow-up|0|||
155515937|NCT03519256|561315683|FG003|Overall Study|Lost to Follow-up|0|||
155515938|NCT00421174|561315684|FG000|Overall Study|Withdrawal by Subject|0|||
155515939|NCT00421174|561315685|FG001|Overall Study|Withdrawal by Subject|1|||
155515940|NCT00421174|561315684|FG000|Overall Study|Ineligible due to infection|2|||
155515941|NCT00421174|561315685|FG001|Overall Study|Ineligible due to infection|0|||
155515942|NCT01631864|561315686|FG000|Overall Study|Withdrawal by Subject|0|||
155515943|NCT01631864|561315687|FG001|Overall Study|Withdrawal by Subject|1|||
155515944|NCT01631864|561315686|FG000|Overall Study|Adverse Event|2|||
155515945|NCT01631864|561315687|FG001|Overall Study|Adverse Event|3|||
155515946|NCT01031537|561315688|FG000|Overall Study|medical reasons not related to study|3|||
155515947|NCT01031537|561315688|FG000|Overall Study|Lack of Efficacy|1|||
155515948|NCT01031537|561315688|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
155515949|NCT01031537|561315688|FG000|Overall Study|moved, met exclusion criteria|10|||
155515950|NCT01031537|561315688|FG000|Overall Study|Withdrawal by Subject|5|||
155457618|NCT01895452|561097193|FG000|Overall Study|Withdrawal by Subject|2|||
155457619|NCT01895452|561097194|FG001|Overall Study|Withdrawal by Subject|14|||
155457620|NCT01895452|561097193|FG000|Overall Study|Underlying disease|0|||
155457621|NCT01895452|561097194|FG001|Overall Study|Underlying disease|3|||
155457622|NCT01895452|561097193|FG000|Overall Study|Noncompliance with study drug|0|||
155515951|NCT01031537|561315688|FG000|Overall Study|PI removal, no longer met eligibility|12|||
155515952|NCT02750761|561315712|FG000|Overall Study|Lost to Follow-up|0|||
155515953|NCT02750761|561315713|FG001|Overall Study|Lost to Follow-up|0|||
155515954|NCT02750761|561315714|FG002|Overall Study|Lost to Follow-up|1|||
155515955|NCT02750761|561315715|FG003|Overall Study|Lost to Follow-up|0|||
155515956|NCT02750761|561315716|FG004|Overall Study|Lost to Follow-up|0|||
155457623|NCT01895452|561097194|FG001|Overall Study|Noncompliance with study drug|1|||
155457624|NCT01653158|561097195|FG000|Overall Study|Death|0|||
155457625|NCT01653158|561097196|FG001|Overall Study|Death|0|||
155651940|NCT02614066|561818228|FG003|Overall Study|Full consent withdrawn|8|||
155651941|NCT02614066|561818225|FG000|Overall Study|Lost to Follow-up|0|||
155651942|NCT02614066|561818226|FG001|Overall Study|Lost to Follow-up|2|||
155651943|NCT02614066|561818227|FG002|Overall Study|Lost to Follow-up|2|||
155651944|NCT02614066|561818228|FG003|Overall Study|Lost to Follow-up|2|||
155651945|NCT02614066|561818225|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
155651946|NCT02614066|561818226|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
155651947|NCT02614066|561818227|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
155651948|NCT02614066|561818228|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
155651949|NCT02614066|561818225|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
155651950|NCT02614066|561818226|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
155651951|NCT02614066|561818227|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
155651952|NCT02614066|561818228|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
155651953|NCT02614066|561818225|FG000|Overall Study|Reason not specified|0|||
155651954|NCT02614066|561818226|FG001|Overall Study|Reason not specified|2|||
155651955|NCT02614066|561818227|FG002|Overall Study|Reason not specified|1|||
155651956|NCT02614066|561818228|FG003|Overall Study|Reason not specified|1|||
155651957|NCT04565756|561818229|FG000|Overall Study|Withdrawal by Subject|0|||
155651958|NCT04565756|561818230|FG001|Overall Study|Withdrawal by Subject|0|||
155651959|NCT04565756|561818231|FG002|Overall Study|Withdrawal by Subject|0|||
155651960|NCT04565756|561818232|FG003|Overall Study|Withdrawal by Subject|0|||
155651961|NCT04565756|561818233|FG004|Overall Study|Withdrawal by Subject|1|||
155651962|NCT04565756|561818234|FG005|Overall Study|Withdrawal by Subject|0|||
155651963|NCT04565756|561818229|FG000|Overall Study|Protocol Violation|0|||
155651964|NCT04565756|561818230|FG001|Overall Study|Protocol Violation|0|||
155651965|NCT04565756|561818231|FG002|Overall Study|Protocol Violation|0|||
155651966|NCT04565756|561818232|FG003|Overall Study|Protocol Violation|0|||
155651967|NCT04565756|561818233|FG004|Overall Study|Protocol Violation|0|||
155651968|NCT04565756|561818234|FG005|Overall Study|Protocol Violation|1|||
155651969|NCT03378635|561818242|FG000|Overall Study|Adverse Event|1|||
155651970|NCT03378635|561818243|FG001|Overall Study|Adverse Event|0|||
155651971|NCT03378635|561818244|FG002|Overall Study|Adverse Event|0|||
155651972|NCT03378635|561818242|FG000|Overall Study|Withdrawal by Subject|1|||
155651973|NCT03378635|561818243|FG001|Overall Study|Withdrawal by Subject|0|||
155651974|NCT03378635|561818244|FG002|Overall Study|Withdrawal by Subject|0|||
155651975|NCT02413346|561818245|FG000|Overall Study|Adverse Event|6|||
155651976|NCT02413346|561818246|FG001|Overall Study|Adverse Event|6|||
155651977|NCT02413346|561818245|FG000|Overall Study|Withdrawal by Subject|30|||
155651978|NCT02413346|561818246|FG001|Overall Study|Withdrawal by Subject|40|||
155651979|NCT02413346|561818245|FG000|Overall Study|Lost to Follow-up|17|||
155651980|NCT02413346|561818246|FG001|Overall Study|Lost to Follow-up|21|||
155651981|NCT02413346|561818245|FG000|Overall Study|Protocol Violation|2|||
155651982|NCT02413346|561818246|FG001|Overall Study|Protocol Violation|0|||
155651983|NCT02413346|561818245|FG000|Overall Study|Other Miscellaneous Reasons|4|||
155651984|NCT02413346|561818246|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155651985|NCT02205359|561818247|FG000|Overall Study|Death|293|||
155651986|NCT02205359|561818248|FG001|Overall Study|Death|327|||
155651987|NCT02205359|561818247|FG000|Overall Study|Lost to Follow-up|182|||
155651988|NCT02205359|561818248|FG001|Overall Study|Lost to Follow-up|162|||
155651989|NCT02205359|561818247|FG000|Overall Study|Physician Decision|51|||
155651990|NCT02205359|561818248|FG001|Overall Study|Physician Decision|53|||
155651991|NCT02205359|561818247|FG000|Overall Study|Withdrawal by Subject|167|||
155651992|NCT02205359|561818248|FG001|Overall Study|Withdrawal by Subject|169|||
155651993|NCT02766478|561818250|FG000|Overall Study|Withdrawal by Subject|1|||
155651994|NCT02766478|561818251|FG001|Overall Study|Withdrawal by Subject|1|||
155651995|NCT00089583|561818252|FG000|Overall Study|Adverse Event|0|||
155651996|NCT00089583|561818253|FG001|Overall Study|Adverse Event|3|||
155651997|NCT00089583|561818252|FG000|Overall Study|Insufficient Viral Load Response|5|||
155651998|NCT00089583|561818253|FG001|Overall Study|Insufficient Viral Load Response|5|||
155457626|NCT01653158|561097197|FG002|Overall Study|Death|0|||
155457627|NCT01653158|561097198|FG003|Overall Study|Death|1|||
155457628|NCT01653158|561097199|FG004|Overall Study|Death|0|||
155457629|NCT01653158|561097200|FG005|Overall Study|Death|0|||
155651999|NCT00089583|561818252|FG000|Overall Study|Withdrawal by Subject|0|||
155652000|NCT00089583|561818253|FG001|Overall Study|Withdrawal by Subject|4|||
155457630|NCT01653158|561097201|FG006|Overall Study|Death|0|||
155652001|NCT00089583|561818252|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
155652002|NCT00089583|561818253|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
155652003|NCT00089583|561818252|FG000|Overall Study|Participant Refused Study Medication|0|||
155652004|NCT00089583|561818253|FG001|Overall Study|Participant Refused Study Medication|2|||
155652005|NCT00089583|561818252|FG000|Overall Study|Non-Compliance|0|||
155652006|NCT00089583|561818253|FG001|Overall Study|Non-Compliance|4|||
155652007|NCT00089583|561818252|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
155652008|NCT00089583|561818253|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
155457631|NCT01653158|561097202|FG007|Overall Study|Death|2|||
155457632|NCT01653158|561097195|FG000|Overall Study|Adverse Event|0|||
155457633|NCT01653158|561097196|FG001|Overall Study|Adverse Event|0|||
155457634|NCT01653158|561097197|FG002|Overall Study|Adverse Event|0|||
155457635|NCT01653158|561097198|FG003|Overall Study|Adverse Event|1|||
155457636|NCT01653158|561097199|FG004|Overall Study|Adverse Event|0|||
155457637|NCT01653158|561097200|FG005|Overall Study|Adverse Event|0|||
155457638|NCT01653158|561097201|FG006|Overall Study|Adverse Event|0|||
155457639|NCT01653158|561097202|FG007|Overall Study|Adverse Event|3|||
155457640|NCT01653158|561097195|FG000|Overall Study|Other|0|||
155457641|NCT01653158|561097196|FG001|Overall Study|Other|0|||
155457642|NCT01653158|561097197|FG002|Overall Study|Other|0|||
155457643|NCT01653158|561097198|FG003|Overall Study|Other|0|||
155457644|NCT01653158|561097199|FG004|Overall Study|Other|0|||
155457645|NCT01653158|561097200|FG005|Overall Study|Other|0|||
155457646|NCT01653158|561097201|FG006|Overall Study|Other|0|||
155457647|NCT01653158|561097202|FG007|Overall Study|Other|1|||
155457648|NCT01653158|561097195|FG000|Overall Study|Progressive disease|0|||
155457649|NCT01653158|561097196|FG001|Overall Study|Progressive disease|0|||
155457650|NCT01653158|561097197|FG002|Overall Study|Progressive disease|0|||
155457651|NCT01653158|561097198|FG003|Overall Study|Progressive disease|0|||
155457652|NCT01653158|561097199|FG004|Overall Study|Progressive disease|1|||
155457653|NCT01653158|561097200|FG005|Overall Study|Progressive disease|1|||
155457654|NCT01653158|561097201|FG006|Overall Study|Progressive disease|2|||
155457655|NCT01653158|561097202|FG007|Overall Study|Progressive disease|9|||
155457656|NCT01653158|561097195|FG000|Overall Study|Withdrawal by Subject|1|||
155457657|NCT01653158|561097196|FG001|Overall Study|Withdrawal by Subject|0|||
155457658|NCT01653158|561097197|FG002|Overall Study|Withdrawal by Subject|0|||
155457659|NCT01653158|561097198|FG003|Overall Study|Withdrawal by Subject|0|||
155457660|NCT01653158|561097199|FG004|Overall Study|Withdrawal by Subject|0|||
155457661|NCT01653158|561097200|FG005|Overall Study|Withdrawal by Subject|0|||
155457662|NCT01653158|561097201|FG006|Overall Study|Withdrawal by Subject|0|||
155457663|NCT01653158|561097202|FG007|Overall Study|Withdrawal by Subject|0|||
155457664|NCT04999969|561097203|FG000|Overall Study|Death|76|||
155457665|NCT04999969|561097203|FG000|Overall Study|Progressive Disease|1|||
155457666|NCT04999969|561097203|FG000|Overall Study|Withdrawal by Subject|8|||
155457667|NCT04321252|561097205|FG000|Overall Study|Withdrawal by Subject|0|||
155457668|NCT04321252|561097206|FG001|Overall Study|Withdrawal by Subject|0|||
155457669|NCT04321252|561097207|FG002|Overall Study|Withdrawal by Subject|0|||
155457670|NCT04321252|561097208|FG003|Overall Study|Withdrawal by Subject|0|||
155457671|NCT04321252|561097209|FG004|Overall Study|Withdrawal by Subject|0|||
155457672|NCT04321252|561097210|FG005|Overall Study|Withdrawal by Subject|1|||
155457673|NCT04321252|561097211|FG006|Overall Study|Withdrawal by Subject|0|||
155457674|NCT04321252|561097212|FG007|Overall Study|Withdrawal by Subject|0|||
155457675|NCT04321252|561097213|FG008|Overall Study|Withdrawal by Subject|0|||
155457676|NCT06245044|561097214|FG000|No MI help|Technical issues|18|||
155457677|NCT01658579|561097218|FG000|Treatment Period A|Other|0|||
155457678|NCT01658579|561097219|FG001|Treatment Period A|Other|0|||
155457679|NCT01658579|561097220|FG002|Treatment Period A|Other|1|||
155457680|NCT01658579|561097221|FG003|Treatment Period A|Other|1|||
155457681|NCT01658579|561097218|FG000|Treatment Period A|Adverse Event|1|||
155457682|NCT01658579|561097219|FG001|Treatment Period A|Adverse Event|0|||
155457683|NCT01658579|561097220|FG002|Treatment Period A|Adverse Event|0|||
155457684|NCT01658579|561097221|FG003|Treatment Period A|Adverse Event|0|||
155457685|NCT01658579|561097218|FG000|Treatment Period B|Other|0|||
155457686|NCT01658579|561097219|FG001|Treatment Period B|Other|0|||
155457687|NCT01658579|561097220|FG002|Treatment Period B|Other|0|||
155457688|NCT01658579|561097221|FG003|Treatment Period B|Other|1|||
155457689|NCT05590767|561097222|FG000|Overall Study|Protocol Violation|1|||
155457690|NCT05590767|561097222|FG000|Overall Study|surgery canceled|1|||
155457691|NCT05590767|561097222|FG000|Overall Study|interscalene brachial block not performed|1|||
155457692|NCT01464788|561097223|FG000|Overall Study|Lost to Follow-up|0|||
155515957|NCT02750761|561315717|FG005|Overall Study|Lost to Follow-up|0|||
155457693|NCT01464788|561097224|FG001|Overall Study|Lost to Follow-up|1|||
155457694|NCT01464788|561097225|FG002|Overall Study|Lost to Follow-up|0|||
155457695|NCT01464788|561097223|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
155457696|NCT01464788|561097224|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
155457697|NCT01464788|561097225|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
155457698|NCT01577160|561097227|FG000|Overall Study|Adverse Event|9|||
155457699|NCT01577160|561097227|FG000|Overall Study|Lack of Efficacy|15|||
155457700|NCT01577160|561097227|FG000|Overall Study|Lost to Follow-up|40|||
155457701|NCT01577160|561097227|FG000|Overall Study|Withdrawal by Subject|18|||
155515958|NCT01860976|561315718|FG000|Blinded Treatment|Adverse Event|1|||
155457702|NCT01577160|561097227|FG000|Overall Study|Subject Uncooperative|7|||
155457703|NCT01577160|561097227|FG000|Overall Study|Other|9|||
155457704|NCT01551758|561097228|FG000|Overall Study|Adverse Event|29|||
155457705|NCT01551758|561097229|FG001|Overall Study|Adverse Event|43|||
155457706|NCT01551758|561097228|FG000|Overall Study|Lack of Efficacy|0|||
155457707|NCT01551758|561097229|FG001|Overall Study|Lack of Efficacy|1|||
155457708|NCT01551758|561097228|FG000|Overall Study|Protocol Violation|5|||
155457709|NCT01551758|561097229|FG001|Overall Study|Protocol Violation|6|||
155457710|NCT01551758|561097228|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
155457711|NCT01551758|561097229|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
155457712|NCT01551758|561097228|FG000|Overall Study|Lost to Follow-up|29|||
155457713|NCT01551758|561097229|FG001|Overall Study|Lost to Follow-up|25|||
155457714|NCT01551758|561097228|FG000|Overall Study|Physician Decision|9|||
155457715|NCT01551758|561097229|FG001|Overall Study|Physician Decision|3|||
155457716|NCT01551758|561097228|FG000|Overall Study|Withdrawal by Subject|14|||
155457717|NCT01551758|561097229|FG001|Overall Study|Withdrawal by Subject|17|||
155457718|NCT01586156|561097231|FG000|Overall Study|Pregnancy|0|||
155457719|NCT01586156|561097232|FG001|Overall Study|Pregnancy|1|||
155457720|NCT01586156|561097233|FG002|Overall Study|Pregnancy|0|||
155457721|NCT00363246|561097234|FG000|Overall Study|Death|40|||
155457722|NCT00363246|561097234|FG000|Overall Study|Withdrawal by Subject|19|||
155457723|NCT00363246|561097234|FG000|Overall Study|Lost to Follow-up|14|||
155457724|NCT00363246|561097234|FG000|Overall Study|Bad health|6|||
155457725|NCT00363246|561097234|FG000|Overall Study|Stopped using wheelchair|11|||
155457726|NCT00363246|561097234|FG000|Overall Study|Subject expressed security concerns|2|||
155457727|NCT00363246|561097234|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
155457728|NCT00264849|561097235|FG000|Overall Study|Adverse Event|7|||
155457729|NCT00264849|561097236|FG001|Overall Study|Adverse Event|2|||
155457730|NCT00264849|561097235|FG000|Overall Study|Withdrawal by Subject|7|||
155457731|NCT00264849|561097236|FG001|Overall Study|Withdrawal by Subject|11|||
155457732|NCT00264849|561097235|FG000|Overall Study|Protocol Violation|5|||
155457733|NCT00264849|561097236|FG001|Overall Study|Protocol Violation|3|||
155457734|NCT00264849|561097235|FG000|Overall Study|Lack of Efficacy|1|||
155457735|NCT00264849|561097236|FG001|Overall Study|Lack of Efficacy|6|||
155457736|NCT00264849|561097235|FG000|Overall Study|Lost to Follow-up|0|||
155457737|NCT00264849|561097236|FG001|Overall Study|Lost to Follow-up|2|||
155457738|NCT00264849|561097235|FG000|Overall Study|Death|0|||
155457739|NCT00264849|561097236|FG001|Overall Study|Death|1|||
155457740|NCT00264849|561097235|FG000|Overall Study|Administrative Problems|2|||
155457741|NCT00264849|561097236|FG001|Overall Study|Administrative Problems|0|||
155457742|NCT00717366|561097239|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
155457743|NCT00717366|561097240|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
155457744|NCT00717366|561097239|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
155457745|NCT00717366|561097240|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
155457746|NCT00717366|561097239|FG000|Core Study Period (20 Weeks)|Death|0|||
155457747|NCT00717366|561097240|FG001|Core Study Period (20 Weeks)|Death|1|||
155515959|NCT01860976|561315719|FG001|Blinded Treatment|Adverse Event|3|||
155515960|NCT01860976|561315718|FG000|Blinded Treatment|Lack of Efficacy|5|||
155515961|NCT01860976|561315719|FG001|Blinded Treatment|Lack of Efficacy|12|||
155515962|NCT01860976|561315718|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
155515963|NCT01860976|561315719|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
155515964|NCT01860976|561315718|FG000|Blinded Treatment|Withdrawal by Subject|3|||
155515965|NCT01860976|561315719|FG001|Blinded Treatment|Withdrawal by Subject|5|||
155515966|NCT01860976|561315718|FG000|Blinded Treatment|Subject no longer met criteria|1|||
155515967|NCT01860976|561315719|FG001|Blinded Treatment|Subject no longer met criteria|0|||
155515968|NCT01860976|561315718|FG000|Blinded Treatment|Entered Open-Label in error|0|||
155515969|NCT01860976|561315719|FG001|Blinded Treatment|Entered Open-Label in error|1|||
155515970|NCT01860976|561315718|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
155515971|NCT01860976|561315719|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
155515972|NCT01860976|561315718|FG000|Open-Label|Adverse Event|2|||
155515973|NCT01860976|561315719|FG001|Open-Label|Adverse Event|4|||
155515974|NCT01860976|561315718|FG000|Open-Label|Lack of Efficacy|16|||
155515975|NCT01860976|561315719|FG001|Open-Label|Lack of Efficacy|8|||
155515976|NCT01860976|561315718|FG000|Open-Label|Lost to Follow-up|1|||
155515977|NCT01860976|561315719|FG001|Open-Label|Lost to Follow-up|2|||
155515978|NCT01860976|561315718|FG000|Open-Label|Subject request discontinue treatment|4|||
155515979|NCT01860976|561315719|FG001|Open-Label|Subject request discontinue treatment|3|||
155457748|NCT00717366|561097239|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
155457749|NCT00717366|561097240|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
155457750|NCT00717366|561097239|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
155457751|NCT00717366|561097240|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
155457752|NCT00717366|561097239|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
155457753|NCT00717366|561097240|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
155457754|NCT00717366|561097239|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
155457755|NCT00717366|561097240|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
155515980|NCT01860976|561315718|FG000|Open-Label|Withdrawal by Subject|4|||
155515981|NCT01860976|561315719|FG001|Open-Label|Withdrawal by Subject|1|||
155652009|NCT00089583|561818252|FG000|Overall Study|Participant Management Criteria Met|0|||
155457756|NCT01553916|561097241|FG000|Overall Study|Withdrawal by Subject|2|||
155652010|NCT00089583|561818253|FG001|Overall Study|Participant Management Criteria Met|1|||
155457757|NCT01553916|561097241|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
155457758|NCT00645567|561097245|FG000|Overall Study|Adverse Event|1|||
155457759|NCT03259490|561097248|FG000|Period 1|Withdrawal by Subject|0|||
155457760|NCT03259490|561097249|FG001|Period 1|Withdrawal by Subject|1|||
155457761|NCT03259490|561097248|FG000|Period 2|Protocol Violation|1|||
155457762|NCT03259490|561097249|FG001|Period 2|Protocol Violation|0|||
155457763|NCT00434122|561097250|FG000|Overall Study|Non-compliance with protocol|0|||
155457764|NCT00434122|561097251|FG001|Overall Study|Non-compliance with protocol|1|||
155457765|NCT00434122|561097250|FG000|Overall Study|loss of subject contact|1|||
155457766|NCT00434122|561097251|FG001|Overall Study|loss of subject contact|1|||
155457767|NCT00434122|561097250|FG000|Overall Study|Personal reasons|1|||
155457768|NCT00434122|561097251|FG001|Overall Study|Personal reasons|1|||
155457769|NCT00434122|561097250|FG000|Overall Study|Large follicle size|2|||
155457770|NCT00434122|561097251|FG001|Overall Study|Large follicle size|2|||
155457771|NCT00434122|561097250|FG000|Overall Study|Low follicular response.|1|||
155457772|NCT00434122|561097251|FG001|Overall Study|Low follicular response.|2|||
155457773|NCT00434122|561097250|FG000|Overall Study|Travelling of subject.|1|||
155457774|NCT00434122|561097251|FG001|Overall Study|Travelling of subject.|0|||
155457775|NCT00255086|561097253|FG000|Overall Study|Adverse Event|1|||
155457776|NCT00255086|561097254|FG001|Overall Study|Adverse Event|1|||
155457777|NCT00255086|561097253|FG000|Overall Study|Protocol Violation|1|||
155457778|NCT00255086|561097254|FG001|Overall Study|Protocol Violation|1|||
155457779|NCT01364233|561097255|FG000|Overall Study|Lost to Follow-up|1|||
155457780|NCT00819585|561097257|FG000|Core Study|Adverse Event|2|||
155457781|NCT00819585|561097258|FG001|Core Study|Adverse Event|1|||
155457782|NCT00819585|561097259|FG002|Core Study|Adverse Event|1|||
155457783|NCT00819585|561097260|FG003|Core Study|Adverse Event|4|||
155457784|NCT00819585|561097261|FG004|Core Study|Adverse Event|1|||
155457785|NCT00819585|561097262|FG005|Core Study|Adverse Event|0|||
155457786|NCT00819585|561097263|FG006|Core Study|Adverse Event|2|||
155457787|NCT00819585|561097264|FG007|Core Study|Adverse Event|0|||
155457788|NCT00819585|561097265|FG008|Core Study|Adverse Event|0|||
155457789|NCT00819585|561097266|FG009|Core Study|Adverse Event|0|||
155457790|NCT00819585|561097267|FG010|Core Study|Adverse Event|0|||
155457791|NCT00819585|561097257|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
155457792|NCT00819585|561097258|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
155457793|NCT00819585|561097259|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
155457794|NCT00819585|561097260|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
155457795|NCT00819585|561097261|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
155457796|NCT00819585|561097262|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
155457797|NCT00819585|561097263|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
155457798|NCT00819585|561097264|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
155457799|NCT00819585|561097265|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
155457800|NCT00819585|561097266|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
155457801|NCT00819585|561097267|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
155457802|NCT00819585|561097257|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457803|NCT00819585|561097258|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
155457804|NCT00819585|561097259|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457805|NCT00819585|561097260|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457806|NCT00819585|561097261|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457807|NCT00819585|561097262|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457808|NCT00819585|561097263|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
155457809|NCT00819585|561097264|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457810|NCT00819585|561097265|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457811|NCT00819585|561097266|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457812|NCT00819585|561097267|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
155457813|NCT00819585|561097257|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
155457814|NCT00819585|561097258|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
155457815|NCT00819585|561097259|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
155457816|NCT00819585|561097260|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
155457817|NCT00819585|561097261|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
155457818|NCT00819585|561097262|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
155457819|NCT00819585|561097263|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
155457820|NCT00819585|561097264|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
155457821|NCT00819585|561097265|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
155457822|NCT00819585|561097266|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
155457823|NCT00819585|561097267|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
155457824|NCT00819585|561097257|FG000|Core Study|Subject Withdrew Consent|0|||
155457825|NCT00819585|561097258|FG001|Core Study|Subject Withdrew Consent|3|||
155457826|NCT00819585|561097259|FG002|Core Study|Subject Withdrew Consent|2|||
155457827|NCT00819585|561097260|FG003|Core Study|Subject Withdrew Consent|1|||
155457828|NCT00819585|561097261|FG004|Core Study|Subject Withdrew Consent|0|||
155457829|NCT00819585|561097262|FG005|Core Study|Subject Withdrew Consent|0|||
155457830|NCT00819585|561097263|FG006|Core Study|Subject Withdrew Consent|3|||
155457831|NCT00819585|561097264|FG007|Core Study|Subject Withdrew Consent|0|||
155457832|NCT00819585|561097265|FG008|Core Study|Subject Withdrew Consent|0|||
155515982|NCT01860976|561315718|FG000|Open-Label|Other Reasons|1|||
155515983|NCT01860976|561315719|FG001|Open-Label|Other Reasons|1|||
155515984|NCT01860976|561315718|FG000|Long Term Extension|Adverse Event|4|||
155515985|NCT01860976|561315719|FG001|Long Term Extension|Adverse Event|0|||
155515986|NCT01860976|561315718|FG000|Long Term Extension|Lack of Efficacy|2|||
155515987|NCT01860976|561315719|FG001|Long Term Extension|Lack of Efficacy|0|||
155457833|NCT00819585|561097266|FG009|Core Study|Subject Withdrew Consent|0|||
155457834|NCT00819585|561097267|FG010|Core Study|Subject Withdrew Consent|0|||
155457835|NCT00819585|561097257|FG000|Core Study|Lost to Follow-up|2|||
155457836|NCT00819585|561097258|FG001|Core Study|Lost to Follow-up|1|||
155457837|NCT00819585|561097259|FG002|Core Study|Lost to Follow-up|2|||
155457838|NCT00819585|561097260|FG003|Core Study|Lost to Follow-up|0|||
155457839|NCT00819585|561097261|FG004|Core Study|Lost to Follow-up|1|||
155457840|NCT00819585|561097262|FG005|Core Study|Lost to Follow-up|1|||
155457841|NCT00819585|561097263|FG006|Core Study|Lost to Follow-up|1|||
155457842|NCT00819585|561097264|FG007|Core Study|Lost to Follow-up|0|||
155457843|NCT00819585|561097265|FG008|Core Study|Lost to Follow-up|0|||
155457844|NCT00819585|561097266|FG009|Core Study|Lost to Follow-up|0|||
155457845|NCT00819585|561097267|FG010|Core Study|Lost to Follow-up|0|||
155457846|NCT00819585|561097257|FG000|Core Study|Administrative Problems|0|||
155457847|NCT00819585|561097258|FG001|Core Study|Administrative Problems|0|||
155457848|NCT00819585|561097259|FG002|Core Study|Administrative Problems|0|||
155457849|NCT00819585|561097260|FG003|Core Study|Administrative Problems|0|||
155457850|NCT00819585|561097261|FG004|Core Study|Administrative Problems|0|||
155457851|NCT00819585|561097262|FG005|Core Study|Administrative Problems|0|||
155457852|NCT00819585|561097263|FG006|Core Study|Administrative Problems|2|||
155457853|NCT00819585|561097264|FG007|Core Study|Administrative Problems|0|||
155457854|NCT00819585|561097265|FG008|Core Study|Administrative Problems|0|||
155457855|NCT00819585|561097266|FG009|Core Study|Administrative Problems|0|||
155457856|NCT00819585|561097267|FG010|Core Study|Administrative Problems|0|||
155457857|NCT00819585|561097257|FG000|Core Study|Death|0|||
155457858|NCT00819585|561097258|FG001|Core Study|Death|0|||
155457859|NCT00819585|561097259|FG002|Core Study|Death|0|||
155457860|NCT00819585|561097260|FG003|Core Study|Death|0|||
155457861|NCT00819585|561097261|FG004|Core Study|Death|0|||
155457862|NCT00819585|561097262|FG005|Core Study|Death|0|||
155457863|NCT00819585|561097263|FG006|Core Study|Death|1|||
155457864|NCT00819585|561097264|FG007|Core Study|Death|0|||
155457865|NCT00819585|561097265|FG008|Core Study|Death|0|||
155457866|NCT00819585|561097266|FG009|Core Study|Death|0|||
155457867|NCT00819585|561097267|FG010|Core Study|Death|0|||
155515988|NCT01860976|561315718|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
155515989|NCT01860976|561315719|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
155515990|NCT01860976|561315718|FG000|Long Term Extension|Lost to Follow-up|2|||
155515991|NCT01860976|561315719|FG001|Long Term Extension|Lost to Follow-up|0|||
155515992|NCT01860976|561315718|FG000|Long Term Extension|subject withdrew consent|7|||
155515993|NCT01860976|561315719|FG001|Long Term Extension|subject withdrew consent|0|||
155515994|NCT01506947|561315721|FG000|Overall Study|Lost to Follow-up|7|||
155515995|NCT01506947|561315721|FG000|Overall Study|Adverse Event|5|||
155515996|NCT01506947|561315721|FG000|Overall Study|Death|1|||
155515997|NCT01506947|561315721|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
155515998|NCT01802879|561315725|FG000|Overall Study|Administrative problems|2|||
155515999|NCT01802879|561315725|FG000|Overall Study|Disease progression|6|||
155516000|NCT00266409|561315726|FG000|Overall Study|Lack of Efficacy|2|||
155516001|NCT00266409|561315727|FG001|Overall Study|Lack of Efficacy|6|||
155457868|NCT00819585|561097257|FG000|Core Study|Protocol Violation|0|||
155457869|NCT00819585|561097258|FG001|Core Study|Protocol Violation|0|||
155457870|NCT00819585|561097259|FG002|Core Study|Protocol Violation|1|||
155457871|NCT00819585|561097260|FG003|Core Study|Protocol Violation|0|||
155457872|NCT00819585|561097261|FG004|Core Study|Protocol Violation|0|||
155457873|NCT00819585|561097262|FG005|Core Study|Protocol Violation|1|||
155457874|NCT00819585|561097263|FG006|Core Study|Protocol Violation|3|||
155457875|NCT00819585|561097264|FG007|Core Study|Protocol Violation|0|||
155457876|NCT00819585|561097265|FG008|Core Study|Protocol Violation|0|||
155457877|NCT00819585|561097266|FG009|Core Study|Protocol Violation|0|||
155457878|NCT00819585|561097267|FG010|Core Study|Protocol Violation|0|||
155457879|NCT00819585|561097257|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
155457880|NCT00819585|561097258|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
155457881|NCT00819585|561097259|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
155457882|NCT00819585|561097260|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
155457883|NCT00819585|561097261|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
155457884|NCT00819585|561097262|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
155516002|NCT00266409|561315728|FG002|Overall Study|Lack of Efficacy|1|||
155457885|NCT00819585|561097263|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
155457886|NCT00819585|561097264|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
155457887|NCT00819585|561097265|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
155457888|NCT00819585|561097266|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
155457889|NCT00819585|561097267|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
155516003|NCT00266409|561315729|FG003|Overall Study|Lack of Efficacy|2|||
155457890|NCT00819585|561097257|FG000|Extension Study|Subject Withdrew Consent|0|||
155457891|NCT00819585|561097258|FG001|Extension Study|Subject Withdrew Consent|0|||
155457892|NCT00819585|561097259|FG002|Extension Study|Subject Withdrew Consent|0|||
155457893|NCT00819585|561097260|FG003|Extension Study|Subject Withdrew Consent|0|||
155457894|NCT00819585|561097261|FG004|Extension Study|Subject Withdrew Consent|0|||
155457895|NCT00819585|561097262|FG005|Extension Study|Subject Withdrew Consent|0|||
155457896|NCT00819585|561097263|FG006|Extension Study|Subject Withdrew Consent|0|||
155457897|NCT00819585|561097264|FG007|Extension Study|Subject Withdrew Consent|0|||
155457898|NCT00819585|561097265|FG008|Extension Study|Subject Withdrew Consent|3|||
155457899|NCT00819585|561097266|FG009|Extension Study|Subject Withdrew Consent|0|||
155457900|NCT00819585|561097267|FG010|Extension Study|Subject Withdrew Consent|1|||
155457901|NCT00819585|561097257|FG000|Extension Study|Lost to Follow-up|0|||
155457902|NCT00819585|561097258|FG001|Extension Study|Lost to Follow-up|0|||
155457903|NCT00819585|561097259|FG002|Extension Study|Lost to Follow-up|0|||
155457904|NCT00819585|561097260|FG003|Extension Study|Lost to Follow-up|0|||
155457905|NCT00819585|561097261|FG004|Extension Study|Lost to Follow-up|0|||
155457906|NCT00819585|561097262|FG005|Extension Study|Lost to Follow-up|0|||
155457907|NCT00819585|561097263|FG006|Extension Study|Lost to Follow-up|0|||
155457908|NCT00819585|561097264|FG007|Extension Study|Lost to Follow-up|0|||
155457909|NCT00819585|561097265|FG008|Extension Study|Lost to Follow-up|2|||
155457910|NCT00819585|561097266|FG009|Extension Study|Lost to Follow-up|1|||
155457911|NCT00819585|561097267|FG010|Extension Study|Lost to Follow-up|1|||
155457912|NCT00819585|561097257|FG000|Extension Study|Death|0|||
155457913|NCT00819585|561097258|FG001|Extension Study|Death|0|||
155457914|NCT00819585|561097259|FG002|Extension Study|Death|0|||
155457915|NCT00819585|561097260|FG003|Extension Study|Death|0|||
155457916|NCT00819585|561097261|FG004|Extension Study|Death|0|||
155457917|NCT00819585|561097262|FG005|Extension Study|Death|0|||
155457918|NCT00819585|561097263|FG006|Extension Study|Death|0|||
155457919|NCT00819585|561097264|FG007|Extension Study|Death|0|||
155457920|NCT00819585|561097265|FG008|Extension Study|Death|2|||
155457921|NCT00819585|561097266|FG009|Extension Study|Death|0|||
155457922|NCT00819585|561097267|FG010|Extension Study|Death|0|||
155457923|NCT00349752|561097268|FG000|Overall Study|Adverse Event|8|||
155457924|NCT00349752|561097269|FG001|Overall Study|Adverse Event|12|||
155457925|NCT00349752|561097268|FG000|Overall Study|Lack of Efficacy|37|||
155457926|NCT00349752|561097269|FG001|Overall Study|Lack of Efficacy|42|||
155457927|NCT00349752|561097268|FG000|Overall Study|Lost to Follow-up|4|||
155457928|NCT00349752|561097269|FG001|Overall Study|Lost to Follow-up|2|||
155457929|NCT00349752|561097268|FG000|Overall Study|Personal reasons|6|||
155457930|NCT00349752|561097269|FG001|Overall Study|Personal reasons|5|||
155457931|NCT00349752|561097268|FG000|Overall Study|Other: Required exclusionary medication|0|||
155457932|NCT00349752|561097269|FG001|Overall Study|Other: Required exclusionary medication|1|||
155457933|NCT00349752|561097268|FG000|Overall Study|Other: Non compliance|0|||
155457934|NCT00349752|561097269|FG001|Overall Study|Other: Non compliance|1|||
155457935|NCT00349752|561097268|FG000|Overall Study|Other: Patient stopped steroids|0|||
155457936|NCT00349752|561097269|FG001|Overall Study|Other: Patient stopped steroids|1|||
155457937|NCT00349752|561097268|FG000|Overall Study|Other: Patient's steroid use|1|||
155457938|NCT00349752|561097269|FG001|Overall Study|Other: Patient's steroid use|0|||
155457939|NCT00349752|561097268|FG000|Overall Study|Other: Ineligible|1|||
155457940|NCT00349752|561097269|FG001|Overall Study|Other: Ineligible|0|||
155516004|NCT00266409|561315726|FG000|Overall Study|Adverse Event|7|||
155516005|NCT00266409|561315727|FG001|Overall Study|Adverse Event|2|||
155516006|NCT00266409|561315728|FG002|Overall Study|Adverse Event|1|||
155457941|NCT00349752|561097268|FG000|Overall Study|Other: Inadvertently unblinded|1|||
155457942|NCT00349752|561097269|FG001|Overall Study|Other: Inadvertently unblinded|0|||
155457943|NCT00349752|561097268|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
155457944|NCT00349752|561097269|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
155457945|NCT03334396|561097270|FG000|Overall Study|Adverse Event|1|||
155457946|NCT03334396|561097271|FG001|Overall Study|Adverse Event|0|||
155457947|NCT03334396|561097272|FG002|Overall Study|Adverse Event|1|||
155457948|NCT03334396|561097273|FG003|Overall Study|Adverse Event|0|||
155457949|NCT03334396|561097274|FG004|Overall Study|Adverse Event|0|||
155457950|NCT03334396|561097275|FG005|Overall Study|Adverse Event|0|||
155457951|NCT03334396|561097276|FG006|Overall Study|Adverse Event|0|||
155457952|NCT03334396|561097277|FG007|Overall Study|Adverse Event|0|||
155457953|NCT03334396|561097270|FG000|Overall Study|Lack of Efficacy|10|||
155457954|NCT03334396|561097271|FG001|Overall Study|Lack of Efficacy|4|||
155457955|NCT03334396|561097272|FG002|Overall Study|Lack of Efficacy|1|||
155457956|NCT03334396|561097273|FG003|Overall Study|Lack of Efficacy|3|||
155457957|NCT03334396|561097274|FG004|Overall Study|Lack of Efficacy|1|||
155457958|NCT03334396|561097275|FG005|Overall Study|Lack of Efficacy|0|||
155457959|NCT03334396|561097276|FG006|Overall Study|Lack of Efficacy|0|||
155457960|NCT03334396|561097277|FG007|Overall Study|Lack of Efficacy|1|||
155457961|NCT03334396|561097270|FG000|Overall Study|Lost to Follow-up|0|||
155457962|NCT03334396|561097271|FG001|Overall Study|Lost to Follow-up|0|||
155457963|NCT03334396|561097272|FG002|Overall Study|Lost to Follow-up|1|||
155457964|NCT03334396|561097273|FG003|Overall Study|Lost to Follow-up|0|||
155457965|NCT03334396|561097274|FG004|Overall Study|Lost to Follow-up|0|||
155457966|NCT03334396|561097275|FG005|Overall Study|Lost to Follow-up|0|||
155457967|NCT03334396|561097276|FG006|Overall Study|Lost to Follow-up|1|||
155457968|NCT03334396|561097277|FG007|Overall Study|Lost to Follow-up|0|||
155457969|NCT03334396|561097270|FG000|Overall Study|Physician Decision|1|||
155457970|NCT03334396|561097271|FG001|Overall Study|Physician Decision|0|||
155457971|NCT03334396|561097272|FG002|Overall Study|Physician Decision|0|||
155457972|NCT03334396|561097273|FG003|Overall Study|Physician Decision|0|||
155457973|NCT03334396|561097274|FG004|Overall Study|Physician Decision|0|||
155457974|NCT03334396|561097275|FG005|Overall Study|Physician Decision|0|||
155457975|NCT03334396|561097276|FG006|Overall Study|Physician Decision|0|||
155457976|NCT03334396|561097277|FG007|Overall Study|Physician Decision|0|||
155457977|NCT03334396|561097270|FG000|Overall Study|Withdrawal by Subject|10|||
155457978|NCT03334396|561097271|FG001|Overall Study|Withdrawal by Subject|5|||
155457979|NCT03334396|561097272|FG002|Overall Study|Withdrawal by Subject|7|||
155457980|NCT03334396|561097273|FG003|Overall Study|Withdrawal by Subject|2|||
155457981|NCT03334396|561097274|FG004|Overall Study|Withdrawal by Subject|2|||
155457982|NCT03334396|561097275|FG005|Overall Study|Withdrawal by Subject|1|||
155457983|NCT03334396|561097276|FG006|Overall Study|Withdrawal by Subject|2|||
155457984|NCT03334396|561097277|FG007|Overall Study|Withdrawal by Subject|0|||
155457985|NCT03334396|561097270|FG000|Overall Study|Pregnancy|0|||
155457986|NCT03334396|561097271|FG001|Overall Study|Pregnancy|1|||
155457987|NCT03334396|561097272|FG002|Overall Study|Pregnancy|0|||
155457988|NCT03334396|561097273|FG003|Overall Study|Pregnancy|0|||
155457989|NCT03334396|561097274|FG004|Overall Study|Pregnancy|0|||
155457990|NCT03334396|561097275|FG005|Overall Study|Pregnancy|0|||
155457991|NCT03334396|561097276|FG006|Overall Study|Pregnancy|0|||
155457992|NCT03334396|561097277|FG007|Overall Study|Pregnancy|0|||
155457993|NCT03334396|561097270|FG000|Overall Study|Ineligible|0|||
155457994|NCT03334396|561097271|FG001|Overall Study|Ineligible|1|||
155457995|NCT03334396|561097272|FG002|Overall Study|Ineligible|0|||
155457996|NCT03334396|561097273|FG003|Overall Study|Ineligible|0|||
155457997|NCT03334396|561097274|FG004|Overall Study|Ineligible|0|||
155457998|NCT03334396|561097275|FG005|Overall Study|Ineligible|0|||
155457999|NCT03334396|561097276|FG006|Overall Study|Ineligible|0|||
155458000|NCT03334396|561097277|FG007|Overall Study|Ineligible|0|||
155458001|NCT03334396|561097270|FG000|Overall Study|Started New Job|1|||
155458002|NCT03334396|561097271|FG001|Overall Study|Started New Job|0|||
155458003|NCT03334396|561097272|FG002|Overall Study|Started New Job|0|||
155458004|NCT03334396|561097273|FG003|Overall Study|Started New Job|0|||
155458005|NCT03334396|561097274|FG004|Overall Study|Started New Job|0|||
155458006|NCT03334396|561097275|FG005|Overall Study|Started New Job|0|||
155458007|NCT03334396|561097276|FG006|Overall Study|Started New Job|0|||
155458008|NCT03334396|561097277|FG007|Overall Study|Started New Job|0|||
155458009|NCT01842607|561097279|FG000|Overall Study|Adverse Event|11|||
155458010|NCT01842607|561097279|FG000|Overall Study|Lack of Efficacy|19|||
155458011|NCT01842607|561097279|FG000|Overall Study|Protocol Violation|8|||
155458012|NCT01842607|561097279|FG000|Overall Study|Protocol defined stopping criteria|2|||
155458013|NCT01842607|561097279|FG000|Overall Study|Lost to Follow-up|3|||
155458014|NCT01842607|561097279|FG000|Overall Study|Physician Decision|9|||
155458015|NCT01842607|561097279|FG000|Overall Study|Withdrawal by Subject|14|||
155458016|NCT03629041|561097280|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
155458017|NCT03629041|561097281|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
155458018|NCT03629041|561097282|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
155458019|NCT03629041|561097283|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
155458020|NCT03814590|561097286|FG000|Overall Study|Adverse Event|0|||
155458021|NCT03814590|561097287|FG001|Overall Study|Adverse Event|0|||
155458022|NCT03814590|561097288|FG002|Overall Study|Adverse Event|0|||
155458023|NCT03814590|561097289|FG003|Overall Study|Adverse Event|0|||
155458024|NCT03814590|561097290|FG004|Overall Study|Adverse Event|0|||
155458025|NCT03814590|561097291|FG005|Overall Study|Adverse Event|1|||
155458026|NCT03814590|561097292|FG006|Overall Study|Adverse Event|1|||
155458027|NCT03814590|561097293|FG007|Overall Study|Adverse Event|1|||
155458028|NCT03814590|561097294|FG008|Overall Study|Adverse Event|0|||
155458029|NCT03814590|561097295|FG009|Overall Study|Adverse Event|0|||
155458030|NCT03814590|561097296|FG010|Overall Study|Adverse Event|1|||
155458031|NCT03814590|561097297|FG011|Overall Study|Adverse Event|0|||
155458032|NCT03814590|561097298|FG012|Overall Study|Adverse Event|3|||
155458033|NCT03814590|561097299|FG013|Overall Study|Adverse Event|0|||
155458034|NCT03814590|561097286|FG000|Overall Study|Lost to Follow-up|0|||
155458035|NCT03814590|561097287|FG001|Overall Study|Lost to Follow-up|2|||
155458036|NCT03814590|561097288|FG002|Overall Study|Lost to Follow-up|1|||
155458037|NCT03814590|561097289|FG003|Overall Study|Lost to Follow-up|0|||
155458038|NCT03814590|561097290|FG004|Overall Study|Lost to Follow-up|1|||
155458039|NCT03814590|561097291|FG005|Overall Study|Lost to Follow-up|1|||
155458040|NCT03814590|561097292|FG006|Overall Study|Lost to Follow-up|1|||
155458041|NCT03814590|561097293|FG007|Overall Study|Lost to Follow-up|1|||
155458042|NCT03814590|561097294|FG008|Overall Study|Lost to Follow-up|0|||
155458043|NCT03814590|561097295|FG009|Overall Study|Lost to Follow-up|0|||
155458044|NCT03814590|561097296|FG010|Overall Study|Lost to Follow-up|1|||
155458045|NCT03814590|561097297|FG011|Overall Study|Lost to Follow-up|0|||
155458046|NCT03814590|561097298|FG012|Overall Study|Lost to Follow-up|0|||
155458047|NCT03814590|561097299|FG013|Overall Study|Lost to Follow-up|1|||
155458048|NCT03814590|561097286|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458049|NCT03814590|561097287|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458050|NCT03814590|561097288|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458051|NCT03814590|561097289|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458052|NCT03814590|561097290|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458053|NCT03814590|561097291|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458054|NCT03814590|561097292|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458055|NCT03814590|561097293|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458056|NCT03814590|561097294|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458057|NCT03814590|561097295|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
155458058|NCT03814590|561097296|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458059|NCT03814590|561097297|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458060|NCT03814590|561097298|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458061|NCT03814590|561097299|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
155458062|NCT03814590|561097286|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458063|NCT03814590|561097287|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458064|NCT03814590|561097288|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458065|NCT03814590|561097289|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458066|NCT03814590|561097290|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458067|NCT03814590|561097291|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
155458068|NCT03814590|561097292|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
155458069|NCT03814590|561097293|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
155458070|NCT03814590|561097294|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458071|NCT03814590|561097295|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
155458072|NCT03814590|561097296|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
155458073|NCT03814590|561097297|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
155458074|NCT03814590|561097298|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
155458075|NCT03814590|561097299|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
155458076|NCT03814590|561097286|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458077|NCT03814590|561097287|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458078|NCT03814590|561097288|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458079|NCT03814590|561097289|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458080|NCT03814590|561097290|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458081|NCT03814590|561097291|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458082|NCT03814590|561097292|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458083|NCT03814590|561097293|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155458084|NCT03814590|561097294|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458085|NCT03814590|561097295|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155458086|NCT03814590|561097296|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458087|NCT03814590|561097297|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458088|NCT03814590|561097298|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458089|NCT03814590|561097299|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155458090|NCT03814590|561097286|FG000|Overall Study|UNKNOWN REASON|0|||
155458091|NCT03814590|561097287|FG001|Overall Study|UNKNOWN REASON|0|||
155458092|NCT03814590|561097288|FG002|Overall Study|UNKNOWN REASON|0|||
155458093|NCT03814590|561097289|FG003|Overall Study|UNKNOWN REASON|0|||
155652011|NCT00089583|561818252|FG000|Overall Study|Reason Not Provided|0|||
155652012|NCT00089583|561818253|FG001|Overall Study|Reason Not Provided|1|||
155458094|NCT03814590|561097290|FG004|Overall Study|UNKNOWN REASON|0|||
155458095|NCT03814590|561097291|FG005|Overall Study|UNKNOWN REASON|0|||
155458096|NCT03814590|561097292|FG006|Overall Study|UNKNOWN REASON|0|||
155458097|NCT03814590|561097293|FG007|Overall Study|UNKNOWN REASON|1|||
155458098|NCT03814590|561097294|FG008|Overall Study|UNKNOWN REASON|0|||
155458099|NCT03814590|561097295|FG009|Overall Study|UNKNOWN REASON|0|||
155652013|NCT00089583|561818252|FG000|Overall Study|Protocol Violation|0|||
155458100|NCT03814590|561097296|FG010|Overall Study|UNKNOWN REASON|0|||
155458101|NCT03814590|561097297|FG011|Overall Study|UNKNOWN REASON|0|||
155458102|NCT03814590|561097298|FG012|Overall Study|UNKNOWN REASON|0|||
155458103|NCT03814590|561097299|FG013|Overall Study|UNKNOWN REASON|0|||
155458104|NCT04971785|561097301|FG000|Overall Study|Withdrew Consent|5|||
155458105|NCT04971785|561097302|FG001|Overall Study|Withdrew Consent|5|||
155458106|NCT04971785|561097303|FG002|Overall Study|Withdrew Consent|17|||
155458107|NCT04971785|561097304|FG003|Overall Study|Withdrew Consent|7|||
155458108|NCT04971785|561097301|FG000|Overall Study|Adverse Event|7|||
155458109|NCT04971785|561097302|FG001|Overall Study|Adverse Event|8|||
155458110|NCT04971785|561097303|FG002|Overall Study|Adverse Event|6|||
155458111|NCT04971785|561097304|FG003|Overall Study|Adverse Event|3|||
155458112|NCT04971785|561097301|FG000|Overall Study|Lost to Follow-up|2|||
155458113|NCT04971785|561097302|FG001|Overall Study|Lost to Follow-up|1|||
155458114|NCT04971785|561097303|FG002|Overall Study|Lost to Follow-up|6|||
155458115|NCT04971785|561097304|FG003|Overall Study|Lost to Follow-up|7|||
155458116|NCT04971785|561097301|FG000|Overall Study|Protocol Violation|3|||
155458117|NCT04971785|561097302|FG001|Overall Study|Protocol Violation|1|||
155458118|NCT04971785|561097303|FG002|Overall Study|Protocol Violation|1|||
155458119|NCT04971785|561097304|FG003|Overall Study|Protocol Violation|2|||
155458120|NCT04971785|561097301|FG000|Overall Study|Investigator's Discretion|3|||
155458121|NCT04971785|561097302|FG001|Overall Study|Investigator's Discretion|1|||
155458122|NCT04971785|561097303|FG002|Overall Study|Investigator's Discretion|1|||
155458123|NCT04971785|561097304|FG003|Overall Study|Investigator's Discretion|0|||
155458124|NCT04971785|561097301|FG000|Overall Study|Randomized but Never Treated|1|||
155458125|NCT04971785|561097302|FG001|Overall Study|Randomized but Never Treated|2|||
155458126|NCT04971785|561097303|FG002|Overall Study|Randomized but Never Treated|0|||
155458127|NCT04971785|561097304|FG003|Overall Study|Randomized but Never Treated|1|||
155458128|NCT04971785|561097301|FG000|Overall Study|Death|0|||
155458129|NCT04971785|561097302|FG001|Overall Study|Death|1|||
155458130|NCT04971785|561097303|FG002|Overall Study|Death|1|||
155458131|NCT04971785|561097304|FG003|Overall Study|Death|0|||
155458132|NCT04971785|561097301|FG000|Overall Study|Site Terminated by Sponsor|1|||
155458133|NCT04971785|561097302|FG001|Overall Study|Site Terminated by Sponsor|1|||
155458134|NCT04971785|561097303|FG002|Overall Study|Site Terminated by Sponsor|0|||
155458135|NCT04971785|561097304|FG003|Overall Study|Site Terminated by Sponsor|0|||
155458136|NCT01255306|561098745|FG000|Overall Study|Physician Decision|1|||
155458137|NCT01255306|561098746|FG001|Overall Study|Physician Decision|1|||
155458138|NCT01677624|561098750|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
155458139|NCT01337167|561098754|FG000|Infant Series|Adverse Event|1|||
155458140|NCT01337167|561098755|FG001|Infant Series|Adverse Event|1|||
155458141|NCT01337167|561098754|FG000|Infant Series|Death|1|||
155458142|NCT01337167|561098755|FG001|Infant Series|Death|1|||
155458143|NCT01337167|561098754|FG000|Infant Series|Lost to Follow-up|13|||
155458144|NCT01337167|561098755|FG001|Infant Series|Lost to Follow-up|7|||
155458145|NCT01337167|561098754|FG000|Infant Series|Non-compliance with study drug|2|||
155458146|NCT01337167|561098755|FG001|Infant Series|Non-compliance with study drug|1|||
155458147|NCT01337167|561098754|FG000|Infant Series|Physician Decision|3|||
155458148|NCT01337167|561098755|FG001|Infant Series|Physician Decision|1|||
155458149|NCT01337167|561098754|FG000|Infant Series|Protocol Violation|22|||
155458150|NCT01337167|561098755|FG001|Infant Series|Protocol Violation|9|||
155458151|NCT01337167|561098754|FG000|Infant Series|Withdrawal by Subject|15|||
155458152|NCT01337167|561098755|FG001|Infant Series|Withdrawal by Subject|4|||
155458153|NCT01337167|561098754|FG000|Infant Series|Randomized but not vaccinated|5|||
155458154|NCT01337167|561098755|FG001|Infant Series|Randomized but not vaccinated|3|||
155458155|NCT01337167|561098754|FG000|Interim Period|Lost to Follow-up|51|||
155458156|NCT01337167|561098755|FG001|Interim Period|Lost to Follow-up|23|||
155458157|NCT01337167|561098754|FG000|Interim Period|Non-compliance with study drug|1|||
155516007|NCT00266409|561315729|FG003|Overall Study|Adverse Event|1|||
155516008|NCT00266409|561315726|FG000|Overall Study|Lost to Follow-up|18|||
155516009|NCT00266409|561315727|FG001|Overall Study|Lost to Follow-up|21|||
155458158|NCT01337167|561098755|FG001|Interim Period|Non-compliance with study drug|0|||
155458159|NCT01337167|561098754|FG000|Interim Period|Physician Decision|6|||
155458160|NCT01337167|561098755|FG001|Interim Period|Physician Decision|3|||
155458161|NCT01337167|561098754|FG000|Interim Period|Protocol Violation|5|||
155458162|NCT01337167|561098755|FG001|Interim Period|Protocol Violation|3|||
155458163|NCT01337167|561098754|FG000|Interim Period|Withdrawal by Subject|18|||
155458164|NCT01337167|561098755|FG001|Interim Period|Withdrawal by Subject|10|||
155458165|NCT01337167|561098754|FG000|Interim Period|Other protocol criterion not met|0|||
155458166|NCT01337167|561098755|FG001|Interim Period|Other protocol criterion not met|1|||
155458167|NCT01337167|561098754|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
155458168|NCT01337167|561098755|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
155458169|NCT01337167|561098754|FG000|Toddler Vaccinations|Protocol Violation|0|||
155458170|NCT01337167|561098755|FG001|Toddler Vaccinations|Protocol Violation|1|||
155458171|NCT01337167|561098754|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
155458172|NCT01337167|561098755|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
155458173|NCT02126670|561098762|FG000|Overall Study|Withdrawal by Subject|1|||
155458174|NCT02126670|561098763|FG001|Overall Study|Withdrawal by Subject|0|||
155458175|NCT02126670|561098764|FG002|Overall Study|Withdrawal by Subject|0|||
155458176|NCT02126670|561098765|FG003|Overall Study|Withdrawal by Subject|1|||
155458177|NCT03363919|561098768|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
155458178|NCT03363919|561098769|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
155516010|NCT00266409|561315728|FG002|Overall Study|Lost to Follow-up|6|||
155458179|NCT03363919|561098768|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
155458180|NCT03363919|561098769|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
155458181|NCT01975246|561098770|FG000|Overall Study|Adverse Event|2|||
155458182|NCT01975246|561098771|FG001|Overall Study|Adverse Event|1|||
155458183|NCT01975246|561098770|FG000|Overall Study|Lack of Efficacy|1|||
155458184|NCT01975246|561098771|FG001|Overall Study|Lack of Efficacy|0|||
155458185|NCT01975246|561098770|FG000|Overall Study|Protocol Violation|1|||
155458186|NCT01975246|561098771|FG001|Overall Study|Protocol Violation|0|||
155458187|NCT01975246|561098770|FG000|Overall Study|Other than stated|0|||
155458188|NCT01975246|561098771|FG001|Overall Study|Other than stated|1|||
155458189|NCT01646398|561098772|FG000|Overall Study|Withdrawal by Subject|1|||
155458190|NCT01646398|561098773|FG001|Overall Study|Withdrawal by Subject|0|||
155458191|NCT01263093|561098774|FG000|Washout|Physician Decision|1|||
155458192|NCT01263093|561098775|FG001|Washout|Physician Decision|0|||
155458193|NCT01263093|561098774|FG000|Period 2|Adverse Event|1|||
155458194|NCT01263093|561098775|FG001|Period 2|Adverse Event|0|||
155458195|NCT01827319|561098776|FG000|Overall Study|Lost to Follow-up|3|||
155458196|NCT02062463|561098781|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
155458197|NCT02062463|561098782|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
155458198|NCT02062463|561098783|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
155458199|NCT02062463|561098784|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
155458200|NCT02062463|561098781|FG000|Stage 2|Adverse Event|0|||
155458201|NCT02062463|561098782|FG001|Stage 2|Adverse Event|0|||
155458202|NCT02062463|561098783|FG002|Stage 2|Adverse Event|12|||
155458203|NCT02062463|561098784|FG003|Stage 2|Adverse Event|20|||
155458204|NCT02062463|561098781|FG000|Stage 2|Lack of Efficacy|0|||
155458205|NCT02062463|561098782|FG001|Stage 2|Lack of Efficacy|0|||
155458206|NCT02062463|561098783|FG002|Stage 2|Lack of Efficacy|3|||
155458207|NCT02062463|561098784|FG003|Stage 2|Lack of Efficacy|4|||
155458208|NCT02062463|561098781|FG000|Stage 2|Lost to Follow-up|0|||
155458209|NCT02062463|561098782|FG001|Stage 2|Lost to Follow-up|0|||
155458210|NCT02062463|561098783|FG002|Stage 2|Lost to Follow-up|20|||
155458211|NCT02062463|561098784|FG003|Stage 2|Lost to Follow-up|20|||
155458212|NCT02062463|561098781|FG000|Stage 2|Non-Compliance|0|||
155458213|NCT02062463|561098782|FG001|Stage 2|Non-Compliance|0|||
155458214|NCT02062463|561098783|FG002|Stage 2|Non-Compliance|0|||
155458215|NCT02062463|561098784|FG003|Stage 2|Non-Compliance|1|||
155458216|NCT02062463|561098781|FG000|Stage 2|Other than specified|0|||
155458217|NCT02062463|561098782|FG001|Stage 2|Other than specified|0|||
155458218|NCT02062463|561098783|FG002|Stage 2|Other than specified|3|||
155458219|NCT02062463|561098784|FG003|Stage 2|Other than specified|1|||
155458220|NCT02062463|561098781|FG000|Stage 2|Withdrawal by Subject|0|||
155458221|NCT02062463|561098782|FG001|Stage 2|Withdrawal by Subject|0|||
155458222|NCT02062463|561098783|FG002|Stage 2|Withdrawal by Subject|15|||
155458223|NCT02062463|561098784|FG003|Stage 2|Withdrawal by Subject|10|||
155458224|NCT00600028|561098795|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155458225|NCT00600028|561098796|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
155458226|NCT00600028|561098795|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
155458227|NCT00600028|561098796|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
155458228|NCT00600028|561098795|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
155458229|NCT00600028|561098796|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
155458230|NCT02716194|561098797|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
155458231|NCT02716194|561098798|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
155458232|NCT02716194|561098799|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
155458233|NCT00363051|561098800|FG000|Overall Study|Adminstrative problems|1|||
155458234|NCT00363051|561098801|FG001|Overall Study|Adminstrative problems|1|||
155458235|NCT00363051|561098800|FG000|Overall Study|Adverse Event|21|||
155458236|NCT00363051|561098801|FG001|Overall Study|Adverse Event|12|||
155458237|NCT00363051|561098800|FG000|Overall Study|New Cancer Therapy|2|||
155458238|NCT00363051|561098801|FG001|Overall Study|New Cancer Therapy|1|||
155458239|NCT00363051|561098800|FG000|Overall Study|Withdrawal by Subject|11|||
155458240|NCT00363051|561098801|FG001|Overall Study|Withdrawal by Subject|3|||
155458241|NCT00363051|561098800|FG000|Overall Study|Lost to Follow-up|0|||
155458242|NCT00363051|561098801|FG001|Overall Study|Lost to Follow-up|1|||
155458243|NCT00363051|561098800|FG000|Overall Study|Protocol Violation|0|||
155458244|NCT00363051|561098801|FG001|Overall Study|Protocol Violation|2|||
155458245|NCT00363051|561098800|FG000|Overall Study|Death|3|||
155458246|NCT00363051|561098801|FG001|Overall Study|Death|2|||
155458247|NCT01107405|561098805|FG000|Overall Study|Adverse Event|1|||
155458248|NCT01107405|561098806|FG001|Overall Study|Adverse Event|1|||
155458249|NCT01107405|561098807|FG002|Overall Study|Adverse Event|0|||
155458250|NCT01107405|561098808|FG003|Overall Study|Adverse Event|0|||
155458251|NCT01107405|561098809|FG004|Overall Study|Adverse Event|2|||
155458252|NCT01107405|561098805|FG000|Overall Study|Withdrawal by Subject|1|||
155458253|NCT01107405|561098806|FG001|Overall Study|Withdrawal by Subject|0|||
155652014|NCT00089583|561818253|FG001|Overall Study|Protocol Violation|3|||
155652015|NCT00089583|561818252|FG000|Overall Study|Principal Investigator Decision|0|||
155458254|NCT01107405|561098807|FG002|Overall Study|Withdrawal by Subject|1|||
155458255|NCT01107405|561098808|FG003|Overall Study|Withdrawal by Subject|2|||
155458256|NCT01107405|561098809|FG004|Overall Study|Withdrawal by Subject|1|||
155458257|NCT01107405|561098805|FG000|Overall Study|Protocol Violation|0|||
155458258|NCT01107405|561098806|FG001|Overall Study|Protocol Violation|0|||
155458259|NCT01107405|561098807|FG002|Overall Study|Protocol Violation|1|||
155458260|NCT01107405|561098808|FG003|Overall Study|Protocol Violation|1|||
155458261|NCT01107405|561098809|FG004|Overall Study|Protocol Violation|0|||
155458262|NCT01170702|561098817|FG000|Overall Study|Exclusion criteria met after consent|1|||
155458263|NCT01170702|561098818|FG001|Overall Study|Exclusion criteria met after consent|2|||
155458264|NCT01170702|561098819|FG002|Overall Study|Exclusion criteria met after consent|0|||
155458265|NCT01170702|561098820|FG003|Overall Study|Exclusion criteria met after consent|2|||
155458266|NCT01677507|561098821|FG000|Initial Assignment|Adverse Event|0|||
155458267|NCT01677507|561098822|FG001|Initial Assignment|Adverse Event|1|||
155458268|NCT01677507|561098821|FG000|Initial Assignment|Protocol Violation|0|||
155458269|NCT01677507|561098822|FG001|Initial Assignment|Protocol Violation|1|||
155458270|NCT01677507|561098821|FG000|Second Assigment|Withdrawal by Subject|2|||
155458271|NCT01677507|561098822|FG001|Second Assigment|Withdrawal by Subject|2|||
155458272|NCT01677507|561098821|FG000|Second Assigment|Adverse Event|1|||
155458273|NCT01677507|561098822|FG001|Second Assigment|Adverse Event|3|||
155458274|NCT03779334|561098823|FG000|Overall Study|Withdrawal by Subject|3|||
155458275|NCT03779334|561098824|FG001|Overall Study|Withdrawal by Subject|0|||
155458276|NCT03779334|561098825|FG002|Overall Study|Withdrawal by Subject|0|||
155458277|NCT03779334|561098823|FG000|Overall Study|Ongoing in Study|5|||
155458278|NCT03779334|561098824|FG001|Overall Study|Ongoing in Study|13|||
155458279|NCT03779334|561098825|FG002|Overall Study|Ongoing in Study|5|||
155458280|NCT00085917|561098826|FG000|Overall Study|Adverse Event|4|||
155458281|NCT00085917|561098827|FG001|Overall Study|Adverse Event|3|||
155458282|NCT01103778|561098830|FG000|Overall Study|Lost to Follow-up|1|||
155458283|NCT01103778|561098830|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
155458284|NCT01103778|561098830|FG000|Overall Study|Screen failure|1|||
155458285|NCT03670641|561098835|FG000|Overall Study|Lost to Follow-up|3|||
155458286|NCT00125190|561098841|FG000|Overall Study|Subject/Parent Decision|7|||
155458287|NCT00125190|561098841|FG000|Overall Study|Non-compliance|2|||
155458288|NCT00125190|561098841|FG000|Overall Study|Adverse Event|1|||
155458289|NCT00125190|561098841|FG000|Overall Study|Other|1|||
155458290|NCT00125190|561098841|FG000|Overall Study|Lost to Follow-up|4|||
155458291|NCT00916370|561098842|FG000|Overall Study|Death|3|||
155458292|NCT00916370|561098843|FG001|Overall Study|Death|1|||
155458293|NCT00916370|561098842|FG000|Overall Study|Withdrawal by Subject|2|||
155458294|NCT00916370|561098843|FG001|Overall Study|Withdrawal by Subject|0|||
155458295|NCT00916370|561098842|FG000|Overall Study|Physician Decision|0|||
155458296|NCT00916370|561098843|FG001|Overall Study|Physician Decision|1|||
155458297|NCT00414960|561098844|FG000|Overall Study|Adverse Event|4|||
155458298|NCT00414960|561098845|FG001|Overall Study|Adverse Event|0|||
155458299|NCT00414960|561098844|FG000|Overall Study|Withdrawal by Subject|3|||
155458300|NCT00414960|561098845|FG001|Overall Study|Withdrawal by Subject|0|||
155458301|NCT00414960|561098844|FG000|Overall Study|Physician Decision|0|||
155458302|NCT00414960|561098845|FG001|Overall Study|Physician Decision|1|||
155458303|NCT03722784|561098846|FG000|Overall Study|Withdrawal by Subject|1|||
155516011|NCT00266409|561315729|FG003|Overall Study|Lost to Follow-up|8|||
155652016|NCT00089583|561818253|FG001|Overall Study|Principal Investigator Decision|10|||
155652017|NCT00089583|561818252|FG000|Overall Study|Start of Disallowed Medication|0|||
155652018|NCT00089583|561818253|FG001|Overall Study|Start of Disallowed Medication|1|||
155652019|NCT00089583|561818252|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
155652020|NCT00089583|561818253|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
155652021|NCT00089583|561818252|FG000|Overall Study|Participant Incarcerated|0|||
155652022|NCT00089583|561818253|FG001|Overall Study|Participant Incarcerated|1|||
155458304|NCT03722784|561098847|FG001|Overall Study|Withdrawal by Subject|0|||
155458305|NCT03722784|561098846|FG000|Overall Study|Physician Decision|1|||
155458306|NCT03722784|561098847|FG001|Overall Study|Physician Decision|1|||
155458307|NCT03722784|561098846|FG000|Overall Study|Protocol Violation|0|||
155458308|NCT03722784|561098847|FG001|Overall Study|Protocol Violation|1|||
155458309|NCT04465396|561098848|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
155458310|NCT04465396|561098849|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
155458311|NCT04465396|561098850|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
155458312|NCT04465396|561098851|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
155458313|NCT01766817|561098853|FG000|Overall Study|Drug-related adverse event|1|||
155458314|NCT01766817|561098854|FG001|Overall Study|Drug-related adverse event|2|||
155516012|NCT00266409|561315726|FG000|Overall Study|Withdrawal by Subject|6|||
155652023|NCT01412983|561818254|FG000|1st Period|Ineligible|0|||
155652024|NCT01412983|561818255|FG001|1st Period|Ineligible|1|||
155652025|NCT01412983|561818254|FG000|1st Period|Positive slit lamp finding|0|||
155458315|NCT01766817|561098855|FG002|Overall Study|Drug-related adverse event|1|||
155458316|NCT01766817|561098853|FG000|Overall Study|Drug-unrelated adverse event|3|||
155458317|NCT01766817|561098854|FG001|Overall Study|Drug-unrelated adverse event|3|||
155458318|NCT01766817|561098855|FG002|Overall Study|Drug-unrelated adverse event|3|||
155458319|NCT01766817|561098853|FG000|Overall Study|Death|1|||
155458320|NCT01766817|561098854|FG001|Overall Study|Death|1|||
155458321|NCT01766817|561098855|FG002|Overall Study|Death|0|||
155458322|NCT01766817|561098853|FG000|Overall Study|Unable to take study drug|0|||
155458323|NCT01766817|561098854|FG001|Overall Study|Unable to take study drug|1|||
155458324|NCT01766817|561098855|FG002|Overall Study|Unable to take study drug|0|||
155458325|NCT01766817|561098853|FG000|Overall Study|Withdrawal by Subject|2|||
155458326|NCT01766817|561098854|FG001|Overall Study|Withdrawal by Subject|0|||
155458327|NCT01766817|561098855|FG002|Overall Study|Withdrawal by Subject|3|||
155458328|NCT01766817|561098853|FG000|Overall Study|Subject non-compliance|0|||
155458329|NCT01766817|561098854|FG001|Overall Study|Subject non-compliance|1|||
155458330|NCT01766817|561098855|FG002|Overall Study|Subject non-compliance|2|||
155458331|NCT01766817|561098853|FG000|Overall Study|Physician Decision|3|||
155458332|NCT01766817|561098854|FG001|Overall Study|Physician Decision|3|||
155458333|NCT01766817|561098855|FG002|Overall Study|Physician Decision|4|||
155458334|NCT01766817|561098853|FG000|Overall Study|Other|1|||
155458335|NCT01766817|561098854|FG001|Overall Study|Other|0|||
155458336|NCT01766817|561098855|FG002|Overall Study|Other|0|||
155458337|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
155458338|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
155458339|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
155458340|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
155458341|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
155458342|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
155458343|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155458344|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155458345|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
155458346|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
155458347|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
155458348|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
155458349|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155458350|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
155458351|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
155458352|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
155458353|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
155458354|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
155458355|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
155458356|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
155458357|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
155458358|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
155458359|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
155458360|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
155458361|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
155458362|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
155458363|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
155458364|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
155458365|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
155458366|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
155458367|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155458368|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
155458369|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
155458370|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
155458371|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
155458372|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
155458373|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
155458374|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
155458375|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
155458376|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
155458377|NCT00383721|561098859|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
155458378|NCT00383721|561098860|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
155458379|NCT00383721|561098861|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
155458380|NCT00383721|561098862|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
155458381|NCT00383721|561098863|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
155458382|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
155458383|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
155458384|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
155458385|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
155458386|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
155458387|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
155458388|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
155458389|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
155458390|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155458391|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
155458392|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
155458393|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155458394|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155458395|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155458396|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155458397|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
155458398|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
155458399|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
155458400|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
155458401|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
155458402|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155458403|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155458404|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155458405|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155458406|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
155458407|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
155458408|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155458409|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155458410|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
155458411|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
155458412|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155458413|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155458414|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155458415|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155458416|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155458417|NCT00383721|561098859|FG000|26-Week Treatment Safety Extension|Administrative|1|||
155458418|NCT00383721|561098860|FG001|26-Week Treatment Safety Extension|Administrative|2|||
155458419|NCT00383721|561098861|FG002|26-Week Treatment Safety Extension|Administrative|3|||
155458420|NCT00383721|561098862|FG003|26-Week Treatment Safety Extension|Administrative|1|||
155458421|NCT00383721|561098863|FG004|26-Week Treatment Safety Extension|Administrative|0|||
155458422|NCT03519516|561098864|FG000|Overall Study|Adverse Event|0|||
155458423|NCT03519516|561098865|FG001|Overall Study|Adverse Event|1|||
155458424|NCT05757427|561098869|FG000|Overall Study|Adverse Event|1|||
155458425|NCT05757427|561098869|FG000|Overall Study|Device deficiency|1|||
155458426|NCT05757427|561098869|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
155458427|NCT05757427|561098869|FG000|Overall Study|MWBI scan of only 1 breast|3|||
155458428|NCT05757427|561098869|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
155458429|NCT01283997|561100557|FG000|Overall Study|Physician Decision|8|||
155458430|NCT01283997|561100558|FG001|Overall Study|Physician Decision|10|||
155458431|NCT01283997|561100557|FG000|Overall Study|Withdrawal by Subject|3|||
155458432|NCT01283997|561100558|FG001|Overall Study|Withdrawal by Subject|2|||
155458433|NCT01283997|561100557|FG000|Overall Study|Physically unable to continue|0|||
155458434|NCT01283997|561100558|FG001|Overall Study|Physically unable to continue|1|||
155458435|NCT01283997|561100557|FG000|Overall Study|Progressive disease|1|||
155458436|NCT01283997|561100558|FG001|Overall Study|Progressive disease|0|||
155458437|NCT01283997|561100557|FG000|Overall Study|Other|4|||
155458438|NCT01283997|561100558|FG001|Overall Study|Other|4|||
155458439|NCT01179347|561100559|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
155458440|NCT01179347|561100560|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
155458441|NCT01179347|561100559|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
155458442|NCT01179347|561100560|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
155458443|NCT01179347|561100559|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
155458444|NCT01179347|561100560|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
155458445|NCT01179347|561100559|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
155458446|NCT01179347|561100560|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
155458447|NCT01179347|561100559|FG000|Double-blind Period (12 Weeks)|Other|2|||
155458448|NCT01179347|561100560|FG001|Double-blind Period (12 Weeks)|Other|4|||
155458449|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
155458450|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
155458451|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
155458452|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
155458453|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
155458454|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
155458455|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
155458456|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
155458457|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
155458458|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
155458459|NCT01179347|561100559|FG000|Open-label Period (12 Weeks)|Other|7|||
155458460|NCT01179347|561100560|FG001|Open-label Period (12 Weeks)|Other|4|||
155458461|NCT02109744|561100561|FG000|Overall Study|Death|1|||
155458462|NCT02109744|561100562|FG001|Overall Study|Death|1|||
155458463|NCT02109744|561100561|FG000|Overall Study|no marrow exam|1|||
155458464|NCT02109744|561100562|FG001|Overall Study|no marrow exam|0|||
155458465|NCT04095442|561100563|FG000|Overall Study|Lost to Follow-up|0|||
155458466|NCT04095442|561100564|FG001|Overall Study|Lost to Follow-up|1|||
155458467|NCT04095442|561100563|FG000|Overall Study|Screen failure|1|||
155458468|NCT04095442|561100564|FG001|Overall Study|Screen failure|0|||
155458469|NCT03833817|561100565|FG000|Overall Study|Withdrawal by Subject|3|||
155458470|NCT03833817|561100566|FG001|Overall Study|Withdrawal by Subject|3|||
155458471|NCT03833817|561100565|FG000|Overall Study|Lost to Follow-up|3|||
155458472|NCT03833817|561100566|FG001|Overall Study|Lost to Follow-up|3|||
155458473|NCT00884221|561100567|FG000|Overall Study|Withdrawal by Subject|0|||
155458474|NCT00884221|561100568|FG001|Overall Study|Withdrawal by Subject|3|||
155458475|NCT00884221|561100567|FG000|Overall Study|Adverse Event|6|||
155458476|NCT00884221|561100568|FG001|Overall Study|Adverse Event|3|||
155458477|NCT00884221|561100567|FG000|Overall Study|Protocol Violation|16|||
155458478|NCT00884221|561100568|FG001|Overall Study|Protocol Violation|13|||
155458479|NCT00884221|561100567|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
155458480|NCT00884221|561100568|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
155458481|NCT00255034|561100571|FG000|Overall Study|Withdrawal by Subject|15|||
155458482|NCT00255034|561100572|FG001|Overall Study|Withdrawal by Subject|38|||
155458483|NCT00424346|561100573|FG000|Core Study|Adverse Event|5|||
155458484|NCT00424346|561100574|FG001|Core Study|Adverse Event|3|||
155458485|NCT00424346|561100575|FG002|Core Study|Adverse Event|1|||
155458486|NCT00424346|561100576|FG003|Core Study|Adverse Event|1|||
155458487|NCT00424346|561100573|FG000|Core Study|Abnormal Laboratory Values|0|||
155458488|NCT00424346|561100574|FG001|Core Study|Abnormal Laboratory Values|1|||
155458489|NCT00424346|561100575|FG002|Core Study|Abnormal Laboratory Values|0|||
155458490|NCT00424346|561100576|FG003|Core Study|Abnormal Laboratory Values|0|||
155458491|NCT00424346|561100573|FG000|Core Study|Lack of Efficacy|1|||
155458492|NCT00424346|561100574|FG001|Core Study|Lack of Efficacy|3|||
155458493|NCT00424346|561100575|FG002|Core Study|Lack of Efficacy|0|||
155458494|NCT00424346|561100576|FG003|Core Study|Lack of Efficacy|4|||
155458495|NCT00424346|561100573|FG000|Core Study|Withdrawal by Subject|1|||
155458496|NCT00424346|561100574|FG001|Core Study|Withdrawal by Subject|0|||
155458497|NCT00424346|561100575|FG002|Core Study|Withdrawal by Subject|0|||
155458498|NCT00424346|561100576|FG003|Core Study|Withdrawal by Subject|2|||
155458499|NCT00424346|561100573|FG000|Core Study|Lost to Follow-up|1|||
155458500|NCT00424346|561100574|FG001|Core Study|Lost to Follow-up|1|||
155458501|NCT00424346|561100575|FG002|Core Study|Lost to Follow-up|0|||
155458502|NCT00424346|561100576|FG003|Core Study|Lost to Follow-up|0|||
155516013|NCT00266409|561315727|FG001|Overall Study|Withdrawal by Subject|10|||
155516014|NCT00266409|561315728|FG002|Overall Study|Withdrawal by Subject|3|||
155516015|NCT00266409|561315729|FG003|Overall Study|Withdrawal by Subject|9|||
155458503|NCT00424346|561100573|FG000|Core Study|Administrative Problems|1|||
155458504|NCT00424346|561100574|FG001|Core Study|Administrative Problems|0|||
155458505|NCT00424346|561100575|FG002|Core Study|Administrative Problems|1|||
155458506|NCT00424346|561100576|FG003|Core Study|Administrative Problems|0|||
155458507|NCT00424346|561100573|FG000|Core Study|Protocol Violation|0|||
155458508|NCT00424346|561100574|FG001|Core Study|Protocol Violation|0|||
155458509|NCT00424346|561100575|FG002|Core Study|Protocol Violation|2|||
155458510|NCT00424346|561100576|FG003|Core Study|Protocol Violation|0|||
155458511|NCT00424346|561100573|FG000|Extension Phase|Adverse Event|0|||
155458512|NCT00424346|561100574|FG001|Extension Phase|Adverse Event|9|||
155458513|NCT00424346|561100575|FG002|Extension Phase|Adverse Event|5|||
155458514|NCT00424346|561100576|FG003|Extension Phase|Adverse Event|4|||
155458515|NCT00424346|561100573|FG000|Extension Phase|Lack of Efficacy|0|||
155458516|NCT00424346|561100574|FG001|Extension Phase|Lack of Efficacy|16|||
155458517|NCT00424346|561100575|FG002|Extension Phase|Lack of Efficacy|14|||
155516016|NCT00266409|561315726|FG000|Overall Study|Protocol Violation|5|||
155458518|NCT00424346|561100576|FG003|Extension Phase|Lack of Efficacy|11|||
155458519|NCT00424346|561100573|FG000|Extension Phase|Withdrawal by Subject|0|||
155458520|NCT00424346|561100574|FG001|Extension Phase|Withdrawal by Subject|5|||
155458521|NCT00424346|561100575|FG002|Extension Phase|Withdrawal by Subject|3|||
155652026|NCT01412983|561818255|FG001|1st Period|Positive slit lamp finding|1|||
155652027|NCT01412983|561818254|FG000|1st Period|Unacceptable lens movement|0|||
155652028|NCT01412983|561818255|FG001|1st Period|Unacceptable lens movement|1|||
155652029|NCT01412983|561818254|FG000|1st Period|Inability to maintain wear|0|||
155652030|NCT01412983|561818255|FG001|1st Period|Inability to maintain wear|1|||
155652031|NCT01623154|561818256|FG000|Overall Study|Did not drink Pranactin Citric|4|||
155652032|NCT04349098|561818257|FG000|Overall Study|Death|16|||
155652033|NCT04349098|561818258|FG001|Overall Study|Death|8|||
155652034|NCT04349098|561818257|FG000|Overall Study|Lost to Follow-up|11|||
155652035|NCT04349098|561818258|FG001|Overall Study|Lost to Follow-up|8|||
155652036|NCT04349098|561818257|FG000|Overall Study|Withdrawal by Subject|8|||
155652037|NCT04349098|561818258|FG001|Overall Study|Withdrawal by Subject|5|||
155652038|NCT04349098|561818257|FG000|Overall Study|Other|3|||
155652039|NCT04349098|561818258|FG001|Overall Study|Other|5|||
155652040|NCT00800384|561818259|FG000|Overall Study|Withdrawal by Subject|24|||
155652041|NCT00800384|561818260|FG001|Overall Study|Withdrawal by Subject|17|||
155652042|NCT00800384|561818259|FG000|Overall Study|Lost to Follow-up|17|||
155652043|NCT00800384|561818260|FG001|Overall Study|Lost to Follow-up|26|||
155652044|NCT01245049|561818262|FG000|Overall Study|Migrated/moved from study area|0|||
155652045|NCT01245049|561818263|FG001|Overall Study|Migrated/moved from study area|1|||
155652046|NCT01245049|561818262|FG000|Overall Study|Withdrawal by Subject|0|||
155652047|NCT01245049|561818263|FG001|Overall Study|Withdrawal by Subject|1|||
155652048|NCT01245049|561818262|FG000|Overall Study|Lost to Follow-up|1|||
155652049|NCT01245049|561818263|FG001|Overall Study|Lost to Follow-up|2|||
155652050|NCT00450749|561818264|FG000|Overall Study|Withdrawal by Subject|0|||
155652051|NCT00450749|561818265|FG001|Overall Study|Withdrawal by Subject|0|||
155652052|NCT00450749|561818266|FG002|Overall Study|Withdrawal by Subject|2|||
155652053|NCT00450749|561818264|FG000|Overall Study|Noncompliant|0|||
155652054|NCT00450749|561818265|FG001|Overall Study|Noncompliant|1|||
155652055|NCT00450749|561818266|FG002|Overall Study|Noncompliant|0|||
155652056|NCT00537082|561818267|FG000|Overall Study|Adverse Event|6|||
155652057|NCT00537082|561818268|FG001|Overall Study|Adverse Event|6|||
155652058|NCT00537082|561818269|FG002|Overall Study|Adverse Event|3|||
155652059|NCT00537082|561818267|FG000|Overall Study|Protocol Violation|0|||
155652060|NCT00537082|561818268|FG001|Overall Study|Protocol Violation|2|||
155652061|NCT00537082|561818269|FG002|Overall Study|Protocol Violation|1|||
155652062|NCT00537082|561818267|FG000|Overall Study|Lack of Efficacy|0|||
155652063|NCT00537082|561818268|FG001|Overall Study|Lack of Efficacy|0|||
155652064|NCT00537082|561818269|FG002|Overall Study|Lack of Efficacy|2|||
155652065|NCT00537082|561818267|FG000|Overall Study|Withdrawal by Subject|0|||
155652066|NCT00537082|561818268|FG001|Overall Study|Withdrawal by Subject|1|||
155652067|NCT00537082|561818269|FG002|Overall Study|Withdrawal by Subject|0|||
155652068|NCT00537082|561818267|FG000|Overall Study|Discontinued before initiating treatment|3|||
155652069|NCT00537082|561818268|FG001|Overall Study|Discontinued before initiating treatment|0|||
155652070|NCT00537082|561818269|FG002|Overall Study|Discontinued before initiating treatment|0|||
155652071|NCT04495478|561818270|FG000|Overall Study|Withdrawal by Subject|0|||
155652072|NCT04495478|561818271|FG001|Overall Study|Withdrawal by Subject|0|||
155652073|NCT04495478|561818272|FG002|Overall Study|Withdrawal by Subject|0|||
155652074|NCT04495478|561818273|FG003|Overall Study|Withdrawal by Subject|1|||
155652075|NCT04495478|561818274|FG004|Overall Study|Withdrawal by Subject|0|||
155652076|NCT04495478|561818275|FG005|Overall Study|Withdrawal by Subject|0|||
155652077|NCT04495478|561818276|FG006|Overall Study|Withdrawal by Subject|0|||
155652078|NCT04495478|561818270|FG000|Overall Study|Physician Decision|0|||
155652079|NCT04495478|561818271|FG001|Overall Study|Physician Decision|1|||
155652080|NCT04495478|561818272|FG002|Overall Study|Physician Decision|0|||
155652081|NCT04495478|561818273|FG003|Overall Study|Physician Decision|0|||
155652082|NCT04495478|561818274|FG004|Overall Study|Physician Decision|1|||
155652083|NCT04495478|561818275|FG005|Overall Study|Physician Decision|0|||
155652084|NCT04495478|561818276|FG006|Overall Study|Physician Decision|0|||
155652085|NCT03061214|561818278|FG000|Overall Study|Withdrawal by Subject|21|||
155652086|NCT03061214|561818279|FG001|Overall Study|Withdrawal by Subject|26|||
155652087|NCT03061214|561818280|FG002|Overall Study|Withdrawal by Subject|9|||
155652088|NCT03061214|561818278|FG000|Overall Study|Lost to Follow-up|3|||
155652089|NCT03061214|561818279|FG001|Overall Study|Lost to Follow-up|1|||
155652090|NCT03061214|561818280|FG002|Overall Study|Lost to Follow-up|1|||
155652091|NCT03061214|561818278|FG000|Overall Study|Death|1|||
155652092|NCT03061214|561818279|FG001|Overall Study|Death|1|||
155458522|NCT00424346|561100576|FG003|Extension Phase|Withdrawal by Subject|4|||
155652093|NCT03061214|561818280|FG002|Overall Study|Death|0|||
155652094|NCT01537432|561820214|FG000|Overall Study|Lost to Follow-up|3|||
155652095|NCT01537432|561820215|FG001|Overall Study|Lost to Follow-up|1|||
155652096|NCT01537432|561820214|FG000|Overall Study|Withdrawal by Subject|0|||
155652097|NCT01537432|561820215|FG001|Overall Study|Withdrawal by Subject|1|||
155652098|NCT01537432|561820214|FG000|Overall Study|Administrative problems|1|||
155652099|NCT01537432|561820215|FG001|Overall Study|Administrative problems|0|||
155652100|NCT01537432|561820214|FG000|Overall Study|Adverse Event|1|||
155652101|NCT01537432|561820215|FG001|Overall Study|Adverse Event|0|||
155652102|NCT01537432|561820214|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155652103|NCT01537432|561820215|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155652104|NCT00889005|561820218|FG000|Overall Study|Lost to Follow-up|4|||
155652105|NCT00889005|561820219|FG001|Overall Study|Lost to Follow-up|2|||
155652106|NCT00889005|561820218|FG000|Overall Study|Withdrawal by Subject|4|||
155652107|NCT00889005|561820219|FG001|Overall Study|Withdrawal by Subject|0|||
155652108|NCT01998477|561820220|FG000|Overall Study|Lost to Follow-up|4|||
155652109|NCT01998477|561820221|FG001|Overall Study|Lost to Follow-up|5|||
155652110|NCT01998477|561820220|FG000|Overall Study|Withdrawal by Subject|6|||
155652111|NCT01998477|561820221|FG001|Overall Study|Withdrawal by Subject|0|||
155652112|NCT00129974|561820222|FG000|Overall Study|Other|1|||
155652113|NCT00128492|561820223|FG000|Overall Study|AE unrelated to study|2|||
155652114|NCT00128492|561820224|FG001|Overall Study|AE unrelated to study|9|||
155652115|NCT00128492|561820223|FG000|Overall Study|Study drug intolerance (AE)|2|||
155652116|NCT00128492|561820224|FG001|Overall Study|Study drug intolerance (AE)|8|||
155652117|NCT00128492|561820223|FG000|Overall Study|AE related to study|1|||
155652118|NCT00128492|561820224|FG001|Overall Study|AE related to study|4|||
155652119|NCT00128492|561820223|FG000|Overall Study|Death|1|||
155652120|NCT00128492|561820224|FG001|Overall Study|Death|0|||
155652121|NCT00128492|561820223|FG000|Overall Study|Lost to Follow-up|1|||
155652122|NCT00128492|561820224|FG001|Overall Study|Lost to Follow-up|5|||
155652123|NCT00128492|561820223|FG000|Overall Study|Noncompliance|0|||
155652124|NCT00128492|561820224|FG001|Overall Study|Noncompliance|5|||
155458523|NCT00424346|561100573|FG000|Extension Phase|Lost to Follow-up|0|||
155458524|NCT00424346|561100574|FG001|Extension Phase|Lost to Follow-up|2|||
155458525|NCT00424346|561100575|FG002|Extension Phase|Lost to Follow-up|0|||
155458526|NCT00424346|561100576|FG003|Extension Phase|Lost to Follow-up|0|||
155458527|NCT00424346|561100573|FG000|Extension Phase|Administrative Problems|0|||
155458528|NCT00424346|561100574|FG001|Extension Phase|Administrative Problems|69|||
155458529|NCT00424346|561100575|FG002|Extension Phase|Administrative Problems|32|||
155458530|NCT00424346|561100576|FG003|Extension Phase|Administrative Problems|35|||
155458531|NCT00424346|561100573|FG000|Extension Phase|Death|0|||
155458532|NCT00424346|561100574|FG001|Extension Phase|Death|0|||
155458533|NCT00424346|561100575|FG002|Extension Phase|Death|0|||
155458534|NCT00424346|561100576|FG003|Extension Phase|Death|1|||
155458535|NCT00424346|561100573|FG000|Extension Phase|Protocol Violation|0|||
155458536|NCT00424346|561100574|FG001|Extension Phase|Protocol Violation|1|||
155458537|NCT00424346|561100575|FG002|Extension Phase|Protocol Violation|1|||
155458538|NCT00424346|561100576|FG003|Extension Phase|Protocol Violation|0|||
155458539|NCT03947255|561100578|FG000|Overall Study|Study Closure by Sponsor|2|||
155458540|NCT03947255|561100579|FG001|Overall Study|Study Closure by Sponsor|2|||
155458541|NCT03947255|561100578|FG000|Overall Study|Withdrawal by Subject|2|||
155458542|NCT03947255|561100579|FG001|Overall Study|Withdrawal by Subject|2|||
155458543|NCT03947255|561100578|FG000|Overall Study|Lost to Follow-up|2|||
155458544|NCT03947255|561100579|FG001|Overall Study|Lost to Follow-up|0|||
155458545|NCT03947255|561100578|FG000|Overall Study|Death|0|||
155458546|NCT03947255|561100579|FG001|Overall Study|Death|2|||
155458547|NCT02499575|561100580|FG000|Overall Study|Protocol Violation|0|||
155458548|NCT02499575|561100581|FG001|Overall Study|Protocol Violation|1|||
155458549|NCT01245764|561100585|FG000|Study Phase A|Other|3|||
155458550|NCT01245764|561100586|FG001|Study Phase A|Other|2|||
155458551|NCT01245764|561100587|FG002|Study Phase A|Other|3|||
155458552|NCT01245764|561100588|FG003|Study Phase A|Other|1|||
155652125|NCT00128492|561820223|FG000|Overall Study|Personal or administrative|10|||
155652126|NCT00128492|561820224|FG001|Overall Study|Personal or administrative|22|||
155652127|NCT00128492|561820223|FG000|Overall Study|Withdrawal by Subject|3|||
155652128|NCT00128492|561820224|FG001|Overall Study|Withdrawal by Subject|5|||
155652129|NCT00128492|561820223|FG000|Overall Study|Pregnancy|0|||
155652130|NCT00128492|561820224|FG001|Overall Study|Pregnancy|1|||
155458553|NCT01245764|561100585|FG000|Study Phase A|Protocol Violation|6|||
155458554|NCT01245764|561100586|FG001|Study Phase A|Protocol Violation|3|||
155458555|NCT01245764|561100587|FG002|Study Phase A|Protocol Violation|2|||
155458556|NCT01245764|561100588|FG003|Study Phase A|Protocol Violation|2|||
155458557|NCT01245764|561100585|FG000|Study Phase A|Lost to Follow-up|0|||
155458558|NCT01245764|561100586|FG001|Study Phase A|Lost to Follow-up|0|||
155458559|NCT01245764|561100587|FG002|Study Phase A|Lost to Follow-up|5|||
155458560|NCT01245764|561100588|FG003|Study Phase A|Lost to Follow-up|0|||
155458561|NCT02667457|561100589|FG000|Overall Study|Withdrawal by Subject|1|||
155458562|NCT02667457|561100590|FG001|Overall Study|Withdrawal by Subject|0|||
155458563|NCT02667457|561100589|FG000|Overall Study|Other Reason|0|||
155458564|NCT02667457|561100590|FG001|Overall Study|Other Reason|2|||
155652131|NCT00867334|561820229|FG000|Overall Study|Withdrawal by Subject|0|||
155652132|NCT00867334|561820230|FG001|Overall Study|Withdrawal by Subject|1|||
155652133|NCT00867334|561820229|FG000|Overall Study|Withdrawal by Subject|1|||
155458565|NCT03097614|561100591|FG000|Overall Study|Adverse Event|3|||
155458566|NCT00781963|561100592|FG000|Overall Study|Death|3|||
155652134|NCT00867334|561820230|FG001|Overall Study|Withdrawal by Subject|0|||
155516017|NCT00266409|561315727|FG001|Overall Study|Protocol Violation|3|||
155458567|NCT00781963|561100593|FG001|Overall Study|Death|0|||
155458568|NCT00781963|561100592|FG000|Overall Study|Lost to Follow-up|2|||
155458569|NCT00781963|561100593|FG001|Overall Study|Lost to Follow-up|1|||
155458570|NCT00781963|561100592|FG000|Overall Study|Withdrawal by Subject|3|||
155458571|NCT00781963|561100593|FG001|Overall Study|Withdrawal by Subject|1|||
155458572|NCT00781963|561100592|FG000|Overall Study|Refused follow-up|9|||
155458573|NCT00781963|561100593|FG001|Overall Study|Refused follow-up|0|||
155458574|NCT03297216|561100594|FG000|Overall Study|Death|0|||
155458575|NCT03297216|561100595|FG001|Overall Study|Death|1|||
155458576|NCT03297216|561100594|FG000|Overall Study|Miscarriage|0|||
155458577|NCT03297216|561100595|FG001|Overall Study|Miscarriage|2|||
155458578|NCT03297216|561100594|FG000|Overall Study|Lost to Follow-up|3|||
155458579|NCT03297216|561100595|FG001|Overall Study|Lost to Follow-up|2|||
155458580|NCT00436982|561100600|FG000|Overall Study|Withdrawal by Subject|3|||
155458581|NCT00436982|561100601|FG001|Overall Study|Withdrawal by Subject|1|||
155458582|NCT00436982|561100600|FG000|Overall Study|Did not receive allocated intervention|0|||
155458583|NCT00436982|561100601|FG001|Overall Study|Did not receive allocated intervention|1|||
155458584|NCT00436982|561100600|FG000|Overall Study|no RSA data|1|||
155458585|NCT00436982|561100601|FG001|Overall Study|no RSA data|2|||
155458586|NCT00953225|561100602|FG000|Overall Study|Withdrawal by Subject|2|||
155458587|NCT00953225|561100603|FG001|Overall Study|Withdrawal by Subject|0|||
155458588|NCT04058158|561100607|FG000|Period 1|Death|1|||
155458589|NCT04058158|561100608|FG001|Period 1|Death|0|||
155458590|NCT04058158|561100607|FG000|Period 1|Adverse Event|1|||
155458591|NCT04058158|561100608|FG001|Period 1|Adverse Event|1|||
155458592|NCT04058158|561100607|FG000|Period 1|Pregnancy|0|||
155458593|NCT04058158|561100608|FG001|Period 1|Pregnancy|1|||
155458594|NCT01634113|561100609|FG000|Overall Study|Not treated|0|||
155458595|NCT01634113|561100610|FG001|Overall Study|Not treated|0|||
155458596|NCT01634113|561100611|FG002|Overall Study|Not treated|1|||
155458597|NCT01956240|561100614|FG000|Overall Study|Lost to Follow-up|6|||
155458598|NCT01956240|561100615|FG001|Overall Study|Lost to Follow-up|20|||
155458599|NCT01956240|561100614|FG000|Overall Study|Adverse Event|17|||
155458600|NCT01956240|561100615|FG001|Overall Study|Adverse Event|4|||
155458601|NCT01830816|561100619|FG000|Overall Study|Progressive Disease|12|||
155458602|NCT01830816|561100620|FG001|Overall Study|Progressive Disease|7|||
155458603|NCT01830816|561100621|FG002|Overall Study|Progressive Disease|7|||
155458604|NCT01830816|561100619|FG000|Overall Study|Adverse Event|3|||
155458605|NCT01830816|561100620|FG001|Overall Study|Adverse Event|4|||
155458606|NCT01830816|561100621|FG002|Overall Study|Adverse Event|0|||
155458607|NCT01830816|561100619|FG000|Overall Study|Study Terminated by Sponsor|1|||
155458608|NCT01830816|561100620|FG001|Overall Study|Study Terminated by Sponsor|1|||
155458609|NCT01830816|561100621|FG002|Overall Study|Study Terminated by Sponsor|0|||
155458610|NCT01830816|561100619|FG000|Overall Study|Withdrawal by Subject|1|||
155458611|NCT01830816|561100620|FG001|Overall Study|Withdrawal by Subject|1|||
155458612|NCT01830816|561100621|FG002|Overall Study|Withdrawal by Subject|0|||
155458613|NCT01830816|561100619|FG000|Overall Study|Lost to Follow-up|0|||
155458614|NCT01830816|561100620|FG001|Overall Study|Lost to Follow-up|1|||
155458615|NCT01830816|561100621|FG002|Overall Study|Lost to Follow-up|0|||
155458616|NCT01830816|561100619|FG000|Overall Study|Symptomatic Deterioration|1|||
155458617|NCT01830816|561100620|FG001|Overall Study|Symptomatic Deterioration|0|||
155458618|NCT01830816|561100621|FG002|Overall Study|Symptomatic Deterioration|0|||
155458619|NCT01830816|561100619|FG000|Overall Study|Reason not Specified|2|||
155516018|NCT00266409|561315728|FG002|Overall Study|Protocol Violation|4|||
155516019|NCT00266409|561315729|FG003|Overall Study|Protocol Violation|2|||
155516020|NCT00266409|561315726|FG000|Overall Study|Other|7|||
155458620|NCT01830816|561100620|FG001|Overall Study|Reason not Specified|0|||
155458621|NCT01830816|561100621|FG002|Overall Study|Reason not Specified|0|||
155458622|NCT03172481|561100622|FG000|Double-blind|Withdrawal by Subject|1|||
155458623|NCT03172481|561100623|FG001|Double-blind|Withdrawal by Subject|0|||
155458624|NCT02759562|561100627|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
155458625|NCT02759562|561100628|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
155458626|NCT02759562|561100627|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
155458627|NCT02759562|561100628|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
155458628|NCT02293993|561100629|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
155458629|NCT02293993|561100630|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
155458630|NCT02293993|561100631|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
155458631|NCT02293993|561100632|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
155458632|NCT02293993|561100629|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
155458633|NCT02293993|561100630|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
155458634|NCT02293993|561100631|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
155458635|NCT02293993|561100632|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
155516021|NCT00266409|561315727|FG001|Overall Study|Other|4|||
155516022|NCT00266409|561315728|FG002|Overall Study|Other|2|||
155516023|NCT00266409|561315729|FG003|Overall Study|Other|0|||
155516024|NCT01766921|561315735|FG000|Overall Study|Administrative Reason|5|||
155516025|NCT01766921|561315736|FG001|Overall Study|Administrative Reason|5|||
155516026|NCT01766921|561315735|FG000|Overall Study|Death|1|||
155516027|NCT01766921|561315736|FG001|Overall Study|Death|1|||
155458636|NCT02293993|561100629|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
155458637|NCT02293993|561100630|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
155458638|NCT02293993|561100631|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
155458639|NCT02293993|561100632|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
155458640|NCT02293993|561100629|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
155458641|NCT02293993|561100630|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
155458642|NCT02293993|561100631|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
155458643|NCT02293993|561100632|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
155458644|NCT02293993|561100629|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
155458645|NCT02293993|561100630|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
155458646|NCT02293993|561100631|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
155458647|NCT02293993|561100632|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
155458648|NCT03587584|561100633|FG000|Overall Study|SOC deviations|4|||
155458649|NCT03587584|561100634|FG001|Overall Study|SOC deviations|6|||
155458650|NCT03587584|561100633|FG000|Overall Study|Incomplete data|0|||
155458651|NCT03587584|561100634|FG001|Overall Study|Incomplete data|3|||
155458652|NCT00830115|561100635|FG000|Overall Study|Adverse Event|2|||
155458653|NCT00830115|561100635|FG000|Overall Study|Improvement/recovery|1|||
155458654|NCT01061736|561100645|FG000|Overall Study|Dose regimen not selected|0|||
155458655|NCT01061736|561100646|FG001|Overall Study|Dose regimen not selected|0|||
155458656|NCT01061736|561100647|FG002|Overall Study|Dose regimen not selected|0|||
155516028|NCT01766921|561315735|FG000|Overall Study|Lost to Follow-up|1|||
155516029|NCT01766921|561315736|FG001|Overall Study|Lost to Follow-up|3|||
155516030|NCT01766921|561315735|FG000|Overall Study|Unclassified|2|||
155458657|NCT01061736|561100648|FG003|Overall Study|Dose regimen not selected|0|||
155458658|NCT01061736|561100649|FG004|Overall Study|Dose regimen not selected|0|||
155458659|NCT01061736|561100650|FG005|Overall Study|Dose regimen not selected|0|||
155458660|NCT01061736|561100651|FG006|Overall Study|Dose regimen not selected|79|||
155458661|NCT01061736|561100652|FG007|Overall Study|Dose regimen not selected|0|||
155458662|NCT01061736|561100653|FG008|Overall Study|Dose regimen not selected|0|||
155458663|NCT01061736|561100654|FG009|Overall Study|Dose regimen not selected|0|||
155458664|NCT01061736|561100645|FG000|Overall Study|Adverse Event|13|||
155458665|NCT01061736|561100646|FG001|Overall Study|Adverse Event|1|||
155458666|NCT01061736|561100647|FG002|Overall Study|Adverse Event|3|||
155458667|NCT01061736|561100648|FG003|Overall Study|Adverse Event|2|||
155458668|NCT01061736|561100649|FG004|Overall Study|Adverse Event|4|||
155458669|NCT01061736|561100650|FG005|Overall Study|Adverse Event|1|||
155458670|NCT01061736|561100651|FG006|Overall Study|Adverse Event|4|||
155458671|NCT01061736|561100652|FG007|Overall Study|Adverse Event|63|||
155458672|NCT01061736|561100653|FG008|Overall Study|Adverse Event|67|||
155458673|NCT01061736|561100654|FG009|Overall Study|Adverse Event|34|||
155458674|NCT01061736|561100645|FG000|Overall Study|Lack of Efficacy|0|||
155458675|NCT01061736|561100646|FG001|Overall Study|Lack of Efficacy|2|||
155458676|NCT01061736|561100647|FG002|Overall Study|Lack of Efficacy|1|||
155458677|NCT01061736|561100648|FG003|Overall Study|Lack of Efficacy|1|||
155458678|NCT01061736|561100649|FG004|Overall Study|Lack of Efficacy|1|||
155458679|NCT01061736|561100650|FG005|Overall Study|Lack of Efficacy|2|||
155458680|NCT01061736|561100651|FG006|Overall Study|Lack of Efficacy|1|||
155458681|NCT01061736|561100652|FG007|Overall Study|Lack of Efficacy|9|||
155458682|NCT01061736|561100653|FG008|Overall Study|Lack of Efficacy|9|||
155458683|NCT01061736|561100654|FG009|Overall Study|Lack of Efficacy|10|||
155458684|NCT01061736|561100645|FG000|Overall Study|Poor compliance to protocol|0|||
155458685|NCT01061736|561100646|FG001|Overall Study|Poor compliance to protocol|0|||
155458686|NCT01061736|561100647|FG002|Overall Study|Poor compliance to protocol|0|||
155458687|NCT01061736|561100648|FG003|Overall Study|Poor compliance to protocol|0|||
155458688|NCT01061736|561100649|FG004|Overall Study|Poor compliance to protocol|0|||
155458689|NCT01061736|561100650|FG005|Overall Study|Poor compliance to protocol|0|||
155458690|NCT01061736|561100651|FG006|Overall Study|Poor compliance to protocol|0|||
155458691|NCT01061736|561100652|FG007|Overall Study|Poor compliance to protocol|2|||
155458692|NCT01061736|561100653|FG008|Overall Study|Poor compliance to protocol|5|||
155458693|NCT01061736|561100654|FG009|Overall Study|Poor compliance to protocol|9|||
155458694|NCT01061736|561100645|FG000|Overall Study|Not treated|0|||
155458695|NCT01061736|561100646|FG001|Overall Study|Not treated|0|||
155458696|NCT01061736|561100647|FG002|Overall Study|Not treated|0|||
155458697|NCT01061736|561100648|FG003|Overall Study|Not treated|0|||
155458698|NCT01061736|561100649|FG004|Overall Study|Not treated|1|||
155458699|NCT01061736|561100650|FG005|Overall Study|Not treated|0|||
155458700|NCT01061736|561100651|FG006|Overall Study|Not treated|0|||
155458701|NCT01061736|561100652|FG007|Overall Study|Not treated|2|||
155458702|NCT01061736|561100653|FG008|Overall Study|Not treated|1|||
155458703|NCT01061736|561100654|FG009|Overall Study|Not treated|0|||
155458704|NCT01061736|561100645|FG000|Overall Study|Other than specified above|0|||
155458705|NCT01061736|561100646|FG001|Overall Study|Other than specified above|1|||
155458706|NCT01061736|561100647|FG002|Overall Study|Other than specified above|2|||
155458707|NCT01061736|561100648|FG003|Overall Study|Other than specified above|0|||
155458708|NCT01061736|561100649|FG004|Overall Study|Other than specified above|1|||
155458709|NCT01061736|561100650|FG005|Overall Study|Other than specified above|0|||
155458710|NCT01061736|561100651|FG006|Overall Study|Other than specified above|0|||
155458711|NCT01061736|561100652|FG007|Overall Study|Other than specified above|18|||
155516031|NCT01766921|561315736|FG001|Overall Study|Unclassified|2|||
155458712|NCT01061736|561100653|FG008|Overall Study|Other than specified above|15|||
155458713|NCT01061736|561100654|FG009|Overall Study|Other than specified above|21|||
155458714|NCT03115112|561100655|FG000|Overall Study|Adverse Event|5|||
155458715|NCT03115112|561100656|FG001|Overall Study|Adverse Event|1|||
155458716|NCT03115112|561100655|FG000|Overall Study|Withdrawal by Subject|4|||
155458717|NCT03115112|561100656|FG001|Overall Study|Withdrawal by Subject|2|||
155458718|NCT03115112|561100655|FG000|Overall Study|Lost to Follow-up|0|||
155458719|NCT03115112|561100656|FG001|Overall Study|Lost to Follow-up|1|||
155458720|NCT03115112|561100655|FG000|Overall Study|Death|1|||
155458721|NCT03115112|561100656|FG001|Overall Study|Death|0|||
155458722|NCT03115112|561100655|FG000|Overall Study|Pregnancy|1|||
155458723|NCT03115112|561100656|FG001|Overall Study|Pregnancy|0|||
155458724|NCT03115112|561100655|FG000|Overall Study|Site closure|1|||
155458725|NCT03115112|561100656|FG001|Overall Study|Site closure|1|||
155458726|NCT01610076|561100657|FG000|Overall Study|Technical issue with video|0|||
155458727|NCT01610076|561100658|FG001|Overall Study|Technical issue with video|1|||
155458728|NCT01610076|561100657|FG000|Overall Study|Lost to Follow-up|3|||
155458729|NCT01610076|561100658|FG001|Overall Study|Lost to Follow-up|4|||
155458730|NCT00980343|561100663|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
155458731|NCT00980343|561100664|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
155458732|NCT02899377|561100669|FG000|Overall Study|Adverse Event|1|||
155458733|NCT02899377|561100670|FG001|Overall Study|Adverse Event|0|||
155458734|NCT01231607|561100671|FG000|Overall Study|Adverse Event|0|||
155458735|NCT01231607|561100672|FG001|Overall Study|Adverse Event|8|||
155458736|NCT01231607|561100673|FG002|Overall Study|Adverse Event|4|||
155458737|NCT01231607|561100674|FG003|Overall Study|Adverse Event|4|||
155458738|NCT01231607|561100675|FG004|Overall Study|Adverse Event|5|||
155458739|NCT01231607|561100671|FG000|Overall Study|Lost to Follow-up|13|||
155458740|NCT01231607|561100672|FG001|Overall Study|Lost to Follow-up|11|||
155458741|NCT01231607|561100673|FG002|Overall Study|Lost to Follow-up|10|||
155458742|NCT01231607|561100674|FG003|Overall Study|Lost to Follow-up|10|||
155458743|NCT01231607|561100675|FG004|Overall Study|Lost to Follow-up|4|||
155458744|NCT01231607|561100671|FG000|Overall Study|Physician Decision|4|||
155458745|NCT01231607|561100672|FG001|Overall Study|Physician Decision|4|||
155458746|NCT01231607|561100673|FG002|Overall Study|Physician Decision|3|||
155458747|NCT01231607|561100674|FG003|Overall Study|Physician Decision|5|||
155458748|NCT01231607|561100675|FG004|Overall Study|Physician Decision|4|||
155458749|NCT01231607|561100671|FG000|Overall Study|Protocol Violation|3|||
155458750|NCT01231607|561100672|FG001|Overall Study|Protocol Violation|2|||
155458751|NCT01231607|561100673|FG002|Overall Study|Protocol Violation|0|||
155458752|NCT01231607|561100674|FG003|Overall Study|Protocol Violation|2|||
155458753|NCT01231607|561100675|FG004|Overall Study|Protocol Violation|2|||
155458754|NCT01231607|561100671|FG000|Overall Study|Withdrawal by Subject|9|||
155458755|NCT01231607|561100672|FG001|Overall Study|Withdrawal by Subject|9|||
155458756|NCT01231607|561100673|FG002|Overall Study|Withdrawal by Subject|14|||
155458757|NCT01231607|561100674|FG003|Overall Study|Withdrawal by Subject|17|||
155458758|NCT01231607|561100675|FG004|Overall Study|Withdrawal by Subject|9|||
155458759|NCT00098020|561100687|FG000|Overall Study|Adverse Event|2|||
155458760|NCT00098020|561100687|FG000|Overall Study|Lost to Follow-up|1|||
155458761|NCT00098020|561100687|FG000|Overall Study|elevated liver enzymes|1|||
155458762|NCT00098020|561100687|FG000|Overall Study|Low urine PCR|1|||
155458763|NCT00098020|561100687|FG000|Overall Study|Low epidermal growth factor receptor|1|||
155458764|NCT01453998|561100688|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
155458765|NCT01453998|561100689|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
155458766|NCT01453998|561100690|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
155458767|NCT01840228|561100691|FG000|Overall Study|Lost to Follow-up|1|||
155458768|NCT01840228|561100692|FG001|Overall Study|Lost to Follow-up|1|||
155458769|NCT03495453|561100695|FG000|Overall Study|Withdrawal by Subject|0|||
155458770|NCT03495453|561100696|FG001|Overall Study|Withdrawal by Subject|1|||
155458771|NCT00712933|561100697|FG000|Overall Study|Adverse Event|69|||
155458772|NCT00712933|561100697|FG000|Overall Study|Lack of Efficacy|6|||
155458773|NCT00712933|561100697|FG000|Overall Study|Lost to Follow-up|22|||
155458774|NCT00712933|561100697|FG000|Overall Study|Non-compliance with study drug|13|||
155458775|NCT00712933|561100697|FG000|Overall Study|Other Pregnancy|37|||
155458776|NCT00712933|561100697|FG000|Overall Study|Sponsor decision|14|||
155458777|NCT00712933|561100697|FG000|Overall Study|Withdrew consent|4|||
155458778|NCT00712933|561100697|FG000|Overall Study|Hip replacement surgery|1|||
155458779|NCT00712933|561100697|FG000|Overall Study|Involved in Clinical research|3|||
155458780|NCT00712933|561100697|FG000|Overall Study|Participant hospitalized|1|||
155458781|NCT00712933|561100697|FG000|Overall Study|Participant travelled overseas|2|||
155458782|NCT00712933|561100697|FG000|Overall Study|Death of patient|1|||
155458783|NCT00712933|561100697|FG000|Overall Study|Other Physician decision|1|||
155458784|NCT00712933|561100697|FG000|Overall Study|Not committed to contraception|1|||
155458785|NCT00712933|561100697|FG000|Overall Study|Participant received medication|1|||
155458786|NCT00712933|561100697|FG000|Overall Study|Physician Decision|36|||
155458787|NCT00712933|561100697|FG000|Overall Study|Protocol Violation|4|||
155458788|NCT00712933|561100697|FG000|Overall Study|Withdrawal by Subject|151|||
155458789|NCT01360762|561100700|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
155458790|NCT01360762|561100700|FG000|Main Study Period (12-month Treatment)|Death|5|||
155458791|NCT01360762|561100700|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
155458792|NCT01360762|561100700|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
155458793|NCT01360762|561100700|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
155458794|NCT01360762|561100700|FG000|Whole Study Period|Lost to Follow-up|10|||
155458795|NCT01360762|561100700|FG000|Whole Study Period|Death|7|||
155458796|NCT01360762|561100700|FG000|Whole Study Period|Patient relapsed|18|||
155458797|NCT01360762|561100700|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
155458798|NCT03084718|561100701|FG000|Overall Study|Withdrawal by Subject|4|||
155458799|NCT03084718|561100702|FG001|Overall Study|Withdrawal by Subject|3|||
155458800|NCT03084718|561100703|FG002|Overall Study|Withdrawal by Subject|4|||
155458801|NCT03084718|561100704|FG003|Overall Study|Withdrawal by Subject|0|||
155458802|NCT03084718|561100705|FG004|Overall Study|Withdrawal by Subject|0|||
155458803|NCT03084718|561100701|FG000|Overall Study|Physician Decision|1|||
155458804|NCT03084718|561100702|FG001|Overall Study|Physician Decision|0|||
155458805|NCT03084718|561100703|FG002|Overall Study|Physician Decision|0|||
155458806|NCT03084718|561100704|FG003|Overall Study|Physician Decision|0|||
155458807|NCT03084718|561100705|FG004|Overall Study|Physician Decision|0|||
155458808|NCT03084718|561100701|FG000|Overall Study|Adverse Event|3|||
155458809|NCT03084718|561100702|FG001|Overall Study|Adverse Event|5|||
155458810|NCT03084718|561100703|FG002|Overall Study|Adverse Event|5|||
155458811|NCT03084718|561100704|FG003|Overall Study|Adverse Event|8|||
155458812|NCT03084718|561100705|FG004|Overall Study|Adverse Event|2|||
155458813|NCT03084718|561100701|FG000|Overall Study|Lack of Efficacy|2|||
155458814|NCT03084718|561100702|FG001|Overall Study|Lack of Efficacy|0|||
155458815|NCT03084718|561100703|FG002|Overall Study|Lack of Efficacy|1|||
155458816|NCT03084718|561100704|FG003|Overall Study|Lack of Efficacy|4|||
155458817|NCT03084718|561100705|FG004|Overall Study|Lack of Efficacy|0|||
155458818|NCT03084718|561100701|FG000|Overall Study|Lost to Follow-up|0|||
155458819|NCT03084718|561100702|FG001|Overall Study|Lost to Follow-up|1|||
155458820|NCT03084718|561100703|FG002|Overall Study|Lost to Follow-up|0|||
155458821|NCT03084718|561100704|FG003|Overall Study|Lost to Follow-up|0|||
155458822|NCT03084718|561100705|FG004|Overall Study|Lost to Follow-up|2|||
155458823|NCT03084718|561100701|FG000|Overall Study|Protocol Violation|0|||
155458824|NCT03084718|561100702|FG001|Overall Study|Protocol Violation|0|||
155458825|NCT03084718|561100703|FG002|Overall Study|Protocol Violation|1|||
155458826|NCT03084718|561100704|FG003|Overall Study|Protocol Violation|0|||
155458827|NCT03084718|561100705|FG004|Overall Study|Protocol Violation|0|||
155458828|NCT03084718|561100701|FG000|Overall Study|Death|0|||
155458829|NCT03084718|561100702|FG001|Overall Study|Death|1|||
155458830|NCT03084718|561100703|FG002|Overall Study|Death|0|||
155458831|NCT03084718|561100704|FG003|Overall Study|Death|0|||
155516032|NCT01766921|561315735|FG000|Overall Study|Protocol Violation|1|||
155516033|NCT01766921|561315736|FG001|Overall Study|Protocol Violation|1|||
155516034|NCT01766921|561315735|FG000|Overall Study|Withdrawal by Subject|14|||
155516035|NCT01766921|561315736|FG001|Overall Study|Withdrawal by Subject|5|||
155516036|NCT01901055|561315739|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
155516037|NCT01901055|561315740|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
155516038|NCT01901055|561315739|FG000|Randomization But Not Titrated|Physician Decision|0|||
155516039|NCT01901055|561315740|FG001|Randomization But Not Titrated|Physician Decision|1|||
155516040|NCT01901055|561315739|FG000|Started Protocol to Week 6|Physician Decision|2|||
155516041|NCT01901055|561315740|FG001|Started Protocol to Week 6|Physician Decision|1|||
155516042|NCT01901055|561315739|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
155516043|NCT01901055|561315740|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
155516044|NCT01901055|561315739|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
155516045|NCT01901055|561315740|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
155516046|NCT01901055|561315739|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
155516047|NCT01901055|561315740|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
155458832|NCT03084718|561100705|FG004|Overall Study|Death|0|||
155458833|NCT03084718|561100701|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
155458834|NCT03084718|561100702|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
155458835|NCT03084718|561100703|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
155458836|NCT03084718|561100704|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
155458837|NCT03084718|561100705|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
155458838|NCT02806947|561100706|FG000|Overall Study|Withdrawal by Subject|5|||
155458839|NCT02806947|561100707|FG001|Overall Study|Withdrawal by Subject|1|||
155516048|NCT01901055|561315739|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
155516049|NCT01901055|561315740|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
155516050|NCT01901055|561315739|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
155458840|NCT00865189|561100708|FG000|Overall Study|Other|1|||
155458841|NCT00865189|561100709|FG001|Overall Study|Other|2|||
155458842|NCT00865189|561100708|FG000|Overall Study|Death|4|||
155458843|NCT00865189|561100709|FG001|Overall Study|Death|11|||
155458844|NCT00865189|561100708|FG000|Overall Study|Lost to Follow-up|6|||
155458845|NCT00865189|561100709|FG001|Overall Study|Lost to Follow-up|6|||
155458846|NCT00865189|561100708|FG000|Overall Study|Withdrawal by Subject|1|||
155458847|NCT00865189|561100709|FG001|Overall Study|Withdrawal by Subject|0|||
155458848|NCT00634114|561100712|FG000|Overall Study|Adverse Event|6|||
155458849|NCT00634114|561100713|FG001|Overall Study|Adverse Event|8|||
155458850|NCT00634114|561100714|FG002|Overall Study|Adverse Event|3|||
155458851|NCT00634114|561100712|FG000|Overall Study|Withdrawal by Subject|9|||
155458852|NCT00634114|561100713|FG001|Overall Study|Withdrawal by Subject|6|||
155458853|NCT00634114|561100714|FG002|Overall Study|Withdrawal by Subject|11|||
155458854|NCT00634114|561100712|FG000|Overall Study|Lost to Follow-up|0|||
155458855|NCT00634114|561100713|FG001|Overall Study|Lost to Follow-up|0|||
155458856|NCT00634114|561100714|FG002|Overall Study|Lost to Follow-up|1|||
155458857|NCT00634114|561100712|FG000|Overall Study|Protocol Violation|3|||
155458858|NCT00634114|561100713|FG001|Overall Study|Protocol Violation|3|||
155458859|NCT00634114|561100714|FG002|Overall Study|Protocol Violation|1|||
155458860|NCT00634114|561100712|FG000|Overall Study|Pregnancy|1|||
155458861|NCT00634114|561100713|FG001|Overall Study|Pregnancy|0|||
155458862|NCT00634114|561100714|FG002|Overall Study|Pregnancy|0|||
155458863|NCT00634114|561100712|FG000|Overall Study|Incorrect enrolment|0|||
155458864|NCT00634114|561100713|FG001|Overall Study|Incorrect enrolment|1|||
155458865|NCT00634114|561100714|FG002|Overall Study|Incorrect enrolment|0|||
155458866|NCT00634114|561100712|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
155458867|NCT00634114|561100713|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
155458868|NCT00634114|561100714|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
155458869|NCT00634114|561100712|FG000|Overall Study|Difficult to continue|3|||
155458870|NCT00634114|561100713|FG001|Overall Study|Difficult to continue|1|||
155458871|NCT00634114|561100714|FG002|Overall Study|Difficult to continue|1|||
155458872|NCT00634114|561100712|FG000|Overall Study|Other reason|1|||
155458873|NCT00634114|561100713|FG001|Overall Study|Other reason|1|||
155458874|NCT00634114|561100714|FG002|Overall Study|Other reason|1|||
155458875|NCT01599754|561100715|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
155458876|NCT01599754|561100716|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
155458877|NCT01599754|561100715|FG000|Overall Study|Participant noncompliance|4|||
155458878|NCT01599754|561100716|FG001|Overall Study|Participant noncompliance|4|||
155458879|NCT01599754|561100715|FG000|Overall Study|Lost to Follow-up|13|||
155458880|NCT01599754|561100716|FG001|Overall Study|Lost to Follow-up|6|||
155458881|NCT01599754|561100715|FG000|Overall Study|Death|31|||
155458882|NCT01599754|561100716|FG001|Overall Study|Death|33|||
155458883|NCT01599754|561100715|FG000|Overall Study|Adverse Event|3|||
155458884|NCT01599754|561100716|FG001|Overall Study|Adverse Event|2|||
155458885|NCT01599754|561100715|FG000|Overall Study|Investigator decision|1|||
155458886|NCT01599754|561100716|FG001|Overall Study|Investigator decision|3|||
155458887|NCT01599754|561100715|FG000|Overall Study|Withdrawal by Subject|24|||
155458888|NCT01599754|561100716|FG001|Overall Study|Withdrawal by Subject|25|||
155458889|NCT01599754|561100715|FG000|Overall Study|Study terminated by sponsor|282|||
155458890|NCT01599754|561100716|FG001|Overall Study|Study terminated by sponsor|285|||
155458891|NCT00738374|561100719|FG000|Induction Treatment Phase|Adverse Event|14|||
155458892|NCT00738374|561100720|FG001|Induction Treatment Phase|Adverse Event|0|||
155458893|NCT00738374|561100721|FG002|Induction Treatment Phase|Adverse Event|0|||
155458894|NCT00738374|561100722|FG003|Induction Treatment Phase|Adverse Event|0|||
155458895|NCT00738374|561100719|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
155458896|NCT00738374|561100720|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
155458897|NCT00738374|561100721|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
155458898|NCT00738374|561100722|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
155458899|NCT00738374|561100719|FG000|Induction Treatment Phase|Physician Decision|2|||
155458900|NCT00738374|561100720|FG001|Induction Treatment Phase|Physician Decision|0|||
155458901|NCT00738374|561100721|FG002|Induction Treatment Phase|Physician Decision|0|||
155458902|NCT00738374|561100722|FG003|Induction Treatment Phase|Physician Decision|0|||
155458903|NCT00738374|561100719|FG000|Induction Treatment Phase|Protocol Violation|2|||
155458904|NCT00738374|561100720|FG001|Induction Treatment Phase|Protocol Violation|0|||
155458905|NCT00738374|561100721|FG002|Induction Treatment Phase|Protocol Violation|0|||
155458906|NCT00738374|561100722|FG003|Induction Treatment Phase|Protocol Violation|0|||
155458907|NCT00738374|561100719|FG000|Induction Treatment Phase|Non-compliance|1|||
155458908|NCT00738374|561100720|FG001|Induction Treatment Phase|Non-compliance|0|||
155458909|NCT00738374|561100721|FG002|Induction Treatment Phase|Non-compliance|0|||
155458910|NCT00738374|561100722|FG003|Induction Treatment Phase|Non-compliance|0|||
155458911|NCT00738374|561100719|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
155458912|NCT00738374|561100720|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
155458913|NCT00738374|561100721|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
155458914|NCT00738374|561100722|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
155458915|NCT00738374|561100719|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
155458916|NCT00738374|561100720|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
155458917|NCT00738374|561100721|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
155458918|NCT00738374|561100722|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
155458919|NCT00738374|561100719|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
155491139|NCT01023815|561223475|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
155491140|NCT01023815|561223476|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
155458920|NCT00738374|561100720|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
155458921|NCT00738374|561100721|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
155458922|NCT00738374|561100722|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
155458923|NCT00738374|561100719|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
155458924|NCT00738374|561100720|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
155458925|NCT00738374|561100721|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
155458926|NCT00738374|561100722|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
155458927|NCT00738374|561100719|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
155458928|NCT00738374|561100720|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
155458929|NCT00738374|561100721|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
155458930|NCT00738374|561100722|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
155458931|NCT00738374|561100719|FG000|Maintenance Treatment/Observation Phase|Other|0|||
155458932|NCT00738374|561100720|FG001|Maintenance Treatment/Observation Phase|Other|1|||
155458933|NCT00738374|561100721|FG002|Maintenance Treatment/Observation Phase|Other|0|||
155458934|NCT00738374|561100722|FG003|Maintenance Treatment/Observation Phase|Other|0|||
155458935|NCT00603733|561102382|FG000|Active Phase ITT|Adverse Event|8|||
155458936|NCT00603733|561102383|FG001|Active Phase ITT|Adverse Event|7|||
155458937|NCT00603733|561102382|FG000|Active Phase ITT|Withdrawal by Subject|0|||
155458938|NCT00603733|561102383|FG001|Active Phase ITT|Withdrawal by Subject|3|||
155458939|NCT00603733|561102382|FG000|Active Phase ITT|Lost to Follow-up|0|||
155458940|NCT00603733|561102383|FG001|Active Phase ITT|Lost to Follow-up|1|||
155458941|NCT00603733|561102382|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
155458942|NCT00603733|561102383|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
155458943|NCT00603733|561102382|FG000|Active Phase ITT|Lack of Efficacy|1|||
155458944|NCT00603733|561102383|FG001|Active Phase ITT|Lack of Efficacy|2|||
155458945|NCT00603733|561102382|FG000|Active Phase ITT|Subject moved, site closed|1|||
155458946|NCT00603733|561102383|FG001|Active Phase ITT|Subject moved, site closed|1|||
155458947|NCT00603733|561102382|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
155458948|NCT00603733|561102383|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
155458949|NCT00603733|561102382|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
155458950|NCT00603733|561102383|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
155458951|NCT00603733|561102382|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
155458952|NCT00603733|561102383|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
155458953|NCT00603733|561102382|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
155458954|NCT00603733|561102383|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
155458955|NCT00603733|561102382|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
155458956|NCT00603733|561102383|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
155458957|NCT00603733|561102382|FG000|Maintenance Phase ITT|Adverse Event|3|||
155458958|NCT00603733|561102383|FG001|Maintenance Phase ITT|Adverse Event|6|||
155458959|NCT00603733|561102382|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
155458960|NCT00603733|561102383|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
155458961|NCT00603733|561102382|FG000|Maintenance Phase ITT|Protocol Violation|1|||
155458962|NCT00603733|561102383|FG001|Maintenance Phase ITT|Protocol Violation|1|||
155458963|NCT00603733|561102382|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
155458964|NCT00603733|561102383|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
155458965|NCT00603733|561102382|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
155458966|NCT00603733|561102383|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
155458967|NCT00603733|561102382|FG000|Maintenance Phase ITT|Physician Decision|0|||
155458968|NCT00603733|561102383|FG001|Maintenance Phase ITT|Physician Decision|1|||
155458969|NCT00603733|561102382|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
155458970|NCT00603733|561102383|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
155458971|NCT02215616|561102385|FG000|Overall Study|Sponsor requested to stop study drug|0|||
155458972|NCT02215616|561102386|FG001|Overall Study|Sponsor requested to stop study drug|0|||
155458973|NCT02215616|561102387|FG002|Overall Study|Sponsor requested to stop study drug|1|||
155458974|NCT02215616|561102388|FG003|Overall Study|Sponsor requested to stop study drug|4|||
155458975|NCT02215616|561102385|FG000|Overall Study|Death|1|||
155458976|NCT02215616|561102386|FG001|Overall Study|Death|0|||
155458977|NCT02215616|561102387|FG002|Overall Study|Death|0|||
155458978|NCT02215616|561102388|FG003|Overall Study|Death|0|||
155458979|NCT02215616|561102385|FG000|Overall Study|Adverse Event|7|||
155458980|NCT02215616|561102386|FG001|Overall Study|Adverse Event|4|||
155458981|NCT02215616|561102387|FG002|Overall Study|Adverse Event|9|||
155458982|NCT02215616|561102388|FG003|Overall Study|Adverse Event|2|||
155458983|NCT02215616|561102385|FG000|Overall Study|Withdrawal by Subject|1|||
155458984|NCT02215616|561102386|FG001|Overall Study|Withdrawal by Subject|8|||
155516051|NCT01901055|561315740|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
155516052|NCT01901055|561315739|FG000|Week 24|Withdrawal by Subject|13|||
155516053|NCT01901055|561315740|FG001|Week 24|Withdrawal by Subject|19|||
155458985|NCT02215616|561102387|FG002|Overall Study|Withdrawal by Subject|2|||
155458986|NCT02215616|561102388|FG003|Overall Study|Withdrawal by Subject|5|||
155458987|NCT02215616|561102385|FG000|Overall Study|Non-compliance|0|||
155516054|NCT01901055|561315739|FG000|Week 24|Physician Decision|1|||
155458988|NCT02215616|561102386|FG001|Overall Study|Non-compliance|2|||
155458989|NCT02215616|561102387|FG002|Overall Study|Non-compliance|1|||
155458990|NCT02215616|561102388|FG003|Overall Study|Non-compliance|0|||
155458991|NCT02215616|561102385|FG000|Overall Study|Protocol Violation|0|||
155458992|NCT02215616|561102386|FG001|Overall Study|Protocol Violation|2|||
155458993|NCT02215616|561102387|FG002|Overall Study|Protocol Violation|0|||
155458994|NCT02215616|561102388|FG003|Overall Study|Protocol Violation|0|||
155458995|NCT02215616|561102385|FG000|Overall Study|Lost to Follow-up|1|||
155458996|NCT02215616|561102386|FG001|Overall Study|Lost to Follow-up|1|||
155458997|NCT02215616|561102387|FG002|Overall Study|Lost to Follow-up|0|||
155458998|NCT02215616|561102388|FG003|Overall Study|Lost to Follow-up|1|||
155458999|NCT02215616|561102385|FG000|Overall Study|Other than specified|1|||
155459000|NCT02215616|561102386|FG001|Overall Study|Other than specified|0|||
155459001|NCT02215616|561102387|FG002|Overall Study|Other than specified|1|||
155459002|NCT02215616|561102388|FG003|Overall Study|Other than specified|1|||
155459003|NCT00520299|561102389|FG000|Overall Study|Withdrawal by Subject|0|||
155459004|NCT00520299|561102390|FG001|Overall Study|Withdrawal by Subject|0|||
155459005|NCT00520299|561102391|FG002|Overall Study|Withdrawal by Subject|2|||
155459006|NCT00520299|561102389|FG000|Overall Study|Progressive disease|0|||
155459007|NCT00520299|561102390|FG001|Overall Study|Progressive disease|3|||
155459008|NCT00520299|561102391|FG002|Overall Study|Progressive disease|4|||
155459009|NCT01352845|561102392|FG000|Overall Study|Lost to Follow-up|313|||
155459010|NCT01352845|561102393|FG001|Overall Study|Lost to Follow-up|92|||
155459011|NCT01352845|561102392|FG000|Overall Study|No Longer Willing to Participate|205|||
155459012|NCT01352845|561102393|FG001|Overall Study|No Longer Willing to Participate|58|||
155459013|NCT01352845|561102392|FG000|Overall Study|Withdrawal by Subject|48|||
155516055|NCT01901055|561315740|FG001|Week 24|Physician Decision|0|||
155516056|NCT01901055|561315739|FG000|Week 36|Withdrawal by Subject|0|||
155516057|NCT01901055|561315740|FG001|Week 36|Withdrawal by Subject|5|||
155516058|NCT03019965|561315743|FG000|Overall Study|Withdrawal by Subject|1|||
155516059|NCT03019965|561315744|FG001|Overall Study|Withdrawal by Subject|0|||
155516060|NCT03019965|561315743|FG000|Overall Study|Protocol Violation|1|||
155516061|NCT03019965|561315744|FG001|Overall Study|Protocol Violation|3|||
155516062|NCT03019965|561315743|FG000|Overall Study|viral or fungal infection|3|||
155516063|NCT03019965|561315744|FG001|Overall Study|viral or fungal infection|4|||
155516064|NCT03019965|561315743|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
155516065|NCT03019965|561315744|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
155516066|NCT03019965|561315743|FG000|Overall Study|Physician Decision|1|||
155516067|NCT03019965|561315744|FG001|Overall Study|Physician Decision|1|||
155516068|NCT01179919|561315745|FG000|Overall Study|Protocol Violation|1|||
155516069|NCT01179919|561315745|FG000|Overall Study|Adverse Event|1|||
155516070|NCT01325207|561315746|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
155516071|NCT01325207|561315747|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
155516072|NCT01325207|561315748|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
155516073|NCT01325207|561315749|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
155516074|NCT01325207|561315750|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
155516075|NCT01325207|561315751|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
155516076|NCT01325207|561315746|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
155516077|NCT01325207|561315747|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
155516078|NCT01325207|561315748|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
155516079|NCT01325207|561315749|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
155516080|NCT01325207|561315750|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
155516081|NCT01325207|561315751|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
155516082|NCT01325207|561315746|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
155516083|NCT01325207|561315747|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
155516084|NCT01325207|561315748|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
155516085|NCT01325207|561315749|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
155516086|NCT01325207|561315750|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
155516087|NCT01325207|561315751|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
155516088|NCT01325207|561315746|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
155459014|NCT01352845|561102393|FG001|Overall Study|Withdrawal by Subject|16|||
155459015|NCT01352845|561102392|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
155459016|NCT01352845|561102393|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
155459017|NCT01352845|561102392|FG000|Overall Study|Pregnancy|27|||
155459018|NCT01352845|561102393|FG001|Overall Study|Pregnancy|7|||
155459019|NCT01352845|561102392|FG000|Overall Study|Adverse Event|22|||
155459020|NCT01352845|561102393|FG001|Overall Study|Adverse Event|6|||
155459021|NCT01352845|561102392|FG000|Overall Study|Other|17|||
155459022|NCT01352845|561102393|FG001|Overall Study|Other|7|||
155459023|NCT01352845|561102392|FG000|Overall Study|Protocol Violation|12|||
155459024|NCT01352845|561102393|FG001|Overall Study|Protocol Violation|6|||
155459025|NCT01352845|561102392|FG000|Overall Study|Death|3|||
155459026|NCT01352845|561102393|FG001|Overall Study|Death|0|||
155459027|NCT01957709|561102394|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
155459028|NCT01925612|561102395|FG000|Overall Study|Progressive Disease|1|||
155459029|NCT01925612|561102396|FG001|Overall Study|Progressive Disease|1|||
155459030|NCT01925612|561102397|FG002|Overall Study|Progressive Disease|1|||
155459031|NCT01925612|561102398|FG003|Overall Study|Progressive Disease|0|||
155459032|NCT01925612|561102399|FG004|Overall Study|Progressive Disease|0|||
155459033|NCT01925612|561102395|FG000|Overall Study|Adverse Event|3|||
155459034|NCT01925612|561102396|FG001|Overall Study|Adverse Event|3|||
155459035|NCT01925612|561102397|FG002|Overall Study|Adverse Event|0|||
155459036|NCT01925612|561102398|FG003|Overall Study|Adverse Event|1|||
155459037|NCT01925612|561102399|FG004|Overall Study|Adverse Event|2|||
155459038|NCT01093755|561102401|FG000|Overall Study|Withdrawal by Subject|3|||
155459039|NCT01093755|561102402|FG001|Overall Study|Withdrawal by Subject|4|||
155459040|NCT02310906|561102405|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
155459041|NCT02310906|561102406|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
155459042|NCT02310906|561102407|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
155459043|NCT02310906|561102408|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
155459044|NCT02310906|561102405|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
155459045|NCT02310906|561102406|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
155459046|NCT02310906|561102407|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
155459047|NCT02310906|561102408|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
155459048|NCT02310906|561102405|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
155459049|NCT02310906|561102406|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
155459050|NCT02310906|561102407|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
155459051|NCT02310906|561102408|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
155459052|NCT02310906|561102405|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
155459053|NCT02310906|561102406|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
155459054|NCT02310906|561102407|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
155459055|NCT02310906|561102408|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
155459056|NCT00433446|561102409|FG000|Overall Study|Adverse Event|4|||
155459057|NCT00433446|561102409|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155459058|NCT00433446|561102409|FG000|Overall Study|Progression|44|||
155459059|NCT00433446|561102409|FG000|Overall Study|Other - Not Protocol specified|3|||
155459060|NCT00433446|561102409|FG000|Overall Study|Ineligible|9|||
155459061|NCT01188538|561102410|FG000|Overall Study|Lost to Follow-up|0|||
155459062|NCT01188538|561102411|FG001|Overall Study|Lost to Follow-up|1|||
155459063|NCT00469209|561102415|FG000|Overall Study|Adverse Event|1|||
155459064|NCT00469209|561102416|FG001|Overall Study|Adverse Event|0|||
155459065|NCT00469209|561102417|FG002|Overall Study|Adverse Event|1|||
155459066|NCT01082367|561102420|FG000|Double-blind Period|Administrative problems|0|||
155459067|NCT01082367|561102421|FG001|Double-blind Period|Administrative problems|1|||
155459068|NCT01082367|561102420|FG000|Double-blind Period|Lack of Efficacy|5|||
155459069|NCT01082367|561102421|FG001|Double-blind Period|Lack of Efficacy|11|||
155459070|NCT01082367|561102420|FG000|Double-blind Period|Adverse Event|0|||
155459071|NCT01082367|561102421|FG001|Double-blind Period|Adverse Event|1|||
155459072|NCT01082367|561102420|FG000|Follow-up (F-U) Period|Administrative problems|1|||
155459073|NCT01082367|561102421|FG001|Follow-up (F-U) Period|Administrative problems|0|||
155459074|NCT01082367|561102420|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
155459075|NCT01082367|561102421|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
155459076|NCT01082367|561102420|FG000|Follow-up (F-U) Period|Adverse Event|0|||
155459077|NCT01082367|561102421|FG001|Follow-up (F-U) Period|Adverse Event|1|||
155459078|NCT02022033|561102434|FG000|Overall Study|Physician Decision|1|||
155459079|NCT01429077|561102435|FG000|Overall Study|Lost to Follow-up|0|||
155459080|NCT01429077|561102436|FG001|Overall Study|Lost to Follow-up|3|||
155459081|NCT01413542|561102438|FG000|Overall Study|Physician Decision|1|||
155459082|NCT01413542|561102439|FG001|Overall Study|Physician Decision|0|||
155459083|NCT01413542|561102440|FG002|Overall Study|Physician Decision|3|||
155459084|NCT01413542|561102441|FG003|Overall Study|Physician Decision|0|||
155459085|NCT01413542|561102438|FG000|Overall Study|Adverse Event|0|||
155459086|NCT01413542|561102439|FG001|Overall Study|Adverse Event|0|||
155459087|NCT01413542|561102440|FG002|Overall Study|Adverse Event|0|||
155459088|NCT01413542|561102441|FG003|Overall Study|Adverse Event|1|||
155459089|NCT04929613|561102442|FG000|Overall Study|Withdrawal by Subject|12|||
155459090|NCT00084929|561102446|FG000|Overall Study|ineligible - medical contraindication|1|||
155459091|NCT00084929|561102446|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
155652135|NCT00867334|561820229|FG000|Overall Study|Withdrawal by Subject|1|||
155652136|NCT00867334|561820230|FG001|Overall Study|Withdrawal by Subject|0|||
155652137|NCT00347269|561820235|FG000|Overall Study|Lost to Follow-up|74|||
155652138|NCT00347269|561820236|FG001|Overall Study|Lost to Follow-up|65|||
155652139|NCT00347269|561820235|FG000|Overall Study|Withdrawal by Subject|18|||
155652140|NCT00347269|561820236|FG001|Overall Study|Withdrawal by Subject|38|||
155652141|NCT00347269|561820235|FG000|Overall Study|Death|2|||
155652142|NCT00347269|561820236|FG001|Overall Study|Death|3|||
155652143|NCT06091956|561820237|FG000|Overall Study|Withdrawal by Subject|1|||
155459092|NCT00084929|561102446|FG000|Overall Study|Ineligible - Medical history|6|||
155459093|NCT00084929|561102446|FG000|Overall Study|Withdrawal by Subject|10|||
155459094|NCT00084929|561102446|FG000|Overall Study|Missing/incomplete CTC exam|9|||
155459095|NCT00084929|561102446|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
155459096|NCT02767856|561102457|FG000|Overall Study|Lost to Follow-up|9|||
155459097|NCT02767856|561102458|FG001|Overall Study|Lost to Follow-up|1|||
155459098|NCT02767856|561102457|FG000|Overall Study|Withdrawal by Subject|2|||
155459099|NCT02767856|561102458|FG001|Overall Study|Withdrawal by Subject|1|||
155459100|NCT00091026|561102459|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
155459101|NCT00091026|561102460|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
155459102|NCT00091026|561102459|FG000|Overall Study|Patient withdrew and never received trea|0|||
155459103|NCT00091026|561102460|FG001|Overall Study|Patient withdrew and never received trea|2|||
155459104|NCT00091026|561102459|FG000|Overall Study|Unknown-never received treatment|0|||
155459105|NCT00091026|561102460|FG001|Overall Study|Unknown-never received treatment|1|||
155459106|NCT01797965|561102461|FG000|Overall Study|Adverse Event|104|||
155459107|NCT01797965|561102462|FG001|Overall Study|Adverse Event|129|||
155459108|NCT01797965|561102463|FG002|Overall Study|Adverse Event|4|||
155459109|NCT01797965|561102464|FG003|Overall Study|Adverse Event|21|||
155459110|NCT01797965|561102461|FG000|Overall Study|Lost to Follow-up|9|||
155459111|NCT01797965|561102462|FG001|Overall Study|Lost to Follow-up|8|||
155459112|NCT01797965|561102463|FG002|Overall Study|Lost to Follow-up|1|||
155459113|NCT01797965|561102464|FG003|Overall Study|Lost to Follow-up|2|||
155459114|NCT01797965|561102461|FG000|Overall Study|Consent withdrawn|130|||
155459115|NCT01797965|561102462|FG001|Overall Study|Consent withdrawn|117|||
155459116|NCT01797965|561102463|FG002|Overall Study|Consent withdrawn|3|||
155459117|NCT01797965|561102464|FG003|Overall Study|Consent withdrawn|35|||
155459118|NCT01797965|561102461|FG000|Overall Study|Investigator decision|21|||
155459119|NCT01797965|561102462|FG001|Overall Study|Investigator decision|15|||
155459120|NCT01797965|561102463|FG002|Overall Study|Investigator decision|0|||
155459121|NCT01797965|561102464|FG003|Overall Study|Investigator decision|0|||
155459122|NCT01797965|561102461|FG000|Overall Study|Death|2|||
155459123|NCT01797965|561102462|FG001|Overall Study|Death|4|||
155459124|NCT01797965|561102463|FG002|Overall Study|Death|0|||
155459125|NCT01797965|561102464|FG003|Overall Study|Death|0|||
155459126|NCT01797965|561102461|FG000|Overall Study|Disease progression, defined by protocol|3|||
155459127|NCT01797965|561102462|FG001|Overall Study|Disease progression, defined by protocol|1|||
155459128|NCT01797965|561102463|FG002|Overall Study|Disease progression, defined by protocol|0|||
155459129|NCT01797965|561102464|FG003|Overall Study|Disease progression, defined by protocol|0|||
155459130|NCT01797965|561102461|FG000|Overall Study|Reason Not Specified|280|||
155459131|NCT01797965|561102462|FG001|Overall Study|Reason Not Specified|295|||
155459132|NCT01797965|561102463|FG002|Overall Study|Reason Not Specified|0|||
155459133|NCT01797965|561102464|FG003|Overall Study|Reason Not Specified|15|||
155652144|NCT06091956|561820237|FG000|Overall Study|Complicating Disease|1|||
155652145|NCT02176525|561820239|FG000|Overall Study|Adverse Event|0|||
155652146|NCT02176525|561820240|FG001|Overall Study|Adverse Event|0|||
155652147|NCT02176525|561820241|FG002|Overall Study|Adverse Event|0|||
155459134|NCT00973921|561102465|FG000|Overall Study|IVUS results were not available|9|||
155459135|NCT02670330|561102476|FG000|Overall Study|Protocol Deviation|1|||
155459136|NCT02670330|561102477|FG001|Overall Study|Protocol Deviation|0|||
155459137|NCT02670330|561102476|FG000|Overall Study|Study Terminated By Sponsor|36|||
155459138|NCT02670330|561102477|FG001|Overall Study|Study Terminated By Sponsor|43|||
155459139|NCT02670330|561102476|FG000|Overall Study|Adverse Event|1|||
155459140|NCT02670330|561102477|FG001|Overall Study|Adverse Event|3|||
155459141|NCT02670330|561102476|FG000|Overall Study|Withdrawal by Subject|34|||
155459142|NCT02670330|561102477|FG001|Overall Study|Withdrawal by Subject|29|||
155459143|NCT02670330|561102476|FG000|Overall Study|Lost to Follow-up|3|||
155459144|NCT02670330|561102477|FG001|Overall Study|Lost to Follow-up|2|||
155459145|NCT04404010|561102478|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
155459146|NCT04404010|561102479|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
155459147|NCT02120157|561102480|FG000|Overall Study|Death|8|||
155459148|NCT01354431|561102484|FG000|Pre-Treatment Period|Not reported|1|||
155652148|NCT02176525|561820242|FG003|Overall Study|Adverse Event|1|||
155459149|NCT01354431|561102485|FG001|Pre-Treatment Period|Not reported|0|||
155652149|NCT02176525|561820243|FG004|Overall Study|Adverse Event|1|||
155652150|NCT02176525|561820244|FG005|Overall Study|Adverse Event|0|||
155652151|NCT02176525|561820245|FG006|Overall Study|Adverse Event|1|||
155459150|NCT01354431|561102486|FG002|Pre-Treatment Period|Not reported|0|||
155459151|NCT01354431|561102484|FG000|Treatment Period|Disease Progression|50|||
155459152|NCT01354431|561102485|FG001|Treatment Period|Disease Progression|40|||
155459153|NCT01354431|561102486|FG002|Treatment Period|Disease Progression|44|||
155459154|NCT01354431|561102484|FG000|Treatment Period|Study Drug Toxicity|5|||
155459155|NCT01354431|561102485|FG001|Treatment Period|Study Drug Toxicity|8|||
155459156|NCT01354431|561102486|FG002|Treatment Period|Study Drug Toxicity|4|||
155459157|NCT01354431|561102484|FG000|Treatment Period|Death|0|||
155459158|NCT01354431|561102485|FG001|Treatment Period|Death|1|||
155459159|NCT01354431|561102486|FG002|Treatment Period|Death|0|||
155459160|NCT01354431|561102484|FG000|Treatment Period|AE unrelated to study drug|1|||
155459161|NCT01354431|561102485|FG001|Treatment Period|AE unrelated to study drug|2|||
155459162|NCT01354431|561102486|FG002|Treatment Period|AE unrelated to study drug|5|||
155459163|NCT01354431|561102484|FG000|Treatment Period|Participant request to discontinue|2|||
155459164|NCT01354431|561102485|FG001|Treatment Period|Participant request to discontinue|2|||
155459165|NCT01354431|561102486|FG002|Treatment Period|Participant request to discontinue|1|||
155459166|NCT01354431|561102484|FG000|Treatment Period|Participant withdrew consent|0|||
155459167|NCT01354431|561102485|FG001|Treatment Period|Participant withdrew consent|1|||
155459168|NCT01354431|561102486|FG002|Treatment Period|Participant withdrew consent|0|||
155459169|NCT01354431|561102484|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
155459170|NCT01354431|561102485|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
155459171|NCT01354431|561102486|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
155459172|NCT03176277|561102487|FG000|Part A Dose Escalation Study|Adverse Event|1|||
155459173|NCT03176277|561102488|FG001|Part A Dose Escalation Study|Adverse Event|0|||
155459174|NCT03176277|561102489|FG002|Part A Dose Escalation Study|Adverse Event|1|||
155459175|NCT03176277|561102490|FG003|Part A Dose Escalation Study|Adverse Event|0|||
155459176|NCT03176277|561102487|FG000|Part A Dose Escalation Study|Physician Decision|1|||
155459177|NCT03176277|561102488|FG001|Part A Dose Escalation Study|Physician Decision|1|||
155459178|NCT03176277|561102489|FG002|Part A Dose Escalation Study|Physician Decision|2|||
155459179|NCT03176277|561102490|FG003|Part A Dose Escalation Study|Physician Decision|0|||
155459180|NCT03176277|561102487|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
155459181|NCT03176277|561102488|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
155459182|NCT03176277|561102489|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
155459183|NCT03176277|561102490|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
155459184|NCT03176277|561102487|FG000|Part A Dose Escalation Study|Progressive disease|3|||
155459185|NCT03176277|561102488|FG001|Part A Dose Escalation Study|Progressive disease|1|||
155459186|NCT03176277|561102489|FG002|Part A Dose Escalation Study|Progressive disease|3|||
155459187|NCT03176277|561102490|FG003|Part A Dose Escalation Study|Progressive disease|0|||
155459188|NCT02802878|561102491|FG000|Overall Study|Withdrawal by Subject|3|||
155459189|NCT02802878|561102492|FG001|Overall Study|Withdrawal by Subject|3|||
155459190|NCT02802878|561102491|FG000|Overall Study|Protocol Violation|1|||
155459191|NCT02802878|561102492|FG001|Overall Study|Protocol Violation|0|||
155459192|NCT00702052|561102493|FG000|Overall Study|Adverse Event|23|||
155459193|NCT00702052|561102493|FG000|Overall Study|Disease Progression|30|||
155459194|NCT00702052|561102493|FG000|Overall Study|Withdrawal by Subject|5|||
155459195|NCT00101192|561102494|FG000|Overall Study|Ineligible|6|||
155459196|NCT00101192|561102494|FG000|Overall Study|Inevaluable|1|||
155459197|NCT03691610|561102495|FG000|Overall Study|Adverse Event|0|||
155459198|NCT03691610|561102496|FG001|Overall Study|Adverse Event|1|||
155459199|NCT03691610|561102497|FG002|Overall Study|Adverse Event|0|||
155459200|NCT03691610|561102498|FG003|Overall Study|Adverse Event|0|||
155459201|NCT03691610|561102495|FG000|Overall Study|Protocol Deviation|15|||
155459202|NCT03691610|561102496|FG001|Overall Study|Protocol Deviation|8|||
155652152|NCT02176525|561820246|FG007|Overall Study|Adverse Event|0|||
155652153|NCT02176525|561820239|FG000|Overall Study|not treated|1|||
155652154|NCT02176525|561820240|FG001|Overall Study|not treated|0|||
155652155|NCT02176525|561820241|FG002|Overall Study|not treated|0|||
155459203|NCT03691610|561102497|FG002|Overall Study|Protocol Deviation|1|||
155459204|NCT03691610|561102498|FG003|Overall Study|Protocol Deviation|2|||
155459205|NCT03691610|561102495|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
155459206|NCT03691610|561102496|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
155459207|NCT03691610|561102497|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
155459208|NCT03691610|561102498|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
155459209|NCT03691610|561102495|FG000|Overall Study|Lost to Follow-up|20|||
155459210|NCT03691610|561102496|FG001|Overall Study|Lost to Follow-up|11|||
155459211|NCT03691610|561102497|FG002|Overall Study|Lost to Follow-up|5|||
155459212|NCT03691610|561102498|FG003|Overall Study|Lost to Follow-up|2|||
155459213|NCT00242580|561102499|FG000|Overall Study|Adverse Event|3|||
155459214|NCT00242580|561102500|FG001|Overall Study|Adverse Event|0|||
155459215|NCT00242580|561102501|FG002|Overall Study|Adverse Event|2|||
155459216|NCT00242580|561102499|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155459217|NCT00242580|561102500|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
155652156|NCT02176525|561820242|FG003|Overall Study|not treated|0|||
155652157|NCT02176525|561820243|FG004|Overall Study|not treated|0|||
155459218|NCT00242580|561102501|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
155459219|NCT00242580|561102499|FG000|Overall Study|Protocol Violation|0|||
155459220|NCT00242580|561102500|FG001|Overall Study|Protocol Violation|0|||
155459221|NCT00242580|561102501|FG002|Overall Study|Protocol Violation|1|||
155459222|NCT00242580|561102499|FG000|Overall Study|Subject withdrew consent|2|||
155459223|NCT00242580|561102500|FG001|Overall Study|Subject withdrew consent|2|||
155459224|NCT00242580|561102501|FG002|Overall Study|Subject withdrew consent|5|||
155459225|NCT00242580|561102499|FG000|Overall Study|Lost to Follow-up|0|||
155459226|NCT00242580|561102500|FG001|Overall Study|Lost to Follow-up|3|||
155459227|NCT00242580|561102501|FG002|Overall Study|Lost to Follow-up|0|||
155459228|NCT00242580|561102499|FG000|Overall Study|Death|1|||
155652158|NCT02176525|561820244|FG005|Overall Study|not treated|1|||
155652159|NCT02176525|561820245|FG006|Overall Study|not treated|0|||
155652160|NCT02176525|561820246|FG007|Overall Study|not treated|0|||
155652161|NCT00728182|561820247|FG000|Overall Study|Adverse Event|1|||
155652162|NCT00728182|561820248|FG001|Overall Study|Adverse Event|0|||
155652163|NCT00728182|561820247|FG000|Overall Study|Lost to Follow-up|2|||
155652164|NCT00728182|561820248|FG001|Overall Study|Lost to Follow-up|0|||
155459229|NCT00242580|561102500|FG001|Overall Study|Death|2|||
155459230|NCT00242580|561102501|FG002|Overall Study|Death|1|||
155459231|NCT01232894|561102502|FG000|Overall Study|Lost to Follow-up|0|||
155459232|NCT01232894|561102503|FG001|Overall Study|Lost to Follow-up|1|||
155459233|NCT01232894|561102502|FG000|Overall Study|Death|1|||
155459234|NCT01232894|561102503|FG001|Overall Study|Death|0|||
155459235|NCT01232894|561102502|FG000|Overall Study|Protocol Violation|1|||
155459236|NCT01232894|561102503|FG001|Overall Study|Protocol Violation|1|||
155459237|NCT01232894|561102502|FG000|Overall Study|Withdrawal by Subject|8|||
155459238|NCT01232894|561102503|FG001|Overall Study|Withdrawal by Subject|5|||
155652165|NCT00728182|561820247|FG000|Overall Study|Death|0|||
155652166|NCT00728182|561820248|FG001|Overall Study|Death|2|||
155652167|NCT00728182|561820247|FG000|Overall Study|Protocol Noncompliance|0|||
155652168|NCT00728182|561820248|FG001|Overall Study|Protocol Noncompliance|1|||
155652169|NCT02369159|561820252|FG000|Overall Study|Adverse Event|0|||
155652170|NCT02369159|561820253|FG001|Overall Study|Adverse Event|1|||
155652171|NCT02369159|561820252|FG000|Overall Study|Lost to Follow-up|1|||
155652172|NCT02369159|561820253|FG001|Overall Study|Lost to Follow-up|1|||
155652173|NCT02369159|561820252|FG000|Overall Study|Withdrawal by Subject|7|||
155652174|NCT02369159|561820253|FG001|Overall Study|Withdrawal by Subject|0|||
155652175|NCT00425854|561820263|FG000|Overall Study|Progressive Disease|19|||
155652176|NCT00425854|561820264|FG001|Overall Study|Progressive Disease|12|||
155652177|NCT00425854|561820263|FG000|Overall Study|Dose reduction toxicity AE|8|||
155652178|NCT00425854|561820264|FG001|Overall Study|Dose reduction toxicity AE|7|||
155652179|NCT00425854|561820263|FG000|Overall Study|Other Adverse Event|2|||
155652180|NCT00425854|561820264|FG001|Overall Study|Other Adverse Event|2|||
155652181|NCT01514422|561820265|FG000|Overall Study|Lost to Follow-up|1|||
155652182|NCT01630811|561820266|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155652183|NCT01630811|561820267|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155652184|NCT01725308|561820270|FG000|Treatment Period I|Did Not Receive Drug|1|||
155652185|NCT01725308|561820271|FG001|Treatment Period I|Did Not Receive Drug|0|||
155652186|NCT01725308|561820272|FG002|Treatment Period I|Did Not Receive Drug|0|||
155652187|NCT01725308|561820270|FG000|Treatment Period I|Adverse Event|5|||
155652188|NCT01725308|561820271|FG001|Treatment Period I|Adverse Event|4|||
155652189|NCT01725308|561820272|FG002|Treatment Period I|Adverse Event|21|||
155652190|NCT01725308|561820270|FG000|Treatment Period I|Insufficient Response|7|||
155652191|NCT01725308|561820271|FG001|Treatment Period I|Insufficient Response|0|||
155652192|NCT01725308|561820272|FG002|Treatment Period I|Insufficient Response|5|||
155652193|NCT01725308|561820270|FG000|Treatment Period I|Worsening of the Target Disease|8|||
155652194|NCT01725308|561820271|FG001|Treatment Period I|Worsening of the Target Disease|0|||
155459239|NCT01232894|561102502|FG000|Overall Study|Physician Decision|2|||
155459240|NCT01232894|561102503|FG001|Overall Study|Physician Decision|1|||
155459241|NCT03970395|561102506|FG000|Overall Study|Withdrawal by Subject|3|||
155459242|NCT03970395|561102507|FG001|Overall Study|Withdrawal by Subject|4|||
155459243|NCT03970395|561102506|FG000|Overall Study|Lost to Follow-up|4|||
155459244|NCT03970395|561102507|FG001|Overall Study|Lost to Follow-up|8|||
155652195|NCT01725308|561820272|FG002|Treatment Period I|Worsening of the Target Disease|2|||
155652196|NCT01725308|561820270|FG000|Treatment Period I|Changes in the Episodes|3|||
155459245|NCT00929734|561102508|FG000|Overall Study|Lost to Follow-up|2|||
155459246|NCT00929734|561102509|FG001|Overall Study|Lost to Follow-up|1|||
155459247|NCT00929734|561102508|FG000|Overall Study|Withdrawal by Subject|0|||
155459248|NCT00929734|561102509|FG001|Overall Study|Withdrawal by Subject|2|||
155459249|NCT00980980|561102510|FG000|Overall Study|Withdrawal by Hospital|0|||
155652197|NCT01725308|561820271|FG001|Treatment Period I|Changes in the Episodes|0|||
155652198|NCT01725308|561820272|FG002|Treatment Period I|Changes in the Episodes|2|||
155652199|NCT01725308|561820270|FG000|Treatment Period I|Withdrawal of Consent|12|||
155652200|NCT01725308|561820271|FG001|Treatment Period I|Withdrawal of Consent|7|||
155459250|NCT00980980|561102511|FG001|Overall Study|Withdrawal by Hospital|1|||
155459251|NCT00980980|561102512|FG002|Overall Study|Withdrawal by Hospital|0|||
155459252|NCT02921919|561102514|FG000|Overall Study|Other|5|||
155459253|NCT02921919|561102515|FG001|Overall Study|Other|6|||
155459254|NCT02921919|561102514|FG000|Overall Study|Lost to Follow-up|0|||
155459255|NCT02921919|561102515|FG001|Overall Study|Lost to Follow-up|1|||
155459256|NCT02921919|561102514|FG000|Overall Study|Withdrawal by Subject|5|||
155459257|NCT02921919|561102515|FG001|Overall Study|Withdrawal by Subject|1|||
155459258|NCT02921919|561102514|FG000|Overall Study|Disease Progression|47|||
155459259|NCT02921919|561102515|FG001|Overall Study|Disease Progression|38|||
155459260|NCT02921919|561102514|FG000|Overall Study|Physician Decision|3|||
155459261|NCT02921919|561102515|FG001|Overall Study|Physician Decision|2|||
155459262|NCT02921919|561102514|FG000|Overall Study|Adverse Event|6|||
155459263|NCT02921919|561102515|FG001|Overall Study|Adverse Event|4|||
155459264|NCT03666858|561102516|FG000|Cohort 1|Adverse Event|1|||
155459265|NCT03666858|561102517|FG001|Cohort 1|Adverse Event|0|||
155459266|NCT03666858|561102516|FG000|Cohort 2|Adverse Event|0|||
155459267|NCT03666858|561102517|FG001|Cohort 2|Adverse Event|1|||
155459268|NCT00121992|561102518|FG000|Overall Study|Treatment not received|2|||
155459269|NCT00121992|561102519|FG001|Overall Study|Treatment not received|11|||
155459270|NCT03282357|561102520|FG000|Overall Study|Lost to Follow-up|3|||
155459271|NCT03282357|561102520|FG000|Overall Study|Withdrawal by Subject|4|||
155459272|NCT03282357|561102520|FG000|Overall Study|Adverse Event|1|||
155459273|NCT03282357|561102520|FG000|Overall Study|Other|9|||
155459274|NCT03550131|561102521|FG000|Overall Study|Lost to Follow-up|16|||
155459275|NCT03550131|561102522|FG001|Overall Study|Lost to Follow-up|24|||
155459276|NCT03550131|561102521|FG000|Overall Study|Withdrawal by Subject|36|||
155459277|NCT03550131|561102522|FG001|Overall Study|Withdrawal by Subject|28|||
155459278|NCT03550131|561102521|FG000|Overall Study|Illness of dyad member|10|||
155459279|NCT03550131|561102522|FG001|Overall Study|Illness of dyad member|2|||
155459280|NCT03550131|561102521|FG000|Overall Study|Death of person with dementia|4|||
155459281|NCT03550131|561102522|FG001|Overall Study|Death of person with dementia|8|||
155459282|NCT01318512|561102523|FG000|Maintenance Period (6 Months)|Death|2|||
155459283|NCT01318512|561102523|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
155459284|NCT02756650|561102526|FG000|Overall Study|Physician Decision|1|||
155459285|NCT02756650|561102526|FG000|Overall Study|Adverse Event|1|||
155459286|NCT04348591|561102532|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
155459287|NCT04348591|561102533|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
155459288|NCT04348591|561102532|FG000|Imaging Session (120 Min)|Physician Decision|0|||
155459289|NCT04348591|561102533|FG001|Imaging Session (120 Min)|Physician Decision|1|||
155459290|NCT04348591|561102532|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
155459291|NCT04348591|561102533|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
155459292|NCT00910429|561102536|FG000|Overall Study|Death|18|||
155459293|NCT00910429|561102537|FG001|Overall Study|Death|12|||
155459294|NCT00910429|561102536|FG000|Overall Study|Withdrawal by Subject|3|||
155459295|NCT00910429|561102537|FG001|Overall Study|Withdrawal by Subject|2|||
155459296|NCT00910429|561102536|FG000|Overall Study|Protocol Violation|1|||
155459297|NCT00910429|561102537|FG001|Overall Study|Protocol Violation|0|||
155459298|NCT00910429|561102536|FG000|Overall Study|Lost to Follow-up|2|||
155459299|NCT00910429|561102537|FG001|Overall Study|Lost to Follow-up|1|||
155459300|NCT00910429|561102536|FG000|Overall Study|Adverse Event|10|||
155459301|NCT00910429|561102537|FG001|Overall Study|Adverse Event|5|||
155459302|NCT00910429|561102536|FG000|Overall Study|Drug non-compliance|1|||
155459303|NCT00910429|561102537|FG001|Overall Study|Drug non-compliance|0|||
155459304|NCT00910429|561102536|FG000|Overall Study|Lack of Efficacy|4|||
155459305|NCT00910429|561102537|FG001|Overall Study|Lack of Efficacy|1|||
155459306|NCT01317615|561102538|FG000|Overall Study|Disease progression|25|||
155459307|NCT01317615|561102538|FG000|Overall Study|New cancer therapy|5|||
155459308|NCT01317615|561102538|FG000|Overall Study|Death|6|||
155459309|NCT01317615|561102538|FG000|Overall Study|Withdrawal by Subject|5|||
155459310|NCT01317615|561102538|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155459311|NCT01317615|561102538|FG000|Overall Study|Adverse Event|7|||
155459312|NCT02648724|561102542|FG000|Overall Study|Withdrawal by Subject|0|||
155459313|NCT02648724|561102543|FG001|Overall Study|Withdrawal by Subject|1|||
155459314|NCT02648724|561102544|FG002|Overall Study|Withdrawal by Subject|1|||
155459315|NCT02648724|561102545|FG003|Overall Study|Withdrawal by Subject|0|||
155459316|NCT02648724|561102546|FG004|Overall Study|Withdrawal by Subject|1|||
155459317|NCT02648724|561102547|FG005|Overall Study|Withdrawal by Subject|0|||
155459318|NCT02648724|561102548|FG006|Overall Study|Withdrawal by Subject|0|||
155459319|NCT02648724|561102542|FG000|Overall Study|Progressive disease|2|||
155459320|NCT02648724|561102543|FG001|Overall Study|Progressive disease|2|||
155459321|NCT02648724|561102544|FG002|Overall Study|Progressive disease|2|||
155459322|NCT02648724|561102545|FG003|Overall Study|Progressive disease|3|||
155459323|NCT02648724|561102546|FG004|Overall Study|Progressive disease|22|||
155459324|NCT02648724|561102547|FG005|Overall Study|Progressive disease|7|||
155459325|NCT02648724|561102548|FG006|Overall Study|Progressive disease|8|||
155459326|NCT02648724|561102542|FG000|Overall Study|Other reason (unknown)|1|||
155459327|NCT02648724|561102543|FG001|Overall Study|Other reason (unknown)|0|||
155652201|NCT01725308|561820272|FG002|Treatment Period I|Withdrawal of Consent|5|||
155652202|NCT01725308|561820270|FG000|Treatment Period I|Lost to Follow-up|3|||
155652203|NCT01725308|561820271|FG001|Treatment Period I|Lost to Follow-up|2|||
155652204|NCT01725308|561820272|FG002|Treatment Period I|Lost to Follow-up|2|||
155652205|NCT01725308|561820270|FG000|Treatment Period I|Protocol Deviations|3|||
155652206|NCT01725308|561820271|FG001|Treatment Period I|Protocol Deviations|1|||
155652207|NCT01725308|561820272|FG002|Treatment Period I|Protocol Deviations|1|||
155652208|NCT01725308|561820270|FG000|Treatment Period I|Miscellaneous|2|||
155652209|NCT01725308|561820271|FG001|Treatment Period I|Miscellaneous|0|||
155652210|NCT01725308|561820272|FG002|Treatment Period I|Miscellaneous|3|||
155652211|NCT01725308|561820270|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
155652212|NCT01725308|561820271|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
155652213|NCT01725308|561820272|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
155652214|NCT01725308|561820270|FG000|Treatment Period II|Did Not Receive Drug|4|||
155652215|NCT01725308|561820271|FG001|Treatment Period II|Did Not Receive Drug|0|||
155652216|NCT01725308|561820272|FG002|Treatment Period II|Did Not Receive Drug|0|||
155652217|NCT01725308|561820270|FG000|Treatment Period II|Adverse Event|13|||
155652218|NCT01725308|561820271|FG001|Treatment Period II|Adverse Event|8|||
155652219|NCT01725308|561820272|FG002|Treatment Period II|Adverse Event|20|||
155652220|NCT01725308|561820270|FG000|Treatment Period II|Insufficient Response|2|||
155652221|NCT01725308|561820271|FG001|Treatment Period II|Insufficient Response|4|||
155652222|NCT01725308|561820272|FG002|Treatment Period II|Insufficient Response|6|||
155652223|NCT01725308|561820270|FG000|Treatment Period II|Worsening of the Target Disease|1|||
155652224|NCT01725308|561820271|FG001|Treatment Period II|Worsening of the Target Disease|4|||
155652225|NCT01725308|561820272|FG002|Treatment Period II|Worsening of the Target Disease|2|||
155652226|NCT01725308|561820270|FG000|Treatment Period II|Changes in the Episodes|1|||
155652227|NCT01725308|561820271|FG001|Treatment Period II|Changes in the Episodes|0|||
155652228|NCT01725308|561820272|FG002|Treatment Period II|Changes in the Episodes|5|||
155652229|NCT01725308|561820270|FG000|Treatment Period II|Withdrawal of Consent|28|||
155652230|NCT01725308|561820271|FG001|Treatment Period II|Withdrawal of Consent|2|||
155652231|NCT01725308|561820272|FG002|Treatment Period II|Withdrawal of Consent|16|||
155652232|NCT01725308|561820270|FG000|Treatment Period II|Lost to Follow-up|1|||
155652233|NCT01725308|561820271|FG001|Treatment Period II|Lost to Follow-up|5|||
155652234|NCT01725308|561820272|FG002|Treatment Period II|Lost to Follow-up|3|||
155652235|NCT01725308|561820270|FG000|Treatment Period II|Protocol Deviations|0|||
155459328|NCT02648724|561102544|FG002|Overall Study|Other reason (unknown)|0|||
155459329|NCT02648724|561102545|FG003|Overall Study|Other reason (unknown)|0|||
155459330|NCT02648724|561102546|FG004|Overall Study|Other reason (unknown)|0|||
155459331|NCT02648724|561102547|FG005|Overall Study|Other reason (unknown)|0|||
155459332|NCT02648724|561102548|FG006|Overall Study|Other reason (unknown)|0|||
155459333|NCT02648724|561102542|FG000|Overall Study|Protocol Violation|0|||
155459334|NCT02648724|561102543|FG001|Overall Study|Protocol Violation|0|||
155459335|NCT02648724|561102544|FG002|Overall Study|Protocol Violation|0|||
155459336|NCT02648724|561102545|FG003|Overall Study|Protocol Violation|0|||
155459337|NCT02648724|561102546|FG004|Overall Study|Protocol Violation|1|||
155459338|NCT02648724|561102547|FG005|Overall Study|Protocol Violation|0|||
155459339|NCT02648724|561102548|FG006|Overall Study|Protocol Violation|0|||
155459340|NCT02648724|561102542|FG000|Overall Study|Death|0|||
155459341|NCT02648724|561102543|FG001|Overall Study|Death|0|||
155459342|NCT02648724|561102544|FG002|Overall Study|Death|0|||
155459343|NCT02648724|561102545|FG003|Overall Study|Death|0|||
155459344|NCT02648724|561102546|FG004|Overall Study|Death|0|||
155459345|NCT02648724|561102547|FG005|Overall Study|Death|0|||
155459346|NCT02648724|561102548|FG006|Overall Study|Death|3|||
155459347|NCT02648724|561102542|FG000|Overall Study|Physician Decision|0|||
155459348|NCT02648724|561102543|FG001|Overall Study|Physician Decision|0|||
155459349|NCT02648724|561102544|FG002|Overall Study|Physician Decision|0|||
155459350|NCT02648724|561102545|FG003|Overall Study|Physician Decision|0|||
155459351|NCT02648724|561102546|FG004|Overall Study|Physician Decision|1|||
155652236|NCT01725308|561820271|FG001|Treatment Period II|Protocol Deviations|0|||
155652237|NCT01725308|561820272|FG002|Treatment Period II|Protocol Deviations|1|||
155652238|NCT01725308|561820270|FG000|Treatment Period II|Miscellaneous|5|||
155652239|NCT01725308|561820271|FG001|Treatment Period II|Miscellaneous|3|||
155459352|NCT02648724|561102547|FG005|Overall Study|Physician Decision|0|||
155459353|NCT02648724|561102548|FG006|Overall Study|Physician Decision|1|||
155459354|NCT02648724|561102542|FG000|Overall Study|Transferred to named patient program|0|||
155459355|NCT02648724|561102543|FG001|Overall Study|Transferred to named patient program|0|||
155459356|NCT02648724|561102544|FG002|Overall Study|Transferred to named patient program|0|||
155459357|NCT02648724|561102545|FG003|Overall Study|Transferred to named patient program|0|||
155459358|NCT02648724|561102546|FG004|Overall Study|Transferred to named patient program|0|||
155459359|NCT02648724|561102547|FG005|Overall Study|Transferred to named patient program|1|||
155459360|NCT02648724|561102548|FG006|Overall Study|Transferred to named patient program|0|||
155459361|NCT00302718|561102549|FG000|Overall Study|Participant left the hospital|1|||
155459362|NCT00302718|561102550|FG001|Overall Study|Participant left the hospital|0|||
155459363|NCT00302718|561102551|FG002|Overall Study|Participant left the hospital|0|||
155459364|NCT00302718|561102552|FG003|Overall Study|Participant left the hospital|1|||
155459365|NCT00302718|561102549|FG000|Overall Study|Withdrawal by Subject|0|||
155459366|NCT00302718|561102550|FG001|Overall Study|Withdrawal by Subject|1|||
155459367|NCT00302718|561102551|FG002|Overall Study|Withdrawal by Subject|0|||
155459368|NCT00302718|561102552|FG003|Overall Study|Withdrawal by Subject|0|||
155459369|NCT00302718|561102549|FG000|Overall Study|Participant left primary care setting|0|||
155459370|NCT00302718|561102550|FG001|Overall Study|Participant left primary care setting|0|||
155459371|NCT00302718|561102551|FG002|Overall Study|Participant left primary care setting|2|||
155459372|NCT00302718|561102552|FG003|Overall Study|Participant left primary care setting|1|||
155459373|NCT00632541|561102553|FG000|Overall Study|Adverse Event|7|||
155459374|NCT06025396|561103898|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
155459375|NCT06025396|561103899|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
155459376|NCT06025396|561103900|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
155459377|NCT06025396|561103901|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
155459378|NCT06025396|561103902|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
155459379|NCT06025396|561103898|FG000|Overall Study|Withdrawal by Subject|0|||
155459380|NCT06025396|561103899|FG001|Overall Study|Withdrawal by Subject|1|||
155459381|NCT06025396|561103900|FG002|Overall Study|Withdrawal by Subject|1|||
155459382|NCT06025396|561103901|FG003|Overall Study|Withdrawal by Subject|0|||
155459383|NCT06025396|561103902|FG004|Overall Study|Withdrawal by Subject|0|||
155459384|NCT01512108|561103903|FG000|Overall Study|Adverse Event|9|||
155459385|NCT01512108|561103904|FG001|Overall Study|Adverse Event|4|||
155459386|NCT01512108|561103903|FG000|Overall Study|Protocol Violation|1|||
155459387|NCT01512108|561103904|FG001|Overall Study|Protocol Violation|2|||
155459388|NCT01512108|561103903|FG000|Overall Study|Withdrawal Criteria|1|||
155459389|NCT01512108|561103904|FG001|Overall Study|Withdrawal Criteria|0|||
155459390|NCT01512108|561103903|FG000|Overall Study|Unclassified|11|||
155459391|NCT01512108|561103904|FG001|Overall Study|Unclassified|3|||
155459392|NCT06422377|561103905|FG000|Overall Study|Study Terminated by Sponsor|1|||
155459393|NCT02017899|561103906|FG000|Overall Study|Withdrawal by Subject|0|||
155459394|NCT02017899|561103907|FG001|Overall Study|Withdrawal by Subject|0|||
155459395|NCT02017899|561103908|FG002|Overall Study|Withdrawal by Subject|0|||
155459396|NCT02017899|561103909|FG003|Overall Study|Withdrawal by Subject|1|||
155459397|NCT02017899|561103910|FG004|Overall Study|Withdrawal by Subject|1|||
155459398|NCT02017899|561103911|FG005|Overall Study|Withdrawal by Subject|0|||
155459399|NCT02420795|561103913|FG000|Overall Study|Withdrawal by Subject|1|||
155459400|NCT02420795|561103914|FG001|Overall Study|Withdrawal by Subject|0|||
155459401|NCT02420795|561103915|FG002|Overall Study|Withdrawal by Subject|0|||
155459402|NCT02420795|561103913|FG000|Overall Study|Adverse Event|1|||
155459403|NCT02420795|561103914|FG001|Overall Study|Adverse Event|0|||
155459404|NCT02420795|561103915|FG002|Overall Study|Adverse Event|0|||
155459405|NCT02420795|561103913|FG000|Overall Study|Progressive disease|2|||
155459406|NCT02420795|561103914|FG001|Overall Study|Progressive disease|2|||
155459407|NCT02420795|561103915|FG002|Overall Study|Progressive disease|4|||
155459408|NCT02420795|561103913|FG000|Overall Study|Death|0|||
155459409|NCT02420795|561103914|FG001|Overall Study|Death|0|||
155459410|NCT02420795|561103915|FG002|Overall Study|Death|1|||
155459411|NCT04019795|561103917|FG000|Overall Study|Withdrawal by Subject|1|||
155459412|NCT04019795|561103918|FG001|Overall Study|Withdrawal by Subject|2|||
155459413|NCT04019795|561103919|FG002|Overall Study|Withdrawal by Subject|2|||
155459414|NCT04019795|561103920|FG003|Overall Study|Withdrawal by Subject|1|||
155459415|NCT04019795|561103917|FG000|Overall Study|Lost to Follow-up|0|||
155459416|NCT04019795|561103918|FG001|Overall Study|Lost to Follow-up|1|||
155459417|NCT04019795|561103919|FG002|Overall Study|Lost to Follow-up|1|||
155459418|NCT04019795|561103920|FG003|Overall Study|Lost to Follow-up|2|||
155459419|NCT04019795|561103917|FG000|Overall Study|Treatment non-compliance|3|||
155459420|NCT04019795|561103918|FG001|Overall Study|Treatment non-compliance|1|||
155459421|NCT04019795|561103919|FG002|Overall Study|Treatment non-compliance|2|||
155459422|NCT04019795|561103920|FG003|Overall Study|Treatment non-compliance|0|||
155459423|NCT04019795|561103917|FG000|Overall Study|Physician Decision|0|||
155652240|NCT01725308|561820272|FG002|Treatment Period II|Miscellaneous|7|||
155652241|NCT03511209|561820273|FG000|Overall Study|Withdrawal by Subject|2|||
155652242|NCT03511209|561820274|FG001|Overall Study|Withdrawal by Subject|4|||
155459424|NCT04019795|561103918|FG001|Overall Study|Physician Decision|0|||
155459425|NCT04019795|561103919|FG002|Overall Study|Physician Decision|1|||
155459426|NCT04019795|561103920|FG003|Overall Study|Physician Decision|0|||
155459427|NCT04019795|561103917|FG000|Overall Study|Adverse Event|1|||
155459428|NCT04019795|561103918|FG001|Overall Study|Adverse Event|0|||
155459429|NCT04019795|561103919|FG002|Overall Study|Adverse Event|0|||
155459430|NCT04019795|561103920|FG003|Overall Study|Adverse Event|0|||
155459431|NCT03625141|561103921|FG000|Overall Study|Adverse Event|0|||
155459432|NCT03625141|561103922|FG001|Overall Study|Adverse Event|2|||
155459433|NCT03625141|561103921|FG000|Overall Study|Study Terminated By Sponsor|1|||
155459434|NCT03625141|561103922|FG001|Overall Study|Study Terminated By Sponsor|13|||
155459435|NCT03625141|561103921|FG000|Overall Study|Withdrawal by Subject|3|||
155459436|NCT03625141|561103922|FG001|Overall Study|Withdrawal by Subject|0|||
155459437|NCT03625141|561103921|FG000|Overall Study|Withdrawal Of Consent|0|||
155459438|NCT03625141|561103922|FG001|Overall Study|Withdrawal Of Consent|1|||
155459439|NCT03625141|561103921|FG000|Overall Study|Death|11|||
155459440|NCT03625141|561103922|FG001|Overall Study|Death|47|||
155459441|NCT03625141|561103921|FG000|Overall Study|Progressive Disease|0|||
155459442|NCT03625141|561103922|FG001|Overall Study|Progressive Disease|2|||
155459443|NCT02168803|561103923|FG000|Overall Study|Lost to Follow-up|1|||
155459444|NCT02168803|561103924|FG001|Overall Study|Lost to Follow-up|0|||
155459445|NCT02168803|561103925|FG002|Overall Study|Lost to Follow-up|1|||
155459446|NCT02168803|561103923|FG000|Overall Study|Withdrawal by Subject|1|||
155459447|NCT02168803|561103924|FG001|Overall Study|Withdrawal by Subject|1|||
155459448|NCT02168803|561103925|FG002|Overall Study|Withdrawal by Subject|2|||
155459449|NCT02168803|561103923|FG000|Overall Study|Physician Decision|0|||
155459450|NCT02168803|561103924|FG001|Overall Study|Physician Decision|1|||
155459451|NCT02168803|561103925|FG002|Overall Study|Physician Decision|0|||
155459452|NCT02168803|561103923|FG000|Overall Study|Adverse Event|0|||
155459453|NCT02168803|561103924|FG001|Overall Study|Adverse Event|1|||
155459454|NCT02168803|561103925|FG002|Overall Study|Adverse Event|1|||
155459455|NCT02168803|561103923|FG000|Overall Study|Death|0|||
155459456|NCT02168803|561103924|FG001|Overall Study|Death|0|||
155459457|NCT02168803|561103925|FG002|Overall Study|Death|1|||
155459458|NCT02168803|561103923|FG000|Overall Study|Sponsor Decision|0|||
155459459|NCT02168803|561103924|FG001|Overall Study|Sponsor Decision|0|||
155459460|NCT02168803|561103925|FG002|Overall Study|Sponsor Decision|1|||
155459461|NCT01280266|561103926|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
155459462|NCT01280266|561103927|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
155459463|NCT01280266|561103926|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
155459464|NCT01280266|561103927|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
155459465|NCT04116073|561103935|FG000|Overall Study|Withdrawal by Subject|2|||
155459466|NCT04116073|561103935|FG000|Overall Study|failed to maintained eligibility|1|||
155459467|NCT01879319|561103940|FG000|Overall Study|Withdrawal by Subject|1|||
155459468|NCT01879319|561103941|FG001|Overall Study|Withdrawal by Subject|0|||
155459469|NCT01879319|561103940|FG000|Overall Study|Lost to Follow-up|1|||
155459470|NCT01879319|561103941|FG001|Overall Study|Lost to Follow-up|5|||
155459471|NCT03067129|561103942|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
155459472|NCT03067129|561103943|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
155459473|NCT03067129|561103944|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
155459474|NCT03067129|561103945|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
155459475|NCT03067129|561103942|FG000|Overall Study|Withdrawal by Subject|0|||
155459476|NCT03067129|561103943|FG001|Overall Study|Withdrawal by Subject|0|||
155459477|NCT03067129|561103944|FG002|Overall Study|Withdrawal by Subject|1|||
155459478|NCT03067129|561103945|FG003|Overall Study|Withdrawal by Subject|2|||
155459479|NCT03067129|561103942|FG000|Overall Study|Lost to Follow-up|5|||
155459480|NCT03067129|561103943|FG001|Overall Study|Lost to Follow-up|5|||
155459481|NCT03067129|561103944|FG002|Overall Study|Lost to Follow-up|4|||
155459482|NCT03067129|561103945|FG003|Overall Study|Lost to Follow-up|3|||
155459483|NCT00664209|561103951|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
155459484|NCT00664209|561103951|FG000|Study Treatment Period|Physician Decision|4|||
155459485|NCT00664209|561103951|FG000|Study Treatment Period|Withdrawal by Subject|2|||
155459486|NCT00418379|561103956|FG000|Year 1|Adverse Event|9|||
155459487|NCT00418379|561103957|FG001|Year 1|Adverse Event|15|||
155459488|NCT00418379|561103958|FG002|Year 1|Adverse Event|3|||
155459489|NCT00418379|561103956|FG000|Year 1|Withdrawal by Subject|7|||
155459490|NCT00418379|561103957|FG001|Year 1|Withdrawal by Subject|8|||
155459491|NCT00418379|561103958|FG002|Year 1|Withdrawal by Subject|5|||
155459492|NCT00418379|561103956|FG000|Year 1|Any other reason not above-mentioned|2|||
155459493|NCT00418379|561103957|FG001|Year 1|Any other reason not above-mentioned|5|||
155459494|NCT00418379|561103958|FG002|Year 1|Any other reason not above-mentioned|7|||
155459495|NCT00418379|561103956|FG000|Year 2|Adverse Event|5|||
155459496|NCT00418379|561103957|FG001|Year 2|Adverse Event|2|||
155459497|NCT00418379|561103958|FG002|Year 2|Adverse Event|1|||
155459498|NCT00418379|561103956|FG000|Year 2|Withdrawal by Subject|1|||
155459499|NCT00418379|561103957|FG001|Year 2|Withdrawal by Subject|1|||
155459500|NCT00418379|561103958|FG002|Year 2|Withdrawal by Subject|3|||
155459501|NCT00418379|561103956|FG000|Year 2|Any other reason not above-mentioned|2|||
155459502|NCT00418379|561103957|FG001|Year 2|Any other reason not above-mentioned|1|||
155459503|NCT00418379|561103958|FG002|Year 2|Any other reason not above-mentioned|6|||
155459504|NCT00418379|561103956|FG000|Year 3|Withdrawal by Subject|1|||
155459505|NCT00418379|561103957|FG001|Year 3|Withdrawal by Subject|1|||
155459506|NCT00418379|561103958|FG002|Year 3|Withdrawal by Subject|2|||
155459507|NCT00418379|561103956|FG000|Year 3|Any other reason not above-mentioned|2|||
155459508|NCT00418379|561103957|FG001|Year 3|Any other reason not above-mentioned|1|||
155459509|NCT00418379|561103958|FG002|Year 3|Any other reason not above-mentioned|1|||
155459510|NCT00418379|561103956|FG000|Year 4|Adverse Event|0|||
155459511|NCT00418379|561103957|FG001|Year 4|Adverse Event|1|||
155459512|NCT00418379|561103958|FG002|Year 4|Adverse Event|0|||
155459513|NCT00418379|561103956|FG000|Year 4|Withdrawal by Subject|2|||
155459514|NCT00418379|561103957|FG001|Year 4|Withdrawal by Subject|3|||
155459515|NCT00418379|561103958|FG002|Year 4|Withdrawal by Subject|2|||
155459516|NCT00418379|561103956|FG000|Year 4|Any other reason not above-mentioned|1|||
155459517|NCT00418379|561103957|FG001|Year 4|Any other reason not above-mentioned|1|||
155459518|NCT00418379|561103958|FG002|Year 4|Any other reason not above-mentioned|0|||
155459519|NCT00418379|561103956|FG000|Year 5|Adverse Event|0|||
155459520|NCT00418379|561103957|FG001|Year 5|Adverse Event|1|||
155459521|NCT00418379|561103958|FG002|Year 5|Adverse Event|0|||
155459522|NCT00418379|561103956|FG000|Year 5|Any other reason not above-mentioned|2|||
155459523|NCT00418379|561103957|FG001|Year 5|Any other reason not above-mentioned|4|||
155459524|NCT00418379|561103958|FG002|Year 5|Any other reason not above-mentioned|3|||
155459525|NCT00843843|561103959|FG000|Overall Study|Physician Decision|1|||
155459526|NCT00843843|561103960|FG001|Overall Study|Physician Decision|1|||
155459527|NCT00843843|561103959|FG000|Overall Study|Protocol Violation|1|||
155459528|NCT00843843|561103960|FG001|Overall Study|Protocol Violation|1|||
155459529|NCT00065442|561103961|FG000|Overall Study|Lost to Follow-up|1|||
155516089|NCT01325207|561315747|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
155516090|NCT01325207|561315748|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
155516091|NCT01325207|561315749|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
155516092|NCT01325207|561315750|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
155516093|NCT01325207|561315751|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
155516094|NCT01325207|561315746|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
155516095|NCT01325207|561315747|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
155516096|NCT01325207|561315748|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
155516097|NCT01325207|561315749|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
155516098|NCT01325207|561315750|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
155516099|NCT01325207|561315751|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
155516100|NCT01325207|561315746|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155516101|NCT01325207|561315747|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155516102|NCT01325207|561315748|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155516103|NCT01325207|561315749|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155516104|NCT01325207|561315750|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155516105|NCT01325207|561315751|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
155516106|NCT01325207|561315746|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
155516107|NCT01325207|561315747|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
155459530|NCT00065442|561103962|FG001|Overall Study|Lost to Follow-up|1|||
155459531|NCT00065442|561103961|FG000|Overall Study|Death|121|||
155459532|NCT00065442|561103962|FG001|Overall Study|Death|210|||
155459533|NCT00065442|561103961|FG000|Overall Study|Withdrawal by Subject|3|||
155459534|NCT00065442|561103962|FG001|Overall Study|Withdrawal by Subject|9|||
155459535|NCT01594333|561103963|FG000|Overall Study|Death|96|||
155459536|NCT01594333|561103964|FG001|Overall Study|Death|83|||
155459537|NCT01594333|561103963|FG000|Overall Study|Lost to Follow-up|5|||
155459538|NCT01594333|561103964|FG001|Overall Study|Lost to Follow-up|5|||
155459539|NCT01594333|561103963|FG000|Overall Study|Withdrawal by Subject|60|||
155459540|NCT01594333|561103964|FG001|Overall Study|Withdrawal by Subject|63|||
155459541|NCT01764256|561103965|FG000|Received All Vaccinations|Adverse Event|1|||
155459542|NCT01764256|561103966|FG001|Received All Vaccinations|Adverse Event|1|||
155459543|NCT01764256|561103967|FG002|Received All Vaccinations|Adverse Event|0|||
155459544|NCT01764256|561103968|FG003|Received All Vaccinations|Adverse Event|0|||
155459545|NCT01764256|561103965|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
155459546|NCT01764256|561103966|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
155459547|NCT01764256|561103967|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
155459548|NCT01764256|561103968|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
155459549|NCT01764256|561103965|FG000|Received All Vaccinations|Lost to Follow-up|1|||
155459550|NCT01764256|561103966|FG001|Received All Vaccinations|Lost to Follow-up|0|||
155459551|NCT01764256|561103967|FG002|Received All Vaccinations|Lost to Follow-up|0|||
155459552|NCT01764256|561103968|FG003|Received All Vaccinations|Lost to Follow-up|0|||
155459553|NCT01764256|561103965|FG000|Completed Study|Lost to Follow-up|0|||
155459554|NCT01764256|561103966|FG001|Completed Study|Lost to Follow-up|0|||
155459555|NCT01764256|561103967|FG002|Completed Study|Lost to Follow-up|0|||
155459556|NCT01764256|561103968|FG003|Completed Study|Lost to Follow-up|1|||
155459557|NCT00304915|561103969|FG000|Overall Study|Lost to Follow-up|11|||
155459558|NCT00304915|561103970|FG001|Overall Study|Lost to Follow-up|11|||
155459559|NCT00304915|561103969|FG000|Overall Study|Death|4|||
155459560|NCT00304915|561103970|FG001|Overall Study|Death|5|||
155459561|NCT00304915|561103969|FG000|Overall Study|Withdrawal by Subject|3|||
155459562|NCT00304915|561103970|FG001|Overall Study|Withdrawal by Subject|0|||
155652243|NCT03511209|561820273|FG000|Overall Study|Death|1|||
155652244|NCT03511209|561820274|FG001|Overall Study|Death|0|||
155459563|NCT00565058|561103971|FG000|Overall Study|Adverse Event|1|||
155459564|NCT00565058|561103972|FG001|Overall Study|Adverse Event|0|||
155459565|NCT02029638|561103973|FG000|Overall Study|Death|0|||
155459566|NCT02029638|561103974|FG001|Overall Study|Death|0|||
155459567|NCT02029638|561103975|FG002|Overall Study|Death|1|||
155459568|NCT02029638|561103973|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
155459569|NCT02029638|561103974|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
155459570|NCT02029638|561103975|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
155459571|NCT05489081|561103977|FG000|Overall Study|student left classroom|0|||
155459572|NCT05489081|561103978|FG001|Overall Study|student left classroom|1|||
155459573|NCT05489081|561103977|FG000|Overall Study|teacher left school|0|||
155459574|NCT05489081|561103978|FG001|Overall Study|teacher left school|2|||
155459575|NCT00712322|561103982|FG000|Overall Study|Protocol deviation|0|||
155459576|NCT00712322|561103983|FG001|Overall Study|Protocol deviation|1|||
155459577|NCT00712322|561103984|FG002|Overall Study|Protocol deviation|0|||
155459578|NCT00400712|561103987|FG000|Overall Study|Death|1|||
155459579|NCT00400712|561103988|FG001|Overall Study|Death|0|||
155459580|NCT00400712|561103987|FG000|Overall Study|Withdrawal by Subject|11|||
155459581|NCT00400712|561103988|FG001|Overall Study|Withdrawal by Subject|12|||
155459582|NCT00400712|561103987|FG000|Overall Study|Physician Decision|5|||
155459583|NCT00400712|561103988|FG001|Overall Study|Physician Decision|4|||
155459584|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
155459585|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
155459586|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
155459587|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
155459588|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
155459589|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
155459590|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Death|1|||
155459591|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Death|3|||
155459592|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
155459593|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
155459594|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
155459595|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
155652245|NCT03511209|561820273|FG000|Overall Study|Lost to Follow-up|0|||
155652246|NCT03511209|561820274|FG001|Overall Study|Lost to Follow-up|2|||
155652247|NCT02971137|561820280|FG000|Overall Study|Lost to Follow-up|44|||
155652248|NCT02971137|561820281|FG001|Overall Study|Lost to Follow-up|56|||
155652249|NCT00215657|561820282|FG000|Overall Study|Adverse Event|5|||
155459596|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
155459597|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
155459598|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
155459599|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
155459600|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
155459601|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
155652250|NCT00215657|561820283|FG001|Overall Study|Adverse Event|1|||
155652251|NCT00215657|561820284|FG002|Overall Study|Adverse Event|3|||
155652252|NCT00215657|561820285|FG003|Overall Study|Adverse Event|0|||
155459602|NCT02553317|561103992|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
155652253|NCT00215657|561820286|FG004|Overall Study|Adverse Event|3|||
155459603|NCT02553317|561103993|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
155459604|NCT00536978|561103997|FG000|Overall Study|Not eligible for Adback Infusion|22|||
155459605|NCT00622869|561103998|FG000|Overall Study|Subject Withdrew Consent|13|||
155459606|NCT00622869|561103999|FG001|Overall Study|Subject Withdrew Consent|17|||
155459607|NCT00622869|561104000|FG002|Overall Study|Subject Withdrew Consent|11|||
155459608|NCT00622869|561103998|FG000|Overall Study|Administrative Problems|11|||
155459609|NCT00622869|561103999|FG001|Overall Study|Administrative Problems|17|||
155459610|NCT00622869|561104000|FG002|Overall Study|Administrative Problems|13|||
155459611|NCT00622869|561103998|FG000|Overall Study|Death|12|||
155459612|NCT00622869|561103999|FG001|Overall Study|Death|15|||
155459613|NCT00622869|561104000|FG002|Overall Study|Death|10|||
155459614|NCT00622869|561103998|FG000|Overall Study|Lost to Follow-up|2|||
155459615|NCT00622869|561103999|FG001|Overall Study|Lost to Follow-up|4|||
155459616|NCT00622869|561104000|FG002|Overall Study|Lost to Follow-up|2|||
155459617|NCT00622869|561103998|FG000|Overall Study|Graft Loss|5|||
155459618|NCT00622869|561103999|FG001|Overall Study|Graft Loss|3|||
155459619|NCT00622869|561104000|FG002|Overall Study|Graft Loss|2|||
155459620|NCT00622869|561103998|FG000|Overall Study|Missing|0|||
155459621|NCT00622869|561103999|FG001|Overall Study|Missing|1|||
155459622|NCT00622869|561104000|FG002|Overall Study|Missing|1|||
155459623|NCT02927873|561104002|FG000|Overall Study|Lost to Follow-up|0|||
155459624|NCT02927873|561104003|FG001|Overall Study|Lost to Follow-up|1|||
155459625|NCT02927873|561104004|FG002|Overall Study|Lost to Follow-up|0|||
155459626|NCT02927873|561104005|FG003|Overall Study|Lost to Follow-up|0|||
155459627|NCT02927873|561104006|FG004|Overall Study|Lost to Follow-up|0|||
155459628|NCT02927873|561104007|FG005|Overall Study|Lost to Follow-up|0|||
155459629|NCT02927873|561104002|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155459630|NCT02927873|561104003|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155459631|NCT02927873|561104004|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155459632|NCT02927873|561104005|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155459633|NCT02927873|561104006|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155459634|NCT02927873|561104007|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155459635|NCT02927873|561104002|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155459636|NCT02927873|561104003|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155459637|NCT02927873|561104004|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155459638|NCT02927873|561104005|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155459639|NCT02927873|561104006|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155459640|NCT02927873|561104007|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155459641|NCT02927873|561104002|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
155459642|NCT02927873|561104003|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
155459643|NCT02927873|561104004|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
155459644|NCT02927873|561104005|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
155459645|NCT02927873|561104006|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
155459646|NCT02927873|561104007|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
155459647|NCT02927873|561104002|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
155459648|NCT02927873|561104003|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
155459649|NCT02927873|561104004|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
155459650|NCT02927873|561104005|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
155459651|NCT02927873|561104006|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
155459652|NCT02927873|561104007|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
155459653|NCT02927873|561104002|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
155459654|NCT02927873|561104003|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
155459655|NCT02927873|561104004|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
155459656|NCT02927873|561104005|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
155459657|NCT02927873|561104006|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
155459658|NCT02927873|561104007|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
155459659|NCT01518244|561104008|FG000|Overall Study|Adverse Event|3|||
155459660|NCT00870818|561104009|FG000|Overall Study|Lost to Follow-up|3|||
155459661|NCT00870818|561104010|FG001|Overall Study|Lost to Follow-up|2|||
155459662|NCT00870818|561104011|FG002|Overall Study|Lost to Follow-up|1|||
155459663|NCT00870818|561104012|FG003|Overall Study|Lost to Follow-up|0|||
155459664|NCT00870818|561104013|FG004|Overall Study|Lost to Follow-up|0|||
155606775|NCT00412217|561649557|FG000|Overall Study|Withdrawal by Subject|2|||
155459665|NCT00870818|561104009|FG000|Overall Study|Withdrawal by Subject|0|||
155459666|NCT00870818|561104010|FG001|Overall Study|Withdrawal by Subject|0|||
155459667|NCT00870818|561104011|FG002|Overall Study|Withdrawal by Subject|1|||
155459668|NCT00870818|561104012|FG003|Overall Study|Withdrawal by Subject|2|||
155606776|NCT00412217|561649558|FG001|Overall Study|Withdrawal by Subject|0|||
155606777|NCT00412217|561649557|FG000|Overall Study|Lost to Follow-up|1|||
155606778|NCT00412217|561649558|FG001|Overall Study|Lost to Follow-up|4|||
155459669|NCT00870818|561104013|FG004|Overall Study|Withdrawal by Subject|0|||
155459670|NCT00870818|561104009|FG000|Overall Study|Terminated by sponsor|29|||
155459671|NCT00870818|561104010|FG001|Overall Study|Terminated by sponsor|70|||
155459672|NCT00870818|561104011|FG002|Overall Study|Terminated by sponsor|36|||
155459673|NCT00870818|561104012|FG003|Overall Study|Terminated by sponsor|36|||
155459674|NCT00870818|561104013|FG004|Overall Study|Terminated by sponsor|38|||
155459675|NCT00870818|561104009|FG000|Overall Study|Other|0|||
155459676|NCT00870818|561104010|FG001|Overall Study|Other|1|||
155459677|NCT00870818|561104011|FG002|Overall Study|Other|0|||
155459678|NCT00870818|561104012|FG003|Overall Study|Other|0|||
155459679|NCT00870818|561104013|FG004|Overall Study|Other|0|||
155459680|NCT04900038|561104016|FG000|Overall Study|Adverse Event|1|||
155459681|NCT04900038|561104017|FG001|Overall Study|Adverse Event|0|||
155459682|NCT04900038|561104018|FG002|Overall Study|Adverse Event|1|||
155459683|NCT04900038|561104019|FG003|Overall Study|Adverse Event|1|||
155459684|NCT04900038|561104016|FG000|Overall Study|Withdrawal by Subject|0|||
155459685|NCT04900038|561104017|FG001|Overall Study|Withdrawal by Subject|1|||
155459686|NCT04900038|561104018|FG002|Overall Study|Withdrawal by Subject|0|||
155459687|NCT04900038|561104019|FG003|Overall Study|Withdrawal by Subject|0|||
155459688|NCT04900038|561104016|FG000|Overall Study|Study terminated by sponsor|18|||
155459689|NCT04900038|561104017|FG001|Overall Study|Study terminated by sponsor|15|||
155459690|NCT04900038|561104018|FG002|Overall Study|Study terminated by sponsor|17|||
155459691|NCT04900038|561104019|FG003|Overall Study|Study terminated by sponsor|14|||
155459692|NCT04900038|561104016|FG000|Overall Study|Protocol Deviation|1|||
155459693|NCT04900038|561104017|FG001|Overall Study|Protocol Deviation|1|||
155459694|NCT04900038|561104018|FG002|Overall Study|Protocol Deviation|0|||
155459695|NCT04900038|561104019|FG003|Overall Study|Protocol Deviation|0|||
155459696|NCT04900038|561104016|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
155459697|NCT04900038|561104017|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
155459698|NCT04900038|561104018|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
155459699|NCT04900038|561104019|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
155459700|NCT04900038|561104016|FG000|Overall Study|Lost to Follow-up|0|||
155459701|NCT04900038|561104017|FG001|Overall Study|Lost to Follow-up|0|||
155459702|NCT04900038|561104018|FG002|Overall Study|Lost to Follow-up|0|||
155459703|NCT04900038|561104019|FG003|Overall Study|Lost to Follow-up|1|||
155459704|NCT03245723|561104029|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
155459705|NCT03245723|561104030|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
155459706|NCT03245723|561104029|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
155459707|NCT03245723|561104030|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
155459708|NCT03245723|561104029|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
155459709|NCT03245723|561104030|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
155459710|NCT03245723|561104029|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
155459711|NCT03245723|561104030|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
155459712|NCT00077376|561104033|FG000|Overall Study|Adverse Event|8|||
155459713|NCT00077376|561104033|FG000|Overall Study|Withdrawal by Subject|2|||
155459714|NCT00077376|561104033|FG000|Overall Study|Death|1|||
155459715|NCT00077376|561104033|FG000|Overall Study|Physician Decision|1|||
155459716|NCT00077376|561104033|FG000|Overall Study|Alternative therapy|5|||
155459717|NCT00077376|561104033|FG000|Overall Study|Complicating disease|1|||
155459718|NCT00077376|561104033|FG000|Overall Study|Still on treatment|1|||
155459719|NCT00077376|561104033|FG000|Overall Study|Symptomatic deterioration|1|||
155459720|NCT00077376|561104033|FG000|Overall Study|Surgery|1|||
155459721|NCT00077376|561104033|FG000|Overall Study|Insurance ran out|1|||
155459722|NCT03784027|561104034|FG000|Period 1|Withdrawal by Subject|0|||
155459723|NCT03784027|561104035|FG001|Period 1|Withdrawal by Subject|1|||
155459724|NCT02843178|561105626|FG000|Overall Study|Lost to Follow-up|8|||
155459725|NCT02843178|561105627|FG001|Overall Study|Lost to Follow-up|8|||
155459726|NCT02843178|561105628|FG002|Overall Study|Lost to Follow-up|6|||
155459727|NCT02843178|561105629|FG003|Overall Study|Lost to Follow-up|3|||
155459728|NCT02843178|561105626|FG000|Overall Study|Withdrawal by Subject|0|||
155459729|NCT02843178|561105627|FG001|Overall Study|Withdrawal by Subject|0|||
155459730|NCT02843178|561105628|FG002|Overall Study|Withdrawal by Subject|1|||
155459731|NCT02843178|561105629|FG003|Overall Study|Withdrawal by Subject|1|||
155459732|NCT00646113|561105630|FG000|Overall Study|Lost to Follow-up|5|||
155459733|NCT00646113|561105630|FG000|Overall Study|Adverse Event|3|||
155459734|NCT03927911|561105639|FG000|Overall Study|problems with eDiary|0|||
155459735|NCT03927911|561105640|FG001|Overall Study|problems with eDiary|1|||
155459736|NCT03927911|561105641|FG002|Overall Study|problems with eDiary|0|||
155459737|NCT03927911|561105642|FG003|Overall Study|problems with eDiary|1|||
155459738|NCT03927911|561105643|FG004|Overall Study|problems with eDiary|0|||
155459739|NCT03927911|561105644|FG005|Overall Study|problems with eDiary|4|||
155459740|NCT03927911|561105639|FG000|Overall Study|Adverse Event|0|||
155459741|NCT03927911|561105640|FG001|Overall Study|Adverse Event|0|||
155459742|NCT03927911|561105641|FG002|Overall Study|Adverse Event|0|||
155459743|NCT03927911|561105642|FG003|Overall Study|Adverse Event|0|||
155459744|NCT03927911|561105643|FG004|Overall Study|Adverse Event|0|||
155459745|NCT03927911|561105644|FG005|Overall Study|Adverse Event|1|||
155459746|NCT03927911|561105639|FG000|Overall Study|not treated -study terminated by sponsor|0|||
155459747|NCT03927911|561105640|FG001|Overall Study|not treated -study terminated by sponsor|1|||
155459748|NCT03927911|561105641|FG002|Overall Study|not treated -study terminated by sponsor|0|||
155459749|NCT03927911|561105642|FG003|Overall Study|not treated -study terminated by sponsor|0|||
155459750|NCT03927911|561105643|FG004|Overall Study|not treated -study terminated by sponsor|0|||
155459751|NCT03927911|561105644|FG005|Overall Study|not treated -study terminated by sponsor|0|||
155459752|NCT03927911|561105639|FG000|Overall Study|Surgery cancelled|0|||
155459753|NCT03927911|561105640|FG001|Overall Study|Surgery cancelled|0|||
155459754|NCT03927911|561105641|FG002|Overall Study|Surgery cancelled|0|||
155459755|NCT03927911|561105642|FG003|Overall Study|Surgery cancelled|1|||
155459756|NCT03927911|561105643|FG004|Overall Study|Surgery cancelled|0|||
155459757|NCT03927911|561105644|FG005|Overall Study|Surgery cancelled|1|||
155459758|NCT03927911|561105639|FG000|Overall Study|Protocol Violation|0|||
155459759|NCT03927911|561105640|FG001|Overall Study|Protocol Violation|0|||
155459760|NCT03927911|561105641|FG002|Overall Study|Protocol Violation|0|||
155459761|NCT03927911|561105642|FG003|Overall Study|Protocol Violation|0|||
155459762|NCT03927911|561105643|FG004|Overall Study|Protocol Violation|0|||
155459763|NCT03927911|561105644|FG005|Overall Study|Protocol Violation|1|||
155459764|NCT02658968|561105645|FG000|Received Rituximab|Adverse Event|0|||
155459765|NCT02658968|561105646|FG001|Received Rituximab|Adverse Event|0|||
155459766|NCT02658968|561105647|FG002|Received Rituximab|Adverse Event|0|||
155459767|NCT02658968|561105648|FG003|Received Rituximab|Adverse Event|0|||
155459768|NCT02658968|561105649|FG004|Received Rituximab|Adverse Event|1|||
155459769|NCT02658968|561105645|FG000|Received Rituximab|Progressive disease|0|||
155459770|NCT02658968|561105646|FG001|Received Rituximab|Progressive disease|0|||
155459771|NCT02658968|561105647|FG002|Received Rituximab|Progressive disease|0|||
155459772|NCT02658968|561105648|FG003|Received Rituximab|Progressive disease|0|||
155459773|NCT02658968|561105649|FG004|Received Rituximab|Progressive disease|1|||
155459774|NCT02658968|561105645|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
155459775|NCT02658968|561105646|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
155459776|NCT02658968|561105647|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
155459777|NCT02658968|561105648|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
155459778|NCT02658968|561105649|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
155459779|NCT02658968|561105645|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
155459780|NCT02658968|561105646|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
155459781|NCT02658968|561105647|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
155459782|NCT02658968|561105648|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
155459783|NCT02658968|561105649|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
155459784|NCT02658968|561105645|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
155459785|NCT02658968|561105646|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
155459786|NCT02658968|561105647|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
155459787|NCT02658968|561105648|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
155459788|NCT02658968|561105649|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
155459789|NCT02658968|561105645|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
155459790|NCT02658968|561105646|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
155459791|NCT02658968|561105647|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
155459792|NCT02658968|561105648|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
155459793|NCT02658968|561105649|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
155459794|NCT02658968|561105645|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
155459795|NCT02658968|561105646|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
155459796|NCT02658968|561105647|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
155459797|NCT02658968|561105648|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
155459798|NCT02658968|561105649|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
155459799|NCT00949910|561105652|FG000|Overall Study|Progressive Disease|3750|||
155459800|NCT00949910|561105652|FG000|Overall Study|Symptomatic Deterioration|1088|||
155459801|NCT00949910|561105652|FG000|Overall Study|Lost to Follow-up|100|||
155459802|NCT00949910|561105652|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
155459803|NCT00949910|561105652|FG000|Overall Study|Participant Refusal|390|||
155459804|NCT00949910|561105652|FG000|Overall Study|Death Due to Malignant Disease|456|||
155459805|NCT00949910|561105652|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
155459806|NCT00949910|561105652|FG000|Overall Study|Death Due to Adverse Event|115|||
155459807|NCT00949910|561105652|FG000|Overall Study|Death Due to Toxicity|3|||
155459808|NCT00949910|561105652|FG000|Overall Study|Death from Unknown Cause|5|||
155459809|NCT00949910|561105652|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
155459810|NCT00949910|561105652|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
155459811|NCT00949910|561105652|FG000|Overall Study|Switched to Commercial Treatment|4|||
155459812|NCT00949910|561105652|FG000|Overall Study|Violation of Eligibility|23|||
155459813|NCT00949910|561105652|FG000|Overall Study|Logistical Reasons|13|||
155459814|NCT00949910|561105652|FG000|Overall Study|Non-Compliance|10|||
155459815|NCT00949910|561105652|FG000|Overall Study|Prolonged Dosing Interruption|4|||
155459816|NCT00949910|561105652|FG000|Overall Study|Adverse Event|83|||
155459817|NCT00949910|561105652|FG000|Overall Study|Serious Adverse Event|6|||
155459818|NCT00949910|561105652|FG000|Overall Study|Physician/Participant Decision|7|||
155459819|NCT00949910|561105652|FG000|Overall Study|Other|4|||
155459820|NCT00949910|561105652|FG000|Overall Study|No Data|9|||
155459821|NCT03287869|561105653|FG000|Overall Study|Adverse Event|14|||
155459822|NCT03287869|561105654|FG001|Overall Study|Adverse Event|12|||
155459823|NCT03287869|561105653|FG000|Overall Study|Lack of Efficacy|1|||
155459824|NCT03287869|561105654|FG001|Overall Study|Lack of Efficacy|0|||
155459825|NCT03287869|561105653|FG000|Overall Study|Lost to Follow-up|13|||
155459826|NCT03287869|561105654|FG001|Overall Study|Lost to Follow-up|19|||
155459827|NCT03287869|561105653|FG000|Overall Study|Non-Compliance With Study Drug|5|||
155459828|NCT03287869|561105654|FG001|Overall Study|Non-Compliance With Study Drug|9|||
155459829|NCT03287869|561105653|FG000|Overall Study|Progressive Disease|1|||
155459830|NCT03287869|561105654|FG001|Overall Study|Progressive Disease|0|||
155459831|NCT03287869|561105653|FG000|Overall Study|Protocol Deviation|2|||
155459832|NCT03287869|561105654|FG001|Overall Study|Protocol Deviation|1|||
155459833|NCT03287869|561105653|FG000|Overall Study|Withdrawal by Subject|36|||
155459834|NCT03287869|561105654|FG001|Overall Study|Withdrawal by Subject|43|||
155459835|NCT03287869|561105653|FG000|Overall Study|Early Closure of the Site|0|||
155459836|NCT03287869|561105654|FG001|Overall Study|Early Closure of the Site|1|||
155459837|NCT03287869|561105653|FG000|Overall Study|Physician Decision|5|||
155459838|NCT03287869|561105654|FG001|Overall Study|Physician Decision|5|||
155459839|NCT03287869|561105653|FG000|Overall Study|Reason not Specified|6|||
155459840|NCT03287869|561105654|FG001|Overall Study|Reason not Specified|3|||
155459841|NCT02591238|561105656|FG000|Overall Study|Pregnancy|1|||
155459842|NCT02591238|561105657|FG001|Overall Study|Pregnancy|0|||
155459843|NCT02591238|561105658|FG002|Overall Study|Pregnancy|0|||
155459844|NCT02591238|561105659|FG003|Overall Study|Pregnancy|0|||
155459845|NCT02591238|561105656|FG000|Overall Study|Withdrawal by Subject|0|||
155459846|NCT02591238|561105657|FG001|Overall Study|Withdrawal by Subject|0|||
155459847|NCT02591238|561105658|FG002|Overall Study|Withdrawal by Subject|0|||
155459848|NCT02591238|561105659|FG003|Overall Study|Withdrawal by Subject|1|||
155459849|NCT02591238|561105656|FG000|Overall Study|influenza|0|||
155459850|NCT02591238|561105657|FG001|Overall Study|influenza|0|||
155459851|NCT02591238|561105658|FG002|Overall Study|influenza|0|||
155459852|NCT02591238|561105659|FG003|Overall Study|influenza|1|||
155459853|NCT02591238|561105656|FG000|Overall Study|personal circumstances|0|||
155459854|NCT02591238|561105657|FG001|Overall Study|personal circumstances|0|||
155459855|NCT02591238|561105658|FG002|Overall Study|personal circumstances|0|||
155459856|NCT02591238|561105659|FG003|Overall Study|personal circumstances|1|||
155459857|NCT02591238|561105656|FG000|Overall Study|personal circumstances|0|||
155459858|NCT02591238|561105657|FG001|Overall Study|personal circumstances|1|||
155459859|NCT02591238|561105658|FG002|Overall Study|personal circumstances|0|||
155459860|NCT02591238|561105659|FG003|Overall Study|personal circumstances|0|||
155459861|NCT00640146|561105660|FG000|Overall Study|Adverse Event|2|||
155459862|NCT00640146|561105661|FG001|Overall Study|Adverse Event|0|||
155459863|NCT00640146|561105660|FG000|Overall Study|Lost to Follow-up|0|||
155459864|NCT00640146|561105661|FG001|Overall Study|Lost to Follow-up|1|||
155459865|NCT00640146|561105660|FG000|Overall Study|Lack of Efficacy|0|||
155459866|NCT00640146|561105661|FG001|Overall Study|Lack of Efficacy|1|||
155459867|NCT00640146|561105660|FG000|Overall Study|Withdrawal by Subject|1|||
155459868|NCT00640146|561105661|FG001|Overall Study|Withdrawal by Subject|1|||
155459869|NCT00640146|561105660|FG000|Overall Study|Randomized but not treated|1|||
155459870|NCT00640146|561105661|FG001|Overall Study|Randomized but not treated|3|||
155459871|NCT02455388|561105662|FG000|Overall Study|Protocol Violation|1|||
155459872|NCT02455388|561105663|FG001|Overall Study|Protocol Violation|0|||
155459873|NCT02455388|561105664|FG002|Overall Study|Protocol Violation|4|||
155459874|NCT02455388|561105662|FG000|Overall Study|Withdrawal by Subject|0|||
155459875|NCT02455388|561105663|FG001|Overall Study|Withdrawal by Subject|0|||
155459876|NCT02455388|561105664|FG002|Overall Study|Withdrawal by Subject|7|||
155459877|NCT00324740|561105665|FG000|Overall Study|Withdrawal by Subject|1|||
155459878|NCT00324740|561105666|FG001|Overall Study|Withdrawal by Subject|0|||
155459879|NCT00324740|561105667|FG002|Overall Study|Withdrawal by Subject|1|||
155459880|NCT00971425|561105670|FG000|Overall Study|Adverse Event|1|||
155459881|NCT00971425|561105671|FG001|Overall Study|Adverse Event|1|||
155459882|NCT00971425|561105670|FG000|Overall Study|Withdrawal by Subject|0|||
155459883|NCT00971425|561105671|FG001|Overall Study|Withdrawal by Subject|1|||
155459884|NCT02528253|561105672|FG000|Overall Study|Adverse Event|3|||
155459885|NCT02528253|561105673|FG001|Overall Study|Adverse Event|4|||
155459886|NCT02528253|561105674|FG002|Overall Study|Adverse Event|4|||
155459887|NCT02528253|561105675|FG003|Overall Study|Adverse Event|8|||
155459888|NCT02528253|561105676|FG004|Overall Study|Adverse Event|18|||
155459889|NCT02528253|561105672|FG000|Overall Study|Death|2|||
155459890|NCT02528253|561105673|FG001|Overall Study|Death|2|||
155459891|NCT02528253|561105674|FG002|Overall Study|Death|1|||
155459892|NCT02528253|561105675|FG003|Overall Study|Death|0|||
155459893|NCT02528253|561105676|FG004|Overall Study|Death|1|||
155459894|NCT02528253|561105672|FG000|Overall Study|Insufficient clinical response|7|||
155459895|NCT02528253|561105673|FG001|Overall Study|Insufficient clinical response|10|||
155459896|NCT02528253|561105674|FG002|Overall Study|Insufficient clinical response|13|||
155459897|NCT02528253|561105675|FG003|Overall Study|Insufficient clinical response|12|||
155459898|NCT02528253|561105676|FG004|Overall Study|Insufficient clinical response|16|||
155459899|NCT02528253|561105672|FG000|Overall Study|Lost to Follow-up|16|||
155459900|NCT02528253|561105673|FG001|Overall Study|Lost to Follow-up|9|||
155459901|NCT02528253|561105674|FG002|Overall Study|Lost to Follow-up|31|||
155459902|NCT02528253|561105675|FG003|Overall Study|Lost to Follow-up|16|||
155459903|NCT02528253|561105676|FG004|Overall Study|Lost to Follow-up|34|||
155459904|NCT02528253|561105672|FG000|Overall Study|Other|21|||
155459905|NCT02528253|561105673|FG001|Overall Study|Other|22|||
155459906|NCT02528253|561105674|FG002|Overall Study|Other|58|||
155459907|NCT02528253|561105675|FG003|Overall Study|Other|52|||
155459908|NCT02528253|561105676|FG004|Overall Study|Other|76|||
155459909|NCT02528253|561105672|FG000|Overall Study|Withdrawal by Subject|25|||
155459910|NCT02528253|561105673|FG001|Overall Study|Withdrawal by Subject|20|||
155459911|NCT02528253|561105674|FG002|Overall Study|Withdrawal by Subject|29|||
155459912|NCT02528253|561105675|FG003|Overall Study|Withdrawal by Subject|48|||
155459913|NCT02528253|561105676|FG004|Overall Study|Withdrawal by Subject|73|||
155459914|NCT02528253|561105672|FG000|Overall Study|Protocol Violation|1|||
155459915|NCT02528253|561105673|FG001|Overall Study|Protocol Violation|2|||
155459916|NCT02528253|561105674|FG002|Overall Study|Protocol Violation|4|||
155459917|NCT02528253|561105675|FG003|Overall Study|Protocol Violation|0|||
155459918|NCT02528253|561105676|FG004|Overall Study|Protocol Violation|4|||
155459919|NCT02528253|561105672|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
155459920|NCT02528253|561105673|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
155459921|NCT02528253|561105674|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
155459922|NCT02528253|561105675|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
155459923|NCT02528253|561105676|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
155459924|NCT00505752|561105677|FG000|Overall Study|Adverse Event|1|||
155459925|NCT00505752|561105678|FG001|Overall Study|Adverse Event|0|||
155459926|NCT00505752|561105679|FG002|Overall Study|Adverse Event|1|||
155459927|NCT00505752|561105680|FG003|Overall Study|Adverse Event|0|||
155459928|NCT00505752|561105677|FG000|Overall Study|Lost to Follow-up|1|||
155459929|NCT00505752|561105678|FG001|Overall Study|Lost to Follow-up|0|||
155459930|NCT00505752|561105679|FG002|Overall Study|Lost to Follow-up|0|||
155459931|NCT00505752|561105680|FG003|Overall Study|Lost to Follow-up|0|||
155459932|NCT00505752|561105677|FG000|Overall Study|Lack of ovarian response|1|||
155459933|NCT00505752|561105678|FG001|Overall Study|Lack of ovarian response|3|||
155459934|NCT00505752|561105679|FG002|Overall Study|Lack of ovarian response|0|||
155459935|NCT00505752|561105680|FG003|Overall Study|Lack of ovarian response|0|||
155459936|NCT00505752|561105677|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155459937|NCT00505752|561105678|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155459938|NCT00505752|561105679|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
155459939|NCT00505752|561105680|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155459940|NCT00505752|561105677|FG000|Overall Study|No oocytes retrieved|0|||
155459941|NCT00505752|561105678|FG001|Overall Study|No oocytes retrieved|2|||
155459942|NCT00505752|561105679|FG002|Overall Study|No oocytes retrieved|0|||
155459943|NCT00505752|561105680|FG003|Overall Study|No oocytes retrieved|1|||
155459944|NCT00505752|561105677|FG000|Overall Study|No Fertilization|1|||
155459945|NCT00505752|561105678|FG001|Overall Study|No Fertilization|1|||
155459946|NCT00505752|561105679|FG002|Overall Study|No Fertilization|2|||
155459947|NCT00505752|561105680|FG003|Overall Study|No Fertilization|1|||
155459948|NCT00505752|561105677|FG000|Overall Study|All embryos/blastocysts discarded|0|||
155459949|NCT00505752|561105678|FG001|Overall Study|All embryos/blastocysts discarded|0|||
155459950|NCT00505752|561105679|FG002|Overall Study|All embryos/blastocysts discarded|1|||
155459951|NCT00505752|561105680|FG003|Overall Study|All embryos/blastocysts discarded|1|||
155459952|NCT00505752|561105677|FG000|Overall Study|Other|1|||
155459953|NCT00505752|561105678|FG001|Overall Study|Other|2|||
155459954|NCT00505752|561105679|FG002|Overall Study|Other|1|||
155459955|NCT00505752|561105680|FG003|Overall Study|Other|2|||
155459956|NCT01624506|561105681|FG000|Overall Study|Lost to Follow-up|29|||
155459957|NCT01624506|561105682|FG001|Overall Study|Lost to Follow-up|15|||
155459958|NCT01624506|561105681|FG000|Overall Study|Withdrawal by Subject|9|||
155459959|NCT01624506|561105682|FG001|Overall Study|Withdrawal by Subject|2|||
155459960|NCT01624506|561105681|FG000|Overall Study|Death|1|||
155459961|NCT01624506|561105682|FG001|Overall Study|Death|0|||
155459962|NCT01624506|561105681|FG000|Overall Study|LINX explants|23|||
155459963|NCT01624506|561105682|FG001|Overall Study|LINX explants|0|||
155459964|NCT01624506|561105681|FG000|Overall Study|Adverse Event|3|||
155459965|NCT01624506|561105682|FG001|Overall Study|Adverse Event|0|||
155459966|NCT01149343|561105683|FG000|Overall Study|Withdrawal by Subject|1|||
155459967|NCT01149343|561105684|FG001|Overall Study|Withdrawal by Subject|1|||
155459968|NCT01149343|561105685|FG002|Overall Study|Withdrawal by Subject|1|||
155459969|NCT01149343|561105686|FG003|Overall Study|Withdrawal by Subject|5|||
155459970|NCT01149343|561105683|FG000|Overall Study|Death|10|||
155459971|NCT01149343|561105684|FG001|Overall Study|Death|13|||
155652254|NCT00215657|561820287|FG005|Overall Study|Adverse Event|1|||
155652255|NCT00215657|561820288|FG006|Overall Study|Adverse Event|0|||
155652256|NCT00215657|561820289|FG007|Overall Study|Adverse Event|3|||
155652257|NCT00215657|561820282|FG000|Overall Study|Withdrawal by Subject|6|||
155652258|NCT00215657|561820283|FG001|Overall Study|Withdrawal by Subject|3|||
155459972|NCT01149343|561105685|FG002|Overall Study|Death|18|||
155459973|NCT01149343|561105686|FG003|Overall Study|Death|18|||
155459974|NCT01149343|561105683|FG000|Overall Study|Lost to Follow-up|1|||
155459975|NCT01149343|561105684|FG001|Overall Study|Lost to Follow-up|0|||
155459976|NCT01149343|561105685|FG002|Overall Study|Lost to Follow-up|0|||
155459977|NCT01149343|561105686|FG003|Overall Study|Lost to Follow-up|1|||
155459978|NCT01149343|561105683|FG000|Overall Study|Other|8|||
155459979|NCT01149343|561105684|FG001|Overall Study|Other|10|||
155459980|NCT01149343|561105685|FG002|Overall Study|Other|2|||
155459981|NCT01149343|561105686|FG003|Overall Study|Other|14|||
155459982|NCT01149343|561105683|FG000|Overall Study|Sponsor study termination|0|||
155459983|NCT01149343|561105684|FG001|Overall Study|Sponsor study termination|0|||
155459984|NCT01149343|561105685|FG002|Overall Study|Sponsor study termination|0|||
155652259|NCT00215657|561820284|FG002|Overall Study|Withdrawal by Subject|3|||
155652260|NCT00215657|561820285|FG003|Overall Study|Withdrawal by Subject|1|||
155652261|NCT00215657|561820286|FG004|Overall Study|Withdrawal by Subject|6|||
155459985|NCT01149343|561105686|FG003|Overall Study|Sponsor study termination|2|||
155459986|NCT01149343|561105683|FG000|Overall Study|Recurrence / Progressive disease|0|||
155459987|NCT01149343|561105684|FG001|Overall Study|Recurrence / Progressive disease|0|||
155459988|NCT01149343|561105685|FG002|Overall Study|Recurrence / Progressive disease|1|||
155459989|NCT01149343|561105686|FG003|Overall Study|Recurrence / Progressive disease|0|||
155459990|NCT00132314|561105695|FG000|Overall Study|Lost to Follow-up|70|||
155459991|NCT00132314|561105696|FG001|Overall Study|Lost to Follow-up|62|||
155459992|NCT00132314|561105695|FG000|Overall Study|Lacked SSN|1|||
155459993|NCT00132314|561105696|FG001|Overall Study|Lacked SSN|3|||
155459994|NCT00132314|561105695|FG000|Overall Study|Refused intervention at baseline|2|||
155459995|NCT00132314|561105696|FG001|Overall Study|Refused intervention at baseline|7|||
155459996|NCT03250377|561105710|FG000|Overall Study|Adverse Event|2|||
155459997|NCT03250377|561105711|FG001|Overall Study|Adverse Event|4|||
155459998|NCT03250377|561105712|FG002|Overall Study|Adverse Event|0|||
155459999|NCT03250377|561105713|FG003|Overall Study|Adverse Event|4|||
155460000|NCT03250377|561105710|FG000|Overall Study|Lack of Efficacy|5|||
155460001|NCT03250377|561105711|FG001|Overall Study|Lack of Efficacy|14|||
155460002|NCT03250377|561105712|FG002|Overall Study|Lack of Efficacy|1|||
155460003|NCT03250377|561105713|FG003|Overall Study|Lack of Efficacy|3|||
155460004|NCT03250377|561105710|FG000|Overall Study|Protocol Violation|0|||
155460005|NCT03250377|561105711|FG001|Overall Study|Protocol Violation|2|||
155460006|NCT03250377|561105712|FG002|Overall Study|Protocol Violation|0|||
155460007|NCT03250377|561105713|FG003|Overall Study|Protocol Violation|1|||
155460008|NCT03250377|561105710|FG000|Overall Study|Lost to Follow-up|0|||
155460009|NCT03250377|561105711|FG001|Overall Study|Lost to Follow-up|1|||
155460010|NCT03250377|561105712|FG002|Overall Study|Lost to Follow-up|0|||
155460011|NCT03250377|561105713|FG003|Overall Study|Lost to Follow-up|0|||
155460012|NCT03250377|561105710|FG000|Overall Study|Withdrawal by Subject|7|||
155460013|NCT03250377|561105711|FG001|Overall Study|Withdrawal by Subject|7|||
155460014|NCT03250377|561105712|FG002|Overall Study|Withdrawal by Subject|0|||
155460015|NCT03250377|561105713|FG003|Overall Study|Withdrawal by Subject|4|||
155460016|NCT03250377|561105710|FG000|Overall Study|Investigator's Judgment|1|||
155460017|NCT03250377|561105711|FG001|Overall Study|Investigator's Judgment|0|||
155460018|NCT03250377|561105712|FG002|Overall Study|Investigator's Judgment|0|||
155460019|NCT03250377|561105713|FG003|Overall Study|Investigator's Judgment|0|||
155460020|NCT03250377|561105710|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
155460021|NCT03250377|561105711|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
155460022|NCT03250377|561105712|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
155460023|NCT03250377|561105713|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
155460024|NCT03250377|561105710|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
155460025|NCT03250377|561105711|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
155460026|NCT03250377|561105712|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
155460027|NCT03250377|561105713|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
155460028|NCT03250377|561105710|FG000|Overall Study|Epilepsy Surgery|0|||
155460029|NCT03250377|561105711|FG001|Overall Study|Epilepsy Surgery|1|||
155460030|NCT03250377|561105712|FG002|Overall Study|Epilepsy Surgery|2|||
155460031|NCT03250377|561105713|FG003|Overall Study|Epilepsy Surgery|0|||
155460032|NCT03250377|561105710|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
155460033|NCT03250377|561105711|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
155460034|NCT03250377|561105712|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
155460035|NCT03250377|561105713|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
155460036|NCT03250377|561105710|FG000|Overall Study|Request From The Sponsor|0|||
155460037|NCT03250377|561105711|FG001|Overall Study|Request From The Sponsor|1|||
155460038|NCT03250377|561105712|FG002|Overall Study|Request From The Sponsor|0|||
155460039|NCT03250377|561105713|FG003|Overall Study|Request From The Sponsor|0|||
155460040|NCT03250377|561105710|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
155460041|NCT03250377|561105711|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
155460042|NCT03250377|561105712|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
155460043|NCT03250377|561105713|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
155460044|NCT03250377|561105710|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
155460045|NCT03250377|561105711|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
155460046|NCT03250377|561105712|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
155460047|NCT03250377|561105713|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
155460048|NCT03250377|561105710|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
155460049|NCT03250377|561105711|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
155460050|NCT03250377|561105712|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
155460051|NCT03250377|561105713|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
155460052|NCT03250377|561105710|FG000|Overall Study|Pregnancy Event|0|||
155460053|NCT03250377|561105711|FG001|Overall Study|Pregnancy Event|1|||
155460054|NCT03250377|561105712|FG002|Overall Study|Pregnancy Event|0|||
155460055|NCT03250377|561105713|FG003|Overall Study|Pregnancy Event|0|||
155460056|NCT03250377|561105710|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
155460057|NCT03250377|561105711|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
155460058|NCT03250377|561105712|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
155460059|NCT03250377|561105713|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
155460060|NCT03250377|561105710|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
155460061|NCT03250377|561105711|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
155460062|NCT03250377|561105712|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
155460063|NCT03250377|561105713|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
155460064|NCT03250377|561105710|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
155460065|NCT03250377|561105711|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
155460066|NCT03250377|561105712|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
155460067|NCT03250377|561105713|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
155460068|NCT03250377|561105710|FG000|Overall Study|Patient requested to change hospital|0|||
155460069|NCT03250377|561105711|FG001|Overall Study|Patient requested to change hospital|0|||
155460070|NCT03250377|561105712|FG002|Overall Study|Patient requested to change hospital|0|||
155460071|NCT03250377|561105713|FG003|Overall Study|Patient requested to change hospital|1|||
155460072|NCT03250377|561105710|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
155460073|NCT03250377|561105711|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
155460074|NCT03250377|561105712|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
155460075|NCT03250377|561105713|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
155460076|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
155460077|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
155460078|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
155460079|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
155460080|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
155460081|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
155460082|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
155460083|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
155460084|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
155460085|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
155460086|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
155460087|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
155460088|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
155460089|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
155460090|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
155460091|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155460092|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155460093|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155460094|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
155460095|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
155652262|NCT00215657|561820287|FG005|Overall Study|Withdrawal by Subject|1|||
155652263|NCT00215657|561820288|FG006|Overall Study|Withdrawal by Subject|10|||
155652264|NCT00215657|561820289|FG007|Overall Study|Withdrawal by Subject|3|||
155652265|NCT00215657|561820282|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
155652266|NCT00215657|561820283|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
155652267|NCT00215657|561820284|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
155652268|NCT00215657|561820285|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
155652269|NCT00215657|561820286|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
155460096|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
155460097|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
155460098|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
155460099|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
155460100|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
155460101|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
155460102|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
155460103|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
155460104|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
155460105|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
155460106|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
155460107|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
155460108|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
155460109|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
155460110|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
155460111|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
155460112|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
155460113|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
155460114|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
155460115|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
155460116|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
155460117|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
155460118|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
155460119|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
155460120|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
155460121|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
155460122|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
155460123|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
155460124|NCT03444870|561105714|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
155460125|NCT03444870|561105715|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
155460126|NCT03444870|561105716|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
155460127|NCT03444870|561105717|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
155460128|NCT03444870|561105718|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
155460129|NCT03444870|561105719|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
155460130|NCT03444870|561105714|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155460131|NCT03444870|561105715|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155460132|NCT03444870|561105716|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155460133|NCT03444870|561105717|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155460134|NCT03444870|561105718|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
155460135|NCT03444870|561105719|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155460136|NCT03444870|561105714|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
155460137|NCT03444870|561105715|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
155460138|NCT03444870|561105716|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
155460139|NCT03444870|561105717|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
155460140|NCT03444870|561105718|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
155460141|NCT03444870|561105719|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
155460142|NCT03444870|561105714|FG000|Open-Label Extension (OLE) Period|Death|0|||
155460143|NCT03444870|561105715|FG001|Open-Label Extension (OLE) Period|Death|0|||
155460144|NCT03444870|561105716|FG002|Open-Label Extension (OLE) Period|Death|0|||
155460145|NCT03444870|561105717|FG003|Open-Label Extension (OLE) Period|Death|0|||
155460146|NCT03444870|561105718|FG004|Open-Label Extension (OLE) Period|Death|1|||
155460147|NCT03444870|561105719|FG005|Open-Label Extension (OLE) Period|Death|0|||
155460148|NCT02034552|561105722|FG000|Overall Study|Never treated|3|||
155460149|NCT02034552|561105723|FG001|Overall Study|Never treated|2|||
155652270|NCT00215657|561820287|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
155652271|NCT00215657|561820288|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
155652272|NCT00215657|561820289|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
155460150|NCT02034552|561105724|FG002|Overall Study|Never treated|0|||
155460151|NCT02034552|561105722|FG000|Overall Study|Radiological progression|3|||
155460152|NCT02034552|561105723|FG001|Overall Study|Radiological progression|5|||
155460153|NCT02034552|561105724|FG002|Overall Study|Radiological progression|4|||
155460154|NCT02034552|561105722|FG000|Overall Study|AE not assoc. with disease progression|1|||
155460155|NCT02034552|561105723|FG001|Overall Study|AE not assoc. with disease progression|4|||
155460156|NCT02034552|561105724|FG002|Overall Study|AE not assoc. with disease progression|2|||
155460157|NCT02034552|561105722|FG000|Overall Study|AE associated with disease progression|0|||
155460158|NCT02034552|561105723|FG001|Overall Study|AE associated with disease progression|1|||
155460159|NCT02034552|561105724|FG002|Overall Study|AE associated with disease progression|0|||
155460160|NCT02034552|561105722|FG000|Overall Study|Withdrawal by Subject|2|||
155460161|NCT02034552|561105723|FG001|Overall Study|Withdrawal by Subject|1|||
155460162|NCT02034552|561105724|FG002|Overall Study|Withdrawal by Subject|1|||
155460163|NCT02034552|561105722|FG000|Overall Study|Non-compliance with study drug|0|||
155460164|NCT02034552|561105723|FG001|Overall Study|Non-compliance with study drug|0|||
155460165|NCT02034552|561105724|FG002|Overall Study|Non-compliance with study drug|1|||
155460166|NCT02034552|561105722|FG000|Overall Study|Clinical progression|5|||
155460167|NCT02034552|561105723|FG001|Overall Study|Clinical progression|7|||
155460168|NCT02034552|561105724|FG002|Overall Study|Clinical progression|9|||
155460169|NCT04295356|561105730|FG000|Overall Study|Physician Decision|1|||
155460170|NCT04295356|561105731|FG001|Overall Study|Physician Decision|0|||
155460171|NCT04295356|561105730|FG000|Overall Study|Lost to Follow-up|0|||
155460172|NCT04295356|561105731|FG001|Overall Study|Lost to Follow-up|3|||
155460173|NCT04295356|561105730|FG000|Overall Study|Protocol Violation|0|||
155460174|NCT04295356|561105731|FG001|Overall Study|Protocol Violation|1|||
155460175|NCT03986190|561105737|FG000|Overall Study|Withdrawal by Subject|12|||
155460176|NCT03986190|561105738|FG001|Overall Study|Withdrawal by Subject|0|||
155460177|NCT04511819|561105739|FG000|Overall Study|Non-compliance with study drug|5|||
155460178|NCT04511819|561105740|FG001|Overall Study|Non-compliance with study drug|1|||
155460179|NCT04511819|561105739|FG000|Overall Study|Withdrawal by Subject|0|||
155460180|NCT04511819|561105740|FG001|Overall Study|Withdrawal by Subject|3|||
155460181|NCT04511819|561105739|FG000|Overall Study|Adverse Event|0|||
155460182|NCT04511819|561105740|FG001|Overall Study|Adverse Event|1|||
155460183|NCT04511819|561105739|FG000|Overall Study|Protocol deviation|1|||
155460184|NCT04511819|561105740|FG001|Overall Study|Protocol deviation|0|||
155460185|NCT02180217|561105746|FG000|Overall Study|Adverse Event|3|||
155460186|NCT02180217|561105747|FG001|Overall Study|Adverse Event|2|||
155460187|NCT02180217|561105748|FG002|Overall Study|Adverse Event|22|||
155460188|NCT02180217|561105746|FG000|Overall Study|Death|1|||
155460189|NCT02180217|561105747|FG001|Overall Study|Death|1|||
155460190|NCT02180217|561105748|FG002|Overall Study|Death|0|||
155460191|NCT02180217|561105746|FG000|Overall Study|Withdrawal by Subject|1|||
155460192|NCT02180217|561105747|FG001|Overall Study|Withdrawal by Subject|1|||
155460193|NCT02180217|561105748|FG002|Overall Study|Withdrawal by Subject|4|||
155460194|NCT02180217|561105746|FG000|Overall Study|Subject/Guardian decision|5|||
155460195|NCT02180217|561105747|FG001|Overall Study|Subject/Guardian decision|3|||
155460196|NCT02180217|561105748|FG002|Overall Study|Subject/Guardian decision|6|||
155460197|NCT02180217|561105746|FG000|Overall Study|Physician Decision|1|||
155460198|NCT02180217|561105747|FG001|Overall Study|Physician Decision|1|||
155460199|NCT02180217|561105748|FG002|Overall Study|Physician Decision|6|||
155460200|NCT02180217|561105746|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155460201|NCT02180217|561105747|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155460202|NCT02180217|561105748|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155460203|NCT00776555|561105749|FG000|Overall Study|Study terminated|3|||
155460204|NCT00776555|561105750|FG001|Overall Study|Study terminated|0|||
155460205|NCT01181102|561105751|FG000|Overall Study|Adverse Event|28|||
155460206|NCT01181102|561105752|FG001|Overall Study|Adverse Event|26|||
155460207|NCT01181102|561105751|FG000|Overall Study|Lack of Efficacy|3|||
155460208|NCT01181102|561105752|FG001|Overall Study|Lack of Efficacy|1|||
155460209|NCT01181102|561105751|FG000|Overall Study|Lost to Follow-up|2|||
155460210|NCT01181102|561105752|FG001|Overall Study|Lost to Follow-up|0|||
155460211|NCT01181102|561105751|FG000|Overall Study|Physician Decision|3|||
155460212|NCT01181102|561105752|FG001|Overall Study|Physician Decision|1|||
155460213|NCT01181102|561105751|FG000|Overall Study|Protocol Violation|5|||
155460214|NCT01181102|561105752|FG001|Overall Study|Protocol Violation|6|||
155460215|NCT01181102|561105751|FG000|Overall Study|Withdrawal by Subject|10|||
155460216|NCT01181102|561105752|FG001|Overall Study|Withdrawal by Subject|12|||
155460217|NCT00239837|561105753|FG000|Overall Study|Lost to Follow-up|3|||
155460218|NCT00239837|561105754|FG001|Overall Study|Lost to Follow-up|7|||
155460219|NCT01838590|561105755|FG000|Overall Study|Lack of Efficacy|12|||
155460220|NCT01838590|561105756|FG001|Overall Study|Lack of Efficacy|4|||
155460221|NCT01838590|561105755|FG000|Overall Study|Lost to Follow-up|0|||
155460222|NCT01838590|561105756|FG001|Overall Study|Lost to Follow-up|1|||
155460223|NCT04685499|561105757|FG000|Overall Study|Study Terminated Early|1|||
155460224|NCT03076190|561105761|FG000|Overall Study|Lost to Follow-up|9|||
155460225|NCT03076190|561105762|FG001|Overall Study|Lost to Follow-up|34|||
155460226|NCT03076190|561105761|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
155460227|NCT03076190|561105762|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
155460228|NCT00393913|561105763|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
155460229|NCT00393913|561105763|FG000|Initial Assessment|Withdrawal by Subject|16|||
155460230|NCT00393913|561105763|FG000|CPAP|Withdrawal by Subject|3|||
155460231|NCT00393913|561105763|FG000|CPAP|Physician Decision|1|||
155460232|NCT00393913|561105763|FG000|CPAP|TEchnical problem with CPAP|3|||
155460233|NCT00594204|561105764|FG000|Overall Study|Adverse Event|15|||
155460234|NCT00594204|561105765|FG001|Overall Study|Adverse Event|3|||
155460235|NCT00594204|561105764|FG000|Overall Study|Lost to Follow-up|9|||
155460236|NCT00594204|561105765|FG001|Overall Study|Lost to Follow-up|5|||
155460237|NCT00594204|561105764|FG000|Overall Study|Withdrawal by Subject|23|||
155460238|NCT00594204|561105765|FG001|Overall Study|Withdrawal by Subject|29|||
155460239|NCT00594204|561105764|FG000|Overall Study|Other|4|||
155460240|NCT00594204|561105765|FG001|Overall Study|Other|3|||
155460241|NCT00594204|561105764|FG000|Overall Study|Lack of Efficacy|3|||
155460242|NCT00594204|561105765|FG001|Overall Study|Lack of Efficacy|4|||
155460243|NCT00594204|561105764|FG000|Overall Study|Randomized but not treated|4|||
155460244|NCT00594204|561105765|FG001|Overall Study|Randomized but not treated|1|||
155460245|NCT00567541|561105766|FG000|Overall Study|Adverse Event|0|||
155460246|NCT00567541|561105767|FG001|Overall Study|Adverse Event|1|||
155460247|NCT01529385|561105768|FG000|Overall Study|Lost to Follow-up|2|||
155460248|NCT01529385|561105769|FG001|Overall Study|Lost to Follow-up|1|||
155460249|NCT01401465|561105770|FG000|Treatment Period 1|Adverse Event|4|||
155460250|NCT01401465|561105771|FG001|Treatment Period 1|Adverse Event|1|||
155460251|NCT01401465|561105770|FG000|Treatment Period 1|Pregnancy|0|||
155460252|NCT01401465|561105771|FG001|Treatment Period 1|Pregnancy|1|||
155460253|NCT01401465|561105770|FG000|Treatment Period 1|Protocol Violation|5|||
155460254|NCT01401465|561105771|FG001|Treatment Period 1|Protocol Violation|0|||
155460255|NCT01401465|561105770|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155460256|NCT01401465|561105771|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155460257|NCT01401465|561105770|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
155460258|NCT01401465|561105771|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
155460259|NCT01401465|561105770|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
155460260|NCT01401465|561105771|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
155460261|NCT01401465|561105770|FG000|Treatment Period 1|Scheduling Difficulties|1|||
155460262|NCT01401465|561105771|FG001|Treatment Period 1|Scheduling Difficulties|1|||
155460263|NCT01401465|561105770|FG000|Treatment Period 2|Lost to Follow-up|0|||
155460264|NCT01401465|561105771|FG001|Treatment Period 2|Lost to Follow-up|1|||
155460265|NCT01401465|561105770|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155460266|NCT01401465|561105771|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155460267|NCT01115738|561105772|FG000|Overall Study|Death|1|||
155460268|NCT01115738|561105773|FG001|Overall Study|Death|0|||
155460269|NCT01115738|561105774|FG002|Overall Study|Death|0|||
155460270|NCT01115738|561105772|FG000|Overall Study|Lost to Follow-up|0|||
155460271|NCT01115738|561105773|FG001|Overall Study|Lost to Follow-up|0|||
155460272|NCT01115738|561105774|FG002|Overall Study|Lost to Follow-up|1|||
155460273|NCT01115738|561105772|FG000|Overall Study|Physician Decision|18|||
155460274|NCT01115738|561105773|FG001|Overall Study|Physician Decision|15|||
155460275|NCT01115738|561105774|FG002|Overall Study|Physician Decision|17|||
155460276|NCT01115738|561105772|FG000|Overall Study|Withdrawal by Subject|6|||
155460277|NCT01115738|561105773|FG001|Overall Study|Withdrawal by Subject|6|||
155460278|NCT01115738|561105774|FG002|Overall Study|Withdrawal by Subject|9|||
155460279|NCT00772382|561105779|FG000|Overall Study|Adverse Event|19|||
155460280|NCT00772382|561105779|FG000|Overall Study|Death|6|||
155460281|NCT00772382|561105779|FG000|Overall Study|Lack of Efficacy|4|||
155460282|NCT00772382|561105779|FG000|Overall Study|Physician Decision|5|||
155460283|NCT00772382|561105779|FG000|Overall Study|Protocol Violation|1|||
155460284|NCT00772382|561105779|FG000|Overall Study|Withdrawal by Subject|10|||
155460285|NCT00772382|561105779|FG000|Overall Study|Other Reasons|10|||
155460286|NCT05691829|561107420|FG000|Overall Study|Physician Decision|2|||
155460287|NCT05691829|561107420|FG000|Overall Study|Eligibility criteria not met|3|||
155460288|NCT01297309|561107421|FG000|Overall Study|Eligibility failure|2|||
155460289|NCT01297309|561107421|FG000|Overall Study|Screen failure|2|||
155460290|NCT01297309|561107421|FG000|Overall Study|Withdrawal by Subject|5|||
155460291|NCT01297309|561107421|FG000|Overall Study|Adverse Event|1|||
155460292|NCT01297309|561107421|FG000|Overall Study|Investigator Decision|2|||
155460293|NCT01297309|561107421|FG000|Overall Study|Death|1|||
155460294|NCT01297309|561107421|FG000|Overall Study|Participant not entering extensionperiod|1|||
155460295|NCT04847141|561107426|FG000|Overall Study|Adverse Event|1|||
155460296|NCT04847141|561107427|FG001|Overall Study|Adverse Event|0|||
155460297|NCT04847141|561107428|FG002|Overall Study|Adverse Event|1|||
155460298|NCT04847141|561107426|FG000|Overall Study|Withdrawal by Subject|2|||
155460299|NCT04847141|561107427|FG001|Overall Study|Withdrawal by Subject|4|||
155460300|NCT04847141|561107428|FG002|Overall Study|Withdrawal by Subject|3|||
155460301|NCT04847141|561107426|FG000|Overall Study|Lost to Follow-up|7|||
155460302|NCT04847141|561107427|FG001|Overall Study|Lost to Follow-up|5|||
155460303|NCT04847141|561107428|FG002|Overall Study|Lost to Follow-up|7|||
155460304|NCT04847141|561107426|FG000|Overall Study|Reason not Specified|0|||
155460305|NCT04847141|561107427|FG001|Overall Study|Reason not Specified|1|||
155460306|NCT04847141|561107428|FG002|Overall Study|Reason not Specified|0|||
155460307|NCT03472040|561107434|FG000|Overall Study|Physician Decision|0|||
155460308|NCT03472040|561107435|FG001|Overall Study|Physician Decision|3|||
155460309|NCT03472040|561107434|FG000|Overall Study|Withdrawal by Subject|10|||
155460310|NCT03472040|561107435|FG001|Overall Study|Withdrawal by Subject|23|||
155460311|NCT03472040|561107434|FG000|Overall Study|Perceived Lack of Efficacy|29|||
155460312|NCT03472040|561107435|FG001|Overall Study|Perceived Lack of Efficacy|30|||
155460313|NCT03472040|561107434|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
155460314|NCT03472040|561107435|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
155460315|NCT03472040|561107434|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
155460316|NCT03472040|561107435|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
155460317|NCT03472040|561107434|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
155460318|NCT03472040|561107435|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
155460319|NCT03472040|561107434|FG000|Overall Study|Subject Non-compliance|2|||
155460320|NCT03472040|561107435|FG001|Overall Study|Subject Non-compliance|5|||
155460321|NCT03472040|561107434|FG000|Overall Study|Discontinuation due to Rash|0|||
155460322|NCT03472040|561107435|FG001|Overall Study|Discontinuation due to Rash|1|||
155460323|NCT03472040|561107434|FG000|Overall Study|Subsequent Ineligibility|0|||
155460324|NCT03472040|561107435|FG001|Overall Study|Subsequent Ineligibility|2|||
155460325|NCT03472040|561107434|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
155460326|NCT03472040|561107435|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
155460327|NCT02769832|561107436|FG000|Overall Study|Death|30|||
155460328|NCT00225147|561107437|FG000|Open-label Phase|Lost to Follow-up|0|||
155460329|NCT00225147|561107438|FG001|Open-label Phase|Lost to Follow-up|0|||
155460330|NCT00225147|561107439|FG002|Open-label Phase|Lost to Follow-up|0|||
155460331|NCT00225147|561107440|FG003|Open-label Phase|Lost to Follow-up|4|||
155460332|NCT00225147|561107437|FG000|Open-label Phase|Withdrawal by Subject|0|||
155460333|NCT00225147|561107438|FG001|Open-label Phase|Withdrawal by Subject|0|||
155460334|NCT00225147|561107439|FG002|Open-label Phase|Withdrawal by Subject|0|||
155460335|NCT00225147|561107440|FG003|Open-label Phase|Withdrawal by Subject|6|||
155460336|NCT01114373|561107445|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
155460337|NCT01114373|561107446|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
155460338|NCT01114373|561107445|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
155460339|NCT01114373|561107446|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
155460340|NCT01114373|561107445|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
155460341|NCT01114373|561107446|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
155460342|NCT01114373|561107445|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
155460343|NCT01114373|561107446|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
155460344|NCT00868166|561107447|FG000|Overall Study|Death|58|||
155460345|NCT00868166|561107448|FG001|Overall Study|Death|65|||
155460346|NCT00868166|561107447|FG000|Overall Study|Withdrawal by Subject|33|||
155460347|NCT00868166|561107448|FG001|Overall Study|Withdrawal by Subject|25|||
155460348|NCT00868166|561107447|FG000|Overall Study|Protocol Violation|1|||
155460349|NCT00868166|561107448|FG001|Overall Study|Protocol Violation|0|||
155460350|NCT00868166|561107447|FG000|Overall Study|Lost to Follow-up|1|||
155460351|NCT00868166|561107448|FG001|Overall Study|Lost to Follow-up|3|||
155460352|NCT00868166|561107447|FG000|Overall Study|Adverse Event|9|||
155460353|NCT00868166|561107448|FG001|Overall Study|Adverse Event|10|||
155460354|NCT00868166|561107447|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
155460355|NCT00868166|561107448|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
155460356|NCT00868166|561107447|FG000|Overall Study|Non-compliance with IMP|1|||
155460357|NCT00868166|561107448|FG001|Overall Study|Non-compliance with IMP|1|||
155460358|NCT03819218|561107453|FG000|Overall Study|Protocol Violation|1|||
155460359|NCT02197897|561107457|FG000|Overall Study|not eligible|1|||
155460360|NCT02501902|561107458|FG000|Overall Study|Subject Refused Further Follow-up|0|||
155460361|NCT02501902|561107459|FG001|Overall Study|Subject Refused Further Follow-up|0|||
155460362|NCT02501902|561107460|FG002|Overall Study|Subject Refused Further Follow-up|0|||
155460363|NCT02501902|561107461|FG003|Overall Study|Subject Refused Further Follow-up|0|||
155460364|NCT02501902|561107462|FG004|Overall Study|Subject Refused Further Follow-up|0|||
155460365|NCT02501902|561107463|FG005|Overall Study|Subject Refused Further Follow-up|0|||
155460366|NCT02501902|561107464|FG006|Overall Study|Subject Refused Further Follow-up|0|||
155460367|NCT02501902|561107465|FG007|Overall Study|Subject Refused Further Follow-up|1|||
155460368|NCT02501902|561107458|FG000|Overall Study|Study Terminated by Sponsor|0|||
155460369|NCT02501902|561107459|FG001|Overall Study|Study Terminated by Sponsor|3|||
155460370|NCT02501902|561107460|FG002|Overall Study|Study Terminated by Sponsor|0|||
155460371|NCT02501902|561107461|FG003|Overall Study|Study Terminated by Sponsor|1|||
155460372|NCT02501902|561107462|FG004|Overall Study|Study Terminated by Sponsor|1|||
155460373|NCT02501902|561107463|FG005|Overall Study|Study Terminated by Sponsor|0|||
155460374|NCT02501902|561107464|FG006|Overall Study|Study Terminated by Sponsor|2|||
155460375|NCT02501902|561107465|FG007|Overall Study|Study Terminated by Sponsor|4|||
155460376|NCT02501902|561107458|FG000|Overall Study|Death|3|||
155460377|NCT02501902|561107459|FG001|Overall Study|Death|4|||
155460378|NCT02501902|561107460|FG002|Overall Study|Death|4|||
155460379|NCT02501902|561107461|FG003|Overall Study|Death|10|||
155460380|NCT02501902|561107462|FG004|Overall Study|Death|10|||
155460381|NCT02501902|561107463|FG005|Overall Study|Death|11|||
155460382|NCT02501902|561107464|FG006|Overall Study|Death|7|||
155460383|NCT02501902|561107465|FG007|Overall Study|Death|15|||
155460384|NCT02267278|561107466|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
155460385|NCT02267278|561107466|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
155460386|NCT02267278|561107466|FG000|Overall Study|Developed new cancer diagnoses|2|||
155460387|NCT02267278|561107466|FG000|Overall Study|prescribed prohibited medication|1|||
155460388|NCT02513771|561107467|FG000|Overall Study|Lost to Follow-up|1|||
155460389|NCT02513771|561107468|FG001|Overall Study|Lost to Follow-up|1|||
155460390|NCT02513771|561107467|FG000|Overall Study|Not being able to get to clinic|1|||
155460391|NCT02513771|561107468|FG001|Overall Study|Not being able to get to clinic|0|||
155460392|NCT00650091|561107469|FG000|Amended Study Design|Withdrawal by Subject|12|||
155460393|NCT00650091|561107470|FG001|Amended Study Design|Withdrawal by Subject|11|||
155460394|NCT00650091|561107471|FG002|Amended Study Design|Withdrawal by Subject|0|||
155460395|NCT00650091|561107469|FG000|Amended Study Design|Physician Decision|5|||
155460396|NCT00650091|561107470|FG001|Amended Study Design|Physician Decision|0|||
155460397|NCT00650091|561107471|FG002|Amended Study Design|Physician Decision|0|||
155460398|NCT00650091|561107469|FG000|Amended Study Design|Adverse Event|1|||
155460399|NCT00650091|561107470|FG001|Amended Study Design|Adverse Event|4|||
155460400|NCT00650091|561107471|FG002|Amended Study Design|Adverse Event|0|||
155460401|NCT00650091|561107469|FG000|Amended Study Design|Lung transplantation|4|||
155460402|NCT00650091|561107470|FG001|Amended Study Design|Lung transplantation|2|||
155460403|NCT00650091|561107471|FG002|Amended Study Design|Lung transplantation|0|||
155460404|NCT00650091|561107469|FG000|Amended Study Design|Other|1|||
155460405|NCT00650091|561107470|FG001|Amended Study Design|Other|3|||
155460406|NCT00650091|561107471|FG002|Amended Study Design|Other|0|||
155460407|NCT01204697|561107472|FG000|Overall Study|Death|26|||
155460408|NCT01204697|561107473|FG001|Overall Study|Death|27|||
155460409|NCT01204697|561107472|FG000|Overall Study|Lost to Follow-up|3|||
155460410|NCT01204697|561107473|FG001|Overall Study|Lost to Follow-up|4|||
155460411|NCT01204697|561107472|FG000|Overall Study|Withdrawal by Subject|2|||
155460412|NCT01204697|561107473|FG001|Overall Study|Withdrawal by Subject|4|||
155460413|NCT01204697|561107472|FG000|Overall Study|Randomized, but not treated|0|||
155460414|NCT01204697|561107473|FG001|Overall Study|Randomized, but not treated|1|||
155460415|NCT03939637|561107484|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
155460416|NCT03939637|561107485|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
155460417|NCT03939637|561107484|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
155460418|NCT03939637|561107485|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
155460419|NCT04268004|561107486|FG000|Overall Study|Excluded from analyses|0|||
155460420|NCT04268004|561107487|FG001|Overall Study|Excluded from analyses|1|||
155460421|NCT04724733|561107488|FG000|Overall Study|Lost to Follow-up|1|||
155460422|NCT04724733|561107489|FG001|Overall Study|Lost to Follow-up|1|||
155460423|NCT04724733|561107490|FG002|Overall Study|Lost to Follow-up|1|||
155460424|NCT03372603|561107491|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
155460425|NCT03372603|561107492|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
155460426|NCT03372603|561107491|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
155460427|NCT03372603|561107492|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
155460428|NCT03341923|561107493|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
155460429|NCT03341923|561107494|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
155460430|NCT00844649|561107495|FG000|Overall Study|Progressive Disease|196|||
155460431|NCT00844649|561107496|FG001|Overall Study|Progressive Disease|245|||
155460432|NCT00844649|561107495|FG000|Overall Study|Adverse Event|128|||
155460433|NCT00844649|561107496|FG001|Overall Study|Adverse Event|73|||
155460434|NCT00844649|561107495|FG000|Overall Study|Physician Decision|25|||
155460435|NCT00844649|561107496|FG001|Overall Study|Physician Decision|18|||
155460436|NCT00844649|561107495|FG000|Overall Study|Protocol Violation|10|||
155460437|NCT00844649|561107496|FG001|Overall Study|Protocol Violation|6|||
155460438|NCT00844649|561107495|FG000|Overall Study|Withdrawal by Subject|28|||
155460439|NCT00844649|561107496|FG001|Overall Study|Withdrawal by Subject|39|||
155460440|NCT00844649|561107495|FG000|Overall Study|Other|7|||
155460441|NCT00844649|561107496|FG001|Overall Study|Other|10|||
155460442|NCT00844649|561107495|FG000|Overall Study|Withdrew prior to starting treatment|11|||
155460443|NCT00844649|561107496|FG001|Overall Study|Withdrew prior to starting treatment|27|||
155460444|NCT00168064|561107497|FG000|Overall Study|Adverse Event|26|||
155460445|NCT00168064|561107498|FG001|Overall Study|Adverse Event|22|||
155460446|NCT00168064|561107497|FG000|Overall Study|Withdrawal by Subject|3|||
155460447|NCT00168064|561107498|FG001|Overall Study|Withdrawal by Subject|4|||
155460448|NCT00168064|561107497|FG000|Overall Study|Lack of Efficacy|4|||
155460449|NCT00168064|561107498|FG001|Overall Study|Lack of Efficacy|4|||
155460450|NCT00168064|561107497|FG000|Overall Study|Lost to Follow-up|4|||
155460451|NCT00168064|561107498|FG001|Overall Study|Lost to Follow-up|3|||
155460452|NCT00168064|561107497|FG000|Overall Study|Non-compliance|2|||
155460453|NCT00168064|561107498|FG001|Overall Study|Non-compliance|3|||
155460454|NCT00168064|561107497|FG000|Overall Study|Concurrent Illness|4|||
155460455|NCT00168064|561107498|FG001|Overall Study|Concurrent Illness|3|||
155460456|NCT00168064|561107497|FG000|Overall Study|Subject's Best interest|2|||
155460457|NCT00168064|561107498|FG001|Overall Study|Subject's Best interest|2|||
155460458|NCT00168064|561107497|FG000|Overall Study|Various|4|||
155460459|NCT00168064|561107498|FG001|Overall Study|Various|3|||
155460460|NCT00589979|561107500|FG000|Run-In Period|Adverse Event|5|||
155460461|NCT00589979|561107501|FG001|Run-In Period|Adverse Event|0|||
155460462|NCT00589979|561107502|FG002|Run-In Period|Adverse Event|0|||
155460463|NCT00589979|561107500|FG000|Run-In Period|Protocol Violation|3|||
155460464|NCT00589979|561107501|FG001|Run-In Period|Protocol Violation|0|||
155460465|NCT00589979|561107502|FG002|Run-In Period|Protocol Violation|0|||
155460466|NCT00589979|561107500|FG000|Run-In Period|Did not qualify for randomization|54|||
155460467|NCT00589979|561107501|FG001|Run-In Period|Did not qualify for randomization|0|||
155460468|NCT00589979|561107502|FG002|Run-In Period|Did not qualify for randomization|0|||
155460469|NCT00589979|561107500|FG000|Run-In Period|Withdrawal by Subject|10|||
155460470|NCT00589979|561107501|FG001|Run-In Period|Withdrawal by Subject|0|||
155460471|NCT00589979|561107502|FG002|Run-In Period|Withdrawal by Subject|0|||
155460472|NCT00589979|561107500|FG000|Run-In Period|Informed Consent Withdrawn|4|||
155460473|NCT00589979|561107501|FG001|Run-In Period|Informed Consent Withdrawn|0|||
155460474|NCT00589979|561107502|FG002|Run-In Period|Informed Consent Withdrawn|0|||
155460475|NCT00589979|561107500|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
155460476|NCT00589979|561107501|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
155460477|NCT00589979|561107502|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
155460478|NCT00589979|561107500|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
155460479|NCT00589979|561107501|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
155460480|NCT00589979|561107502|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
155460481|NCT00589979|561107500|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
155460482|NCT00589979|561107501|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
155460483|NCT00589979|561107502|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
155460484|NCT00589979|561107500|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
155460485|NCT00589979|561107501|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
155460486|NCT00589979|561107502|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
155460487|NCT00589979|561107500|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
155460488|NCT00589979|561107501|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
155460489|NCT00589979|561107502|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
155460490|NCT00589979|561107500|FG000|Double-Blind Treatment Period 2|Other|0|||
155460491|NCT00589979|561107501|FG001|Double-Blind Treatment Period 2|Other|0|||
155460492|NCT00589979|561107502|FG002|Double-Blind Treatment Period 2|Other|1|||
155460493|NCT00589979|561107500|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
155460494|NCT00589979|561107501|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
155460495|NCT00589979|561107502|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
155460496|NCT00589979|561107500|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
155652273|NCT00215657|561820282|FG000|Overall Study|Insufficient testosterone response|5|||
155652274|NCT00215657|561820283|FG001|Overall Study|Insufficient testosterone response|4|||
155652275|NCT00215657|561820284|FG002|Overall Study|Insufficient testosterone response|1|||
155652276|NCT00215657|561820285|FG003|Overall Study|Insufficient testosterone response|12|||
155652277|NCT00215657|561820286|FG004|Overall Study|Insufficient testosterone response|8|||
155652278|NCT00215657|561820287|FG005|Overall Study|Insufficient testosterone response|12|||
155652279|NCT00215657|561820288|FG006|Overall Study|Insufficient testosterone response|4|||
155652280|NCT00215657|561820289|FG007|Overall Study|Insufficient testosterone response|7|||
155652281|NCT00215657|561820282|FG000|Overall Study|Other|3|||
155652282|NCT00215657|561820283|FG001|Overall Study|Other|1|||
155652283|NCT00215657|561820284|FG002|Overall Study|Other|2|||
155652284|NCT00215657|561820285|FG003|Overall Study|Other|3|||
155652285|NCT00215657|561820286|FG004|Overall Study|Other|5|||
155652286|NCT00215657|561820287|FG005|Overall Study|Other|4|||
155652287|NCT00215657|561820288|FG006|Overall Study|Other|6|||
155652288|NCT00215657|561820289|FG007|Overall Study|Other|1|||
155652289|NCT01887600|561820292|FG000|Overall Study|Death|39|||
155652290|NCT01887600|561820293|FG001|Overall Study|Death|16|||
155652291|NCT01887600|561820292|FG000|Overall Study|Lack of Efficacy|3|||
155652292|NCT01887600|561820293|FG001|Overall Study|Lack of Efficacy|26|||
155652293|NCT01887600|561820292|FG000|Overall Study|Lost to Follow-up|5|||
155460497|NCT00589979|561107501|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
155460498|NCT00589979|561107502|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
155460499|NCT01153841|561107503|FG000|Overall Study|Adverse Event|1|||
155460500|NCT01153841|561107504|FG001|Overall Study|Adverse Event|0|||
155460501|NCT01153841|561107503|FG000|Overall Study|Withdrawal by Subject|1|||
155460502|NCT01153841|561107504|FG001|Overall Study|Withdrawal by Subject|0|||
155460503|NCT01153841|561107503|FG000|Overall Study|Protocol Violation|2|||
155460504|NCT01153841|561107504|FG001|Overall Study|Protocol Violation|0|||
155652294|NCT01887600|561820293|FG001|Overall Study|Lost to Follow-up|1|||
155652295|NCT01887600|561820292|FG000|Overall Study|Physician Decision|7|||
155652296|NCT01887600|561820293|FG001|Overall Study|Physician Decision|8|||
155652297|NCT01887600|561820292|FG000|Overall Study|Protocol Deviation|3|||
155652298|NCT01887600|561820293|FG001|Overall Study|Protocol Deviation|0|||
155652299|NCT01887600|561820292|FG000|Overall Study|Withdrawal by Subject|58|||
155652300|NCT01887600|561820293|FG001|Overall Study|Withdrawal by Subject|52|||
155652301|NCT01887600|561820292|FG000|Overall Study|Adverse Event|21|||
155652302|NCT01887600|561820293|FG001|Overall Study|Adverse Event|9|||
155652303|NCT01887600|561820292|FG000|Overall Study|Non-compliance with study drug|3|||
155652304|NCT01887600|561820293|FG001|Overall Study|Non-compliance with study drug|0|||
155652305|NCT01887600|561820292|FG000|Overall Study|Miscellaneous|6|||
155652306|NCT01887600|561820293|FG001|Overall Study|Miscellaneous|2|||
155652307|NCT01887600|561820292|FG000|Overall Study|Progressive Disease|1|||
155652308|NCT01887600|561820293|FG001|Overall Study|Progressive Disease|0|||
155460505|NCT01153841|561107503|FG000|Overall Study|Lost to Follow-up|2|||
155460506|NCT01153841|561107504|FG001|Overall Study|Lost to Follow-up|0|||
155460507|NCT00830804|561107508|FG000|Overall Study|Lost to Follow-up|4|||
155460508|NCT00830804|561107508|FG000|Overall Study|Death|1|||
155460509|NCT00830804|561107508|FG000|Overall Study|Unable to get to clinic|7|||
155460510|NCT00830804|561107508|FG000|Overall Study|Consent withdrawn|2|||
155460511|NCT00830804|561107508|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
155460512|NCT03428997|561107514|FG000|Overall Study|Sponsor decision.|1|||
155460513|NCT03428997|561107514|FG000|Overall Study|Withdrawal by Subject|3|||
155460514|NCT03428997|561107514|FG000|Overall Study|Lost to Follow-up|4|||
155460515|NCT00510068|561107518|FG000|Double-blind Period|Disease progression|98|||
155460516|NCT00510068|561107519|FG001|Double-blind Period|Disease progression|169|||
155460517|NCT00510068|561107518|FG000|Double-blind Period|Final primary analysis|52|||
155460518|NCT00510068|561107519|FG001|Double-blind Period|Final primary analysis|18|||
155460519|NCT00510068|561107518|FG000|Double-blind Period|Adverse Event|37|||
155460520|NCT00510068|561107519|FG001|Double-blind Period|Adverse Event|7|||
155460521|NCT00510068|561107518|FG000|Double-blind Period|Withdrawal by Subject|8|||
155460522|NCT00510068|561107519|FG001|Double-blind Period|Withdrawal by Subject|6|||
155460523|NCT00510068|561107518|FG000|Double-blind Period|Death|4|||
155460524|NCT00510068|561107519|FG001|Double-blind Period|Death|3|||
155460525|NCT00510068|561107518|FG000|Double-blind Period|Abnormal test result (s)|1|||
155460526|NCT00510068|561107519|FG001|Double-blind Period|Abnormal test result (s)|0|||
155460527|NCT00510068|561107518|FG000|Double-blind Period|Lost to Follow-up|1|||
155460528|NCT00510068|561107519|FG001|Double-blind Period|Lost to Follow-up|0|||
155460529|NCT00510068|561107518|FG000|Double-blind Period|Protocol Violation|6|||
155460530|NCT00510068|561107519|FG001|Double-blind Period|Protocol Violation|0|||
155460531|NCT00510068|561107518|FG000|Open-label Period|Disease Progression|124|||
155460532|NCT00510068|561107519|FG001|Open-label Period|Disease Progression|0|||
155460533|NCT00510068|561107518|FG000|Open-label Period|Adverse Event|46|||
155460534|NCT00510068|561107519|FG001|Open-label Period|Adverse Event|0|||
155460535|NCT00510068|561107518|FG000|Open-label Period|Withdrawal by Subject|21|||
155460536|NCT00510068|561107519|FG001|Open-label Period|Withdrawal by Subject|0|||
155460537|NCT00510068|561107518|FG000|Open-label Period|Administrative problems|17|||
155460538|NCT00510068|561107519|FG001|Open-label Period|Administrative problems|0|||
155460539|NCT00510068|561107518|FG000|Open-label Period|Death|7|||
155516108|NCT01325207|561315748|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
155652309|NCT03688139|561820294|FG000|Overall Study|Lost to Follow-up|2|||
155460540|NCT00510068|561107519|FG001|Open-label Period|Death|0|||
155460541|NCT00510068|561107518|FG000|Open-label Period|New cancer therapy|7|||
155460542|NCT00510068|561107519|FG001|Open-label Period|New cancer therapy|0|||
155460543|NCT00510068|561107518|FG000|Open-label Period|Protocol Violation|2|||
155460544|NCT00510068|561107519|FG001|Open-label Period|Protocol Violation|0|||
155460545|NCT00510068|561107518|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
155460546|NCT00510068|561107519|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
155460547|NCT01397448|561107520|FG000|Overall Study|Adverse Event|4|||
155460548|NCT01397448|561107521|FG001|Overall Study|Adverse Event|4|||
155460549|NCT01397448|561107522|FG002|Overall Study|Adverse Event|6|||
155460550|NCT01397448|561107520|FG000|Overall Study|Withdrawal by Subject|4|||
155460551|NCT01397448|561107521|FG001|Overall Study|Withdrawal by Subject|4|||
155460552|NCT01397448|561107522|FG002|Overall Study|Withdrawal by Subject|3|||
155460553|NCT01397448|561107520|FG000|Overall Study|Lack of Efficacy|2|||
155460554|NCT01397448|561107521|FG001|Overall Study|Lack of Efficacy|0|||
155460555|NCT01397448|561107522|FG002|Overall Study|Lack of Efficacy|5|||
155516109|NCT01325207|561315749|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
155516110|NCT01325207|561315750|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
155516111|NCT01325207|561315751|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
155516112|NCT00698685|561315752|FG000|Overall Study|Sister withdrew as donor|1|||
155516113|NCT00698685|561315752|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
155516114|NCT00708422|561315753|FG000|Overall Study|Adverse Event|3|||
155516115|NCT00708422|561315754|FG001|Overall Study|Adverse Event|1|||
155516116|NCT00708422|561315753|FG000|Overall Study|Withdrawal by Subject|1|||
155516117|NCT00708422|561315754|FG001|Overall Study|Withdrawal by Subject|0|||
155516118|NCT01254409|561315755|FG000|Overall Study|Adverse Event|0|||
155516119|NCT01254409|561315756|FG001|Overall Study|Adverse Event|1|||
155516120|NCT01254409|561315757|FG002|Overall Study|Adverse Event|0|||
155516121|NCT01254409|561315758|FG003|Overall Study|Adverse Event|0|||
155516122|NCT00337571|561315761|FG000|Overall Study|Lack of Efficacy|3|||
155516123|NCT00337571|561315762|FG001|Overall Study|Lack of Efficacy|0|||
155516124|NCT00337571|561315763|FG002|Overall Study|Lack of Efficacy|0|||
155516125|NCT00337571|561315764|FG003|Overall Study|Lack of Efficacy|0|||
155516126|NCT00337571|561315761|FG000|Overall Study|Adverse Event|4|||
155516127|NCT00337571|561315762|FG001|Overall Study|Adverse Event|5|||
155516128|NCT00337571|561315763|FG002|Overall Study|Adverse Event|8|||
155516129|NCT00337571|561315764|FG003|Overall Study|Adverse Event|4|||
155516130|NCT00337571|561315761|FG000|Overall Study|Withdrawal by Subject|2|||
155516131|NCT00337571|561315762|FG001|Overall Study|Withdrawal by Subject|2|||
155516132|NCT00337571|561315763|FG002|Overall Study|Withdrawal by Subject|1|||
155516133|NCT00337571|561315764|FG003|Overall Study|Withdrawal by Subject|0|||
155516134|NCT00337571|561315761|FG000|Overall Study|Lost to Follow-up|3|||
155516135|NCT00337571|561315762|FG001|Overall Study|Lost to Follow-up|1|||
155516136|NCT00337571|561315763|FG002|Overall Study|Lost to Follow-up|0|||
155516137|NCT00337571|561315764|FG003|Overall Study|Lost to Follow-up|1|||
155516138|NCT00337571|561315761|FG000|Overall Study|Poor/noncompliance|1|||
155516139|NCT00337571|561315762|FG001|Overall Study|Poor/noncompliance|1|||
155516140|NCT00337571|561315763|FG002|Overall Study|Poor/noncompliance|1|||
155516141|NCT00337571|561315764|FG003|Overall Study|Poor/noncompliance|1|||
155516142|NCT00337571|561315761|FG000|Overall Study|No longer met study criteria|1|||
155516143|NCT00337571|561315762|FG001|Overall Study|No longer met study criteria|0|||
155516144|NCT00337571|561315763|FG002|Overall Study|No longer met study criteria|0|||
155516145|NCT00337571|561315764|FG003|Overall Study|No longer met study criteria|0|||
155516146|NCT00337571|561315761|FG000|Overall Study|High Potassium level|0|||
155652310|NCT03688139|561820295|FG001|Overall Study|Lost to Follow-up|0|||
155652311|NCT03688139|561820294|FG000|Overall Study|Physician Decision|0|||
155652312|NCT03688139|561820295|FG001|Overall Study|Physician Decision|1|||
155652313|NCT03688139|561820294|FG000|Overall Study|Withdrawal by Subject|2|||
155652314|NCT03688139|561820295|FG001|Overall Study|Withdrawal by Subject|3|||
155652315|NCT01185366|561820296|FG000|First Line Therapy|Insurance Coverage Denied|1|||
155652316|NCT01185366|561820297|FG001|First Line Therapy|Insurance Coverage Denied|1|||
155652317|NCT01185366|561820296|FG000|First Line Therapy|Withdrawal by Subject|1|||
155652318|NCT01185366|561820297|FG001|First Line Therapy|Withdrawal by Subject|0|||
155460556|NCT01397448|561107520|FG000|Overall Study|Other|8|||
155460557|NCT01397448|561107521|FG001|Overall Study|Other|7|||
155460558|NCT01397448|561107522|FG002|Overall Study|Other|4|||
155460559|NCT03483116|561107526|FG000|Overall Study|Adverse Event|0|||
155460560|NCT03483116|561107527|FG001|Overall Study|Adverse Event|1|||
155460561|NCT03483116|561107528|FG002|Overall Study|Adverse Event|0|||
155460562|NCT03483116|561107529|FG003|Overall Study|Adverse Event|1|||
155460563|NCT03483116|561107526|FG000|Overall Study|Protocol Violation|1|||
155460564|NCT03483116|561107527|FG001|Overall Study|Protocol Violation|0|||
155460565|NCT03483116|561107528|FG002|Overall Study|Protocol Violation|0|||
155460566|NCT03483116|561107529|FG003|Overall Study|Protocol Violation|7|||
155460567|NCT03483116|561107526|FG000|Overall Study|Lost to Follow-up|9|||
155460568|NCT03483116|561107527|FG001|Overall Study|Lost to Follow-up|4|||
155652319|NCT01185366|561820296|FG000|First Line Therapy|Lack of Metastatic Site|1|||
155460569|NCT03483116|561107528|FG002|Overall Study|Lost to Follow-up|9|||
155460570|NCT03483116|561107529|FG003|Overall Study|Lost to Follow-up|5|||
155460571|NCT03483116|561107526|FG000|Overall Study|Death|1|||
155460572|NCT03483116|561107527|FG001|Overall Study|Death|0|||
155516147|NCT00337571|561315762|FG001|Overall Study|High Potassium level|0|||
155516148|NCT00337571|561315763|FG002|Overall Study|High Potassium level|0|||
155516149|NCT00337571|561315764|FG003|Overall Study|High Potassium level|1|||
155516150|NCT01974895|561315770|FG000|Overall Study|Protocol Violation|1|||
155460573|NCT03483116|561107528|FG002|Overall Study|Death|2|||
155460574|NCT03483116|561107529|FG003|Overall Study|Death|1|||
155460575|NCT03483116|561107526|FG000|Overall Study|Withdrawal by Subject|14|||
155516151|NCT01974895|561315771|FG001|Overall Study|Protocol Violation|0|||
155460576|NCT03483116|561107527|FG001|Overall Study|Withdrawal by Subject|16|||
155460577|NCT03483116|561107528|FG002|Overall Study|Withdrawal by Subject|14|||
155460578|NCT03483116|561107529|FG003|Overall Study|Withdrawal by Subject|16|||
155460579|NCT03483116|561107526|FG000|Overall Study|Unknown other reason|3|||
155460580|NCT03483116|561107527|FG001|Overall Study|Unknown other reason|2|||
155460581|NCT03483116|561107528|FG002|Overall Study|Unknown other reason|1|||
155460582|NCT03483116|561107529|FG003|Overall Study|Unknown other reason|1|||
155460583|NCT01309841|561107534|FG000|Overall Study|Other|0|||
155460584|NCT01309841|561107535|FG001|Overall Study|Other|1|||
155460585|NCT01309841|561107536|FG002|Overall Study|Other|1|||
155460586|NCT01309841|561107534|FG000|Overall Study|Lost to Follow-up|7|||
155460587|NCT01309841|561107535|FG001|Overall Study|Lost to Follow-up|6|||
155460588|NCT01309841|561107536|FG002|Overall Study|Lost to Follow-up|4|||
155460589|NCT01309841|561107534|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
155460590|NCT01309841|561107535|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155460591|NCT01309841|561107536|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
155460592|NCT01309841|561107534|FG000|Overall Study|Lack of Efficacy|0|||
155460593|NCT01309841|561107535|FG001|Overall Study|Lack of Efficacy|0|||
155460594|NCT01309841|561107536|FG002|Overall Study|Lack of Efficacy|2|||
155460595|NCT01309841|561107534|FG000|Overall Study|Adverse Event|9|||
155460596|NCT01309841|561107535|FG001|Overall Study|Adverse Event|22|||
155460597|NCT01309841|561107536|FG002|Overall Study|Adverse Event|11|||
155460598|NCT01309841|561107534|FG000|Overall Study|Death|1|||
155460599|NCT01309841|561107535|FG001|Overall Study|Death|0|||
155460600|NCT01309841|561107536|FG002|Overall Study|Death|0|||
155460601|NCT01309841|561107534|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155460602|NCT01309841|561107535|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155460603|NCT01309841|561107536|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
155460604|NCT01309841|561107534|FG000|Overall Study|Withdrawal by Subject|17|||
155460605|NCT01309841|561107535|FG001|Overall Study|Withdrawal by Subject|6|||
155460606|NCT01309841|561107536|FG002|Overall Study|Withdrawal by Subject|13|||
155460607|NCT01309841|561107534|FG000|Overall Study|Did Not Receive Treatment|2|||
155460608|NCT01309841|561107535|FG001|Overall Study|Did Not Receive Treatment|0|||
155460609|NCT01309841|561107536|FG002|Overall Study|Did Not Receive Treatment|1|||
155460610|NCT01309841|561107534|FG000|Overall Study|Severe non-compliance with protocol|0|||
155460611|NCT01309841|561107535|FG001|Overall Study|Severe non-compliance with protocol|5|||
155460612|NCT01309841|561107536|FG002|Overall Study|Severe non-compliance with protocol|2|||
155460613|NCT04664855|561107537|FG000|Overall Study|Withdrawal by Subject|0|||
155460614|NCT04664855|561107538|FG001|Overall Study|Withdrawal by Subject|2|||
155460615|NCT01441115|561107539|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
155460616|NCT02475395|561107547|FG000|Overall Study|Protocol Violation|30|||
155460617|NCT02475395|561107548|FG001|Overall Study|Protocol Violation|3|||
155460618|NCT01086150|561107549|FG000|Overall Study|Withdrawal by Subject|0|||
155460619|NCT01086150|561107550|FG001|Overall Study|Withdrawal by Subject|4|||
155460620|NCT01086150|561107551|FG002|Overall Study|Withdrawal by Subject|1|||
155460621|NCT01086150|561107549|FG000|Overall Study|Lost to Follow-up|0|||
155460622|NCT01086150|561107550|FG001|Overall Study|Lost to Follow-up|1|||
155460623|NCT01086150|561107551|FG002|Overall Study|Lost to Follow-up|0|||
155460624|NCT01086150|561107549|FG000|Overall Study|Screen Failure|0|||
155516152|NCT01974895|561315770|FG000|Overall Study|Lost to Follow-up|4|||
155460625|NCT01086150|561107550|FG001|Overall Study|Screen Failure|1|||
155460626|NCT01086150|561107551|FG002|Overall Study|Screen Failure|0|||
155460627|NCT01681576|561107552|FG000|Period 1|Adverse Event|1|||
155460628|NCT01681576|561107553|FG001|Period 1|Adverse Event|0|||
155460629|NCT01681576|561107552|FG000|Period 1|Protocol Deviation|1|||
155460630|NCT01681576|561107553|FG001|Period 1|Protocol Deviation|0|||
155460631|NCT01681576|561107552|FG000|Period 2|subject/guardian decision|3|||
155460632|NCT01681576|561107553|FG001|Period 2|subject/guardian decision|1|||
155460633|NCT01681576|561107552|FG000|Period 2|Non-compliance with study treatment|1|||
155460634|NCT01681576|561107553|FG001|Period 2|Non-compliance with study treatment|0|||
155460635|NCT03543358|561107555|FG000|Overall Study|Death|1|||
155460636|NCT03543358|561107556|FG001|Overall Study|Death|0|||
155460637|NCT03543358|561107555|FG000|Overall Study|Disease Progression|1|||
155460638|NCT03543358|561107556|FG001|Overall Study|Disease Progression|0|||
155460639|NCT03543358|561107555|FG000|Overall Study|Parent Study Closure|1|||
155460640|NCT03543358|561107556|FG001|Overall Study|Parent Study Closure|0|||
155460641|NCT00178464|561107557|FG000|Overall Study|Withdrawal by Subject|1|||
155460642|NCT00178464|561107557|FG000|Overall Study|Physician Decision|1|||
155460643|NCT02260648|561107558|FG000|Overall Study|Adverse Event|3|||
155460644|NCT02260648|561107559|FG001|Overall Study|Adverse Event|0|||
155460645|NCT02260648|561107560|FG002|Overall Study|Adverse Event|1|||
155460646|NCT02260648|561107558|FG000|Overall Study|Withdrawal by Subject|1|||
155460647|NCT02260648|561107559|FG001|Overall Study|Withdrawal by Subject|1|||
155460648|NCT02260648|561107560|FG002|Overall Study|Withdrawal by Subject|0|||
155460649|NCT02260648|561107558|FG000|Overall Study|Protocol Violation|1|||
155460650|NCT02260648|561107559|FG001|Overall Study|Protocol Violation|0|||
155460651|NCT02260648|561107560|FG002|Overall Study|Protocol Violation|0|||
155460652|NCT02260648|561107558|FG000|Overall Study|Discontinue Due to Study Termination|13|||
155460653|NCT02260648|561107559|FG001|Overall Study|Discontinue Due to Study Termination|12|||
155460654|NCT02260648|561107560|FG002|Overall Study|Discontinue Due to Study Termination|7|||
155460655|NCT04093258|561107561|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
155460656|NCT04093258|561107562|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
155460657|NCT01890512|561107563|FG000|Overall Study|Physician Decision|1|||
155460658|NCT01890512|561107563|FG000|Overall Study|Withdrawal by Subject|1|||
155460659|NCT01890512|561107563|FG000|Overall Study|Protocol Violation|1|||
155460660|NCT02379390|561107564|FG000|Overall Study|Adverse Event|1|||
155460661|NCT02379390|561107565|FG001|Overall Study|Adverse Event|1|||
155460662|NCT02379390|561107564|FG000|Overall Study|Investigator's decision|1|||
155460663|NCT02379390|561107565|FG001|Overall Study|Investigator's decision|0|||
155460664|NCT02379390|561107564|FG000|Overall Study|Study Termination|0|||
155460665|NCT02379390|561107565|FG001|Overall Study|Study Termination|1|||
155460666|NCT00575094|561107566|FG000|Overall Study|Adverse Event|2|||
155460667|NCT00575094|561107566|FG000|Overall Study|Withdrawal by Subject|1|||
155460668|NCT02721251|561107569|FG000|Overall Study|Withdrawal by Subject|8|||
155460669|NCT02721251|561107570|FG001|Overall Study|Withdrawal by Subject|7|||
155460670|NCT02721251|561107571|FG002|Overall Study|Withdrawal by Subject|9|||
155460671|NCT02721251|561107569|FG000|Overall Study|poor adherence|2|||
155460672|NCT02721251|561107570|FG001|Overall Study|poor adherence|2|||
155460673|NCT02721251|561107571|FG002|Overall Study|poor adherence|2|||
155460674|NCT02921763|561107574|FG000|Overall Study|Adverse Event|4|||
155460675|NCT02921763|561107574|FG000|Overall Study|Lost to Follow-up|4|||
155460676|NCT02921763|561107574|FG000|Overall Study|Lack of Efficacy|3|||
155460677|NCT02921763|561107574|FG000|Overall Study|Protocol Violation|2|||
155460678|NCT02921763|561107574|FG000|Overall Study|Withdrawal by Subject|2|||
155460679|NCT02921763|561107574|FG000|Overall Study|Physician Decision|1|||
155460680|NCT02921763|561107574|FG000|Overall Study|No data obtained|2|||
155460681|NCT01740388|561107577|FG000|Overall Study|Withdrawal by Subject|1|||
155460682|NCT01740388|561107578|FG001|Overall Study|Withdrawal by Subject|2|||
155460683|NCT01740388|561107577|FG000|Overall Study|Lost to Follow-up|2|||
155460684|NCT01740388|561107578|FG001|Overall Study|Lost to Follow-up|0|||
155460685|NCT01740388|561107577|FG000|Overall Study|Physician Decision|2|||
155460686|NCT01740388|561107578|FG001|Overall Study|Physician Decision|6|||
155460687|NCT01740388|561107577|FG000|Overall Study|Subjects missing data, completed|41|||
155460688|NCT01740388|561107578|FG001|Overall Study|Subjects missing data, completed|36|||
155460689|NCT04142216|561107579|FG000|Overall Study|Hospitalization|0|||
155460690|NCT04142216|561107580|FG001|Overall Study|Hospitalization|2|||
155460691|NCT04142216|561107579|FG000|Overall Study|Death|3|||
155460692|NCT04142216|561107580|FG001|Overall Study|Death|1|||
155516153|NCT01974895|561315771|FG001|Overall Study|Lost to Follow-up|6|||
155516154|NCT01974895|561315770|FG000|Overall Study|Withdrawal by Subject|0|||
155516155|NCT01974895|561315771|FG001|Overall Study|Withdrawal by Subject|1|||
155460693|NCT04142216|561107579|FG000|Overall Study|Referral to another hemodialysis unit|3|||
155460694|NCT04142216|561107580|FG001|Overall Study|Referral to another hemodialysis unit|2|||
155460695|NCT04142216|561107579|FG000|Overall Study|Use of clove|0|||
155460696|NCT04142216|561107580|FG001|Overall Study|Use of clove|1|||
155460697|NCT00862121|561107583|FG000|Overall Study|Adverse Event|1|||
155460698|NCT00862121|561107584|FG001|Overall Study|Adverse Event|2|||
155460699|NCT00862121|561107583|FG000|Overall Study|Lack of Efficacy|0|||
155460700|NCT00862121|561107584|FG001|Overall Study|Lack of Efficacy|3|||
155460701|NCT00862121|561107583|FG000|Overall Study|Protocol Violation|0|||
155460702|NCT00862121|561107584|FG001|Overall Study|Protocol Violation|1|||
155460703|NCT00862121|561107583|FG000|Overall Study|Exclusion criterion violation|0|||
155460704|NCT00862121|561107584|FG001|Overall Study|Exclusion criterion violation|1|||
155460705|NCT00862121|561107583|FG000|Overall Study|Incorrect randomisation|0|||
155460706|NCT00862121|561107584|FG001|Overall Study|Incorrect randomisation|1|||
155460707|NCT01582971|561107585|FG000|Overall Study|Death|2|||
155460708|NCT01582971|561107586|FG001|Overall Study|Death|1|||
155460709|NCT01582971|561107585|FG000|Overall Study|Lost to Follow-up|18|||
155460710|NCT01582971|561107586|FG001|Overall Study|Lost to Follow-up|21|||
155460711|NCT01582971|561107585|FG000|Overall Study|Withdrawal by Subject|4|||
155460712|NCT01582971|561107586|FG001|Overall Study|Withdrawal by Subject|2|||
155460713|NCT01582971|561107585|FG000|Overall Study|Other|15|||
155460714|NCT01582971|561107586|FG001|Overall Study|Other|13|||
155460715|NCT00453180|561109527|FG000|Overall Study|Lost to Follow-up|2|||
155460716|NCT00453180|561109528|FG001|Overall Study|Lost to Follow-up|1|||
155460717|NCT00453180|561109527|FG000|Overall Study|Adverse Event|1|||
155460718|NCT00453180|561109528|FG001|Overall Study|Adverse Event|2|||
155460719|NCT00804843|561109529|FG000|Overall Study|Protocol Violation|1|||
155460720|NCT00804843|561109530|FG001|Overall Study|Protocol Violation|0|||
155460721|NCT00804843|561109529|FG000|Overall Study|Adverse Event|8|||
155460722|NCT00804843|561109530|FG001|Overall Study|Adverse Event|5|||
155460723|NCT00804843|561109529|FG000|Overall Study|Withdrawal by Subject|1|||
155460724|NCT00804843|561109530|FG001|Overall Study|Withdrawal by Subject|2|||
155460725|NCT03326869|561109536|FG000|Overall Study|Study data has been lost to natural disa|1|||
155460726|NCT03326869|561109537|FG001|Overall Study|Study data has been lost to natural disa|1|||
155460727|NCT01002742|561109540|FG000|Overall Study|Determined to be ineligible|0|||
155516156|NCT01974895|561315770|FG000|Overall Study|Other (Missed Visit)|1|||
155516157|NCT01974895|561315771|FG001|Overall Study|Other (Missed Visit)|0|||
155516158|NCT01974895|561315770|FG000|Overall Study|Other (Reason unknown)|9|||
155516159|NCT01974895|561315771|FG001|Overall Study|Other (Reason unknown)|8|||
155516160|NCT00635154|561315772|FG000|Overall Study|Alternative Treatment|8|||
155516161|NCT00635154|561315772|FG000|Overall Study|Other|4|||
155516162|NCT00635154|561315772|FG000|Overall Study|Still on treatment|21|||
155516163|NCT01513148|561315773|FG000|Overall Study|Protocol Violation|2|||
155516164|NCT01513148|561315774|FG001|Overall Study|Protocol Violation|2|||
155516165|NCT03552757|561315775|FG000|Overall Study|Withdrawal by Subject|10|||
155516166|NCT03552757|561315776|FG001|Overall Study|Withdrawal by Subject|5|||
155516167|NCT03552757|561315777|FG002|Overall Study|Withdrawal by Subject|12|||
155516168|NCT03552757|561315775|FG000|Overall Study|Lost to Follow-up|2|||
155516169|NCT03552757|561315776|FG001|Overall Study|Lost to Follow-up|7|||
155516170|NCT03552757|561315777|FG002|Overall Study|Lost to Follow-up|7|||
155516171|NCT03552757|561315775|FG000|Overall Study|Death|1|||
155516172|NCT03552757|561315776|FG001|Overall Study|Death|1|||
155516173|NCT03552757|561315777|FG002|Overall Study|Death|1|||
155516174|NCT02192099|561315780|FG000|Overall Study|Adverse Event|1|||
155516175|NCT02192099|561315780|FG000|Overall Study|Lost to Follow-up|2|||
155516176|NCT02192099|561315780|FG000|Overall Study|Physician Decision|1|||
155516177|NCT02192099|561315780|FG000|Overall Study|Pregnancy|1|||
155516178|NCT02192099|561315780|FG000|Overall Study|Protocol Violation|8|||
155516179|NCT02192099|561315780|FG000|Overall Study|Study Terminated by Sponsor|32|||
155516180|NCT02192099|561315780|FG000|Overall Study|Withdrawal by Subject|11|||
155516181|NCT02192099|561315780|FG000|Overall Study|Miscellaneous Reasons|5|||
155516182|NCT00386009|561315781|FG000|Overall Study|Adverse Event|0|||
155516183|NCT00386009|561315782|FG001|Overall Study|Adverse Event|2|||
155516184|NCT00386009|561315781|FG000|Overall Study|Death|1|||
155516185|NCT00386009|561315782|FG001|Overall Study|Death|0|||
155516186|NCT00386009|561315781|FG000|Overall Study|Entry Criteria Not Met|0|||
155516187|NCT00386009|561315782|FG001|Overall Study|Entry Criteria Not Met|2|||
155516188|NCT00386009|561315781|FG000|Overall Study|Lost to Follow-up|1|||
155516189|NCT00386009|561315782|FG001|Overall Study|Lost to Follow-up|1|||
155516190|NCT00386009|561315781|FG000|Overall Study|Protocol Violation|1|||
155516191|NCT00386009|561315782|FG001|Overall Study|Protocol Violation|0|||
155516192|NCT00386009|561315781|FG000|Overall Study|Sponsor Decision|1|||
155516193|NCT00386009|561315782|FG001|Overall Study|Sponsor Decision|1|||
155516194|NCT00386009|561315781|FG000|Overall Study|Withdrawal by Subject|5|||
155460728|NCT01002742|561109541|FG001|Overall Study|Determined to be ineligible|1|||
155516195|NCT00386009|561315782|FG001|Overall Study|Withdrawal by Subject|4|||
155516196|NCT01862328|561315794|FG000|Overall Study|Progressive Disease|3|||
155516197|NCT01862328|561315795|FG001|Overall Study|Progressive Disease|11|||
155516198|NCT01862328|561315796|FG002|Overall Study|Progressive Disease|5|||
155516199|NCT01862328|561315797|FG003|Overall Study|Progressive Disease|6|||
155516200|NCT01862328|561315798|FG004|Overall Study|Progressive Disease|7|||
155460729|NCT00562640|561109542|FG000|Overall Study|Death|0|||
155516201|NCT01862328|561315799|FG005|Overall Study|Progressive Disease|4|||
155516202|NCT01862328|561315800|FG006|Overall Study|Progressive Disease|3|||
155516203|NCT01862328|561315794|FG000|Overall Study|Adverse Event|0|||
155516204|NCT01862328|561315795|FG001|Overall Study|Adverse Event|4|||
155652320|NCT01185366|561820297|FG001|First Line Therapy|Lack of Metastatic Site|0|||
155460730|NCT00562640|561109543|FG001|Overall Study|Death|1|||
155460731|NCT00562640|561109544|FG002|Overall Study|Death|1|||
155460732|NCT00562640|561109545|FG003|Overall Study|Death|0|||
155516205|NCT01862328|561315796|FG002|Overall Study|Adverse Event|0|||
155516206|NCT01862328|561315797|FG003|Overall Study|Adverse Event|1|||
155516207|NCT01862328|561315798|FG004|Overall Study|Adverse Event|0|||
155516208|NCT01862328|561315799|FG005|Overall Study|Adverse Event|2|||
155516209|NCT01862328|561315800|FG006|Overall Study|Adverse Event|4|||
155460733|NCT01357980|561109546|FG000|Overall Study|Lack of Efficacy|0|||
155460734|NCT01357980|561109547|FG001|Overall Study|Lack of Efficacy|1|||
155460735|NCT01357980|561109548|FG002|Overall Study|Lack of Efficacy|0|||
155460736|NCT01357980|561109549|FG003|Overall Study|Lack of Efficacy|0|||
155460737|NCT01357980|561109546|FG000|Overall Study|Consent withdrawn|0|||
155460738|NCT01357980|561109547|FG001|Overall Study|Consent withdrawn|0|||
155460739|NCT01357980|561109548|FG002|Overall Study|Consent withdrawn|1|||
155460740|NCT01357980|561109549|FG003|Overall Study|Consent withdrawn|0|||
155460741|NCT00094835|561109552|FG000|Overall Study|Physician Decision|1|||
155460742|NCT00094835|561109553|FG001|Overall Study|Physician Decision|0|||
155460743|NCT00094835|561109554|FG002|Overall Study|Physician Decision|0|||
155460744|NCT00094835|561109555|FG003|Overall Study|Physician Decision|0|||
155460745|NCT00094835|561109556|FG004|Overall Study|Physician Decision|0|||
155460746|NCT00094835|561109557|FG005|Overall Study|Physician Decision|1|||
155460747|NCT00094835|561109558|FG006|Overall Study|Physician Decision|0|||
155460748|NCT00094835|561109552|FG000|Overall Study|Withdrawal by Subject|0|||
155460749|NCT00094835|561109553|FG001|Overall Study|Withdrawal by Subject|0|||
155460750|NCT00094835|561109554|FG002|Overall Study|Withdrawal by Subject|0|||
155460751|NCT00094835|561109555|FG003|Overall Study|Withdrawal by Subject|0|||
155460752|NCT00094835|561109556|FG004|Overall Study|Withdrawal by Subject|0|||
155460753|NCT00094835|561109557|FG005|Overall Study|Withdrawal by Subject|0|||
155460754|NCT00094835|561109558|FG006|Overall Study|Withdrawal by Subject|1|||
155460755|NCT00094835|561109552|FG000|Overall Study|Lost to Follow-up|0|||
155460756|NCT00094835|561109553|FG001|Overall Study|Lost to Follow-up|0|||
155460757|NCT00094835|561109554|FG002|Overall Study|Lost to Follow-up|0|||
155460758|NCT00094835|561109555|FG003|Overall Study|Lost to Follow-up|0|||
155460759|NCT00094835|561109556|FG004|Overall Study|Lost to Follow-up|1|||
155460760|NCT00094835|561109557|FG005|Overall Study|Lost to Follow-up|0|||
155460761|NCT00094835|561109558|FG006|Overall Study|Lost to Follow-up|0|||
155460762|NCT00094835|561109552|FG000|Overall Study|Death|1|||
155460763|NCT00094835|561109553|FG001|Overall Study|Death|0|||
155460764|NCT00094835|561109554|FG002|Overall Study|Death|0|||
155460765|NCT00094835|561109555|FG003|Overall Study|Death|0|||
155460766|NCT00094835|561109556|FG004|Overall Study|Death|1|||
155460767|NCT00094835|561109557|FG005|Overall Study|Death|0|||
155460768|NCT00094835|561109558|FG006|Overall Study|Death|0|||
155460769|NCT00094835|561109552|FG000|Overall Study|Non-compliance|1|||
155460770|NCT00094835|561109553|FG001|Overall Study|Non-compliance|2|||
155460771|NCT00094835|561109554|FG002|Overall Study|Non-compliance|2|||
155460772|NCT00094835|561109555|FG003|Overall Study|Non-compliance|0|||
155460773|NCT00094835|561109556|FG004|Overall Study|Non-compliance|2|||
155460774|NCT00094835|561109557|FG005|Overall Study|Non-compliance|2|||
155460775|NCT00094835|561109558|FG006|Overall Study|Non-compliance|1|||
155460776|NCT00094835|561109552|FG000|Overall Study|Other|1|||
155460777|NCT00094835|561109553|FG001|Overall Study|Other|1|||
155460778|NCT00094835|561109554|FG002|Overall Study|Other|1|||
155460779|NCT00094835|561109555|FG003|Overall Study|Other|1|||
155460780|NCT00094835|561109556|FG004|Overall Study|Other|0|||
155460781|NCT00094835|561109557|FG005|Overall Study|Other|0|||
155460782|NCT00094835|561109558|FG006|Overall Study|Other|0|||
155460783|NCT00092677|561109569|FG000|Overall Study|Lost to Follow-up|0|||
155460784|NCT00092677|561109570|FG001|Overall Study|Lost to Follow-up|2|||
155460785|NCT00092677|561109569|FG000|Overall Study|Adminstrative|5|||
155460786|NCT00092677|561109570|FG001|Overall Study|Adminstrative|9|||
155460787|NCT04624672|561109571|FG000|Overall Study|Early Study Closure|2|||
155460788|NCT04624672|561109572|FG001|Overall Study|Early Study Closure|1|||
155460789|NCT03024255|561109575|FG000|Overall Study|Adverse Event|1|||
155460790|NCT03024255|561109576|FG001|Overall Study|Adverse Event|4|||
155460791|NCT03024255|561109577|FG002|Overall Study|Adverse Event|8|||
155460792|NCT03024255|561109578|FG003|Overall Study|Adverse Event|0|||
155460793|NCT03024255|561109575|FG000|Overall Study|Withdrawal by Subject|3|||
155460794|NCT03024255|561109576|FG001|Overall Study|Withdrawal by Subject|1|||
155460795|NCT03024255|561109577|FG002|Overall Study|Withdrawal by Subject|0|||
155460796|NCT03024255|561109578|FG003|Overall Study|Withdrawal by Subject|3|||
155460797|NCT03024255|561109575|FG000|Overall Study|Protocol Violation|0|||
155460798|NCT03024255|561109576|FG001|Overall Study|Protocol Violation|0|||
155460799|NCT03024255|561109577|FG002|Overall Study|Protocol Violation|2|||
155460800|NCT03024255|561109578|FG003|Overall Study|Protocol Violation|0|||
155460801|NCT03024255|561109575|FG000|Overall Study|Lost to Follow-up|1|||
155460802|NCT03024255|561109576|FG001|Overall Study|Lost to Follow-up|2|||
155460803|NCT03024255|561109577|FG002|Overall Study|Lost to Follow-up|1|||
155460804|NCT03024255|561109578|FG003|Overall Study|Lost to Follow-up|1|||
155460805|NCT03024255|561109575|FG000|Overall Study|Lack of Efficacy|1|||
155460806|NCT03024255|561109576|FG001|Overall Study|Lack of Efficacy|0|||
155460807|NCT03024255|561109577|FG002|Overall Study|Lack of Efficacy|0|||
155460808|NCT03024255|561109578|FG003|Overall Study|Lack of Efficacy|0|||
155460809|NCT03024255|561109575|FG000|Overall Study|Protocol Noncompliance|1|||
155460810|NCT03024255|561109576|FG001|Overall Study|Protocol Noncompliance|1|||
155460811|NCT03024255|561109577|FG002|Overall Study|Protocol Noncompliance|0|||
155460812|NCT03024255|561109578|FG003|Overall Study|Protocol Noncompliance|1|||
155460813|NCT01415908|561109579|FG000|Overall Study|Withdrawal by Subject|1|||
155460814|NCT01415908|561109580|FG001|Overall Study|Withdrawal by Subject|0|||
155460815|NCT02685995|561109583|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
155460816|NCT02685995|561109584|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
155460817|NCT01188096|561109585|FG000|Overall Study|progression of disease|4|||
155460818|NCT01188096|561109585|FG000|Overall Study|Withdrawal by Subject|2|||
155460819|NCT01797445|561109586|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
155460820|NCT01797445|561109587|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
155460821|NCT01797445|561109586|FG000|Double-Blind Phase|Adverse Event|3|||
155460822|NCT01797445|561109587|FG001|Double-Blind Phase|Adverse Event|0|||
155460823|NCT01797445|561109586|FG000|Double-Blind Phase|Death|5|||
155460824|NCT01797445|561109587|FG001|Double-Blind Phase|Death|4|||
155460825|NCT01797445|561109586|FG000|Double-Blind Phase|Pregnancy|0|||
155460826|NCT01797445|561109587|FG001|Double-Blind Phase|Pregnancy|1|||
155460827|NCT01797445|561109586|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155460828|NCT01797445|561109587|FG001|Double-Blind Phase|Lack of Efficacy|2|||
155460829|NCT01797445|561109586|FG000|Double-Blind Phase|Investigator's Discretion|15|||
155460830|NCT01797445|561109587|FG001|Double-Blind Phase|Investigator's Discretion|17|||
155460831|NCT01797445|561109586|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
155460832|NCT01797445|561109587|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
155460833|NCT01797445|561109586|FG000|Double-Blind Phase|Protocol Violation|0|||
155460834|NCT01797445|561109587|FG001|Double-Blind Phase|Protocol Violation|1|||
155460835|NCT01797445|561109586|FG000|Double-Blind Phase|Withdrew Consent|20|||
155460836|NCT01797445|561109587|FG001|Double-Blind Phase|Withdrew Consent|35|||
155460837|NCT01797445|561109586|FG000|Double-Blind Phase|Lost to Follow-up|34|||
155460838|NCT01797445|561109587|FG001|Double-Blind Phase|Lost to Follow-up|26|||
155460839|NCT01797445|561109586|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
155460840|NCT01797445|561109587|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
155460841|NCT00688545|561109588|FG000|Overall Study|Lost to Follow-up|1|||
155460842|NCT00688545|561109589|FG001|Overall Study|Lost to Follow-up|4|||
155460843|NCT00688545|561109588|FG000|Overall Study|Insurance/cost of drug|0|||
155460844|NCT00688545|561109589|FG001|Overall Study|Insurance/cost of drug|1|||
155460845|NCT00688545|561109588|FG000|Overall Study|Withdrawal by Subject|2|||
155460846|NCT00688545|561109589|FG001|Overall Study|Withdrawal by Subject|3|||
155460847|NCT00688545|561109588|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
155460848|NCT00688545|561109589|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
155460849|NCT01878097|561109590|FG000|Baseline|Surveys not fully completed|2497|||
155460850|NCT01878097|561109591|FG001|Baseline|Surveys not fully completed|1800|||
155460851|NCT01878097|561109590|FG000|Implementation Year 1|Surveys not fully completed|3202|||
155460852|NCT01878097|561109591|FG001|Implementation Year 1|Surveys not fully completed|2549|||
155460853|NCT01878097|561109590|FG000|Implementation Year 2|Surveys not fully completed|3281|||
155460854|NCT01878097|561109591|FG001|Implementation Year 2|Surveys not fully completed|2841|||
155460855|NCT01878097|561109590|FG000|Implementation Year 3|Surveys not fully completed|3494|||
155460856|NCT01878097|561109591|FG001|Implementation Year 3|Surveys not fully completed|2980|||
155460857|NCT01878097|561109590|FG000|Implementation Year 4|Surveys not fully completed|3604|||
155460858|NCT01878097|561109591|FG001|Implementation Year 4|Surveys not fully completed|3007|||
155460859|NCT01595438|561109594|FG000|Overall Study|Lost to Follow-up|20|||
155460860|NCT01595438|561109595|FG001|Overall Study|Lost to Follow-up|20|||
155460861|NCT01595438|561109594|FG000|Overall Study|Withdrawal by Subject|12|||
155460862|NCT01595438|561109595|FG001|Overall Study|Withdrawal by Subject|12|||
155460863|NCT01595438|561109594|FG000|Overall Study|Other Eligibility criteria|11|||
155460864|NCT01595438|561109595|FG001|Overall Study|Other Eligibility criteria|9|||
155460865|NCT03783442|561109601|FG000|Overall Study|Death|252|||
155460866|NCT03783442|561109602|FG001|Overall Study|Death|268|||
155460867|NCT03783442|561109601|FG000|Overall Study|Withdrawal by Subject|19|||
155460868|NCT03783442|561109602|FG001|Overall Study|Withdrawal by Subject|21|||
155460869|NCT03783442|561109601|FG000|Overall Study|Lost to Follow-up|7|||
155460870|NCT03783442|561109602|FG001|Overall Study|Lost to Follow-up|6|||
155460871|NCT03783442|561109601|FG000|Overall Study|Sponsor Ended Study|48|||
155460872|NCT03783442|561109602|FG001|Overall Study|Sponsor Ended Study|28|||
155460873|NCT00973622|561109603|FG000|Overall Study|did not attend MRI|14|||
155460874|NCT00973622|561109604|FG001|Overall Study|did not attend MRI|3|||
155460875|NCT00973622|561109603|FG000|Overall Study|did not pass MRI screen|6|||
155460876|NCT00973622|561109604|FG001|Overall Study|did not pass MRI screen|0|||
155460877|NCT00973622|561109603|FG000|Overall Study|did not complete rTMS sessions|11|||
155460878|NCT00973622|561109604|FG001|Overall Study|did not complete rTMS sessions|2|||
155460879|NCT00171314|561109605|FG000|Overall Study|Adverse Event|44|||
155460880|NCT00171314|561109606|FG001|Overall Study|Adverse Event|41|||
155460881|NCT00171314|561109605|FG000|Overall Study|Lack of Efficacy|19|||
155460882|NCT00171314|561109606|FG001|Overall Study|Lack of Efficacy|14|||
155460883|NCT00171314|561109605|FG000|Overall Study|Withdrawal by Subject|9|||
155460884|NCT00171314|561109606|FG001|Overall Study|Withdrawal by Subject|6|||
155460885|NCT00171314|561109605|FG000|Overall Study|Abnormal Test Procedure Results|9|||
155460886|NCT00171314|561109606|FG001|Overall Study|Abnormal Test Procedure Results|3|||
155460887|NCT00171314|561109605|FG000|Overall Study|Protocol Violation|3|||
155460888|NCT00171314|561109606|FG001|Overall Study|Protocol Violation|7|||
155460889|NCT00171314|561109605|FG000|Overall Study|Administrative Problems|4|||
155460890|NCT00171314|561109606|FG001|Overall Study|Administrative Problems|3|||
155460891|NCT00171314|561109605|FG000|Overall Study|Lost to Follow-up|1|||
155460892|NCT00171314|561109606|FG001|Overall Study|Lost to Follow-up|3|||
155460893|NCT00171314|561109605|FG000|Overall Study|Death|2|||
155460894|NCT00171314|561109606|FG001|Overall Study|Death|1|||
155460895|NCT02855450|561109607|FG000|Overall Study|Adverse Event|1|||
155460896|NCT02855450|561109608|FG001|Overall Study|Adverse Event|0|||
155460897|NCT02855450|561109607|FG000|Overall Study|Lost to Follow-up|4|||
155460898|NCT02855450|561109608|FG001|Overall Study|Lost to Follow-up|0|||
155460899|NCT01996904|561109609|FG000|Overall Study|Lost to Follow-up|38|||
155460900|NCT01996904|561109610|FG001|Overall Study|Lost to Follow-up|27|||
155460901|NCT00585923|561109612|FG000|Overall Study|Physician decided not to continue|31|||
155460902|NCT00585923|561109613|FG001|Overall Study|Physician decided not to continue|33|||
155460903|NCT00878215|561109614|FG000|Overall Study|Determined to be ineligible|0|||
155460904|NCT00878215|561109615|FG001|Overall Study|Determined to be ineligible|10|||
155460905|NCT00878215|561109616|FG002|Overall Study|Determined to be ineligible|0|||
155460906|NCT00878215|561109617|FG003|Overall Study|Determined to be ineligible|0|||
155460907|NCT02815293|561109618|FG000|Overall Study|Study termination by sponsor|10|||
155460908|NCT02815293|561109619|FG001|Overall Study|Study termination by sponsor|7|||
155460909|NCT02815293|561109620|FG002|Overall Study|Study termination by sponsor|0|||
155460910|NCT02815293|561109618|FG000|Overall Study|Participants not randomized|0|||
155460911|NCT02815293|561109619|FG001|Overall Study|Participants not randomized|0|||
155460912|NCT02815293|561109620|FG002|Overall Study|Participants not randomized|18|||
155460913|NCT02815293|561109618|FG000|Overall Study|Adverse Event|0|||
155460914|NCT02815293|561109619|FG001|Overall Study|Adverse Event|1|||
155460915|NCT02815293|561109620|FG002|Overall Study|Adverse Event|0|||
155460916|NCT00805545|561109625|FG000|Overall Study|Protocol Violation|3|||
155460917|NCT00805545|561109626|FG001|Overall Study|Protocol Violation|2|||
155460918|NCT00805545|561109625|FG000|Overall Study|Protocol Violation|3|||
155460919|NCT00805545|561109626|FG001|Overall Study|Protocol Violation|1|||
155460920|NCT00986427|561109629|FG000|Overall Study|Lost to Follow-up|2|||
155460921|NCT00986427|561109630|FG001|Overall Study|Lost to Follow-up|0|||
155460922|NCT00986427|561109629|FG000|Overall Study|Lack of Efficacy|1|||
155460923|NCT00986427|561109630|FG001|Overall Study|Lack of Efficacy|0|||
155460924|NCT00986427|561109629|FG000|Overall Study|Withdrawal by Subject|1|||
155460925|NCT00986427|561109630|FG001|Overall Study|Withdrawal by Subject|0|||
155460926|NCT00643604|561109634|FG000|Overall Study|Death|1|||
155460927|NCT02007954|561109635|FG000|Overall Study|Received liver transplant|3|||
155460928|NCT02007954|561109635|FG000|Overall Study|Switch in treatment modality|2|||
155460929|NCT02007954|561109635|FG000|Overall Study|Disease progression and unrelated AE|1|||
155460930|NCT02007954|561109635|FG000|Overall Study|Death|1|||
155460931|NCT01641991|561109640|FG000|Overall Study|Physician Decision|0|||
155460932|NCT01641991|561109641|FG001|Overall Study|Physician Decision|1|||
155460933|NCT01641991|561109642|FG002|Overall Study|Physician Decision|7|||
155460934|NCT01641991|561109643|FG003|Overall Study|Physician Decision|5|||
155460935|NCT01641991|561109640|FG000|Overall Study|Withdrawal by Subject|4|||
155460936|NCT01641991|561109641|FG001|Overall Study|Withdrawal by Subject|2|||
155460937|NCT01641991|561109642|FG002|Overall Study|Withdrawal by Subject|1|||
155460938|NCT01641991|561109643|FG003|Overall Study|Withdrawal by Subject|5|||
155460939|NCT01641991|561109640|FG000|Overall Study|Adverse Event|2|||
155460940|NCT01641991|561109641|FG001|Overall Study|Adverse Event|1|||
155460941|NCT01641991|561109642|FG002|Overall Study|Adverse Event|2|||
155460942|NCT01641991|561109643|FG003|Overall Study|Adverse Event|1|||
155460943|NCT01641991|561109640|FG000|Overall Study|Lost to Follow-up|0|||
155460944|NCT01641991|561109641|FG001|Overall Study|Lost to Follow-up|2|||
155460945|NCT01641991|561109642|FG002|Overall Study|Lost to Follow-up|3|||
155460946|NCT01641991|561109643|FG003|Overall Study|Lost to Follow-up|1|||
155460947|NCT01641991|561109640|FG000|Overall Study|Protocol Violation|1|||
155460948|NCT01641991|561109641|FG001|Overall Study|Protocol Violation|1|||
155460949|NCT01641991|561109642|FG002|Overall Study|Protocol Violation|3|||
155460950|NCT01641991|561109643|FG003|Overall Study|Protocol Violation|0|||
155460951|NCT01641991|561109640|FG000|Overall Study|Pregnancy|0|||
155460952|NCT01641991|561109641|FG001|Overall Study|Pregnancy|0|||
155460953|NCT01641991|561109642|FG002|Overall Study|Pregnancy|1|||
155460954|NCT01641991|561109643|FG003|Overall Study|Pregnancy|0|||
155460955|NCT01641991|561109640|FG000|Overall Study|no longer eligible|2|||
155460956|NCT01641991|561109641|FG001|Overall Study|no longer eligible|1|||
155460957|NCT01641991|561109642|FG002|Overall Study|no longer eligible|0|||
155460958|NCT01641991|561109643|FG003|Overall Study|no longer eligible|4|||
155460959|NCT01054976|561109644|FG000|Overall Study|Adverse Event|16|||
155460960|NCT01054976|561109644|FG000|Overall Study|Uncooperative participations to study|7|||
155460961|NCT01054976|561109644|FG000|Overall Study|Withdrawal by Subject|4|||
155460962|NCT01054976|561109644|FG000|Overall Study|Other|8|||
155460963|NCT01195363|561109646|FG000|Overall Study|Lost to Follow-up|7|||
155460964|NCT01195363|561109647|FG001|Overall Study|Lost to Follow-up|4|||
155460965|NCT01195363|561109646|FG000|Overall Study|Adverse Event|3|||
155460966|NCT01195363|561109647|FG001|Overall Study|Adverse Event|1|||
155460967|NCT01195363|561109646|FG000|Overall Study|Lack of Efficacy|0|||
155460968|NCT01195363|561109647|FG001|Overall Study|Lack of Efficacy|4|||
155460969|NCT01195363|561109646|FG000|Overall Study|incarceration|1|||
155460970|NCT01195363|561109647|FG001|Overall Study|incarceration|0|||
155460971|NCT01763866|561109649|FG000|Overall Study|Withdrawal by Subject|2|||
155460972|NCT01763866|561109650|FG001|Overall Study|Withdrawal by Subject|1|||
155460973|NCT01763866|561109651|FG002|Overall Study|Withdrawal by Subject|4|||
155460974|NCT01763866|561109652|FG003|Overall Study|Withdrawal by Subject|0|||
155460975|NCT01763866|561109653|FG004|Overall Study|Withdrawal by Subject|0|||
155460976|NCT01763866|561109654|FG005|Overall Study|Withdrawal by Subject|3|||
155460977|NCT01763866|561109655|FG006|Overall Study|Withdrawal by Subject|4|||
155460978|NCT01763866|561109656|FG007|Overall Study|Withdrawal by Subject|0|||
155460979|NCT01763866|561109657|FG008|Overall Study|Withdrawal by Subject|1|||
155460980|NCT01763866|561109658|FG009|Overall Study|Withdrawal by Subject|1|||
155460981|NCT01763866|561109659|FG010|Overall Study|Withdrawal by Subject|2|||
155460982|NCT01763866|561109660|FG011|Overall Study|Withdrawal by Subject|2|||
155460983|NCT01763866|561109661|FG012|Overall Study|Withdrawal by Subject|2|||
155460984|NCT01763866|561109662|FG013|Overall Study|Withdrawal by Subject|0|||
155460985|NCT01763866|561109663|FG014|Overall Study|Withdrawal by Subject|6|||
155460986|NCT01763866|561109664|FG015|Overall Study|Withdrawal by Subject|3|||
155460987|NCT01763866|561109665|FG016|Overall Study|Withdrawal by Subject|0|||
155460988|NCT01763866|561109666|FG017|Overall Study|Withdrawal by Subject|1|||
155460989|NCT01763866|561109667|FG018|Overall Study|Withdrawal by Subject|1|||
155460990|NCT01763866|561109668|FG019|Overall Study|Withdrawal by Subject|1|||
155460991|NCT01763866|561109669|FG020|Overall Study|Withdrawal by Subject|2|||
155460992|NCT01763866|561109670|FG021|Overall Study|Withdrawal by Subject|1|||
155460993|NCT01763866|561109671|FG022|Overall Study|Withdrawal by Subject|2|||
155460994|NCT01763866|561109672|FG023|Overall Study|Withdrawal by Subject|1|||
155460995|NCT01763866|561109649|FG000|Overall Study|Decision by sponsor|0|||
155460996|NCT01763866|561109650|FG001|Overall Study|Decision by sponsor|0|||
155460997|NCT01763866|561109651|FG002|Overall Study|Decision by sponsor|1|||
155460998|NCT01763866|561109652|FG003|Overall Study|Decision by sponsor|0|||
155460999|NCT01763866|561109653|FG004|Overall Study|Decision by sponsor|2|||
155461000|NCT01763866|561109654|FG005|Overall Study|Decision by sponsor|0|||
155461001|NCT01763866|561109655|FG006|Overall Study|Decision by sponsor|2|||
155461002|NCT01763866|561109656|FG007|Overall Study|Decision by sponsor|0|||
155461003|NCT01763866|561109657|FG008|Overall Study|Decision by sponsor|2|||
155461004|NCT01763866|561109658|FG009|Overall Study|Decision by sponsor|0|||
155461005|NCT01763866|561109659|FG010|Overall Study|Decision by sponsor|6|||
155652321|NCT01185366|561820296|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
155652322|NCT01185366|561820297|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
155461006|NCT01763866|561109660|FG011|Overall Study|Decision by sponsor|0|||
155461007|NCT01763866|561109661|FG012|Overall Study|Decision by sponsor|1|||
155461008|NCT01763866|561109662|FG013|Overall Study|Decision by sponsor|0|||
155461009|NCT01763866|561109663|FG014|Overall Study|Decision by sponsor|5|||
155461010|NCT01763866|561109664|FG015|Overall Study|Decision by sponsor|0|||
155461011|NCT01763866|561109665|FG016|Overall Study|Decision by sponsor|0|||
155461012|NCT01763866|561109666|FG017|Overall Study|Decision by sponsor|0|||
155461013|NCT01763866|561109667|FG018|Overall Study|Decision by sponsor|4|||
155461014|NCT01763866|561109668|FG019|Overall Study|Decision by sponsor|0|||
155461015|NCT01763866|561109669|FG020|Overall Study|Decision by sponsor|2|||
155461016|NCT01763866|561109670|FG021|Overall Study|Decision by sponsor|0|||
155461017|NCT01763866|561109671|FG022|Overall Study|Decision by sponsor|1|||
155461018|NCT01763866|561109672|FG023|Overall Study|Decision by sponsor|0|||
155461019|NCT01763866|561109649|FG000|Overall Study|Lost to Follow-up|0|||
155461020|NCT01763866|561109650|FG001|Overall Study|Lost to Follow-up|0|||
155461021|NCT01763866|561109651|FG002|Overall Study|Lost to Follow-up|0|||
155461022|NCT01763866|561109652|FG003|Overall Study|Lost to Follow-up|0|||
155461023|NCT01763866|561109653|FG004|Overall Study|Lost to Follow-up|0|||
155461024|NCT01763866|561109654|FG005|Overall Study|Lost to Follow-up|0|||
155461025|NCT01763866|561109655|FG006|Overall Study|Lost to Follow-up|1|||
155461026|NCT01763866|561109656|FG007|Overall Study|Lost to Follow-up|0|||
155461027|NCT01763866|561109657|FG008|Overall Study|Lost to Follow-up|0|||
155461028|NCT01763866|561109658|FG009|Overall Study|Lost to Follow-up|0|||
155461029|NCT01763866|561109659|FG010|Overall Study|Lost to Follow-up|0|||
155461030|NCT01763866|561109660|FG011|Overall Study|Lost to Follow-up|0|||
155461031|NCT01763866|561109661|FG012|Overall Study|Lost to Follow-up|1|||
155461032|NCT01763866|561109662|FG013|Overall Study|Lost to Follow-up|0|||
155461033|NCT01763866|561109663|FG014|Overall Study|Lost to Follow-up|1|||
155461034|NCT01763866|561109664|FG015|Overall Study|Lost to Follow-up|0|||
155461035|NCT01763866|561109665|FG016|Overall Study|Lost to Follow-up|0|||
155461036|NCT01763866|561109666|FG017|Overall Study|Lost to Follow-up|0|||
155461037|NCT01763866|561109667|FG018|Overall Study|Lost to Follow-up|1|||
155461038|NCT01763866|561109668|FG019|Overall Study|Lost to Follow-up|1|||
155461039|NCT01763866|561109669|FG020|Overall Study|Lost to Follow-up|0|||
155461040|NCT01763866|561109670|FG021|Overall Study|Lost to Follow-up|0|||
155461041|NCT01763866|561109671|FG022|Overall Study|Lost to Follow-up|0|||
155461042|NCT01763866|561109672|FG023|Overall Study|Lost to Follow-up|1|||
155461043|NCT01763866|561109649|FG000|Overall Study|Death|0|||
155461044|NCT01763866|561109650|FG001|Overall Study|Death|0|||
155461045|NCT01763866|561109651|FG002|Overall Study|Death|0|||
155461046|NCT01763866|561109652|FG003|Overall Study|Death|0|||
155461047|NCT01763866|561109653|FG004|Overall Study|Death|0|||
155461048|NCT01763866|561109654|FG005|Overall Study|Death|0|||
155461049|NCT01763866|561109655|FG006|Overall Study|Death|0|||
155461050|NCT01763866|561109656|FG007|Overall Study|Death|0|||
155461051|NCT01763866|561109657|FG008|Overall Study|Death|0|||
155461052|NCT01763866|561109658|FG009|Overall Study|Death|0|||
155461053|NCT01763866|561109659|FG010|Overall Study|Death|0|||
155461054|NCT01763866|561109660|FG011|Overall Study|Death|0|||
155461055|NCT01763866|561109661|FG012|Overall Study|Death|0|||
155461056|NCT01763866|561109662|FG013|Overall Study|Death|0|||
155461057|NCT01763866|561109663|FG014|Overall Study|Death|0|||
155461058|NCT01763866|561109664|FG015|Overall Study|Death|0|||
155461059|NCT01763866|561109665|FG016|Overall Study|Death|1|||
155461060|NCT01763866|561109666|FG017|Overall Study|Death|0|||
155461061|NCT01763866|561109667|FG018|Overall Study|Death|0|||
155461062|NCT01763866|561109668|FG019|Overall Study|Death|0|||
155461063|NCT01763866|561109669|FG020|Overall Study|Death|0|||
155461064|NCT01763866|561109670|FG021|Overall Study|Death|0|||
155461065|NCT01763866|561109671|FG022|Overall Study|Death|0|||
155461066|NCT01763866|561109672|FG023|Overall Study|Death|0|||
155461067|NCT01164865|561109682|FG000|Overall Study|Lost to Follow-up|2|||
155461068|NCT01164865|561109683|FG001|Overall Study|Lost to Follow-up|1|||
155461069|NCT00475540|561109684|FG000|36 Months|Lost to Follow-up|4|||
155461070|NCT00475540|561109685|FG001|36 Months|Lost to Follow-up|4|||
155461071|NCT00475540|561109684|FG000|36 Months|Death|1|||
155461072|NCT00475540|561109685|FG001|36 Months|Death|2|||
155461073|NCT00475540|561109684|FG000|36 Months|Censored due to reoperation|3|||
155461074|NCT00475540|561109685|FG001|36 Months|Censored due to reoperation|0|||
155461075|NCT00377429|561109686|FG000|Overall Study|Withdrawal by Subject|5|||
155461076|NCT00377429|561109686|FG000|Overall Study|Adverse Event|8|||
155461077|NCT00377429|561109686|FG000|Overall Study|Physician Decision|1|||
155461078|NCT00377429|561109686|FG000|Overall Study|Patient non-compliance|1|||
155461079|NCT02394795|561109689|FG000|Overall Study|Adverse Event|92|||
155461080|NCT02394795|561109690|FG001|Overall Study|Adverse Event|70|||
155461081|NCT02394795|561109689|FG000|Overall Study|Lost to Follow-up|0|||
155461082|NCT02394795|561109690|FG001|Overall Study|Lost to Follow-up|1|||
155461083|NCT02394795|561109689|FG000|Overall Study|Withdrawal by Subject|17|||
155461084|NCT02394795|561109690|FG001|Overall Study|Withdrawal by Subject|26|||
155461085|NCT02394795|561109689|FG000|Overall Study|Lack of Efficacy|181|||
155461086|NCT02394795|561109690|FG001|Overall Study|Lack of Efficacy|211|||
155461087|NCT02394795|561109689|FG000|Overall Study|Death|4|||
155461088|NCT02394795|561109690|FG001|Overall Study|Death|5|||
155461089|NCT02394795|561109689|FG000|Overall Study|Physician Decision|109|||
155652323|NCT01185366|561820296|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
155461090|NCT02394795|561109690|FG001|Overall Study|Physician Decision|93|||
155461091|NCT01669811|561109692|FG000|Overall Study|Investigator decision|0|||
155461092|NCT01669811|561109693|FG001|Overall Study|Investigator decision|1|||
155461093|NCT01669811|561109692|FG000|Overall Study|Withdrawal by Subject|1|||
155461094|NCT01669811|561109693|FG001|Overall Study|Withdrawal by Subject|2|||
155461095|NCT01669811|561109692|FG000|Overall Study|Adverse Event|2|||
155461096|NCT01669811|561109693|FG001|Overall Study|Adverse Event|6|||
155461097|NCT01669811|561109692|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155461098|NCT01669811|561109693|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155461099|NCT03288493|561109694|FG000|Overall Study|Withdrawal by Subject|4|||
155461100|NCT03288493|561109695|FG001|Overall Study|Withdrawal by Subject|0|||
155461101|NCT03288493|561109696|FG002|Overall Study|Withdrawal by Subject|0|||
155461102|NCT03288493|561109697|FG003|Overall Study|Withdrawal by Subject|0|||
155461103|NCT03288493|561109698|FG004|Overall Study|Withdrawal by Subject|0|||
155461104|NCT03288493|561109699|FG005|Overall Study|Withdrawal by Subject|2|||
155461105|NCT03288493|561109700|FG006|Overall Study|Withdrawal by Subject|0|||
155461106|NCT03288493|561109694|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
155461107|NCT03288493|561109695|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
155461108|NCT03288493|561109696|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
155461109|NCT03288493|561109697|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
155461110|NCT03288493|561109698|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
155461111|NCT03288493|561109699|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
155461112|NCT03288493|561109700|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
155461113|NCT03288493|561109694|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
155461114|NCT03288493|561109695|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
155461115|NCT03288493|561109696|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
155461116|NCT03288493|561109697|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
155461117|NCT03288493|561109698|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
155461118|NCT03288493|561109699|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
155516210|NCT01862328|561315794|FG000|Overall Study|Other|0|||
155461119|NCT03288493|561109700|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
155461120|NCT03288493|561109694|FG000|Overall Study|Death|2|||
155461121|NCT03288493|561109695|FG001|Overall Study|Death|0|||
155461122|NCT03288493|561109696|FG002|Overall Study|Death|0|||
155461123|NCT03288493|561109697|FG003|Overall Study|Death|0|||
155461124|NCT03288493|561109698|FG004|Overall Study|Death|0|||
155461125|NCT03288493|561109699|FG005|Overall Study|Death|0|||
155461126|NCT03288493|561109700|FG006|Overall Study|Death|0|||
155461127|NCT03288493|561109694|FG000|Overall Study|other reason not listed above|2|||
155461128|NCT03288493|561109695|FG001|Overall Study|other reason not listed above|0|||
155461129|NCT03288493|561109696|FG002|Overall Study|other reason not listed above|0|||
155461130|NCT03288493|561109697|FG003|Overall Study|other reason not listed above|0|||
155461131|NCT03288493|561109698|FG004|Overall Study|other reason not listed above|0|||
155461132|NCT03288493|561109699|FG005|Overall Study|other reason not listed above|0|||
155461133|NCT03288493|561109700|FG006|Overall Study|other reason not listed above|0|||
155461134|NCT01871896|561109701|FG000|Overall Study|Lost to Follow-up|1|||
155461135|NCT05263921|561111347|FG000|Overall Study|Other: family emergency.|0|||
155461136|NCT05263921|561111348|FG001|Overall Study|Other: family emergency.|0|||
155461137|NCT05263921|561111349|FG002|Overall Study|Other: family emergency.|1|||
155461138|NCT05263921|561111350|FG003|Overall Study|Other: family emergency.|0|||
155461139|NCT02670928|561111354|FG000|Overall Study|Adverse Event|3|||
155461140|NCT02670928|561111355|FG001|Overall Study|Adverse Event|1|||
155461141|NCT02670928|561111354|FG000|Overall Study|Withdrawal by Subject|4|||
155461142|NCT02670928|561111355|FG001|Overall Study|Withdrawal by Subject|0|||
155461143|NCT02670928|561111354|FG000|Overall Study|Lost to Follow-up|1|||
155461144|NCT02670928|561111355|FG001|Overall Study|Lost to Follow-up|0|||
155461145|NCT02670928|561111354|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
155461146|NCT02670928|561111355|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
155461147|NCT02678312|561111356|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
155461148|NCT02678312|561111357|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
155461149|NCT02678312|561111358|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
155461150|NCT02678312|561111359|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
155461151|NCT02678312|561111360|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
155461152|NCT02678312|561111356|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
155461153|NCT02678312|561111357|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
155461154|NCT02678312|561111358|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
155461155|NCT02678312|561111359|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
155461156|NCT02678312|561111360|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
155461157|NCT02678312|561111356|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
155461158|NCT02678312|561111357|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
155461159|NCT02678312|561111358|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
155461160|NCT02678312|561111359|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
155461161|NCT02678312|561111360|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
155461162|NCT02678312|561111356|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
155461163|NCT02678312|561111357|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
155461164|NCT02678312|561111358|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
155461165|NCT02678312|561111359|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
155461166|NCT02678312|561111360|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
155461167|NCT02678312|561111356|FG000|Part 2 Double Blind Epoch|Death|0|||
155461168|NCT02678312|561111357|FG001|Part 2 Double Blind Epoch|Death|0|||
155461169|NCT02678312|561111358|FG002|Part 2 Double Blind Epoch|Death|0|||
155461170|NCT02678312|561111359|FG003|Part 2 Double Blind Epoch|Death|8|||
155461171|NCT02678312|561111360|FG004|Part 2 Double Blind Epoch|Death|12|||
155461172|NCT02678312|561111356|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
155461173|NCT02678312|561111357|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
155461174|NCT02678312|561111358|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
155461175|NCT02678312|561111359|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
155461176|NCT02678312|561111360|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
155461177|NCT02678312|561111356|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
155461178|NCT02678312|561111357|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
155461179|NCT02678312|561111358|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
155461180|NCT02678312|561111359|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
155461181|NCT02678312|561111360|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
155461182|NCT02678312|561111356|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
155461183|NCT02678312|561111357|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
155461184|NCT02678312|561111358|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
155461185|NCT02678312|561111359|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
155461186|NCT02678312|561111360|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
155461187|NCT00656084|561111361|FG000|Overall Study|Adverse Event|4|||
155461188|NCT00656084|561111361|FG000|Overall Study|Withdrawal by Subject|1|||
155461189|NCT00656084|561111361|FG000|Overall Study|Patient Request|1|||
155461190|NCT00656084|561111361|FG000|Overall Study|Investigator Request|1|||
155461191|NCT00525785|561111364|FG000|Overall Study|Withdrawal by Subject|1|||
155461192|NCT00525785|561111364|FG000|Overall Study|Lack of Efficacy|1|||
155461193|NCT00525785|561111364|FG000|Overall Study|Physician Decision|1|||
155461194|NCT04507776|561111365|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
155461195|NCT00387348|561111367|FG000|Overall Study|Death|1|||
155461196|NCT00387348|561111368|FG001|Overall Study|Death|1|||
155461197|NCT00387348|561111369|FG002|Overall Study|Death|0|||
155461198|NCT00387348|561111367|FG000|Overall Study|Physician Decision|1|||
155461199|NCT00387348|561111368|FG001|Overall Study|Physician Decision|0|||
155461200|NCT00387348|561111369|FG002|Overall Study|Physician Decision|1|||
155461201|NCT00387348|561111367|FG000|Overall Study|Withdrawal by Subject|0|||
155461202|NCT00387348|561111368|FG001|Overall Study|Withdrawal by Subject|2|||
155461203|NCT00387348|561111369|FG002|Overall Study|Withdrawal by Subject|2|||
155461204|NCT00387348|561111367|FG000|Overall Study|Adverse Event|1|||
155461205|NCT00387348|561111368|FG001|Overall Study|Adverse Event|0|||
155461206|NCT00387348|561111369|FG002|Overall Study|Adverse Event|1|||
155461207|NCT03628599|561111370|FG000|Overall Study|Adverse Event|0|||
155461208|NCT03628599|561111371|FG001|Overall Study|Adverse Event|1|||
155461209|NCT01136746|561111372|FG000|Overall Study|Lost to Follow-up|0|||
155461210|NCT01136746|561111373|FG001|Overall Study|Lost to Follow-up|2|||
155461211|NCT01136746|561111372|FG000|Overall Study|Protocol Violation|2|||
155461212|NCT01136746|561111373|FG001|Overall Study|Protocol Violation|1|||
155461213|NCT01136746|561111372|FG000|Overall Study|Death|1|||
155461214|NCT01136746|561111373|FG001|Overall Study|Death|0|||
155461215|NCT00010803|561111382|FG000|Overall Study|Withdrawal by Subject|97|||
155461216|NCT00010803|561111383|FG001|Overall Study|Withdrawal by Subject|98|||
155461217|NCT05905601|561111384|FG000|Overall Study|Lost to Follow-up|1|||
155461218|NCT05905601|561111385|FG001|Overall Study|Lost to Follow-up|3|||
155461219|NCT01779648|561111387|FG000|Overall Study|Protocol Violation|1|||
155461220|NCT01779648|561111388|FG001|Overall Study|Protocol Violation|0|||
155461221|NCT02384395|561111389|FG000|Overall Study|Physician Decision|4|||
155461222|NCT02384395|561111389|FG000|Overall Study|Withdrawal by Subject|3|||
155461223|NCT02384395|561111389|FG000|Overall Study|Lost to Follow-up|3|||
155461224|NCT00985738|561111391|FG000|Overall Study|Study closed prematurely|8|||
155461225|NCT00985738|561111392|FG001|Overall Study|Study closed prematurely|8|||
155461226|NCT02119026|561111393|FG000|1st-line Treatment|Adverse Event|9|||
155461227|NCT02119026|561111394|FG001|1st-line Treatment|Adverse Event|14|||
155461228|NCT02119026|561111393|FG000|1st-line Treatment|Physician Decision|3|||
155461229|NCT02119026|561111394|FG001|1st-line Treatment|Physician Decision|8|||
155461230|NCT02119026|561111393|FG000|1st-line Treatment|Withdrawal by Subject|4|||
155461231|NCT02119026|561111394|FG001|1st-line Treatment|Withdrawal by Subject|10|||
155461232|NCT02119026|561111393|FG000|1st-line Treatment|Patient condition or compliance|6|||
155461233|NCT02119026|561111394|FG001|1st-line Treatment|Patient condition or compliance|4|||
155461234|NCT02119026|561111393|FG000|1st-line Treatment|Surgery of metastases|2|||
155461235|NCT02119026|561111394|FG001|1st-line Treatment|Surgery of metastases|1|||
155461236|NCT02119026|561111393|FG000|1st-line Treatment|Death|2|||
155461237|NCT02119026|561111394|FG001|1st-line Treatment|Death|1|||
155461238|NCT02119026|561111393|FG000|2nd-line Treatment|Lost to Follow-up|2|||
155461239|NCT02119026|561111394|FG001|2nd-line Treatment|Lost to Follow-up|0|||
155461240|NCT02119026|561111393|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
155461241|NCT02119026|561111394|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
155461242|NCT02119026|561111393|FG000|2nd-line Treatment|Adverse Event|4|||
155461243|NCT02119026|561111394|FG001|2nd-line Treatment|Adverse Event|1|||
155461244|NCT00340834|561111397|FG000|Core Phase of Study|Adverse Event|26|||
155461245|NCT00340834|561111398|FG001|Core Phase of Study|Adverse Event|9|||
155461246|NCT00340834|561111399|FG002|Core Phase of Study|Adverse Event|9|||
155461247|NCT00340834|561111400|FG003|Core Phase of Study|Adverse Event|0|||
155461248|NCT00340834|561111401|FG004|Core Phase of Study|Adverse Event|0|||
155461249|NCT00340834|561111397|FG000|Core Phase of Study|Withdrawal by Subject|11|||
155461250|NCT00340834|561111398|FG001|Core Phase of Study|Withdrawal by Subject|9|||
155461251|NCT00340834|561111399|FG002|Core Phase of Study|Withdrawal by Subject|16|||
155461252|NCT00340834|561111400|FG003|Core Phase of Study|Withdrawal by Subject|0|||
155461253|NCT00340834|561111401|FG004|Core Phase of Study|Withdrawal by Subject|0|||
155461254|NCT00340834|561111397|FG000|Core Phase of Study|Administrative Problems|6|||
155461255|NCT00340834|561111398|FG001|Core Phase of Study|Administrative Problems|2|||
155461256|NCT00340834|561111399|FG002|Core Phase of Study|Administrative Problems|7|||
155461257|NCT00340834|561111400|FG003|Core Phase of Study|Administrative Problems|0|||
155461258|NCT00340834|561111401|FG004|Core Phase of Study|Administrative Problems|0|||
155461259|NCT00340834|561111397|FG000|Core Phase of Study|Lack of Efficacy|3|||
155461260|NCT00340834|561111398|FG001|Core Phase of Study|Lack of Efficacy|3|||
155461261|NCT00340834|561111399|FG002|Core Phase of Study|Lack of Efficacy|7|||
155461262|NCT00340834|561111400|FG003|Core Phase of Study|Lack of Efficacy|0|||
155461263|NCT00340834|561111401|FG004|Core Phase of Study|Lack of Efficacy|0|||
155461264|NCT00340834|561111397|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
155461265|NCT00340834|561111398|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
155461266|NCT00340834|561111399|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
155461267|NCT00340834|561111400|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
155461268|NCT00340834|561111401|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
155461269|NCT00340834|561111397|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
155461270|NCT00340834|561111398|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
155461271|NCT00340834|561111399|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
155461272|NCT00340834|561111400|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
155461273|NCT00340834|561111401|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
155461274|NCT00340834|561111397|FG000|Core Phase of Study|Lost to Follow-up|1|||
155461275|NCT00340834|561111398|FG001|Core Phase of Study|Lost to Follow-up|1|||
155461276|NCT00340834|561111399|FG002|Core Phase of Study|Lost to Follow-up|4|||
155461277|NCT00340834|561111400|FG003|Core Phase of Study|Lost to Follow-up|0|||
155461278|NCT00340834|561111401|FG004|Core Phase of Study|Lost to Follow-up|0|||
155461279|NCT00340834|561111397|FG000|Core Phase of Study|Death|2|||
155461280|NCT00340834|561111398|FG001|Core Phase of Study|Death|0|||
155461281|NCT00340834|561111399|FG002|Core Phase of Study|Death|0|||
155461282|NCT00340834|561111400|FG003|Core Phase of Study|Death|0|||
155461283|NCT00340834|561111401|FG004|Core Phase of Study|Death|0|||
155461284|NCT00340834|561111397|FG000|Core Phase of Study|Protocol Violation|0|||
155461285|NCT00340834|561111398|FG001|Core Phase of Study|Protocol Violation|0|||
155461286|NCT00340834|561111399|FG002|Core Phase of Study|Protocol Violation|2|||
155461287|NCT00340834|561111400|FG003|Core Phase of Study|Protocol Violation|0|||
155461288|NCT00340834|561111401|FG004|Core Phase of Study|Protocol Violation|0|||
155461289|NCT00340834|561111397|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
155461290|NCT00340834|561111398|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
155461291|NCT00340834|561111399|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
155461292|NCT00340834|561111400|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
155461293|NCT00340834|561111401|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
155461294|NCT00340834|561111397|FG000|Extension Phase of Study|Subject withdrew consent|26|||
155461295|NCT00340834|561111398|FG001|Extension Phase of Study|Subject withdrew consent|31|||
155461296|NCT00340834|561111399|FG002|Extension Phase of Study|Subject withdrew consent|0|||
155461297|NCT00340834|561111400|FG003|Extension Phase of Study|Subject withdrew consent|12|||
155461298|NCT00340834|561111401|FG004|Extension Phase of Study|Subject withdrew consent|15|||
155461299|NCT00340834|561111397|FG000|Extension Phase of Study|Adverse Event|21|||
155461300|NCT00340834|561111398|FG001|Extension Phase of Study|Adverse Event|22|||
155461301|NCT00340834|561111399|FG002|Extension Phase of Study|Adverse Event|0|||
155461302|NCT00340834|561111400|FG003|Extension Phase of Study|Adverse Event|19|||
155461303|NCT00340834|561111401|FG004|Extension Phase of Study|Adverse Event|7|||
155461304|NCT00340834|561111397|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
155461305|NCT00340834|561111398|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
155461306|NCT00340834|561111399|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
155461307|NCT00340834|561111400|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
155461308|NCT00340834|561111401|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
155461309|NCT00340834|561111397|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
155461310|NCT00340834|561111398|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
155461311|NCT00340834|561111399|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
155461312|NCT00340834|561111400|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
155461313|NCT00340834|561111401|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
155461314|NCT00340834|561111397|FG000|Extension Phase of Study|Lost to Follow-up|1|||
155461315|NCT00340834|561111398|FG001|Extension Phase of Study|Lost to Follow-up|1|||
155461316|NCT00340834|561111399|FG002|Extension Phase of Study|Lost to Follow-up|0|||
155461317|NCT00340834|561111400|FG003|Extension Phase of Study|Lost to Follow-up|2|||
155461318|NCT00340834|561111401|FG004|Extension Phase of Study|Lost to Follow-up|3|||
155461319|NCT00340834|561111397|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
155516211|NCT01862328|561315795|FG001|Overall Study|Other|2|||
155516212|NCT01862328|561315796|FG002|Overall Study|Other|1|||
155516213|NCT01862328|561315797|FG003|Overall Study|Other|0|||
155516214|NCT01862328|561315798|FG004|Overall Study|Other|4|||
155516215|NCT01862328|561315799|FG005|Overall Study|Other|0|||
155461320|NCT00340834|561111398|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
155461321|NCT00340834|561111399|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
155461322|NCT00340834|561111400|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
155516216|NCT01862328|561315800|FG006|Overall Study|Other|1|||
155516217|NCT01862328|561315794|FG000|Overall Study|Withdrawal by Subject|1|||
155461323|NCT00340834|561111401|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
155461324|NCT00340834|561111397|FG000|Extension Phase of Study|Administrative problems|3|||
155516218|NCT01862328|561315795|FG001|Overall Study|Withdrawal by Subject|1|||
155516219|NCT01862328|561315796|FG002|Overall Study|Withdrawal by Subject|0|||
155461325|NCT00340834|561111398|FG001|Extension Phase of Study|Administrative problems|0|||
155461326|NCT00340834|561111399|FG002|Extension Phase of Study|Administrative problems|0|||
155516220|NCT01862328|561315797|FG003|Overall Study|Withdrawal by Subject|0|||
155461327|NCT00340834|561111400|FG003|Extension Phase of Study|Administrative problems|1|||
155461328|NCT00340834|561111401|FG004|Extension Phase of Study|Administrative problems|1|||
155461329|NCT00340834|561111397|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
155461330|NCT00340834|561111398|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
155461331|NCT00340834|561111399|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
155461332|NCT00340834|561111400|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
155461333|NCT00340834|561111401|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
155461334|NCT00340834|561111397|FG000|Extension Phase of Study|Protocol Violation|3|||
155461335|NCT00340834|561111398|FG001|Extension Phase of Study|Protocol Violation|0|||
155461336|NCT00340834|561111399|FG002|Extension Phase of Study|Protocol Violation|0|||
155461337|NCT00340834|561111400|FG003|Extension Phase of Study|Protocol Violation|0|||
155461338|NCT00340834|561111401|FG004|Extension Phase of Study|Protocol Violation|0|||
155461339|NCT00340834|561111397|FG000|Extension Phase of Study|Death|0|||
155461340|NCT00340834|561111398|FG001|Extension Phase of Study|Death|0|||
155461341|NCT00340834|561111399|FG002|Extension Phase of Study|Death|0|||
155461342|NCT00340834|561111400|FG003|Extension Phase of Study|Death|0|||
155461343|NCT00340834|561111401|FG004|Extension Phase of Study|Death|1|||
155461344|NCT00291499|561111402|FG000|Overall Study|Adverse Event|3|||
155461345|NCT00291499|561111403|FG001|Overall Study|Adverse Event|8|||
155461346|NCT00291499|561111402|FG000|Overall Study|Change to other therapy|2|||
155461347|NCT00291499|561111403|FG001|Overall Study|Change to other therapy|1|||
155516221|NCT01862328|561315798|FG004|Overall Study|Withdrawal by Subject|1|||
155516222|NCT01862328|561315799|FG005|Overall Study|Withdrawal by Subject|1|||
155516223|NCT01862328|561315800|FG006|Overall Study|Withdrawal by Subject|1|||
155516224|NCT01862328|561315794|FG000|Overall Study|Symptomatic Deterioration|0|||
155516225|NCT01862328|561315795|FG001|Overall Study|Symptomatic Deterioration|0|||
155516226|NCT01862328|561315796|FG002|Overall Study|Symptomatic Deterioration|0|||
155516227|NCT01862328|561315797|FG003|Overall Study|Symptomatic Deterioration|0|||
155516228|NCT01862328|561315798|FG004|Overall Study|Symptomatic Deterioration|0|||
155516229|NCT01862328|561315799|FG005|Overall Study|Symptomatic Deterioration|0|||
155516230|NCT01862328|561315800|FG006|Overall Study|Symptomatic Deterioration|1|||
155516231|NCT03276975|561315801|FG000|Overall Study|Withdrawal by Subject|1|||
155652324|NCT01185366|561820297|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
155652325|NCT01185366|561820296|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
155652326|NCT01185366|561820297|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
155652327|NCT01185366|561820296|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
155652328|NCT01185366|561820297|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
155461348|NCT00291499|561111402|FG000|Overall Study|Intercurrent illness|1|||
155461349|NCT00291499|561111403|FG001|Overall Study|Intercurrent illness|0|||
155461350|NCT00291499|561111402|FG000|Overall Study|Protocol Violation|2|||
155461351|NCT00291499|561111403|FG001|Overall Study|Protocol Violation|2|||
155461352|NCT00291499|561111402|FG000|Overall Study|Other reasons|1|||
155461353|NCT00291499|561111403|FG001|Overall Study|Other reasons|4|||
155461354|NCT02786836|561111404|FG000|Overall Study|Death|1|||
155461355|NCT02786836|561111404|FG000|Overall Study|Lack of Efficacy|2|||
155461356|NCT02786836|561111404|FG000|Overall Study|Protocol Violation|3|||
155461357|NCT02786836|561111404|FG000|Overall Study|Withdrawal by Subject|3|||
155461358|NCT02786836|561111404|FG000|Overall Study|Liver Transplantation|2|||
155461359|NCT02786836|561111404|FG000|Overall Study|Device or Pharmacy Issues|3|||
155461360|NCT01143714|561111405|FG000|Overall Study|Adverse Event|4|||
155461361|NCT01143714|561111406|FG001|Overall Study|Adverse Event|2|||
155516232|NCT03276975|561315802|FG001|Overall Study|Withdrawal by Subject|0|||
155516233|NCT01485536|561315805|FG000|Overall Study|Withdrawal by Subject|3|||
155516234|NCT01485536|561315805|FG000|Overall Study|Adverse Event|1|||
155516235|NCT00306384|561315806|FG000|Overall Study|Adverse Event|103|||
155516236|NCT00306384|561315807|FG001|Overall Study|Adverse Event|87|||
155516237|NCT00306384|561315808|FG002|Overall Study|Adverse Event|40|||
155516238|NCT00306384|561315806|FG000|Overall Study|Major protocol deviation|43|||
155516239|NCT00306384|561315807|FG001|Overall Study|Major protocol deviation|51|||
155516240|NCT00306384|561315808|FG002|Overall Study|Major protocol deviation|18|||
155516241|NCT00306384|561315806|FG000|Overall Study|Lost to Follow-up|57|||
155516242|NCT00306384|561315807|FG001|Overall Study|Lost to Follow-up|41|||
155516243|NCT00306384|561315808|FG002|Overall Study|Lost to Follow-up|35|||
155516244|NCT00306384|561315806|FG000|Overall Study|Voluntary withdrawal|199|||
155516245|NCT00306384|561315807|FG001|Overall Study|Voluntary withdrawal|187|||
155516246|NCT00306384|561315808|FG002|Overall Study|Voluntary withdrawal|91|||
155516247|NCT00306384|561315806|FG000|Overall Study|Study termination|1|||
155516248|NCT00306384|561315807|FG001|Overall Study|Study termination|0|||
155516249|NCT00306384|561315808|FG002|Overall Study|Study termination|1|||
155516250|NCT00306384|561315806|FG000|Overall Study|Pregnancy|3|||
155461362|NCT01143714|561111405|FG000|Overall Study|Withdrawal by Subject|1|||
155461363|NCT01143714|561111406|FG001|Overall Study|Withdrawal by Subject|0|||
155516251|NCT00306384|561315807|FG001|Overall Study|Pregnancy|1|||
155461364|NCT01143714|561111405|FG000|Overall Study|Subject non-compliance|0|||
155461365|NCT01143714|561111406|FG001|Overall Study|Subject non-compliance|1|||
155461366|NCT01143714|561111405|FG000|Overall Study|wound closed = deemed healed|1|||
155461367|NCT01143714|561111406|FG001|Overall Study|wound closed = deemed healed|0|||
155461368|NCT01143714|561111405|FG000|Overall Study|wound size increased|1|||
155461369|NCT01143714|561111406|FG001|Overall Study|wound size increased|0|||
155461370|NCT02016898|561111416|FG000|Overall Study|Death|1|||
155461371|NCT02016898|561111417|FG001|Overall Study|Death|1|||
155461372|NCT02016898|561111416|FG000|Overall Study|Lost to Follow-up|4|||
155461373|NCT02016898|561111417|FG001|Overall Study|Lost to Follow-up|4|||
155461374|NCT01381718|561111418|FG000|Overall Study|Withdrawal by Subject|2|||
155461375|NCT01381718|561111419|FG001|Overall Study|Withdrawal by Subject|5|||
155461376|NCT01381718|561111418|FG000|Overall Study|Lost to Follow-up|3|||
155461377|NCT01381718|561111419|FG001|Overall Study|Lost to Follow-up|5|||
155461378|NCT01381718|561111418|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
155461379|NCT01381718|561111419|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
155461380|NCT01306032|561111422|FG000|First Intervention|Adverse Event|1|||
155461381|NCT01306032|561111423|FG001|First Intervention|Adverse Event|0|||
155461382|NCT01306032|561111424|FG002|First Intervention|Adverse Event|1|||
155461383|NCT01306032|561111425|FG003|First Intervention|Adverse Event|0|||
155461384|NCT01306032|561111426|FG004|First Intervention|Adverse Event|0|||
155461385|NCT01306032|561111427|FG005|First Intervention|Adverse Event|1|||
155461386|NCT01306032|561111422|FG000|First Intervention|Withdrawal by Subject|0|||
155461387|NCT01306032|561111423|FG001|First Intervention|Withdrawal by Subject|2|||
155461388|NCT01306032|561111424|FG002|First Intervention|Withdrawal by Subject|0|||
155461389|NCT01306032|561111425|FG003|First Intervention|Withdrawal by Subject|1|||
155461390|NCT01306032|561111426|FG004|First Intervention|Withdrawal by Subject|0|||
155461391|NCT01306032|561111427|FG005|First Intervention|Withdrawal by Subject|0|||
155461392|NCT01306032|561111422|FG000|First Intervention|Death|0|||
155461393|NCT01306032|561111423|FG001|First Intervention|Death|0|||
155461394|NCT01306032|561111424|FG002|First Intervention|Death|1|||
155461395|NCT01306032|561111425|FG003|First Intervention|Death|0|||
155461396|NCT01306032|561111426|FG004|First Intervention|Death|0|||
155461397|NCT01306032|561111427|FG005|First Intervention|Death|0|||
155461398|NCT01306032|561111422|FG000|First Intervention|Ineligible|0|||
155461399|NCT01306032|561111423|FG001|First Intervention|Ineligible|0|||
155461400|NCT01306032|561111424|FG002|First Intervention|Ineligible|0|||
155461401|NCT01306032|561111425|FG003|First Intervention|Ineligible|0|||
155461402|NCT01306032|561111426|FG004|First Intervention|Ineligible|0|||
155461403|NCT01306032|561111427|FG005|First Intervention|Ineligible|1|||
155461404|NCT01306032|561111422|FG000|First Intervention|Progressive disease|0|||
155461405|NCT01306032|561111423|FG001|First Intervention|Progressive disease|0|||
155461406|NCT01306032|561111424|FG002|First Intervention|Progressive disease|0|||
155461407|NCT01306032|561111425|FG003|First Intervention|Progressive disease|0|||
155461408|NCT01306032|561111426|FG004|First Intervention|Progressive disease|2|||
155461409|NCT01306032|561111427|FG005|First Intervention|Progressive disease|0|||
155461410|NCT01306032|561111422|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
155461411|NCT01306032|561111423|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
155461412|NCT01306032|561111424|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
155461413|NCT01306032|561111425|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
155461414|NCT01306032|561111426|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
155461415|NCT01306032|561111427|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
155461416|NCT01306032|561111422|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
155461417|NCT01306032|561111423|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
155461418|NCT01306032|561111424|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
155461419|NCT01306032|561111425|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
155461420|NCT01306032|561111426|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
155461421|NCT01306032|561111427|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
155461422|NCT00992186|561111428|FG000|Overall Study|Withdrawal by Subject|2|||
155461423|NCT00992186|561111428|FG000|Overall Study|Protocol Violation|1|||
155461424|NCT00992186|561111428|FG000|Overall Study|Physician Decision|1|||
155461425|NCT00992186|561111428|FG000|Overall Study|Adverse Event|9|||
155461426|NCT00992186|561111428|FG000|Overall Study|Progressive Disease|30|||
155461427|NCT00992186|561111428|FG000|Overall Study|Refusal To Receive Study Agent|3|||
155461428|NCT02677220|561111435|FG000|Overall Study|Adverse Event|1|||
155461429|NCT00830960|561111438|FG000|Overall Study|Death|5|||
155461430|NCT00830960|561111439|FG001|Overall Study|Death|4|||
155461431|NCT00830960|561111440|FG002|Overall Study|Death|3|||
155461432|NCT00830960|561111441|FG003|Overall Study|Death|2|||
155461433|NCT00830960|561111442|FG004|Overall Study|Death|6|||
155461434|NCT00830960|561111443|FG005|Overall Study|Death|1|||
155461435|NCT00830960|561111438|FG000|Overall Study|Lost to Follow-up|1|||
155461436|NCT00830960|561111439|FG001|Overall Study|Lost to Follow-up|1|||
155461437|NCT00830960|561111440|FG002|Overall Study|Lost to Follow-up|1|||
155461438|NCT00830960|561111441|FG003|Overall Study|Lost to Follow-up|0|||
155652329|NCT01783938|561820303|FG000|Overall Study|Disease Progression|18|||
155516252|NCT00306384|561315808|FG002|Overall Study|Pregnancy|1|||
155516253|NCT00306384|561315806|FG000|Overall Study|Lack of Efficacy|26|||
155516254|NCT00306384|561315807|FG001|Overall Study|Lack of Efficacy|40|||
155516255|NCT00306384|561315808|FG002|Overall Study|Lack of Efficacy|38|||
155516256|NCT00306384|561315806|FG000|Overall Study|Investigator discretion|28|||
155516257|NCT00306384|561315807|FG001|Overall Study|Investigator discretion|31|||
155516258|NCT00306384|561315808|FG002|Overall Study|Investigator discretion|21|||
155516259|NCT00306384|561315806|FG000|Overall Study|Other|80|||
155516260|NCT00306384|561315807|FG001|Overall Study|Other|70|||
155516261|NCT00306384|561315808|FG002|Overall Study|Other|32|||
155516262|NCT00306384|561315806|FG000|Overall Study|Site closure|2|||
155516263|NCT00306384|561315807|FG001|Overall Study|Site closure|0|||
155516264|NCT00306384|561315808|FG002|Overall Study|Site closure|0|||
155516265|NCT00673790|561315809|FG000|Overall Study|Adverse Event|23|||
155516266|NCT00673790|561315810|FG001|Overall Study|Adverse Event|14|||
155516267|NCT00673790|561315811|FG002|Overall Study|Adverse Event|2|||
155516268|NCT00673790|561315809|FG000|Overall Study|Lack of Efficacy|2|||
155516269|NCT00673790|561315810|FG001|Overall Study|Lack of Efficacy|2|||
155516270|NCT00673790|561315811|FG002|Overall Study|Lack of Efficacy|2|||
155516271|NCT00673790|561315809|FG000|Overall Study|Protocol Violation|6|||
155516272|NCT00673790|561315810|FG001|Overall Study|Protocol Violation|9|||
155516273|NCT00673790|561315811|FG002|Overall Study|Protocol Violation|1|||
155516274|NCT00673790|561315809|FG000|Overall Study|Withdrawal by Subject|7|||
155516275|NCT00673790|561315810|FG001|Overall Study|Withdrawal by Subject|4|||
155516276|NCT00673790|561315811|FG002|Overall Study|Withdrawal by Subject|1|||
155516277|NCT00673790|561315809|FG000|Overall Study|Lost to Follow-up|6|||
155516278|NCT00673790|561315810|FG001|Overall Study|Lost to Follow-up|6|||
155516279|NCT00673790|561315811|FG002|Overall Study|Lost to Follow-up|5|||
155516280|NCT00673790|561315809|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
155516281|NCT00673790|561315810|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
155516282|NCT00673790|561315811|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
155516283|NCT00673790|561315809|FG000|Overall Study|Poor compliance|1|||
155516284|NCT00673790|561315810|FG001|Overall Study|Poor compliance|0|||
155516285|NCT00673790|561315811|FG002|Overall Study|Poor compliance|0|||
155516286|NCT00673790|561315809|FG000|Overall Study|Participated in two Nebivolol studies|0|||
155516287|NCT00673790|561315810|FG001|Overall Study|Participated in two Nebivolol studies|0|||
155516288|NCT00673790|561315811|FG002|Overall Study|Participated in two Nebivolol studies|1|||
155516289|NCT00673790|561315809|FG000|Overall Study|Unconfirmed pregnancy|0|||
155516290|NCT00673790|561315810|FG001|Overall Study|Unconfirmed pregnancy|1|||
155461439|NCT00830960|561111442|FG004|Overall Study|Lost to Follow-up|0|||
155516291|NCT00673790|561315811|FG002|Overall Study|Unconfirmed pregnancy|0|||
155516292|NCT00673790|561315809|FG000|Overall Study|Randomization criteria not met|0|||
155516293|NCT00673790|561315810|FG001|Overall Study|Randomization criteria not met|1|||
155516294|NCT00673790|561315811|FG002|Overall Study|Randomization criteria not met|0|||
155516295|NCT00601484|561315812|FG000|Overall Study|Adverse Event|0|||
155516296|NCT00601484|561315813|FG001|Overall Study|Adverse Event|1|||
155516297|NCT00601484|561315812|FG000|Overall Study|Lost to Follow-up|4|||
155516298|NCT00601484|561315813|FG001|Overall Study|Lost to Follow-up|3|||
155516299|NCT00601484|561315812|FG000|Overall Study|Lack of Efficacy|0|||
155516300|NCT00601484|561315813|FG001|Overall Study|Lack of Efficacy|2|||
155516301|NCT00601484|561315812|FG000|Overall Study|Withdrawal by Subject|1|||
155652330|NCT01783938|561820304|FG001|Overall Study|Disease Progression|41|||
155461440|NCT00830960|561111443|FG005|Overall Study|Lost to Follow-up|1|||
155461441|NCT00830960|561111438|FG000|Overall Study|Withdrawal by Subject|19|||
155461442|NCT00830960|561111439|FG001|Overall Study|Withdrawal by Subject|19|||
155461443|NCT00830960|561111440|FG002|Overall Study|Withdrawal by Subject|18|||
155461444|NCT00830960|561111441|FG003|Overall Study|Withdrawal by Subject|23|||
155461445|NCT00830960|561111442|FG004|Overall Study|Withdrawal by Subject|16|||
155461446|NCT00830960|561111443|FG005|Overall Study|Withdrawal by Subject|21|||
155461447|NCT00830960|561111438|FG000|Overall Study|Sponsor Decision|1|||
155461448|NCT00830960|561111439|FG001|Overall Study|Sponsor Decision|2|||
155461449|NCT00830960|561111440|FG002|Overall Study|Sponsor Decision|3|||
155461450|NCT00830960|561111441|FG003|Overall Study|Sponsor Decision|4|||
155461451|NCT00830960|561111442|FG004|Overall Study|Sponsor Decision|5|||
155461452|NCT00830960|561111443|FG005|Overall Study|Sponsor Decision|7|||
155461453|NCT00830960|561111438|FG000|Overall Study|No study drug received|7|||
155461454|NCT00830960|561111439|FG001|Overall Study|No study drug received|2|||
155516302|NCT00601484|561315813|FG001|Overall Study|Withdrawal by Subject|1|||
155516303|NCT00601484|561315812|FG000|Overall Study|Randomized, but not treated|0|||
155461455|NCT00830960|561111440|FG002|Overall Study|No study drug received|4|||
155461456|NCT00830960|561111441|FG003|Overall Study|No study drug received|3|||
155461457|NCT00830960|561111442|FG004|Overall Study|No study drug received|5|||
155461458|NCT00830960|561111443|FG005|Overall Study|No study drug received|7|||
155461459|NCT03074149|561111444|FG000|Overall Study|Reason unknown|22|||
155461460|NCT03074149|561111445|FG001|Overall Study|Reason unknown|35|||
155461461|NCT03074149|561111444|FG000|Overall Study|Death|10|||
155461462|NCT03074149|561111445|FG001|Overall Study|Death|45|||
155461463|NCT01376245|561111448|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
155461464|NCT01376245|561111449|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
155461465|NCT01376245|561111450|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
155461466|NCT01376245|561111451|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
155461467|NCT01376245|561111452|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
155461468|NCT01376245|561111448|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
155516304|NCT00601484|561315813|FG001|Overall Study|Randomized, but not treated|1|||
155516305|NCT03504852|561315814|FG000|Overall Study|Withdrawal of informed consent|2|||
155516306|NCT03504852|561315815|FG001|Overall Study|Withdrawal of informed consent|1|||
155516307|NCT03504852|561315816|FG002|Overall Study|Withdrawal of informed consent|0|||
155516308|NCT03504852|561315814|FG000|Overall Study|Withdrawal by Subject|5|||
155516309|NCT03504852|561315815|FG001|Overall Study|Withdrawal by Subject|5|||
155516310|NCT03504852|561315816|FG002|Overall Study|Withdrawal by Subject|1|||
155516311|NCT03504852|561315814|FG000|Overall Study|Lost to Follow-up|4|||
155516312|NCT03504852|561315815|FG001|Overall Study|Lost to Follow-up|1|||
155516313|NCT03504852|561315816|FG002|Overall Study|Lost to Follow-up|0|||
155516314|NCT03504852|561315814|FG000|Overall Study|New therapy for study indication|1|||
155516315|NCT03504852|561315815|FG001|Overall Study|New therapy for study indication|0|||
155516316|NCT03504852|561315816|FG002|Overall Study|New therapy for study indication|0|||
155516317|NCT03504852|561315814|FG000|Overall Study|Lack of Efficacy|1|||
155516318|NCT03504852|561315815|FG001|Overall Study|Lack of Efficacy|2|||
155516319|NCT03504852|561315816|FG002|Overall Study|Lack of Efficacy|0|||
155516320|NCT03504852|561315814|FG000|Overall Study|Death|0|||
155516321|NCT03504852|561315815|FG001|Overall Study|Death|1|||
155516322|NCT03504852|561315816|FG002|Overall Study|Death|0|||
155516323|NCT03504852|561315814|FG000|Overall Study|Adverse Event|4|||
155516324|NCT03504852|561315815|FG001|Overall Study|Adverse Event|8|||
155516325|NCT03504852|561315816|FG002|Overall Study|Adverse Event|2|||
155516326|NCT02928848|561315817|FG000|Arm 2|Withdrawal by Subject|1|||
155516327|NCT02928848|561315818|FG001|Arm 2|Withdrawal by Subject|0|||
155461469|NCT01376245|561111449|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
155516328|NCT00969332|561315819|FG000|Overall Study|Physician Decision|8|||
155516329|NCT00969332|561315819|FG000|Overall Study|Withdrawal by Subject|3|||
155516330|NCT00576199|561315820|FG000|Overall Study|Adverse Event|12|||
155461470|NCT01376245|561111450|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
155461471|NCT01376245|561111451|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
155461472|NCT01376245|561111452|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
155461473|NCT01376245|561111448|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
155461474|NCT01376245|561111449|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
155461475|NCT01376245|561111450|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
155461476|NCT01376245|561111451|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
155461477|NCT01376245|561111452|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
155516331|NCT00576199|561315820|FG000|Overall Study|Insufficient Therapeutic Response|14|||
155516332|NCT00576199|561315820|FG000|Overall Study|Refused Treatment|2|||
155516333|NCT00576199|561315820|FG000|Overall Study|Reason Unspecified|2|||
155516334|NCT00663871|561315823|FG000|Overall Study|Lost to Follow-up|5|||
155516335|NCT00663871|561315824|FG001|Overall Study|Lost to Follow-up|5|||
155516336|NCT00663871|561315823|FG000|Overall Study|Withdrawal by Subject|5|||
155516337|NCT00663871|561315824|FG001|Overall Study|Withdrawal by Subject|2|||
155461478|NCT01376245|561111448|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
155461479|NCT01376245|561111449|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
155461480|NCT01376245|561111450|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
155461481|NCT01376245|561111451|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
155461482|NCT01376245|561111452|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
155461483|NCT01376245|561111448|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
155461484|NCT01376245|561111449|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
155461485|NCT01376245|561111450|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
155461486|NCT01376245|561111451|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
155461487|NCT01376245|561111452|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
155461488|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155516338|NCT00582309|561315825|FG000|Overall Study|Protocol Violation|0|||
155516339|NCT00582309|561315826|FG001|Overall Study|Protocol Violation|0|||
155516340|NCT00582309|561315827|FG002|Overall Study|Protocol Violation|2|||
155516341|NCT03922477|561315828|FG000|Overall Study|Death|9|||
155516342|NCT03922477|561315828|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
155516343|NCT03922477|561315828|FG000|Overall Study|Physician Decision|1|||
155516344|NCT03922477|561315828|FG000|Overall Study|Withdrawal by Subject|2|||
155516345|NCT03111147|561315832|FG000|Overall Study|Lost to Follow-up|2|||
155516346|NCT03111147|561315833|FG001|Overall Study|Lost to Follow-up|5|||
155516347|NCT03111147|561315832|FG000|Overall Study|Withdrawal by Subject|4|||
155516348|NCT03111147|561315833|FG001|Overall Study|Withdrawal by Subject|3|||
155461489|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
155461490|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
155461491|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
155461492|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
155461493|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
155461494|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
155461495|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
155461496|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
155461497|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
155461498|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155461499|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155461500|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155461501|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155461502|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
155461503|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155461504|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
155461505|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
155461506|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
155461507|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155461508|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155461509|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155461510|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155461511|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155461512|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155461513|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155461514|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
155461515|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
155461516|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
155461517|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
155461518|NCT01376245|561111448|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155461519|NCT01376245|561111449|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
155461520|NCT01376245|561111450|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155461521|NCT01376245|561111451|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
155461522|NCT01376245|561111452|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
155461523|NCT01170221|561111453|FG000|Overall Study|Lost to Follow-up|22|||
155461524|NCT01170221|561111454|FG001|Overall Study|Lost to Follow-up|21|||
155461525|NCT01170221|561111453|FG000|Overall Study|Withdrawal by Subject|9|||
155461526|NCT01170221|561111454|FG001|Overall Study|Withdrawal by Subject|7|||
155461527|NCT01170221|561111453|FG000|Overall Study|Subject completed only screening and LFU|1|||
155461528|NCT01170221|561111454|FG001|Overall Study|Subject completed only screening and LFU|0|||
155461529|NCT01170221|561111453|FG000|Overall Study|Randomized but not treated|1|||
155461530|NCT01170221|561111454|FG001|Overall Study|Randomized but not treated|0|||
155461531|NCT00050960|561111455|FG000|Overall Study|Progressive Disease|137|||
155461532|NCT00050960|561111456|FG001|Overall Study|Progressive Disease|93|||
155461533|NCT00050960|561111455|FG000|Overall Study|Stable Disease|19|||
155461534|NCT00050960|561111456|FG001|Overall Study|Stable Disease|48|||
155461535|NCT00050960|561111455|FG000|Overall Study|Partial Response|14|||
155461536|NCT00050960|561111456|FG001|Overall Study|Partial Response|19|||
155461537|NCT00050960|561111455|FG000|Overall Study|Complete Response|0|||
155461538|NCT00050960|561111456|FG001|Overall Study|Complete Response|2|||
155461539|NCT00050960|561111455|FG000|Overall Study|Adverse Event|62|||
155461540|NCT00050960|561111456|FG001|Overall Study|Adverse Event|61|||
155461541|NCT00050960|561111455|FG000|Overall Study|Lost to Follow-up|0|||
155461542|NCT00050960|561111456|FG001|Overall Study|Lost to Follow-up|1|||
155461543|NCT00050960|561111455|FG000|Overall Study|Withdrawal by Subject|23|||
155461544|NCT00050960|561111456|FG001|Overall Study|Withdrawal by Subject|18|||
155461545|NCT00050960|561111455|FG000|Overall Study|Administrative|31|||
155461546|NCT00050960|561111456|FG001|Overall Study|Administrative|46|||
155461547|NCT00050960|561111455|FG000|Overall Study|Non-compliance|3|||
155461548|NCT00050960|561111456|FG001|Overall Study|Non-compliance|1|||
155461549|NCT00050960|561111455|FG000|Overall Study|Death|13|||
155461550|NCT00050960|561111456|FG001|Overall Study|Death|15|||
155516349|NCT03111147|561315832|FG000|Overall Study|Protocol Violation|2|||
155516350|NCT03111147|561315833|FG001|Overall Study|Protocol Violation|1|||
155461551|NCT00764946|561111457|FG000|Overall Study|Lack of Efficacy|1|||
155461552|NCT00764946|561111458|FG001|Overall Study|Lack of Efficacy|0|||
155461553|NCT00764946|561111459|FG002|Overall Study|Lack of Efficacy|0|||
155461554|NCT00764946|561111457|FG000|Overall Study|Lost to Follow-up|3|||
155516351|NCT03111147|561315832|FG000|Overall Study|Death|1|||
155516352|NCT03111147|561315833|FG001|Overall Study|Death|1|||
155461555|NCT00764946|561111458|FG001|Overall Study|Lost to Follow-up|4|||
155516353|NCT03384745|561315836|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
155516354|NCT03384745|561315837|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
155516355|NCT03384745|561315838|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
155516356|NCT03384745|561315839|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
155516357|NCT03384745|561315840|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
155516358|NCT03384745|561315841|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
155516359|NCT03384745|561315836|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
155516360|NCT03384745|561315837|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
155516361|NCT03384745|561315838|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
155516362|NCT03384745|561315839|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
155516363|NCT03384745|561315840|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
155516364|NCT03384745|561315841|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
155652331|NCT01783938|561820303|FG000|Overall Study|Study Drug Toxicity|27|||
155652332|NCT01783938|561820304|FG001|Overall Study|Study Drug Toxicity|14|||
155516365|NCT03384745|561315836|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
155516366|NCT03384745|561315837|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
155516367|NCT03384745|561315838|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
155516368|NCT03384745|561315839|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
155516369|NCT03384745|561315840|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
155516370|NCT03384745|561315841|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
155516371|NCT03384745|561315836|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
155516372|NCT03384745|561315837|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
155516373|NCT03384745|561315838|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
155516374|NCT03384745|561315839|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
155516375|NCT03384745|561315840|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
155516376|NCT03384745|561315841|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
155516377|NCT03384745|561315836|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
155516378|NCT03384745|561315837|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
155652333|NCT01783938|561820303|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
155652334|NCT01783938|561820304|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155652335|NCT01783938|561820303|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
155652336|NCT01783938|561820304|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
155652337|NCT01783938|561820303|FG000|Overall Study|Participant Withdrew Consent|2|||
155652338|NCT01783938|561820304|FG001|Overall Study|Participant Withdrew Consent|0|||
155652339|NCT01783938|561820303|FG000|Overall Study|Maximum Clinical Benefit|1|||
155652340|NCT01783938|561820304|FG001|Overall Study|Maximum Clinical Benefit|0|||
155652341|NCT01783938|561820303|FG000|Overall Study|Other Reasons|3|||
155461556|NCT00764946|561111459|FG002|Overall Study|Lost to Follow-up|0|||
155461557|NCT00764946|561111457|FG000|Overall Study|Physician Decision|2|||
155461558|NCT00764946|561111458|FG001|Overall Study|Physician Decision|4|||
155461559|NCT00764946|561111459|FG002|Overall Study|Physician Decision|0|||
155461560|NCT00764946|561111457|FG000|Overall Study|Adverse Event|3|||
155461561|NCT00764946|561111458|FG001|Overall Study|Adverse Event|2|||
155461562|NCT00764946|561111459|FG002|Overall Study|Adverse Event|1|||
155461563|NCT00764946|561111457|FG000|Overall Study|Withdrawal by Subject|3|||
155461564|NCT00764946|561111458|FG001|Overall Study|Withdrawal by Subject|6|||
155516379|NCT03384745|561315838|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
155516380|NCT03384745|561315839|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
155516381|NCT03384745|561315840|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
155516382|NCT03384745|561315841|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
155516383|NCT03384745|561315836|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155516384|NCT03384745|561315837|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155516385|NCT03384745|561315838|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155516386|NCT03384745|561315839|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155516387|NCT03384745|561315840|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
155516388|NCT03384745|561315841|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155516389|NCT03384745|561315836|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
155516390|NCT03384745|561315837|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
155516391|NCT03384745|561315838|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
155516392|NCT03384745|561315839|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
155516393|NCT03384745|561315840|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
155516394|NCT03384745|561315841|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
155516395|NCT03384745|561315836|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
155516396|NCT03384745|561315837|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
155516397|NCT03384745|561315838|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
155516398|NCT03384745|561315839|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
155516399|NCT03384745|561315840|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
155516400|NCT03384745|561315841|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
155516401|NCT03384745|561315836|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
155516402|NCT03384745|561315837|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
155516403|NCT03384745|561315838|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
155516404|NCT03384745|561315839|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
155516405|NCT03384745|561315840|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
155516406|NCT03384745|561315841|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
155516407|NCT03384745|561315836|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
155516408|NCT03384745|561315837|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
155516409|NCT03384745|561315838|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
155516410|NCT03384745|561315839|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
155516411|NCT03384745|561315840|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
155516412|NCT03384745|561315841|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
155516413|NCT03384745|561315836|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
155516414|NCT03384745|561315837|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
155516415|NCT03384745|561315838|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
155516416|NCT03384745|561315839|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
155516417|NCT03384745|561315840|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
155516418|NCT03384745|561315841|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
155516419|NCT01058421|561315842|FG000|1 Month Outcomes|Death|10|||
155516420|NCT01058421|561315843|FG001|1 Month Outcomes|Death|6|||
155516421|NCT01058421|561315842|FG000|1 Month Outcomes|Lost to Follow-up|8|||
155516422|NCT01058421|561315843|FG001|1 Month Outcomes|Lost to Follow-up|7|||
155516423|NCT01058421|561315842|FG000|1 Month Outcomes|Remained in Hospital|5|||
155516424|NCT01058421|561315843|FG001|1 Month Outcomes|Remained in Hospital|12|||
155516425|NCT01058421|561315842|FG000|1 Month Outcomes|Remained in Other Facility|16|||
155516426|NCT01058421|561315843|FG001|1 Month Outcomes|Remained in Other Facility|17|||
155516427|NCT01058421|561315842|FG000|3 Month Outcomes|Death|3|||
155516428|NCT01058421|561315843|FG001|3 Month Outcomes|Death|5|||
155516429|NCT01058421|561315842|FG000|3 Month Outcomes|Lost to Follow-up|12|||
155516430|NCT01058421|561315843|FG001|3 Month Outcomes|Lost to Follow-up|11|||
155516431|NCT01058421|561315842|FG000|3 Month Outcomes|Remained in Hospital|0|||
155516432|NCT01058421|561315843|FG001|3 Month Outcomes|Remained in Hospital|2|||
155516433|NCT01058421|561315842|FG000|3 Month Outcomes|Remained in Other Facility|5|||
155516434|NCT01058421|561315843|FG001|3 Month Outcomes|Remained in Other Facility|8|||
155516435|NCT01058421|561315842|FG000|6 Month Outcomes|Death|2|||
155516436|NCT01058421|561315843|FG001|6 Month Outcomes|Death|2|||
155461565|NCT00764946|561111459|FG002|Overall Study|Withdrawal by Subject|2|||
155461566|NCT00764946|561111457|FG000|Overall Study|Never Treated|1|||
155516437|NCT01058421|561315842|FG000|6 Month Outcomes|Lost to Follow-up|16|||
155516438|NCT01058421|561315843|FG001|6 Month Outcomes|Lost to Follow-up|21|||
155461567|NCT00764946|561111458|FG001|Overall Study|Never Treated|1|||
155461568|NCT00764946|561111459|FG002|Overall Study|Never Treated|1|||
155461569|NCT02219087|561111460|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
155461570|NCT02219087|561111461|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
155461571|NCT04311177|561111462|FG000|Overall Study|Adverse Event|3|||
155461572|NCT04311177|561111463|FG001|Overall Study|Adverse Event|1|||
155461573|NCT04311177|561111462|FG000|Overall Study|Physician Decision|4|||
155461574|NCT04311177|561111463|FG001|Overall Study|Physician Decision|3|||
155461575|NCT04311177|561111462|FG000|Overall Study|Withdrawal by Subject|1|||
155461576|NCT04311177|561111463|FG001|Overall Study|Withdrawal by Subject|0|||
155461577|NCT02176291|561111468|FG000|Overall Study|Death|1|||
155461578|NCT02176291|561111469|FG001|Overall Study|Death|0|||
155461579|NCT02176291|561111468|FG000|Overall Study|non compliance with protocol|2|||
155461580|NCT02176291|561111469|FG001|Overall Study|non compliance with protocol|0|||
155461581|NCT02176291|561111468|FG000|Overall Study|Withdrawal by Subject|2|||
155461582|NCT02176291|561111469|FG001|Overall Study|Withdrawal by Subject|0|||
155461583|NCT01969799|561111470|FG000|Overall Study|Adverse Event|0|||
155461584|NCT01969799|561111471|FG001|Overall Study|Adverse Event|1|||
155461585|NCT01969799|561111470|FG000|Overall Study|Death|16|||
155461586|NCT01969799|561111471|FG001|Overall Study|Death|11|||
155461587|NCT01969799|561111470|FG000|Overall Study|Lost to Follow-up|0|||
155461588|NCT01969799|561111471|FG001|Overall Study|Lost to Follow-up|2|||
155461589|NCT01969799|561111470|FG000|Overall Study|Physician Decision|1|||
155461590|NCT01969799|561111471|FG001|Overall Study|Physician Decision|0|||
155461591|NCT02431468|561111472|FG000|Overall Study|Adverse Event|2|||
155461592|NCT02431468|561111473|FG001|Overall Study|Adverse Event|4|||
155516439|NCT01058421|561315842|FG000|6 Month Outcomes|Remained in Other Facility|1|||
155516440|NCT01058421|561315843|FG001|6 Month Outcomes|Remained in Other Facility|3|||
155516441|NCT02984683|561315844|FG000|Overall Study|Adverse Event|3|||
155516442|NCT02984683|561315845|FG001|Overall Study|Adverse Event|3|||
155516443|NCT02984683|561315844|FG000|Overall Study|Withdrawal by Subject|1|||
155516444|NCT02984683|561315845|FG001|Overall Study|Withdrawal by Subject|0|||
155516445|NCT02984683|561315844|FG000|Overall Study|Disease progression|7|||
155516446|NCT02984683|561315845|FG001|Overall Study|Disease progression|9|||
155516447|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
155516448|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
155516449|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
155516450|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
155516451|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
155516452|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
155516453|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
155516454|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
155516455|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
155516456|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
155652342|NCT01783938|561820304|FG001|Overall Study|Other Reasons|1|||
155652343|NCT00498485|561820305|FG000|Overall Study|Adverse Event|1|||
155461593|NCT02431468|561111474|FG002|Overall Study|Adverse Event|5|||
155461594|NCT02431468|561111472|FG000|Overall Study|Withdrawal by Subject|4|||
155461595|NCT02431468|561111473|FG001|Overall Study|Withdrawal by Subject|12|||
155461596|NCT02431468|561111474|FG002|Overall Study|Withdrawal by Subject|2|||
155461597|NCT02431468|561111472|FG000|Overall Study|noncompliance, investigator termination,|2|||
155461598|NCT02431468|561111473|FG001|Overall Study|noncompliance, investigator termination,|2|||
155461599|NCT02431468|561111474|FG002|Overall Study|noncompliance, investigator termination,|2|||
155461600|NCT01056341|561111475|FG000|Overall Study|Treatment Intolerance|0|||
155461601|NCT01056341|561111476|FG001|Overall Study|Treatment Intolerance|2|||
155461602|NCT01056341|561111477|FG002|Overall Study|Treatment Intolerance|0|||
155461603|NCT01056341|561111478|FG003|Overall Study|Treatment Intolerance|2|||
155461604|NCT01056341|561111479|FG004|Overall Study|Treatment Intolerance|0|||
155461605|NCT01056341|561111475|FG000|Overall Study|Lack of Efficacy|32|||
155461606|NCT01056341|561111476|FG001|Overall Study|Lack of Efficacy|30|||
155461607|NCT01056341|561111477|FG002|Overall Study|Lack of Efficacy|7|||
155461608|NCT01056341|561111478|FG003|Overall Study|Lack of Efficacy|25|||
155461609|NCT01056341|561111479|FG004|Overall Study|Lack of Efficacy|9|||
155461610|NCT01056341|561111475|FG000|Overall Study|Other reasons|4|||
155461611|NCT01056341|561111476|FG001|Overall Study|Other reasons|4|||
155461612|NCT01056341|561111477|FG002|Overall Study|Other reasons|8|||
155461613|NCT01056341|561111478|FG003|Overall Study|Other reasons|9|||
155461614|NCT01056341|561111479|FG004|Overall Study|Other reasons|5|||
155461615|NCT01361919|561111480|FG000|Overall Study|technical issues|10|||
155461616|NCT01361919|561111481|FG001|Overall Study|technical issues|12|||
155461617|NCT01361919|561111482|FG002|Overall Study|technical issues|10|||
155461618|NCT02227108|561111485|FG000|Overall Study|Did not receive treatment|2|||
155461619|NCT02227108|561111485|FG000|Overall Study|Other|3|||
155461620|NCT02227108|561111485|FG000|Overall Study|Progressive disease|17|||
155461621|NCT02227108|561111485|FG000|Overall Study|Initiation of alternative therapy|2|||
155461622|NCT02227108|561111485|FG000|Overall Study|Investigator discretion|1|||
155461623|NCT02227108|561111485|FG000|Overall Study|Adverse Event|6|||
155461624|NCT02486952|561111486|FG000|Overall Study|Not Started Induction Therapy|3|||
155461625|NCT02486952|561111486|FG000|Overall Study|Adverse Event|1|||
155461626|NCT02486952|561111486|FG000|Overall Study|Death|15|||
155461627|NCT02486952|561111486|FG000|Overall Study|Lack of Efficacy|3|||
155461628|NCT02486952|561111486|FG000|Overall Study|Lost to Follow-up|26|||
155461629|NCT02486952|561111486|FG000|Overall Study|Other|2|||
155461630|NCT04111107|561111487|FG000|Overall Study|Withdrawal by Subject|6|||
155461631|NCT04111107|561111487|FG000|Overall Study|Declining Health|5|||
155461632|NCT03589885|561111488|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
155461633|NCT03589885|561111489|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
155461634|NCT03589885|561111490|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
155461635|NCT03589885|561111491|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
155461636|NCT03589885|561111492|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
155461637|NCT03589885|561111488|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
155461638|NCT03589885|561111489|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
155461639|NCT03589885|561111490|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
155461640|NCT03589885|561111491|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
155461641|NCT03589885|561111492|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
155461642|NCT03589885|561111488|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
155461643|NCT03589885|561111489|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
155461644|NCT03589885|561111490|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
155461645|NCT03589885|561111491|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
155461646|NCT03589885|561111492|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
155461647|NCT03589885|561111488|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
155461648|NCT03589885|561111489|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
155461649|NCT03589885|561111490|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
155461650|NCT03589885|561111491|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
155461651|NCT03589885|561111492|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
155461652|NCT03589885|561111488|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
155461653|NCT03589885|561111489|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
155461654|NCT03589885|561111490|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
155461655|NCT03589885|561111491|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
155461656|NCT03589885|561111492|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
155461657|NCT03589885|561111488|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
155461658|NCT03589885|561111489|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
155461659|NCT03589885|561111490|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
155461660|NCT03589885|561111491|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
155461661|NCT03589885|561111492|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
155461662|NCT03589885|561111488|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
155461663|NCT03589885|561111489|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
155461664|NCT03589885|561111490|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
155461665|NCT03589885|561111491|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
155461666|NCT03589885|561111492|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
155461667|NCT03589885|561111488|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
155461668|NCT03589885|561111489|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
155461669|NCT03589885|561111490|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
155461670|NCT03589885|561111491|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
155461671|NCT03589885|561111492|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
155461672|NCT03956225|561111493|FG000|Overall Study|Lack of Efficacy|1|||
155461673|NCT03956225|561111494|FG001|Overall Study|Lack of Efficacy|1|||
155461674|NCT03956225|561111493|FG000|Overall Study|Lost to Follow-up|0|||
155461675|NCT03956225|561111494|FG001|Overall Study|Lost to Follow-up|1|||
155461676|NCT03956225|561111493|FG000|Overall Study|Withdrawal by Subject|2|||
155461677|NCT03956225|561111494|FG001|Overall Study|Withdrawal by Subject|1|||
155461678|NCT03956225|561111493|FG000|Overall Study|Other Reasons|2|||
155461679|NCT03956225|561111494|FG001|Overall Study|Other Reasons|1|||
155461680|NCT02157506|561111495|FG000|Overall Study|Adverse Event|0|||
155461681|NCT02157506|561111496|FG001|Overall Study|Adverse Event|1|||
155461682|NCT02157506|561111497|FG002|Overall Study|Adverse Event|0|||
155461683|NCT02157506|561111498|FG003|Overall Study|Adverse Event|0|||
155461684|NCT02157506|561111499|FG004|Overall Study|Adverse Event|0|||
155461685|NCT02157506|561111495|FG000|Overall Study|Lost to Follow-up|0|||
155461686|NCT02157506|561111496|FG001|Overall Study|Lost to Follow-up|0|||
155461687|NCT02157506|561111497|FG002|Overall Study|Lost to Follow-up|1|||
155461688|NCT02157506|561111498|FG003|Overall Study|Lost to Follow-up|0|||
155461689|NCT02157506|561111499|FG004|Overall Study|Lost to Follow-up|0|||
155461690|NCT03448224|561111500|FG000|Overall Study|Provided same answer to every question|1|||
155461691|NCT03448224|561111501|FG001|Overall Study|Provided same answer to every question|0|||
155461692|NCT03103906|561111502|FG000|Overall Study|Adverse Event|2|||
155461693|NCT03103906|561111503|FG001|Overall Study|Adverse Event|3|||
155461694|NCT03103906|561111502|FG000|Overall Study|Other|2|||
155461695|NCT03103906|561111503|FG001|Overall Study|Other|0|||
155461696|NCT00764478|561111504|FG000|Overall Study|Adverse Event|1|||
155461697|NCT00764478|561111505|FG001|Overall Study|Adverse Event|1|||
155461698|NCT00764478|561111506|FG002|Overall Study|Adverse Event|1|||
155461699|NCT00764478|561111504|FG000|Overall Study|Withdrawal by Subject|7|||
155461700|NCT00764478|561111505|FG001|Overall Study|Withdrawal by Subject|12|||
155461701|NCT00764478|561111506|FG002|Overall Study|Withdrawal by Subject|1|||
155461702|NCT00764478|561111504|FG000|Overall Study|Lost to Follow-up|7|||
155461703|NCT00764478|561111505|FG001|Overall Study|Lost to Follow-up|8|||
155461704|NCT00764478|561111506|FG002|Overall Study|Lost to Follow-up|5|||
155461705|NCT00764478|561111504|FG000|Overall Study|Protocol Violation|0|||
155461706|NCT00764478|561111505|FG001|Overall Study|Protocol Violation|1|||
155461707|NCT00764478|561111506|FG002|Overall Study|Protocol Violation|1|||
155461708|NCT02702011|561111509|FG000|Overall Study|Withdrawal by Subject|0|||
155461709|NCT02702011|561111510|FG001|Overall Study|Withdrawal by Subject|1|||
155461710|NCT02702011|561111511|FG002|Overall Study|Withdrawal by Subject|0|||
155461711|NCT02702011|561111512|FG003|Overall Study|Withdrawal by Subject|0|||
155461712|NCT03498287|561111516|FG000|Overall Study|Withdrawal by Subject|3|||
155461713|NCT03498287|561111517|FG001|Overall Study|Withdrawal by Subject|0|||
155461714|NCT03498287|561111516|FG000|Overall Study|Protocol Violation|0|||
155461715|NCT03498287|561111517|FG001|Overall Study|Protocol Violation|4|||
155461716|NCT03498287|561111516|FG000|Overall Study|Adverse Event|0|||
155461717|NCT03498287|561111517|FG001|Overall Study|Adverse Event|1|||
155461718|NCT02939599|561111518|FG000|Overall Study|Adverse Event|1|||
155461719|NCT02939599|561111519|FG001|Overall Study|Adverse Event|0|||
155461720|NCT02939599|561111518|FG000|Overall Study|Study Terminated By Sponsor|2|||
155461721|NCT02939599|561111519|FG001|Overall Study|Study Terminated By Sponsor|2|||
155461722|NCT00093470|561113334|FG000|Overall Study|Disease progression|39|||
155461723|NCT00093470|561113335|FG001|Overall Study|Disease progression|0|||
155461724|NCT00093470|561113334|FG000|Overall Study|Adverse Event|15|||
155461725|NCT00093470|561113335|FG001|Overall Study|Adverse Event|0|||
155461726|NCT00093470|561113334|FG000|Overall Study|Death|2|||
155461727|NCT00093470|561113335|FG001|Overall Study|Death|0|||
155461728|NCT00093470|561113334|FG000|Overall Study|Withdrawal by Subject|8|||
155461729|NCT00093470|561113335|FG001|Overall Study|Withdrawal by Subject|0|||
155461730|NCT00093470|561113334|FG000|Overall Study|Alternative therapy|2|||
155516457|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
155516458|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
155516459|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
155461731|NCT00093470|561113335|FG001|Overall Study|Alternative therapy|0|||
155461732|NCT00093470|561113334|FG000|Overall Study|Other complicating disease|3|||
155461733|NCT00093470|561113335|FG001|Overall Study|Other complicating disease|0|||
155461734|NCT00093470|561113334|FG000|Overall Study|Physician Decision|2|||
155461735|NCT00093470|561113335|FG001|Overall Study|Physician Decision|0|||
155461736|NCT00093470|561113334|FG000|Overall Study|Never started treatment|1|||
155461737|NCT00093470|561113335|FG001|Overall Study|Never started treatment|0|||
155461738|NCT00093470|561113334|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
155461739|NCT00093470|561113335|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
155461740|NCT02514772|561113341|FG000|Overall Study|Adverse Event|1|||
155461741|NCT02514772|561113342|FG001|Overall Study|Adverse Event|0|||
155461742|NCT02514772|561113341|FG000|Overall Study|Death|0|||
155461743|NCT02514772|561113342|FG001|Overall Study|Death|1|||
155461744|NCT02514772|561113341|FG000|Overall Study|Withdrawal by Subject|2|||
155461745|NCT02514772|561113342|FG001|Overall Study|Withdrawal by Subject|1|||
155461746|NCT00877006|561113343|FG000|Treatment Period|Death|2|||
155461747|NCT00877006|561113344|FG001|Treatment Period|Death|1|||
155461748|NCT00877006|561113343|FG000|Treatment Period|Adverse Event|10|||
155461749|NCT00877006|561113344|FG001|Treatment Period|Adverse Event|3|||
155461750|NCT00877006|561113343|FG000|Treatment Period|Withdrawal by Subject|2|||
155461751|NCT00877006|561113344|FG001|Treatment Period|Withdrawal by Subject|3|||
155461752|NCT00877006|561113343|FG000|Treatment Period|Protocol Violation|1|||
155516460|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
155516461|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
155516462|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
155516463|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
155516464|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
155516465|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
155516466|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
155516467|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
155516468|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
155652344|NCT00498485|561820306|FG001|Overall Study|Adverse Event|5|||
155652345|NCT00452400|561820309|FG000|Overall Study|Adverse Event|1|||
155652346|NCT00452400|561820310|FG001|Overall Study|Adverse Event|1|||
155652347|NCT00452400|561820311|FG002|Overall Study|Adverse Event|5|||
155652348|NCT00452400|561820312|FG003|Overall Study|Adverse Event|0|||
155652349|NCT00452400|561820313|FG004|Overall Study|Adverse Event|2|||
155652350|NCT00452400|561820309|FG000|Overall Study|Protocol Violation|0|||
155652351|NCT00452400|561820310|FG001|Overall Study|Protocol Violation|0|||
155652352|NCT00452400|561820311|FG002|Overall Study|Protocol Violation|1|||
155652353|NCT00452400|561820312|FG003|Overall Study|Protocol Violation|0|||
155652354|NCT00452400|561820313|FG004|Overall Study|Protocol Violation|0|||
155652355|NCT00452400|561820309|FG000|Overall Study|Lost to Follow-up|1|||
155652356|NCT00452400|561820310|FG001|Overall Study|Lost to Follow-up|0|||
155652357|NCT00452400|561820311|FG002|Overall Study|Lost to Follow-up|0|||
155652358|NCT00452400|561820312|FG003|Overall Study|Lost to Follow-up|0|||
155652359|NCT00452400|561820313|FG004|Overall Study|Lost to Follow-up|0|||
155652360|NCT00452400|561820309|FG000|Overall Study|Withdrawal by Subject|1|||
155652361|NCT00452400|561820310|FG001|Overall Study|Withdrawal by Subject|0|||
155652362|NCT00452400|561820311|FG002|Overall Study|Withdrawal by Subject|1|||
155652363|NCT00452400|561820312|FG003|Overall Study|Withdrawal by Subject|0|||
155652364|NCT00452400|561820313|FG004|Overall Study|Withdrawal by Subject|0|||
155652365|NCT00452400|561820309|FG000|Overall Study|Lack of Efficacy|2|||
155652366|NCT00452400|561820310|FG001|Overall Study|Lack of Efficacy|0|||
155652367|NCT00452400|561820311|FG002|Overall Study|Lack of Efficacy|0|||
155652368|NCT00452400|561820312|FG003|Overall Study|Lack of Efficacy|0|||
155652369|NCT00452400|561820313|FG004|Overall Study|Lack of Efficacy|0|||
155652370|NCT00452400|561820309|FG000|Overall Study|Other reasons not listed above|0|||
155652371|NCT00452400|561820310|FG001|Overall Study|Other reasons not listed above|0|||
155652372|NCT00452400|561820311|FG002|Overall Study|Other reasons not listed above|0|||
155652373|NCT00452400|561820312|FG003|Overall Study|Other reasons not listed above|1|||
155652374|NCT00452400|561820313|FG004|Overall Study|Other reasons not listed above|1|||
155652375|NCT01712074|561820316|FG000|Placebo Run-in Period|Adverse Event|2|||
155652376|NCT01712074|561820317|FG001|Placebo Run-in Period|Adverse Event|0|||
155652377|NCT01712074|561820318|FG002|Placebo Run-in Period|Adverse Event|0|||
155652378|NCT01712074|561820316|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
155652379|NCT01712074|561820317|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
155652380|NCT01712074|561820318|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
155652381|NCT01712074|561820316|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
155652382|NCT01712074|561820317|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
155652383|NCT01712074|561820318|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
155652384|NCT01712074|561820316|FG000|Placebo Run-in Period|Other|1|||
155652385|NCT01712074|561820317|FG001|Placebo Run-in Period|Other|0|||
155652386|NCT01712074|561820318|FG002|Placebo Run-in Period|Other|0|||
155461753|NCT00877006|561113344|FG001|Treatment Period|Protocol Violation|0|||
155461754|NCT00877006|561113343|FG000|Treatment Period|Lost to Follow-up|0|||
155652387|NCT01712074|561820316|FG000|Placebo Run-in Period|No longer willing to participate|1|||
155461755|NCT00877006|561113344|FG001|Treatment Period|Lost to Follow-up|1|||
155461756|NCT00877006|561113343|FG000|Treatment Period|Disease Progression|1|||
155461757|NCT00877006|561113344|FG001|Treatment Period|Disease Progression|2|||
155461758|NCT00877006|561113343|FG000|Treatment Period|Started New Treatment Regimen|2|||
155461759|NCT00877006|561113344|FG001|Treatment Period|Started New Treatment Regimen|5|||
155461760|NCT00877006|561113343|FG000|Treatment Period|Other|4|||
155461761|NCT00877006|561113344|FG001|Treatment Period|Other|4|||
155461762|NCT00877006|561113343|FG000|Treatment Period|Randomized but Not Treated|3|||
155461763|NCT00877006|561113344|FG001|Treatment Period|Randomized but Not Treated|8|||
155461764|NCT00877006|561113343|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
155461765|NCT00877006|561113344|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
155461766|NCT00877006|561113343|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
155461767|NCT00877006|561113344|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
155461768|NCT00877006|561113343|FG000|Long-Term Follow-up Period|Death|26|||
155461769|NCT00877006|561113344|FG001|Long-Term Follow-up Period|Death|18|||
155461770|NCT00877006|561113343|FG000|Long-Term Follow-up Period|Other|7|||
155461771|NCT00877006|561113344|FG001|Long-Term Follow-up Period|Other|9|||
155461772|NCT04671342|561113345|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
155461773|NCT04671342|561113345|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
155461774|NCT04671342|561113345|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
155461775|NCT04671342|561113345|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
155461776|NCT04671342|561113345|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
155461777|NCT04671342|561113345|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
155461778|NCT03583606|561113346|FG000|Overall Study|Lost to Follow-up|0|||
155461779|NCT03583606|561113347|FG001|Overall Study|Lost to Follow-up|1|||
155461780|NCT03583606|561113348|FG002|Overall Study|Lost to Follow-up|0|||
155461781|NCT03583606|561113346|FG000|Overall Study|Ineligible at baseline|1|||
155461782|NCT03583606|561113347|FG001|Overall Study|Ineligible at baseline|0|||
155461783|NCT03583606|561113348|FG002|Overall Study|Ineligible at baseline|0|||
155461784|NCT00817206|561113349|FG000|Overall Study|Adverse Event|10|||
155461785|NCT00817206|561113350|FG001|Overall Study|Adverse Event|3|||
155461786|NCT00817206|561113349|FG000|Overall Study|Protocol Violation|0|||
155461787|NCT00817206|561113350|FG001|Overall Study|Protocol Violation|2|||
155461788|NCT00817206|561113349|FG000|Overall Study|Lost to Follow-up|0|||
155461789|NCT00817206|561113350|FG001|Overall Study|Lost to Follow-up|1|||
155461790|NCT00817206|561113349|FG000|Overall Study|Death|2|||
155461791|NCT00817206|561113350|FG001|Overall Study|Death|0|||
155461792|NCT00817206|561113349|FG000|Overall Study|Withdrawal by Subject|7|||
155461793|NCT00817206|561113350|FG001|Overall Study|Withdrawal by Subject|3|||
155461794|NCT00817206|561113349|FG000|Overall Study|Physician Decision|2|||
155461795|NCT00817206|561113350|FG001|Overall Study|Physician Decision|0|||
155461796|NCT00126581|561113351|FG000|Overall Study|Adverse Event|3|||
155461797|NCT00126581|561113352|FG001|Overall Study|Adverse Event|7|||
155461798|NCT00126581|561113351|FG000|Overall Study|Death|3|||
155461799|NCT00126581|561113352|FG001|Overall Study|Death|2|||
155461800|NCT00126581|561113351|FG000|Overall Study|Withdrawal by Subject|1|||
155461801|NCT00126581|561113352|FG001|Overall Study|Withdrawal by Subject|4|||
155461802|NCT00126581|561113351|FG000|Overall Study|Alternative therapy|3|||
155461803|NCT00126581|561113352|FG001|Overall Study|Alternative therapy|3|||
155461804|NCT00126581|561113351|FG000|Overall Study|Other illness/MD discretion|3|||
155461805|NCT00126581|561113352|FG001|Overall Study|Other illness/MD discretion|4|||
155461806|NCT00793182|561113353|FG000|Overall Study|Adverse Event|0|||
155461807|NCT00793182|561113354|FG001|Overall Study|Adverse Event|1|||
155461808|NCT03728140|561113355|FG000|Overall Study|Abnormal embryo transfer operation|10|||
155461809|NCT03728140|561113356|FG001|Overall Study|Abnormal embryo transfer operation|7|||
155461810|NCT00851253|561113357|FG000|Overall Study|Disease Progression|1|||
155461811|NCT00851253|561113358|FG001|Overall Study|Disease Progression|0|||
155461812|NCT00555568|561113364|FG000|Overall Study|Lost to Follow-up|26|||
155461813|NCT00555568|561113365|FG001|Overall Study|Lost to Follow-up|16|||
155461814|NCT00555568|561113366|FG002|Overall Study|Lost to Follow-up|16|||
155461815|NCT01588353|561113367|FG000|Step2|Withdrawal by Subject|0|||
155461816|NCT01588353|561113368|FG001|Step2|Withdrawal by Subject|1|||
155461817|NCT01588353|561113369|FG002|Step2|Withdrawal by Subject|0|||
155461818|NCT01588353|561113367|FG000|Step3|Adverse Event|0|||
155461819|NCT01588353|561113368|FG001|Step3|Adverse Event|0|||
155461820|NCT01588353|561113369|FG002|Step3|Adverse Event|2|||
155461821|NCT00493467|561113370|FG000|Overall Study|Death|1|||
155461822|NCT01409993|561113371|FG000|Overall Study|Adverse Event|4|||
155461823|NCT01409993|561113372|FG001|Overall Study|Adverse Event|4|||
155461824|NCT01409993|561113373|FG002|Overall Study|Adverse Event|3|||
155461825|NCT01409993|561113374|FG003|Overall Study|Adverse Event|1|||
155461826|NCT01409993|561113371|FG000|Overall Study|Withdrawal by Subject|0|||
155461827|NCT01409993|561113372|FG001|Overall Study|Withdrawal by Subject|0|||
155461828|NCT01409993|561113373|FG002|Overall Study|Withdrawal by Subject|0|||
155461829|NCT01409993|561113374|FG003|Overall Study|Withdrawal by Subject|4|||
155461830|NCT01409993|561113371|FG000|Overall Study|Lost to Follow-up|0|||
155461831|NCT01409993|561113372|FG001|Overall Study|Lost to Follow-up|1|||
155461832|NCT01409993|561113373|FG002|Overall Study|Lost to Follow-up|0|||
155461833|NCT01409993|561113374|FG003|Overall Study|Lost to Follow-up|0|||
155461834|NCT01803711|561113382|FG000|Overall Study|Adverse Event|1|||
155461835|NCT01803711|561113383|FG001|Overall Study|Adverse Event|1|||
155461836|NCT00225212|561113384|FG000|Overall Study|Disease progression|2|||
155461837|NCT00225212|561113384|FG000|Overall Study|Death|1|||
155461838|NCT00225212|561113384|FG000|Overall Study|Adverse Event|2|||
155461839|NCT00225212|561113384|FG000|Overall Study|Intercurrent illness|1|||
155461840|NCT05159362|561113385|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
155461841|NCT05159362|561113386|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
155461842|NCT05159362|561113387|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
155461843|NCT01335698|561113388|FG000|Treatment Stage 1|Lack of Efficacy|3|||
155461844|NCT01335698|561113389|FG001|Treatment Stage 1|Lack of Efficacy|1|||
155461845|NCT01335698|561113390|FG002|Treatment Stage 1|Lack of Efficacy|3|||
155461846|NCT01335698|561113391|FG003|Treatment Stage 1|Lack of Efficacy|3|||
155461847|NCT01335698|561113392|FG004|Treatment Stage 1|Lack of Efficacy|1|||
155461848|NCT01335698|561113388|FG000|Treatment Stage 1|Adverse Event|1|||
155461849|NCT01335698|561113389|FG001|Treatment Stage 1|Adverse Event|2|||
155461850|NCT01335698|561113390|FG002|Treatment Stage 1|Adverse Event|2|||
155461851|NCT01335698|561113391|FG003|Treatment Stage 1|Adverse Event|1|||
155461852|NCT01335698|561113392|FG004|Treatment Stage 1|Adverse Event|1|||
155461853|NCT01335698|561113388|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
155461854|NCT01335698|561113389|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
155461855|NCT01335698|561113390|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
155461856|NCT01335698|561113391|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
155461857|NCT01335698|561113392|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
155461858|NCT01335698|561113388|FG000|Treatment Stage 1|Lost to Follow-up|1|||
155461859|NCT01335698|561113389|FG001|Treatment Stage 1|Lost to Follow-up|1|||
155461860|NCT01335698|561113390|FG002|Treatment Stage 1|Lost to Follow-up|0|||
155461861|NCT01335698|561113391|FG003|Treatment Stage 1|Lost to Follow-up|0|||
155461862|NCT01335698|561113392|FG004|Treatment Stage 1|Lost to Follow-up|0|||
155461863|NCT01335698|561113388|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
155461864|NCT01335698|561113389|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
155461865|NCT01335698|561113390|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
155461866|NCT01335698|561113391|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
155461867|NCT01335698|561113392|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
155461868|NCT01335698|561113388|FG000|Treatment Stage 1|No longer meets study criteria|1|||
155461869|NCT01335698|561113389|FG001|Treatment Stage 1|No longer meets study criteria|1|||
155461870|NCT01335698|561113390|FG002|Treatment Stage 1|No longer meets study criteria|0|||
155461871|NCT01335698|561113391|FG003|Treatment Stage 1|No longer meets study criteria|1|||
155516469|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
155461872|NCT01335698|561113392|FG004|Treatment Stage 1|No longer meets study criteria|0|||
155461873|NCT01335698|561113388|FG000|Treatment Stage 1|Other|1|||
155516470|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
155461874|NCT01335698|561113389|FG001|Treatment Stage 1|Other|0|||
155461875|NCT01335698|561113390|FG002|Treatment Stage 1|Other|0|||
155461876|NCT01335698|561113391|FG003|Treatment Stage 1|Other|1|||
155516471|NCT00455533|561315848|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
155461877|NCT01335698|561113392|FG004|Treatment Stage 1|Other|0|||
155461878|NCT01335698|561113388|FG000|Treatment Stage 2|Lack of Efficacy|2|||
155461879|NCT01335698|561113389|FG001|Treatment Stage 2|Lack of Efficacy|1|||
155461880|NCT01335698|561113390|FG002|Treatment Stage 2|Lack of Efficacy|3|||
155461881|NCT01335698|561113391|FG003|Treatment Stage 2|Lack of Efficacy|1|||
155461882|NCT01335698|561113392|FG004|Treatment Stage 2|Lack of Efficacy|0|||
155461883|NCT01335698|561113388|FG000|Treatment Stage 2|Adverse Event|2|||
155461884|NCT01335698|561113389|FG001|Treatment Stage 2|Adverse Event|0|||
155461885|NCT01335698|561113390|FG002|Treatment Stage 2|Adverse Event|0|||
155461886|NCT01335698|561113391|FG003|Treatment Stage 2|Adverse Event|3|||
155461887|NCT01335698|561113392|FG004|Treatment Stage 2|Adverse Event|0|||
155461888|NCT01335698|561113388|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
155461889|NCT01335698|561113389|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
155461890|NCT01335698|561113390|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
155461891|NCT01335698|561113391|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
155461892|NCT01335698|561113392|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
155461893|NCT01335698|561113388|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
155461894|NCT01335698|561113389|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
155461895|NCT01335698|561113390|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
155461896|NCT01335698|561113391|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
155461897|NCT01335698|561113392|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
155461898|NCT01335698|561113388|FG000|Treatment Stage 2|Lost to Follow-up|1|||
155461899|NCT01335698|561113389|FG001|Treatment Stage 2|Lost to Follow-up|0|||
155461900|NCT01335698|561113390|FG002|Treatment Stage 2|Lost to Follow-up|0|||
155461901|NCT01335698|561113391|FG003|Treatment Stage 2|Lost to Follow-up|0|||
155461902|NCT01335698|561113392|FG004|Treatment Stage 2|Lost to Follow-up|0|||
155461903|NCT01335698|561113388|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
155461904|NCT01335698|561113389|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
155461905|NCT01335698|561113390|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
155461906|NCT01335698|561113391|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
155461907|NCT01335698|561113392|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
155461908|NCT01335698|561113388|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
155461909|NCT01335698|561113389|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
155461910|NCT01335698|561113390|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
155461911|NCT01335698|561113391|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
155461912|NCT01335698|561113392|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
155461913|NCT01335698|561113388|FG000|Treatment Stage 2|Switched to another formulation|1|||
155461914|NCT01335698|561113389|FG001|Treatment Stage 2|Switched to another formulation|1|||
155461915|NCT01335698|561113390|FG002|Treatment Stage 2|Switched to another formulation|0|||
155461916|NCT01335698|561113391|FG003|Treatment Stage 2|Switched to another formulation|0|||
155461917|NCT01335698|561113392|FG004|Treatment Stage 2|Switched to another formulation|0|||
155461918|NCT01162304|561113396|FG000|Overall Study|Beck scale to high|11|||
155516472|NCT00455533|561315849|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
155516473|NCT00455533|561315850|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
155516474|NCT00455533|561315848|FG000|Period Two: Randomized Period|Death|0|||
155516475|NCT00455533|561315849|FG001|Period Two: Randomized Period|Death|0|||
155652388|NCT01712074|561820317|FG001|Placebo Run-in Period|No longer willing to participate|0|||
155461919|NCT01315847|561113397|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
155461920|NCT01315847|561113398|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
155461921|NCT01315847|561113397|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
155461922|NCT01315847|561113398|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
155461923|NCT02940626|561113399|FG000|Overall Study|Death|40|||
155461924|NCT02940626|561113400|FG001|Overall Study|Death|32|||
155461925|NCT02940626|561113399|FG000|Overall Study|Lost to Follow-up|5|||
155461926|NCT02940626|561113400|FG001|Overall Study|Lost to Follow-up|2|||
155461927|NCT02940626|561113399|FG000|Overall Study|Withdrawal by Subject|1|||
155461928|NCT02940626|561113400|FG001|Overall Study|Withdrawal by Subject|0|||
155461929|NCT02940626|561113399|FG000|Overall Study|Transfer to Hospice Care|1|||
155461930|NCT02940626|561113400|FG001|Overall Study|Transfer to Hospice Care|0|||
155461931|NCT02940626|561113399|FG000|Overall Study|Prohibited Concomitant Medication|0|||
155461932|NCT02940626|561113400|FG001|Overall Study|Prohibited Concomitant Medication|1|||
155461933|NCT01324622|561113401|FG000|Overall Study|Lost to Follow-up|7|||
155461934|NCT01324622|561113402|FG001|Overall Study|Lost to Follow-up|7|||
155461935|NCT01324622|561113401|FG000|Overall Study|Death|1|||
155461936|NCT01324622|561113402|FG001|Overall Study|Death|0|||
155652389|NCT01712074|561820318|FG002|Placebo Run-in Period|No longer willing to participate|0|||
155652390|NCT01712074|561820316|FG000|Double Blind Period|Adverse Event|0|||
155652391|NCT01712074|561820317|FG001|Double Blind Period|Adverse Event|2|||
155652392|NCT01712074|561820318|FG002|Double Blind Period|Adverse Event|1|||
155652393|NCT01712074|561820316|FG000|Double Blind Period|No longer willing to participate|0|||
155652394|NCT01712074|561820317|FG001|Double Blind Period|No longer willing to participate|2|||
155652395|NCT01712074|561820318|FG002|Double Blind Period|No longer willing to participate|4|||
155652396|NCT01712074|561820316|FG000|Double Blind Period|Death|0|||
155652397|NCT01712074|561820317|FG001|Double Blind Period|Death|1|||
155652398|NCT01712074|561820318|FG002|Double Blind Period|Death|0|||
155652399|NCT01712074|561820316|FG000|Double Blind Period|Lost to Follow-up|0|||
155652400|NCT01712074|561820317|FG001|Double Blind Period|Lost to Follow-up|2|||
155652401|NCT01712074|561820318|FG002|Double Blind Period|Lost to Follow-up|1|||
155652402|NCT01712074|561820316|FG000|Double Blind Period|Other|0|||
155652403|NCT01712074|561820317|FG001|Double Blind Period|Other|4|||
155652404|NCT01712074|561820318|FG002|Double Blind Period|Other|1|||
155652405|NCT01712074|561820316|FG000|Double Blind Period|Protocol Violation|0|||
155652406|NCT01712074|561820317|FG001|Double Blind Period|Protocol Violation|0|||
155652407|NCT01712074|561820318|FG002|Double Blind Period|Protocol Violation|1|||
155652408|NCT01712074|561820316|FG000|Double Blind Period|No longer met eligibility criteria|0|||
155652409|NCT01712074|561820317|FG001|Double Blind Period|No longer met eligibility criteria|3|||
155652410|NCT01712074|561820318|FG002|Double Blind Period|No longer met eligibility criteria|0|||
155652411|NCT03478787|561820319|FG000|Overall Study|Adverse Event|5|||
155652412|NCT03478787|561820320|FG001|Overall Study|Adverse Event|1|||
155652413|NCT03478787|561820319|FG000|Overall Study|Protocol Violation|3|||
155652414|NCT03478787|561820320|FG001|Overall Study|Protocol Violation|0|||
155652415|NCT03478787|561820319|FG000|Overall Study|Lack of Efficacy|7|||
155652416|NCT03478787|561820320|FG001|Overall Study|Lack of Efficacy|1|||
155652417|NCT03478787|561820319|FG000|Overall Study|Lost to Follow-up|9|||
155652418|NCT03478787|561820320|FG001|Overall Study|Lost to Follow-up|5|||
155652419|NCT03478787|561820319|FG000|Overall Study|Withdrawal by Subject|2|||
155652420|NCT03478787|561820320|FG001|Overall Study|Withdrawal by Subject|6|||
155652421|NCT03478787|561820319|FG000|Overall Study|Other, Not Specified|3|||
155652422|NCT03478787|561820320|FG001|Overall Study|Other, Not Specified|0|||
155652423|NCT02539394|561820321|FG000|Overall Study|Protocol Violation|1|||
155652424|NCT02539394|561820322|FG001|Overall Study|Protocol Violation|3|||
155652425|NCT02539394|561820321|FG000|Overall Study|Lost to Follow-up|1|||
155652426|NCT02539394|561820322|FG001|Overall Study|Lost to Follow-up|2|||
155652427|NCT02539394|561820321|FG000|Overall Study|Incomplete dataset|6|||
155652428|NCT02539394|561820322|FG001|Overall Study|Incomplete dataset|6|||
155652429|NCT01316900|561820343|FG000|Overall Study|Adverse Event|10|||
155652430|NCT01316900|561820344|FG001|Overall Study|Adverse Event|10|||
155652431|NCT01316900|561820345|FG002|Overall Study|Adverse Event|15|||
155652432|NCT01316900|561820346|FG003|Overall Study|Adverse Event|9|||
155652433|NCT01316900|561820343|FG000|Overall Study|Lack of Efficacy|17|||
155652434|NCT01316900|561820344|FG001|Overall Study|Lack of Efficacy|9|||
155652435|NCT01316900|561820345|FG002|Overall Study|Lack of Efficacy|5|||
155652436|NCT01316900|561820346|FG003|Overall Study|Lack of Efficacy|7|||
155652437|NCT01316900|561820343|FG000|Overall Study|Protocol Violation|7|||
155652438|NCT01316900|561820344|FG001|Overall Study|Protocol Violation|1|||
155652439|NCT01316900|561820345|FG002|Overall Study|Protocol Violation|4|||
155652440|NCT01316900|561820346|FG003|Overall Study|Protocol Violation|0|||
155652441|NCT01316900|561820343|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
155652442|NCT01316900|561820344|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
155652443|NCT01316900|561820345|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
155652444|NCT01316900|561820346|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
155652445|NCT01316900|561820343|FG000|Overall Study|Lost to Follow-up|1|||
155652446|NCT01316900|561820344|FG001|Overall Study|Lost to Follow-up|0|||
155652447|NCT01316900|561820345|FG002|Overall Study|Lost to Follow-up|1|||
155652448|NCT01316900|561820346|FG003|Overall Study|Lost to Follow-up|1|||
155652449|NCT01316900|561820343|FG000|Overall Study|Withdrawal by Subject|7|||
155461937|NCT01324622|561113401|FG000|Overall Study|Lack of Efficacy|1|||
155652450|NCT01316900|561820344|FG001|Overall Study|Withdrawal by Subject|8|||
155461938|NCT01324622|561113402|FG001|Overall Study|Lack of Efficacy|0|||
155461939|NCT00618449|561113403|FG000|Overall Study|Lost to Follow-up|98|||
155461940|NCT00618449|561113404|FG001|Overall Study|Lost to Follow-up|110|||
155461941|NCT05127421|561113405|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
155461942|NCT05127421|561113406|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
155461943|NCT05127421|561113407|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
155461944|NCT05127421|561113408|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
155461945|NCT05127421|561113405|FG000|4-Week Double-Blind Period|Physician Decision|1|||
155461946|NCT05127421|561113406|FG001|4-Week Double-Blind Period|Physician Decision|0|||
155652451|NCT01316900|561820345|FG002|Overall Study|Withdrawal by Subject|6|||
155652452|NCT01316900|561820346|FG003|Overall Study|Withdrawal by Subject|9|||
155652453|NCT00562861|561820347|FG000|Overall Study|Adverse Event|1|||
155652454|NCT00562861|561820348|FG001|Overall Study|Adverse Event|1|||
155652455|NCT00562861|561820347|FG000|Overall Study|Lack of Efficacy|5|||
155652456|NCT00562861|561820348|FG001|Overall Study|Lack of Efficacy|5|||
155652457|NCT00562861|561820347|FG000|Overall Study|noncompliance, moved|7|||
155652458|NCT00562861|561820348|FG001|Overall Study|noncompliance, moved|2|||
155652459|NCT00562861|561820347|FG000|Overall Study|Lost to Follow-up|7|||
155461947|NCT05127421|561113407|FG002|4-Week Double-Blind Period|Physician Decision|0|||
155461948|NCT05127421|561113408|FG003|4-Week Double-Blind Period|Physician Decision|0|||
155461949|NCT05127421|561113405|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
155461950|NCT05127421|561113406|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
155461951|NCT05127421|561113407|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
155461952|NCT05127421|561113408|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
155461953|NCT05127421|561113405|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
155461954|NCT05127421|561113406|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
155461955|NCT05127421|561113407|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
155461956|NCT05127421|561113408|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
155461957|NCT05127421|561113405|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
155461958|NCT05127421|561113406|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
155652460|NCT00562861|561820348|FG001|Overall Study|Lost to Follow-up|3|||
155652461|NCT00655356|561820349|FG000|Overall Study|Withdrawal by Subject|3|||
155652462|NCT00655356|561820350|FG001|Overall Study|Withdrawal by Subject|4|||
155652463|NCT00655356|561820349|FG000|Overall Study|Sponsor Request|10|||
155652464|NCT00655356|561820350|FG001|Overall Study|Sponsor Request|4|||
155652465|NCT00655356|561820349|FG000|Overall Study|Adverse Event|1|||
155652466|NCT00655356|561820350|FG001|Overall Study|Adverse Event|1|||
155652467|NCT00655356|561820349|FG000|Overall Study|Protocol Violation|2|||
155652468|NCT00655356|561820350|FG001|Overall Study|Protocol Violation|1|||
155652469|NCT00655356|561820349|FG000|Overall Study|Other Reason|1|||
155652470|NCT00655356|561820350|FG001|Overall Study|Other Reason|0|||
155652471|NCT01684033|561820351|FG000|Period 1, First 30 Days|Adverse Event|1|||
155652472|NCT01684033|561820352|FG001|Period 1, First 30 Days|Adverse Event|1|||
155652473|NCT01684033|561820351|FG000|Period 1, First 30 Days|Noncompliance|1|||
155652474|NCT01684033|561820352|FG001|Period 1, First 30 Days|Noncompliance|0|||
155652475|NCT01684033|561820351|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
155652476|NCT01684033|561820352|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
155652477|NCT01684033|561820351|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
155652478|NCT01684033|561820352|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
155652479|NCT01684033|561820351|FG000|Period 2, Second 30 Days|Adverse Event|1|||
155652480|NCT01684033|561820352|FG001|Period 2, Second 30 Days|Adverse Event|0|||
155652481|NCT05626686|561820357|FG000|Overall Study|Protocol Violation|3|||
155652482|NCT05626686|561820357|FG000|Overall Study|Withdrawal by Subject|3|||
155652483|NCT01093573|561820358|FG000|Overall Study|Physician Decision|0|||
155652484|NCT01093573|561820359|FG001|Overall Study|Physician Decision|0|||
155652485|NCT01093573|561820360|FG002|Overall Study|Physician Decision|1|||
155652486|NCT01093573|561820358|FG000|Overall Study|Insurance Denied|0|||
155652487|NCT01093573|561820359|FG001|Overall Study|Insurance Denied|0|||
155652488|NCT01093573|561820360|FG002|Overall Study|Insurance Denied|1|||
155461959|NCT05127421|561113407|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
155461960|NCT05127421|561113408|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
155461961|NCT05127421|561113405|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
155461962|NCT05127421|561113406|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
155461963|NCT05127421|561113407|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
155461964|NCT05127421|561113408|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
155461965|NCT05127421|561113405|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
155461966|NCT05127421|561113406|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
155461967|NCT05127421|561113407|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
155461968|NCT05127421|561113408|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
155461969|NCT05127421|561113405|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
155461970|NCT05127421|561113406|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
155461971|NCT05127421|561113407|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
155652489|NCT02496156|561820361|FG000|Overall Study|Lost to Follow-up|5|||
155652490|NCT02496156|561820362|FG001|Overall Study|Lost to Follow-up|0|||
155652491|NCT02496156|561820361|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
155652492|NCT02496156|561820362|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
155652493|NCT00289900|561820363|FG000|Overall Study|Adverse Event|28|||
155652494|NCT00289900|561820364|FG001|Overall Study|Adverse Event|40|||
155516476|NCT00455533|561315850|FG002|Period Two: Randomized Period|Death|3|||
155516477|NCT00455533|561315848|FG000|Period Two: Randomized Period|Disease Progression|0|||
155516478|NCT00455533|561315849|FG001|Period Two: Randomized Period|Disease Progression|1|||
155516479|NCT00455533|561315850|FG002|Period Two: Randomized Period|Disease Progression|1|||
155516480|NCT00455533|561315848|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
155516481|NCT00455533|561315849|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
155461972|NCT05127421|561113408|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
155461973|NCT00138424|561113409|FG000|Overall Study|Physician Decision|0|||
155461974|NCT00138424|561113410|FG001|Overall Study|Physician Decision|1|||
155461975|NCT00138424|561113411|FG002|Overall Study|Physician Decision|0|||
155461976|NCT00138424|561113412|FG003|Overall Study|Physician Decision|0|||
155461977|NCT00574496|561113417|FG000|Overall Study|Withdrawal by Subject|1|||
155461978|NCT00413062|561113418|FG000|Overall Study|Adverse event/serious adverse event|289|||
155461979|NCT00413062|561113419|FG001|Overall Study|Adverse event/serious adverse event|56|||
155461980|NCT00413062|561113418|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
155461981|NCT00413062|561113419|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
155461982|NCT00413062|561113418|FG000|Overall Study|Withdrawal of informed consent|111|||
155461983|NCT00413062|561113419|FG001|Overall Study|Withdrawal of informed consent|36|||
155461984|NCT00413062|561113418|FG000|Overall Study|Pregnancy|15|||
155461985|NCT00413062|561113419|FG001|Overall Study|Pregnancy|5|||
155461986|NCT00413062|561113418|FG000|Overall Study|Pregnancy wish|17|||
155461987|NCT00413062|561113419|FG001|Overall Study|Pregnancy wish|6|||
155461988|NCT00413062|561113418|FG000|Overall Study|Lost to Follow-up|175|||
155461989|NCT00413062|561113419|FG001|Overall Study|Lost to Follow-up|73|||
155461990|NCT00413062|561113418|FG000|Overall Study|Other reason|70|||
155461991|NCT00413062|561113419|FG001|Overall Study|Other reason|34|||
155461992|NCT00006604|561113420|FG000|Overall Study|Met study objective - no further FU|1|||
155461993|NCT00006604|561113421|FG001|Overall Study|Met study objective - no further FU|0|||
155461994|NCT00006604|561113422|FG002|Overall Study|Met study objective - no further FU|0|||
155461995|NCT00006604|561113423|FG003|Overall Study|Met study objective - no further FU|0|||
155461996|NCT00006604|561113424|FG004|Overall Study|Met study objective - no further FU|0|||
155461997|NCT00006604|561113425|FG005|Overall Study|Met study objective - no further FU|0|||
155461998|NCT00006604|561113426|FG006|Overall Study|Met study objective - no further FU|0|||
155461999|NCT00006604|561113427|FG007|Overall Study|Met study objective - no further FU|0|||
155462000|NCT00006604|561113428|FG008|Overall Study|Met study objective - no further FU|0|||
155462001|NCT00006604|561113429|FG009|Overall Study|Met study objective - no further FU|0|||
155462002|NCT00006604|561113430|FG010|Overall Study|Met study objective - no further FU|0|||
155462003|NCT00006604|561113431|FG011|Overall Study|Met study objective - no further FU|0|||
155462004|NCT00006604|561113432|FG012|Overall Study|Met study objective - no further FU|0|||
155462005|NCT00006604|561113433|FG013|Overall Study|Met study objective - no further FU|0|||
155462006|NCT00006604|561113434|FG014|Overall Study|Met study objective - no further FU|1|||
155462007|NCT00006604|561113435|FG015|Overall Study|Met study objective - no further FU|1|||
155462008|NCT00006604|561113436|FG016|Overall Study|Met study objective - no further FU|0|||
155462009|NCT00006604|561113420|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
155462010|NCT00006604|561113421|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
155462011|NCT00006604|561113422|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
155462012|NCT00006604|561113423|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
155462013|NCT00006604|561113424|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
155462014|NCT00006604|561113425|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
155462015|NCT00006604|561113426|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
155462016|NCT00006604|561113427|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
155462017|NCT00006604|561113428|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
155462018|NCT00006604|561113429|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
155462019|NCT00006604|561113430|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
155462020|NCT00006604|561113431|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
155462021|NCT00006604|561113432|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
155462022|NCT00006604|561113433|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
155462023|NCT00006604|561113434|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
155462024|NCT00006604|561113435|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
155462025|NCT00006604|561113436|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
155462026|NCT00006604|561113420|FG000|Overall Study|Death|0|||
155462027|NCT00006604|561113421|FG001|Overall Study|Death|0|||
155462028|NCT00006604|561113422|FG002|Overall Study|Death|0|||
155462029|NCT00006604|561113423|FG003|Overall Study|Death|0|||
155462030|NCT00006604|561113424|FG004|Overall Study|Death|0|||
155462031|NCT00006604|561113425|FG005|Overall Study|Death|0|||
155462032|NCT00006604|561113426|FG006|Overall Study|Death|0|||
155462033|NCT00006604|561113427|FG007|Overall Study|Death|0|||
155462034|NCT00006604|561113428|FG008|Overall Study|Death|0|||
155462035|NCT00006604|561113429|FG009|Overall Study|Death|1|||
155462036|NCT00006604|561113430|FG010|Overall Study|Death|1|||
155462037|NCT00006604|561113431|FG011|Overall Study|Death|1|||
155516482|NCT00455533|561315850|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
155516483|NCT00455533|561315848|FG000|Period Two: Randomized Period|Other - need reasons|0|||
155516484|NCT00455533|561315849|FG001|Period Two: Randomized Period|Other - need reasons|1|||
155516485|NCT00455533|561315850|FG002|Period Two: Randomized Period|Other - need reasons|0|||
155516486|NCT00455533|561315848|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
155516487|NCT00455533|561315849|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
155516488|NCT00455533|561315850|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
155516489|NCT00455533|561315848|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
155516490|NCT00455533|561315849|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
155516491|NCT00455533|561315850|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
155516492|NCT04634409|561315853|FG000|Overall Study|Death|0|||
155516493|NCT04634409|561315854|FG001|Overall Study|Death|0|||
155516494|NCT04634409|561315855|FG002|Overall Study|Death|0|||
155516495|NCT04634409|561315856|FG003|Overall Study|Death|0|||
155516496|NCT04634409|561315857|FG004|Overall Study|Death|0|||
155516497|NCT04634409|561315858|FG005|Overall Study|Death|0|||
155516498|NCT04634409|561315859|FG006|Overall Study|Death|0|||
155516499|NCT04634409|561315860|FG007|Overall Study|Death|0|||
155516500|NCT04634409|561315861|FG008|Overall Study|Death|0|||
155516501|NCT04634409|561315862|FG009|Overall Study|Death|0|||
155516502|NCT04634409|561315863|FG010|Overall Study|Death|1|||
155516503|NCT04634409|561315864|FG011|Overall Study|Death|0|||
155516504|NCT04634409|561315865|FG012|Overall Study|Death|1|||
155516505|NCT04634409|561315866|FG013|Overall Study|Death|0|||
155462038|NCT00006604|561113432|FG012|Overall Study|Death|0|||
155462039|NCT00006604|561113433|FG013|Overall Study|Death|0|||
155462040|NCT00006604|561113434|FG014|Overall Study|Death|0|||
155516506|NCT04634409|561315867|FG014|Overall Study|Death|0|||
155462041|NCT00006604|561113435|FG015|Overall Study|Death|0|||
155462042|NCT00006604|561113436|FG016|Overall Study|Death|0|||
155462043|NCT00006604|561113420|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155462044|NCT00006604|561113421|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155462045|NCT00006604|561113422|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155462046|NCT00006604|561113423|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155462047|NCT00006604|561113424|FG004|Overall Study|Severe debilitation, unable to continue|0|||
155462048|NCT00006604|561113425|FG005|Overall Study|Severe debilitation, unable to continue|0|||
155462049|NCT00006604|561113426|FG006|Overall Study|Severe debilitation, unable to continue|3|||
155462050|NCT00006604|561113427|FG007|Overall Study|Severe debilitation, unable to continue|0|||
155462051|NCT00006604|561113428|FG008|Overall Study|Severe debilitation, unable to continue|0|||
155462052|NCT00006604|561113429|FG009|Overall Study|Severe debilitation, unable to continue|5|||
155462053|NCT00006604|561113430|FG010|Overall Study|Severe debilitation, unable to continue|0|||
155462054|NCT00006604|561113431|FG011|Overall Study|Severe debilitation, unable to continue|2|||
155462055|NCT00006604|561113432|FG012|Overall Study|Severe debilitation, unable to continue|1|||
155462056|NCT00006604|561113433|FG013|Overall Study|Severe debilitation, unable to continue|0|||
155462057|NCT00006604|561113434|FG014|Overall Study|Severe debilitation, unable to continue|2|||
155462058|NCT00006604|561113435|FG015|Overall Study|Severe debilitation, unable to continue|0|||
155462059|NCT00006604|561113436|FG016|Overall Study|Severe debilitation, unable to continue|0|||
155462060|NCT00006604|561113420|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
155462061|NCT00006604|561113421|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
155462062|NCT00006604|561113422|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
155462063|NCT00006604|561113423|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
155462064|NCT00006604|561113424|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
155462065|NCT00006604|561113425|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
155462066|NCT00006604|561113426|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
155462067|NCT00006604|561113427|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
155462068|NCT00006604|561113428|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
155462069|NCT00006604|561113429|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
155462070|NCT00006604|561113430|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
155462071|NCT00006604|561113431|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
155462072|NCT00006604|561113432|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
155462073|NCT00006604|561113433|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
155462074|NCT00006604|561113434|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
155462075|NCT00006604|561113435|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
155462076|NCT00006604|561113436|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
155462077|NCT00006604|561113420|FG000|Overall Study|Site closing|0|||
155462078|NCT00006604|561113421|FG001|Overall Study|Site closing|0|||
155462079|NCT00006604|561113422|FG002|Overall Study|Site closing|1|||
155462080|NCT00006604|561113423|FG003|Overall Study|Site closing|1|||
155462081|NCT00006604|561113424|FG004|Overall Study|Site closing|0|||
155462082|NCT00006604|561113425|FG005|Overall Study|Site closing|0|||
155462083|NCT00006604|561113426|FG006|Overall Study|Site closing|0|||
155462084|NCT00006604|561113427|FG007|Overall Study|Site closing|1|||
155462085|NCT00006604|561113428|FG008|Overall Study|Site closing|0|||
155462086|NCT00006604|561113429|FG009|Overall Study|Site closing|0|||
155462087|NCT00006604|561113430|FG010|Overall Study|Site closing|0|||
155462088|NCT00006604|561113431|FG011|Overall Study|Site closing|1|||
155462089|NCT00006604|561113432|FG012|Overall Study|Site closing|1|||
155462090|NCT00006604|561113433|FG013|Overall Study|Site closing|1|||
155462091|NCT00006604|561113434|FG014|Overall Study|Site closing|0|||
155462092|NCT00006604|561113435|FG015|Overall Study|Site closing|0|||
155462093|NCT00006604|561113436|FG016|Overall Study|Site closing|1|||
155462094|NCT00006604|561113420|FG000|Overall Study|Withdrawal by Subject|1|||
155462095|NCT00006604|561113421|FG001|Overall Study|Withdrawal by Subject|0|||
155462096|NCT00006604|561113422|FG002|Overall Study|Withdrawal by Subject|2|||
155462097|NCT00006604|561113423|FG003|Overall Study|Withdrawal by Subject|0|||
155462098|NCT00006604|561113424|FG004|Overall Study|Withdrawal by Subject|1|||
155462099|NCT00006604|561113425|FG005|Overall Study|Withdrawal by Subject|2|||
155462100|NCT00006604|561113426|FG006|Overall Study|Withdrawal by Subject|2|||
155462101|NCT00006604|561113427|FG007|Overall Study|Withdrawal by Subject|0|||
155462102|NCT00006604|561113428|FG008|Overall Study|Withdrawal by Subject|1|||
155462103|NCT00006604|561113429|FG009|Overall Study|Withdrawal by Subject|3|||
155462104|NCT00006604|561113430|FG010|Overall Study|Withdrawal by Subject|2|||
155462105|NCT00006604|561113431|FG011|Overall Study|Withdrawal by Subject|0|||
155462106|NCT00006604|561113432|FG012|Overall Study|Withdrawal by Subject|1|||
155462107|NCT00006604|561113433|FG013|Overall Study|Withdrawal by Subject|2|||
155462108|NCT00006604|561113434|FG014|Overall Study|Withdrawal by Subject|1|||
155462109|NCT00006604|561113435|FG015|Overall Study|Withdrawal by Subject|0|||
155462110|NCT00006604|561113436|FG016|Overall Study|Withdrawal by Subject|1|||
155462111|NCT00006604|561113420|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
155462112|NCT00006604|561113421|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
155462113|NCT00006604|561113422|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
155462114|NCT00006604|561113423|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
155462115|NCT00006604|561113424|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
155462116|NCT00006604|561113425|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
155462117|NCT00006604|561113426|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
155462118|NCT00006604|561113427|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
155462119|NCT00006604|561113428|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
155462120|NCT00006604|561113429|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
155462121|NCT00006604|561113430|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
155462122|NCT00006604|561113431|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
155462123|NCT00006604|561113432|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
155462124|NCT00006604|561113433|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
155462125|NCT00006604|561113434|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
155462126|NCT00006604|561113435|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
155462127|NCT00006604|561113436|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
155462128|NCT00006604|561113420|FG000|Overall Study|Lost to Follow-up|0|||
155462129|NCT00006604|561113421|FG001|Overall Study|Lost to Follow-up|0|||
155462130|NCT00006604|561113422|FG002|Overall Study|Lost to Follow-up|0|||
155462131|NCT00006604|561113423|FG003|Overall Study|Lost to Follow-up|0|||
155462132|NCT00006604|561113424|FG004|Overall Study|Lost to Follow-up|0|||
155462133|NCT00006604|561113425|FG005|Overall Study|Lost to Follow-up|0|||
155462134|NCT00006604|561113426|FG006|Overall Study|Lost to Follow-up|0|||
155462135|NCT00006604|561113427|FG007|Overall Study|Lost to Follow-up|1|||
155462136|NCT00006604|561113428|FG008|Overall Study|Lost to Follow-up|0|||
155462137|NCT00006604|561113429|FG009|Overall Study|Lost to Follow-up|2|||
155462138|NCT00006604|561113430|FG010|Overall Study|Lost to Follow-up|0|||
155462139|NCT00006604|561113431|FG011|Overall Study|Lost to Follow-up|0|||
155462140|NCT00006604|561113432|FG012|Overall Study|Lost to Follow-up|0|||
155462141|NCT00006604|561113433|FG013|Overall Study|Lost to Follow-up|0|||
155462142|NCT00006604|561113434|FG014|Overall Study|Lost to Follow-up|0|||
155462143|NCT00006604|561113435|FG015|Overall Study|Lost to Follow-up|1|||
155462144|NCT00006604|561113436|FG016|Overall Study|Lost to Follow-up|3|||
155462145|NCT00006604|561113420|FG000|Overall Study|Other Reason|0|||
155462146|NCT00006604|561113421|FG001|Overall Study|Other Reason|0|||
155462147|NCT00006604|561113422|FG002|Overall Study|Other Reason|0|||
155462148|NCT00006604|561113423|FG003|Overall Study|Other Reason|0|||
155462149|NCT00006604|561113424|FG004|Overall Study|Other Reason|0|||
155462150|NCT00006604|561113425|FG005|Overall Study|Other Reason|1|||
155462151|NCT00006604|561113426|FG006|Overall Study|Other Reason|0|||
155462152|NCT00006604|561113427|FG007|Overall Study|Other Reason|0|||
155462153|NCT00006604|561113428|FG008|Overall Study|Other Reason|0|||
155462154|NCT00006604|561113429|FG009|Overall Study|Other Reason|1|||
155462155|NCT00006604|561113430|FG010|Overall Study|Other Reason|0|||
155462156|NCT00006604|561113431|FG011|Overall Study|Other Reason|0|||
155462157|NCT00006604|561113432|FG012|Overall Study|Other Reason|0|||
155462158|NCT00006604|561113433|FG013|Overall Study|Other Reason|0|||
155462159|NCT00006604|561113434|FG014|Overall Study|Other Reason|0|||
155462160|NCT00006604|561113435|FG015|Overall Study|Other Reason|0|||
155462161|NCT00006604|561113436|FG016|Overall Study|Other Reason|0|||
155462162|NCT03454412|561113437|FG000|Baseline Assesment|Physician Decision|12|||
155462163|NCT01167582|561113438|FG000|Overall Study|Lost to Follow-up|0|||
155462164|NCT01167582|561113439|FG001|Overall Study|Lost to Follow-up|1|||
155462165|NCT01928485|561113440|FG000|Overall Study|Physician Decision|0|||
155462166|NCT01928485|561113441|FG001|Overall Study|Physician Decision|1|||
155462167|NCT00946881|561113444|FG000|First Treatment|Withdrawal by Subject|1|||
155462168|NCT00946881|561113444|FG000|First Treatment|Patient relocated to another state|1|||
155462169|NCT00946881|561113444|FG000|Retreatment|Withdrawal by Subject|1|||
155462170|NCT00293423|561113445|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
155462171|NCT00293423|561113446|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
155462172|NCT00293423|561113445|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
155462173|NCT00293423|561113446|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
155462174|NCT00293423|561113445|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
155462175|NCT00293423|561113446|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
155462176|NCT00293423|561113445|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
155462177|NCT00293423|561113446|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
155462178|NCT00293423|561113445|FG000|Surgical Resection|processing error during surgical resection|1|||
155462179|NCT00293423|561113446|FG001|Surgical Resection|processing error during surgical resection|0|||
155462180|NCT00293423|561113445|FG000|Surgical Resection|Withdrawal by Subject|4|||
155462181|NCT00293423|561113446|FG001|Surgical Resection|Withdrawal by Subject|0|||
155462182|NCT00293423|561113445|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
155462183|NCT00293423|561113446|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
155462184|NCT01182337|561113449|FG000|Overall Study|Withdrawal by Subject|3|||
155462185|NCT01182337|561113450|FG001|Overall Study|Withdrawal by Subject|1|||
155462186|NCT01182337|561113449|FG000|Overall Study|Lost to Follow-up|0|||
155516507|NCT04634409|561315868|FG015|Overall Study|Death|0|||
155516508|NCT04634409|561315869|FG016|Overall Study|Death|0|||
155516509|NCT04634409|561315870|FG017|Overall Study|Death|0|||
155516510|NCT04634409|561315871|FG018|Overall Study|Death|0|||
155516511|NCT04634409|561315872|FG019|Overall Study|Death|0|||
155516512|NCT04634409|561315873|FG020|Overall Study|Death|0|||
155516513|NCT04634409|561315874|FG021|Overall Study|Death|0|||
155516514|NCT04634409|561315875|FG022|Overall Study|Death|0|||
155516515|NCT04634409|561315876|FG023|Overall Study|Death|0|||
155516516|NCT04634409|561315877|FG024|Overall Study|Death|0|||
155516517|NCT04634409|561315878|FG025|Overall Study|Death|0|||
155516518|NCT04634409|561315879|FG026|Overall Study|Death|0|||
155516519|NCT04634409|561315853|FG000|Overall Study|Adverse Event|0|||
155516520|NCT04634409|561315854|FG001|Overall Study|Adverse Event|0|||
155516521|NCT04634409|561315855|FG002|Overall Study|Adverse Event|1|||
155516522|NCT04634409|561315856|FG003|Overall Study|Adverse Event|0|||
155516523|NCT04634409|561315857|FG004|Overall Study|Adverse Event|0|||
155516524|NCT04634409|561315858|FG005|Overall Study|Adverse Event|1|||
155516525|NCT04634409|561315859|FG006|Overall Study|Adverse Event|0|||
155516526|NCT04634409|561315860|FG007|Overall Study|Adverse Event|0|||
155516527|NCT04634409|561315861|FG008|Overall Study|Adverse Event|0|||
155516528|NCT04634409|561315862|FG009|Overall Study|Adverse Event|0|||
155516529|NCT04634409|561315863|FG010|Overall Study|Adverse Event|0|||
155516530|NCT04634409|561315864|FG011|Overall Study|Adverse Event|0|||
155516531|NCT04634409|561315865|FG012|Overall Study|Adverse Event|0|||
155516532|NCT04634409|561315866|FG013|Overall Study|Adverse Event|0|||
155516533|NCT04634409|561315867|FG014|Overall Study|Adverse Event|0|||
155516534|NCT04634409|561315868|FG015|Overall Study|Adverse Event|0|||
155516535|NCT04634409|561315869|FG016|Overall Study|Adverse Event|0|||
155516536|NCT04634409|561315870|FG017|Overall Study|Adverse Event|0|||
155516537|NCT04634409|561315871|FG018|Overall Study|Adverse Event|0|||
155516538|NCT04634409|561315872|FG019|Overall Study|Adverse Event|0|||
155516539|NCT04634409|561315873|FG020|Overall Study|Adverse Event|0|||
155516540|NCT04634409|561315874|FG021|Overall Study|Adverse Event|0|||
155516541|NCT04634409|561315875|FG022|Overall Study|Adverse Event|0|||
155516542|NCT04634409|561315876|FG023|Overall Study|Adverse Event|0|||
155516543|NCT04634409|561315877|FG024|Overall Study|Adverse Event|0|||
155462187|NCT01182337|561113450|FG001|Overall Study|Lost to Follow-up|1|||
155462188|NCT01714817|561113454|FG000|Year 1 Period|Lack of Efficacy|11|||
155462189|NCT01714817|561113455|FG001|Year 1 Period|Lack of Efficacy|9|||
155462190|NCT01714817|561113454|FG000|Year 1 Period|Adverse Event|20|||
155462191|NCT01714817|561113455|FG001|Year 1 Period|Adverse Event|17|||
155462192|NCT01714817|561113454|FG000|Year 1 Period|Withdrawal by Subject|6|||
155462193|NCT01714817|561113455|FG001|Year 1 Period|Withdrawal by Subject|7|||
155462194|NCT01714817|561113454|FG000|Year 1 Period|Death|1|||
155462195|NCT01714817|561113455|FG001|Year 1 Period|Death|1|||
155462196|NCT01714817|561113454|FG000|Year 1 Period|Lost to Follow-up|0|||
155462197|NCT01714817|561113455|FG001|Year 1 Period|Lost to Follow-up|2|||
155462198|NCT01714817|561113454|FG000|Year 1 Period|Poor / non-compliance|0|||
155462199|NCT01714817|561113455|FG001|Year 1 Period|Poor / non-compliance|1|||
155462200|NCT01714817|561113454|FG000|Year 1 Period|Pregnancy|2|||
155462201|NCT01714817|561113455|FG001|Year 1 Period|Pregnancy|0|||
155462202|NCT01714817|561113454|FG000|Year 1 Period|Participant no longer meets criteria|6|||
155462203|NCT01714817|561113455|FG001|Year 1 Period|Participant no longer meets criteria|2|||
155462204|NCT01714817|561113454|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
155462205|NCT01714817|561113455|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
155462206|NCT01714817|561113454|FG000|Year 1 Period|Change in Concomitant Medication|0|||
155462207|NCT01714817|561113455|FG001|Year 1 Period|Change in Concomitant Medication|1|||
155462208|NCT01714817|561113454|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
155462209|NCT01714817|561113455|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
155462210|NCT01714817|561113454|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
155462211|NCT01714817|561113455|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
155462212|NCT01714817|561113454|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
155462213|NCT01714817|561113455|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
155462214|NCT01714817|561113454|FG000|Year 2 Period|Lack of Efficacy|4|||
155462215|NCT01714817|561113455|FG001|Year 2 Period|Lack of Efficacy|12|||
155462216|NCT01714817|561113454|FG000|Year 2 Period|Adverse Event|7|||
155462217|NCT01714817|561113455|FG001|Year 2 Period|Adverse Event|6|||
155462218|NCT01714817|561113454|FG000|Year 2 Period|Participant request to stop treatment|4|||
155462219|NCT01714817|561113455|FG001|Year 2 Period|Participant request to stop treatment|4|||
155462220|NCT01714817|561113454|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
155462221|NCT01714817|561113455|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
155462222|NCT01714817|561113454|FG000|Year 2 Period|Participant withdrew consent|1|||
155462223|NCT01714817|561113455|FG001|Year 2 Period|Participant withdrew consent|5|||
155462224|NCT01714817|561113454|FG000|Year 2 Period|Participant no longer meets criteria|1|||
155462225|NCT01714817|561113455|FG001|Year 2 Period|Participant no longer meets criteria|4|||
155462226|NCT01714817|561113454|FG000|Year 2 Period|Lost to Follow-up|2|||
155462227|NCT01714817|561113455|FG001|Year 2 Period|Lost to Follow-up|0|||
155462228|NCT01714817|561113454|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
155516544|NCT04634409|561315878|FG025|Overall Study|Adverse Event|0|||
155516545|NCT04634409|561315879|FG026|Overall Study|Adverse Event|0|||
155516546|NCT04634409|561315853|FG000|Overall Study|Lost to Follow-up|3|||
155516547|NCT04634409|561315854|FG001|Overall Study|Lost to Follow-up|1|||
155516548|NCT04634409|561315855|FG002|Overall Study|Lost to Follow-up|1|||
155516549|NCT04634409|561315856|FG003|Overall Study|Lost to Follow-up|3|||
155516550|NCT04634409|561315857|FG004|Overall Study|Lost to Follow-up|1|||
155516551|NCT04634409|561315858|FG005|Overall Study|Lost to Follow-up|1|||
155516552|NCT04634409|561315859|FG006|Overall Study|Lost to Follow-up|1|||
155516553|NCT04634409|561315860|FG007|Overall Study|Lost to Follow-up|3|||
155516554|NCT04634409|561315861|FG008|Overall Study|Lost to Follow-up|3|||
155516555|NCT04634409|561315862|FG009|Overall Study|Lost to Follow-up|11|||
155516556|NCT04634409|561315863|FG010|Overall Study|Lost to Follow-up|8|||
155516557|NCT04634409|561315864|FG011|Overall Study|Lost to Follow-up|15|||
155516558|NCT04634409|561315865|FG012|Overall Study|Lost to Follow-up|3|||
155516559|NCT04634409|561315866|FG013|Overall Study|Lost to Follow-up|2|||
155516560|NCT04634409|561315867|FG014|Overall Study|Lost to Follow-up|7|||
155516561|NCT04634409|561315868|FG015|Overall Study|Lost to Follow-up|0|||
155516562|NCT04634409|561315869|FG016|Overall Study|Lost to Follow-up|0|||
155516563|NCT04634409|561315870|FG017|Overall Study|Lost to Follow-up|0|||
155516564|NCT04634409|561315871|FG018|Overall Study|Lost to Follow-up|0|||
155516565|NCT04634409|561315872|FG019|Overall Study|Lost to Follow-up|0|||
155516566|NCT04634409|561315873|FG020|Overall Study|Lost to Follow-up|0|||
155516567|NCT04634409|561315874|FG021|Overall Study|Lost to Follow-up|0|||
155462229|NCT01714817|561113455|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
155462230|NCT01714817|561113454|FG000|Year 2 Period|Pregnancy|1|||
155462231|NCT01714817|561113455|FG001|Year 2 Period|Pregnancy|1|||
155462232|NCT01714817|561113454|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
155462233|NCT01714817|561113455|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
155462234|NCT01714817|561113454|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
155462235|NCT01714817|561113455|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
155462236|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
155462237|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
155462238|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
155462239|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
155462240|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
155462241|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
155462242|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
155652495|NCT00289900|561820365|FG002|Overall Study|Adverse Event|13|||
155462243|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
155516568|NCT04634409|561315875|FG022|Overall Study|Lost to Follow-up|0|||
155516569|NCT04634409|561315876|FG023|Overall Study|Lost to Follow-up|0|||
155516570|NCT04634409|561315877|FG024|Overall Study|Lost to Follow-up|0|||
155516571|NCT04634409|561315878|FG025|Overall Study|Lost to Follow-up|0|||
155516572|NCT04634409|561315879|FG026|Overall Study|Lost to Follow-up|0|||
155516573|NCT04634409|561315853|FG000|Overall Study|Withdrawal by Subject|3|||
155516574|NCT04634409|561315854|FG001|Overall Study|Withdrawal by Subject|1|||
155516575|NCT04634409|561315855|FG002|Overall Study|Withdrawal by Subject|6|||
155516576|NCT04634409|561315856|FG003|Overall Study|Withdrawal by Subject|4|||
155516577|NCT04634409|561315857|FG004|Overall Study|Withdrawal by Subject|2|||
155516578|NCT04634409|561315858|FG005|Overall Study|Withdrawal by Subject|0|||
155516579|NCT04634409|561315859|FG006|Overall Study|Withdrawal by Subject|0|||
155516580|NCT04634409|561315860|FG007|Overall Study|Withdrawal by Subject|2|||
155516581|NCT04634409|561315861|FG008|Overall Study|Withdrawal by Subject|3|||
155516582|NCT04634409|561315862|FG009|Overall Study|Withdrawal by Subject|2|||
155516583|NCT04634409|561315863|FG010|Overall Study|Withdrawal by Subject|3|||
155516584|NCT04634409|561315864|FG011|Overall Study|Withdrawal by Subject|2|||
155516585|NCT04634409|561315865|FG012|Overall Study|Withdrawal by Subject|2|||
155516586|NCT04634409|561315866|FG013|Overall Study|Withdrawal by Subject|1|||
155516587|NCT04634409|561315867|FG014|Overall Study|Withdrawal by Subject|5|||
155516588|NCT04634409|561315868|FG015|Overall Study|Withdrawal by Subject|0|||
155516589|NCT04634409|561315869|FG016|Overall Study|Withdrawal by Subject|0|||
155516590|NCT04634409|561315870|FG017|Overall Study|Withdrawal by Subject|1|||
155516591|NCT04634409|561315871|FG018|Overall Study|Withdrawal by Subject|0|||
155516592|NCT04634409|561315872|FG019|Overall Study|Withdrawal by Subject|0|||
155516593|NCT04634409|561315873|FG020|Overall Study|Withdrawal by Subject|0|||
155516594|NCT04634409|561315874|FG021|Overall Study|Withdrawal by Subject|0|||
155516595|NCT04634409|561315875|FG022|Overall Study|Withdrawal by Subject|0|||
155516596|NCT04634409|561315876|FG023|Overall Study|Withdrawal by Subject|1|||
155516597|NCT04634409|561315877|FG024|Overall Study|Withdrawal by Subject|0|||
155516598|NCT04634409|561315878|FG025|Overall Study|Withdrawal by Subject|0|||
155516599|NCT04634409|561315879|FG026|Overall Study|Withdrawal by Subject|0|||
155516600|NCT04634409|561315853|FG000|Overall Study|Other - As reported by Investigator|1|||
155516601|NCT04634409|561315854|FG001|Overall Study|Other - As reported by Investigator|0|||
155516602|NCT04634409|561315855|FG002|Overall Study|Other - As reported by Investigator|0|||
155516603|NCT04634409|561315856|FG003|Overall Study|Other - As reported by Investigator|0|||
155516604|NCT04634409|561315857|FG004|Overall Study|Other - As reported by Investigator|0|||
155516605|NCT04634409|561315858|FG005|Overall Study|Other - As reported by Investigator|0|||
155516606|NCT04634409|561315859|FG006|Overall Study|Other - As reported by Investigator|0|||
155516607|NCT04634409|561315860|FG007|Overall Study|Other - As reported by Investigator|6|||
155516608|NCT04634409|561315861|FG008|Overall Study|Other - As reported by Investigator|4|||
155516609|NCT04634409|561315862|FG009|Overall Study|Other - As reported by Investigator|0|||
155516610|NCT04634409|561315863|FG010|Overall Study|Other - As reported by Investigator|1|||
155516611|NCT04634409|561315864|FG011|Overall Study|Other - As reported by Investigator|2|||
155516612|NCT04634409|561315865|FG012|Overall Study|Other - As reported by Investigator|2|||
155516613|NCT04634409|561315866|FG013|Overall Study|Other - As reported by Investigator|1|||
155516614|NCT04634409|561315867|FG014|Overall Study|Other - As reported by Investigator|0|||
155516615|NCT04634409|561315868|FG015|Overall Study|Other - As reported by Investigator|0|||
155516616|NCT04634409|561315869|FG016|Overall Study|Other - As reported by Investigator|0|||
155516617|NCT04634409|561315870|FG017|Overall Study|Other - As reported by Investigator|0|||
155516618|NCT04634409|561315871|FG018|Overall Study|Other - As reported by Investigator|0|||
155516619|NCT04634409|561315872|FG019|Overall Study|Other - As reported by Investigator|0|||
155516620|NCT04634409|561315873|FG020|Overall Study|Other - As reported by Investigator|0|||
155516621|NCT04634409|561315874|FG021|Overall Study|Other - As reported by Investigator|0|||
155462244|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
155462245|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
155462246|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
155462247|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
155462248|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155462249|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
155462250|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
155462251|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
155462252|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
155462253|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
155462254|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
155462255|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
155462256|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
155462257|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
155462258|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
155462259|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
155462260|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
155462261|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
155462262|NCT01714817|561113454|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
155462263|NCT01714817|561113455|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
155462264|NCT04169061|561113458|FG000|Overall Study|Adverse Event|2|||
155462265|NCT04169061|561113458|FG000|Overall Study|Death|1|||
155462266|NCT04169061|561113458|FG000|Overall Study|Withdrawal by Subject|1|||
155462267|NCT04169061|561113458|FG000|Overall Study|Protocol Violation|1|||
155462268|NCT02555657|561113459|FG000|Overall Study|Death|274|||
155462269|NCT02555657|561113460|FG001|Overall Study|Death|262|||
155462270|NCT02555657|561113459|FG000|Overall Study|Physician Decision|0|||
155462271|NCT02555657|561113460|FG001|Overall Study|Physician Decision|1|||
155462272|NCT02555657|561113459|FG000|Overall Study|Sponsor Decision|27|||
155462273|NCT02555657|561113460|FG001|Overall Study|Sponsor Decision|15|||
155462274|NCT02555657|561113459|FG000|Overall Study|Withdrawal by Subject|11|||
155462275|NCT02555657|561113460|FG001|Overall Study|Withdrawal by Subject|32|||
155462276|NCT02807363|561113461|FG000|Dosing Period|Adverse Event|0|||
155462277|NCT02807363|561113462|FG001|Dosing Period|Adverse Event|1|||
155462278|NCT02807363|561113463|FG002|Dosing Period|Adverse Event|0|||
155462279|NCT02807363|561113464|FG003|Dosing Period|Adverse Event|0|||
155462280|NCT02188719|561113466|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
155462281|NCT02188719|561113467|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
155462282|NCT02188719|561113468|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
155462283|NCT02188719|561113469|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
155462284|NCT01578785|561113472|FG000|Overall Study|Withdrawal by Subject|0|||
155462285|NCT01578785|561113473|FG001|Overall Study|Withdrawal by Subject|1|||
155462286|NCT01578785|561113472|FG000|Overall Study|Study terminated by sponsor|59|||
155462287|NCT01578785|561113473|FG001|Overall Study|Study terminated by sponsor|118|||
155462288|NCT00192036|561113474|FG000|Overall Study|Protocol Violation|3|||
155462289|NCT00192036|561113474|FG000|Overall Study|Adverse Event|6|||
155462290|NCT00192036|561113474|FG000|Overall Study|Patient/Physician Perception|1|||
155462291|NCT00192036|561113474|FG000|Overall Study|Objective Tumor Progression|4|||
155462292|NCT00192036|561113474|FG000|Overall Study|Clinical Disease Progression|1|||
155462293|NCT00192036|561113474|FG000|Overall Study|Death|1|||
155462294|NCT00192036|561113474|FG000|Overall Study|Unknown or Not Specified|5|||
155462295|NCT03371732|561113475|FG000|Overall Study|Withdrawal by Subject|9|||
155462296|NCT03371732|561113476|FG001|Overall Study|Withdrawal by Subject|3|||
155462297|NCT03371732|561113475|FG000|Overall Study|Refusal to continue|3|||
155462298|NCT03371732|561113476|FG001|Overall Study|Refusal to continue|4|||
155462299|NCT00599027|561113477|FG000|Overall Study|Withdrawal by Subject|1|||
155462300|NCT00599027|561113478|FG001|Overall Study|Withdrawal by Subject|1|||
155462301|NCT00599027|561113477|FG000|Overall Study|Adverse Event|0|||
155462302|NCT00599027|561113478|FG001|Overall Study|Adverse Event|1|||
155462303|NCT00599027|561113477|FG000|Overall Study|Treatment Failure|0|||
155462304|NCT00599027|561113478|FG001|Overall Study|Treatment Failure|1|||
155462305|NCT02581982|561113479|FG000|Overall Study|Lack of Efficacy|12|||
155462306|NCT02581982|561113479|FG000|Overall Study|Adverse Event|3|||
155462307|NCT02581982|561113479|FG000|Overall Study|Physician Decision|1|||
155462308|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
155462309|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
155462310|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
155462311|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
155462312|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
155462313|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
155462314|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
155462315|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
155462316|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
155462317|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
155462318|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
155462319|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
155462320|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
155462321|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
155462322|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
155462323|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
155462324|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
155462325|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
155462326|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
155462327|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
155462328|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
155462329|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
155462330|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
155462331|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
155462332|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
155462333|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
155462334|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
155462335|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
155462336|NCT00476996|561113484|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
155462337|NCT00476996|561113485|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
155462338|NCT00476996|561113486|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
155462339|NCT00476996|561113487|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
155462340|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
155462341|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
155462342|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
155462343|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
155462344|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
155462345|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
155462346|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
155462347|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
155462348|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Death|0|||
155462349|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Death|0|||
155462350|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Death|0|||
155462351|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Death|7|||
155462352|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
155462353|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
155462354|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
155462355|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
155462356|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
155462357|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
155462358|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
155462359|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
155462360|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
155462361|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
155462362|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
155462363|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
155462364|NCT00476996|561113484|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
155462365|NCT00476996|561113485|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
155462366|NCT00476996|561113486|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
155516622|NCT04634409|561315875|FG022|Overall Study|Other - As reported by Investigator|0|||
155516623|NCT04634409|561315876|FG023|Overall Study|Other - As reported by Investigator|0|||
155516624|NCT04634409|561315877|FG024|Overall Study|Other - As reported by Investigator|0|||
155516625|NCT04634409|561315878|FG025|Overall Study|Other - As reported by Investigator|0|||
155516626|NCT04634409|561315879|FG026|Overall Study|Other - As reported by Investigator|0|||
155462367|NCT00476996|561113487|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
155516627|NCT01739790|561317372|FG000|Overall Study|Early Trial Termination|2|||
155516628|NCT01739790|561317373|FG001|Overall Study|Early Trial Termination|4|||
155462368|NCT02133742|561113517|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
155462369|NCT02133742|561113517|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
155516629|NCT03471078|561317381|FG000|Overall Study|Withdrawal by Subject|9|||
155516630|NCT03471078|561317382|FG001|Overall Study|Withdrawal by Subject|1|||
155516631|NCT03471078|561317381|FG000|Overall Study|Adverse Event|4|||
155516632|NCT03471078|561317382|FG001|Overall Study|Adverse Event|1|||
155516633|NCT03471078|561317381|FG000|Overall Study|Physician Decision|3|||
155516634|NCT03471078|561317382|FG001|Overall Study|Physician Decision|2|||
155462370|NCT02133742|561113517|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
155462371|NCT02133742|561113517|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
155462372|NCT02133742|561113517|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
155462373|NCT03479216|561113518|FG000|Overall Study|Withdrawal by Subject|3|||
155462374|NCT03479216|561113519|FG001|Overall Study|Withdrawal by Subject|2|||
155462375|NCT03479216|561113518|FG000|Overall Study|Physician Decision|2|||
155462376|NCT03479216|561113519|FG001|Overall Study|Physician Decision|3|||
155462377|NCT05406440|561115360|FG000|Overall Study|Lost to Follow-up|0|||
155462378|NCT05406440|561115361|FG001|Overall Study|Lost to Follow-up|0|||
155462379|NCT05406440|561115362|FG002|Overall Study|Lost to Follow-up|0|||
155462380|NCT05406440|561115363|FG003|Overall Study|Lost to Follow-up|0|||
155462381|NCT05406440|561115364|FG004|Overall Study|Lost to Follow-up|2|||
155462382|NCT05406440|561115365|FG005|Overall Study|Lost to Follow-up|0|||
155462383|NCT05406440|561115366|FG006|Overall Study|Lost to Follow-up|0|||
155462384|NCT05406440|561115360|FG000|Overall Study|Physician Decision|0|||
155462385|NCT05406440|561115361|FG001|Overall Study|Physician Decision|0|||
155462386|NCT05406440|561115362|FG002|Overall Study|Physician Decision|0|||
155462387|NCT05406440|561115363|FG003|Overall Study|Physician Decision|0|||
155462388|NCT05406440|561115364|FG004|Overall Study|Physician Decision|1|||
155462389|NCT05406440|561115365|FG005|Overall Study|Physician Decision|0|||
155462390|NCT05406440|561115366|FG006|Overall Study|Physician Decision|0|||
155516635|NCT03471078|561317381|FG000|Overall Study|Death|2|||
155516636|NCT03471078|561317382|FG001|Overall Study|Death|0|||
155516637|NCT03471078|561317381|FG000|Overall Study|Other|3|||
155516638|NCT03471078|561317382|FG001|Overall Study|Other|2|||
155516639|NCT05568225|561317388|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
155516640|NCT05568225|561317389|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
155516641|NCT05568225|561317390|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
155516642|NCT05568225|561317388|FG000|Primary Treatment Period|Physician Decision|0|||
155516643|NCT05568225|561317389|FG001|Primary Treatment Period|Physician Decision|1|||
155516644|NCT05568225|561317390|FG002|Primary Treatment Period|Physician Decision|0|||
155516645|NCT05568225|561317388|FG000|Primary Treatment Period|Disease progression|0|||
155516646|NCT05568225|561317389|FG001|Primary Treatment Period|Disease progression|1|||
155516647|NCT05568225|561317390|FG002|Primary Treatment Period|Disease progression|0|||
155516648|NCT05568225|561317388|FG000|Primary Treatment Period|Lack of Efficacy|0|||
155516649|NCT05568225|561317389|FG001|Primary Treatment Period|Lack of Efficacy|1|||
155516650|NCT05568225|561317390|FG002|Primary Treatment Period|Lack of Efficacy|0|||
155516651|NCT05568225|561317388|FG000|Primary Treatment Period|Withdrawal of conset|1|||
155516652|NCT05568225|561317389|FG001|Primary Treatment Period|Withdrawal of conset|0|||
155516653|NCT05568225|561317390|FG002|Primary Treatment Period|Withdrawal of conset|4|||
155516654|NCT05568225|561317388|FG000|Primary Treatment Period|Adverse Event|1|||
155516655|NCT05568225|561317389|FG001|Primary Treatment Period|Adverse Event|0|||
155516656|NCT05568225|561317390|FG002|Primary Treatment Period|Adverse Event|0|||
155516657|NCT05568225|561317388|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
155516658|NCT05568225|561317389|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
155516659|NCT05568225|561317390|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
155516660|NCT05568225|561317388|FG000|Extension Treatment Period|Protocol Violation|0|||
155516661|NCT05568225|561317389|FG001|Extension Treatment Period|Protocol Violation|0|||
155516662|NCT05568225|561317390|FG002|Extension Treatment Period|Protocol Violation|1|||
155516663|NCT05568225|561317388|FG000|Extension Treatment Period|Lack of Efficacy|0|||
155516664|NCT05568225|561317389|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155516665|NCT05568225|561317390|FG002|Extension Treatment Period|Lack of Efficacy|1|||
155516666|NCT05456529|561317393|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
155516667|NCT05456529|561317393|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
155516668|NCT05456529|561317393|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
155516669|NCT05456529|561317393|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
155516670|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
155516671|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
155516672|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Physician Decision|2|||
155516673|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
155516674|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
155516675|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
155516676|NCT05456529|561317393|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
155516677|NCT00576381|561317400|FG000|Overall Study|Reoperation|3|||
155516678|NCT00576381|561317400|FG000|Overall Study|Adverse Event|4|||
155516679|NCT00797108|561317401|FG000|Overall Study|Adverse Event|1|||
155516680|NCT00797108|561317402|FG001|Overall Study|Adverse Event|0|||
155516681|NCT00797108|561317403|FG002|Overall Study|Adverse Event|3|||
155462391|NCT05406440|561115360|FG000|Overall Study|Withdrawal by Subject|0|||
155462392|NCT05406440|561115361|FG001|Overall Study|Withdrawal by Subject|0|||
155462393|NCT05406440|561115362|FG002|Overall Study|Withdrawal by Subject|0|||
155462394|NCT05406440|561115363|FG003|Overall Study|Withdrawal by Subject|0|||
155462395|NCT05406440|561115364|FG004|Overall Study|Withdrawal by Subject|0|||
155462396|NCT05406440|561115365|FG005|Overall Study|Withdrawal by Subject|2|||
155462397|NCT05406440|561115366|FG006|Overall Study|Withdrawal by Subject|0|||
155462398|NCT01412151|561115367|FG000|Week 0 - 306 - Treatment Period|Death|1|||
155462399|NCT01412151|561115367|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
155462400|NCT01412151|561115367|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
155462401|NCT01412151|561115367|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
155462402|NCT03127852|561115368|FG000|Overall Study|Withdrawal by Subject|4|||
155462403|NCT03127852|561115369|FG001|Overall Study|Withdrawal by Subject|1|||
155462404|NCT03127852|561115368|FG000|Overall Study|Death|1|||
155462405|NCT03127852|561115369|FG001|Overall Study|Death|1|||
155462406|NCT01824693|561115370|FG000|Overall Study|Death|0|||
155462407|NCT01824693|561115371|FG001|Overall Study|Death|1|||
155462408|NCT01824693|561115372|FG002|Overall Study|Death|0|||
155462409|NCT01824693|561115370|FG000|Overall Study|Physician Decision|1|||
155462410|NCT01824693|561115371|FG001|Overall Study|Physician Decision|1|||
155462411|NCT01824693|561115372|FG002|Overall Study|Physician Decision|1|||
155462412|NCT01824693|561115370|FG000|Overall Study|Withdrawal by Subject|0|||
155462413|NCT01824693|561115371|FG001|Overall Study|Withdrawal by Subject|0|||
155462414|NCT01824693|561115372|FG002|Overall Study|Withdrawal by Subject|1|||
155462415|NCT01824693|561115370|FG000|Overall Study|Progressive Disease|0|||
155462416|NCT01824693|561115371|FG001|Overall Study|Progressive Disease|5|||
155462417|NCT01824693|561115372|FG002|Overall Study|Progressive Disease|0|||
155462418|NCT01824693|561115370|FG000|Overall Study|Ineligible|0|||
155462419|NCT01824693|561115371|FG001|Overall Study|Ineligible|0|||
155462420|NCT01824693|561115372|FG002|Overall Study|Ineligible|3|||
155462421|NCT01824693|561115370|FG000|Overall Study|No Transplant Planned|0|||
155462422|NCT01824693|561115371|FG001|Overall Study|No Transplant Planned|0|||
155462423|NCT01824693|561115372|FG002|Overall Study|No Transplant Planned|10|||
155462424|NCT02150213|561115373|FG000|Overall Study|Lost to Follow-up|1|||
155462425|NCT02150213|561115373|FG000|Overall Study|Withdrawal by Subject|1|||
155462426|NCT01175590|561115374|FG000|Overall Study|Lost to Follow-up|1|||
155462427|NCT01175590|561115375|FG001|Overall Study|Lost to Follow-up|0|||
155462428|NCT01175590|561115374|FG000|Overall Study|Withdrawal by Subject|0|||
155462429|NCT01175590|561115375|FG001|Overall Study|Withdrawal by Subject|2|||
155462430|NCT01175590|561115374|FG000|Overall Study|Adverse Event|4|||
155462431|NCT01175590|561115375|FG001|Overall Study|Adverse Event|0|||
155462432|NCT01175590|561115374|FG000|Overall Study|Physician Decision|1|||
155462433|NCT01175590|561115375|FG001|Overall Study|Physician Decision|4|||
155462434|NCT01175590|561115374|FG000|Overall Study|Lack of Efficacy|1|||
155462435|NCT01175590|561115375|FG001|Overall Study|Lack of Efficacy|1|||
155462436|NCT01175590|561115374|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
155462437|NCT01175590|561115375|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
155462438|NCT01175590|561115374|FG000|Overall Study|Treated not as randomized|3|||
155462439|NCT01175590|561115375|FG001|Overall Study|Treated not as randomized|2|||
155462440|NCT01175590|561115374|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
155462441|NCT01175590|561115375|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
155462442|NCT01175590|561115374|FG000|Overall Study|Protocol Violation|0|||
155462443|NCT01175590|561115375|FG001|Overall Study|Protocol Violation|1|||
155462444|NCT01090102|561115376|FG000|First 12 Weeks|Withdrawal by Subject|1|||
155462445|NCT01090102|561115377|FG001|First 12 Weeks|Withdrawal by Subject|1|||
155462446|NCT01090102|561115376|FG000|First 12 Weeks|Adverse Event|2|||
155462447|NCT01090102|561115377|FG001|First 12 Weeks|Adverse Event|0|||
155462448|NCT01090102|561115376|FG000|First 12 Weeks|Death|1|||
155462449|NCT01090102|561115377|FG001|First 12 Weeks|Death|1|||
155462450|NCT01090102|561115376|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
155462451|NCT01090102|561115377|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
155462452|NCT01019252|561115378|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
155462453|NCT01019252|561115379|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
155462454|NCT01019252|561115378|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
155462455|NCT01019252|561115379|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
155462456|NCT01019252|561115378|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
155462457|NCT01019252|561115379|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
155462458|NCT01019252|561115378|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
155462459|NCT01019252|561115379|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
155462460|NCT02062398|561115381|FG000|Overall Study|Implant removal|1|||
155462461|NCT02227849|561115386|FG000|Overall Study|Adverse Event|4|||
155462462|NCT02227849|561115386|FG000|Overall Study|Physician Decision|1|||
155462463|NCT02227849|561115386|FG000|Overall Study|Withdrawal by Subject|3|||
155462464|NCT00762268|561115388|FG000|Overall Study|Withdrawal by Subject|3|||
155462465|NCT00762268|561115389|FG001|Overall Study|Withdrawal by Subject|3|||
155462466|NCT03004976|561115390|FG000|Overall Study|Lost to Follow-up|7|||
155462467|NCT03004976|561115391|FG001|Overall Study|Lost to Follow-up|5|||
155462468|NCT03004976|561115390|FG000|Overall Study|Physician Decision|1|||
155462469|NCT03004976|561115391|FG001|Overall Study|Physician Decision|0|||
155462470|NCT03004976|561115390|FG000|Overall Study|Withdrawal by Subject|1|||
155462471|NCT03004976|561115391|FG001|Overall Study|Withdrawal by Subject|0|||
155462472|NCT03004976|561115390|FG000|Overall Study|Death|4|||
155462473|NCT03004976|561115391|FG001|Overall Study|Death|1|||
155462474|NCT01106391|561115392|FG000|Overall Study|Death|12|||
155462475|NCT01106391|561115392|FG000|Overall Study|Withdrawal by Subject|7|||
155462476|NCT04190186|561115393|FG000|Overall Study|ILR is no longer functioning|0|||
155462477|NCT04190186|561115394|FG001|Overall Study|ILR is no longer functioning|1|||
155462478|NCT04190186|561115393|FG000|Overall Study|Lost to Follow-up|0|||
155462479|NCT04190186|561115394|FG001|Overall Study|Lost to Follow-up|1|||
155462480|NCT04190186|561115393|FG000|Overall Study|Withdrawal by Subject|2|||
155462481|NCT04190186|561115394|FG001|Overall Study|Withdrawal by Subject|0|||
155462482|NCT04190186|561115393|FG000|Overall Study|Subject choice to explant|1|||
155462483|NCT04190186|561115394|FG001|Overall Study|Subject choice to explant|0|||
155462484|NCT04190186|561115393|FG000|Overall Study|Physician Decision|0|||
155462485|NCT04190186|561115394|FG001|Overall Study|Physician Decision|1|||
155462486|NCT04190186|561115393|FG000|Overall Study|Study was stopped|4|||
155462487|NCT04190186|561115394|FG001|Overall Study|Study was stopped|5|||
155462488|NCT02141217|561115395|FG000|Overall Study|Adverse Event|1|||
155462489|NCT02141217|561115396|FG001|Overall Study|Adverse Event|2|||
155462490|NCT02141217|561115395|FG000|Overall Study|Protocol Violation|1|||
155462491|NCT02141217|561115396|FG001|Overall Study|Protocol Violation|4|||
155462492|NCT02141217|561115395|FG000|Overall Study|Withdrawal by Subject|6|||
155462493|NCT02141217|561115396|FG001|Overall Study|Withdrawal by Subject|0|||
155462494|NCT02141217|561115395|FG000|Overall Study|Lost to Follow-up|1|||
155462495|NCT02141217|561115396|FG001|Overall Study|Lost to Follow-up|1|||
155462496|NCT02141217|561115395|FG000|Overall Study|Physician Decision|1|||
155462497|NCT02141217|561115396|FG001|Overall Study|Physician Decision|0|||
155462498|NCT02141217|561115395|FG000|Overall Study|Surgical Intervention|1|||
155462499|NCT02141217|561115396|FG001|Overall Study|Surgical Intervention|1|||
155462500|NCT02505542|561115397|FG000|Part A: Open-Label Period|Adverse Event|31|||
155462501|NCT02505542|561115398|FG001|Part A: Open-Label Period|Adverse Event|0|||
155462502|NCT02505542|561115399|FG002|Part A: Open-Label Period|Adverse Event|0|||
155462503|NCT02505542|561115400|FG003|Part A: Open-Label Period|Adverse Event|0|||
155462504|NCT02505542|561115397|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
155462505|NCT02505542|561115398|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
155516682|NCT00797108|561317401|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
155516683|NCT00797108|561317402|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
155516684|NCT00797108|561317403|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
155516685|NCT00797108|561317401|FG000|Overall Study|Global Deterioration of Health Status|0|||
155516686|NCT00797108|561317402|FG001|Overall Study|Global Deterioration of Health Status|1|||
155516687|NCT00797108|561317403|FG002|Overall Study|Global Deterioration of Health Status|0|||
155516688|NCT00797108|561317401|FG000|Overall Study|Lack of Efficacy|1|||
155462506|NCT02505542|561115399|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
155462507|NCT02505542|561115400|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
155462508|NCT02505542|561115397|FG000|Part A: Open-Label Period|Protocol Violation|1|||
155462509|NCT02505542|561115398|FG001|Part A: Open-Label Period|Protocol Violation|0|||
155462510|NCT02505542|561115399|FG002|Part A: Open-Label Period|Protocol Violation|0|||
155462511|NCT02505542|561115400|FG003|Part A: Open-Label Period|Protocol Violation|0|||
155462512|NCT02505542|561115397|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
155462513|NCT02505542|561115398|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
155462514|NCT02505542|561115399|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
155462515|NCT02505542|561115400|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
155462516|NCT02505542|561115397|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
155462517|NCT02505542|561115398|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
155462518|NCT02505542|561115399|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
155462519|NCT02505542|561115400|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
155462520|NCT02505542|561115397|FG000|Part A: Open-Label Period|New medical history available|1|||
155462521|NCT02505542|561115398|FG001|Part A: Open-Label Period|New medical history available|0|||
155462522|NCT02505542|561115399|FG002|Part A: Open-Label Period|New medical history available|0|||
155462523|NCT02505542|561115400|FG003|Part A: Open-Label Period|New medical history available|0|||
155462524|NCT02505542|561115397|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
155462525|NCT02505542|561115398|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
155462526|NCT02505542|561115399|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
155462527|NCT02505542|561115400|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
155462528|NCT02505542|561115397|FG000|Part A: Open-Label Period|Pregnancy|2|||
155462529|NCT02505542|561115398|FG001|Part A: Open-Label Period|Pregnancy|0|||
155462530|NCT02505542|561115399|FG002|Part A: Open-Label Period|Pregnancy|0|||
155462531|NCT02505542|561115400|FG003|Part A: Open-Label Period|Pregnancy|0|||
155462532|NCT02505542|561115397|FG000|Part A: Open-Label Period|Sponsor directive|1|||
155462533|NCT02505542|561115398|FG001|Part A: Open-Label Period|Sponsor directive|0|||
155462534|NCT02505542|561115399|FG002|Part A: Open-Label Period|Sponsor directive|0|||
155462535|NCT02505542|561115400|FG003|Part A: Open-Label Period|Sponsor directive|0|||
155462536|NCT02505542|561115397|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
155462537|NCT02505542|561115398|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
155462538|NCT02505542|561115399|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
155462539|NCT02505542|561115400|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
155462540|NCT02505542|561115397|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
155462541|NCT02505542|561115398|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
155462542|NCT02505542|561115399|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
155462543|NCT02505542|561115400|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
155462544|NCT02505542|561115397|FG000|Part A: Open-Label Period|Non-compliance|1|||
155462545|NCT02505542|561115398|FG001|Part A: Open-Label Period|Non-compliance|0|||
155462546|NCT02505542|561115399|FG002|Part A: Open-Label Period|Non-compliance|0|||
155462547|NCT02505542|561115400|FG003|Part A: Open-Label Period|Non-compliance|0|||
155462548|NCT02505542|561115397|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
155462549|NCT02505542|561115398|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
155462550|NCT02505542|561115399|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
155462551|NCT02505542|561115400|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
155462552|NCT02505542|561115397|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
155462553|NCT02505542|561115398|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
155462554|NCT02505542|561115399|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
155462555|NCT02505542|561115400|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
155462556|NCT02505542|561115397|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
155462557|NCT02505542|561115398|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
155462558|NCT02505542|561115399|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
155462559|NCT02505542|561115400|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
155462560|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Adverse Event|0|||
155462561|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Adverse Event|0|||
155462562|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Adverse Event|1|||
155462563|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Adverse Event|3|||
155462564|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
155462565|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
155462566|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
155462567|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
155462568|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
155462569|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
155462570|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
155462571|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
155462572|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
155516689|NCT00797108|561317402|FG001|Overall Study|Lack of Efficacy|0|||
155516690|NCT00797108|561317403|FG002|Overall Study|Lack of Efficacy|1|||
155516691|NCT00797108|561317401|FG000|Overall Study|Other|0|||
155516692|NCT00797108|561317402|FG001|Overall Study|Other|0|||
155516693|NCT00797108|561317403|FG002|Overall Study|Other|2|||
155516694|NCT00797108|561317401|FG000|Overall Study|Randomized but not Treated|2|||
155516695|NCT00797108|561317402|FG001|Overall Study|Randomized but not Treated|0|||
155462573|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
155462574|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
155462575|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
155462576|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
155462577|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
155462578|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
155462579|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
155462580|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
155462581|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
155462582|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
155462583|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
155462584|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
155462585|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
155462586|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
155462587|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
155462588|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Miscalculation|0|||
155462589|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Miscalculation|1|||
155462590|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Miscalculation|0|||
155462591|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Miscalculation|0|||
155462592|NCT02505542|561115397|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
155462593|NCT02505542|561115398|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
155462594|NCT02505542|561115399|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
155462595|NCT02505542|561115400|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
155462596|NCT00618995|561115403|FG000|Period 1|Adverse Event|0|||
155462597|NCT00618995|561115404|FG001|Period 1|Adverse Event|0|||
155462598|NCT00618995|561115405|FG002|Period 1|Adverse Event|1|||
155462599|NCT00618995|561115406|FG003|Period 1|Adverse Event|0|||
155462600|NCT00618995|561115403|FG000|Period 1|Protocol Violation|0|||
155462601|NCT00618995|561115404|FG001|Period 1|Protocol Violation|1|||
155462602|NCT00618995|561115405|FG002|Period 1|Protocol Violation|1|||
155462603|NCT00618995|561115406|FG003|Period 1|Protocol Violation|0|||
155462604|NCT00618995|561115403|FG000|Period 2|Protocol Violation|0|||
155462605|NCT00618995|561115404|FG001|Period 2|Protocol Violation|0|||
155462606|NCT00618995|561115405|FG002|Period 2|Protocol Violation|1|||
155462607|NCT00618995|561115406|FG003|Period 2|Protocol Violation|0|||
155462608|NCT00618995|561115403|FG000|Period 4|Adverse Event|1|||
155462609|NCT00618995|561115404|FG001|Period 4|Adverse Event|0|||
155462610|NCT00618995|561115405|FG002|Period 4|Adverse Event|0|||
155462611|NCT00618995|561115406|FG003|Period 4|Adverse Event|0|||
155462612|NCT01213264|561115407|FG000|Overall Study|Adverse Event|1|||
155462613|NCT01213264|561115408|FG001|Overall Study|Adverse Event|0|||
155462614|NCT01213264|561115409|FG002|Overall Study|Adverse Event|0|||
155462615|NCT01213264|561115407|FG000|Overall Study|Lost to Follow-up|1|||
155462616|NCT01213264|561115408|FG001|Overall Study|Lost to Follow-up|2|||
155462617|NCT01213264|561115409|FG002|Overall Study|Lost to Follow-up|6|||
155462618|NCT01504971|561115411|FG000|Overall Study|Physician Decision|13|||
155462619|NCT00050622|561115412|FG000|Overall Study|Adverse Event|1|||
155462620|NCT00936117|561115415|FG000|Overall Study|Adverse Event|7|||
155462621|NCT00936117|561115415|FG000|Overall Study|Unable to continue oral medication|3|||
155462622|NCT01342952|561115416|FG000|Overall Study|Adverse Event|0|||
155462623|NCT01342952|561115417|FG001|Overall Study|Adverse Event|5|||
155462624|NCT01342952|561115418|FG002|Overall Study|Adverse Event|1|||
155462625|NCT01342952|561115419|FG003|Overall Study|Adverse Event|0|||
155462626|NCT01342952|561115416|FG000|Overall Study|Lost to Follow-up|0|||
155462627|NCT01342952|561115417|FG001|Overall Study|Lost to Follow-up|2|||
155462628|NCT01342952|561115418|FG002|Overall Study|Lost to Follow-up|0|||
155462629|NCT01342952|561115419|FG003|Overall Study|Lost to Follow-up|0|||
155462630|NCT01342952|561115416|FG000|Overall Study|Withdrawal by Subject|1|||
155462631|NCT01342952|561115417|FG001|Overall Study|Withdrawal by Subject|1|||
155462632|NCT01342952|561115418|FG002|Overall Study|Withdrawal by Subject|0|||
155462633|NCT01342952|561115419|FG003|Overall Study|Withdrawal by Subject|0|||
155462634|NCT01342952|561115416|FG000|Overall Study|Physician Decision|3|||
155462635|NCT01342952|561115417|FG001|Overall Study|Physician Decision|3|||
155462636|NCT01342952|561115418|FG002|Overall Study|Physician Decision|1|||
155462637|NCT01342952|561115419|FG003|Overall Study|Physician Decision|0|||
155462638|NCT04581863|561115420|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
155462639|NCT04581863|561115421|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
155462640|NCT01357889|561115425|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
155462641|NCT01357889|561115426|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
155462642|NCT01357889|561115425|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
155462643|NCT01357889|561115426|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
155462644|NCT01357889|561115425|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
155462645|NCT01357889|561115426|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
155462646|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
155462647|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
155462648|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
155462649|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
155462650|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
155462651|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
155462652|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
155462653|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
155462654|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
155462655|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
155462656|NCT01357889|561115425|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
155462657|NCT01357889|561115426|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
155462658|NCT01357889|561115425|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
155462659|NCT01357889|561115426|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
155462660|NCT01357889|561115425|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
155462661|NCT01357889|561115426|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
155462662|NCT01357889|561115425|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
155462663|NCT01357889|561115426|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
155462664|NCT01357889|561115425|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
155462665|NCT01357889|561115426|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
155462666|NCT02693691|561115427|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
155462667|NCT02693691|561115427|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
155462668|NCT02693691|561115427|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
155462669|NCT02693691|561115427|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
155462670|NCT02693691|561115427|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
155462671|NCT02693691|561115427|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
155462672|NCT02693691|561115427|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
155462673|NCT00416312|561115429|FG000|Overall Study|tumors not visible on imaging|2|||
155462674|NCT02727660|561115430|FG000|Overall Study|Lack of Efficacy|40|||
155462675|NCT02727660|561115431|FG001|Overall Study|Lack of Efficacy|40|||
155462676|NCT02727660|561115432|FG002|Overall Study|Lack of Efficacy|70|||
155462677|NCT02727660|561115430|FG000|Overall Study|Adverse Event|28|||
155462678|NCT02727660|561115431|FG001|Overall Study|Adverse Event|21|||
155462679|NCT02727660|561115432|FG002|Overall Study|Adverse Event|32|||
155462680|NCT02727660|561115430|FG000|Overall Study|Withdrawal by Subject|26|||
155462681|NCT02727660|561115431|FG001|Overall Study|Withdrawal by Subject|25|||
155462682|NCT02727660|561115432|FG002|Overall Study|Withdrawal by Subject|30|||
155462683|NCT02727660|561115430|FG000|Overall Study|Physician Decision|3|||
155462684|NCT02727660|561115431|FG001|Overall Study|Physician Decision|8|||
155462685|NCT02727660|561115432|FG002|Overall Study|Physician Decision|14|||
155462686|NCT02727660|561115430|FG000|Overall Study|Lost to Follow-up|5|||
155462687|NCT02727660|561115431|FG001|Overall Study|Lost to Follow-up|9|||
155462688|NCT02727660|561115432|FG002|Overall Study|Lost to Follow-up|8|||
155462689|NCT02727660|561115430|FG000|Overall Study|Protocol Violation|7|||
155462690|NCT02727660|561115431|FG001|Overall Study|Protocol Violation|5|||
155462691|NCT02727660|561115432|FG002|Overall Study|Protocol Violation|5|||
155462692|NCT02727660|561115430|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
155462693|NCT02727660|561115431|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
155462694|NCT02727660|561115432|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
155462695|NCT02727660|561115430|FG000|Overall Study|Administrative Reasons|2|||
155462696|NCT02727660|561115431|FG001|Overall Study|Administrative Reasons|3|||
155462697|NCT02727660|561115432|FG002|Overall Study|Administrative Reasons|4|||
155462698|NCT01192204|561115435|FG000|Overall Study|could not keep recall appointments|1|||
155462699|NCT01192204|561115436|FG001|Overall Study|could not keep recall appointments|0|||
155462700|NCT03571256|561115437|FG000|Overall Study|Adverse Event|3|||
155462701|NCT03571256|561115438|FG001|Overall Study|Adverse Event|0|||
155462702|NCT03571256|561115439|FG002|Overall Study|Adverse Event|1|||
155462703|NCT03571256|561115437|FG000|Overall Study|Withdrawal by Subject|3|||
155462704|NCT03571256|561115438|FG001|Overall Study|Withdrawal by Subject|1|||
155462705|NCT03571256|561115439|FG002|Overall Study|Withdrawal by Subject|1|||
155462706|NCT03571256|561115437|FG000|Overall Study|Other than specified|0|||
155462707|NCT03571256|561115438|FG001|Overall Study|Other than specified|1|||
155462708|NCT03571256|561115439|FG002|Overall Study|Other than specified|1|||
155462709|NCT03571256|561115437|FG000|Overall Study|Protocol Violation|0|||
155462710|NCT03571256|561115438|FG001|Overall Study|Protocol Violation|1|||
155462711|NCT03571256|561115439|FG002|Overall Study|Protocol Violation|1|||
155462712|NCT02270684|561115442|FG000|Overall Study|Lost to Follow-up|0|||
155462713|NCT02270684|561115443|FG001|Overall Study|Lost to Follow-up|3|||
155462714|NCT02270684|561115442|FG000|Overall Study|Study terminated|1|||
155462715|NCT02270684|561115443|FG001|Overall Study|Study terminated|0|||
155462716|NCT02247401|561115446|FG000|Overall Study|Adverse Event|1|||
155462717|NCT02247401|561115447|FG001|Overall Study|Adverse Event|0|||
155462718|NCT02247401|561115448|FG002|Overall Study|Adverse Event|0|||
155516696|NCT00797108|561317403|FG002|Overall Study|Randomized but not Treated|0|||
155516697|NCT02518113|561317404|FG000|Overall Study|Adverse Event|1|||
155516698|NCT02518113|561317405|FG001|Overall Study|Adverse Event|0|||
155462719|NCT02247401|561115446|FG000|Overall Study|Withdrawal by Subject|4|||
155462720|NCT02247401|561115447|FG001|Overall Study|Withdrawal by Subject|1|||
155462721|NCT02247401|561115448|FG002|Overall Study|Withdrawal by Subject|1|||
155462722|NCT02247401|561115446|FG000|Overall Study|Lost to Follow-up|1|||
155462723|NCT02247401|561115447|FG001|Overall Study|Lost to Follow-up|1|||
155462724|NCT02247401|561115448|FG002|Overall Study|Lost to Follow-up|1|||
155462725|NCT01374217|561115449|FG000|Overall Study|Lack of Efficacy|13|||
155462726|NCT03695393|561115453|FG000|Overall Study|Death|3|||
155462727|NCT03695393|561115454|FG001|Overall Study|Death|1|||
155462728|NCT03695393|561115453|FG000|Overall Study|Lost to Follow-up|0|||
155462729|NCT03695393|561115454|FG001|Overall Study|Lost to Follow-up|1|||
155462730|NCT04585451|561115455|FG000|Overall Study|Withdrawal by Subject|26|||
155462731|NCT04585451|561115456|FG001|Overall Study|Withdrawal by Subject|0|||
155462732|NCT00966693|561115457|FG000|Overall Study|Adverse Event|0|||
155462733|NCT00966693|561115458|FG001|Overall Study|Adverse Event|0|||
155462734|NCT00966693|561115459|FG002|Overall Study|Adverse Event|1|||
155462735|NCT00966693|561115460|FG003|Overall Study|Adverse Event|2|||
155462736|NCT00966693|561115457|FG000|Overall Study|Death|0|||
155462737|NCT00966693|561115458|FG001|Overall Study|Death|0|||
155462738|NCT00966693|561115459|FG002|Overall Study|Death|1|||
155462739|NCT00966693|561115460|FG003|Overall Study|Death|0|||
155462740|NCT00966693|561115457|FG000|Overall Study|Withdrawal by Subject|1|||
155462741|NCT00966693|561115458|FG001|Overall Study|Withdrawal by Subject|0|||
155462742|NCT00966693|561115459|FG002|Overall Study|Withdrawal by Subject|0|||
155462743|NCT00966693|561115460|FG003|Overall Study|Withdrawal by Subject|5|||
155462744|NCT00966693|561115457|FG000|Overall Study|Disease Progression|0|||
155462745|NCT00966693|561115458|FG001|Overall Study|Disease Progression|0|||
155462746|NCT00966693|561115459|FG002|Overall Study|Disease Progression|1|||
155462747|NCT00966693|561115460|FG003|Overall Study|Disease Progression|16|||
155462748|NCT00405821|561115463|FG000|Overall Study|Death|5|||
155462749|NCT00405821|561115464|FG001|Overall Study|Death|7|||
155462750|NCT00405821|561115463|FG000|Overall Study|Lost to Follow-up|7|||
155462751|NCT00405821|561115464|FG001|Overall Study|Lost to Follow-up|7|||
155462752|NCT00405821|561115463|FG000|Overall Study|Protocol Violation|1|||
155462753|NCT00405821|561115464|FG001|Overall Study|Protocol Violation|0|||
155462754|NCT00405821|561115463|FG000|Overall Study|initiated ART|9|||
155462755|NCT00405821|561115464|FG001|Overall Study|initiated ART|8|||
155462756|NCT01769469|561115466|FG000|Overall Study|Consent Withdrawn|5|||
155462757|NCT01769469|561115466|FG000|Overall Study|Moved Out Of Area|3|||
155462758|NCT01769469|561115466|FG000|Overall Study|Lost to Follow-up|17|||
155462759|NCT01769469|561115466|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
155462760|NCT01769469|561115466|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
155462761|NCT02031432|561115469|FG000|Overall Study|Protocol Violation|1|||
155462762|NCT02031432|561115469|FG000|Overall Study|Lack of Efficacy|5|||
155462763|NCT02031432|561115469|FG000|Overall Study|Cancer Progression|2|||
155462764|NCT02031432|561115469|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
155462765|NCT02031432|561115469|FG000|Overall Study|Adverse Event|8|||
155462766|NCT02031432|561115469|FG000|Overall Study|Withdrawal by Subject|5|||
155462767|NCT02031432|561115469|FG000|Overall Study|Lost to Follow-up|1|||
155462768|NCT02031432|561115469|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
155462769|NCT02031432|561115469|FG000|Overall Study|Death|10|||
155516699|NCT02518113|561317406|FG002|Overall Study|Adverse Event|1|||
155462770|NCT02148211|561115470|FG000|Overall Study|Lost to Follow-up|352|||
155462771|NCT01617187|561115472|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
155462772|NCT01617187|561115473|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
155462773|NCT01617187|561115474|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
155462774|NCT01617187|561115475|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
155462775|NCT01617187|561115472|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
155462776|NCT01617187|561115473|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
155462777|NCT01617187|561115474|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
155462778|NCT01617187|561115475|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
155462779|NCT01617187|561115472|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
155462780|NCT01617187|561115473|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
155462781|NCT01617187|561115474|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
155462782|NCT01617187|561115475|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
155462783|NCT01617187|561115472|FG000|Treatment Through Study Completion|Adverse Event|1|||
155462784|NCT01617187|561115473|FG001|Treatment Through Study Completion|Adverse Event|1|||
155462785|NCT01617187|561115474|FG002|Treatment Through Study Completion|Adverse Event|0|||
155462786|NCT01617187|561115475|FG003|Treatment Through Study Completion|Adverse Event|1|||
155462787|NCT01617187|561115472|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
155462788|NCT01617187|561115473|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
155462789|NCT01617187|561115474|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
155462790|NCT01617187|561115475|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
155462791|NCT01617187|561115472|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
155462792|NCT01617187|561115473|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
155462793|NCT01617187|561115474|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
155462794|NCT01617187|561115475|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
155462795|NCT01617187|561115472|FG000|Treatment Through Study Completion|Protocol Violation|1|||
155462796|NCT01617187|561115473|FG001|Treatment Through Study Completion|Protocol Violation|0|||
155462797|NCT01617187|561115474|FG002|Treatment Through Study Completion|Protocol Violation|0|||
155462798|NCT01617187|561115475|FG003|Treatment Through Study Completion|Protocol Violation|1|||
155516700|NCT02518113|561317407|FG003|Overall Study|Adverse Event|0|||
155516701|NCT02518113|561317404|FG000|Overall Study|Death|1|||
155516702|NCT02518113|561317405|FG001|Overall Study|Death|2|||
155516703|NCT02518113|561317406|FG002|Overall Study|Death|0|||
155516704|NCT02518113|561317407|FG003|Overall Study|Death|0|||
155516705|NCT02518113|561317404|FG000|Overall Study|Physician Decision|0|||
155462799|NCT01265420|561115477|FG000|Overall Study|Lost to Follow-up|1|||
155462800|NCT03337139|561115480|FG000|Phase I|Withdrawal by Subject|10|||
155516706|NCT02518113|561317405|FG001|Overall Study|Physician Decision|1|||
155516707|NCT02518113|561317406|FG002|Overall Study|Physician Decision|0|||
155516708|NCT02518113|561317407|FG003|Overall Study|Physician Decision|0|||
155516709|NCT02518113|561317404|FG000|Overall Study|Progressive Disease|1|||
155516710|NCT02518113|561317405|FG001|Overall Study|Progressive Disease|2|||
155516711|NCT02518113|561317406|FG002|Overall Study|Progressive Disease|3|||
155516712|NCT02518113|561317407|FG003|Overall Study|Progressive Disease|0|||
155516713|NCT00287118|561317408|FG000|Overall Study|Adverse Event|30|||
155516714|NCT00287118|561317408|FG000|Overall Study|Death|1|||
155516715|NCT00287118|561317408|FG000|Overall Study|Lack of Efficacy|11|||
155516716|NCT00287118|561317408|FG000|Overall Study|Lost to Follow-up|1|||
155516717|NCT00287118|561317408|FG000|Overall Study|Protocol Violation|2|||
155516718|NCT00287118|561317408|FG000|Overall Study|Other|7|||
155516719|NCT02324465|561317409|FG000|Overall Study|device failure|0|||
155516720|NCT02324465|561317410|FG001|Overall Study|device failure|1|||
155516721|NCT00419926|561317411|FG000|Overall Study|Withdrawal by Subject|7|||
155516722|NCT00419926|561317412|FG001|Overall Study|Withdrawal by Subject|3|||
155516723|NCT00419926|561317411|FG000|Overall Study|Administrative Problem|4|||
155516724|NCT00419926|561317412|FG001|Overall Study|Administrative Problem|4|||
155516725|NCT00419926|561317411|FG000|Overall Study|Lost to Follow-up|1|||
155516726|NCT00419926|561317412|FG001|Overall Study|Lost to Follow-up|2|||
155462801|NCT03337139|561115481|FG001|Phase I|Withdrawal by Subject|0|||
155462802|NCT02554253|561115485|FG000|Overall Study|ineligible after enrollment|1|||
155462803|NCT02554253|561115486|FG001|Overall Study|ineligible after enrollment|0|||
155462804|NCT02554253|561115485|FG000|Overall Study|converted to transcatheter procedure|0|||
155462805|NCT02554253|561115486|FG001|Overall Study|converted to transcatheter procedure|1|||
155516727|NCT00419926|561317411|FG000|Overall Study|Death|2|||
155516728|NCT00419926|561317412|FG001|Overall Study|Death|1|||
155462806|NCT02554253|561115485|FG000|Overall Study|received both drugs|0|||
155462807|NCT02554253|561115486|FG001|Overall Study|received both drugs|1|||
155462808|NCT01561560|561115490|FG000|First Two Weeks of Wear|Time/job conflict|0|||
155462809|NCT01561560|561115491|FG001|First Two Weeks of Wear|Time/job conflict|1|||
155462810|NCT01561560|561115490|FG000|First Two Weeks of Wear|Adverse Event|0|||
155462811|NCT01561560|561115491|FG001|First Two Weeks of Wear|Adverse Event|1|||
155462812|NCT01561560|561115490|FG000|Second Two Weeks of Wear|Adverse Event|0|||
155462813|NCT01561560|561115491|FG001|Second Two Weeks of Wear|Adverse Event|1|||
155462814|NCT03862131|561115492|FG000|Overall Study|Lost to Follow-up|1|||
155462815|NCT03862131|561115493|FG001|Overall Study|Lost to Follow-up|0|||
155462816|NCT03862131|561115494|FG002|Overall Study|Lost to Follow-up|1|||
155462817|NCT03862131|561115492|FG000|Overall Study|Determined to be ineligible|0|||
155462818|NCT03862131|561115493|FG001|Overall Study|Determined to be ineligible|0|||
155462819|NCT03862131|561115494|FG002|Overall Study|Determined to be ineligible|5|||
155462820|NCT03862131|561115492|FG000|Overall Study|Death|4|||
155462821|NCT03862131|561115493|FG001|Overall Study|Death|4|||
155462822|NCT03862131|561115494|FG002|Overall Study|Death|0|||
155462823|NCT03862131|561115492|FG000|Overall Study|Withdrawal by Subject|5|||
155462824|NCT03862131|561115493|FG001|Overall Study|Withdrawal by Subject|3|||
155462825|NCT03862131|561115494|FG002|Overall Study|Withdrawal by Subject|0|||
155462826|NCT03862131|561115492|FG000|Overall Study|Physician Decision|0|||
155462827|NCT03862131|561115493|FG001|Overall Study|Physician Decision|1|||
155462828|NCT03862131|561115494|FG002|Overall Study|Physician Decision|0|||
155462829|NCT01770145|561117571|FG000|Baseline|Adverse Event|20|||
155462830|NCT01770145|561117571|FG000|Baseline|Withdrawal by Subject|1|||
155462831|NCT01770145|561117571|FG000|Baseline|Lost to Follow-up|1|||
155462832|NCT01770145|561117571|FG000|Baseline|Unable to define optimal dose|4|||
155462833|NCT01770145|561117571|FG000|Treatment|Adverse Event|3|||
155462834|NCT01770145|561117571|FG000|Treatment|Withdrawal by Subject|1|||
155462835|NCT03488238|561117572|FG000|Overall Study|Equipment malfunction|1|||
155462836|NCT03488238|561117572|FG000|Overall Study|Adverse Event|1|||
155462837|NCT01316939|561117573|FG000|Overall Study|Study closed/terminated|26|||
155462838|NCT01316939|561117574|FG001|Overall Study|Study closed/terminated|25|||
155462839|NCT01316939|561117575|FG002|Overall Study|Study closed/terminated|23|||
155462840|NCT01316939|561117573|FG000|Overall Study|Lack of Efficacy|24|||
155462841|NCT01316939|561117574|FG001|Overall Study|Lack of Efficacy|25|||
155462842|NCT01316939|561117575|FG002|Overall Study|Lack of Efficacy|25|||
155462843|NCT01316939|561117573|FG000|Overall Study|Adverse Event|9|||
155462844|NCT01316939|561117574|FG001|Overall Study|Adverse Event|12|||
155462845|NCT01316939|561117575|FG002|Overall Study|Adverse Event|11|||
155462846|NCT01316939|561117573|FG000|Overall Study|Withdrawal by Subject|1|||
155462847|NCT01316939|561117574|FG001|Overall Study|Withdrawal by Subject|3|||
155462848|NCT01316939|561117575|FG002|Overall Study|Withdrawal by Subject|6|||
155462849|NCT01316939|561117573|FG000|Overall Study|Physician Decision|2|||
155462850|NCT01316939|561117574|FG001|Overall Study|Physician Decision|2|||
155462851|NCT01316939|561117575|FG002|Overall Study|Physician Decision|1|||
155462852|NCT01316939|561117573|FG000|Overall Study|Lost to Follow-up|0|||
155462853|NCT01316939|561117574|FG001|Overall Study|Lost to Follow-up|0|||
155462854|NCT01316939|561117575|FG002|Overall Study|Lost to Follow-up|2|||
155462855|NCT01316939|561117573|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
155462856|NCT01316939|561117574|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
155462857|NCT01316939|561117575|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
155462858|NCT01316939|561117573|FG000|Overall Study|Protocol Violation|0|||
155462859|NCT01316939|561117574|FG001|Overall Study|Protocol Violation|1|||
155462860|NCT01316939|561117575|FG002|Overall Study|Protocol Violation|0|||
155462861|NCT01432457|561117576|FG000|Overall Study|Adverse Event|7|||
155462862|NCT01432457|561117577|FG001|Overall Study|Adverse Event|10|||
155462863|NCT01432457|561117578|FG002|Overall Study|Adverse Event|16|||
155462864|NCT01432457|561117576|FG000|Overall Study|Lack of Efficacy|2|||
155462865|NCT01432457|561117577|FG001|Overall Study|Lack of Efficacy|1|||
155462866|NCT01432457|561117578|FG002|Overall Study|Lack of Efficacy|1|||
155462867|NCT01432457|561117576|FG000|Overall Study|Lost to Follow-up|11|||
155462868|NCT01432457|561117577|FG001|Overall Study|Lost to Follow-up|15|||
155462869|NCT01432457|561117578|FG002|Overall Study|Lost to Follow-up|20|||
155462870|NCT01432457|561117576|FG000|Overall Study|Protocol Violation|3|||
155462871|NCT01432457|561117577|FG001|Overall Study|Protocol Violation|2|||
155462872|NCT01432457|561117578|FG002|Overall Study|Protocol Violation|6|||
155462873|NCT01432457|561117576|FG000|Overall Study|Withdrawal by Subject|6|||
155462874|NCT01432457|561117577|FG001|Overall Study|Withdrawal by Subject|11|||
155462875|NCT01432457|561117578|FG002|Overall Study|Withdrawal by Subject|9|||
155462876|NCT01432457|561117576|FG000|Overall Study|Reasons not defined|2|||
155462877|NCT01432457|561117577|FG001|Overall Study|Reasons not defined|3|||
155462878|NCT01432457|561117578|FG002|Overall Study|Reasons not defined|4|||
155462879|NCT01432457|561117576|FG000|Overall Study|Did not take study drug|6|||
155462880|NCT01432457|561117577|FG001|Overall Study|Did not take study drug|6|||
155462881|NCT01432457|561117578|FG002|Overall Study|Did not take study drug|3|||
155462882|NCT04134728|561117579|FG000|Overall Study|Adverse Event|3|||
155462883|NCT04134728|561117580|FG001|Overall Study|Adverse Event|2|||
155462884|NCT04134728|561117581|FG002|Overall Study|Adverse Event|9|||
155462885|NCT04134728|561117582|FG003|Overall Study|Adverse Event|0|||
155462886|NCT04134728|561117583|FG004|Overall Study|Adverse Event|0|||
155462887|NCT04134728|561117584|FG005|Overall Study|Adverse Event|0|||
155462888|NCT04134728|561117579|FG000|Overall Study|Lack of Efficacy|3|||
155462889|NCT04134728|561117580|FG001|Overall Study|Lack of Efficacy|3|||
155462890|NCT04134728|561117581|FG002|Overall Study|Lack of Efficacy|1|||
155462891|NCT04134728|561117582|FG003|Overall Study|Lack of Efficacy|2|||
155462892|NCT04134728|561117583|FG004|Overall Study|Lack of Efficacy|0|||
155462893|NCT04134728|561117584|FG005|Overall Study|Lack of Efficacy|0|||
155462894|NCT04134728|561117579|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155462895|NCT04134728|561117580|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155462896|NCT04134728|561117581|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
155462897|NCT04134728|561117582|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155462898|NCT04134728|561117583|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155462899|NCT04134728|561117584|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155462900|NCT04134728|561117579|FG000|Overall Study|Protocol Deviation|0|||
155462901|NCT04134728|561117580|FG001|Overall Study|Protocol Deviation|0|||
155462902|NCT04134728|561117581|FG002|Overall Study|Protocol Deviation|1|||
155462903|NCT04134728|561117582|FG003|Overall Study|Protocol Deviation|0|||
155462904|NCT04134728|561117583|FG004|Overall Study|Protocol Deviation|0|||
155462905|NCT04134728|561117584|FG005|Overall Study|Protocol Deviation|0|||
155462906|NCT04134728|561117579|FG000|Overall Study|Informed Consent Withdrawn|3|||
155462907|NCT04134728|561117580|FG001|Overall Study|Informed Consent Withdrawn|6|||
155462908|NCT04134728|561117581|FG002|Overall Study|Informed Consent Withdrawn|8|||
155462909|NCT04134728|561117582|FG003|Overall Study|Informed Consent Withdrawn|1|||
155462910|NCT04134728|561117583|FG004|Overall Study|Informed Consent Withdrawn|1|||
155462911|NCT04134728|561117584|FG005|Overall Study|Informed Consent Withdrawn|0|||
155462912|NCT04134728|561117579|FG000|Overall Study|Physician Decision|2|||
155516729|NCT02153398|561317414|FG000|Overall Study|Withdrawal by Subject|1|||
155516730|NCT02153398|561317415|FG001|Overall Study|Withdrawal by Subject|0|||
155516731|NCT02153398|561317416|FG002|Overall Study|Withdrawal by Subject|0|||
155516732|NCT02153398|561317417|FG003|Overall Study|Withdrawal by Subject|0|||
155516733|NCT02153398|561317418|FG004|Overall Study|Withdrawal by Subject|0|||
155516734|NCT02153398|561317414|FG000|Overall Study|Adverse Event|0|||
155516735|NCT02153398|561317415|FG001|Overall Study|Adverse Event|0|||
155516736|NCT02153398|561317416|FG002|Overall Study|Adverse Event|1|||
155516737|NCT02153398|561317417|FG003|Overall Study|Adverse Event|1|||
155516738|NCT02153398|561317418|FG004|Overall Study|Adverse Event|0|||
155516739|NCT02374918|561317419|FG000|Overall Study|Protocol Violation|2|||
155516740|NCT02374918|561317420|FG001|Overall Study|Protocol Violation|0|||
155516741|NCT02374918|561317421|FG002|Overall Study|Protocol Violation|2|||
155516742|NCT02374918|561317422|FG003|Overall Study|Protocol Violation|1|||
155516743|NCT02374918|561317419|FG000|Overall Study|Withdrawal by Subject|1|||
155516744|NCT02374918|561317420|FG001|Overall Study|Withdrawal by Subject|1|||
155516745|NCT02374918|561317421|FG002|Overall Study|Withdrawal by Subject|1|||
155516746|NCT02374918|561317422|FG003|Overall Study|Withdrawal by Subject|0|||
155516747|NCT02374918|561317419|FG000|Overall Study|Lack of Efficacy|0|||
155516748|NCT02374918|561317420|FG001|Overall Study|Lack of Efficacy|0|||
155516749|NCT02374918|561317421|FG002|Overall Study|Lack of Efficacy|1|||
155516750|NCT02374918|561317422|FG003|Overall Study|Lack of Efficacy|1|||
155516751|NCT02204371|561317423|FG000|Overall Study|Adverse Event|1|||
155516752|NCT03594123|561317426|FG000|Overall Study|Lost to Follow-up|0|||
155516753|NCT03594123|561317427|FG001|Overall Study|Lost to Follow-up|1|||
155516754|NCT03594123|561317426|FG000|Overall Study|Adverse Event|8|||
155516755|NCT03594123|561317427|FG001|Overall Study|Adverse Event|5|||
155516756|NCT03594123|561317426|FG000|Overall Study|Site Terminated by Sponsor|4|||
155516757|NCT03594123|561317427|FG001|Overall Study|Site Terminated by Sponsor|1|||
155516758|NCT03594123|561317426|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
155516759|NCT03594123|561317427|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
155516760|NCT03594123|561317426|FG000|Overall Study|Lack of Efficacy|1|||
155516761|NCT03594123|561317427|FG001|Overall Study|Lack of Efficacy|0|||
155516762|NCT03594123|561317426|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
155516763|NCT03594123|561317427|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
155516764|NCT02483975|561317428|FG000|Overall Study|Adverse Event|0|||
155516765|NCT02483975|561317429|FG001|Overall Study|Adverse Event|1|||
155516766|NCT02483975|561317428|FG000|Overall Study|Lost to Follow-up|0|||
155462913|NCT04134728|561117580|FG001|Overall Study|Physician Decision|0|||
155462914|NCT04134728|561117581|FG002|Overall Study|Physician Decision|0|||
155462915|NCT04134728|561117582|FG003|Overall Study|Physician Decision|0|||
155462916|NCT04134728|561117583|FG004|Overall Study|Physician Decision|0|||
155462917|NCT04134728|561117584|FG005|Overall Study|Physician Decision|0|||
155462918|NCT04134728|561117579|FG000|Overall Study|Lost to Follow-up|1|||
155516767|NCT02483975|561317429|FG001|Overall Study|Lost to Follow-up|1|||
155516768|NCT02483975|561317428|FG000|Overall Study|Physician Decision|2|||
155462919|NCT04134728|561117580|FG001|Overall Study|Lost to Follow-up|2|||
155516769|NCT02483975|561317429|FG001|Overall Study|Physician Decision|0|||
155516770|NCT03365375|561317430|FG000|Overall Study|Withdrawal by Subject|0|||
155462920|NCT04134728|561117581|FG002|Overall Study|Lost to Follow-up|1|||
155462921|NCT04134728|561117582|FG003|Overall Study|Lost to Follow-up|0|||
155462922|NCT04134728|561117583|FG004|Overall Study|Lost to Follow-up|0|||
155462923|NCT04134728|561117584|FG005|Overall Study|Lost to Follow-up|1|||
155462924|NCT04134728|561117579|FG000|Overall Study|Investigator Site Closed|0|||
155462925|NCT04134728|561117580|FG001|Overall Study|Investigator Site Closed|1|||
155462926|NCT04134728|561117581|FG002|Overall Study|Investigator Site Closed|1|||
155462927|NCT04134728|561117582|FG003|Overall Study|Investigator Site Closed|0|||
155462928|NCT04134728|561117583|FG004|Overall Study|Investigator Site Closed|0|||
155462929|NCT04134728|561117584|FG005|Overall Study|Investigator Site Closed|0|||
155462930|NCT00801892|561117585|FG000|Main Study Period|Withdrawal by Subject|0|||
155462931|NCT00801892|561117586|FG001|Main Study Period|Withdrawal by Subject|1|||
155462932|NCT00801892|561117585|FG000|Sham Crossover Period|Lost to Follow-up|0|||
155462933|NCT00801892|561117586|FG001|Sham Crossover Period|Lost to Follow-up|2|||
155462934|NCT01711541|561117587|FG000|Overall Study|Cancel prior to treatment|0|||
155462935|NCT01711541|561117588|FG001|Overall Study|Cancel prior to treatment|0|||
155462936|NCT01711541|561117589|FG002|Overall Study|Cancel prior to treatment|0|||
155462937|NCT01711541|561117590|FG003|Overall Study|Cancel prior to treatment|1|||
155462938|NCT01711541|561117591|FG004|Overall Study|Cancel prior to treatment|0|||
155462939|NCT01711541|561117587|FG000|Overall Study|Ineligible|0|||
155462940|NCT01711541|561117588|FG001|Overall Study|Ineligible|1|||
155462941|NCT01711541|561117589|FG002|Overall Study|Ineligible|0|||
155462942|NCT01711541|561117590|FG003|Overall Study|Ineligible|0|||
155462943|NCT01711541|561117591|FG004|Overall Study|Ineligible|0|||
155462944|NCT00728936|561117592|FG000|Overall Study|Withdrawal by Subject|0|||
155462945|NCT00728936|561117593|FG001|Overall Study|Withdrawal by Subject|0|||
155462946|NCT00728936|561117594|FG002|Overall Study|Withdrawal by Subject|0|||
155462947|NCT00728936|561117595|FG003|Overall Study|Withdrawal by Subject|0|||
155462948|NCT00728936|561117596|FG004|Overall Study|Withdrawal by Subject|0|||
155462949|NCT00728936|561117597|FG005|Overall Study|Withdrawal by Subject|1|||
155462950|NCT00728936|561117598|FG006|Overall Study|Withdrawal by Subject|0|||
155462951|NCT05355818|561117603|FG000|Overall Study|Adverse Event|1|||
155462952|NCT05355818|561117604|FG001|Overall Study|Adverse Event|1|||
155462953|NCT05355818|561117603|FG000|Overall Study|Lack of Efficacy|2|||
155462954|NCT05355818|561117604|FG001|Overall Study|Lack of Efficacy|1|||
155462955|NCT05355818|561117603|FG000|Overall Study|Lost to Follow-up|0|||
155462956|NCT05355818|561117604|FG001|Overall Study|Lost to Follow-up|1|||
155462957|NCT02966353|561117605|FG000|Overall Study|Withdrawal by Subject|7|||
155462958|NCT02966353|561117605|FG000|Overall Study|Adverse Event|4|||
155462959|NCT02966353|561117605|FG000|Overall Study|Death|4|||
155462960|NCT02966353|561117605|FG000|Overall Study|Physician Decision|3|||
155462961|NCT02966353|561117605|FG000|Overall Study|Progressive disease|2|||
155462962|NCT02966353|561117605|FG000|Overall Study|Protocol deviation|2|||
155462963|NCT02273037|561117606|FG000|Overall Study|Lost to Follow-up|1|||
155462964|NCT02273037|561117607|FG001|Overall Study|Lost to Follow-up|0|||
155462965|NCT02273037|561117606|FG000|Overall Study|Delivered before monitoring initiated|1|||
155462966|NCT02273037|561117607|FG001|Overall Study|Delivered before monitoring initiated|3|||
155462967|NCT02273037|561117606|FG000|Overall Study|Breech delivery|2|||
155462968|NCT02273037|561117607|FG001|Overall Study|Breech delivery|3|||
155462969|NCT02273037|561117606|FG000|Overall Study|Multiple delivery|2|||
155462970|NCT02273037|561117607|FG001|Overall Study|Multiple delivery|2|||
155462971|NCT02273037|561117606|FG000|Overall Study|Other complication|2|||
155462972|NCT02273037|561117607|FG001|Overall Study|Other complication|0|||
155462973|NCT03351478|561117608|FG000|Overall Study|At the subject's own request|11|||
155462974|NCT03351478|561117609|FG001|Overall Study|At the subject's own request|12|||
155462975|NCT03351478|561117610|FG002|Overall Study|At the subject's own request|5|||
155462976|NCT03351478|561117608|FG000|Overall Study|Adverse Event|1|||
155462977|NCT03351478|561117609|FG001|Overall Study|Adverse Event|2|||
155462978|NCT03351478|561117610|FG002|Overall Study|Adverse Event|1|||
155462979|NCT03351478|561117608|FG000|Overall Study|Poor compliance to protocol|1|||
155462980|NCT03351478|561117609|FG001|Overall Study|Poor compliance to protocol|0|||
155462981|NCT03351478|561117610|FG002|Overall Study|Poor compliance to protocol|0|||
155462982|NCT03351478|561117608|FG000|Overall Study|Reason not Specified|1|||
155462983|NCT03351478|561117609|FG001|Overall Study|Reason not Specified|3|||
155462984|NCT03351478|561117610|FG002|Overall Study|Reason not Specified|0|||
155462985|NCT03351478|561117608|FG000|Overall Study|Lost to Follow-up|0|||
155462986|NCT03351478|561117609|FG001|Overall Study|Lost to Follow-up|0|||
155462987|NCT03351478|561117610|FG002|Overall Study|Lost to Follow-up|1|||
155462988|NCT03657810|561117611|FG000|Overall Study|Adverse Event|0|||
155462989|NCT03657810|561117612|FG001|Overall Study|Adverse Event|1|||
155462990|NCT03657810|561117613|FG002|Overall Study|Adverse Event|0|||
155462991|NCT03657810|561117611|FG000|Overall Study|Lack of Efficacy|4|||
155462992|NCT03657810|561117612|FG001|Overall Study|Lack of Efficacy|1|||
155462993|NCT03657810|561117613|FG002|Overall Study|Lack of Efficacy|3|||
155462994|NCT03657810|561117611|FG000|Overall Study|Protocol Violation|1|||
155462995|NCT03657810|561117612|FG001|Overall Study|Protocol Violation|0|||
155462996|NCT03657810|561117613|FG002|Overall Study|Protocol Violation|0|||
155462997|NCT03657810|561117611|FG000|Overall Study|Lost to Follow-up|0|||
155462998|NCT03657810|561117612|FG001|Overall Study|Lost to Follow-up|1|||
155462999|NCT03657810|561117613|FG002|Overall Study|Lost to Follow-up|0|||
155463000|NCT03657810|561117611|FG000|Overall Study|Not provided|0|||
155463001|NCT03657810|561117612|FG001|Overall Study|Not provided|1|||
155463002|NCT03657810|561117613|FG002|Overall Study|Not provided|0|||
155463003|NCT03911869|561117614|FG000|Safety Lead-in Phase|Death|7|||
155463004|NCT03911869|561117615|FG001|Safety Lead-in Phase|Death|0|||
155463005|NCT03911869|561117616|FG002|Safety Lead-in Phase|Death|0|||
155463006|NCT03911869|561117614|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
155463007|NCT03911869|561117615|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
155463008|NCT03911869|561117616|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
155463009|NCT03911869|561117614|FG000|Safety Lead-in Phase|Other|1|||
155463010|NCT03911869|561117615|FG001|Safety Lead-in Phase|Other|0|||
155463011|NCT03911869|561117616|FG002|Safety Lead-in Phase|Other|0|||
155463012|NCT03911869|561117614|FG000|Phase 2|Death|0|||
155463013|NCT03911869|561117615|FG001|Phase 2|Death|3|||
155463014|NCT03911869|561117616|FG002|Phase 2|Death|0|||
155463015|NCT00367341|561117619|FG000|Overall Study|Physician Decision|1|||
155463016|NCT00367341|561117620|FG001|Overall Study|Physician Decision|0|||
155463017|NCT00367341|561117619|FG000|Overall Study|Protocol Violation|1|||
155463018|NCT00367341|561117620|FG001|Overall Study|Protocol Violation|0|||
155463019|NCT03325556|561117621|FG000|Open-label Period|Lack of Response in OL period|70|||
155463020|NCT03325556|561117622|FG001|Open-label Period|Lack of Response in OL period|0|||
155463021|NCT03325556|561117623|FG002|Open-label Period|Lack of Response in OL period|0|||
155463022|NCT03325556|561117621|FG000|Open-label Period|Adverse Event|27|||
155463023|NCT03325556|561117622|FG001|Open-label Period|Adverse Event|0|||
155463024|NCT03325556|561117623|FG002|Open-label Period|Adverse Event|0|||
155463025|NCT03325556|561117621|FG000|Open-label Period|Death|1|||
155463026|NCT03325556|561117622|FG001|Open-label Period|Death|0|||
155463027|NCT03325556|561117623|FG002|Open-label Period|Death|0|||
155463028|NCT03325556|561117621|FG000|Open-label Period|Lost to Follow-up|1|||
155463029|NCT03325556|561117622|FG001|Open-label Period|Lost to Follow-up|0|||
155463030|NCT03325556|561117623|FG002|Open-label Period|Lost to Follow-up|0|||
155463031|NCT03325556|561117621|FG000|Open-label Period|Non-compliance with study drug|5|||
155463032|NCT03325556|561117622|FG001|Open-label Period|Non-compliance with study drug|0|||
155463033|NCT03325556|561117623|FG002|Open-label Period|Non-compliance with study drug|0|||
155463034|NCT03325556|561117621|FG000|Open-label Period|Use of prohibited medication|1|||
155463035|NCT03325556|561117622|FG001|Open-label Period|Use of prohibited medication|0|||
155463036|NCT03325556|561117623|FG002|Open-label Period|Use of prohibited medication|0|||
155463037|NCT03325556|561117621|FG000|Open-label Period|Protocol Violation|4|||
155463038|NCT03325556|561117622|FG001|Open-label Period|Protocol Violation|0|||
155463039|NCT03325556|561117623|FG002|Open-label Period|Protocol Violation|0|||
155463040|NCT03325556|561117621|FG000|Open-label Period|Withdrawal by Subject|17|||
155463041|NCT03325556|561117622|FG001|Open-label Period|Withdrawal by Subject|0|||
155463042|NCT03325556|561117623|FG002|Open-label Period|Withdrawal by Subject|0|||
155463043|NCT03325556|561117621|FG000|Open-label Period|Not otherwise specified|8|||
155463044|NCT03325556|561117622|FG001|Open-label Period|Not otherwise specified|0|||
155463045|NCT03325556|561117623|FG002|Open-label Period|Not otherwise specified|0|||
155463046|NCT03325556|561117621|FG000|Open-label Period|Administrative discont. at study termination|41|||
155463047|NCT03325556|561117622|FG001|Open-label Period|Administrative discont. at study termination|0|||
155463048|NCT03325556|561117623|FG002|Open-label Period|Administrative discont. at study termination|0|||
155463049|NCT03325556|561117621|FG000|Double-blind Period|Relapse|0|||
155463050|NCT03325556|561117622|FG001|Double-blind Period|Relapse|15|||
155463051|NCT03325556|561117623|FG002|Double-blind Period|Relapse|34|||
155463052|NCT03325556|561117621|FG000|Double-blind Period|Adverse Event|0|||
155463053|NCT03325556|561117622|FG001|Double-blind Period|Adverse Event|3|||
155516771|NCT03365375|561317431|FG001|Overall Study|Withdrawal by Subject|1|||
155516772|NCT03365375|561317430|FG000|Overall Study|Lost to Follow-up|0|||
155516773|NCT03365375|561317431|FG001|Overall Study|Lost to Follow-up|4|||
155516774|NCT00818883|561317432|FG000|Overall Study|Adverse Event|28|||
155516775|NCT00818883|561317433|FG001|Overall Study|Adverse Event|19|||
155516776|NCT00818883|561317432|FG000|Overall Study|Protocol Violation|2|||
155516777|NCT00818883|561317433|FG001|Overall Study|Protocol Violation|2|||
155516778|NCT00818883|561317432|FG000|Overall Study|Lost to Follow-up|3|||
155516779|NCT00818883|561317433|FG001|Overall Study|Lost to Follow-up|2|||
155516780|NCT00818883|561317432|FG000|Overall Study|Withdrawal by Subject|16|||
155516781|NCT00818883|561317433|FG001|Overall Study|Withdrawal by Subject|14|||
155516782|NCT00818883|561317432|FG000|Overall Study|Lack of Efficacy|0|||
155516783|NCT00818883|561317433|FG001|Overall Study|Lack of Efficacy|2|||
155516784|NCT00818883|561317432|FG000|Overall Study|Other|2|||
155516785|NCT00818883|561317433|FG001|Overall Study|Other|7|||
155516786|NCT00290745|561317438|FG000|Overall Study|Withdrawal by Subject|4|||
155516787|NCT00290745|561317438|FG000|Overall Study|Physician Decision|2|||
155516788|NCT00290745|561317438|FG000|Overall Study|Surgery after 3 months for progression|3|||
155516789|NCT00290745|561317438|FG000|Overall Study|Baseline MRI not available|3|||
155516790|NCT00108732|561317441|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
155516791|NCT00108732|561317441|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
155516792|NCT00108732|561317441|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
155516793|NCT00108732|561317441|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
155516794|NCT00108732|561317441|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
155516795|NCT00108732|561317441|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
155516796|NCT00108732|561317441|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
155516797|NCT02187042|561317442|FG000|Overall Study|Death|1|||
155516798|NCT02187042|561317443|FG001|Overall Study|Death|1|||
155463054|NCT03325556|561117623|FG002|Double-blind Period|Adverse Event|1|||
155463055|NCT03325556|561117621|FG000|Double-blind Period|Noncompliance with study drug|0|||
155463056|NCT03325556|561117622|FG001|Double-blind Period|Noncompliance with study drug|0|||
155463057|NCT03325556|561117623|FG002|Double-blind Period|Noncompliance with study drug|1|||
155463058|NCT03325556|561117621|FG000|Double-blind Period|Use of prohibited medication|0|||
155463059|NCT03325556|561117622|FG001|Double-blind Period|Use of prohibited medication|1|||
155463060|NCT03325556|561117623|FG002|Double-blind Period|Use of prohibited medication|0|||
155463061|NCT03325556|561117621|FG000|Double-blind Period|Physician Decision|0|||
155463062|NCT03325556|561117622|FG001|Double-blind Period|Physician Decision|0|||
155463063|NCT03325556|561117623|FG002|Double-blind Period|Physician Decision|1|||
155463064|NCT03325556|561117621|FG000|Double-blind Period|Withdrawal by Subject|0|||
155463065|NCT03325556|561117622|FG001|Double-blind Period|Withdrawal by Subject|6|||
155463066|NCT03325556|561117623|FG002|Double-blind Period|Withdrawal by Subject|4|||
155463067|NCT03325556|561117621|FG000|Double-blind Period|Not otherwise specified|0|||
155463068|NCT03325556|561117622|FG001|Double-blind Period|Not otherwise specified|1|||
155463069|NCT03325556|561117623|FG002|Double-blind Period|Not otherwise specified|5|||
155463070|NCT03325556|561117621|FG000|Double-blind Period|Administrative discont. at study termination|0|||
155463071|NCT03325556|561117622|FG001|Double-blind Period|Administrative discont. at study termination|35|||
155463072|NCT03325556|561117623|FG002|Double-blind Period|Administrative discont. at study termination|31|||
155463073|NCT01705587|561117624|FG000|Overall Study|Withdrawal by Subject|0|||
155463074|NCT01705587|561117625|FG001|Overall Study|Withdrawal by Subject|1|||
155463075|NCT00510484|561117628|FG000|Wash-out Period|Adverse Event|0|||
155463076|NCT00510484|561117629|FG001|Wash-out Period|Adverse Event|1|||
155463077|NCT02533401|561117630|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
155463078|NCT02533401|561117630|FG000|Overall Study|Death|5|||
155463079|NCT02533401|561117630|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
155463080|NCT02533401|561117630|FG000|Overall Study|Lost to Follow-up|1|||
155463081|NCT02533401|561117630|FG000|Overall Study|Violation of Selection Criteria|1|||
155463082|NCT04897594|561117634|FG000|Overall Study|Lost to Follow-up|0|||
155463083|NCT04897594|561117635|FG001|Overall Study|Lost to Follow-up|1|||
155516799|NCT02187042|561317442|FG000|Overall Study|Toxicity|6|||
155516800|NCT02187042|561317443|FG001|Overall Study|Toxicity|5|||
155516801|NCT02187042|561317442|FG000|Overall Study|Participant choice|1|||
155463084|NCT04897594|561117636|FG002|Overall Study|Lost to Follow-up|1|||
155463085|NCT04897594|561117634|FG000|Overall Study|Sponsor Decision|0|||
155463086|NCT04897594|561117635|FG001|Overall Study|Sponsor Decision|0|||
155463087|NCT04897594|561117636|FG002|Overall Study|Sponsor Decision|1|||
155463088|NCT04897594|561117634|FG000|Overall Study|Withdrawal by Subject|1|||
155516802|NCT02187042|561317443|FG001|Overall Study|Participant choice|0|||
155516803|NCT02187042|561317442|FG000|Overall Study|Doctor choice|1|||
155516804|NCT02187042|561317443|FG001|Overall Study|Doctor choice|0|||
155516805|NCT02187042|561317442|FG000|Overall Study|Progressive disease|4|||
155516806|NCT02187042|561317443|FG001|Overall Study|Progressive disease|8|||
155516807|NCT01659567|561317444|FG000|Overall Study|Lack of Efficacy|22|||
155516808|NCT01659567|561317444|FG000|Overall Study|Switched to Pegferon|6|||
155516809|NCT01659567|561317444|FG000|Overall Study|Adverse Event|12|||
155463089|NCT04897594|561117635|FG001|Overall Study|Withdrawal by Subject|0|||
155463090|NCT04897594|561117636|FG002|Overall Study|Withdrawal by Subject|1|||
155463091|NCT00511108|561117637|FG000|Overall Study|Adverse Event|2|||
155463092|NCT00511108|561117638|FG001|Overall Study|Adverse Event|0|||
155463093|NCT00511108|561117639|FG002|Overall Study|Adverse Event|1|||
155463094|NCT00511108|561117640|FG003|Overall Study|Adverse Event|2|||
155463095|NCT00511108|561117637|FG000|Overall Study|Lost to Follow-up|0|||
155463096|NCT00511108|561117638|FG001|Overall Study|Lost to Follow-up|2|||
155463097|NCT00511108|561117639|FG002|Overall Study|Lost to Follow-up|1|||
155463098|NCT00511108|561117640|FG003|Overall Study|Lost to Follow-up|0|||
155463099|NCT00511108|561117637|FG000|Overall Study|Physician Decision|0|||
155463100|NCT00511108|561117638|FG001|Overall Study|Physician Decision|0|||
155463101|NCT00511108|561117639|FG002|Overall Study|Physician Decision|0|||
155463102|NCT00511108|561117640|FG003|Overall Study|Physician Decision|1|||
155463103|NCT00511108|561117637|FG000|Overall Study|Withdrawal by Subject|4|||
155463104|NCT00511108|561117638|FG001|Overall Study|Withdrawal by Subject|0|||
155463105|NCT00511108|561117639|FG002|Overall Study|Withdrawal by Subject|3|||
155463106|NCT00511108|561117640|FG003|Overall Study|Withdrawal by Subject|2|||
155463107|NCT00150345|561117643|FG000|Overall Study|Death|5|||
155463108|NCT00150345|561117644|FG001|Overall Study|Death|2|||
155463109|NCT00150345|561117643|FG000|Overall Study|Adverse Event|8|||
155463110|NCT00150345|561117644|FG001|Overall Study|Adverse Event|6|||
155463111|NCT00150345|561117643|FG000|Overall Study|Lack of Efficacy|5|||
155463112|NCT00150345|561117644|FG001|Overall Study|Lack of Efficacy|4|||
155463113|NCT00150345|561117643|FG000|Overall Study|Withdrawal by Subject|3|||
155463114|NCT00150345|561117644|FG001|Overall Study|Withdrawal by Subject|4|||
155463115|NCT00150345|561117643|FG000|Overall Study|Laboratory abnormality|1|||
155463116|NCT00150345|561117644|FG001|Overall Study|Laboratory abnormality|2|||
155463117|NCT00150345|561117643|FG000|Overall Study|Other|12|||
155463118|NCT00150345|561117644|FG001|Overall Study|Other|14|||
155463119|NCT01998958|561117645|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463120|NCT01998958|561117646|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
155463121|NCT01998958|561117647|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463122|NCT01998958|561117648|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463123|NCT01998958|561117649|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463124|NCT01998958|561117650|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463125|NCT01998958|561117651|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463126|NCT01998958|561117652|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463127|NCT01998958|561117653|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463128|NCT01998958|561117654|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463129|NCT01998958|561117655|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463130|NCT01998958|561117656|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463131|NCT01998958|561117657|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463132|NCT01998958|561117658|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463133|NCT01998958|561117659|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463134|NCT01998958|561117660|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463135|NCT01998958|561117661|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463136|NCT01998958|561117662|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463137|NCT01998958|561117663|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463138|NCT01998958|561117664|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463139|NCT01998958|561117665|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463140|NCT01998958|561117666|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463141|NCT01998958|561117667|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463142|NCT01998958|561117668|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463143|NCT01998958|561117669|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463144|NCT01998958|561117670|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463145|NCT01998958|561117671|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463146|NCT01998958|561117672|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463147|NCT01998958|561117673|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463148|NCT01998958|561117674|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463149|NCT01998958|561117675|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463150|NCT01998958|561117676|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
155463151|NCT01998958|561117645|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463152|NCT01998958|561117646|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
155463153|NCT01998958|561117647|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463154|NCT01998958|561117648|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463155|NCT01998958|561117649|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463156|NCT01998958|561117650|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463157|NCT01998958|561117651|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463158|NCT01998958|561117652|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463159|NCT01998958|561117653|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463160|NCT01998958|561117654|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463161|NCT01998958|561117655|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463162|NCT01998958|561117656|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463163|NCT01998958|561117657|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463164|NCT01998958|561117658|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463165|NCT01998958|561117659|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463166|NCT01998958|561117660|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463167|NCT01998958|561117661|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463168|NCT01998958|561117662|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463169|NCT01998958|561117663|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463170|NCT01998958|561117664|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463171|NCT01998958|561117665|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463172|NCT01998958|561117666|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463173|NCT01998958|561117667|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463174|NCT01998958|561117668|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463175|NCT01998958|561117669|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463176|NCT01998958|561117670|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463177|NCT01998958|561117671|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463178|NCT01998958|561117672|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463179|NCT01998958|561117673|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463180|NCT01998958|561117674|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463181|NCT01998958|561117675|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463182|NCT01998958|561117676|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
155463183|NCT01998958|561117645|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
155463184|NCT01998958|561117646|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
155463185|NCT01998958|561117647|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
155463186|NCT01998958|561117648|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
155463187|NCT01998958|561117649|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
155463188|NCT01998958|561117650|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
155463189|NCT01998958|561117651|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
155463190|NCT01998958|561117652|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
155463191|NCT01998958|561117653|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
155463192|NCT01998958|561117654|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
155463193|NCT01998958|561117655|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
155463194|NCT01998958|561117656|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
155463195|NCT01998958|561117657|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
155463196|NCT01998958|561117658|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
155463197|NCT01998958|561117659|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
155463198|NCT01998958|561117660|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
155463199|NCT01998958|561117661|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
155463200|NCT01998958|561117662|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
155463201|NCT01998958|561117663|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
155463202|NCT01998958|561117664|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
155463203|NCT01998958|561117665|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
155463204|NCT01998958|561117666|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
155463205|NCT01998958|561117667|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
155463206|NCT01998958|561117668|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
155463207|NCT01998958|561117669|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
155463208|NCT01998958|561117670|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
155463209|NCT01998958|561117671|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
155463210|NCT01998958|561117672|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
155463211|NCT01998958|561117673|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
155463212|NCT01998958|561117674|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
155463213|NCT01998958|561117675|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
155463214|NCT01998958|561117676|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
155516810|NCT01659567|561317444|FG000|Overall Study|Good result at early stage of treatment|5|||
155516811|NCT01659567|561317444|FG000|Overall Study|Withdrawal by Subject|64|||
155463215|NCT01998958|561117645|FG000|Period 1 (Panel A and B)|Other|1|||
155463216|NCT01998958|561117646|FG001|Period 1 (Panel A and B)|Other|0|||
155463217|NCT01998958|561117647|FG002|Period 1 (Panel A and B)|Other|0|||
155463218|NCT01998958|561117648|FG003|Period 1 (Panel A and B)|Other|0|||
155463219|NCT01998958|561117649|FG004|Period 1 (Panel A and B)|Other|0|||
155463220|NCT01998958|561117650|FG005|Period 1 (Panel A and B)|Other|0|||
155463221|NCT01998958|561117651|FG006|Period 1 (Panel A and B)|Other|0|||
155463222|NCT01998958|561117652|FG007|Period 1 (Panel A and B)|Other|0|||
155652496|NCT00289900|561820366|FG003|Overall Study|Adverse Event|19|||
155463223|NCT01998958|561117653|FG008|Period 1 (Panel A and B)|Other|0|||
155463224|NCT01998958|561117654|FG009|Period 1 (Panel A and B)|Other|0|||
155463225|NCT01998958|561117655|FG010|Period 1 (Panel A and B)|Other|0|||
155463226|NCT01998958|561117656|FG011|Period 1 (Panel A and B)|Other|0|||
155463227|NCT01998958|561117657|FG012|Period 1 (Panel A and B)|Other|0|||
155463228|NCT01998958|561117658|FG013|Period 1 (Panel A and B)|Other|0|||
155463229|NCT01998958|561117659|FG014|Period 1 (Panel A and B)|Other|0|||
155463230|NCT01998958|561117660|FG015|Period 1 (Panel A and B)|Other|0|||
155463231|NCT01998958|561117661|FG016|Period 1 (Panel A and B)|Other|0|||
155463232|NCT01998958|561117662|FG017|Period 1 (Panel A and B)|Other|0|||
155463233|NCT01998958|561117663|FG018|Period 1 (Panel A and B)|Other|0|||
155463234|NCT01998958|561117664|FG019|Period 1 (Panel A and B)|Other|0|||
155463235|NCT01998958|561117665|FG020|Period 1 (Panel A and B)|Other|0|||
155463236|NCT01998958|561117666|FG021|Period 1 (Panel A and B)|Other|0|||
155463237|NCT01998958|561117667|FG022|Period 1 (Panel A and B)|Other|0|||
155463238|NCT01998958|561117668|FG023|Period 1 (Panel A and B)|Other|0|||
155463239|NCT01998958|561117669|FG024|Period 1 (Panel A and B)|Other|0|||
155463240|NCT01998958|561117670|FG025|Period 1 (Panel A and B)|Other|0|||
155463241|NCT01998958|561117671|FG026|Period 1 (Panel A and B)|Other|0|||
155463242|NCT01998958|561117672|FG027|Period 1 (Panel A and B)|Other|0|||
155463243|NCT01998958|561117673|FG028|Period 1 (Panel A and B)|Other|0|||
155463244|NCT01998958|561117674|FG029|Period 1 (Panel A and B)|Other|0|||
155463245|NCT01998958|561117675|FG030|Period 1 (Panel A and B)|Other|0|||
155463246|NCT01998958|561117676|FG031|Period 1 (Panel A and B)|Other|0|||
155463247|NCT01998958|561117645|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
155463248|NCT01998958|561117646|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
155463249|NCT01998958|561117647|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
155463250|NCT01998958|561117648|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
155463251|NCT01998958|561117649|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
155463252|NCT01998958|561117650|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
155463253|NCT01998958|561117651|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
155463254|NCT01998958|561117652|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
155463255|NCT01998958|561117653|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
155463256|NCT01998958|561117654|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
155463257|NCT01998958|561117655|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
155463258|NCT01998958|561117656|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
155463259|NCT01998958|561117657|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
155463260|NCT01998958|561117658|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
155463261|NCT01998958|561117659|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
155463262|NCT01998958|561117660|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
155463263|NCT01998958|561117661|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
155463264|NCT01998958|561117662|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
155463265|NCT01998958|561117663|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
155463266|NCT01998958|561117664|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
155463267|NCT01998958|561117665|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
155463268|NCT01998958|561117666|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
155463269|NCT01998958|561117667|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
155463270|NCT01998958|561117668|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
155463271|NCT01998958|561117669|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
155463272|NCT01998958|561117670|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
155463273|NCT01998958|561117671|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
155463274|NCT01998958|561117672|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
155463275|NCT01998958|561117673|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
155463276|NCT01998958|561117674|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
155463277|NCT01998958|561117675|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
155463278|NCT01998958|561117676|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
155463279|NCT01998958|561117645|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463280|NCT01998958|561117646|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463281|NCT01998958|561117647|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463282|NCT01998958|561117648|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463283|NCT01998958|561117649|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463284|NCT01998958|561117650|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463285|NCT01998958|561117651|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155516812|NCT01659567|561317444|FG000|Overall Study|Progression of the main disease|1|||
155463286|NCT01998958|561117652|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463287|NCT01998958|561117653|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463288|NCT01998958|561117654|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463289|NCT01998958|561117655|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463290|NCT01998958|561117656|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155516813|NCT01659567|561317444|FG000|Overall Study|Other|13|||
155463291|NCT01998958|561117657|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463292|NCT01998958|561117658|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463293|NCT01998958|561117659|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
155463294|NCT01998958|561117660|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463295|NCT01998958|561117661|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463296|NCT01998958|561117662|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463297|NCT01998958|561117663|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
155463298|NCT01998958|561117664|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463299|NCT01998958|561117665|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463300|NCT01998958|561117666|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463301|NCT01998958|561117667|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463302|NCT01998958|561117668|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463303|NCT01998958|561117669|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463304|NCT01998958|561117670|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463305|NCT01998958|561117671|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463306|NCT01998958|561117672|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463307|NCT01998958|561117673|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463308|NCT01998958|561117674|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463309|NCT01998958|561117675|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463310|NCT01998958|561117676|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
155463311|NCT01998958|561117645|FG000|Open Label Phase (Optional)|Adverse Event|0|||
155463312|NCT01998958|561117646|FG001|Open Label Phase (Optional)|Adverse Event|0|||
155463313|NCT01998958|561117647|FG002|Open Label Phase (Optional)|Adverse Event|0|||
155463314|NCT01998958|561117648|FG003|Open Label Phase (Optional)|Adverse Event|0|||
155463315|NCT01998958|561117649|FG004|Open Label Phase (Optional)|Adverse Event|0|||
155463316|NCT01998958|561117650|FG005|Open Label Phase (Optional)|Adverse Event|0|||
155463317|NCT01998958|561117651|FG006|Open Label Phase (Optional)|Adverse Event|0|||
155463318|NCT01998958|561117652|FG007|Open Label Phase (Optional)|Adverse Event|0|||
155463319|NCT01998958|561117653|FG008|Open Label Phase (Optional)|Adverse Event|0|||
155463320|NCT01998958|561117654|FG009|Open Label Phase (Optional)|Adverse Event|0|||
155463321|NCT01998958|561117655|FG010|Open Label Phase (Optional)|Adverse Event|0|||
155463322|NCT01998958|561117656|FG011|Open Label Phase (Optional)|Adverse Event|0|||
155463323|NCT01998958|561117657|FG012|Open Label Phase (Optional)|Adverse Event|0|||
155463324|NCT01998958|561117658|FG013|Open Label Phase (Optional)|Adverse Event|0|||
155463325|NCT01998958|561117659|FG014|Open Label Phase (Optional)|Adverse Event|0|||
155463326|NCT01998958|561117660|FG015|Open Label Phase (Optional)|Adverse Event|0|||
155463327|NCT01998958|561117661|FG016|Open Label Phase (Optional)|Adverse Event|0|||
155463328|NCT01998958|561117662|FG017|Open Label Phase (Optional)|Adverse Event|0|||
155463329|NCT01998958|561117663|FG018|Open Label Phase (Optional)|Adverse Event|0|||
155463330|NCT01998958|561117664|FG019|Open Label Phase (Optional)|Adverse Event|0|||
155463331|NCT01998958|561117665|FG020|Open Label Phase (Optional)|Adverse Event|0|||
155463332|NCT01998958|561117666|FG021|Open Label Phase (Optional)|Adverse Event|0|||
155463333|NCT01998958|561117667|FG022|Open Label Phase (Optional)|Adverse Event|0|||
155463334|NCT01998958|561117668|FG023|Open Label Phase (Optional)|Adverse Event|1|||
155463335|NCT01998958|561117669|FG024|Open Label Phase (Optional)|Adverse Event|0|||
155463336|NCT01998958|561117670|FG025|Open Label Phase (Optional)|Adverse Event|0|||
155463337|NCT01998958|561117671|FG026|Open Label Phase (Optional)|Adverse Event|0|||
155463338|NCT01998958|561117672|FG027|Open Label Phase (Optional)|Adverse Event|0|||
155463339|NCT01998958|561117673|FG028|Open Label Phase (Optional)|Adverse Event|0|||
155463340|NCT01998958|561117674|FG029|Open Label Phase (Optional)|Adverse Event|0|||
155463341|NCT01998958|561117675|FG030|Open Label Phase (Optional)|Adverse Event|0|||
155463342|NCT01998958|561117676|FG031|Open Label Phase (Optional)|Adverse Event|0|||
155463343|NCT01998958|561117645|FG000|Open Label Phase (Optional)|Other|0|||
155463344|NCT01998958|561117646|FG001|Open Label Phase (Optional)|Other|0|||
155463345|NCT01998958|561117647|FG002|Open Label Phase (Optional)|Other|0|||
155463346|NCT01998958|561117648|FG003|Open Label Phase (Optional)|Other|0|||
155463347|NCT01998958|561117649|FG004|Open Label Phase (Optional)|Other|0|||
155463348|NCT01998958|561117650|FG005|Open Label Phase (Optional)|Other|0|||
155463349|NCT01998958|561117651|FG006|Open Label Phase (Optional)|Other|0|||
155463350|NCT01998958|561117652|FG007|Open Label Phase (Optional)|Other|0|||
155463351|NCT01998958|561117653|FG008|Open Label Phase (Optional)|Other|0|||
155463352|NCT01998958|561117654|FG009|Open Label Phase (Optional)|Other|0|||
155463353|NCT01998958|561117655|FG010|Open Label Phase (Optional)|Other|0|||
155463354|NCT01998958|561117656|FG011|Open Label Phase (Optional)|Other|0|||
155463355|NCT01998958|561117657|FG012|Open Label Phase (Optional)|Other|0|||
155463356|NCT01998958|561117658|FG013|Open Label Phase (Optional)|Other|0|||
155463357|NCT01998958|561117659|FG014|Open Label Phase (Optional)|Other|0|||
155463358|NCT01998958|561117660|FG015|Open Label Phase (Optional)|Other|0|||
155463359|NCT01998958|561117661|FG016|Open Label Phase (Optional)|Other|0|||
155463360|NCT01998958|561117662|FG017|Open Label Phase (Optional)|Other|0|||
155463361|NCT01998958|561117663|FG018|Open Label Phase (Optional)|Other|0|||
155463362|NCT01998958|561117664|FG019|Open Label Phase (Optional)|Other|0|||
155463363|NCT01998958|561117665|FG020|Open Label Phase (Optional)|Other|0|||
155463364|NCT01998958|561117666|FG021|Open Label Phase (Optional)|Other|0|||
155463365|NCT01998958|561117667|FG022|Open Label Phase (Optional)|Other|5|||
155463366|NCT01998958|561117668|FG023|Open Label Phase (Optional)|Other|1|||
155463367|NCT01998958|561117669|FG024|Open Label Phase (Optional)|Other|0|||
155463368|NCT01998958|561117670|FG025|Open Label Phase (Optional)|Other|0|||
155463369|NCT01998958|561117671|FG026|Open Label Phase (Optional)|Other|0|||
155463370|NCT01998958|561117672|FG027|Open Label Phase (Optional)|Other|0|||
155463371|NCT01998958|561117673|FG028|Open Label Phase (Optional)|Other|0|||
155463372|NCT01998958|561117674|FG029|Open Label Phase (Optional)|Other|0|||
155463373|NCT01998958|561117675|FG030|Open Label Phase (Optional)|Other|0|||
155463374|NCT01998958|561117676|FG031|Open Label Phase (Optional)|Other|0|||
155463375|NCT01998958|561117645|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463376|NCT01998958|561117646|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463377|NCT01998958|561117647|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463378|NCT01998958|561117648|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463379|NCT01998958|561117649|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463380|NCT01998958|561117650|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463381|NCT01998958|561117651|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463382|NCT01998958|561117652|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463383|NCT01998958|561117653|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463384|NCT01998958|561117654|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463385|NCT01998958|561117655|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463386|NCT01998958|561117656|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463387|NCT01998958|561117657|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463388|NCT01998958|561117658|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463389|NCT01998958|561117659|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463390|NCT01998958|561117660|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463391|NCT01998958|561117661|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463392|NCT01998958|561117662|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463393|NCT01998958|561117663|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463394|NCT01998958|561117664|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463395|NCT01998958|561117665|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463396|NCT01998958|561117666|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463397|NCT01998958|561117667|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
155463398|NCT01998958|561117668|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463399|NCT01998958|561117669|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463400|NCT01998958|561117670|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463401|NCT01998958|561117671|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463402|NCT01998958|561117672|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463403|NCT01998958|561117673|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463404|NCT01998958|561117674|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463405|NCT01998958|561117675|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463406|NCT01998958|561117676|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
155463407|NCT01998958|561117645|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463408|NCT01998958|561117646|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463409|NCT01998958|561117647|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463410|NCT01998958|561117648|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463411|NCT01998958|561117649|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463412|NCT01998958|561117650|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463413|NCT01998958|561117651|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463414|NCT01998958|561117652|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463415|NCT01998958|561117653|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463416|NCT01998958|561117654|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463417|NCT01998958|561117655|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463418|NCT01998958|561117656|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463419|NCT01998958|561117657|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463420|NCT01998958|561117658|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463421|NCT01998958|561117659|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463422|NCT01998958|561117660|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463423|NCT01998958|561117661|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463424|NCT01998958|561117662|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463425|NCT01998958|561117663|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463426|NCT01998958|561117664|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463427|NCT01998958|561117665|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463428|NCT01998958|561117666|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
155463429|NCT01998958|561117667|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
155463430|NCT01998958|561117668|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463431|NCT01998958|561117669|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463432|NCT01998958|561117670|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463433|NCT01998958|561117671|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463434|NCT01998958|561117672|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463435|NCT01998958|561117673|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463436|NCT01998958|561117674|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463437|NCT01998958|561117675|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463438|NCT01998958|561117676|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
155463439|NCT01998958|561117645|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463440|NCT01998958|561117646|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463441|NCT01998958|561117647|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463442|NCT01998958|561117648|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463443|NCT01998958|561117649|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463444|NCT01998958|561117650|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463445|NCT01998958|561117651|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463446|NCT01998958|561117652|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463447|NCT01998958|561117653|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463448|NCT01998958|561117654|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463449|NCT01998958|561117655|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463450|NCT01998958|561117656|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463451|NCT01998958|561117657|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463452|NCT01998958|561117658|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463453|NCT01998958|561117659|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463454|NCT01998958|561117660|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463455|NCT01998958|561117661|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463456|NCT01998958|561117662|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463457|NCT01998958|561117663|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463458|NCT01998958|561117664|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463459|NCT01998958|561117665|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463460|NCT01998958|561117666|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
155463461|NCT01998958|561117667|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
155463462|NCT01998958|561117668|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
155463463|NCT01998958|561117669|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463464|NCT01998958|561117670|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463465|NCT01998958|561117671|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463466|NCT01998958|561117672|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463467|NCT01998958|561117673|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463468|NCT01998958|561117674|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463469|NCT01998958|561117675|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463470|NCT01998958|561117676|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155463471|NCT01532570|561117680|FG000|Overall Study|Lack of Efficacy|1|||
155463472|NCT01532570|561117681|FG001|Overall Study|Lack of Efficacy|0|||
155463473|NCT01532570|561117682|FG002|Overall Study|Lack of Efficacy|0|||
155463474|NCT01532570|561117683|FG003|Overall Study|Lack of Efficacy|0|||
155463475|NCT01532570|561117680|FG000|Overall Study|Withdrawal by Subject|0|||
155463476|NCT01532570|561117681|FG001|Overall Study|Withdrawal by Subject|1|||
155463477|NCT01532570|561117682|FG002|Overall Study|Withdrawal by Subject|0|||
155463478|NCT01532570|561117683|FG003|Overall Study|Withdrawal by Subject|0|||
155463479|NCT03892707|561117690|FG000|Overall Study|Screen failure|6|||
155463480|NCT03892707|561117691|FG001|Overall Study|Screen failure|0|||
155463481|NCT03892707|561117690|FG000|Overall Study|Pain resolution|0|||
155463482|NCT03892707|561117691|FG001|Overall Study|Pain resolution|4|||
155463483|NCT03892707|561117690|FG000|Overall Study|Withdrawal by Subject|0|||
155463484|NCT03892707|561117691|FG001|Overall Study|Withdrawal by Subject|1|||
155463485|NCT03892707|561117690|FG000|Overall Study|Other (long business trip)|0|||
155463486|NCT03892707|561117691|FG001|Overall Study|Other (long business trip)|1|||
155463487|NCT05224076|561117694|FG000|Overall Study|Lost to Follow-up|24|||
155463488|NCT01807949|561117696|FG000|Overall Study|Adverse Event|1|||
155463489|NCT01807949|561117697|FG001|Overall Study|Adverse Event|2|||
155463490|NCT01807949|561117698|FG002|Overall Study|Adverse Event|2|||
155463491|NCT01807949|561117696|FG000|Overall Study|Withdrawal by Subject|1|||
155463492|NCT01807949|561117697|FG001|Overall Study|Withdrawal by Subject|2|||
155463493|NCT01807949|561117698|FG002|Overall Study|Withdrawal by Subject|2|||
155463494|NCT01807949|561117696|FG000|Overall Study|Non-Compliance|0|||
155463495|NCT01807949|561117697|FG001|Overall Study|Non-Compliance|0|||
155463496|NCT01807949|561117698|FG002|Overall Study|Non-Compliance|1|||
155463497|NCT01807949|561117696|FG000|Overall Study|Undefined|0|||
155463498|NCT01807949|561117697|FG001|Overall Study|Undefined|1|||
155463499|NCT01807949|561117698|FG002|Overall Study|Undefined|2|||
155463500|NCT01807949|561117696|FG000|Overall Study|Randomized But Not Treated|0|||
155463501|NCT01807949|561117697|FG001|Overall Study|Randomized But Not Treated|2|||
155463502|NCT01807949|561117698|FG002|Overall Study|Randomized But Not Treated|2|||
155463503|NCT00881361|561117699|FG000|Overall Study|Terminated prior to surgery|27|||
155463504|NCT00881361|561117700|FG001|Overall Study|Terminated prior to surgery|7|||
155463505|NCT00881361|561117701|FG002|Overall Study|Terminated prior to surgery|0|||
155463506|NCT00881361|561117699|FG000|Overall Study|Ineligible|17|||
155463507|NCT00881361|561117700|FG001|Overall Study|Ineligible|2|||
155463508|NCT00881361|561117701|FG002|Overall Study|Ineligible|2|||
155463509|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
155463510|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
155463511|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
155463512|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
155463513|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
155463514|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
155463515|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
155463516|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
155463517|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
155463518|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
155463519|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
155463520|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
155463521|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
155463522|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
155463523|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
155463524|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
155463525|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
155463526|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
155463527|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
155463528|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
155463529|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
155463530|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
155463531|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
155463532|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
155463533|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
155463534|NCT01457924|561117702|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
155463535|NCT01457924|561117703|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
155463536|NCT01457924|561117704|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
155463537|NCT01457924|561117705|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
155463538|NCT01457924|561117706|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
155463539|NCT01457924|561117702|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
155463540|NCT01457924|561117703|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
155463541|NCT01457924|561117704|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
155463542|NCT01457924|561117705|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
155463543|NCT01457924|561117706|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
155463544|NCT01457924|561117702|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
155463545|NCT01457924|561117703|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
155463546|NCT01457924|561117704|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
155463547|NCT01457924|561117705|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
155463548|NCT01457924|561117706|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
155463549|NCT01457924|561117702|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
155463550|NCT01457924|561117703|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
155463551|NCT01457924|561117704|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
155463552|NCT01457924|561117705|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
155463553|NCT01457924|561117706|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
155463554|NCT01457924|561117702|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
155463555|NCT01457924|561117703|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
155463556|NCT01457924|561117704|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
155463557|NCT01457924|561117705|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
155463558|NCT01457924|561117706|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
155463559|NCT01457924|561117702|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
155463560|NCT01457924|561117703|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
155463561|NCT01457924|561117704|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
155463562|NCT01457924|561117705|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
155463563|NCT01457924|561117706|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
155463564|NCT01457924|561117702|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
155463565|NCT01457924|561117703|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
155463566|NCT01457924|561117704|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
155463567|NCT01457924|561117705|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
155463568|NCT01457924|561117706|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
155463569|NCT01457924|561117702|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
155463570|NCT01457924|561117703|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
155463571|NCT01457924|561117704|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
155463572|NCT01457924|561117705|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
155463573|NCT01457924|561117706|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
155463574|NCT01665768|561117709|FG000|Overall Study|Adverse Event|3|||
155463575|NCT01665768|561117709|FG000|Overall Study|Lack of Efficacy|19|||
155463576|NCT01665768|561117709|FG000|Overall Study|Withdrawal by Subject|1|||
155463577|NCT01329341|561117710|FG000|Overall Study|Withdrawal by Subject|44|||
155463578|NCT00448760|561117711|FG000|Overall Study|Death|3|||
155463579|NCT03017846|561117716|FG000|Overall Study|Lost to Follow-up|3|||
155463580|NCT03017846|561117716|FG000|Overall Study|Adverse Event|2|||
155463581|NCT04603391|561117718|FG000|First Intervention (4 Days)|Adverse Event|1|||
155463582|NCT04603391|561117719|FG001|First Intervention (4 Days)|Adverse Event|0|||
155463583|NCT04603391|561117718|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
155463584|NCT04603391|561117719|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
155463585|NCT02759861|561117720|FG000|Overall Study|Death|1|||
155463586|NCT02151682|561117721|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
155463587|NCT02151682|561117722|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
155463588|NCT02151682|561117723|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
155463589|NCT02151682|561117724|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
155463590|NCT02151682|561117725|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
155463591|NCT02151682|561117726|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
155463592|NCT02151682|561117721|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
155463593|NCT02151682|561117722|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
155463594|NCT02151682|561117723|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
155463595|NCT02151682|561117724|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
155463596|NCT02151682|561117725|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
155463597|NCT02151682|561117726|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
155463598|NCT02151682|561117721|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
155463599|NCT02151682|561117722|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
155463600|NCT02151682|561117723|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
155463601|NCT02151682|561117724|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
155463602|NCT02151682|561117725|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
155463603|NCT02151682|561117726|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
155463604|NCT02151682|561117721|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
155463605|NCT02151682|561117722|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
155463606|NCT02151682|561117723|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
155463607|NCT02151682|561117724|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
155463608|NCT02151682|561117725|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
155463609|NCT02151682|561117726|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
155516814|NCT01915732|561317455|FG000|Overall Study|Withdrawal by Subject|18|||
155516815|NCT01915732|561317456|FG001|Overall Study|Withdrawal by Subject|18|||
155516816|NCT01915732|561317455|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
155516817|NCT01915732|561317456|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155516818|NCT01915732|561317455|FG000|Overall Study|Adverse Event|12|||
155516819|NCT01915732|561317456|FG001|Overall Study|Adverse Event|4|||
155516820|NCT01915732|561317455|FG000|Overall Study|Protocol Violation|5|||
155516821|NCT01915732|561317456|FG001|Overall Study|Protocol Violation|5|||
155516822|NCT01915732|561317455|FG000|Overall Study|Lack of Efficacy|6|||
155516823|NCT01915732|561317456|FG001|Overall Study|Lack of Efficacy|11|||
155516824|NCT01915732|561317455|FG000|Overall Study|Lost to Follow-up|22|||
155516825|NCT01915732|561317456|FG001|Overall Study|Lost to Follow-up|26|||
155516826|NCT01915732|561317455|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
155516827|NCT01915732|561317456|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
155516828|NCT01915732|561317455|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
155516829|NCT01915732|561317456|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
155516830|NCT01915732|561317455|FG000|Overall Study|Drug Release Error|1|||
155516831|NCT01915732|561317456|FG001|Overall Study|Drug Release Error|0|||
155516832|NCT01915732|561317455|FG000|Overall Study|Recovered|1|||
155516833|NCT01915732|561317456|FG001|Overall Study|Recovered|0|||
155516834|NCT01915732|561317455|FG000|Overall Study|Pregnancy|1|||
155516835|NCT01915732|561317456|FG001|Overall Study|Pregnancy|0|||
155516836|NCT01915732|561317455|FG000|Overall Study|Poor Perceived Efficacy|1|||
155516837|NCT01915732|561317456|FG001|Overall Study|Poor Perceived Efficacy|0|||
155516838|NCT01915732|561317455|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
155516839|NCT01915732|561317456|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
155516840|NCT01915732|561317455|FG000|Overall Study|Got Well|0|||
155516841|NCT01915732|561317456|FG001|Overall Study|Got Well|1|||
155516842|NCT01915732|561317455|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
155516843|NCT01915732|561317456|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
155516844|NCT01915732|561317455|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
155516845|NCT01915732|561317456|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
155516846|NCT01915732|561317455|FG000|Overall Study|Job Transfer|0|||
155516847|NCT01915732|561317456|FG001|Overall Study|Job Transfer|1|||
155516848|NCT01915732|561317455|FG000|Overall Study|Improper Facial Procedure|0|||
155463610|NCT02151682|561117721|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
155463611|NCT02151682|561117722|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
155463612|NCT02151682|561117723|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
155463613|NCT02151682|561117724|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
155463614|NCT02151682|561117725|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
155463615|NCT02151682|561117726|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
155463616|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
155463617|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
155463618|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
155463619|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
155463620|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
155463621|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
155463622|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
155463623|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
155463624|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
155463625|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
155463626|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
155463627|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
155652497|NCT00289900|561820367|FG004|Overall Study|Adverse Event|20|||
155652498|NCT00289900|561820368|FG005|Overall Study|Adverse Event|33|||
155463628|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
155463629|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
155463630|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
155463631|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
155463632|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
155463633|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
155463634|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
155463635|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
155463636|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
155463637|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
155463638|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
155463639|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
155463640|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
155463641|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
155463642|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
155463643|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
155463644|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
155463645|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
155463646|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
155463647|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
155463648|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
155463649|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
155463650|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
155463651|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
155463652|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
155463653|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
155463654|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
155463655|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
155463656|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
155463657|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
155463658|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
155463659|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
155463660|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
155463661|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
155463662|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
155463663|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
155463664|NCT02151682|561117721|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
155463665|NCT02151682|561117722|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
155463666|NCT02151682|561117723|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
155463667|NCT02151682|561117724|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
155463668|NCT02151682|561117725|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
155463669|NCT02151682|561117726|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
155652499|NCT00289900|561820363|FG000|Overall Study|Lost to Follow-up|7|||
155652500|NCT00289900|561820364|FG001|Overall Study|Lost to Follow-up|7|||
155652501|NCT00289900|561820365|FG002|Overall Study|Lost to Follow-up|8|||
155463670|NCT02151682|561117721|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
155463671|NCT02151682|561117722|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
155463672|NCT02151682|561117723|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
155463673|NCT02151682|561117724|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
155463674|NCT02151682|561117725|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
155463675|NCT02151682|561117726|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
155463676|NCT02151682|561117721|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
155463677|NCT02151682|561117722|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
155463678|NCT02151682|561117723|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
155463679|NCT02151682|561117724|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
155463680|NCT02151682|561117725|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
155463681|NCT02151682|561117726|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
155463682|NCT02151682|561117721|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
155463683|NCT02151682|561117722|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
155463684|NCT02151682|561117723|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
155463685|NCT02151682|561117724|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
155463686|NCT02151682|561117725|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
155463687|NCT02151682|561117726|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
155463688|NCT02151682|561117721|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
155463689|NCT02151682|561117722|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
155463690|NCT02151682|561117723|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
155463691|NCT02151682|561117724|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
155463692|NCT02151682|561117725|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
155463693|NCT02151682|561117726|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
155463694|NCT00290589|561117727|FG000|Overall Study|Lost to Follow-up|2|||
155463695|NCT00290589|561117728|FG001|Overall Study|Lost to Follow-up|2|||
155463696|NCT05014542|561117729|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
155463697|NCT05014542|561117730|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
155463698|NCT05014542|561117729|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
155463699|NCT05014542|561117730|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
155463700|NCT05014542|561117729|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
155463701|NCT05014542|561117730|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
155463702|NCT05014542|561117729|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
155463703|NCT05014542|561117730|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
155463704|NCT01438307|561117731|FG000|Overall Study|Death|1|||
155463705|NCT01438307|561117732|FG001|Overall Study|Death|1|||
155463706|NCT06000501|561117733|FG000|Overall Study|Screen failure|3|||
155463707|NCT06000501|561117733|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
155463708|NCT06000501|561117733|FG000|Overall Study|Physician Decision|4|||
155463709|NCT06000501|561117733|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
155463710|NCT06000501|561117733|FG000|Overall Study|Scheduling issues|2|||
155463711|NCT02378883|561117734|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
155463712|NCT02378883|561117734|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
155463713|NCT02378883|561117734|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
155463714|NCT02378883|561117734|FG000|30 Day Follow-Up|Physician Decision|2|||
155463715|NCT02378883|561117734|FG000|30 Day Follow-Up|Missed Visit|2|||
155463716|NCT02378883|561117734|FG000|30 Day Follow-Up|Death|1|||
155463717|NCT02378883|561117734|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
155463718|NCT02378883|561117734|FG000|12 Months Follow-Up|Death|2|||
155463719|NCT00318565|561117735|FG000|Overall Study|Excluded per protocol|24|||
155463720|NCT00691093|561117736|FG000|Overall Study|Adverse Event|1|||
155463721|NCT00691093|561117736|FG000|Overall Study|Lost to Follow-up|1|||
155463722|NCT00691093|561117736|FG000|Overall Study|Lack of Efficacy|1|||
155463723|NCT00691093|561117736|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
155463724|NCT01700985|561117740|FG000|Overall Study|Incarcerated|0|||
155463725|NCT01700985|561117741|FG001|Overall Study|Incarcerated|1|||
155463726|NCT00965146|561117742|FG000|Overall Study|Death|7|||
155463727|NCT00965146|561117742|FG000|Overall Study|Lost to Follow-up|22|||
155463728|NCT00965146|561117742|FG000|Overall Study|Withdrawal by Subject|17|||
155463729|NCT00965146|561117742|FG000|Overall Study|Unable to return|1|||
155463730|NCT00965146|561117742|FG000|Overall Study|Unwilling to return|11|||
155463731|NCT00965146|561117742|FG000|Overall Study|Intercurrent illness|1|||
155463732|NCT00965146|561117742|FG000|Overall Study|Revision / Removal of Study Implant|6|||
155463733|NCT00965146|561117742|FG000|Overall Study|Overall Study Termination|145|||
155463734|NCT00067470|561117743|FG000|Overall Study|Withdrawal by Subject|0|||
155463735|NCT00067470|561117744|FG001|Overall Study|Withdrawal by Subject|1|||
155463736|NCT01148693|561117745|FG000|Overall Study|Attempts for cannulation were failed|13|||
155463737|NCT01148693|561117746|FG001|Overall Study|Attempts for cannulation were failed|10|||
155463738|NCT01135017|561117747|FG000|Overall Study|Adverse Event|3|||
155463739|NCT01135017|561117748|FG001|Overall Study|Adverse Event|8|||
155463740|NCT01135017|561117747|FG000|Overall Study|Other than above|3|||
155463741|NCT01135017|561117748|FG001|Overall Study|Other than above|4|||
155463742|NCT02146248|561117750|FG000|Overall Study|Withdrawal by Subject|2|||
155463743|NCT03699631|561117753|FG000|Overall Study|Adverse Event|3|||
155463744|NCT00039741|561117754|FG000|Overall Study|Death|0|||
155463745|NCT00039741|561117755|FG001|Overall Study|Death|1|||
155463746|NCT00039741|561117756|FG002|Overall Study|Death|0|||
155463747|NCT00039741|561117757|FG003|Overall Study|Death|0|||
155463748|NCT00039741|561117754|FG000|Overall Study|Lost to Follow-up|3|||
155463749|NCT00039741|561117755|FG001|Overall Study|Lost to Follow-up|1|||
155463750|NCT00039741|561117756|FG002|Overall Study|Lost to Follow-up|5|||
155463751|NCT00039741|561117757|FG003|Overall Study|Lost to Follow-up|2|||
155463752|NCT00039741|561117754|FG000|Overall Study|Confounding medical condition|1|||
155463753|NCT00039741|561117755|FG001|Overall Study|Confounding medical condition|0|||
155463754|NCT00039741|561117756|FG002|Overall Study|Confounding medical condition|0|||
155463755|NCT00039741|561117757|FG003|Overall Study|Confounding medical condition|0|||
155463756|NCT00039741|561117754|FG000|Overall Study|Not able to get to clinic|5|||
155463757|NCT00039741|561117755|FG001|Overall Study|Not able to get to clinic|2|||
155463758|NCT00039741|561117756|FG002|Overall Study|Not able to get to clinic|0|||
155463759|NCT00039741|561117757|FG003|Overall Study|Not able to get to clinic|3|||
155463760|NCT00039741|561117754|FG000|Overall Study|Moved|3|||
155463761|NCT00039741|561117755|FG001|Overall Study|Moved|2|||
155463762|NCT00039741|561117756|FG002|Overall Study|Moved|3|||
155463763|NCT00039741|561117757|FG003|Overall Study|Moved|6|||
155463764|NCT00039741|561117754|FG000|Overall Study|Non-compliance with protocol|1|||
155463765|NCT00039741|561117755|FG001|Overall Study|Non-compliance with protocol|0|||
155463766|NCT00039741|561117756|FG002|Overall Study|Non-compliance with protocol|1|||
155463767|NCT00039741|561117757|FG003|Overall Study|Non-compliance with protocol|0|||
155463768|NCT00039741|561117754|FG000|Overall Study|Withdrew consent|0|||
155463769|NCT00039741|561117755|FG001|Overall Study|Withdrew consent|5|||
155463770|NCT00039741|561117756|FG002|Overall Study|Withdrew consent|0|||
155463771|NCT00039741|561117757|FG003|Overall Study|Withdrew consent|1|||
155463772|NCT00039741|561117754|FG000|Overall Study|Missed final visit|2|||
155463773|NCT00039741|561117755|FG001|Overall Study|Missed final visit|1|||
155463774|NCT00039741|561117756|FG002|Overall Study|Missed final visit|2|||
155463775|NCT00039741|561117757|FG003|Overall Study|Missed final visit|2|||
155463776|NCT00507416|561117758|FG000|Overall Study|Adverse Event|58|||
155463777|NCT00507416|561117759|FG001|Overall Study|Adverse Event|67|||
155463778|NCT00507416|561117760|FG002|Overall Study|Adverse Event|65|||
155463779|NCT00507416|561117758|FG000|Overall Study|Protocol Violation|1|||
155463780|NCT00507416|561117759|FG001|Overall Study|Protocol Violation|2|||
155463781|NCT00507416|561117760|FG002|Overall Study|Protocol Violation|0|||
155463782|NCT00507416|561117758|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
155463783|NCT00507416|561117759|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
155463784|NCT00507416|561117760|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
155463785|NCT00507416|561117758|FG000|Overall Study|Progressive Disease|20|||
155463786|NCT00507416|561117759|FG001|Overall Study|Progressive Disease|10|||
155463787|NCT00507416|561117760|FG002|Overall Study|Progressive Disease|13|||
155463788|NCT00507416|561117758|FG000|Overall Study|Patient declined further treatment|18|||
155463789|NCT00507416|561117759|FG001|Overall Study|Patient declined further treatment|14|||
155463790|NCT00507416|561117760|FG002|Overall Study|Patient declined further treatment|11|||
155463791|NCT00507416|561117758|FG000|Overall Study|Other|11|||
155463792|NCT00507416|561117759|FG001|Overall Study|Other|16|||
155463793|NCT00507416|561117760|FG002|Overall Study|Other|13|||
155463794|NCT00507416|561117758|FG000|Overall Study|Did not Receive Study Treatment|3|||
155463795|NCT00507416|561117759|FG001|Overall Study|Did not Receive Study Treatment|9|||
155463796|NCT00507416|561117760|FG002|Overall Study|Did not Receive Study Treatment|4|||
155463797|NCT00964158|561117761|FG000|Overall Study|Lost to Follow-up|0|||
155463798|NCT00964158|561117762|FG001|Overall Study|Lost to Follow-up|1|||
155463799|NCT00964158|561117763|FG002|Overall Study|Lost to Follow-up|2|||
155463800|NCT00964158|561117761|FG000|Overall Study|Withdrawal by Subject|0|||
155463801|NCT00964158|561117762|FG001|Overall Study|Withdrawal by Subject|0|||
155463802|NCT00964158|561117763|FG002|Overall Study|Withdrawal by Subject|6|||
155463803|NCT03101514|561117764|FG000|Overall Study|Withdrawal by Subject|4|||
155463804|NCT03101514|561117764|FG000|Overall Study|Protocol Violation|2|||
155463805|NCT03101514|561117764|FG000|Overall Study|patient's information was incomplete|1|||
155463806|NCT01736254|561117766|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
155463807|NCT01736254|561117766|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
155463808|NCT02559206|561117767|FG000|Overall Study|Adverse Event|0|||
155463809|NCT02559206|561117768|FG001|Overall Study|Adverse Event|4|||
155463810|NCT02559206|561117769|FG002|Overall Study|Adverse Event|1|||
155463811|NCT02559206|561117770|FG003|Overall Study|Adverse Event|5|||
155463812|NCT02559206|561117771|FG004|Overall Study|Adverse Event|3|||
155463813|NCT02559206|561117772|FG005|Overall Study|Adverse Event|0|||
155463814|NCT02559206|561117773|FG006|Overall Study|Adverse Event|1|||
155463815|NCT02559206|561117774|FG007|Overall Study|Adverse Event|0|||
155463816|NCT02559206|561117767|FG000|Overall Study|Protocol Violation|1|||
155463817|NCT02559206|561117768|FG001|Overall Study|Protocol Violation|0|||
155463818|NCT02559206|561117769|FG002|Overall Study|Protocol Violation|1|||
155463819|NCT02559206|561117770|FG003|Overall Study|Protocol Violation|0|||
155463820|NCT02559206|561117771|FG004|Overall Study|Protocol Violation|0|||
155463821|NCT02559206|561117772|FG005|Overall Study|Protocol Violation|2|||
155463822|NCT02559206|561117773|FG006|Overall Study|Protocol Violation|0|||
155463823|NCT02559206|561117774|FG007|Overall Study|Protocol Violation|0|||
155463824|NCT02559206|561117767|FG000|Overall Study|Withdrawal by Subject|3|||
155463825|NCT02559206|561117768|FG001|Overall Study|Withdrawal by Subject|3|||
155463826|NCT02559206|561117769|FG002|Overall Study|Withdrawal by Subject|1|||
155463827|NCT02559206|561117770|FG003|Overall Study|Withdrawal by Subject|3|||
155463828|NCT02559206|561117771|FG004|Overall Study|Withdrawal by Subject|5|||
155463829|NCT02559206|561117772|FG005|Overall Study|Withdrawal by Subject|4|||
155463830|NCT02559206|561117773|FG006|Overall Study|Withdrawal by Subject|1|||
155463831|NCT02559206|561117774|FG007|Overall Study|Withdrawal by Subject|2|||
155463832|NCT02559206|561117767|FG000|Overall Study|Lost to Follow-up|3|||
155463833|NCT02559206|561117768|FG001|Overall Study|Lost to Follow-up|5|||
155463834|NCT02559206|561117769|FG002|Overall Study|Lost to Follow-up|3|||
155463835|NCT02559206|561117770|FG003|Overall Study|Lost to Follow-up|3|||
155463836|NCT02559206|561117771|FG004|Overall Study|Lost to Follow-up|2|||
155463837|NCT02559206|561117772|FG005|Overall Study|Lost to Follow-up|5|||
155463838|NCT02559206|561117773|FG006|Overall Study|Lost to Follow-up|1|||
155463839|NCT02559206|561117774|FG007|Overall Study|Lost to Follow-up|4|||
155463840|NCT02559206|561117767|FG000|Overall Study|Lack of Efficacy|1|||
155463841|NCT02559206|561117768|FG001|Overall Study|Lack of Efficacy|0|||
155463842|NCT02559206|561117769|FG002|Overall Study|Lack of Efficacy|3|||
155463843|NCT02559206|561117770|FG003|Overall Study|Lack of Efficacy|2|||
155463844|NCT02559206|561117771|FG004|Overall Study|Lack of Efficacy|2|||
155463845|NCT02559206|561117772|FG005|Overall Study|Lack of Efficacy|3|||
155463846|NCT02559206|561117773|FG006|Overall Study|Lack of Efficacy|3|||
155463847|NCT02559206|561117774|FG007|Overall Study|Lack of Efficacy|3|||
155463848|NCT02559206|561117767|FG000|Overall Study|Other Not Specified|0|||
155463849|NCT02559206|561117768|FG001|Overall Study|Other Not Specified|0|||
155463850|NCT02559206|561117769|FG002|Overall Study|Other Not Specified|0|||
155463851|NCT02559206|561117770|FG003|Overall Study|Other Not Specified|1|||
155463852|NCT02559206|561117771|FG004|Overall Study|Other Not Specified|0|||
155463853|NCT02559206|561117772|FG005|Overall Study|Other Not Specified|0|||
155463854|NCT02559206|561117773|FG006|Overall Study|Other Not Specified|0|||
155463855|NCT02559206|561117774|FG007|Overall Study|Other Not Specified|0|||
155463856|NCT01375647|561119485|FG000|Overall Study|Lost to Follow-up|3|||
155463857|NCT01375647|561119486|FG001|Overall Study|Lost to Follow-up|3|||
155463858|NCT01375647|561119487|FG002|Overall Study|Lost to Follow-up|7|||
155463859|NCT01375647|561119488|FG003|Overall Study|Lost to Follow-up|10|||
155463860|NCT01375647|561119485|FG000|Overall Study|Death|1|||
155463861|NCT01375647|561119486|FG001|Overall Study|Death|2|||
155463862|NCT01375647|561119487|FG002|Overall Study|Death|1|||
155463863|NCT01375647|561119488|FG003|Overall Study|Death|0|||
155463864|NCT01375647|561119485|FG000|Overall Study|Withdrawal by Subject|17|||
155463865|NCT01375647|561119486|FG001|Overall Study|Withdrawal by Subject|20|||
155463866|NCT01375647|561119487|FG002|Overall Study|Withdrawal by Subject|26|||
155463867|NCT01375647|561119488|FG003|Overall Study|Withdrawal by Subject|14|||
155463868|NCT01375647|561119485|FG000|Overall Study|Physician Decision|1|||
155463869|NCT01375647|561119486|FG001|Overall Study|Physician Decision|0|||
155463870|NCT01375647|561119487|FG002|Overall Study|Physician Decision|0|||
155463871|NCT01375647|561119488|FG003|Overall Study|Physician Decision|0|||
155463872|NCT01102140|561119489|FG000|Overall Study|Lost to Follow-up|1|||
155463873|NCT01102140|561119490|FG001|Overall Study|Lost to Follow-up|0|||
155463874|NCT01102140|561119489|FG000|Overall Study|Investigator terminated study|2|||
155463875|NCT01102140|561119490|FG001|Overall Study|Investigator terminated study|2|||
155463876|NCT03788967|561119491|FG000|Overall Study|Lost to Follow-up|14|||
155463877|NCT03788967|561119492|FG001|Overall Study|Lost to Follow-up|10|||
155463878|NCT03788967|561119491|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
155463879|NCT03788967|561119492|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
155463880|NCT03788967|561119491|FG000|Overall Study|Participant Withdrawal of Consent|13|||
155463881|NCT03788967|561119492|FG001|Overall Study|Participant Withdrawal of Consent|5|||
155463882|NCT03788967|561119491|FG000|Overall Study|Adverse Event|1|||
155463883|NCT03788967|561119492|FG001|Overall Study|Adverse Event|1|||
155463884|NCT03788967|561119491|FG000|Overall Study|COVID-19|1|||
155463885|NCT03788967|561119492|FG001|Overall Study|COVID-19|2|||
155463886|NCT04268303|561119493|FG000|Overall Study|Lost to Follow-up|1|||
155463887|NCT04268303|561119494|FG001|Overall Study|Lost to Follow-up|1|||
155463888|NCT04268303|561119495|FG002|Overall Study|Lost to Follow-up|2|||
155463889|NCT04268303|561119493|FG000|Overall Study|Withdrawal by Subject|0|||
155463890|NCT04268303|561119494|FG001|Overall Study|Withdrawal by Subject|1|||
155463891|NCT04268303|561119495|FG002|Overall Study|Withdrawal by Subject|1|||
155463892|NCT04268303|561119493|FG000|Overall Study|Adverse Event|2|||
155463893|NCT04268303|561119494|FG001|Overall Study|Adverse Event|0|||
155463894|NCT04268303|561119495|FG002|Overall Study|Adverse Event|0|||
155463895|NCT00355134|561119496|FG000|Core Phase|Withdrawal by Subject|35|||
155463896|NCT00355134|561119497|FG001|Core Phase|Withdrawal by Subject|24|||
155463897|NCT00355134|561119498|FG002|Core Phase|Withdrawal by Subject|35|||
155463898|NCT00355134|561119499|FG003|Core Phase|Withdrawal by Subject|0|||
155463899|NCT00355134|561119500|FG004|Core Phase|Withdrawal by Subject|0|||
155463900|NCT00355134|561119496|FG000|Core Phase|Adverse Event|28|||
155463901|NCT00355134|561119497|FG001|Core Phase|Adverse Event|22|||
155463902|NCT00355134|561119498|FG002|Core Phase|Adverse Event|16|||
155463903|NCT00355134|561119499|FG003|Core Phase|Adverse Event|0|||
155463904|NCT00355134|561119500|FG004|Core Phase|Adverse Event|0|||
155463905|NCT00355134|561119496|FG000|Core Phase|Lost to Follow-up|17|||
155463906|NCT00355134|561119497|FG001|Core Phase|Lost to Follow-up|13|||
155463907|NCT00355134|561119498|FG002|Core Phase|Lost to Follow-up|21|||
155463908|NCT00355134|561119499|FG003|Core Phase|Lost to Follow-up|0|||
155463909|NCT00355134|561119500|FG004|Core Phase|Lost to Follow-up|0|||
155463910|NCT00355134|561119496|FG000|Core Phase|Abnormal laboratory value(s)|19|||
155463911|NCT00355134|561119497|FG001|Core Phase|Abnormal laboratory value(s)|14|||
155463912|NCT00355134|561119498|FG002|Core Phase|Abnormal laboratory value(s)|2|||
155463913|NCT00355134|561119499|FG003|Core Phase|Abnormal laboratory value(s)|0|||
155463914|NCT00355134|561119500|FG004|Core Phase|Abnormal laboratory value(s)|0|||
155463915|NCT00355134|561119496|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
155463916|NCT00355134|561119497|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
155463917|NCT00355134|561119498|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
155463918|NCT00355134|561119499|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
155463919|NCT00355134|561119500|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
155463920|NCT00355134|561119496|FG000|Core Phase|Administrative problems|5|||
155463921|NCT00355134|561119497|FG001|Core Phase|Administrative problems|3|||
155463922|NCT00355134|561119498|FG002|Core Phase|Administrative problems|5|||
155463923|NCT00355134|561119499|FG003|Core Phase|Administrative problems|0|||
155463924|NCT00355134|561119500|FG004|Core Phase|Administrative problems|0|||
155463925|NCT00355134|561119496|FG000|Core Phase|Protocol Violation|3|||
155463926|NCT00355134|561119497|FG001|Core Phase|Protocol Violation|2|||
155463927|NCT00355134|561119498|FG002|Core Phase|Protocol Violation|2|||
155463928|NCT00355134|561119499|FG003|Core Phase|Protocol Violation|0|||
155463929|NCT00355134|561119500|FG004|Core Phase|Protocol Violation|0|||
155463930|NCT00355134|561119496|FG000|Core Phase|Abnormal test procedure result(s)|1|||
155516849|NCT01915732|561317456|FG001|Overall Study|Improper Facial Procedure|1|||
155516850|NCT01915732|561317455|FG000|Overall Study|Poor Conscious Effect|0|||
155516851|NCT01915732|561317456|FG001|Overall Study|Poor Conscious Effect|1|||
155516852|NCT00449150|561317462|FG000|Overall Study|Adverse Event|11|||
155516853|NCT00449150|561317463|FG001|Overall Study|Adverse Event|18|||
155516854|NCT00449150|561317464|FG002|Overall Study|Adverse Event|9|||
155516855|NCT00449150|561317462|FG000|Overall Study|Lack of Efficacy|1|||
155516856|NCT00449150|561317463|FG001|Overall Study|Lack of Efficacy|2|||
155516857|NCT00449150|561317464|FG002|Overall Study|Lack of Efficacy|2|||
155516858|NCT00449150|561317462|FG000|Overall Study|Other|16|||
155516859|NCT00449150|561317463|FG001|Overall Study|Other|13|||
155516860|NCT00449150|561317464|FG002|Overall Study|Other|14|||
155516861|NCT00449150|561317462|FG000|Overall Study|Withdrawal by Subject|17|||
155516862|NCT00449150|561317463|FG001|Overall Study|Withdrawal by Subject|18|||
155516863|NCT00449150|561317464|FG002|Overall Study|Withdrawal by Subject|21|||
155516864|NCT00449150|561317462|FG000|Overall Study|Protocol Violation|1|||
155516865|NCT00449150|561317463|FG001|Overall Study|Protocol Violation|2|||
155516866|NCT00449150|561317464|FG002|Overall Study|Protocol Violation|1|||
155516867|NCT02246478|561317465|FG000|Multiple-dose Phase|Protocol Violation|1|||
155516868|NCT02246478|561317466|FG001|Multiple-dose Phase|Protocol Violation|0|||
155516869|NCT02246478|561317467|FG002|Multiple-dose Phase|Protocol Violation|0|||
155516870|NCT02246478|561317468|FG003|Multiple-dose Phase|Protocol Violation|1|||
155516871|NCT00429923|561317470|FG000|Overall Study|Adverse Event|0|||
155516872|NCT00429923|561317471|FG001|Overall Study|Adverse Event|2|||
155516873|NCT00429923|561317472|FG002|Overall Study|Adverse Event|3|||
155516874|NCT00429923|561317470|FG000|Overall Study|Lack of Efficacy|4|||
155516875|NCT00429923|561317471|FG001|Overall Study|Lack of Efficacy|1|||
155516876|NCT00429923|561317472|FG002|Overall Study|Lack of Efficacy|33|||
155516877|NCT00429923|561317470|FG000|Overall Study|Lost to Follow-up|0|||
155516878|NCT00429923|561317471|FG001|Overall Study|Lost to Follow-up|0|||
155463931|NCT00355134|561119497|FG001|Core Phase|Abnormal test procedure result(s)|2|||
155516879|NCT00429923|561317472|FG002|Overall Study|Lost to Follow-up|2|||
155516880|NCT00429923|561317470|FG000|Overall Study|Withdrew Consent|1|||
155463932|NCT00355134|561119498|FG002|Core Phase|Abnormal test procedure result(s)|1|||
155463933|NCT00355134|561119499|FG003|Core Phase|Abnormal test procedure result(s)|0|||
155463934|NCT00355134|561119500|FG004|Core Phase|Abnormal test procedure result(s)|0|||
155516881|NCT00429923|561317471|FG001|Overall Study|Withdrew Consent|0|||
155463935|NCT00355134|561119496|FG000|Core Phase|Condition no longer requires study drug|1|||
155463936|NCT00355134|561119497|FG001|Core Phase|Condition no longer requires study drug|0|||
155463937|NCT00355134|561119498|FG002|Core Phase|Condition no longer requires study drug|1|||
155516882|NCT00429923|561317472|FG002|Overall Study|Withdrew Consent|1|||
155516883|NCT00429923|561317470|FG000|Overall Study|Early Termination|0|||
155516884|NCT00429923|561317471|FG001|Overall Study|Early Termination|1|||
155516885|NCT00429923|561317472|FG002|Overall Study|Early Termination|0|||
155516886|NCT00662129|561317473|FG000|Overall Study|Protocol Violation|1|||
155516887|NCT00662129|561317473|FG000|Overall Study|Cancel prior to beginning treatment|1|||
155463938|NCT00355134|561119499|FG003|Core Phase|Condition no longer requires study drug|0|||
155463939|NCT00355134|561119500|FG004|Core Phase|Condition no longer requires study drug|0|||
155463940|NCT00355134|561119496|FG000|Extension Phase|Withdrawal by Subject|7|||
155463941|NCT00355134|561119497|FG001|Extension Phase|Withdrawal by Subject|11|||
155463942|NCT00355134|561119498|FG002|Extension Phase|Withdrawal by Subject|0|||
155463943|NCT00355134|561119499|FG003|Extension Phase|Withdrawal by Subject|7|||
155463944|NCT00355134|561119500|FG004|Extension Phase|Withdrawal by Subject|5|||
155463945|NCT00355134|561119496|FG000|Extension Phase|Adverse Event|13|||
155463946|NCT00355134|561119497|FG001|Extension Phase|Adverse Event|9|||
155463947|NCT00355134|561119498|FG002|Extension Phase|Adverse Event|0|||
155463948|NCT00355134|561119499|FG003|Extension Phase|Adverse Event|3|||
155463949|NCT00355134|561119500|FG004|Extension Phase|Adverse Event|5|||
155463950|NCT00355134|561119496|FG000|Extension Phase|Lost to Follow-up|2|||
155463951|NCT00355134|561119497|FG001|Extension Phase|Lost to Follow-up|6|||
155463952|NCT00355134|561119498|FG002|Extension Phase|Lost to Follow-up|0|||
155463953|NCT00355134|561119499|FG003|Extension Phase|Lost to Follow-up|2|||
155463954|NCT00355134|561119500|FG004|Extension Phase|Lost to Follow-up|4|||
155463955|NCT00355134|561119496|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
155463956|NCT00355134|561119497|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
155463957|NCT00355134|561119498|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
155463958|NCT00355134|561119499|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
155463959|NCT00355134|561119500|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
155463960|NCT00355134|561119496|FG000|Extension Phase|Administrative problems|2|||
155463961|NCT00355134|561119497|FG001|Extension Phase|Administrative problems|4|||
155463962|NCT00355134|561119498|FG002|Extension Phase|Administrative problems|0|||
155463963|NCT00355134|561119499|FG003|Extension Phase|Administrative problems|1|||
155463964|NCT00355134|561119500|FG004|Extension Phase|Administrative problems|1|||
155463965|NCT00355134|561119496|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
155463966|NCT00355134|561119497|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
155463967|NCT00355134|561119498|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
155463968|NCT00355134|561119499|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
155463969|NCT00355134|561119500|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
155463970|NCT00355134|561119496|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
155463971|NCT00355134|561119497|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
155463972|NCT00355134|561119498|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
155516888|NCT00662129|561317473|FG000|Overall Study|Ineligible|1|||
155516889|NCT00329602|561317476|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
155516890|NCT00329602|561317477|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
155516891|NCT00329602|561317478|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
155516892|NCT00329602|561317476|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
155516893|NCT00329602|561317477|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
155516894|NCT00329602|561317478|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
155516895|NCT00329602|561317476|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
155516896|NCT00329602|561317477|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
155516897|NCT00329602|561317478|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
155516898|NCT00329602|561317476|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
155516899|NCT00329602|561317477|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
155516900|NCT00329602|561317478|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
155516901|NCT00329602|561317476|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
155516902|NCT00329602|561317477|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
155516903|NCT00329602|561317478|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
155516904|NCT00329602|561317476|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
155516905|NCT00329602|561317477|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
155516906|NCT00329602|561317478|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
155516907|NCT02579096|561317479|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
155516908|NCT02579096|561317480|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
155463973|NCT00355134|561119499|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
155463974|NCT00355134|561119500|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
155463975|NCT00355134|561119496|FG000|Extension Phase|Protocol Violation|0|||
155516909|NCT02579096|561317479|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
155463976|NCT00355134|561119497|FG001|Extension Phase|Protocol Violation|0|||
155463977|NCT00355134|561119498|FG002|Extension Phase|Protocol Violation|0|||
155463978|NCT00355134|561119499|FG003|Extension Phase|Protocol Violation|1|||
155463979|NCT00355134|561119500|FG004|Extension Phase|Protocol Violation|0|||
155463980|NCT03621189|561119513|FG000|Overall Study|Withdrawal by Subject|0|||
155463981|NCT03621189|561119514|FG001|Overall Study|Withdrawal by Subject|3|||
155463982|NCT03621189|561119513|FG000|Overall Study|Physician Decision|0|||
155463983|NCT03621189|561119514|FG001|Overall Study|Physician Decision|2|||
155463984|NCT00233324|561119515|FG000|Main Study|Death|68|||
155463985|NCT00233324|561119516|FG001|Main Study|Death|60|||
155463986|NCT00233324|561119517|FG002|Main Study|Death|62|||
155463987|NCT00233324|561119518|FG003|Main Study|Death|47|||
155463988|NCT00233324|561119515|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
155463989|NCT00233324|561119516|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
155463990|NCT00233324|561119517|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
155463991|NCT00233324|561119518|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
155463992|NCT00233324|561119515|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
155463993|NCT00233324|561119516|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
155463994|NCT00233324|561119517|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
155463995|NCT00233324|561119518|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
155463996|NCT00438464|561119519|FG000|Overall Study|Terminated Early|14|||
155463997|NCT00438464|561119520|FG001|Overall Study|Terminated Early|5|||
155463998|NCT00438464|561119519|FG000|Overall Study|Incomplete data submission|0|||
155463999|NCT00438464|561119520|FG001|Overall Study|Incomplete data submission|2|||
155464000|NCT01281189|561119528|FG000|Overall Study|Adverse Event|7|||
155464001|NCT01281189|561119529|FG001|Overall Study|Adverse Event|9|||
155464002|NCT01281189|561119528|FG000|Overall Study|Lost to Follow-up|6|||
155464003|NCT01281189|561119529|FG001|Overall Study|Lost to Follow-up|4|||
155464004|NCT01281189|561119528|FG000|Overall Study|Withdrawal by Subject|21|||
155464005|NCT01281189|561119529|FG001|Overall Study|Withdrawal by Subject|24|||
155464006|NCT01281189|561119528|FG000|Overall Study|Physician Decision|2|||
155464007|NCT01281189|561119529|FG001|Overall Study|Physician Decision|3|||
155464008|NCT01281189|561119528|FG000|Overall Study|Death|103|||
155464009|NCT01281189|561119529|FG001|Overall Study|Death|91|||
155464010|NCT01281189|561119528|FG000|Overall Study|Other|8|||
155464011|NCT01281189|561119529|FG001|Overall Study|Other|12|||
155464012|NCT03518034|561119530|FG000|Overall Study|Not Treated|5|||
155464013|NCT03518034|561119531|FG001|Overall Study|Not Treated|1|||
155464014|NCT03518034|561119530|FG000|Overall Study|Withdrawal by Subject|309|||
155464015|NCT03518034|561119531|FG001|Overall Study|Withdrawal by Subject|351|||
155464016|NCT03518034|561119530|FG000|Overall Study|Lost to Follow-up|446|||
155464017|NCT03518034|561119531|FG001|Overall Study|Lost to Follow-up|458|||
155464018|NCT03518034|561119530|FG000|Overall Study|Adverse Event|138|||
155464019|NCT03518034|561119531|FG001|Overall Study|Adverse Event|130|||
155464020|NCT03518034|561119530|FG000|Overall Study|Lack of Efficacy|11|||
155516910|NCT02579096|561317480|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
155516911|NCT02579096|561317479|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
155516912|NCT02579096|561317480|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
155516913|NCT02579096|561317479|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
155516914|NCT02579096|561317480|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
155516915|NCT02579096|561317479|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
155516916|NCT02579096|561317480|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
155516917|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Death|2|||
155516918|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Death|4|||
155516919|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
155516920|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
155516921|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
155516922|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
155516923|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
155516924|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
155516925|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
155516926|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
155516927|NCT02579096|561317479|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
155516928|NCT02579096|561317480|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
155516929|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Death|3|||
155516930|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Death|2|||
155464021|NCT03518034|561119531|FG001|Overall Study|Lack of Efficacy|23|||
155464022|NCT03518034|561119530|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
155464023|NCT03518034|561119531|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
155464024|NCT03518034|561119530|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
155464025|NCT03518034|561119531|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
155464026|NCT03518034|561119530|FG000|Overall Study|Other, Not Specified|84|||
155464027|NCT03518034|561119531|FG001|Overall Study|Other, Not Specified|53|||
155464028|NCT03518034|561119530|FG000|Overall Study|Reason Missing|2|||
155464029|NCT03518034|561119531|FG001|Overall Study|Reason Missing|3|||
155516931|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
155516932|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
155516933|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
155464030|NCT00415519|561119532|FG000|Overall Study|Adverse Event|1|||
155464031|NCT00415519|561119533|FG001|Overall Study|Adverse Event|0|||
155464032|NCT00415519|561119532|FG000|Overall Study|Withdrawal by Subject|2|||
155464033|NCT00415519|561119533|FG001|Overall Study|Withdrawal by Subject|0|||
155464034|NCT00415519|561119532|FG000|Overall Study|Patient's convenience|1|||
155464035|NCT00415519|561119533|FG001|Overall Study|Patient's convenience|0|||
155464036|NCT03485222|561119536|FG000|Overall Study|Death|0|||
155464037|NCT03485222|561119537|FG001|Overall Study|Death|1|||
155464038|NCT03485222|561119536|FG000|Overall Study|Lost to Follow-up|2|||
155464039|NCT03485222|561119537|FG001|Overall Study|Lost to Follow-up|1|||
155464040|NCT01527110|561119538|FG000|Overall Study|Adverse Event|1|||
155464041|NCT02007252|561119539|FG000|Overall Study|Administrative problems|3|||
155464042|NCT02007252|561119540|FG001|Overall Study|Administrative problems|7|||
155464043|NCT02007252|561119539|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155464044|NCT02007252|561119540|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155464045|NCT02007252|561119539|FG000|Overall Study|Adverse Event|7|||
155464046|NCT02007252|561119540|FG001|Overall Study|Adverse Event|4|||
155464047|NCT00608881|561119541|FG000|Overall Study|Death|22|||
155464048|NCT00608881|561119542|FG001|Overall Study|Death|13|||
155464049|NCT00608881|561119541|FG000|Overall Study|Adverse Event|5|||
155464050|NCT00608881|561119542|FG001|Overall Study|Adverse Event|3|||
155464051|NCT00608881|561119541|FG000|Overall Study|Lost to Follow-up|28|||
155464052|NCT00608881|561119542|FG001|Overall Study|Lost to Follow-up|14|||
155464053|NCT00608881|561119541|FG000|Overall Study|Withdrawal by Subject|18|||
155464054|NCT00608881|561119542|FG001|Overall Study|Withdrawal by Subject|29|||
155464055|NCT00608881|561119541|FG000|Overall Study|Physician Decision|5|||
155464056|NCT00608881|561119542|FG001|Overall Study|Physician Decision|5|||
155464057|NCT00608881|561119541|FG000|Overall Study|Institutionalized|1|||
155464058|NCT00608881|561119542|FG001|Overall Study|Institutionalized|2|||
155464059|NCT01373918|561119543|FG000|Overall Study|Physician Decision|0|||
155464060|NCT01373918|561119544|FG001|Overall Study|Physician Decision|1|||
155464061|NCT01590212|561119545|FG000|Overall Study|Withdrawal by Subject|2|||
155464062|NCT01590212|561119546|FG001|Overall Study|Withdrawal by Subject|2|||
155464063|NCT01590212|561119547|FG002|Overall Study|Withdrawal by Subject|2|||
155464064|NCT01590212|561119545|FG000|Overall Study|Lost to Follow-up|1|||
155464065|NCT01590212|561119546|FG001|Overall Study|Lost to Follow-up|2|||
155464066|NCT01590212|561119547|FG002|Overall Study|Lost to Follow-up|3|||
155464067|NCT01387074|561119548|FG000|Overall Study|Lost to Follow-up|7|||
155464068|NCT01387074|561119548|FG000|Overall Study|Lack of Efficacy|1|||
155464069|NCT02147691|561119549|FG000|Overall Study|Withdrawal by Subject|2|||
155464070|NCT02147691|561119550|FG001|Overall Study|Withdrawal by Subject|0|||
155464071|NCT02147691|561119549|FG000|Overall Study|Adverse Event|2|||
155464072|NCT02147691|561119550|FG001|Overall Study|Adverse Event|0|||
155464073|NCT02147691|561119549|FG000|Overall Study|Lost to Follow-up|0|||
155464074|NCT02147691|561119550|FG001|Overall Study|Lost to Follow-up|1|||
155464075|NCT01392742|561119551|FG000|Overall Study|Premature study termination|42|||
155464076|NCT01392742|561119551|FG000|Overall Study|Failure to return|35|||
155464077|NCT01392742|561119551|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
155464078|NCT01392742|561119551|FG000|Overall Study|Lost to Follow-up|34|||
155464079|NCT01392742|561119551|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
155464080|NCT01392742|561119551|FG000|Overall Study|ITR and Protocol deviation|1|||
155464081|NCT01392742|561119551|FG000|Overall Study|Adverse event/intercurrent illness|17|||
155464082|NCT01392742|561119551|FG000|Overall Study|Protocol Violation|14|||
155464083|NCT01392742|561119551|FG000|Overall Study|Other|3|||
155464084|NCT01392742|561119551|FG000|Overall Study|Missing information|13|||
155464085|NCT01628393|561119556|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
155464086|NCT01628393|561119557|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155464087|NCT01628393|561119558|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155464088|NCT01628393|561119559|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155464089|NCT01628393|561119560|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
155464090|NCT01628393|561119556|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
155464091|NCT01628393|561119557|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
155464092|NCT01628393|561119558|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
155464093|NCT01628393|561119559|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
155464094|NCT01628393|561119560|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
155464095|NCT01628393|561119556|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
155464096|NCT01628393|561119557|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
155464097|NCT01628393|561119558|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
155464098|NCT01628393|561119559|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
155464099|NCT01628393|561119560|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
155464100|NCT01628393|561119556|FG000|Blinded Active Extension Period|Adverse Event|0|||
155464101|NCT01628393|561119557|FG001|Blinded Active Extension Period|Adverse Event|1|||
155464102|NCT01628393|561119558|FG002|Blinded Active Extension Period|Adverse Event|0|||
155464103|NCT01628393|561119559|FG003|Blinded Active Extension Period|Adverse Event|2|||
155464104|NCT01628393|561119560|FG004|Blinded Active Extension Period|Adverse Event|2|||
155464105|NCT01628393|561119556|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
155464106|NCT01628393|561119557|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
155464107|NCT01628393|561119558|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
155464108|NCT01628393|561119559|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
155464109|NCT01628393|561119560|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
155464110|NCT01628393|561119556|FG000|Blinded Active Extension Period|Physician Decision|0|||
155464111|NCT01628393|561119557|FG001|Blinded Active Extension Period|Physician Decision|3|||
155464112|NCT01628393|561119558|FG002|Blinded Active Extension Period|Physician Decision|0|||
155516934|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
155464113|NCT01628393|561119559|FG003|Blinded Active Extension Period|Physician Decision|1|||
155464114|NCT01628393|561119560|FG004|Blinded Active Extension Period|Physician Decision|0|||
155464115|NCT01628393|561119556|FG000|Blinded Active Extension Period|Protocol Violation|0|||
155464116|NCT01628393|561119557|FG001|Blinded Active Extension Period|Protocol Violation|0|||
155464117|NCT01628393|561119558|FG002|Blinded Active Extension Period|Protocol Violation|2|||
155464118|NCT01628393|561119559|FG003|Blinded Active Extension Period|Protocol Violation|1|||
155464119|NCT01628393|561119560|FG004|Blinded Active Extension Period|Protocol Violation|0|||
155464120|NCT01628393|561119556|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
155464121|NCT01628393|561119557|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
155464122|NCT01628393|561119558|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
155464123|NCT01628393|561119559|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
155464124|NCT01628393|561119560|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
155464125|NCT02988219|561119561|FG000|Overall Study|Lack of Efficacy|1|||
155464126|NCT02988219|561119562|FG001|Overall Study|Lack of Efficacy|1|||
155464127|NCT02988219|561119561|FG000|Overall Study|Withdrawal by Subject|0|||
155464128|NCT02988219|561119562|FG001|Overall Study|Withdrawal by Subject|2|||
155464129|NCT01522443|561119564|FG000|Overall Study|No longer receiving clinical benefit|36|||
155464130|NCT01522443|561119565|FG001|Overall Study|No longer receiving clinical benefit|28|||
155464131|NCT01522443|561119564|FG000|Overall Study|Adverse Event|10|||
155464132|NCT01522443|561119565|FG001|Overall Study|Adverse Event|15|||
155464133|NCT01522443|561119564|FG000|Overall Study|Withdrawal by Subject|5|||
155464134|NCT01522443|561119565|FG001|Overall Study|Withdrawal by Subject|8|||
155464135|NCT01522443|561119564|FG000|Overall Study|No study treatment given|1|||
155464136|NCT01522443|561119565|FG001|Overall Study|No study treatment given|1|||
155464137|NCT01522443|561119564|FG000|Overall Study|Other|1|||
155464138|NCT01522443|561119565|FG001|Overall Study|Other|3|||
155464139|NCT03260894|561119566|FG000|Overall Study|Death|6|||
155464140|NCT03260894|561119567|FG001|Overall Study|Death|8|||
155464141|NCT03260894|561119566|FG000|Overall Study|Withdrawal by Subject|4|||
155464142|NCT03260894|561119567|FG001|Overall Study|Withdrawal by Subject|11|||
155464143|NCT03260894|561119566|FG000|Overall Study|On-going at clinical cut off date|36|||
155464144|NCT03260894|561119567|FG001|Overall Study|On-going at clinical cut off date|31|||
155464145|NCT00118911|561119569|FG000|Overall Study|Withdrawal by Subject|2|||
155464146|NCT00118911|561119570|FG001|Overall Study|Withdrawal by Subject|5|||
155464147|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
155464148|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
155464149|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
155464150|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
155464151|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
155464152|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
155464153|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
155464154|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
155464155|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
155464156|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
155464157|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
155464158|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
155464159|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
155464160|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
155464161|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
155464162|NCT03814005|561119572|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
155464163|NCT03814005|561119573|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
155464164|NCT03814005|561119574|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
155464165|NCT01896856|561119575|FG000|Overall Study|Transportation issues / Non-compliance|0|||
155464166|NCT01896856|561119576|FG001|Overall Study|Transportation issues / Non-compliance|0|||
155464167|NCT01896856|561119577|FG002|Overall Study|Transportation issues / Non-compliance|1|||
155464168|NCT01896856|561119578|FG003|Overall Study|Transportation issues / Non-compliance|0|||
155464169|NCT01896856|561119579|FG004|Overall Study|Transportation issues / Non-compliance|0|||
155652502|NCT00289900|561820366|FG003|Overall Study|Lost to Follow-up|8|||
155652503|NCT00289900|561820367|FG004|Overall Study|Lost to Follow-up|4|||
155652504|NCT00289900|561820368|FG005|Overall Study|Lost to Follow-up|8|||
155652505|NCT00289900|561820363|FG000|Overall Study|Participant had flushing|18|||
155652506|NCT00289900|561820364|FG001|Overall Study|Participant had flushing|42|||
155464170|NCT01896856|561119580|FG005|Overall Study|Transportation issues / Non-compliance|0|||
155516935|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
155652507|NCT00289900|561820365|FG002|Overall Study|Participant had flushing|1|||
155464171|NCT02563925|561119583|FG000|Overall Study|Withdrawal by Subject|2|||
155464172|NCT00282867|561119584|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
155464173|NCT00282867|561119585|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
155652508|NCT00289900|561820366|FG003|Overall Study|Participant had flushing|2|||
155652509|NCT00289900|561820367|FG004|Overall Study|Participant had flushing|0|||
155652510|NCT00289900|561820368|FG005|Overall Study|Participant had flushing|4|||
155464174|NCT00282867|561119586|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
155464175|NCT05067452|561119587|FG000|Overall Study|Lost to Follow-up|0|||
155464176|NCT05067452|561119588|FG001|Overall Study|Lost to Follow-up|4|||
155464177|NCT00426556|561119589|FG000|Phase I - Core Phase|Disease Progression|0|||
155464178|NCT00426556|561119590|FG001|Phase I - Core Phase|Disease Progression|6|||
155464179|NCT00426556|561119591|FG002|Phase I - Core Phase|Disease Progression|2|||
155464180|NCT00426556|561119592|FG003|Phase I - Core Phase|Disease Progression|0|||
155464181|NCT00426556|561119589|FG000|Phase I - Core Phase|Adverse Event|1|||
155464182|NCT00426556|561119590|FG001|Phase I - Core Phase|Adverse Event|3|||
155464183|NCT00426556|561119591|FG002|Phase I - Core Phase|Adverse Event|1|||
155464184|NCT00426556|561119592|FG003|Phase I - Core Phase|Adverse Event|0|||
155464185|NCT00426556|561119589|FG000|Phase I - Core Phase|Death|0|||
155464186|NCT00426556|561119590|FG001|Phase I - Core Phase|Death|1|||
155464187|NCT00426556|561119591|FG002|Phase I - Core Phase|Death|0|||
155464188|NCT00426556|561119592|FG003|Phase I - Core Phase|Death|0|||
155464189|NCT00426556|561119589|FG000|Phase I - Extension Phase|Adverse Event|0|||
155464190|NCT00426556|561119590|FG001|Phase I - Extension Phase|Adverse Event|1|||
155464191|NCT00426556|561119591|FG002|Phase I - Extension Phase|Adverse Event|1|||
155464192|NCT00426556|561119592|FG003|Phase I - Extension Phase|Adverse Event|0|||
155464193|NCT00426556|561119589|FG000|Phase I - Extension Phase|Disease Progression|5|||
155464194|NCT00426556|561119590|FG001|Phase I - Extension Phase|Disease Progression|5|||
155464195|NCT00426556|561119591|FG002|Phase I - Extension Phase|Disease Progression|6|||
155464196|NCT00426556|561119592|FG003|Phase I - Extension Phase|Disease Progression|0|||
155464197|NCT00426556|561119589|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
155464198|NCT00426556|561119590|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
155464199|NCT00426556|561119591|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
155464200|NCT00426556|561119592|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
155464201|NCT00426556|561119589|FG000|Phase II - Core Phase|Disease Progression|0|||
155464202|NCT00426556|561119590|FG001|Phase II - Core Phase|Disease Progression|0|||
155464203|NCT00426556|561119591|FG002|Phase II - Core Phase|Disease Progression|0|||
155464204|NCT00426556|561119592|FG003|Phase II - Core Phase|Disease Progression|16|||
155464205|NCT00426556|561119589|FG000|Phase II - Core Phase|Adverse Event|0|||
155464206|NCT00426556|561119590|FG001|Phase II - Core Phase|Adverse Event|0|||
155464207|NCT00426556|561119591|FG002|Phase II - Core Phase|Adverse Event|0|||
155464208|NCT00426556|561119592|FG003|Phase II - Core Phase|Adverse Event|8|||
155464209|NCT00426556|561119589|FG000|Phase II - Extension Phase|Disease Progression|0|||
155464210|NCT00426556|561119590|FG001|Phase II - Extension Phase|Disease Progression|0|||
155464211|NCT00426556|561119591|FG002|Phase II - Extension Phase|Disease Progression|0|||
155464212|NCT00426556|561119592|FG003|Phase II - Extension Phase|Disease Progression|21|||
155464213|NCT00426556|561119589|FG000|Phase II - Extension Phase|Adverse Event|0|||
155464214|NCT00426556|561119590|FG001|Phase II - Extension Phase|Adverse Event|0|||
155464215|NCT00426556|561119591|FG002|Phase II - Extension Phase|Adverse Event|0|||
155464216|NCT00426556|561119592|FG003|Phase II - Extension Phase|Adverse Event|2|||
155464217|NCT00432562|561119598|FG000|Overall Study|Death|3|||
155464218|NCT00432562|561119599|FG001|Overall Study|Death|0|||
155464219|NCT03970824|561119600|FG000|Overall Study|Withdrawal by Subject|1|||
155464220|NCT03970824|561119601|FG001|Overall Study|Withdrawal by Subject|1|||
155464221|NCT03970824|561119602|FG002|Overall Study|Withdrawal by Subject|3|||
155464222|NCT03970824|561119600|FG000|Overall Study|Lost to Follow-up|0|||
155464223|NCT03970824|561119601|FG001|Overall Study|Lost to Follow-up|2|||
155464224|NCT03970824|561119602|FG002|Overall Study|Lost to Follow-up|1|||
155464225|NCT03970824|561119600|FG000|Overall Study|Adverse Event|1|||
155464226|NCT03970824|561119601|FG001|Overall Study|Adverse Event|0|||
155464227|NCT03970824|561119602|FG002|Overall Study|Adverse Event|0|||
155464228|NCT00425100|561119605|FG000|Overall Study|Adverse Event|36|||
155464229|NCT00425100|561119605|FG000|Overall Study|Lack of Efficacy|4|||
155464230|NCT00425100|561119605|FG000|Overall Study|Lost to Follow-up|2|||
155464231|NCT00425100|561119605|FG000|Overall Study|Protocol Violation|4|||
155464232|NCT00425100|561119605|FG000|Overall Study|Withdrawal by Subject|7|||
155464233|NCT01767519|561119609|FG000|Overall Study|Other Reasons|4|||
155464234|NCT01767519|561119610|FG001|Overall Study|Other Reasons|4|||
155464235|NCT01767519|561119611|FG002|Overall Study|Other Reasons|2|||
155464236|NCT01767519|561119609|FG000|Overall Study|Protocol Violation|0|||
155464237|NCT01767519|561119610|FG001|Overall Study|Protocol Violation|3|||
155464238|NCT01767519|561119611|FG002|Overall Study|Protocol Violation|0|||
155464239|NCT01767519|561119609|FG000|Overall Study|Personal Reasons|1|||
155464240|NCT01767519|561119610|FG001|Overall Study|Personal Reasons|0|||
155464241|NCT01767519|561119611|FG002|Overall Study|Personal Reasons|0|||
155464242|NCT01767519|561119609|FG000|Overall Study|Lost to Follow-up|3|||
155464243|NCT01767519|561119610|FG001|Overall Study|Lost to Follow-up|1|||
155464244|NCT01767519|561119611|FG002|Overall Study|Lost to Follow-up|2|||
155464245|NCT01767519|561119609|FG000|Overall Study|Lack of Efficacy|1|||
155464246|NCT01767519|561119610|FG001|Overall Study|Lack of Efficacy|0|||
155464247|NCT01767519|561119611|FG002|Overall Study|Lack of Efficacy|0|||
155464248|NCT01767519|561119609|FG000|Overall Study|Adverse Event|5|||
155464249|NCT01767519|561119610|FG001|Overall Study|Adverse Event|5|||
155464250|NCT01767519|561119611|FG002|Overall Study|Adverse Event|1|||
155464251|NCT00493974|561119614|FG000|Overall Study|Death|1|||
155464252|NCT00493974|561119615|FG001|Overall Study|Death|2|||
155464253|NCT00493974|561119614|FG000|Overall Study|Withdrawal by Subject|8|||
155464254|NCT00493974|561119615|FG001|Overall Study|Withdrawal by Subject|6|||
155464255|NCT00493974|561119614|FG000|Overall Study|Lost to Follow-up|4|||
155464256|NCT00493974|561119615|FG001|Overall Study|Lost to Follow-up|6|||
155464257|NCT00862654|561119616|FG000|Overall Study|Lack of Efficacy|1|||
155464258|NCT00862654|561119617|FG001|Overall Study|Lack of Efficacy|0|||
155464259|NCT00862654|561119618|FG002|Overall Study|Lack of Efficacy|1|||
155464260|NCT00862654|561119619|FG003|Overall Study|Lack of Efficacy|0|||
155464261|NCT00862654|561119616|FG000|Overall Study|Lost to Follow-up|1|||
155464262|NCT00862654|561119617|FG001|Overall Study|Lost to Follow-up|2|||
155464263|NCT00862654|561119618|FG002|Overall Study|Lost to Follow-up|1|||
155464264|NCT00862654|561119619|FG003|Overall Study|Lost to Follow-up|3|||
155464265|NCT00862654|561119616|FG000|Overall Study|Adverse Event|0|||
155464266|NCT00862654|561119617|FG001|Overall Study|Adverse Event|1|||
155464267|NCT00862654|561119618|FG002|Overall Study|Adverse Event|1|||
155464268|NCT00862654|561119619|FG003|Overall Study|Adverse Event|0|||
155464269|NCT00862654|561119616|FG000|Overall Study|Pregnancy|1|||
155464270|NCT00862654|561119617|FG001|Overall Study|Pregnancy|1|||
155464271|NCT00862654|561119618|FG002|Overall Study|Pregnancy|0|||
155464272|NCT00862654|561119619|FG003|Overall Study|Pregnancy|0|||
155464273|NCT00862654|561119616|FG000|Overall Study|Withdrawal by Subject|2|||
155464274|NCT00862654|561119617|FG001|Overall Study|Withdrawal by Subject|2|||
155464275|NCT00862654|561119618|FG002|Overall Study|Withdrawal by Subject|2|||
155464276|NCT00862654|561119619|FG003|Overall Study|Withdrawal by Subject|3|||
155464277|NCT00862654|561119616|FG000|Overall Study|Subject mistake|0|||
155464278|NCT00862654|561119617|FG001|Overall Study|Subject mistake|1|||
155464279|NCT00862654|561119618|FG002|Overall Study|Subject mistake|0|||
155464280|NCT00862654|561119619|FG003|Overall Study|Subject mistake|0|||
155464281|NCT00862654|561119616|FG000|Overall Study|Familly constraint|0|||
155464282|NCT00862654|561119617|FG001|Overall Study|Familly constraint|1|||
155464283|NCT00862654|561119618|FG002|Overall Study|Familly constraint|0|||
155464284|NCT00862654|561119619|FG003|Overall Study|Familly constraint|0|||
155464285|NCT00862654|561119616|FG000|Overall Study|Never used study drugs|1|||
155464286|NCT00862654|561119617|FG001|Overall Study|Never used study drugs|0|||
155464287|NCT00862654|561119618|FG002|Overall Study|Never used study drugs|0|||
155464288|NCT00862654|561119619|FG003|Overall Study|Never used study drugs|0|||
155464289|NCT00862654|561119616|FG000|Overall Study|Included after end of inclusions|0|||
155464290|NCT00862654|561119617|FG001|Overall Study|Included after end of inclusions|0|||
155464291|NCT00862654|561119618|FG002|Overall Study|Included after end of inclusions|1|||
155464292|NCT00862654|561119619|FG003|Overall Study|Included after end of inclusions|0|||
155464293|NCT03219567|561119620|FG000|Overall Study|Withdrawal by Subject|0|||
155464294|NCT03219567|561119621|FG001|Overall Study|Withdrawal by Subject|1|||
155464295|NCT01181778|561119627|FG000|Overall Study|Physician Decision|48|||
155464296|NCT02713789|561119628|FG000|Overall Study|Lost to Follow-up|0|||
155464297|NCT02713789|561119629|FG001|Overall Study|Lost to Follow-up|1|||
155464298|NCT02713789|561119630|FG002|Overall Study|Lost to Follow-up|1|||
155464299|NCT02726113|561119634|FG000|Total Enrollment|Physician Decision|0|||
155464300|NCT02726113|561119635|FG001|Total Enrollment|Physician Decision|1|||
155464301|NCT02726113|561119634|FG000|Total Enrollment|Protocol Violation|1|||
155464302|NCT02726113|561119635|FG001|Total Enrollment|Protocol Violation|0|||
155464303|NCT02726113|561119634|FG000|Total Enrollment|Withdrawal by Subject|2|||
155464304|NCT02726113|561119635|FG001|Total Enrollment|Withdrawal by Subject|1|||
155464305|NCT02726113|561119634|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
155464306|NCT02726113|561119635|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
155464307|NCT02726113|561119634|FG000|Genomic Analysis|Protocol Violation|1|||
155464308|NCT02726113|561119635|FG001|Genomic Analysis|Protocol Violation|0|||
155464309|NCT02726113|561119634|FG000|Genomic Analysis|Withdrawal by Subject|2|||
155464310|NCT02726113|561119635|FG001|Genomic Analysis|Withdrawal by Subject|1|||
155464311|NCT02726113|561119634|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
155464312|NCT02726113|561119635|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
155464313|NCT03549117|561119636|FG000|Overall Study|Withdrawal by Subject|1|||
155464314|NCT03549117|561119637|FG001|Overall Study|Withdrawal by Subject|0|||
155464315|NCT03148756|561119641|FG000|Overall Study|Study Terminated|0|||
155464316|NCT03148756|561119642|FG001|Overall Study|Study Terminated|1|||
155464317|NCT00637377|561119644|FG000|Overall Study|Adverse Event|2|||
155464318|NCT00637377|561119645|FG001|Overall Study|Adverse Event|6|||
155464319|NCT00637377|561119646|FG002|Overall Study|Adverse Event|8|||
155464320|NCT00637377|561119647|FG003|Overall Study|Adverse Event|9|||
155464321|NCT00637377|561119644|FG000|Overall Study|Death|1|||
155464322|NCT00637377|561119645|FG001|Overall Study|Death|3|||
155464323|NCT00637377|561119646|FG002|Overall Study|Death|2|||
155464324|NCT00637377|561119647|FG003|Overall Study|Death|1|||
155464325|NCT00637377|561119644|FG000|Overall Study|Lack of Efficacy|0|||
155464326|NCT00637377|561119645|FG001|Overall Study|Lack of Efficacy|0|||
155464327|NCT00637377|561119646|FG002|Overall Study|Lack of Efficacy|1|||
155464328|NCT00637377|561119647|FG003|Overall Study|Lack of Efficacy|1|||
155464329|NCT00637377|561119644|FG000|Overall Study|Lost to Follow-up|4|||
155464330|NCT00637377|561119645|FG001|Overall Study|Lost to Follow-up|1|||
155464331|NCT00637377|561119646|FG002|Overall Study|Lost to Follow-up|2|||
155464332|NCT00637377|561119647|FG003|Overall Study|Lost to Follow-up|2|||
155464333|NCT00637377|561119644|FG000|Overall Study|Protocol Violation|2|||
155464334|NCT00637377|561119645|FG001|Overall Study|Protocol Violation|1|||
155464335|NCT00637377|561119646|FG002|Overall Study|Protocol Violation|1|||
155464336|NCT00637377|561119647|FG003|Overall Study|Protocol Violation|0|||
155464337|NCT00637377|561119644|FG000|Overall Study|Withdrawal by Subject|11|||
155464338|NCT00637377|561119645|FG001|Overall Study|Withdrawal by Subject|15|||
155464339|NCT00637377|561119646|FG002|Overall Study|Withdrawal by Subject|13|||
155464340|NCT00637377|561119647|FG003|Overall Study|Withdrawal by Subject|11|||
155464341|NCT00637377|561119644|FG000|Overall Study|Other (no further information available)|7|||
155464342|NCT00637377|561119645|FG001|Overall Study|Other (no further information available)|6|||
155464343|NCT00637377|561119646|FG002|Overall Study|Other (no further information available)|10|||
155464344|NCT00637377|561119647|FG003|Overall Study|Other (no further information available)|5|||
155464345|NCT04021706|561121486|FG000|Overall Study|Adverse Event|2|||
155464346|NCT04021706|561121487|FG001|Overall Study|Adverse Event|0|||
155464347|NCT04021706|561121486|FG000|Overall Study|Withdrawal by Subject|1|||
155464348|NCT04021706|561121487|FG001|Overall Study|Withdrawal by Subject|2|||
155464349|NCT04021706|561121486|FG000|Overall Study|Physician Decision|1|||
155464350|NCT04021706|561121487|FG001|Overall Study|Physician Decision|0|||
155464351|NCT02332798|561121490|FG000|Overall Study|Unwilling to Participate in Study|0|||
155464352|NCT02332798|561121491|FG001|Overall Study|Unwilling to Participate in Study|1|||
155464353|NCT02332798|561121492|FG002|Overall Study|Unwilling to Participate in Study|1|||
155464354|NCT02332798|561121490|FG000|Overall Study|Positive Urine Drug Test|0|||
155464355|NCT02332798|561121491|FG001|Overall Study|Positive Urine Drug Test|1|||
155464356|NCT02332798|561121492|FG002|Overall Study|Positive Urine Drug Test|0|||
155464357|NCT02332798|561121490|FG000|Overall Study|Abnormal Laboratory Findings|1|||
155464358|NCT02332798|561121491|FG001|Overall Study|Abnormal Laboratory Findings|0|||
155464359|NCT02332798|561121492|FG002|Overall Study|Abnormal Laboratory Findings|0|||
155464360|NCT02688153|561121493|FG000|Overall Study|Death|7|||
155464361|NCT02688153|561121494|FG001|Overall Study|Death|5|||
155464362|NCT02688153|561121493|FG000|Overall Study|Withdrawal by Subject|4|||
155464363|NCT02688153|561121494|FG001|Overall Study|Withdrawal by Subject|2|||
155464364|NCT02688153|561121493|FG000|Overall Study|Valve Explant|1|||
155464365|NCT02688153|561121494|FG001|Overall Study|Valve Explant|0|||
155464366|NCT02688153|561121493|FG000|Overall Study|Conversion to Commercial Valve|3|||
155464367|NCT02688153|561121494|FG001|Overall Study|Conversion to Commercial Valve|0|||
155464368|NCT00595868|561121495|FG000|Overall Study|Lost to Follow-up|45|||
155464369|NCT00595868|561121496|FG001|Overall Study|Lost to Follow-up|50|||
155464370|NCT00107172|561121497|FG000|Overall Study|Withdrawal by Subject|1|||
155464371|NCT00107172|561121498|FG001|Overall Study|Withdrawal by Subject|0|||
155464372|NCT00107172|561121497|FG000|Overall Study|Death|0|||
155464373|NCT00107172|561121498|FG001|Overall Study|Death|2|||
155464374|NCT00107172|561121497|FG000|Overall Study|Other Reason|4|||
155464375|NCT00107172|561121498|FG001|Overall Study|Other Reason|3|||
155464376|NCT00859573|561121504|FG000|Overall Study|Withdrawal by Subject|4|||
155464377|NCT00859573|561121505|FG001|Overall Study|Withdrawal by Subject|1|||
155464378|NCT00859573|561121504|FG000|Overall Study|Physician Decision|1|||
155464379|NCT00859573|561121505|FG001|Overall Study|Physician Decision|1|||
155464380|NCT01135394|561121506|FG000|Screening|Lost to Follow-up|2|||
155464381|NCT01135394|561121506|FG000|Screening|Withdrawal by Subject|10|||
155464382|NCT01135394|561121506|FG000|Screening|Screening failure|16|||
155464383|NCT01135394|561121506|FG000|Screening|Physician Decision|5|||
155464384|NCT01135394|561121506|FG000|Baseline Assessment|Withdrawal by Subject|9|||
155464385|NCT01135394|561121506|FG000|Baseline Assessment|Physician Decision|3|||
155464386|NCT01135394|561121506|FG000|Baseline Assessment|Lost to Follow-up|2|||
155464387|NCT01135394|561121506|FG000|Baseline Assessment|Adverse Event|1|||
155464388|NCT01135394|561121506|FG000|Study Treatment|Withdrawal by Subject|1|||
155464389|NCT01135394|561121506|FG000|Study Treatment|Physician Decision|1|||
155464390|NCT01135394|561121506|FG000|Study Treatment|Adverse Event|2|||
155464391|NCT03750240|561121509|FG000|Overall Study|Technical Difficulties|2|||
155464392|NCT03510910|561121510|FG000|Overall Study|Incomplete Survey|2|||
155464393|NCT03510910|561121511|FG001|Overall Study|Incomplete Survey|3|||
155464394|NCT03382262|561121512|FG000|Overall Study|Physician Decision|0|||
155464395|NCT03382262|561121513|FG001|Overall Study|Physician Decision|0|||
155464396|NCT03382262|561121514|FG002|Overall Study|Physician Decision|1|||
155464397|NCT03382262|561121515|FG003|Overall Study|Physician Decision|0|||
155464398|NCT03382262|561121512|FG000|Overall Study|Withdrawal by Subject|0|||
155464399|NCT03382262|561121513|FG001|Overall Study|Withdrawal by Subject|0|||
155464400|NCT03382262|561121514|FG002|Overall Study|Withdrawal by Subject|0|||
155464401|NCT03382262|561121515|FG003|Overall Study|Withdrawal by Subject|1|||
155464402|NCT04914819|561121516|FG000|Overall Study|Pregnancy|3|||
155464403|NCT04914819|561121517|FG001|Overall Study|Pregnancy|1|||
155464404|NCT04914819|561121516|FG000|Overall Study|Discontinued study|4|||
155464405|NCT04914819|561121517|FG001|Overall Study|Discontinued study|1|||
155464406|NCT04914819|561121516|FG000|Overall Study|Lost to Follow-up|7|||
155464407|NCT04914819|561121517|FG001|Overall Study|Lost to Follow-up|0|||
155464408|NCT03943446|561121520|FG000|Overall Study|Lost to Follow-up|0|||
155464409|NCT03943446|561121521|FG001|Overall Study|Lost to Follow-up|0|||
155464410|NCT03943446|561121522|FG002|Overall Study|Lost to Follow-up|1|||
155464411|NCT03943446|561121520|FG000|Overall Study|Withdrawal by Subject|1|||
155464412|NCT03943446|561121521|FG001|Overall Study|Withdrawal by Subject|1|||
155464413|NCT03943446|561121522|FG002|Overall Study|Withdrawal by Subject|2|||
155464414|NCT03943446|561121520|FG000|Overall Study|Study Terminated by Sponsor|1|||
155464415|NCT03943446|561121521|FG001|Overall Study|Study Terminated by Sponsor|2|||
155464416|NCT03943446|561121522|FG002|Overall Study|Study Terminated by Sponsor|1|||
155464417|NCT03943446|561121520|FG000|Overall Study|Reason not Specified|5|||
155464418|NCT03943446|561121521|FG001|Overall Study|Reason not Specified|1|||
155464419|NCT03943446|561121522|FG002|Overall Study|Reason not Specified|3|||
155464420|NCT02905825|561121523|FG000|Overall Study|Protocol Violation|11|||
155464421|NCT02905825|561121523|FG000|Overall Study|Device Malfunction|1|||
155464422|NCT01601704|561121525|FG000|Overall Study|Randomized but not dispensed study med|1|||
155464423|NCT01601704|561121526|FG001|Overall Study|Randomized but not dispensed study med|4|||
155464424|NCT01709708|561121528|FG000|Overall Study|Protocol Violation|1|||
155464425|NCT01709708|561121529|FG001|Overall Study|Protocol Violation|2|||
155464426|NCT02657434|561121530|FG000|Overall Study|Study Terminated By Sponsor|64|||
155464427|NCT02657434|561121531|FG001|Overall Study|Study Terminated By Sponsor|82|||
155464428|NCT02657434|561121530|FG000|Overall Study|Death|189|||
155464429|NCT02657434|561121531|FG001|Overall Study|Death|190|||
155464430|NCT02657434|561121530|FG000|Overall Study|Lost to Follow-up|2|||
155464431|NCT02657434|561121531|FG001|Overall Study|Lost to Follow-up|2|||
155464432|NCT02657434|561121530|FG000|Overall Study|Randomization by Error|2|||
155464433|NCT02657434|561121531|FG001|Overall Study|Randomization by Error|0|||
155464434|NCT02657434|561121530|FG000|Overall Study|Withdrawal by Subject|28|||
155464435|NCT02657434|561121531|FG001|Overall Study|Withdrawal by Subject|17|||
155464436|NCT02657434|561121530|FG000|Overall Study|Protocol Violation|1|||
155464437|NCT02657434|561121531|FG001|Overall Study|Protocol Violation|0|||
155464438|NCT02657434|561121530|FG000|Overall Study|Physician Decision|0|||
155464439|NCT02657434|561121531|FG001|Overall Study|Physician Decision|1|||
155464440|NCT02432703|561121537|FG000|Overall Study|Adverse Event|1|||
155464441|NCT02432703|561121538|FG001|Overall Study|Adverse Event|4|||
155464442|NCT02432703|561121537|FG000|Overall Study|Lack of Efficacy|1|||
155464443|NCT02432703|561121538|FG001|Overall Study|Lack of Efficacy|0|||
155464444|NCT02432703|561121537|FG000|Overall Study|Lost to Follow-up|5|||
155464445|NCT02432703|561121538|FG001|Overall Study|Lost to Follow-up|3|||
155464446|NCT02432703|561121537|FG000|Overall Study|Withdrawal by Subject|9|||
155464447|NCT02432703|561121538|FG001|Overall Study|Withdrawal by Subject|6|||
155464448|NCT02432703|561121537|FG000|Overall Study|Other|6|||
155464449|NCT02432703|561121538|FG001|Overall Study|Other|5|||
155516936|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
155464450|NCT04325906|561121541|FG000|Overall Study|Withdrawal by Subject|2|||
155464451|NCT04325906|561121542|FG001|Overall Study|Withdrawal by Subject|0|||
155464452|NCT01181141|561121543|FG000|Overall Study|Adverse Event|2|||
155516937|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
155464453|NCT01181141|561121544|FG001|Overall Study|Adverse Event|1|||
155464454|NCT01181141|561121543|FG000|Overall Study|Lack of Efficacy|1|||
155464455|NCT01181141|561121544|FG001|Overall Study|Lack of Efficacy|0|||
155464456|NCT01181141|561121543|FG000|Overall Study|Lost to Follow-up|1|||
155464457|NCT01181141|561121544|FG001|Overall Study|Lost to Follow-up|1|||
155464458|NCT01181141|561121543|FG000|Overall Study|Physician Decision|2|||
155464459|NCT01181141|561121544|FG001|Overall Study|Physician Decision|0|||
155464460|NCT01181141|561121543|FG000|Overall Study|Protocol Violation|3|||
155464461|NCT01181141|561121544|FG001|Overall Study|Protocol Violation|1|||
155464462|NCT01181141|561121543|FG000|Overall Study|Withdrawal by Subject|3|||
155464463|NCT01181141|561121544|FG001|Overall Study|Withdrawal by Subject|1|||
155464464|NCT00561340|561121545|FG000|Overall Study|refused to drink pediasure|6|||
155464465|NCT00561340|561121546|FG001|Overall Study|refused to drink pediasure|0|||
155464466|NCT03496662|561121550|FG000|Overall Study|Adverse Event|0|||
155464467|NCT03496662|561121551|FG001|Overall Study|Adverse Event|0|||
155464468|NCT03496662|561121552|FG002|Overall Study|Adverse Event|4|||
155464469|NCT03496662|561121550|FG000|Overall Study|Withdrawal by Subject|1|||
155464470|NCT03496662|561121551|FG001|Overall Study|Withdrawal by Subject|0|||
155464471|NCT03496662|561121552|FG002|Overall Study|Withdrawal by Subject|2|||
155464472|NCT03496662|561121550|FG000|Overall Study|Death|0|||
155464473|NCT03496662|561121551|FG001|Overall Study|Death|0|||
155464474|NCT03496662|561121552|FG002|Overall Study|Death|2|||
155464475|NCT03496662|561121550|FG000|Overall Study|Noncompliance|0|||
155464476|NCT03496662|561121551|FG001|Overall Study|Noncompliance|0|||
155464477|NCT03496662|561121552|FG002|Overall Study|Noncompliance|1|||
155464478|NCT03395223|561121554|FG000|Overall Study|Lost to Follow-up|3|||
155464479|NCT03395223|561121554|FG000|Overall Study|Other|1|||
155464480|NCT00810810|561121555|FG000|Overall Study|Withdrawal by Subject|0|||
155464481|NCT00810810|561121556|FG001|Overall Study|Withdrawal by Subject|8|||
155464482|NCT00810810|561121557|FG002|Overall Study|Withdrawal by Subject|10|||
155464483|NCT00810810|561121558|FG003|Overall Study|Withdrawal by Subject|8|||
155464484|NCT00810810|561121555|FG000|Overall Study|Physician Decision|0|||
155464485|NCT00810810|561121556|FG001|Overall Study|Physician Decision|3|||
155464486|NCT00810810|561121557|FG002|Overall Study|Physician Decision|1|||
155464487|NCT00810810|561121558|FG003|Overall Study|Physician Decision|5|||
155464488|NCT01156532|561121559|FG000|Overall Study|Family Reasons|1|||
155464489|NCT01156532|561121559|FG000|Overall Study|Lost to Follow-up|1|||
155464490|NCT01074658|561121563|FG000|Overall Study|No implant attempted|19|||
155464491|NCT00105560|561121567|FG000|Overall Study|Lost to Follow-up|1|||
155464492|NCT01248364|561121568|FG000|Overall Study|Adverse Event|0|||
155464493|NCT01248364|561121569|FG001|Overall Study|Adverse Event|1|||
155464494|NCT01248364|561121570|FG002|Overall Study|Adverse Event|0|||
155464495|NCT01248364|561121571|FG003|Overall Study|Adverse Event|0|||
155464496|NCT02559713|561121574|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
155464497|NCT01021813|561121575|FG000|DB Treatment Phase|Adverse Event|60|||
155464498|NCT01021813|561121576|FG001|DB Treatment Phase|Adverse Event|22|||
155464499|NCT01021813|561121577|FG002|DB Treatment Phase|Adverse Event|0|||
155464500|NCT01021813|561121578|FG003|DB Treatment Phase|Adverse Event|0|||
155464501|NCT01021813|561121579|FG004|DB Treatment Phase|Adverse Event|0|||
155464502|NCT01021813|561121575|FG000|DB Treatment Phase|Lack of Efficacy|44|||
155464503|NCT01021813|561121576|FG001|DB Treatment Phase|Lack of Efficacy|28|||
155464504|NCT01021813|561121577|FG002|DB Treatment Phase|Lack of Efficacy|0|||
155464505|NCT01021813|561121578|FG003|DB Treatment Phase|Lack of Efficacy|0|||
155464506|NCT01021813|561121579|FG004|DB Treatment Phase|Lack of Efficacy|0|||
155464507|NCT01021813|561121575|FG000|DB Treatment Phase|Lost to Follow-up|14|||
155464508|NCT01021813|561121576|FG001|DB Treatment Phase|Lost to Follow-up|12|||
155464509|NCT01021813|561121577|FG002|DB Treatment Phase|Lost to Follow-up|0|||
155464510|NCT01021813|561121578|FG003|DB Treatment Phase|Lost to Follow-up|0|||
155464511|NCT01021813|561121579|FG004|DB Treatment Phase|Lost to Follow-up|0|||
155464512|NCT01021813|561121575|FG000|DB Treatment Phase|Physician Decision|17|||
155464513|NCT01021813|561121576|FG001|DB Treatment Phase|Physician Decision|8|||
155464514|NCT01021813|561121577|FG002|DB Treatment Phase|Physician Decision|0|||
155464515|NCT01021813|561121578|FG003|DB Treatment Phase|Physician Decision|0|||
155464516|NCT01021813|561121579|FG004|DB Treatment Phase|Physician Decision|0|||
155464517|NCT01021813|561121575|FG000|DB Treatment Phase|Pregnancy|1|||
155464518|NCT01021813|561121576|FG001|DB Treatment Phase|Pregnancy|0|||
155464519|NCT01021813|561121577|FG002|DB Treatment Phase|Pregnancy|0|||
155464520|NCT01021813|561121578|FG003|DB Treatment Phase|Pregnancy|0|||
155464521|NCT01021813|561121579|FG004|DB Treatment Phase|Pregnancy|0|||
155464522|NCT01021813|561121575|FG000|DB Treatment Phase|Protocol Violation|4|||
155464523|NCT01021813|561121576|FG001|DB Treatment Phase|Protocol Violation|3|||
155464524|NCT01021813|561121577|FG002|DB Treatment Phase|Protocol Violation|0|||
155464525|NCT01021813|561121578|FG003|DB Treatment Phase|Protocol Violation|0|||
155464526|NCT01021813|561121579|FG004|DB Treatment Phase|Protocol Violation|0|||
155652511|NCT00289900|561820363|FG000|Overall Study|Other|0|||
155652512|NCT00289900|561820364|FG001|Overall Study|Other|0|||
155464527|NCT01021813|561121575|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
155464528|NCT01021813|561121576|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
155464529|NCT01021813|561121577|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
155464530|NCT01021813|561121578|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
155464531|NCT01021813|561121579|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
155464532|NCT01021813|561121575|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
155464533|NCT01021813|561121576|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
155464534|NCT01021813|561121577|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
155464535|NCT01021813|561121578|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
155464536|NCT01021813|561121579|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
155464537|NCT01021813|561121575|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
155652513|NCT00289900|561820365|FG002|Overall Study|Other|0|||
155464538|NCT01021813|561121576|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
155464539|NCT01021813|561121577|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
155464540|NCT01021813|561121578|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
155464541|NCT01021813|561121579|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
155464542|NCT01021813|561121575|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
155464543|NCT01021813|561121576|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
155464544|NCT01021813|561121577|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
155464545|NCT01021813|561121578|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
155464546|NCT01021813|561121579|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
155464547|NCT01021813|561121575|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
155464548|NCT01021813|561121576|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
155464549|NCT01021813|561121577|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
155464550|NCT01021813|561121578|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
155464551|NCT01021813|561121579|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
155464552|NCT01021813|561121575|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
155464553|NCT01021813|561121576|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
155464554|NCT01021813|561121577|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
155464555|NCT01021813|561121578|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
155464556|NCT01021813|561121579|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
155464557|NCT00673894|561121586|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
155464558|NCT00673894|561121587|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
155464559|NCT00673894|561121586|FG000|First Intervention 4 Weeks|Adverse Event|1|||
155464560|NCT00673894|561121587|FG001|First Intervention 4 Weeks|Adverse Event|0|||
155464561|NCT00326417|561121588|FG000|Overall Study|Withdrawal by Subject|0|||
155464562|NCT00326417|561121589|FG001|Overall Study|Withdrawal by Subject|0|||
155464563|NCT00326417|561121590|FG002|Overall Study|Withdrawal by Subject|1|||
155464564|NCT00326417|561121591|FG003|Overall Study|Withdrawal by Subject|0|||
155464565|NCT00326417|561121588|FG000|Overall Study|Arm Closed|7|||
155464566|NCT00326417|561121589|FG001|Overall Study|Arm Closed|0|||
155464567|NCT00326417|561121590|FG002|Overall Study|Arm Closed|0|||
155464568|NCT00326417|561121591|FG003|Overall Study|Arm Closed|3|||
155464569|NCT00326417|561121588|FG000|Overall Study|Death|7|||
155464570|NCT00326417|561121589|FG001|Overall Study|Death|0|||
155464571|NCT00326417|561121590|FG002|Overall Study|Death|0|||
155464572|NCT00326417|561121591|FG003|Overall Study|Death|0|||
155464573|NCT04682353|561121594|FG000|Overall Study|Lost to Follow-up|0|||
155464574|NCT04682353|561121595|FG001|Overall Study|Lost to Follow-up|1|||
155464575|NCT04682353|561121596|FG002|Overall Study|Lost to Follow-up|0|||
155464576|NCT04682353|561121597|FG003|Overall Study|Lost to Follow-up|1|||
155464577|NCT04682353|561121594|FG000|Overall Study|Personal reasons|0|||
155464578|NCT04682353|561121595|FG001|Overall Study|Personal reasons|1|||
155464579|NCT04682353|561121596|FG002|Overall Study|Personal reasons|0|||
155464580|NCT04682353|561121597|FG003|Overall Study|Personal reasons|0|||
155464581|NCT00555906|561121598|FG000|Phase 1|Objective Progression or Relapse|3|||
155464582|NCT00555906|561121599|FG001|Phase 1|Objective Progression or Relapse|5|||
155464583|NCT00555906|561121600|FG002|Phase 1|Objective Progression or Relapse|3|||
155464584|NCT00555906|561121601|FG003|Phase 1|Objective Progression or Relapse|1|||
155464585|NCT00555906|561121602|FG004|Phase 1|Objective Progression or Relapse|0|||
155464586|NCT00555906|561121598|FG000|Phase 1|Global Deterioration of Health Status|0|||
155464587|NCT00555906|561121599|FG001|Phase 1|Global Deterioration of Health Status|1|||
155464588|NCT00555906|561121600|FG002|Phase 1|Global Deterioration of Health Status|1|||
155464589|NCT00555906|561121601|FG003|Phase 1|Global Deterioration of Health Status|1|||
155464590|NCT00555906|561121602|FG004|Phase 1|Global Deterioration of Health Status|0|||
155464591|NCT00555906|561121598|FG000|Phase 1|Adverse Event|0|||
155464592|NCT00555906|561121599|FG001|Phase 1|Adverse Event|0|||
155464593|NCT00555906|561121600|FG002|Phase 1|Adverse Event|3|||
155464594|NCT00555906|561121601|FG003|Phase 1|Adverse Event|2|||
155464595|NCT00555906|561121602|FG004|Phase 1|Adverse Event|0|||
155464596|NCT00555906|561121598|FG000|Phase 1|Withdrawal by Subject|0|||
155464597|NCT00555906|561121599|FG001|Phase 1|Withdrawal by Subject|0|||
155464598|NCT00555906|561121600|FG002|Phase 1|Withdrawal by Subject|0|||
155464599|NCT00555906|561121601|FG003|Phase 1|Withdrawal by Subject|1|||
155464600|NCT00555906|561121602|FG004|Phase 1|Withdrawal by Subject|0|||
155464601|NCT00555906|561121598|FG000|Phase 2|Adverse Event|0|||
155464602|NCT00555906|561121599|FG001|Phase 2|Adverse Event|0|||
155464603|NCT00555906|561121600|FG002|Phase 2|Adverse Event|0|||
155464604|NCT00555906|561121601|FG003|Phase 2|Adverse Event|0|||
155464605|NCT00555906|561121602|FG004|Phase 2|Adverse Event|4|||
155464606|NCT00555906|561121598|FG000|Phase 2|Global Deterioration of Health Status|0|||
155464607|NCT00555906|561121599|FG001|Phase 2|Global Deterioration of Health Status|0|||
155464608|NCT00555906|561121600|FG002|Phase 2|Global Deterioration of Health Status|0|||
155464609|NCT00555906|561121601|FG003|Phase 2|Global Deterioration of Health Status|0|||
155464610|NCT00555906|561121602|FG004|Phase 2|Global Deterioration of Health Status|2|||
155464611|NCT00555906|561121598|FG000|Phase 2|Objective Progression or Relapse|0|||
155464612|NCT00555906|561121599|FG001|Phase 2|Objective Progression or Relapse|0|||
155464613|NCT00555906|561121600|FG002|Phase 2|Objective Progression or Relapse|0|||
155464614|NCT00555906|561121601|FG003|Phase 2|Objective Progression or Relapse|0|||
155464615|NCT00555906|561121602|FG004|Phase 2|Objective Progression or Relapse|16|||
155464616|NCT00555906|561121598|FG000|Phase 2|Withdrawal by Subject|0|||
155464617|NCT00555906|561121599|FG001|Phase 2|Withdrawal by Subject|0|||
155464618|NCT00555906|561121600|FG002|Phase 2|Withdrawal by Subject|0|||
155464619|NCT00555906|561121601|FG003|Phase 2|Withdrawal by Subject|0|||
155464620|NCT00555906|561121602|FG004|Phase 2|Withdrawal by Subject|2|||
155464621|NCT00555906|561121598|FG000|Phase 2|Other|0|||
155464622|NCT00555906|561121599|FG001|Phase 2|Other|0|||
155464623|NCT00555906|561121600|FG002|Phase 2|Other|0|||
155464624|NCT00555906|561121601|FG003|Phase 2|Other|0|||
155464625|NCT00555906|561121602|FG004|Phase 2|Other|6|||
155464626|NCT00555906|561121598|FG000|Phase 2|Randomized but not Treated|0|||
155464627|NCT00555906|561121599|FG001|Phase 2|Randomized but not Treated|0|||
155464628|NCT00555906|561121600|FG002|Phase 2|Randomized but not Treated|0|||
155464629|NCT00555906|561121601|FG003|Phase 2|Randomized but not Treated|0|||
155464630|NCT00555906|561121602|FG004|Phase 2|Randomized but not Treated|2|||
155464631|NCT01586806|561121603|FG000|Overall Study|Protocol Violation|0|||
155464632|NCT01586806|561121604|FG001|Overall Study|Protocol Violation|1|||
155464633|NCT01586806|561121605|FG002|Overall Study|Protocol Violation|0|||
155464634|NCT01586806|561121603|FG000|Overall Study|Withdrawal by Subject|1|||
155464635|NCT01586806|561121604|FG001|Overall Study|Withdrawal by Subject|0|||
155464636|NCT01586806|561121605|FG002|Overall Study|Withdrawal by Subject|0|||
155464637|NCT01586806|561121603|FG000|Overall Study|Lost to Follow-up|2|||
155464638|NCT01586806|561121604|FG001|Overall Study|Lost to Follow-up|3|||
155464639|NCT01586806|561121605|FG002|Overall Study|Lost to Follow-up|2|||
155464640|NCT01185704|561121606|FG000|Overall Study|Randomized but not treated|3|||
155464641|NCT01185704|561121607|FG001|Overall Study|Randomized but not treated|3|||
155464642|NCT01185704|561121606|FG000|Overall Study|Lack of ovarian response|5|||
155464643|NCT01185704|561121607|FG001|Overall Study|Lack of ovarian response|1|||
155464644|NCT01185704|561121606|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
155464645|NCT01185704|561121607|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
155464646|NCT01185704|561121606|FG000|Overall Study|Ectopic pregnancy|0|||
155464647|NCT01185704|561121607|FG001|Overall Study|Ectopic pregnancy|1|||
155464648|NCT01313208|561121608|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
155464649|NCT01313208|561121609|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
155464650|NCT01313208|561121608|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
155464651|NCT01313208|561121609|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
155464652|NCT01313208|561121608|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
155464653|NCT01313208|561121609|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
155464654|NCT01313208|561121608|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
155464655|NCT01313208|561121609|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
155464656|NCT01313208|561121608|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
155464657|NCT01313208|561121609|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
155464658|NCT01313208|561121608|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
155464659|NCT01313208|561121609|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
155464660|NCT01313208|561121608|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
155464661|NCT01313208|561121609|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
155464662|NCT01313208|561121608|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
155464663|NCT01313208|561121609|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
155464664|NCT01313208|561121608|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
155464665|NCT01313208|561121609|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
155464666|NCT00187889|561121610|FG000|Overall Study|Withdrawal by Subject|6|||
155464667|NCT00187889|561121611|FG001|Overall Study|Withdrawal by Subject|4|||
155464668|NCT01998880|561121616|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
155464669|NCT01998880|561121617|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
155464670|NCT01998880|561121616|FG000|Overall Study|Disease Progression|1|||
155464671|NCT01998880|561121617|FG001|Overall Study|Disease Progression|8|||
155464672|NCT01998880|561121616|FG000|Overall Study|Withdrew Consent|2|||
155464673|NCT01998880|561121617|FG001|Overall Study|Withdrew Consent|1|||
155464674|NCT01998880|561121616|FG000|Overall Study|Death|3|||
155464675|NCT01998880|561121617|FG001|Overall Study|Death|6|||
155464676|NCT01998880|561121616|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155464677|NCT01998880|561121617|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155464678|NCT01998880|561121616|FG000|Overall Study|Administrative/Other|1|||
155464679|NCT01998880|561121617|FG001|Overall Study|Administrative/Other|1|||
155464680|NCT01998880|561121616|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
155464681|NCT01998880|561121617|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155464682|NCT01998880|561121616|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155464683|NCT01998880|561121617|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155464684|NCT01998880|561121616|FG000|Overall Study|Did Not Receive Treatment|3|||
155464685|NCT01998880|561121617|FG001|Overall Study|Did Not Receive Treatment|2|||
155464686|NCT02248857|561121618|FG000|3 Month|Withdrawal by Subject|9|||
155464687|NCT02248857|561121619|FG001|3 Month|Withdrawal by Subject|3|||
155464688|NCT02248857|561121620|FG002|3 Month|Withdrawal by Subject|4|||
155464689|NCT02248857|561121618|FG000|3 Month|Unable to reach for 3 month|35|||
155464690|NCT02248857|561121619|FG001|3 Month|Unable to reach for 3 month|29|||
155464691|NCT02248857|561121620|FG002|3 Month|Unable to reach for 3 month|26|||
155464692|NCT02248857|561121618|FG000|3 Month|Partially completed, unable to finish|2|||
155464693|NCT02248857|561121619|FG001|3 Month|Partially completed, unable to finish|2|||
155464694|NCT02248857|561121620|FG002|3 Month|Partially completed, unable to finish|1|||
155464695|NCT02248857|561121618|FG000|6 Month|Lost to Follow-up|27|||
155464696|NCT02248857|561121619|FG001|6 Month|Lost to Follow-up|26|||
155464697|NCT02248857|561121620|FG002|6 Month|Lost to Follow-up|15|||
155464698|NCT02248857|561121618|FG000|6 Month|Partially completed, unable to finish|0|||
155464699|NCT02248857|561121619|FG001|6 Month|Partially completed, unable to finish|1|||
155464700|NCT02248857|561121620|FG002|6 Month|Partially completed, unable to finish|0|||
155464701|NCT02248857|561121618|FG000|6 Month|Withdrawal by Subject|0|||
155464702|NCT02248857|561121619|FG001|6 Month|Withdrawal by Subject|2|||
155464703|NCT02248857|561121620|FG002|6 Month|Withdrawal by Subject|2|||
155464704|NCT02248857|561121618|FG000|6 Month|Death|1|||
155464705|NCT02248857|561121619|FG001|6 Month|Death|0|||
155464706|NCT02248857|561121620|FG002|6 Month|Death|0|||
155464707|NCT02671461|561121621|FG000|Treatment|Adverse Event|0|||
155464708|NCT02671461|561121622|FG001|Treatment|Adverse Event|0|||
155464709|NCT02671461|561121623|FG002|Treatment|Adverse Event|1|||
155464710|NCT02671461|561121621|FG000|Treatment|Administrative Reason by Sponsor|1|||
155464711|NCT02671461|561121622|FG001|Treatment|Administrative Reason by Sponsor|3|||
155464712|NCT02671461|561121623|FG002|Treatment|Administrative Reason by Sponsor|4|||
155464713|NCT02671461|561121621|FG000|Treatment|Randomized, not treated|1|||
155464714|NCT02671461|561121622|FG001|Treatment|Randomized, not treated|0|||
155464715|NCT02671461|561121623|FG002|Treatment|Randomized, not treated|0|||
155464716|NCT02671461|561121621|FG000|Follow-up|Withdrawal by Subject|1|||
155464717|NCT02671461|561121622|FG001|Follow-up|Withdrawal by Subject|0|||
155464718|NCT02671461|561121623|FG002|Follow-up|Withdrawal by Subject|0|||
155464719|NCT02671461|561121621|FG000|Follow-up|Lost to Follow-up|0|||
155464720|NCT02671461|561121622|FG001|Follow-up|Lost to Follow-up|0|||
155464721|NCT02671461|561121623|FG002|Follow-up|Lost to Follow-up|1|||
155464722|NCT02671461|561121621|FG000|Follow-up|Administrative Reason by Sponsor|0|||
155464723|NCT02671461|561121622|FG001|Follow-up|Administrative Reason by Sponsor|1|||
155464724|NCT02671461|561121623|FG002|Follow-up|Administrative Reason by Sponsor|0|||
155464725|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
155464726|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
155464727|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
155464728|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
155464729|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
155464730|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
155464731|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
155464732|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
155464733|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
155464734|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
155464735|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
155464736|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
155464737|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
155652514|NCT00289900|561820366|FG003|Overall Study|Other|5|||
155652515|NCT00289900|561820367|FG004|Overall Study|Other|1|||
155652516|NCT00289900|561820368|FG005|Overall Study|Other|0|||
155652517|NCT00289900|561820363|FG000|Overall Study|Participant moved|1|||
155652518|NCT00289900|561820364|FG001|Overall Study|Participant moved|0|||
155652519|NCT00289900|561820365|FG002|Overall Study|Participant moved|0|||
155652520|NCT00289900|561820366|FG003|Overall Study|Participant moved|1|||
155652521|NCT00289900|561820367|FG004|Overall Study|Participant moved|1|||
155652522|NCT00289900|561820368|FG005|Overall Study|Participant moved|1|||
155652523|NCT00289900|561820363|FG000|Overall Study|Withdrawal by Subject|10|||
155652524|NCT00289900|561820364|FG001|Overall Study|Withdrawal by Subject|21|||
155652525|NCT00289900|561820365|FG002|Overall Study|Withdrawal by Subject|8|||
155652526|NCT00289900|561820366|FG003|Overall Study|Withdrawal by Subject|18|||
155652527|NCT00289900|561820367|FG004|Overall Study|Withdrawal by Subject|12|||
155652528|NCT00289900|561820368|FG005|Overall Study|Withdrawal by Subject|11|||
155652529|NCT00289900|561820363|FG000|Overall Study|Protocol Violation|3|||
155652530|NCT00289900|561820364|FG001|Overall Study|Protocol Violation|9|||
155652531|NCT00289900|561820365|FG002|Overall Study|Protocol Violation|2|||
155652532|NCT00289900|561820366|FG003|Overall Study|Protocol Violation|6|||
155652533|NCT00289900|561820367|FG004|Overall Study|Protocol Violation|7|||
155652534|NCT00289900|561820368|FG005|Overall Study|Protocol Violation|4|||
155652535|NCT00289900|561820363|FG000|Overall Study|site terminated|1|||
155464738|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
155464739|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
155464740|NCT01412060|561121624|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
155464741|NCT01412060|561121625|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
155464742|NCT01412060|561121626|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
155464743|NCT01412060|561121624|FG000|Period Between RIP and SP|Adverse Event|4|||
155464744|NCT01412060|561121625|FG001|Period Between RIP and SP|Adverse Event|0|||
155464745|NCT01412060|561121626|FG002|Period Between RIP and SP|Adverse Event|0|||
155464746|NCT01412060|561121624|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
155464747|NCT01412060|561121625|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
155464748|NCT01412060|561121626|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
155464749|NCT01412060|561121624|FG000|Period Between RIP and SP|Protocol Violation|2|||
155464750|NCT01412060|561121625|FG001|Period Between RIP and SP|Protocol Violation|0|||
155464751|NCT01412060|561121626|FG002|Period Between RIP and SP|Protocol Violation|0|||
155464752|NCT01412060|561121624|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
155464753|NCT01412060|561121625|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
155464754|NCT01412060|561121626|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
155464755|NCT01412060|561121624|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
155464756|NCT01412060|561121625|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
155464757|NCT01412060|561121626|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
155464758|NCT01412060|561121624|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
155464759|NCT01412060|561121625|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
155464760|NCT01412060|561121626|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
155464761|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
155464762|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
155464763|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
155464764|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
155464765|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
155516938|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
155516939|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
155516940|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
155516941|NCT02579096|561317479|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
155516942|NCT02579096|561317480|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
155516943|NCT02729896|561317483|FG000|Overall Study|Death|0|||
155516944|NCT02729896|561317484|FG001|Overall Study|Death|2|||
155516945|NCT02729896|561317485|FG002|Overall Study|Death|13|||
155516946|NCT02729896|561317483|FG000|Overall Study|Lost to Follow-up|0|||
155652536|NCT00289900|561820364|FG001|Overall Study|site terminated|0|||
155464766|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
155516947|NCT02729896|561317484|FG001|Overall Study|Lost to Follow-up|2|||
155516948|NCT02729896|561317485|FG002|Overall Study|Lost to Follow-up|3|||
155652537|NCT00289900|561820365|FG002|Overall Study|site terminated|1|||
155652538|NCT00289900|561820366|FG003|Overall Study|site terminated|0|||
155652539|NCT00289900|561820367|FG004|Overall Study|site terminated|0|||
155652540|NCT00289900|561820368|FG005|Overall Study|site terminated|0|||
155652541|NCT00289900|561820363|FG000|Overall Study|Not treated|0|||
155464767|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
155464768|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
155464769|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
155464770|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
155464771|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
155464772|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
155464773|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
155516949|NCT02729896|561317483|FG000|Overall Study|Other|0|||
155516950|NCT02729896|561317484|FG001|Overall Study|Other|2|||
155516951|NCT02729896|561317485|FG002|Overall Study|Other|0|||
155516952|NCT02729896|561317483|FG000|Overall Study|Physician Decision|1|||
155516953|NCT02729896|561317484|FG001|Overall Study|Physician Decision|2|||
155516954|NCT02729896|561317485|FG002|Overall Study|Physician Decision|3|||
155516955|NCT02729896|561317483|FG000|Overall Study|Progressive Disease|0|||
155516956|NCT02729896|561317484|FG001|Overall Study|Progressive Disease|1|||
155516957|NCT02729896|561317485|FG002|Overall Study|Progressive Disease|0|||
155516958|NCT02729896|561317483|FG000|Overall Study|Withdrawal by Subject|1|||
155516959|NCT02729896|561317484|FG001|Overall Study|Withdrawal by Subject|0|||
155516960|NCT02729896|561317485|FG002|Overall Study|Withdrawal by Subject|3|||
155516961|NCT01592370|561317489|FG000|Overall Study|Disease Progression|62|||
155516962|NCT01592370|561317490|FG001|Overall Study|Disease Progression|16|||
155516963|NCT01592370|561317491|FG002|Overall Study|Disease Progression|52|||
155516964|NCT01592370|561317492|FG003|Overall Study|Disease Progression|3|||
155516965|NCT01592370|561317493|FG004|Overall Study|Disease Progression|3|||
155516966|NCT01592370|561317494|FG005|Overall Study|Disease Progression|31|||
155516967|NCT01592370|561317495|FG006|Overall Study|Disease Progression|14|||
155516968|NCT01592370|561317489|FG000|Overall Study|Study Drug Toxicity|14|||
155516969|NCT01592370|561317490|FG001|Overall Study|Study Drug Toxicity|3|||
155516970|NCT01592370|561317491|FG002|Overall Study|Study Drug Toxicity|0|||
155516971|NCT01592370|561317492|FG003|Overall Study|Study Drug Toxicity|0|||
155516972|NCT01592370|561317493|FG004|Overall Study|Study Drug Toxicity|0|||
155516973|NCT01592370|561317494|FG005|Overall Study|Study Drug Toxicity|0|||
155516974|NCT01592370|561317495|FG006|Overall Study|Study Drug Toxicity|1|||
155516975|NCT01592370|561317489|FG000|Overall Study|AE unrelated to study drug|4|||
155516976|NCT01592370|561317490|FG001|Overall Study|AE unrelated to study drug|3|||
155516977|NCT01592370|561317491|FG002|Overall Study|AE unrelated to study drug|0|||
155464774|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
155464775|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
155464776|NCT01412060|561121624|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
155464777|NCT01412060|561121625|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
155464778|NCT01412060|561121626|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
155516978|NCT01592370|561317492|FG003|Overall Study|AE unrelated to study drug|0|||
155516979|NCT01592370|561317493|FG004|Overall Study|AE unrelated to study drug|0|||
155516980|NCT01592370|561317494|FG005|Overall Study|AE unrelated to study drug|0|||
155516981|NCT01592370|561317495|FG006|Overall Study|AE unrelated to study drug|1|||
155516982|NCT01592370|561317489|FG000|Overall Study|Request to discontinue study treatment|5|||
155516983|NCT01592370|561317490|FG001|Overall Study|Request to discontinue study treatment|0|||
155516984|NCT01592370|561317491|FG002|Overall Study|Request to discontinue study treatment|2|||
155516985|NCT01592370|561317492|FG003|Overall Study|Request to discontinue study treatment|0|||
155516986|NCT01592370|561317493|FG004|Overall Study|Request to discontinue study treatment|1|||
155516987|NCT01592370|561317494|FG005|Overall Study|Request to discontinue study treatment|2|||
155516988|NCT01592370|561317495|FG006|Overall Study|Request to discontinue study treatment|0|||
155516989|NCT01592370|561317489|FG000|Overall Study|Withdrew consent|1|||
155516990|NCT01592370|561317490|FG001|Overall Study|Withdrew consent|2|||
155516991|NCT01592370|561317491|FG002|Overall Study|Withdrew consent|1|||
155516992|NCT01592370|561317492|FG003|Overall Study|Withdrew consent|1|||
155516993|NCT01592370|561317493|FG004|Overall Study|Withdrew consent|0|||
155516994|NCT01592370|561317494|FG005|Overall Study|Withdrew consent|0|||
155516995|NCT01592370|561317495|FG006|Overall Study|Withdrew consent|0|||
155516996|NCT01592370|561317489|FG000|Overall Study|Maximum clinical benefit|11|||
155516997|NCT01592370|561317490|FG001|Overall Study|Maximum clinical benefit|1|||
155516998|NCT01592370|561317491|FG002|Overall Study|Maximum clinical benefit|7|||
155516999|NCT01592370|561317492|FG003|Overall Study|Maximum clinical benefit|1|||
155464779|NCT01412060|561121624|FG000|Period Between SP and DBP|Protocol Violation|2|||
155517000|NCT01592370|561317493|FG004|Overall Study|Maximum clinical benefit|0|||
155517001|NCT01592370|561317494|FG005|Overall Study|Maximum clinical benefit|0|||
155517002|NCT01592370|561317495|FG006|Overall Study|Maximum clinical benefit|0|||
155517003|NCT01592370|561317489|FG000|Overall Study|No longer meets study criteria|1|||
155517004|NCT01592370|561317490|FG001|Overall Study|No longer meets study criteria|0|||
155517005|NCT01592370|561317491|FG002|Overall Study|No longer meets study criteria|0|||
155517006|NCT01592370|561317492|FG003|Overall Study|No longer meets study criteria|0|||
155517007|NCT01592370|561317493|FG004|Overall Study|No longer meets study criteria|0|||
155517008|NCT01592370|561317494|FG005|Overall Study|No longer meets study criteria|0|||
155517009|NCT01592370|561317495|FG006|Overall Study|No longer meets study criteria|0|||
155464780|NCT01412060|561121625|FG001|Period Between SP and DBP|Protocol Violation|0|||
155464781|NCT01412060|561121626|FG002|Period Between SP and DBP|Protocol Violation|0|||
155464782|NCT01412060|561121624|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
155464783|NCT01412060|561121625|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
155464784|NCT01412060|561121626|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
155464785|NCT01412060|561121624|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
155464786|NCT01412060|561121625|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
155464787|NCT01412060|561121626|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
155464788|NCT01412060|561121624|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
155464789|NCT01412060|561121625|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
155464790|NCT01412060|561121626|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
155464791|NCT01412060|561121624|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
155464792|NCT01412060|561121625|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
155464793|NCT01412060|561121626|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
155464794|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
155464795|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
155464796|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
155464797|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
155464798|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
155464799|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
155464800|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
155464801|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
155464802|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
155464803|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
155464804|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
155464805|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
155464806|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
155464807|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
155464808|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
155464809|NCT01412060|561121624|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
155464810|NCT01412060|561121625|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
155464811|NCT01412060|561121626|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
155464812|NCT00004732|561121627|FG000|Overall Study|Withdrawal by Subject|36|||
155464813|NCT00004732|561121628|FG001|Overall Study|Withdrawal by Subject|64|||
155464814|NCT00004732|561121627|FG000|Overall Study|Lost to Follow-up|33|||
155464815|NCT00004732|561121628|FG001|Overall Study|Lost to Follow-up|47|||
155464816|NCT01688635|561121632|FG000|Washout 1|Withdrawal by Subject|1|||
155464817|NCT01688635|561121633|FG001|Washout 1|Withdrawal by Subject|0|||
155464818|NCT01688635|561121632|FG000|Washout 1|Adverse Event|0|||
155464819|NCT01688635|561121633|FG001|Washout 1|Adverse Event|1|||
155464820|NCT01688635|561121632|FG000|Washout 1|Physician Decision|0|||
155464821|NCT01688635|561121633|FG001|Washout 1|Physician Decision|1|||
155464822|NCT01688635|561121632|FG000|Washout 2|Physician Decision|1|||
155464823|NCT01688635|561121633|FG001|Washout 2|Physician Decision|0|||
155464824|NCT01688635|561121632|FG000|Washout 2|Withdrawal by Subject|1|||
155464825|NCT01688635|561121633|FG001|Washout 2|Withdrawal by Subject|0|||
155464826|NCT01688635|561121632|FG000|Washout 2|Sponsor Decision|1|||
155464827|NCT01688635|561121633|FG001|Washout 2|Sponsor Decision|2|||
155464828|NCT01688635|561121632|FG000|Washout 3|Withdrawal by Subject|1|||
155464829|NCT01688635|561121633|FG001|Washout 3|Withdrawal by Subject|0|||
155464830|NCT02674685|561121634|FG000|Overall Study|Withdrawal by Subject|4|||
155464831|NCT02661464|561121637|FG000|Overall Study|Lost to Follow-up|28|||
155464832|NCT02661464|561121638|FG001|Overall Study|Lost to Follow-up|0|||
155464833|NCT02661464|561121639|FG002|Overall Study|Lost to Follow-up|0|||
155464834|NCT02661464|561121640|FG003|Overall Study|Lost to Follow-up|0|||
155464835|NCT02661464|561121637|FG000|Overall Study|Withdrawal by Subject|3|||
155464836|NCT02661464|561121638|FG001|Overall Study|Withdrawal by Subject|1|||
155464837|NCT02661464|561121639|FG002|Overall Study|Withdrawal by Subject|0|||
155464838|NCT02661464|561121640|FG003|Overall Study|Withdrawal by Subject|0|||
155464839|NCT02661464|561121637|FG000|Overall Study|Participants terminated prematurely|288|||
155464840|NCT02661464|561121638|FG001|Overall Study|Participants terminated prematurely|52|||
155464841|NCT02661464|561121639|FG002|Overall Study|Participants terminated prematurely|1|||
155464842|NCT02661464|561121640|FG003|Overall Study|Participants terminated prematurely|1|||
155464843|NCT02661464|561121637|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
155464844|NCT02661464|561121638|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
155464845|NCT02661464|561121639|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
155464846|NCT02661464|561121640|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
155464847|NCT01924299|561121641|FG000|Period 2|Withdrawal by Subject|1|||
155464848|NCT01924299|561121642|FG001|Period 2|Withdrawal by Subject|0|||
155464849|NCT01924299|561121641|FG000|Period 2|Adverse Event|0|||
155464850|NCT01924299|561121642|FG001|Period 2|Adverse Event|1|||
155464851|NCT02177175|561121643|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
155464852|NCT02177175|561121644|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
155464853|NCT03820726|561121649|FG000|Overall Study|Other than listed|23|||
155464854|NCT03820726|561121649|FG000|Overall Study|Withdrawal by Subject|37|||
155464855|NCT03820726|561121649|FG000|Overall Study|Lost to Follow-up|3|||
155464856|NCT03820726|561121649|FG000|Overall Study|Protocol deviation|1|||
155464857|NCT03820726|561121649|FG000|Overall Study|Adverse Event|146|||
155464858|NCT03820726|561121649|FG000|Overall Study|Not treated|1|||
155464859|NCT01293084|561121653|FG000|Overall Study|Physician Decision|3|||
155464860|NCT01293084|561121653|FG000|Overall Study|Withdrawal by Subject|2|||
155464861|NCT04186663|561121654|FG000|Overall Study|Lost to Follow-up|1|||
155464862|NCT04186663|561121654|FG000|Overall Study|Unable to complete blood draw|3|||
155464863|NCT00719862|561121659|FG000|Overall Study|Adverse Event|1|||
155464864|NCT00719862|561121660|FG001|Overall Study|Adverse Event|2|||
155464865|NCT00719862|561121659|FG000|Overall Study|Lack of Efficacy|3|||
155464866|NCT00719862|561121660|FG001|Overall Study|Lack of Efficacy|0|||
155464867|NCT00719862|561121659|FG000|Overall Study|Non-Compliance|1|||
155464868|NCT00719862|561121660|FG001|Overall Study|Non-Compliance|0|||
155464869|NCT00719862|561121659|FG000|Overall Study|Withdrawal by Subject|1|||
155464870|NCT00719862|561121660|FG001|Overall Study|Withdrawal by Subject|0|||
155464871|NCT00719862|561121659|FG000|Overall Study|Lost to Follow-up|0|||
155464872|NCT00719862|561121660|FG001|Overall Study|Lost to Follow-up|1|||
155464873|NCT00719862|561121659|FG000|Overall Study|Other|2|||
155464874|NCT00719862|561121660|FG001|Overall Study|Other|3|||
155464875|NCT01184846|561121661|FG000|Overall Study|Adverse Event|2|||
155464876|NCT01184846|561121661|FG000|Overall Study|Insufficient response|1|||
155464877|NCT04432376|561123886|FG000|Double-blind Treatment Period|Adverse Event|2|||
155464878|NCT04432376|561123887|FG001|Double-blind Treatment Period|Adverse Event|6|||
155464879|NCT04432376|561123888|FG002|Double-blind Treatment Period|Adverse Event|0|||
155464880|NCT04432376|561123886|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
155464881|NCT04432376|561123887|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155464882|NCT04432376|561123888|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155464883|NCT04432376|561123886|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155464884|NCT04432376|561123887|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155464885|NCT04432376|561123888|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155464886|NCT04432376|561123886|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155464887|NCT04432376|561123887|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155464888|NCT04432376|561123888|FG002|Double-blind Treatment Period|Protocol Violation|0|||
155464889|NCT04432376|561123886|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
155464890|NCT04432376|561123887|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
155464891|NCT04432376|561123888|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
155464892|NCT00462488|561123889|FG000|Overall Study|Protocol Violation|1|||
155464893|NCT00462488|561123890|FG001|Overall Study|Protocol Violation|0|||
155464894|NCT00462488|561123889|FG000|Overall Study|Lack of Efficacy|19|||
155464895|NCT00462488|561123890|FG001|Overall Study|Lack of Efficacy|17|||
155464896|NCT01742091|561123895|FG000|Overall Study|Adverse Event|0|||
155652542|NCT00289900|561820364|FG001|Overall Study|Not treated|1|||
155652543|NCT00289900|561820365|FG002|Overall Study|Not treated|0|||
155652544|NCT00289900|561820366|FG003|Overall Study|Not treated|0|||
155652545|NCT00289900|561820367|FG004|Overall Study|Not treated|0|||
155652546|NCT00289900|561820368|FG005|Overall Study|Not treated|0|||
155652547|NCT01703221|561820369|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155652548|NCT01703221|561820370|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
155464897|NCT01742091|561123896|FG001|Overall Study|Adverse Event|0|||
155652549|NCT01703221|561820371|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155652550|NCT01703221|561820369|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
155652551|NCT01703221|561820370|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
155652552|NCT01703221|561820371|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
155652553|NCT01703221|561820369|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
155464898|NCT01742091|561123897|FG002|Overall Study|Adverse Event|0|||
155464899|NCT01742091|561123898|FG003|Overall Study|Adverse Event|0|||
155464900|NCT01742091|561123899|FG004|Overall Study|Adverse Event|1|||
155464901|NCT01742091|561123900|FG005|Overall Study|Adverse Event|0|||
155464902|NCT01742091|561123895|FG000|Overall Study|Physician Decision|0|||
155464903|NCT01742091|561123896|FG001|Overall Study|Physician Decision|0|||
155464904|NCT01742091|561123897|FG002|Overall Study|Physician Decision|0|||
155464905|NCT01742091|561123898|FG003|Overall Study|Physician Decision|0|||
155464906|NCT01742091|561123899|FG004|Overall Study|Physician Decision|0|||
155464907|NCT01742091|561123900|FG005|Overall Study|Physician Decision|1|||
155464908|NCT01742091|561123895|FG000|Overall Study|Withdrawal by Subject|0|||
155464909|NCT01742091|561123896|FG001|Overall Study|Withdrawal by Subject|0|||
155464910|NCT01742091|561123897|FG002|Overall Study|Withdrawal by Subject|0|||
155464911|NCT01742091|561123898|FG003|Overall Study|Withdrawal by Subject|1|||
155464912|NCT01742091|561123899|FG004|Overall Study|Withdrawal by Subject|0|||
155652554|NCT01703221|561820370|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155652555|NCT01703221|561820371|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155652556|NCT01703221|561820369|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
155652557|NCT01703221|561820370|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155652558|NCT01703221|561820371|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155652559|NCT01703221|561820369|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155652560|NCT01703221|561820370|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155652561|NCT01703221|561820371|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
155652562|NCT01703221|561820369|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
155652563|NCT01703221|561820370|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
155652564|NCT01703221|561820371|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
155652565|NCT01703221|561820369|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
155652566|NCT01703221|561820370|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
155652567|NCT01703221|561820371|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
155652568|NCT01703221|561820369|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
155517010|NCT01592370|561317489|FG000|Overall Study|Other Reasons|6|||
155517011|NCT01592370|561317490|FG001|Overall Study|Other Reasons|0|||
155517012|NCT01592370|561317491|FG002|Overall Study|Other Reasons|10|||
155517013|NCT01592370|561317492|FG003|Overall Study|Other Reasons|0|||
155517014|NCT01592370|561317493|FG004|Overall Study|Other Reasons|0|||
155464913|NCT01742091|561123900|FG005|Overall Study|Withdrawal by Subject|0|||
155464914|NCT01742091|561123895|FG000|Overall Study|Lost to Follow-up|0|||
155464915|NCT01742091|561123896|FG001|Overall Study|Lost to Follow-up|0|||
155464916|NCT01742091|561123897|FG002|Overall Study|Lost to Follow-up|0|||
155464917|NCT01742091|561123898|FG003|Overall Study|Lost to Follow-up|0|||
155464918|NCT01742091|561123899|FG004|Overall Study|Lost to Follow-up|0|||
155464919|NCT01742091|561123900|FG005|Overall Study|Lost to Follow-up|1|||
155464920|NCT02088541|561123901|FG000|Overall Study|Adverse Event|3|||
155464921|NCT02088541|561123902|FG001|Overall Study|Adverse Event|0|||
155464922|NCT02088541|561123903|FG002|Overall Study|Adverse Event|3|||
155464923|NCT02088541|561123904|FG003|Overall Study|Adverse Event|3|||
155464924|NCT02088541|561123905|FG004|Overall Study|Adverse Event|0|||
155464925|NCT02088541|561123901|FG000|Overall Study|Death|51|||
155464926|NCT02088541|561123902|FG001|Overall Study|Death|21|||
155464927|NCT02088541|561123903|FG002|Overall Study|Death|85|||
155652569|NCT01703221|561820370|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
155652570|NCT01703221|561820371|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
155464928|NCT02088541|561123904|FG003|Overall Study|Death|28|||
155464929|NCT02088541|561123905|FG004|Overall Study|Death|38|||
155652571|NCT03927846|561820373|FG000|Overall Study|Lost to Follow-up|10|||
155652572|NCT03927846|561820374|FG001|Overall Study|Lost to Follow-up|11|||
155652573|NCT00176254|561820375|FG000|Overall Study|Lost to Follow-up|1|||
155652574|NCT00992394|561820378|FG000|Overall Study|Lack of Efficacy|6|||
155652575|NCT00992394|561820379|FG001|Overall Study|Lack of Efficacy|3|||
155464930|NCT02088541|561123901|FG000|Overall Study|Lost to Follow-up|2|||
155464931|NCT02088541|561123902|FG001|Overall Study|Lost to Follow-up|0|||
155464932|NCT02088541|561123903|FG002|Overall Study|Lost to Follow-up|1|||
155464933|NCT02088541|561123904|FG003|Overall Study|Lost to Follow-up|0|||
155652576|NCT00992394|561820378|FG000|Overall Study|Adverse Event|4|||
155464934|NCT02088541|561123905|FG004|Overall Study|Lost to Follow-up|0|||
155464935|NCT02088541|561123901|FG000|Overall Study|Physician Decision|2|||
155464936|NCT02088541|561123902|FG001|Overall Study|Physician Decision|1|||
155464937|NCT02088541|561123903|FG002|Overall Study|Physician Decision|2|||
155464938|NCT02088541|561123904|FG003|Overall Study|Physician Decision|0|||
155464939|NCT02088541|561123905|FG004|Overall Study|Physician Decision|2|||
155464940|NCT02088541|561123901|FG000|Overall Study|Disease progression|7|||
155464941|NCT02088541|561123902|FG001|Overall Study|Disease progression|1|||
155464942|NCT02088541|561123903|FG002|Overall Study|Disease progression|2|||
155464943|NCT02088541|561123904|FG003|Overall Study|Disease progression|3|||
155464944|NCT02088541|561123905|FG004|Overall Study|Disease progression|1|||
155464945|NCT02088541|561123901|FG000|Overall Study|Study terminated by sponsor|1|||
155464946|NCT02088541|561123902|FG001|Overall Study|Study terminated by sponsor|1|||
155464947|NCT02088541|561123903|FG002|Overall Study|Study terminated by sponsor|12|||
155464948|NCT02088541|561123904|FG003|Overall Study|Study terminated by sponsor|2|||
155464949|NCT02088541|561123905|FG004|Overall Study|Study terminated by sponsor|6|||
155464950|NCT02088541|561123901|FG000|Overall Study|Withdrawal by Subject|3|||
155464951|NCT02088541|561123902|FG001|Overall Study|Withdrawal by Subject|2|||
155464952|NCT02088541|561123903|FG002|Overall Study|Withdrawal by Subject|9|||
155464953|NCT02088541|561123904|FG003|Overall Study|Withdrawal by Subject|7|||
155464954|NCT02088541|561123905|FG004|Overall Study|Withdrawal by Subject|10|||
155464955|NCT02088541|561123901|FG000|Overall Study|Other|2|||
155464956|NCT02088541|561123902|FG001|Overall Study|Other|1|||
155464957|NCT02088541|561123903|FG002|Overall Study|Other|3|||
155464958|NCT02088541|561123904|FG003|Overall Study|Other|1|||
155464959|NCT02088541|561123905|FG004|Overall Study|Other|1|||
155464960|NCT05742841|561123906|FG000|Overall Study|Withdrawal by Subject|1|||
155464961|NCT05742841|561123906|FG000|Overall Study|Lost to Follow-up|1|||
155464962|NCT00439725|561123908|FG000|Treatment Period|Withdrawal by Subject|22|||
155464963|NCT00439725|561123909|FG001|Treatment Period|Withdrawal by Subject|19|||
155464964|NCT00439725|561123908|FG000|Treatment Period|Study terminated by sponsor|156|||
155464965|NCT00439725|561123909|FG001|Treatment Period|Study terminated by sponsor|148|||
155464966|NCT00439725|561123908|FG000|Treatment Period|Site closed by investigator|1|||
155464967|NCT00439725|561123909|FG001|Treatment Period|Site closed by investigator|2|||
155464968|NCT00439725|561123908|FG000|Treatment Period|Adverse Event|39|||
155464969|NCT00439725|561123909|FG001|Treatment Period|Adverse Event|18|||
155464970|NCT00439725|561123908|FG000|Treatment Period|Physician Decision|1|||
155464971|NCT00439725|561123909|FG001|Treatment Period|Physician Decision|1|||
155464972|NCT00439725|561123908|FG000|Treatment Period|Protocol Violation|2|||
155464973|NCT00439725|561123909|FG001|Treatment Period|Protocol Violation|1|||
155464974|NCT00439725|561123908|FG000|Treatment Period|Clinical endpoint reached|6|||
155464975|NCT00439725|561123909|FG001|Treatment Period|Clinical endpoint reached|50|||
155464976|NCT00439725|561123908|FG000|Treatment Period|Technical problems|1|||
155464977|NCT00439725|561123909|FG001|Treatment Period|Technical problems|0|||
155464978|NCT00439725|561123908|FG000|Treatment Period|Lost to Follow-up|1|||
155464979|NCT00439725|561123909|FG001|Treatment Period|Lost to Follow-up|1|||
155464980|NCT00439725|561123908|FG000|Treatment Period|Participant convenience|1|||
155464981|NCT00439725|561123909|FG001|Treatment Period|Participant convenience|0|||
155464982|NCT00439725|561123908|FG000|Treatment Period|Protocol driven decision point|1|||
155464983|NCT00439725|561123909|FG001|Treatment Period|Protocol driven decision point|1|||
155464984|NCT00439725|561123908|FG000|Treatment Period|Death|1|||
155464985|NCT00439725|561123909|FG001|Treatment Period|Death|1|||
155464986|NCT00439725|561123908|FG000|Treatment Period|Participant did not receive treatment|4|||
155464987|NCT00439725|561123909|FG001|Treatment Period|Participant did not receive treatment|4|||
155464988|NCT00439725|561123908|FG000|Observational Period|Withdrawal by Subject|2|||
155464989|NCT00439725|561123909|FG001|Observational Period|Withdrawal by Subject|2|||
155464990|NCT00439725|561123908|FG000|Observational Period|Lost to Follow-up|0|||
155464991|NCT00439725|561123909|FG001|Observational Period|Lost to Follow-up|1|||
155464992|NCT00439725|561123908|FG000|Observational Period|Death|0|||
155464993|NCT00439725|561123909|FG001|Observational Period|Death|2|||
155464994|NCT00439725|561123908|FG000|Observational Period|Study termination by sponsor|1|||
155464995|NCT00439725|561123909|FG001|Observational Period|Study termination by sponsor|1|||
155464996|NCT00439725|561123908|FG000|Observational Period|Clinical endpoint reached|3|||
155464997|NCT00439725|561123909|FG001|Observational Period|Clinical endpoint reached|1|||
155464998|NCT00439725|561123908|FG000|Observational Period|Technical problems|1|||
155464999|NCT00439725|561123909|FG001|Observational Period|Technical problems|0|||
155465000|NCT00439725|561123908|FG000|Observational Period|Participant convenience|1|||
155465001|NCT00439725|561123909|FG001|Observational Period|Participant convenience|0|||
155465002|NCT02848313|561123910|FG000|Overall Study|Adverse Event|1|||
155465003|NCT02848313|561123911|FG001|Overall Study|Adverse Event|2|||
155465004|NCT02848313|561123910|FG000|Overall Study|Lack of Efficacy|0|||
155465005|NCT02848313|561123911|FG001|Overall Study|Lack of Efficacy|1|||
155465006|NCT02848313|561123910|FG000|Overall Study|Withdrawal by Subject|1|||
155465007|NCT02848313|561123911|FG001|Overall Study|Withdrawal by Subject|1|||
155465008|NCT02848313|561123910|FG000|Overall Study|Lost to follow up|1|||
155465009|NCT02848313|561123911|FG001|Overall Study|Lost to follow up|0|||
155465010|NCT01673490|561123912|FG000|Overall Study|Lost to Follow-up|1|||
155465011|NCT01673490|561123912|FG000|Overall Study|Adverse Event|3|||
155465012|NCT01673490|561123912|FG000|Overall Study|Withdrawal by Subject|3|||
155465013|NCT00379236|561123913|FG000|Double-blind|Adverse Event|11|||
155465014|NCT00379236|561123914|FG001|Double-blind|Adverse Event|6|||
155465015|NCT00379236|561123915|FG002|Double-blind|Adverse Event|0|||
155465016|NCT00379236|561123913|FG000|Double-blind|Protocol Violation|3|||
155465017|NCT00379236|561123914|FG001|Double-blind|Protocol Violation|3|||
155465018|NCT00379236|561123915|FG002|Double-blind|Protocol Violation|0|||
155465019|NCT00379236|561123913|FG000|Double-blind|Withdrawal by Subject|12|||
155465020|NCT00379236|561123914|FG001|Double-blind|Withdrawal by Subject|13|||
155465021|NCT00379236|561123915|FG002|Double-blind|Withdrawal by Subject|0|||
155465022|NCT00379236|561123913|FG000|Double-blind|Lost to Follow-up|4|||
155465023|NCT00379236|561123914|FG001|Double-blind|Lost to Follow-up|3|||
155465024|NCT00379236|561123915|FG002|Double-blind|Lost to Follow-up|0|||
155465025|NCT00379236|561123913|FG000|Double-blind|Use of exclusionary medication|1|||
155465026|NCT00379236|561123914|FG001|Double-blind|Use of exclusionary medication|2|||
155465027|NCT00379236|561123915|FG002|Double-blind|Use of exclusionary medication|0|||
155465028|NCT00379236|561123913|FG000|Double-blind|Other|3|||
155465029|NCT00379236|561123914|FG001|Double-blind|Other|7|||
155465030|NCT00379236|561123915|FG002|Double-blind|Other|0|||
155465031|NCT00379236|561123913|FG000|Double-blind|Data could not be retrieved|2|||
155465032|NCT00379236|561123914|FG001|Double-blind|Data could not be retrieved|2|||
155465033|NCT00379236|561123915|FG002|Double-blind|Data could not be retrieved|0|||
155465034|NCT00379236|561123913|FG000|Open-label Extension|Adverse Event|0|||
155465035|NCT00379236|561123914|FG001|Open-label Extension|Adverse Event|0|||
155465036|NCT00379236|561123915|FG002|Open-label Extension|Adverse Event|13|||
155465037|NCT00379236|561123913|FG000|Open-label Extension|Protocol Violation|0|||
155465038|NCT00379236|561123914|FG001|Open-label Extension|Protocol Violation|0|||
155465039|NCT00379236|561123915|FG002|Open-label Extension|Protocol Violation|7|||
155465040|NCT00379236|561123913|FG000|Open-label Extension|Withdrawal by Subject|0|||
155465041|NCT00379236|561123914|FG001|Open-label Extension|Withdrawal by Subject|0|||
155465042|NCT00379236|561123915|FG002|Open-label Extension|Withdrawal by Subject|13|||
155465043|NCT00379236|561123913|FG000|Open-label Extension|Lost to Follow-up|0|||
155465044|NCT00379236|561123914|FG001|Open-label Extension|Lost to Follow-up|0|||
155465045|NCT00379236|561123915|FG002|Open-label Extension|Lost to Follow-up|12|||
155465046|NCT00379236|561123913|FG000|Open-label Extension|Use of exclusionary medication|0|||
155465047|NCT00379236|561123914|FG001|Open-label Extension|Use of exclusionary medication|0|||
155465048|NCT00379236|561123915|FG002|Open-label Extension|Use of exclusionary medication|3|||
155465049|NCT00379236|561123913|FG000|Open-label Extension|Other|0|||
155465050|NCT00379236|561123914|FG001|Open-label Extension|Other|0|||
155465051|NCT00379236|561123915|FG002|Open-label Extension|Other|7|||
155465052|NCT02715804|561123921|FG000|Overall Study|Death|222|||
155465053|NCT02715804|561123922|FG001|Overall Study|Death|106|||
155465054|NCT02715804|561123921|FG000|Overall Study|Withdrawal by Subject|5|||
155465055|NCT02715804|561123922|FG001|Overall Study|Withdrawal by Subject|4|||
155465056|NCT02715804|561123921|FG000|Overall Study|Other than specified|2|||
155465057|NCT02715804|561123922|FG001|Overall Study|Other than specified|3|||
155465058|NCT01625611|561123925|FG000|Overall Study|No adlib drinks Lab 1|3|||
155465059|NCT01625611|561123926|FG001|Overall Study|No adlib drinks Lab 1|0|||
155465060|NCT01625611|561123925|FG000|Overall Study|Technical issues with PET|1|||
155465061|NCT01625611|561123926|FG001|Overall Study|Technical issues with PET|0|||
155465062|NCT01625611|561123925|FG000|Overall Study|Unable to complete study procedures|1|||
155465063|NCT01625611|561123926|FG001|Overall Study|Unable to complete study procedures|0|||
155465064|NCT01625611|561123925|FG000|Overall Study|Withdrawal by Subject|3|||
155465065|NCT01625611|561123926|FG001|Overall Study|Withdrawal by Subject|0|||
155465066|NCT00948194|561123927|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
155465067|NCT00948194|561123928|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
155465068|NCT00527072|561123935|FG000|Overall Study|Adverse Event|13|||
155517015|NCT01592370|561317494|FG005|Overall Study|Other Reasons|1|||
155517016|NCT01592370|561317495|FG006|Overall Study|Other Reasons|0|||
155517017|NCT01592370|561317489|FG000|Overall Study|Not Treated|0|||
155517018|NCT01592370|561317490|FG001|Overall Study|Not Treated|0|||
155517019|NCT01592370|561317491|FG002|Overall Study|Not Treated|0|||
155465069|NCT00527072|561123935|FG000|Overall Study|Lack of Efficacy|11|||
155465070|NCT00527072|561123935|FG000|Overall Study|Lost to Follow-up|3|||
155465071|NCT00527072|561123935|FG000|Overall Study|Protocol Violation|2|||
155465072|NCT00527072|561123935|FG000|Overall Study|Withdrawal by Subject|7|||
155465073|NCT02137837|561123936|FG000|Overall Study|Adverse Event|0|||
155465074|NCT02137837|561123937|FG001|Overall Study|Adverse Event|2|||
155465075|NCT02137837|561123938|FG002|Overall Study|Adverse Event|1|||
155465076|NCT02137837|561123936|FG000|Overall Study|Refusal unrelated to adverse event|2|||
155517020|NCT01592370|561317492|FG003|Overall Study|Not Treated|0|||
155465077|NCT02137837|561123937|FG001|Overall Study|Refusal unrelated to adverse event|2|||
155465078|NCT02137837|561123938|FG002|Overall Study|Refusal unrelated to adverse event|1|||
155465079|NCT02137837|561123936|FG000|Overall Study|Progression/relapse|9|||
155517021|NCT01592370|561317493|FG004|Overall Study|Not Treated|2|||
155465080|NCT02137837|561123937|FG001|Overall Study|Progression/relapse|7|||
155465081|NCT02137837|561123938|FG002|Overall Study|Progression/relapse|7|||
155465082|NCT02137837|561123936|FG000|Overall Study|Not protocol specified|2|||
155465083|NCT02137837|561123937|FG001|Overall Study|Not protocol specified|1|||
155465084|NCT02137837|561123938|FG002|Overall Study|Not protocol specified|3|||
155465085|NCT01467661|561123939|FG000|Overall Study|Adverse Event|16|||
155465086|NCT01467661|561123939|FG000|Overall Study|Withdrawal by Subject|1|||
155465087|NCT01467661|561123939|FG000|Overall Study|Lack of Efficacy|3|||
155465088|NCT01467661|561123939|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
155465089|NCT00270998|561123940|FG000|3 Month Follow-up|Adverse Event|1|||
155465090|NCT00270998|561123941|FG001|3 Month Follow-up|Adverse Event|0|||
155465091|NCT00270998|561123942|FG002|3 Month Follow-up|Adverse Event|0|||
155465092|NCT00270998|561123940|FG000|3 Month Follow-up|Lack of Efficacy|1|||
155465093|NCT00270998|561123941|FG001|3 Month Follow-up|Lack of Efficacy|2|||
155465094|NCT00270998|561123942|FG002|3 Month Follow-up|Lack of Efficacy|1|||
155465095|NCT00270998|561123940|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
155465096|NCT00270998|561123941|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
155465097|NCT00270998|561123942|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
155465098|NCT00270998|561123940|FG000|3 Month Follow-up|Pessary did not fit|12|||
155465099|NCT00270998|561123941|FG001|3 Month Follow-up|Pessary did not fit|0|||
155465100|NCT00270998|561123942|FG002|3 Month Follow-up|Pessary did not fit|0|||
155465101|NCT00270998|561123940|FG000|3 Month Follow-up|Personal/family health|1|||
155465102|NCT00270998|561123941|FG001|3 Month Follow-up|Personal/family health|1|||
155465103|NCT00270998|561123942|FG002|3 Month Follow-up|Personal/family health|0|||
155465104|NCT00270998|561123940|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
155465105|NCT00270998|561123941|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
155465106|NCT00270998|561123942|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
155465107|NCT00270998|561123940|FG000|12 Month Follow-up|Lack of Efficacy|5|||
155465108|NCT00270998|561123941|FG001|12 Month Follow-up|Lack of Efficacy|4|||
155465109|NCT00270998|561123942|FG002|12 Month Follow-up|Lack of Efficacy|3|||
155465110|NCT00270998|561123940|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
155465111|NCT00270998|561123941|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
155465112|NCT00270998|561123942|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
155465113|NCT00270998|561123940|FG000|12 Month Follow-up|Pessary did not fit|1|||
155465114|NCT00270998|561123941|FG001|12 Month Follow-up|Pessary did not fit|0|||
155465115|NCT00270998|561123942|FG002|12 Month Follow-up|Pessary did not fit|0|||
155465116|NCT00270998|561123940|FG000|12 Month Follow-up|Personal/family health|0|||
155465117|NCT00270998|561123941|FG001|12 Month Follow-up|Personal/family health|5|||
155465118|NCT00270998|561123942|FG002|12 Month Follow-up|Personal/family health|1|||
155465119|NCT00270998|561123940|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
155465120|NCT00270998|561123941|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
155465121|NCT00270998|561123942|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
155465122|NCT04075396|561123945|FG000|Overall Study|Death|11|||
155465123|NCT04075396|561123946|FG001|Overall Study|Death|9|||
155465124|NCT04075396|561123945|FG000|Overall Study|Withdrawal by Subject|1|||
155465125|NCT04075396|561123946|FG001|Overall Study|Withdrawal by Subject|2|||
155465126|NCT04075396|561123945|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
155465127|NCT04075396|561123946|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
155465128|NCT04075396|561123945|FG000|Overall Study|Enrolled but not-treated|0|||
155465129|NCT04075396|561123946|FG001|Overall Study|Enrolled but not-treated|1|||
155465130|NCT01855945|561123947|FG000|Overall Study|Adverse Event|0|||
155465131|NCT01855945|561123948|FG001|Overall Study|Adverse Event|0|||
155465132|NCT01855945|561123949|FG002|Overall Study|Adverse Event|0|||
155465133|NCT01855945|561123950|FG003|Overall Study|Adverse Event|0|||
155465134|NCT01855945|561123951|FG004|Overall Study|Adverse Event|0|||
155517022|NCT01592370|561317494|FG005|Overall Study|Not Treated|2|||
155517023|NCT01592370|561317495|FG006|Overall Study|Not Treated|0|||
155517024|NCT02415959|561317496|FG000|Overall Study|Adverse Event|0|||
155465135|NCT01855945|561123952|FG005|Overall Study|Adverse Event|0|||
155465136|NCT01855945|561123953|FG006|Overall Study|Adverse Event|1|||
155465137|NCT01855945|561123954|FG007|Overall Study|Adverse Event|0|||
155465138|NCT01855945|561123955|FG008|Overall Study|Adverse Event|0|||
155465139|NCT01855945|561123956|FG009|Overall Study|Adverse Event|0|||
155465140|NCT01855945|561123957|FG010|Overall Study|Adverse Event|0|||
155465141|NCT01855945|561123958|FG011|Overall Study|Adverse Event|0|||
155465142|NCT01855945|561123947|FG000|Overall Study|Death|0|||
155465143|NCT01855945|561123948|FG001|Overall Study|Death|0|||
155465144|NCT01855945|561123949|FG002|Overall Study|Death|0|||
155517025|NCT02415959|561317497|FG001|Overall Study|Adverse Event|1|||
155465145|NCT01855945|561123950|FG003|Overall Study|Death|0|||
155465146|NCT01855945|561123951|FG004|Overall Study|Death|0|||
155465147|NCT01855945|561123952|FG005|Overall Study|Death|0|||
155465148|NCT01855945|561123953|FG006|Overall Study|Death|2|||
155465149|NCT01855945|561123954|FG007|Overall Study|Death|0|||
155465150|NCT01855945|561123955|FG008|Overall Study|Death|0|||
155465151|NCT01855945|561123956|FG009|Overall Study|Death|0|||
155465152|NCT01855945|561123957|FG010|Overall Study|Death|0|||
155465153|NCT01855945|561123958|FG011|Overall Study|Death|0|||
155465154|NCT01855945|561123947|FG000|Overall Study|Lost to Follow-up|11|||
155465155|NCT01855945|561123948|FG001|Overall Study|Lost to Follow-up|10|||
155465156|NCT01855945|561123949|FG002|Overall Study|Lost to Follow-up|7|||
155465157|NCT01855945|561123950|FG003|Overall Study|Lost to Follow-up|3|||
155465158|NCT01855945|561123951|FG004|Overall Study|Lost to Follow-up|0|||
155465159|NCT01855945|561123952|FG005|Overall Study|Lost to Follow-up|3|||
155465160|NCT01855945|561123953|FG006|Overall Study|Lost to Follow-up|4|||
155465161|NCT01855945|561123954|FG007|Overall Study|Lost to Follow-up|7|||
155465162|NCT01855945|561123955|FG008|Overall Study|Lost to Follow-up|2|||
155465163|NCT01855945|561123956|FG009|Overall Study|Lost to Follow-up|0|||
155465164|NCT01855945|561123957|FG010|Overall Study|Lost to Follow-up|0|||
155465165|NCT01855945|561123958|FG011|Overall Study|Lost to Follow-up|2|||
155465166|NCT01855945|561123947|FG000|Overall Study|Other - Unclassified|1|||
155465167|NCT01855945|561123948|FG001|Overall Study|Other - Unclassified|1|||
155465168|NCT01855945|561123949|FG002|Overall Study|Other - Unclassified|1|||
155465169|NCT01855945|561123950|FG003|Overall Study|Other - Unclassified|0|||
155465170|NCT01855945|561123951|FG004|Overall Study|Other - Unclassified|0|||
155465171|NCT01855945|561123952|FG005|Overall Study|Other - Unclassified|0|||
155465172|NCT01855945|561123953|FG006|Overall Study|Other - Unclassified|2|||
155465173|NCT01855945|561123954|FG007|Overall Study|Other - Unclassified|1|||
155465174|NCT01855945|561123955|FG008|Overall Study|Other - Unclassified|0|||
155465175|NCT01855945|561123956|FG009|Overall Study|Other - Unclassified|0|||
155465176|NCT01855945|561123957|FG010|Overall Study|Other - Unclassified|1|||
155465177|NCT01855945|561123958|FG011|Overall Study|Other - Unclassified|0|||
155465178|NCT01855945|561123947|FG000|Overall Study|Withdrawal by Subject|4|||
155465179|NCT01855945|561123948|FG001|Overall Study|Withdrawal by Subject|0|||
155465180|NCT01855945|561123949|FG002|Overall Study|Withdrawal by Subject|4|||
155465181|NCT01855945|561123950|FG003|Overall Study|Withdrawal by Subject|1|||
155465182|NCT01855945|561123951|FG004|Overall Study|Withdrawal by Subject|1|||
155465183|NCT01855945|561123952|FG005|Overall Study|Withdrawal by Subject|0|||
155465184|NCT01855945|561123953|FG006|Overall Study|Withdrawal by Subject|1|||
155465185|NCT01855945|561123954|FG007|Overall Study|Withdrawal by Subject|0|||
155465186|NCT01855945|561123955|FG008|Overall Study|Withdrawal by Subject|0|||
155465187|NCT01855945|561123956|FG009|Overall Study|Withdrawal by Subject|2|||
155465188|NCT01855945|561123957|FG010|Overall Study|Withdrawal by Subject|4|||
155465189|NCT01855945|561123958|FG011|Overall Study|Withdrawal by Subject|1|||
155465190|NCT02156804|561123959|FG000|Overall Study|Withdrawal by Subject|1|||
155465191|NCT03228394|561123960|FG000|Overall Study|Lost to Follow-up|0|||
155465192|NCT03228394|561123961|FG001|Overall Study|Lost to Follow-up|0|||
155465193|NCT03228394|561123962|FG002|Overall Study|Lost to Follow-up|1|||
155465194|NCT03228394|561123963|FG003|Overall Study|Lost to Follow-up|1|||
155465195|NCT03228394|561123964|FG004|Overall Study|Lost to Follow-up|0|||
155465196|NCT03228394|561123965|FG005|Overall Study|Lost to Follow-up|0|||
155465197|NCT03228394|561123966|FG006|Overall Study|Lost to Follow-up|2|||
155465198|NCT03228394|561123967|FG007|Overall Study|Lost to Follow-up|0|||
155465199|NCT03228394|561123960|FG000|Overall Study|Withdrawal by Subject|0|||
155465200|NCT03228394|561123961|FG001|Overall Study|Withdrawal by Subject|0|||
155465201|NCT03228394|561123962|FG002|Overall Study|Withdrawal by Subject|1|||
155465202|NCT03228394|561123963|FG003|Overall Study|Withdrawal by Subject|0|||
155465203|NCT03228394|561123964|FG004|Overall Study|Withdrawal by Subject|0|||
155465204|NCT03228394|561123965|FG005|Overall Study|Withdrawal by Subject|0|||
155465205|NCT03228394|561123966|FG006|Overall Study|Withdrawal by Subject|1|||
155465206|NCT03228394|561123967|FG007|Overall Study|Withdrawal by Subject|3|||
155465207|NCT03228394|561123960|FG000|Overall Study|Protocol Violation|0|||
155465208|NCT03228394|561123961|FG001|Overall Study|Protocol Violation|0|||
155465209|NCT03228394|561123962|FG002|Overall Study|Protocol Violation|0|||
155465210|NCT03228394|561123963|FG003|Overall Study|Protocol Violation|1|||
155465211|NCT03228394|561123964|FG004|Overall Study|Protocol Violation|0|||
155465212|NCT03228394|561123965|FG005|Overall Study|Protocol Violation|0|||
155465213|NCT03228394|561123966|FG006|Overall Study|Protocol Violation|0|||
155465214|NCT03228394|561123967|FG007|Overall Study|Protocol Violation|0|||
155465215|NCT03228394|561123960|FG000|Overall Study|Physician Decision|0|||
155465216|NCT03228394|561123961|FG001|Overall Study|Physician Decision|0|||
155465217|NCT03228394|561123962|FG002|Overall Study|Physician Decision|0|||
155465218|NCT03228394|561123963|FG003|Overall Study|Physician Decision|0|||
155465219|NCT03228394|561123964|FG004|Overall Study|Physician Decision|0|||
155465220|NCT03228394|561123965|FG005|Overall Study|Physician Decision|0|||
155465221|NCT03228394|561123966|FG006|Overall Study|Physician Decision|1|||
155465222|NCT03228394|561123967|FG007|Overall Study|Physician Decision|0|||
155465223|NCT03228394|561123960|FG000|Overall Study|Noncompliance|0|||
155465224|NCT03228394|561123961|FG001|Overall Study|Noncompliance|0|||
155465225|NCT03228394|561123962|FG002|Overall Study|Noncompliance|0|||
155465226|NCT03228394|561123963|FG003|Overall Study|Noncompliance|0|||
155465227|NCT03228394|561123964|FG004|Overall Study|Noncompliance|0|||
155465228|NCT03228394|561123965|FG005|Overall Study|Noncompliance|0|||
155465229|NCT03228394|561123966|FG006|Overall Study|Noncompliance|1|||
155465230|NCT03228394|561123967|FG007|Overall Study|Noncompliance|0|||
155465231|NCT02443805|561123974|FG000|Overall Study|Adverse Event|100|||
155465232|NCT02443805|561123975|FG001|Overall Study|Adverse Event|18|||
155465233|NCT02443805|561123974|FG000|Overall Study|Withdrawal by Subject|73|||
155465234|NCT02443805|561123975|FG001|Overall Study|Withdrawal by Subject|74|||
155465235|NCT02443805|561123974|FG000|Overall Study|Lost to Follow-up|19|||
155465236|NCT02443805|561123975|FG001|Overall Study|Lost to Follow-up|14|||
155465237|NCT02443805|561123974|FG000|Overall Study|Pregnancy|6|||
155465238|NCT02443805|561123975|FG001|Overall Study|Pregnancy|5|||
155465239|NCT02443805|561123974|FG000|Overall Study|Protocol Violation|2|||
155465240|NCT02443805|561123975|FG001|Overall Study|Protocol Violation|4|||
155465241|NCT02443805|561123974|FG000|Overall Study|Lack of Efficacy|1|||
155465242|NCT02443805|561123975|FG001|Overall Study|Lack of Efficacy|1|||
155465243|NCT02443805|561123974|FG000|Overall Study|Non-compliance with study drug|6|||
155465244|NCT02443805|561123975|FG001|Overall Study|Non-compliance with study drug|4|||
155465245|NCT02443805|561123974|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155465246|NCT02443805|561123975|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155465247|NCT02443805|561123974|FG000|Overall Study|Any other reason not above-mentioned|3|||
155465248|NCT02443805|561123975|FG001|Overall Study|Any other reason not above-mentioned|2|||
155465249|NCT00961116|561123976|FG000|Washout Period of 7 Days|Adverse Event|1|||
155465250|NCT00961116|561123977|FG001|Washout Period of 7 Days|Adverse Event|1|||
155465251|NCT00961116|561123976|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
155465252|NCT00961116|561123977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155465253|NCT00961116|561123976|FG000|Washout Period of 7 Days|Protocol Violation|0|||
155465254|NCT00961116|561123977|FG001|Washout Period of 7 Days|Protocol Violation|1|||
155465255|NCT00968708|561123978|FG000|Overall Study|Adverse Event|169|||
155465256|NCT00968708|561123979|FG001|Overall Study|Adverse Event|150|||
155465257|NCT00968708|561123978|FG000|Overall Study|Major Protocol Deviation|0|||
155465258|NCT00968708|561123979|FG001|Overall Study|Major Protocol Deviation|1|||
155465259|NCT00968708|561123978|FG000|Overall Study|Lost to Follow-up|19|||
155465260|NCT00968708|561123979|FG001|Overall Study|Lost to Follow-up|11|||
155465261|NCT00968708|561123978|FG000|Overall Study|Voluntary Withdrawal|104|||
155465262|NCT00968708|561123979|FG001|Overall Study|Voluntary Withdrawal|101|||
155465263|NCT00968708|561123978|FG000|Overall Study|Investigator Discretion|0|||
155465264|NCT00968708|561123979|FG001|Overall Study|Investigator Discretion|1|||
155465265|NCT00968708|561123978|FG000|Overall Study|Other|26|||
155465266|NCT00968708|561123979|FG001|Overall Study|Other|34|||
155465267|NCT02708966|561123980|FG000|Overall Study|Lost to Follow-up|2|||
155465268|NCT02708966|561123981|FG001|Overall Study|Lost to Follow-up|2|||
155465269|NCT02260388|561123984|FG000|Overall Study|Lost to Follow-up|2|||
155465270|NCT02260388|561123985|FG001|Overall Study|Lost to Follow-up|8|||
155465271|NCT02260388|561123986|FG002|Overall Study|Lost to Follow-up|3|||
155465272|NCT02260388|561123987|FG003|Overall Study|Lost to Follow-up|4|||
155465273|NCT00389441|561123988|FG000|Overall Study|Adverse Event|7|||
155465274|NCT00389441|561123988|FG000|Overall Study|Death|4|||
155465275|NCT00389441|561123988|FG000|Overall Study|Lost to Follow-up|2|||
155465276|NCT00389441|561123988|FG000|Overall Study|Withdrawal by Subject|4|||
155465277|NCT00389441|561123988|FG000|Overall Study|Physician Decision|1|||
155465278|NCT00389441|561123988|FG000|Overall Study|Protocol Violation|1|||
155465279|NCT00389441|561123988|FG000|Overall Study|Global deterioration of health status|4|||
155465280|NCT00389441|561123988|FG000|Overall Study|Objective progression or relapse|26|||
155465281|NCT00389441|561123988|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
155465282|NCT00389441|561123988|FG000|Overall Study|Clinical progression|1|||
155465283|NCT01981109|561123989|FG000|Overall Study|Death|36|||
155465284|NCT01981109|561123989|FG000|Overall Study|Withdrawal by Subject|40|||
155465285|NCT01981109|561123989|FG000|Overall Study|Lost to Follow-up|9|||
155465286|NCT01981109|561123989|FG000|Overall Study|No Discontinuation Documentation|37|||
155465287|NCT01981109|561123989|FG000|Overall Study|Study Termination|100|||
155465288|NCT01981109|561123989|FG000|Overall Study|No data available|2|||
155465289|NCT03407170|561123990|FG000|Overall Study|Adverse Event|1|||
155465290|NCT00305604|561123993|FG000|Overall Study|Adverse Event|6|||
155465291|NCT00305604|561123994|FG001|Overall Study|Adverse Event|3|||
155465292|NCT00305604|561123993|FG000|Overall Study|Lack of Efficacy|11|||
155465293|NCT00305604|561123994|FG001|Overall Study|Lack of Efficacy|18|||
155465294|NCT00305604|561123993|FG000|Overall Study|Lost to Follow-up|0|||
155465295|NCT00305604|561123994|FG001|Overall Study|Lost to Follow-up|4|||
155465296|NCT00305604|561123993|FG000|Overall Study|Protocol Violation|2|||
155465297|NCT00305604|561123994|FG001|Overall Study|Protocol Violation|1|||
155465298|NCT00305604|561123993|FG000|Overall Study|Withdrawal by Subject|12|||
155465299|NCT00305604|561123994|FG001|Overall Study|Withdrawal by Subject|21|||
155465300|NCT00305604|561123993|FG000|Overall Study|Patient moved|1|||
155465301|NCT00305604|561123994|FG001|Overall Study|Patient moved|0|||
155465302|NCT00636441|561123995|FG000|Overall Study|Adverse Event|0|||
155465303|NCT00636441|561123996|FG001|Overall Study|Adverse Event|1|||
155465304|NCT00636441|561123997|FG002|Overall Study|Adverse Event|1|||
155465305|NCT00636441|561123998|FG003|Overall Study|Adverse Event|0|||
155465306|NCT00636441|561123999|FG004|Overall Study|Adverse Event|0|||
155465307|NCT00636441|561124000|FG005|Overall Study|Adverse Event|1|||
155465308|NCT00636441|561124001|FG006|Overall Study|Adverse Event|0|||
155465309|NCT00636441|561123995|FG000|Overall Study|Late, ineligible|0|||
155465310|NCT00636441|561123996|FG001|Overall Study|Late, ineligible|0|||
155465311|NCT00636441|561123997|FG002|Overall Study|Late, ineligible|0|||
155465312|NCT00636441|561123998|FG003|Overall Study|Late, ineligible|0|||
155465313|NCT00636441|561123999|FG004|Overall Study|Late, ineligible|0|||
155465314|NCT00636441|561124000|FG005|Overall Study|Late, ineligible|0|||
155465315|NCT00636441|561124001|FG006|Overall Study|Late, ineligible|1|||
155465316|NCT00636441|561123995|FG000|Overall Study|Screen Failure|0|||
155465317|NCT00636441|561123996|FG001|Overall Study|Screen Failure|0|||
155465318|NCT00636441|561123997|FG002|Overall Study|Screen Failure|0|||
155465319|NCT00636441|561123998|FG003|Overall Study|Screen Failure|0|||
155465320|NCT00636441|561123999|FG004|Overall Study|Screen Failure|0|||
155465321|NCT00636441|561124000|FG005|Overall Study|Screen Failure|0|||
155465322|NCT00636441|561124001|FG006|Overall Study|Screen Failure|17|||
155465323|NCT02849626|561124003|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
155465324|NCT02849626|561124004|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
155465325|NCT02849626|561124005|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
155465326|NCT02849626|561124006|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
155465327|NCT02849626|561124003|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
155465328|NCT02849626|561124004|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
155465329|NCT02849626|561124005|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
155465330|NCT02849626|561124006|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
155465331|NCT02849626|561124003|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
155465332|NCT02849626|561124004|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
155465333|NCT02849626|561124005|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
155465334|NCT02849626|561124006|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
155465335|NCT02849626|561124003|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
155465336|NCT02849626|561124004|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
155465337|NCT02849626|561124005|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
155465338|NCT02849626|561124006|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
155465339|NCT02849626|561124003|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
155465340|NCT02849626|561124004|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
155465341|NCT02849626|561124005|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
155465342|NCT02849626|561124006|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
155465343|NCT02849626|561124003|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
155465344|NCT02849626|561124004|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
155465345|NCT02849626|561124005|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
155465346|NCT02849626|561124006|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
155465347|NCT02849626|561124003|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
155465348|NCT02849626|561124004|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
155465349|NCT02849626|561124005|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
155465350|NCT02849626|561124006|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
155465351|NCT02849626|561124003|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
155465352|NCT02849626|561124004|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
155465353|NCT02849626|561124005|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
155465354|NCT02849626|561124006|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
155465355|NCT02849626|561124003|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
155465356|NCT02849626|561124004|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
155465357|NCT02849626|561124005|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
155465358|NCT02849626|561124006|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
155465359|NCT02849626|561124003|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
155465360|NCT02849626|561124004|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
155465361|NCT02849626|561124005|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
155465362|NCT02849626|561124006|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
155465363|NCT02849626|561124003|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
155465364|NCT02849626|561124004|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
155465365|NCT02849626|561124005|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
155465366|NCT02849626|561124006|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
155465367|NCT04176445|561124007|FG000|Overall Study|Adverse Event|0|||
155465368|NCT04176445|561124008|FG001|Overall Study|Adverse Event|1|||
155465369|NCT04176445|561124007|FG000|Overall Study|change plans weaning after first intervention|0|||
155465370|NCT04176445|561124008|FG001|Overall Study|change plans weaning after first intervention|1|||
155465371|NCT04046341|561124009|FG000|Overall Study|Lost to Follow-up|2|||
155465372|NCT04046341|561124009|FG000|Overall Study|Withdrawal by Subject|1|||
155517026|NCT02415959|561317498|FG002|Overall Study|Adverse Event|0|||
155517027|NCT02415959|561317499|FG003|Overall Study|Adverse Event|0|||
155517028|NCT02415959|561317500|FG004|Overall Study|Adverse Event|0|||
155517029|NCT02415959|561317496|FG000|Overall Study|Protocol Violation|0|||
155517030|NCT02415959|561317497|FG001|Overall Study|Protocol Violation|0|||
155517031|NCT02415959|561317498|FG002|Overall Study|Protocol Violation|0|||
155517032|NCT02415959|561317499|FG003|Overall Study|Protocol Violation|1|||
155652577|NCT00992394|561820379|FG001|Overall Study|Adverse Event|5|||
155465373|NCT04377672|561124010|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
155465374|NCT02447458|561124011|FG000|Overall Study|Other|0|||
155465375|NCT02447458|561124012|FG001|Overall Study|Other|0|||
155465376|NCT02447458|561124013|FG002|Overall Study|Other|1|||
155465377|NCT02447458|561124014|FG003|Overall Study|Other|0|||
155465378|NCT02447458|561124015|FG004|Overall Study|Other|0|||
155465379|NCT02447458|561124016|FG005|Overall Study|Other|0|||
155465380|NCT03505749|561124017|FG000|Overall Study|Lost to Follow-up|7|||
155465381|NCT03505749|561124018|FG001|Overall Study|Lost to Follow-up|11|||
155465382|NCT03505749|561124017|FG000|Overall Study|Withdrawal by Subject|6|||
155465383|NCT03505749|561124018|FG001|Overall Study|Withdrawal by Subject|0|||
155465384|NCT03505749|561124017|FG000|Overall Study|Discharged from treatment|3|||
155465385|NCT03505749|561124018|FG001|Overall Study|Discharged from treatment|6|||
155465386|NCT00435994|561124019|FG000|Overall Study|Lost to Follow-up|7|||
155465387|NCT00435994|561124020|FG001|Overall Study|Lost to Follow-up|0|||
155465388|NCT00435994|561124021|FG002|Overall Study|Lost to Follow-up|0|||
155465389|NCT01151540|561124022|FG000|Overall Study|Other|2|||
155465390|NCT01151540|561124022|FG000|Overall Study|Adverse event, non-fatal|4|||
155465391|NCT01151540|561124022|FG000|Overall Study|Withdrawal by Subject|7|||
155465392|NCT03846219|561124024|FG000|Overall Study|Withdrawal by Subject|3|||
155465393|NCT03846219|561124025|FG001|Overall Study|Withdrawal by Subject|2|||
155465394|NCT03846219|561124026|FG002|Overall Study|Withdrawal by Subject|2|||
155465395|NCT03846219|561124024|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
155465396|NCT03846219|561124025|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
155465397|NCT03846219|561124026|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
155652578|NCT00992394|561820378|FG000|Overall Study|Withdrawal by Subject|8|||
155652579|NCT00992394|561820379|FG001|Overall Study|Withdrawal by Subject|2|||
155652580|NCT00992394|561820378|FG000|Overall Study|Physician Decision|1|||
155652581|NCT00992394|561820379|FG001|Overall Study|Physician Decision|0|||
155652582|NCT00992394|561820378|FG000|Overall Study|Protocol Violation|2|||
155652583|NCT00992394|561820379|FG001|Overall Study|Protocol Violation|4|||
155652584|NCT00992394|561820378|FG000|Overall Study|Lost to Follow-up|2|||
155652585|NCT00992394|561820379|FG001|Overall Study|Lost to Follow-up|0|||
155652586|NCT00992394|561820378|FG000|Overall Study|Other event|1|||
155652587|NCT00992394|561820379|FG001|Overall Study|Other event|0|||
155652588|NCT00561821|561820380|FG000|Overall Study|Not treated|0|||
155652589|NCT00561821|561820381|FG001|Overall Study|Not treated|0|||
155652590|NCT00561821|561820382|FG002|Overall Study|Not treated|1|||
155652591|NCT00561821|561820383|FG003|Overall Study|Not treated|0|||
155652592|NCT00561821|561820380|FG000|Overall Study|Withdrawal by Subject|0|||
155652593|NCT00561821|561820381|FG001|Overall Study|Withdrawal by Subject|1|||
155652594|NCT00561821|561820382|FG002|Overall Study|Withdrawal by Subject|0|||
155652595|NCT00561821|561820383|FG003|Overall Study|Withdrawal by Subject|2|||
155652596|NCT00561821|561820380|FG000|Overall Study|Reasons not related to trial|2|||
155652597|NCT00561821|561820381|FG001|Overall Study|Reasons not related to trial|1|||
155652598|NCT00561821|561820382|FG002|Overall Study|Reasons not related to trial|0|||
155652599|NCT00561821|561820383|FG003|Overall Study|Reasons not related to trial|0|||
155652600|NCT00561821|561820380|FG000|Overall Study|Other (reason not specified)|1|||
155652601|NCT00561821|561820381|FG001|Overall Study|Other (reason not specified)|1|||
155652602|NCT00561821|561820382|FG002|Overall Study|Other (reason not specified)|0|||
155652603|NCT00561821|561820383|FG003|Overall Study|Other (reason not specified)|0|||
155652604|NCT00561821|561820380|FG000|Overall Study|Adverse Event|2|||
155652605|NCT00561821|561820381|FG001|Overall Study|Adverse Event|3|||
155652606|NCT00561821|561820382|FG002|Overall Study|Adverse Event|1|||
155465398|NCT03846219|561124024|FG000|Overall Study|Physician Decision|0|||
155465399|NCT03846219|561124025|FG001|Overall Study|Physician Decision|0|||
155465400|NCT03846219|561124026|FG002|Overall Study|Physician Decision|2|||
155465401|NCT05109702|561124027|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
155465402|NCT05109702|561124028|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
155465403|NCT05109702|561124029|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
155465404|NCT05109702|561124027|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
155465405|NCT05109702|561124028|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
155517033|NCT02415959|561317500|FG004|Overall Study|Protocol Violation|0|||
155517034|NCT01048333|561317501|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
155517035|NCT01048333|561317502|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
155652607|NCT00561821|561820383|FG003|Overall Study|Adverse Event|1|||
155652608|NCT04744831|561822103|FG000|Overall Study|Progressive Disease|31|||
155652609|NCT04744831|561822104|FG001|Overall Study|Progressive Disease|27|||
155652610|NCT04744831|561822105|FG002|Overall Study|Progressive Disease|25|||
155465406|NCT05109702|561124029|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
155465407|NCT05109702|561124027|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
155465408|NCT05109702|561124028|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
155465409|NCT05109702|561124029|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
155465410|NCT05109702|561124027|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
155465411|NCT05109702|561124028|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
155465412|NCT05109702|561124029|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
155465413|NCT05109702|561124027|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
155465414|NCT05109702|561124028|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
155465415|NCT05109702|561124029|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
155465416|NCT01392378|561124032|FG000|Infant Series|Adverse Event|0|||
155465417|NCT01392378|561124033|FG001|Infant Series|Adverse Event|0|||
155465418|NCT01392378|561124034|FG002|Infant Series|Adverse Event|0|||
155465419|NCT01392378|561124035|FG003|Infant Series|Adverse Event|1|||
155465420|NCT01392378|561124036|FG004|Infant Series|Adverse Event|0|||
155465421|NCT01392378|561124032|FG000|Infant Series|Lost to Follow-up|0|||
155465422|NCT01392378|561124033|FG001|Infant Series|Lost to Follow-up|0|||
155465423|NCT01392378|561124034|FG002|Infant Series|Lost to Follow-up|0|||
155465424|NCT01392378|561124035|FG003|Infant Series|Lost to Follow-up|1|||
155465425|NCT01392378|561124036|FG004|Infant Series|Lost to Follow-up|0|||
155465426|NCT01392378|561124032|FG000|Infant Series|Protocol Violation|0|||
155465427|NCT01392378|561124033|FG001|Infant Series|Protocol Violation|1|||
155465428|NCT01392378|561124034|FG002|Infant Series|Protocol Violation|0|||
155465429|NCT01392378|561124035|FG003|Infant Series|Protocol Violation|0|||
155465430|NCT01392378|561124036|FG004|Infant Series|Protocol Violation|0|||
155465431|NCT01392378|561124032|FG000|Infant Series|Withdrawal by Parent|4|||
155465432|NCT01392378|561124033|FG001|Infant Series|Withdrawal by Parent|1|||
155465433|NCT01392378|561124034|FG002|Infant Series|Withdrawal by Parent|0|||
155465434|NCT01392378|561124035|FG003|Infant Series|Withdrawal by Parent|0|||
155465435|NCT01392378|561124036|FG004|Infant Series|Withdrawal by Parent|0|||
155465436|NCT01392378|561124032|FG000|After Infant Series|Lost to Follow-up|0|||
155465437|NCT01392378|561124033|FG001|After Infant Series|Lost to Follow-up|0|||
155465438|NCT01392378|561124034|FG002|After Infant Series|Lost to Follow-up|1|||
155465439|NCT01392378|561124035|FG003|After Infant Series|Lost to Follow-up|0|||
155465440|NCT01392378|561124036|FG004|After Infant Series|Lost to Follow-up|0|||
155465441|NCT01392378|561124032|FG000|After Infant Series|Withdrawal by Parent|0|||
155465442|NCT01392378|561124033|FG001|After Infant Series|Withdrawal by Parent|1|||
155465443|NCT01392378|561124034|FG002|After Infant Series|Withdrawal by Parent|1|||
155465444|NCT01392378|561124035|FG003|After Infant Series|Withdrawal by Parent|0|||
155465445|NCT01392378|561124036|FG004|After Infant Series|Withdrawal by Parent|1|||
155465446|NCT01392378|561124032|FG000|Toddler Dose|Lost to Follow-up|0|||
155465447|NCT01392378|561124033|FG001|Toddler Dose|Lost to Follow-up|0|||
155465448|NCT01392378|561124034|FG002|Toddler Dose|Lost to Follow-up|0|||
155465449|NCT01392378|561124035|FG003|Toddler Dose|Lost to Follow-up|1|||
155465450|NCT01392378|561124036|FG004|Toddler Dose|Lost to Follow-up|0|||
155465451|NCT01392378|561124032|FG000|Toddler Dose|Withdrawal by Parent|0|||
155465452|NCT01392378|561124033|FG001|Toddler Dose|Withdrawal by Parent|1|||
155465453|NCT01392378|561124034|FG002|Toddler Dose|Withdrawal by Parent|0|||
155465454|NCT01392378|561124035|FG003|Toddler Dose|Withdrawal by Parent|1|||
155465455|NCT01392378|561124036|FG004|Toddler Dose|Withdrawal by Parent|1|||
155465456|NCT02322411|561124037|FG000|Overall Study|Lost to Follow-up|4|||
155465457|NCT02322411|561124038|FG001|Overall Study|Lost to Follow-up|7|||
155465458|NCT02322411|561124037|FG000|Overall Study|Withdrawal by Subject|1|||
155465459|NCT02322411|561124038|FG001|Overall Study|Withdrawal by Subject|0|||
155465460|NCT02261883|561124039|FG000|Overall Study|Death|3|||
155465461|NCT02261883|561124040|FG001|Overall Study|Death|2|||
155465462|NCT02261883|561124039|FG000|Overall Study|Physician Decision|1|||
155465463|NCT02261883|561124040|FG001|Overall Study|Physician Decision|0|||
155465464|NCT02261883|561124039|FG000|Overall Study|Protocol Violation|1|||
155465465|NCT02261883|561124040|FG001|Overall Study|Protocol Violation|0|||
155465466|NCT02261883|561124039|FG000|Overall Study|Withdrawal by Subject|0|||
155465467|NCT02261883|561124040|FG001|Overall Study|Withdrawal by Subject|1|||
155465468|NCT02261883|561124039|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
155465469|NCT02261883|561124040|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
155517036|NCT01048333|561317503|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
155465470|NCT05567393|561124043|FG000|Overall Study|Voluntary Withdrawal|0|||
155465471|NCT05567393|561124044|FG001|Overall Study|Voluntary Withdrawal|0|||
155465472|NCT05567393|561124045|FG002|Overall Study|Voluntary Withdrawal|0|||
155465473|NCT05567393|561124046|FG003|Overall Study|Voluntary Withdrawal|0|||
155465474|NCT05567393|561124047|FG004|Overall Study|Voluntary Withdrawal|0|||
155465475|NCT05567393|561124048|FG005|Overall Study|Voluntary Withdrawal|0|||
155465476|NCT05567393|561124049|FG006|Overall Study|Voluntary Withdrawal|0|||
155465477|NCT05567393|561124050|FG007|Overall Study|Voluntary Withdrawal|0|||
155465478|NCT05567393|561124051|FG008|Overall Study|Voluntary Withdrawal|0|||
155465479|NCT05567393|561124052|FG009|Overall Study|Voluntary Withdrawal|0|||
155465480|NCT05567393|561124053|FG010|Overall Study|Voluntary Withdrawal|0|||
155652611|NCT04744831|561822103|FG000|Overall Study|Adverse Event|3|||
155465481|NCT05567393|561124054|FG011|Overall Study|Voluntary Withdrawal|0|||
155465482|NCT05567393|561124055|FG012|Overall Study|Voluntary Withdrawal|0|||
155465483|NCT05567393|561124056|FG013|Overall Study|Voluntary Withdrawal|1|||
155465484|NCT05567393|561124057|FG014|Overall Study|Voluntary Withdrawal|0|||
155465485|NCT05567393|561124058|FG015|Overall Study|Voluntary Withdrawal|0|||
155465486|NCT05567393|561124059|FG016|Overall Study|Voluntary Withdrawal|0|||
155465487|NCT05567393|561124060|FG017|Overall Study|Voluntary Withdrawal|0|||
155465488|NCT04199793|561124065|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
155465489|NCT04199793|561124066|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
155465490|NCT04199793|561124065|FG000|Overall Study|Withdrawal by Subject|1|||
155465491|NCT04199793|561124066|FG001|Overall Study|Withdrawal by Subject|1|||
155465492|NCT00888615|561124068|FG000|Overall Study|No treatment|2|||
155465493|NCT00141037|561124069|FG000|Overall Study|Physician Decision|1|||
155465494|NCT00141037|561124070|FG001|Overall Study|Physician Decision|2|||
155465495|NCT00141037|561124069|FG000|Overall Study|Lost to Follow-up|3|||
155465496|NCT00141037|561124070|FG001|Overall Study|Lost to Follow-up|1|||
155465497|NCT00141037|561124069|FG000|Overall Study|Protocol Violation|0|||
155465498|NCT00141037|561124070|FG001|Overall Study|Protocol Violation|2|||
155465499|NCT00141037|561124069|FG000|Overall Study|Withdrawal by Subject|2|||
155465500|NCT00141037|561124070|FG001|Overall Study|Withdrawal by Subject|1|||
155465501|NCT00141037|561124069|FG000|Overall Study|Other|0|||
155465502|NCT00141037|561124070|FG001|Overall Study|Other|1|||
155465503|NCT00141037|561124069|FG000|Overall Study|Moved from area|1|||
155465504|NCT00141037|561124070|FG001|Overall Study|Moved from area|7|||
155465505|NCT00141037|561124069|FG000|Overall Study|Graft Failure|3|||
155465506|NCT00141037|561124070|FG001|Overall Study|Graft Failure|4|||
155465507|NCT00861380|561124071|FG000|Overall Study|Withdrawal Information not recorded|8427|||
155465508|NCT00861380|561124072|FG001|Overall Study|Withdrawal Information not recorded|9112|||
155465509|NCT00861380|561124073|FG002|Overall Study|Withdrawal Information not recorded|8872|||
155465510|NCT00861380|561124074|FG003|Overall Study|Withdrawal Information not recorded|3689|||
155465511|NCT00861380|561124075|FG004|Overall Study|Withdrawal Information not recorded|1812|||
155465512|NCT00861380|561124076|FG005|Overall Study|Withdrawal Information not recorded|6249|||
155465513|NCT00861380|561124077|FG006|Overall Study|Withdrawal Information not recorded|3020|||
155465514|NCT00628758|561124078|FG000|Overall Study|Adverse Event|2|||
155465515|NCT00628758|561124079|FG001|Overall Study|Adverse Event|3|||
155465516|NCT00628758|561124078|FG000|Overall Study|Withdrawal by Subject|6|||
155465517|NCT00628758|561124079|FG001|Overall Study|Withdrawal by Subject|3|||
155465518|NCT00628758|561124078|FG000|Overall Study|Death|1|||
155465519|NCT00628758|561124079|FG001|Overall Study|Death|0|||
155465520|NCT00628758|561124078|FG000|Overall Study|Protocol Violation|5|||
155465521|NCT00628758|561124079|FG001|Overall Study|Protocol Violation|1|||
155465522|NCT00628758|561124078|FG000|Overall Study|Lost to Follow-up|25|||
155465523|NCT00628758|561124079|FG001|Overall Study|Lost to Follow-up|31|||
155465524|NCT00628758|561124078|FG000|Overall Study|Pregnancy|2|||
155465525|NCT00628758|561124079|FG001|Overall Study|Pregnancy|2|||
155465526|NCT00628758|561124078|FG000|Overall Study|Investigator Moved|3|||
155465527|NCT00628758|561124079|FG001|Overall Study|Investigator Moved|0|||
155465528|NCT00628758|561124078|FG000|Overall Study|Treatment Failure|0|||
155465529|NCT00628758|561124079|FG001|Overall Study|Treatment Failure|2|||
155491141|NCT01023815|561223477|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
155491142|NCT01977625|561223483|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
155491143|NCT01977625|561223484|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155491144|NCT01977625|561223483|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155491145|NCT01977625|561223484|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155491146|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
155491147|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
155491148|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
155491149|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
155491150|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
155491151|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Death|1|||
155491152|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Death|0|||
155491153|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Death|0|||
155491154|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Death|0|||
155491155|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Death|0|||
155491156|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
155491157|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
155491158|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
155491159|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
155491160|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
155491161|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
155491162|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
155491163|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
155491164|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
155491165|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
155652612|NCT04744831|561822104|FG001|Overall Study|Adverse Event|3|||
155465530|NCT03706040|561125828|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
155465531|NCT03706040|561125829|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
155465532|NCT03706040|561125830|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
155465533|NCT03706040|561125831|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
155465534|NCT03706040|561125832|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
155465535|NCT03706040|561125833|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
155465536|NCT03706040|561125834|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
155465537|NCT03706040|561125828|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
155465538|NCT03706040|561125829|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
155465539|NCT03706040|561125830|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
155465540|NCT03706040|561125831|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
155465541|NCT03706040|561125832|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
155465542|NCT03706040|561125833|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
155465543|NCT03706040|561125834|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
155465544|NCT03706040|561125828|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
155465545|NCT03706040|561125829|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
155465546|NCT03706040|561125830|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
155465547|NCT03706040|561125831|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
155465548|NCT03706040|561125832|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
155465549|NCT03706040|561125833|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
155465550|NCT03706040|561125834|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
155465551|NCT03706040|561125828|FG000|Period A (Week 0 to Week 16)|Other|2|||
155465552|NCT03706040|561125829|FG001|Period A (Week 0 to Week 16)|Other|0|||
155465553|NCT03706040|561125830|FG002|Period A (Week 0 to Week 16)|Other|2|||
155465554|NCT03706040|561125831|FG003|Period A (Week 0 to Week 16)|Other|0|||
155465555|NCT03706040|561125832|FG004|Period A (Week 0 to Week 16)|Other|0|||
155465556|NCT03706040|561125833|FG005|Period A (Week 0 to Week 16)|Other|0|||
155465557|NCT03706040|561125834|FG006|Period A (Week 0 to Week 16)|Other|0|||
155465558|NCT03706040|561125828|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
155465559|NCT03706040|561125829|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
155465560|NCT03706040|561125830|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
155465561|NCT03706040|561125831|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
155465562|NCT03706040|561125832|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
155465563|NCT03706040|561125833|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
155465564|NCT03706040|561125834|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
155465565|NCT03706040|561125828|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
155465566|NCT03706040|561125829|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
155465567|NCT03706040|561125830|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
155465568|NCT03706040|561125831|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
155465569|NCT03706040|561125832|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
155465570|NCT03706040|561125833|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
155465571|NCT03706040|561125834|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
155465572|NCT03706040|561125828|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155465573|NCT03706040|561125829|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155465574|NCT03706040|561125830|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155465575|NCT03706040|561125831|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155465576|NCT03706040|561125832|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155465577|NCT03706040|561125833|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
155465578|NCT03706040|561125834|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
155465579|NCT03706040|561125828|FG000|Period B (Week 16 to Week 52)|Other|0|||
155465580|NCT03706040|561125829|FG001|Period B (Week 16 to Week 52)|Other|0|||
155517037|NCT01048333|561317504|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
155517038|NCT01048333|561317505|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
155517039|NCT01048333|561317506|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
155517040|NCT03131999|561317508|FG000|Overall Study|Withdrawal by Subject|0|||
155517041|NCT03131999|561317509|FG001|Overall Study|Withdrawal by Subject|1|||
155517042|NCT02260492|561317510|FG000|Overall Study|Adverse Event|6|||
155517043|NCT02260492|561317511|FG001|Overall Study|Adverse Event|1|||
155517044|NCT02260492|561317512|FG002|Overall Study|Adverse Event|2|||
155517045|NCT02260492|561317510|FG000|Overall Study|Death|0|||
155465581|NCT03706040|561125830|FG002|Period B (Week 16 to Week 52)|Other|0|||
155465582|NCT03706040|561125831|FG003|Period B (Week 16 to Week 52)|Other|4|||
155465583|NCT03706040|561125832|FG004|Period B (Week 16 to Week 52)|Other|5|||
155465584|NCT03706040|561125833|FG005|Period B (Week 16 to Week 52)|Other|23|||
155465585|NCT03706040|561125834|FG006|Period B (Week 16 to Week 52)|Other|17|||
155465586|NCT00927758|561125835|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
155465587|NCT00927758|561125836|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
155465588|NCT00927758|561125837|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
155465589|NCT00927758|561125838|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
155465590|NCT00927758|561125839|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
155465591|NCT00927758|561125840|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
155465592|NCT00927758|561125835|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
155465593|NCT00927758|561125836|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
155465594|NCT00927758|561125837|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
155465595|NCT00927758|561125838|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
155465596|NCT00927758|561125839|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
155465597|NCT00927758|561125840|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
155465598|NCT01544478|561125841|FG000|Overall Study|Adverse Event|1|||
155465599|NCT01544478|561125841|FG000|Overall Study|Death|1|||
155465600|NCT01544478|561125841|FG000|Overall Study|Lost to Follow-up|48|||
155465601|NCT01544478|561125841|FG000|Overall Study|Physician Decision|15|||
155465602|NCT01544478|561125841|FG000|Overall Study|Pregnancy|1|||
155465603|NCT01544478|561125841|FG000|Overall Study|Withdrawal by Subject|52|||
155465604|NCT00212758|561125842|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
155465605|NCT00212758|561125843|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
155465606|NCT00212758|561125842|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
155465607|NCT00212758|561125843|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
155465608|NCT02940860|561125846|FG000|Overall Study|Non-serious AE|1|||
155465609|NCT02940860|561125847|FG001|Overall Study|Non-serious AE|2|||
155465610|NCT02940860|561125846|FG000|Overall Study|Serious AE|7|||
155465611|NCT02940860|561125847|FG001|Overall Study|Serious AE|3|||
155465612|NCT02940860|561125846|FG000|Overall Study|Withdrawal by Subject|19|||
155465613|NCT02940860|561125847|FG001|Overall Study|Withdrawal by Subject|9|||
155465614|NCT02940860|561125846|FG000|Overall Study|Lost to Follow-up|13|||
155465615|NCT02940860|561125847|FG001|Overall Study|Lost to Follow-up|7|||
155465616|NCT02940860|561125846|FG000|Overall Study|Physician Decision|5|||
155465617|NCT02940860|561125847|FG001|Overall Study|Physician Decision|3|||
155465618|NCT02940860|561125846|FG000|Overall Study|Sponsor Decision|0|||
155465619|NCT02940860|561125847|FG001|Overall Study|Sponsor Decision|1|||
155465620|NCT02940860|561125846|FG000|Overall Study|Protocol Violation|0|||
155465621|NCT02940860|561125847|FG001|Overall Study|Protocol Violation|2|||
155465622|NCT02940860|561125846|FG000|Overall Study|Death|3|||
155465623|NCT02940860|561125847|FG001|Overall Study|Death|2|||
155465624|NCT02940860|561125846|FG000|Overall Study|Moved, poor venous access, transport|6|||
155465625|NCT02940860|561125847|FG001|Overall Study|Moved, poor venous access, transport|4|||
155517046|NCT02260492|561317511|FG001|Overall Study|Death|1|||
155465626|NCT02940860|561125846|FG000|Overall Study|Not treated|2|||
155465627|NCT02940860|561125847|FG001|Overall Study|Not treated|2|||
155465628|NCT02431793|561125849|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
155465629|NCT02431793|561125850|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
155465630|NCT02431793|561125851|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
155465631|NCT02431793|561125849|FG000|Overall Study|Withdrawal by Subject|7|||
155465632|NCT02431793|561125850|FG001|Overall Study|Withdrawal by Subject|5|||
155465633|NCT02431793|561125851|FG002|Overall Study|Withdrawal by Subject|5|||
155465634|NCT02431793|561125849|FG000|Overall Study|Lost to Follow-up|101|||
155517047|NCT02260492|561317512|FG002|Overall Study|Death|0|||
155517048|NCT02260492|561317510|FG000|Overall Study|Lost to Follow-up|12|||
155517049|NCT02260492|561317511|FG001|Overall Study|Lost to Follow-up|9|||
155465635|NCT02431793|561125850|FG001|Overall Study|Lost to Follow-up|122|||
155465636|NCT02431793|561125851|FG002|Overall Study|Lost to Follow-up|104|||
155465637|NCT01563107|561125856|FG000|Overall Study|Physician Decision|0|||
155465638|NCT01563107|561125857|FG001|Overall Study|Physician Decision|1|||
155465639|NCT01563107|561125858|FG002|Overall Study|Physician Decision|1|||
155465640|NCT01563107|561125859|FG003|Overall Study|Physician Decision|3|||
155465641|NCT01563107|561125856|FG000|Overall Study|Withdrawal by Subject|1|||
155465642|NCT01563107|561125857|FG001|Overall Study|Withdrawal by Subject|2|||
155465643|NCT01563107|561125858|FG002|Overall Study|Withdrawal by Subject|1|||
155465644|NCT01563107|561125859|FG003|Overall Study|Withdrawal by Subject|2|||
155465645|NCT02707601|561125860|FG000|Overall Study|Death|0|||
155465646|NCT02707601|561125861|FG001|Overall Study|Death|1|||
155465647|NCT02707601|561125860|FG000|Overall Study|Lack of Efficacy|0|||
155465648|NCT02707601|561125861|FG001|Overall Study|Lack of Efficacy|1|||
155465649|NCT02707601|561125860|FG000|Overall Study|Investigator's Discretion|1|||
155465650|NCT02707601|561125861|FG001|Overall Study|Investigator's Discretion|0|||
155465651|NCT02707601|561125860|FG000|Overall Study|Withdrew Consent|0|||
155465652|NCT02707601|561125861|FG001|Overall Study|Withdrew Consent|1|||
155465653|NCT02707601|561125860|FG000|Overall Study|Lost to Follow-up|1|||
155465654|NCT02707601|561125861|FG001|Overall Study|Lost to Follow-up|1|||
155465655|NCT02707601|561125860|FG000|Overall Study|Participants Randomized but Not Treated|2|||
155465656|NCT02707601|561125861|FG001|Overall Study|Participants Randomized but Not Treated|0|||
155465657|NCT00063986|561125863|FG000|Overall Study|Withdrawal by Subject|1|||
155465658|NCT00063986|561125863|FG000|Overall Study|Ineligible|1|||
155465659|NCT00063986|561125863|FG000|Overall Study|Intra-operatively ineligible|4|||
155465660|NCT00247273|561125864|FG000|Overall Study|Adverse Event|85|||
155465661|NCT00247273|561125865|FG001|Overall Study|Adverse Event|80|||
155465662|NCT00247273|561125864|FG000|Overall Study|Physician Decision|6|||
155465663|NCT00247273|561125865|FG001|Overall Study|Physician Decision|3|||
155465664|NCT00247273|561125864|FG000|Overall Study|Lost to Follow-up|7|||
155465665|NCT00247273|561125865|FG001|Overall Study|Lost to Follow-up|7|||
155465666|NCT00247273|561125864|FG000|Overall Study|Withdrawal by Subject|46|||
155465667|NCT00247273|561125865|FG001|Overall Study|Withdrawal by Subject|47|||
155465668|NCT00247273|561125864|FG000|Overall Study|Did not take any study drug|2|||
155465669|NCT00247273|561125865|FG001|Overall Study|Did not take any study drug|0|||
155465670|NCT02580240|561125866|FG000|Overall Study|Physician Decision|2|||
155465671|NCT02580240|561125867|FG001|Overall Study|Physician Decision|0|||
155465672|NCT00607919|561125868|FG000|Acute Phase|Adverse Event|9|||
155465673|NCT00607919|561125869|FG001|Acute Phase|Adverse Event|2|||
155465674|NCT00607919|561125868|FG000|Acute Phase|Entry Criteria Not Met|1|||
155465675|NCT00607919|561125869|FG001|Acute Phase|Entry Criteria Not Met|1|||
155465676|NCT00607919|561125868|FG000|Acute Phase|Lack of Efficacy|1|||
155465677|NCT00607919|561125869|FG001|Acute Phase|Lack of Efficacy|2|||
155465678|NCT00607919|561125868|FG000|Acute Phase|Lost to Follow-up|9|||
155465679|NCT00607919|561125869|FG001|Acute Phase|Lost to Follow-up|3|||
155465680|NCT00607919|561125868|FG000|Acute Phase|Parent/Caregiver Decision|6|||
155465681|NCT00607919|561125869|FG001|Acute Phase|Parent/Caregiver Decision|4|||
155465682|NCT00607919|561125868|FG000|Acute Phase|Protocol Violation|5|||
155465683|NCT00607919|561125869|FG001|Acute Phase|Protocol Violation|1|||
155465684|NCT00607919|561125868|FG000|Acute Phase|Withdrawal by Subject|3|||
155465685|NCT00607919|561125869|FG001|Acute Phase|Withdrawal by Subject|3|||
155465686|NCT00607919|561125868|FG000|Open-Label Phase|Adverse Event|1|||
155465687|NCT00607919|561125869|FG001|Open-Label Phase|Adverse Event|5|||
155465688|NCT00607919|561125868|FG000|Open-Label Phase|Lost to Follow-up|4|||
155465689|NCT00607919|561125869|FG001|Open-Label Phase|Lost to Follow-up|1|||
155465690|NCT00607919|561125868|FG000|Open-Label Phase|Protocol Violation|2|||
155465691|NCT00607919|561125869|FG001|Open-Label Phase|Protocol Violation|2|||
155465692|NCT00607919|561125868|FG000|Open-Label Phase|Withdrawal by Subject|2|||
155465693|NCT00607919|561125869|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155465694|NCT00607919|561125868|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
155465695|NCT00607919|561125869|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
155465696|NCT02911519|561125872|FG000|Overall Study|Lost to Follow-up|2|||
155465697|NCT02911519|561125873|FG001|Overall Study|Lost to Follow-up|2|||
155465698|NCT02911519|561125872|FG000|Overall Study|Death|0|||
155465699|NCT02911519|561125873|FG001|Overall Study|Death|2|||
155465700|NCT02001688|561125876|FG000|Overall Study|Withdrawal by Subject|0|||
155465701|NCT02001688|561125877|FG001|Overall Study|Withdrawal by Subject|0|||
155465702|NCT02001688|561125878|FG002|Overall Study|Withdrawal by Subject|1|||
155465703|NCT02001688|561125876|FG000|Overall Study|Adverse Event|0|||
155465704|NCT02001688|561125877|FG001|Overall Study|Adverse Event|1|||
155465705|NCT02001688|561125878|FG002|Overall Study|Adverse Event|0|||
155465706|NCT00445341|561125880|FG000|Overall Study|refused further treatment|1|||
155465707|NCT00445341|561125880|FG000|Overall Study|taken off treatment too early|1|||
155465708|NCT03051217|561125881|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
155465709|NCT03051217|561125882|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155465710|NCT03051217|561125883|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
155465711|NCT03051217|561125884|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155465712|NCT03051217|561125885|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155465713|NCT03051217|561125886|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155465714|NCT03051217|561125887|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155465715|NCT03051217|561125881|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465716|NCT03051217|561125882|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
155465717|NCT03051217|561125883|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465718|NCT03051217|561125884|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465719|NCT03051217|561125885|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465720|NCT03051217|561125886|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465721|NCT03051217|561125887|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
155465722|NCT03051217|561125881|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
155465723|NCT03051217|561125882|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
155465724|NCT03051217|561125883|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
155465725|NCT03051217|561125884|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155465726|NCT03051217|561125885|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155465727|NCT03051217|561125886|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155465728|NCT03051217|561125887|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155465729|NCT03051217|561125881|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
155465730|NCT03051217|561125882|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
155465731|NCT03051217|561125883|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
155465732|NCT03051217|561125884|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
155465733|NCT03051217|561125885|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
155465734|NCT03051217|561125886|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
155465735|NCT03051217|561125887|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
155465736|NCT03051217|561125881|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465737|NCT03051217|561125882|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465738|NCT03051217|561125883|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465739|NCT03051217|561125884|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
155465740|NCT03051217|561125885|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465741|NCT03051217|561125886|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465742|NCT03051217|561125887|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
155465743|NCT03051217|561125881|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155465744|NCT03051217|561125882|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155465745|NCT03051217|561125883|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155517050|NCT02260492|561317512|FG002|Overall Study|Lost to Follow-up|0|||
155517051|NCT02260492|561317510|FG000|Overall Study|Physician Decision|2|||
155517052|NCT02260492|561317511|FG001|Overall Study|Physician Decision|0|||
155517053|NCT02260492|561317512|FG002|Overall Study|Physician Decision|1|||
155517054|NCT02260492|561317510|FG000|Overall Study|Withdrawal by Subject|3|||
155517055|NCT02260492|561317511|FG001|Overall Study|Withdrawal by Subject|2|||
155517056|NCT02260492|561317512|FG002|Overall Study|Withdrawal by Subject|2|||
155517057|NCT00996736|561317513|FG000|Overall Study|Death|1|||
155517058|NCT00996736|561317514|FG001|Overall Study|Death|1|||
155517059|NCT00996736|561317513|FG000|Overall Study|Lost to Follow-up|15|||
155517060|NCT00996736|561317514|FG001|Overall Study|Lost to Follow-up|14|||
155465746|NCT03051217|561125884|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
155465747|NCT03051217|561125885|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155465748|NCT03051217|561125886|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155465749|NCT03051217|561125887|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
155465750|NCT03051217|561125881|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155465751|NCT03051217|561125882|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155465752|NCT03051217|561125883|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155465753|NCT03051217|561125884|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155517061|NCT00996736|561317513|FG000|Overall Study|Visit not within 3-month window|5|||
155517062|NCT00996736|561317514|FG001|Overall Study|Visit not within 3-month window|3|||
155465754|NCT03051217|561125885|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
155465755|NCT03051217|561125886|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155465756|NCT03051217|561125887|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
155465757|NCT03051217|561125881|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465758|NCT03051217|561125882|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465759|NCT03051217|561125883|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465760|NCT03051217|561125884|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465761|NCT03051217|561125885|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465762|NCT03051217|561125886|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
155465763|NCT03051217|561125887|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
155465764|NCT01675141|561125888|FG000|Overall Study|Lenalidomide outside NIH|3|||
155465765|NCT01675141|561125888|FG000|Overall Study|Withdrawal by Subject|3|||
155465766|NCT01675141|561125888|FG000|Overall Study|Physician Decision|4|||
155465767|NCT01675141|561125888|FG000|Overall Study|No treatment, per protocol|1|||
155465768|NCT00109772|561125889|FG000|Double-blind Treatment|Adverse Event|14|||
155465769|NCT00109772|561125890|FG001|Double-blind Treatment|Adverse Event|5|||
155465770|NCT00109772|561125889|FG000|Double-blind Treatment|Lack of Efficacy|1|||
155465771|NCT00109772|561125890|FG001|Double-blind Treatment|Lack of Efficacy|0|||
155465772|NCT00109772|561125889|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
155465773|NCT00109772|561125890|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
155465774|NCT00109772|561125889|FG000|Double-blind Treatment|Lost to Follow-up|2|||
155465775|NCT00109772|561125890|FG001|Double-blind Treatment|Lost to Follow-up|3|||
155465776|NCT00109772|561125889|FG000|Double-blind Treatment|Protocol Violation|0|||
155465777|NCT00109772|561125890|FG001|Double-blind Treatment|Protocol Violation|1|||
155465778|NCT00109772|561125889|FG000|Double-blind Treatment|Other|0|||
155465779|NCT00109772|561125890|FG001|Double-blind Treatment|Other|4|||
155465780|NCT00109772|561125889|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
155465781|NCT00109772|561125890|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
155465782|NCT00109772|561125889|FG000|Open-label Extension|Adverse Event|10|||
155465783|NCT00109772|561125890|FG001|Open-label Extension|Adverse Event|19|||
155465784|NCT00109772|561125889|FG000|Open-label Extension|Lack of Efficacy|19|||
155465785|NCT00109772|561125890|FG001|Open-label Extension|Lack of Efficacy|11|||
155465786|NCT00109772|561125889|FG000|Open-label Extension|Withdrawal by Subject|9|||
155465787|NCT00109772|561125890|FG001|Open-label Extension|Withdrawal by Subject|6|||
155465788|NCT00109772|561125889|FG000|Open-label Extension|Lost to Follow-up|1|||
155465789|NCT00109772|561125890|FG001|Open-label Extension|Lost to Follow-up|0|||
155465790|NCT00109772|561125889|FG000|Open-label Extension|Death|0|||
155465791|NCT00109772|561125890|FG001|Open-label Extension|Death|1|||
155465792|NCT00109772|561125889|FG000|Open-label Extension|Protocol Violation|2|||
155465793|NCT00109772|561125890|FG001|Open-label Extension|Protocol Violation|2|||
155465794|NCT00109772|561125889|FG000|Open-label Extension|Other|4|||
155465795|NCT00109772|561125890|FG001|Open-label Extension|Other|10|||
155465796|NCT01369225|561125892|FG000|Overall Study|Withdrawal by Subject|1|||
155465797|NCT01369225|561125893|FG001|Overall Study|Withdrawal by Subject|0|||
155465798|NCT01369225|561125894|FG002|Overall Study|Withdrawal by Subject|2|||
155465799|NCT01369225|561125895|FG003|Overall Study|Withdrawal by Subject|1|||
155465800|NCT01369225|561125896|FG004|Overall Study|Withdrawal by Subject|0|||
155465801|NCT01369225|561125897|FG005|Overall Study|Withdrawal by Subject|0|||
155465802|NCT01369225|561125892|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
155465803|NCT01369225|561125893|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
155465804|NCT01369225|561125894|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
155465805|NCT01369225|561125895|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
155465806|NCT01369225|561125896|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
155465807|NCT01369225|561125897|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
155465808|NCT01369225|561125892|FG000|Overall Study|Other|1|||
155465809|NCT01369225|561125893|FG001|Overall Study|Other|0|||
155465810|NCT01369225|561125894|FG002|Overall Study|Other|0|||
155465811|NCT01369225|561125895|FG003|Overall Study|Other|0|||
155465812|NCT01369225|561125896|FG004|Overall Study|Other|1|||
155465813|NCT01369225|561125897|FG005|Overall Study|Other|0|||
155465814|NCT01369225|561125892|FG000|Overall Study|Adverse Event|0|||
155465815|NCT01369225|561125893|FG001|Overall Study|Adverse Event|0|||
155465816|NCT01369225|561125894|FG002|Overall Study|Adverse Event|0|||
155465817|NCT01369225|561125895|FG003|Overall Study|Adverse Event|1|||
155465818|NCT01369225|561125896|FG004|Overall Study|Adverse Event|1|||
155465819|NCT01369225|561125897|FG005|Overall Study|Adverse Event|0|||
155465820|NCT00105183|561125901|FG000|Overall Study|Death|19|||
155465821|NCT00105183|561125902|FG001|Overall Study|Death|13|||
155465822|NCT00105183|561125903|FG002|Overall Study|Death|15|||
155465823|NCT00105183|561125901|FG000|Overall Study|Withdrawal by Subject|1|||
155465824|NCT00105183|561125902|FG001|Overall Study|Withdrawal by Subject|1|||
155465825|NCT00105183|561125903|FG002|Overall Study|Withdrawal by Subject|4|||
155465826|NCT00105183|561125901|FG000|Overall Study|Physician Decision|1|||
155465827|NCT00105183|561125902|FG001|Overall Study|Physician Decision|2|||
155465828|NCT00105183|561125903|FG002|Overall Study|Physician Decision|3|||
155465829|NCT00105183|561125901|FG000|Overall Study|Lost to Follow-up|0|||
155465830|NCT00105183|561125902|FG001|Overall Study|Lost to Follow-up|1|||
155465831|NCT00105183|561125903|FG002|Overall Study|Lost to Follow-up|1|||
155465832|NCT00105183|561125901|FG000|Overall Study|Other reason|1|||
155465833|NCT00105183|561125902|FG001|Overall Study|Other reason|2|||
155465834|NCT00105183|561125903|FG002|Overall Study|Other reason|0|||
155465835|NCT00792701|561125904|FG000|Overall Study|Adverse Event|0|||
155465836|NCT00792701|561125905|FG001|Overall Study|Adverse Event|22|||
155465837|NCT00792701|561125904|FG000|Overall Study|Ineligible|1|||
155465838|NCT00792701|561125905|FG001|Overall Study|Ineligible|3|||
155465839|NCT00792701|561125904|FG000|Overall Study|Withdrawal by Subject|1|||
155465840|NCT00792701|561125905|FG001|Overall Study|Withdrawal by Subject|19|||
155465841|NCT00792701|561125904|FG000|Overall Study|Not protocol specified|17|||
155465842|NCT00792701|561125905|FG001|Overall Study|Not protocol specified|0|||
155465843|NCT05507580|561125906|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155465844|NCT05507580|561125907|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155465845|NCT05507580|561125908|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
155465846|NCT05507580|561125909|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
155465847|NCT05507580|561125910|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
155465848|NCT05507580|561125911|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
155465849|NCT05507580|561125906|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
155465850|NCT05507580|561125907|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155465851|NCT05507580|561125908|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155465852|NCT05507580|561125909|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155465853|NCT05507580|561125910|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155465854|NCT05507580|561125911|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155465855|NCT05507580|561125906|FG000|Double-Blind Treatment Period|Other, not specified|5|||
155465856|NCT05507580|561125907|FG001|Double-Blind Treatment Period|Other, not specified|4|||
155465857|NCT05507580|561125908|FG002|Double-Blind Treatment Period|Other, not specified|0|||
155465858|NCT05507580|561125909|FG003|Double-Blind Treatment Period|Other, not specified|0|||
155465859|NCT05507580|561125910|FG004|Double-Blind Treatment Period|Other, not specified|0|||
155465860|NCT05507580|561125911|FG005|Double-Blind Treatment Period|Other, not specified|0|||
155465861|NCT05507580|561125906|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
155465862|NCT05507580|561125907|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
155465863|NCT05507580|561125908|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
155465864|NCT05507580|561125909|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
155517063|NCT02346201|561317516|FG000|Overall Study|Adverse Event|3|||
155517064|NCT02346201|561317517|FG001|Overall Study|Adverse Event|2|||
155517065|NCT02346201|561317516|FG000|Overall Study|Lost to Follow-up|1|||
155465865|NCT05507580|561125910|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
155465866|NCT05507580|561125911|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
155465867|NCT05507580|561125906|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
155517066|NCT02346201|561317517|FG001|Overall Study|Lost to Follow-up|0|||
155517067|NCT02346201|561317516|FG000|Overall Study|Withdrawal by Subject|6|||
155517068|NCT02346201|561317517|FG001|Overall Study|Withdrawal by Subject|3|||
155517069|NCT02346201|561317516|FG000|Overall Study|Unavailable for future follow-up|0|||
155465868|NCT05507580|561125907|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
155465869|NCT05507580|561125908|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
155465870|NCT05507580|561125909|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
155465871|NCT05507580|561125910|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
155517070|NCT02346201|561317517|FG001|Overall Study|Unavailable for future follow-up|1|||
155517071|NCT02346201|561317516|FG000|Overall Study|Physician Decision|0|||
155465872|NCT05507580|561125911|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
155465873|NCT05507580|561125906|FG000|Single-Blind Treatment Period|Other, not specified|0|||
155465874|NCT05507580|561125907|FG001|Single-Blind Treatment Period|Other, not specified|0|||
155465875|NCT05507580|561125908|FG002|Single-Blind Treatment Period|Other, not specified|2|||
155465876|NCT05507580|561125909|FG003|Single-Blind Treatment Period|Other, not specified|7|||
155465877|NCT05507580|561125910|FG004|Single-Blind Treatment Period|Other, not specified|3|||
155465878|NCT05507580|561125911|FG005|Single-Blind Treatment Period|Other, not specified|5|||
155465879|NCT00615914|561125915|FG000|Overall Study|Adverse Event|274|||
155465880|NCT00615914|561125915|FG000|Overall Study|Death|20|||
155465881|NCT00615914|561125915|FG000|Overall Study|Lack of Efficacy|59|||
155465882|NCT00615914|561125915|FG000|Overall Study|Lost to Follow-up|187|||
155465883|NCT00615914|561125915|FG000|Overall Study|Withdrawal by Subject|16|||
155465884|NCT00615914|561125915|FG000|Overall Study|Physician Decision|4|||
155465885|NCT00615914|561125915|FG000|Overall Study|No data was collected.|65|||
155465886|NCT00615914|561125915|FG000|Overall Study|No treatment|2|||
155465887|NCT00615914|561125915|FG000|Overall Study|Irregularly enrolled patients|10|||
155465888|NCT03673956|561125916|FG000|Overall Study|Lost to Follow-up|1|||
155465889|NCT03673956|561125917|FG001|Overall Study|Lost to Follow-up|0|||
155465890|NCT03673956|561125918|FG002|Overall Study|Lost to Follow-up|0|||
155465891|NCT03673956|561125919|FG003|Overall Study|Lost to Follow-up|0|||
155465892|NCT03673956|561125916|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
155465893|NCT03673956|561125917|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
155465894|NCT03673956|561125918|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
155465895|NCT03673956|561125919|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
155465896|NCT01117012|561125925|FG000|Overall Study|Adverse Event|0|||
155465897|NCT01117012|561125926|FG001|Overall Study|Adverse Event|1|||
155465898|NCT01117012|561125925|FG000|Overall Study|Death|1|||
155465899|NCT01117012|561125926|FG001|Overall Study|Death|1|||
155465900|NCT01117012|561125925|FG000|Overall Study|Withdrawal by Subject|3|||
155465901|NCT01117012|561125926|FG001|Overall Study|Withdrawal by Subject|0|||
155465902|NCT01117012|561125925|FG000|Overall Study|Undefined|4|||
155465903|NCT01117012|561125926|FG001|Overall Study|Undefined|3|||
155465904|NCT00844285|561125927|FG000|Overall Study|Other|0|||
155465905|NCT00844285|561125928|FG001|Overall Study|Other|1|||
155465906|NCT00844285|561125929|FG002|Overall Study|Other|0|||
155465907|NCT00844285|561125927|FG000|Overall Study|Other than specified|95|||
155465908|NCT00844285|561125928|FG001|Overall Study|Other than specified|129|||
155465909|NCT00844285|561125929|FG002|Overall Study|Other than specified|12|||
155465910|NCT00844285|561125927|FG000|Overall Study|Site closure|256|||
155465911|NCT00844285|561125928|FG001|Overall Study|Site closure|450|||
155465912|NCT00844285|561125929|FG002|Overall Study|Site closure|50|||
155465913|NCT00844285|561125927|FG000|Overall Study|Follow-up < 8 years|16|||
155465914|NCT00844285|561125928|FG001|Overall Study|Follow-up < 8 years|23|||
155465915|NCT00844285|561125929|FG002|Overall Study|Follow-up < 8 years|4|||
155465916|NCT00844285|561125927|FG000|Overall Study|Protocol Violation|26|||
155465917|NCT00844285|561125928|FG001|Overall Study|Protocol Violation|28|||
155465918|NCT00844285|561125929|FG002|Overall Study|Protocol Violation|54|||
155465919|NCT00844285|561125927|FG000|Overall Study|Death|22|||
155465920|NCT00844285|561125928|FG001|Overall Study|Death|21|||
155465921|NCT00844285|561125929|FG002|Overall Study|Death|8|||
155465922|NCT00844285|561125927|FG000|Overall Study|Withdrew Consent|344|||
155465923|NCT00844285|561125928|FG001|Overall Study|Withdrew Consent|466|||
155465924|NCT00844285|561125929|FG002|Overall Study|Withdrew Consent|70|||
155465925|NCT00844285|561125927|FG000|Overall Study|Lost to Follow-up|330|||
155465926|NCT00844285|561125928|FG001|Overall Study|Lost to Follow-up|486|||
155465927|NCT00844285|561125929|FG002|Overall Study|Lost to Follow-up|74|||
155465928|NCT05425719|561125932|FG000|Overall Study|Lost to Follow-up|4|||
155465929|NCT05425719|561125933|FG001|Overall Study|Lost to Follow-up|0|||
155465930|NCT05425719|561125932|FG000|Overall Study|Withdrew consent|1|||
155465931|NCT05425719|561125933|FG001|Overall Study|Withdrew consent|1|||
155465932|NCT01033487|561125934|FG000|Fourth Intervention Period|Adverse Event|0|||
155465933|NCT01033487|561125935|FG001|Fourth Intervention Period|Adverse Event|0|||
155465934|NCT01033487|561125936|FG002|Fourth Intervention Period|Adverse Event|0|||
155465935|NCT01033487|561125937|FG003|Fourth Intervention Period|Adverse Event|0|||
155652613|NCT04744831|561822105|FG002|Overall Study|Adverse Event|3|||
155652614|NCT04744831|561822103|FG000|Overall Study|Clinical Progression|3|||
155652615|NCT04744831|561822104|FG001|Overall Study|Clinical Progression|2|||
155652616|NCT04744831|561822105|FG002|Overall Study|Clinical Progression|5|||
155652617|NCT04744831|561822103|FG000|Overall Study|Other|0|||
155652618|NCT04744831|561822104|FG001|Overall Study|Other|2|||
155652619|NCT04744831|561822105|FG002|Overall Study|Other|1|||
155652620|NCT04744831|561822103|FG000|Overall Study|Death|0|||
155652621|NCT04744831|561822104|FG001|Overall Study|Death|2|||
155652622|NCT04744831|561822105|FG002|Overall Study|Death|1|||
155652623|NCT05401409|561822108|FG000|Overall Study|Lost to Follow-up|1|||
155652624|NCT05401409|561822109|FG001|Overall Study|Lost to Follow-up|0|||
155652625|NCT02410200|561822111|FG000|Overall Study|Adverse Event|2|||
155652626|NCT02144337|561822112|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
155652627|NCT02144337|561822113|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
155652628|NCT02144337|561822112|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
155652629|NCT02144337|561822113|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
155652630|NCT02144337|561822112|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
155652631|NCT02144337|561822113|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
155652632|NCT02144337|561822112|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
155652633|NCT02144337|561822113|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
155652634|NCT02144337|561822112|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
155652635|NCT02144337|561822113|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
155652636|NCT02402907|561822114|FG000|Overall Study|Delivered vaginally|9|||
155652637|NCT02402907|561822115|FG001|Overall Study|Delivered vaginally|3|||
155652638|NCT02402907|561822114|FG000|Overall Study|Delivered outside of Sinai|1|||
155652639|NCT02402907|561822115|FG001|Overall Study|Delivered outside of Sinai|1|||
155652640|NCT02402907|561822114|FG000|Overall Study|Lost to follow up after C-Section|10|||
155652641|NCT02402907|561822115|FG001|Overall Study|Lost to follow up after C-Section|23|||
155652642|NCT03701074|561822116|FG000|Overall Study|Physician Decision|1|||
155652643|NCT03701074|561822117|FG001|Overall Study|Physician Decision|0|||
155652644|NCT01500135|561822122|FG000|Overall Study|Withdrawal of Consent|4|||
155652645|NCT01500135|561822123|FG001|Overall Study|Withdrawal of Consent|0|||
155652646|NCT01500135|561822122|FG000|Overall Study|Lost to Follow-up|6|||
155652647|NCT01500135|561822123|FG001|Overall Study|Lost to Follow-up|4|||
155652648|NCT01500135|561822122|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
155652649|NCT01500135|561822123|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
155652650|NCT01500135|561822122|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
155652651|NCT01500135|561822123|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
155652652|NCT01500135|561822122|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
155652653|NCT01500135|561822123|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
155652654|NCT01500135|561822122|FG000|Overall Study|Participant was a Safety Concern|1|||
155652655|NCT01500135|561822123|FG001|Overall Study|Participant was a Safety Concern|0|||
155652656|NCT01500135|561822122|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
155652657|NCT01500135|561822123|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
155652658|NCT01661595|561822124|FG000|Phase 1: Week 0-4|Adverse Event|1|||
155652659|NCT01661595|561822125|FG001|Phase 1: Week 0-4|Adverse Event|0|||
155652660|NCT01661595|561822126|FG002|Phase 1: Week 0-4|Adverse Event|0|||
155652661|NCT01661595|561822127|FG003|Phase 1: Week 0-4|Adverse Event|0|||
155652662|NCT01661595|561822124|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
155652663|NCT01661595|561822125|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
155652664|NCT01661595|561822126|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
155652665|NCT01661595|561822127|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
155652666|NCT00661687|561822128|FG000|Overall Study|Study related symptoms and complaints|5|||
155652667|NCT00661687|561822128|FG000|Overall Study|Positive slit lamp findings|4|||
155652668|NCT00661687|561822128|FG000|Overall Study|Inability to maintain wearing schedule|3|||
155652669|NCT00661687|561822128|FG000|Overall Study|Physician Decision|1|||
155652670|NCT00661687|561822128|FG000|Overall Study|Adverse Event|2|||
155652671|NCT00912509|561822129|FG000|Overall Study|Lost to Follow-up|1|||
155652672|NCT00912509|561822130|FG001|Overall Study|Lost to Follow-up|0|||
155465936|NCT01033487|561125938|FG004|Fourth Intervention Period|Adverse Event|0|||
155652673|NCT00912509|561822129|FG000|Overall Study|Lack of Efficacy|4|||
155652674|NCT00912509|561822130|FG001|Overall Study|Lack of Efficacy|3|||
155652675|NCT01362530|561822132|FG000|Base Study (Cycle 1)|Adverse Event|2|||
155652676|NCT01362530|561822133|FG001|Base Study (Cycle 1)|Adverse Event|0|||
155652677|NCT01362530|561822132|FG000|Base Study (Cycle 1)|Physician Decision|0|||
155652678|NCT01362530|561822133|FG001|Base Study (Cycle 1)|Physician Decision|1|||
155652679|NCT01362530|561822132|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
155652680|NCT01362530|561822133|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
155652681|NCT01362530|561822132|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
155652682|NCT01362530|561822133|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
155652683|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
155652684|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
155465937|NCT01033487|561125939|FG005|Fourth Intervention Period|Adverse Event|0|||
155465938|NCT01033487|561125940|FG006|Fourth Intervention Period|Adverse Event|0|||
155465939|NCT01033487|561125941|FG007|Fourth Intervention Period|Adverse Event|0|||
155465940|NCT01033487|561125942|FG008|Fourth Intervention Period|Adverse Event|1|||
155465941|NCT01033487|561125943|FG009|Fourth Intervention Period|Adverse Event|0|||
155465942|NCT02193828|561125944|FG000|Overall Study|Withdrawal by Subject|0|||
155465943|NCT02193828|561125945|FG001|Overall Study|Withdrawal by Subject|0|||
155465944|NCT02193828|561125946|FG002|Overall Study|Withdrawal by Subject|1|||
155465945|NCT02193828|561125947|FG003|Overall Study|Withdrawal by Subject|1|||
155465946|NCT00889681|561125948|FG000|Overall Study|Not meeting qualification Criteria|2|||
155465947|NCT00889681|561125948|FG000|Overall Study|Insurance disapproval|1|||
155517072|NCT02346201|561317517|FG001|Overall Study|Physician Decision|1|||
155517073|NCT02346201|561317516|FG000|Overall Study|Missed final visit|0|||
155517074|NCT02346201|561317517|FG001|Overall Study|Missed final visit|2|||
155517075|NCT01497938|561317518|FG000|Overall Study|Adverse Event|0|||
155517076|NCT01497938|561317519|FG001|Overall Study|Adverse Event|1|||
155517077|NCT01497938|561317518|FG000|Overall Study|Physician Decision|0|||
155517078|NCT01497938|561317519|FG001|Overall Study|Physician Decision|1|||
155517079|NCT01497938|561317518|FG000|Overall Study|Withdrawal by Subject|4|||
155517080|NCT01497938|561317519|FG001|Overall Study|Withdrawal by Subject|0|||
155517081|NCT01497938|561317518|FG000|Overall Study|Device Violation|1|||
155517082|NCT01497938|561317519|FG001|Overall Study|Device Violation|0|||
155517083|NCT03708211|561317520|FG000|Overall Study|Progressive Disease|10|||
155517084|NCT03708211|561317521|FG001|Overall Study|Progressive Disease|7|||
155517085|NCT03708211|561317520|FG000|Overall Study|Withdrawal by Subject|0|||
155517086|NCT03708211|561317521|FG001|Overall Study|Withdrawal by Subject|1|||
155517087|NCT03708211|561317520|FG000|Overall Study|Other|2|||
155517088|NCT03708211|561317521|FG001|Overall Study|Other|0|||
155517089|NCT00462982|561317526|FG000|Overall Study|Adverse Event|1|||
155517090|NCT00462982|561317526|FG000|Overall Study|Patient Not Treated|2|||
155517091|NCT05200858|561317529|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
155517092|NCT05200858|561317530|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
155517093|NCT05200858|561317531|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
155517094|NCT05200858|561317532|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
155517095|NCT02683187|561317533|FG000|Overall Study|Failed IV access|3|||
155517096|NCT02683187|561317533|FG000|Overall Study|Withdrawal by Subject|5|||
155517097|NCT01402908|561319572|FG000|Overall Study|Withdrawal by Subject|30|||
155517098|NCT01402908|561319573|FG001|Overall Study|Withdrawal by Subject|17|||
155517099|NCT01402908|561319572|FG000|Overall Study|Lost to Follow-up|3|||
155517100|NCT01402908|561319573|FG001|Overall Study|Lost to Follow-up|1|||
155517101|NCT01402908|561319572|FG000|Overall Study|Physician Decision|1|||
155517102|NCT01402908|561319573|FG001|Overall Study|Physician Decision|0|||
155517103|NCT02581345|561319574|FG000|Part 1: up to Week 16|Adverse Event|3|||
155517104|NCT02581345|561319575|FG001|Part 1: up to Week 16|Adverse Event|8|||
155517105|NCT02581345|561319576|FG002|Part 1: up to Week 16|Adverse Event|0|||
155517106|NCT02581345|561319577|FG003|Part 1: up to Week 16|Adverse Event|0|||
155517107|NCT02581345|561319574|FG000|Part 1: up to Week 16|Physician Decision|2|||
155517108|NCT02581345|561319575|FG001|Part 1: up to Week 16|Physician Decision|4|||
155517109|NCT02581345|561319576|FG002|Part 1: up to Week 16|Physician Decision|0|||
155517110|NCT02581345|561319577|FG003|Part 1: up to Week 16|Physician Decision|0|||
155517111|NCT02581345|561319574|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
155517112|NCT02581345|561319575|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
155517113|NCT02581345|561319576|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
155517114|NCT02581345|561319577|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
155517115|NCT02581345|561319574|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
155517116|NCT02581345|561319575|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
155517117|NCT02581345|561319576|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
155517118|NCT02581345|561319577|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
155517119|NCT02581345|561319574|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
155517120|NCT02581345|561319575|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
155517121|NCT02581345|561319576|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
155652685|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
155465948|NCT01957787|561125949|FG000|Overall Study|Death|18|||
155465949|NCT01957787|561125949|FG000|Overall Study|Lost to Follow-up|3|||
155517122|NCT02581345|561319577|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
155652686|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
155465950|NCT01957787|561125949|FG000|Overall Study|Withdrawal by Subject|3|||
155465951|NCT01957787|561125949|FG000|Overall Study|Entered Hospice or Similar Program|2|||
155465952|NCT01957787|561125949|FG000|Overall Study|Index Tumor(s) Resected|2|||
155465953|NCT01957787|561125949|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
155517123|NCT02581345|561319574|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
155517124|NCT02581345|561319575|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
155517125|NCT02581345|561319576|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
155517126|NCT02581345|561319577|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
155517127|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
155517128|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
155517129|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
155465954|NCT01957787|561125949|FG000|Overall Study|Local therapy, not cryoablation|6|||
155465955|NCT03954444|561125950|FG000|Overall Study|Withdrawal by Subject|5|||
155465956|NCT03954444|561125951|FG001|Overall Study|Withdrawal by Subject|5|||
155465957|NCT03954444|561125952|FG002|Overall Study|Withdrawal by Subject|5|||
155465958|NCT03954444|561125950|FG000|Overall Study|Adverse Event|1|||
155465959|NCT03954444|561125951|FG001|Overall Study|Adverse Event|3|||
155465960|NCT03954444|561125952|FG002|Overall Study|Adverse Event|2|||
155465961|NCT03954444|561125950|FG000|Overall Study|Protocol Violation|0|||
155465962|NCT03954444|561125951|FG001|Overall Study|Protocol Violation|3|||
155517130|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
155517131|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
155517132|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
155517133|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
155517134|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
155517135|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
155517136|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
155517137|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
155517138|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
155517139|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
155517140|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
155517141|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
155517142|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
155517143|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
155517144|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
155517145|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
155517146|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
155465963|NCT03954444|561125952|FG002|Overall Study|Protocol Violation|5|||
155517147|NCT02581345|561319574|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
155465964|NCT03954444|561125950|FG000|Overall Study|Use of prohibited therapy|1|||
155465965|NCT03954444|561125951|FG001|Overall Study|Use of prohibited therapy|1|||
155517148|NCT02581345|561319575|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
155517149|NCT02581345|561319576|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
155517150|NCT02581345|561319577|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
155517151|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
155517152|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
155517153|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
155465966|NCT03954444|561125952|FG002|Overall Study|Use of prohibited therapy|2|||
155465967|NCT03954444|561125950|FG000|Overall Study|Lost to Follow-up|1|||
155465968|NCT03954444|561125951|FG001|Overall Study|Lost to Follow-up|0|||
155465969|NCT03954444|561125952|FG002|Overall Study|Lost to Follow-up|1|||
155465970|NCT03954444|561125950|FG000|Overall Study|Non-compliant with study drug application|2|||
155465971|NCT03954444|561125951|FG001|Overall Study|Non-compliant with study drug application|2|||
155465972|NCT03954444|561125952|FG002|Overall Study|Non-compliant with study drug application|0|||
155465973|NCT03954444|561125950|FG000|Overall Study|Administrative reasons|0|||
155465974|NCT03954444|561125951|FG001|Overall Study|Administrative reasons|0|||
155465975|NCT03954444|561125952|FG002|Overall Study|Administrative reasons|1|||
155465976|NCT03954444|561125950|FG000|Overall Study|Miscellaneous|3|||
155465977|NCT03954444|561125951|FG001|Overall Study|Miscellaneous|2|||
155465978|NCT03954444|561125952|FG002|Overall Study|Miscellaneous|1|||
155465979|NCT03094832|561125959|FG000|Overall Study|Lost to Follow-up|0|||
155465980|NCT03094832|561125960|FG001|Overall Study|Lost to Follow-up|0|||
155465981|NCT03094832|561125961|FG002|Overall Study|Lost to Follow-up|0|||
155465982|NCT03094832|561125962|FG003|Overall Study|Lost to Follow-up|1|||
155465983|NCT03094832|561125963|FG004|Overall Study|Lost to Follow-up|1|||
155465984|NCT03094832|561125959|FG000|Overall Study|Death|1|||
155465985|NCT03094832|561125960|FG001|Overall Study|Death|0|||
155465986|NCT03094832|561125961|FG002|Overall Study|Death|0|||
155465987|NCT03094832|561125962|FG003|Overall Study|Death|0|||
155465988|NCT03094832|561125963|FG004|Overall Study|Death|0|||
155465989|NCT03094832|561125959|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155465990|NCT03094832|561125960|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155465991|NCT03094832|561125961|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155465992|NCT03094832|561125962|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155465993|NCT03094832|561125963|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155465994|NCT03094832|561125959|FG000|Overall Study|Other|13|||
155465995|NCT03094832|561125960|FG001|Overall Study|Other|20|||
155465996|NCT03094832|561125961|FG002|Overall Study|Other|1|||
155465997|NCT03094832|561125962|FG003|Overall Study|Other|7|||
155465998|NCT03094832|561125963|FG004|Overall Study|Other|1|||
155465999|NCT00788697|561125966|FG000|Overall Study|No study drug administered|12|||
155466000|NCT00788697|561125966|FG000|Overall Study|Training Patients|74|||
155466001|NCT00788697|561125966|FG000|Overall Study|no truth standard procedure available|5|||
155466002|NCT00788697|561125966|FG000|Overall Study|Technically inadequate truth standard|1|||
155466003|NCT00788697|561125966|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
155466004|NCT00367432|561125967|FG000|First Period (16 Weeks)|Adverse Event|6|||
155466005|NCT00367432|561125968|FG001|First Period (16 Weeks)|Adverse Event|0|||
155466006|NCT00367432|561125967|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
155466007|NCT00367432|561125968|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
155466008|NCT00367432|561125967|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
155466009|NCT00367432|561125968|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
155466010|NCT00367432|561125967|FG000|First Period (16 Weeks)|Other Reason|2|||
155466011|NCT00367432|561125968|FG001|First Period (16 Weeks)|Other Reason|0|||
155466012|NCT00367432|561125967|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
155466013|NCT00367432|561125968|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
155466014|NCT00367432|561125967|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
155466015|NCT00367432|561125968|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
155466016|NCT00367432|561125967|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
155466017|NCT00367432|561125968|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
155466018|NCT00367432|561125967|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
155466019|NCT00367432|561125968|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
155466020|NCT00367432|561125967|FG000|Second Period (up to 54 Months)|Other Reason|6|||
155466021|NCT00367432|561125968|FG001|Second Period (up to 54 Months)|Other Reason|2|||
155466022|NCT00903370|561125969|FG000|Overall Study|Death|13|||
155466023|NCT00903370|561125970|FG001|Overall Study|Death|10|||
155466024|NCT00903370|561125969|FG000|Overall Study|Withdrawal by Subject|9|||
155466025|NCT00903370|561125970|FG001|Overall Study|Withdrawal by Subject|6|||
155466026|NCT00903370|561125969|FG000|Overall Study|Lost to Follow-up|6|||
155466027|NCT00903370|561125970|FG001|Overall Study|Lost to Follow-up|8|||
155466028|NCT00014911|561125971|FG000|Overall Study|Adverse Event|1|||
155466029|NCT00014911|561125971|FG000|Overall Study|Lost to Follow-up|1|||
155466030|NCT00014911|561125971|FG000|Overall Study|Withdrawal by Subject|6|||
155466031|NCT00014911|561125971|FG000|Overall Study|Unknown Reasons|2|||
155466032|NCT00014911|561125971|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
155466033|NCT00345540|561125974|FG000|Overall Study|Withdrawal by Subject|1|||
155466034|NCT04179786|561125975|FG000|Overall Study|Withdrawal by Subject|8|||
155466035|NCT01938001|561125976|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
155466036|NCT01938001|561125977|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
155466037|NCT01938001|561125976|FG000|Pre-Treatment|Death|1|||
155466038|NCT01938001|561125977|FG001|Pre-Treatment|Death|0|||
155466039|NCT01938001|561125976|FG000|Treatment|Death|2|||
155466040|NCT01938001|561125977|FG001|Treatment|Death|0|||
155466041|NCT01938001|561125976|FG000|Treatment|Adverse Event|14|||
155466042|NCT01938001|561125977|FG001|Treatment|Adverse Event|8|||
155466043|NCT01938001|561125976|FG000|Treatment|Progressive Disease|21|||
155466044|NCT01938001|561125977|FG001|Treatment|Progressive Disease|54|||
155466045|NCT01938001|561125976|FG000|Treatment|Withdrawal by Subject|13|||
155466046|NCT01938001|561125977|FG001|Treatment|Withdrawal by Subject|7|||
155466047|NCT01938001|561125976|FG000|Treatment|Other reasons|2|||
155466048|NCT01938001|561125977|FG001|Treatment|Other reasons|1|||
155466049|NCT03310580|561125978|FG000|Overall Study|Adverse Event|0|||
155466050|NCT03310580|561125979|FG001|Overall Study|Adverse Event|1|||
155466051|NCT03310580|561125980|FG002|Overall Study|Adverse Event|0|||
155466052|NCT03205982|561125987|FG000|Overall Study|Lost to Follow-up|20|||
155466053|NCT03205982|561125988|FG001|Overall Study|Lost to Follow-up|19|||
155466054|NCT03205982|561125987|FG000|Overall Study|Withdrawal by Subject|4|||
155466055|NCT03205982|561125988|FG001|Overall Study|Withdrawal by Subject|3|||
155466056|NCT03205982|561125987|FG000|Overall Study|Withdrawal by PI|0|||
155466057|NCT03205982|561125988|FG001|Overall Study|Withdrawal by PI|1|||
155466058|NCT02983799|561125991|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
155466059|NCT02983799|561125992|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
155466060|NCT02983799|561125993|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
155466061|NCT02983799|561125994|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
155466062|NCT02983799|561125995|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
155466063|NCT02983799|561125991|FG000|Overall Study|Death|20|||
155466064|NCT02983799|561125992|FG001|Overall Study|Death|5|||
155466065|NCT02983799|561125993|FG002|Overall Study|Death|23|||
155466066|NCT02983799|561125994|FG003|Overall Study|Death|47|||
155466067|NCT02983799|561125995|FG004|Overall Study|Death|7|||
155466068|NCT02983799|561125991|FG000|Overall Study|Withdrawal by Subject|1|||
155466069|NCT02983799|561125992|FG001|Overall Study|Withdrawal by Subject|0|||
155466070|NCT02983799|561125993|FG002|Overall Study|Withdrawal by Subject|3|||
155466071|NCT02983799|561125994|FG003|Overall Study|Withdrawal by Subject|4|||
155466072|NCT02983799|561125995|FG004|Overall Study|Withdrawal by Subject|1|||
155466073|NCT02983799|561125991|FG000|Overall Study|Protocol Violation|0|||
155466074|NCT02983799|561125992|FG001|Overall Study|Protocol Violation|1|||
155466075|NCT02983799|561125993|FG002|Overall Study|Protocol Violation|0|||
155466076|NCT02983799|561125994|FG003|Overall Study|Protocol Violation|0|||
155466077|NCT02983799|561125995|FG004|Overall Study|Protocol Violation|1|||
155466078|NCT02983799|561125991|FG000|Overall Study|Lost to Follow-up|1|||
155466079|NCT02983799|561125992|FG001|Overall Study|Lost to Follow-up|0|||
155466080|NCT02983799|561125993|FG002|Overall Study|Lost to Follow-up|1|||
155466081|NCT02983799|561125994|FG003|Overall Study|Lost to Follow-up|0|||
155466082|NCT02983799|561125995|FG004|Overall Study|Lost to Follow-up|0|||
155466083|NCT01626989|561126006|FG000|Screening Period|Screen Failure|15|||
155466084|NCT01626989|561126007|FG001|Screening Period|Screen Failure|0|||
155466085|NCT01626989|561126008|FG002|Screening Period|Screen Failure|0|||
155466086|NCT01626989|561126006|FG000|Screening Period|Withdrawal by Subject|2|||
155466087|NCT01626989|561126007|FG001|Screening Period|Withdrawal by Subject|0|||
155466088|NCT01626989|561126008|FG002|Screening Period|Withdrawal by Subject|0|||
155466089|NCT02293902|561126017|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
155466090|NCT02293902|561126018|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
155466091|NCT02293902|561126019|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
155466092|NCT02293902|561126020|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
155466093|NCT02293902|561126021|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
155466094|NCT02293902|561126017|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
155466095|NCT02293902|561126018|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
155466096|NCT02293902|561126019|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
155466097|NCT02293902|561126020|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
155466098|NCT02293902|561126021|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
155466099|NCT02293902|561126017|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
155466100|NCT02293902|561126018|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
155466101|NCT02293902|561126019|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
155466102|NCT02293902|561126020|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
155652687|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
155466103|NCT02293902|561126021|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
155466104|NCT02293902|561126017|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
155466105|NCT02293902|561126018|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
155466106|NCT02293902|561126019|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
155466107|NCT02293902|561126020|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
155466108|NCT02293902|561126021|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
155466109|NCT02293902|561126017|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
155466110|NCT02293902|561126018|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
155466111|NCT02293902|561126019|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
155466112|NCT02293902|561126020|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
155466113|NCT02293902|561126021|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
155466114|NCT02947022|561126022|FG000|Overall Study|Study Stopped|1|||
155466115|NCT03366844|561127714|FG000|Overall Study|Physician Decision|1|||
155466116|NCT03366844|561127714|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
155466117|NCT03077243|561127717|FG000|Overall Study|Death|1|||
155466118|NCT03077243|561127718|FG001|Overall Study|Death|2|||
155466119|NCT03077243|561127719|FG002|Overall Study|Death|0|||
155466120|NCT03077243|561127720|FG003|Overall Study|Death|0|||
155466121|NCT03077243|561127717|FG000|Overall Study|Withdrawal by Subject|1|||
155466122|NCT03077243|561127718|FG001|Overall Study|Withdrawal by Subject|3|||
155466123|NCT03077243|561127719|FG002|Overall Study|Withdrawal by Subject|0|||
155466124|NCT03077243|561127720|FG003|Overall Study|Withdrawal by Subject|0|||
155466125|NCT03077243|561127717|FG000|Overall Study|Physician Decision|1|||
155466126|NCT03077243|561127718|FG001|Overall Study|Physician Decision|0|||
155466127|NCT03077243|561127719|FG002|Overall Study|Physician Decision|0|||
155466128|NCT03077243|561127720|FG003|Overall Study|Physician Decision|0|||
155466129|NCT03077243|561127717|FG000|Overall Study|Research at two study sites terminated early|0|||
155466130|NCT03077243|561127718|FG001|Overall Study|Research at two study sites terminated early|0|||
155466131|NCT03077243|561127719|FG002|Overall Study|Research at two study sites terminated early|0|||
155466132|NCT03077243|561127720|FG003|Overall Study|Research at two study sites terminated early|69|||
155466133|NCT03984812|561127724|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466134|NCT03984812|561127725|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466135|NCT03984812|561127726|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
155466136|NCT03984812|561127727|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466137|NCT03984812|561127728|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466138|NCT03984812|561127729|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466139|NCT03984812|561127730|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466140|NCT03984812|561127731|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466141|NCT03984812|561127732|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466142|NCT03984812|561127733|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466143|NCT03984812|561127734|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
155466144|NCT02574481|561127735|FG000|Overall Study|Withdrawal by Subject|29|||
155466145|NCT02574481|561127736|FG001|Overall Study|Withdrawal by Subject|15|||
155466146|NCT02574481|561127737|FG002|Overall Study|Withdrawal by Subject|4|||
155466147|NCT02574481|561127738|FG003|Overall Study|Withdrawal by Subject|1|||
155466148|NCT02574481|561127735|FG000|Overall Study|Adverse Event|5|||
155466149|NCT02574481|561127736|FG001|Overall Study|Adverse Event|1|||
155466150|NCT02574481|561127737|FG002|Overall Study|Adverse Event|1|||
155466151|NCT02574481|561127738|FG003|Overall Study|Adverse Event|0|||
155466152|NCT02574481|561127735|FG000|Overall Study|Visit Missed|15|||
155466153|NCT02574481|561127736|FG001|Overall Study|Visit Missed|7|||
155466154|NCT02574481|561127737|FG002|Overall Study|Visit Missed|5|||
155466155|NCT02574481|561127738|FG003|Overall Study|Visit Missed|0|||
155466156|NCT02574481|561127735|FG000|Overall Study|Other|7|||
155466157|NCT02574481|561127736|FG001|Overall Study|Other|2|||
155466158|NCT02574481|561127737|FG002|Overall Study|Other|0|||
155466159|NCT02574481|561127738|FG003|Overall Study|Other|0|||
155466160|NCT02574481|561127735|FG000|Overall Study|Death|48|||
155466161|NCT02574481|561127736|FG001|Overall Study|Death|26|||
155466162|NCT02574481|561127737|FG002|Overall Study|Death|12|||
155466163|NCT02574481|561127738|FG003|Overall Study|Death|4|||
155517154|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
155517155|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
155517156|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
155517157|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
155517158|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
155517159|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
155517160|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
155517161|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
155466164|NCT02574481|561127735|FG000|Overall Study|Physician Decision|5|||
155466165|NCT02574481|561127736|FG001|Overall Study|Physician Decision|2|||
155466166|NCT02574481|561127737|FG002|Overall Study|Physician Decision|0|||
155466167|NCT02574481|561127738|FG003|Overall Study|Physician Decision|0|||
155517162|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
155466168|NCT02574481|561127735|FG000|Overall Study|Lost to Follow-up|5|||
155466169|NCT02574481|561127736|FG001|Overall Study|Lost to Follow-up|1|||
155466170|NCT02574481|561127737|FG002|Overall Study|Lost to Follow-up|3|||
155466171|NCT02574481|561127738|FG003|Overall Study|Lost to Follow-up|0|||
155466172|NCT01105936|561127739|FG000|Period 1|Adverse Event|0|||
155466173|NCT01105936|561127740|FG001|Period 1|Adverse Event|0|||
155466174|NCT01105936|561127741|FG002|Period 1|Adverse Event|0|||
155466175|NCT01105936|561127742|FG003|Period 1|Adverse Event|1|||
155466176|NCT01105936|561127739|FG000|Period 2|Adverse Event|1|||
155466177|NCT01105936|561127740|FG001|Period 2|Adverse Event|0|||
155466178|NCT01105936|561127741|FG002|Period 2|Adverse Event|0|||
155466179|NCT01105936|561127742|FG003|Period 2|Adverse Event|0|||
155466180|NCT01105936|561127739|FG000|Period 3|Protocol Violation|0|||
155466181|NCT01105936|561127740|FG001|Period 3|Protocol Violation|2|||
155466182|NCT01105936|561127741|FG002|Period 3|Protocol Violation|0|||
155466183|NCT01105936|561127742|FG003|Period 3|Protocol Violation|0|||
155466184|NCT02971007|561127744|FG000|Overall Study|Adverse Event|1|||
155466185|NCT02971007|561127745|FG001|Overall Study|Adverse Event|0|||
155466186|NCT02971007|561127746|FG002|Overall Study|Adverse Event|0|||
155466187|NCT02971007|561127744|FG000|Overall Study|Lost to Follow-up|0|||
155466188|NCT02971007|561127745|FG001|Overall Study|Lost to Follow-up|1|||
155466189|NCT02971007|561127746|FG002|Overall Study|Lost to Follow-up|1|||
155517163|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
155517164|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
155517165|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
155517166|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
155517167|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
155517168|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
155517169|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
155517170|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
155466190|NCT02971007|561127744|FG000|Overall Study|Withdrawal by Subject|0|||
155466191|NCT02971007|561127745|FG001|Overall Study|Withdrawal by Subject|1|||
155466192|NCT02971007|561127746|FG002|Overall Study|Withdrawal by Subject|0|||
155466193|NCT02971007|561127744|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
155466194|NCT02971007|561127745|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
155466195|NCT02971007|561127746|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
155466196|NCT02971007|561127744|FG000|Overall Study|Patient discontinued study drug|0|||
155466197|NCT02971007|561127745|FG001|Overall Study|Patient discontinued study drug|1|||
155466198|NCT02971007|561127746|FG002|Overall Study|Patient discontinued study drug|0|||
155466199|NCT03170258|561127750|FG000|Overall Study|Physician Decision|4|||
155466200|NCT03170258|561127751|FG001|Overall Study|Physician Decision|0|||
155466201|NCT03170258|561127750|FG000|Overall Study|Equipment issues|1|||
155466202|NCT03170258|561127751|FG001|Overall Study|Equipment issues|0|||
155466203|NCT03170258|561127750|FG000|Overall Study|Medication|1|||
155466204|NCT03170258|561127751|FG001|Overall Study|Medication|0|||
155466205|NCT03170258|561127750|FG000|Overall Study|Sleep issues|1|||
155466206|NCT03170258|561127751|FG001|Overall Study|Sleep issues|0|||
155466207|NCT03276572|561127757|FG000|Overall Study|In follow-up|0|||
155466208|NCT03276572|561127758|FG001|Overall Study|In follow-up|0|||
155466209|NCT03276572|561127759|FG002|Overall Study|In follow-up|0|||
155466210|NCT03276572|561127760|FG003|Overall Study|In follow-up|0|||
155466211|NCT03276572|561127761|FG004|Overall Study|In follow-up|0|||
155466212|NCT03276572|561127762|FG005|Overall Study|In follow-up|1|||
155466213|NCT03276572|561127763|FG006|Overall Study|In follow-up|1|||
155466214|NCT03276572|561127757|FG000|Overall Study|Lost to Follow-up|0|||
155517171|NCT02207231|561319586|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
155517172|NCT02207231|561319587|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
155517173|NCT02207231|561319588|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
155466215|NCT03276572|561127758|FG001|Overall Study|Lost to Follow-up|0|||
155466216|NCT03276572|561127759|FG002|Overall Study|Lost to Follow-up|0|||
155466217|NCT03276572|561127760|FG003|Overall Study|Lost to Follow-up|0|||
155466218|NCT03276572|561127761|FG004|Overall Study|Lost to Follow-up|0|||
155466219|NCT03276572|561127762|FG005|Overall Study|Lost to Follow-up|0|||
155466220|NCT03276572|561127763|FG006|Overall Study|Lost to Follow-up|1|||
155466221|NCT02954952|561127776|FG000|Overall Study|Withdrawal by Subject|1|||
155466222|NCT02954952|561127777|FG001|Overall Study|Withdrawal by Subject|0|||
155466223|NCT02954952|561127778|FG002|Overall Study|Withdrawal by Subject|0|||
155466224|NCT02954952|561127776|FG000|Overall Study|No data collected|0|||
155466225|NCT02954952|561127777|FG001|Overall Study|No data collected|1|||
155652688|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
155652689|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
155652690|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
155652691|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
155652692|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
155652693|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
155652694|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
155652695|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
155652696|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
155652697|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
155652698|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
155652699|NCT01362530|561822132|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
155652700|NCT01362530|561822133|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
155652701|NCT01034657|561822134|FG000|Core Phase|Withdrawal by Subject|1|||
155652702|NCT01034657|561822135|FG001|Core Phase|Withdrawal by Subject|0|||
155652703|NCT01034657|561822136|FG002|Core Phase|Withdrawal by Subject|0|||
155652704|NCT01034657|561822134|FG000|Core Phase|Lack of Efficacy|2|||
155652705|NCT01034657|561822135|FG001|Core Phase|Lack of Efficacy|0|||
155466226|NCT02954952|561127778|FG002|Overall Study|No data collected|0|||
155466227|NCT00724815|561127779|FG000|Overall Study|Randomized, not treated|31|||
155466228|NCT00724815|561127780|FG001|Overall Study|Randomized, not treated|30|||
155466229|NCT00724815|561127779|FG000|Overall Study|Adverse Event|5|||
155466230|NCT00724815|561127780|FG001|Overall Study|Adverse Event|3|||
155466231|NCT00724815|561127779|FG000|Overall Study|Lost to Follow-up|4|||
155466232|NCT00724815|561127780|FG001|Overall Study|Lost to Follow-up|1|||
155466233|NCT00724815|561127779|FG000|Overall Study|Other Various|3|||
155466234|NCT00724815|561127780|FG001|Overall Study|Other Various|5|||
155466235|NCT00810043|561127781|FG000|Overall Study|Withdrawal by Subject|1|||
155466236|NCT00810043|561127782|FG001|Overall Study|Withdrawal by Subject|0|||
155466237|NCT00810043|561127783|FG002|Overall Study|Withdrawal by Subject|2|||
155652706|NCT01034657|561822136|FG002|Core Phase|Lack of Efficacy|0|||
155652707|NCT01034657|561822134|FG000|Core Phase|Abnormal laboratory value|1|||
155466238|NCT00810043|561127781|FG000|Overall Study|Lost to Follow-up|1|||
155466239|NCT00810043|561127782|FG001|Overall Study|Lost to Follow-up|0|||
155466240|NCT00810043|561127783|FG002|Overall Study|Lost to Follow-up|0|||
155466241|NCT00810043|561127781|FG000|Overall Study|Physician Decision|0|||
155466242|NCT00810043|561127782|FG001|Overall Study|Physician Decision|0|||
155652708|NCT01034657|561822135|FG001|Core Phase|Abnormal laboratory value|0|||
155652709|NCT01034657|561822136|FG002|Core Phase|Abnormal laboratory value|0|||
155652710|NCT01034657|561822134|FG000|Core Phase|Adverse Event|8|||
155652711|NCT01034657|561822135|FG001|Core Phase|Adverse Event|0|||
155652712|NCT01034657|561822136|FG002|Core Phase|Adverse Event|0|||
155652713|NCT01034657|561822134|FG000|Core Phase|Protocol Violation|2|||
155652714|NCT01034657|561822135|FG001|Core Phase|Protocol Violation|0|||
155652715|NCT01034657|561822136|FG002|Core Phase|Protocol Violation|0|||
155652716|NCT01034657|561822134|FG000|Randomized Phase|Withdrawal by Subject|0|||
155652717|NCT01034657|561822135|FG001|Randomized Phase|Withdrawal by Subject|2|||
155652718|NCT01034657|561822136|FG002|Randomized Phase|Withdrawal by Subject|0|||
155652719|NCT01034657|561822134|FG000|Randomized Phase|Lack of Efficacy|5|||
155652720|NCT01034657|561822135|FG001|Randomized Phase|Lack of Efficacy|1|||
155652721|NCT01034657|561822136|FG002|Randomized Phase|Lack of Efficacy|0|||
155652722|NCT01034657|561822134|FG000|Randomized Phase|Abnormal laboratory value|0|||
155652723|NCT01034657|561822135|FG001|Randomized Phase|Abnormal laboratory value|1|||
155652724|NCT01034657|561822136|FG002|Randomized Phase|Abnormal laboratory value|0|||
155652725|NCT01034657|561822134|FG000|Randomized Phase|Adverse Event|0|||
155652726|NCT01034657|561822135|FG001|Randomized Phase|Adverse Event|2|||
155652727|NCT01034657|561822136|FG002|Randomized Phase|Adverse Event|1|||
155652728|NCT02715856|561822137|FG000|Overall Study|Software Issues|12|||
155652729|NCT02715856|561822138|FG001|Overall Study|Software Issues|7|||
155652730|NCT02715856|561822137|FG000|Overall Study|Death|6|||
155652731|NCT02715856|561822138|FG001|Overall Study|Death|5|||
155652732|NCT02715856|561822137|FG000|Overall Study|Non- Compliant|0|||
155652733|NCT02715856|561822138|FG001|Overall Study|Non- Compliant|40|||
155652734|NCT01557569|561822139|FG000|Overall Study|Adverse Event|2|||
155652735|NCT01557569|561822140|FG001|Overall Study|Adverse Event|0|||
155652736|NCT01557569|561822139|FG000|Overall Study|high blood pressure|0|||
155652737|NCT01557569|561822140|FG001|Overall Study|high blood pressure|1|||
155652738|NCT01557569|561822139|FG000|Overall Study|Withdrawal by Subject|3|||
155652739|NCT01557569|561822140|FG001|Overall Study|Withdrawal by Subject|5|||
155652740|NCT01557569|561822139|FG000|Overall Study|noncompliance with rules of residential|0|||
155466243|NCT00810043|561127783|FG002|Overall Study|Physician Decision|2|||
155466244|NCT00810043|561127781|FG000|Overall Study|Death|2|||
155466245|NCT00810043|561127782|FG001|Overall Study|Death|0|||
155466246|NCT00810043|561127783|FG002|Overall Study|Death|0|||
155466247|NCT00810043|561127781|FG000|Overall Study|Unrelated medical problem|0|||
155466248|NCT00810043|561127782|FG001|Overall Study|Unrelated medical problem|1|||
155466249|NCT00810043|561127783|FG002|Overall Study|Unrelated medical problem|0|||
155466250|NCT00810043|561127781|FG000|Overall Study|Non-medical problem|0|||
155466251|NCT00810043|561127782|FG001|Overall Study|Non-medical problem|0|||
155466252|NCT00810043|561127783|FG002|Overall Study|Non-medical problem|1|||
155466253|NCT00810043|561127781|FG000|Overall Study|No longer met enrollment criteria|0|||
155466254|NCT00810043|561127782|FG001|Overall Study|No longer met enrollment criteria|0|||
155466255|NCT00810043|561127783|FG002|Overall Study|No longer met enrollment criteria|3|||
155466256|NCT00641706|561127789|FG000|Overall Study|Adverse Event|2|||
155466257|NCT00641706|561127790|FG001|Overall Study|Adverse Event|1|||
155466258|NCT00641706|561127789|FG000|Overall Study|Withdrawal by Subject|6|||
155466259|NCT00641706|561127790|FG001|Overall Study|Withdrawal by Subject|1|||
155466260|NCT00641706|561127789|FG000|Overall Study|Clinical Decline|1|||
155466261|NCT00641706|561127790|FG001|Overall Study|Clinical Decline|0|||
155466262|NCT00641706|561127789|FG000|Overall Study|Lead Investigator Decision|0|||
155466263|NCT00641706|561127790|FG001|Overall Study|Lead Investigator Decision|1|||
155466264|NCT01989754|561127791|FG000|Overall Study|Withdrawal by Subject|10|||
155466265|NCT01989754|561127792|FG001|Overall Study|Withdrawal by Subject|14|||
155466266|NCT01989754|561127791|FG000|Overall Study|Lost to Follow-up|28|||
155466267|NCT01989754|561127792|FG001|Overall Study|Lost to Follow-up|20|||
155466268|NCT01989754|561127791|FG000|Overall Study|Closed Site|1|||
155466269|NCT01989754|561127792|FG001|Overall Study|Closed Site|1|||
155466270|NCT01359046|561127793|FG000|Overall Study|Did not receive allocated intervention|6|||
155466271|NCT01359046|561127794|FG001|Overall Study|Did not receive allocated intervention|6|||
155466272|NCT01359046|561127793|FG000|Overall Study|Physician Decision|1|||
155466273|NCT01359046|561127794|FG001|Overall Study|Physician Decision|11|||
155466274|NCT03037307|561127797|FG000|Period 1|Did Not Meet Study Criteria|0|||
155466275|NCT03037307|561127798|FG001|Period 1|Did Not Meet Study Criteria|0|||
155466276|NCT03037307|561127799|FG002|Period 1|Did Not Meet Study Criteria|0|||
155466277|NCT03037307|561127800|FG003|Period 1|Did Not Meet Study Criteria|1|||
155466278|NCT03037307|561127801|FG004|Period 1|Did Not Meet Study Criteria|0|||
155466279|NCT03037307|561127802|FG005|Period 1|Did Not Meet Study Criteria|0|||
155466280|NCT00802867|561127805|FG000|Overall Study|Lost to Follow-up|6|||
155466281|NCT00802867|561127805|FG000|Overall Study|Protocol Violation|6|||
155466282|NCT00802867|561127805|FG000|Overall Study|Withdrawal by Subject|1|||
155466283|NCT03000686|561127810|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
155466284|NCT03000686|561127811|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
155466285|NCT03000686|561127812|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
155466286|NCT03000686|561127813|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
155466287|NCT02920450|561127814|FG000|Overall Study|Death|1|||
155466288|NCT02920450|561127815|FG001|Overall Study|Death|0|||
155466289|NCT02920450|561127816|FG002|Overall Study|Death|0|||
155466290|NCT02920450|561127817|FG003|Overall Study|Death|0|||
155466291|NCT02920450|561127814|FG000|Overall Study|Withdrawal by Subject|1|||
155466292|NCT02920450|561127815|FG001|Overall Study|Withdrawal by Subject|0|||
155466293|NCT02920450|561127816|FG002|Overall Study|Withdrawal by Subject|0|||
155466294|NCT02920450|561127817|FG003|Overall Study|Withdrawal by Subject|0|||
155466295|NCT00770224|561127824|FG000|Step 1: Induction|Adverse Event|3|||
155517174|NCT02207231|561319589|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
155466296|NCT00770224|561127825|FG001|Step 1: Induction|Adverse Event|0|||
155466297|NCT00770224|561127824|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
155466298|NCT00770224|561127825|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
155466299|NCT00770224|561127824|FG000|Step 1: Induction|Other reason not protocol specified|2|||
155466300|NCT00770224|561127825|FG001|Step 1: Induction|Other reason not protocol specified|0|||
155466301|NCT00770224|561127824|FG000|Step 1: Induction|Ineligible|2|||
155466302|NCT00770224|561127825|FG001|Step 1: Induction|Ineligible|0|||
155466303|NCT00770224|561127824|FG000|Step 1: Induction|No protocol treatment given|1|||
155466304|NCT00770224|561127825|FG001|Step 1: Induction|No protocol treatment given|0|||
155466305|NCT00770224|561127824|FG000|Step 2: Maintenance|Adverse Event|0|||
155466306|NCT00770224|561127825|FG001|Step 2: Maintenance|Adverse Event|10|||
155466307|NCT00770224|561127824|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
155466308|NCT00770224|561127825|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
155466309|NCT00770224|561127824|FG000|Step 2: Maintenance|Progression/relapse|0|||
155466310|NCT00770224|561127825|FG001|Step 2: Maintenance|Progression/relapse|1|||
155466311|NCT00770224|561127824|FG000|Step 2: Maintenance|Death|0|||
155466312|NCT00770224|561127825|FG001|Step 2: Maintenance|Death|2|||
155466313|NCT00770224|561127824|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
155466314|NCT00770224|561127825|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
155466315|NCT00770224|561127824|FG000|Step 2: Maintenance|Ineligible|0|||
155466316|NCT00770224|561127825|FG001|Step 2: Maintenance|Ineligible|2|||
155466317|NCT04737759|561127826|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
155466318|NCT04737759|561127827|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
155466319|NCT04737759|561127826|FG000|Overall Study|Death|2|||
155466320|NCT04737759|561127827|FG001|Overall Study|Death|0|||
155466321|NCT04737759|561127826|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
155466322|NCT04737759|561127827|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
155466323|NCT04737759|561127826|FG000|Overall Study|Lost to Follow-up|4|||
155466324|NCT04737759|561127827|FG001|Overall Study|Lost to Follow-up|12|||
155466325|NCT01484561|561127828|FG000|Overall Study|Lack of Efficacy|3|||
155466326|NCT01484561|561127829|FG001|Overall Study|Lack of Efficacy|1|||
155466327|NCT01484561|561127828|FG000|Overall Study|Lost to Follow-up|1|||
155466328|NCT01484561|561127829|FG001|Overall Study|Lost to Follow-up|0|||
155466329|NCT01484561|561127828|FG000|Overall Study|Withdrawal by Subject|3|||
155466330|NCT01484561|561127829|FG001|Overall Study|Withdrawal by Subject|0|||
155466331|NCT01484561|561127828|FG000|Overall Study|Other|1|||
155466332|NCT01484561|561127829|FG001|Overall Study|Other|1|||
155466333|NCT01484561|561127828|FG000|Overall Study|Adverse Event|1|||
155466334|NCT01484561|561127829|FG001|Overall Study|Adverse Event|4|||
155466335|NCT01112982|561127830|FG000|Overall Study|Withdrawal by Subject|1|||
155466336|NCT01112982|561127830|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
155466337|NCT03371251|561127831|FG000|Overall Study|Withdrawal by Subject|1|||
155466338|NCT03371251|561127832|FG001|Overall Study|Withdrawal by Subject|0|||
155466339|NCT03371251|561127833|FG002|Overall Study|Withdrawal by Subject|1|||
155466340|NCT03371251|561127834|FG003|Overall Study|Withdrawal by Subject|0|||
155466341|NCT03371251|561127835|FG004|Overall Study|Withdrawal by Subject|2|||
155466342|NCT03371251|561127836|FG005|Overall Study|Withdrawal by Subject|2|||
155466343|NCT03371251|561127831|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
155466344|NCT03371251|561127832|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
155466345|NCT03371251|561127833|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
155466346|NCT03371251|561127834|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
155466347|NCT03371251|561127835|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
155466348|NCT03371251|561127836|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
155466349|NCT03371251|561127831|FG000|Overall Study|Adverse Event|0|||
155466350|NCT03371251|561127832|FG001|Overall Study|Adverse Event|0|||
155466351|NCT03371251|561127833|FG002|Overall Study|Adverse Event|0|||
155466352|NCT03371251|561127834|FG003|Overall Study|Adverse Event|0|||
155466353|NCT03371251|561127835|FG004|Overall Study|Adverse Event|1|||
155466354|NCT03371251|561127836|FG005|Overall Study|Adverse Event|0|||
155466355|NCT03371251|561127831|FG000|Overall Study|Decision by Sponsor|0|||
155466356|NCT03371251|561127832|FG001|Overall Study|Decision by Sponsor|0|||
155466357|NCT03371251|561127833|FG002|Overall Study|Decision by Sponsor|0|||
155466358|NCT03371251|561127834|FG003|Overall Study|Decision by Sponsor|0|||
155466359|NCT03371251|561127835|FG004|Overall Study|Decision by Sponsor|2|||
155466360|NCT03371251|561127836|FG005|Overall Study|Decision by Sponsor|0|||
155466361|NCT00294684|561127837|FG000|Overall Study|Lost to Follow-up|5|||
155466362|NCT00294684|561127838|FG001|Overall Study|Lost to Follow-up|8|||
155466363|NCT00126672|561127839|FG000|Overall Study|Adverse Event|4|||
155466364|NCT00126672|561127839|FG000|Overall Study|Lost to Follow-up|4|||
155466365|NCT01001234|561127840|FG000|Overall Study|Withdrawal by Subject|2|||
155466366|NCT01001234|561127841|FG001|Overall Study|Withdrawal by Subject|0|||
155466367|NCT01001234|561127842|FG002|Overall Study|Withdrawal by Subject|3|||
155466368|NCT01001234|561127843|FG003|Overall Study|Withdrawal by Subject|0|||
155466369|NCT01001234|561127844|FG004|Overall Study|Withdrawal by Subject|0|||
155466370|NCT01001234|561127840|FG000|Overall Study|Protocol Violation|34|||
155466371|NCT01001234|561127841|FG001|Overall Study|Protocol Violation|3|||
155466372|NCT01001234|561127842|FG002|Overall Study|Protocol Violation|19|||
155466373|NCT01001234|561127843|FG003|Overall Study|Protocol Violation|18|||
155466374|NCT01001234|561127844|FG004|Overall Study|Protocol Violation|0|||
155466375|NCT01001234|561127840|FG000|Overall Study|Lost to Follow-up|0|||
155466376|NCT01001234|561127841|FG001|Overall Study|Lost to Follow-up|0|||
155466377|NCT01001234|561127842|FG002|Overall Study|Lost to Follow-up|1|||
155466378|NCT01001234|561127843|FG003|Overall Study|Lost to Follow-up|2|||
155466379|NCT01001234|561127844|FG004|Overall Study|Lost to Follow-up|0|||
155466380|NCT01001234|561127840|FG000|Overall Study|Physician Decision|1|||
155466381|NCT01001234|561127841|FG001|Overall Study|Physician Decision|0|||
155466382|NCT01001234|561127842|FG002|Overall Study|Physician Decision|0|||
155466383|NCT01001234|561127843|FG003|Overall Study|Physician Decision|0|||
155466384|NCT01001234|561127844|FG004|Overall Study|Physician Decision|0|||
155466385|NCT01001234|561127840|FG000|Overall Study|Not Treated: Adverse Event|1|||
155517175|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
155466386|NCT01001234|561127841|FG001|Overall Study|Not Treated: Adverse Event|0|||
155466387|NCT01001234|561127842|FG002|Overall Study|Not Treated: Adverse Event|0|||
155466388|NCT01001234|561127843|FG003|Overall Study|Not Treated: Adverse Event|0|||
155466389|NCT01001234|561127844|FG004|Overall Study|Not Treated: Adverse Event|0|||
155466390|NCT01001234|561127840|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
155466391|NCT01001234|561127841|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
155466392|NCT01001234|561127842|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
155466393|NCT01001234|561127843|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
155466394|NCT01001234|561127844|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
155466395|NCT01001234|561127840|FG000|Overall Study|Not Treated: Protocol Violation|3|||
155466396|NCT01001234|561127841|FG001|Overall Study|Not Treated: Protocol Violation|0|||
155466397|NCT01001234|561127842|FG002|Overall Study|Not Treated: Protocol Violation|0|||
155466398|NCT01001234|561127843|FG003|Overall Study|Not Treated: Protocol Violation|0|||
155466399|NCT01001234|561127844|FG004|Overall Study|Not Treated: Protocol Violation|0|||
155466400|NCT01001234|561127840|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
155466401|NCT01001234|561127841|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
155466402|NCT01001234|561127842|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
155466403|NCT01001234|561127843|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
155466404|NCT01001234|561127844|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
155466405|NCT01001234|561127840|FG000|Overall Study|Not Treated: Pregnancy|3|||
155466406|NCT01001234|561127841|FG001|Overall Study|Not Treated: Pregnancy|0|||
155466407|NCT01001234|561127842|FG002|Overall Study|Not Treated: Pregnancy|0|||
155466408|NCT01001234|561127843|FG003|Overall Study|Not Treated: Pregnancy|0|||
155466409|NCT01001234|561127844|FG004|Overall Study|Not Treated: Pregnancy|0|||
155466410|NCT01001234|561127840|FG000|Overall Study|Not Treated: Physician Decision|37|||
155466411|NCT01001234|561127841|FG001|Overall Study|Not Treated: Physician Decision|4|||
155466412|NCT01001234|561127842|FG002|Overall Study|Not Treated: Physician Decision|0|||
155466413|NCT01001234|561127843|FG003|Overall Study|Not Treated: Physician Decision|0|||
155517176|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
155517177|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
155466414|NCT01001234|561127844|FG004|Overall Study|Not Treated: Physician Decision|0|||
155466415|NCT01001234|561127840|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
155466416|NCT01001234|561127841|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
155466417|NCT01001234|561127842|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
155466418|NCT01001234|561127843|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
155466419|NCT01001234|561127844|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
155466420|NCT01851863|561127846|FG000|Overall Study|Did not receive study medication|2|||
155466421|NCT01851863|561127847|FG001|Overall Study|Did not receive study medication|5|||
155466422|NCT01851863|561127848|FG002|Overall Study|Did not receive study medication|3|||
155466423|NCT01851863|561127849|FG003|Overall Study|Did not receive study medication|0|||
155466424|NCT01851863|561127846|FG000|Overall Study|Lost to Follow-up|3|||
155466425|NCT01851863|561127847|FG001|Overall Study|Lost to Follow-up|4|||
155466426|NCT01851863|561127848|FG002|Overall Study|Lost to Follow-up|2|||
155466427|NCT01851863|561127849|FG003|Overall Study|Lost to Follow-up|3|||
155466428|NCT00753623|561127850|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
155466429|NCT00753623|561127851|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
155466430|NCT00753623|561127850|FG000|Phase I (14 Days)|Physician Decision|1|||
155466431|NCT00753623|561127851|FG001|Phase I (14 Days)|Physician Decision|2|||
155466432|NCT00753623|561127850|FG000|Phase I (14 Days)|Adverse Event|0|||
155466433|NCT00753623|561127851|FG001|Phase I (14 Days)|Adverse Event|1|||
155466434|NCT00753623|561127850|FG000|Washout (7 Days)|Physician Decision|1|||
155466435|NCT00753623|561127851|FG001|Washout (7 Days)|Physician Decision|0|||
155466436|NCT00753623|561127850|FG000|Phase II (14 Days)|Physician Decision|0|||
155466437|NCT00753623|561127851|FG001|Phase II (14 Days)|Physician Decision|1|||
155466438|NCT03332303|561127852|FG000|Overall Study|Participant did not dose|1|||
155466439|NCT03332303|561127853|FG001|Overall Study|Participant did not dose|2|||
155466440|NCT03332303|561127854|FG002|Overall Study|Participant did not dose|0|||
155466441|NCT03332303|561127852|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
155466442|NCT03332303|561127853|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
155466443|NCT03332303|561127854|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
155466444|NCT03332303|561127852|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
155466445|NCT03332303|561127853|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
155466446|NCT03332303|561127854|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
155466447|NCT03332303|561127852|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
155466448|NCT03332303|561127853|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
155466449|NCT03332303|561127854|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
155466450|NCT03332303|561127852|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
155466451|NCT03332303|561127853|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
155466452|NCT03332303|561127854|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
155466453|NCT03332303|561127852|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
155466454|NCT03332303|561127853|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
155466455|NCT03332303|561127854|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
155517178|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
155517179|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
155517180|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
155517181|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
155517182|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
155517183|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
155517184|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
155517185|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
155517186|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
155517187|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
155517188|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
155517189|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
155517190|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
155517191|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
155517192|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
155517193|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
155517194|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
155517195|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
155517196|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
155517197|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
155517198|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
155517199|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
155517200|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
155517201|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
155517202|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
155517203|NCT02207231|561319586|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
155517204|NCT02207231|561319587|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
155517205|NCT02207231|561319588|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
155517206|NCT02207231|561319589|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
155517207|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
155517208|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
155517209|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
155517210|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
155517211|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
155517212|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
155517213|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
155466456|NCT03332303|561127852|FG000|Overall Study|Participant had a significant protocol deviation|0|||
155466457|NCT03332303|561127853|FG001|Overall Study|Participant had a significant protocol deviation|1|||
155466458|NCT03332303|561127854|FG002|Overall Study|Participant had a significant protocol deviation|0|||
155466459|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
155466460|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
155466461|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
155466462|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
155466463|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
155466464|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
155466465|NCT00996593|561127855|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
155466466|NCT00996593|561127855|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
155517214|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
155517215|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
155517216|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
155517217|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
155517218|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
155466467|NCT00996593|561127855|FG000|Long-Term Follow-Up|Site Closed|1|||
155466468|NCT00871572|561127856|FG000|Overall Study|Adverse Event|0|||
155466469|NCT00871572|561127857|FG001|Overall Study|Adverse Event|2|||
155466470|NCT00871572|561127858|FG002|Overall Study|Adverse Event|0|||
155466471|NCT00871572|561127859|FG003|Overall Study|Adverse Event|3|||
155466472|NCT00871572|561127856|FG000|Overall Study|Investigator Decision|0|||
155466473|NCT00871572|561127857|FG001|Overall Study|Investigator Decision|1|||
155466474|NCT00871572|561127858|FG002|Overall Study|Investigator Decision|0|||
155466475|NCT00871572|561127859|FG003|Overall Study|Investigator Decision|1|||
155466476|NCT00871572|561127856|FG000|Overall Study|Lost to Follow-up|0|||
155466477|NCT00871572|561127857|FG001|Overall Study|Lost to Follow-up|1|||
155466478|NCT00871572|561127858|FG002|Overall Study|Lost to Follow-up|0|||
155466479|NCT00871572|561127859|FG003|Overall Study|Lost to Follow-up|1|||
155466480|NCT00871572|561127856|FG000|Overall Study|Protocol Violation|0|||
155466481|NCT00871572|561127857|FG001|Overall Study|Protocol Violation|0|||
155466482|NCT00871572|561127858|FG002|Overall Study|Protocol Violation|1|||
155466483|NCT00871572|561127859|FG003|Overall Study|Protocol Violation|1|||
155466484|NCT00871572|561127856|FG000|Overall Study|Sponsor Decision|1|||
155466485|NCT00871572|561127857|FG001|Overall Study|Sponsor Decision|0|||
155466486|NCT00871572|561127858|FG002|Overall Study|Sponsor Decision|0|||
155466487|NCT00871572|561127859|FG003|Overall Study|Sponsor Decision|0|||
155466488|NCT00871572|561127856|FG000|Overall Study|Withdrawal by Subject|1|||
155466489|NCT00871572|561127857|FG001|Overall Study|Withdrawal by Subject|2|||
155466490|NCT00871572|561127858|FG002|Overall Study|Withdrawal by Subject|3|||
155466491|NCT00871572|561127859|FG003|Overall Study|Withdrawal by Subject|1|||
155466492|NCT00405652|561127864|FG000|Overall Study|Adverse Event|4|||
155466493|NCT00631540|561127867|FG000|Overall Study|Withdrawal by Subject|5|||
155466494|NCT00631540|561127867|FG000|Overall Study|Death|4|||
155466495|NCT00631540|561127867|FG000|Overall Study|Lost to Follow-up|2|||
155466496|NCT00631540|561127867|FG000|Overall Study|Core Lab Data Unavailable|3|||
155466497|NCT00795509|561127868|FG000|Overall Study|Protocol Violation|31|||
155466498|NCT00970268|561127869|FG000|Overall Study|Withdrawal by Subject|12|||
155466499|NCT00970268|561127870|FG001|Overall Study|Withdrawal by Subject|19|||
155466500|NCT00970268|561127869|FG000|Overall Study|Adverse Event|15|||
155466501|NCT00970268|561127870|FG001|Overall Study|Adverse Event|12|||
155466502|NCT00970268|561127869|FG000|Overall Study|Lack of Efficacy|3|||
155466503|NCT00970268|561127870|FG001|Overall Study|Lack of Efficacy|6|||
155466504|NCT00970268|561127869|FG000|Overall Study|Protocol Violation|4|||
155466505|NCT00970268|561127870|FG001|Overall Study|Protocol Violation|7|||
155466506|NCT00970268|561127869|FG000|Overall Study|Other Reason|3|||
155466507|NCT00970268|561127870|FG001|Overall Study|Other Reason|1|||
155466508|NCT00970268|561127869|FG000|Overall Study|COPD Exacerbation|4|||
155466509|NCT00970268|561127870|FG001|Overall Study|COPD Exacerbation|2|||
155466510|NCT00970268|561127869|FG000|Overall Study|Lost to Follow-up|1|||
155466511|NCT00970268|561127870|FG001|Overall Study|Lost to Follow-up|2|||
155466512|NCT00970268|561127869|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
155466513|NCT00970268|561127870|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
155466514|NCT01079195|561127871|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
155466515|NCT01079195|561127871|FG000|Overall Study|No Documentation Available|437|||
155466516|NCT01079195|561127871|FG000|Overall Study|Adverse Event|157|||
155466517|NCT01079195|561127871|FG000|Overall Study|Reason Unknown|39|||
155466518|NCT01079195|561127871|FG000|Overall Study|Withdrawal by Subject|18|||
155466519|NCT01079195|561127871|FG000|Overall Study|Financial Reasons|15|||
155466520|NCT01079195|561127871|FG000|Overall Study|Lack of Effectiveness|12|||
155466521|NCT01079195|561127871|FG000|Overall Study|Physician Decision|4|||
155466522|NCT01079195|561127871|FG000|Overall Study|Improved Status of Participant|4|||
155466523|NCT01079195|561127871|FG000|Overall Study|No Follow-up Documentation Available|4|||
155466524|NCT01079195|561127871|FG000|Overall Study|Non-compliance|2|||
155466525|NCT01999946|561127875|FG000|Overall Study|Participant not released from jail|2|||
155466526|NCT01999946|561127876|FG001|Overall Study|Participant not released from jail|2|||
155466527|NCT01999946|561127877|FG002|Overall Study|Participant not released from jail|0|||
155466528|NCT01999946|561127875|FG000|Overall Study|Not included in primary outcome analysis|0|||
155466529|NCT01999946|561127876|FG001|Overall Study|Not included in primary outcome analysis|0|||
155466530|NCT01999946|561127877|FG002|Overall Study|Not included in primary outcome analysis|79|||
155466531|NCT02687711|561129640|FG000|Overall Study|Adverse Event|89|||
155466532|NCT02687711|561129640|FG000|Overall Study|Lack of Efficacy|70|||
155466533|NCT02687711|561129640|FG000|Overall Study|Lost to Follow-up|20|||
155466534|NCT02687711|561129640|FG000|Overall Study|Consent withdrawn|15|||
155466535|NCT02687711|561129640|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
155466536|NCT02687711|561129640|FG000|Overall Study|Too expensive|4|||
155466537|NCT02687711|561129640|FG000|Overall Study|Participant moved abroad|1|||
155466538|NCT02687711|561129640|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
155466539|NCT02687711|561129640|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
155466540|NCT02687711|561129640|FG000|Overall Study|Disliked taste|1|||
155466541|NCT02687711|561129640|FG000|Overall Study|Low mood|1|||
155466542|NCT02687711|561129640|FG000|Overall Study|Side effects|1|||
155466543|NCT02687711|561129640|FG000|Overall Study|Change of Hospital|1|||
155466544|NCT02687711|561129640|FG000|Overall Study|Liver Encephalopathy|1|||
155466545|NCT02687711|561129640|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
155466546|NCT02687711|561129640|FG000|Overall Study|Withdrawn due to intake interruption|1|||
155466547|NCT02687711|561129640|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
155466548|NCT02687711|561129640|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
155466549|NCT02687711|561129640|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
155466550|NCT02038790|561129645|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
155466551|NCT02038790|561129646|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
155466552|NCT02431702|561129647|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
155466553|NCT02431702|561129648|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466554|NCT02431702|561129649|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466555|NCT02431702|561129650|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466556|NCT02431702|561129651|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466557|NCT02431702|561129652|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466558|NCT02431702|561129653|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
155466559|NCT02431702|561129647|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
155466560|NCT02431702|561129648|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
155466561|NCT02431702|561129649|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
155466562|NCT02431702|561129650|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
155466563|NCT02431702|561129651|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
155466564|NCT02431702|561129652|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
155466565|NCT02431702|561129653|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
155466566|NCT02431702|561129647|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
155466567|NCT02431702|561129648|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
155466568|NCT02431702|561129649|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
155466569|NCT02431702|561129650|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
155466570|NCT02431702|561129651|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
155466571|NCT02431702|561129652|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
155466572|NCT02431702|561129653|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
155466573|NCT02431702|561129647|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
155466574|NCT02431702|561129648|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
155466575|NCT02431702|561129649|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
155466576|NCT02431702|561129650|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
155466577|NCT02431702|561129651|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
155466578|NCT02431702|561129652|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
155466579|NCT02431702|561129653|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
155466580|NCT02431702|561129647|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
155466581|NCT02431702|561129648|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466582|NCT02431702|561129649|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466583|NCT02431702|561129650|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466584|NCT02431702|561129651|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466585|NCT02431702|561129652|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466586|NCT02431702|561129653|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155466587|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
155466588|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
155466589|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
155466590|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
155466591|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
155466592|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
155466593|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
155466594|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
155517219|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
155517220|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
155517221|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
155517222|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
155517223|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
155517224|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
155517225|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
155517226|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
155517227|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
155517228|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
155517229|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
155517230|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
155517231|NCT02207231|561319586|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
155466595|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
155466596|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
155466597|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
155466598|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
155466599|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
155466600|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
155466601|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
155466602|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
155466603|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
155466604|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
155466605|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
155466606|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
155466607|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
155466608|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466609|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
155466610|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466611|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466612|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466613|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466614|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
155466615|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
155466616|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
155466617|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
155466618|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
155466619|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
155466620|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
155466621|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
155466622|NCT02431702|561129647|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466623|NCT02431702|561129648|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466624|NCT02431702|561129649|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
155466625|NCT02431702|561129650|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466626|NCT02431702|561129651|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466627|NCT02431702|561129652|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466628|NCT02431702|561129653|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
155466629|NCT02431702|561129647|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
155466630|NCT02431702|561129648|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
155466631|NCT02431702|561129649|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
155466632|NCT02431702|561129650|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
155466633|NCT02431702|561129651|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
155466634|NCT02431702|561129652|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
155466635|NCT02431702|561129653|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
155466636|NCT02431702|561129647|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
155466637|NCT02431702|561129648|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
155466638|NCT02431702|561129649|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
155517232|NCT02207231|561319587|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
155517233|NCT02207231|561319588|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
155517234|NCT02207231|561319589|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
155517235|NCT01290263|561319593|FG000|Overall Study|Adverse Event|0|||
155517236|NCT01290263|561319594|FG001|Overall Study|Adverse Event|0|||
155517237|NCT01290263|561319595|FG002|Overall Study|Adverse Event|0|||
155517238|NCT01290263|561319596|FG003|Overall Study|Adverse Event|1|||
155517239|NCT01290263|561319597|FG004|Overall Study|Adverse Event|1|||
155517240|NCT01290263|561319593|FG000|Overall Study|Lack of Efficacy|8|||
155517241|NCT01290263|561319594|FG001|Overall Study|Lack of Efficacy|2|||
155517242|NCT01290263|561319595|FG002|Overall Study|Lack of Efficacy|7|||
155517243|NCT01290263|561319596|FG003|Overall Study|Lack of Efficacy|24|||
155517244|NCT01290263|561319597|FG004|Overall Study|Lack of Efficacy|33|||
155517245|NCT01290263|561319593|FG000|Overall Study|Withdrawal by Subject|3|||
155517246|NCT01290263|561319594|FG001|Overall Study|Withdrawal by Subject|1|||
155517247|NCT01290263|561319595|FG002|Overall Study|Withdrawal by Subject|0|||
155652741|NCT01557569|561822140|FG001|Overall Study|noncompliance with rules of residential|1|||
155652742|NCT01050218|561822141|FG000|Overall Study|Adverse Event|37|||
155517248|NCT01290263|561319596|FG003|Overall Study|Withdrawal by Subject|1|||
155517249|NCT01290263|561319597|FG004|Overall Study|Withdrawal by Subject|2|||
155517250|NCT01290263|561319593|FG000|Overall Study|Participant Non-Compliance|0|||
155517251|NCT01290263|561319594|FG001|Overall Study|Participant Non-Compliance|0|||
155517252|NCT01290263|561319595|FG002|Overall Study|Participant Non-Compliance|0|||
155466639|NCT02431702|561129650|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
155466640|NCT02431702|561129651|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
155466641|NCT02431702|561129652|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
155466642|NCT02431702|561129653|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
155466643|NCT02431702|561129647|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
155466644|NCT02431702|561129648|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
155466645|NCT02431702|561129649|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
155466646|NCT02431702|561129650|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
155466647|NCT02431702|561129651|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
155466648|NCT02431702|561129652|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
155466649|NCT02431702|561129653|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
155466650|NCT02431702|561129647|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
155466651|NCT02431702|561129648|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
155466652|NCT02431702|561129649|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
155466653|NCT02431702|561129650|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
155466654|NCT02431702|561129651|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
155517253|NCT01290263|561319596|FG003|Overall Study|Participant Non-Compliance|1|||
155466655|NCT02431702|561129652|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
155466656|NCT02431702|561129653|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
155466657|NCT03907969|561129654|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
155466658|NCT03907969|561129655|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
155466659|NCT03907969|561129656|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
155466660|NCT03907969|561129657|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
155466661|NCT03907969|561129658|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
155466662|NCT03907969|561129659|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
155466663|NCT03907969|561129660|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
155466664|NCT03907969|561129661|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
155466665|NCT03907969|561129662|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
155466666|NCT03907969|561129663|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
155466667|NCT03907969|561129664|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
155466668|NCT03907969|561129654|FG000|Monotherapy Part A|Progressive Disease|0|||
155466669|NCT03907969|561129655|FG001|Monotherapy Part A|Progressive Disease|1|||
155466670|NCT03907969|561129656|FG002|Monotherapy Part A|Progressive Disease|0|||
155466671|NCT03907969|561129657|FG003|Monotherapy Part A|Progressive Disease|0|||
155466672|NCT03907969|561129658|FG004|Monotherapy Part A|Progressive Disease|0|||
155466673|NCT03907969|561129659|FG005|Monotherapy Part A|Progressive Disease|1|||
155466674|NCT03907969|561129660|FG006|Monotherapy Part A|Progressive Disease|2|||
155466675|NCT03907969|561129661|FG007|Monotherapy Part A|Progressive Disease|0|||
155466676|NCT03907969|561129662|FG008|Monotherapy Part A|Progressive Disease|0|||
155466677|NCT03907969|561129663|FG009|Monotherapy Part A|Progressive Disease|0|||
155466678|NCT03907969|561129664|FG010|Monotherapy Part A|Progressive Disease|0|||
155466679|NCT03907969|561129654|FG000|Monotherapy Part A|Death|0|||
155466680|NCT03907969|561129655|FG001|Monotherapy Part A|Death|0|||
155466681|NCT03907969|561129656|FG002|Monotherapy Part A|Death|1|||
155466682|NCT03907969|561129657|FG003|Monotherapy Part A|Death|1|||
155466683|NCT03907969|561129658|FG004|Monotherapy Part A|Death|0|||
155466684|NCT03907969|561129659|FG005|Monotherapy Part A|Death|1|||
155466685|NCT03907969|561129660|FG006|Monotherapy Part A|Death|0|||
155466686|NCT03907969|561129661|FG007|Monotherapy Part A|Death|0|||
155466687|NCT03907969|561129662|FG008|Monotherapy Part A|Death|0|||
155466688|NCT03907969|561129663|FG009|Monotherapy Part A|Death|0|||
155466689|NCT03907969|561129664|FG010|Monotherapy Part A|Death|0|||
155466690|NCT03907969|561129654|FG000|Combination Therapy Part A|Adverse Event|0|||
155466691|NCT03907969|561129655|FG001|Combination Therapy Part A|Adverse Event|0|||
155466692|NCT03907969|561129656|FG002|Combination Therapy Part A|Adverse Event|0|||
155466693|NCT03907969|561129657|FG003|Combination Therapy Part A|Adverse Event|0|||
155466694|NCT03907969|561129658|FG004|Combination Therapy Part A|Adverse Event|0|||
155466695|NCT03907969|561129659|FG005|Combination Therapy Part A|Adverse Event|0|||
155466696|NCT03907969|561129660|FG006|Combination Therapy Part A|Adverse Event|0|||
155466697|NCT03907969|561129661|FG007|Combination Therapy Part A|Adverse Event|0|||
155466698|NCT03907969|561129662|FG008|Combination Therapy Part A|Adverse Event|0|||
155466699|NCT03907969|561129663|FG009|Combination Therapy Part A|Adverse Event|1|||
155466700|NCT03907969|561129664|FG010|Combination Therapy Part A|Adverse Event|1|||
155466701|NCT03907969|561129654|FG000|Combination Therapy Part A|Progressive disease|0|||
155466702|NCT03907969|561129655|FG001|Combination Therapy Part A|Progressive disease|0|||
155466703|NCT03907969|561129656|FG002|Combination Therapy Part A|Progressive disease|0|||
155466704|NCT03907969|561129657|FG003|Combination Therapy Part A|Progressive disease|0|||
155466705|NCT03907969|561129658|FG004|Combination Therapy Part A|Progressive disease|0|||
155466706|NCT03907969|561129659|FG005|Combination Therapy Part A|Progressive disease|0|||
155466707|NCT03907969|561129660|FG006|Combination Therapy Part A|Progressive disease|0|||
155466708|NCT03907969|561129661|FG007|Combination Therapy Part A|Progressive disease|1|||
155466709|NCT03907969|561129662|FG008|Combination Therapy Part A|Progressive disease|0|||
155466710|NCT03907969|561129663|FG009|Combination Therapy Part A|Progressive disease|2|||
155466711|NCT03907969|561129664|FG010|Combination Therapy Part A|Progressive disease|3|||
155466712|NCT03907969|561129654|FG000|Combination Therapy Part A|Death|0|||
155466713|NCT03907969|561129655|FG001|Combination Therapy Part A|Death|0|||
155466714|NCT03907969|561129656|FG002|Combination Therapy Part A|Death|0|||
155466715|NCT03907969|561129657|FG003|Combination Therapy Part A|Death|0|||
155466716|NCT03907969|561129658|FG004|Combination Therapy Part A|Death|0|||
155466717|NCT03907969|561129659|FG005|Combination Therapy Part A|Death|0|||
155466718|NCT03907969|561129660|FG006|Combination Therapy Part A|Death|0|||
155466719|NCT03907969|561129661|FG007|Combination Therapy Part A|Death|0|||
155466720|NCT03907969|561129662|FG008|Combination Therapy Part A|Death|1|||
155466721|NCT03907969|561129663|FG009|Combination Therapy Part A|Death|0|||
155466722|NCT03907969|561129664|FG010|Combination Therapy Part A|Death|1|||
155466723|NCT03907969|561129654|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
155466724|NCT03907969|561129655|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
155466725|NCT03907969|561129656|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
155466726|NCT03907969|561129657|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
155466727|NCT03907969|561129658|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
155466728|NCT03907969|561129659|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
155466729|NCT03907969|561129660|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
155466730|NCT03907969|561129661|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
155466731|NCT03907969|561129662|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
155466732|NCT03907969|561129663|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
155466733|NCT03907969|561129664|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
155466734|NCT03907969|561129654|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
155466735|NCT03907969|561129655|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
155652743|NCT01050218|561822141|FG000|Overall Study|Lack of Efficacy|8|||
155652744|NCT01050218|561822141|FG000|Overall Study|Protocol Violation|3|||
155652745|NCT01050218|561822141|FG000|Overall Study|Withdrawal by Subject|18|||
155652746|NCT01050218|561822141|FG000|Overall Study|Discontinued by sponsor|18|||
155652747|NCT01050218|561822141|FG000|Overall Study|Compliance|2|||
155652748|NCT01050218|561822141|FG000|Overall Study|Failed to return|7|||
155652749|NCT01050218|561822141|FG000|Overall Study|Serious Adverse Event|1|||
155652750|NCT01050218|561822141|FG000|Overall Study|Family emergency|1|||
155652751|NCT03682367|561822144|FG000|Overall Study|Protocol Violation|2|||
155466736|NCT03907969|561129656|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
155466737|NCT03907969|561129657|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
155466738|NCT03907969|561129658|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
155466739|NCT03907969|561129659|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
155466740|NCT03907969|561129660|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
155466741|NCT03907969|561129661|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
155466742|NCT03907969|561129662|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
155466743|NCT03907969|561129663|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
155466744|NCT03907969|561129664|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
155652752|NCT03682367|561822145|FG001|Overall Study|Protocol Violation|1|||
155652753|NCT03682367|561822144|FG000|Overall Study|Closed Study Early|0|||
155652754|NCT03682367|561822145|FG001|Overall Study|Closed Study Early|3|||
155466745|NCT03907969|561129654|FG000|Combination Therapy Part A|Physician Decision|0|||
155466746|NCT03907969|561129655|FG001|Combination Therapy Part A|Physician Decision|0|||
155466747|NCT03907969|561129656|FG002|Combination Therapy Part A|Physician Decision|0|||
155466748|NCT03907969|561129657|FG003|Combination Therapy Part A|Physician Decision|0|||
155466749|NCT03907969|561129658|FG004|Combination Therapy Part A|Physician Decision|0|||
155466750|NCT03907969|561129659|FG005|Combination Therapy Part A|Physician Decision|0|||
155652755|NCT00756314|561822146|FG000|Overall Study|Lost to Follow-up|2|||
155652756|NCT00756314|561822147|FG001|Overall Study|Lost to Follow-up|59|||
155652757|NCT02872142|561822148|FG000|Overall Study|Adverse Event|2|||
155466751|NCT03907969|561129660|FG006|Combination Therapy Part A|Physician Decision|0|||
155466752|NCT03907969|561129661|FG007|Combination Therapy Part A|Physician Decision|1|||
155466753|NCT03907969|561129662|FG008|Combination Therapy Part A|Physician Decision|0|||
155466754|NCT03907969|561129663|FG009|Combination Therapy Part A|Physician Decision|0|||
155466755|NCT03907969|561129664|FG010|Combination Therapy Part A|Physician Decision|1|||
155466756|NCT04209530|561129666|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
155466757|NCT04209530|561129667|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
155466758|NCT04209530|561129666|FG000|Overall Study|Withdrawal by Subject|0|||
155466759|NCT04209530|561129667|FG001|Overall Study|Withdrawal by Subject|1|||
155466760|NCT00633893|561129668|FG000|Overall Study|Death|1|||
155466761|NCT00633893|561129669|FG001|Overall Study|Death|3|||
155466762|NCT00633893|561129670|FG002|Overall Study|Death|9|||
155466763|NCT00633893|561129668|FG000|Overall Study|Adverse Event|65|||
155466764|NCT00633893|561129669|FG001|Overall Study|Adverse Event|58|||
155466765|NCT00633893|561129670|FG002|Overall Study|Adverse Event|126|||
155466766|NCT00633893|561129668|FG000|Overall Study|Withdrawal by Subject|7|||
155466767|NCT00633893|561129669|FG001|Overall Study|Withdrawal by Subject|12|||
155466768|NCT00633893|561129670|FG002|Overall Study|Withdrawal by Subject|6|||
155466769|NCT00633893|561129668|FG000|Overall Study|Lost to Follow-up|2|||
155466770|NCT00633893|561129669|FG001|Overall Study|Lost to Follow-up|4|||
155466771|NCT00633893|561129670|FG002|Overall Study|Lost to Follow-up|8|||
155466772|NCT00633893|561129668|FG000|Overall Study|Poor/non-compliance|5|||
155466773|NCT00633893|561129669|FG001|Overall Study|Poor/non-compliance|12|||
155466774|NCT00633893|561129670|FG002|Overall Study|Poor/non-compliance|3|||
155466775|NCT00633893|561129668|FG000|Overall Study|Pregnancy|2|||
155466776|NCT00633893|561129669|FG001|Overall Study|Pregnancy|1|||
155466777|NCT00633893|561129670|FG002|Overall Study|Pregnancy|1|||
155466778|NCT00633893|561129668|FG000|Overall Study|Not meet/no longer meets criteria|4|||
155466779|NCT00633893|561129669|FG001|Overall Study|Not meet/no longer meets criteria|6|||
155466780|NCT00633893|561129670|FG002|Overall Study|Not meet/no longer meets criteria|4|||
155466781|NCT00633893|561129668|FG000|Overall Study|Other|28|||
155466782|NCT00633893|561129669|FG001|Overall Study|Other|33|||
155466783|NCT00633893|561129670|FG002|Overall Study|Other|31|||
155466784|NCT02044822|561129671|FG000|Overall Study|Study Terminated by Sponsor|77|||
155466785|NCT02044822|561129671|FG000|Overall Study|Investigator's Discretion|10|||
155466786|NCT02044822|561129671|FG000|Overall Study|Withdrew Consent|3|||
155466787|NCT02044822|561129671|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
155466788|NCT02044822|561129671|FG000|Overall Study|Lost to Follow-up|1|||
155466789|NCT02025530|561129674|FG000|Overall Study|No longer met elligibility criteria|5|||
155466790|NCT02025530|561129675|FG001|Overall Study|No longer met elligibility criteria|1|||
155466791|NCT03551626|561129676|FG000|Overall Study|Adverse Event|88|||
155466792|NCT03551626|561129676|FG000|Overall Study|Disease relapse|18|||
155466793|NCT03551626|561129676|FG000|Overall Study|Withdrawal of informed consent|6|||
155466794|NCT03551626|561129676|FG000|Overall Study|Patient decision|5|||
155466795|NCT03551626|561129676|FG000|Overall Study|Physician Decision|4|||
155466796|NCT03551626|561129676|FG000|Overall Study|Lost to Follow-up|3|||
155466797|NCT03551626|561129676|FG000|Overall Study|Pregnancy|1|||
155466798|NCT03551626|561129676|FG000|Overall Study|Protocol deviation|1|||
155466799|NCT03551626|561129676|FG000|Overall Study|Technical problems|1|||
155466800|NCT00653328|561129677|FG000|Overall Study|Withdrawal by Subject|1|||
155466801|NCT00653328|561129677|FG000|Overall Study|Adverse Event|2|||
155466802|NCT00653328|561129677|FG000|Overall Study|Disease progression|10|||
155466803|NCT00653328|561129677|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
155466804|NCT01237223|561129684|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
155466805|NCT01237223|561129685|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
155466806|NCT01237223|561129686|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
155466807|NCT01237223|561129687|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
155466808|NCT01237223|561129688|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
155466809|NCT01237223|561129689|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
155466810|NCT01237223|561129684|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
155466811|NCT01237223|561129685|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
155466812|NCT01237223|561129686|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
155466813|NCT01237223|561129687|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
155466814|NCT01237223|561129688|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
155466815|NCT01237223|561129689|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
155466816|NCT01237223|561129684|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
155466817|NCT01237223|561129685|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
155517254|NCT01290263|561319597|FG004|Overall Study|Participant Non-Compliance|1|||
155466818|NCT01237223|561129686|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
155466819|NCT01237223|561129687|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
155466820|NCT01237223|561129688|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
155466821|NCT01237223|561129689|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
155466822|NCT01237223|561129684|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
155466823|NCT01237223|561129685|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
155466824|NCT01237223|561129686|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
155466825|NCT01237223|561129687|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
155466826|NCT01237223|561129688|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
155466827|NCT01237223|561129689|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
155466828|NCT01237223|561129684|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
155466829|NCT01237223|561129685|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
155466830|NCT01237223|561129686|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
155466831|NCT01237223|561129687|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
155466832|NCT01237223|561129688|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
155466833|NCT01237223|561129689|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
155466834|NCT01237223|561129684|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
155466835|NCT01237223|561129685|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
155466836|NCT01237223|561129686|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
155466837|NCT01237223|561129687|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
155466838|NCT01237223|561129688|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
155466839|NCT01237223|561129689|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
155466840|NCT01237223|561129684|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
155466841|NCT01237223|561129685|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
155466842|NCT01237223|561129686|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
155466843|NCT01237223|561129687|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
155466844|NCT01237223|561129688|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
155466845|NCT01237223|561129689|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
155466846|NCT01237223|561129684|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
155466847|NCT01237223|561129685|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
155466848|NCT01237223|561129686|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
155466849|NCT01237223|561129687|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
155466850|NCT01237223|561129688|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
155466851|NCT01237223|561129689|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
155466852|NCT01237223|561129684|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
155466853|NCT01237223|561129685|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
155466854|NCT01237223|561129686|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
155466855|NCT01237223|561129687|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
155466856|NCT01237223|561129688|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
155466857|NCT01237223|561129689|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
155466858|NCT01237223|561129684|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
155466859|NCT01237223|561129685|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
155466860|NCT01237223|561129686|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
155466861|NCT01237223|561129687|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
155466862|NCT01237223|561129688|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
155466863|NCT01237223|561129689|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
155466864|NCT01017549|561129692|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
155466865|NCT01017549|561129692|FG000|One-year Follow-up|Lost to Follow-up|2|||
155466866|NCT01017549|561129692|FG000|One-year Follow-up|Withdrawal by Subject|5|||
155466867|NCT01017549|561129692|FG000|5 Year Follow-up|Lost to Follow-up|9|||
155466868|NCT01017549|561129692|FG000|5 Year Follow-up|Mastectomy|3|||
155466869|NCT00443846|561129694|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
155466870|NCT00443846|561129695|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
155466871|NCT00443846|561129694|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
155466872|NCT00443846|561129695|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
155466873|NCT00443846|561129694|FG000|Overall Study|Adverse Event|0|||
155466874|NCT00443846|561129695|FG001|Overall Study|Adverse Event|1|||
155466875|NCT00443846|561129694|FG000|Overall Study|Personal reason|8|||
155466876|NCT00443846|561129695|FG001|Overall Study|Personal reason|3|||
155466877|NCT00443846|561129694|FG000|Overall Study|Lost to Follow-up|1|||
155466878|NCT00443846|561129695|FG001|Overall Study|Lost to Follow-up|2|||
155517255|NCT02309099|561319600|FG000|Overall Study|Adverse Event|2|||
155517256|NCT02309099|561319601|FG001|Overall Study|Adverse Event|0|||
155517257|NCT02819362|561319603|FG000|Overall Study|On-site MRI could not be performed|70|||
155466879|NCT00391807|561129704|FG000|Overall Study|Did not receive study medication|23|||
155466880|NCT00391807|561129704|FG000|Overall Study|Adverse Event|177|||
155466881|NCT00391807|561129704|FG000|Overall Study|Pregnancy|25|||
155466882|NCT00391807|561129704|FG000|Overall Study|Lost to Follow-up|227|||
155466883|NCT00391807|561129704|FG000|Overall Study|Withdrawal by Subject|147|||
155466884|NCT00391807|561129704|FG000|Overall Study|Protocol Violation|20|||
155466885|NCT00391807|561129704|FG000|Overall Study|Various|96|||
155466886|NCT05441540|561129707|FG000|Overall Study|Withdrawal by Subject|2|||
155466887|NCT00813917|561129708|FG000|Overall Study|Adverse Event|0|||
155466888|NCT00813917|561129709|FG001|Overall Study|Adverse Event|1|||
155466889|NCT00813917|561129708|FG000|Overall Study|Withdrawal by Subject|3|||
155466890|NCT00813917|561129709|FG001|Overall Study|Withdrawal by Subject|4|||
155466891|NCT00813917|561129708|FG000|Overall Study|Lost to Follow-up|3|||
155466892|NCT00813917|561129709|FG001|Overall Study|Lost to Follow-up|1|||
155466893|NCT04539262|561129712|FG000|Overall Study|Adverse Event|0|||
155466894|NCT04539262|561129713|FG001|Overall Study|Adverse Event|0|||
155466895|NCT04539262|561129714|FG002|Overall Study|Adverse Event|1|||
155466896|NCT04539262|561129715|FG003|Overall Study|Adverse Event|0|||
155466897|NCT04539262|561129716|FG004|Overall Study|Adverse Event|0|||
155466898|NCT04539262|561129717|FG005|Overall Study|Adverse Event|0|||
155466899|NCT04539262|561129718|FG006|Overall Study|Adverse Event|0|||
155466900|NCT04539262|561129719|FG007|Overall Study|Adverse Event|0|||
155466901|NCT04539262|561129712|FG000|Overall Study|Withdrew Consent|0|||
155466902|NCT04539262|561129713|FG001|Overall Study|Withdrew Consent|0|||
155466903|NCT04539262|561129714|FG002|Overall Study|Withdrew Consent|0|||
155466904|NCT04539262|561129715|FG003|Overall Study|Withdrew Consent|1|||
155466905|NCT04539262|561129716|FG004|Overall Study|Withdrew Consent|0|||
155466906|NCT04539262|561129717|FG005|Overall Study|Withdrew Consent|0|||
155466907|NCT04539262|561129718|FG006|Overall Study|Withdrew Consent|0|||
155466908|NCT04539262|561129719|FG007|Overall Study|Withdrew Consent|0|||
155466909|NCT04539262|561129712|FG000|Overall Study|Randomized, Not treated|0|||
155466910|NCT04539262|561129713|FG001|Overall Study|Randomized, Not treated|1|||
155466911|NCT04539262|561129714|FG002|Overall Study|Randomized, Not treated|0|||
155466912|NCT04539262|561129715|FG003|Overall Study|Randomized, Not treated|0|||
155466913|NCT04539262|561129716|FG004|Overall Study|Randomized, Not treated|0|||
155517258|NCT01545076|561319604|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
155517259|NCT01545076|561319605|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
155517260|NCT01545076|561319606|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
155517261|NCT01545076|561319607|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
155517262|NCT01545076|561319608|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
155517263|NCT01545076|561319604|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
155517264|NCT01545076|561319605|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
155517265|NCT01545076|561319606|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
155517266|NCT01545076|561319607|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
155517267|NCT01545076|561319608|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
155652758|NCT02872142|561822148|FG000|Overall Study|Death|1|||
155652759|NCT02872142|561822148|FG000|Overall Study|Participant Decision|3|||
155466914|NCT04539262|561129717|FG005|Overall Study|Randomized, Not treated|0|||
155466915|NCT04539262|561129718|FG006|Overall Study|Randomized, Not treated|1|||
155517268|NCT01545076|561319604|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
155652760|NCT00309946|561822149|FG000|Overall Study|Withdrawal by Subject|1|||
155652761|NCT02244957|561822150|FG000|Overall Study|Lack of Efficacy|1|||
155652762|NCT02244957|561822151|FG001|Overall Study|Lack of Efficacy|0|||
155652763|NCT04691115|561822154|FG000|Overall Study|Withdrawal by Subject|0|||
155652764|NCT04691115|561822155|FG001|Overall Study|Withdrawal by Subject|0|||
155652765|NCT04691115|561822156|FG002|Overall Study|Withdrawal by Subject|0|||
155652766|NCT04691115|561822157|FG003|Overall Study|Withdrawal by Subject|0|||
155652767|NCT04691115|561822158|FG004|Overall Study|Withdrawal by Subject|0|||
155652768|NCT04691115|561822159|FG005|Overall Study|Withdrawal by Subject|1|||
155652769|NCT04691115|561822160|FG006|Overall Study|Withdrawal by Subject|0|||
155652770|NCT04691115|561822161|FG007|Overall Study|Withdrawal by Subject|0|||
155652771|NCT04691115|561822162|FG008|Overall Study|Withdrawal by Subject|0|||
155652772|NCT04691115|561822163|FG009|Overall Study|Withdrawal by Subject|0|||
155652773|NCT04691115|561822164|FG010|Overall Study|Withdrawal by Subject|0|||
155652774|NCT04691115|561822165|FG011|Overall Study|Withdrawal by Subject|0|||
155652775|NCT04691115|561822166|FG012|Overall Study|Withdrawal by Subject|0|||
155652776|NCT04691115|561822167|FG013|Overall Study|Withdrawal by Subject|0|||
155466916|NCT04539262|561129719|FG007|Overall Study|Randomized, Not treated|0|||
155466917|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
155466918|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
155466919|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
155466920|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
155466921|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
155466922|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
155466923|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
155466924|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
155466925|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
155652777|NCT00830336|561822171|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
155652778|NCT00830336|561822172|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
155652779|NCT01437189|561822173|FG000|Overall Study|Adverse Event|3|||
155652780|NCT01437189|561822173|FG000|Overall Study|Lack of Efficacy|4|||
155652781|NCT01437189|561822173|FG000|Overall Study|Withdrawal by Subject|8|||
155652782|NCT03032484|561822174|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
155652783|NCT03032484|561822175|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
155652784|NCT03032484|561822174|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
155652785|NCT03032484|561822175|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
155652786|NCT01689649|561822176|FG000|Overall Study|Lack of Efficacy|3|||
155652787|NCT01689649|561822176|FG000|Overall Study|Non-compliance|11|||
155652788|NCT01689649|561822176|FG000|Overall Study|Protocol Violation|3|||
155652789|NCT01689649|561822176|FG000|Overall Study|Lost to Follow-up|5|||
155652790|NCT01725282|561822179|FG000|Overall Study|Adverse Event|1|||
155652791|NCT01725282|561822180|FG001|Overall Study|Adverse Event|3|||
155652792|NCT01725282|561822181|FG002|Overall Study|Adverse Event|6|||
155652793|NCT01725282|561822182|FG003|Overall Study|Adverse Event|4|||
155652794|NCT01725282|561822179|FG000|Overall Study|Exacerbation of Target Disease|1|||
155652795|NCT01725282|561822180|FG001|Overall Study|Exacerbation of Target Disease|0|||
155652796|NCT01725282|561822181|FG002|Overall Study|Exacerbation of Target Disease|0|||
155652797|NCT01725282|561822182|FG003|Overall Study|Exacerbation of Target Disease|1|||
155652798|NCT01725282|561822179|FG000|Overall Study|Met Exclusion Criteria|0|||
155652799|NCT01725282|561822180|FG001|Overall Study|Met Exclusion Criteria|0|||
155652800|NCT01725282|561822181|FG002|Overall Study|Met Exclusion Criteria|1|||
155652801|NCT01725282|561822182|FG003|Overall Study|Met Exclusion Criteria|0|||
155652802|NCT01725282|561822179|FG000|Overall Study|Study Site Withdrawal|0|||
155652803|NCT01725282|561822180|FG001|Overall Study|Study Site Withdrawal|1|||
155652804|NCT01725282|561822181|FG002|Overall Study|Study Site Withdrawal|0|||
155652805|NCT01725282|561822182|FG003|Overall Study|Study Site Withdrawal|0|||
155652806|NCT01725282|561822179|FG000|Overall Study|Withdrawal by Subject|0|||
155652807|NCT01725282|561822180|FG001|Overall Study|Withdrawal by Subject|0|||
155652808|NCT01725282|561822181|FG002|Overall Study|Withdrawal by Subject|1|||
155652809|NCT01725282|561822182|FG003|Overall Study|Withdrawal by Subject|1|||
155652810|NCT01725282|561822179|FG000|Overall Study|Lack of Efficacy|0|||
155652811|NCT01725282|561822180|FG001|Overall Study|Lack of Efficacy|1|||
155652812|NCT01725282|561822181|FG002|Overall Study|Lack of Efficacy|0|||
155652813|NCT01725282|561822182|FG003|Overall Study|Lack of Efficacy|1|||
155466926|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
155466927|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
155652814|NCT01646216|561822190|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
155652815|NCT01646216|561822191|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
155652816|NCT01646216|561822190|FG000|Overall Study|Did not complete training|0|||
155652817|NCT01646216|561822191|FG001|Overall Study|Did not complete training|2|||
155652818|NCT01646216|561822190|FG000|Overall Study|Investigator decision|1|||
155652819|NCT01646216|561822191|FG001|Overall Study|Investigator decision|1|||
155652820|NCT00113373|561822192|FG000|Overall Study|Ineligible: wrong primary|1|||
155652821|NCT00113373|561822192|FG000|Overall Study|Ineligible: second primary|1|||
155466928|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
155652822|NCT00113373|561822192|FG000|Overall Study|Never Treated|1|||
155517269|NCT01545076|561319605|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
155517270|NCT01545076|561319606|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
155517271|NCT01545076|561319607|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
155517272|NCT01545076|561319608|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
155517273|NCT01545076|561319604|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
155517274|NCT01545076|561319605|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
155517275|NCT01545076|561319606|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
155517276|NCT01545076|561319607|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
155517277|NCT01545076|561319608|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
155517278|NCT01545076|561319604|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
155517279|NCT01545076|561319605|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
155517280|NCT01545076|561319606|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
155517281|NCT01545076|561319607|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
155517282|NCT01545076|561319608|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
155517283|NCT01545076|561319604|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
155517284|NCT01545076|561319605|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
155517285|NCT01545076|561319606|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
155517286|NCT01545076|561319607|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
155517287|NCT01545076|561319608|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
155517288|NCT01545076|561319604|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
155517289|NCT01545076|561319605|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
155517290|NCT01545076|561319606|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
155517291|NCT01545076|561319607|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
155517292|NCT01545076|561319608|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
155517293|NCT01545076|561319604|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
155517294|NCT01545076|561319605|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
155517295|NCT01545076|561319606|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
155517296|NCT01545076|561319607|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
155517297|NCT01545076|561319608|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
155517298|NCT01545076|561319604|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
155517299|NCT01545076|561319605|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
155517300|NCT01545076|561319606|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
155517301|NCT01545076|561319607|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
155517302|NCT01545076|561319608|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
155517303|NCT00262600|561319609|FG000|Overall Study|Lost to Follow-up|17|||
155517304|NCT00262600|561319610|FG001|Overall Study|Lost to Follow-up|31|||
155517305|NCT00262600|561319611|FG002|Overall Study|Lost to Follow-up|41|||
155652823|NCT02395627|561822193|FG000|Overall Study|Withdrawal by Subject|0|||
155517306|NCT00262600|561319609|FG000|Overall Study|Withdrawal by Subject|128|||
155517307|NCT00262600|561319610|FG001|Overall Study|Withdrawal by Subject|145|||
155517308|NCT00262600|561319611|FG002|Overall Study|Withdrawal by Subject|139|||
155517309|NCT00262600|561319609|FG000|Overall Study|Not Treated|32|||
155517310|NCT00262600|561319610|FG001|Overall Study|Not Treated|17|||
155517311|NCT00262600|561319611|FG002|Overall Study|Not Treated|24|||
155517312|NCT00262600|561319609|FG000|Overall Study|Other|58|||
155517313|NCT00262600|561319610|FG001|Overall Study|Other|59|||
155517314|NCT00262600|561319611|FG002|Overall Study|Other|62|||
155517315|NCT02710123|561319612|FG000|Overall Study|Lost to Follow-up|3|||
155517316|NCT02710123|561319613|FG001|Overall Study|Lost to Follow-up|4|||
155517317|NCT02710123|561319612|FG000|Overall Study|Withdrawal by Subject|1|||
155517318|NCT02710123|561319613|FG001|Overall Study|Withdrawal by Subject|1|||
155517319|NCT02710123|561319612|FG000|Overall Study|Illness unrelated to study intervention|1|||
155517320|NCT02710123|561319613|FG001|Overall Study|Illness unrelated to study intervention|0|||
155517321|NCT05381948|561319614|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
155517322|NCT05381948|561319615|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
155517323|NCT05381948|561319616|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
155517324|NCT05381948|561319614|FG000|Overall Study|Adverse Event: Non-ocular|0|||
155517325|NCT05381948|561319615|FG001|Overall Study|Adverse Event: Non-ocular|1|||
155517326|NCT05381948|561319616|FG002|Overall Study|Adverse Event: Non-ocular|0|||
155517327|NCT05381948|561319614|FG000|Overall Study|Lost to Follow-up|1|||
155517328|NCT05381948|561319615|FG001|Overall Study|Lost to Follow-up|0|||
155517329|NCT05381948|561319616|FG002|Overall Study|Lost to Follow-up|0|||
155517330|NCT05381948|561319614|FG000|Overall Study|Protocol Deviation|0|||
155517331|NCT05381948|561319615|FG001|Overall Study|Protocol Deviation|2|||
155517332|NCT05381948|561319616|FG002|Overall Study|Protocol Deviation|0|||
155517333|NCT05381948|561319614|FG000|Overall Study|Withdrawal by Subject|1|||
155517334|NCT05381948|561319615|FG001|Overall Study|Withdrawal by Subject|0|||
155517335|NCT05381948|561319616|FG002|Overall Study|Withdrawal by Subject|1|||
155517336|NCT05381948|561319614|FG000|Overall Study|Death|0|||
155517337|NCT05381948|561319615|FG001|Overall Study|Death|2|||
155517338|NCT05381948|561319616|FG002|Overall Study|Death|0|||
155517339|NCT05381948|561319614|FG000|Overall Study|Discontinued study without receiving study drug|0|||
155517340|NCT05381948|561319615|FG001|Overall Study|Discontinued study without receiving study drug|0|||
155517341|NCT05381948|561319616|FG002|Overall Study|Discontinued study without receiving study drug|1|||
155517342|NCT04471207|561319617|FG000|Overall Study|Lost to Follow-up|4|||
155517343|NCT04471207|561319618|FG001|Overall Study|Lost to Follow-up|1|||
155517344|NCT04471207|561319617|FG000|Overall Study|Medication Contraindication|0|||
155517345|NCT04471207|561319618|FG001|Overall Study|Medication Contraindication|1|||
155517346|NCT04471207|561319617|FG000|Overall Study|Loss of Interest|2|||
155517347|NCT04471207|561319618|FG001|Overall Study|Loss of Interest|1|||
155517348|NCT04471207|561319617|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
155517349|NCT04471207|561319618|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
155517350|NCT04471207|561319617|FG000|Overall Study|Scheduling Conflicts|3|||
155517351|NCT04471207|561319618|FG001|Overall Study|Scheduling Conflicts|1|||
155517352|NCT04471207|561319617|FG000|Overall Study|Physician Decision|1|||
155517353|NCT04471207|561319618|FG001|Overall Study|Physician Decision|0|||
155517354|NCT04471207|561319617|FG000|Overall Study|Unwilling to Use System|0|||
155517355|NCT04471207|561319618|FG001|Overall Study|Unwilling to Use System|1|||
155517356|NCT02132247|561319621|FG000|Overall Study|Protocol Violation|1|||
155517357|NCT02132247|561319622|FG001|Overall Study|Protocol Violation|0|||
155466929|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
155466930|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
155466931|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
155466932|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
155466933|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
155466934|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
155466935|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
155466936|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
155466937|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
155466938|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
155466939|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
155466940|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
155466941|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
155466942|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Other|1|||
155466943|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Other|0|||
155466944|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Other|0|||
155466945|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Other|0|||
155466946|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Other|1|||
155466947|NCT02980692|561129722|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
155466948|NCT02980692|561129723|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
155466949|NCT02980692|561129724|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
155466950|NCT02980692|561129725|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
155466951|NCT02980692|561129726|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
155466952|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Adverse Event|0|||
155466953|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Adverse Event|0|||
155466954|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Adverse Event|0|||
155466955|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Adverse Event|1|||
155466956|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Adverse Event|1|||
155466957|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
155466958|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
155466959|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
155466960|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
155466961|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
155466962|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
155466963|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
155466964|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
155466965|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
155466966|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
155466967|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Pregnancy|0|||
155466968|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Pregnancy|0|||
155466969|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Pregnancy|1|||
155466970|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Pregnancy|1|||
155466971|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Pregnancy|0|||
155466972|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
155466973|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
155466974|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
155466975|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
155466976|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
155466977|NCT02980692|561129722|FG000|Double-blind Follow-up Period|Other|0|||
155466978|NCT02980692|561129723|FG001|Double-blind Follow-up Period|Other|0|||
155466979|NCT02980692|561129724|FG002|Double-blind Follow-up Period|Other|1|||
155466980|NCT02980692|561129725|FG003|Double-blind Follow-up Period|Other|1|||
155466981|NCT02980692|561129726|FG004|Double-blind Follow-up Period|Other|3|||
155466982|NCT04702984|561129736|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
155466983|NCT03725293|561129737|FG000|Overall Study|Physician Decision|9|||
155466984|NCT03725293|561129738|FG001|Overall Study|Physician Decision|6|||
155466985|NCT03725293|561129737|FG000|Overall Study|alternative vascular access needs|1|||
155466986|NCT03725293|561129738|FG001|Overall Study|alternative vascular access needs|2|||
155466987|NCT03725293|561129737|FG000|Overall Study|venous anatomy screen failures|2|||
155466988|NCT03725293|561129738|FG001|Overall Study|venous anatomy screen failures|1|||
155466989|NCT03862495|561129739|FG000|Overall Study|Lost to Follow-up|37|||
155466990|NCT03862495|561129740|FG001|Overall Study|Lost to Follow-up|35|||
155466991|NCT00064077|561129741|FG000|Overall Study|Improper prior treatment|1|||
155466992|NCT00064077|561129742|FG001|Overall Study|Improper prior treatment|0|||
155466993|NCT00064077|561129743|FG002|Overall Study|Improper prior treatment|0|||
155466994|NCT00064077|561129744|FG003|Overall Study|Improper prior treatment|0|||
155466995|NCT00064077|561129741|FG000|Overall Study|Poor risk|2|||
155466996|NCT00064077|561129742|FG001|Overall Study|Poor risk|0|||
155466997|NCT00064077|561129743|FG002|Overall Study|Poor risk|1|||
155466998|NCT00064077|561129744|FG003|Overall Study|Poor risk|1|||
155466999|NCT00064077|561129741|FG000|Overall Study|Pathology|10|||
155467000|NCT00064077|561129742|FG001|Overall Study|Pathology|7|||
155467001|NCT00064077|561129743|FG002|Overall Study|Pathology|3|||
155467002|NCT00064077|561129744|FG003|Overall Study|Pathology|4|||
155467003|NCT00064077|561129741|FG000|Overall Study|No surgery|0|||
155467004|NCT00064077|561129742|FG001|Overall Study|No surgery|0|||
155467005|NCT00064077|561129743|FG002|Overall Study|No surgery|1|||
155652824|NCT02395627|561822194|FG001|Overall Study|Withdrawal by Subject|2|||
155467006|NCT00064077|561129744|FG003|Overall Study|No surgery|0|||
155467007|NCT00064077|561129741|FG000|Overall Study|No tumor|0|||
155467008|NCT00064077|561129742|FG001|Overall Study|No tumor|0|||
155467009|NCT00064077|561129743|FG002|Overall Study|No tumor|1|||
155652825|NCT02395627|561822195|FG002|Overall Study|Withdrawal by Subject|0|||
155652826|NCT02395627|561822193|FG000|Overall Study|Did not receive pembrolizumab|3|||
155652827|NCT02395627|561822194|FG001|Overall Study|Did not receive pembrolizumab|1|||
155652828|NCT02395627|561822195|FG002|Overall Study|Did not receive pembrolizumab|0|||
155467010|NCT00064077|561129744|FG003|Overall Study|No tumor|0|||
155467011|NCT00064077|561129741|FG000|Overall Study|Other reasons|2|||
155467012|NCT00064077|561129742|FG001|Overall Study|Other reasons|2|||
155467013|NCT00064077|561129743|FG002|Overall Study|Other reasons|1|||
155467014|NCT00064077|561129744|FG003|Overall Study|Other reasons|2|||
155467015|NCT01057862|561129745|FG000|Overall Study|Withdrawal by Subject|1|||
155467016|NCT01057862|561129746|FG001|Overall Study|Withdrawal by Subject|2|||
155467017|NCT03363165|561129747|FG000|3-month Follow-up|Death|0|||
155467018|NCT03363165|561129748|FG001|3-month Follow-up|Death|1|||
155467019|NCT03363165|561129747|FG000|6-month Follow-up|Death|0|||
155467020|NCT03363165|561129748|FG001|6-month Follow-up|Death|1|||
155467021|NCT03363165|561129747|FG000|6-month Follow-up|Withdrawal by Subject|1|||
155467022|NCT03363165|561129748|FG001|6-month Follow-up|Withdrawal by Subject|1|||
155467023|NCT03363165|561129747|FG000|12-month Follow-up|Death|1|||
155467024|NCT03363165|561129748|FG001|12-month Follow-up|Death|1|||
155467025|NCT03363165|561129747|FG000|12-month Follow-up|Withdrawal by Subject|1|||
155467026|NCT03363165|561129748|FG001|12-month Follow-up|Withdrawal by Subject|1|||
155467027|NCT02255760|561129749|FG000|Overall Study|Lost to Follow-up|0|||
155652829|NCT02757963|561822198|FG000|Overall Study|Adverse Event|3|||
155467028|NCT02255760|561129750|FG001|Overall Study|Lost to Follow-up|1|||
155467029|NCT02255760|561129751|FG002|Overall Study|Lost to Follow-up|0|||
155467030|NCT02255760|561129752|FG003|Overall Study|Lost to Follow-up|0|||
155467031|NCT02255760|561129753|FG004|Overall Study|Lost to Follow-up|0|||
155467032|NCT00003838|561129754|FG000|Overall Study|Death|0|||
155467033|NCT00003838|561129755|FG001|Overall Study|Death|12|||
155467034|NCT00003838|561129756|FG002|Overall Study|Death|7|||
155467035|NCT00003838|561129754|FG000|Overall Study|Lost to Follow-up|0|||
155467036|NCT00003838|561129755|FG001|Overall Study|Lost to Follow-up|1|||
155467037|NCT00003838|561129756|FG002|Overall Study|Lost to Follow-up|1|||
155467038|NCT00003838|561129754|FG000|Overall Study|Disease Progression|0|||
155467039|NCT00003838|561129755|FG001|Overall Study|Disease Progression|12|||
155467040|NCT00003838|561129756|FG002|Overall Study|Disease Progression|0|||
155467041|NCT00618813|561129757|FG000|Overall Study|Lack of Efficacy|1|||
155467042|NCT00618813|561129757|FG000|Overall Study|Physician Decision|2|||
155467043|NCT00618813|561129757|FG000|Overall Study|Withdrawal by Subject|1|||
155467044|NCT00268463|561129758|FG000|Overall Study|study terminated due to low accrual|10|||
155467045|NCT00268463|561129759|FG001|Overall Study|study terminated due to low accrual|12|||
155467046|NCT03495817|561129760|FG000|26 Week Open Label|Adverse Event|3|||
155467047|NCT03495817|561129760|FG000|26 Week Open Label|Withdrawal by Subject|4|||
155467048|NCT03495817|561129760|FG000|26 Week Open Label|Lost to Follow-up|1|||
155467049|NCT03495817|561129760|FG000|26 Week Extension|Lost to Follow-up|2|||
155467050|NCT01686958|561129761|FG000|Overall Study|Withdrawal by Subject|1|||
155467051|NCT02224638|561129771|FG000|Overall Study|Adverse Event|1|||
155467052|NCT02224638|561129772|FG001|Overall Study|Adverse Event|1|||
155467053|NCT01406652|561129773|FG000|Overall Study|Lost-to-follow-up|3|||
155467054|NCT01406652|561129774|FG001|Overall Study|Lost-to-follow-up|4|||
155467055|NCT01406652|561129773|FG000|Overall Study|Withdrawal by Subject|2|||
155467056|NCT01406652|561129774|FG001|Overall Study|Withdrawal by Subject|2|||
155467057|NCT01406652|561129773|FG000|Overall Study|Insufficient follow-up|5|||
155467058|NCT01406652|561129774|FG001|Overall Study|Insufficient follow-up|4|||
155467059|NCT01406652|561129773|FG000|Overall Study|Infection not sure|10|||
155467060|NCT01406652|561129774|FG001|Overall Study|Infection not sure|10|||
155467061|NCT00587301|561129781|FG000|Overall Study|Screen Failure|9|||
155467062|NCT00587301|561129781|FG000|Overall Study|Lost to Follow-up|22|||
155467063|NCT00587301|561129781|FG000|Overall Study|Withdrawal by Subject|7|||
155467064|NCT00587301|561129781|FG000|Overall Study|Protocol Violation|7|||
155467065|NCT00418717|561129782|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
155467066|NCT00418717|561129782|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
155467067|NCT01400139|561129784|FG000|HYD Core Study|Adverse Event|210|||
155467068|NCT01400139|561129784|FG000|HYD Core Study|Lack of Efficacy|59|||
155467069|NCT01400139|561129784|FG000|HYD Core Study|Withdrawal by Subject|114|||
155467070|NCT01400139|561129784|FG000|HYD Core Study|Lost to Follow-up|39|||
155467071|NCT01400139|561129784|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
155467072|NCT01400139|561129784|FG000|HYD Core Study|Administrative|56|||
155467073|NCT01400139|561129784|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
155467074|NCT01400139|561129784|FG000|HYD Extension Period|Adverse Event|8|||
155467075|NCT01400139|561129784|FG000|HYD Extension Period|Withdrawal by Subject|5|||
155467076|NCT01400139|561129784|FG000|HYD Extension Period|Administrative|10|||
155467077|NCT00994162|561129787|FG000|Overall Study|Withdrawal by Subject|1|||
155467078|NCT00994162|561129787|FG000|Overall Study|Lost to Follow-up|2|||
155467079|NCT00994162|561129787|FG000|Overall Study|Product Complaint|1|||
155467080|NCT00994162|561129787|FG000|Overall Study|Poor Compliance|5|||
155467081|NCT00994162|561129787|FG000|Overall Study|Lack of Response|3|||
155467082|NCT00994162|561129787|FG000|Overall Study|Discharged from Hospital|4|||
155467083|NCT00994162|561129787|FG000|Overall Study|Death|2|||
155467084|NCT00994162|561129787|FG000|Overall Study|Care Transferred to Another Physician|2|||
155467085|NCT00994162|561129787|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
155467086|NCT00994162|561129787|FG000|Overall Study|Physician Decision|2|||
155467087|NCT00994162|561129787|FG000|Overall Study|Surrounding Wound Erythematous|1|||
155467088|NCT00994162|561129787|FG000|Overall Study|Machine Losing Vaccum|1|||
155467089|NCT00994162|561129787|FG000|Overall Study|Patient Lived Too Far Away|1|||
155467090|NCT00994162|561129787|FG000|Overall Study|Above Knee Amputation|1|||
155467091|NCT00994162|561129787|FG000|Overall Study|Reason Not Reported By Site|1|||
155467092|NCT02762708|561129790|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
155467093|NCT02762708|561129791|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
155467094|NCT02762708|561129792|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
155467095|NCT02762708|561129793|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
155467096|NCT01468701|561129794|FG000|Overall Study|Not eligible|91|||
155467097|NCT01468701|561129795|FG001|Overall Study|Not eligible|140|||
155467098|NCT01468701|561129796|FG002|Overall Study|Not eligible|29|||
155467099|NCT01468701|561129797|FG003|Overall Study|Not eligible|12|||
155467100|NCT01468701|561129798|FG004|Overall Study|Not eligible|22|||
155467101|NCT01468701|561129799|FG005|Overall Study|Not eligible|2|||
155467102|NCT01468701|561129800|FG006|Overall Study|Not eligible|39|||
155467103|NCT01468701|561129801|FG007|Overall Study|Not eligible|1|||
155467104|NCT01468701|561129802|FG008|Overall Study|Not eligible|40|||
155467105|NCT01468701|561129803|FG009|Overall Study|Not eligible|126|||
155467106|NCT01468701|561129804|FG010|Overall Study|Not eligible|39|||
155467107|NCT01468701|561129805|FG011|Overall Study|Not eligible|33|||
155467108|NCT01468701|561129806|FG012|Overall Study|Not eligible|1|||
155467109|NCT01468701|561129807|FG013|Overall Study|Not eligible|19|||
155467110|NCT01468701|561129808|FG014|Overall Study|Not eligible|1|||
155467111|NCT01468701|561129809|FG015|Overall Study|Not eligible|32|||
155467112|NCT01468701|561129810|FG016|Overall Study|Not eligible|0|||
155517358|NCT00561730|561319625|FG000|Overall Study|Adverse Event|2|||
155517359|NCT00561730|561319625|FG000|Overall Study|Handling of the drug|1|||
155467113|NCT01468701|561129794|FG000|Overall Study|Lost to Follow-up|306|||
155467114|NCT01468701|561129795|FG001|Overall Study|Lost to Follow-up|0|||
155467115|NCT01468701|561129796|FG002|Overall Study|Lost to Follow-up|0|||
155467116|NCT01468701|561129797|FG003|Overall Study|Lost to Follow-up|0|||
155467117|NCT01468701|561129798|FG004|Overall Study|Lost to Follow-up|0|||
155467118|NCT01468701|561129799|FG005|Overall Study|Lost to Follow-up|0|||
155467119|NCT01468701|561129800|FG006|Overall Study|Lost to Follow-up|0|||
155467120|NCT01468701|561129801|FG007|Overall Study|Lost to Follow-up|0|||
155467121|NCT01468701|561129802|FG008|Overall Study|Lost to Follow-up|215|||
155467122|NCT01468701|561129803|FG009|Overall Study|Lost to Follow-up|309|||
155467123|NCT01468701|561129804|FG010|Overall Study|Lost to Follow-up|224|||
155467124|NCT01468701|561129805|FG011|Overall Study|Lost to Follow-up|212|||
155467125|NCT01468701|561129806|FG012|Overall Study|Lost to Follow-up|11|||
155467126|NCT01468701|561129807|FG013|Overall Study|Lost to Follow-up|164|||
155467127|NCT01468701|561129808|FG014|Overall Study|Lost to Follow-up|17|||
155467128|NCT01468701|561129809|FG015|Overall Study|Lost to Follow-up|127|||
155467129|NCT01468701|561129810|FG016|Overall Study|Lost to Follow-up|1|||
155467130|NCT01468701|561129794|FG000|Overall Study|Withdrawal by Subject|165|||
155467131|NCT01468701|561129795|FG001|Overall Study|Withdrawal by Subject|0|||
155467132|NCT01468701|561129796|FG002|Overall Study|Withdrawal by Subject|0|||
155467133|NCT01468701|561129797|FG003|Overall Study|Withdrawal by Subject|0|||
155467134|NCT01468701|561129798|FG004|Overall Study|Withdrawal by Subject|0|||
155467135|NCT01468701|561129799|FG005|Overall Study|Withdrawal by Subject|0|||
155467136|NCT01468701|561129800|FG006|Overall Study|Withdrawal by Subject|0|||
155467137|NCT01468701|561129801|FG007|Overall Study|Withdrawal by Subject|0|||
155467138|NCT01468701|561129802|FG008|Overall Study|Withdrawal by Subject|83|||
155467139|NCT01468701|561129803|FG009|Overall Study|Withdrawal by Subject|88|||
155467140|NCT01468701|561129804|FG010|Overall Study|Withdrawal by Subject|100|||
155467141|NCT01468701|561129805|FG011|Overall Study|Withdrawal by Subject|114|||
155467142|NCT01468701|561129806|FG012|Overall Study|Withdrawal by Subject|9|||
155467143|NCT01468701|561129807|FG013|Overall Study|Withdrawal by Subject|47|||
155467144|NCT01468701|561129808|FG014|Overall Study|Withdrawal by Subject|6|||
155467145|NCT01468701|561129809|FG015|Overall Study|Withdrawal by Subject|31|||
155467146|NCT01468701|561129810|FG016|Overall Study|Withdrawal by Subject|0|||
155467147|NCT01468701|561129794|FG000|Overall Study|Other reasons than listed|437|||
155467148|NCT01468701|561129795|FG001|Overall Study|Other reasons than listed|0|||
155467149|NCT01468701|561129796|FG002|Overall Study|Other reasons than listed|0|||
155467150|NCT01468701|561129797|FG003|Overall Study|Other reasons than listed|0|||
155467151|NCT01468701|561129798|FG004|Overall Study|Other reasons than listed|0|||
155467152|NCT01468701|561129799|FG005|Overall Study|Other reasons than listed|0|||
155467153|NCT01468701|561129800|FG006|Overall Study|Other reasons than listed|0|||
155467154|NCT01468701|561129801|FG007|Overall Study|Other reasons than listed|0|||
155467155|NCT01468701|561129802|FG008|Overall Study|Other reasons than listed|318|||
155467156|NCT01468701|561129803|FG009|Overall Study|Other reasons than listed|658|||
155467157|NCT01468701|561129804|FG010|Overall Study|Other reasons than listed|433|||
155467158|NCT01468701|561129805|FG011|Overall Study|Other reasons than listed|504|||
155467159|NCT01468701|561129806|FG012|Overall Study|Other reasons than listed|28|||
155467160|NCT01468701|561129807|FG013|Overall Study|Other reasons than listed|239|||
155467161|NCT01468701|561129808|FG014|Overall Study|Other reasons than listed|39|||
155467162|NCT01468701|561129809|FG015|Overall Study|Other reasons than listed|172|||
155467163|NCT01468701|561129810|FG016|Overall Study|Other reasons than listed|0|||
155467164|NCT01468701|561129794|FG000|Overall Study|No end of study case report form|0|||
155467165|NCT01468701|561129795|FG001|Overall Study|No end of study case report form|0|||
155467166|NCT01468701|561129796|FG002|Overall Study|No end of study case report form|0|||
155467167|NCT01468701|561129797|FG003|Overall Study|No end of study case report form|0|||
155467168|NCT01468701|561129798|FG004|Overall Study|No end of study case report form|0|||
155467169|NCT01468701|561129799|FG005|Overall Study|No end of study case report form|0|||
155467170|NCT01468701|561129800|FG006|Overall Study|No end of study case report form|0|||
155467171|NCT01468701|561129801|FG007|Overall Study|No end of study case report form|0|||
155467172|NCT01468701|561129802|FG008|Overall Study|No end of study case report form|4|||
155467173|NCT01468701|561129803|FG009|Overall Study|No end of study case report form|1|||
155467174|NCT01468701|561129804|FG010|Overall Study|No end of study case report form|2|||
155467175|NCT01468701|561129805|FG011|Overall Study|No end of study case report form|3|||
155467176|NCT01468701|561129806|FG012|Overall Study|No end of study case report form|0|||
155467177|NCT01468701|561129807|FG013|Overall Study|No end of study case report form|1|||
155467178|NCT01468701|561129808|FG014|Overall Study|No end of study case report form|0|||
155467179|NCT01468701|561129809|FG015|Overall Study|No end of study case report form|0|||
155467180|NCT01468701|561129810|FG016|Overall Study|No end of study case report form|0|||
155467181|NCT01468701|561129794|FG000|Overall Study|Not being followed up|0|||
155467182|NCT01468701|561129795|FG001|Overall Study|Not being followed up|4963|||
155467183|NCT01468701|561129796|FG002|Overall Study|Not being followed up|1755|||
155467184|NCT01468701|561129797|FG003|Overall Study|Not being followed up|703|||
155467185|NCT01468701|561129798|FG004|Overall Study|Not being followed up|1714|||
155467186|NCT01468701|561129799|FG005|Overall Study|Not being followed up|126|||
155467187|NCT01468701|561129800|FG006|Overall Study|Not being followed up|1170|||
155467188|NCT01468701|561129801|FG007|Overall Study|Not being followed up|4|||
155467189|NCT01468701|561129802|FG008|Overall Study|Not being followed up|0|||
155467190|NCT01468701|561129803|FG009|Overall Study|Not being followed up|0|||
155467191|NCT01468701|561129804|FG010|Overall Study|Not being followed up|0|||
155467192|NCT01468701|561129805|FG011|Overall Study|Not being followed up|0|||
155467193|NCT01468701|561129806|FG012|Overall Study|Not being followed up|0|||
155467194|NCT01468701|561129807|FG013|Overall Study|Not being followed up|0|||
155467195|NCT01468701|561129808|FG014|Overall Study|Not being followed up|0|||
155467196|NCT01468701|561129809|FG015|Overall Study|Not being followed up|0|||
155467197|NCT01468701|561129810|FG016|Overall Study|Not being followed up|0|||
155467198|NCT00719953|561129812|FG000|Overall Study|Adverse Event|4|||
155467199|NCT03175562|561129817|FG000|Overall Study|Adverse Event|1|||
155467200|NCT03175562|561129817|FG000|Overall Study|Lost to Follow-up|3|||
155467201|NCT03175562|561129817|FG000|Overall Study|Withdrawal by Subject|7|||
155467202|NCT03175562|561129817|FG000|Overall Study|Other (Not Specified)|5|||
155467203|NCT01230749|561129820|FG000|Overall Study|Adverse Event|0|||
155467204|NCT01230749|561129821|FG001|Overall Study|Adverse Event|0|||
155517360|NCT00561730|561319625|FG000|Overall Study|Lost to Follow-up|5|||
155467205|NCT01230749|561129822|FG002|Overall Study|Adverse Event|0|||
155467206|NCT01230749|561129823|FG003|Overall Study|Adverse Event|1|||
155467207|NCT01230749|561129820|FG000|Overall Study|Physician Decision|0|||
155467208|NCT01230749|561129821|FG001|Overall Study|Physician Decision|0|||
155467209|NCT01230749|561129822|FG002|Overall Study|Physician Decision|1|||
155517361|NCT00561730|561319625|FG000|Overall Study|Not specified reasons|1|||
155517362|NCT00520741|561319630|FG000|Overall Study|Adverse Event|16|||
155517363|NCT00520741|561319631|FG001|Overall Study|Adverse Event|56|||
155517364|NCT00520741|561319630|FG000|Overall Study|Lack of Efficacy|11|||
155517365|NCT00520741|561319631|FG001|Overall Study|Lack of Efficacy|30|||
155517366|NCT00520741|561319630|FG000|Overall Study|Withdrawal by Subject|0|||
155517367|NCT00520741|561319631|FG001|Overall Study|Withdrawal by Subject|11|||
155517368|NCT00520741|561319630|FG000|Overall Study|Protocol Violation|2|||
155517369|NCT00520741|561319631|FG001|Overall Study|Protocol Violation|15|||
155517370|NCT00520741|561319630|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
155517371|NCT00520741|561319631|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
155517372|NCT00520741|561319630|FG000|Overall Study|Lost to Follow-up|4|||
155517373|NCT00520741|561319631|FG001|Overall Study|Lost to Follow-up|4|||
155517374|NCT00520741|561319630|FG000|Overall Study|Other reasons for premature termination|0|||
155517375|NCT00520741|561319631|FG001|Overall Study|Other reasons for premature termination|6|||
155517376|NCT01505530|561319632|FG000|Overall Study|Progressive Disease|19|||
155517377|NCT01505530|561319633|FG001|Overall Study|Progressive Disease|17|||
155517378|NCT01505530|561319634|FG002|Overall Study|Progressive Disease|18|||
155517379|NCT01505530|561319632|FG000|Overall Study|Adverse Event|1|||
155517380|NCT01505530|561319633|FG001|Overall Study|Adverse Event|1|||
155517381|NCT01505530|561319634|FG002|Overall Study|Adverse Event|0|||
155517382|NCT01505530|561319632|FG000|Overall Study|Withdrawal by Subject|7|||
155517383|NCT01505530|561319633|FG001|Overall Study|Withdrawal by Subject|8|||
155517384|NCT01505530|561319634|FG002|Overall Study|Withdrawal by Subject|6|||
155517385|NCT01505530|561319632|FG000|Overall Study|Physician Decision|6|||
155517386|NCT01505530|561319633|FG001|Overall Study|Physician Decision|2|||
155517387|NCT01505530|561319634|FG002|Overall Study|Physician Decision|5|||
155517388|NCT01505530|561319632|FG000|Overall Study|Sponsor Decision|1|||
155517389|NCT01505530|561319633|FG001|Overall Study|Sponsor Decision|8|||
155517390|NCT01505530|561319634|FG002|Overall Study|Sponsor Decision|7|||
155517391|NCT01505530|561319632|FG000|Overall Study|Death|7|||
155517392|NCT01505530|561319633|FG001|Overall Study|Death|6|||
155517393|NCT01505530|561319634|FG002|Overall Study|Death|5|||
155517394|NCT01505530|561319632|FG000|Overall Study|entry criteria not met|0|||
155517395|NCT01505530|561319633|FG001|Overall Study|entry criteria not met|1|||
155517396|NCT01505530|561319634|FG002|Overall Study|entry criteria not met|0|||
155517397|NCT01153984|561319635|FG000|Overall Study|Withdrawal by Subject|1|||
155517398|NCT01153984|561319635|FG000|Overall Study|Adverse Event|1|||
155517399|NCT00973700|561319636|FG000|Overall Study|Withdrawal by Subject|2|||
155517400|NCT00973700|561319637|FG001|Overall Study|Withdrawal by Subject|2|||
155517401|NCT00973700|561319638|FG002|Overall Study|Withdrawal by Subject|8|||
155517402|NCT00973700|561319639|FG003|Overall Study|Withdrawal by Subject|4|||
155517403|NCT00973700|561319640|FG004|Overall Study|Withdrawal by Subject|4|||
155517404|NCT00973700|561319636|FG000|Overall Study|Lost to Follow-up|5|||
155517405|NCT00973700|561319637|FG001|Overall Study|Lost to Follow-up|0|||
155517406|NCT00973700|561319638|FG002|Overall Study|Lost to Follow-up|1|||
155517407|NCT00973700|561319639|FG003|Overall Study|Lost to Follow-up|8|||
155517408|NCT00973700|561319640|FG004|Overall Study|Lost to Follow-up|5|||
155517409|NCT00973700|561319636|FG000|Overall Study|Inappropriate enrolment|0|||
155517410|NCT00973700|561319637|FG001|Overall Study|Inappropriate enrolment|0|||
155517411|NCT00973700|561319638|FG002|Overall Study|Inappropriate enrolment|0|||
155517412|NCT00973700|561319639|FG003|Overall Study|Inappropriate enrolment|4|||
155517413|NCT00973700|561319640|FG004|Overall Study|Inappropriate enrolment|0|||
155517414|NCT00973700|561319636|FG000|Overall Study|Unable to Classify|0|||
155517415|NCT00973700|561319637|FG001|Overall Study|Unable to Classify|0|||
155517416|NCT00973700|561319638|FG002|Overall Study|Unable to Classify|1|||
155517417|NCT00973700|561319639|FG003|Overall Study|Unable to Classify|2|||
155517418|NCT00973700|561319640|FG004|Overall Study|Unable to Classify|1|||
155517419|NCT01618266|561319649|FG000|Overall Study|Lost to Follow-up|9|||
155517420|NCT01618266|561319649|FG000|Overall Study|Treatment satisfaction|10|||
155517421|NCT01618266|561319649|FG000|Overall Study|Other reasons|11|||
155517422|NCT01618266|561319649|FG000|Overall Study|Lack of Efficacy|23|||
155517423|NCT01618266|561319649|FG000|Overall Study|Protocol Violation|43|||
155517424|NCT00626925|561319650|FG000|Overall Study|Lost to Follow-up|1|||
155517425|NCT00626925|561319651|FG001|Overall Study|Lost to Follow-up|2|||
155517426|NCT00626925|561319650|FG000|Overall Study|relapse|1|||
155517427|NCT00626925|561319651|FG001|Overall Study|relapse|0|||
155517428|NCT00626925|561319650|FG000|Overall Study|Adverse effect|6|||
155517429|NCT00626925|561319651|FG001|Overall Study|Adverse effect|2|||
155517430|NCT00626925|561319650|FG000|Overall Study|Lack of Efficacy|1|||
155517431|NCT00626925|561319651|FG001|Overall Study|Lack of Efficacy|4|||
155517432|NCT00626925|561319650|FG000|Overall Study|Time constraints|3|||
155517433|NCT00626925|561319651|FG001|Overall Study|Time constraints|1|||
155517434|NCT00625807|561319652|FG000|Overall Study|schedule conflict|2|||
155517435|NCT00625807|561319653|FG001|Overall Study|schedule conflict|8|||
155517436|NCT01966042|561319654|FG000|Overall Study|Death|2|||
155517437|NCT03267264|561319655|FG000|Overall Study|Withdrawal by Subject|1|||
155517438|NCT03267264|561319656|FG001|Overall Study|Withdrawal by Subject|0|||
155517439|NCT03267264|561319657|FG002|Overall Study|Withdrawal by Subject|2|||
155652830|NCT02757963|561822198|FG000|Overall Study|Reached Stopping Criteria|1054|||
155652831|NCT02757963|561822198|FG000|Overall Study|Lost to Follow-up|5|||
155652832|NCT02757963|561822198|FG000|Overall Study|Physician Decision|1|||
155652833|NCT02757963|561822198|FG000|Overall Study|Withdrawal by Subject|34|||
155652834|NCT00911157|561822199|FG000|Overall Study|Adverse Event|4|||
155652835|NCT00911157|561822200|FG001|Overall Study|Adverse Event|1|||
155652836|NCT00911157|561822199|FG000|Overall Study|Withdrawal by Subject|1|||
155652837|NCT00911157|561822200|FG001|Overall Study|Withdrawal by Subject|1|||
155652838|NCT00911157|561822199|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
155652839|NCT00911157|561822200|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
155652840|NCT00911157|561822199|FG000|Overall Study|Need to treat for lung cancer|1|||
155652841|NCT00911157|561822200|FG001|Overall Study|Need to treat for lung cancer|0|||
155652842|NCT03769467|561822204|FG000|Overall Study|Adverse Event|1|||
155652843|NCT03769467|561822205|FG001|Overall Study|Adverse Event|1|||
155652844|NCT03769467|561822206|FG002|Overall Study|Adverse Event|0|||
155652845|NCT03769467|561822204|FG000|Overall Study|Death|3|||
155517440|NCT03267264|561319658|FG003|Overall Study|Withdrawal by Subject|4|||
155517441|NCT02492958|561319659|FG000|Overall Study|Withdrawal by Subject|0|||
155517442|NCT02492958|561319660|FG001|Overall Study|Withdrawal by Subject|0|||
155467210|NCT01230749|561129823|FG003|Overall Study|Physician Decision|0|||
155467211|NCT01230749|561129820|FG000|Overall Study|Withdrawal by Subject|0|||
155467212|NCT01230749|561129821|FG001|Overall Study|Withdrawal by Subject|1|||
155517443|NCT02492958|561319661|FG002|Overall Study|Withdrawal by Subject|1|||
155517444|NCT02492958|561319662|FG003|Overall Study|Withdrawal by Subject|0|||
155517445|NCT02492958|561319659|FG000|Overall Study|Adverse Event|1|||
155517446|NCT02492958|561319660|FG001|Overall Study|Adverse Event|0|||
155517447|NCT02492958|561319661|FG002|Overall Study|Adverse Event|1|||
155517448|NCT02492958|561319662|FG003|Overall Study|Adverse Event|0|||
155517449|NCT03522948|561319663|FG000|Overall Study|Lost to Follow-up|1|||
155517450|NCT00712010|561319664|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
155517451|NCT01946165|561319665|FG000|Overall Study|Physician Decision|2|||
155517452|NCT01946165|561319666|FG001|Overall Study|Physician Decision|0|||
155517453|NCT01946165|561319665|FG000|Overall Study|Withdrawal by Subject|0|||
155517454|NCT01946165|561319666|FG001|Overall Study|Withdrawal by Subject|2|||
155517455|NCT02114697|561319669|FG000|Overall Study|Study terminated|5|||
155517456|NCT02114697|561319670|FG001|Overall Study|Study terminated|4|||
155517457|NCT00424489|561319671|FG000|Overall Study|Death|3|||
155517458|NCT01984242|561319672|FG000|Overall Study|Death|52|||
155517459|NCT01984242|561319673|FG001|Overall Study|Death|50|||
155517460|NCT01984242|561319674|FG002|Overall Study|Death|52|||
155467213|NCT01230749|561129822|FG002|Overall Study|Withdrawal by Subject|0|||
155467214|NCT01230749|561129823|FG003|Overall Study|Withdrawal by Subject|0|||
155467215|NCT01230749|561129820|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
155467216|NCT01230749|561129821|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
155652846|NCT03769467|561822205|FG001|Overall Study|Death|3|||
155652847|NCT03769467|561822206|FG002|Overall Study|Death|0|||
155652848|NCT03769467|561822204|FG000|Overall Study|Study Terminated By Sponsor|2|||
155467217|NCT01230749|561129822|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
155467218|NCT01230749|561129823|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
155467219|NCT03906136|561131270|FG000|Overall Study|Adverse Event|1|||
155467220|NCT03906136|561131271|FG001|Overall Study|Adverse Event|0|||
155467221|NCT03906136|561131270|FG000|Overall Study|Lost to Follow-up|7|||
155467222|NCT03906136|561131271|FG001|Overall Study|Lost to Follow-up|4|||
155467223|NCT03906136|561131270|FG000|Overall Study|Physician Decision|1|||
155467224|NCT03906136|561131271|FG001|Overall Study|Physician Decision|0|||
155467225|NCT03906136|561131270|FG000|Overall Study|Withdrawal by Subject|3|||
155467226|NCT03906136|561131271|FG001|Overall Study|Withdrawal by Subject|7|||
155467227|NCT02371980|561131281|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
155467228|NCT02371980|561131282|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
155467229|NCT02371980|561131283|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
155467230|NCT02371980|561131284|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
155467231|NCT02371980|561131285|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
155467232|NCT02371980|561131281|FG000|Open-label Period|Significant Protocol Deviation|19|||
155467233|NCT02371980|561131282|FG001|Open-label Period|Significant Protocol Deviation|0|||
155467234|NCT02371980|561131283|FG002|Open-label Period|Significant Protocol Deviation|0|||
155467235|NCT02371980|561131284|FG003|Open-label Period|Significant Protocol Deviation|0|||
155467236|NCT02371980|561131285|FG004|Open-label Period|Significant Protocol Deviation|0|||
155467237|NCT02371980|561131281|FG000|Open-label Period|Noncompliance with Study Drug|10|||
155467238|NCT02371980|561131282|FG001|Open-label Period|Noncompliance with Study Drug|0|||
155467239|NCT02371980|561131283|FG002|Open-label Period|Noncompliance with Study Drug|0|||
155467240|NCT02371980|561131284|FG003|Open-label Period|Noncompliance with Study Drug|0|||
155467241|NCT02371980|561131285|FG004|Open-label Period|Noncompliance with Study Drug|0|||
155467242|NCT02371980|561131281|FG000|Open-label Period|Lost to Follow-up|55|||
155467243|NCT02371980|561131282|FG001|Open-label Period|Lost to Follow-up|0|||
155467244|NCT02371980|561131283|FG002|Open-label Period|Lost to Follow-up|0|||
155467245|NCT02371980|561131284|FG003|Open-label Period|Lost to Follow-up|0|||
155467246|NCT02371980|561131285|FG004|Open-label Period|Lost to Follow-up|0|||
155467247|NCT02371980|561131281|FG000|Open-label Period|Voluntary Withdrawal|91|||
155467248|NCT02371980|561131282|FG001|Open-label Period|Voluntary Withdrawal|0|||
155467249|NCT02371980|561131283|FG002|Open-label Period|Voluntary Withdrawal|0|||
155467250|NCT02371980|561131284|FG003|Open-label Period|Voluntary Withdrawal|0|||
155467251|NCT02371980|561131285|FG004|Open-label Period|Voluntary Withdrawal|0|||
155467252|NCT02371980|561131281|FG000|Open-label Period|Pregnancy|1|||
155467253|NCT02371980|561131282|FG001|Open-label Period|Pregnancy|0|||
155467254|NCT02371980|561131283|FG002|Open-label Period|Pregnancy|0|||
155467255|NCT02371980|561131284|FG003|Open-label Period|Pregnancy|0|||
155652849|NCT03769467|561822205|FG001|Overall Study|Study Terminated By Sponsor|1|||
155652850|NCT03769467|561822206|FG002|Overall Study|Study Terminated By Sponsor|0|||
155652851|NCT03769467|561822204|FG000|Overall Study|Withdrawal by Subject|0|||
155652852|NCT03769467|561822205|FG001|Overall Study|Withdrawal by Subject|1|||
155652853|NCT03769467|561822206|FG002|Overall Study|Withdrawal by Subject|0|||
155652854|NCT05259722|561822209|FG000|Overall Study|Adverse Event|2|||
155652855|NCT05259722|561822210|FG001|Overall Study|Adverse Event|24|||
155652856|NCT05259722|561822209|FG000|Overall Study|Lost to Follow-up|5|||
155652857|NCT05259722|561822210|FG001|Overall Study|Lost to Follow-up|1|||
155652858|NCT05259722|561822209|FG000|Overall Study|Lack of Efficacy|8|||
155652859|NCT05259722|561822210|FG001|Overall Study|Lack of Efficacy|26|||
155652860|NCT05259722|561822209|FG000|Overall Study|Withdrawal by Subject|15|||
155652861|NCT05259722|561822210|FG001|Overall Study|Withdrawal by Subject|33|||
155652862|NCT05259722|561822209|FG000|Overall Study|Various reasons|3|||
155652863|NCT05259722|561822210|FG001|Overall Study|Various reasons|9|||
155652864|NCT05259722|561822209|FG000|Overall Study|Not exposed to IMP|1|||
155652865|NCT05259722|561822210|FG001|Overall Study|Not exposed to IMP|12|||
155652866|NCT05259722|561822209|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
155652867|NCT05259722|561822210|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
155652868|NCT00962650|561822211|FG000|Overall Study|Transgastric DP was not completed|2|||
155467256|NCT02371980|561131285|FG004|Open-label Period|Pregnancy|0|||
155467257|NCT02371980|561131281|FG000|Open-label Period|Lack of Efficacy|116|||
155467258|NCT02371980|561131282|FG001|Open-label Period|Lack of Efficacy|0|||
155467259|NCT02371980|561131283|FG002|Open-label Period|Lack of Efficacy|0|||
155467260|NCT02371980|561131284|FG003|Open-label Period|Lack of Efficacy|0|||
155467261|NCT02371980|561131285|FG004|Open-label Period|Lack of Efficacy|0|||
155652869|NCT00420056|561822212|FG000|Overall Study|Objective progression or relapse|17|||
155652870|NCT00127933|561822218|FG000|Overall Study|Randomized but not dosed|1|||
155652871|NCT00127933|561822219|FG001|Overall Study|Randomized but not dosed|0|||
155652872|NCT03111732|561822221|FG000|Overall Study|Enrolled in different study|1|||
155652873|NCT03111732|561822221|FG000|Overall Study|Progressive disease|3|||
155652874|NCT03111732|561822221|FG000|Overall Study|Withdrawal by Subject|1|||
155652875|NCT03072875|561822225|FG000|Overall Study|Lost to Follow-up|1|||
155652876|NCT00401830|561822226|FG000|Overall Study|Adverse Event|10|||
155652877|NCT00401830|561822227|FG001|Overall Study|Adverse Event|18|||
155467262|NCT02371980|561131281|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
155467263|NCT02371980|561131282|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
155467264|NCT02371980|561131283|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
155467265|NCT02371980|561131284|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
155467266|NCT02371980|561131285|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
155467267|NCT02371980|561131281|FG000|Open-label Period|Reason not Specified|9|||
155467268|NCT02371980|561131282|FG001|Open-label Period|Reason not Specified|0|||
155467269|NCT02371980|561131283|FG002|Open-label Period|Reason not Specified|0|||
155467270|NCT02371980|561131284|FG003|Open-label Period|Reason not Specified|0|||
155467271|NCT02371980|561131285|FG004|Open-label Period|Reason not Specified|0|||
155467272|NCT02371980|561131281|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
155467273|NCT02371980|561131282|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
155467274|NCT02371980|561131283|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
155652878|NCT00401830|561822226|FG000|Overall Study|Lack of Efficacy|11|||
155652879|NCT00401830|561822227|FG001|Overall Study|Lack of Efficacy|5|||
155652880|NCT00401830|561822226|FG000|Overall Study|Withdrawal by Subject|4|||
155652881|NCT00401830|561822227|FG001|Overall Study|Withdrawal by Subject|3|||
155652882|NCT00401830|561822226|FG000|Overall Study|Protocol Violation|3|||
155652883|NCT00401830|561822227|FG001|Overall Study|Protocol Violation|3|||
155467275|NCT02371980|561131284|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
155467276|NCT02371980|561131285|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
155467277|NCT02371980|561131281|FG000|Double-blind Period|Significant Protocol Deviation|0|||
155467278|NCT02371980|561131282|FG001|Double-blind Period|Significant Protocol Deviation|2|||
155467279|NCT02371980|561131283|FG002|Double-blind Period|Significant Protocol Deviation|7|||
155467280|NCT02371980|561131284|FG003|Double-blind Period|Significant Protocol Deviation|3|||
155467281|NCT02371980|561131285|FG004|Double-blind Period|Significant Protocol Deviation|3|||
155467282|NCT02371980|561131281|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
155467283|NCT02371980|561131282|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
155467284|NCT02371980|561131283|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
155467285|NCT02371980|561131284|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
155467286|NCT02371980|561131285|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
155467287|NCT02371980|561131281|FG000|Double-blind Period|Lost to Follow-up|0|||
155467288|NCT02371980|561131282|FG001|Double-blind Period|Lost to Follow-up|8|||
155467289|NCT02371980|561131283|FG002|Double-blind Period|Lost to Follow-up|8|||
155467290|NCT02371980|561131284|FG003|Double-blind Period|Lost to Follow-up|6|||
155467291|NCT02371980|561131285|FG004|Double-blind Period|Lost to Follow-up|5|||
155467292|NCT02371980|561131281|FG000|Double-blind Period|Voluntary Withdrawal|0|||
155467293|NCT02371980|561131282|FG001|Double-blind Period|Voluntary Withdrawal|12|||
155467294|NCT02371980|561131283|FG002|Double-blind Period|Voluntary Withdrawal|8|||
155467295|NCT02371980|561131284|FG003|Double-blind Period|Voluntary Withdrawal|9|||
155467296|NCT02371980|561131285|FG004|Double-blind Period|Voluntary Withdrawal|11|||
155467297|NCT02371980|561131281|FG000|Double-blind Period|Relapse|0|||
155467298|NCT02371980|561131282|FG001|Double-blind Period|Relapse|50|||
155467299|NCT02371980|561131283|FG002|Double-blind Period|Relapse|25|||
155467300|NCT02371980|561131284|FG003|Double-blind Period|Relapse|25|||
155467301|NCT02371980|561131285|FG004|Double-blind Period|Relapse|26|||
155467302|NCT02371980|561131281|FG000|Double-blind Period|Reason not Specified|0|||
155467303|NCT02371980|561131282|FG001|Double-blind Period|Reason not Specified|3|||
155467304|NCT02371980|561131283|FG002|Double-blind Period|Reason not Specified|3|||
155467305|NCT02371980|561131284|FG003|Double-blind Period|Reason not Specified|2|||
155467306|NCT02371980|561131285|FG004|Double-blind Period|Reason not Specified|1|||
155652884|NCT00401830|561822226|FG000|Overall Study|Non-compliance with drug study|1|||
155652885|NCT00401830|561822227|FG001|Overall Study|Non-compliance with drug study|0|||
155652886|NCT00401830|561822226|FG000|Overall Study|Lost to Follow-up|1|||
155652887|NCT00401830|561822227|FG001|Overall Study|Lost to Follow-up|3|||
155652888|NCT00401830|561822226|FG000|Overall Study|Other: Personal / Family problems|1|||
155652889|NCT00401830|561822227|FG001|Overall Study|Other: Personal / Family problems|0|||
155652890|NCT01943825|561822228|FG000|Overall Study|Lost to Follow-up|9|||
155652891|NCT01943825|561822229|FG001|Overall Study|Lost to Follow-up|3|||
155467307|NCT02371980|561131281|FG000|Double-blind Period|Missing|0|||
155467308|NCT02371980|561131282|FG001|Double-blind Period|Missing|1|||
155467309|NCT02371980|561131283|FG002|Double-blind Period|Missing|0|||
155467310|NCT02371980|561131284|FG003|Double-blind Period|Missing|0|||
155467311|NCT02371980|561131285|FG004|Double-blind Period|Missing|0|||
155467312|NCT01280812|561131287|FG000|Overall Study|Withdrawal by Subject|2|||
155467313|NCT01280812|561131288|FG001|Overall Study|Withdrawal by Subject|1|||
155467314|NCT01280812|561131289|FG002|Overall Study|Withdrawal by Subject|0|||
155467315|NCT01280812|561131287|FG000|Overall Study|Lost to Follow-up|1|||
155467316|NCT01280812|561131288|FG001|Overall Study|Lost to Follow-up|1|||
155467317|NCT01280812|561131289|FG002|Overall Study|Lost to Follow-up|1|||
155467318|NCT00959894|561131295|FG000|Overall Study|Lost to Follow-up|10|||
155467319|NCT00959894|561131295|FG000|Overall Study|Adverse Event|3|||
155467320|NCT00959894|561131295|FG000|Overall Study|Withdrawal by Subject|1|||
155467321|NCT00959894|561131295|FG000|Overall Study|Need for contraindicated medication|1|||
155467322|NCT00959894|561131295|FG000|Overall Study|Subject moved out of town|1|||
155467323|NCT00922974|561131296|FG000|Phase II Component|Protocol Violation|2|||
155467324|NCT00922974|561131297|FG001|Phase II Component|Protocol Violation|0|||
155467325|NCT00922974|561131296|FG000|Phase II Component|Not evaluable for treatment review|5|||
155467326|NCT00922974|561131297|FG001|Phase II Component|Not evaluable for treatment review|0|||
155467327|NCT00922974|561131296|FG000|Phase III Component|Protocol Violation|8|||
155467328|NCT00922974|561131297|FG001|Phase III Component|Protocol Violation|6|||
155467329|NCT03682055|561131298|FG000|Overall Study|Lack of Efficacy|1|||
155467330|NCT03682055|561131299|FG001|Overall Study|Lack of Efficacy|2|||
155467331|NCT03682055|561131300|FG002|Overall Study|Lack of Efficacy|1|||
155467332|NCT03682055|561131301|FG003|Overall Study|Lack of Efficacy|2|||
155467333|NCT03682055|561131302|FG004|Overall Study|Lack of Efficacy|1|||
155467334|NCT03682055|561131303|FG005|Overall Study|Lack of Efficacy|3|||
155467335|NCT03682055|561131298|FG000|Overall Study|Withdrawal by Subject|0|||
155467336|NCT03682055|561131299|FG001|Overall Study|Withdrawal by Subject|0|||
155467337|NCT03682055|561131300|FG002|Overall Study|Withdrawal by Subject|0|||
155467338|NCT03682055|561131301|FG003|Overall Study|Withdrawal by Subject|0|||
155467339|NCT03682055|561131302|FG004|Overall Study|Withdrawal by Subject|0|||
155467340|NCT03682055|561131303|FG005|Overall Study|Withdrawal by Subject|1|||
155467341|NCT03682055|561131298|FG000|Overall Study|Termination of Study by Sponsor|0|||
155467342|NCT03682055|561131299|FG001|Overall Study|Termination of Study by Sponsor|0|||
155467343|NCT03682055|561131300|FG002|Overall Study|Termination of Study by Sponsor|0|||
155467344|NCT03682055|561131301|FG003|Overall Study|Termination of Study by Sponsor|0|||
155467345|NCT03682055|561131302|FG004|Overall Study|Termination of Study by Sponsor|0|||
155467346|NCT03682055|561131303|FG005|Overall Study|Termination of Study by Sponsor|3|||
155467347|NCT00191386|561131304|FG000|Overall Study|Adverse Event|16|||
155467348|NCT00191386|561131304|FG000|Overall Study|Lost to Follow-up|1|||
155467349|NCT00191386|561131304|FG000|Overall Study|Entry Criteria Exclusion|3|||
155467350|NCT00191386|561131304|FG000|Overall Study|Protocol Violation|18|||
155467351|NCT00191386|561131304|FG000|Overall Study|Withdrawal by Subject|96|||
155467352|NCT00191386|561131304|FG000|Overall Study|Physician Decision|11|||
155467353|NCT00191386|561131304|FG000|Overall Study|Lack of Efficacy|15|||
155467354|NCT01826448|561131306|FG000|Overall Study|Adverse Event|1|||
155467355|NCT01826448|561131307|FG001|Overall Study|Adverse Event|3|||
155517461|NCT01984242|561319672|FG000|Overall Study|Withdrawal by Subject|5|||
155517462|NCT01984242|561319673|FG001|Overall Study|Withdrawal by Subject|3|||
155517463|NCT01984242|561319674|FG002|Overall Study|Withdrawal by Subject|10|||
155517464|NCT01984242|561319672|FG000|Overall Study|Physician Decision|0|||
155517465|NCT01984242|561319673|FG001|Overall Study|Physician Decision|0|||
155517466|NCT01984242|561319674|FG002|Overall Study|Physician Decision|1|||
155517467|NCT01984242|561319672|FG000|Overall Study|Lost to Follow-up|4|||
155517468|NCT01984242|561319673|FG001|Overall Study|Lost to Follow-up|0|||
155517469|NCT01984242|561319674|FG002|Overall Study|Lost to Follow-up|3|||
155517470|NCT01984242|561319672|FG000|Overall Study|Sponsor Decision|1|||
155517471|NCT01984242|561319673|FG001|Overall Study|Sponsor Decision|0|||
155517472|NCT01984242|561319674|FG002|Overall Study|Sponsor Decision|0|||
155517473|NCT01984242|561319672|FG000|Overall Study|Non-Compliance|1|||
155517474|NCT01984242|561319673|FG001|Overall Study|Non-Compliance|0|||
155517475|NCT01984242|561319674|FG002|Overall Study|Non-Compliance|0|||
155517476|NCT01984242|561319672|FG000|Overall Study|Study terminated by Sponsor|38|||
155517477|NCT01984242|561319673|FG001|Overall Study|Study terminated by Sponsor|50|||
155517478|NCT01984242|561319674|FG002|Overall Study|Study terminated by Sponsor|34|||
155517479|NCT01984242|561319672|FG000|Overall Study|Disease Progression|0|||
155517480|NCT01984242|561319673|FG001|Overall Study|Disease Progression|0|||
155517481|NCT01984242|561319674|FG002|Overall Study|Disease Progression|1|||
155517482|NCT00536575|561319675|FG000|Overall Study|Withdrawal by Subject|1|||
155517483|NCT00536575|561319675|FG000|Overall Study|Death|1|||
155517484|NCT00865709|561319684|FG000|Treatment|Adverse Event|9|||
155517485|NCT00865709|561319685|FG001|Treatment|Adverse Event|6|||
155517486|NCT00865709|561319684|FG000|Treatment|Withdrawal by Subject|10|||
155517487|NCT00865709|561319685|FG001|Treatment|Withdrawal by Subject|7|||
155517488|NCT00865709|561319684|FG000|Treatment|Physician Decision|3|||
155517489|NCT00865709|561319685|FG001|Treatment|Physician Decision|2|||
155517490|NCT00865709|561319684|FG000|Treatment|Surgery|8|||
155517491|NCT00865709|561319685|FG001|Treatment|Surgery|3|||
155517492|NCT01265784|561319686|FG000|Overall Study|Lost to Follow-up|5|||
155517493|NCT01265784|561319687|FG001|Overall Study|Lost to Follow-up|3|||
155517494|NCT01265784|561319688|FG002|Overall Study|Lost to Follow-up|2|||
155517495|NCT01265784|561319686|FG000|Overall Study|Withdrawal by Subject|0|||
155517496|NCT01265784|561319687|FG001|Overall Study|Withdrawal by Subject|5|||
155517497|NCT01265784|561319688|FG002|Overall Study|Withdrawal by Subject|0|||
155517498|NCT01265784|561319686|FG000|Overall Study|Physician Decision|1|||
155517499|NCT01265784|561319687|FG001|Overall Study|Physician Decision|0|||
155517500|NCT01265784|561319688|FG002|Overall Study|Physician Decision|1|||
155517501|NCT01265784|561319686|FG000|Overall Study|Adverse Event|1|||
155517502|NCT01265784|561319687|FG001|Overall Study|Adverse Event|0|||
155517503|NCT01265784|561319688|FG002|Overall Study|Adverse Event|0|||
155517504|NCT01265784|561319686|FG000|Overall Study|Death|3|||
155517505|NCT01265784|561319687|FG001|Overall Study|Death|0|||
155517506|NCT01265784|561319688|FG002|Overall Study|Death|0|||
155517507|NCT01265784|561319686|FG000|Overall Study|Protocol Violation|2|||
155517508|NCT01265784|561319687|FG001|Overall Study|Protocol Violation|0|||
155517509|NCT01265784|561319688|FG002|Overall Study|Protocol Violation|0|||
155517510|NCT01265784|561319686|FG000|Overall Study|Incorrectly Randomized|0|||
155517511|NCT01265784|561319687|FG001|Overall Study|Incorrectly Randomized|0|||
155517512|NCT01265784|561319688|FG002|Overall Study|Incorrectly Randomized|1|||
155517513|NCT04333095|561319691|FG000|Overall Study|Protocol Violation|4|||
155517514|NCT04333095|561319692|FG001|Overall Study|Protocol Violation|0|||
155517515|NCT04333095|561319691|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
155517516|NCT04333095|561319692|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
155517517|NCT04333095|561319691|FG000|Overall Study|Mini Sternotomy|4|||
155517518|NCT04333095|561319692|FG001|Overall Study|Mini Sternotomy|5|||
155517519|NCT00984295|561319693|FG000|Overall Study|Lost to Follow-up|31|||
155517520|NCT00984295|561319694|FG001|Overall Study|Lost to Follow-up|12|||
155517521|NCT00984295|561319695|FG002|Overall Study|Lost to Follow-up|13|||
155517522|NCT00984295|561319693|FG000|Overall Study|Protocol Violation|2|||
155517523|NCT00984295|561319694|FG001|Overall Study|Protocol Violation|1|||
155517524|NCT00984295|561319695|FG002|Overall Study|Protocol Violation|4|||
155517525|NCT00984295|561319693|FG000|Overall Study|Withdrawal by Subject|18|||
155517526|NCT00984295|561319694|FG001|Overall Study|Withdrawal by Subject|9|||
155517527|NCT00984295|561319695|FG002|Overall Study|Withdrawal by Subject|12|||
155517528|NCT00984295|561319693|FG000|Overall Study|CAE - discontinued test vaccine|0|||
155517529|NCT00984295|561319694|FG001|Overall Study|CAE - discontinued test vaccine|1|||
155517530|NCT00984295|561319695|FG002|Overall Study|CAE - discontinued test vaccine|3|||
155517531|NCT00984295|561319693|FG000|Overall Study|Missed one or more blood samplings|3|||
155517532|NCT00984295|561319694|FG001|Overall Study|Missed one or more blood samplings|7|||
155517533|NCT00984295|561319695|FG002|Overall Study|Missed one or more blood samplings|2|||
155517534|NCT00984295|561319693|FG000|Overall Study|Incomplete safety follow-up|11|||
155517535|NCT00984295|561319694|FG001|Overall Study|Incomplete safety follow-up|2|||
155517536|NCT00984295|561319695|FG002|Overall Study|Incomplete safety follow-up|3|||
155517537|NCT03740165|561319696|FG000|Overall Study|Death|232|||
155517538|NCT03740165|561319697|FG001|Overall Study|Death|242|||
155467356|NCT01826448|561131306|FG000|Overall Study|Disease progression|2|||
155467357|NCT01826448|561131307|FG001|Overall Study|Disease progression|4|||
155467358|NCT01826448|561131306|FG000|Overall Study|Withdrawal by Subject|1|||
155467359|NCT01826448|561131307|FG001|Overall Study|Withdrawal by Subject|0|||
155467360|NCT01826448|561131306|FG000|Overall Study|Physician Decision|0|||
155467361|NCT01826448|561131307|FG001|Overall Study|Physician Decision|1|||
155467362|NCT01826448|561131306|FG000|Overall Study|2 active cancers|0|||
155467363|NCT01826448|561131307|FG001|Overall Study|2 active cancers|1|||
155467364|NCT04038385|561131308|FG000|Overall Study|Completed baseline assessment only|7|||
155467365|NCT04038385|561131309|FG001|Overall Study|Completed baseline assessment only|4|||
155517539|NCT03740165|561319698|FG002|Overall Study|Death|229|||
155517540|NCT03740165|561319696|FG000|Overall Study|Lost to Follow-up|0|||
155517541|NCT03740165|561319697|FG001|Overall Study|Lost to Follow-up|0|||
155467366|NCT04038385|561131308|FG000|Overall Study|Moved out of area|4|||
155467367|NCT04038385|561131309|FG001|Overall Study|Moved out of area|2|||
155467368|NCT04038385|561131308|FG000|Overall Study|Discontinued study involvement|6|||
155467369|NCT04038385|561131309|FG001|Overall Study|Discontinued study involvement|1|||
155467370|NCT00402285|561131313|FG000|Overall Study|insufficient RNA quality|7|||
155467371|NCT00402285|561131314|FG001|Overall Study|insufficient RNA quality|6|||
155467372|NCT00402285|561131315|FG002|Overall Study|insufficient RNA quality|2|||
155517542|NCT03740165|561319698|FG002|Overall Study|Lost to Follow-up|1|||
155517543|NCT03740165|561319696|FG000|Overall Study|Withdrawal by Subject|7|||
155517544|NCT03740165|561319697|FG001|Overall Study|Withdrawal by Subject|4|||
155517545|NCT03740165|561319698|FG002|Overall Study|Withdrawal by Subject|3|||
155517546|NCT03740165|561319696|FG000|Overall Study|Ongoing in Study|216|||
155517547|NCT03740165|561319697|FG001|Overall Study|Ongoing in Study|212|||
155517548|NCT03740165|561319698|FG002|Overall Study|Ongoing in Study|221|||
155517549|NCT03049618|561319699|FG000|Overall Study|Death|1|||
155517550|NCT03049618|561319700|FG001|Overall Study|Death|0|||
155517551|NCT03049618|561319699|FG000|Overall Study|Lack of Efficacy|1|||
155517552|NCT03049618|561319700|FG001|Overall Study|Lack of Efficacy|2|||
155517553|NCT04582539|561319701|FG000|Overall Study|Death|1|||
155517554|NCT04582539|561319702|FG001|Overall Study|Death|1|||
155517555|NCT04582539|561319703|FG002|Overall Study|Death|0|||
155517556|NCT04582539|561319704|FG003|Overall Study|Death|1|||
155517557|NCT04582539|561319705|FG004|Overall Study|Death|0|||
155517558|NCT04582539|561319701|FG000|Overall Study|Lost to Follow-up|1|||
155517559|NCT04582539|561319702|FG001|Overall Study|Lost to Follow-up|0|||
155517560|NCT04582539|561319703|FG002|Overall Study|Lost to Follow-up|0|||
155517561|NCT04582539|561319704|FG003|Overall Study|Lost to Follow-up|0|||
155517562|NCT04582539|561319705|FG004|Overall Study|Lost to Follow-up|0|||
155517563|NCT04582539|561319701|FG000|Overall Study|Study Terminated by Sponsor|1|||
155517564|NCT04582539|561319702|FG001|Overall Study|Study Terminated by Sponsor|3|||
155517565|NCT04582539|561319703|FG002|Overall Study|Study Terminated by Sponsor|2|||
155517566|NCT04582539|561319704|FG003|Overall Study|Study Terminated by Sponsor|2|||
155517567|NCT04582539|561319705|FG004|Overall Study|Study Terminated by Sponsor|3|||
155517568|NCT04582539|561319701|FG000|Overall Study|Physician Decision|0|||
155517569|NCT04582539|561319702|FG001|Overall Study|Physician Decision|1|||
155517570|NCT04582539|561319703|FG002|Overall Study|Physician Decision|0|||
155517571|NCT04582539|561319704|FG003|Overall Study|Physician Decision|0|||
155517572|NCT04582539|561319705|FG004|Overall Study|Physician Decision|0|||
155517573|NCT04582539|561319701|FG000|Overall Study|Withdrawal by Subject|1|||
155517574|NCT04582539|561319702|FG001|Overall Study|Withdrawal by Subject|0|||
155517575|NCT04582539|561319703|FG002|Overall Study|Withdrawal by Subject|2|||
155517576|NCT04582539|561319704|FG003|Overall Study|Withdrawal by Subject|1|||
155517577|NCT04582539|561319705|FG004|Overall Study|Withdrawal by Subject|0|||
155517578|NCT04582539|561319701|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
155517579|NCT04582539|561319702|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
155517580|NCT04582539|561319703|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
155517581|NCT04582539|561319704|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
155517582|NCT04582539|561319705|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
155517583|NCT00788957|561319714|FG000|Part 1|Death|8|||
155517584|NCT00788957|561319715|FG001|Part 1|Death|0|||
155517585|NCT00788957|561319716|FG002|Part 1|Death|0|||
155517586|NCT00788957|561319717|FG003|Part 1|Death|0|||
155467373|NCT00784459|561131316|FG000|Overall Study|Adverse Event|0|||
155467374|NCT00784459|561131317|FG001|Overall Study|Adverse Event|2|||
155467375|NCT02471586|561131323|FG000|Overall Study|Lost to Follow-up|3|||
155467376|NCT02471586|561131324|FG001|Overall Study|Lost to Follow-up|8|||
155467377|NCT02471586|561131325|FG002|Overall Study|Lost to Follow-up|4|||
155467378|NCT02471586|561131323|FG000|Overall Study|Death|2|||
155467379|NCT02471586|561131324|FG001|Overall Study|Death|2|||
155467380|NCT02471586|561131325|FG002|Overall Study|Death|0|||
155467381|NCT01419015|561131330|FG000|Overall Study|Death|2|||
155467382|NCT04839393|561131331|FG000|Overall Study|Adverse Event|0|||
155467383|NCT04839393|561131332|FG001|Overall Study|Adverse Event|0|||
155467384|NCT04839393|561131333|FG002|Overall Study|Adverse Event|2|||
155517587|NCT00788957|561319718|FG004|Part 1|Death|0|||
155652892|NCT01943825|561822230|FG002|Overall Study|Lost to Follow-up|12|||
155467385|NCT04839393|561131331|FG000|Overall Study|Withdrawal by participant|0|||
155517588|NCT00788957|561319719|FG005|Part 1|Death|0|||
155517589|NCT00788957|561319714|FG000|Part 1|Lost to Follow-up|1|||
155517590|NCT00788957|561319715|FG001|Part 1|Lost to Follow-up|0|||
155652893|NCT01943825|561822231|FG003|Overall Study|Lost to Follow-up|8|||
155652894|NCT01943825|561822228|FG000|Overall Study|Withdrawal by Subject|1|||
155467386|NCT04839393|561131332|FG001|Overall Study|Withdrawal by participant|0|||
155467387|NCT04839393|561131333|FG002|Overall Study|Withdrawal by participant|1|||
155467388|NCT01510028|561131334|FG000|Overall Study|Lack of Efficacy|1|||
155467389|NCT01510028|561131335|FG001|Overall Study|Lack of Efficacy|0|||
155517591|NCT00788957|561319716|FG002|Part 1|Lost to Follow-up|0|||
155517592|NCT00788957|561319717|FG003|Part 1|Lost to Follow-up|0|||
155517593|NCT00788957|561319718|FG004|Part 1|Lost to Follow-up|0|||
155517594|NCT00788957|561319719|FG005|Part 1|Lost to Follow-up|0|||
155517595|NCT00788957|561319714|FG000|Part 2|Withdrawal by Subject|0|||
155517596|NCT00788957|561319715|FG001|Part 2|Withdrawal by Subject|9|||
155517597|NCT00788957|561319716|FG002|Part 2|Withdrawal by Subject|5|||
155517598|NCT00788957|561319717|FG003|Part 2|Withdrawal by Subject|3|||
155517599|NCT00788957|561319718|FG004|Part 2|Withdrawal by Subject|0|||
155517600|NCT00788957|561319719|FG005|Part 2|Withdrawal by Subject|0|||
155517601|NCT00788957|561319714|FG000|Part 2|Death|0|||
155652895|NCT01943825|561822229|FG001|Overall Study|Withdrawal by Subject|0|||
155467390|NCT01510028|561131336|FG002|Overall Study|Lack of Efficacy|0|||
155467391|NCT01510028|561131337|FG003|Overall Study|Lack of Efficacy|0|||
155467392|NCT02741310|561131338|FG000|Overall Study|Sponsor Decision|2|||
155467393|NCT02741310|561131339|FG001|Overall Study|Sponsor Decision|2|||
155467394|NCT05091918|561131340|FG000|Overall Study|Adverse Event|1|||
155467395|NCT05091918|561131340|FG000|Overall Study|Withdrawal by Subject|81|||
155467396|NCT01100658|561131345|FG000|Overall Study|Withdrawal by Subject|1|||
155467397|NCT01784211|561131346|FG000|Part A (Days 1-15)|Adverse Event|1|||
155467398|NCT01784211|561131347|FG001|Part A (Days 1-15)|Adverse Event|1|||
155467399|NCT01784211|561131348|FG002|Part A (Days 1-15)|Adverse Event|0|||
155467400|NCT01784211|561131349|FG003|Part A (Days 1-15)|Adverse Event|0|||
155467401|NCT01784211|561131350|FG004|Part A (Days 1-15)|Adverse Event|0|||
155467402|NCT01784211|561131351|FG005|Part A (Days 1-15)|Adverse Event|0|||
155467403|NCT01784211|561131346|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
155467404|NCT01784211|561131347|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
155467405|NCT01784211|561131348|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
155467406|NCT01784211|561131349|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
155467407|NCT01784211|561131350|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
155467408|NCT01784211|561131351|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
155467409|NCT00239356|561131354|FG000|Overall Study|Lack of Efficacy|1|||
155467410|NCT00239356|561131355|FG001|Overall Study|Lack of Efficacy|0|||
155467411|NCT00239356|561131354|FG000|Overall Study|Adverse Event|6|||
155467412|NCT00239356|561131355|FG001|Overall Study|Adverse Event|0|||
155467413|NCT00239356|561131354|FG000|Overall Study|Withdrawal by Subject|15|||
155467414|NCT00239356|561131355|FG001|Overall Study|Withdrawal by Subject|6|||
155467415|NCT00239356|561131354|FG000|Overall Study|Lost to Follow-up|3|||
155467416|NCT00239356|561131355|FG001|Overall Study|Lost to Follow-up|0|||
155467417|NCT00239356|561131354|FG000|Overall Study|poor/non-compliance|2|||
155467418|NCT00239356|561131355|FG001|Overall Study|poor/non-compliance|0|||
155467419|NCT00239356|561131354|FG000|Overall Study|Pregnancy|1|||
155467420|NCT00239356|561131355|FG001|Overall Study|Pregnancy|0|||
155467421|NCT00239356|561131354|FG000|Overall Study|Administrative reason|0|||
155467422|NCT00239356|561131355|FG001|Overall Study|Administrative reason|1|||
155467423|NCT00239356|561131354|FG000|Overall Study|Drug available on market|11|||
155467424|NCT00239356|561131355|FG001|Overall Study|Drug available on market|2|||
155467425|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
155467426|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
155467427|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
155467428|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
155467429|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
155467430|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
155467431|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
155467432|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
155467433|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
155467434|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
155467435|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
155467436|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
155467437|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
155467438|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
155467439|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
155467440|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
155467441|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
155467442|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
155467443|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
155467444|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
155467445|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
155467446|NCT01001572|561131356|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
155467447|NCT01001572|561131357|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
155467448|NCT01001572|561131358|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
155467449|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155467450|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
155467451|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
155467452|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155467453|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
155467454|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
155467455|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
155467456|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
155467457|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
155467458|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
155467459|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
155517602|NCT00788957|561319715|FG001|Part 2|Death|32|||
155517603|NCT00788957|561319716|FG002|Part 2|Death|35|||
155467460|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
155467461|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
155467462|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
155467463|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
155467464|NCT01001572|561131356|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155467465|NCT01001572|561131357|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155467466|NCT01001572|561131358|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155467467|NCT01094808|561131359|FG000|Overall Study|Withdrawal by Subject|1|||
155467468|NCT01094808|561131360|FG001|Overall Study|Withdrawal by Subject|1|||
155467469|NCT01094808|561131361|FG002|Overall Study|Withdrawal by Subject|0|||
155467470|NCT00369278|561131362|FG000|Overall Study|Adverse Event|14|||
155467471|NCT00369278|561131363|FG001|Overall Study|Adverse Event|11|||
155467472|NCT00369278|561131362|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155467473|NCT00369278|561131363|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
155467474|NCT00369278|561131362|FG000|Overall Study|Protocol Violation|2|||
155467475|NCT00369278|561131363|FG001|Overall Study|Protocol Violation|1|||
155467476|NCT00369278|561131362|FG000|Overall Study|Withdrawal by Subject|2|||
155467477|NCT00369278|561131363|FG001|Overall Study|Withdrawal by Subject|2|||
155467478|NCT00369278|561131362|FG000|Overall Study|Lost to Follow-up|1|||
155467479|NCT00369278|561131363|FG001|Overall Study|Lost to Follow-up|0|||
155467480|NCT00369278|561131362|FG000|Overall Study|Graft loss|1|||
155467481|NCT00369278|561131363|FG001|Overall Study|Graft loss|2|||
155467482|NCT02143141|561131372|FG000|Overall Study|pain scores at 24 hours not collected|1|||
155467483|NCT02143141|561131373|FG001|Overall Study|pain scores at 24 hours not collected|0|||
155467484|NCT04397796|561131374|FG000|Overall Study|Death|3|||
155467485|NCT04397796|561131375|FG001|Overall Study|Death|1|||
155467486|NCT01809197|561131376|FG000|Overall Study|Lost to Follow-up|4|||
155467487|NCT01809197|561131377|FG001|Overall Study|Lost to Follow-up|2|||
155467488|NCT01809197|561131376|FG000|Overall Study|Adverse Event|2|||
155467489|NCT01809197|561131377|FG001|Overall Study|Adverse Event|3|||
155467490|NCT01809197|561131376|FG000|Overall Study|Failed slit lamp exam|1|||
155467491|NCT01809197|561131377|FG001|Overall Study|Failed slit lamp exam|0|||
155467492|NCT01809197|561131376|FG000|Overall Study|Non-Compliance|1|||
155467493|NCT01809197|561131377|FG001|Overall Study|Non-Compliance|1|||
155467494|NCT01809197|561131376|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
155517604|NCT00788957|561319717|FG003|Part 2|Death|37|||
155517605|NCT00788957|561319718|FG004|Part 2|Death|0|||
155517606|NCT00788957|561319719|FG005|Part 2|Death|0|||
155467495|NCT01809197|561131377|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
155467496|NCT01809197|561131376|FG000|Overall Study|Withdrawal by Subject|1|||
155467497|NCT01809197|561131377|FG001|Overall Study|Withdrawal by Subject|1|||
155467498|NCT01809197|561131376|FG000|Overall Study|Product not available|0|||
155467499|NCT01809197|561131377|FG001|Overall Study|Product not available|1|||
155467500|NCT00425113|561131378|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
155467501|NCT00425113|561131379|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
155467502|NCT00425113|561131378|FG000|Overall Study|diagnosis of abdominal TB|0|||
155467503|NCT00425113|561131379|FG001|Overall Study|diagnosis of abdominal TB|1|||
155517607|NCT00788957|561319714|FG000|Part 2|Lost to Follow-up|0|||
155517608|NCT00788957|561319715|FG001|Part 2|Lost to Follow-up|0|||
155467504|NCT00425113|561131378|FG000|Overall Study|missing study drug more than 14 days|0|||
155467505|NCT00425113|561131379|FG001|Overall Study|missing study drug more than 14 days|1|||
155467506|NCT00425113|561131378|FG000|Overall Study|Withdrawal by Subject|1|||
155467507|NCT00425113|561131379|FG001|Overall Study|Withdrawal by Subject|0|||
155467508|NCT04362813|561131380|FG000|Overall Study|Death|12|||
155467509|NCT04362813|561131381|FG001|Overall Study|Death|16|||
155467510|NCT04362813|561131380|FG000|Overall Study|Withdrawal by Subject|3|||
155467511|NCT04362813|561131381|FG001|Overall Study|Withdrawal by Subject|1|||
155467512|NCT04362813|561131380|FG000|Overall Study|Protocol Violation|0|||
155467513|NCT04362813|561131381|FG001|Overall Study|Protocol Violation|3|||
155467514|NCT04362813|561131380|FG000|Overall Study|Lost to Follow-up|1|||
155467515|NCT04362813|561131381|FG001|Overall Study|Lost to Follow-up|1|||
155467516|NCT04362813|561131380|FG000|Overall Study|Enrolled but did not receive treatment|2|||
155467517|NCT04362813|561131381|FG001|Overall Study|Enrolled but did not receive treatment|4|||
155467518|NCT02076334|561131388|FG000|Overall Study|Protocol Violation|1|||
155467519|NCT02076334|561131389|FG001|Overall Study|Protocol Violation|0|||
155467520|NCT02076334|561131390|FG002|Overall Study|Protocol Violation|0|||
155467521|NCT02076334|561131391|FG003|Overall Study|Protocol Violation|0|||
155467522|NCT02076334|561131388|FG000|Overall Study|Lost to Follow-up|0|||
155467523|NCT02076334|561131389|FG001|Overall Study|Lost to Follow-up|1|||
155467524|NCT02076334|561131390|FG002|Overall Study|Lost to Follow-up|1|||
155467525|NCT02076334|561131391|FG003|Overall Study|Lost to Follow-up|0|||
155467526|NCT02076334|561131388|FG000|Overall Study|muscle soreness|0|||
155467527|NCT02076334|561131389|FG001|Overall Study|muscle soreness|0|||
155467528|NCT02076334|561131390|FG002|Overall Study|muscle soreness|0|||
155467529|NCT02076334|561131391|FG003|Overall Study|muscle soreness|1|||
155467530|NCT03238352|561131392|FG000|Overall Study|Lost to Follow-up|0|||
155467531|NCT03238352|561131393|FG001|Overall Study|Lost to Follow-up|2|||
155467532|NCT03238352|561131394|FG002|Overall Study|Lost to Follow-up|1|||
155467533|NCT03238352|561131392|FG000|Overall Study|Withdrawal by Subject|0|||
155467534|NCT03238352|561131393|FG001|Overall Study|Withdrawal by Subject|1|||
155517609|NCT00788957|561319716|FG002|Part 2|Lost to Follow-up|3|||
155467535|NCT03238352|561131394|FG002|Overall Study|Withdrawal by Subject|0|||
155467536|NCT01654523|561131396|FG000|Overall Study|Withdrawal by Subject|1|||
155467537|NCT04294095|561131397|FG000|Overall Study|Adverse Event|1|||
155517610|NCT00788957|561319717|FG003|Part 2|Lost to Follow-up|0|||
155467538|NCT04294095|561131398|FG001|Overall Study|Adverse Event|0|||
155467539|NCT01142193|561131399|FG000|Overall Study|Adverse Event|12|||
155467540|NCT01142193|561131400|FG001|Overall Study|Adverse Event|4|||
155467541|NCT01142193|561131399|FG000|Overall Study|Lack of Efficacy|2|||
155467542|NCT01142193|561131400|FG001|Overall Study|Lack of Efficacy|1|||
155467543|NCT01142193|561131399|FG000|Overall Study|Physician Decision|1|||
155467544|NCT01142193|561131400|FG001|Overall Study|Physician Decision|1|||
155467545|NCT01142193|561131399|FG000|Overall Study|Withdrawal by Subject|4|||
155467546|NCT01142193|561131400|FG001|Overall Study|Withdrawal by Subject|3|||
155467547|NCT01142193|561131399|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
155467548|NCT01142193|561131400|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
155467549|NCT01142193|561131399|FG000|Overall Study|Other|1|||
155467550|NCT01142193|561131400|FG001|Overall Study|Other|2|||
155467551|NCT03136367|561131415|FG000|T1 Consultation|discontinued mistakenly included|2|||
155467552|NCT03136367|561131416|FG001|T1 Consultation|discontinued mistakenly included|6|||
155467553|NCT03136367|561131417|FG002|T1 Consultation|discontinued mistakenly included|1|||
155467554|NCT03136367|561131415|FG000|T1 Consultation|Discontinued other|0|||
155467555|NCT03136367|561131416|FG001|T1 Consultation|Discontinued other|1|||
155467556|NCT03136367|561131417|FG002|T1 Consultation|Discontinued other|0|||
155467557|NCT03136367|561131415|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
155467558|NCT03136367|561131416|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
155467559|NCT03136367|561131417|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
155467560|NCT03136367|561131415|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
155467561|NCT03136367|561131416|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
155467562|NCT03136367|561131417|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
155467563|NCT03136367|561131415|FG000|T2 Post-consultation|Discontinued other|0|||
155467564|NCT03136367|561131416|FG001|T2 Post-consultation|Discontinued other|2|||
155467565|NCT03136367|561131417|FG002|T2 Post-consultation|Discontinued other|6|||
155467566|NCT03136367|561131415|FG000|T2 Post-consultation|Discontinued transferred care|0|||
155467567|NCT03136367|561131416|FG001|T2 Post-consultation|Discontinued transferred care|0|||
155652896|NCT01943825|561822230|FG002|Overall Study|Withdrawal by Subject|3|||
155652897|NCT01943825|561822231|FG003|Overall Study|Withdrawal by Subject|2|||
155652898|NCT01943825|561822228|FG000|Overall Study|Other than specified above|0|||
155652899|NCT01943825|561822229|FG001|Overall Study|Other than specified above|1|||
155652900|NCT01943825|561822230|FG002|Overall Study|Other than specified above|0|||
155652901|NCT01943825|561822231|FG003|Overall Study|Other than specified above|1|||
155652902|NCT01472835|561822232|FG000|Overall Study|Lost to Follow-up|2|||
155652903|NCT01472835|561822233|FG001|Overall Study|Lost to Follow-up|0|||
155652904|NCT03425188|561822235|FG000|Overall Study|Withdrawal by Subject|1|||
155652905|NCT01044459|561822236|FG000|Overall Study|Withdrawal by Subject|21|||
155652906|NCT01044459|561822237|FG001|Overall Study|Withdrawal by Subject|28|||
155652907|NCT01044459|561822236|FG000|Overall Study|Terminated by Sponsor|22|||
155467568|NCT03136367|561131417|FG002|T2 Post-consultation|Discontinued transferred care|3|||
155652908|NCT01044459|561822237|FG001|Overall Study|Terminated by Sponsor|21|||
155652909|NCT01044459|561822236|FG000|Overall Study|Adverse Event|22|||
155652910|NCT01044459|561822237|FG001|Overall Study|Adverse Event|20|||
155652911|NCT01044459|561822236|FG000|Overall Study|Lack of Efficacy|23|||
155652912|NCT01044459|561822237|FG001|Overall Study|Lack of Efficacy|12|||
155652913|NCT01044459|561822236|FG000|Overall Study|Protocol Violation|11|||
155652914|NCT01044459|561822237|FG001|Overall Study|Protocol Violation|16|||
155652915|NCT01044459|561822236|FG000|Overall Study|Other Reason|7|||
155652916|NCT01044459|561822237|FG001|Overall Study|Other Reason|14|||
155652917|NCT01044459|561822236|FG000|Overall Study|COPD exacerbation|9|||
155652918|NCT01044459|561822237|FG001|Overall Study|COPD exacerbation|8|||
155652919|NCT01044459|561822236|FG000|Overall Study|Lost to Follow-up|18|||
155652920|NCT01044459|561822237|FG001|Overall Study|Lost to Follow-up|12|||
155652921|NCT05346640|561822238|FG000|Overall Study|Lack of Efficacy|2|||
155652922|NCT05346640|561822238|FG000|Overall Study|Lost to Follow-up|14|||
155652923|NCT05346640|561822238|FG000|Overall Study|Protocol Violation|4|||
155652924|NCT05346640|561822238|FG000|Overall Study|Withdrawal by Subject|2|||
155652925|NCT05346640|561822238|FG000|Overall Study|Physiological Complications|3|||
155652926|NCT05346640|561822238|FG000|Overall Study|Other Reason|3|||
155652927|NCT04634331|561822239|FG000|Overall Study|Withdrawal by Subject|2|||
155652928|NCT04634331|561822240|FG001|Overall Study|Withdrawal by Subject|2|||
155652929|NCT03726879|561822241|FG000|Overall Study|Death|11|||
155467569|NCT03136367|561131415|FG000|T2 Post-consultation|Discontinued lost contact|0|||
155467570|NCT03136367|561131416|FG001|T2 Post-consultation|Discontinued lost contact|1|||
155467571|NCT03136367|561131417|FG002|T2 Post-consultation|Discontinued lost contact|0|||
155467572|NCT03136367|561131415|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
155652930|NCT03726879|561822242|FG001|Overall Study|Death|13|||
155467573|NCT03136367|561131416|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
155652931|NCT03726879|561822241|FG000|Overall Study|Physician Decision|0|||
155652932|NCT03726879|561822242|FG001|Overall Study|Physician Decision|2|||
155652933|NCT03726879|561822241|FG000|Overall Study|Protocol Violation|0|||
155652934|NCT03726879|561822242|FG001|Overall Study|Protocol Violation|1|||
155652935|NCT03726879|561822241|FG000|Overall Study|Withdrawal by Subject|5|||
155467574|NCT03136367|561131417|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
155467575|NCT03136367|561131415|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
155467576|NCT03136367|561131416|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
155467577|NCT03136367|561131417|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
155467578|NCT03136367|561131415|FG000|T3 1 Week After Surgery|other discontinued|2|||
155467579|NCT03136367|561131416|FG001|T3 1 Week After Surgery|other discontinued|4|||
155467580|NCT03136367|561131417|FG002|T3 1 Week After Surgery|other discontinued|3|||
155467581|NCT03136367|561131415|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
155467582|NCT03136367|561131416|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
155467583|NCT03136367|561131417|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
155467584|NCT03136367|561131415|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
155467585|NCT03136367|561131416|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
155467586|NCT03136367|561131417|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
155467587|NCT03136367|561131415|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
155467588|NCT03136367|561131416|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
155467589|NCT03136367|561131417|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
155467590|NCT03136367|561131415|FG000|T4 12 Weeks After Surgery|Death|0|||
155467591|NCT03136367|561131416|FG001|T4 12 Weeks After Surgery|Death|1|||
155467592|NCT03136367|561131417|FG002|T4 12 Weeks After Surgery|Death|3|||
155467593|NCT03136367|561131415|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
155467594|NCT03136367|561131416|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
155517611|NCT00788957|561319718|FG004|Part 2|Lost to Follow-up|0|||
155517612|NCT00788957|561319719|FG005|Part 2|Lost to Follow-up|0|||
155517613|NCT00788957|561319714|FG000|Part 2|On-study at time of data cut-off|0|||
155517614|NCT00788957|561319715|FG001|Part 2|On-study at time of data cut-off|1|||
155517615|NCT00788957|561319716|FG002|Part 2|On-study at time of data cut-off|1|||
155517616|NCT00788957|561319717|FG003|Part 2|On-study at time of data cut-off|1|||
155517617|NCT00788957|561319718|FG004|Part 2|On-study at time of data cut-off|0|||
155517618|NCT00788957|561319719|FG005|Part 2|On-study at time of data cut-off|0|||
155467595|NCT03136367|561131417|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
155467596|NCT03136367|561131415|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
155467597|NCT03136367|561131416|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
155467598|NCT03136367|561131417|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
155467599|NCT03136367|561131415|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
155467600|NCT03136367|561131416|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
155467601|NCT03136367|561131417|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
155467602|NCT03136367|561131415|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
155467603|NCT03136367|561131416|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
155517619|NCT00788957|561319714|FG000|Part 3|Withdrawal by Subject|0|||
155467604|NCT03136367|561131417|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
155517620|NCT00788957|561319715|FG001|Part 3|Withdrawal by Subject|0|||
155467605|NCT03136367|561131415|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
155467606|NCT03136367|561131416|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
155467607|NCT03136367|561131417|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
155467608|NCT03136367|561131415|FG000|T5 1 Year After Surgery|Death|0|||
155467609|NCT03136367|561131416|FG001|T5 1 Year After Surgery|Death|0|||
155467610|NCT03136367|561131417|FG002|T5 1 Year After Surgery|Death|1|||
155467611|NCT03136367|561131415|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
155467612|NCT03136367|561131416|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
155467613|NCT03136367|561131417|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
155467614|NCT03136367|561131415|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
155467615|NCT03136367|561131416|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
155467616|NCT03136367|561131417|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
155467617|NCT03136367|561131415|FG000|T5 1 Year After Surgery|study ended before due|31|||
155467618|NCT03136367|561131416|FG001|T5 1 Year After Surgery|study ended before due|103|||
155467619|NCT03136367|561131417|FG002|T5 1 Year After Surgery|study ended before due|110|||
155467620|NCT03136367|561131415|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
155467621|NCT03136367|561131416|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
155467622|NCT03136367|561131417|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
155467623|NCT02146833|561131421|FG000|Overall Study|Death|10|||
155467624|NCT02146833|561131421|FG000|Overall Study|No longer consented to study treatment|1|||
155467625|NCT03726333|561131422|FG000|Overall Study|Progressive Disease|0|||
155467626|NCT03726333|561131423|FG001|Overall Study|Progressive Disease|0|||
155467627|NCT03726333|561131424|FG002|Overall Study|Progressive Disease|1|||
155467628|NCT03726333|561131425|FG003|Overall Study|Progressive Disease|0|||
155467629|NCT03726333|561131426|FG004|Overall Study|Progressive Disease|0|||
155467630|NCT00405275|561133604|FG000|Overall Study|Death|1|||
155467631|NCT00405275|561133605|FG001|Overall Study|Death|0|||
155467632|NCT00405275|561133604|FG000|Overall Study|Lost to Follow-up|5|||
155467633|NCT00405275|561133605|FG001|Overall Study|Lost to Follow-up|1|||
155467634|NCT00405275|561133604|FG000|Overall Study|Withdrawal by Subject|7|||
155467635|NCT00405275|561133605|FG001|Overall Study|Withdrawal by Subject|9|||
155467636|NCT00405275|561133604|FG000|Overall Study|Unwilling to continue|10|||
155467637|NCT00405275|561133605|FG001|Overall Study|Unwilling to continue|9|||
155467638|NCT00088595|561133606|FG000|Overall Study|Adverse Event|11|||
155467639|NCT00088595|561133606|FG000|Overall Study|Withdrawal by Subject|8|||
155467640|NCT00088595|561133606|FG000|Overall Study|Ongoing (After Core)|7|||
155467641|NCT00088595|561133606|FG000|Overall Study|New Cancer Therapy|2|||
155467642|NCT01308853|561133611|FG000|Overall Study|Adverse Event|1|||
155467643|NCT01308853|561133611|FG000|Overall Study|Lost to Follow-up|2|||
155467644|NCT01308853|561133611|FG000|Overall Study|Insertion of permanent implants|1|||
155467645|NCT01376388|561133616|FG000|Overall Study|Adverse Event|13|||
155467646|NCT01376388|561133616|FG000|Overall Study|Lack of Efficacy|2|||
155467647|NCT01376388|561133616|FG000|Overall Study|Withdrawal by Subject|3|||
155467648|NCT02009930|561133624|FG000|Overall Study|withdrawn|5|||
155467649|NCT00666536|561133627|FG000|Overall Study|Adverse Event|9|||
155467650|NCT00666536|561133628|FG001|Overall Study|Adverse Event|19|||
155467651|NCT00666536|561133627|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155467652|NCT00666536|561133628|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155467653|NCT00666536|561133627|FG000|Overall Study|Protocol deviation(s)|8|||
155467654|NCT00666536|561133628|FG001|Overall Study|Protocol deviation(s)|6|||
155652936|NCT03726879|561822242|FG001|Overall Study|Withdrawal by Subject|6|||
155467655|NCT00666536|561133627|FG000|Overall Study|Withdrawal by Subject|10|||
155652937|NCT03726879|561822241|FG000|Overall Study|TSH result is unstable|0|||
155467656|NCT00666536|561133628|FG001|Overall Study|Withdrawal by Subject|9|||
155652938|NCT03726879|561822242|FG001|Overall Study|TSH result is unstable|1|||
155652939|NCT03726879|561822241|FG000|Overall Study|Disease relapse|1|||
155467657|NCT00666536|561133627|FG000|Overall Study|Lost to Follow-up|4|||
155467658|NCT00666536|561133628|FG001|Overall Study|Lost to Follow-up|3|||
155467659|NCT02853123|561133632|FG000|Treatment Period 1|Adverse Event|0|||
155467660|NCT02853123|561133633|FG001|Treatment Period 1|Adverse Event|3|||
155467661|NCT02853123|561133632|FG000|Washout Period|Worsening of COPD|0|||
155467662|NCT02853123|561133633|FG001|Washout Period|Worsening of COPD|3|||
155467663|NCT02853123|561133632|FG000|Washout Period|Adverse Event|1|||
155467664|NCT02853123|561133633|FG001|Washout Period|Adverse Event|0|||
155467665|NCT03417505|561133636|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
155467666|NCT03417505|561133637|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
155467667|NCT03235726|561133642|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467668|NCT03235726|561133643|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467669|NCT03235726|561133644|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467670|NCT03235726|561133645|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467671|NCT03235726|561133646|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
155467672|NCT03235726|561133647|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467673|NCT03235726|561133648|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467674|NCT03235726|561133649|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467675|NCT03235726|561133650|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155652940|NCT03726879|561822242|FG001|Overall Study|Disease relapse|0|||
155467676|NCT03235726|561133651|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
155467677|NCT03235726|561133642|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467678|NCT03235726|561133643|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467679|NCT03235726|561133644|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467680|NCT03235726|561133645|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155652941|NCT03726879|561822241|FG000|Overall Study|Lost to Follow-up|3|||
155467681|NCT03235726|561133646|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
155467682|NCT03235726|561133647|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467683|NCT03235726|561133648|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467684|NCT03235726|561133649|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467685|NCT03235726|561133650|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467686|NCT03235726|561133651|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155467687|NCT00879437|561133652|FG000|Overall Study|Protocol Violation|0|||
155467688|NCT00879437|561133653|FG001|Overall Study|Protocol Violation|1|||
155467689|NCT00879437|561133652|FG000|Overall Study|Death|1|||
155517621|NCT00788957|561319716|FG002|Part 3|Withdrawal by Subject|0|||
155517622|NCT00788957|561319717|FG003|Part 3|Withdrawal by Subject|0|||
155517623|NCT00788957|561319718|FG004|Part 3|Withdrawal by Subject|0|||
155517624|NCT00788957|561319719|FG005|Part 3|Withdrawal by Subject|2|||
155517625|NCT00788957|561319714|FG000|Part 3|Death|0|||
155517626|NCT00788957|561319715|FG001|Part 3|Death|0|||
155517627|NCT00788957|561319716|FG002|Part 3|Death|0|||
155517628|NCT00788957|561319717|FG003|Part 3|Death|0|||
155517629|NCT00788957|561319718|FG004|Part 3|Death|8|||
155517630|NCT00788957|561319719|FG005|Part 3|Death|8|||
155517631|NCT00788957|561319714|FG000|Part 3|On-study at time of data cut-off|0|||
155517632|NCT00788957|561319715|FG001|Part 3|On-study at time of data cut-off|0|||
155517633|NCT00788957|561319716|FG002|Part 3|On-study at time of data cut-off|0|||
155517634|NCT00788957|561319717|FG003|Part 3|On-study at time of data cut-off|0|||
155517635|NCT00788957|561319718|FG004|Part 3|On-study at time of data cut-off|1|||
155517636|NCT00788957|561319719|FG005|Part 3|On-study at time of data cut-off|0|||
155517637|NCT02275364|561319720|FG000|Period 1|Withdrawal by Subject|1|||
155517638|NCT02275364|561319721|FG001|Period 1|Withdrawal by Subject|0|||
155517639|NCT02275364|561319720|FG000|Period 1|Other reason|1|||
155517640|NCT02275364|561319721|FG001|Period 1|Other reason|0|||
155517641|NCT00510510|561319722|FG000|Overall Study|Adverse Event|4|||
155517642|NCT00510510|561319723|FG001|Overall Study|Adverse Event|3|||
155517643|NCT00510510|561319724|FG002|Overall Study|Adverse Event|6|||
155517644|NCT00510510|561319722|FG000|Overall Study|Lack of Efficacy|0|||
155517645|NCT00510510|561319723|FG001|Overall Study|Lack of Efficacy|1|||
155517646|NCT00510510|561319724|FG002|Overall Study|Lack of Efficacy|1|||
155517647|NCT00510510|561319722|FG000|Overall Study|Subjects no longer requires study drug|0|||
155517648|NCT00510510|561319723|FG001|Overall Study|Subjects no longer requires study drug|0|||
155517649|NCT00510510|561319724|FG002|Overall Study|Subjects no longer requires study drug|2|||
155517650|NCT00510510|561319722|FG000|Overall Study|Withdrawal by Subject|1|||
155517651|NCT00510510|561319723|FG001|Overall Study|Withdrawal by Subject|2|||
155517652|NCT00510510|561319724|FG002|Overall Study|Withdrawal by Subject|3|||
155467690|NCT00879437|561133653|FG001|Overall Study|Death|0|||
155467691|NCT00291187|561133654|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
155467692|NCT00291187|561133655|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
155467693|NCT00291187|561133656|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
155467694|NCT00291187|561133657|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
155467695|NCT01040845|561133658|FG000|Overall Study|Withdrawal by Subject|1|||
155467696|NCT01040845|561133659|FG001|Overall Study|Withdrawal by Subject|1|||
155467697|NCT01040845|561133658|FG000|Overall Study|Physician Decision|1|||
155467698|NCT01040845|561133659|FG001|Overall Study|Physician Decision|0|||
155467699|NCT01732107|561133661|FG000|Overall Study|Adverse Event|2|||
155467700|NCT01732107|561133661|FG000|Overall Study|Disease Progression|8|||
155467701|NCT01732107|561133661|FG000|Overall Study|Physician Decision|1|||
155467702|NCT01732107|561133661|FG000|Overall Study|Withdrawal by Subject|2|||
155467703|NCT02023268|561133662|FG000|Overall Study|Lack of Efficacy|0|||
155467704|NCT02023268|561133663|FG001|Overall Study|Lack of Efficacy|1|||
155467705|NCT02023268|561133662|FG000|Overall Study|Adverse Event|0|||
155467706|NCT02023268|561133663|FG001|Overall Study|Adverse Event|2|||
155467707|NCT02023268|561133662|FG000|Overall Study|Withdrawal by Subject|0|||
155467708|NCT02023268|561133663|FG001|Overall Study|Withdrawal by Subject|1|||
155467709|NCT04445688|561133664|FG000|Washout (One Week)|Adverse Event|2|||
155467710|NCT04445688|561133664|FG000|Washout (One Week)|Withdrawal by Subject|1|||
155467711|NCT00615459|561133665|FG000|Period I|Adverse Event|2|||
155467712|NCT00615459|561133666|FG001|Period I|Adverse Event|0|||
155467713|NCT00615459|561133667|FG002|Period I|Adverse Event|1|||
155467714|NCT00615459|561133668|FG003|Period I|Adverse Event|0|||
155467715|NCT00615459|561133665|FG000|Period I|Subject withdrew consent|1|||
155467716|NCT00615459|561133666|FG001|Period I|Subject withdrew consent|0|||
155467717|NCT00615459|561133667|FG002|Period I|Subject withdrew consent|0|||
155467718|NCT00615459|561133668|FG003|Period I|Subject withdrew consent|1|||
155467719|NCT00615459|561133665|FG000|Period I|Abnormal test procedure results|1|||
155467720|NCT00615459|561133666|FG001|Period I|Abnormal test procedure results|1|||
155467721|NCT00615459|561133667|FG002|Period I|Abnormal test procedure results|1|||
155467722|NCT00615459|561133668|FG003|Period I|Abnormal test procedure results|0|||
155467723|NCT00615459|561133665|FG000|Period II|Adverse Event|1|||
155467724|NCT00615459|561133666|FG001|Period II|Adverse Event|0|||
155467725|NCT00615459|561133667|FG002|Period II|Adverse Event|0|||
155467726|NCT00615459|561133668|FG003|Period II|Adverse Event|0|||
155467727|NCT00615459|561133665|FG000|Period II|Lost to Follow-up|0|||
155467728|NCT00615459|561133666|FG001|Period II|Lost to Follow-up|0|||
155467729|NCT00615459|561133667|FG002|Period II|Lost to Follow-up|0|||
155467730|NCT00615459|561133668|FG003|Period II|Lost to Follow-up|1|||
155467731|NCT00615459|561133665|FG000|Period III|Adverse Event|0|||
155467732|NCT00615459|561133666|FG001|Period III|Adverse Event|1|||
155467733|NCT00615459|561133667|FG002|Period III|Adverse Event|0|||
155467734|NCT00615459|561133668|FG003|Period III|Adverse Event|0|||
155467735|NCT00615459|561133665|FG000|Period III|Administrative problems|0|||
155467736|NCT00615459|561133666|FG001|Period III|Administrative problems|1|||
155467737|NCT00615459|561133667|FG002|Period III|Administrative problems|1|||
155467738|NCT00615459|561133668|FG003|Period III|Administrative problems|0|||
155467739|NCT00615459|561133665|FG000|Period III|Unsatisfactory therapeutic effect|0|||
155467740|NCT00615459|561133666|FG001|Period III|Unsatisfactory therapeutic effect|1|||
155467741|NCT00615459|561133667|FG002|Period III|Unsatisfactory therapeutic effect|0|||
155467742|NCT00615459|561133668|FG003|Period III|Unsatisfactory therapeutic effect|0|||
155467743|NCT00918346|561133678|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
155467744|NCT00918346|561133679|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
155467745|NCT03379376|561133680|FG000|Overall Study|Lost to Follow-up|2|||
155467746|NCT03379376|561133680|FG000|Overall Study|Did not wish to complete follow up|1|||
155467747|NCT03379376|561133680|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
155467748|NCT03379376|561133680|FG000|Overall Study|Death|1|||
155467749|NCT01611298|561133681|FG000|Overall Study|Relapsed|2|||
155467750|NCT04153929|561133682|FG000|Overall Study|Other than listed|2|||
155467751|NCT04153929|561133683|FG001|Overall Study|Other than listed|2|||
155467752|NCT04153929|561133684|FG002|Overall Study|Other than listed|0|||
155467753|NCT04153929|561133685|FG003|Overall Study|Other than listed|1|||
155467754|NCT04153929|561133686|FG004|Overall Study|Other than listed|0|||
155467755|NCT04153929|561133687|FG005|Overall Study|Other than listed|2|||
155467756|NCT04153929|561133688|FG006|Overall Study|Other than listed|2|||
155467757|NCT04153929|561133689|FG007|Overall Study|Other than listed|1|||
155467758|NCT04153929|561133682|FG000|Overall Study|Lost to Follow-up|2|||
155467759|NCT04153929|561133683|FG001|Overall Study|Lost to Follow-up|1|||
155467760|NCT04153929|561133684|FG002|Overall Study|Lost to Follow-up|0|||
155467761|NCT04153929|561133685|FG003|Overall Study|Lost to Follow-up|1|||
155467762|NCT04153929|561133686|FG004|Overall Study|Lost to Follow-up|1|||
155467763|NCT04153929|561133687|FG005|Overall Study|Lost to Follow-up|0|||
155467764|NCT04153929|561133688|FG006|Overall Study|Lost to Follow-up|0|||
155467765|NCT04153929|561133689|FG007|Overall Study|Lost to Follow-up|0|||
155467766|NCT04153929|561133682|FG000|Overall Study|Withdrawal by Subject|3|||
155467767|NCT04153929|561133683|FG001|Overall Study|Withdrawal by Subject|1|||
155467768|NCT04153929|561133684|FG002|Overall Study|Withdrawal by Subject|0|||
155467769|NCT04153929|561133685|FG003|Overall Study|Withdrawal by Subject|3|||
155467770|NCT04153929|561133686|FG004|Overall Study|Withdrawal by Subject|1|||
155467771|NCT04153929|561133687|FG005|Overall Study|Withdrawal by Subject|0|||
155467772|NCT04153929|561133688|FG006|Overall Study|Withdrawal by Subject|1|||
155467773|NCT04153929|561133689|FG007|Overall Study|Withdrawal by Subject|0|||
155467774|NCT04153929|561133682|FG000|Overall Study|Protocol Violation|0|||
155467775|NCT04153929|561133683|FG001|Overall Study|Protocol Violation|0|||
155467776|NCT04153929|561133684|FG002|Overall Study|Protocol Violation|0|||
155467777|NCT04153929|561133685|FG003|Overall Study|Protocol Violation|0|||
155467778|NCT04153929|561133686|FG004|Overall Study|Protocol Violation|0|||
155467779|NCT04153929|561133687|FG005|Overall Study|Protocol Violation|0|||
155467780|NCT04153929|561133688|FG006|Overall Study|Protocol Violation|1|||
155467781|NCT04153929|561133689|FG007|Overall Study|Protocol Violation|2|||
155467782|NCT04153929|561133682|FG000|Overall Study|Adverse Event|3|||
155467783|NCT04153929|561133683|FG001|Overall Study|Adverse Event|5|||
155467784|NCT04153929|561133684|FG002|Overall Study|Adverse Event|5|||
155467785|NCT04153929|561133685|FG003|Overall Study|Adverse Event|11|||
155467786|NCT04153929|561133686|FG004|Overall Study|Adverse Event|15|||
155517653|NCT00510510|561319722|FG000|Overall Study|Lost to Follow-up|0|||
155467787|NCT04153929|561133687|FG005|Overall Study|Adverse Event|4|||
155467788|NCT04153929|561133688|FG006|Overall Study|Adverse Event|8|||
155467789|NCT04153929|561133689|FG007|Overall Study|Adverse Event|2|||
155467790|NCT04153929|561133682|FG000|Overall Study|Not treated|1|||
155467791|NCT04153929|561133683|FG001|Overall Study|Not treated|0|||
155467792|NCT04153929|561133684|FG002|Overall Study|Not treated|0|||
155517654|NCT00510510|561319723|FG001|Overall Study|Lost to Follow-up|0|||
155467793|NCT04153929|561133685|FG003|Overall Study|Not treated|0|||
155467794|NCT04153929|561133686|FG004|Overall Study|Not treated|0|||
155467795|NCT04153929|561133687|FG005|Overall Study|Not treated|0|||
155467796|NCT04153929|561133688|FG006|Overall Study|Not treated|1|||
155467797|NCT04153929|561133689|FG007|Overall Study|Not treated|0|||
155467798|NCT04083794|561133690|FG000|Overall Study|Lost to Follow-up|9|||
155467799|NCT01749800|561133693|FG000|Overall Study|not meeting inclusion criteria|3|||
155467800|NCT01749800|561133694|FG001|Overall Study|not meeting inclusion criteria|0|||
155467801|NCT01749800|561133695|FG002|Overall Study|not meeting inclusion criteria|0|||
155467802|NCT01749800|561133693|FG000|Overall Study|Withdrawal by Subject|0|||
155467803|NCT01749800|561133694|FG001|Overall Study|Withdrawal by Subject|1|||
155467804|NCT01749800|561133695|FG002|Overall Study|Withdrawal by Subject|0|||
155467805|NCT01975675|561133698|FG000|Overall Study|Death|0|||
155467806|NCT01975675|561133699|FG001|Overall Study|Death|1|||
155467807|NCT01975675|561133700|FG002|Overall Study|Death|0|||
155467808|NCT01975675|561133701|FG003|Overall Study|Death|0|||
155467809|NCT03639987|561133702|FG000|Overall Study|Study terminated by sponsor|26|||
155467810|NCT03639987|561133703|FG001|Overall Study|Study terminated by sponsor|25|||
155467811|NCT03639987|561133702|FG000|Overall Study|Lost to Follow-up|0|||
155467812|NCT03639987|561133703|FG001|Overall Study|Lost to Follow-up|1|||
155467813|NCT00224003|561133704|FG000|Overall Study|Adverse Event|1|||
155467814|NCT00224003|561133704|FG000|Overall Study|Protocol Violation|2|||
155467815|NCT00224003|561133704|FG000|Overall Study|Withdrawal by Subject|1|||
155467816|NCT00224003|561133704|FG000|Overall Study|unk|3|||
155467817|NCT00729326|561133709|FG000|Overall Study|Lost to Follow-up|2|||
155467818|NCT00729326|561133710|FG001|Overall Study|Lost to Follow-up|0|||
155467819|NCT00729326|561133709|FG000|Overall Study|Physician Decision|0|||
155467820|NCT00729326|561133710|FG001|Overall Study|Physician Decision|1|||
155467821|NCT00729326|561133709|FG000|Overall Study|Protocol Violation|3|||
155467822|NCT00729326|561133710|FG001|Overall Study|Protocol Violation|2|||
155467823|NCT00729326|561133709|FG000|Overall Study|Subject Decision|4|||
155467824|NCT00729326|561133710|FG001|Overall Study|Subject Decision|4|||
155467825|NCT00729326|561133709|FG000|Overall Study|Sponsor Decision|1|||
155467826|NCT00729326|561133710|FG001|Overall Study|Sponsor Decision|2|||
155467827|NCT01235728|561133714|FG000|Overall Study|Protocol Violation|0|||
155467828|NCT01235728|561133715|FG001|Overall Study|Protocol Violation|0|||
155467829|NCT01235728|561133716|FG002|Overall Study|Protocol Violation|0|||
155467830|NCT01235728|561133717|FG003|Overall Study|Protocol Violation|1|||
155467831|NCT01235728|561133718|FG004|Overall Study|Protocol Violation|0|||
155467832|NCT01235728|561133719|FG005|Overall Study|Protocol Violation|0|||
155467833|NCT01235728|561133720|FG006|Overall Study|Protocol Violation|0|||
155467834|NCT01235728|561133721|FG007|Overall Study|Protocol Violation|0|||
155467835|NCT01000025|561133722|FG000|Overall Study|Adverse Event|43|||
155467836|NCT01000025|561133723|FG001|Overall Study|Adverse Event|2|||
155467837|NCT01000025|561133722|FG000|Overall Study|Withdrawal by Subject|13|||
155467838|NCT01000025|561133723|FG001|Overall Study|Withdrawal by Subject|8|||
155467839|NCT01000025|561133722|FG000|Overall Study|Death|23|||
155467840|NCT01000025|561133723|FG001|Overall Study|Death|13|||
155467841|NCT01000025|561133722|FG000|Overall Study|Lack of Efficacy|363|||
155467842|NCT01000025|561133723|FG001|Overall Study|Lack of Efficacy|208|||
155467843|NCT01000025|561133722|FG000|Overall Study|Intercurrent Illness|26|||
155467844|NCT01000025|561133723|FG001|Overall Study|Intercurrent Illness|7|||
155467845|NCT02738580|561133724|FG000|Overall Study|Adverse Event|1|||
155467846|NCT02738580|561133725|FG001|Overall Study|Adverse Event|0|||
155467847|NCT02738580|561133724|FG000|Overall Study|Lack of Efficacy|3|||
155467848|NCT02738580|561133725|FG001|Overall Study|Lack of Efficacy|2|||
155467849|NCT02738580|561133724|FG000|Overall Study|Withdrawal by Subject|0|||
155467850|NCT02738580|561133725|FG001|Overall Study|Withdrawal by Subject|1|||
155467851|NCT02738580|561133724|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
155652942|NCT03726879|561822242|FG001|Overall Study|Lost to Follow-up|0|||
155467852|NCT02738580|561133725|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
155467853|NCT04354155|561133726|FG000|Overall Study|Withdrawal by Subject|1|||
155467854|NCT04354155|561133726|FG000|Overall Study|Did not meet criteria for study intervention|1|||
155467855|NCT01575899|561133731|FG000|Overall Study|Lost to Follow-up|3|||
155467856|NCT01575899|561133732|FG001|Overall Study|Lost to Follow-up|4|||
155467857|NCT01575899|561133733|FG002|Overall Study|Lost to Follow-up|2|||
155467858|NCT01575899|561133731|FG000|Overall Study|Protocol Violation|2|||
155467859|NCT01575899|561133732|FG001|Overall Study|Protocol Violation|1|||
155467860|NCT01575899|561133733|FG002|Overall Study|Protocol Violation|0|||
155467861|NCT03097029|561133734|FG000|Overall Study|Withdrawal by Subject|1|||
155467862|NCT02807844|561133735|FG000|Overall Study|Physician Decision|0|||
155467863|NCT02807844|561133736|FG001|Overall Study|Physician Decision|0|||
155467864|NCT02807844|561133737|FG002|Overall Study|Physician Decision|0|||
155467865|NCT02807844|561133738|FG003|Overall Study|Physician Decision|0|||
155467866|NCT02807844|561133739|FG004|Overall Study|Physician Decision|0|||
155467867|NCT02807844|561133740|FG005|Overall Study|Physician Decision|0|||
155467868|NCT02807844|561133741|FG006|Overall Study|Physician Decision|3|||
155467869|NCT02807844|561133742|FG007|Overall Study|Physician Decision|0|||
155467870|NCT02807844|561133743|FG008|Overall Study|Physician Decision|1|||
155467871|NCT02807844|561133744|FG009|Overall Study|Physician Decision|2|||
155467872|NCT02807844|561133735|FG000|Overall Study|Death|0|||
155467873|NCT02807844|561133736|FG001|Overall Study|Death|0|||
155467874|NCT02807844|561133737|FG002|Overall Study|Death|2|||
155467875|NCT02807844|561133738|FG003|Overall Study|Death|4|||
155467876|NCT02807844|561133739|FG004|Overall Study|Death|1|||
155467877|NCT02807844|561133740|FG005|Overall Study|Death|2|||
155467878|NCT02807844|561133741|FG006|Overall Study|Death|1|||
155467879|NCT02807844|561133742|FG007|Overall Study|Death|2|||
155467880|NCT02807844|561133743|FG008|Overall Study|Death|0|||
155467881|NCT02807844|561133744|FG009|Overall Study|Death|1|||
155467882|NCT02807844|561133735|FG000|Overall Study|Withdrawal by Subject|0|||
155467883|NCT02807844|561133736|FG001|Overall Study|Withdrawal by Subject|0|||
155467884|NCT02807844|561133737|FG002|Overall Study|Withdrawal by Subject|2|||
155467885|NCT02807844|561133738|FG003|Overall Study|Withdrawal by Subject|1|||
155467886|NCT02807844|561133739|FG004|Overall Study|Withdrawal by Subject|1|||
155467887|NCT02807844|561133740|FG005|Overall Study|Withdrawal by Subject|0|||
155467888|NCT02807844|561133741|FG006|Overall Study|Withdrawal by Subject|1|||
155467889|NCT02807844|561133742|FG007|Overall Study|Withdrawal by Subject|0|||
155467890|NCT02807844|561133743|FG008|Overall Study|Withdrawal by Subject|0|||
155467891|NCT02807844|561133744|FG009|Overall Study|Withdrawal by Subject|0|||
155467892|NCT02807844|561133735|FG000|Overall Study|Progressive disease|5|||
155467893|NCT02807844|561133736|FG001|Overall Study|Progressive disease|12|||
155467894|NCT02807844|561133737|FG002|Overall Study|Progressive disease|8|||
155467895|NCT02807844|561133738|FG003|Overall Study|Progressive disease|8|||
155467896|NCT02807844|561133739|FG004|Overall Study|Progressive disease|3|||
155467897|NCT02807844|561133740|FG005|Overall Study|Progressive disease|8|||
155467898|NCT02807844|561133741|FG006|Overall Study|Progressive disease|14|||
155467899|NCT02807844|561133742|FG007|Overall Study|Progressive disease|17|||
155467900|NCT02807844|561133743|FG008|Overall Study|Progressive disease|19|||
155467901|NCT02807844|561133744|FG009|Overall Study|Progressive disease|15|||
155467902|NCT02807844|561133735|FG000|Overall Study|Adverse Event|1|||
155467903|NCT02807844|561133736|FG001|Overall Study|Adverse Event|0|||
155467904|NCT02807844|561133737|FG002|Overall Study|Adverse Event|0|||
155467905|NCT02807844|561133738|FG003|Overall Study|Adverse Event|0|||
155467906|NCT02807844|561133739|FG004|Overall Study|Adverse Event|1|||
155467907|NCT02807844|561133740|FG005|Overall Study|Adverse Event|1|||
155467908|NCT02807844|561133741|FG006|Overall Study|Adverse Event|1|||
155467909|NCT02807844|561133742|FG007|Overall Study|Adverse Event|1|||
155467910|NCT02807844|561133743|FG008|Overall Study|Adverse Event|1|||
155467911|NCT02807844|561133744|FG009|Overall Study|Adverse Event|2|||
155467912|NCT00709124|561133745|FG000|Overall Study|Death|3|||
155467913|NCT00709124|561133746|FG001|Overall Study|Death|1|||
155467914|NCT00709124|561133745|FG000|Overall Study|encephalopathy; can't do assessment|1|||
155467915|NCT00709124|561133746|FG001|Overall Study|encephalopathy; can't do assessment|0|||
155467916|NCT00373490|561133747|FG000|Overall Study|Adverse Event|0|||
155467917|NCT00373490|561133748|FG001|Overall Study|Adverse Event|1|||
155467918|NCT00373490|561133747|FG000|Overall Study|Lack of Efficacy|9|||
155467919|NCT00373490|561133748|FG001|Overall Study|Lack of Efficacy|4|||
155467920|NCT00373490|561133747|FG000|Overall Study|Withdrawal by Subject|0|||
155467921|NCT00373490|561133748|FG001|Overall Study|Withdrawal by Subject|1|||
155467922|NCT00753688|561133755|FG000|Overall Study|Death|102|||
155467923|NCT00753688|561133756|FG001|Overall Study|Death|203|||
155467924|NCT00753688|561133755|FG000|Overall Study|Missing|4|||
155467925|NCT00753688|561133756|FG001|Overall Study|Missing|9|||
155467926|NCT00753688|561133755|FG000|Overall Study|Participant Withdrew Consent|2|||
155467927|NCT00753688|561133756|FG001|Overall Study|Participant Withdrew Consent|2|||
155467928|NCT00753688|561133755|FG000|Overall Study|Ongoing - in Follow-up|15|||
155467929|NCT00753688|561133756|FG001|Overall Study|Ongoing - in Follow-up|31|||
155467930|NCT00753688|561133755|FG000|Overall Study|Adverse Event|0|||
155467931|NCT00753688|561133756|FG001|Overall Study|Adverse Event|1|||
155467932|NCT00108953|561133757|FG000|Follow-up|Death|18|||
155467933|NCT00108953|561133758|FG001|Follow-up|Death|26|||
155467934|NCT00108953|561133757|FG000|Follow-up|Lost to Follow-up|1|||
155467935|NCT00108953|561133758|FG001|Follow-up|Lost to Follow-up|1|||
155467936|NCT00108953|561133757|FG000|Follow-up|Study terminated by sponsor|10|||
155467937|NCT00108953|561133758|FG001|Follow-up|Study terminated by sponsor|6|||
155467938|NCT02999100|561133759|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
155467939|NCT02999100|561133760|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
155467940|NCT02999100|561133761|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
155467941|NCT02999100|561133762|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
155467942|NCT02999100|561133763|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
155467943|NCT02999100|561133764|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
155467944|NCT02999100|561133759|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
155467945|NCT02999100|561133760|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
155467946|NCT02999100|561133761|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
155652943|NCT00553475|561822244|FG000|Overall Study|Adverse Event|7|||
155467947|NCT02999100|561133762|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
155467948|NCT02999100|561133763|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
155467949|NCT02999100|561133764|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
155467950|NCT02999100|561133759|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
155467951|NCT02999100|561133760|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
155467952|NCT02999100|561133761|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
155467953|NCT02999100|561133762|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
155467954|NCT02999100|561133763|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
155467955|NCT02999100|561133764|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
155467956|NCT03803202|561133765|FG000|Overall Study|Other|0|||
155467957|NCT03803202|561133766|FG001|Overall Study|Other|1|||
155467958|NCT03803202|561133767|FG002|Overall Study|Other|0|||
155467959|NCT03803202|561133768|FG003|Overall Study|Other|0|||
155467960|NCT03803202|561133769|FG004|Overall Study|Other|0|||
155467961|NCT03803202|561133770|FG005|Overall Study|Other|0|||
155467962|NCT03803202|561133771|FG006|Overall Study|Other|0|||
155467963|NCT03803202|561133772|FG007|Overall Study|Other|0|||
155467964|NCT03803202|561133773|FG008|Overall Study|Other|0|||
155467965|NCT03803202|561133765|FG000|Overall Study|Death|0|||
155467966|NCT03803202|561133766|FG001|Overall Study|Death|0|||
155467967|NCT03803202|561133767|FG002|Overall Study|Death|0|||
155467968|NCT03803202|561133768|FG003|Overall Study|Death|0|||
155467969|NCT03803202|561133769|FG004|Overall Study|Death|0|||
155467970|NCT03803202|561133770|FG005|Overall Study|Death|1|||
155467971|NCT03803202|561133771|FG006|Overall Study|Death|0|||
155467972|NCT03803202|561133772|FG007|Overall Study|Death|0|||
155467973|NCT03803202|561133773|FG008|Overall Study|Death|0|||
155467974|NCT03803202|561133765|FG000|Overall Study|Withdrawal by Subject|0|||
155467975|NCT03803202|561133766|FG001|Overall Study|Withdrawal by Subject|0|||
155467976|NCT03803202|561133767|FG002|Overall Study|Withdrawal by Subject|1|||
155467977|NCT03803202|561133768|FG003|Overall Study|Withdrawal by Subject|0|||
155467978|NCT03803202|561133769|FG004|Overall Study|Withdrawal by Subject|0|||
155467979|NCT03803202|561133770|FG005|Overall Study|Withdrawal by Subject|0|||
155467980|NCT03803202|561133771|FG006|Overall Study|Withdrawal by Subject|0|||
155467981|NCT03803202|561133772|FG007|Overall Study|Withdrawal by Subject|1|||
155467982|NCT03803202|561133773|FG008|Overall Study|Withdrawal by Subject|0|||
155467983|NCT03803202|561133765|FG000|Overall Study|Lost to Follow-up|0|||
155467984|NCT03803202|561133766|FG001|Overall Study|Lost to Follow-up|0|||
155467985|NCT03803202|561133767|FG002|Overall Study|Lost to Follow-up|0|||
155467986|NCT03803202|561133768|FG003|Overall Study|Lost to Follow-up|1|||
155467987|NCT03803202|561133769|FG004|Overall Study|Lost to Follow-up|1|||
155467988|NCT03803202|561133770|FG005|Overall Study|Lost to Follow-up|0|||
155467989|NCT03803202|561133771|FG006|Overall Study|Lost to Follow-up|1|||
155467990|NCT03803202|561133772|FG007|Overall Study|Lost to Follow-up|0|||
155467991|NCT03803202|561133773|FG008|Overall Study|Lost to Follow-up|0|||
155467992|NCT03595384|561133774|FG000|Overall Study|Other time commitments|8|||
155467993|NCT03595384|561133774|FG000|Overall Study|Changes to session time|7|||
155467994|NCT03595384|561133774|FG000|Overall Study|Relocation out of country|1|||
155467995|NCT01125293|561133775|FG000|Overall Study|Disease Progression|1|||
155467996|NCT01125293|561133776|FG001|Overall Study|Disease Progression|3|||
155467997|NCT01125293|561133777|FG002|Overall Study|Disease Progression|4|||
155467998|NCT01125293|561133778|FG003|Overall Study|Disease Progression|3|||
155467999|NCT01125293|561133779|FG004|Overall Study|Disease Progression|5|||
155468000|NCT01125293|561133780|FG005|Overall Study|Disease Progression|12|||
155468001|NCT01125293|561133775|FG000|Overall Study|Adverse Event|1|||
155468002|NCT01125293|561133776|FG001|Overall Study|Adverse Event|0|||
155468003|NCT01125293|561133777|FG002|Overall Study|Adverse Event|0|||
155468004|NCT01125293|561133778|FG003|Overall Study|Adverse Event|0|||
155468005|NCT01125293|561133779|FG004|Overall Study|Adverse Event|2|||
155468006|NCT01125293|561133780|FG005|Overall Study|Adverse Event|8|||
155468007|NCT01125293|561133775|FG000|Overall Study|Symptomatic Deterioration|1|||
155468008|NCT01125293|561133776|FG001|Overall Study|Symptomatic Deterioration|0|||
155468009|NCT01125293|561133777|FG002|Overall Study|Symptomatic Deterioration|0|||
155468010|NCT01125293|561133778|FG003|Overall Study|Symptomatic Deterioration|0|||
155468011|NCT01125293|561133779|FG004|Overall Study|Symptomatic Deterioration|0|||
155468012|NCT01125293|561133780|FG005|Overall Study|Symptomatic Deterioration|0|||
155468013|NCT01125293|561133775|FG000|Overall Study|Death|0|||
155468014|NCT01125293|561133776|FG001|Overall Study|Death|0|||
155468015|NCT01125293|561133777|FG002|Overall Study|Death|0|||
155468016|NCT01125293|561133778|FG003|Overall Study|Death|0|||
155468017|NCT01125293|561133779|FG004|Overall Study|Death|1|||
155468018|NCT01125293|561133780|FG005|Overall Study|Death|0|||
155468019|NCT01125293|561133775|FG000|Overall Study|Withdrawal by Subject|0|||
155468020|NCT01125293|561133776|FG001|Overall Study|Withdrawal by Subject|0|||
155468021|NCT01125293|561133777|FG002|Overall Study|Withdrawal by Subject|0|||
155468022|NCT01125293|561133778|FG003|Overall Study|Withdrawal by Subject|0|||
155468023|NCT01125293|561133779|FG004|Overall Study|Withdrawal by Subject|2|||
155468024|NCT01125293|561133780|FG005|Overall Study|Withdrawal by Subject|1|||
155468025|NCT01125293|561133775|FG000|Overall Study|Physician Decision|0|||
155468026|NCT01125293|561133776|FG001|Overall Study|Physician Decision|0|||
155468027|NCT01125293|561133777|FG002|Overall Study|Physician Decision|0|||
155468028|NCT01125293|561133778|FG003|Overall Study|Physician Decision|0|||
155468029|NCT01125293|561133779|FG004|Overall Study|Physician Decision|0|||
155468030|NCT01125293|561133780|FG005|Overall Study|Physician Decision|2|||
155468031|NCT00659126|561133783|FG000|Overall Study|Adverse Event|2|||
155468032|NCT00659126|561133784|FG001|Overall Study|Adverse Event|2|||
155468033|NCT00659126|561133783|FG000|Overall Study|Screen failure|1|||
155468034|NCT00659126|561133784|FG001|Overall Study|Screen failure|1|||
155468035|NCT00659126|561133783|FG000|Overall Study|Technical problems with MRI|0|||
155468036|NCT00659126|561133784|FG001|Overall Study|Technical problems with MRI|1|||
155468037|NCT02228564|561133788|FG000|Overall Study|Withdrawal by Subject|10|||
155468038|NCT02228564|561133788|FG000|Overall Study|Death|11|||
155468039|NCT02228564|561133788|FG000|Overall Study|Physician Decision|5|||
155468040|NCT02228564|561133788|FG000|Overall Study|Lost to Follow-up|17|||
155468041|NCT02228564|561133788|FG000|Overall Study|Other|6|||
155468042|NCT02633046|561133793|FG000|Overall Study|Adverse Event|8|||
155468043|NCT02633046|561133793|FG000|Overall Study|Physician Decision|7|||
155468044|NCT02633046|561133793|FG000|Overall Study|Withdrawal by Subject|8|||
155468045|NCT02633046|561133793|FG000|Overall Study|Increased proteinuria|2|||
155468046|NCT02633046|561133793|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
155468047|NCT02633046|561133793|FG000|Overall Study|Mutual decision patient and physician|1|||
155468048|NCT01068717|561133797|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
155468049|NCT01068717|561133798|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
155468050|NCT01068717|561133799|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
155468051|NCT01068717|561133800|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
155468052|NCT02679781|561133801|FG000|Overall Study|Lost to Follow-up|1|||
155468053|NCT02679781|561133802|FG001|Overall Study|Lost to Follow-up|2|||
155468054|NCT02679781|561133801|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
155468055|NCT02679781|561133802|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
155468056|NCT03700736|561133803|FG000|Overall Study|Pregnancy|1|||
155468057|NCT03700736|561133804|FG001|Overall Study|Pregnancy|1|||
155468058|NCT03700736|561133803|FG000|Overall Study|Withdrawal by Subject|2|||
155468059|NCT03700736|561133804|FG001|Overall Study|Withdrawal by Subject|6|||
155468060|NCT00446641|561135898|FG000|Overall Study|Withdrawal by Subject|8|||
155468061|NCT00446641|561135899|FG001|Overall Study|Withdrawal by Subject|3|||
155652944|NCT00553475|561822245|FG001|Overall Study|Adverse Event|17|||
155652945|NCT00553475|561822246|FG002|Overall Study|Adverse Event|13|||
155468062|NCT00446641|561135898|FG000|Overall Study|poor compliance|8|||
155468063|NCT00446641|561135899|FG001|Overall Study|poor compliance|6|||
155468064|NCT00446641|561135898|FG000|Overall Study|Lost to Follow-up|1|||
155468065|NCT00446641|561135899|FG001|Overall Study|Lost to Follow-up|1|||
155468066|NCT02959970|561135911|FG000|Overall Study|Adverse Event|1|||
155468067|NCT02959970|561135912|FG001|Overall Study|Adverse Event|0|||
155468068|NCT02959970|561135911|FG000|Overall Study|Withdrawal by Subject|0|||
155468069|NCT02959970|561135912|FG001|Overall Study|Withdrawal by Subject|2|||
155468070|NCT02959970|561135911|FG000|Overall Study|Lost to Follow-up|1|||
155468071|NCT02959970|561135912|FG001|Overall Study|Lost to Follow-up|5|||
155652946|NCT00553475|561822244|FG000|Overall Study|Lack of Efficacy|7|||
155468072|NCT01473355|561135917|FG000|Overall Study|Protocol Violation|2|||
155468073|NCT01473355|561135917|FG000|Overall Study|Adverse Event|2|||
155468074|NCT01473355|561135917|FG000|Overall Study|Lost to Follow-up|2|||
155468075|NCT04685538|561135918|FG000|Overall Study|Adverse Event|0|||
155468076|NCT04685538|561135919|FG001|Overall Study|Adverse Event|1|||
155468077|NCT04685538|561135918|FG000|Overall Study|Lost to Follow-up|0|||
155468078|NCT04685538|561135919|FG001|Overall Study|Lost to Follow-up|2|||
155468079|NCT02017704|561135921|FG000|Overall Study|Withdrawal by Subject|2|||
155468080|NCT02017704|561135922|FG001|Overall Study|Withdrawal by Subject|0|||
155468081|NCT02475629|561135923|FG000|Overall Study|Adverse Event|1|||
155468082|NCT02475629|561135923|FG000|Overall Study|Death|4|||
155468083|NCT02475629|561135923|FG000|Overall Study|Physician Decision|1|||
155468084|NCT02475629|561135923|FG000|Overall Study|Withdrawal by Subject|1|||
155468085|NCT02475629|561135923|FG000|Overall Study|Lost to Follow-up|1|||
155468086|NCT02475629|561135923|FG000|Overall Study|Subject non-compliance|1|||
155468087|NCT00928512|561135924|FG000|Overall Study|Adverse Event|4|||
155468088|NCT00928512|561135925|FG001|Overall Study|Adverse Event|3|||
155468089|NCT00928512|561135926|FG002|Overall Study|Adverse Event|2|||
155468090|NCT00928512|561135927|FG003|Overall Study|Adverse Event|8|||
155468091|NCT00928512|561135928|FG004|Overall Study|Adverse Event|6|||
155468092|NCT00928512|561135924|FG000|Overall Study|Lack of Efficacy|2|||
155468093|NCT00928512|561135925|FG001|Overall Study|Lack of Efficacy|0|||
155468094|NCT00928512|561135926|FG002|Overall Study|Lack of Efficacy|4|||
155468095|NCT00928512|561135927|FG003|Overall Study|Lack of Efficacy|7|||
155468096|NCT00928512|561135928|FG004|Overall Study|Lack of Efficacy|3|||
155468097|NCT00928512|561135924|FG000|Overall Study|Protocol Violation|0|||
155468098|NCT00928512|561135925|FG001|Overall Study|Protocol Violation|1|||
155468099|NCT00928512|561135926|FG002|Overall Study|Protocol Violation|0|||
155468100|NCT00928512|561135927|FG003|Overall Study|Protocol Violation|1|||
155468101|NCT00928512|561135928|FG004|Overall Study|Protocol Violation|3|||
155468102|NCT00928512|561135924|FG000|Overall Study|Withdrawal by Subject|3|||
155468103|NCT00928512|561135925|FG001|Overall Study|Withdrawal by Subject|0|||
155468104|NCT00928512|561135926|FG002|Overall Study|Withdrawal by Subject|3|||
155468105|NCT00928512|561135927|FG003|Overall Study|Withdrawal by Subject|4|||
155468106|NCT00928512|561135928|FG004|Overall Study|Withdrawal by Subject|0|||
155468107|NCT00928512|561135924|FG000|Overall Study|Lost to Follow-up|1|||
155468108|NCT00928512|561135925|FG001|Overall Study|Lost to Follow-up|1|||
155468109|NCT00928512|561135926|FG002|Overall Study|Lost to Follow-up|2|||
155468110|NCT00928512|561135927|FG003|Overall Study|Lost to Follow-up|1|||
155468111|NCT00928512|561135928|FG004|Overall Study|Lost to Follow-up|3|||
155468112|NCT00928512|561135924|FG000|Overall Study|Administrative Problems|0|||
155468113|NCT00928512|561135925|FG001|Overall Study|Administrative Problems|1|||
155468114|NCT00928512|561135926|FG002|Overall Study|Administrative Problems|0|||
155468115|NCT00928512|561135927|FG003|Overall Study|Administrative Problems|0|||
155468116|NCT00928512|561135928|FG004|Overall Study|Administrative Problems|0|||
155468117|NCT01963780|561135929|FG000|Overall Study|Death|7|||
155468118|NCT03383614|561135930|FG000|Overall Study|Withdrawal by Subject|0|||
155468119|NCT03383614|561135931|FG001|Overall Study|Withdrawal by Subject|1|||
155468120|NCT03383614|561135932|FG002|Overall Study|Withdrawal by Subject|0|||
155468121|NCT03383614|561135933|FG003|Overall Study|Withdrawal by Subject|0|||
155468122|NCT01296698|561135934|FG000|Overall Study|Adverse Event|1|||
155468123|NCT01296698|561135935|FG001|Overall Study|Adverse Event|0|||
155468124|NCT01296698|561135934|FG000|Overall Study|Death|1|||
155468125|NCT01296698|561135935|FG001|Overall Study|Death|0|||
155468126|NCT01296698|561135934|FG000|Overall Study|Lost to Follow-up|19|||
155468127|NCT01296698|561135935|FG001|Overall Study|Lost to Follow-up|1|||
155468128|NCT01296698|561135934|FG000|Overall Study|Withdrawal by Subject|12|||
155468129|NCT01296698|561135935|FG001|Overall Study|Withdrawal by Subject|0|||
155468130|NCT01296698|561135934|FG000|Overall Study|Difficulty Contacting Subject|2|||
155517655|NCT00510510|561319724|FG002|Overall Study|Lost to Follow-up|1|||
155517656|NCT00510510|561319722|FG000|Overall Study|Protocol Violation|0|||
155517657|NCT00510510|561319723|FG001|Overall Study|Protocol Violation|3|||
155517658|NCT00510510|561319724|FG002|Overall Study|Protocol Violation|4|||
155517659|NCT01200394|561319725|FG000|Overall Study|Adverse Event|0|||
155517660|NCT01200394|561319726|FG001|Overall Study|Adverse Event|14|||
155517661|NCT01200394|561319725|FG000|Overall Study|Death|1|||
155517662|NCT01200394|561319726|FG001|Overall Study|Death|0|||
155652947|NCT00553475|561822245|FG001|Overall Study|Lack of Efficacy|1|||
155652948|NCT00553475|561822246|FG002|Overall Study|Lack of Efficacy|0|||
155468131|NCT01296698|561135935|FG001|Overall Study|Difficulty Contacting Subject|0|||
155517663|NCT01200394|561319725|FG000|Overall Study|Lost to Follow-up|0|||
155468132|NCT01296698|561135934|FG000|Overall Study|Study Terminated by Sponsor|209|||
155468133|NCT01296698|561135935|FG001|Overall Study|Study Terminated by Sponsor|12|||
155468134|NCT03549429|561135940|FG000|Overall Study|Protocol Violation|5|||
155468135|NCT03549429|561135941|FG001|Overall Study|Protocol Violation|3|||
155517664|NCT01200394|561319726|FG001|Overall Study|Lost to Follow-up|1|||
155652949|NCT00553475|561822244|FG000|Overall Study|Withdrawal by Subject|1|||
155468136|NCT04423757|561135944|FG000|Overall Study|Adverse Event|2|||
155468137|NCT04423757|561135945|FG001|Overall Study|Adverse Event|0|||
155468138|NCT04423757|561135944|FG000|Overall Study|Not treated|1|||
155468139|NCT04423757|561135945|FG001|Overall Study|Not treated|1|||
155468140|NCT01202760|561135946|FG000|Overall Study|Entry Criteria Not Met|0|||
155468141|NCT01202760|561135947|FG001|Overall Study|Entry Criteria Not Met|3|||
155468142|NCT01202760|561135948|FG002|Overall Study|Entry Criteria Not Met|1|||
155468143|NCT01202760|561135946|FG000|Overall Study|Adverse Event|11|||
155468144|NCT01202760|561135947|FG001|Overall Study|Adverse Event|9|||
155468145|NCT01202760|561135948|FG002|Overall Study|Adverse Event|10|||
155468146|NCT01202760|561135946|FG000|Overall Study|Death|2|||
155468147|NCT01202760|561135947|FG001|Overall Study|Death|1|||
155468148|NCT01202760|561135948|FG002|Overall Study|Death|0|||
155468149|NCT01202760|561135946|FG000|Overall Study|Lack of Efficacy|6|||
155468150|NCT01202760|561135947|FG001|Overall Study|Lack of Efficacy|8|||
155468151|NCT01202760|561135948|FG002|Overall Study|Lack of Efficacy|7|||
155468152|NCT01202760|561135946|FG000|Overall Study|Lost to Follow-up|0|||
155468153|NCT01202760|561135947|FG001|Overall Study|Lost to Follow-up|2|||
155468154|NCT01202760|561135948|FG002|Overall Study|Lost to Follow-up|1|||
155468155|NCT01202760|561135946|FG000|Overall Study|Parent / Caregiver Decision|0|||
155468156|NCT01202760|561135947|FG001|Overall Study|Parent / Caregiver Decision|1|||
155468157|NCT01202760|561135948|FG002|Overall Study|Parent / Caregiver Decision|0|||
155468158|NCT01202760|561135946|FG000|Overall Study|Withdrawal by Subject|17|||
155468159|NCT01202760|561135947|FG001|Overall Study|Withdrawal by Subject|18|||
155468160|NCT01202760|561135948|FG002|Overall Study|Withdrawal by Subject|14|||
155468161|NCT01202760|561135946|FG000|Overall Study|Physician Decision|0|||
155468162|NCT01202760|561135947|FG001|Overall Study|Physician Decision|1|||
155468163|NCT01202760|561135948|FG002|Overall Study|Physician Decision|0|||
155468164|NCT01202760|561135946|FG000|Overall Study|Protocol Violation|7|||
155468165|NCT01202760|561135947|FG001|Overall Study|Protocol Violation|5|||
155468166|NCT01202760|561135948|FG002|Overall Study|Protocol Violation|2|||
155468167|NCT01202760|561135946|FG000|Overall Study|Sponsor Decision|4|||
155468168|NCT01202760|561135947|FG001|Overall Study|Sponsor Decision|4|||
155468169|NCT01202760|561135948|FG002|Overall Study|Sponsor Decision|0|||
155468170|NCT02810951|561135949|FG000|Overall Study|Adverse Event|1|||
155468171|NCT03199638|561135950|FG000|Overall Study|inability to drink glutamine during regularly|0|||
155468172|NCT03199638|561135951|FG001|Overall Study|inability to drink glutamine during regularly|2|||
155468173|NCT00293241|561135952|FG000|Overall Study|Lost to Follow-up|9|||
155468174|NCT00293241|561135953|FG001|Overall Study|Lost to Follow-up|16|||
155468175|NCT00293241|561135952|FG000|Overall Study|Physician Decision|23|||
155468176|NCT00293241|561135953|FG001|Overall Study|Physician Decision|17|||
155468177|NCT00293241|561135952|FG000|Overall Study|Withdrawal by Subject|4|||
155468178|NCT00293241|561135953|FG001|Overall Study|Withdrawal by Subject|8|||
155468179|NCT01270958|561135957|FG000|Overall Study|Lost to Follow-up|2|||
155468180|NCT01270958|561135957|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
155468181|NCT00260429|561135958|FG000|Overall Study|failure to follow appointments|1|||
155468182|NCT00260429|561135959|FG001|Overall Study|failure to follow appointments|0|||
155468183|NCT00260429|561135958|FG000|Overall Study|scheduled hand surgery|1|||
155468184|NCT00260429|561135959|FG001|Overall Study|scheduled hand surgery|0|||
155468185|NCT02142504|561135961|FG000|Overall Study|Protocol Violation|2|||
155468186|NCT02142504|561135962|FG001|Overall Study|Protocol Violation|1|||
155468187|NCT02142504|561135963|FG002|Overall Study|Protocol Violation|2|||
155468188|NCT02142504|561135961|FG000|Overall Study|Adverse Event|2|||
155468189|NCT02142504|561135962|FG001|Overall Study|Adverse Event|3|||
155468190|NCT02142504|561135963|FG002|Overall Study|Adverse Event|4|||
155468191|NCT02142504|561135961|FG000|Overall Study|Lost to Follow-up|12|||
155468192|NCT02142504|561135962|FG001|Overall Study|Lost to Follow-up|19|||
155468193|NCT02142504|561135963|FG002|Overall Study|Lost to Follow-up|17|||
155468194|NCT02142504|561135961|FG000|Overall Study|Withdrawal by Subject|7|||
155468195|NCT02142504|561135962|FG001|Overall Study|Withdrawal by Subject|9|||
155468196|NCT02142504|561135963|FG002|Overall Study|Withdrawal by Subject|11|||
155468197|NCT02142504|561135961|FG000|Overall Study|Pregnancy|4|||
155468198|NCT02142504|561135962|FG001|Overall Study|Pregnancy|4|||
155468199|NCT02142504|561135963|FG002|Overall Study|Pregnancy|2|||
155468200|NCT02142504|561135961|FG000|Overall Study|Physician Decision|0|||
155468201|NCT02142504|561135962|FG001|Overall Study|Physician Decision|1|||
155468202|NCT02142504|561135963|FG002|Overall Study|Physician Decision|3|||
155468203|NCT02142504|561135961|FG000|Overall Study|Reason Not Specified|4|||
155468204|NCT02142504|561135962|FG001|Overall Study|Reason Not Specified|5|||
155468205|NCT02142504|561135963|FG002|Overall Study|Reason Not Specified|4|||
155468206|NCT01998399|561135964|FG000|Overall Study|Lost to Follow-up|1|||
155468207|NCT01998399|561135965|FG001|Overall Study|Lost to Follow-up|3|||
155468208|NCT01998399|561135964|FG000|Overall Study|Death|4|||
155468209|NCT01998399|561135965|FG001|Overall Study|Death|2|||
155468210|NCT01998399|561135964|FG000|Overall Study|Study stopped before dosing completed|3|||
155468211|NCT01998399|561135965|FG001|Overall Study|Study stopped before dosing completed|3|||
155468212|NCT01998399|561135964|FG000|Overall Study|Withdrawal by Subject|0|||
155468213|NCT01998399|561135965|FG001|Overall Study|Withdrawal by Subject|1|||
155468214|NCT04114539|561135973|FG000|Overall Study|Adverse Event|14|||
155468215|NCT04114539|561135973|FG000|Overall Study|Lost to Follow-up|2|||
155468216|NCT04114539|561135973|FG000|Overall Study|Non-compliance with Protocol|2|||
155468217|NCT04114539|561135973|FG000|Overall Study|Non-compliance with Study Drug|1|||
155468218|NCT04114539|561135973|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
155468219|NCT04114539|561135973|FG000|Overall Study|Withdrew consent|10|||
155517665|NCT01200394|561319725|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155517666|NCT01200394|561319726|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
155517667|NCT01200394|561319725|FG000|Overall Study|Protocol Violation|0|||
155517668|NCT01200394|561319726|FG001|Overall Study|Protocol Violation|3|||
155517669|NCT01200394|561319725|FG000|Overall Study|Withdrawal by Subject|0|||
155517670|NCT01200394|561319726|FG001|Overall Study|Withdrawal by Subject|5|||
155517671|NCT01200394|561319725|FG000|Overall Study|Other|0|||
155517672|NCT01200394|561319726|FG001|Overall Study|Other|1|||
155517673|NCT00319449|561319727|FG000|Overall Study|Subject did not wish to continue|1|||
155517674|NCT00319449|561319728|FG001|Overall Study|Subject did not wish to continue|0|||
155517675|NCT00319449|561319727|FG000|Overall Study|Noncompliance with the protocol|1|||
155517676|NCT00319449|561319728|FG001|Overall Study|Noncompliance with the protocol|0|||
155517677|NCT00365352|561319729|FG000|Overall Study|Adverse Event|6|||
155517678|NCT00365352|561319730|FG001|Overall Study|Adverse Event|7|||
155517679|NCT00365352|561319731|FG002|Overall Study|Adverse Event|8|||
155517680|NCT00365352|561319729|FG000|Overall Study|Participant Withdrew Consent|8|||
155517681|NCT00365352|561319730|FG001|Overall Study|Participant Withdrew Consent|3|||
155517682|NCT00365352|561319731|FG002|Overall Study|Participant Withdrew Consent|4|||
155517683|NCT00365352|561319729|FG000|Overall Study|Lack of Efficacy|3|||
155517684|NCT00365352|561319730|FG001|Overall Study|Lack of Efficacy|0|||
155517685|NCT00365352|561319731|FG002|Overall Study|Lack of Efficacy|0|||
155517686|NCT00365352|561319729|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
155517687|NCT00365352|561319730|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
155517688|NCT00365352|561319731|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
155517689|NCT00365352|561319729|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
155517690|NCT00365352|561319730|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
155517691|NCT00365352|561319731|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
155517692|NCT00365352|561319729|FG000|Overall Study|Lost to Follow-up|1|||
155517693|NCT00365352|561319730|FG001|Overall Study|Lost to Follow-up|1|||
155517694|NCT00365352|561319731|FG002|Overall Study|Lost to Follow-up|0|||
155517695|NCT00365352|561319729|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
155517696|NCT00365352|561319730|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
155517697|NCT00365352|561319731|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
155517698|NCT02109133|561319732|FG000|Overall Study|Lost to Follow-up|1|||
155517699|NCT02109133|561319733|FG001|Overall Study|Lost to Follow-up|0|||
155517700|NCT02448771|561319734|FG000|Overall Study|Disease Progression|30|||
155517701|NCT02448771|561319734|FG000|Overall Study|Unacceptable Toxicity|1|||
155517702|NCT02448771|561319734|FG000|Overall Study|Physician Decision|3|||
155517703|NCT02448771|561319734|FG000|Overall Study|Started new therapy|2|||
155517704|NCT03968224|561319735|FG000|Overall Study|Lost to Follow-up|11|||
155517705|NCT03968224|561319736|FG001|Overall Study|Lost to Follow-up|18|||
155468220|NCT04114539|561135973|FG000|Overall Study|Others not specified|5|||
155517706|NCT00770315|561319738|FG000|Overall Study|Adverse Event|11|||
155517707|NCT00770315|561319739|FG001|Overall Study|Adverse Event|17|||
155517708|NCT00770315|561319740|FG002|Overall Study|Adverse Event|16|||
155517709|NCT00770315|561319741|FG003|Overall Study|Adverse Event|6|||
155517710|NCT00770315|561319738|FG000|Overall Study|Lost to Follow-up|9|||
155517711|NCT00770315|561319739|FG001|Overall Study|Lost to Follow-up|5|||
155517712|NCT00770315|561319740|FG002|Overall Study|Lost to Follow-up|10|||
155517713|NCT00770315|561319741|FG003|Overall Study|Lost to Follow-up|3|||
155517714|NCT00770315|561319738|FG000|Overall Study|Withdrawal by Subject|13|||
155517715|NCT00770315|561319739|FG001|Overall Study|Withdrawal by Subject|17|||
155517716|NCT00770315|561319740|FG002|Overall Study|Withdrawal by Subject|24|||
155517717|NCT00770315|561319741|FG003|Overall Study|Withdrawal by Subject|20|||
155517718|NCT00770315|561319738|FG000|Overall Study|Noncompliance with Protocol|7|||
155468221|NCT04114539|561135973|FG000|Overall Study|Investigator Decision|2|||
155517719|NCT00770315|561319739|FG001|Overall Study|Noncompliance with Protocol|4|||
155517720|NCT00770315|561319740|FG002|Overall Study|Noncompliance with Protocol|7|||
155517721|NCT00770315|561319741|FG003|Overall Study|Noncompliance with Protocol|9|||
155517722|NCT04256421|561319742|FG000|Overall Study|Death|171|||
155517723|NCT04256421|561319743|FG001|Overall Study|Death|180|||
155517724|NCT04256421|561319742|FG000|Overall Study|Lost to Follow-up|1|||
155517725|NCT04256421|561319743|FG001|Overall Study|Lost to Follow-up|1|||
155517726|NCT04256421|561319742|FG000|Overall Study|Withdrawal by Subject|9|||
155517727|NCT04256421|561319743|FG001|Overall Study|Withdrawal by Subject|10|||
155517728|NCT04256421|561319742|FG000|Overall Study|Ongoing in Study|66|||
155652950|NCT00553475|561822245|FG001|Overall Study|Withdrawal by Subject|1|||
155517729|NCT04256421|561319743|FG001|Overall Study|Ongoing in Study|52|||
155652951|NCT00553475|561822246|FG002|Overall Study|Withdrawal by Subject|0|||
155652952|NCT00553475|561822244|FG000|Overall Study|Physician Decision|1|||
155652953|NCT00553475|561822245|FG001|Overall Study|Physician Decision|0|||
155652954|NCT00553475|561822246|FG002|Overall Study|Physician Decision|0|||
155652955|NCT00553475|561822244|FG000|Overall Study|Due to moving|0|||
155652956|NCT00553475|561822245|FG001|Overall Study|Due to moving|1|||
155652957|NCT00553475|561822246|FG002|Overall Study|Due to moving|0|||
155652958|NCT00890097|561822247|FG000|Overall Study|Adverse Event|21|||
155652959|NCT00890097|561822248|FG001|Overall Study|Adverse Event|32|||
155652960|NCT00890097|561822249|FG002|Overall Study|Adverse Event|28|||
155652961|NCT00890097|561822247|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
155652962|NCT00890097|561822248|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
155652963|NCT00890097|561822249|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
155652964|NCT00890097|561822247|FG000|Overall Study|Withdrew Consent|9|||
155652965|NCT00890097|561822248|FG001|Overall Study|Withdrew Consent|6|||
155652966|NCT00890097|561822249|FG002|Overall Study|Withdrew Consent|9|||
155652967|NCT00890097|561822247|FG000|Overall Study|Lost to Follow-up|5|||
155468222|NCT00617591|561135974|FG000|Overall Study|Withdrew consent during Induction|4|||
155468223|NCT00617591|561135974|FG000|Overall Study|Withdrew consent during Maintenance|6|||
155468224|NCT00376246|561135975|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
155468225|NCT00376246|561135976|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
155468226|NCT00376246|561135975|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155468227|NCT00376246|561135976|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
155468228|NCT00376246|561135975|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155468229|NCT00376246|561135976|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155468230|NCT00166517|561135981|FG000|Overall Study|Lost to Follow-up|1|||
155468231|NCT00166517|561135982|FG001|Overall Study|Lost to Follow-up|0|||
155468232|NCT00166517|561135981|FG000|Overall Study|Protocol Violation|4|||
155468233|NCT00166517|561135982|FG001|Overall Study|Protocol Violation|1|||
155468234|NCT00166517|561135981|FG000|Overall Study|Withdrawal by Subject|0|||
155468235|NCT00166517|561135982|FG001|Overall Study|Withdrawal by Subject|1|||
155468236|NCT01455415|561135986|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
155468237|NCT01455415|561135987|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
155468238|NCT01455415|561135986|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
155468239|NCT01455415|561135987|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
155468240|NCT01455415|561135986|FG000|Period 1|Drug Error not Associated to AE|0|||
155468241|NCT01455415|561135987|FG001|Period 1|Drug Error not Associated to AE|1|||
155468242|NCT01455415|561135986|FG000|Period 1|AE Not Related to Study Drug|2|||
155468243|NCT01455415|561135987|FG001|Period 1|AE Not Related to Study Drug|6|||
155468244|NCT01455415|561135986|FG000|Period 1|Withdrawal by Subject|4|||
155468245|NCT01455415|561135987|FG001|Period 1|Withdrawal by Subject|5|||
155468246|NCT01455415|561135986|FG000|Period 1|Unspecified Reason|1|||
155468247|NCT01455415|561135987|FG001|Period 1|Unspecified Reason|1|||
155468248|NCT01455415|561135986|FG000|Period 1|Protocol Violation|0|||
155468249|NCT01455415|561135987|FG001|Period 1|Protocol Violation|2|||
155468250|NCT01455415|561135986|FG000|Washout|AE Related to Study Drug|2|||
155468251|NCT01455415|561135987|FG001|Washout|AE Related to Study Drug|0|||
155468252|NCT01455415|561135986|FG000|Washout|Lost to Follow-up|1|||
155468253|NCT01455415|561135987|FG001|Washout|Lost to Follow-up|0|||
155468254|NCT01455415|561135986|FG000|Washout|Drug Error not Associated to AE|2|||
155468255|NCT01455415|561135987|FG001|Washout|Drug Error not Associated to AE|1|||
155468256|NCT01455415|561135986|FG000|Washout|AE Not Related to Study Drug|2|||
155468257|NCT01455415|561135987|FG001|Washout|AE Not Related to Study Drug|3|||
155468258|NCT01455415|561135986|FG000|Washout|Unspecified Reason|1|||
155468259|NCT01455415|561135987|FG001|Washout|Unspecified Reason|2|||
155468260|NCT01455415|561135986|FG000|Washout|Protocol Violation|0|||
155468261|NCT01455415|561135987|FG001|Washout|Protocol Violation|1|||
155468262|NCT01455415|561135986|FG000|Period 2|AE Related to Study Drug|1|||
155468263|NCT01455415|561135987|FG001|Period 2|AE Related to Study Drug|2|||
155468264|NCT01455415|561135986|FG000|Period 2|Lost to Follow-up|2|||
155468265|NCT01455415|561135987|FG001|Period 2|Lost to Follow-up|1|||
155468266|NCT01455415|561135986|FG000|Period 2|AE Not Related to Study Drug|2|||
155468267|NCT01455415|561135987|FG001|Period 2|AE Not Related to Study Drug|1|||
155468268|NCT01455415|561135986|FG000|Period 2|Lack of Efficacy|2|||
155468269|NCT01455415|561135987|FG001|Period 2|Lack of Efficacy|0|||
155468270|NCT01455415|561135986|FG000|Period 2|Withdrawal by Subject|2|||
155468271|NCT01455415|561135987|FG001|Period 2|Withdrawal by Subject|3|||
155468272|NCT01455415|561135986|FG000|Period 2|Unspecified Reason|2|||
155468273|NCT01455415|561135987|FG001|Period 2|Unspecified Reason|3|||
155468274|NCT01455415|561135986|FG000|Period 2|Protocol Violation|2|||
155468275|NCT01455415|561135987|FG001|Period 2|Protocol Violation|0|||
155468276|NCT01455415|561135986|FG000|Follow-up|AE Related to Study Drug|0|||
155652968|NCT00890097|561822248|FG001|Overall Study|Lost to Follow-up|5|||
155468277|NCT01455415|561135987|FG001|Follow-up|AE Related to Study Drug|1|||
155468278|NCT01455415|561135986|FG000|Follow-up|Lack of Efficacy|0|||
155468279|NCT01455415|561135987|FG001|Follow-up|Lack of Efficacy|1|||
155468280|NCT01455415|561135986|FG000|Follow-up|Withdrawal by Subject|2|||
155652969|NCT00890097|561822249|FG002|Overall Study|Lost to Follow-up|5|||
155652970|NCT00890097|561822247|FG000|Overall Study|Noncompliance|0|||
155468281|NCT01455415|561135987|FG001|Follow-up|Withdrawal by Subject|0|||
155468282|NCT01455415|561135986|FG000|Follow-up|Unspecified Reason|1|||
155468283|NCT01455415|561135987|FG001|Follow-up|Unspecified Reason|0|||
155468284|NCT03094611|561135988|FG000|Overall Study|Lack of Efficacy|1|||
155468285|NCT03094611|561135988|FG000|Overall Study|Stem Cell Transplant|1|||
155468286|NCT04285853|561135989|FG000|Overall Study|Withdrawal by Subject|1|||
155468287|NCT04285853|561135990|FG001|Overall Study|Withdrawal by Subject|0|||
155468288|NCT04285853|561135989|FG000|Overall Study|Lost to Follow-up|9|||
155468289|NCT04285853|561135990|FG001|Overall Study|Lost to Follow-up|5|||
155468290|NCT02758613|561135992|FG000|Treatment|Physician and Sponsor Decision|1|||
155468291|NCT02758613|561135993|FG001|Treatment|Physician and Sponsor Decision|0|||
155468292|NCT02758613|561135994|FG002|Treatment|Physician and Sponsor Decision|0|||
155468293|NCT02758613|561135995|FG003|Treatment|Physician and Sponsor Decision|0|||
155468294|NCT02758613|561135992|FG000|Treatment|Withdrawal by Subject|1|||
155468295|NCT02758613|561135993|FG001|Treatment|Withdrawal by Subject|0|||
155468296|NCT02758613|561135994|FG002|Treatment|Withdrawal by Subject|1|||
155468297|NCT02758613|561135995|FG003|Treatment|Withdrawal by Subject|0|||
155468298|NCT01496274|561135996|FG000|Overall Study|Protocol Violation|0|||
155468299|NCT01496274|561135997|FG001|Overall Study|Protocol Violation|1|||
155468300|NCT01496274|561135996|FG000|Overall Study|Adverse Event|1|||
155468301|NCT01496274|561135997|FG001|Overall Study|Adverse Event|1|||
155468302|NCT01496274|561135996|FG000|Overall Study|Withdrawal by Subject|2|||
155468303|NCT01496274|561135997|FG001|Overall Study|Withdrawal by Subject|0|||
155468304|NCT01496274|561135996|FG000|Overall Study|Lost to Follow-up|0|||
155468305|NCT01496274|561135997|FG001|Overall Study|Lost to Follow-up|3|||
155468306|NCT00351819|561135999|FG000|Overall Study|Lost to Follow-up|4|||
155468307|NCT00351819|561136000|FG001|Overall Study|Lost to Follow-up|4|||
155468308|NCT00351819|561135999|FG000|Overall Study|Withdrawal by Subject|0|||
155468309|NCT00351819|561136000|FG001|Overall Study|Withdrawal by Subject|4|||
155468310|NCT00351819|561135999|FG000|Overall Study|Elevated PSA|1|||
155468311|NCT00351819|561136000|FG001|Overall Study|Elevated PSA|1|||
155468312|NCT00351819|561135999|FG000|Overall Study|Traumatic ankle fracture|1|||
155468313|NCT00351819|561136000|FG001|Overall Study|Traumatic ankle fracture|0|||
155468314|NCT00351819|561135999|FG000|Overall Study|Unprofessional behavior|1|||
155468315|NCT00351819|561136000|FG001|Overall Study|Unprofessional behavior|0|||
155468316|NCT00351819|561135999|FG000|Overall Study|Non-compliance|0|||
155468317|NCT00351819|561136000|FG001|Overall Study|Non-compliance|1|||
155468318|NCT00351819|561135999|FG000|Overall Study|Incarcerated|0|||
155468319|NCT00351819|561136000|FG001|Overall Study|Incarcerated|1|||
155468320|NCT00351819|561135999|FG000|Overall Study|Enrolled in another trial|0|||
155468321|NCT00351819|561136000|FG001|Overall Study|Enrolled in another trial|1|||
155468322|NCT00249795|561136002|FG000|Overall Study|Not treated|16|||
155468323|NCT00249795|561136003|FG001|Overall Study|Not treated|14|||
155468324|NCT00249795|561136002|FG000|Overall Study|Symptomatic hypotension|127|||
155468325|NCT00249795|561136003|FG001|Overall Study|Symptomatic hypotension|64|||
155468326|NCT00249795|561136002|FG000|Overall Study|Other Serious Adverse Event|84|||
155468327|NCT00249795|561136003|FG001|Overall Study|Other Serious Adverse Event|93|||
155468328|NCT00249795|561136002|FG000|Overall Study|Qualifying condition not present|26|||
155468329|NCT00249795|561136003|FG001|Overall Study|Qualifying condition not present|29|||
155468330|NCT00249795|561136002|FG000|Overall Study|Withdrawal by Subject|678|||
155468331|NCT00249795|561136003|FG001|Overall Study|Withdrawal by Subject|742|||
155468332|NCT00249795|561136002|FG000|Overall Study|Thromboembolic / outcome event|39|||
155468333|NCT00249795|561136003|FG001|Overall Study|Thromboembolic / outcome event|45|||
155468334|NCT00249795|561136002|FG000|Overall Study|Oral anticoagulant required|2|||
155468335|NCT00249795|561136003|FG001|Overall Study|Oral anticoagulant required|0|||
155468336|NCT00249795|561136002|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
155468337|NCT00249795|561136003|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
155468338|NCT00249795|561136002|FG000|Overall Study|Non-compliance|71|||
155468339|NCT00249795|561136003|FG001|Overall Study|Non-compliance|69|||
155468340|NCT00249795|561136002|FG000|Overall Study|Study drug intolerance|3|||
155468341|NCT00249795|561136003|FG001|Overall Study|Study drug intolerance|3|||
155517730|NCT02785913|561321304|FG000|Overall Study|Adverse Event|5|||
155652971|NCT00890097|561822248|FG001|Overall Study|Noncompliance|4|||
155468342|NCT00249795|561136002|FG000|Overall Study|Other adverse events (non-serious)|188|||
155468343|NCT00249795|561136003|FG001|Overall Study|Other adverse events (non-serious)|159|||
155468344|NCT00249795|561136002|FG000|Overall Study|Physician withdrew consent|71|||
155468345|NCT00249795|561136003|FG001|Overall Study|Physician withdrew consent|63|||
155468346|NCT00249795|561136002|FG000|Overall Study|Surgery / procedure|4|||
155468347|NCT00249795|561136003|FG001|Overall Study|Surgery / procedure|5|||
155468348|NCT00249795|561136002|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
155468349|NCT00249795|561136003|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
155468350|NCT00249795|561136002|FG000|Overall Study|Lightheadedness / dizziness|15|||
155468351|NCT00249795|561136003|FG001|Overall Study|Lightheadedness / dizziness|11|||
155468352|NCT00249795|561136002|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
155468353|NCT00249795|561136003|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
155468354|NCT00249795|561136002|FG000|Overall Study|Other contraindicated medication|1|||
155468355|NCT00249795|561136003|FG001|Overall Study|Other contraindicated medication|1|||
155468356|NCT00249795|561136002|FG000|Overall Study|Event related to cardiac condition|17|||
155468357|NCT00249795|561136003|FG001|Overall Study|Event related to cardiac condition|16|||
155468358|NCT00249795|561136002|FG000|Overall Study|Patient not wish to continue after May08|4|||
155468359|NCT00249795|561136003|FG001|Overall Study|Patient not wish to continue after May08|6|||
155468360|NCT00249795|561136002|FG000|Overall Study|Site not agree to continue after May08|1|||
155468361|NCT00249795|561136003|FG001|Overall Study|Site not agree to continue after May08|1|||
155468362|NCT00249795|561136002|FG000|Overall Study|Lost to Follow-up|0|||
155468363|NCT00249795|561136003|FG001|Overall Study|Lost to Follow-up|2|||
155468364|NCT00249795|561136002|FG000|Overall Study|Missing|0|||
155468365|NCT00249795|561136003|FG001|Overall Study|Missing|1|||
155468366|NCT00719537|561136005|FG000|Overall Study|Withdrawal by Subject|1|||
155468367|NCT00719537|561136006|FG001|Overall Study|Withdrawal by Subject|0|||
155468368|NCT00719537|561136005|FG000|Overall Study|Lost to Follow-up|0|||
155468369|NCT00719537|561136006|FG001|Overall Study|Lost to Follow-up|1|||
155468370|NCT02460978|561136007|FG000|Overall Study|Adverse Event|17|||
155468371|NCT02460978|561136008|FG001|Overall Study|Adverse Event|11|||
155468372|NCT02460978|561136009|FG002|Overall Study|Adverse Event|11|||
155468373|NCT02460978|561136007|FG000|Overall Study|Withdrawal by Subject|5|||
155468374|NCT02460978|561136008|FG001|Overall Study|Withdrawal by Subject|5|||
155468375|NCT02460978|561136009|FG002|Overall Study|Withdrawal by Subject|14|||
155468376|NCT02460978|561136007|FG000|Overall Study|Lost to Follow-up|2|||
155468377|NCT02460978|561136008|FG001|Overall Study|Lost to Follow-up|3|||
155468378|NCT02460978|561136009|FG002|Overall Study|Lost to Follow-up|1|||
155468379|NCT02460978|561136007|FG000|Overall Study|Protocol Violation|1|||
155468380|NCT02460978|561136008|FG001|Overall Study|Protocol Violation|1|||
155468381|NCT02460978|561136009|FG002|Overall Study|Protocol Violation|1|||
155468382|NCT02460978|561136007|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
155468383|NCT02460978|561136008|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
155468384|NCT02460978|561136009|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
155468385|NCT02460978|561136007|FG000|Overall Study|Pregnancy|0|||
155468386|NCT02460978|561136008|FG001|Overall Study|Pregnancy|0|||
155468387|NCT02460978|561136009|FG002|Overall Study|Pregnancy|2|||
155468388|NCT00588523|561136015|FG000|Overall Study|Not treated|3|||
155468389|NCT01459068|561136016|FG000|Overall Study|Withdrawal by Subject|8|||
155468390|NCT01459068|561136017|FG001|Overall Study|Withdrawal by Subject|18|||
155468391|NCT01459068|561136016|FG000|Overall Study|Lost to Follow-up|31|||
155468392|NCT01459068|561136017|FG001|Overall Study|Lost to Follow-up|15|||
155468393|NCT01459068|561136016|FG000|Overall Study|Death|0|||
155468394|NCT01459068|561136017|FG001|Overall Study|Death|1|||
155468395|NCT02023112|561136022|FG000|Overall Study|Withdrawal by Subject|2|||
155468396|NCT02023112|561136023|FG001|Overall Study|Withdrawal by Subject|1|||
155468397|NCT02910219|561136024|FG000|Overall Study|Withdrawal by Subject|1|||
155468398|NCT02910219|561136025|FG001|Overall Study|Withdrawal by Subject|1|||
155468399|NCT01425749|561136026|FG000|Overall Study|progression of melanoma|0|||
155468400|NCT01425749|561136027|FG001|Overall Study|progression of melanoma|1|||
155468401|NCT02096042|561136028|FG000|Overall Study|Disease Progression|1|||
155468402|NCT02096042|561136029|FG001|Overall Study|Disease Progression|0|||
155468403|NCT02096042|561136030|FG002|Overall Study|Disease Progression|0|||
155468404|NCT00701441|561136031|FG000|Overall Study|failure in cpap compliance|0|||
155468405|NCT00701441|561136032|FG001|Overall Study|failure in cpap compliance|4|||
155468406|NCT04209400|561136034|FG000|Overall Study|Withdrawal by Subject|0|||
155468407|NCT04209400|561136035|FG001|Overall Study|Withdrawal by Subject|1|||
155468408|NCT03404518|561136036|FG000|Overall Study|Lost to Follow-up|28|||
155468409|NCT03404518|561136037|FG001|Overall Study|Lost to Follow-up|30|||
155468410|NCT03404518|561136036|FG000|Overall Study|Protocol Violation|13|||
155468411|NCT03404518|561136037|FG001|Overall Study|Protocol Violation|6|||
155468412|NCT00651313|561136041|FG000|Overall Study|Adverse Event|0|||
155468413|NCT00651313|561136042|FG001|Overall Study|Adverse Event|1|||
155468414|NCT00651313|561136041|FG000|Overall Study|Withdrawal by Subject|3|||
155468415|NCT00651313|561136042|FG001|Overall Study|Withdrawal by Subject|1|||
155468416|NCT00651313|561136041|FG000|Overall Study|Lost to Follow-up|1|||
155468417|NCT00651313|561136042|FG001|Overall Study|Lost to Follow-up|1|||
155468418|NCT00651313|561136041|FG000|Overall Study|Adminstrative Discontinuation|2|||
155468419|NCT00651313|561136042|FG001|Overall Study|Adminstrative Discontinuation|3|||
155468420|NCT02853032|561136053|FG000|Overall Study|Adverse Event|4|||
155468421|NCT02853032|561136054|FG001|Overall Study|Adverse Event|0|||
155468422|NCT02853032|561136053|FG000|Overall Study|Withdrawal by Subject|3|||
155468423|NCT02853032|561136054|FG001|Overall Study|Withdrawal by Subject|1|||
155468424|NCT02853032|561136053|FG000|Overall Study|Requested to withdraw from all treatment|2|||
155468425|NCT02853032|561136054|FG001|Overall Study|Requested to withdraw from all treatment|2|||
155468426|NCT00676208|561136059|FG000|Overall Study|Lost to Follow-up|0|||
155468427|NCT00676208|561136060|FG001|Overall Study|Lost to Follow-up|2|||
155468428|NCT00676208|561136059|FG000|Overall Study|Incomplete data|2|||
155468429|NCT00676208|561136060|FG001|Overall Study|Incomplete data|4|||
155468430|NCT01410799|561136061|FG000|Overall Study|PI decision|13|||
155468431|NCT00617656|561136062|FG000|Overall Study|Inclusion error|4|||
155468432|NCT00617656|561136063|FG001|Overall Study|Inclusion error|4|||
155468433|NCT00617656|561136064|FG002|Overall Study|Inclusion error|0|||
155468434|NCT00617656|561136065|FG003|Overall Study|Inclusion error|0|||
155468435|NCT00617656|561136062|FG000|Overall Study|Missing data|44|||
155468436|NCT00617656|561136063|FG001|Overall Study|Missing data|30|||
155468437|NCT00617656|561136064|FG002|Overall Study|Missing data|13|||
155468438|NCT00617656|561136065|FG003|Overall Study|Missing data|6|||
155468439|NCT00617656|561136062|FG000|Overall Study|Withdrawal by Subject|0|||
155468440|NCT00617656|561136063|FG001|Overall Study|Withdrawal by Subject|2|||
155468441|NCT00617656|561136064|FG002|Overall Study|Withdrawal by Subject|0|||
155468442|NCT00617656|561136065|FG003|Overall Study|Withdrawal by Subject|0|||
155468443|NCT01696396|561138212|FG000|Overall Study|Withdrawal by Subject|19|||
155468444|NCT01696396|561138213|FG001|Overall Study|Withdrawal by Subject|5|||
155468445|NCT01696396|561138214|FG002|Overall Study|Withdrawal by Subject|19|||
155468446|NCT01696396|561138215|FG003|Overall Study|Withdrawal by Subject|11|||
155468447|NCT01696396|561138212|FG000|Overall Study|Decision by Sponsor|3|||
155468448|NCT01696396|561138213|FG001|Overall Study|Decision by Sponsor|1|||
155468449|NCT01696396|561138214|FG002|Overall Study|Decision by Sponsor|2|||
155468450|NCT01696396|561138215|FG003|Overall Study|Decision by Sponsor|2|||
155468451|NCT01696396|561138212|FG000|Overall Study|Lost to Follow-up|9|||
155468452|NCT01696396|561138213|FG001|Overall Study|Lost to Follow-up|1|||
155468453|NCT01696396|561138214|FG002|Overall Study|Lost to Follow-up|4|||
155468454|NCT01696396|561138215|FG003|Overall Study|Lost to Follow-up|1|||
155468455|NCT01696396|561138212|FG000|Overall Study|Death|0|||
155468456|NCT01696396|561138213|FG001|Overall Study|Death|0|||
155468457|NCT01696396|561138214|FG002|Overall Study|Death|1|||
155468458|NCT01696396|561138215|FG003|Overall Study|Death|0|||
155468459|NCT00323310|561138217|FG000|Overall Study|Withdrawal by Subject|1|||
155468460|NCT00323310|561138217|FG000|Overall Study|a parent refused blood draw|1|||
155468461|NCT00323310|561138217|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
155468462|NCT03565991|561138218|FG000|Overall Study|Other|11|||
155468463|NCT03565991|561138219|FG001|Overall Study|Other|0|||
155468464|NCT03565991|561138218|FG000|Overall Study|Global deterioration of health status|14|||
155468465|NCT03565991|561138219|FG001|Overall Study|Global deterioration of health status|4|||
155468466|NCT03565991|561138218|FG000|Overall Study|Withdrawal by Subject|2|||
155468467|NCT03565991|561138219|FG001|Overall Study|Withdrawal by Subject|6|||
155468468|NCT03565991|561138218|FG000|Overall Study|Progressive disease|121|||
155468469|NCT03565991|561138219|FG001|Overall Study|Progressive disease|29|||
155468470|NCT03565991|561138218|FG000|Overall Study|Death|3|||
155468471|NCT03565991|561138219|FG001|Overall Study|Death|0|||
155468472|NCT03565991|561138218|FG000|Overall Study|Adverse Event|7|||
155468473|NCT03565991|561138219|FG001|Overall Study|Adverse Event|2|||
155468474|NCT00937326|561138221|FG000|Overall Study|Adverse Event|0|||
155468475|NCT00937326|561138222|FG001|Overall Study|Adverse Event|3|||
155468476|NCT00937326|561138223|FG002|Overall Study|Adverse Event|1|||
155468477|NCT00937326|561138224|FG003|Overall Study|Adverse Event|1|||
155468478|NCT00937326|561138225|FG004|Overall Study|Adverse Event|2|||
155468479|NCT00937326|561138221|FG000|Overall Study|Death|0|||
155468480|NCT00937326|561138222|FG001|Overall Study|Death|0|||
155468481|NCT00937326|561138223|FG002|Overall Study|Death|1|||
155468482|NCT00937326|561138224|FG003|Overall Study|Death|0|||
155468483|NCT00937326|561138225|FG004|Overall Study|Death|0|||
155468484|NCT00937326|561138221|FG000|Overall Study|Withdrawal by Subject|3|||
155468485|NCT00937326|561138222|FG001|Overall Study|Withdrawal by Subject|4|||
155468486|NCT00937326|561138223|FG002|Overall Study|Withdrawal by Subject|1|||
155468487|NCT00937326|561138224|FG003|Overall Study|Withdrawal by Subject|4|||
155468488|NCT00937326|561138225|FG004|Overall Study|Withdrawal by Subject|3|||
155468489|NCT00937326|561138221|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
155468490|NCT00937326|561138222|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
155468491|NCT00937326|561138223|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
155468492|NCT00937326|561138224|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
155468493|NCT00937326|561138225|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
155468494|NCT00790218|561138228|FG000|Overall Study|Death|1|||
155468495|NCT00790218|561138229|FG001|Overall Study|Death|0|||
155468496|NCT00790218|561138230|FG002|Overall Study|Death|0|||
155652972|NCT00890097|561822249|FG002|Overall Study|Noncompliance|4|||
155652973|NCT00890097|561822247|FG000|Overall Study|Sponsor Decision|7|||
155652974|NCT00890097|561822248|FG001|Overall Study|Sponsor Decision|11|||
155652975|NCT00890097|561822249|FG002|Overall Study|Sponsor Decision|7|||
155468497|NCT00086385|561138231|FG000|Overall Study|Death|2|||
155468498|NCT00086385|561138232|FG001|Overall Study|Death|2|||
155468499|NCT00086385|561138233|FG002|Overall Study|Death|1|||
155468500|NCT00086385|561138234|FG003|Overall Study|Death|1|||
155468501|NCT00880100|561138239|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
155468502|NCT00880100|561138239|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
155468503|NCT00880100|561138239|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
155468504|NCT03424044|561138241|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468505|NCT03424044|561138242|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468506|NCT03424044|561138243|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
155468507|NCT03424044|561138244|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468508|NCT03424044|561138245|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468509|NCT03424044|561138246|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468510|NCT03424044|561138247|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468511|NCT03424044|561138248|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468512|NCT03424044|561138249|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
155468513|NCT03424044|561138241|FG000|First Intervention (76 Hours)|Adverse Event|0|||
155468514|NCT03424044|561138242|FG001|First Intervention (76 Hours)|Adverse Event|0|||
155652976|NCT00890097|561822247|FG000|Overall Study|Did not attend final visit|2|||
155652977|NCT00890097|561822248|FG001|Overall Study|Did not attend final visit|3|||
155468515|NCT03424044|561138243|FG002|First Intervention (76 Hours)|Adverse Event|0|||
155468516|NCT03424044|561138244|FG003|First Intervention (76 Hours)|Adverse Event|0|||
155468517|NCT03424044|561138245|FG004|First Intervention (76 Hours)|Adverse Event|1|||
155468518|NCT03424044|561138246|FG005|First Intervention (76 Hours)|Adverse Event|0|||
155468519|NCT03424044|561138247|FG006|First Intervention (76 Hours)|Adverse Event|0|||
155468520|NCT03424044|561138248|FG007|First Intervention (76 Hours)|Adverse Event|0|||
155468521|NCT03424044|561138249|FG008|First Intervention (76 Hours)|Adverse Event|0|||
155468522|NCT03424044|561138241|FG000|First Intervention (76 Hours)|device issues|0|||
155468523|NCT03424044|561138242|FG001|First Intervention (76 Hours)|device issues|0|||
155468524|NCT03424044|561138243|FG002|First Intervention (76 Hours)|device issues|0|||
155468525|NCT03424044|561138244|FG003|First Intervention (76 Hours)|device issues|0|||
155468526|NCT03424044|561138245|FG004|First Intervention (76 Hours)|device issues|0|||
155468527|NCT03424044|561138246|FG005|First Intervention (76 Hours)|device issues|0|||
155468528|NCT03424044|561138247|FG006|First Intervention (76 Hours)|device issues|1|||
155468529|NCT03424044|561138248|FG007|First Intervention (76 Hours)|device issues|1|||
155468530|NCT03424044|561138249|FG008|First Intervention (76 Hours)|device issues|1|||
155468531|NCT03424044|561138241|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
155468532|NCT03424044|561138242|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
155468533|NCT03424044|561138243|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
155468534|NCT03424044|561138244|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
155468535|NCT03424044|561138245|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
155468536|NCT03424044|561138246|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
155468537|NCT03424044|561138247|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
155468538|NCT03424044|561138248|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
155468539|NCT03424044|561138249|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
155468540|NCT03424044|561138241|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468541|NCT03424044|561138242|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468542|NCT03424044|561138243|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468543|NCT03424044|561138244|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
155468544|NCT03424044|561138245|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468545|NCT03424044|561138246|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468546|NCT03424044|561138247|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468547|NCT03424044|561138248|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468548|NCT03424044|561138249|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
155468549|NCT04402385|561138253|FG000|Overall Study|Withdrawal by Subject|4|||
155468550|NCT04402385|561138254|FG001|Overall Study|Withdrawal by Subject|4|||
155468551|NCT04402385|561138253|FG000|Overall Study|Lost to Follow-up|1|||
155468552|NCT04402385|561138254|FG001|Overall Study|Lost to Follow-up|1|||
155468553|NCT04402385|561138253|FG000|Overall Study|Physician Decision|0|||
155468554|NCT04402385|561138254|FG001|Overall Study|Physician Decision|1|||
155468555|NCT00731666|561138255|FG000|Overall Study|Adverse Event|2|||
155468556|NCT00731666|561138255|FG000|Overall Study|Lost to Follow-up|8|||
155468557|NCT00731666|561138255|FG000|Overall Study|Withdrawal by Subject|2|||
155468558|NCT00693420|561138256|FG000|Overall Study|Adverse Event|4|||
155468559|NCT00693420|561138257|FG001|Overall Study|Adverse Event|4|||
155468560|NCT00693420|561138256|FG000|Overall Study|Lost to Follow-up|0|||
155468561|NCT00693420|561138257|FG001|Overall Study|Lost to Follow-up|3|||
155468562|NCT00693420|561138256|FG000|Overall Study|Withdrawal by Subject|1|||
155468563|NCT00693420|561138257|FG001|Overall Study|Withdrawal by Subject|0|||
155468564|NCT00693420|561138256|FG000|Overall Study|Protocol Violation|0|||
155468565|NCT00693420|561138257|FG001|Overall Study|Protocol Violation|2|||
155468566|NCT00693420|561138256|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
155468567|NCT00693420|561138257|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
155468568|NCT00693420|561138256|FG000|Overall Study|Personal Reasons|1|||
155468569|NCT00693420|561138257|FG001|Overall Study|Personal Reasons|4|||
155468570|NCT00509028|561138258|FG000|Overall Study|Adverse Event|2|||
155468571|NCT00509028|561138259|FG001|Overall Study|Adverse Event|0|||
155468572|NCT00509028|561138258|FG000|Overall Study|Withdrawal by Subject|4|||
155468573|NCT00509028|561138259|FG001|Overall Study|Withdrawal by Subject|3|||
155468574|NCT00509028|561138258|FG000|Overall Study|Lost to Follow-up|0|||
155468575|NCT00509028|561138259|FG001|Overall Study|Lost to Follow-up|1|||
155468576|NCT00509028|561138258|FG000|Overall Study|Protocol Violation|4|||
155468577|NCT00509028|561138259|FG001|Overall Study|Protocol Violation|2|||
155468578|NCT00509028|561138258|FG000|Overall Study|Non-compliance|2|||
155468579|NCT00509028|561138259|FG001|Overall Study|Non-compliance|1|||
155468580|NCT05516134|561138268|FG000|Overall Study|Lost to Follow-up|1|||
155468581|NCT05516134|561138269|FG001|Overall Study|Lost to Follow-up|0|||
155468582|NCT05516134|561138270|FG002|Overall Study|Lost to Follow-up|0|||
155468583|NCT01355497|561138277|FG000|Overall Study|Death|19|||
155468584|NCT01355497|561138278|FG001|Overall Study|Death|18|||
155468585|NCT01355497|561138277|FG000|Overall Study|Lost to Follow-up|3|||
155468586|NCT01355497|561138278|FG001|Overall Study|Lost to Follow-up|0|||
155468587|NCT01355497|561138277|FG000|Overall Study|Protocol Violation|0|||
155468588|NCT01355497|561138278|FG001|Overall Study|Protocol Violation|1|||
155468589|NCT01355497|561138277|FG000|Overall Study|other-not provided|9|||
155468590|NCT01355497|561138278|FG001|Overall Study|other-not provided|4|||
155468591|NCT01355497|561138277|FG000|Overall Study|Withdrawal by Subject|12|||
155468592|NCT01355497|561138278|FG001|Overall Study|Withdrawal by Subject|20|||
155468593|NCT01355497|561138277|FG000|Overall Study|noncompliance|1|||
155468594|NCT01355497|561138278|FG001|Overall Study|noncompliance|2|||
155468595|NCT01355497|561138277|FG000|Overall Study|progressive disease|11|||
155468596|NCT01355497|561138278|FG001|Overall Study|progressive disease|8|||
155468597|NCT01355497|561138277|FG000|Overall Study|Adverse Event|11|||
155468598|NCT01355497|561138278|FG001|Overall Study|Adverse Event|10|||
155468599|NCT01831804|561138286|FG000|Overall Study|Adverse Event|0|||
155468600|NCT01831804|561138287|FG001|Overall Study|Adverse Event|0|||
155468601|NCT01831804|561138288|FG002|Overall Study|Adverse Event|0|||
155468602|NCT01831804|561138289|FG003|Overall Study|Adverse Event|0|||
155468603|NCT01831804|561138290|FG004|Overall Study|Adverse Event|0|||
155468604|NCT01831804|561138291|FG005|Overall Study|Adverse Event|0|||
155468605|NCT01831804|561138292|FG006|Overall Study|Adverse Event|1|||
155468606|NCT01831804|561138293|FG007|Overall Study|Adverse Event|0|||
155468607|NCT01831804|561138294|FG008|Overall Study|Adverse Event|1|||
155468608|NCT01831804|561138286|FG000|Overall Study|Protocol Violation|0|||
155468609|NCT01831804|561138287|FG001|Overall Study|Protocol Violation|0|||
155468610|NCT01831804|561138288|FG002|Overall Study|Protocol Violation|2|||
155468611|NCT01831804|561138289|FG003|Overall Study|Protocol Violation|0|||
155468612|NCT01831804|561138290|FG004|Overall Study|Protocol Violation|0|||
155468613|NCT01831804|561138291|FG005|Overall Study|Protocol Violation|0|||
155468614|NCT01831804|561138292|FG006|Overall Study|Protocol Violation|0|||
155468615|NCT01831804|561138293|FG007|Overall Study|Protocol Violation|0|||
155468616|NCT01831804|561138294|FG008|Overall Study|Protocol Violation|0|||
155468617|NCT01831804|561138286|FG000|Overall Study|Protocol defined stopping criteria|1|||
155468618|NCT01831804|561138287|FG001|Overall Study|Protocol defined stopping criteria|1|||
155468619|NCT01831804|561138288|FG002|Overall Study|Protocol defined stopping criteria|3|||
155468620|NCT01831804|561138289|FG003|Overall Study|Protocol defined stopping criteria|0|||
155468621|NCT01831804|561138290|FG004|Overall Study|Protocol defined stopping criteria|1|||
155468622|NCT01831804|561138291|FG005|Overall Study|Protocol defined stopping criteria|0|||
155468623|NCT01831804|561138292|FG006|Overall Study|Protocol defined stopping criteria|0|||
155468624|NCT01831804|561138293|FG007|Overall Study|Protocol defined stopping criteria|0|||
155468625|NCT01831804|561138294|FG008|Overall Study|Protocol defined stopping criteria|0|||
155468626|NCT01831804|561138286|FG000|Overall Study|Lost to Follow-up|0|||
155468627|NCT01831804|561138287|FG001|Overall Study|Lost to Follow-up|0|||
155468628|NCT01831804|561138288|FG002|Overall Study|Lost to Follow-up|1|||
155468629|NCT01831804|561138289|FG003|Overall Study|Lost to Follow-up|0|||
155468630|NCT01831804|561138290|FG004|Overall Study|Lost to Follow-up|0|||
155468631|NCT01831804|561138291|FG005|Overall Study|Lost to Follow-up|0|||
155468632|NCT01831804|561138292|FG006|Overall Study|Lost to Follow-up|0|||
155468633|NCT01831804|561138293|FG007|Overall Study|Lost to Follow-up|0|||
155468634|NCT01831804|561138294|FG008|Overall Study|Lost to Follow-up|1|||
155468635|NCT01831804|561138286|FG000|Overall Study|Investigator discretion|0|||
155468636|NCT01831804|561138287|FG001|Overall Study|Investigator discretion|0|||
155468637|NCT01831804|561138288|FG002|Overall Study|Investigator discretion|0|||
155517731|NCT02785913|561321304|FG000|Overall Study|Death|2|||
155468638|NCT01831804|561138289|FG003|Overall Study|Investigator discretion|0|||
155468639|NCT01831804|561138290|FG004|Overall Study|Investigator discretion|1|||
155468640|NCT01831804|561138291|FG005|Overall Study|Investigator discretion|0|||
155468641|NCT01831804|561138292|FG006|Overall Study|Investigator discretion|0|||
155468642|NCT01831804|561138293|FG007|Overall Study|Investigator discretion|1|||
155468643|NCT01831804|561138294|FG008|Overall Study|Investigator discretion|0|||
155468644|NCT01831804|561138286|FG000|Overall Study|Withdrew Consent|0|||
155468645|NCT01831804|561138287|FG001|Overall Study|Withdrew Consent|1|||
155468646|NCT01831804|561138288|FG002|Overall Study|Withdrew Consent|0|||
155468647|NCT01831804|561138289|FG003|Overall Study|Withdrew Consent|0|||
155468648|NCT01831804|561138290|FG004|Overall Study|Withdrew Consent|0|||
155468649|NCT01831804|561138291|FG005|Overall Study|Withdrew Consent|0|||
155468650|NCT01831804|561138292|FG006|Overall Study|Withdrew Consent|0|||
155468651|NCT01831804|561138293|FG007|Overall Study|Withdrew Consent|2|||
155468652|NCT01831804|561138294|FG008|Overall Study|Withdrew Consent|0|||
155468653|NCT01819506|561138295|FG000|Overall Study|Physician Decision|5|||
155468654|NCT01819506|561138296|FG001|Overall Study|Physician Decision|2|||
155468655|NCT01819506|561138295|FG000|Overall Study|Withdrawal by Subject|3|||
155468656|NCT01819506|561138296|FG001|Overall Study|Withdrawal by Subject|3|||
155468657|NCT00114218|561138310|FG000|Overall Study|Wrong Cell Type|2|||
155468658|NCT00114218|561138310|FG000|Overall Study|Wrong Primary|1|||
155468659|NCT00114218|561138310|FG000|Overall Study|Never Treated|1|||
155468660|NCT01505114|561138311|FG000|Overall Study|Withdrawal by Subject|5|||
155468661|NCT01505114|561138312|FG001|Overall Study|Withdrawal by Subject|4|||
155468662|NCT01505114|561138313|FG002|Overall Study|Withdrawal by Subject|4|||
155468663|NCT01505114|561138314|FG003|Overall Study|Withdrawal by Subject|7|||
155468664|NCT01505114|561138311|FG000|Overall Study|Death|1|||
155468665|NCT01505114|561138312|FG001|Overall Study|Death|0|||
155468666|NCT01505114|561138313|FG002|Overall Study|Death|0|||
155468667|NCT01505114|561138314|FG003|Overall Study|Death|1|||
155468668|NCT01505114|561138311|FG000|Overall Study|unable to adhere to visit schedule|3|||
155468669|NCT01505114|561138312|FG001|Overall Study|unable to adhere to visit schedule|2|||
155468670|NCT01505114|561138313|FG002|Overall Study|unable to adhere to visit schedule|3|||
155468671|NCT01505114|561138314|FG003|Overall Study|unable to adhere to visit schedule|3|||
155468672|NCT01505114|561138311|FG000|Overall Study|Lost to Follow-up|11|||
155468673|NCT01505114|561138312|FG001|Overall Study|Lost to Follow-up|5|||
155468674|NCT01505114|561138313|FG002|Overall Study|Lost to Follow-up|8|||
155468675|NCT01505114|561138314|FG003|Overall Study|Lost to Follow-up|7|||
155468676|NCT01505114|561138311|FG000|Overall Study|relocated|4|||
155468677|NCT01505114|561138312|FG001|Overall Study|relocated|2|||
155468678|NCT01505114|561138313|FG002|Overall Study|relocated|2|||
155468679|NCT01505114|561138314|FG003|Overall Study|relocated|3|||
155468680|NCT01505114|561138311|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
155468681|NCT01505114|561138312|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
155468682|NCT01505114|561138313|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
155468683|NCT01505114|561138314|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
155468684|NCT01505114|561138311|FG000|Overall Study|staff safety concerns|0|||
155468685|NCT01505114|561138312|FG001|Overall Study|staff safety concerns|0|||
155468686|NCT01505114|561138313|FG002|Overall Study|staff safety concerns|0|||
155468687|NCT01505114|561138314|FG003|Overall Study|staff safety concerns|1|||
155468688|NCT01505114|561138311|FG000|Overall Study|investigator decision|1|||
155468689|NCT01505114|561138312|FG001|Overall Study|investigator decision|0|||
155468690|NCT01505114|561138313|FG002|Overall Study|investigator decision|1|||
155468691|NCT01505114|561138314|FG003|Overall Study|investigator decision|0|||
155468692|NCT03168555|561138315|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
155468693|NCT03168555|561138315|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
155468694|NCT03168555|561138315|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
155468695|NCT03168555|561138315|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
155468696|NCT01235507|561138317|FG000|Overall Study|Adverse Event|1|||
155468697|NCT01235507|561138317|FG000|Overall Study|Withdrawal by Subject|1|||
155468698|NCT01587274|561138320|FG000|Overall Study|Lost to Follow-up|4|||
155468699|NCT01587274|561138321|FG001|Overall Study|Lost to Follow-up|5|||
155468700|NCT01587274|561138322|FG002|Overall Study|Lost to Follow-up|3|||
155468701|NCT01421069|561138323|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
155468702|NCT01421069|561138323|FG000|Parent Study|Failed to return|3|||
155468703|NCT01421069|561138323|FG000|Parent Study|Withdrawal by Subject|1|||
155468704|NCT01421069|561138323|FG000|Parent Study|Lost to Follow-up|2|||
155468705|NCT01421069|561138323|FG000|Parent Study|Lack of Efficacy|1|||
155468706|NCT01421069|561138323|FG000|Overall Period for Extension Study|Other|2|||
155468707|NCT01421069|561138323|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
155468708|NCT01421069|561138323|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
155468709|NCT01421069|561138323|FG000|Overall Period for Extension Study|Pregnancy|1|||
155468710|NCT01421069|561138323|FG000|Overall Period for Extension Study|Adverse Event|1|||
155468711|NCT01421069|561138323|FG000|Overall Period for Extension Study|Protocol Violation|1|||
155468712|NCT01421069|561138323|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
155468713|NCT01421069|561138323|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
155468714|NCT01421069|561138323|FG000|Active Treatment Period|Other|1|||
155468715|NCT01421069|561138323|FG000|Active Treatment Period|No longer willing to participate in study|8|||
155468716|NCT01421069|561138323|FG000|Active Treatment Period|Insufficient clinical response|1|||
155468717|NCT01421069|561138323|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
155468718|NCT01421069|561138323|FG000|Active Treatment Period|Pregnancy|1|||
155468719|NCT01421069|561138323|FG000|Active Treatment Period|Adverse Event|1|||
155468720|NCT01421069|561138323|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
155468721|NCT01421069|561138323|FG000|Active Treatment Period|Enrolled in observational period|29|||
155468722|NCT01421069|561138323|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
155652978|NCT00890097|561822249|FG002|Overall Study|Did not attend final visit|0|||
155652979|NCT00890097|561822247|FG000|Overall Study|Subject Decision|3|||
155468723|NCT01421069|561138323|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
155468724|NCT01421069|561138323|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
155468725|NCT01421069|561138323|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
155468726|NCT01421069|561138323|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
155468727|NCT01421069|561138323|FG000|2b. Retreatment Period|Protocol Violation|1|||
155468728|NCT01421069|561138323|FG000|Observational Period|Other|1|||
155468729|NCT01421069|561138323|FG000|Observational Period|No longer willing to participate in study|4|||
155468730|NCT01421069|561138323|FG000|Observational Period|Lost to Follow-up|3|||
155468731|NCT01641081|561138324|FG000|Period 1|Sponsor request (potential unblinding)|0|||
155468732|NCT01641081|561138325|FG001|Period 1|Sponsor request (potential unblinding)|0|||
155468733|NCT01641081|561138326|FG002|Period 1|Sponsor request (potential unblinding)|0|||
155468734|NCT01641081|561138327|FG003|Period 1|Sponsor request (potential unblinding)|0|||
155468735|NCT01641081|561138328|FG004|Period 1|Sponsor request (potential unblinding)|0|||
155468736|NCT01641081|561138329|FG005|Period 1|Sponsor request (potential unblinding)|0|||
155468737|NCT01641081|561138330|FG006|Period 1|Sponsor request (potential unblinding)|1|||
155468738|NCT01641081|561138331|FG007|Period 1|Sponsor request (potential unblinding)|0|||
155468739|NCT01641081|561138332|FG008|Period 1|Sponsor request (potential unblinding)|0|||
155468740|NCT01641081|561138333|FG009|Period 1|Sponsor request (potential unblinding)|0|||
155468741|NCT01641081|561138324|FG000|Period 1|Protocol Violation|0|||
155468742|NCT01641081|561138325|FG001|Period 1|Protocol Violation|0|||
155468743|NCT01641081|561138326|FG002|Period 1|Protocol Violation|0|||
155468744|NCT01641081|561138327|FG003|Period 1|Protocol Violation|0|||
155468745|NCT01641081|561138328|FG004|Period 1|Protocol Violation|1|||
155468746|NCT01641081|561138329|FG005|Period 1|Protocol Violation|0|||
155468747|NCT01641081|561138330|FG006|Period 1|Protocol Violation|0|||
155468748|NCT01641081|561138331|FG007|Period 1|Protocol Violation|1|||
155468749|NCT01641081|561138332|FG008|Period 1|Protocol Violation|0|||
155468750|NCT01641081|561138333|FG009|Period 1|Protocol Violation|0|||
155468751|NCT01641081|561138324|FG000|Period 1|Adverse Event|1|||
155468752|NCT01641081|561138325|FG001|Period 1|Adverse Event|0|||
155468753|NCT01641081|561138326|FG002|Period 1|Adverse Event|0|||
155468754|NCT01641081|561138327|FG003|Period 1|Adverse Event|0|||
155468755|NCT01641081|561138328|FG004|Period 1|Adverse Event|0|||
155468756|NCT01641081|561138329|FG005|Period 1|Adverse Event|0|||
155468757|NCT01641081|561138330|FG006|Period 1|Adverse Event|0|||
155468758|NCT01641081|561138331|FG007|Period 1|Adverse Event|2|||
155468759|NCT01641081|561138332|FG008|Period 1|Adverse Event|0|||
155468760|NCT01641081|561138333|FG009|Period 1|Adverse Event|0|||
155468761|NCT01641081|561138324|FG000|Period 2|Adverse Event|0|||
155468762|NCT01641081|561138325|FG001|Period 2|Adverse Event|0|||
155468763|NCT01641081|561138326|FG002|Period 2|Adverse Event|0|||
155468764|NCT01641081|561138327|FG003|Period 2|Adverse Event|0|||
155468765|NCT01641081|561138328|FG004|Period 2|Adverse Event|0|||
155468766|NCT01641081|561138329|FG005|Period 2|Adverse Event|1|||
155468767|NCT01641081|561138330|FG006|Period 2|Adverse Event|0|||
155468768|NCT01641081|561138331|FG007|Period 2|Adverse Event|0|||
155468769|NCT01641081|561138332|FG008|Period 2|Adverse Event|0|||
155468770|NCT01641081|561138333|FG009|Period 2|Adverse Event|0|||
155468771|NCT01641081|561138324|FG000|Period 2|Withdrawal by Subject|0|||
155468772|NCT01641081|561138325|FG001|Period 2|Withdrawal by Subject|0|||
155468773|NCT01641081|561138326|FG002|Period 2|Withdrawal by Subject|0|||
155468774|NCT01641081|561138327|FG003|Period 2|Withdrawal by Subject|1|||
155468775|NCT01641081|561138328|FG004|Period 2|Withdrawal by Subject|0|||
155468776|NCT01641081|561138329|FG005|Period 2|Withdrawal by Subject|0|||
155468777|NCT01641081|561138330|FG006|Period 2|Withdrawal by Subject|2|||
155468778|NCT01641081|561138331|FG007|Period 2|Withdrawal by Subject|0|||
155468779|NCT01641081|561138332|FG008|Period 2|Withdrawal by Subject|0|||
155468780|NCT01641081|561138333|FG009|Period 2|Withdrawal by Subject|0|||
155468781|NCT01641081|561138324|FG000|Period 2|Protocol Violation|1|||
155468782|NCT01641081|561138325|FG001|Period 2|Protocol Violation|0|||
155468783|NCT01641081|561138326|FG002|Period 2|Protocol Violation|0|||
155468784|NCT01641081|561138327|FG003|Period 2|Protocol Violation|0|||
155468785|NCT01641081|561138328|FG004|Period 2|Protocol Violation|0|||
155468786|NCT01641081|561138329|FG005|Period 2|Protocol Violation|0|||
155468787|NCT01641081|561138330|FG006|Period 2|Protocol Violation|0|||
155468788|NCT01641081|561138331|FG007|Period 2|Protocol Violation|0|||
155652980|NCT00890097|561822248|FG001|Overall Study|Subject Decision|2|||
155468789|NCT01641081|561138332|FG008|Period 2|Protocol Violation|0|||
155468790|NCT01641081|561138333|FG009|Period 2|Protocol Violation|0|||
155468791|NCT01641081|561138324|FG000|Period 3|Adverse Event|0|||
155468792|NCT01641081|561138325|FG001|Period 3|Adverse Event|0|||
155468793|NCT01641081|561138326|FG002|Period 3|Adverse Event|1|||
155468794|NCT01641081|561138327|FG003|Period 3|Adverse Event|0|||
155468795|NCT01641081|561138328|FG004|Period 3|Adverse Event|0|||
155468796|NCT01641081|561138329|FG005|Period 3|Adverse Event|0|||
155468797|NCT01641081|561138330|FG006|Period 3|Adverse Event|0|||
155468798|NCT01641081|561138331|FG007|Period 3|Adverse Event|0|||
155468799|NCT01641081|561138332|FG008|Period 3|Adverse Event|0|||
155468800|NCT01641081|561138333|FG009|Period 3|Adverse Event|0|||
155468801|NCT01641081|561138324|FG000|Period 3|Withdrawal by Subject|0|||
155468802|NCT01641081|561138325|FG001|Period 3|Withdrawal by Subject|0|||
155468803|NCT01641081|561138326|FG002|Period 3|Withdrawal by Subject|0|||
155468804|NCT01641081|561138327|FG003|Period 3|Withdrawal by Subject|0|||
155468805|NCT01641081|561138328|FG004|Period 3|Withdrawal by Subject|0|||
155468806|NCT01641081|561138329|FG005|Period 3|Withdrawal by Subject|0|||
155468807|NCT01641081|561138330|FG006|Period 3|Withdrawal by Subject|0|||
155468808|NCT01641081|561138331|FG007|Period 3|Withdrawal by Subject|0|||
155468809|NCT01641081|561138332|FG008|Period 3|Withdrawal by Subject|1|||
155468810|NCT01641081|561138333|FG009|Period 3|Withdrawal by Subject|0|||
155468811|NCT01641081|561138324|FG000|Period 4|Adverse Event|0|||
155468812|NCT01641081|561138325|FG001|Period 4|Adverse Event|1|||
155468813|NCT01641081|561138326|FG002|Period 4|Adverse Event|0|||
155468814|NCT01641081|561138327|FG003|Period 4|Adverse Event|1|||
155468815|NCT01641081|561138328|FG004|Period 4|Adverse Event|0|||
155468816|NCT01641081|561138329|FG005|Period 4|Adverse Event|0|||
155468817|NCT01641081|561138330|FG006|Period 4|Adverse Event|0|||
155468818|NCT01641081|561138331|FG007|Period 4|Adverse Event|0|||
155468819|NCT01641081|561138332|FG008|Period 4|Adverse Event|0|||
155468820|NCT01641081|561138333|FG009|Period 4|Adverse Event|0|||
155468821|NCT01641081|561138324|FG000|Period 5|Adverse Event|0|||
155468822|NCT01641081|561138325|FG001|Period 5|Adverse Event|0|||
155468823|NCT01641081|561138326|FG002|Period 5|Adverse Event|2|||
155468824|NCT01641081|561138327|FG003|Period 5|Adverse Event|0|||
155468825|NCT01641081|561138328|FG004|Period 5|Adverse Event|0|||
155468826|NCT01641081|561138329|FG005|Period 5|Adverse Event|0|||
155468827|NCT01641081|561138330|FG006|Period 5|Adverse Event|0|||
155468828|NCT01641081|561138331|FG007|Period 5|Adverse Event|0|||
155468829|NCT01641081|561138332|FG008|Period 5|Adverse Event|0|||
155517732|NCT02785913|561321304|FG000|Overall Study|Progression|18|||
155517733|NCT02785913|561321304|FG000|Overall Study|Not protocol specified|1|||
155517734|NCT01052116|561321305|FG000|Overall Study|Lost to Follow-up|11|||
155517735|NCT01052116|561321306|FG001|Overall Study|Lost to Follow-up|17|||
155517736|NCT01052116|561321305|FG000|Overall Study|Withdrawal by Subject|3|||
155517737|NCT01052116|561321306|FG001|Overall Study|Withdrawal by Subject|6|||
155517738|NCT01052116|561321305|FG000|Overall Study|Spirometry not performed|0|||
155517739|NCT01052116|561321306|FG001|Overall Study|Spirometry not performed|4|||
155517740|NCT00502775|561321307|FG000|Overall Study|Adverse Event|1|||
155517741|NCT00502775|561321308|FG001|Overall Study|Adverse Event|2|||
155517742|NCT00502775|561321309|FG002|Overall Study|Adverse Event|1|||
155517743|NCT00502775|561321307|FG000|Overall Study|Protocol Violation|1|||
155517744|NCT00502775|561321308|FG001|Overall Study|Protocol Violation|5|||
155517745|NCT00502775|561321309|FG002|Overall Study|Protocol Violation|2|||
155517746|NCT00502775|561321307|FG000|Overall Study|Withdrawal by Subject|1|||
155517747|NCT00502775|561321308|FG001|Overall Study|Withdrawal by Subject|1|||
155517748|NCT00502775|561321309|FG002|Overall Study|Withdrawal by Subject|2|||
155517749|NCT00502775|561321307|FG000|Overall Study|Sponsor Terminated Study|1|||
155517750|NCT00502775|561321308|FG001|Overall Study|Sponsor Terminated Study|0|||
155517751|NCT00502775|561321309|FG002|Overall Study|Sponsor Terminated Study|1|||
155517752|NCT00502775|561321307|FG000|Overall Study|Non-compliance with eDiary|4|||
155517753|NCT00502775|561321308|FG001|Overall Study|Non-compliance with eDiary|1|||
155517754|NCT00502775|561321309|FG002|Overall Study|Non-compliance with eDiary|1|||
155517755|NCT00502775|561321307|FG000|Overall Study|Subject unable to swallow capsule|1|||
155517756|NCT00502775|561321308|FG001|Overall Study|Subject unable to swallow capsule|0|||
155517757|NCT00502775|561321309|FG002|Overall Study|Subject unable to swallow capsule|1|||
155517758|NCT00502775|561321307|FG000|Overall Study|Logpad compliance <80%|1|||
155517759|NCT00502775|561321308|FG001|Overall Study|Logpad compliance <80%|0|||
155517760|NCT00502775|561321309|FG002|Overall Study|Logpad compliance <80%|0|||
155517761|NCT00502775|561321307|FG000|Overall Study|Randomized in error|0|||
155517762|NCT00502775|561321308|FG001|Overall Study|Randomized in error|1|||
155517763|NCT00502775|561321309|FG002|Overall Study|Randomized in error|1|||
155517764|NCT00502775|561321307|FG000|Overall Study|Non-compliance|0|||
155517765|NCT00502775|561321308|FG001|Overall Study|Non-compliance|2|||
155652981|NCT00890097|561822249|FG002|Overall Study|Subject Decision|6|||
155652982|NCT00890097|561822247|FG000|Overall Study|Randomization Error|2|||
155468830|NCT01641081|561138333|FG009|Period 5|Adverse Event|0|||
155468831|NCT01095666|561138337|FG000|Overall Study|Lack of Efficacy|0|||
155468832|NCT01095666|561138338|FG001|Overall Study|Lack of Efficacy|0|||
155468833|NCT01095666|561138339|FG002|Overall Study|Lack of Efficacy|1|||
155468834|NCT01095666|561138337|FG000|Overall Study|Adverse Event|2|||
155468835|NCT01095666|561138338|FG001|Overall Study|Adverse Event|1|||
155468836|NCT01095666|561138339|FG002|Overall Study|Adverse Event|3|||
155468837|NCT01095666|561138337|FG000|Overall Study|Lost to Follow-up|2|||
155468838|NCT01095666|561138338|FG001|Overall Study|Lost to Follow-up|2|||
155468839|NCT01095666|561138339|FG002|Overall Study|Lost to Follow-up|0|||
155468840|NCT01095666|561138337|FG000|Overall Study|Withdrawal by Subject|6|||
155517766|NCT00502775|561321309|FG002|Overall Study|Non-compliance|2|||
155517767|NCT00502775|561321307|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
155517768|NCT00502775|561321308|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
155652983|NCT00890097|561822248|FG001|Overall Study|Randomization Error|0|||
155517769|NCT00502775|561321309|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
155517770|NCT00502775|561321307|FG000|Overall Study|Declining pollen counts|0|||
155517771|NCT00502775|561321308|FG001|Overall Study|Declining pollen counts|1|||
155517772|NCT00502775|561321309|FG002|Overall Study|Declining pollen counts|1|||
155517773|NCT00502775|561321307|FG000|Overall Study|Subject in jail|0|||
155517774|NCT00502775|561321308|FG001|Overall Study|Subject in jail|1|||
155517775|NCT00502775|561321309|FG002|Overall Study|Subject in jail|0|||
155517776|NCT00502775|561321307|FG000|Overall Study|Subject took disallowed drug|0|||
155517777|NCT00502775|561321308|FG001|Overall Study|Subject took disallowed drug|0|||
155517778|NCT00502775|561321309|FG002|Overall Study|Subject took disallowed drug|1|||
155517779|NCT02270736|561321313|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155517780|NCT02270736|561321314|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
155517781|NCT02270736|561321315|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155517782|NCT02270736|561321316|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155517783|NCT02270736|561321317|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155517784|NCT02270736|561321313|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
155517785|NCT02270736|561321314|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
155517786|NCT02270736|561321315|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
155517787|NCT02270736|561321316|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
155517788|NCT02270736|561321317|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
155517789|NCT02270736|561321313|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
155517790|NCT02270736|561321314|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
155517791|NCT02270736|561321315|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
155517792|NCT02270736|561321316|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
155517793|NCT02270736|561321317|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
155517794|NCT02270736|561321313|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
155517795|NCT02270736|561321314|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
155517796|NCT02270736|561321315|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
155517797|NCT02270736|561321316|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
155517798|NCT02270736|561321317|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
155517799|NCT02270736|561321313|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
155517800|NCT02270736|561321314|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
155517801|NCT02270736|561321315|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
155517802|NCT02270736|561321316|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
155517803|NCT02270736|561321317|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
155517804|NCT02270736|561321313|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
155517805|NCT02270736|561321314|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
155517806|NCT02270736|561321315|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
155517807|NCT02270736|561321316|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
155517808|NCT02270736|561321317|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
155517809|NCT02270736|561321313|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
155517810|NCT02270736|561321314|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
155517811|NCT02270736|561321315|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
155517812|NCT02270736|561321316|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
155517813|NCT02270736|561321317|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
155517814|NCT02270736|561321313|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
155517815|NCT02270736|561321314|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
155517816|NCT02270736|561321315|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
155517817|NCT02270736|561321316|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
155517818|NCT02270736|561321317|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
155517819|NCT02270736|561321313|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
155517820|NCT02270736|561321314|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
155517821|NCT02270736|561321315|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
155517822|NCT02270736|561321316|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
155517823|NCT02270736|561321317|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
155517824|NCT04373434|561321320|FG000|Overall Study|Lost to Follow-up|37|||
155517825|NCT04373434|561321321|FG001|Overall Study|Lost to Follow-up|32|||
155517826|NCT04373434|561321320|FG000|Overall Study|Refused at 9 months|1|||
155517827|NCT04373434|561321321|FG001|Overall Study|Refused at 9 months|2|||
155517828|NCT04373434|561321320|FG000|Overall Study|Refused at 4 months|7|||
155517829|NCT04373434|561321321|FG001|Overall Study|Refused at 4 months|3|||
155517830|NCT04373434|561321320|FG000|Overall Study|Excluded|2|||
155517831|NCT04373434|561321321|FG001|Overall Study|Excluded|0|||
155517832|NCT03702621|561321322|FG000|Overall Study|Physician Decision|6|||
155517833|NCT03702621|561321323|FG001|Overall Study|Physician Decision|6|||
155517834|NCT00527423|561321324|FG000|Overall Study|Protocol Violation|1|||
155517835|NCT00527423|561321324|FG000|Overall Study|Adverse Event|5|||
155468841|NCT01095666|561138338|FG001|Overall Study|Withdrawal by Subject|6|||
155468842|NCT01095666|561138339|FG002|Overall Study|Withdrawal by Subject|1|||
155468843|NCT01095666|561138337|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
155468844|NCT01095666|561138338|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
155468845|NCT01095666|561138339|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
155468846|NCT01250756|561138342|FG000|Infant Series|Withdrawal by Subject|4|||
155468847|NCT01250756|561138343|FG001|Infant Series|Withdrawal by Subject|5|||
155468848|NCT01250756|561138342|FG000|Infant Series|Randomized, Not Vaccinated|2|||
155468849|NCT01250756|561138343|FG001|Infant Series|Randomized, Not Vaccinated|2|||
155468850|NCT01250756|561138342|FG000|Infant Series|Other|22|||
155468851|NCT01250756|561138343|FG001|Infant Series|Other|0|||
155468852|NCT01250756|561138342|FG000|After Infant Series|Adverse Event|5|||
155468853|NCT01250756|561138343|FG001|After Infant Series|Adverse Event|2|||
155468854|NCT01250756|561138342|FG000|After Infant Series|Withdrawal by Subject|4|||
155468855|NCT01250756|561138343|FG001|After Infant Series|Withdrawal by Subject|1|||
155468856|NCT01250756|561138342|FG000|After Infant Series|Other|2|||
155468857|NCT01250756|561138343|FG001|After Infant Series|Other|1|||
155468858|NCT01250756|561138342|FG000|Toddler Dose|Adverse Event|0|||
155468859|NCT01250756|561138343|FG001|Toddler Dose|Adverse Event|1|||
155468860|NCT01250756|561138342|FG000|After Toddler Dose|Adverse Event|0|||
155468861|NCT01250756|561138343|FG001|After Toddler Dose|Adverse Event|1|||
155468862|NCT02925312|561138346|FG000|Overall Study|Lost to Follow-up|25|||
155468863|NCT02925312|561138347|FG001|Overall Study|Lost to Follow-up|0|||
155468864|NCT02925312|561138346|FG000|Overall Study|Adverse Event|2|||
155468865|NCT02925312|561138347|FG001|Overall Study|Adverse Event|0|||
155468866|NCT01225172|561138351|FG000|Overall Study|Subject decision to stop|1|||
155468867|NCT01225172|561138352|FG001|Overall Study|Subject decision to stop|0|||
155468868|NCT01225172|561138351|FG000|Overall Study|Subject request to discontinue treatment|3|||
155468869|NCT01225172|561138352|FG001|Overall Study|Subject request to discontinue treatment|1|||
155468870|NCT01225172|561138351|FG000|Overall Study|Subject no longer meets study criteria|1|||
155468871|NCT01225172|561138352|FG001|Overall Study|Subject no longer meets study criteria|0|||
155468872|NCT01225172|561138351|FG000|Overall Study|Withdrawal by Subject|1|||
155468873|NCT01225172|561138352|FG001|Overall Study|Withdrawal by Subject|0|||
155468874|NCT01822223|561138355|FG000|Overall Study|Death|0|||
155468875|NCT01822223|561138356|FG001|Overall Study|Death|1|||
155468876|NCT05041062|561138363|FG000|Overall Study|Adverse Event|2|||
155468877|NCT04018612|561138364|FG000|Overall Study|Withdrawal by Subject|1|||
155468878|NCT04018612|561138365|FG001|Overall Study|Withdrawal by Subject|0|||
155468879|NCT04018612|561138366|FG002|Overall Study|Withdrawal by Subject|1|||
155468880|NCT00361218|561138369|FG000|Overall Study|Lost to Follow-up|11|||
155468881|NCT00361218|561138369|FG000|Overall Study|Personal Reasons|7|||
155468882|NCT00361218|561138369|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
155468883|NCT03693404|561138370|FG000|Overall Study|Withdrawal by Subject|1|||
155468884|NCT03693404|561138371|FG001|Overall Study|Withdrawal by Subject|0|||
155468885|NCT03693404|561138370|FG000|Overall Study|Lost to Follow-up|0|||
155468886|NCT03693404|561138371|FG001|Overall Study|Lost to Follow-up|5|||
155468887|NCT03693404|561138370|FG000|Overall Study|Excluded from Analysis|0|||
155468888|NCT03693404|561138371|FG001|Overall Study|Excluded from Analysis|1|||
155468889|NCT01176240|561138372|FG000|Study 306A|Lack of Efficacy|2|||
155468890|NCT01176240|561138373|FG001|Study 306A|Lack of Efficacy|1|||
155517836|NCT00527423|561321324|FG000|Overall Study|Physician Decision|4|||
155517837|NCT00527423|561321324|FG000|Overall Study|Withdrawal by Subject|10|||
155468891|NCT01176240|561138372|FG000|Study 306A|Protocol Violation|0|||
155468892|NCT01176240|561138373|FG001|Study 306A|Protocol Violation|1|||
155468893|NCT01176240|561138372|FG000|Study 306A|Withdrawal by Subject|0|||
155468894|NCT01176240|561138373|FG001|Study 306A|Withdrawal by Subject|1|||
155468895|NCT01176240|561138372|FG000|Study 306A|Stop due to diverse problems|1|||
155468896|NCT01176240|561138373|FG001|Study 306A|Stop due to diverse problems|0|||
155468897|NCT01176240|561138372|FG000|Study 306B|Lack of Efficacy|5|||
155468898|NCT01176240|561138373|FG001|Study 306B|Lack of Efficacy|3|||
155652984|NCT00890097|561822249|FG002|Overall Study|Randomization Error|0|||
155652985|NCT00890097|561822247|FG000|Overall Study|Failed inclusion criteria|3|||
155652986|NCT00890097|561822248|FG001|Overall Study|Failed inclusion criteria|4|||
155652987|NCT00890097|561822249|FG002|Overall Study|Failed inclusion criteria|0|||
155652988|NCT00890097|561822247|FG000|Overall Study|Transportation|0|||
155652989|NCT00890097|561822248|FG001|Overall Study|Transportation|2|||
155652990|NCT00890097|561822249|FG002|Overall Study|Transportation|0|||
155652991|NCT00890097|561822247|FG000|Overall Study|Subject Moved|0|||
155652992|NCT00890097|561822248|FG001|Overall Study|Subject Moved|4|||
155652993|NCT00890097|561822249|FG002|Overall Study|Subject Moved|0|||
155652994|NCT00890097|561822247|FG000|Overall Study|Protocol Deviation|1|||
155652995|NCT00890097|561822248|FG001|Overall Study|Protocol Deviation|1|||
155468899|NCT01176240|561138372|FG000|Study 306B|Adverse Event|10|||
155468900|NCT01176240|561138373|FG001|Study 306B|Adverse Event|5|||
155468901|NCT01176240|561138372|FG000|Study 306B|Protocol Violation|2|||
155468902|NCT01176240|561138373|FG001|Study 306B|Protocol Violation|3|||
155468903|NCT01176240|561138372|FG000|Study 306B|Withdrawal by Subject|4|||
155468904|NCT01176240|561138373|FG001|Study 306B|Withdrawal by Subject|1|||
155652996|NCT00890097|561822249|FG002|Overall Study|Protocol Deviation|1|||
155652997|NCT01152385|561822250|FG000|Overall Study|Withdrawal by Subject|3|||
155652998|NCT01152385|561822251|FG001|Overall Study|Withdrawal by Subject|1|||
155652999|NCT01152385|561822252|FG002|Overall Study|Withdrawal by Subject|1|||
155653000|NCT01152385|561822253|FG003|Overall Study|Withdrawal by Subject|1|||
155653001|NCT01152385|561822250|FG000|Overall Study|Protocol Violation|0|||
155653002|NCT01152385|561822251|FG001|Overall Study|Protocol Violation|0|||
155653003|NCT01152385|561822252|FG002|Overall Study|Protocol Violation|0|||
155653004|NCT01152385|561822253|FG003|Overall Study|Protocol Violation|1|||
155653005|NCT01152385|561822250|FG000|Overall Study|Adverse Event|1|||
155653006|NCT01152385|561822251|FG001|Overall Study|Adverse Event|1|||
155653007|NCT01152385|561822252|FG002|Overall Study|Adverse Event|0|||
155653008|NCT01152385|561822253|FG003|Overall Study|Adverse Event|0|||
155653009|NCT01152385|561822250|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155653010|NCT01152385|561822251|FG001|Overall Study|Study-specific withdrawal criteria|1|||
155653011|NCT01152385|561822252|FG002|Overall Study|Study-specific withdrawal criteria|2|||
155653012|NCT01152385|561822253|FG003|Overall Study|Study-specific withdrawal criteria|0|||
155653013|NCT01152385|561822250|FG000|Overall Study|Other|4|||
155653014|NCT01152385|561822251|FG001|Overall Study|Other|3|||
155653015|NCT01152385|561822252|FG002|Overall Study|Other|2|||
155653016|NCT01152385|561822253|FG003|Overall Study|Other|3|||
155653017|NCT02656173|561822254|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
155468905|NCT01176240|561138372|FG000|Study 306B|Physician Decision|2|||
155468906|NCT01176240|561138373|FG001|Study 306B|Physician Decision|1|||
155468907|NCT01176240|561138372|FG000|Study 306B|Supine Hypertension|1|||
155468908|NCT01176240|561138373|FG001|Study 306B|Supine Hypertension|2|||
155468909|NCT01176240|561138372|FG000|Study 306B|Lost to Follow-up|0|||
155468910|NCT01176240|561138373|FG001|Study 306B|Lost to Follow-up|1|||
155468911|NCT01176240|561138372|FG000|Study 306B|withdrew prior to dosing|2|||
155468912|NCT01176240|561138373|FG001|Study 306B|withdrew prior to dosing|1|||
155468913|NCT05200455|561138374|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
155468914|NCT00807014|561138375|FG000|Overall Study|Participant Considered Disease Cured|13|||
155468915|NCT00807014|561138376|FG001|Overall Study|Participant Considered Disease Cured|2|||
155468916|NCT00807014|561138375|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
155468917|NCT00807014|561138376|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
155468918|NCT00807014|561138375|FG000|Overall Study|Protocol Violation|2|||
155468919|NCT00807014|561138376|FG001|Overall Study|Protocol Violation|8|||
155468920|NCT00807014|561138375|FG000|Overall Study|Adverse Event|0|||
155517838|NCT00527423|561321324|FG000|Overall Study|Lost to Follow-up|4|||
155517839|NCT00527423|561321324|FG000|Overall Study|OTHER|4|||
155653018|NCT02656173|561822255|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
155653019|NCT02656173|561822254|FG000|Overall Study|Adverse Event|7|||
155653020|NCT02656173|561822255|FG001|Overall Study|Adverse Event|5|||
155653021|NCT02656173|561822254|FG000|Overall Study|Withdrawal by Subject|1|||
155653022|NCT02656173|561822255|FG001|Overall Study|Withdrawal by Subject|3|||
155653023|NCT02656173|561822254|FG000|Overall Study|Protocol Violation|0|||
155653024|NCT02656173|561822255|FG001|Overall Study|Protocol Violation|1|||
155653025|NCT02656173|561822254|FG000|Overall Study|Miscellaneous|2|||
155653026|NCT02656173|561822255|FG001|Overall Study|Miscellaneous|0|||
155653027|NCT00834587|561822258|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155468921|NCT00807014|561138376|FG001|Overall Study|Adverse Event|2|||
155468922|NCT00807014|561138375|FG000|Overall Study|Lost to Follow-up|9|||
155468923|NCT00807014|561138376|FG001|Overall Study|Lost to Follow-up|7|||
155468924|NCT00807014|561138375|FG000|Overall Study|Recovery|1|||
155468925|NCT00807014|561138376|FG001|Overall Study|Recovery|0|||
155468926|NCT00807014|561138375|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
155468927|NCT00807014|561138376|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
155468928|NCT00892957|561138377|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
155468929|NCT00892957|561138378|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
155468930|NCT00892957|561138377|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
155468931|NCT00892957|561138378|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
155468932|NCT03307629|561138379|FG000|Overall Study|Withdrawal by Subject|0|||
155468933|NCT03307629|561138380|FG001|Overall Study|Withdrawal by Subject|0|||
155468934|NCT03307629|561138381|FG002|Overall Study|Withdrawal by Subject|0|||
155468935|NCT03307629|561138382|FG003|Overall Study|Withdrawal by Subject|2|||
155468936|NCT03307629|561138379|FG000|Overall Study|Disease Progression|0|||
155468937|NCT03307629|561138380|FG001|Overall Study|Disease Progression|0|||
155468938|NCT03307629|561138381|FG002|Overall Study|Disease Progression|0|||
155468939|NCT03307629|561138382|FG003|Overall Study|Disease Progression|3|||
155468940|NCT03307629|561138379|FG000|Overall Study|Death|0|||
155468941|NCT03307629|561138380|FG001|Overall Study|Death|3|||
155468942|NCT03307629|561138381|FG002|Overall Study|Death|0|||
155468943|NCT03307629|561138382|FG003|Overall Study|Death|1|||
155468944|NCT04876599|561138383|FG000|Overall Study|Missed|2|||
155468945|NCT04876599|561138384|FG001|Overall Study|Missed|0|||
155468946|NCT04876599|561138383|FG000|Overall Study|Declined|2|||
155468947|NCT04876599|561138384|FG001|Overall Study|Declined|3|||
155468948|NCT00669032|561138387|FG000|Overall Study|Lost to Follow-up|6|||
155517840|NCT00527423|561321324|FG000|Overall Study|Death|9|||
155517841|NCT03194464|561321327|FG000|Overall Study|data not usable|2|||
155517842|NCT02446132|561321328|FG000|Overall Study|Adverse Event|10|||
155517843|NCT02446132|561321329|FG001|Overall Study|Adverse Event|27|||
155517844|NCT02446132|561321330|FG002|Overall Study|Adverse Event|27|||
155517845|NCT02446132|561321328|FG000|Overall Study|Death|2|||
155517846|NCT02446132|561321329|FG001|Overall Study|Death|13|||
155517847|NCT02446132|561321330|FG002|Overall Study|Death|10|||
155468949|NCT00669032|561138388|FG001|Overall Study|Lost to Follow-up|5|||
155468950|NCT00669032|561138387|FG000|Overall Study|Lack of Efficacy|8|||
155468951|NCT00669032|561138388|FG001|Overall Study|Lack of Efficacy|19|||
155468952|NCT00669032|561138387|FG000|Overall Study|Withdrawal by Subject|12|||
155468953|NCT00669032|561138388|FG001|Overall Study|Withdrawal by Subject|13|||
155468954|NCT00669032|561138387|FG000|Overall Study|Adverse Event|12|||
155517848|NCT02446132|561321328|FG000|Overall Study|Lack of Efficacy|1|||
155468955|NCT00669032|561138388|FG001|Overall Study|Adverse Event|16|||
155468956|NCT00669032|561138387|FG000|Overall Study|Physician Decision|1|||
155468957|NCT00669032|561138388|FG001|Overall Study|Physician Decision|1|||
155468958|NCT00669032|561138387|FG000|Overall Study|No fulfilment of the selection criteria|5|||
155468959|NCT00669032|561138388|FG001|Overall Study|No fulfilment of the selection criteria|5|||
155468960|NCT00642018|561138391|FG000|Overall Study|Adverse Event|11|||
155468961|NCT00642018|561138392|FG001|Overall Study|Adverse Event|36|||
155468962|NCT00642018|561138391|FG000|Overall Study|Withdrawal by Subject|4|||
155468963|NCT00642018|561138392|FG001|Overall Study|Withdrawal by Subject|10|||
155468964|NCT00642018|561138391|FG000|Overall Study|Progressive Disease|13|||
155468965|NCT00642018|561138392|FG001|Overall Study|Progressive Disease|18|||
155468966|NCT00642018|561138391|FG000|Overall Study|Physician Decision|0|||
155468967|NCT00642018|561138392|FG001|Overall Study|Physician Decision|10|||
155468968|NCT00642018|561138391|FG000|Overall Study|Protocol Violation|0|||
155468969|NCT00642018|561138392|FG001|Overall Study|Protocol Violation|1|||
155468970|NCT00642018|561138391|FG000|Overall Study|Death|0|||
155468971|NCT00642018|561138392|FG001|Overall Study|Death|3|||
155468972|NCT00642018|561138391|FG000|Overall Study|Entry Criteria Not Met|0|||
155468973|NCT00642018|561138392|FG001|Overall Study|Entry Criteria Not Met|1|||
155468974|NCT01607073|561138393|FG000|Overall Study|Adverse Event|1|||
155468975|NCT04126031|561138395|FG000|Part A|Withdrawal by Subject|0|||
155468976|NCT04126031|561138396|FG001|Part A|Withdrawal by Subject|0|||
155468977|NCT04126031|561138397|FG002|Part A|Withdrawal by Subject|1|||
155468978|NCT04126031|561138398|FG003|Part A|Withdrawal by Subject|0|||
155468979|NCT04126031|561138399|FG004|Part A|Withdrawal by Subject|0|||
155468980|NCT04126031|561138400|FG005|Part A|Withdrawal by Subject|0|||
155468981|NCT04126031|561138395|FG000|Part A|Other|1|||
155468982|NCT04126031|561138396|FG001|Part A|Other|0|||
155468983|NCT04126031|561138397|FG002|Part A|Other|0|||
155468984|NCT04126031|561138398|FG003|Part A|Other|0|||
155468985|NCT04126031|561138399|FG004|Part A|Other|0|||
155468986|NCT04126031|561138400|FG005|Part A|Other|0|||
155468987|NCT04126031|561138395|FG000|Part B|Adverse Event|0|||
155468988|NCT04126031|561138396|FG001|Part B|Adverse Event|0|||
155468989|NCT04126031|561138397|FG002|Part B|Adverse Event|0|||
155468990|NCT04126031|561138398|FG003|Part B|Adverse Event|0|||
155468991|NCT04126031|561138399|FG004|Part B|Adverse Event|0|||
155468992|NCT04126031|561138400|FG005|Part B|Adverse Event|2|||
155468993|NCT04126031|561138395|FG000|Part B|Pre-existing hypertransaminasemia|0|||
155468994|NCT04126031|561138396|FG001|Part B|Pre-existing hypertransaminasemia|0|||
155468995|NCT04126031|561138397|FG002|Part B|Pre-existing hypertransaminasemia|0|||
155468996|NCT04126031|561138398|FG003|Part B|Pre-existing hypertransaminasemia|0|||
155468997|NCT04126031|561138399|FG004|Part B|Pre-existing hypertransaminasemia|1|||
155468998|NCT04126031|561138400|FG005|Part B|Pre-existing hypertransaminasemia|0|||
155468999|NCT00131664|561138401|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
155469000|NCT00131664|561138402|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
155469001|NCT00131664|561138403|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
155469002|NCT00131664|561138404|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
155469003|NCT00131664|561138405|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
155469004|NCT00131664|561138406|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
155469005|NCT00131664|561138401|FG000|First Period (First 6 Months)|Death|0|||
155469006|NCT00131664|561138402|FG001|First Period (First 6 Months)|Death|1|||
155469007|NCT00131664|561138403|FG002|First Period (First 6 Months)|Death|0|||
155469008|NCT00131664|561138404|FG003|First Period (First 6 Months)|Death|0|||
155469009|NCT00131664|561138405|FG004|First Period (First 6 Months)|Death|0|||
155469010|NCT00131664|561138406|FG005|First Period (First 6 Months)|Death|0|||
155469011|NCT00131664|561138401|FG000|First Period (First 6 Months)|Protocol Violation|2|||
155469012|NCT00131664|561138402|FG001|First Period (First 6 Months)|Protocol Violation|2|||
155469013|NCT00131664|561138403|FG002|First Period (First 6 Months)|Protocol Violation|1|||
155469014|NCT00131664|561138404|FG003|First Period (First 6 Months)|Protocol Violation|0|||
155469015|NCT00131664|561138405|FG004|First Period (First 6 Months)|Protocol Violation|0|||
155469016|NCT00131664|561138406|FG005|First Period (First 6 Months)|Protocol Violation|0|||
155469017|NCT00131664|561138401|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
155469018|NCT00131664|561138402|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
155469019|NCT00131664|561138403|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
155469020|NCT00131664|561138404|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
155517849|NCT02446132|561321329|FG001|Overall Study|Lack of Efficacy|10|||
155517850|NCT02446132|561321330|FG002|Overall Study|Lack of Efficacy|6|||
155517851|NCT02446132|561321328|FG000|Overall Study|Lost to Follow-up|2|||
155517852|NCT02446132|561321329|FG001|Overall Study|Lost to Follow-up|4|||
155517853|NCT02446132|561321330|FG002|Overall Study|Lost to Follow-up|5|||
155517854|NCT02446132|561321328|FG000|Overall Study|Non-compliance With Study Drug|2|||
155517855|NCT02446132|561321329|FG001|Overall Study|Non-compliance With Study Drug|2|||
155469021|NCT00131664|561138405|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
155469022|NCT00131664|561138406|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
155469023|NCT00131664|561138401|FG000|First Period (First 6 Months)|Adverse Event|9|||
155469024|NCT00131664|561138402|FG001|First Period (First 6 Months)|Adverse Event|4|||
155469025|NCT00131664|561138403|FG002|First Period (First 6 Months)|Adverse Event|5|||
155469026|NCT00131664|561138404|FG003|First Period (First 6 Months)|Adverse Event|0|||
155469027|NCT00131664|561138405|FG004|First Period (First 6 Months)|Adverse Event|0|||
155469028|NCT00131664|561138406|FG005|First Period (First 6 Months)|Adverse Event|0|||
155469029|NCT00131664|561138401|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
155469030|NCT00131664|561138402|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
155469031|NCT00131664|561138403|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
155469032|NCT00131664|561138404|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
155469033|NCT00131664|561138405|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
155469034|NCT00131664|561138406|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
155469035|NCT00131664|561138401|FG000|First Period (First 6 Months)|Administrative reasons|2|||
155469036|NCT00131664|561138402|FG001|First Period (First 6 Months)|Administrative reasons|0|||
155469037|NCT00131664|561138403|FG002|First Period (First 6 Months)|Administrative reasons|5|||
155469038|NCT00131664|561138404|FG003|First Period (First 6 Months)|Administrative reasons|0|||
155469039|NCT00131664|561138405|FG004|First Period (First 6 Months)|Administrative reasons|0|||
155469040|NCT00131664|561138406|FG005|First Period (First 6 Months)|Administrative reasons|0|||
155469041|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
155469042|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
155469043|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
155469044|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
155469045|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
155469046|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
155469047|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
155469048|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
155469049|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
155469050|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
155469051|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
155469052|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
155469053|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
155469054|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
155517856|NCT02446132|561321330|FG002|Overall Study|Non-compliance With Study Drug|3|||
155517857|NCT02446132|561321328|FG000|Overall Study|Physician Decision|1|||
155517858|NCT02446132|561321329|FG001|Overall Study|Physician Decision|8|||
155517859|NCT02446132|561321330|FG002|Overall Study|Physician Decision|13|||
155517860|NCT02446132|561321328|FG000|Overall Study|Protocol Deviation|0|||
155517861|NCT02446132|561321329|FG001|Overall Study|Protocol Deviation|0|||
155469055|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
155469056|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
155469057|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
155469058|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
155469059|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
155469060|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
155469061|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
155469062|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
155469063|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
155469064|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
155469065|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
155469066|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
155469067|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
155469068|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
155469069|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
155469070|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
155469071|NCT00131664|561138401|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
155469072|NCT00131664|561138402|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
155469073|NCT00131664|561138403|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
155469074|NCT00131664|561138404|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
155469075|NCT00131664|561138405|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
155469076|NCT00131664|561138406|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
155469077|NCT01946412|561138407|FG000|Overall Study|Adverse Event|1|||
155469078|NCT01946412|561138407|FG000|Overall Study|Non-Compliance|1|||
155469079|NCT01946412|561138407|FG000|Overall Study|Continued with commercial Kalydeco|2|||
155469080|NCT01946412|561138407|FG000|Overall Study|Difficulty in swallowing|1|||
155469081|NCT03250624|561140456|FG000|Overall Study|Lack of Efficacy|1|||
155469082|NCT03250624|561140457|FG001|Overall Study|Lack of Efficacy|4|||
155469083|NCT03250624|561140456|FG000|Overall Study|Adverse Event|0|||
155469084|NCT03250624|561140457|FG001|Overall Study|Adverse Event|1|||
155469085|NCT03250624|561140456|FG000|Overall Study|Other|1|||
155469086|NCT03250624|561140457|FG001|Overall Study|Other|2|||
155469087|NCT00106249|561140458|FG000|Overall Study|Lost to Follow-up|3|||
155469088|NCT00106249|561140459|FG001|Overall Study|Lost to Follow-up|2|||
155469089|NCT00948428|561140464|FG000|Overall Study|Withdrawal by Subject|6|||
155469090|NCT00948428|561140465|FG001|Overall Study|Withdrawal by Subject|12|||
155469091|NCT00948428|561140466|FG002|Overall Study|Withdrawal by Subject|7|||
155469092|NCT00948428|561140464|FG000|Overall Study|Adverse Event|6|||
155469093|NCT00948428|561140465|FG001|Overall Study|Adverse Event|3|||
155469094|NCT00948428|561140466|FG002|Overall Study|Adverse Event|0|||
155469095|NCT00948428|561140464|FG000|Overall Study|Lost to Follow-up|2|||
155469096|NCT00948428|561140465|FG001|Overall Study|Lost to Follow-up|1|||
155469097|NCT00948428|561140466|FG002|Overall Study|Lost to Follow-up|1|||
155469098|NCT00948428|561140464|FG000|Overall Study|Death|2|||
155469099|NCT00948428|561140465|FG001|Overall Study|Death|0|||
155469100|NCT00948428|561140466|FG002|Overall Study|Death|0|||
155469101|NCT00948428|561140464|FG000|Overall Study|Intercurrent Illness|1|||
155469102|NCT00948428|561140465|FG001|Overall Study|Intercurrent Illness|0|||
155469103|NCT00948428|561140466|FG002|Overall Study|Intercurrent Illness|0|||
155469104|NCT00948428|561140464|FG000|Overall Study|Non-compliance|1|||
155469105|NCT00948428|561140465|FG001|Overall Study|Non-compliance|2|||
155469106|NCT00948428|561140466|FG002|Overall Study|Non-compliance|0|||
155469107|NCT01843205|561140469|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
155469108|NCT01843205|561140470|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
155469109|NCT00606177|561140471|FG000|Overall Study|Adverse Event|9|||
155469110|NCT00606177|561140472|FG001|Overall Study|Adverse Event|5|||
155469111|NCT00606177|561140471|FG000|Overall Study|Lack of Efficacy|3|||
155469112|NCT00606177|561140472|FG001|Overall Study|Lack of Efficacy|7|||
155469113|NCT00606177|561140471|FG000|Overall Study|Physician Decision|1|||
155469114|NCT00606177|561140472|FG001|Overall Study|Physician Decision|0|||
155469115|NCT00606177|561140471|FG000|Overall Study|Protocol Violation|1|||
155469116|NCT00606177|561140472|FG001|Overall Study|Protocol Violation|4|||
155469117|NCT00606177|561140471|FG000|Overall Study|Withdrawal by Subject|5|||
155469118|NCT00606177|561140472|FG001|Overall Study|Withdrawal by Subject|6|||
155469119|NCT00606177|561140471|FG000|Overall Study|Progression to depressive phase|6|||
155469120|NCT00606177|561140472|FG001|Overall Study|Progression to depressive phase|1|||
155469121|NCT00606177|561140471|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
155469122|NCT00606177|561140472|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
155469123|NCT00606177|561140471|FG000|Overall Study|Change of residence or other commitments|1|||
155469124|NCT00606177|561140472|FG001|Overall Study|Change of residence or other commitments|1|||
155469125|NCT00136357|561140473|FG000|Overall Study|Withdrawal by Subject|3|||
155469126|NCT00136357|561140474|FG001|Overall Study|Withdrawal by Subject|2|||
155469127|NCT01518309|561140475|FG000|Overall Study|Adverse Event|6|||
155469128|NCT01518309|561140475|FG000|Overall Study|Death|6|||
155469129|NCT01518309|561140475|FG000|Overall Study|Lack of Efficacy|7|||
155469130|NCT01518309|561140475|FG000|Overall Study|Withdrawal by Subject|6|||
155469131|NCT01518309|561140475|FG000|Overall Study|Physician Decision|3|||
155469132|NCT01518309|561140475|FG000|Overall Study|Sponsor Decision|2|||
155469133|NCT01518309|561140475|FG000|Overall Study|Not in Predefined Categories|9|||
155469134|NCT02603172|561140476|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469135|NCT02603172|561140477|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469136|NCT02603172|561140478|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
155469137|NCT02603172|561140479|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469138|NCT02603172|561140480|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469139|NCT02603172|561140481|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469140|NCT02603172|561140482|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469141|NCT02603172|561140483|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155469142|NCT00863317|561140484|FG000|Overall Study|Lost to Follow-up|8|||
155469143|NCT00863317|561140485|FG001|Overall Study|Lost to Follow-up|9|||
155469144|NCT00038142|561140488|FG000|Overall Study|Ineligible|1|||
155469145|NCT00038142|561140489|FG001|Overall Study|Ineligible|0|||
155469146|NCT00038142|561140488|FG000|Overall Study|Progressive Disease|11|||
155469147|NCT00038142|561140489|FG001|Overall Study|Progressive Disease|7|||
155469148|NCT00038142|561140488|FG000|Overall Study|Death|1|||
155469149|NCT00038142|561140489|FG001|Overall Study|Death|0|||
155469150|NCT00038142|561140488|FG000|Overall Study|Adverse Event|1|||
155469151|NCT00038142|561140489|FG001|Overall Study|Adverse Event|0|||
155469152|NCT00038142|561140488|FG000|Overall Study|Unknown Reason|8|||
155469153|NCT00038142|561140489|FG001|Overall Study|Unknown Reason|0|||
155469154|NCT00441727|561140490|FG000|Overall Study|Protocol Violation|19|||
155469155|NCT00441727|561140491|FG001|Overall Study|Protocol Violation|28|||
155469156|NCT00441727|561140492|FG002|Overall Study|Protocol Violation|32|||
155469157|NCT00441727|561140490|FG000|Overall Study|Adverse Event|26|||
155469158|NCT00441727|561140491|FG001|Overall Study|Adverse Event|33|||
155469159|NCT00441727|561140492|FG002|Overall Study|Adverse Event|28|||
155469160|NCT00441727|561140490|FG000|Overall Study|Lack of Efficacy|7|||
155469161|NCT00441727|561140491|FG001|Overall Study|Lack of Efficacy|8|||
155469162|NCT00441727|561140492|FG002|Overall Study|Lack of Efficacy|48|||
155469163|NCT00441727|561140490|FG000|Overall Study|Withdrawal by Subject|40|||
155469164|NCT00441727|561140491|FG001|Overall Study|Withdrawal by Subject|34|||
155469165|NCT00441727|561140492|FG002|Overall Study|Withdrawal by Subject|47|||
155469166|NCT00441727|561140490|FG000|Overall Study|Lost to Follow-up|5|||
155469167|NCT00441727|561140491|FG001|Overall Study|Lost to Follow-up|6|||
155469168|NCT00441727|561140492|FG002|Overall Study|Lost to Follow-up|5|||
155469169|NCT00441727|561140490|FG000|Overall Study|Safety Reasons|3|||
155469170|NCT00441727|561140491|FG001|Overall Study|Safety Reasons|1|||
155469171|NCT00441727|561140492|FG002|Overall Study|Safety Reasons|3|||
155469172|NCT00441727|561140490|FG000|Overall Study|Various reason specified|6|||
155469173|NCT00441727|561140491|FG001|Overall Study|Various reason specified|8|||
155469174|NCT00441727|561140492|FG002|Overall Study|Various reason specified|5|||
155469175|NCT02133001|561140497|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
155469176|NCT02133001|561140498|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
155469177|NCT02133001|561140497|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
155469178|NCT02133001|561140498|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
155469179|NCT02133001|561140497|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
155469180|NCT02133001|561140498|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
155469181|NCT02133001|561140497|FG000|Double Blind (Day 1-25)|Other|2|||
155469182|NCT02133001|561140498|FG001|Double Blind (Day 1-25)|Other|2|||
155469183|NCT02133001|561140497|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
155469184|NCT02133001|561140498|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
155469185|NCT02133001|561140497|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
155517862|NCT02446132|561321330|FG002|Overall Study|Protocol Deviation|1|||
155653028|NCT00834587|561822259|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155653029|NCT03810495|561822260|FG000|Overall Study|Lost to Follow-up|2|||
155653030|NCT03810495|561822260|FG000|Overall Study|Withdrawal by Subject|1|||
155653031|NCT03289741|561822261|FG000|Overall Study|Adverse Event|1|||
155653032|NCT03289741|561822262|FG001|Overall Study|Adverse Event|1|||
155653033|NCT03289741|561822261|FG000|Overall Study|Physician Decision|2|||
155653034|NCT03289741|561822262|FG001|Overall Study|Physician Decision|2|||
155653035|NCT03289741|561822261|FG000|Overall Study|Withdrawal by Subject|1|||
155653036|NCT03289741|561822262|FG001|Overall Study|Withdrawal by Subject|0|||
155653037|NCT03449147|561822263|FG000|52-week Treatment Period|Death|0|||
155653038|NCT03449147|561822264|FG001|52-week Treatment Period|Death|1|||
155653039|NCT03449147|561822265|FG002|52-week Treatment Period|Death|0|||
155653040|NCT03449147|561822263|FG000|52-week Treatment Period|Lost to Follow-up|6|||
155653041|NCT03449147|561822264|FG001|52-week Treatment Period|Lost to Follow-up|2|||
155653042|NCT03449147|561822265|FG002|52-week Treatment Period|Lost to Follow-up|5|||
155653043|NCT03449147|561822263|FG000|52-week Treatment Period|Other|0|||
155653044|NCT03449147|561822264|FG001|52-week Treatment Period|Other|1|||
155653045|NCT03449147|561822265|FG002|52-week Treatment Period|Other|2|||
155653046|NCT03449147|561822263|FG000|52-week Treatment Period|Physician Decision|1|||
155653047|NCT03449147|561822264|FG001|52-week Treatment Period|Physician Decision|0|||
155653048|NCT03449147|561822265|FG002|52-week Treatment Period|Physician Decision|3|||
155653049|NCT03449147|561822263|FG000|52-week Treatment Period|Screen Failure|1|||
155653050|NCT03449147|561822264|FG001|52-week Treatment Period|Screen Failure|2|||
155653051|NCT03449147|561822265|FG002|52-week Treatment Period|Screen Failure|0|||
155653052|NCT03449147|561822263|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
155653053|NCT03449147|561822264|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
155653054|NCT03449147|561822265|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
155653055|NCT03449147|561822263|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
155653056|NCT03449147|561822264|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
155653057|NCT03449147|561822265|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
155653058|NCT03449147|561822263|FG000|12-Week Off-Treatment Durability Period|Other|0|||
155653059|NCT03449147|561822264|FG001|12-Week Off-Treatment Durability Period|Other|1|||
155653060|NCT03449147|561822265|FG002|12-Week Off-Treatment Durability Period|Other|0|||
155653061|NCT00954538|561822269|FG000|Part III|Withdrawal by Subject|0|||
155653062|NCT00954538|561822270|FG001|Part III|Withdrawal by Subject|0|||
155653063|NCT00954538|561822271|FG002|Part III|Withdrawal by Subject|0|||
155653064|NCT00954538|561822272|FG003|Part III|Withdrawal by Subject|0|||
155653065|NCT00954538|561822273|FG004|Part III|Withdrawal by Subject|1|||
155653066|NCT00954538|561822274|FG005|Part III|Withdrawal by Subject|0|||
155653067|NCT01657942|561822275|FG000|Overall Study|Alternative Treatment|7|||
155653068|NCT01657942|561822275|FG000|Overall Study|Lost to Follow-up|1|||
155653069|NCT04280783|561823764|FG000|Overall Study|Family issues unrelated to the study.|1|||
155653070|NCT04280783|561823765|FG001|Overall Study|Family issues unrelated to the study.|0|||
155653071|NCT04280783|561823764|FG000|Overall Study|Withdrawal by Subject|0|||
155653072|NCT04280783|561823765|FG001|Overall Study|Withdrawal by Subject|1|||
155653073|NCT03443401|561823772|FG000|Overall Study|Lost to Follow-up|13|||
155653074|NCT03443401|561823772|FG000|Overall Study|Influential outlier|1|||
155653075|NCT02363283|561823773|FG000|Overall Study|Withdrawal by Subject|1|||
155653076|NCT02363283|561823773|FG000|Overall Study|Not eligible due to transaminitis|1|||
155653077|NCT01394185|561823774|FG000|Overall Study|Withdrawal by Subject|2|||
155653078|NCT01394185|561823775|FG001|Overall Study|Withdrawal by Subject|0|||
155653079|NCT01394185|561823776|FG002|Overall Study|Withdrawal by Subject|0|||
155653080|NCT01394185|561823777|FG003|Overall Study|Withdrawal by Subject|0|||
155653081|NCT01394185|561823778|FG004|Overall Study|Withdrawal by Subject|1|||
155653082|NCT01394185|561823779|FG005|Overall Study|Withdrawal by Subject|0|||
155653083|NCT01394185|561823774|FG000|Overall Study|Change in protocol|3|||
155653084|NCT01394185|561823775|FG001|Overall Study|Change in protocol|0|||
155653085|NCT01394185|561823776|FG002|Overall Study|Change in protocol|0|||
155653086|NCT01394185|561823777|FG003|Overall Study|Change in protocol|0|||
155653087|NCT01394185|561823778|FG004|Overall Study|Change in protocol|3|||
155653088|NCT01394185|561823779|FG005|Overall Study|Change in protocol|0|||
155653089|NCT01394185|561823774|FG000|Overall Study|Protocol Violation|1|||
155653090|NCT01394185|561823775|FG001|Overall Study|Protocol Violation|0|||
155653091|NCT01394185|561823776|FG002|Overall Study|Protocol Violation|0|||
155653092|NCT01394185|561823777|FG003|Overall Study|Protocol Violation|1|||
155653093|NCT01394185|561823778|FG004|Overall Study|Protocol Violation|0|||
155653094|NCT01394185|561823779|FG005|Overall Study|Protocol Violation|1|||
155653095|NCT04110145|561823780|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155653096|NCT04110145|561823781|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155517863|NCT02446132|561321328|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
155517864|NCT02446132|561321329|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
155517865|NCT02446132|561321330|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
155517866|NCT02446132|561321328|FG000|Overall Study|Study Terminated by Sponsor|4|||
155517867|NCT02446132|561321329|FG001|Overall Study|Study Terminated by Sponsor|35|||
155517868|NCT02446132|561321330|FG002|Overall Study|Study Terminated by Sponsor|58|||
155517869|NCT02446132|561321328|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
155517870|NCT02446132|561321329|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
155517871|NCT02446132|561321330|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
155517872|NCT02446132|561321328|FG000|Overall Study|Withdrawal by Subject|11|||
155517873|NCT02446132|561321329|FG001|Overall Study|Withdrawal by Subject|29|||
155517874|NCT02446132|561321330|FG002|Overall Study|Withdrawal by Subject|25|||
155517875|NCT02446132|561321328|FG000|Overall Study|Reason not Specified|4|||
155517876|NCT02446132|561321329|FG001|Overall Study|Reason not Specified|16|||
155517877|NCT02446132|561321330|FG002|Overall Study|Reason not Specified|10|||
155517878|NCT02446132|561321328|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
155517879|NCT02446132|561321329|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
155517880|NCT02446132|561321330|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
155517881|NCT03444038|561321331|FG000|Overall Study|Adverse Event|12|||
155517882|NCT03444038|561321331|FG000|Overall Study|Withdrawal by Subject|7|||
155517883|NCT03444038|561321331|FG000|Overall Study|Lost to Follow-up|1|||
155517884|NCT03444038|561321331|FG000|Overall Study|Physician Decision|2|||
155517885|NCT03444038|561321331|FG000|Overall Study|Lack of Efficacy|7|||
155517886|NCT02354586|561321334|FG000|Overall Study|Death|230|||
155517887|NCT02354586|561321334|FG000|Overall Study|Withdrawal by Subject|59|||
155517888|NCT02354586|561321334|FG000|Overall Study|Lost to Follow-up|11|||
155517889|NCT02354586|561321334|FG000|Overall Study|Sponsor decision|51|||
155517890|NCT02354586|561321334|FG000|Overall Study|Site closure|2|||
155517891|NCT02354586|561321334|FG000|Overall Study|Intercurrent illness|1|||
155517892|NCT02354586|561321334|FG000|Overall Study|Protocol Violation|3|||
155517893|NCT02354586|561321334|FG000|Overall Study|Physician Decision|13|||
155517894|NCT02354586|561321334|FG000|Overall Study|Lack of Efficacy|86|||
155517895|NCT02354586|561321334|FG000|Overall Study|Adverse Event|7|||
155517896|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
155517897|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
155517898|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
155517899|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
155517900|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
155517901|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
155517902|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
155517903|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
155517904|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
155469186|NCT02133001|561140498|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
155469187|NCT02133001|561140497|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
155469188|NCT02133001|561140498|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
155469189|NCT02133001|561140497|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
155469190|NCT02133001|561140498|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
155469191|NCT04211961|561140499|FG000|Overall Study|Death|0|||
155469192|NCT04211961|561140500|FG001|Overall Study|Death|1|||
155469193|NCT04211961|561140499|FG000|Overall Study|Lost to Follow-up|0|||
155469194|NCT04211961|561140500|FG001|Overall Study|Lost to Follow-up|1|||
155469195|NCT04211961|561140499|FG000|Overall Study|Withdrawal by Subject|0|||
155469196|NCT04211961|561140500|FG001|Overall Study|Withdrawal by Subject|1|||
155469197|NCT00420342|561140501|FG000|Overall Study|Lost to Follow-up|1|||
155469198|NCT00420342|561140502|FG001|Overall Study|Lost to Follow-up|0|||
155469199|NCT00420342|561140503|FG002|Overall Study|Lost to Follow-up|1|||
155469200|NCT00420342|561140501|FG000|Overall Study|Withdrawal by Subject|0|||
155469201|NCT00420342|561140502|FG001|Overall Study|Withdrawal by Subject|2|||
155469202|NCT00420342|561140503|FG002|Overall Study|Withdrawal by Subject|0|||
155469203|NCT03933215|561140504|FG000|Overall Study|Other|6|||
155469204|NCT03933215|561140504|FG000|Overall Study|Sponsor decision|5|||
155517905|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
155517906|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
155517907|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
155517908|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
155469205|NCT03933215|561140504|FG000|Overall Study|Protocol Violation|5|||
155469206|NCT03933215|561140504|FG000|Overall Study|Withdrawal by Subject|6|||
155469207|NCT03933215|561140504|FG000|Overall Study|Lost to Follow-up|6|||
155469208|NCT03933215|561140504|FG000|Overall Study|Enrolled but not treated|38|||
155469209|NCT05784129|561140507|FG000|Overall Study|Study terminated by sponsor|2|||
155469210|NCT05784129|561140508|FG001|Overall Study|Study terminated by sponsor|2|||
155469211|NCT00407550|561140509|FG000|Overall Study|Adverse Event|0|||
155469212|NCT00407550|561140510|FG001|Overall Study|Adverse Event|1|||
155517909|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
155517910|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
155517911|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
155517912|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
155517913|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
155517914|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155517915|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155517916|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155517917|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155517918|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155517919|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
155517920|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
155517921|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
155517922|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
155517923|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
155517924|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
155517925|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
155517926|NCT01957488|561321337|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
155517927|NCT01957488|561321338|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
155517928|NCT01957488|561321339|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
155517929|NCT01957488|561321340|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
155517930|NCT01957488|561321341|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
155517931|NCT01957488|561321342|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
155517932|NCT01957488|561321337|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
155517933|NCT01957488|561321338|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
155517934|NCT01957488|561321339|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
155517935|NCT01957488|561321340|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
155517936|NCT01957488|561321341|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
155517937|NCT01957488|561321342|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
155517938|NCT01957488|561321337|FG000|Test Period 2 (2 Weeks)|Other|1|||
155517939|NCT01957488|561321338|FG001|Test Period 2 (2 Weeks)|Other|0|||
155517940|NCT01957488|561321339|FG002|Test Period 2 (2 Weeks)|Other|0|||
155517941|NCT01957488|561321340|FG003|Test Period 2 (2 Weeks)|Other|0|||
155517942|NCT01957488|561321341|FG004|Test Period 2 (2 Weeks)|Other|0|||
155517943|NCT01957488|561321342|FG005|Test Period 2 (2 Weeks)|Other|0|||
155517944|NCT01957488|561321337|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
155517945|NCT01957488|561321338|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
155517946|NCT01957488|561321339|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
155517947|NCT01957488|561321340|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
155517948|NCT01957488|561321341|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
155517949|NCT01957488|561321342|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
155517950|NCT01957488|561321337|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
155517951|NCT01957488|561321338|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
155517952|NCT01957488|561321339|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
155517953|NCT01957488|561321340|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
155517954|NCT01957488|561321341|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
155517955|NCT01957488|561321342|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
155517956|NCT01957488|561321337|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
155517957|NCT01957488|561321338|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
155517958|NCT01957488|561321339|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
155517959|NCT01957488|561321340|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
155517960|NCT01957488|561321341|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
155517961|NCT01957488|561321342|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
155517962|NCT01957488|561321337|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
155517963|NCT01957488|561321338|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
155517964|NCT01957488|561321339|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
155517965|NCT01957488|561321340|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
155517966|NCT01957488|561321341|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
155517967|NCT01957488|561321342|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
155517968|NCT01957488|561321337|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
155517969|NCT01957488|561321338|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
155517970|NCT01957488|561321339|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
155517971|NCT01957488|561321340|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
155517972|NCT01957488|561321341|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
155517973|NCT01957488|561321342|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
155517974|NCT00721409|561321344|FG000|Overall Study|Global deterioration of health status|2|||
155517975|NCT00721409|561321345|FG001|Overall Study|Global deterioration of health status|6|||
155517976|NCT00721409|561321346|FG002|Overall Study|Global deterioration of health status|3|||
155469213|NCT00407550|561140509|FG000|Overall Study|Withdrawal by Subject|0|||
155469214|NCT00407550|561140510|FG001|Overall Study|Withdrawal by Subject|2|||
155469215|NCT00407550|561140509|FG000|Overall Study|Death|1|||
155469216|NCT00407550|561140510|FG001|Overall Study|Death|0|||
155469217|NCT00407550|561140509|FG000|Overall Study|Insurance or Other medical condition|2|||
155469218|NCT00407550|561140510|FG001|Overall Study|Insurance or Other medical condition|1|||
155469219|NCT01444898|561140511|FG000|Overall Study|Withdrawal by Subject|1|||
155469220|NCT02580591|561140513|FG000|Overall Study|Adverse Event|0|||
155517977|NCT00721409|561321344|FG000|Overall Study|Death|0|||
155517978|NCT00721409|561321345|FG001|Overall Study|Death|1|||
155517979|NCT00721409|561321346|FG002|Overall Study|Death|0|||
155517980|NCT00721409|561321344|FG000|Overall Study|Randomized not Treated|0|||
155517981|NCT00721409|561321345|FG001|Overall Study|Randomized not Treated|1|||
155517982|NCT00721409|561321346|FG002|Overall Study|Randomized not Treated|4|||
155517983|NCT00721409|561321344|FG000|Overall Study|Reason not specified|1|||
155517984|NCT00721409|561321345|FG001|Overall Study|Reason not specified|0|||
155517985|NCT00721409|561321346|FG002|Overall Study|Reason not specified|2|||
155517986|NCT00721409|561321344|FG000|Overall Study|Adverse Event|0|||
155517987|NCT00721409|561321345|FG001|Overall Study|Adverse Event|13|||
155517988|NCT00721409|561321346|FG002|Overall Study|Adverse Event|2|||
155517989|NCT00721409|561321344|FG000|Overall Study|Lost to Follow-up|0|||
155517990|NCT00721409|561321345|FG001|Overall Study|Lost to Follow-up|0|||
155517991|NCT00721409|561321346|FG002|Overall Study|Lost to Follow-up|1|||
155517992|NCT00721409|561321344|FG000|Overall Study|Withdrawal by Subject|1|||
155517993|NCT00721409|561321345|FG001|Overall Study|Withdrawal by Subject|6|||
155517994|NCT00721409|561321346|FG002|Overall Study|Withdrawal by Subject|5|||
155517995|NCT00721409|561321344|FG000|Overall Study|Objective progression or relapse|8|||
155517996|NCT00721409|561321345|FG001|Overall Study|Objective progression or relapse|55|||
155517997|NCT00721409|561321346|FG002|Overall Study|Objective progression or relapse|62|||
155517998|NCT02402166|561321348|FG000|Overall Study|Adverse Event|2|||
155517999|NCT02402166|561321348|FG000|Overall Study|Withdrawal by Subject|2|||
155518000|NCT02402166|561321348|FG000|Overall Study|Lost to Follow-up|1|||
155518001|NCT00810368|561321349|FG000|Overall Study|Lost to Follow-up|4|||
155518002|NCT00810368|561321350|FG001|Overall Study|Lost to Follow-up|2|||
155518003|NCT00810368|561321349|FG000|Overall Study|Lack of Efficacy|2|||
155518004|NCT00810368|561321350|FG001|Overall Study|Lack of Efficacy|0|||
155518005|NCT00623103|561321351|FG000|Overall Study|Adverse Event|70|||
155518006|NCT00623103|561321352|FG001|Overall Study|Adverse Event|60|||
155518007|NCT00623103|561321351|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155518008|NCT00623103|561321352|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
155518009|NCT00623103|561321351|FG000|Overall Study|Withdrawal by Subject|18|||
155518010|NCT00623103|561321352|FG001|Overall Study|Withdrawal by Subject|24|||
155518011|NCT00623103|561321351|FG000|Overall Study|Lost to Follow-up|4|||
155518012|NCT00623103|561321352|FG001|Overall Study|Lost to Follow-up|1|||
155518013|NCT00623103|561321351|FG000|Overall Study|Administrative problems|2|||
155518014|NCT00623103|561321352|FG001|Overall Study|Administrative problems|4|||
155518015|NCT00623103|561321351|FG000|Overall Study|Death|11|||
155518016|NCT00623103|561321352|FG001|Overall Study|Death|11|||
155518017|NCT00623103|561321351|FG000|Overall Study|Protocol deviation|2|||
155518018|NCT00623103|561321352|FG001|Overall Study|Protocol deviation|1|||
155518019|NCT03803943|561321361|FG000|Overall Study|Withdrawal by Subject|2|||
155518020|NCT03803943|561321362|FG001|Overall Study|Withdrawal by Subject|2|||
155518021|NCT03803943|561321363|FG002|Overall Study|Withdrawal by Subject|2|||
155518022|NCT03803943|561321364|FG003|Overall Study|Withdrawal by Subject|2|||
155518023|NCT01781286|561321365|FG000|Overall Study|Lost to Follow-up|0|||
155518024|NCT01781286|561321366|FG001|Overall Study|Lost to Follow-up|0|||
155518025|NCT01781286|561321367|FG002|Overall Study|Lost to Follow-up|0|||
155518026|NCT01781286|561321368|FG003|Overall Study|Lost to Follow-up|0|||
155518027|NCT01781286|561321369|FG004|Overall Study|Lost to Follow-up|0|||
155518028|NCT01781286|561321370|FG005|Overall Study|Lost to Follow-up|1|||
155518029|NCT01781286|561321365|FG000|Overall Study|Time Constraints|2|||
155469221|NCT02580591|561140514|FG001|Overall Study|Adverse Event|1|||
155518030|NCT01781286|561321366|FG001|Overall Study|Time Constraints|0|||
155518031|NCT01781286|561321367|FG002|Overall Study|Time Constraints|2|||
155518032|NCT01781286|561321368|FG003|Overall Study|Time Constraints|0|||
155518033|NCT01781286|561321369|FG004|Overall Study|Time Constraints|0|||
155518034|NCT01781286|561321370|FG005|Overall Study|Time Constraints|0|||
155518035|NCT01781286|561321365|FG000|Overall Study|Noncompliance|0|||
155518036|NCT01781286|561321366|FG001|Overall Study|Noncompliance|0|||
155469222|NCT02580591|561140515|FG002|Overall Study|Adverse Event|2|||
155469223|NCT02580591|561140516|FG003|Overall Study|Adverse Event|5|||
155469224|NCT02580591|561140513|FG000|Overall Study|Protocol Violation|3|||
155469225|NCT02580591|561140514|FG001|Overall Study|Protocol Violation|2|||
155469226|NCT02580591|561140515|FG002|Overall Study|Protocol Violation|1|||
155469227|NCT02580591|561140516|FG003|Overall Study|Protocol Violation|1|||
155469228|NCT02580591|561140513|FG000|Overall Study|Lost to Follow-up|5|||
155469229|NCT02580591|561140514|FG001|Overall Study|Lost to Follow-up|3|||
155469230|NCT02580591|561140515|FG002|Overall Study|Lost to Follow-up|3|||
155469231|NCT02580591|561140516|FG003|Overall Study|Lost to Follow-up|1|||
155469232|NCT02580591|561140513|FG000|Overall Study|Withdrawal by Subject|6|||
155469233|NCT02580591|561140514|FG001|Overall Study|Withdrawal by Subject|1|||
155469234|NCT02580591|561140515|FG002|Overall Study|Withdrawal by Subject|2|||
155518037|NCT01781286|561321367|FG002|Overall Study|Noncompliance|0|||
155518038|NCT01781286|561321368|FG003|Overall Study|Noncompliance|1|||
155518039|NCT01781286|561321369|FG004|Overall Study|Noncompliance|0|||
155518040|NCT01781286|561321370|FG005|Overall Study|Noncompliance|0|||
155518041|NCT00995410|561321371|FG000|Overall Study|Adverse Event|51|||
155518042|NCT00995410|561321371|FG000|Overall Study|Withdrawal by Subject|7|||
155518043|NCT00995410|561321371|FG000|Overall Study|Lost to Follow-up|2|||
155518044|NCT00995410|561321371|FG000|Overall Study|Misc|28|||
155518045|NCT02166697|561321372|FG000|Overall Study|Protocol Violation|347|||
155518046|NCT02720510|561321375|FG000|Overall Study|Study Terminated by the sponsor|2|||
155518047|NCT02720510|561321376|FG001|Overall Study|Study Terminated by the sponsor|0|||
155518048|NCT02720510|561321375|FG000|Overall Study|Adverse Event|0|||
155518049|NCT02720510|561321376|FG001|Overall Study|Adverse Event|1|||
155518050|NCT02720510|561321375|FG000|Overall Study|Physician Decision|1|||
155518051|NCT02720510|561321376|FG001|Overall Study|Physician Decision|2|||
155518052|NCT01047345|561321381|FG000|Base Study|Adverse Event|3|||
155518053|NCT01047345|561321382|FG001|Base Study|Adverse Event|0|||
155518054|NCT01047345|561321383|FG002|Base Study|Adverse Event|0|||
155518055|NCT01047345|561321381|FG000|Base Study|Lost to Follow-up|4|||
155518056|NCT01047345|561321382|FG001|Base Study|Lost to Follow-up|1|||
155518057|NCT01047345|561321383|FG002|Base Study|Lost to Follow-up|0|||
155518058|NCT01047345|561321381|FG000|Base Study|Protocol Violation|3|||
155518059|NCT01047345|561321382|FG001|Base Study|Protocol Violation|1|||
155518060|NCT01047345|561321383|FG002|Base Study|Protocol Violation|0|||
155518061|NCT01047345|561321381|FG000|Base Study|Withdrawal by Subject|12|||
155518062|NCT01047345|561321382|FG001|Base Study|Withdrawal by Subject|4|||
155518063|NCT01047345|561321383|FG002|Base Study|Withdrawal by Subject|0|||
155518064|NCT01047345|561321381|FG000|Extension|Withdrawal by Subject|0|||
155518065|NCT01047345|561321382|FG001|Extension|Withdrawal by Subject|0|||
155518066|NCT01047345|561321383|FG002|Extension|Withdrawal by Subject|1|||
155518067|NCT01047345|561321381|FG000|Extension|Lost to Follow-up|0|||
155518068|NCT01047345|561321382|FG001|Extension|Lost to Follow-up|0|||
155518069|NCT01047345|561321383|FG002|Extension|Lost to Follow-up|5|||
155518070|NCT00806156|561321384|FG000|Overall Study|Death|35|||
155518071|NCT00806156|561321385|FG001|Overall Study|Death|95|||
155518072|NCT00806156|561321384|FG000|Overall Study|Did not meet eligibility criteria|1|||
155518073|NCT00806156|561321385|FG001|Overall Study|Did not meet eligibility criteria|0|||
155518074|NCT00806156|561321384|FG000|Overall Study|Study terminated by Sponsor|2|||
155518075|NCT00806156|561321385|FG001|Overall Study|Study terminated by Sponsor|40|||
155518076|NCT00806156|561321384|FG000|Overall Study|Consent withdrawn by subject|1|||
155518077|NCT00806156|561321385|FG001|Overall Study|Consent withdrawn by subject|3|||
155518078|NCT00806156|561321384|FG000|Overall Study|Lost to Follow-up|0|||
155518079|NCT00806156|561321385|FG001|Overall Study|Lost to Follow-up|1|||
155518080|NCT00282256|561321386|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
155518081|NCT00282256|561321386|FG000|Extension Treatment Period|Adverse Event|2|||
155518082|NCT01890915|561321394|FG000|Overall Study|Adverse Event|1|||
155518083|NCT01890915|561321395|FG001|Overall Study|Adverse Event|0|||
155518084|NCT01890915|561321394|FG000|Overall Study|Protocol Violation|2|||
155518085|NCT01890915|561321395|FG001|Overall Study|Protocol Violation|0|||
155518086|NCT01890915|561321394|FG000|Overall Study|Equipment Malfunction|0|||
155653097|NCT04110145|561823782|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155469235|NCT02580591|561140516|FG003|Overall Study|Withdrawal by Subject|3|||
155518087|NCT01890915|561321395|FG001|Overall Study|Equipment Malfunction|1|||
155518088|NCT00770510|561321401|FG000|Overall Study|Lost to Follow-up|2|||
155518089|NCT00770510|561321401|FG000|Overall Study|Pregnancy|1|||
155518090|NCT00770510|561321401|FG000|Overall Study|Withdrawal by Subject|2|||
155518091|NCT05030753|561321415|FG000|9-week|Lost to Follow-up|10|||
155518092|NCT05030753|561321416|FG001|9-week|Lost to Follow-up|7|||
155518093|NCT05030753|561321415|FG000|9-week|Withdrawal by Subject|1|||
155653098|NCT04110145|561823783|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
155469236|NCT02580591|561140513|FG000|Overall Study|Not treated|1|||
155518094|NCT05030753|561321416|FG001|9-week|Withdrawal by Subject|0|||
155469237|NCT02580591|561140514|FG001|Overall Study|Not treated|1|||
155469238|NCT02580591|561140515|FG002|Overall Study|Not treated|0|||
155518095|NCT05030753|561321415|FG000|9-week|Excluded from analysis due to missing covariates|2|||
155518096|NCT05030753|561321416|FG001|9-week|Excluded from analysis due to missing covariates|1|||
155518097|NCT05030753|561321415|FG000|6-month post intervention|Lost to Follow-up|5|||
155518098|NCT05030753|561321416|FG001|6-month post intervention|Lost to Follow-up|4|||
155518099|NCT05030753|561321415|FG000|6-month post intervention|Withdrawal by Subject|4|||
155518100|NCT05030753|561321416|FG001|6-month post intervention|Withdrawal by Subject|0|||
155518101|NCT05030753|561321415|FG000|18-month post intervention|Lost to Follow-up|3|||
155518102|NCT05030753|561321416|FG001|18-month post intervention|Lost to Follow-up|1|||
155518103|NCT00720122|561321425|FG000|Overall Study|Lost to Follow-up|1|||
155518104|NCT00720122|561321425|FG000|Overall Study|Physician Decision|1|||
155518105|NCT00720122|561321425|FG000|Overall Study|Withdrawal by Subject|7|||
155518106|NCT03072459|561321426|FG000|Overall Study|Device revised/removed|1|||
155518107|NCT03072459|561321426|FG000|Overall Study|Subject not able to return|1|||
155518108|NCT02097121|561321431|FG000|Overall Study|Other, not specified|4|||
155518109|NCT02097121|561321432|FG001|Overall Study|Other, not specified|2|||
155518110|NCT02097121|561321433|FG002|Overall Study|Other, not specified|3|||
155518111|NCT02097121|561321431|FG000|Overall Study|Lack of Efficacy|2|||
155518112|NCT02097121|561321432|FG001|Overall Study|Lack of Efficacy|1|||
155518113|NCT02097121|561321433|FG002|Overall Study|Lack of Efficacy|3|||
155518114|NCT02097121|561321431|FG000|Overall Study|Withdrawal by Subject|0|||
155518115|NCT02097121|561321432|FG001|Overall Study|Withdrawal by Subject|1|||
155518116|NCT02097121|561321433|FG002|Overall Study|Withdrawal by Subject|2|||
155518117|NCT02097121|561321431|FG000|Overall Study|Adverse Event|0|||
155518118|NCT02097121|561321432|FG001|Overall Study|Adverse Event|1|||
155518119|NCT02097121|561321433|FG002|Overall Study|Adverse Event|0|||
155518120|NCT02097121|561321431|FG000|Overall Study|Lost to Follow-up|1|||
155518121|NCT02097121|561321432|FG001|Overall Study|Lost to Follow-up|1|||
155518122|NCT02097121|561321433|FG002|Overall Study|Lost to Follow-up|2|||
155518123|NCT03595657|561321434|FG000|Overall Study|Adverse Event|14|||
155518124|NCT03595657|561321434|FG000|Overall Study|Death|1|||
155518125|NCT03595657|561321434|FG000|Overall Study|Lack of Efficacy|40|||
155518126|NCT03595657|561321434|FG000|Overall Study|Withdrawal by Subject|10|||
155518127|NCT03595657|561321434|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
155518128|NCT03595657|561321434|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
155518129|NCT01066052|561321435|FG000|Overall Study|Enrolled But Not Treated|3|||
155518130|NCT01066052|561321436|FG001|Overall Study|Enrolled But Not Treated|0|||
155518131|NCT01835145|561321437|FG000|Overall Study|Ineligible prior to treatment|1|||
155518132|NCT01835145|561321438|FG001|Overall Study|Ineligible prior to treatment|0|||
155518133|NCT04094870|561321439|FG000|Overall Study|Lost to Follow-up|1|||
155518134|NCT04094870|561321440|FG001|Overall Study|Lost to Follow-up|1|||
155518135|NCT02708277|561321441|FG000|Overall Study|Lost to Follow-up|7|||
155518136|NCT02708277|561321442|FG001|Overall Study|Lost to Follow-up|4|||
155518137|NCT02742181|561321443|FG000|Overall Study|Physician Decision|1|||
155518138|NCT02742181|561321444|FG001|Overall Study|Physician Decision|0|||
155518139|NCT02739984|561321445|FG000|Overall Study|Sponsor Decision|1|||
155518140|NCT02739984|561321446|FG001|Overall Study|Sponsor Decision|0|||
155518141|NCT02739984|561321445|FG000|Overall Study|Withdrawal by Subject|1|||
155518142|NCT02739984|561321446|FG001|Overall Study|Withdrawal by Subject|1|||
155469239|NCT02580591|561140516|FG003|Overall Study|Not treated|0|||
155469240|NCT02580591|561140513|FG000|Overall Study|Other than specified|3|||
155469241|NCT02580591|561140514|FG001|Overall Study|Other than specified|2|||
155469242|NCT02580591|561140515|FG002|Overall Study|Other than specified|5|||
155469243|NCT02580591|561140516|FG003|Overall Study|Other than specified|2|||
155469244|NCT01599806|561140518|FG000|Overall Study|Lost to Follow-up|20|||
155469245|NCT01599806|561140519|FG001|Overall Study|Lost to Follow-up|20|||
155469246|NCT01599806|561140518|FG000|Overall Study|Withdrawal by Subject|12|||
155469247|NCT01599806|561140519|FG001|Overall Study|Withdrawal by Subject|12|||
155469248|NCT01599806|561140518|FG000|Overall Study|Other Eligibility criteria|11|||
155469249|NCT01599806|561140519|FG001|Overall Study|Other Eligibility criteria|9|||
155469250|NCT00990249|561140525|FG000|Overall Study|Disease Progression|8|||
155469251|NCT00990249|561140525|FG000|Overall Study|Non-Compliance|1|||
155518143|NCT02739984|561321445|FG000|Overall Study|Death|0|||
155518144|NCT02739984|561321446|FG001|Overall Study|Death|1|||
155518145|NCT02739984|561321445|FG000|Overall Study|Lost to Follow-up|3|||
155469252|NCT00990249|561140525|FG000|Overall Study|Death|2|||
155469253|NCT00990249|561140525|FG000|Overall Study|Not treated|2|||
155518146|NCT02739984|561321446|FG001|Overall Study|Lost to Follow-up|0|||
155518147|NCT00409578|561321453|FG000|Overall Study|Adverse Event|27|||
155469254|NCT02873208|561140528|FG000|Overall Study|Withdrawal by Subject|36|||
155469255|NCT02873208|561140528|FG000|Overall Study|Lost to Follow-up|22|||
155469256|NCT02873208|561140528|FG000|Overall Study|Adverse Event|15|||
155469257|NCT02873208|561140528|FG000|Overall Study|Non-compliance with study drug|12|||
155518148|NCT00409578|561321454|FG001|Overall Study|Adverse Event|37|||
155518149|NCT00409578|561321455|FG002|Overall Study|Adverse Event|25|||
155518150|NCT00409578|561321456|FG003|Overall Study|Adverse Event|33|||
155518151|NCT00409578|561321453|FG000|Overall Study|Abnormal laboratory value(s)|2|||
155518152|NCT00409578|561321454|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155518153|NCT00409578|561321455|FG002|Overall Study|Abnormal laboratory value(s)|2|||
155518154|NCT00409578|561321456|FG003|Overall Study|Abnormal laboratory value(s)|4|||
155469258|NCT02873208|561140528|FG000|Overall Study|Protocol Violation|8|||
155469259|NCT02873208|561140528|FG000|Overall Study|Pregnancy|2|||
155469260|NCT02873208|561140528|FG000|Overall Study|Incarceration|1|||
155469261|NCT02873208|561140528|FG000|Overall Study|Lack of Efficacy|1|||
155469262|NCT02873208|561140528|FG000|Overall Study|Physician Decision|1|||
155469263|NCT00415584|561140529|FG000|Overall Study|Withdrawal by Subject|1|||
155469264|NCT01061567|561140530|FG000|Overall Study|Adverse Event|32|||
155469265|NCT01061567|561140530|FG000|Overall Study|Death|2|||
155469266|NCT01061567|561140530|FG000|Overall Study|Lack of Efficacy|3|||
155469267|NCT01061567|561140530|FG000|Overall Study|Lost to Follow-up|24|||
155469268|NCT01061567|561140530|FG000|Overall Study|Protocol Violation|1|||
155469269|NCT01061567|561140530|FG000|Overall Study|Withdrawal by Subject|11|||
155469270|NCT01061567|561140530|FG000|Overall Study|Other reason than stated above|3|||
155469271|NCT00563368|561140531|FG000|Overall Study|Lost to Follow-up|14|||
155469272|NCT00563368|561140532|FG001|Overall Study|Lost to Follow-up|14|||
155469273|NCT00563368|561140533|FG002|Overall Study|Lost to Follow-up|12|||
155469274|NCT00563368|561140534|FG003|Overall Study|Lost to Follow-up|6|||
155469275|NCT00563368|561140535|FG004|Overall Study|Lost to Follow-up|9|||
155469276|NCT00563368|561140536|FG005|Overall Study|Lost to Follow-up|8|||
155469277|NCT00563368|561140537|FG006|Overall Study|Lost to Follow-up|9|||
155469278|NCT00563368|561140531|FG000|Overall Study|Adverse Event|3|||
155469279|NCT00563368|561140532|FG001|Overall Study|Adverse Event|4|||
155469280|NCT00563368|561140533|FG002|Overall Study|Adverse Event|5|||
155469281|NCT00563368|561140534|FG003|Overall Study|Adverse Event|9|||
155469282|NCT00563368|561140535|FG004|Overall Study|Adverse Event|6|||
155469283|NCT00563368|561140536|FG005|Overall Study|Adverse Event|10|||
155469284|NCT00563368|561140537|FG006|Overall Study|Adverse Event|17|||
155469285|NCT00563368|561140531|FG000|Overall Study|Withdrawal by Subject|11|||
155469286|NCT00563368|561140532|FG001|Overall Study|Withdrawal by Subject|6|||
155469287|NCT00563368|561140533|FG002|Overall Study|Withdrawal by Subject|5|||
155469288|NCT00563368|561140534|FG003|Overall Study|Withdrawal by Subject|7|||
155469289|NCT00563368|561140535|FG004|Overall Study|Withdrawal by Subject|8|||
155469290|NCT00563368|561140536|FG005|Overall Study|Withdrawal by Subject|5|||
155469291|NCT00563368|561140537|FG006|Overall Study|Withdrawal by Subject|4|||
155469292|NCT00563368|561140531|FG000|Overall Study|protocol non-compliance|1|||
155469293|NCT00563368|561140532|FG001|Overall Study|protocol non-compliance|1|||
155469294|NCT00563368|561140533|FG002|Overall Study|protocol non-compliance|2|||
155469295|NCT00563368|561140534|FG003|Overall Study|protocol non-compliance|1|||
155469296|NCT00563368|561140535|FG004|Overall Study|protocol non-compliance|0|||
155469297|NCT00563368|561140536|FG005|Overall Study|protocol non-compliance|1|||
155469298|NCT00563368|561140537|FG006|Overall Study|protocol non-compliance|3|||
155469299|NCT00563368|561140531|FG000|Overall Study|Pregnancy|1|||
155469300|NCT00563368|561140532|FG001|Overall Study|Pregnancy|0|||
155469301|NCT00563368|561140533|FG002|Overall Study|Pregnancy|1|||
155469302|NCT00563368|561140534|FG003|Overall Study|Pregnancy|2|||
155469303|NCT00563368|561140535|FG004|Overall Study|Pregnancy|1|||
155469304|NCT00563368|561140536|FG005|Overall Study|Pregnancy|2|||
155469305|NCT00563368|561140537|FG006|Overall Study|Pregnancy|0|||
155469306|NCT00563368|561140531|FG000|Overall Study|requirement for restricted medication|0|||
155469307|NCT00563368|561140532|FG001|Overall Study|requirement for restricted medication|0|||
155469308|NCT00563368|561140533|FG002|Overall Study|requirement for restricted medication|2|||
155469309|NCT00563368|561140534|FG003|Overall Study|requirement for restricted medication|0|||
155469310|NCT00563368|561140535|FG004|Overall Study|requirement for restricted medication|0|||
155469311|NCT00563368|561140536|FG005|Overall Study|requirement for restricted medication|0|||
155469312|NCT00563368|561140537|FG006|Overall Study|requirement for restricted medication|0|||
155469313|NCT00563368|561140531|FG000|Overall Study|Other|5|||
155469314|NCT00563368|561140532|FG001|Overall Study|Other|5|||
155469315|NCT00563368|561140533|FG002|Overall Study|Other|3|||
155469316|NCT00563368|561140534|FG003|Overall Study|Other|4|||
155469317|NCT00563368|561140535|FG004|Overall Study|Other|4|||
155469318|NCT00563368|561140536|FG005|Overall Study|Other|4|||
155469319|NCT00563368|561140537|FG006|Overall Study|Other|0|||
155469320|NCT02640755|561140538|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
155469321|NCT02640755|561140539|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
155469322|NCT02640755|561140538|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
155469323|NCT02640755|561140539|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
155469324|NCT02640755|561140538|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
155469325|NCT02640755|561140539|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
155469326|NCT01192100|561140544|FG000|Overall Study|Withdrawal by Subject|0|||
155469327|NCT01192100|561140545|FG001|Overall Study|Withdrawal by Subject|0|||
155469328|NCT01192100|561140546|FG002|Overall Study|Withdrawal by Subject|0|||
155469329|NCT01192100|561140547|FG003|Overall Study|Withdrawal by Subject|0|||
155469330|NCT01192100|561140548|FG004|Overall Study|Withdrawal by Subject|1|||
155469331|NCT01192100|561140549|FG005|Overall Study|Withdrawal by Subject|0|||
155469332|NCT01192100|561140544|FG000|Overall Study|Protocol Violation|0|||
155469333|NCT01192100|561140545|FG001|Overall Study|Protocol Violation|0|||
155469334|NCT01192100|561140546|FG002|Overall Study|Protocol Violation|0|||
155469335|NCT01192100|561140547|FG003|Overall Study|Protocol Violation|1|||
155469336|NCT01192100|561140548|FG004|Overall Study|Protocol Violation|0|||
155653099|NCT04110145|561823784|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155653100|NCT02371889|561823785|FG000|Overall Study|Adverse medication effect|11|||
155653101|NCT02371889|561823786|FG001|Overall Study|Adverse medication effect|2|||
155653102|NCT02371889|561823785|FG000|Overall Study|Lost to Follow-up|6|||
155653103|NCT02371889|561823786|FG001|Overall Study|Lost to Follow-up|5|||
155653104|NCT02371889|561823785|FG000|Overall Study|Personal time constraints|2|||
155653105|NCT02371889|561823786|FG001|Overall Study|Personal time constraints|4|||
155653106|NCT02371889|561823785|FG000|Overall Study|Lack of Efficacy|0|||
155653107|NCT02371889|561823786|FG001|Overall Study|Lack of Efficacy|2|||
155653108|NCT02371889|561823785|FG000|Overall Study|Relapse|0|||
155653109|NCT02371889|561823786|FG001|Overall Study|Relapse|1|||
155653110|NCT05520333|561823787|FG000|Overall Study|Lost to Follow-up|3|||
155653111|NCT05520333|561823788|FG001|Overall Study|Lost to Follow-up|6|||
155653112|NCT05538728|561823789|FG000|Overall Study|Withdrawal by Subject|1|||
155653113|NCT05538728|561823790|FG001|Overall Study|Withdrawal by Subject|1|||
155653114|NCT02254460|561823791|FG000|Overall Study|Adverse Event|1|||
155653115|NCT02254460|561823792|FG001|Overall Study|Adverse Event|0|||
155653116|NCT02336555|561823793|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155653117|NCT02336555|561823794|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155653118|NCT02336555|561823793|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
155653119|NCT02336555|561823794|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
155653120|NCT02336555|561823793|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
155653121|NCT02336555|561823794|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
155653122|NCT01772693|561823795|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
155653123|NCT01772693|561823796|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
155653124|NCT01772693|561823795|FG000|Overall Study|Withdrawal by Subject|2|||
155653125|NCT01772693|561823796|FG001|Overall Study|Withdrawal by Subject|0|||
155653126|NCT01772693|561823795|FG000|Overall Study|Alternative Treatment|2|||
155653127|NCT01772693|561823796|FG001|Overall Study|Alternative Treatment|0|||
155653128|NCT01633112|561823799|FG000|Overall Study|Lack of Efficacy|1|||
155653129|NCT01633112|561823800|FG001|Overall Study|Lack of Efficacy|6|||
155653130|NCT01633112|561823801|FG002|Overall Study|Lack of Efficacy|13|||
155653131|NCT01633112|561823799|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155653132|NCT01633112|561823800|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155653133|NCT01633112|561823801|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155653134|NCT01633112|561823799|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155653135|NCT01633112|561823800|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155653136|NCT01633112|561823801|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155653137|NCT01633112|561823799|FG000|Overall Study|Administrative problems|1|||
155653138|NCT01633112|561823800|FG001|Overall Study|Administrative problems|2|||
155653139|NCT01633112|561823801|FG002|Overall Study|Administrative problems|5|||
155653140|NCT01633112|561823799|FG000|Overall Study|Adverse Event|16|||
155653141|NCT01633112|561823800|FG001|Overall Study|Adverse Event|18|||
155653142|NCT01633112|561823801|FG002|Overall Study|Adverse Event|20|||
155653143|NCT01633112|561823799|FG000|Overall Study|Lost to Follow-up|7|||
155653144|NCT01633112|561823800|FG001|Overall Study|Lost to Follow-up|19|||
155653145|NCT01633112|561823801|FG002|Overall Study|Lost to Follow-up|6|||
155653146|NCT01633112|561823799|FG000|Overall Study|Protocol Violation|4|||
155653147|NCT01633112|561823800|FG001|Overall Study|Protocol Violation|0|||
155653148|NCT01633112|561823801|FG002|Overall Study|Protocol Violation|2|||
155653149|NCT01633112|561823799|FG000|Overall Study|Subject no longer requires study drug|0|||
155653150|NCT01633112|561823800|FG001|Overall Study|Subject no longer requires study drug|0|||
155653151|NCT01633112|561823801|FG002|Overall Study|Subject no longer requires study drug|1|||
155653152|NCT01633112|561823799|FG000|Overall Study|Withdrawal by Subject|20|||
155653153|NCT01633112|561823800|FG001|Overall Study|Withdrawal by Subject|12|||
155653154|NCT01633112|561823801|FG002|Overall Study|Withdrawal by Subject|41|||
155653155|NCT01633112|561823799|FG000|Overall Study|missing Study Completion CRF|1|||
155653156|NCT01633112|561823800|FG001|Overall Study|missing Study Completion CRF|1|||
155653157|NCT01633112|561823801|FG002|Overall Study|missing Study Completion CRF|4|||
155653158|NCT02605967|561823810|FG000|Overall Study|subject / guardian decision|1|||
155653159|NCT02605967|561823811|FG001|Overall Study|subject / guardian decision|2|||
155653160|NCT02605967|561823810|FG000|Overall Study|Physician Decision|10|||
155653161|NCT02605967|561823811|FG001|Overall Study|Physician Decision|1|||
155653162|NCT02605967|561823810|FG000|Overall Study|Death|4|||
155653163|NCT02605967|561823811|FG001|Overall Study|Death|2|||
155653164|NCT02605967|561823810|FG000|Overall Study|Adverse Event|1|||
155653165|NCT02605967|561823811|FG001|Overall Study|Adverse Event|0|||
155653166|NCT02605967|561823810|FG000|Overall Study|progressive disease|66|||
155653167|NCT02605967|561823811|FG001|Overall Study|progressive disease|35|||
155653168|NCT05122143|561823817|FG000|Overall Study|Adverse Event|1|||
155653169|NCT05122143|561823818|FG001|Overall Study|Adverse Event|0|||
155469337|NCT01192100|561140549|FG005|Overall Study|Protocol Violation|0|||
155469338|NCT00841672|561140551|FG000|Overall Study|Adverse Event|7|||
155469339|NCT00841672|561140552|FG001|Overall Study|Adverse Event|16|||
155469340|NCT00841672|561140551|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155469341|NCT00841672|561140552|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155469342|NCT00841672|561140551|FG000|Overall Study|Subject withdrew consent|2|||
155469343|NCT00841672|561140552|FG001|Overall Study|Subject withdrew consent|4|||
155469344|NCT00841672|561140551|FG000|Overall Study|Lost to Follow-up|1|||
155469345|NCT00841672|561140552|FG001|Overall Study|Lost to Follow-up|1|||
155469346|NCT00841672|561140551|FG000|Overall Study|Administrative problems|9|||
155469347|NCT00841672|561140552|FG001|Overall Study|Administrative problems|9|||
155469348|NCT00841672|561140551|FG000|Overall Study|Misrandomized|1|||
155469349|NCT00841672|561140552|FG001|Overall Study|Misrandomized|0|||
155469350|NCT00841672|561140551|FG000|Overall Study|Protocol Deviation|0|||
155469351|NCT00841672|561140552|FG001|Overall Study|Protocol Deviation|1|||
155469352|NCT02186561|561140555|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
155469353|NCT02186561|561140555|FG000|Enrollment|Enrollment Cap Reached|5|||
155469354|NCT02186561|561140555|FG000|Enrollment|Insurance Denial|2|||
155469355|NCT02186561|561140555|FG000|Enrollment|Withdrawal by Subject|2|||
155469356|NCT02186561|561140555|FG000|Enrollment|Investigator Withdrew Consent|1|||
155469357|NCT02186561|561140555|FG000|30-Day Post Index Procedure Visit|Death|1|||
155469358|NCT02186561|561140555|FG000|1- Year Post Index Procedure Visit|Death|1|||
155469359|NCT02186561|561140555|FG000|1- Year Post Index Procedure Visit|Missed|1|||
155469360|NCT00842361|561140556|FG000|Overall Study|Protocol Violation|1|||
155469361|NCT00842361|561140557|FG001|Overall Study|Protocol Violation|0|||
155469362|NCT00842361|561140556|FG000|Overall Study|Unclassified|0|||
155469363|NCT00842361|561140557|FG001|Overall Study|Unclassified|2|||
155469364|NCT01072448|561140560|FG000|Overall Study|Adverse Event|9|||
155469365|NCT01072448|561140561|FG001|Overall Study|Adverse Event|10|||
155469366|NCT01072448|561140560|FG000|Overall Study|Subject withdrew consent|4|||
155469367|NCT01072448|561140561|FG001|Overall Study|Subject withdrew consent|9|||
155469368|NCT01072448|561140560|FG000|Overall Study|Protocol deviation|3|||
155469369|NCT01072448|561140561|FG001|Overall Study|Protocol deviation|4|||
155469370|NCT01072448|561140560|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155469371|NCT01072448|561140561|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155469372|NCT01072448|561140560|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155469373|NCT01072448|561140561|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155469374|NCT01072448|561140560|FG000|Overall Study|Lost to Follow-up|1|||
155469375|NCT01072448|561140561|FG001|Overall Study|Lost to Follow-up|1|||
155469376|NCT01072448|561140560|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155469377|NCT01072448|561140561|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155469378|NCT01072448|561140560|FG000|Overall Study|Death|0|||
155469379|NCT01072448|561140561|FG001|Overall Study|Death|2|||
155469380|NCT00196196|561140566|FG000|Overall Study|Withdrawal by Subject|2|||
155469381|NCT00196196|561140566|FG000|Overall Study|Did not have required condition (hydroce|5|||
155469382|NCT01015820|561140569|FG000|Overall Study|Suboptimal measurements|1|||
155469383|NCT01015820|561140570|FG001|Overall Study|Suboptimal measurements|0|||
155469384|NCT03034057|561140571|FG000|Overall Study|Withdrawal by Subject|10|||
155469385|NCT03034057|561140571|FG000|Overall Study|Protocol Violation|1|||
155469386|NCT03034057|561140571|FG000|Overall Study|Not defined|2|||
155469387|NCT03034057|561140571|FG000|Overall Study|Lost to Follow-up|19|||
155469388|NCT03034057|561140571|FG000|Overall Study|Adverse Event|22|||
155469389|NCT03034057|561140571|FG000|Overall Study|Medication error without associated AE|1|||
155469390|NCT03339401|561140572|FG000|Overall Study|Death|2|||
155469391|NCT03339401|561140573|FG001|Overall Study|Death|1|||
155469392|NCT03339401|561140572|FG000|Overall Study|Withdrawal by Subject|2|||
155469393|NCT03339401|561140573|FG001|Overall Study|Withdrawal by Subject|0|||
155469394|NCT03339401|561140572|FG000|Overall Study|Study terminated|4|||
155469395|NCT03339401|561140573|FG001|Overall Study|Study terminated|3|||
155469396|NCT03339401|561140572|FG000|Overall Study|Investigator Decision|1|||
155518155|NCT00409578|561321453|FG000|Overall Study|Lack of Efficacy|0|||
155518156|NCT00409578|561321454|FG001|Overall Study|Lack of Efficacy|0|||
155469397|NCT03339401|561140573|FG001|Overall Study|Investigator Decision|0|||
155469398|NCT00718523|561140574|FG000|Overall Study|Withdrawal by Subject|5|||
155469399|NCT00718523|561140575|FG001|Overall Study|Withdrawal by Subject|7|||
155469400|NCT00718523|561140574|FG000|Overall Study|Death|13|||
155469401|NCT00718523|561140575|FG001|Overall Study|Death|17|||
155518157|NCT00409578|561321455|FG002|Overall Study|Lack of Efficacy|0|||
155469402|NCT01313078|561140576|FG000|Overall Study|Death|1|||
155469403|NCT01313078|561140576|FG000|Overall Study|Discontinued study drug|1|||
155469404|NCT01313078|561140576|FG000|Overall Study|Withdrawal by Subject|1|||
155469405|NCT00910728|561140577|FG000|Overall Study|Lack of Efficacy|2|||
155469406|NCT00910728|561140578|FG001|Overall Study|Lack of Efficacy|3|||
155469407|NCT00910728|561140579|FG002|Overall Study|Lack of Efficacy|1|||
155469408|NCT00910728|561140580|FG003|Overall Study|Lack of Efficacy|2|||
155469409|NCT00910728|561140581|FG004|Overall Study|Lack of Efficacy|1|||
155469410|NCT00910728|561140582|FG005|Overall Study|Lack of Efficacy|0|||
155469411|NCT00910728|561140583|FG006|Overall Study|Lack of Efficacy|2|||
155469412|NCT00910728|561140584|FG007|Overall Study|Lack of Efficacy|2|||
155469413|NCT00910728|561140585|FG008|Overall Study|Lack of Efficacy|2|||
155469414|NCT00910728|561140577|FG000|Overall Study|Withdrawal by Subject|0|||
155469415|NCT00910728|561140578|FG001|Overall Study|Withdrawal by Subject|0|||
155469416|NCT00910728|561140579|FG002|Overall Study|Withdrawal by Subject|0|||
155469417|NCT00910728|561140580|FG003|Overall Study|Withdrawal by Subject|0|||
155469418|NCT00910728|561140581|FG004|Overall Study|Withdrawal by Subject|3|||
155469419|NCT00910728|561140582|FG005|Overall Study|Withdrawal by Subject|1|||
155469420|NCT00910728|561140583|FG006|Overall Study|Withdrawal by Subject|2|||
155469421|NCT00910728|561140584|FG007|Overall Study|Withdrawal by Subject|0|||
155469422|NCT00910728|561140585|FG008|Overall Study|Withdrawal by Subject|0|||
155469423|NCT00910728|561140577|FG000|Overall Study|(not specified)|2|||
155469424|NCT00910728|561140578|FG001|Overall Study|(not specified)|0|||
155469425|NCT00910728|561140579|FG002|Overall Study|(not specified)|1|||
155469426|NCT00910728|561140580|FG003|Overall Study|(not specified)|0|||
155469427|NCT00910728|561140581|FG004|Overall Study|(not specified)|1|||
155469428|NCT00910728|561140582|FG005|Overall Study|(not specified)|0|||
155469429|NCT00910728|561140583|FG006|Overall Study|(not specified)|0|||
155469430|NCT00910728|561140584|FG007|Overall Study|(not specified)|0|||
155469431|NCT00910728|561140585|FG008|Overall Study|(not specified)|0|||
155469432|NCT00910728|561140577|FG000|Overall Study|Adverse Event|2|||
155469433|NCT00910728|561140578|FG001|Overall Study|Adverse Event|0|||
155469434|NCT00910728|561140579|FG002|Overall Study|Adverse Event|1|||
155469435|NCT00910728|561140580|FG003|Overall Study|Adverse Event|1|||
155469436|NCT00910728|561140581|FG004|Overall Study|Adverse Event|0|||
155469437|NCT00910728|561140582|FG005|Overall Study|Adverse Event|0|||
155469438|NCT00910728|561140583|FG006|Overall Study|Adverse Event|2|||
155469439|NCT00910728|561140584|FG007|Overall Study|Adverse Event|1|||
155469440|NCT00910728|561140585|FG008|Overall Study|Adverse Event|1|||
155469441|NCT01042938|561140586|FG000|Overall Study|Withdrawal by Subject|1|||
155469442|NCT01042938|561140587|FG001|Overall Study|Withdrawal by Subject|1|||
155469443|NCT01042938|561140586|FG000|Overall Study|Protocol Violation|1|||
155469444|NCT01042938|561140587|FG001|Overall Study|Protocol Violation|1|||
155469445|NCT01042938|561140586|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
155469446|NCT01042938|561140587|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
155469447|NCT03136484|561140588|FG000|Overall Study|Withdrawal by Subject|19|||
155469448|NCT03136484|561140589|FG001|Overall Study|Withdrawal by Subject|14|||
155469449|NCT03136484|561140588|FG000|Overall Study|Lost to Follow-up|7|||
155469450|NCT03136484|561140589|FG001|Overall Study|Lost to Follow-up|8|||
155469451|NCT03136484|561140588|FG000|Overall Study|Death|1|||
155469452|NCT03136484|561140589|FG001|Overall Study|Death|0|||
155469453|NCT01449955|561140592|FG000|Overall Study|Withdrawal by Subject|1|||
155469454|NCT01449955|561140593|FG001|Overall Study|Withdrawal by Subject|2|||
155469455|NCT01203787|561140594|FG000|Overall Study|Death|12|||
155469456|NCT01203787|561140595|FG001|Overall Study|Death|10|||
155469457|NCT01203787|561140594|FG000|Overall Study|Withdrawal by Subject|6|||
155469458|NCT01203787|561140595|FG001|Overall Study|Withdrawal by Subject|2|||
155469459|NCT01203787|561140594|FG000|Overall Study|Lost to Follow-up|2|||
155469460|NCT01203787|561140595|FG001|Overall Study|Lost to Follow-up|0|||
155469461|NCT01203787|561140594|FG000|Overall Study|Adverse Event|11|||
155469462|NCT01203787|561140595|FG001|Overall Study|Adverse Event|15|||
155469463|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
155469464|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
155469465|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
155469466|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
155469467|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
155469468|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
155469469|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
155469470|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
155469471|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
155469472|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
155469473|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
155469474|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
155518158|NCT00409578|561321456|FG003|Overall Study|Lack of Efficacy|2|||
155518159|NCT00409578|561321453|FG000|Overall Study|Subject no longer requires study drug|0|||
155518160|NCT00409578|561321454|FG001|Overall Study|Subject no longer requires study drug|0|||
155469475|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
155469476|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
155469477|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
155469478|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
155469479|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
155469480|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
155469481|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
155469482|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
155469483|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
155653170|NCT05122143|561823819|FG002|Overall Study|Adverse Event|0|||
155653171|NCT05122143|561823820|FG003|Overall Study|Adverse Event|0|||
155653172|NCT05122143|561823821|FG004|Overall Study|Adverse Event|1|||
155469484|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
155469485|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
155469486|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
155469487|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
155469488|NCT00856986|561140596|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
155653173|NCT05122143|561823822|FG005|Overall Study|Adverse Event|0|||
155653174|NCT05122143|561823817|FG000|Overall Study|Protocol non-compliance|0|||
155653175|NCT05122143|561823818|FG001|Overall Study|Protocol non-compliance|0|||
155653176|NCT05122143|561823819|FG002|Overall Study|Protocol non-compliance|1|||
155653177|NCT05122143|561823820|FG003|Overall Study|Protocol non-compliance|0|||
155653178|NCT05122143|561823821|FG004|Overall Study|Protocol non-compliance|0|||
155653179|NCT05122143|561823822|FG005|Overall Study|Protocol non-compliance|0|||
155653180|NCT05122143|561823817|FG000|Overall Study|Covid contact|0|||
155653181|NCT05122143|561823818|FG001|Overall Study|Covid contact|0|||
155653182|NCT05122143|561823819|FG002|Overall Study|Covid contact|0|||
155653183|NCT05122143|561823820|FG003|Overall Study|Covid contact|0|||
155653184|NCT05122143|561823821|FG004|Overall Study|Covid contact|1|||
155653185|NCT05122143|561823822|FG005|Overall Study|Covid contact|0|||
155653186|NCT01475825|561823823|FG000|Overall Study|Adverse Event|41|||
155653187|NCT01475825|561823824|FG001|Overall Study|Adverse Event|15|||
155653188|NCT01475825|561823825|FG002|Overall Study|Adverse Event|27|||
155653189|NCT01475825|561823826|FG003|Overall Study|Adverse Event|11|||
155653190|NCT01475825|561823823|FG000|Overall Study|Death|1|||
155653191|NCT01475825|561823824|FG001|Overall Study|Death|0|||
155653192|NCT01475825|561823825|FG002|Overall Study|Death|1|||
155653193|NCT01475825|561823826|FG003|Overall Study|Death|0|||
155653194|NCT01475825|561823823|FG000|Overall Study|Lack of Efficacy|0|||
155653195|NCT01475825|561823824|FG001|Overall Study|Lack of Efficacy|0|||
155653196|NCT01475825|561823825|FG002|Overall Study|Lack of Efficacy|1|||
155653197|NCT01475825|561823826|FG003|Overall Study|Lack of Efficacy|0|||
155653198|NCT01475825|561823823|FG000|Overall Study|Lost to Follow-up|0|||
155653199|NCT01475825|561823824|FG001|Overall Study|Lost to Follow-up|0|||
155653200|NCT01475825|561823825|FG002|Overall Study|Lost to Follow-up|3|||
155653201|NCT01475825|561823826|FG003|Overall Study|Lost to Follow-up|1|||
155653202|NCT01475825|561823823|FG000|Overall Study|Non-compliance with Study Drug|1|||
155653203|NCT01475825|561823824|FG001|Overall Study|Non-compliance with Study Drug|2|||
155653204|NCT01475825|561823825|FG002|Overall Study|Non-compliance with Study Drug|4|||
155653205|NCT01475825|561823826|FG003|Overall Study|Non-compliance with Study Drug|0|||
155653206|NCT01475825|561823823|FG000|Overall Study|Other: Not available|0|||
155653207|NCT01475825|561823824|FG001|Overall Study|Other: Not available|0|||
155653208|NCT01475825|561823825|FG002|Overall Study|Other: Not available|2|||
155653209|NCT01475825|561823826|FG003|Overall Study|Other: Not available|0|||
155653210|NCT01475825|561823823|FG000|Overall Study|Protocol Violation|1|||
155653211|NCT01475825|561823824|FG001|Overall Study|Protocol Violation|0|||
155653212|NCT01475825|561823825|FG002|Overall Study|Protocol Violation|0|||
155653213|NCT01475825|561823826|FG003|Overall Study|Protocol Violation|0|||
155653214|NCT01475825|561823823|FG000|Overall Study|Physician Decision|0|||
155653215|NCT01475825|561823824|FG001|Overall Study|Physician Decision|1|||
155653216|NCT01475825|561823825|FG002|Overall Study|Physician Decision|0|||
155653217|NCT01475825|561823826|FG003|Overall Study|Physician Decision|0|||
155653218|NCT01475825|561823823|FG000|Overall Study|Withdrawal by Subject|8|||
155653219|NCT01475825|561823824|FG001|Overall Study|Withdrawal by Subject|3|||
155653220|NCT01475825|561823825|FG002|Overall Study|Withdrawal by Subject|11|||
155653221|NCT01475825|561823826|FG003|Overall Study|Withdrawal by Subject|7|||
155653222|NCT01475825|561823823|FG000|Overall Study|Did not enter OLC|15|||
155653223|NCT01475825|561823824|FG001|Overall Study|Did not enter OLC|11|||
155653224|NCT01475825|561823825|FG002|Overall Study|Did not enter OLC|15|||
155653225|NCT01475825|561823826|FG003|Overall Study|Did not enter OLC|11|||
155653226|NCT00160563|561823827|FG000|Overall Study|Adverse Event|1|||
155469489|NCT00856986|561140597|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
155469490|NCT00856986|561140598|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
155653227|NCT00160563|561823828|FG001|Overall Study|Adverse Event|1|||
155653228|NCT00160563|561823829|FG002|Overall Study|Adverse Event|1|||
155653229|NCT00160563|561823827|FG000|Overall Study|Lost to Follow-up|1|||
155653230|NCT00160563|561823828|FG001|Overall Study|Lost to Follow-up|1|||
155653231|NCT00160563|561823829|FG002|Overall Study|Lost to Follow-up|2|||
155653232|NCT00160563|561823827|FG000|Overall Study|Protocol Violation|0|||
155653233|NCT00160563|561823828|FG001|Overall Study|Protocol Violation|0|||
155653234|NCT00160563|561823829|FG002|Overall Study|Protocol Violation|3|||
155653235|NCT00160563|561823827|FG000|Overall Study|Withdrawal by Subject|1|||
155653236|NCT00160563|561823828|FG001|Overall Study|Withdrawal by Subject|2|||
155653237|NCT00160563|561823829|FG002|Overall Study|Withdrawal by Subject|3|||
155653238|NCT00160563|561823827|FG000|Overall Study|Other (listed in the study report)|48|||
155653239|NCT00160563|561823828|FG001|Overall Study|Other (listed in the study report)|40|||
155653240|NCT00160563|561823829|FG002|Overall Study|Other (listed in the study report)|81|||
155469491|NCT00856986|561140599|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
155469492|NCT00856986|561140600|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
155469493|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
155469494|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
155469495|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
155469496|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
155469497|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
155518161|NCT00409578|561321455|FG002|Overall Study|Subject no longer requires study drug|0|||
155518162|NCT00409578|561321456|FG003|Overall Study|Subject no longer requires study drug|1|||
155518163|NCT00409578|561321453|FG000|Overall Study|Withdrawal by Subject|8|||
155518164|NCT00409578|561321454|FG001|Overall Study|Withdrawal by Subject|15|||
155518165|NCT00409578|561321455|FG002|Overall Study|Withdrawal by Subject|16|||
155518166|NCT00409578|561321456|FG003|Overall Study|Withdrawal by Subject|17|||
155518167|NCT00409578|561321453|FG000|Overall Study|Lost to Follow-up|2|||
155469498|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
155469499|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
155518168|NCT00409578|561321454|FG001|Overall Study|Lost to Follow-up|0|||
155518169|NCT00409578|561321455|FG002|Overall Study|Lost to Follow-up|2|||
155518170|NCT00409578|561321456|FG003|Overall Study|Lost to Follow-up|2|||
155518171|NCT00409578|561321453|FG000|Overall Study|Administrative problems|8|||
155518172|NCT00409578|561321454|FG001|Overall Study|Administrative problems|9|||
155518173|NCT00409578|561321455|FG002|Overall Study|Administrative problems|2|||
155518174|NCT00409578|561321456|FG003|Overall Study|Administrative problems|4|||
155518175|NCT00409578|561321453|FG000|Overall Study|Death|2|||
155518176|NCT00409578|561321454|FG001|Overall Study|Death|4|||
155518177|NCT00409578|561321455|FG002|Overall Study|Death|4|||
155518178|NCT00409578|561321456|FG003|Overall Study|Death|2|||
155518179|NCT00409578|561321453|FG000|Overall Study|Protocol Violation|3|||
155518180|NCT00409578|561321454|FG001|Overall Study|Protocol Violation|2|||
155518181|NCT00409578|561321455|FG002|Overall Study|Protocol Violation|3|||
155518182|NCT00409578|561321456|FG003|Overall Study|Protocol Violation|1|||
155518183|NCT00409578|561321453|FG000|Overall Study|Missing|0|||
155518184|NCT00409578|561321454|FG001|Overall Study|Missing|1|||
155518185|NCT00409578|561321455|FG002|Overall Study|Missing|0|||
155518186|NCT00409578|561321456|FG003|Overall Study|Missing|1|||
155518187|NCT01298570|561322929|FG000|Overall Study|Disease progression, relapse during acti|64|||
155518188|NCT01298570|561322930|FG001|Overall Study|Disease progression, relapse during acti|40|||
155518189|NCT01298570|561322929|FG000|Overall Study|Adverse Event|20|||
155518190|NCT01298570|561322930|FG001|Overall Study|Adverse Event|2|||
155518191|NCT01298570|561322929|FG000|Overall Study|Withdrawal by Subject|21|||
155469500|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
155469501|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
155469502|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
155518192|NCT01298570|561322930|FG001|Overall Study|Withdrawal by Subject|6|||
155518193|NCT01298570|561322929|FG000|Overall Study|Treatment delay > 4 weeks|4|||
155518194|NCT01298570|561322930|FG001|Overall Study|Treatment delay > 4 weeks|5|||
155518195|NCT01298570|561322929|FG000|Overall Study|Physician Decision|4|||
155518196|NCT01298570|561322930|FG001|Overall Study|Physician Decision|2|||
155518197|NCT01298570|561322929|FG000|Overall Study|Other complicating disease|2|||
155518198|NCT01298570|561322930|FG001|Overall Study|Other complicating disease|1|||
155518199|NCT01298570|561322929|FG000|Overall Study|Surgery|2|||
155518200|NCT01298570|561322930|FG001|Overall Study|Surgery|1|||
155469503|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
155469504|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
155469505|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
155469506|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
155469507|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
155469508|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
155469509|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
155469510|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
155469511|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
155469512|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
155469513|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
155469514|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
155469515|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
155469516|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
155469517|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
155469518|NCT00856986|561140596|FG000|Main Period, Weeks 0-26|Unclassified|7|||
155469519|NCT00856986|561140597|FG001|Main Period, Weeks 0-26|Unclassified|6|||
155469520|NCT00856986|561140598|FG002|Main Period, Weeks 0-26|Unclassified|7|||
155469521|NCT00856986|561140599|FG003|Main Period, Weeks 0-26|Unclassified|0|||
155469522|NCT00856986|561140600|FG004|Main Period, Weeks 0-26|Unclassified|0|||
155469523|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
155469524|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
155469525|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
155469526|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
155469527|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
155469528|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
155469529|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
155469530|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
155469531|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
155469532|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
155469533|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
155469534|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
155469535|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
155469536|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
155469537|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
155469538|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
155469539|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
155469540|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
155469541|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
155469542|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
155469543|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
155469544|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
155469545|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
155469546|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
155469547|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
155469548|NCT00856986|561140596|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
155469549|NCT00856986|561140597|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
155469550|NCT00856986|561140598|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
155469551|NCT00856986|561140599|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
155469552|NCT00856986|561140600|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
155469553|NCT01601470|561140601|FG000|Period 2 - LCZ696|Physician Decision|1|||
155469554|NCT03032510|561140602|FG000|Overall Study|Adverse Event|5|||
155469555|NCT03032510|561140603|FG001|Overall Study|Adverse Event|2|||
155469556|NCT03032510|561140602|FG000|Overall Study|Lost to Follow-up|8|||
155469557|NCT03032510|561140603|FG001|Overall Study|Lost to Follow-up|7|||
155469558|NCT03032510|561140602|FG000|Overall Study|Withdrawal by Subject|8|||
155469559|NCT03032510|561140603|FG001|Overall Study|Withdrawal by Subject|7|||
155469560|NCT03032510|561140602|FG000|Overall Study|Subject noncompliance|4|||
155518201|NCT01298570|561322929|FG000|Overall Study|Symptomatic progression/deterioration|3|||
155469561|NCT03032510|561140603|FG001|Overall Study|Subject noncompliance|2|||
155469562|NCT03032510|561140602|FG000|Overall Study|Physician Decision|2|||
155469563|NCT03032510|561140603|FG001|Overall Study|Physician Decision|0|||
155469564|NCT01602549|561140606|FG000|Overall Study|Protocol Violation|0|||
155469565|NCT01602549|561140607|FG001|Overall Study|Protocol Violation|1|||
155469566|NCT01602549|561140606|FG000|Overall Study|Withdrawal by Subject|1|||
155469567|NCT01602549|561140607|FG001|Overall Study|Withdrawal by Subject|0|||
155469568|NCT01576406|561140608|FG000|Overall Study|Lost to Follow-up|1|||
155469569|NCT01576406|561140609|FG001|Overall Study|Lost to Follow-up|2|||
155469570|NCT01576406|561140610|FG002|Overall Study|Lost to Follow-up|0|||
155469571|NCT01576406|561140611|FG003|Overall Study|Lost to Follow-up|0|||
155469572|NCT01576406|561140612|FG004|Overall Study|Lost to Follow-up|0|||
155518202|NCT01298570|561322930|FG001|Overall Study|Symptomatic progression/deterioration|2|||
155518203|NCT01298570|561322929|FG000|Overall Study|Death|0|||
155518204|NCT01298570|561322930|FG001|Overall Study|Death|1|||
155469573|NCT01576406|561140613|FG005|Overall Study|Lost to Follow-up|0|||
155469574|NCT01576406|561140608|FG000|Overall Study|Death|3|||
155469575|NCT01576406|561140609|FG001|Overall Study|Death|4|||
155469576|NCT01576406|561140610|FG002|Overall Study|Death|8|||
155469577|NCT01576406|561140611|FG003|Overall Study|Death|5|||
155469578|NCT01576406|561140612|FG004|Overall Study|Death|7|||
155469579|NCT01576406|561140613|FG005|Overall Study|Death|9|||
155518205|NCT01298570|561322929|FG000|Overall Study|Ineligibility|0|||
155518206|NCT01298570|561322930|FG001|Overall Study|Ineligibility|1|||
155518207|NCT02841709|561322931|FG000|5th Intervention|Adverse Event|2|||
155518208|NCT02841709|561322932|FG001|5th Intervention|Adverse Event|0|||
155518209|NCT02841709|561322933|FG002|5th Intervention|Adverse Event|0|||
155518210|NCT02841709|561322934|FG003|5th Intervention|Adverse Event|0|||
155518211|NCT02841709|561322935|FG004|5th Intervention|Adverse Event|2|||
155518212|NCT01929109|561322936|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
155518213|NCT01929109|561322937|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
155518214|NCT01929109|561322938|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
155518215|NCT01929109|561322939|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
155518216|NCT01929109|561322940|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
155518217|NCT00076102|561322941|FG000|Overall Study|Clinical progression|1|||
155653241|NCT00160563|561823827|FG000|Overall Study|Missing reason|0|||
155653242|NCT00160563|561823828|FG001|Overall Study|Missing reason|1|||
155653243|NCT00160563|561823829|FG002|Overall Study|Missing reason|0|||
155653244|NCT04157738|561823830|FG000|Overall Study|Moved out of state|0|||
155653245|NCT04157738|561823831|FG001|Overall Study|Moved out of state|2|||
155653246|NCT04157738|561823830|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
155653247|NCT04157738|561823831|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
155653248|NCT00395447|561823838|FG000|Overall Study|Death|37|||
155653249|NCT00395447|561823839|FG001|Overall Study|Death|32|||
155653250|NCT00395447|561823838|FG000|Overall Study|Lost to Follow-up|52|||
155653251|NCT00395447|561823839|FG001|Overall Study|Lost to Follow-up|43|||
155653252|NCT00395447|561823838|FG000|Overall Study|Withdrawal by Subject|24|||
155653253|NCT00395447|561823839|FG001|Overall Study|Withdrawal by Subject|19|||
155653254|NCT00395447|561823838|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
155653255|NCT00395447|561823839|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
155653256|NCT03766906|561823840|FG000|Overall Study|Withdrawal by Subject|6|||
155653257|NCT04064567|561823852|FG000|Overall Study|Lost to Follow-up|23|||
155653258|NCT04064567|561823853|FG001|Overall Study|Lost to Follow-up|22|||
155653259|NCT04064567|561823852|FG000|Overall Study|Withdrawal by Subject|0|||
155653260|NCT04064567|561823853|FG001|Overall Study|Withdrawal by Subject|1|||
155653261|NCT04064567|561823852|FG000|Overall Study|Reincarcerated|7|||
155653262|NCT04064567|561823853|FG001|Overall Study|Reincarcerated|10|||
155653263|NCT04064567|561823852|FG000|Overall Study|Moved out of U.S.|0|||
155653264|NCT04064567|561823853|FG001|Overall Study|Moved out of U.S.|1|||
155653265|NCT03464461|561823854|FG000|Overall Study|exclusionary medication given ,|1|||
155653266|NCT03464461|561823855|FG001|Overall Study|exclusionary medication given ,|2|||
155653267|NCT03464461|561823856|FG002|Overall Study|exclusionary medication given ,|0|||
155653268|NCT03464461|561823854|FG000|Overall Study|Physician Decision|0|||
155653269|NCT03464461|561823855|FG001|Overall Study|Physician Decision|1|||
155653270|NCT03464461|561823856|FG002|Overall Study|Physician Decision|0|||
155653271|NCT05524948|561823857|FG000|Overall Study|Withdrawal by Subject|1|||
155653272|NCT05524948|561823858|FG001|Overall Study|Withdrawal by Subject|0|||
155653273|NCT05524948|561823857|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
155653274|NCT05524948|561823858|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
155653275|NCT05463952|561823859|FG000|Treatment|Progressive disease|4|||
155653276|NCT05463952|561823859|FG000|Treatment|Ongoing|2|||
155653277|NCT04629521|561823863|FG000|Overall Study|Death|1|||
155653278|NCT04629521|561823863|FG000|Overall Study|Lost to Follow-up|3|||
155653279|NCT04629521|561823863|FG000|Overall Study|Subject withdrew consent|3|||
155653280|NCT04629521|561823863|FG000|Overall Study|Enrolled in error|1|||
155653281|NCT03163667|561823864|FG000|Overall Study|Death|15|||
155653282|NCT03163667|561823865|FG001|Overall Study|Death|27|||
155653283|NCT03163667|561823864|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
155653284|NCT03163667|561823865|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
155653285|NCT01335685|561823866|FG000|Overall Study|Study Terminated by Sponsor|2|||
155469580|NCT01576406|561140608|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
155653286|NCT01335685|561823867|FG001|Overall Study|Study Terminated by Sponsor|1|||
155653287|NCT01335685|561823868|FG002|Overall Study|Study Terminated by Sponsor|1|||
155653288|NCT01335685|561823869|FG003|Overall Study|Study Terminated by Sponsor|10|||
155653289|NCT01335685|561823870|FG004|Overall Study|Study Terminated by Sponsor|0|||
155653290|NCT01335685|561823871|FG005|Overall Study|Study Terminated by Sponsor|4|||
155653291|NCT01335685|561823872|FG006|Overall Study|Study Terminated by Sponsor|2|||
155518218|NCT00076102|561322941|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
155518219|NCT00076102|561322941|FG000|Overall Study|plexiform neurofibroma surgery|1|||
155518220|NCT00076102|561322941|FG000|Overall Study|refusal of further therapy|2|||
155469581|NCT01576406|561140609|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
155469582|NCT01576406|561140610|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
155469583|NCT01576406|561140611|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
155469584|NCT01576406|561140612|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
155469585|NCT01576406|561140613|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
155469586|NCT01576406|561140608|FG000|Overall Study|Withdrawal the consent|2|||
155469587|NCT01576406|561140609|FG001|Overall Study|Withdrawal the consent|2|||
155469588|NCT01576406|561140610|FG002|Overall Study|Withdrawal the consent|5|||
155469589|NCT01576406|561140611|FG003|Overall Study|Withdrawal the consent|1|||
155469590|NCT01576406|561140612|FG004|Overall Study|Withdrawal the consent|1|||
155469591|NCT01576406|561140613|FG005|Overall Study|Withdrawal the consent|3|||
155469592|NCT01576406|561140608|FG000|Overall Study|Other|0|||
155469593|NCT01576406|561140609|FG001|Overall Study|Other|0|||
155469594|NCT01576406|561140610|FG002|Overall Study|Other|2|||
155469595|NCT01576406|561140611|FG003|Overall Study|Other|2|||
155469596|NCT01576406|561140612|FG004|Overall Study|Other|0|||
155469597|NCT01576406|561140613|FG005|Overall Study|Other|0|||
155469598|NCT02091921|561140614|FG000|Overall Study|Adverse Event|3|||
155469599|NCT02483078|561140615|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
155469600|NCT02483078|561140616|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
155469601|NCT02483078|561140615|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
155469602|NCT02483078|561140616|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
155469603|NCT02483078|561140615|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
155469604|NCT02483078|561140616|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
155469605|NCT02483078|561140615|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
155469606|NCT02483078|561140616|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
155469607|NCT02483078|561140615|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
155469608|NCT02483078|561140616|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
155469609|NCT02483078|561140615|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
155469610|NCT02483078|561140616|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
155469611|NCT01731990|561142323|FG000|Overall Study|Adverse Event|1|||
155518221|NCT02016300|561322952|FG000|Overall Study|Lost to Follow-up|0|||
155518222|NCT02016300|561322953|FG001|Overall Study|Lost to Follow-up|3|||
155518223|NCT05301751|561322954|FG000|Overall Study|Withdrawal by Subject|0|||
155518224|NCT05301751|561322955|FG001|Overall Study|Withdrawal by Subject|0|||
155518225|NCT05301751|561322956|FG002|Overall Study|Withdrawal by Subject|1|||
155518226|NCT05301751|561322957|FG003|Overall Study|Withdrawal by Subject|0|||
155518227|NCT06165744|561322958|FG000|Overall Study|Non device-related adverse event|1|||
155518228|NCT01546987|561322959|FG000|Overall Study|Protocol Violation|3|||
155518229|NCT01546987|561322960|FG001|Overall Study|Protocol Violation|4|||
155518230|NCT01424722|561322971|FG000|Overall Study|Sponsor terminated investigation|2258|||
155518231|NCT02684578|561322972|FG000|Overall Study|Withdrawal by Subject|10|||
155518232|NCT02684578|561322973|FG001|Overall Study|Withdrawal by Subject|7|||
155518233|NCT02684578|561322972|FG000|Overall Study|Lost to Follow-up|0|||
155518234|NCT02684578|561322973|FG001|Overall Study|Lost to Follow-up|3|||
155518235|NCT02684578|561322972|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
155518236|NCT02684578|561322973|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
155518237|NCT02684578|561322972|FG000|Overall Study|Missing follow-up data|0|||
155518238|NCT02684578|561322973|FG001|Overall Study|Missing follow-up data|1|||
155518239|NCT03499964|561322976|FG000|Overall Study|Lack of Efficacy|6|||
155518240|NCT03499964|561322977|FG001|Overall Study|Lack of Efficacy|26|||
155518241|NCT03499964|561322976|FG000|Overall Study|Adverse Event|1|||
155518242|NCT03499964|561322977|FG001|Overall Study|Adverse Event|0|||
155518243|NCT03499964|561322976|FG000|Overall Study|Death|1|||
155518244|NCT03499964|561322977|FG001|Overall Study|Death|0|||
155518245|NCT03499964|561322976|FG000|Overall Study|Withdrawal by Subject|2|||
155518246|NCT03499964|561322977|FG001|Overall Study|Withdrawal by Subject|1|||
155518247|NCT03499964|561322976|FG000|Overall Study|Lost to Follow-up|1|||
155653292|NCT01335685|561823873|FG007|Overall Study|Study Terminated by Sponsor|3|||
155653293|NCT01335685|561823866|FG000|Overall Study|Withdrawal by Subject|1|||
155518248|NCT03499964|561322977|FG001|Overall Study|Lost to Follow-up|0|||
155518249|NCT02224391|561322978|FG000|Overall Study|Lost to Follow-up|26|||
155653294|NCT01335685|561823867|FG001|Overall Study|Withdrawal by Subject|0|||
155653295|NCT01335685|561823868|FG002|Overall Study|Withdrawal by Subject|0|||
155469612|NCT01731990|561142324|FG001|Overall Study|Adverse Event|5|||
155469613|NCT01731990|561142323|FG000|Overall Study|Withdrawal by Subject|1|||
155469614|NCT01731990|561142324|FG001|Overall Study|Withdrawal by Subject|1|||
155469615|NCT01731990|561142323|FG000|Overall Study|Protocol deviation|1|||
155469616|NCT01731990|561142324|FG001|Overall Study|Protocol deviation|2|||
155469617|NCT01731990|561142323|FG000|Overall Study|Death|1|||
155469618|NCT01731990|561142324|FG001|Overall Study|Death|0|||
155518250|NCT02224391|561322979|FG001|Overall Study|Lost to Follow-up|19|||
155518251|NCT02224391|561322978|FG000|Overall Study|Withdrawal by Subject|6|||
155518252|NCT02224391|561322979|FG001|Overall Study|Withdrawal by Subject|5|||
155653296|NCT01335685|561823869|FG003|Overall Study|Withdrawal by Subject|1|||
155653297|NCT01335685|561823870|FG004|Overall Study|Withdrawal by Subject|0|||
155653298|NCT01335685|561823871|FG005|Overall Study|Withdrawal by Subject|0|||
155653299|NCT01335685|561823872|FG006|Overall Study|Withdrawal by Subject|0|||
155653300|NCT01335685|561823873|FG007|Overall Study|Withdrawal by Subject|0|||
155653301|NCT01335685|561823866|FG000|Overall Study|Reason not Specified|0|||
155653302|NCT01335685|561823867|FG001|Overall Study|Reason not Specified|0|||
155653303|NCT01335685|561823868|FG002|Overall Study|Reason not Specified|1|||
155653304|NCT01335685|561823869|FG003|Overall Study|Reason not Specified|0|||
155653305|NCT01335685|561823870|FG004|Overall Study|Reason not Specified|0|||
155653306|NCT01335685|561823871|FG005|Overall Study|Reason not Specified|1|||
155653307|NCT01335685|561823872|FG006|Overall Study|Reason not Specified|0|||
155653308|NCT01335685|561823873|FG007|Overall Study|Reason not Specified|0|||
155653309|NCT02554474|561823876|FG000|Overall Study|Protocol Violation|1|||
155653310|NCT02554474|561823877|FG001|Overall Study|Protocol Violation|1|||
155653311|NCT02554474|561823876|FG000|Overall Study|Health issue not related to the study|1|||
155653312|NCT02554474|561823877|FG001|Overall Study|Health issue not related to the study|0|||
155653313|NCT02554474|561823876|FG000|Overall Study|Withdrawal by Subject|1|||
155653314|NCT02554474|561823877|FG001|Overall Study|Withdrawal by Subject|1|||
155653315|NCT03211832|561823878|FG000|Overall Study|No longer with agency|32|||
155653316|NCT03211832|561823879|FG001|Overall Study|No longer with agency|49|||
155653317|NCT03211832|561823880|FG002|Overall Study|No longer with agency|30|||
155653318|NCT03211832|561823878|FG000|Overall Study|Declined survey|3|||
155653319|NCT03211832|561823879|FG001|Overall Study|Declined survey|3|||
155653320|NCT03211832|561823880|FG002|Overall Study|Declined survey|2|||
155653321|NCT03211832|561823878|FG000|Overall Study|Not available during data collection|1|||
155653322|NCT03211832|561823879|FG001|Overall Study|Not available during data collection|0|||
155653323|NCT03211832|561823880|FG002|Overall Study|Not available during data collection|2|||
155653324|NCT00855166|561823881|FG000|Overall Study|Adverse Event|0|||
155653325|NCT00855166|561823882|FG001|Overall Study|Adverse Event|2|||
155653326|NCT00855166|561823881|FG000|Overall Study|Death|0|||
155653327|NCT00855166|561823882|FG001|Overall Study|Death|1|||
155653328|NCT00855166|561823881|FG000|Overall Study|Withdrawal by Subject|1|||
155653329|NCT00855166|561823882|FG001|Overall Study|Withdrawal by Subject|4|||
155653330|NCT00855166|561823881|FG000|Overall Study|Poor/non-compliance|2|||
155653331|NCT00855166|561823882|FG001|Overall Study|Poor/non-compliance|0|||
155653332|NCT00855166|561823881|FG000|Overall Study|Administrative reasons by sponsor|1|||
155653333|NCT00855166|561823882|FG001|Overall Study|Administrative reasons by sponsor|0|||
155653334|NCT00855166|561823881|FG000|Overall Study|Subject no longer meets study criteria|1|||
155653335|NCT00855166|561823882|FG001|Overall Study|Subject no longer meets study criteria|1|||
155653336|NCT03777020|561823886|FG000|Overall Study|Withdrawal by Subject|4|||
155653337|NCT03777020|561823887|FG001|Overall Study|Withdrawal by Subject|4|||
155653338|NCT03777020|561823886|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
155653339|NCT03777020|561823887|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
155653340|NCT00489476|561823888|FG000|Overall Study|Lost to Follow-up|0|||
155653341|NCT00489476|561823889|FG001|Overall Study|Lost to Follow-up|1|||
155653342|NCT00489476|561823890|FG002|Overall Study|Lost to Follow-up|0|||
155653343|NCT00489476|561823891|FG003|Overall Study|Lost to Follow-up|0|||
155653344|NCT02913326|561823892|FG000|Overall Study|Reason not listed|0|||
155653345|NCT02913326|561823893|FG001|Overall Study|Reason not listed|1|||
155653346|NCT02913326|561823892|FG000|Overall Study|Lost to Follow-up|0|||
155653347|NCT02913326|561823893|FG001|Overall Study|Lost to Follow-up|1|||
155653348|NCT02913326|561823892|FG000|Overall Study|Adverse Event|1|||
155653349|NCT02913326|561823893|FG001|Overall Study|Adverse Event|0|||
155653350|NCT01421459|561823894|FG000|Overall Study|Adverse Event|6|||
155653351|NCT01421459|561823895|FG001|Overall Study|Adverse Event|10|||
155653352|NCT01421459|561823894|FG000|Overall Study|Death|1|||
155653353|NCT01421459|561823895|FG001|Overall Study|Death|1|||
155653354|NCT01421459|561823894|FG000|Overall Study|Lack of Efficacy|1|||
155653355|NCT01421459|561823895|FG001|Overall Study|Lack of Efficacy|2|||
155653356|NCT01421459|561823894|FG000|Overall Study|Lost to Follow-up|8|||
155653357|NCT01421459|561823895|FG001|Overall Study|Lost to Follow-up|9|||
155653358|NCT01421459|561823894|FG000|Overall Study|Physician Decision|9|||
155653359|NCT01421459|561823895|FG001|Overall Study|Physician Decision|9|||
155653360|NCT01421459|561823894|FG000|Overall Study|Protocol Violation|8|||
155653361|NCT01421459|561823895|FG001|Overall Study|Protocol Violation|5|||
155653362|NCT01421459|561823894|FG000|Overall Study|Withdrawal by Subject|12|||
155653363|NCT01421459|561823895|FG001|Overall Study|Withdrawal by Subject|16|||
155653364|NCT01422382|561823896|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
155653365|NCT00231465|561823904|FG000|Overall Study|Completed only one cycle|1|||
155653366|NCT00231465|561823904|FG000|Overall Study|Did not have follow up CT scans|1|||
155653367|NCT03624036|561823905|FG000|Overall Study|Death|2|||
155653368|NCT03624036|561823906|FG001|Overall Study|Death|3|||
155653369|NCT03624036|561823907|FG002|Overall Study|Death|0|||
155653370|NCT03624036|561823908|FG003|Overall Study|Death|1|||
155653371|NCT03624036|561823905|FG000|Overall Study|Withdrawal by Subject|1|||
155653372|NCT03624036|561823906|FG001|Overall Study|Withdrawal by Subject|0|||
155653373|NCT03624036|561823907|FG002|Overall Study|Withdrawal by Subject|1|||
155653374|NCT03624036|561823908|FG003|Overall Study|Withdrawal by Subject|0|||
155653375|NCT03624036|561823905|FG000|Overall Study|Enrolled but Never Treated|1|||
155653376|NCT03624036|561823906|FG001|Overall Study|Enrolled but Never Treated|0|||
155653377|NCT03624036|561823907|FG002|Overall Study|Enrolled but Never Treated|0|||
155653378|NCT03624036|561823908|FG003|Overall Study|Enrolled but Never Treated|0|||
155653379|NCT03624036|561823905|FG000|Overall Study|Reason not Specified|3|||
155653380|NCT03624036|561823906|FG001|Overall Study|Reason not Specified|0|||
155653381|NCT03624036|561823907|FG002|Overall Study|Reason not Specified|2|||
155653382|NCT03624036|561823908|FG003|Overall Study|Reason not Specified|2|||
155653383|NCT01390584|561823912|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
155653384|NCT01390584|561823913|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
155653385|NCT01390584|561823914|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
155653386|NCT01539525|561823915|FG000|Overall Study|Lost to Follow-up|19|||
155653387|NCT01539525|561823916|FG001|Overall Study|Lost to Follow-up|12|||
155653388|NCT01539525|561823917|FG002|Overall Study|Lost to Follow-up|11|||
155653389|NCT01539525|561823915|FG000|Overall Study|Withdrawal by Subject|0|||
155653390|NCT01539525|561823916|FG001|Overall Study|Withdrawal by Subject|3|||
155653391|NCT01539525|561823917|FG002|Overall Study|Withdrawal by Subject|2|||
155653392|NCT01539525|561823915|FG000|Overall Study|Protocol Violation|1|||
155653393|NCT01539525|561823916|FG001|Overall Study|Protocol Violation|1|||
155653394|NCT01539525|561823917|FG002|Overall Study|Protocol Violation|4|||
155653395|NCT02268851|561823918|FG000|Overall Study|Death|0|||
155653396|NCT02268851|561823919|FG001|Overall Study|Death|0|||
155653397|NCT02268851|561823920|FG002|Overall Study|Death|0|||
155653398|NCT02268851|561823921|FG003|Overall Study|Death|1|||
155653399|NCT02268851|561823922|FG004|Overall Study|Death|2|||
155653400|NCT02268851|561823923|FG005|Overall Study|Death|1|||
155653401|NCT02268851|561823918|FG000|Overall Study|Adverse Event|0|||
155653402|NCT02268851|561823919|FG001|Overall Study|Adverse Event|0|||
155653403|NCT02268851|561823920|FG002|Overall Study|Adverse Event|0|||
155653404|NCT02268851|561823921|FG003|Overall Study|Adverse Event|0|||
155653405|NCT02268851|561823922|FG004|Overall Study|Adverse Event|2|||
155653406|NCT02268851|561823923|FG005|Overall Study|Adverse Event|2|||
155653407|NCT02268851|561823918|FG000|Overall Study|Withdrawal by Subject|0|||
155653408|NCT02268851|561823919|FG001|Overall Study|Withdrawal by Subject|0|||
155653409|NCT02268851|561823920|FG002|Overall Study|Withdrawal by Subject|0|||
155653410|NCT02268851|561823921|FG003|Overall Study|Withdrawal by Subject|2|||
155653411|NCT02268851|561823922|FG004|Overall Study|Withdrawal by Subject|0|||
155653412|NCT02268851|561823923|FG005|Overall Study|Withdrawal by Subject|1|||
155653413|NCT02268851|561823918|FG000|Overall Study|Progressive Disease|1|||
155653414|NCT02268851|561823919|FG001|Overall Study|Progressive Disease|3|||
155653415|NCT02268851|561823920|FG002|Overall Study|Progressive Disease|0|||
155653416|NCT02268851|561823921|FG003|Overall Study|Progressive Disease|0|||
155653417|NCT02268851|561823922|FG004|Overall Study|Progressive Disease|1|||
155653418|NCT02268851|561823923|FG005|Overall Study|Progressive Disease|4|||
155653419|NCT02268851|561823918|FG000|Overall Study|Physician Decision|0|||
155653420|NCT02268851|561823919|FG001|Overall Study|Physician Decision|0|||
155653421|NCT02268851|561823920|FG002|Overall Study|Physician Decision|1|||
155653422|NCT02268851|561823921|FG003|Overall Study|Physician Decision|0|||
155653423|NCT02268851|561823922|FG004|Overall Study|Physician Decision|0|||
155653424|NCT02268851|561823923|FG005|Overall Study|Physician Decision|1|||
155653425|NCT02268851|561823918|FG000|Overall Study|Patient Compliance|0|||
155653426|NCT02268851|561823919|FG001|Overall Study|Patient Compliance|0|||
155653427|NCT02268851|561823920|FG002|Overall Study|Patient Compliance|0|||
155653428|NCT02268851|561823921|FG003|Overall Study|Patient Compliance|0|||
155653429|NCT02268851|561823922|FG004|Overall Study|Patient Compliance|1|||
155653430|NCT02268851|561823923|FG005|Overall Study|Patient Compliance|1|||
155653431|NCT02268851|561823918|FG000|Overall Study|Co-Morbid Condition|0|||
155518253|NCT00084084|561322981|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
155653432|NCT02268851|561823919|FG001|Overall Study|Co-Morbid Condition|0|||
155653433|NCT02268851|561823920|FG002|Overall Study|Co-Morbid Condition|0|||
155653434|NCT02268851|561823921|FG003|Overall Study|Co-Morbid Condition|0|||
155653435|NCT02268851|561823922|FG004|Overall Study|Co-Morbid Condition|1|||
155653436|NCT02268851|561823923|FG005|Overall Study|Co-Morbid Condition|1|||
155653437|NCT01694771|561823926|FG000|Overall Study|Adverse Event|18|||
155653438|NCT01694771|561823927|FG001|Overall Study|Adverse Event|16|||
155653439|NCT01694771|561823926|FG000|Overall Study|Lack of Efficacy|1|||
155653440|NCT01694771|561823927|FG001|Overall Study|Lack of Efficacy|0|||
155653441|NCT01694771|561823926|FG000|Overall Study|Non compliance protocol|7|||
155653442|NCT01694771|561823927|FG001|Overall Study|Non compliance protocol|6|||
155653443|NCT01694771|561823926|FG000|Overall Study|Lost to Follow-up|2|||
155653444|NCT01694771|561823927|FG001|Overall Study|Lost to Follow-up|3|||
155653445|NCT01694771|561823926|FG000|Overall Study|Consent withdrawn|7|||
155469619|NCT01183104|561142327|FG000|Overall Study|Adverse Event|8|||
155469620|NCT01183104|561142328|FG001|Overall Study|Adverse Event|6|||
155469621|NCT01183104|561142327|FG000|Overall Study|Death|0|||
155469622|NCT01183104|561142328|FG001|Overall Study|Death|1|||
155469623|NCT01183104|561142327|FG000|Overall Study|Lost to Follow-up|14|||
155469624|NCT01183104|561142328|FG001|Overall Study|Lost to Follow-up|7|||
155469625|NCT01183104|561142327|FG000|Overall Study|Physician Decision|5|||
155469626|NCT01183104|561142328|FG001|Overall Study|Physician Decision|8|||
155469627|NCT01183104|561142327|FG000|Overall Study|Withdrawal by Subject|6|||
155469628|NCT01183104|561142328|FG001|Overall Study|Withdrawal by Subject|11|||
155469629|NCT01183104|561142327|FG000|Overall Study|Nonparticipation in Extension Study|39|||
155469630|NCT01183104|561142328|FG001|Overall Study|Nonparticipation in Extension Study|50|||
155469631|NCT01183104|561142327|FG000|Overall Study|Did not receive study drug|5|||
155469632|NCT01183104|561142328|FG001|Overall Study|Did not receive study drug|9|||
155469633|NCT01594749|561142329|FG000|Overall Study|Adverse Event|2|||
155518254|NCT00084084|561322981|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
155518255|NCT02236130|561322985|FG000|Overall Study|Lost to Follow-up|7|||
155518256|NCT02236130|561322986|FG001|Overall Study|Lost to Follow-up|12|||
155518257|NCT00454636|561322987|FG000|Overall Study|Adverse Event|10|||
155518258|NCT00454636|561322988|FG001|Overall Study|Adverse Event|6|||
155518259|NCT00454636|561322989|FG002|Overall Study|Adverse Event|9|||
155518260|NCT00454636|561322990|FG003|Overall Study|Adverse Event|15|||
155518261|NCT00454636|561322987|FG000|Overall Study|Disease Progression|11|||
155518262|NCT00454636|561322988|FG001|Overall Study|Disease Progression|12|||
155518263|NCT00454636|561322989|FG002|Overall Study|Disease Progression|4|||
155518264|NCT00454636|561322990|FG003|Overall Study|Disease Progression|11|||
155518265|NCT00454636|561322987|FG000|Overall Study|Protocol Violation|3|||
155518266|NCT00454636|561322988|FG001|Overall Study|Protocol Violation|2|||
155518267|NCT00454636|561322989|FG002|Overall Study|Protocol Violation|3|||
155518268|NCT00454636|561322990|FG003|Overall Study|Protocol Violation|3|||
155518269|NCT00454636|561322987|FG000|Overall Study|Death|6|||
155518270|NCT00454636|561322988|FG001|Overall Study|Death|1|||
155518271|NCT00454636|561322989|FG002|Overall Study|Death|1|||
155518272|NCT00454636|561322990|FG003|Overall Study|Death|1|||
155518273|NCT00454636|561322987|FG000|Overall Study|Patient refusal|1|||
155518274|NCT00454636|561322988|FG001|Overall Study|Patient refusal|1|||
155518275|NCT00454636|561322989|FG002|Overall Study|Patient refusal|3|||
155518276|NCT00454636|561322990|FG003|Overall Study|Patient refusal|2|||
155518277|NCT00454636|561322987|FG000|Overall Study|Lost to Follow-up|0|||
155518278|NCT00454636|561322988|FG001|Overall Study|Lost to Follow-up|1|||
155518279|NCT00454636|561322989|FG002|Overall Study|Lost to Follow-up|0|||
155518280|NCT00454636|561322990|FG003|Overall Study|Lost to Follow-up|0|||
155518281|NCT01400113|561322991|FG000|Overall Study|Withdrawal by Subject|1|||
155518282|NCT01400113|561322992|FG001|Overall Study|Withdrawal by Subject|1|||
155518283|NCT01025037|561322993|FG000|Overall Study|Adverse Event|3|||
155518284|NCT01025037|561322993|FG000|Overall Study|Lost to Follow-up|7|||
155518285|NCT01025037|561322993|FG000|Overall Study|Withdrawal by Subject|1|||
155518286|NCT02660242|561322996|FG000|Glucose Tabs|Lost to Follow-up|1|||
155518287|NCT02660242|561322996|FG000|Glucagon Injection|Lost to Follow-up|1|||
155518288|NCT02796664|561322997|FG000|Overall Study|Withdrawal by Subject|0|||
155518289|NCT02796664|561322998|FG001|Overall Study|Withdrawal by Subject|3|||
155518290|NCT02796664|561322997|FG000|Overall Study|Noncompliance|1|||
155518291|NCT02796664|561322998|FG001|Overall Study|Noncompliance|1|||
155518292|NCT02796664|561322997|FG000|Overall Study|Death|0|||
155518293|NCT02796664|561322998|FG001|Overall Study|Death|1|||
155518294|NCT01089647|561323002|FG000|Overall Study|Lost to Follow-up|2|||
155518295|NCT01089647|561323003|FG001|Overall Study|Lost to Follow-up|2|||
155518296|NCT01089647|561323002|FG000|Overall Study|Withdrawal by Subject|2|||
155469634|NCT01594749|561142330|FG001|Overall Study|Adverse Event|1|||
155469635|NCT01594749|561142329|FG000|Overall Study|Withdrawal by Subject|2|||
155518297|NCT01089647|561323003|FG001|Overall Study|Withdrawal by Subject|1|||
155518298|NCT01089647|561323002|FG000|Overall Study|Adverse Event|0|||
155518299|NCT01089647|561323003|FG001|Overall Study|Adverse Event|1|||
155518300|NCT00995553|561323004|FG000|Overall Study|Withdrawal by Subject|2|||
155518301|NCT00995553|561323005|FG001|Overall Study|Withdrawal by Subject|6|||
155518302|NCT01531205|561323006|FG000|Overall Study|Did not proceed to surgery|1|||
155518303|NCT00198029|561323009|FG000|Overall Study|Withdrawal by Subject|4|||
155518304|NCT02465567|561323010|FG000|Overall Study|Adverse Event|118|||
155518305|NCT02465567|561323011|FG001|Overall Study|Adverse Event|113|||
155469636|NCT01594749|561142330|FG001|Overall Study|Withdrawal by Subject|2|||
155469637|NCT01594749|561142329|FG000|Overall Study|Protocol Violation|2|||
155518306|NCT02465567|561323012|FG002|Overall Study|Adverse Event|147|||
155469638|NCT01594749|561142330|FG001|Overall Study|Protocol Violation|0|||
155469639|NCT01594749|561142329|FG000|Overall Study|Physician Decision|1|||
155469640|NCT01594749|561142330|FG001|Overall Study|Physician Decision|1|||
155518307|NCT02465567|561323013|FG003|Overall Study|Adverse Event|138|||
155518308|NCT02465567|561323010|FG000|Overall Study|Lack of Efficacy|103|||
155518309|NCT02465567|561323011|FG001|Overall Study|Lack of Efficacy|102|||
155518310|NCT02465567|561323012|FG002|Overall Study|Lack of Efficacy|171|||
155518311|NCT02465567|561323013|FG003|Overall Study|Lack of Efficacy|135|||
155653446|NCT01694771|561823927|FG001|Overall Study|Consent withdrawn|9|||
155469641|NCT01594749|561142329|FG000|Overall Study|Non-compliance with Protocol|0|||
155469642|NCT01594749|561142330|FG001|Overall Study|Non-compliance with Protocol|1|||
155469643|NCT01594749|561142329|FG000|Overall Study|Lost to Follow-up|1|||
155469644|NCT01594749|561142330|FG001|Overall Study|Lost to Follow-up|0|||
155469645|NCT01594749|561142329|FG000|Overall Study|Death|9|||
155469646|NCT01594749|561142330|FG001|Overall Study|Death|3|||
155469647|NCT01594749|561142329|FG000|Overall Study|Not Treated|4|||
155469648|NCT01594749|561142330|FG001|Overall Study|Not Treated|10|||
155469649|NCT01594749|561142329|FG000|Overall Study|Lost Source Documentation|1|||
155469650|NCT01594749|561142330|FG001|Overall Study|Lost Source Documentation|0|||
155518312|NCT02465567|561323010|FG000|Overall Study|Withdrawal by Subject|104|||
155518313|NCT02465567|561323011|FG001|Overall Study|Withdrawal by Subject|94|||
155518314|NCT02465567|561323012|FG002|Overall Study|Withdrawal by Subject|123|||
155518315|NCT02465567|561323013|FG003|Overall Study|Withdrawal by Subject|130|||
155518316|NCT02465567|561323010|FG000|Overall Study|Physician Decision|23|||
155518317|NCT02465567|561323011|FG001|Overall Study|Physician Decision|33|||
155518318|NCT02465567|561323012|FG002|Overall Study|Physician Decision|38|||
155518319|NCT02465567|561323013|FG003|Overall Study|Physician Decision|28|||
155518320|NCT02465567|561323010|FG000|Overall Study|Major Protocol Deviation|24|||
155518321|NCT02465567|561323011|FG001|Overall Study|Major Protocol Deviation|26|||
155518322|NCT02465567|561323012|FG002|Overall Study|Major Protocol Deviation|22|||
155518323|NCT02465567|561323013|FG003|Overall Study|Major Protocol Deviation|25|||
155518324|NCT02465567|561323010|FG000|Overall Study|Lost to Follow-up|25|||
155518325|NCT02465567|561323011|FG001|Overall Study|Lost to Follow-up|21|||
155518326|NCT02465567|561323012|FG002|Overall Study|Lost to Follow-up|19|||
155518327|NCT02465567|561323013|FG003|Overall Study|Lost to Follow-up|15|||
155518328|NCT02465567|561323010|FG000|Overall Study|Protocol Specified Criteria|20|||
155518329|NCT02465567|561323011|FG001|Overall Study|Protocol Specified Criteria|10|||
155518330|NCT02465567|561323012|FG002|Overall Study|Protocol Specified Criteria|9|||
155518331|NCT02465567|561323013|FG003|Overall Study|Protocol Specified Criteria|12|||
155518332|NCT02465567|561323010|FG000|Overall Study|Administrative Reasons|12|||
155518333|NCT02465567|561323011|FG001|Overall Study|Administrative Reasons|9|||
155518334|NCT02465567|561323012|FG002|Overall Study|Administrative Reasons|11|||
155518335|NCT02465567|561323013|FG003|Overall Study|Administrative Reasons|5|||
155518336|NCT02465567|561323010|FG000|Overall Study|Randomized but not treated|1|||
155518337|NCT02465567|561323011|FG001|Overall Study|Randomized but not treated|5|||
155518338|NCT02465567|561323012|FG002|Overall Study|Randomized but not treated|4|||
155518339|NCT02465567|561323013|FG003|Overall Study|Randomized but not treated|5|||
155518340|NCT02465567|561323010|FG000|Overall Study|enrolled in >1 studies|18|||
155518341|NCT02465567|561323011|FG001|Overall Study|enrolled in >1 studies|11|||
155518342|NCT02465567|561323012|FG002|Overall Study|enrolled in >1 studies|19|||
155518343|NCT02465567|561323013|FG003|Overall Study|enrolled in >1 studies|15|||
155518344|NCT02465567|561323010|FG000|Overall Study|missing PI Signature|1|||
155518345|NCT02465567|561323011|FG001|Overall Study|missing PI Signature|0|||
155518346|NCT02465567|561323012|FG002|Overall Study|missing PI Signature|0|||
155518347|NCT02465567|561323013|FG003|Overall Study|missing PI Signature|0|||
155518348|NCT02001558|561323014|FG000|Overall Study|Lost to Follow-up|8|||
155518349|NCT02001558|561323015|FG001|Overall Study|Lost to Follow-up|14|||
155518350|NCT04117607|561323016|FG000|Overall Study|Early Termination|0|||
155518351|NCT04117607|561323017|FG001|Overall Study|Early Termination|1|||
155518352|NCT04117607|561323018|FG002|Overall Study|Early Termination|0|||
155518353|NCT04117607|561323019|FG003|Overall Study|Early Termination|0|||
155518354|NCT04117607|561323020|FG004|Overall Study|Early Termination|0|||
155518355|NCT04117607|561323021|FG005|Overall Study|Early Termination|0|||
155518356|NCT04117607|561323022|FG006|Overall Study|Early Termination|1|||
155518357|NCT04117607|561323023|FG007|Overall Study|Early Termination|0|||
155518358|NCT04117607|561323024|FG008|Overall Study|Early Termination|0|||
155518359|NCT04117607|561323025|FG009|Overall Study|Early Termination|0|||
155518360|NCT04117607|561323026|FG010|Overall Study|Early Termination|0|||
155518361|NCT04117607|561323027|FG011|Overall Study|Early Termination|0|||
155518362|NCT04117607|561323028|FG012|Overall Study|Early Termination|0|||
155518363|NCT04117607|561323029|FG013|Overall Study|Early Termination|0|||
155469651|NCT01957215|561142335|FG000|Overall Study|Adverse Event|2|||
155518364|NCT00950807|561323032|FG000|Treatment Period 1|Lack of Efficacy|1|||
155518365|NCT00950807|561323033|FG001|Treatment Period 1|Lack of Efficacy|0|||
155469652|NCT01957215|561142336|FG001|Overall Study|Adverse Event|2|||
155469653|NCT01957215|561142335|FG000|Overall Study|Lost to Follow-up|3|||
155469654|NCT01957215|561142336|FG001|Overall Study|Lost to Follow-up|3|||
155518366|NCT00950807|561323034|FG002|Treatment Period 1|Lack of Efficacy|0|||
155518367|NCT00950807|561323035|FG003|Treatment Period 1|Lack of Efficacy|0|||
155518368|NCT00950807|561323036|FG004|Treatment Period 1|Lack of Efficacy|0|||
155469655|NCT01957215|561142335|FG000|Overall Study|Protocol Violation|1|||
155469656|NCT01957215|561142336|FG001|Overall Study|Protocol Violation|2|||
155518369|NCT00950807|561323037|FG005|Treatment Period 1|Lack of Efficacy|1|||
155518370|NCT00950807|561323038|FG006|Treatment Period 1|Lack of Efficacy|0|||
155469657|NCT01957215|561142335|FG000|Overall Study|Withdrawal by Subject|7|||
155469658|NCT01957215|561142336|FG001|Overall Study|Withdrawal by Subject|5|||
155469659|NCT03597503|561142340|FG000|Overall Study|Withdrawal by Subject|0|||
155469660|NCT03597503|561142341|FG001|Overall Study|Withdrawal by Subject|2|||
155469661|NCT03597503|561142340|FG000|Overall Study|Lost to Follow-up|1|||
155469662|NCT03597503|561142341|FG001|Overall Study|Lost to Follow-up|2|||
155469663|NCT03597503|561142340|FG000|Overall Study|Protocol Violation|1|||
155469664|NCT03597503|561142341|FG001|Overall Study|Protocol Violation|0|||
155469665|NCT02944513|561142342|FG000|Overall Study|Withdrawal by Subject|4|||
155469666|NCT02944513|561142343|FG001|Overall Study|Withdrawal by Subject|1|||
155469667|NCT02578992|561142346|FG000|Overall Study|equipment not available or malfunction|3|||
155469668|NCT02578992|561142347|FG001|Overall Study|equipment not available or malfunction|3|||
155469669|NCT01495689|561142352|FG000|Overall Study|Death|0|||
155469670|NCT01495689|561142353|FG001|Overall Study|Death|1|||
155469671|NCT01495689|561142352|FG000|Overall Study|Withdrawal by Subject|3|||
155469672|NCT01495689|561142353|FG001|Overall Study|Withdrawal by Subject|0|||
155469673|NCT01495689|561142352|FG000|Overall Study|Lost to Follow-up|7|||
155469674|NCT01495689|561142353|FG001|Overall Study|Lost to Follow-up|6|||
155469675|NCT03805971|561142354|FG000|Overall Study|Withdrawal by Subject|1|||
155469676|NCT03805971|561142354|FG000|Overall Study|Protocol Violation|2|||
155469677|NCT00517413|561142362|FG000|Overall Study|Adverse Event|7|||
155469678|NCT00517413|561142362|FG000|Overall Study|Death|13|||
155469679|NCT00517413|561142362|FG000|Overall Study|Protocol Violation|15|||
155469680|NCT00517413|561142362|FG000|Overall Study|Withdrawal by Subject|2|||
155469681|NCT00517413|561142362|FG000|Overall Study|Failure to return|1|||
155469682|NCT00517413|561142362|FG000|Overall Study|Other-Reasons|23|||
155469683|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Death|3|||
155469684|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Death|0|||
155469685|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Death|0|||
155469686|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Death|0|||
155469687|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Death|0|||
155469688|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
155469689|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
155469690|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
155469691|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
155469692|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
155469693|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155469694|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
155469695|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
155469696|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155469697|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
155469698|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Other|0|||
155469699|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Other|0|||
155469700|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Other|1|||
155469701|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Other|0|||
155469702|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Other|0|||
155469703|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
155469704|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
155469705|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
155469706|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
155469707|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
155469708|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
155469709|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
155469710|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
155469711|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
155469712|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
155469713|NCT01224106|561142363|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155469714|NCT01224106|561142364|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155469715|NCT01224106|561142365|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155469716|NCT01224106|561142366|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155469717|NCT01224106|561142367|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155469718|NCT01224106|561142363|FG000|Open-Label Extension (OLE) Phase|Death|0|||
155469719|NCT01224106|561142364|FG001|Open-Label Extension (OLE) Phase|Death|0|||
155469720|NCT01224106|561142365|FG002|Open-Label Extension (OLE) Phase|Death|0|||
155469721|NCT01224106|561142366|FG003|Open-Label Extension (OLE) Phase|Death|1|||
155469722|NCT01224106|561142367|FG004|Open-Label Extension (OLE) Phase|Death|3|||
155469723|NCT01224106|561142363|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
155469724|NCT01224106|561142364|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
155469725|NCT01224106|561142365|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
155469726|NCT01224106|561142366|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
155469727|NCT01224106|561142367|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
155469728|NCT01224106|561142363|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
155469729|NCT01224106|561142364|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
155469730|NCT01224106|561142365|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
155469731|NCT01224106|561142366|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
155469732|NCT01224106|561142367|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
155469733|NCT01224106|561142363|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
155469734|NCT01224106|561142364|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
155469735|NCT01224106|561142365|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
155469736|NCT01224106|561142366|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
155469737|NCT01224106|561142367|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
155469738|NCT01224106|561142363|FG000|Open-Label Extension (OLE) Phase|Other|0|||
155469739|NCT01224106|561142364|FG001|Open-Label Extension (OLE) Phase|Other|0|||
155469740|NCT01224106|561142365|FG002|Open-Label Extension (OLE) Phase|Other|0|||
155469741|NCT01224106|561142366|FG003|Open-Label Extension (OLE) Phase|Other|5|||
155469742|NCT01224106|561142367|FG004|Open-Label Extension (OLE) Phase|Other|3|||
155469743|NCT03210220|561142368|FG000|Overall Study|Physician Decision|1|||
155469744|NCT03210220|561142369|FG001|Overall Study|Physician Decision|0|||
155469745|NCT00839436|561142374|FG000|Overall Study|Developed exclusionary condition|1|||
155469746|NCT00839436|561142375|FG001|Overall Study|Developed exclusionary condition|0|||
155469747|NCT00839436|561142376|FG002|Overall Study|Developed exclusionary condition|0|||
155469748|NCT00839436|561142374|FG000|Overall Study|Withdrawal by Subject|0|||
155469749|NCT00839436|561142375|FG001|Overall Study|Withdrawal by Subject|1|||
155469750|NCT00839436|561142376|FG002|Overall Study|Withdrawal by Subject|0|||
155469751|NCT00839436|561142374|FG000|Overall Study|Study drug no longer available|0|||
155469752|NCT00839436|561142375|FG001|Overall Study|Study drug no longer available|0|||
155469753|NCT00839436|561142376|FG002|Overall Study|Study drug no longer available|1|||
155469754|NCT01440972|561142377|FG000|Overall Study|Withdrawal by Subject|3|||
155469755|NCT01440972|561142378|FG001|Overall Study|Withdrawal by Subject|2|||
155469756|NCT04072575|561142379|FG000|Overall Study|Physician Decision|1|||
155469757|NCT04072575|561142379|FG000|Overall Study|Adverse Event|7|||
155469758|NCT04072575|561142379|FG000|Overall Study|Withdrawal by Subject|14|||
155469759|NCT04072575|561142379|FG000|Overall Study|Other|2|||
155469760|NCT03006926|561142382|FG000|Overall Study|Adverse Event|0|||
155469761|NCT03006926|561142383|FG001|Overall Study|Adverse Event|27|||
155469762|NCT03006926|561142382|FG000|Overall Study|Withdrawal by Subject|0|||
155469763|NCT03006926|561142383|FG001|Overall Study|Withdrawal by Subject|1|||
155469764|NCT03006926|561142382|FG000|Overall Study|Radiological Disease Progression|0|||
155469765|NCT03006926|561142383|FG001|Overall Study|Radiological Disease Progression|52|||
155469766|NCT03006926|561142382|FG000|Overall Study|Clinical Disease Progression|0|||
155469767|NCT03006926|561142383|FG001|Overall Study|Clinical Disease Progression|10|||
155469768|NCT03006926|561142382|FG000|Overall Study|Other|0|||
155469769|NCT03006926|561142383|FG001|Overall Study|Other|8|||
155469770|NCT01838213|561142384|FG000|Overall Study|Ineligible|166|||
155469771|NCT01838213|561142385|FG001|Overall Study|Ineligible|191|||
155469772|NCT04882072|561142386|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
155469773|NCT04882072|561142387|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
155469774|NCT04882072|561142386|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
155469775|NCT04882072|561142387|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
155469776|NCT04882072|561142386|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
155469777|NCT04882072|561142387|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
155469778|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
155469779|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
155469780|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
155469781|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
155469782|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
155469783|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
155469784|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
155469785|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
155469786|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
155469787|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
155469788|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
155469789|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
155469790|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
155469791|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
155469792|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
155469793|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
155469794|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
155469795|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
155469796|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
155469797|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
155469798|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
155469799|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
155469800|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
155469801|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
155469802|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
155469803|NCT02918318|561142388|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
155469804|NCT02918318|561142389|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
155469805|NCT02918318|561142390|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
155469806|NCT02918318|561142391|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
155469807|NCT02918318|561142392|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
155469808|NCT02918318|561142388|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
155469809|NCT02918318|561142389|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
155469810|NCT02918318|561142390|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
155469811|NCT02918318|561142391|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
155469812|NCT02918318|561142392|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
155469813|NCT02918318|561142388|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
155469814|NCT02918318|561142389|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469815|NCT02918318|561142390|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
155469816|NCT02918318|561142391|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
155469817|NCT02918318|561142392|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469818|NCT02918318|561142388|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
155469819|NCT02918318|561142389|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
155469820|NCT02918318|561142390|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
155469821|NCT02918318|561142391|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
155518371|NCT00950807|561323039|FG007|Treatment Period 1|Lack of Efficacy|0|||
155518372|NCT00950807|561323040|FG008|Treatment Period 1|Lack of Efficacy|0|||
155518373|NCT00950807|561323041|FG009|Treatment Period 1|Lack of Efficacy|0|||
155518374|NCT00950807|561323032|FG000|Treatment Period 1|Protocol Violation|1|||
155518375|NCT00950807|561323033|FG001|Treatment Period 1|Protocol Violation|0|||
155518376|NCT00950807|561323034|FG002|Treatment Period 1|Protocol Violation|0|||
155518377|NCT00950807|561323035|FG003|Treatment Period 1|Protocol Violation|0|||
155518378|NCT00950807|561323036|FG004|Treatment Period 1|Protocol Violation|0|||
155518379|NCT00950807|561323037|FG005|Treatment Period 1|Protocol Violation|0|||
155518380|NCT00950807|561323038|FG006|Treatment Period 1|Protocol Violation|0|||
155518381|NCT00950807|561323039|FG007|Treatment Period 1|Protocol Violation|0|||
155518382|NCT00950807|561323040|FG008|Treatment Period 1|Protocol Violation|0|||
155518383|NCT00950807|561323041|FG009|Treatment Period 1|Protocol Violation|0|||
155518384|NCT00950807|561323032|FG000|Treatment Period 1|Lost to Follow-up|0|||
155518385|NCT00950807|561323033|FG001|Treatment Period 1|Lost to Follow-up|0|||
155518386|NCT00950807|561323034|FG002|Treatment Period 1|Lost to Follow-up|1|||
155518387|NCT00950807|561323035|FG003|Treatment Period 1|Lost to Follow-up|0|||
155518388|NCT00950807|561323036|FG004|Treatment Period 1|Lost to Follow-up|0|||
155518389|NCT00950807|561323037|FG005|Treatment Period 1|Lost to Follow-up|0|||
155518390|NCT00950807|561323038|FG006|Treatment Period 1|Lost to Follow-up|0|||
155518391|NCT00950807|561323039|FG007|Treatment Period 1|Lost to Follow-up|0|||
155518392|NCT00950807|561323040|FG008|Treatment Period 1|Lost to Follow-up|0|||
155518393|NCT00950807|561323041|FG009|Treatment Period 1|Lost to Follow-up|0|||
155518394|NCT00950807|561323032|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155518395|NCT00950807|561323033|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155518396|NCT00950807|561323034|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155518397|NCT00950807|561323035|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155518398|NCT00950807|561323036|FG004|Treatment Period 1|Withdrawal by Subject|1|||
155653447|NCT01694771|561823926|FG000|Overall Study|Other reasons|5|||
155653448|NCT01694771|561823927|FG001|Overall Study|Other reasons|6|||
155653449|NCT02536339|561823929|FG000|Overall Study|Death|20|||
155653450|NCT02536339|561823929|FG000|Overall Study|Withdrawal by Subject|3|||
155653451|NCT02536339|561823929|FG000|Overall Study|Lost to Follow-up|2|||
155653452|NCT02536339|561823929|FG000|Overall Study|Treatment discontinued|2|||
155653453|NCT02536339|561823929|FG000|Overall Study|Physician Decision|1|||
155653454|NCT01905683|561823930|FG000|Overall Study|Protocol Violation|1|||
155653455|NCT01905683|561823930|FG000|Overall Study|Re-injection criteria not met; others|13|||
155653456|NCT01905683|561823930|FG000|Overall Study|Physician Decision|1|||
155653457|NCT01905683|561823930|FG000|Overall Study|Lack of Efficacy|8|||
155653458|NCT01905683|561823930|FG000|Overall Study|Withdrawal by Subject|20|||
155653459|NCT01905683|561823930|FG000|Overall Study|Adverse Event|4|||
155653460|NCT01905683|561823930|FG000|Overall Study|Lost to Follow-up|4|||
155653461|NCT02037984|561823933|FG000|Overall Study|Lack of Efficacy|0|||
155653462|NCT02037984|561823934|FG001|Overall Study|Lack of Efficacy|0|||
155653463|NCT02037984|561823935|FG002|Overall Study|Lack of Efficacy|3|||
155653464|NCT02037984|561823936|FG003|Overall Study|Lack of Efficacy|10|||
155653465|NCT02037984|561823937|FG004|Overall Study|Lack of Efficacy|2|||
155653466|NCT02037984|561823938|FG005|Overall Study|Lack of Efficacy|2|||
155653467|NCT02037984|561823939|FG006|Overall Study|Lack of Efficacy|4|||
155653468|NCT02037984|561823940|FG007|Overall Study|Lack of Efficacy|3|||
155653469|NCT02037984|561823933|FG000|Overall Study|Lost to Follow-up|1|||
155653470|NCT02037984|561823934|FG001|Overall Study|Lost to Follow-up|0|||
155653471|NCT02037984|561823935|FG002|Overall Study|Lost to Follow-up|3|||
155469822|NCT02918318|561142392|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
155469823|NCT02918318|561142388|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
155469824|NCT02918318|561142389|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
155469825|NCT02918318|561142390|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
155469826|NCT02918318|561142391|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
155469827|NCT02918318|561142392|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
155469828|NCT02918318|561142388|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
155469829|NCT02918318|561142389|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
155469830|NCT02918318|561142390|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
155469831|NCT02918318|561142391|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
155469832|NCT02918318|561142392|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
155469833|NCT02918318|561142388|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469834|NCT02918318|561142389|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469835|NCT02918318|561142390|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469836|NCT02918318|561142391|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
155469837|NCT02918318|561142392|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
155469838|NCT01548417|561142393|FG000|Overall Study|Withdrawal by Subject|0|||
155469839|NCT01548417|561142394|FG001|Overall Study|Withdrawal by Subject|2|||
155469840|NCT04583969|561142395|FG000|Overall Study|Death|31|||
155469841|NCT04583969|561142396|FG001|Overall Study|Death|38|||
155469842|NCT04583969|561142395|FG000|Overall Study|Lost to Follow-up|16|||
155469843|NCT04583969|561142396|FG001|Overall Study|Lost to Follow-up|13|||
155469844|NCT04583969|561142395|FG000|Overall Study|Protocol Violation|1|||
155469845|NCT04583969|561142396|FG001|Overall Study|Protocol Violation|0|||
155469846|NCT04583969|561142395|FG000|Overall Study|Withdrawal by Subject|3|||
155469847|NCT04583969|561142396|FG001|Overall Study|Withdrawal by Subject|3|||
155469848|NCT04583969|561142395|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
155469849|NCT04583969|561142396|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
155469850|NCT04583969|561142395|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
155469851|NCT04583969|561142396|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
155469852|NCT04583969|561142395|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
155469853|NCT04583969|561142396|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
155469854|NCT04583969|561142395|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
155469855|NCT04583969|561142396|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
155469856|NCT04583969|561142395|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
155469857|NCT04583969|561142396|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
155469858|NCT02057068|561142399|FG000|Overall Study|Withdrawal by Subject|2|||
155469859|NCT02057068|561142400|FG001|Overall Study|Withdrawal by Subject|2|||
155469860|NCT02057068|561142399|FG000|Overall Study|Caregiver (CG) Health|0|||
155469861|NCT02057068|561142400|FG001|Overall Study|Caregiver (CG) Health|2|||
155469862|NCT02057068|561142399|FG000|Overall Study|Carepartner (CP) Health|4|||
155469863|NCT02057068|561142400|FG001|Overall Study|Carepartner (CP) Health|2|||
155469864|NCT02057068|561142399|FG000|Overall Study|Lost to Follow-up|2|||
155469865|NCT02057068|561142400|FG001|Overall Study|Lost to Follow-up|2|||
155469866|NCT00865046|561142402|FG000|Overall Study|Lost to Follow-up|1|||
155653472|NCT02037984|561823936|FG003|Overall Study|Lost to Follow-up|5|||
155469867|NCT00865046|561142403|FG001|Overall Study|Lost to Follow-up|4|||
155469868|NCT00865046|561142404|FG002|Overall Study|Lost to Follow-up|0|||
155469869|NCT00865046|561142402|FG000|Overall Study|Death|0|||
155653473|NCT02037984|561823937|FG004|Overall Study|Lost to Follow-up|2|||
155653474|NCT02037984|561823938|FG005|Overall Study|Lost to Follow-up|2|||
155653475|NCT02037984|561823939|FG006|Overall Study|Lost to Follow-up|2|||
155653476|NCT02037984|561823940|FG007|Overall Study|Lost to Follow-up|4|||
155469870|NCT00865046|561142403|FG001|Overall Study|Death|1|||
155469871|NCT00865046|561142404|FG002|Overall Study|Death|1|||
155653477|NCT02037984|561823933|FG000|Overall Study|Physician Decision|0|||
155653478|NCT02037984|561823934|FG001|Overall Study|Physician Decision|0|||
155469872|NCT00865046|561142402|FG000|Overall Study|Withdrawal by Subject|5|||
155469873|NCT00865046|561142403|FG001|Overall Study|Withdrawal by Subject|0|||
155469874|NCT00865046|561142404|FG002|Overall Study|Withdrawal by Subject|0|||
155469875|NCT01098032|561142410|FG000|Overall Study|Withdrawal by Subject|1|||
155469876|NCT01098032|561142411|FG001|Overall Study|Withdrawal by Subject|1|||
155469877|NCT02959190|561142412|FG000|Open Label|Adverse Event|5|||
155469878|NCT02959190|561142413|FG001|Open Label|Adverse Event|7|||
155469879|NCT02959190|561142414|FG002|Open Label|Adverse Event|3|||
155469880|NCT02959190|561142415|FG003|Open Label|Adverse Event|4|||
155469881|NCT02959190|561142412|FG000|Open Label|Pregnancy|0|||
155469882|NCT02959190|561142413|FG001|Open Label|Pregnancy|1|||
155469883|NCT02959190|561142414|FG002|Open Label|Pregnancy|0|||
155469884|NCT02959190|561142415|FG003|Open Label|Pregnancy|0|||
155469885|NCT02959190|561142412|FG000|Open Label|Withdrawal by Subject|2|||
155469886|NCT02959190|561142413|FG001|Open Label|Withdrawal by Subject|8|||
155469887|NCT02959190|561142414|FG002|Open Label|Withdrawal by Subject|0|||
155469888|NCT02959190|561142415|FG003|Open Label|Withdrawal by Subject|0|||
155469889|NCT02959190|561142412|FG000|Open Label|Physician Decision|0|||
155469890|NCT02959190|561142413|FG001|Open Label|Physician Decision|0|||
155469891|NCT02959190|561142414|FG002|Open Label|Physician Decision|1|||
155469892|NCT02959190|561142415|FG003|Open Label|Physician Decision|0|||
155469893|NCT02959190|561142412|FG000|Open Label|Protocol Violation|0|||
155469894|NCT02959190|561142413|FG001|Open Label|Protocol Violation|0|||
155469895|NCT02959190|561142414|FG002|Open Label|Protocol Violation|0|||
155469896|NCT02959190|561142415|FG003|Open Label|Protocol Violation|2|||
155469897|NCT02959190|561142412|FG000|Post Treatment Follow Up|Adverse Event|1|||
155469898|NCT02959190|561142413|FG001|Post Treatment Follow Up|Adverse Event|1|||
155469899|NCT02959190|561142414|FG002|Post Treatment Follow Up|Adverse Event|0|||
155469900|NCT02959190|561142415|FG003|Post Treatment Follow Up|Adverse Event|0|||
155469901|NCT02959190|561142412|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
155469902|NCT02959190|561142413|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
155469903|NCT02959190|561142414|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
155469904|NCT02959190|561142415|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
155469905|NCT02709109|561142417|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
155469906|NCT02709109|561142418|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
155469907|NCT02709109|561142419|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
155469908|NCT02709109|561142420|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
155469909|NCT02709109|561142417|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
155469910|NCT02709109|561142418|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
155469911|NCT02709109|561142419|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
155469912|NCT02709109|561142420|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
155469913|NCT02709109|561142417|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
155469914|NCT02709109|561142418|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
155469915|NCT02709109|561142419|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
155469916|NCT02709109|561142420|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
155469917|NCT02709109|561142417|FG000|Washout Period (28 Days)|Other|2|||
155469918|NCT02709109|561142418|FG001|Washout Period (28 Days)|Other|2|||
155469919|NCT02709109|561142419|FG002|Washout Period (28 Days)|Other|3|||
155469920|NCT02709109|561142420|FG003|Washout Period (28 Days)|Other|0|||
155469921|NCT02709109|561142417|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
155469922|NCT02709109|561142418|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
155469923|NCT02709109|561142419|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
155469924|NCT02709109|561142420|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
155469925|NCT02709109|561142417|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
155469926|NCT02709109|561142418|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
155469927|NCT02709109|561142419|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
155469928|NCT02709109|561142420|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
155469929|NCT02709109|561142417|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
155469930|NCT02709109|561142418|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
155469931|NCT02709109|561142419|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
155469932|NCT02709109|561142420|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
155469933|NCT02709109|561142417|FG000|Treatment Period 2 (28 Days)|Other|0|||
155469934|NCT02709109|561142418|FG001|Treatment Period 2 (28 Days)|Other|0|||
155469935|NCT02709109|561142419|FG002|Treatment Period 2 (28 Days)|Other|1|||
155469936|NCT02709109|561142420|FG003|Treatment Period 2 (28 Days)|Other|0|||
155469937|NCT01928082|561142422|FG000|Overall Study|Study terminated.|1|||
155469938|NCT01815580|561142425|FG000|Overall Study|Lost to Follow-up|4|||
155469939|NCT01815580|561142426|FG001|Overall Study|Lost to Follow-up|7|||
155469940|NCT01815580|561142425|FG000|Overall Study|Withdrawal by Subject|3|||
155469941|NCT01815580|561142426|FG001|Overall Study|Withdrawal by Subject|4|||
155469942|NCT01815580|561142425|FG000|Overall Study|Excluded from analysis|5|||
155518399|NCT00950807|561323037|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155518400|NCT00950807|561323038|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155518401|NCT00950807|561323039|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155518402|NCT00950807|561323040|FG008|Treatment Period 1|Withdrawal by Subject|1|||
155518403|NCT00950807|561323041|FG009|Treatment Period 1|Withdrawal by Subject|0|||
155518404|NCT00950807|561323032|FG000|Treatment Period 1|Adverse Event|0|||
155518405|NCT00950807|561323033|FG001|Treatment Period 1|Adverse Event|0|||
155518406|NCT00950807|561323034|FG002|Treatment Period 1|Adverse Event|0|||
155518407|NCT00950807|561323035|FG003|Treatment Period 1|Adverse Event|0|||
155518408|NCT00950807|561323036|FG004|Treatment Period 1|Adverse Event|0|||
155518409|NCT00950807|561323037|FG005|Treatment Period 1|Adverse Event|1|||
155518410|NCT00950807|561323038|FG006|Treatment Period 1|Adverse Event|0|||
155518411|NCT00950807|561323039|FG007|Treatment Period 1|Adverse Event|0|||
155518412|NCT00950807|561323040|FG008|Treatment Period 1|Adverse Event|0|||
155518413|NCT00950807|561323041|FG009|Treatment Period 1|Adverse Event|0|||
155518414|NCT00950807|561323032|FG000|Washout Period 1|Lack of Efficacy|0|||
155518415|NCT00950807|561323033|FG001|Washout Period 1|Lack of Efficacy|0|||
155518416|NCT00950807|561323034|FG002|Washout Period 1|Lack of Efficacy|0|||
155518417|NCT00950807|561323035|FG003|Washout Period 1|Lack of Efficacy|0|||
155518418|NCT00950807|561323036|FG004|Washout Period 1|Lack of Efficacy|0|||
155518419|NCT00950807|561323037|FG005|Washout Period 1|Lack of Efficacy|0|||
155518420|NCT00950807|561323038|FG006|Washout Period 1|Lack of Efficacy|1|||
155518421|NCT00950807|561323039|FG007|Washout Period 1|Lack of Efficacy|0|||
155518422|NCT00950807|561323040|FG008|Washout Period 1|Lack of Efficacy|0|||
155518423|NCT00950807|561323041|FG009|Washout Period 1|Lack of Efficacy|0|||
155518424|NCT00950807|561323032|FG000|Washout Period 1|Withdrawal by Subject|0|||
155518425|NCT00950807|561323033|FG001|Washout Period 1|Withdrawal by Subject|0|||
155518426|NCT00950807|561323034|FG002|Washout Period 1|Withdrawal by Subject|0|||
155518427|NCT00950807|561323035|FG003|Washout Period 1|Withdrawal by Subject|0|||
155518428|NCT00950807|561323036|FG004|Washout Period 1|Withdrawal by Subject|0|||
155518429|NCT00950807|561323037|FG005|Washout Period 1|Withdrawal by Subject|0|||
155518430|NCT00950807|561323038|FG006|Washout Period 1|Withdrawal by Subject|0|||
155518431|NCT00950807|561323039|FG007|Washout Period 1|Withdrawal by Subject|0|||
155518432|NCT00950807|561323040|FG008|Washout Period 1|Withdrawal by Subject|1|||
155518433|NCT00950807|561323041|FG009|Washout Period 1|Withdrawal by Subject|0|||
155518434|NCT00950807|561323032|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
155518435|NCT00950807|561323033|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518436|NCT00950807|561323034|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518437|NCT00950807|561323035|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518438|NCT00950807|561323036|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518439|NCT00950807|561323037|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518440|NCT00950807|561323038|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
155518441|NCT00950807|561323039|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
155518442|NCT00950807|561323040|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518443|NCT00950807|561323041|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
155518444|NCT00950807|561323032|FG000|Washout Period 1|Adverse Event|2|||
155518445|NCT00950807|561323033|FG001|Washout Period 1|Adverse Event|0|||
155518446|NCT00950807|561323034|FG002|Washout Period 1|Adverse Event|0|||
155518447|NCT00950807|561323035|FG003|Washout Period 1|Adverse Event|1|||
155518448|NCT00950807|561323036|FG004|Washout Period 1|Adverse Event|1|||
155518449|NCT00950807|561323037|FG005|Washout Period 1|Adverse Event|0|||
155518450|NCT00950807|561323038|FG006|Washout Period 1|Adverse Event|0|||
155518451|NCT00950807|561323039|FG007|Washout Period 1|Adverse Event|0|||
155518452|NCT00950807|561323040|FG008|Washout Period 1|Adverse Event|0|||
155518453|NCT00950807|561323041|FG009|Washout Period 1|Adverse Event|0|||
155518454|NCT00950807|561323032|FG000|Treatment Period 2|Lack of Efficacy|1|||
155518455|NCT00950807|561323033|FG001|Treatment Period 2|Lack of Efficacy|0|||
155518456|NCT00950807|561323034|FG002|Treatment Period 2|Lack of Efficacy|0|||
155518457|NCT00950807|561323035|FG003|Treatment Period 2|Lack of Efficacy|0|||
155518458|NCT00950807|561323036|FG004|Treatment Period 2|Lack of Efficacy|0|||
155518459|NCT00950807|561323037|FG005|Treatment Period 2|Lack of Efficacy|0|||
155518460|NCT00950807|561323038|FG006|Treatment Period 2|Lack of Efficacy|0|||
155518461|NCT00950807|561323039|FG007|Treatment Period 2|Lack of Efficacy|0|||
155518462|NCT00950807|561323040|FG008|Treatment Period 2|Lack of Efficacy|0|||
155518463|NCT00950807|561323041|FG009|Treatment Period 2|Lack of Efficacy|0|||
155518464|NCT00950807|561323032|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155518465|NCT00950807|561323033|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155518466|NCT00950807|561323034|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155518467|NCT00950807|561323035|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155518468|NCT00950807|561323036|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155518469|NCT00950807|561323037|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155518470|NCT00950807|561323038|FG006|Treatment Period 2|Withdrawal by Subject|1|||
155518471|NCT00950807|561323039|FG007|Treatment Period 2|Withdrawal by Subject|2|||
155518472|NCT00950807|561323040|FG008|Treatment Period 2|Withdrawal by Subject|0|||
155518473|NCT00950807|561323041|FG009|Treatment Period 2|Withdrawal by Subject|0|||
155518474|NCT00950807|561323032|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
155469943|NCT01815580|561142426|FG001|Overall Study|Excluded from analysis|4|||
155469944|NCT01814826|561142431|FG000|Overall Study|Other|3|||
155469945|NCT01814826|561142432|FG001|Overall Study|Other|5|||
155469946|NCT01814826|561142433|FG002|Overall Study|Other|0|||
155469947|NCT01814826|561142431|FG000|Overall Study|Death|29|||
155469948|NCT01814826|561142432|FG001|Overall Study|Death|24|||
155469949|NCT01814826|561142433|FG002|Overall Study|Death|3|||
155469950|NCT02917629|561142434|FG000|Overall Study|Withdrawal by Subject|0|||
155469951|NCT02917629|561142435|FG001|Overall Study|Withdrawal by Subject|1|||
155469952|NCT03271307|561142436|FG000|Overall Study|Lost to Follow-up|0|||
155469953|NCT03271307|561142437|FG001|Overall Study|Lost to Follow-up|0|||
155469954|NCT03271307|561142438|FG002|Overall Study|Lost to Follow-up|0|||
155469955|NCT03271307|561142439|FG003|Overall Study|Lost to Follow-up|28|||
155469956|NCT03271307|561142440|FG004|Overall Study|Lost to Follow-up|91|||
155469957|NCT03997760|561142441|FG000|Overall Study|Protocol Deviation|0|||
155469958|NCT03997760|561142442|FG001|Overall Study|Protocol Deviation|1|||
155469959|NCT03997760|561142443|FG002|Overall Study|Protocol Deviation|0|||
155469960|NCT03997760|561142444|FG003|Overall Study|Protocol Deviation|0|||
155469961|NCT02079519|561142450|FG000|Overall Study|Disease Progression|9|||
155469962|NCT02079519|561142450|FG000|Overall Study|Adverse Event|1|||
155469963|NCT01802515|561142451|FG000|Overall Study|Withdrawal by Subject|3|||
155469964|NCT01802515|561142452|FG001|Overall Study|Withdrawal by Subject|0|||
155469965|NCT01802515|561142453|FG002|Overall Study|Withdrawal by Subject|0|||
155469966|NCT02566109|561142454|FG000|Overall Study|Withdrawal by Subject|1|||
155469967|NCT01906476|561142455|FG000|Overall Study|Lost to Follow-up|17|||
155469968|NCT01906476|561142456|FG001|Overall Study|Lost to Follow-up|16|||
155469969|NCT01041404|561142459|FG000|Overall Study|Adverse Event|45|||
155469970|NCT01041404|561142460|FG001|Overall Study|Adverse Event|35|||
155469971|NCT01041404|561142459|FG000|Overall Study|Lack of Efficacy|200|||
155469972|NCT01041404|561142460|FG001|Overall Study|Lack of Efficacy|210|||
155469973|NCT01041404|561142459|FG000|Overall Study|Violation of Selection Criteria|0|||
155469974|NCT01041404|561142460|FG001|Overall Study|Violation of Selection Criteria|1|||
155469975|NCT01041404|561142459|FG000|Overall Study|Protocol Violation|4|||
155469976|NCT01041404|561142460|FG001|Overall Study|Protocol Violation|0|||
155469977|NCT01041404|561142459|FG000|Overall Study|Withdrawal by Subject|29|||
155469978|NCT01041404|561142460|FG001|Overall Study|Withdrawal by Subject|23|||
155469979|NCT01041404|561142459|FG000|Overall Study|Failure to Return|1|||
155469980|NCT01041404|561142460|FG001|Overall Study|Failure to Return|2|||
155469981|NCT01041404|561142459|FG000|Overall Study|Other|11|||
155469982|NCT01041404|561142460|FG001|Overall Study|Other|23|||
155469983|NCT00318370|561142463|FG000|Period 1|Lack of Efficacy|5|||
155469984|NCT00318370|561142464|FG001|Period 1|Lack of Efficacy|0|||
155469985|NCT00318370|561142465|FG002|Period 1|Lack of Efficacy|0|||
155469986|NCT00318370|561142463|FG000|Period 1|Physician Decision|1|||
155469987|NCT00318370|561142464|FG001|Period 1|Physician Decision|0|||
155469988|NCT00318370|561142465|FG002|Period 1|Physician Decision|0|||
155469989|NCT00318370|561142463|FG000|Period 1|Withdrawal by Subject|1|||
155469990|NCT00318370|561142464|FG001|Period 1|Withdrawal by Subject|0|||
155469991|NCT00318370|561142465|FG002|Period 1|Withdrawal by Subject|0|||
155469992|NCT00318370|561142463|FG000|Period 2|Adverse Event|0|||
155469993|NCT00318370|561142464|FG001|Period 2|Adverse Event|3|||
155469994|NCT00318370|561142465|FG002|Period 2|Adverse Event|0|||
155469995|NCT00318370|561142463|FG000|Period 2|Lack of Efficacy|0|||
155469996|NCT00318370|561142464|FG001|Period 2|Lack of Efficacy|5|||
155469997|NCT00318370|561142465|FG002|Period 2|Lack of Efficacy|0|||
155469998|NCT00318370|561142463|FG000|Period 2|Physician Decision|0|||
155469999|NCT00318370|561142464|FG001|Period 2|Physician Decision|1|||
155470000|NCT00318370|561142465|FG002|Period 2|Physician Decision|0|||
155470001|NCT00318370|561142463|FG000|Period 2|Withdrawal by Subject|0|||
155470002|NCT00318370|561142464|FG001|Period 2|Withdrawal by Subject|1|||
155470003|NCT00318370|561142465|FG002|Period 2|Withdrawal by Subject|0|||
155470004|NCT00318370|561142463|FG000|Period 2|Other|0|||
155470005|NCT00318370|561142464|FG001|Period 2|Other|1|||
155470006|NCT00318370|561142465|FG002|Period 2|Other|0|||
155470007|NCT00318370|561142463|FG000|Period 3|Adverse Event|0|||
155518475|NCT00950807|561323033|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518476|NCT00950807|561323034|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518477|NCT00950807|561323035|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155470008|NCT00318370|561142464|FG001|Period 3|Adverse Event|0|||
155470009|NCT00318370|561142465|FG002|Period 3|Adverse Event|1|||
155470010|NCT00318370|561142463|FG000|Period 3|Lack of Efficacy|0|||
155470011|NCT00318370|561142464|FG001|Period 3|Lack of Efficacy|0|||
155470012|NCT00318370|561142465|FG002|Period 3|Lack of Efficacy|24|||
155470013|NCT00318370|561142463|FG000|Period 3|Death|0|||
155470014|NCT00318370|561142464|FG001|Period 3|Death|0|||
155470015|NCT00318370|561142465|FG002|Period 3|Death|1|||
155470016|NCT00318370|561142463|FG000|Period 3|Physician Decision|0|||
155518478|NCT00950807|561323036|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155470017|NCT00318370|561142464|FG001|Period 3|Physician Decision|0|||
155470018|NCT00318370|561142465|FG002|Period 3|Physician Decision|1|||
155470019|NCT00318370|561142463|FG000|Period 3|Withdrawal by Subject|0|||
155653479|NCT02037984|561823935|FG002|Overall Study|Physician Decision|0|||
155653480|NCT02037984|561823936|FG003|Overall Study|Physician Decision|0|||
155653481|NCT02037984|561823937|FG004|Overall Study|Physician Decision|0|||
155653482|NCT02037984|561823938|FG005|Overall Study|Physician Decision|0|||
155653483|NCT02037984|561823939|FG006|Overall Study|Physician Decision|1|||
155653484|NCT02037984|561823940|FG007|Overall Study|Physician Decision|0|||
155653485|NCT02037984|561823933|FG000|Overall Study|Protocol Violation|0|||
155653486|NCT02037984|561823934|FG001|Overall Study|Protocol Violation|0|||
155653487|NCT02037984|561823935|FG002|Overall Study|Protocol Violation|0|||
155653488|NCT02037984|561823936|FG003|Overall Study|Protocol Violation|0|||
155653489|NCT02037984|561823937|FG004|Overall Study|Protocol Violation|0|||
155653490|NCT02037984|561823938|FG005|Overall Study|Protocol Violation|1|||
155653491|NCT02037984|561823939|FG006|Overall Study|Protocol Violation|2|||
155653492|NCT02037984|561823940|FG007|Overall Study|Protocol Violation|0|||
155653493|NCT02037984|561823933|FG000|Overall Study|Technical Problems|0|||
155518479|NCT00950807|561323037|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518480|NCT00950807|561323038|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518481|NCT00950807|561323039|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518482|NCT00950807|561323040|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518483|NCT00950807|561323041|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155518484|NCT00950807|561323032|FG000|Treatment Period 2|Adverse Event|0|||
155470020|NCT00318370|561142464|FG001|Period 3|Withdrawal by Subject|0|||
155518485|NCT00950807|561323033|FG001|Treatment Period 2|Adverse Event|1|||
155518486|NCT00950807|561323034|FG002|Treatment Period 2|Adverse Event|0|||
155518487|NCT00950807|561323035|FG003|Treatment Period 2|Adverse Event|1|||
155518488|NCT00950807|561323036|FG004|Treatment Period 2|Adverse Event|0|||
155518489|NCT00950807|561323037|FG005|Treatment Period 2|Adverse Event|1|||
155518490|NCT00950807|561323038|FG006|Treatment Period 2|Adverse Event|0|||
155518491|NCT00950807|561323039|FG007|Treatment Period 2|Adverse Event|1|||
155518492|NCT00950807|561323040|FG008|Treatment Period 2|Adverse Event|0|||
155518493|NCT00950807|561323041|FG009|Treatment Period 2|Adverse Event|0|||
155518494|NCT00950807|561323032|FG000|Washout Period 2|Lack of Efficacy|1|||
155518495|NCT00950807|561323033|FG001|Washout Period 2|Lack of Efficacy|0|||
155518496|NCT00950807|561323034|FG002|Washout Period 2|Lack of Efficacy|0|||
155518497|NCT00950807|561323035|FG003|Washout Period 2|Lack of Efficacy|0|||
155518498|NCT00950807|561323036|FG004|Washout Period 2|Lack of Efficacy|0|||
155518499|NCT00950807|561323037|FG005|Washout Period 2|Lack of Efficacy|0|||
155518500|NCT00950807|561323038|FG006|Washout Period 2|Lack of Efficacy|0|||
155518501|NCT00950807|561323039|FG007|Washout Period 2|Lack of Efficacy|0|||
155518502|NCT00950807|561323040|FG008|Washout Period 2|Lack of Efficacy|0|||
155518503|NCT00950807|561323041|FG009|Washout Period 2|Lack of Efficacy|0|||
155653494|NCT02037984|561823934|FG001|Overall Study|Technical Problems|0|||
155653495|NCT02037984|561823935|FG002|Overall Study|Technical Problems|3|||
155653496|NCT02037984|561823936|FG003|Overall Study|Technical Problems|3|||
155653497|NCT02037984|561823937|FG004|Overall Study|Technical Problems|2|||
155653498|NCT02037984|561823938|FG005|Overall Study|Technical Problems|3|||
155470021|NCT00318370|561142465|FG002|Period 3|Withdrawal by Subject|3|||
155470022|NCT00318370|561142463|FG000|Period 3|Other|0|||
155470023|NCT00318370|561142464|FG001|Period 3|Other|0|||
155470024|NCT00318370|561142465|FG002|Period 3|Other|3|||
155470025|NCT03627494|561142470|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
155470026|NCT03627494|561142471|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470027|NCT03627494|561142472|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
155470028|NCT03627494|561142473|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470029|NCT03627494|561142474|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470030|NCT03627494|561142475|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470031|NCT03627494|561142476|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470032|NCT03627494|561142477|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470033|NCT03627494|561142478|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
155518504|NCT00950807|561323032|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155653499|NCT02037984|561823939|FG006|Overall Study|Technical Problems|4|||
155653500|NCT02037984|561823940|FG007|Overall Study|Technical Problems|2|||
155653501|NCT02037984|561823933|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155653502|NCT02037984|561823934|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155653503|NCT02037984|561823935|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
155653504|NCT02037984|561823936|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
155653505|NCT02037984|561823937|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
155470034|NCT03627494|561142479|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470035|NCT03627494|561142480|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
155518505|NCT00950807|561323033|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
155518506|NCT00950807|561323034|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155653506|NCT02037984|561823938|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
155653507|NCT02037984|561823939|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
155653508|NCT02037984|561823940|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
155653509|NCT02037984|561823933|FG000|Overall Study|Withdrawal by Subject|0|||
155518507|NCT00950807|561323035|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155653510|NCT02037984|561823934|FG001|Overall Study|Withdrawal by Subject|0|||
155470036|NCT03627494|561142481|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
155470037|NCT03627494|561142470|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470038|NCT03627494|561142471|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470039|NCT03627494|561142472|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470040|NCT03627494|561142473|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470041|NCT03627494|561142474|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470042|NCT03627494|561142475|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470043|NCT03627494|561142476|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470044|NCT03627494|561142477|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470045|NCT03627494|561142478|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
155470046|NCT03627494|561142479|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470047|NCT03627494|561142480|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470048|NCT03627494|561142481|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
155470049|NCT03627494|561142470|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470050|NCT03627494|561142471|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470051|NCT03627494|561142472|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470052|NCT03627494|561142473|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
155653511|NCT02037984|561823935|FG002|Overall Study|Withdrawal by Subject|0|||
155653512|NCT02037984|561823936|FG003|Overall Study|Withdrawal by Subject|1|||
155470053|NCT03627494|561142474|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470054|NCT03627494|561142475|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470055|NCT03627494|561142476|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470056|NCT03627494|561142477|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470057|NCT03627494|561142478|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470058|NCT03627494|561142479|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
155470059|NCT03627494|561142480|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
155470060|NCT03627494|561142481|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
155470061|NCT00688623|561144206|FG000|Overall Study|Adverse Event|22|||
155470062|NCT00688623|561144206|FG000|Overall Study|abnormal lab value|1|||
155470063|NCT00688623|561144206|FG000|Overall Study|Withdrawal by Subject|4|||
155470064|NCT00688623|561144206|FG000|Overall Study|Death|3|||
155470065|NCT00688623|561144206|FG000|Overall Study|disease progression|23|||
155470066|NCT00688623|561144206|FG000|Overall Study|Protocol Violation|2|||
155470067|NCT02443155|561144207|FG000|Overall Study|Adverse Event|3|||
155470068|NCT02443155|561144208|FG001|Overall Study|Adverse Event|4|||
155470069|NCT02443155|561144209|FG002|Overall Study|Adverse Event|1|||
155470070|NCT02443155|561144210|FG003|Overall Study|Adverse Event|2|||
155470071|NCT02443155|561144207|FG000|Overall Study|Unclassified|0|||
155470072|NCT02443155|561144208|FG001|Overall Study|Unclassified|0|||
155470073|NCT02443155|561144209|FG002|Overall Study|Unclassified|2|||
155470074|NCT02443155|561144210|FG003|Overall Study|Unclassified|1|||
155470075|NCT02443155|561144207|FG000|Overall Study|Withdrawal by Subject|4|||
155470076|NCT02443155|561144208|FG001|Overall Study|Withdrawal by Subject|7|||
155470077|NCT02443155|561144209|FG002|Overall Study|Withdrawal by Subject|3|||
155470078|NCT02443155|561144210|FG003|Overall Study|Withdrawal by Subject|9|||
155470079|NCT02443155|561144207|FG000|Overall Study|Pregnancy|3|||
155470080|NCT02443155|561144208|FG001|Overall Study|Pregnancy|1|||
155470081|NCT02443155|561144209|FG002|Overall Study|Pregnancy|1|||
155470082|NCT02443155|561144210|FG003|Overall Study|Pregnancy|2|||
155470083|NCT02443155|561144207|FG000|Overall Study|Lost to Follow-up|1|||
155470084|NCT02443155|561144208|FG001|Overall Study|Lost to Follow-up|2|||
155470085|NCT02443155|561144209|FG002|Overall Study|Lost to Follow-up|0|||
155470086|NCT02443155|561144210|FG003|Overall Study|Lost to Follow-up|1|||
155470087|NCT02443155|561144207|FG000|Overall Study|Protocol Violation|1|||
155470088|NCT02443155|561144208|FG001|Overall Study|Protocol Violation|0|||
155470089|NCT02443155|561144209|FG002|Overall Study|Protocol Violation|1|||
155470090|NCT02443155|561144210|FG003|Overall Study|Protocol Violation|1|||
155470091|NCT02443155|561144207|FG000|Overall Study|Death|0|||
155470092|NCT02443155|561144208|FG001|Overall Study|Death|0|||
155470093|NCT02443155|561144209|FG002|Overall Study|Death|1|||
155470094|NCT02443155|561144210|FG003|Overall Study|Death|0|||
155470095|NCT00608894|561144214|FG000|Overall Study|Withdrawal by Subject|0|||
155470096|NCT00608894|561144215|FG001|Overall Study|Withdrawal by Subject|2|||
155470097|NCT02809118|561144217|FG000|Overall Study|Withdrawal by Subject|0|||
155470098|NCT02809118|561144218|FG001|Overall Study|Withdrawal by Subject|1|||
155470099|NCT02809118|561144219|FG002|Overall Study|Withdrawal by Subject|1|||
155470100|NCT02828644|561144221|FG000|Overall Study|Lost to Follow-up|23|||
155470101|NCT02828644|561144222|FG001|Overall Study|Lost to Follow-up|22|||
155470102|NCT02408484|561144223|FG000|Overall Study|Withdrawal by Subject|3|||
155470103|NCT02408484|561144223|FG000|Overall Study|Not treated during study period|1|||
155518508|NCT00950807|561323036|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
155470104|NCT02436915|561144224|FG000|Overall Study|Withdrawal by Subject|0|||
155518509|NCT00950807|561323037|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155653513|NCT02037984|561823937|FG004|Overall Study|Withdrawal by Subject|1|||
155470105|NCT02436915|561144225|FG001|Overall Study|Withdrawal by Subject|1|||
155470106|NCT01117181|561144227|FG000|Overall Study|Lost to Follow-up|1|||
155470107|NCT01117181|561144228|FG001|Overall Study|Lost to Follow-up|0|||
155470108|NCT01117181|561144227|FG000|Overall Study|Withdrawal by Subject|0|||
155470109|NCT01117181|561144228|FG001|Overall Study|Withdrawal by Subject|2|||
155470110|NCT01119963|561144231|FG000|Overall Study|Lost to Follow-up|1|||
155470111|NCT01119963|561144232|FG001|Overall Study|Lost to Follow-up|1|||
155470112|NCT00254163|561144233|FG000|Overall Study|Adverse Event|29|||
155470113|NCT00254163|561144234|FG001|Overall Study|Adverse Event|26|||
155470114|NCT00254163|561144233|FG000|Overall Study|Patient request/withdrew consent|6|||
155470115|NCT00254163|561144234|FG001|Overall Study|Patient request/withdrew consent|4|||
155470116|NCT00254163|561144233|FG000|Overall Study|Investigator request|1|||
155470117|NCT00254163|561144234|FG001|Overall Study|Investigator request|3|||
155470118|NCT00254163|561144233|FG000|Overall Study|Failed entry|1|||
155470119|NCT00254163|561144234|FG001|Overall Study|Failed entry|3|||
155470120|NCT00254163|561144233|FG000|Overall Study|Progressive disease|0|||
155470121|NCT00254163|561144234|FG001|Overall Study|Progressive disease|1|||
155470122|NCT00254163|561144233|FG000|Overall Study|Death|0|||
155470123|NCT00254163|561144234|FG001|Overall Study|Death|1|||
155470124|NCT00254163|561144233|FG000|Overall Study|Other|8|||
155470125|NCT00254163|561144234|FG001|Overall Study|Other|8|||
155470126|NCT00216086|561144239|FG000|Overall Study|Protocol Violation|1|||
155470127|NCT00216086|561144239|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
155470128|NCT00216086|561144239|FG000|Overall Study|Social Reasons|2|||
155470129|NCT00809614|561144240|FG000|Overall Study|Lack of Efficacy|2|||
155470130|NCT00809614|561144241|FG001|Overall Study|Lack of Efficacy|3|||
155470131|NCT00809614|561144240|FG000|Overall Study|Withdrawal by Subject|1|||
155470132|NCT00809614|561144241|FG001|Overall Study|Withdrawal by Subject|1|||
155470133|NCT01080625|561144242|FG000|Overall Study|Physician Decision|0|||
155470134|NCT01080625|561144243|FG001|Overall Study|Physician Decision|2|||
155470135|NCT01080625|561144244|FG002|Overall Study|Physician Decision|1|||
155470136|NCT00446797|561144247|FG000|Overall Study|Lack of Efficacy|0|||
155470137|NCT00446797|561144248|FG001|Overall Study|Lack of Efficacy|2|||
155470138|NCT00446797|561144247|FG000|Overall Study|Lost to Follow-up|5|||
155470139|NCT00446797|561144248|FG001|Overall Study|Lost to Follow-up|3|||
155470140|NCT00446797|561144247|FG000|Overall Study|Withdrawal by Subject|2|||
155470141|NCT00446797|561144248|FG001|Overall Study|Withdrawal by Subject|2|||
155470142|NCT00446797|561144247|FG000|Overall Study|Protocol Violation|1|||
155470143|NCT00446797|561144248|FG001|Overall Study|Protocol Violation|3|||
155470144|NCT00446797|561144247|FG000|Overall Study|subject entered at another site|0|||
155470145|NCT00446797|561144248|FG001|Overall Study|subject entered at another site|1|||
155470146|NCT00446797|561144247|FG000|Overall Study|did not meet entrance criteria|0|||
155470147|NCT00446797|561144248|FG001|Overall Study|did not meet entrance criteria|1|||
155470148|NCT00364832|561144252|FG000|Core Period|Early Withdrawals|2|||
155470149|NCT00364832|561144253|FG001|Core Period|Early Withdrawals|2|||
155470150|NCT00364832|561144254|FG002|Core Period|Early Withdrawals|1|||
155470151|NCT00364832|561144255|FG003|Core Period|Early Withdrawals|1|||
155470152|NCT00364832|561144256|FG004|Core Period|Early Withdrawals|0|||
155470153|NCT00364832|561144257|FG005|Core Period|Early Withdrawals|0|||
155470154|NCT00364832|561144258|FG006|Core Period|Early Withdrawals|4|||
155470155|NCT00364832|561144259|FG007|Core Period|Early Withdrawals|1|||
155470156|NCT00364832|561144260|FG008|Core Period|Early Withdrawals|0|||
155470157|NCT00364832|561144261|FG009|Core Period|Early Withdrawals|0|||
155470158|NCT00364832|561144262|FG010|Core Period|Early Withdrawals|0|||
155470159|NCT00364832|561144263|FG011|Core Period|Early Withdrawals|0|||
155470160|NCT00364832|561144252|FG000|Extension Year 1|Early Withdrawals|0|||
155470161|NCT00364832|561144253|FG001|Extension Year 1|Early Withdrawals|0|||
155470162|NCT00364832|561144254|FG002|Extension Year 1|Early Withdrawals|0|||
155470163|NCT00364832|561144255|FG003|Extension Year 1|Early Withdrawals|0|||
155470164|NCT00364832|561144256|FG004|Extension Year 1|Early Withdrawals|0|||
155470165|NCT00364832|561144257|FG005|Extension Year 1|Early Withdrawals|0|||
155470166|NCT00364832|561144258|FG006|Extension Year 1|Early Withdrawals|0|||
155470167|NCT00364832|561144259|FG007|Extension Year 1|Early Withdrawals|0|||
155470168|NCT00364832|561144260|FG008|Extension Year 1|Early Withdrawals|0|||
155470169|NCT00364832|561144261|FG009|Extension Year 1|Early Withdrawals|4|||
155470170|NCT00364832|561144262|FG010|Extension Year 1|Early Withdrawals|2|||
155470171|NCT00364832|561144263|FG011|Extension Year 1|Early Withdrawals|10|||
155470172|NCT00364832|561144252|FG000|Extension Year 2|Early Withdrawals|0|||
155470173|NCT00364832|561144253|FG001|Extension Year 2|Early Withdrawals|0|||
155518510|NCT00950807|561323038|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
155470174|NCT00364832|561144254|FG002|Extension Year 2|Early Withdrawals|0|||
155470175|NCT00364832|561144255|FG003|Extension Year 2|Early Withdrawals|0|||
155470176|NCT00364832|561144256|FG004|Extension Year 2|Early Withdrawals|0|||
155470177|NCT00364832|561144257|FG005|Extension Year 2|Early Withdrawals|0|||
155470178|NCT00364832|561144258|FG006|Extension Year 2|Early Withdrawals|0|||
155470179|NCT00364832|561144259|FG007|Extension Year 2|Early Withdrawals|0|||
155470180|NCT00364832|561144260|FG008|Extension Year 2|Early Withdrawals|0|||
155470181|NCT00364832|561144261|FG009|Extension Year 2|Early Withdrawals|5|||
155518511|NCT00950807|561323039|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
155518512|NCT00950807|561323040|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155518513|NCT00950807|561323041|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155518514|NCT00950807|561323032|FG000|Washout Period 2|Adverse Event|3|||
155518515|NCT00950807|561323033|FG001|Washout Period 2|Adverse Event|0|||
155470182|NCT00364832|561144262|FG010|Extension Year 2|Early Withdrawals|5|||
155470183|NCT00364832|561144263|FG011|Extension Year 2|Early Withdrawals|3|||
155518516|NCT00950807|561323034|FG002|Washout Period 2|Adverse Event|0|||
155518517|NCT00950807|561323035|FG003|Washout Period 2|Adverse Event|1|||
155518518|NCT00950807|561323036|FG004|Washout Period 2|Adverse Event|0|||
155518519|NCT00950807|561323037|FG005|Washout Period 2|Adverse Event|0|||
155518520|NCT00950807|561323038|FG006|Washout Period 2|Adverse Event|0|||
155518521|NCT00950807|561323039|FG007|Washout Period 2|Adverse Event|0|||
155470184|NCT01929018|561144279|FG000|Overall Study|Lost to Follow-up|1|||
155470185|NCT01929018|561144280|FG001|Overall Study|Lost to Follow-up|0|||
155470186|NCT01929018|561144279|FG000|Overall Study|Hospitalization|0|||
155470187|NCT01929018|561144280|FG001|Overall Study|Hospitalization|1|||
155470188|NCT00282568|561144281|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
155470189|NCT00282568|561144281|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
155470190|NCT00282568|561144281|FG000|Extended Treatment Period|Adverse Event|17|||
155470191|NCT00282568|561144281|FG000|Extended Treatment Period|Non-compliance|4|||
155470192|NCT00282568|561144281|FG000|Extended Treatment Period|Physician Decision|1|||
155470193|NCT00282568|561144281|FG000|Extended Treatment Period|Lost to Follow-up|2|||
155470194|NCT01266070|561144282|FG000|Overall Study|Adverse Event|3|||
155470195|NCT01266070|561144282|FG000|Overall Study|Protocol Violation|1|||
155470196|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
155470197|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
155470198|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
155470199|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
155470200|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
155470201|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
155470202|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
155470203|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
155470204|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
155470205|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
155470206|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
155470207|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
155470208|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
155470209|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
155470210|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
155470211|NCT02417064|561144283|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
155470212|NCT02417064|561144284|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
155470213|NCT02417064|561144285|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
155470214|NCT02417064|561144283|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
155470215|NCT02417064|561144284|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
155470216|NCT02417064|561144285|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
155470217|NCT02417064|561144283|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
155470218|NCT02417064|561144284|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
155470219|NCT02417064|561144285|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
155470220|NCT02417064|561144283|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
155470221|NCT02417064|561144284|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
155470222|NCT02417064|561144285|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
155470223|NCT02417064|561144283|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
155470224|NCT02417064|561144284|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
155470225|NCT02417064|561144285|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
155470226|NCT02417064|561144283|FG000|Follow-up Phase (24 Weeks)|Other|2|||
155470227|NCT02417064|561144284|FG001|Follow-up Phase (24 Weeks)|Other|2|||
155518522|NCT00950807|561323040|FG008|Washout Period 2|Adverse Event|0|||
155518523|NCT00950807|561323041|FG009|Washout Period 2|Adverse Event|0|||
155518524|NCT00950807|561323032|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155518525|NCT00950807|561323033|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155518526|NCT00950807|561323034|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155518527|NCT00950807|561323035|FG003|Treatment Period 3|Withdrawal by Subject|0|||
155518528|NCT00950807|561323036|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155653514|NCT02037984|561823938|FG005|Overall Study|Withdrawal by Subject|3|||
155470228|NCT02417064|561144285|FG002|Follow-up Phase (24 Weeks)|Other|3|||
155470229|NCT03185819|561144286|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
155518529|NCT00950807|561323037|FG005|Treatment Period 3|Withdrawal by Subject|0|||
155518530|NCT00950807|561323038|FG006|Treatment Period 3|Withdrawal by Subject|0|||
155653515|NCT02037984|561823939|FG006|Overall Study|Withdrawal by Subject|0|||
155518531|NCT00950807|561323039|FG007|Treatment Period 3|Withdrawal by Subject|0|||
155653516|NCT02037984|561823940|FG007|Overall Study|Withdrawal by Subject|1|||
155470230|NCT03185819|561144287|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
155470231|NCT03185819|561144288|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
155470232|NCT03185819|561144289|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
155470233|NCT03185819|561144286|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
155470234|NCT03185819|561144287|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
155470235|NCT03185819|561144288|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
155470236|NCT03185819|561144289|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
155470237|NCT03185819|561144286|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
155470238|NCT03185819|561144287|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
155470239|NCT03185819|561144288|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
155470240|NCT03185819|561144289|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
155470241|NCT03185819|561144286|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
155470242|NCT03185819|561144287|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
155470243|NCT03185819|561144288|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
155470244|NCT03185819|561144289|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
155470245|NCT03185819|561144286|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
155470246|NCT03185819|561144287|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
155470247|NCT03185819|561144288|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
155470248|NCT03185819|561144289|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
155470249|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
155470250|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
155470251|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
155470252|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
155470253|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
155470254|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
155470255|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
155470256|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
155470257|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
155470258|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
155470259|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
155470260|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
155470261|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
155470262|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
155470263|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
155470264|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
155470265|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
155470266|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
155470267|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
155470268|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
155470269|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
155470270|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
155470271|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
155470272|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
155470273|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
155470274|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
155470275|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
155470276|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
155470277|NCT03185819|561144286|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
155470278|NCT03185819|561144287|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
155470279|NCT03185819|561144288|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
155470280|NCT03185819|561144289|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
155470281|NCT02939976|561144290|FG000|Overall Study|Lost to Follow-up|7|||
155470282|NCT02939976|561144291|FG001|Overall Study|Lost to Follow-up|1|||
155470283|NCT02939976|561144292|FG002|Overall Study|Lost to Follow-up|1|||
155470284|NCT02939976|561144293|FG003|Overall Study|Lost to Follow-up|2|||
155470285|NCT02939976|561144290|FG000|Overall Study|Withdrawal by Subject|4|||
155470286|NCT02939976|561144291|FG001|Overall Study|Withdrawal by Subject|0|||
155470287|NCT02939976|561144292|FG002|Overall Study|Withdrawal by Subject|2|||
155470288|NCT02939976|561144293|FG003|Overall Study|Withdrawal by Subject|4|||
155470289|NCT02939976|561144290|FG000|Overall Study|Due to early study closure|4|||
155470290|NCT02939976|561144291|FG001|Overall Study|Due to early study closure|3|||
155470291|NCT02939976|561144292|FG002|Overall Study|Due to early study closure|2|||
155470292|NCT02939976|561144293|FG003|Overall Study|Due to early study closure|3|||
155470293|NCT04080752|561144294|FG000|Overall Study|Adverse Event|2|||
155653517|NCT00974233|561823946|FG000|Induction Chemoimmunotherapy|Death|2|||
155653518|NCT00974233|561823946|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
155653519|NCT00974233|561823946|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
155653520|NCT00974233|561823946|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
155653521|NCT00974233|561823946|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
155653522|NCT00974233|561823946|FG000|Maintenance Lenalidomide|Adverse Event|8|||
155653523|NCT01691092|561823947|FG000|Overall Study|Lost to Follow-up|10|||
155653524|NCT01691092|561823947|FG000|Overall Study|Physician Decision|4|||
155653525|NCT01691092|561823947|FG000|Overall Study|Withdrawal by Subject|3|||
155653526|NCT01691092|561823947|FG000|Overall Study|non-compliance|3|||
155653527|NCT01691092|561823947|FG000|Overall Study|used for different study|2|||
155653528|NCT01691092|561823947|FG000|Overall Study|screen fail|19|||
155653529|NCT00581100|561825255|FG000|Overall Study|Death|1|||
155653530|NCT00581100|561825256|FG001|Overall Study|Death|0|||
155653531|NCT00581100|561825255|FG000|Overall Study|Adverse Event|2|||
155653532|NCT00581100|561825256|FG001|Overall Study|Adverse Event|1|||
155653533|NCT00581100|561825255|FG000|Overall Study|Withdrawal by Subject|1|||
155653534|NCT00581100|561825256|FG001|Overall Study|Withdrawal by Subject|4|||
155653535|NCT00581100|561825255|FG000|Overall Study|Other|3|||
155470294|NCT04080752|561144295|FG001|Overall Study|Adverse Event|3|||
155470295|NCT04080752|561144294|FG000|Overall Study|Lack of Efficacy|1|||
155470296|NCT04080752|561144295|FG001|Overall Study|Lack of Efficacy|0|||
155470297|NCT04080752|561144294|FG000|Overall Study|Lost to Follow-up|1|||
155470298|NCT04080752|561144295|FG001|Overall Study|Lost to Follow-up|0|||
155470299|NCT04080752|561144294|FG000|Overall Study|Pregnancy|0|||
155470300|NCT04080752|561144295|FG001|Overall Study|Pregnancy|1|||
155470301|NCT04080752|561144294|FG000|Overall Study|Withdrawal by Subject|7|||
155470302|NCT04080752|561144295|FG001|Overall Study|Withdrawal by Subject|0|||
155470303|NCT04080752|561144294|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155470304|NCT04080752|561144295|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155470305|NCT04080752|561144294|FG000|Overall Study|Other|2|||
155470306|NCT04080752|561144295|FG001|Overall Study|Other|1|||
155470307|NCT01585168|561144296|FG000|Overall Study|Lost to Follow-up|3|||
155470308|NCT01585168|561144297|FG001|Overall Study|Lost to Follow-up|1|||
155470309|NCT01585168|561144298|FG002|Overall Study|Lost to Follow-up|1|||
155470310|NCT01585168|561144299|FG003|Overall Study|Lost to Follow-up|1|||
155470311|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
155470312|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
155470313|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
155470314|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
155470315|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
155470316|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
155470317|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
155470318|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
155470319|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
155470320|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
155470321|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
155470322|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
155470323|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
155470324|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
155470325|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
155470326|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
155470327|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
155470328|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
155470329|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
155470330|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
155470331|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
155470332|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
155470333|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
155470334|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
155470335|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Other|0|||
155470336|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Other|1|||
155470337|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Other|0|||
155470338|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Other|0|||
155470339|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
155653536|NCT00581100|561825256|FG001|Overall Study|Other|0|||
155470340|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
155470341|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
155653537|NCT04129398|561825257|FG000|Overall Study|Physician Decision|2|||
155653538|NCT00590317|561825258|FG000|Overall Study|Lack of Efficacy|1|||
155653539|NCT00590317|561825259|FG001|Overall Study|Lack of Efficacy|5|||
155470342|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
155653540|NCT02904265|561825260|FG000|Overall Study|Physician Decision|1|||
155653541|NCT02904265|561825261|FG001|Overall Study|Physician Decision|2|||
155470343|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
155470344|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
155470345|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
155470346|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
155470347|NCT01194414|561144300|FG000|24 Weeks Double Blind Period|Death|0|||
155470348|NCT01194414|561144301|FG001|24 Weeks Double Blind Period|Death|1|||
155470349|NCT01194414|561144302|FG002|24 Weeks Double Blind Period|Death|0|||
155470350|NCT01194414|561144303|FG003|24 Weeks Double Blind Period|Death|0|||
155470351|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
155470352|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
155470353|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
155470354|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
155470355|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
155470356|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
155470357|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
155470358|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
155470359|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
155470360|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
155470361|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
155470362|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
155470363|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
155470364|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
155470365|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
155470366|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
155470367|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
155470368|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
155470369|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
155470370|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
155470371|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
155470372|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
155470373|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
155470374|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
155470375|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Other|2|||
155470376|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Other|1|||
155470377|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Other|0|||
155470378|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Other|0|||
155470379|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
155470380|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
155470381|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
155470382|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
155470383|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
155470384|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
155470385|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
155470386|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
155470387|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
155470388|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
155470389|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
155470390|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
155470391|NCT01194414|561144300|FG000|72 Weeks Open Label Extension|Death|1|||
155470392|NCT01194414|561144301|FG001|72 Weeks Open Label Extension|Death|2|||
155470393|NCT01194414|561144302|FG002|72 Weeks Open Label Extension|Death|0|||
155470394|NCT01194414|561144303|FG003|72 Weeks Open Label Extension|Death|2|||
155470395|NCT01782885|561144305|FG000|Overall Study|Lost to Follow-up|4|||
155470396|NCT01782885|561144306|FG001|Overall Study|Lost to Follow-up|6|||
155470397|NCT03447821|561144307|FG000|Overall Study|Withdrawal by Subject|1|||
155470398|NCT03447821|561144308|FG001|Overall Study|Withdrawal by Subject|1|||
155470399|NCT03447821|561144309|FG002|Overall Study|Withdrawal by Subject|0|||
155518532|NCT00950807|561323040|FG008|Treatment Period 3|Withdrawal by Subject|0|||
155518533|NCT00950807|561323041|FG009|Treatment Period 3|Withdrawal by Subject|1|||
155470400|NCT03447821|561144307|FG000|Overall Study|Lost to Follow-up|0|||
155470401|NCT03447821|561144308|FG001|Overall Study|Lost to Follow-up|0|||
155470402|NCT03447821|561144309|FG002|Overall Study|Lost to Follow-up|1|||
155470403|NCT00654420|561144310|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
155470404|NCT00654420|561144311|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
155470405|NCT00654420|561144312|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
155470406|NCT00654420|561144313|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
155470407|NCT00654420|561144310|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
155518534|NCT00950807|561323032|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
155470408|NCT00654420|561144311|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
155470409|NCT00654420|561144312|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
155470410|NCT00654420|561144313|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
155470411|NCT00654420|561144310|FG000|Phase II|Adverse Event|0|||
155470412|NCT00654420|561144311|FG001|Phase II|Adverse Event|0|||
155470413|NCT00654420|561144312|FG002|Phase II|Adverse Event|3|||
155470414|NCT00654420|561144313|FG003|Phase II|Adverse Event|3|||
155470415|NCT00654420|561144310|FG000|Phase II|Lost to Follow-up|0|||
155470416|NCT00654420|561144311|FG001|Phase II|Lost to Follow-up|0|||
155470417|NCT00654420|561144312|FG002|Phase II|Lost to Follow-up|0|||
155470418|NCT00654420|561144313|FG003|Phase II|Lost to Follow-up|1|||
155470419|NCT00654420|561144310|FG000|Phase II|Physician Decision|0|||
155470420|NCT00654420|561144311|FG001|Phase II|Physician Decision|0|||
155470421|NCT00654420|561144312|FG002|Phase II|Physician Decision|0|||
155470422|NCT00654420|561144313|FG003|Phase II|Physician Decision|4|||
155470423|NCT00654420|561144310|FG000|Phase II|Progressive Disease|0|||
155470424|NCT00654420|561144311|FG001|Phase II|Progressive Disease|0|||
155470425|NCT00654420|561144312|FG002|Phase II|Progressive Disease|29|||
155470426|NCT00654420|561144313|FG003|Phase II|Progressive Disease|29|||
155470427|NCT00654420|561144310|FG000|Phase II|Withdrawal by Subject|0|||
155470428|NCT00654420|561144311|FG001|Phase II|Withdrawal by Subject|0|||
155470429|NCT00654420|561144312|FG002|Phase II|Withdrawal by Subject|4|||
155470430|NCT00654420|561144313|FG003|Phase II|Withdrawal by Subject|1|||
155470431|NCT00654420|561144310|FG000|Phase II|Missing Disposition Record|0|||
155470432|NCT00654420|561144311|FG001|Phase II|Missing Disposition Record|0|||
155470433|NCT00654420|561144312|FG002|Phase II|Missing Disposition Record|1|||
155470434|NCT00654420|561144313|FG003|Phase II|Missing Disposition Record|0|||
155470435|NCT00431496|561144323|FG000|Overall Study|Adverse Event|3|||
155470436|NCT00431496|561144323|FG000|Overall Study|Lost to Follow-up|1|||
155470437|NCT00431496|561144323|FG000|Overall Study|Withdrawal by Subject|2|||
155470438|NCT00431496|561144323|FG000|Overall Study|Protocol-specified criteria|5|||
155470439|NCT02343952|561144324|FG000|Study Treatment|Disease Progression|23|||
155470440|NCT02343952|561144324|FG000|Study Treatment|Death|3|||
155470441|NCT02343952|561144324|FG000|Study Treatment|Adverse Event|19|||
155470442|NCT02343952|561144324|FG000|Study Treatment|Withdrawal by Subject|7|||
155470443|NCT02343952|561144324|FG000|Study Treatment|other complicating Diseases|1|||
155470444|NCT02343952|561144324|FG000|Follow up|Withdrawal by Subject|3|||
155470445|NCT02343952|561144324|FG000|Follow up|Death|33|||
155470446|NCT02343952|561144324|FG000|Follow up|Patient does not meet eligibility for study.|1|||
155470447|NCT02343952|561144324|FG000|Follow up|Research department closed by the practice.|5|||
155470448|NCT02343952|561144324|FG000|Follow up|Patient went home to Russia|1|||
155470449|NCT02343952|561144324|FG000|Follow up|Disease Progression|1|||
155470450|NCT02343952|561144324|FG000|Follow up|study terminated|1|||
155470451|NCT02671760|561144326|FG000|Overall Study|Lost to Follow-up|0|||
155470452|NCT02671760|561144327|FG001|Overall Study|Lost to Follow-up|1|||
155470453|NCT02671760|561144328|FG002|Overall Study|Lost to Follow-up|0|||
155470454|NCT02999191|561144329|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
155470455|NCT02999191|561144330|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
155470456|NCT02999191|561144331|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
155470457|NCT01993667|561144339|FG000|Overall Study|Insufficient data to analyze|16|||
155470458|NCT01993667|561144340|FG001|Overall Study|Insufficient data to analyze|16|||
155470459|NCT01993667|561144339|FG000|Overall Study|Insufficient altitude reached|3|||
155470460|NCT01993667|561144340|FG001|Overall Study|Insufficient altitude reached|1|||
155470461|NCT01993667|561144339|FG000|Overall Study|Lost to Follow-up|2|||
155470462|NCT01993667|561144340|FG001|Overall Study|Lost to Follow-up|2|||
155470463|NCT01931150|561144341|FG000|Overall Study|Withdrawal by Subject|1|||
155470464|NCT01931150|561144342|FG001|Overall Study|Withdrawal by Subject|2|||
155470465|NCT04968353|561144345|FG000|Overall Study|Non-compliance|1|||
155470466|NCT04968353|561144346|FG001|Overall Study|Non-compliance|0|||
155470467|NCT04968353|561144347|FG002|Overall Study|Non-compliance|2|||
155470468|NCT04968353|561144348|FG003|Overall Study|Non-compliance|0|||
155470469|NCT00845845|561144349|FG000|Overall Study|Lost to Follow-up|0|||
155470470|NCT00845845|561144350|FG001|Overall Study|Lost to Follow-up|4|||
155470471|NCT01685203|561144351|FG000|Overall Study|Lost to Follow-up|3|||
155470472|NCT01685203|561144352|FG001|Overall Study|Lost to Follow-up|3|||
155470473|NCT01685203|561144353|FG002|Overall Study|Lost to Follow-up|0|||
155470474|NCT01685203|561144354|FG003|Overall Study|Lost to Follow-up|1|||
155470475|NCT01685203|561144355|FG004|Overall Study|Lost to Follow-up|0|||
155470476|NCT01685203|561144356|FG005|Overall Study|Lost to Follow-up|0|||
155470477|NCT01685203|561144357|FG006|Overall Study|Lost to Follow-up|0|||
155470478|NCT01685203|561144351|FG000|Overall Study|Adverse Event|0|||
155470479|NCT01685203|561144352|FG001|Overall Study|Adverse Event|0|||
155470480|NCT01685203|561144353|FG002|Overall Study|Adverse Event|0|||
155470481|NCT01685203|561144354|FG003|Overall Study|Adverse Event|0|||
155470482|NCT01685203|561144355|FG004|Overall Study|Adverse Event|0|||
155470483|NCT01685203|561144356|FG005|Overall Study|Adverse Event|2|||
155470484|NCT01685203|561144357|FG006|Overall Study|Adverse Event|0|||
155470485|NCT01685203|561144351|FG000|Overall Study|Adverse event and withdrew consent|1|||
155470486|NCT01685203|561144352|FG001|Overall Study|Adverse event and withdrew consent|0|||
155470487|NCT01685203|561144353|FG002|Overall Study|Adverse event and withdrew consent|0|||
155470488|NCT01685203|561144354|FG003|Overall Study|Adverse event and withdrew consent|0|||
155470489|NCT01685203|561144355|FG004|Overall Study|Adverse event and withdrew consent|0|||
155470490|NCT01685203|561144356|FG005|Overall Study|Adverse event and withdrew consent|0|||
155470491|NCT01685203|561144357|FG006|Overall Study|Adverse event and withdrew consent|0|||
155470492|NCT01685203|561144351|FG000|Overall Study|Patient's decision|0|||
155470493|NCT01685203|561144352|FG001|Overall Study|Patient's decision|0|||
155470494|NCT01685203|561144353|FG002|Overall Study|Patient's decision|0|||
155470495|NCT01685203|561144354|FG003|Overall Study|Patient's decision|0|||
155470496|NCT01685203|561144355|FG004|Overall Study|Patient's decision|0|||
155470497|NCT01685203|561144356|FG005|Overall Study|Patient's decision|1|||
155470498|NCT01685203|561144357|FG006|Overall Study|Patient's decision|0|||
155470499|NCT02896192|561144358|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
155470500|NCT02896192|561144358|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
155470501|NCT02896192|561144358|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
155470502|NCT01750840|561144362|FG000|Overall Study|Lost to Follow-up|4|||
155470503|NCT00479167|561144363|FG000|Overall Study|Withdrawal by Subject|1|||
155470504|NCT01570309|561144364|FG000|Overall Study|Withdrawal by Subject|3|||
155470505|NCT01570309|561144365|FG001|Overall Study|Withdrawal by Subject|3|||
155518535|NCT00950807|561323033|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518536|NCT00950807|561323034|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518537|NCT00950807|561323035|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518538|NCT00950807|561323036|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518539|NCT00950807|561323037|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518540|NCT00950807|561323038|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518541|NCT00950807|561323039|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
155518542|NCT00950807|561323040|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518543|NCT00950807|561323041|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155518544|NCT00950807|561323032|FG000|Treatment Period 3|Adverse Event|0|||
155518545|NCT00950807|561323033|FG001|Treatment Period 3|Adverse Event|0|||
155518546|NCT00950807|561323034|FG002|Treatment Period 3|Adverse Event|0|||
155518547|NCT00950807|561323035|FG003|Treatment Period 3|Adverse Event|0|||
155518548|NCT00950807|561323036|FG004|Treatment Period 3|Adverse Event|0|||
155518549|NCT00950807|561323037|FG005|Treatment Period 3|Adverse Event|0|||
155518550|NCT00950807|561323038|FG006|Treatment Period 3|Adverse Event|1|||
155518551|NCT00950807|561323039|FG007|Treatment Period 3|Adverse Event|0|||
155518552|NCT00950807|561323040|FG008|Treatment Period 3|Adverse Event|0|||
155518553|NCT00950807|561323041|FG009|Treatment Period 3|Adverse Event|0|||
155518554|NCT01492400|561323045|FG000|Overall Study|Miscellaneous Reasons|2|||
155518555|NCT01492400|561323046|FG001|Overall Study|Miscellaneous Reasons|3|||
155518556|NCT01492400|561323045|FG000|Overall Study|Personal Reasons|0|||
155518557|NCT01492400|561323046|FG001|Overall Study|Personal Reasons|5|||
155518558|NCT01492400|561323045|FG000|Overall Study|Lost to Follow-up|3|||
155518559|NCT01492400|561323046|FG001|Overall Study|Lost to Follow-up|1|||
155518560|NCT01492400|561323045|FG000|Overall Study|Pregnancy|0|||
155518561|NCT01492400|561323046|FG001|Overall Study|Pregnancy|1|||
155518562|NCT01492400|561323045|FG000|Overall Study|Lack of Efficacy|1|||
155518563|NCT01492400|561323046|FG001|Overall Study|Lack of Efficacy|1|||
155518564|NCT01492400|561323045|FG000|Overall Study|Adverse Event|10|||
155518565|NCT01492400|561323046|FG001|Overall Study|Adverse Event|5|||
155518566|NCT00659607|561323047|FG000|Overall Study|No blood pressure recorded|147|||
155518567|NCT00659607|561323047|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
155518568|NCT00659607|561323047|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
155518569|NCT00659607|561323047|FG000|Overall Study|No recorded efficacy data|15|||
155518570|NCT00659607|561323047|FG000|Overall Study|Inconsistent BP measuring date|2|||
155518571|NCT06179108|561323049|FG000|Overall Study|Withdrawal by Subject|16|||
155518572|NCT06179108|561323050|FG001|Overall Study|Withdrawal by Subject|19|||
155518573|NCT06179108|561323051|FG002|Overall Study|Withdrawal by Subject|10|||
155470506|NCT03619837|561144366|FG000|Screening|received organs from HCV-negative donors|47|||
155470507|NCT03619837|561144366|FG000|Screening|died on the wait-list|2|||
155518574|NCT06179108|561323052|FG003|Overall Study|Withdrawal by Subject|11|||
155518575|NCT06179108|561323049|FG000|Overall Study|Lost to Follow-up|12|||
155518576|NCT06179108|561323050|FG001|Overall Study|Lost to Follow-up|4|||
155518577|NCT06179108|561323051|FG002|Overall Study|Lost to Follow-up|1|||
155518578|NCT06179108|561323052|FG003|Overall Study|Lost to Follow-up|9|||
155518579|NCT06179108|561323049|FG000|Overall Study|Adverse Event|2|||
155470508|NCT03619837|561144366|FG000|Screening|remained on the wait list|40|||
155470509|NCT03619837|561144366|FG000|Screening|didn't meet eligibility criteria|3|||
155470510|NCT03619837|561144366|FG000|Screening|withdrew consent|2|||
155653542|NCT00185614|561825264|FG000|Inter-treatment Period|Physician Decision|1|||
155653543|NCT00185614|561825264|FG000|Inter-treatment Period|Relapse|2|||
155653544|NCT00185614|561825264|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
155653545|NCT00866775|561825274|FG000|Overall Study|Adverse Event|5|||
155653546|NCT00866775|561825275|FG001|Overall Study|Adverse Event|19|||
155653547|NCT00866775|561825274|FG000|Overall Study|Death|1|||
155653548|NCT00866775|561825275|FG001|Overall Study|Death|0|||
155653549|NCT00866775|561825274|FG000|Overall Study|Lost to Follow-up|0|||
155653550|NCT00866775|561825275|FG001|Overall Study|Lost to Follow-up|4|||
155653551|NCT00866775|561825274|FG000|Overall Study|Physician Decision|0|||
155653552|NCT00866775|561825275|FG001|Overall Study|Physician Decision|3|||
155653553|NCT00866775|561825274|FG000|Overall Study|Protocol Violation|3|||
155653554|NCT00866775|561825275|FG001|Overall Study|Protocol Violation|4|||
155653555|NCT00866775|561825274|FG000|Overall Study|Withdrawal by Subject|4|||
155653556|NCT00866775|561825275|FG001|Overall Study|Withdrawal by Subject|4|||
155653557|NCT00866775|561825274|FG000|Overall Study|met exit criteria|23|||
155653558|NCT00866775|561825275|FG001|Overall Study|met exit criteria|17|||
155653559|NCT00866775|561825274|FG000|Overall Study|discontinued due to communication error|0|||
155653560|NCT00866775|561825275|FG001|Overall Study|discontinued due to communication error|1|||
155653561|NCT00003907|561825276|FG000|Overall Study|Adverse Event|2|||
155653562|NCT00003907|561825277|FG001|Overall Study|Adverse Event|11|||
155653563|NCT00003907|561825276|FG000|Overall Study|Death|2|||
155653564|NCT00003907|561825277|FG001|Overall Study|Death|0|||
155653565|NCT00003907|561825276|FG000|Overall Study|Withdrawal by Subject|1|||
155653566|NCT00003907|561825277|FG001|Overall Study|Withdrawal by Subject|3|||
155653567|NCT00003907|561825276|FG000|Overall Study|Progressive disease|4|||
155653568|NCT00003907|561825277|FG001|Overall Study|Progressive disease|4|||
155653569|NCT00003907|561825276|FG000|Overall Study|Complicating disease|1|||
155653570|NCT00003907|561825277|FG001|Overall Study|Complicating disease|0|||
155653571|NCT00003907|561825276|FG000|Overall Study|Other|1|||
155653572|NCT00003907|561825277|FG001|Overall Study|Other|3|||
155653573|NCT00003907|561825276|FG000|Overall Study|ineligible or not treated|2|||
155653574|NCT00003907|561825277|FG001|Overall Study|ineligible or not treated|2|||
155653575|NCT00993473|561825280|FG000|Overall Study|Adverse Event|0|||
155653576|NCT00993473|561825281|FG001|Overall Study|Adverse Event|2|||
155653577|NCT00993473|561825280|FG000|Overall Study|Protocol Violation|1|||
155653578|NCT00993473|561825281|FG001|Overall Study|Protocol Violation|2|||
155653579|NCT00993473|561825280|FG000|Overall Study|Lost to Follow-up|1|||
155653580|NCT00993473|561825281|FG001|Overall Study|Lost to Follow-up|0|||
155653581|NCT00993473|561825280|FG000|Overall Study|Withdrawal by Subject|1|||
155653582|NCT00993473|561825281|FG001|Overall Study|Withdrawal by Subject|5|||
155653583|NCT00993473|561825280|FG000|Overall Study|Technical problem with CGM device|0|||
155653584|NCT00993473|561825281|FG001|Overall Study|Technical problem with CGM device|1|||
155653585|NCT00993473|561825280|FG000|Overall Study|Family event|1|||
155653586|NCT00993473|561825281|FG001|Overall Study|Family event|0|||
155653587|NCT00770679|561825284|FG000|Overall Study|Lost to Follow-up|3|||
155653588|NCT00770679|561825284|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
155653589|NCT00836901|561825286|FG000|First Intervention|Withdrawal by Subject|1|||
155653590|NCT00836901|561825287|FG001|First Intervention|Withdrawal by Subject|0|||
155653591|NCT01148771|561825288|FG000|Washout Period|Withdrawal by Subject|0|||
155653592|NCT01148771|561825289|FG001|Washout Period|Withdrawal by Subject|1|||
155653593|NCT01047540|561825290|FG000|Overall Study|Protocol Violation|1|||
155653594|NCT01047540|561825291|FG001|Overall Study|Protocol Violation|0|||
155653595|NCT01047540|561825292|FG002|Overall Study|Protocol Violation|0|||
155653596|NCT01047540|561825293|FG003|Overall Study|Protocol Violation|0|||
155653597|NCT01047540|561825294|FG004|Overall Study|Protocol Violation|0|||
155653598|NCT01047540|561825290|FG000|Overall Study|Lost to Follow-up|1|||
155653599|NCT01047540|561825291|FG001|Overall Study|Lost to Follow-up|0|||
155653600|NCT01047540|561825292|FG002|Overall Study|Lost to Follow-up|0|||
155653601|NCT01047540|561825293|FG003|Overall Study|Lost to Follow-up|0|||
155653602|NCT01047540|561825294|FG004|Overall Study|Lost to Follow-up|0|||
155653603|NCT01047540|561825290|FG000|Overall Study|Withdrawal by Subject|1|||
155653604|NCT01047540|561825291|FG001|Overall Study|Withdrawal by Subject|0|||
155653605|NCT01047540|561825292|FG002|Overall Study|Withdrawal by Subject|3|||
155653606|NCT01047540|561825293|FG003|Overall Study|Withdrawal by Subject|0|||
155653607|NCT01047540|561825294|FG004|Overall Study|Withdrawal by Subject|1|||
155653608|NCT01047540|561825290|FG000|Overall Study|Pregnancy|1|||
155653609|NCT01047540|561825291|FG001|Overall Study|Pregnancy|0|||
155653610|NCT01047540|561825292|FG002|Overall Study|Pregnancy|0|||
155653611|NCT01047540|561825293|FG003|Overall Study|Pregnancy|0|||
155653612|NCT01047540|561825294|FG004|Overall Study|Pregnancy|0|||
155653613|NCT01047540|561825290|FG000|Overall Study|Adverse Event|1|||
155653614|NCT01047540|561825291|FG001|Overall Study|Adverse Event|0|||
155653615|NCT01047540|561825292|FG002|Overall Study|Adverse Event|0|||
155653616|NCT01047540|561825293|FG003|Overall Study|Adverse Event|0|||
155653617|NCT01047540|561825294|FG004|Overall Study|Adverse Event|0|||
155653618|NCT03268499|561825295|FG000|Overall Study|Withdrawal by Subject|2|||
155653619|NCT03268499|561825296|FG001|Overall Study|Withdrawal by Subject|1|||
155653620|NCT05071027|561825297|FG000|Overall Study|Lost to Follow-up|1|||
155470511|NCT03619837|561144366|FG000|Screening|never listed for HCV-viremic donor|1|||
155470512|NCT03619837|561144366|FG000|Screening|developed exclusion criteria|2|||
155470513|NCT03619837|561144366|FG000|Screening|excluded by the investigator due to non-compliance|1|||
155470514|NCT04095793|561144367|FG000|Overall Study|Adverse Event|3|||
155470515|NCT04095793|561144367|FG000|Overall Study|Study Terminated by Sponsor|103|||
155470516|NCT04095793|561144367|FG000|Overall Study|Withdrawal by Subject|4|||
155470517|NCT01199198|561146769|FG000|Overall Study|Adverse Event|3|||
155470518|NCT01199198|561146770|FG001|Overall Study|Adverse Event|0|||
155470519|NCT01199198|561146769|FG000|Overall Study|Lost to Follow-up|1|||
155470520|NCT01199198|561146770|FG001|Overall Study|Lost to Follow-up|5|||
155470521|NCT01199198|561146769|FG000|Overall Study|Withdrawal by Subject|1|||
155470522|NCT01199198|561146770|FG001|Overall Study|Withdrawal by Subject|2|||
155470523|NCT01199198|561146769|FG000|Overall Study|ICU Transfer|1|||
155470524|NCT01199198|561146770|FG001|Overall Study|ICU Transfer|2|||
155470525|NCT01199198|561146769|FG000|Overall Study|Hospice-care transfer|1|||
155470526|NCT01199198|561146770|FG001|Overall Study|Hospice-care transfer|2|||
155470527|NCT04315298|561146771|FG000|Overall Study|Withdrawal by Subject|0|||
155470528|NCT04315298|561146772|FG001|Overall Study|Withdrawal by Subject|0|||
155470529|NCT04315298|561146773|FG002|Overall Study|Withdrawal by Subject|0|||
155470530|NCT04315298|561146774|FG003|Overall Study|Withdrawal by Subject|2|||
155470531|NCT04315298|561146775|FG004|Overall Study|Withdrawal by Subject|2|||
155470532|NCT04315298|561146776|FG005|Overall Study|Withdrawal by Subject|2|||
155470533|NCT04315298|561146777|FG006|Overall Study|Withdrawal by Subject|0|||
155470534|NCT04315298|561146778|FG007|Overall Study|Withdrawal by Subject|1|||
155470535|NCT04315298|561146779|FG008|Overall Study|Withdrawal by Subject|1|||
155470536|NCT04315298|561146780|FG009|Overall Study|Withdrawal by Subject|1|||
155470537|NCT04315298|561146781|FG010|Overall Study|Withdrawal by Subject|0|||
155470538|NCT04315298|561146782|FG011|Overall Study|Withdrawal by Subject|0|||
155470539|NCT04315298|561146783|FG012|Overall Study|Withdrawal by Subject|0|||
155470540|NCT04315298|561146784|FG013|Overall Study|Withdrawal by Subject|0|||
155470541|NCT04315298|561146785|FG014|Overall Study|Withdrawal by Subject|0|||
155470542|NCT04315298|561146786|FG015|Overall Study|Withdrawal by Subject|0|||
155470543|NCT04315298|561146787|FG016|Overall Study|Withdrawal by Subject|0|||
155470544|NCT04315298|561146788|FG017|Overall Study|Withdrawal by Subject|0|||
155470545|NCT04315298|561146789|FG018|Overall Study|Withdrawal by Subject|0|||
155470546|NCT04315298|561146771|FG000|Overall Study|Physician Decision|0|||
155470547|NCT04315298|561146772|FG001|Overall Study|Physician Decision|0|||
155470548|NCT04315298|561146773|FG002|Overall Study|Physician Decision|0|||
155470549|NCT04315298|561146774|FG003|Overall Study|Physician Decision|0|||
155470550|NCT04315298|561146775|FG004|Overall Study|Physician Decision|1|||
155470551|NCT04315298|561146776|FG005|Overall Study|Physician Decision|0|||
155470552|NCT04315298|561146777|FG006|Overall Study|Physician Decision|0|||
155470553|NCT04315298|561146778|FG007|Overall Study|Physician Decision|0|||
155470554|NCT04315298|561146779|FG008|Overall Study|Physician Decision|0|||
155470555|NCT04315298|561146780|FG009|Overall Study|Physician Decision|0|||
155470556|NCT04315298|561146781|FG010|Overall Study|Physician Decision|0|||
155470557|NCT04315298|561146782|FG011|Overall Study|Physician Decision|0|||
155470558|NCT04315298|561146783|FG012|Overall Study|Physician Decision|0|||
155470559|NCT04315298|561146784|FG013|Overall Study|Physician Decision|0|||
155470560|NCT04315298|561146785|FG014|Overall Study|Physician Decision|0|||
155470561|NCT04315298|561146786|FG015|Overall Study|Physician Decision|0|||
155470562|NCT04315298|561146787|FG016|Overall Study|Physician Decision|0|||
155470563|NCT04315298|561146788|FG017|Overall Study|Physician Decision|0|||
155470564|NCT04315298|561146789|FG018|Overall Study|Physician Decision|0|||
155470565|NCT04315298|561146771|FG000|Overall Study|Lost to Follow-up|5|||
155470566|NCT04315298|561146772|FG001|Overall Study|Lost to Follow-up|10|||
155470567|NCT04315298|561146773|FG002|Overall Study|Lost to Follow-up|6|||
155470568|NCT04315298|561146774|FG003|Overall Study|Lost to Follow-up|8|||
155470569|NCT04315298|561146775|FG004|Overall Study|Lost to Follow-up|12|||
155470570|NCT04315298|561146776|FG005|Overall Study|Lost to Follow-up|13|||
155470571|NCT04315298|561146777|FG006|Overall Study|Lost to Follow-up|9|||
155470572|NCT04315298|561146778|FG007|Overall Study|Lost to Follow-up|16|||
155470573|NCT04315298|561146779|FG008|Overall Study|Lost to Follow-up|14|||
155470574|NCT04315298|561146780|FG009|Overall Study|Lost to Follow-up|0|||
155470575|NCT04315298|561146781|FG010|Overall Study|Lost to Follow-up|2|||
155470576|NCT04315298|561146782|FG011|Overall Study|Lost to Follow-up|1|||
155470577|NCT04315298|561146783|FG012|Overall Study|Lost to Follow-up|0|||
155470578|NCT04315298|561146784|FG013|Overall Study|Lost to Follow-up|0|||
155653621|NCT05071027|561825298|FG001|Overall Study|Lost to Follow-up|4|||
155470579|NCT04315298|561146785|FG014|Overall Study|Lost to Follow-up|0|||
155470580|NCT04315298|561146786|FG015|Overall Study|Lost to Follow-up|2|||
155470581|NCT04315298|561146787|FG016|Overall Study|Lost to Follow-up|0|||
155470582|NCT04315298|561146788|FG017|Overall Study|Lost to Follow-up|0|||
155470583|NCT04315298|561146789|FG018|Overall Study|Lost to Follow-up|0|||
155470584|NCT04315298|561146771|FG000|Overall Study|Death|24|||
155470585|NCT04315298|561146772|FG001|Overall Study|Death|60|||
155470586|NCT04315298|561146773|FG002|Overall Study|Death|49|||
155470587|NCT04315298|561146774|FG003|Overall Study|Death|59|||
155470588|NCT04315298|561146775|FG004|Overall Study|Death|70|||
155653622|NCT04576481|561825299|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
155653623|NCT04576481|561825300|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
155653624|NCT04576481|561825301|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
155653625|NCT04576481|561825302|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
155653626|NCT00595075|561825313|FG000|Overall Study|Withdrawal by Subject|1|||
155653627|NCT00595075|561825314|FG001|Overall Study|Withdrawal by Subject|0|||
155653628|NCT05261490|561825317|FG000|Overall Study|Other|1|||
155653629|NCT05261490|561825318|FG001|Overall Study|Other|0|||
155653630|NCT05261490|561825319|FG002|Overall Study|Other|0|||
155653631|NCT05261490|561825317|FG000|Overall Study|Study Terminated by Sponsor|1|||
155653632|NCT05261490|561825318|FG001|Overall Study|Study Terminated by Sponsor|1|||
155653633|NCT05261490|561825319|FG002|Overall Study|Study Terminated by Sponsor|4|||
155653634|NCT05261490|561825317|FG000|Overall Study|Death|1|||
155653635|NCT05261490|561825318|FG001|Overall Study|Death|2|||
155653636|NCT05261490|561825319|FG002|Overall Study|Death|0|||
155653637|NCT01682720|561825323|FG000|Overall Study|Randomized but Not Treated|0|||
155653638|NCT01682720|561825324|FG001|Overall Study|Randomized but Not Treated|1|||
155653639|NCT01682720|561825325|FG002|Overall Study|Randomized but Not Treated|1|||
155653640|NCT01682720|561825326|FG003|Overall Study|Randomized but Not Treated|0|||
155653641|NCT01682720|561825323|FG000|Overall Study|Terminated by Sponsor|83|||
155653642|NCT01682720|561825324|FG001|Overall Study|Terminated by Sponsor|0|||
155653643|NCT01682720|561825325|FG002|Overall Study|Terminated by Sponsor|0|||
155653644|NCT01682720|561825326|FG003|Overall Study|Terminated by Sponsor|0|||
155653645|NCT01682720|561825323|FG000|Overall Study|Efficacy Failure|0|||
155653646|NCT01682720|561825324|FG001|Overall Study|Efficacy Failure|3|||
155653647|NCT01682720|561825325|FG002|Overall Study|Efficacy Failure|3|||
155653648|NCT01682720|561825326|FG003|Overall Study|Efficacy Failure|30|||
155518580|NCT06179108|561323050|FG001|Overall Study|Adverse Event|3|||
155518581|NCT06179108|561323051|FG002|Overall Study|Adverse Event|3|||
155518582|NCT06179108|561323052|FG003|Overall Study|Adverse Event|2|||
155518583|NCT06179108|561323049|FG000|Overall Study|Protocol Violation|0|||
155518584|NCT06179108|561323050|FG001|Overall Study|Protocol Violation|1|||
155518585|NCT06179108|561323051|FG002|Overall Study|Protocol Violation|0|||
155518586|NCT06179108|561323052|FG003|Overall Study|Protocol Violation|1|||
155518587|NCT06179108|561323049|FG000|Overall Study|Physician Decision|1|||
155518588|NCT06179108|561323050|FG001|Overall Study|Physician Decision|1|||
155518589|NCT06179108|561323051|FG002|Overall Study|Physician Decision|0|||
155518590|NCT06179108|561323052|FG003|Overall Study|Physician Decision|0|||
155518591|NCT06179108|561323049|FG000|Overall Study|Lack of Efficacy|0|||
155653649|NCT01682720|561825323|FG000|Overall Study|Lost to Follow-up|1|||
155653650|NCT01682720|561825324|FG001|Overall Study|Lost to Follow-up|1|||
155653651|NCT01682720|561825325|FG002|Overall Study|Lost to Follow-up|0|||
155653652|NCT01682720|561825326|FG003|Overall Study|Lost to Follow-up|6|||
155653653|NCT01682720|561825323|FG000|Overall Study|Subject Withdrew Consent|0|||
155653654|NCT01682720|561825324|FG001|Overall Study|Subject Withdrew Consent|0|||
155653655|NCT01682720|561825325|FG002|Overall Study|Subject Withdrew Consent|2|||
155653656|NCT01682720|561825326|FG003|Overall Study|Subject Withdrew Consent|2|||
155653657|NCT01682720|561825323|FG000|Overall Study|Adverse Event|1|||
155653658|NCT01682720|561825324|FG001|Overall Study|Adverse Event|0|||
155653659|NCT01682720|561825325|FG002|Overall Study|Adverse Event|1|||
155653660|NCT01682720|561825326|FG003|Overall Study|Adverse Event|1|||
155653661|NCT01687595|561825327|FG000|Overall Study|Withdrawal by Subject|8|||
155653662|NCT01687595|561825328|FG001|Overall Study|Withdrawal by Subject|0|||
155653663|NCT01687595|561825327|FG000|Overall Study|Lost to Follow-up|3|||
155653664|NCT01687595|561825328|FG001|Overall Study|Lost to Follow-up|1|||
155653665|NCT01687595|561825327|FG000|Overall Study|Investigator's decision|1|||
155653666|NCT01687595|561825328|FG001|Overall Study|Investigator's decision|0|||
155653667|NCT01687595|561825327|FG000|Overall Study|Sponsor's decision|1|||
155653668|NCT01687595|561825328|FG001|Overall Study|Sponsor's decision|0|||
155653669|NCT01687595|561825327|FG000|Overall Study|Noncompliance|1|||
155653670|NCT01687595|561825328|FG001|Overall Study|Noncompliance|2|||
155653671|NCT01687595|561825327|FG000|Overall Study|Other than specified|56|||
155653672|NCT01687595|561825328|FG001|Overall Study|Other than specified|7|||
155653673|NCT04204902|561825329|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
155653674|NCT04204902|561825330|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
155653675|NCT05451329|561825331|FG000|Overall Study|Adverse Event|1|||
155653676|NCT05451329|561825332|FG001|Overall Study|Adverse Event|1|||
155653677|NCT05451329|561825333|FG002|Overall Study|Adverse Event|0|||
155653678|NCT05451329|561825331|FG000|Overall Study|Withdrawal by Subject|1|||
155653679|NCT05451329|561825332|FG001|Overall Study|Withdrawal by Subject|0|||
155653680|NCT05451329|561825333|FG002|Overall Study|Withdrawal by Subject|0|||
155653681|NCT05451329|561825331|FG000|Overall Study|Investigational Product Lot exchange|1|||
155653682|NCT05451329|561825332|FG001|Overall Study|Investigational Product Lot exchange|1|||
155653683|NCT05451329|561825333|FG002|Overall Study|Investigational Product Lot exchange|0|||
155653684|NCT00069953|561825334|FG000|Overall Study|Protocol Violation|2|||
155653685|NCT03253627|561825337|FG000|Overall Study|Lost to Follow-up|1|||
155653686|NCT03253627|561825338|FG001|Overall Study|Lost to Follow-up|2|||
155653687|NCT03253627|561825337|FG000|Overall Study|Withdrawal by Subject|0|||
155653688|NCT03253627|561825338|FG001|Overall Study|Withdrawal by Subject|2|||
155653689|NCT03253627|561825337|FG000|Overall Study|Inability to complete MRI|1|||
155653690|NCT03253627|561825338|FG001|Overall Study|Inability to complete MRI|0|||
155653691|NCT03829683|561825339|FG000|Overall Study|Lost to Follow-up|1|||
155653692|NCT03829683|561825340|FG001|Overall Study|Lost to Follow-up|0|||
155653693|NCT03829683|561825339|FG000|Overall Study|Physician Decision|3|||
155653694|NCT03829683|561825340|FG001|Overall Study|Physician Decision|1|||
155653695|NCT03829683|561825339|FG000|Overall Study|Withdrawal by Subject|0|||
155653696|NCT03829683|561825340|FG001|Overall Study|Withdrawal by Subject|1|||
155653697|NCT03829683|561825339|FG000|Overall Study|Discharge from hospital|1|||
155653698|NCT03829683|561825340|FG001|Overall Study|Discharge from hospital|0|||
155653699|NCT03460704|561825347|FG000|Overall Study|Withdrawal by Subject|11|||
155653700|NCT03460704|561825348|FG001|Overall Study|Withdrawal by Subject|14|||
155653701|NCT03460704|561825347|FG000|Overall Study|Study terminated by the Sponsor|29|||
155653702|NCT03460704|561825348|FG001|Overall Study|Study terminated by the Sponsor|19|||
155653703|NCT03460704|561825347|FG000|Overall Study|Adverse Event|10|||
155653704|NCT03460704|561825348|FG001|Overall Study|Adverse Event|5|||
155653705|NCT03460704|561825347|FG000|Overall Study|Death|3|||
155653706|NCT03460704|561825348|FG001|Overall Study|Death|2|||
155653707|NCT03460704|561825347|FG000|Overall Study|Non-Compliance with Study Drug|3|||
155653708|NCT03460704|561825348|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155653709|NCT03460704|561825347|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155653710|NCT03460704|561825348|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
155653711|NCT03460704|561825347|FG000|Overall Study|Other|2|||
155653712|NCT03460704|561825348|FG001|Overall Study|Other|1|||
155653713|NCT01767857|561825349|FG000|Overall Study|Adverse Event|27|||
155653714|NCT01767857|561825350|FG001|Overall Study|Adverse Event|7|||
155653715|NCT01767857|561825349|FG000|Overall Study|Death|28|||
155653716|NCT01767857|561825350|FG001|Overall Study|Death|13|||
155653717|NCT01767857|561825349|FG000|Overall Study|Lack of Efficacy|299|||
155653718|NCT01767857|561825350|FG001|Overall Study|Lack of Efficacy|151|||
155653719|NCT01767857|561825349|FG000|Overall Study|Lost to Follow-up|1|||
155653720|NCT01767857|561825350|FG001|Overall Study|Lost to Follow-up|1|||
155653721|NCT01767857|561825349|FG000|Overall Study|Withdrawal by Subject|38|||
155653722|NCT01767857|561825350|FG001|Overall Study|Withdrawal by Subject|18|||
155653723|NCT01767857|561825349|FG000|Overall Study|Physician Decision|17|||
155653724|NCT01767857|561825350|FG001|Overall Study|Physician Decision|10|||
155653725|NCT01767857|561825349|FG000|Overall Study|Protocol Terminated|1|||
155653726|NCT01767857|561825350|FG001|Overall Study|Protocol Terminated|0|||
155653727|NCT01767857|561825349|FG000|Overall Study|Randomized But Never Treated|19|||
155653728|NCT01767857|561825350|FG001|Overall Study|Randomized But Never Treated|13|||
155653729|NCT02899754|561825351|FG000|Overall Study|Lost to Follow-up|7|||
155653730|NCT02899754|561825352|FG001|Overall Study|Lost to Follow-up|9|||
155470589|NCT04315298|561146776|FG005|Overall Study|Death|114|||
155653731|NCT04082364|561825353|FG000|Overall Study|Death|23|||
155653732|NCT04082364|561825354|FG001|Overall Study|Death|1|||
155653733|NCT04082364|561825355|FG002|Overall Study|Death|1|||
155653734|NCT04082364|561825356|FG003|Overall Study|Death|2|||
155653735|NCT04082364|561825357|FG004|Overall Study|Death|1|||
155653736|NCT04082364|561825353|FG000|Overall Study|Lost to Follow-up|1|||
155653737|NCT04082364|561825354|FG001|Overall Study|Lost to Follow-up|0|||
155653738|NCT04082364|561825355|FG002|Overall Study|Lost to Follow-up|0|||
155653739|NCT04082364|561825356|FG003|Overall Study|Lost to Follow-up|0|||
155653740|NCT04082364|561825357|FG004|Overall Study|Lost to Follow-up|1|||
155653741|NCT04082364|561825353|FG000|Overall Study|Physician Decision|1|||
155653742|NCT04082364|561825354|FG001|Overall Study|Physician Decision|1|||
155653743|NCT04082364|561825355|FG002|Overall Study|Physician Decision|0|||
155653744|NCT04082364|561825356|FG003|Overall Study|Physician Decision|2|||
155653745|NCT04082364|561825357|FG004|Overall Study|Physician Decision|1|||
155653746|NCT04082364|561825353|FG000|Overall Study|Withdrawal by Subject|1|||
155653747|NCT04082364|561825354|FG001|Overall Study|Withdrawal by Subject|1|||
155653748|NCT04082364|561825355|FG002|Overall Study|Withdrawal by Subject|0|||
155653749|NCT04082364|561825356|FG003|Overall Study|Withdrawal by Subject|0|||
155653750|NCT04082364|561825357|FG004|Overall Study|Withdrawal by Subject|1|||
155653751|NCT04082364|561825353|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
155653752|NCT04082364|561825354|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
155653753|NCT04082364|561825355|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
155653754|NCT04082364|561825356|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
155653755|NCT04082364|561825357|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
155653756|NCT04082364|561825353|FG000|Overall Study|Disease progression|0|||
155653757|NCT04082364|561825354|FG001|Overall Study|Disease progression|0|||
155653758|NCT04082364|561825355|FG002|Overall Study|Disease progression|0|||
155653759|NCT04082364|561825356|FG003|Overall Study|Disease progression|1|||
155653760|NCT04082364|561825357|FG004|Overall Study|Disease progression|0|||
155653761|NCT02514746|561825362|FG000|Overall Study|Chronically Ill|1|||
155653762|NCT02514746|561825363|FG001|Overall Study|Chronically Ill|2|||
155653763|NCT02514746|561825362|FG000|Overall Study|Physician Decision|4|||
155653764|NCT02514746|561825363|FG001|Overall Study|Physician Decision|2|||
155653765|NCT02514746|561825362|FG000|Overall Study|Withdrawal by Subject|12|||
155653766|NCT02514746|561825363|FG001|Overall Study|Withdrawal by Subject|10|||
155653767|NCT02514746|561825362|FG000|Overall Study|Other|5|||
155653768|NCT02514746|561825363|FG001|Overall Study|Other|1|||
155653769|NCT04003142|561825364|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
155653770|NCT04003142|561825365|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
155653771|NCT04003142|561825366|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
155653772|NCT04003142|561825367|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
155653773|NCT04003142|561825368|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
155653774|NCT04003142|561825364|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
155653775|NCT04003142|561825365|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
155653776|NCT04003142|561825366|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
155653777|NCT04003142|561825367|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
155653778|NCT04003142|561825368|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
155653779|NCT04003142|561825364|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
155653780|NCT04003142|561825365|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
155653781|NCT04003142|561825366|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155653782|NCT04003142|561825367|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155653783|NCT04003142|561825368|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155653784|NCT04003142|561825364|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
155470590|NCT04315298|561146777|FG006|Overall Study|Death|9|||
155653785|NCT04003142|561825365|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
155653786|NCT04003142|561825366|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
155653787|NCT04003142|561825367|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
155653788|NCT04003142|561825368|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
155653789|NCT04003142|561825364|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
155653790|NCT04003142|561825365|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
155653791|NCT04003142|561825366|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
155653792|NCT04003142|561825367|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
155653793|NCT04003142|561825368|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
155470591|NCT04315298|561146778|FG007|Overall Study|Death|12|||
155470592|NCT04315298|561146779|FG008|Overall Study|Death|21|||
155470593|NCT04315298|561146780|FG009|Overall Study|Death|16|||
155470594|NCT04315298|561146781|FG010|Overall Study|Death|40|||
155470595|NCT04315298|561146782|FG011|Overall Study|Death|40|||
155470596|NCT04315298|561146783|FG012|Overall Study|Death|3|||
155470597|NCT04315298|561146784|FG013|Overall Study|Death|4|||
155470598|NCT04315298|561146785|FG014|Overall Study|Death|6|||
155470599|NCT04315298|561146786|FG015|Overall Study|Death|4|||
155470600|NCT04315298|561146787|FG016|Overall Study|Death|3|||
155470601|NCT04315298|561146788|FG017|Overall Study|Death|1|||
155470602|NCT04315298|561146789|FG018|Overall Study|Death|0|||
155470603|NCT03267511|561146790|FG000|Overall Study|Lost to Follow-up|0|||
155470604|NCT03267511|561146791|FG001|Overall Study|Lost to Follow-up|0|||
155470605|NCT03267511|561146792|FG002|Overall Study|Lost to Follow-up|0|||
155470606|NCT03267511|561146793|FG003|Overall Study|Lost to Follow-up|1|||
155470607|NCT01977040|561146795|FG000|Overall Study|Vasa previa not confirmed|2|||
155470608|NCT02000219|561146796|FG000|14-Week Study Period|Physician Decision|1|||
155470609|NCT02000219|561146796|FG000|14-Week Study Period|Adverse Event|1|||
155470610|NCT02000219|561146796|FG000|14-Week Study Period|Underwent transplantation|1|||
155470611|NCT02000219|561146796|FG000|Continuation Period|Withdrawal by Subject|1|||
155470612|NCT02000219|561146796|FG000|Continuation Period|Had liver transplant|2|||
155470613|NCT02000219|561146796|FG000|Continuation Period|Non-compliance with study drug|2|||
155470614|NCT02667236|561146797|FG000|Overall Study|Adverse Event|1|||
155470615|NCT02667236|561146798|FG001|Overall Study|Adverse Event|1|||
155470616|NCT02667236|561146797|FG000|Overall Study|Withdrawal by Subject|2|||
155470617|NCT02667236|561146798|FG001|Overall Study|Withdrawal by Subject|0|||
155470618|NCT00634751|561146800|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
155470619|NCT00634751|561146801|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
155470620|NCT00634751|561146802|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
155470621|NCT00634751|561146803|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
155470622|NCT00634751|561146800|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
155470623|NCT00634751|561146801|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
155470624|NCT00634751|561146802|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
155470625|NCT00634751|561146803|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
155470626|NCT00634751|561146800|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
155470627|NCT00634751|561146801|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
155470628|NCT00634751|561146802|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
155470629|NCT00634751|561146803|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
155470630|NCT01572844|561146804|FG000|Overall Study|Physician Decision|1|||
155470631|NCT01572844|561146805|FG001|Overall Study|Physician Decision|1|||
155470632|NCT03654560|561146814|FG000|Overall Study|Death|3|||
155470633|NCT03654560|561146815|FG001|Overall Study|Death|1|||
155470634|NCT03654560|561146814|FG000|Overall Study|Lost to Follow-up|1|||
155470635|NCT03654560|561146815|FG001|Overall Study|Lost to Follow-up|0|||
155470636|NCT00209092|561146816|FG000|Overall Study|Progression of disease|7|||
155470637|NCT00209092|561146817|FG001|Overall Study|Progression of disease|1|||
155470638|NCT00209092|561146816|FG000|Overall Study|Adverse Event|0|||
155470639|NCT00209092|561146817|FG001|Overall Study|Adverse Event|1|||
155470640|NCT00209092|561146816|FG000|Overall Study|Withdrawal by Subject|1|||
155470641|NCT00209092|561146817|FG001|Overall Study|Withdrawal by Subject|0|||
155470642|NCT01235338|561146818|FG000|Overall Study|Adverse Event|3|||
155470643|NCT01235338|561146819|FG001|Overall Study|Adverse Event|2|||
155470644|NCT01235338|561146818|FG000|Overall Study|Protocol Violation|1|||
155470645|NCT01235338|561146819|FG001|Overall Study|Protocol Violation|1|||
155470646|NCT01235338|561146818|FG000|Overall Study|Withdrawal by Subject|5|||
155470647|NCT01235338|561146819|FG001|Overall Study|Withdrawal by Subject|0|||
155470648|NCT01235338|561146818|FG000|Overall Study|Exclusion criteria violations|1|||
155470649|NCT01235338|561146819|FG001|Overall Study|Exclusion criteria violations|1|||
155470650|NCT01235338|561146818|FG000|Overall Study|Positive drug screen|0|||
155470651|NCT01235338|561146819|FG001|Overall Study|Positive drug screen|1|||
155470652|NCT01235338|561146818|FG000|Overall Study|Prohibited meds|1|||
155470653|NCT01235338|561146819|FG001|Overall Study|Prohibited meds|0|||
155470654|NCT05283499|561146820|FG000|Overall Study|Did not receive intervention|1|||
155470655|NCT05283499|561146821|FG001|Overall Study|Did not receive intervention|2|||
155470656|NCT02996110|561146822|FG000|Pre-Treatment|Other Reasons|0|||
155470657|NCT02996110|561146823|FG001|Pre-Treatment|Other Reasons|1|||
155470658|NCT02996110|561146824|FG002|Pre-Treatment|Other Reasons|0|||
155470659|NCT02996110|561146825|FG003|Pre-Treatment|Other Reasons|0|||
155470660|NCT02996110|561146826|FG004|Pre-Treatment|Other Reasons|1|||
155470661|NCT02996110|561146822|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
155470662|NCT02996110|561146823|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
155470663|NCT02996110|561146824|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
155470664|NCT02996110|561146825|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
155470665|NCT02996110|561146826|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
155470666|NCT02996110|561146822|FG000|Track 1|Disease Progression|15|||
155470667|NCT02996110|561146823|FG001|Track 1|Disease Progression|17|||
155470668|NCT02996110|561146824|FG002|Track 1|Disease Progression|0|||
155470669|NCT02996110|561146825|FG003|Track 1|Disease Progression|0|||
155470670|NCT02996110|561146826|FG004|Track 1|Disease Progression|0|||
155518592|NCT06179108|561323050|FG001|Overall Study|Lack of Efficacy|0|||
155518593|NCT06179108|561323051|FG002|Overall Study|Lack of Efficacy|0|||
155518594|NCT06179108|561323052|FG003|Overall Study|Lack of Efficacy|1|||
155518595|NCT06179108|561323049|FG000|Overall Study|Death|0|||
155518596|NCT06179108|561323050|FG001|Overall Study|Death|0|||
155518597|NCT06179108|561323051|FG002|Overall Study|Death|0|||
155518598|NCT06179108|561323052|FG003|Overall Study|Death|1|||
155518599|NCT02364557|561323056|FG000|Overall Study|Protocol Violation|3|||
155518600|NCT02364557|561323057|FG001|Overall Study|Protocol Violation|1|||
155518601|NCT04347239|561323058|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
155518602|NCT04347239|561323059|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
155518603|NCT04347239|561323060|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
155518604|NCT04347239|561323058|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
155470671|NCT02996110|561146822|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
155470672|NCT02996110|561146823|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
155470673|NCT02996110|561146824|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
155470674|NCT02996110|561146825|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
155470675|NCT02996110|561146826|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
155470676|NCT02996110|561146822|FG000|Track 1|Study Drug Toxicity|5|||
155470677|NCT02996110|561146823|FG001|Track 1|Study Drug Toxicity|3|||
155470678|NCT02996110|561146824|FG002|Track 1|Study Drug Toxicity|0|||
155470679|NCT02996110|561146825|FG003|Track 1|Study Drug Toxicity|0|||
155470680|NCT02996110|561146826|FG004|Track 1|Study Drug Toxicity|0|||
155470681|NCT02996110|561146822|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
155470682|NCT02996110|561146823|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
155470683|NCT02996110|561146824|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
155470684|NCT02996110|561146825|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
155518605|NCT04347239|561323059|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
155518606|NCT04347239|561323060|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
155518607|NCT02153736|561323075|FG000|Overall Study|Lost to Follow-up|1|||
155518608|NCT02153736|561323076|FG001|Overall Study|Lost to Follow-up|0|||
155518609|NCT02153736|561323075|FG000|Overall Study|Medical status change made ineligible|1|||
155518610|NCT02153736|561323076|FG001|Overall Study|Medical status change made ineligible|0|||
155518611|NCT02153736|561323075|FG000|Overall Study|Death|0|||
155518612|NCT02153736|561323076|FG001|Overall Study|Death|1|||
155518613|NCT02153736|561323075|FG000|Overall Study|Withdrawal by Subject|0|||
155518614|NCT02153736|561323076|FG001|Overall Study|Withdrawal by Subject|1|||
155518615|NCT02568384|561323077|FG000|Overall Study|Mobile devices incompatible with App|2|||
155518616|NCT00796510|561323078|FG000|Overall Study|Death|1|||
155518617|NCT00796510|561323079|FG001|Overall Study|Death|0|||
155518618|NCT00796510|561323078|FG000|Overall Study|Study Terminated|2|||
155518619|NCT00796510|561323079|FG001|Overall Study|Study Terminated|0|||
155518620|NCT01734772|561323080|FG000|Overall Study|Adverse Event|1|||
155518621|NCT01734772|561323081|FG001|Overall Study|Adverse Event|2|||
155518622|NCT01734772|561323080|FG000|Overall Study|Withdrawal by Subject|0|||
155518623|NCT01734772|561323081|FG001|Overall Study|Withdrawal by Subject|1|||
155518624|NCT01139164|561323082|FG000|Overall Study|Withdrawn prior to study start|0|||
155518625|NCT01139164|561323083|FG001|Overall Study|Withdrawn prior to study start|2|||
155518626|NCT01139164|561323084|FG002|Overall Study|Withdrawn prior to study start|0|||
155518627|NCT01790568|561323085|FG000|Overall Study|Progression prior to transplant|0|||
155518628|NCT01790568|561323086|FG001|Overall Study|Progression prior to transplant|1|||
155518629|NCT03184441|561323087|FG000|Overall Study|Withdrawal by Subject|1|||
155518630|NCT02994056|561323088|FG000|Overall Study|Death|8|||
155518631|NCT02994056|561323088|FG000|Overall Study|Withdrew Consent|1|||
155518632|NCT00979628|561323089|FG000|Overall Study|received regimen < 24 hours|7|||
155518633|NCT00979628|561323090|FG001|Overall Study|received regimen < 24 hours|6|||
155518634|NCT00979628|561323091|FG002|Overall Study|received regimen < 24 hours|5|||
155518635|NCT00979628|561323089|FG000|Overall Study|received steroids|1|||
155518636|NCT00979628|561323090|FG001|Overall Study|received steroids|1|||
155470685|NCT02996110|561146826|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
155470686|NCT02996110|561146822|FG000|Track 1|Administrative Reason by Sponsor|0|||
155470687|NCT02996110|561146823|FG001|Track 1|Administrative Reason by Sponsor|1|||
155470688|NCT02996110|561146824|FG002|Track 1|Administrative Reason by Sponsor|0|||
155518637|NCT00979628|561323091|FG002|Overall Study|received steroids|0|||
155470689|NCT02996110|561146825|FG003|Track 1|Administrative Reason by Sponsor|0|||
155518638|NCT00979628|561323089|FG000|Overall Study|transferred to ICU|1|||
155518639|NCT00979628|561323090|FG001|Overall Study|transferred to ICU|2|||
155518640|NCT00979628|561323091|FG002|Overall Study|transferred to ICU|1|||
155518641|NCT00911859|561323092|FG000|Treatment Period|Adverse Event|3|||
155518642|NCT00911859|561323093|FG001|Treatment Period|Adverse Event|3|||
155470690|NCT02996110|561146826|FG004|Track 1|Administrative Reason by Sponsor|0|||
155518643|NCT00911859|561323094|FG002|Treatment Period|Adverse Event|7|||
155518644|NCT00911859|561323092|FG000|Treatment Period|Death|1|||
155518645|NCT00911859|561323093|FG001|Treatment Period|Death|3|||
155518646|NCT00911859|561323094|FG002|Treatment Period|Death|5|||
155518647|NCT00911859|561323092|FG000|Treatment Period|Lack of Efficacy|1|||
155518648|NCT00911859|561323093|FG001|Treatment Period|Lack of Efficacy|7|||
155518649|NCT00911859|561323094|FG002|Treatment Period|Lack of Efficacy|5|||
155518650|NCT00911859|561323092|FG000|Treatment Period|Physician Decision|3|||
155518651|NCT00911859|561323093|FG001|Treatment Period|Physician Decision|3|||
155518652|NCT00911859|561323094|FG002|Treatment Period|Physician Decision|3|||
155518653|NCT00911859|561323092|FG000|Treatment Period|Withdrawal by Subject|0|||
155518654|NCT00911859|561323093|FG001|Treatment Period|Withdrawal by Subject|4|||
155518655|NCT00911859|561323094|FG002|Treatment Period|Withdrawal by Subject|5|||
155518656|NCT00911859|561323092|FG000|Treatment Period|Did not receive study treatment|0|||
155518657|NCT00911859|561323093|FG001|Treatment Period|Did not receive study treatment|1|||
155518658|NCT00911859|561323094|FG002|Treatment Period|Did not receive study treatment|0|||
155518659|NCT00911859|561323092|FG000|Maintainance Period|Lack of Efficacy|0|||
155518660|NCT00911859|561323093|FG001|Maintainance Period|Lack of Efficacy|0|||
155518661|NCT00911859|561323094|FG002|Maintainance Period|Lack of Efficacy|9|||
155518662|NCT00911859|561323092|FG000|Maintainance Period|Physician Decision|0|||
155518663|NCT00911859|561323093|FG001|Maintainance Period|Physician Decision|0|||
155518664|NCT00911859|561323094|FG002|Maintainance Period|Physician Decision|9|||
155518665|NCT00911859|561323092|FG000|Maintainance Period|Withdrawal by Subject|0|||
155518666|NCT00911859|561323093|FG001|Maintainance Period|Withdrawal by Subject|0|||
155518667|NCT00911859|561323094|FG002|Maintainance Period|Withdrawal by Subject|3|||
155518668|NCT00911859|561323092|FG000|Follow-up Period|Death|5|||
155518669|NCT00911859|561323093|FG001|Follow-up Period|Death|8|||
155518670|NCT00911859|561323094|FG002|Follow-up Period|Death|10|||
155518671|NCT00911859|561323092|FG000|Follow-up Period|Lost to Follow-up|1|||
155518672|NCT00911859|561323093|FG001|Follow-up Period|Lost to Follow-up|1|||
155518673|NCT00911859|561323094|FG002|Follow-up Period|Lost to Follow-up|0|||
155518674|NCT00911859|561323092|FG000|Follow-up Period|Withdrawal by Subject|0|||
155518675|NCT00911859|561323093|FG001|Follow-up Period|Withdrawal by Subject|4|||
155518676|NCT00911859|561323094|FG002|Follow-up Period|Withdrawal by Subject|4|||
155518677|NCT00911859|561323092|FG000|Follow-up Period|Study terminated by sponsor|5|||
155518678|NCT00911859|561323093|FG001|Follow-up Period|Study terminated by sponsor|33|||
155518679|NCT00911859|561323094|FG002|Follow-up Period|Study terminated by sponsor|27|||
155518680|NCT03008460|561323097|FG000|Overall Study|Protocol deviation|0|||
155518681|NCT03008460|561323098|FG001|Overall Study|Protocol deviation|2|||
155518682|NCT03008460|561323097|FG000|Overall Study|Study drug not dispensed|0|||
155518683|NCT03008460|561323098|FG001|Overall Study|Study drug not dispensed|1|||
155518684|NCT03008460|561323097|FG000|Overall Study|Adverse Event|0|||
155518685|NCT03008460|561323098|FG001|Overall Study|Adverse Event|1|||
155518686|NCT03008460|561323097|FG000|Overall Study|Withdrawal by Subject|5|||
155518687|NCT03008460|561323098|FG001|Overall Study|Withdrawal by Subject|6|||
155518688|NCT03008460|561323097|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
155518689|NCT03008460|561323098|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
155518690|NCT03008460|561323097|FG000|Overall Study|End of study visit outside permitted time window|0|||
155518691|NCT03008460|561323098|FG001|Overall Study|End of study visit outside permitted time window|1|||
155518692|NCT03008460|561323097|FG000|Overall Study|Lost to Follow-up|1|||
155518693|NCT03008460|561323098|FG001|Overall Study|Lost to Follow-up|3|||
155518694|NCT00767325|561323102|FG000|Overall Study|Lack of Efficacy|2|||
155518695|NCT00767325|561323102|FG000|Overall Study|Adverse Event|7|||
155518696|NCT00767325|561323102|FG000|Overall Study|Lost to Follow-up|3|||
155518697|NCT00767325|561323102|FG000|Overall Study|No longer met study criteria|2|||
155518698|NCT00767325|561323102|FG000|Overall Study|Missed visit due to family reasons|1|||
155518699|NCT03538756|561323103|FG000|Long-Term Follow-up|Adverse Event|0|||
155518700|NCT03538756|561323104|FG001|Long-Term Follow-up|Adverse Event|0|||
155518701|NCT03538756|561323105|FG002|Long-Term Follow-up|Adverse Event|6|||
155518702|NCT03538756|561323103|FG000|Long-Term Follow-up|Death|0|||
155518703|NCT03538756|561323104|FG001|Long-Term Follow-up|Death|0|||
155518704|NCT03538756|561323105|FG002|Long-Term Follow-up|Death|1|||
155518705|NCT03538756|561323103|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
155518706|NCT03538756|561323104|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
155518707|NCT03538756|561323105|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
155518708|NCT03538756|561323103|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
155518709|NCT03538756|561323104|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
155518710|NCT03538756|561323105|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
155518711|NCT03538756|561323103|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
155518712|NCT03538756|561323104|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
155518713|NCT03538756|561323105|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
155518714|NCT00752856|561323106|FG000|Overall Study|randomized but did not do viral kinetics|0|||
155518715|NCT00752856|561323107|FG001|Overall Study|randomized but did not do viral kinetics|1|||
155518716|NCT02688608|561323108|FG000|Overall Study|Lost to Follow-up|1|||
155518717|NCT04529109|561323110|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
155653794|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
155653795|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
155653796|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
155653797|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
155653798|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
155653799|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Death|0|||
155653800|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Death|0|||
155653801|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Death|0|||
155653802|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Death|0|||
155653803|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Death|1|||
155653804|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
155653805|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
155653806|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
155653807|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
155653808|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
155653809|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
155653810|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
155653811|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
155653812|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
155653813|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
155653814|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
155653815|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
155653816|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
155653817|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
155653818|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
155653819|NCT04003142|561825364|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
155653820|NCT04003142|561825365|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
155653821|NCT04003142|561825366|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
155653822|NCT04003142|561825367|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
155653823|NCT04003142|561825368|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
155653824|NCT03973489|561825371|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
155653825|NCT03973489|561825372|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155653826|NCT03973489|561825373|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155653827|NCT03973489|561825374|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155470691|NCT02996110|561146822|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
155470692|NCT02996110|561146823|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
155470693|NCT02996110|561146824|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
155653828|NCT03973489|561825375|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
155653829|NCT03973489|561825376|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155653830|NCT03973489|561825377|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155653831|NCT03973489|561825378|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155653832|NCT03973489|561825371|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653833|NCT03973489|561825372|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653834|NCT03973489|561825373|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653835|NCT03973489|561825374|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
155653836|NCT03973489|561825375|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
155653837|NCT03973489|561825376|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653838|NCT03973489|561825377|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653839|NCT03973489|561825378|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155653840|NCT03973489|561825371|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653841|NCT03973489|561825372|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653842|NCT03973489|561825373|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653843|NCT03973489|561825374|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653844|NCT03973489|561825375|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
155653845|NCT03973489|561825376|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653846|NCT03973489|561825377|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
155653847|NCT03973489|561825378|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
155653848|NCT03973489|561825371|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
155470694|NCT02996110|561146825|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
155470695|NCT02996110|561146826|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
155653849|NCT03973489|561825372|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155653850|NCT03973489|561825373|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155470696|NCT02996110|561146822|FG000|Track 2|Disease Progression|33|||
155470697|NCT02996110|561146823|FG001|Track 2|Disease Progression|26|||
155470698|NCT02996110|561146824|FG002|Track 2|Disease Progression|19|||
155470699|NCT02996110|561146825|FG003|Track 2|Disease Progression|16|||
155470700|NCT02996110|561146826|FG004|Track 2|Disease Progression|15|||
155470701|NCT02996110|561146822|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
155470702|NCT02996110|561146823|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
155470703|NCT02996110|561146824|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
155470704|NCT02996110|561146825|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
155470705|NCT02996110|561146826|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
155470706|NCT02996110|561146822|FG000|Track 2|Death|0|||
155470707|NCT02996110|561146823|FG001|Track 2|Death|0|||
155470708|NCT02996110|561146824|FG002|Track 2|Death|1|||
155470709|NCT02996110|561146825|FG003|Track 2|Death|0|||
155470710|NCT02996110|561146826|FG004|Track 2|Death|1|||
155470711|NCT02996110|561146822|FG000|Track 2|Study Drug Toxicity|4|||
155470712|NCT02996110|561146823|FG001|Track 2|Study Drug Toxicity|1|||
155470713|NCT02996110|561146824|FG002|Track 2|Study Drug Toxicity|4|||
155470714|NCT02996110|561146825|FG003|Track 2|Study Drug Toxicity|1|||
155470715|NCT02996110|561146826|FG004|Track 2|Study Drug Toxicity|0|||
155470716|NCT02996110|561146822|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
155470717|NCT02996110|561146823|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
155470718|NCT02996110|561146824|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
155470719|NCT02996110|561146825|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
155470720|NCT02996110|561146826|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
155470721|NCT02996110|561146822|FG000|Track 2|Participant Withdrew Consent|1|||
155470722|NCT02996110|561146823|FG001|Track 2|Participant Withdrew Consent|2|||
155470723|NCT02996110|561146824|FG002|Track 2|Participant Withdrew Consent|3|||
155470724|NCT02996110|561146825|FG003|Track 2|Participant Withdrew Consent|1|||
155470725|NCT02996110|561146826|FG004|Track 2|Participant Withdrew Consent|1|||
155470726|NCT02996110|561146822|FG000|Track 2|Other Reasons|0|||
155470727|NCT02996110|561146823|FG001|Track 2|Other Reasons|0|||
155470728|NCT02996110|561146824|FG002|Track 2|Other Reasons|1|||
155470729|NCT02996110|561146825|FG003|Track 2|Other Reasons|0|||
155470730|NCT02996110|561146826|FG004|Track 2|Other Reasons|1|||
155470731|NCT00524043|561146827|FG000|Overall Study|Lack of Efficacy|15|||
155470732|NCT00524043|561146828|FG001|Overall Study|Lack of Efficacy|13|||
155470733|NCT00524043|561146829|FG002|Overall Study|Lack of Efficacy|14|||
155470734|NCT00524043|561146827|FG000|Overall Study|Withdrawal by Subject|5|||
155470735|NCT00524043|561146828|FG001|Overall Study|Withdrawal by Subject|7|||
155470736|NCT00524043|561146829|FG002|Overall Study|Withdrawal by Subject|7|||
155470737|NCT00524043|561146827|FG000|Overall Study|Adverse Event|5|||
155470738|NCT00524043|561146828|FG001|Overall Study|Adverse Event|2|||
155470739|NCT00524043|561146829|FG002|Overall Study|Adverse Event|7|||
155470740|NCT00524043|561146827|FG000|Overall Study|Lost to Follow-up|3|||
155470741|NCT00524043|561146828|FG001|Overall Study|Lost to Follow-up|5|||
155470742|NCT00524043|561146829|FG002|Overall Study|Lost to Follow-up|3|||
155470743|NCT00524043|561146827|FG000|Overall Study|Various (eg, incarceration)|2|||
155470744|NCT00524043|561146828|FG001|Overall Study|Various (eg, incarceration)|1|||
155470745|NCT00524043|561146829|FG002|Overall Study|Various (eg, incarceration)|0|||
155470746|NCT03938636|561146830|FG000|Overall Study|Protocol Violation|0|||
155470747|NCT03938636|561146831|FG001|Overall Study|Protocol Violation|1|||
155470748|NCT03938636|561146832|FG002|Overall Study|Protocol Violation|1|||
155470749|NCT03938636|561146830|FG000|Overall Study|Subject withdrew due to death in family|0|||
155470750|NCT03938636|561146831|FG001|Overall Study|Subject withdrew due to death in family|1|||
155470751|NCT03938636|561146832|FG002|Overall Study|Subject withdrew due to death in family|0|||
155470752|NCT03938636|561146830|FG000|Overall Study|Missed visit|0|||
155653851|NCT03973489|561825374|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
155653852|NCT03973489|561825375|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155653853|NCT03973489|561825376|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155470753|NCT03938636|561146831|FG001|Overall Study|Missed visit|1|||
155470754|NCT03938636|561146832|FG002|Overall Study|Missed visit|0|||
155470755|NCT03938636|561146830|FG000|Overall Study|Adverse Event|0|||
155470756|NCT03938636|561146831|FG001|Overall Study|Adverse Event|0|||
155470757|NCT03938636|561146832|FG002|Overall Study|Adverse Event|1|||
155470758|NCT03938636|561146830|FG000|Overall Study|Lost to Follow-up|0|||
155470759|NCT03938636|561146831|FG001|Overall Study|Lost to Follow-up|0|||
155470760|NCT03938636|561146832|FG002|Overall Study|Lost to Follow-up|1|||
155470761|NCT02579863|561146833|FG000|Overall Study|Final Disposition Unknown|2|||
155653854|NCT03973489|561825377|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155470762|NCT02579863|561146834|FG001|Overall Study|Final Disposition Unknown|1|||
155470763|NCT02579863|561146833|FG000|Overall Study|Adverse Event|18|||
155470764|NCT02579863|561146834|FG001|Overall Study|Adverse Event|11|||
155470765|NCT02579863|561146833|FG000|Overall Study|Death|31|||
155470766|NCT02579863|561146834|FG001|Overall Study|Death|29|||
155470767|NCT02579863|561146833|FG000|Overall Study|Lost to Follow-up|2|||
155470768|NCT02579863|561146834|FG001|Overall Study|Lost to Follow-up|1|||
155470769|NCT02579863|561146833|FG000|Overall Study|Physician Decision|1|||
155470770|NCT02579863|561146834|FG001|Overall Study|Physician Decision|2|||
155470771|NCT02579863|561146833|FG000|Overall Study|Screen Failure|0|||
155653855|NCT03973489|561825378|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155653856|NCT03973489|561825371|FG000|Second Intervention (1 Day)|Adverse Event|0|||
155653857|NCT03973489|561825372|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155653858|NCT03973489|561825373|FG002|Second Intervention (1 Day)|Adverse Event|0|||
155653859|NCT03973489|561825374|FG003|Second Intervention (1 Day)|Adverse Event|1|||
155653860|NCT03973489|561825375|FG004|Second Intervention (1 Day)|Adverse Event|0|||
155653861|NCT03973489|561825376|FG005|Second Intervention (1 Day)|Adverse Event|0|||
155470772|NCT02579863|561146834|FG001|Overall Study|Screen Failure|2|||
155470773|NCT02579863|561146833|FG000|Overall Study|Study Terminated at Selected Sites|82|||
155653862|NCT03973489|561825377|FG006|Second Intervention (1 Day)|Adverse Event|0|||
155653863|NCT03973489|561825378|FG007|Second Intervention (1 Day)|Adverse Event|0|||
155653864|NCT03247673|561825379|FG000|Overall Study|Withdrawal by Subject|1|||
155653865|NCT03247673|561825380|FG001|Overall Study|Withdrawal by Subject|0|||
155653866|NCT03247673|561825381|FG002|Overall Study|Withdrawal by Subject|3|||
155653867|NCT03247673|561825379|FG000|Overall Study|Lost to Follow-up|0|||
155653868|NCT03247673|561825380|FG001|Overall Study|Lost to Follow-up|0|||
155653869|NCT03247673|561825381|FG002|Overall Study|Lost to Follow-up|1|||
155653870|NCT04754399|561825385|FG000|Overall Study|Adverse Event|5|||
155653871|NCT04754399|561825385|FG000|Overall Study|Withdrawal by Subject|6|||
155653872|NCT04105725|561825392|FG000|Primary Intervention|Lost to Follow-up|0|||
155653873|NCT04105725|561825393|FG001|Primary Intervention|Lost to Follow-up|2|||
155653874|NCT04105725|561825392|FG000|Primary Intervention|Withdrawal by Subject|0|||
155653875|NCT04105725|561825393|FG001|Primary Intervention|Withdrawal by Subject|1|||
155653876|NCT02691494|561825398|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
155653877|NCT02691494|561825399|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155653878|NCT02691494|561825400|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155653879|NCT02691494|561825398|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155653880|NCT02691494|561825399|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155653881|NCT02691494|561825400|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155653882|NCT02691494|561825398|FG000|Post-Treatment Follow-Up Period|Other|2|||
155653883|NCT02691494|561825399|FG001|Post-Treatment Follow-Up Period|Other|1|||
155653884|NCT02691494|561825400|FG002|Post-Treatment Follow-Up Period|Other|1|||
155653885|NCT02691494|561825398|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
155653886|NCT02691494|561825399|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
155653887|NCT02691494|561825400|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
155653888|NCT02691494|561825398|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155653889|NCT02691494|561825399|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155653890|NCT02691494|561825400|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155653891|NCT02916433|561825401|FG000|Overall Study|Withdrawal by Subject|1|||
155653892|NCT02916433|561825402|FG001|Overall Study|Withdrawal by Subject|0|||
155653893|NCT02916433|561825401|FG000|Overall Study|Physician Decision|1|||
155653894|NCT02916433|561825402|FG001|Overall Study|Physician Decision|0|||
155653895|NCT04616196|561826809|FG000|Overall Study|Progressive Disease|3|||
155653896|NCT04616196|561826810|FG001|Overall Study|Progressive Disease|0|||
155653897|NCT04616196|561826811|FG002|Overall Study|Progressive Disease|4|||
155653898|NCT04616196|561826812|FG003|Overall Study|Progressive Disease|1|||
155653899|NCT04616196|561826809|FG000|Overall Study|Death|2|||
155653900|NCT04616196|561826810|FG001|Overall Study|Death|4|||
155653901|NCT04616196|561826811|FG002|Overall Study|Death|1|||
155653902|NCT04616196|561826812|FG003|Overall Study|Death|0|||
155653903|NCT04616196|561826809|FG000|Overall Study|Withdrawal by Subject|0|||
155653904|NCT04616196|561826810|FG001|Overall Study|Withdrawal by Subject|2|||
155653905|NCT04616196|561826811|FG002|Overall Study|Withdrawal by Subject|0|||
155653906|NCT04616196|561826812|FG003|Overall Study|Withdrawal by Subject|0|||
155653907|NCT04616196|561826809|FG000|Overall Study|Lost to Follow-up|1|||
155653908|NCT04616196|561826810|FG001|Overall Study|Lost to Follow-up|0|||
155470774|NCT02579863|561146834|FG001|Overall Study|Study Terminated at Selected Sites|88|||
155470775|NCT02579863|561146833|FG000|Overall Study|Withdrawal by Subject|20|||
155470776|NCT02579863|561146834|FG001|Overall Study|Withdrawal by Subject|20|||
155470777|NCT03135262|561146835|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
155470778|NCT03135262|561146836|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
155470779|NCT03135262|561146837|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
155470780|NCT03135262|561146838|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
155470781|NCT03135262|561146839|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
155470782|NCT03135262|561146835|FG000|Overall Study|Progression of disease|0|||
155653909|NCT04616196|561826811|FG002|Overall Study|Lost to Follow-up|0|||
155653910|NCT04616196|561826812|FG003|Overall Study|Lost to Follow-up|0|||
155653911|NCT04616196|561826809|FG000|Overall Study|Sponsor request|2|||
155653912|NCT04616196|561826810|FG001|Overall Study|Sponsor request|1|||
155653913|NCT04616196|561826811|FG002|Overall Study|Sponsor request|1|||
155653914|NCT04616196|561826812|FG003|Overall Study|Sponsor request|2|||
155470783|NCT03135262|561146836|FG001|Overall Study|Progression of disease|0|||
155470784|NCT03135262|561146837|FG002|Overall Study|Progression of disease|0|||
155470785|NCT03135262|561146838|FG003|Overall Study|Progression of disease|1|||
155470786|NCT03135262|561146839|FG004|Overall Study|Progression of disease|0|||
155470787|NCT03135262|561146835|FG000|Overall Study|Death|6|||
155470788|NCT03135262|561146836|FG001|Overall Study|Death|2|||
155470789|NCT03135262|561146837|FG002|Overall Study|Death|2|||
155470790|NCT03135262|561146838|FG003|Overall Study|Death|2|||
155470791|NCT03135262|561146839|FG004|Overall Study|Death|0|||
155470792|NCT03135262|561146835|FG000|Overall Study|Withdrawal by Subject|0|||
155470793|NCT03135262|561146836|FG001|Overall Study|Withdrawal by Subject|0|||
155470794|NCT03135262|561146837|FG002|Overall Study|Withdrawal by Subject|1|||
155470795|NCT03135262|561146838|FG003|Overall Study|Withdrawal by Subject|0|||
155470796|NCT03135262|561146839|FG004|Overall Study|Withdrawal by Subject|1|||
155470797|NCT03135262|561146835|FG000|Overall Study|Study terminated by sponsor|2|||
155470798|NCT03135262|561146836|FG001|Overall Study|Study terminated by sponsor|4|||
155470799|NCT03135262|561146837|FG002|Overall Study|Study terminated by sponsor|4|||
155470800|NCT03135262|561146838|FG003|Overall Study|Study terminated by sponsor|3|||
155470801|NCT03135262|561146839|FG004|Overall Study|Study terminated by sponsor|0|||
155470802|NCT02728206|561146840|FG000|Overall Study|Death|1|||
155470803|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
155470804|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
155470805|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
155470806|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
155470807|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
155470808|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
155470809|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
155470810|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
155470811|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
155470812|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
155470813|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
155470814|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
155470815|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
155470816|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
155470817|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
155470818|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
155470819|NCT01291511|561146841|FG000|Cross-Titration and Stabilization Phase|Death|1|||
155470820|NCT01291511|561146842|FG001|Cross-Titration and Stabilization Phase|Death|0|||
155470821|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
155470822|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
155470823|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
155470824|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
155470825|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
155470826|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
155470827|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
155470828|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
155470829|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
155470830|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
155470831|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
155470832|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
155470833|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
155470834|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
155470835|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
155470836|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
155470837|NCT01291511|561146841|FG000|Double-blind Relapse Prevention Phase|Death|1|||
155470838|NCT01291511|561146842|FG001|Double-blind Relapse Prevention Phase|Death|0|||
155470839|NCT01366534|561146843|FG000|Overall Study|Lost to Follow-up|1|||
155470840|NCT01366534|561146844|FG001|Overall Study|Lost to Follow-up|0|||
155470841|NCT01366534|561146845|FG002|Overall Study|Lost to Follow-up|0|||
155470842|NCT01366534|561146843|FG000|Overall Study|Migrated|1|||
155470843|NCT01366534|561146844|FG001|Overall Study|Migrated|1|||
155470844|NCT01366534|561146845|FG002|Overall Study|Migrated|0|||
155470845|NCT01366534|561146843|FG000|Overall Study|Declined challenged|0|||
155518718|NCT04529109|561323111|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155518719|NCT01508936|561323113|FG000|Overall Study|Adverse Event|11|||
155470846|NCT01366534|561146844|FG001|Overall Study|Declined challenged|1|||
155518720|NCT01508936|561323114|FG001|Overall Study|Adverse Event|32|||
155518721|NCT01508936|561323113|FG000|Overall Study|Lack of Efficacy|0|||
155470847|NCT01366534|561146845|FG002|Overall Study|Declined challenged|0|||
155470848|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
155470849|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
155470850|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
155470851|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
155470852|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
155470853|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
155470854|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
155470855|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
155470856|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
155653915|NCT01904279|561826815|FG000|Overall Study|Lack of Efficacy|2|||
155653916|NCT01904279|561826816|FG001|Overall Study|Lack of Efficacy|3|||
155653917|NCT01904279|561826815|FG000|Overall Study|Withdrawal by Subject|1|||
155653918|NCT01904279|561826816|FG001|Overall Study|Withdrawal by Subject|0|||
155653919|NCT03283241|561826824|FG000|Overall Study|Adverse Event|4|||
155653920|NCT03283241|561826825|FG001|Overall Study|Adverse Event|1|||
155653921|NCT03283241|561826824|FG000|Overall Study|Withdrawal by Subject|0|||
155653922|NCT03283241|561826825|FG001|Overall Study|Withdrawal by Subject|1|||
155653923|NCT03283241|561826824|FG000|Overall Study|Subject relocated to Finland|0|||
155653924|NCT03283241|561826825|FG001|Overall Study|Subject relocated to Finland|1|||
155653925|NCT02439957|561826826|FG000|Overall Study|Study Terminated|3|||
155653926|NCT02439957|561826827|FG001|Overall Study|Study Terminated|3|||
155653927|NCT00586157|561826828|FG000|First Intervention|Worsening behavior|1|||
155653928|NCT00586157|561826829|FG001|First Intervention|Worsening behavior|0|||
155653929|NCT00586157|561826828|FG000|Second Intervention|Withdrawal by Subject|1|||
155653930|NCT00586157|561826829|FG001|Second Intervention|Withdrawal by Subject|0|||
155653931|NCT00586157|561826828|FG000|Second Intervention|Worsening behavior|1|||
155653932|NCT00586157|561826829|FG001|Second Intervention|Worsening behavior|0|||
155653933|NCT00586157|561826828|FG000|Second Intervention|Adverse Event|0|||
155653934|NCT00586157|561826829|FG001|Second Intervention|Adverse Event|1|||
155653935|NCT01225952|561826831|FG000|Overall Study|Lost to Follow-up|1|||
155653936|NCT01225952|561826832|FG001|Overall Study|Lost to Follow-up|0|||
155653937|NCT01225952|561826833|FG002|Overall Study|Lost to Follow-up|0|||
155653938|NCT01225952|561826831|FG000|Overall Study|Study Eye Explanted|0|||
155653939|NCT01225952|561826832|FG001|Overall Study|Study Eye Explanted|0|||
155653940|NCT01225952|561826833|FG002|Overall Study|Study Eye Explanted|1|||
155653941|NCT01225952|561826831|FG000|Overall Study|Withdrawal by Subject|4|||
155653942|NCT01225952|561826832|FG001|Overall Study|Withdrawal by Subject|4|||
155653943|NCT01225952|561826833|FG002|Overall Study|Withdrawal by Subject|5|||
155653944|NCT01225952|561826831|FG000|Overall Study|Surgical complications|1|||
155653945|NCT01225952|561826832|FG001|Overall Study|Surgical complications|0|||
155653946|NCT01225952|561826833|FG002|Overall Study|Surgical complications|0|||
155653947|NCT00831389|561826834|FG000|Overall Study|Withdrawal by Subject|0|||
155653948|NCT00831389|561826835|FG001|Overall Study|Withdrawal by Subject|1|||
155653949|NCT00278161|561826837|FG000|Overall Study|Death|11|||
155653950|NCT01817777|561826838|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
155653951|NCT01817777|561826839|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
155653952|NCT01817777|561826840|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
155653953|NCT01817777|561826838|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
155653954|NCT01817777|561826839|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
155653955|NCT01817777|561826840|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
155653956|NCT01817777|561826838|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
155653957|NCT01817777|561826839|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
155653958|NCT01817777|561826840|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
155653959|NCT01817777|561826838|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
155653960|NCT01817777|561826839|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
155653961|NCT01817777|561826840|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
155653962|NCT01817777|561826838|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
155653963|NCT01817777|561826839|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
155470857|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
155518722|NCT01508936|561323114|FG001|Overall Study|Lack of Efficacy|1|||
155653964|NCT01817777|561826840|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
155653965|NCT01935947|561826841|FG000|Overall Study|Adverse Event|0|||
155653966|NCT01935947|561826842|FG001|Overall Study|Adverse Event|2|||
155653967|NCT01935947|561826843|FG002|Overall Study|Adverse Event|0|||
155653968|NCT01935947|561826841|FG000|Overall Study|Diease Progression|2|||
155653969|NCT01935947|561826842|FG001|Overall Study|Diease Progression|2|||
155653970|NCT01935947|561826843|FG002|Overall Study|Diease Progression|2|||
155653971|NCT01935947|561826841|FG000|Overall Study|Death|1|||
155653972|NCT01935947|561826842|FG001|Overall Study|Death|0|||
155653973|NCT01935947|561826843|FG002|Overall Study|Death|0|||
155653974|NCT00692237|561826844|FG000|Overall Study|Withdrawal by Subject|1|||
155653975|NCT00692237|561826845|FG001|Overall Study|Withdrawal by Subject|3|||
155653976|NCT00692237|561826844|FG000|Overall Study|Adverse Event|0|||
155653977|NCT00692237|561826845|FG001|Overall Study|Adverse Event|1|||
155653978|NCT00752219|561826846|FG000|Overall Study|Clinical failure|0|||
155653979|NCT00752219|561826847|FG001|Overall Study|Clinical failure|1|||
155653980|NCT00752219|561826846|FG000|Overall Study|Adverse Event|5|||
155518723|NCT01508936|561323113|FG000|Overall Study|Withdrawal by Subject|4|||
155518724|NCT01508936|561323114|FG001|Overall Study|Withdrawal by Subject|18|||
155518725|NCT01508936|561323113|FG000|Overall Study|Protocol Violation|2|||
155518726|NCT01508936|561323114|FG001|Overall Study|Protocol Violation|3|||
155518727|NCT01508936|561323113|FG000|Overall Study|Lost to Follow-up|2|||
155518728|NCT01508936|561323114|FG001|Overall Study|Lost to Follow-up|9|||
155518729|NCT01508936|561323113|FG000|Overall Study|Other|0|||
155518730|NCT01508936|561323114|FG001|Overall Study|Other|5|||
155518731|NCT01508936|561323113|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
155518732|NCT01508936|561323114|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
155518733|NCT00679367|561323115|FG000|Overall Study|Adverse Event|7|||
155518734|NCT00679367|561323115|FG000|Overall Study|inability to swallow oral drugs|1|||
155518735|NCT00679367|561323115|FG000|Overall Study|Lack of Efficacy|3|||
155518736|NCT00679367|561323115|FG000|Overall Study|Withdrawal by Subject|1|||
155518737|NCT03365947|561323116|FG000|Overall Study|Lost to Follow-up|0|||
155518738|NCT03365947|561323117|FG001|Overall Study|Lost to Follow-up|0|||
155518739|NCT03365947|561323118|FG002|Overall Study|Lost to Follow-up|0|||
155518740|NCT03365947|561323119|FG003|Overall Study|Lost to Follow-up|0|||
155518741|NCT03365947|561323120|FG004|Overall Study|Lost to Follow-up|0|||
155518742|NCT03365947|561323121|FG005|Overall Study|Lost to Follow-up|1|||
155518743|NCT03365947|561323122|FG006|Overall Study|Lost to Follow-up|0|||
155518744|NCT03365947|561323123|FG007|Overall Study|Lost to Follow-up|0|||
155518745|NCT03365947|561323124|FG008|Overall Study|Lost to Follow-up|0|||
155518746|NCT03365947|561323125|FG009|Overall Study|Lost to Follow-up|0|||
155518747|NCT03365947|561323126|FG010|Overall Study|Lost to Follow-up|0|||
155518748|NCT03365947|561323127|FG011|Overall Study|Lost to Follow-up|0|||
155518749|NCT03365947|561323128|FG012|Overall Study|Lost to Follow-up|0|||
155653981|NCT00752219|561826847|FG001|Overall Study|Adverse Event|3|||
155653982|NCT00752219|561826846|FG000|Overall Study|Protocol deviation|1|||
155653983|NCT00752219|561826847|FG001|Overall Study|Protocol deviation|0|||
155518750|NCT03365947|561323129|FG013|Overall Study|Lost to Follow-up|0|||
155518751|NCT03365947|561323130|FG014|Overall Study|Lost to Follow-up|0|||
155518752|NCT03365947|561323131|FG015|Overall Study|Lost to Follow-up|0|||
155518753|NCT03365947|561323132|FG016|Overall Study|Lost to Follow-up|0|||
155518754|NCT03365947|561323133|FG017|Overall Study|Lost to Follow-up|0|||
155518755|NCT03365947|561323134|FG018|Overall Study|Lost to Follow-up|0|||
155518756|NCT05665595|561325089|FG000|Overall Study|Ongoing|692|||
155518757|NCT05665595|561325090|FG001|Overall Study|Ongoing|698|||
155518758|NCT05665595|561325089|FG000|Overall Study|Withdrawal by Subject|2|||
155518759|NCT05665595|561325090|FG001|Overall Study|Withdrawal by Subject|2|||
155518760|NCT05665595|561325089|FG000|Overall Study|Lost to Follow-up|1|||
155653984|NCT00752219|561826846|FG000|Overall Study|Lost to Follow-up|1|||
155653985|NCT00752219|561826847|FG001|Overall Study|Lost to Follow-up|2|||
155653986|NCT00752219|561826846|FG000|Overall Study|Randomized but not treated|1|||
155653987|NCT00752219|561826847|FG001|Overall Study|Randomized but not treated|0|||
155653988|NCT00752219|561826846|FG000|Overall Study|Other|3|||
155653989|NCT00752219|561826847|FG001|Overall Study|Other|0|||
155653990|NCT02758626|561826856|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
155653991|NCT02758626|561826857|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
155653992|NCT02758626|561826856|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
155653993|NCT02758626|561826857|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
155653994|NCT02758626|561826856|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
155653995|NCT02758626|561826857|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
155653996|NCT02758626|561826856|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
155653997|NCT02758626|561826857|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
155518761|NCT05665595|561325090|FG001|Overall Study|Lost to Follow-up|0|||
155518762|NCT05665595|561325089|FG000|Overall Study|Death|6|||
155518763|NCT05665595|561325090|FG001|Overall Study|Death|1|||
155518764|NCT03815942|561325091|FG000|Overall Study|Withdrawal by Subject|0|||
155518765|NCT03815942|561325092|FG001|Overall Study|Withdrawal by Subject|17|||
155518766|NCT03717064|561325093|FG000|Period 2|Adverse Event|1|||
155518767|NCT03480425|561325095|FG000|Overall Study|Force transducer technical failure|1|||
155518768|NCT01244126|561325096|FG000|Overall Study|Protocol Violation|3|||
155518769|NCT01244126|561325097|FG001|Overall Study|Protocol Violation|3|||
155518770|NCT01244126|561325098|FG002|Overall Study|Protocol Violation|9|||
155518771|NCT00863746|561325104|FG000|Treatment|Not treated|4|||
155653998|NCT00456365|561826866|FG000|Overall Study|Lost to Follow-up|1|||
155653999|NCT00456365|561826867|FG001|Overall Study|Lost to Follow-up|3|||
155654000|NCT00456365|561826866|FG000|Overall Study|Withdrawal by Subject|4|||
155654001|NCT00456365|561826867|FG001|Overall Study|Withdrawal by Subject|7|||
155654002|NCT00456365|561826866|FG000|Overall Study|Pregnancy|1|||
155654003|NCT00456365|561826867|FG001|Overall Study|Pregnancy|1|||
155654004|NCT00456365|561826866|FG000|Overall Study|oncologic diagnosis|1|||
155518772|NCT00863746|561325105|FG001|Treatment|Not treated|2|||
155518773|NCT00863746|561325104|FG000|Treatment|Adverse Event|41|||
155518774|NCT00863746|561325105|FG001|Treatment|Adverse Event|16|||
155518775|NCT00863746|561325104|FG000|Treatment|non-compliant with study medication|4|||
155518776|NCT00863746|561325105|FG001|Treatment|non-compliant with study medication|0|||
155470858|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
155470859|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
155470860|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
155470861|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
155470862|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
155470863|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
155470864|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
155470865|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
155470866|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
155470867|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
155470868|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
155470869|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
155470870|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
155470871|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
155470872|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
155470873|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
155470874|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
155470875|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
155470876|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
155470877|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
155470878|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
155470879|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
155470880|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
155470881|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
155470882|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
155470883|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
155470884|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
155470885|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
155470886|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
155470887|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
155470888|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
155470889|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
155470890|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
155470891|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
155470892|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
155470893|NCT03689972|561146848|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
155470894|NCT03689972|561146849|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
155470895|NCT03689972|561146850|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
155470896|NCT03689972|561146851|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
155470897|NCT03689972|561146852|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
155470898|NCT03689972|561146848|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
155470899|NCT03689972|561146849|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
155470900|NCT03689972|561146850|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
155470901|NCT03689972|561146851|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
155470902|NCT03689972|561146852|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
155470903|NCT03689972|561146848|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
155470904|NCT03689972|561146849|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
155470905|NCT03689972|561146850|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
155470906|NCT03689972|561146851|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
155470907|NCT03689972|561146852|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
155470908|NCT03689972|561146848|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
155470909|NCT03689972|561146849|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
155470910|NCT03689972|561146850|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
155518777|NCT00863746|561325104|FG000|Treatment|Consent withdrawn|15|||
155470911|NCT03689972|561146851|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
155518778|NCT00863746|561325105|FG001|Treatment|Consent withdrawn|14|||
155654005|NCT00456365|561826867|FG001|Overall Study|oncologic diagnosis|1|||
155470912|NCT03689972|561146852|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
155470913|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
155470914|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
155470915|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
155470916|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
155470917|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
155470918|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
155470919|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
155470920|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
155470921|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
155470922|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
155470923|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
155470924|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
155470925|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
155470926|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
155470927|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
155470928|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
155470929|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
155470930|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
155470931|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
155470932|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
155470933|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
155470934|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
155470935|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
155470936|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
155470937|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
155470938|NCT03689972|561146848|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
155470939|NCT03689972|561146849|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
155470940|NCT03689972|561146850|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
155470941|NCT03689972|561146851|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
155470942|NCT03689972|561146852|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
155470943|NCT00732641|561146853|FG000|Overall Study|Relapse or Progressive Disease|65|||
155470944|NCT00732641|561146854|FG001|Overall Study|Relapse or Progressive Disease|101|||
155470945|NCT00732641|561146853|FG000|Overall Study|Serious Adverse Events|12|||
155470946|NCT00732641|561146854|FG001|Overall Study|Serious Adverse Events|3|||
155470947|NCT00732641|561146853|FG000|Overall Study|Physician Decision|6|||
155470948|NCT00732641|561146854|FG001|Overall Study|Physician Decision|0|||
155470949|NCT00732641|561146853|FG000|Overall Study|Withdrawal by Subject|4|||
155470950|NCT00732641|561146854|FG001|Overall Study|Withdrawal by Subject|2|||
155470951|NCT00732641|561146853|FG000|Overall Study|Unable to Complete|1|||
155470952|NCT00732641|561146854|FG001|Overall Study|Unable to Complete|1|||
155470953|NCT00732641|561146853|FG000|Overall Study|Other|18|||
155470954|NCT00732641|561146854|FG001|Overall Study|Other|5|||
155470955|NCT00732238|561146855|FG000|Overall Study|Bacteremia|4|||
155470956|NCT00732238|561146856|FG001|Overall Study|Bacteremia|1|||
155470957|NCT00732238|561146855|FG000|Overall Study|Asymptomatic bacteriuria|1|||
155470958|NCT00732238|561146856|FG001|Overall Study|Asymptomatic bacteriuria|0|||
155470959|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
155470960|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
155470961|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
155470962|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
155470963|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
155470964|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
155470965|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
155470966|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
155470967|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
155470968|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
155470969|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
155470970|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
155470971|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
155470972|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
155470973|NCT03434041|561146857|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
155470974|NCT03434041|561146858|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
155470975|NCT03434041|561146857|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
155470976|NCT03434041|561146858|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
155470977|NCT03434041|561146857|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
155470978|NCT03434041|561146858|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
155470979|NCT03434041|561146857|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
155470980|NCT03434041|561146858|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
155470981|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
155470982|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
155470983|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
155470984|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
155470985|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
155470986|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
155470987|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
155470988|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
155470989|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
155470990|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
155470991|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
155470992|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
155470993|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
155470994|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
155470995|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
155470996|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
155470997|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
155470998|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
155470999|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
155471000|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
155471001|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
155471002|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
155471003|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
155471004|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
155471005|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
155471006|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
155471007|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
155471008|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
155471009|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
155471010|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
155471011|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
155471012|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
155471013|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
155471014|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
155471015|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
155471016|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
155471017|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
155471018|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
155471019|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
155471020|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
155471021|NCT03605836|561146859|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
155471022|NCT03605836|561146860|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
155471023|NCT03605836|561146861|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
155471024|NCT03605836|561146862|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
155471025|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
155471026|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
155491166|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
155491167|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
155491168|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
155491169|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
155491170|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
155491171|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
155491172|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
155491173|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
155491174|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
155491175|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
155491176|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
155491177|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
155491178|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
155491179|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
155471027|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
155471028|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
155471029|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
155471030|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
155471031|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
155471032|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
155471033|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
155471034|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
155471035|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
155471036|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
155471037|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
155471038|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
155471039|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
155471040|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
155471041|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
155471042|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
155471043|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
155471044|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
155471045|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
155471046|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
155471047|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
155471048|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
155471049|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
155471050|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
155471051|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
155471052|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
155471053|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
155471054|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
155471055|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
155471056|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
155471057|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
155471058|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
155471059|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
155471060|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
155471061|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
155471062|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
155471063|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
155471064|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
155471065|NCT03605836|561146859|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
155471066|NCT03605836|561146860|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
155471067|NCT03605836|561146861|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
155471068|NCT03605836|561146862|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
155471069|NCT02977507|561146863|FG000|Overall Study|Protocol Deviation|1|||
155471070|NCT02977507|561146864|FG001|Overall Study|Protocol Deviation|0|||
155471071|NCT02977507|561146863|FG000|Overall Study|Lost to Follow-up|1|||
155471072|NCT02977507|561146864|FG001|Overall Study|Lost to Follow-up|0|||
155471073|NCT00610207|561146867|FG000|Overall Study|Lost to Follow-up|3|||
155471074|NCT01594411|561146879|FG000|Overall Study|Lost to Follow-up|2|||
155471075|NCT01451398|561146886|FG000|Overall Study|Adverse Event|7|||
155471076|NCT01451398|561146887|FG001|Overall Study|Adverse Event|9|||
155471077|NCT01451398|561146886|FG000|Overall Study|Protocol Violation|1|||
155471078|NCT01451398|561146887|FG001|Overall Study|Protocol Violation|2|||
155471079|NCT01451398|561146886|FG000|Overall Study|Physician Decision|1|||
155471080|NCT01451398|561146887|FG001|Overall Study|Physician Decision|1|||
155471081|NCT01451398|561146886|FG000|Overall Study|Withdrawal by Subject|10|||
155471082|NCT01451398|561146887|FG001|Overall Study|Withdrawal by Subject|14|||
155471083|NCT01451398|561146886|FG000|Overall Study|Lost to Follow-up|6|||
155471084|NCT01451398|561146887|FG001|Overall Study|Lost to Follow-up|4|||
155471085|NCT01451398|561146886|FG000|Overall Study|Non-compliance with study drug|1|||
155471086|NCT01451398|561146887|FG001|Overall Study|Non-compliance with study drug|3|||
155471087|NCT01451398|561146886|FG000|Overall Study|Non-compliance with protocol|1|||
155471088|NCT01451398|561146887|FG001|Overall Study|Non-compliance with protocol|1|||
155471089|NCT01451398|561146886|FG000|Overall Study|Moved out of country|0|||
155471090|NCT01451398|561146887|FG001|Overall Study|Moved out of country|1|||
155471091|NCT01451398|561146886|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
155471092|NCT01451398|561146887|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
155471093|NCT01451398|561146886|FG000|Overall Study|Lack of Efficacy|0|||
155471094|NCT01451398|561146887|FG001|Overall Study|Lack of Efficacy|1|||
155471095|NCT00422669|561146888|FG000|Overall Study|The study was terminated early.|98|||
155471096|NCT00422669|561146889|FG001|Overall Study|The study was terminated early.|100|||
155471097|NCT00422669|561146890|FG002|Overall Study|The study was terminated early.|7|||
155471098|NCT00741260|561146892|FG000|Overall Study|Disease Progression|3|||
155471099|NCT00741260|561146893|FG001|Overall Study|Disease Progression|5|||
155471100|NCT00741260|561146894|FG002|Overall Study|Disease Progression|3|||
155471101|NCT00741260|561146895|FG003|Overall Study|Disease Progression|3|||
155471102|NCT00741260|561146896|FG004|Overall Study|Disease Progression|5|||
155471103|NCT00741260|561146897|FG005|Overall Study|Disease Progression|37|||
155471104|NCT00741260|561146898|FG006|Overall Study|Disease Progression|4|||
155471105|NCT00741260|561146892|FG000|Overall Study|Death|0|||
155471106|NCT00741260|561146893|FG001|Overall Study|Death|1|||
155471107|NCT00741260|561146894|FG002|Overall Study|Death|0|||
155471108|NCT00741260|561146895|FG003|Overall Study|Death|1|||
155471109|NCT00741260|561146896|FG004|Overall Study|Death|2|||
155471110|NCT00741260|561146897|FG005|Overall Study|Death|2|||
155471111|NCT00741260|561146898|FG006|Overall Study|Death|1|||
155471112|NCT00741260|561146892|FG000|Overall Study|Withdrawal by Subject|0|||
155471113|NCT00741260|561146893|FG001|Overall Study|Withdrawal by Subject|0|||
155471114|NCT00741260|561146894|FG002|Overall Study|Withdrawal by Subject|0|||
155471115|NCT00741260|561146895|FG003|Overall Study|Withdrawal by Subject|0|||
155471116|NCT00741260|561146896|FG004|Overall Study|Withdrawal by Subject|1|||
155471117|NCT00741260|561146897|FG005|Overall Study|Withdrawal by Subject|3|||
155471118|NCT00741260|561146898|FG006|Overall Study|Withdrawal by Subject|1|||
155471119|NCT00741260|561146892|FG000|Overall Study|Physician Decision|1|||
155471120|NCT00741260|561146893|FG001|Overall Study|Physician Decision|1|||
155471121|NCT00741260|561146894|FG002|Overall Study|Physician Decision|0|||
155471122|NCT00741260|561146895|FG003|Overall Study|Physician Decision|0|||
155471123|NCT00741260|561146896|FG004|Overall Study|Physician Decision|0|||
155471124|NCT00741260|561146897|FG005|Overall Study|Physician Decision|0|||
155471125|NCT00741260|561146898|FG006|Overall Study|Physician Decision|0|||
155471126|NCT00741260|561146892|FG000|Overall Study|Other|2|||
155471127|NCT00741260|561146893|FG001|Overall Study|Other|1|||
155471128|NCT00741260|561146894|FG002|Overall Study|Other|1|||
155471129|NCT00741260|561146895|FG003|Overall Study|Other|2|||
155471130|NCT00741260|561146896|FG004|Overall Study|Other|1|||
155471131|NCT00741260|561146897|FG005|Overall Study|Other|3|||
155471132|NCT00741260|561146898|FG006|Overall Study|Other|1|||
155471133|NCT02565615|561146899|FG000|Overall Study|Death|0|||
155471134|NCT02565615|561146900|FG001|Overall Study|Death|1|||
155471135|NCT02565615|561146901|FG002|Overall Study|Death|0|||
155471136|NCT02565615|561146902|FG003|Overall Study|Death|0|||
155471137|NCT02565615|561146903|FG004|Overall Study|Death|4|||
155471138|NCT02565615|561146899|FG000|Overall Study|Not willing to participate in study|2|||
155471139|NCT02565615|561146900|FG001|Overall Study|Not willing to participate in study|21|||
155471140|NCT02565615|561146901|FG002|Overall Study|Not willing to participate in study|0|||
155471141|NCT02565615|561146902|FG003|Overall Study|Not willing to participate in study|1|||
155471142|NCT02565615|561146903|FG004|Overall Study|Not willing to participate in study|169|||
155471143|NCT02565615|561146899|FG000|Overall Study|Lost to Follow-up|0|||
155518779|NCT00863746|561325104|FG000|Treatment|Lost to Follow-up|1|||
155518780|NCT00863746|561325105|FG001|Treatment|Lost to Follow-up|0|||
155518781|NCT00863746|561325104|FG000|Treatment|Protocol Violation|5|||
155518782|NCT00863746|561325105|FG001|Treatment|Protocol Violation|3|||
155471144|NCT02565615|561146900|FG001|Overall Study|Lost to Follow-up|4|||
155471145|NCT02565615|561146901|FG002|Overall Study|Lost to Follow-up|0|||
155471146|NCT02565615|561146902|FG003|Overall Study|Lost to Follow-up|1|||
155471147|NCT02565615|561146903|FG004|Overall Study|Lost to Follow-up|765|||
155471148|NCT02565615|561146899|FG000|Overall Study|Not meeting eligibility criteria|0|||
155471149|NCT02565615|561146900|FG001|Overall Study|Not meeting eligibility criteria|7|||
155471150|NCT02565615|561146901|FG002|Overall Study|Not meeting eligibility criteria|0|||
155471151|NCT02565615|561146902|FG003|Overall Study|Not meeting eligibility criteria|0|||
155471152|NCT02565615|561146903|FG004|Overall Study|Not meeting eligibility criteria|25|||
155471153|NCT02565615|561146899|FG000|Overall Study|Reason not defined|0|||
155471154|NCT02565615|561146900|FG001|Overall Study|Reason not defined|2|||
155471155|NCT02565615|561146901|FG002|Overall Study|Reason not defined|0|||
155471156|NCT02565615|561146902|FG003|Overall Study|Reason not defined|1|||
155471157|NCT02565615|561146903|FG004|Overall Study|Reason not defined|62|||
155471158|NCT02565615|561146899|FG000|Overall Study|Adverse Event|1|||
155471159|NCT02565615|561146900|FG001|Overall Study|Adverse Event|1|||
155471160|NCT02565615|561146901|FG002|Overall Study|Adverse Event|0|||
155471161|NCT02565615|561146902|FG003|Overall Study|Adverse Event|0|||
155471162|NCT02565615|561146903|FG004|Overall Study|Adverse Event|9|||
155471163|NCT02565615|561146899|FG000|Overall Study|Untreated|0|||
155471164|NCT02565615|561146900|FG001|Overall Study|Untreated|0|||
155471165|NCT02565615|561146901|FG002|Overall Study|Untreated|0|||
155471166|NCT02565615|561146902|FG003|Overall Study|Untreated|0|||
155471167|NCT02565615|561146903|FG004|Overall Study|Untreated|567|||
155471168|NCT05563714|561146908|FG000|Overall Study|Death|2|||
155471169|NCT05563714|561146909|FG001|Overall Study|Death|2|||
155471170|NCT05563714|561146910|FG002|Overall Study|Death|0|||
155471171|NCT05563714|561146911|FG003|Overall Study|Death|0|||
155471172|NCT05563714|561146908|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
155471173|NCT05563714|561146909|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
155471174|NCT05563714|561146910|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
155471175|NCT05563714|561146911|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
155471176|NCT05563714|561146908|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
155471177|NCT05563714|561146909|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
155471178|NCT05563714|561146910|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
155471179|NCT05563714|561146911|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
155471180|NCT05563714|561146908|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
155471181|NCT05563714|561146909|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
155471182|NCT05563714|561146910|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
155471183|NCT05563714|561146911|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
155471184|NCT05563714|561146908|FG000|Overall Study|Lost to Follow-up|22|||
155471185|NCT05563714|561146909|FG001|Overall Study|Lost to Follow-up|19|||
155471186|NCT05563714|561146910|FG002|Overall Study|Lost to Follow-up|0|||
155471187|NCT05563714|561146911|FG003|Overall Study|Lost to Follow-up|0|||
155471188|NCT02427100|561146914|FG000|Overall Study|Lost to Follow-up|0|||
155471189|NCT02427100|561146915|FG001|Overall Study|Lost to Follow-up|2|||
155471190|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
155471191|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
155471192|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
155471193|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
155471194|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
155471195|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
155471196|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
155471197|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
155471198|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471199|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471200|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471201|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471202|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471203|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
155471204|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
155471205|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
155471206|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
155471207|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
155471208|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
155471209|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
155471210|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
155471211|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
155471212|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471213|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471214|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471215|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471216|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471217|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
155471218|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
155471219|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471220|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471221|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471222|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471223|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471224|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
155471225|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
155471226|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471227|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471228|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471229|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471230|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471231|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
155471232|NCT02120352|561146918|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
155471233|NCT02120352|561146919|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
155471234|NCT02120352|561146920|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
155471235|NCT02120352|561146921|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
155471236|NCT02120352|561146922|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
155471237|NCT02120352|561146923|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
155471238|NCT02120352|561146924|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
155471239|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
155471240|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
155471241|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
155471242|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
155471243|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
155471244|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
155471245|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
155471246|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
155471247|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
155471248|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
155471249|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
155471250|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
155471251|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
155471252|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
155471253|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
155471254|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
155471255|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
155471256|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
155471257|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
155471258|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
155471259|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
155471260|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
155471261|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
155471262|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
155471263|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
155471264|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
155471265|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
155471266|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
155471267|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471268|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471269|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471270|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
155471271|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471272|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471273|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
155471274|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
155471275|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
155471276|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
155471277|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
155471278|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
155471279|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
155471280|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
155471281|NCT02120352|561146918|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471282|NCT02120352|561146919|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
155471283|NCT02120352|561146920|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471284|NCT02120352|561146921|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471285|NCT02120352|561146922|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471286|NCT02120352|561146923|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471287|NCT02120352|561146924|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
155471288|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
155471289|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
155471290|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
155471291|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
155471292|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
155518783|NCT00863746|561325104|FG000|Treatment|Other|1|||
155518784|NCT00863746|561325105|FG001|Treatment|Other|0|||
155518785|NCT00863746|561325104|FG000|Survival Follow up|Death|244|||
155518786|NCT00863746|561325105|FG001|Survival Follow up|Death|271|||
155518787|NCT00863746|561325104|FG000|Survival Follow up|Lost to Follow-up|2|||
155518788|NCT00863746|561325105|FG001|Survival Follow up|Lost to Follow-up|1|||
155518789|NCT00863746|561325104|FG000|Survival Follow up|Consent Withdrawn|7|||
155518790|NCT00863746|561325105|FG001|Survival Follow up|Consent Withdrawn|8|||
155518791|NCT00531206|561325106|FG000|Overall Study|Adverse Event related|5|||
155518792|NCT00531206|561325106|FG000|Overall Study|Lack of Efficacy|2|||
155518793|NCT00531206|561325106|FG000|Overall Study|Lost to Follow-up|5|||
155518794|NCT00531206|561325106|FG000|Overall Study|including non-related adverse events|8|||
155518795|NCT00977106|561325108|FG000|Overall Study|Adverse Event|5|||
155518796|NCT00977106|561325109|FG001|Overall Study|Adverse Event|6|||
155518797|NCT00977106|561325108|FG000|Overall Study|Withdrawal by Subject|2|||
155518798|NCT00977106|561325109|FG001|Overall Study|Withdrawal by Subject|2|||
155654006|NCT00803049|561826873|FG000|Overall Study|Adverse Event|21|||
155471293|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
155471294|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
155471295|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471296|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471297|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471298|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471299|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
155471300|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471301|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
155471302|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
155471303|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
155471304|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
155471305|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
155471306|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
155471307|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
155471308|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
155471309|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
155471310|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
155471311|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
155471312|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
155471313|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
155471314|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
155471315|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
155471316|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
155471317|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
155471318|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
155471319|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
155471320|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
155471321|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
155518799|NCT00977106|561325108|FG000|Overall Study|Lack of Efficacy|2|||
155518800|NCT00977106|561325109|FG001|Overall Study|Lack of Efficacy|2|||
155518801|NCT00977106|561325108|FG000|Overall Study|Protocol Violation|0|||
155518802|NCT00977106|561325109|FG001|Overall Study|Protocol Violation|1|||
155654007|NCT00803049|561826874|FG001|Overall Study|Adverse Event|33|||
155654008|NCT00803049|561826875|FG002|Overall Study|Adverse Event|13|||
155654009|NCT00803049|561826876|FG003|Overall Study|Adverse Event|27|||
155654010|NCT00803049|561826873|FG000|Overall Study|Lack of Efficacy|10|||
155654011|NCT00803049|561826874|FG001|Overall Study|Lack of Efficacy|19|||
155654012|NCT00803049|561826875|FG002|Overall Study|Lack of Efficacy|6|||
155654013|NCT00803049|561826876|FG003|Overall Study|Lack of Efficacy|13|||
155654014|NCT00803049|561826873|FG000|Overall Study|Lost to Follow-up|0|||
155654015|NCT00803049|561826874|FG001|Overall Study|Lost to Follow-up|2|||
155654016|NCT00803049|561826875|FG002|Overall Study|Lost to Follow-up|0|||
155654017|NCT00803049|561826876|FG003|Overall Study|Lost to Follow-up|3|||
155654018|NCT00803049|561826873|FG000|Overall Study|Death|2|||
155518803|NCT00977106|561325108|FG000|Overall Study|Other|1|||
155518804|NCT00977106|561325109|FG001|Overall Study|Other|0|||
155518805|NCT00436007|561325116|FG000|Overall Study|Withdrawal by Subject|5|||
155518806|NCT00436007|561325117|FG001|Overall Study|Withdrawal by Subject|3|||
155654019|NCT00803049|561826874|FG001|Overall Study|Death|1|||
155518807|NCT00436007|561325118|FG002|Overall Study|Withdrawal by Subject|4|||
155518808|NCT00436007|561325116|FG000|Overall Study|Lost to Follow-up|14|||
155654020|NCT00803049|561826875|FG002|Overall Study|Death|0|||
155654021|NCT00803049|561826876|FG003|Overall Study|Death|2|||
155654022|NCT00803049|561826873|FG000|Overall Study|Progressive Disease|6|||
155654023|NCT00803049|561826874|FG001|Overall Study|Progressive Disease|10|||
155471322|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
155471323|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
155471324|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
155471325|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
155471326|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
155471327|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
155471328|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
155471329|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
155471330|NCT02120352|561146918|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
155471331|NCT02120352|561146919|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
155471332|NCT02120352|561146920|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
155471333|NCT02120352|561146921|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
155471334|NCT02120352|561146922|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
155471335|NCT02120352|561146923|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
155471336|NCT02120352|561146924|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
155471337|NCT02120352|561146918|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471338|NCT02120352|561146919|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471339|NCT02120352|561146920|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471340|NCT02120352|561146921|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471341|NCT02120352|561146922|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471342|NCT02120352|561146923|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155471343|NCT02120352|561146924|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
155471344|NCT01610206|561146925|FG000|Overall Study|Adverse Event|10|||
155471345|NCT01610206|561146926|FG001|Overall Study|Adverse Event|30|||
155471346|NCT00924729|561146927|FG000|Overall Study|insufficient volume for analysis|1|||
155471347|NCT00924729|561146928|FG001|Overall Study|insufficient volume for analysis|0|||
155471348|NCT00924729|561146927|FG000|Overall Study|Protocol Violation|1|||
155471349|NCT00924729|561146928|FG001|Overall Study|Protocol Violation|0|||
155471350|NCT01929707|561146929|FG000|Intervention Period 1|Lost to Follow-up|0|||
155471351|NCT01929707|561146930|FG001|Intervention Period 1|Lost to Follow-up|0|||
155471352|NCT01929707|561146931|FG002|Intervention Period 1|Lost to Follow-up|0|||
155518809|NCT00436007|561325117|FG001|Overall Study|Lost to Follow-up|10|||
155518810|NCT00436007|561325118|FG002|Overall Study|Lost to Follow-up|13|||
155518811|NCT00436007|561325116|FG000|Overall Study|Physician Decision|0|||
155518812|NCT00436007|561325117|FG001|Overall Study|Physician Decision|0|||
155518813|NCT00436007|561325118|FG002|Overall Study|Physician Decision|2|||
155518814|NCT00436007|561325116|FG000|Overall Study|Death|0|||
155518815|NCT00436007|561325117|FG001|Overall Study|Death|1|||
155518816|NCT00436007|561325118|FG002|Overall Study|Death|3|||
155518817|NCT00436007|561325116|FG000|Overall Study|Other|0|||
155518818|NCT00436007|561325117|FG001|Overall Study|Other|0|||
155518819|NCT00436007|561325118|FG002|Overall Study|Other|1|||
155518820|NCT01439165|561325119|FG000|Overall Study|Protocol Violation|3|||
155518821|NCT01439165|561325120|FG001|Overall Study|Protocol Violation|0|||
155518822|NCT01439165|561325119|FG000|Overall Study|Lost to Follow-up|11|||
155518823|NCT01439165|561325120|FG001|Overall Study|Lost to Follow-up|1|||
155518824|NCT01439165|561325119|FG000|Overall Study|Withdrawal by Subject|7|||
155518825|NCT01439165|561325120|FG001|Overall Study|Withdrawal by Subject|1|||
155518826|NCT02419313|561325121|FG000|First Intervention|Lost to Follow-up|2|||
155518827|NCT02419313|561325122|FG001|First Intervention|Lost to Follow-up|0|||
155654024|NCT00803049|561826875|FG002|Overall Study|Progressive Disease|6|||
155654025|NCT00803049|561826876|FG003|Overall Study|Progressive Disease|6|||
155654026|NCT00803049|561826873|FG000|Overall Study|Withdrawal by Subject|19|||
155654027|NCT00803049|561826874|FG001|Overall Study|Withdrawal by Subject|43|||
155654028|NCT00803049|561826875|FG002|Overall Study|Withdrawal by Subject|16|||
155654029|NCT00803049|561826876|FG003|Overall Study|Withdrawal by Subject|44|||
155654030|NCT00803049|561826873|FG000|Overall Study|Protocol Violation|0|||
155654031|NCT00803049|561826874|FG001|Overall Study|Protocol Violation|1|||
155654032|NCT00803049|561826875|FG002|Overall Study|Protocol Violation|1|||
155654033|NCT00803049|561826876|FG003|Overall Study|Protocol Violation|0|||
155471353|NCT01929707|561146932|FG003|Intervention Period 1|Lost to Follow-up|1|||
155471354|NCT01929707|561146933|FG004|Intervention Period 1|Lost to Follow-up|0|||
155471355|NCT01929707|561146934|FG005|Intervention Period 1|Lost to Follow-up|0|||
155518828|NCT02419313|561325121|FG000|Second Intervention|Lost to Follow-up|1|||
155518829|NCT02419313|561325122|FG001|Second Intervention|Lost to Follow-up|0|||
155518830|NCT03331042|561325123|FG000|Overall Study|Protocol Violation|1|||
155518831|NCT03331042|561325124|FG001|Overall Study|Protocol Violation|0|||
155518832|NCT03331042|561325125|FG002|Overall Study|Protocol Violation|0|||
155654034|NCT00803049|561826873|FG000|Overall Study|Randomized and Not Treated|0|||
155518833|NCT03331042|561325126|FG003|Overall Study|Protocol Violation|0|||
155518834|NCT03331042|561325123|FG000|Overall Study|Physician Decision|0|||
155518835|NCT03331042|561325124|FG001|Overall Study|Physician Decision|0|||
155654035|NCT00803049|561826874|FG001|Overall Study|Randomized and Not Treated|0|||
155471356|NCT01929707|561146935|FG006|Intervention Period 1|Lost to Follow-up|0|||
155471357|NCT01929707|561146936|FG007|Intervention Period 1|Lost to Follow-up|0|||
155471358|NCT01929707|561146929|FG000|Intervention Period 1|Withdrawal by Subject|0|||
155471359|NCT01929707|561146930|FG001|Intervention Period 1|Withdrawal by Subject|0|||
155471360|NCT01929707|561146931|FG002|Intervention Period 1|Withdrawal by Subject|0|||
155471361|NCT01929707|561146932|FG003|Intervention Period 1|Withdrawal by Subject|2|||
155471362|NCT01929707|561146933|FG004|Intervention Period 1|Withdrawal by Subject|0|||
155471363|NCT01929707|561146934|FG005|Intervention Period 1|Withdrawal by Subject|0|||
155471364|NCT01929707|561146935|FG006|Intervention Period 1|Withdrawal by Subject|0|||
155471365|NCT01929707|561146936|FG007|Intervention Period 1|Withdrawal by Subject|0|||
155471366|NCT01929707|561146929|FG000|Intervention Period 2|Withdrawal by Subject|0|||
155471367|NCT01929707|561146930|FG001|Intervention Period 2|Withdrawal by Subject|0|||
155471368|NCT01929707|561146931|FG002|Intervention Period 2|Withdrawal by Subject|0|||
155471369|NCT01929707|561146932|FG003|Intervention Period 2|Withdrawal by Subject|0|||
155471370|NCT01929707|561146933|FG004|Intervention Period 2|Withdrawal by Subject|0|||
155471371|NCT01929707|561146934|FG005|Intervention Period 2|Withdrawal by Subject|2|||
155471372|NCT01929707|561146935|FG006|Intervention Period 2|Withdrawal by Subject|0|||
155471373|NCT01929707|561146936|FG007|Intervention Period 2|Withdrawal by Subject|0|||
155471374|NCT00023712|561146937|FG000|Overall Study|Not platinum sensitive|1|||
155471375|NCT00023712|561146938|FG001|Overall Study|Not platinum sensitive|0|||
155471376|NCT00023712|561146937|FG000|Overall Study|Never treated|1|||
155471377|NCT00023712|561146938|FG001|Overall Study|Never treated|1|||
155471378|NCT00437203|561146939|FG000|Overall Study|Death|0|||
155471379|NCT00437203|561146940|FG001|Overall Study|Death|0|||
155471380|NCT00437203|561146941|FG002|Overall Study|Death|1|||
155471381|NCT00437203|561146942|FG003|Overall Study|Death|0|||
155471382|NCT00437203|561146943|FG004|Overall Study|Death|0|||
155471383|NCT00437203|561146944|FG005|Overall Study|Death|0|||
155471384|NCT00437203|561146945|FG006|Overall Study|Death|0|||
155471385|NCT00437203|561146946|FG007|Overall Study|Death|1|||
155471386|NCT00437203|561146947|FG008|Overall Study|Death|0|||
155471387|NCT00437203|561146948|FG009|Overall Study|Death|1|||
155471388|NCT00437203|561146939|FG000|Overall Study|Adverse Event|1|||
155471389|NCT00437203|561146940|FG001|Overall Study|Adverse Event|1|||
155471390|NCT00437203|561146941|FG002|Overall Study|Adverse Event|0|||
155471391|NCT00437203|561146942|FG003|Overall Study|Adverse Event|0|||
155471392|NCT00437203|561146943|FG004|Overall Study|Adverse Event|0|||
155471393|NCT00437203|561146944|FG005|Overall Study|Adverse Event|0|||
155471394|NCT00437203|561146945|FG006|Overall Study|Adverse Event|0|||
155471395|NCT00437203|561146946|FG007|Overall Study|Adverse Event|1|||
155471396|NCT00437203|561146947|FG008|Overall Study|Adverse Event|0|||
155471397|NCT00437203|561146948|FG009|Overall Study|Adverse Event|1|||
155471398|NCT00437203|561146939|FG000|Overall Study|Study terminated by sponsor|0|||
155471399|NCT00437203|561146940|FG001|Overall Study|Study terminated by sponsor|0|||
155471400|NCT00437203|561146941|FG002|Overall Study|Study terminated by sponsor|0|||
155471401|NCT00437203|561146942|FG003|Overall Study|Study terminated by sponsor|0|||
155471402|NCT00437203|561146943|FG004|Overall Study|Study terminated by sponsor|0|||
155471403|NCT00437203|561146944|FG005|Overall Study|Study terminated by sponsor|0|||
155471404|NCT00437203|561146945|FG006|Overall Study|Study terminated by sponsor|0|||
155471405|NCT00437203|561146946|FG007|Overall Study|Study terminated by sponsor|0|||
155471406|NCT00437203|561146947|FG008|Overall Study|Study terminated by sponsor|1|||
155471407|NCT00437203|561146948|FG009|Overall Study|Study terminated by sponsor|0|||
155471408|NCT00437203|561146939|FG000|Overall Study|Objective progression or relapse|5|||
155471409|NCT00437203|561146940|FG001|Overall Study|Objective progression or relapse|6|||
155471410|NCT00437203|561146941|FG002|Overall Study|Objective progression or relapse|2|||
155471411|NCT00437203|561146942|FG003|Overall Study|Objective progression or relapse|3|||
155471412|NCT00437203|561146943|FG004|Overall Study|Objective progression or relapse|3|||
155471413|NCT00437203|561146944|FG005|Overall Study|Objective progression or relapse|3|||
155471414|NCT00437203|561146945|FG006|Overall Study|Objective progression or relapse|6|||
155471415|NCT00437203|561146946|FG007|Overall Study|Objective progression or relapse|1|||
155471416|NCT00437203|561146947|FG008|Overall Study|Objective progression or relapse|2|||
155471417|NCT00437203|561146948|FG009|Overall Study|Objective progression or relapse|2|||
155471418|NCT00437203|561146939|FG000|Overall Study|Other|0|||
155471419|NCT00437203|561146940|FG001|Overall Study|Other|1|||
155471420|NCT00437203|561146941|FG002|Overall Study|Other|0|||
155471421|NCT00437203|561146942|FG003|Overall Study|Other|0|||
155471422|NCT00437203|561146943|FG004|Overall Study|Other|0|||
155471423|NCT00437203|561146944|FG005|Overall Study|Other|0|||
155471424|NCT00437203|561146945|FG006|Overall Study|Other|1|||
155471425|NCT00437203|561146946|FG007|Overall Study|Other|0|||
155471426|NCT00437203|561146947|FG008|Overall Study|Other|0|||
155471427|NCT00437203|561146948|FG009|Overall Study|Other|0|||
155491180|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
155491181|NCT00634933|561223487|FG000|Part A: Baseline to Week 24|Other|1|||
155471428|NCT01915095|561146955|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
155471429|NCT01915095|561146956|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
155471430|NCT01915095|561146957|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
155471431|NCT01915095|561146958|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
155471432|NCT01915095|561146959|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
155471433|NCT02067533|561146960|FG000|Overall Study|Lost to Follow-up|4|||
155471434|NCT02067533|561146961|FG001|Overall Study|Lost to Follow-up|2|||
155471435|NCT00565812|561146962|FG000|Overall Study|Death|2|||
155471436|NCT00565812|561146963|FG001|Overall Study|Death|1|||
155471437|NCT00565812|561146964|FG002|Overall Study|Death|3|||
155471438|NCT00565812|561146962|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
155471439|NCT00565812|561146963|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
155471440|NCT00565812|561146964|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
155471441|NCT00565812|561146962|FG000|Overall Study|Lost to Follow-up|10|||
155471442|NCT00565812|561146963|FG001|Overall Study|Lost to Follow-up|8|||
155471443|NCT00565812|561146964|FG002|Overall Study|Lost to Follow-up|8|||
155471444|NCT00565812|561146962|FG000|Overall Study|Withdrawal by Subject|58|||
155471445|NCT00565812|561146963|FG001|Overall Study|Withdrawal by Subject|47|||
155471446|NCT00565812|561146964|FG002|Overall Study|Withdrawal by Subject|48|||
155471447|NCT00565812|561146962|FG000|Overall Study|Work Schedule|5|||
155471448|NCT00565812|561146963|FG001|Overall Study|Work Schedule|3|||
155471449|NCT00565812|561146964|FG002|Overall Study|Work Schedule|1|||
155471450|NCT00565812|561146962|FG000|Overall Study|Protocol Violation|2|||
155471451|NCT00565812|561146963|FG001|Overall Study|Protocol Violation|6|||
155471452|NCT00565812|561146964|FG002|Overall Study|Protocol Violation|4|||
155471453|NCT00565812|561146962|FG000|Overall Study|Adverse Event|41|||
155471454|NCT00565812|561146963|FG001|Overall Study|Adverse Event|54|||
155471455|NCT00565812|561146964|FG002|Overall Study|Adverse Event|40|||
155471456|NCT00565812|561146962|FG000|Overall Study|Jury Duty|1|||
155471457|NCT00565812|561146963|FG001|Overall Study|Jury Duty|0|||
155471458|NCT00565812|561146964|FG002|Overall Study|Jury Duty|0|||
155471459|NCT00565812|561146962|FG000|Overall Study|Relocated Out of Area|5|||
155471460|NCT00565812|561146963|FG001|Overall Study|Relocated Out of Area|8|||
155471461|NCT00565812|561146964|FG002|Overall Study|Relocated Out of Area|9|||
155471462|NCT00565812|561146962|FG000|Overall Study|Sponsor Decision|1|||
155471463|NCT00565812|561146963|FG001|Overall Study|Sponsor Decision|5|||
155471464|NCT00565812|561146964|FG002|Overall Study|Sponsor Decision|1|||
155471465|NCT00565812|561146962|FG000|Overall Study|Domestic Reasons|7|||
155471466|NCT00565812|561146963|FG001|Overall Study|Domestic Reasons|1|||
155471467|NCT00565812|561146964|FG002|Overall Study|Domestic Reasons|3|||
155471468|NCT00565812|561146962|FG000|Overall Study|Research Site Closure|6|||
155471469|NCT00565812|561146963|FG001|Overall Study|Research Site Closure|1|||
155518836|NCT03331042|561325125|FG002|Overall Study|Physician Decision|1|||
155518837|NCT03331042|561325126|FG003|Overall Study|Physician Decision|0|||
155518838|NCT03331042|561325123|FG000|Overall Study|Lost to Follow-up|0|||
155518839|NCT03331042|561325124|FG001|Overall Study|Lost to Follow-up|0|||
155518840|NCT03331042|561325125|FG002|Overall Study|Lost to Follow-up|0|||
155518841|NCT03331042|561325126|FG003|Overall Study|Lost to Follow-up|1|||
155518842|NCT02433678|561325131|FG000|Overall Study|Lost to Follow-up|1|||
155518843|NCT02433678|561325132|FG001|Overall Study|Lost to Follow-up|2|||
155518844|NCT00927810|561325135|FG000|Overall Study|Withdrawal by Subject|0|||
155518845|NCT00927810|561325136|FG001|Overall Study|Withdrawal by Subject|3|||
155518846|NCT00927810|561325137|FG002|Overall Study|Withdrawal by Subject|0|||
155518847|NCT00927810|561325138|FG003|Overall Study|Withdrawal by Subject|1|||
155518848|NCT00927810|561325135|FG000|Overall Study|Lost to Follow-up|0|||
155518849|NCT00927810|561325136|FG001|Overall Study|Lost to Follow-up|2|||
155518850|NCT00927810|561325137|FG002|Overall Study|Lost to Follow-up|1|||
155518851|NCT00927810|561325138|FG003|Overall Study|Lost to Follow-up|1|||
155518852|NCT00927810|561325135|FG000|Overall Study|Death|0|||
155518853|NCT00927810|561325136|FG001|Overall Study|Death|2|||
155518854|NCT00927810|561325137|FG002|Overall Study|Death|0|||
155518855|NCT00927810|561325138|FG003|Overall Study|Death|0|||
155654036|NCT00803049|561826875|FG002|Overall Study|Randomized and Not Treated|0|||
155654037|NCT00803049|561826876|FG003|Overall Study|Randomized and Not Treated|2|||
155471470|NCT00565812|561146964|FG002|Overall Study|Research Site Closure|8|||
155471471|NCT00565812|561146962|FG000|Overall Study|Surgical Intervention|0|||
155471472|NCT00565812|561146963|FG001|Overall Study|Surgical Intervention|1|||
155471473|NCT00565812|561146964|FG002|Overall Study|Surgical Intervention|2|||
155471474|NCT00565812|561146962|FG000|Overall Study|Low Compliance|1|||
155471475|NCT00565812|561146963|FG001|Overall Study|Low Compliance|0|||
155471476|NCT00565812|561146964|FG002|Overall Study|Low Compliance|1|||
155518856|NCT00927810|561325135|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155518857|NCT00927810|561325136|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155471477|NCT00565812|561146962|FG000|Overall Study|Follow-up Visit Not Completed|2|||
155471478|NCT00565812|561146963|FG001|Overall Study|Follow-up Visit Not Completed|0|||
155471479|NCT00565812|561146964|FG002|Overall Study|Follow-up Visit Not Completed|1|||
155471480|NCT00565812|561146962|FG000|Overall Study|Physician Decision|2|||
155471481|NCT00565812|561146963|FG001|Overall Study|Physician Decision|0|||
155471482|NCT00565812|561146964|FG002|Overall Study|Physician Decision|0|||
155471483|NCT00383708|561146965|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
155471484|NCT00383708|561146965|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
155471485|NCT00383708|561146965|FG000|Run-in Period|Protocol Violation|4|||
155471486|NCT00383708|561146965|FG000|Run-in Period|Adverse Event|2|||
155471487|NCT00383708|561146965|FG000|Run-in Period|Claustrophobia|1|||
155471488|NCT00383708|561146965|FG000|Co-administration Period|Adverse Event|5|||
155471489|NCT01997281|561146969|FG000|Overall Study|Withdrawal by Subject|1|||
155471490|NCT01997281|561146970|FG001|Overall Study|Withdrawal by Subject|0|||
155471491|NCT02384993|561146971|FG000|Overall Study|Adverse Event|0|||
155471492|NCT02384993|561146972|FG001|Overall Study|Adverse Event|1|||
155471493|NCT02650895|561146974|FG000|Overall Study|Withdrawal by Subject|0|||
155471494|NCT02650895|561146975|FG001|Overall Study|Withdrawal by Subject|1|||
155471495|NCT02650895|561146976|FG002|Overall Study|Withdrawal by Subject|0|||
155471496|NCT02650895|561146977|FG003|Overall Study|Withdrawal by Subject|0|||
155471497|NCT02650895|561146978|FG004|Overall Study|Withdrawal by Subject|0|||
155471498|NCT02650895|561146979|FG005|Overall Study|Withdrawal by Subject|0|||
155471499|NCT02859558|561148523|FG000|Step 1|Not Eligible|0|||
155471500|NCT02859558|561148524|FG001|Step 1|Not Eligible|0|||
155471501|NCT02859558|561148525|FG002|Step 1|Not Eligible|0|||
155471502|NCT02859558|561148526|FG003|Step 1|Not Eligible|0|||
155471503|NCT02859558|561148527|FG004|Step 1|Not Eligible|3|||
155471504|NCT02859558|561148523|FG000|Step 1|Lost to Follow-up|1|||
155471505|NCT02859558|561148524|FG001|Step 1|Lost to Follow-up|3|||
155471506|NCT02859558|561148525|FG002|Step 1|Lost to Follow-up|3|||
155471507|NCT02859558|561148526|FG003|Step 1|Lost to Follow-up|0|||
155471508|NCT02859558|561148527|FG004|Step 1|Lost to Follow-up|0|||
155471509|NCT02859558|561148523|FG000|Step 1|Did Not Return to Clinic|2|||
155471510|NCT02859558|561148524|FG001|Step 1|Did Not Return to Clinic|3|||
155471511|NCT02859558|561148525|FG002|Step 1|Did Not Return to Clinic|4|||
155471512|NCT02859558|561148526|FG003|Step 1|Did Not Return to Clinic|0|||
155471513|NCT02859558|561148527|FG004|Step 1|Did Not Return to Clinic|0|||
155471514|NCT02859558|561148523|FG000|Step 1|Moved|0|||
155471515|NCT02859558|561148524|FG001|Step 1|Moved|1|||
155471516|NCT02859558|561148525|FG002|Step 1|Moved|1|||
155471517|NCT02859558|561148526|FG003|Step 1|Moved|0|||
155471518|NCT02859558|561148527|FG004|Step 1|Moved|0|||
155471519|NCT02859558|561148523|FG000|Step 1|Withdrawal By Participant|1|||
155471520|NCT02859558|561148524|FG001|Step 1|Withdrawal By Participant|2|||
155471521|NCT02859558|561148525|FG002|Step 1|Withdrawal By Participant|1|||
155471522|NCT02859558|561148526|FG003|Step 1|Withdrawal By Participant|0|||
155471523|NCT02859558|561148527|FG004|Step 1|Withdrawal By Participant|0|||
155471524|NCT02859558|561148523|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
155471525|NCT02859558|561148524|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
155471526|NCT02859558|561148525|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
155471527|NCT02859558|561148526|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
155471528|NCT02859558|561148527|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
155471529|NCT02859558|561148523|FG000|Step 1|Incarceration|0|||
155471530|NCT02859558|561148524|FG001|Step 1|Incarceration|1|||
155471531|NCT02859558|561148525|FG002|Step 1|Incarceration|0|||
155471532|NCT02859558|561148526|FG003|Step 1|Incarceration|0|||
155471533|NCT02859558|561148527|FG004|Step 1|Incarceration|0|||
155471534|NCT02859558|561148523|FG000|Step 1|Non-Adherence to Study Drug|2|||
155471535|NCT02859558|561148524|FG001|Step 1|Non-Adherence to Study Drug|0|||
155471536|NCT02859558|561148525|FG002|Step 1|Non-Adherence to Study Drug|1|||
155471537|NCT02859558|561148526|FG003|Step 1|Non-Adherence to Study Drug|0|||
155471538|NCT02859558|561148527|FG004|Step 1|Non-Adherence to Study Drug|0|||
155471539|NCT02859558|561148523|FG000|Step 1|Non-Adherence to Study Requirements|3|||
155471540|NCT02859558|561148524|FG001|Step 1|Non-Adherence to Study Requirements|1|||
155471541|NCT02859558|561148525|FG002|Step 1|Non-Adherence to Study Requirements|0|||
155518858|NCT00927810|561325137|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155518859|NCT00927810|561325138|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155471542|NCT02859558|561148526|FG003|Step 1|Non-Adherence to Study Requirements|0|||
155471543|NCT02859558|561148527|FG004|Step 1|Non-Adherence to Study Requirements|0|||
155471544|NCT02859558|561148523|FG000|Step 1|Virologic Failure|2|||
155471545|NCT02859558|561148524|FG001|Step 1|Virologic Failure|1|||
155471546|NCT02859558|561148525|FG002|Step 1|Virologic Failure|1|||
155518860|NCT01626079|561325139|FG000|Overall Study|Death|167|||
155518861|NCT01626079|561325140|FG001|Overall Study|Death|192|||
155518862|NCT01626079|561325141|FG002|Overall Study|Death|39|||
155471547|NCT02859558|561148526|FG003|Step 1|Virologic Failure|0|||
155471548|NCT02859558|561148527|FG004|Step 1|Virologic Failure|0|||
155471549|NCT02859558|561148523|FG000|Step 2|Lost to Follow-up|3|||
155471550|NCT02859558|561148524|FG001|Step 2|Lost to Follow-up|3|||
155471551|NCT02859558|561148525|FG002|Step 2|Lost to Follow-up|1|||
155471552|NCT02859558|561148526|FG003|Step 2|Lost to Follow-up|0|||
155471553|NCT02859558|561148527|FG004|Step 2|Lost to Follow-up|0|||
155471554|NCT02859558|561148523|FG000|Step 2|Withdrawal by Subject|0|||
155471555|NCT02859558|561148524|FG001|Step 2|Withdrawal by Subject|1|||
155471556|NCT02859558|561148525|FG002|Step 2|Withdrawal by Subject|1|||
155471557|NCT02859558|561148526|FG003|Step 2|Withdrawal by Subject|0|||
155471558|NCT02859558|561148527|FG004|Step 2|Withdrawal by Subject|0|||
155471559|NCT02859558|561148523|FG000|Step 2|Unexpected Closure of Site|0|||
155471560|NCT02859558|561148524|FG001|Step 2|Unexpected Closure of Site|1|||
155471561|NCT02859558|561148525|FG002|Step 2|Unexpected Closure of Site|1|||
155471562|NCT02859558|561148526|FG003|Step 2|Unexpected Closure of Site|0|||
155471563|NCT02859558|561148527|FG004|Step 2|Unexpected Closure of Site|0|||
155471564|NCT02859558|561148523|FG000|Step 2|Death|1|||
155471565|NCT02859558|561148524|FG001|Step 2|Death|0|||
155471566|NCT02859558|561148525|FG002|Step 2|Death|0|||
155471567|NCT02859558|561148526|FG003|Step 2|Death|0|||
155471568|NCT02859558|561148527|FG004|Step 2|Death|0|||
155471569|NCT02859558|561148523|FG000|Step 2|Incarceration|0|||
155471570|NCT02859558|561148524|FG001|Step 2|Incarceration|0|||
155471571|NCT02859558|561148525|FG002|Step 2|Incarceration|1|||
155471572|NCT02859558|561148526|FG003|Step 2|Incarceration|0|||
155471573|NCT02859558|561148527|FG004|Step 2|Incarceration|0|||
155471574|NCT04507360|561148528|FG000|Week 1|Lost to Follow-up|0|||
155471575|NCT04507360|561148529|FG001|Week 1|Lost to Follow-up|0|||
155471576|NCT04507360|561148530|FG002|Week 1|Lost to Follow-up|0|||
155471577|NCT04507360|561148531|FG003|Week 1|Lost to Follow-up|0|||
155471578|NCT04507360|561148532|FG004|Week 1|Lost to Follow-up|0|||
155471579|NCT04507360|561148533|FG005|Week 1|Lost to Follow-up|0|||
155471580|NCT04507360|561148534|FG006|Week 1|Lost to Follow-up|0|||
155471581|NCT04507360|561148535|FG007|Week 1|Lost to Follow-up|0|||
155471582|NCT04507360|561148536|FG008|Week 1|Lost to Follow-up|72|||
155471583|NCT04507360|561148537|FG009|Week 1|Lost to Follow-up|22|||
155471584|NCT04507360|561148538|FG010|Week 1|Lost to Follow-up|10|||
155471585|NCT04507360|561148528|FG000|Week 2|Lost to Follow-up|0|||
155471586|NCT04507360|561148529|FG001|Week 2|Lost to Follow-up|0|||
155471587|NCT04507360|561148530|FG002|Week 2|Lost to Follow-up|0|||
155471588|NCT04507360|561148531|FG003|Week 2|Lost to Follow-up|0|||
155471589|NCT04507360|561148532|FG004|Week 2|Lost to Follow-up|0|||
155471590|NCT04507360|561148533|FG005|Week 2|Lost to Follow-up|0|||
155471591|NCT04507360|561148534|FG006|Week 2|Lost to Follow-up|0|||
155471592|NCT04507360|561148535|FG007|Week 2|Lost to Follow-up|0|||
155471593|NCT04507360|561148536|FG008|Week 2|Lost to Follow-up|121|||
155471594|NCT04507360|561148537|FG009|Week 2|Lost to Follow-up|85|||
155471595|NCT04507360|561148538|FG010|Week 2|Lost to Follow-up|82|||
155471596|NCT04507360|561148528|FG000|Week 3|Lost to Follow-up|0|||
155471597|NCT04507360|561148529|FG001|Week 3|Lost to Follow-up|0|||
155471598|NCT04507360|561148530|FG002|Week 3|Lost to Follow-up|0|||
155471599|NCT04507360|561148531|FG003|Week 3|Lost to Follow-up|0|||
155471600|NCT04507360|561148532|FG004|Week 3|Lost to Follow-up|0|||
155471601|NCT04507360|561148533|FG005|Week 3|Lost to Follow-up|0|||
155471602|NCT04507360|561148534|FG006|Week 3|Lost to Follow-up|0|||
155471603|NCT04507360|561148535|FG007|Week 3|Lost to Follow-up|0|||
155471604|NCT04507360|561148536|FG008|Week 3|Lost to Follow-up|123|||
155471605|NCT04507360|561148537|FG009|Week 3|Lost to Follow-up|92|||
155471606|NCT04507360|561148538|FG010|Week 3|Lost to Follow-up|84|||
155471607|NCT04507360|561148528|FG000|Week 4|Lost to Follow-up|0|||
155471608|NCT04507360|561148529|FG001|Week 4|Lost to Follow-up|0|||
155471609|NCT04507360|561148530|FG002|Week 4|Lost to Follow-up|0|||
155471610|NCT04507360|561148531|FG003|Week 4|Lost to Follow-up|0|||
155471611|NCT04507360|561148532|FG004|Week 4|Lost to Follow-up|0|||
155471612|NCT04507360|561148533|FG005|Week 4|Lost to Follow-up|0|||
155471613|NCT04507360|561148534|FG006|Week 4|Lost to Follow-up|0|||
155471614|NCT04507360|561148535|FG007|Week 4|Lost to Follow-up|0|||
155471615|NCT04507360|561148536|FG008|Week 4|Lost to Follow-up|131|||
155471616|NCT04507360|561148537|FG009|Week 4|Lost to Follow-up|115|||
155471617|NCT04507360|561148538|FG010|Week 4|Lost to Follow-up|102|||
155471618|NCT04507360|561148528|FG000|Week 5|Lost to Follow-up|0|||
155518863|NCT01626079|561325139|FG000|Overall Study|Withdrawal by Subject|23|||
155471619|NCT04507360|561148529|FG001|Week 5|Lost to Follow-up|0|||
155471620|NCT04507360|561148530|FG002|Week 5|Lost to Follow-up|0|||
155471621|NCT04507360|561148531|FG003|Week 5|Lost to Follow-up|0|||
155471622|NCT04507360|561148532|FG004|Week 5|Lost to Follow-up|0|||
155471623|NCT04507360|561148533|FG005|Week 5|Lost to Follow-up|0|||
155471624|NCT04507360|561148534|FG006|Week 5|Lost to Follow-up|0|||
155471625|NCT04507360|561148535|FG007|Week 5|Lost to Follow-up|0|||
155471626|NCT04507360|561148536|FG008|Week 5|Lost to Follow-up|103|||
155471627|NCT04507360|561148537|FG009|Week 5|Lost to Follow-up|135|||
155471628|NCT04507360|561148538|FG010|Week 5|Lost to Follow-up|143|||
155471629|NCT04507360|561148528|FG000|Week 8|Lost to Follow-up|0|||
155471630|NCT04507360|561148529|FG001|Week 8|Lost to Follow-up|0|||
155471631|NCT04507360|561148530|FG002|Week 8|Lost to Follow-up|0|||
155471632|NCT04507360|561148531|FG003|Week 8|Lost to Follow-up|0|||
155471633|NCT04507360|561148532|FG004|Week 8|Lost to Follow-up|0|||
155471634|NCT04507360|561148533|FG005|Week 8|Lost to Follow-up|0|||
155471635|NCT04507360|561148534|FG006|Week 8|Lost to Follow-up|0|||
155471636|NCT04507360|561148535|FG007|Week 8|Lost to Follow-up|0|||
155471637|NCT04507360|561148536|FG008|Week 8|Lost to Follow-up|139|||
155471638|NCT04507360|561148537|FG009|Week 8|Lost to Follow-up|145|||
155471639|NCT04507360|561148538|FG010|Week 8|Lost to Follow-up|152|||
155471640|NCT01432756|561148539|FG000|Overall Study|Lost to Follow-up|1|||
155471641|NCT01432756|561148540|FG001|Overall Study|Lost to Follow-up|0|||
155471642|NCT01432756|561148541|FG002|Overall Study|Lost to Follow-up|2|||
155471643|NCT01432756|561148542|FG003|Overall Study|Lost to Follow-up|1|||
155471644|NCT01004159|561148545|FG000|Overall Study|Adverse Event|2|||
155471645|NCT01004159|561148545|FG000|Overall Study|Disease Progression|18|||
155471646|NCT02712008|561148546|FG000|Baseline (Day 1) up to Week 12|Death|3|||
155471647|NCT02712008|561148547|FG001|Baseline (Day 1) up to Week 12|Death|0|||
155471648|NCT02712008|561148548|FG002|Baseline (Day 1) up to Week 12|Death|0|||
155471649|NCT02712008|561148549|FG003|Baseline (Day 1) up to Week 12|Death|0|||
155471650|NCT02712008|561148550|FG004|Baseline (Day 1) up to Week 12|Death|0|||
155471651|NCT02712008|561148551|FG005|Baseline (Day 1) up to Week 12|Death|0|||
155471652|NCT02712008|561148552|FG006|Baseline (Day 1) up to Week 12|Death|0|||
155471653|NCT02712008|561148553|FG007|Baseline (Day 1) up to Week 12|Death|0|||
155471654|NCT02712008|561148546|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471655|NCT02712008|561148547|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
155471656|NCT02712008|561148548|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
155471657|NCT02712008|561148549|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471658|NCT02712008|561148550|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471659|NCT02712008|561148551|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471660|NCT02712008|561148552|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471661|NCT02712008|561148553|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155471662|NCT02712008|561148546|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
155471663|NCT02712008|561148547|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471664|NCT02712008|561148548|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
155471665|NCT02712008|561148549|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471666|NCT02712008|561148550|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471667|NCT02712008|561148551|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471668|NCT02712008|561148552|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471669|NCT02712008|561148553|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155471670|NCT02712008|561148546|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471671|NCT02712008|561148547|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471672|NCT02712008|561148548|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
155471673|NCT02712008|561148549|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471674|NCT02712008|561148550|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471675|NCT02712008|561148551|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471676|NCT02712008|561148552|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471677|NCT02712008|561148553|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
155471678|NCT02712008|561148546|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471679|NCT02712008|561148547|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
155471680|NCT02712008|561148548|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471681|NCT02712008|561148549|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471682|NCT02712008|561148550|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471683|NCT02712008|561148551|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471684|NCT02712008|561148552|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471685|NCT02712008|561148553|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
155471686|NCT02712008|561148546|FG000|From Week 12 up to Week 36|Adverse Event|0|||
155471687|NCT02712008|561148547|FG001|From Week 12 up to Week 36|Adverse Event|0|||
155471688|NCT02712008|561148548|FG002|From Week 12 up to Week 36|Adverse Event|0|||
155471689|NCT02712008|561148549|FG003|From Week 12 up to Week 36|Adverse Event|0|||
155471690|NCT02712008|561148550|FG004|From Week 12 up to Week 36|Adverse Event|1|||
155471691|NCT02712008|561148551|FG005|From Week 12 up to Week 36|Adverse Event|0|||
155518864|NCT01626079|561325140|FG001|Overall Study|Withdrawal by Subject|37|||
155518865|NCT01626079|561325141|FG002|Overall Study|Withdrawal by Subject|5|||
155518866|NCT01626079|561325139|FG000|Overall Study|Lost to Follow-up|7|||
155518867|NCT01626079|561325140|FG001|Overall Study|Lost to Follow-up|4|||
155518868|NCT01626079|561325141|FG002|Overall Study|Lost to Follow-up|2|||
155518869|NCT01626079|561325139|FG000|Overall Study|Missed Visits|1|||
155518870|NCT01626079|561325140|FG001|Overall Study|Missed Visits|4|||
155518871|NCT01626079|561325141|FG002|Overall Study|Missed Visits|6|||
155518872|NCT00337077|561325142|FG000|Overall Study|Progressive disease|25|||
155654038|NCT00803049|561826873|FG000|Overall Study|Other than Specified Above|3|||
155471692|NCT02712008|561148552|FG006|From Week 12 up to Week 36|Adverse Event|0|||
155518873|NCT00337077|561325143|FG001|Overall Study|Progressive disease|37|||
155471693|NCT02712008|561148553|FG007|From Week 12 up to Week 36|Adverse Event|2|||
155518874|NCT00337077|561325144|FG002|Overall Study|Progressive disease|19|||
155654039|NCT00803049|561826874|FG001|Overall Study|Other than Specified Above|9|||
155471694|NCT02712008|561148546|FG000|From Week 12 up to Week 36|Death|1|||
155471695|NCT02712008|561148547|FG001|From Week 12 up to Week 36|Death|0|||
155518875|NCT00337077|561325142|FG000|Overall Study|Adverse Event|7|||
155654040|NCT00803049|561826875|FG002|Overall Study|Other than Specified Above|2|||
155471696|NCT02712008|561148548|FG002|From Week 12 up to Week 36|Death|0|||
155471697|NCT02712008|561148549|FG003|From Week 12 up to Week 36|Death|0|||
155654041|NCT00803049|561826876|FG003|Overall Study|Other than Specified Above|5|||
155471698|NCT02712008|561148550|FG004|From Week 12 up to Week 36|Death|0|||
155471699|NCT02712008|561148551|FG005|From Week 12 up to Week 36|Death|0|||
155471700|NCT02712008|561148552|FG006|From Week 12 up to Week 36|Death|1|||
155471701|NCT02712008|561148553|FG007|From Week 12 up to Week 36|Death|0|||
155471702|NCT02712008|561148546|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471703|NCT02712008|561148547|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471704|NCT02712008|561148548|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471705|NCT02712008|561148549|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
155471706|NCT02712008|561148550|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471707|NCT02712008|561148551|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471708|NCT02712008|561148552|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
155471709|NCT02712008|561148553|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
155471710|NCT02712008|561148546|FG000|From Week 12 up to Week 36|Physician Decision|0|||
155471711|NCT02712008|561148547|FG001|From Week 12 up to Week 36|Physician Decision|0|||
155471712|NCT02712008|561148548|FG002|From Week 12 up to Week 36|Physician Decision|0|||
155471713|NCT02712008|561148549|FG003|From Week 12 up to Week 36|Physician Decision|1|||
155471714|NCT02712008|561148550|FG004|From Week 12 up to Week 36|Physician Decision|1|||
155471715|NCT02712008|561148551|FG005|From Week 12 up to Week 36|Physician Decision|0|||
155471716|NCT02712008|561148552|FG006|From Week 12 up to Week 36|Physician Decision|0|||
155471717|NCT02712008|561148553|FG007|From Week 12 up to Week 36|Physician Decision|0|||
155471718|NCT02712008|561148546|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471719|NCT02712008|561148547|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471720|NCT02712008|561148548|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471721|NCT02712008|561148549|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471722|NCT02712008|561148550|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471723|NCT02712008|561148551|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
155471724|NCT02712008|561148552|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
155471725|NCT02712008|561148553|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
155471726|NCT04483544|561148555|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
155471727|NCT04483544|561148555|FG000|Post-Treatment|Admitted to hospice|2|||
155471728|NCT04483544|561148555|FG000|Post-Treatment|Study terminated|3|||
155471729|NCT01131078|561148560|FG000|Overall Study|Adverse Event|22|||
155471730|NCT01131078|561148561|FG001|Overall Study|Adverse Event|12|||
155471731|NCT01131078|561148562|FG002|Overall Study|Adverse Event|17|||
155471732|NCT01131078|561148560|FG000|Overall Study|Progressive Disease|58|||
155471733|NCT01131078|561148561|FG001|Overall Study|Progressive Disease|77|||
155471734|NCT01131078|561148562|FG002|Overall Study|Progressive Disease|71|||
155471735|NCT01131078|561148560|FG000|Overall Study|Protocol Violation|1|||
155471736|NCT01131078|561148561|FG001|Overall Study|Protocol Violation|0|||
155471737|NCT01131078|561148562|FG002|Overall Study|Protocol Violation|0|||
155471738|NCT01131078|561148560|FG000|Overall Study|Lost to Follow-up|1|||
155471739|NCT01131078|561148561|FG001|Overall Study|Lost to Follow-up|1|||
155471740|NCT01131078|561148562|FG002|Overall Study|Lost to Follow-up|1|||
155471741|NCT01131078|561148560|FG000|Overall Study|Withdrawal by Subject|2|||
155471742|NCT01131078|561148561|FG001|Overall Study|Withdrawal by Subject|4|||
155471743|NCT01131078|561148562|FG002|Overall Study|Withdrawal by Subject|3|||
155471744|NCT01131078|561148560|FG000|Overall Study|Non-compliance|3|||
155471745|NCT01131078|561148561|FG001|Overall Study|Non-compliance|0|||
155471746|NCT01131078|561148562|FG002|Overall Study|Non-compliance|0|||
155471747|NCT01131078|561148560|FG000|Overall Study|Physician Decision|10|||
155471748|NCT01131078|561148561|FG001|Overall Study|Physician Decision|6|||
155471749|NCT01131078|561148562|FG002|Overall Study|Physician Decision|8|||
155518876|NCT00337077|561325143|FG001|Overall Study|Adverse Event|7|||
155518877|NCT00337077|561325144|FG002|Overall Study|Adverse Event|1|||
155518878|NCT00337077|561325142|FG000|Overall Study|Death|0|||
155518879|NCT00337077|561325143|FG001|Overall Study|Death|1|||
155518880|NCT00337077|561325144|FG002|Overall Study|Death|0|||
155518881|NCT00337077|561325142|FG000|Overall Study|Withdrawal by Subject|7|||
155518882|NCT00337077|561325143|FG001|Overall Study|Withdrawal by Subject|2|||
155518883|NCT00337077|561325144|FG002|Overall Study|Withdrawal by Subject|2|||
155518884|NCT00337077|561325142|FG000|Overall Study|Alternative therapy|1|||
155518885|NCT00337077|561325143|FG001|Overall Study|Alternative therapy|0|||
155518886|NCT00337077|561325144|FG002|Overall Study|Alternative therapy|0|||
155518887|NCT00337077|561325142|FG000|Overall Study|Physician Decision|1|||
155471750|NCT01131078|561148560|FG000|Overall Study|Death|4|||
155471751|NCT01131078|561148561|FG001|Overall Study|Death|0|||
155471752|NCT01131078|561148562|FG002|Overall Study|Death|2|||
155471753|NCT01131078|561148560|FG000|Overall Study|Other|0|||
155471754|NCT01131078|561148561|FG001|Overall Study|Other|1|||
155471755|NCT01131078|561148562|FG002|Overall Study|Other|0|||
155518888|NCT00337077|561325143|FG001|Overall Study|Physician Decision|4|||
155518889|NCT00337077|561325144|FG002|Overall Study|Physician Decision|2|||
155518890|NCT00337077|561325142|FG000|Overall Study|Never started treatment|1|||
155471756|NCT00736385|561148563|FG000|Overall Study|Withdrawal by Subject|2|||
155471757|NCT00736385|561148564|FG001|Overall Study|Withdrawal by Subject|2|||
155471758|NCT00736385|561148563|FG000|Overall Study|Adverse Event|0|||
155518891|NCT00337077|561325143|FG001|Overall Study|Never started treatment|1|||
155471759|NCT00736385|561148564|FG001|Overall Study|Adverse Event|1|||
155471760|NCT00098865|561148565|FG000|Overall Study|Progressive Disease|6|||
155471761|NCT00098865|561148565|FG000|Overall Study|Adverse Event|2|||
155471762|NCT00098865|561148565|FG000|Overall Study|Alternative Therapy|1|||
155471763|NCT00364351|561148566|FG000|Overall Study|Adverse Event|90|||
155654042|NCT04126174|561826877|FG000|Overall Study|Lost to Follow-up|3|||
155471764|NCT00364351|561148567|FG001|Overall Study|Adverse Event|44|||
155471765|NCT00364351|561148566|FG000|Overall Study|Condition under investigation worsened|469|||
155471766|NCT00364351|561148567|FG001|Overall Study|Condition under investigation worsened|497|||
155471767|NCT00364351|561148566|FG000|Overall Study|Prohibited concomitant medication|0|||
155471768|NCT00364351|561148567|FG001|Overall Study|Prohibited concomitant medication|2|||
155471769|NCT00364351|561148566|FG000|Overall Study|Lost to Follow-up|1|||
155471770|NCT00364351|561148567|FG001|Overall Study|Lost to Follow-up|1|||
155471771|NCT00364351|561148566|FG000|Overall Study|Withdrawal by Subject|30|||
155471772|NCT00364351|561148567|FG001|Overall Study|Withdrawal by Subject|29|||
155471773|NCT00364351|561148566|FG000|Overall Study|Incorrect enrollment|1|||
155471774|NCT00364351|561148567|FG001|Overall Study|Incorrect enrollment|1|||
155471775|NCT00364351|561148566|FG000|Overall Study|Sponsor decision|1|||
155471776|NCT00364351|561148567|FG001|Overall Study|Sponsor decision|0|||
155471777|NCT00364351|561148566|FG000|Overall Study|Poor treatment compliance|0|||
155471778|NCT00364351|561148567|FG001|Overall Study|Poor treatment compliance|3|||
155471779|NCT00364351|561148566|FG000|Overall Study|Investigator error|0|||
155471780|NCT00364351|561148567|FG001|Overall Study|Investigator error|2|||
155471781|NCT00364351|561148566|FG000|Overall Study|Patient could not travel to site|0|||
155471782|NCT00364351|561148567|FG001|Overall Study|Patient could not travel to site|1|||
155471783|NCT00364351|561148566|FG000|Overall Study|Randomised treatment not started|0|||
155471784|NCT00364351|561148567|FG001|Overall Study|Randomised treatment not started|3|||
155471785|NCT00653068|561148568|FG000|Overall Study|Death|9|||
155471786|NCT00653068|561148568|FG000|Overall Study|Lack of Efficacy|34|||
155471787|NCT00653068|561148568|FG000|Overall Study|Physician Decision|4|||
155471788|NCT00653068|561148568|FG000|Overall Study|Withdrawal by Subject|1|||
155471789|NCT00653068|561148568|FG000|Overall Study|Ineligible|2|||
155471790|NCT02177786|561148569|FG000|Overall Study|Withdrew Consent|2|||
155471791|NCT02177786|561148570|FG001|Overall Study|Withdrew Consent|6|||
155471792|NCT02177786|561148571|FG002|Overall Study|Withdrew Consent|9|||
155471793|NCT02177786|561148572|FG003|Overall Study|Withdrew Consent|5|||
155654043|NCT04126174|561826878|FG001|Overall Study|Lost to Follow-up|3|||
155654044|NCT01272219|561826889|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
155654045|NCT01272219|561826890|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
155654046|NCT01272219|561826891|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
155471794|NCT02177786|561148569|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
155471795|NCT02177786|561148570|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
155471796|NCT02177786|561148571|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
155471797|NCT02177786|561148572|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
155471798|NCT02177786|561148569|FG000|Overall Study|Adverse Event|1|||
155471799|NCT02177786|561148570|FG001|Overall Study|Adverse Event|1|||
155471800|NCT02177786|561148571|FG002|Overall Study|Adverse Event|2|||
155471801|NCT02177786|561148572|FG003|Overall Study|Adverse Event|3|||
155471802|NCT02177786|561148569|FG000|Overall Study|Death|1|||
155471803|NCT02177786|561148570|FG001|Overall Study|Death|1|||
155471804|NCT02177786|561148571|FG002|Overall Study|Death|1|||
155471805|NCT02177786|561148572|FG003|Overall Study|Death|1|||
155471806|NCT02177786|561148569|FG000|Overall Study|Lost to Follow-up|0|||
155471807|NCT02177786|561148570|FG001|Overall Study|Lost to Follow-up|0|||
155471808|NCT02177786|561148571|FG002|Overall Study|Lost to Follow-up|2|||
155471809|NCT02177786|561148572|FG003|Overall Study|Lost to Follow-up|2|||
155471810|NCT02177786|561148569|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155471811|NCT02177786|561148570|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155471812|NCT02177786|561148571|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155471813|NCT02177786|561148572|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155471814|NCT02177786|561148569|FG000|Overall Study|Protocol Violation|0|||
155471815|NCT02177786|561148570|FG001|Overall Study|Protocol Violation|0|||
155471816|NCT02177786|561148571|FG002|Overall Study|Protocol Violation|2|||
155471817|NCT02177786|561148572|FG003|Overall Study|Protocol Violation|0|||
155471818|NCT02177786|561148569|FG000|Overall Study|Progressive Disease|0|||
155471819|NCT02177786|561148570|FG001|Overall Study|Progressive Disease|1|||
155518892|NCT00337077|561325144|FG002|Overall Study|Never started treatment|0|||
155471820|NCT02177786|561148571|FG002|Overall Study|Progressive Disease|0|||
155518893|NCT00337077|561325142|FG000|Overall Study|Ineligible|1|||
155471821|NCT02177786|561148572|FG003|Overall Study|Progressive Disease|0|||
155471822|NCT02177786|561148569|FG000|Overall Study|Missing study completion status|0|||
155471823|NCT02177786|561148570|FG001|Overall Study|Missing study completion status|1|||
155518894|NCT00337077|561325143|FG001|Overall Study|Ineligible|1|||
155518895|NCT00337077|561325144|FG002|Overall Study|Ineligible|1|||
155518896|NCT02899338|561325145|FG000|Overall Study|Adverse Event|1|||
155518897|NCT02899338|561325146|FG001|Overall Study|Adverse Event|2|||
155518898|NCT02899338|561325145|FG000|Overall Study|Withdrawal by Subject|2|||
155518899|NCT02899338|561325146|FG001|Overall Study|Withdrawal by Subject|0|||
155518900|NCT01457053|561325147|FG000|Overall Study|Unable to undergo selected treatment|1|||
155518901|NCT01457053|561325148|FG001|Overall Study|Unable to undergo selected treatment|1|||
155518902|NCT00814463|561325149|FG000|Overall Study|Lost to Follow-up|1|||
155471824|NCT02177786|561148571|FG002|Overall Study|Missing study completion status|0|||
155471825|NCT02177786|561148572|FG003|Overall Study|Missing study completion status|0|||
155471826|NCT01305941|561148573|FG000|Overall Study|Adverse Event|6|||
155471827|NCT01305941|561148573|FG000|Overall Study|Clinical decline|2|||
155471828|NCT01305941|561148573|FG000|Overall Study|Withdrawal by Subject|1|||
155471829|NCT01305941|561148573|FG000|Overall Study|Death|1|||
155471830|NCT03950440|561148574|FG000|Overall Study|Death|8|||
155471831|NCT03950440|561148575|FG001|Overall Study|Death|2|||
155471832|NCT03950440|561148576|FG002|Overall Study|Death|1|||
155471833|NCT02892734|561148577|FG000|Treatment on Study|Progressive Disease|2|||
155471834|NCT02892734|561148577|FG000|Follow up for 2 Years|Death|2|||
155471835|NCT02892734|561148577|FG000|Follow up for 2 Years|Study closed early|1|||
155471836|NCT02043509|561148578|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
155471837|NCT02043509|561148579|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
155471838|NCT02043509|561148578|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
155471839|NCT02043509|561148579|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
155471840|NCT02043509|561148578|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
155471841|NCT02043509|561148579|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
155471842|NCT02043509|561148578|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
155471843|NCT02043509|561148579|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
155471844|NCT00608244|561148585|FG000|Overall Study|Adverse Event|1|||
155471845|NCT00608244|561148585|FG000|Overall Study|Low trough levels|1|||
155471846|NCT00430027|561148586|FG000|Overall Study|Study terminated|8|||
155471847|NCT01685060|561148591|FG000|Overall Study|Rollover patients|16|||
155471848|NCT01685060|561148591|FG000|Overall Study|Adverse Event|12|||
155471849|NCT01685060|561148591|FG000|Overall Study|Progressive disease|69|||
155471850|NCT01685060|561148591|FG000|Overall Study|Physician Decision|14|||
155471851|NCT01685060|561148591|FG000|Overall Study|Subject/guardian decision|20|||
155471852|NCT01685060|561148591|FG000|Overall Study|Lost to Follow-up|1|||
155471853|NCT01685060|561148591|FG000|Overall Study|Death|8|||
155471854|NCT02158728|561148604|FG000|Overall Study|no procedure according to CIP done|3|||
155471855|NCT02158728|561148604|FG000|Overall Study|no qualified dataset|24|||
155471856|NCT01536418|561148612|FG000|Overall Study|Protocol Violation|2|||
155471857|NCT01536418|561148613|FG001|Overall Study|Protocol Violation|3|||
155471858|NCT01536418|561148612|FG000|Overall Study|Physician Decision|1|||
155471859|NCT01536418|561148613|FG001|Overall Study|Physician Decision|3|||
155471860|NCT01536418|561148612|FG000|Overall Study|Study closed/terminated|41|||
155471861|NCT01536418|561148613|FG001|Overall Study|Study closed/terminated|37|||
155471862|NCT01536418|561148612|FG000|Overall Study|Lack of Efficacy|10|||
155471863|NCT01536418|561148613|FG001|Overall Study|Lack of Efficacy|16|||
155471864|NCT01536418|561148612|FG000|Overall Study|Adverse Event|9|||
155471865|NCT01536418|561148613|FG001|Overall Study|Adverse Event|4|||
155471866|NCT01536418|561148612|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
155471867|NCT01536418|561148613|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
155471868|NCT01536418|561148612|FG000|Overall Study|Withdrawal by Subject|5|||
155471869|NCT01536418|561148613|FG001|Overall Study|Withdrawal by Subject|3|||
155471870|NCT02658149|561148618|FG000|Overall Study|Physician Decision|1|||
155471871|NCT02658149|561148619|FG001|Overall Study|Physician Decision|0|||
155471872|NCT00711412|561148620|FG000|Induction Treatment|Death|2|||
155518903|NCT01370408|561325150|FG000|Overall Study|treatment failure|9|||
155471873|NCT00711412|561148620|FG000|Induction Treatment|Adverse Event|1|||
155518904|NCT02073643|561325151|FG000|Overall Study|Lost to Follow-up|24|||
155518905|NCT02430870|561325153|FG000|Part 2|Voluntary Withdrawal|0|||
155518906|NCT02430870|561325154|FG001|Part 2|Voluntary Withdrawal|0|||
155518907|NCT02430870|561325155|FG002|Part 2|Voluntary Withdrawal|0|||
155518908|NCT02430870|561325156|FG003|Part 2|Voluntary Withdrawal|0|||
155471874|NCT00711412|561148620|FG000|Induction Treatment|Other|1|||
155471875|NCT00711412|561148620|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
155471876|NCT00711412|561148620|FG000|Evaluated for Combination Treatment|Death|1|||
155471877|NCT00711412|561148620|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
155471878|NCT00711412|561148620|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
155471879|NCT00711412|561148620|FG000|Combination Treatment|Progressive Disease|1|||
155471880|NCT00711412|561148620|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
155471881|NCT00711412|561148620|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
155471882|NCT00711412|561148620|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
155471883|NCT00711412|561148620|FG000|Evaluation for Response and Surgery|Death|1|||
155471884|NCT00711412|561148620|FG000|Survival Follow up Until Death|Other|12|||
155471885|NCT04097028|561148621|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
155471886|NCT04097028|561148621|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
155471887|NCT04097028|561148621|FG000|Overall Study|Disease Progression prior to Surgery|2|||
155471888|NCT04097028|561148621|FG000|Overall Study|Adverse Event prior to Surgery|1|||
155471889|NCT02473289|561148622|FG000|Overall Study|Adverse Event|2|||
155471890|NCT02473289|561148623|FG001|Overall Study|Adverse Event|3|||
155471891|NCT02473289|561148622|FG000|Overall Study|Lost to Follow-up|1|||
155471892|NCT02473289|561148623|FG001|Overall Study|Lost to Follow-up|1|||
155471893|NCT02473289|561148622|FG000|Overall Study|Protocol Violation|0|||
155471894|NCT02473289|561148623|FG001|Overall Study|Protocol Violation|1|||
155471895|NCT02473289|561148622|FG000|Overall Study|Withdrawal of consent|6|||
155471896|NCT02473289|561148623|FG001|Overall Study|Withdrawal of consent|7|||
155471897|NCT02473289|561148622|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
155471898|NCT02473289|561148623|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
155471899|NCT02473289|561148622|FG000|Overall Study|Other|2|||
155471900|NCT02473289|561148623|FG001|Overall Study|Other|0|||
155471901|NCT02244619|561148624|FG000|Overall Study|Did not receive study intervention|8|||
155471902|NCT02244619|561148625|FG001|Overall Study|Did not receive study intervention|21|||
155471903|NCT01156363|561148626|FG000|Overall Study|Adverse Event|6|||
155471904|NCT01156363|561148626|FG000|Overall Study|Insufficient Therapeutic Response|5|||
155471905|NCT01156363|561148626|FG000|Overall Study|Failure to Return|1|||
155471906|NCT01156363|561148626|FG000|Overall Study|Refused Treatment|4|||
155471907|NCT01156363|561148626|FG000|Overall Study|Other|6|||
155471908|NCT03285490|561148628|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
155471909|NCT03285490|561148629|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
155471910|NCT03285490|561148628|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
155471911|NCT03285490|561148629|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
155471912|NCT03745989|561148630|FG000|Overall Study|Death|3|||
155471913|NCT03745989|561148631|FG001|Overall Study|Death|7|||
155471914|NCT03745989|561148632|FG002|Overall Study|Death|4|||
155471915|NCT03745989|561148630|FG000|Overall Study|Lost to Follow-up|0|||
155471916|NCT03745989|561148631|FG001|Overall Study|Lost to Follow-up|2|||
155471917|NCT03745989|561148632|FG002|Overall Study|Lost to Follow-up|0|||
155471918|NCT03745989|561148630|FG000|Overall Study|Sponsor Decision|0|||
155471919|NCT03745989|561148631|FG001|Overall Study|Sponsor Decision|2|||
155471920|NCT03745989|561148632|FG002|Overall Study|Sponsor Decision|8|||
155471921|NCT03745989|561148630|FG000|Overall Study|Withdrawal by Subject|0|||
155471922|NCT03745989|561148631|FG001|Overall Study|Withdrawal by Subject|1|||
155471923|NCT03745989|561148632|FG002|Overall Study|Withdrawal by Subject|3|||
155471924|NCT00068822|561148633|FG000|First Randomized Intervention|Lost to Follow-up|1|||
155471925|NCT00068822|561148634|FG001|First Randomized Intervention|Lost to Follow-up|2|||
155471926|NCT00735072|561148640|FG000|Overall Study|interrupted study med during ARV change|1|||
155471927|NCT00735072|561148641|FG001|Overall Study|interrupted study med during ARV change|0|||
155471928|NCT00735072|561148640|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
155471929|NCT00735072|561148641|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
155471930|NCT00911144|561148642|FG000|Overall Study|Withdrawal by Subject|16|||
155471931|NCT00911144|561148643|FG001|Overall Study|Withdrawal by Subject|5|||
155471932|NCT00047008|561148645|FG000|Overall Study|Withdrawn consent|2|||
155518909|NCT02430870|561325157|FG004|Part 2|Voluntary Withdrawal|0|||
155518910|NCT02430870|561325158|FG005|Part 2|Voluntary Withdrawal|0|||
155518911|NCT02430870|561325159|FG006|Part 2|Voluntary Withdrawal|1|||
155471933|NCT00047008|561148646|FG001|Overall Study|Withdrawn consent|3|||
155471934|NCT00047008|561148645|FG000|Overall Study|Ineligible|9|||
155471935|NCT00047008|561148646|FG001|Overall Study|Ineligible|8|||
155471936|NCT00429572|561148647|FG000|Overall Study|Disease progression|1|||
155471937|NCT02773368|561148648|FG000|Overall Study|Lost to Follow-up|4|||
155471938|NCT02773368|561148649|FG001|Overall Study|Lost to Follow-up|1|||
155471939|NCT02773368|561148648|FG000|Overall Study|Withdrawal by Subject|5|||
155471940|NCT02773368|561148649|FG001|Overall Study|Withdrawal by Subject|1|||
155471941|NCT02773368|561148648|FG000|Overall Study|Unclassified|1|||
155471942|NCT02773368|561148649|FG001|Overall Study|Unclassified|1|||
155471943|NCT02773368|561148648|FG000|Overall Study|Missing|0|||
155471944|NCT02773368|561148649|FG001|Overall Study|Missing|1|||
155471945|NCT01047436|561148653|FG000|Overall Study|Protocol Violation|1|||
155471946|NCT01047436|561148654|FG001|Overall Study|Protocol Violation|0|||
155471947|NCT02635867|561148657|FG000|Overall Study|Lost to Follow-up|4|||
155471948|NCT02635867|561148658|FG001|Overall Study|Lost to Follow-up|3|||
155471949|NCT02635867|561148659|FG002|Overall Study|Lost to Follow-up|3|||
155471950|NCT02635867|561148660|FG003|Overall Study|Lost to Follow-up|4|||
155471951|NCT02635867|561148661|FG004|Overall Study|Lost to Follow-up|1|||
155471952|NCT02565576|561148664|FG000|Overall Study|abnormal lab value|2|||
155471953|NCT02565576|561148665|FG001|Overall Study|abnormal lab value|0|||
155471954|NCT02565576|561148664|FG000|Overall Study|subject / guardian decision|1|||
155471955|NCT02565576|561148665|FG001|Overall Study|subject / guardian decision|3|||
155471956|NCT02565576|561148664|FG000|Overall Study|Lost to Follow-up|1|||
155471957|NCT02565576|561148665|FG001|Overall Study|Lost to Follow-up|0|||
155471958|NCT02565576|561148664|FG000|Overall Study|Death|0|||
155471959|NCT02565576|561148665|FG001|Overall Study|Death|2|||
155471960|NCT02565576|561148664|FG000|Overall Study|Adverse Event|1|||
155471961|NCT02565576|561148665|FG001|Overall Study|Adverse Event|0|||
155471962|NCT00939341|561148666|FG000|Overall Study|Adverse Event|15|||
155471963|NCT00939341|561148666|FG000|Overall Study|Pregnancy|1|||
155471964|NCT00939341|561148666|FG000|Overall Study|Lost to Follow-up|23|||
155471965|NCT00939341|561148666|FG000|Overall Study|Withdrawal by Subject|13|||
155471966|NCT00939341|561148666|FG000|Overall Study|Protocol Violation|6|||
155471967|NCT00939341|561148666|FG000|Overall Study|Incorrect enrolment|8|||
155471968|NCT00424099|561148667|FG000|Overall Study|Adverse Event|0|||
155471969|NCT00424099|561148668|FG001|Overall Study|Adverse Event|1|||
155471970|NCT00424099|561148669|FG002|Overall Study|Adverse Event|1|||
155471971|NCT00424099|561148670|FG003|Overall Study|Adverse Event|0|||
155471972|NCT00424099|561148667|FG000|Overall Study|Death|0|||
155471973|NCT00424099|561148668|FG001|Overall Study|Death|1|||
155471974|NCT00424099|561148669|FG002|Overall Study|Death|0|||
155471975|NCT00424099|561148670|FG003|Overall Study|Death|0|||
155471976|NCT00424099|561148667|FG000|Overall Study|Illness|2|||
155471977|NCT00424099|561148668|FG001|Overall Study|Illness|0|||
155471978|NCT00424099|561148669|FG002|Overall Study|Illness|1|||
155471979|NCT00424099|561148670|FG003|Overall Study|Illness|4|||
155471980|NCT00424099|561148667|FG000|Overall Study|Lost to Follow-up|0|||
155471981|NCT00424099|561148668|FG001|Overall Study|Lost to Follow-up|0|||
155471982|NCT00424099|561148669|FG002|Overall Study|Lost to Follow-up|3|||
155471983|NCT00424099|561148670|FG003|Overall Study|Lost to Follow-up|0|||
155471984|NCT00424099|561148667|FG000|Overall Study|Hospitalized|1|||
155471985|NCT00424099|561148668|FG001|Overall Study|Hospitalized|2|||
155471986|NCT00424099|561148669|FG002|Overall Study|Hospitalized|1|||
155471987|NCT00424099|561148670|FG003|Overall Study|Hospitalized|3|||
155471988|NCT00424099|561148667|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
155471989|NCT00424099|561148668|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
155471990|NCT00424099|561148669|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
155471991|NCT00424099|561148670|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
155471992|NCT00424099|561148667|FG000|Overall Study|Withdrawal by Subject|1|||
155471993|NCT00424099|561148668|FG001|Overall Study|Withdrawal by Subject|9|||
155471994|NCT00424099|561148669|FG002|Overall Study|Withdrawal by Subject|4|||
155471995|NCT00424099|561148670|FG003|Overall Study|Withdrawal by Subject|6|||
155471996|NCT00424099|561148667|FG000|Overall Study|Physician Decision|0|||
155471997|NCT00424099|561148668|FG001|Overall Study|Physician Decision|0|||
155471998|NCT00424099|561148669|FG002|Overall Study|Physician Decision|1|||
155471999|NCT00424099|561148670|FG003|Overall Study|Physician Decision|0|||
155472000|NCT00424099|561148667|FG000|Overall Study|Missing|0|||
155472001|NCT00424099|561148668|FG001|Overall Study|Missing|0|||
155472002|NCT00424099|561148669|FG002|Overall Study|Missing|1|||
155654047|NCT01272219|561826892|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
155654048|NCT01272219|561826893|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
155472003|NCT00424099|561148670|FG003|Overall Study|Missing|0|||
155472004|NCT01408732|561148671|FG000|Overall Study|Withdrawal by Subject|2|||
155472005|NCT01408732|561148672|FG001|Overall Study|Withdrawal by Subject|2|||
155472006|NCT00764322|561148674|FG000|Overall Study|Withdrawal by Subject|11|||
155472007|NCT00764322|561148674|FG000|Overall Study|No CYP2D6 genotyping|9|||
155472008|NCT03097133|561148675|FG000|Overall Study|Lost to Follow-up|3|||
155472009|NCT03097133|561148676|FG001|Overall Study|Lost to Follow-up|2|||
155472010|NCT03097133|561148675|FG000|Overall Study|Withdrawal by Subject|2|||
155472011|NCT03097133|561148676|FG001|Overall Study|Withdrawal by Subject|5|||
155472012|NCT03097133|561148675|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
155472013|NCT03097133|561148676|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
155472014|NCT03097133|561148675|FG000|Overall Study|Other|3|||
155472015|NCT03097133|561148676|FG001|Overall Study|Other|2|||
155472016|NCT03097133|561148675|FG000|Overall Study|Adverse Event|1|||
155472017|NCT03097133|561148676|FG001|Overall Study|Adverse Event|0|||
155472018|NCT02910089|561148679|FG000|Overall Study|Lost insurance eligibility|22|||
155472019|NCT02910089|561148680|FG001|Overall Study|Lost insurance eligibility|16|||
155472020|NCT00633360|561148681|FG000|Overall Study|Lost to Follow-up|1|||
155472021|NCT00633360|561148682|FG001|Overall Study|Lost to Follow-up|1|||
155472022|NCT00633360|561148681|FG000|Overall Study|Adverse Event|3|||
155472023|NCT00633360|561148682|FG001|Overall Study|Adverse Event|1|||
155472024|NCT00633360|561148681|FG000|Overall Study|Protocol Violation|0|||
155472025|NCT00633360|561148682|FG001|Overall Study|Protocol Violation|1|||
155472026|NCT00329784|561148683|FG000|Overall Study|Lost to Follow-up|0|||
155472027|NCT00329784|561148684|FG001|Overall Study|Lost to Follow-up|1|||
155472028|NCT00329784|561148685|FG002|Overall Study|Lost to Follow-up|0|||
155472029|NCT00329784|561148686|FG003|Overall Study|Lost to Follow-up|0|||
155472030|NCT00329784|561148683|FG000|Overall Study|Withdrawal by Subject|4|||
155472031|NCT00329784|561148684|FG001|Overall Study|Withdrawal by Subject|2|||
155472032|NCT00329784|561148685|FG002|Overall Study|Withdrawal by Subject|0|||
155472033|NCT00329784|561148686|FG003|Overall Study|Withdrawal by Subject|0|||
155472034|NCT00329784|561148683|FG000|Overall Study|Other|1|||
155472035|NCT00329784|561148684|FG001|Overall Study|Other|2|||
155472036|NCT00329784|561148685|FG002|Overall Study|Other|0|||
155472037|NCT00329784|561148686|FG003|Overall Study|Other|0|||
155472038|NCT03236506|561148689|FG000|Overall Study|Death|1|||
155472039|NCT03236506|561148690|FG001|Overall Study|Death|1|||
155472040|NCT03236506|561148691|FG002|Overall Study|Death|1|||
155472041|NCT03236506|561148689|FG000|Overall Study|Withdrawal by Subject|3|||
155472042|NCT03236506|561148690|FG001|Overall Study|Withdrawal by Subject|3|||
155472043|NCT03236506|561148691|FG002|Overall Study|Withdrawal by Subject|4|||
155472044|NCT03236506|561148689|FG000|Overall Study|Did not initiate treatment|2|||
155472045|NCT03236506|561148690|FG001|Overall Study|Did not initiate treatment|1|||
155472046|NCT03236506|561148691|FG002|Overall Study|Did not initiate treatment|2|||
155472047|NCT00643448|561148696|FG000|Overall Study|Lack of Efficacy|2|||
155472048|NCT00643448|561148697|FG001|Overall Study|Lack of Efficacy|0|||
155472049|NCT00643448|561148698|FG002|Overall Study|Lack of Efficacy|4|||
155472050|NCT00643448|561148696|FG000|Overall Study|Adverse Event|2|||
155472051|NCT00643448|561148697|FG001|Overall Study|Adverse Event|2|||
155472052|NCT00643448|561148698|FG002|Overall Study|Adverse Event|2|||
155472053|NCT00643448|561148696|FG000|Overall Study|QTcF>550 ms|0|||
155472054|NCT00643448|561148697|FG001|Overall Study|QTcF>550 ms|3|||
155472055|NCT00643448|561148698|FG002|Overall Study|QTcF>550 ms|0|||
155472056|NCT00981682|561148699|FG000|Overall Study|Adverse Event|48|||
155472057|NCT00981682|561148699|FG000|Overall Study|Withdrawal by Subject|52|||
155472058|NCT00981682|561148699|FG000|Overall Study|Lost to Follow-up|14|||
155472059|NCT00981682|561148699|FG000|Overall Study|Lack of Efficacy|13|||
155472060|NCT00981682|561148699|FG000|Overall Study|Protocol Violation|6|||
155472061|NCT00981682|561148699|FG000|Overall Study|administrative|9|||
155472062|NCT03695471|561150564|FG000|Overall Study|Cancellation|1|||
155472063|NCT00400946|561150565|FG000|Overall Study|Ineligible|0|||
155472064|NCT00400946|561150566|FG001|Overall Study|Ineligible|0|||
155472065|NCT00400946|561150567|FG002|Overall Study|Ineligible|0|||
155472066|NCT00400946|561150568|FG003|Overall Study|Ineligible|5|||
155472067|NCT00400946|561150569|FG004|Overall Study|Ineligible|1|||
155472068|NCT00400946|561150565|FG000|Overall Study|Induction Failure|0|||
155472069|NCT00400946|561150566|FG001|Overall Study|Induction Failure|0|||
155472070|NCT00400946|561150567|FG002|Overall Study|Induction Failure|0|||
155472071|NCT00400946|561150568|FG003|Overall Study|Induction Failure|11|||
155472072|NCT00400946|561150569|FG004|Overall Study|Induction Failure|8|||
155472073|NCT00400946|561150565|FG000|Overall Study|Induction Death|0|||
155472074|NCT00400946|561150566|FG001|Overall Study|Induction Death|0|||
155472075|NCT00400946|561150567|FG002|Overall Study|Induction Death|0|||
155472076|NCT00400946|561150568|FG003|Overall Study|Induction Death|13|||
155472077|NCT00400946|561150569|FG004|Overall Study|Induction Death|3|||
155472078|NCT00400946|561150565|FG000|Overall Study|Lost to Follow-up|1|||
155472079|NCT00400946|561150566|FG001|Overall Study|Lost to Follow-up|1|||
155472080|NCT00400946|561150567|FG002|Overall Study|Lost to Follow-up|0|||
155472081|NCT00400946|561150568|FG003|Overall Study|Lost to Follow-up|0|||
155472082|NCT00400946|561150569|FG004|Overall Study|Lost to Follow-up|1|||
155472083|NCT00400946|561150565|FG000|Overall Study|Remission Death|1|||
155518912|NCT02430870|561325160|FG007|Part 2|Voluntary Withdrawal|0|||
155472084|NCT00400946|561150566|FG001|Overall Study|Remission Death|1|||
155472085|NCT00400946|561150567|FG002|Overall Study|Remission Death|0|||
155472086|NCT00400946|561150568|FG003|Overall Study|Remission Death|0|||
155472087|NCT00400946|561150569|FG004|Overall Study|Remission Death|1|||
155472088|NCT00400946|561150565|FG000|Overall Study|Relapse|9|||
155472089|NCT00400946|561150566|FG001|Overall Study|Relapse|2|||
155472090|NCT00400946|561150567|FG002|Overall Study|Relapse|1|||
155472091|NCT00400946|561150568|FG003|Overall Study|Relapse|1|||
155472092|NCT00400946|561150569|FG004|Overall Study|Relapse|5|||
155472093|NCT00400946|561150565|FG000|Overall Study|Transplant in CR1|0|||
155472094|NCT00400946|561150566|FG001|Overall Study|Transplant in CR1|0|||
155472095|NCT00400946|561150567|FG002|Overall Study|Transplant in CR1|0|||
155472096|NCT00400946|561150568|FG003|Overall Study|Transplant in CR1|10|||
155472097|NCT00400946|561150569|FG004|Overall Study|Transplant in CR1|1|||
155472098|NCT00400946|561150565|FG000|Overall Study|Withdrawal by Subject|2|||
155472099|NCT00400946|561150566|FG001|Overall Study|Withdrawal by Subject|5|||
155472100|NCT00400946|561150567|FG002|Overall Study|Withdrawal by Subject|1|||
155472101|NCT00400946|561150568|FG003|Overall Study|Withdrawal by Subject|5|||
155472102|NCT00400946|561150569|FG004|Overall Study|Withdrawal by Subject|8|||
155472103|NCT00400946|561150565|FG000|Overall Study|Clinical|1|||
155472104|NCT00400946|561150566|FG001|Overall Study|Clinical|2|||
155472105|NCT00400946|561150567|FG002|Overall Study|Clinical|0|||
155472106|NCT00400946|561150568|FG003|Overall Study|Clinical|2|||
155472107|NCT00400946|561150569|FG004|Overall Study|Clinical|9|||
155472108|NCT00400946|561150565|FG000|Overall Study|Other|0|||
155472109|NCT00400946|561150566|FG001|Overall Study|Other|0|||
155472110|NCT00400946|561150567|FG002|Overall Study|Other|0|||
155472111|NCT00400946|561150568|FG003|Overall Study|Other|0|||
155472112|NCT00400946|561150569|FG004|Overall Study|Other|1|||
155472113|NCT03050307|561150571|FG000|Overall Study|Adverse Event|4|||
155472114|NCT03050307|561150572|FG001|Overall Study|Adverse Event|2|||
155472115|NCT03050307|561150571|FG000|Overall Study|Significant Protocol Deviation|0|||
155472116|NCT03050307|561150572|FG001|Overall Study|Significant Protocol Deviation|1|||
155472117|NCT03050307|561150571|FG000|Overall Study|Lost to Follow-up|0|||
155472118|NCT03050307|561150572|FG001|Overall Study|Lost to Follow-up|1|||
155472119|NCT03050307|561150571|FG000|Overall Study|Voluntary Withdrawal|3|||
155472120|NCT03050307|561150572|FG001|Overall Study|Voluntary Withdrawal|4|||
155472121|NCT03050307|561150571|FG000|Overall Study|Reason not Specified|1|||
155472122|NCT03050307|561150572|FG001|Overall Study|Reason not Specified|1|||
155472123|NCT00439309|561150573|FG000|Follow-Up|Death|1|||
155472124|NCT00439309|561150574|FG001|Follow-Up|Death|0|||
155472125|NCT00439309|561150573|FG000|Follow-Up|Lost to Follow-up|2|||
155472126|NCT00439309|561150574|FG001|Follow-Up|Lost to Follow-up|0|||
155472127|NCT00439309|561150573|FG000|Follow-Up|Withdrawal by Subject|0|||
155472128|NCT00439309|561150574|FG001|Follow-Up|Withdrawal by Subject|1|||
155472129|NCT00439309|561150573|FG000|Follow-Up|Late response by subject|0|||
155472130|NCT00439309|561150574|FG001|Follow-Up|Late response by subject|1|||
155472131|NCT00464620|561150575|FG000|Overall Study|Physician Decision|1|||
155472132|NCT00464620|561150576|FG001|Overall Study|Physician Decision|0|||
155472133|NCT00464620|561150577|FG002|Overall Study|Physician Decision|0|||
155472134|NCT00464620|561150575|FG000|Overall Study|Withdrawal by Subject|1|||
155472135|NCT00464620|561150576|FG001|Overall Study|Withdrawal by Subject|0|||
155472136|NCT00464620|561150577|FG002|Overall Study|Withdrawal by Subject|3|||
155472137|NCT00464620|561150575|FG000|Overall Study|Ineligible sarcoma subtype|0|||
155472138|NCT00464620|561150576|FG001|Overall Study|Ineligible sarcoma subtype|2|||
155472139|NCT00464620|561150577|FG002|Overall Study|Ineligible sarcoma subtype|2|||
155472140|NCT00464620|561150575|FG000|Overall Study|Use of prohibited concomitant medication|0|||
155472141|NCT00464620|561150576|FG001|Overall Study|Use of prohibited concomitant medication|0|||
155472142|NCT00464620|561150577|FG002|Overall Study|Use of prohibited concomitant medication|2|||
155472143|NCT01998906|561150578|FG000|Overall Study|Participants ongoing in follow-up|77|||
155472144|NCT01998906|561150579|FG001|Overall Study|Participants ongoing in follow-up|60|||
155518913|NCT02430870|561325153|FG000|Part 2|Other Reason Not Specified|0|||
155518914|NCT02430870|561325154|FG001|Part 2|Other Reason Not Specified|0|||
155518915|NCT02430870|561325155|FG002|Part 2|Other Reason Not Specified|0|||
155472145|NCT01998906|561150580|FG002|Overall Study|Participants ongoing in follow-up|58|||
155472146|NCT01998906|561150578|FG000|Overall Study|Death|21|||
155472147|NCT01998906|561150579|FG001|Overall Study|Death|30|||
155518916|NCT02430870|561325156|FG003|Part 2|Other Reason Not Specified|0|||
155518917|NCT02430870|561325157|FG004|Part 2|Other Reason Not Specified|0|||
155518918|NCT02430870|561325158|FG005|Part 2|Other Reason Not Specified|0|||
155472148|NCT01998906|561150580|FG002|Overall Study|Death|17|||
155472149|NCT01998906|561150578|FG000|Overall Study|Lack of Efficacy|10|||
155472150|NCT01998906|561150579|FG001|Overall Study|Lack of Efficacy|9|||
155472151|NCT01998906|561150580|FG002|Overall Study|Lack of Efficacy|8|||
155518919|NCT02430870|561325159|FG006|Part 2|Other Reason Not Specified|0|||
155518920|NCT02430870|561325160|FG007|Part 2|Other Reason Not Specified|1|||
155472152|NCT01998906|561150578|FG000|Overall Study|Failure to return|0|||
155518921|NCT02780687|561325161|FG000|Overall Study|Adverse Event|1|||
155472153|NCT01998906|561150579|FG001|Overall Study|Failure to return|2|||
155472154|NCT01998906|561150580|FG002|Overall Study|Failure to return|4|||
155472155|NCT01998906|561150578|FG000|Overall Study|Violation of Selection Criteria|0|||
155472156|NCT01998906|561150579|FG001|Overall Study|Violation of Selection Criteria|0|||
155472157|NCT01998906|561150580|FG002|Overall Study|Violation of Selection Criteria|1|||
155518922|NCT02780687|561325162|FG001|Overall Study|Adverse Event|1|||
155472158|NCT01998906|561150578|FG000|Overall Study|Withdrawal by Subject|1|||
155472159|NCT01998906|561150579|FG001|Overall Study|Withdrawal by Subject|4|||
155472160|NCT01998906|561150580|FG002|Overall Study|Withdrawal by Subject|3|||
155472161|NCT01998906|561150578|FG000|Overall Study|Administrative/Other|2|||
155472162|NCT01998906|561150579|FG001|Overall Study|Administrative/Other|1|||
155472163|NCT01998906|561150580|FG002|Overall Study|Administrative/Other|3|||
155472164|NCT01998906|561150578|FG000|Overall Study|Other|3|||
155472165|NCT01998906|561150579|FG001|Overall Study|Other|8|||
155472166|NCT01998906|561150580|FG002|Overall Study|Other|4|||
155472167|NCT02204410|561150581|FG000|Overall Study|Lost to Follow-up|5|||
155472168|NCT02204410|561150581|FG000|Overall Study|Physician Decision|2|||
155472169|NCT02204410|561150581|FG000|Overall Study|Protocol Violation|1|||
155472170|NCT02204410|561150581|FG000|Overall Study|Withdrawal by Subject|3|||
155472171|NCT06048809|561150589|FG000|Overall Study|Adverse Event|2|||
155472172|NCT06048809|561150590|FG001|Overall Study|Adverse Event|0|||
155472173|NCT06048809|561150589|FG000|Overall Study|Withdrawal by Subject|1|||
155472174|NCT06048809|561150590|FG001|Overall Study|Withdrawal by Subject|1|||
155472175|NCT02234050|561150610|FG000|Overall Study|Lack of Efficacy|38|||
155472176|NCT02234050|561150611|FG001|Overall Study|Lack of Efficacy|22|||
155472177|NCT02234050|561150610|FG000|Overall Study|Adverse Event|13|||
155472178|NCT02234050|561150611|FG001|Overall Study|Adverse Event|1|||
155472179|NCT02234050|561150610|FG000|Overall Study|Withdrawal by Subject|4|||
155472180|NCT02234050|561150611|FG001|Overall Study|Withdrawal by Subject|2|||
155472181|NCT02234050|561150610|FG000|Overall Study|Sponsor's decision|6|||
155472182|NCT02234050|561150611|FG001|Overall Study|Sponsor's decision|0|||
155472183|NCT01680991|561150618|FG000|Overall Study|Adverse Event|1|||
155472184|NCT01680991|561150619|FG001|Overall Study|Adverse Event|0|||
155472185|NCT01680991|561150620|FG002|Overall Study|Adverse Event|0|||
155472186|NCT01680991|561150618|FG000|Overall Study|Death|1|||
155472187|NCT01680991|561150619|FG001|Overall Study|Death|0|||
155472188|NCT01680991|561150620|FG002|Overall Study|Death|1|||
155472189|NCT01680991|561150618|FG000|Overall Study|Protocol Violation|0|||
155472190|NCT01680991|561150619|FG001|Overall Study|Protocol Violation|1|||
155472191|NCT01680991|561150620|FG002|Overall Study|Protocol Violation|0|||
155472192|NCT01680991|561150618|FG000|Overall Study|Withdrawal by Subject|5|||
155472193|NCT01680991|561150619|FG001|Overall Study|Withdrawal by Subject|1|||
155472194|NCT01680991|561150620|FG002|Overall Study|Withdrawal by Subject|0|||
155472195|NCT01680991|561150618|FG000|Overall Study|Progressive disease (PD)|0|||
155472196|NCT01680991|561150619|FG001|Overall Study|Progressive disease (PD)|10|||
155472197|NCT01680991|561150620|FG002|Overall Study|Progressive disease (PD)|0|||
155518923|NCT02780687|561325161|FG000|Overall Study|Withdrawal by Subject|2|||
155518924|NCT02780687|561325162|FG001|Overall Study|Withdrawal by Subject|1|||
155518925|NCT02780687|561325161|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
155518926|NCT02780687|561325162|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
155518927|NCT02780687|561325161|FG000|Overall Study|progressive disease|29|||
155518928|NCT02780687|561325162|FG001|Overall Study|progressive disease|6|||
155518929|NCT02353169|561325164|FG000|Overall Study|QTc > 450 msec|1|||
155518930|NCT02353169|561325165|FG001|Overall Study|QTc > 450 msec|1|||
155518931|NCT02353169|561325166|FG002|Overall Study|QTc > 450 msec|1|||
155518932|NCT02353169|561325167|FG003|Overall Study|QTc > 450 msec|1|||
155518933|NCT02353169|561325164|FG000|Overall Study|OR team declined|2|||
155518934|NCT02353169|561325165|FG001|Overall Study|OR team declined|0|||
155518935|NCT02353169|561325166|FG002|Overall Study|OR team declined|0|||
155518936|NCT02353169|561325167|FG003|Overall Study|OR team declined|0|||
155518937|NCT02353169|561325164|FG000|Overall Study|Inhalational induction|0|||
155518938|NCT02353169|561325165|FG001|Overall Study|Inhalational induction|2|||
155518939|NCT02353169|561325166|FG002|Overall Study|Inhalational induction|0|||
155518940|NCT02353169|561325167|FG003|Overall Study|Inhalational induction|0|||
155518941|NCT02353169|561325164|FG000|Overall Study|ECG data error|0|||
155518942|NCT02353169|561325165|FG001|Overall Study|ECG data error|3|||
155518943|NCT02353169|561325166|FG002|Overall Study|ECG data error|2|||
155472198|NCT01680991|561150618|FG000|Overall Study|Physician Decision|0|||
155518944|NCT02353169|561325167|FG003|Overall Study|ECG data error|2|||
155518945|NCT02353169|561325164|FG000|Overall Study|Pre-op medication|0|||
155518946|NCT02353169|561325165|FG001|Overall Study|Pre-op medication|0|||
155654049|NCT01272219|561826894|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
155518947|NCT02353169|561325166|FG002|Overall Study|Pre-op medication|1|||
155518948|NCT02353169|561325167|FG003|Overall Study|Pre-op medication|0|||
155518949|NCT00414765|561325168|FG000|Overall Study|Adverse Event|5|||
155518950|NCT00414765|561325169|FG001|Overall Study|Adverse Event|9|||
155518951|NCT00414765|561325168|FG000|Overall Study|Withdrawal by Subject|1|||
155472199|NCT01680991|561150619|FG001|Overall Study|Physician Decision|7|||
155472200|NCT01680991|561150620|FG002|Overall Study|Physician Decision|2|||
155472201|NCT01680991|561150618|FG000|Overall Study|Bad physical condition|0|||
155472202|NCT01680991|561150619|FG001|Overall Study|Bad physical condition|0|||
155472203|NCT01680991|561150620|FG002|Overall Study|Bad physical condition|1|||
155472204|NCT01680991|561150618|FG000|Overall Study|PD confirmed in other hospital|1|||
155472205|NCT01680991|561150619|FG001|Overall Study|PD confirmed in other hospital|0|||
155472206|NCT01680991|561150620|FG002|Overall Study|PD confirmed in other hospital|0|||
155472207|NCT06073054|561150621|FG000|Overall Study|Withdrawal by Subject|2|||
155472208|NCT00796003|561150622|FG000|Overall Study|Disease Progression|2|||
155472209|NCT00796003|561150623|FG001|Overall Study|Disease Progression|13|||
155472210|NCT00796003|561150622|FG000|Overall Study|Adverse Event|1|||
155472211|NCT00796003|561150623|FG001|Overall Study|Adverse Event|7|||
155472212|NCT00796003|561150622|FG000|Overall Study|Specified organ function not met|0|||
155472213|NCT00796003|561150623|FG001|Overall Study|Specified organ function not met|1|||
155472214|NCT00796003|561150622|FG000|Overall Study|Physician Decision|0|||
155472215|NCT00796003|561150623|FG001|Overall Study|Physician Decision|4|||
155472216|NCT00796003|561150622|FG000|Overall Study|Withdrawal by Subject|0|||
155472217|NCT00796003|561150623|FG001|Overall Study|Withdrawal by Subject|1|||
155472218|NCT00796003|561150622|FG000|Overall Study|Other|0|||
155472219|NCT00796003|561150623|FG001|Overall Study|Other|1|||
155472220|NCT00796003|561150622|FG000|Overall Study|Participants Not treated|0|||
155472221|NCT00796003|561150623|FG001|Overall Study|Participants Not treated|2|||
155472222|NCT01131130|561150625|FG000|Period 1 - Baseline|Pregnancy|1|||
155472223|NCT01131130|561150625|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
155472224|NCT03345342|561150626|FG000|Open-Label Phase|Adverse Event|30|||
155472225|NCT03345342|561150627|FG001|Open-Label Phase|Adverse Event|0|||
155472226|NCT03345342|561150628|FG002|Open-Label Phase|Adverse Event|0|||
155472227|NCT03345342|561150629|FG003|Open-Label Phase|Adverse Event|0|||
155472228|NCT03345342|561150630|FG004|Open-Label Phase|Adverse Event|0|||
155472229|NCT03345342|561150626|FG000|Open-Label Phase|Death|1|||
155472230|NCT03345342|561150627|FG001|Open-Label Phase|Death|0|||
155472231|NCT03345342|561150628|FG002|Open-Label Phase|Death|0|||
155472232|NCT03345342|561150629|FG003|Open-Label Phase|Death|0|||
155472233|NCT03345342|561150630|FG004|Open-Label Phase|Death|0|||
155472234|NCT03345342|561150626|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
155472235|NCT03345342|561150627|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
155472236|NCT03345342|561150628|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
155472237|NCT03345342|561150629|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
155472238|NCT03345342|561150630|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
155472239|NCT03345342|561150626|FG000|Open-Label Phase|Lack of Efficacy|6|||
155472240|NCT03345342|561150627|FG001|Open-Label Phase|Lack of Efficacy|0|||
155472241|NCT03345342|561150628|FG002|Open-Label Phase|Lack of Efficacy|0|||
155472242|NCT03345342|561150629|FG003|Open-Label Phase|Lack of Efficacy|0|||
155472243|NCT03345342|561150630|FG004|Open-Label Phase|Lack of Efficacy|0|||
155472244|NCT03345342|561150626|FG000|Open-Label Phase|Lost to Follow-up|9|||
155472245|NCT03345342|561150627|FG001|Open-Label Phase|Lost to Follow-up|0|||
155472246|NCT03345342|561150628|FG002|Open-Label Phase|Lost to Follow-up|0|||
155472247|NCT03345342|561150629|FG003|Open-Label Phase|Lost to Follow-up|0|||
155472248|NCT03345342|561150630|FG004|Open-Label Phase|Lost to Follow-up|0|||
155472249|NCT03345342|561150626|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
155472250|NCT03345342|561150627|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
155472251|NCT03345342|561150628|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
155472252|NCT03345342|561150629|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
155472253|NCT03345342|561150630|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
155472254|NCT03345342|561150626|FG000|Open-Label Phase|Physician Decision|4|||
155472255|NCT03345342|561150627|FG001|Open-Label Phase|Physician Decision|0|||
155472256|NCT03345342|561150628|FG002|Open-Label Phase|Physician Decision|0|||
155472257|NCT03345342|561150629|FG003|Open-Label Phase|Physician Decision|0|||
155472258|NCT03345342|561150630|FG004|Open-Label Phase|Physician Decision|0|||
155472259|NCT03345342|561150626|FG000|Open-Label Phase|Protocol Violation|8|||
155472260|NCT03345342|561150627|FG001|Open-Label Phase|Protocol Violation|0|||
155472261|NCT03345342|561150628|FG002|Open-Label Phase|Protocol Violation|0|||
155472262|NCT03345342|561150629|FG003|Open-Label Phase|Protocol Violation|0|||
155472263|NCT03345342|561150630|FG004|Open-Label Phase|Protocol Violation|0|||
155472264|NCT03345342|561150626|FG000|Open-Label Phase|Withdrawal by Subject|57|||
155472265|NCT03345342|561150627|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155472266|NCT03345342|561150628|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155472267|NCT03345342|561150629|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155472268|NCT03345342|561150630|FG004|Open-Label Phase|Withdrawal by Subject|0|||
155472269|NCT03345342|561150626|FG000|Open-Label Phase|Other|15|||
155472270|NCT03345342|561150627|FG001|Open-Label Phase|Other|0|||
155472271|NCT03345342|561150628|FG002|Open-Label Phase|Other|0|||
155472272|NCT03345342|561150629|FG003|Open-Label Phase|Other|0|||
155472273|NCT03345342|561150630|FG004|Open-Label Phase|Other|0|||
155472274|NCT03345342|561150626|FG000|Double-Blind Phase|Adverse Event|0|||
155472275|NCT03345342|561150627|FG001|Double-Blind Phase|Adverse Event|1|||
155472276|NCT03345342|561150628|FG002|Double-Blind Phase|Adverse Event|6|||
155472277|NCT03345342|561150629|FG003|Double-Blind Phase|Adverse Event|0|||
155472278|NCT03345342|561150630|FG004|Double-Blind Phase|Adverse Event|0|||
155472279|NCT03345342|561150626|FG000|Double-Blind Phase|Death|0|||
155472280|NCT03345342|561150627|FG001|Double-Blind Phase|Death|2|||
155472281|NCT03345342|561150628|FG002|Double-Blind Phase|Death|1|||
155472282|NCT03345342|561150629|FG003|Double-Blind Phase|Death|0|||
155472283|NCT03345342|561150630|FG004|Double-Blind Phase|Death|0|||
155472284|NCT03345342|561150626|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
155472285|NCT03345342|561150627|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
155472286|NCT03345342|561150628|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
155472287|NCT03345342|561150629|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
155472288|NCT03345342|561150630|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
155472289|NCT03345342|561150626|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155472290|NCT03345342|561150627|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155472291|NCT03345342|561150628|FG002|Double-Blind Phase|Lost to Follow-up|7|||
155472292|NCT03345342|561150629|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155472293|NCT03345342|561150630|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155472294|NCT03345342|561150626|FG000|Double-Blind Phase|Physician Decision|0|||
155472295|NCT03345342|561150627|FG001|Double-Blind Phase|Physician Decision|1|||
155472296|NCT03345342|561150628|FG002|Double-Blind Phase|Physician Decision|4|||
155472297|NCT03345342|561150629|FG003|Double-Blind Phase|Physician Decision|0|||
155472298|NCT03345342|561150630|FG004|Double-Blind Phase|Physician Decision|0|||
155472299|NCT03345342|561150626|FG000|Double-Blind Phase|Protocol Violation|0|||
155472300|NCT03345342|561150627|FG001|Double-Blind Phase|Protocol Violation|0|||
155472301|NCT03345342|561150628|FG002|Double-Blind Phase|Protocol Violation|1|||
155472302|NCT03345342|561150629|FG003|Double-Blind Phase|Protocol Violation|0|||
155472303|NCT03345342|561150630|FG004|Double-Blind Phase|Protocol Violation|0|||
155472304|NCT03345342|561150626|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155472305|NCT03345342|561150627|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
155472306|NCT03345342|561150628|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
155472307|NCT03345342|561150629|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155472308|NCT03345342|561150630|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155472309|NCT03345342|561150626|FG000|Double-Blind Phase|Other|0|||
155472310|NCT03345342|561150627|FG001|Double-Blind Phase|Other|1|||
155472311|NCT03345342|561150628|FG002|Double-Blind Phase|Other|3|||
155472312|NCT03345342|561150629|FG003|Double-Blind Phase|Other|0|||
155472313|NCT03345342|561150630|FG004|Double-Blind Phase|Other|0|||
155472314|NCT03345342|561150626|FG000|Follow-Up Phase|Adverse Event|0|||
155472315|NCT03345342|561150627|FG001|Follow-Up Phase|Adverse Event|0|||
155472316|NCT03345342|561150628|FG002|Follow-Up Phase|Adverse Event|0|||
155472317|NCT03345342|561150629|FG003|Follow-Up Phase|Adverse Event|0|||
155472318|NCT03345342|561150630|FG004|Follow-Up Phase|Adverse Event|4|||
155472319|NCT03345342|561150626|FG000|Follow-Up Phase|Lost to Follow-up|0|||
155472320|NCT03345342|561150627|FG001|Follow-Up Phase|Lost to Follow-up|0|||
155472321|NCT03345342|561150628|FG002|Follow-Up Phase|Lost to Follow-up|0|||
155472322|NCT03345342|561150629|FG003|Follow-Up Phase|Lost to Follow-up|0|||
155472323|NCT03345342|561150630|FG004|Follow-Up Phase|Lost to Follow-up|6|||
155472324|NCT03345342|561150626|FG000|Follow-Up Phase|Physician Decision|0|||
155472325|NCT03345342|561150627|FG001|Follow-Up Phase|Physician Decision|0|||
155472326|NCT03345342|561150628|FG002|Follow-Up Phase|Physician Decision|0|||
155472327|NCT03345342|561150629|FG003|Follow-Up Phase|Physician Decision|0|||
155472328|NCT03345342|561150630|FG004|Follow-Up Phase|Physician Decision|5|||
155472329|NCT03345342|561150626|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
155472330|NCT03345342|561150627|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
155472331|NCT03345342|561150628|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
155472332|NCT03345342|561150629|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
155472333|NCT03345342|561150630|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
155472334|NCT03345342|561150626|FG000|Follow-Up Phase|Other|0|||
155472335|NCT03345342|561150627|FG001|Follow-Up Phase|Other|0|||
155472336|NCT03345342|561150628|FG002|Follow-Up Phase|Other|0|||
155472337|NCT03345342|561150629|FG003|Follow-Up Phase|Other|3|||
155472338|NCT03345342|561150630|FG004|Follow-Up Phase|Other|1|||
155472339|NCT02437162|561150635|FG000|Overall Study|Protocol Violation|0|||
155472340|NCT02437162|561150636|FG001|Overall Study|Protocol Violation|1|||
155472341|NCT02437162|561150637|FG002|Overall Study|Protocol Violation|0|||
155472342|NCT02437162|561150635|FG000|Overall Study|Randomized but not treated|0|||
155472343|NCT02437162|561150636|FG001|Overall Study|Randomized but not treated|0|||
155472344|NCT02437162|561150637|FG002|Overall Study|Randomized but not treated|1|||
155472345|NCT02437162|561150635|FG000|Overall Study|Study discontinued by Sponsor|93|||
155472346|NCT02437162|561150636|FG001|Overall Study|Study discontinued by Sponsor|98|||
155472347|NCT02437162|561150637|FG002|Overall Study|Study discontinued by Sponsor|97|||
155472348|NCT02437162|561150635|FG000|Overall Study|Withdrawal by Subject|13|||
155472349|NCT02437162|561150636|FG001|Overall Study|Withdrawal by Subject|7|||
155472350|NCT02437162|561150637|FG002|Overall Study|Withdrawal by Subject|9|||
155472351|NCT02437162|561150635|FG000|Overall Study|Adverse Event|0|||
155472352|NCT02437162|561150636|FG001|Overall Study|Adverse Event|1|||
155472353|NCT02437162|561150637|FG002|Overall Study|Adverse Event|0|||
155472354|NCT02437162|561150635|FG000|Overall Study|Lost to Follow-up|1|||
155472355|NCT02437162|561150636|FG001|Overall Study|Lost to Follow-up|0|||
155472356|NCT02437162|561150637|FG002|Overall Study|Lost to Follow-up|1|||
155472357|NCT02437162|561150635|FG000|Overall Study|Death|0|||
155654050|NCT01272219|561826889|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
155472358|NCT02437162|561150636|FG001|Overall Study|Death|1|||
155472359|NCT02437162|561150637|FG002|Overall Study|Death|0|||
155472360|NCT02437162|561150635|FG000|Overall Study|Other|0|||
155472361|NCT02437162|561150636|FG001|Overall Study|Other|0|||
155472362|NCT02437162|561150637|FG002|Overall Study|Other|1|||
155472363|NCT03981744|561150638|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
155472364|NCT03981744|561150639|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
155472365|NCT03981744|561150640|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
155472366|NCT03981744|561150641|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
155472367|NCT03981744|561150638|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
155472368|NCT03981744|561150639|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
155472369|NCT03981744|561150640|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
155472370|NCT03981744|561150641|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
155472371|NCT03981744|561150638|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
155472372|NCT03981744|561150639|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
155472373|NCT03981744|561150640|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
155472374|NCT03981744|561150641|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
155472375|NCT04338321|561150642|FG000|Overall Study|Adverse Event|4|||
155472376|NCT04338321|561150643|FG001|Overall Study|Adverse Event|10|||
155472377|NCT04338321|561150642|FG000|Overall Study|Death|1|||
155472378|NCT04338321|561150643|FG001|Overall Study|Death|1|||
155472379|NCT04338321|561150642|FG000|Overall Study|Lost to Follow-up|4|||
155472380|NCT04338321|561150643|FG001|Overall Study|Lost to Follow-up|9|||
155472381|NCT04338321|561150642|FG000|Overall Study|Withdrawal by Subject|45|||
155472382|NCT04338321|561150643|FG001|Overall Study|Withdrawal by Subject|69|||
155472383|NCT04338321|561150642|FG000|Overall Study|Physician Decision|5|||
155472384|NCT04338321|561150643|FG001|Overall Study|Physician Decision|9|||
155472385|NCT04338321|561150642|FG000|Overall Study|Other|3|||
155472386|NCT04338321|561150643|FG001|Overall Study|Other|10|||
155472387|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
155472388|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
155472389|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
155472390|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
155472391|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
155472392|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
155472393|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
155472394|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
155472395|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
155472396|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
155654051|NCT01272219|561826890|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
155654052|NCT01272219|561826891|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
155654053|NCT01272219|561826892|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
155654054|NCT01272219|561826893|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
155654055|NCT01272219|561826894|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
155472397|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
155472398|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
155654056|NCT01272219|561826889|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
155472399|NCT03321526|561150644|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
155472400|NCT03321526|561150645|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
155472401|NCT03321526|561150644|FG000|Follow-up Phase (2 Weeks)|Other|24|||
155472402|NCT03321526|561150645|FG001|Follow-up Phase (2 Weeks)|Other|24|||
155472403|NCT01989572|561150646|FG000|Overall Study|Lack of Efficacy|35|||
155472404|NCT01989572|561150647|FG001|Overall Study|Lack of Efficacy|48|||
155472405|NCT01989572|561150648|FG002|Overall Study|Lack of Efficacy|48|||
155472406|NCT01989572|561150649|FG003|Overall Study|Lack of Efficacy|43|||
155472407|NCT01989572|561150650|FG004|Overall Study|Lack of Efficacy|71|||
155472408|NCT01989572|561150651|FG005|Overall Study|Lack of Efficacy|79|||
155654057|NCT01272219|561826890|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
155472409|NCT01989572|561150646|FG000|Overall Study|Adverse Event|2|||
155472410|NCT01989572|561150647|FG001|Overall Study|Adverse Event|1|||
155654058|NCT01272219|561826891|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
155654059|NCT01272219|561826892|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
155654060|NCT01272219|561826893|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
155472411|NCT01989572|561150648|FG002|Overall Study|Adverse Event|3|||
155472412|NCT01989572|561150649|FG003|Overall Study|Adverse Event|0|||
155472413|NCT01989572|561150650|FG004|Overall Study|Adverse Event|3|||
155654061|NCT01272219|561826894|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
155472414|NCT01989572|561150651|FG005|Overall Study|Adverse Event|0|||
155472415|NCT01989572|561150646|FG000|Overall Study|Death|0|||
155472416|NCT01989572|561150647|FG001|Overall Study|Death|0|||
155472417|NCT01989572|561150648|FG002|Overall Study|Death|0|||
155472418|NCT01989572|561150649|FG003|Overall Study|Death|0|||
155472419|NCT01989572|561150650|FG004|Overall Study|Death|1|||
155472420|NCT01989572|561150651|FG005|Overall Study|Death|0|||
155472421|NCT01989572|561150646|FG000|Overall Study|Withdrawal by Subject|4|||
155472422|NCT01989572|561150647|FG001|Overall Study|Withdrawal by Subject|1|||
155472423|NCT01989572|561150648|FG002|Overall Study|Withdrawal by Subject|5|||
155472424|NCT01989572|561150649|FG003|Overall Study|Withdrawal by Subject|1|||
155472425|NCT01989572|561150650|FG004|Overall Study|Withdrawal by Subject|12|||
155472426|NCT01989572|561150651|FG005|Overall Study|Withdrawal by Subject|4|||
155472427|NCT01989572|561150646|FG000|Overall Study|complicating disease|1|||
155472428|NCT01989572|561150647|FG001|Overall Study|complicating disease|1|||
155472429|NCT01989572|561150648|FG002|Overall Study|complicating disease|2|||
155472430|NCT01989572|561150649|FG003|Overall Study|complicating disease|0|||
155472431|NCT01989572|561150650|FG004|Overall Study|complicating disease|1|||
155472432|NCT01989572|561150651|FG005|Overall Study|complicating disease|0|||
155472433|NCT01989572|561150646|FG000|Overall Study|error|2|||
155472434|NCT01989572|561150647|FG001|Overall Study|error|1|||
155472435|NCT01989572|561150648|FG002|Overall Study|error|1|||
155472436|NCT01989572|561150649|FG003|Overall Study|error|1|||
155472437|NCT01989572|561150650|FG004|Overall Study|error|1|||
155472438|NCT01989572|561150651|FG005|Overall Study|error|1|||
155472439|NCT01989572|561150646|FG000|Overall Study|maximum dose reached|0|||
155472440|NCT01989572|561150647|FG001|Overall Study|maximum dose reached|1|||
155472441|NCT01989572|561150648|FG002|Overall Study|maximum dose reached|0|||
155472442|NCT01989572|561150649|FG003|Overall Study|maximum dose reached|0|||
155472443|NCT01989572|561150650|FG004|Overall Study|maximum dose reached|1|||
155472444|NCT01989572|561150651|FG005|Overall Study|maximum dose reached|0|||
155472445|NCT01989572|561150646|FG000|Overall Study|unknown/not specify|3|||
155472446|NCT01989572|561150647|FG001|Overall Study|unknown/not specify|4|||
155472447|NCT01989572|561150648|FG002|Overall Study|unknown/not specify|1|||
155472448|NCT01989572|561150649|FG003|Overall Study|unknown/not specify|3|||
155472449|NCT01989572|561150650|FG004|Overall Study|unknown/not specify|3|||
155472450|NCT01989572|561150651|FG005|Overall Study|unknown/not specify|5|||
155472451|NCT01989572|561150646|FG000|Overall Study|not start protocol therapy|5|||
155472452|NCT01989572|561150647|FG001|Overall Study|not start protocol therapy|1|||
155472453|NCT01989572|561150648|FG002|Overall Study|not start protocol therapy|2|||
155472454|NCT01989572|561150649|FG003|Overall Study|not start protocol therapy|3|||
155472455|NCT01989572|561150650|FG004|Overall Study|not start protocol therapy|4|||
155472456|NCT01989572|561150651|FG005|Overall Study|not start protocol therapy|18|||
155472457|NCT01989572|561150646|FG000|Overall Study|alternative therapy|3|||
155472458|NCT01989572|561150647|FG001|Overall Study|alternative therapy|0|||
155472459|NCT01989572|561150648|FG002|Overall Study|alternative therapy|0|||
155472460|NCT01989572|561150649|FG003|Overall Study|alternative therapy|0|||
155472461|NCT01989572|561150650|FG004|Overall Study|alternative therapy|1|||
155472462|NCT01989572|561150651|FG005|Overall Study|alternative therapy|3|||
155472463|NCT02280096|561150656|FG000|Overall Study|Pregnancy|1|||
155472464|NCT02280096|561150657|FG001|Overall Study|Pregnancy|0|||
155472465|NCT02280096|561150656|FG000|Overall Study|Functional neurological disorder|1|||
155472466|NCT02280096|561150657|FG001|Overall Study|Functional neurological disorder|0|||
155472467|NCT02280096|561150656|FG000|Overall Study|Lack of attachment|0|||
155472468|NCT02280096|561150657|FG001|Overall Study|Lack of attachment|1|||
155472469|NCT00246376|561150662|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
155472470|NCT00246376|561150663|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
155472471|NCT00246376|561150664|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
155472472|NCT00246376|561150665|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
155472473|NCT00246376|561150666|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
155472474|NCT00246376|561150662|FG000|Overall Study|Adverse Event|2|||
155472475|NCT00246376|561150663|FG001|Overall Study|Adverse Event|3|||
155472476|NCT00246376|561150664|FG002|Overall Study|Adverse Event|1|||
155472477|NCT00246376|561150665|FG003|Overall Study|Adverse Event|3|||
155472478|NCT00246376|561150666|FG004|Overall Study|Adverse Event|1|||
155472479|NCT00246376|561150662|FG000|Overall Study|Lost to Follow-up|2|||
155472480|NCT00246376|561150663|FG001|Overall Study|Lost to Follow-up|11|||
155472481|NCT00246376|561150664|FG002|Overall Study|Lost to Follow-up|11|||
155472482|NCT00246376|561150665|FG003|Overall Study|Lost to Follow-up|16|||
155472483|NCT00246376|561150666|FG004|Overall Study|Lost to Follow-up|13|||
155472484|NCT01849562|561150675|FG000|Overall Study|Lost to Follow-up|1|||
155472485|NCT01849562|561150676|FG001|Overall Study|Lost to Follow-up|0|||
155472486|NCT01849562|561150677|FG002|Overall Study|Lost to Follow-up|0|||
155472487|NCT01849562|561150675|FG000|Overall Study|Non-compliance with Study Drug|1|||
155472488|NCT01849562|561150676|FG001|Overall Study|Non-compliance with Study Drug|0|||
155472489|NCT01849562|561150677|FG002|Overall Study|Non-compliance with Study Drug|0|||
155472490|NCT00481988|561150678|FG000|Overall Study|Withdrawal by Subject|1|||
155472491|NCT00481988|561150679|FG001|Overall Study|Withdrawal by Subject|1|||
155472492|NCT04599972|561150686|FG000|Overall Study|Withdrawal by Subject|6|||
155472493|NCT04599972|561150687|FG001|Overall Study|Withdrawal by Subject|1|||
155472494|NCT04599972|561150686|FG000|Overall Study|Adverse Event|1|||
155472495|NCT04599972|561150687|FG001|Overall Study|Adverse Event|1|||
155472496|NCT04599972|561150686|FG000|Overall Study|Lost to Follow-up|1|||
155472497|NCT04599972|561150687|FG001|Overall Study|Lost to Follow-up|6|||
155472498|NCT04599972|561150686|FG000|Overall Study|Protocol Violation|1|||
155472499|NCT04599972|561150687|FG001|Overall Study|Protocol Violation|0|||
155472500|NCT04599972|561150686|FG000|Overall Study|Other reason|1|||
155472501|NCT04599972|561150687|FG001|Overall Study|Other reason|0|||
155472502|NCT01347073|561150690|FG000|Overall Study|Adverse Event|1|||
155472503|NCT01347073|561150690|FG000|Overall Study|Liver Transplant|1|||
155472504|NCT00621244|561150695|FG000|Overall Study|Withdrawal by Subject|7|||
155472505|NCT00621244|561150696|FG001|Overall Study|Withdrawal by Subject|3|||
155472506|NCT00621244|561150697|FG002|Overall Study|Withdrawal by Subject|3|||
155472507|NCT00621244|561150698|FG003|Overall Study|Withdrawal by Subject|3|||
155472508|NCT00621244|561150695|FG000|Overall Study|Disease progression|44|||
155472509|NCT00621244|561150696|FG001|Overall Study|Disease progression|20|||
155472510|NCT00621244|561150697|FG002|Overall Study|Disease progression|20|||
155472511|NCT00621244|561150698|FG003|Overall Study|Disease progression|15|||
155472512|NCT00621244|561150695|FG000|Overall Study|Death|3|||
155472513|NCT00621244|561150696|FG001|Overall Study|Death|3|||
155472514|NCT00621244|561150697|FG002|Overall Study|Death|1|||
155472515|NCT00621244|561150698|FG003|Overall Study|Death|1|||
155472516|NCT00621244|561150695|FG000|Overall Study|Adverse Event|27|||
155472517|NCT00621244|561150696|FG001|Overall Study|Adverse Event|7|||
155472518|NCT00621244|561150697|FG002|Overall Study|Adverse Event|9|||
155472519|NCT00621244|561150698|FG003|Overall Study|Adverse Event|2|||
155472520|NCT00621244|561150695|FG000|Overall Study|Administrative problems|5|||
155472521|NCT00621244|561150696|FG001|Overall Study|Administrative problems|1|||
155472522|NCT00621244|561150697|FG002|Overall Study|Administrative problems|0|||
155472523|NCT00621244|561150698|FG003|Overall Study|Administrative problems|2|||
155472524|NCT01690988|561150699|FG000|Overall Study|Withdrawal by Subject|2|||
155472525|NCT01690988|561150700|FG001|Overall Study|Withdrawal by Subject|2|||
155472526|NCT01690988|561150701|FG002|Overall Study|Withdrawal by Subject|3|||
155472527|NCT01690988|561150699|FG000|Overall Study|Physician Decision|0|||
155472528|NCT01690988|561150700|FG001|Overall Study|Physician Decision|0|||
155472529|NCT01690988|561150701|FG002|Overall Study|Physician Decision|1|||
155472530|NCT01690988|561150699|FG000|Overall Study|Operation Cancelled|1|||
155472531|NCT01690988|561150700|FG001|Overall Study|Operation Cancelled|1|||
155472532|NCT01690988|561150701|FG002|Overall Study|Operation Cancelled|0|||
155472533|NCT01690988|561150699|FG000|Overall Study|Determined ineligible|1|||
155472534|NCT01690988|561150700|FG001|Overall Study|Determined ineligible|0|||
155472535|NCT01690988|561150701|FG002|Overall Study|Determined ineligible|0|||
155472536|NCT01690988|561150699|FG000|Overall Study|Death|1|||
155472537|NCT01690988|561150700|FG001|Overall Study|Death|1|||
155472538|NCT01690988|561150701|FG002|Overall Study|Death|1|||
155472539|NCT01690988|561150699|FG000|Overall Study|Sedated|1|||
155472540|NCT01690988|561150700|FG001|Overall Study|Sedated|1|||
155472541|NCT01690988|561150701|FG002|Overall Study|Sedated|2|||
155472542|NCT00312728|561150702|FG000|Overall Study|Progressive disease|53|||
155472543|NCT00312728|561150702|FG000|Overall Study|Adverse Event|32|||
155472544|NCT00312728|561150702|FG000|Overall Study|Withdrawal by Subject|10|||
155472545|NCT00312728|561150702|FG000|Overall Study|Required non-protocol cancer treatment|2|||
155472546|NCT00312728|561150702|FG000|Overall Study|Protocol Violation|2|||
155472547|NCT00312728|561150702|FG000|Overall Study|Other|10|||
155472548|NCT00312728|561150702|FG000|Overall Study|Other|1|||
155472549|NCT03696576|561150703|FG000|Overall Study|Soreness of throat after therapy|1|||
155472550|NCT03696576|561150704|FG001|Overall Study|Soreness of throat after therapy|1|||
155472551|NCT03696576|561150703|FG000|Overall Study|Lost to Follow-up|2|||
155472552|NCT03696576|561150704|FG001|Overall Study|Lost to Follow-up|4|||
155472553|NCT00179517|561150715|FG000|Overall Study|Withdrawal by Subject|2|||
155472554|NCT00179517|561150716|FG001|Overall Study|Withdrawal by Subject|1|||
155472555|NCT04857892|561150718|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
155472556|NCT04857892|561150719|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
155472557|NCT04857892|561150720|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
155654062|NCT01272219|561826889|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
155472558|NCT04857892|561150721|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
155472559|NCT04857892|561150722|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
155472560|NCT04857892|561150718|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
155472561|NCT04857892|561150719|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
155472562|NCT04857892|561150720|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
155472563|NCT04857892|561150721|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
155472564|NCT04857892|561150722|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
155472565|NCT04857892|561150718|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
155472566|NCT04857892|561150719|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
155472567|NCT04857892|561150720|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
155472568|NCT04857892|561150721|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
155491182|NCT00634933|561223488|FG001|Part A: Baseline to Week 24|Other|8|||
155472569|NCT04857892|561150722|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
155472570|NCT00880607|561150726|FG000|Overall Study|Physician Decision|2|||
155472571|NCT00880607|561150727|FG001|Overall Study|Physician Decision|2|||
155472572|NCT00880607|561150726|FG000|Overall Study|Protocol Violation|2|||
155472573|NCT00880607|561150727|FG001|Overall Study|Protocol Violation|1|||
155472574|NCT00880607|561150726|FG000|Overall Study|surgery did not extend past L1 level|3|||
155472575|NCT00880607|561150727|FG001|Overall Study|surgery did not extend past L1 level|0|||
155472576|NCT01627782|561150730|FG000|Overall Study|Adverse Event|1|||
155472577|NCT01627782|561150731|FG001|Overall Study|Adverse Event|2|||
155472578|NCT01627782|561150732|FG002|Overall Study|Adverse Event|0|||
155472579|NCT01627782|561150733|FG003|Overall Study|Adverse Event|1|||
155472580|NCT01627782|561150730|FG000|Overall Study|Lack of Efficacy|11|||
155472581|NCT01627782|561150731|FG001|Overall Study|Lack of Efficacy|1|||
155472582|NCT01627782|561150732|FG002|Overall Study|Lack of Efficacy|15|||
155472583|NCT01627782|561150733|FG003|Overall Study|Lack of Efficacy|2|||
155472584|NCT01627782|561150730|FG000|Overall Study|Protocol Violation|1|||
155472585|NCT01627782|561150731|FG001|Overall Study|Protocol Violation|0|||
155472586|NCT01627782|561150732|FG002|Overall Study|Protocol Violation|0|||
155472587|NCT01627782|561150733|FG003|Overall Study|Protocol Violation|0|||
155472588|NCT01627782|561150730|FG000|Overall Study|Withdrawal by Subject|2|||
155472589|NCT01627782|561150731|FG001|Overall Study|Withdrawal by Subject|1|||
155472590|NCT01627782|561150732|FG002|Overall Study|Withdrawal by Subject|0|||
155472591|NCT01627782|561150733|FG003|Overall Study|Withdrawal by Subject|0|||
155472592|NCT01627782|561150730|FG000|Overall Study|Other|0|||
155472593|NCT01627782|561150731|FG001|Overall Study|Other|2|||
155472594|NCT01627782|561150732|FG002|Overall Study|Other|0|||
155472595|NCT01627782|561150733|FG003|Overall Study|Other|3|||
155472596|NCT01627782|561150730|FG000|Overall Study|Randomized But Not Treated|1|||
155472597|NCT01627782|561150731|FG001|Overall Study|Randomized But Not Treated|0|||
155472598|NCT01627782|561150732|FG002|Overall Study|Randomized But Not Treated|0|||
155472599|NCT01627782|561150733|FG003|Overall Study|Randomized But Not Treated|0|||
155472600|NCT01431521|561152970|FG000|Overall Study|Withdrawal by Subject|0|||
155472601|NCT01431521|561152971|FG001|Overall Study|Withdrawal by Subject|0|||
155472602|NCT01431521|561152972|FG002|Overall Study|Withdrawal by Subject|1|||
155472603|NCT01431521|561152973|FG003|Overall Study|Withdrawal by Subject|0|||
155472604|NCT02782104|561152974|FG000|Overall Study|Other|215|||
155472605|NCT02782104|561152974|FG000|Overall Study|Induction Day 28 Non Responder|9|||
155472606|NCT02782104|561152974|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155472607|NCT02782104|561152974|FG000|Overall Study|Death|8|||
155472608|NCT02782104|561152974|FG000|Overall Study|Pregnancy|6|||
155472609|NCT02782104|561152974|FG000|Overall Study|Withdrawal by Subject|63|||
155472610|NCT02782104|561152974|FG000|Overall Study|Protocol Violation|7|||
155472611|NCT02782104|561152974|FG000|Overall Study|Lack of Efficacy|61|||
155472612|NCT02782104|561152974|FG000|Overall Study|Lost to Follow-up|23|||
155472613|NCT02782104|561152974|FG000|Overall Study|Adverse Event|74|||
155472614|NCT03464136|561152975|FG000|Overall Study|Lost to Follow-up|5|||
155472615|NCT03464136|561152976|FG001|Overall Study|Lost to Follow-up|8|||
155472616|NCT03464136|561152975|FG000|Overall Study|Withdrawal by Subject|16|||
155472617|NCT03464136|561152976|FG001|Overall Study|Withdrawal by Subject|13|||
155472618|NCT03464136|561152975|FG000|Overall Study|Death|1|||
155472619|NCT03464136|561152976|FG001|Overall Study|Death|0|||
155472620|NCT03464136|561152975|FG000|Overall Study|Other|8|||
155472621|NCT03464136|561152976|FG001|Overall Study|Other|4|||
155472622|NCT02438787|561152977|FG000|Overall Study|Adverse Event|1|||
155472623|NCT02438787|561152978|FG001|Overall Study|Adverse Event|0|||
155472624|NCT02438787|561152979|FG002|Overall Study|Adverse Event|2|||
155472625|NCT02438787|561152977|FG000|Overall Study|Lack of Efficacy|1|||
155472626|NCT02438787|561152978|FG001|Overall Study|Lack of Efficacy|2|||
155472627|NCT02438787|561152979|FG002|Overall Study|Lack of Efficacy|0|||
155472628|NCT02438787|561152977|FG000|Overall Study|Lost to Follow-up|0|||
155472629|NCT02438787|561152978|FG001|Overall Study|Lost to Follow-up|1|||
155472630|NCT02438787|561152979|FG002|Overall Study|Lost to Follow-up|0|||
155518952|NCT00414765|561325169|FG001|Overall Study|Withdrawal by Subject|1|||
155518953|NCT00414765|561325168|FG000|Overall Study|Disease Progression|0|||
155518954|NCT00414765|561325169|FG001|Overall Study|Disease Progression|1|||
155518955|NCT05694013|561325170|FG000|Overall Study|Death|6|||
155472631|NCT02438787|561152977|FG000|Overall Study|Protocol Violation|0|||
155472632|NCT02438787|561152978|FG001|Overall Study|Protocol Violation|0|||
155472633|NCT02438787|561152979|FG002|Overall Study|Protocol Violation|1|||
155472634|NCT02438787|561152977|FG000|Overall Study|Withdrawal by Subject|15|||
155472635|NCT02438787|561152978|FG001|Overall Study|Withdrawal by Subject|7|||
155472636|NCT02438787|561152979|FG002|Overall Study|Withdrawal by Subject|10|||
155472637|NCT02438787|561152977|FG000|Overall Study|Study discontinued by sponsor|64|||
155472638|NCT02438787|561152978|FG001|Overall Study|Study discontinued by sponsor|72|||
155472639|NCT02438787|561152979|FG002|Overall Study|Study discontinued by sponsor|69|||
155472640|NCT02438787|561152977|FG000|Overall Study|Other|0|||
155472641|NCT02438787|561152978|FG001|Overall Study|Other|1|||
155472642|NCT02438787|561152979|FG002|Overall Study|Other|0|||
155472643|NCT02438787|561152977|FG000|Overall Study|Site terminated by sponsor|0|||
155472644|NCT02438787|561152978|FG001|Overall Study|Site terminated by sponsor|0|||
155472645|NCT02438787|561152979|FG002|Overall Study|Site terminated by sponsor|1|||
155472646|NCT03412565|561152980|FG000|Overall Study|Lost to Follow-up|0|||
155472647|NCT03412565|561152981|FG001|Overall Study|Lost to Follow-up|0|||
155472648|NCT03412565|561152982|FG002|Overall Study|Lost to Follow-up|1|||
155472649|NCT03412565|561152983|FG003|Overall Study|Lost to Follow-up|0|||
155472650|NCT03412565|561152980|FG000|Overall Study|Physician Decision|0|||
155472651|NCT03412565|561152981|FG001|Overall Study|Physician Decision|0|||
155472652|NCT03412565|561152982|FG002|Overall Study|Physician Decision|0|||
155472653|NCT03412565|561152983|FG003|Overall Study|Physician Decision|1|||
155472654|NCT03412565|561152980|FG000|Overall Study|Withdrawal by Subject|0|||
155472655|NCT03412565|561152981|FG001|Overall Study|Withdrawal by Subject|4|||
155472656|NCT03412565|561152982|FG002|Overall Study|Withdrawal by Subject|5|||
155472657|NCT03412565|561152983|FG003|Overall Study|Withdrawal by Subject|5|||
155472658|NCT03412565|561152980|FG000|Overall Study|Death|1|||
155472659|NCT03412565|561152981|FG001|Overall Study|Death|3|||
155472660|NCT03412565|561152982|FG002|Overall Study|Death|4|||
155472661|NCT03412565|561152983|FG003|Overall Study|Death|5|||
155472662|NCT03412565|561152980|FG000|Overall Study|Data collection ended|0|||
155472663|NCT03412565|561152981|FG001|Overall Study|Data collection ended|41|||
155472664|NCT03412565|561152982|FG002|Overall Study|Data collection ended|41|||
155472665|NCT03412565|561152983|FG003|Overall Study|Data collection ended|40|||
155472666|NCT03277105|561152984|FG000|Overall Study|Death|129|||
155472667|NCT03277105|561152985|FG001|Overall Study|Death|124|||
155472668|NCT03277105|561152984|FG000|Overall Study|Lost to Follow-up|2|||
155472669|NCT03277105|561152985|FG001|Overall Study|Lost to Follow-up|4|||
155472670|NCT03277105|561152984|FG000|Overall Study|Withdrawal by Subject|10|||
155472671|NCT03277105|561152985|FG001|Overall Study|Withdrawal by Subject|10|||
155472672|NCT03277105|561152984|FG000|Overall Study|Other|118|||
155472673|NCT03277105|561152985|FG001|Overall Study|Other|125|||
155472674|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
155472675|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
155472676|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
155472677|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
155472678|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
155472679|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
155472680|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
155472681|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
155472682|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
155472683|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
155472684|NCT02418585|561152989|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
155472685|NCT02418585|561152990|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
155472686|NCT02418585|561152989|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
155472687|NCT02418585|561152990|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
155472688|NCT02418585|561152989|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
155472689|NCT02418585|561152990|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
155472690|NCT02418585|561152989|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
155472691|NCT02418585|561152990|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
155472692|NCT02418585|561152989|FG000|Follow-up Phase (24 Weeks)|Other|3|||
155472693|NCT02418585|561152990|FG001|Follow-up Phase (24 Weeks)|Other|2|||
155472694|NCT04159701|561152991|FG000|Period 1: Treatment Period|Pregnancy|1|||
155472695|NCT04159701|561152992|FG001|Period 1: Treatment Period|Pregnancy|0|||
155472696|NCT04159701|561152991|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
155472697|NCT04159701|561152992|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
155472698|NCT04159701|561152991|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
155472699|NCT04159701|561152992|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
155472700|NCT04159701|561152991|FG000|Washout Period|site terminated by sponsor|0|||
155472701|NCT04159701|561152992|FG001|Washout Period|site terminated by sponsor|1|||
155472702|NCT04159701|561152991|FG000|Washout Period|study terminated by sponsor|10|||
155472703|NCT04159701|561152992|FG001|Washout Period|study terminated by sponsor|3|||
155472704|NCT04159701|561152991|FG000|Washout Period|Withdrawal by Subject|1|||
155472705|NCT04159701|561152992|FG001|Washout Period|Withdrawal by Subject|0|||
155472706|NCT04159701|561152991|FG000|Washout Period|Inadvertent Enrollment|1|||
155472707|NCT04159701|561152992|FG001|Washout Period|Inadvertent Enrollment|0|||
155472708|NCT04159701|561152991|FG000|Washout Period|Miscellaneous|1|||
155472709|NCT04159701|561152992|FG001|Washout Period|Miscellaneous|0|||
155472710|NCT04159701|561152991|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
155472711|NCT04159701|561152992|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
155472712|NCT04159701|561152991|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
155472713|NCT04159701|561152992|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
155491183|NCT00634933|561223489|FG002|Part A: Baseline to Week 24|Other|5|||
155472714|NCT04159701|561152991|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
155472715|NCT04159701|561152992|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
155472716|NCT04159701|561152991|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
155472717|NCT04159701|561152992|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
155472718|NCT04159701|561152991|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
155472719|NCT04159701|561152992|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
155472720|NCT00638690|561152995|FG000|Overall Study|Death|655|||
155472721|NCT00638690|561152996|FG001|Overall Study|Death|335|||
155472722|NCT00638690|561152995|FG000|Overall Study|Withdrawal by Subject|22|||
155472723|NCT00638690|561152996|FG001|Overall Study|Withdrawal by Subject|5|||
155472724|NCT00638690|561152995|FG000|Overall Study|Lost to Follow-up|4|||
155472725|NCT00638690|561152996|FG001|Overall Study|Lost to Follow-up|2|||
155472726|NCT02348840|561153004|FG000|Overall Study|Withdrawal by Subject|2|||
155472727|NCT02348840|561153005|FG001|Overall Study|Withdrawal by Subject|1|||
155472728|NCT02348840|561153006|FG002|Overall Study|Withdrawal by Subject|0|||
155472729|NCT02348840|561153007|FG003|Overall Study|Withdrawal by Subject|0|||
155472730|NCT00373880|561153008|FG000|Overall Study|Physician Decision|3|||
155472731|NCT00373880|561153008|FG000|Overall Study|Arrested|1|||
155472732|NCT00373880|561153008|FG000|Overall Study|Protocol Violation|14|||
155472733|NCT02865928|561153016|FG000|Overall Study|Withdrawal by Subject|1|||
155472734|NCT02865928|561153017|FG001|Overall Study|Withdrawal by Subject|0|||
155472735|NCT02865928|561153016|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
155472736|NCT02865928|561153017|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
155472737|NCT02865928|561153016|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
155472738|NCT02865928|561153017|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
155472739|NCT03152110|561153018|FG000|Overall Study|Withdrawal by Subject|3|||
155472740|NCT00552344|561153023|FG000|Overall Study|Lack of Efficacy|55|||
155472741|NCT00552344|561153023|FG000|Overall Study|Loss of efficacy|75|||
155472742|NCT00552344|561153023|FG000|Overall Study|Lost to Follow-up|8|||
155472743|NCT00552344|561153023|FG000|Overall Study|Withdrawal by Subject|48|||
155472744|NCT00552344|561153023|FG000|Overall Study|SAE, non-fatal|6|||
155472745|NCT00552344|561153023|FG000|Overall Study|AE, non-serious non-fatal|38|||
155472746|NCT00552344|561153023|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
155472747|NCT00552344|561153023|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
155472748|NCT00552344|561153023|FG000|Overall Study|Other Reason|22|||
155472749|NCT01634100|561153024|FG000|Overall Study|Withdrawal by Subject|1|||
155472750|NCT01634100|561153025|FG001|Overall Study|Withdrawal by Subject|0|||
155472751|NCT01634100|561153026|FG002|Overall Study|Withdrawal by Subject|1|||
155472752|NCT01634100|561153027|FG003|Overall Study|Withdrawal by Subject|0|||
155472753|NCT01634100|561153028|FG004|Overall Study|Withdrawal by Subject|0|||
155472754|NCT01634100|561153029|FG005|Overall Study|Withdrawal by Subject|0|||
155472755|NCT00471276|561153030|FG000|Overall Study|Death|2|||
155472756|NCT00471276|561153030|FG000|Overall Study|Adverse Event|16|||
155472757|NCT00471276|561153030|FG000|Overall Study|Protocol Violation|1|||
155472758|NCT00471276|561153030|FG000|Overall Study|Objective progression or relapse|54|||
155472759|NCT00471276|561153030|FG000|Overall Study|Global deterioration of health status|1|||
155472760|NCT00471276|561153030|FG000|Overall Study|Other|3|||
155472761|NCT00471276|561153030|FG000|Overall Study|Refused treatment|6|||
155472762|NCT00338806|561153031|FG000|Acute Phase|Withdrawal by Subject|0|||
155472763|NCT00338806|561153032|FG001|Acute Phase|Withdrawal by Subject|1|||
155472764|NCT00338806|561153031|FG000|Follow-up|Lost to Follow-up|1|||
155518956|NCT05694013|561325171|FG001|Overall Study|Death|2|||
155518957|NCT05694013|561325170|FG000|Overall Study|Participant Decision|0|||
155518958|NCT05694013|561325171|FG001|Overall Study|Participant Decision|1|||
155518959|NCT05694013|561325170|FG000|Overall Study|Physician Decision|1|||
155518960|NCT05694013|561325171|FG001|Overall Study|Physician Decision|0|||
155518961|NCT05694013|561325170|FG000|Overall Study|Progressive Disease|0|||
155518962|NCT05694013|561325171|FG001|Overall Study|Progressive Disease|1|||
155518963|NCT05694013|561325170|FG000|Overall Study|Study Terminated by Sponsor|12|||
155654063|NCT01272219|561826890|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
155654064|NCT01272219|561826891|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
155654065|NCT01272219|561826892|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
155472765|NCT00338806|561153032|FG001|Follow-up|Lost to Follow-up|3|||
155472766|NCT00744991|561153035|FG000|Overall Study|Progressive Disease|11|||
155472767|NCT00744991|561153035|FG000|Overall Study|Withdrawal by Subject|8|||
155518964|NCT05694013|561325171|FG001|Overall Study|Study Terminated by Sponsor|17|||
155518965|NCT05694013|561325170|FG000|Overall Study|Withdrawal by Subject|3|||
155472768|NCT00744991|561153035|FG000|Overall Study|Physician Decision|3|||
155472769|NCT00744991|561153035|FG000|Overall Study|Adverse Event|2|||
155472770|NCT00744991|561153035|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
155472771|NCT01662986|561153038|FG000|Overall Study|Adverse Event|5|||
155472772|NCT01662986|561153039|FG001|Overall Study|Adverse Event|4|||
155472773|NCT01662986|561153038|FG000|Overall Study|Protocol Violation|2|||
155472774|NCT01662986|561153039|FG001|Overall Study|Protocol Violation|3|||
155472775|NCT01662986|561153038|FG000|Overall Study|Lost to Follow-up|5|||
155472776|NCT01662986|561153039|FG001|Overall Study|Lost to Follow-up|4|||
155472777|NCT01662986|561153038|FG000|Overall Study|Withdrawal by Subject|2|||
155472778|NCT01662986|561153039|FG001|Overall Study|Withdrawal by Subject|2|||
155472779|NCT01662986|561153038|FG000|Overall Study|Not Treated|1|||
155472780|NCT01662986|561153039|FG001|Overall Study|Not Treated|0|||
155472781|NCT01662986|561153038|FG000|Overall Study|Other than stated above|3|||
155472782|NCT01662986|561153039|FG001|Overall Study|Other than stated above|0|||
155472783|NCT01975376|561153040|FG000|Overall Study|Adverse Event|5|||
155472784|NCT01975376|561153041|FG001|Overall Study|Adverse Event|5|||
155472785|NCT01975376|561153040|FG000|Overall Study|Death|65|||
155472786|NCT01975376|561153041|FG001|Overall Study|Death|72|||
155472787|NCT01975376|561153040|FG000|Overall Study|Lost to Follow-up|70|||
155472788|NCT01975376|561153041|FG001|Overall Study|Lost to Follow-up|66|||
155472789|NCT01975376|561153040|FG000|Overall Study|Withdrew consent|68|||
155472790|NCT01975376|561153041|FG001|Overall Study|Withdrew consent|62|||
155472791|NCT01975376|561153040|FG000|Overall Study|Other|2|||
155472792|NCT01975376|561153041|FG001|Overall Study|Other|4|||
155472793|NCT01975376|561153040|FG000|Overall Study|Randomized, Not Treated|16|||
155472794|NCT01975376|561153041|FG001|Overall Study|Randomized, Not Treated|8|||
155472795|NCT01448707|561153047|FG000|Overall Study|Adverse Event|3|||
155472796|NCT01448707|561153048|FG001|Overall Study|Adverse Event|1|||
155472797|NCT01448707|561153047|FG000|Overall Study|Lost to Follow-up|2|||
155472798|NCT01448707|561153048|FG001|Overall Study|Lost to Follow-up|6|||
155472799|NCT01448707|561153047|FG000|Overall Study|Withdrawal by Subject|6|||
155472800|NCT01448707|561153048|FG001|Overall Study|Withdrawal by Subject|7|||
155472801|NCT01448707|561153047|FG000|Overall Study|Other|7|||
155472802|NCT01448707|561153048|FG001|Overall Study|Other|4|||
155472803|NCT02033850|561153054|FG000|Overall Study|Death|1|||
155472804|NCT02033850|561153055|FG001|Overall Study|Death|0|||
155472805|NCT02033850|561153054|FG000|Overall Study|unrelated medical reason|1|||
155472806|NCT02033850|561153055|FG001|Overall Study|unrelated medical reason|1|||
155472807|NCT02820038|561153059|FG000|Overall Study|Lost to Follow-up|7|||
155472808|NCT02820038|561153060|FG001|Overall Study|Lost to Follow-up|11|||
155472809|NCT02820038|561153061|FG002|Overall Study|Lost to Follow-up|2|||
155472810|NCT02820038|561153062|FG003|Overall Study|Lost to Follow-up|9|||
155472811|NCT02820038|561153059|FG000|Overall Study|Withdrawal by Subject|3|||
155472812|NCT02820038|561153060|FG001|Overall Study|Withdrawal by Subject|14|||
155472813|NCT02820038|561153061|FG002|Overall Study|Withdrawal by Subject|3|||
155472814|NCT02820038|561153062|FG003|Overall Study|Withdrawal by Subject|13|||
155472815|NCT03215667|561153063|FG000|Overall Study|Physician Decision|4|||
155472816|NCT00560794|561153064|FG000|Overall Study|Adverse Event|2|||
155472817|NCT00560794|561153064|FG000|Overall Study|Patient was not Compliant|1|||
155472818|NCT00560794|561153064|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
155472819|NCT00560794|561153064|FG000|Overall Study|Hematological Relapse|1|||
155472820|NCT00560794|561153064|FG000|Overall Study|Received Bone Marrow Transplant|6|||
155472821|NCT00614991|561153065|FG000|Overall Study|Adverse Event|3|||
155472822|NCT00614991|561153066|FG001|Overall Study|Adverse Event|3|||
155472823|NCT00614991|561153067|FG002|Overall Study|Adverse Event|0|||
155472824|NCT00614991|561153068|FG003|Overall Study|Adverse Event|0|||
155472825|NCT00614991|561153069|FG004|Overall Study|Adverse Event|1|||
155472826|NCT00614991|561153070|FG005|Overall Study|Adverse Event|0|||
155472827|NCT00368472|561153074|FG000|Overall Study|Adverse Event|22|||
155472828|NCT00368472|561153074|FG000|Overall Study|Medication non-compliance|4|||
155472829|NCT00368472|561153074|FG000|Overall Study|Protocol Violation|2|||
155472830|NCT00368472|561153074|FG000|Overall Study|Request of Investigator or Sponsor|3|||
155472831|NCT00368472|561153074|FG000|Overall Study|Withdrawal by Subject|40|||
155472832|NCT00368472|561153074|FG000|Overall Study|Diary non-compliance|1|||
155472833|NCT00368472|561153074|FG000|Overall Study|Other|32|||
155472834|NCT00368472|561153074|FG000|Overall Study|Missing Final Disposition Date|1|||
155472835|NCT01922739|561153078|FG000|Titration/Adjustment Period|Adverse Event|3|||
155472836|NCT01922739|561153078|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
155472837|NCT01922739|561153078|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
155472838|NCT01922739|561153078|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
155472839|NCT01922739|561153078|FG000|Open-label Treatment Period|Adverse Event|6|||
155472840|NCT01922739|561153078|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
155472841|NCT01922739|561153078|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
155472842|NCT01922739|561153078|FG000|Open-label Treatment Period|Protocol Violation|5|||
155472843|NCT01922739|561153078|FG000|Open-label Treatment Period|Pregnancy|1|||
155472844|NCT01922739|561153078|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
155472845|NCT01922739|561153078|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
155472846|NCT01922739|561153078|FG000|Open-label Treatment Period|Physician Decision|1|||
155472847|NCT01922739|561153078|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
155472848|NCT00044213|561153079|FG000|Overall Study|Withdrawal by Subject|50|||
155472849|NCT00044213|561153080|FG001|Overall Study|Withdrawal by Subject|65|||
155472850|NCT00044213|561153081|FG002|Overall Study|Withdrawal by Subject|91|||
155472851|NCT00044213|561153082|FG003|Overall Study|Withdrawal by Subject|83|||
155472852|NCT00044213|561153079|FG000|Overall Study|Death|42|||
155472853|NCT00044213|561153080|FG001|Overall Study|Death|42|||
155472854|NCT00044213|561153081|FG002|Overall Study|Death|42|||
155472855|NCT00044213|561153082|FG003|Overall Study|Death|49|||
155472856|NCT00044213|561153079|FG000|Overall Study|Lost to Follow-up|8|||
155472857|NCT00044213|561153080|FG001|Overall Study|Lost to Follow-up|5|||
155472858|NCT00044213|561153081|FG002|Overall Study|Lost to Follow-up|5|||
155472859|NCT00044213|561153082|FG003|Overall Study|Lost to Follow-up|4|||
155472860|NCT00422240|561153083|FG000|Overall Study|Lack of Efficacy|1|||
155472861|NCT00422240|561153084|FG001|Overall Study|Lack of Efficacy|2|||
155472862|NCT00422240|561153085|FG002|Overall Study|Lack of Efficacy|0|||
155472863|NCT00422240|561153086|FG003|Overall Study|Lack of Efficacy|1|||
155472864|NCT00422240|561153083|FG000|Overall Study|Adverse Event|11|||
155472865|NCT00422240|561153084|FG001|Overall Study|Adverse Event|4|||
155472866|NCT00422240|561153085|FG002|Overall Study|Adverse Event|5|||
155472867|NCT00422240|561153086|FG003|Overall Study|Adverse Event|2|||
155472868|NCT00422240|561153083|FG000|Overall Study|Subject request|21|||
155472869|NCT00422240|561153084|FG001|Overall Study|Subject request|17|||
155472870|NCT00422240|561153085|FG002|Overall Study|Subject request|18|||
155472871|NCT00422240|561153086|FG003|Overall Study|Subject request|30|||
155472872|NCT00422240|561153083|FG000|Overall Study|Protocol Violation|0|||
155472873|NCT00422240|561153084|FG001|Overall Study|Protocol Violation|1|||
155472874|NCT00422240|561153085|FG002|Overall Study|Protocol Violation|0|||
155472875|NCT00422240|561153086|FG003|Overall Study|Protocol Violation|1|||
155472876|NCT00422240|561153083|FG000|Overall Study|Lost to Follow-up|31|||
155472877|NCT00422240|561153084|FG001|Overall Study|Lost to Follow-up|32|||
155472878|NCT00422240|561153085|FG002|Overall Study|Lost to Follow-up|19|||
155472879|NCT00422240|561153086|FG003|Overall Study|Lost to Follow-up|34|||
155472880|NCT00422240|561153083|FG000|Overall Study|Other|1|||
155472881|NCT00422240|561153084|FG001|Overall Study|Other|0|||
155472882|NCT00422240|561153085|FG002|Overall Study|Other|0|||
155472883|NCT00422240|561153086|FG003|Overall Study|Other|1|||
155472884|NCT00422240|561153083|FG000|Overall Study|Pregnancy|3|||
155472885|NCT00422240|561153084|FG001|Overall Study|Pregnancy|1|||
155472886|NCT00422240|561153085|FG002|Overall Study|Pregnancy|1|||
155472887|NCT00422240|561153086|FG003|Overall Study|Pregnancy|2|||
155472888|NCT01927068|561153087|FG000|Overall Study|Death|37|||
155472889|NCT01927068|561153088|FG001|Overall Study|Death|3|||
155472890|NCT01927068|561153087|FG000|Overall Study|Withdrawal by Subject|50|||
155472891|NCT01927068|561153088|FG001|Overall Study|Withdrawal by Subject|3|||
155472892|NCT01927068|561153087|FG000|Overall Study|Lost to Follow-up|10|||
155472893|NCT01927068|561153088|FG001|Overall Study|Lost to Follow-up|2|||
155472894|NCT01927068|561153087|FG000|Overall Study|Physician Decision|9|||
155472895|NCT01927068|561153088|FG001|Overall Study|Physician Decision|0|||
155472896|NCT01927068|561153087|FG000|Overall Study|Missed last follow-up visit|2|||
155472897|NCT01927068|561153088|FG001|Overall Study|Missed last follow-up visit|0|||
155472898|NCT05104749|561153092|FG000|Overall Study|Lost to Follow-up|2|||
155472899|NCT05104749|561153093|FG001|Overall Study|Lost to Follow-up|3|||
155472900|NCT03964493|561153094|FG000|Overall Study|Withdrawal by Subject|4|||
155472901|NCT03964493|561153095|FG001|Overall Study|Withdrawal by Subject|1|||
155472902|NCT03964493|561153094|FG000|Overall Study|Lost to Follow-up|13|||
155472903|NCT03964493|561153095|FG001|Overall Study|Lost to Follow-up|4|||
155472904|NCT02963766|561153096|FG000|Double-Blind Period|Adverse Event|1|||
155472905|NCT02963766|561153097|FG001|Double-Blind Period|Adverse Event|0|||
155472906|NCT02963766|561153098|FG002|Double-Blind Period|Adverse Event|1|||
155518966|NCT05694013|561325171|FG001|Overall Study|Withdrawal by Subject|0|||
155518967|NCT04817891|561325172|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
155518968|NCT04817891|561325172|FG000|Overall Study|Adverse Event|1|||
155518969|NCT04817891|561325172|FG000|Overall Study|Withdrawal by Subject|1|||
155654066|NCT01272219|561826893|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
155472907|NCT02963766|561153096|FG000|Double-Blind Period|Physician Decision|1|||
155472908|NCT02963766|561153097|FG001|Double-Blind Period|Physician Decision|0|||
155472909|NCT02963766|561153098|FG002|Double-Blind Period|Physician Decision|0|||
155472910|NCT02963766|561153096|FG000|Double-Blind Period|Withdrawal by Subject|1|||
155472911|NCT02963766|561153097|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155472912|NCT02963766|561153098|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155472913|NCT02963766|561153096|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
155472914|NCT02963766|561153097|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
155472915|NCT02963766|561153098|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
155472916|NCT02963766|561153096|FG000|Double-Blind Period|Protocol Violation|1|||
155472917|NCT02963766|561153097|FG001|Double-Blind Period|Protocol Violation|0|||
155472918|NCT02963766|561153098|FG002|Double-Blind Period|Protocol Violation|0|||
155472919|NCT02963766|561153096|FG000|Double-Blind Period|Lost to Follow-up|0|||
155472920|NCT02963766|561153097|FG001|Double-Blind Period|Lost to Follow-up|1|||
155472921|NCT02963766|561153098|FG002|Double-Blind Period|Lost to Follow-up|0|||
155472922|NCT02963766|561153096|FG000|Open Label Extension (OLE)|Physician Decision|1|||
155472923|NCT02963766|561153097|FG001|Open Label Extension (OLE)|Physician Decision|2|||
155472924|NCT02963766|561153098|FG002|Open Label Extension (OLE)|Physician Decision|2|||
155472925|NCT02963766|561153096|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
155472926|NCT02963766|561153097|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
155472927|NCT02963766|561153098|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
155472928|NCT02224274|561153102|FG000|Overall Study|Death|1|||
155472929|NCT02224274|561153103|FG001|Overall Study|Death|0|||
155472930|NCT00887068|561153104|FG000|Overall Study|Withdrawal by Subject|2|||
155472931|NCT00887068|561153105|FG001|Overall Study|Withdrawal by Subject|0|||
155472932|NCT00887068|561153104|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
155472933|NCT00887068|561153105|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
155472934|NCT00499460|561153106|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
155472935|NCT00499460|561153107|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
155472936|NCT00499460|561153106|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
155472937|NCT00499460|561153107|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
155472938|NCT00499460|561153106|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
155472939|NCT00499460|561153107|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
155472940|NCT03073200|561153116|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155472941|NCT03073200|561153117|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155472942|NCT03073200|561153118|FG002|Double Blind Treatment Period|Protocol Violation|0|||
155472943|NCT03073200|561153119|FG003|Double Blind Treatment Period|Protocol Violation|0|||
155472944|NCT03073200|561153120|FG004|Double Blind Treatment Period|Protocol Violation|0|||
155472945|NCT03073200|561153121|FG005|Double Blind Treatment Period|Protocol Violation|0|||
155472946|NCT03073200|561153122|FG006|Double Blind Treatment Period|Protocol Violation|0|||
155472947|NCT03073200|561153123|FG007|Double Blind Treatment Period|Protocol Violation|0|||
155472948|NCT03073200|561153124|FG008|Double Blind Treatment Period|Protocol Violation|0|||
155472949|NCT03073200|561153125|FG009|Double Blind Treatment Period|Protocol Violation|0|||
155472950|NCT03073200|561153126|FG010|Double Blind Treatment Period|Protocol Violation|0|||
155472951|NCT03073200|561153127|FG011|Double Blind Treatment Period|Protocol Violation|0|||
155472952|NCT03073200|561153128|FG012|Double Blind Treatment Period|Protocol Violation|0|||
155472953|NCT03073200|561153129|FG013|Double Blind Treatment Period|Protocol Violation|0|||
155472954|NCT03073200|561153130|FG014|Double Blind Treatment Period|Protocol Violation|0|||
155472955|NCT03073200|561153116|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472956|NCT03073200|561153117|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
155472957|NCT03073200|561153118|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472958|NCT03073200|561153119|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472959|NCT03073200|561153120|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472960|NCT03073200|561153121|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472961|NCT03073200|561153122|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472962|NCT03073200|561153123|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472963|NCT03073200|561153124|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472964|NCT03073200|561153125|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472965|NCT03073200|561153126|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472966|NCT03073200|561153127|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472967|NCT03073200|561153128|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472968|NCT03073200|561153129|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472969|NCT03073200|561153130|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155472970|NCT03073200|561153116|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
155472971|NCT03073200|561153117|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472972|NCT03073200|561153118|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472973|NCT03073200|561153119|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472974|NCT03073200|561153120|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472975|NCT03073200|561153121|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472976|NCT03073200|561153122|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472977|NCT03073200|561153123|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472978|NCT03073200|561153124|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472979|NCT03073200|561153125|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472980|NCT03073200|561153126|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472981|NCT03073200|561153127|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472982|NCT03073200|561153128|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472983|NCT03073200|561153129|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472984|NCT03073200|561153130|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
155472985|NCT03073200|561153116|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472986|NCT03073200|561153117|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472987|NCT03073200|561153118|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472988|NCT03073200|561153119|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
155472989|NCT03073200|561153120|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
155472990|NCT03073200|561153121|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472991|NCT03073200|561153122|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472992|NCT03073200|561153123|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472993|NCT03073200|561153124|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472994|NCT03073200|561153125|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472995|NCT03073200|561153126|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472996|NCT03073200|561153127|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472997|NCT03073200|561153128|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472998|NCT03073200|561153129|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
155472999|NCT03073200|561153130|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
155473000|NCT03073200|561153116|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
155473001|NCT03073200|561153117|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
155473002|NCT03073200|561153118|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
155473003|NCT03073200|561153119|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
155473004|NCT03073200|561153120|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
155473005|NCT03073200|561153121|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
155473006|NCT03073200|561153122|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
155473007|NCT03073200|561153123|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
155473008|NCT03073200|561153124|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
155473009|NCT03073200|561153125|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
155473010|NCT03073200|561153126|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
155473011|NCT03073200|561153127|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
155473012|NCT03073200|561153128|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
155473013|NCT03073200|561153129|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
155473014|NCT03073200|561153130|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
155473015|NCT03073200|561153116|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473016|NCT03073200|561153117|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473017|NCT03073200|561153118|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473018|NCT03073200|561153119|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473019|NCT03073200|561153120|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
155473020|NCT03073200|561153121|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473021|NCT03073200|561153122|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473022|NCT03073200|561153123|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473023|NCT03073200|561153124|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473024|NCT03073200|561153125|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473025|NCT03073200|561153126|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473026|NCT03073200|561153127|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473027|NCT03073200|561153128|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473028|NCT03073200|561153129|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473029|NCT03073200|561153130|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
155473030|NCT03073200|561153116|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473031|NCT03073200|561153117|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473032|NCT03073200|561153118|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473033|NCT03073200|561153119|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
155473034|NCT03073200|561153120|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
155473035|NCT03073200|561153121|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473036|NCT03073200|561153122|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473037|NCT03073200|561153123|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473038|NCT03073200|561153124|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473039|NCT03073200|561153125|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473040|NCT03073200|561153126|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473041|NCT03073200|561153127|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473042|NCT03073200|561153128|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473043|NCT03073200|561153129|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473044|NCT03073200|561153130|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
155473045|NCT03073200|561153116|FG000|Extension Period|Lost to Follow-up|0|||
155654067|NCT01272219|561826894|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
155473046|NCT03073200|561153117|FG001|Extension Period|Lost to Follow-up|0|||
155473047|NCT03073200|561153118|FG002|Extension Period|Lost to Follow-up|0|||
155473048|NCT03073200|561153119|FG003|Extension Period|Lost to Follow-up|0|||
155473049|NCT03073200|561153120|FG004|Extension Period|Lost to Follow-up|0|||
155473050|NCT03073200|561153121|FG005|Extension Period|Lost to Follow-up|0|||
155491184|NCT00634933|561223490|FG003|Part A: Baseline to Week 24|Other|0|||
155473051|NCT03073200|561153122|FG006|Extension Period|Lost to Follow-up|1|||
155473052|NCT03073200|561153123|FG007|Extension Period|Lost to Follow-up|1|||
155473053|NCT03073200|561153124|FG008|Extension Period|Lost to Follow-up|0|||
155473054|NCT03073200|561153125|FG009|Extension Period|Lost to Follow-up|0|||
155473055|NCT03073200|561153126|FG010|Extension Period|Lost to Follow-up|0|||
155473056|NCT03073200|561153127|FG011|Extension Period|Lost to Follow-up|0|||
155473057|NCT03073200|561153128|FG012|Extension Period|Lost to Follow-up|0|||
155473058|NCT03073200|561153129|FG013|Extension Period|Lost to Follow-up|0|||
155473059|NCT03073200|561153130|FG014|Extension Period|Lost to Follow-up|0|||
155473060|NCT03073200|561153116|FG000|Extension Period|Sponsor Decision|0|||
155473061|NCT03073200|561153117|FG001|Extension Period|Sponsor Decision|0|||
155473062|NCT03073200|561153118|FG002|Extension Period|Sponsor Decision|0|||
155473063|NCT03073200|561153119|FG003|Extension Period|Sponsor Decision|0|||
155473064|NCT03073200|561153120|FG004|Extension Period|Sponsor Decision|0|||
155473065|NCT03073200|561153121|FG005|Extension Period|Sponsor Decision|0|||
155473066|NCT03073200|561153122|FG006|Extension Period|Sponsor Decision|0|||
155473067|NCT03073200|561153123|FG007|Extension Period|Sponsor Decision|0|||
155473068|NCT03073200|561153124|FG008|Extension Period|Sponsor Decision|1|||
155473069|NCT03073200|561153125|FG009|Extension Period|Sponsor Decision|0|||
155473070|NCT03073200|561153126|FG010|Extension Period|Sponsor Decision|0|||
155473071|NCT03073200|561153127|FG011|Extension Period|Sponsor Decision|0|||
155473072|NCT03073200|561153128|FG012|Extension Period|Sponsor Decision|0|||
155473073|NCT03073200|561153129|FG013|Extension Period|Sponsor Decision|0|||
155473074|NCT03073200|561153130|FG014|Extension Period|Sponsor Decision|0|||
155473075|NCT03073200|561153116|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
155473076|NCT03073200|561153117|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
155473077|NCT03073200|561153118|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
155473078|NCT03073200|561153119|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
155473079|NCT03073200|561153120|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
155473080|NCT03073200|561153121|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
155473081|NCT03073200|561153122|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
155473082|NCT03073200|561153123|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
155473083|NCT03073200|561153124|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
155473084|NCT03073200|561153125|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
155473085|NCT03073200|561153126|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
155473086|NCT03073200|561153127|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
155473087|NCT03073200|561153128|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
155473088|NCT03073200|561153129|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
155473089|NCT03073200|561153130|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
155473090|NCT03073200|561153116|FG000|Extension Period|Withdrawal by Subject|0|||
155473091|NCT03073200|561153117|FG001|Extension Period|Withdrawal by Subject|0|||
155473092|NCT03073200|561153118|FG002|Extension Period|Withdrawal by Subject|0|||
155473093|NCT03073200|561153119|FG003|Extension Period|Withdrawal by Subject|0|||
155473094|NCT03073200|561153120|FG004|Extension Period|Withdrawal by Subject|0|||
155473095|NCT03073200|561153121|FG005|Extension Period|Withdrawal by Subject|0|||
155473096|NCT03073200|561153122|FG006|Extension Period|Withdrawal by Subject|1|||
155473097|NCT03073200|561153123|FG007|Extension Period|Withdrawal by Subject|2|||
155473098|NCT03073200|561153124|FG008|Extension Period|Withdrawal by Subject|0|||
155473099|NCT03073200|561153125|FG009|Extension Period|Withdrawal by Subject|0|||
155473100|NCT03073200|561153126|FG010|Extension Period|Withdrawal by Subject|0|||
155518970|NCT03982433|561325173|FG000|Overall Study|Lost to Follow-up|1|||
155518971|NCT04981912|561325174|FG000|Overall Study|Physician Decision|2|||
155518972|NCT05049460|561325175|FG000|Overall Study|Withdrawal by Subject|2|||
155518973|NCT05049460|561325176|FG001|Overall Study|Withdrawal by Subject|2|||
155518974|NCT05049460|561325175|FG000|Overall Study|Lost to Follow-up|2|||
155518975|NCT05049460|561325176|FG001|Overall Study|Lost to Follow-up|2|||
155518976|NCT00918567|561325177|FG000|Overall Study|Lack of Efficacy|3|||
155518977|NCT00918567|561325178|FG001|Overall Study|Lack of Efficacy|1|||
155518978|NCT00918567|561325177|FG000|Overall Study|Withdrawal by Subject|1|||
155518979|NCT00918567|561325178|FG001|Overall Study|Withdrawal by Subject|1|||
155518980|NCT00918567|561325177|FG000|Overall Study|Adverse Event|1|||
155518981|NCT00918567|561325178|FG001|Overall Study|Adverse Event|0|||
155473101|NCT03073200|561153127|FG011|Extension Period|Withdrawal by Subject|0|||
155473102|NCT03073200|561153128|FG012|Extension Period|Withdrawal by Subject|0|||
155473103|NCT03073200|561153129|FG013|Extension Period|Withdrawal by Subject|0|||
155473104|NCT03073200|561153130|FG014|Extension Period|Withdrawal by Subject|0|||
155473105|NCT03073200|561153116|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473106|NCT03073200|561153117|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473107|NCT03073200|561153118|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473108|NCT03073200|561153119|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473109|NCT03073200|561153120|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473110|NCT03073200|561153121|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473111|NCT03073200|561153122|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
155518982|NCT05275998|561325179|FG000|Overall Study|Adverse Event|0|||
155473112|NCT03073200|561153123|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473113|NCT03073200|561153124|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473114|NCT03073200|561153125|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473115|NCT03073200|561153126|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473116|NCT03073200|561153127|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
155473117|NCT03073200|561153128|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473118|NCT03073200|561153129|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473119|NCT03073200|561153130|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
155473120|NCT03073200|561153116|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473121|NCT03073200|561153117|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473122|NCT03073200|561153118|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473123|NCT03073200|561153119|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473124|NCT03073200|561153120|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473125|NCT03073200|561153121|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473126|NCT03073200|561153122|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473127|NCT03073200|561153123|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473128|NCT03073200|561153124|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473129|NCT03073200|561153125|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473130|NCT03073200|561153126|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473131|NCT03073200|561153127|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
155473132|NCT03073200|561153128|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473133|NCT03073200|561153129|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473134|NCT03073200|561153130|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155473135|NCT03073200|561153116|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473136|NCT03073200|561153117|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473137|NCT03073200|561153118|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473138|NCT03073200|561153119|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473139|NCT03073200|561153120|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473140|NCT03073200|561153121|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473141|NCT03073200|561153122|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473142|NCT03073200|561153123|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473143|NCT03073200|561153124|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473144|NCT03073200|561153125|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473145|NCT03073200|561153126|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
155473146|NCT03073200|561153127|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
155473147|NCT03073200|561153128|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473148|NCT03073200|561153129|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473149|NCT03073200|561153130|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155473150|NCT03073200|561153116|FG000|Randomized Withdrawal Period|Adverse Event|0|||
155473151|NCT03073200|561153117|FG001|Randomized Withdrawal Period|Adverse Event|0|||
155473152|NCT03073200|561153118|FG002|Randomized Withdrawal Period|Adverse Event|0|||
155473153|NCT03073200|561153119|FG003|Randomized Withdrawal Period|Adverse Event|0|||
155473154|NCT03073200|561153120|FG004|Randomized Withdrawal Period|Adverse Event|0|||
155473155|NCT03073200|561153121|FG005|Randomized Withdrawal Period|Adverse Event|0|||
155473156|NCT03073200|561153122|FG006|Randomized Withdrawal Period|Adverse Event|0|||
155473157|NCT03073200|561153123|FG007|Randomized Withdrawal Period|Adverse Event|0|||
155473158|NCT03073200|561153124|FG008|Randomized Withdrawal Period|Adverse Event|0|||
155473159|NCT03073200|561153125|FG009|Randomized Withdrawal Period|Adverse Event|0|||
155473160|NCT03073200|561153126|FG010|Randomized Withdrawal Period|Adverse Event|1|||
155473161|NCT03073200|561153127|FG011|Randomized Withdrawal Period|Adverse Event|0|||
155473162|NCT03073200|561153128|FG012|Randomized Withdrawal Period|Adverse Event|0|||
155473163|NCT03073200|561153129|FG013|Randomized Withdrawal Period|Adverse Event|0|||
155473164|NCT03073200|561153130|FG014|Randomized Withdrawal Period|Adverse Event|0|||
155473165|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473166|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473167|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473168|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473169|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473170|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473171|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473172|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473173|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473174|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473175|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473176|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473177|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473178|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
155473179|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
155473180|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473181|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473182|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473183|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473184|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473185|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473186|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473187|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473188|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473189|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473190|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473191|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473192|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473193|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
155473194|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155473195|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473196|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473197|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473198|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473199|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473200|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473201|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473202|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473203|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473204|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473205|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473206|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473207|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473208|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
155473209|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
155473210|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473211|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473212|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473213|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473214|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473215|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473216|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473217|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473218|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473219|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473220|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473221|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473222|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473223|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
155473224|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155473225|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473226|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473227|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473228|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473229|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473230|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473231|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473232|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473233|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473234|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473235|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473236|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473237|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473238|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
155473239|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
155473240|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473241|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473242|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473243|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473244|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473245|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473246|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473247|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473248|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473249|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473250|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473251|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473252|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473253|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
155473254|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
155473255|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473256|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473257|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473258|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473259|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473260|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473261|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473262|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473263|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473264|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473265|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473266|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473267|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473268|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
155473269|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155473270|NCT03073200|561153116|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473271|NCT03073200|561153117|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473272|NCT03073200|561153118|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473273|NCT03073200|561153119|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473274|NCT03073200|561153120|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473275|NCT03073200|561153121|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473276|NCT03073200|561153122|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473277|NCT03073200|561153123|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473278|NCT03073200|561153124|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473279|NCT03073200|561153125|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473280|NCT03073200|561153126|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473281|NCT03073200|561153127|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473282|NCT03073200|561153128|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473283|NCT03073200|561153129|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
155473284|NCT03073200|561153130|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
155473285|NCT00901394|561153131|FG000|Overall Study|Physician Decision|1|||
155473286|NCT00901394|561153132|FG001|Overall Study|Physician Decision|1|||
155473287|NCT00901394|561153133|FG002|Overall Study|Physician Decision|2|||
155473288|NCT01474889|561153134|FG000|Overall Study|Physician Decision|1|||
155473289|NCT01474889|561153135|FG001|Overall Study|Physician Decision|0|||
155473290|NCT01474889|561153136|FG002|Overall Study|Physician Decision|0|||
155473291|NCT01474889|561153134|FG000|Overall Study|Did not meet inclusion|1|||
155473292|NCT01474889|561153135|FG001|Overall Study|Did not meet inclusion|0|||
155473293|NCT01474889|561153136|FG002|Overall Study|Did not meet inclusion|0|||
155473294|NCT01474889|561153134|FG000|Overall Study|Withdrawal by Subject|0|||
155473295|NCT01474889|561153135|FG001|Overall Study|Withdrawal by Subject|1|||
155473296|NCT01474889|561153136|FG002|Overall Study|Withdrawal by Subject|0|||
155473297|NCT02290340|561153139|FG000|Overall Study|Lost to Follow-up|0|||
155473298|NCT02290340|561153140|FG001|Overall Study|Lost to Follow-up|0|||
155473299|NCT02290340|561153141|FG002|Overall Study|Lost to Follow-up|0|||
155473300|NCT02290340|561153142|FG003|Overall Study|Lost to Follow-up|1|||
155473301|NCT02290340|561153139|FG000|Overall Study|Withdrawal by Subject|1|||
155473302|NCT02290340|561153140|FG001|Overall Study|Withdrawal by Subject|0|||
155473303|NCT02290340|561153141|FG002|Overall Study|Withdrawal by Subject|0|||
155473304|NCT02290340|561153142|FG003|Overall Study|Withdrawal by Subject|0|||
155473305|NCT02290340|561153139|FG000|Overall Study|Other|1|||
155473306|NCT02290340|561153140|FG001|Overall Study|Other|0|||
155473307|NCT02290340|561153141|FG002|Overall Study|Other|0|||
155473308|NCT02290340|561153142|FG003|Overall Study|Other|1|||
155473309|NCT04964557|561153145|FG000|Overall Study|Withdrawal by Subject|3|||
155473310|NCT04964557|561153146|FG001|Overall Study|Withdrawal by Subject|2|||
155473311|NCT04964557|561153145|FG000|Overall Study|Lost to Follow-up|1|||
155473312|NCT04964557|561153146|FG001|Overall Study|Lost to Follow-up|2|||
155473313|NCT04964557|561153145|FG000|Overall Study|Physician Decision|2|||
155473314|NCT04964557|561153146|FG001|Overall Study|Physician Decision|0|||
155654068|NCT01272219|561826889|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
155654069|NCT01272219|561826890|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
155654070|NCT01272219|561826891|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
155654071|NCT01272219|561826892|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
155654072|NCT01272219|561826893|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
155654073|NCT01272219|561826894|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
155473315|NCT04964557|561153145|FG000|Overall Study|Death|3|||
155473316|NCT04964557|561153146|FG001|Overall Study|Death|0|||
155473317|NCT04964557|561153145|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
155473318|NCT04964557|561153146|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
155473319|NCT03209362|561153148|FG000|Overall Study|Adverse Event|0|||
155473320|NCT03209362|561153149|FG001|Overall Study|Adverse Event|1|||
155473321|NCT03209362|561153148|FG000|Overall Study|Lost to Follow-up|0|||
155473322|NCT03209362|561153149|FG001|Overall Study|Lost to Follow-up|1|||
155473323|NCT03209362|561153148|FG000|Overall Study|Withdrawal by Subject|2|||
155473324|NCT03209362|561153149|FG001|Overall Study|Withdrawal by Subject|0|||
155473325|NCT03209362|561153148|FG000|Overall Study|Other|0|||
155473326|NCT03209362|561153149|FG001|Overall Study|Other|1|||
155473327|NCT00251589|561153150|FG000|Overall Study|Adverse Event|5|||
155473328|NCT00251589|561153151|FG001|Overall Study|Adverse Event|1|||
155473329|NCT00251589|561153152|FG002|Overall Study|Adverse Event|2|||
155473330|NCT00251589|561153153|FG003|Overall Study|Adverse Event|1|||
155473331|NCT00251589|561153150|FG000|Overall Study|Withdrawal by Subject|1|||
155473332|NCT00251589|561153151|FG001|Overall Study|Withdrawal by Subject|1|||
155473333|NCT00251589|561153152|FG002|Overall Study|Withdrawal by Subject|0|||
155473334|NCT00251589|561153153|FG003|Overall Study|Withdrawal by Subject|0|||
155473335|NCT00251589|561153150|FG000|Overall Study|Discontinued due to progressive disease|9|||
155473336|NCT00251589|561153151|FG001|Overall Study|Discontinued due to progressive disease|1|||
155473337|NCT00251589|561153152|FG002|Overall Study|Discontinued due to progressive disease|0|||
155473338|NCT00251589|561153153|FG003|Overall Study|Discontinued due to progressive disease|1|||
155473339|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Adverse Event|22|||
155473340|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Adverse Event|0|||
155473341|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
155473342|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
155473343|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
155473344|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
155473345|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
155473346|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
155473347|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
155473348|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
155473349|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
155473350|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
155473351|NCT02493868|561153156|FG000|Induction Phase: DE Participants|Other|8|||
155473352|NCT02493868|561153157|FG001|Induction Phase: DE Participants|Other|0|||
155473353|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
155473354|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
155473355|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
155473356|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
155473357|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
155473358|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
155473359|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
155473360|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
155473361|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
155473362|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
155473363|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
155473364|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
155473365|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
155473366|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
155518983|NCT05275998|561325180|FG001|Overall Study|Adverse Event|0|||
155654074|NCT01272219|561826889|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155473367|NCT02493868|561153156|FG000|Optimization Phase: DE+TE Participants|Other|10|||
155473368|NCT02493868|561153157|FG001|Optimization Phase: DE+TE Participants|Other|2|||
155473369|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
155473370|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
155473371|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
155473372|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
155473373|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
155473374|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
155473375|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
155473376|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
155473377|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
155473378|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
155473379|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
155473380|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
155473381|NCT02493868|561153156|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
155473382|NCT02493868|561153157|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
155473383|NCT02493868|561153156|FG000|Follow-up Phase|Lost to Follow-up|1|||
155473384|NCT02493868|561153157|FG001|Follow-up Phase|Lost to Follow-up|0|||
155473385|NCT02493868|561153156|FG000|Follow-up Phase|Withdrawal by Subject|3|||
155473386|NCT02493868|561153157|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155473387|NCT02493868|561153156|FG000|Follow-up Phase|Investigator Decision|5|||
155473388|NCT02493868|561153157|FG001|Follow-up Phase|Investigator Decision|1|||
155473389|NCT02493868|561153156|FG000|Follow-up Phase|Other|2|||
155473390|NCT02493868|561153157|FG001|Follow-up Phase|Other|1|||
155473391|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
155473392|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
155473393|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
155473394|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
155473395|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
155473396|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
155473397|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
155654075|NCT01272219|561826890|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
155654076|NCT01272219|561826891|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
155654077|NCT01272219|561826892|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
155473398|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
155473399|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
155473400|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
155473401|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
155473402|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
155473403|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
155473404|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Death|0|||
155473405|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Death|0|||
155473406|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Death|1|||
155473407|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Death|0|||
155473408|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Death|0|||
155473409|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Death|0|||
155473410|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Death|0|||
155473411|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Death|0|||
155473412|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Death|0|||
155473413|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Death|0|||
155473414|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Death|0|||
155473415|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Death|0|||
155654078|NCT01272219|561826893|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155473416|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Death|0|||
155473417|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
155473418|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
155473419|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
155473420|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473421|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473422|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155654079|NCT01272219|561826894|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155473423|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473424|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473425|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473426|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473427|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473428|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473429|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
155473430|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473431|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473432|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
155654080|NCT01272219|561826889|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155473433|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473434|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473435|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473436|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473437|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473438|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473439|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473440|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473441|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473442|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155473443|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
155473444|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
155473445|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
155473446|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
155473447|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
155473448|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
155473449|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
155473450|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
155473451|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
155473452|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
155473453|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
155473454|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
155473455|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
155473456|NCT02407236|561153158|FG000|Induction Study (8 Weeks)|Other|2|||
155473457|NCT02407236|561153159|FG001|Induction Study (8 Weeks)|Other|1|||
155473458|NCT02407236|561153160|FG002|Induction Study (8 Weeks)|Other|5|||
155473459|NCT02407236|561153161|FG003|Induction Study (8 Weeks)|Other|0|||
155473460|NCT02407236|561153162|FG004|Induction Study (8 Weeks)|Other|0|||
155473461|NCT02407236|561153163|FG005|Induction Study (8 Weeks)|Other|0|||
155473462|NCT02407236|561153164|FG006|Induction Study (8 Weeks)|Other|0|||
155473463|NCT02407236|561153165|FG007|Induction Study (8 Weeks)|Other|0|||
155473464|NCT02407236|561153166|FG008|Induction Study (8 Weeks)|Other|0|||
155473465|NCT02407236|561153167|FG009|Induction Study (8 Weeks)|Other|0|||
155473466|NCT02407236|561153168|FG010|Induction Study (8 Weeks)|Other|0|||
155473467|NCT02407236|561153169|FG011|Induction Study (8 Weeks)|Other|0|||
155473468|NCT02407236|561153170|FG012|Induction Study (8 Weeks)|Other|0|||
155473469|NCT02407236|561153158|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473470|NCT02407236|561153159|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473471|NCT02407236|561153160|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473472|NCT02407236|561153161|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
155473473|NCT02407236|561153162|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
155473474|NCT02407236|561153163|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
155473475|NCT02407236|561153164|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
155473476|NCT02407236|561153165|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
155473477|NCT02407236|561153166|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473478|NCT02407236|561153167|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473479|NCT02407236|561153168|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473480|NCT02407236|561153169|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473481|NCT02407236|561153170|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
155473482|NCT02407236|561153158|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473483|NCT02407236|561153159|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473484|NCT02407236|561153160|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473485|NCT02407236|561153161|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
155473486|NCT02407236|561153162|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
155473487|NCT02407236|561153163|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
155473488|NCT02407236|561153164|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
155518984|NCT05275998|561325181|FG002|Overall Study|Adverse Event|0|||
155473489|NCT02407236|561153165|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
155473490|NCT02407236|561153166|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473491|NCT02407236|561153167|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473492|NCT02407236|561153168|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155518985|NCT05275998|561325182|FG003|Overall Study|Adverse Event|1|||
155473493|NCT02407236|561153169|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473494|NCT02407236|561153170|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
155473495|NCT02407236|561153158|FG000|Maintenance Study (44 Weeks)|Other|0|||
155473496|NCT02407236|561153159|FG001|Maintenance Study (44 Weeks)|Other|0|||
155473497|NCT02407236|561153160|FG002|Maintenance Study (44 Weeks)|Other|0|||
155473498|NCT02407236|561153161|FG003|Maintenance Study (44 Weeks)|Other|5|||
155473499|NCT02407236|561153162|FG004|Maintenance Study (44 Weeks)|Other|7|||
155473500|NCT02407236|561153163|FG005|Maintenance Study (44 Weeks)|Other|8|||
155473501|NCT02407236|561153164|FG006|Maintenance Study (44 Weeks)|Other|4|||
155473502|NCT02407236|561153165|FG007|Maintenance Study (44 Weeks)|Other|6|||
155473503|NCT02407236|561153166|FG008|Maintenance Study (44 Weeks)|Other|0|||
155473504|NCT02407236|561153167|FG009|Maintenance Study (44 Weeks)|Other|0|||
155473505|NCT02407236|561153168|FG010|Maintenance Study (44 Weeks)|Other|0|||
155473506|NCT02407236|561153169|FG011|Maintenance Study (44 Weeks)|Other|0|||
155473507|NCT02407236|561153170|FG012|Maintenance Study (44 Weeks)|Other|0|||
155473508|NCT02407236|561153158|FG000|Maintenance Study (44 Weeks)|Death|0|||
155473509|NCT02407236|561153159|FG001|Maintenance Study (44 Weeks)|Death|0|||
155473510|NCT02407236|561153160|FG002|Maintenance Study (44 Weeks)|Death|0|||
155473511|NCT02407236|561153161|FG003|Maintenance Study (44 Weeks)|Death|0|||
155473512|NCT02407236|561153162|FG004|Maintenance Study (44 Weeks)|Death|0|||
155473513|NCT02407236|561153163|FG005|Maintenance Study (44 Weeks)|Death|0|||
155473514|NCT02407236|561153164|FG006|Maintenance Study (44 Weeks)|Death|0|||
155473515|NCT02407236|561153165|FG007|Maintenance Study (44 Weeks)|Death|1|||
155473516|NCT02407236|561153166|FG008|Maintenance Study (44 Weeks)|Death|0|||
155473517|NCT02407236|561153167|FG009|Maintenance Study (44 Weeks)|Death|0|||
155473518|NCT02407236|561153168|FG010|Maintenance Study (44 Weeks)|Death|0|||
155473519|NCT02407236|561153169|FG011|Maintenance Study (44 Weeks)|Death|0|||
155473520|NCT02407236|561153170|FG012|Maintenance Study (44 Weeks)|Death|0|||
155473521|NCT02407236|561153158|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473522|NCT02407236|561153159|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473523|NCT02407236|561153160|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473524|NCT02407236|561153161|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473525|NCT02407236|561153162|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473526|NCT02407236|561153163|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473527|NCT02407236|561153164|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473528|NCT02407236|561153165|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
155473529|NCT02407236|561153166|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
155473530|NCT02407236|561153167|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
155518986|NCT05275998|561325179|FG000|Overall Study|Withdrawal by Subject|0|||
155518987|NCT05275998|561325180|FG001|Overall Study|Withdrawal by Subject|0|||
155518988|NCT05275998|561325181|FG002|Overall Study|Withdrawal by Subject|0|||
155518989|NCT05275998|561325182|FG003|Overall Study|Withdrawal by Subject|1|||
155518990|NCT05275998|561325179|FG000|Overall Study|Physician Decision|0|||
155473531|NCT02407236|561153168|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
155518991|NCT05275998|561325180|FG001|Overall Study|Physician Decision|0|||
155473532|NCT02407236|561153169|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
155473533|NCT02407236|561153170|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
155473534|NCT02407236|561153158|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473535|NCT02407236|561153159|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155518992|NCT05275998|561325181|FG002|Overall Study|Physician Decision|0|||
155518993|NCT05275998|561325182|FG003|Overall Study|Physician Decision|1|||
155518994|NCT05275998|561325179|FG000|Overall Study|Protocol Violation|0|||
155518995|NCT05275998|561325180|FG001|Overall Study|Protocol Violation|0|||
155473536|NCT02407236|561153160|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473537|NCT02407236|561153161|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473538|NCT02407236|561153162|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473539|NCT02407236|561153163|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473540|NCT02407236|561153164|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473541|NCT02407236|561153165|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473542|NCT02407236|561153166|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473543|NCT02407236|561153167|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473544|NCT02407236|561153168|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
155473545|NCT02407236|561153169|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473546|NCT02407236|561153170|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
155473547|NCT02407236|561153158|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473548|NCT02407236|561153159|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473549|NCT02407236|561153160|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473550|NCT02407236|561153161|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473551|NCT02407236|561153162|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473552|NCT02407236|561153163|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473553|NCT02407236|561153164|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473554|NCT02407236|561153165|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
155473555|NCT02407236|561153166|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
155473556|NCT02407236|561153167|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
155473557|NCT02407236|561153168|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
155473558|NCT02407236|561153169|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
155473559|NCT02407236|561153170|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
155473560|NCT02407236|561153158|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
155473561|NCT02407236|561153159|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
155473562|NCT02407236|561153160|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
155473563|NCT02407236|561153161|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
155473564|NCT02407236|561153162|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
155473565|NCT02407236|561153163|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
155473566|NCT02407236|561153164|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
155473567|NCT02407236|561153165|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
155473568|NCT02407236|561153166|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
155473569|NCT02407236|561153167|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
155473570|NCT02407236|561153168|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
155473571|NCT02407236|561153169|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
155473572|NCT02407236|561153170|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
155473573|NCT02177812|561153176|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155473574|NCT02177812|561153177|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155473575|NCT02177812|561153178|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155518996|NCT05275998|561325181|FG002|Overall Study|Protocol Violation|1|||
155518997|NCT05275998|561325182|FG003|Overall Study|Protocol Violation|0|||
155518998|NCT01867242|561325185|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
155518999|NCT01867242|561325186|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
155519000|NCT01867242|561325187|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
155519001|NCT00661999|561325188|FG000|Overall Study|Adverse Event|11|||
155519002|NCT00661999|561325189|FG001|Overall Study|Adverse Event|5|||
155519003|NCT00661999|561325190|FG002|Overall Study|Adverse Event|8|||
155519004|NCT00661999|561325188|FG000|Overall Study|Death|8|||
155519005|NCT00661999|561325189|FG001|Overall Study|Death|6|||
155519006|NCT00661999|561325190|FG002|Overall Study|Death|3|||
155654081|NCT01272219|561826890|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155473576|NCT02177812|561153179|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155473577|NCT02177812|561153180|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155473578|NCT02177812|561153181|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
155473579|NCT02177812|561153182|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
155473580|NCT02177812|561153183|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
155473581|NCT02177812|561153184|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
155473582|NCT02177812|561153176|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473583|NCT02177812|561153177|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473584|NCT02177812|561153178|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473585|NCT02177812|561153179|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473586|NCT02177812|561153180|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473587|NCT02177812|561153181|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
155473588|NCT02177812|561153182|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
155473589|NCT02177812|561153183|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473590|NCT02177812|561153184|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
155473591|NCT02177812|561153176|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
155473592|NCT02177812|561153177|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
155473593|NCT02177812|561153178|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
155473594|NCT02177812|561153179|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
155473595|NCT02177812|561153180|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
155473596|NCT02177812|561153181|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
155473597|NCT02177812|561153182|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
155473598|NCT02177812|561153183|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
155473599|NCT02177812|561153184|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
155473600|NCT04888507|561155366|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
155473601|NCT00636155|561155367|FG000|Overall Study|Adverse Event|8|||
155473602|NCT00636155|561155367|FG000|Overall Study|Lack of Efficacy|1|||
155473603|NCT00636155|561155367|FG000|Overall Study|Withdrawal by Subject|3|||
155473604|NCT00636155|561155367|FG000|Overall Study|Stem cell transplant|1|||
155473605|NCT00636155|561155367|FG000|Overall Study|Physician Decision|5|||
155473606|NCT00766142|561155368|FG000|Overall Study|Protocol Violation|4|||
155473607|NCT05643170|561155374|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
155473608|NCT05643170|561155374|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
155473609|NCT02358863|561155379|FG000|Overall Study|Physician Decision|3|||
155473610|NCT02632344|561155392|FG000|Overall Study|Adverse Event|3|||
155473611|NCT02632344|561155392|FG000|Overall Study|Lack of Efficacy|3|||
155473612|NCT02632344|561155392|FG000|Overall Study|Withdrawal by Subject|2|||
155473613|NCT00777257|561155393|FG000|Overall Study|Adverse Event|3|||
155473614|NCT00777257|561155394|FG001|Overall Study|Adverse Event|1|||
155473615|NCT00777257|561155395|FG002|Overall Study|Adverse Event|0|||
155473616|NCT00777257|561155393|FG000|Overall Study|Lost to Follow-up|3|||
155473617|NCT00777257|561155394|FG001|Overall Study|Lost to Follow-up|3|||
155473618|NCT00777257|561155395|FG002|Overall Study|Lost to Follow-up|2|||
155473619|NCT00777257|561155393|FG000|Overall Study|Protocol Violation|2|||
155473620|NCT00777257|561155394|FG001|Overall Study|Protocol Violation|2|||
155473621|NCT00777257|561155395|FG002|Overall Study|Protocol Violation|2|||
155473622|NCT00777257|561155393|FG000|Overall Study|Withdrawal by Subject|3|||
155473623|NCT00777257|561155394|FG001|Overall Study|Withdrawal by Subject|6|||
155473624|NCT00777257|561155395|FG002|Overall Study|Withdrawal by Subject|5|||
155473625|NCT05426460|561155396|FG000|Overall Study|Protocol Violation|1|||
155473626|NCT05426460|561155397|FG001|Overall Study|Protocol Violation|1|||
155473627|NCT05426460|561155398|FG002|Overall Study|Protocol Violation|1|||
155473628|NCT05426460|561155399|FG003|Overall Study|Protocol Violation|0|||
155473629|NCT02973997|561155403|FG000|Overall Study|Withdrawal by Subject|4|||
155473630|NCT02973997|561155404|FG001|Overall Study|Withdrawal by Subject|0|||
155473631|NCT02973997|561155403|FG000|Overall Study|Adverse Event|4|||
155473632|NCT02973997|561155404|FG001|Overall Study|Adverse Event|1|||
155473633|NCT02973997|561155403|FG000|Overall Study|Disease Progression|11|||
155473634|NCT02973997|561155404|FG001|Overall Study|Disease Progression|20|||
155473635|NCT02973997|561155403|FG000|Overall Study|Alternative Therapy|3|||
155473636|NCT02973997|561155404|FG001|Overall Study|Alternative Therapy|0|||
155473637|NCT02973997|561155403|FG000|Overall Study|Other complicating disease|0|||
155473638|NCT02973997|561155404|FG001|Overall Study|Other complicating disease|1|||
155473639|NCT02973997|561155403|FG000|Overall Study|Death|0|||
155473640|NCT02973997|561155404|FG001|Overall Study|Death|1|||
155473641|NCT00444951|561155405|FG000|Overall Study|Lost to Follow-up|1|||
155473642|NCT00444951|561155406|FG001|Overall Study|Lost to Follow-up|1|||
155473643|NCT00444951|561155407|FG002|Overall Study|Lost to Follow-up|0|||
155473644|NCT00444951|561155405|FG000|Overall Study|Withdrawal by Subject|4|||
155473645|NCT00444951|561155406|FG001|Overall Study|Withdrawal by Subject|5|||
155473646|NCT00444951|561155407|FG002|Overall Study|Withdrawal by Subject|3|||
155473647|NCT00366444|561155408|FG000|Overall Study|Withdrawal by Subject|1|||
155473648|NCT00366444|561155409|FG001|Overall Study|Withdrawal by Subject|1|||
155473649|NCT00366444|561155408|FG000|Overall Study|Lack of Efficacy|0|||
155654082|NCT01272219|561826891|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155654083|NCT01272219|561826892|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
155654084|NCT01272219|561826893|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155654085|NCT01272219|561826894|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155654086|NCT01272219|561826889|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155654087|NCT01272219|561826890|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
155654088|NCT01272219|561826891|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155654089|NCT01272219|561826892|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
155654090|NCT01272219|561826893|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155654091|NCT01272219|561826894|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155654092|NCT01272219|561826889|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155654093|NCT01272219|561826890|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
155654094|NCT01272219|561826891|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
155654095|NCT01272219|561826892|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
155654096|NCT01272219|561826893|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155654097|NCT01272219|561826894|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155654098|NCT01272219|561826889|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155473650|NCT00366444|561155409|FG001|Overall Study|Lack of Efficacy|1|||
155473651|NCT04984876|561155410|FG000|Overall Study|Subject decision|2|||
155473652|NCT04984876|561155411|FG001|Overall Study|Subject decision|10|||
155473653|NCT04984876|561155412|FG002|Overall Study|Subject decision|3|||
155473654|NCT04984876|561155413|FG003|Overall Study|Subject decision|3|||
155473655|NCT04984876|561155414|FG004|Overall Study|Subject decision|3|||
155473656|NCT04984876|561155415|FG005|Overall Study|Subject decision|0|||
155473657|NCT04984876|561155410|FG000|Overall Study|Guardian decision|0|||
155473658|NCT04984876|561155411|FG001|Overall Study|Guardian decision|1|||
155473659|NCT04984876|561155412|FG002|Overall Study|Guardian decision|0|||
155473660|NCT04984876|561155413|FG003|Overall Study|Guardian decision|2|||
155473661|NCT04984876|561155414|FG004|Overall Study|Guardian decision|0|||
155473662|NCT04984876|561155415|FG005|Overall Study|Guardian decision|1|||
155473663|NCT04984876|561155410|FG000|Overall Study|Lost to Follow-up|0|||
155473664|NCT04984876|561155411|FG001|Overall Study|Lost to Follow-up|0|||
155473665|NCT04984876|561155412|FG002|Overall Study|Lost to Follow-up|1|||
155473666|NCT04984876|561155413|FG003|Overall Study|Lost to Follow-up|1|||
155473667|NCT04984876|561155414|FG004|Overall Study|Lost to Follow-up|0|||
155473668|NCT04984876|561155415|FG005|Overall Study|Lost to Follow-up|0|||
155473669|NCT04984876|561155410|FG000|Overall Study|Physician Decision|1|||
155473670|NCT04984876|561155411|FG001|Overall Study|Physician Decision|0|||
155473671|NCT04984876|561155412|FG002|Overall Study|Physician Decision|0|||
155473672|NCT04984876|561155413|FG003|Overall Study|Physician Decision|1|||
155473673|NCT04984876|561155414|FG004|Overall Study|Physician Decision|0|||
155473674|NCT04984876|561155415|FG005|Overall Study|Physician Decision|0|||
155473675|NCT04984876|561155410|FG000|Overall Study|Adverse Event|0|||
155473676|NCT04984876|561155411|FG001|Overall Study|Adverse Event|0|||
155473677|NCT04984876|561155412|FG002|Overall Study|Adverse Event|1|||
155473678|NCT04984876|561155413|FG003|Overall Study|Adverse Event|0|||
155473679|NCT04984876|561155414|FG004|Overall Study|Adverse Event|0|||
155473680|NCT04984876|561155415|FG005|Overall Study|Adverse Event|0|||
155473681|NCT02000622|561155416|FG000|Overall Study|Withdrawal by Subject|5|||
155473682|NCT02000622|561155417|FG001|Overall Study|Withdrawal by Subject|7|||
155473683|NCT02000622|561155416|FG000|Overall Study|Lost to Follow-up|4|||
155473684|NCT02000622|561155417|FG001|Overall Study|Lost to Follow-up|0|||
155473685|NCT02000622|561155416|FG000|Overall Study|Death|159|||
155473686|NCT02000622|561155417|FG001|Overall Study|Death|73|||
155473687|NCT02000622|561155416|FG000|Overall Study|Withdrawn due to site closure|1|||
155473688|NCT02000622|561155417|FG001|Overall Study|Withdrawn due to site closure|0|||
155473689|NCT01405027|561155418|FG000|Overall Study|Withdrawn consent|3|||
155473690|NCT01405027|561155419|FG001|Overall Study|Withdrawn consent|0|||
155654099|NCT01272219|561826890|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
155654100|NCT01272219|561826891|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
155654101|NCT01272219|561826892|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
155654102|NCT01272219|561826893|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155473691|NCT01405027|561155418|FG000|Overall Study|Lost to Follow-up|16|||
155519007|NCT00661999|561325188|FG000|Overall Study|Other Reasons|5|||
155519008|NCT00661999|561325189|FG001|Overall Study|Other Reasons|12|||
155473692|NCT01405027|561155419|FG001|Overall Study|Lost to Follow-up|24|||
155473693|NCT01405027|561155418|FG000|Overall Study|Investigator judgement|0|||
155473694|NCT01405027|561155419|FG001|Overall Study|Investigator judgement|2|||
155473695|NCT01405027|561155418|FG000|Overall Study|Death|1|||
155473696|NCT01405027|561155419|FG001|Overall Study|Death|0|||
155473697|NCT01405027|561155418|FG000|Overall Study|Other or Unknown|12|||
155473698|NCT01405027|561155419|FG001|Overall Study|Other or Unknown|25|||
155473699|NCT01938391|561155423|FG000|6 Month Follow up|Withdrawal by Subject|1|||
155473700|NCT01938391|561155423|FG000|12 Month Follow up|Physician Decision|1|||
155473701|NCT01938391|561155423|FG000|12 Month Follow up|Withdrawal by Subject|1|||
155473702|NCT01077193|561155424|FG000|Overall Study|Lost to Follow-up|1|||
155473703|NCT01077193|561155424|FG000|Overall Study|Withdrawal by Subject|2|||
155473704|NCT01077193|561155424|FG000|Overall Study|Lack of Efficacy|1|||
155473705|NCT01077193|561155424|FG000|Overall Study|Study Terminated by Sponsor|40|||
155473706|NCT04924114|561155428|FG000|Overall Study|Withdrawal by Subject|0|||
155473707|NCT04924114|561155429|FG001|Overall Study|Withdrawal by Subject|2|||
155473708|NCT04924114|561155430|FG002|Overall Study|Withdrawal by Subject|2|||
155473709|NCT04924114|561155431|FG003|Overall Study|Withdrawal by Subject|0|||
155473710|NCT04924114|561155432|FG004|Overall Study|Withdrawal by Subject|2|||
155473711|NCT04960202|561155433|FG000|Overall Study|Other|5|||
155473712|NCT04960202|561155434|FG001|Overall Study|Other|0|||
155473713|NCT04960202|561155433|FG000|Overall Study|Withdrawal by Subject|37|||
155473714|NCT04960202|561155434|FG001|Overall Study|Withdrawal by Subject|43|||
155473715|NCT04960202|561155433|FG000|Overall Study|Lost to Follow-up|20|||
155473716|NCT04960202|561155434|FG001|Overall Study|Lost to Follow-up|16|||
155473717|NCT04960202|561155433|FG000|Overall Study|Death|0|||
155473718|NCT04960202|561155434|FG001|Overall Study|Death|15|||
155473719|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
155473720|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
155473721|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
155473722|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
155473723|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
155473724|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
155473725|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
155473726|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
155473727|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
155473728|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
155473729|NCT03774875|561155436|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
155473730|NCT03774875|561155437|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
155473731|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
155473732|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
155473733|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
155473734|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
155473735|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
155473736|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
155473737|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
155473738|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
155473739|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
155473740|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
155473741|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
155473742|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
155473743|NCT03774875|561155436|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
155473744|NCT03774875|561155437|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
155473745|NCT02498392|561155438|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
155473746|NCT02498392|561155439|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
155473747|NCT02498392|561155438|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
155473748|NCT02498392|561155439|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
155473749|NCT02498392|561155438|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
155473750|NCT02498392|561155439|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
155473751|NCT02498392|561155438|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
155473752|NCT02498392|561155439|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
155473753|NCT02498392|561155438|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
155473754|NCT02498392|561155439|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
155519009|NCT00661999|561325190|FG002|Overall Study|Other Reasons|23|||
155519010|NCT00661999|561325188|FG000|Overall Study|Withdrawal by Subject|30|||
155473755|NCT02498392|561155438|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
155654103|NCT01272219|561826894|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155654104|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
155654105|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
155654106|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
155654107|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
155654108|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
155654109|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
155654110|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155654111|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155654112|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155654113|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155654114|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
155654115|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
155654116|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155654117|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155654118|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155654119|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155654120|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
155654121|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
155654122|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155654123|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155654124|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155473756|NCT02498392|561155439|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
155654125|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155654126|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
155654127|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
155654128|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
155654129|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
155654130|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
155654131|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
155654132|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
155654133|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
155654134|NCT01272219|561826889|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
155654135|NCT01272219|561826890|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
155473757|NCT02352090|561155440|FG000|Overall Study|general malaise|1|||
155473758|NCT02352090|561155441|FG001|Overall Study|general malaise|0|||
155473759|NCT02352090|561155442|FG002|Overall Study|general malaise|0|||
155473760|NCT02352090|561155440|FG000|Overall Study|non-specified mild side-effects|0|||
155473761|NCT02352090|561155441|FG001|Overall Study|non-specified mild side-effects|0|||
155473762|NCT02352090|561155442|FG002|Overall Study|non-specified mild side-effects|2|||
155473763|NCT03687827|561155443|FG000|Treatment Period 1|Death|0|||
155473764|NCT03687827|561155444|FG001|Treatment Period 1|Death|1|||
155473765|NCT03687827|561155443|FG000|Treatment Period 1|Lost to Follow-up|2|||
155473766|NCT03687827|561155444|FG001|Treatment Period 1|Lost to Follow-up|2|||
155473767|NCT03687827|561155443|FG000|Treatment Period 1|Physician Decision|5|||
155473768|NCT03687827|561155444|FG001|Treatment Period 1|Physician Decision|2|||
155473769|NCT03687827|561155443|FG000|Treatment Period 1|Withdrawal by Subject|7|||
155473770|NCT03687827|561155444|FG001|Treatment Period 1|Withdrawal by Subject|3|||
155473771|NCT03687827|561155443|FG000|Treatment Period 2|Physician Decision|4|||
155473772|NCT03687827|561155444|FG001|Treatment Period 2|Physician Decision|1|||
155473773|NCT03687827|561155443|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155473774|NCT03687827|561155444|FG001|Treatment Period 2|Withdrawal by Subject|2|||
155473775|NCT01678313|561155450|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
155473776|NCT01678313|561155451|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
155473777|NCT01678313|561155450|FG000|Completed the 3-month Therapy|Physician Decision|3|||
155473778|NCT01678313|561155451|FG001|Completed the 3-month Therapy|Physician Decision|4|||
155473779|NCT01678313|561155450|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
155654136|NCT01272219|561826891|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
155654137|NCT01272219|561826892|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
155654138|NCT01272219|561826893|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
155473780|NCT01678313|561155451|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
155473781|NCT01678313|561155450|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
155473782|NCT01678313|561155451|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
155473783|NCT00981292|561155452|FG000|Day 1|Protocol Violation|1|||
155473784|NCT00981292|561155453|FG001|Day 1|Protocol Violation|0|||
155473785|NCT00981292|561155454|FG002|Day 1|Protocol Violation|0|||
155654139|NCT01272219|561826894|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
155654140|NCT03131479|561826895|FG000|Overall Study|Adverse Event|0|||
155654141|NCT03131479|561826896|FG001|Overall Study|Adverse Event|0|||
155654142|NCT03131479|561826897|FG002|Overall Study|Adverse Event|1|||
155654143|NCT03131479|561826898|FG003|Overall Study|Adverse Event|1|||
155473786|NCT00981292|561155455|FG003|Day 1|Protocol Violation|0|||
155473787|NCT00981292|561155456|FG004|Day 1|Protocol Violation|0|||
155473788|NCT00981292|561155457|FG005|Day 1|Protocol Violation|2|||
155473789|NCT00981292|561155452|FG000|Day 2|Protocol Violation|2|||
155473790|NCT00981292|561155453|FG001|Day 2|Protocol Violation|0|||
155473791|NCT00981292|561155454|FG002|Day 2|Protocol Violation|0|||
155473792|NCT00981292|561155455|FG003|Day 2|Protocol Violation|0|||
155473793|NCT00981292|561155456|FG004|Day 2|Protocol Violation|0|||
155473794|NCT00981292|561155457|FG005|Day 2|Protocol Violation|0|||
155473795|NCT00981292|561155452|FG000|Day 3|Protocol Violation|0|||
155473796|NCT00981292|561155453|FG001|Day 3|Protocol Violation|0|||
155473797|NCT00981292|561155454|FG002|Day 3|Protocol Violation|0|||
155473798|NCT00981292|561155455|FG003|Day 3|Protocol Violation|0|||
155473799|NCT00981292|561155456|FG004|Day 3|Protocol Violation|0|||
155473800|NCT00981292|561155457|FG005|Day 3|Protocol Violation|1|||
155473801|NCT03377452|561155458|FG000|Overall Study|Refused assessment|0|||
155473802|NCT03377452|561155459|FG001|Overall Study|Refused assessment|2|||
155473803|NCT03377452|561155458|FG000|Overall Study|Lost to Follow-up|5|||
155473804|NCT03377452|561155459|FG001|Overall Study|Lost to Follow-up|4|||
155473805|NCT05179057|561155460|FG000|Overall Study|Adverse Event|3|||
155654144|NCT03131479|561826899|FG004|Overall Study|Adverse Event|0|||
155654145|NCT03131479|561826895|FG000|Overall Study|Subject/Guardian Decision|0|||
155473806|NCT05179057|561155461|FG001|Overall Study|Adverse Event|2|||
155654146|NCT03131479|561826896|FG001|Overall Study|Subject/Guardian Decision|0|||
155654147|NCT03131479|561826897|FG002|Overall Study|Subject/Guardian Decision|0|||
155654148|NCT03131479|561826898|FG003|Overall Study|Subject/Guardian Decision|1|||
155654149|NCT03131479|561826899|FG004|Overall Study|Subject/Guardian Decision|0|||
155473807|NCT05179057|561155460|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
155473808|NCT05179057|561155461|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
155473809|NCT05179057|561155460|FG000|Overall Study|Study terminated|13|||
155473810|NCT05179057|561155461|FG001|Overall Study|Study terminated|7|||
155473811|NCT05179057|561155460|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
155473812|NCT05179057|561155461|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
155654150|NCT05305651|561826900|FG000|Overall Study|Death|1|||
155473813|NCT05179057|561155460|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
155473814|NCT05179057|561155461|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
155473815|NCT03375203|561155462|FG000|Overall Study|Protocol Violation|0|||
155473816|NCT03375203|561155463|FG001|Overall Study|Protocol Violation|0|||
155473817|NCT03375203|561155464|FG002|Overall Study|Protocol Violation|1|||
155473818|NCT03375203|561155465|FG003|Overall Study|Protocol Violation|0|||
155473819|NCT03375203|561155466|FG004|Overall Study|Protocol Violation|0|||
155473820|NCT03375203|561155462|FG000|Overall Study|Adverse Event|2|||
155473821|NCT03375203|561155463|FG001|Overall Study|Adverse Event|3|||
155473822|NCT03375203|561155464|FG002|Overall Study|Adverse Event|0|||
155473823|NCT03375203|561155465|FG003|Overall Study|Adverse Event|2|||
155473824|NCT03375203|561155466|FG004|Overall Study|Adverse Event|2|||
155473825|NCT03375203|561155462|FG000|Overall Study|Withdrawal by Subject|3|||
155473826|NCT03375203|561155463|FG001|Overall Study|Withdrawal by Subject|0|||
155473827|NCT03375203|561155464|FG002|Overall Study|Withdrawal by Subject|1|||
155473828|NCT03375203|561155465|FG003|Overall Study|Withdrawal by Subject|0|||
155473829|NCT03375203|561155466|FG004|Overall Study|Withdrawal by Subject|2|||
155473830|NCT03375203|561155462|FG000|Overall Study|Non-compliance with study drug|1|||
155473831|NCT03375203|561155463|FG001|Overall Study|Non-compliance with study drug|0|||
155473832|NCT03375203|561155464|FG002|Overall Study|Non-compliance with study drug|0|||
155473833|NCT03375203|561155465|FG003|Overall Study|Non-compliance with study drug|0|||
155473834|NCT03375203|561155466|FG004|Overall Study|Non-compliance with study drug|0|||
155473835|NCT03375203|561155462|FG000|Overall Study|Randomized, not treated.|0|||
155473836|NCT03375203|561155463|FG001|Overall Study|Randomized, not treated.|1|||
155473837|NCT03375203|561155464|FG002|Overall Study|Randomized, not treated.|0|||
155473838|NCT03375203|561155465|FG003|Overall Study|Randomized, not treated.|0|||
155473839|NCT03375203|561155466|FG004|Overall Study|Randomized, not treated.|0|||
155473840|NCT03107793|561155467|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
155473841|NCT03107793|561155468|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
155473842|NCT03107793|561155469|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
155519011|NCT00661999|561325189|FG001|Overall Study|Withdrawal by Subject|23|||
155519012|NCT00661999|561325190|FG002|Overall Study|Withdrawal by Subject|14|||
155519013|NCT00661999|561325188|FG000|Overall Study|Alternative Treatment|1|||
155519014|NCT00661999|561325189|FG001|Overall Study|Alternative Treatment|0|||
155519015|NCT00661999|561325190|FG002|Overall Study|Alternative Treatment|0|||
155519016|NCT00661999|561325188|FG000|Overall Study|Other Medical Problems|4|||
155519017|NCT00661999|561325189|FG001|Overall Study|Other Medical Problems|4|||
155519018|NCT00661999|561325190|FG002|Overall Study|Other Medical Problems|9|||
155519019|NCT03066999|561325191|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
155519020|NCT03066999|561325192|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
155519021|NCT01361126|561325195|FG000|Overall Study|Sponsor decision|0|||
155519022|NCT01361126|561325196|FG001|Overall Study|Sponsor decision|2|||
155519023|NCT00264810|561325197|FG000|Baseline|Withdrawal by Subject|10|||
155519024|NCT00264810|561325198|FG001|Baseline|Withdrawal by Subject|10|||
155519025|NCT00264810|561325197|FG000|Baseline|Physician Decision|7|||
155519026|NCT00264810|561325198|FG001|Baseline|Physician Decision|8|||
155519027|NCT00264810|561325197|FG000|Baseline|Subject Compliance Failure|3|||
155519028|NCT00264810|561325198|FG001|Baseline|Subject Compliance Failure|3|||
155519029|NCT00264810|561325197|FG000|Baseline|Insufficient Seizure Frequency|2|||
155519030|NCT00264810|561325198|FG001|Baseline|Insufficient Seizure Frequency|2|||
155519031|NCT00264810|561325197|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
155519032|NCT00264810|561325198|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
155519033|NCT00264810|561325197|FG000|Baseline|Other|0|||
155519034|NCT00264810|561325198|FG001|Baseline|Other|1|||
155519035|NCT00264810|561325197|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
155519036|NCT00264810|561325198|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
155519037|NCT00264810|561325197|FG000|Stimulation Optimization Period|Death|0|||
155519038|NCT00264810|561325198|FG001|Stimulation Optimization Period|Death|1|||
155519039|NCT00264810|561325197|FG000|Blinded Evaluation Period|Explant due to infection|1|||
155519040|NCT00264810|561325198|FG001|Blinded Evaluation Period|Explant due to infection|1|||
155473843|NCT03107793|561155470|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
155473844|NCT03107793|561155471|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155519041|NCT00264810|561325197|FG000|Open Label Evaluation Period|Explant due to infection|1|||
155519042|NCT00264810|561325198|FG001|Open Label Evaluation Period|Explant due to infection|1|||
155654151|NCT05305651|561826900|FG000|Overall Study|Withdrawal by Subject|4|||
155473845|NCT03107793|561155467|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
155473846|NCT03107793|561155468|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
155473847|NCT03107793|561155469|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
155519043|NCT00264810|561325197|FG000|Open Label Evaluation Period|Death|3|||
155519044|NCT00264810|561325198|FG001|Open Label Evaluation Period|Death|2|||
155654152|NCT05305651|561826900|FG000|Overall Study|Lost to Follow-up|4|||
155654153|NCT01491919|561826903|FG000|Overall Study|Insufficient PK sampling|1|||
155473848|NCT03107793|561155470|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
155473849|NCT03107793|561155471|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
155473850|NCT03107793|561155467|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
155473851|NCT03107793|561155468|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
155473852|NCT03107793|561155469|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
155473853|NCT03107793|561155470|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
155473854|NCT03107793|561155471|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
155473855|NCT03107793|561155467|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
155473856|NCT03107793|561155468|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155473857|NCT03107793|561155469|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155473858|NCT03107793|561155470|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155473859|NCT03107793|561155471|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155473860|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155473861|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
155473862|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
155473863|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155473864|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155473865|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155473866|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155473867|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
155473868|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155473869|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155473870|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
155473871|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
155473872|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
155473873|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
155473874|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
155473875|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155473876|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
155473877|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
155473878|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155473879|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155473880|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
155473881|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
155473882|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
155473883|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
155473884|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
155473885|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
155473886|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
155473887|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
155473888|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
155473889|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
155473890|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155473891|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155473892|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155473893|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155473894|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155473895|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
155473896|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
155473897|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
155473898|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
155473899|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
155473900|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
155473901|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
155473902|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
155473903|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
155473904|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
155473905|NCT03107793|561155467|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155473906|NCT03107793|561155468|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
155473907|NCT03107793|561155469|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
155473908|NCT03107793|561155470|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155473909|NCT03107793|561155471|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155473910|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
155473911|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
155654154|NCT01491919|561826904|FG001|Overall Study|Insufficient PK sampling|2|||
155654155|NCT01491919|561826905|FG002|Overall Study|Insufficient PK sampling|1|||
155654156|NCT00967499|561826908|FG000|Overall Study|Adverse Event|0|||
155654157|NCT00967499|561826909|FG001|Overall Study|Adverse Event|1|||
155654158|NCT00967499|561826908|FG000|Overall Study|Protocol Violation|1|||
155654159|NCT00967499|561826909|FG001|Overall Study|Protocol Violation|0|||
155654160|NCT00967499|561826908|FG000|Overall Study|Sponsor Decision|1|||
155654161|NCT00967499|561826909|FG001|Overall Study|Sponsor Decision|0|||
155654162|NCT00967499|561826908|FG000|Overall Study|Randomized but not treated|63|||
155473912|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
155473913|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
155473914|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
155473915|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
155473916|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
155473917|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
155473918|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
155473919|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
155473920|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
155473921|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
155473922|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
155473923|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
155473924|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
155473925|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Death|0|||
155473926|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Death|0|||
155473927|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Death|0|||
155473928|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Death|0|||
155473929|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Death|1|||
155473930|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
155473931|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
155473932|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
155473933|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
155473934|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
155473935|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
155473936|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
155473937|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
155473938|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
155473939|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
155473940|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
155473941|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
155473942|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
155473943|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
155473944|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
155473945|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
155473946|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
155473947|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
155473948|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
155473949|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
155473950|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
155473951|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
155473952|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
155473953|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
155473954|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
155473955|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Other|0|||
155473956|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Other|0|||
155473957|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Other|0|||
155473958|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Other|1|||
155473959|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Other|3|||
155473960|NCT03107793|561155467|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
155473961|NCT03107793|561155468|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
155473962|NCT03107793|561155469|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
155473963|NCT03107793|561155470|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
155473964|NCT03107793|561155471|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
155473965|NCT01872897|561155479|FG000|Overall Study|Withdrawal by Subject|1|||
155473966|NCT01872897|561155480|FG001|Overall Study|Withdrawal by Subject|0|||
155473967|NCT02040857|561155481|FG000|Overall Study|Adverse Event|14|||
155473968|NCT02040857|561155481|FG000|Overall Study|Physician Decision|5|||
155473969|NCT02040857|561155481|FG000|Overall Study|Withdrawal by Subject|31|||
155654163|NCT00967499|561826909|FG001|Overall Study|Randomized but not treated|59|||
155654164|NCT04003389|561826910|FG000|Overall Study|Adverse Event|27|||
155654165|NCT04003389|561826911|FG001|Overall Study|Adverse Event|34|||
155473970|NCT02040857|561155481|FG000|Overall Study|patient non-compliance|3|||
155473971|NCT02040857|561155481|FG000|Overall Study|Lost to Follow-up|2|||
155473972|NCT02040857|561155481|FG000|Overall Study|recurrence|4|||
155473973|NCT02040857|561155481|FG000|Overall Study|ineligible|1|||
155473974|NCT03146403|561155487|FG000|Overall Study|Withdrawal by Subject|0|||
155473975|NCT03146403|561155488|FG001|Overall Study|Withdrawal by Subject|3|||
155473976|NCT03146403|561155487|FG000|Overall Study|Lost to Follow-up|2|||
155473977|NCT03146403|561155488|FG001|Overall Study|Lost to Follow-up|0|||
155473978|NCT01024920|561155489|FG000|Overall Study|Progressive disease|47|||
155473979|NCT01024920|561155490|FG001|Overall Study|Progressive disease|25|||
155473980|NCT01024920|561155489|FG000|Overall Study|Adverse Event|8|||
155473981|NCT01024920|561155490|FG001|Overall Study|Adverse Event|4|||
155473982|NCT01024920|561155489|FG000|Overall Study|Lost to Follow-up|0|||
155473983|NCT01024920|561155490|FG001|Overall Study|Lost to Follow-up|1|||
155473984|NCT01024920|561155489|FG000|Overall Study|Patient refusal to continue|4|||
155473985|NCT01024920|561155490|FG001|Overall Study|Patient refusal to continue|0|||
155473986|NCT01024920|561155489|FG000|Overall Study|Other than listed|5|||
155473987|NCT01024920|561155490|FG001|Overall Study|Other than listed|1|||
155473988|NCT01024920|561155489|FG000|Overall Study|Not treated|3|||
155473989|NCT01024920|561155490|FG001|Overall Study|Not treated|0|||
155473990|NCT01024920|561155489|FG000|Overall Study|Protocol Violation|0|||
155473991|NCT01024920|561155490|FG001|Overall Study|Protocol Violation|1|||
155473992|NCT02182999|561155492|FG000|Overall Study|Adverse Event|4|||
155473993|NCT02182999|561155493|FG001|Overall Study|Adverse Event|3|||
155473994|NCT02182999|561155492|FG000|Overall Study|Physician Decision|1|||
155473995|NCT02182999|561155493|FG001|Overall Study|Physician Decision|0|||
155473996|NCT02252588|561155494|FG000|Overall Study|Withdrawal by Subject|4|||
155473997|NCT02252588|561155495|FG001|Overall Study|Withdrawal by Subject|0|||
155473998|NCT00693693|561155497|FG000|Overall Study|Lost to Follow-up|1|||
155473999|NCT00693693|561155498|FG001|Overall Study|Lost to Follow-up|1|||
155474000|NCT00693693|561155499|FG002|Overall Study|Lost to Follow-up|2|||
155474001|NCT02972593|561155500|FG000|Overall Study|Lost to Follow-up|19|||
155474002|NCT02972593|561155501|FG001|Overall Study|Lost to Follow-up|15|||
155474003|NCT02972593|561155500|FG000|Overall Study|Protocol Violation|1|||
155474004|NCT02972593|561155501|FG001|Overall Study|Protocol Violation|0|||
155474005|NCT00285649|561155502|FG000|Overall Study|Lost to Follow-up|6|||
155474006|NCT00285649|561155503|FG001|Overall Study|Lost to Follow-up|4|||
155474007|NCT00285649|561155504|FG002|Overall Study|Lost to Follow-up|4|||
155474008|NCT00285649|561155502|FG000|Overall Study|Withdrawal by Subject|3|||
155474009|NCT00285649|561155503|FG001|Overall Study|Withdrawal by Subject|2|||
155474010|NCT00285649|561155504|FG002|Overall Study|Withdrawal by Subject|2|||
155474011|NCT02203916|561155505|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155474012|NCT02203916|561155506|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
155474013|NCT02203916|561155507|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
155474014|NCT02203916|561155505|FG000|Overall Study|Major Protocol Deviation|1|||
155474015|NCT02203916|561155506|FG001|Overall Study|Major Protocol Deviation|1|||
155474016|NCT02203916|561155507|FG002|Overall Study|Major Protocol Deviation|0|||
155474017|NCT02203916|561155505|FG000|Overall Study|Lost to Follow-up|0|||
155474018|NCT02203916|561155506|FG001|Overall Study|Lost to Follow-up|1|||
155474019|NCT02203916|561155507|FG002|Overall Study|Lost to Follow-up|0|||
155474020|NCT02203916|561155505|FG000|Overall Study|Voluntary Withdrawal|3|||
155474021|NCT02203916|561155506|FG001|Overall Study|Voluntary Withdrawal|3|||
155474022|NCT02203916|561155507|FG002|Overall Study|Voluntary Withdrawal|8|||
155474023|NCT02203916|561155505|FG000|Overall Study|Lack of Efficacy|3|||
155474024|NCT02203916|561155506|FG001|Overall Study|Lack of Efficacy|0|||
155474025|NCT02203916|561155507|FG002|Overall Study|Lack of Efficacy|0|||
155474026|NCT02203916|561155505|FG000|Overall Study|Reason Not Specified|0|||
155474027|NCT02203916|561155506|FG001|Overall Study|Reason Not Specified|2|||
155474028|NCT02203916|561155507|FG002|Overall Study|Reason Not Specified|1|||
155474029|NCT01466062|561155508|FG000|Overall Study|Adverse Event|1|||
155474030|NCT01466062|561155508|FG000|Overall Study|Withdrawal by Subject|1|||
155474031|NCT01925014|561155509|FG000|Overall Study|Inappropriate enrollment|4|||
155474032|NCT01925014|561155510|FG001|Overall Study|Inappropriate enrollment|6|||
155474033|NCT01925014|561155509|FG000|Overall Study|Withdrawal by Subject|5|||
155474034|NCT01925014|561155510|FG001|Overall Study|Withdrawal by Subject|13|||
155654166|NCT04003389|561826912|FG002|Overall Study|Adverse Event|28|||
155474035|NCT03077711|561155511|FG000|Overall Study|Lost to Follow-up|2|||
155474036|NCT03077711|561155512|FG001|Overall Study|Lost to Follow-up|2|||
155474037|NCT03077711|561155511|FG000|Overall Study|noncompliant taking medication|2|||
155474038|NCT03077711|561155512|FG001|Overall Study|noncompliant taking medication|0|||
155474039|NCT01819194|561155513|FG000|Overall Study|Loss of study articles|2|||
155474040|NCT00045630|561155514|FG000|Overall Study|Adverse Event|1|||
155474041|NCT00045630|561155514|FG000|Overall Study|Refusal unrelated to adverse event|1|||
155474042|NCT00045630|561155514|FG000|Overall Study|Progression/relapse|1|||
155474043|NCT00045630|561155514|FG000|Overall Study|Death|1|||
155474044|NCT00045630|561155514|FG000|Overall Study|Ineligible|2|||
155474045|NCT04449276|561155515|FG000|Overall Study|Adverse Event|1|||
155474046|NCT04449276|561155516|FG001|Overall Study|Adverse Event|2|||
155474047|NCT04449276|561155517|FG002|Overall Study|Adverse Event|0|||
155474048|NCT04449276|561155518|FG003|Overall Study|Adverse Event|0|||
155474049|NCT04449276|561155519|FG004|Overall Study|Adverse Event|2|||
155474050|NCT04449276|561155520|FG005|Overall Study|Adverse Event|0|||
155474051|NCT04449276|561155521|FG006|Overall Study|Adverse Event|0|||
155474052|NCT04449276|561155522|FG007|Overall Study|Adverse Event|1|||
155474053|NCT04449276|561155515|FG000|Overall Study|Withdrawal by Subject|2|||
155474054|NCT04449276|561155516|FG001|Overall Study|Withdrawal by Subject|0|||
155474055|NCT04449276|561155517|FG002|Overall Study|Withdrawal by Subject|0|||
155474056|NCT04449276|561155518|FG003|Overall Study|Withdrawal by Subject|1|||
155474057|NCT04449276|561155519|FG004|Overall Study|Withdrawal by Subject|0|||
155474058|NCT04449276|561155520|FG005|Overall Study|Withdrawal by Subject|0|||
155474059|NCT04449276|561155521|FG006|Overall Study|Withdrawal by Subject|0|||
155474060|NCT04449276|561155522|FG007|Overall Study|Withdrawal by Subject|0|||
155474061|NCT04449276|561155515|FG000|Overall Study|Other|0|||
155474062|NCT04449276|561155516|FG001|Overall Study|Other|2|||
155474063|NCT04449276|561155517|FG002|Overall Study|Other|3|||
155474064|NCT04449276|561155518|FG003|Overall Study|Other|2|||
155474065|NCT04449276|561155519|FG004|Overall Study|Other|0|||
155474066|NCT04449276|561155520|FG005|Overall Study|Other|0|||
155474067|NCT04449276|561155521|FG006|Overall Study|Other|0|||
155474068|NCT04449276|561155522|FG007|Overall Study|Other|1|||
155474069|NCT01614795|561155523|FG000|Overall Study|Adverse Event|0|||
155474070|NCT01614795|561155524|FG001|Overall Study|Adverse Event|0|||
155474071|NCT01614795|561155525|FG002|Overall Study|Adverse Event|1|||
155474072|NCT01614795|561155526|FG003|Overall Study|Adverse Event|1|||
155474073|NCT01614795|561155523|FG000|Overall Study|Lack of Efficacy|10|||
155474074|NCT01614795|561155524|FG001|Overall Study|Lack of Efficacy|10|||
155474075|NCT01614795|561155525|FG002|Overall Study|Lack of Efficacy|9|||
155474076|NCT01614795|561155526|FG003|Overall Study|Lack of Efficacy|8|||
155474077|NCT01614795|561155523|FG000|Overall Study|Physician Decision|1|||
155474078|NCT01614795|561155524|FG001|Overall Study|Physician Decision|0|||
155474079|NCT01614795|561155525|FG002|Overall Study|Physician Decision|1|||
155474080|NCT01614795|561155526|FG003|Overall Study|Physician Decision|1|||
155474081|NCT01614795|561155523|FG000|Overall Study|Withdrawal by Subject|0|||
155474082|NCT01614795|561155524|FG001|Overall Study|Withdrawal by Subject|1|||
155474083|NCT01614795|561155525|FG002|Overall Study|Withdrawal by Subject|0|||
155474084|NCT01614795|561155526|FG003|Overall Study|Withdrawal by Subject|2|||
155474085|NCT01614795|561155523|FG000|Overall Study|Ineligible|0|||
155474086|NCT01614795|561155524|FG001|Overall Study|Ineligible|1|||
155474087|NCT01614795|561155525|FG002|Overall Study|Ineligible|0|||
155474088|NCT01614795|561155526|FG003|Overall Study|Ineligible|0|||
155474089|NCT00701103|561155527|FG000|Overall Study|Adverse Event|0|||
155474090|NCT00701103|561155528|FG001|Overall Study|Adverse Event|0|||
155474091|NCT00701103|561155529|FG002|Overall Study|Adverse Event|1|||
155474092|NCT00701103|561155530|FG003|Overall Study|Adverse Event|1|||
155474093|NCT00701103|561155531|FG004|Overall Study|Adverse Event|0|||
155474094|NCT00701103|561155532|FG005|Overall Study|Adverse Event|1|||
155474095|NCT00701103|561155533|FG006|Overall Study|Adverse Event|1|||
155474096|NCT00701103|561155534|FG007|Overall Study|Adverse Event|0|||
155474097|NCT00701103|561155535|FG008|Overall Study|Adverse Event|0|||
155474098|NCT00701103|561155536|FG009|Overall Study|Adverse Event|2|||
155474099|NCT00701103|561155537|FG010|Overall Study|Adverse Event|0|||
155474100|NCT00701103|561155527|FG000|Overall Study|Progressive Disease|5|||
155474101|NCT00701103|561155528|FG001|Overall Study|Progressive Disease|2|||
155474102|NCT00701103|561155529|FG002|Overall Study|Progressive Disease|6|||
155474103|NCT00701103|561155530|FG003|Overall Study|Progressive Disease|5|||
155474104|NCT00701103|561155531|FG004|Overall Study|Progressive Disease|6|||
155474105|NCT00701103|561155532|FG005|Overall Study|Progressive Disease|5|||
155474106|NCT00701103|561155533|FG006|Overall Study|Progressive Disease|7|||
155474107|NCT00701103|561155534|FG007|Overall Study|Progressive Disease|7|||
155474108|NCT00701103|561155535|FG008|Overall Study|Progressive Disease|8|||
155474109|NCT00701103|561155536|FG009|Overall Study|Progressive Disease|8|||
155474110|NCT00701103|561155537|FG010|Overall Study|Progressive Disease|11|||
155474111|NCT00701103|561155527|FG000|Overall Study|Withdrawal by Subject|0|||
155474112|NCT00701103|561155528|FG001|Overall Study|Withdrawal by Subject|1|||
155474113|NCT00701103|561155529|FG002|Overall Study|Withdrawal by Subject|1|||
155474114|NCT00701103|561155530|FG003|Overall Study|Withdrawal by Subject|0|||
155474115|NCT00701103|561155531|FG004|Overall Study|Withdrawal by Subject|0|||
155474116|NCT00701103|561155532|FG005|Overall Study|Withdrawal by Subject|0|||
155474117|NCT00701103|561155533|FG006|Overall Study|Withdrawal by Subject|0|||
155474118|NCT00701103|561155534|FG007|Overall Study|Withdrawal by Subject|0|||
155474119|NCT00701103|561155535|FG008|Overall Study|Withdrawal by Subject|0|||
155474120|NCT00701103|561155536|FG009|Overall Study|Withdrawal by Subject|0|||
155474121|NCT00701103|561155537|FG010|Overall Study|Withdrawal by Subject|0|||
155474122|NCT00701103|561155527|FG000|Overall Study|Other|0|||
155474123|NCT00701103|561155528|FG001|Overall Study|Other|0|||
155474124|NCT00701103|561155529|FG002|Overall Study|Other|0|||
155474125|NCT00701103|561155530|FG003|Overall Study|Other|0|||
155474126|NCT00701103|561155531|FG004|Overall Study|Other|0|||
155474127|NCT00701103|561155532|FG005|Overall Study|Other|0|||
155474128|NCT00701103|561155533|FG006|Overall Study|Other|0|||
155474129|NCT00701103|561155534|FG007|Overall Study|Other|0|||
155474130|NCT00701103|561155535|FG008|Overall Study|Other|1|||
155474131|NCT00701103|561155536|FG009|Overall Study|Other|1|||
155474132|NCT00701103|561155537|FG010|Overall Study|Other|0|||
155474133|NCT01624467|561155541|FG000|Overall Study|Withdrawal by Subject|2|||
155474134|NCT01624467|561155541|FG000|Overall Study|Lost to Follow-up|1|||
155474135|NCT01624467|561155541|FG000|Overall Study|Adverse Event|7|||
155474136|NCT01624467|561155541|FG000|Overall Study|Progressive Disease|19|||
155474137|NCT01624467|561155541|FG000|Overall Study|Per Sponsor Requirement|1|||
155474138|NCT01624467|561155541|FG000|Overall Study|Subject Withdrew from Treatment|1|||
155474139|NCT00089999|561155542|FG000|Overall Study|Adverse Event|4|||
155474140|NCT00089999|561155543|FG001|Overall Study|Adverse Event|7|||
155474141|NCT00089999|561155542|FG000|Overall Study|Withdrawal by Subject|0|||
155474142|NCT00089999|561155543|FG001|Overall Study|Withdrawal by Subject|4|||
155474143|NCT00089999|561155542|FG000|Overall Study|Lost to Follow-up|2|||
155474144|NCT00089999|561155543|FG001|Overall Study|Lost to Follow-up|1|||
155474145|NCT00089999|561155542|FG000|Overall Study|Radiological Progression of Cancer|52|||
155474146|NCT00089999|561155543|FG001|Overall Study|Radiological Progression of Cancer|44|||
155474147|NCT00089999|561155542|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
155474148|NCT00089999|561155543|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
155474149|NCT00089999|561155542|FG000|Overall Study|Death|3|||
155474150|NCT00089999|561155543|FG001|Overall Study|Death|3|||
155474151|NCT00089999|561155542|FG000|Overall Study|Poor General Condition|1|||
155474152|NCT00089999|561155543|FG001|Overall Study|Poor General Condition|0|||
155474153|NCT00089999|561155542|FG000|Overall Study|Clinical Progression|1|||
155474154|NCT00089999|561155543|FG001|Overall Study|Clinical Progression|2|||
155474155|NCT00089999|561155542|FG000|Overall Study|Physician Decision|2|||
155474156|NCT00089999|561155543|FG001|Overall Study|Physician Decision|2|||
155474157|NCT00089999|561155542|FG000|Overall Study|Patient Underwent Surgery|2|||
155474158|NCT00089999|561155543|FG001|Overall Study|Patient Underwent Surgery|0|||
155474159|NCT00089999|561155542|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
155474160|NCT00089999|561155543|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
155474161|NCT03039569|561155544|FG000|Overall Study|Lost to Follow-up|5|||
155474162|NCT03039569|561155545|FG001|Overall Study|Lost to Follow-up|4|||
155474163|NCT01167153|561155546|FG000|Overall Study|Non-effective therapy|1|||
155474164|NCT01167153|561155547|FG001|Overall Study|Non-effective therapy|4|||
155474165|NCT01167153|561155546|FG000|Overall Study|AE including clinical laboratory AE|2|||
155474166|NCT01167153|561155547|FG001|Overall Study|AE including clinical laboratory AE|8|||
155474167|NCT01167153|561155546|FG000|Overall Study|Hypotension|1|||
155474168|NCT01167153|561155547|FG001|Overall Study|Hypotension|0|||
155474169|NCT01167153|561155546|FG000|Overall Study|Lost to Follow-up|7|||
155474170|NCT01167153|561155547|FG001|Overall Study|Lost to Follow-up|9|||
155474171|NCT01167153|561155546|FG000|Overall Study|Non-compliance to concomitant medication|0|||
155474172|NCT01167153|561155547|FG001|Overall Study|Non-compliance to concomitant medication|2|||
155474173|NCT01167153|561155546|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
155474174|NCT01167153|561155547|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
155474175|NCT01167153|561155546|FG000|Overall Study|Withdrawal consent|1|||
155474176|NCT01167153|561155547|FG001|Overall Study|Withdrawal consent|1|||
155474177|NCT01167153|561155546|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
155474178|NCT01167153|561155547|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
155474179|NCT01462045|561156876|FG000|Overall Study|Family matter|0|||
155474180|NCT01462045|561156877|FG001|Overall Study|Family matter|1|||
155474181|NCT01462045|561156878|FG002|Overall Study|Family matter|0|||
155474182|NCT03558828|561156879|FG000|Overall Study|Lost to Follow-up|4|||
155474183|NCT03558828|561156880|FG001|Overall Study|Lost to Follow-up|3|||
155474184|NCT03558828|561156881|FG002|Overall Study|Lost to Follow-up|3|||
155474185|NCT03558828|561156882|FG003|Overall Study|Lost to Follow-up|5|||
155474186|NCT03558828|561156883|FG004|Overall Study|Lost to Follow-up|2|||
155474187|NCT03558828|561156884|FG005|Overall Study|Lost to Follow-up|3|||
155474188|NCT03558828|561156879|FG000|Overall Study|dropped before the intervention|1|||
155474189|NCT03558828|561156880|FG001|Overall Study|dropped before the intervention|1|||
155474190|NCT03558828|561156881|FG002|Overall Study|dropped before the intervention|0|||
155474191|NCT03558828|561156882|FG003|Overall Study|dropped before the intervention|0|||
155474192|NCT03558828|561156883|FG004|Overall Study|dropped before the intervention|0|||
155474193|NCT03558828|561156884|FG005|Overall Study|dropped before the intervention|0|||
155474194|NCT03671148|561156885|FG000|Overall Study|Adverse Event|3|||
155474195|NCT03671148|561156886|FG001|Overall Study|Adverse Event|2|||
155474196|NCT03671148|561156885|FG000|Overall Study|Withdrawal by Subject|8|||
155474197|NCT03671148|561156886|FG001|Overall Study|Withdrawal by Subject|2|||
155474198|NCT03671148|561156885|FG000|Overall Study|Lost to Follow-up|1|||
155474199|NCT03671148|561156886|FG001|Overall Study|Lost to Follow-up|2|||
155474200|NCT03671148|561156885|FG000|Overall Study|Lack of Efficacy|7|||
155474201|NCT03671148|561156886|FG001|Overall Study|Lack of Efficacy|2|||
155474202|NCT03671148|561156885|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
155474203|NCT03671148|561156886|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
155474204|NCT03671148|561156885|FG000|Overall Study|Other|1|||
155474205|NCT03671148|561156886|FG001|Overall Study|Other|0|||
155474206|NCT03671148|561156885|FG000|Overall Study|Incomplete Randomization Visit|1|||
155474207|NCT03671148|561156886|FG001|Overall Study|Incomplete Randomization Visit|0|||
155474208|NCT00673816|561156889|FG000|Overall Study|Adverse Event|1|||
155474209|NCT00673816|561156889|FG000|Overall Study|Withdrawal by Subject|1|||
155474210|NCT01804842|561156890|FG000|Overall Study|Adverse Event|1|||
155474211|NCT01804842|561156891|FG001|Overall Study|Adverse Event|1|||
155474212|NCT01804842|561156892|FG002|Overall Study|Adverse Event|0|||
155474213|NCT01804842|561156890|FG000|Overall Study|Lost to Follow-up|1|||
155474214|NCT01804842|561156891|FG001|Overall Study|Lost to Follow-up|0|||
155474215|NCT01804842|561156892|FG002|Overall Study|Lost to Follow-up|0|||
155474216|NCT01804842|561156890|FG000|Overall Study|Non-Compliance|1|||
155474217|NCT01804842|561156891|FG001|Overall Study|Non-Compliance|1|||
155474218|NCT01804842|561156892|FG002|Overall Study|Non-Compliance|0|||
155474219|NCT01804842|561156890|FG000|Overall Study|Personal Reason|0|||
155474220|NCT01804842|561156891|FG001|Overall Study|Personal Reason|0|||
155474221|NCT01804842|561156892|FG002|Overall Study|Personal Reason|1|||
155474222|NCT00413777|561156893|FG000|Fixed-dose Period|Lost to Follow-up|1|||
155474223|NCT00413777|561156894|FG001|Fixed-dose Period|Lost to Follow-up|1|||
155474224|NCT00413777|561156893|FG000|Fixed-dose Period|Adverse Event|2|||
155474225|NCT00413777|561156894|FG001|Fixed-dose Period|Adverse Event|1|||
155474226|NCT00413777|561156893|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
155474227|NCT00413777|561156894|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
155474228|NCT00413777|561156893|FG000|Fixed-dose Period|Withdrew Consent|0|||
155474229|NCT00413777|561156894|FG001|Fixed-dose Period|Withdrew Consent|1|||
155474230|NCT05180721|561156897|FG000|Overall Study|Lost to Follow-up|4|||
155474231|NCT02736929|561156910|FG000|Main Study|Lost to Follow-up|7|||
155474232|NCT02736929|561156911|FG001|Main Study|Lost to Follow-up|1|||
155474233|NCT02736929|561156912|FG002|Main Study|Lost to Follow-up|0|||
155474234|NCT02736929|561156910|FG000|Main Study|Withdrawal by Subject|1|||
155474235|NCT02736929|561156911|FG001|Main Study|Withdrawal by Subject|1|||
155474236|NCT02736929|561156912|FG002|Main Study|Withdrawal by Subject|0|||
155474237|NCT02736929|561156910|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
155474238|NCT02736929|561156911|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
155474239|NCT02736929|561156912|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
155474240|NCT02465489|561156915|FG000|Overall Study|Adverse Event|5|||
155474241|NCT01855425|561156922|FG000|Overall Study|Physician Decision|20|||
155474242|NCT00414973|561156930|FG000|Overall Study|Withdrawal by Subject|14|||
155474243|NCT00414973|561156931|FG001|Overall Study|Withdrawal by Subject|4|||
155474244|NCT00414973|561156932|FG002|Overall Study|Withdrawal by Subject|1|||
155474245|NCT00414973|561156933|FG003|Overall Study|Withdrawal by Subject|0|||
155474246|NCT00414973|561156930|FG000|Overall Study|Adverse Event|10|||
155474247|NCT00414973|561156931|FG001|Overall Study|Adverse Event|0|||
155474248|NCT00414973|561156932|FG002|Overall Study|Adverse Event|1|||
155474249|NCT00414973|561156933|FG003|Overall Study|Adverse Event|0|||
155474250|NCT00414973|561156930|FG000|Overall Study|Protocol Violation|3|||
155474251|NCT00414973|561156931|FG001|Overall Study|Protocol Violation|4|||
155474252|NCT00414973|561156932|FG002|Overall Study|Protocol Violation|0|||
155474253|NCT00414973|561156933|FG003|Overall Study|Protocol Violation|0|||
155474254|NCT00414973|561156930|FG000|Overall Study|Lost to Follow-up|0|||
155474255|NCT00414973|561156931|FG001|Overall Study|Lost to Follow-up|2|||
155474256|NCT00414973|561156932|FG002|Overall Study|Lost to Follow-up|0|||
155474257|NCT00414973|561156933|FG003|Overall Study|Lost to Follow-up|0|||
155474258|NCT00414973|561156930|FG000|Overall Study|Sponsor Decision|1|||
155474259|NCT00414973|561156931|FG001|Overall Study|Sponsor Decision|0|||
155474260|NCT00414973|561156932|FG002|Overall Study|Sponsor Decision|0|||
155474261|NCT00414973|561156933|FG003|Overall Study|Sponsor Decision|0|||
155474262|NCT00414973|561156930|FG000|Overall Study|Death|0|||
155474263|NCT00414973|561156931|FG001|Overall Study|Death|0|||
155474264|NCT00414973|561156932|FG002|Overall Study|Death|1|||
155474265|NCT00414973|561156933|FG003|Overall Study|Death|0|||
155474266|NCT01196091|561156937|FG000|Overall Study|Adverse Event|22|||
155474267|NCT01196091|561156938|FG001|Overall Study|Adverse Event|27|||
155474268|NCT01196091|561156939|FG002|Overall Study|Adverse Event|26|||
155474269|NCT01196091|561156937|FG000|Overall Study|Death|3|||
155474270|NCT01196091|561156938|FG001|Overall Study|Death|2|||
155474271|NCT01196091|561156939|FG002|Overall Study|Death|2|||
155474272|NCT01196091|561156937|FG000|Overall Study|Entry Criteria Not Met|11|||
155474273|NCT01196091|561156938|FG001|Overall Study|Entry Criteria Not Met|11|||
155474274|NCT01196091|561156939|FG002|Overall Study|Entry Criteria Not Met|10|||
155474275|NCT01196091|561156937|FG000|Overall Study|Lack of Efficacy|15|||
155474276|NCT01196091|561156938|FG001|Overall Study|Lack of Efficacy|12|||
155474277|NCT01196091|561156939|FG002|Overall Study|Lack of Efficacy|17|||
155474278|NCT01196091|561156937|FG000|Overall Study|Lost to Follow-up|5|||
155474279|NCT01196091|561156938|FG001|Overall Study|Lost to Follow-up|5|||
155474280|NCT01196091|561156939|FG002|Overall Study|Lost to Follow-up|6|||
155474281|NCT01196091|561156937|FG000|Overall Study|Parent/Caregiver Decision|0|||
155474282|NCT01196091|561156938|FG001|Overall Study|Parent/Caregiver Decision|0|||
155474283|NCT01196091|561156939|FG002|Overall Study|Parent/Caregiver Decision|1|||
155474284|NCT01196091|561156937|FG000|Overall Study|Withdrawal by Subject|16|||
155474285|NCT01196091|561156938|FG001|Overall Study|Withdrawal by Subject|19|||
155474286|NCT01196091|561156939|FG002|Overall Study|Withdrawal by Subject|22|||
155474287|NCT01196091|561156937|FG000|Overall Study|Physician Decision|3|||
155474288|NCT01196091|561156938|FG001|Overall Study|Physician Decision|3|||
155474289|NCT01196091|561156939|FG002|Overall Study|Physician Decision|4|||
155474290|NCT01196091|561156937|FG000|Overall Study|Protocol Violation|1|||
155474291|NCT01196091|561156938|FG001|Overall Study|Protocol Violation|3|||
155474292|NCT01196091|561156939|FG002|Overall Study|Protocol Violation|3|||
155474293|NCT01196091|561156937|FG000|Overall Study|Sponsor Decision|6|||
155474294|NCT01196091|561156938|FG001|Overall Study|Sponsor Decision|5|||
155474295|NCT01196091|561156939|FG002|Overall Study|Sponsor Decision|4|||
155474296|NCT01196091|561156937|FG000|Overall Study|Excluded Site|5|||
155474297|NCT01196091|561156938|FG001|Overall Study|Excluded Site|11|||
155474298|NCT01196091|561156939|FG002|Overall Study|Excluded Site|8|||
155474299|NCT01196091|561156937|FG000|Overall Study|Randomized, No Study Drug Received|1|||
155474300|NCT01196091|561156938|FG001|Overall Study|Randomized, No Study Drug Received|0|||
155474301|NCT01196091|561156939|FG002|Overall Study|Randomized, No Study Drug Received|1|||
155474302|NCT01487863|561156943|FG000|Overall Study|Death|19|||
155474303|NCT01487863|561156944|FG001|Overall Study|Death|19|||
155474304|NCT04247828|561156948|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
155474305|NCT02324049|561156949|FG000|Part C|Study terminated|11|||
155474306|NCT03198728|561156950|FG000|Overall Study|Adverse Event|10|||
155474307|NCT03198728|561156951|FG001|Overall Study|Adverse Event|5|||
155474308|NCT03198728|561156950|FG000|Overall Study|Lost to Follow-up|21|||
155474309|NCT03198728|561156951|FG001|Overall Study|Lost to Follow-up|7|||
155474310|NCT03198728|561156950|FG000|Overall Study|Physician Decision|7|||
155474311|NCT03198728|561156951|FG001|Overall Study|Physician Decision|2|||
155474312|NCT03198728|561156950|FG000|Overall Study|Withdrawal by Subject|14|||
155474313|NCT03198728|561156951|FG001|Overall Study|Withdrawal by Subject|10|||
155474314|NCT03083470|561156952|FG000|Overall Study|Lost to Follow-up|0|||
155474315|NCT03083470|561156953|FG001|Overall Study|Lost to Follow-up|0|||
155474316|NCT03083470|561156954|FG002|Overall Study|Lost to Follow-up|0|||
155474317|NCT03083470|561156955|FG003|Overall Study|Lost to Follow-up|0|||
155474318|NCT03083470|561156956|FG004|Overall Study|Lost to Follow-up|1|||
155474319|NCT03083470|561156952|FG000|Overall Study|Withdrawal by Subject|0|||
155474320|NCT03083470|561156953|FG001|Overall Study|Withdrawal by Subject|0|||
155474321|NCT03083470|561156954|FG002|Overall Study|Withdrawal by Subject|0|||
155474322|NCT03083470|561156955|FG003|Overall Study|Withdrawal by Subject|0|||
155474323|NCT03083470|561156956|FG004|Overall Study|Withdrawal by Subject|1|||
155474324|NCT01512693|561156957|FG000|Overall Study|Withdrawal by Subject|0|||
155474325|NCT01512693|561156958|FG001|Overall Study|Withdrawal by Subject|1|||
155474326|NCT00736450|561156968|FG000|Overall Study|Not ABC gene eligible|19|||
155474327|NCT00736450|561156968|FG000|Overall Study|Withdrawal by Subject|5|||
155474328|NCT00736450|561156968|FG000|Overall Study|Physician Decision|1|||
155474329|NCT00981747|561156982|FG000|Losartan|Withdrawal by Subject|1|||
155474330|NCT00981747|561156982|FG000|Losartan|Death|1|||
155474331|NCT00981747|561156982|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
155474332|NCT01437267|561156988|FG000|Overall Study|Withdrawal by Subject|0|||
155474333|NCT01437267|561156989|FG001|Overall Study|Withdrawal by Subject|0|||
155474334|NCT01437267|561156990|FG002|Overall Study|Withdrawal by Subject|0|||
155474335|NCT01437267|561156991|FG003|Overall Study|Withdrawal by Subject|1|||
155474336|NCT01437267|561156992|FG004|Overall Study|Withdrawal by Subject|0|||
155474337|NCT01437267|561156993|FG005|Overall Study|Withdrawal by Subject|0|||
155474338|NCT01437267|561156988|FG000|Overall Study|Protocol Violation|0|||
155474339|NCT01437267|561156989|FG001|Overall Study|Protocol Violation|1|||
155474340|NCT01437267|561156990|FG002|Overall Study|Protocol Violation|0|||
155474341|NCT01437267|561156991|FG003|Overall Study|Protocol Violation|0|||
155474342|NCT01437267|561156992|FG004|Overall Study|Protocol Violation|0|||
155474343|NCT01437267|561156993|FG005|Overall Study|Protocol Violation|0|||
155474344|NCT03934203|561156994|FG000|Overall Study|Adverse Event|0|||
155474345|NCT03934203|561156995|FG001|Overall Study|Adverse Event|0|||
155474346|NCT03934203|561156996|FG002|Overall Study|Adverse Event|1|||
155474347|NCT03934203|561156997|FG003|Overall Study|Adverse Event|0|||
155474348|NCT03934203|561156998|FG004|Overall Study|Adverse Event|1|||
155474349|NCT03934203|561156999|FG005|Overall Study|Adverse Event|0|||
155474350|NCT03934203|561157000|FG006|Overall Study|Adverse Event|2|||
155474351|NCT03934203|561157001|FG007|Overall Study|Adverse Event|0|||
155474352|NCT03934203|561157002|FG008|Overall Study|Adverse Event|0|||
155474353|NCT03934203|561157003|FG009|Overall Study|Adverse Event|0|||
155474354|NCT03934203|561157004|FG010|Overall Study|Adverse Event|0|||
155474355|NCT03934203|561157005|FG011|Overall Study|Adverse Event|0|||
155474356|NCT03934203|561157006|FG012|Overall Study|Adverse Event|0|||
155474357|NCT03934203|561157007|FG013|Overall Study|Adverse Event|1|||
155474358|NCT03934203|561157008|FG014|Overall Study|Adverse Event|0|||
155474359|NCT00333970|561157011|FG000|Overall Study|Withdrawal by Subject|13|||
155474360|NCT00333970|561157012|FG001|Overall Study|Withdrawal by Subject|7|||
155474361|NCT00441480|561157013|FG000|Overall Study|Protocol Violation|1|||
155474362|NCT00441480|561157014|FG001|Overall Study|Protocol Violation|1|||
155519045|NCT00264810|561325197|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
155519046|NCT00264810|561325198|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
155519047|NCT00182091|561325202|FG000|Overall Study|Withdrawal by Subject|1|||
155519048|NCT00182091|561325203|FG001|Overall Study|Withdrawal by Subject|0|||
155474363|NCT00441480|561157013|FG000|Overall Study|Withdrawal by Subject|2|||
155474364|NCT00441480|561157014|FG001|Overall Study|Withdrawal by Subject|3|||
155474365|NCT00899678|561157015|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
155474366|NCT00899678|561157016|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
155474367|NCT00899678|561157017|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
155474368|NCT00899678|561157015|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
155474369|NCT00899678|561157016|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
155474370|NCT00899678|561157017|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
155474371|NCT00899678|561157015|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
155474372|NCT00899678|561157016|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
155474373|NCT00899678|561157017|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
155474374|NCT00899678|561157015|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
155474375|NCT00899678|561157016|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
155474376|NCT00899678|561157017|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
155474377|NCT00899678|561157015|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
155474378|NCT00899678|561157016|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
155474379|NCT00899678|561157017|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
155474380|NCT00899678|561157015|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
155474381|NCT00899678|561157016|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
155474382|NCT00899678|561157017|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
155474383|NCT00899678|561157015|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
155474384|NCT00899678|561157016|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
155474385|NCT00899678|561157017|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
155474386|NCT00899678|561157015|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
155474387|NCT00899678|561157016|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
155474388|NCT00899678|561157017|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
155474389|NCT00899678|561157015|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
155474390|NCT00899678|561157016|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
155474391|NCT00899678|561157017|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
155474392|NCT02092324|561157018|FG000|Overall Study|Adverse Event|1|||
155474393|NCT02092324|561157018|FG000|Overall Study|Lack of Efficacy|6|||
155474394|NCT02092324|561157018|FG000|Overall Study|Proceed to Transplant|3|||
155474395|NCT02092324|561157018|FG000|Overall Study|Physician Decision|7|||
155474396|NCT02092324|561157018|FG000|Overall Study|Misdiagnosis|2|||
155474397|NCT00398138|561157019|FG000|Overall Study|Adverse Event|2|||
155474398|NCT03954704|561157025|FG000|Overall Study|Death|1|||
155474399|NCT03954704|561157026|FG001|Overall Study|Death|1|||
155474400|NCT03954704|561157027|FG002|Overall Study|Death|1|||
155474401|NCT03954704|561157028|FG003|Overall Study|Death|3|||
155474402|NCT03954704|561157029|FG004|Overall Study|Death|2|||
155474403|NCT03954704|561157030|FG005|Overall Study|Death|2|||
155474404|NCT03954704|561157031|FG006|Overall Study|Death|0|||
155474405|NCT03954704|561157025|FG000|Overall Study|Withdrew Consent|0|||
155474406|NCT03954704|561157026|FG001|Overall Study|Withdrew Consent|0|||
155474407|NCT03954704|561157027|FG002|Overall Study|Withdrew Consent|1|||
155519049|NCT00182091|561325204|FG002|Overall Study|Withdrawal by Subject|0|||
155519050|NCT00182091|561325205|FG003|Overall Study|Withdrawal by Subject|0|||
155474408|NCT03954704|561157028|FG003|Overall Study|Withdrew Consent|0|||
155474409|NCT03954704|561157029|FG004|Overall Study|Withdrew Consent|0|||
155474410|NCT03954704|561157030|FG005|Overall Study|Withdrew Consent|1|||
155474411|NCT03954704|561157031|FG006|Overall Study|Withdrew Consent|0|||
155474412|NCT03954704|561157025|FG000|Overall Study|Lost to Follow-up|0|||
155474413|NCT03954704|561157026|FG001|Overall Study|Lost to Follow-up|0|||
155474414|NCT03954704|561157027|FG002|Overall Study|Lost to Follow-up|0|||
155474415|NCT03954704|561157028|FG003|Overall Study|Lost to Follow-up|0|||
155474416|NCT03954704|561157029|FG004|Overall Study|Lost to Follow-up|0|||
155474417|NCT03954704|561157030|FG005|Overall Study|Lost to Follow-up|0|||
155474418|NCT03954704|561157031|FG006|Overall Study|Lost to Follow-up|1|||
155474419|NCT03954704|561157025|FG000|Overall Study|Study Terminated by Sponsor|0|||
155474420|NCT03954704|561157026|FG001|Overall Study|Study Terminated by Sponsor|0|||
155474421|NCT03954704|561157027|FG002|Overall Study|Study Terminated by Sponsor|1|||
155474422|NCT03954704|561157028|FG003|Overall Study|Study Terminated by Sponsor|0|||
155474423|NCT03954704|561157029|FG004|Overall Study|Study Terminated by Sponsor|1|||
155474424|NCT03954704|561157030|FG005|Overall Study|Study Terminated by Sponsor|4|||
155474425|NCT03954704|561157031|FG006|Overall Study|Study Terminated by Sponsor|2|||
155474426|NCT03954704|561157025|FG000|Overall Study|Enrolled but not Treated|0|||
155474427|NCT03954704|561157026|FG001|Overall Study|Enrolled but not Treated|0|||
155474428|NCT03954704|561157027|FG002|Overall Study|Enrolled but not Treated|0|||
155474429|NCT03954704|561157028|FG003|Overall Study|Enrolled but not Treated|0|||
155474430|NCT03954704|561157029|FG004|Overall Study|Enrolled but not Treated|0|||
155474431|NCT03954704|561157030|FG005|Overall Study|Enrolled but not Treated|1|||
155474432|NCT03954704|561157031|FG006|Overall Study|Enrolled but not Treated|0|||
155474433|NCT02569398|561157034|FG000|Overall Study|Adverse Event|0|||
155474434|NCT02569398|561157035|FG001|Overall Study|Adverse Event|1|||
155474435|NCT02569398|561157036|FG002|Overall Study|Adverse Event|6|||
155474436|NCT02569398|561157034|FG000|Overall Study|Withdrawal by Subject|43|||
155474437|NCT02569398|561157035|FG001|Overall Study|Withdrawal by Subject|43|||
155474438|NCT02569398|561157036|FG002|Overall Study|Withdrawal by Subject|30|||
155474439|NCT02569398|561157034|FG000|Overall Study|Study terminated by sponsor|130|||
155474440|NCT02569398|561157035|FG001|Overall Study|Study terminated by sponsor|131|||
155474441|NCT02569398|561157036|FG002|Overall Study|Study terminated by sponsor|134|||
155474442|NCT02569398|561157034|FG000|Overall Study|Other|12|||
155474443|NCT02569398|561157035|FG001|Overall Study|Other|14|||
155474444|NCT02569398|561157036|FG002|Overall Study|Other|13|||
155474445|NCT02571972|561157037|FG000|Overall Study|Protocol Violation|2|||
155474446|NCT02571972|561157037|FG000|Overall Study|Withdrawal by Subject|2|||
155474447|NCT03559192|561157040|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
155474448|NCT03559192|561157041|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
155474449|NCT03559192|561157042|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
155474450|NCT03559192|561157040|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
155474451|NCT03559192|561157041|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
155474452|NCT03559192|561157042|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
155474453|NCT03559192|561157040|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
155474454|NCT03559192|561157041|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
155474455|NCT03559192|561157042|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
155474456|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
155474457|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
155474458|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
155474459|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
155474460|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
155474461|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
155474462|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
155474463|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
155474464|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
155474465|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
155474466|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
155474467|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
155474468|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
155474469|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
155474470|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
155474471|NCT03559192|561157040|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
155474472|NCT03559192|561157041|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
155474473|NCT03559192|561157042|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
155474474|NCT03039192|561157043|FG000|Overall Study|Lost to Follow-up|4|||
155474475|NCT03039192|561157044|FG001|Overall Study|Lost to Follow-up|4|||
155474476|NCT03039192|561157043|FG000|Overall Study|Adverse event, serious fatal|0|||
155474477|NCT03039192|561157044|FG001|Overall Study|Adverse event, serious fatal|1|||
155474478|NCT03039192|561157043|FG000|Overall Study|Adverse event, non-fatal|0|||
155474479|NCT03039192|561157044|FG001|Overall Study|Adverse event, non-fatal|2|||
155474480|NCT03039192|561157043|FG000|Overall Study|Withdrawal by Subject|6|||
155474481|NCT03039192|561157044|FG001|Overall Study|Withdrawal by Subject|9|||
155474482|NCT03039192|561157043|FG000|Overall Study|Discontinued from treatment phase|19|||
155474483|NCT03039192|561157044|FG001|Overall Study|Discontinued from treatment phase|12|||
155474484|NCT03039192|561157043|FG000|Overall Study|Other|3|||
155474485|NCT03039192|561157044|FG001|Overall Study|Other|2|||
155474486|NCT03287830|561159389|FG000|Overall Study|Withdrawal by Subject|1|||
155474487|NCT03287830|561159390|FG001|Overall Study|Withdrawal by Subject|1|||
155474488|NCT03287830|561159389|FG000|Overall Study|not meeting inclusion criteria|5|||
155474489|NCT03287830|561159390|FG001|Overall Study|not meeting inclusion criteria|12|||
155474490|NCT00608842|561159391|FG000|Overall Study|Participant's Request|0|||
155474491|NCT00608842|561159392|FG001|Overall Study|Participant's Request|1|||
155474492|NCT00608842|561159393|FG002|Overall Study|Participant's Request|2|||
155474493|NCT00608842|561159394|FG003|Overall Study|Participant's Request|1|||
155474494|NCT00608842|561159391|FG000|Overall Study|Lost to Follow-up|1|||
155474495|NCT00608842|561159392|FG001|Overall Study|Lost to Follow-up|0|||
155474496|NCT00608842|561159393|FG002|Overall Study|Lost to Follow-up|0|||
155474497|NCT00608842|561159394|FG003|Overall Study|Lost to Follow-up|0|||
155474498|NCT01688999|561159395|FG000|Overall Study|Withdrawal by Subject|5|||
155474499|NCT01688999|561159396|FG001|Overall Study|Withdrawal by Subject|1|||
155474500|NCT01688999|561159397|FG002|Overall Study|Withdrawal by Subject|1|||
155474501|NCT01688999|561159395|FG000|Overall Study|Adverse Event|2|||
155474502|NCT01688999|561159396|FG001|Overall Study|Adverse Event|0|||
155474503|NCT01688999|561159397|FG002|Overall Study|Adverse Event|2|||
155474504|NCT01688999|561159395|FG000|Overall Study|Ineligible/Not treated|1|||
155474505|NCT01688999|561159396|FG001|Overall Study|Ineligible/Not treated|0|||
155474506|NCT01688999|561159397|FG002|Overall Study|Ineligible/Not treated|0|||
155474507|NCT02768103|561159398|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
155474508|NCT03039790|561159415|FG000|Overall Study|Lost to Follow-up|2|||
155474509|NCT03039790|561159416|FG001|Overall Study|Lost to Follow-up|0|||
155474510|NCT03039790|561159417|FG002|Overall Study|Lost to Follow-up|1|||
155474511|NCT03039790|561159418|FG003|Overall Study|Lost to Follow-up|1|||
155474512|NCT03039790|561159419|FG004|Overall Study|Lost to Follow-up|0|||
155474513|NCT03039790|561159420|FG005|Overall Study|Lost to Follow-up|1|||
155474514|NCT03039790|561159421|FG006|Overall Study|Lost to Follow-up|1|||
155474515|NCT03039790|561159422|FG007|Overall Study|Lost to Follow-up|1|||
155474516|NCT03039790|561159423|FG008|Overall Study|Lost to Follow-up|0|||
155474517|NCT03039790|561159424|FG009|Overall Study|Lost to Follow-up|1|||
155474518|NCT03039790|561159425|FG010|Overall Study|Lost to Follow-up|1|||
155474519|NCT03039790|561159426|FG011|Overall Study|Lost to Follow-up|0|||
155474520|NCT03039790|561159427|FG012|Overall Study|Lost to Follow-up|1|||
155474521|NCT03039790|561159428|FG013|Overall Study|Lost to Follow-up|0|||
155474522|NCT03039790|561159429|FG014|Overall Study|Lost to Follow-up|3|||
155474523|NCT03039790|561159430|FG015|Overall Study|Lost to Follow-up|1|||
155474524|NCT03039790|561159431|FG016|Overall Study|Lost to Follow-up|2|||
155474525|NCT03039790|561159432|FG017|Overall Study|Lost to Follow-up|2|||
155474526|NCT03039790|561159433|FG018|Overall Study|Lost to Follow-up|1|||
155474527|NCT03039790|561159434|FG019|Overall Study|Lost to Follow-up|3|||
155474528|NCT03039790|561159415|FG000|Overall Study|Withdrawal of Consent|1|||
155474529|NCT03039790|561159416|FG001|Overall Study|Withdrawal of Consent|0|||
155474530|NCT03039790|561159417|FG002|Overall Study|Withdrawal of Consent|0|||
155474531|NCT03039790|561159418|FG003|Overall Study|Withdrawal of Consent|1|||
155474532|NCT03039790|561159419|FG004|Overall Study|Withdrawal of Consent|0|||
155474533|NCT03039790|561159420|FG005|Overall Study|Withdrawal of Consent|0|||
155474534|NCT03039790|561159421|FG006|Overall Study|Withdrawal of Consent|0|||
155474535|NCT03039790|561159422|FG007|Overall Study|Withdrawal of Consent|0|||
155474536|NCT03039790|561159423|FG008|Overall Study|Withdrawal of Consent|0|||
155474537|NCT03039790|561159424|FG009|Overall Study|Withdrawal of Consent|1|||
155474538|NCT03039790|561159425|FG010|Overall Study|Withdrawal of Consent|0|||
155474539|NCT03039790|561159426|FG011|Overall Study|Withdrawal of Consent|0|||
155474540|NCT03039790|561159427|FG012|Overall Study|Withdrawal of Consent|2|||
155474541|NCT03039790|561159428|FG013|Overall Study|Withdrawal of Consent|0|||
155474542|NCT03039790|561159429|FG014|Overall Study|Withdrawal of Consent|1|||
155474543|NCT03039790|561159430|FG015|Overall Study|Withdrawal of Consent|5|||
155474544|NCT03039790|561159431|FG016|Overall Study|Withdrawal of Consent|3|||
155474545|NCT03039790|561159432|FG017|Overall Study|Withdrawal of Consent|0|||
155474546|NCT03039790|561159433|FG018|Overall Study|Withdrawal of Consent|2|||
155474547|NCT03039790|561159434|FG019|Overall Study|Withdrawal of Consent|5|||
155474548|NCT03039790|561159415|FG000|Overall Study|Death|0|||
155474549|NCT03039790|561159416|FG001|Overall Study|Death|0|||
155474550|NCT03039790|561159417|FG002|Overall Study|Death|0|||
155474551|NCT03039790|561159418|FG003|Overall Study|Death|0|||
155474552|NCT03039790|561159419|FG004|Overall Study|Death|0|||
155474553|NCT03039790|561159420|FG005|Overall Study|Death|0|||
155474554|NCT03039790|561159421|FG006|Overall Study|Death|0|||
155474555|NCT03039790|561159422|FG007|Overall Study|Death|0|||
155474556|NCT03039790|561159423|FG008|Overall Study|Death|0|||
155474557|NCT03039790|561159424|FG009|Overall Study|Death|0|||
155474558|NCT03039790|561159425|FG010|Overall Study|Death|0|||
155474559|NCT03039790|561159426|FG011|Overall Study|Death|0|||
155474560|NCT03039790|561159427|FG012|Overall Study|Death|0|||
155474561|NCT03039790|561159428|FG013|Overall Study|Death|0|||
155474562|NCT03039790|561159429|FG014|Overall Study|Death|0|||
155474563|NCT03039790|561159430|FG015|Overall Study|Death|1|||
155474564|NCT03039790|561159431|FG016|Overall Study|Death|3|||
155474565|NCT03039790|561159432|FG017|Overall Study|Death|0|||
155474566|NCT03039790|561159433|FG018|Overall Study|Death|2|||
155474567|NCT03039790|561159434|FG019|Overall Study|Death|0|||
155474568|NCT03039790|561159415|FG000|Overall Study|Reason, not Specified|1|||
155474569|NCT03039790|561159416|FG001|Overall Study|Reason, not Specified|0|||
155474570|NCT03039790|561159417|FG002|Overall Study|Reason, not Specified|0|||
155474571|NCT03039790|561159418|FG003|Overall Study|Reason, not Specified|0|||
155474572|NCT03039790|561159419|FG004|Overall Study|Reason, not Specified|0|||
155474573|NCT03039790|561159420|FG005|Overall Study|Reason, not Specified|0|||
155474574|NCT03039790|561159421|FG006|Overall Study|Reason, not Specified|0|||
155474575|NCT03039790|561159422|FG007|Overall Study|Reason, not Specified|0|||
155474576|NCT03039790|561159423|FG008|Overall Study|Reason, not Specified|0|||
155474577|NCT03039790|561159424|FG009|Overall Study|Reason, not Specified|0|||
155474578|NCT03039790|561159425|FG010|Overall Study|Reason, not Specified|0|||
155474579|NCT03039790|561159426|FG011|Overall Study|Reason, not Specified|0|||
155474580|NCT03039790|561159427|FG012|Overall Study|Reason, not Specified|0|||
155474581|NCT03039790|561159428|FG013|Overall Study|Reason, not Specified|0|||
155474582|NCT03039790|561159429|FG014|Overall Study|Reason, not Specified|0|||
155474583|NCT03039790|561159430|FG015|Overall Study|Reason, not Specified|0|||
155474584|NCT03039790|561159431|FG016|Overall Study|Reason, not Specified|2|||
155474585|NCT03039790|561159432|FG017|Overall Study|Reason, not Specified|0|||
155474586|NCT03039790|561159433|FG018|Overall Study|Reason, not Specified|1|||
155474587|NCT03039790|561159434|FG019|Overall Study|Reason, not Specified|0|||
155474588|NCT00498368|561159437|FG000|Overall Study|Withdrawal by Subject|3|||
155474589|NCT00498368|561159438|FG001|Overall Study|Withdrawal by Subject|2|||
155474590|NCT02266004|561159439|FG000|Overall Study|unrelated adverse event|1|||
155474591|NCT02266004|561159439|FG000|Overall Study|Physician Decision|1|||
155474592|NCT01025232|561159446|FG000|Overall Study|Study drug no longer available|3|||
155474593|NCT01025232|561159447|FG001|Overall Study|Study drug no longer available|6|||
155474594|NCT03748420|561159448|FG000|Overall Study|No 12 month medication adherence data available|0|||
155474595|NCT03748420|561159449|FG001|Overall Study|No 12 month medication adherence data available|1|||
155474596|NCT03748420|561159448|FG000|Overall Study|Death|24|||
155474597|NCT03748420|561159449|FG001|Overall Study|Death|28|||
155474598|NCT03748420|561159448|FG000|Overall Study|Lost to Follow-up|231|||
155474599|NCT03748420|561159449|FG001|Overall Study|Lost to Follow-up|230|||
155474600|NCT01263444|561159450|FG000|Overall Study|Adverse Event|8|||
155474601|NCT01263444|561159450|FG000|Overall Study|Withdrawal by Subject|1|||
155474602|NCT01263444|561159450|FG000|Overall Study|Protocol Violation|1|||
155474603|NCT01764022|561159451|FG000|Overall Study|Death|3|||
155474604|NCT01764022|561159452|FG001|Overall Study|Death|5|||
155474605|NCT01764022|561159451|FG000|Overall Study|Withdrawal by Subject|2|||
155474606|NCT01764022|561159452|FG001|Overall Study|Withdrawal by Subject|6|||
155474607|NCT01764022|561159451|FG000|Overall Study|Lack of Efficacy|0|||
155474608|NCT01764022|561159452|FG001|Overall Study|Lack of Efficacy|1|||
155474609|NCT01764022|561159451|FG000|Overall Study|Physician Decision|0|||
155474610|NCT01764022|561159452|FG001|Overall Study|Physician Decision|2|||
155474611|NCT01764022|561159451|FG000|Overall Study|Lost to Follow-up|2|||
155474612|NCT01764022|561159452|FG001|Overall Study|Lost to Follow-up|0|||
155474613|NCT01764022|561159451|FG000|Overall Study|Protocol Violation|1|||
155474614|NCT01764022|561159452|FG001|Overall Study|Protocol Violation|0|||
155474615|NCT01899768|561159453|FG000|Part A|Adverse Event|2|||
155474616|NCT01899768|561159453|FG000|Part A|Withdrawal by Subject|1|||
155474617|NCT01899768|561159453|FG000|Part B|Adverse Event|1|||
155474618|NCT01899768|561159453|FG000|Part B|Withdrawal by Subject|1|||
155474619|NCT04476108|561159454|FG000|Overall Study|Adverse Event|4|||
155474620|NCT04476108|561159455|FG001|Overall Study|Adverse Event|1|||
155474621|NCT04476108|561159454|FG000|Overall Study|Lost to Follow-up|1|||
155474622|NCT04476108|561159455|FG001|Overall Study|Lost to Follow-up|0|||
155474623|NCT04476108|561159454|FG000|Overall Study|Inadvertent Enrollment|1|||
155474624|NCT04476108|561159455|FG001|Overall Study|Inadvertent Enrollment|0|||
155474625|NCT04476108|561159454|FG000|Overall Study|Protocol Violation|1|||
155474626|NCT04476108|561159455|FG001|Overall Study|Protocol Violation|1|||
155474627|NCT04476108|561159454|FG000|Overall Study|Withdrawal by Subject|1|||
155474628|NCT04476108|561159455|FG001|Overall Study|Withdrawal by Subject|1|||
155474629|NCT00850135|561159456|FG000|Overall Study|Physician Decision|1|||
155474630|NCT02253992|561159457|FG000|Overall Study|Study drug toxicity|1|||
155474631|NCT02253992|561159458|FG001|Overall Study|Study drug toxicity|0|||
155474632|NCT02253992|561159459|FG002|Overall Study|Study drug toxicity|10|||
155474633|NCT02253992|561159457|FG000|Overall Study|Disease progression|4|||
155474634|NCT02253992|561159458|FG001|Overall Study|Disease progression|3|||
155474635|NCT02253992|561159459|FG002|Overall Study|Disease progression|98|||
155474636|NCT02253992|561159457|FG000|Overall Study|Withdrawal by Subject|0|||
155474637|NCT02253992|561159458|FG001|Overall Study|Withdrawal by Subject|0|||
155474638|NCT02253992|561159459|FG002|Overall Study|Withdrawal by Subject|3|||
155474639|NCT02253992|561159457|FG000|Overall Study|Adverse Event|0|||
155474640|NCT02253992|561159458|FG001|Overall Study|Adverse Event|0|||
155474641|NCT02253992|561159459|FG002|Overall Study|Adverse Event|8|||
155474642|NCT02253992|561159457|FG000|Overall Study|Death|0|||
155474643|NCT02253992|561159458|FG001|Overall Study|Death|0|||
155474644|NCT02253992|561159459|FG002|Overall Study|Death|1|||
155474645|NCT02253992|561159457|FG000|Overall Study|Subject discontinued study drug|1|||
155474646|NCT02253992|561159458|FG001|Overall Study|Subject discontinued study drug|0|||
155474647|NCT02253992|561159459|FG002|Overall Study|Subject discontinued study drug|1|||
155474648|NCT02253992|561159457|FG000|Overall Study|Completed treatment as per protocol|0|||
155474649|NCT02253992|561159458|FG001|Overall Study|Completed treatment as per protocol|1|||
155474650|NCT02253992|561159459|FG002|Overall Study|Completed treatment as per protocol|22|||
155474651|NCT02253992|561159457|FG000|Overall Study|Other|0|||
155519051|NCT02199509|561325206|FG000|Overall Study|Suicidal Ideation|0|||
155474652|NCT02253992|561159458|FG001|Overall Study|Other|0|||
155474653|NCT02253992|561159459|FG002|Overall Study|Other|1|||
155474654|NCT02159365|561159460|FG000|Overall Study|Disease Progression|23|||
155474655|NCT02159365|561159460|FG000|Overall Study|Other reasons|11|||
155474656|NCT02159365|561159460|FG000|Overall Study|Administrative reason by Sponsor|9|||
155474657|NCT02159365|561159460|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
155474658|NCT02159365|561159460|FG000|Overall Study|Study drug toxicity|7|||
155474659|NCT02159365|561159460|FG000|Overall Study|Maximum clinical benefit|3|||
155474660|NCT02159365|561159460|FG000|Overall Study|Subject request to discontinue treatment|3|||
155474661|NCT02159365|561159460|FG000|Overall Study|Subject withdrew consent|3|||
155474662|NCT02159365|561159460|FG000|Overall Study|Death|1|||
155474663|NCT02159365|561159460|FG000|Overall Study|Lost to Follow-up|1|||
155474664|NCT04051944|561159461|FG000|Overall Study|Study ending|1|||
155474665|NCT04051944|561159462|FG001|Overall Study|Study ending|1|||
155474666|NCT04051944|561159461|FG000|Overall Study|Early study termination by participant|1|||
155474667|NCT04051944|561159462|FG001|Overall Study|Early study termination by participant|0|||
155474668|NCT04051944|561159461|FG000|Overall Study|Withdrawal by Subject|2|||
155474669|NCT04051944|561159462|FG001|Overall Study|Withdrawal by Subject|2|||
155474670|NCT04051944|561159461|FG000|Overall Study|Lack of Efficacy|3|||
155474671|NCT04051944|561159462|FG001|Overall Study|Lack of Efficacy|0|||
155474672|NCT04051944|561159461|FG000|Overall Study|Adverse event, non- fatal|1|||
155474673|NCT04051944|561159462|FG001|Overall Study|Adverse event, non- fatal|1|||
155474674|NCT01526928|561159463|FG000|Overall Study|Progressive Disease|35|||
155474675|NCT01526928|561159464|FG001|Overall Study|Progressive Disease|17|||
155474676|NCT01526928|561159465|FG002|Overall Study|Progressive Disease|150|||
155474677|NCT01526928|561159466|FG003|Overall Study|Progressive Disease|182|||
155474678|NCT01526928|561159467|FG004|Overall Study|Progressive Disease|76|||
155474679|NCT01526928|561159468|FG005|Overall Study|Progressive Disease|4|||
155474680|NCT01526928|561159463|FG000|Overall Study|Adverse Event|2|||
155474681|NCT01526928|561159464|FG001|Overall Study|Adverse Event|1|||
155474682|NCT01526928|561159465|FG002|Overall Study|Adverse Event|29|||
155474683|NCT01526928|561159466|FG003|Overall Study|Adverse Event|40|||
155474684|NCT01526928|561159467|FG004|Overall Study|Adverse Event|13|||
155474685|NCT01526928|561159468|FG005|Overall Study|Adverse Event|2|||
155474686|NCT01526928|561159463|FG000|Overall Study|Death|0|||
155474687|NCT01526928|561159464|FG001|Overall Study|Death|0|||
155474688|NCT01526928|561159465|FG002|Overall Study|Death|3|||
155474689|NCT01526928|561159466|FG003|Overall Study|Death|0|||
155474690|NCT01526928|561159467|FG004|Overall Study|Death|0|||
155474691|NCT01526928|561159468|FG005|Overall Study|Death|0|||
155474692|NCT01526928|561159463|FG000|Overall Study|Withdrawal by Subject|1|||
155474693|NCT01526928|561159464|FG001|Overall Study|Withdrawal by Subject|0|||
155474694|NCT01526928|561159465|FG002|Overall Study|Withdrawal by Subject|13|||
155474695|NCT01526928|561159466|FG003|Overall Study|Withdrawal by Subject|11|||
155474696|NCT01526928|561159467|FG004|Overall Study|Withdrawal by Subject|3|||
155474697|NCT01526928|561159468|FG005|Overall Study|Withdrawal by Subject|0|||
155474698|NCT01526928|561159463|FG000|Overall Study|Physician Decision|0|||
155474699|NCT01526928|561159464|FG001|Overall Study|Physician Decision|0|||
155474700|NCT01526928|561159465|FG002|Overall Study|Physician Decision|2|||
155474701|NCT01526928|561159466|FG003|Overall Study|Physician Decision|5|||
155474702|NCT01526928|561159467|FG004|Overall Study|Physician Decision|0|||
155474703|NCT01526928|561159468|FG005|Overall Study|Physician Decision|0|||
155474704|NCT01526928|561159463|FG000|Overall Study|Other Reason|0|||
155474705|NCT01526928|561159464|FG001|Overall Study|Other Reason|1|||
155474706|NCT01526928|561159465|FG002|Overall Study|Other Reason|11|||
155474707|NCT01526928|561159466|FG003|Overall Study|Other Reason|4|||
155474708|NCT01526928|561159467|FG004|Overall Study|Other Reason|1|||
155519052|NCT02199509|561325207|FG001|Overall Study|Suicidal Ideation|1|||
155519053|NCT02199509|561325206|FG000|Overall Study|Misunderstood titration schedule|1|||
155519054|NCT02199509|561325207|FG001|Overall Study|Misunderstood titration schedule|0|||
155519055|NCT01658943|561325209|FG000|Overall Study|Adverse Event|6|||
155519056|NCT01658943|561325210|FG001|Overall Study|Adverse Event|13|||
155474709|NCT01526928|561159468|FG005|Overall Study|Other Reason|0|||
155474710|NCT01526928|561159463|FG000|Overall Study|Lost to Follow-up|0|||
155474711|NCT01526928|561159464|FG001|Overall Study|Lost to Follow-up|0|||
155474712|NCT01526928|561159465|FG002|Overall Study|Lost to Follow-up|0|||
155474713|NCT01526928|561159466|FG003|Overall Study|Lost to Follow-up|1|||
155519057|NCT01658943|561325209|FG000|Overall Study|Withdrawal by Subject|9|||
155519058|NCT01658943|561325210|FG001|Overall Study|Withdrawal by Subject|2|||
155474714|NCT01526928|561159467|FG004|Overall Study|Lost to Follow-up|0|||
155474715|NCT01526928|561159468|FG005|Overall Study|Lost to Follow-up|0|||
155474716|NCT01526928|561159463|FG000|Overall Study|Protocol Deviation|0|||
155474717|NCT01526928|561159464|FG001|Overall Study|Protocol Deviation|0|||
155474718|NCT01526928|561159465|FG002|Overall Study|Protocol Deviation|0|||
155474719|NCT01526928|561159466|FG003|Overall Study|Protocol Deviation|2|||
155474720|NCT01526928|561159467|FG004|Overall Study|Protocol Deviation|0|||
155474721|NCT01526928|561159468|FG005|Overall Study|Protocol Deviation|0|||
155474722|NCT01526928|561159463|FG000|Overall Study|Missing|0|||
155474723|NCT01526928|561159464|FG001|Overall Study|Missing|0|||
155474724|NCT01526928|561159465|FG002|Overall Study|Missing|1|||
155474725|NCT01526928|561159466|FG003|Overall Study|Missing|0|||
155474726|NCT01526928|561159467|FG004|Overall Study|Missing|2|||
155474727|NCT01526928|561159468|FG005|Overall Study|Missing|0|||
155474728|NCT04157751|561159469|FG000|Overall Study|Withdrawal by Subject|12|||
155474729|NCT04157751|561159470|FG001|Overall Study|Withdrawal by Subject|17|||
155474730|NCT04157751|561159469|FG000|Overall Study|Lost to Follow-up|6|||
155474731|NCT04157751|561159470|FG001|Overall Study|Lost to Follow-up|2|||
155474732|NCT04157751|561159469|FG000|Overall Study|Adverse Event|34|||
155474733|NCT04157751|561159470|FG001|Overall Study|Adverse Event|23|||
155474734|NCT04157751|561159469|FG000|Overall Study|Not treated|1|||
155474735|NCT04157751|561159470|FG001|Overall Study|Not treated|5|||
155474736|NCT04157751|561159469|FG000|Overall Study|Other reason not stated above|10|||
155474737|NCT04157751|561159470|FG001|Overall Study|Other reason not stated above|10|||
155474738|NCT04731922|561159471|FG000|Overall Study|Adverse Event|0|||
155474739|NCT04731922|561159472|FG001|Overall Study|Adverse Event|0|||
155474740|NCT04731922|561159473|FG002|Overall Study|Adverse Event|0|||
155474741|NCT04731922|561159474|FG003|Overall Study|Adverse Event|0|||
155474742|NCT04731922|561159475|FG004|Overall Study|Adverse Event|0|||
155474743|NCT04731922|561159476|FG005|Overall Study|Adverse Event|0|||
155474744|NCT04731922|561159477|FG006|Overall Study|Adverse Event|0|||
155474745|NCT04731922|561159478|FG007|Overall Study|Adverse Event|0|||
155474746|NCT04731922|561159479|FG008|Overall Study|Adverse Event|0|||
155474747|NCT04731922|561159480|FG009|Overall Study|Adverse Event|0|||
155474748|NCT04731922|561159481|FG010|Overall Study|Adverse Event|1|||
155474749|NCT04731922|561159482|FG011|Overall Study|Adverse Event|0|||
155474750|NCT04731922|561159483|FG012|Overall Study|Adverse Event|0|||
155474751|NCT04731922|561159484|FG013|Overall Study|Adverse Event|0|||
155474752|NCT04731922|561159485|FG014|Overall Study|Adverse Event|0|||
155519059|NCT01658943|561325209|FG000|Overall Study|Progression/Relapse|39|||
155519060|NCT01658943|561325210|FG001|Overall Study|Progression/Relapse|40|||
155519061|NCT01658943|561325209|FG000|Overall Study|Death|4|||
155519062|NCT01658943|561325210|FG001|Overall Study|Death|2|||
155519063|NCT01658943|561325209|FG000|Overall Study|not protocol specified|4|||
155519064|NCT01658943|561325210|FG001|Overall Study|not protocol specified|1|||
155519065|NCT01658943|561325209|FG000|Overall Study|Not eligible|7|||
155519066|NCT01658943|561325210|FG001|Overall Study|Not eligible|9|||
155519067|NCT01658943|561325209|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
155519068|NCT01658943|561325210|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
155519069|NCT02576990|561325212|FG000|Overall Study|Death|29|||
155519070|NCT02576990|561325213|FG001|Overall Study|Death|18|||
155519071|NCT02576990|561325212|FG000|Overall Study|Physician Decision|1|||
155519072|NCT02576990|561325213|FG001|Overall Study|Physician Decision|0|||
155519073|NCT02576990|561325212|FG000|Overall Study|Screen failure|2|||
155519074|NCT02576990|561325213|FG001|Overall Study|Screen failure|0|||
155519075|NCT02576990|561325212|FG000|Overall Study|Sponsor's decision|24|||
155519076|NCT02576990|561325213|FG001|Overall Study|Sponsor's decision|4|||
155519077|NCT02576990|561325212|FG000|Overall Study|Withdrawal by Subject|0|||
155519078|NCT02576990|561325213|FG001|Overall Study|Withdrawal by Subject|2|||
155519079|NCT05905783|561325214|FG000|Overall Study|Lost to Follow-up|12|||
155519080|NCT05905783|561325215|FG001|Overall Study|Lost to Follow-up|18|||
155519081|NCT05905783|561325214|FG000|Overall Study|Withdrawal by Subject|29|||
155519082|NCT05905783|561325215|FG001|Overall Study|Withdrawal by Subject|37|||
155519083|NCT05905783|561325214|FG000|Overall Study|Decision by sponsor|69|||
155519084|NCT05905783|561325215|FG001|Overall Study|Decision by sponsor|65|||
155519085|NCT02768298|561325218|FG000|Overall Study|Adverse Event|1|||
155519086|NCT02768298|561325219|FG001|Overall Study|Adverse Event|4|||
155519087|NCT02768298|561325218|FG000|Overall Study|Death|2|||
155519088|NCT02768298|561325219|FG001|Overall Study|Death|1|||
155519089|NCT02768298|561325218|FG000|Overall Study|Non-compliance with study treatment|0|||
155474753|NCT04731922|561159486|FG015|Overall Study|Adverse Event|0|||
155474754|NCT04731922|561159487|FG016|Overall Study|Adverse Event|0|||
155474755|NCT04731922|561159471|FG000|Overall Study|Lost to Follow-up|0|||
155474756|NCT04731922|561159472|FG001|Overall Study|Lost to Follow-up|0|||
155474757|NCT04731922|561159473|FG002|Overall Study|Lost to Follow-up|0|||
155474758|NCT04731922|561159474|FG003|Overall Study|Lost to Follow-up|1|||
155474759|NCT04731922|561159475|FG004|Overall Study|Lost to Follow-up|0|||
155474760|NCT04731922|561159476|FG005|Overall Study|Lost to Follow-up|1|||
155474761|NCT04731922|561159477|FG006|Overall Study|Lost to Follow-up|0|||
155474762|NCT04731922|561159478|FG007|Overall Study|Lost to Follow-up|0|||
155474763|NCT04731922|561159479|FG008|Overall Study|Lost to Follow-up|0|||
155519090|NCT02768298|561325219|FG001|Overall Study|Non-compliance with study treatment|1|||
155519091|NCT02768298|561325218|FG000|Overall Study|Subject/guardian decision|1|||
155519092|NCT02768298|561325219|FG001|Overall Study|Subject/guardian decision|0|||
155519093|NCT02768298|561325218|FG000|Overall Study|Withdrawal of informed consent|0|||
155474764|NCT04731922|561159480|FG009|Overall Study|Lost to Follow-up|0|||
155474765|NCT04731922|561159481|FG010|Overall Study|Lost to Follow-up|0|||
155474766|NCT04731922|561159482|FG011|Overall Study|Lost to Follow-up|0|||
155474767|NCT04731922|561159483|FG012|Overall Study|Lost to Follow-up|0|||
155474768|NCT04731922|561159484|FG013|Overall Study|Lost to Follow-up|0|||
155474769|NCT04731922|561159485|FG014|Overall Study|Lost to Follow-up|0|||
155474770|NCT04731922|561159486|FG015|Overall Study|Lost to Follow-up|0|||
155474771|NCT04731922|561159487|FG016|Overall Study|Lost to Follow-up|0|||
155474772|NCT04731922|561159471|FG000|Overall Study|Withdrawal by Subject|1|||
155474773|NCT04731922|561159472|FG001|Overall Study|Withdrawal by Subject|0|||
155474774|NCT04731922|561159473|FG002|Overall Study|Withdrawal by Subject|0|||
155474775|NCT04731922|561159474|FG003|Overall Study|Withdrawal by Subject|0|||
155474776|NCT04731922|561159475|FG004|Overall Study|Withdrawal by Subject|1|||
155474777|NCT04731922|561159476|FG005|Overall Study|Withdrawal by Subject|0|||
155474778|NCT04731922|561159477|FG006|Overall Study|Withdrawal by Subject|1|||
155474779|NCT04731922|561159478|FG007|Overall Study|Withdrawal by Subject|0|||
155474780|NCT04731922|561159479|FG008|Overall Study|Withdrawal by Subject|0|||
155474781|NCT04731922|561159480|FG009|Overall Study|Withdrawal by Subject|0|||
155474782|NCT04731922|561159481|FG010|Overall Study|Withdrawal by Subject|0|||
155474783|NCT04731922|561159482|FG011|Overall Study|Withdrawal by Subject|0|||
155474784|NCT04731922|561159483|FG012|Overall Study|Withdrawal by Subject|0|||
155474785|NCT04731922|561159484|FG013|Overall Study|Withdrawal by Subject|1|||
155474786|NCT04731922|561159485|FG014|Overall Study|Withdrawal by Subject|0|||
155474787|NCT04731922|561159486|FG015|Overall Study|Withdrawal by Subject|0|||
155474788|NCT04731922|561159487|FG016|Overall Study|Withdrawal by Subject|0|||
155474789|NCT04731922|561159471|FG000|Overall Study|Other|0|||
155474790|NCT04731922|561159472|FG001|Overall Study|Other|0|||
155474791|NCT04731922|561159473|FG002|Overall Study|Other|0|||
155474792|NCT04731922|561159474|FG003|Overall Study|Other|0|||
155474793|NCT04731922|561159475|FG004|Overall Study|Other|0|||
155474794|NCT04731922|561159476|FG005|Overall Study|Other|0|||
155474795|NCT04731922|561159477|FG006|Overall Study|Other|1|||
155474796|NCT04731922|561159478|FG007|Overall Study|Other|0|||
155474797|NCT04731922|561159479|FG008|Overall Study|Other|0|||
155474798|NCT04731922|561159480|FG009|Overall Study|Other|0|||
155474799|NCT04731922|561159481|FG010|Overall Study|Other|0|||
155474800|NCT04731922|561159482|FG011|Overall Study|Other|0|||
155474801|NCT04731922|561159483|FG012|Overall Study|Other|0|||
155474802|NCT04731922|561159484|FG013|Overall Study|Other|0|||
155474803|NCT04731922|561159485|FG014|Overall Study|Other|0|||
155474804|NCT04731922|561159486|FG015|Overall Study|Other|0|||
155474805|NCT04731922|561159487|FG016|Overall Study|Other|0|||
155474806|NCT00422903|561159490|FG000|Overall Study|Disease Progression|3|||
155474807|NCT00422903|561159491|FG001|Overall Study|Disease Progression|1|||
155474808|NCT00422903|561159490|FG000|Overall Study|Adverse Event|0|||
155474809|NCT00422903|561159491|FG001|Overall Study|Adverse Event|2|||
155474810|NCT00422903|561159490|FG000|Overall Study|Informed Consent Withdrawn|1|||
155474811|NCT00422903|561159491|FG001|Overall Study|Informed Consent Withdrawn|2|||
155474812|NCT03446612|561159496|FG000|Overall Study|Protocol defined stopping criteria|0|||
155474813|NCT03446612|561159497|FG001|Overall Study|Protocol defined stopping criteria|1|||
155474814|NCT01810380|561159503|FG000|Overall Study|Randomised not treated|2|||
155474815|NCT01810380|561159504|FG001|Overall Study|Randomised not treated|1|||
155474816|NCT01810380|561159505|FG002|Overall Study|Randomised not treated|1|||
155474817|NCT01810380|561159503|FG000|Overall Study|Adverse Event|11|||
155474818|NCT01810380|561159504|FG001|Overall Study|Adverse Event|14|||
155474819|NCT01810380|561159505|FG002|Overall Study|Adverse Event|4|||
155474820|NCT01810380|561159503|FG000|Overall Study|Lack of Efficacy|24|||
155474821|NCT01810380|561159504|FG001|Overall Study|Lack of Efficacy|10|||
155474822|NCT01810380|561159505|FG002|Overall Study|Lack of Efficacy|11|||
155474823|NCT01810380|561159503|FG000|Overall Study|Protocol Violation|1|||
155474824|NCT01810380|561159504|FG001|Overall Study|Protocol Violation|0|||
155474825|NCT01810380|561159505|FG002|Overall Study|Protocol Violation|1|||
155474826|NCT01810380|561159503|FG000|Overall Study|Withdrawal by Subject|6|||
155474827|NCT01810380|561159504|FG001|Overall Study|Withdrawal by Subject|0|||
155474828|NCT01810380|561159505|FG002|Overall Study|Withdrawal by Subject|6|||
155474829|NCT01810380|561159503|FG000|Overall Study|Administrative or other reasons|11|||
155474830|NCT01810380|561159504|FG001|Overall Study|Administrative or other reasons|13|||
155474831|NCT01810380|561159505|FG002|Overall Study|Administrative or other reasons|9|||
155474832|NCT02829775|561159506|FG000|Overall Study|Death|1|||
155474833|NCT02829775|561159506|FG000|Overall Study|Withdrawal by Subject|3|||
155474834|NCT02829775|561159506|FG000|Overall Study|Disease remission|1|||
155474835|NCT00033371|561159507|FG000|Overall Study|Adverse Event|1|||
155474836|NCT00033371|561159508|FG001|Overall Study|Adverse Event|5|||
155474837|NCT00033371|561159507|FG000|Overall Study|Lost to Follow-up|2|||
155474838|NCT00033371|561159508|FG001|Overall Study|Lost to Follow-up|1|||
155474839|NCT00033371|561159507|FG000|Overall Study|Withdrawal by Subject|3|||
155474840|NCT00033371|561159508|FG001|Overall Study|Withdrawal by Subject|3|||
155474841|NCT00033371|561159507|FG000|Overall Study|Disease Progression|0|||
155474842|NCT00033371|561159508|FG001|Overall Study|Disease Progression|1|||
155474843|NCT02699125|561159511|FG000|Placebo|Lost to Follow-up|2|||
155474844|NCT02699125|561159512|FG001|Placebo|Lost to Follow-up|0|||
155474845|NCT02699125|561159511|FG000|Placebo|Protocol Violation|1|||
155474846|NCT02699125|561159512|FG001|Placebo|Protocol Violation|0|||
155474847|NCT02699125|561159511|FG000|Placebo|Withdrawal by Subject|0|||
155474848|NCT02699125|561159512|FG001|Placebo|Withdrawal by Subject|4|||
155474849|NCT02699125|561159511|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
155474850|NCT02699125|561159512|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
155474851|NCT01390038|561159515|FG000|Overall Study|Death|1|||
155474852|NCT01390038|561159515|FG000|Overall Study|Lost to Follow-up|1|||
155474853|NCT01390038|561159515|FG000|Overall Study|Withdrawal by Subject|4|||
155474854|NCT01390038|561159515|FG000|Overall Study|Simpliciti System Removal|2|||
155474855|NCT03799627|561159516|FG000|Overall Study|Adverse Event|1|||
155474856|NCT03799627|561159517|FG001|Overall Study|Adverse Event|2|||
155474857|NCT03799627|561159518|FG002|Overall Study|Adverse Event|0|||
155474858|NCT03799627|561159519|FG003|Overall Study|Adverse Event|0|||
155474859|NCT03799627|561159520|FG004|Overall Study|Adverse Event|2|||
155474860|NCT03799627|561159521|FG005|Overall Study|Adverse Event|5|||
155474861|NCT03799627|561159522|FG006|Overall Study|Adverse Event|0|||
155474862|NCT03799627|561159523|FG007|Overall Study|Adverse Event|2|||
155474863|NCT03799627|561159524|FG008|Overall Study|Adverse Event|0|||
155474864|NCT03799627|561159516|FG000|Overall Study|Physician Decision|2|||
155474865|NCT03799627|561159517|FG001|Overall Study|Physician Decision|2|||
155474866|NCT03799627|561159518|FG002|Overall Study|Physician Decision|0|||
155474867|NCT03799627|561159519|FG003|Overall Study|Physician Decision|0|||
155474868|NCT03799627|561159520|FG004|Overall Study|Physician Decision|2|||
155474869|NCT03799627|561159521|FG005|Overall Study|Physician Decision|2|||
155474870|NCT03799627|561159522|FG006|Overall Study|Physician Decision|0|||
155474871|NCT03799627|561159523|FG007|Overall Study|Physician Decision|0|||
155474872|NCT03799627|561159524|FG008|Overall Study|Physician Decision|0|||
155474873|NCT03799627|561159516|FG000|Overall Study|Withdrawal by Subject|1|||
155474874|NCT03799627|561159517|FG001|Overall Study|Withdrawal by Subject|1|||
155474875|NCT03799627|561159518|FG002|Overall Study|Withdrawal by Subject|0|||
155474876|NCT03799627|561159519|FG003|Overall Study|Withdrawal by Subject|2|||
155474877|NCT03799627|561159520|FG004|Overall Study|Withdrawal by Subject|0|||
155474878|NCT03799627|561159521|FG005|Overall Study|Withdrawal by Subject|3|||
155474879|NCT03799627|561159522|FG006|Overall Study|Withdrawal by Subject|0|||
155474880|NCT03799627|561159523|FG007|Overall Study|Withdrawal by Subject|0|||
155474881|NCT03799627|561159524|FG008|Overall Study|Withdrawal by Subject|0|||
155474882|NCT03799627|561159516|FG000|Overall Study|Lack of Efficacy|0|||
155474883|NCT03799627|561159517|FG001|Overall Study|Lack of Efficacy|0|||
155474884|NCT03799627|561159518|FG002|Overall Study|Lack of Efficacy|0|||
155474885|NCT03799627|561159519|FG003|Overall Study|Lack of Efficacy|1|||
155474886|NCT03799627|561159520|FG004|Overall Study|Lack of Efficacy|0|||
155474887|NCT03799627|561159521|FG005|Overall Study|Lack of Efficacy|0|||
155474888|NCT03799627|561159522|FG006|Overall Study|Lack of Efficacy|0|||
155474889|NCT03799627|561159523|FG007|Overall Study|Lack of Efficacy|0|||
155474890|NCT03799627|561159524|FG008|Overall Study|Lack of Efficacy|0|||
155474891|NCT03799627|561159516|FG000|Overall Study|Lost to Follow-up|0|||
155474892|NCT03799627|561159517|FG001|Overall Study|Lost to Follow-up|0|||
155474893|NCT03799627|561159518|FG002|Overall Study|Lost to Follow-up|0|||
155474894|NCT03799627|561159519|FG003|Overall Study|Lost to Follow-up|0|||
155474895|NCT03799627|561159520|FG004|Overall Study|Lost to Follow-up|0|||
155474896|NCT03799627|561159521|FG005|Overall Study|Lost to Follow-up|0|||
155474897|NCT03799627|561159522|FG006|Overall Study|Lost to Follow-up|1|||
155474898|NCT03799627|561159523|FG007|Overall Study|Lost to Follow-up|0|||
155474899|NCT03799627|561159524|FG008|Overall Study|Lost to Follow-up|1|||
155519094|NCT02768298|561325219|FG001|Overall Study|Withdrawal of informed consent|1|||
155519095|NCT01611090|561325220|FG000|Randomized Period|Lost to Follow-up|8|||
155519096|NCT01611090|561325221|FG001|Randomized Period|Lost to Follow-up|3|||
155519097|NCT01611090|561325222|FG002|Randomized Period|Lost to Follow-up|0|||
155474900|NCT03799627|561159516|FG000|Overall Study|Death|0|||
155474901|NCT03799627|561159517|FG001|Overall Study|Death|0|||
155474902|NCT03799627|561159518|FG002|Overall Study|Death|0|||
155474903|NCT03799627|561159519|FG003|Overall Study|Death|1|||
155474904|NCT03799627|561159520|FG004|Overall Study|Death|0|||
155474905|NCT03799627|561159521|FG005|Overall Study|Death|0|||
155474906|NCT03799627|561159522|FG006|Overall Study|Death|0|||
155474907|NCT03799627|561159523|FG007|Overall Study|Death|0|||
155474908|NCT03799627|561159524|FG008|Overall Study|Death|0|||
155474909|NCT03799627|561159516|FG000|Overall Study|Study Drug Put on Hold|1|||
155474910|NCT03799627|561159517|FG001|Overall Study|Study Drug Put on Hold|0|||
155474911|NCT03799627|561159518|FG002|Overall Study|Study Drug Put on Hold|0|||
155474912|NCT03799627|561159519|FG003|Overall Study|Study Drug Put on Hold|0|||
155474913|NCT03799627|561159520|FG004|Overall Study|Study Drug Put on Hold|0|||
155519098|NCT01611090|561325220|FG000|Randomized Period|Withdrawal by Subject|22|||
155474914|NCT03799627|561159521|FG005|Overall Study|Study Drug Put on Hold|0|||
155474915|NCT03799627|561159522|FG006|Overall Study|Study Drug Put on Hold|0|||
155474916|NCT03799627|561159523|FG007|Overall Study|Study Drug Put on Hold|0|||
155474917|NCT03799627|561159524|FG008|Overall Study|Study Drug Put on Hold|0|||
155474918|NCT03799627|561159516|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
155474919|NCT03799627|561159517|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
155474920|NCT03799627|561159518|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
155474921|NCT03799627|561159519|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
155474922|NCT03799627|561159520|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
155474923|NCT03799627|561159521|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
155474924|NCT03799627|561159522|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
155474925|NCT03799627|561159523|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
155474926|NCT03799627|561159524|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
155474927|NCT03799627|561159516|FG000|Overall Study|Kidney Transplantation|1|||
155474928|NCT03799627|561159517|FG001|Overall Study|Kidney Transplantation|0|||
155474929|NCT03799627|561159518|FG002|Overall Study|Kidney Transplantation|0|||
155474930|NCT03799627|561159519|FG003|Overall Study|Kidney Transplantation|1|||
155474931|NCT03799627|561159520|FG004|Overall Study|Kidney Transplantation|1|||
155474932|NCT03799627|561159521|FG005|Overall Study|Kidney Transplantation|0|||
155474933|NCT03799627|561159522|FG006|Overall Study|Kidney Transplantation|0|||
155474934|NCT03799627|561159523|FG007|Overall Study|Kidney Transplantation|0|||
155474935|NCT03799627|561159524|FG008|Overall Study|Kidney Transplantation|0|||
155474936|NCT03799627|561159516|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
155474937|NCT03799627|561159517|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
155474938|NCT03799627|561159518|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
155474939|NCT03799627|561159519|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
155474940|NCT03799627|561159520|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
155474941|NCT03799627|561159521|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
155474942|NCT03799627|561159522|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
155474943|NCT03799627|561159523|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
155474944|NCT03799627|561159524|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
155474945|NCT03799627|561159516|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474946|NCT03799627|561159517|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
155474947|NCT03799627|561159518|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474948|NCT03799627|561159519|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474949|NCT03799627|561159520|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474950|NCT03799627|561159521|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474951|NCT03799627|561159522|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474952|NCT03799627|561159523|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474953|NCT03799627|561159524|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
155474954|NCT03799627|561159516|FG000|Overall Study|Met Exclusion Criteria|0|||
155474955|NCT03799627|561159517|FG001|Overall Study|Met Exclusion Criteria|0|||
155474956|NCT03799627|561159518|FG002|Overall Study|Met Exclusion Criteria|0|||
155474957|NCT03799627|561159519|FG003|Overall Study|Met Exclusion Criteria|1|||
155519099|NCT01611090|561325221|FG001|Randomized Period|Withdrawal by Subject|26|||
155519100|NCT01611090|561325222|FG002|Randomized Period|Withdrawal by Subject|0|||
155519101|NCT01611090|561325220|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
155519102|NCT01611090|561325221|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
155474958|NCT03799627|561159520|FG004|Overall Study|Met Exclusion Criteria|0|||
155474959|NCT03799627|561159521|FG005|Overall Study|Met Exclusion Criteria|0|||
155474960|NCT03799627|561159522|FG006|Overall Study|Met Exclusion Criteria|0|||
155474961|NCT03799627|561159523|FG007|Overall Study|Met Exclusion Criteria|0|||
155474962|NCT03799627|561159524|FG008|Overall Study|Met Exclusion Criteria|0|||
155474963|NCT03799627|561159516|FG000|Overall Study|Investigational Product Noncompliance|0|||
155474964|NCT03799627|561159517|FG001|Overall Study|Investigational Product Noncompliance|0|||
155474965|NCT03799627|561159518|FG002|Overall Study|Investigational Product Noncompliance|0|||
155474966|NCT03799627|561159519|FG003|Overall Study|Investigational Product Noncompliance|1|||
155474967|NCT03799627|561159520|FG004|Overall Study|Investigational Product Noncompliance|0|||
155474968|NCT03799627|561159521|FG005|Overall Study|Investigational Product Noncompliance|0|||
155474969|NCT03799627|561159522|FG006|Overall Study|Investigational Product Noncompliance|0|||
155474970|NCT03799627|561159523|FG007|Overall Study|Investigational Product Noncompliance|0|||
155474971|NCT03799627|561159524|FG008|Overall Study|Investigational Product Noncompliance|0|||
155474972|NCT03799627|561159516|FG000|Overall Study|Participant Relocation|0|||
155474973|NCT03799627|561159517|FG001|Overall Study|Participant Relocation|0|||
155474974|NCT03799627|561159518|FG002|Overall Study|Participant Relocation|0|||
155474975|NCT03799627|561159519|FG003|Overall Study|Participant Relocation|1|||
155474976|NCT03799627|561159520|FG004|Overall Study|Participant Relocation|0|||
155474977|NCT03799627|561159521|FG005|Overall Study|Participant Relocation|1|||
155474978|NCT03799627|561159522|FG006|Overall Study|Participant Relocation|0|||
155474979|NCT03799627|561159523|FG007|Overall Study|Participant Relocation|0|||
155474980|NCT03799627|561159524|FG008|Overall Study|Participant Relocation|0|||
155474981|NCT03799627|561159516|FG000|Overall Study|Eurofin Issue|0|||
155474982|NCT03799627|561159517|FG001|Overall Study|Eurofin Issue|0|||
155474983|NCT03799627|561159518|FG002|Overall Study|Eurofin Issue|0|||
155474984|NCT03799627|561159519|FG003|Overall Study|Eurofin Issue|0|||
155474985|NCT03799627|561159520|FG004|Overall Study|Eurofin Issue|1|||
155474986|NCT03799627|561159521|FG005|Overall Study|Eurofin Issue|0|||
155474987|NCT03799627|561159522|FG006|Overall Study|Eurofin Issue|0|||
155474988|NCT03799627|561159523|FG007|Overall Study|Eurofin Issue|0|||
155474989|NCT03799627|561159524|FG008|Overall Study|Eurofin Issue|0|||
155474990|NCT03799627|561159516|FG000|Overall Study|Noncompliance with Site Instructions|0|||
155474991|NCT03799627|561159517|FG001|Overall Study|Noncompliance with Site Instructions|0|||
155474992|NCT03799627|561159518|FG002|Overall Study|Noncompliance with Site Instructions|0|||
155474993|NCT03799627|561159519|FG003|Overall Study|Noncompliance with Site Instructions|0|||
155474994|NCT03799627|561159520|FG004|Overall Study|Noncompliance with Site Instructions|1|||
155474995|NCT03799627|561159521|FG005|Overall Study|Noncompliance with Site Instructions|0|||
155474996|NCT03799627|561159522|FG006|Overall Study|Noncompliance with Site Instructions|0|||
155474997|NCT03799627|561159523|FG007|Overall Study|Noncompliance with Site Instructions|0|||
155474998|NCT03799627|561159524|FG008|Overall Study|Noncompliance with Site Instructions|0|||
155474999|NCT03799627|561159516|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475000|NCT03799627|561159517|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475001|NCT03799627|561159518|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155491185|NCT00634933|561223491|FG004|Part A: Baseline to Week 24|Other|0|||
155491186|NCT00634933|561223487|FG000|Between Part A and Part B|Physician Decision|0|||
155491187|NCT00634933|561223488|FG001|Between Part A and Part B|Physician Decision|1|||
155475002|NCT03799627|561159519|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475003|NCT03799627|561159520|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
155475004|NCT03799627|561159521|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475005|NCT03799627|561159522|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475006|NCT03799627|561159523|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475007|NCT03799627|561159524|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
155475008|NCT03799627|561159516|FG000|Overall Study|Changes In Hemoglobin Values|1|||
155475009|NCT03799627|561159517|FG001|Overall Study|Changes In Hemoglobin Values|2|||
155475010|NCT03799627|561159518|FG002|Overall Study|Changes In Hemoglobin Values|1|||
155475011|NCT03799627|561159519|FG003|Overall Study|Changes In Hemoglobin Values|0|||
155475012|NCT03799627|561159520|FG004|Overall Study|Changes In Hemoglobin Values|0|||
155519103|NCT01611090|561325222|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
155519104|NCT01611090|561325220|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
155519105|NCT01611090|561325221|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
155519106|NCT01611090|561325222|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
155519107|NCT05771428|561327190|FG000|Overall Study|Adverse Event|0|||
155519108|NCT05771428|561327191|FG001|Overall Study|Adverse Event|1|||
155519109|NCT05771428|561327192|FG002|Overall Study|Adverse Event|1|||
155654167|NCT04003389|561826910|FG000|Overall Study|Lost to Follow-up|39|||
155654168|NCT04003389|561826911|FG001|Overall Study|Lost to Follow-up|30|||
155654169|NCT04003389|561826912|FG002|Overall Study|Lost to Follow-up|33|||
155654170|NCT04003389|561826910|FG000|Overall Study|Protocol Violation|1|||
155654171|NCT04003389|561826911|FG001|Overall Study|Protocol Violation|6|||
155654172|NCT04003389|561826912|FG002|Overall Study|Protocol Violation|5|||
155654173|NCT04003389|561826910|FG000|Overall Study|Withdrawal by Subject|119|||
155654174|NCT04003389|561826911|FG001|Overall Study|Withdrawal by Subject|79|||
155654175|NCT04003389|561826912|FG002|Overall Study|Withdrawal by Subject|85|||
155654176|NCT04003389|561826910|FG000|Overall Study|Miscellaneous|14|||
155654177|NCT04003389|561826911|FG001|Overall Study|Miscellaneous|11|||
155654178|NCT04003389|561826912|FG002|Overall Study|Miscellaneous|14|||
155654179|NCT04003389|561826910|FG000|Overall Study|Participant did not receive study drug|1|||
155654180|NCT04003389|561826911|FG001|Overall Study|Participant did not receive study drug|0|||
155654181|NCT04003389|561826912|FG002|Overall Study|Participant did not receive study drug|0|||
155654182|NCT04818229|561826913|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
155654183|NCT04818229|561826914|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
155654184|NCT04818229|561826915|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
155654185|NCT04818229|561826913|FG000|Overall Study|Adverse Event|3|||
155654186|NCT04818229|561826914|FG001|Overall Study|Adverse Event|1|||
155654187|NCT04818229|561826915|FG002|Overall Study|Adverse Event|1|||
155654188|NCT04818229|561826913|FG000|Overall Study|Withdrawal by Subject|0|||
155654189|NCT04818229|561826914|FG001|Overall Study|Withdrawal by Subject|0|||
155654190|NCT04818229|561826915|FG002|Overall Study|Withdrawal by Subject|2|||
155654191|NCT04818229|561826913|FG000|Overall Study|Lost to Follow-up|0|||
155654192|NCT04818229|561826914|FG001|Overall Study|Lost to Follow-up|0|||
155654193|NCT04818229|561826915|FG002|Overall Study|Lost to Follow-up|1|||
155654194|NCT03186378|561826916|FG000|Overall Study|Lost to Follow-up|1|||
155654195|NCT03186378|561826917|FG001|Overall Study|Lost to Follow-up|0|||
155654196|NCT03769116|561826918|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
155654197|NCT03769116|561826919|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
155654198|NCT03769116|561826918|FG000|Part 3 - Open Label|Physician Decision|1|||
155654199|NCT03769116|561826919|FG001|Part 3 - Open Label|Physician Decision|0|||
155654200|NCT03769116|561826918|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
155654201|NCT03769116|561826919|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
155654202|NCT03382873|561826920|FG000|Overall Study|Lost to Follow-up|9|||
155654203|NCT03382873|561826921|FG001|Overall Study|Lost to Follow-up|10|||
155654204|NCT03382873|561826920|FG000|Overall Study|Withdrawal by Subject|6|||
155519110|NCT05771428|561327193|FG003|Overall Study|Adverse Event|1|||
155519111|NCT05771428|561327190|FG000|Overall Study|Withdrawal by Subject|3|||
155519112|NCT05771428|561327191|FG001|Overall Study|Withdrawal by Subject|2|||
155519113|NCT05771428|561327192|FG002|Overall Study|Withdrawal by Subject|1|||
155519114|NCT05771428|561327193|FG003|Overall Study|Withdrawal by Subject|4|||
155654205|NCT03382873|561826921|FG001|Overall Study|Withdrawal by Subject|11|||
155654206|NCT03382873|561826920|FG000|Overall Study|Visit not completed due to pandemic|16|||
155654207|NCT03382873|561826921|FG001|Overall Study|Visit not completed due to pandemic|41|||
155654208|NCT05021224|561826923|FG000|Overall Study|Did not complete all survey items|4|||
155654209|NCT05021224|561826924|FG001|Overall Study|Did not complete all survey items|1|||
155519115|NCT05771428|561327190|FG000|Overall Study|Other|0|||
155519116|NCT05771428|561327191|FG001|Overall Study|Other|1|||
155519117|NCT05771428|561327192|FG002|Overall Study|Other|2|||
155519118|NCT05771428|561327193|FG003|Overall Study|Other|1|||
155654210|NCT05021224|561826925|FG002|Overall Study|Did not complete all survey items|0|||
155654211|NCT05021224|561826926|FG003|Overall Study|Did not complete all survey items|2|||
155475013|NCT03799627|561159521|FG005|Overall Study|Changes In Hemoglobin Values|2|||
155475014|NCT03799627|561159522|FG006|Overall Study|Changes In Hemoglobin Values|1|||
155475015|NCT03799627|561159523|FG007|Overall Study|Changes In Hemoglobin Values|0|||
155475016|NCT03799627|561159524|FG008|Overall Study|Changes In Hemoglobin Values|1|||
155475017|NCT03148795|561159537|FG000|Overall Study|Progressive Disease|1|||
155475018|NCT00441012|561159538|FG000|Overall Study|Adverse Event|0|||
155475019|NCT00441012|561159539|FG001|Overall Study|Adverse Event|1|||
155475020|NCT00441012|561159538|FG000|Overall Study|Lost to Follow-up|3|||
155475021|NCT00441012|561159539|FG001|Overall Study|Lost to Follow-up|3|||
155475022|NCT00441012|561159538|FG000|Overall Study|Protocol Violation|10|||
155475023|NCT00441012|561159539|FG001|Overall Study|Protocol Violation|9|||
155475024|NCT00441012|561159538|FG000|Overall Study|Withdrawal by Subject|4|||
155475025|NCT00441012|561159539|FG001|Overall Study|Withdrawal by Subject|0|||
155475026|NCT00441012|561159538|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
155475027|NCT00441012|561159539|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
155475028|NCT04489940|561159540|FG000|Overall Study|Other|2|||
155475029|NCT04489940|561159540|FG000|Overall Study|Withdrawal by Subject|2|||
155475030|NCT04489940|561159540|FG000|Overall Study|Death|5|||
155475031|NCT04489940|561159540|FG000|Overall Study|Lost to Follow-up|1|||
155475032|NCT04498468|561159541|FG000|Overall Study|Lost to Follow-up|3|||
155475033|NCT02725268|561159542|FG000|Overall Study|Death|58|||
155475034|NCT02725268|561159543|FG001|Overall Study|Death|59|||
155475035|NCT02725268|561159544|FG002|Overall Study|Death|30|||
155475036|NCT02725268|561159545|FG003|Overall Study|Death|16|||
155475037|NCT02725268|561159542|FG000|Overall Study|Lost to Follow-up|4|||
155475038|NCT02725268|561159543|FG001|Overall Study|Lost to Follow-up|3|||
155475039|NCT02725268|561159544|FG002|Overall Study|Lost to Follow-up|0|||
155475040|NCT02725268|561159545|FG003|Overall Study|Lost to Follow-up|1|||
155475041|NCT02725268|561159542|FG000|Overall Study|Site Terminated by Sponsor|0|||
155475042|NCT02725268|561159543|FG001|Overall Study|Site Terminated by Sponsor|1|||
155475043|NCT02725268|561159544|FG002|Overall Study|Site Terminated by Sponsor|0|||
155475044|NCT02725268|561159545|FG003|Overall Study|Site Terminated by Sponsor|0|||
155475045|NCT02725268|561159542|FG000|Overall Study|Withdrawal by Subject|8|||
155475046|NCT02725268|561159543|FG001|Overall Study|Withdrawal by Subject|6|||
155654212|NCT03996395|561826927|FG000|Overall Study|Lost to Follow-up|4|||
155475047|NCT02725268|561159544|FG002|Overall Study|Withdrawal by Subject|8|||
155475048|NCT02725268|561159545|FG003|Overall Study|Withdrawal by Subject|1|||
155475049|NCT02725268|561159542|FG000|Overall Study|Reason not Specified|2|||
155475050|NCT02725268|561159543|FG001|Overall Study|Reason not Specified|1|||
155475051|NCT02725268|561159544|FG002|Overall Study|Reason not Specified|0|||
155475052|NCT02725268|561159545|FG003|Overall Study|Reason not Specified|0|||
155475053|NCT00262314|561159551|FG000|Overall Study|Changing physicians|38|||
155475054|NCT00262314|561159551|FG000|Overall Study|Death|12|||
155475055|NCT00262314|561159551|FG000|Overall Study|Patient's decision|92|||
155519119|NCT05771428|561327190|FG000|Overall Study|Randomized but Not Treated|0|||
155519120|NCT05771428|561327191|FG001|Overall Study|Randomized but Not Treated|0|||
155519121|NCT05771428|561327192|FG002|Overall Study|Randomized but Not Treated|1|||
155519122|NCT05771428|561327193|FG003|Overall Study|Randomized but Not Treated|0|||
155519123|NCT04025229|561327194|FG000|Overall Study|Adverse Event|1|||
155519124|NCT04025229|561327195|FG001|Overall Study|Adverse Event|0|||
155519125|NCT04025229|561327194|FG000|Overall Study|Withdrawal by Subject|0|||
155519126|NCT04025229|561327195|FG001|Overall Study|Withdrawal by Subject|2|||
155519127|NCT04025229|561327194|FG000|Overall Study|Death|0|||
155519128|NCT04025229|561327195|FG001|Overall Study|Death|1|||
155519129|NCT04025229|561327194|FG000|Overall Study|Physician Decision|0|||
155519130|NCT04025229|561327195|FG001|Overall Study|Physician Decision|1|||
155519131|NCT00788125|561327196|FG000|Overall Study|Death|6|||
155519132|NCT02180711|561327203|FG000|Overall Study|Death|0|||
155519133|NCT02180711|561327204|FG001|Overall Study|Death|1|||
155519134|NCT02180711|561327205|FG002|Overall Study|Death|0|||
155519135|NCT02180711|561327206|FG003|Overall Study|Death|0|||
155519136|NCT02180711|561327207|FG004|Overall Study|Death|7|||
155519137|NCT02180711|561327208|FG005|Overall Study|Death|0|||
155519138|NCT02180711|561327209|FG006|Overall Study|Death|1|||
155519139|NCT02180711|561327210|FG007|Overall Study|Death|3|||
155519140|NCT02180711|561327203|FG000|Overall Study|Lost to Follow-up|0|||
155519141|NCT02180711|561327204|FG001|Overall Study|Lost to Follow-up|1|||
155519142|NCT02180711|561327205|FG002|Overall Study|Lost to Follow-up|0|||
155519143|NCT02180711|561327206|FG003|Overall Study|Lost to Follow-up|0|||
155519144|NCT02180711|561327207|FG004|Overall Study|Lost to Follow-up|1|||
155519145|NCT02180711|561327208|FG005|Overall Study|Lost to Follow-up|1|||
155519146|NCT02180711|561327209|FG006|Overall Study|Lost to Follow-up|0|||
155519147|NCT02180711|561327210|FG007|Overall Study|Lost to Follow-up|3|||
155519148|NCT02180711|561327203|FG000|Overall Study|Withdrawal by Subject|2|||
155519149|NCT02180711|561327204|FG001|Overall Study|Withdrawal by Subject|1|||
155519150|NCT02180711|561327205|FG002|Overall Study|Withdrawal by Subject|0|||
155519151|NCT02180711|561327206|FG003|Overall Study|Withdrawal by Subject|4|||
155519152|NCT02180711|561327207|FG004|Overall Study|Withdrawal by Subject|3|||
155519153|NCT02180711|561327208|FG005|Overall Study|Withdrawal by Subject|0|||
155654213|NCT03996395|561826927|FG000|Overall Study|Withdrawal by Subject|1|||
155654214|NCT03996395|561826927|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
155654215|NCT05375929|561826934|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
155654216|NCT05375929|561826935|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155654217|NCT05375929|561826936|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155654218|NCT05375929|561826937|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155475056|NCT00262314|561159551|FG000|Overall Study|Other|95|||
155475057|NCT00262314|561159551|FG000|Overall Study|Lost to Follow-up|70|||
155475058|NCT00262314|561159551|FG000|Overall Study|Administrative withdrawal|30|||
155475059|NCT04973085|561159556|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
155475060|NCT04973085|561159557|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
155475061|NCT00654368|561159560|FG000|Overall Study|Ineligibility determined|6|||
155475062|NCT00654368|561159561|FG001|Overall Study|Ineligibility determined|0|||
155475063|NCT00654368|561159562|FG002|Overall Study|Ineligibility determined|0|||
155475064|NCT00654368|561159560|FG000|Overall Study|Protocol deviation|3|||
155475065|NCT00654368|561159561|FG001|Overall Study|Protocol deviation|2|||
155475066|NCT00654368|561159562|FG002|Overall Study|Protocol deviation|1|||
155475067|NCT00654368|561159560|FG000|Overall Study|Non-compliance|2|||
155475068|NCT00654368|561159561|FG001|Overall Study|Non-compliance|1|||
155475069|NCT00654368|561159562|FG002|Overall Study|Non-compliance|2|||
155475070|NCT00654368|561159560|FG000|Overall Study|Withdrawal by Subject|5|||
155475071|NCT00654368|561159561|FG001|Overall Study|Withdrawal by Subject|2|||
155475072|NCT00654368|561159562|FG002|Overall Study|Withdrawal by Subject|2|||
155475073|NCT00654368|561159560|FG000|Overall Study|Disease progression|21|||
155475074|NCT00654368|561159561|FG001|Overall Study|Disease progression|31|||
155475075|NCT00654368|561159562|FG002|Overall Study|Disease progression|13|||
155475076|NCT00654368|561159560|FG000|Overall Study|Requirement for alternative therapy|1|||
155475077|NCT00654368|561159561|FG001|Overall Study|Requirement for alternative therapy|1|||
155475078|NCT00654368|561159562|FG002|Overall Study|Requirement for alternative therapy|1|||
155475079|NCT00654368|561159560|FG000|Overall Study|Physician Decision|0|||
155475080|NCT00654368|561159561|FG001|Overall Study|Physician Decision|0|||
155475081|NCT00654368|561159562|FG002|Overall Study|Physician Decision|2|||
155475082|NCT00654368|561159560|FG000|Overall Study|Death|1|||
155475083|NCT00654368|561159561|FG001|Overall Study|Death|0|||
155475084|NCT00654368|561159562|FG002|Overall Study|Death|0|||
155475085|NCT00654368|561159560|FG000|Overall Study|Pregnancy|0|||
155475086|NCT00654368|561159561|FG001|Overall Study|Pregnancy|0|||
155475087|NCT00654368|561159562|FG002|Overall Study|Pregnancy|2|||
155475088|NCT00654368|561159560|FG000|Overall Study|Other|0|||
155475089|NCT00654368|561159561|FG001|Overall Study|Other|2|||
155475090|NCT00654368|561159562|FG002|Overall Study|Other|3|||
155475091|NCT00654368|561159560|FG000|Overall Study|Adverse Event|14|||
155475092|NCT00654368|561159561|FG001|Overall Study|Adverse Event|9|||
155475093|NCT00654368|561159562|FG002|Overall Study|Adverse Event|6|||
155475094|NCT03418376|561159567|FG000|Overall Study|Musculoskeletal injury|1|||
155475095|NCT03418376|561159568|FG001|Overall Study|Musculoskeletal injury|2|||
155475096|NCT03418376|561159569|FG002|Overall Study|Musculoskeletal injury|1|||
155475097|NCT03418376|561159570|FG003|Overall Study|Musculoskeletal injury|0|||
155475098|NCT03418376|561159567|FG000|Overall Study|Personal reasons|0|||
155475099|NCT03418376|561159568|FG001|Overall Study|Personal reasons|2|||
155475100|NCT03418376|561159569|FG002|Overall Study|Personal reasons|2|||
155475101|NCT03418376|561159570|FG003|Overall Study|Personal reasons|1|||
155475102|NCT03418376|561159567|FG000|Overall Study|Exacerbation|0|||
155475103|NCT03418376|561159568|FG001|Overall Study|Exacerbation|1|||
155475104|NCT03418376|561159569|FG002|Overall Study|Exacerbation|0|||
155475105|NCT03418376|561159570|FG003|Overall Study|Exacerbation|0|||
155475106|NCT00814307|561159571|FG000|Overall Study|Randomized but not treated|1|||
155475107|NCT00814307|561159572|FG001|Overall Study|Randomized but not treated|0|||
155475108|NCT00814307|561159573|FG002|Overall Study|Randomized but not treated|0|||
155475109|NCT00814307|561159574|FG003|Overall Study|Randomized but not treated|0|||
155475110|NCT00814307|561159571|FG000|Overall Study|Adverse Event|3|||
155654219|NCT05375929|561826934|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155654220|NCT05375929|561826935|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155475111|NCT00814307|561159572|FG001|Overall Study|Adverse Event|9|||
155475112|NCT00814307|561159573|FG002|Overall Study|Adverse Event|3|||
155475113|NCT00814307|561159574|FG003|Overall Study|Adverse Event|2|||
155475114|NCT00814307|561159571|FG000|Overall Study|Lack of Efficacy|1|||
155475115|NCT00814307|561159572|FG001|Overall Study|Lack of Efficacy|1|||
155475116|NCT00814307|561159573|FG002|Overall Study|Lack of Efficacy|3|||
155475117|NCT00814307|561159574|FG003|Overall Study|Lack of Efficacy|4|||
155475118|NCT00814307|561159571|FG000|Overall Study|Other|1|||
155475119|NCT00814307|561159572|FG001|Overall Study|Other|2|||
155654221|NCT05375929|561826936|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155475120|NCT00814307|561159573|FG002|Overall Study|Other|0|||
155475121|NCT00814307|561159574|FG003|Overall Study|Other|1|||
155475122|NCT00814307|561159571|FG000|Overall Study|Protocol Violation|2|||
155475123|NCT00814307|561159572|FG001|Overall Study|Protocol Violation|8|||
155475124|NCT00814307|561159573|FG002|Overall Study|Protocol Violation|1|||
155475125|NCT00814307|561159574|FG003|Overall Study|Protocol Violation|1|||
155475126|NCT00814307|561159571|FG000|Overall Study|Withdrawal by Subject|4|||
155475127|NCT00814307|561159572|FG001|Overall Study|Withdrawal by Subject|6|||
155475128|NCT00814307|561159573|FG002|Overall Study|Withdrawal by Subject|0|||
155475129|NCT00814307|561159574|FG003|Overall Study|Withdrawal by Subject|2|||
155475130|NCT00814307|561159571|FG000|Overall Study|Death|0|||
155475131|NCT00814307|561159572|FG001|Overall Study|Death|1|||
155475132|NCT00814307|561159573|FG002|Overall Study|Death|0|||
155475133|NCT00814307|561159574|FG003|Overall Study|Death|0|||
155475134|NCT00149890|561159578|FG000|Overall Study|Adverse Event|1|||
155475135|NCT00149890|561159579|FG001|Overall Study|Adverse Event|8|||
155475136|NCT00149890|561159578|FG000|Overall Study|Lack of Efficacy|8|||
155475137|NCT00149890|561159579|FG001|Overall Study|Lack of Efficacy|9|||
155475138|NCT00149890|561159578|FG000|Overall Study|Protocol Violation|1|||
155475139|NCT00149890|561159579|FG001|Overall Study|Protocol Violation|0|||
155475140|NCT00149890|561159578|FG000|Overall Study|Lost to Follow-up|1|||
155519154|NCT02180711|561327209|FG006|Overall Study|Withdrawal by Subject|3|||
155519155|NCT02180711|561327210|FG007|Overall Study|Withdrawal by Subject|2|||
155519156|NCT02180711|561327203|FG000|Overall Study|- Disease Progression|0|||
155519157|NCT02180711|561327204|FG001|Overall Study|- Disease Progression|1|||
155475141|NCT00149890|561159579|FG001|Overall Study|Lost to Follow-up|0|||
155475142|NCT00149890|561159578|FG000|Overall Study|Graft Loss|2|||
155475143|NCT00149890|561159579|FG001|Overall Study|Graft Loss|1|||
155475144|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
155519158|NCT02180711|561327205|FG002|Overall Study|- Disease Progression|0|||
155519159|NCT02180711|561327206|FG003|Overall Study|- Disease Progression|0|||
155519160|NCT02180711|561327207|FG004|Overall Study|- Disease Progression|0|||
155519161|NCT02180711|561327208|FG005|Overall Study|- Disease Progression|0|||
155519162|NCT02180711|561327209|FG006|Overall Study|- Disease Progression|0|||
155519163|NCT02180711|561327210|FG007|Overall Study|- Disease Progression|0|||
155519164|NCT02180711|561327203|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
155519165|NCT02180711|561327204|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
155519166|NCT02180711|561327205|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
155519167|NCT02180711|561327206|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
155519168|NCT02180711|561327207|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
155519169|NCT02180711|561327208|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
155519170|NCT02180711|561327209|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
155519171|NCT02180711|561327210|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
155519172|NCT02180711|561327203|FG000|Overall Study|- Study Terminated by Sponsor|2|||
155519173|NCT02180711|561327204|FG001|Overall Study|- Study Terminated by Sponsor|3|||
155519174|NCT02180711|561327205|FG002|Overall Study|- Study Terminated by Sponsor|0|||
155519175|NCT02180711|561327206|FG003|Overall Study|- Study Terminated by Sponsor|5|||
155519176|NCT02180711|561327207|FG004|Overall Study|- Study Terminated by Sponsor|32|||
155519177|NCT02180711|561327208|FG005|Overall Study|- Study Terminated by Sponsor|0|||
155519178|NCT02180711|561327209|FG006|Overall Study|- Study Terminated by Sponsor|4|||
155519179|NCT02180711|561327210|FG007|Overall Study|- Study Terminated by Sponsor|13|||
155519180|NCT02180711|561327203|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
155519181|NCT02180711|561327204|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
155519182|NCT02180711|561327205|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
155519183|NCT02180711|561327206|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
155519184|NCT02180711|561327207|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
155519185|NCT02180711|561327208|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
155519186|NCT02180711|561327209|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
155519187|NCT02180711|561327210|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
155519188|NCT02180711|561327203|FG000|Overall Study|- Other|1|||
155475145|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
155475146|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
155475147|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
155475148|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
155519189|NCT02180711|561327204|FG001|Overall Study|- Other|0|||
155475149|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
155475150|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
155475151|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
155475152|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
155475153|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
155475154|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
155475155|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
155475156|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
155475157|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
155475158|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
155475159|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
155475160|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
155475161|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
155475162|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
155475163|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
155475164|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
155475165|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
155475166|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
155475167|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
155475168|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
155475169|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
155475170|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
155475171|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
155475172|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
155475173|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
155475174|NCT04757376|561159582|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
155475175|NCT04757376|561159583|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
155475176|NCT04757376|561159584|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
155475177|NCT04757376|561159585|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
155475178|NCT04757376|561159586|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
155475179|NCT04757376|561159582|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
155475180|NCT04757376|561159583|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
155475181|NCT04757376|561159584|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
155475182|NCT04757376|561159585|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
155475183|NCT04757376|561159586|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
155475184|NCT01307046|561159587|FG000|Overall Study|Adverse Event|3|||
155475185|NCT01307046|561159588|FG001|Overall Study|Adverse Event|3|||
155475186|NCT01307046|561159587|FG000|Overall Study|Lack of Efficacy|0|||
155475187|NCT01307046|561159588|FG001|Overall Study|Lack of Efficacy|2|||
155475188|NCT01307046|561159587|FG000|Overall Study|Physician Decision|2|||
155475189|NCT01307046|561159588|FG001|Overall Study|Physician Decision|0|||
155475190|NCT01307046|561159587|FG000|Overall Study|Withdrawal by Subject|1|||
155475191|NCT01307046|561159588|FG001|Overall Study|Withdrawal by Subject|1|||
155475192|NCT01307046|561159587|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
155475193|NCT01307046|561159588|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
155475194|NCT01307046|561159587|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
155475195|NCT01307046|561159588|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
155475196|NCT03898323|561159589|FG000|Overall Study|Physician Decision|1|||
155475197|NCT03277794|561159597|FG000|Overall Study|Lost to Follow-up|2|||
155475198|NCT03277794|561159598|FG001|Overall Study|Lost to Follow-up|4|||
155475199|NCT03277794|561159597|FG000|Overall Study|Withdrew due to high acuity|1|||
155475200|NCT03277794|561159598|FG001|Overall Study|Withdrew due to high acuity|0|||
155475201|NCT05166603|561159604|FG000|Overall Study|Withdrawal by Subject|68|||
155475202|NCT05166603|561159605|FG001|Overall Study|Withdrawal by Subject|0|||
155475203|NCT01673373|561161529|FG000|Overall Study|Death|2|||
155475204|NCT02710422|561161530|FG000|Overall Study|Termination of study|9|||
155475205|NCT02710422|561161531|FG001|Overall Study|Termination of study|9|||
155475206|NCT01370499|561161532|FG000|Overall Study|Adverse Event|38|||
155475207|NCT01370499|561161533|FG001|Overall Study|Adverse Event|12|||
155475208|NCT01370499|561161532|FG000|Overall Study|Lack of Efficacy|4|||
155475209|NCT01370499|561161533|FG001|Overall Study|Lack of Efficacy|2|||
155475210|NCT01370499|561161532|FG000|Overall Study|Lost to Follow-up|2|||
155475211|NCT01370499|561161533|FG001|Overall Study|Lost to Follow-up|1|||
155519190|NCT02180711|561327205|FG002|Overall Study|- Other|0|||
155475212|NCT01370499|561161532|FG000|Overall Study|Physician Decision|3|||
155475213|NCT01370499|561161533|FG001|Overall Study|Physician Decision|3|||
155475214|NCT01370499|561161532|FG000|Overall Study|Protocol Violation|5|||
155475215|NCT01370499|561161533|FG001|Overall Study|Protocol Violation|4|||
155475216|NCT01370499|561161532|FG000|Overall Study|Withdrawal by Subject|18|||
155475217|NCT01370499|561161533|FG001|Overall Study|Withdrawal by Subject|7|||
155475218|NCT01370499|561161532|FG000|Overall Study|Sponsor Decision|41|||
155475219|NCT01370499|561161533|FG001|Overall Study|Sponsor Decision|15|||
155475220|NCT00887822|561161534|FG000|Overall Study|Insufficient therapeutic response|53|||
155475221|NCT00887822|561161535|FG001|Overall Study|Insufficient therapeutic response|55|||
155475222|NCT00887822|561161534|FG000|Overall Study|Adverse Event|14|||
155475223|NCT00887822|561161535|FG001|Overall Study|Adverse Event|17|||
155475224|NCT00887822|561161534|FG000|Overall Study|Failure to return|11|||
155475225|NCT00887822|561161535|FG001|Overall Study|Failure to return|11|||
155475226|NCT00887822|561161534|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
155475227|NCT00887822|561161535|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
155475228|NCT00887822|561161534|FG000|Overall Study|Administrative/Other than specified|5|||
155475229|NCT00887822|561161535|FG001|Overall Study|Administrative/Other than specified|4|||
155475230|NCT00887822|561161534|FG000|Overall Study|Death|2|||
155475231|NCT00887822|561161535|FG001|Overall Study|Death|3|||
155475232|NCT00887822|561161534|FG000|Overall Study|Protocol Violation|0|||
155475233|NCT00887822|561161535|FG001|Overall Study|Protocol Violation|1|||
155475234|NCT00887822|561161534|FG000|Overall Study|Randomized but not treated|0|||
155475235|NCT00887822|561161535|FG001|Overall Study|Randomized but not treated|1|||
155475236|NCT02045979|561161539|FG000|Overall Study|Informed Consent Withdrawn|2|||
155475237|NCT02045979|561161540|FG001|Overall Study|Informed Consent Withdrawn|0|||
155475238|NCT02045979|561161541|FG002|Overall Study|Informed Consent Withdrawn|1|||
155475239|NCT02045979|561161539|FG000|Overall Study|not specified above|0|||
155475240|NCT02045979|561161540|FG001|Overall Study|not specified above|1|||
155475241|NCT02045979|561161541|FG002|Overall Study|not specified above|0|||
155475242|NCT00378534|561161551|FG000|Overall Study|Participants did not receive transplant|3|||
155475243|NCT00378534|561161552|FG001|Overall Study|Participants did not receive transplant|0|||
155475244|NCT04969900|561161553|FG000|Overall Study|Physician Decision|1|||
155475245|NCT04969900|561161554|FG001|Overall Study|Physician Decision|1|||
155475246|NCT04969900|561161553|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
155475247|NCT04969900|561161554|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
155475248|NCT03261037|561161558|FG000|Overall Study|Withdrawal by Subject|2|||
155475249|NCT03261037|561161559|FG001|Overall Study|Withdrawal by Subject|13|||
155475250|NCT03261037|561161560|FG002|Overall Study|Withdrawal by Subject|0|||
155475251|NCT03261037|561161561|FG003|Overall Study|Withdrawal by Subject|18|||
155475252|NCT03261037|561161558|FG000|Overall Study|Non-compliance with study procedures|0|||
155475253|NCT03261037|561161559|FG001|Overall Study|Non-compliance with study procedures|2|||
155475254|NCT03261037|561161560|FG002|Overall Study|Non-compliance with study procedures|0|||
155475255|NCT03261037|561161561|FG003|Overall Study|Non-compliance with study procedures|6|||
155475256|NCT03261037|561161558|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
155654222|NCT05375929|561826937|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155475257|NCT03261037|561161559|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
155475258|NCT03261037|561161560|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
155475259|NCT03261037|561161561|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
155491188|NCT00634933|561223489|FG002|Between Part A and Part B|Physician Decision|0|||
155491189|NCT00634933|561223490|FG003|Between Part A and Part B|Physician Decision|0|||
155491190|NCT00634933|561223491|FG004|Between Part A and Part B|Physician Decision|0|||
155491191|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
155491192|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
155491193|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
155491194|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
155491195|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
155491196|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
155491197|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
155491198|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
155491199|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
155491200|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
155491201|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
155491202|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
155491203|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
155491204|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
155491205|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
155491206|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
155491207|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
155491208|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
155475260|NCT03261037|561161558|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
155475261|NCT03261037|561161559|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
155475262|NCT03261037|561161560|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
155475263|NCT03261037|561161561|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
155475264|NCT03261037|561161558|FG000|Overall Study|Diagnosed but protocol deviation|1|||
155475265|NCT03261037|561161559|FG001|Overall Study|Diagnosed but protocol deviation|0|||
155475266|NCT03261037|561161560|FG002|Overall Study|Diagnosed but protocol deviation|0|||
155475267|NCT03261037|561161561|FG003|Overall Study|Diagnosed but protocol deviation|0|||
155475268|NCT03261037|561161558|FG000|Overall Study|Participant did not want to continue the study|0|||
155475269|NCT03261037|561161559|FG001|Overall Study|Participant did not want to continue the study|1|||
155475270|NCT03261037|561161560|FG002|Overall Study|Participant did not want to continue the study|0|||
155475271|NCT03261037|561161561|FG003|Overall Study|Participant did not want to continue the study|0|||
155475272|NCT03261037|561161558|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
155475273|NCT03261037|561161559|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
155475274|NCT03261037|561161560|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
155475275|NCT03261037|561161561|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
155475276|NCT03261037|561161558|FG000|Overall Study|Participant presented clinical improvement|0|||
155475277|NCT03261037|561161559|FG001|Overall Study|Participant presented clinical improvement|2|||
155475278|NCT03261037|561161560|FG002|Overall Study|Participant presented clinical improvement|0|||
155475279|NCT03261037|561161561|FG003|Overall Study|Participant presented clinical improvement|0|||
155475280|NCT03261037|561161558|FG000|Overall Study|Technical difficulties|0|||
155475281|NCT03261037|561161559|FG001|Overall Study|Technical difficulties|0|||
155475282|NCT03261037|561161560|FG002|Overall Study|Technical difficulties|0|||
155475283|NCT03261037|561161561|FG003|Overall Study|Technical difficulties|1|||
155475284|NCT03261037|561161558|FG000|Overall Study|Equipment failed to work|0|||
155475285|NCT03261037|561161559|FG001|Overall Study|Equipment failed to work|0|||
155519191|NCT02180711|561327206|FG003|Overall Study|- Other|1|||
155519192|NCT02180711|561327207|FG004|Overall Study|- Other|0|||
155519193|NCT02180711|561327208|FG005|Overall Study|- Other|0|||
155475286|NCT03261037|561161560|FG002|Overall Study|Equipment failed to work|0|||
155475287|NCT03261037|561161561|FG003|Overall Study|Equipment failed to work|1|||
155475288|NCT03261037|561161558|FG000|Overall Study|End of study for participant and no follow up|0|||
155475289|NCT03261037|561161559|FG001|Overall Study|End of study for participant and no follow up|0|||
155475290|NCT03261037|561161560|FG002|Overall Study|End of study for participant and no follow up|0|||
155475291|NCT03261037|561161561|FG003|Overall Study|End of study for participant and no follow up|1|||
155475292|NCT03261037|561161558|FG000|Overall Study|Participant was too weak to continue in study|1|||
155475293|NCT03261037|561161559|FG001|Overall Study|Participant was too weak to continue in study|0|||
155475294|NCT03261037|561161560|FG002|Overall Study|Participant was too weak to continue in study|0|||
155475295|NCT03261037|561161561|FG003|Overall Study|Participant was too weak to continue in study|0|||
155475296|NCT00425945|561161562|FG000|Overall Study|Concern about Supplement|2|||
155475297|NCT00425945|561161563|FG001|Overall Study|Concern about Supplement|0|||
155475298|NCT00425945|561161562|FG000|Overall Study|Inconvenience|0|||
155475299|NCT00425945|561161563|FG001|Overall Study|Inconvenience|2|||
155475300|NCT00425945|561161562|FG000|Overall Study|Lost to Follow-up|0|||
155475301|NCT00425945|561161563|FG001|Overall Study|Lost to Follow-up|2|||
155475302|NCT00425945|561161562|FG000|Overall Study|Began hypertension medication|1|||
155475303|NCT00425945|561161563|FG001|Overall Study|Began hypertension medication|0|||
155475304|NCT00425945|561161562|FG000|Overall Study|Began cancer treatments|1|||
155475305|NCT00425945|561161563|FG001|Overall Study|Began cancer treatments|0|||
155475306|NCT00425945|561161562|FG000|Overall Study|Moved from area|0|||
155475307|NCT00425945|561161563|FG001|Overall Study|Moved from area|1|||
155475308|NCT03878160|561161567|FG000|Overall Study|Lost to Follow-up|1|||
155475309|NCT03878160|561161568|FG001|Overall Study|Lost to Follow-up|1|||
155519194|NCT02180711|561327209|FG006|Overall Study|- Other|0|||
155519195|NCT02180711|561327210|FG007|Overall Study|- Other|0|||
155519196|NCT00444145|561327214|FG000|Overall Study|Withdrawal by Subject|2|||
155519197|NCT00444145|561327214|FG000|Overall Study|Lost to Follow-up|1|||
155519198|NCT00444145|561327214|FG000|Overall Study|non-compliant|11|||
155519199|NCT00444145|561327214|FG000|Overall Study|Screen Failures|5|||
155519200|NCT01619800|561327215|FG000|Overall Study|study terminated|2|||
155519201|NCT01619800|561327216|FG001|Overall Study|study terminated|0|||
155519202|NCT00414466|561327218|FG000|Overall Study|Adverse Event|0|||
155519203|NCT00414466|561327219|FG001|Overall Study|Adverse Event|0|||
155654223|NCT05375929|561826934|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
155654224|NCT05375929|561826935|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
155519204|NCT00414466|561327220|FG002|Overall Study|Adverse Event|1|||
155519205|NCT00414466|561327221|FG003|Overall Study|Adverse Event|1|||
155654225|NCT05375929|561826936|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
155654226|NCT05375929|561826937|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
155654227|NCT05375929|561826934|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155654228|NCT05375929|561826935|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
155654229|NCT05375929|561826936|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155654230|NCT05375929|561826937|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155654231|NCT05375929|561826934|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
155654232|NCT05375929|561826935|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155654233|NCT05375929|561826936|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155475310|NCT03878160|561161569|FG002|Overall Study|Lost to Follow-up|1|||
155475311|NCT03878160|561161567|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
155475312|NCT03878160|561161568|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
155475313|NCT03878160|561161569|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
155475314|NCT02881151|561161572|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
155475315|NCT00589602|561161577|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
155475316|NCT05618808|561161578|FG000|Overall Study|Withdrawal by Subject|3|||
155475317|NCT05618808|561161579|FG001|Overall Study|Withdrawal by Subject|1|||
155475318|NCT05618808|561161580|FG002|Overall Study|Withdrawal by Subject|3|||
155475319|NCT03887052|561161581|FG000|Overall Study|Adverse Event|2|||
155475320|NCT03887052|561161581|FG000|Overall Study|Physician Decision|2|||
155475321|NCT03887052|561161581|FG000|Overall Study|Withdrawal by Subject|3|||
155475322|NCT03887052|561161581|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
155475323|NCT03887052|561161581|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
155475324|NCT02365506|561161582|FG000|Overall Study|Investigator's Discretion|0|||
155475325|NCT02365506|561161583|FG001|Overall Study|Investigator's Discretion|0|||
155475326|NCT02365506|561161584|FG002|Overall Study|Investigator's Discretion|1|||
155475327|NCT02155712|561161589|FG000|Overall Study|Death|12|||
155475328|NCT02155712|561161590|FG001|Overall Study|Death|0|||
155475329|NCT02155712|561161589|FG000|Overall Study|Lost to Follow-up|37|||
155475330|NCT02155712|561161590|FG001|Overall Study|Lost to Follow-up|22|||
155475331|NCT02155712|561161589|FG000|Overall Study|Revision of device|4|||
155475332|NCT02155712|561161590|FG001|Overall Study|Revision of device|3|||
155475333|NCT02155712|561161589|FG000|Overall Study|Withdrawal by Subject|39|||
155475334|NCT02155712|561161590|FG001|Overall Study|Withdrawal by Subject|21|||
155475335|NCT02155712|561161589|FG000|Overall Study|Site termination|77|||
155475336|NCT02155712|561161590|FG001|Overall Study|Site termination|19|||
155475337|NCT02155712|561161589|FG000|Overall Study|Sponsor terminated study early|150|||
155475338|NCT02155712|561161590|FG001|Overall Study|Sponsor terminated study early|0|||
155475339|NCT02155712|561161589|FG000|Overall Study|Missed final 5-year protocol visit|0|||
155475340|NCT02155712|561161590|FG001|Overall Study|Missed final 5-year protocol visit|32|||
155475341|NCT02155712|561161589|FG000|Overall Study|Censored because surgery cancelled|6|||
155475342|NCT02155712|561161590|FG001|Overall Study|Censored because surgery cancelled|10|||
155475343|NCT02155712|561161589|FG000|Overall Study|Censored because study device was not implanted|61|||
155475344|NCT02155712|561161590|FG001|Overall Study|Censored because study device was not implanted|66|||
155475345|NCT02155712|561161589|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
155475346|NCT02155712|561161590|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
155475347|NCT04288089|561161591|FG000|Overall Study|Ongoing Treatment|2|||
155475348|NCT04288089|561161592|FG001|Overall Study|Ongoing Treatment|1|||
155475349|NCT04288089|561161593|FG002|Overall Study|Ongoing Treatment|1|||
155475350|NCT04288089|561161594|FG003|Overall Study|Ongoing Treatment|4|||
155475351|NCT00976963|561161595|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
155475352|NCT00976963|561161596|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
155654234|NCT05375929|561826937|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155475353|NCT00976963|561161595|FG000|Overall Study|administrative error|1|||
155475354|NCT00976963|561161596|FG001|Overall Study|administrative error|0|||
155475355|NCT00976963|561161595|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
155475356|NCT00976963|561161596|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
155475357|NCT00537771|561161599|FG000|Overall Study|Withdrawal by Subject|6|||
155475358|NCT00537771|561161600|FG001|Overall Study|Withdrawal by Subject|23|||
155475359|NCT00537771|561161599|FG000|Overall Study|Adverse Event|8|||
155475360|NCT00537771|561161600|FG001|Overall Study|Adverse Event|15|||
155475361|NCT00537771|561161599|FG000|Overall Study|Lost to Follow-up|9|||
155475362|NCT00537771|561161600|FG001|Overall Study|Lost to Follow-up|15|||
155475363|NCT00537771|561161599|FG000|Overall Study|Protocol Violation|2|||
155475364|NCT00537771|561161600|FG001|Overall Study|Protocol Violation|6|||
155475365|NCT00537771|561161599|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
155475366|NCT00537771|561161600|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155475367|NCT02148952|561161601|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
155475368|NCT02148952|561161602|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
155654235|NCT05375929|561826934|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155475369|NCT02148952|561161601|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
155475370|NCT02148952|561161602|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
155475371|NCT02148952|561161601|FG000|Follow-Up|Lost to Follow-up|219|||
155475372|NCT02148952|561161602|FG001|Follow-Up|Lost to Follow-up|231|||
155475373|NCT02148952|561161601|FG000|Follow-Up|Withdrawal by Subject|46|||
155475374|NCT02148952|561161602|FG001|Follow-Up|Withdrawal by Subject|48|||
155475375|NCT01600105|561161603|FG000|Total Participants|Withdrawal by Subject|1|||
155654236|NCT05375929|561826935|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
155654237|NCT05375929|561826936|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155654238|NCT05375929|561826937|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155654239|NCT05375929|561826934|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155654240|NCT05375929|561826935|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155654241|NCT05375929|561826936|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155654242|NCT05375929|561826937|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
155654243|NCT05375929|561826934|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155654244|NCT05375929|561826935|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155654245|NCT05375929|561826936|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
155654246|NCT05375929|561826937|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155654247|NCT05375929|561826934|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155654248|NCT05375929|561826935|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155654249|NCT05375929|561826936|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
155654250|NCT05375929|561826937|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155654251|NCT05375929|561826934|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155654252|NCT05375929|561826935|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155654253|NCT05375929|561826936|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
155475376|NCT01600105|561161604|FG001|Total Participants|Withdrawal by Subject|0|||
155475377|NCT01600105|561161603|FG000|Total Participants|No images in PACS|10|||
155654254|NCT05375929|561826937|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155475378|NCT01600105|561161604|FG001|Total Participants|No images in PACS|0|||
155475379|NCT01600105|561161603|FG000|Total Participants|Insufficient image quality|30|||
155475380|NCT01600105|561161604|FG001|Total Participants|Insufficient image quality|10|||
155475381|NCT01600105|561161603|FG000|Sub Study I|Insufficient image quality|0|||
155475382|NCT01600105|561161604|FG001|Sub Study I|Insufficient image quality|10|||
155475383|NCT01600105|561161603|FG000|Sub Study II|Withdrawal by Subject|1|||
155475384|NCT01600105|561161604|FG001|Sub Study II|Withdrawal by Subject|0|||
155475385|NCT01600105|561161603|FG000|Sub Study II|No images in PACS|1|||
155475386|NCT01600105|561161604|FG001|Sub Study II|No images in PACS|0|||
155475387|NCT01600105|561161603|FG000|Sub Study II|Insufficient image quality|3|||
155475388|NCT01600105|561161604|FG001|Sub Study II|Insufficient image quality|0|||
155475389|NCT01600105|561161603|FG000|Sub Study III|Insufficient image quality|5|||
155475390|NCT01600105|561161604|FG001|Sub Study III|Insufficient image quality|0|||
155475391|NCT01600105|561161603|FG000|Sub Study V|Poor Image Quality|2|||
155475392|NCT01600105|561161604|FG001|Sub Study V|Poor Image Quality|0|||
155475393|NCT04007367|561161605|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
155475394|NCT04007367|561161606|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
155475395|NCT04007367|561161607|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
155475396|NCT04007367|561161605|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
155475397|NCT04007367|561161606|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
155475398|NCT04007367|561161607|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
155475399|NCT04007367|561161605|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
155475400|NCT04007367|561161606|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
155475401|NCT04007367|561161607|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
155475402|NCT04007367|561161605|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
155475403|NCT04007367|561161606|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
155475404|NCT04007367|561161607|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
155475405|NCT04007367|561161605|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
155475406|NCT04007367|561161606|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
155475407|NCT04007367|561161607|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
155475408|NCT04043416|561161608|FG000|Washout|Change in health condition|0|||
155475409|NCT04043416|561161609|FG001|Washout|Change in health condition|1|||
155475410|NCT00623766|561161617|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
155475411|NCT00623766|561161618|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
155475412|NCT00623766|561161617|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
155475413|NCT00623766|561161618|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
155475414|NCT00623766|561161617|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
155475415|NCT00623766|561161618|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
155475416|NCT00623766|561161617|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
155475417|NCT00623766|561161618|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
155654255|NCT03301415|561826938|FG000|Overall Study|Lost to Follow-up|2|||
155475418|NCT00623766|561161617|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
155475419|NCT00623766|561161618|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
155475420|NCT00893763|561161619|FG000|Overall Study|extubated|110|||
155475421|NCT00893763|561161620|FG001|Overall Study|extubated|110|||
155475422|NCT00796549|561161621|FG000|Overall Study|Adverse Event|11|||
155475423|NCT00796549|561161621|FG000|Overall Study|not entered|149|||
155475424|NCT00796549|561161621|FG000|Overall Study|Other|2|||
155475425|NCT00796549|561161621|FG000|Overall Study|Progressive disease|56|||
155475426|NCT03523715|561161623|FG000|Overall Study|Lost to Follow-up|11|||
155475427|NCT03523715|561161624|FG001|Overall Study|Lost to Follow-up|14|||
155475428|NCT03523715|561161623|FG000|Overall Study|Did not meet inclusion criteria|1|||
155475429|NCT03523715|561161624|FG001|Overall Study|Did not meet inclusion criteria|0|||
155475430|NCT03523715|561161623|FG000|Overall Study|Internally inconsistent reporting|0|||
155475431|NCT03523715|561161624|FG001|Overall Study|Internally inconsistent reporting|2|||
155475432|NCT00606229|561161625|FG000|Overall Study|Adverse Event|11|||
155475433|NCT00606229|561161625|FG000|Overall Study|Lack of Efficacy|1|||
155475434|NCT00606229|561161625|FG000|Overall Study|Withdrawal by Subject|4|||
155475435|NCT00606229|561161625|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
155475436|NCT00606229|561161625|FG000|Overall Study|change of residence or other commitments|2|||
155475437|NCT02139280|561161626|FG000|Overall Study|No longer eligible|2|||
155475438|NCT02139280|561161627|FG001|Overall Study|No longer eligible|0|||
155475439|NCT01302691|561161630|FG000|Overall Study|Adverse Event|2|||
155475440|NCT01302691|561161631|FG001|Overall Study|Adverse Event|0|||
155475441|NCT01302691|561161630|FG000|Overall Study|Death|0|||
155475442|NCT01302691|561161631|FG001|Overall Study|Death|1|||
155475443|NCT01302691|561161630|FG000|Overall Study|Lost to Follow-up|1|||
155475444|NCT01302691|561161631|FG001|Overall Study|Lost to Follow-up|0|||
155475445|NCT01302691|561161630|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
155475446|NCT01302691|561161631|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
155475447|NCT01302691|561161630|FG000|Overall Study|Physician Decision|0|||
155475448|NCT01302691|561161631|FG001|Overall Study|Physician Decision|1|||
155475449|NCT01302691|561161630|FG000|Overall Study|Protocol Violation|1|||
155475450|NCT01302691|561161631|FG001|Overall Study|Protocol Violation|0|||
155475451|NCT01039428|561161640|FG000|Overall Study|Protocol Violation|1|||
155475452|NCT01039428|561161641|FG001|Overall Study|Protocol Violation|0|||
155475453|NCT01039428|561161640|FG000|Overall Study|Withdrawal by Subject|1|||
155475454|NCT01039428|561161641|FG001|Overall Study|Withdrawal by Subject|0|||
155475455|NCT01313039|561161642|FG000|Overall Study|Physician Decision|1|||
155475456|NCT01313039|561161642|FG000|Overall Study|Adverse Event|1|||
155475457|NCT00117572|561161643|FG000|Overall Study|Site withdrew before starting treatment|2|||
155475458|NCT00117572|561161644|FG001|Overall Study|Site withdrew before starting treatment|3|||
155475459|NCT00117572|561161643|FG000|Overall Study|Withdrawal by Subject|3|||
155475460|NCT00117572|561161644|FG001|Overall Study|Withdrawal by Subject|3|||
155475461|NCT00117572|561161643|FG000|Overall Study|Protocol Violation|1|||
155475462|NCT00117572|561161644|FG001|Overall Study|Protocol Violation|0|||
155475463|NCT00090766|561161645|FG000|Overall Study|Nephrectomy Planned|0|||
155475464|NCT00090766|561161646|FG001|Overall Study|Nephrectomy Planned|0|||
155475465|NCT00090766|561161647|FG002|Overall Study|Nephrectomy Planned|1|||
155475466|NCT00090766|561161645|FG000|Overall Study|Death|1|||
155475467|NCT00090766|561161646|FG001|Overall Study|Death|0|||
155475468|NCT00090766|561161647|FG002|Overall Study|Death|0|||
155475469|NCT00090766|561161645|FG000|Overall Study|Admin|0|||
155475470|NCT00090766|561161646|FG001|Overall Study|Admin|2|||
155475471|NCT00090766|561161647|FG002|Overall Study|Admin|0|||
155475472|NCT00090766|561161645|FG000|Overall Study|Lost to Follow-up|2|||
155475473|NCT00090766|561161646|FG001|Overall Study|Lost to Follow-up|0|||
155475474|NCT00090766|561161647|FG002|Overall Study|Lost to Follow-up|2|||
155475475|NCT00804986|561161648|FG000|Overall Study|Adverse Event|0|||
155475476|NCT00804986|561161649|FG001|Overall Study|Adverse Event|1|||
155475477|NCT00804986|561161650|FG002|Overall Study|Adverse Event|2|||
155475478|NCT00804986|561161651|FG003|Overall Study|Adverse Event|1|||
155475479|NCT00804986|561161652|FG004|Overall Study|Adverse Event|3|||
155475480|NCT00804986|561161653|FG005|Overall Study|Adverse Event|0|||
155475481|NCT00804986|561161648|FG000|Overall Study|Lack of Efficacy|0|||
155475482|NCT00804986|561161649|FG001|Overall Study|Lack of Efficacy|0|||
155475483|NCT00804986|561161650|FG002|Overall Study|Lack of Efficacy|0|||
155475484|NCT00804986|561161651|FG003|Overall Study|Lack of Efficacy|1|||
155475485|NCT00804986|561161652|FG004|Overall Study|Lack of Efficacy|0|||
155475486|NCT00804986|561161653|FG005|Overall Study|Lack of Efficacy|3|||
155475487|NCT00804986|561161648|FG000|Overall Study|Lost to Follow-up|0|||
155475488|NCT00804986|561161649|FG001|Overall Study|Lost to Follow-up|0|||
155475489|NCT00804986|561161650|FG002|Overall Study|Lost to Follow-up|0|||
155475490|NCT00804986|561161651|FG003|Overall Study|Lost to Follow-up|1|||
155475491|NCT00804986|561161652|FG004|Overall Study|Lost to Follow-up|1|||
155475492|NCT00804986|561161653|FG005|Overall Study|Lost to Follow-up|3|||
155475493|NCT00804986|561161648|FG000|Overall Study|Protocol Violation|0|||
155475494|NCT00804986|561161649|FG001|Overall Study|Protocol Violation|1|||
155475495|NCT00804986|561161650|FG002|Overall Study|Protocol Violation|0|||
155475496|NCT00804986|561161651|FG003|Overall Study|Protocol Violation|1|||
155475497|NCT00804986|561161652|FG004|Overall Study|Protocol Violation|0|||
155475498|NCT00804986|561161653|FG005|Overall Study|Protocol Violation|0|||
155475499|NCT00804986|561161648|FG000|Overall Study|Withdrawal by Subject|0|||
155475500|NCT00804986|561161649|FG001|Overall Study|Withdrawal by Subject|3|||
155475501|NCT00804986|561161650|FG002|Overall Study|Withdrawal by Subject|0|||
155475502|NCT00804986|561161651|FG003|Overall Study|Withdrawal by Subject|3|||
155475503|NCT00804986|561161652|FG004|Overall Study|Withdrawal by Subject|5|||
155475504|NCT00804986|561161653|FG005|Overall Study|Withdrawal by Subject|3|||
155475505|NCT00804986|561161648|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155475506|NCT00804986|561161649|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
155475507|NCT00804986|561161650|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
155475508|NCT00804986|561161651|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
155475509|NCT00804986|561161652|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
155475510|NCT00804986|561161653|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
155475511|NCT00804986|561161648|FG000|Overall Study|Sponsor Decision|0|||
155475512|NCT00804986|561161649|FG001|Overall Study|Sponsor Decision|1|||
155475513|NCT00804986|561161650|FG002|Overall Study|Sponsor Decision|0|||
155475514|NCT00804986|561161651|FG003|Overall Study|Sponsor Decision|0|||
155475515|NCT00804986|561161652|FG004|Overall Study|Sponsor Decision|0|||
155475516|NCT00804986|561161653|FG005|Overall Study|Sponsor Decision|0|||
155475517|NCT00804986|561161648|FG000|Overall Study|Physician Decision|1|||
155475518|NCT00804986|561161649|FG001|Overall Study|Physician Decision|0|||
155475519|NCT00804986|561161650|FG002|Overall Study|Physician Decision|0|||
155475520|NCT00804986|561161651|FG003|Overall Study|Physician Decision|0|||
155475521|NCT00804986|561161652|FG004|Overall Study|Physician Decision|0|||
155475522|NCT00804986|561161653|FG005|Overall Study|Physician Decision|0|||
155475523|NCT02774291|561161654|FG000|Overall Study|Lost to Follow-up|1|||
155475524|NCT01387594|561161655|FG000|Overall Study|Withdrawal by Subject|0|||
155475525|NCT01387594|561161656|FG001|Overall Study|Withdrawal by Subject|2|||
155475526|NCT01387594|561161655|FG000|Overall Study|Lost to Follow-up|0|||
155475527|NCT01387594|561161656|FG001|Overall Study|Lost to Follow-up|1|||
155475528|NCT00397891|561161665|FG000|Overall Study|Withdrawal by Subject|1|||
155475529|NCT00397891|561161666|FG001|Overall Study|Withdrawal by Subject|0|||
155475530|NCT00397891|561161667|FG002|Overall Study|Withdrawal by Subject|0|||
155475531|NCT00397891|561161668|FG003|Overall Study|Withdrawal by Subject|0|||
155475532|NCT00397891|561161669|FG004|Overall Study|Withdrawal by Subject|1|||
155475533|NCT00412113|561161670|FG000|Overall Study|Adverse Event|11|||
155475534|NCT00412113|561161671|FG001|Overall Study|Adverse Event|15|||
155475535|NCT00412113|561161670|FG000|Overall Study|did not receive treatment|1|||
155475536|NCT00412113|561161671|FG001|Overall Study|did not receive treatment|0|||
155475537|NCT00796224|561161672|FG000|Overall Study|Adverse Event|1|||
155475538|NCT00796224|561161673|FG001|Overall Study|Adverse Event|0|||
155475539|NCT00796224|561161672|FG000|Overall Study|Protocol Violation|0|||
155475540|NCT00796224|561161673|FG001|Overall Study|Protocol Violation|1|||
155475541|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
155475542|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
155475543|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
155475544|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
155475545|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
155475546|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
155475547|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155475548|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155475549|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
155475550|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
155475551|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
155475552|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
155475553|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155475554|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155475555|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155475556|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155475557|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
155475558|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
155475559|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
155475560|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
155475561|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
155475562|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
155475563|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
155475564|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
155475565|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
155475566|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155475567|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
155475568|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155475569|NCT03227224|561161674|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
155475570|NCT03227224|561161675|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
155475571|NCT03227224|561161676|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
155475572|NCT03227224|561161677|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
155475573|NCT03227224|561161674|FG000|Follow-up Phase (2 Weeks)|Other|4|||
155475574|NCT03227224|561161675|FG001|Follow-up Phase (2 Weeks)|Other|4|||
155475575|NCT03227224|561161676|FG002|Follow-up Phase (2 Weeks)|Other|6|||
155475576|NCT03227224|561161677|FG003|Follow-up Phase (2 Weeks)|Other|3|||
155475577|NCT04195750|561161678|FG000|Overall Study|Death|245|||
155475578|NCT04195750|561161679|FG001|Overall Study|Death|253|||
155475579|NCT04195750|561161680|FG002|Overall Study|Death|5|||
155475580|NCT04195750|561161678|FG000|Overall Study|Physician Decision|0|||
155475581|NCT04195750|561161679|FG001|Overall Study|Physician Decision|1|||
155475582|NCT04195750|561161680|FG002|Overall Study|Physician Decision|0|||
155475583|NCT04195750|561161678|FG000|Overall Study|Withdrawal by Subject|9|||
155475584|NCT04195750|561161679|FG001|Overall Study|Withdrawal by Subject|8|||
155475585|NCT04195750|561161680|FG002|Overall Study|Withdrawal by Subject|0|||
155475586|NCT04195750|561161678|FG000|Overall Study|Ongoing|120|||
155475587|NCT04195750|561161679|FG001|Overall Study|Ongoing|110|||
155475588|NCT04195750|561161680|FG002|Overall Study|Ongoing|4|||
155475589|NCT02406027|561161681|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
155475590|NCT02406027|561161682|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
155475591|NCT02406027|561161683|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
155475592|NCT02406027|561161684|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
155475593|NCT02406027|561161685|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
155475594|NCT02406027|561161686|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
155475595|NCT02406027|561161687|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
155475596|NCT02406027|561161681|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
155475597|NCT02406027|561161682|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
155475598|NCT02406027|561161683|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
155475599|NCT02406027|561161684|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
155475600|NCT02406027|561161685|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
155475601|NCT02406027|561161686|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
155475602|NCT02406027|561161687|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
155475603|NCT02406027|561161681|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
155475604|NCT02406027|561161682|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
155475605|NCT02406027|561161683|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
155475606|NCT02406027|561161684|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
155475607|NCT02406027|561161685|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
155475608|NCT02406027|561161686|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
155475609|NCT02406027|561161687|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
155475610|NCT02406027|561161681|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
155475611|NCT02406027|561161682|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
155475612|NCT02406027|561161683|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
155475613|NCT02406027|561161684|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
155475614|NCT02406027|561161685|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
155475615|NCT02406027|561161686|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
155475616|NCT02406027|561161687|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
155475617|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
155475618|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
155475619|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
155475620|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
155475621|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
155475622|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
155475623|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
155475624|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
155475625|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
155475626|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
155475627|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
155475628|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
155475629|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
155475630|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
155475631|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
155475632|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
155475633|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
155475634|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
155519206|NCT00414466|561327218|FG000|Overall Study|Lack of Efficacy|1|||
155519207|NCT00414466|561327219|FG001|Overall Study|Lack of Efficacy|0|||
155519208|NCT00414466|561327220|FG002|Overall Study|Lack of Efficacy|0|||
155519209|NCT00414466|561327221|FG003|Overall Study|Lack of Efficacy|0|||
155519210|NCT00414466|561327218|FG000|Overall Study|Withdrawn by Sponsor|1|||
155519211|NCT00414466|561327219|FG001|Overall Study|Withdrawn by Sponsor|0|||
155519212|NCT00414466|561327220|FG002|Overall Study|Withdrawn by Sponsor|0|||
155519213|NCT00414466|561327221|FG003|Overall Study|Withdrawn by Sponsor|0|||
155519214|NCT04526210|561327222|FG000|Overall Study|Sponsor decision|7|||
155475635|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
155475636|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
155475637|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
155475638|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
155475639|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
155475640|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
155475641|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
155475642|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
155475643|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
155475644|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
155475645|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475646|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475647|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475648|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475649|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475650|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
155475651|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155475652|NCT02406027|561161681|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475653|NCT02406027|561161682|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475654|NCT02406027|561161683|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475655|NCT02406027|561161684|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475656|NCT02406027|561161685|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
155475657|NCT02406027|561161686|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475658|NCT02406027|561161687|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
155475659|NCT02254304|561161690|FG000|Overall Study|Adverse Event|2|||
155475660|NCT02254304|561161691|FG001|Overall Study|Adverse Event|1|||
155475661|NCT02254304|561161690|FG000|Overall Study|Lost to Follow-up|2|||
155475662|NCT02254304|561161691|FG001|Overall Study|Lost to Follow-up|2|||
155475663|NCT02254304|561161690|FG000|Overall Study|Protocol Violation|1|||
155475664|NCT02254304|561161691|FG001|Overall Study|Protocol Violation|0|||
155475665|NCT02254304|561161690|FG000|Overall Study|Withdrawal by Subject|3|||
155475666|NCT02254304|561161691|FG001|Overall Study|Withdrawal by Subject|0|||
155475667|NCT02254304|561161690|FG000|Overall Study|Injection site pain and Injection fear|1|||
155475668|NCT02254304|561161691|FG001|Overall Study|Injection site pain and Injection fear|0|||
155475669|NCT02254304|561161690|FG000|Overall Study|Personal causes|4|||
155475670|NCT02254304|561161691|FG001|Overall Study|Personal causes|1|||
155475671|NCT02254304|561161690|FG000|Overall Study|Personal decision|1|||
155475672|NCT02254304|561161691|FG001|Overall Study|Personal decision|0|||
155475673|NCT04284787|561163860|FG000|Overall Study|Disease Progression|9|||
155475674|NCT04284787|561163861|FG001|Overall Study|Disease Progression|12|||
155475675|NCT04284787|561163860|FG000|Overall Study|Physician Decision|12|||
155475676|NCT04284787|561163861|FG001|Overall Study|Physician Decision|7|||
155475677|NCT04284787|561163860|FG000|Overall Study|Transplant|5|||
155475678|NCT04284787|561163861|FG001|Overall Study|Transplant|4|||
155475679|NCT04284787|561163860|FG000|Overall Study|Death|1|||
155475680|NCT04284787|561163861|FG001|Overall Study|Death|2|||
155475681|NCT04284787|561163860|FG000|Overall Study|Adverse Event|0|||
155475682|NCT04284787|561163861|FG001|Overall Study|Adverse Event|4|||
155475683|NCT04284787|561163860|FG000|Overall Study|Non-adherence|2|||
155475684|NCT04284787|561163861|FG001|Overall Study|Non-adherence|0|||
155475685|NCT04284787|561163860|FG000|Overall Study|Lack of Efficacy|2|||
155475686|NCT04284787|561163861|FG001|Overall Study|Lack of Efficacy|0|||
155475687|NCT01874353|561163862|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
155475688|NCT01874353|561163863|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
155475689|NCT01874353|561163864|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
155475690|NCT01874353|561163865|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
155475691|NCT01874353|561163862|FG000|Overall Study|Lost to Follow-up|2|||
155475692|NCT01874353|561163863|FG001|Overall Study|Lost to Follow-up|2|||
155519215|NCT04526210|561327223|FG001|Overall Study|Sponsor decision|5|||
155519216|NCT04526210|561327222|FG000|Overall Study|Withdrawal by Subject|3|||
155519217|NCT04526210|561327223|FG001|Overall Study|Withdrawal by Subject|2|||
155654256|NCT03301415|561826938|FG000|Overall Study|Unable to comply with visit schedule|2|||
155475693|NCT01874353|561163864|FG002|Overall Study|Lost to Follow-up|2|||
155475694|NCT01874353|561163865|FG003|Overall Study|Lost to Follow-up|0|||
155475695|NCT01874353|561163862|FG000|Overall Study|Death|110|||
155475696|NCT01874353|561163863|FG001|Overall Study|Death|60|||
155475697|NCT01874353|561163864|FG002|Overall Study|Death|13|||
155475698|NCT01874353|561163865|FG003|Overall Study|Death|7|||
155475699|NCT01874353|561163862|FG000|Overall Study|Withdrawal by Subject|13|||
155475700|NCT01874353|561163863|FG001|Overall Study|Withdrawal by Subject|11|||
155475701|NCT01874353|561163864|FG002|Overall Study|Withdrawal by Subject|0|||
155475702|NCT01874353|561163865|FG003|Overall Study|Withdrawal by Subject|0|||
155475703|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
155475704|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
155475705|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Death|1|||
155475706|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Death|1|||
155475707|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
155475708|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
155475709|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
155475710|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
155475711|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
155475712|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
155475713|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
155475714|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
155475715|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
155475716|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
155519218|NCT01781637|561327224|FG000|Overall Study|Adverse Event|1|||
155519219|NCT01781637|561327225|FG001|Overall Study|Adverse Event|0|||
155519220|NCT01781637|561327224|FG000|Overall Study|Lack of Efficacy|2|||
155519221|NCT01781637|561327225|FG001|Overall Study|Lack of Efficacy|6|||
155519222|NCT01781637|561327224|FG000|Overall Study|Withdrawal by Subject|1|||
155519223|NCT01781637|561327225|FG001|Overall Study|Withdrawal by Subject|0|||
155519224|NCT02637232|561327226|FG000|Overall Study|Lost to Follow-up|42|||
155519225|NCT02637232|561327226|FG000|Overall Study|Adverse Event|11|||
155519226|NCT02637232|561327226|FG000|Overall Study|patient 's decision|2|||
155519227|NCT02999178|561327227|FG000|Overall Study|Adverse Event|85|||
155519228|NCT02999178|561327228|FG001|Overall Study|Adverse Event|62|||
155519229|NCT02999178|561327227|FG000|Overall Study|Protocol Violation|1|||
155519230|NCT02999178|561327228|FG001|Overall Study|Protocol Violation|2|||
155519231|NCT02999178|561327227|FG000|Overall Study|Lost to Follow-up|0|||
155519232|NCT02999178|561327228|FG001|Overall Study|Lost to Follow-up|2|||
155519233|NCT02999178|561327227|FG000|Overall Study|Withdrawal by Subject|21|||
155519234|NCT02999178|561327228|FG001|Overall Study|Withdrawal by Subject|21|||
155519235|NCT02999178|561327227|FG000|Overall Study|Other reason not defined above|7|||
155519236|NCT02999178|561327228|FG001|Overall Study|Other reason not defined above|13|||
155519237|NCT00090857|561327229|FG000|Overall Study|Lost to Follow-up|0|||
155519238|NCT00090857|561327230|FG001|Overall Study|Lost to Follow-up|1|||
155519239|NCT00090857|561327229|FG000|Overall Study|Withdrawal by Subject|2|||
155519240|NCT00090857|561327230|FG001|Overall Study|Withdrawal by Subject|0|||
155519241|NCT00090857|561327229|FG000|Overall Study|Adverse Event|2|||
155519242|NCT00090857|561327230|FG001|Overall Study|Adverse Event|2|||
155519243|NCT05097326|561327232|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
155519244|NCT05097326|561327233|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
155519245|NCT02473640|561327234|FG000|Treatment Period 1|Adverse Event|1|||
155519246|NCT02395822|561327235|FG000|Overall Study|Withdrawal by Subject|1|||
155519247|NCT02395822|561327235|FG000|Overall Study|Death|1|||
155519248|NCT02127281|561327236|FG000|Overall Study|Lost to Follow-up|1|||
155519249|NCT02127281|561327237|FG001|Overall Study|Lost to Follow-up|0|||
155519250|NCT03292653|561327240|FG000|Overall Study|Adverse Event|0|||
155519251|NCT03292653|561327241|FG001|Overall Study|Adverse Event|0|||
155519252|NCT03292653|561327242|FG002|Overall Study|Adverse Event|1|||
155475717|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
155475718|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
155475719|NCT03728881|561163866|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
155475720|NCT03728881|561163867|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
155475721|NCT03728881|561163866|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
155519253|NCT03292653|561327240|FG000|Overall Study|Did not Receive Treatment|1|||
155519254|NCT03292653|561327241|FG001|Overall Study|Did not Receive Treatment|0|||
155519255|NCT03292653|561327242|FG002|Overall Study|Did not Receive Treatment|0|||
155519256|NCT04720664|561327243|FG000|Overall Study|Adverse Event|2|||
155519257|NCT04720664|561327243|FG000|Overall Study|Lack of Efficacy|9|||
155519258|NCT03311646|561327248|FG000|Overall Study|Physician Decision|1|||
155519259|NCT03311646|561327248|FG000|Overall Study|Withdrawal by Subject|5|||
155654257|NCT00392288|561826939|FG000|Overall Study|Adverse Event|17|||
155654258|NCT00392288|561826940|FG001|Overall Study|Adverse Event|7|||
155654259|NCT00392288|561826941|FG002|Overall Study|Adverse Event|8|||
155519260|NCT03311646|561327248|FG000|Overall Study|Lost to Follow-up|5|||
155475722|NCT03728881|561163867|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
155475723|NCT03728881|561163866|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
155475724|NCT03728881|561163867|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
155475725|NCT04517253|561163870|FG000|Primary Treatment Period|Adverse Event|1|||
155475726|NCT04517253|561163871|FG001|Primary Treatment Period|Adverse Event|0|||
155475727|NCT04517253|561163872|FG002|Primary Treatment Period|Adverse Event|0|||
155475728|NCT04517253|561163870|FG000|Primary Treatment Period|Death|0|||
155475729|NCT04517253|561163871|FG001|Primary Treatment Period|Death|1|||
155475730|NCT04517253|561163872|FG002|Primary Treatment Period|Death|0|||
155475731|NCT04517253|561163870|FG000|Maintenance Period|Withdrawal by Subject|1|||
155475732|NCT04517253|561163871|FG001|Maintenance Period|Withdrawal by Subject|0|||
155475733|NCT04517253|561163872|FG002|Maintenance Period|Withdrawal by Subject|0|||
155475734|NCT04517253|561163870|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
155475735|NCT04517253|561163871|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
155475736|NCT04517253|561163872|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
155475737|NCT06048367|561163873|FG000|Overall Study|Withdrawal by Subject|0|||
155475738|NCT06048367|561163874|FG001|Overall Study|Withdrawal by Subject|1|||
155475739|NCT06048367|561163875|FG002|Overall Study|Withdrawal by Subject|0|||
155475740|NCT06048367|561163876|FG003|Overall Study|Withdrawal by Subject|0|||
155475741|NCT06048367|561163877|FG004|Overall Study|Withdrawal by Subject|0|||
155475742|NCT06048367|561163873|FG000|Overall Study|Withdrawal by Subject|0|||
155475743|NCT06048367|561163874|FG001|Overall Study|Withdrawal by Subject|0|||
155475744|NCT06048367|561163875|FG002|Overall Study|Withdrawal by Subject|1|||
155475745|NCT06048367|561163876|FG003|Overall Study|Withdrawal by Subject|0|||
155475746|NCT06048367|561163877|FG004|Overall Study|Withdrawal by Subject|0|||
155475747|NCT06048367|561163873|FG000|Overall Study|Withdrawal by Subject|0|||
155475748|NCT06048367|561163874|FG001|Overall Study|Withdrawal by Subject|0|||
155475749|NCT06048367|561163875|FG002|Overall Study|Withdrawal by Subject|0|||
155475750|NCT06048367|561163876|FG003|Overall Study|Withdrawal by Subject|1|||
155475751|NCT06048367|561163877|FG004|Overall Study|Withdrawal by Subject|0|||
155475752|NCT06048367|561163873|FG000|Overall Study|Withdrawal by Subject|0|||
155475753|NCT06048367|561163874|FG001|Overall Study|Withdrawal by Subject|0|||
155475754|NCT06048367|561163875|FG002|Overall Study|Withdrawal by Subject|0|||
155475755|NCT06048367|561163876|FG003|Overall Study|Withdrawal by Subject|1|||
155519261|NCT03311646|561327248|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
155519262|NCT03103100|561327249|FG000|Overall Study|Adverse Event|1|||
155519263|NCT03103100|561327250|FG001|Overall Study|Adverse Event|0|||
155519264|NCT03103100|561327251|FG002|Overall Study|Adverse Event|0|||
155519265|NCT03103100|561327249|FG000|Overall Study|Physician Decision|1|||
155519266|NCT03103100|561327250|FG001|Overall Study|Physician Decision|0|||
155519267|NCT03103100|561327251|FG002|Overall Study|Physician Decision|2|||
155519268|NCT02906709|561327252|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
155519269|NCT02906709|561327253|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
155519270|NCT02906709|561327252|FG000|Phase A (Week 0 to Week 16)|Death|0|||
155519271|NCT02906709|561327253|FG001|Phase A (Week 0 to Week 16)|Death|1|||
155519272|NCT02906709|561327252|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
155519273|NCT02906709|561327253|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
155519274|NCT02906709|561327252|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
155519275|NCT02906709|561327253|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
155519276|NCT00920140|561327254|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
155519277|NCT00920140|561327255|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
155519278|NCT00920140|561327256|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
155519279|NCT00920140|561327257|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
155519280|NCT00920140|561327258|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
155519281|NCT00920140|561327254|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
155519282|NCT00920140|561327255|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
155654260|NCT00392288|561826939|FG000|Overall Study|Lack of Efficacy|8|||
155654261|NCT00392288|561826940|FG001|Overall Study|Lack of Efficacy|5|||
155654262|NCT00392288|561826941|FG002|Overall Study|Lack of Efficacy|3|||
155654263|NCT00392288|561826939|FG000|Overall Study|Protocol Violation|1|||
155654264|NCT00392288|561826940|FG001|Overall Study|Protocol Violation|3|||
155654265|NCT00392288|561826941|FG002|Overall Study|Protocol Violation|1|||
155519283|NCT00920140|561327256|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
155519284|NCT00920140|561327257|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
155519285|NCT00920140|561327258|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
155519286|NCT00920140|561327254|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155654266|NCT00392288|561826939|FG000|Overall Study|Lost to Follow-up|1|||
155654267|NCT00392288|561826940|FG001|Overall Study|Lost to Follow-up|1|||
155475756|NCT06048367|561163877|FG004|Overall Study|Withdrawal by Subject|0|||
155475757|NCT04088331|561163878|FG000|Overall Study|Lost to Follow-up|3|||
155519287|NCT00920140|561327255|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
155654268|NCT00392288|561826941|FG002|Overall Study|Lost to Follow-up|1|||
155475758|NCT04088331|561163878|FG000|Overall Study|Withdrawal by Subject|7|||
155475759|NCT04088331|561163878|FG000|Overall Study|Adverse Event|4|||
155475760|NCT05505734|561163879|FG000|Overall Study|Withdrawal by Subject|51|||
155475761|NCT05505734|561163880|FG001|Overall Study|Withdrawal by Subject|64|||
155475762|NCT05505734|561163879|FG000|Overall Study|Adverse Event|6|||
155475763|NCT05505734|561163880|FG001|Overall Study|Adverse Event|20|||
155475764|NCT05505734|561163879|FG000|Overall Study|Protocol Violation|8|||
155475765|NCT05505734|561163880|FG001|Overall Study|Protocol Violation|15|||
155475766|NCT05505734|561163879|FG000|Overall Study|Lack of therapeutic response|0|||
155475767|NCT05505734|561163880|FG001|Overall Study|Lack of therapeutic response|1|||
155475768|NCT05505734|561163879|FG000|Overall Study|Lost to Follow-up|247|||
155475769|NCT05505734|561163880|FG001|Overall Study|Lost to Follow-up|237|||
155475770|NCT05505734|561163879|FG000|Overall Study|Physician Decision|22|||
155475771|NCT05505734|561163880|FG001|Overall Study|Physician Decision|13|||
155475772|NCT05505734|561163879|FG000|Overall Study|Death|2|||
155475773|NCT05505734|561163880|FG001|Overall Study|Death|1|||
155475774|NCT05505734|561163879|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155475775|NCT05505734|561163880|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155475776|NCT05505734|561163879|FG000|Overall Study|Pregnancy|1|||
155475777|NCT05505734|561163880|FG001|Overall Study|Pregnancy|0|||
155475778|NCT05505734|561163879|FG000|Overall Study|Other|17|||
155475779|NCT05505734|561163880|FG001|Overall Study|Other|13|||
155475780|NCT03598140|561163881|FG000|Overall Study|enrolled but didn't start|1|||
155475781|NCT03598140|561163882|FG001|Overall Study|enrolled but didn't start|0|||
155475782|NCT01266876|561163886|FG000|Overall Study|Adverse Event|0|||
155475783|NCT01266876|561163887|FG001|Overall Study|Adverse Event|0|||
155475784|NCT01266876|561163888|FG002|Overall Study|Adverse Event|0|||
155475785|NCT01266876|561163889|FG003|Overall Study|Adverse Event|1|||
155475786|NCT01266876|561163890|FG004|Overall Study|Adverse Event|0|||
155475787|NCT05016037|561163892|FG000|Overall Study|Lost to Follow-up|2|||
155475788|NCT03575351|561163893|FG000|Overall Study|Adverse Event|1|||
155475789|NCT03575351|561163894|FG001|Overall Study|Adverse Event|0|||
155475790|NCT03575351|561163893|FG000|Overall Study|Death|2|||
155475791|NCT03575351|561163894|FG001|Overall Study|Death|2|||
155475792|NCT03575351|561163893|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
155475793|NCT03575351|561163894|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
155475794|NCT03575351|561163893|FG000|Overall Study|Lack of Efficacy|28|||
155475795|NCT03575351|561163894|FG001|Overall Study|Lack of Efficacy|0|||
155475796|NCT03575351|561163893|FG000|Overall Study|Withdrawal by Subject|1|||
155475797|NCT03575351|561163894|FG001|Overall Study|Withdrawal by Subject|1|||
155475798|NCT03575351|561163893|FG000|Overall Study|Physician Decision|3|||
155475799|NCT03575351|561163894|FG001|Overall Study|Physician Decision|0|||
155475800|NCT03575351|561163893|FG000|Overall Study|Disease relapse|15|||
155475801|NCT03575351|561163894|FG001|Overall Study|Disease relapse|6|||
155475802|NCT03575351|561163893|FG000|Overall Study|Study drug manufacturing failure|0|||
155475803|NCT03575351|561163894|FG001|Overall Study|Study drug manufacturing failure|1|||
155475804|NCT03575351|561163893|FG000|Overall Study|other reasons|5|||
155475805|NCT03575351|561163894|FG001|Overall Study|other reasons|0|||
155475806|NCT03715205|561163895|FG000|Overall Study|Death|13|||
155475807|NCT03715205|561163895|FG000|Overall Study|Lost to Follow-up|2|||
155475808|NCT03715205|561163895|FG000|Overall Study|Physician Decision|93|||
155475809|NCT03715205|561163895|FG000|Overall Study|Withdrawal by Subject|26|||
155475810|NCT02623699|561163896|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475811|NCT02623699|561163897|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
155475812|NCT02623699|561163898|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475813|NCT02623699|561163899|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475814|NCT02623699|561163900|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475815|NCT02623699|561163901|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475816|NCT02623699|561163902|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475817|NCT02623699|561163903|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475818|NCT02623699|561163904|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475819|NCT02623699|561163905|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475820|NCT02623699|561163906|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475821|NCT02623699|561163907|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155475822|NCT02623699|561163896|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475823|NCT02623699|561163897|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475824|NCT02623699|561163898|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475825|NCT02623699|561163899|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475826|NCT02623699|561163900|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475827|NCT02623699|561163901|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475828|NCT02623699|561163902|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
155475829|NCT02623699|561163903|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475830|NCT02623699|561163904|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475831|NCT02623699|561163905|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475832|NCT02623699|561163906|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475833|NCT02623699|561163907|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155475834|NCT02623699|561163896|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475835|NCT02623699|561163897|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475836|NCT02623699|561163898|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475837|NCT02623699|561163899|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475838|NCT02623699|561163900|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475839|NCT02623699|561163901|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
155475840|NCT02623699|561163902|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475841|NCT02623699|561163903|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475842|NCT02623699|561163904|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475843|NCT02623699|561163905|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475844|NCT02623699|561163906|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475845|NCT02623699|561163907|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155475846|NCT02623699|561163896|FG000|Part B (Up to 289 Days)|Death|0|||
155475847|NCT02623699|561163897|FG001|Part B (Up to 289 Days)|Death|0|||
155475848|NCT02623699|561163898|FG002|Part B (Up to 289 Days)|Death|0|||
155475849|NCT02623699|561163899|FG003|Part B (Up to 289 Days)|Death|0|||
155475850|NCT02623699|561163900|FG004|Part B (Up to 289 Days)|Death|0|||
155475851|NCT02623699|561163901|FG005|Part B (Up to 289 Days)|Death|1|||
155475852|NCT02623699|561163902|FG006|Part B (Up to 289 Days)|Death|1|||
155475853|NCT02623699|561163903|FG007|Part B (Up to 289 Days)|Death|0|||
155475854|NCT02623699|561163904|FG008|Part B (Up to 289 Days)|Death|1|||
155475855|NCT02623699|561163905|FG009|Part B (Up to 289 Days)|Death|0|||
155475856|NCT02623699|561163906|FG010|Part B (Up to 289 Days)|Death|0|||
155475857|NCT02623699|561163907|FG011|Part B (Up to 289 Days)|Death|0|||
155475858|NCT02623699|561163896|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
155475859|NCT02623699|561163897|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
155475860|NCT02623699|561163898|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
155475861|NCT02623699|561163899|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
155475862|NCT02623699|561163900|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
155475863|NCT02623699|561163901|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
155475864|NCT02623699|561163902|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
155654269|NCT00392288|561826939|FG000|Overall Study|Withdrawal by Subject|1|||
155654270|NCT00392288|561826940|FG001|Overall Study|Withdrawal by Subject|0|||
155654271|NCT00392288|561826941|FG002|Overall Study|Withdrawal by Subject|2|||
155475865|NCT02623699|561163903|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
155475866|NCT02623699|561163904|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
155475867|NCT02623699|561163905|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
155475868|NCT02623699|561163906|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
155475869|NCT02623699|561163907|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
155475870|NCT02623699|561163896|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475871|NCT02623699|561163897|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475872|NCT02623699|561163898|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475873|NCT02623699|561163899|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475874|NCT02623699|561163900|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475875|NCT02623699|561163901|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475876|NCT02623699|561163902|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475877|NCT02623699|561163903|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475878|NCT02623699|561163904|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475879|NCT02623699|561163905|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
155475880|NCT02623699|561163906|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
155475881|NCT02623699|561163907|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
155475882|NCT02623699|561163896|FG000|Part C (Up to 236 Days)|Death|0|||
155475883|NCT02623699|561163897|FG001|Part C (Up to 236 Days)|Death|0|||
155475884|NCT02623699|561163898|FG002|Part C (Up to 236 Days)|Death|0|||
155475885|NCT02623699|561163899|FG003|Part C (Up to 236 Days)|Death|0|||
155475886|NCT02623699|561163900|FG004|Part C (Up to 236 Days)|Death|0|||
155475887|NCT02623699|561163901|FG005|Part C (Up to 236 Days)|Death|0|||
155475888|NCT02623699|561163902|FG006|Part C (Up to 236 Days)|Death|0|||
155475889|NCT02623699|561163903|FG007|Part C (Up to 236 Days)|Death|0|||
155475890|NCT02623699|561163904|FG008|Part C (Up to 236 Days)|Death|0|||
155475891|NCT02623699|561163905|FG009|Part C (Up to 236 Days)|Death|0|||
155475892|NCT02623699|561163906|FG010|Part C (Up to 236 Days)|Death|0|||
155475893|NCT02623699|561163907|FG011|Part C (Up to 236 Days)|Death|1|||
155475894|NCT02623699|561163896|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
155475895|NCT02623699|561163897|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
155475896|NCT02623699|561163898|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
155475897|NCT02623699|561163899|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
155475898|NCT02623699|561163900|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
155475899|NCT02623699|561163901|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
155475900|NCT02623699|561163902|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
155475901|NCT02623699|561163903|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
155475902|NCT02623699|561163904|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
155475903|NCT02623699|561163905|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
155475904|NCT02623699|561163906|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
155475905|NCT02623699|561163907|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
155475906|NCT00557323|561163908|FG000|Overall Study|Death|3|||
155475907|NCT00557323|561163908|FG000|Overall Study|Withdrawal by Subject|2|||
155475908|NCT00557323|561163908|FG000|Overall Study|Administrative change|2|||
155475909|NCT00592072|561163909|FG000|Wash Out Period|Lost to Follow-up|1|||
155475910|NCT00592072|561163910|FG001|Wash Out Period|Lost to Follow-up|1|||
155475911|NCT03369704|561163911|FG000|Treatment Epoch|technical problems|1|||
155475912|NCT03369704|561163912|FG001|Treatment Epoch|technical problems|0|||
155475913|NCT03369704|561163911|FG000|Treatment Epoch|Protocol Violation|1|||
155475914|NCT03369704|561163912|FG001|Treatment Epoch|Protocol Violation|0|||
155475915|NCT03369704|561163911|FG000|Treatment Epoch|Lost to Follow-up|0|||
155475916|NCT03369704|561163912|FG001|Treatment Epoch|Lost to Follow-up|1|||
155475917|NCT03369704|561163911|FG000|Treatment Epoch|Lack of Efficacy|0|||
155475918|NCT03369704|561163912|FG001|Treatment Epoch|Lack of Efficacy|2|||
155475919|NCT03369704|561163911|FG000|Treatment Epoch|Adverse Event|2|||
155475920|NCT03369704|561163912|FG001|Treatment Epoch|Adverse Event|0|||
155475921|NCT03369704|561163911|FG000|Follow-up Epoch|Lost to Follow-up|1|||
155475922|NCT03369704|561163912|FG001|Follow-up Epoch|Lost to Follow-up|0|||
155475923|NCT02010567|561163916|FG000|Overall Study|Adverse Event|0|||
155475924|NCT02010567|561163917|FG001|Overall Study|Adverse Event|0|||
155475925|NCT02010567|561163918|FG002|Overall Study|Adverse Event|1|||
155475926|NCT02010567|561163919|FG003|Overall Study|Adverse Event|0|||
155475927|NCT02010567|561163920|FG004|Overall Study|Adverse Event|1|||
155475928|NCT00118040|561163921|FG000|Overall Study|Adverse Event|0|||
155475929|NCT00118040|561163922|FG001|Overall Study|Adverse Event|1|||
155475930|NCT00118040|561163923|FG002|Overall Study|Adverse Event|0|||
155475931|NCT00118040|561163921|FG000|Overall Study|Withdrawal by Subject|0|||
155475932|NCT00118040|561163922|FG001|Overall Study|Withdrawal by Subject|0|||
155475933|NCT00118040|561163923|FG002|Overall Study|Withdrawal by Subject|2|||
155475934|NCT00118040|561163921|FG000|Overall Study|Medical Contraindication|0|||
155475935|NCT00118040|561163922|FG001|Overall Study|Medical Contraindication|0|||
155475936|NCT00118040|561163923|FG002|Overall Study|Medical Contraindication|1|||
155475937|NCT00118040|561163921|FG000|Overall Study|Non-Compliant Participant|1|||
155475938|NCT00118040|561163922|FG001|Overall Study|Non-Compliant Participant|1|||
155475939|NCT00118040|561163923|FG002|Overall Study|Non-Compliant Participant|2|||
155475940|NCT00118040|561163921|FG000|Overall Study|Other|0|||
155475941|NCT00118040|561163922|FG001|Overall Study|Other|0|||
155475942|NCT00118040|561163923|FG002|Overall Study|Other|1|||
155475943|NCT03733249|561163924|FG000|Overall Study|Death|7|||
155475944|NCT03733249|561163924|FG000|Overall Study|Disease relapse|16|||
155475945|NCT03733249|561163924|FG000|Overall Study|Lost to Follow-up|4|||
155475946|NCT03733249|561163924|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
155475947|NCT03733249|561163924|FG000|Overall Study|Withdrawal by Subject|1|||
155475948|NCT00772889|561163926|FG000|Overall Study|Adverse Event|7|||
155475949|NCT00772889|561163927|FG001|Overall Study|Adverse Event|4|||
155475950|NCT00772889|561163928|FG002|Overall Study|Adverse Event|0|||
155475951|NCT00772889|561163926|FG000|Overall Study|Withdrawal by Subject|9|||
155475952|NCT00772889|561163927|FG001|Overall Study|Withdrawal by Subject|8|||
155475953|NCT00772889|561163928|FG002|Overall Study|Withdrawal by Subject|9|||
155475954|NCT00772889|561163926|FG000|Overall Study|Lost to Follow-up|6|||
155475955|NCT00772889|561163927|FG001|Overall Study|Lost to Follow-up|6|||
155475956|NCT00772889|561163928|FG002|Overall Study|Lost to Follow-up|7|||
155475957|NCT03323086|561163929|FG000|Overall Study|Lost to Follow-up|3|||
155475958|NCT03323086|561163930|FG001|Overall Study|Lost to Follow-up|2|||
155475959|NCT00355615|561163931|FG000|Randomized Double Blind Period|Adverse Event|1|||
155475960|NCT00355615|561163932|FG001|Randomized Double Blind Period|Adverse Event|0|||
155475961|NCT00355615|561163933|FG002|Randomized Double Blind Period|Adverse Event|0|||
155475962|NCT00355615|561163934|FG003|Randomized Double Blind Period|Adverse Event|0|||
155475963|NCT00355615|561163935|FG004|Randomized Double Blind Period|Adverse Event|0|||
155475964|NCT00355615|561163931|FG000|Randomized Double Blind Period|Protocol Violation|0|||
155475965|NCT00355615|561163932|FG001|Randomized Double Blind Period|Protocol Violation|0|||
155475966|NCT00355615|561163933|FG002|Randomized Double Blind Period|Protocol Violation|1|||
155475967|NCT00355615|561163934|FG003|Randomized Double Blind Period|Protocol Violation|1|||
155475968|NCT00355615|561163935|FG004|Randomized Double Blind Period|Protocol Violation|0|||
155475969|NCT00355615|561163931|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
155475970|NCT00355615|561163932|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
155475971|NCT00355615|561163933|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
155475972|NCT00355615|561163934|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
155475973|NCT00355615|561163935|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
155475974|NCT00355615|561163931|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
155475975|NCT00355615|561163932|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
155475976|NCT00355615|561163933|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
155475977|NCT00355615|561163934|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
155475978|NCT00355615|561163935|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
155475979|NCT00355615|561163931|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
155475980|NCT00355615|561163932|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
155475981|NCT00355615|561163933|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
155475982|NCT00355615|561163934|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
155475983|NCT00355615|561163935|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
155475984|NCT00355615|561163931|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
155475985|NCT00355615|561163932|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
155475986|NCT00355615|561163933|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
155475987|NCT00355615|561163934|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
155475988|NCT00355615|561163935|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
155475989|NCT00085644|561163936|FG000|Double-Blind Period|Adverse Event|5|||
155475990|NCT00085644|561163937|FG001|Double-Blind Period|Adverse Event|2|||
155475991|NCT00085644|561163938|FG002|Double-Blind Period|Adverse Event|0|||
155475992|NCT00085644|561163936|FG000|Double-Blind Period|Withdrawal by Subject|3|||
155475993|NCT00085644|561163937|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155475994|NCT00085644|561163938|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155475995|NCT00085644|561163936|FG000|Double-Blind Period|Lost to Follow-up|2|||
155475996|NCT00085644|561163937|FG001|Double-Blind Period|Lost to Follow-up|1|||
155475997|NCT00085644|561163938|FG002|Double-Blind Period|Lost to Follow-up|0|||
155475998|NCT00085644|561163936|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
155475999|NCT00085644|561163937|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
155476000|NCT00085644|561163938|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
155476001|NCT00085644|561163936|FG000|Double-Blind Period|Contemplating pregnancy|1|||
155476002|NCT00085644|561163937|FG001|Double-Blind Period|Contemplating pregnancy|0|||
155476003|NCT00085644|561163938|FG002|Double-Blind Period|Contemplating pregnancy|0|||
155476004|NCT00085644|561163936|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
155476005|NCT00085644|561163937|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
155519288|NCT00920140|561327256|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155476006|NCT00085644|561163938|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
155476007|NCT00085644|561163936|FG000|Open-Label Period|Adverse Event|0|||
155476008|NCT00085644|561163937|FG001|Open-Label Period|Adverse Event|0|||
155476009|NCT00085644|561163938|FG002|Open-Label Period|Adverse Event|38|||
155476010|NCT00085644|561163936|FG000|Open-Label Period|Withdrawal by Subject|0|||
155476011|NCT00085644|561163937|FG001|Open-Label Period|Withdrawal by Subject|0|||
155476012|NCT00085644|561163938|FG002|Open-Label Period|Withdrawal by Subject|29|||
155476013|NCT00085644|561163936|FG000|Open-Label Period|Lost to Follow-up|0|||
155476014|NCT00085644|561163937|FG001|Open-Label Period|Lost to Follow-up|0|||
155476015|NCT00085644|561163938|FG002|Open-Label Period|Lost to Follow-up|13|||
155476016|NCT00085644|561163936|FG000|Open-Label Period|Lack of Efficacy|0|||
155476017|NCT00085644|561163937|FG001|Open-Label Period|Lack of Efficacy|0|||
155476018|NCT00085644|561163938|FG002|Open-Label Period|Lack of Efficacy|15|||
155476019|NCT00085644|561163936|FG000|Open-Label Period|Pregnancy|0|||
155476020|NCT00085644|561163937|FG001|Open-Label Period|Pregnancy|0|||
155476021|NCT00085644|561163938|FG002|Open-Label Period|Pregnancy|3|||
155476022|NCT00085644|561163936|FG000|Open-Label Period|Contemplating pregnancy|0|||
155476023|NCT00085644|561163937|FG001|Open-Label Period|Contemplating pregnancy|0|||
155476024|NCT00085644|561163938|FG002|Open-Label Period|Contemplating pregnancy|3|||
155476025|NCT00085644|561163936|FG000|Open-Label Period|Protocol Violation|0|||
155476026|NCT00085644|561163937|FG001|Open-Label Period|Protocol Violation|0|||
155476027|NCT00085644|561163938|FG002|Open-Label Period|Protocol Violation|4|||
155476028|NCT00085644|561163936|FG000|Open-Label Period|Personal reason|0|||
155476029|NCT00085644|561163937|FG001|Open-Label Period|Personal reason|0|||
155476030|NCT00085644|561163938|FG002|Open-Label Period|Personal reason|4|||
155476031|NCT04259346|561163941|FG000|Overall Study|Lost to Follow-up|1|||
155476032|NCT04259346|561163942|FG001|Overall Study|Lost to Follow-up|3|||
155476033|NCT04259346|561163941|FG000|Overall Study|Protocol Violation|1|||
155476034|NCT04259346|561163942|FG001|Overall Study|Protocol Violation|0|||
155476035|NCT04259346|561163941|FG000|Overall Study|Withdrawal by Subject|1|||
155476036|NCT04259346|561163942|FG001|Overall Study|Withdrawal by Subject|0|||
155476037|NCT04259346|561163941|FG000|Overall Study|Adverse Event|1|||
155476038|NCT04259346|561163942|FG001|Overall Study|Adverse Event|1|||
155476039|NCT03330106|561163943|FG000|Part A|Withdrawal by Subject|1|||
155476040|NCT03330106|561163944|FG001|Part A|Withdrawal by Subject|1|||
155476041|NCT03330106|561163945|FG002|Part A|Withdrawal by Subject|0|||
155476042|NCT03330106|561163946|FG003|Part A|Withdrawal by Subject|0|||
155476043|NCT03330106|561163943|FG000|Part A|Death|2|||
155476044|NCT03330106|561163944|FG001|Part A|Death|1|||
155476045|NCT03330106|561163945|FG002|Part A|Death|0|||
155476046|NCT03330106|561163946|FG003|Part A|Death|0|||
155476047|NCT03330106|561163943|FG000|Part A|Adverse Event|0|||
155476048|NCT03330106|561163944|FG001|Part A|Adverse Event|1|||
155476049|NCT03330106|561163945|FG002|Part A|Adverse Event|0|||
155476050|NCT03330106|561163946|FG003|Part A|Adverse Event|0|||
155476051|NCT03330106|561163943|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
155476052|NCT03330106|561163944|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
155476053|NCT03330106|561163945|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
155476054|NCT03330106|561163946|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
155476055|NCT03330106|561163943|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
155476056|NCT03330106|561163944|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
155476057|NCT03330106|561163945|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
155476058|NCT03330106|561163946|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
155476059|NCT03330106|561163943|FG000|Part A|Progressive Disease|0|||
155476060|NCT03330106|561163944|FG001|Part A|Progressive Disease|1|||
155476061|NCT03330106|561163945|FG002|Part A|Progressive Disease|0|||
155476062|NCT03330106|561163946|FG003|Part A|Progressive Disease|0|||
155476063|NCT03330106|561163943|FG000|Part B|Lost to Follow-up|0|||
155476064|NCT03330106|561163944|FG001|Part B|Lost to Follow-up|0|||
155476065|NCT03330106|561163945|FG002|Part B|Lost to Follow-up|0|||
155476066|NCT03330106|561163946|FG003|Part B|Lost to Follow-up|1|||
155476067|NCT03330106|561163943|FG000|Part B|Withdrawal by Subject|0|||
155476068|NCT03330106|561163944|FG001|Part B|Withdrawal by Subject|0|||
155476069|NCT03330106|561163945|FG002|Part B|Withdrawal by Subject|4|||
155476070|NCT03330106|561163946|FG003|Part B|Withdrawal by Subject|0|||
155476071|NCT03330106|561163943|FG000|Part B|Death|0|||
155476072|NCT03330106|561163944|FG001|Part B|Death|0|||
155476073|NCT03330106|561163945|FG002|Part B|Death|2|||
155476074|NCT03330106|561163946|FG003|Part B|Death|0|||
155476075|NCT03330106|561163943|FG000|Part B|Clinical Progression|0|||
155476076|NCT03330106|561163944|FG001|Part B|Clinical Progression|0|||
155476077|NCT03330106|561163945|FG002|Part B|Clinical Progression|1|||
155476078|NCT03330106|561163946|FG003|Part B|Clinical Progression|1|||
155476079|NCT03330106|561163943|FG000|Part B|Symptomatic Deterioration|0|||
155476080|NCT03330106|561163944|FG001|Part B|Symptomatic Deterioration|0|||
155476081|NCT03330106|561163945|FG002|Part B|Symptomatic Deterioration|0|||
155476082|NCT03330106|561163946|FG003|Part B|Symptomatic Deterioration|1|||
155476083|NCT03330106|561163943|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
155476084|NCT03330106|561163944|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
155476085|NCT03330106|561163945|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
155476086|NCT03330106|561163946|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
155476087|NCT03330106|561163943|FG000|Part B|Progressive Disease|0|||
155476088|NCT03330106|561163944|FG001|Part B|Progressive Disease|0|||
155476089|NCT03330106|561163945|FG002|Part B|Progressive Disease|11|||
155476090|NCT03330106|561163946|FG003|Part B|Progressive Disease|4|||
155476091|NCT00486889|561163948|FG000|Overall Study|Death|3|||
155476092|NCT00486889|561163948|FG000|Overall Study|Non-compliant|2|||
155476093|NCT00486889|561163948|FG000|Overall Study|Withdrawal by Subject|6|||
155476094|NCT01738594|561163950|FG000|Registration and Treatment Start|Adverse Event|0|||
155476095|NCT01738594|561163951|FG001|Registration and Treatment Start|Adverse Event|1|||
155476096|NCT01738594|561163952|FG002|Registration and Treatment Start|Adverse Event|0|||
155519289|NCT00920140|561327257|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155476097|NCT01738594|561163953|FG003|Registration and Treatment Start|Adverse Event|0|||
155476098|NCT01738594|561163954|FG004|Registration and Treatment Start|Adverse Event|0|||
155476099|NCT01738594|561163955|FG005|Registration and Treatment Start|Adverse Event|0|||
155476100|NCT01738594|561163956|FG006|Registration and Treatment Start|Adverse Event|0|||
155476101|NCT01738594|561163957|FG007|Registration and Treatment Start|Adverse Event|0|||
155476102|NCT01738594|561163950|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155519290|NCT00920140|561327258|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155519291|NCT00920140|561327254|FG000|Phase 2|Adverse Event|0|||
155519292|NCT00920140|561327255|FG001|Phase 2|Adverse Event|0|||
155519293|NCT00920140|561327256|FG002|Phase 2|Adverse Event|14|||
155519294|NCT00920140|561327257|FG003|Phase 2|Adverse Event|2|||
155519295|NCT00920140|561327258|FG004|Phase 2|Adverse Event|3|||
155519296|NCT00920140|561327254|FG000|Phase 2|Lack of Efficacy|0|||
155476103|NCT01738594|561163951|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155519297|NCT00920140|561327255|FG001|Phase 2|Lack of Efficacy|0|||
155519298|NCT00920140|561327256|FG002|Phase 2|Lack of Efficacy|29|||
155654272|NCT00392288|561826939|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
155476104|NCT01738594|561163952|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155476105|NCT01738594|561163953|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155476106|NCT01738594|561163954|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155519299|NCT00920140|561327257|FG003|Phase 2|Lack of Efficacy|14|||
155519300|NCT00920140|561327258|FG004|Phase 2|Lack of Efficacy|5|||
155654273|NCT00392288|561826940|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
155476107|NCT01738594|561163955|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
155476108|NCT01738594|561163956|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155476109|NCT01738594|561163957|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
155476110|NCT01738594|561163950|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476111|NCT01738594|561163951|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
155476112|NCT01738594|561163952|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476113|NCT01738594|561163953|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476114|NCT01738594|561163954|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476115|NCT01738594|561163955|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476116|NCT01738594|561163956|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476117|NCT01738594|561163957|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
155476118|NCT01738594|561163950|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476119|NCT01738594|561163951|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476120|NCT01738594|561163952|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476121|NCT01738594|561163953|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476122|NCT01738594|561163954|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476123|NCT01738594|561163955|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
155476124|NCT01738594|561163956|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476125|NCT01738594|561163957|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
155476126|NCT01738594|561163950|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476127|NCT01738594|561163951|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476128|NCT01738594|561163952|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476129|NCT01738594|561163953|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476130|NCT01738594|561163954|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476131|NCT01738594|561163955|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
155476132|NCT01738594|561163956|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476133|NCT01738594|561163957|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
155476134|NCT01738594|561163950|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476135|NCT01738594|561163951|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476136|NCT01738594|561163952|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476137|NCT01738594|561163953|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476138|NCT01738594|561163954|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
155476139|NCT01738594|561163955|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476140|NCT01738594|561163956|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476141|NCT01738594|561163957|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
155476142|NCT01738594|561163950|FG000|Follow up for 1 Year|Death|0|||
155476143|NCT01738594|561163951|FG001|Follow up for 1 Year|Death|0|||
155476144|NCT01738594|561163952|FG002|Follow up for 1 Year|Death|0|||
155476145|NCT01738594|561163953|FG003|Follow up for 1 Year|Death|0|||
155476146|NCT01738594|561163954|FG004|Follow up for 1 Year|Death|0|||
155476147|NCT01738594|561163955|FG005|Follow up for 1 Year|Death|1|||
155476148|NCT01738594|561163956|FG006|Follow up for 1 Year|Death|0|||
155476149|NCT01738594|561163957|FG007|Follow up for 1 Year|Death|0|||
155476150|NCT01738594|561163950|FG000|Follow up for 1 Year|Other|0|||
155476151|NCT01738594|561163951|FG001|Follow up for 1 Year|Other|0|||
155476152|NCT01738594|561163952|FG002|Follow up for 1 Year|Other|0|||
155476153|NCT01738594|561163953|FG003|Follow up for 1 Year|Other|0|||
155476154|NCT01738594|561163954|FG004|Follow up for 1 Year|Other|0|||
155476155|NCT01738594|561163955|FG005|Follow up for 1 Year|Other|2|||
155476156|NCT01738594|561163956|FG006|Follow up for 1 Year|Other|0|||
155476157|NCT01738594|561163957|FG007|Follow up for 1 Year|Other|0|||
155476158|NCT00376675|561163960|FG000|Overall Study|Withdrawal by Subject|9|||
155476159|NCT00376675|561163961|FG001|Overall Study|Withdrawal by Subject|2|||
155476160|NCT00376675|561163960|FG000|Overall Study|Adverse Event|10|||
155476161|NCT00376675|561163961|FG001|Overall Study|Adverse Event|5|||
155519301|NCT00920140|561327254|FG000|Phase 2|Lost to Follow-up|0|||
155519302|NCT00920140|561327255|FG001|Phase 2|Lost to Follow-up|0|||
155519303|NCT00920140|561327256|FG002|Phase 2|Lost to Follow-up|0|||
155519304|NCT00920140|561327257|FG003|Phase 2|Lost to Follow-up|1|||
155519305|NCT00920140|561327258|FG004|Phase 2|Lost to Follow-up|0|||
155519306|NCT00920140|561327254|FG000|Phase 2|Physician Decision|0|||
155519307|NCT00920140|561327255|FG001|Phase 2|Physician Decision|0|||
155519308|NCT00920140|561327256|FG002|Phase 2|Physician Decision|3|||
155519309|NCT00920140|561327257|FG003|Phase 2|Physician Decision|3|||
155519310|NCT00920140|561327258|FG004|Phase 2|Physician Decision|2|||
155519311|NCT00920140|561327254|FG000|Phase 2|Withdrawal by Subject|0|||
155519312|NCT00920140|561327255|FG001|Phase 2|Withdrawal by Subject|0|||
155519313|NCT00920140|561327256|FG002|Phase 2|Withdrawal by Subject|4|||
155519314|NCT00920140|561327257|FG003|Phase 2|Withdrawal by Subject|2|||
155519315|NCT00920140|561327258|FG004|Phase 2|Withdrawal by Subject|1|||
155519316|NCT01124149|561327259|FG000|Acute Phase|Withdrawal by Subject|22|||
155519317|NCT01124149|561327259|FG000|Acute Phase|Adverse Event|21|||
155519318|NCT01124149|561327259|FG000|Acute Phase|Lack of Efficacy|17|||
155519319|NCT01124149|561327259|FG000|Acute Phase|Protocol Violation|14|||
155476162|NCT00376675|561163960|FG000|Overall Study|Other Reason|1|||
155476163|NCT00376675|561163961|FG001|Overall Study|Other Reason|7|||
155476164|NCT00942422|561163964|FG000|Overall Study|Withdrawal by Subject|1|||
155476165|NCT00942422|561163964|FG000|Overall Study|Death|1|||
155476166|NCT00942422|561163964|FG000|Overall Study|Progressive diease|1|||
155519320|NCT01124149|561327259|FG000|Acute Phase|Lost to Follow-up|2|||
155519321|NCT01124149|561327259|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
155519322|NCT01124149|561327259|FG000|Acute Phase|Sponsor request|1|||
155519323|NCT01124149|561327259|FG000|Acute Phase|UC symptoms not ameliorated|1|||
155519324|NCT01124149|561327259|FG000|Acute Phase|Non-compliance|1|||
155476167|NCT01332851|561163965|FG000|Overall Study|Withdrawal by Subject|4|||
155476168|NCT01332851|561163966|FG001|Overall Study|Withdrawal by Subject|2|||
155476169|NCT01332851|561163965|FG000|Overall Study|Lost to Follow-up|7|||
155476170|NCT01332851|561163966|FG001|Overall Study|Lost to Follow-up|11|||
155476171|NCT01947894|561163967|FG000|Overall Study|Other|3|||
155476172|NCT01947894|561163968|FG001|Overall Study|Other|4|||
155476173|NCT01947894|561163969|FG002|Overall Study|Other|3|||
155476174|NCT01947894|561163967|FG000|Overall Study|Withdrawal by Subject|12|||
155476175|NCT01947894|561163968|FG001|Overall Study|Withdrawal by Subject|4|||
155476176|NCT01947894|561163969|FG002|Overall Study|Withdrawal by Subject|1|||
155476177|NCT01947894|561163967|FG000|Overall Study|Death|12|||
155476178|NCT01947894|561163968|FG001|Overall Study|Death|1|||
155476179|NCT01947894|561163969|FG002|Overall Study|Death|0|||
155476180|NCT01947894|561163967|FG000|Overall Study|Physician Decision|2|||
155476181|NCT01947894|561163968|FG001|Overall Study|Physician Decision|0|||
155476182|NCT01947894|561163969|FG002|Overall Study|Physician Decision|0|||
155476183|NCT01947894|561163967|FG000|Overall Study|Adverse Event|5|||
155476184|NCT01947894|561163968|FG001|Overall Study|Adverse Event|1|||
155476185|NCT01947894|561163969|FG002|Overall Study|Adverse Event|0|||
155476186|NCT01947894|561163967|FG000|Overall Study|Switched to other growth hormone brand|53|||
155476187|NCT01947894|561163968|FG001|Overall Study|Switched to other growth hormone brand|8|||
155476188|NCT01947894|561163969|FG002|Overall Study|Switched to other growth hormone brand|23|||
155476189|NCT03796195|561163970|FG000|Overall Study|Study closed early|1|||
155476190|NCT04445051|561163971|FG000|Overall Study|Adverse Event|0|||
155476191|NCT04445051|561163972|FG001|Overall Study|Adverse Event|0|||
155476192|NCT04445051|561163973|FG002|Overall Study|Adverse Event|1|||
155476193|NCT04445051|561163974|FG003|Overall Study|Adverse Event|0|||
155476194|NCT04445051|561163975|FG004|Overall Study|Adverse Event|0|||
155476195|NCT04445051|561163976|FG005|Overall Study|Adverse Event|0|||
155476196|NCT02201472|561163977|FG000|Overall Study|Lack of Efficacy|2|||
155476197|NCT01300767|561163978|FG000|Overall Study|Discomfort|2|||
155476198|NCT01300767|561163978|FG000|Overall Study|Biomicroscopy|1|||
155476199|NCT01300767|561163978|FG000|Overall Study|Unacceptable fit|1|||
155476200|NCT01188811|561163983|FG000|Overall Study|Withdrawal by Subject|0|||
155476201|NCT01188811|561163984|FG001|Overall Study|Withdrawal by Subject|2|||
155476202|NCT01188811|561163983|FG000|Overall Study|Adverse Event|6|||
155476203|NCT01188811|561163984|FG001|Overall Study|Adverse Event|0|||
155476204|NCT01602744|561163985|FG000|Overall Study|Death|17|||
155476205|NCT01602744|561163986|FG001|Overall Study|Death|15|||
155476206|NCT01602744|561163985|FG000|Overall Study|Lost to Follow-up|13|||
155476207|NCT01602744|561163986|FG001|Overall Study|Lost to Follow-up|8|||
155476208|NCT01316380|561163989|FG000|Overall Study|Adverse Event|0|||
155476209|NCT01316380|561163990|FG001|Overall Study|Adverse Event|2|||
155476210|NCT01316380|561163991|FG002|Overall Study|Adverse Event|1|||
155476211|NCT01316380|561163989|FG000|Overall Study|Protocol Violation|0|||
155476212|NCT01316380|561163990|FG001|Overall Study|Protocol Violation|0|||
155476213|NCT01316380|561163991|FG002|Overall Study|Protocol Violation|1|||
155476214|NCT01316380|561163989|FG000|Overall Study|Withdrawal by Subject|1|||
155476215|NCT01316380|561163990|FG001|Overall Study|Withdrawal by Subject|2|||
155476216|NCT01316380|561163991|FG002|Overall Study|Withdrawal by Subject|0|||
155476217|NCT01316380|561163989|FG000|Overall Study|Other|0|||
155476218|NCT01316380|561163990|FG001|Overall Study|Other|1|||
155476219|NCT01316380|561163991|FG002|Overall Study|Other|1|||
155476220|NCT01316380|561163989|FG000|Overall Study|Not treated|1|||
155476221|NCT01316380|561163990|FG001|Overall Study|Not treated|0|||
155476222|NCT01316380|561163991|FG002|Overall Study|Not treated|0|||
155476223|NCT00609167|561163995|FG000|Overall Study|Withdrawal by Subject|1|||
155476224|NCT00609167|561163996|FG001|Overall Study|Withdrawal by Subject|0|||
155476225|NCT00609167|561163995|FG000|Overall Study|Lack of Efficacy|1|||
155476226|NCT00609167|561163996|FG001|Overall Study|Lack of Efficacy|0|||
155476227|NCT00609167|561163995|FG000|Overall Study|Adverse Event|5|||
155476228|NCT00609167|561163996|FG001|Overall Study|Adverse Event|1|||
155654274|NCT00392288|561826941|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
155476229|NCT00609167|561163995|FG000|Overall Study|Disease Progression|1|||
155476230|NCT00609167|561163996|FG001|Overall Study|Disease Progression|0|||
155476231|NCT00609167|561163995|FG000|Overall Study|Stem Cell Transplant|0|||
155476232|NCT00609167|561163996|FG001|Overall Study|Stem Cell Transplant|6|||
155476233|NCT00712270|561163997|FG000|Overall Study|Withdrawal by Subject|11|||
155654275|NCT00392288|561826939|FG000|Overall Study|Other|3|||
155476234|NCT00712270|561163997|FG000|Overall Study|Screen Failure|3|||
155519325|NCT01124149|561327259|FG000|Acute Phase|Low hemoglobin|1|||
155519326|NCT01124149|561327259|FG000|Acute Phase|Travelling to another country|1|||
155519327|NCT01124149|561327259|FG000|Acute Phase|Sponsor decision|1|||
155519328|NCT01124149|561327259|FG000|Maintenance Phase|Lack of Efficacy|40|||
155519329|NCT01124149|561327259|FG000|Maintenance Phase|Adverse Event|24|||
155519330|NCT01124149|561327259|FG000|Maintenance Phase|Lost to Follow-up|15|||
155476235|NCT02574520|561163998|FG000|Overall Study|Not dosed|2|||
155476236|NCT02574520|561163999|FG001|Overall Study|Not dosed|0|||
155476237|NCT02574520|561164000|FG002|Overall Study|Not dosed|5|||
155476238|NCT02574520|561164001|FG003|Overall Study|Not dosed|4|||
155476239|NCT02574520|561163998|FG000|Overall Study|Adverse Event|0|||
155476240|NCT02574520|561163999|FG001|Overall Study|Adverse Event|0|||
155476241|NCT02574520|561164000|FG002|Overall Study|Adverse Event|0|||
155476242|NCT02574520|561164001|FG003|Overall Study|Adverse Event|1|||
155476243|NCT02574520|561163998|FG000|Overall Study|Withdrawal by Subject|0|||
155476244|NCT02574520|561163999|FG001|Overall Study|Withdrawal by Subject|0|||
155476245|NCT02574520|561164000|FG002|Overall Study|Withdrawal by Subject|0|||
155476246|NCT02574520|561164001|FG003|Overall Study|Withdrawal by Subject|1|||
155476247|NCT02574520|561163998|FG000|Overall Study|Other|0|||
155476248|NCT02574520|561163999|FG001|Overall Study|Other|0|||
155476249|NCT02574520|561164000|FG002|Overall Study|Other|0|||
155476250|NCT02574520|561164001|FG003|Overall Study|Other|2|||
155476251|NCT03935594|561164010|FG000|Overall Study|Physician Decision|3|||
155476252|NCT01435122|561164011|FG000|Overall Study|Early withdrawal due to toxicity|8|||
155476253|NCT04412668|561164012|FG000|Overall Study|Death - multiple comorbidities|2|||
155476254|NCT04412668|561164013|FG001|Overall Study|Death - multiple comorbidities|0|||
155519331|NCT01124149|561327259|FG000|Maintenance Phase|Withdrawal by Subject|10|||
155519332|NCT01124149|561327259|FG000|Maintenance Phase|Protocol Violation|5|||
155519333|NCT01124149|561327259|FG000|Maintenance Phase|Coordinator error|1|||
155519334|NCT01124149|561327259|FG000|Maintenance Phase|Non-compliance|1|||
155519335|NCT02460159|561327260|FG000|Overall Study|Adverse Event|4|||
155519336|NCT02460159|561327261|FG001|Overall Study|Adverse Event|1|||
155519337|NCT02460159|561327260|FG000|Overall Study|Withdrawal by Subject|2|||
155519338|NCT02460159|561327261|FG001|Overall Study|Withdrawal by Subject|0|||
155519339|NCT00243932|561327262|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
155519340|NCT00243932|561327263|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
155519341|NCT00243932|561327264|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
155519342|NCT05518487|561327265|FG000|Overall Study|Withdrawal by Subject|3|||
155519343|NCT01458405|561327271|FG000|Phase 1 (up to 12 Months)|Other|0|||
155519344|NCT01458405|561327272|FG001|Phase 1 (up to 12 Months)|Other|1|||
155519345|NCT01458405|561327273|FG002|Phase 1 (up to 12 Months)|Other|0|||
155519346|NCT01458405|561327274|FG003|Phase 1 (up to 12 Months)|Other|0|||
155519347|NCT01458405|561327271|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
155519348|NCT01458405|561327272|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
155519349|NCT01458405|561327273|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
155519350|NCT01458405|561327274|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
155519351|NCT01458405|561327271|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
155519352|NCT01458405|561327272|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
155519353|NCT01458405|561327273|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
155519354|NCT01458405|561327274|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
155519355|NCT01458405|561327271|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
155519356|NCT01458405|561327272|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
155519357|NCT01458405|561327273|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
155519358|NCT01458405|561327274|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
155519359|NCT02497781|561327275|FG000|Overall Study|Withdrawal by Subject|2|||
155519360|NCT02497781|561327276|FG001|Overall Study|Withdrawal by Subject|0|||
155519361|NCT02497781|561327275|FG000|Overall Study|Lack of Efficacy|0|||
155519362|NCT02497781|561327276|FG001|Overall Study|Lack of Efficacy|1|||
155519363|NCT02497781|561327275|FG000|Overall Study|Randomised but not treated|1|||
155519364|NCT02497781|561327276|FG001|Overall Study|Randomised but not treated|1|||
155519365|NCT02497781|561327275|FG000|Overall Study|Lost to Follow-up|1|||
155519366|NCT02497781|561327276|FG001|Overall Study|Lost to Follow-up|1|||
155519367|NCT02674334|561327277|FG000|Overall Study|Lost to Follow-up|5|||
155519368|NCT02674334|561327278|FG001|Overall Study|Lost to Follow-up|3|||
155519369|NCT02674334|561327277|FG000|Overall Study|participant difficulty breathing|1|||
155519370|NCT02674334|561327278|FG001|Overall Study|participant difficulty breathing|0|||
155519371|NCT02674334|561327277|FG000|Overall Study|NIRS not recording|1|||
155476255|NCT04412668|561164014|FG002|Overall Study|Death - multiple comorbidities|0|||
155476256|NCT04412668|561164012|FG000|Overall Study|Withdrawal by Subject|3|||
155476257|NCT04412668|561164013|FG001|Overall Study|Withdrawal by Subject|0|||
155519372|NCT02674334|561327278|FG001|Overall Study|NIRS not recording|0|||
155519373|NCT05014412|561327283|FG000|Overall Study|Death|11|||
155519374|NCT05014412|561327284|FG001|Overall Study|Death|7|||
155476258|NCT04412668|561164014|FG002|Overall Study|Withdrawal by Subject|0|||
155476259|NCT04412668|561164012|FG000|Overall Study|Other than Specified|2|||
155519375|NCT05014412|561327285|FG002|Overall Study|Death|4|||
155476260|NCT04412668|561164013|FG001|Overall Study|Other than Specified|0|||
155476261|NCT04412668|561164014|FG002|Overall Study|Other than Specified|0|||
155476262|NCT03864627|561164016|FG000|Overall Study|Adverse Event|0|||
155476263|NCT03864627|561164017|FG001|Overall Study|Adverse Event|1|||
155476264|NCT03864627|561164016|FG000|Overall Study|Lack of Efficacy|0|||
155476265|NCT03864627|561164017|FG001|Overall Study|Lack of Efficacy|1|||
155476266|NCT03864627|561164016|FG000|Overall Study|Lost to Follow-up|0|||
155476267|NCT03864627|561164017|FG001|Overall Study|Lost to Follow-up|1|||
155476268|NCT03864627|561164016|FG000|Overall Study|Withdrawal by Subject|4|||
155476269|NCT03864627|561164017|FG001|Overall Study|Withdrawal by Subject|8|||
155476270|NCT03864627|561164016|FG000|Overall Study|Study terminated by sponsor|0|||
155476271|NCT03864627|561164017|FG001|Overall Study|Study terminated by sponsor|1|||
155476272|NCT01388491|561164019|FG000|Overall Study|Adverse Event|10|||
155476273|NCT01388491|561164020|FG001|Overall Study|Adverse Event|9|||
155476274|NCT01388491|561164019|FG000|Overall Study|Sponsor Request|9|||
155476275|NCT01388491|561164020|FG001|Overall Study|Sponsor Request|7|||
155476276|NCT01388491|561164019|FG000|Overall Study|Withdrawal by Subject|6|||
155476277|NCT01388491|561164020|FG001|Overall Study|Withdrawal by Subject|10|||
155476278|NCT01388491|561164019|FG000|Overall Study|Lost to Follow-up|4|||
155476279|NCT01388491|561164020|FG001|Overall Study|Lost to Follow-up|3|||
155476280|NCT01388491|561164019|FG000|Overall Study|Protocol Violation|2|||
155476281|NCT01388491|561164020|FG001|Overall Study|Protocol Violation|0|||
155476282|NCT01388491|561164019|FG000|Overall Study|Noncompliance|2|||
155519376|NCT05014412|561327286|FG003|Overall Study|Death|7|||
155654276|NCT00392288|561826940|FG001|Overall Study|Other|4|||
155654277|NCT00392288|561826941|FG002|Overall Study|Other|1|||
155654278|NCT04755231|561826944|FG000|Overall Study|Lost to Follow-up|5|||
155654279|NCT04755231|561826944|FG000|Overall Study|Withdrawal by Subject|5|||
155654280|NCT00025233|561826947|FG000|Overall Study|Ineligible: wrong cell type|1|||
155654281|NCT00025233|561826947|FG000|Overall Study|Ineligible: wrong primary|1|||
155654282|NCT00025233|561826947|FG000|Overall Study|Ineligible: improper prior treatment|1|||
155654283|NCT00025233|561826947|FG000|Overall Study|Never treated|1|||
155654284|NCT01720602|561826948|FG000|Overall Study|Adverse Event|3|||
155654285|NCT01720602|561826948|FG000|Overall Study|Progressive disease on therapy|2|||
155654286|NCT02184442|561826949|FG000|Overall Study|Death|61|||
155654287|NCT02184442|561826950|FG001|Overall Study|Death|65|||
155654288|NCT02184442|561826949|FG000|Overall Study|Withdrawal by Subject|3|||
155654289|NCT02184442|561826950|FG001|Overall Study|Withdrawal by Subject|11|||
155654290|NCT00787800|561826951|FG000|Overall Study|Withdrawal by Subject|3|||
155519377|NCT05014412|561327283|FG000|Overall Study|Withdrawal by Subject|1|||
155519378|NCT05014412|561327284|FG001|Overall Study|Withdrawal by Subject|1|||
155654291|NCT00787800|561826952|FG001|Overall Study|Withdrawal by Subject|5|||
155476283|NCT01388491|561164020|FG001|Overall Study|Noncompliance|0|||
155476284|NCT01388491|561164019|FG000|Overall Study|Pregnancy|1|||
155476285|NCT01388491|561164020|FG001|Overall Study|Pregnancy|0|||
155476286|NCT04035473|561164021|FG000|Screening/Baseline|Death|0|||
155476287|NCT04035473|561164022|FG001|Screening/Baseline|Death|1|||
155654292|NCT00787800|561826951|FG000|Overall Study|Death|0|||
155654293|NCT00787800|561826952|FG001|Overall Study|Death|2|||
155476288|NCT04035473|561164021|FG000|Screening/Baseline|Adverse Event|0|||
155654294|NCT00507507|561826956|FG000|Treatment Period|Lost to Follow-up|0|||
155654295|NCT00507507|561826957|FG001|Treatment Period|Lost to Follow-up|2|||
155654296|NCT00507507|561826956|FG000|Treatment Period|Physician Decision|4|||
155476289|NCT04035473|561164022|FG001|Screening/Baseline|Adverse Event|1|||
155476290|NCT04035473|561164021|FG000|Follow-up Period|Adverse Event|2|||
155476291|NCT04035473|561164022|FG001|Follow-up Period|Adverse Event|0|||
155476292|NCT00112840|561164023|FG000|Overall Study|Physician Decision|1|||
155476293|NCT00112840|561164024|FG001|Overall Study|Physician Decision|0|||
155476294|NCT00112840|561164025|FG002|Overall Study|Physician Decision|0|||
155476295|NCT00112840|561164023|FG000|Overall Study|Withdrawal by Subject|1|||
155476296|NCT00112840|561164024|FG001|Overall Study|Withdrawal by Subject|0|||
155476297|NCT00112840|561164025|FG002|Overall Study|Withdrawal by Subject|1|||
155476298|NCT00112840|561164023|FG000|Overall Study|Protocol Violation|0|||
155476299|NCT00112840|561164024|FG001|Overall Study|Protocol Violation|0|||
155519379|NCT05014412|561327285|FG002|Overall Study|Withdrawal by Subject|1|||
155519380|NCT05014412|561327286|FG003|Overall Study|Withdrawal by Subject|2|||
155519381|NCT05014412|561327283|FG000|Overall Study|Ongoing|21|||
155519382|NCT05014412|561327284|FG001|Overall Study|Ongoing|4|||
155476300|NCT00112840|561164025|FG002|Overall Study|Protocol Violation|5|||
155476301|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
155476302|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
155519383|NCT05014412|561327285|FG002|Overall Study|Ongoing|6|||
155654297|NCT00507507|561826957|FG001|Treatment Period|Physician Decision|1|||
155654298|NCT00507507|561826956|FG000|Treatment Period|Protocol Violation|1|||
155654299|NCT00507507|561826957|FG001|Treatment Period|Protocol Violation|2|||
155654300|NCT00507507|561826956|FG000|Treatment Period|Adverse Event|1|||
155654301|NCT00507507|561826957|FG001|Treatment Period|Adverse Event|1|||
155654302|NCT00507507|561826956|FG000|Treatment Period|Withdrawal by Subject|46|||
155654303|NCT00507507|561826957|FG001|Treatment Period|Withdrawal by Subject|47|||
155654304|NCT00507507|561826956|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
155654305|NCT00507507|561826957|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
155476303|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
155476304|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
155476305|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Other|13|||
155476306|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
155476307|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
155476308|NCT02497287|561164028|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
155476309|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
155476310|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
155476311|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
155476312|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
155476313|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
155654306|NCT00507507|561826956|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
155654307|NCT00507507|561826957|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
155476314|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
155476315|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
155476316|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
155476317|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
155476318|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
155476319|NCT02497287|561164028|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
155476320|NCT02497287|561164028|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
155476321|NCT02497287|561164028|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
155476322|NCT02497287|561164028|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
155476323|NCT02497287|561164028|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
155476324|NCT02497287|561164028|FG000|Follow-up Phase (4 Week)|Other|1|||
155476325|NCT03782376|561164029|FG000|Overall Study|Lost to Follow-up|2|||
155476326|NCT03782376|561164030|FG001|Overall Study|Lost to Follow-up|2|||
155476327|NCT03782376|561164029|FG000|Overall Study|Withdrawal by Subject|7|||
155476328|NCT03782376|561164030|FG001|Overall Study|Withdrawal by Subject|11|||
155476329|NCT03782376|561164029|FG000|Overall Study|Death|1|||
155476330|NCT03782376|561164030|FG001|Overall Study|Death|0|||
155654308|NCT00507507|561826956|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
155476331|NCT03782376|561164029|FG000|Overall Study|Other|16|||
155476332|NCT03782376|561164030|FG001|Overall Study|Other|17|||
155476333|NCT02659098|561164031|FG000|Overall Study|Withdrawal by Subject|7|||
155476334|NCT04363944|561164032|FG000|Overall Study|Withdrawal by Subject|2|||
155476335|NCT04363944|561164033|FG001|Overall Study|Withdrawal by Subject|0|||
155476336|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
155476337|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
155476338|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Death|0|||
155476339|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Death|4|||
155476340|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
155476341|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
155476342|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
155476343|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
155476344|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
155476345|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
155476346|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
155476347|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
155476348|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
155476349|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
155476350|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Other|4|||
155476351|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Other|3|||
155476352|NCT03517722|561164034|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
155476353|NCT03517722|561164035|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
155476354|NCT03517722|561164034|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
155476355|NCT03517722|561164035|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
155476356|NCT03517722|561164034|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
155476357|NCT03517722|561164035|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
155476358|NCT03517722|561164034|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
155476359|NCT03517722|561164035|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
155476360|NCT03517722|561164034|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
155476361|NCT03517722|561164035|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
155476362|NCT03573804|561164037|FG000|Overall Study|claustrophobia or MRI table problems|10|||
155476363|NCT00952419|561164038|FG000|Overall Study|Adverse Event|2|||
155476364|NCT00952419|561164039|FG001|Overall Study|Adverse Event|0|||
155476365|NCT00952419|561164040|FG002|Overall Study|Adverse Event|0|||
155476366|NCT00952419|561164038|FG000|Overall Study|Protocol Violation|3|||
155476367|NCT00952419|561164039|FG001|Overall Study|Protocol Violation|7|||
155476368|NCT00952419|561164040|FG002|Overall Study|Protocol Violation|0|||
155476369|NCT00952419|561164038|FG000|Overall Study|Withdrawal by Subject|1|||
155476370|NCT00952419|561164039|FG001|Overall Study|Withdrawal by Subject|3|||
155476371|NCT00952419|561164040|FG002|Overall Study|Withdrawal by Subject|0|||
155476372|NCT01592773|561165554|FG000|Overall Study|Study Terminated by Sponsor|582|||
155654309|NCT00507507|561826957|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
155476373|NCT01592773|561165554|FG000|Overall Study|Withdrawal by Subject|35|||
155476374|NCT01592773|561165554|FG000|Overall Study|Lost to Follow-up|19|||
155476375|NCT01592773|561165554|FG000|Overall Study|Adverse Event|17|||
155476376|NCT01592773|561165554|FG000|Overall Study|Lack of Efficacy|9|||
155476377|NCT01592773|561165554|FG000|Overall Study|Protocol Violation|2|||
155476378|NCT01592773|561165554|FG000|Overall Study|Inclusion/exclusion not meet|1|||
155476379|NCT01592773|561165554|FG000|Overall Study|Other Reason|1|||
155476380|NCT04418427|561165555|FG000|Overall Study|Death|0|||
155476381|NCT04418427|561165556|FG001|Overall Study|Death|1|||
155476382|NCT04418427|561165557|FG002|Overall Study|Death|0|||
155476383|NCT04418427|561165555|FG000|Overall Study|Lost to Follow-up|0|||
155476384|NCT04418427|561165556|FG001|Overall Study|Lost to Follow-up|2|||
155476385|NCT04418427|561165557|FG002|Overall Study|Lost to Follow-up|2|||
155476386|NCT04418427|561165555|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
155476387|NCT04418427|561165556|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
155476388|NCT04418427|561165557|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
155476389|NCT04418427|561165555|FG000|Overall Study|Pre-existing medical condition|0|||
155476390|NCT04418427|561165556|FG001|Overall Study|Pre-existing medical condition|1|||
155476391|NCT04418427|561165557|FG002|Overall Study|Pre-existing medical condition|0|||
155476392|NCT00121485|561165558|FG000|Overall Study|Not implanted|1|||
155476393|NCT00121485|561165559|FG001|Overall Study|Not implanted|5|||
155476394|NCT00121485|561165558|FG000|Overall Study|Crossover|0|||
155476395|NCT00121485|561165559|FG001|Overall Study|Crossover|2|||
155476396|NCT01654224|561165560|FG000|Overall Study|Lost to Follow-up|2|||
155476397|NCT01654224|561165561|FG001|Overall Study|Lost to Follow-up|2|||
155476398|NCT01654224|561165560|FG000|Overall Study|Did not receive allocation|1|||
155476399|NCT01654224|561165561|FG001|Overall Study|Did not receive allocation|8|||
155476400|NCT01654224|561165560|FG000|Overall Study|Insufficient blood sample|3|||
155476401|NCT01654224|561165561|FG001|Overall Study|Insufficient blood sample|2|||
155476402|NCT03763942|561165563|FG000|Overall Study|Lost to Follow-up|114|||
155476403|NCT03763942|561165564|FG001|Overall Study|Lost to Follow-up|54|||
155476404|NCT03763942|561165563|FG000|Overall Study|Protocol Violation|1|||
155476405|NCT03763942|561165564|FG001|Overall Study|Protocol Violation|0|||
155476406|NCT03763942|561165563|FG000|Overall Study|Withdrawal by Subject|2|||
155476407|NCT03763942|561165564|FG001|Overall Study|Withdrawal by Subject|0|||
155476408|NCT03763942|561165563|FG000|Overall Study|Other|2|||
155476409|NCT03763942|561165564|FG001|Overall Study|Other|3|||
155476410|NCT00166504|561165565|FG000|Overall Study|Adverse Event|3|||
155476411|NCT00166504|561165566|FG001|Overall Study|Adverse Event|3|||
155476412|NCT00166504|561165565|FG000|Overall Study|Lost to Follow-up|1|||
155476413|NCT00166504|561165566|FG001|Overall Study|Lost to Follow-up|1|||
155476414|NCT00166504|561165565|FG000|Overall Study|Withdrawal by Subject|1|||
155476415|NCT00166504|561165566|FG001|Overall Study|Withdrawal by Subject|0|||
155476416|NCT02200510|561165567|FG000|Overall Study|Death|1|||
155476417|NCT02200510|561165568|FG001|Overall Study|Death|1|||
155519384|NCT05014412|561327286|FG003|Overall Study|Ongoing|20|||
155519385|NCT00486837|561327288|FG000|Overall Study|Withdrawal by Subject|1|||
155654310|NCT03878069|561826958|FG000|Overall Study|Death|0|||
155476418|NCT02200510|561165567|FG000|Overall Study|Protocol Violation|0|||
155476419|NCT02200510|561165568|FG001|Overall Study|Protocol Violation|1|||
155476420|NCT02200510|561165567|FG000|Overall Study|Lost to Follow-up|7|||
155476421|NCT02200510|561165568|FG001|Overall Study|Lost to Follow-up|1|||
155476422|NCT02200510|561165567|FG000|Overall Study|potential COI - joined study team|1|||
155654311|NCT03878069|561826959|FG001|Overall Study|Death|1|||
155476423|NCT02200510|561165568|FG001|Overall Study|potential COI - joined study team|0|||
155476424|NCT04423718|561165573|FG000|Main Study|Adverse Event|9|||
155476425|NCT04423718|561165574|FG001|Main Study|Adverse Event|5|||
155476426|NCT04423718|561165575|FG002|Main Study|Adverse Event|8|||
155476427|NCT04423718|561165573|FG000|Main Study|Physician Decision|3|||
155476428|NCT04423718|561165574|FG001|Main Study|Physician Decision|3|||
155476429|NCT04423718|561165575|FG002|Main Study|Physician Decision|2|||
155476430|NCT04423718|561165573|FG000|Main Study|Protocol Violation|0|||
155476431|NCT04423718|561165574|FG001|Main Study|Protocol Violation|0|||
155476432|NCT04423718|561165575|FG002|Main Study|Protocol Violation|1|||
155476433|NCT04423718|561165573|FG000|Main Study|Lost to Follow-up|3|||
155476434|NCT04423718|561165574|FG001|Main Study|Lost to Follow-up|3|||
155476435|NCT04423718|561165575|FG002|Main Study|Lost to Follow-up|4|||
155476436|NCT04423718|561165573|FG000|Main Study|Lack of Efficacy|2|||
155476437|NCT04423718|561165574|FG001|Main Study|Lack of Efficacy|1|||
155476438|NCT04423718|561165575|FG002|Main Study|Lack of Efficacy|0|||
155476439|NCT04423718|561165573|FG000|Main Study|Withdrawal by Subject|14|||
155476440|NCT04423718|561165574|FG001|Main Study|Withdrawal by Subject|20|||
155476441|NCT04423718|561165575|FG002|Main Study|Withdrawal by Subject|20|||
155476442|NCT04423718|561165573|FG000|Main Study|Death|10|||
155476443|NCT04423718|561165574|FG001|Main Study|Death|7|||
155476444|NCT04423718|561165575|FG002|Main Study|Death|7|||
155476445|NCT04423718|561165573|FG000|Main Study|COVID-19 pandemic|2|||
155476446|NCT04423718|561165574|FG001|Main Study|COVID-19 pandemic|2|||
155476447|NCT04423718|561165575|FG002|Main Study|COVID-19 pandemic|2|||
155476448|NCT04423718|561165573|FG000|Main Study|Other|7|||
155476449|NCT04423718|561165574|FG001|Main Study|Other|3|||
155476450|NCT04423718|561165575|FG002|Main Study|Other|2|||
155476451|NCT04423718|561165573|FG000|Extension Phase|Other|1|||
155476452|NCT04423718|561165574|FG001|Extension Phase|Other|0|||
155476453|NCT04423718|561165575|FG002|Extension Phase|Other|0|||
155476454|NCT04423718|561165573|FG000|Extension Phase|Logistical problems|0|||
155476455|NCT04423718|561165574|FG001|Extension Phase|Logistical problems|1|||
155476456|NCT04423718|561165575|FG002|Extension Phase|Logistical problems|1|||
155476457|NCT04423718|561165573|FG000|Extension Phase|Physician Decision|1|||
155476458|NCT04423718|561165574|FG001|Extension Phase|Physician Decision|0|||
155476459|NCT04423718|561165575|FG002|Extension Phase|Physician Decision|1|||
155476460|NCT04423718|561165573|FG000|Extension Phase|Lack of Efficacy|2|||
155476461|NCT04423718|561165574|FG001|Extension Phase|Lack of Efficacy|0|||
155476462|NCT04423718|561165575|FG002|Extension Phase|Lack of Efficacy|1|||
155476463|NCT04423718|561165573|FG000|Extension Phase|Lost to Follow-up|0|||
155476464|NCT04423718|561165574|FG001|Extension Phase|Lost to Follow-up|2|||
155476465|NCT04423718|561165575|FG002|Extension Phase|Lost to Follow-up|3|||
155476466|NCT04423718|561165573|FG000|Extension Phase|Adverse Event|2|||
155476467|NCT04423718|561165574|FG001|Extension Phase|Adverse Event|3|||
155476468|NCT04423718|561165575|FG002|Extension Phase|Adverse Event|1|||
155476469|NCT04423718|561165573|FG000|Extension Phase|Death|4|||
155476470|NCT04423718|561165574|FG001|Extension Phase|Death|7|||
155476471|NCT04423718|561165575|FG002|Extension Phase|Death|2|||
155476472|NCT04423718|561165573|FG000|Extension Phase|Withdrawal by Subject|11|||
155476473|NCT04423718|561165574|FG001|Extension Phase|Withdrawal by Subject|11|||
155476474|NCT04423718|561165575|FG002|Extension Phase|Withdrawal by Subject|7|||
155476475|NCT05298774|561165580|FG000|Overall Study|Physician Decision|3|||
155476476|NCT05298774|561165580|FG000|Overall Study|Withdrawal by Subject|2|||
155476477|NCT05298774|561165580|FG000|Overall Study|Lost to Follow-up|3|||
155476478|NCT05298774|561165580|FG000|Overall Study|Screen failure|1|||
155476479|NCT04992507|561165581|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
155476480|NCT04992507|561165582|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
155476481|NCT04992507|561165581|FG000|Overall Study|Death|0|||
155476482|NCT04992507|561165582|FG001|Overall Study|Death|1|||
155476483|NCT04651777|561165584|FG000|Overall Study|Adverse Event|1|||
155476484|NCT04651777|561165584|FG000|Overall Study|Withdrawal by Subject|2|||
155476485|NCT03070119|561165586|FG000|Overall Study|Adverse Event|0|||
155476486|NCT03070119|561165587|FG001|Overall Study|Adverse Event|0|||
155476487|NCT03070119|561165588|FG002|Overall Study|Adverse Event|1|||
155476488|NCT03070119|561165586|FG000|Overall Study|Lost to Follow-up|0|||
155476489|NCT03070119|561165587|FG001|Overall Study|Lost to Follow-up|1|||
155476490|NCT03070119|561165588|FG002|Overall Study|Lost to Follow-up|0|||
155476491|NCT03070119|561165586|FG000|Overall Study|Consent Withdrawn|6|||
155476492|NCT03070119|561165587|FG001|Overall Study|Consent Withdrawn|5|||
155476493|NCT03070119|561165588|FG002|Overall Study|Consent Withdrawn|3|||
155476494|NCT03070119|561165586|FG000|Overall Study|Investigator Decision|0|||
155476495|NCT03070119|561165587|FG001|Overall Study|Investigator Decision|0|||
155476496|NCT03070119|561165588|FG002|Overall Study|Investigator Decision|1|||
155476497|NCT03070119|561165586|FG000|Overall Study|Death|7|||
155476498|NCT03070119|561165587|FG001|Overall Study|Death|14|||
155476499|NCT03070119|561165588|FG002|Overall Study|Death|5|||
155476500|NCT03070119|561165586|FG000|Overall Study|Disease Progression|5|||
155476501|NCT03070119|561165587|FG001|Overall Study|Disease Progression|7|||
155476502|NCT03070119|561165588|FG002|Overall Study|Disease Progression|7|||
155476503|NCT03070119|561165586|FG000|Overall Study|Reason not Specified|2|||
155476504|NCT03070119|561165587|FG001|Overall Study|Reason not Specified|2|||
155476505|NCT03070119|561165588|FG002|Overall Study|Reason not Specified|1|||
155476506|NCT01023516|561165589|FG000|Overall Study|Voluntary discontinuation|7|||
155476507|NCT01023516|561165590|FG001|Overall Study|Voluntary discontinuation|5|||
155476508|NCT01023516|561165589|FG000|Overall Study|Adverse Event|9|||
155476509|NCT01023516|561165590|FG001|Overall Study|Adverse Event|6|||
155476510|NCT01023516|561165589|FG000|Overall Study|Safety reason|0|||
155476511|NCT01023516|561165590|FG001|Overall Study|Safety reason|3|||
155476512|NCT01023516|561165589|FG000|Overall Study|Study-specific criteria|4|||
155476513|NCT01023516|561165590|FG001|Overall Study|Study-specific criteria|2|||
155476514|NCT01023516|561165589|FG000|Overall Study|Incorrect enrolment|4|||
155476515|NCT01023516|561165590|FG001|Overall Study|Incorrect enrolment|2|||
155476516|NCT02060903|561165591|FG000|Overall Study|Lost to Follow-up|4|||
155476517|NCT02060903|561165592|FG001|Overall Study|Lost to Follow-up|0|||
155476518|NCT02060903|561165591|FG000|Overall Study|Withdrawal by Subject|0|||
155476519|NCT02060903|561165592|FG001|Overall Study|Withdrawal by Subject|7|||
155476520|NCT01058395|561165593|FG000|Overall Study|Death|2|||
155476521|NCT01058395|561165594|FG001|Overall Study|Death|1|||
155476522|NCT01058395|561165593|FG000|Overall Study|Lost to Follow-up|1|||
155476523|NCT01058395|561165594|FG001|Overall Study|Lost to Follow-up|0|||
155476524|NCT01996865|561165595|FG000|Induction Period|Protocol Violation|1|||
155476525|NCT01996865|561165596|FG001|Induction Period|Protocol Violation|0|||
155476526|NCT01996865|561165597|FG002|Induction Period|Protocol Violation|0|||
155476527|NCT01996865|561165595|FG000|Induction Period|Progressive Disease|4|||
155476528|NCT01996865|561165596|FG001|Induction Period|Progressive Disease|0|||
155476529|NCT01996865|561165597|FG002|Induction Period|Progressive Disease|0|||
155476530|NCT01996865|561165595|FG000|Induction Period|Lost to Follow-up|10|||
155476531|NCT01996865|561165596|FG001|Induction Period|Lost to Follow-up|0|||
155476532|NCT01996865|561165597|FG002|Induction Period|Lost to Follow-up|0|||
155476533|NCT01996865|561165595|FG000|Induction Period|Other Reasons|13|||
155476534|NCT01996865|561165596|FG001|Induction Period|Other Reasons|0|||
155476535|NCT01996865|561165597|FG002|Induction Period|Other Reasons|0|||
155476536|NCT01996865|561165595|FG000|Induction Period|Adverse Event|20|||
155476537|NCT01996865|561165596|FG001|Induction Period|Adverse Event|0|||
155476538|NCT01996865|561165597|FG002|Induction Period|Adverse Event|0|||
155476539|NCT01996865|561165595|FG000|Induction Period|Withdrawal by Subject|60|||
155476540|NCT01996865|561165596|FG001|Induction Period|Withdrawal by Subject|0|||
155476541|NCT01996865|561165597|FG002|Induction Period|Withdrawal by Subject|0|||
155476542|NCT01996865|561165595|FG000|Induction Period|Death|111|||
155476543|NCT01996865|561165596|FG001|Induction Period|Death|0|||
155476544|NCT01996865|561165597|FG002|Induction Period|Death|0|||
155476545|NCT01996865|561165595|FG000|Maintenance Period|Protocol Violation|0|||
155476546|NCT01996865|561165596|FG001|Maintenance Period|Protocol Violation|1|||
155476547|NCT01996865|561165597|FG002|Maintenance Period|Protocol Violation|1|||
155476548|NCT01996865|561165595|FG000|Maintenance Period|Other reasons|0|||
155476549|NCT01996865|561165596|FG001|Maintenance Period|Other reasons|8|||
155476550|NCT01996865|561165597|FG002|Maintenance Period|Other reasons|5|||
155476551|NCT01996865|561165595|FG000|Maintenance Period|Progressive Disease|0|||
155476552|NCT01996865|561165596|FG001|Maintenance Period|Progressive Disease|6|||
155476553|NCT01996865|561165597|FG002|Maintenance Period|Progressive Disease|23|||
155476554|NCT01996865|561165595|FG000|Maintenance Period|Withdrawal by Subject|0|||
155476555|NCT01996865|561165596|FG001|Maintenance Period|Withdrawal by Subject|18|||
155519386|NCT00486837|561327289|FG001|Overall Study|Withdrawal by Subject|0|||
155519387|NCT00486837|561327288|FG000|Overall Study|Adverse Event|1|||
155519388|NCT00486837|561327289|FG001|Overall Study|Adverse Event|1|||
155519389|NCT00486837|561327288|FG000|Overall Study|Protocol Violation|4|||
155519390|NCT00486837|561327289|FG001|Overall Study|Protocol Violation|2|||
155519391|NCT00486837|561327288|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
155519392|NCT00486837|561327289|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
155476556|NCT01996865|561165597|FG002|Maintenance Period|Withdrawal by Subject|4|||
155476557|NCT01996865|561165595|FG000|Maintenance Period|Adverse Event|0|||
155476558|NCT01996865|561165596|FG001|Maintenance Period|Adverse Event|7|||
155476559|NCT01996865|561165597|FG002|Maintenance Period|Adverse Event|7|||
155476560|NCT01996865|561165595|FG000|Maintenance Period|Death|0|||
155476561|NCT01996865|561165596|FG001|Maintenance Period|Death|15|||
155519393|NCT05295953|561327290|FG000|Overall Study|Withdrawal by Subject|0|||
155519394|NCT05295953|561327291|FG001|Overall Study|Withdrawal by Subject|1|||
155519395|NCT04257929|561327293|FG000|Overall Study|Adverse Event|1|||
155519396|NCT04257929|561327294|FG001|Overall Study|Adverse Event|0|||
155519397|NCT04257929|561327295|FG002|Overall Study|Adverse Event|1|||
155519398|NCT04257929|561327293|FG000|Overall Study|Withdrawal by Subject|1|||
155519399|NCT04257929|561327294|FG001|Overall Study|Withdrawal by Subject|0|||
155519400|NCT04257929|561327295|FG002|Overall Study|Withdrawal by Subject|0|||
155519401|NCT04257929|561327293|FG000|Overall Study|COVID-19|0|||
155519402|NCT04257929|561327294|FG001|Overall Study|COVID-19|1|||
155519403|NCT04257929|561327295|FG002|Overall Study|COVID-19|1|||
155519404|NCT04257929|561327293|FG000|Overall Study|Lost to Follow-up|0|||
155519405|NCT04257929|561327294|FG001|Overall Study|Lost to Follow-up|0|||
155519406|NCT04257929|561327295|FG002|Overall Study|Lost to Follow-up|1|||
155654312|NCT03878069|561826960|FG002|Overall Study|Death|0|||
155519407|NCT05630547|561327296|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
155519408|NCT05630547|561327297|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
155519409|NCT05630547|561327298|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
155519410|NCT05630547|561327299|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
155519411|NCT05630547|561327296|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
155519412|NCT05630547|561327297|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
155519413|NCT05630547|561327298|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
155519414|NCT05630547|561327299|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
155519415|NCT05630547|561327296|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
155519416|NCT05630547|561327297|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
155519417|NCT05630547|561327298|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
155519418|NCT05630547|561327299|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
155519419|NCT05630547|561327296|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
155519420|NCT05630547|561327297|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
155519421|NCT05630547|561327298|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
155519422|NCT05630547|561327299|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
155519423|NCT05630547|561327296|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
155519424|NCT05630547|561327297|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
155519425|NCT05630547|561327298|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
155519426|NCT05630547|561327299|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
155519427|NCT05630547|561327296|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
155519428|NCT05630547|561327297|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
155476562|NCT01996865|561165597|FG002|Maintenance Period|Death|3|||
155476563|NCT01996865|561165595|FG000|Maintenance Period|Lost to Follow-up|0|||
155476564|NCT01996865|561165596|FG001|Maintenance Period|Lost to Follow-up|2|||
155476565|NCT01996865|561165597|FG002|Maintenance Period|Lost to Follow-up|0|||
155476566|NCT05304611|561165598|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476567|NCT05304611|561165599|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476568|NCT05304611|561165600|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476569|NCT05304611|561165601|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476570|NCT05304611|561165602|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476571|NCT05304611|561165603|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476572|NCT05304611|561165604|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
155476573|NCT05304611|561165605|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476574|NCT05304611|561165606|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
155476575|NCT05304611|561165607|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476576|NCT05304611|561165608|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476577|NCT05304611|561165609|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
155476578|NCT05304611|561165598|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
155476579|NCT05304611|561165599|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
155476580|NCT05304611|561165600|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
155476581|NCT05304611|561165601|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
155476582|NCT05304611|561165602|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
155476583|NCT05304611|561165603|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
155476584|NCT05304611|561165604|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
155476585|NCT05304611|561165605|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
155476586|NCT05304611|561165606|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
155476587|NCT05304611|561165607|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
155476588|NCT05304611|561165608|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
155476589|NCT05304611|561165609|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
155476590|NCT05304611|561165598|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
155476591|NCT05304611|561165599|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
155654313|NCT06790303|561828830|FG000|Overall Study|Study Terminated by sponsor|4|||
155654314|NCT06790303|561828830|FG000|Overall Study|Death|4|||
155654315|NCT02579759|561828836|FG000|Overall Study|Protocol Violation|2|||
155654316|NCT02579759|561828837|FG001|Overall Study|Protocol Violation|0|||
155654317|NCT02579759|561828838|FG002|Overall Study|Protocol Violation|0|||
155654318|NCT02579759|561828836|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
155654319|NCT02579759|561828837|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
155654320|NCT02579759|561828838|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
155654321|NCT02579759|561828836|FG000|Overall Study|BfArM hold|13|||
155654322|NCT02579759|561828837|FG001|Overall Study|BfArM hold|12|||
155654323|NCT02579759|561828838|FG002|Overall Study|BfArM hold|12|||
155654324|NCT02579759|561828836|FG000|Overall Study|Sponsor stopped Dose 2|0|||
155654325|NCT02579759|561828837|FG001|Overall Study|Sponsor stopped Dose 2|41|||
155654326|NCT02579759|561828838|FG002|Overall Study|Sponsor stopped Dose 2|0|||
155654327|NCT02579759|561828836|FG000|Overall Study|Non compliance|0|||
155654328|NCT02579759|561828837|FG001|Overall Study|Non compliance|1|||
155654329|NCT02579759|561828838|FG002|Overall Study|Non compliance|0|||
155654330|NCT02579759|561828836|FG000|Overall Study|Pregnancy|0|||
155654331|NCT02579759|561828837|FG001|Overall Study|Pregnancy|1|||
155654332|NCT02579759|561828838|FG002|Overall Study|Pregnancy|0|||
155654333|NCT02579759|561828836|FG000|Overall Study|Inclusion/exclusion criteria|0|||
155654334|NCT02579759|561828837|FG001|Overall Study|Inclusion/exclusion criteria|0|||
155654335|NCT02579759|561828838|FG002|Overall Study|Inclusion/exclusion criteria|1|||
155654336|NCT02579759|561828836|FG000|Overall Study|Adverse Event|4|||
155654337|NCT02579759|561828837|FG001|Overall Study|Adverse Event|3|||
155654338|NCT02579759|561828838|FG002|Overall Study|Adverse Event|1|||
155654339|NCT02579759|561828836|FG000|Overall Study|Withdrawal by Subject|3|||
155654340|NCT02579759|561828837|FG001|Overall Study|Withdrawal by Subject|3|||
155476592|NCT05304611|561165600|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
155476593|NCT05304611|561165601|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
155654341|NCT02579759|561828838|FG002|Overall Study|Withdrawal by Subject|5|||
155654342|NCT02579759|561828836|FG000|Overall Study|Lost to Follow-up|2|||
155654343|NCT02579759|561828837|FG001|Overall Study|Lost to Follow-up|2|||
155654344|NCT02579759|561828838|FG002|Overall Study|Lost to Follow-up|2|||
155654345|NCT00833703|561828841|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
155654346|NCT00833703|561828842|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
155654347|NCT01356940|561828850|FG000|First Intervention (28 Days)|Adverse Event|1|||
155654348|NCT01356940|561828851|FG001|First Intervention (28 Days)|Adverse Event|0|||
155654349|NCT01356940|561828850|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
155476594|NCT05304611|561165602|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
155476595|NCT05304611|561165603|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
155476596|NCT05304611|561165604|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
155476597|NCT05304611|561165605|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
155476598|NCT05304611|561165606|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
155476599|NCT05304611|561165607|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
155476600|NCT05304611|561165608|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
155476601|NCT05304611|561165609|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
155476602|NCT02354690|561165610|FG000|Overall Study|Physician Decision|1|||
155476603|NCT00515099|561165611|FG000|Overall Study|Lost to Follow-up|0|||
155476604|NCT00515099|561165612|FG001|Overall Study|Lost to Follow-up|4|||
155476605|NCT00515099|561165611|FG000|Overall Study|Withdrawal by Subject|2|||
155476606|NCT00515099|561165612|FG001|Overall Study|Withdrawal by Subject|0|||
155476607|NCT00515099|561165611|FG000|Overall Study|IRB Recommendation|1|||
155476608|NCT00515099|561165612|FG001|Overall Study|IRB Recommendation|0|||
155476609|NCT03342404|561165613|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
155476610|NCT03342404|561165614|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
155476611|NCT03342404|561165613|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
155476612|NCT03342404|561165614|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
155476613|NCT03342404|561165613|FG000|Blinded Treatment Phase|Adverse Event|5|||
155476614|NCT03342404|561165614|FG001|Blinded Treatment Phase|Adverse Event|4|||
155476615|NCT03342404|561165613|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
155476616|NCT03342404|561165614|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
155476617|NCT03342404|561165613|FG000|Blinded Treatment Phase|Other reasons|1|||
155476618|NCT03342404|561165614|FG001|Blinded Treatment Phase|Other reasons|0|||
155476619|NCT03342404|561165613|FG000|Blinded Treatment Phase|Physician Decision|1|||
155476620|NCT03342404|561165614|FG001|Blinded Treatment Phase|Physician Decision|0|||
155476621|NCT03342404|561165613|FG000|Blinded Treatment Phase|Death|1|||
155476622|NCT03342404|561165614|FG001|Blinded Treatment Phase|Death|0|||
155654350|NCT01356940|561828851|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
155654351|NCT03412591|561828857|FG000|Overall Study|Withdrawal by Subject|1|||
155654352|NCT03412591|561828858|FG001|Overall Study|Withdrawal by Subject|8|||
155654353|NCT03412591|561828857|FG000|Overall Study|Adverse Event|0|||
155654354|NCT03412591|561828858|FG001|Overall Study|Adverse Event|1|||
155654355|NCT02272985|561828859|FG000|Overall Study|Withdrawal by Subject|1|||
155654356|NCT02272985|561828859|FG000|Overall Study|hip fracture|1|||
155654357|NCT02272985|561828859|FG000|Overall Study|kidney transplantation|1|||
155476623|NCT03342404|561165613|FG000|Open-Label Phase|Lost to Follow-up|0|||
155476624|NCT03342404|561165614|FG001|Open-Label Phase|Lost to Follow-up|1|||
155476625|NCT03342404|561165613|FG000|Open-Label Phase|Other reasons|0|||
155476626|NCT03342404|561165614|FG001|Open-Label Phase|Other reasons|1|||
155476627|NCT03342404|561165613|FG000|Open-Label Phase|Adverse Event|0|||
155476628|NCT03342404|561165614|FG001|Open-Label Phase|Adverse Event|3|||
155476629|NCT03342404|561165613|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155476630|NCT03342404|561165614|FG001|Open-Label Phase|Withdrawal by Subject|6|||
155476631|NCT05333289|561165615|FG000|Overall Study|Other|1|||
155476632|NCT05333289|561165616|FG001|Overall Study|Other|0|||
155476633|NCT05333289|561165617|FG002|Overall Study|Other|0|||
155476634|NCT05333289|561165618|FG003|Overall Study|Other|1|||
155476635|NCT05333289|561165619|FG004|Overall Study|Other|1|||
155476636|NCT05333289|561165620|FG005|Overall Study|Other|2|||
155476637|NCT05333289|561165621|FG006|Overall Study|Other|2|||
155476638|NCT05333289|561165622|FG007|Overall Study|Other|0|||
155476639|NCT05333289|561165615|FG000|Overall Study|Withdrawal by Subject|1|||
155476640|NCT05333289|561165616|FG001|Overall Study|Withdrawal by Subject|2|||
155476641|NCT05333289|561165617|FG002|Overall Study|Withdrawal by Subject|2|||
155476642|NCT05333289|561165618|FG003|Overall Study|Withdrawal by Subject|1|||
155476643|NCT05333289|561165619|FG004|Overall Study|Withdrawal by Subject|1|||
155476644|NCT05333289|561165620|FG005|Overall Study|Withdrawal by Subject|2|||
155476645|NCT05333289|561165621|FG006|Overall Study|Withdrawal by Subject|1|||
155476646|NCT05333289|561165622|FG007|Overall Study|Withdrawal by Subject|3|||
155476647|NCT05333289|561165615|FG000|Overall Study|Protocol Violation|1|||
155476648|NCT05333289|561165616|FG001|Overall Study|Protocol Violation|0|||
155476649|NCT05333289|561165617|FG002|Overall Study|Protocol Violation|0|||
155476650|NCT05333289|561165618|FG003|Overall Study|Protocol Violation|0|||
155476651|NCT05333289|561165619|FG004|Overall Study|Protocol Violation|0|||
155476652|NCT05333289|561165620|FG005|Overall Study|Protocol Violation|0|||
155476653|NCT05333289|561165621|FG006|Overall Study|Protocol Violation|0|||
155476654|NCT05333289|561165622|FG007|Overall Study|Protocol Violation|0|||
155476655|NCT05333289|561165615|FG000|Overall Study|Physician Decision|0|||
155476656|NCT05333289|561165616|FG001|Overall Study|Physician Decision|0|||
155476657|NCT05333289|561165617|FG002|Overall Study|Physician Decision|1|||
155476658|NCT05333289|561165618|FG003|Overall Study|Physician Decision|0|||
155476659|NCT05333289|561165619|FG004|Overall Study|Physician Decision|0|||
155476660|NCT05333289|561165620|FG005|Overall Study|Physician Decision|2|||
155476661|NCT05333289|561165621|FG006|Overall Study|Physician Decision|0|||
155476662|NCT05333289|561165622|FG007|Overall Study|Physician Decision|0|||
155476663|NCT05333289|561165615|FG000|Overall Study|Lost to Follow-up|6|||
155476664|NCT05333289|561165616|FG001|Overall Study|Lost to Follow-up|0|||
155476665|NCT05333289|561165617|FG002|Overall Study|Lost to Follow-up|1|||
155476666|NCT05333289|561165618|FG003|Overall Study|Lost to Follow-up|6|||
155476667|NCT05333289|561165619|FG004|Overall Study|Lost to Follow-up|3|||
155476668|NCT05333289|561165620|FG005|Overall Study|Lost to Follow-up|3|||
155476669|NCT05333289|561165621|FG006|Overall Study|Lost to Follow-up|2|||
155654358|NCT00505687|561828862|FG000|Overall Study|Important protocol violation|2|||
155476670|NCT05333289|561165622|FG007|Overall Study|Lost to Follow-up|1|||
155476671|NCT05333289|561165615|FG000|Overall Study|Death|1|||
155476672|NCT05333289|561165616|FG001|Overall Study|Death|0|||
155476673|NCT05333289|561165617|FG002|Overall Study|Death|0|||
155476674|NCT05333289|561165618|FG003|Overall Study|Death|0|||
155654359|NCT00505687|561828862|FG000|Overall Study|Lack of Efficacy|15|||
155476675|NCT05333289|561165619|FG004|Overall Study|Death|0|||
155476676|NCT05333289|561165620|FG005|Overall Study|Death|0|||
155476677|NCT05333289|561165621|FG006|Overall Study|Death|0|||
155476678|NCT05333289|561165622|FG007|Overall Study|Death|0|||
155476679|NCT00372489|561165625|FG000|Overall Study|Adverse Event|18|||
155476680|NCT00372489|561165625|FG000|Overall Study|Lack of Efficacy|1|||
155476681|NCT00372489|561165625|FG000|Overall Study|Lost to Follow-up|3|||
155476682|NCT00372489|561165625|FG000|Overall Study|Physician Decision|3|||
155476683|NCT00372489|561165625|FG000|Overall Study|Withdrawal by Subject|5|||
155476684|NCT00372489|561165625|FG000|Overall Study|Patient Relocation|2|||
155476685|NCT00372489|561165625|FG000|Overall Study|Renal transplant|6|||
155476686|NCT00372489|561165625|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
155476687|NCT04430036|561165633|FG000|Safety Run in Phase|Progression of disease|2|||
155476688|NCT05559203|561165634|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
155476689|NCT01249157|561165635|FG000|Overall Study|Withdrawal by Subject|1|||
155476690|NCT02392468|561165636|FG000|Overall Study|Adverse Event|0|||
155476691|NCT02392468|561165637|FG001|Overall Study|Adverse Event|1|||
155476692|NCT02392468|561165638|FG002|Overall Study|Adverse Event|0|||
155476693|NCT02392468|561165639|FG003|Overall Study|Adverse Event|0|||
155476694|NCT02392468|561165640|FG004|Overall Study|Adverse Event|0|||
155476695|NCT02392468|561165641|FG005|Overall Study|Adverse Event|1|||
155476696|NCT03630016|561165642|FG000|Overall Study|Poor Sensor Placement|1|||
155476697|NCT05083949|561165643|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
155476698|NCT05083949|561165644|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
155476699|NCT05083949|561165643|FG000|Period 1|Adverse Event|1|||
155476700|NCT05083949|561165644|FG001|Period 1|Adverse Event|1|||
155476701|NCT05083949|561165643|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
155476702|NCT05083949|561165644|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
155476703|NCT05083949|561165643|FG000|Period 2|Adverse Event|0|||
155476704|NCT05083949|561165644|FG001|Period 2|Adverse Event|2|||
155476705|NCT01678560|561165647|FG000|Overall Study|Physician Decision|4|||
155476706|NCT01678560|561165648|FG001|Overall Study|Physician Decision|4|||
155476707|NCT01678560|561165647|FG000|Overall Study|Death|0|||
155476708|NCT01678560|561165648|FG001|Overall Study|Death|1|||
155476709|NCT01678560|561165647|FG000|Overall Study|Withdrawal by Subject|0|||
155476710|NCT01678560|561165648|FG001|Overall Study|Withdrawal by Subject|1|||
155476711|NCT00959699|561165649|FG000|Treatment Period|Adverse Event|3|||
155476712|NCT00959699|561165650|FG001|Treatment Period|Adverse Event|13|||
155476713|NCT00959699|561165649|FG000|Treatment Period|Lack of Efficacy|15|||
155476714|NCT00959699|561165650|FG001|Treatment Period|Lack of Efficacy|6|||
155476715|NCT00959699|561165649|FG000|Treatment Period|Lost to Follow-up|0|||
155476716|NCT00959699|561165650|FG001|Treatment Period|Lost to Follow-up|1|||
155476717|NCT00959699|561165649|FG000|Treatment Period|Withdrawal by Subject|1|||
155476718|NCT00959699|561165650|FG001|Treatment Period|Withdrawal by Subject|3|||
155476719|NCT00959699|561165649|FG000|Treatment Period|Non-Compliance with Protocol|0|||
155476720|NCT00959699|561165650|FG001|Treatment Period|Non-Compliance with Protocol|1|||
155476721|NCT00959699|561165649|FG000|Treatment Period|Did not receive treatment|0|||
155476722|NCT00959699|561165650|FG001|Treatment Period|Did not receive treatment|1|||
155476723|NCT00959699|561165649|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
155476724|NCT00959699|561165650|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
155476725|NCT00959699|561165649|FG000|Follow-up Period|Lost to Follow-up|3|||
155476726|NCT00959699|561165650|FG001|Follow-up Period|Lost to Follow-up|2|||
155476727|NCT00959699|561165649|FG000|Follow-up Period|Withdrawal by Subject|3|||
155476728|NCT00959699|561165650|FG001|Follow-up Period|Withdrawal by Subject|4|||
155476729|NCT04228445|561165651|FG000|Overall Study|Lost to Follow-up|1|||
155476730|NCT04228445|561165652|FG001|Overall Study|Lost to Follow-up|1|||
155476731|NCT04228445|561165651|FG000|Overall Study|Physician Decision|1|||
155476732|NCT04228445|561165652|FG001|Overall Study|Physician Decision|2|||
155476733|NCT04228445|561165651|FG000|Overall Study|Withdrawal by Subject|0|||
155476734|NCT04228445|561165652|FG001|Overall Study|Withdrawal by Subject|1|||
155476735|NCT04228445|561165651|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
155476736|NCT04228445|561165652|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
155476737|NCT00606294|561165655|FG000|Overall Study|Withdrawal by Subject|36|||
155476738|NCT00606294|561165656|FG001|Overall Study|Withdrawal by Subject|0|||
155476739|NCT03924427|561165657|FG000|Overall Study|Adverse Event|4|||
155476740|NCT03924427|561165657|FG000|Overall Study|Lack of Efficacy|1|||
155476741|NCT03924427|561165657|FG000|Overall Study|Withdrawal by Subject|1|||
155476742|NCT00471315|561165663|FG000|Overall Study|Adverse Event|7|||
155476743|NCT00471315|561165663|FG000|Overall Study|Withdrawal by Subject|1|||
155476744|NCT01365091|561165664|FG000|Period 1|Adverse Event|1|||
155476745|NCT01365091|561165665|FG001|Period 1|Adverse Event|0|||
155476746|NCT01365091|561165666|FG002|Period 1|Adverse Event|2|||
155476747|NCT01365091|561165667|FG003|Period 1|Adverse Event|3|||
155476748|NCT01365091|561165664|FG000|Period 1|Positive test result for drugs of abuse|1|||
155476749|NCT01365091|561165665|FG001|Period 1|Positive test result for drugs of abuse|0|||
155476750|NCT01365091|561165666|FG002|Period 1|Positive test result for drugs of abuse|0|||
155476751|NCT01365091|561165667|FG003|Period 1|Positive test result for drugs of abuse|0|||
155476752|NCT01365091|561165664|FG000|Period 1|No longer met study criteria|0|||
155476753|NCT01365091|561165665|FG001|Period 1|No longer met study criteria|1|||
155476754|NCT01365091|561165666|FG002|Period 1|No longer met study criteria|0|||
155476755|NCT01365091|561165667|FG003|Period 1|No longer met study criteria|0|||
155476756|NCT01365091|561165664|FG000|Period 1|Withdrawal by Subject|0|||
155519429|NCT05630547|561327298|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
155519430|NCT05630547|561327299|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
155519431|NCT05630547|561327296|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
155519432|NCT05630547|561327297|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
155519433|NCT05630547|561327298|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
155519434|NCT05630547|561327299|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
155519435|NCT05630547|561327296|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
155519436|NCT05630547|561327297|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
155519437|NCT05630547|561327298|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
155519438|NCT05630547|561327299|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
155519439|NCT05630547|561327296|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
155519440|NCT05630547|561327297|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
155519441|NCT05630547|561327298|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
155519442|NCT05630547|561327299|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
155519443|NCT05630547|561327296|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
155519444|NCT05630547|561327297|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
155519445|NCT05630547|561327298|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
155519446|NCT05630547|561327299|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
155519447|NCT03257462|561327302|FG000|Cohort A|Lost to Follow-up|1|||
155519448|NCT03257462|561327303|FG001|Cohort A|Lost to Follow-up|0|||
155519449|NCT03257462|561327304|FG002|Cohort A|Lost to Follow-up|0|||
155519450|NCT03257462|561327305|FG003|Cohort A|Lost to Follow-up|0|||
155519451|NCT03257462|561327302|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
155519452|NCT03257462|561327303|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
155519453|NCT03257462|561327304|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
155519454|NCT03257462|561327305|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
155519455|NCT00796822|561327306|FG000|Overall Study|Lost to Follow-up|2|||
155519456|NCT00796822|561327307|FG001|Overall Study|Lost to Follow-up|0|||
155519457|NCT00796822|561327306|FG000|Overall Study|Adverse Event|1|||
155519458|NCT00796822|561327307|FG001|Overall Study|Adverse Event|0|||
155519459|NCT00368277|561327308|FG000|Overall Study|Adverse Event|33|||
155519460|NCT00368277|561327309|FG001|Overall Study|Adverse Event|49|||
155519461|NCT00368277|561327308|FG000|Overall Study|Death|2|||
155519462|NCT00368277|561327309|FG001|Overall Study|Death|1|||
155519463|NCT00368277|561327308|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
155519464|NCT00368277|561327309|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
155519465|NCT00368277|561327308|FG000|Overall Study|Protocol deviation|7|||
155519466|NCT00368277|561327309|FG001|Overall Study|Protocol deviation|0|||
155519467|NCT00368277|561327308|FG000|Overall Study|Patient withdrew consent|32|||
155519468|NCT00368277|561327309|FG001|Overall Study|Patient withdrew consent|28|||
155519469|NCT00368277|561327308|FG000|Overall Study|Lost to Follow-up|8|||
155519470|NCT00368277|561327309|FG001|Overall Study|Lost to Follow-up|6|||
155519471|NCT03978624|561327310|FG000|Overall Study|Protocol Violation|1|||
155519472|NCT03978624|561327311|FG001|Overall Study|Protocol Violation|0|||
155519473|NCT05097989|561327312|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519474|NCT05097989|561327313|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519475|NCT05097989|561327314|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155654360|NCT00505687|561828862|FG000|Overall Study|Adverse Event|48|||
155654361|NCT00505687|561828862|FG000|Overall Study|Subject withdrew consent|15|||
155654362|NCT00505687|561828862|FG000|Overall Study|Lost to Follow-up|1|||
155654363|NCT00505687|561828862|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
155654364|NCT00505687|561828862|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
155654365|NCT00505687|561828862|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
155654366|NCT00505687|561828862|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
155476757|NCT01365091|561165665|FG001|Period 1|Withdrawal by Subject|1|||
155476758|NCT01365091|561165666|FG002|Period 1|Withdrawal by Subject|0|||
155519476|NCT05097989|561327315|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519477|NCT05097989|561327316|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155654367|NCT00505687|561828862|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
155476759|NCT01365091|561165667|FG003|Period 1|Withdrawal by Subject|0|||
155476760|NCT01365091|561165664|FG000|Period 1|Personal reasons|0|||
155476761|NCT01365091|561165665|FG001|Period 1|Personal reasons|0|||
155476762|NCT01365091|561165666|FG002|Period 1|Personal reasons|1|||
155476763|NCT01365091|561165667|FG003|Period 1|Personal reasons|0|||
155476764|NCT01365091|561165664|FG000|Period 2|Withdrawal by Subject|1|||
155476765|NCT01365091|561165665|FG001|Period 2|Withdrawal by Subject|0|||
155476766|NCT01365091|561165666|FG002|Period 2|Withdrawal by Subject|0|||
155476767|NCT01365091|561165667|FG003|Period 2|Withdrawal by Subject|0|||
155476768|NCT01365091|561165664|FG000|Period 2|Adverse Event|0|||
155476769|NCT01365091|561165665|FG001|Period 2|Adverse Event|0|||
155476770|NCT01365091|561165666|FG002|Period 2|Adverse Event|1|||
155476771|NCT01365091|561165667|FG003|Period 2|Adverse Event|0|||
155476772|NCT05307523|561165669|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
155476773|NCT05307523|561165670|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
155476774|NCT05307523|561165669|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
155476775|NCT05307523|561165670|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
155476776|NCT05116683|561165671|FG000|Overall Study|Physician Decision|4|||
155476777|NCT02875366|561165676|FG000|Overall Study|Adverse Event|0|||
155476778|NCT02875366|561165677|FG001|Overall Study|Adverse Event|2|||
155476779|NCT02875366|561165676|FG000|Overall Study|Noncompliance|0|||
155476780|NCT02875366|561165677|FG001|Overall Study|Noncompliance|1|||
155476781|NCT00683774|561165678|FG000|Overall Study|Withdrawal by Subject|0|||
155476782|NCT00683774|561165679|FG001|Overall Study|Withdrawal by Subject|1|||
155476783|NCT00683774|561165678|FG000|Overall Study|Physician Decision|3|||
155476784|NCT00683774|561165679|FG001|Overall Study|Physician Decision|0|||
155476785|NCT03595176|561165680|FG000|Overall Study|Death|0|||
155476786|NCT03595176|561165681|FG001|Overall Study|Death|2|||
155476787|NCT03595176|561165680|FG000|Overall Study|Lost to Follow-up|0|||
155476788|NCT03595176|561165681|FG001|Overall Study|Lost to Follow-up|1|||
155476789|NCT02735044|561165683|FG000|Overall Study|Adverse Event|3|||
155476790|NCT02735044|561165684|FG001|Overall Study|Adverse Event|3|||
155476791|NCT02735044|561165683|FG000|Overall Study|Lack of Efficacy|1|||
155476792|NCT02735044|561165684|FG001|Overall Study|Lack of Efficacy|0|||
155476793|NCT02735044|561165683|FG000|Overall Study|Poor compliance to protocol|7|||
155476794|NCT02735044|561165684|FG001|Overall Study|Poor compliance to protocol|7|||
155476795|NCT02735044|561165683|FG000|Overall Study|Randomized and not treated|0|||
155476796|NCT02735044|561165684|FG001|Overall Study|Randomized and not treated|2|||
155476797|NCT02735044|561165683|FG000|Overall Study|Other, not specified above|5|||
155476798|NCT02735044|561165684|FG001|Overall Study|Other, not specified above|11|||
155476799|NCT01682759|561165685|FG000|Overall Study|Death|2|||
155476800|NCT01682759|561165686|FG001|Overall Study|Death|1|||
155476801|NCT01682759|561165685|FG000|Overall Study|Lost to Follow-up|10|||
155476802|NCT01682759|561165686|FG001|Overall Study|Lost to Follow-up|13|||
155476803|NCT01682759|561165685|FG000|Overall Study|Physician Decision|1|||
155476804|NCT01682759|561165686|FG001|Overall Study|Physician Decision|1|||
155476805|NCT01682759|561165685|FG000|Overall Study|Withdrawal by Subject|56|||
155476806|NCT01682759|561165686|FG001|Overall Study|Withdrawal by Subject|55|||
155476807|NCT01201967|561165690|FG000|Overall Study|Lost to Follow-up|6|||
155476808|NCT01201967|561165691|FG001|Overall Study|Lost to Follow-up|5|||
155476809|NCT02116361|561165694|FG000|Overall Study|Pregnancy|0|||
155476810|NCT02116361|561165695|FG001|Overall Study|Pregnancy|0|||
155476811|NCT02116361|561165696|FG002|Overall Study|Pregnancy|0|||
155476812|NCT02116361|561165697|FG003|Overall Study|Pregnancy|1|||
155476813|NCT02116361|561165694|FG000|Overall Study|Protocol Violation|1|||
155476814|NCT02116361|561165695|FG001|Overall Study|Protocol Violation|0|||
155476815|NCT02116361|561165696|FG002|Overall Study|Protocol Violation|0|||
155476816|NCT02116361|561165697|FG003|Overall Study|Protocol Violation|2|||
155476817|NCT02116361|561165694|FG000|Overall Study|Physician Decision|2|||
155476818|NCT02116361|561165695|FG001|Overall Study|Physician Decision|3|||
155476819|NCT02116361|561165696|FG002|Overall Study|Physician Decision|0|||
155476820|NCT02116361|561165697|FG003|Overall Study|Physician Decision|0|||
155476821|NCT02116361|561165694|FG000|Overall Study|Adverse Event|1|||
155519478|NCT05097989|561327317|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
155519479|NCT05097989|561327318|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519480|NCT05097989|561327319|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519481|NCT05097989|561327320|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
155519482|NCT05097989|561327312|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
155476822|NCT02116361|561165695|FG001|Overall Study|Adverse Event|0|||
155476823|NCT02116361|561165696|FG002|Overall Study|Adverse Event|0|||
155476824|NCT02116361|561165697|FG003|Overall Study|Adverse Event|3|||
155476825|NCT02116361|561165694|FG000|Overall Study|Other Reasons|3|||
155476826|NCT02116361|561165695|FG001|Overall Study|Other Reasons|3|||
155476827|NCT02116361|561165696|FG002|Overall Study|Other Reasons|3|||
155476828|NCT02116361|561165697|FG003|Overall Study|Other Reasons|3|||
155476829|NCT02116361|561165694|FG000|Overall Study|Lack of Efficacy|5|||
155476830|NCT02116361|561165695|FG001|Overall Study|Lack of Efficacy|7|||
155476831|NCT02116361|561165696|FG002|Overall Study|Lack of Efficacy|4|||
155476832|NCT02116361|561165697|FG003|Overall Study|Lack of Efficacy|3|||
155476833|NCT02116361|561165694|FG000|Overall Study|Lost to Follow-up|4|||
155476834|NCT02116361|561165695|FG001|Overall Study|Lost to Follow-up|5|||
155476835|NCT02116361|561165696|FG002|Overall Study|Lost to Follow-up|7|||
155476836|NCT02116361|561165697|FG003|Overall Study|Lost to Follow-up|5|||
155476837|NCT02116361|561165694|FG000|Overall Study|Personal Reasons|6|||
155476838|NCT02116361|561165695|FG001|Overall Study|Personal Reasons|6|||
155476839|NCT02116361|561165696|FG002|Overall Study|Personal Reasons|4|||
155476840|NCT02116361|561165697|FG003|Overall Study|Personal Reasons|9|||
155476841|NCT02116361|561165694|FG000|Overall Study|Investigator Decision - Relapse|9|||
155476842|NCT02116361|561165695|FG001|Overall Study|Investigator Decision - Relapse|7|||
155476843|NCT02116361|561165696|FG002|Overall Study|Investigator Decision - Relapse|8|||
155476844|NCT02116361|561165697|FG003|Overall Study|Investigator Decision - Relapse|5|||
155476845|NCT04076579|561167658|FG000|Overall Study|Adverse Event|2|||
155476846|NCT04076579|561167659|FG001|Overall Study|Adverse Event|0|||
155476847|NCT04076579|561167658|FG000|Overall Study|discontinued due to toxicity|1|||
155476848|NCT04076579|561167659|FG001|Overall Study|discontinued due to toxicity|0|||
155476849|NCT04076579|561167658|FG000|Overall Study|Physician Decision|1|||
155476850|NCT04076579|561167659|FG001|Overall Study|Physician Decision|0|||
155476851|NCT04076579|561167658|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
155476852|NCT04076579|561167659|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
155476853|NCT04076579|561167658|FG000|Overall Study|Noncompliance|0|||
155476854|NCT04076579|561167659|FG001|Overall Study|Noncompliance|1|||
155476855|NCT04076579|561167658|FG000|Overall Study|Withdrawal by Subject|0|||
155476856|NCT04076579|561167659|FG001|Overall Study|Withdrawal by Subject|2|||
155476857|NCT01997892|561167662|FG000|Overall Study|Physician Decision|2|||
155476858|NCT01997892|561167662|FG000|Overall Study|Lost to Follow-up|6|||
155476859|NCT01997892|561167662|FG000|Overall Study|Death|14|||
155476860|NCT01997892|561167662|FG000|Overall Study|Renal transplant|8|||
155476861|NCT01997892|561167662|FG000|Overall Study|Other|3|||
155476862|NCT01997892|561167662|FG000|Overall Study|Study completion data not recorded|35|||
155476863|NCT02531633|561167663|FG000|Part A (52 Weeks)|Sponsor request|24|||
155476864|NCT02531633|561167664|FG001|Part A (52 Weeks)|Sponsor request|24|||
155476865|NCT02531633|561167665|FG002|Part A (52 Weeks)|Sponsor request|18|||
155476866|NCT02531633|561167666|FG003|Part A (52 Weeks)|Sponsor request|18|||
155476867|NCT02531633|561167667|FG004|Part A (52 Weeks)|Sponsor request|19|||
155476868|NCT02531633|561167668|FG005|Part A (52 Weeks)|Sponsor request|0|||
155476869|NCT02531633|561167669|FG006|Part A (52 Weeks)|Sponsor request|0|||
155476870|NCT02531633|561167670|FG007|Part A (52 Weeks)|Sponsor request|0|||
155476871|NCT02531633|561167671|FG008|Part A (52 Weeks)|Sponsor request|0|||
155476872|NCT02531633|561167672|FG009|Part A (52 Weeks)|Sponsor request|0|||
155476873|NCT02531633|561167663|FG000|Part A (52 Weeks)|Protocol Violation|1|||
155476874|NCT02531633|561167664|FG001|Part A (52 Weeks)|Protocol Violation|0|||
155476875|NCT02531633|561167665|FG002|Part A (52 Weeks)|Protocol Violation|0|||
155476876|NCT02531633|561167666|FG003|Part A (52 Weeks)|Protocol Violation|0|||
155476877|NCT02531633|561167667|FG004|Part A (52 Weeks)|Protocol Violation|0|||
155476878|NCT02531633|561167668|FG005|Part A (52 Weeks)|Protocol Violation|0|||
155476879|NCT02531633|561167669|FG006|Part A (52 Weeks)|Protocol Violation|0|||
155476880|NCT02531633|561167670|FG007|Part A (52 Weeks)|Protocol Violation|0|||
155476881|NCT02531633|561167671|FG008|Part A (52 Weeks)|Protocol Violation|0|||
155476882|NCT02531633|561167672|FG009|Part A (52 Weeks)|Protocol Violation|0|||
155476883|NCT02531633|561167663|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
155476884|NCT02531633|561167664|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
155476885|NCT02531633|561167665|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
155476886|NCT02531633|561167666|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
155476887|NCT02531633|561167667|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
155476888|NCT02531633|561167668|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
155476889|NCT02531633|561167669|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
155476890|NCT02531633|561167670|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
155476891|NCT02531633|561167671|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
155476892|NCT02531633|561167672|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
155476893|NCT02531633|561167663|FG000|Part A (52 Weeks)|Physician Decision|1|||
155476894|NCT02531633|561167664|FG001|Part A (52 Weeks)|Physician Decision|4|||
155654368|NCT00505687|561828862|FG000|Overall Study|Other: Disease Progression|1|||
155654369|NCT00505687|561828862|FG000|Overall Study|Other: As Per Sponsor|8|||
155476895|NCT02531633|561167665|FG002|Part A (52 Weeks)|Physician Decision|3|||
155476896|NCT02531633|561167666|FG003|Part A (52 Weeks)|Physician Decision|1|||
155476897|NCT02531633|561167667|FG004|Part A (52 Weeks)|Physician Decision|0|||
155476898|NCT02531633|561167668|FG005|Part A (52 Weeks)|Physician Decision|0|||
155476899|NCT02531633|561167669|FG006|Part A (52 Weeks)|Physician Decision|0|||
155519483|NCT05097989|561327313|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
155519484|NCT05097989|561327314|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
155654370|NCT00666263|561828865|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
155654371|NCT00666263|561828866|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
155476900|NCT02531633|561167670|FG007|Part A (52 Weeks)|Physician Decision|0|||
155476901|NCT02531633|561167671|FG008|Part A (52 Weeks)|Physician Decision|0|||
155476902|NCT02531633|561167672|FG009|Part A (52 Weeks)|Physician Decision|0|||
155476903|NCT02531633|561167663|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
155476904|NCT02531633|561167664|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
155476905|NCT02531633|561167665|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
155519485|NCT05097989|561327315|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
155519486|NCT05097989|561327316|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
155519487|NCT05097989|561327317|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
155519488|NCT05097989|561327318|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
155519489|NCT05097989|561327319|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
155519490|NCT05097989|561327320|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
155519491|NCT05097989|561327312|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519492|NCT05097989|561327313|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519493|NCT05097989|561327314|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519494|NCT05097989|561327315|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519495|NCT05097989|561327316|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519496|NCT05097989|561327317|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
155519497|NCT05097989|561327318|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
155519498|NCT05097989|561327319|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
155519499|NCT05097989|561327320|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155519500|NCT05097989|561327312|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519501|NCT05097989|561327313|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519502|NCT05097989|561327314|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
155519503|NCT05097989|561327315|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519504|NCT05097989|561327316|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519505|NCT05097989|561327317|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
155519506|NCT05097989|561327318|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519507|NCT05097989|561327319|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
155519508|NCT05097989|561327320|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
155519509|NCT05097989|561327312|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519510|NCT05097989|561327313|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519511|NCT05097989|561327314|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
155519512|NCT05097989|561327315|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519513|NCT05097989|561327316|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519514|NCT05097989|561327317|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519515|NCT05097989|561327318|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519516|NCT05097989|561327319|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519517|NCT05097989|561327320|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
155519518|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155519519|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
155519520|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155654372|NCT00666263|561828865|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
155654373|NCT00666263|561828866|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
155654374|NCT00666263|561828865|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
155654375|NCT00666263|561828866|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
155654376|NCT03242434|561828867|FG000|Overall Study|Death|0|||
155654377|NCT03242434|561828868|FG001|Overall Study|Death|2|||
155654378|NCT00414609|561828869|FG000|Core Study|Adverse Event|9|||
155654379|NCT00414609|561828870|FG001|Core Study|Adverse Event|11|||
155654380|NCT00414609|561828871|FG002|Core Study|Adverse Event|0|||
155654381|NCT00414609|561828869|FG000|Core Study|Abnormal laboratory values|0|||
155476906|NCT02531633|561167666|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
155476907|NCT02531633|561167667|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
155476908|NCT02531633|561167668|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
155476909|NCT02531633|561167669|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
155476910|NCT02531633|561167670|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
155476911|NCT02531633|561167671|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
155476912|NCT02531633|561167672|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
155476913|NCT02531633|561167663|FG000|Part A (52 Weeks)|Other|2|||
155476914|NCT02531633|561167664|FG001|Part A (52 Weeks)|Other|0|||
155476915|NCT02531633|561167665|FG002|Part A (52 Weeks)|Other|0|||
155519521|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155519522|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155654382|NCT00414609|561828870|FG001|Core Study|Abnormal laboratory values|1|||
155654383|NCT00414609|561828871|FG002|Core Study|Abnormal laboratory values|0|||
155654384|NCT00414609|561828869|FG000|Core Study|Abnormal test procedure results|1|||
155476916|NCT02531633|561167666|FG003|Part A (52 Weeks)|Other|0|||
155476917|NCT02531633|561167667|FG004|Part A (52 Weeks)|Other|0|||
155476918|NCT02531633|561167668|FG005|Part A (52 Weeks)|Other|0|||
155476919|NCT02531633|561167669|FG006|Part A (52 Weeks)|Other|0|||
155476920|NCT02531633|561167670|FG007|Part A (52 Weeks)|Other|0|||
155476921|NCT02531633|561167671|FG008|Part A (52 Weeks)|Other|0|||
155476922|NCT02531633|561167672|FG009|Part A (52 Weeks)|Other|0|||
155476923|NCT02531633|561167663|FG000|Part B (104 Weeks)|Sponsor request|0|||
155476924|NCT02531633|561167664|FG001|Part B (104 Weeks)|Sponsor request|0|||
155476925|NCT02531633|561167665|FG002|Part B (104 Weeks)|Sponsor request|0|||
155476926|NCT02531633|561167666|FG003|Part B (104 Weeks)|Sponsor request|0|||
155476927|NCT02531633|561167667|FG004|Part B (104 Weeks)|Sponsor request|0|||
155476928|NCT02531633|561167668|FG005|Part B (104 Weeks)|Sponsor request|8|||
155476929|NCT02531633|561167669|FG006|Part B (104 Weeks)|Sponsor request|5|||
155476930|NCT02531633|561167670|FG007|Part B (104 Weeks)|Sponsor request|3|||
155476931|NCT02531633|561167671|FG008|Part B (104 Weeks)|Sponsor request|5|||
155476932|NCT02531633|561167672|FG009|Part B (104 Weeks)|Sponsor request|4|||
155476933|NCT02531633|561167663|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
155476934|NCT02531633|561167664|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
155476935|NCT02531633|561167665|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
155476936|NCT02531633|561167666|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
155476937|NCT02531633|561167667|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
155476938|NCT02531633|561167668|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
155476939|NCT02531633|561167669|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
155476940|NCT02531633|561167670|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
155476941|NCT02531633|561167671|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
155476942|NCT02531633|561167672|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
155476943|NCT04097925|561167673|FG000|Overall Study|Withdrawal by Subject|1|||
155476944|NCT02608099|561167674|FG000|Overall Study|Ablation procedure not initiated|3|||
155476945|NCT02608099|561167675|FG001|Overall Study|Ablation procedure not initiated|2|||
155476946|NCT01952041|561167676|FG000|Overall Study|Lost to Follow-up|9|||
155476947|NCT01952041|561167677|FG001|Overall Study|Lost to Follow-up|16|||
155476948|NCT01952041|561167676|FG000|Overall Study|Withdrawal by Subject|7|||
155476949|NCT01952041|561167677|FG001|Overall Study|Withdrawal by Subject|5|||
155476950|NCT01952041|561167676|FG000|Overall Study|Death|1|||
155476951|NCT01952041|561167677|FG001|Overall Study|Death|0|||
155476952|NCT01736176|561167678|FG000|Overall Study|Adverse Event|3|||
155476953|NCT01736176|561167678|FG000|Overall Study|Withdrawal by Subject|4|||
155476954|NCT01736176|561167678|FG000|Overall Study|Lack of Efficacy|3|||
155476955|NCT01736176|561167678|FG000|Overall Study|Unable to Complete PEG Placement|1|||
155476956|NCT00186121|561167679|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
155476957|NCT00186121|561167679|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
155476958|NCT00186121|561167679|FG000|Overall Study|Not eligible (no treatment)|1|||
155476959|NCT03650387|561167680|FG000|Overall Study|Withdrawal by Subject|13|||
155476960|NCT03650387|561167680|FG000|Overall Study|Lost to Follow-up|12|||
155476961|NCT03650387|561167680|FG000|Overall Study|Adverse Event (Not related)|1|||
155476962|NCT03650387|561167680|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
155476963|NCT00417248|561167681|FG000|Overall Study|Study Terminated|6|||
155476964|NCT00417248|561167681|FG000|Overall Study|Death|1|||
155476965|NCT00417248|561167681|FG000|Overall Study|Lack of Efficacy|1|||
155476966|NCT01569568|561167682|FG000|Overall Study|Physician Decision|0|||
155476967|NCT01569568|561167683|FG001|Overall Study|Physician Decision|2|||
155476968|NCT05815758|561167684|FG000|Overall Study|Adverse Event|6|||
155476969|NCT05815758|561167685|FG001|Overall Study|Adverse Event|2|||
155476970|NCT05815758|561167684|FG000|Overall Study|Lost to Follow-up|14|||
155476971|NCT05815758|561167685|FG001|Overall Study|Lost to Follow-up|1|||
155476972|NCT05815758|561167684|FG000|Overall Study|Withdrawal by Subject|6|||
155476973|NCT05815758|561167685|FG001|Overall Study|Withdrawal by Subject|6|||
155476974|NCT05815758|561167684|FG000|Overall Study|Protocol Violation|1|||
155476975|NCT05815758|561167685|FG001|Overall Study|Protocol Violation|1|||
155476976|NCT05815758|561167684|FG000|Overall Study|Discontinued|4|||
155476977|NCT05815758|561167685|FG001|Overall Study|Discontinued|4|||
155476978|NCT03661983|561167686|FG000|Open Label Stabilization Phase|Adverse Event|5|||
155476979|NCT03661983|561167687|FG001|Open Label Stabilization Phase|Adverse Event|0|||
155476980|NCT03661983|561167688|FG002|Open Label Stabilization Phase|Adverse Event|0|||
155476981|NCT03661983|561167689|FG003|Open Label Stabilization Phase|Adverse Event|0|||
155476982|NCT03661983|561167686|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
155476983|NCT03661983|561167687|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
155476984|NCT03661983|561167688|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
155476985|NCT03661983|561167689|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
155476986|NCT03661983|561167686|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
155476987|NCT03661983|561167687|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
155476988|NCT03661983|561167688|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
155476989|NCT03661983|561167689|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
155476990|NCT03661983|561167686|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
155476991|NCT03661983|561167687|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
155476992|NCT03661983|561167688|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
155476993|NCT03661983|561167689|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
155476994|NCT03661983|561167686|FG000|Double-blind Randomized Phase|Adverse Event|0|||
155476995|NCT03661983|561167687|FG001|Double-blind Randomized Phase|Adverse Event|1|||
155476996|NCT03661983|561167688|FG002|Double-blind Randomized Phase|Adverse Event|0|||
155476997|NCT03661983|561167689|FG003|Double-blind Randomized Phase|Adverse Event|0|||
155476998|NCT03661983|561167686|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
155476999|NCT03661983|561167687|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
155477000|NCT03661983|561167688|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
155477001|NCT03661983|561167689|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
155477002|NCT03661983|561167686|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
155477003|NCT03661983|561167687|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
155477004|NCT03661983|561167688|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
155477005|NCT03661983|561167689|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
155477006|NCT03661983|561167686|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
155477007|NCT03661983|561167687|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
155477008|NCT03661983|561167688|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
155477009|NCT03661983|561167689|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
155477010|NCT02903966|561167690|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
155477011|NCT02903966|561167691|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
155477012|NCT02903966|561167690|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
155477013|NCT02903966|561167691|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
155477014|NCT02903966|561167690|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
155477015|NCT02903966|561167691|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
155477016|NCT00934791|561167692|FG000|Overall Study|Withdrawal by Subject|1|||
155477017|NCT00934791|561167693|FG001|Overall Study|Withdrawal by Subject|0|||
155477018|NCT01320033|561167695|FG000|Overall Study|Lack of Efficacy|0|||
155477019|NCT01320033|561167696|FG001|Overall Study|Lack of Efficacy|0|||
155477020|NCT01320033|561167697|FG002|Overall Study|Lack of Efficacy|1|||
155477021|NCT01320033|561167695|FG000|Overall Study|Adverse Event|9|||
155477022|NCT01320033|561167696|FG001|Overall Study|Adverse Event|7|||
155477023|NCT01320033|561167697|FG002|Overall Study|Adverse Event|8|||
155477024|NCT01320033|561167695|FG000|Overall Study|Withdrawal by Subject|22|||
155477025|NCT01320033|561167696|FG001|Overall Study|Withdrawal by Subject|23|||
155477026|NCT01320033|561167697|FG002|Overall Study|Withdrawal by Subject|23|||
155477027|NCT01320033|561167695|FG000|Overall Study|Protocol Violation|3|||
155477028|NCT01320033|561167696|FG001|Overall Study|Protocol Violation|5|||
155477029|NCT01320033|561167697|FG002|Overall Study|Protocol Violation|3|||
155477030|NCT01320033|561167695|FG000|Overall Study|Lost to Follow-up|22|||
155477031|NCT01320033|561167696|FG001|Overall Study|Lost to Follow-up|26|||
155477032|NCT01320033|561167697|FG002|Overall Study|Lost to Follow-up|17|||
155477033|NCT01320033|561167695|FG000|Overall Study|Other|2|||
155477034|NCT01320033|561167696|FG001|Overall Study|Other|3|||
155477035|NCT01320033|561167697|FG002|Overall Study|Other|1|||
155477036|NCT02425891|561167698|FG000|Overall Study|Death|333|||
155477037|NCT02425891|561167699|FG001|Overall Study|Death|314|||
155477038|NCT02425891|561167698|FG000|Overall Study|Lost to Follow-up|4|||
155477039|NCT02425891|561167699|FG001|Overall Study|Lost to Follow-up|6|||
155477040|NCT02425891|561167698|FG000|Overall Study|Non-Compliance|1|||
155477041|NCT02425891|561167699|FG001|Overall Study|Non-Compliance|1|||
155477042|NCT02425891|561167698|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
155477043|NCT02425891|561167699|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
155477044|NCT02425891|561167698|FG000|Overall Study|Physician Decision|0|||
155477045|NCT02425891|561167699|FG001|Overall Study|Physician Decision|1|||
155477046|NCT02425891|561167698|FG000|Overall Study|Protocol Violation|1|||
155477047|NCT02425891|561167699|FG001|Overall Study|Protocol Violation|1|||
155477048|NCT02425891|561167698|FG000|Overall Study|Study Terminated By Sponsor|85|||
155477049|NCT02425891|561167699|FG001|Overall Study|Study Terminated By Sponsor|95|||
155477050|NCT02425891|561167698|FG000|Overall Study|Withdrawal by Subject|27|||
155477051|NCT02425891|561167699|FG001|Overall Study|Withdrawal by Subject|32|||
155477052|NCT00963469|561167700|FG000|Overall Study|Adverse Event|15|||
155477053|NCT00963469|561167701|FG001|Overall Study|Adverse Event|11|||
155477054|NCT00963469|561167702|FG002|Overall Study|Adverse Event|1|||
155477055|NCT00963469|561167700|FG000|Overall Study|Lack of Efficacy|10|||
155477056|NCT00963469|561167701|FG001|Overall Study|Lack of Efficacy|7|||
155477057|NCT00963469|561167702|FG002|Overall Study|Lack of Efficacy|2|||
155477058|NCT00963469|561167700|FG000|Overall Study|Lost to Follow-up|1|||
155477059|NCT00963469|561167701|FG001|Overall Study|Lost to Follow-up|1|||
155477060|NCT00963469|561167702|FG002|Overall Study|Lost to Follow-up|0|||
155477061|NCT00963469|561167700|FG000|Overall Study|Protocol Violation|5|||
155477062|NCT00963469|561167701|FG001|Overall Study|Protocol Violation|5|||
155477063|NCT00963469|561167702|FG002|Overall Study|Protocol Violation|3|||
155477064|NCT00963469|561167700|FG000|Overall Study|Withdrawal by Subject|4|||
155477065|NCT00963469|561167701|FG001|Overall Study|Withdrawal by Subject|1|||
155477066|NCT00963469|561167702|FG002|Overall Study|Withdrawal by Subject|1|||
155477067|NCT00963469|561167700|FG000|Overall Study|Pre-randomization Adverse Event|1|||
155477068|NCT00963469|561167701|FG001|Overall Study|Pre-randomization Adverse Event|2|||
155477069|NCT00963469|561167702|FG002|Overall Study|Pre-randomization Adverse Event|0|||
155477070|NCT00963469|561167700|FG000|Overall Study|Moved|1|||
155477071|NCT00963469|561167701|FG001|Overall Study|Moved|0|||
155477072|NCT00963469|561167702|FG002|Overall Study|Moved|0|||
155477073|NCT00963469|561167700|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
155477074|NCT00963469|561167701|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
155477075|NCT00963469|561167702|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
155477076|NCT04124952|561167705|FG000|Overall Study|Lost to Follow-up|1|||
155477077|NCT02943577|561167706|FG000|Overall Study|Protocol Violation|0|||
155477078|NCT02943577|561167707|FG001|Overall Study|Protocol Violation|1|||
155477079|NCT02943577|561167706|FG000|Overall Study|Adverse Event|3|||
155477080|NCT02943577|561167707|FG001|Overall Study|Adverse Event|2|||
155477081|NCT02943577|561167706|FG000|Overall Study|Lost to Follow-up|0|||
155477082|NCT02943577|561167707|FG001|Overall Study|Lost to Follow-up|1|||
155477083|NCT02943577|561167706|FG000|Overall Study|Withdrawal by Subject|1|||
155477084|NCT02943577|561167707|FG001|Overall Study|Withdrawal by Subject|1|||
155477085|NCT02943577|561167706|FG000|Overall Study|Pregnancy|1|||
155477086|NCT02943577|561167707|FG001|Overall Study|Pregnancy|0|||
155477087|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
155477088|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
155477089|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
155477090|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
155477091|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Other|1|||
155477092|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Other|0|||
155477093|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Other|2|||
155477094|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Other|4|||
155477095|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
155477096|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
155477097|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
155477098|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
155477099|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Adverse Event|0|||
155477100|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Adverse Event|0|||
155477101|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Adverse Event|1|||
155477102|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Adverse Event|2|||
155477103|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
155477104|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
155477105|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
155477106|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
155477107|NCT00808028|561167712|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
155477108|NCT00808028|561167713|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
155477109|NCT00808028|561167714|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
155477110|NCT00808028|561167715|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
155477111|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
155477112|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
155477113|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
155477114|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
155477115|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
155477116|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
155477117|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
155477118|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
155477119|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
155477120|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
155477121|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
155477122|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
155477123|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
155477124|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
155477125|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
155477126|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
155477127|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
155477128|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
155477129|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
155477130|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
155477131|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
155477132|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
155477133|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
155477134|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
155477135|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
155477136|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
155654385|NCT00414609|561828870|FG001|Core Study|Abnormal test procedure results|1|||
155654386|NCT00414609|561828871|FG002|Core Study|Abnormal test procedure results|0|||
155477137|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
155477138|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
155477139|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
155477140|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
155477141|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
155477142|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
155477143|NCT00808028|561167712|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
155477144|NCT00808028|561167713|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
155477145|NCT00808028|561167714|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
155477146|NCT00808028|561167715|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
155477147|NCT01222767|561167716|FG000|Overall Study|Progressive disease|13|||
155477148|NCT01222767|561167716|FG000|Overall Study|Adverse Event|2|||
155477149|NCT01222767|561167716|FG000|Overall Study|Surgical resection|1|||
155477150|NCT01222767|561167716|FG000|Overall Study|Never treated|1|||
155477151|NCT00081263|561167721|FG000|Overall Study|clerical error|1|||
155477152|NCT00081263|561167722|FG001|Overall Study|clerical error|0|||
155477153|NCT00081263|561167721|FG000|Overall Study|wrong cell type|7|||
155477154|NCT00081263|561167722|FG001|Overall Study|wrong cell type|5|||
155477155|NCT00081263|561167721|FG000|Overall Study|improper pre-protocol therapy|0|||
155477156|NCT00081263|561167722|FG001|Overall Study|improper pre-protocol therapy|1|||
155477157|NCT00081263|561167721|FG000|Overall Study|Inadequate pathology|0|||
155477158|NCT00081263|561167722|FG001|Overall Study|Inadequate pathology|1|||
155477159|NCT00081263|561167721|FG000|Overall Study|Never treated|4|||
155477160|NCT00081263|561167722|FG001|Overall Study|Never treated|5|||
155477161|NCT00081263|561167721|FG000|Overall Study|Inadequate data|5|||
155477162|NCT00081263|561167722|FG001|Overall Study|Inadequate data|10|||
155477163|NCT01852591|561167723|FG000|Overall Study|Withdrawal by Subject|2|||
155477164|NCT01852591|561167723|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
155477165|NCT01267955|561167726|FG000|Stage 1 (6 Months)|Death|3|||
155477166|NCT01267955|561167726|FG000|Stage 2 (6 Months)|Death|5|||
155477167|NCT01267955|561167726|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
155477168|NCT00729560|561167727|FG000|Overall Study|Withdrawal by Subject|3|||
155477169|NCT03233308|561167728|FG000|Overall Study|Adverse Event|1|||
155477170|NCT03233308|561167728|FG000|Overall Study|Protocol Violation|1|||
155477171|NCT03662789|561167729|FG000|Overall Study|Lost to Follow-up|1|||
155477172|NCT03662789|561167730|FG001|Overall Study|Lost to Follow-up|2|||
155477173|NCT03662789|561167729|FG000|Overall Study|Could not perform treadmill test|4|||
155477174|NCT03662789|561167730|FG001|Overall Study|Could not perform treadmill test|4|||
155477175|NCT03662789|561167729|FG000|Overall Study|Death|0|||
155477176|NCT03662789|561167730|FG001|Overall Study|Death|1|||
155477177|NCT02136134|561167731|FG000|Overall Study|Death|170|||
155477178|NCT02136134|561167732|FG001|Overall Study|Death|148|||
155477179|NCT02136134|561167731|FG000|Overall Study|Withdrawal by Subject|19|||
155477180|NCT02136134|561167732|FG001|Overall Study|Withdrawal by Subject|10|||
155477181|NCT02136134|561167731|FG000|Overall Study|Lost to Follow-up|3|||
155477182|NCT02136134|561167732|FG001|Overall Study|Lost to Follow-up|3|||
155477183|NCT02136134|561167731|FG000|Overall Study|Uspecified|55|||
155477184|NCT02136134|561167732|FG001|Overall Study|Uspecified|90|||
155477185|NCT02974621|561167733|FG000|Overall Study|Didn't receive study treatment|1|||
155477186|NCT02974621|561167734|FG001|Overall Study|Didn't receive study treatment|10|||
155477187|NCT00732472|561167735|FG000|Overall Study|Adverse Event|0|||
155477188|NCT00732472|561167736|FG001|Overall Study|Adverse Event|1|||
155477189|NCT00732472|561167737|FG002|Overall Study|Adverse Event|1|||
155477190|NCT00732472|561167738|FG003|Overall Study|Adverse Event|1|||
155477191|NCT00732472|561167735|FG000|Overall Study|Protocol Violation|0|||
155477192|NCT00732472|561167736|FG001|Overall Study|Protocol Violation|0|||
155477193|NCT00732472|561167737|FG002|Overall Study|Protocol Violation|0|||
155477194|NCT00732472|561167738|FG003|Overall Study|Protocol Violation|1|||
155477195|NCT00732472|561167735|FG000|Overall Study|Withdrawal by Subject|0|||
155477196|NCT00732472|561167736|FG001|Overall Study|Withdrawal by Subject|2|||
155477197|NCT00732472|561167737|FG002|Overall Study|Withdrawal by Subject|0|||
155477198|NCT00732472|561167738|FG003|Overall Study|Withdrawal by Subject|1|||
155477199|NCT02559115|561167741|FG000|Overall Study|Withdrawal by Subject|3|||
155477200|NCT00963820|561167748|FG000|Dose Escalation Phase|Progressive Disease|3|||
155519523|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155519524|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155519525|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155477201|NCT00963820|561167749|FG001|Dose Escalation Phase|Progressive Disease|3|||
155477202|NCT00963820|561167750|FG002|Dose Escalation Phase|Progressive Disease|3|||
155477203|NCT00963820|561167751|FG003|Dose Escalation Phase|Progressive Disease|3|||
155477204|NCT00963820|561167752|FG004|Dose Escalation Phase|Progressive Disease|4|||
155477205|NCT00963820|561167753|FG005|Dose Escalation Phase|Progressive Disease|3|||
155477206|NCT00963820|561167754|FG006|Dose Escalation Phase|Progressive Disease|3|||
155477207|NCT00963820|561167755|FG007|Dose Escalation Phase|Progressive Disease|2|||
155477208|NCT00963820|561167756|FG008|Dose Escalation Phase|Progressive Disease|0|||
155477209|NCT00963820|561167757|FG009|Dose Escalation Phase|Progressive Disease|0|||
155654387|NCT00414609|561828869|FG000|Core Study|Protocol deviation|0|||
155477210|NCT00963820|561167758|FG010|Dose Escalation Phase|Progressive Disease|0|||
155477211|NCT00963820|561167759|FG011|Dose Escalation Phase|Progressive Disease|0|||
155477212|NCT00963820|561167748|FG000|Dose Escalation Phase|Adverse Event|0|||
155477213|NCT00963820|561167749|FG001|Dose Escalation Phase|Adverse Event|0|||
155477214|NCT00963820|561167750|FG002|Dose Escalation Phase|Adverse Event|0|||
155477215|NCT00963820|561167751|FG003|Dose Escalation Phase|Adverse Event|0|||
155477216|NCT00963820|561167752|FG004|Dose Escalation Phase|Adverse Event|0|||
155477217|NCT00963820|561167753|FG005|Dose Escalation Phase|Adverse Event|0|||
155477218|NCT00963820|561167754|FG006|Dose Escalation Phase|Adverse Event|3|||
155477219|NCT00963820|561167755|FG007|Dose Escalation Phase|Adverse Event|1|||
155477220|NCT00963820|561167756|FG008|Dose Escalation Phase|Adverse Event|0|||
155477221|NCT00963820|561167757|FG009|Dose Escalation Phase|Adverse Event|0|||
155477222|NCT00963820|561167758|FG010|Dose Escalation Phase|Adverse Event|0|||
155477223|NCT00963820|561167759|FG011|Dose Escalation Phase|Adverse Event|0|||
155477224|NCT00963820|561167748|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155477225|NCT00963820|561167749|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155477226|NCT00963820|561167750|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155477227|NCT00963820|561167751|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155477228|NCT00963820|561167752|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
155477229|NCT00963820|561167753|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
155477230|NCT00963820|561167754|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
155477231|NCT00963820|561167755|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
155477232|NCT00963820|561167756|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
155477233|NCT00963820|561167757|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
155477234|NCT00963820|561167758|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
155477235|NCT00963820|561167759|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
155477236|NCT00963820|561167748|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477237|NCT00963820|561167749|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477238|NCT00963820|561167750|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477239|NCT00963820|561167751|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477240|NCT00963820|561167752|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477241|NCT00963820|561167753|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477242|NCT00963820|561167754|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
155477243|NCT00963820|561167755|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477244|NCT00963820|561167756|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477245|NCT00963820|561167757|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477246|NCT00963820|561167758|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477247|NCT00963820|561167759|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
155477248|NCT00963820|561167748|FG000|Expansion Phase|Progressive Disease|0|||
155477249|NCT00963820|561167749|FG001|Expansion Phase|Progressive Disease|0|||
155477250|NCT00963820|561167750|FG002|Expansion Phase|Progressive Disease|0|||
155477251|NCT00963820|561167751|FG003|Expansion Phase|Progressive Disease|0|||
155477252|NCT00963820|561167752|FG004|Expansion Phase|Progressive Disease|0|||
155477253|NCT00963820|561167753|FG005|Expansion Phase|Progressive Disease|0|||
155477254|NCT00963820|561167754|FG006|Expansion Phase|Progressive Disease|0|||
155477255|NCT00963820|561167755|FG007|Expansion Phase|Progressive Disease|0|||
155477256|NCT00963820|561167756|FG008|Expansion Phase|Progressive Disease|8|||
155477257|NCT00963820|561167757|FG009|Expansion Phase|Progressive Disease|6|||
155477258|NCT00963820|561167758|FG010|Expansion Phase|Progressive Disease|4|||
155477259|NCT00963820|561167759|FG011|Expansion Phase|Progressive Disease|2|||
155477260|NCT00963820|561167748|FG000|Expansion Phase|Adverse Event|0|||
155477261|NCT00963820|561167749|FG001|Expansion Phase|Adverse Event|0|||
155477262|NCT00963820|561167750|FG002|Expansion Phase|Adverse Event|0|||
155477263|NCT00963820|561167751|FG003|Expansion Phase|Adverse Event|0|||
155477264|NCT00963820|561167752|FG004|Expansion Phase|Adverse Event|0|||
155477265|NCT00963820|561167753|FG005|Expansion Phase|Adverse Event|0|||
155477266|NCT00963820|561167754|FG006|Expansion Phase|Adverse Event|0|||
155477267|NCT00963820|561167755|FG007|Expansion Phase|Adverse Event|0|||
155477268|NCT00963820|561167756|FG008|Expansion Phase|Adverse Event|1|||
155477269|NCT00963820|561167757|FG009|Expansion Phase|Adverse Event|3|||
155477270|NCT00963820|561167758|FG010|Expansion Phase|Adverse Event|0|||
155477271|NCT00963820|561167759|FG011|Expansion Phase|Adverse Event|0|||
155477272|NCT00963820|561167748|FG000|Expansion Phase|Withdrawal by Subject|0|||
155477273|NCT00963820|561167749|FG001|Expansion Phase|Withdrawal by Subject|0|||
155477274|NCT00963820|561167750|FG002|Expansion Phase|Withdrawal by Subject|0|||
155477275|NCT00963820|561167751|FG003|Expansion Phase|Withdrawal by Subject|0|||
155477276|NCT00963820|561167752|FG004|Expansion Phase|Withdrawal by Subject|0|||
155477277|NCT00963820|561167753|FG005|Expansion Phase|Withdrawal by Subject|0|||
155519526|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
155477278|NCT00963820|561167754|FG006|Expansion Phase|Withdrawal by Subject|0|||
155477279|NCT00963820|561167755|FG007|Expansion Phase|Withdrawal by Subject|0|||
155477280|NCT00963820|561167756|FG008|Expansion Phase|Withdrawal by Subject|1|||
155477281|NCT00963820|561167757|FG009|Expansion Phase|Withdrawal by Subject|0|||
155477282|NCT00963820|561167758|FG010|Expansion Phase|Withdrawal by Subject|1|||
155477283|NCT00963820|561167759|FG011|Expansion Phase|Withdrawal by Subject|1|||
155477284|NCT00963820|561167748|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477285|NCT00963820|561167749|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477286|NCT00963820|561167750|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477287|NCT00963820|561167751|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477288|NCT00963820|561167752|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477289|NCT00963820|561167753|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477290|NCT00963820|561167754|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477291|NCT00963820|561167755|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477292|NCT00963820|561167756|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477293|NCT00963820|561167757|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477294|NCT00963820|561167758|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
155477295|NCT00963820|561167759|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
155477296|NCT04556175|561167764|FG000|Overall Study|Study terminated due to COVID-19|8|||
155477297|NCT04556175|561167765|FG001|Overall Study|Study terminated due to COVID-19|8|||
155477298|NCT05549505|561167766|FG000|Overall Study|Lost to Follow-up|2|||
155477299|NCT05549505|561167767|FG001|Overall Study|Lost to Follow-up|0|||
155477300|NCT05549505|561167766|FG000|Overall Study|Withdrawal by Subject|3|||
155477301|NCT05549505|561167767|FG001|Overall Study|Withdrawal by Subject|3|||
155477302|NCT05549505|561167766|FG000|Overall Study|Other: Miscellaneous|3|||
155477303|NCT05549505|561167767|FG001|Overall Study|Other: Miscellaneous|6|||
155477304|NCT02756845|561167770|FG000|Overall Study|Death|12|||
155477305|NCT02756845|561167771|FG001|Overall Study|Death|2|||
155477306|NCT02756845|561167770|FG000|Overall Study|Withdrawal by Subject|1|||
155477307|NCT02756845|561167771|FG001|Overall Study|Withdrawal by Subject|0|||
155477308|NCT01878175|561167772|FG000|Overall Study|Developed contraindicated health problem|2|||
155477309|NCT01842334|561167773|FG000|Overall Study|Withdrawal by Subject|3|||
155477310|NCT01842334|561167774|FG001|Overall Study|Withdrawal by Subject|3|||
155477311|NCT01842334|561167773|FG000|Overall Study|Moved away mid-study|0|||
155477312|NCT01842334|561167774|FG001|Overall Study|Moved away mid-study|1|||
155477313|NCT03299166|561167775|FG000|Overall Study|Adverse Event|9|||
155477314|NCT03299166|561167776|FG001|Overall Study|Adverse Event|4|||
155477315|NCT03299166|561167775|FG000|Overall Study|Withdrawal by Subject|6|||
155477316|NCT03299166|561167776|FG001|Overall Study|Withdrawal by Subject|5|||
155477317|NCT03299166|561167775|FG000|Overall Study|Physician Decision|1|||
155477318|NCT03299166|561167776|FG001|Overall Study|Physician Decision|1|||
155477319|NCT03299166|561167775|FG000|Overall Study|Sponsor Decision|3|||
155477320|NCT03299166|561167776|FG001|Overall Study|Sponsor Decision|0|||
155477321|NCT03299166|561167775|FG000|Overall Study|Lost to Follow-up|2|||
155477322|NCT03299166|561167776|FG001|Overall Study|Lost to Follow-up|4|||
155477323|NCT03299166|561167775|FG000|Overall Study|Randomization Error|0|||
155477324|NCT03299166|561167776|FG001|Overall Study|Randomization Error|1|||
155477325|NCT03299166|561167775|FG000|Overall Study|Subject unable to return due to COVID|1|||
155477326|NCT03299166|561167776|FG001|Overall Study|Subject unable to return due to COVID|0|||
155477327|NCT03299166|561167775|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
155477328|NCT03299166|561167776|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
155477329|NCT00423592|561167778|FG000|Overall Study|Adverse Event (through Week 12)|2|||
155477330|NCT00423592|561167778|FG000|Overall Study|Adverse Event (post Week 12)|5|||
155477331|NCT00062647|561167779|FG000|Overall Study|Death|2|||
155477332|NCT00062647|561167780|FG001|Overall Study|Death|2|||
155477333|NCT00062647|561167779|FG000|Overall Study|Adverse Event|1|||
155477334|NCT00062647|561167780|FG001|Overall Study|Adverse Event|1|||
155477335|NCT00062647|561167779|FG000|Overall Study|Withdrawal by Subject|2|||
155477336|NCT00062647|561167780|FG001|Overall Study|Withdrawal by Subject|1|||
155477337|NCT00062647|561167779|FG000|Overall Study|Protocol Violation|1|||
155477338|NCT00062647|561167780|FG001|Overall Study|Protocol Violation|0|||
155477339|NCT00062647|561167779|FG000|Overall Study|Lost to Follow-up|1|||
155477340|NCT00062647|561167780|FG001|Overall Study|Lost to Follow-up|2|||
155477341|NCT00062647|561167779|FG000|Overall Study|Failed continuation criteria|4|||
155519527|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155519528|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155477342|NCT00062647|561167780|FG001|Overall Study|Failed continuation criteria|2|||
155477343|NCT00062647|561167779|FG000|Overall Study|Other|4|||
155477344|NCT00062647|561167780|FG001|Overall Study|Other|4|||
155477345|NCT00062647|561167779|FG000|Overall Study|Never received study treatment|1|||
155477346|NCT00062647|561167780|FG001|Overall Study|Never received study treatment|1|||
155477347|NCT00255008|561167785|FG000|Overall Study|Adverse Event|1|||
155477348|NCT00255008|561167786|FG001|Overall Study|Adverse Event|1|||
155477349|NCT00255008|561167787|FG002|Overall Study|Adverse Event|2|||
155654388|NCT00414609|561828870|FG001|Core Study|Protocol deviation|1|||
155477350|NCT00255008|561167788|FG003|Overall Study|Adverse Event|0|||
155477351|NCT00255008|561167785|FG000|Overall Study|Lost to Follow-up|1|||
155477352|NCT00255008|561167786|FG001|Overall Study|Lost to Follow-up|0|||
155477353|NCT00255008|561167787|FG002|Overall Study|Lost to Follow-up|1|||
155477354|NCT00255008|561167788|FG003|Overall Study|Lost to Follow-up|2|||
155477355|NCT00255008|561167785|FG000|Overall Study|Did not meet viral reduction criteria|4|||
155477356|NCT00255008|561167786|FG001|Overall Study|Did not meet viral reduction criteria|5|||
155477357|NCT00255008|561167787|FG002|Overall Study|Did not meet viral reduction criteria|0|||
155477358|NCT00255008|561167788|FG003|Overall Study|Did not meet viral reduction criteria|1|||
155477359|NCT00255008|561167785|FG000|Overall Study|Withdrew consent|0|||
155477360|NCT00255008|561167786|FG001|Overall Study|Withdrew consent|0|||
155477361|NCT00255008|561167787|FG002|Overall Study|Withdrew consent|2|||
155477362|NCT00255008|561167788|FG003|Overall Study|Withdrew consent|0|||
155477363|NCT00255008|561167785|FG000|Overall Study|Sponsor request|18|||
155477364|NCT00255008|561167786|FG001|Overall Study|Sponsor request|3|||
155477365|NCT00255008|561167787|FG002|Overall Study|Sponsor request|8|||
155477366|NCT00255008|561167788|FG003|Overall Study|Sponsor request|17|||
155477367|NCT00255008|561167785|FG000|Overall Study|Adverse lab experience|1|||
155477368|NCT00255008|561167786|FG001|Overall Study|Adverse lab experience|0|||
155477369|NCT00255008|561167787|FG002|Overall Study|Adverse lab experience|0|||
155477370|NCT00255008|561167788|FG003|Overall Study|Adverse lab experience|0|||
155477371|NCT00255008|561167785|FG000|Overall Study|Other|7|||
155477372|NCT00255008|561167786|FG001|Overall Study|Other|0|||
155477373|NCT00255008|561167787|FG002|Overall Study|Other|3|||
155477374|NCT00255008|561167788|FG003|Overall Study|Other|2|||
155477375|NCT02470429|561167789|FG000|Overall Study|Adverse Event|1|||
155477376|NCT02470429|561167790|FG001|Overall Study|Adverse Event|0|||
155477377|NCT02470429|561167789|FG000|Overall Study|Withdrawal by Subject|1|||
155477378|NCT02470429|561167790|FG001|Overall Study|Withdrawal by Subject|0|||
155477379|NCT00322387|561167791|FG000|Treatment Period|Adverse Event|0|||
155477380|NCT00322387|561167792|FG001|Treatment Period|Adverse Event|1|||
155477381|NCT00322387|561167791|FG000|Follow-up Period|Final assessment not done|1|||
155477382|NCT00322387|561167792|FG001|Follow-up Period|Final assessment not done|3|||
155477383|NCT00322387|561167791|FG000|Follow-up Period|Death|1|||
155477384|NCT00322387|561167792|FG001|Follow-up Period|Death|0|||
155477385|NCT00707486|561167795|FG000|Overall Study|Withdrawal by Subject|1|||
155477386|NCT01976624|561167796|FG000|Overall Study|Participants contraindicated|2|||
155477387|NCT01976624|561167796|FG000|Overall Study|Participants age less than 19 years|12|||
155477388|NCT02299206|561167799|FG000|Overall Study|Lost to Follow-up|1|||
155477389|NCT02299206|561167799|FG000|Overall Study|Withdrawal by Subject|1|||
155477390|NCT00691054|561167800|FG000|Overall Study|Withdrawal by Subject|1|||
155477391|NCT01226472|561167805|FG000|Overall Study|Progressive Disease|1|||
155477392|NCT03128307|561167806|FG000|Overall Study|Lost to Follow-up|29|||
155477393|NCT03128307|561167806|FG000|Overall Study|Withdrawal by Subject|5|||
155477394|NCT00740116|561169304|FG000|Overall Study|Withdrawal by Subject|1|||
155477395|NCT00740116|561169305|FG001|Overall Study|Withdrawal by Subject|1|||
155477396|NCT00740116|561169304|FG000|Overall Study|Protocol Violation|1|||
155477397|NCT00740116|561169305|FG001|Overall Study|Protocol Violation|4|||
155477398|NCT02499172|561169306|FG000|Overall Study|Financial reason|0|||
155477399|NCT02499172|561169307|FG001|Overall Study|Financial reason|0|||
155477400|NCT02499172|561169308|FG002|Overall Study|Financial reason|523|||
155477401|NCT02499172|561169309|FG003|Overall Study|Financial reason|436|||
155477402|NCT02499172|561169306|FG000|Overall Study|Lost to Follow-up|65|||
155477403|NCT02499172|561169307|FG001|Overall Study|Lost to Follow-up|64|||
155477404|NCT02499172|561169308|FG002|Overall Study|Lost to Follow-up|0|||
155477405|NCT02499172|561169309|FG003|Overall Study|Lost to Follow-up|0|||
155477406|NCT01293123|561169310|FG000|Overall Study|Lost to Follow-up|0|||
155477407|NCT01293123|561169311|FG001|Overall Study|Lost to Follow-up|1|||
155477408|NCT01888965|561169321|FG000|Overall Study|Adverse Event|5|||
155519529|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155519530|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155519531|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155519532|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155519533|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155519534|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155477409|NCT01888965|561169321|FG000|Overall Study|Lack of Efficacy|4|||
155477410|NCT03793010|561169322|FG000|Overall Study|Withdrawal by Subject|5|||
155477411|NCT03793010|561169323|FG001|Overall Study|Withdrawal by Subject|7|||
155477412|NCT03793010|561169322|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
155519535|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155477413|NCT03793010|561169323|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
155477414|NCT03793010|561169322|FG000|Overall Study|Lost to Follow-up|1|||
155477415|NCT03793010|561169323|FG001|Overall Study|Lost to Follow-up|2|||
155477416|NCT03793010|561169322|FG000|Overall Study|Patient couldn't sit still for injection|1|||
155519536|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155477417|NCT03793010|561169323|FG001|Overall Study|Patient couldn't sit still for injection|0|||
155477418|NCT03793010|561169322|FG000|Overall Study|Withdrew to pursue other treatment|1|||
155477419|NCT03793010|561169323|FG001|Overall Study|Withdrew to pursue other treatment|0|||
155477420|NCT03793010|561169322|FG000|Overall Study|Did not meet eligibility criteria|1|||
155477421|NCT03793010|561169323|FG001|Overall Study|Did not meet eligibility criteria|0|||
155477422|NCT02145429|561169364|FG000|Overall Study|Death|4|||
155477423|NCT02145429|561169365|FG001|Overall Study|Death|5|||
155477424|NCT02145429|561169364|FG000|Overall Study|Lost to Follow-up|4|||
155477425|NCT02145429|561169365|FG001|Overall Study|Lost to Follow-up|3|||
155477426|NCT02145429|561169364|FG000|Overall Study|Withdrawal by Subject|8|||
155477427|NCT02145429|561169365|FG001|Overall Study|Withdrawal by Subject|3|||
155477428|NCT01944462|561169368|FG000|PPPP Educational Program|Lost to Follow-up|60|||
155477429|NCT02274311|561169371|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
155477430|NCT00508001|561169372|FG000|Overall Study|Adverse Event|2|||
155477431|NCT00508001|561169373|FG001|Overall Study|Adverse Event|0|||
155477432|NCT00508001|561169374|FG002|Overall Study|Adverse Event|4|||
155477433|NCT00508001|561169372|FG000|Overall Study|condition under investigation worsened|13|||
155477434|NCT00508001|561169373|FG001|Overall Study|condition under investigation worsened|7|||
155477435|NCT00508001|561169374|FG002|Overall Study|condition under investigation worsened|1|||
155477436|NCT00508001|561169372|FG000|Overall Study|Death|0|||
155477437|NCT00508001|561169373|FG001|Overall Study|Death|1|||
155477438|NCT00508001|561169374|FG002|Overall Study|Death|1|||
155477439|NCT00508001|561169372|FG000|Overall Study|Withdrawal by Subject|4|||
155477440|NCT00508001|561169373|FG001|Overall Study|Withdrawal by Subject|4|||
155477441|NCT00508001|561169374|FG002|Overall Study|Withdrawal by Subject|1|||
155477442|NCT04437511|561169375|FG000|Overall Study|Adverse Event|50|||
155477443|NCT04437511|561169376|FG001|Overall Study|Adverse Event|21|||
155477444|NCT04437511|561169375|FG000|Overall Study|Death|15|||
155477445|NCT04437511|561169376|FG001|Overall Study|Death|10|||
155477446|NCT04437511|561169375|FG000|Overall Study|Lost to Follow-up|11|||
155477447|NCT04437511|561169376|FG001|Overall Study|Lost to Follow-up|11|||
155477448|NCT04437511|561169375|FG000|Overall Study|Physician Decision|19|||
155477449|NCT04437511|561169376|FG001|Overall Study|Physician Decision|10|||
155477450|NCT04437511|561169375|FG000|Overall Study|Progressive Disease|4|||
155477451|NCT04437511|561169376|FG001|Overall Study|Progressive Disease|7|||
155477452|NCT04437511|561169375|FG000|Overall Study|Withdrawal by Subject|111|||
155477453|NCT04437511|561169376|FG001|Overall Study|Withdrawal by Subject|94|||
155477454|NCT04437511|561169375|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
155477455|NCT04437511|561169376|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
155477456|NCT04437511|561169375|FG000|Overall Study|Continuing Study|7|||
155477457|NCT04437511|561169376|FG001|Overall Study|Continuing Study|5|||
155477458|NCT03093350|561169381|FG000|Overall Study|Death|1|||
155477459|NCT03093350|561169381|FG000|Overall Study|Signed consent, never began treartment|1|||
155477460|NCT01602822|561169393|FG000|Overall Study|Adverse Event|11|||
155477461|NCT00853112|561169395|FG000|Overall Study|Randomized but not treated|0|||
155477462|NCT00853112|561169396|FG001|Overall Study|Randomized but not treated|1|||
155477463|NCT00853112|561169397|FG002|Overall Study|Randomized but not treated|0|||
155477464|NCT00853112|561169398|FG003|Overall Study|Randomized but not treated|2|||
155477465|NCT00853112|561169399|FG004|Overall Study|Randomized but not treated|0|||
155477466|NCT00853112|561169400|FG005|Overall Study|Randomized but not treated|0|||
155477467|NCT00853112|561169401|FG006|Overall Study|Randomized but not treated|1|||
155477468|NCT02750501|561169407|FG000|Overall Study|Adverse Event|4|||
155477469|NCT02750501|561169407|FG000|Overall Study|Physician Decision|1|||
155477470|NCT02750501|561169407|FG000|Overall Study|Protocol Violation|1|||
155477471|NCT02750501|561169407|FG000|Overall Study|G-tube came out|1|||
155477472|NCT02750501|561169407|FG000|Overall Study|Non-compliant use of PERT|1|||
155477473|NCT03797144|561169408|FG000|Enrollment|Protocol Violation|4|||
155477474|NCT03797144|561169409|FG001|Enrollment|Protocol Violation|1|||
155477475|NCT03797144|561169408|FG000|Surgery|Protocol Violation|1|||
155477476|NCT03797144|561169409|FG001|Surgery|Protocol Violation|0|||
155519537|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155519538|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155519539|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155519540|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
155519541|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155477477|NCT03797144|561169408|FG000|3 Month|Early termination cut-off date|2|||
155477478|NCT03797144|561169409|FG001|3 Month|Early termination cut-off date|0|||
155477479|NCT03797144|561169408|FG000|12 Month|Early termination cut-off date|8|||
155519542|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155477480|NCT03797144|561169409|FG001|12 Month|Early termination cut-off date|9|||
155477481|NCT03797144|561169408|FG000|24 Month|Early termination cut-off date|1|||
155477482|NCT03797144|561169409|FG001|24 Month|Early termination cut-off date|1|||
155477483|NCT00403390|561169410|FG000|Overall Study|Withdrawal by Subject|1|||
155477484|NCT00403390|561169411|FG001|Overall Study|Withdrawal by Subject|0|||
155519543|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155477485|NCT00403390|561169410|FG000|Overall Study|samples lost|1|||
155477486|NCT00403390|561169411|FG001|Overall Study|samples lost|0|||
155654389|NCT00414609|561828871|FG002|Core Study|Protocol deviation|0|||
155654390|NCT00414609|561828869|FG000|Core Study|Patient withdrew consent|10|||
155654391|NCT00414609|561828870|FG001|Core Study|Patient withdrew consent|11|||
155654392|NCT00414609|561828871|FG002|Core Study|Patient withdrew consent|0|||
155654393|NCT00414609|561828869|FG000|Core Study|Lost to Follow-up|7|||
155654394|NCT00414609|561828870|FG001|Core Study|Lost to Follow-up|4|||
155654395|NCT00414609|561828871|FG002|Core Study|Lost to Follow-up|0|||
155654396|NCT00414609|561828869|FG000|Core Study|Administrative problems|0|||
155654397|NCT00414609|561828870|FG001|Core Study|Administrative problems|2|||
155654398|NCT00414609|561828871|FG002|Core Study|Administrative problems|0|||
155654399|NCT00414609|561828869|FG000|Core Study|Death|7|||
155654400|NCT00414609|561828870|FG001|Core Study|Death|14|||
155654401|NCT00414609|561828871|FG002|Core Study|Death|0|||
155654402|NCT00414609|561828869|FG000|Extension Study|Adverse Event|0|||
155654403|NCT00414609|561828870|FG001|Extension Study|Adverse Event|0|||
155654404|NCT00414609|561828871|FG002|Extension Study|Adverse Event|14|||
155654405|NCT00414609|561828869|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
155654406|NCT00414609|561828870|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
155654407|NCT00414609|561828871|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
155654408|NCT00414609|561828869|FG000|Extension Study|Withdrawal by Subject|0|||
155654409|NCT00414609|561828870|FG001|Extension Study|Withdrawal by Subject|0|||
155654410|NCT00414609|561828871|FG002|Extension Study|Withdrawal by Subject|13|||
155654411|NCT00414609|561828869|FG000|Extension Study|Lost to Follow-up|0|||
155654412|NCT00414609|561828870|FG001|Extension Study|Lost to Follow-up|0|||
155654413|NCT00414609|561828871|FG002|Extension Study|Lost to Follow-up|10|||
155654414|NCT00414609|561828869|FG000|Extension Study|Administrative problems|0|||
155654415|NCT00414609|561828870|FG001|Extension Study|Administrative problems|0|||
155654416|NCT00414609|561828871|FG002|Extension Study|Administrative problems|1|||
155654417|NCT00414609|561828869|FG000|Extension Study|Death|0|||
155654418|NCT00414609|561828870|FG001|Extension Study|Death|0|||
155654419|NCT00414609|561828871|FG002|Extension Study|Death|17|||
155654420|NCT00266032|561828872|FG000|Treatment|Adverse Event|42|||
155654421|NCT00266032|561828873|FG001|Treatment|Adverse Event|26|||
155654422|NCT00266032|561828874|FG002|Treatment|Adverse Event|10|||
155654423|NCT00266032|561828872|FG000|Treatment|Lost to Follow-up|19|||
155654424|NCT00266032|561828873|FG001|Treatment|Lost to Follow-up|4|||
155654425|NCT00266032|561828874|FG002|Treatment|Lost to Follow-up|2|||
155654426|NCT00266032|561828872|FG000|Treatment|Pregnancy|3|||
155654427|NCT00266032|561828873|FG001|Treatment|Pregnancy|2|||
155654428|NCT00266032|561828874|FG002|Treatment|Pregnancy|2|||
155654429|NCT00266032|561828872|FG000|Treatment|Protocol Violation|6|||
155654430|NCT00266032|561828873|FG001|Treatment|Protocol Violation|14|||
155654431|NCT00266032|561828874|FG002|Treatment|Protocol Violation|13|||
155654432|NCT00266032|561828872|FG000|Treatment|Withdrawal by Subject|28|||
155477487|NCT00403390|561169410|FG000|Overall Study|non-compliant|1|||
155477488|NCT00403390|561169411|FG001|Overall Study|non-compliant|0|||
155477489|NCT01796106|561169412|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
155477490|NCT01796106|561169413|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
155477491|NCT04107935|561169414|FG000|Overall Study|Death|1|||
155477492|NCT04107935|561169415|FG001|Overall Study|Death|0|||
155477493|NCT00002981|561169419|FG000|Overall Study|Inevaluable|6|||
155477494|NCT01833806|561169423|FG000|Overall Study|Alternative treatment|2|||
155477495|NCT01833806|561169423|FG000|Overall Study|Death|5|||
155477496|NCT01833806|561169423|FG000|Overall Study|Physician Decision|1|||
155477497|NCT01833806|561169423|FG000|Overall Study|Lost to Follow-up|1|||
155477498|NCT01885104|561169438|FG000|Overall Study|Withdrawal of Consent|1|||
155477499|NCT01885104|561169439|FG001|Overall Study|Withdrawal of Consent|0|||
155477500|NCT01885104|561169438|FG000|Overall Study|Lost to Follow-up|0|||
155477501|NCT01885104|561169439|FG001|Overall Study|Lost to Follow-up|1|||
155477502|NCT01885104|561169438|FG000|Overall Study|Physician Decision|1|||
155477503|NCT01885104|561169439|FG001|Overall Study|Physician Decision|0|||
155477504|NCT00126425|561169440|FG000|Overall Study|Withdrawal by Subject|17|||
155477505|NCT00126425|561169441|FG001|Overall Study|Withdrawal by Subject|1|||
155654433|NCT00266032|561828873|FG001|Treatment|Withdrawal by Subject|13|||
155654434|NCT00266032|561828874|FG002|Treatment|Withdrawal by Subject|12|||
155654435|NCT00266032|561828872|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
155654436|NCT00266032|561828873|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
155654437|NCT00266032|561828874|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
155654438|NCT00266032|561828872|FG000|Open-label Safety Extension|Adverse Event|5|||
155654439|NCT00266032|561828873|FG001|Open-label Safety Extension|Adverse Event|0|||
155654440|NCT00266032|561828874|FG002|Open-label Safety Extension|Adverse Event|4|||
155654441|NCT00266032|561828872|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
155654442|NCT00266032|561828873|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
155654443|NCT00266032|561828874|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
155654444|NCT00266032|561828872|FG000|Open-label Safety Extension|Pregnancy|4|||
155654445|NCT00266032|561828873|FG001|Open-label Safety Extension|Pregnancy|1|||
155654446|NCT00266032|561828874|FG002|Open-label Safety Extension|Pregnancy|2|||
155654447|NCT00266032|561828872|FG000|Open-label Safety Extension|Protocol Violation|1|||
155477506|NCT00126425|561169440|FG000|Overall Study|Lost to Follow-up|8|||
155477507|NCT00126425|561169441|FG001|Overall Study|Lost to Follow-up|4|||
155477508|NCT00126425|561169440|FG000|Overall Study|Protocol Violation|9|||
155477509|NCT00126425|561169441|FG001|Overall Study|Protocol Violation|6|||
155477510|NCT00126425|561169440|FG000|Overall Study|Adverse Event|1|||
155477511|NCT00126425|561169441|FG001|Overall Study|Adverse Event|0|||
155477512|NCT00126425|561169440|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
155477513|NCT00126425|561169441|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
155477514|NCT00126425|561169440|FG000|Overall Study|Other|5|||
155477515|NCT00126425|561169441|FG001|Overall Study|Other|0|||
155477516|NCT01894776|561169442|FG000|Overall Study|Withdrawal by Subject|1|||
155477517|NCT02415595|561169443|FG000|Overall Study|Administrative reason by sponsor|39|||
155477518|NCT02415595|561169444|FG001|Overall Study|Administrative reason by sponsor|40|||
155477519|NCT02415595|561169445|FG002|Overall Study|Administrative reason by sponsor|41|||
155477520|NCT02415595|561169446|FG003|Overall Study|Administrative reason by sponsor|39|||
155477521|NCT02415595|561169443|FG000|Overall Study|Adverse Event|1|||
155477522|NCT02415595|561169444|FG001|Overall Study|Adverse Event|3|||
155477523|NCT02415595|561169445|FG002|Overall Study|Adverse Event|5|||
155477524|NCT02415595|561169446|FG003|Overall Study|Adverse Event|10|||
155477525|NCT02415595|561169443|FG000|Overall Study|Lack of Efficacy|4|||
155477526|NCT02415595|561169444|FG001|Overall Study|Lack of Efficacy|4|||
155477527|NCT02415595|561169445|FG002|Overall Study|Lack of Efficacy|0|||
155477528|NCT02415595|561169446|FG003|Overall Study|Lack of Efficacy|0|||
155477529|NCT02415595|561169443|FG000|Overall Study|Lost to Follow-up|1|||
155477530|NCT02415595|561169444|FG001|Overall Study|Lost to Follow-up|3|||
155477531|NCT02415595|561169445|FG002|Overall Study|Lost to Follow-up|1|||
155477532|NCT02415595|561169446|FG003|Overall Study|Lost to Follow-up|1|||
155477533|NCT02415595|561169443|FG000|Overall Study|Poor/Non-compliance|1|||
155477534|NCT02415595|561169444|FG001|Overall Study|Poor/Non-compliance|0|||
155477535|NCT02415595|561169445|FG002|Overall Study|Poor/Non-compliance|1|||
155477536|NCT02415595|561169446|FG003|Overall Study|Poor/Non-compliance|0|||
155477537|NCT02415595|561169443|FG000|Overall Study|Reached stopping criteria|0|||
155477538|NCT02415595|561169444|FG001|Overall Study|Reached stopping criteria|1|||
155477539|NCT02415595|561169445|FG002|Overall Study|Reached stopping criteria|1|||
155477540|NCT02415595|561169446|FG003|Overall Study|Reached stopping criteria|0|||
155477541|NCT02415595|561169443|FG000|Overall Study|Withdrawal by Subject|4|||
155477542|NCT02415595|561169444|FG001|Overall Study|Withdrawal by Subject|0|||
155477543|NCT02415595|561169445|FG002|Overall Study|Withdrawal by Subject|1|||
155477544|NCT02415595|561169446|FG003|Overall Study|Withdrawal by Subject|3|||
155477545|NCT02415595|561169443|FG000|Overall Study|Other|0|||
155477546|NCT02415595|561169444|FG001|Overall Study|Other|1|||
155477547|NCT02415595|561169445|FG002|Overall Study|Other|1|||
155477548|NCT02415595|561169446|FG003|Overall Study|Other|0|||
155477549|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
155477550|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155477551|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
155477552|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155477553|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
155477554|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155477555|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155477556|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155477557|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
155477558|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
155477559|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155477560|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155477561|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
155477562|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
155477563|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
155477564|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
155477565|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
155477566|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
155477567|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
155477568|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
155477569|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
155477570|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155477571|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155477572|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
155477573|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Screen failure|0|||
155477574|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Screen failure|1|||
155477575|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Screen failure|2|||
155477576|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Screen failure|0|||
155477577|NCT02614261|561169447|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
155477578|NCT02614261|561169448|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155477579|NCT02614261|561169449|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
155477580|NCT02614261|561169450|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155477581|NCT02614261|561169447|FG000|Open-Label Extension Phase|Adverse Event|23|||
155477582|NCT02614261|561169448|FG001|Open-Label Extension Phase|Adverse Event|12|||
155477583|NCT02614261|561169449|FG002|Open-Label Extension Phase|Adverse Event|11|||
155477584|NCT02614261|561169450|FG003|Open-Label Extension Phase|Adverse Event|0|||
155477585|NCT02614261|561169447|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
155477586|NCT02614261|561169448|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
155477587|NCT02614261|561169449|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
155477588|NCT02614261|561169450|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
155477589|NCT02614261|561169447|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
155477590|NCT02614261|561169448|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
155477591|NCT02614261|561169449|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
155477592|NCT02614261|561169450|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
155477593|NCT02614261|561169447|FG000|Open-Label Extension Phase|Physician Decision|2|||
155477594|NCT02614261|561169448|FG001|Open-Label Extension Phase|Physician Decision|0|||
155477595|NCT02614261|561169449|FG002|Open-Label Extension Phase|Physician Decision|0|||
155477596|NCT02614261|561169450|FG003|Open-Label Extension Phase|Physician Decision|0|||
155477597|NCT02614261|561169447|FG000|Open-Label Extension Phase|Pregnancy|1|||
155477598|NCT02614261|561169448|FG001|Open-Label Extension Phase|Pregnancy|2|||
155477599|NCT02614261|561169449|FG002|Open-Label Extension Phase|Pregnancy|1|||
155477600|NCT02614261|561169450|FG003|Open-Label Extension Phase|Pregnancy|0|||
155477601|NCT02614261|561169447|FG000|Open-Label Extension Phase|Protocol Violation|3|||
155477602|NCT02614261|561169448|FG001|Open-Label Extension Phase|Protocol Violation|4|||
155477603|NCT02614261|561169449|FG002|Open-Label Extension Phase|Protocol Violation|1|||
155477604|NCT02614261|561169450|FG003|Open-Label Extension Phase|Protocol Violation|0|||
155477605|NCT02614261|561169447|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
155477606|NCT02614261|561169448|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
155477607|NCT02614261|561169449|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
155477608|NCT02614261|561169450|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
155477609|NCT02614261|561169447|FG000|Follow-up Phase|Adverse Event|2|||
155477610|NCT02614261|561169448|FG001|Follow-up Phase|Adverse Event|0|||
155477611|NCT02614261|561169449|FG002|Follow-up Phase|Adverse Event|1|||
155477612|NCT02614261|561169450|FG003|Follow-up Phase|Adverse Event|0|||
155477613|NCT02614261|561169447|FG000|Follow-up Phase|Lost to Follow-up|12|||
155477614|NCT02614261|561169448|FG001|Follow-up Phase|Lost to Follow-up|5|||
155477615|NCT02614261|561169449|FG002|Follow-up Phase|Lost to Follow-up|2|||
155477616|NCT02614261|561169450|FG003|Follow-up Phase|Lost to Follow-up|0|||
155477617|NCT02614261|561169447|FG000|Follow-up Phase|Physician Decision|5|||
155477618|NCT02614261|561169448|FG001|Follow-up Phase|Physician Decision|1|||
155477619|NCT02614261|561169449|FG002|Follow-up Phase|Physician Decision|0|||
155477620|NCT02614261|561169450|FG003|Follow-up Phase|Physician Decision|0|||
155477621|NCT02614261|561169447|FG000|Follow-up Phase|Pregnancy|0|||
155477622|NCT02614261|561169448|FG001|Follow-up Phase|Pregnancy|1|||
155477623|NCT02614261|561169449|FG002|Follow-up Phase|Pregnancy|0|||
155477624|NCT02614261|561169450|FG003|Follow-up Phase|Pregnancy|0|||
155477625|NCT02614261|561169447|FG000|Follow-up Phase|Protocol Violation|1|||
155477626|NCT02614261|561169448|FG001|Follow-up Phase|Protocol Violation|0|||
155477627|NCT02614261|561169449|FG002|Follow-up Phase|Protocol Violation|0|||
155477628|NCT02614261|561169450|FG003|Follow-up Phase|Protocol Violation|0|||
155477629|NCT02614261|561169447|FG000|Follow-up Phase|Withdrawal by Subject|12|||
155477630|NCT02614261|561169448|FG001|Follow-up Phase|Withdrawal by Subject|4|||
155477631|NCT02614261|561169449|FG002|Follow-up Phase|Withdrawal by Subject|11|||
155654448|NCT00266032|561828873|FG001|Open-label Safety Extension|Protocol Violation|3|||
155654449|NCT00266032|561828874|FG002|Open-label Safety Extension|Protocol Violation|2|||
155654450|NCT00266032|561828872|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
155654451|NCT00266032|561828873|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
155477632|NCT02614261|561169450|FG003|Follow-up Phase|Withdrawal by Subject|0|||
155477633|NCT02614261|561169447|FG000|Israel Addendum|Withdrawal by Subject|0|||
155477634|NCT02614261|561169448|FG001|Israel Addendum|Withdrawal by Subject|0|||
155477635|NCT02614261|561169449|FG002|Israel Addendum|Withdrawal by Subject|0|||
155477636|NCT02614261|561169450|FG003|Israel Addendum|Withdrawal by Subject|4|||
155477637|NCT04350372|561169454|FG000|Overall Study|Death|1|||
155477638|NCT03512275|561169455|FG000|Overall Study|Withdrawal by Subject|1|||
155477639|NCT03512275|561169456|FG001|Overall Study|Withdrawal by Subject|3|||
155477640|NCT03512275|561169455|FG000|Overall Study|Physician Decision|0|||
155477641|NCT03512275|561169456|FG001|Overall Study|Physician Decision|1|||
155477642|NCT03512275|561169455|FG000|Overall Study|Lost to Follow-up|0|||
155477643|NCT03512275|561169456|FG001|Overall Study|Lost to Follow-up|3|||
155477644|NCT03512275|561169455|FG000|Overall Study|Other|1|||
155477645|NCT03512275|561169456|FG001|Overall Study|Other|0|||
155477646|NCT00113555|561169457|FG000|Overall Study|Baseline Failure|59|||
155477647|NCT00113555|561169457|FG000|Overall Study|Permanently Explanted|7|||
155477648|NCT00113555|561169457|FG000|Overall Study|Death|1|||
155477649|NCT00113555|561169457|FG000|Overall Study|Missed Followup|4|||
155477650|NCT00113555|561169457|FG000|Overall Study|Lost to Follow-up|8|||
155654452|NCT00266032|561828874|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
155477651|NCT03858686|561169458|FG000|Period 1|Adverse Event|1|||
155477652|NCT03858686|561169459|FG001|Period 1|Adverse Event|1|||
155477653|NCT03858686|561169458|FG000|Period 1|Lack of compliance|0|||
155477654|NCT03858686|561169459|FG001|Period 1|Lack of compliance|1|||
155477655|NCT03858686|561169458|FG000|Period 1|Adverse Event|0|||
155477656|NCT03858686|561169459|FG001|Period 1|Adverse Event|1|||
155477657|NCT03858686|561169458|FG000|Period 2|Adverse Event|0|||
155477658|NCT03858686|561169459|FG001|Period 2|Adverse Event|1|||
155477659|NCT00102804|561169460|FG000|Overall Study|Progressive Disease (PD)|307|||
155477660|NCT00102804|561169461|FG001|Overall Study|Progressive Disease (PD)|196|||
155477661|NCT00102804|561169460|FG000|Overall Study|Withdrawal by Subject|46|||
155477662|NCT00102804|561169461|FG001|Overall Study|Withdrawal by Subject|7|||
155477663|NCT00102804|561169460|FG000|Overall Study|Adverse Event|37|||
155477664|NCT00102804|561169461|FG001|Overall Study|Adverse Event|3|||
155477665|NCT00102804|561169460|FG000|Overall Study|Physician Decision|24|||
155477666|NCT00102804|561169461|FG001|Overall Study|Physician Decision|6|||
155477667|NCT00102804|561169460|FG000|Overall Study|Death|5|||
155477668|NCT00102804|561169461|FG001|Overall Study|Death|6|||
155477669|NCT00102804|561169460|FG000|Overall Study|Enrollment Criteria Not Met|6|||
155477670|NCT00102804|561169461|FG001|Overall Study|Enrollment Criteria Not Met|0|||
155477671|NCT00102804|561169460|FG000|Overall Study|Lost to Follow-up|4|||
155477672|NCT00102804|561169461|FG001|Overall Study|Lost to Follow-up|1|||
155477673|NCT00102804|561169460|FG000|Overall Study|Protocol Violation|2|||
155477674|NCT00102804|561169461|FG001|Overall Study|Protocol Violation|1|||
155477675|NCT00102804|561169460|FG000|Overall Study|Satisfactory Response|2|||
155477676|NCT00102804|561169461|FG001|Overall Study|Satisfactory Response|0|||
155477677|NCT00102804|561169460|FG000|Overall Study|Sponsor Decision|1|||
155477678|NCT00102804|561169461|FG001|Overall Study|Sponsor Decision|0|||
155477679|NCT00102804|561169460|FG000|Overall Study|Alive, Receiving Treatment|7|||
155477680|NCT00102804|561169461|FG001|Overall Study|Alive, Receiving Treatment|2|||
155477681|NCT01855919|561171054|FG000|Overall Study|Adverse Event|16|||
155477682|NCT01855919|561171055|FG001|Overall Study|Adverse Event|8|||
155477683|NCT01855919|561171054|FG000|Overall Study|Lack of Efficacy|1|||
155477684|NCT01855919|561171055|FG001|Overall Study|Lack of Efficacy|3|||
155477685|NCT01855919|561171054|FG000|Overall Study|Withdrawal by Subject|4|||
155477686|NCT01855919|561171055|FG001|Overall Study|Withdrawal by Subject|10|||
155477687|NCT01855919|561171054|FG000|Overall Study|Entry Criteria Not Met|1|||
155477688|NCT01855919|561171055|FG001|Overall Study|Entry Criteria Not Met|1|||
155477689|NCT01855919|561171054|FG000|Overall Study|Protocol Violation|1|||
155477690|NCT01855919|561171055|FG001|Overall Study|Protocol Violation|4|||
155477691|NCT03455530|561171056|FG000|Overall Study|Withdrawal by Subject|9|||
155477692|NCT03455530|561171057|FG001|Overall Study|Withdrawal by Subject|1|||
155477693|NCT03455530|561171058|FG002|Overall Study|Withdrawal by Subject|3|||
155477694|NCT03455530|561171059|FG003|Overall Study|Withdrawal by Subject|3|||
155477695|NCT03037489|561171061|FG000|Overall Study|Adverse Event|4|||
155477696|NCT03037489|561171062|FG001|Overall Study|Adverse Event|0|||
155477697|NCT03037489|561171061|FG000|Overall Study|Withdrawal by Subject|3|||
155477698|NCT03037489|561171062|FG001|Overall Study|Withdrawal by Subject|0|||
155477699|NCT04167514|561171063|FG000|Overall Study|Adverse event, not serious|0|||
155477700|NCT04167514|561171064|FG001|Overall Study|Adverse event, not serious|1|||
155477701|NCT04167514|561171063|FG000|Overall Study|Lost to Follow-up|1|||
155477702|NCT04167514|561171064|FG001|Overall Study|Lost to Follow-up|0|||
155477703|NCT04167514|561171063|FG000|Overall Study|Participant Decision|2|||
155477704|NCT04167514|561171064|FG001|Overall Study|Participant Decision|4|||
155477705|NCT04167514|561171063|FG000|Overall Study|Physician Decision|3|||
155477706|NCT04167514|561171064|FG001|Overall Study|Physician Decision|2|||
155477707|NCT04167514|561171063|FG000|Overall Study|Death|14|||
155477708|NCT04167514|561171064|FG001|Overall Study|Death|18|||
155477709|NCT04167514|561171063|FG000|Overall Study|Enrolled but treatment not administered|2|||
155477710|NCT04167514|561171064|FG001|Overall Study|Enrolled but treatment not administered|0|||
155477711|NCT04167514|561171063|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
155477712|NCT04167514|561171064|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
155477713|NCT04167514|561171063|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
155477714|NCT04167514|561171064|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
155477715|NCT00939055|561171065|FG000|Overall Study|Discontinuation prior to procedure|4|||
155477716|NCT00939055|561171066|FG001|Overall Study|Discontinuation prior to procedure|0|||
155477717|NCT00584987|561171067|FG000|Overall Study|Protocol Violation|1|||
155477718|NCT00584987|561171068|FG001|Overall Study|Protocol Violation|1|||
155477719|NCT00584987|561171069|FG002|Overall Study|Protocol Violation|1|||
155477720|NCT00584987|561171070|FG003|Overall Study|Protocol Violation|0|||
155477721|NCT00584987|561171067|FG000|Overall Study|Adverse Event|0|||
155477722|NCT00584987|561171068|FG001|Overall Study|Adverse Event|0|||
155477723|NCT00584987|561171069|FG002|Overall Study|Adverse Event|0|||
155477724|NCT00584987|561171070|FG003|Overall Study|Adverse Event|1|||
155477725|NCT02773849|561171077|FG000|Overall Study|Lost to Follow-up|11|||
155477726|NCT02773849|561171077|FG000|Overall Study|Death|26|||
155477727|NCT02773849|561171077|FG000|Overall Study|Withdrawal by Subject|5|||
155477728|NCT02773849|561171077|FG000|Overall Study|Withdrawal of Consent|9|||
155477729|NCT02773849|561171077|FG000|Overall Study|Other: not due to lack of tolerability|11|||
155477730|NCT00723489|561171078|FG000|Overall Study|Physician Decision|0|||
155477731|NCT00723489|561171079|FG001|Overall Study|Physician Decision|1|||
155477732|NCT00723489|561171080|FG002|Overall Study|Physician Decision|0|||
155477733|NCT00723489|561171081|FG003|Overall Study|Physician Decision|0|||
155477734|NCT00723489|561171078|FG000|Overall Study|Pregnancy|0|||
155477735|NCT00723489|561171079|FG001|Overall Study|Pregnancy|0|||
155477736|NCT00723489|561171080|FG002|Overall Study|Pregnancy|0|||
155477737|NCT00723489|561171081|FG003|Overall Study|Pregnancy|1|||
155477738|NCT00723489|561171078|FG000|Overall Study|Withdrawal by Subject|0|||
155477739|NCT00723489|561171079|FG001|Overall Study|Withdrawal by Subject|0|||
155477740|NCT00723489|561171080|FG002|Overall Study|Withdrawal by Subject|0|||
155477741|NCT00723489|561171081|FG003|Overall Study|Withdrawal by Subject|1|||
155477742|NCT00723489|561171078|FG000|Overall Study|Seropositive at baseline|1|||
155477743|NCT00723489|561171079|FG001|Overall Study|Seropositive at baseline|0|||
155477744|NCT00723489|561171080|FG002|Overall Study|Seropositive at baseline|0|||
155477745|NCT00723489|561171081|FG003|Overall Study|Seropositive at baseline|0|||
155477746|NCT00723489|561171078|FG000|Overall Study|Prohibited Medication|0|||
155477747|NCT00723489|561171079|FG001|Overall Study|Prohibited Medication|0|||
155477748|NCT00723489|561171080|FG002|Overall Study|Prohibited Medication|0|||
155477749|NCT00723489|561171081|FG003|Overall Study|Prohibited Medication|1|||
155477750|NCT00723489|561171078|FG000|Overall Study|Samples Collected Out of Window|0|||
155477751|NCT00723489|561171079|FG001|Overall Study|Samples Collected Out of Window|3|||
155477752|NCT00723489|561171080|FG002|Overall Study|Samples Collected Out of Window|0|||
155477753|NCT00723489|561171081|FG003|Overall Study|Samples Collected Out of Window|0|||
155477754|NCT01599585|561171082|FG000|Overall Study|Withdrawal by Subject|16|||
155477755|NCT01599585|561171083|FG001|Overall Study|Withdrawal by Subject|9|||
155477756|NCT01599585|561171082|FG000|Overall Study|Lost to Follow-up|3|||
155477757|NCT01599585|561171083|FG001|Overall Study|Lost to Follow-up|5|||
155477758|NCT01599585|561171082|FG000|Overall Study|randomized did not start treatment|3|||
155477759|NCT01599585|561171083|FG001|Overall Study|randomized did not start treatment|3|||
155477760|NCT03657576|561171084|FG000|Overall Study|Death|0|||
155477761|NCT03657576|561171085|FG001|Overall Study|Death|1|||
155477762|NCT03657576|561171086|FG002|Overall Study|Death|1|||
155477763|NCT03657576|561171087|FG003|Overall Study|Death|0|||
155477764|NCT03657576|561171088|FG004|Overall Study|Death|0|||
155477765|NCT03657576|561171089|FG005|Overall Study|Death|0|||
155477766|NCT03657576|561171084|FG000|Overall Study|Withdrawal by Subject|0|||
155477767|NCT03657576|561171085|FG001|Overall Study|Withdrawal by Subject|0|||
155477768|NCT03657576|561171086|FG002|Overall Study|Withdrawal by Subject|0|||
155477769|NCT03657576|561171087|FG003|Overall Study|Withdrawal by Subject|1|||
155477770|NCT03657576|561171088|FG004|Overall Study|Withdrawal by Subject|0|||
155477771|NCT03657576|561171089|FG005|Overall Study|Withdrawal by Subject|0|||
155477772|NCT03657576|561171084|FG000|Overall Study|Screen Fail|0|||
155477773|NCT03657576|561171085|FG001|Overall Study|Screen Fail|0|||
155477774|NCT03657576|561171086|FG002|Overall Study|Screen Fail|0|||
155477775|NCT03657576|561171087|FG003|Overall Study|Screen Fail|0|||
155477776|NCT03657576|561171088|FG004|Overall Study|Screen Fail|0|||
155477777|NCT03657576|561171089|FG005|Overall Study|Screen Fail|5|||
155477778|NCT03657576|561171084|FG000|Overall Study|Disease Progression|1|||
155477779|NCT03657576|561171085|FG001|Overall Study|Disease Progression|1|||
155477780|NCT03657576|561171086|FG002|Overall Study|Disease Progression|0|||
155477781|NCT03657576|561171087|FG003|Overall Study|Disease Progression|5|||
155477782|NCT03657576|561171088|FG004|Overall Study|Disease Progression|0|||
155477783|NCT03657576|561171089|FG005|Overall Study|Disease Progression|0|||
155477784|NCT03657576|561171084|FG000|Overall Study|Insurance Coverage|0|||
155477785|NCT03657576|561171085|FG001|Overall Study|Insurance Coverage|0|||
155477786|NCT03657576|561171086|FG002|Overall Study|Insurance Coverage|0|||
155477787|NCT03657576|561171087|FG003|Overall Study|Insurance Coverage|1|||
155519544|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155519545|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155477788|NCT03657576|561171088|FG004|Overall Study|Insurance Coverage|0|||
155477789|NCT03657576|561171089|FG005|Overall Study|Insurance Coverage|0|||
155477790|NCT01263470|561171092|FG000|Overall Study|Adverse Event|2|||
155477791|NCT01263470|561171093|FG001|Overall Study|Adverse Event|2|||
155477792|NCT01263470|561171094|FG002|Overall Study|Adverse Event|1|||
155477793|NCT01263470|561171095|FG003|Overall Study|Adverse Event|1|||
155477794|NCT01263470|561171096|FG004|Overall Study|Adverse Event|2|||
155477795|NCT01263470|561171097|FG005|Overall Study|Adverse Event|2|||
155477796|NCT01263470|561171092|FG000|Overall Study|Protocol Violation|0|||
155477797|NCT01263470|561171093|FG001|Overall Study|Protocol Violation|1|||
155477798|NCT01263470|561171094|FG002|Overall Study|Protocol Violation|0|||
155477799|NCT01263470|561171095|FG003|Overall Study|Protocol Violation|0|||
155477800|NCT01263470|561171096|FG004|Overall Study|Protocol Violation|0|||
155477801|NCT01263470|561171097|FG005|Overall Study|Protocol Violation|1|||
155477802|NCT01263470|561171092|FG000|Overall Study|Withdrawal by Subject|0|||
155477803|NCT01263470|561171093|FG001|Overall Study|Withdrawal by Subject|1|||
155654453|NCT00266032|561828872|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
155654454|NCT00266032|561828873|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
155654455|NCT00266032|561828874|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
155654456|NCT00814983|561828877|FG000|Overall Study|Screen failure|1|||
155654457|NCT00814983|561828878|FG001|Overall Study|Screen failure|0|||
155477804|NCT01263470|561171094|FG002|Overall Study|Withdrawal by Subject|1|||
155477805|NCT01263470|561171095|FG003|Overall Study|Withdrawal by Subject|2|||
155477806|NCT01263470|561171096|FG004|Overall Study|Withdrawal by Subject|0|||
155477807|NCT01263470|561171097|FG005|Overall Study|Withdrawal by Subject|2|||
155477808|NCT01263470|561171092|FG000|Overall Study|Lack of Efficacy|0|||
155477809|NCT01263470|561171093|FG001|Overall Study|Lack of Efficacy|0|||
155477810|NCT01263470|561171094|FG002|Overall Study|Lack of Efficacy|2|||
155477811|NCT01263470|561171095|FG003|Overall Study|Lack of Efficacy|0|||
155477812|NCT01263470|561171096|FG004|Overall Study|Lack of Efficacy|0|||
155477813|NCT01263470|561171097|FG005|Overall Study|Lack of Efficacy|0|||
155477814|NCT01263470|561171092|FG000|Overall Study|Participant Unavailability|0|||
155477815|NCT01263470|561171093|FG001|Overall Study|Participant Unavailability|1|||
155477816|NCT01263470|561171094|FG002|Overall Study|Participant Unavailability|0|||
155477817|NCT01263470|561171095|FG003|Overall Study|Participant Unavailability|0|||
155477818|NCT01263470|561171096|FG004|Overall Study|Participant Unavailability|0|||
155477819|NCT01263470|561171097|FG005|Overall Study|Participant Unavailability|0|||
155477820|NCT01263470|561171092|FG000|Overall Study|Study Drug Non-compliance|0|||
155477821|NCT01263470|561171093|FG001|Overall Study|Study Drug Non-compliance|0|||
155477822|NCT01263470|561171094|FG002|Overall Study|Study Drug Non-compliance|0|||
155477823|NCT01263470|561171095|FG003|Overall Study|Study Drug Non-compliance|0|||
155477824|NCT01263470|561171096|FG004|Overall Study|Study Drug Non-compliance|1|||
155477825|NCT01263470|561171097|FG005|Overall Study|Study Drug Non-compliance|0|||
155477826|NCT00610714|561171098|FG000|Overall Study|Adverse Event|3|||
155477827|NCT00610714|561171099|FG001|Overall Study|Adverse Event|1|||
155477828|NCT00610714|561171098|FG000|Overall Study|Death|12|||
155477829|NCT00610714|561171099|FG001|Overall Study|Death|18|||
155477830|NCT00610714|561171098|FG000|Overall Study|Withdrawal by Subject|9|||
155477831|NCT00610714|561171099|FG001|Overall Study|Withdrawal by Subject|3|||
155477832|NCT00610714|561171098|FG000|Overall Study|Study completion at 120 PFS events|2|||
155477833|NCT00610714|561171099|FG001|Overall Study|Study completion at 120 PFS events|2|||
155477834|NCT01327573|561171100|FG000|Overall Study|Physician Decision|3|||
155477835|NCT01327573|561171101|FG001|Overall Study|Physician Decision|1|||
155477836|NCT01108263|561171102|FG000|Overall Study|Adverse Event|0|||
155477837|NCT01108263|561171103|FG001|Overall Study|Adverse Event|1|||
155477838|NCT00638989|561171104|FG000|Overall Study|Lost to Follow-up|0|||
155477839|NCT00638989|561171105|FG001|Overall Study|Lost to Follow-up|0|||
155477840|NCT00638989|561171106|FG002|Overall Study|Lost to Follow-up|1|||
155477841|NCT05245071|561171107|FG000|Overall Study|Progressive disease|18|||
155477842|NCT05245071|561171107|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
155477843|NCT05245071|561171107|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
155477844|NCT01553591|561171110|FG000|Overall Study|Voluntarily withdrew|94|||
155477845|NCT01553591|561171111|FG001|Overall Study|Voluntarily withdrew|79|||
155477846|NCT01553591|561171112|FG002|Overall Study|Voluntarily withdrew|96|||
155477847|NCT01553591|561171110|FG000|Overall Study|Adverse Event|36|||
155477848|NCT01553591|561171111|FG001|Overall Study|Adverse Event|45|||
155477849|NCT01553591|561171112|FG002|Overall Study|Adverse Event|16|||
155477850|NCT01553591|561171110|FG000|Overall Study|Lost to Follow-up|25|||
155477851|NCT01553591|561171111|FG001|Overall Study|Lost to Follow-up|23|||
155477852|NCT01553591|561171112|FG002|Overall Study|Lost to Follow-up|16|||
155477853|NCT01553591|561171110|FG000|Overall Study|Physician decision: other|11|||
155477854|NCT01553591|561171111|FG001|Overall Study|Physician decision: other|14|||
155477855|NCT01553591|561171112|FG002|Overall Study|Physician decision: other|16|||
155477856|NCT01553591|561171110|FG000|Overall Study|Physician decision: lack of efficacy|2|||
155654458|NCT00814983|561828877|FG000|Overall Study|Withdrawal by Subject|1|||
155654459|NCT00814983|561828878|FG001|Overall Study|Withdrawal by Subject|0|||
155654460|NCT00814983|561828877|FG000|Overall Study|Graft failure|1|||
155477857|NCT01553591|561171111|FG001|Overall Study|Physician decision: lack of efficacy|3|||
155477858|NCT01553591|561171112|FG002|Overall Study|Physician decision: lack of efficacy|7|||
155477859|NCT01553591|561171110|FG000|Overall Study|Protocol Violation|3|||
155477860|NCT01553591|561171111|FG001|Overall Study|Protocol Violation|4|||
155477861|NCT01553591|561171112|FG002|Overall Study|Protocol Violation|4|||
155477862|NCT01553591|561171110|FG000|Overall Study|Sponsor decision|1|||
155477863|NCT01553591|561171111|FG001|Overall Study|Sponsor decision|0|||
155477864|NCT01553591|561171112|FG002|Overall Study|Sponsor decision|3|||
155477865|NCT01553591|561171110|FG000|Overall Study|Randomized and never dispensed drug|0|||
155477866|NCT01553591|561171111|FG001|Overall Study|Randomized and never dispensed drug|1|||
155477867|NCT01553591|561171112|FG002|Overall Study|Randomized and never dispensed drug|0|||
155477868|NCT02477800|561171113|FG000|Placebo-Controlled Period|Adverse Event|16|||
155654461|NCT00814983|561828878|FG001|Overall Study|Graft failure|0|||
155654462|NCT01229111|561828879|FG000|Overall Study|Death|1|||
155654463|NCT04102514|561828880|FG000|Overall Study|Death|3|||
155477869|NCT02477800|561171114|FG001|Placebo-Controlled Period|Adverse Event|25|||
155477870|NCT02477800|561171115|FG002|Placebo-Controlled Period|Adverse Event|28|||
155477871|NCT02477800|561171116|FG003|Placebo-Controlled Period|Adverse Event|0|||
155477872|NCT02477800|561171117|FG004|Placebo-Controlled Period|Adverse Event|0|||
155477873|NCT02477800|561171118|FG005|Placebo-Controlled Period|Adverse Event|0|||
155477874|NCT02477800|561171119|FG006|Placebo-Controlled Period|Adverse Event|0|||
155477875|NCT02477800|561171113|FG000|Placebo-Controlled Period|Change of Treatment|1|||
155477876|NCT02477800|561171114|FG001|Placebo-Controlled Period|Change of Treatment|2|||
155477877|NCT02477800|561171115|FG002|Placebo-Controlled Period|Change of Treatment|1|||
155477878|NCT02477800|561171116|FG003|Placebo-Controlled Period|Change of Treatment|0|||
155477879|NCT02477800|561171117|FG004|Placebo-Controlled Period|Change of Treatment|0|||
155477880|NCT02477800|561171118|FG005|Placebo-Controlled Period|Change of Treatment|0|||
155477881|NCT02477800|561171119|FG006|Placebo-Controlled Period|Change of Treatment|0|||
155477882|NCT02477800|561171113|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
155477883|NCT02477800|561171114|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
155477884|NCT02477800|561171115|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
155477885|NCT02477800|561171116|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
155477886|NCT02477800|561171117|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
155477887|NCT02477800|561171118|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
155477888|NCT02477800|561171119|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
155477889|NCT02477800|561171113|FG000|Placebo-Controlled Period|Death|0|||
155477890|NCT02477800|561171114|FG001|Placebo-Controlled Period|Death|3|||
155477891|NCT02477800|561171115|FG002|Placebo-Controlled Period|Death|2|||
155477892|NCT02477800|561171116|FG003|Placebo-Controlled Period|Death|0|||
155477893|NCT02477800|561171117|FG004|Placebo-Controlled Period|Death|0|||
155477894|NCT02477800|561171118|FG005|Placebo-Controlled Period|Death|0|||
155477895|NCT02477800|561171119|FG006|Placebo-Controlled Period|Death|0|||
155477896|NCT02477800|561171113|FG000|Placebo-Controlled Period|Disease Progression|1|||
155477897|NCT02477800|561171114|FG001|Placebo-Controlled Period|Disease Progression|0|||
155477898|NCT02477800|561171115|FG002|Placebo-Controlled Period|Disease Progression|1|||
155477899|NCT02477800|561171116|FG003|Placebo-Controlled Period|Disease Progression|0|||
155477900|NCT02477800|561171117|FG004|Placebo-Controlled Period|Disease Progression|0|||
155477901|NCT02477800|561171118|FG005|Placebo-Controlled Period|Disease Progression|0|||
155477902|NCT02477800|561171119|FG006|Placebo-Controlled Period|Disease Progression|0|||
155477903|NCT02477800|561171113|FG000|Placebo-Controlled Period|Investigator Decision|3|||
155477904|NCT02477800|561171114|FG001|Placebo-Controlled Period|Investigator Decision|2|||
155477905|NCT02477800|561171115|FG002|Placebo-Controlled Period|Investigator Decision|1|||
155477906|NCT02477800|561171116|FG003|Placebo-Controlled Period|Investigator Decision|0|||
155477907|NCT02477800|561171117|FG004|Placebo-Controlled Period|Investigator Decision|0|||
155477908|NCT02477800|561171118|FG005|Placebo-Controlled Period|Investigator Decision|0|||
155477909|NCT02477800|561171119|FG006|Placebo-Controlled Period|Investigator Decision|0|||
155477910|NCT02477800|561171113|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
155477911|NCT02477800|561171114|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
155477912|NCT02477800|561171115|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
155477913|NCT02477800|561171116|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
155477914|NCT02477800|561171117|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
155477915|NCT02477800|561171118|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
155477916|NCT02477800|561171119|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
155477917|NCT02477800|561171113|FG000|Placebo-Controlled Period|Relocation|2|||
155477918|NCT02477800|561171114|FG001|Placebo-Controlled Period|Relocation|0|||
155477919|NCT02477800|561171115|FG002|Placebo-Controlled Period|Relocation|0|||
155477920|NCT02477800|561171116|FG003|Placebo-Controlled Period|Relocation|0|||
155477921|NCT02477800|561171117|FG004|Placebo-Controlled Period|Relocation|0|||
155477922|NCT02477800|561171118|FG005|Placebo-Controlled Period|Relocation|0|||
155477923|NCT02477800|561171119|FG006|Placebo-Controlled Period|Relocation|0|||
155477924|NCT02477800|561171113|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
155477925|NCT02477800|561171114|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
155477926|NCT02477800|561171115|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
155477927|NCT02477800|561171116|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
155477928|NCT02477800|561171117|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
155477929|NCT02477800|561171118|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
155477930|NCT02477800|561171119|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
155477931|NCT02477800|561171113|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
155477932|NCT02477800|561171114|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
155477933|NCT02477800|561171115|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
155477934|NCT02477800|561171116|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
155477935|NCT02477800|561171117|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
155477936|NCT02477800|561171118|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
155477937|NCT02477800|561171119|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
155477938|NCT02477800|561171113|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
155477939|NCT02477800|561171114|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
155477940|NCT02477800|561171115|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
155477941|NCT02477800|561171116|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
155477942|NCT02477800|561171117|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
155477943|NCT02477800|561171118|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
155477944|NCT02477800|561171119|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
155477945|NCT02477800|561171113|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155477946|NCT02477800|561171114|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
155477947|NCT02477800|561171115|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
155477948|NCT02477800|561171116|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155477949|NCT02477800|561171117|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155477950|NCT02477800|561171118|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155477951|NCT02477800|561171119|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155477952|NCT02477800|561171113|FG000|Placebo-Controlled Period|Reason not Specified|161|||
155477953|NCT02477800|561171114|FG001|Placebo-Controlled Period|Reason not Specified|161|||
155477954|NCT02477800|561171115|FG002|Placebo-Controlled Period|Reason not Specified|189|||
155477955|NCT02477800|561171116|FG003|Placebo-Controlled Period|Reason not Specified|0|||
155477956|NCT02477800|561171117|FG004|Placebo-Controlled Period|Reason not Specified|0|||
155477957|NCT02477800|561171118|FG005|Placebo-Controlled Period|Reason not Specified|0|||
155477958|NCT02477800|561171119|FG006|Placebo-Controlled Period|Reason not Specified|0|||
155477959|NCT02477800|561171113|FG000|Long Term Extension Period|Adverse Event|0|||
155477960|NCT02477800|561171114|FG001|Long Term Extension Period|Adverse Event|0|||
155477961|NCT02477800|561171115|FG002|Long Term Extension Period|Adverse Event|0|||
155477962|NCT02477800|561171116|FG003|Long Term Extension Period|Adverse Event|6|||
155519546|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155519547|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519548|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155519549|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519550|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519551|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519552|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519553|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155519554|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
155519555|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
155519556|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
155519557|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
155519558|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
155519559|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
155519560|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
155519561|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
155519562|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
155519563|NCT05097989|561327312|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
155519564|NCT05097989|561327313|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
155519565|NCT05097989|561327314|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
155519566|NCT05097989|561327315|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
155519567|NCT05097989|561327316|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
155519568|NCT05097989|561327317|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
155519569|NCT05097989|561327318|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
155519570|NCT05097989|561327319|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
155519571|NCT05097989|561327320|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
155519572|NCT05097989|561327312|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519573|NCT05097989|561327313|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519574|NCT05097989|561327314|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519575|NCT05097989|561327315|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519576|NCT05097989|561327316|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
155519577|NCT05097989|561327317|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519578|NCT05097989|561327318|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519579|NCT05097989|561327319|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
155519580|NCT05097989|561327320|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
155477963|NCT02477800|561171117|FG004|Long Term Extension Period|Adverse Event|2|||
155477964|NCT02477800|561171118|FG005|Long Term Extension Period|Adverse Event|4|||
155519581|NCT05097989|561327312|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
155477965|NCT02477800|561171119|FG006|Long Term Extension Period|Adverse Event|3|||
155477966|NCT02477800|561171113|FG000|Long Term Extension Period|Death|0|||
155477967|NCT02477800|561171114|FG001|Long Term Extension Period|Death|0|||
155477968|NCT02477800|561171115|FG002|Long Term Extension Period|Death|0|||
155477969|NCT02477800|561171116|FG003|Long Term Extension Period|Death|1|||
155477970|NCT02477800|561171117|FG004|Long Term Extension Period|Death|1|||
155477971|NCT02477800|561171118|FG005|Long Term Extension Period|Death|1|||
155477972|NCT02477800|561171119|FG006|Long Term Extension Period|Death|2|||
155477973|NCT02477800|561171113|FG000|Long Term Extension Period|Consent Withdrawn|0|||
155477974|NCT02477800|561171114|FG001|Long Term Extension Period|Consent Withdrawn|0|||
155477975|NCT02477800|561171115|FG002|Long Term Extension Period|Consent Withdrawn|0|||
155477976|NCT02477800|561171116|FG003|Long Term Extension Period|Consent Withdrawn|10|||
155477977|NCT02477800|561171117|FG004|Long Term Extension Period|Consent Withdrawn|4|||
155477978|NCT02477800|561171118|FG005|Long Term Extension Period|Consent Withdrawn|13|||
155477979|NCT02477800|561171119|FG006|Long Term Extension Period|Consent Withdrawn|16|||
155477980|NCT02477800|561171113|FG000|Long Term Extension Period|Disease Progression|0|||
155477981|NCT02477800|561171114|FG001|Long Term Extension Period|Disease Progression|0|||
155477982|NCT02477800|561171115|FG002|Long Term Extension Period|Disease Progression|0|||
155477983|NCT02477800|561171116|FG003|Long Term Extension Period|Disease Progression|3|||
155477984|NCT02477800|561171117|FG004|Long Term Extension Period|Disease Progression|1|||
155477985|NCT02477800|561171118|FG005|Long Term Extension Period|Disease Progression|1|||
155477986|NCT02477800|561171119|FG006|Long Term Extension Period|Disease Progression|0|||
155477987|NCT02477800|561171113|FG000|Long Term Extension Period|Investigator Decision|0|||
155477988|NCT02477800|561171114|FG001|Long Term Extension Period|Investigator Decision|0|||
155477989|NCT02477800|561171115|FG002|Long Term Extension Period|Investigator Decision|0|||
155477990|NCT02477800|561171116|FG003|Long Term Extension Period|Investigator Decision|0|||
155477991|NCT02477800|561171117|FG004|Long Term Extension Period|Investigator Decision|0|||
155477992|NCT02477800|561171118|FG005|Long Term Extension Period|Investigator Decision|0|||
155477993|NCT02477800|561171119|FG006|Long Term Extension Period|Investigator Decision|2|||
155477994|NCT02477800|561171113|FG000|Long Term Extension Period|Lost to Follow-up|0|||
155477995|NCT02477800|561171114|FG001|Long Term Extension Period|Lost to Follow-up|0|||
155477996|NCT02477800|561171115|FG002|Long Term Extension Period|Lost to Follow-up|0|||
155477997|NCT02477800|561171116|FG003|Long Term Extension Period|Lost to Follow-up|0|||
155477998|NCT02477800|561171117|FG004|Long Term Extension Period|Lost to Follow-up|1|||
155477999|NCT02477800|561171118|FG005|Long Term Extension Period|Lost to Follow-up|3|||
155478000|NCT02477800|561171119|FG006|Long Term Extension Period|Lost to Follow-up|0|||
155478001|NCT02477800|561171113|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
155478002|NCT02477800|561171114|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
155478003|NCT02477800|561171115|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
155478004|NCT02477800|561171116|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
155478005|NCT02477800|561171117|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
155478006|NCT02477800|561171118|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
155478007|NCT02477800|561171119|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
155478008|NCT02477800|561171113|FG000|Long Term Extension Period|Study Visit Burden|0|||
155478009|NCT02477800|561171114|FG001|Long Term Extension Period|Study Visit Burden|0|||
155478010|NCT02477800|561171115|FG002|Long Term Extension Period|Study Visit Burden|0|||
155478011|NCT02477800|561171116|FG003|Long Term Extension Period|Study Visit Burden|3|||
155478012|NCT02477800|561171117|FG004|Long Term Extension Period|Study Visit Burden|0|||
155478013|NCT02477800|561171118|FG005|Long Term Extension Period|Study Visit Burden|2|||
155478014|NCT02477800|561171119|FG006|Long Term Extension Period|Study Visit Burden|2|||
155478015|NCT02477800|561171113|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
155478016|NCT02477800|561171114|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
155478017|NCT02477800|561171115|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
155478018|NCT02477800|561171116|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
155478019|NCT02477800|561171117|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
155478020|NCT02477800|561171118|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
155478021|NCT02477800|561171119|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
155478022|NCT02477800|561171113|FG000|Long Term Extension Period|Reason not Specified|0|||
155478023|NCT02477800|561171114|FG001|Long Term Extension Period|Reason not Specified|0|||
155478024|NCT02477800|561171115|FG002|Long Term Extension Period|Reason not Specified|0|||
155478025|NCT02477800|561171116|FG003|Long Term Extension Period|Reason not Specified|126|||
155478026|NCT02477800|561171117|FG004|Long Term Extension Period|Reason not Specified|140|||
155478027|NCT02477800|561171118|FG005|Long Term Extension Period|Reason not Specified|270|||
155519582|NCT05097989|561327313|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
155654464|NCT04102514|561828881|FG001|Overall Study|Death|0|||
155654465|NCT04102514|561828882|FG002|Overall Study|Death|0|||
155478028|NCT02477800|561171119|FG006|Long Term Extension Period|Reason not Specified|224|||
155478029|NCT02871791|561171120|FG000|Phase 1b|Death|0|||
155478030|NCT02871791|561171121|FG001|Phase 1b|Death|1|||
155654466|NCT04102514|561828883|FG003|Overall Study|Death|0|||
155654467|NCT04102514|561828880|FG000|Overall Study|Lost to Follow-up|0|||
155478031|NCT02871791|561171120|FG000|Phase 1b|progressive disease|6|||
155478032|NCT02871791|561171121|FG001|Phase 1b|progressive disease|2|||
155478033|NCT02871791|561171120|FG000|Phase 2|Death|1|||
155478034|NCT02871791|561171121|FG001|Phase 2|Death|0|||
155478035|NCT02871791|561171120|FG000|Phase 2|Lost to Follow-up|2|||
155478036|NCT02871791|561171121|FG001|Phase 2|Lost to Follow-up|0|||
155478037|NCT01426009|561171122|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
155478038|NCT01426009|561171122|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
155478039|NCT01426009|561171122|FG000|Washout 1|Withdrawal by Subject|1|||
155478040|NCT01426009|561171122|FG000|Washout 1|Personal Reasons|1|||
155478041|NCT01426009|561171122|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
155478042|NCT01426009|561171122|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
155478043|NCT01426009|561171122|FG000|Washout 2|electrive surgery|1|||
155478044|NCT01426009|561171122|FG000|Washout 3|personal reasons|1|||
155478045|NCT01426009|561171122|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
155478046|NCT01426009|561171122|FG000|Washout 4|Lost to Follow-up|1|||
155478047|NCT02005211|561171131|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478048|NCT02005211|561171132|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478049|NCT02005211|561171133|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478050|NCT02005211|561171134|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478051|NCT02005211|561171135|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
155478052|NCT02005211|561171136|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478053|NCT02005211|561171137|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
155478054|NCT00397631|561171140|FG000|Overall Study|Adverse Event|5|||
155478055|NCT00397631|561171141|FG001|Overall Study|Adverse Event|6|||
155478056|NCT00397631|561171140|FG000|Overall Study|Lack of Efficacy|7|||
155478057|NCT00397631|561171141|FG001|Overall Study|Lack of Efficacy|10|||
155478058|NCT00397631|561171140|FG000|Overall Study|Lost to Follow-up|8|||
155478059|NCT00397631|561171141|FG001|Overall Study|Lost to Follow-up|9|||
155478060|NCT00397631|561171140|FG000|Overall Study|Physician Decision|2|||
155478061|NCT00397631|561171141|FG001|Overall Study|Physician Decision|0|||
155478062|NCT00397631|561171140|FG000|Overall Study|Protocol Violation|0|||
155478063|NCT00397631|561171141|FG001|Overall Study|Protocol Violation|1|||
155478064|NCT00397631|561171140|FG000|Overall Study|Withdrawal by Subject|7|||
155478065|NCT00397631|561171141|FG001|Overall Study|Withdrawal by Subject|14|||
155478066|NCT00397631|561171140|FG000|Overall Study|protocol discontinuation criteria|1|||
155478067|NCT00397631|561171141|FG001|Overall Study|protocol discontinuation criteria|4|||
155478068|NCT02202161|561171142|FG000|Overall Study|Adverse Event|1|||
155478069|NCT02202161|561171143|FG001|Overall Study|Adverse Event|1|||
155478070|NCT02202161|561171144|FG002|Overall Study|Adverse Event|0|||
155478071|NCT02202161|561171145|FG003|Overall Study|Adverse Event|0|||
155478072|NCT02202161|561171146|FG004|Overall Study|Adverse Event|0|||
155478073|NCT02202161|561171147|FG005|Overall Study|Adverse Event|1|||
155478074|NCT02202161|561171148|FG006|Overall Study|Adverse Event|0|||
155478075|NCT02202161|561171149|FG007|Overall Study|Adverse Event|0|||
155478076|NCT02202161|561171142|FG000|Overall Study|Did not meet continuation criteria|0|||
155478077|NCT02202161|561171143|FG001|Overall Study|Did not meet continuation criteria|0|||
155478078|NCT02202161|561171144|FG002|Overall Study|Did not meet continuation criteria|0|||
155478079|NCT02202161|561171145|FG003|Overall Study|Did not meet continuation criteria|0|||
155478080|NCT02202161|561171146|FG004|Overall Study|Did not meet continuation criteria|0|||
155478081|NCT02202161|561171147|FG005|Overall Study|Did not meet continuation criteria|0|||
155478082|NCT02202161|561171148|FG006|Overall Study|Did not meet continuation criteria|0|||
155478083|NCT02202161|561171149|FG007|Overall Study|Did not meet continuation criteria|3|||
155478084|NCT02202161|561171142|FG000|Overall Study|Physician Decision|0|||
155478085|NCT02202161|561171143|FG001|Overall Study|Physician Decision|0|||
155478086|NCT02202161|561171144|FG002|Overall Study|Physician Decision|0|||
155478087|NCT02202161|561171145|FG003|Overall Study|Physician Decision|0|||
155478088|NCT02202161|561171146|FG004|Overall Study|Physician Decision|0|||
155478089|NCT02202161|561171147|FG005|Overall Study|Physician Decision|0|||
155478090|NCT02202161|561171148|FG006|Overall Study|Physician Decision|0|||
155478091|NCT02202161|561171149|FG007|Overall Study|Physician Decision|3|||
155478092|NCT02202161|561171142|FG000|Overall Study|Withdrawal by Subject|0|||
155478093|NCT02202161|561171143|FG001|Overall Study|Withdrawal by Subject|0|||
155478094|NCT02202161|561171144|FG002|Overall Study|Withdrawal by Subject|0|||
155478095|NCT02202161|561171145|FG003|Overall Study|Withdrawal by Subject|0|||
155478096|NCT02202161|561171146|FG004|Overall Study|Withdrawal by Subject|1|||
155654468|NCT04102514|561828881|FG001|Overall Study|Lost to Follow-up|0|||
155478097|NCT02202161|561171147|FG005|Overall Study|Withdrawal by Subject|0|||
155478098|NCT02202161|561171148|FG006|Overall Study|Withdrawal by Subject|0|||
155478099|NCT02202161|561171149|FG007|Overall Study|Withdrawal by Subject|0|||
155478100|NCT03685643|561171152|FG000|Overall Study|Lost to Follow-up|14|||
155478101|NCT03685643|561171153|FG001|Overall Study|Lost to Follow-up|22|||
155478102|NCT02943668|561171155|FG000|Overall Study|Disease Progression|1|||
155478103|NCT01828567|561171164|FG000|Overall Study|Lost to Follow-up|27|||
155478104|NCT01828567|561171165|FG001|Overall Study|Lost to Follow-up|9|||
155478105|NCT01828567|561171164|FG000|Overall Study|Excluded - did not meet criteria|4|||
155478106|NCT01828567|561171165|FG001|Overall Study|Excluded - did not meet criteria|1|||
155478107|NCT02332876|561171170|FG000|Overall Study|Lost to Follow-up|1|||
155478108|NCT02332876|561171171|FG001|Overall Study|Lost to Follow-up|1|||
155478109|NCT03325010|561171174|FG000|Overall Study|Adverse Event|3|||
155478110|NCT03325010|561171175|FG001|Overall Study|Adverse Event|8|||
155478111|NCT03325010|561171174|FG000|Overall Study|Protocol Violation|1|||
155478112|NCT03325010|561171175|FG001|Overall Study|Protocol Violation|8|||
155478113|NCT03325010|561171174|FG000|Overall Study|Withdrawal by Subject|1|||
155478114|NCT03325010|561171175|FG001|Overall Study|Withdrawal by Subject|3|||
155478115|NCT03325010|561171174|FG000|Overall Study|Lost to Follow-up|1|||
155478116|NCT03325010|561171175|FG001|Overall Study|Lost to Follow-up|0|||
155478117|NCT03325010|561171174|FG000|Overall Study|Physician Decision|1|||
155478118|NCT03325010|561171175|FG001|Overall Study|Physician Decision|1|||
155478119|NCT03325010|561171174|FG000|Overall Study|Lack of Efficacy|2|||
155478120|NCT03325010|561171175|FG001|Overall Study|Lack of Efficacy|0|||
155478121|NCT04474366|561171178|FG000|Overall Study|Lost to Follow-up|2|||
155478122|NCT04474366|561171179|FG001|Overall Study|Lost to Follow-up|5|||
155478123|NCT04063865|561171180|FG000|Overall Study|Physician Decision|1|||
155478124|NCT04063865|561171181|FG001|Overall Study|Physician Decision|3|||
155478125|NCT04063865|561171180|FG000|Overall Study|Study Closed Prior to Completion|4|||
155478126|NCT04063865|561171181|FG001|Overall Study|Study Closed Prior to Completion|4|||
155478127|NCT04063865|561171180|FG000|Overall Study|Withdrawal by Subject|1|||
155478128|NCT04063865|561171181|FG001|Overall Study|Withdrawal by Subject|1|||
155478129|NCT00320190|561171182|FG000|First 12 Months|Completed but did not enter extension|5|||
155478130|NCT00320190|561171183|FG001|First 12 Months|Completed but did not enter extension|3|||
155478131|NCT00320190|561171182|FG000|First 12 Months|Sponsor terminated study|2|||
155478132|NCT00320190|561171183|FG001|First 12 Months|Sponsor terminated study|2|||
155478133|NCT00320190|561171182|FG000|First 12 Months|Lost to Follow-up|0|||
155478134|NCT00320190|561171183|FG001|First 12 Months|Lost to Follow-up|1|||
155478135|NCT00320190|561171182|FG000|First 12 Months|Enrollment failure|0|||
155478136|NCT00320190|561171183|FG001|First 12 Months|Enrollment failure|1|||
155478137|NCT00320190|561171182|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
155478138|NCT00320190|561171183|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
155478139|NCT00320190|561171182|FG000|First 12 Months|Investigator request|0|||
155478140|NCT00320190|561171183|FG001|First 12 Months|Investigator request|1|||
155478141|NCT00320190|561171182|FG000|First 12 Months|Study drug toxicity|0|||
155478142|NCT00320190|561171183|FG001|First 12 Months|Study drug toxicity|1|||
155478143|NCT00320190|561171182|FG000|First 12 Months|Withdrawal by Subject|0|||
155478144|NCT00320190|561171183|FG001|First 12 Months|Withdrawal by Subject|1|||
155478145|NCT00320190|561171182|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
155478146|NCT00320190|561171183|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
155478147|NCT00320190|561171182|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
155478148|NCT00320190|561171183|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
155478149|NCT00320190|561171182|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
155478150|NCT00320190|561171183|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
155478151|NCT01700140|561171184|FG000|Overall Study|Use of rescue drugs|3|||
155478152|NCT01700140|561171185|FG001|Overall Study|Use of rescue drugs|3|||
155478153|NCT01700140|561171186|FG002|Overall Study|Use of rescue drugs|1|||
155478154|NCT01700140|561171184|FG000|Overall Study|Discontinuation of radiotherapy|1|||
155478155|NCT01700140|561171185|FG001|Overall Study|Discontinuation of radiotherapy|0|||
155478156|NCT01700140|561171186|FG002|Overall Study|Discontinuation of radiotherapy|0|||
155478157|NCT01700140|561171184|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
155478158|NCT01700140|561171185|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
155478159|NCT01700140|561171186|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
155478160|NCT01700140|561171184|FG000|Overall Study|Aggravation of symptoms|1|||
155478161|NCT01700140|561171185|FG001|Overall Study|Aggravation of symptoms|0|||
155478162|NCT01700140|561171186|FG002|Overall Study|Aggravation of symptoms|0|||
155478163|NCT01700140|561171184|FG000|Overall Study|Adverse Event|0|||
155478164|NCT01700140|561171185|FG001|Overall Study|Adverse Event|1|||
155478165|NCT01700140|561171186|FG002|Overall Study|Adverse Event|0|||
155478166|NCT01700140|561171184|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
155478167|NCT01700140|561171185|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
155478168|NCT01700140|561171186|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
155478169|NCT01060124|561171187|FG000|Overall Study|Other|16|||
155478170|NCT01060124|561171187|FG000|Overall Study|Adverse Event|14|||
155478171|NCT01060124|561171187|FG000|Overall Study|Withdrawal by Subject|7|||
155478172|NCT00518336|561171193|FG000|Year 7|Lost to Follow-up|2|||
155478173|NCT00518336|561171194|FG001|Year 7|Lost to Follow-up|0|||
155478174|NCT00518336|561171193|FG000|Year 7|Could not attend in time|0|||
155478175|NCT00518336|561171194|FG001|Year 7|Could not attend in time|3|||
155478176|NCT00518336|561171193|FG000|Year 8|Lost to Follow-up|1|||
155478177|NCT00518336|561171194|FG001|Year 8|Lost to Follow-up|1|||
155478178|NCT00518336|561171193|FG000|Year 8|Could not attend in time|0|||
155478179|NCT00518336|561171194|FG001|Year 8|Could not attend in time|1|||
155478180|NCT00518336|561171193|FG000|Year 9|Migrated/moved from study area|1|||
155478181|NCT00518336|561171194|FG001|Year 9|Migrated/moved from study area|1|||
155478182|NCT00518336|561171193|FG000|Year 9|Lost to Follow-up|3|||
155478183|NCT00518336|561171194|FG001|Year 9|Lost to Follow-up|0|||
155478184|NCT00518336|561171193|FG000|Year 9|Personal reasons|1|||
155478185|NCT00518336|561171194|FG001|Year 9|Personal reasons|0|||
155478186|NCT03074318|561171195|FG000|Overall Study|Adverse Event|0|||
155478187|NCT03074318|561171196|FG001|Overall Study|Adverse Event|1|||
155478188|NCT03074318|561171197|FG002|Overall Study|Adverse Event|1|||
155478189|NCT03074318|561171198|FG003|Overall Study|Adverse Event|1|||
155478190|NCT03074318|561171195|FG000|Overall Study|Death|1|||
155478191|NCT03074318|561171196|FG001|Overall Study|Death|0|||
155478192|NCT03074318|561171197|FG002|Overall Study|Death|0|||
155478193|NCT03074318|561171198|FG003|Overall Study|Death|0|||
155478194|NCT03074318|561171195|FG000|Overall Study|Withdrawal by Subject|1|||
155478195|NCT03074318|561171196|FG001|Overall Study|Withdrawal by Subject|2|||
155478196|NCT03074318|561171197|FG002|Overall Study|Withdrawal by Subject|2|||
155478197|NCT03074318|561171198|FG003|Overall Study|Withdrawal by Subject|4|||
155478198|NCT03074318|561171195|FG000|Overall Study|Trial Closure|2|||
155478199|NCT03074318|561171196|FG001|Overall Study|Trial Closure|2|||
155478200|NCT03074318|561171197|FG002|Overall Study|Trial Closure|3|||
155478201|NCT03074318|561171198|FG003|Overall Study|Trial Closure|11|||
155478202|NCT03399786|561171199|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155478203|NCT03399786|561171200|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155478204|NCT03399786|561171201|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155478205|NCT03399786|561171202|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155478206|NCT03399786|561171199|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
155478207|NCT03399786|561171200|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
155478208|NCT03399786|561171201|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
155478209|NCT03399786|561171202|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
155478210|NCT03399786|561171199|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
155478211|NCT03399786|561171200|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
155478212|NCT03399786|561171201|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
155478213|NCT03399786|561171202|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
155478214|NCT02972658|561172836|FG000|Overall Study|Adverse Event|0|||
155478215|NCT02972658|561172837|FG001|Overall Study|Adverse Event|3|||
155478216|NCT02972658|561172838|FG002|Overall Study|Adverse Event|0|||
155478217|NCT02972658|561172839|FG003|Overall Study|Adverse Event|2|||
155478218|NCT02972658|561172836|FG000|Overall Study|Other-determined by Investigator|1|||
155478219|NCT02972658|561172837|FG001|Overall Study|Other-determined by Investigator|1|||
155478220|NCT02972658|561172838|FG002|Overall Study|Other-determined by Investigator|0|||
155478221|NCT02972658|561172839|FG003|Overall Study|Other-determined by Investigator|0|||
155478222|NCT02972658|561172836|FG000|Overall Study|Death|0|||
155478223|NCT02972658|561172837|FG001|Overall Study|Death|0|||
155478224|NCT02972658|561172838|FG002|Overall Study|Death|0|||
155478225|NCT02972658|561172839|FG003|Overall Study|Death|1|||
155478226|NCT02972658|561172836|FG000|Overall Study|Lost to Follow-up|0|||
155478227|NCT02972658|561172837|FG001|Overall Study|Lost to Follow-up|1|||
155478228|NCT02972658|561172838|FG002|Overall Study|Lost to Follow-up|1|||
155478229|NCT02972658|561172839|FG003|Overall Study|Lost to Follow-up|2|||
155478230|NCT02972658|561172836|FG000|Overall Study|Progressive Disease|0|||
155478231|NCT02972658|561172837|FG001|Overall Study|Progressive Disease|1|||
155478232|NCT02972658|561172838|FG002|Overall Study|Progressive Disease|0|||
155478233|NCT02972658|561172839|FG003|Overall Study|Progressive Disease|1|||
155478234|NCT02972658|561172836|FG000|Overall Study|Withdrawal by Subject|4|||
155478235|NCT02972658|561172837|FG001|Overall Study|Withdrawal by Subject|4|||
155478236|NCT02972658|561172838|FG002|Overall Study|Withdrawal by Subject|1|||
155478237|NCT02972658|561172839|FG003|Overall Study|Withdrawal by Subject|6|||
155478238|NCT02972658|561172836|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
155478239|NCT02972658|561172837|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
155478240|NCT02972658|561172838|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
155478241|NCT02972658|561172839|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
155654469|NCT04102514|561828882|FG002|Overall Study|Lost to Follow-up|3|||
155478242|NCT02972658|561172836|FG000|Overall Study|Sponsor Decision|70|||
155478243|NCT02972658|561172837|FG001|Overall Study|Sponsor Decision|127|||
155478244|NCT02972658|561172838|FG002|Overall Study|Sponsor Decision|72|||
155478245|NCT02972658|561172839|FG003|Overall Study|Sponsor Decision|119|||
155478246|NCT03958149|561172843|FG000|Overall Study|Withdrawal by Subject|0|||
155478247|NCT03958149|561172844|FG001|Overall Study|Withdrawal by Subject|1|||
155478248|NCT02785588|561172845|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
155478249|NCT02785588|561172845|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
155478250|NCT00621764|561172847|FG000|Overall Study|Protocol Violation|0|||
155478251|NCT00621764|561172848|FG001|Overall Study|Protocol Violation|0|||
155654470|NCT04102514|561828883|FG003|Overall Study|Lost to Follow-up|0|||
155654471|NCT04102514|561828880|FG000|Overall Study|Physician Decision|0|||
155654472|NCT04102514|561828881|FG001|Overall Study|Physician Decision|0|||
155654473|NCT04102514|561828882|FG002|Overall Study|Physician Decision|1|||
155654474|NCT04102514|561828883|FG003|Overall Study|Physician Decision|0|||
155654475|NCT04102514|561828880|FG000|Overall Study|Withdrawal by Subject|7|||
155478252|NCT00621764|561172849|FG002|Overall Study|Protocol Violation|0|||
155478253|NCT00621764|561172850|FG003|Overall Study|Protocol Violation|1|||
155478254|NCT00724243|561172855|FG000|Overall Study|Lack of Efficacy|10|||
155478255|NCT00724243|561172855|FG000|Overall Study|Adverse Event|5|||
155478256|NCT03031327|561172856|FG000|Overall Study|Withdrawal by Subject|0|||
155478257|NCT03031327|561172857|FG001|Overall Study|Withdrawal by Subject|1|||
155478258|NCT03031327|561172858|FG002|Overall Study|Withdrawal by Subject|1|||
155478259|NCT00669240|561172859|FG000|Overall Study|Lack of Efficacy|33|||
155478260|NCT00669240|561172859|FG000|Overall Study|Withdrawal by Subject|42|||
155478261|NCT00669240|561172859|FG000|Overall Study|Lost to Follow-up|34|||
155478262|NCT00669240|561172859|FG000|Overall Study|Adverse Event|21|||
155478263|NCT00669240|561172859|FG000|Overall Study|Other|19|||
155478264|NCT00669240|561172859|FG000|Overall Study|Enrolled but not treated|15|||
155478265|NCT00669240|561172859|FG000|Overall Study|Enrolled but no dosing record|1|||
155478266|NCT00686699|561172860|FG000|Treatment Period 1|Adverse Event|0|||
155478267|NCT00686699|561172861|FG001|Treatment Period 1|Adverse Event|2|||
155478268|NCT00908895|561172862|FG000|Overall Study|Lost to Follow-up|1|||
155478269|NCT00908895|561172863|FG001|Overall Study|Lost to Follow-up|3|||
155478270|NCT00908895|561172862|FG000|Overall Study|algodystrophy|2|||
155478271|NCT00908895|561172863|FG001|Overall Study|algodystrophy|2|||
155478272|NCT00908895|561172862|FG000|Overall Study|Adverse Event|1|||
155478273|NCT00908895|561172863|FG001|Overall Study|Adverse Event|1|||
155478274|NCT00364611|561172864|FG000|Overall Study|Did not receive study medication|0|||
155478275|NCT00364611|561172865|FG001|Overall Study|Did not receive study medication|1|||
155478276|NCT00364611|561172864|FG000|Overall Study|Adverse Event|7|||
155478277|NCT00364611|561172865|FG001|Overall Study|Adverse Event|4|||
155478278|NCT00364611|561172864|FG000|Overall Study|Participant's Request|3|||
155478279|NCT00364611|561172865|FG001|Overall Study|Participant's Request|4|||
155478280|NCT00364611|561172864|FG000|Overall Study|Disease Progression|38|||
155478281|NCT00364611|561172865|FG001|Overall Study|Disease Progression|8|||
155478282|NCT00364611|561172864|FG000|Overall Study|Investigator decision|2|||
155478283|NCT00364611|561172865|FG001|Overall Study|Investigator decision|2|||
155519583|NCT05097989|561327314|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519584|NCT05097989|561327315|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519585|NCT05097989|561327316|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519586|NCT05097989|561327317|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519587|NCT05097989|561327318|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519588|NCT05097989|561327319|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519589|NCT05097989|561327320|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
155519590|NCT05097989|561327312|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
155519591|NCT05097989|561327313|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
155519592|NCT05097989|561327314|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
155519593|NCT05097989|561327315|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
155519594|NCT05097989|561327316|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
155654476|NCT04102514|561828881|FG001|Overall Study|Withdrawal by Subject|13|||
155654477|NCT04102514|561828882|FG002|Overall Study|Withdrawal by Subject|7|||
155654478|NCT04102514|561828883|FG003|Overall Study|Withdrawal by Subject|14|||
155654479|NCT04102514|561828880|FG000|Overall Study|Moved to longterm care facility|6|||
155654480|NCT04102514|561828881|FG001|Overall Study|Moved to longterm care facility|0|||
155654481|NCT04102514|561828882|FG002|Overall Study|Moved to longterm care facility|4|||
155654482|NCT04102514|561828883|FG003|Overall Study|Moved to longterm care facility|0|||
155654483|NCT05418426|561828888|FG000|Overall Study|Adverse Event|0|||
155654484|NCT05418426|561828889|FG001|Overall Study|Adverse Event|1|||
155654485|NCT05418426|561828890|FG002|Overall Study|Adverse Event|0|||
155654486|NCT05418426|561828888|FG000|Overall Study|Withdrawal by Subject|0|||
155654487|NCT05418426|561828889|FG001|Overall Study|Withdrawal by Subject|1|||
155654488|NCT05418426|561828890|FG002|Overall Study|Withdrawal by Subject|0|||
155654489|NCT05418426|561828888|FG000|Overall Study|Protocol Violation|0|||
155478284|NCT00364611|561172864|FG000|Overall Study|Found Ineligible|1|||
155478285|NCT00364611|561172865|FG001|Overall Study|Found Ineligible|0|||
155478286|NCT00364611|561172864|FG000|Overall Study|Presumed CR on Study|0|||
155478287|NCT00364611|561172865|FG001|Overall Study|Presumed CR on Study|1|||
155478288|NCT00364611|561172864|FG000|Overall Study|Receiving Liver Ablation|0|||
155478289|NCT00364611|561172865|FG001|Overall Study|Receiving Liver Ablation|1|||
155654490|NCT05418426|561828889|FG001|Overall Study|Protocol Violation|0|||
155654491|NCT05418426|561828890|FG002|Overall Study|Protocol Violation|1|||
155478290|NCT02059174|561172866|FG000|Period 1|Withdrawal by Subject|0|||
155478291|NCT02059174|561172867|FG001|Period 1|Withdrawal by Subject|2|||
155478292|NCT02059174|561172866|FG000|Period 2|Withdrawal by Subject|0|||
155478293|NCT02059174|561172867|FG001|Period 2|Withdrawal by Subject|2|||
155478294|NCT02059174|561172866|FG000|Period 2|Protocol Violation|1|||
155478295|NCT02059174|561172867|FG001|Period 2|Protocol Violation|0|||
155478296|NCT02059174|561172866|FG000|Period 3|Physician Decision|1|||
155478297|NCT02059174|561172867|FG001|Period 3|Physician Decision|0|||
155478298|NCT00087594|561172868|FG000|Overall Study|Adverse Event|2|||
155478299|NCT00087594|561172869|FG001|Overall Study|Adverse Event|3|||
155478300|NCT00087594|561172868|FG000|Overall Study|Lost to Follow-up|0|||
155478301|NCT00087594|561172869|FG001|Overall Study|Lost to Follow-up|2|||
155478302|NCT00087594|561172868|FG000|Overall Study|Withdrawal by Subject|4|||
155478303|NCT00087594|561172869|FG001|Overall Study|Withdrawal by Subject|2|||
155478304|NCT00087594|561172868|FG000|Overall Study|Lack of Efficacy|2|||
155478305|NCT00087594|561172869|FG001|Overall Study|Lack of Efficacy|5|||
155478306|NCT00768040|561172870|FG000|Overall Study|Adverse Event|3|||
155478307|NCT00768040|561172871|FG001|Overall Study|Adverse Event|2|||
155478308|NCT00768040|561172870|FG000|Overall Study|Abnormal laboratory value|1|||
155478309|NCT00768040|561172871|FG001|Overall Study|Abnormal laboratory value|1|||
155478310|NCT02094612|561172876|FG000|Overall Study|Lost to Follow-up|47|||
155478311|NCT02094612|561172877|FG001|Overall Study|Lost to Follow-up|47|||
155478312|NCT02094612|561172876|FG000|Overall Study|Never started ADHD medication|32|||
155478313|NCT02094612|561172877|FG001|Overall Study|Never started ADHD medication|23|||
155478314|NCT00290355|561172878|FG000|Overall Study|Serious adverse event|7|||
155478315|NCT00290355|561172879|FG001|Overall Study|Serious adverse event|4|||
155478316|NCT00290355|561172878|FG000|Overall Study|Study product reactogenicity|1|||
155478317|NCT00290355|561172879|FG001|Overall Study|Study product reactogenicity|0|||
155478318|NCT00290355|561172878|FG000|Overall Study|Protocol Violation|1|||
155478319|NCT00290355|561172879|FG001|Overall Study|Protocol Violation|0|||
155478320|NCT00290355|561172878|FG000|Overall Study|Withdrawal by Subject|2|||
155478321|NCT00290355|561172879|FG001|Overall Study|Withdrawal by Subject|0|||
155478322|NCT00290355|561172878|FG000|Overall Study|Migrated / moved from the study area|1|||
155478323|NCT00290355|561172879|FG001|Overall Study|Migrated / moved from the study area|0|||
155478324|NCT00290355|561172878|FG000|Overall Study|Lost to Follow-up|3|||
155478325|NCT00290355|561172879|FG001|Overall Study|Lost to Follow-up|1|||
155478326|NCT00290355|561172878|FG000|Overall Study|Other|2|||
155478327|NCT00290355|561172879|FG001|Overall Study|Other|0|||
155478328|NCT03345849|561172880|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
155478329|NCT03345849|561172881|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
155478330|NCT03345849|561172882|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
155478331|NCT03345849|561172883|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
155478332|NCT03345849|561172880|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
155478333|NCT03345849|561172881|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
155478334|NCT03345849|561172882|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
155478335|NCT03345849|561172883|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
155478336|NCT03345849|561172880|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
155478337|NCT03345849|561172881|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
155478338|NCT03345849|561172882|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
155478339|NCT03345849|561172883|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
155478340|NCT03345849|561172880|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
155519595|NCT05097989|561327317|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
155519596|NCT05097989|561327318|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
155519597|NCT05097989|561327319|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
155519598|NCT05097989|561327320|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
155519599|NCT03283709|561327330|FG000|Overall Study|trial terminated|0|||
155519600|NCT03283709|561327331|FG001|Overall Study|trial terminated|1|||
155519601|NCT00117949|561327332|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
155519602|NCT00117949|561327333|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
155519603|NCT00117949|561327334|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
155478341|NCT03345849|561172881|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
155478342|NCT03345849|561172882|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
155478343|NCT03345849|561172883|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
155478344|NCT03345849|561172880|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
155478345|NCT03345849|561172881|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
155654492|NCT02096354|561828896|FG000|Overall Study|Physician Decision|4|||
155478346|NCT03345849|561172882|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
155478347|NCT03345849|561172883|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
155478348|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
155478349|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
155519604|NCT00117949|561327335|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
155654493|NCT02096354|561828897|FG001|Overall Study|Physician Decision|5|||
155654494|NCT02096354|561828898|FG002|Overall Study|Physician Decision|0|||
155654495|NCT02096354|561828896|FG000|Overall Study|Withdrawal by Subject|3|||
155654496|NCT02096354|561828897|FG001|Overall Study|Withdrawal by Subject|1|||
155654497|NCT02096354|561828898|FG002|Overall Study|Withdrawal by Subject|0|||
155654498|NCT02096354|561828896|FG000|Overall Study|Adverse Event|7|||
155654499|NCT02096354|561828897|FG001|Overall Study|Adverse Event|4|||
155654500|NCT02096354|561828898|FG002|Overall Study|Adverse Event|0|||
155654501|NCT02096354|561828896|FG000|Overall Study|Ineligible|0|||
155654502|NCT02096354|561828897|FG001|Overall Study|Ineligible|0|||
155478350|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
155478351|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
155478352|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
155478353|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
155478354|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
155478355|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
155478356|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
155478357|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
155478358|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
155478359|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
155478360|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155478361|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155478362|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155478363|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
155478364|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
155478365|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
155478366|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
155478367|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
155478368|NCT03345849|561172880|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
155478369|NCT03345849|561172881|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
155478370|NCT03345849|561172882|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
155478371|NCT03345849|561172883|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
155478372|NCT03991936|561172884|FG000|Overall Study|Lost to Follow-up|1|||
155478373|NCT03991936|561172885|FG001|Overall Study|Lost to Follow-up|1|||
155478374|NCT03991936|561172886|FG002|Overall Study|Lost to Follow-up|1|||
155478375|NCT03991936|561172887|FG003|Overall Study|Lost to Follow-up|1|||
155478376|NCT03991936|561172888|FG004|Overall Study|Lost to Follow-up|1|||
155478377|NCT00777036|561172895|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
155478378|NCT00777036|561172896|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
155478379|NCT00777036|561172897|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
155478380|NCT00777036|561172898|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
155478381|NCT00777036|561172895|FG000|On Treatment|Administrative Reason By Sponsor|1|||
155478382|NCT00777036|561172896|FG001|On Treatment|Administrative Reason By Sponsor|0|||
155478383|NCT00777036|561172897|FG002|On Treatment|Administrative Reason By Sponsor|9|||
155478384|NCT00777036|561172898|FG003|On Treatment|Administrative Reason By Sponsor|0|||
155478385|NCT00777036|561172895|FG000|On Treatment|Failure to Meet Study Criteria|0|||
155478386|NCT00777036|561172896|FG001|On Treatment|Failure to Meet Study Criteria|1|||
155478387|NCT00777036|561172897|FG002|On Treatment|Failure to Meet Study Criteria|4|||
155478388|NCT00777036|561172898|FG003|On Treatment|Failure to Meet Study Criteria|0|||
155478389|NCT00777036|561172895|FG000|On Treatment|Pregnancy|1|||
155478390|NCT00777036|561172896|FG001|On Treatment|Pregnancy|0|||
155478391|NCT00777036|561172897|FG002|On Treatment|Pregnancy|1|||
155478392|NCT00777036|561172898|FG003|On Treatment|Pregnancy|0|||
155478393|NCT00777036|561172895|FG000|On Treatment|Non-compliance with Study Drug|1|||
155478394|NCT00777036|561172896|FG001|On Treatment|Non-compliance with Study Drug|0|||
155478395|NCT00777036|561172897|FG002|On Treatment|Non-compliance with Study Drug|1|||
155654503|NCT02096354|561828898|FG002|Overall Study|Ineligible|11|||
155654504|NCT02951819|561828899|FG000|Overall Study|Death|9|||
155654505|NCT02951819|561828900|FG001|Overall Study|Death|7|||
155654506|NCT02951819|561828899|FG000|Overall Study|Withdrawal by Subject|3|||
155654507|NCT02951819|561828900|FG001|Overall Study|Withdrawal by Subject|0|||
155478396|NCT00777036|561172898|FG003|On Treatment|Non-compliance with Study Drug|0|||
155654508|NCT02951819|561828899|FG000|Overall Study|Adverse Event|1|||
155654509|NCT02951819|561828900|FG001|Overall Study|Adverse Event|0|||
155654510|NCT02951819|561828899|FG000|Overall Study|Lack of Efficacy|4|||
155478397|NCT00777036|561172895|FG000|On Treatment|Maximum Clinical Benefit|2|||
155478398|NCT00777036|561172896|FG001|On Treatment|Maximum Clinical Benefit|0|||
155478399|NCT00777036|561172897|FG002|On Treatment|Maximum Clinical Benefit|5|||
155478400|NCT00777036|561172898|FG003|On Treatment|Maximum Clinical Benefit|0|||
155478401|NCT00777036|561172895|FG000|On Treatment|Withdrawal by Subject|0|||
155478402|NCT00777036|561172896|FG001|On Treatment|Withdrawal by Subject|2|||
155478403|NCT00777036|561172897|FG002|On Treatment|Withdrawal by Subject|2|||
155478404|NCT00777036|561172898|FG003|On Treatment|Withdrawal by Subject|0|||
155478405|NCT00777036|561172895|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
155478406|NCT00777036|561172896|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
155478407|NCT00777036|561172897|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
155478408|NCT00777036|561172898|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
155478409|NCT00777036|561172895|FG000|On Treatment|Death|0|||
155478410|NCT00777036|561172896|FG001|On Treatment|Death|2|||
155478411|NCT00777036|561172897|FG002|On Treatment|Death|0|||
155478412|NCT00777036|561172898|FG003|On Treatment|Death|0|||
155478413|NCT00777036|561172895|FG000|On Treatment|Study Drug Toxicity|1|||
155478414|NCT00777036|561172896|FG001|On Treatment|Study Drug Toxicity|0|||
155478415|NCT00777036|561172897|FG002|On Treatment|Study Drug Toxicity|4|||
155478416|NCT00777036|561172898|FG003|On Treatment|Study Drug Toxicity|0|||
155478417|NCT00777036|561172895|FG000|On Treatment|Progressive Disease|6|||
155478418|NCT00777036|561172896|FG001|On Treatment|Progressive Disease|4|||
155478419|NCT00777036|561172897|FG002|On Treatment|Progressive Disease|7|||
155478420|NCT00777036|561172898|FG003|On Treatment|Progressive Disease|0|||
155478421|NCT00777036|561172895|FG000|On Treatment|Not Reported|0|||
155478422|NCT00777036|561172896|FG001|On Treatment|Not Reported|0|||
155478423|NCT00777036|561172897|FG002|On Treatment|Not Reported|2|||
155478424|NCT00777036|561172898|FG003|On Treatment|Not Reported|0|||
155478425|NCT00777036|561172895|FG000|On Treatment|Site Closed|0|||
155478426|NCT00777036|561172896|FG001|On Treatment|Site Closed|1|||
155478427|NCT00777036|561172897|FG002|On Treatment|Site Closed|1|||
155478428|NCT00777036|561172898|FG003|On Treatment|Site Closed|0|||
155478429|NCT00777036|561172895|FG000|Follow-Up|Withdrawal by Subject|0|||
155478430|NCT00777036|561172896|FG001|Follow-Up|Withdrawal by Subject|0|||
155478431|NCT00777036|561172897|FG002|Follow-Up|Withdrawal by Subject|5|||
155478432|NCT00777036|561172898|FG003|Follow-Up|Withdrawal by Subject|0|||
155478433|NCT00777036|561172895|FG000|Follow-Up|Death|1|||
155478434|NCT00777036|561172896|FG001|Follow-Up|Death|9|||
155478435|NCT00777036|561172897|FG002|Follow-Up|Death|0|||
155519605|NCT00117949|561327332|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
155478436|NCT00777036|561172898|FG003|Follow-Up|Death|0|||
155478437|NCT00777036|561172895|FG000|Follow-Up|Lost to Follow-up|3|||
155478438|NCT00777036|561172896|FG001|Follow-Up|Lost to Follow-up|0|||
155519606|NCT00117949|561327333|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
155478439|NCT00777036|561172897|FG002|Follow-Up|Lost to Follow-up|0|||
155519607|NCT00117949|561327334|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
155519608|NCT00117949|561327335|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
155478440|NCT00777036|561172898|FG003|Follow-Up|Lost to Follow-up|0|||
155478441|NCT00777036|561172895|FG000|Follow-Up|Reason Not Specified|4|||
155478442|NCT00777036|561172896|FG001|Follow-Up|Reason Not Specified|0|||
155478443|NCT00777036|561172897|FG002|Follow-Up|Reason Not Specified|13|||
155478444|NCT00777036|561172898|FG003|Follow-Up|Reason Not Specified|0|||
155478445|NCT00777036|561172895|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
155478446|NCT00777036|561172896|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
155478447|NCT00777036|561172897|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
155478448|NCT00777036|561172898|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
155478449|NCT05564039|561172899|FG000|Overall Study|Adverse Event|1|||
155478450|NCT05564039|561172900|FG001|Overall Study|Adverse Event|0|||
155654511|NCT02951819|561828900|FG001|Overall Study|Lack of Efficacy|0|||
155654512|NCT02951819|561828899|FG000|Overall Study|Lost to Follow-up|1|||
155654513|NCT02951819|561828900|FG001|Overall Study|Lost to Follow-up|0|||
155478451|NCT05564039|561172899|FG000|Overall Study|Death|1|||
155478452|NCT05564039|561172900|FG001|Overall Study|Death|1|||
155478453|NCT05564039|561172899|FG000|Overall Study|Lost to Follow-up|3|||
155478454|NCT05564039|561172900|FG001|Overall Study|Lost to Follow-up|2|||
155478455|NCT05564039|561172899|FG000|Overall Study|Withdrawal by Subject|2|||
155478456|NCT05564039|561172900|FG001|Overall Study|Withdrawal by Subject|0|||
155478457|NCT05564039|561172899|FG000|Overall Study|Inadvertent enrollment|3|||
155478458|NCT05564039|561172900|FG001|Overall Study|Inadvertent enrollment|6|||
155478459|NCT01685372|561172901|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
155478460|NCT01685372|561172902|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
155478461|NCT00829010|561172905|FG000|Overall Study|Adverse Event|1|||
155478462|NCT00829010|561172906|FG001|Overall Study|Adverse Event|0|||
155478463|NCT00829010|561172907|FG002|Overall Study|Adverse Event|0|||
155478464|NCT00829010|561172908|FG003|Overall Study|Adverse Event|0|||
155478465|NCT00829010|561172909|FG004|Overall Study|Adverse Event|0|||
155478466|NCT00829010|561172905|FG000|Overall Study|Withdrawal by Subject|0|||
155478467|NCT00829010|561172906|FG001|Overall Study|Withdrawal by Subject|1|||
155478468|NCT00829010|561172907|FG002|Overall Study|Withdrawal by Subject|1|||
155478469|NCT00829010|561172908|FG003|Overall Study|Withdrawal by Subject|0|||
155478470|NCT00829010|561172909|FG004|Overall Study|Withdrawal by Subject|2|||
155478471|NCT00829010|561172905|FG000|Overall Study|Lost to Follow-up|1|||
155478472|NCT00829010|561172906|FG001|Overall Study|Lost to Follow-up|0|||
155478473|NCT00829010|561172907|FG002|Overall Study|Lost to Follow-up|2|||
155478474|NCT00829010|561172908|FG003|Overall Study|Lost to Follow-up|0|||
155478475|NCT00829010|561172909|FG004|Overall Study|Lost to Follow-up|0|||
155478476|NCT00829010|561172905|FG000|Overall Study|Fatality|5|||
155478477|NCT00829010|561172906|FG001|Overall Study|Fatality|4|||
155478478|NCT00829010|561172907|FG002|Overall Study|Fatality|0|||
155519609|NCT00117949|561327332|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
155519610|NCT00117949|561327333|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
155519611|NCT00117949|561327334|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
155478479|NCT00829010|561172908|FG003|Overall Study|Fatality|3|||
155478480|NCT00829010|561172909|FG004|Overall Study|Fatality|0|||
155478481|NCT00829010|561172905|FG000|Overall Study|Migrated/Moved from study area|3|||
155654514|NCT02951819|561828899|FG000|Overall Study|Progressive Disease|1|||
155478482|NCT00829010|561172906|FG001|Overall Study|Migrated/Moved from study area|4|||
155478483|NCT00829010|561172907|FG002|Overall Study|Migrated/Moved from study area|0|||
155478484|NCT00829010|561172908|FG003|Overall Study|Migrated/Moved from study area|5|||
155478485|NCT00829010|561172909|FG004|Overall Study|Migrated/Moved from study area|0|||
155478486|NCT01029691|561172910|FG000|Continued APAP to Delivery|Death|0|||
155478487|NCT01029691|561172911|FG001|Continued APAP to Delivery|Death|0|||
155478488|NCT01029691|561172912|FG002|Continued APAP to Delivery|Death|1|||
155478489|NCT00137267|561172915|FG000|Overall Study|Lost to Follow-up|15|||
155478490|NCT00137267|561172916|FG001|Overall Study|Lost to Follow-up|21|||
155478491|NCT05492877|561172918|FG000|Overall Study|Adverse Event|11|||
155478492|NCT05492877|561172919|FG001|Overall Study|Adverse Event|7|||
155478493|NCT05492877|561172918|FG000|Overall Study|Death|1|||
155478494|NCT05492877|561172919|FG001|Overall Study|Death|0|||
155478495|NCT05492877|561172918|FG000|Overall Study|Lost to Follow-up|1|||
155478496|NCT05492877|561172919|FG001|Overall Study|Lost to Follow-up|1|||
155478497|NCT05492877|561172918|FG000|Overall Study|Physician Decision|1|||
155478498|NCT05492877|561172919|FG001|Overall Study|Physician Decision|2|||
155478499|NCT05492877|561172918|FG000|Overall Study|Protocol Violation|1|||
155478500|NCT05492877|561172919|FG001|Overall Study|Protocol Violation|1|||
155478501|NCT05492877|561172918|FG000|Overall Study|Withdrawal by Subject|3|||
155478502|NCT05492877|561172919|FG001|Overall Study|Withdrawal by Subject|7|||
155478503|NCT05492877|561172918|FG000|Overall Study|Reason not specified|6|||
155478504|NCT05492877|561172919|FG001|Overall Study|Reason not specified|4|||
155478505|NCT00129376|561172920|FG000|Overall Study|Adverse Event|1|||
155478506|NCT00129376|561172920|FG000|Overall Study|Lack of Efficacy|1|||
155478507|NCT00528840|561172929|FG000|Overall Study|Lost to Follow-up|10|||
155478508|NCT00528840|561172929|FG000|Overall Study|Adverse Event|1|||
155478509|NCT00528840|561172929|FG000|Overall Study|Withdrawal by Subject|17|||
155478510|NCT00528840|561172929|FG000|Overall Study|Death|2|||
155478511|NCT00528840|561172929|FG000|Overall Study|Administrative Reasons|1|||
155478512|NCT00528840|561172929|FG000|Overall Study|Other|2|||
155478513|NCT01603628|561172930|FG000|Overall Study|Personal Reasons|1|||
155478514|NCT01603628|561172931|FG001|Overall Study|Personal Reasons|1|||
155478515|NCT01603628|561172932|FG002|Overall Study|Personal Reasons|2|||
155478516|NCT01603628|561172930|FG000|Overall Study|Protocol Violation|1|||
155478517|NCT01603628|561172931|FG001|Overall Study|Protocol Violation|1|||
155478518|NCT01603628|561172932|FG002|Overall Study|Protocol Violation|0|||
155478519|NCT01603628|561172930|FG000|Overall Study|Lost to Follow-up|0|||
155478520|NCT01603628|561172931|FG001|Overall Study|Lost to Follow-up|1|||
155478521|NCT01603628|561172932|FG002|Overall Study|Lost to Follow-up|0|||
155478522|NCT01603628|561172930|FG000|Overall Study|Other Miscellaneous Reason|1|||
155478523|NCT01603628|561172931|FG001|Overall Study|Other Miscellaneous Reason|0|||
155478524|NCT01603628|561172932|FG002|Overall Study|Other Miscellaneous Reason|0|||
155519612|NCT00117949|561327335|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
155519613|NCT00117949|561327332|FG000|Overall Study|PSA increase >=10ng/mL|0|||
155519614|NCT00117949|561327333|FG001|Overall Study|PSA increase >=10ng/mL|1|||
155654515|NCT02951819|561828900|FG001|Overall Study|Progressive Disease|0|||
155654516|NCT02951819|561828899|FG000|Overall Study|Other|9|||
155654517|NCT02951819|561828900|FG001|Overall Study|Other|0|||
155654518|NCT03715829|561828901|FG000|Dose Ranging Period|Adverse Event|2|||
155654519|NCT03715829|561828902|FG001|Dose Ranging Period|Adverse Event|4|||
155654520|NCT03715829|561828903|FG002|Dose Ranging Period|Adverse Event|5|||
155654521|NCT03715829|561828904|FG003|Dose Ranging Period|Adverse Event|2|||
155654522|NCT03715829|561828905|FG004|Dose Ranging Period|Adverse Event|3|||
155654523|NCT03715829|561828906|FG005|Dose Ranging Period|Adverse Event|3|||
155654524|NCT03715829|561828907|FG006|Dose Ranging Period|Adverse Event|0|||
155654525|NCT03715829|561828908|FG007|Dose Ranging Period|Adverse Event|0|||
155654526|NCT03715829|561828909|FG008|Dose Ranging Period|Adverse Event|0|||
155654527|NCT03715829|561828910|FG009|Dose Ranging Period|Adverse Event|0|||
155654528|NCT03715829|561828911|FG010|Dose Ranging Period|Adverse Event|0|||
155654529|NCT03715829|561828901|FG000|Dose Ranging Period|Lack of Efficacy|0|||
155654530|NCT03715829|561828902|FG001|Dose Ranging Period|Lack of Efficacy|1|||
155654531|NCT03715829|561828903|FG002|Dose Ranging Period|Lack of Efficacy|0|||
155654532|NCT03715829|561828904|FG003|Dose Ranging Period|Lack of Efficacy|1|||
155654533|NCT03715829|561828905|FG004|Dose Ranging Period|Lack of Efficacy|0|||
155654534|NCT03715829|561828906|FG005|Dose Ranging Period|Lack of Efficacy|0|||
155654535|NCT03715829|561828907|FG006|Dose Ranging Period|Lack of Efficacy|0|||
155654536|NCT03715829|561828908|FG007|Dose Ranging Period|Lack of Efficacy|0|||
155654537|NCT03715829|561828909|FG008|Dose Ranging Period|Lack of Efficacy|0|||
155654538|NCT03715829|561828910|FG009|Dose Ranging Period|Lack of Efficacy|0|||
155654539|NCT03715829|561828911|FG010|Dose Ranging Period|Lack of Efficacy|0|||
155654540|NCT03715829|561828901|FG000|Dose Ranging Period|Lost to Follow-up|2|||
155654541|NCT03715829|561828902|FG001|Dose Ranging Period|Lost to Follow-up|0|||
155654542|NCT03715829|561828903|FG002|Dose Ranging Period|Lost to Follow-up|1|||
155654543|NCT03715829|561828904|FG003|Dose Ranging Period|Lost to Follow-up|1|||
155654544|NCT03715829|561828905|FG004|Dose Ranging Period|Lost to Follow-up|1|||
155654545|NCT03715829|561828906|FG005|Dose Ranging Period|Lost to Follow-up|2|||
155654546|NCT03715829|561828907|FG006|Dose Ranging Period|Lost to Follow-up|0|||
155654547|NCT03715829|561828908|FG007|Dose Ranging Period|Lost to Follow-up|0|||
155654548|NCT03715829|561828909|FG008|Dose Ranging Period|Lost to Follow-up|0|||
155654549|NCT03715829|561828910|FG009|Dose Ranging Period|Lost to Follow-up|0|||
155654550|NCT03715829|561828911|FG010|Dose Ranging Period|Lost to Follow-up|0|||
155654551|NCT03715829|561828901|FG000|Dose Ranging Period|Protocol Violation|0|||
155654552|NCT03715829|561828902|FG001|Dose Ranging Period|Protocol Violation|0|||
155654553|NCT03715829|561828903|FG002|Dose Ranging Period|Protocol Violation|0|||
155654554|NCT03715829|561828904|FG003|Dose Ranging Period|Protocol Violation|1|||
155478525|NCT01969565|561172933|FG000|Overall Study|Withdrawal by Subject|1|||
155478526|NCT00832091|561172934|FG000|Overall Study|Adverse Event|1|||
155478527|NCT00832091|561172935|FG001|Overall Study|Adverse Event|1|||
155478528|NCT00832091|561172934|FG000|Overall Study|Protocol Violation|1|||
155478529|NCT00832091|561172935|FG001|Overall Study|Protocol Violation|0|||
155478530|NCT00832091|561172934|FG000|Overall Study|Withdrawal by Subject|2|||
155478531|NCT00832091|561172935|FG001|Overall Study|Withdrawal by Subject|1|||
155478532|NCT00832091|561172934|FG000|Overall Study|Prohibited Medication|1|||
155478533|NCT00832091|561172935|FG001|Overall Study|Prohibited Medication|0|||
155478534|NCT00952588|561172936|FG000|Overall Study|Death|28|||
155478535|NCT00952588|561172937|FG001|Overall Study|Death|13|||
155478536|NCT00952588|561172936|FG000|Overall Study|Withdrawal by Subject|2|||
155478537|NCT00952588|561172937|FG001|Overall Study|Withdrawal by Subject|5|||
155478538|NCT00952588|561172936|FG000|Overall Study|Adverse Event|2|||
155478539|NCT00952588|561172937|FG001|Overall Study|Adverse Event|3|||
155478540|NCT00952588|561172936|FG000|Overall Study|Lost to Follow-up|2|||
155478541|NCT00952588|561172937|FG001|Overall Study|Lost to Follow-up|0|||
155478542|NCT00952588|561172936|FG000|Overall Study|Physician Decision|0|||
155478543|NCT00952588|561172937|FG001|Overall Study|Physician Decision|1|||
155478544|NCT00952588|561172936|FG000|Overall Study|Lack of Efficacy|2|||
155478545|NCT00952588|561172937|FG001|Overall Study|Lack of Efficacy|2|||
155478546|NCT00398086|561172938|FG000|Overall Study|Unacceptable Toxicity|2|||
155478547|NCT00398086|561172939|FG001|Overall Study|Unacceptable Toxicity|8|||
155478548|NCT00398086|561172940|FG002|Overall Study|Unacceptable Toxicity|2|||
155478549|NCT00398086|561172938|FG000|Overall Study|Adverse Event|1|||
155478550|NCT00398086|561172939|FG001|Overall Study|Adverse Event|4|||
155478551|NCT00398086|561172940|FG002|Overall Study|Adverse Event|0|||
155478552|NCT00398086|561172938|FG000|Overall Study|Physician Decision|1|||
155478553|NCT00398086|561172939|FG001|Overall Study|Physician Decision|4|||
155478554|NCT00398086|561172940|FG002|Overall Study|Physician Decision|0|||
155478555|NCT00398086|561172938|FG000|Overall Study|Withdrawal by Subject|5|||
155478556|NCT00398086|561172939|FG001|Overall Study|Withdrawal by Subject|7|||
155478557|NCT00398086|561172940|FG002|Overall Study|Withdrawal by Subject|0|||
155478558|NCT02087241|561172947|FG000|Overall Study|Death|2|||
155478559|NCT02087241|561172948|FG001|Overall Study|Death|1|||
155478560|NCT02087241|561172949|FG002|Overall Study|Death|1|||
155478561|NCT02087241|561172950|FG003|Overall Study|Death|1|||
155478562|NCT02087241|561172947|FG000|Overall Study|Withdrawal by Subject|1|||
155478563|NCT02087241|561172948|FG001|Overall Study|Withdrawal by Subject|0|||
155478564|NCT02087241|561172949|FG002|Overall Study|Withdrawal by Subject|0|||
155478565|NCT02087241|561172950|FG003|Overall Study|Withdrawal by Subject|1|||
155478566|NCT02087241|561172947|FG000|Overall Study|Progressive Disease|0|||
155478567|NCT02087241|561172948|FG001|Overall Study|Progressive Disease|0|||
155478568|NCT02087241|561172949|FG002|Overall Study|Progressive Disease|0|||
155478569|NCT02087241|561172950|FG003|Overall Study|Progressive Disease|1|||
155478570|NCT02087241|561172947|FG000|Overall Study|Study Terminated by Sponsor|0|||
155478571|NCT02087241|561172948|FG001|Overall Study|Study Terminated by Sponsor|2|||
155478572|NCT02087241|561172949|FG002|Overall Study|Study Terminated by Sponsor|0|||
155478573|NCT02087241|561172950|FG003|Overall Study|Study Terminated by Sponsor|4|||
155478574|NCT01955005|561172951|FG000|Overall Study|Withdrawal by Subject|3|||
155478575|NCT01955005|561172952|FG001|Overall Study|Withdrawal by Subject|5|||
155478576|NCT02201251|561172953|FG000|Overall Study|Adverse Event|1|||
155478577|NCT02201251|561172954|FG001|Overall Study|Adverse Event|1|||
155478578|NCT02201251|561172953|FG000|Overall Study|Protocol Violation|1|||
155478579|NCT02201251|561172954|FG001|Overall Study|Protocol Violation|0|||
155478580|NCT02201251|561172953|FG000|Overall Study|Noncompliance with Study Drug|0|||
155478581|NCT02201251|561172954|FG001|Overall Study|Noncompliance with Study Drug|1|||
155478582|NCT02201251|561172953|FG000|Overall Study|Withdrawal by Subject|2|||
155478583|NCT02201251|561172954|FG001|Overall Study|Withdrawal by Subject|1|||
155478584|NCT00572728|561172959|FG000|Overall Study|Withdrawal by Subject|10|||
155478585|NCT00572728|561172959|FG000|Overall Study|Ineligible|3|||
155478586|NCT00572728|561172959|FG000|Overall Study|Enrolled under Amendment 4|5|||
155478587|NCT00572728|561172959|FG000|Overall Study|Offstudy due to complicating disease|1|||
155478588|NCT00572728|561172959|FG000|Overall Study|FLT1 not completed|4|||
155478589|NCT00572728|561172959|FG000|Overall Study|First Chemotherapy not initiated|2|||
155478590|NCT00572728|561172959|FG000|Overall Study|FLT2 not completed|5|||
155478591|NCT00572728|561172959|FG000|Overall Study|Second chemotherapy not initiated|1|||
155478592|NCT00572728|561172959|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
155478593|NCT00572728|561172959|FG000|Overall Study|Pathology missing|1|||
155478594|NCT02724111|561172964|FG000|Overall Study|Protocol Violation|2|||
155478595|NCT02724111|561172965|FG001|Overall Study|Protocol Violation|5|||
155478596|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
155478597|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155478598|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155519615|NCT00117949|561327334|FG002|Overall Study|PSA increase >=10ng/mL|1|||
155519616|NCT00117949|561327335|FG003|Overall Study|PSA increase >=10ng/mL|0|||
155519617|NCT00117949|561327332|FG000|Overall Study|PSA reduction <=50%|0|||
155519618|NCT00117949|561327333|FG001|Overall Study|PSA reduction <=50%|2|||
155519619|NCT00117949|561327334|FG002|Overall Study|PSA reduction <=50%|2|||
155519620|NCT00117949|561327335|FG003|Overall Study|PSA reduction <=50%|4|||
155519621|NCT00117949|561327332|FG000|Overall Study|Hepatic abnormalities|0|||
155519622|NCT00117949|561327333|FG001|Overall Study|Hepatic abnormalities|1|||
155519623|NCT00117949|561327334|FG002|Overall Study|Hepatic abnormalities|0|||
155519624|NCT00117949|561327335|FG003|Overall Study|Hepatic abnormalities|1|||
155519625|NCT00406848|561327338|FG000|Overall Study|Withdrawal by Subject|27|||
155519626|NCT00406848|561327339|FG001|Overall Study|Withdrawal by Subject|22|||
155519627|NCT00406848|561327338|FG000|Overall Study|Adverse Event|38|||
155519628|NCT00406848|561327339|FG001|Overall Study|Adverse Event|7|||
155519629|NCT00406848|561327338|FG000|Overall Study|Lack of Efficacy|9|||
155519630|NCT00406848|561327339|FG001|Overall Study|Lack of Efficacy|14|||
155519631|NCT00406848|561327338|FG000|Overall Study|Protocol Violation|10|||
155519632|NCT00406848|561327339|FG001|Overall Study|Protocol Violation|6|||
155519633|NCT00406848|561327338|FG000|Overall Study|Lost to Follow-up|6|||
155519634|NCT00406848|561327339|FG001|Overall Study|Lost to Follow-up|2|||
155519635|NCT00406848|561327338|FG000|Overall Study|Physician Decision|2|||
155519636|NCT00406848|561327339|FG001|Overall Study|Physician Decision|2|||
155519637|NCT00406848|561327338|FG000|Overall Study|Sponsor Decision|1|||
155519638|NCT00406848|561327339|FG001|Overall Study|Sponsor Decision|1|||
155519639|NCT04803357|561327340|FG000|Overall Study|Withdrawal by Subject|31|||
155519640|NCT04803357|561327341|FG001|Overall Study|Withdrawal by Subject|5|||
155519641|NCT02879643|561327343|FG000|Overall Study|Adverse Event|0|||
155519642|NCT02879643|561327344|FG001|Overall Study|Adverse Event|0|||
155519643|NCT02879643|561327345|FG002|Overall Study|Adverse Event|1|||
155519644|NCT02879643|561327346|FG003|Overall Study|Adverse Event|1|||
155519645|NCT02879643|561327347|FG004|Overall Study|Adverse Event|0|||
155519646|NCT01346410|561327348|FG000|Overall Study|Death|1|||
155519647|NCT00936390|561327349|FG000|Overall Study|Protocol Violation|21|||
155519648|NCT00936390|561327350|FG001|Overall Study|Protocol Violation|25|||
155519649|NCT02093689|561327351|FG000|Overall Study|Physician Decision|4|||
155519650|NCT02093689|561327352|FG001|Overall Study|Physician Decision|0|||
155519651|NCT02093689|561327353|FG002|Overall Study|Physician Decision|0|||
155519652|NCT00634179|561327354|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
155519653|NCT04947579|561327355|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155519654|NCT04947579|561327356|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155519655|NCT04947579|561327357|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155519656|NCT04947579|561327358|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
155519657|NCT04947579|561327359|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155519658|NCT04947579|561327360|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155519659|NCT04947579|561327355|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
155519660|NCT04947579|561327356|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
155519661|NCT04947579|561327357|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
155519662|NCT04947579|561327358|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
155519663|NCT04947579|561327359|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
155519664|NCT04947579|561327360|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
155519665|NCT04947579|561327355|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
155519666|NCT04947579|561327356|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
155519667|NCT04947579|561327357|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
155519668|NCT04947579|561327358|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
155519669|NCT04947579|561327359|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
155519670|NCT04947579|561327360|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
155519671|NCT04947579|561327355|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
155519672|NCT04947579|561327356|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
155519673|NCT04947579|561327357|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
155519674|NCT04947579|561327358|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
155519675|NCT04947579|561327359|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
155519676|NCT04947579|561327360|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
155519677|NCT04947579|561327355|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
155519678|NCT04947579|561327356|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
155519679|NCT04947579|561327357|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
155519680|NCT04947579|561327358|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
155519681|NCT04947579|561327359|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
155519682|NCT04947579|561327360|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
155519683|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
155519684|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
155519685|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
155478599|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155478600|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155478601|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155478602|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
155478603|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155478604|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155478605|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155478606|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155478607|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155478608|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
155478609|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155478610|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155478611|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155478612|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155478613|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155478614|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Other|14|||
155478615|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Other|0|||
155478616|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Other|0|||
155478617|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Other|0|||
155478618|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Other|0|||
155478619|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Other|0|||
155478620|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
155478621|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
155478622|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
155519686|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
155519687|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
155519688|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
155519689|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
155519690|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
155519691|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
155519692|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
155519693|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
155519694|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
155519695|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
155519696|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
155519697|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
155519698|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
155519699|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
155519700|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
155519701|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
155519702|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
155519703|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
155519704|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
155519705|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
155519706|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
155519707|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
155519708|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
155519709|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
155519710|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
155519711|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
155519712|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
155519713|NCT04947579|561327355|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
155519714|NCT04947579|561327356|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
155519715|NCT04947579|561327357|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
155519716|NCT04947579|561327358|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
155519717|NCT04947579|561327359|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
155519718|NCT04947579|561327360|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
155519719|NCT04272801|561327363|FG000|Overall Study|Withdrawal by Subject|4|||
155519720|NCT04272801|561327363|FG000|Overall Study|Lost to Follow-up|4|||
155519721|NCT04272801|561327363|FG000|Overall Study|Ineligible|1|||
155519722|NCT00475020|561327364|FG000|Overall Study|Physician Decision|3|||
155519723|NCT00475020|561327364|FG000|Overall Study|Insurance Denial|1|||
155519724|NCT00475020|561327364|FG000|Overall Study|Donor not able to donate the last minute|1|||
155519725|NCT03481309|561327365|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
155519726|NCT03481309|561327366|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
155519727|NCT03481309|561327367|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
155519728|NCT03481309|561327368|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
155519729|NCT03481309|561327369|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
155519730|NCT03481309|561327370|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
155519731|NCT01575054|561327371|FG000|Overall Study|Other Reasons|5|||
155519732|NCT01575054|561327372|FG001|Overall Study|Other Reasons|3|||
155519733|NCT01575054|561327371|FG000|Overall Study|Protocol Violation|2|||
155519734|NCT01575054|561327372|FG001|Overall Study|Protocol Violation|1|||
155478623|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
155478624|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
155478625|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
155519735|NCT01575054|561327371|FG000|Overall Study|Personal Reasons|10|||
155519736|NCT01575054|561327372|FG001|Overall Study|Personal Reasons|11|||
155519737|NCT01575054|561327371|FG000|Overall Study|Lost to Follow-up|3|||
155519738|NCT01575054|561327372|FG001|Overall Study|Lost to Follow-up|3|||
155519739|NCT01575054|561327371|FG000|Overall Study|Adverse Event|9|||
155519740|NCT01575054|561327372|FG001|Overall Study|Adverse Event|8|||
155519741|NCT02130466|561327375|FG000|Overall Study|Death|4|||
155519742|NCT02130466|561327376|FG001|Overall Study|Death|1|||
155519743|NCT02130466|561327377|FG002|Overall Study|Death|1|||
155519744|NCT02130466|561327378|FG003|Overall Study|Death|3|||
155519745|NCT02130466|561327379|FG004|Overall Study|Death|2|||
155519746|NCT02130466|561327380|FG005|Overall Study|Death|30|||
155519747|NCT02130466|561327381|FG006|Overall Study|Death|45|||
155519748|NCT02130466|561327382|FG007|Overall Study|Death|2|||
155519749|NCT02130466|561327383|FG008|Overall Study|Death|3|||
155519750|NCT02130466|561327384|FG009|Overall Study|Death|4|||
155519751|NCT02130466|561327385|FG010|Overall Study|Death|5|||
155519752|NCT02130466|561327386|FG011|Overall Study|Death|3|||
155519753|NCT02130466|561327387|FG012|Overall Study|Death|11|||
155519754|NCT02130466|561327388|FG013|Overall Study|Death|7|||
155519755|NCT02130466|561327375|FG000|Overall Study|Lost to Follow-up|1|||
155519756|NCT02130466|561327376|FG001|Overall Study|Lost to Follow-up|0|||
155519757|NCT02130466|561327377|FG002|Overall Study|Lost to Follow-up|0|||
155519758|NCT02130466|561327378|FG003|Overall Study|Lost to Follow-up|0|||
155519759|NCT02130466|561327379|FG004|Overall Study|Lost to Follow-up|0|||
155519760|NCT02130466|561327380|FG005|Overall Study|Lost to Follow-up|1|||
155519761|NCT02130466|561327381|FG006|Overall Study|Lost to Follow-up|0|||
155519762|NCT02130466|561327382|FG007|Overall Study|Lost to Follow-up|0|||
155519763|NCT02130466|561327383|FG008|Overall Study|Lost to Follow-up|0|||
155519764|NCT02130466|561327384|FG009|Overall Study|Lost to Follow-up|0|||
155519765|NCT02130466|561327385|FG010|Overall Study|Lost to Follow-up|0|||
155519766|NCT02130466|561327386|FG011|Overall Study|Lost to Follow-up|0|||
155519767|NCT02130466|561327387|FG012|Overall Study|Lost to Follow-up|1|||
155519768|NCT02130466|561327388|FG013|Overall Study|Lost to Follow-up|0|||
155519769|NCT02130466|561327375|FG000|Overall Study|Physician Decision|0|||
155519770|NCT02130466|561327376|FG001|Overall Study|Physician Decision|0|||
155519771|NCT02130466|561327377|FG002|Overall Study|Physician Decision|0|||
155519772|NCT02130466|561327378|FG003|Overall Study|Physician Decision|0|||
155519773|NCT02130466|561327379|FG004|Overall Study|Physician Decision|0|||
155519774|NCT02130466|561327380|FG005|Overall Study|Physician Decision|1|||
155519775|NCT02130466|561327381|FG006|Overall Study|Physician Decision|1|||
155519776|NCT02130466|561327382|FG007|Overall Study|Physician Decision|0|||
155519777|NCT02130466|561327383|FG008|Overall Study|Physician Decision|0|||
155519778|NCT02130466|561327384|FG009|Overall Study|Physician Decision|0|||
155519779|NCT02130466|561327385|FG010|Overall Study|Physician Decision|0|||
155519780|NCT02130466|561327386|FG011|Overall Study|Physician Decision|0|||
155519781|NCT02130466|561327387|FG012|Overall Study|Physician Decision|0|||
155519782|NCT02130466|561327388|FG013|Overall Study|Physician Decision|0|||
155519783|NCT02130466|561327375|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
155519784|NCT02130466|561327376|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
155519785|NCT02130466|561327377|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
155519786|NCT02130466|561327378|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
155519787|NCT02130466|561327379|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
155519788|NCT02130466|561327380|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
155519789|NCT02130466|561327381|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
155519790|NCT02130466|561327382|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
155519791|NCT02130466|561327383|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
155519792|NCT02130466|561327384|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
155519793|NCT02130466|561327385|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
155519794|NCT02130466|561327386|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
155519795|NCT02130466|561327387|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
155519796|NCT02130466|561327388|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
155519797|NCT02130466|561327375|FG000|Overall Study|Withdrawal by Subject|1|||
155519798|NCT02130466|561327376|FG001|Overall Study|Withdrawal by Subject|0|||
155519799|NCT02130466|561327377|FG002|Overall Study|Withdrawal by Subject|0|||
155519800|NCT02130466|561327378|FG003|Overall Study|Withdrawal by Subject|0|||
155519801|NCT02130466|561327379|FG004|Overall Study|Withdrawal by Subject|0|||
155519802|NCT02130466|561327380|FG005|Overall Study|Withdrawal by Subject|1|||
155519803|NCT02130466|561327381|FG006|Overall Study|Withdrawal by Subject|0|||
155478626|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
155478627|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155478628|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155478629|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155478630|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155478631|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155478632|NCT02141854|561172969|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
155478633|NCT02141854|561172970|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155519804|NCT02130466|561327382|FG007|Overall Study|Withdrawal by Subject|0|||
155519805|NCT02130466|561327383|FG008|Overall Study|Withdrawal by Subject|1|||
155519806|NCT02130466|561327384|FG009|Overall Study|Withdrawal by Subject|0|||
155519807|NCT02130466|561327385|FG010|Overall Study|Withdrawal by Subject|0|||
155519808|NCT02130466|561327386|FG011|Overall Study|Withdrawal by Subject|0|||
155519809|NCT02130466|561327387|FG012|Overall Study|Withdrawal by Subject|0|||
155519810|NCT02130466|561327388|FG013|Overall Study|Withdrawal by Subject|0|||
155519811|NCT02518685|561327389|FG000|Overall Study|Adverse Event|29|||
155519812|NCT02518685|561327390|FG001|Overall Study|Adverse Event|1|||
155519813|NCT02518685|561327389|FG000|Overall Study|Withdrawal by Subject|10|||
155519814|NCT02518685|561327390|FG001|Overall Study|Withdrawal by Subject|3|||
155519815|NCT02518685|561327389|FG000|Overall Study|relocation, study fatigue|7|||
155519816|NCT02518685|561327390|FG001|Overall Study|relocation, study fatigue|2|||
155519817|NCT02518685|561327389|FG000|Overall Study|Pregnancy|1|||
155519818|NCT02518685|561327390|FG001|Overall Study|Pregnancy|0|||
155519819|NCT02518685|561327389|FG000|Overall Study|Physician Decision|1|||
155519820|NCT02518685|561327390|FG001|Overall Study|Physician Decision|0|||
155519821|NCT02518685|561327389|FG000|Overall Study|Lost to Follow-up|1|||
155519822|NCT02518685|561327390|FG001|Overall Study|Lost to Follow-up|4|||
155519823|NCT01922349|561327391|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
155519824|NCT01922349|561327392|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
155519825|NCT01922349|561327393|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
155519826|NCT01922349|561327394|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
155519827|NCT00922779|561327395|FG000|Overall Study|Adverse Event|67|||
155519828|NCT00922779|561327395|FG000|Overall Study|Pregnancy|7|||
155519829|NCT00922779|561327395|FG000|Overall Study|Withdrawal by Subject|308|||
155519830|NCT00922779|561327395|FG000|Overall Study|Lost to Follow-up|44|||
155519831|NCT00922779|561327395|FG000|Overall Study|Other|27|||
155519832|NCT00922779|561327395|FG000|Overall Study|Missing|1874|||
155519833|NCT05109234|561327396|FG000|Overall Study|Adverse Event|2|||
155519834|NCT05109234|561327397|FG001|Overall Study|Adverse Event|2|||
155519835|NCT05109234|561327396|FG000|Overall Study|Lack of Efficacy|5|||
155519836|NCT05109234|561327397|FG001|Overall Study|Lack of Efficacy|0|||
155519837|NCT05109234|561327396|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
155519838|NCT05109234|561327397|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
155519839|NCT05109234|561327396|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
155519840|NCT05109234|561327397|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
155519841|NCT05109234|561327396|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
155519842|NCT05109234|561327397|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
155519843|NCT05109234|561327396|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
155519844|NCT05109234|561327397|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
155519845|NCT00336024|561327398|FG000|Overall Study|Death|2|||
155519846|NCT00336024|561327399|FG001|Overall Study|Death|1|||
155519847|NCT00336024|561327398|FG000|Overall Study|Physician Decision|4|||
155519848|NCT00336024|561327399|FG001|Overall Study|Physician Decision|1|||
155519849|NCT00336024|561327398|FG000|Overall Study|Protocol Violation|1|||
155519850|NCT00336024|561327399|FG001|Overall Study|Protocol Violation|0|||
155519851|NCT00336024|561327398|FG000|Overall Study|Withdrawal by Subject|1|||
155519852|NCT00336024|561327399|FG001|Overall Study|Withdrawal by Subject|2|||
155519853|NCT00336024|561327398|FG000|Overall Study|Failure to fulfill consolidation|1|||
155519854|NCT00336024|561327399|FG001|Overall Study|Failure to fulfill consolidation|1|||
155519855|NCT00336024|561327398|FG000|Overall Study|Progressive Disease|4|||
155519856|NCT00336024|561327399|FG001|Overall Study|Progressive Disease|7|||
155519857|NCT00336024|561327398|FG000|Overall Study|Ineligible|7|||
155519858|NCT00336024|561327399|FG001|Overall Study|Ineligible|7|||
155519859|NCT03946449|561327400|FG000|Treatment Extension II|Rolled over to another study|0|||
155519860|NCT03946449|561327401|FG001|Treatment Extension II|Rolled over to another study|0|||
155519861|NCT03946449|561327402|FG002|Treatment Extension II|Rolled over to another study|2|||
155519862|NCT03946449|561327400|FG000|Treatment Extension II|Withdrawal by Subject|0|||
155519863|NCT03946449|561327401|FG001|Treatment Extension II|Withdrawal by Subject|0|||
155519864|NCT03946449|561327402|FG002|Treatment Extension II|Withdrawal by Subject|1|||
155519865|NCT05067504|561327404|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
155519866|NCT05067504|561327405|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
155519867|NCT05067504|561327404|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
155519868|NCT05067504|561327405|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
155519869|NCT05067504|561327404|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
155519870|NCT05067504|561327405|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
155519871|NCT01374919|561329285|FG000|Overall Study|Withdrawal by Subject|2|||
155519872|NCT03805438|561329286|FG000|Overall Study|Lack of Efficacy|1|||
155519873|NCT03805438|561329286|FG000|Overall Study|Protocol Violation|1|||
155519874|NCT00366899|561329287|FG000|Infant Series|Withdrawal by Subject|4|||
155519875|NCT00366899|561329288|FG001|Infant Series|Withdrawal by Subject|7|||
155519876|NCT00366899|561329287|FG000|Infant Series|Protocol Violation|2|||
155519877|NCT00366899|561329288|FG001|Infant Series|Protocol Violation|1|||
155478634|NCT02141854|561172971|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155478635|NCT02141854|561172972|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155478636|NCT02141854|561172973|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155654555|NCT03715829|561828905|FG004|Dose Ranging Period|Protocol Violation|0|||
155478637|NCT02141854|561172974|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155478638|NCT02141854|561172969|FG000|Treatment Period|Protocol Violation|0|||
155478639|NCT02141854|561172970|FG001|Treatment Period|Protocol Violation|1|||
155478640|NCT02141854|561172971|FG002|Treatment Period|Protocol Violation|0|||
155478641|NCT02141854|561172972|FG003|Treatment Period|Protocol Violation|2|||
155478642|NCT02141854|561172973|FG004|Treatment Period|Protocol Violation|2|||
155478643|NCT02141854|561172974|FG005|Treatment Period|Protocol Violation|1|||
155478644|NCT02141854|561172969|FG000|Treatment Period|Noncompliance|0|||
155478645|NCT02141854|561172970|FG001|Treatment Period|Noncompliance|0|||
155478646|NCT02141854|561172971|FG002|Treatment Period|Noncompliance|0|||
155478647|NCT02141854|561172972|FG003|Treatment Period|Noncompliance|1|||
155478648|NCT02141854|561172973|FG004|Treatment Period|Noncompliance|0|||
155478649|NCT02141854|561172974|FG005|Treatment Period|Noncompliance|0|||
155478650|NCT02141854|561172969|FG000|Treatment Period|Lack of Efficacy|0|||
155478651|NCT02141854|561172970|FG001|Treatment Period|Lack of Efficacy|0|||
155478652|NCT02141854|561172971|FG002|Treatment Period|Lack of Efficacy|0|||
155478653|NCT02141854|561172972|FG003|Treatment Period|Lack of Efficacy|1|||
155478654|NCT02141854|561172973|FG004|Treatment Period|Lack of Efficacy|1|||
155478655|NCT02141854|561172974|FG005|Treatment Period|Lack of Efficacy|7|||
155478656|NCT02141854|561172969|FG000|Treatment Period|Pregnancy|0|||
155478657|NCT02141854|561172970|FG001|Treatment Period|Pregnancy|1|||
155478658|NCT02141854|561172971|FG002|Treatment Period|Pregnancy|0|||
155478659|NCT02141854|561172972|FG003|Treatment Period|Pregnancy|0|||
155478660|NCT02141854|561172973|FG004|Treatment Period|Pregnancy|0|||
155478661|NCT02141854|561172974|FG005|Treatment Period|Pregnancy|0|||
155478662|NCT02141854|561172969|FG000|Treatment Period|Other|0|||
155478663|NCT02141854|561172970|FG001|Treatment Period|Other|1|||
155654556|NCT03715829|561828906|FG005|Dose Ranging Period|Protocol Violation|0|||
155654557|NCT03715829|561828907|FG006|Dose Ranging Period|Protocol Violation|0|||
155478664|NCT02141854|561172971|FG002|Treatment Period|Other|2|||
155654558|NCT03715829|561828908|FG007|Dose Ranging Period|Protocol Violation|0|||
155478665|NCT02141854|561172972|FG003|Treatment Period|Other|0|||
155478666|NCT02141854|561172973|FG004|Treatment Period|Other|1|||
155478667|NCT02141854|561172974|FG005|Treatment Period|Other|2|||
155478668|NCT02141854|561172969|FG000|Treatment Period|Adverse Event|0|||
155478669|NCT02141854|561172970|FG001|Treatment Period|Adverse Event|2|||
155478670|NCT02141854|561172971|FG002|Treatment Period|Adverse Event|2|||
155478671|NCT02141854|561172972|FG003|Treatment Period|Adverse Event|0|||
155478672|NCT02141854|561172973|FG004|Treatment Period|Adverse Event|2|||
155478673|NCT02141854|561172974|FG005|Treatment Period|Adverse Event|2|||
155478674|NCT02141854|561172969|FG000|Treatment Period|Withdrawal by Subject|0|||
155478675|NCT02141854|561172970|FG001|Treatment Period|Withdrawal by Subject|2|||
155478676|NCT02141854|561172971|FG002|Treatment Period|Withdrawal by Subject|3|||
155478677|NCT02141854|561172972|FG003|Treatment Period|Withdrawal by Subject|3|||
155478678|NCT02141854|561172973|FG004|Treatment Period|Withdrawal by Subject|4|||
155478679|NCT02141854|561172974|FG005|Treatment Period|Withdrawal by Subject|7|||
155478680|NCT02141854|561172969|FG000|Treatment Period|Disease progression|0|||
155478681|NCT02141854|561172970|FG001|Treatment Period|Disease progression|2|||
155478682|NCT02141854|561172971|FG002|Treatment Period|Disease progression|1|||
155478683|NCT02141854|561172972|FG003|Treatment Period|Disease progression|3|||
155478684|NCT02141854|561172973|FG004|Treatment Period|Disease progression|0|||
155478685|NCT02141854|561172974|FG005|Treatment Period|Disease progression|18|||
155478686|NCT02141854|561172969|FG000|Treatment Period|Lost to Follow-up|0|||
155478687|NCT02141854|561172970|FG001|Treatment Period|Lost to Follow-up|1|||
155478688|NCT02141854|561172971|FG002|Treatment Period|Lost to Follow-up|1|||
155654559|NCT03715829|561828909|FG008|Dose Ranging Period|Protocol Violation|0|||
155478689|NCT02141854|561172972|FG003|Treatment Period|Lost to Follow-up|1|||
155478690|NCT02141854|561172973|FG004|Treatment Period|Lost to Follow-up|0|||
155478691|NCT02141854|561172974|FG005|Treatment Period|Lost to Follow-up|1|||
155654560|NCT03715829|561828910|FG009|Dose Ranging Period|Protocol Violation|0|||
155654561|NCT03715829|561828911|FG010|Dose Ranging Period|Protocol Violation|0|||
155654562|NCT03715829|561828901|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
155654563|NCT03715829|561828902|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
155654564|NCT03715829|561828903|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
155654565|NCT03715829|561828904|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
155654566|NCT03715829|561828905|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
155654567|NCT03715829|561828906|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
155654568|NCT03715829|561828907|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
155654569|NCT03715829|561828908|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
155654570|NCT03715829|561828909|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
155654571|NCT03715829|561828910|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
155654572|NCT03715829|561828911|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
155654573|NCT03715829|561828901|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654574|NCT03715829|561828902|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654575|NCT03715829|561828903|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
155654576|NCT03715829|561828904|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654577|NCT03715829|561828905|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654578|NCT03715829|561828906|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654579|NCT03715829|561828907|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654580|NCT03715829|561828908|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654581|NCT03715829|561828909|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654582|NCT03715829|561828910|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654583|NCT03715829|561828911|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155654584|NCT03715829|561828901|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155478692|NCT03258762|561172975|FG000|Overall Study|Lost to Follow-up|0|||
155478693|NCT03258762|561172976|FG001|Overall Study|Lost to Follow-up|1|||
155478694|NCT01868594|561172977|FG000|Overall Study|Do not meet inclusion criteria|4|||
155478695|NCT01868594|561172978|FG001|Overall Study|Do not meet inclusion criteria|3|||
155478696|NCT01190020|561172981|FG000|Overall Study|Adverse Event|2|||
155478697|NCT01190020|561172982|FG001|Overall Study|Adverse Event|0|||
155478698|NCT01190020|561172981|FG000|Overall Study|Lost to Follow-up|2|||
155478699|NCT01190020|561172982|FG001|Overall Study|Lost to Follow-up|0|||
155478700|NCT01190020|561172981|FG000|Overall Study|Withdrawal by Subject|3|||
155478701|NCT01190020|561172982|FG001|Overall Study|Withdrawal by Subject|0|||
155478702|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
155478703|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
155478704|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
155478705|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
155478706|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
155478707|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
155478708|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
155478709|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
155654585|NCT03715829|561828902|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654586|NCT03715829|561828903|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
155654587|NCT03715829|561828904|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155478710|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
155478711|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
155478712|NCT02422186|561172985|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
155478713|NCT02422186|561172986|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
155478714|NCT02422186|561172985|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
155478715|NCT02422186|561172986|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
155478716|NCT02422186|561172985|FG000|Follow-up Phase (2 Weeks)|Other|3|||
155478717|NCT02422186|561172986|FG001|Follow-up Phase (2 Weeks)|Other|0|||
155478718|NCT03053180|561175339|FG000|Overall Study|Failure to Return|1|||
155478719|NCT01465958|561175344|FG000|Run-in Phase|Protocol Violation|1|||
155478720|NCT01465958|561175345|FG001|Run-in Phase|Protocol Violation|0|||
155478721|NCT01465958|561175344|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
155478722|NCT01465958|561175345|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
155478723|NCT00211536|561175348|FG000|Overall Study|Withdrawal by Subject|2|||
155478724|NCT00211536|561175349|FG001|Overall Study|Withdrawal by Subject|2|||
155478725|NCT00211536|561175348|FG000|Overall Study|Physician Decision|0|||
155478726|NCT00211536|561175349|FG001|Overall Study|Physician Decision|5|||
155478727|NCT00211536|561175348|FG000|Overall Study|Adverse Event|2|||
155478728|NCT00211536|561175349|FG001|Overall Study|Adverse Event|0|||
155478729|NCT02583399|561175350|FG000|Overall Study|Able to be discharged|3|||
155478730|NCT02583399|561175350|FG000|Overall Study|Wanted to use a restricted medication|3|||
155478731|NCT02759939|561175351|FG000|Overall Study|Missing data on first outcome assessed|11|||
155478732|NCT02759939|561175352|FG001|Overall Study|Missing data on first outcome assessed|2|||
155478733|NCT02759939|561175353|FG002|Overall Study|Missing data on first outcome assessed|5|||
155478734|NCT02759939|561175354|FG003|Overall Study|Missing data on first outcome assessed|2|||
155478735|NCT02759939|561175351|FG000|Overall Study|Ineligible for T2 and T3|310|||
155478736|NCT02759939|561175352|FG001|Overall Study|Ineligible for T2 and T3|179|||
155478737|NCT02759939|561175353|FG002|Overall Study|Ineligible for T2 and T3|366|||
155478738|NCT02759939|561175354|FG003|Overall Study|Ineligible for T2 and T3|391|||
155478739|NCT02759939|561175351|FG000|Overall Study|Lost to Follow-up|735|||
155478740|NCT02759939|561175352|FG001|Overall Study|Lost to Follow-up|791|||
155478741|NCT02759939|561175353|FG002|Overall Study|Lost to Follow-up|783|||
155478742|NCT02759939|561175354|FG003|Overall Study|Lost to Follow-up|650|||
155478743|NCT04397757|561175355|FG000|Overall Study|Death|3|||
155478744|NCT04397757|561175356|FG001|Overall Study|Death|11|||
155478745|NCT04397757|561175355|FG000|Overall Study|Withdrawal by Subject|2|||
155478746|NCT04397757|561175356|FG001|Overall Study|Withdrawal by Subject|0|||
155478747|NCT04397757|561175355|FG000|Overall Study|Lost to Follow-up|4|||
155478748|NCT04397757|561175356|FG001|Overall Study|Lost to Follow-up|3|||
155478749|NCT02306148|561175357|FG000|Overall Study|Adverse Event|12|||
155478750|NCT02306148|561175358|FG001|Overall Study|Adverse Event|6|||
155478751|NCT02306148|561175357|FG000|Overall Study|Lost to Follow-up|1|||
155478752|NCT02306148|561175358|FG001|Overall Study|Lost to Follow-up|4|||
155478753|NCT02646891|561175365|FG000|Overall Study|Adverse Event|0|||
155478754|NCT02646891|561175366|FG001|Overall Study|Adverse Event|1|||
155478755|NCT02646891|561175367|FG002|Overall Study|Adverse Event|0|||
155478756|NCT02646891|561175368|FG003|Overall Study|Adverse Event|0|||
155478757|NCT02646891|561175369|FG004|Overall Study|Adverse Event|0|||
155478758|NCT02646891|561175370|FG005|Overall Study|Adverse Event|0|||
155478759|NCT02646891|561175371|FG006|Overall Study|Adverse Event|0|||
155478760|NCT02646891|561175372|FG007|Overall Study|Adverse Event|0|||
155478761|NCT02646891|561175373|FG008|Overall Study|Adverse Event|0|||
155478762|NCT02646891|561175374|FG009|Overall Study|Adverse Event|0|||
155478763|NCT02646891|561175365|FG000|Overall Study|Lost to Follow-up|0|||
155478764|NCT02646891|561175366|FG001|Overall Study|Lost to Follow-up|0|||
155478765|NCT02646891|561175367|FG002|Overall Study|Lost to Follow-up|0|||
155478766|NCT02646891|561175368|FG003|Overall Study|Lost to Follow-up|0|||
155478767|NCT02646891|561175369|FG004|Overall Study|Lost to Follow-up|0|||
155478768|NCT02646891|561175370|FG005|Overall Study|Lost to Follow-up|0|||
155478769|NCT02646891|561175371|FG006|Overall Study|Lost to Follow-up|2|||
155478770|NCT02646891|561175372|FG007|Overall Study|Lost to Follow-up|2|||
155478771|NCT02646891|561175373|FG008|Overall Study|Lost to Follow-up|2|||
155478772|NCT02646891|561175374|FG009|Overall Study|Lost to Follow-up|2|||
155478773|NCT02646891|561175365|FG000|Overall Study|Protocol Violation|0|||
155478774|NCT02646891|561175366|FG001|Overall Study|Protocol Violation|0|||
155478775|NCT02646891|561175367|FG002|Overall Study|Protocol Violation|0|||
155478776|NCT02646891|561175368|FG003|Overall Study|Protocol Violation|0|||
155478777|NCT02646891|561175369|FG004|Overall Study|Protocol Violation|0|||
155519878|NCT00366899|561329287|FG000|Infant Series|Failed to return|1|||
155519879|NCT00366899|561329288|FG001|Infant Series|Failed to return|1|||
155519880|NCT00366899|561329287|FG000|Infant Series|Lost to Follow-up|0|||
155519881|NCT00366899|561329288|FG001|Infant Series|Lost to Follow-up|2|||
155519882|NCT00366899|561329287|FG000|Infant Series|Adverse Event|0|||
155519883|NCT00366899|561329288|FG001|Infant Series|Adverse Event|1|||
155519884|NCT00366899|561329287|FG000|Infant Series|Physician Decision|1|||
155519885|NCT00366899|561329288|FG001|Infant Series|Physician Decision|0|||
155519886|NCT00366899|561329287|FG000|Infant Series|Randomized but not consented|1|||
155519887|NCT00366899|561329288|FG001|Infant Series|Randomized but not consented|0|||
155478778|NCT02646891|561175370|FG005|Overall Study|Protocol Violation|0|||
155478779|NCT02646891|561175371|FG006|Overall Study|Protocol Violation|1|||
155478780|NCT02646891|561175372|FG007|Overall Study|Protocol Violation|1|||
155478781|NCT02646891|561175373|FG008|Overall Study|Protocol Violation|0|||
155478782|NCT02646891|561175374|FG009|Overall Study|Protocol Violation|0|||
155478783|NCT02646891|561175365|FG000|Overall Study|Withdrawal by Subject|2|||
155478784|NCT02646891|561175366|FG001|Overall Study|Withdrawal by Subject|0|||
155478785|NCT02646891|561175367|FG002|Overall Study|Withdrawal by Subject|1|||
155478786|NCT02646891|561175368|FG003|Overall Study|Withdrawal by Subject|0|||
155478787|NCT02646891|561175369|FG004|Overall Study|Withdrawal by Subject|0|||
155478788|NCT02646891|561175370|FG005|Overall Study|Withdrawal by Subject|0|||
155478789|NCT02646891|561175371|FG006|Overall Study|Withdrawal by Subject|5|||
155478790|NCT02646891|561175372|FG007|Overall Study|Withdrawal by Subject|9|||
155478791|NCT02646891|561175373|FG008|Overall Study|Withdrawal by Subject|7|||
155478792|NCT02646891|561175374|FG009|Overall Study|Withdrawal by Subject|3|||
155478793|NCT02646891|561175365|FG000|Overall Study|Death|0|||
155478794|NCT02646891|561175366|FG001|Overall Study|Death|0|||
155478795|NCT02646891|561175367|FG002|Overall Study|Death|0|||
155478796|NCT02646891|561175368|FG003|Overall Study|Death|0|||
155478797|NCT02646891|561175369|FG004|Overall Study|Death|0|||
155478798|NCT02646891|561175370|FG005|Overall Study|Death|0|||
155478799|NCT02646891|561175371|FG006|Overall Study|Death|1|||
155478800|NCT02646891|561175372|FG007|Overall Study|Death|1|||
155478801|NCT02646891|561175373|FG008|Overall Study|Death|1|||
155478802|NCT02646891|561175374|FG009|Overall Study|Death|0|||
155478803|NCT01542632|561175375|FG000|Overall Study|Withdrawal of Consent|0|||
155478804|NCT01542632|561175376|FG001|Overall Study|Withdrawal of Consent|0|||
155478805|NCT01542632|561175377|FG002|Overall Study|Withdrawal of Consent|0|||
155478806|NCT01542632|561175378|FG003|Overall Study|Withdrawal of Consent|2|||
155478807|NCT01542632|561175379|FG004|Overall Study|Withdrawal of Consent|3|||
155478808|NCT01542632|561175380|FG005|Overall Study|Withdrawal of Consent|0|||
155478809|NCT01542632|561175375|FG000|Overall Study|Adverse Event|0|||
155478810|NCT01542632|561175376|FG001|Overall Study|Adverse Event|0|||
155478811|NCT01542632|561175377|FG002|Overall Study|Adverse Event|1|||
155478812|NCT01542632|561175378|FG003|Overall Study|Adverse Event|0|||
155478813|NCT01542632|561175379|FG004|Overall Study|Adverse Event|0|||
155478814|NCT01542632|561175380|FG005|Overall Study|Adverse Event|0|||
155478815|NCT01542632|561175375|FG000|Overall Study|Lost to Follow-up|0|||
155478816|NCT01542632|561175376|FG001|Overall Study|Lost to Follow-up|1|||
155478817|NCT01542632|561175377|FG002|Overall Study|Lost to Follow-up|0|||
155478818|NCT01542632|561175378|FG003|Overall Study|Lost to Follow-up|0|||
155478819|NCT01542632|561175379|FG004|Overall Study|Lost to Follow-up|0|||
155478820|NCT01542632|561175380|FG005|Overall Study|Lost to Follow-up|0|||
155478821|NCT01542632|561175375|FG000|Overall Study|Sponsor/Investigator Decision|0|||
155478822|NCT01542632|561175376|FG001|Overall Study|Sponsor/Investigator Decision|0|||
155478823|NCT01542632|561175377|FG002|Overall Study|Sponsor/Investigator Decision|0|||
155478824|NCT01542632|561175378|FG003|Overall Study|Sponsor/Investigator Decision|0|||
155478825|NCT01542632|561175379|FG004|Overall Study|Sponsor/Investigator Decision|1|||
155478826|NCT01542632|561175380|FG005|Overall Study|Sponsor/Investigator Decision|0|||
155478827|NCT00033514|561175381|FG000|Overall Study|Lost to Follow-up|1|||
155478828|NCT00033514|561175382|FG001|Overall Study|Lost to Follow-up|1|||
155478829|NCT00033514|561175381|FG000|Overall Study|Withdrawal by Subject|0|||
155478830|NCT00033514|561175382|FG001|Overall Study|Withdrawal by Subject|3|||
155478831|NCT03225833|561175383|FG000|Overall Study|Adverse Event|0|||
155478832|NCT03225833|561175384|FG001|Overall Study|Adverse Event|1|||
155478833|NCT03225833|561175385|FG002|Overall Study|Adverse Event|2|||
155478834|NCT03225833|561175386|FG003|Overall Study|Adverse Event|0|||
155478835|NCT03225833|561175387|FG004|Overall Study|Adverse Event|0|||
155478836|NCT03225833|561175388|FG005|Overall Study|Adverse Event|2|||
155478837|NCT03225833|561175383|FG000|Overall Study|Withdrawal by Subject|1|||
155478838|NCT03225833|561175384|FG001|Overall Study|Withdrawal by Subject|0|||
155478839|NCT03225833|561175385|FG002|Overall Study|Withdrawal by Subject|0|||
155478840|NCT03225833|561175386|FG003|Overall Study|Withdrawal by Subject|0|||
155478841|NCT03225833|561175387|FG004|Overall Study|Withdrawal by Subject|1|||
155478842|NCT03225833|561175388|FG005|Overall Study|Withdrawal by Subject|0|||
155478843|NCT03225833|561175383|FG000|Overall Study|Termination of Study by Sponsor|4|||
155478844|NCT03225833|561175384|FG001|Overall Study|Termination of Study by Sponsor|0|||
155478845|NCT03225833|561175385|FG002|Overall Study|Termination of Study by Sponsor|0|||
155478846|NCT03225833|561175386|FG003|Overall Study|Termination of Study by Sponsor|0|||
155478847|NCT03225833|561175387|FG004|Overall Study|Termination of Study by Sponsor|0|||
155478848|NCT03225833|561175388|FG005|Overall Study|Termination of Study by Sponsor|7|||
155478849|NCT03225833|561175383|FG000|Overall Study|Sponsor Decision|0|||
155478850|NCT03225833|561175384|FG001|Overall Study|Sponsor Decision|0|||
155478851|NCT03225833|561175385|FG002|Overall Study|Sponsor Decision|0|||
155478852|NCT03225833|561175386|FG003|Overall Study|Sponsor Decision|0|||
155478853|NCT03225833|561175387|FG004|Overall Study|Sponsor Decision|0|||
155478854|NCT03225833|561175388|FG005|Overall Study|Sponsor Decision|1|||
155478855|NCT04564027|561175400|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
155478856|NCT04564027|561175401|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
155478857|NCT04564027|561175402|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
155478858|NCT04564027|561175403|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
155478859|NCT05827978|561175404|FG000|Overall Study|Adverse Event|1|||
155478860|NCT05827978|561175405|FG001|Overall Study|Adverse Event|0|||
155478861|NCT05827978|561175406|FG002|Overall Study|Adverse Event|0|||
155478862|NCT05827978|561175407|FG003|Overall Study|Adverse Event|1|||
155478863|NCT05827978|561175408|FG004|Overall Study|Adverse Event|0|||
155478864|NCT05827978|561175409|FG005|Overall Study|Adverse Event|0|||
155478865|NCT05827978|561175404|FG000|Overall Study|Death|1|||
155478866|NCT05827978|561175405|FG001|Overall Study|Death|5|||
155478867|NCT05827978|561175406|FG002|Overall Study|Death|2|||
155478868|NCT05827978|561175407|FG003|Overall Study|Death|3|||
155478869|NCT05827978|561175408|FG004|Overall Study|Death|1|||
155478870|NCT05827978|561175409|FG005|Overall Study|Death|3|||
155478871|NCT05827978|561175404|FG000|Overall Study|Lost to Follow-up|57|||
155478872|NCT05827978|561175405|FG001|Overall Study|Lost to Follow-up|88|||
155478873|NCT05827978|561175406|FG002|Overall Study|Lost to Follow-up|54|||
155478874|NCT05827978|561175407|FG003|Overall Study|Lost to Follow-up|47|||
155478875|NCT05827978|561175408|FG004|Overall Study|Lost to Follow-up|25|||
155478876|NCT05827978|561175409|FG005|Overall Study|Lost to Follow-up|10|||
155478877|NCT05827978|561175404|FG000|Overall Study|Noncompliance with Study Procedures|0|||
155478878|NCT05827978|561175405|FG001|Overall Study|Noncompliance with Study Procedures|1|||
155478879|NCT05827978|561175406|FG002|Overall Study|Noncompliance with Study Procedures|1|||
155478880|NCT05827978|561175407|FG003|Overall Study|Noncompliance with Study Procedures|1|||
155478881|NCT05827978|561175408|FG004|Overall Study|Noncompliance with Study Procedures|1|||
155478882|NCT05827978|561175409|FG005|Overall Study|Noncompliance with Study Procedures|0|||
155478883|NCT05827978|561175404|FG000|Overall Study|Physician Decision|2|||
155478884|NCT05827978|561175405|FG001|Overall Study|Physician Decision|0|||
155478885|NCT05827978|561175406|FG002|Overall Study|Physician Decision|1|||
155478886|NCT05827978|561175407|FG003|Overall Study|Physician Decision|2|||
155478887|NCT05827978|561175408|FG004|Overall Study|Physician Decision|1|||
155478888|NCT05827978|561175409|FG005|Overall Study|Physician Decision|1|||
155478889|NCT05827978|561175404|FG000|Overall Study|Protocol Violation|5|||
155478890|NCT05827978|561175405|FG001|Overall Study|Protocol Violation|2|||
155478891|NCT05827978|561175406|FG002|Overall Study|Protocol Violation|0|||
155478892|NCT05827978|561175407|FG003|Overall Study|Protocol Violation|0|||
155478893|NCT05827978|561175408|FG004|Overall Study|Protocol Violation|0|||
155478894|NCT05827978|561175409|FG005|Overall Study|Protocol Violation|0|||
155478895|NCT05827978|561175404|FG000|Overall Study|Withdrawal by Subject|17|||
155478896|NCT05827978|561175405|FG001|Overall Study|Withdrawal by Subject|16|||
155478897|NCT05827978|561175406|FG002|Overall Study|Withdrawal by Subject|10|||
155478898|NCT05827978|561175407|FG003|Overall Study|Withdrawal by Subject|12|||
155478899|NCT05827978|561175408|FG004|Overall Study|Withdrawal by Subject|10|||
155478900|NCT05827978|561175409|FG005|Overall Study|Withdrawal by Subject|9|||
155478901|NCT05827978|561175404|FG000|Overall Study|Other Than Specified|0|||
155478902|NCT05827978|561175405|FG001|Overall Study|Other Than Specified|0|||
155478903|NCT05827978|561175406|FG002|Overall Study|Other Than Specified|1|||
155478904|NCT05827978|561175407|FG003|Overall Study|Other Than Specified|0|||
155478905|NCT05827978|561175408|FG004|Overall Study|Other Than Specified|2|||
155478906|NCT05827978|561175409|FG005|Overall Study|Other Than Specified|0|||
155478907|NCT04785144|561175410|FG000|Overall Study|Withdrawal by Subject|4|||
155478908|NCT04785144|561175411|FG001|Overall Study|Withdrawal by Subject|1|||
155478909|NCT04785144|561175412|FG002|Overall Study|Withdrawal by Subject|0|||
155478910|NCT04785144|561175413|FG003|Overall Study|Withdrawal by Subject|0|||
155519888|NCT00366899|561329287|FG000|After Infant Series|Lost to Follow-up|4|||
155519889|NCT00366899|561329288|FG001|After Infant Series|Lost to Follow-up|3|||
155519890|NCT00366899|561329287|FG000|After Infant Series|Withdrawal by Subject|1|||
155519891|NCT00366899|561329288|FG001|After Infant Series|Withdrawal by Subject|4|||
155519892|NCT00366899|561329287|FG000|After Infant Series|Adverse Event|1|||
155519893|NCT00366899|561329288|FG001|After Infant Series|Adverse Event|2|||
155519894|NCT00366899|561329287|FG000|After Infant Series|Protocol Violation|1|||
155519895|NCT00366899|561329288|FG001|After Infant Series|Protocol Violation|0|||
155519896|NCT00366899|561329287|FG000|Toddler Dose|Withdrawal by Subject|1|||
155519897|NCT00366899|561329288|FG001|Toddler Dose|Withdrawal by Subject|1|||
155519898|NCT00366899|561329287|FG000|Toddler Dose|Protocol Violation|1|||
155519899|NCT00366899|561329288|FG001|Toddler Dose|Protocol Violation|0|||
155519900|NCT02684344|561329294|FG000|Overall Study|Withdrawal by Subject|0|||
155478911|NCT04785144|561175414|FG004|Overall Study|Withdrawal by Subject|0|||
155478912|NCT04785144|561175415|FG005|Overall Study|Withdrawal by Subject|2|||
155478913|NCT04785144|561175416|FG006|Overall Study|Withdrawal by Subject|2|||
155519901|NCT02684344|561329295|FG001|Overall Study|Withdrawal by Subject|1|||
155519902|NCT01451762|561329296|FG000|Overall Study|Lost to Follow-up|3|||
155519903|NCT01451762|561329297|FG001|Overall Study|Lost to Follow-up|6|||
155519904|NCT01451762|561329298|FG002|Overall Study|Lost to Follow-up|6|||
155519905|NCT02424188|561329304|FG000|Overall Study|Death|2|||
155478914|NCT04785144|561175417|FG007|Overall Study|Withdrawal by Subject|0|||
155478915|NCT04785144|561175418|FG008|Overall Study|Withdrawal by Subject|1|||
155478916|NCT04785144|561175419|FG009|Overall Study|Withdrawal by Subject|0|||
155478917|NCT04785144|561175410|FG000|Overall Study|Lost to Follow-up|1|||
155478918|NCT04785144|561175411|FG001|Overall Study|Lost to Follow-up|0|||
155478919|NCT04785144|561175412|FG002|Overall Study|Lost to Follow-up|0|||
155478920|NCT04785144|561175413|FG003|Overall Study|Lost to Follow-up|0|||
155478921|NCT04785144|561175414|FG004|Overall Study|Lost to Follow-up|1|||
155478922|NCT04785144|561175415|FG005|Overall Study|Lost to Follow-up|2|||
155519906|NCT02424188|561329305|FG001|Overall Study|Death|2|||
155519907|NCT02424188|561329304|FG000|Overall Study|Lost to Follow-up|1|||
155519908|NCT02424188|561329305|FG001|Overall Study|Lost to Follow-up|3|||
155519909|NCT02424188|561329304|FG000|Overall Study|Incarceration|1|||
155519910|NCT02424188|561329305|FG001|Overall Study|Incarceration|0|||
155519911|NCT00630305|561329306|FG000|Overall Study|Withdrawal by Subject|1|||
155478923|NCT04785144|561175416|FG006|Overall Study|Lost to Follow-up|1|||
155478924|NCT04785144|561175417|FG007|Overall Study|Lost to Follow-up|2|||
155519912|NCT00630305|561329306|FG000|Overall Study|Inability to insert contact lens|1|||
155519913|NCT01085045|561329307|FG000|Part A|Withdrawal by Subject|4|||
155478925|NCT04785144|561175418|FG008|Overall Study|Lost to Follow-up|4|||
155478926|NCT04785144|561175419|FG009|Overall Study|Lost to Follow-up|1|||
155478927|NCT04785144|561175410|FG000|Overall Study|Protocol Violation|0|||
155478928|NCT04785144|561175411|FG001|Overall Study|Protocol Violation|0|||
155478929|NCT04785144|561175412|FG002|Overall Study|Protocol Violation|0|||
155478930|NCT04785144|561175413|FG003|Overall Study|Protocol Violation|0|||
155478931|NCT04785144|561175414|FG004|Overall Study|Protocol Violation|0|||
155478932|NCT04785144|561175415|FG005|Overall Study|Protocol Violation|0|||
155478933|NCT04785144|561175416|FG006|Overall Study|Protocol Violation|1|||
155478934|NCT04785144|561175417|FG007|Overall Study|Protocol Violation|0|||
155478935|NCT04785144|561175418|FG008|Overall Study|Protocol Violation|0|||
155478936|NCT04785144|561175419|FG009|Overall Study|Protocol Violation|0|||
155478937|NCT04785144|561175410|FG000|Overall Study|Physician Decision|0|||
155478938|NCT04785144|561175411|FG001|Overall Study|Physician Decision|0|||
155478939|NCT04785144|561175412|FG002|Overall Study|Physician Decision|0|||
155478940|NCT04785144|561175413|FG003|Overall Study|Physician Decision|0|||
155478941|NCT04785144|561175414|FG004|Overall Study|Physician Decision|0|||
155519914|NCT01085045|561329307|FG000|Part A|Adverse Event|6|||
155519915|NCT01085045|561329307|FG000|Part A|Protocol Violation|1|||
155519916|NCT01085045|561329307|FG000|Part A|Protocol Specified Criteria|7|||
155519917|NCT01085045|561329307|FG000|Part B|Withdrawal by Subject|2|||
155519918|NCT01085045|561329307|FG000|Part B|Protocol Specified Criteria|6|||
155519919|NCT01085045|561329307|FG000|Part B|Lost to Follow-up|1|||
155519920|NCT01085045|561329307|FG000|Part B|Adverse Event|6|||
155519921|NCT01494506|561329314|FG000|Overall Study|Lack of Efficacy|77|||
155519922|NCT01494506|561329315|FG001|Overall Study|Lack of Efficacy|83|||
155519923|NCT01494506|561329316|FG002|Overall Study|Lack of Efficacy|57|||
155519924|NCT01494506|561329314|FG000|Overall Study|Adverse Event|17|||
155519925|NCT01494506|561329315|FG001|Overall Study|Adverse Event|10|||
155519926|NCT01494506|561329316|FG002|Overall Study|Adverse Event|11|||
155519927|NCT01494506|561329314|FG000|Overall Study|Death|9|||
155519928|NCT01494506|561329315|FG001|Overall Study|Death|5|||
155519929|NCT01494506|561329316|FG002|Overall Study|Death|2|||
155519930|NCT01494506|561329314|FG000|Overall Study|Physician Decision|7|||
155478942|NCT04785144|561175415|FG005|Overall Study|Physician Decision|0|||
155478943|NCT04785144|561175416|FG006|Overall Study|Physician Decision|0|||
155478944|NCT04785144|561175417|FG007|Overall Study|Physician Decision|0|||
155478945|NCT04785144|561175418|FG008|Overall Study|Physician Decision|0|||
155478946|NCT04785144|561175419|FG009|Overall Study|Physician Decision|1|||
155478947|NCT04785144|561175410|FG000|Overall Study|Unable to continue due to work schedule|0|||
155478948|NCT04785144|561175411|FG001|Overall Study|Unable to continue due to work schedule|0|||
155478949|NCT04785144|561175412|FG002|Overall Study|Unable to continue due to work schedule|0|||
155478950|NCT04785144|561175413|FG003|Overall Study|Unable to continue due to work schedule|0|||
155478951|NCT04785144|561175414|FG004|Overall Study|Unable to continue due to work schedule|0|||
155478952|NCT04785144|561175415|FG005|Overall Study|Unable to continue due to work schedule|0|||
155478953|NCT04785144|561175416|FG006|Overall Study|Unable to continue due to work schedule|0|||
155478954|NCT04785144|561175417|FG007|Overall Study|Unable to continue due to work schedule|0|||
155478955|NCT04785144|561175418|FG008|Overall Study|Unable to continue due to work schedule|0|||
155478956|NCT04785144|561175419|FG009|Overall Study|Unable to continue due to work schedule|1|||
155478957|NCT00712712|561175422|FG000|Overall Study|Protocol Violation|11|||
155478958|NCT00712712|561175422|FG000|Overall Study|Radiofrequency not done|3|||
155478959|NCT00712712|561175422|FG000|Overall Study|Death|8|||
155478960|NCT00712712|561175422|FG000|Overall Study|Withdrawal by Subject|1|||
155478961|NCT02289833|561175428|FG000|Overall Study|Study discontinuation|0|||
155478962|NCT02289833|561175429|FG001|Overall Study|Study discontinuation|1|||
155478963|NCT02289833|561175428|FG000|Overall Study|Lost to Follow-up|4|||
155478964|NCT02289833|561175429|FG001|Overall Study|Lost to Follow-up|0|||
155478965|NCT02289833|561175428|FG000|Overall Study|Death|23|||
155478966|NCT02289833|561175429|FG001|Overall Study|Death|16|||
155478967|NCT01756833|561175441|FG000|Overall Study|Withdrawal by Subject|4|||
155478968|NCT01756833|561175442|FG001|Overall Study|Withdrawal by Subject|3|||
155478969|NCT04554394|561175443|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
155478970|NCT04554394|561175444|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
155478971|NCT04554394|561175443|FG000|Overall Study|Withdrawal by Subject|2|||
155478972|NCT04554394|561175444|FG001|Overall Study|Withdrawal by Subject|2|||
155478973|NCT04554394|561175443|FG000|Overall Study|Lost to Follow-up|2|||
155478974|NCT04554394|561175444|FG001|Overall Study|Lost to Follow-up|2|||
155478975|NCT04554394|561175443|FG000|Overall Study|Physician Decision|1|||
155478976|NCT04554394|561175444|FG001|Overall Study|Physician Decision|1|||
155478977|NCT01766401|561175445|FG000|Overall Study|Adverse Event|7|||
155478978|NCT01766401|561175446|FG001|Overall Study|Adverse Event|22|||
155478979|NCT01766401|561175445|FG000|Overall Study|Lack of Efficacy|1|||
155478980|NCT01766401|561175446|FG001|Overall Study|Lack of Efficacy|2|||
155478981|NCT01766401|561175445|FG000|Overall Study|Protocol Violation|3|||
155478982|NCT01766401|561175446|FG001|Overall Study|Protocol Violation|8|||
155478983|NCT01766401|561175445|FG000|Overall Study|Withdrawal by Subject|15|||
155478984|NCT01766401|561175446|FG001|Overall Study|Withdrawal by Subject|12|||
155478985|NCT01766401|561175445|FG000|Overall Study|Lost to Follow-up|10|||
155478986|NCT01766401|561175446|FG001|Overall Study|Lost to Follow-up|11|||
155478987|NCT01766401|561175445|FG000|Overall Study|Pregnancy|1|||
155478988|NCT01766401|561175446|FG001|Overall Study|Pregnancy|1|||
155478989|NCT00886587|561175447|FG000|Overall Study|Adverse Event|2|||
155478990|NCT00886587|561175448|FG001|Overall Study|Adverse Event|1|||
155478991|NCT00886587|561175447|FG000|Overall Study|Protocol Violation|2|||
155478992|NCT00886587|561175448|FG001|Overall Study|Protocol Violation|0|||
155478993|NCT00886587|561175447|FG000|Overall Study|Withdrawal by Subject|0|||
155478994|NCT00886587|561175448|FG001|Overall Study|Withdrawal by Subject|1|||
155478995|NCT00808132|561175452|FG000|Overall Study|Adverse Event|34|||
155478996|NCT00808132|561175453|FG001|Overall Study|Adverse Event|33|||
155478997|NCT00808132|561175454|FG002|Overall Study|Adverse Event|16|||
155478998|NCT00808132|561175455|FG003|Overall Study|Adverse Event|31|||
155478999|NCT00808132|561175456|FG004|Overall Study|Adverse Event|33|||
155479000|NCT00808132|561175452|FG000|Overall Study|Death|0|||
155479001|NCT00808132|561175453|FG001|Overall Study|Death|0|||
155479002|NCT00808132|561175454|FG002|Overall Study|Death|0|||
155479003|NCT00808132|561175455|FG003|Overall Study|Death|0|||
155479004|NCT00808132|561175456|FG004|Overall Study|Death|1|||
155479005|NCT00808132|561175452|FG000|Overall Study|Physician Decision|0|||
155479006|NCT00808132|561175453|FG001|Overall Study|Physician Decision|1|||
155654588|NCT03715829|561828905|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
155654589|NCT03715829|561828906|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654590|NCT03715829|561828907|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654591|NCT03715829|561828908|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654592|NCT03715829|561828909|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654593|NCT03715829|561828910|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654594|NCT03715829|561828911|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155654595|NCT03715829|561828901|FG000|Dose Ranging Period|Other|0|||
155654596|NCT03715829|561828902|FG001|Dose Ranging Period|Other|0|||
155654597|NCT03715829|561828903|FG002|Dose Ranging Period|Other|2|||
155654598|NCT03715829|561828904|FG003|Dose Ranging Period|Other|0|||
155654599|NCT03715829|561828905|FG004|Dose Ranging Period|Other|0|||
155654600|NCT03715829|561828906|FG005|Dose Ranging Period|Other|3|||
155479007|NCT00808132|561175454|FG002|Overall Study|Physician Decision|0|||
155479008|NCT00808132|561175455|FG003|Overall Study|Physician Decision|0|||
155479009|NCT00808132|561175456|FG004|Overall Study|Physician Decision|0|||
155479010|NCT00808132|561175452|FG000|Overall Study|Lost to Follow-up|8|||
155654601|NCT03715829|561828907|FG006|Dose Ranging Period|Other|0|||
155654602|NCT03715829|561828908|FG007|Dose Ranging Period|Other|0|||
155479011|NCT00808132|561175453|FG001|Overall Study|Lost to Follow-up|10|||
155479012|NCT00808132|561175454|FG002|Overall Study|Lost to Follow-up|11|||
155479013|NCT00808132|561175455|FG003|Overall Study|Lost to Follow-up|8|||
155479014|NCT00808132|561175456|FG004|Overall Study|Lost to Follow-up|9|||
155479015|NCT00808132|561175452|FG000|Overall Study|Protocol Violation|8|||
155479016|NCT00808132|561175453|FG001|Overall Study|Protocol Violation|9|||
155479017|NCT00808132|561175454|FG002|Overall Study|Protocol Violation|4|||
155479018|NCT00808132|561175455|FG003|Overall Study|Protocol Violation|9|||
155479019|NCT00808132|561175456|FG004|Overall Study|Protocol Violation|5|||
155479020|NCT00808132|561175452|FG000|Overall Study|Withdrawal by Subject|27|||
155479021|NCT00808132|561175453|FG001|Overall Study|Withdrawal by Subject|18|||
155479022|NCT00808132|561175454|FG002|Overall Study|Withdrawal by Subject|2|||
155479023|NCT00808132|561175455|FG003|Overall Study|Withdrawal by Subject|7|||
155479024|NCT00808132|561175456|FG004|Overall Study|Withdrawal by Subject|16|||
155479025|NCT00808132|561175452|FG000|Overall Study|Other|6|||
155479026|NCT00808132|561175453|FG001|Overall Study|Other|4|||
155479027|NCT00808132|561175454|FG002|Overall Study|Other|6|||
155479028|NCT00808132|561175455|FG003|Overall Study|Other|2|||
155479029|NCT00808132|561175456|FG004|Overall Study|Other|15|||
155479030|NCT00808132|561175452|FG000|Overall Study|Randomized, but not treated|10|||
155479031|NCT00808132|561175453|FG001|Overall Study|Randomized, but not treated|7|||
155479032|NCT00808132|561175454|FG002|Overall Study|Randomized, but not treated|9|||
155479033|NCT00808132|561175455|FG003|Overall Study|Randomized, but not treated|8|||
155479034|NCT00808132|561175456|FG004|Overall Study|Randomized, but not treated|9|||
155519931|NCT01494506|561329315|FG001|Overall Study|Physician Decision|5|||
155519932|NCT01494506|561329316|FG002|Overall Study|Physician Decision|4|||
155519933|NCT01494506|561329314|FG000|Overall Study|Withdrawal by Subject|17|||
155519934|NCT01494506|561329315|FG001|Overall Study|Withdrawal by Subject|20|||
155519935|NCT01494506|561329316|FG002|Overall Study|Withdrawal by Subject|14|||
155519936|NCT01494506|561329314|FG000|Overall Study|Clinical Deterioration|21|||
155519937|NCT01494506|561329315|FG001|Overall Study|Clinical Deterioration|17|||
155519938|NCT01494506|561329316|FG002|Overall Study|Clinical Deterioration|13|||
155519939|NCT01494506|561329314|FG000|Overall Study|Sponsor Decision|0|||
155519940|NCT01494506|561329315|FG001|Overall Study|Sponsor Decision|0|||
155519941|NCT01494506|561329316|FG002|Overall Study|Sponsor Decision|1|||
155519942|NCT01494506|561329314|FG000|Overall Study|Other|0|||
155519943|NCT01494506|561329315|FG001|Overall Study|Other|3|||
155519944|NCT01494506|561329316|FG002|Overall Study|Other|1|||
155519945|NCT02924038|561329317|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
155519946|NCT02924038|561329318|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
155519947|NCT02777528|561329322|FG000|Overall Study|Still in study|24|||
155519948|NCT02777528|561329323|FG001|Overall Study|Still in study|10|||
155519949|NCT02777528|561329324|FG002|Overall Study|Still in study|1|||
155519950|NCT02777528|561329322|FG000|Overall Study|Study Device Explanted|1|||
155519951|NCT02777528|561329323|FG001|Overall Study|Study Device Explanted|0|||
155519952|NCT02777528|561329324|FG002|Overall Study|Study Device Explanted|0|||
155519953|NCT02777528|561329322|FG000|Overall Study|Death|14|||
155519954|NCT02777528|561329323|FG001|Overall Study|Death|7|||
155519955|NCT02777528|561329324|FG002|Overall Study|Death|1|||
155519956|NCT02777528|561329322|FG000|Overall Study|Withdrawal by Subject|2|||
155519957|NCT02777528|561329323|FG001|Overall Study|Withdrawal by Subject|2|||
155519958|NCT02777528|561329324|FG002|Overall Study|Withdrawal by Subject|1|||
155519959|NCT02777528|561329322|FG000|Overall Study|Physician Decision|2|||
155519960|NCT02777528|561329323|FG001|Overall Study|Physician Decision|1|||
155519961|NCT02777528|561329324|FG002|Overall Study|Physician Decision|0|||
155519962|NCT02777528|561329322|FG000|Overall Study|Lost to Follow-up|2|||
155519963|NCT02777528|561329323|FG001|Overall Study|Lost to Follow-up|0|||
155519964|NCT02777528|561329324|FG002|Overall Study|Lost to Follow-up|0|||
155519965|NCT02777528|561329322|FG000|Overall Study|Discontinued due to Other|1|||
155519966|NCT02777528|561329323|FG001|Overall Study|Discontinued due to Other|0|||
155519967|NCT02777528|561329324|FG002|Overall Study|Discontinued due to Other|0|||
155654603|NCT03715829|561828909|FG008|Dose Ranging Period|Other|0|||
155479035|NCT00808132|561175452|FG000|Overall Study|Unsatisfactory response|5|||
155479036|NCT00808132|561175453|FG001|Overall Study|Unsatisfactory response|6|||
155479037|NCT00808132|561175454|FG002|Overall Study|Unsatisfactory response|6|||
155519968|NCT00453362|561329325|FG000|Overall Study|Adverse Event|5|||
155519969|NCT00453362|561329325|FG000|Overall Study|Death|7|||
155519970|NCT00453362|561329325|FG000|Overall Study|Physician Decision|2|||
155519971|NCT00453362|561329325|FG000|Overall Study|Withdrawal by Subject|3|||
155519972|NCT00453362|561329325|FG000|Overall Study|Progression of disease|56|||
155519973|NCT00453362|561329325|FG000|Overall Study|Screening Failure|14|||
155519974|NCT04885296|561329326|FG000|Period 1|Covid-19 Related|1|||
155519975|NCT04885296|561329327|FG001|Period 1|Covid-19 Related|0|||
155519976|NCT04885296|561329326|FG000|Period 1|Adverse Event|0|||
155479038|NCT00808132|561175455|FG003|Overall Study|Unsatisfactory response|4|||
155479039|NCT00808132|561175456|FG004|Overall Study|Unsatisfactory response|12|||
155479040|NCT02795182|561175457|FG000|Overall Study|Death|5|||
155479041|NCT02795182|561175458|FG001|Overall Study|Death|4|||
155479042|NCT02795182|561175459|FG002|Overall Study|Death|4|||
155479043|NCT02795182|561175460|FG003|Overall Study|Death|18|||
155479044|NCT02795182|561175457|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
155479045|NCT02795182|561175458|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
155479046|NCT02795182|561175459|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
155479047|NCT02795182|561175460|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
155479048|NCT02795182|561175457|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
155479049|NCT02795182|561175458|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
155479050|NCT02795182|561175459|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
155479051|NCT02795182|561175460|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
155479052|NCT02795182|561175457|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
155479053|NCT02795182|561175458|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
155479054|NCT02795182|561175459|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
155479055|NCT02795182|561175460|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
155479056|NCT02795182|561175457|FG000|Overall Study|Withdrawal by Subject|4|||
155479057|NCT02795182|561175458|FG001|Overall Study|Withdrawal by Subject|0|||
155479058|NCT02795182|561175459|FG002|Overall Study|Withdrawal by Subject|0|||
155479059|NCT02795182|561175460|FG003|Overall Study|Withdrawal by Subject|3|||
155479060|NCT02795182|561175457|FG000|Overall Study|Lost to Follow-up|0|||
155479061|NCT02795182|561175458|FG001|Overall Study|Lost to Follow-up|0|||
155479062|NCT02795182|561175459|FG002|Overall Study|Lost to Follow-up|1|||
155479063|NCT02795182|561175460|FG003|Overall Study|Lost to Follow-up|1|||
155479064|NCT02795182|561175457|FG000|Overall Study|Roll Over to Long Term Extension|3|||
155519977|NCT04885296|561329327|FG001|Period 1|Adverse Event|1|||
155519978|NCT04885296|561329326|FG000|Period 1|Withdrawal by Subject|1|||
155519979|NCT04885296|561329327|FG001|Period 1|Withdrawal by Subject|1|||
155519980|NCT04885296|561329326|FG000|Period 1|Test Article No Longer Available|1|||
155519981|NCT04885296|561329327|FG001|Period 1|Test Article No Longer Available|0|||
155519982|NCT04885296|561329326|FG000|Period 1|Dispensed Study lens in Error|1|||
155519983|NCT04885296|561329327|FG001|Period 1|Dispensed Study lens in Error|0|||
155519984|NCT04885296|561329326|FG000|Period 1|Lost to Follow-up|1|||
155519985|NCT04885296|561329327|FG001|Period 1|Lost to Follow-up|0|||
155519986|NCT04885296|561329326|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
155519987|NCT04885296|561329327|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
155519988|NCT00433147|561329328|FG000|Overall Study|Adverse Event|0|||
155519989|NCT00433147|561329329|FG001|Overall Study|Adverse Event|1|||
155519990|NCT00433147|561329330|FG002|Overall Study|Adverse Event|0|||
155519991|NCT00433147|561329331|FG003|Overall Study|Adverse Event|0|||
155519992|NCT01882647|561329332|FG000|Overall Study|Lost to Follow-up|2|||
155519993|NCT01882647|561329333|FG001|Overall Study|Lost to Follow-up|2|||
155519994|NCT01882647|561329332|FG000|Overall Study|Withdrawal by Subject|0|||
155519995|NCT01882647|561329333|FG001|Overall Study|Withdrawal by Subject|4|||
155519996|NCT03601637|561329334|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
155519997|NCT03601637|561329335|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
155519998|NCT03601637|561329334|FG000|Overall Study|Adverse Event|1|||
155519999|NCT03601637|561329335|FG001|Overall Study|Adverse Event|1|||
155520000|NCT03601637|561329334|FG000|Overall Study|Other|0|||
155520001|NCT03601637|561329335|FG001|Overall Study|Other|1|||
155520002|NCT05037097|561329337|FG000|Overall Study|Withdrawal by Subject|0|||
155520003|NCT05037097|561329338|FG001|Overall Study|Withdrawal by Subject|1|||
155520004|NCT05037097|561329339|FG002|Overall Study|Withdrawal by Subject|0|||
155520005|NCT05037097|561329340|FG003|Overall Study|Withdrawal by Subject|1|||
155520006|NCT05037097|561329341|FG004|Overall Study|Withdrawal by Subject|0|||
155520007|NCT05037097|561329342|FG005|Overall Study|Withdrawal by Subject|2|||
155520008|NCT05037097|561329343|FG006|Overall Study|Withdrawal by Subject|0|||
155654604|NCT03715829|561828910|FG009|Dose Ranging Period|Other|0|||
155520009|NCT05037097|561329344|FG007|Overall Study|Withdrawal by Subject|0|||
155520010|NCT05037097|561329337|FG000|Overall Study|Lost to Follow-up|0|||
155520011|NCT05037097|561329338|FG001|Overall Study|Lost to Follow-up|1|||
155520012|NCT05037097|561329339|FG002|Overall Study|Lost to Follow-up|0|||
155520013|NCT05037097|561329340|FG003|Overall Study|Lost to Follow-up|0|||
155520014|NCT05037097|561329341|FG004|Overall Study|Lost to Follow-up|1|||
155520015|NCT05037097|561329342|FG005|Overall Study|Lost to Follow-up|1|||
155479065|NCT02795182|561175458|FG001|Overall Study|Roll Over to Long Term Extension|3|||
155479066|NCT02795182|561175459|FG002|Overall Study|Roll Over to Long Term Extension|2|||
155479067|NCT02795182|561175460|FG003|Overall Study|Roll Over to Long Term Extension|5|||
155479068|NCT02795182|561175457|FG000|Overall Study|Progressive Disease|0|||
155479069|NCT02795182|561175458|FG001|Overall Study|Progressive Disease|1|||
155479070|NCT02795182|561175459|FG002|Overall Study|Progressive Disease|0|||
155479071|NCT02795182|561175460|FG003|Overall Study|Progressive Disease|4|||
155479072|NCT02795182|561175457|FG000|Overall Study|Physician Decision|0|||
155479073|NCT02795182|561175458|FG001|Overall Study|Physician Decision|0|||
155479074|NCT02795182|561175459|FG002|Overall Study|Physician Decision|0|||
155479075|NCT02795182|561175460|FG003|Overall Study|Physician Decision|1|||
155479076|NCT01108068|561175461|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
155479077|NCT01108068|561175462|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
155479078|NCT01021553|561175463|FG000|Overall Study|Adverse Event|1|||
155479079|NCT01021553|561175464|FG001|Overall Study|Adverse Event|0|||
155479080|NCT01021553|561175465|FG002|Overall Study|Adverse Event|0|||
155479081|NCT01021553|561175463|FG000|Overall Study|Lack of Efficacy|2|||
155479082|NCT01021553|561175464|FG001|Overall Study|Lack of Efficacy|2|||
155479083|NCT01021553|561175465|FG002|Overall Study|Lack of Efficacy|0|||
155479084|NCT01021553|561175463|FG000|Overall Study|Protocol Violation|0|||
155479085|NCT01021553|561175464|FG001|Overall Study|Protocol Violation|2|||
155479086|NCT01021553|561175465|FG002|Overall Study|Protocol Violation|2|||
155479087|NCT01021553|561175463|FG000|Overall Study|Lost to Follow-up|0|||
155479088|NCT01021553|561175464|FG001|Overall Study|Lost to Follow-up|0|||
155479089|NCT01021553|561175465|FG002|Overall Study|Lost to Follow-up|1|||
155479090|NCT01021553|561175463|FG000|Overall Study|Withdrawal by Subject|1|||
155479091|NCT01021553|561175464|FG001|Overall Study|Withdrawal by Subject|1|||
155479092|NCT01021553|561175465|FG002|Overall Study|Withdrawal by Subject|0|||
155479093|NCT00696774|561175466|FG000|Period II|Adverse Event|0|||
155479094|NCT00696774|561175467|FG001|Period II|Adverse Event|0|||
155479095|NCT00696774|561175468|FG002|Period II|Adverse Event|15|||
155479096|NCT00696774|561175466|FG000|Period II|Lost to Follow-up|0|||
155479097|NCT00696774|561175467|FG001|Period II|Lost to Follow-up|0|||
155479098|NCT00696774|561175468|FG002|Period II|Lost to Follow-up|4|||
155479099|NCT00696774|561175466|FG000|Period II|Protocol Violation|0|||
155479100|NCT00696774|561175467|FG001|Period II|Protocol Violation|0|||
155479101|NCT00696774|561175468|FG002|Period II|Protocol Violation|11|||
155479102|NCT00696774|561175466|FG000|Period II|Withdrawal by Subject|0|||
155479103|NCT00696774|561175467|FG001|Period II|Withdrawal by Subject|0|||
155479104|NCT00696774|561175468|FG002|Period II|Withdrawal by Subject|4|||
155479105|NCT00696774|561175466|FG000|Period II|Sponsor Decision|0|||
155479106|NCT00696774|561175467|FG001|Period II|Sponsor Decision|0|||
155479107|NCT00696774|561175468|FG002|Period II|Sponsor Decision|0|||
155479108|NCT00696774|561175466|FG000|Period II|Lack of Efficacy|0|||
155479109|NCT00696774|561175467|FG001|Period II|Lack of Efficacy|0|||
155479110|NCT00696774|561175468|FG002|Period II|Lack of Efficacy|2|||
155479111|NCT00696774|561175466|FG000|Period III|Adverse Event|1|||
155479112|NCT00696774|561175467|FG001|Period III|Adverse Event|1|||
155479113|NCT00696774|561175468|FG002|Period III|Adverse Event|0|||
155479114|NCT00696774|561175466|FG000|Period III|Lost to Follow-up|2|||
155479115|NCT00696774|561175467|FG001|Period III|Lost to Follow-up|1|||
155479116|NCT00696774|561175468|FG002|Period III|Lost to Follow-up|0|||
155479117|NCT00696774|561175466|FG000|Period III|Protocol Violation|1|||
155479118|NCT00696774|561175467|FG001|Period III|Protocol Violation|1|||
155479119|NCT00696774|561175468|FG002|Period III|Protocol Violation|0|||
155479120|NCT00696774|561175466|FG000|Period III|Withdrawal by Subject|1|||
155479121|NCT00696774|561175467|FG001|Period III|Withdrawal by Subject|2|||
155479122|NCT00696774|561175468|FG002|Period III|Withdrawal by Subject|0|||
155479123|NCT00696774|561175466|FG000|Period III|Sponsor Decision|2|||
155479124|NCT00696774|561175467|FG001|Period III|Sponsor Decision|0|||
155479125|NCT00696774|561175468|FG002|Period III|Sponsor Decision|0|||
155479126|NCT00696774|561175466|FG000|Period III|Lack of Efficacy|0|||
155479127|NCT00696774|561175467|FG001|Period III|Lack of Efficacy|2|||
155479128|NCT00696774|561175468|FG002|Period III|Lack of Efficacy|0|||
155520016|NCT05037097|561329343|FG006|Overall Study|Lost to Follow-up|0|||
155479129|NCT01950364|561175469|FG000|Overall Study|Adverse Event|3|||
155479130|NCT01950364|561175470|FG001|Overall Study|Adverse Event|0|||
155479131|NCT01950364|561175469|FG000|Overall Study|Stem Cell Transplant|2|||
155479132|NCT01950364|561175470|FG001|Overall Study|Stem Cell Transplant|6|||
155479133|NCT01950364|561175469|FG000|Overall Study|Disease Progression|5|||
155479134|NCT01950364|561175470|FG001|Overall Study|Disease Progression|2|||
155479135|NCT01950364|561175469|FG000|Overall Study|Withdrawal by Subject|0|||
155479136|NCT01950364|561175470|FG001|Overall Study|Withdrawal by Subject|1|||
155479137|NCT01950364|561175469|FG000|Overall Study|Protocol Violation|0|||
155654605|NCT03715829|561828911|FG010|Dose Ranging Period|Other|0|||
155479138|NCT01950364|561175470|FG001|Overall Study|Protocol Violation|1|||
155479139|NCT00033293|561175471|FG000|Overall Study|Death|0|||
155479140|NCT00033293|561175472|FG001|Overall Study|Death|1|||
155479141|NCT00033293|561175471|FG000|Overall Study|Lack of Efficacy|5|||
155479142|NCT00033293|561175472|FG001|Overall Study|Lack of Efficacy|8|||
155479143|NCT00033293|561175471|FG000|Overall Study|Lost to Follow-up|0|||
155479144|NCT00033293|561175472|FG001|Overall Study|Lost to Follow-up|1|||
155479145|NCT00033293|561175471|FG000|Overall Study|Physician Decision|3|||
155479146|NCT00033293|561175472|FG001|Overall Study|Physician Decision|1|||
155479147|NCT00033293|561175471|FG000|Overall Study|Withdrawal by Subject|1|||
155479148|NCT00033293|561175472|FG001|Overall Study|Withdrawal by Subject|0|||
155479149|NCT00033293|561175471|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
155479150|NCT00033293|561175472|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
155479151|NCT00033293|561175471|FG000|Overall Study|Treatment refused|0|||
155479152|NCT00033293|561175472|FG001|Overall Study|Treatment refused|6|||
155479153|NCT00935701|561175473|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
155479154|NCT00836953|561175474|FG000|Overall Study|Withdrawal by Subject|1|||
155479155|NCT00836953|561175474|FG000|Overall Study|Lost to Follow-up|1|||
155479156|NCT01200758|561175475|FG000|Stage I|Death|0|||
155479157|NCT01200758|561175476|FG001|Stage I|Death|1|||
155479158|NCT01200758|561175477|FG002|Stage I|Death|0|||
155479159|NCT01200758|561175478|FG003|Stage I|Death|0|||
155479160|NCT01200758|561175475|FG000|Stage I|Physician Decision|1|||
155479161|NCT01200758|561175476|FG001|Stage I|Physician Decision|1|||
155479162|NCT01200758|561175477|FG002|Stage I|Physician Decision|0|||
155479163|NCT01200758|561175478|FG003|Stage I|Physician Decision|0|||
155479164|NCT01200758|561175475|FG000|Stage I|Lack of Efficacy|2|||
155479165|NCT01200758|561175476|FG001|Stage I|Lack of Efficacy|1|||
155479166|NCT01200758|561175477|FG002|Stage I|Lack of Efficacy|0|||
155479167|NCT01200758|561175478|FG003|Stage I|Lack of Efficacy|0|||
155479168|NCT01200758|561175475|FG000|Stage I|Adverse Event|5|||
155479169|NCT01200758|561175476|FG001|Stage I|Adverse Event|5|||
155479170|NCT01200758|561175477|FG002|Stage I|Adverse Event|0|||
155479171|NCT01200758|561175478|FG003|Stage I|Adverse Event|0|||
155479172|NCT01200758|561175475|FG000|Stage I|Withdrawal by Subject|1|||
155479173|NCT01200758|561175476|FG001|Stage I|Withdrawal by Subject|2|||
155479174|NCT01200758|561175477|FG002|Stage I|Withdrawal by Subject|0|||
155479175|NCT01200758|561175478|FG003|Stage I|Withdrawal by Subject|0|||
155479176|NCT01200758|561175475|FG000|Stage I|Disease Progression|9|||
155479177|NCT01200758|561175476|FG001|Stage I|Disease Progression|7|||
155479178|NCT01200758|561175477|FG002|Stage I|Disease Progression|0|||
155479179|NCT01200758|561175478|FG003|Stage I|Disease Progression|0|||
155479180|NCT01200758|561175475|FG000|Stage 2|Disease Progression|0|||
155479181|NCT01200758|561175476|FG001|Stage 2|Disease Progression|0|||
155520017|NCT05037097|561329344|FG007|Overall Study|Lost to Follow-up|0|||
155520018|NCT02322047|561329345|FG000|Overall Study|Physician Decision|1|||
155520019|NCT02322047|561329346|FG001|Overall Study|Physician Decision|0|||
155520020|NCT02322047|561329347|FG002|Overall Study|Physician Decision|0|||
155520021|NCT02322047|561329348|FG003|Overall Study|Physician Decision|0|||
155520022|NCT02322047|561329345|FG000|Overall Study|Withdrawal by Subject|1|||
155520023|NCT02322047|561329346|FG001|Overall Study|Withdrawal by Subject|0|||
155520024|NCT02322047|561329347|FG002|Overall Study|Withdrawal by Subject|0|||
155520025|NCT02322047|561329348|FG003|Overall Study|Withdrawal by Subject|1|||
155520026|NCT02322047|561329345|FG000|Overall Study|Adverse Event|0|||
155520027|NCT02322047|561329346|FG001|Overall Study|Adverse Event|1|||
155520028|NCT02322047|561329347|FG002|Overall Study|Adverse Event|0|||
155520029|NCT02322047|561329348|FG003|Overall Study|Adverse Event|0|||
155520030|NCT02322047|561329345|FG000|Overall Study|Lost to Follow-up|0|||
155520031|NCT02322047|561329346|FG001|Overall Study|Lost to Follow-up|0|||
155479182|NCT01200758|561175477|FG002|Stage 2|Disease Progression|16|||
155520032|NCT02322047|561329347|FG002|Overall Study|Lost to Follow-up|1|||
155479183|NCT01200758|561175478|FG003|Stage 2|Disease Progression|21|||
155479184|NCT01200758|561175475|FG000|Stage 2|Lack of Efficacy|0|||
155479185|NCT01200758|561175476|FG001|Stage 2|Lack of Efficacy|0|||
155479186|NCT01200758|561175477|FG002|Stage 2|Lack of Efficacy|4|||
155479187|NCT01200758|561175478|FG003|Stage 2|Lack of Efficacy|2|||
155479188|NCT01200758|561175475|FG000|Stage 2|Physician Decision|0|||
155520033|NCT02322047|561329348|FG003|Overall Study|Lost to Follow-up|1|||
155520034|NCT00376220|561329351|FG000|Overall Study|Lost to Follow-up|7|||
155520035|NCT00376220|561329352|FG001|Overall Study|Lost to Follow-up|10|||
155520036|NCT00376220|561329351|FG000|Overall Study|Withdrawal by Subject|3|||
155479189|NCT01200758|561175476|FG001|Stage 2|Physician Decision|0|||
155479190|NCT01200758|561175477|FG002|Stage 2|Physician Decision|5|||
155479191|NCT01200758|561175478|FG003|Stage 2|Physician Decision|7|||
155479192|NCT01200758|561175475|FG000|Stage 2|Adverse Event|0|||
155479193|NCT01200758|561175476|FG001|Stage 2|Adverse Event|0|||
155479194|NCT01200758|561175477|FG002|Stage 2|Adverse Event|5|||
155479195|NCT01200758|561175478|FG003|Stage 2|Adverse Event|9|||
155479196|NCT01200758|561175475|FG000|Stage 2|Withdrawal by Subject|0|||
155479197|NCT01200758|561175476|FG001|Stage 2|Withdrawal by Subject|0|||
155479198|NCT01200758|561175477|FG002|Stage 2|Withdrawal by Subject|4|||
155479199|NCT01200758|561175478|FG003|Stage 2|Withdrawal by Subject|1|||
155479200|NCT01200758|561175475|FG000|Stage 2|Lost to Follow-up|0|||
155479201|NCT01200758|561175476|FG001|Stage 2|Lost to Follow-up|0|||
155479202|NCT01200758|561175477|FG002|Stage 2|Lost to Follow-up|3|||
155479203|NCT01200758|561175478|FG003|Stage 2|Lost to Follow-up|1|||
155479204|NCT01200758|561175475|FG000|Stage 2|Protocol Violation|0|||
155479205|NCT01200758|561175476|FG001|Stage 2|Protocol Violation|0|||
155479206|NCT01200758|561175477|FG002|Stage 2|Protocol Violation|1|||
155479207|NCT01200758|561175478|FG003|Stage 2|Protocol Violation|4|||
155479208|NCT01200758|561175475|FG000|Stage 2|Death|0|||
155479209|NCT01200758|561175476|FG001|Stage 2|Death|0|||
155479210|NCT01200758|561175477|FG002|Stage 2|Death|3|||
155479211|NCT01200758|561175478|FG003|Stage 2|Death|5|||
155479212|NCT02711553|561175479|FG000|Overall Study|Withdrawal by Subject|2|||
155479213|NCT02711553|561175480|FG001|Overall Study|Withdrawal by Subject|1|||
155479214|NCT02711553|561175481|FG002|Overall Study|Withdrawal by Subject|1|||
155479215|NCT02711553|561175482|FG003|Overall Study|Withdrawal by Subject|0|||
155479216|NCT02711553|561175479|FG000|Overall Study|Lost to Follow-up|3|||
155479217|NCT02711553|561175480|FG001|Overall Study|Lost to Follow-up|3|||
155479218|NCT02711553|561175481|FG002|Overall Study|Lost to Follow-up|6|||
155479219|NCT02711553|561175482|FG003|Overall Study|Lost to Follow-up|3|||
155479220|NCT02711553|561175479|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
155479221|NCT02711553|561175480|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
155479222|NCT02711553|561175481|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
155479223|NCT02711553|561175482|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
155479224|NCT04048876|561175485|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
155479225|NCT04048876|561175486|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
155479226|NCT04048876|561175487|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
155479227|NCT04048876|561175488|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
155479228|NCT04048876|561175485|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
155479229|NCT04048876|561175486|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
155479230|NCT04048876|561175487|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
155479231|NCT04048876|561175488|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
155479232|NCT04048876|561175485|FG000|Placebo Controlled Phase|Adverse Event|0|||
155479233|NCT04048876|561175486|FG001|Placebo Controlled Phase|Adverse Event|1|||
155479234|NCT04048876|561175487|FG002|Placebo Controlled Phase|Adverse Event|0|||
155479235|NCT04048876|561175488|FG003|Placebo Controlled Phase|Adverse Event|0|||
155479236|NCT04048876|561175485|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
155479237|NCT04048876|561175486|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
155520037|NCT00376220|561329352|FG001|Overall Study|Withdrawal by Subject|2|||
155520038|NCT02564263|561329353|FG000|Overall Study|Adverse Event|31|||
155520039|NCT02564263|561329354|FG001|Overall Study|Adverse Event|29|||
155479238|NCT04048876|561175487|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
155479239|NCT04048876|561175488|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
155479240|NCT01197794|561175489|FG000|Overall Study|Adverse Event|3|||
155520040|NCT02564263|561329353|FG000|Overall Study|Death|270|||
155520041|NCT02564263|561329354|FG001|Overall Study|Death|262|||
155520042|NCT02564263|561329353|FG000|Overall Study|Withdrawal by Subject|4|||
155520043|NCT02564263|561329354|FG001|Overall Study|Withdrawal by Subject|19|||
155520044|NCT02564263|561329353|FG000|Overall Study|Sponsor's decision|9|||
155520045|NCT02564263|561329354|FG001|Overall Study|Sponsor's decision|4|||
155520046|NCT01644500|561329355|FG000|Overall Study|Adverse Event|6|||
155479241|NCT01197794|561175490|FG001|Overall Study|Adverse Event|2|||
155479242|NCT01197794|561175491|FG002|Overall Study|Adverse Event|4|||
155479243|NCT01197794|561175492|FG003|Overall Study|Adverse Event|4|||
155479244|NCT01197794|561175493|FG004|Overall Study|Adverse Event|4|||
155479245|NCT01197794|561175494|FG005|Overall Study|Adverse Event|2|||
155479246|NCT01197794|561175495|FG006|Overall Study|Adverse Event|3|||
155479247|NCT01197794|561175489|FG000|Overall Study|Protocol Violation|0|||
155479248|NCT01197794|561175490|FG001|Overall Study|Protocol Violation|0|||
155479249|NCT01197794|561175491|FG002|Overall Study|Protocol Violation|0|||
155479250|NCT01197794|561175492|FG003|Overall Study|Protocol Violation|0|||
155479251|NCT01197794|561175493|FG004|Overall Study|Protocol Violation|2|||
155479252|NCT01197794|561175494|FG005|Overall Study|Protocol Violation|0|||
155479253|NCT01197794|561175495|FG006|Overall Study|Protocol Violation|1|||
155479254|NCT01197794|561175489|FG000|Overall Study|Development of study withdrawal criteria|3|||
155479255|NCT01197794|561175490|FG001|Overall Study|Development of study withdrawal criteria|0|||
155479256|NCT01197794|561175491|FG002|Overall Study|Development of study withdrawal criteria|0|||
155479257|NCT01197794|561175492|FG003|Overall Study|Development of study withdrawal criteria|1|||
155479258|NCT01197794|561175493|FG004|Overall Study|Development of study withdrawal criteria|0|||
155479259|NCT01197794|561175494|FG005|Overall Study|Development of study withdrawal criteria|0|||
155479260|NCT01197794|561175495|FG006|Overall Study|Development of study withdrawal criteria|1|||
155479261|NCT01197794|561175489|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
155479262|NCT01197794|561175490|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
155479263|NCT01197794|561175491|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
155479264|NCT01197794|561175492|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
155479265|NCT01197794|561175493|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
155479266|NCT01197794|561175494|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
155479267|NCT01197794|561175495|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
155479268|NCT01197794|561175489|FG000|Overall Study|Withdrawal by Subject|3|||
155479269|NCT01197794|561175490|FG001|Overall Study|Withdrawal by Subject|3|||
155479270|NCT01197794|561175491|FG002|Overall Study|Withdrawal by Subject|4|||
155479271|NCT01197794|561175492|FG003|Overall Study|Withdrawal by Subject|1|||
155479272|NCT01197794|561175493|FG004|Overall Study|Withdrawal by Subject|1|||
155479273|NCT01197794|561175494|FG005|Overall Study|Withdrawal by Subject|5|||
155479274|NCT01197794|561175495|FG006|Overall Study|Withdrawal by Subject|6|||
155479275|NCT01197794|561175489|FG000|Overall Study|Lost to Follow-up|1|||
155479276|NCT01197794|561175490|FG001|Overall Study|Lost to Follow-up|1|||
155479277|NCT01197794|561175491|FG002|Overall Study|Lost to Follow-up|0|||
155479278|NCT01197794|561175492|FG003|Overall Study|Lost to Follow-up|1|||
155479279|NCT01197794|561175493|FG004|Overall Study|Lost to Follow-up|0|||
155479280|NCT01197794|561175494|FG005|Overall Study|Lost to Follow-up|1|||
155479281|NCT01197794|561175495|FG006|Overall Study|Lost to Follow-up|0|||
155479282|NCT01197794|561175489|FG000|Overall Study|Other|1|||
155479283|NCT01197794|561175490|FG001|Overall Study|Other|1|||
155479284|NCT01197794|561175491|FG002|Overall Study|Other|3|||
155479285|NCT01197794|561175492|FG003|Overall Study|Other|0|||
155479286|NCT01197794|561175493|FG004|Overall Study|Other|2|||
155479287|NCT01197794|561175494|FG005|Overall Study|Other|2|||
155479288|NCT01197794|561175495|FG006|Overall Study|Other|4|||
155479289|NCT04055844|561175496|FG000|Overall Study|Adverse Event|12|||
155479290|NCT04055844|561175496|FG000|Overall Study|Poor Performance|1|||
155479291|NCT04055844|561175496|FG000|Overall Study|Death|1|||
155479292|NCT03457636|561175503|FG000|Overall Study|Lost to Follow-up|2|||
155479293|NCT02996500|561175504|FG000|Overall Study|Adverse Event|1|||
155479294|NCT02996500|561175505|FG001|Overall Study|Adverse Event|1|||
155479295|NCT02996500|561175506|FG002|Overall Study|Adverse Event|4|||
155479296|NCT02996500|561175507|FG003|Overall Study|Adverse Event|3|||
155479297|NCT02996500|561175508|FG004|Overall Study|Adverse Event|1|||
155479298|NCT02996500|561175509|FG005|Overall Study|Adverse Event|2|||
155479299|NCT02996500|561175504|FG000|Overall Study|Lack of Efficacy|0|||
155479300|NCT02996500|561175505|FG001|Overall Study|Lack of Efficacy|0|||
155479301|NCT02996500|561175506|FG002|Overall Study|Lack of Efficacy|0|||
155479302|NCT02996500|561175507|FG003|Overall Study|Lack of Efficacy|0|||
155479303|NCT02996500|561175508|FG004|Overall Study|Lack of Efficacy|2|||
155479304|NCT02996500|561175509|FG005|Overall Study|Lack of Efficacy|0|||
155479305|NCT02996500|561175504|FG000|Overall Study|Lost to Follow-up|1|||
155479306|NCT02996500|561175505|FG001|Overall Study|Lost to Follow-up|0|||
155479307|NCT02996500|561175506|FG002|Overall Study|Lost to Follow-up|0|||
155479308|NCT02996500|561175507|FG003|Overall Study|Lost to Follow-up|0|||
155479309|NCT02996500|561175508|FG004|Overall Study|Lost to Follow-up|0|||
155479310|NCT02996500|561175509|FG005|Overall Study|Lost to Follow-up|1|||
155479311|NCT02996500|561175504|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155479312|NCT02996500|561175505|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155520047|NCT01644500|561329356|FG001|Overall Study|Adverse Event|1|||
155520048|NCT01644500|561329357|FG002|Overall Study|Adverse Event|2|||
155520049|NCT01644500|561329355|FG000|Overall Study|Death|0|||
155520050|NCT01644500|561329356|FG001|Overall Study|Death|1|||
155520051|NCT01644500|561329357|FG002|Overall Study|Death|0|||
155654606|NCT03715829|561828901|FG000|Extension Period|Adverse Event|0|||
155520052|NCT01644500|561329355|FG000|Overall Study|Lost to Follow-up|3|||
155520053|NCT01644500|561329356|FG001|Overall Study|Lost to Follow-up|8|||
155520054|NCT01644500|561329357|FG002|Overall Study|Lost to Follow-up|0|||
155520055|NCT01644500|561329355|FG000|Overall Study|Protocol Violation|1|||
155520056|NCT01644500|561329356|FG001|Overall Study|Protocol Violation|1|||
155520057|NCT01644500|561329357|FG002|Overall Study|Protocol Violation|0|||
155520058|NCT01644500|561329355|FG000|Overall Study|Withdrawal by Subject|11|||
155654607|NCT03715829|561828902|FG001|Extension Period|Adverse Event|0|||
155654608|NCT03715829|561828903|FG002|Extension Period|Adverse Event|0|||
155520059|NCT01644500|561329356|FG001|Overall Study|Withdrawal by Subject|12|||
155520060|NCT01644500|561329357|FG002|Overall Study|Withdrawal by Subject|12|||
155520061|NCT01644500|561329355|FG000|Overall Study|Physician Decision|1|||
155520062|NCT01644500|561329356|FG001|Overall Study|Physician Decision|1|||
155520063|NCT01644500|561329357|FG002|Overall Study|Physician Decision|1|||
155520064|NCT01400425|561329361|FG000|Overall Study|Withdrawal by Subject|10|||
155520065|NCT00688064|561329362|FG000|Overall Study|Protocol Violation|0|||
155654609|NCT03715829|561828904|FG003|Extension Period|Adverse Event|0|||
155654610|NCT03715829|561828905|FG004|Extension Period|Adverse Event|0|||
155520066|NCT00688064|561329363|FG001|Overall Study|Protocol Violation|1|||
155479313|NCT02996500|561175506|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
155479314|NCT02996500|561175507|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155479315|NCT02996500|561175508|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155479316|NCT02996500|561175509|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155479317|NCT02996500|561175504|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155479318|NCT02996500|561175505|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155479319|NCT02996500|561175506|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155479320|NCT02996500|561175507|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155479321|NCT02996500|561175508|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155479322|NCT02996500|561175509|FG005|Overall Study|Non-Compliance With Study Drug|1|||
155479323|NCT02996500|561175504|FG000|Overall Study|Progressive Disease|1|||
155479324|NCT02996500|561175505|FG001|Overall Study|Progressive Disease|0|||
155479325|NCT02996500|561175506|FG002|Overall Study|Progressive Disease|0|||
155479326|NCT02996500|561175507|FG003|Overall Study|Progressive Disease|0|||
155479327|NCT02996500|561175508|FG004|Overall Study|Progressive Disease|0|||
155479328|NCT02996500|561175509|FG005|Overall Study|Progressive Disease|0|||
155479329|NCT02996500|561175504|FG000|Overall Study|Other|2|||
155479330|NCT02996500|561175505|FG001|Overall Study|Other|0|||
155479331|NCT02996500|561175506|FG002|Overall Study|Other|2|||
155479332|NCT02996500|561175507|FG003|Overall Study|Other|0|||
155654611|NCT03715829|561828906|FG005|Extension Period|Adverse Event|0|||
155654612|NCT03715829|561828907|FG006|Extension Period|Adverse Event|3|||
155654613|NCT03715829|561828908|FG007|Extension Period|Adverse Event|1|||
155479333|NCT02996500|561175508|FG004|Overall Study|Other|0|||
155479334|NCT02996500|561175509|FG005|Overall Study|Other|0|||
155479335|NCT02996500|561175504|FG000|Overall Study|Protocol Violation|0|||
155479336|NCT02996500|561175505|FG001|Overall Study|Protocol Violation|0|||
155479337|NCT02996500|561175506|FG002|Overall Study|Protocol Violation|0|||
155479338|NCT02996500|561175507|FG003|Overall Study|Protocol Violation|1|||
155479339|NCT02996500|561175508|FG004|Overall Study|Protocol Violation|0|||
155479340|NCT02996500|561175509|FG005|Overall Study|Protocol Violation|0|||
155479341|NCT02996500|561175504|FG000|Overall Study|Withdrawal by Subject|3|||
155479342|NCT02996500|561175505|FG001|Overall Study|Withdrawal by Subject|0|||
155479343|NCT02996500|561175506|FG002|Overall Study|Withdrawal by Subject|3|||
155479344|NCT02996500|561175507|FG003|Overall Study|Withdrawal by Subject|0|||
155479345|NCT02996500|561175508|FG004|Overall Study|Withdrawal by Subject|2|||
155479346|NCT02996500|561175509|FG005|Overall Study|Withdrawal by Subject|0|||
155479347|NCT02187224|561175510|FG000|Overall Study|Did not show up for test day|1|||
155479348|NCT02187224|561175511|FG001|Overall Study|Did not show up for test day|0|||
155479349|NCT01347840|561175514|FG000|Overall Study|Withdrawal by Subject|1|||
155479350|NCT01010776|561175515|FG000|Main Phase|Withdrawal by Subject|14|||
155479351|NCT01010776|561175515|FG000|Main Phase|Lack of Efficacy|8|||
155479352|NCT01010776|561175515|FG000|Main Phase|Adverse Event|7|||
155479353|NCT01010776|561175515|FG000|Main Phase|Lost to Follow-up|6|||
155479354|NCT01010776|561175515|FG000|Main Phase|Non-compliance to study medication|5|||
155479355|NCT01010776|561175515|FG000|Main Phase|Selection failure|2|||
155479356|NCT01010776|561175515|FG000|Main Phase|Inform consent withdrawal|1|||
155479357|NCT01010776|561175515|FG000|Main Phase|Other|1|||
155479358|NCT01010776|561175515|FG000|Main Phase|Did not received study medication|5|||
155479359|NCT01010776|561175515|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
155479360|NCT01010776|561175515|FG000|Extension Phase|Other|3|||
155479361|NCT02545049|561175531|FG000|Overall Study|Withdrawal by Subject|1|||
155479362|NCT02545049|561175532|FG001|Overall Study|Withdrawal by Subject|7|||
155479363|NCT02545049|561175531|FG000|Overall Study|Lost to Follow-up|4|||
155479364|NCT02545049|561175532|FG001|Overall Study|Lost to Follow-up|6|||
155479365|NCT02545049|561175531|FG000|Overall Study|GCP violations|37|||
155479366|NCT02545049|561175532|FG001|Overall Study|GCP violations|48|||
155479367|NCT04223778|561175537|FG000|Overall Study|Death|1|||
155479368|NCT04223778|561175538|FG001|Overall Study|Death|1|||
155479369|NCT04223778|561175537|FG000|Overall Study|Lost to Follow-up|4|||
155479370|NCT04223778|561175538|FG001|Overall Study|Lost to Follow-up|5|||
155479371|NCT04223778|561175537|FG000|Overall Study|Physician Decision|10|||
155479372|NCT04223778|561175538|FG001|Overall Study|Physician Decision|6|||
155479373|NCT04223778|561175537|FG000|Overall Study|Withdrawal by Subject|35|||
155479374|NCT04223778|561175538|FG001|Overall Study|Withdrawal by Subject|17|||
155479375|NCT04223778|561175537|FG000|Overall Study|Not Reported|7|||
155479376|NCT04223778|561175538|FG001|Overall Study|Not Reported|8|||
155479377|NCT01004861|561177740|FG000|Overall Study|Disease progression|3|||
155479378|NCT01004861|561177741|FG001|Overall Study|Disease progression|4|||
155479379|NCT01004861|561177742|FG002|Overall Study|Disease progression|5|||
155479380|NCT01004861|561177743|FG003|Overall Study|Disease progression|4|||
155479381|NCT01004861|561177744|FG004|Overall Study|Disease progression|4|||
155479382|NCT01004861|561177745|FG005|Overall Study|Disease progression|4|||
155479383|NCT01004861|561177746|FG006|Overall Study|Disease progression|5|||
155479384|NCT01004861|561177747|FG007|Overall Study|Disease progression|1|||
155479385|NCT01004861|561177748|FG008|Overall Study|Disease progression|4|||
155479386|NCT01004861|561177749|FG009|Overall Study|Disease progression|7|||
155479387|NCT01004861|561177750|FG010|Overall Study|Disease progression|6|||
155479388|NCT01004861|561177751|FG011|Overall Study|Disease progression|3|||
155479389|NCT01004861|561177752|FG012|Overall Study|Disease progression|8|||
155479390|NCT01004861|561177740|FG000|Overall Study|Physician Decision|0|||
155479391|NCT01004861|561177741|FG001|Overall Study|Physician Decision|2|||
155479392|NCT01004861|561177742|FG002|Overall Study|Physician Decision|1|||
155479393|NCT01004861|561177743|FG003|Overall Study|Physician Decision|1|||
155479394|NCT01004861|561177744|FG004|Overall Study|Physician Decision|1|||
155479395|NCT01004861|561177745|FG005|Overall Study|Physician Decision|0|||
155479396|NCT01004861|561177746|FG006|Overall Study|Physician Decision|0|||
155479397|NCT01004861|561177747|FG007|Overall Study|Physician Decision|1|||
155479398|NCT01004861|561177748|FG008|Overall Study|Physician Decision|0|||
155479399|NCT01004861|561177749|FG009|Overall Study|Physician Decision|0|||
155479400|NCT01004861|561177750|FG010|Overall Study|Physician Decision|0|||
155479401|NCT01004861|561177751|FG011|Overall Study|Physician Decision|0|||
155520067|NCT00688064|561329362|FG000|Overall Study|Adverse Event|2|||
155520068|NCT00688064|561329363|FG001|Overall Study|Adverse Event|4|||
155520069|NCT00688064|561329362|FG000|Overall Study|Withdrawal by Subject|7|||
155479402|NCT01004861|561177752|FG012|Overall Study|Physician Decision|3|||
155479403|NCT01004861|561177740|FG000|Overall Study|Adverse Event|0|||
155479404|NCT01004861|561177741|FG001|Overall Study|Adverse Event|0|||
155479405|NCT01004861|561177742|FG002|Overall Study|Adverse Event|0|||
155479406|NCT01004861|561177743|FG003|Overall Study|Adverse Event|1|||
155479407|NCT01004861|561177744|FG004|Overall Study|Adverse Event|0|||
155520070|NCT00688064|561329363|FG001|Overall Study|Withdrawal by Subject|7|||
155479408|NCT01004861|561177745|FG005|Overall Study|Adverse Event|2|||
155520071|NCT00688064|561329362|FG000|Overall Study|Lost to Follow-up|10|||
155520072|NCT00688064|561329363|FG001|Overall Study|Lost to Follow-up|10|||
155479409|NCT01004861|561177746|FG006|Overall Study|Adverse Event|1|||
155479410|NCT01004861|561177747|FG007|Overall Study|Adverse Event|1|||
155479411|NCT01004861|561177748|FG008|Overall Study|Adverse Event|13|||
155479412|NCT01004861|561177749|FG009|Overall Study|Adverse Event|1|||
155479413|NCT01004861|561177750|FG010|Overall Study|Adverse Event|1|||
155479414|NCT01004861|561177751|FG011|Overall Study|Adverse Event|0|||
155479415|NCT01004861|561177752|FG012|Overall Study|Adverse Event|2|||
155479416|NCT01004861|561177740|FG000|Overall Study|Protocol Violation|0|||
155479417|NCT01004861|561177741|FG001|Overall Study|Protocol Violation|0|||
155479418|NCT01004861|561177742|FG002|Overall Study|Protocol Violation|0|||
155479419|NCT01004861|561177743|FG003|Overall Study|Protocol Violation|0|||
155479420|NCT01004861|561177744|FG004|Overall Study|Protocol Violation|1|||
155479421|NCT01004861|561177745|FG005|Overall Study|Protocol Violation|0|||
155479422|NCT01004861|561177746|FG006|Overall Study|Protocol Violation|0|||
155479423|NCT01004861|561177747|FG007|Overall Study|Protocol Violation|0|||
155479424|NCT01004861|561177748|FG008|Overall Study|Protocol Violation|0|||
155479425|NCT01004861|561177749|FG009|Overall Study|Protocol Violation|0|||
155479426|NCT01004861|561177750|FG010|Overall Study|Protocol Violation|0|||
155479427|NCT01004861|561177751|FG011|Overall Study|Protocol Violation|0|||
155479428|NCT01004861|561177752|FG012|Overall Study|Protocol Violation|0|||
155479429|NCT01004861|561177740|FG000|Overall Study|Lost to Follow-up|0|||
155479430|NCT01004861|561177741|FG001|Overall Study|Lost to Follow-up|0|||
155479431|NCT01004861|561177742|FG002|Overall Study|Lost to Follow-up|0|||
155479432|NCT01004861|561177743|FG003|Overall Study|Lost to Follow-up|0|||
155479433|NCT01004861|561177744|FG004|Overall Study|Lost to Follow-up|0|||
155479434|NCT01004861|561177745|FG005|Overall Study|Lost to Follow-up|0|||
155479435|NCT01004861|561177746|FG006|Overall Study|Lost to Follow-up|0|||
155479436|NCT01004861|561177747|FG007|Overall Study|Lost to Follow-up|1|||
155479437|NCT01004861|561177748|FG008|Overall Study|Lost to Follow-up|3|||
155479438|NCT01004861|561177749|FG009|Overall Study|Lost to Follow-up|0|||
155479439|NCT01004861|561177750|FG010|Overall Study|Lost to Follow-up|0|||
155479440|NCT01004861|561177751|FG011|Overall Study|Lost to Follow-up|1|||
155479441|NCT01004861|561177752|FG012|Overall Study|Lost to Follow-up|0|||
155479442|NCT01004861|561177740|FG000|Overall Study|Non-compliance|0|||
155479443|NCT01004861|561177741|FG001|Overall Study|Non-compliance|0|||
155479444|NCT01004861|561177742|FG002|Overall Study|Non-compliance|0|||
155479445|NCT01004861|561177743|FG003|Overall Study|Non-compliance|0|||
155479446|NCT01004861|561177744|FG004|Overall Study|Non-compliance|0|||
155479447|NCT01004861|561177745|FG005|Overall Study|Non-compliance|0|||
155479448|NCT01004861|561177746|FG006|Overall Study|Non-compliance|0|||
155479449|NCT01004861|561177747|FG007|Overall Study|Non-compliance|0|||
155479450|NCT01004861|561177748|FG008|Overall Study|Non-compliance|5|||
155479451|NCT01004861|561177749|FG009|Overall Study|Non-compliance|0|||
155479452|NCT01004861|561177750|FG010|Overall Study|Non-compliance|0|||
155479453|NCT01004861|561177751|FG011|Overall Study|Non-compliance|0|||
155479454|NCT01004861|561177752|FG012|Overall Study|Non-compliance|1|||
155479455|NCT01004861|561177740|FG000|Overall Study|Other|0|||
155479456|NCT01004861|561177741|FG001|Overall Study|Other|0|||
155479457|NCT01004861|561177742|FG002|Overall Study|Other|0|||
155479458|NCT01004861|561177743|FG003|Overall Study|Other|0|||
155479459|NCT01004861|561177744|FG004|Overall Study|Other|0|||
155479460|NCT01004861|561177745|FG005|Overall Study|Other|0|||
155479461|NCT01004861|561177746|FG006|Overall Study|Other|0|||
155479462|NCT01004861|561177747|FG007|Overall Study|Other|0|||
155479463|NCT01004861|561177748|FG008|Overall Study|Other|0|||
155479464|NCT01004861|561177749|FG009|Overall Study|Other|2|||
155479465|NCT01004861|561177750|FG010|Overall Study|Other|1|||
155479466|NCT01004861|561177751|FG011|Overall Study|Other|2|||
155479467|NCT01004861|561177752|FG012|Overall Study|Other|3|||
155479468|NCT01004861|561177740|FG000|Overall Study|Patient decision|0|||
155479469|NCT01004861|561177741|FG001|Overall Study|Patient decision|0|||
155479470|NCT01004861|561177742|FG002|Overall Study|Patient decision|0|||
155479471|NCT01004861|561177743|FG003|Overall Study|Patient decision|0|||
155479472|NCT01004861|561177744|FG004|Overall Study|Patient decision|1|||
155479473|NCT01004861|561177745|FG005|Overall Study|Patient decision|0|||
155479474|NCT01004861|561177746|FG006|Overall Study|Patient decision|1|||
155479475|NCT01004861|561177747|FG007|Overall Study|Patient decision|0|||
155479476|NCT01004861|561177748|FG008|Overall Study|Patient decision|7|||
155479477|NCT01004861|561177749|FG009|Overall Study|Patient decision|1|||
155479478|NCT01004861|561177750|FG010|Overall Study|Patient decision|1|||
155479479|NCT01004861|561177751|FG011|Overall Study|Patient decision|2|||
155479480|NCT01004861|561177752|FG012|Overall Study|Patient decision|3|||
155479481|NCT01004861|561177740|FG000|Overall Study|Transitioned to Phase 4 study|0|||
155479482|NCT01004861|561177741|FG001|Overall Study|Transitioned to Phase 4 study|0|||
155479483|NCT01004861|561177742|FG002|Overall Study|Transitioned to Phase 4 study|0|||
155479484|NCT01004861|561177743|FG003|Overall Study|Transitioned to Phase 4 study|0|||
155479485|NCT01004861|561177744|FG004|Overall Study|Transitioned to Phase 4 study|0|||
155479486|NCT01004861|561177745|FG005|Overall Study|Transitioned to Phase 4 study|0|||
155479487|NCT01004861|561177746|FG006|Overall Study|Transitioned to Phase 4 study|0|||
155479488|NCT01004861|561177747|FG007|Overall Study|Transitioned to Phase 4 study|0|||
155479489|NCT01004861|561177748|FG008|Overall Study|Transitioned to Phase 4 study|2|||
155479490|NCT01004861|561177749|FG009|Overall Study|Transitioned to Phase 4 study|0|||
155479491|NCT01004861|561177750|FG010|Overall Study|Transitioned to Phase 4 study|0|||
155479492|NCT01004861|561177751|FG011|Overall Study|Transitioned to Phase 4 study|0|||
155479493|NCT01004861|561177752|FG012|Overall Study|Transitioned to Phase 4 study|0|||
155520073|NCT00688064|561329362|FG000|Overall Study|Lack of Efficacy|0|||
155520074|NCT00688064|561329363|FG001|Overall Study|Lack of Efficacy|1|||
155520075|NCT00688064|561329362|FG000|Overall Study|Pregnancy|1|||
155520076|NCT00688064|561329363|FG001|Overall Study|Pregnancy|0|||
155520077|NCT00688064|561329362|FG000|Overall Study|Any other reasons|1|||
155520078|NCT00688064|561329363|FG001|Overall Study|Any other reasons|3|||
155520079|NCT00720096|561329364|FG000|Overall Study|Withdrawal by Subject|0|||
155520080|NCT00720096|561329365|FG001|Overall Study|Withdrawal by Subject|2|||
155520081|NCT04557124|561329368|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
155520082|NCT04557124|561329369|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
155654614|NCT03715829|561828909|FG008|Extension Period|Adverse Event|6|||
155654615|NCT03715829|561828910|FG009|Extension Period|Adverse Event|0|||
155654616|NCT03715829|561828911|FG010|Extension Period|Adverse Event|0|||
155654617|NCT03715829|561828901|FG000|Extension Period|Lack of Efficacy|0|||
155654618|NCT03715829|561828902|FG001|Extension Period|Lack of Efficacy|0|||
155654619|NCT03715829|561828903|FG002|Extension Period|Lack of Efficacy|0|||
155654620|NCT03715829|561828904|FG003|Extension Period|Lack of Efficacy|0|||
155520083|NCT04557124|561329368|FG000|Mid-point (1 Month)|Missed testing|5|||
155520084|NCT04557124|561329369|FG001|Mid-point (1 Month)|Missed testing|4|||
155520085|NCT04557124|561329368|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
155520086|NCT04557124|561329369|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
155520087|NCT04557124|561329368|FG000|Post-testing (2 Months)|Missed testing|1|||
155520088|NCT04557124|561329369|FG001|Post-testing (2 Months)|Missed testing|5|||
155520089|NCT04557124|561329368|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
155520090|NCT04557124|561329369|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
155520091|NCT04557124|561329368|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
155520092|NCT04557124|561329369|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
155520093|NCT00001849|561329370|FG000|Overall Study|Death|4|||
155520094|NCT00001849|561329370|FG000|Overall Study|Lost to Follow-up|2|||
155520095|NCT00001849|561329370|FG000|Overall Study|Withdrawal by Subject|2|||
155520096|NCT00001849|561329370|FG000|Overall Study|tumor remained occult|6|||
155520097|NCT00442936|561329371|FG000|Overall Study|Protocol Violation|1|||
155520098|NCT00442936|561329372|FG001|Overall Study|Protocol Violation|0|||
155520099|NCT00442936|561329373|FG002|Overall Study|Protocol Violation|1|||
155520100|NCT00442936|561329374|FG003|Overall Study|Protocol Violation|1|||
155520101|NCT00524459|561329379|FG000|Overall Study|Withdrawal by Subject|1|||
155520102|NCT00524459|561329379|FG000|Overall Study|Other|1|||
155520103|NCT02428699|561329380|FG000|Washout Period 1|Screen Failure|1|||
155520104|NCT02428699|561329381|FG001|Washout Period 1|Screen Failure|2|||
155520105|NCT03127137|561329382|FG000|Overall Study|Requested sedation after consent|1|||
155520106|NCT03127137|561329383|FG001|Overall Study|Requested sedation after consent|0|||
155520107|NCT03127137|561329382|FG000|Overall Study|Malfunction in electronic data collection|1|||
155520108|NCT03127137|561329383|FG001|Overall Study|Malfunction in electronic data collection|0|||
155520109|NCT03127137|561329382|FG000|Overall Study|Post procedure testing could not be obtained|0|||
155520110|NCT03127137|561329383|FG001|Overall Study|Post procedure testing could not be obtained|1|||
155520111|NCT04424407|561329384|FG000|Overall Study|Withdrawal by Subject|2|||
155520112|NCT04424407|561329384|FG000|Overall Study|Lost to Follow-up|1|||
155520113|NCT01574248|561329389|FG000|Overall Study|Withdrawal by Subject|2|||
155520114|NCT01574248|561329390|FG001|Overall Study|Withdrawal by Subject|0|||
155520115|NCT01574248|561329389|FG000|Overall Study|Missing primary endpoint data|1|||
155520116|NCT01574248|561329390|FG001|Overall Study|Missing primary endpoint data|0|||
155520117|NCT00264797|561329393|FG000|Overall Study|Withdrawal by Subject|11|||
155520118|NCT00264797|561329394|FG001|Overall Study|Withdrawal by Subject|11|||
155520119|NCT00264797|561329393|FG000|Overall Study|Lost to Follow-up|9|||
155520120|NCT00264797|561329394|FG001|Overall Study|Lost to Follow-up|17|||
155520121|NCT00264797|561329393|FG000|Overall Study|Moved from area|3|||
155520122|NCT00264797|561329394|FG001|Overall Study|Moved from area|1|||
155520123|NCT00264797|561329393|FG000|Overall Study|Practical Problems|2|||
155520124|NCT00264797|561329394|FG001|Overall Study|Practical Problems|3|||
155520125|NCT00264797|561329393|FG000|Overall Study|Incarceration|4|||
155520126|NCT00264797|561329394|FG001|Overall Study|Incarceration|5|||
155520127|NCT00264797|561329393|FG000|Overall Study|Pressure/advice from Outsiders|1|||
155520128|NCT00264797|561329394|FG001|Overall Study|Pressure/advice from Outsiders|1|||
155654621|NCT03715829|561828905|FG004|Extension Period|Lack of Efficacy|0|||
155654622|NCT03715829|561828906|FG005|Extension Period|Lack of Efficacy|0|||
155520129|NCT00264797|561329393|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
155520130|NCT00264797|561329394|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
155520131|NCT00264797|561329393|FG000|Overall Study|Other|3|||
155520132|NCT00264797|561329394|FG001|Overall Study|Other|4|||
155520133|NCT01604850|561329397|FG000|Overall Study|Enrolled but never treated|0|||
155520134|NCT01604850|561329398|FG001|Overall Study|Enrolled but never treated|1|||
155520135|NCT01604850|561329397|FG000|Overall Study|Efficacy Failure|50|||
155520136|NCT01604850|561329398|FG001|Overall Study|Efficacy Failure|29|||
155520137|NCT01604850|561329397|FG000|Overall Study|Lost to Follow-up|1|||
155520138|NCT01604850|561329398|FG001|Overall Study|Lost to Follow-up|0|||
155520139|NCT01604850|561329397|FG000|Overall Study|Subject withdrew consent|1|||
155520140|NCT01604850|561329398|FG001|Overall Study|Subject withdrew consent|0|||
155479494|NCT01004861|561177740|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479495|NCT01004861|561177741|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479496|NCT01004861|561177742|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479497|NCT01004861|561177743|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479498|NCT01004861|561177744|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479499|NCT01004861|561177745|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479500|NCT01004861|561177746|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479501|NCT01004861|561177747|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479502|NCT01004861|561177748|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
155479503|NCT01004861|561177749|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479504|NCT01004861|561177750|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479505|NCT01004861|561177751|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479506|NCT01004861|561177752|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
155479507|NCT01004861|561177740|FG000|Overall Study|Patient withdrew|0|||
155479508|NCT01004861|561177741|FG001|Overall Study|Patient withdrew|0|||
155479509|NCT01004861|561177742|FG002|Overall Study|Patient withdrew|0|||
155479510|NCT01004861|561177743|FG003|Overall Study|Patient withdrew|0|||
155520141|NCT01703832|561329399|FG000|Overall Study|Withdrawal by Subject|1|||
155479511|NCT01004861|561177744|FG004|Overall Study|Patient withdrew|0|||
155479512|NCT01004861|561177745|FG005|Overall Study|Patient withdrew|0|||
155479513|NCT01004861|561177746|FG006|Overall Study|Patient withdrew|0|||
155479514|NCT01004861|561177747|FG007|Overall Study|Patient withdrew|0|||
155479515|NCT01004861|561177748|FG008|Overall Study|Patient withdrew|1|||
155479516|NCT01004861|561177749|FG009|Overall Study|Patient withdrew|0|||
155479517|NCT01004861|561177750|FG010|Overall Study|Patient withdrew|0|||
155520142|NCT01703832|561329400|FG001|Overall Study|Withdrawal by Subject|0|||
155479518|NCT01004861|561177751|FG011|Overall Study|Patient withdrew|0|||
155479519|NCT01004861|561177752|FG012|Overall Study|Patient withdrew|0|||
155520143|NCT01193608|561329401|FG000|Overall Study|Other|0|||
155520144|NCT01193608|561329402|FG001|Overall Study|Other|1|||
155520145|NCT01193608|561329403|FG002|Overall Study|Other|0|||
155520146|NCT01193608|561329404|FG003|Overall Study|Other|0|||
155520147|NCT01193608|561329405|FG004|Overall Study|Other|0|||
155520148|NCT01193608|561329406|FG005|Overall Study|Other|0|||
155520149|NCT01193608|561329401|FG000|Overall Study|Withdrawal by Subject|0|||
155520150|NCT01193608|561329402|FG001|Overall Study|Withdrawal by Subject|1|||
155520151|NCT01193608|561329403|FG002|Overall Study|Withdrawal by Subject|2|||
155520152|NCT01193608|561329404|FG003|Overall Study|Withdrawal by Subject|3|||
155520153|NCT01193608|561329405|FG004|Overall Study|Withdrawal by Subject|3|||
155520154|NCT01193608|561329406|FG005|Overall Study|Withdrawal by Subject|0|||
155520155|NCT01193608|561329401|FG000|Overall Study|Lost to Follow-up|0|||
155520156|NCT01193608|561329402|FG001|Overall Study|Lost to Follow-up|0|||
155654623|NCT03715829|561828907|FG006|Extension Period|Lack of Efficacy|1|||
155520157|NCT01193608|561329403|FG002|Overall Study|Lost to Follow-up|0|||
155520158|NCT01193608|561329404|FG003|Overall Study|Lost to Follow-up|0|||
155520159|NCT01193608|561329405|FG004|Overall Study|Lost to Follow-up|1|||
155654624|NCT03715829|561828908|FG007|Extension Period|Lack of Efficacy|9|||
155479520|NCT01004861|561177740|FG000|Overall Study|Surgical resection|0|||
155479521|NCT01004861|561177741|FG001|Overall Study|Surgical resection|0|||
155479522|NCT01004861|561177742|FG002|Overall Study|Surgical resection|0|||
155479523|NCT01004861|561177743|FG003|Overall Study|Surgical resection|0|||
155479524|NCT01004861|561177744|FG004|Overall Study|Surgical resection|0|||
155479525|NCT01004861|561177745|FG005|Overall Study|Surgical resection|0|||
155479526|NCT01004861|561177746|FG006|Overall Study|Surgical resection|0|||
155479527|NCT01004861|561177747|FG007|Overall Study|Surgical resection|0|||
155479528|NCT01004861|561177748|FG008|Overall Study|Surgical resection|1|||
155479529|NCT01004861|561177749|FG009|Overall Study|Surgical resection|0|||
155479530|NCT01004861|561177750|FG010|Overall Study|Surgical resection|0|||
155479531|NCT01004861|561177751|FG011|Overall Study|Surgical resection|0|||
155479532|NCT01004861|561177752|FG012|Overall Study|Surgical resection|0|||
155479533|NCT01004861|561177740|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479534|NCT01004861|561177741|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479535|NCT01004861|561177742|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479536|NCT01004861|561177743|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479537|NCT01004861|561177744|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479538|NCT01004861|561177745|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479539|NCT01004861|561177746|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479540|NCT01004861|561177747|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479541|NCT01004861|561177748|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
155479542|NCT01004861|561177749|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479543|NCT01004861|561177750|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479544|NCT01004861|561177751|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479545|NCT01004861|561177752|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
155479546|NCT01004861|561177740|FG000|Overall Study|Study termination by Sponsor|0|||
155479547|NCT01004861|561177741|FG001|Overall Study|Study termination by Sponsor|0|||
155479548|NCT01004861|561177742|FG002|Overall Study|Study termination by Sponsor|0|||
155479549|NCT01004861|561177743|FG003|Overall Study|Study termination by Sponsor|0|||
155479550|NCT01004861|561177744|FG004|Overall Study|Study termination by Sponsor|0|||
155479551|NCT01004861|561177745|FG005|Overall Study|Study termination by Sponsor|0|||
155479552|NCT01004861|561177746|FG006|Overall Study|Study termination by Sponsor|0|||
155479553|NCT01004861|561177747|FG007|Overall Study|Study termination by Sponsor|0|||
155479554|NCT01004861|561177748|FG008|Overall Study|Study termination by Sponsor|1|||
155479555|NCT01004861|561177749|FG009|Overall Study|Study termination by Sponsor|0|||
155479556|NCT01004861|561177750|FG010|Overall Study|Study termination by Sponsor|0|||
155479557|NCT01004861|561177751|FG011|Overall Study|Study termination by Sponsor|0|||
155479558|NCT01004861|561177752|FG012|Overall Study|Study termination by Sponsor|0|||
155520160|NCT01193608|561329406|FG005|Overall Study|Lost to Follow-up|2|||
155520161|NCT01193608|561329401|FG000|Overall Study|Adverse Event|0|||
155520162|NCT01193608|561329402|FG001|Overall Study|Adverse Event|0|||
155520163|NCT01193608|561329403|FG002|Overall Study|Adverse Event|0|||
155520164|NCT01193608|561329404|FG003|Overall Study|Adverse Event|0|||
155520165|NCT01193608|561329405|FG004|Overall Study|Adverse Event|1|||
155520166|NCT01193608|561329406|FG005|Overall Study|Adverse Event|0|||
155520167|NCT00864097|561329411|FG000|Overall Study|Death|0|||
155520168|NCT00864097|561329412|FG001|Overall Study|Death|1|||
155479559|NCT04610827|561177754|FG000|Overall Study|Withdrawal by Subject|1|||
155479560|NCT04610827|561177755|FG001|Overall Study|Withdrawal by Subject|1|||
155479561|NCT04610827|561177756|FG002|Overall Study|Withdrawal by Subject|0|||
155479562|NCT01693562|561177757|FG000|Escalation Phase|Withdrawal by Subject|0|||
155479563|NCT01693562|561177758|FG001|Escalation Phase|Withdrawal by Subject|1|||
155479564|NCT01693562|561177759|FG002|Escalation Phase|Withdrawal by Subject|0|||
155520169|NCT00864097|561329413|FG002|Overall Study|Death|0|||
155520170|NCT00864097|561329414|FG003|Overall Study|Death|0|||
155520171|NCT00864097|561329411|FG000|Overall Study|Adverse Event|6|||
155520172|NCT00864097|561329412|FG001|Overall Study|Adverse Event|8|||
155520173|NCT00864097|561329413|FG002|Overall Study|Adverse Event|11|||
155479565|NCT01693562|561177760|FG003|Escalation Phase|Withdrawal by Subject|0|||
155479566|NCT01693562|561177761|FG004|Escalation Phase|Withdrawal by Subject|0|||
155479567|NCT01693562|561177762|FG005|Escalation Phase|Withdrawal by Subject|2|||
155479568|NCT01693562|561177763|FG006|Escalation Phase|Withdrawal by Subject|0|||
155479569|NCT01693562|561177764|FG007|Escalation Phase|Withdrawal by Subject|0|||
155479570|NCT01693562|561177765|FG008|Escalation Phase|Withdrawal by Subject|0|||
155479571|NCT01693562|561177766|FG009|Escalation Phase|Withdrawal by Subject|0|||
155479572|NCT01693562|561177767|FG010|Escalation Phase|Withdrawal by Subject|0|||
155479573|NCT01693562|561177768|FG011|Escalation Phase|Withdrawal by Subject|0|||
155479574|NCT01693562|561177769|FG012|Escalation Phase|Withdrawal by Subject|0|||
155479575|NCT01693562|561177770|FG013|Escalation Phase|Withdrawal by Subject|0|||
155479576|NCT01693562|561177771|FG014|Escalation Phase|Withdrawal by Subject|0|||
155479577|NCT01693562|561177772|FG015|Escalation Phase|Withdrawal by Subject|0|||
155479578|NCT01693562|561177773|FG016|Escalation Phase|Withdrawal by Subject|0|||
155479579|NCT01693562|561177774|FG017|Escalation Phase|Withdrawal by Subject|0|||
155479580|NCT01693562|561177775|FG018|Escalation Phase|Withdrawal by Subject|0|||
155479581|NCT01693562|561177776|FG019|Escalation Phase|Withdrawal by Subject|0|||
155479582|NCT01693562|561177777|FG020|Escalation Phase|Withdrawal by Subject|0|||
155479583|NCT01693562|561177778|FG021|Escalation Phase|Withdrawal by Subject|0|||
155479584|NCT01693562|561177779|FG022|Escalation Phase|Withdrawal by Subject|0|||
155479585|NCT01693562|561177757|FG000|Escalation Phase|Death|4|||
155479586|NCT01693562|561177758|FG001|Escalation Phase|Death|2|||
155479587|NCT01693562|561177759|FG002|Escalation Phase|Death|0|||
155479588|NCT01693562|561177760|FG003|Escalation Phase|Death|3|||
155479589|NCT01693562|561177761|FG004|Escalation Phase|Death|6|||
155479590|NCT01693562|561177762|FG005|Escalation Phase|Death|4|||
155479591|NCT01693562|561177763|FG006|Escalation Phase|Death|0|||
155479592|NCT01693562|561177764|FG007|Escalation Phase|Death|0|||
155479593|NCT01693562|561177765|FG008|Escalation Phase|Death|0|||
155479594|NCT01693562|561177766|FG009|Escalation Phase|Death|0|||
155479595|NCT01693562|561177767|FG010|Escalation Phase|Death|0|||
155479596|NCT01693562|561177768|FG011|Escalation Phase|Death|0|||
155479597|NCT01693562|561177769|FG012|Escalation Phase|Death|0|||
155479598|NCT01693562|561177770|FG013|Escalation Phase|Death|0|||
155479599|NCT01693562|561177771|FG014|Escalation Phase|Death|0|||
155479600|NCT01693562|561177772|FG015|Escalation Phase|Death|0|||
155479601|NCT01693562|561177773|FG016|Escalation Phase|Death|0|||
155479602|NCT01693562|561177774|FG017|Escalation Phase|Death|0|||
155479603|NCT01693562|561177775|FG018|Escalation Phase|Death|0|||
155479604|NCT01693562|561177776|FG019|Escalation Phase|Death|0|||
155479605|NCT01693562|561177777|FG020|Escalation Phase|Death|0|||
155479606|NCT01693562|561177778|FG021|Escalation Phase|Death|0|||
155479607|NCT01693562|561177779|FG022|Escalation Phase|Death|0|||
155479608|NCT01693562|561177757|FG000|Escalation Phase|Lost to Follow-up|0|||
155479609|NCT01693562|561177758|FG001|Escalation Phase|Lost to Follow-up|1|||
155479610|NCT01693562|561177759|FG002|Escalation Phase|Lost to Follow-up|1|||
155479611|NCT01693562|561177760|FG003|Escalation Phase|Lost to Follow-up|0|||
155479612|NCT01693562|561177761|FG004|Escalation Phase|Lost to Follow-up|0|||
155479613|NCT01693562|561177762|FG005|Escalation Phase|Lost to Follow-up|0|||
155479614|NCT01693562|561177763|FG006|Escalation Phase|Lost to Follow-up|0|||
155479615|NCT01693562|561177764|FG007|Escalation Phase|Lost to Follow-up|0|||
155479616|NCT01693562|561177765|FG008|Escalation Phase|Lost to Follow-up|0|||
155479617|NCT01693562|561177766|FG009|Escalation Phase|Lost to Follow-up|0|||
155479618|NCT01693562|561177767|FG010|Escalation Phase|Lost to Follow-up|0|||
155479619|NCT01693562|561177768|FG011|Escalation Phase|Lost to Follow-up|0|||
155479620|NCT01693562|561177769|FG012|Escalation Phase|Lost to Follow-up|0|||
155479621|NCT01693562|561177770|FG013|Escalation Phase|Lost to Follow-up|0|||
155479622|NCT01693562|561177771|FG014|Escalation Phase|Lost to Follow-up|0|||
155479623|NCT01693562|561177772|FG015|Escalation Phase|Lost to Follow-up|0|||
155479624|NCT01693562|561177773|FG016|Escalation Phase|Lost to Follow-up|0|||
155479625|NCT01693562|561177774|FG017|Escalation Phase|Lost to Follow-up|0|||
155479626|NCT01693562|561177775|FG018|Escalation Phase|Lost to Follow-up|0|||
155479627|NCT01693562|561177776|FG019|Escalation Phase|Lost to Follow-up|0|||
155479628|NCT01693562|561177777|FG020|Escalation Phase|Lost to Follow-up|0|||
155479629|NCT01693562|561177778|FG021|Escalation Phase|Lost to Follow-up|0|||
155479630|NCT01693562|561177779|FG022|Escalation Phase|Lost to Follow-up|0|||
155479631|NCT01693562|561177757|FG000|Escalation Phase|Other|0|||
155479632|NCT01693562|561177758|FG001|Escalation Phase|Other|0|||
155479633|NCT01693562|561177759|FG002|Escalation Phase|Other|2|||
155479634|NCT01693562|561177760|FG003|Escalation Phase|Other|0|||
155479635|NCT01693562|561177761|FG004|Escalation Phase|Other|0|||
155479636|NCT01693562|561177762|FG005|Escalation Phase|Other|1|||
155479637|NCT01693562|561177763|FG006|Escalation Phase|Other|0|||
155479638|NCT01693562|561177764|FG007|Escalation Phase|Other|0|||
155479639|NCT01693562|561177765|FG008|Escalation Phase|Other|0|||
155479640|NCT01693562|561177766|FG009|Escalation Phase|Other|0|||
155479641|NCT01693562|561177767|FG010|Escalation Phase|Other|0|||
155479642|NCT01693562|561177768|FG011|Escalation Phase|Other|0|||
155479643|NCT01693562|561177769|FG012|Escalation Phase|Other|0|||
155479644|NCT01693562|561177770|FG013|Escalation Phase|Other|0|||
155479645|NCT01693562|561177771|FG014|Escalation Phase|Other|0|||
155479646|NCT01693562|561177772|FG015|Escalation Phase|Other|0|||
155479647|NCT01693562|561177773|FG016|Escalation Phase|Other|0|||
155479648|NCT01693562|561177774|FG017|Escalation Phase|Other|0|||
155479649|NCT01693562|561177775|FG018|Escalation Phase|Other|0|||
155479650|NCT01693562|561177776|FG019|Escalation Phase|Other|0|||
155479651|NCT01693562|561177777|FG020|Escalation Phase|Other|0|||
155479652|NCT01693562|561177778|FG021|Escalation Phase|Other|0|||
155479653|NCT01693562|561177779|FG022|Escalation Phase|Other|0|||
155479654|NCT01693562|561177757|FG000|Exploration Phase|Withdrawal by Subject|0|||
155479655|NCT01693562|561177758|FG001|Exploration Phase|Withdrawal by Subject|0|||
155479656|NCT01693562|561177759|FG002|Exploration Phase|Withdrawal by Subject|0|||
155479657|NCT01693562|561177760|FG003|Exploration Phase|Withdrawal by Subject|0|||
155479658|NCT01693562|561177761|FG004|Exploration Phase|Withdrawal by Subject|0|||
155479659|NCT01693562|561177762|FG005|Exploration Phase|Withdrawal by Subject|0|||
155479660|NCT01693562|561177763|FG006|Exploration Phase|Withdrawal by Subject|2|||
155479661|NCT01693562|561177764|FG007|Exploration Phase|Withdrawal by Subject|0|||
155479662|NCT01693562|561177765|FG008|Exploration Phase|Withdrawal by Subject|0|||
155479663|NCT01693562|561177766|FG009|Exploration Phase|Withdrawal by Subject|0|||
155479664|NCT01693562|561177767|FG010|Exploration Phase|Withdrawal by Subject|0|||
155479665|NCT01693562|561177768|FG011|Exploration Phase|Withdrawal by Subject|0|||
155479666|NCT01693562|561177769|FG012|Exploration Phase|Withdrawal by Subject|0|||
155479667|NCT01693562|561177770|FG013|Exploration Phase|Withdrawal by Subject|0|||
155479668|NCT01693562|561177771|FG014|Exploration Phase|Withdrawal by Subject|0|||
155479669|NCT01693562|561177772|FG015|Exploration Phase|Withdrawal by Subject|0|||
155479670|NCT01693562|561177773|FG016|Exploration Phase|Withdrawal by Subject|0|||
155479671|NCT01693562|561177774|FG017|Exploration Phase|Withdrawal by Subject|0|||
155479672|NCT01693562|561177775|FG018|Exploration Phase|Withdrawal by Subject|0|||
155479673|NCT01693562|561177776|FG019|Exploration Phase|Withdrawal by Subject|0|||
155479674|NCT01693562|561177777|FG020|Exploration Phase|Withdrawal by Subject|0|||
155479675|NCT01693562|561177778|FG021|Exploration Phase|Withdrawal by Subject|0|||
155479676|NCT01693562|561177779|FG022|Exploration Phase|Withdrawal by Subject|0|||
155479677|NCT01693562|561177757|FG000|Exploration Phase|Death|0|||
155479678|NCT01693562|561177758|FG001|Exploration Phase|Death|0|||
155479679|NCT01693562|561177759|FG002|Exploration Phase|Death|0|||
155479680|NCT01693562|561177760|FG003|Exploration Phase|Death|0|||
155479681|NCT01693562|561177761|FG004|Exploration Phase|Death|0|||
155479682|NCT01693562|561177762|FG005|Exploration Phase|Death|0|||
155479683|NCT01693562|561177763|FG006|Exploration Phase|Death|17|||
155479684|NCT01693562|561177764|FG007|Exploration Phase|Death|0|||
155479685|NCT01693562|561177765|FG008|Exploration Phase|Death|0|||
155479686|NCT01693562|561177766|FG009|Exploration Phase|Death|0|||
155479687|NCT01693562|561177767|FG010|Exploration Phase|Death|0|||
155479688|NCT01693562|561177768|FG011|Exploration Phase|Death|0|||
155479689|NCT01693562|561177769|FG012|Exploration Phase|Death|0|||
155479690|NCT01693562|561177770|FG013|Exploration Phase|Death|0|||
155479691|NCT01693562|561177771|FG014|Exploration Phase|Death|0|||
155479692|NCT01693562|561177772|FG015|Exploration Phase|Death|0|||
155479693|NCT01693562|561177773|FG016|Exploration Phase|Death|0|||
155479694|NCT01693562|561177774|FG017|Exploration Phase|Death|0|||
155479695|NCT01693562|561177775|FG018|Exploration Phase|Death|0|||
155479696|NCT01693562|561177776|FG019|Exploration Phase|Death|0|||
155479697|NCT01693562|561177777|FG020|Exploration Phase|Death|0|||
155479698|NCT01693562|561177778|FG021|Exploration Phase|Death|0|||
155479699|NCT01693562|561177779|FG022|Exploration Phase|Death|0|||
155479700|NCT01693562|561177757|FG000|Exploration Phase|Other|0|||
155479701|NCT01693562|561177758|FG001|Exploration Phase|Other|0|||
155479702|NCT01693562|561177759|FG002|Exploration Phase|Other|0|||
155479703|NCT01693562|561177760|FG003|Exploration Phase|Other|0|||
155479704|NCT01693562|561177761|FG004|Exploration Phase|Other|0|||
155479705|NCT01693562|561177762|FG005|Exploration Phase|Other|0|||
155479706|NCT01693562|561177763|FG006|Exploration Phase|Other|2|||
155479707|NCT01693562|561177764|FG007|Exploration Phase|Other|0|||
155654625|NCT03715829|561828909|FG008|Extension Period|Lack of Efficacy|2|||
155479708|NCT01693562|561177765|FG008|Exploration Phase|Other|0|||
155479709|NCT01693562|561177766|FG009|Exploration Phase|Other|0|||
155479710|NCT01693562|561177767|FG010|Exploration Phase|Other|0|||
155479711|NCT01693562|561177768|FG011|Exploration Phase|Other|0|||
155479712|NCT01693562|561177769|FG012|Exploration Phase|Other|0|||
155479713|NCT01693562|561177770|FG013|Exploration Phase|Other|0|||
155479714|NCT01693562|561177771|FG014|Exploration Phase|Other|0|||
155479715|NCT01693562|561177772|FG015|Exploration Phase|Other|0|||
155479716|NCT01693562|561177773|FG016|Exploration Phase|Other|0|||
155479717|NCT01693562|561177774|FG017|Exploration Phase|Other|0|||
155479718|NCT01693562|561177775|FG018|Exploration Phase|Other|0|||
155479719|NCT01693562|561177776|FG019|Exploration Phase|Other|0|||
155479720|NCT01693562|561177777|FG020|Exploration Phase|Other|0|||
155479721|NCT01693562|561177778|FG021|Exploration Phase|Other|0|||
155479722|NCT01693562|561177779|FG022|Exploration Phase|Other|0|||
155479723|NCT01693562|561177757|FG000|Expansion Phase|Withdrawal by Subject|0|||
155654626|NCT03715829|561828910|FG009|Extension Period|Lack of Efficacy|0|||
155654627|NCT03715829|561828911|FG010|Extension Period|Lack of Efficacy|0|||
155479724|NCT01693562|561177758|FG001|Expansion Phase|Withdrawal by Subject|0|||
155520174|NCT00864097|561329414|FG003|Overall Study|Adverse Event|9|||
155479725|NCT01693562|561177759|FG002|Expansion Phase|Withdrawal by Subject|0|||
155479726|NCT01693562|561177760|FG003|Expansion Phase|Withdrawal by Subject|0|||
155479727|NCT01693562|561177761|FG004|Expansion Phase|Withdrawal by Subject|0|||
155479728|NCT01693562|561177762|FG005|Expansion Phase|Withdrawal by Subject|0|||
155479729|NCT01693562|561177763|FG006|Expansion Phase|Withdrawal by Subject|0|||
155479730|NCT01693562|561177764|FG007|Expansion Phase|Withdrawal by Subject|16|||
155479731|NCT01693562|561177765|FG008|Expansion Phase|Withdrawal by Subject|2|||
155479732|NCT01693562|561177766|FG009|Expansion Phase|Withdrawal by Subject|54|||
155479733|NCT01693562|561177767|FG010|Expansion Phase|Withdrawal by Subject|2|||
155479734|NCT01693562|561177768|FG011|Expansion Phase|Withdrawal by Subject|2|||
155479735|NCT01693562|561177769|FG012|Expansion Phase|Withdrawal by Subject|3|||
155479736|NCT01693562|561177770|FG013|Expansion Phase|Withdrawal by Subject|5|||
155479737|NCT01693562|561177771|FG014|Expansion Phase|Withdrawal by Subject|16|||
155479738|NCT01693562|561177772|FG015|Expansion Phase|Withdrawal by Subject|7|||
155479739|NCT01693562|561177773|FG016|Expansion Phase|Withdrawal by Subject|40|||
155479740|NCT01693562|561177774|FG017|Expansion Phase|Withdrawal by Subject|4|||
155479741|NCT01693562|561177775|FG018|Expansion Phase|Withdrawal by Subject|8|||
155479742|NCT01693562|561177776|FG019|Expansion Phase|Withdrawal by Subject|3|||
155479743|NCT01693562|561177777|FG020|Expansion Phase|Withdrawal by Subject|1|||
155479744|NCT01693562|561177778|FG021|Expansion Phase|Withdrawal by Subject|8|||
155479745|NCT01693562|561177779|FG022|Expansion Phase|Withdrawal by Subject|1|||
155479746|NCT01693562|561177757|FG000|Expansion Phase|Death|0|||
155479747|NCT01693562|561177758|FG001|Expansion Phase|Death|0|||
155479748|NCT01693562|561177759|FG002|Expansion Phase|Death|0|||
155479749|NCT01693562|561177760|FG003|Expansion Phase|Death|0|||
155479750|NCT01693562|561177761|FG004|Expansion Phase|Death|0|||
155479751|NCT01693562|561177762|FG005|Expansion Phase|Death|0|||
155479752|NCT01693562|561177763|FG006|Expansion Phase|Death|0|||
155479753|NCT01693562|561177764|FG007|Expansion Phase|Death|42|||
155479754|NCT01693562|561177765|FG008|Expansion Phase|Death|17|||
155479755|NCT01693562|561177766|FG009|Expansion Phase|Death|208|||
155479756|NCT01693562|561177767|FG010|Expansion Phase|Death|30|||
155479757|NCT01693562|561177768|FG011|Expansion Phase|Death|8|||
155479758|NCT01693562|561177769|FG012|Expansion Phase|Death|19|||
155479759|NCT01693562|561177770|FG013|Expansion Phase|Death|42|||
155479760|NCT01693562|561177771|FG014|Expansion Phase|Death|23|||
155479761|NCT01693562|561177772|FG015|Expansion Phase|Death|23|||
155479762|NCT01693562|561177773|FG016|Expansion Phase|Death|128|||
155479763|NCT01693562|561177774|FG017|Expansion Phase|Death|16|||
155479764|NCT01693562|561177775|FG018|Expansion Phase|Death|36|||
155479765|NCT01693562|561177776|FG019|Expansion Phase|Death|16|||
155479766|NCT01693562|561177777|FG020|Expansion Phase|Death|17|||
155479767|NCT01693562|561177778|FG021|Expansion Phase|Death|35|||
155479768|NCT01693562|561177779|FG022|Expansion Phase|Death|7|||
155479769|NCT01693562|561177757|FG000|Expansion Phase|Lost to Follow-up|0|||
155479770|NCT01693562|561177758|FG001|Expansion Phase|Lost to Follow-up|0|||
155654628|NCT03715829|561828901|FG000|Extension Period|Lost to Follow-up|0|||
155654629|NCT03715829|561828902|FG001|Extension Period|Lost to Follow-up|0|||
155479771|NCT01693562|561177759|FG002|Expansion Phase|Lost to Follow-up|0|||
155479772|NCT01693562|561177760|FG003|Expansion Phase|Lost to Follow-up|0|||
155479773|NCT01693562|561177761|FG004|Expansion Phase|Lost to Follow-up|0|||
155479774|NCT01693562|561177762|FG005|Expansion Phase|Lost to Follow-up|0|||
155479775|NCT01693562|561177763|FG006|Expansion Phase|Lost to Follow-up|0|||
155479776|NCT01693562|561177764|FG007|Expansion Phase|Lost to Follow-up|1|||
155479777|NCT01693562|561177765|FG008|Expansion Phase|Lost to Follow-up|2|||
155479778|NCT01693562|561177766|FG009|Expansion Phase|Lost to Follow-up|10|||
155479779|NCT01693562|561177767|FG010|Expansion Phase|Lost to Follow-up|4|||
155479780|NCT01693562|561177768|FG011|Expansion Phase|Lost to Follow-up|4|||
155479781|NCT01693562|561177769|FG012|Expansion Phase|Lost to Follow-up|1|||
155479782|NCT01693562|561177770|FG013|Expansion Phase|Lost to Follow-up|3|||
155479783|NCT01693562|561177771|FG014|Expansion Phase|Lost to Follow-up|0|||
155479784|NCT01693562|561177772|FG015|Expansion Phase|Lost to Follow-up|1|||
155479785|NCT01693562|561177773|FG016|Expansion Phase|Lost to Follow-up|1|||
155479786|NCT01693562|561177774|FG017|Expansion Phase|Lost to Follow-up|0|||
155479787|NCT01693562|561177775|FG018|Expansion Phase|Lost to Follow-up|2|||
155479788|NCT01693562|561177776|FG019|Expansion Phase|Lost to Follow-up|1|||
155479789|NCT01693562|561177777|FG020|Expansion Phase|Lost to Follow-up|2|||
155479790|NCT01693562|561177778|FG021|Expansion Phase|Lost to Follow-up|2|||
155479791|NCT01693562|561177779|FG022|Expansion Phase|Lost to Follow-up|1|||
155479792|NCT01693562|561177757|FG000|Expansion Phase|Other|0|||
155479793|NCT01693562|561177758|FG001|Expansion Phase|Other|0|||
155479794|NCT01693562|561177759|FG002|Expansion Phase|Other|0|||
155479795|NCT01693562|561177760|FG003|Expansion Phase|Other|0|||
155479796|NCT01693562|561177761|FG004|Expansion Phase|Other|0|||
155479797|NCT01693562|561177762|FG005|Expansion Phase|Other|0|||
155479798|NCT01693562|561177763|FG006|Expansion Phase|Other|0|||
155479799|NCT01693562|561177764|FG007|Expansion Phase|Other|3|||
155479800|NCT01693562|561177765|FG008|Expansion Phase|Other|1|||
155479801|NCT01693562|561177766|FG009|Expansion Phase|Other|28|||
155479802|NCT01693562|561177767|FG010|Expansion Phase|Other|4|||
155479803|NCT01693562|561177768|FG011|Expansion Phase|Other|7|||
155479804|NCT01693562|561177769|FG012|Expansion Phase|Other|0|||
155479805|NCT01693562|561177770|FG013|Expansion Phase|Other|1|||
155479806|NCT01693562|561177771|FG014|Expansion Phase|Other|1|||
155479807|NCT01693562|561177772|FG015|Expansion Phase|Other|0|||
155479808|NCT01693562|561177773|FG016|Expansion Phase|Other|28|||
155479809|NCT01693562|561177774|FG017|Expansion Phase|Other|0|||
155479810|NCT01693562|561177775|FG018|Expansion Phase|Other|1|||
155479811|NCT01693562|561177776|FG019|Expansion Phase|Other|0|||
155479812|NCT01693562|561177777|FG020|Expansion Phase|Other|1|||
155479813|NCT01693562|561177778|FG021|Expansion Phase|Other|17|||
155479814|NCT01693562|561177779|FG022|Expansion Phase|Other|1|||
155479815|NCT04735432|561177780|FG000|Overall Study|Other - due to personal reason|1|||
155479816|NCT04735432|561177781|FG001|Overall Study|Other - due to personal reason|0|||
155479817|NCT04735432|561177780|FG000|Overall Study|Adverse Event|2|||
155479818|NCT04735432|561177781|FG001|Overall Study|Adverse Event|0|||
155479819|NCT04657003|561177782|FG000|Overall Study|Adverse Event|5|||
155479820|NCT04657003|561177783|FG001|Overall Study|Adverse Event|1|||
155479821|NCT04657003|561177784|FG002|Overall Study|Adverse Event|5|||
155479822|NCT04657003|561177782|FG000|Overall Study|Death|0|||
155479823|NCT04657003|561177783|FG001|Overall Study|Death|2|||
155479824|NCT04657003|561177784|FG002|Overall Study|Death|0|||
155479825|NCT04657003|561177782|FG000|Overall Study|Lost to Follow-up|8|||
155479826|NCT04657003|561177783|FG001|Overall Study|Lost to Follow-up|4|||
155479827|NCT04657003|561177784|FG002|Overall Study|Lost to Follow-up|10|||
155479828|NCT04657003|561177782|FG000|Overall Study|Other - As Reported by Investigator|3|||
155479829|NCT04657003|561177783|FG001|Overall Study|Other - As Reported by Investigator|2|||
155479830|NCT04657003|561177784|FG002|Overall Study|Other - As Reported by Investigator|2|||
155479831|NCT04657003|561177782|FG000|Overall Study|Pregnancy|2|||
155479832|NCT04657003|561177783|FG001|Overall Study|Pregnancy|0|||
155479833|NCT04657003|561177784|FG002|Overall Study|Pregnancy|2|||
155479834|NCT04657003|561177782|FG000|Overall Study|Withdrawal by Subject|16|||
155479835|NCT04657003|561177783|FG001|Overall Study|Withdrawal by Subject|7|||
155479836|NCT04657003|561177784|FG002|Overall Study|Withdrawal by Subject|10|||
155479837|NCT01823991|561177787|FG000|Overall Study|Withdrawal by Subject|8|||
155479838|NCT01823991|561177788|FG001|Overall Study|Withdrawal by Subject|5|||
155479839|NCT05158244|561177789|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
155479840|NCT05158244|561177790|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
155479841|NCT05158244|561177791|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
155479842|NCT05158244|561177792|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
155479843|NCT05158244|561177793|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
155479844|NCT05158244|561177789|FG000|Overall Study|Withdrawal by Subject|0|||
155479845|NCT05158244|561177790|FG001|Overall Study|Withdrawal by Subject|0|||
155479846|NCT05158244|561177791|FG002|Overall Study|Withdrawal by Subject|1|||
155479847|NCT05158244|561177792|FG003|Overall Study|Withdrawal by Subject|0|||
155654630|NCT03715829|561828903|FG002|Extension Period|Lost to Follow-up|0|||
155479848|NCT05158244|561177793|FG004|Overall Study|Withdrawal by Subject|0|||
155479849|NCT02408016|561177795|FG000|Overall Study|Death|6|||
155479850|NCT02408016|561177796|FG001|Overall Study|Death|1|||
155479851|NCT02408016|561177797|FG002|Overall Study|Death|0|||
155479852|NCT02408016|561177795|FG000|Overall Study|Physician Decision|0|||
155479853|NCT02408016|561177796|FG001|Overall Study|Physician Decision|2|||
155479854|NCT02408016|561177797|FG002|Overall Study|Physician Decision|0|||
155479855|NCT00805194|561177798|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
155479856|NCT00805194|561177799|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
155479857|NCT00805194|561177798|FG000|Overall Study|Worsening or AE of underlying disease|64|||
155479858|NCT00805194|561177799|FG001|Overall Study|Worsening or AE of underlying disease|70|||
155479859|NCT00805194|561177798|FG000|Overall Study|Other AE|84|||
155479860|NCT00805194|561177799|FG001|Overall Study|Other AE|73|||
155479861|NCT00805194|561177798|FG000|Overall Study|Protocol Violation|9|||
155479862|NCT00805194|561177799|FG001|Overall Study|Protocol Violation|9|||
155479863|NCT00805194|561177798|FG000|Overall Study|Lost to Follow-up|5|||
155479864|NCT00805194|561177799|FG001|Overall Study|Lost to Follow-up|5|||
155479865|NCT00805194|561177798|FG000|Overall Study|Withdrawal by Subject|60|||
155479866|NCT00805194|561177799|FG001|Overall Study|Withdrawal by Subject|42|||
155479867|NCT00805194|561177798|FG000|Overall Study|Not treated|3|||
155479868|NCT00805194|561177799|FG001|Overall Study|Not treated|4|||
155479869|NCT00805194|561177798|FG000|Overall Study|Reasons other than stated above|20|||
155479870|NCT00805194|561177799|FG001|Overall Study|Reasons other than stated above|16|||
155479871|NCT02185040|561177803|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
155479872|NCT02185040|561177804|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
155479873|NCT02185040|561177805|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
155479874|NCT02185040|561177806|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
155479875|NCT02185040|561177807|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
155479876|NCT02185040|561177808|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
155479877|NCT02185040|561177809|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
155479878|NCT02185040|561177803|FG000|Part 1 Treatment Phase|Adverse Event|1|||
155479879|NCT02185040|561177804|FG001|Part 1 Treatment Phase|Adverse Event|0|||
155479880|NCT02185040|561177805|FG002|Part 1 Treatment Phase|Adverse Event|0|||
155479881|NCT02185040|561177806|FG003|Part 1 Treatment Phase|Adverse Event|2|||
155479882|NCT02185040|561177807|FG004|Part 1 Treatment Phase|Adverse Event|3|||
155479883|NCT02185040|561177808|FG005|Part 1 Treatment Phase|Adverse Event|0|||
155479884|NCT02185040|561177809|FG006|Part 1 Treatment Phase|Adverse Event|0|||
155479885|NCT02185040|561177803|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479886|NCT02185040|561177804|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
155479887|NCT02185040|561177805|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479888|NCT02185040|561177806|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479889|NCT02185040|561177807|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479890|NCT02185040|561177808|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479891|NCT02185040|561177809|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
155479892|NCT02185040|561177803|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479893|NCT02185040|561177804|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
155479894|NCT02185040|561177805|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479895|NCT02185040|561177806|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479896|NCT02185040|561177807|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479897|NCT02185040|561177808|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479898|NCT02185040|561177809|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
155479899|NCT02185040|561177803|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
155479900|NCT02185040|561177804|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
155479901|NCT02185040|561177805|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
155479902|NCT02185040|561177806|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
155479903|NCT02185040|561177807|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
155479904|NCT02185040|561177808|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
155479905|NCT02185040|561177809|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
155479906|NCT02185040|561177803|FG000|Active Treatment Extension Phase|Adverse Event|0|||
155479907|NCT02185040|561177804|FG001|Active Treatment Extension Phase|Adverse Event|0|||
155479908|NCT02185040|561177805|FG002|Active Treatment Extension Phase|Adverse Event|0|||
155479909|NCT02185040|561177806|FG003|Active Treatment Extension Phase|Adverse Event|0|||
155479910|NCT02185040|561177807|FG004|Active Treatment Extension Phase|Adverse Event|0|||
155479911|NCT02185040|561177808|FG005|Active Treatment Extension Phase|Adverse Event|1|||
155479912|NCT02185040|561177809|FG006|Active Treatment Extension Phase|Adverse Event|4|||
155479913|NCT02185040|561177803|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
155479914|NCT02185040|561177804|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
155479915|NCT02185040|561177805|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
155479916|NCT02185040|561177806|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
155479917|NCT02185040|561177807|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
155479918|NCT02185040|561177808|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
155479919|NCT02185040|561177809|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
155479920|NCT02185040|561177803|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
155479921|NCT02185040|561177804|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
155479922|NCT02185040|561177805|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
155520175|NCT00864097|561329411|FG000|Overall Study|Lack of Efficacy|9|||
155479923|NCT02185040|561177806|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
155479924|NCT02185040|561177807|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
155479925|NCT02185040|561177808|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
155479926|NCT02185040|561177809|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
155479927|NCT03557801|561177812|FG000|Overall Study|Protocol Violation|1|||
155479928|NCT03557801|561177813|FG001|Overall Study|Protocol Violation|0|||
155479929|NCT03557801|561177814|FG002|Overall Study|Protocol Violation|0|||
155479930|NCT03557801|561177812|FG000|Overall Study|Withdrawal by Subject|1|||
155479931|NCT03557801|561177813|FG001|Overall Study|Withdrawal by Subject|0|||
155479932|NCT03557801|561177814|FG002|Overall Study|Withdrawal by Subject|3|||
155479933|NCT03557801|561177812|FG000|Overall Study|Lost to Follow-up|0|||
155479934|NCT03557801|561177813|FG001|Overall Study|Lost to Follow-up|1|||
155479935|NCT03557801|561177814|FG002|Overall Study|Lost to Follow-up|0|||
155479936|NCT00535236|561177815|FG000|Overall Study|Adverse Event|1|||
155479937|NCT00535236|561177816|FG001|Overall Study|Adverse Event|0|||
155479938|NCT00535236|561177817|FG002|Overall Study|Adverse Event|9|||
155479939|NCT00535236|561177818|FG003|Overall Study|Adverse Event|3|||
155479940|NCT00535236|561177819|FG004|Overall Study|Adverse Event|3|||
155479941|NCT00535236|561177820|FG005|Overall Study|Adverse Event|0|||
155479942|NCT00535236|561177821|FG006|Overall Study|Adverse Event|5|||
155479943|NCT00535236|561177822|FG007|Overall Study|Adverse Event|1|||
155479944|NCT00535236|561177823|FG008|Overall Study|Adverse Event|2|||
155479945|NCT00535236|561177824|FG009|Overall Study|Adverse Event|1|||
155479946|NCT00535236|561177815|FG000|Overall Study|Lost to Follow-up|1|||
155479947|NCT00535236|561177816|FG001|Overall Study|Lost to Follow-up|2|||
155479948|NCT00535236|561177817|FG002|Overall Study|Lost to Follow-up|0|||
155479949|NCT00535236|561177818|FG003|Overall Study|Lost to Follow-up|0|||
155479950|NCT00535236|561177819|FG004|Overall Study|Lost to Follow-up|2|||
155479951|NCT00535236|561177820|FG005|Overall Study|Lost to Follow-up|0|||
155479952|NCT00535236|561177821|FG006|Overall Study|Lost to Follow-up|0|||
155479953|NCT00535236|561177822|FG007|Overall Study|Lost to Follow-up|0|||
155479954|NCT00535236|561177823|FG008|Overall Study|Lost to Follow-up|6|||
155479955|NCT00535236|561177824|FG009|Overall Study|Lost to Follow-up|1|||
155479956|NCT00535236|561177815|FG000|Overall Study|Physician Decision|0|||
155479957|NCT00535236|561177816|FG001|Overall Study|Physician Decision|0|||
155479958|NCT00535236|561177817|FG002|Overall Study|Physician Decision|0|||
155479959|NCT00535236|561177818|FG003|Overall Study|Physician Decision|0|||
155479960|NCT00535236|561177819|FG004|Overall Study|Physician Decision|1|||
155479961|NCT00535236|561177820|FG005|Overall Study|Physician Decision|0|||
155479962|NCT00535236|561177821|FG006|Overall Study|Physician Decision|1|||
155479963|NCT00535236|561177822|FG007|Overall Study|Physician Decision|0|||
155479964|NCT00535236|561177823|FG008|Overall Study|Physician Decision|0|||
155479965|NCT00535236|561177824|FG009|Overall Study|Physician Decision|0|||
155479966|NCT00535236|561177815|FG000|Overall Study|Protocol Violation|2|||
155479967|NCT00535236|561177816|FG001|Overall Study|Protocol Violation|0|||
155479968|NCT00535236|561177817|FG002|Overall Study|Protocol Violation|1|||
155479969|NCT00535236|561177818|FG003|Overall Study|Protocol Violation|0|||
155479970|NCT00535236|561177819|FG004|Overall Study|Protocol Violation|0|||
155479971|NCT00535236|561177820|FG005|Overall Study|Protocol Violation|0|||
155479972|NCT00535236|561177821|FG006|Overall Study|Protocol Violation|0|||
155479973|NCT00535236|561177822|FG007|Overall Study|Protocol Violation|0|||
155479974|NCT00535236|561177823|FG008|Overall Study|Protocol Violation|1|||
155479975|NCT00535236|561177824|FG009|Overall Study|Protocol Violation|0|||
155479976|NCT00535236|561177815|FG000|Overall Study|Withdrawal by Subject|3|||
155479977|NCT00535236|561177816|FG001|Overall Study|Withdrawal by Subject|0|||
155479978|NCT00535236|561177817|FG002|Overall Study|Withdrawal by Subject|2|||
155479979|NCT00535236|561177818|FG003|Overall Study|Withdrawal by Subject|1|||
155479980|NCT00535236|561177819|FG004|Overall Study|Withdrawal by Subject|6|||
155479981|NCT00535236|561177820|FG005|Overall Study|Withdrawal by Subject|1|||
155479982|NCT00535236|561177821|FG006|Overall Study|Withdrawal by Subject|5|||
155479983|NCT00535236|561177822|FG007|Overall Study|Withdrawal by Subject|0|||
155479984|NCT00535236|561177823|FG008|Overall Study|Withdrawal by Subject|4|||
155479985|NCT00535236|561177824|FG009|Overall Study|Withdrawal by Subject|2|||
155479986|NCT00141297|561177826|FG000|Overall Study|Adverse Event|0|||
155479987|NCT00141297|561177827|FG001|Overall Study|Adverse Event|0|||
155479988|NCT00141297|561177828|FG002|Overall Study|Adverse Event|1|||
155479989|NCT00141297|561177829|FG003|Overall Study|Adverse Event|0|||
155479990|NCT00141297|561177830|FG004|Overall Study|Adverse Event|1|||
155479991|NCT00141297|561177831|FG005|Overall Study|Adverse Event|1|||
155479992|NCT00141297|561177832|FG006|Overall Study|Adverse Event|0|||
155479993|NCT00141297|561177833|FG007|Overall Study|Adverse Event|1|||
155479994|NCT00141297|561177834|FG008|Overall Study|Adverse Event|1|||
155479995|NCT00141297|561177835|FG009|Overall Study|Adverse Event|0|||
155479996|NCT00141297|561177826|FG000|Overall Study|Death|1|||
155479997|NCT00141297|561177827|FG001|Overall Study|Death|0|||
155479998|NCT00141297|561177828|FG002|Overall Study|Death|0|||
155479999|NCT00141297|561177829|FG003|Overall Study|Death|0|||
155480000|NCT00141297|561177830|FG004|Overall Study|Death|0|||
155480001|NCT00141297|561177831|FG005|Overall Study|Death|0|||
155480002|NCT00141297|561177832|FG006|Overall Study|Death|0|||
155480003|NCT00141297|561177833|FG007|Overall Study|Death|0|||
155480004|NCT00141297|561177834|FG008|Overall Study|Death|1|||
155480005|NCT00141297|561177835|FG009|Overall Study|Death|0|||
155480006|NCT00141297|561177826|FG000|Overall Study|Withdrawal by Subject|0|||
155480007|NCT00141297|561177827|FG001|Overall Study|Withdrawal by Subject|0|||
155480008|NCT00141297|561177828|FG002|Overall Study|Withdrawal by Subject|0|||
155480009|NCT00141297|561177829|FG003|Overall Study|Withdrawal by Subject|0|||
155480010|NCT00141297|561177830|FG004|Overall Study|Withdrawal by Subject|0|||
155480011|NCT00141297|561177831|FG005|Overall Study|Withdrawal by Subject|0|||
155480012|NCT00141297|561177832|FG006|Overall Study|Withdrawal by Subject|0|||
155480013|NCT00141297|561177833|FG007|Overall Study|Withdrawal by Subject|0|||
155480014|NCT00141297|561177834|FG008|Overall Study|Withdrawal by Subject|1|||
155480015|NCT00141297|561177835|FG009|Overall Study|Withdrawal by Subject|0|||
155480016|NCT00141297|561177826|FG000|Overall Study|Other|0|||
155480017|NCT00141297|561177827|FG001|Overall Study|Other|0|||
155480018|NCT00141297|561177828|FG002|Overall Study|Other|0|||
155480019|NCT00141297|561177829|FG003|Overall Study|Other|1|||
155480020|NCT00141297|561177830|FG004|Overall Study|Other|5|||
155480021|NCT00141297|561177831|FG005|Overall Study|Other|0|||
155480022|NCT00141297|561177832|FG006|Overall Study|Other|0|||
155480023|NCT00141297|561177833|FG007|Overall Study|Other|0|||
155480024|NCT00141297|561177834|FG008|Overall Study|Other|2|||
155480025|NCT00141297|561177835|FG009|Overall Study|Other|0|||
155480026|NCT00141297|561177826|FG000|Overall Study|Progressive Disease|2|||
155480027|NCT00141297|561177827|FG001|Overall Study|Progressive Disease|3|||
155480028|NCT00141297|561177828|FG002|Overall Study|Progressive Disease|6|||
155480029|NCT00141297|561177829|FG003|Overall Study|Progressive Disease|2|||
155480030|NCT00141297|561177830|FG004|Overall Study|Progressive Disease|15|||
155480031|NCT00141297|561177831|FG005|Overall Study|Progressive Disease|2|||
155480032|NCT00141297|561177832|FG006|Overall Study|Progressive Disease|3|||
155480033|NCT00141297|561177833|FG007|Overall Study|Progressive Disease|3|||
155480034|NCT00141297|561177834|FG008|Overall Study|Progressive Disease|15|||
155480035|NCT00141297|561177835|FG009|Overall Study|Progressive Disease|6|||
155480036|NCT00141297|561177826|FG000|Overall Study|Transitioned|0|||
155480037|NCT00141297|561177827|FG001|Overall Study|Transitioned|0|||
155480038|NCT00141297|561177828|FG002|Overall Study|Transitioned|0|||
155480039|NCT00141297|561177829|FG003|Overall Study|Transitioned|0|||
155480040|NCT00141297|561177830|FG004|Overall Study|Transitioned|1|||
155480041|NCT00141297|561177831|FG005|Overall Study|Transitioned|0|||
155480042|NCT00141297|561177832|FG006|Overall Study|Transitioned|0|||
155480043|NCT00141297|561177833|FG007|Overall Study|Transitioned|0|||
155480044|NCT00141297|561177834|FG008|Overall Study|Transitioned|0|||
155480045|NCT00141297|561177835|FG009|Overall Study|Transitioned|0|||
155480046|NCT02987205|561177837|FG000|Overall Study|Adverse Event|1|||
155480047|NCT02987205|561177837|FG000|Overall Study|Withdrawal by Subject|3|||
155480048|NCT03558503|561177838|FG000|Overall Study|Adverse Event|1|||
155480049|NCT03558503|561177838|FG000|Overall Study|Death|1|||
155480050|NCT03558503|561177838|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
155480051|NCT04566445|561177843|FG000|Overall Study|Death|4|||
155480052|NCT04566445|561177844|FG001|Overall Study|Death|1|||
155480053|NCT04566445|561177845|FG002|Overall Study|Death|1|||
155480054|NCT04566445|561177843|FG000|Overall Study|Lost to Follow-up|3|||
155480055|NCT04566445|561177844|FG001|Overall Study|Lost to Follow-up|1|||
155480056|NCT04566445|561177845|FG002|Overall Study|Lost to Follow-up|1|||
155480057|NCT04566445|561177843|FG000|Overall Study|Study terminated by sponsor|11|||
155480058|NCT04566445|561177844|FG001|Overall Study|Study terminated by sponsor|17|||
155480059|NCT04566445|561177845|FG002|Overall Study|Study terminated by sponsor|32|||
155480060|NCT04566445|561177843|FG000|Overall Study|Withdrawal by Subject|12|||
155480061|NCT04566445|561177844|FG001|Overall Study|Withdrawal by Subject|14|||
155480062|NCT04566445|561177845|FG002|Overall Study|Withdrawal by Subject|13|||
155480063|NCT04566445|561177843|FG000|Overall Study|Randomized but not treated due to AE|2|||
155480064|NCT04566445|561177844|FG001|Overall Study|Randomized but not treated due to AE|1|||
155480065|NCT04566445|561177845|FG002|Overall Study|Randomized but not treated due to AE|0|||
155480066|NCT04566445|561177843|FG000|Overall Study|Adverse Event|1|||
155480067|NCT04566445|561177844|FG001|Overall Study|Adverse Event|1|||
155480068|NCT04566445|561177845|FG002|Overall Study|Adverse Event|0|||
155480069|NCT02061540|561177846|FG000|Overall Study|Adverse Event|2|||
155480070|NCT02061540|561177846|FG000|Overall Study|Withdrawal by Subject|2|||
155520176|NCT00864097|561329412|FG001|Overall Study|Lack of Efficacy|3|||
155520177|NCT00864097|561329413|FG002|Overall Study|Lack of Efficacy|7|||
155480071|NCT04005755|561177849|FG000|Overall Study|Adverse Event|6|||
155480072|NCT04005755|561177849|FG000|Overall Study|Physician Decision|3|||
155480073|NCT04005755|561177849|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
155480074|NCT04005755|561177849|FG000|Overall Study|Withdrawal by Subject|3|||
155480075|NCT04005755|561177849|FG000|Overall Study|Lost to Follow-up|1|||
155480076|NCT02561273|561177856|FG000|Overall Study|Protocol Violation|1|||
155480077|NCT02561273|561177857|FG001|Overall Study|Protocol Violation|0|||
155480078|NCT02723019|561177858|FG000|Overall Study|Death|17|||
155480079|NCT02723019|561177859|FG001|Overall Study|Death|13|||
155480080|NCT02723019|561177858|FG000|Overall Study|Withdrawal by Subject|11|||
155480081|NCT02723019|561177859|FG001|Overall Study|Withdrawal by Subject|7|||
155480082|NCT02723019|561177858|FG000|Overall Study|Lost to Follow-up|57|||
155480083|NCT02723019|561177859|FG001|Overall Study|Lost to Follow-up|70|||
155480084|NCT00958191|561177861|FG000|Overall Study|Death|4|||
155480085|NCT00958191|561177861|FG000|Overall Study|Lost to Follow-up|5|||
155480086|NCT00958191|561177861|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
155480087|NCT00958191|561177861|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
155480088|NCT00958191|561177861|FG000|Overall Study|Revision of study device|4|||
155480089|NCT00958191|561177861|FG000|Overall Study|Site termination|11|||
155480090|NCT00958191|561177861|FG000|Overall Study|No 5 yr x-rays|56|||
155480091|NCT00611767|561177862|FG000|Overall Study|Withdrawal by Subject|4|||
155480092|NCT00611767|561177863|FG001|Overall Study|Withdrawal by Subject|1|||
155480093|NCT00611767|561177862|FG000|Overall Study|Thiopental not available|3|||
155480094|NCT00611767|561177863|FG001|Overall Study|Thiopental not available|0|||
155480095|NCT00611767|561177862|FG000|Overall Study|didn't like the medication|1|||
155480096|NCT00611767|561177863|FG001|Overall Study|didn't like the medication|1|||
155480097|NCT00611767|561177862|FG000|Overall Study|Physician Decision|1|||
155480098|NCT00611767|561177863|FG001|Overall Study|Physician Decision|0|||
155480099|NCT01642004|561177864|FG000|Randomization|Adverse Event unrelated to study drug|1|||
155480100|NCT01642004|561177865|FG001|Randomization|Adverse Event unrelated to study drug|0|||
155480101|NCT01642004|561177864|FG000|Randomization|Participant withdrew consent|1|||
155480102|NCT01642004|561177865|FG001|Randomization|Participant withdrew consent|6|||
155480103|NCT01642004|561177864|FG000|Randomization|No longer meets study criteria|2|||
155480104|NCT01642004|561177865|FG001|Randomization|No longer meets study criteria|2|||
155480105|NCT01642004|561177864|FG000|Treatment|Disease progression|95|||
155480106|NCT01642004|561177865|FG001|Treatment|Disease progression|79|||
155480107|NCT01642004|561177864|FG000|Treatment|Study drug toxicity|10|||
155480108|NCT01642004|561177865|FG001|Treatment|Study drug toxicity|13|||
155480109|NCT01642004|561177864|FG000|Treatment|Death|1|||
155480110|NCT01642004|561177865|FG001|Treatment|Death|1|||
155480111|NCT01642004|561177864|FG000|Treatment|Adverse event unrelated to study drug|9|||
155480112|NCT01642004|561177865|FG001|Treatment|Adverse event unrelated to study drug|13|||
155480113|NCT01642004|561177864|FG000|Treatment|Maximum clinical benefit|1|||
155480114|NCT01642004|561177865|FG001|Treatment|Maximum clinical benefit|9|||
155480115|NCT01642004|561177864|FG000|Treatment|Poor/non-compliance|1|||
155480116|NCT01642004|561177865|FG001|Treatment|Poor/non-compliance|0|||
155480117|NCT01642004|561177864|FG000|Treatment|No longer meets study criteria|1|||
155480118|NCT01642004|561177865|FG001|Treatment|No longer meets study criteria|2|||
155480119|NCT01642004|561177864|FG000|Treatment|Other reasons|2|||
155480120|NCT01642004|561177865|FG001|Treatment|Other reasons|0|||
155480121|NCT01642004|561177864|FG000|Treatment|Not reported|0|||
155480122|NCT01642004|561177865|FG001|Treatment|Not reported|3|||
155480123|NCT01642004|561177864|FG000|Treatment|Participant request to discontinue study treatment|6|||
155480124|NCT01642004|561177865|FG001|Treatment|Participant request to discontinue study treatment|4|||
155480125|NCT01642004|561177864|FG000|Treatment|Participant withdrew consent|5|||
155480126|NCT01642004|561177865|FG001|Treatment|Participant withdrew consent|5|||
155480127|NCT02718625|561177866|FG000|Overall Study|Adverse Event|0|||
155520178|NCT00864097|561329414|FG003|Overall Study|Lack of Efficacy|2|||
155480128|NCT02718625|561177867|FG001|Overall Study|Adverse Event|1|||
155480129|NCT02718625|561177866|FG000|Overall Study|Termination of Study by Sponsor|0|||
155480130|NCT02718625|561177867|FG001|Overall Study|Termination of Study by Sponsor|1|||
155480131|NCT01818765|561177870|FG000|Overall Study|Death|2|||
155480132|NCT01562327|561177871|FG000|Overall Study|Adverse Event|2|||
155480133|NCT01562327|561177871|FG000|Overall Study|Lack of Efficacy|1|||
155480134|NCT01562327|561177871|FG000|Overall Study|Participant drop-out|1|||
155480135|NCT01562327|561177871|FG000|Overall Study|Infusion not received at 6 month window|4|||
155480136|NCT01947127|561177872|FG000|Overall Study|Protocol Violation|18|||
155480137|NCT01947127|561177873|FG001|Overall Study|Protocol Violation|38|||
155480138|NCT01947127|561177872|FG000|Overall Study|Withdrawal by Subject|1|||
155480139|NCT01947127|561177873|FG001|Overall Study|Withdrawal by Subject|1|||
155480140|NCT01947127|561177872|FG000|Overall Study|Data loss|4|||
155480141|NCT01947127|561177873|FG001|Overall Study|Data loss|4|||
155480142|NCT00170846|561177874|FG000|Overall Study|Subject withdrew Informed Consent|5|||
155480143|NCT00170846|561177875|FG001|Overall Study|Subject withdrew Informed Consent|12|||
155480144|NCT00170846|561177876|FG002|Overall Study|Subject withdrew Informed Consent|8|||
155480145|NCT00170846|561177874|FG000|Overall Study|Lost to Follow-up|6|||
155480146|NCT00170846|561177875|FG001|Overall Study|Lost to Follow-up|3|||
155480147|NCT00170846|561177876|FG002|Overall Study|Lost to Follow-up|2|||
155480148|NCT00170846|561177874|FG000|Overall Study|Death|0|||
155480149|NCT00170846|561177875|FG001|Overall Study|Death|3|||
155480150|NCT00170846|561177876|FG002|Overall Study|Death|3|||
155480151|NCT00170846|561177874|FG000|Overall Study|Reason Missing|0|||
155480152|NCT00170846|561177875|FG001|Overall Study|Reason Missing|1|||
155480153|NCT00170846|561177876|FG002|Overall Study|Reason Missing|0|||
155480154|NCT00887913|561177881|FG000|Overall Study|Withdrawal by Subject|6|||
155480155|NCT01708915|561177884|FG000|Overall Study|Adverse Event|1|||
155480156|NCT01708915|561177885|FG001|Overall Study|Adverse Event|0|||
155480157|NCT01708915|561177886|FG002|Overall Study|Adverse Event|9|||
155480158|NCT01708915|561177887|FG003|Overall Study|Adverse Event|13|||
155480159|NCT01708915|561177884|FG000|Overall Study|Lack of Efficacy|84|||
155480160|NCT01708915|561177885|FG001|Overall Study|Lack of Efficacy|60|||
155480161|NCT01708915|561177886|FG002|Overall Study|Lack of Efficacy|35|||
155480162|NCT01708915|561177887|FG003|Overall Study|Lack of Efficacy|15|||
155480163|NCT01708915|561177884|FG000|Overall Study|Protocol Violation|0|||
155480164|NCT01708915|561177885|FG001|Overall Study|Protocol Violation|0|||
155480165|NCT01708915|561177886|FG002|Overall Study|Protocol Violation|0|||
155480166|NCT01708915|561177887|FG003|Overall Study|Protocol Violation|1|||
155480167|NCT01708915|561177884|FG000|Overall Study|Withdrawal by Subject|0|||
155480168|NCT01708915|561177885|FG001|Overall Study|Withdrawal by Subject|1|||
155480169|NCT01708915|561177886|FG002|Overall Study|Withdrawal by Subject|2|||
155480170|NCT01708915|561177887|FG003|Overall Study|Withdrawal by Subject|2|||
155480171|NCT01708915|561177884|FG000|Overall Study|Other reasons than stated above|1|||
155480172|NCT01708915|561177885|FG001|Overall Study|Other reasons than stated above|1|||
155480173|NCT01708915|561177886|FG002|Overall Study|Other reasons than stated above|0|||
155480174|NCT01708915|561177887|FG003|Overall Study|Other reasons than stated above|2|||
155480175|NCT01369069|561177888|FG000|Overall Study|Lost to Follow-up|8|||
155480176|NCT01369069|561177889|FG001|Overall Study|Lost to Follow-up|9|||
155480177|NCT01369069|561177888|FG000|Overall Study|Withdrawal by Subject|9|||
155480178|NCT01369069|561177889|FG001|Overall Study|Withdrawal by Subject|7|||
155480179|NCT02573012|561177892|FG000|Overall Study|Adverse Event|5|||
155480180|NCT02573012|561177893|FG001|Overall Study|Adverse Event|5|||
155480181|NCT02573012|561177892|FG000|Overall Study|Lack of Efficacy|5|||
155480182|NCT02573012|561177893|FG001|Overall Study|Lack of Efficacy|4|||
155480183|NCT02573012|561177892|FG000|Overall Study|Non-compliance|1|||
155480184|NCT02573012|561177893|FG001|Overall Study|Non-compliance|2|||
155480185|NCT02573012|561177892|FG000|Overall Study|Withdrawal by Subject|2|||
155480186|NCT02573012|561177893|FG001|Overall Study|Withdrawal by Subject|2|||
155480187|NCT02573012|561177892|FG000|Overall Study|Study Ended per Protocol|1|||
155480188|NCT02573012|561177893|FG001|Overall Study|Study Ended per Protocol|0|||
155480189|NCT02573012|561177892|FG000|Overall Study|Physician Decision|1|||
155480190|NCT02573012|561177893|FG001|Overall Study|Physician Decision|2|||
155480191|NCT01846208|561177894|FG000|Overall Study|Withdrew prior to treatment|1|||
155480192|NCT01846208|561177895|FG001|Overall Study|Withdrew prior to treatment|1|||
155480193|NCT01846208|561177896|FG002|Overall Study|Withdrew prior to treatment|1|||
155480194|NCT01846208|561177894|FG000|Overall Study|Dosing Symptoms|1|||
155480195|NCT01846208|561177895|FG001|Overall Study|Dosing Symptoms|2|||
155480196|NCT01846208|561177896|FG002|Overall Study|Dosing Symptoms|6|||
155480197|NCT01846208|561177894|FG000|Overall Study|Withdrawal by Subject|5|||
155480198|NCT01846208|561177895|FG001|Overall Study|Withdrawal by Subject|0|||
155480199|NCT01846208|561177896|FG002|Overall Study|Withdrawal by Subject|0|||
155480200|NCT01846208|561177894|FG000|Overall Study|Non-compliance|1|||
155480201|NCT01846208|561177895|FG001|Overall Study|Non-compliance|1|||
155480202|NCT01846208|561177896|FG002|Overall Study|Non-compliance|0|||
155480203|NCT01846208|561177894|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
155480204|NCT01846208|561177895|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
155480205|NCT01846208|561177896|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
155520179|NCT00864097|561329411|FG000|Overall Study|Lost to Follow-up|0|||
155520180|NCT00864097|561329412|FG001|Overall Study|Lost to Follow-up|1|||
155520181|NCT00864097|561329413|FG002|Overall Study|Lost to Follow-up|0|||
155520182|NCT00864097|561329414|FG003|Overall Study|Lost to Follow-up|1|||
155520183|NCT00864097|561329411|FG000|Overall Study|Withdrawal by Subject|15|||
155520184|NCT00864097|561329412|FG001|Overall Study|Withdrawal by Subject|11|||
155480206|NCT01846208|561177894|FG000|Overall Study|Refused SU OFC|0|||
155480207|NCT01846208|561177895|FG001|Overall Study|Refused SU OFC|0|||
155480208|NCT01846208|561177896|FG002|Overall Study|Refused SU OFC|1|||
155480209|NCT01424306|561177897|FG000|Overall Study|Protocol Violation|0|||
155480210|NCT01424306|561177898|FG001|Overall Study|Protocol Violation|0|||
155520185|NCT00864097|561329413|FG002|Overall Study|Withdrawal by Subject|11|||
155480211|NCT01424306|561177899|FG002|Overall Study|Protocol Violation|0|||
155480212|NCT01424306|561177900|FG003|Overall Study|Protocol Violation|0|||
155480213|NCT01424306|561177901|FG004|Overall Study|Protocol Violation|1|||
155480214|NCT01424306|561177902|FG005|Overall Study|Protocol Violation|0|||
155480215|NCT03231228|561177903|FG000|Overall Study|Lost to Follow-up|2|||
155480216|NCT03231228|561177904|FG001|Overall Study|Lost to Follow-up|0|||
155480217|NCT03231228|561177903|FG000|Overall Study|Physician Decision|1|||
155480218|NCT03231228|561177904|FG001|Overall Study|Physician Decision|0|||
155480219|NCT01875874|561177908|FG000|Overall Study|Death|3|||
155480220|NCT02096471|561177911|FG000|Overall Study|Adverse Event|1|||
155480221|NCT02096471|561177911|FG000|Overall Study|Lack of Efficacy|7|||
155480222|NCT02096471|561177911|FG000|Overall Study|Withdrawal by Subject|3|||
155480223|NCT02096471|561177911|FG000|Overall Study|Non-Compliant|2|||
155480224|NCT00374127|561177912|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
155480225|NCT00374127|561177912|FG000|Overall Study|Blood could not be drawn.|2|||
155480226|NCT00374127|561177912|FG000|Overall Study|Protocol Violation|5|||
155480227|NCT00374127|561177912|FG000|Overall Study|Pregnancy|1|||
155480228|NCT03344562|561177913|FG000|Overall Study|Withdrawal by Subject|2|||
155480229|NCT03344562|561177914|FG001|Overall Study|Withdrawal by Subject|0|||
155480230|NCT02463331|561177920|FG000|Overall Study|Adverse Event|4|||
155480231|NCT02463331|561177921|FG001|Overall Study|Adverse Event|2|||
155480232|NCT02463331|561177920|FG000|Overall Study|Lost to Follow-up|1|||
155480233|NCT02463331|561177921|FG001|Overall Study|Lost to Follow-up|1|||
155480234|NCT02463331|561177920|FG000|Overall Study|Pregnancy|2|||
155480235|NCT02463331|561177921|FG001|Overall Study|Pregnancy|3|||
155480236|NCT02463331|561177920|FG000|Overall Study|Lack of Efficacy|6|||
155480237|NCT02463331|561177921|FG001|Overall Study|Lack of Efficacy|0|||
155480238|NCT02463331|561177920|FG000|Overall Study|Physician Decision|3|||
155480239|NCT02463331|561177921|FG001|Overall Study|Physician Decision|0|||
155480240|NCT02382276|561177922|FG000|Overall Study|Withdrawal by Subject|4|||
155480241|NCT02382276|561177923|FG001|Overall Study|Withdrawal by Subject|8|||
155480242|NCT02382276|561177924|FG002|Overall Study|Withdrawal by Subject|5|||
155480243|NCT02382276|561177922|FG000|Overall Study|Adverse Event|7|||
155480244|NCT02382276|561177923|FG001|Overall Study|Adverse Event|2|||
155480245|NCT02382276|561177924|FG002|Overall Study|Adverse Event|32|||
155480246|NCT02382276|561177922|FG000|Overall Study|Physician Decision|0|||
155480247|NCT02382276|561177923|FG001|Overall Study|Physician Decision|0|||
155480248|NCT02382276|561177924|FG002|Overall Study|Physician Decision|2|||
155480249|NCT01222416|561177925|FG000|Overall Study|ineligible;metastasis|3|||
155480250|NCT01222416|561177926|FG001|Overall Study|ineligible;metastasis|0|||
155480251|NCT01222416|561177925|FG000|Overall Study|Adverse Event|4|||
155480252|NCT01222416|561177926|FG001|Overall Study|Adverse Event|0|||
155480253|NCT01222416|561177925|FG000|Overall Study|Withdrawal by Subject|5|||
155480254|NCT01222416|561177926|FG001|Overall Study|Withdrawal by Subject|0|||
155480255|NCT01222416|561177925|FG000|Overall Study|scheduling|6|||
155480256|NCT01222416|561177926|FG001|Overall Study|scheduling|0|||
155480257|NCT01222416|561177925|FG000|Overall Study|missed view/scan|1|||
155480258|NCT01222416|561177926|FG001|Overall Study|missed view/scan|0|||
155480259|NCT01222416|561177925|FG000|Overall Study|Death|1|||
155480260|NCT01222416|561177926|FG001|Overall Study|Death|0|||
155480261|NCT00281528|561177929|FG000|Overall Study|Progressive Disease|28|||
155480262|NCT00281528|561177930|FG001|Overall Study|Progressive Disease|18|||
155480263|NCT00281528|561177931|FG002|Overall Study|Progressive Disease|27|||
155480264|NCT00281528|561177929|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
155480265|NCT00281528|561177930|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
155480266|NCT00281528|561177931|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
155480267|NCT00281528|561177929|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
155480268|NCT00281528|561177930|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
155480269|NCT00281528|561177931|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
155480270|NCT00281528|561177929|FG000|Overall Study|Physician Decision|11|||
155480271|NCT00281528|561177930|FG001|Overall Study|Physician Decision|4|||
155480272|NCT00281528|561177931|FG002|Overall Study|Physician Decision|5|||
155480273|NCT00281528|561177929|FG000|Overall Study|Protocol Violation|1|||
155480274|NCT00281528|561177930|FG001|Overall Study|Protocol Violation|0|||
155480275|NCT00281528|561177931|FG002|Overall Study|Protocol Violation|1|||
155480276|NCT00281528|561177929|FG000|Overall Study|Withdrawal by Subject|5|||
155480277|NCT00281528|561177930|FG001|Overall Study|Withdrawal by Subject|5|||
155520186|NCT00864097|561329414|FG003|Overall Study|Withdrawal by Subject|12|||
155520187|NCT00864097|561329411|FG000|Overall Study|Protocol Violation|2|||
155520188|NCT00864097|561329412|FG001|Overall Study|Protocol Violation|1|||
155480278|NCT00281528|561177931|FG002|Overall Study|Withdrawal by Subject|7|||
155480279|NCT00281528|561177929|FG000|Overall Study|Other|6|||
155480280|NCT00281528|561177930|FG001|Overall Study|Other|3|||
155480281|NCT00281528|561177931|FG002|Overall Study|Other|5|||
155480282|NCT03049852|561177938|FG000|Overall Study|Lost to Follow-up|0|||
155480283|NCT03049852|561177939|FG001|Overall Study|Lost to Follow-up|1|||
155480284|NCT03049852|561177940|FG002|Overall Study|Lost to Follow-up|0|||
155480285|NCT02709889|561177941|FG000|Overall Study|Withdrawal by Subject|11|||
155480286|NCT02709889|561177942|FG001|Overall Study|Withdrawal by Subject|10|||
155480287|NCT02709889|561177943|FG002|Overall Study|Withdrawal by Subject|2|||
155480288|NCT02709889|561177944|FG003|Overall Study|Withdrawal by Subject|12|||
155480289|NCT02709889|561177941|FG000|Overall Study|Death|25|||
155480290|NCT02709889|561177942|FG001|Overall Study|Death|38|||
155480291|NCT02709889|561177943|FG002|Overall Study|Death|4|||
155480292|NCT02709889|561177944|FG003|Overall Study|Death|44|||
155480293|NCT02709889|561177941|FG000|Overall Study|Physician Decision|1|||
155480294|NCT02709889|561177942|FG001|Overall Study|Physician Decision|2|||
155480295|NCT02709889|561177943|FG002|Overall Study|Physician Decision|3|||
155480296|NCT02709889|561177944|FG003|Overall Study|Physician Decision|5|||
155480297|NCT02709889|561177941|FG000|Overall Study|Lost to Follow-up|2|||
155480298|NCT02709889|561177942|FG001|Overall Study|Lost to Follow-up|0|||
155480299|NCT02709889|561177943|FG002|Overall Study|Lost to Follow-up|0|||
155480300|NCT02709889|561177944|FG003|Overall Study|Lost to Follow-up|4|||
155480301|NCT02709889|561177941|FG000|Overall Study|Study Terminated by Sponsor|4|||
155480302|NCT02709889|561177942|FG001|Overall Study|Study Terminated by Sponsor|6|||
155480303|NCT02709889|561177943|FG002|Overall Study|Study Terminated by Sponsor|2|||
155480304|NCT02709889|561177944|FG003|Overall Study|Study Terminated by Sponsor|17|||
155480305|NCT02709889|561177941|FG000|Overall Study|Other, Not Specified|0|||
155480306|NCT02709889|561177942|FG001|Overall Study|Other, Not Specified|1|||
155480307|NCT02709889|561177943|FG002|Overall Study|Other, Not Specified|1|||
155480308|NCT02709889|561177944|FG003|Overall Study|Other, Not Specified|6|||
155480309|NCT00656799|561177945|FG000|Overall Study|Death|2|||
155480310|NCT05281094|561177946|FG000|Overall Study|Adverse Event|1|||
155480311|NCT05281094|561177947|FG001|Overall Study|Adverse Event|0|||
155480312|NCT05281094|561177946|FG000|Overall Study|Lost to Follow-up|29|||
155480313|NCT05281094|561177947|FG001|Overall Study|Lost to Follow-up|22|||
155480314|NCT05281094|561177946|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
155480315|NCT05281094|561177947|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
155480316|NCT05281094|561177946|FG000|Overall Study|Death|1|||
155480317|NCT05281094|561177947|FG001|Overall Study|Death|2|||
155480318|NCT05281094|561177946|FG000|Overall Study|Not pre-specified reason|8|||
155480319|NCT05281094|561177947|FG001|Overall Study|Not pre-specified reason|5|||
155480320|NCT03347279|561179820|FG000|Overall Study|Withdrawal by Subject|8|||
155480321|NCT03347279|561179821|FG001|Overall Study|Withdrawal by Subject|15|||
155480322|NCT03347279|561179820|FG000|Overall Study|Death|0|||
155480323|NCT03347279|561179821|FG001|Overall Study|Death|2|||
155480324|NCT03347279|561179820|FG000|Overall Study|Lost to Follow-up|5|||
155480325|NCT03347279|561179821|FG001|Overall Study|Lost to Follow-up|2|||
155480326|NCT03347279|561179820|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
155480327|NCT03347279|561179821|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
155480328|NCT03818399|561179825|FG000|Overall Study|Lost to Follow-up|11|||
155480329|NCT03818399|561179825|FG000|Overall Study|Withdrawal by Subject|1|||
155480330|NCT03818399|561179825|FG000|Overall Study|Protocol Violation|2|||
155480331|NCT00718887|561179826|FG000|Overall Study|Withdrawal by Subject|3|||
155480332|NCT00718887|561179827|FG001|Overall Study|Withdrawal by Subject|2|||
155480333|NCT00718887|561179826|FG000|Overall Study|Not identified|2|||
155480334|NCT00718887|561179827|FG001|Overall Study|Not identified|7|||
155480335|NCT00775138|561179828|FG000|Overall Study|Withdrawal by Subject|0|||
155480336|NCT00775138|561179829|FG001|Overall Study|Withdrawal by Subject|0|||
155480337|NCT00775138|561179830|FG002|Overall Study|Withdrawal by Subject|2|||
155480338|NCT00775138|561179831|FG003|Overall Study|Withdrawal by Subject|2|||
155480339|NCT00775138|561179828|FG000|Overall Study|Adverse Event|0|||
155480340|NCT00775138|561179829|FG001|Overall Study|Adverse Event|0|||
155480341|NCT00775138|561179830|FG002|Overall Study|Adverse Event|1|||
155480342|NCT00775138|561179831|FG003|Overall Study|Adverse Event|0|||
155480343|NCT00103207|561179832|FG000|Overall Study|Adverse Event|3|||
155480344|NCT00103207|561179832|FG000|Overall Study|Death|1|||
155480345|NCT00103207|561179832|FG000|Overall Study|Withdrawal by Subject|2|||
155480346|NCT00103207|561179832|FG000|Overall Study|Other complicating disease|1|||
155480347|NCT00103207|561179832|FG000|Overall Study|Ineligible|4|||
155480348|NCT00103207|561179832|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
155480349|NCT00811395|561179833|FG000|Extension Treatment|Adverse Event|1|||
155480350|NCT00811395|561179834|FG001|Extension Treatment|Adverse Event|2|||
155480351|NCT00811395|561179835|FG002|Extension Treatment|Adverse Event|2|||
155480352|NCT00811395|561179836|FG003|Extension Treatment|Adverse Event|2|||
155520189|NCT00864097|561329413|FG002|Overall Study|Protocol Violation|0|||
155520190|NCT00864097|561329414|FG003|Overall Study|Protocol Violation|1|||
155520191|NCT00864097|561329411|FG000|Overall Study|Terminated by sponsor|105|||
155480353|NCT00811395|561179837|FG004|Extension Treatment|Adverse Event|0|||
155480354|NCT00811395|561179838|FG005|Extension Treatment|Adverse Event|1|||
155480355|NCT00811395|561179833|FG000|Extension Treatment|Progressive disease|1|||
155480356|NCT00811395|561179834|FG001|Extension Treatment|Progressive disease|1|||
155480357|NCT00811395|561179835|FG002|Extension Treatment|Progressive disease|0|||
155480358|NCT00811395|561179836|FG003|Extension Treatment|Progressive disease|0|||
155480359|NCT00811395|561179837|FG004|Extension Treatment|Progressive disease|0|||
155480360|NCT00811395|561179838|FG005|Extension Treatment|Progressive disease|0|||
155480361|NCT00811395|561179833|FG000|Extension Treatment|Participant did not wish to continue|0|||
155480362|NCT00811395|561179834|FG001|Extension Treatment|Participant did not wish to continue|3|||
155480363|NCT00811395|561179835|FG002|Extension Treatment|Participant did not wish to continue|0|||
155480364|NCT00811395|561179836|FG003|Extension Treatment|Participant did not wish to continue|1|||
155480365|NCT00811395|561179837|FG004|Extension Treatment|Participant did not wish to continue|0|||
155480366|NCT00811395|561179838|FG005|Extension Treatment|Participant did not wish to continue|1|||
155480367|NCT00811395|561179833|FG000|Extension Treatment|Other than above|0|||
155480368|NCT00811395|561179834|FG001|Extension Treatment|Other than above|0|||
155480369|NCT00811395|561179835|FG002|Extension Treatment|Other than above|1|||
155480370|NCT00811395|561179836|FG003|Extension Treatment|Other than above|0|||
155480371|NCT00811395|561179837|FG004|Extension Treatment|Other than above|0|||
155480372|NCT00811395|561179838|FG005|Extension Treatment|Other than above|0|||
155480373|NCT00890201|561179845|FG000|Overall Study|Protocol Violation|5|||
155480374|NCT00890201|561179846|FG001|Overall Study|Protocol Violation|56|||
155480375|NCT02181504|561179847|FG000|Overall Study|Adverse Event|1|||
155480376|NCT02181504|561179848|FG001|Overall Study|Adverse Event|1|||
155480377|NCT02181504|561179849|FG002|Overall Study|Adverse Event|1|||
155480378|NCT01469637|561179852|FG000|First Intervention|Unacceptable behavior|0|||
155480379|NCT01469637|561179853|FG001|First Intervention|Unacceptable behavior|1|||
155480380|NCT01469637|561179852|FG000|Second Intervention|Incarcerated|1|||
155480381|NCT01469637|561179853|FG001|Second Intervention|Incarcerated|0|||
155480382|NCT01371721|561179854|FG000|Overall Study|Adverse Event|5|||
155480383|NCT01371721|561179855|FG001|Overall Study|Adverse Event|4|||
155480384|NCT01371721|561179856|FG002|Overall Study|Adverse Event|5|||
155480385|NCT01371721|561179854|FG000|Overall Study|Protocol Violation|6|||
155480386|NCT01371721|561179855|FG001|Overall Study|Protocol Violation|4|||
155480387|NCT01371721|561179856|FG002|Overall Study|Protocol Violation|5|||
155480388|NCT01371721|561179854|FG000|Overall Study|Lost to Follow-up|8|||
155480389|NCT01371721|561179855|FG001|Overall Study|Lost to Follow-up|2|||
155480390|NCT01371721|561179856|FG002|Overall Study|Lost to Follow-up|6|||
155480391|NCT01371721|561179854|FG000|Overall Study|Withdrawal by Subject|5|||
155480392|NCT01371721|561179855|FG001|Overall Study|Withdrawal by Subject|7|||
155480393|NCT01371721|561179856|FG002|Overall Study|Withdrawal by Subject|11|||
155480394|NCT01371721|561179854|FG000|Overall Study|Other|2|||
155480395|NCT01371721|561179855|FG001|Overall Study|Other|3|||
155480396|NCT01371721|561179856|FG002|Overall Study|Other|0|||
155480397|NCT01371721|561179854|FG000|Overall Study|Lack of Efficacy|2|||
155480398|NCT01371721|561179855|FG001|Overall Study|Lack of Efficacy|4|||
155480399|NCT01371721|561179856|FG002|Overall Study|Lack of Efficacy|3|||
155480400|NCT01371721|561179854|FG000|Overall Study|Randomized but not treated|1|||
155480401|NCT01371721|561179855|FG001|Overall Study|Randomized but not treated|0|||
155480402|NCT01371721|561179856|FG002|Overall Study|Randomized but not treated|0|||
155480403|NCT02877134|561179859|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480404|NCT02877134|561179860|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
155480405|NCT02877134|561179861|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480406|NCT02877134|561179862|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480407|NCT02877134|561179863|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
155520192|NCT00864097|561329412|FG001|Overall Study|Terminated by sponsor|112|||
155520193|NCT00864097|561329413|FG002|Overall Study|Terminated by sponsor|102|||
155520194|NCT00864097|561329414|FG003|Overall Study|Terminated by sponsor|99|||
155520195|NCT00864097|561329411|FG000|Overall Study|Randomized but not treated|2|||
155520196|NCT00864097|561329412|FG001|Overall Study|Randomized but not treated|0|||
155520197|NCT00864097|561329413|FG002|Overall Study|Randomized but not treated|1|||
155520198|NCT00864097|561329414|FG003|Overall Study|Randomized but not treated|0|||
155520199|NCT00864097|561329411|FG000|Overall Study|Other|0|||
155520200|NCT00864097|561329412|FG001|Overall Study|Other|0|||
155520201|NCT00864097|561329413|FG002|Overall Study|Other|0|||
155520202|NCT00864097|561329414|FG003|Overall Study|Other|1|||
155520203|NCT00320112|561329416|FG000|Overall Study|Lost to Follow-up|3|||
155480408|NCT02877134|561179864|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
155480409|NCT02877134|561179865|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480410|NCT02877134|561179866|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480411|NCT02877134|561179867|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480412|NCT02877134|561179868|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480413|NCT02877134|561179869|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480414|NCT02877134|561179870|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
155480415|NCT02877134|561179859|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155520204|NCT00320112|561329417|FG001|Overall Study|Lost to Follow-up|4|||
155520205|NCT00320112|561329416|FG000|Overall Study|Withdrawal by Subject|3|||
155520206|NCT00320112|561329417|FG001|Overall Study|Withdrawal by Subject|0|||
155520207|NCT00320112|561329416|FG000|Overall Study|Death|2|||
155520208|NCT00320112|561329417|FG001|Overall Study|Death|1|||
155520209|NCT01199861|561329419|FG000|Overall Study|Administrative problems|1|||
155520210|NCT01199861|561329420|FG001|Overall Study|Administrative problems|0|||
155654631|NCT03715829|561828904|FG003|Extension Period|Lost to Follow-up|0|||
155654632|NCT03715829|561828905|FG004|Extension Period|Lost to Follow-up|0|||
155480416|NCT02877134|561179860|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
155480417|NCT02877134|561179861|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480418|NCT02877134|561179862|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
155480419|NCT02877134|561179863|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480420|NCT02877134|561179864|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480421|NCT02877134|561179865|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
155480422|NCT02877134|561179866|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480423|NCT02877134|561179867|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480424|NCT02877134|561179868|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480425|NCT02877134|561179869|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480426|NCT02877134|561179870|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
155480427|NCT02877134|561179859|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
155480428|NCT02877134|561179860|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
155480429|NCT02877134|561179861|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
155480430|NCT02877134|561179862|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
155480431|NCT02877134|561179863|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
155480432|NCT02877134|561179864|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
155480433|NCT02877134|561179865|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
155480434|NCT02877134|561179866|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155480435|NCT02877134|561179867|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155480436|NCT02877134|561179868|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155480437|NCT02877134|561179869|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155480438|NCT02877134|561179870|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155480439|NCT02877134|561179859|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
155480440|NCT02877134|561179860|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
155480441|NCT02877134|561179861|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
155480442|NCT02877134|561179862|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
155480443|NCT02877134|561179863|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
155480444|NCT02877134|561179864|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
155480445|NCT02877134|561179865|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
155480446|NCT02877134|561179866|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
155480447|NCT02877134|561179867|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
155480448|NCT02877134|561179868|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
155480449|NCT02877134|561179869|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
155480450|NCT02877134|561179870|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
155480451|NCT02877134|561179859|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480452|NCT02877134|561179860|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480453|NCT02877134|561179861|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480454|NCT02877134|561179862|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480455|NCT02877134|561179863|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480456|NCT02877134|561179864|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480457|NCT02877134|561179865|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480458|NCT02877134|561179866|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155654633|NCT03715829|561828906|FG005|Extension Period|Lost to Follow-up|0|||
155654634|NCT03715829|561828907|FG006|Extension Period|Lost to Follow-up|0|||
155654635|NCT03715829|561828908|FG007|Extension Period|Lost to Follow-up|0|||
155480459|NCT02877134|561179867|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
155654636|NCT03715829|561828909|FG008|Extension Period|Lost to Follow-up|2|||
155654637|NCT03715829|561828910|FG009|Extension Period|Lost to Follow-up|0|||
155654638|NCT03715829|561828911|FG010|Extension Period|Lost to Follow-up|0|||
155480460|NCT02877134|561179868|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480461|NCT02877134|561179869|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480462|NCT02877134|561179870|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
155480463|NCT02877134|561179859|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480464|NCT02877134|561179860|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480465|NCT02877134|561179861|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480466|NCT02877134|561179862|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480467|NCT02877134|561179863|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480468|NCT02877134|561179864|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480469|NCT02877134|561179865|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
155480470|NCT02877134|561179866|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
155480471|NCT02877134|561179867|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
155480472|NCT02877134|561179868|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
155480473|NCT02877134|561179869|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
155480474|NCT02877134|561179870|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
155480475|NCT02877134|561179859|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480476|NCT02877134|561179860|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480477|NCT02877134|561179861|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480478|NCT02877134|561179862|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480479|NCT02877134|561179863|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480480|NCT02877134|561179864|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480481|NCT02877134|561179865|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480482|NCT02877134|561179866|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
155480483|NCT02877134|561179867|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
155480484|NCT02877134|561179868|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
155480485|NCT02877134|561179869|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480486|NCT02877134|561179870|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
155480487|NCT02877134|561179859|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
155480488|NCT02877134|561179860|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
155480489|NCT02877134|561179861|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
155480490|NCT02877134|561179862|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
155480491|NCT02877134|561179863|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
155480492|NCT02877134|561179864|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
155480493|NCT02877134|561179865|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
155480494|NCT02877134|561179866|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
155480495|NCT02877134|561179867|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
155480496|NCT02877134|561179868|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
155480497|NCT02877134|561179869|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
155480498|NCT02877134|561179870|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
155480499|NCT01055457|561179871|FG000|Overall Study|Lost to Follow-up|0|||
155480500|NCT01055457|561179872|FG001|Overall Study|Lost to Follow-up|1|||
155480501|NCT01055457|561179873|FG002|Overall Study|Lost to Follow-up|0|||
155480502|NCT01055457|561179874|FG003|Overall Study|Lost to Follow-up|0|||
155480503|NCT01055457|561179875|FG004|Overall Study|Lost to Follow-up|0|||
155480504|NCT01055457|561179876|FG005|Overall Study|Lost to Follow-up|1|||
155480505|NCT01055457|561179877|FG006|Overall Study|Lost to Follow-up|0|||
155480506|NCT01055457|561179878|FG007|Overall Study|Lost to Follow-up|0|||
155480507|NCT01055457|561179879|FG008|Overall Study|Lost to Follow-up|0|||
155480508|NCT01055457|561179880|FG009|Overall Study|Lost to Follow-up|0|||
155480509|NCT01055457|561179871|FG000|Overall Study|Protocol Violation|0|||
155480510|NCT01055457|561179872|FG001|Overall Study|Protocol Violation|0|||
155480511|NCT01055457|561179873|FG002|Overall Study|Protocol Violation|1|||
155480512|NCT01055457|561179874|FG003|Overall Study|Protocol Violation|1|||
155480513|NCT01055457|561179875|FG004|Overall Study|Protocol Violation|1|||
155480514|NCT01055457|561179876|FG005|Overall Study|Protocol Violation|2|||
155480515|NCT01055457|561179877|FG006|Overall Study|Protocol Violation|1|||
155480516|NCT01055457|561179878|FG007|Overall Study|Protocol Violation|0|||
155480517|NCT01055457|561179879|FG008|Overall Study|Protocol Violation|0|||
155480518|NCT01055457|561179880|FG009|Overall Study|Protocol Violation|1|||
155480519|NCT01055457|561179871|FG000|Overall Study|Subject Disinterest|0|||
155480520|NCT01055457|561179872|FG001|Overall Study|Subject Disinterest|0|||
155480521|NCT01055457|561179873|FG002|Overall Study|Subject Disinterest|0|||
155480522|NCT01055457|561179874|FG003|Overall Study|Subject Disinterest|0|||
155480523|NCT01055457|561179875|FG004|Overall Study|Subject Disinterest|0|||
155480524|NCT01055457|561179876|FG005|Overall Study|Subject Disinterest|0|||
155480525|NCT01055457|561179877|FG006|Overall Study|Subject Disinterest|0|||
155480526|NCT01055457|561179878|FG007|Overall Study|Subject Disinterest|1|||
155480527|NCT01055457|561179879|FG008|Overall Study|Subject Disinterest|0|||
155480528|NCT01055457|561179880|FG009|Overall Study|Subject Disinterest|0|||
155480529|NCT01055457|561179871|FG000|Overall Study|Subject Ineligible|1|||
155480530|NCT01055457|561179872|FG001|Overall Study|Subject Ineligible|0|||
155480531|NCT01055457|561179873|FG002|Overall Study|Subject Ineligible|1|||
155480532|NCT01055457|561179874|FG003|Overall Study|Subject Ineligible|0|||
155480533|NCT01055457|561179875|FG004|Overall Study|Subject Ineligible|1|||
155480534|NCT01055457|561179876|FG005|Overall Study|Subject Ineligible|0|||
155480535|NCT01055457|561179877|FG006|Overall Study|Subject Ineligible|0|||
155480536|NCT01055457|561179878|FG007|Overall Study|Subject Ineligible|0|||
155480537|NCT01055457|561179879|FG008|Overall Study|Subject Ineligible|0|||
155480538|NCT01055457|561179880|FG009|Overall Study|Subject Ineligible|0|||
155480539|NCT01055457|561179871|FG000|Overall Study|Discomfort|0|||
155480540|NCT01055457|561179872|FG001|Overall Study|Discomfort|0|||
155480541|NCT01055457|561179873|FG002|Overall Study|Discomfort|0|||
155480542|NCT01055457|561179874|FG003|Overall Study|Discomfort|0|||
155480543|NCT01055457|561179875|FG004|Overall Study|Discomfort|1|||
155480544|NCT01055457|561179876|FG005|Overall Study|Discomfort|0|||
155480545|NCT01055457|561179877|FG006|Overall Study|Discomfort|0|||
155480546|NCT01055457|561179878|FG007|Overall Study|Discomfort|0|||
155480547|NCT01055457|561179879|FG008|Overall Study|Discomfort|0|||
155480548|NCT01055457|561179880|FG009|Overall Study|Discomfort|0|||
155480549|NCT01055457|561179871|FG000|Overall Study|Pregnancy|0|||
155480550|NCT01055457|561179872|FG001|Overall Study|Pregnancy|0|||
155480551|NCT01055457|561179873|FG002|Overall Study|Pregnancy|0|||
155480552|NCT01055457|561179874|FG003|Overall Study|Pregnancy|1|||
155480553|NCT01055457|561179875|FG004|Overall Study|Pregnancy|0|||
155480554|NCT01055457|561179876|FG005|Overall Study|Pregnancy|0|||
155480555|NCT01055457|561179877|FG006|Overall Study|Pregnancy|0|||
155480556|NCT01055457|561179878|FG007|Overall Study|Pregnancy|0|||
155480557|NCT01055457|561179879|FG008|Overall Study|Pregnancy|0|||
155480558|NCT01055457|561179880|FG009|Overall Study|Pregnancy|0|||
155480559|NCT01055457|561179871|FG000|Overall Study|Adverse Event|0|||
155480560|NCT01055457|561179872|FG001|Overall Study|Adverse Event|0|||
155480561|NCT01055457|561179873|FG002|Overall Study|Adverse Event|0|||
155480562|NCT01055457|561179874|FG003|Overall Study|Adverse Event|1|||
155480563|NCT01055457|561179875|FG004|Overall Study|Adverse Event|0|||
155480564|NCT01055457|561179876|FG005|Overall Study|Adverse Event|0|||
155480565|NCT01055457|561179877|FG006|Overall Study|Adverse Event|0|||
155480566|NCT01055457|561179878|FG007|Overall Study|Adverse Event|0|||
155480567|NCT01055457|561179879|FG008|Overall Study|Adverse Event|0|||
155480568|NCT01055457|561179880|FG009|Overall Study|Adverse Event|0|||
155480569|NCT03267576|561179888|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
155480570|NCT03267576|561179889|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
155480571|NCT03267576|561179888|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
155480572|NCT03267576|561179889|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
155480573|NCT00882362|561179890|FG000|Overall Study|Adverse Event|13|||
155480574|NCT00882362|561179891|FG001|Overall Study|Adverse Event|10|||
155480575|NCT00882362|561179890|FG000|Overall Study|Withdrawal by Subject|13|||
155480576|NCT00882362|561179891|FG001|Overall Study|Withdrawal by Subject|10|||
155480577|NCT00882362|561179890|FG000|Overall Study|Lack of Efficacy|3|||
155480578|NCT00882362|561179891|FG001|Overall Study|Lack of Efficacy|0|||
155480579|NCT00882362|561179890|FG000|Overall Study|Protocol Violation|7|||
155480580|NCT00882362|561179891|FG001|Overall Study|Protocol Violation|2|||
155480581|NCT00882362|561179890|FG000|Overall Study|Pregnancy|1|||
155480582|NCT00882362|561179891|FG001|Overall Study|Pregnancy|0|||
155480583|NCT00882362|561179890|FG000|Overall Study|Physician Decision|5|||
155480584|NCT00882362|561179891|FG001|Overall Study|Physician Decision|1|||
155480585|NCT00882362|561179890|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
155480586|NCT00882362|561179891|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
155480587|NCT00882362|561179890|FG000|Overall Study|change of residence or other commitments|5|||
155480588|NCT00882362|561179891|FG001|Overall Study|change of residence or other commitments|0|||
155480589|NCT01268514|561179892|FG000|Overall Study|Adverse Event|20|||
155480590|NCT01268514|561179892|FG000|Overall Study|Death|8|||
155480591|NCT01268514|561179892|FG000|Overall Study|Lost to Follow-up|5|||
155480592|NCT01268514|561179892|FG000|Overall Study|Withdrawal by Subject|3|||
155480593|NCT01268514|561179892|FG000|Overall Study|Withdrawal by Surgeon|5|||
155480594|NCT01432938|561179893|FG000|First Intervention|Protocol Violation|1|||
155480595|NCT01432938|561179894|FG001|First Intervention|Protocol Violation|0|||
155480596|NCT01432938|561179893|FG000|First Intervention|Physician Decision|1|||
155480597|NCT01432938|561179894|FG001|First Intervention|Physician Decision|0|||
155480598|NCT01432938|561179893|FG000|Second Intervention|Adverse Event|1|||
155480599|NCT01432938|561179894|FG001|Second Intervention|Adverse Event|0|||
155480600|NCT01601873|561179895|FG000|Overall Study|Lost to Follow-up|2|||
155480601|NCT01601873|561179896|FG001|Overall Study|Lost to Follow-up|3|||
155480602|NCT02736474|561179898|FG000|Overall Study|Lost to Follow-up|0|||
155480603|NCT02736474|561179899|FG001|Overall Study|Lost to Follow-up|1|||
155480604|NCT03147495|561179900|FG000|Overall Study|Physician Decision|0|||
155480605|NCT03147495|561179901|FG001|Overall Study|Physician Decision|6|||
155480606|NCT01024946|561179902|FG000|Overall Study|Screen Failure|3|||
155480607|NCT01024946|561179902|FG000|Overall Study|Withdrawal by Subject|1|||
155480608|NCT01024946|561179902|FG000|Overall Study|Adverse Event|1|||
155480609|NCT02483611|561179903|FG000|Overall Study|Protocol Violation|0|||
155480610|NCT02483611|561179904|FG001|Overall Study|Protocol Violation|0|||
155480611|NCT02483611|561179905|FG002|Overall Study|Protocol Violation|1|||
155480612|NCT02608892|561179906|FG000|Overall Study|Lost to Follow-up|1|||
155480613|NCT02608892|561179907|FG001|Overall Study|Lost to Follow-up|0|||
155480614|NCT00877890|561179908|FG000|Overall Study|Adverse Event|6|||
155480615|NCT00877890|561179909|FG001|Overall Study|Adverse Event|6|||
155480616|NCT00877890|561179908|FG000|Overall Study|Lost to Follow-up|5|||
155480617|NCT00877890|561179909|FG001|Overall Study|Lost to Follow-up|5|||
155480618|NCT00877890|561179908|FG000|Overall Study|Protocol Violation|0|||
155480619|NCT00877890|561179909|FG001|Overall Study|Protocol Violation|1|||
155480620|NCT00877890|561179908|FG000|Overall Study|Withdrawal of Consent|6|||
155480621|NCT00877890|561179909|FG001|Overall Study|Withdrawal of Consent|12|||
155480622|NCT00877890|561179908|FG000|Overall Study|Investigator Decision|0|||
155480623|NCT00877890|561179909|FG001|Overall Study|Investigator Decision|2|||
155480624|NCT00877890|561179908|FG000|Overall Study|Loss of Glucose Control|3|||
155480625|NCT00877890|561179909|FG001|Overall Study|Loss of Glucose Control|4|||
155480626|NCT00984009|561179910|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
155480627|NCT00703781|561179921|FG000|Overall Study|Withdrawal by Subject|1|||
155480628|NCT00703781|561179922|FG001|Overall Study|Withdrawal by Subject|2|||
155480629|NCT00703781|561179921|FG000|Overall Study|Cancelled surgery|1|||
155480630|NCT00703781|561179922|FG001|Overall Study|Cancelled surgery|0|||
155480631|NCT01225211|561179925|FG000|Overall Study|Adverse Event|0|||
155480632|NCT01225211|561179926|FG001|Overall Study|Adverse Event|0|||
155480633|NCT01225211|561179927|FG002|Overall Study|Adverse Event|1|||
155480634|NCT01225211|561179928|FG003|Overall Study|Adverse Event|0|||
155480635|NCT01225211|561179929|FG004|Overall Study|Adverse Event|0|||
155480636|NCT01225211|561179930|FG005|Overall Study|Adverse Event|0|||
155480637|NCT01225211|561179931|FG006|Overall Study|Adverse Event|0|||
155480638|NCT01225211|561179932|FG007|Overall Study|Adverse Event|0|||
155480639|NCT01225211|561179933|FG008|Overall Study|Adverse Event|0|||
155480640|NCT01225211|561179934|FG009|Overall Study|Adverse Event|1|||
155480641|NCT01225211|561179925|FG000|Overall Study|Withdrawal by Subject|0|||
155480642|NCT01225211|561179926|FG001|Overall Study|Withdrawal by Subject|0|||
155480643|NCT01225211|561179927|FG002|Overall Study|Withdrawal by Subject|0|||
155480644|NCT01225211|561179928|FG003|Overall Study|Withdrawal by Subject|0|||
155480645|NCT01225211|561179929|FG004|Overall Study|Withdrawal by Subject|0|||
155520211|NCT01199861|561329419|FG000|Overall Study|Adverse Event|1|||
155520212|NCT01199861|561329420|FG001|Overall Study|Adverse Event|0|||
155480646|NCT01225211|561179930|FG005|Overall Study|Withdrawal by Subject|0|||
155480647|NCT01225211|561179931|FG006|Overall Study|Withdrawal by Subject|1|||
155480648|NCT01225211|561179932|FG007|Overall Study|Withdrawal by Subject|0|||
155480649|NCT01225211|561179933|FG008|Overall Study|Withdrawal by Subject|1|||
155654639|NCT03715829|561828901|FG000|Extension Period|Protocol Violation|0|||
155654640|NCT03715829|561828902|FG001|Extension Period|Protocol Violation|0|||
155654641|NCT03715829|561828903|FG002|Extension Period|Protocol Violation|0|||
155654642|NCT03715829|561828904|FG003|Extension Period|Protocol Violation|0|||
155654643|NCT03715829|561828905|FG004|Extension Period|Protocol Violation|0|||
155654644|NCT03715829|561828906|FG005|Extension Period|Protocol Violation|0|||
155654645|NCT03715829|561828907|FG006|Extension Period|Protocol Violation|0|||
155654646|NCT03715829|561828908|FG007|Extension Period|Protocol Violation|0|||
155654647|NCT03715829|561828909|FG008|Extension Period|Protocol Violation|1|||
155480650|NCT01225211|561179934|FG009|Overall Study|Withdrawal by Subject|3|||
155480651|NCT01225211|561179925|FG000|Overall Study|Other|0|||
155480652|NCT01225211|561179926|FG001|Overall Study|Other|0|||
155480653|NCT01225211|561179927|FG002|Overall Study|Other|0|||
155480654|NCT01225211|561179928|FG003|Overall Study|Other|0|||
155480655|NCT01225211|561179929|FG004|Overall Study|Other|0|||
155480656|NCT01225211|561179930|FG005|Overall Study|Other|0|||
155520213|NCT00661505|561329421|FG000|Overall Study|Adverse Event|3|||
155654648|NCT03715829|561828910|FG009|Extension Period|Protocol Violation|0|||
155654649|NCT03715829|561828911|FG010|Extension Period|Protocol Violation|0|||
155480657|NCT01225211|561179931|FG006|Overall Study|Other|0|||
155480658|NCT01225211|561179932|FG007|Overall Study|Other|0|||
155480659|NCT01225211|561179933|FG008|Overall Study|Other|0|||
155480660|NCT01225211|561179934|FG009|Overall Study|Other|1|||
155480661|NCT01987609|561179935|FG000|Overall Study|Adverse Event|1|||
155480662|NCT00537810|561179940|FG000|Overall Study|Withdrawal by Subject|4|||
155480663|NCT00537810|561179941|FG001|Overall Study|Withdrawal by Subject|11|||
155480664|NCT00537810|561179942|FG002|Overall Study|Withdrawal by Subject|4|||
155480665|NCT00537810|561179943|FG003|Overall Study|Withdrawal by Subject|3|||
155480666|NCT00537810|561179940|FG000|Overall Study|Medically withdrawn|2|||
155480667|NCT00537810|561179941|FG001|Overall Study|Medically withdrawn|2|||
155480668|NCT00537810|561179942|FG002|Overall Study|Medically withdrawn|0|||
155480669|NCT00537810|561179943|FG003|Overall Study|Medically withdrawn|1|||
155480670|NCT01066546|561179944|FG000|Overall Study|Study terminated by sponsor|5|||
155480671|NCT03452397|561179949|FG000|Overall Study|Adverse Event|1|||
155480672|NCT03452397|561179950|FG001|Overall Study|Adverse Event|0|||
155480673|NCT03452397|561179951|FG002|Overall Study|Adverse Event|0|||
155480674|NCT03452397|561179952|FG003|Overall Study|Adverse Event|0|||
155480675|NCT03452397|561179949|FG000|Overall Study|Administrative reason|0|||
155480676|NCT03452397|561179950|FG001|Overall Study|Administrative reason|0|||
155480677|NCT03452397|561179951|FG002|Overall Study|Administrative reason|1|||
155480678|NCT03452397|561179952|FG003|Overall Study|Administrative reason|1|||
155480679|NCT03452397|561179949|FG000|Overall Study|Withdrawal by Subject|0|||
155480680|NCT03452397|561179950|FG001|Overall Study|Withdrawal by Subject|0|||
155480681|NCT03452397|561179951|FG002|Overall Study|Withdrawal by Subject|1|||
155480682|NCT03452397|561179952|FG003|Overall Study|Withdrawal by Subject|0|||
155480683|NCT00125268|561179953|FG000|Overall Study|Withdrawal by Subject|1|||
155480684|NCT00125268|561179954|FG001|Overall Study|Withdrawal by Subject|1|||
155480685|NCT00925522|561179955|FG000|Overall Study|study closed -- business decision|20|||
155480686|NCT02561572|561179960|FG000|Overall Study|Inadequate time before surgery|2|||
155480687|NCT02561572|561179961|FG001|Overall Study|Inadequate time before surgery|1|||
155480688|NCT02561572|561179960|FG000|Overall Study|Protocol Violation|0|||
155480689|NCT02561572|561179961|FG001|Overall Study|Protocol Violation|1|||
155480690|NCT02691468|561179962|FG000|Overall Study|Bronchial blocker use|2|||
155480691|NCT02691468|561179963|FG001|Overall Study|Bronchial blocker use|1|||
155480692|NCT02691468|561179962|FG000|Overall Study|Lost to Follow-up|2|||
155480693|NCT02691468|561179963|FG001|Overall Study|Lost to Follow-up|1|||
155480694|NCT02691468|561179962|FG000|Overall Study|Failure to advance FOB|2|||
155480695|NCT02691468|561179963|FG001|Overall Study|Failure to advance FOB|0|||
155480696|NCT01436357|561179966|FG000|Overall Study|Death|5|||
155480697|NCT01436357|561179967|FG001|Overall Study|Death|1|||
155480698|NCT01436357|561179966|FG000|Overall Study|Enrolled but not vaccinated|1|||
155480699|NCT01436357|561179967|FG001|Overall Study|Enrolled but not vaccinated|1|||
155480700|NCT01436357|561179966|FG000|Overall Study|Incarceration|18|||
155480701|NCT01436357|561179967|FG001|Overall Study|Incarceration|20|||
155480702|NCT01436357|561179966|FG000|Overall Study|Lost to Follow-up|67|||
155480703|NCT01436357|561179967|FG001|Overall Study|Lost to Follow-up|61|||
155480704|NCT01436357|561179966|FG000|Overall Study|Protocol Violation|1|||
155480705|NCT01436357|561179967|FG001|Overall Study|Protocol Violation|0|||
155520214|NCT00661505|561329421|FG000|Overall Study|Protocol Violation|14|||
155520215|NCT00661505|561329421|FG000|Overall Study|Withdrawal by Subject|8|||
155520216|NCT00661505|561329421|FG000|Overall Study|Lost to Follow-up|3|||
155520217|NCT00661505|561329421|FG000|Overall Study|Other|2|||
155520218|NCT04534283|561329422|FG000|Overall Study|Physician Decision|2|||
155520219|NCT04534283|561329422|FG000|Overall Study|Withdrawal by Subject|1|||
155520220|NCT04534283|561329422|FG000|Overall Study|Disease Progression|12|||
155480706|NCT01436357|561179966|FG000|Overall Study|Withdrawal by Subject|26|||
155480707|NCT01436357|561179967|FG001|Overall Study|Withdrawal by Subject|38|||
155480708|NCT01436357|561179966|FG000|Overall Study|Physician Decision|3|||
155480709|NCT01436357|561179967|FG001|Overall Study|Physician Decision|4|||
155480710|NCT01436357|561179966|FG000|Overall Study|Moved out of area|1|||
155520221|NCT04534283|561329422|FG000|Overall Study|Adverse Event|1|||
155520222|NCT00977470|561329425|FG000|Overall Study|Lack of Efficacy|32|||
155520223|NCT00977470|561329426|FG001|Overall Study|Lack of Efficacy|30|||
155520224|NCT00977470|561329425|FG000|Overall Study|Physician Decision|2|||
155520225|NCT00977470|561329426|FG001|Overall Study|Physician Decision|0|||
155480711|NCT01436357|561179967|FG001|Overall Study|Moved out of area|2|||
155480712|NCT01436357|561179966|FG000|Overall Study|Subject in rehab|0|||
155480713|NCT01436357|561179967|FG001|Overall Study|Subject in rehab|1|||
155480714|NCT04191096|561179978|FG000|Overall Study|Death|102|||
155480715|NCT04191096|561179979|FG001|Overall Study|Death|89|||
155480716|NCT04191096|561179978|FG000|Overall Study|Lost to Follow-up|1|||
155480717|NCT04191096|561179979|FG001|Overall Study|Lost to Follow-up|1|||
155480718|NCT04191096|561179978|FG000|Overall Study|Withdrawal by Subject|5|||
155520226|NCT00977470|561329425|FG000|Overall Study|Adverse Event|1|||
155520227|NCT00977470|561329426|FG001|Overall Study|Adverse Event|2|||
155480719|NCT04191096|561179979|FG001|Overall Study|Withdrawal by Subject|5|||
155480720|NCT04191096|561179978|FG000|Overall Study|Participants Ongoing|518|||
155480721|NCT04191096|561179979|FG001|Overall Study|Participants Ongoing|530|||
155480722|NCT02683668|561179982|FG000|Period 2|Withdrawal by Subject|0|||
155480723|NCT02683668|561179983|FG001|Period 2|Withdrawal by Subject|1|||
155480724|NCT02683668|561179984|FG002|Period 2|Withdrawal by Subject|0|||
155480725|NCT00631969|561179985|FG000|Overall Study|Adverse Event|3|||
155480726|NCT00631969|561179986|FG001|Overall Study|Adverse Event|1|||
155480727|NCT00631969|561179985|FG000|Overall Study|Lack of Efficacy|2|||
155480728|NCT00631969|561179986|FG001|Overall Study|Lack of Efficacy|8|||
155480729|NCT00631969|561179985|FG000|Overall Study|Lost to Follow-up|2|||
155480730|NCT00631969|561179986|FG001|Overall Study|Lost to Follow-up|1|||
155480731|NCT00631969|561179985|FG000|Overall Study|Protocol Violation|1|||
155480732|NCT00631969|561179986|FG001|Overall Study|Protocol Violation|1|||
155480733|NCT00631969|561179985|FG000|Overall Study|Consent Withdrawn|5|||
155480734|NCT00631969|561179986|FG001|Overall Study|Consent Withdrawn|7|||
155480735|NCT00631969|561179985|FG000|Overall Study|Noncompliant With Study Medication|0|||
155480736|NCT00631969|561179986|FG001|Overall Study|Noncompliant With Study Medication|1|||
155480737|NCT00631969|561179985|FG000|Overall Study|No Drug Exposure|2|||
155480738|NCT00631969|561179986|FG001|Overall Study|No Drug Exposure|2|||
155480739|NCT03893630|561179987|FG000|Overall Study|Lost to Follow-up|5|||
155480740|NCT03893630|561179988|FG001|Overall Study|Lost to Follow-up|4|||
155480741|NCT03893630|561179989|FG002|Overall Study|Lost to Follow-up|2|||
155480742|NCT03893630|561179987|FG000|Overall Study|Withdrawal by Subject|3|||
155480743|NCT03893630|561179988|FG001|Overall Study|Withdrawal by Subject|6|||
155480744|NCT03893630|561179989|FG002|Overall Study|Withdrawal by Subject|3|||
155480745|NCT03893630|561179987|FG000|Overall Study|Discontinued Intervention|0|||
155480746|NCT03893630|561179988|FG001|Overall Study|Discontinued Intervention|4|||
155480747|NCT03893630|561179989|FG002|Overall Study|Discontinued Intervention|2|||
155480748|NCT02390167|561181303|FG000|Overall Study|Lost to Follow-up|1|||
155480749|NCT00027027|561181304|FG000|Overall Study|Adverse Event|0|||
155480750|NCT00027027|561181305|FG001|Overall Study|Adverse Event|0|||
155480751|NCT00027027|561181306|FG002|Overall Study|Adverse Event|1|||
155480752|NCT00027027|561181307|FG003|Overall Study|Adverse Event|0|||
155480753|NCT00027027|561181308|FG004|Overall Study|Adverse Event|1|||
155480754|NCT00027027|561181304|FG000|Overall Study|Admitted for Signs of PD|0|||
155480755|NCT00027027|561181305|FG001|Overall Study|Admitted for Signs of PD|0|||
155480756|NCT00027027|561181306|FG002|Overall Study|Admitted for Signs of PD|0|||
155480757|NCT00027027|561181307|FG003|Overall Study|Admitted for Signs of PD|0|||
155480758|NCT00027027|561181308|FG004|Overall Study|Admitted for Signs of PD|1|||
155480759|NCT00027027|561181304|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
155480760|NCT00027027|561181305|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
155480761|NCT00027027|561181306|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
155480762|NCT00027027|561181307|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
155480763|NCT00027027|561181308|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
155480764|NCT00027027|561181304|FG000|Overall Study|PD Requiring Surgery|0|||
155480765|NCT00027027|561181305|FG001|Overall Study|PD Requiring Surgery|0|||
155480766|NCT00027027|561181306|FG002|Overall Study|PD Requiring Surgery|1|||
155480767|NCT00027027|561181307|FG003|Overall Study|PD Requiring Surgery|0|||
155480768|NCT00027027|561181308|FG004|Overall Study|PD Requiring Surgery|0|||
155480769|NCT00027027|561181304|FG000|Overall Study|Physician Decision Due To PD|2|||
155480770|NCT00027027|561181305|FG001|Overall Study|Physician Decision Due To PD|3|||
155480771|NCT00027027|561181306|FG002|Overall Study|Physician Decision Due To PD|2|||
155480772|NCT00027027|561181307|FG003|Overall Study|Physician Decision Due To PD|3|||
155480773|NCT00027027|561181308|FG004|Overall Study|Physician Decision Due To PD|5|||
155480774|NCT00027027|561181304|FG000|Overall Study|Withdrawal by Subject|0|||
155480775|NCT00027027|561181305|FG001|Overall Study|Withdrawal by Subject|0|||
155480776|NCT00027027|561181306|FG002|Overall Study|Withdrawal by Subject|0|||
155480777|NCT00027027|561181307|FG003|Overall Study|Withdrawal by Subject|0|||
155480778|NCT00027027|561181308|FG004|Overall Study|Withdrawal by Subject|1|||
155480779|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
155480780|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
155480781|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
155480782|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
155480783|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
155480784|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
155480785|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
155480786|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
155480787|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Death|0|||
155480788|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Death|0|||
155480789|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Death|0|||
155480790|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Death|1|||
155480791|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Death|1|||
155480792|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Death|0|||
155480793|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Death|2|||
155480794|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Death|0|||
155480795|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480796|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480797|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480798|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
155480799|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480800|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480801|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480802|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
155480803|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480804|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480805|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480806|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
155480807|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480808|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480809|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480810|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
155480811|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
155480812|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
155480813|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
155480814|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
155480815|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
155480816|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
155480817|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
155480818|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
155480819|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
155480820|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
155480821|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
155480822|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
155480823|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
155480824|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
155480825|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
155480826|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
155480827|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
155480828|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
155480829|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
155480830|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
155480831|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
155480832|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
155480833|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
155480834|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
155480835|NCT02442765|561181312|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480836|NCT02442765|561181313|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480837|NCT02442765|561181314|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480838|NCT02442765|561181315|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480839|NCT02442765|561181316|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
155480840|NCT02442765|561181317|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480841|NCT02442765|561181318|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
155480842|NCT02442765|561181319|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
155480843|NCT00003389|561181320|FG000|Overall Study|Disease progression|6|||
155480844|NCT00003389|561181321|FG001|Overall Study|Disease progression|1|||
155480845|NCT00003389|561181320|FG000|Overall Study|Adverse Event|13|||
155480846|NCT00003389|561181321|FG001|Overall Study|Adverse Event|2|||
155480847|NCT00003389|561181320|FG000|Overall Study|Death|0|||
155480848|NCT00003389|561181321|FG001|Overall Study|Death|3|||
155480849|NCT00003389|561181320|FG000|Overall Study|Withdrawal by Subject|12|||
155480850|NCT00003389|561181321|FG001|Overall Study|Withdrawal by Subject|5|||
155480851|NCT00003389|561181320|FG000|Overall Study|Alternative therapy|2|||
155480852|NCT00003389|561181321|FG001|Overall Study|Alternative therapy|1|||
155480853|NCT00003389|561181320|FG000|Overall Study|Complicating disease|1|||
155480854|NCT00003389|561181321|FG001|Overall Study|Complicating disease|0|||
155520228|NCT00977470|561329425|FG000|Overall Study|Protocol Violation|1|||
155520229|NCT00977470|561329426|FG001|Overall Study|Protocol Violation|0|||
155520230|NCT00977470|561329425|FG000|Overall Study|Withdrawal by Subject|0|||
155520231|NCT00977470|561329426|FG001|Overall Study|Withdrawal by Subject|2|||
155520232|NCT00977470|561329425|FG000|Overall Study|Death|0|||
155520233|NCT00977470|561329426|FG001|Overall Study|Death|2|||
155520234|NCT00977470|561329425|FG000|Overall Study|clinical decline|0|||
155520235|NCT00977470|561329426|FG001|Overall Study|clinical decline|1|||
155520236|NCT00977470|561329425|FG000|Overall Study|prolonged recovery post-surgery|0|||
155520237|NCT00977470|561329426|FG001|Overall Study|prolonged recovery post-surgery|1|||
155480855|NCT00003389|561181320|FG000|Overall Study|Off-treatment reason missing|31|||
155480856|NCT00003389|561181321|FG001|Overall Study|Off-treatment reason missing|21|||
155480857|NCT00003389|561181320|FG000|Overall Study|Ineligible|33|||
155480858|NCT00003389|561181321|FG001|Overall Study|Ineligible|27|||
155480859|NCT05466240|561181323|FG000|Overall Study|Adverse Event|1|||
155480860|NCT05466240|561181324|FG001|Overall Study|Adverse Event|0|||
155480861|NCT05466240|561181323|FG000|Overall Study|Withdrawal by Subject|1|||
155480862|NCT05466240|561181324|FG001|Overall Study|Withdrawal by Subject|0|||
155480863|NCT04880642|561181325|FG000|Randomization|Withdrawal by Subject|2|||
155480864|NCT04880642|561181326|FG001|Randomization|Withdrawal by Subject|3|||
155480865|NCT04880642|561181325|FG000|Treatment Period|Adverse Event|0|||
155480866|NCT04880642|561181326|FG001|Treatment Period|Adverse Event|1|||
155480867|NCT04880642|561181325|FG000|Treatment Period|Death|6|||
155480868|NCT04880642|561181326|FG001|Treatment Period|Death|6|||
155480869|NCT04880642|561181325|FG000|Treatment Period|Lost to Follow-up|1|||
155480870|NCT04880642|561181326|FG001|Treatment Period|Lost to Follow-up|0|||
155480871|NCT04880642|561181325|FG000|Treatment Period|Protocol Violation|0|||
155480872|NCT04880642|561181326|FG001|Treatment Period|Protocol Violation|1|||
155480873|NCT04880642|561181325|FG000|Treatment Period|Withdrawal by Subject|5|||
155480874|NCT04880642|561181326|FG001|Treatment Period|Withdrawal by Subject|3|||
155480875|NCT04880642|561181325|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
155480876|NCT04880642|561181326|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
155480877|NCT04880642|561181325|FG000|Follow-up|Death|4|||
155480878|NCT04880642|561181326|FG001|Follow-up|Death|3|||
155480879|NCT04880642|561181325|FG000|Follow-up|Withdrawal by Subject|1|||
155520238|NCT00977470|561329425|FG000|Overall Study|Still on-study|2|||
155520239|NCT00977470|561329426|FG001|Overall Study|Still on-study|0|||
155520240|NCT01004172|561329427|FG000|Overall Study|Progressive Disease in CNS Only|16|||
155520241|NCT01004172|561329427|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
155520242|NCT01004172|561329427|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
155520243|NCT01004172|561329427|FG000|Overall Study|Adverse Event|1|||
155520244|NCT01004172|561329427|FG000|Overall Study|Physician Decision|1|||
155520245|NCT01004172|561329427|FG000|Overall Study|Symptomatic Deterioration|2|||
155520246|NCT01355081|561329431|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
155520247|NCT01355081|561329432|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
155520248|NCT01355081|561329433|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
155520249|NCT01355081|561329431|FG000|Overall Study|Major Protocol Deviation|0|||
155520250|NCT01355081|561329432|FG001|Overall Study|Major Protocol Deviation|1|||
155520251|NCT01355081|561329433|FG002|Overall Study|Major Protocol Deviation|0|||
155520252|NCT01355081|561329431|FG000|Overall Study|Lost to Follow-up|0|||
155520253|NCT01355081|561329432|FG001|Overall Study|Lost to Follow-up|0|||
155520254|NCT01355081|561329433|FG002|Overall Study|Lost to Follow-up|1|||
155520255|NCT01355081|561329431|FG000|Overall Study|Withdrawal of Consent|2|||
155520256|NCT01355081|561329432|FG001|Overall Study|Withdrawal of Consent|3|||
155520257|NCT01355081|561329433|FG002|Overall Study|Withdrawal of Consent|3|||
155520258|NCT01355081|561329431|FG000|Overall Study|Lack of Efficacy|2|||
155520259|NCT01355081|561329432|FG001|Overall Study|Lack of Efficacy|1|||
155520260|NCT01355081|561329433|FG002|Overall Study|Lack of Efficacy|1|||
155520261|NCT01355081|561329431|FG000|Overall Study|Non Compliance with Study Medication|0|||
155520262|NCT01355081|561329432|FG001|Overall Study|Non Compliance with Study Medication|1|||
155520263|NCT01355081|561329433|FG002|Overall Study|Non Compliance with Study Medication|0|||
155520264|NCT02719522|561329434|FG000|Overall Study|Implant Failure|4|||
155520265|NCT02719522|561329434|FG000|Overall Study|Death|2|||
155520266|NCT02719522|561329434|FG000|Overall Study|Lost to Follow-up|5|||
155520267|NCT02456909|561329435|FG000|Overall Study|Did not receive allocated intervention|24|||
155520268|NCT02456909|561329436|FG001|Overall Study|Did not receive allocated intervention|26|||
155520269|NCT02456909|561329435|FG000|Overall Study|Did not complete the primary outcome|0|||
155520270|NCT02456909|561329436|FG001|Overall Study|Did not complete the primary outcome|1|||
155520271|NCT03309956|561329437|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
155520272|NCT04603937|561329438|FG000|Overall Study|Adverse Event|9|||
155520273|NCT04603937|561329439|FG001|Overall Study|Adverse Event|10|||
155520274|NCT04603937|561329438|FG000|Overall Study|Withdrawal by Subject|7|||
155520275|NCT04603937|561329439|FG001|Overall Study|Withdrawal by Subject|6|||
155654650|NCT03715829|561828901|FG000|Extension Period|Withdrawal by Subject|0|||
155480880|NCT04880642|561181326|FG001|Follow-up|Withdrawal by Subject|0|||
155480881|NCT00561795|561181327|FG000|Overall Study|Adverse Event|3|||
155480882|NCT00561795|561181328|FG001|Overall Study|Adverse Event|3|||
155480883|NCT00561795|561181329|FG002|Overall Study|Adverse Event|0|||
155480884|NCT00561795|561181330|FG003|Overall Study|Adverse Event|0|||
155480885|NCT00561795|561181327|FG000|Overall Study|Study Closed/Terminated|0|||
155480886|NCT00561795|561181328|FG001|Overall Study|Study Closed/Terminated|3|||
155520276|NCT04603937|561329438|FG000|Overall Study|Lost to Follow-up|5|||
155520277|NCT04603937|561329439|FG001|Overall Study|Lost to Follow-up|6|||
155520278|NCT04603937|561329438|FG000|Overall Study|Physician Decision|0|||
155520279|NCT04603937|561329439|FG001|Overall Study|Physician Decision|1|||
155520280|NCT04603937|561329438|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
155654651|NCT03715829|561828902|FG001|Extension Period|Withdrawal by Subject|0|||
155480887|NCT00561795|561181329|FG002|Overall Study|Study Closed/Terminated|0|||
155480888|NCT00561795|561181330|FG003|Overall Study|Study Closed/Terminated|0|||
155480889|NCT00561795|561181327|FG000|Overall Study|Physician Decision|1|||
155480890|NCT00561795|561181328|FG001|Overall Study|Physician Decision|0|||
155480891|NCT00561795|561181329|FG002|Overall Study|Physician Decision|0|||
155480892|NCT00561795|561181330|FG003|Overall Study|Physician Decision|0|||
155480893|NCT02807376|561181331|FG000|Overall Study|Intra-operative exclusion criteria|3|||
155480894|NCT02807376|561181332|FG001|Overall Study|Intra-operative exclusion criteria|0|||
155480895|NCT02807376|561181331|FG000|Overall Study|Lost to Follow-up|0|||
155480896|NCT02807376|561181332|FG001|Overall Study|Lost to Follow-up|1|||
155480897|NCT00948389|561181335|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
155480898|NCT00948389|561181336|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
155480899|NCT00948389|561181337|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
155480900|NCT00948389|561181338|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
155480901|NCT00948389|561181339|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
155480902|NCT00948389|561181335|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
155480903|NCT00948389|561181336|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
155520281|NCT04603937|561329439|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
155520282|NCT00993616|561329440|FG000|Overall Study|No tumor at entry|1|||
155520283|NCT00993616|561329440|FG000|Overall Study|Never treated|1|||
155520284|NCT01210001|561330903|FG000|Overall Study|Not treated|1|||
155520285|NCT01210001|561330904|FG001|Overall Study|Not treated|0|||
155520286|NCT01210001|561330905|FG002|Overall Study|Not treated|0|||
155520287|NCT01210001|561330903|FG000|Overall Study|Adverse Event|4|||
155520288|NCT01210001|561330904|FG001|Overall Study|Adverse Event|2|||
155520289|NCT01210001|561330905|FG002|Overall Study|Adverse Event|5|||
155520290|NCT01210001|561330903|FG000|Overall Study|Non compliant with protocol|2|||
155520291|NCT01210001|561330904|FG001|Overall Study|Non compliant with protocol|2|||
155520292|NCT01210001|561330905|FG002|Overall Study|Non compliant with protocol|3|||
155520293|NCT01210001|561330903|FG000|Overall Study|Lost to Follow-up|4|||
155520294|NCT01210001|561330904|FG001|Overall Study|Lost to Follow-up|3|||
155520295|NCT01210001|561330905|FG002|Overall Study|Lost to Follow-up|2|||
155520296|NCT01210001|561330903|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
155520297|NCT01210001|561330904|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
155520298|NCT01210001|561330905|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
155520299|NCT01210001|561330903|FG000|Overall Study|Other reason not defined above|2|||
155520300|NCT01210001|561330904|FG001|Overall Study|Other reason not defined above|2|||
155520301|NCT01210001|561330905|FG002|Overall Study|Other reason not defined above|1|||
155520302|NCT00419770|561330909|FG000|Overall Study|Withdrawal by Subject|5|||
155520303|NCT00419770|561330910|FG001|Overall Study|Withdrawal by Subject|1|||
155520304|NCT02848326|561330911|FG000|Treatment Period|Adverse Event|5|||
155520305|NCT02848326|561330912|FG001|Treatment Period|Adverse Event|4|||
155520306|NCT02848326|561330913|FG002|Treatment Period|Adverse Event|11|||
155520307|NCT02848326|561330914|FG003|Treatment Period|Adverse Event|6|||
155520308|NCT02848326|561330915|FG004|Treatment Period|Adverse Event|5|||
155520309|NCT02848326|561330916|FG005|Treatment Period|Adverse Event|7|||
155520310|NCT02848326|561330911|FG000|Treatment Period|Withdrawal of Consent|20|||
155520311|NCT02848326|561330912|FG001|Treatment Period|Withdrawal of Consent|6|||
155520312|NCT02848326|561330913|FG002|Treatment Period|Withdrawal of Consent|9|||
155520313|NCT02848326|561330914|FG003|Treatment Period|Withdrawal of Consent|6|||
155520314|NCT02848326|561330915|FG004|Treatment Period|Withdrawal of Consent|9|||
155520315|NCT02848326|561330916|FG005|Treatment Period|Withdrawal of Consent|6|||
155520316|NCT02848326|561330911|FG000|Treatment Period|Lost to Follow-up|5|||
155520317|NCT02848326|561330912|FG001|Treatment Period|Lost to Follow-up|1|||
155520318|NCT02848326|561330913|FG002|Treatment Period|Lost to Follow-up|11|||
155520319|NCT02848326|561330914|FG003|Treatment Period|Lost to Follow-up|7|||
155520320|NCT02848326|561330915|FG004|Treatment Period|Lost to Follow-up|2|||
155520321|NCT02848326|561330916|FG005|Treatment Period|Lost to Follow-up|3|||
155520322|NCT02848326|561330911|FG000|Treatment Period|Pregnancy|0|||
155520323|NCT02848326|561330912|FG001|Treatment Period|Pregnancy|0|||
155520324|NCT02848326|561330913|FG002|Treatment Period|Pregnancy|1|||
155520325|NCT02848326|561330914|FG003|Treatment Period|Pregnancy|1|||
155520326|NCT02848326|561330915|FG004|Treatment Period|Pregnancy|0|||
155520327|NCT02848326|561330916|FG005|Treatment Period|Pregnancy|1|||
155520328|NCT02848326|561330911|FG000|Treatment Period|Protocol Violation|4|||
155520329|NCT02848326|561330912|FG001|Treatment Period|Protocol Violation|3|||
155520330|NCT02848326|561330913|FG002|Treatment Period|Protocol Violation|4|||
155520331|NCT02848326|561330914|FG003|Treatment Period|Protocol Violation|2|||
155480904|NCT00948389|561181337|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
155480905|NCT00948389|561181338|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
155480906|NCT00948389|561181339|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
155520332|NCT02848326|561330915|FG004|Treatment Period|Protocol Violation|3|||
155480907|NCT00948389|561181335|FG000|Overall Study|Both Progression and Toxicity|1|||
155480908|NCT00948389|561181336|FG001|Overall Study|Both Progression and Toxicity|0|||
155520333|NCT02848326|561330916|FG005|Treatment Period|Protocol Violation|3|||
155520334|NCT02848326|561330911|FG000|Treatment Period|Non-compliance with Study Drug|4|||
155520335|NCT02848326|561330912|FG001|Treatment Period|Non-compliance with Study Drug|0|||
155480909|NCT00948389|561181337|FG002|Overall Study|Both Progression and Toxicity|0|||
155480910|NCT00948389|561181338|FG003|Overall Study|Both Progression and Toxicity|0|||
155480911|NCT00948389|561181339|FG004|Overall Study|Both Progression and Toxicity|0|||
155480912|NCT01072500|561181346|FG000|Overall Study|Death|2|||
155480913|NCT01072500|561181347|FG001|Overall Study|Death|2|||
155480914|NCT01072500|561181346|FG000|Overall Study|Lost to Follow-up|5|||
155480915|NCT01072500|561181347|FG001|Overall Study|Lost to Follow-up|2|||
155480916|NCT01072500|561181346|FG000|Overall Study|Withdrawal by Subject|17|||
155480917|NCT01072500|561181347|FG001|Overall Study|Withdrawal by Subject|10|||
155480918|NCT01611558|561181348|FG000|Induction Phase|Study drug toxicity|15|||
155480919|NCT01611558|561181348|FG000|Induction Phase|Disease progression|18|||
155480920|NCT01611558|561181348|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
155480921|NCT01611558|561181348|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
155480922|NCT01611558|561181348|FG000|Induction Phase|Death|1|||
155480923|NCT01611558|561181348|FG000|Maintenance Phase|Withdrawal by Subject|1|||
155480924|NCT01611558|561181348|FG000|Maintenance Phase|Elevated Uric acid|1|||
155480925|NCT03798366|561181358|FG000|Overall Study|Lost to Follow-up|0|||
155480926|NCT03798366|561181359|FG001|Overall Study|Lost to Follow-up|1|||
155480927|NCT04005885|561181363|FG000|First Intervention|Withdrawal by Subject|1|||
155480928|NCT04005885|561181364|FG001|First Intervention|Withdrawal by Subject|1|||
155480929|NCT04005885|561181363|FG000|Second Intervention|Withdrawal by Subject|0|||
155480930|NCT04005885|561181364|FG001|Second Intervention|Withdrawal by Subject|2|||
155480931|NCT01412333|561181366|FG000|Overall Study|Adverse Event|40|||
155480932|NCT01412333|561181367|FG001|Overall Study|Adverse Event|42|||
155480933|NCT01412333|561181366|FG000|Overall Study|Death|5|||
155480934|NCT01412333|561181367|FG001|Overall Study|Death|6|||
155480935|NCT01412333|561181366|FG000|Overall Study|Lack of Efficacy|22|||
155480936|NCT01412333|561181367|FG001|Overall Study|Lack of Efficacy|10|||
155480937|NCT01412333|561181366|FG000|Overall Study|Lost to Follow-up|15|||
155480938|NCT01412333|561181367|FG001|Overall Study|Lost to Follow-up|12|||
155480939|NCT01412333|561181366|FG000|Overall Study|Non-Compliance|3|||
155480940|NCT01412333|561181367|FG001|Overall Study|Non-Compliance|7|||
155480941|NCT01412333|561181366|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155480942|NCT01412333|561181367|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155480943|NCT01412333|561181366|FG000|Overall Study|Other|30|||
155480944|NCT01412333|561181367|FG001|Overall Study|Other|33|||
155480945|NCT01412333|561181366|FG000|Overall Study|Physician Decision|11|||
155480946|NCT01412333|561181367|FG001|Overall Study|Physician Decision|16|||
155480947|NCT01412333|561181366|FG000|Overall Study|Pregnancy|6|||
155480948|NCT01412333|561181367|FG001|Overall Study|Pregnancy|4|||
155480949|NCT01412333|561181366|FG000|Overall Study|Protocol Violation|1|||
155480950|NCT01412333|561181367|FG001|Overall Study|Protocol Violation|2|||
155480951|NCT01412333|561181366|FG000|Overall Study|Study Terminated By Sponsor|3|||
155480952|NCT01412333|561181367|FG001|Overall Study|Study Terminated By Sponsor|2|||
155480953|NCT01412333|561181366|FG000|Overall Study|Withdrawal by Subject|51|||
155480954|NCT01412333|561181367|FG001|Overall Study|Withdrawal by Subject|54|||
155480955|NCT01412333|561181366|FG000|Overall Study|Missing|1|||
155480956|NCT01412333|561181367|FG001|Overall Study|Missing|3|||
155480957|NCT00750867|561181370|FG000|Overall Study|Adverse Event|2|||
155480958|NCT00394654|561181371|FG000|Overall Study|Lost to Follow-up|1|||
155480959|NCT00394654|561181372|FG001|Overall Study|Lost to Follow-up|0|||
155480960|NCT00394654|561181371|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
155480961|NCT00394654|561181372|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
155480962|NCT00474539|561181373|FG000|Infant Series|Withdrawal by Subject|3|||
155520336|NCT02848326|561330913|FG002|Treatment Period|Non-compliance with Study Drug|0|||
155520337|NCT02848326|561330914|FG003|Treatment Period|Non-compliance with Study Drug|1|||
155520338|NCT02848326|561330915|FG004|Treatment Period|Non-compliance with Study Drug|0|||
155520339|NCT02848326|561330916|FG005|Treatment Period|Non-compliance with Study Drug|0|||
155520340|NCT02848326|561330911|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
155480963|NCT00474539|561181374|FG001|Infant Series|Withdrawal by Subject|4|||
155480964|NCT00474539|561181373|FG000|Infant Series|Randomization error|5|||
155480965|NCT00474539|561181374|FG001|Infant Series|Randomization error|0|||
155480966|NCT00474539|561181373|FG000|Infant Series|Lost to Follow-up|2|||
155480967|NCT00474539|561181374|FG001|Infant Series|Lost to Follow-up|1|||
155480968|NCT00474539|561181373|FG000|Infant Series|Protocol Violation|0|||
155480969|NCT00474539|561181374|FG001|Infant Series|Protocol Violation|1|||
155480970|NCT00474539|561181373|FG000|After Infant Series|Lost to Follow-up|3|||
155480971|NCT00474539|561181374|FG001|After Infant Series|Lost to Follow-up|0|||
155480972|NCT00474539|561181373|FG000|After Infant Series|Withdrawal by Subject|1|||
155480973|NCT00474539|561181374|FG001|After Infant Series|Withdrawal by Subject|0|||
155480974|NCT00474539|561181373|FG000|Toddler Dose|Protocol Violation|1|||
155480975|NCT00474539|561181374|FG001|Toddler Dose|Protocol Violation|0|||
155480976|NCT03442595|561181375|FG000|Overall Study|Lost to Follow-up|94|||
155480977|NCT03442595|561181376|FG001|Overall Study|Lost to Follow-up|0|||
155480978|NCT03018340|561181379|FG000|Overall Study|Adverse Event|1|||
155480979|NCT03018340|561181380|FG001|Overall Study|Adverse Event|2|||
155480980|NCT03018340|561181379|FG000|Overall Study|Withdrawal by Subject|0|||
155480981|NCT03018340|561181380|FG001|Overall Study|Withdrawal by Subject|8|||
155480982|NCT03018340|561181379|FG000|Overall Study|Lack of Efficacy|0|||
155480983|NCT03018340|561181380|FG001|Overall Study|Lack of Efficacy|1|||
155480984|NCT03018340|561181379|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
155480985|NCT03018340|561181380|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
155480986|NCT03018340|561181379|FG000|Overall Study|Lost to Follow-up|1|||
155480987|NCT03018340|561181380|FG001|Overall Study|Lost to Follow-up|7|||
155480988|NCT03018340|561181379|FG000|Overall Study|Protocol Violation|3|||
155480989|NCT03018340|561181380|FG001|Overall Study|Protocol Violation|7|||
155480990|NCT03018340|561181379|FG000|Overall Study|Not further specified|0|||
155480991|NCT03018340|561181380|FG001|Overall Study|Not further specified|1|||
155480992|NCT01836549|561181381|FG000|Overall Study|Did not receive study drug|0|||
155480993|NCT01836549|561181382|FG001|Overall Study|Did not receive study drug|0|||
155480994|NCT01836549|561181383|FG002|Overall Study|Did not receive study drug|1|||
155480995|NCT01836549|561181384|FG003|Overall Study|Did not receive study drug|0|||
155480996|NCT01836549|561181385|FG004|Overall Study|Did not receive study drug|0|||
155480997|NCT01836549|561181386|FG005|Overall Study|Did not receive study drug|0|||
155480998|NCT01836549|561181387|FG006|Overall Study|Did not receive study drug|0|||
155480999|NCT01836549|561181381|FG000|Overall Study|Patient declared ineligible|0|||
155481000|NCT01836549|561181382|FG001|Overall Study|Patient declared ineligible|0|||
155481001|NCT01836549|561181383|FG002|Overall Study|Patient declared ineligible|0|||
155520341|NCT02848326|561330912|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
155520342|NCT02848326|561330913|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
155520343|NCT02848326|561330914|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
155520344|NCT02848326|561330915|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
155520345|NCT02848326|561330916|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
155520346|NCT02848326|561330911|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
155520347|NCT02848326|561330912|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
155520348|NCT02848326|561330913|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
155520349|NCT02848326|561330914|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
155520350|NCT02848326|561330915|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
155520351|NCT02848326|561330916|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
155520352|NCT02937701|561330922|FG000|Day 1 to Week 22|Adverse Event|11|||
155520353|NCT02937701|561330923|FG001|Day 1 to Week 22|Adverse Event|14|||
155481002|NCT01836549|561181384|FG003|Overall Study|Patient declared ineligible|1|||
155481003|NCT01836549|561181385|FG004|Overall Study|Patient declared ineligible|0|||
155481004|NCT01836549|561181386|FG005|Overall Study|Patient declared ineligible|0|||
155481005|NCT01836549|561181387|FG006|Overall Study|Patient declared ineligible|0|||
155481006|NCT01836549|561181381|FG000|Overall Study|Patient inevaluable to start therapy|0|||
155481007|NCT01836549|561181382|FG001|Overall Study|Patient inevaluable to start therapy|0|||
155481008|NCT01836549|561181383|FG002|Overall Study|Patient inevaluable to start therapy|0|||
155481009|NCT01836549|561181384|FG003|Overall Study|Patient inevaluable to start therapy|0|||
155481010|NCT01836549|561181385|FG004|Overall Study|Patient inevaluable to start therapy|0|||
155481011|NCT01836549|561181386|FG005|Overall Study|Patient inevaluable to start therapy|0|||
155520354|NCT02937701|561330924|FG002|Day 1 to Week 22|Adverse Event|0|||
155520355|NCT02937701|561330925|FG003|Day 1 to Week 22|Adverse Event|0|||
155520356|NCT02937701|561330926|FG004|Day 1 to Week 22|Adverse Event|0|||
155520357|NCT02937701|561330922|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
155520358|NCT02937701|561330923|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
155520359|NCT02937701|561330924|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
155520360|NCT02937701|561330925|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
155520361|NCT02937701|561330926|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
155520362|NCT02937701|561330922|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
155520363|NCT02937701|561330923|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
155520364|NCT02937701|561330924|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
155520365|NCT02937701|561330925|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
155520366|NCT02937701|561330926|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
155520367|NCT02937701|561330922|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
155654652|NCT03715829|561828903|FG002|Extension Period|Withdrawal by Subject|0|||
155654653|NCT03715829|561828904|FG003|Extension Period|Withdrawal by Subject|0|||
155654654|NCT03715829|561828905|FG004|Extension Period|Withdrawal by Subject|0|||
155654655|NCT03715829|561828906|FG005|Extension Period|Withdrawal by Subject|0|||
155481012|NCT01836549|561181387|FG006|Overall Study|Patient inevaluable to start therapy|1|||
155481013|NCT04652102|561181388|FG000|Overall Study|Adverse Event|14|||
155481014|NCT04652102|561181389|FG001|Overall Study|Adverse Event|13|||
155481015|NCT04652102|561181388|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
155481016|NCT04652102|561181389|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
155481017|NCT04652102|561181388|FG000|Overall Study|Physician Decision|78|||
155481018|NCT04652102|561181389|FG001|Overall Study|Physician Decision|40|||
155481019|NCT04652102|561181388|FG000|Overall Study|Study Ended by Sponsor|64|||
155481020|NCT04652102|561181389|FG001|Overall Study|Study Ended by Sponsor|17|||
155481021|NCT04652102|561181388|FG000|Overall Study|Withdrawal by Subject|4625|||
155481022|NCT04652102|561181389|FG001|Overall Study|Withdrawal by Subject|5594|||
155481023|NCT04652102|561181388|FG000|Overall Study|Lost to Follow-up|2019|||
155481024|NCT04652102|561181389|FG001|Overall Study|Lost to Follow-up|1082|||
155481025|NCT04652102|561181388|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
155481026|NCT04652102|561181389|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
155481027|NCT04652102|561181388|FG000|Overall Study|Miscellaneous|80|||
155481028|NCT04652102|561181389|FG001|Overall Study|Miscellaneous|64|||
155481029|NCT02192190|561181390|FG000|Overall Study|Adverse Event|1|||
155481030|NCT02192190|561181391|FG001|Overall Study|Adverse Event|1|||
155481031|NCT02192190|561181392|FG002|Overall Study|Adverse Event|0|||
155481032|NCT02192190|561181393|FG003|Overall Study|Adverse Event|0|||
155481033|NCT02192190|561181394|FG004|Overall Study|Adverse Event|0|||
155481034|NCT02192190|561181395|FG005|Overall Study|Adverse Event|0|||
155481035|NCT02192190|561181390|FG000|Overall Study|Lost to Follow-up|3|||
155481036|NCT02192190|561181391|FG001|Overall Study|Lost to Follow-up|3|||
155481037|NCT02192190|561181392|FG002|Overall Study|Lost to Follow-up|2|||
155481038|NCT02192190|561181393|FG003|Overall Study|Lost to Follow-up|1|||
155481039|NCT02192190|561181394|FG004|Overall Study|Lost to Follow-up|4|||
155481040|NCT02192190|561181395|FG005|Overall Study|Lost to Follow-up|3|||
155481041|NCT02192190|561181390|FG000|Overall Study|Physician Decision|2|||
155481042|NCT02192190|561181391|FG001|Overall Study|Physician Decision|0|||
155481043|NCT02192190|561181392|FG002|Overall Study|Physician Decision|0|||
155481044|NCT02192190|561181393|FG003|Overall Study|Physician Decision|0|||
155481045|NCT02192190|561181394|FG004|Overall Study|Physician Decision|0|||
155481046|NCT02192190|561181395|FG005|Overall Study|Physician Decision|0|||
155481047|NCT02192190|561181390|FG000|Overall Study|Terminated by Sponsor|43|||
155481048|NCT02192190|561181391|FG001|Overall Study|Terminated by Sponsor|23|||
155481049|NCT02192190|561181392|FG002|Overall Study|Terminated by Sponsor|20|||
155481050|NCT02192190|561181393|FG003|Overall Study|Terminated by Sponsor|23|||
155481051|NCT02192190|561181394|FG004|Overall Study|Terminated by Sponsor|21|||
155481052|NCT02192190|561181395|FG005|Overall Study|Terminated by Sponsor|23|||
155481053|NCT02192190|561181390|FG000|Overall Study|Withdrawal by Subject|4|||
155481054|NCT02192190|561181391|FG001|Overall Study|Withdrawal by Subject|1|||
155481055|NCT02192190|561181392|FG002|Overall Study|Withdrawal by Subject|2|||
155481056|NCT02192190|561181393|FG003|Overall Study|Withdrawal by Subject|1|||
155481057|NCT02192190|561181394|FG004|Overall Study|Withdrawal by Subject|5|||
155481058|NCT02192190|561181395|FG005|Overall Study|Withdrawal by Subject|3|||
155481059|NCT02192190|561181390|FG000|Overall Study|Could not Keep Visit Schedule|1|||
155481060|NCT02192190|561181391|FG001|Overall Study|Could not Keep Visit Schedule|0|||
155481061|NCT02192190|561181392|FG002|Overall Study|Could not Keep Visit Schedule|0|||
155481062|NCT02192190|561181393|FG003|Overall Study|Could not Keep Visit Schedule|0|||
155481063|NCT02192190|561181394|FG004|Overall Study|Could not Keep Visit Schedule|0|||
155481064|NCT02192190|561181395|FG005|Overall Study|Could not Keep Visit Schedule|0|||
155481065|NCT02192190|561181390|FG000|Overall Study|Positive Drug Screen|0|||
155481066|NCT02192190|561181391|FG001|Overall Study|Positive Drug Screen|0|||
155481067|NCT02192190|561181392|FG002|Overall Study|Positive Drug Screen|0|||
155481068|NCT02192190|561181393|FG003|Overall Study|Positive Drug Screen|1|||
155481069|NCT02192190|561181394|FG004|Overall Study|Positive Drug Screen|0|||
155481070|NCT02192190|561181395|FG005|Overall Study|Positive Drug Screen|0|||
155481071|NCT02192190|561181390|FG000|Overall Study|Inadequate Pain Relief|0|||
155481072|NCT02192190|561181391|FG001|Overall Study|Inadequate Pain Relief|1|||
155481073|NCT02192190|561181392|FG002|Overall Study|Inadequate Pain Relief|1|||
155481074|NCT02192190|561181393|FG003|Overall Study|Inadequate Pain Relief|0|||
155481075|NCT02192190|561181394|FG004|Overall Study|Inadequate Pain Relief|0|||
155481076|NCT02192190|561181395|FG005|Overall Study|Inadequate Pain Relief|0|||
155481077|NCT01657253|561181396|FG000|Overall Study|Lost to Follow-up|6|||
155481078|NCT01657253|561181397|FG001|Overall Study|Lost to Follow-up|5|||
155481079|NCT01657253|561181396|FG000|Overall Study|Withdrawal by Subject|11|||
155481080|NCT01657253|561181397|FG001|Overall Study|Withdrawal by Subject|12|||
155481081|NCT01657253|561181396|FG000|Overall Study|Adverse Event|0|||
155481082|NCT01657253|561181397|FG001|Overall Study|Adverse Event|1|||
155481083|NCT00381706|561181398|FG000|Overall Study|Never treated|7|||
155481084|NCT00381706|561181399|FG001|Overall Study|Never treated|2|||
155481085|NCT00381706|561181400|FG002|Overall Study|Never treated|1|||
155481086|NCT02364999|561181401|FG000|Overall Study|Death|136|||
155654656|NCT03715829|561828907|FG006|Extension Period|Withdrawal by Subject|3|||
155481087|NCT02364999|561181402|FG001|Overall Study|Death|138|||
155481088|NCT02364999|561181401|FG000|Overall Study|Lost to Follow-up|10|||
155481089|NCT02364999|561181402|FG001|Overall Study|Lost to Follow-up|15|||
155481090|NCT02364999|561181401|FG000|Overall Study|Protocol Violation|3|||
155481091|NCT02364999|561181402|FG001|Overall Study|Protocol Violation|2|||
155481092|NCT02364999|561181401|FG000|Overall Study|Withdrawal by Subject|14|||
155481093|NCT02364999|561181402|FG001|Overall Study|Withdrawal by Subject|14|||
155481094|NCT02364999|561181401|FG000|Overall Study|Other|0|||
155481095|NCT02364999|561181402|FG001|Overall Study|Other|1|||
155520368|NCT02937701|561330923|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
155520369|NCT02937701|561330924|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
155520370|NCT02937701|561330925|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
155520371|NCT02937701|561330926|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
155481096|NCT02364999|561181401|FG000|Overall Study|Randomized but did not receive treatment|2|||
155481097|NCT02364999|561181402|FG001|Overall Study|Randomized but did not receive treatment|3|||
155481098|NCT00550615|561181403|FG000|Overall Study|Withdrawal by Subject|0|||
155481099|NCT00550615|561181404|FG001|Overall Study|Withdrawal by Subject|0|||
155481100|NCT00550615|561181405|FG002|Overall Study|Withdrawal by Subject|2|||
155481101|NCT00550615|561181406|FG003|Overall Study|Withdrawal by Subject|3|||
155481102|NCT00550615|561181403|FG000|Overall Study|Not evaluable|0|||
155481103|NCT00550615|561181404|FG001|Overall Study|Not evaluable|0|||
155481104|NCT00550615|561181405|FG002|Overall Study|Not evaluable|2|||
155481105|NCT00550615|561181406|FG003|Overall Study|Not evaluable|7|||
155481106|NCT00598585|561181407|FG000|Overall Study|Lost to Follow-up|1|||
155481107|NCT00598585|561181408|FG001|Overall Study|Lost to Follow-up|0|||
155481108|NCT00545584|561181409|FG000|Overall Study|Only one reason for discontinuation|62|||
155481109|NCT00545584|561181410|FG001|Overall Study|Only one reason for discontinuation|61|||
155481110|NCT00545584|561181411|FG002|Overall Study|Only one reason for discontinuation|48|||
155481111|NCT00545584|561181409|FG000|Overall Study|Two or more reasons for discontinuation|17|||
155481112|NCT00545584|561181410|FG001|Overall Study|Two or more reasons for discontinuation|19|||
155481113|NCT00545584|561181411|FG002|Overall Study|Two or more reasons for discontinuation|8|||
155481114|NCT00461552|561181415|FG000|Overall Study|Drug Dispensing error|0|||
155481115|NCT00461552|561181416|FG001|Overall Study|Drug Dispensing error|2|||
155481116|NCT00523744|561181417|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
155481117|NCT00523744|561181417|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
155481118|NCT00523744|561181417|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
155481119|NCT00523744|561181417|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
155481120|NCT00523744|561181417|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
155481121|NCT00523744|561181417|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
155481122|NCT01289028|561181418|FG000|Overall Study|Progressive Disease|49|||
155481123|NCT01289028|561181418|FG000|Overall Study|Adverse Event|14|||
155481124|NCT01289028|561181418|FG000|Overall Study|Withdrawal by Subject|6|||
155481125|NCT01289028|561181418|FG000|Overall Study|Death|4|||
155481126|NCT01289028|561181418|FG000|Overall Study|Lack of Efficacy|2|||
155481127|NCT01289028|561181418|FG000|Overall Study|No longer required|2|||
155481128|NCT01289028|561181418|FG000|Overall Study|Lost to Follow-up|2|||
155481129|NCT01289028|561181418|FG000|Overall Study|New Cancer Therapy|2|||
155481130|NCT01289028|561181418|FG000|Overall Study|Abnormal Lab Value|1|||
155481131|NCT01289028|561181418|FG000|Overall Study|Missing reason for discon|1|||
155481132|NCT00998985|561181421|FG000|Overall Study|Withdrawal by Subject|0|||
155481133|NCT00998985|561181422|FG001|Overall Study|Withdrawal by Subject|0|||
155481134|NCT00998985|561181423|FG002|Overall Study|Withdrawal by Subject|0|||
155481135|NCT00998985|561181424|FG003|Overall Study|Withdrawal by Subject|0|||
155481136|NCT00998985|561181425|FG004|Overall Study|Withdrawal by Subject|0|||
155481137|NCT00998985|561181426|FG005|Overall Study|Withdrawal by Subject|0|||
155481138|NCT00998985|561181427|FG006|Overall Study|Withdrawal by Subject|0|||
155481139|NCT00998985|561181428|FG007|Overall Study|Withdrawal by Subject|0|||
155481140|NCT00998985|561181429|FG008|Overall Study|Withdrawal by Subject|1|||
155481141|NCT00998985|561181430|FG009|Overall Study|Withdrawal by Subject|0|||
155481142|NCT00998985|561181431|FG010|Overall Study|Withdrawal by Subject|0|||
155520372|NCT02937701|561330922|FG000|Day 1 to Week 22|Death|1|||
155520373|NCT02937701|561330923|FG001|Day 1 to Week 22|Death|1|||
155520374|NCT02937701|561330924|FG002|Day 1 to Week 22|Death|0|||
155520375|NCT02937701|561330925|FG003|Day 1 to Week 22|Death|0|||
155481143|NCT00998985|561181432|FG011|Overall Study|Withdrawal by Subject|0|||
155481144|NCT00998985|561181433|FG012|Overall Study|Withdrawal by Subject|0|||
155481145|NCT00998985|561181434|FG013|Overall Study|Withdrawal by Subject|0|||
155481146|NCT00998985|561181421|FG000|Overall Study|Protocol Violation|0|||
155481147|NCT00998985|561181422|FG001|Overall Study|Protocol Violation|0|||
155481148|NCT00998985|561181423|FG002|Overall Study|Protocol Violation|0|||
155481149|NCT00998985|561181424|FG003|Overall Study|Protocol Violation|0|||
155481150|NCT00998985|561181425|FG004|Overall Study|Protocol Violation|0|||
155481151|NCT00998985|561181426|FG005|Overall Study|Protocol Violation|1|||
155520376|NCT02937701|561330926|FG004|Day 1 to Week 22|Death|0|||
155481152|NCT00998985|561181427|FG006|Overall Study|Protocol Violation|0|||
155481153|NCT00998985|561181428|FG007|Overall Study|Protocol Violation|0|||
155481154|NCT00998985|561181429|FG008|Overall Study|Protocol Violation|0|||
155481155|NCT00998985|561181430|FG009|Overall Study|Protocol Violation|0|||
155481156|NCT00998985|561181431|FG010|Overall Study|Protocol Violation|0|||
155481157|NCT00998985|561181432|FG011|Overall Study|Protocol Violation|0|||
155520377|NCT02937701|561330922|FG000|Day 1 to Week 22|Protocol Violation|1|||
155520378|NCT02937701|561330923|FG001|Day 1 to Week 22|Protocol Violation|1|||
155481158|NCT00998985|561181433|FG012|Overall Study|Protocol Violation|0|||
155481159|NCT00998985|561181434|FG013|Overall Study|Protocol Violation|0|||
155481160|NCT00415623|561181437|FG000|Overall Study|Adverse Event|3|||
155481161|NCT00415623|561181438|FG001|Overall Study|Adverse Event|4|||
155481162|NCT00415623|561181437|FG000|Overall Study|Death|1|||
155481163|NCT00415623|561181438|FG001|Overall Study|Death|0|||
155481164|NCT00415623|561181437|FG000|Overall Study|Withdrawal by Subject|1|||
155481165|NCT00415623|561181438|FG001|Overall Study|Withdrawal by Subject|1|||
155481166|NCT02520141|561181444|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
155481167|NCT02036476|561181445|FG000|Overall Study|Withdrawal by Subject|2|||
155481168|NCT02036476|561181445|FG000|Overall Study|Progressive Disease|4|||
155481169|NCT02036476|561181445|FG000|Overall Study|Unacceptable Toxicity|2|||
155481170|NCT02168816|561181446|FG000|Overall Study|Lost to Follow-up|2|||
155481171|NCT02168816|561181447|FG001|Overall Study|Lost to Follow-up|2|||
155481172|NCT00410514|561181450|FG000|Overall Study|Adverse Event|2|||
155481173|NCT00410514|561181451|FG001|Overall Study|Adverse Event|2|||
155481174|NCT00410514|561181452|FG002|Overall Study|Adverse Event|2|||
155481175|NCT00410514|561181450|FG000|Overall Study|Protocol Violation|0|||
155481176|NCT00410514|561181451|FG001|Overall Study|Protocol Violation|1|||
155481177|NCT00410514|561181452|FG002|Overall Study|Protocol Violation|1|||
155481178|NCT00410514|561181450|FG000|Overall Study|Lost to Follow-up|0|||
155481179|NCT00410514|561181451|FG001|Overall Study|Lost to Follow-up|0|||
155481180|NCT00410514|561181452|FG002|Overall Study|Lost to Follow-up|2|||
155481181|NCT00410514|561181450|FG000|Overall Study|Non-compliant with study procedures|0|||
155481182|NCT00410514|561181451|FG001|Overall Study|Non-compliant with study procedures|0|||
155481183|NCT00410514|561181452|FG002|Overall Study|Non-compliant with study procedures|2|||
155481184|NCT02985684|561181455|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
155481185|NCT02985684|561181455|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
155481186|NCT02985684|561181455|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
155481187|NCT01265719|561182614|FG000|Overall Study|Does not meet entrance criteria|0|||
155481188|NCT01265719|561182615|FG001|Overall Study|Does not meet entrance criteria|3|||
155481189|NCT01265719|561182614|FG000|Overall Study|Other reasons|2|||
155481190|NCT01265719|561182615|FG001|Overall Study|Other reasons|0|||
155481191|NCT01265719|561182614|FG000|Overall Study|Withdrawal by Subject|8|||
155481192|NCT01265719|561182615|FG001|Overall Study|Withdrawal by Subject|3|||
155481193|NCT01265719|561182614|FG000|Overall Study|Lost to Follow-up|2|||
155481194|NCT01265719|561182615|FG001|Overall Study|Lost to Follow-up|7|||
155481195|NCT01265719|561182614|FG000|Overall Study|Adverse Event|2|||
155481196|NCT01265719|561182615|FG001|Overall Study|Adverse Event|0|||
155481197|NCT01451203|561182618|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
155481198|NCT01451203|561182619|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
155481199|NCT01451203|561182618|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
155481200|NCT01451203|561182619|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
155481201|NCT01451203|561182618|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
155481202|NCT01451203|561182619|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
155481203|NCT01451203|561182618|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
155481204|NCT01451203|561182619|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
155481205|NCT01451203|561182618|FG000|Double-blind Treatment Period|Adverse Event|6|||
155481206|NCT01451203|561182619|FG001|Double-blind Treatment Period|Adverse Event|9|||
155481207|NCT01451203|561182618|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
155481208|NCT01451203|561182619|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
155481209|NCT01451203|561182618|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
155481210|NCT01451203|561182619|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
155481211|NCT01451203|561182618|FG000|Double-blind Treatment Period|Investigator decision|2|||
155481212|NCT01451203|561182619|FG001|Double-blind Treatment Period|Investigator decision|0|||
155481213|NCT01451203|561182618|FG000|Post-treatment Period|Consent withdrawn|2|||
155481214|NCT01451203|561182619|FG001|Post-treatment Period|Consent withdrawn|4|||
155481215|NCT01451203|561182618|FG000|Post-treatment Period|Lack of Efficacy|12|||
155481216|NCT01451203|561182619|FG001|Post-treatment Period|Lack of Efficacy|28|||
155481217|NCT01451203|561182618|FG000|Post-treatment Period|Adverse Event|0|||
155481218|NCT01451203|561182619|FG001|Post-treatment Period|Adverse Event|1|||
155481219|NCT01451203|561182618|FG000|Post-treatment Period|Investigator decision|0|||
155481220|NCT01451203|561182619|FG001|Post-treatment Period|Investigator decision|1|||
155481221|NCT02554721|561182620|FG000|Overall Study|Adverse Event|1|||
155481222|NCT02554721|561182621|FG001|Overall Study|Adverse Event|0|||
155481223|NCT02554721|561182622|FG002|Overall Study|Adverse Event|0|||
155481224|NCT02554721|561182623|FG003|Overall Study|Adverse Event|0|||
155481225|NCT02554721|561182624|FG004|Overall Study|Adverse Event|1|||
155481226|NCT02554721|561182620|FG000|Overall Study|Noncompliance|0|||
155481227|NCT02554721|561182621|FG001|Overall Study|Noncompliance|0|||
155481228|NCT02554721|561182622|FG002|Overall Study|Noncompliance|0|||
155481229|NCT02554721|561182623|FG003|Overall Study|Noncompliance|0|||
155481230|NCT02554721|561182624|FG004|Overall Study|Noncompliance|1|||
155481231|NCT00945945|561182630|FG000|Overall Study|Adverse Event|15|||
155481232|NCT00945945|561182631|FG001|Overall Study|Adverse Event|35|||
155481233|NCT00945945|561182630|FG000|Overall Study|Withdrawal by Subject|7|||
155481234|NCT00945945|561182631|FG001|Overall Study|Withdrawal by Subject|10|||
155481235|NCT00945945|561182630|FG000|Overall Study|Lost to Follow-up|4|||
155481236|NCT00945945|561182631|FG001|Overall Study|Lost to Follow-up|5|||
155481237|NCT00945945|561182630|FG000|Overall Study|Lack of Efficacy|6|||
155481238|NCT00945945|561182631|FG001|Overall Study|Lack of Efficacy|2|||
155481239|NCT00945945|561182630|FG000|Overall Study|Protocol Violation|4|||
155481240|NCT00945945|561182631|FG001|Overall Study|Protocol Violation|2|||
155481241|NCT00945945|561182630|FG000|Overall Study|Entry Criteria Not Met|0|||
155481242|NCT00945945|561182631|FG001|Overall Study|Entry Criteria Not Met|1|||
155481243|NCT00626327|561182632|FG000|Overall Study|Withdrawal by Subject|21|||
155481244|NCT00626327|561182633|FG001|Overall Study|Withdrawal by Subject|29|||
155481245|NCT00626327|561182634|FG002|Overall Study|Withdrawal by Subject|30|||
155481246|NCT00626327|561182632|FG000|Overall Study|Adverse Event|1|||
155481247|NCT00626327|561182633|FG001|Overall Study|Adverse Event|0|||
155481248|NCT00626327|561182634|FG002|Overall Study|Adverse Event|0|||
155481249|NCT00626327|561182632|FG000|Overall Study|Lost to Follow-up|24|||
155481250|NCT00626327|561182633|FG001|Overall Study|Lost to Follow-up|21|||
155481251|NCT00626327|561182634|FG002|Overall Study|Lost to Follow-up|23|||
155481252|NCT00626327|561182632|FG000|Overall Study|Inappropriate enrollment|4|||
155481253|NCT00626327|561182633|FG001|Overall Study|Inappropriate enrollment|5|||
155481254|NCT00626327|561182634|FG002|Overall Study|Inappropriate enrollment|3|||
155481255|NCT00626327|561182632|FG000|Overall Study|Administrative Reason|2|||
155481256|NCT00626327|561182633|FG001|Overall Study|Administrative Reason|0|||
155481257|NCT00626327|561182634|FG002|Overall Study|Administrative Reason|6|||
155481258|NCT00626327|561182632|FG000|Overall Study|Protocol Violation|26|||
155481259|NCT00626327|561182633|FG001|Overall Study|Protocol Violation|4|||
155481260|NCT00626327|561182634|FG002|Overall Study|Protocol Violation|26|||
155481261|NCT02967562|561182637|FG000|Overall Study|Consent not obtained|1|||
155481262|NCT02967562|561182638|FG001|Overall Study|Consent not obtained|0|||
155481263|NCT02967562|561182637|FG000|Overall Study|High leak precluding analysis|1|||
155481264|NCT02967562|561182638|FG001|Overall Study|High leak precluding analysis|1|||
155520379|NCT02937701|561330924|FG002|Day 1 to Week 22|Protocol Violation|0|||
155520380|NCT02937701|561330925|FG003|Day 1 to Week 22|Protocol Violation|0|||
155520381|NCT02937701|561330926|FG004|Day 1 to Week 22|Protocol Violation|0|||
155520382|NCT02937701|561330922|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
155520383|NCT02937701|561330923|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
155520384|NCT02937701|561330924|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
155520385|NCT02937701|561330925|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
155520386|NCT02937701|561330926|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
155520387|NCT02937701|561330922|FG000|Day 1 to Week 22|Physician Decision|2|||
155520388|NCT02937701|561330923|FG001|Day 1 to Week 22|Physician Decision|0|||
155481265|NCT00286156|561182642|FG000|Overall Study|Missed 12 month visit|0|||
155481266|NCT00286156|561182643|FG001|Overall Study|Missed 12 month visit|0|||
155481267|NCT00286156|561182644|FG002|Overall Study|Missed 12 month visit|1|||
155481268|NCT00286156|561182642|FG000|Overall Study|AE: pulmonary embolus|0|||
155481269|NCT00286156|561182643|FG001|Overall Study|AE: pulmonary embolus|1|||
155481270|NCT00286156|561182644|FG002|Overall Study|AE: pulmonary embolus|0|||
155481271|NCT00286156|561182642|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
155481272|NCT00286156|561182643|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
155481273|NCT00286156|561182644|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
155481274|NCT00286156|561182642|FG000|Overall Study|AE: pneumonia|1|||
155481275|NCT00286156|561182643|FG001|Overall Study|AE: pneumonia|0|||
155481276|NCT00286156|561182644|FG002|Overall Study|AE: pneumonia|0|||
155481277|NCT02447952|561182649|FG000|Overall Study|Adverse Event|2|||
155481278|NCT02447952|561182649|FG000|Overall Study|Physician Decision|1|||
155481279|NCT02447952|561182649|FG000|Overall Study|Withdrawal by Subject|4|||
155481280|NCT00579527|561182650|FG000|Overall Study|Death|4|||
155481281|NCT00203294|561182651|FG000|Overall Study|Withdrawal by Subject|8|||
155481282|NCT00203294|561182652|FG001|Overall Study|Withdrawal by Subject|13|||
155481283|NCT02405091|561182654|FG000|Overall Study|Adverse Event|16|||
155481284|NCT02405091|561182655|FG001|Overall Study|Adverse Event|10|||
155481285|NCT02405091|561182656|FG002|Overall Study|Adverse Event|0|||
155481286|NCT02405091|561182654|FG000|Overall Study|Protocol Violation|1|||
155481287|NCT02405091|561182655|FG001|Overall Study|Protocol Violation|0|||
155481288|NCT02405091|561182656|FG002|Overall Study|Protocol Violation|0|||
155481289|NCT02405091|561182654|FG000|Overall Study|Noncompliance|1|||
155481290|NCT02405091|561182655|FG001|Overall Study|Noncompliance|6|||
155481291|NCT02405091|561182656|FG002|Overall Study|Noncompliance|2|||
155481292|NCT02405091|561182654|FG000|Overall Study|Withdrawal by Subject|4|||
155481293|NCT02405091|561182655|FG001|Overall Study|Withdrawal by Subject|8|||
155481294|NCT02405091|561182656|FG002|Overall Study|Withdrawal by Subject|0|||
155481295|NCT02405091|561182654|FG000|Overall Study|Death|0|||
155481296|NCT02405091|561182655|FG001|Overall Study|Death|1|||
155481297|NCT02405091|561182656|FG002|Overall Study|Death|0|||
155481298|NCT02405091|561182654|FG000|Overall Study|Lost to Follow-up|5|||
155481299|NCT02405091|561182655|FG001|Overall Study|Lost to Follow-up|6|||
155481300|NCT02405091|561182656|FG002|Overall Study|Lost to Follow-up|0|||
155481301|NCT02405091|561182654|FG000|Overall Study|Physician Decision|2|||
155481302|NCT02405091|561182655|FG001|Overall Study|Physician Decision|2|||
155481303|NCT02405091|561182656|FG002|Overall Study|Physician Decision|0|||
155481304|NCT01948791|561182663|FG000|Overall Study|Adverse Event|12|||
155481305|NCT01948791|561182663|FG000|Overall Study|Lack of Efficacy|3|||
155481306|NCT01948791|561182663|FG000|Overall Study|Protocol Violation|2|||
155481307|NCT01948791|561182663|FG000|Overall Study|Withdrawal by Subject|5|||
155481308|NCT01948791|561182663|FG000|Overall Study|Lost to Follow-up|6|||
155481309|NCT01948791|561182663|FG000|Overall Study|Management issues|1|||
155481310|NCT01948791|561182663|FG000|Overall Study|Others|7|||
155481311|NCT01948791|561182663|FG000|Overall Study|Screening failure|35|||
155481312|NCT00135694|561182669|FG000|Overall Study|Adverse Event|17|||
155481313|NCT00135694|561182670|FG001|Overall Study|Adverse Event|4|||
155481314|NCT00135694|561182671|FG002|Overall Study|Adverse Event|0|||
155481315|NCT00135694|561182669|FG000|Overall Study|Death|14|||
155481316|NCT00135694|561182670|FG001|Overall Study|Death|1|||
155481317|NCT00135694|561182671|FG002|Overall Study|Death|2|||
155481318|NCT00135694|561182669|FG000|Overall Study|Lost to Follow-up|8|||
155481319|NCT00135694|561182670|FG001|Overall Study|Lost to Follow-up|7|||
155481320|NCT00135694|561182671|FG002|Overall Study|Lost to Follow-up|1|||
155481321|NCT00135694|561182669|FG000|Overall Study|Withdrawal by Subject|41|||
155481322|NCT00135694|561182670|FG001|Overall Study|Withdrawal by Subject|7|||
155481323|NCT00135694|561182671|FG002|Overall Study|Withdrawal by Subject|4|||
155481324|NCT00135694|561182669|FG000|Overall Study|Protocol Violation|19|||
155481325|NCT00135694|561182670|FG001|Overall Study|Protocol Violation|1|||
155481326|NCT00135694|561182671|FG002|Overall Study|Protocol Violation|0|||
155481327|NCT00135694|561182669|FG000|Overall Study|Hepatitis C related reasons|39|||
155481328|NCT00135694|561182670|FG001|Overall Study|Hepatitis C related reasons|1|||
155481329|NCT00135694|561182671|FG002|Overall Study|Hepatitis C related reasons|0|||
155481330|NCT00135694|561182669|FG000|Overall Study|Ineligible for Random assignment|42|||
155481331|NCT00135694|561182670|FG001|Overall Study|Ineligible for Random assignment|0|||
155481332|NCT00135694|561182671|FG002|Overall Study|Ineligible for Random assignment|0|||
155481333|NCT02584660|561182672|FG000|Overall Study|Adverse Event|4|||
155481334|NCT02584660|561182673|FG001|Overall Study|Adverse Event|0|||
155481335|NCT02584660|561182672|FG000|Overall Study|Lost to Follow-up|3|||
155481336|NCT02584660|561182673|FG001|Overall Study|Lost to Follow-up|4|||
155481337|NCT02584660|561182672|FG000|Overall Study|Protocol Violation|0|||
155481338|NCT02584660|561182673|FG001|Overall Study|Protocol Violation|1|||
155481339|NCT02584660|561182672|FG000|Overall Study|Withdrawal by Subject|0|||
155481340|NCT02584660|561182673|FG001|Overall Study|Withdrawal by Subject|2|||
155481341|NCT02584660|561182672|FG000|Overall Study|Other|0|||
155481342|NCT02584660|561182673|FG001|Overall Study|Other|1|||
155481343|NCT00660816|561182674|FG000|Overall Study|Adverse Event|1|||
155481344|NCT00660816|561182675|FG001|Overall Study|Adverse Event|2|||
155520389|NCT02937701|561330924|FG002|Day 1 to Week 22|Physician Decision|0|||
155520390|NCT02937701|561330925|FG003|Day 1 to Week 22|Physician Decision|0|||
155481345|NCT00660816|561182674|FG000|Overall Study|Withdrawal by Subject|1|||
155481346|NCT00660816|561182675|FG001|Overall Study|Withdrawal by Subject|0|||
155481347|NCT00660816|561182674|FG000|Overall Study|Death|0|||
155481348|NCT00660816|561182675|FG001|Overall Study|Death|2|||
155481349|NCT00660816|561182674|FG000|Overall Study|Lack of Efficacy|1|||
155481350|NCT00660816|561182675|FG001|Overall Study|Lack of Efficacy|0|||
155481351|NCT00660816|561182674|FG000|Overall Study|Physician Decision|0|||
155481352|NCT00660816|561182675|FG001|Overall Study|Physician Decision|2|||
155481353|NCT00660816|561182674|FG000|Overall Study|Protocol Violation|1|||
155481354|NCT00660816|561182675|FG001|Overall Study|Protocol Violation|0|||
155481355|NCT00660816|561182674|FG000|Overall Study|Disease Progression|16|||
155481356|NCT00660816|561182675|FG001|Overall Study|Disease Progression|12|||
155654657|NCT03715829|561828908|FG007|Extension Period|Withdrawal by Subject|3|||
155481357|NCT00660816|561182674|FG000|Overall Study|Complicating Disease|0|||
155481358|NCT00660816|561182675|FG001|Overall Study|Complicating Disease|1|||
155654658|NCT03715829|561828909|FG008|Extension Period|Withdrawal by Subject|12|||
155481359|NCT00374452|561182676|FG000|Overall Study|Left clinic before intervention started|4|||
155481360|NCT00374452|561182677|FG001|Overall Study|Left clinic before intervention started|1|||
155481361|NCT00374452|561182676|FG000|Overall Study|Change in job role before intervention|0|||
155481362|NCT00374452|561182677|FG001|Overall Study|Change in job role before intervention|1|||
155481363|NCT00374452|561182676|FG000|Overall Study|Left clinic after intervention started|1|||
155481364|NCT00374452|561182677|FG001|Overall Study|Left clinic after intervention started|1|||
155481365|NCT00374452|561182676|FG000|Overall Study|Withdrawal by Subject|0|||
155481366|NCT00374452|561182677|FG001|Overall Study|Withdrawal by Subject|2|||
155481367|NCT01012037|561182680|FG000|Overall Study|Adverse Event|0|||
155481368|NCT01012037|561182681|FG001|Overall Study|Adverse Event|8|||
155481369|NCT01012037|561182682|FG002|Overall Study|Adverse Event|3|||
155481370|NCT01012037|561182680|FG000|Overall Study|Protocol Violation|0|||
155481371|NCT01012037|561182681|FG001|Overall Study|Protocol Violation|3|||
155481372|NCT01012037|561182682|FG002|Overall Study|Protocol Violation|5|||
155481373|NCT01012037|561182680|FG000|Overall Study|Withdrawal by Subject|0|||
155481374|NCT01012037|561182681|FG001|Overall Study|Withdrawal by Subject|4|||
155481375|NCT01012037|561182682|FG002|Overall Study|Withdrawal by Subject|1|||
155481376|NCT01012037|561182680|FG000|Overall Study|Other reason (not specified)|1|||
155481377|NCT01012037|561182681|FG001|Overall Study|Other reason (not specified)|1|||
155481378|NCT01012037|561182682|FG002|Overall Study|Other reason (not specified)|1|||
155481379|NCT02583711|561182683|FG000|Overall Study|Withdrawal by Subject|0|||
155481380|NCT02583711|561182684|FG001|Overall Study|Withdrawal by Subject|10|||
155481381|NCT02583711|561182685|FG002|Overall Study|Withdrawal by Subject|0|||
155481382|NCT00542425|561182691|FG000|Initial 24 Weeks|Administrative reasons|0|||
155481383|NCT00542425|561182692|FG001|Initial 24 Weeks|Administrative reasons|0|||
155481384|NCT00542425|561182693|FG002|Initial 24 Weeks|Administrative reasons|1|||
155481385|NCT00542425|561182694|FG003|Initial 24 Weeks|Administrative reasons|1|||
155481386|NCT00542425|561182695|FG004|Initial 24 Weeks|Administrative reasons|0|||
155481387|NCT00542425|561182691|FG000|Initial 24 Weeks|Adverse Event|0|||
155481388|NCT00542425|561182692|FG001|Initial 24 Weeks|Adverse Event|1|||
155481389|NCT00542425|561182693|FG002|Initial 24 Weeks|Adverse Event|1|||
155481390|NCT00542425|561182694|FG003|Initial 24 Weeks|Adverse Event|3|||
155481391|NCT00542425|561182695|FG004|Initial 24 Weeks|Adverse Event|2|||
155481392|NCT00542425|561182691|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
155481393|NCT00542425|561182692|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
155481394|NCT00542425|561182693|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
155481395|NCT00542425|561182694|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
155481396|NCT00542425|561182695|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
155481397|NCT00542425|561182691|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
155481398|NCT00542425|561182692|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
155481399|NCT00542425|561182693|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
155520391|NCT02937701|561330926|FG004|Day 1 to Week 22|Physician Decision|0|||
155520392|NCT02937701|561330922|FG000|Day 1 to Week 22|Other|1|||
155520393|NCT02937701|561330923|FG001|Day 1 to Week 22|Other|0|||
155520394|NCT02937701|561330924|FG002|Day 1 to Week 22|Other|0|||
155520395|NCT02937701|561330925|FG003|Day 1 to Week 22|Other|0|||
155520396|NCT02937701|561330926|FG004|Day 1 to Week 22|Other|0|||
155520397|NCT02937701|561330922|FG000|Week 22 to Week 50|Adverse Event|0|||
155520398|NCT02937701|561330923|FG001|Week 22 to Week 50|Adverse Event|0|||
155520399|NCT02937701|561330924|FG002|Week 22 to Week 50|Adverse Event|10|||
155520400|NCT02937701|561330925|FG003|Week 22 to Week 50|Adverse Event|3|||
155520401|NCT02937701|561330926|FG004|Week 22 to Week 50|Adverse Event|3|||
155520402|NCT02937701|561330922|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
155654659|NCT03715829|561828910|FG009|Extension Period|Withdrawal by Subject|3|||
155654660|NCT03715829|561828911|FG010|Extension Period|Withdrawal by Subject|0|||
155520403|NCT02937701|561330923|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
155520404|NCT02937701|561330924|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
155520405|NCT02937701|561330925|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
155481400|NCT00542425|561182694|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
155481401|NCT00542425|561182695|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
155481402|NCT00542425|561182691|FG000|Initial 24 Weeks|Non-compliance|0|||
155481403|NCT00542425|561182692|FG001|Initial 24 Weeks|Non-compliance|0|||
155481404|NCT00542425|561182693|FG002|Initial 24 Weeks|Non-compliance|0|||
155520406|NCT02937701|561330926|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
155520407|NCT02937701|561330922|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
155520408|NCT02937701|561330923|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
155654661|NCT03715829|561828901|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
155654662|NCT03715829|561828902|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
155654663|NCT03715829|561828903|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
155481405|NCT00542425|561182694|FG003|Initial 24 Weeks|Non-compliance|1|||
155481406|NCT00542425|561182695|FG004|Initial 24 Weeks|Non-compliance|1|||
155481407|NCT00542425|561182691|FG000|Initial 24 Weeks|Protocol Violation|0|||
155481408|NCT00542425|561182692|FG001|Initial 24 Weeks|Protocol Violation|0|||
155481409|NCT00542425|561182693|FG002|Initial 24 Weeks|Protocol Violation|0|||
155481410|NCT00542425|561182694|FG003|Initial 24 Weeks|Protocol Violation|1|||
155481411|NCT00542425|561182695|FG004|Initial 24 Weeks|Protocol Violation|0|||
155481412|NCT00542425|561182691|FG000|Initial 24 Weeks|Refusal of treatment|2|||
155481413|NCT00542425|561182692|FG001|Initial 24 Weeks|Refusal of treatment|2|||
155481414|NCT00542425|561182693|FG002|Initial 24 Weeks|Refusal of treatment|1|||
155481415|NCT00542425|561182694|FG003|Initial 24 Weeks|Refusal of treatment|4|||
155481416|NCT00542425|561182695|FG004|Initial 24 Weeks|Refusal of treatment|1|||
155481417|NCT00542425|561182691|FG000|Initial 24 Weeks|Other|0|||
155481418|NCT00542425|561182692|FG001|Initial 24 Weeks|Other|2|||
155481419|NCT00542425|561182693|FG002|Initial 24 Weeks|Other|1|||
155481420|NCT00542425|561182694|FG003|Initial 24 Weeks|Other|0|||
155481421|NCT00542425|561182695|FG004|Initial 24 Weeks|Other|0|||
155481422|NCT00542425|561182691|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
155481423|NCT00542425|561182692|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
155481424|NCT00542425|561182693|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
155481425|NCT00542425|561182694|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
155481426|NCT00542425|561182695|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
155481427|NCT00542425|561182691|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
155481428|NCT00542425|561182692|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
155481429|NCT00542425|561182693|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
155481430|NCT00542425|561182694|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
155481431|NCT00542425|561182695|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
155481432|NCT00542425|561182691|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
155481433|NCT00542425|561182692|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
155481434|NCT00542425|561182693|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
155481435|NCT00542425|561182694|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
155481436|NCT00542425|561182695|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
155481437|NCT00542425|561182691|FG000|Extended 24 Weeks of Treatment|Other|1|||
155481438|NCT00542425|561182692|FG001|Extended 24 Weeks of Treatment|Other|1|||
155481439|NCT00542425|561182693|FG002|Extended 24 Weeks of Treatment|Other|0|||
155481440|NCT00542425|561182694|FG003|Extended 24 Weeks of Treatment|Other|0|||
155481441|NCT00542425|561182695|FG004|Extended 24 Weeks of Treatment|Other|1|||
155481442|NCT00472043|561182696|FG000|Overall Study|Withdrawal by Subject|1|||
155481443|NCT00472043|561182697|FG001|Overall Study|Withdrawal by Subject|0|||
155481444|NCT00472043|561182696|FG000|Overall Study|Death|1|||
155481445|NCT00472043|561182697|FG001|Overall Study|Death|0|||
155481446|NCT03032523|561182700|FG000|Overall Study|Withdrawal by Subject|2|||
155481447|NCT03032523|561182701|FG001|Overall Study|Withdrawal by Subject|2|||
155481448|NCT03032523|561182700|FG000|Overall Study|Physician Decision|1|||
155481449|NCT03032523|561182701|FG001|Overall Study|Physician Decision|0|||
155481450|NCT02590406|561182702|FG000|Overall Study|Adverse Event|1|||
155481451|NCT02590406|561182703|FG001|Overall Study|Adverse Event|0|||
155481452|NCT02590406|561182702|FG000|Overall Study|Saturometer malfunction|0|||
155481453|NCT02590406|561182703|FG001|Overall Study|Saturometer malfunction|1|||
155481454|NCT05375838|561182704|FG000|Overall Study|Other|0|||
155481455|NCT05375838|561182705|FG001|Overall Study|Other|0|||
155481456|NCT05375838|561182706|FG002|Overall Study|Other|0|||
155481457|NCT05375838|561182707|FG003|Overall Study|Other|1|||
155481458|NCT05375838|561182708|FG004|Overall Study|Other|1|||
155481459|NCT05375838|561182709|FG005|Overall Study|Other|0|||
155481460|NCT05375838|561182704|FG000|Overall Study|Withdrawal by Subject|2|||
155481461|NCT05375838|561182705|FG001|Overall Study|Withdrawal by Subject|1|||
155481462|NCT05375838|561182706|FG002|Overall Study|Withdrawal by Subject|3|||
155481463|NCT05375838|561182707|FG003|Overall Study|Withdrawal by Subject|2|||
155481464|NCT05375838|561182708|FG004|Overall Study|Withdrawal by Subject|2|||
155481465|NCT05375838|561182709|FG005|Overall Study|Withdrawal by Subject|0|||
155481466|NCT05375838|561182704|FG000|Overall Study|Protocol Violation|0|||
155481467|NCT05375838|561182705|FG001|Overall Study|Protocol Violation|0|||
155481468|NCT05375838|561182706|FG002|Overall Study|Protocol Violation|0|||
155481469|NCT05375838|561182707|FG003|Overall Study|Protocol Violation|0|||
155481470|NCT05375838|561182708|FG004|Overall Study|Protocol Violation|1|||
155481471|NCT05375838|561182709|FG005|Overall Study|Protocol Violation|0|||
155481472|NCT05375838|561182704|FG000|Overall Study|Physician Decision|0|||
155481473|NCT05375838|561182705|FG001|Overall Study|Physician Decision|1|||
155481474|NCT05375838|561182706|FG002|Overall Study|Physician Decision|0|||
155481475|NCT05375838|561182707|FG003|Overall Study|Physician Decision|0|||
155481476|NCT05375838|561182708|FG004|Overall Study|Physician Decision|0|||
155481477|NCT05375838|561182709|FG005|Overall Study|Physician Decision|1|||
155481478|NCT05375838|561182704|FG000|Overall Study|Lost to Follow-up|2|||
155481479|NCT05375838|561182705|FG001|Overall Study|Lost to Follow-up|7|||
155481480|NCT05375838|561182706|FG002|Overall Study|Lost to Follow-up|0|||
155481481|NCT05375838|561182707|FG003|Overall Study|Lost to Follow-up|4|||
155481482|NCT05375838|561182708|FG004|Overall Study|Lost to Follow-up|2|||
155481483|NCT05375838|561182709|FG005|Overall Study|Lost to Follow-up|3|||
155481484|NCT00957723|561182710|FG000|Overall Study|Death|3|||
155481485|NCT00957723|561182710|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
155481486|NCT00957723|561182710|FG000|Overall Study|Lost to Follow-up|8|||
155481487|NCT00957723|561182710|FG000|Overall Study|Withdrawal by Subject|24|||
155481488|NCT00957723|561182710|FG000|Overall Study|Investigative Site Terminated|61|||
155481489|NCT00957723|561182710|FG000|Overall Study|Intercurrent Illness|2|||
155481490|NCT00957723|561182710|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
155481491|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
155481492|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
155481493|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
155481494|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
155481495|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
155481496|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
155481497|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
155481498|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
155481499|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
155481500|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
155481501|NCT02178592|561182711|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
155481502|NCT02178592|561182712|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
155481503|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
155481504|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
155481505|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
155481506|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
155481507|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
155481508|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
155481509|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
155481510|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
155481511|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
155481512|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
155481513|NCT02178592|561182711|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
155481514|NCT02178592|561182712|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
155481515|NCT02975206|561182713|FG000|Overall Study|Withdrawal by Subject|14|||
155481516|NCT02975206|561182714|FG001|Overall Study|Withdrawal by Subject|11|||
155481517|NCT02975206|561182715|FG002|Overall Study|Withdrawal by Subject|11|||
155481518|NCT02975206|561182713|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
155481519|NCT02975206|561182714|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
155481520|NCT02975206|561182715|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
155481521|NCT01984294|561182718|FG000|Overall Study|Randomized but Never Treated|0|||
155481522|NCT01984294|561182719|FG001|Overall Study|Randomized but Never Treated|0|||
155481523|NCT01984294|561182720|FG002|Overall Study|Randomized but Never Treated|1|||
155481524|NCT01984294|561182718|FG000|Overall Study|Lack of Efficacy|4|||
155481525|NCT01984294|561182719|FG001|Overall Study|Lack of Efficacy|2|||
155481526|NCT01984294|561182720|FG002|Overall Study|Lack of Efficacy|6|||
155520409|NCT02937701|561330924|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
155520410|NCT02937701|561330925|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
155520411|NCT02937701|561330926|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
155520412|NCT02937701|561330922|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
155520413|NCT02937701|561330923|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
155520414|NCT02937701|561330924|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
155520415|NCT02937701|561330925|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
155520416|NCT02937701|561330926|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
155481527|NCT01984294|561182718|FG000|Overall Study|Adverse Event|0|||
155481528|NCT01984294|561182719|FG001|Overall Study|Adverse Event|1|||
155481529|NCT01984294|561182720|FG002|Overall Study|Adverse Event|0|||
155481530|NCT00392210|561182722|FG000|First Voiding Trial|Physician Decision|2|||
155520417|NCT02937701|561330922|FG000|Week 22 to Week 50|Physician Decision|0|||
155520418|NCT02937701|561330923|FG001|Week 22 to Week 50|Physician Decision|0|||
155520419|NCT02937701|561330924|FG002|Week 22 to Week 50|Physician Decision|2|||
155520420|NCT02937701|561330925|FG003|Week 22 to Week 50|Physician Decision|0|||
155520421|NCT02937701|561330926|FG004|Week 22 to Week 50|Physician Decision|1|||
155481531|NCT00392210|561182723|FG001|First Voiding Trial|Physician Decision|2|||
155481532|NCT02067104|561182724|FG000|Overall Study|Study termination due to low accrual|4|||
155481533|NCT02067104|561182725|FG001|Overall Study|Study termination due to low accrual|5|||
155520422|NCT02937701|561330922|FG000|Week 22 to Week 50|Other|0|||
155520423|NCT02937701|561330923|FG001|Week 22 to Week 50|Other|0|||
155520424|NCT02937701|561330924|FG002|Week 22 to Week 50|Other|0|||
155520425|NCT02937701|561330925|FG003|Week 22 to Week 50|Other|0|||
155481534|NCT02610231|561182726|FG000|Overall Study|Withdrawal by Subject|27|||
155481535|NCT02610231|561182726|FG000|Overall Study|Adverse Event|20|||
155481536|NCT02610231|561182726|FG000|Overall Study|Death|5|||
155481537|NCT02610231|561182726|FG000|Overall Study|Surgery|2|||
155481538|NCT02610231|561182726|FG000|Overall Study|Physician Decision|1|||
155481539|NCT02610231|561182726|FG000|Overall Study|Non Compliance|2|||
155481540|NCT02610231|561182726|FG000|Overall Study|Other|3|||
155520426|NCT02937701|561330926|FG004|Week 22 to Week 50|Other|1|||
155520427|NCT00416520|561330928|FG000|Open-label Period|Adverse Event|28|||
155520428|NCT00416520|561330929|FG001|Open-label Period|Adverse Event|10|||
155520429|NCT00416520|561330930|FG002|Open-label Period|Adverse Event|0|||
155520430|NCT00416520|561330931|FG003|Open-label Period|Adverse Event|0|||
155520431|NCT00416520|561330928|FG000|Open-label Period|Death|2|||
155520432|NCT00416520|561330929|FG001|Open-label Period|Death|1|||
155520433|NCT00416520|561330930|FG002|Open-label Period|Death|0|||
155520434|NCT00416520|561330931|FG003|Open-label Period|Death|0|||
155520435|NCT00416520|561330928|FG000|Open-label Period|Lack of Efficacy|8|||
155520436|NCT00416520|561330929|FG001|Open-label Period|Lack of Efficacy|1|||
155481541|NCT01279954|561182734|FG000|Overall Study|Lack of Efficacy|3|||
155481542|NCT01279954|561182735|FG001|Overall Study|Lack of Efficacy|4|||
155481543|NCT02140762|561182736|FG000|Overall Study|Adverse Event|1|||
155520437|NCT00416520|561330930|FG002|Open-label Period|Lack of Efficacy|0|||
155520438|NCT00416520|561330931|FG003|Open-label Period|Lack of Efficacy|0|||
155520439|NCT00416520|561330928|FG000|Open-label Period|Protocol Violation|3|||
155520440|NCT00416520|561330929|FG001|Open-label Period|Protocol Violation|3|||
155520441|NCT00416520|561330930|FG002|Open-label Period|Protocol Violation|0|||
155520442|NCT00416520|561330931|FG003|Open-label Period|Protocol Violation|0|||
155520443|NCT00416520|561330928|FG000|Open-label Period|Withdrawal by Subject|16|||
155520444|NCT00416520|561330929|FG001|Open-label Period|Withdrawal by Subject|5|||
155520445|NCT00416520|561330930|FG002|Open-label Period|Withdrawal by Subject|0|||
155520446|NCT00416520|561330931|FG003|Open-label Period|Withdrawal by Subject|0|||
155520447|NCT00416520|561330928|FG000|Open-label Period|Other Reasons|3|||
155520448|NCT00416520|561330929|FG001|Open-label Period|Other Reasons|12|||
155520449|NCT00416520|561330930|FG002|Open-label Period|Other Reasons|0|||
155520450|NCT00416520|561330931|FG003|Open-label Period|Other Reasons|0|||
155520451|NCT00416520|561330928|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
155520452|NCT00416520|561330929|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
155520453|NCT00416520|561330930|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
155520454|NCT00416520|561330931|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
155520455|NCT00416520|561330928|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
155520456|NCT00416520|561330929|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
155520457|NCT00416520|561330930|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
155520458|NCT00416520|561330931|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
155520459|NCT00416520|561330928|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
155520460|NCT00416520|561330929|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
155520461|NCT00416520|561330930|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
155520462|NCT00416520|561330931|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
155520463|NCT01108094|561330932|FG000|Overall Study|Adverse Event|2|||
155520464|NCT01108094|561330933|FG001|Overall Study|Adverse Event|0|||
155520465|NCT01108094|561330934|FG002|Overall Study|Adverse Event|0|||
155520466|NCT01108094|561330935|FG003|Overall Study|Adverse Event|0|||
155520467|NCT01108094|561330932|FG000|Overall Study|Withdrawal by Subject|1|||
155520468|NCT01108094|561330933|FG001|Overall Study|Withdrawal by Subject|0|||
155520469|NCT01108094|561330934|FG002|Overall Study|Withdrawal by Subject|0|||
155520470|NCT01108094|561330935|FG003|Overall Study|Withdrawal by Subject|0|||
155520471|NCT00088829|561330939|FG000|Overall Study|PI left institution and study was close|22|||
155520472|NCT05818137|561330940|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
155520473|NCT05818137|561330940|FG000|Extension Treatment Period|Ongoing participants|44|||
155520474|NCT01367275|561330941|FG000|Overall Study|Ineligible|1|||
155520475|NCT01367275|561330941|FG000|Overall Study|Disease Progression|2|||
155520476|NCT04510857|561330942|FG000|Overall Study|Withdrawal by Subject|1|||
155654664|NCT03715829|561828904|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
155481544|NCT02140762|561182737|FG001|Overall Study|Adverse Event|1|||
155520477|NCT04510857|561330943|FG001|Overall Study|Withdrawal by Subject|2|||
155654665|NCT03715829|561828905|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
155520478|NCT00322491|561330944|FG000|Overall Study|Adverse Event|1|||
155520479|NCT00322491|561330945|FG001|Overall Study|Adverse Event|0|||
155520480|NCT00322491|561330944|FG000|Overall Study|Death|1|||
155481545|NCT02140762|561182736|FG000|Overall Study|Lost to Follow-up|9|||
155481546|NCT02140762|561182737|FG001|Overall Study|Lost to Follow-up|5|||
155481547|NCT02140762|561182736|FG000|Overall Study|Protocol Violation|1|||
155520481|NCT00322491|561330945|FG001|Overall Study|Death|2|||
155520482|NCT02319148|561330946|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
155520483|NCT02319148|561330947|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
155520484|NCT02319148|561330948|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
155481548|NCT02140762|561182737|FG001|Overall Study|Protocol Violation|1|||
155481549|NCT02140762|561182736|FG000|Overall Study|Withdrawal by Subject|6|||
155481550|NCT02140762|561182737|FG001|Overall Study|Withdrawal by Subject|4|||
155481551|NCT02140762|561182736|FG000|Overall Study|Other|0|||
155481552|NCT02140762|561182737|FG001|Overall Study|Other|1|||
155481553|NCT01711359|561182739|FG000|Treatment Period|Withdrawal by Subject|18|||
155481554|NCT01711359|561182740|FG001|Treatment Period|Withdrawal by Subject|7|||
155481555|NCT01711359|561182741|FG002|Treatment Period|Withdrawal by Subject|13|||
155481556|NCT01711359|561182739|FG000|Treatment Period|Lack of Efficacy|13|||
155481557|NCT01711359|561182740|FG001|Treatment Period|Lack of Efficacy|2|||
155481558|NCT01711359|561182741|FG002|Treatment Period|Lack of Efficacy|2|||
155481559|NCT01711359|561182739|FG000|Treatment Period|Adverse Event|8|||
155481560|NCT01711359|561182740|FG001|Treatment Period|Adverse Event|10|||
155481561|NCT01711359|561182741|FG002|Treatment Period|Adverse Event|24|||
155481562|NCT01711359|561182739|FG000|Treatment Period|Physician Decision|4|||
155481563|NCT01711359|561182740|FG001|Treatment Period|Physician Decision|3|||
155481564|NCT01711359|561182741|FG002|Treatment Period|Physician Decision|2|||
155481565|NCT01711359|561182739|FG000|Treatment Period|Death|3|||
155481566|NCT01711359|561182740|FG001|Treatment Period|Death|0|||
155481567|NCT01711359|561182741|FG002|Treatment Period|Death|0|||
155481568|NCT01711359|561182739|FG000|Treatment Period|Entry Criteria Not Met|1|||
155481569|NCT01711359|561182740|FG001|Treatment Period|Entry Criteria Not Met|0|||
155481570|NCT01711359|561182741|FG002|Treatment Period|Entry Criteria Not Met|0|||
155481571|NCT01711359|561182739|FG000|Treatment Period|Sponsor Decision|1|||
155481572|NCT01711359|561182740|FG001|Treatment Period|Sponsor Decision|0|||
155481573|NCT01711359|561182741|FG002|Treatment Period|Sponsor Decision|0|||
155481574|NCT01711359|561182739|FG000|Treatment Period|Lost to Follow-up|1|||
155481575|NCT01711359|561182740|FG001|Treatment Period|Lost to Follow-up|1|||
155481576|NCT01711359|561182741|FG002|Treatment Period|Lost to Follow-up|1|||
155481577|NCT01711359|561182739|FG000|Treatment Period|Randomized, Not Treated|3|||
155481578|NCT01711359|561182740|FG001|Treatment Period|Randomized, Not Treated|1|||
155481579|NCT01711359|561182741|FG002|Treatment Period|Randomized, Not Treated|0|||
155481580|NCT01385098|561182744|FG000|Overall Study|Adverse Event|10|||
155481581|NCT01385098|561182744|FG000|Overall Study|Lost to Follow-up|4|||
155481582|NCT02698176|561182745|FG000|Overall Study|Progressive disease|4|||
155481583|NCT02698176|561182746|FG001|Overall Study|Progressive disease|3|||
155481584|NCT02698176|561182747|FG002|Overall Study|Progressive disease|1|||
155481585|NCT02698176|561182748|FG003|Overall Study|Progressive disease|0|||
155481586|NCT02698176|561182745|FG000|Overall Study|Adverse Event|2|||
155481587|NCT02698176|561182746|FG001|Overall Study|Adverse Event|0|||
155481588|NCT02698176|561182747|FG002|Overall Study|Adverse Event|0|||
155481589|NCT02698176|561182748|FG003|Overall Study|Adverse Event|0|||
155481590|NCT02698176|561182745|FG000|Overall Study|Clinical progression|3|||
155481591|NCT02698176|561182746|FG001|Overall Study|Clinical progression|0|||
155481592|NCT02698176|561182747|FG002|Overall Study|Clinical progression|0|||
155481593|NCT02698176|561182748|FG003|Overall Study|Clinical progression|0|||
155481594|NCT02449915|561182749|FG000|Overall Study|Exclusion criteria - drug use|1|||
155481595|NCT02449915|561182750|FG001|Overall Study|Exclusion criteria - drug use|0|||
155481596|NCT02449915|561182749|FG000|Overall Study|Withdrawal by Subject|0|||
155481597|NCT02449915|561182750|FG001|Overall Study|Withdrawal by Subject|2|||
155481598|NCT02449915|561182749|FG000|Overall Study|Intraoperative surgical findings|1|||
155481599|NCT02449915|561182750|FG001|Overall Study|Intraoperative surgical findings|1|||
155481600|NCT02449915|561182749|FG000|Overall Study|Abnormal preop lab|0|||
155481601|NCT02449915|561182750|FG001|Overall Study|Abnormal preop lab|1|||
155481602|NCT01021293|561182752|FG000|Overall Study|Serious Adverse Event|2|||
155481603|NCT01021293|561182753|FG001|Overall Study|Serious Adverse Event|1|||
155481604|NCT01021293|561182752|FG000|Overall Study|Adverse Event|2|||
155481605|NCT01021293|561182753|FG001|Overall Study|Adverse Event|1|||
155481606|NCT01021293|561182752|FG000|Overall Study|Withdrawal by Subject|1|||
155481607|NCT01021293|561182753|FG001|Overall Study|Withdrawal by Subject|3|||
155481608|NCT01021293|561182752|FG000|Overall Study|Migrated/moved from study area|6|||
155481609|NCT01021293|561182753|FG001|Overall Study|Migrated/moved from study area|18|||
155481610|NCT01021293|561182752|FG000|Overall Study|Lost to Follow-up|1|||
155654666|NCT03715829|561828906|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
155481611|NCT01021293|561182753|FG001|Overall Study|Lost to Follow-up|1|||
155654667|NCT03715829|561828907|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
155654668|NCT03715829|561828908|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
155654669|NCT03715829|561828909|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
155481612|NCT04235959|561184384|FG000|Overall Study|Protocol Violation|0|||
155481613|NCT04235959|561184385|FG001|Overall Study|Protocol Violation|1|||
155481614|NCT04235959|561184386|FG002|Overall Study|Protocol Violation|0|||
155481615|NCT04235959|561184384|FG000|Overall Study|Adverse Event|1|||
155481616|NCT04235959|561184385|FG001|Overall Study|Adverse Event|0|||
155481617|NCT04235959|561184386|FG002|Overall Study|Adverse Event|0|||
155481618|NCT00125138|561184387|FG000|Overall Study|Adverse Event|1|||
155481619|NCT00125138|561184388|FG001|Overall Study|Adverse Event|0|||
155481620|NCT00125138|561184389|FG002|Overall Study|Adverse Event|3|||
155481621|NCT00125138|561184390|FG003|Overall Study|Adverse Event|2|||
155481622|NCT00125138|561184387|FG000|Overall Study|Withdrawal by Subject|2|||
155481623|NCT00125138|561184388|FG001|Overall Study|Withdrawal by Subject|3|||
155481624|NCT00125138|561184389|FG002|Overall Study|Withdrawal by Subject|1|||
155481625|NCT00125138|561184390|FG003|Overall Study|Withdrawal by Subject|1|||
155481626|NCT00125138|561184387|FG000|Overall Study|Lack of Efficacy|0|||
155481627|NCT00125138|561184388|FG001|Overall Study|Lack of Efficacy|0|||
155481628|NCT00125138|561184389|FG002|Overall Study|Lack of Efficacy|0|||
155481629|NCT00125138|561184390|FG003|Overall Study|Lack of Efficacy|1|||
155481630|NCT00125138|561184387|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
155481631|NCT00125138|561184388|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
155481632|NCT00125138|561184389|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
155481633|NCT00125138|561184390|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
155481634|NCT03228836|561184395|FG000|Overall Study|Adverse Event|3|||
155481635|NCT03228836|561184395|FG000|Overall Study|Withdrawal by Subject|1|||
155481636|NCT03228836|561184395|FG000|Overall Study|Death|1|||
155481637|NCT03228836|561184395|FG000|Overall Study|Physician Decision|1|||
155481638|NCT03228836|561184395|FG000|Overall Study|Disease Progression|7|||
155481639|NCT03228836|561184395|FG000|Overall Study|Other|4|||
155481640|NCT00405756|561184397|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
155481641|NCT00405756|561184398|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
155481642|NCT00405756|561184399|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
155481643|NCT00405756|561184397|FG000|Double-blind Treatment|Adverse Event|31|||
155481644|NCT00405756|561184398|FG001|Double-blind Treatment|Adverse Event|27|||
155481645|NCT00405756|561184399|FG002|Double-blind Treatment|Adverse Event|12|||
155481646|NCT00405756|561184397|FG000|Double-blind Treatment|Disease Progression|47|||
155481647|NCT00405756|561184398|FG001|Double-blind Treatment|Disease Progression|81|||
155481648|NCT00405756|561184399|FG002|Double-blind Treatment|Disease Progression|102|||
155481649|NCT00405756|561184397|FG000|Double-blind Treatment|Lack of Efficacy|1|||
155481650|NCT00405756|561184398|FG001|Double-blind Treatment|Lack of Efficacy|4|||
155481651|NCT00405756|561184399|FG002|Double-blind Treatment|Lack of Efficacy|2|||
155481652|NCT00405756|561184397|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
155481653|NCT00405756|561184398|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
155481654|NCT00405756|561184399|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
155481655|NCT00405756|561184397|FG000|Double-blind Treatment|Lost to Follow-up|1|||
155481656|NCT00405756|561184398|FG001|Double-blind Treatment|Lost to Follow-up|0|||
155481657|NCT00405756|561184399|FG002|Double-blind Treatment|Lost to Follow-up|0|||
155481658|NCT00405756|561184397|FG000|Double-blind Treatment|Death|4|||
155481659|NCT00405756|561184398|FG001|Double-blind Treatment|Death|4|||
155481660|NCT00405756|561184399|FG002|Double-blind Treatment|Death|4|||
155481661|NCT00405756|561184397|FG000|Double-blind Treatment|Protocol Violation|1|||
155481662|NCT00405756|561184398|FG001|Double-blind Treatment|Protocol Violation|0|||
155481663|NCT00405756|561184399|FG002|Double-blind Treatment|Protocol Violation|2|||
155481664|NCT00405756|561184397|FG000|Double-blind Treatment|Other|7|||
155481665|NCT00405756|561184398|FG001|Double-blind Treatment|Other|4|||
155481666|NCT00405756|561184399|FG002|Double-blind Treatment|Other|4|||
155481667|NCT00405756|561184397|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
155481668|NCT00405756|561184398|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
155481669|NCT00405756|561184399|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
155481670|NCT00405756|561184397|FG000|Open-label Extension|Adverse Event|1|||
155481671|NCT00405756|561184398|FG001|Open-label Extension|Adverse Event|3|||
155481672|NCT00405756|561184399|FG002|Open-label Extension|Adverse Event|7|||
155481673|NCT00405756|561184397|FG000|Open-label Extension|Disease Progression|8|||
155481674|NCT00405756|561184398|FG001|Open-label Extension|Disease Progression|23|||
155481675|NCT00405756|561184399|FG002|Open-label Extension|Disease Progression|26|||
155481676|NCT00405756|561184397|FG000|Open-label Extension|Withdrawal by Subject|2|||
155481677|NCT00405756|561184398|FG001|Open-label Extension|Withdrawal by Subject|3|||
155481678|NCT00405756|561184399|FG002|Open-label Extension|Withdrawal by Subject|3|||
155481679|NCT00405756|561184397|FG000|Open-label Extension|Death|1|||
155481680|NCT00405756|561184398|FG001|Open-label Extension|Death|2|||
155481681|NCT00405756|561184399|FG002|Open-label Extension|Death|4|||
155481682|NCT00405756|561184397|FG000|Open-label Extension|Other|0|||
155481683|NCT00405756|561184398|FG001|Open-label Extension|Other|1|||
155481684|NCT00405756|561184399|FG002|Open-label Extension|Other|7|||
155481685|NCT00405756|561184397|FG000|Follow-up|Ongoing in Follow-up Period|52|||
155481686|NCT00405756|561184398|FG001|Follow-up|Ongoing in Follow-up Period|51|||
155481687|NCT00405756|561184399|FG002|Follow-up|Ongoing in Follow-up Period|60|||
155481688|NCT00405756|561184397|FG000|Follow-up|Death|21|||
155654670|NCT03715829|561828910|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
155654671|NCT03715829|561828911|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
155481689|NCT00405756|561184398|FG001|Follow-up|Death|31|||
155481690|NCT00405756|561184399|FG002|Follow-up|Death|24|||
155481691|NCT00405756|561184397|FG000|Follow-up|Lost to Follow-up|2|||
155481692|NCT00405756|561184398|FG001|Follow-up|Lost to Follow-up|8|||
155481693|NCT00405756|561184399|FG002|Follow-up|Lost to Follow-up|4|||
155481694|NCT02870348|561184402|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
155481695|NCT01051856|561184403|FG000|Overall Study|Withdrawal by Subject|1|||
155481696|NCT01051856|561184404|FG001|Overall Study|Withdrawal by Subject|0|||
155481697|NCT00672139|561184405|FG000|Overall Study|Death|14|||
155481698|NCT00672139|561184406|FG001|Overall Study|Death|23|||
155481699|NCT00672139|561184405|FG000|Overall Study|Withdrawal by Subject|2|||
155481700|NCT00672139|561184406|FG001|Overall Study|Withdrawal by Subject|11|||
155481701|NCT00672139|561184405|FG000|Overall Study|Adverse Event|4|||
155481702|NCT00672139|561184406|FG001|Overall Study|Adverse Event|7|||
155481703|NCT00672139|561184405|FG000|Overall Study|Physician Decision|2|||
155481704|NCT00672139|561184406|FG001|Overall Study|Physician Decision|0|||
155481705|NCT00672139|561184405|FG000|Overall Study|Lack of Efficacy|4|||
155481706|NCT00672139|561184406|FG001|Overall Study|Lack of Efficacy|1|||
155481707|NCT00672139|561184405|FG000|Overall Study|Protocol Violation|1|||
155481708|NCT00672139|561184406|FG001|Overall Study|Protocol Violation|1|||
155481709|NCT00672139|561184405|FG000|Overall Study|hospice discharge, caregiver requests|3|||
155481710|NCT00672139|561184406|FG001|Overall Study|hospice discharge, caregiver requests|2|||
155481711|NCT02381795|561184407|FG000|Overall Study|Withdrawal by Subject|1|||
155481712|NCT02381795|561184407|FG000|Overall Study|Study Terminated|2|||
155481713|NCT02176226|561184408|FG000|Overall Study|Lost to Follow-up|3|||
155481714|NCT02176226|561184408|FG000|Overall Study|Withdrew prior to treatment|6|||
155481715|NCT01488994|561184411|FG000|Overall Study|Withdrawal by Subject|0|||
155481716|NCT01488994|561184412|FG001|Overall Study|Withdrawal by Subject|1|||
155481717|NCT02908841|561184413|FG000|Overall Study|Physician Decision|4|||
155481718|NCT02908841|561184414|FG001|Overall Study|Physician Decision|0|||
155481719|NCT01117428|561184417|FG000|Overall Study|Lack of Efficacy|1|||
155481720|NCT01117428|561184418|FG001|Overall Study|Lack of Efficacy|0|||
155481721|NCT01117428|561184419|FG002|Overall Study|Lack of Efficacy|0|||
155481722|NCT01117428|561184420|FG003|Overall Study|Lack of Efficacy|0|||
155481723|NCT01117428|561184421|FG004|Overall Study|Lack of Efficacy|0|||
155481724|NCT01117428|561184422|FG005|Overall Study|Lack of Efficacy|0|||
155481725|NCT01117428|561184417|FG000|Overall Study|Adverse Event|4|||
155481726|NCT01117428|561184418|FG001|Overall Study|Adverse Event|0|||
155481727|NCT01117428|561184419|FG002|Overall Study|Adverse Event|0|||
155481728|NCT01117428|561184420|FG003|Overall Study|Adverse Event|0|||
155481729|NCT01117428|561184421|FG004|Overall Study|Adverse Event|1|||
155481730|NCT01117428|561184422|FG005|Overall Study|Adverse Event|2|||
155481731|NCT01117428|561184417|FG000|Overall Study|Death|0|||
155481732|NCT01117428|561184418|FG001|Overall Study|Death|1|||
155481733|NCT01117428|561184419|FG002|Overall Study|Death|2|||
155481734|NCT01117428|561184420|FG003|Overall Study|Death|0|||
155481735|NCT01117428|561184421|FG004|Overall Study|Death|0|||
155481736|NCT01117428|561184422|FG005|Overall Study|Death|1|||
155481737|NCT01117428|561184417|FG000|Overall Study|Physician Decision|0|||
155481738|NCT01117428|561184418|FG001|Overall Study|Physician Decision|1|||
155481739|NCT01117428|561184419|FG002|Overall Study|Physician Decision|0|||
155481740|NCT01117428|561184420|FG003|Overall Study|Physician Decision|0|||
155481741|NCT01117428|561184421|FG004|Overall Study|Physician Decision|0|||
155481742|NCT01117428|561184422|FG005|Overall Study|Physician Decision|0|||
155481743|NCT01117428|561184417|FG000|Overall Study|Withdrawal by Subject|0|||
155481744|NCT01117428|561184418|FG001|Overall Study|Withdrawal by Subject|0|||
155481745|NCT01117428|561184419|FG002|Overall Study|Withdrawal by Subject|1|||
155481746|NCT01117428|561184420|FG003|Overall Study|Withdrawal by Subject|0|||
155481747|NCT01117428|561184421|FG004|Overall Study|Withdrawal by Subject|0|||
155481748|NCT01117428|561184422|FG005|Overall Study|Withdrawal by Subject|0|||
155481749|NCT01117428|561184417|FG000|Overall Study|Progressive disease|15|||
155481750|NCT01117428|561184418|FG001|Overall Study|Progressive disease|27|||
155481751|NCT01117428|561184419|FG002|Overall Study|Progressive disease|10|||
155481752|NCT01117428|561184420|FG003|Overall Study|Progressive disease|12|||
155481753|NCT01117428|561184421|FG004|Overall Study|Progressive disease|16|||
155481754|NCT01117428|561184422|FG005|Overall Study|Progressive disease|17|||
155481755|NCT01038635|561184424|FG000|Overall Study|Disease Progression|2|||
155481756|NCT01038635|561184425|FG001|Overall Study|Disease Progression|0|||
155481757|NCT01038635|561184426|FG002|Overall Study|Disease Progression|0|||
155481758|NCT01038635|561184427|FG003|Overall Study|Disease Progression|0|||
155481759|NCT01038635|561184428|FG004|Overall Study|Disease Progression|0|||
155481760|NCT01038635|561184429|FG005|Overall Study|Disease Progression|0|||
155481761|NCT01038635|561184430|FG006|Overall Study|Disease Progression|1|||
155481762|NCT01038635|561184431|FG007|Overall Study|Disease Progression|4|||
155481763|NCT01038635|561184432|FG008|Overall Study|Disease Progression|0|||
155481764|NCT01038635|561184424|FG000|Overall Study|Death|0|||
155481765|NCT01038635|561184425|FG001|Overall Study|Death|0|||
155481766|NCT01038635|561184426|FG002|Overall Study|Death|0|||
155481767|NCT01038635|561184427|FG003|Overall Study|Death|0|||
155481768|NCT01038635|561184428|FG004|Overall Study|Death|1|||
155481769|NCT01038635|561184429|FG005|Overall Study|Death|0|||
155481770|NCT01038635|561184430|FG006|Overall Study|Death|1|||
155481771|NCT01038635|561184431|FG007|Overall Study|Death|1|||
155481772|NCT01038635|561184432|FG008|Overall Study|Death|2|||
155481773|NCT01227252|561184433|FG000|Overall Study|Sponsor Decision|0|||
155481774|NCT01227252|561184434|FG001|Overall Study|Sponsor Decision|1|||
155481775|NCT01227252|561184435|FG002|Overall Study|Sponsor Decision|0|||
155481776|NCT01227252|561184436|FG003|Overall Study|Sponsor Decision|0|||
155481777|NCT01227252|561184433|FG000|Overall Study|Lost to Follow-up|0|||
155481778|NCT01227252|561184434|FG001|Overall Study|Lost to Follow-up|1|||
155481779|NCT01227252|561184435|FG002|Overall Study|Lost to Follow-up|0|||
155481780|NCT01227252|561184436|FG003|Overall Study|Lost to Follow-up|0|||
155481781|NCT01227252|561184433|FG000|Overall Study|Withdrawal by Subject|0|||
155481782|NCT01227252|561184434|FG001|Overall Study|Withdrawal by Subject|1|||
155481783|NCT01227252|561184435|FG002|Overall Study|Withdrawal by Subject|0|||
155481784|NCT01227252|561184436|FG003|Overall Study|Withdrawal by Subject|0|||
155481785|NCT01034709|561184440|FG000|Overall Study|Protocol Violation|9|||
155481786|NCT01034709|561184441|FG001|Overall Study|Protocol Violation|16|||
155481787|NCT01060150|561184442|FG000|Overall Study|Adverse Event|6|||
155481788|NCT01060150|561184442|FG000|Overall Study|Lost to Follow-up|1|||
155481789|NCT01060150|561184442|FG000|Overall Study|Protocol Violation|6|||
155481790|NCT01060150|561184442|FG000|Overall Study|Withdrawal by Subject|8|||
155481791|NCT01060150|561184442|FG000|Overall Study|Enrolled, but not treated|2|||
155481792|NCT01970540|561184443|FG000|Overall Study|Non-treatment-related AE|0|||
155481793|NCT01970540|561184444|FG001|Overall Study|Non-treatment-related AE|0|||
155481794|NCT01970540|561184445|FG002|Overall Study|Non-treatment-related AE|1|||
155481795|NCT01970540|561184443|FG000|Overall Study|Progressive disease|55|||
155481796|NCT01970540|561184444|FG001|Overall Study|Progressive disease|23|||
155481797|NCT01970540|561184445|FG002|Overall Study|Progressive disease|10|||
155481798|NCT01970540|561184443|FG000|Overall Study|Treatment delay over protocol|0|||
155481799|NCT01970540|561184444|FG001|Overall Study|Treatment delay over protocol|0|||
155481800|NCT01970540|561184445|FG002|Overall Study|Treatment delay over protocol|1|||
155481801|NCT01970540|561184443|FG000|Overall Study|Physician Decision|7|||
155481802|NCT01970540|561184444|FG001|Overall Study|Physician Decision|2|||
155481803|NCT01970540|561184445|FG002|Overall Study|Physician Decision|0|||
155481804|NCT01970540|561184443|FG000|Overall Study|Clinical progression|0|||
155481805|NCT01970540|561184444|FG001|Overall Study|Clinical progression|1|||
155481806|NCT01970540|561184445|FG002|Overall Study|Clinical progression|1|||
155481807|NCT01970540|561184443|FG000|Overall Study|End of study|2|||
155481808|NCT01970540|561184444|FG001|Overall Study|End of study|0|||
155481809|NCT01970540|561184445|FG002|Overall Study|End of study|2|||
155481810|NCT01970540|561184443|FG000|Overall Study|Adverse Event|0|||
155481811|NCT01970540|561184444|FG001|Overall Study|Adverse Event|2|||
155481812|NCT01970540|561184445|FG002|Overall Study|Adverse Event|1|||
155481813|NCT01970540|561184443|FG000|Overall Study|Treatment-related AE|4|||
155481814|NCT01970540|561184444|FG001|Overall Study|Treatment-related AE|0|||
155481815|NCT01970540|561184445|FG002|Overall Study|Treatment-related AE|2|||
155481816|NCT01970540|561184443|FG000|Overall Study|Withdrawal by Subject|4|||
155481817|NCT01970540|561184444|FG001|Overall Study|Withdrawal by Subject|0|||
155481818|NCT01970540|561184445|FG002|Overall Study|Withdrawal by Subject|1|||
155481819|NCT01970540|561184443|FG000|Overall Study|Clinical deterioration|1|||
155481820|NCT01970540|561184444|FG001|Overall Study|Clinical deterioration|0|||
155481821|NCT01970540|561184445|FG002|Overall Study|Clinical deterioration|0|||
155481822|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Adverse Event|30|||
155481823|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Adverse Event|25|||
155481824|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Adverse Event|23|||
155481825|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Adverse Event|14|||
155481826|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Death|0|||
155481827|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Death|0|||
155481828|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Death|1|||
155481829|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Death|0|||
155481830|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Physician Decision|0|||
155481831|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Physician Decision|1|||
155481832|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Physician Decision|0|||
155481833|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Physician Decision|1|||
155481834|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
155481835|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
155481836|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
155481837|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
155481838|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Other|6|||
155481839|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Other|1|||
155481840|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Other|0|||
155481841|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Other|2|||
155481842|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
155481843|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
155481844|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
155481845|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
155481846|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
155481847|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
155481848|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
155481849|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
155481850|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
155481851|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
155481852|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
155481853|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
155481854|NCT00242710|561184447|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
155481855|NCT00242710|561184448|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
155481856|NCT00242710|561184449|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
155481857|NCT00242710|561184450|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
155481858|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Adverse Event|2|||
155481859|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Adverse Event|3|||
155481860|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Adverse Event|5|||
155481861|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Adverse Event|2|||
155481862|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Physician Decision|1|||
155481863|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Physician Decision|1|||
155481864|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Physician Decision|0|||
155481865|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Physician Decision|0|||
155481866|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Other|24|||
155481867|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Other|24|||
155481868|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Other|9|||
155481869|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Other|11|||
155481870|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Extension not Available|17|||
155481871|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Extension not Available|21|||
155481872|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Extension not Available|8|||
155481873|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Extension not Available|7|||
155481874|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
155481875|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
155481876|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
155481877|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
155481878|NCT00242710|561184447|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
155481879|NCT00242710|561184448|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
155481880|NCT00242710|561184449|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
155481881|NCT00242710|561184450|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
155481882|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
155481883|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
155481884|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
155481885|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
155481886|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Death|0|||
155481887|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Death|0|||
155481888|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Death|0|||
155481889|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Death|1|||
155481890|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
155481891|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
155481892|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
155481893|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
155481894|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Other|3|||
155481895|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Other|5|||
155481896|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Other|4|||
155481897|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Other|3|||
155481898|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
155481899|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
155481900|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
155481901|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
155481902|NCT00242710|561184447|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
155481903|NCT00242710|561184448|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
155481904|NCT00242710|561184449|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
155481905|NCT00242710|561184450|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
155481906|NCT01683058|561184451|FG000|Overall Study|Lost to Follow-up|9|||
155481907|NCT01683058|561184451|FG000|Overall Study|Adverse Event|6|||
155481908|NCT01683058|561184451|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
155654672|NCT03715829|561828901|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654673|NCT03715829|561828902|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
155481909|NCT01683058|561184451|FG000|Overall Study|Withdrawal by Subject|7|||
155481910|NCT01683058|561184451|FG000|Overall Study|Lack of Efficacy|2|||
155481911|NCT01057394|561184452|FG000|Overall Study|Not eligible|0|||
155481912|NCT01057394|561184453|FG001|Overall Study|Not eligible|2|||
155481913|NCT01195636|561184454|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
155481914|NCT01195636|561184455|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
155481915|NCT01195636|561184454|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
155481916|NCT01195636|561184455|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
155481917|NCT01195636|561184454|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155481918|NCT01195636|561184455|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155481919|NCT01195636|561184454|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
155481920|NCT01195636|561184455|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
155481921|NCT01195636|561184454|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
155481922|NCT01195636|561184455|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
155481923|NCT01195636|561184454|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
155481924|NCT01195636|561184455|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
155481925|NCT01195636|561184454|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
155481926|NCT01195636|561184455|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
155481927|NCT01195636|561184454|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155481928|NCT01195636|561184455|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
155481929|NCT01566981|561184465|FG000|Overall Study|Lost to Follow-up|5|||
155481930|NCT01566981|561184466|FG001|Overall Study|Lost to Follow-up|8|||
155481931|NCT02177942|561184467|FG000|Overall Study|Adverse Event|1|||
155481932|NCT02177942|561184468|FG001|Overall Study|Adverse Event|0|||
155481933|NCT02177942|561184467|FG000|Overall Study|Lost to Follow-up|1|||
155481934|NCT02177942|561184468|FG001|Overall Study|Lost to Follow-up|1|||
155481935|NCT02177942|561184467|FG000|Overall Study|Protocol Violation|4|||
155481936|NCT02177942|561184468|FG001|Overall Study|Protocol Violation|6|||
155481937|NCT02177942|561184467|FG000|Overall Study|Withdrawal by Subject|71|||
155481938|NCT02177942|561184468|FG001|Overall Study|Withdrawal by Subject|81|||
155481939|NCT01234337|561184474|FG000|Overall Study|Adverse Event|58|||
155481940|NCT01234337|561184475|FG001|Overall Study|Adverse Event|21|||
155481941|NCT01234337|561184474|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
155481942|NCT01234337|561184475|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
155481943|NCT01234337|561184474|FG000|Overall Study|Investi. decision not protocol driven|5|||
155481944|NCT01234337|561184475|FG001|Overall Study|Investi. decision not protocol driven|6|||
155481945|NCT01234337|561184474|FG000|Overall Study|Non-compliant with study medication|3|||
155481946|NCT01234337|561184475|FG001|Overall Study|Non-compliant with study medication|2|||
155481947|NCT01234337|561184474|FG000|Overall Study|Randomized but not treated|6|||
155481948|NCT01234337|561184475|FG001|Overall Study|Randomized but not treated|4|||
155481949|NCT01234337|561184474|FG000|Overall Study|Lost to Follow-up|0|||
155481950|NCT01234337|561184475|FG001|Overall Study|Lost to Follow-up|1|||
155481951|NCT01234337|561184474|FG000|Overall Study|Protocol Violation|2|||
155481952|NCT01234337|561184475|FG001|Overall Study|Protocol Violation|3|||
155481953|NCT01234337|561184474|FG000|Overall Study|Withdrawal by Subject|11|||
155481954|NCT01234337|561184475|FG001|Overall Study|Withdrawal by Subject|9|||
155481955|NCT01234337|561184474|FG000|Overall Study|Death|0|||
155481956|NCT01234337|561184475|FG001|Overall Study|Death|1|||
155481957|NCT01234337|561184474|FG000|Overall Study|Switch to commercial drug|0|||
155481958|NCT01234337|561184475|FG001|Overall Study|Switch to commercial drug|1|||
155481959|NCT00247962|561184482|FG000|Overall Study|Adverse Event|15|||
155481960|NCT00247962|561184483|FG001|Overall Study|Adverse Event|12|||
155481961|NCT00247962|561184482|FG000|Overall Study|Lost to Follow-up|3|||
155481962|NCT00247962|561184483|FG001|Overall Study|Lost to Follow-up|1|||
155481963|NCT00247962|561184482|FG000|Overall Study|Physician Decision|0|||
155481964|NCT00247962|561184483|FG001|Overall Study|Physician Decision|1|||
155481965|NCT00247962|561184482|FG000|Overall Study|Protocol Violation|1|||
155481966|NCT00247962|561184483|FG001|Overall Study|Protocol Violation|1|||
155481967|NCT00247962|561184482|FG000|Overall Study|Withdrawal by Subject|3|||
155481968|NCT00247962|561184483|FG001|Overall Study|Withdrawal by Subject|2|||
155481969|NCT00247962|561184482|FG000|Overall Study|Lack of Efficacy|4|||
155481970|NCT00247962|561184483|FG001|Overall Study|Lack of Efficacy|2|||
155481971|NCT02555722|561184484|FG000|Week 2|Adverse Event|0|||
155481972|NCT02555722|561184485|FG001|Week 2|Adverse Event|1|||
155481973|NCT02555722|561184484|FG000|Week 2|Withdrawal by Subject|1|||
155481974|NCT02555722|561184485|FG001|Week 2|Withdrawal by Subject|0|||
155481975|NCT02555722|561184484|FG000|Month 1|Lens Discomfort|1|||
155481976|NCT02555722|561184485|FG001|Month 1|Lens Discomfort|0|||
155481977|NCT02555722|561184484|FG000|Month 2|Withdrawal by Subject|3|||
155481978|NCT02555722|561184485|FG001|Month 2|Withdrawal by Subject|0|||
155481979|NCT02555722|561184484|FG000|Month 2|Lost to Follow-up|1|||
155481980|NCT02555722|561184485|FG001|Month 2|Lost to Follow-up|0|||
155481981|NCT00702949|561184486|FG000|Overall Study|Refusal|3|||
155481982|NCT00702949|561184487|FG001|Overall Study|Refusal|2|||
155481983|NCT00702949|561184488|FG002|Overall Study|Refusal|2|||
155481984|NCT00702949|561184486|FG000|Overall Study|Adverse Event|1|||
155481985|NCT00702949|561184487|FG001|Overall Study|Adverse Event|6|||
155481986|NCT00702949|561184488|FG002|Overall Study|Adverse Event|3|||
155481987|NCT00702949|561184486|FG000|Overall Study|Other Medical Reason/unknown|1|||
155481988|NCT00702949|561184487|FG001|Overall Study|Other Medical Reason/unknown|1|||
155481989|NCT00702949|561184488|FG002|Overall Study|Other Medical Reason/unknown|3|||
155481990|NCT03525613|561184493|FG000|Overall Study|Adverse Event|11|||
155481991|NCT03525613|561184494|FG001|Overall Study|Adverse Event|8|||
155481992|NCT03525613|561184495|FG002|Overall Study|Adverse Event|3|||
155481993|NCT03525613|561184496|FG003|Overall Study|Adverse Event|3|||
155481994|NCT03525613|561184493|FG000|Overall Study|Lost to Follow-up|4|||
155481995|NCT03525613|561184494|FG001|Overall Study|Lost to Follow-up|5|||
155481996|NCT03525613|561184495|FG002|Overall Study|Lost to Follow-up|3|||
155481997|NCT03525613|561184496|FG003|Overall Study|Lost to Follow-up|2|||
155481998|NCT03525613|561184493|FG000|Overall Study|Physician Decision|0|||
155481999|NCT03525613|561184494|FG001|Overall Study|Physician Decision|1|||
155482000|NCT03525613|561184495|FG002|Overall Study|Physician Decision|0|||
155482001|NCT03525613|561184496|FG003|Overall Study|Physician Decision|1|||
155482002|NCT03525613|561184493|FG000|Overall Study|Consent Withdrawal|25|||
155482003|NCT03525613|561184494|FG001|Overall Study|Consent Withdrawal|16|||
155482004|NCT03525613|561184495|FG002|Overall Study|Consent Withdrawal|12|||
155482005|NCT03525613|561184496|FG003|Overall Study|Consent Withdrawal|9|||
155482006|NCT03525613|561184493|FG000|Overall Study|Death|20|||
155482007|NCT03525613|561184494|FG001|Overall Study|Death|9|||
155482008|NCT03525613|561184495|FG002|Overall Study|Death|7|||
155482009|NCT03525613|561184496|FG003|Overall Study|Death|1|||
155482010|NCT03525613|561184493|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
155482011|NCT03525613|561184494|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
155482012|NCT03525613|561184495|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
155482013|NCT03525613|561184496|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
155482014|NCT03480360|561184497|FG000|Overall Study|Death|2|||
155482015|NCT02120469|561184502|FG000|Overall Study|HER-2/neu-amplified|1|||
155482016|NCT02120469|561184503|FG001|Overall Study|HER-2/neu-amplified|0|||
155482017|NCT02120469|561184504|FG002|Overall Study|HER-2/neu-amplified|1|||
155482018|NCT01040728|561184505|FG000|Overall Study|Adverse Event|4|||
155482019|NCT01040728|561184506|FG001|Overall Study|Adverse Event|8|||
155482020|NCT01040728|561184507|FG002|Overall Study|Adverse Event|0|||
155482021|NCT01040728|561184508|FG003|Overall Study|Adverse Event|4|||
155482022|NCT01040728|561184505|FG000|Overall Study|Withdrawal by Subject|0|||
155482023|NCT01040728|561184506|FG001|Overall Study|Withdrawal by Subject|1|||
155482024|NCT01040728|561184507|FG002|Overall Study|Withdrawal by Subject|1|||
155482025|NCT01040728|561184508|FG003|Overall Study|Withdrawal by Subject|0|||
155482026|NCT01040728|561184505|FG000|Overall Study|Protocol Violation|0|||
155482027|NCT01040728|561184506|FG001|Overall Study|Protocol Violation|0|||
155482028|NCT01040728|561184507|FG002|Overall Study|Protocol Violation|0|||
155482029|NCT01040728|561184508|FG003|Overall Study|Protocol Violation|1|||
155482030|NCT01040728|561184505|FG000|Overall Study|Lack of Efficacy|0|||
155482031|NCT01040728|561184506|FG001|Overall Study|Lack of Efficacy|1|||
155482032|NCT01040728|561184507|FG002|Overall Study|Lack of Efficacy|0|||
155482033|NCT01040728|561184508|FG003|Overall Study|Lack of Efficacy|1|||
155482034|NCT01040728|561184505|FG000|Overall Study|Other reasons not listed above|0|||
155482035|NCT01040728|561184506|FG001|Overall Study|Other reasons not listed above|1|||
155482036|NCT01040728|561184507|FG002|Overall Study|Other reasons not listed above|0|||
155482037|NCT01040728|561184508|FG003|Overall Study|Other reasons not listed above|0|||
155482038|NCT00590031|561184510|FG000|Overall Study|Adverse Event|3|||
155482039|NCT00590031|561184510|FG000|Overall Study|Withdrawal by Subject|1|||
155482040|NCT00590031|561184510|FG000|Overall Study|Metastatic Disease|1|||
155482041|NCT00590031|561184510|FG000|Overall Study|Admin Hold|1|||
155482042|NCT01809327|561184511|FG000|Overall Study|Lost to Follow-up|5|||
155482043|NCT01809327|561184512|FG001|Overall Study|Lost to Follow-up|2|||
155482044|NCT01809327|561184513|FG002|Overall Study|Lost to Follow-up|4|||
155482045|NCT01809327|561184514|FG003|Overall Study|Lost to Follow-up|2|||
155482046|NCT01809327|561184515|FG004|Overall Study|Lost to Follow-up|3|||
155482047|NCT01809327|561184511|FG000|Overall Study|Withdrawal by Subject|6|||
155482048|NCT01809327|561184512|FG001|Overall Study|Withdrawal by Subject|4|||
155482049|NCT01809327|561184513|FG002|Overall Study|Withdrawal by Subject|4|||
155482050|NCT01809327|561184514|FG003|Overall Study|Withdrawal by Subject|2|||
155482051|NCT01809327|561184515|FG004|Overall Study|Withdrawal by Subject|5|||
155482052|NCT01809327|561184511|FG000|Overall Study|Adverse Event|4|||
155482053|NCT01809327|561184512|FG001|Overall Study|Adverse Event|3|||
155482054|NCT01809327|561184513|FG002|Overall Study|Adverse Event|7|||
155482055|NCT01809327|561184514|FG003|Overall Study|Adverse Event|4|||
155482056|NCT01809327|561184515|FG004|Overall Study|Adverse Event|8|||
155482057|NCT01809327|561184511|FG000|Overall Study|Death|1|||
155482058|NCT01809327|561184512|FG001|Overall Study|Death|0|||
155482059|NCT01809327|561184513|FG002|Overall Study|Death|0|||
155482060|NCT01809327|561184514|FG003|Overall Study|Death|0|||
155482061|NCT01809327|561184515|FG004|Overall Study|Death|0|||
155482062|NCT01809327|561184511|FG000|Overall Study|Protocol Violation|0|||
155482063|NCT01809327|561184512|FG001|Overall Study|Protocol Violation|1|||
155482064|NCT01809327|561184513|FG002|Overall Study|Protocol Violation|0|||
155482065|NCT01809327|561184514|FG003|Overall Study|Protocol Violation|0|||
155482066|NCT01809327|561184515|FG004|Overall Study|Protocol Violation|0|||
155482067|NCT01809327|561184511|FG000|Overall Study|Physician Decision|1|||
155482068|NCT01809327|561184512|FG001|Overall Study|Physician Decision|1|||
155482069|NCT01809327|561184513|FG002|Overall Study|Physician Decision|0|||
155482070|NCT01809327|561184514|FG003|Overall Study|Physician Decision|0|||
155482071|NCT01809327|561184515|FG004|Overall Study|Physician Decision|0|||
155482072|NCT01809327|561184511|FG000|Overall Study|Pregnancy|1|||
155482073|NCT01809327|561184512|FG001|Overall Study|Pregnancy|0|||
155482074|NCT01809327|561184513|FG002|Overall Study|Pregnancy|0|||
155482075|NCT01809327|561184514|FG003|Overall Study|Pregnancy|0|||
155482076|NCT01809327|561184515|FG004|Overall Study|Pregnancy|0|||
155482077|NCT01809327|561184511|FG000|Overall Study|Other|14|||
155482078|NCT01809327|561184512|FG001|Overall Study|Other|15|||
155482079|NCT01809327|561184513|FG002|Overall Study|Other|7|||
155482080|NCT01809327|561184514|FG003|Overall Study|Other|4|||
155482081|NCT01809327|561184515|FG004|Overall Study|Other|9|||
155482082|NCT03196973|561184516|FG000|Overall Study|Adverse Event|1|||
155482083|NCT03196973|561184517|FG001|Overall Study|Adverse Event|1|||
155482084|NCT03196973|561184518|FG002|Overall Study|Adverse Event|2|||
155482085|NCT03196973|561184516|FG000|Overall Study|Lack of Efficacy|2|||
155482086|NCT03196973|561184517|FG001|Overall Study|Lack of Efficacy|6|||
155482087|NCT03196973|561184518|FG002|Overall Study|Lack of Efficacy|1|||
155482088|NCT03196973|561184516|FG000|Overall Study|Lost to Follow-up|4|||
155482089|NCT03196973|561184517|FG001|Overall Study|Lost to Follow-up|3|||
155482090|NCT03196973|561184518|FG002|Overall Study|Lost to Follow-up|2|||
155482091|NCT03196973|561184516|FG000|Overall Study|Consent withdrawn|2|||
155482092|NCT03196973|561184517|FG001|Overall Study|Consent withdrawn|1|||
155482093|NCT03196973|561184518|FG002|Overall Study|Consent withdrawn|0|||
155482094|NCT03196973|561184516|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
155482095|NCT03196973|561184517|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
155482096|NCT03196973|561184518|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
155482097|NCT01610414|561184519|FG000|Study Start - Month 13|Serious Adverse Event|65|||
155482098|NCT01610414|561184520|FG001|Study Start - Month 13|Serious Adverse Event|67|||
155482099|NCT01610414|561184519|FG000|Study Start - Month 13|Adverse Event|14|||
155482100|NCT01610414|561184520|FG001|Study Start - Month 13|Adverse Event|14|||
155482101|NCT01610414|561184519|FG000|Study Start - Month 13|Protocol Violation|3|||
155482102|NCT01610414|561184520|FG001|Study Start - Month 13|Protocol Violation|1|||
155482103|NCT01610414|561184519|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
155482104|NCT01610414|561184520|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
155482105|NCT01610414|561184519|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
155482106|NCT01610414|561184520|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
155482107|NCT01610414|561184519|FG000|Study Start - Month 13|Lost to Follow-up|4|||
155482108|NCT01610414|561184520|FG001|Study Start - Month 13|Lost to Follow-up|6|||
155482109|NCT01610414|561184519|FG000|Study Start - Month 13|Suspected HZ episode|1|||
155482110|NCT01610414|561184520|FG001|Study Start - Month 13|Suspected HZ episode|3|||
155482111|NCT01610414|561184519|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
155482112|NCT01610414|561184520|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
155482113|NCT01610414|561184519|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
155482114|NCT01610414|561184520|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
155482115|NCT01610414|561184519|FG000|Month 13 - Month 25|Adverse Event|8|||
155482116|NCT01610414|561184520|FG001|Month 13 - Month 25|Adverse Event|4|||
155482117|NCT01610414|561184519|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
155482118|NCT01610414|561184520|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
155482119|NCT01610414|561184519|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
155482120|NCT01610414|561184520|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
155482121|NCT01610414|561184519|FG000|Month 13 - Month 25|Protocol Violation|0|||
155482122|NCT01610414|561184520|FG001|Month 13 - Month 25|Protocol Violation|2|||
155482123|NCT01610414|561184519|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
155482124|NCT01610414|561184520|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
155482125|NCT01610414|561184519|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
155482126|NCT01610414|561184520|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
155482127|NCT01610414|561184519|FG000|After Month 25|Study end not reached|48|||
155482128|NCT01610414|561184520|FG001|After Month 25|Study end not reached|53|||
155482129|NCT00826540|561184525|FG000|Overall Study|ineligible|3|||
155482130|NCT00826540|561184525|FG000|Overall Study|Withdrawal by Subject|1|||
155482131|NCT01166386|561184526|FG000|Overall Study|Withdrawal by Subject|3|||
155482132|NCT01166386|561184527|FG001|Overall Study|Withdrawal by Subject|5|||
155482133|NCT02802735|561184528|FG000|Overall Study|Withdrawal by Subject|0|||
155482134|NCT02802735|561184529|FG001|Overall Study|Withdrawal by Subject|1|||
155482135|NCT02802735|561184530|FG002|Overall Study|Withdrawal by Subject|0|||
155482136|NCT02802735|561184531|FG003|Overall Study|Withdrawal by Subject|0|||
155482137|NCT02802735|561184532|FG004|Overall Study|Withdrawal by Subject|0|||
155482138|NCT03922711|561184537|FG000|Overall Study|Adverse Event|3|||
155482139|NCT03922711|561184538|FG001|Overall Study|Adverse Event|2|||
155482140|NCT03922711|561184539|FG002|Overall Study|Adverse Event|2|||
155482141|NCT03922711|561184537|FG000|Overall Study|Protocol Violation|1|||
155482142|NCT03922711|561184538|FG001|Overall Study|Protocol Violation|0|||
155482143|NCT03922711|561184539|FG002|Overall Study|Protocol Violation|0|||
155482144|NCT03922711|561184537|FG000|Overall Study|Withdrawal by Subject|0|||
155482145|NCT03922711|561184538|FG001|Overall Study|Withdrawal by Subject|3|||
155482146|NCT03922711|561184539|FG002|Overall Study|Withdrawal by Subject|1|||
155482147|NCT03922711|561184537|FG000|Overall Study|Not further specified|0|||
155482148|NCT03922711|561184538|FG001|Overall Study|Not further specified|0|||
155482149|NCT03922711|561184539|FG002|Overall Study|Not further specified|1|||
155482150|NCT02390362|561184540|FG000|Overall Study|Withdrawal by Subject|0|||
155482151|NCT02390362|561184541|FG001|Overall Study|Withdrawal by Subject|1|||
155482152|NCT04009824|561184542|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
155482153|NCT04009824|561184543|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
155482154|NCT04009824|561184544|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
155482155|NCT04009824|561184545|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
155482156|NCT04009824|561184546|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
155482157|NCT00554840|561184551|FG000|Overall Study|Physician Decision|0|||
155482158|NCT00554840|561184552|FG001|Overall Study|Physician Decision|1|||
155482159|NCT04728815|561184553|FG000|Overall Study|Lost to Follow-up|3|||
155482160|NCT04728815|561184554|FG001|Overall Study|Lost to Follow-up|0|||
155482161|NCT04728815|561184555|FG002|Overall Study|Lost to Follow-up|0|||
155482162|NCT04728815|561184556|FG003|Overall Study|Lost to Follow-up|1|||
155482163|NCT04728815|561184557|FG004|Overall Study|Lost to Follow-up|1|||
155482164|NCT04728815|561184558|FG005|Overall Study|Lost to Follow-up|0|||
155482165|NCT04728815|561184559|FG006|Overall Study|Lost to Follow-up|2|||
155482166|NCT04728815|561184560|FG007|Overall Study|Lost to Follow-up|0|||
155482167|NCT04728815|561184553|FG000|Overall Study|Physician Decision|0|||
155482168|NCT04728815|561184554|FG001|Overall Study|Physician Decision|0|||
155482169|NCT04728815|561184555|FG002|Overall Study|Physician Decision|1|||
155482170|NCT04728815|561184556|FG003|Overall Study|Physician Decision|0|||
155482171|NCT04728815|561184557|FG004|Overall Study|Physician Decision|0|||
155482172|NCT04728815|561184558|FG005|Overall Study|Physician Decision|0|||
155482173|NCT04728815|561184559|FG006|Overall Study|Physician Decision|0|||
155482174|NCT04728815|561184560|FG007|Overall Study|Physician Decision|0|||
155482175|NCT04728815|561184553|FG000|Overall Study|Treatment drop|0|||
155482176|NCT04728815|561184554|FG001|Overall Study|Treatment drop|2|||
155482177|NCT04728815|561184555|FG002|Overall Study|Treatment drop|1|||
155482178|NCT04728815|561184556|FG003|Overall Study|Treatment drop|0|||
155482179|NCT04728815|561184557|FG004|Overall Study|Treatment drop|3|||
155482180|NCT04728815|561184558|FG005|Overall Study|Treatment drop|1|||
155482181|NCT04728815|561184559|FG006|Overall Study|Treatment drop|3|||
155482182|NCT04728815|561184560|FG007|Overall Study|Treatment drop|0|||
155482183|NCT04728815|561184553|FG000|Overall Study|Study drop|0|||
155482184|NCT04728815|561184554|FG001|Overall Study|Study drop|3|||
155482185|NCT04728815|561184555|FG002|Overall Study|Study drop|3|||
155482186|NCT04728815|561184556|FG003|Overall Study|Study drop|0|||
155482187|NCT04728815|561184557|FG004|Overall Study|Study drop|0|||
155482188|NCT04728815|561184558|FG005|Overall Study|Study drop|0|||
155482189|NCT04728815|561184559|FG006|Overall Study|Study drop|7|||
155482190|NCT04728815|561184560|FG007|Overall Study|Study drop|0|||
155482191|NCT01084096|561187074|FG000|Overall Study|Lost to Follow-up|1501|||
155482192|NCT01084096|561187075|FG001|Overall Study|Lost to Follow-up|1833|||
155482193|NCT01084096|561187074|FG000|Overall Study|Withdrawal by Subject|3|||
155482194|NCT01084096|561187075|FG001|Overall Study|Withdrawal by Subject|0|||
155482195|NCT01084096|561187074|FG000|Overall Study|Woman had a miscarriage|21|||
155482196|NCT01084096|561187075|FG001|Overall Study|Woman had a miscarriage|17|||
155482197|NCT02033369|561187076|FG000|Overall Study|Physician Decision|1|||
155482198|NCT02033369|561187077|FG001|Overall Study|Physician Decision|2|||
155482199|NCT02033369|561187076|FG000|Overall Study|Not a good demographic match|0|||
155482200|NCT02033369|561187077|FG001|Overall Study|Not a good demographic match|2|||
155482201|NCT02033369|561187076|FG000|Overall Study|Withdrawal by Subject|1|||
155482202|NCT02033369|561187077|FG001|Overall Study|Withdrawal by Subject|1|||
155482203|NCT02033369|561187076|FG000|Overall Study|Lost to Follow-up|1|||
155482204|NCT02033369|561187077|FG001|Overall Study|Lost to Follow-up|0|||
155482205|NCT02033369|561187076|FG000|Overall Study|Protocol Violation|2|||
155482206|NCT02033369|561187077|FG001|Overall Study|Protocol Violation|0|||
155482207|NCT00711009|561187078|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
155482208|NCT00711009|561187079|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
155482209|NCT00711009|561187078|FG000|Overall Study|Withdrawal by Subject|4|||
155482210|NCT00711009|561187079|FG001|Overall Study|Withdrawal by Subject|2|||
155482211|NCT00711009|561187078|FG000|Overall Study|Lost to Follow-up|3|||
155482212|NCT00711009|561187079|FG001|Overall Study|Lost to Follow-up|9|||
155482213|NCT00711009|561187078|FG000|Overall Study|Participant Noncompliant|0|||
155482214|NCT00711009|561187079|FG001|Overall Study|Participant Noncompliant|1|||
155482215|NCT00711009|561187078|FG000|Overall Study|Virologic Failure|2|||
155482216|NCT00711009|561187079|FG001|Overall Study|Virologic Failure|1|||
155482217|NCT00711009|561187078|FG000|Overall Study|Pregnancy|1|||
155482218|NCT00711009|561187079|FG001|Overall Study|Pregnancy|0|||
155482219|NCT00711009|561187078|FG000|Overall Study|Site closing|0|||
155482220|NCT00711009|561187079|FG001|Overall Study|Site closing|1|||
155482221|NCT00711009|561187078|FG000|Overall Study|Dose adjustment|1|||
155482222|NCT00711009|561187079|FG001|Overall Study|Dose adjustment|0|||
155482223|NCT04335929|561187080|FG000|Overall Study|Lost to Follow-up|10|||
155482224|NCT02534324|561187086|FG000|Overall Study|Protocol Violation|4|||
155482225|NCT02534324|561187087|FG001|Overall Study|Protocol Violation|1|||
155482226|NCT02534324|561187086|FG000|Overall Study|Lost to Follow-up|20|||
155482227|NCT02534324|561187087|FG001|Overall Study|Lost to Follow-up|7|||
155482228|NCT02534324|561187086|FG000|Overall Study|Adverse Event|1|||
155482229|NCT02534324|561187087|FG001|Overall Study|Adverse Event|0|||
155482230|NCT05604781|561187090|FG000|Overall Study|Lost to Follow-up|3|||
155482231|NCT05604781|561187090|FG000|Overall Study|Adverse Event|1|||
155482232|NCT00303602|561187091|FG000|Overall Study|Adverse Event|2|||
155482233|NCT00303602|561187092|FG001|Overall Study|Adverse Event|2|||
155482234|NCT00303602|561187091|FG000|Overall Study|Withdrawal by Subject|5|||
155482235|NCT00303602|561187092|FG001|Overall Study|Withdrawal by Subject|6|||
155482236|NCT00303602|561187091|FG000|Overall Study|Lost to Follow-up|5|||
155482237|NCT00303602|561187092|FG001|Overall Study|Lost to Follow-up|2|||
155482238|NCT00303602|561187091|FG000|Overall Study|Protocol entry criteria not met|2|||
155482239|NCT00303602|561187092|FG001|Overall Study|Protocol entry criteria not met|2|||
155482240|NCT00303602|561187091|FG000|Overall Study|Physician Decision|2|||
155482241|NCT00303602|561187092|FG001|Overall Study|Physician Decision|1|||
155482242|NCT00303602|561187091|FG000|Overall Study|Noncompliance|2|||
155482243|NCT00303602|561187092|FG001|Overall Study|Noncompliance|2|||
155482244|NCT00303602|561187091|FG000|Overall Study|Protocol Violation|1|||
155482245|NCT00303602|561187092|FG001|Overall Study|Protocol Violation|0|||
155482246|NCT02889861|561187103|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
155482247|NCT02551874|561187110|FG000|Overall Study|Lost to Follow-up|0|||
155482248|NCT02551874|561187111|FG001|Overall Study|Lost to Follow-up|2|||
155482249|NCT02551874|561187110|FG000|Overall Study|Pregnancy|0|||
155482250|NCT02551874|561187111|FG001|Overall Study|Pregnancy|1|||
155482251|NCT02551874|561187110|FG000|Overall Study|Reason not reported|10|||
155482252|NCT02551874|561187111|FG001|Overall Study|Reason not reported|4|||
155482253|NCT02551874|561187110|FG000|Overall Study|Did not receive randomized treatment|0|||
155482254|NCT02551874|561187111|FG001|Overall Study|Did not receive randomized treatment|7|||
155482255|NCT02551874|561187110|FG000|Overall Study|Did not enter long-term study|18|||
155482256|NCT02551874|561187111|FG001|Overall Study|Did not enter long-term study|25|||
155482257|NCT00313716|561187112|FG000|Overall Study|Death|3|||
155482258|NCT00313716|561187113|FG001|Overall Study|Death|2|||
155482259|NCT00313716|561187114|FG002|Overall Study|Death|9|||
155482260|NCT00313716|561187115|FG003|Overall Study|Death|3|||
155482261|NCT00313716|561187116|FG004|Overall Study|Death|5|||
155482262|NCT00313716|561187117|FG005|Overall Study|Death|9|||
155482263|NCT00313716|561187112|FG000|Overall Study|Lost to Follow-up|2|||
155482264|NCT00313716|561187113|FG001|Overall Study|Lost to Follow-up|5|||
155482265|NCT00313716|561187114|FG002|Overall Study|Lost to Follow-up|2|||
155482266|NCT00313716|561187115|FG003|Overall Study|Lost to Follow-up|1|||
155482267|NCT00313716|561187116|FG004|Overall Study|Lost to Follow-up|0|||
155482268|NCT00313716|561187117|FG005|Overall Study|Lost to Follow-up|4|||
155482269|NCT00313716|561187112|FG000|Overall Study|Withdrawal by Subject|0|||
155482270|NCT00313716|561187113|FG001|Overall Study|Withdrawal by Subject|1|||
155482271|NCT00313716|561187114|FG002|Overall Study|Withdrawal by Subject|1|||
155482272|NCT00313716|561187115|FG003|Overall Study|Withdrawal by Subject|0|||
155482273|NCT00313716|561187116|FG004|Overall Study|Withdrawal by Subject|1|||
155482274|NCT00313716|561187117|FG005|Overall Study|Withdrawal by Subject|0|||
155654674|NCT03715829|561828903|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654675|NCT03715829|561828904|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
155482275|NCT02491463|561187118|FG000|Overall Study|Withdrawal by Subject|1|||
155482276|NCT02491463|561187119|FG001|Overall Study|Withdrawal by Subject|2|||
155654676|NCT03715829|561828905|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
155482277|NCT02491463|561187120|FG002|Overall Study|Withdrawal by Subject|0|||
155482278|NCT02491463|561187121|FG003|Overall Study|Withdrawal by Subject|0|||
155482279|NCT02491463|561187118|FG000|Overall Study|Migrated/moved from study area|1|||
155482280|NCT02491463|561187119|FG001|Overall Study|Migrated/moved from study area|5|||
155482281|NCT02491463|561187120|FG002|Overall Study|Migrated/moved from study area|1|||
155482282|NCT02491463|561187121|FG003|Overall Study|Migrated/moved from study area|1|||
155482283|NCT02491463|561187118|FG000|Overall Study|Lost to Follow-up|0|||
155482284|NCT02491463|561187119|FG001|Overall Study|Lost to Follow-up|3|||
155482285|NCT02491463|561187120|FG002|Overall Study|Lost to Follow-up|3|||
155482286|NCT02491463|561187121|FG003|Overall Study|Lost to Follow-up|0|||
155482287|NCT01491802|561187122|FG000|Overall Study|Adverse Event|1|||
155482288|NCT01491802|561187123|FG001|Overall Study|Adverse Event|1|||
155482289|NCT01491802|561187122|FG000|Overall Study|Withdrawal by Subject|0|||
155482290|NCT01491802|561187123|FG001|Overall Study|Withdrawal by Subject|1|||
155482291|NCT01864746|561187126|FG000|Overall Study|Disease recurrence|25|||
155482292|NCT01864746|561187127|FG001|Overall Study|Disease recurrence|40|||
155482293|NCT01864746|561187126|FG000|Overall Study|Second primary invasive nonbreast|2|||
155482294|NCT01864746|561187127|FG001|Overall Study|Second primary invasive nonbreast|3|||
155482295|NCT01864746|561187126|FG000|Overall Study|Death|2|||
155482296|NCT01864746|561187127|FG001|Overall Study|Death|1|||
155482297|NCT01864746|561187126|FG000|Overall Study|Adverse Event|33|||
155482298|NCT01864746|561187127|FG001|Overall Study|Adverse Event|5|||
155482299|NCT01864746|561187126|FG000|Overall Study|Withdrawal by Subject|56|||
155482300|NCT01864746|561187127|FG001|Overall Study|Withdrawal by Subject|41|||
155482301|NCT01864746|561187126|FG000|Overall Study|Physician Decision|5|||
155482302|NCT01864746|561187127|FG001|Overall Study|Physician Decision|6|||
155482303|NCT00663208|561187128|FG000|Treatment Period|Lost to Follow-up|0|||
155482304|NCT00663208|561187129|FG001|Treatment Period|Lost to Follow-up|1|||
155482305|NCT00663208|561187130|FG002|Treatment Period|Lost to Follow-up|0|||
155482306|NCT00663208|561187131|FG003|Treatment Period|Lost to Follow-up|0|||
155482307|NCT00663208|561187132|FG004|Treatment Period|Lost to Follow-up|0|||
155482308|NCT00663208|561187133|FG005|Treatment Period|Lost to Follow-up|0|||
155482309|NCT00663208|561187134|FG006|Treatment Period|Lost to Follow-up|0|||
155482310|NCT00663208|561187128|FG000|Follow-up Period|Lost to Follow-up|2|||
155482311|NCT00663208|561187129|FG001|Follow-up Period|Lost to Follow-up|0|||
155482312|NCT00663208|561187130|FG002|Follow-up Period|Lost to Follow-up|3|||
155482313|NCT00663208|561187131|FG003|Follow-up Period|Lost to Follow-up|2|||
155482314|NCT00663208|561187132|FG004|Follow-up Period|Lost to Follow-up|0|||
155482315|NCT00663208|561187133|FG005|Follow-up Period|Lost to Follow-up|0|||
155482316|NCT00663208|561187134|FG006|Follow-up Period|Lost to Follow-up|0|||
155482317|NCT00663208|561187128|FG000|Follow-up Period|Other reason|1|||
155482318|NCT00663208|561187129|FG001|Follow-up Period|Other reason|0|||
155482319|NCT00663208|561187130|FG002|Follow-up Period|Other reason|0|||
155482320|NCT00663208|561187131|FG003|Follow-up Period|Other reason|0|||
155482321|NCT00663208|561187132|FG004|Follow-up Period|Other reason|0|||
155482322|NCT00663208|561187133|FG005|Follow-up Period|Other reason|0|||
155482323|NCT00663208|561187134|FG006|Follow-up Period|Other reason|1|||
155482324|NCT01005966|561187135|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155482325|NCT01005966|561187136|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155482326|NCT01005966|561187137|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
155482327|NCT01005966|561187138|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
155482328|NCT01005966|561187139|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
155482329|NCT01005966|561187135|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155482330|NCT01005966|561187136|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
155482331|NCT01005966|561187137|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155482332|NCT01005966|561187138|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
155482333|NCT01005966|561187139|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
155482334|NCT01005966|561187135|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
155482335|NCT01005966|561187136|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
155482336|NCT01005966|561187137|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
155482337|NCT01005966|561187138|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
155482338|NCT01005966|561187139|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
155482339|NCT01005966|561187135|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
155482340|NCT01005966|561187136|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
155482341|NCT01005966|561187137|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
155482342|NCT01005966|561187138|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
155482343|NCT01005966|561187139|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
155482344|NCT01005966|561187135|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155520485|NCT02319148|561330949|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
155520486|NCT02319148|561330946|FG000|Second Intervention Period|No longer willing to participate|0|||
155520487|NCT02319148|561330947|FG001|Second Intervention Period|No longer willing to participate|1|||
155520488|NCT02319148|561330948|FG002|Second Intervention Period|No longer willing to participate|0|||
155520489|NCT02319148|561330949|FG003|Second Intervention Period|No longer willing to participate|0|||
155520490|NCT02319148|561330946|FG000|Second Intervention Period|Other|0|||
155482345|NCT01005966|561187136|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155482346|NCT01005966|561187137|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155482347|NCT01005966|561187138|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155482348|NCT01005966|561187139|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155520491|NCT02319148|561330947|FG001|Second Intervention Period|Other|0|||
155482349|NCT01005966|561187135|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155482350|NCT01005966|561187136|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155482351|NCT01005966|561187137|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155482352|NCT01005966|561187138|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155482353|NCT01005966|561187139|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155482354|NCT01005966|561187135|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
155482355|NCT01005966|561187136|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
155482356|NCT01005966|561187137|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
155482357|NCT01005966|561187138|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
155482358|NCT01005966|561187139|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
155482359|NCT01005966|561187135|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
155482360|NCT01005966|561187136|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
155482361|NCT01005966|561187137|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
155482362|NCT01005966|561187138|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
155482363|NCT01005966|561187139|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
155482364|NCT01005966|561187135|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
155482365|NCT01005966|561187136|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
155482366|NCT01005966|561187137|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
155482367|NCT01005966|561187138|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
155482368|NCT01005966|561187139|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
155482369|NCT00039377|561187142|FG000|Initial Registration|Adverse Event|2|||
155482370|NCT00039377|561187143|FG001|Initial Registration|Adverse Event|0|||
155482371|NCT00039377|561187144|FG002|Initial Registration|Adverse Event|0|||
155482372|NCT00039377|561187145|FG003|Initial Registration|Adverse Event|0|||
155482373|NCT00039377|561187142|FG000|Initial Registration|Relapsed|6|||
155482374|NCT00039377|561187143|FG001|Initial Registration|Relapsed|0|||
155482375|NCT00039377|561187144|FG002|Initial Registration|Relapsed|0|||
155482376|NCT00039377|561187145|FG003|Initial Registration|Relapsed|0|||
155482377|NCT00039377|561187142|FG000|Initial Registration|Received non-protocol therapy|11|||
155482378|NCT00039377|561187143|FG001|Initial Registration|Received non-protocol therapy|0|||
155482379|NCT00039377|561187144|FG002|Initial Registration|Received non-protocol therapy|0|||
155482380|NCT00039377|561187145|FG003|Initial Registration|Received non-protocol therapy|0|||
155482381|NCT00039377|561187142|FG000|Initial Registration|Withdrawal by Subject|3|||
155482382|NCT00039377|561187143|FG001|Initial Registration|Withdrawal by Subject|0|||
155482383|NCT00039377|561187144|FG002|Initial Registration|Withdrawal by Subject|0|||
155482384|NCT00039377|561187145|FG003|Initial Registration|Withdrawal by Subject|0|||
155482385|NCT04067310|561187149|FG000|Overall Study|Physician Decision|2|||
155482386|NCT04067310|561187150|FG001|Overall Study|Physician Decision|6|||
155482387|NCT04067310|561187149|FG000|Overall Study|Lost to Follow-up|0|||
155482388|NCT04067310|561187150|FG001|Overall Study|Lost to Follow-up|1|||
155482389|NCT04067310|561187149|FG000|Overall Study|Withdrawal by Subject|3|||
155482390|NCT04067310|561187150|FG001|Overall Study|Withdrawal by Subject|0|||
155482391|NCT01041027|561187151|FG000|Overall Study|Withdrawal by Subject|2|||
155482392|NCT01041027|561187151|FG000|Overall Study|Protocol Violation|1|||
155482393|NCT01041027|561187151|FG000|Overall Study|Delayed Radiation Therapy|1|||
155482394|NCT01041027|561187151|FG000|Overall Study|Adverse Event|4|||
155482395|NCT01347931|561187152|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
155482396|NCT01249404|561187153|FG000|Overall Study|Study treatment not received|0|||
155482397|NCT01249404|561187154|FG001|Overall Study|Study treatment not received|1|||
155482398|NCT01249404|561187155|FG002|Overall Study|Study treatment not received|2|||
155482399|NCT01249404|561187153|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
155482400|NCT01249404|561187154|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
155482401|NCT01249404|561187155|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
155482402|NCT01249404|561187153|FG000|Overall Study|Adverse Event|2|||
155482403|NCT01249404|561187154|FG001|Overall Study|Adverse Event|2|||
155482404|NCT01249404|561187155|FG002|Overall Study|Adverse Event|2|||
155482405|NCT01249404|561187153|FG000|Overall Study|Withdrawal by Subject|2|||
155482406|NCT01249404|561187154|FG001|Overall Study|Withdrawal by Subject|2|||
155482407|NCT01249404|561187155|FG002|Overall Study|Withdrawal by Subject|0|||
155482408|NCT01249404|561187153|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
155520492|NCT02319148|561330948|FG002|Second Intervention Period|Other|0|||
155520493|NCT02319148|561330949|FG003|Second Intervention Period|Other|1|||
155520494|NCT00048048|561330950|FG000|Core Treatment|Withdrawal by Subject|0|||
155520495|NCT00048048|561330951|FG001|Core Treatment|Withdrawal by Subject|0|||
155520496|NCT00048048|561330952|FG002|Core Treatment|Withdrawal by Subject|1|||
155520497|NCT00048048|561330953|FG003|Core Treatment|Withdrawal by Subject|0|||
155482409|NCT01249404|561187154|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
155482410|NCT01249404|561187155|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
155482411|NCT01249404|561187153|FG000|Overall Study|Non compliance to visit schedule|0|||
155482412|NCT01249404|561187154|FG001|Overall Study|Non compliance to visit schedule|1|||
155482413|NCT01249404|561187155|FG002|Overall Study|Non compliance to visit schedule|0|||
155482414|NCT03890731|561187156|FG000|Overall Study|Progressive disease|1|||
155520498|NCT00048048|561330954|FG004|Core Treatment|Withdrawal by Subject|0|||
155482415|NCT03890731|561187156|FG000|Overall Study|Patient's decision|1|||
155482416|NCT03890731|561187156|FG000|Overall Study|Adverse Event|4|||
155482417|NCT04144140|561187157|FG000|Overall Study|Other|0|||
155482418|NCT04144140|561187158|FG001|Overall Study|Other|0|||
155482419|NCT04144140|561187159|FG002|Overall Study|Other|0|||
155482420|NCT04144140|561187160|FG003|Overall Study|Other|0|||
155482421|NCT04144140|561187161|FG004|Overall Study|Other|0|||
155482422|NCT04144140|561187162|FG005|Overall Study|Other|1|||
155482423|NCT04144140|561187163|FG006|Overall Study|Other|0|||
155482424|NCT01640353|561187164|FG000|Overall Study|Withdrew prior to treatment|10|||
155482425|NCT01640353|561187164|FG000|Overall Study|Withdrawn from analysis at term site|12|||
155482426|NCT01640353|561187164|FG000|Overall Study|Withdrawal by Subject|5|||
155482427|NCT01640353|561187164|FG000|Overall Study|Death|2|||
155482428|NCT01640353|561187164|FG000|Overall Study|Early site termination|3|||
155482429|NCT01640353|561187164|FG000|Overall Study|Lost to Follow-up|12|||
155482430|NCT01640353|561187164|FG000|Overall Study|Physician Decision|1|||
155482431|NCT02679222|561187166|FG000|Overall Study|No time for project|1|||
155482432|NCT04354870|561187167|FG000|Overall Study|Lost to Follow-up|32|||
155482433|NCT04354870|561187168|FG001|Overall Study|Lost to Follow-up|12|||
155482434|NCT04354870|561187167|FG000|Overall Study|Withdrawal by Subject|10|||
155482435|NCT04354870|561187168|FG001|Overall Study|Withdrawal by Subject|16|||
155482436|NCT04354870|561187167|FG000|Overall Study|Did not complete all study visits|6|||
155482437|NCT04354870|561187168|FG001|Overall Study|Did not complete all study visits|5|||
155482438|NCT04450394|561187169|FG000|Overall Study|Adverse Event|2|||
155482439|NCT04450394|561187170|FG001|Overall Study|Adverse Event|0|||
155482440|NCT04450394|561187171|FG002|Overall Study|Adverse Event|0|||
155482441|NCT04450394|561187169|FG000|Overall Study|Death|0|||
155482442|NCT04450394|561187170|FG001|Overall Study|Death|1|||
155482443|NCT04450394|561187171|FG002|Overall Study|Death|0|||
155482444|NCT04450394|561187169|FG000|Overall Study|Lost to Follow-up|0|||
155482445|NCT04450394|561187170|FG001|Overall Study|Lost to Follow-up|3|||
155482446|NCT04450394|561187171|FG002|Overall Study|Lost to Follow-up|0|||
155482447|NCT04450394|561187169|FG000|Overall Study|Physician Decision|0|||
155482448|NCT04450394|561187170|FG001|Overall Study|Physician Decision|1|||
155482449|NCT04450394|561187171|FG002|Overall Study|Physician Decision|0|||
155482450|NCT04450394|561187169|FG000|Overall Study|Protocol Violation|2|||
155482451|NCT04450394|561187170|FG001|Overall Study|Protocol Violation|0|||
155482452|NCT04450394|561187171|FG002|Overall Study|Protocol Violation|0|||
155482453|NCT04450394|561187169|FG000|Overall Study|Withdrawal by Subject|6|||
155482454|NCT04450394|561187170|FG001|Overall Study|Withdrawal by Subject|9|||
155482455|NCT04450394|561187171|FG002|Overall Study|Withdrawal by Subject|0|||
155482456|NCT01066819|561187172|FG000|Overall Study|Adverse Event|18|||
155482457|NCT01066819|561187173|FG001|Overall Study|Adverse Event|1|||
155482458|NCT01066819|561187174|FG002|Overall Study|Adverse Event|6|||
155482459|NCT01066819|561187175|FG003|Overall Study|Adverse Event|0|||
155482460|NCT01066819|561187176|FG004|Overall Study|Adverse Event|0|||
155482461|NCT01066819|561187177|FG005|Overall Study|Adverse Event|0|||
155482462|NCT01066819|561187172|FG000|Overall Study|Death|5|||
155482463|NCT01066819|561187173|FG001|Overall Study|Death|0|||
155482464|NCT01066819|561187174|FG002|Overall Study|Death|1|||
155482465|NCT01066819|561187175|FG003|Overall Study|Death|0|||
155482466|NCT01066819|561187176|FG004|Overall Study|Death|0|||
155482467|NCT01066819|561187177|FG005|Overall Study|Death|0|||
155482468|NCT01066819|561187172|FG000|Overall Study|Lack of Efficacy|22|||
155482469|NCT01066819|561187173|FG001|Overall Study|Lack of Efficacy|1|||
155482470|NCT01066819|561187174|FG002|Overall Study|Lack of Efficacy|2|||
155482471|NCT01066819|561187175|FG003|Overall Study|Lack of Efficacy|1|||
155482472|NCT01066819|561187176|FG004|Overall Study|Lack of Efficacy|0|||
155482473|NCT01066819|561187177|FG005|Overall Study|Lack of Efficacy|0|||
155482474|NCT01066819|561187172|FG000|Overall Study|Physician Decision|6|||
155482475|NCT01066819|561187173|FG001|Overall Study|Physician Decision|2|||
155482476|NCT01066819|561187174|FG002|Overall Study|Physician Decision|3|||
155482477|NCT01066819|561187175|FG003|Overall Study|Physician Decision|0|||
155482478|NCT01066819|561187176|FG004|Overall Study|Physician Decision|0|||
155482479|NCT01066819|561187177|FG005|Overall Study|Physician Decision|0|||
155482480|NCT01066819|561187172|FG000|Overall Study|Protocol Violation|12|||
155520499|NCT00048048|561330955|FG005|Core Treatment|Withdrawal by Subject|0|||
155520500|NCT00048048|561330956|FG006|Core Treatment|Withdrawal by Subject|0|||
155482481|NCT01066819|561187173|FG001|Overall Study|Protocol Violation|6|||
155482482|NCT01066819|561187174|FG002|Overall Study|Protocol Violation|0|||
155482483|NCT01066819|561187175|FG003|Overall Study|Protocol Violation|0|||
155482484|NCT01066819|561187176|FG004|Overall Study|Protocol Violation|0|||
155482485|NCT01066819|561187177|FG005|Overall Study|Protocol Violation|0|||
155482486|NCT01066819|561187172|FG000|Overall Study|Withdrawal by Subject|29|||
155482487|NCT01066819|561187173|FG001|Overall Study|Withdrawal by Subject|11|||
155482488|NCT01066819|561187174|FG002|Overall Study|Withdrawal by Subject|6|||
155482489|NCT01066819|561187175|FG003|Overall Study|Withdrawal by Subject|0|||
155482490|NCT01066819|561187176|FG004|Overall Study|Withdrawal by Subject|0|||
155482491|NCT01066819|561187177|FG005|Overall Study|Withdrawal by Subject|0|||
155482492|NCT01066819|561187172|FG000|Overall Study|Administrative|6|||
155482493|NCT01066819|561187173|FG001|Overall Study|Administrative|4|||
155482494|NCT01066819|561187174|FG002|Overall Study|Administrative|2|||
155482495|NCT01066819|561187175|FG003|Overall Study|Administrative|0|||
155482496|NCT01066819|561187176|FG004|Overall Study|Administrative|0|||
155482497|NCT01066819|561187177|FG005|Overall Study|Administrative|0|||
155482498|NCT01066819|561187172|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
155482499|NCT01066819|561187173|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
155482500|NCT01066819|561187174|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
155482501|NCT01066819|561187175|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
155482502|NCT01066819|561187176|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
155482503|NCT01066819|561187177|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
155482504|NCT01066819|561187172|FG000|Overall Study|Early termination|2|||
155482505|NCT01066819|561187173|FG001|Overall Study|Early termination|0|||
155482506|NCT01066819|561187174|FG002|Overall Study|Early termination|0|||
155482507|NCT01066819|561187175|FG003|Overall Study|Early termination|0|||
155482508|NCT01066819|561187176|FG004|Overall Study|Early termination|0|||
155482509|NCT01066819|561187177|FG005|Overall Study|Early termination|0|||
155482510|NCT01066819|561187172|FG000|Overall Study|Failed to return|298|||
155482511|NCT01066819|561187173|FG001|Overall Study|Failed to return|107|||
155482512|NCT01066819|561187174|FG002|Overall Study|Failed to return|68|||
155482513|NCT01066819|561187175|FG003|Overall Study|Failed to return|7|||
155482514|NCT01066819|561187176|FG004|Overall Study|Failed to return|2|||
155482515|NCT01066819|561187177|FG005|Overall Study|Failed to return|3|||
155482516|NCT01066819|561187172|FG000|Overall Study|Lab test not done|9|||
155482517|NCT01066819|561187173|FG001|Overall Study|Lab test not done|0|||
155482518|NCT01066819|561187174|FG002|Overall Study|Lab test not done|2|||
155482519|NCT01066819|561187175|FG003|Overall Study|Lab test not done|1|||
155482520|NCT01066819|561187176|FG004|Overall Study|Lab test not done|0|||
155482521|NCT01066819|561187177|FG005|Overall Study|Lab test not done|0|||
155482522|NCT01066819|561187172|FG000|Overall Study|Miscellaneous|28|||
155482523|NCT01066819|561187173|FG001|Overall Study|Miscellaneous|10|||
155482524|NCT01066819|561187174|FG002|Overall Study|Miscellaneous|18|||
155482525|NCT01066819|561187175|FG003|Overall Study|Miscellaneous|1|||
155482526|NCT01066819|561187176|FG004|Overall Study|Miscellaneous|0|||
155482527|NCT01066819|561187177|FG005|Overall Study|Miscellaneous|0|||
155482528|NCT01066819|561187172|FG000|Overall Study|Non responders|123|||
155482529|NCT01066819|561187173|FG001|Overall Study|Non responders|2|||
155482530|NCT01066819|561187174|FG002|Overall Study|Non responders|7|||
155482531|NCT01066819|561187175|FG003|Overall Study|Non responders|2|||
155482532|NCT01066819|561187176|FG004|Overall Study|Non responders|0|||
155482533|NCT01066819|561187177|FG005|Overall Study|Non responders|1|||
155482534|NCT01066819|561187172|FG000|Overall Study|Not categorised|9|||
155482535|NCT01066819|561187173|FG001|Overall Study|Not categorised|2|||
155482536|NCT01066819|561187174|FG002|Overall Study|Not categorised|6|||
155482537|NCT01066819|561187175|FG003|Overall Study|Not categorised|1|||
155482538|NCT01066819|561187176|FG004|Overall Study|Not categorised|0|||
155482539|NCT01066819|561187177|FG005|Overall Study|Not categorised|0|||
155482540|NCT01066819|561187172|FG000|Overall Study|Relapse|16|||
155482541|NCT01066819|561187173|FG001|Overall Study|Relapse|4|||
155482542|NCT01066819|561187174|FG002|Overall Study|Relapse|3|||
155482543|NCT01066819|561187175|FG003|Overall Study|Relapse|0|||
155482544|NCT01066819|561187176|FG004|Overall Study|Relapse|0|||
155482545|NCT01066819|561187177|FG005|Overall Study|Relapse|0|||
155482546|NCT01066819|561187172|FG000|Overall Study|Results not available|1|||
155482547|NCT01066819|561187173|FG001|Overall Study|Results not available|0|||
155482548|NCT01066819|561187174|FG002|Overall Study|Results not available|0|||
155482549|NCT01066819|561187175|FG003|Overall Study|Results not available|0|||
155482550|NCT01066819|561187176|FG004|Overall Study|Results not available|0|||
155482551|NCT01066819|561187177|FG005|Overall Study|Results not available|0|||
155482552|NCT01066819|561187172|FG000|Overall Study|Screen failure|1|||
155482553|NCT01066819|561187173|FG001|Overall Study|Screen failure|0|||
155482554|NCT01066819|561187174|FG002|Overall Study|Screen failure|0|||
155482555|NCT01066819|561187175|FG003|Overall Study|Screen failure|0|||
155482556|NCT01066819|561187176|FG004|Overall Study|Screen failure|0|||
155482557|NCT01066819|561187177|FG005|Overall Study|Screen failure|0|||
155482558|NCT01066819|561187172|FG000|Overall Study|Spontaneous cure|1|||
155482559|NCT01066819|561187173|FG001|Overall Study|Spontaneous cure|0|||
155482560|NCT01066819|561187174|FG002|Overall Study|Spontaneous cure|0|||
155482561|NCT01066819|561187175|FG003|Overall Study|Spontaneous cure|0|||
155482562|NCT01066819|561187176|FG004|Overall Study|Spontaneous cure|0|||
155482563|NCT01066819|561187177|FG005|Overall Study|Spontaneous cure|0|||
155482564|NCT01066819|561187172|FG000|Overall Study|Treatment never started|85|||
155482565|NCT01066819|561187173|FG001|Overall Study|Treatment never started|19|||
155482566|NCT01066819|561187174|FG002|Overall Study|Treatment never started|19|||
155482567|NCT01066819|561187175|FG003|Overall Study|Treatment never started|3|||
155482568|NCT01066819|561187176|FG004|Overall Study|Treatment never started|2|||
155482569|NCT01066819|561187177|FG005|Overall Study|Treatment never started|2|||
155482570|NCT01066819|561187172|FG000|Overall Study|Treatment stopped|12|||
155482571|NCT01066819|561187173|FG001|Overall Study|Treatment stopped|1|||
155482572|NCT01066819|561187174|FG002|Overall Study|Treatment stopped|2|||
155482573|NCT01066819|561187175|FG003|Overall Study|Treatment stopped|1|||
155482574|NCT01066819|561187176|FG004|Overall Study|Treatment stopped|0|||
155482575|NCT01066819|561187177|FG005|Overall Study|Treatment stopped|0|||
155482576|NCT01066819|561187172|FG000|Overall Study|Other|5|||
155482577|NCT01066819|561187173|FG001|Overall Study|Other|1|||
155482578|NCT01066819|561187174|FG002|Overall Study|Other|1|||
155482579|NCT01066819|561187175|FG003|Overall Study|Other|0|||
155482580|NCT01066819|561187176|FG004|Overall Study|Other|0|||
155482581|NCT01066819|561187177|FG005|Overall Study|Other|0|||
155482582|NCT00303719|561187180|FG000|Overall Study|Not evaluable, prior therapies|0|||
155482583|NCT00303719|561187181|FG001|Overall Study|Not evaluable, prior therapies|30|||
155482584|NCT00303719|561187180|FG000|Overall Study|Lost to Follow-up|0|||
155482585|NCT00303719|561187181|FG001|Overall Study|Lost to Follow-up|7|||
155482586|NCT01641952|561187182|FG000|Overall Study|Lost to Follow-up|28|||
155482587|NCT01641952|561187182|FG000|Overall Study|Adverse Event|6|||
155482588|NCT03633461|561187193|FG000|Overall Study|Lost to Follow-up|0|||
155482589|NCT03633461|561187194|FG001|Overall Study|Lost to Follow-up|1|||
155482590|NCT02516605|561187201|FG000|Overall Study|Protocol Violation|0|||
155482591|NCT02516605|561187202|FG001|Overall Study|Protocol Violation|0|||
155482592|NCT02516605|561187203|FG002|Overall Study|Protocol Violation|0|||
155482593|NCT02516605|561187204|FG003|Overall Study|Protocol Violation|0|||
155482594|NCT02516605|561187205|FG004|Overall Study|Protocol Violation|1|||
155482595|NCT02516605|561187201|FG000|Overall Study|Withdrawal by Subject|0|||
155482596|NCT02516605|561187202|FG001|Overall Study|Withdrawal by Subject|0|||
155482597|NCT02516605|561187203|FG002|Overall Study|Withdrawal by Subject|0|||
155482598|NCT02516605|561187204|FG003|Overall Study|Withdrawal by Subject|1|||
155482599|NCT02516605|561187205|FG004|Overall Study|Withdrawal by Subject|0|||
155482600|NCT02643420|561187206|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
155482601|NCT02643420|561187207|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
155482602|NCT02643420|561187206|FG000|Overall Study|Withdrawal by Subject|25|||
155482603|NCT02643420|561187207|FG001|Overall Study|Withdrawal by Subject|19|||
155482604|NCT02643420|561187206|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
155482605|NCT02643420|561187207|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
155482606|NCT02643420|561187206|FG000|Overall Study|Lost to Follow-up|6|||
155482607|NCT02643420|561187207|FG001|Overall Study|Lost to Follow-up|10|||
155482608|NCT02643420|561187206|FG000|Overall Study|Investigator Decision|2|||
155482609|NCT02643420|561187207|FG001|Overall Study|Investigator Decision|4|||
155482610|NCT02643420|561187206|FG000|Overall Study|Sponsor decision|1|||
155482611|NCT02643420|561187207|FG001|Overall Study|Sponsor decision|1|||
155482612|NCT02643420|561187206|FG000|Overall Study|Death|0|||
155482613|NCT02643420|561187207|FG001|Overall Study|Death|2|||
155482614|NCT02643420|561187206|FG000|Overall Study|Reason not Specified|8|||
155482615|NCT02643420|561187207|FG001|Overall Study|Reason not Specified|7|||
155482616|NCT01710709|561187208|FG000|Overall Study|Lost to Follow-up|29|||
155482617|NCT01710709|561187208|FG000|Overall Study|Adverse Event|48|||
155482618|NCT01710709|561187208|FG000|Overall Study|Participant met withdrawal criteria|33|||
155482619|NCT01710709|561187208|FG000|Overall Study|Participant withdrawn by investigator|2|||
155482620|NCT01710709|561187208|FG000|Overall Study|Withdrawal by Subject|53|||
155482621|NCT01710709|561187208|FG000|Overall Study|Protocol Violation|5|||
155482622|NCT01710709|561187208|FG000|Overall Study|Lack of Efficacy|3|||
155482623|NCT01716585|561187212|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
155482624|NCT01716585|561187213|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
155482625|NCT01716585|561187212|FG000|Double-blind Treatment|Adverse Event|2|||
155482626|NCT01716585|561187213|FG001|Double-blind Treatment|Adverse Event|1|||
155482627|NCT01716585|561187212|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
155482628|NCT01716585|561187213|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
155482629|NCT01716585|561187212|FG000|Double-blind Treatment|Lost to Follow-up|2|||
155482630|NCT01716585|561187213|FG001|Double-blind Treatment|Lost to Follow-up|0|||
155482631|NCT01716585|561187212|FG000|Double-blind Treatment|Subject Noncompliant|1|||
155482632|NCT01716585|561187213|FG001|Double-blind Treatment|Subject Noncompliant|0|||
155482633|NCT01716585|561187212|FG000|Double-blind Treatment|Other|1|||
155482634|NCT01716585|561187213|FG001|Double-blind Treatment|Other|0|||
155482635|NCT01716585|561187212|FG000|Open-label Treatment|Adverse Event|0|||
155482636|NCT01716585|561187213|FG001|Open-label Treatment|Adverse Event|2|||
155482637|NCT01716585|561187212|FG000|Open-label Treatment|Virologic Failure|0|||
155482638|NCT01716585|561187213|FG001|Open-label Treatment|Virologic Failure|2|||
155482639|NCT01716585|561187212|FG000|Open-label Treatment|Withdrawal by Subject|0|||
155482640|NCT01716585|561187213|FG001|Open-label Treatment|Withdrawal by Subject|3|||
155482641|NCT02275052|561187214|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155482642|NCT02275052|561187215|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155482643|NCT02275052|561187216|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155482644|NCT02275052|561187217|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155482645|NCT02275052|561187214|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
155482646|NCT02275052|561187215|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
155482647|NCT02275052|561187216|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
155482648|NCT02275052|561187217|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
155482649|NCT02275052|561187214|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
155482650|NCT02275052|561187215|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
155482651|NCT02275052|561187216|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155482652|NCT02275052|561187217|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155482653|NCT02275052|561187214|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
155482654|NCT02275052|561187215|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
155482655|NCT02275052|561187216|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
155482656|NCT02275052|561187217|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
155482657|NCT02275052|561187214|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
155482658|NCT02275052|561187215|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
155482659|NCT02275052|561187216|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
155482660|NCT02275052|561187217|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
155482661|NCT02275052|561187214|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
155482662|NCT02275052|561187215|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
155482663|NCT02275052|561187216|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
155482664|NCT02275052|561187217|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
155482665|NCT02275052|561187214|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
155482666|NCT02275052|561187215|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
155482667|NCT02275052|561187216|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
155482668|NCT02275052|561187217|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
155482669|NCT02275052|561187214|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155482670|NCT02275052|561187215|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155482671|NCT02275052|561187216|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
155482672|NCT02275052|561187217|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
155482673|NCT02275052|561187214|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155482674|NCT02275052|561187215|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155482675|NCT02275052|561187216|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155654677|NCT03715829|561828906|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654678|NCT03715829|561828907|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654679|NCT03715829|561828908|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
155482676|NCT02275052|561187217|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
155482677|NCT02275052|561187214|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155482678|NCT02275052|561187215|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155482679|NCT02275052|561187216|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155482680|NCT02275052|561187217|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
155482681|NCT02275052|561187214|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155482682|NCT02275052|561187215|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155491209|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
155491210|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
155491211|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
155491212|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
155491213|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
155491214|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
155491215|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
155491216|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
155491217|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
155491218|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
155491219|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
155491220|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
155491221|NCT00634933|561223487|FG000|Part B: Week 24 to Week 52|Other|0|||
155491222|NCT00634933|561223488|FG001|Part B: Week 24 to Week 52|Other|0|||
155491223|NCT00634933|561223489|FG002|Part B: Week 24 to Week 52|Other|5|||
155491224|NCT00634933|561223490|FG003|Part B: Week 24 to Week 52|Other|0|||
155491225|NCT00634933|561223491|FG004|Part B: Week 24 to Week 52|Other|1|||
155491226|NCT02304484|561223492|FG000|Overall Study|Death|9|||
155491227|NCT02304484|561223492|FG000|Overall Study|Withdrawal by Subject|14|||
155491228|NCT02304484|561223492|FG000|Overall Study|Lost to Follow-up|2|||
155491229|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Adverse Event|6|||
155491230|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Adverse Event|6|||
155491231|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Death|14|||
155491232|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Death|11|||
155491233|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
155491234|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
155491235|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
155482683|NCT02275052|561187216|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155482684|NCT02275052|561187217|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
155482685|NCT05102734|561187218|FG000|Overall Study|Did not require vasopressors|1|||
155482686|NCT05102734|561187219|FG001|Overall Study|Did not require vasopressors|0|||
155482687|NCT05102734|561187218|FG000|Overall Study|Did not have functioning PA catheter|1|||
155482688|NCT05102734|561187219|FG001|Overall Study|Did not have functioning PA catheter|0|||
155482689|NCT05102734|561187218|FG000|Overall Study|Inadequate video quality|2|||
155482690|NCT05102734|561187219|FG001|Overall Study|Inadequate video quality|0|||
155482691|NCT03055806|561187225|FG000|Overall Study|Adverse Event|0|||
155482692|NCT03055806|561187226|FG001|Overall Study|Adverse Event|0|||
155482693|NCT03055806|561187227|FG002|Overall Study|Adverse Event|1|||
155482694|NCT03055806|561187228|FG003|Overall Study|Adverse Event|1|||
155482695|NCT03055806|561187225|FG000|Overall Study|Lost to Follow-up|0|||
155482696|NCT03055806|561187226|FG001|Overall Study|Lost to Follow-up|3|||
155482697|NCT03055806|561187227|FG002|Overall Study|Lost to Follow-up|6|||
155482698|NCT03055806|561187228|FG003|Overall Study|Lost to Follow-up|7|||
155482699|NCT03055806|561187225|FG000|Overall Study|Physician Decision|1|||
155482700|NCT03055806|561187226|FG001|Overall Study|Physician Decision|0|||
155482701|NCT03055806|561187227|FG002|Overall Study|Physician Decision|0|||
155482702|NCT03055806|561187228|FG003|Overall Study|Physician Decision|1|||
155482703|NCT03055806|561187225|FG000|Overall Study|Protocol Violation|1|||
155482704|NCT03055806|561187226|FG001|Overall Study|Protocol Violation|0|||
155482705|NCT03055806|561187227|FG002|Overall Study|Protocol Violation|0|||
155482706|NCT03055806|561187228|FG003|Overall Study|Protocol Violation|0|||
155482707|NCT03055806|561187225|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
155482708|NCT03055806|561187226|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
155482709|NCT03055806|561187227|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
155482710|NCT03055806|561187228|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
155482711|NCT03055806|561187225|FG000|Overall Study|Withdrawal of consent to continue study|2|||
155482712|NCT03055806|561187226|FG001|Overall Study|Withdrawal of consent to continue study|3|||
155482713|NCT03055806|561187227|FG002|Overall Study|Withdrawal of consent to continue study|4|||
155482714|NCT03055806|561187228|FG003|Overall Study|Withdrawal of consent to continue study|6|||
155482715|NCT03055806|561187225|FG000|Overall Study|Partner not willing to try intercourse|1|||
155482716|NCT03055806|561187226|FG001|Overall Study|Partner not willing to try intercourse|0|||
155482717|NCT03055806|561187227|FG002|Overall Study|Partner not willing to try intercourse|0|||
155482718|NCT03055806|561187228|FG003|Overall Study|Partner not willing to try intercourse|0|||
155482719|NCT04601194|561187229|FG000|Overall Study|Lost to Follow-up|7|||
155482720|NCT02630459|561187230|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482721|NCT02630459|561187231|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
155482722|NCT02630459|561187232|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482723|NCT02630459|561187233|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
155482724|NCT02630459|561187234|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482725|NCT02630459|561187235|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482726|NCT02630459|561187236|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482727|NCT02630459|561187237|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
155482728|NCT02630459|561187230|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482729|NCT02630459|561187231|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482730|NCT02630459|561187232|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
155482731|NCT02630459|561187233|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482732|NCT02630459|561187234|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482733|NCT02630459|561187235|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482734|NCT02630459|561187236|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482735|NCT02630459|561187237|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
155482736|NCT02630459|561187230|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
155482737|NCT02630459|561187231|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
155482738|NCT02630459|561187232|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
155482739|NCT02630459|561187233|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
155482740|NCT02630459|561187234|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
155482741|NCT02630459|561187235|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
155482742|NCT02630459|561187236|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
155482743|NCT02630459|561187237|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
155482744|NCT02630459|561187230|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
155482745|NCT02630459|561187231|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482746|NCT02630459|561187232|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482747|NCT02630459|561187233|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482748|NCT02630459|561187234|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482749|NCT02630459|561187235|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482750|NCT02630459|561187236|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482751|NCT02630459|561187237|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
155482752|NCT02630459|561187230|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482753|NCT02630459|561187231|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482754|NCT02630459|561187232|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482755|NCT02630459|561187233|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482756|NCT02630459|561187234|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
155482757|NCT02630459|561187235|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
155482758|NCT02630459|561187236|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482759|NCT02630459|561187237|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
155482760|NCT02630459|561187230|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482761|NCT02630459|561187231|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482762|NCT02630459|561187232|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482763|NCT02630459|561187233|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482764|NCT02630459|561187234|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
155482765|NCT02630459|561187235|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
155482766|NCT02630459|561187236|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482767|NCT02630459|561187237|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155482768|NCT02630459|561187230|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482769|NCT02630459|561187231|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482770|NCT02630459|561187232|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482771|NCT02630459|561187233|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482772|NCT02630459|561187234|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
155482773|NCT02630459|561187235|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482774|NCT02630459|561187236|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482775|NCT02630459|561187237|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
155482776|NCT00846027|561187238|FG000|Overall Study|Death|3|||
155482777|NCT00846027|561187238|FG000|Overall Study|Disease Progression|30|||
155482778|NCT00846027|561187238|FG000|Overall Study|Toxicity|12|||
155482779|NCT00846027|561187238|FG000|Overall Study|Patient Decision|7|||
155482780|NCT00846027|561187238|FG000|Overall Study|Investigator Discretion|29|||
155482781|NCT00846027|561187238|FG000|Overall Study|Protocol Violation|2|||
155482782|NCT00846027|561187238|FG000|Overall Study|Subject Not Treated|7|||
155482783|NCT04905563|561187241|FG000|Overall Study|Withdrawal by Subject|1|||
155482784|NCT04905563|561187242|FG001|Overall Study|Withdrawal by Subject|0|||
155482785|NCT04905563|561187241|FG000|Overall Study|Standard of care orders entered by resident|1|||
155482786|NCT04905563|561187242|FG001|Overall Study|Standard of care orders entered by resident|0|||
155482787|NCT04905563|561187241|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
155482788|NCT04905563|561187242|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
155482789|NCT04905563|561187241|FG000|Overall Study|Withdrawal by Subject|0|||
155482790|NCT04905563|561187242|FG001|Overall Study|Withdrawal by Subject|1|||
155482791|NCT01797302|561187243|FG000|Overall Study|Lost to Follow-up|16|||
155482792|NCT01797302|561187244|FG001|Overall Study|Lost to Follow-up|23|||
155482793|NCT01797302|561187245|FG002|Overall Study|Lost to Follow-up|22|||
155482794|NCT01797302|561187243|FG000|Overall Study|Withdrawal by Subject|1|||
155482795|NCT01797302|561187244|FG001|Overall Study|Withdrawal by Subject|3|||
155482796|NCT01797302|561187245|FG002|Overall Study|Withdrawal by Subject|4|||
155482797|NCT00689611|561187248|FG000|Overall Study|Death|6|||
155482798|NCT00689611|561187249|FG001|Overall Study|Death|9|||
155482799|NCT00689611|561187248|FG000|Overall Study|Withdrawal by Subject|8|||
155482800|NCT00689611|561187249|FG001|Overall Study|Withdrawal by Subject|9|||
155482801|NCT00689611|561187248|FG000|Overall Study|Lost to Follow-up|27|||
155482802|NCT00689611|561187249|FG001|Overall Study|Lost to Follow-up|28|||
155482803|NCT00568399|561187250|FG000|Overall Study|Death|2|||
155482804|NCT00568399|561187250|FG000|Overall Study|Adverse Event|5|||
155482805|NCT00568399|561187250|FG000|Overall Study|Withdrawal by Subject|8|||
155654680|NCT03715829|561828909|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
155654681|NCT03715829|561828910|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654682|NCT03715829|561828911|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
155654683|NCT03715829|561828901|FG000|Extension Period|Other|0|||
155654684|NCT03715829|561828902|FG001|Extension Period|Other|0|||
155654685|NCT03715829|561828903|FG002|Extension Period|Other|0|||
155654686|NCT03715829|561828904|FG003|Extension Period|Other|0|||
155654687|NCT03715829|561828905|FG004|Extension Period|Other|0|||
155654688|NCT03715829|561828906|FG005|Extension Period|Other|0|||
155654689|NCT03715829|561828907|FG006|Extension Period|Other|1|||
155482806|NCT00106626|561187251|FG000|Overall Study|Adverse Event|5|||
155482807|NCT00106626|561187252|FG001|Overall Study|Adverse Event|4|||
155482808|NCT00106626|561187253|FG002|Overall Study|Adverse Event|3|||
155482809|NCT00106626|561187254|FG003|Overall Study|Adverse Event|3|||
155482810|NCT00106626|561187251|FG000|Overall Study|Progressive Disease|4|||
155482811|NCT00106626|561187252|FG001|Overall Study|Progressive Disease|1|||
155654690|NCT03715829|561828908|FG007|Extension Period|Other|2|||
155482812|NCT00106626|561187253|FG002|Overall Study|Progressive Disease|9|||
155482813|NCT00106626|561187254|FG003|Overall Study|Progressive Disease|10|||
155482814|NCT00106626|561187251|FG000|Overall Study|Received radiation on new therapy|1|||
155482815|NCT00106626|561187252|FG001|Overall Study|Received radiation on new therapy|0|||
155482816|NCT00106626|561187253|FG002|Overall Study|Received radiation on new therapy|0|||
155482817|NCT00106626|561187254|FG003|Overall Study|Received radiation on new therapy|0|||
155482818|NCT00106626|561187251|FG000|Overall Study|> 14 day delay in therapy start|0|||
155482819|NCT00106626|561187252|FG001|Overall Study|> 14 day delay in therapy start|1|||
155482820|NCT00106626|561187253|FG002|Overall Study|> 14 day delay in therapy start|0|||
155482821|NCT00106626|561187254|FG003|Overall Study|> 14 day delay in therapy start|0|||
155482822|NCT02519777|561187255|FG000|Overall Study|Death|1|||
155482823|NCT02519777|561187256|FG001|Overall Study|Death|0|||
155482824|NCT02519777|561187257|FG002|Overall Study|Death|0|||
155482825|NCT02519777|561187255|FG000|Overall Study|Lost to Follow-up|0|||
155482826|NCT02519777|561187256|FG001|Overall Study|Lost to Follow-up|4|||
155482827|NCT02519777|561187257|FG002|Overall Study|Lost to Follow-up|2|||
155482828|NCT02519777|561187255|FG000|Overall Study|Withdrawal by Subject|3|||
155482829|NCT02519777|561187256|FG001|Overall Study|Withdrawal by Subject|1|||
155482830|NCT02519777|561187257|FG002|Overall Study|Withdrawal by Subject|0|||
155482831|NCT02519777|561187255|FG000|Overall Study|Severe Debilitation|1|||
155482832|NCT02519777|561187256|FG001|Overall Study|Severe Debilitation|1|||
155482833|NCT02519777|561187257|FG002|Overall Study|Severe Debilitation|1|||
155482834|NCT02519777|561187255|FG000|Overall Study|Not able to get to clinic|1|||
155482835|NCT02519777|561187256|FG001|Overall Study|Not able to get to clinic|2|||
155482836|NCT02519777|561187257|FG002|Overall Study|Not able to get to clinic|1|||
155482837|NCT02607865|561187260|FG000|Overall Study|Lost to Follow-up|9|||
155482838|NCT02607865|561187261|FG001|Overall Study|Lost to Follow-up|7|||
155482839|NCT02607865|561187262|FG002|Overall Study|Lost to Follow-up|7|||
155482840|NCT02607865|561187263|FG003|Overall Study|Lost to Follow-up|5|||
155482841|NCT02607865|561187260|FG000|Overall Study|Withdrawal by Subject|18|||
155482842|NCT02607865|561187261|FG001|Overall Study|Withdrawal by Subject|18|||
155482843|NCT02607865|561187262|FG002|Overall Study|Withdrawal by Subject|17|||
155482844|NCT02607865|561187263|FG003|Overall Study|Withdrawal by Subject|8|||
155482845|NCT02607865|561187260|FG000|Overall Study|Death|5|||
155482846|NCT02607865|561187261|FG001|Overall Study|Death|4|||
155482847|NCT02607865|561187262|FG002|Overall Study|Death|1|||
155482848|NCT02607865|561187263|FG003|Overall Study|Death|3|||
155482849|NCT02607865|561187260|FG000|Overall Study|Unclassified|1|||
155482850|NCT02607865|561187261|FG001|Overall Study|Unclassified|1|||
155482851|NCT02607865|561187262|FG002|Overall Study|Unclassified|2|||
155482852|NCT02607865|561187263|FG003|Overall Study|Unclassified|0|||
155482853|NCT00994890|561187264|FG000|Overall Study|Adverse Event|13|||
155482854|NCT00994890|561187265|FG001|Overall Study|Adverse Event|9|||
155482855|NCT00994890|561187266|FG002|Overall Study|Adverse Event|11|||
155482856|NCT00994890|561187264|FG000|Overall Study|Lack of Efficacy|0|||
155482857|NCT00994890|561187265|FG001|Overall Study|Lack of Efficacy|0|||
155482858|NCT00994890|561187266|FG002|Overall Study|Lack of Efficacy|1|||
155482859|NCT00994890|561187264|FG000|Overall Study|Lost to Follow-up|6|||
155482860|NCT00994890|561187265|FG001|Overall Study|Lost to Follow-up|1|||
155482861|NCT00994890|561187266|FG002|Overall Study|Lost to Follow-up|3|||
155482862|NCT00994890|561187264|FG000|Overall Study|No longer willing to participate|8|||
155482863|NCT00994890|561187265|FG001|Overall Study|No longer willing to participate|5|||
155482864|NCT00994890|561187266|FG002|Overall Study|No longer willing to participate|13|||
155482865|NCT00994890|561187264|FG000|Overall Study|Protocol Violation|2|||
155482866|NCT00994890|561187265|FG001|Overall Study|Protocol Violation|4|||
155482867|NCT00994890|561187266|FG002|Overall Study|Protocol Violation|0|||
155482868|NCT00994890|561187264|FG000|Overall Study|Study terminated by sponsor|199|||
155482869|NCT00994890|561187265|FG001|Overall Study|Study terminated by sponsor|201|||
155482870|NCT00994890|561187266|FG002|Overall Study|Study terminated by sponsor|197|||
155482871|NCT00994890|561187264|FG000|Overall Study|Randomized, but not treated|1|||
155482872|NCT00994890|561187265|FG001|Overall Study|Randomized, but not treated|0|||
155482873|NCT00994890|561187266|FG002|Overall Study|Randomized, but not treated|0|||
155482874|NCT00994890|561187264|FG000|Overall Study|Other|2|||
155520501|NCT00048048|561330957|FG007|Core Treatment|Withdrawal by Subject|0|||
155482875|NCT00994890|561187265|FG001|Overall Study|Other|2|||
155482876|NCT00994890|561187266|FG002|Overall Study|Other|1|||
155482877|NCT01899729|561187269|FG000|Overall Study|Adverse Event|1|||
155482878|NCT01899729|561187270|FG001|Overall Study|Adverse Event|0|||
155482879|NCT01899729|561187271|FG002|Overall Study|Adverse Event|0|||
155482880|NCT01899729|561187272|FG003|Overall Study|Adverse Event|0|||
155482881|NCT01899729|561187273|FG004|Overall Study|Adverse Event|1|||
155482882|NCT01899729|561187269|FG000|Overall Study|Withdrawal by Subject|1|||
155482883|NCT01899729|561187270|FG001|Overall Study|Withdrawal by Subject|2|||
155482884|NCT01899729|561187271|FG002|Overall Study|Withdrawal by Subject|0|||
155482885|NCT01899729|561187272|FG003|Overall Study|Withdrawal by Subject|0|||
155482886|NCT01899729|561187273|FG004|Overall Study|Withdrawal by Subject|0|||
155482887|NCT01899729|561187269|FG000|Overall Study|Lack of Efficacy|0|||
155482888|NCT01899729|561187270|FG001|Overall Study|Lack of Efficacy|0|||
155482889|NCT01899729|561187271|FG002|Overall Study|Lack of Efficacy|2|||
155482890|NCT01899729|561187272|FG003|Overall Study|Lack of Efficacy|0|||
155482891|NCT01899729|561187273|FG004|Overall Study|Lack of Efficacy|1|||
155482892|NCT00795717|561187276|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
155482893|NCT00795717|561187277|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
155482894|NCT00795717|561187276|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
155482895|NCT00795717|561187277|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
155482896|NCT00795717|561187276|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
155482897|NCT00795717|561187277|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
155482898|NCT00795717|561187276|FG000|Phase II|too busy|0|||
155482899|NCT00795717|561187277|FG001|Phase II|too busy|1|||
155482900|NCT01021423|561187280|FG000|Overall Study|Study terminated|4|||
155482901|NCT01021423|561187281|FG001|Overall Study|Study terminated|5|||
155482902|NCT00122317|561187282|FG000|Overall Study|Death|3|||
155482903|NCT00122317|561187282|FG000|Overall Study|Adverse Event|4|||
155482904|NCT00122317|561187282|FG000|Overall Study|Physician Decision|2|||
155482905|NCT00122317|561187282|FG000|Overall Study|patient non-compliance|1|||
155482906|NCT00122317|561187282|FG000|Overall Study|Withdrawal by Subject|1|||
155482907|NCT03756285|561187283|FG000|Overall Study|Lost to Follow-up|0|||
155482908|NCT03756285|561187284|FG001|Overall Study|Lost to Follow-up|1|||
155482909|NCT03756285|561187283|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
155482910|NCT03756285|561187284|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
155482911|NCT03756285|561187283|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
155482912|NCT03756285|561187284|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
155482913|NCT00957034|561187285|FG000|Overall Study|Adverse Event|0|||
155482914|NCT00957034|561187286|FG001|Overall Study|Adverse Event|1|||
155482915|NCT00957034|561187287|FG002|Overall Study|Adverse Event|1|||
155482916|NCT00957034|561187285|FG000|Overall Study|Sponsor Terminated Study|6|||
155482917|NCT00957034|561187286|FG001|Overall Study|Sponsor Terminated Study|1|||
155482918|NCT00957034|561187287|FG002|Overall Study|Sponsor Terminated Study|5|||
155482919|NCT00957034|561187285|FG000|Overall Study|Withdrawal by Subject|0|||
155482920|NCT00957034|561187286|FG001|Overall Study|Withdrawal by Subject|2|||
155482921|NCT00957034|561187287|FG002|Overall Study|Withdrawal by Subject|0|||
155482922|NCT05315297|561187288|FG000|Overall Study|Lost to Follow-up|6|||
155482923|NCT05315297|561187289|FG001|Overall Study|Lost to Follow-up|4|||
155482924|NCT05315297|561187288|FG000|Overall Study|Withdrawal by Subject|0|||
155482925|NCT05315297|561187289|FG001|Overall Study|Withdrawal by Subject|1|||
155482926|NCT00027846|561189169|FG000|Overall Study|Lost to Follow-up|0|||
155482927|NCT00027846|561189170|FG001|Overall Study|Lost to Follow-up|41|||
155482928|NCT00027846|561189171|FG002|Overall Study|Lost to Follow-up|9|||
155482929|NCT00027846|561189169|FG000|Overall Study|Withdrawal by Subject|0|||
155482930|NCT00027846|561189170|FG001|Overall Study|Withdrawal by Subject|14|||
155482931|NCT00027846|561189171|FG002|Overall Study|Withdrawal by Subject|7|||
155482932|NCT00027846|561189169|FG000|Overall Study|Ineligible for study|2|||
155482933|NCT00027846|561189170|FG001|Overall Study|Ineligible for study|6|||
155482934|NCT00027846|561189171|FG002|Overall Study|Ineligible for study|14|||
155482935|NCT00027846|561189169|FG000|Overall Study|Entry into another COG therapeutic study|0|||
155482936|NCT00027846|561189170|FG001|Overall Study|Entry into another COG therapeutic study|5|||
155482937|NCT00027846|561189171|FG002|Overall Study|Entry into another COG therapeutic study|2|||
155482938|NCT00027846|561189169|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
155520502|NCT00048048|561330958|FG008|Core Treatment|Withdrawal by Subject|0|||
155482939|NCT00027846|561189170|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
155482940|NCT00027846|561189171|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
155482941|NCT01503229|561189172|FG000|Overall Study|Withdrew consent|1|||
155482942|NCT01354964|561189173|FG000|Overall Study|Lost to Follow-up|2|||
155482943|NCT01354964|561189174|FG001|Overall Study|Lost to Follow-up|0|||
155482944|NCT01354964|561189173|FG000|Overall Study|IV access issues|1|||
155482945|NCT01354964|561189174|FG001|Overall Study|IV access issues|1|||
155482946|NCT01354964|561189173|FG000|Overall Study|Physician Decision|1|||
155482947|NCT01354964|561189174|FG001|Overall Study|Physician Decision|0|||
155482948|NCT01459016|561189176|FG000|Overall Study|Withdrawal by Subject|11|||
155482949|NCT01459016|561189176|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
155482950|NCT03922945|561189180|FG000|Overall Study|Adverse Event|1|||
155482951|NCT03922945|561189181|FG001|Overall Study|Adverse Event|1|||
155482952|NCT03922945|561189182|FG002|Overall Study|Adverse Event|2|||
155482953|NCT03922945|561189180|FG000|Overall Study|Lost to Follow-up|13|||
155482954|NCT03922945|561189181|FG001|Overall Study|Lost to Follow-up|9|||
155482955|NCT03922945|561189182|FG002|Overall Study|Lost to Follow-up|20|||
155482956|NCT03922945|561189180|FG000|Overall Study|Lack of Efficacy|2|||
155482957|NCT03922945|561189181|FG001|Overall Study|Lack of Efficacy|0|||
155482958|NCT03922945|561189182|FG002|Overall Study|Lack of Efficacy|1|||
155482959|NCT03922945|561189180|FG000|Overall Study|Protocol Non-Compliance|0|||
155482960|NCT03922945|561189181|FG001|Overall Study|Protocol Non-Compliance|0|||
155482961|NCT03922945|561189182|FG002|Overall Study|Protocol Non-Compliance|1|||
155482962|NCT03922945|561189180|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
155482963|NCT03922945|561189181|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
155482964|NCT03922945|561189182|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
155482965|NCT03922945|561189180|FG000|Overall Study|All Other Personal Reasons|1|||
155482966|NCT03922945|561189181|FG001|Overall Study|All Other Personal Reasons|1|||
155482967|NCT03922945|561189182|FG002|Overall Study|All Other Personal Reasons|2|||
155482968|NCT02493712|561189183|FG000|Overall Study|Withdrawal by Subject|1|||
155482969|NCT02493712|561189184|FG001|Overall Study|Withdrawal by Subject|0|||
155482970|NCT02493712|561189185|FG002|Overall Study|Withdrawal by Subject|2|||
155482971|NCT02493712|561189183|FG000|Overall Study|Protocol Violation|0|||
155482972|NCT02493712|561189184|FG001|Overall Study|Protocol Violation|0|||
155482973|NCT02493712|561189185|FG002|Overall Study|Protocol Violation|1|||
155482974|NCT02493712|561189183|FG000|Overall Study|Lost to Follow-up|1|||
155482975|NCT02493712|561189184|FG001|Overall Study|Lost to Follow-up|0|||
155482976|NCT02493712|561189185|FG002|Overall Study|Lost to Follow-up|0|||
155482977|NCT02493712|561189183|FG000|Overall Study|Physician Decision|0|||
155482978|NCT02493712|561189184|FG001|Overall Study|Physician Decision|1|||
155482979|NCT02493712|561189185|FG002|Overall Study|Physician Decision|0|||
155482980|NCT02493712|561189183|FG000|Overall Study|Lack of Efficacy|0|||
155482981|NCT02493712|561189184|FG001|Overall Study|Lack of Efficacy|5|||
155482982|NCT02493712|561189185|FG002|Overall Study|Lack of Efficacy|3|||
155482983|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
155482984|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
155482985|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
155482986|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
155482987|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
155482988|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
155482989|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
155482990|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
155482991|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
155482992|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
155482993|NCT02528643|561189186|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
155482994|NCT02528643|561189187|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
155482995|NCT02528643|561189186|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
155482996|NCT02528643|561189187|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
155482997|NCT02058940|561189188|FG000|Overall Study|Discharged from Critical Care Unit|1|||
155482998|NCT02039687|561189194|FG000|Overall Study|Adverse Event|0|||
155482999|NCT02039687|561189195|FG001|Overall Study|Adverse Event|0|||
155483000|NCT02039687|561189196|FG002|Overall Study|Adverse Event|1|||
155483001|NCT02039687|561189197|FG003|Overall Study|Adverse Event|0|||
155483002|NCT02039687|561189194|FG000|Overall Study|Withdrawal by Subject|0|||
155483003|NCT02039687|561189195|FG001|Overall Study|Withdrawal by Subject|1|||
155483004|NCT02039687|561189196|FG002|Overall Study|Withdrawal by Subject|0|||
155483005|NCT02039687|561189197|FG003|Overall Study|Withdrawal by Subject|0|||
155483006|NCT02039687|561189194|FG000|Overall Study|treatment assignment could not be confir|0|||
155483007|NCT02039687|561189195|FG001|Overall Study|treatment assignment could not be confir|0|||
155483008|NCT02039687|561189196|FG002|Overall Study|treatment assignment could not be confir|2|||
155483009|NCT02039687|561189197|FG003|Overall Study|treatment assignment could not be confir|0|||
155483010|NCT01524900|561189211|FG000|Overall Study|Lost to Follow-up|3|||
155483011|NCT01524900|561189212|FG001|Overall Study|Lost to Follow-up|12|||
155483012|NCT01524900|561189213|FG002|Overall Study|Lost to Follow-up|1|||
155483013|NCT01524900|561189214|FG003|Overall Study|Lost to Follow-up|0|||
155483014|NCT01524900|561189215|FG004|Overall Study|Lost to Follow-up|0|||
155654691|NCT03715829|561828909|FG008|Extension Period|Other|4|||
155483015|NCT01524900|561189211|FG000|Overall Study|Other reason than stated above|1|||
155483016|NCT01524900|561189212|FG001|Overall Study|Other reason than stated above|1|||
155483017|NCT01524900|561189213|FG002|Overall Study|Other reason than stated above|0|||
155483018|NCT01524900|561189214|FG003|Overall Study|Other reason than stated above|0|||
155483019|NCT01524900|561189215|FG004|Overall Study|Other reason than stated above|0|||
155483020|NCT01524900|561189211|FG000|Overall Study|No reason documented|2|||
155483021|NCT01524900|561189212|FG001|Overall Study|No reason documented|1|||
155483022|NCT01524900|561189213|FG002|Overall Study|No reason documented|0|||
155483023|NCT01524900|561189214|FG003|Overall Study|No reason documented|1|||
155483024|NCT01524900|561189215|FG004|Overall Study|No reason documented|0|||
155483025|NCT03758612|561189216|FG000|Washout Period|Withdrawal by Subject|0|||
155483026|NCT03758612|561189217|FG001|Washout Period|Withdrawal by Subject|0|||
155483027|NCT03758612|561189218|FG002|Washout Period|Withdrawal by Subject|2|||
155483028|NCT03758612|561189219|FG003|Washout Period|Withdrawal by Subject|0|||
155483029|NCT03758612|561189220|FG004|Washout Period|Withdrawal by Subject|0|||
155483030|NCT03758612|561189221|FG005|Washout Period|Withdrawal by Subject|0|||
155483031|NCT03758612|561189222|FG006|Washout Period|Withdrawal by Subject|0|||
155483032|NCT03758612|561189223|FG007|Washout Period|Withdrawal by Subject|0|||
155483033|NCT03758612|561189224|FG008|Washout Period|Withdrawal by Subject|0|||
155483034|NCT03758612|561189225|FG009|Washout Period|Withdrawal by Subject|0|||
155483035|NCT03758612|561189226|FG010|Washout Period|Withdrawal by Subject|0|||
155483036|NCT03758612|561189227|FG011|Washout Period|Withdrawal by Subject|0|||
155483037|NCT03758612|561189216|FG000|Period 2|Protocol Violation|0|||
155483038|NCT03758612|561189217|FG001|Period 2|Protocol Violation|0|||
155483039|NCT03758612|561189218|FG002|Period 2|Protocol Violation|0|||
155483040|NCT03758612|561189219|FG003|Period 2|Protocol Violation|0|||
155483041|NCT03758612|561189220|FG004|Period 2|Protocol Violation|1|||
155483042|NCT03758612|561189221|FG005|Period 2|Protocol Violation|0|||
155483043|NCT03758612|561189222|FG006|Period 2|Protocol Violation|0|||
155483044|NCT03758612|561189223|FG007|Period 2|Protocol Violation|0|||
155483045|NCT03758612|561189224|FG008|Period 2|Protocol Violation|0|||
155483046|NCT03758612|561189225|FG009|Period 2|Protocol Violation|0|||
155483047|NCT03758612|561189226|FG010|Period 2|Protocol Violation|0|||
155483048|NCT03758612|561189227|FG011|Period 2|Protocol Violation|0|||
155483049|NCT00959192|561189228|FG000|Overall Study|Adverse Event|1|||
155483050|NCT00959192|561189229|FG001|Overall Study|Adverse Event|1|||
155483051|NCT00959192|561189230|FG002|Overall Study|Adverse Event|1|||
155483052|NCT00959192|561189231|FG003|Overall Study|Adverse Event|0|||
155483053|NCT00959192|561189228|FG000|Overall Study|Investigator Request|1|||
155483054|NCT00959192|561189229|FG001|Overall Study|Investigator Request|0|||
155483055|NCT00959192|561189230|FG002|Overall Study|Investigator Request|0|||
155483056|NCT00959192|561189231|FG003|Overall Study|Investigator Request|0|||
155483057|NCT00959192|561189228|FG000|Overall Study|Caregiver Request|0|||
155483058|NCT00959192|561189229|FG001|Overall Study|Caregiver Request|0|||
155483059|NCT00959192|561189230|FG002|Overall Study|Caregiver Request|2|||
155483060|NCT00959192|561189231|FG003|Overall Study|Caregiver Request|1|||
155483061|NCT00532441|561189232|FG000|Overall Study|Death|1|||
155483062|NCT00532441|561189233|FG001|Overall Study|Death|0|||
155483063|NCT01967134|561189234|FG000|Overall Study|Lost to Follow-up|0|||
155483064|NCT01967134|561189235|FG001|Overall Study|Lost to Follow-up|1|||
155483065|NCT01967134|561189236|FG002|Overall Study|Lost to Follow-up|0|||
155520503|NCT00048048|561330959|FG009|Core Treatment|Withdrawal by Subject|0|||
155520504|NCT00048048|561330960|FG010|Core Treatment|Withdrawal by Subject|0|||
155520505|NCT00048048|561330961|FG011|Core Treatment|Withdrawal by Subject|0|||
155520506|NCT00048048|561330950|FG000|Core Treatment|Adverse Event|0|||
155520507|NCT00048048|561330951|FG001|Core Treatment|Adverse Event|0|||
155520508|NCT00048048|561330952|FG002|Core Treatment|Adverse Event|0|||
155520509|NCT00048048|561330953|FG003|Core Treatment|Adverse Event|0|||
155654692|NCT03715829|561828910|FG009|Extension Period|Other|0|||
155654693|NCT03715829|561828911|FG010|Extension Period|Other|0|||
155483066|NCT00443534|561189237|FG000|Overall Study|Lack of Efficacy|67|||
155483067|NCT00443534|561189237|FG000|Overall Study|Adverse Event|16|||
155483068|NCT00443534|561189237|FG000|Overall Study|Death|9|||
155483069|NCT00443534|561189237|FG000|Overall Study|Withdrawal by Subject|8|||
155483070|NCT00443534|561189237|FG000|Overall Study|Study Terminated by Sponsor|12|||
155483071|NCT00443534|561189237|FG000|Overall Study|Other|10|||
155483072|NCT00443534|561189237|FG000|Overall Study|Enrolled, Not Treated|1|||
155483073|NCT01603615|561189238|FG000|Overall Study|Did not Receive Treatment|7|||
155483074|NCT01603615|561189238|FG000|Overall Study|Lost to Follow-up|9|||
155483075|NCT01603615|561189238|FG000|Overall Study|Personal Reasons|17|||
155483076|NCT01603615|561189238|FG000|Overall Study|Other Miscellaneous|1|||
155483077|NCT00305773|561189239|FG000|Overall Study|Death|3|||
155483078|NCT00305773|561189240|FG001|Overall Study|Death|2|||
155483079|NCT00305773|561189239|FG000|Overall Study|Adverse Event|1|||
155483080|NCT00305773|561189240|FG001|Overall Study|Adverse Event|2|||
155483081|NCT00305773|561189239|FG000|Overall Study|Alternative Treatment|4|||
155483082|NCT00305773|561189240|FG001|Overall Study|Alternative Treatment|4|||
155520510|NCT00048048|561330954|FG004|Core Treatment|Adverse Event|0|||
155654694|NCT03647137|561828913|FG000|Overall Study|Scan Limitation|2|||
155483083|NCT00305773|561189239|FG000|Overall Study|Physician Decision|1|||
155483084|NCT00305773|561189240|FG001|Overall Study|Physician Decision|1|||
155483085|NCT00305773|561189239|FG000|Overall Study|Withdrawal by Subject|1|||
155483086|NCT00305773|561189240|FG001|Overall Study|Withdrawal by Subject|4|||
155483087|NCT00305773|561189239|FG000|Overall Study|Disease Progression|1|||
155483088|NCT00305773|561189240|FG001|Overall Study|Disease Progression|3|||
155483089|NCT00305773|561189239|FG000|Overall Study|All other reasons|3|||
155483090|NCT00305773|561189240|FG001|Overall Study|All other reasons|2|||
155483091|NCT03419741|561189241|FG000|Overall Study|Adverse Event|1|||
155483092|NCT03419741|561189242|FG001|Overall Study|Adverse Event|0|||
155483093|NCT03419741|561189241|FG000|Overall Study|Withdrawal by Subject|1|||
155483094|NCT03419741|561189242|FG001|Overall Study|Withdrawal by Subject|2|||
155483095|NCT00303329|561189243|FG000|Overall Study|Adverse Event|7|||
155483096|NCT00303329|561189244|FG001|Overall Study|Adverse Event|14|||
155483097|NCT00303329|561189243|FG000|Overall Study|Abnormal Laboratory Values|0|||
155483098|NCT00303329|561189244|FG001|Overall Study|Abnormal Laboratory Values|1|||
155483099|NCT00303329|561189243|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
155483100|NCT00303329|561189244|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155483101|NCT00303329|561189243|FG000|Overall Study|Condition no longer requires study drug|0|||
155483102|NCT00303329|561189244|FG001|Overall Study|Condition no longer requires study drug|8|||
155483103|NCT00303329|561189243|FG000|Overall Study|Protocol Violation|3|||
155483104|NCT00303329|561189244|FG001|Overall Study|Protocol Violation|0|||
155483105|NCT00303329|561189243|FG000|Overall Study|Withdrawal by Subject|9|||
155483106|NCT00303329|561189244|FG001|Overall Study|Withdrawal by Subject|15|||
155483107|NCT00303329|561189243|FG000|Overall Study|Lost to Follow-up|0|||
155483108|NCT00303329|561189244|FG001|Overall Study|Lost to Follow-up|1|||
155483109|NCT00303329|561189243|FG000|Overall Study|Administrative problems|1|||
155483110|NCT00303329|561189244|FG001|Overall Study|Administrative problems|0|||
155483111|NCT00303329|561189243|FG000|Overall Study|Death|2|||
155483112|NCT00303329|561189244|FG001|Overall Study|Death|12|||
155483113|NCT00303329|561189243|FG000|Overall Study|Stopped at end of core|3|||
155483114|NCT00303329|561189244|FG001|Overall Study|Stopped at end of core|9|||
155483115|NCT00303329|561189243|FG000|Overall Study|Stopped at end of extension 1|1|||
155483116|NCT00303329|561189244|FG001|Overall Study|Stopped at end of extension 1|0|||
155483117|NCT03384316|561189247|FG000|Overall Study|Screen failure|0|||
155483118|NCT03384316|561189248|FG001|Overall Study|Screen failure|1|||
155483119|NCT00413231|561189249|FG000|0 to 30-day Post Treatment|Death|5|||
155483120|NCT00413231|561189249|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
155483121|NCT00413231|561189249|FG000|30-day to 365-day Post Treatment|Death|13|||
155483122|NCT00413231|561189249|FG000|365-day to 60-month Post Treatment|Death|36|||
155483123|NCT00413231|561189249|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
155483124|NCT00413231|561189249|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
155483125|NCT00413231|561189249|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
155483126|NCT01539720|561189257|FG000|Overall Study|Screen Fail|15|||
155483127|NCT01539720|561189258|FG001|Overall Study|Screen Fail|3|||
155483128|NCT01539720|561189257|FG000|Overall Study|Lost to Follow-up|14|||
155483129|NCT01539720|561189258|FG001|Overall Study|Lost to Follow-up|7|||
155483130|NCT00298766|561189259|FG000|Overall Study|Adverse Event|18|||
155483131|NCT00298766|561189259|FG000|Overall Study|Death|2|||
155483132|NCT00298766|561189259|FG000|Overall Study|Withdrawal by Subject|9|||
155483133|NCT00298766|561189259|FG000|Overall Study|Treatment ongoing|4|||
155483134|NCT00298766|561189259|FG000|Overall Study|Progression of amyloid markers|4|||
155483135|NCT00298766|561189259|FG000|Overall Study|Deterioration in KPS and organ function|1|||
155483136|NCT00298766|561189259|FG000|Overall Study|Subjects overall condition deterioration|4|||
155483137|NCT00298766|561189259|FG000|Overall Study|Other|4|||
155483138|NCT03812224|561189266|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
155483139|NCT03812224|561189267|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155483140|NCT03812224|561189266|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
155483141|NCT03812224|561189267|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
155483142|NCT03812224|561189266|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
155483143|NCT03812224|561189267|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
155483144|NCT03812224|561189266|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
155654695|NCT03647137|561828914|FG001|Overall Study|Scan Limitation|1|||
155654696|NCT03647137|561828915|FG002|Overall Study|Scan Limitation|1|||
155483145|NCT03812224|561189267|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
155483146|NCT01731951|561189268|FG000|Overall Study|Documented Disease Progression|1|||
155483147|NCT01731951|561189269|FG001|Overall Study|Documented Disease Progression|0|||
155483148|NCT01731951|561189270|FG002|Overall Study|Documented Disease Progression|0|||
155483149|NCT01731951|561189271|FG003|Overall Study|Documented Disease Progression|0|||
155483150|NCT01731951|561189272|FG004|Overall Study|Documented Disease Progression|0|||
155483151|NCT01731951|561189273|FG005|Overall Study|Documented Disease Progression|0|||
155654697|NCT03647137|561828916|FG003|Overall Study|Scan Limitation|2|||
155483152|NCT01731951|561189268|FG000|Overall Study|Lost to Follow-up|2|||
155483153|NCT01731951|561189269|FG001|Overall Study|Lost to Follow-up|0|||
155483154|NCT01731951|561189270|FG002|Overall Study|Lost to Follow-up|0|||
155483155|NCT01731951|561189271|FG003|Overall Study|Lost to Follow-up|1|||
155483156|NCT01731951|561189272|FG004|Overall Study|Lost to Follow-up|3|||
155483157|NCT01731951|561189273|FG005|Overall Study|Lost to Follow-up|1|||
155483158|NCT01731951|561189268|FG000|Overall Study|Withdrawal of Consent|1|||
155483159|NCT01731951|561189269|FG001|Overall Study|Withdrawal of Consent|0|||
155483160|NCT01731951|561189270|FG002|Overall Study|Withdrawal of Consent|0|||
155483161|NCT01731951|561189271|FG003|Overall Study|Withdrawal of Consent|0|||
155483162|NCT01731951|561189272|FG004|Overall Study|Withdrawal of Consent|0|||
155483163|NCT01731951|561189273|FG005|Overall Study|Withdrawal of Consent|2|||
155483164|NCT01731951|561189268|FG000|Overall Study|Death|13|||
155483165|NCT01731951|561189269|FG001|Overall Study|Death|15|||
155483166|NCT01731951|561189270|FG002|Overall Study|Death|9|||
155483167|NCT01731951|561189271|FG003|Overall Study|Death|8|||
155483168|NCT01731951|561189272|FG004|Overall Study|Death|9|||
155483169|NCT01731951|561189273|FG005|Overall Study|Death|6|||
155483170|NCT00348686|561189274|FG000|Overall Study|Withdrawal by Subject|45|||
155483171|NCT00348686|561189274|FG000|Overall Study|Adverse Event|5|||
155483172|NCT00348686|561189274|FG000|Overall Study|Protocol Violation|6|||
155483173|NCT00348686|561189274|FG000|Overall Study|Lost to Follow-up|2|||
155483174|NCT00348686|561189274|FG000|Overall Study|Multiple Reasons|8|||
155483175|NCT01258738|561189275|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
155483176|NCT01258738|561189276|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
155483177|NCT01258738|561189275|FG000|Double-blind Period|Withdrawal by Subject|2|||
155483178|NCT01258738|561189276|FG001|Double-blind Period|Withdrawal by Subject|2|||
155483179|NCT01258738|561189275|FG000|Double-blind Period|Protocol Violation|1|||
155483180|NCT01258738|561189276|FG001|Double-blind Period|Protocol Violation|1|||
155483181|NCT01258738|561189275|FG000|Double-blind Period|Adverse Event|3|||
155483182|NCT01258738|561189276|FG001|Double-blind Period|Adverse Event|1|||
155483183|NCT01258738|561189275|FG000|Open-label Period|Did not meet inclusion criteria|0|||
155483184|NCT01258738|561189276|FG001|Open-label Period|Did not meet inclusion criteria|1|||
155483185|NCT01258738|561189275|FG000|Open-label Period|Insufficient clinical response|5|||
155483186|NCT01258738|561189276|FG001|Open-label Period|Insufficient clinical response|3|||
155483187|NCT01258738|561189275|FG000|Open-label Period|Lost to Follow-up|0|||
155483188|NCT01258738|561189276|FG001|Open-label Period|Lost to Follow-up|2|||
155483189|NCT01258738|561189275|FG000|Open-label Period|Withdrawal by Subject|5|||
155483190|NCT01258738|561189276|FG001|Open-label Period|Withdrawal by Subject|6|||
155483191|NCT01258738|561189275|FG000|Open-label Period|Protocol Violation|2|||
155483192|NCT01258738|561189276|FG001|Open-label Period|Protocol Violation|2|||
155483193|NCT01258738|561189275|FG000|Open-label Period|Adverse Event|4|||
155483194|NCT01258738|561189276|FG001|Open-label Period|Adverse Event|5|||
155483195|NCT01258738|561189275|FG000|Open-label Period|Other Reasons|0|||
155483196|NCT01258738|561189276|FG001|Open-label Period|Other Reasons|1|||
155483197|NCT01258738|561189275|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
155483198|NCT01258738|561189276|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
155483199|NCT02418000|561189277|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
155483200|NCT02418000|561189278|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483201|NCT02418000|561189279|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483202|NCT02418000|561189280|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483203|NCT02418000|561189281|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483204|NCT02418000|561189277|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
155483205|NCT02418000|561189278|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
155483206|NCT02418000|561189279|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
155483207|NCT02418000|561189280|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
155483208|NCT02418000|561189281|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
155483209|NCT02418000|561189277|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
155483210|NCT02418000|561189278|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
155483211|NCT02418000|561189279|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
155483212|NCT02418000|561189280|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
155483213|NCT02418000|561189281|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
155483214|NCT02418000|561189277|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483215|NCT02418000|561189278|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
155483216|NCT02418000|561189279|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483217|NCT02418000|561189280|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483218|NCT02418000|561189281|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
155483219|NCT02418000|561189277|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
155654698|NCT03579719|561828918|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
155483220|NCT02418000|561189278|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
155483221|NCT02418000|561189279|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
155483222|NCT02418000|561189280|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
155483223|NCT02418000|561189281|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
155483224|NCT02418000|561189277|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483225|NCT02418000|561189278|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483226|NCT02418000|561189279|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
155483227|NCT02418000|561189280|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483228|NCT02418000|561189281|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483229|NCT02418000|561189277|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483230|NCT02418000|561189278|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483231|NCT02418000|561189279|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483232|NCT02418000|561189280|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
155483233|NCT02418000|561189281|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483234|NCT02418000|561189277|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
155483235|NCT02418000|561189278|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
155483236|NCT02418000|561189279|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
155483237|NCT02418000|561189280|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
155483238|NCT02418000|561189281|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
155483239|NCT02418000|561189277|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483240|NCT02418000|561189278|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483241|NCT02418000|561189279|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483242|NCT02418000|561189280|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
155483243|NCT02418000|561189281|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
155483244|NCT00490815|561189286|FG000|Overall Study|Adverse Event|2|||
155483245|NCT00490815|561189287|FG001|Overall Study|Adverse Event|3|||
155483246|NCT00490815|561189286|FG000|Overall Study|Withdrawal by Subject|4|||
155483247|NCT00490815|561189287|FG001|Overall Study|Withdrawal by Subject|0|||
155483248|NCT00490815|561189286|FG000|Overall Study|Lost to Follow-up|1|||
155483249|NCT00490815|561189287|FG001|Overall Study|Lost to Follow-up|3|||
155483250|NCT00490815|561189286|FG000|Overall Study|Death|1|||
155483251|NCT00490815|561189287|FG001|Overall Study|Death|3|||
155483252|NCT02195531|561189292|FG000|Overall Study|Withdrawal by Subject|1|||
155483253|NCT02195531|561189293|FG001|Overall Study|Withdrawal by Subject|1|||
155483254|NCT02195531|561189294|FG002|Overall Study|Withdrawal by Subject|1|||
155483255|NCT01284127|561189295|FG000|Overall Study|Adverse Event|2|||
155483256|NCT01284127|561189295|FG000|Overall Study|Withdrawal by Subject|4|||
155483257|NCT01284127|561189295|FG000|Overall Study|Physician Decision|1|||
155483258|NCT02516306|561189296|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
155483259|NCT02516306|561189297|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
155483260|NCT03227692|561189299|FG000|Overall Study|Protocol Violation|1|||
155483261|NCT03227692|561189300|FG001|Overall Study|Protocol Violation|1|||
155483262|NCT03227692|561189299|FG000|Overall Study|Lost to Follow-up|4|||
155483263|NCT03227692|561189300|FG001|Overall Study|Lost to Follow-up|2|||
155483264|NCT03227692|561189299|FG000|Overall Study|Adverse Event|0|||
155483265|NCT03227692|561189300|FG001|Overall Study|Adverse Event|2|||
155483266|NCT00256204|561189302|FG000|Overall Study|Adverse Event|10|||
155483267|NCT00256204|561189303|FG001|Overall Study|Adverse Event|14|||
155483268|NCT00256204|561189304|FG002|Overall Study|Adverse Event|16|||
155483269|NCT00256204|561189305|FG003|Overall Study|Adverse Event|14|||
155483270|NCT00256204|561189302|FG000|Overall Study|Death|0|||
155483271|NCT00256204|561189303|FG001|Overall Study|Death|1|||
155483272|NCT00256204|561189304|FG002|Overall Study|Death|0|||
155483273|NCT00256204|561189305|FG003|Overall Study|Death|0|||
155483274|NCT00256204|561189302|FG000|Overall Study|Lost to Follow-up|1|||
155483275|NCT00256204|561189303|FG001|Overall Study|Lost to Follow-up|1|||
155483276|NCT00256204|561189304|FG002|Overall Study|Lost to Follow-up|1|||
155483277|NCT00256204|561189305|FG003|Overall Study|Lost to Follow-up|2|||
155483278|NCT00256204|561189302|FG000|Overall Study|Protocol Violation|1|||
155483279|NCT00256204|561189303|FG001|Overall Study|Protocol Violation|0|||
155483280|NCT00256204|561189304|FG002|Overall Study|Protocol Violation|2|||
155483281|NCT00256204|561189305|FG003|Overall Study|Protocol Violation|1|||
155483282|NCT00256204|561189302|FG000|Overall Study|Physician Decision|0|||
155483283|NCT00256204|561189303|FG001|Overall Study|Physician Decision|0|||
155483284|NCT00256204|561189304|FG002|Overall Study|Physician Decision|1|||
155483285|NCT00256204|561189305|FG003|Overall Study|Physician Decision|2|||
155483286|NCT00256204|561189302|FG000|Overall Study|Withdrawal by Subject|17|||
155520511|NCT00048048|561330955|FG005|Core Treatment|Adverse Event|0|||
155520512|NCT00048048|561330956|FG006|Core Treatment|Adverse Event|0|||
155520513|NCT00048048|561330957|FG007|Core Treatment|Adverse Event|1|||
155520514|NCT00048048|561330958|FG008|Core Treatment|Adverse Event|0|||
155483287|NCT00256204|561189303|FG001|Overall Study|Withdrawal by Subject|6|||
155483288|NCT00256204|561189304|FG002|Overall Study|Withdrawal by Subject|7|||
155483289|NCT00256204|561189305|FG003|Overall Study|Withdrawal by Subject|5|||
155483290|NCT00256204|561189302|FG000|Overall Study|Need for additional prohibited treatment|38|||
155483291|NCT00256204|561189303|FG001|Overall Study|Need for additional prohibited treatment|28|||
155483292|NCT00256204|561189304|FG002|Overall Study|Need for additional prohibited treatment|27|||
155483293|NCT00256204|561189305|FG003|Overall Study|Need for additional prohibited treatment|25|||
155483294|NCT01351415|561189306|FG000|Overall Study|Withdrawal by Subject|15|||
155483295|NCT01351415|561189307|FG001|Overall Study|Withdrawal by Subject|17|||
155520515|NCT00048048|561330959|FG009|Core Treatment|Adverse Event|0|||
155520516|NCT00048048|561330960|FG010|Core Treatment|Adverse Event|0|||
155520517|NCT00048048|561330961|FG011|Core Treatment|Adverse Event|0|||
155520518|NCT00048048|561330950|FG000|Extension Year 1|Early withdrawals|0|||
155520519|NCT00048048|561330951|FG001|Extension Year 1|Early withdrawals|0|||
155520520|NCT00048048|561330952|FG002|Extension Year 1|Early withdrawals|0|||
155483296|NCT01351415|561189306|FG000|Overall Study|Trial termination by the Sponsor|28|||
155483297|NCT01351415|561189307|FG001|Overall Study|Trial termination by the Sponsor|19|||
155483298|NCT01351415|561189306|FG000|Overall Study|Lost to Follow-up|5|||
155483299|NCT01351415|561189307|FG001|Overall Study|Lost to Follow-up|7|||
155483300|NCT01351415|561189306|FG000|Overall Study|Death|190|||
155483301|NCT01351415|561189307|FG001|Overall Study|Death|187|||
155483302|NCT01351415|561189306|FG000|Overall Study|Physician Decision|2|||
155483303|NCT01351415|561189307|FG001|Overall Study|Physician Decision|3|||
155483304|NCT01351415|561189306|FG000|Overall Study|Reason unknown|0|||
155483305|NCT01351415|561189307|FG001|Overall Study|Reason unknown|2|||
155483306|NCT01351415|561189306|FG000|Overall Study|Never Started|5|||
155483307|NCT01351415|561189307|FG001|Overall Study|Never Started|5|||
155483308|NCT00699582|561189315|FG000|Overall Study|Adverse Event|4|||
155483309|NCT00699582|561189316|FG001|Overall Study|Adverse Event|11|||
155483310|NCT00699582|561189317|FG002|Overall Study|Adverse Event|23|||
155483311|NCT00699582|561189315|FG000|Overall Study|Withdrawal by Subject|6|||
155483312|NCT00699582|561189316|FG001|Overall Study|Withdrawal by Subject|7|||
155483313|NCT00699582|561189317|FG002|Overall Study|Withdrawal by Subject|4|||
155483314|NCT00699582|561189315|FG000|Overall Study|Lack of Efficacy|1|||
155483315|NCT00699582|561189316|FG001|Overall Study|Lack of Efficacy|0|||
155483316|NCT00699582|561189317|FG002|Overall Study|Lack of Efficacy|1|||
155483317|NCT00699582|561189315|FG000|Overall Study|Progressive Disease|1|||
155483318|NCT00699582|561189316|FG001|Overall Study|Progressive Disease|0|||
155483319|NCT00699582|561189317|FG002|Overall Study|Progressive Disease|0|||
155483320|NCT00699582|561189315|FG000|Overall Study|Administrative/Other|4|||
155483321|NCT00699582|561189316|FG001|Overall Study|Administrative/Other|3|||
155483322|NCT00699582|561189317|FG002|Overall Study|Administrative/Other|0|||
155483323|NCT00699582|561189315|FG000|Overall Study|Randomized, Not Treated|2|||
155483324|NCT00699582|561189316|FG001|Overall Study|Randomized, Not Treated|1|||
155483325|NCT00699582|561189317|FG002|Overall Study|Randomized, Not Treated|0|||
155483326|NCT03117309|561189320|FG000|Overall Study|Not meeting inclusion criteria|0|||
155483327|NCT03117309|561189321|FG001|Overall Study|Not meeting inclusion criteria|1|||
155483328|NCT01142791|561189340|FG000|Overall Study|Alternative Treatment|1|||
155483329|NCT01142791|561189341|FG001|Overall Study|Alternative Treatment|0|||
155520521|NCT00048048|561330953|FG003|Extension Year 1|Early withdrawals|0|||
155520522|NCT00048048|561330954|FG004|Extension Year 1|Early withdrawals|0|||
155520523|NCT00048048|561330955|FG005|Extension Year 1|Early withdrawals|0|||
155520524|NCT00048048|561330956|FG006|Extension Year 1|Early withdrawals|0|||
155520525|NCT00048048|561330957|FG007|Extension Year 1|Early withdrawals|0|||
155520526|NCT00048048|561330958|FG008|Extension Year 1|Early withdrawals|0|||
155520527|NCT00048048|561330959|FG009|Extension Year 1|Early withdrawals|2|||
155520528|NCT00048048|561330960|FG010|Extension Year 1|Early withdrawals|2|||
155520529|NCT00048048|561330961|FG011|Extension Year 1|Early withdrawals|4|||
155520530|NCT00048048|561330950|FG000|Extension Year 2|Early withdrawals|0|||
155520531|NCT00048048|561330951|FG001|Extension Year 2|Early withdrawals|0|||
155520532|NCT00048048|561330952|FG002|Extension Year 2|Early withdrawals|0|||
155520533|NCT00048048|561330953|FG003|Extension Year 2|Early withdrawals|0|||
155520534|NCT00048048|561330954|FG004|Extension Year 2|Early withdrawals|0|||
155520535|NCT00048048|561330955|FG005|Extension Year 2|Early withdrawals|0|||
155520536|NCT00048048|561330956|FG006|Extension Year 2|Early withdrawals|0|||
155520537|NCT00048048|561330957|FG007|Extension Year 2|Early withdrawals|0|||
155520538|NCT00048048|561330958|FG008|Extension Year 2|Early withdrawals|0|||
155520539|NCT00048048|561330959|FG009|Extension Year 2|Early withdrawals|0|||
155654699|NCT01443026|561828919|FG000|Overall Study|Physician Decision|1|||
155654700|NCT01443026|561828920|FG001|Overall Study|Physician Decision|0|||
155520540|NCT00048048|561330960|FG010|Extension Year 2|Early withdrawals|4|||
155520541|NCT00048048|561330961|FG011|Extension Year 2|Early withdrawals|2|||
155520542|NCT03992196|561330962|FG000|Enrollment|lost to follow-up prior dosing|1|||
155483330|NCT01142791|561189340|FG000|Overall Study|Lost to Follow-up|1|||
155483331|NCT01142791|561189341|FG001|Overall Study|Lost to Follow-up|0|||
155483332|NCT01142791|561189340|FG000|Overall Study|Withdrawal by Subject|5|||
155483333|NCT01142791|561189341|FG001|Overall Study|Withdrawal by Subject|0|||
155483334|NCT01142791|561189340|FG000|Overall Study|Received only 1 sonication|0|||
155483335|NCT01142791|561189341|FG001|Overall Study|Received only 1 sonication|6|||
155520543|NCT03992196|561330963|FG001|Enrollment|lost to follow-up prior dosing|0|||
155520544|NCT03992196|561330964|FG002|Enrollment|lost to follow-up prior dosing|0|||
155483336|NCT01981096|561189343|FG000|Overall Study|Parent illness|1|||
155483337|NCT01981096|561189344|FG001|Overall Study|Parent illness|0|||
155483338|NCT01981096|561189343|FG000|Overall Study|Withdrawal by Subject|0|||
155483339|NCT01981096|561189344|FG001|Overall Study|Withdrawal by Subject|1|||
155483340|NCT01981096|561189343|FG000|Overall Study|Lost to Follow-up|2|||
155483341|NCT01981096|561189344|FG001|Overall Study|Lost to Follow-up|0|||
155483342|NCT01454531|561189345|FG000|Overall Study|Adverse Event|14|||
155483343|NCT01454531|561189345|FG000|Overall Study|Withdrawal by Subject|5|||
155483344|NCT01454531|561189345|FG000|Overall Study|Lost to Follow-up|1|||
155483345|NCT01454531|561189345|FG000|Overall Study|Physician Decision|1|||
155483346|NCT01454531|561189345|FG000|Overall Study|Delay in IMP administration|1|||
155483347|NCT01454531|561189345|FG000|Overall Study|Other|1|||
155483348|NCT01277666|561189346|FG000|Overall Study|Adverse Event|26|||
155483349|NCT01277666|561189347|FG001|Overall Study|Adverse Event|25|||
155483350|NCT01277666|561189348|FG002|Overall Study|Adverse Event|20|||
155483351|NCT01277666|561189346|FG000|Overall Study|Lack of Efficacy|8|||
155483352|NCT01277666|561189347|FG001|Overall Study|Lack of Efficacy|20|||
155483353|NCT01277666|561189348|FG002|Overall Study|Lack of Efficacy|12|||
155483354|NCT01277666|561189346|FG000|Overall Study|Protocol Violation|2|||
155483355|NCT01277666|561189347|FG001|Overall Study|Protocol Violation|3|||
155483356|NCT01277666|561189348|FG002|Overall Study|Protocol Violation|2|||
155483357|NCT01277666|561189346|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
155483358|NCT01277666|561189347|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
155483359|NCT01277666|561189348|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
155483360|NCT01277666|561189346|FG000|Overall Study|Lost to Follow-up|1|||
155483361|NCT01277666|561189347|FG001|Overall Study|Lost to Follow-up|1|||
155483362|NCT01277666|561189348|FG002|Overall Study|Lost to Follow-up|2|||
155483363|NCT01277666|561189346|FG000|Overall Study|Withdrawal by Subject|7|||
155483364|NCT01277666|561189347|FG001|Overall Study|Withdrawal by Subject|8|||
155483365|NCT01277666|561189348|FG002|Overall Study|Withdrawal by Subject|6|||
155483366|NCT01277666|561189346|FG000|Overall Study|Death|0|||
155483367|NCT01277666|561189347|FG001|Overall Study|Death|0|||
155483368|NCT01277666|561189348|FG002|Overall Study|Death|1|||
155483369|NCT02886338|561189349|FG000|Overall Study|Withdrawal by Subject|1|||
155483370|NCT06334055|561189351|FG000|Overall Study|Adverse Event|4|||
155483371|NCT06334055|561189351|FG000|Overall Study|Disqualified|72|||
155483372|NCT02146274|561191294|FG000|Overall Study|Protocol Violation|73|||
155483373|NCT00656136|561191308|FG000|Overall Study|Progressive disease|177|||
155483374|NCT00656136|561191309|FG001|Overall Study|Progressive disease|322|||
155483375|NCT00656136|561191308|FG000|Overall Study|Other Adverse Event|5|||
155483376|NCT00656136|561191309|FG001|Overall Study|Other Adverse Event|51|||
155483377|NCT00656136|561191308|FG000|Overall Study|Protocol Violation|2|||
155483378|NCT00656136|561191309|FG001|Overall Study|Protocol Violation|3|||
155483379|NCT00656136|561191308|FG000|Overall Study|Patient refused to take study medication|7|||
155483380|NCT00656136|561191309|FG001|Overall Study|Patient refused to take study medication|10|||
155483381|NCT00656136|561191308|FG000|Overall Study|Unknown and others|4|||
155483382|NCT00656136|561191309|FG001|Overall Study|Unknown and others|4|||
155483383|NCT02500901|561191310|FG000|Overall Study|Disease ProgressionDD|2|||
155483384|NCT03938857|561191318|FG000|Overall Study|Physician Decision|1|||
155483385|NCT03938857|561191319|FG001|Overall Study|Physician Decision|0|||
155483386|NCT03938857|561191320|FG002|Overall Study|Physician Decision|0|||
155483387|NCT03938857|561191321|FG003|Overall Study|Physician Decision|0|||
155483388|NCT02127970|561191322|FG000|Overall Study|Adverse Event|2|||
155483389|NCT02127970|561191323|FG001|Overall Study|Adverse Event|1|||
155483390|NCT02127970|561191322|FG000|Overall Study|Death|1|||
155483391|NCT02127970|561191323|FG001|Overall Study|Death|1|||
155654701|NCT01443026|561828919|FG000|Overall Study|Death|0|||
155483392|NCT02127970|561191322|FG000|Overall Study|Lost to Follow-up|14|||
155483393|NCT02127970|561191323|FG001|Overall Study|Lost to Follow-up|14|||
155483394|NCT02127970|561191322|FG000|Overall Study|Reason not Specified|4|||
155483395|NCT02127970|561191323|FG001|Overall Study|Reason not Specified|7|||
155483396|NCT02127970|561191322|FG000|Overall Study|Pregnancy|0|||
155483397|NCT02127970|561191323|FG001|Overall Study|Pregnancy|1|||
155483398|NCT02127970|561191322|FG000|Overall Study|Subject Withdrew Consent|5|||
155483399|NCT02127970|561191323|FG001|Overall Study|Subject Withdrew Consent|3|||
155483400|NCT01398176|561191324|FG000|Overall Study|Lost to Follow-up|1|||
155483401|NCT01398176|561191325|FG001|Overall Study|Lost to Follow-up|3|||
155483402|NCT01398176|561191324|FG000|Overall Study|Physician Decision|2|||
155483403|NCT01398176|561191325|FG001|Overall Study|Physician Decision|3|||
155483404|NCT00542321|561191326|FG000|Overall Study|Death|0|||
155483405|NCT00542321|561191327|FG001|Overall Study|Death|1|||
155483406|NCT01871870|561191331|FG000|Overall Study|Hardware issues|7|||
155654702|NCT01443026|561828920|FG001|Overall Study|Death|1|||
155483407|NCT01871870|561191331|FG000|Overall Study|hyperglycemia|2|||
155483408|NCT02988115|561191337|FG000|Overall Study|Adverse Event|6|||
155483409|NCT02988115|561191338|FG001|Overall Study|Adverse Event|1|||
155483410|NCT02988115|561191337|FG000|Overall Study|Sponsor Decision|5|||
155654703|NCT01443026|561828919|FG000|Overall Study|Withdrawal by Subject|0|||
155654704|NCT01443026|561828920|FG001|Overall Study|Withdrawal by Subject|3|||
155654705|NCT01443026|561828919|FG000|Overall Study|Lost to Follow-up|2|||
155654706|NCT01443026|561828920|FG001|Overall Study|Lost to Follow-up|1|||
155654707|NCT00829868|561828921|FG000|Washout|Physician Decision|1|||
155654708|NCT00829868|561828922|FG001|Washout|Physician Decision|0|||
155654709|NCT02799043|561828924|FG000|Overall Study|Adverse Event|0|||
155654710|NCT02799043|561828925|FG001|Overall Study|Adverse Event|1|||
155654711|NCT02799043|561828924|FG000|Overall Study|Death|1|||
155654712|NCT02799043|561828925|FG001|Overall Study|Death|1|||
155654713|NCT02799043|561828924|FG000|Overall Study|Lost to Follow-up|3|||
155654714|NCT02799043|561828925|FG001|Overall Study|Lost to Follow-up|6|||
155654715|NCT02799043|561828924|FG000|Overall Study|Withdrawal by Subject|4|||
155654716|NCT02799043|561828925|FG001|Overall Study|Withdrawal by Subject|4|||
155654717|NCT02799043|561828924|FG000|Overall Study|Moved to different country|0|||
155654718|NCT02799043|561828925|FG001|Overall Study|Moved to different country|1|||
155654719|NCT02799043|561828924|FG000|Overall Study|Trial Screen Failure|1|||
155654720|NCT02799043|561828925|FG001|Overall Study|Trial Screen Failure|0|||
155654721|NCT02799043|561828924|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
155654722|NCT02799043|561828925|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
155654723|NCT02852005|561828928|FG000|Overall Study|Lost to Follow-up|0|||
155654724|NCT02852005|561828929|FG001|Overall Study|Lost to Follow-up|0|||
155654725|NCT02852005|561828930|FG002|Overall Study|Lost to Follow-up|0|||
155654726|NCT02852005|561828931|FG003|Overall Study|Lost to Follow-up|0|||
155654727|NCT02852005|561828932|FG004|Overall Study|Lost to Follow-up|1|||
155654728|NCT02852005|561828928|FG000|Overall Study|Withdrawal by Subject|1|||
155654729|NCT02852005|561828929|FG001|Overall Study|Withdrawal by Subject|0|||
155654730|NCT02852005|561828930|FG002|Overall Study|Withdrawal by Subject|0|||
155654731|NCT02852005|561828931|FG003|Overall Study|Withdrawal by Subject|0|||
155654732|NCT02852005|561828932|FG004|Overall Study|Withdrawal by Subject|0|||
155483411|NCT02988115|561191338|FG001|Overall Study|Sponsor Decision|2|||
155483412|NCT02988115|561191337|FG000|Overall Study|Withdrawal by Subject|1|||
155483413|NCT02988115|561191338|FG001|Overall Study|Withdrawal by Subject|1|||
155483414|NCT02988115|561191337|FG000|Overall Study|Withdrawn by Mistake|1|||
155483415|NCT02988115|561191338|FG001|Overall Study|Withdrawn by Mistake|0|||
155483416|NCT02988115|561191337|FG000|Overall Study|Lost to Follow-up|1|||
155483417|NCT02988115|561191338|FG001|Overall Study|Lost to Follow-up|0|||
155483418|NCT00253747|561191339|FG000|Overall Study|Lost to Follow-up|13|||
155483419|NCT00253747|561191340|FG001|Overall Study|Lost to Follow-up|14|||
155483420|NCT00253747|561191339|FG000|Overall Study|Withdrawal by Subject|10|||
155483421|NCT00253747|561191340|FG001|Overall Study|Withdrawal by Subject|11|||
155483422|NCT00253747|561191339|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
155483423|NCT00253747|561191340|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
155483424|NCT00104299|561191342|FG000|Overall Study|Adverse Event|3|||
155483425|NCT00104299|561191343|FG001|Overall Study|Adverse Event|1|||
155483426|NCT00104299|561191342|FG000|Overall Study|Death|2|||
155483427|NCT00104299|561191343|FG001|Overall Study|Death|2|||
155483428|NCT00104299|561191342|FG000|Overall Study|Withdrawal by Subject|2|||
155483429|NCT00104299|561191343|FG001|Overall Study|Withdrawal by Subject|6|||
155483430|NCT00104299|561191342|FG000|Overall Study|Physician Decision|1|||
155483431|NCT00104299|561191343|FG001|Overall Study|Physician Decision|1|||
155483432|NCT00104299|561191342|FG000|Overall Study|To have renal transplant|1|||
155483433|NCT00104299|561191343|FG001|Overall Study|To have renal transplant|0|||
155483434|NCT02452034|561191344|FG000|Overall Study|Adverse Event|0|||
155483435|NCT02452034|561191345|FG001|Overall Study|Adverse Event|0|||
155483436|NCT02452034|561191346|FG002|Overall Study|Adverse Event|0|||
155483437|NCT02452034|561191347|FG003|Overall Study|Adverse Event|0|||
155483438|NCT02452034|561191348|FG004|Overall Study|Adverse Event|0|||
155483439|NCT02452034|561191349|FG005|Overall Study|Adverse Event|1|||
155483440|NCT02452034|561191344|FG000|Overall Study|Death|0|||
155654733|NCT01922895|561828933|FG000|Overall Study|Death|0|||
155654734|NCT01922895|561828934|FG001|Overall Study|Death|1|||
155654735|NCT01922895|561828933|FG000|Overall Study|Withdrawal by Subject|1|||
155654736|NCT01922895|561828934|FG001|Overall Study|Withdrawal by Subject|2|||
155654737|NCT01922895|561828933|FG000|Overall Study|Lost to Follow-up|5|||
155654738|NCT01922895|561828934|FG001|Overall Study|Lost to Follow-up|11|||
155483441|NCT02452034|561191345|FG001|Overall Study|Death|0|||
155483442|NCT02452034|561191346|FG002|Overall Study|Death|0|||
155483443|NCT02452034|561191347|FG003|Overall Study|Death|0|||
155483444|NCT02452034|561191348|FG004|Overall Study|Death|1|||
155483445|NCT02452034|561191349|FG005|Overall Study|Death|1|||
155483446|NCT02452034|561191344|FG000|Overall Study|Physician Decision|0|||
155483447|NCT02452034|561191345|FG001|Overall Study|Physician Decision|1|||
155654739|NCT01916226|561828935|FG000|Overall Study|Adverse Event|1|||
155483448|NCT02452034|561191346|FG002|Overall Study|Physician Decision|1|||
155483449|NCT02452034|561191347|FG003|Overall Study|Physician Decision|0|||
155483450|NCT02452034|561191348|FG004|Overall Study|Physician Decision|0|||
155483451|NCT02452034|561191349|FG005|Overall Study|Physician Decision|0|||
155483452|NCT02452034|561191344|FG000|Overall Study|Protocol Violation|0|||
155483453|NCT02452034|561191345|FG001|Overall Study|Protocol Violation|0|||
155483454|NCT02452034|561191346|FG002|Overall Study|Protocol Violation|0|||
155483455|NCT02452034|561191347|FG003|Overall Study|Protocol Violation|0|||
155483456|NCT02452034|561191348|FG004|Overall Study|Protocol Violation|0|||
155483457|NCT02452034|561191349|FG005|Overall Study|Protocol Violation|1|||
155483458|NCT02452034|561191344|FG000|Overall Study|Screen Failure|1|||
155483459|NCT02452034|561191345|FG001|Overall Study|Screen Failure|0|||
155483460|NCT02452034|561191346|FG002|Overall Study|Screen Failure|0|||
155483461|NCT02452034|561191347|FG003|Overall Study|Screen Failure|1|||
155483462|NCT02452034|561191348|FG004|Overall Study|Screen Failure|0|||
155483463|NCT02452034|561191349|FG005|Overall Study|Screen Failure|0|||
155483464|NCT02452034|561191344|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
155483465|NCT02452034|561191345|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
155483466|NCT02452034|561191346|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
155483467|NCT02452034|561191347|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
155483468|NCT02452034|561191348|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
155483469|NCT02452034|561191349|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
155483470|NCT03672006|561191353|FG000|Overall Study|exclusion criteria met|0|||
155483471|NCT03672006|561191354|FG001|Overall Study|exclusion criteria met|1|||
155483472|NCT03288987|561191355|FG000|Overall Study|Protocol Violation|10|||
155483473|NCT03288987|561191356|FG001|Overall Study|Protocol Violation|4|||
155483474|NCT02764229|561191358|FG000|Overall Study|Withdrawal by Subject|15|||
155483475|NCT02764229|561191358|FG000|Overall Study|Adverse Event|9|||
155483476|NCT02764229|561191358|FG000|Overall Study|Physician Decision|5|||
155483477|NCT02764229|561191358|FG000|Overall Study|Lost to Follow-up|3|||
155483478|NCT02764229|561191358|FG000|Overall Study|Lack of Efficacy|1|||
155483479|NCT02764229|561191358|FG000|Overall Study|Study Stopped by Sponsor|69|||
155483480|NCT01904760|561191359|FG000|Overall Study|Protocol Violation|1|||
155483481|NCT01904760|561191360|FG001|Overall Study|Protocol Violation|0|||
155483482|NCT00783263|561191361|FG000|Overall Study|Adverse Event|3|||
155483483|NCT00783263|561191362|FG001|Overall Study|Adverse Event|0|||
155483484|NCT00783263|561191363|FG002|Overall Study|Adverse Event|2|||
155483485|NCT00783263|561191364|FG003|Overall Study|Adverse Event|1|||
155483486|NCT00783263|561191361|FG000|Overall Study|Lost to Follow-up|1|||
155483487|NCT00783263|561191362|FG001|Overall Study|Lost to Follow-up|1|||
155483488|NCT00783263|561191363|FG002|Overall Study|Lost to Follow-up|0|||
155483489|NCT00783263|561191364|FG003|Overall Study|Lost to Follow-up|0|||
155483490|NCT00783263|561191361|FG000|Overall Study|Withdrawal by Subject|0|||
155483491|NCT00783263|561191362|FG001|Overall Study|Withdrawal by Subject|1|||
155483492|NCT00783263|561191363|FG002|Overall Study|Withdrawal by Subject|1|||
155483493|NCT00783263|561191364|FG003|Overall Study|Withdrawal by Subject|2|||
155483494|NCT00732199|561191369|FG000|Overall Study|Withdrawal by Subject|25|||
155483495|NCT00732199|561191370|FG001|Overall Study|Withdrawal by Subject|18|||
155483496|NCT00732199|561191369|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
155483497|NCT00732199|561191370|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
155483498|NCT02242305|561191379|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
155483499|NCT02242305|561191380|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
155483500|NCT02242305|561191379|FG000|Overall Study|Adverse Event|1|||
155483501|NCT02242305|561191380|FG001|Overall Study|Adverse Event|0|||
155483502|NCT02242305|561191379|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
155483503|NCT02242305|561191380|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
155483504|NCT02242305|561191379|FG000|Overall Study|Subject withdraws inform consent|0|||
155483505|NCT02242305|561191380|FG001|Overall Study|Subject withdraws inform consent|4|||
155483506|NCT02242305|561191379|FG000|Overall Study|Lost to Follow-up|2|||
155483507|NCT02242305|561191380|FG001|Overall Study|Lost to Follow-up|0|||
155483508|NCT03018028|561191385|FG000|Overall Study|Withdrawal by Subject|3|||
155483509|NCT03018028|561191386|FG001|Overall Study|Withdrawal by Subject|0|||
155483510|NCT03018028|561191387|FG002|Overall Study|Withdrawal by Subject|1|||
155483511|NCT03018028|561191388|FG003|Overall Study|Withdrawal by Subject|2|||
155483512|NCT03018028|561191389|FG004|Overall Study|Withdrawal by Subject|0|||
155483513|NCT02543801|561191391|FG000|Overall Study|Protocol Violation|1|||
155483514|NCT02543801|561191392|FG001|Overall Study|Protocol Violation|2|||
155483515|NCT02543801|561191393|FG002|Overall Study|Protocol Violation|0|||
155483516|NCT02543801|561191394|FG003|Overall Study|Protocol Violation|0|||
155483517|NCT01756846|561191395|FG000|Overall Study|Lost to Follow-up|5|||
155483518|NCT01756846|561191396|FG001|Overall Study|Lost to Follow-up|10|||
155483519|NCT01756846|561191395|FG000|Overall Study|Withdrawal by Subject|1|||
155483520|NCT01756846|561191396|FG001|Overall Study|Withdrawal by Subject|2|||
155483521|NCT03490734|561191405|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
155483522|NCT03490734|561191406|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
155483523|NCT03490734|561191407|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
155483524|NCT03490734|561191408|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
155483525|NCT03490734|561191405|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
155483526|NCT03490734|561191406|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
155483527|NCT03490734|561191407|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
155483528|NCT03490734|561191408|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
155483529|NCT03490734|561191405|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
155483530|NCT03490734|561191406|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
155483531|NCT03490734|561191407|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
155483532|NCT03490734|561191408|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
155483533|NCT03490734|561191405|FG000|Post-intervention Scan Visit|Adverse Event|2|||
155483534|NCT03490734|561191406|FG001|Post-intervention Scan Visit|Adverse Event|0|||
155483535|NCT03490734|561191407|FG002|Post-intervention Scan Visit|Adverse Event|0|||
155483536|NCT03490734|561191408|FG003|Post-intervention Scan Visit|Adverse Event|0|||
155483537|NCT03490734|561191405|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
155483538|NCT03490734|561191406|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
155483539|NCT03490734|561191407|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
155483540|NCT03490734|561191408|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
155483541|NCT03490734|561191405|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
155483542|NCT03490734|561191406|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
155483543|NCT03490734|561191407|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
155483544|NCT03490734|561191408|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
155483545|NCT02692560|561191414|FG000|Overall Study|Withdrawal by Subject|0|||
155483546|NCT02692560|561191415|FG001|Overall Study|Withdrawal by Subject|6|||
155483547|NCT00715949|561191418|FG000|Overall Study|could not finish first test|4|||
155483548|NCT00420212|561191419|FG000|Overall Study|Adverse Event|22|||
155483549|NCT00420212|561191420|FG001|Overall Study|Adverse Event|40|||
155483550|NCT00420212|561191421|FG002|Overall Study|Adverse Event|36|||
155483551|NCT00420212|561191419|FG000|Overall Study|Lost to Follow-up|9|||
155483552|NCT00420212|561191420|FG001|Overall Study|Lost to Follow-up|11|||
155483553|NCT00420212|561191421|FG002|Overall Study|Lost to Follow-up|11|||
155483554|NCT00420212|561191419|FG000|Overall Study|Withdrawal by Subject|31|||
155483555|NCT00420212|561191420|FG001|Overall Study|Withdrawal by Subject|22|||
155483556|NCT00420212|561191421|FG002|Overall Study|Withdrawal by Subject|19|||
155483557|NCT00420212|561191419|FG000|Overall Study|Physician Decision|4|||
155483558|NCT00420212|561191420|FG001|Overall Study|Physician Decision|4|||
155483559|NCT00420212|561191421|FG002|Overall Study|Physician Decision|3|||
155483560|NCT00420212|561191419|FG000|Overall Study|Protocol Violation|4|||
155483561|NCT00420212|561191420|FG001|Overall Study|Protocol Violation|4|||
155483562|NCT00420212|561191421|FG002|Overall Study|Protocol Violation|8|||
155483563|NCT00420212|561191419|FG000|Overall Study|Death|0|||
155483564|NCT00420212|561191420|FG001|Overall Study|Death|0|||
155483565|NCT00420212|561191421|FG002|Overall Study|Death|1|||
155483566|NCT00420212|561191419|FG000|Overall Study|Other-Unspecified|21|||
155483567|NCT00420212|561191420|FG001|Overall Study|Other-Unspecified|14|||
155483568|NCT00420212|561191421|FG002|Overall Study|Other-Unspecified|18|||
155483569|NCT01326910|561191422|FG000|Overall Study|Withdrawal by Subject|3|||
155483570|NCT01326910|561191423|FG001|Overall Study|Withdrawal by Subject|2|||
155483571|NCT01326910|561191422|FG000|Overall Study|Protocol Violation|1|||
155483572|NCT01326910|561191423|FG001|Overall Study|Protocol Violation|1|||
155483573|NCT02274766|561191426|FG000|Overall Study|Withdrawal by Subject|3|||
155483574|NCT02274766|561191427|FG001|Overall Study|Withdrawal by Subject|6|||
155483575|NCT02274766|561191426|FG000|Overall Study|Did Not Receive Study Drug|1|||
155483576|NCT02274766|561191427|FG001|Overall Study|Did Not Receive Study Drug|1|||
155483577|NCT02274766|561191426|FG000|Overall Study|Subject Unwilling to Proceed|0|||
155483578|NCT02274766|561191427|FG001|Overall Study|Subject Unwilling to Proceed|1|||
155483579|NCT02274766|561191426|FG000|Overall Study|Adverse Event|0|||
155483580|NCT02274766|561191427|FG001|Overall Study|Adverse Event|1|||
155483581|NCT02394028|561191430|FG000|Induction Phase|Adverse Event|2|||
155483582|NCT02394028|561191431|FG001|Induction Phase|Adverse Event|4|||
155483583|NCT02394028|561191432|FG002|Induction Phase|Adverse Event|1|||
155483584|NCT02394028|561191433|FG003|Induction Phase|Adverse Event|2|||
155483585|NCT02394028|561191434|FG004|Induction Phase|Adverse Event|5|||
155483586|NCT02394028|561191435|FG005|Induction Phase|Adverse Event|2|||
155483587|NCT02394028|561191436|FG006|Induction Phase|Adverse Event|0|||
155483588|NCT02394028|561191437|FG007|Induction Phase|Adverse Event|0|||
155483589|NCT02394028|561191438|FG008|Induction Phase|Adverse Event|0|||
155483590|NCT02394028|561191439|FG009|Induction Phase|Adverse Event|0|||
155520545|NCT03992196|561330962|FG000|Treatment|Protocol Violation|0|||
155520546|NCT03992196|561330963|FG001|Treatment|Protocol Violation|0|||
155520547|NCT03992196|561330964|FG002|Treatment|Protocol Violation|1|||
155520548|NCT03992196|561330962|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
155520549|NCT03992196|561330963|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
155520550|NCT03992196|561330964|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
155520551|NCT03992196|561330962|FG000|Treatment|Withdrawal due to non-compliance|0|||
155520552|NCT03992196|561330963|FG001|Treatment|Withdrawal due to non-compliance|0|||
155483591|NCT02394028|561191440|FG010|Induction Phase|Adverse Event|0|||
155520553|NCT03992196|561330964|FG002|Treatment|Withdrawal due to non-compliance|1|||
155483592|NCT02394028|561191430|FG000|Induction Phase|Lack of Efficacy|3|||
155483593|NCT02394028|561191431|FG001|Induction Phase|Lack of Efficacy|6|||
155483594|NCT02394028|561191432|FG002|Induction Phase|Lack of Efficacy|2|||
155483595|NCT02394028|561191433|FG003|Induction Phase|Lack of Efficacy|17|||
155483596|NCT02394028|561191434|FG004|Induction Phase|Lack of Efficacy|14|||
155483597|NCT02394028|561191435|FG005|Induction Phase|Lack of Efficacy|8|||
155483598|NCT02394028|561191436|FG006|Induction Phase|Lack of Efficacy|17|||
155483599|NCT02394028|561191437|FG007|Induction Phase|Lack of Efficacy|23|||
155483600|NCT02394028|561191438|FG008|Induction Phase|Lack of Efficacy|0|||
155483601|NCT02394028|561191439|FG009|Induction Phase|Lack of Efficacy|0|||
155483602|NCT02394028|561191440|FG010|Induction Phase|Lack of Efficacy|0|||
155483603|NCT02394028|561191430|FG000|Induction Phase|Lost to Follow-up|1|||
155483604|NCT02394028|561191431|FG001|Induction Phase|Lost to Follow-up|0|||
155483605|NCT02394028|561191432|FG002|Induction Phase|Lost to Follow-up|0|||
155483606|NCT02394028|561191433|FG003|Induction Phase|Lost to Follow-up|1|||
155483607|NCT02394028|561191434|FG004|Induction Phase|Lost to Follow-up|0|||
155483608|NCT02394028|561191435|FG005|Induction Phase|Lost to Follow-up|0|||
155483609|NCT02394028|561191436|FG006|Induction Phase|Lost to Follow-up|1|||
155483610|NCT02394028|561191437|FG007|Induction Phase|Lost to Follow-up|0|||
155483611|NCT02394028|561191438|FG008|Induction Phase|Lost to Follow-up|0|||
155483612|NCT02394028|561191439|FG009|Induction Phase|Lost to Follow-up|0|||
155483613|NCT02394028|561191440|FG010|Induction Phase|Lost to Follow-up|0|||
155483614|NCT02394028|561191430|FG000|Induction Phase|Non-compliance|0|||
155483615|NCT02394028|561191431|FG001|Induction Phase|Non-compliance|1|||
155483616|NCT02394028|561191432|FG002|Induction Phase|Non-compliance|3|||
155483617|NCT02394028|561191433|FG003|Induction Phase|Non-compliance|1|||
155483618|NCT02394028|561191434|FG004|Induction Phase|Non-compliance|3|||
155483619|NCT02394028|561191435|FG005|Induction Phase|Non-compliance|0|||
155483620|NCT02394028|561191436|FG006|Induction Phase|Non-compliance|1|||
155483621|NCT02394028|561191437|FG007|Induction Phase|Non-compliance|1|||
155483622|NCT02394028|561191438|FG008|Induction Phase|Non-compliance|0|||
155483623|NCT02394028|561191439|FG009|Induction Phase|Non-compliance|0|||
155483624|NCT02394028|561191440|FG010|Induction Phase|Non-compliance|0|||
155483625|NCT02394028|561191430|FG000|Induction Phase|Physician Decision|0|||
155483626|NCT02394028|561191431|FG001|Induction Phase|Physician Decision|0|||
155483627|NCT02394028|561191432|FG002|Induction Phase|Physician Decision|1|||
155483628|NCT02394028|561191433|FG003|Induction Phase|Physician Decision|4|||
155483629|NCT02394028|561191434|FG004|Induction Phase|Physician Decision|0|||
155483630|NCT02394028|561191435|FG005|Induction Phase|Physician Decision|2|||
155483631|NCT02394028|561191436|FG006|Induction Phase|Physician Decision|1|||
155520554|NCT03992196|561330962|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
155520555|NCT03992196|561330963|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
155520556|NCT03992196|561330964|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
155520557|NCT03992196|561330962|FG000|Treatment|Withdrawal by parent/guardian|0|||
155520558|NCT03992196|561330963|FG001|Treatment|Withdrawal by parent/guardian|0|||
155520559|NCT03992196|561330964|FG002|Treatment|Withdrawal by parent/guardian|2|||
155520560|NCT00755196|561330966|FG000|Overall Study|Lost to Follow-up|1|||
155654740|NCT01916226|561828936|FG001|Overall Study|Adverse Event|0|||
155654741|NCT01916226|561828937|FG002|Overall Study|Adverse Event|1|||
155483632|NCT02394028|561191437|FG007|Induction Phase|Physician Decision|0|||
155520561|NCT00755196|561330966|FG000|Overall Study|Lack of Efficiency|1|||
155520562|NCT02388763|561330967|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
155520563|NCT02388763|561330968|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
155520564|NCT02388763|561330967|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
155520565|NCT02388763|561330968|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
155520566|NCT00543309|561330969|FG000|Overall Study|Physician Decision|0|||
155483633|NCT02394028|561191438|FG008|Induction Phase|Physician Decision|0|||
155483634|NCT02394028|561191439|FG009|Induction Phase|Physician Decision|0|||
155483635|NCT02394028|561191440|FG010|Induction Phase|Physician Decision|0|||
155483636|NCT02394028|561191430|FG000|Induction Phase|Protocol Violation|0|||
155483637|NCT02394028|561191431|FG001|Induction Phase|Protocol Violation|2|||
155483638|NCT02394028|561191432|FG002|Induction Phase|Protocol Violation|0|||
155483639|NCT02394028|561191433|FG003|Induction Phase|Protocol Violation|3|||
155483640|NCT02394028|561191434|FG004|Induction Phase|Protocol Violation|0|||
155483641|NCT02394028|561191435|FG005|Induction Phase|Protocol Violation|1|||
155483642|NCT02394028|561191436|FG006|Induction Phase|Protocol Violation|1|||
155483643|NCT02394028|561191437|FG007|Induction Phase|Protocol Violation|0|||
155483644|NCT02394028|561191438|FG008|Induction Phase|Protocol Violation|0|||
155483645|NCT02394028|561191439|FG009|Induction Phase|Protocol Violation|0|||
155483646|NCT02394028|561191440|FG010|Induction Phase|Protocol Violation|0|||
155483647|NCT02394028|561191430|FG000|Induction Phase|Withdrawal by Subject|1|||
155483648|NCT02394028|561191431|FG001|Induction Phase|Withdrawal by Subject|2|||
155483649|NCT02394028|561191432|FG002|Induction Phase|Withdrawal by Subject|4|||
155483650|NCT02394028|561191433|FG003|Induction Phase|Withdrawal by Subject|6|||
155483651|NCT02394028|561191434|FG004|Induction Phase|Withdrawal by Subject|7|||
155483652|NCT02394028|561191435|FG005|Induction Phase|Withdrawal by Subject|4|||
155483653|NCT02394028|561191436|FG006|Induction Phase|Withdrawal by Subject|3|||
155483654|NCT02394028|561191437|FG007|Induction Phase|Withdrawal by Subject|6|||
155483655|NCT02394028|561191438|FG008|Induction Phase|Withdrawal by Subject|0|||
155483656|NCT02394028|561191439|FG009|Induction Phase|Withdrawal by Subject|0|||
155483657|NCT02394028|561191440|FG010|Induction Phase|Withdrawal by Subject|0|||
155483658|NCT02394028|561191430|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483659|NCT02394028|561191431|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483660|NCT02394028|561191432|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483661|NCT02394028|561191433|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483662|NCT02394028|561191434|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483663|NCT02394028|561191435|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483664|NCT02394028|561191436|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
155483665|NCT02394028|561191437|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483666|NCT02394028|561191438|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483667|NCT02394028|561191439|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483668|NCT02394028|561191440|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
155483669|NCT02394028|561191430|FG000|Induction Phase|Sponsor decision|0|||
155483670|NCT02394028|561191431|FG001|Induction Phase|Sponsor decision|1|||
155483671|NCT02394028|561191432|FG002|Induction Phase|Sponsor decision|2|||
155483672|NCT02394028|561191433|FG003|Induction Phase|Sponsor decision|0|||
155483673|NCT02394028|561191434|FG004|Induction Phase|Sponsor decision|0|||
155483674|NCT02394028|561191435|FG005|Induction Phase|Sponsor decision|0|||
155483675|NCT02394028|561191436|FG006|Induction Phase|Sponsor decision|0|||
155483676|NCT02394028|561191437|FG007|Induction Phase|Sponsor decision|0|||
155483677|NCT02394028|561191438|FG008|Induction Phase|Sponsor decision|0|||
155483678|NCT02394028|561191439|FG009|Induction Phase|Sponsor decision|0|||
155483679|NCT02394028|561191440|FG010|Induction Phase|Sponsor decision|0|||
155483680|NCT02394028|561191430|FG000|Induction Phase|Technical reason|0|||
155483681|NCT02394028|561191431|FG001|Induction Phase|Technical reason|0|||
155483682|NCT02394028|561191432|FG002|Induction Phase|Technical reason|0|||
155483683|NCT02394028|561191433|FG003|Induction Phase|Technical reason|1|||
155483684|NCT02394028|561191434|FG004|Induction Phase|Technical reason|0|||
155520567|NCT00543309|561330970|FG001|Overall Study|Physician Decision|1|||
155520568|NCT00543309|561330971|FG002|Overall Study|Physician Decision|0|||
155520569|NCT02194998|561330976|FG000|On-HCV Treatment|Did not pick up study medication|0|||
155520570|NCT02194998|561330977|FG001|On-HCV Treatment|Did not pick up study medication|1|||
155520571|NCT02194998|561330978|FG002|On-HCV Treatment|Did not pick up study medication|0|||
155520572|NCT02194998|561330979|FG003|On-HCV Treatment|Did not pick up study medication|0|||
155520573|NCT02194998|561330976|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
155483685|NCT02394028|561191435|FG005|Induction Phase|Technical reason|0|||
155483686|NCT02394028|561191436|FG006|Induction Phase|Technical reason|0|||
155483687|NCT02394028|561191437|FG007|Induction Phase|Technical reason|0|||
155483688|NCT02394028|561191438|FG008|Induction Phase|Technical reason|0|||
155520574|NCT02194998|561330977|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
155520575|NCT02194998|561330978|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
155520576|NCT02194998|561330979|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
155483689|NCT02394028|561191439|FG009|Induction Phase|Technical reason|0|||
155520577|NCT01249664|561330980|FG000|Overall Study|Withdrawal by Subject|5|||
155483690|NCT02394028|561191440|FG010|Induction Phase|Technical reason|0|||
155483691|NCT02394028|561191430|FG000|Induction Phase|:ack of calculation|0|||
155483692|NCT02394028|561191431|FG001|Induction Phase|:ack of calculation|0|||
155483693|NCT02394028|561191432|FG002|Induction Phase|:ack of calculation|0|||
155483694|NCT02394028|561191433|FG003|Induction Phase|:ack of calculation|0|||
155483695|NCT02394028|561191434|FG004|Induction Phase|:ack of calculation|0|||
155483696|NCT02394028|561191435|FG005|Induction Phase|:ack of calculation|0|||
155483697|NCT02394028|561191436|FG006|Induction Phase|:ack of calculation|0|||
155483698|NCT02394028|561191437|FG007|Induction Phase|:ack of calculation|1|||
155483699|NCT02394028|561191438|FG008|Induction Phase|:ack of calculation|0|||
155483700|NCT02394028|561191439|FG009|Induction Phase|:ack of calculation|0|||
155483701|NCT02394028|561191440|FG010|Induction Phase|:ack of calculation|0|||
155483702|NCT02394028|561191430|FG000|Maintenance Phase|Protocol Violation|0|||
155483703|NCT02394028|561191431|FG001|Maintenance Phase|Protocol Violation|0|||
155483704|NCT02394028|561191432|FG002|Maintenance Phase|Protocol Violation|0|||
155483705|NCT02394028|561191433|FG003|Maintenance Phase|Protocol Violation|0|||
155483706|NCT02394028|561191434|FG004|Maintenance Phase|Protocol Violation|0|||
155483707|NCT02394028|561191435|FG005|Maintenance Phase|Protocol Violation|0|||
155483708|NCT02394028|561191436|FG006|Maintenance Phase|Protocol Violation|0|||
155483709|NCT02394028|561191437|FG007|Maintenance Phase|Protocol Violation|0|||
155483710|NCT02394028|561191438|FG008|Maintenance Phase|Protocol Violation|0|||
155483711|NCT02394028|561191439|FG009|Maintenance Phase|Protocol Violation|0|||
155483712|NCT02394028|561191440|FG010|Maintenance Phase|Protocol Violation|1|||
155483713|NCT02394028|561191430|FG000|Maintenance Phase|Physician Decision|0|||
155483714|NCT02394028|561191431|FG001|Maintenance Phase|Physician Decision|0|||
155483715|NCT02394028|561191432|FG002|Maintenance Phase|Physician Decision|0|||
155483716|NCT02394028|561191433|FG003|Maintenance Phase|Physician Decision|0|||
155483717|NCT02394028|561191434|FG004|Maintenance Phase|Physician Decision|0|||
155483718|NCT02394028|561191435|FG005|Maintenance Phase|Physician Decision|0|||
155483719|NCT02394028|561191436|FG006|Maintenance Phase|Physician Decision|0|||
155483720|NCT02394028|561191437|FG007|Maintenance Phase|Physician Decision|0|||
155483721|NCT02394028|561191438|FG008|Maintenance Phase|Physician Decision|1|||
155483722|NCT02394028|561191439|FG009|Maintenance Phase|Physician Decision|3|||
155483723|NCT02394028|561191440|FG010|Maintenance Phase|Physician Decision|2|||
155483724|NCT02394028|561191430|FG000|Maintenance Phase|Lack of Efficacy|0|||
155483725|NCT02394028|561191431|FG001|Maintenance Phase|Lack of Efficacy|0|||
155483726|NCT02394028|561191432|FG002|Maintenance Phase|Lack of Efficacy|0|||
155483727|NCT02394028|561191433|FG003|Maintenance Phase|Lack of Efficacy|0|||
155483728|NCT02394028|561191434|FG004|Maintenance Phase|Lack of Efficacy|0|||
155483729|NCT02394028|561191435|FG005|Maintenance Phase|Lack of Efficacy|0|||
155483730|NCT02394028|561191436|FG006|Maintenance Phase|Lack of Efficacy|0|||
155483731|NCT02394028|561191437|FG007|Maintenance Phase|Lack of Efficacy|0|||
155483732|NCT02394028|561191438|FG008|Maintenance Phase|Lack of Efficacy|7|||
155483733|NCT02394028|561191439|FG009|Maintenance Phase|Lack of Efficacy|25|||
155483734|NCT02394028|561191440|FG010|Maintenance Phase|Lack of Efficacy|33|||
155483735|NCT02394028|561191430|FG000|Maintenance Phase|Death|0|||
155483736|NCT02394028|561191431|FG001|Maintenance Phase|Death|0|||
155483737|NCT02394028|561191432|FG002|Maintenance Phase|Death|0|||
155483738|NCT02394028|561191433|FG003|Maintenance Phase|Death|0|||
155483739|NCT02394028|561191434|FG004|Maintenance Phase|Death|0|||
155483740|NCT02394028|561191435|FG005|Maintenance Phase|Death|0|||
155483741|NCT02394028|561191436|FG006|Maintenance Phase|Death|0|||
155483742|NCT02394028|561191437|FG007|Maintenance Phase|Death|0|||
155483743|NCT02394028|561191438|FG008|Maintenance Phase|Death|0|||
155483744|NCT02394028|561191439|FG009|Maintenance Phase|Death|0|||
155483745|NCT02394028|561191440|FG010|Maintenance Phase|Death|1|||
155483746|NCT02394028|561191430|FG000|Maintenance Phase|Adverse Event|0|||
155483747|NCT02394028|561191431|FG001|Maintenance Phase|Adverse Event|0|||
155483748|NCT02394028|561191432|FG002|Maintenance Phase|Adverse Event|0|||
155483749|NCT02394028|561191433|FG003|Maintenance Phase|Adverse Event|0|||
155483750|NCT02394028|561191434|FG004|Maintenance Phase|Adverse Event|0|||
155483751|NCT02394028|561191435|FG005|Maintenance Phase|Adverse Event|0|||
155483752|NCT02394028|561191436|FG006|Maintenance Phase|Adverse Event|0|||
155483753|NCT02394028|561191437|FG007|Maintenance Phase|Adverse Event|0|||
155483754|NCT02394028|561191438|FG008|Maintenance Phase|Adverse Event|1|||
155483755|NCT02394028|561191439|FG009|Maintenance Phase|Adverse Event|1|||
155483756|NCT02394028|561191440|FG010|Maintenance Phase|Adverse Event|3|||
155483757|NCT02394028|561191430|FG000|Maintenance Phase|Site closure|0|||
155483758|NCT02394028|561191431|FG001|Maintenance Phase|Site closure|0|||
155483759|NCT02394028|561191432|FG002|Maintenance Phase|Site closure|0|||
155483760|NCT02394028|561191433|FG003|Maintenance Phase|Site closure|0|||
155483761|NCT02394028|561191434|FG004|Maintenance Phase|Site closure|0|||
155483762|NCT02394028|561191435|FG005|Maintenance Phase|Site closure|0|||
155483763|NCT02394028|561191436|FG006|Maintenance Phase|Site closure|0|||
155483764|NCT02394028|561191437|FG007|Maintenance Phase|Site closure|0|||
155483765|NCT02394028|561191438|FG008|Maintenance Phase|Site closure|0|||
155483766|NCT02394028|561191439|FG009|Maintenance Phase|Site closure|1|||
155483767|NCT02394028|561191440|FG010|Maintenance Phase|Site closure|0|||
155483768|NCT02394028|561191430|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155483769|NCT02394028|561191431|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155483770|NCT02394028|561191432|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155483771|NCT02394028|561191433|FG003|Maintenance Phase|Withdrawal by Subject|0|||
155483772|NCT02394028|561191434|FG004|Maintenance Phase|Withdrawal by Subject|0|||
155483773|NCT02394028|561191435|FG005|Maintenance Phase|Withdrawal by Subject|0|||
155483774|NCT02394028|561191436|FG006|Maintenance Phase|Withdrawal by Subject|0|||
155483775|NCT02394028|561191437|FG007|Maintenance Phase|Withdrawal by Subject|0|||
155483776|NCT02394028|561191438|FG008|Maintenance Phase|Withdrawal by Subject|3|||
155483777|NCT02394028|561191439|FG009|Maintenance Phase|Withdrawal by Subject|12|||
155483778|NCT02394028|561191440|FG010|Maintenance Phase|Withdrawal by Subject|12|||
155483779|NCT00866606|561191442|FG000|Overall Study|Lost to Follow-up|3|||
155483780|NCT00866606|561191442|FG000|Overall Study|Adverse Event|1|||
155483781|NCT04129242|561191444|FG000|Overall Study|Physician Decision|1|||
155483782|NCT04129242|561191445|FG001|Overall Study|Physician Decision|1|||
155483783|NCT04129242|561191444|FG000|Overall Study|Protocol Violation|0|||
155483784|NCT04129242|561191445|FG001|Overall Study|Protocol Violation|1|||
155483785|NCT00806494|561191449|FG000|Overall Study|Adverse Event|29|||
155483786|NCT00806494|561191449|FG000|Overall Study|Lack of Efficacy|6|||
155483787|NCT00806494|561191449|FG000|Overall Study|Lost to Follow-up|10|||
155483788|NCT00806494|561191449|FG000|Overall Study|Other|30|||
155483789|NCT00806494|561191449|FG000|Overall Study|Withdrawal by Subject|5|||
155483790|NCT02504424|561191452|FG000|Overall Study|Withdrawal by Subject|2|||
155483791|NCT00426842|561191453|FG000|Overall Study|Lost to Follow-up|1|||
155483792|NCT01230827|561191454|FG000|Overall Study|Lost to Follow-up|0|||
155483793|NCT01230827|561191455|FG001|Overall Study|Lost to Follow-up|0|||
155483794|NCT01230827|561191456|FG002|Overall Study|Lost to Follow-up|1|||
155483795|NCT01230827|561191457|FG003|Overall Study|Lost to Follow-up|3|||
155483796|NCT01230827|561191454|FG000|Overall Study|Withdrawal by Subject|1|||
155483797|NCT01230827|561191455|FG001|Overall Study|Withdrawal by Subject|0|||
155483798|NCT01230827|561191456|FG002|Overall Study|Withdrawal by Subject|3|||
155483799|NCT01230827|561191457|FG003|Overall Study|Withdrawal by Subject|2|||
155483800|NCT01230827|561191454|FG000|Overall Study|Lack of Efficacy|14|||
155483801|NCT01230827|561191455|FG001|Overall Study|Lack of Efficacy|1|||
155483802|NCT01230827|561191456|FG002|Overall Study|Lack of Efficacy|2|||
155483803|NCT01230827|561191457|FG003|Overall Study|Lack of Efficacy|3|||
155483804|NCT01230827|561191454|FG000|Overall Study|Adverse Event|4|||
155483805|NCT01230827|561191455|FG001|Overall Study|Adverse Event|2|||
155483806|NCT01230827|561191456|FG002|Overall Study|Adverse Event|3|||
155483807|NCT01230827|561191457|FG003|Overall Study|Adverse Event|7|||
155483808|NCT01230827|561191454|FG000|Overall Study|Recovery|0|||
155483809|NCT01230827|561191455|FG001|Overall Study|Recovery|6|||
155483810|NCT01230827|561191456|FG002|Overall Study|Recovery|0|||
155483811|NCT01230827|561191457|FG003|Overall Study|Recovery|0|||
155483812|NCT01230827|561191454|FG000|Overall Study|Study terminated by Sponsor|0|||
155483813|NCT01230827|561191455|FG001|Overall Study|Study terminated by Sponsor|2|||
155483814|NCT01230827|561191456|FG002|Overall Study|Study terminated by Sponsor|56|||
155483815|NCT01230827|561191457|FG003|Overall Study|Study terminated by Sponsor|63|||
155483816|NCT00805142|561191458|FG000|Titration Period|Adverse Event|3|||
155483817|NCT00805142|561191459|FG001|Titration Period|Adverse Event|3|||
155483818|NCT00805142|561191458|FG000|Titration Period|Lack of Efficacy|1|||
155483819|NCT00805142|561191459|FG001|Titration Period|Lack of Efficacy|1|||
155483820|NCT00805142|561191458|FG000|Titration Period|Lost to Follow-up|0|||
155483821|NCT00805142|561191459|FG001|Titration Period|Lost to Follow-up|1|||
155483822|NCT00805142|561191458|FG000|Titration Period|Disease Progression|2|||
155483823|NCT00805142|561191459|FG001|Titration Period|Disease Progression|1|||
155483824|NCT00805142|561191458|FG000|Titration Period|Withdrawal of consent|0|||
155483825|NCT00805142|561191459|FG001|Titration Period|Withdrawal of consent|1|||
155483826|NCT00805142|561191458|FG000|Titration Period|Other|0|||
155483827|NCT00805142|561191459|FG001|Titration Period|Other|3|||
155483828|NCT00805142|561191458|FG000|Maintenance Period|Adverse Event|0|||
155483829|NCT00805142|561191459|FG001|Maintenance Period|Adverse Event|1|||
155483830|NCT00805142|561191458|FG000|Maintenance Period|Other|0|||
155483831|NCT00805142|561191459|FG001|Maintenance Period|Other|1|||
155483832|NCT00424463|561191460|FG000|Overall Study|Adverse Event|2|||
155483833|NCT00424463|561191461|FG001|Overall Study|Adverse Event|3|||
155483834|NCT00424463|561191462|FG002|Overall Study|Adverse Event|2|||
155483835|NCT00424463|561191460|FG000|Overall Study|Physician Decision|0|||
155483836|NCT00424463|561191461|FG001|Overall Study|Physician Decision|2|||
155483837|NCT00424463|561191462|FG002|Overall Study|Physician Decision|2|||
155483838|NCT00424463|561191460|FG000|Overall Study|Withdrawal by Subject|4|||
155483839|NCT00424463|561191461|FG001|Overall Study|Withdrawal by Subject|2|||
155483840|NCT00424463|561191462|FG002|Overall Study|Withdrawal by Subject|5|||
155483841|NCT00424463|561191460|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
155483842|NCT00424463|561191461|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
155483843|NCT00424463|561191462|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
155483844|NCT00424463|561191460|FG000|Overall Study|Patient's convenience|0|||
155483845|NCT00424463|561191461|FG001|Overall Study|Patient's convenience|0|||
155483846|NCT00424463|561191462|FG002|Overall Study|Patient's convenience|1|||
155483847|NCT02927990|561193644|FG000|Overall Study|Protocol Violation|4|||
155483848|NCT02927990|561193644|FG000|Overall Study|Physician Decision|9|||
155483849|NCT02927990|561193644|FG000|Overall Study|Room switched and therefore no study device available|15|||
155483850|NCT02927990|561193644|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
155483851|NCT00960323|561193645|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
155483852|NCT00772031|561193649|FG000|Overall Study|Early termination of trial|12|||
155483853|NCT00772031|561193650|FG001|Overall Study|Early termination of trial|10|||
155483854|NCT00772031|561193649|FG000|Overall Study|Lost to Follow-up|20|||
155483855|NCT00772031|561193650|FG001|Overall Study|Lost to Follow-up|33|||
155483856|NCT02194699|561193655|FG000|Randomised|Did not receive treatment|1|||
155483857|NCT02194699|561193656|FG001|Randomised|Did not receive treatment|5|||
155483858|NCT02194699|561193655|FG000|Randomised|Without potential for 52 weeks of IP|5|||
155483859|NCT02194699|561193656|FG001|Randomised|Without potential for 52 weeks of IP|5|||
155483860|NCT02194699|561193655|FG000|Randomised|Duplicate patient|2|||
155483861|NCT02194699|561193656|FG001|Randomised|Duplicate patient|1|||
155483862|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
155483863|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
155483864|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
155483865|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
155483866|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
155483867|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
155483868|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
155483869|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
155483870|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
155483871|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
155483872|NCT02194699|561193655|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
155483873|NCT02194699|561193656|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
155483874|NCT02719028|561193657|FG000|Overall Study|Adverse Event|2|||
155483875|NCT02719028|561193658|FG001|Overall Study|Adverse Event|1|||
155483876|NCT02719028|561193659|FG002|Overall Study|Adverse Event|4|||
155483877|NCT02719028|561193660|FG003|Overall Study|Adverse Event|8|||
155483878|NCT02719028|561193657|FG000|Overall Study|Physician Decision|0|||
155483879|NCT02719028|561193658|FG001|Overall Study|Physician Decision|1|||
155483880|NCT02719028|561193659|FG002|Overall Study|Physician Decision|1|||
155483881|NCT02719028|561193660|FG003|Overall Study|Physician Decision|1|||
155483882|NCT02719028|561193657|FG000|Overall Study|Use of prohibited medication|0|||
155483883|NCT02719028|561193658|FG001|Overall Study|Use of prohibited medication|0|||
155483884|NCT02719028|561193659|FG002|Overall Study|Use of prohibited medication|1|||
155483885|NCT02719028|561193660|FG003|Overall Study|Use of prohibited medication|0|||
155483886|NCT02719028|561193657|FG000|Overall Study|Protocol Violation|0|||
155483887|NCT02719028|561193658|FG001|Overall Study|Protocol Violation|0|||
155483888|NCT02719028|561193659|FG002|Overall Study|Protocol Violation|0|||
155483889|NCT02719028|561193660|FG003|Overall Study|Protocol Violation|1|||
155483890|NCT03287960|561193661|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
155483891|NCT03287960|561193661|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
155483892|NCT01191190|561193662|FG000|Overall Study|Withdrawal by Subject|1|||
155483893|NCT01667731|561193664|FG000|Overall Study|Enrolled but not treated|0|||
155483894|NCT01667731|561193665|FG001|Overall Study|Enrolled but not treated|0|||
155483895|NCT01667731|561193666|FG002|Overall Study|Enrolled but not treated|0|||
155483896|NCT01667731|561193667|FG003|Overall Study|Enrolled but not treated|0|||
155483897|NCT01667731|561193668|FG004|Overall Study|Enrolled but not treated|1|||
155483898|NCT01667731|561193664|FG000|Overall Study|Efficacy Failure|1|||
155483899|NCT01667731|561193665|FG001|Overall Study|Efficacy Failure|12|||
155520578|NCT01249664|561330981|FG001|Overall Study|Withdrawal by Subject|0|||
155520579|NCT01249664|561330980|FG000|Overall Study|Adverse Event|1|||
155520580|NCT01249664|561330981|FG001|Overall Study|Adverse Event|0|||
155520581|NCT00525590|561330982|FG000|Overall Study|Adverse Event|3|||
155520582|NCT00525590|561330982|FG000|Overall Study|Physician Decision|3|||
155483900|NCT01667731|561193666|FG002|Overall Study|Efficacy Failure|0|||
155483901|NCT01667731|561193667|FG003|Overall Study|Efficacy Failure|1|||
155483902|NCT01667731|561193668|FG004|Overall Study|Efficacy Failure|24|||
155483903|NCT01667731|561193664|FG000|Overall Study|Lost to Follow-up|2|||
155483904|NCT01667731|561193665|FG001|Overall Study|Lost to Follow-up|3|||
155483905|NCT01667731|561193666|FG002|Overall Study|Lost to Follow-up|1|||
155483906|NCT01667731|561193667|FG003|Overall Study|Lost to Follow-up|1|||
155483907|NCT01667731|561193668|FG004|Overall Study|Lost to Follow-up|2|||
155483908|NCT01667731|561193664|FG000|Overall Study|Subject Withdrew Consent|2|||
155483909|NCT01667731|561193665|FG001|Overall Study|Subject Withdrew Consent|0|||
155483910|NCT01667731|561193666|FG002|Overall Study|Subject Withdrew Consent|1|||
155483911|NCT01667731|561193667|FG003|Overall Study|Subject Withdrew Consent|0|||
155483912|NCT01667731|561193668|FG004|Overall Study|Subject Withdrew Consent|1|||
155483913|NCT01667731|561193664|FG000|Overall Study|Death|0|||
155483914|NCT01667731|561193665|FG001|Overall Study|Death|1|||
155483915|NCT01667731|561193666|FG002|Overall Study|Death|0|||
155483916|NCT01667731|561193667|FG003|Overall Study|Death|0|||
155483917|NCT01667731|561193668|FG004|Overall Study|Death|0|||
155483918|NCT00561912|561193669|FG000|Overall Study|ineligible|1|||
155483919|NCT01977651|561193670|FG000|4 Month Treatment Period|Adverse Event|34|||
155483920|NCT01977651|561193670|FG000|4 Month Treatment Period|Death|3|||
155483921|NCT01977651|561193670|FG000|4 Month Treatment Period|Progressive Disease|43|||
155483922|NCT01977651|561193670|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
155483923|NCT01977651|561193670|FG000|4 Month Treatment Period|Physician Decision|4|||
155483924|NCT01977651|561193670|FG000|1 Year Extension Period|Adverse Event|14|||
155483925|NCT01977651|561193670|FG000|1 Year Extension Period|Death|10|||
155483926|NCT01977651|561193670|FG000|1 Year Extension Period|Lost to Follow-up|2|||
155483927|NCT01977651|561193670|FG000|1 Year Extension Period|Progressive Disease|86|||
155483928|NCT01977651|561193670|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
155483929|NCT01977651|561193670|FG000|1 Year Extension Period|Physician Decision|6|||
155483930|NCT01977651|561193670|FG000|1 Year Extension Period|Miscellaneous|1|||
155654742|NCT01916226|561828938|FG003|Overall Study|Adverse Event|1|||
155483931|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Adverse Event|5|||
155483932|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Death|13|||
155483933|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
155483934|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
155483935|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Physician Decision|4|||
155483936|NCT01977651|561193670|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
155483937|NCT03287089|561193675|FG000|Overall Study|Lost to Follow-up|0|||
155483938|NCT03287089|561193676|FG001|Overall Study|Lost to Follow-up|2|||
155483939|NCT03287089|561193675|FG000|Overall Study|Physician Decision|0|||
155483940|NCT03287089|561193676|FG001|Overall Study|Physician Decision|2|||
155483941|NCT03287089|561193675|FG000|Overall Study|Withdrawal by Subject|0|||
155483942|NCT03287089|561193676|FG001|Overall Study|Withdrawal by Subject|2|||
155483943|NCT01729559|561193677|FG000|Overall Study|Protocol Violation|31|||
155483944|NCT01729559|561193678|FG001|Overall Study|Protocol Violation|28|||
155483945|NCT04249076|561193699|FG000|Overall Study|Adverse Event|1|||
155483946|NCT04249076|561193700|FG001|Overall Study|Adverse Event|1|||
155483947|NCT04249076|561193699|FG000|Overall Study|Protocol Violation|1|||
155483948|NCT04249076|561193700|FG001|Overall Study|Protocol Violation|2|||
155483949|NCT04249076|561193699|FG000|Overall Study|Lack of Efficacy|0|||
155483950|NCT04249076|561193700|FG001|Overall Study|Lack of Efficacy|1|||
155483951|NCT04249076|561193699|FG000|Overall Study|Withdrawal by Subject|0|||
155483952|NCT04249076|561193700|FG001|Overall Study|Withdrawal by Subject|1|||
155483953|NCT00265382|561193704|FG000|Overall Study|Adverse Event|21|||
155483954|NCT00265382|561193704|FG000|Overall Study|Laboratory Abnormality|1|||
155483955|NCT00265382|561193704|FG000|Overall Study|Lost to Follow-up|3|||
155483956|NCT00265382|561193704|FG000|Overall Study|Lack of Efficacy|6|||
155483957|NCT00265382|561193704|FG000|Overall Study|Miscellaneous|6|||
155483958|NCT00265382|561193704|FG000|Overall Study|Withdrawal by Subject|13|||
155483959|NCT00265382|561193704|FG000|Overall Study|Study terminated by sponsor|94|||
155483960|NCT00265382|561193704|FG000|Overall Study|Death|1|||
155483961|NCT00082628|561193712|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
155483962|NCT00082628|561193713|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
155483963|NCT00082628|561193714|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
155483964|NCT00082628|561193715|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
155483965|NCT00082628|561193716|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
155483966|NCT00082628|561193712|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
155491236|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
155654743|NCT01916226|561828935|FG000|Overall Study|Lack of Efficacy|0|||
155491237|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
155520583|NCT00525590|561330982|FG000|Overall Study|Withdrawal by Subject|16|||
155520584|NCT00525590|561330982|FG000|Overall Study|Lost to Follow-up|1|||
155520585|NCT00525590|561330982|FG000|Overall Study|Death|9|||
155520586|NCT00525590|561330982|FG000|Overall Study|Other|13|||
155520587|NCT00860405|561330989|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
155520588|NCT00860405|561330990|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
155520589|NCT01074554|561330994|FG000|Overall Study|Adverse Event|3|||
155520590|NCT01074554|561330995|FG001|Overall Study|Adverse Event|3|||
155520591|NCT01074554|561330994|FG000|Overall Study|Lost to Follow-up|0|||
155520592|NCT01074554|561330995|FG001|Overall Study|Lost to Follow-up|1|||
155520593|NCT00497796|561330996|FG000|Overall Study|Adverse event (not related)|9|||
155520594|NCT00497796|561330997|FG001|Overall Study|Adverse event (not related)|9|||
155520595|NCT00497796|561330996|FG000|Overall Study|Adverse event (related)|5|||
155520596|NCT00497796|561330997|FG001|Overall Study|Adverse event (related)|4|||
155520597|NCT00497796|561330996|FG000|Overall Study|CMV infection or disease treatment|30|||
155520598|NCT00497796|561330997|FG001|Overall Study|CMV infection or disease treatment|4|||
155520599|NCT00497796|561330996|FG000|Overall Study|Consent withdrawn|10|||
155520600|NCT00497796|561330997|FG001|Overall Study|Consent withdrawn|3|||
155520601|NCT00497796|561330996|FG000|Overall Study|Investigator/sponsor discretion|31|||
155483967|NCT00082628|561193713|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
155483968|NCT00082628|561193714|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
155483969|NCT00082628|561193715|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
155483970|NCT00082628|561193716|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
155483971|NCT00082628|561193712|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
155483972|NCT00082628|561193713|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
155483973|NCT00082628|561193714|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
155483974|NCT00082628|561193715|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
155483975|NCT00082628|561193716|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
155483976|NCT00082628|561193712|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
155483977|NCT00082628|561193713|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
155483978|NCT00082628|561193714|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
155483979|NCT00082628|561193715|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
155483980|NCT00082628|561193716|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
155483981|NCT00082628|561193712|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
155483982|NCT00082628|561193713|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
155483983|NCT00082628|561193714|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
155483984|NCT00082628|561193715|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
155483985|NCT00082628|561193716|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
155483986|NCT00082628|561193712|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
155483987|NCT00082628|561193713|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
155483988|NCT00082628|561193714|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
155483989|NCT00082628|561193715|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
155483990|NCT00082628|561193716|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
155483991|NCT00082628|561193712|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
155483992|NCT00082628|561193713|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
155483993|NCT00082628|561193714|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
155483994|NCT00082628|561193715|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
155483995|NCT00082628|561193716|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
155483996|NCT03481634|561193721|FG000|Overall Study|Withdrawal by Subject|16|||
155483997|NCT03481634|561193722|FG001|Overall Study|Withdrawal by Subject|19|||
155483998|NCT03481634|561193723|FG002|Overall Study|Withdrawal by Subject|14|||
155483999|NCT03481634|561193721|FG000|Overall Study|Protocol Violation|1|||
155484000|NCT03481634|561193722|FG001|Overall Study|Protocol Violation|0|||
155484001|NCT03481634|561193723|FG002|Overall Study|Protocol Violation|1|||
155484002|NCT03481634|561193721|FG000|Overall Study|Progressive disease|0|||
155484003|NCT03481634|561193722|FG001|Overall Study|Progressive disease|1|||
155484004|NCT03481634|561193723|FG002|Overall Study|Progressive disease|0|||
155484005|NCT03481634|561193721|FG000|Overall Study|Physician Decision|3|||
155520602|NCT00497796|561330997|FG001|Overall Study|Investigator/sponsor discretion|34|||
155520603|NCT00497796|561330996|FG000|Overall Study|Lost to Follow-up|0|||
155520604|NCT00497796|561330997|FG001|Overall Study|Lost to Follow-up|1|||
155520605|NCT00497796|561330996|FG000|Overall Study|Not applicable (randomized not treated)|0|||
155520606|NCT00497796|561330997|FG001|Overall Study|Not applicable (randomized not treated)|4|||
155520607|NCT00220337|561330999|FG000|Overall Study|Adverse Event|70|||
155520608|NCT00220337|561330999|FG000|Overall Study|Lack of Efficacy|17|||
155520609|NCT00220337|561330999|FG000|Overall Study|Withdrawal by Subject|68|||
155520610|NCT00220337|561330999|FG000|Overall Study|Protocol Violation|2|||
155520611|NCT00220337|561330999|FG000|Overall Study|Lost to Follow-up|5|||
155654744|NCT01916226|561828936|FG001|Overall Study|Lack of Efficacy|0|||
155654745|NCT01916226|561828937|FG002|Overall Study|Lack of Efficacy|2|||
155654746|NCT01916226|561828938|FG003|Overall Study|Lack of Efficacy|1|||
155654747|NCT01916226|561828935|FG000|Overall Study|Protocol Violation|0|||
155484006|NCT03481634|561193722|FG001|Overall Study|Physician Decision|0|||
155484007|NCT03481634|561193723|FG002|Overall Study|Physician Decision|1|||
155484008|NCT03481634|561193721|FG000|Overall Study|Lost to Follow-up|3|||
155484009|NCT03481634|561193722|FG001|Overall Study|Lost to Follow-up|4|||
155484010|NCT03481634|561193723|FG002|Overall Study|Lost to Follow-up|4|||
155484011|NCT03481634|561193721|FG000|Overall Study|Death|4|||
155484012|NCT03481634|561193722|FG001|Overall Study|Death|8|||
155484013|NCT03481634|561193723|FG002|Overall Study|Death|7|||
155484014|NCT03481634|561193721|FG000|Overall Study|Adverse Event|6|||
155484015|NCT03481634|561193722|FG001|Overall Study|Adverse Event|3|||
155484016|NCT03481634|561193723|FG002|Overall Study|Adverse Event|7|||
155484017|NCT01849289|561193729|FG000|Overall Study|Adverse Event|3|||
155484018|NCT01849289|561193730|FG001|Overall Study|Adverse Event|3|||
155484019|NCT01849289|561193729|FG000|Overall Study|Protocol Violation|3|||
155484020|NCT01849289|561193730|FG001|Overall Study|Protocol Violation|3|||
155484021|NCT01849289|561193729|FG000|Overall Study|Withdrawal criteria|1|||
155484022|NCT01849289|561193730|FG001|Overall Study|Withdrawal criteria|0|||
155484023|NCT01849289|561193729|FG000|Overall Study|Unclassified|25|||
155484024|NCT01849289|561193730|FG001|Overall Study|Unclassified|18|||
155484025|NCT00352027|561193731|FG000|Overall Study|Progressive disease|3|||
155484026|NCT04491591|561193732|FG000|Overall Study|Accidently randomized|3|||
155484027|NCT04491591|561193733|FG001|Overall Study|Accidently randomized|1|||
155484028|NCT04491591|561193734|FG002|Overall Study|Accidently randomized|0|||
155484029|NCT04491591|561193732|FG000|Overall Study|Did not complete survey|28|||
155484030|NCT04491591|561193733|FG001|Overall Study|Did not complete survey|20|||
155484031|NCT04491591|561193734|FG002|Overall Study|Did not complete survey|3|||
155484032|NCT03099304|561193735|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
155484033|NCT03099304|561193736|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
155484034|NCT03099304|561193737|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
155484035|NCT03099304|561193738|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
155484036|NCT03099304|561193739|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
155484037|NCT03099304|561193740|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
155484038|NCT03099304|561193735|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
155484039|NCT03099304|561193736|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
155484040|NCT03099304|561193737|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
155484041|NCT03099304|561193738|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
155654748|NCT01916226|561828936|FG001|Overall Study|Protocol Violation|1|||
155484042|NCT03099304|561193739|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
155484043|NCT03099304|561193740|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
155484044|NCT03099304|561193735|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
155484045|NCT03099304|561193736|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
155484046|NCT03099304|561193737|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
155484047|NCT03099304|561193738|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
155484048|NCT03099304|561193739|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
155484049|NCT03099304|561193740|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
155484050|NCT03099304|561193735|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
155484051|NCT03099304|561193736|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
155484052|NCT03099304|561193737|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
155484053|NCT03099304|561193738|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
155484054|NCT03099304|561193739|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
155484055|NCT03099304|561193740|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
155484056|NCT03099304|561193735|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
155484057|NCT03099304|561193736|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
155484058|NCT03099304|561193737|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
155484059|NCT03099304|561193738|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
155484060|NCT03099304|561193739|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
155654749|NCT01916226|561828937|FG002|Overall Study|Protocol Violation|0|||
155654750|NCT01916226|561828938|FG003|Overall Study|Protocol Violation|1|||
155654751|NCT01916226|561828935|FG000|Overall Study|Physician Decision|0|||
155654752|NCT01916226|561828936|FG001|Overall Study|Physician Decision|0|||
155654753|NCT01916226|561828937|FG002|Overall Study|Physician Decision|0|||
155654754|NCT01916226|561828938|FG003|Overall Study|Physician Decision|1|||
155484061|NCT03099304|561193740|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
155484062|NCT03099304|561193735|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
155484063|NCT03099304|561193736|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
155484064|NCT03099304|561193737|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
155484065|NCT03099304|561193738|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
155484066|NCT03099304|561193739|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
155484067|NCT03099304|561193740|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
155484068|NCT03099304|561193735|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
155654755|NCT00979407|561828939|FG000|Overall Study|Withdrawal by Subject|3|||
155484069|NCT03099304|561193736|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
155484070|NCT03099304|561193737|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
155484071|NCT03099304|561193738|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
155484072|NCT03099304|561193739|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
155484073|NCT03099304|561193740|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
155484074|NCT03099304|561193735|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
155484075|NCT03099304|561193736|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
155484076|NCT03099304|561193737|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
155484077|NCT03099304|561193738|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
155484078|NCT03099304|561193739|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
155484079|NCT03099304|561193740|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
155484080|NCT03099304|561193735|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
155484081|NCT03099304|561193736|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
155484082|NCT03099304|561193737|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
155484083|NCT03099304|561193738|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
155484084|NCT03099304|561193739|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
155484085|NCT03099304|561193740|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
155484086|NCT03099304|561193735|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
155484087|NCT03099304|561193736|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
155484088|NCT03099304|561193737|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
155484089|NCT03099304|561193738|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
155484090|NCT03099304|561193739|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
155484091|NCT03099304|561193740|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
155484092|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
155484093|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
155484094|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
155484095|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
155484096|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
155484097|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
155484098|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
155484099|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
155484100|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
155484101|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
155484102|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
155484103|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
155484104|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
155484105|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
155484106|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
155484107|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
155484108|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
155484109|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
155484110|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
155484111|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
155484112|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
155484113|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
155484114|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
155484115|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
155484116|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
155484117|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
155484118|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
155484119|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
155484120|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
155484121|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
155484122|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
155520612|NCT00220337|561330999|FG000|Overall Study|Other|12|||
155520613|NCT00220337|561330999|FG000|Overall Study|Unsatisfactory compliance|5|||
155520614|NCT03661528|561331000|FG000|Overall Study|Death|1|||
155520615|NCT03661528|561331001|FG001|Overall Study|Death|0|||
155520616|NCT03661528|561331000|FG000|Overall Study|Physician Decision|3|||
155520617|NCT03661528|561331001|FG001|Overall Study|Physician Decision|1|||
155520618|NCT03661528|561331000|FG000|Overall Study|Other than Specified|5|||
155520619|NCT03661528|561331001|FG001|Overall Study|Other than Specified|2|||
155520620|NCT03661528|561331000|FG000|Overall Study|Withdrawal by Subject|5|||
155520621|NCT03661528|561331001|FG001|Overall Study|Withdrawal by Subject|3|||
155520622|NCT03661528|561331000|FG000|Overall Study|Disease Progression|8|||
155520623|NCT03661528|561331001|FG001|Overall Study|Disease Progression|13|||
155654756|NCT00979407|561828940|FG001|Overall Study|Withdrawal by Subject|4|||
155484123|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
155484124|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
155520624|NCT03661528|561331000|FG000|Overall Study|Adverse Event|61|||
155484125|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
155484126|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
155484127|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
155484128|NCT03099304|561193735|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
155484129|NCT03099304|561193736|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
155484130|NCT03099304|561193737|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
155484131|NCT03099304|561193738|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
155484132|NCT03099304|561193739|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
155484133|NCT03099304|561193740|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
155484134|NCT02142712|561193741|FG000|Overall Study|Lost to Follow-up|1|||
155484135|NCT02142712|561193742|FG001|Overall Study|Lost to Follow-up|1|||
155484136|NCT02142712|561193743|FG002|Overall Study|Lost to Follow-up|1|||
155484137|NCT02142712|561193744|FG003|Overall Study|Lost to Follow-up|0|||
155484138|NCT01058356|561193760|FG000|Overall Study|Adverse Event|5|||
155484139|NCT01058356|561193760|FG000|Overall Study|Administration of contraindicated drugs|12|||
155484140|NCT01058356|561193760|FG000|Overall Study|Withdrawal by Subject|21|||
155484141|NCT01058356|561193760|FG000|Overall Study|Lost to Follow-up|4|||
155484142|NCT02993783|561193761|FG000|Overall Study|Reason not Specified|6|||
155484143|NCT02993783|561193762|FG001|Overall Study|Reason not Specified|9|||
155484144|NCT00606021|561193763|FG000|Induction Phase|Death|73|||
155484145|NCT00606021|561193764|FG001|Induction Phase|Death|0|||
155484146|NCT00606021|561193765|FG002|Induction Phase|Death|0|||
155484147|NCT00606021|561193763|FG000|Induction Phase|Physician Decision|2|||
155484148|NCT00606021|561193764|FG001|Induction Phase|Physician Decision|0|||
155484149|NCT00606021|561193765|FG002|Induction Phase|Physician Decision|0|||
155484150|NCT00606021|561193763|FG000|Induction Phase|Withdrawal by Subject|2|||
155484151|NCT00606021|561193764|FG001|Induction Phase|Withdrawal by Subject|0|||
155484152|NCT00606021|561193765|FG002|Induction Phase|Withdrawal by Subject|0|||
155484153|NCT00606021|561193763|FG000|Induction Phase|Lost to Follow-up|10|||
155484154|NCT00606021|561193764|FG001|Induction Phase|Lost to Follow-up|0|||
155484155|NCT00606021|561193765|FG002|Induction Phase|Lost to Follow-up|0|||
155484156|NCT00606021|561193763|FG000|Maintenance Phase|Death|0|||
155484157|NCT00606021|561193764|FG001|Maintenance Phase|Death|17|||
155484158|NCT00606021|561193765|FG002|Maintenance Phase|Death|15|||
155484159|NCT00606021|561193763|FG000|Maintenance Phase|Physician Decision|0|||
155484160|NCT00606021|561193764|FG001|Maintenance Phase|Physician Decision|1|||
155484161|NCT00606021|561193765|FG002|Maintenance Phase|Physician Decision|0|||
155484162|NCT00606021|561193763|FG000|Maintenance Phase|Lost to Follow-up|0|||
155484163|NCT00606021|561193764|FG001|Maintenance Phase|Lost to Follow-up|5|||
155484164|NCT00606021|561193765|FG002|Maintenance Phase|Lost to Follow-up|2|||
155484165|NCT03480841|561193768|FG000|Overall Study|Lost to Follow-up|2|||
155484166|NCT01362049|561193769|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
155484167|NCT01362049|561193770|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
155484168|NCT01362049|561193771|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
155484169|NCT01362049|561193772|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
155484170|NCT01362049|561193769|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
155484171|NCT01362049|561193770|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
155484172|NCT01362049|561193771|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
155484173|NCT01362049|561193772|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
155484174|NCT02417935|561193775|FG000|Treatment Period|Adverse Event|12|||
155484175|NCT02417935|561193776|FG001|Treatment Period|Adverse Event|10|||
155484176|NCT02417935|561193775|FG000|Treatment Period|Lost to Follow-up|1|||
155484177|NCT02417935|561193776|FG001|Treatment Period|Lost to Follow-up|0|||
155484178|NCT02417935|561193775|FG000|Treatment Period|Entry Criteria not met|0|||
155484179|NCT02417935|561193776|FG001|Treatment Period|Entry Criteria not met|1|||
155484180|NCT02417935|561193775|FG000|Treatment Period|Protocol Violation|2|||
155484181|NCT02417935|561193776|FG001|Treatment Period|Protocol Violation|1|||
155484182|NCT02417935|561193775|FG000|Treatment Period|Withdrawal by Subject|3|||
155484183|NCT02417935|561193776|FG001|Treatment Period|Withdrawal by Subject|3|||
155484184|NCT02417935|561193775|FG000|Treatment Period|Physician Decision|3|||
155484185|NCT02417935|561193776|FG001|Treatment Period|Physician Decision|1|||
155484186|NCT02850276|561193779|FG000|Overall Study|screen failure|43|||
155484187|NCT02850276|561193779|FG000|Overall Study|Withdrawal by Subject|14|||
155484188|NCT02850276|561193779|FG000|Overall Study|Physician Decision|2|||
155520625|NCT03661528|561331001|FG001|Overall Study|Adverse Event|55|||
155520626|NCT04276883|561331002|FG000|Overall Study|Withdrawal by Subject|2|||
155484189|NCT02850276|561193779|FG000|Overall Study|Lost to Follow-up|2|||
155484190|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
155484191|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
155484192|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
155484193|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
155520627|NCT04276883|561331003|FG001|Overall Study|Withdrawal by Subject|3|||
155484194|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
155484195|NCT00989664|561193781|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
155484196|NCT00989664|561193781|FG000|Long-Term Follow-Up|Death|3|||
155484197|NCT00095836|561193784|FG000|Overall Study|Lost to Follow-up|1|||
155484198|NCT00095836|561193784|FG000|Overall Study|Adverse Event|1|||
155484199|NCT00095836|561193784|FG000|Overall Study|Death|2|||
155484200|NCT00962780|561193785|FG000|Overall Study|Death|0|||
155484201|NCT00962780|561193786|FG001|Overall Study|Death|1|||
155484202|NCT00962780|561193785|FG000|Overall Study|Protocol Violation|9|||
155484203|NCT00962780|561193786|FG001|Overall Study|Protocol Violation|4|||
155484204|NCT00962780|561193785|FG000|Overall Study|Withdrawal by Subject|1|||
155484205|NCT00962780|561193786|FG001|Overall Study|Withdrawal by Subject|8|||
155484206|NCT00962780|561193785|FG000|Overall Study|Other|0|||
155484207|NCT00962780|561193786|FG001|Overall Study|Other|1|||
155484208|NCT00982111|561193790|FG000|Overall Study|Adverse Event|1|||
155484209|NCT00982111|561193791|FG001|Overall Study|Adverse Event|1|||
155484210|NCT00982111|561193790|FG000|Overall Study|Progressive Disease|46|||
155484211|NCT00982111|561193791|FG001|Overall Study|Progressive Disease|39|||
155484212|NCT00982111|561193790|FG000|Overall Study|Lost to Follow-up|9|||
155484213|NCT00982111|561193791|FG001|Overall Study|Lost to Follow-up|6|||
155484214|NCT00982111|561193790|FG000|Overall Study|New Anti-Cancer Therapy|5|||
155484215|NCT00982111|561193791|FG001|Overall Study|New Anti-Cancer Therapy|5|||
155484216|NCT00982111|561193790|FG000|Overall Study|Medical Decision|1|||
155484217|NCT00982111|561193791|FG001|Overall Study|Medical Decision|0|||
155484218|NCT00982111|561193790|FG000|Overall Study|Withdrawal by Subject|17|||
155484219|NCT00982111|561193791|FG001|Overall Study|Withdrawal by Subject|19|||
155484220|NCT00982111|561193790|FG000|Overall Study|Global Study End|0|||
155484221|NCT00982111|561193791|FG001|Overall Study|Global Study End|1|||
155484222|NCT00982111|561193790|FG000|Overall Study|Sponsor's Decision|0|||
155484223|NCT00982111|561193791|FG001|Overall Study|Sponsor's Decision|1|||
155484224|NCT00620815|561193792|FG000|Overall Study|Adverse Event|1|||
155484225|NCT00620815|561193793|FG001|Overall Study|Adverse Event|1|||
155484226|NCT00620815|561193794|FG002|Overall Study|Adverse Event|2|||
155484227|NCT00620815|561193792|FG000|Overall Study|Withdrawal by Subject|1|||
155484228|NCT00620815|561193793|FG001|Overall Study|Withdrawal by Subject|2|||
155484229|NCT00620815|561193794|FG002|Overall Study|Withdrawal by Subject|0|||
155484230|NCT00620815|561193792|FG000|Overall Study|Lost to Follow-up|1|||
155484231|NCT00620815|561193793|FG001|Overall Study|Lost to Follow-up|6|||
155484232|NCT00620815|561193794|FG002|Overall Study|Lost to Follow-up|3|||
155484233|NCT00620815|561193792|FG000|Overall Study|Inappropriate enrolment|0|||
155484234|NCT00620815|561193793|FG001|Overall Study|Inappropriate enrolment|0|||
155484235|NCT00620815|561193794|FG002|Overall Study|Inappropriate enrolment|1|||
155484236|NCT00620815|561193792|FG000|Overall Study|Protocol Violation|1|||
155484237|NCT00620815|561193793|FG001|Overall Study|Protocol Violation|2|||
155484238|NCT00620815|561193794|FG002|Overall Study|Protocol Violation|1|||
155484239|NCT00983827|561193795|FG000|Overall Study|Withdrawal by Subject|1|||
155484240|NCT00422942|561193797|FG000|Overall Study|Study terminated by Sponsor|3|||
155484241|NCT02828982|561193800|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155484242|NCT02828982|561193801|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155484243|NCT02312934|561193802|FG000|Overall Study|Lost to Follow-up|1|||
155484244|NCT02312934|561193803|FG001|Overall Study|Lost to Follow-up|0|||
155484245|NCT02312934|561193802|FG000|Overall Study|Physician Decision|1|||
155484246|NCT02312934|561193803|FG001|Overall Study|Physician Decision|0|||
155484247|NCT03395704|561193804|FG000|Overall Study|Adverse Event|2|||
155484248|NCT03395704|561193805|FG001|Overall Study|Adverse Event|1|||
155484249|NCT03395704|561193804|FG000|Overall Study|Withdrawal by Subject|2|||
155484250|NCT03395704|561193805|FG001|Overall Study|Withdrawal by Subject|1|||
155484251|NCT03395704|561193804|FG000|Overall Study|Physician Decision|0|||
155484252|NCT03395704|561193805|FG001|Overall Study|Physician Decision|1|||
155484253|NCT01156012|561193806|FG000|Overall Study|Adverse Event|3|||
155484254|NCT01156012|561193807|FG001|Overall Study|Adverse Event|1|||
155484255|NCT01156012|561193806|FG000|Overall Study|Lost to Follow-up|1|||
155484256|NCT01156012|561193807|FG001|Overall Study|Lost to Follow-up|0|||
155484257|NCT01156012|561193806|FG000|Overall Study|Withdrawal by Subject|1|||
155484258|NCT01156012|561193807|FG001|Overall Study|Withdrawal by Subject|0|||
155484259|NCT01156012|561193806|FG000|Overall Study|use of commercial drug instead of study|0|||
155484260|NCT01156012|561193807|FG001|Overall Study|use of commercial drug instead of study|1|||
155484261|NCT01156012|561193806|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
155484262|NCT01156012|561193807|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
155484263|NCT03458234|561193808|FG000|Overall Study|Withdrawal by Subject|1|||
155484264|NCT00577382|561195570|FG000|Overall Study|Adverse Event|0|||
155484265|NCT00577382|561195571|FG001|Overall Study|Adverse Event|6|||
155484266|NCT00577382|561195570|FG000|Overall Study|Withdrawal by Subject|0|||
155484267|NCT00577382|561195571|FG001|Overall Study|Withdrawal by Subject|1|||
155484268|NCT00577382|561195570|FG000|Overall Study|Progressive Disease|17|||
155484269|NCT00577382|561195571|FG001|Overall Study|Progressive Disease|19|||
155484270|NCT00577382|561195570|FG000|Overall Study|Intercurrent Illness|1|||
155484271|NCT00577382|561195571|FG001|Overall Study|Intercurrent Illness|2|||
155484272|NCT00577382|561195570|FG000|Overall Study|Death|1|||
155520628|NCT04276883|561331004|FG002|Overall Study|Withdrawal by Subject|6|||
155520629|NCT04276883|561331002|FG000|Overall Study|Lost to Follow-up|1|||
155520630|NCT04276883|561331003|FG001|Overall Study|Lost to Follow-up|3|||
155520631|NCT04276883|561331004|FG002|Overall Study|Lost to Follow-up|0|||
155520632|NCT04276883|561331002|FG000|Overall Study|Adverse Event|0|||
155520633|NCT04276883|561331003|FG001|Overall Study|Adverse Event|1|||
155520634|NCT04276883|561331004|FG002|Overall Study|Adverse Event|0|||
155520635|NCT04276883|561331002|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
155520636|NCT04276883|561331003|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
155520637|NCT04276883|561331004|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
155520638|NCT02732210|561331005|FG000|Overall Study|Site Closed|0|||
155520639|NCT02732210|561331006|FG001|Overall Study|Site Closed|11|||
155520640|NCT02732210|561331005|FG000|Overall Study|Study Ended|13|||
155520641|NCT02732210|561331006|FG001|Overall Study|Study Ended|13|||
155520642|NCT02732210|561331005|FG000|Overall Study|Withdrawal by Subject|28|||
155520643|NCT02732210|561331006|FG001|Overall Study|Withdrawal by Subject|87|||
155520644|NCT02732210|561331005|FG000|Overall Study|Lost to Follow-up|5|||
155520645|NCT02732210|561331006|FG001|Overall Study|Lost to Follow-up|57|||
155520646|NCT02732210|561331005|FG000|Overall Study|Death|4|||
155520647|NCT02732210|561331006|FG001|Overall Study|Death|15|||
155520648|NCT02732210|561331005|FG000|Overall Study|Other|35|||
155520649|NCT02732210|561331006|FG001|Overall Study|Other|103|||
155520650|NCT02732210|561331005|FG000|Overall Study|Missing|0|||
155520651|NCT02732210|561331006|FG001|Overall Study|Missing|8|||
155520652|NCT01876706|561331007|FG000|Overall Study|BPH Intervention|9|||
155520653|NCT01876706|561331007|FG000|Overall Study|Lost to Follow-up|7|||
155520654|NCT01876706|561331007|FG000|Overall Study|Withdrawals|6|||
155520655|NCT01876706|561331007|FG000|Overall Study|Death|3|||
155484273|NCT00577382|561195571|FG001|Overall Study|Death|1|||
155484274|NCT00577382|561195570|FG000|Overall Study|Lost to Follow-up|2|||
155484275|NCT00577382|561195571|FG001|Overall Study|Lost to Follow-up|2|||
155484276|NCT01345162|561195572|FG000|Overall Study|Protocol Violation|2|||
155484277|NCT01345162|561195573|FG001|Overall Study|Protocol Violation|4|||
155484278|NCT03007472|561195575|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
155484279|NCT03007472|561195575|FG000|Overall Study|Death|2|||
155484280|NCT03007472|561195575|FG000|Overall Study|Loss to Follow Up|1|||
155484281|NCT00649220|561195576|FG000|Overall Study|Adverse Event|2|||
155484282|NCT00649220|561195576|FG000|Overall Study|Withdrawal by Subject|1|||
155484283|NCT00525499|561195577|FG000|Overall Study|Lost to Follow-up|2|||
155484284|NCT00525499|561195578|FG001|Overall Study|Lost to Follow-up|4|||
155484285|NCT00525499|561195579|FG002|Overall Study|Lost to Follow-up|1|||
155484286|NCT00525499|561195580|FG003|Overall Study|Lost to Follow-up|4|||
155484287|NCT00525499|561195577|FG000|Overall Study|Adverse Event|0|||
155484288|NCT00525499|561195578|FG001|Overall Study|Adverse Event|1|||
155484289|NCT00525499|561195579|FG002|Overall Study|Adverse Event|0|||
155484290|NCT00525499|561195580|FG003|Overall Study|Adverse Event|1|||
155484291|NCT00525499|561195577|FG000|Overall Study|Withdrawal by Subject|5|||
155484292|NCT00525499|561195578|FG001|Overall Study|Withdrawal by Subject|1|||
155484293|NCT00525499|561195579|FG002|Overall Study|Withdrawal by Subject|5|||
155484294|NCT00525499|561195580|FG003|Overall Study|Withdrawal by Subject|2|||
155484295|NCT00525499|561195577|FG000|Overall Study|Protocol Violation|0|||
155484296|NCT00525499|561195578|FG001|Overall Study|Protocol Violation|1|||
155484297|NCT00525499|561195579|FG002|Overall Study|Protocol Violation|1|||
155484298|NCT00525499|561195580|FG003|Overall Study|Protocol Violation|0|||
155484299|NCT01856920|561195581|FG000|Overall Study|Disease Progression On Study|3|||
155484300|NCT01856920|561195582|FG001|Overall Study|Disease Progression On Study|4|||
155484301|NCT01856920|561195581|FG000|Overall Study|Disease Progression before Treatment|1|||
155484302|NCT01856920|561195582|FG001|Overall Study|Disease Progression before Treatment|0|||
155520656|NCT00604500|561331008|FG000|Overall Study|Adverse Event|2|||
155520657|NCT00604500|561331008|FG000|Overall Study|Protocol Violation|2|||
155520658|NCT00604500|561331008|FG000|Overall Study|Treatment Failure|1|||
155520659|NCT00604500|561331008|FG000|Overall Study|Withdrawal by Subject|4|||
155520660|NCT00604500|561331008|FG000|Overall Study|Administrative|1|||
155520661|NCT00604500|561331008|FG000|Overall Study|Did not meet protocol eligibility|1|||
155520662|NCT03130699|561331014|FG000|Overall Study|Lost to Follow-up|34|||
155520663|NCT03130699|561331015|FG001|Overall Study|Lost to Follow-up|37|||
155520664|NCT03130699|561331016|FG002|Overall Study|Lost to Follow-up|26|||
155520665|NCT03130699|561331014|FG000|Overall Study|Withdrawal by Subject|5|||
155520666|NCT03130699|561331015|FG001|Overall Study|Withdrawal by Subject|1|||
155484303|NCT01856920|561195581|FG000|Overall Study|Ineligible|0|||
155484304|NCT01856920|561195582|FG001|Overall Study|Ineligible|1|||
155484305|NCT01856920|561195581|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
155484306|NCT01856920|561195582|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
155484307|NCT01856920|561195581|FG000|Overall Study|Refused further Treatment|5|||
155484308|NCT01856920|561195582|FG001|Overall Study|Refused further Treatment|1|||
155520667|NCT03130699|561331016|FG002|Overall Study|Withdrawal by Subject|0|||
155520668|NCT03130699|561331014|FG000|Overall Study|Withdrawal by PI|1|||
155520669|NCT03130699|561331015|FG001|Overall Study|Withdrawal by PI|2|||
155654757|NCT00979407|561828939|FG000|Overall Study|Lost to Follow-up|3|||
155654758|NCT00979407|561828940|FG001|Overall Study|Lost to Follow-up|3|||
155654759|NCT01166646|561828941|FG000|Overall Study|Protocol Violation|0|||
155654760|NCT01166646|561828942|FG001|Overall Study|Protocol Violation|1|||
155654761|NCT01166646|561828941|FG000|Overall Study|Adverse Event|1|||
155654762|NCT01166646|561828942|FG001|Overall Study|Adverse Event|0|||
155484309|NCT01856920|561195581|FG000|Overall Study|Other Reasons|0|||
155484310|NCT01856920|561195582|FG001|Overall Study|Other Reasons|1|||
155484311|NCT01856920|561195581|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
155484312|NCT01856920|561195582|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
155484313|NCT02906644|561195590|FG000|First 2 Weeks|Withdrawal by Subject|0|||
155484314|NCT02906644|561195591|FG001|First 2 Weeks|Withdrawal by Subject|2|||
155484315|NCT02906644|561195590|FG000|First 2 Weeks|Physician Decision|1|||
155484316|NCT02906644|561195591|FG001|First 2 Weeks|Physician Decision|1|||
155484317|NCT02906644|561195590|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
155484318|NCT02906644|561195591|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
155484319|NCT02906644|561195590|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
155484320|NCT02906644|561195591|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
155484321|NCT00608426|561195592|FG000|Overall Study|Death|32|||
155484322|NCT00608426|561195593|FG001|Overall Study|Death|36|||
155484323|NCT00608426|561195592|FG000|Overall Study|Lost to Follow-up|485|||
155484324|NCT00608426|561195593|FG001|Overall Study|Lost to Follow-up|521|||
155484325|NCT00608426|561195592|FG000|Overall Study|refused, health issues, wrong address|319|||
155484326|NCT00608426|561195593|FG001|Overall Study|refused, health issues, wrong address|348|||
155484327|NCT00761891|561195594|FG000|Overall Study|Withdrawal by Subject|10|||
155484328|NCT01453439|561195598|FG000|Treatment Phase|Withdrawal by Subject|13|||
155484329|NCT01453439|561195599|FG001|Treatment Phase|Withdrawal by Subject|10|||
155484330|NCT01453439|561195598|FG000|Treatment Phase|Suicidal Ideation|2|||
155484331|NCT01453439|561195599|FG001|Treatment Phase|Suicidal Ideation|0|||
155484332|NCT01453439|561195598|FG000|Treatment Phase|Need for higher level of care|1|||
155484333|NCT01453439|561195599|FG001|Treatment Phase|Need for higher level of care|1|||
155484334|NCT01453439|561195598|FG000|Treatment Phase|Therapist conflict of interest|1|||
155484335|NCT01453439|561195599|FG001|Treatment Phase|Therapist conflict of interest|0|||
155484336|NCT01453439|561195598|FG000|Follow-up|Withdrawal by Subject|0|||
155484337|NCT01453439|561195599|FG001|Follow-up|Withdrawal by Subject|1|||
155484338|NCT01453439|561195598|FG000|Follow-up|Lost to Follow-up|5|||
155484339|NCT01453439|561195599|FG001|Follow-up|Lost to Follow-up|10|||
155484340|NCT01014442|561195600|FG000|Overall Study|Adverse Event|0|||
155484341|NCT01014442|561195601|FG001|Overall Study|Adverse Event|8|||
155484342|NCT01014442|561195600|FG000|Overall Study|Withdrawal by Subject|4|||
155484343|NCT01014442|561195601|FG001|Overall Study|Withdrawal by Subject|4|||
155484344|NCT01014442|561195600|FG000|Overall Study|Protocol Violation|2|||
155484345|NCT01014442|561195601|FG001|Overall Study|Protocol Violation|5|||
155484346|NCT01014442|561195600|FG000|Overall Study|Lack of Compliance|0|||
155484347|NCT01014442|561195601|FG001|Overall Study|Lack of Compliance|1|||
155484348|NCT01014442|561195600|FG000|Overall Study|Unspecified Reason|1|||
155484349|NCT01014442|561195601|FG001|Overall Study|Unspecified Reason|1|||
155484350|NCT02074059|561195602|FG000|Overall Study|Death|0|||
155484351|NCT02074059|561195603|FG001|Overall Study|Death|0|||
155484352|NCT02074059|561195604|FG002|Overall Study|Death|0|||
155484353|NCT02074059|561195605|FG003|Overall Study|Death|0|||
155484354|NCT02074059|561195606|FG004|Overall Study|Death|1|||
155484355|NCT02074059|561195607|FG005|Overall Study|Death|1|||
155484356|NCT00672490|561195611|FG000|Overall Study|Withdrawal by Subject|8|||
155484357|NCT00672490|561195612|FG001|Overall Study|Withdrawal by Subject|8|||
155484358|NCT00672490|561195611|FG000|Overall Study|Lack of Compliance|2|||
155484359|NCT00672490|561195612|FG001|Overall Study|Lack of Compliance|7|||
155484360|NCT00672490|561195611|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
155484361|NCT00672490|561195612|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
155484362|NCT00672490|561195611|FG000|Overall Study|Adverse Event|5|||
155484363|NCT00672490|561195612|FG001|Overall Study|Adverse Event|8|||
155484364|NCT00672490|561195611|FG000|Overall Study|Violation of Concomitant Medicine|1|||
155484365|NCT00672490|561195612|FG001|Overall Study|Violation of Concomitant Medicine|0|||
155484366|NCT00672490|561195611|FG000|Overall Study|Intolerance|0|||
155484367|NCT00672490|561195612|FG001|Overall Study|Intolerance|2|||
155484368|NCT00672490|561195611|FG000|Overall Study|Lost to Follow-up|1|||
155484369|NCT00672490|561195612|FG001|Overall Study|Lost to Follow-up|5|||
155484370|NCT00672490|561195611|FG000|Overall Study|No reason was provided|6|||
155484371|NCT00672490|561195612|FG001|Overall Study|No reason was provided|2|||
155654763|NCT02420314|561828943|FG000|Overall Study|Withdrawal by Subject|1|||
155484372|NCT02030067|561195615|FG000|Overall Study|Disease Progression|1|||
155484373|NCT02030067|561195616|FG001|Overall Study|Disease Progression|1|||
155484374|NCT02030067|561195617|FG002|Overall Study|Disease Progression|2|||
155484375|NCT02030067|561195618|FG003|Overall Study|Disease Progression|2|||
155484376|NCT02030067|561195619|FG004|Overall Study|Disease Progression|3|||
155484377|NCT02030067|561195620|FG005|Overall Study|Disease Progression|2|||
155484378|NCT02030067|561195621|FG006|Overall Study|Disease Progression|3|||
155484379|NCT02030067|561195622|FG007|Overall Study|Disease Progression|3|||
155484380|NCT02030067|561195623|FG008|Overall Study|Disease Progression|4|||
155484381|NCT02030067|561195624|FG009|Overall Study|Disease Progression|3|||
155484382|NCT02030067|561195625|FG010|Overall Study|Disease Progression|7|||
155484383|NCT02030067|561195626|FG011|Overall Study|Disease Progression|2|||
155484384|NCT02030067|561195627|FG012|Overall Study|Disease Progression|59|||
155484385|NCT02030067|561195615|FG000|Overall Study|Withdrawal by Subject|0|||
155484386|NCT02030067|561195616|FG001|Overall Study|Withdrawal by Subject|0|||
155484387|NCT02030067|561195617|FG002|Overall Study|Withdrawal by Subject|0|||
155484388|NCT02030067|561195618|FG003|Overall Study|Withdrawal by Subject|1|||
155484389|NCT02030067|561195619|FG004|Overall Study|Withdrawal by Subject|0|||
155484390|NCT02030067|561195620|FG005|Overall Study|Withdrawal by Subject|0|||
155484391|NCT02030067|561195621|FG006|Overall Study|Withdrawal by Subject|0|||
155484392|NCT02030067|561195622|FG007|Overall Study|Withdrawal by Subject|1|||
155484393|NCT02030067|561195623|FG008|Overall Study|Withdrawal by Subject|0|||
155484394|NCT02030067|561195624|FG009|Overall Study|Withdrawal by Subject|0|||
155484395|NCT02030067|561195625|FG010|Overall Study|Withdrawal by Subject|3|||
155484396|NCT02030067|561195626|FG011|Overall Study|Withdrawal by Subject|0|||
155484397|NCT02030067|561195627|FG012|Overall Study|Withdrawal by Subject|6|||
155484398|NCT02030067|561195615|FG000|Overall Study|Physician Decision|0|||
155484399|NCT02030067|561195616|FG001|Overall Study|Physician Decision|0|||
155484400|NCT02030067|561195617|FG002|Overall Study|Physician Decision|0|||
155484401|NCT02030067|561195618|FG003|Overall Study|Physician Decision|0|||
155484402|NCT02030067|561195619|FG004|Overall Study|Physician Decision|0|||
155484403|NCT02030067|561195620|FG005|Overall Study|Physician Decision|0|||
155484404|NCT02030067|561195621|FG006|Overall Study|Physician Decision|0|||
155484405|NCT02030067|561195622|FG007|Overall Study|Physician Decision|0|||
155484406|NCT02030067|561195623|FG008|Overall Study|Physician Decision|0|||
155484407|NCT02030067|561195624|FG009|Overall Study|Physician Decision|0|||
155484408|NCT02030067|561195625|FG010|Overall Study|Physician Decision|1|||
155484409|NCT02030067|561195626|FG011|Overall Study|Physician Decision|0|||
155484410|NCT02030067|561195627|FG012|Overall Study|Physician Decision|3|||
155484411|NCT02030067|561195615|FG000|Overall Study|other reasons|0|||
155484412|NCT02030067|561195616|FG001|Overall Study|other reasons|0|||
155484413|NCT02030067|561195617|FG002|Overall Study|other reasons|0|||
155484414|NCT02030067|561195618|FG003|Overall Study|other reasons|0|||
155484415|NCT02030067|561195619|FG004|Overall Study|other reasons|0|||
155484416|NCT02030067|561195620|FG005|Overall Study|other reasons|1|||
155484417|NCT02030067|561195621|FG006|Overall Study|other reasons|0|||
155484418|NCT02030067|561195622|FG007|Overall Study|other reasons|0|||
155484419|NCT02030067|561195623|FG008|Overall Study|other reasons|2|||
155484420|NCT02030067|561195624|FG009|Overall Study|other reasons|0|||
155484421|NCT02030067|561195625|FG010|Overall Study|other reasons|0|||
155484422|NCT02030067|561195626|FG011|Overall Study|other reasons|0|||
155484423|NCT02030067|561195627|FG012|Overall Study|other reasons|4|||
155484424|NCT02030067|561195615|FG000|Overall Study|Adverse Event|0|||
155484425|NCT02030067|561195616|FG001|Overall Study|Adverse Event|0|||
155484426|NCT02030067|561195617|FG002|Overall Study|Adverse Event|0|||
155484427|NCT02030067|561195618|FG003|Overall Study|Adverse Event|0|||
155484428|NCT02030067|561195619|FG004|Overall Study|Adverse Event|0|||
155484429|NCT02030067|561195620|FG005|Overall Study|Adverse Event|0|||
155484430|NCT02030067|561195621|FG006|Overall Study|Adverse Event|0|||
155484431|NCT02030067|561195622|FG007|Overall Study|Adverse Event|0|||
155484432|NCT02030067|561195623|FG008|Overall Study|Adverse Event|0|||
155484433|NCT02030067|561195624|FG009|Overall Study|Adverse Event|0|||
155484434|NCT02030067|561195625|FG010|Overall Study|Adverse Event|0|||
155484435|NCT02030067|561195626|FG011|Overall Study|Adverse Event|1|||
155484436|NCT02030067|561195627|FG012|Overall Study|Adverse Event|8|||
155484437|NCT00545740|561195633|FG000|Overall Study|Lack of Efficacy|34|||
155484438|NCT00545740|561195634|FG001|Overall Study|Lack of Efficacy|35|||
155484439|NCT00545740|561195635|FG002|Overall Study|Lack of Efficacy|47|||
155484440|NCT00545740|561195636|FG003|Overall Study|Lack of Efficacy|36|||
155484441|NCT00545740|561195633|FG000|Overall Study|Withdrawal by Subject|17|||
155484442|NCT00545740|561195634|FG001|Overall Study|Withdrawal by Subject|15|||
155484443|NCT00545740|561195635|FG002|Overall Study|Withdrawal by Subject|16|||
155484444|NCT00545740|561195636|FG003|Overall Study|Withdrawal by Subject|18|||
155484445|NCT00545740|561195633|FG000|Overall Study|Adverse Event|10|||
155484446|NCT00545740|561195634|FG001|Overall Study|Adverse Event|18|||
155484447|NCT00545740|561195635|FG002|Overall Study|Adverse Event|19|||
155484448|NCT00545740|561195636|FG003|Overall Study|Adverse Event|9|||
155484449|NCT00545740|561195633|FG000|Overall Study|Lost to Follow-up|7|||
155484450|NCT00545740|561195634|FG001|Overall Study|Lost to Follow-up|5|||
155484451|NCT00545740|561195635|FG002|Overall Study|Lost to Follow-up|5|||
155484452|NCT00545740|561195636|FG003|Overall Study|Lost to Follow-up|6|||
155484453|NCT00545740|561195633|FG000|Overall Study|Protocol Violation|1|||
155484454|NCT00545740|561195634|FG001|Overall Study|Protocol Violation|3|||
155484455|NCT00545740|561195635|FG002|Overall Study|Protocol Violation|1|||
155484456|NCT00545740|561195636|FG003|Overall Study|Protocol Violation|0|||
155484457|NCT00545740|561195633|FG000|Overall Study|Non-compliance|0|||
155484458|NCT00545740|561195634|FG001|Overall Study|Non-compliance|2|||
155484459|NCT00545740|561195635|FG002|Overall Study|Non-compliance|1|||
155484460|NCT00545740|561195636|FG003|Overall Study|Non-compliance|0|||
155484461|NCT00545740|561195633|FG000|Overall Study|Moved|2|||
155484462|NCT00545740|561195634|FG001|Overall Study|Moved|0|||
155484463|NCT00545740|561195635|FG002|Overall Study|Moved|1|||
155484464|NCT00545740|561195636|FG003|Overall Study|Moved|0|||
155484465|NCT00545740|561195633|FG000|Overall Study|Diverticulitis attack|0|||
155484466|NCT00545740|561195634|FG001|Overall Study|Diverticulitis attack|0|||
155484467|NCT00545740|561195635|FG002|Overall Study|Diverticulitis attack|1|||
155484468|NCT00545740|561195636|FG003|Overall Study|Diverticulitis attack|1|||
155484469|NCT00545740|561195633|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
155484470|NCT00545740|561195634|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
155484471|NCT00545740|561195635|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
155484472|NCT00545740|561195636|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
155484473|NCT00545740|561195633|FG000|Overall Study|Site closure|1|||
155484474|NCT00545740|561195634|FG001|Overall Study|Site closure|0|||
155484475|NCT00545740|561195635|FG002|Overall Study|Site closure|0|||
155484476|NCT00545740|561195636|FG003|Overall Study|Site closure|0|||
155484477|NCT00545740|561195633|FG000|Overall Study|Missed visit|1|||
155484478|NCT00545740|561195634|FG001|Overall Study|Missed visit|0|||
155484479|NCT00545740|561195635|FG002|Overall Study|Missed visit|0|||
155484480|NCT00545740|561195636|FG003|Overall Study|Missed visit|0|||
155484481|NCT00545740|561195633|FG000|Overall Study|Physician Decision|0|||
155484482|NCT00545740|561195634|FG001|Overall Study|Physician Decision|0|||
155484483|NCT00545740|561195635|FG002|Overall Study|Physician Decision|3|||
155484484|NCT00545740|561195636|FG003|Overall Study|Physician Decision|0|||
155484485|NCT00545740|561195633|FG000|Overall Study|Accepted only monthly telephone calls|1|||
155484486|NCT00545740|561195634|FG001|Overall Study|Accepted only monthly telephone calls|0|||
155484487|NCT00545740|561195635|FG002|Overall Study|Accepted only monthly telephone calls|0|||
155484488|NCT00545740|561195636|FG003|Overall Study|Accepted only monthly telephone calls|0|||
155484489|NCT00545740|561195633|FG000|Overall Study|Sponsor decision|0|||
155484490|NCT00545740|561195634|FG001|Overall Study|Sponsor decision|1|||
155484491|NCT00545740|561195635|FG002|Overall Study|Sponsor decision|0|||
155484492|NCT00545740|561195636|FG003|Overall Study|Sponsor decision|0|||
155484493|NCT00545740|561195633|FG000|Overall Study|Lack of time|0|||
155484494|NCT00545740|561195634|FG001|Overall Study|Lack of time|1|||
155484495|NCT00545740|561195635|FG002|Overall Study|Lack of time|0|||
155484496|NCT00545740|561195636|FG003|Overall Study|Lack of time|0|||
155484497|NCT00545740|561195633|FG000|Overall Study|Non-adherence to visits|0|||
155484498|NCT00545740|561195634|FG001|Overall Study|Non-adherence to visits|1|||
155484499|NCT00545740|561195635|FG002|Overall Study|Non-adherence to visits|0|||
155484500|NCT00545740|561195636|FG003|Overall Study|Non-adherence to visits|0|||
155484501|NCT00545740|561195633|FG000|Overall Study|Patient difficulties|0|||
155484502|NCT00545740|561195634|FG001|Overall Study|Patient difficulties|1|||
155484503|NCT00545740|561195635|FG002|Overall Study|Patient difficulties|0|||
155484504|NCT00545740|561195636|FG003|Overall Study|Patient difficulties|0|||
155484505|NCT00545740|561195633|FG000|Overall Study|Husband against study|0|||
155484506|NCT00545740|561195634|FG001|Overall Study|Husband against study|0|||
155484507|NCT00545740|561195635|FG002|Overall Study|Husband against study|1|||
155484508|NCT00545740|561195636|FG003|Overall Study|Husband against study|0|||
155484509|NCT02117024|561195637|FG000|Overall Study|Progressive Disease|26|||
155484510|NCT02117024|561195638|FG001|Overall Study|Progressive Disease|9|||
155484511|NCT02117024|561195637|FG000|Overall Study|Significant Clinical Progression|7|||
155484512|NCT02117024|561195638|FG001|Overall Study|Significant Clinical Progression|4|||
155484513|NCT02117024|561195637|FG000|Overall Study|Death|5|||
155484514|NCT02117024|561195638|FG001|Overall Study|Death|0|||
155484515|NCT02117024|561195637|FG000|Overall Study|Withdrawal by Subject|3|||
155484516|NCT02117024|561195638|FG001|Overall Study|Withdrawal by Subject|1|||
155484517|NCT02117024|561195637|FG000|Overall Study|Protocol Violation|1|||
155484518|NCT02117024|561195638|FG001|Overall Study|Protocol Violation|0|||
155484519|NCT02117024|561195637|FG000|Overall Study|Adverse Event|1|||
155484520|NCT02117024|561195638|FG001|Overall Study|Adverse Event|2|||
155484521|NCT02117024|561195637|FG000|Overall Study|Randomized in Error|1|||
155484522|NCT02117024|561195638|FG001|Overall Study|Randomized in Error|0|||
155484523|NCT02117024|561195637|FG000|Overall Study|Patient returned to primary oncologist|0|||
155484524|NCT02117024|561195638|FG001|Overall Study|Patient returned to primary oncologist|1|||
155520670|NCT03130699|561331016|FG002|Overall Study|Withdrawal by PI|5|||
155520671|NCT03130699|561331014|FG000|Overall Study|Death|0|||
155520672|NCT03130699|561331015|FG001|Overall Study|Death|0|||
155520673|NCT03130699|561331016|FG002|Overall Study|Death|1|||
155520674|NCT06354270|561331024|FG000|Overall Study|Withdrawal by Subject|1|||
155520675|NCT06354270|561331025|FG001|Overall Study|Withdrawal by Subject|0|||
155520676|NCT04028843|561331040|FG000|Overall Study|Lost to Follow-up|32|||
155520677|NCT04028843|561331041|FG001|Overall Study|Lost to Follow-up|39|||
155520678|NCT04028843|561331040|FG000|Overall Study|Adverse Event|1|||
155520679|NCT04028843|561331041|FG001|Overall Study|Adverse Event|0|||
155520680|NCT04028843|561331040|FG000|Overall Study|Non-viable Pregnancy|0|||
155520681|NCT04028843|561331041|FG001|Overall Study|Non-viable Pregnancy|1|||
155520682|NCT04028843|561331040|FG000|Overall Study|Withdrawal by Subject|4|||
155520683|NCT04028843|561331041|FG001|Overall Study|Withdrawal by Subject|2|||
155520684|NCT01606306|561331046|FG000|Overall Study|Lack of Efficacy|2|||
155520685|NCT01606306|561331047|FG001|Overall Study|Lack of Efficacy|1|||
155520686|NCT01606306|561331048|FG002|Overall Study|Lack of Efficacy|4|||
155484525|NCT02117024|561195637|FG000|Overall Study|Patient took treatment break|0|||
155484526|NCT02117024|561195638|FG001|Overall Study|Patient took treatment break|1|||
155484527|NCT02117024|561195637|FG000|Overall Study|Physician Decision|0|||
155484528|NCT02117024|561195638|FG001|Overall Study|Physician Decision|2|||
155484529|NCT00565721|561195639|FG000|Overall Study|Screen Failure|2|||
155484530|NCT00565721|561195639|FG000|Overall Study|Lost to Follow-up|6|||
155484531|NCT00565721|561195639|FG000|Overall Study|Technical Problems|1|||
155484532|NCT00565721|561195639|FG000|Overall Study|Physician Decision|2|||
155484533|NCT00565721|561195639|FG000|Overall Study|Other reasons|6|||
155484534|NCT04062240|561195642|FG000|Overall Study|equipment malfunction|1|||
155484535|NCT03323385|561195648|FG000|Overall Study|Withdrawal by Subject|1|||
155484536|NCT03323385|561195649|FG001|Overall Study|Withdrawal by Subject|2|||
155484537|NCT03323385|561195648|FG000|Overall Study|Noncompliance|0|||
155484538|NCT03323385|561195649|FG001|Overall Study|Noncompliance|1|||
155484539|NCT04118127|561195651|FG000|Overall Study|Trial terminated by sponsor|0|||
155484540|NCT04118127|561195652|FG001|Overall Study|Trial terminated by sponsor|12|||
155484541|NCT04118127|561195651|FG000|Overall Study|Adverse Event|1|||
155484542|NCT04118127|561195652|FG001|Overall Study|Adverse Event|2|||
155484543|NCT04118127|561195651|FG000|Overall Study|Physician Decision|0|||
155484544|NCT04118127|561195652|FG001|Overall Study|Physician Decision|1|||
155484545|NCT04118127|561195651|FG000|Overall Study|Withdrawal by Subject|2|||
155484546|NCT04118127|561195652|FG001|Overall Study|Withdrawal by Subject|1|||
155484547|NCT01681836|561195658|FG000|Second Intervention|Withdrawal by Subject|0|||
155484548|NCT01681836|561195659|FG001|Second Intervention|Withdrawal by Subject|1|||
155484549|NCT04815291|561195662|FG000|Overall Study|Lost to Follow-up|1|||
155484550|NCT04815291|561195662|FG000|Overall Study|Physician Decision|4|||
155484551|NCT04815291|561195662|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
155484552|NCT02646332|561195663|FG000|Overall Study|Lost to Follow-up|0|||
155484553|NCT02646332|561195664|FG001|Overall Study|Lost to Follow-up|3|||
155484554|NCT02363322|561195667|FG000|Overall Study|Lost to Follow-up|1|||
155484555|NCT02363322|561195668|FG001|Overall Study|Lost to Follow-up|0|||
155484556|NCT02269709|561195669|FG000|Time of Enrollment|Withdrawal by Subject|3|||
155484557|NCT02269709|561195669|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
155484558|NCT02269709|561195669|FG000|Six Month Follow-up|Lost to Follow-up|12|||
155484559|NCT02909504|561195670|FG000|Overall Study|Adverse Event|2|||
155484560|NCT02909504|561195670|FG000|Overall Study|Lack of Efficacy|3|||
155484561|NCT02909504|561195670|FG000|Overall Study|Withdrawal by Subject|4|||
155484562|NCT02909504|561195670|FG000|Overall Study|Pregnancy|1|||
155484563|NCT02909504|561195670|FG000|Overall Study|Subject moved|1|||
155484564|NCT02909504|561195670|FG000|Overall Study|Lost to Follow-up|1|||
155484565|NCT02055976|561195671|FG000|Overall Study|Other|0|||
155484566|NCT02055976|561195672|FG001|Overall Study|Other|0|||
155520687|NCT01606306|561331049|FG003|Overall Study|Lack of Efficacy|4|||
155520688|NCT01606306|561331050|FG004|Overall Study|Lack of Efficacy|1|||
155520689|NCT01606306|561331051|FG005|Overall Study|Lack of Efficacy|2|||
155484567|NCT02055976|561195673|FG002|Overall Study|Other|1|||
155484568|NCT02055976|561195674|FG003|Overall Study|Other|0|||
155484569|NCT02055976|561195675|FG004|Overall Study|Other|0|||
155484570|NCT02055976|561195676|FG005|Overall Study|Other|0|||
155484571|NCT02055976|561195677|FG006|Overall Study|Other|0|||
155484572|NCT02055976|561195678|FG007|Overall Study|Other|0|||
155484573|NCT02055976|561195679|FG008|Overall Study|Other|0|||
155484574|NCT02055976|561195671|FG000|Overall Study|Adverse Event|0|||
155484575|NCT02055976|561195672|FG001|Overall Study|Adverse Event|0|||
155484576|NCT02055976|561195673|FG002|Overall Study|Adverse Event|0|||
155484577|NCT02055976|561195674|FG003|Overall Study|Adverse Event|0|||
155484578|NCT02055976|561195675|FG004|Overall Study|Adverse Event|0|||
155484579|NCT02055976|561195676|FG005|Overall Study|Adverse Event|1|||
155484580|NCT02055976|561195677|FG006|Overall Study|Adverse Event|1|||
155520690|NCT01606306|561331046|FG000|Overall Study|Adverse Event|1|||
155520691|NCT01606306|561331047|FG001|Overall Study|Adverse Event|0|||
155520692|NCT01606306|561331048|FG002|Overall Study|Adverse Event|1|||
155520693|NCT01606306|561331049|FG003|Overall Study|Adverse Event|1|||
155520694|NCT01606306|561331050|FG004|Overall Study|Adverse Event|2|||
155520695|NCT01606306|561331051|FG005|Overall Study|Adverse Event|0|||
155520696|NCT01606306|561331046|FG000|Overall Study|Lost to Follow-up|7|||
155520697|NCT01606306|561331047|FG001|Overall Study|Lost to Follow-up|4|||
155520698|NCT01606306|561331048|FG002|Overall Study|Lost to Follow-up|5|||
155520699|NCT01606306|561331049|FG003|Overall Study|Lost to Follow-up|4|||
155520700|NCT01606306|561331050|FG004|Overall Study|Lost to Follow-up|3|||
155520701|NCT01606306|561331051|FG005|Overall Study|Lost to Follow-up|5|||
155520702|NCT01606306|561331046|FG000|Overall Study|Withdrawal by Subject|4|||
155520703|NCT01606306|561331047|FG001|Overall Study|Withdrawal by Subject|3|||
155520704|NCT01606306|561331048|FG002|Overall Study|Withdrawal by Subject|4|||
155520705|NCT01606306|561331049|FG003|Overall Study|Withdrawal by Subject|4|||
155520706|NCT01606306|561331050|FG004|Overall Study|Withdrawal by Subject|5|||
155520707|NCT01606306|561331051|FG005|Overall Study|Withdrawal by Subject|4|||
155520708|NCT01606306|561331046|FG000|Overall Study|Physician Decision|1|||
155520709|NCT01606306|561331047|FG001|Overall Study|Physician Decision|2|||
155520710|NCT01606306|561331048|FG002|Overall Study|Physician Decision|0|||
155520711|NCT01606306|561331049|FG003|Overall Study|Physician Decision|0|||
155520712|NCT01606306|561331050|FG004|Overall Study|Physician Decision|0|||
155520713|NCT01606306|561331051|FG005|Overall Study|Physician Decision|0|||
155520714|NCT00950872|561331054|FG000|Overall Study|Withdrawal by Subject|1|||
155520715|NCT00950872|561331054|FG000|Overall Study|Did not have surgery|2|||
155520716|NCT00860028|561331055|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
155520717|NCT00860028|561331056|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
155520718|NCT02585258|561331057|FG000|Overall Study|Adverse Event|28|||
155520719|NCT02585258|561331058|FG001|Overall Study|Adverse Event|29|||
155520720|NCT02585258|561331057|FG000|Overall Study|Death|3|||
155520721|NCT02585258|561331058|FG001|Overall Study|Death|2|||
155520722|NCT02585258|561331057|FG000|Overall Study|Lack of Efficacy|7|||
155520723|NCT02585258|561331058|FG001|Overall Study|Lack of Efficacy|9|||
155520724|NCT02585258|561331057|FG000|Overall Study|includes covid-related access problems|42|||
155520725|NCT02585258|561331058|FG001|Overall Study|includes covid-related access problems|46|||
155520726|NCT02585258|561331057|FG000|Overall Study|Lost to Follow-up|5|||
155520727|NCT02585258|561331058|FG001|Overall Study|Lost to Follow-up|2|||
155520728|NCT05125952|561331059|FG000|Overall Study|Physician Decision|1|||
155520729|NCT02918877|561332493|FG000|Overall Study|Withdrawal by Subject|2|||
155520730|NCT02918877|561332494|FG001|Overall Study|Withdrawal by Subject|2|||
155520731|NCT02918877|561332493|FG000|Overall Study|Surgery cancelled|1|||
155520732|NCT02918877|561332494|FG001|Overall Study|Surgery cancelled|0|||
155520733|NCT02918877|561332493|FG000|Overall Study|Physician Decision|1|||
155520734|NCT02918877|561332494|FG001|Overall Study|Physician Decision|0|||
155520735|NCT02918877|561332493|FG000|Overall Study|Received intraoperative steroids|1|||
155520736|NCT02918877|561332494|FG001|Overall Study|Received intraoperative steroids|0|||
155520737|NCT02918877|561332493|FG000|Overall Study|Unable to obtain lab samples|1|||
155520738|NCT02918877|561332494|FG001|Overall Study|Unable to obtain lab samples|0|||
155484581|NCT02055976|561195678|FG007|Overall Study|Adverse Event|0|||
155484582|NCT02055976|561195679|FG008|Overall Study|Adverse Event|0|||
155484583|NCT02055976|561195671|FG000|Overall Study|Does not meet entrance criteria|0|||
155484584|NCT02055976|561195672|FG001|Overall Study|Does not meet entrance criteria|0|||
155484585|NCT02055976|561195673|FG002|Overall Study|Does not meet entrance criteria|0|||
155484586|NCT02055976|561195674|FG003|Overall Study|Does not meet entrance criteria|0|||
155484587|NCT02055976|561195675|FG004|Overall Study|Does not meet entrance criteria|0|||
155484588|NCT02055976|561195676|FG005|Overall Study|Does not meet entrance criteria|0|||
155484589|NCT02055976|561195677|FG006|Overall Study|Does not meet entrance criteria|1|||
155484590|NCT02055976|561195678|FG007|Overall Study|Does not meet entrance criteria|0|||
155484591|NCT02055976|561195679|FG008|Overall Study|Does not meet entrance criteria|0|||
155484592|NCT02055976|561195671|FG000|Overall Study|Lost to Follow-up|0|||
155484593|NCT02055976|561195672|FG001|Overall Study|Lost to Follow-up|0|||
155484594|NCT02055976|561195673|FG002|Overall Study|Lost to Follow-up|0|||
155484595|NCT02055976|561195674|FG003|Overall Study|Lost to Follow-up|1|||
155484596|NCT02055976|561195675|FG004|Overall Study|Lost to Follow-up|0|||
155484597|NCT02055976|561195676|FG005|Overall Study|Lost to Follow-up|0|||
155484598|NCT02055976|561195677|FG006|Overall Study|Lost to Follow-up|0|||
155484599|NCT02055976|561195678|FG007|Overall Study|Lost to Follow-up|0|||
155484600|NCT02055976|561195679|FG008|Overall Study|Lost to Follow-up|0|||
155484601|NCT03769753|561195684|FG000|Overall Study|Not Treated|6|||
155484602|NCT03769753|561195684|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
155484603|NCT01070381|561195685|FG000|Period 2, 1 Week of Wear|Handling|0|||
155484604|NCT01070381|561195686|FG001|Period 2, 1 Week of Wear|Handling|1|||
155484605|NCT01070381|561195685|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
155484606|NCT01070381|561195686|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
155520739|NCT02918877|561332493|FG000|Overall Study|Unsafe to perform BAL|0|||
155520740|NCT02918877|561332494|FG001|Overall Study|Unsafe to perform BAL|1|||
155520741|NCT05346055|561332497|FG000|Overall Study|Withdrawal by Subject|1|||
155520742|NCT05346055|561332497|FG000|Overall Study|Protocol Violation|1|||
155520743|NCT05346055|561332497|FG000|Overall Study|Therapist decision|1|||
155484607|NCT01657903|561195688|FG000|Overall Study|Lost to Follow-up|1|||
155484608|NCT01657903|561195688|FG000|Overall Study|Withdrawal by Subject|1|||
155484609|NCT01888367|561195691|FG000|Overall Study|Physician Decision|3|||
155484610|NCT01888367|561195692|FG001|Overall Study|Physician Decision|4|||
155484611|NCT01888367|561195693|FG002|Overall Study|Physician Decision|2|||
155484612|NCT01888367|561195691|FG000|Overall Study|Death|2|||
155484613|NCT01888367|561195692|FG001|Overall Study|Death|0|||
155484614|NCT01888367|561195693|FG002|Overall Study|Death|1|||
155484615|NCT01888367|561195691|FG000|Overall Study|Withdrawal by Subject|1|||
155484616|NCT01888367|561195692|FG001|Overall Study|Withdrawal by Subject|0|||
155484617|NCT01888367|561195693|FG002|Overall Study|Withdrawal by Subject|1|||
155484618|NCT01888367|561195691|FG000|Overall Study|Lost to Follow-up|1|||
155484619|NCT01888367|561195692|FG001|Overall Study|Lost to Follow-up|1|||
155484620|NCT01888367|561195693|FG002|Overall Study|Lost to Follow-up|0|||
155484621|NCT01888367|561195691|FG000|Overall Study|Protocol Violation|0|||
155484622|NCT01888367|561195692|FG001|Overall Study|Protocol Violation|0|||
155484623|NCT01888367|561195693|FG002|Overall Study|Protocol Violation|1|||
155484624|NCT01888367|561195691|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
155484625|NCT01888367|561195692|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
155484626|NCT01888367|561195693|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
155484627|NCT01854918|561195694|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
155484628|NCT01854918|561195695|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
155484629|NCT01854918|561195694|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
155484630|NCT01854918|561195695|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
155484631|NCT01854918|561195694|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
155484632|NCT01854918|561195695|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
155484633|NCT01854918|561195694|FG000|SOC-controlled Period (Year 1)|Death|5|||
155484634|NCT01854918|561195695|FG001|SOC-controlled Period (Year 1)|Death|5|||
155484635|NCT01854918|561195694|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
155484636|NCT01854918|561195695|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
155484637|NCT01854918|561195694|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
155484638|NCT01854918|561195695|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
155484639|NCT01854918|561195694|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
155484640|NCT01854918|561195695|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
155484641|NCT01854918|561195694|FG000|All-IP Period (Years 2 and 3)|Death|5|||
155484642|NCT01854918|561195695|FG001|All-IP Period (Years 2 and 3)|Death|16|||
155484643|NCT02146352|561195701|FG000|Overall Study|Death|1|||
155484644|NCT02146352|561195701|FG000|Overall Study|Patient entered hospice care|1|||
155484645|NCT02918006|561195702|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
155484646|NCT02918006|561195703|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
155484647|NCT02918006|561195704|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
155484648|NCT02918006|561195702|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
155484649|NCT02918006|561195703|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
155484650|NCT02918006|561195704|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
155484651|NCT02918006|561195702|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
155484652|NCT02918006|561195703|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
155484653|NCT02918006|561195704|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
155484654|NCT02918006|561195702|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
155484655|NCT02918006|561195703|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
155484656|NCT02918006|561195704|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
155484657|NCT02918006|561195702|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
155484658|NCT02918006|561195703|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
155484659|NCT02918006|561195704|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
155484660|NCT02918006|561195702|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
155484661|NCT02918006|561195703|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
155484662|NCT02918006|561195704|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
155484663|NCT02918006|561195702|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
155484664|NCT02918006|561195703|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
155484665|NCT02918006|561195704|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
155484666|NCT02918006|561195702|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
155484667|NCT02918006|561195703|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
155484668|NCT02918006|561195704|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
155484669|NCT02918006|561195702|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
155484670|NCT02918006|561195703|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
155484671|NCT02918006|561195704|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
155484672|NCT03091920|561195708|FG000|Overall Study|Adverse Event|0|||
155484673|NCT03091920|561195709|FG001|Overall Study|Adverse Event|1|||
155484674|NCT03091920|561195710|FG002|Overall Study|Adverse Event|0|||
155484675|NCT00453349|561195711|FG000|Randomized|Adverse Event|12|||
155484676|NCT00453349|561195712|FG001|Randomized|Adverse Event|11|||
155484677|NCT00453349|561195711|FG000|Randomized|Lack of Efficacy|2|||
155484678|NCT00453349|561195712|FG001|Randomized|Lack of Efficacy|1|||
155484679|NCT00453349|561195711|FG000|Randomized|Lost to Follow-up|7|||
155520744|NCT00728949|561332505|FG000|Overall Study|Adverse Event|8|||
155520745|NCT00728949|561332506|FG001|Overall Study|Adverse Event|0|||
155520746|NCT00728949|561332505|FG000|Overall Study|Withdrawal by Subject|2|||
155520747|NCT00728949|561332506|FG001|Overall Study|Withdrawal by Subject|2|||
155520748|NCT00728949|561332505|FG000|Overall Study|Abnormal Lab Results|0|||
155654764|NCT02420314|561828943|FG000|Overall Study|Protocol Violation|1|||
155654765|NCT05430919|561828944|FG000|Overall Study|Protocol Violation|0|||
155654766|NCT05430919|561828945|FG001|Overall Study|Protocol Violation|0|||
155654767|NCT05430919|561828946|FG002|Overall Study|Protocol Violation|1|||
155654768|NCT05430919|561828947|FG003|Overall Study|Protocol Violation|0|||
155654769|NCT05430919|561828944|FG000|Overall Study|Lost to Follow-up|0|||
155654770|NCT05430919|561828945|FG001|Overall Study|Lost to Follow-up|1|||
155654771|NCT05430919|561828946|FG002|Overall Study|Lost to Follow-up|0|||
155654772|NCT05430919|561828947|FG003|Overall Study|Lost to Follow-up|0|||
155654773|NCT05430919|561828944|FG000|Overall Study|Withdrawal by Subject|3|||
155654774|NCT05430919|561828945|FG001|Overall Study|Withdrawal by Subject|0|||
155654775|NCT05430919|561828946|FG002|Overall Study|Withdrawal by Subject|0|||
155654776|NCT05430919|561828947|FG003|Overall Study|Withdrawal by Subject|1|||
155654777|NCT04439903|561828950|FG000|Overall Study|Withdrawal by Subject|2|||
155654778|NCT04439903|561828950|FG000|Overall Study|Screen Failure|1|||
155654779|NCT02181413|561828959|FG000|Overall Study|Withdrawal by Subject|45|||
155654780|NCT02181413|561828960|FG001|Overall Study|Withdrawal by Subject|61|||
155654781|NCT02181413|561828959|FG000|Overall Study|Reason Not Specified|2|||
155654782|NCT02181413|561828960|FG001|Overall Study|Reason Not Specified|5|||
155654783|NCT02181413|561828959|FG000|Overall Study|Lost to Follow-up|8|||
155654784|NCT02181413|561828960|FG001|Overall Study|Lost to Follow-up|7|||
155654785|NCT04806373|561828963|FG000|Overall Study|Withdrawal by Subject|1|||
155654786|NCT04806373|561828964|FG001|Overall Study|Withdrawal by Subject|1|||
155654787|NCT05810597|561828965|FG000|Period 1|Adverse Event|2|||
155654788|NCT05810597|561828966|FG001|Period 1|Adverse Event|0|||
155654789|NCT05810597|561828965|FG000|Period 1|Physician Decision|1|||
155654790|NCT05810597|561828966|FG001|Period 1|Physician Decision|0|||
155654791|NCT01450631|561828967|FG000|Overall Study|Lost to Follow-up|2|||
155654792|NCT01450631|561828968|FG001|Overall Study|Lost to Follow-up|4|||
155484680|NCT00453349|561195712|FG001|Randomized|Lost to Follow-up|5|||
155484681|NCT00453349|561195711|FG000|Randomized|Protocol Violation|1|||
155484682|NCT00453349|561195712|FG001|Randomized|Protocol Violation|1|||
155484683|NCT00453349|561195711|FG000|Randomized|Withdrawal by Subject|3|||
155484684|NCT00453349|561195712|FG001|Randomized|Withdrawal by Subject|5|||
155484685|NCT00453349|561195711|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
155484686|NCT00453349|561195712|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
155484687|NCT00453349|561195711|FG000|Completed Study|Adverse Event|12|||
155484688|NCT00453349|561195712|FG001|Completed Study|Adverse Event|11|||
155484689|NCT00453349|561195711|FG000|Completed Study|Lack of Efficacy|2|||
155484690|NCT00453349|561195712|FG001|Completed Study|Lack of Efficacy|1|||
155484691|NCT00453349|561195711|FG000|Completed Study|Lost to Follow-up|7|||
155484692|NCT00453349|561195712|FG001|Completed Study|Lost to Follow-up|5|||
155484693|NCT00453349|561195711|FG000|Completed Study|Protocol Violation|1|||
155484694|NCT00453349|561195712|FG001|Completed Study|Protocol Violation|1|||
155484695|NCT00453349|561195711|FG000|Completed Study|Withdrawal by Subject|3|||
155484696|NCT00453349|561195712|FG001|Completed Study|Withdrawal by Subject|5|||
155484697|NCT00453349|561195711|FG000|Completed Study|Lost to follow up after study treatment|2|||
155484698|NCT00453349|561195712|FG001|Completed Study|Lost to follow up after study treatment|11|||
155484699|NCT01513460|561195718|FG000|Overall Study|Death|0|||
155484700|NCT01513460|561195719|FG001|Overall Study|Death|0|||
155484701|NCT01513460|561195720|FG002|Overall Study|Death|1|||
155484702|NCT01513460|561195718|FG000|Overall Study|Lost to Follow-up|0|||
155484703|NCT01513460|561195719|FG001|Overall Study|Lost to Follow-up|0|||
155484704|NCT01513460|561195720|FG002|Overall Study|Lost to Follow-up|2|||
155484705|NCT01513460|561195718|FG000|Overall Study|Abnormal laboratory value|1|||
155484706|NCT01513460|561195719|FG001|Overall Study|Abnormal laboratory value|0|||
155484707|NCT01513460|561195720|FG002|Overall Study|Abnormal laboratory value|1|||
155484708|NCT01513460|561195718|FG000|Overall Study|Lack of Efficacy|1|||
155484709|NCT01513460|561195719|FG001|Overall Study|Lack of Efficacy|2|||
155484710|NCT01513460|561195720|FG002|Overall Study|Lack of Efficacy|5|||
155520749|NCT00728949|561332506|FG001|Overall Study|Abnormal Lab Results|2|||
155654793|NCT01450631|561828967|FG000|Overall Study|Withdrawal by Subject|1|||
155654794|NCT01450631|561828968|FG001|Overall Study|Withdrawal by Subject|0|||
155654795|NCT03249558|561828977|FG000|Overall Study|Lost to Follow-up|2|||
155654796|NCT03249558|561828978|FG001|Overall Study|Lost to Follow-up|1|||
155484711|NCT01513460|561195718|FG000|Overall Study|Protocol deviations|3|||
155484712|NCT01513460|561195719|FG001|Overall Study|Protocol deviations|4|||
155484713|NCT01513460|561195720|FG002|Overall Study|Protocol deviations|3|||
155484714|NCT01513460|561195718|FG000|Overall Study|Withdrawal by Subject|7|||
155484715|NCT01513460|561195719|FG001|Overall Study|Withdrawal by Subject|8|||
155484716|NCT01513460|561195720|FG002|Overall Study|Withdrawal by Subject|21|||
155484717|NCT01513460|561195718|FG000|Overall Study|Adverse Event|16|||
155484718|NCT01513460|561195719|FG001|Overall Study|Adverse Event|18|||
155484719|NCT01513460|561195720|FG002|Overall Study|Adverse Event|23|||
155484720|NCT01513460|561195718|FG000|Overall Study|Abnormal test procedure|1|||
155484721|NCT01513460|561195719|FG001|Overall Study|Abnormal test procedure|0|||
155484722|NCT01513460|561195720|FG002|Overall Study|Abnormal test procedure|0|||
155484723|NCT00489216|561195721|FG000|Overall Study|Adverse Event|1|||
155484724|NCT02475564|561195724|FG000|Overall Study|Withdrawal by Subject|1|||
155484725|NCT02475564|561195725|FG001|Overall Study|Withdrawal by Subject|0|||
155484726|NCT02475564|561195724|FG000|Overall Study|Lost to Follow-up|2|||
155484727|NCT02475564|561195725|FG001|Overall Study|Lost to Follow-up|1|||
155484728|NCT02475564|561195724|FG000|Overall Study|Intense Menstrual bleeding|1|||
155484729|NCT02475564|561195725|FG001|Overall Study|Intense Menstrual bleeding|0|||
155484730|NCT02705755|561195726|FG000|Part A (6 Days)|Adverse Event|1|||
155484731|NCT02705755|561195727|FG001|Part A (6 Days)|Adverse Event|0|||
155484732|NCT02705755|561195728|FG002|Part A (6 Days)|Adverse Event|0|||
155484733|NCT02705755|561195729|FG003|Part A (6 Days)|Adverse Event|0|||
155484734|NCT02705755|561195726|FG000|Part A (6 Days)|Physician Decision|3|||
155484735|NCT02705755|561195727|FG001|Part A (6 Days)|Physician Decision|0|||
155484736|NCT02705755|561195728|FG002|Part A (6 Days)|Physician Decision|0|||
155484737|NCT02705755|561195729|FG003|Part A (6 Days)|Physician Decision|0|||
155484738|NCT02705755|561195726|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
155484739|NCT02705755|561195727|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
155484740|NCT02705755|561195728|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
155484741|NCT02705755|561195729|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
155484742|NCT02705755|561195726|FG000|Part C (20 Weeks)|Physician Decision|0|||
155484743|NCT02705755|561195727|FG001|Part C (20 Weeks)|Physician Decision|0|||
155484744|NCT02705755|561195728|FG002|Part C (20 Weeks)|Physician Decision|0|||
155484745|NCT02705755|561195729|FG003|Part C (20 Weeks)|Physician Decision|2|||
155484746|NCT02705755|561195726|FG000|Part C (20 Weeks)|Adverse Event|0|||
155484747|NCT02705755|561195727|FG001|Part C (20 Weeks)|Adverse Event|0|||
155484748|NCT02705755|561195728|FG002|Part C (20 Weeks)|Adverse Event|0|||
155484749|NCT02705755|561195729|FG003|Part C (20 Weeks)|Adverse Event|6|||
155484750|NCT02705755|561195726|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
155484751|NCT02705755|561195727|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
155484752|NCT02705755|561195728|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
155484753|NCT02705755|561195729|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
155484754|NCT01906489|561195730|FG000|Overall Study|Adverse Event|10|||
155484755|NCT01906489|561195731|FG001|Overall Study|Adverse Event|3|||
155484756|NCT01906489|561195730|FG000|Overall Study|Worsening of CKD|6|||
155484757|NCT01906489|561195731|FG001|Overall Study|Worsening of CKD|4|||
155484758|NCT01906489|561195730|FG000|Overall Study|Withdrawal by Subject|5|||
155484759|NCT01906489|561195731|FG001|Overall Study|Withdrawal by Subject|0|||
155484760|NCT01906489|561195730|FG000|Overall Study|Worsening of Anemia|1|||
155484761|NCT01906489|561195731|FG001|Overall Study|Worsening of Anemia|0|||
155484762|NCT01906489|561195730|FG000|Overall Study|Protocol Violation|0|||
155484763|NCT01906489|561195731|FG001|Overall Study|Protocol Violation|1|||
155484764|NCT01906489|561195730|FG000|Overall Study|Non- Compliance|1|||
155484765|NCT01906489|561195731|FG001|Overall Study|Non- Compliance|0|||
155484766|NCT01906489|561195730|FG000|Overall Study|Sponsor Decision|1|||
155484767|NCT01906489|561195731|FG001|Overall Study|Sponsor Decision|0|||
155484768|NCT01906489|561195730|FG000|Overall Study|Lost to Follow-up|1|||
155484769|NCT01906489|561195731|FG001|Overall Study|Lost to Follow-up|1|||
155484770|NCT01906489|561195730|FG000|Overall Study|Other|1|||
155484771|NCT01906489|561195731|FG001|Overall Study|Other|0|||
155484772|NCT04524663|561197438|FG000|Overall Study|Withdrawal by Subject|0|||
155484773|NCT04524663|561197439|FG001|Overall Study|Withdrawal by Subject|2|||
155484774|NCT03359811|561197440|FG000|Overall Study|Protocol Violation|2|||
155484775|NCT03359811|561197441|FG001|Overall Study|Protocol Violation|0|||
155484776|NCT01233076|561197442|FG000|Period 2, One Week|Lost to Follow-up|1|||
155484777|NCT01233076|561197443|FG001|Period 2, One Week|Lost to Follow-up|0|||
155484778|NCT04308668|561197444|FG000|Overall Study|Lost to Follow-up|32|||
155484779|NCT04308668|561197445|FG001|Overall Study|Lost to Follow-up|38|||
155484780|NCT04308668|561197444|FG000|Overall Study|Withdrawal by Subject|4|||
155654797|NCT03249558|561828979|FG002|Overall Study|Lost to Follow-up|4|||
155654798|NCT03249558|561828977|FG000|Overall Study|Physician Decision|1|||
155654799|NCT03249558|561828978|FG001|Overall Study|Physician Decision|0|||
155654800|NCT03249558|561828979|FG002|Overall Study|Physician Decision|0|||
155484781|NCT04308668|561197445|FG001|Overall Study|Withdrawal by Subject|4|||
155484782|NCT01266967|561197446|FG000|Overall Study|Death|69|||
155484783|NCT01266967|561197447|FG001|Overall Study|Death|61|||
155484784|NCT01266967|561197446|FG000|Overall Study|Study Closed/Terminated|15|||
155484785|NCT01266967|561197447|FG001|Overall Study|Study Closed/Terminated|17|||
155484786|NCT01266967|561197446|FG000|Overall Study|Lost to Follow-up|2|||
155484787|NCT01266967|561197447|FG001|Overall Study|Lost to Follow-up|1|||
155484788|NCT01266967|561197446|FG000|Overall Study|Physician Decision|0|||
155484789|NCT01266967|561197447|FG001|Overall Study|Physician Decision|1|||
155484790|NCT01266967|561197446|FG000|Overall Study|Withdrawal by Subject|3|||
155484791|NCT01266967|561197447|FG001|Overall Study|Withdrawal by Subject|3|||
155484792|NCT01519700|561197448|FG000|Overall Study|Death|1|||
155484793|NCT01519700|561197449|FG001|Overall Study|Death|0|||
155484794|NCT01519700|561197450|FG002|Overall Study|Death|0|||
155484795|NCT01519700|561197451|FG003|Overall Study|Death|0|||
155484796|NCT01519700|561197448|FG000|Overall Study|Lost to Follow-up|0|||
155484797|NCT01519700|561197449|FG001|Overall Study|Lost to Follow-up|0|||
155484798|NCT01519700|561197450|FG002|Overall Study|Lost to Follow-up|1|||
155484799|NCT01519700|561197451|FG003|Overall Study|Lost to Follow-up|1|||
155484800|NCT01519700|561197448|FG000|Overall Study|Physician Decision|1|||
155484801|NCT01519700|561197449|FG001|Overall Study|Physician Decision|1|||
155484802|NCT01519700|561197450|FG002|Overall Study|Physician Decision|3|||
155484803|NCT01519700|561197451|FG003|Overall Study|Physician Decision|0|||
155484804|NCT01519700|561197448|FG000|Overall Study|Withdrawal by Subject|5|||
155484805|NCT01519700|561197449|FG001|Overall Study|Withdrawal by Subject|3|||
155484806|NCT01519700|561197450|FG002|Overall Study|Withdrawal by Subject|3|||
155484807|NCT01519700|561197451|FG003|Overall Study|Withdrawal by Subject|2|||
155484808|NCT01519700|561197448|FG000|Overall Study|Other Reason|2|||
155484809|NCT01519700|561197449|FG001|Overall Study|Other Reason|2|||
155484810|NCT01519700|561197450|FG002|Overall Study|Other Reason|0|||
155484811|NCT01519700|561197451|FG003|Overall Study|Other Reason|4|||
155484812|NCT05111548|561197452|FG000|Overall Study|Withdrawal by Subject|2|||
155484813|NCT05111548|561197453|FG001|Overall Study|Withdrawal by Subject|1|||
155484814|NCT05111548|561197452|FG000|Overall Study|Adverse Event|1|||
155484815|NCT05111548|561197453|FG001|Overall Study|Adverse Event|0|||
155484816|NCT00386152|561197457|FG000|Overall Study|Adverse Event|6|||
155484817|NCT00386152|561197458|FG001|Overall Study|Adverse Event|5|||
155484818|NCT00386152|561197459|FG002|Overall Study|Adverse Event|4|||
155484819|NCT00386152|561197457|FG000|Overall Study|Chang from original chemo stratification|4|||
155484820|NCT00386152|561197458|FG001|Overall Study|Chang from original chemo stratification|5|||
155484821|NCT00386152|561197459|FG002|Overall Study|Chang from original chemo stratification|6|||
155484822|NCT00386152|561197457|FG000|Overall Study|Death|3|||
155484823|NCT00386152|561197458|FG001|Overall Study|Death|0|||
155484824|NCT00386152|561197459|FG002|Overall Study|Death|1|||
155484825|NCT00386152|561197457|FG000|Overall Study|Disease progression|7|||
155484826|NCT00386152|561197458|FG001|Overall Study|Disease progression|4|||
155484827|NCT00386152|561197459|FG002|Overall Study|Disease progression|5|||
155484828|NCT00386152|561197457|FG000|Overall Study|Physician Decision|13|||
155484829|NCT00386152|561197458|FG001|Overall Study|Physician Decision|10|||
155484830|NCT00386152|561197459|FG002|Overall Study|Physician Decision|4|||
155484831|NCT00386152|561197457|FG000|Overall Study|Lost to Follow-up|1|||
155484832|NCT00386152|561197458|FG001|Overall Study|Lost to Follow-up|0|||
155484833|NCT00386152|561197459|FG002|Overall Study|Lost to Follow-up|0|||
155484834|NCT00386152|561197457|FG000|Overall Study|Completed chemotherapy|4|||
155484835|NCT00386152|561197458|FG001|Overall Study|Completed chemotherapy|5|||
155484836|NCT00386152|561197459|FG002|Overall Study|Completed chemotherapy|1|||
155484837|NCT00386152|561197457|FG000|Overall Study|Protocol Violation|3|||
155484838|NCT00386152|561197458|FG001|Overall Study|Protocol Violation|5|||
155484839|NCT00386152|561197459|FG002|Overall Study|Protocol Violation|2|||
155484840|NCT00386152|561197457|FG000|Overall Study|Withdrawal by Subject|3|||
155484841|NCT00386152|561197458|FG001|Overall Study|Withdrawal by Subject|6|||
155484842|NCT00386152|561197459|FG002|Overall Study|Withdrawal by Subject|10|||
155484843|NCT01101321|561197460|FG000|Period 1|Withdrawal by Subject|1|||
155484844|NCT01101321|561197461|FG001|Period 1|Withdrawal by Subject|1|||
155484845|NCT01101321|561197460|FG000|Period 1|Adverse Event|3|||
155484846|NCT01101321|561197461|FG001|Period 1|Adverse Event|3|||
155484847|NCT02577107|561197465|FG000|Overall Study|Protocol deviation|0|||
155484848|NCT02577107|561197466|FG001|Overall Study|Protocol deviation|1|||
155484849|NCT01980056|561197468|FG000|Overall Study|Death|1|||
155484850|NCT01980056|561197469|FG001|Overall Study|Death|1|||
155484851|NCT01980056|561197470|FG002|Overall Study|Death|0|||
155484852|NCT02135848|561197476|FG000|Overall Study|Adverse Event|2|||
155484853|NCT02135848|561197477|FG001|Overall Study|Adverse Event|0|||
155654801|NCT03249558|561828977|FG000|Overall Study|Withdrawal by Subject|6|||
155484854|NCT02135848|561197476|FG000|Overall Study|Withdrawal by Subject|1|||
155484855|NCT02135848|561197477|FG001|Overall Study|Withdrawal by Subject|1|||
155484856|NCT00083616|561197478|FG000|Overall Study|Disease Progression|16|||
155484857|NCT00083616|561197478|FG000|Overall Study|Lost to Follow-up|1|||
155484858|NCT00083616|561197478|FG000|Overall Study|Physician Decision|2|||
155484859|NCT00083616|561197478|FG000|Overall Study|Withdrawal by Subject|3|||
155484860|NCT00083616|561197478|FG000|Overall Study|Ineligibility determined|2|||
155484861|NCT00083616|561197478|FG000|Overall Study|Non-compliance|1|||
155484862|NCT00083616|561197478|FG000|Overall Study|Other|6|||
155484863|NCT01474993|561197479|FG000|Overall Study|Lost to Follow-up|1|||
155484864|NCT01474993|561197480|FG001|Overall Study|Lost to Follow-up|2|||
155484865|NCT01474993|561197479|FG000|Overall Study|Adverse Event|0|||
155484866|NCT01474993|561197480|FG001|Overall Study|Adverse Event|1|||
155484867|NCT03258710|561197481|FG000|Overall Study|Adverse Event|1|||
155484868|NCT03258710|561197481|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155484869|NCT03258710|561197481|FG000|Overall Study|Physician Decision|1|||
155484870|NCT03451630|561197482|FG000|Overall Study|Death|15|||
155484871|NCT03451630|561197483|FG001|Overall Study|Death|16|||
155484872|NCT03451630|561197484|FG002|Overall Study|Death|11|||
155484873|NCT03451630|561197482|FG000|Overall Study|Lost to Follow-up|9|||
155484874|NCT03451630|561197483|FG001|Overall Study|Lost to Follow-up|0|||
155484875|NCT03451630|561197484|FG002|Overall Study|Lost to Follow-up|4|||
155484876|NCT03451630|561197482|FG000|Overall Study|Withdrawal by Subject|0|||
155484877|NCT03451630|561197483|FG001|Overall Study|Withdrawal by Subject|3|||
155484878|NCT03451630|561197484|FG002|Overall Study|Withdrawal by Subject|0|||
155484879|NCT03451630|561197482|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
155484880|NCT03451630|561197483|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
155484881|NCT03451630|561197484|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
155484882|NCT02041533|561197485|FG000|Pre-Treatment Period|Disease Progression|1|||
155484883|NCT02041533|561197486|FG001|Pre-Treatment Period|Disease Progression|1|||
155484884|NCT02041533|561197485|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
155484885|NCT02041533|561197486|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
155484886|NCT02041533|561197485|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
155484887|NCT02041533|561197486|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
155484888|NCT02041533|561197485|FG000|Treatment Period|Disease progression|189|||
155484889|NCT02041533|561197486|FG001|Treatment Period|Disease progression|146|||
155484890|NCT02041533|561197485|FG000|Treatment Period|Study drug toxicity|30|||
155484891|NCT02041533|561197486|FG001|Treatment Period|Study drug toxicity|34|||
155484892|NCT02041533|561197485|FG000|Treatment Period|Death|1|||
155484893|NCT02041533|561197486|FG001|Treatment Period|Death|0|||
155484894|NCT02041533|561197485|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
155484895|NCT02041533|561197486|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
155484896|NCT02041533|561197485|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
155484897|NCT02041533|561197486|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
155484898|NCT02041533|561197485|FG000|Treatment Period|Participant withdrew consent|2|||
155484899|NCT02041533|561197486|FG001|Treatment Period|Participant withdrew consent|2|||
155484900|NCT02041533|561197485|FG000|Treatment Period|Maximum clinical benefit|0|||
155484901|NCT02041533|561197486|FG001|Treatment Period|Maximum clinical benefit|18|||
155484902|NCT02041533|561197485|FG000|Treatment Period|Poor/Non-compliance|1|||
155484903|NCT02041533|561197486|FG001|Treatment Period|Poor/Non-compliance|0|||
155484904|NCT02041533|561197485|FG000|Treatment Period|Administrative reason by sponsor|1|||
155484905|NCT02041533|561197486|FG001|Treatment Period|Administrative reason by sponsor|0|||
155484906|NCT02041533|561197485|FG000|Treatment Period|Other reasons|9|||
155484907|NCT02041533|561197486|FG001|Treatment Period|Other reasons|2|||
155484908|NCT02041533|561197485|FG000|Treatment Period|Not Reported|0|||
155484909|NCT02041533|561197486|FG001|Treatment Period|Not Reported|1|||
155484910|NCT02813681|561197487|FG000|Overall Study|Physician Decision|5|||
155484911|NCT02813681|561197488|FG001|Overall Study|Physician Decision|5|||
155484912|NCT02813681|561197489|FG002|Overall Study|Physician Decision|0|||
155484913|NCT02813681|561197487|FG000|Overall Study|Lost to Follow-up|0|||
155484914|NCT02813681|561197488|FG001|Overall Study|Lost to Follow-up|1|||
155484915|NCT02813681|561197489|FG002|Overall Study|Lost to Follow-up|0|||
155484916|NCT01957111|561197492|FG000|Overall Study|Withdrawal by Subject|1|||
155484917|NCT01957111|561197493|FG001|Overall Study|Withdrawal by Subject|1|||
155484918|NCT03961529|561197494|FG000|Overall Study|Adverse Event|13|||
155484919|NCT03961529|561197495|FG001|Overall Study|Adverse Event|5|||
155484920|NCT03961529|561197496|FG002|Overall Study|Adverse Event|2|||
155484921|NCT03961529|561197494|FG000|Overall Study|Withdrawal by Subject|17|||
155484922|NCT03961529|561197495|FG001|Overall Study|Withdrawal by Subject|2|||
155484923|NCT03961529|561197496|FG002|Overall Study|Withdrawal by Subject|1|||
155484924|NCT03961529|561197494|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155484925|NCT03961529|561197495|FG001|Overall Study|Withdrawal by parent/guardian|7|||
155484926|NCT03961529|561197496|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155484927|NCT03961529|561197494|FG000|Overall Study|Physician Decision|2|||
155484928|NCT03961529|561197495|FG001|Overall Study|Physician Decision|1|||
155484929|NCT03961529|561197496|FG002|Overall Study|Physician Decision|1|||
155484930|NCT03961529|561197494|FG000|Overall Study|Lost to Follow-up|2|||
155484931|NCT03961529|561197495|FG001|Overall Study|Lost to Follow-up|1|||
155484932|NCT03961529|561197496|FG002|Overall Study|Lost to Follow-up|0|||
155484933|NCT03961529|561197494|FG000|Overall Study|Lack of Efficacy|2|||
155484934|NCT03961529|561197495|FG001|Overall Study|Lack of Efficacy|0|||
155484935|NCT03961529|561197496|FG002|Overall Study|Lack of Efficacy|1|||
155484936|NCT03961529|561197494|FG000|Overall Study|Other|6|||
155484937|NCT03961529|561197495|FG001|Overall Study|Other|1|||
155484938|NCT03961529|561197496|FG002|Overall Study|Other|0|||
155484939|NCT03644173|561197497|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
155484940|NCT03644173|561197497|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
155484941|NCT03644173|561197497|FG000|Participants at the 1-month Follow up|Death|2|||
155484942|NCT03644173|561197497|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
155484943|NCT03500419|561197498|FG000|Overall Study|Withdrawal by Subject|2|||
155484944|NCT03500419|561197499|FG001|Overall Study|Withdrawal by Subject|25|||
155484945|NCT01497899|561197500|FG000|Double-Blind Phase|Randomized but not Treated|1|||
155484946|NCT01497899|561197501|FG001|Double-Blind Phase|Randomized but not Treated|0|||
155484947|NCT01497899|561197502|FG002|Double-Blind Phase|Randomized but not Treated|0|||
155484948|NCT01497899|561197503|FG003|Double-Blind Phase|Randomized but not Treated|0|||
155484949|NCT01497899|561197500|FG000|Double-Blind Phase|Adverse Event|1|||
155484950|NCT01497899|561197501|FG001|Double-Blind Phase|Adverse Event|0|||
155484951|NCT01497899|561197502|FG002|Double-Blind Phase|Adverse Event|0|||
155484952|NCT01497899|561197503|FG003|Double-Blind Phase|Adverse Event|0|||
155484953|NCT01497899|561197500|FG000|Double-Blind Phase|Lack of Efficacy|0|||
155484954|NCT01497899|561197501|FG001|Double-Blind Phase|Lack of Efficacy|1|||
155484955|NCT01497899|561197502|FG002|Double-Blind Phase|Lack of Efficacy|0|||
155484956|NCT01497899|561197503|FG003|Double-Blind Phase|Lack of Efficacy|0|||
155654802|NCT03249558|561828978|FG001|Overall Study|Withdrawal by Subject|5|||
155484957|NCT01497899|561197500|FG000|Double-Blind Phase|Investigator's Discretion|1|||
155484958|NCT01497899|561197501|FG001|Double-Blind Phase|Investigator's Discretion|0|||
155484959|NCT01497899|561197502|FG002|Double-Blind Phase|Investigator's Discretion|0|||
155484960|NCT01497899|561197503|FG003|Double-Blind Phase|Investigator's Discretion|0|||
155484961|NCT01497899|561197500|FG000|Double-Blind Phase|Withdrew Consent|0|||
155484962|NCT01497899|561197501|FG001|Double-Blind Phase|Withdrew Consent|1|||
155484963|NCT01497899|561197502|FG002|Double-Blind Phase|Withdrew Consent|0|||
155484964|NCT01497899|561197503|FG003|Double-Blind Phase|Withdrew Consent|0|||
155520750|NCT00728949|561332505|FG000|Overall Study|On treatment at cutoff date|1|||
155520751|NCT00728949|561332506|FG001|Overall Study|On treatment at cutoff date|0|||
155520752|NCT01996033|561332508|FG000|Overall Study|Death|1|||
155520753|NCT01996033|561332508|FG000|Overall Study|Physician Decision|1|||
155520754|NCT01996033|561332508|FG000|Overall Study|Withdrawal by Subject|4|||
155520755|NCT01996033|561332508|FG000|Overall Study|Lost to Follow-up|3|||
155520756|NCT02143102|561332536|FG000|Overall Study|Lost to Follow-up|11|||
155520757|NCT02143102|561332537|FG001|Overall Study|Lost to Follow-up|0|||
155520758|NCT01345019|561332540|FG000|Blinded Treatment Phase|Death|147|||
155520759|NCT01345019|561332541|FG001|Blinded Treatment Phase|Death|137|||
155520760|NCT01345019|561332540|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
155520761|NCT01345019|561332541|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
155520762|NCT01345019|561332540|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
155520763|NCT01345019|561332541|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
155520764|NCT01345019|561332540|FG000|Blinded Treatment Phase|Disease Progression|12|||
155520765|NCT01345019|561332541|FG001|Blinded Treatment Phase|Disease Progression|10|||
155520766|NCT01345019|561332540|FG000|Blinded Treatment Phase|Adverse Event|6|||
155520767|NCT01345019|561332541|FG001|Blinded Treatment Phase|Adverse Event|13|||
155520768|NCT01345019|561332540|FG000|Blinded Treatment Phase|Administrative Decision|10|||
155520769|NCT01345019|561332541|FG001|Blinded Treatment Phase|Administrative Decision|8|||
155520770|NCT01345019|561332540|FG000|Blinded Treatment Phase|Noncompliance|5|||
155520771|NCT01345019|561332541|FG001|Blinded Treatment Phase|Noncompliance|3|||
155520772|NCT01345019|561332540|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
155520773|NCT01345019|561332541|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
155520774|NCT01345019|561332540|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
155520775|NCT01345019|561332541|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
155520776|NCT01345019|561332540|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
155520777|NCT01345019|561332541|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
155520778|NCT01345019|561332540|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
155520779|NCT01345019|561332541|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
155520780|NCT01345019|561332540|FG000|Open Label Treatment Phase|Death|49|||
155520781|NCT01345019|561332541|FG001|Open Label Treatment Phase|Death|48|||
155520782|NCT01345019|561332540|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
155520783|NCT01345019|561332541|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
155520784|NCT01345019|561332540|FG000|Open Label Treatment Phase|Adverse Event|30|||
155520785|NCT01345019|561332541|FG001|Open Label Treatment Phase|Adverse Event|51|||
155520786|NCT01345019|561332540|FG000|Open Label Treatment Phase|Administrative Decision|30|||
155520787|NCT01345019|561332541|FG001|Open Label Treatment Phase|Administrative Decision|15|||
155520788|NCT01345019|561332540|FG000|Open Label Treatment Phase|Disease Progression|17|||
155520789|NCT01345019|561332541|FG001|Open Label Treatment Phase|Disease Progression|18|||
155520790|NCT01345019|561332540|FG000|Open Label Treatment Phase|Noncompliance|5|||
155520791|NCT01345019|561332541|FG001|Open Label Treatment Phase|Noncompliance|4|||
155520792|NCT01345019|561332540|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
155520793|NCT01345019|561332541|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
155520794|NCT01345019|561332540|FG000|Open Label Treatment Phase|Pregnancy|1|||
155520795|NCT01345019|561332541|FG001|Open Label Treatment Phase|Pregnancy|0|||
155520796|NCT01345019|561332540|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
155520797|NCT01345019|561332541|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
155520798|NCT01345019|561332540|FG000|Open Label Treatment Phase|Protocol Violation|0|||
155520799|NCT01345019|561332541|FG001|Open Label Treatment Phase|Protocol Violation|1|||
155520800|NCT02636907|561332542|FG000|Autoinjector Assessment Period|Adverse Event|2|||
155520801|NCT02636907|561332542|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
155520802|NCT02636907|561332542|FG000|Extension Phase|Adverse Event|2|||
155520803|NCT02636907|561332542|FG000|Extension Phase|Withdrawal by Subject|4|||
155520804|NCT02636907|561332542|FG000|Extension Phase|Physician Decision|1|||
155520805|NCT02636907|561332542|FG000|Extension Phase|Lost to Follow-up|2|||
155520806|NCT02636907|561332542|FG000|Extension Phase|Lack of Efficacy|1|||
155520807|NCT00762086|561332543|FG000|Overall Study|Adverse Event|2|||
155520808|NCT00762086|561332544|FG001|Overall Study|Adverse Event|0|||
155520809|NCT00762086|561332543|FG000|Overall Study|Lost to Follow-up|0|||
155520810|NCT00762086|561332544|FG001|Overall Study|Lost to Follow-up|2|||
155520811|NCT00762086|561332543|FG000|Overall Study|Non compliance|1|||
155520812|NCT00762086|561332544|FG001|Overall Study|Non compliance|0|||
155520813|NCT00762086|561332543|FG000|Overall Study|Withdrawal by Subject|2|||
155520814|NCT00762086|561332544|FG001|Overall Study|Withdrawal by Subject|2|||
155520815|NCT00762086|561332543|FG000|Overall Study|Ineligible to participate in the study|1|||
155520816|NCT00762086|561332544|FG001|Overall Study|Ineligible to participate in the study|0|||
155520817|NCT03830164|561332549|FG000|Overall Study|Adverse Event|0|||
155520818|NCT03830164|561332550|FG001|Overall Study|Adverse Event|2|||
155520819|NCT03830164|561332551|FG002|Overall Study|Adverse Event|0|||
155520820|NCT03830164|561332549|FG000|Overall Study|Lack of Efficacy|1|||
155520821|NCT03830164|561332550|FG001|Overall Study|Lack of Efficacy|5|||
155520822|NCT03830164|561332551|FG002|Overall Study|Lack of Efficacy|0|||
155520823|NCT03830164|561332549|FG000|Overall Study|Lost to Follow-up|0|||
155484965|NCT01497899|561197500|FG000|Double-Blind Phase|Lost to Follow-up|3|||
155484966|NCT01497899|561197501|FG001|Double-Blind Phase|Lost to Follow-up|2|||
155484967|NCT01497899|561197502|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155484968|NCT01497899|561197503|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155484969|NCT01497899|561197500|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
155484970|NCT01497899|561197501|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
155484971|NCT01497899|561197502|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
155484972|NCT01497899|561197503|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
155484973|NCT01497899|561197500|FG000|Open-Label Extension Phase|Adverse Event|1|||
155484974|NCT01497899|561197501|FG001|Open-Label Extension Phase|Adverse Event|0|||
155484975|NCT01497899|561197502|FG002|Open-Label Extension Phase|Adverse Event|0|||
155484976|NCT01497899|561197503|FG003|Open-Label Extension Phase|Adverse Event|0|||
155484977|NCT01497899|561197500|FG000|Open-Label Extension Phase|Death|1|||
155484978|NCT01497899|561197501|FG001|Open-Label Extension Phase|Death|0|||
155484979|NCT01497899|561197502|FG002|Open-Label Extension Phase|Death|0|||
155484980|NCT01497899|561197503|FG003|Open-Label Extension Phase|Death|0|||
155484981|NCT01497899|561197500|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
155484982|NCT01497899|561197501|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
155484983|NCT01497899|561197502|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
155484984|NCT01497899|561197503|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
155484985|NCT01497899|561197500|FG000|Open-Label Extension Phase|Pregnancy|0|||
155484986|NCT01497899|561197501|FG001|Open-Label Extension Phase|Pregnancy|1|||
155484987|NCT01497899|561197502|FG002|Open-Label Extension Phase|Pregnancy|1|||
155484988|NCT01497899|561197503|FG003|Open-Label Extension Phase|Pregnancy|0|||
155484989|NCT01497899|561197500|FG000|Open-Label Extension Phase|Protocol Violation|0|||
155484990|NCT01497899|561197501|FG001|Open-Label Extension Phase|Protocol Violation|0|||
155484991|NCT01497899|561197502|FG002|Open-Label Extension Phase|Protocol Violation|1|||
155484992|NCT01497899|561197503|FG003|Open-Label Extension Phase|Protocol Violation|0|||
155484993|NCT01497899|561197500|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
155484994|NCT01497899|561197501|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
155484995|NCT01497899|561197502|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
155484996|NCT01497899|561197503|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
155484997|NCT01874288|561197507|FG000|Overall Study|Withdrawal by Subject|1|||
155484998|NCT01874288|561197508|FG001|Overall Study|Withdrawal by Subject|0|||
155484999|NCT01874288|561197509|FG002|Overall Study|Withdrawal by Subject|2|||
155485000|NCT01874288|561197510|FG003|Overall Study|Withdrawal by Subject|1|||
155485001|NCT01874288|561197511|FG004|Overall Study|Withdrawal by Subject|1|||
155485002|NCT01874288|561197507|FG000|Overall Study|Physician Decision|0|||
155485003|NCT01874288|561197508|FG001|Overall Study|Physician Decision|0|||
155485004|NCT01874288|561197509|FG002|Overall Study|Physician Decision|0|||
155485005|NCT01874288|561197510|FG003|Overall Study|Physician Decision|1|||
155485006|NCT01874288|561197511|FG004|Overall Study|Physician Decision|0|||
155485007|NCT01874288|561197507|FG000|Overall Study|Progressive disease|2|||
155485008|NCT01874288|561197508|FG001|Overall Study|Progressive disease|0|||
155485009|NCT01874288|561197509|FG002|Overall Study|Progressive disease|3|||
155485010|NCT01874288|561197510|FG003|Overall Study|Progressive disease|5|||
155485011|NCT01874288|561197511|FG004|Overall Study|Progressive disease|1|||
155485012|NCT04212221|561197512|FG000|Overall Study|Remained on Treatment|0|||
155485013|NCT04212221|561197513|FG001|Overall Study|Remained on Treatment|0|||
155485014|NCT04212221|561197514|FG002|Overall Study|Remained on Treatment|0|||
155485015|NCT04212221|561197515|FG003|Overall Study|Remained on Treatment|1|||
155485016|NCT04212221|561197516|FG004|Overall Study|Remained on Treatment|0|||
155485017|NCT04212221|561197517|FG005|Overall Study|Remained on Treatment|0|||
155485018|NCT04212221|561197518|FG006|Overall Study|Remained on Treatment|3|||
155485019|NCT04212221|561197519|FG007|Overall Study|Remained on Treatment|9|||
155485020|NCT04212221|561197512|FG000|Overall Study|Adverse Event|0|||
155485021|NCT04212221|561197513|FG001|Overall Study|Adverse Event|0|||
155485022|NCT04212221|561197514|FG002|Overall Study|Adverse Event|0|||
155485023|NCT04212221|561197515|FG003|Overall Study|Adverse Event|0|||
155485024|NCT04212221|561197516|FG004|Overall Study|Adverse Event|0|||
155485025|NCT04212221|561197517|FG005|Overall Study|Adverse Event|0|||
155485026|NCT04212221|561197518|FG006|Overall Study|Adverse Event|2|||
155485027|NCT04212221|561197519|FG007|Overall Study|Adverse Event|3|||
155485028|NCT04212221|561197512|FG000|Overall Study|Death|0|||
155485029|NCT04212221|561197513|FG001|Overall Study|Death|0|||
155485030|NCT04212221|561197514|FG002|Overall Study|Death|0|||
155485031|NCT04212221|561197515|FG003|Overall Study|Death|0|||
155485032|NCT04212221|561197516|FG004|Overall Study|Death|0|||
155485033|NCT04212221|561197517|FG005|Overall Study|Death|0|||
155485034|NCT04212221|561197518|FG006|Overall Study|Death|0|||
155485035|NCT04212221|561197519|FG007|Overall Study|Death|2|||
155485036|NCT04212221|561197512|FG000|Overall Study|Disease progression according to irRECIST|1|||
155485037|NCT04212221|561197513|FG001|Overall Study|Disease progression according to irRECIST|2|||
155485038|NCT04212221|561197514|FG002|Overall Study|Disease progression according to irRECIST|3|||
155485039|NCT04212221|561197515|FG003|Overall Study|Disease progression according to irRECIST|3|||
155520824|NCT03830164|561332550|FG001|Overall Study|Lost to Follow-up|1|||
155520825|NCT03830164|561332551|FG002|Overall Study|Lost to Follow-up|0|||
155520826|NCT03830164|561332549|FG000|Overall Study|Withdrawal by Subject|1|||
155520827|NCT03830164|561332550|FG001|Overall Study|Withdrawal by Subject|0|||
155520828|NCT03830164|561332551|FG002|Overall Study|Withdrawal by Subject|0|||
155520829|NCT04099888|561332552|FG000|Overall Study|Study terminated by sponsor|9|||
155520830|NCT04099888|561332553|FG001|Overall Study|Study terminated by sponsor|11|||
155520831|NCT04099888|561332552|FG000|Overall Study|Lost to Follow-up|1|||
155520832|NCT04099888|561332553|FG001|Overall Study|Lost to Follow-up|1|||
155520833|NCT04099888|561332552|FG000|Overall Study|Withdrawal by Subject|5|||
155520834|NCT04099888|561332553|FG001|Overall Study|Withdrawal by Subject|6|||
155520835|NCT04099888|561332552|FG000|Overall Study|Death|5|||
155520836|NCT04099888|561332553|FG001|Overall Study|Death|2|||
155520837|NCT04099888|561332552|FG000|Overall Study|Other|1|||
155520838|NCT04099888|561332553|FG001|Overall Study|Other|0|||
155520839|NCT02731157|561332559|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
155520840|NCT01856309|561332562|FG000|Overall Study|Death|4|||
155520841|NCT01856309|561332563|FG001|Overall Study|Death|6|||
155520842|NCT01856309|561332564|FG002|Overall Study|Death|11|||
155520843|NCT01856309|561332565|FG003|Overall Study|Death|6|||
155520844|NCT01856309|561332562|FG000|Overall Study|Lost to Follow-up|6|||
155520845|NCT01856309|561332563|FG001|Overall Study|Lost to Follow-up|2|||
155520846|NCT01856309|561332564|FG002|Overall Study|Lost to Follow-up|4|||
155520847|NCT01856309|561332565|FG003|Overall Study|Lost to Follow-up|8|||
155520848|NCT01856309|561332562|FG000|Overall Study|Withdrawal by Subject|11|||
155520849|NCT01856309|561332563|FG001|Overall Study|Withdrawal by Subject|13|||
155520850|NCT01856309|561332564|FG002|Overall Study|Withdrawal by Subject|28|||
155520851|NCT01856309|561332565|FG003|Overall Study|Withdrawal by Subject|26|||
155520852|NCT01856309|561332562|FG000|Overall Study|Other|227|||
155520853|NCT01856309|561332563|FG001|Overall Study|Other|225|||
155520854|NCT01856309|561332564|FG002|Overall Study|Other|447|||
155520855|NCT01856309|561332565|FG003|Overall Study|Other|469|||
155520856|NCT01856309|561332562|FG000|Overall Study|Lack of Efficacy|14|||
155520857|NCT01856309|561332563|FG001|Overall Study|Lack of Efficacy|9|||
155520858|NCT01856309|561332564|FG002|Overall Study|Lack of Efficacy|40|||
155520859|NCT01856309|561332565|FG003|Overall Study|Lack of Efficacy|25|||
155520860|NCT01856309|561332562|FG000|Overall Study|Adverse Event|31|||
155520861|NCT01856309|561332563|FG001|Overall Study|Adverse Event|31|||
155520862|NCT01856309|561332564|FG002|Overall Study|Adverse Event|55|||
155520863|NCT01856309|561332565|FG003|Overall Study|Adverse Event|65|||
155520864|NCT01856309|561332562|FG000|Overall Study|Pregnancy|0|||
155520865|NCT01856309|561332563|FG001|Overall Study|Pregnancy|0|||
155520866|NCT01856309|561332564|FG002|Overall Study|Pregnancy|0|||
155520867|NCT01856309|561332565|FG003|Overall Study|Pregnancy|1|||
155520868|NCT01856309|561332562|FG000|Overall Study|Physician Decision|6|||
155520869|NCT01856309|561332563|FG001|Overall Study|Physician Decision|1|||
155520870|NCT01856309|561332564|FG002|Overall Study|Physician Decision|6|||
155520871|NCT01856309|561332565|FG003|Overall Study|Physician Decision|8|||
155520872|NCT01856309|561332562|FG000|Overall Study|Noncompliance With Study Drug|0|||
155520873|NCT01856309|561332563|FG001|Overall Study|Noncompliance With Study Drug|1|||
155520874|NCT01856309|561332564|FG002|Overall Study|Noncompliance With Study Drug|4|||
155520875|NCT01856309|561332565|FG003|Overall Study|Noncompliance With Study Drug|1|||
155520876|NCT00832377|561332566|FG000|Overall Study|Protocol Violation|1|||
155520877|NCT01273181|561332569|FG000|Phase I, Dose 1|Study termination|1|||
155520878|NCT01273181|561332570|FG001|Phase I, Dose 1|Study termination|0|||
155520879|NCT01273181|561332571|FG002|Phase I, Dose 1|Study termination|0|||
155520880|NCT01273181|561332572|FG003|Phase I, Dose 1|Study termination|0|||
155520881|NCT01273181|561332569|FG000|Phase I, Dose 2|Death during treatment|0|||
155520882|NCT01273181|561332570|FG001|Phase I, Dose 2|Death during treatment|1|||
155520883|NCT01273181|561332571|FG002|Phase I, Dose 2|Death during treatment|0|||
155520884|NCT01273181|561332572|FG003|Phase I, Dose 2|Death during treatment|0|||
155520885|NCT01273181|561332569|FG000|Phase 2, Dose 1|Study termination|0|||
155520886|NCT01273181|561332570|FG001|Phase 2, Dose 1|Study termination|0|||
155520887|NCT01273181|561332571|FG002|Phase 2, Dose 1|Study termination|1|||
155520888|NCT01273181|561332572|FG003|Phase 2, Dose 1|Study termination|0|||
155520889|NCT01273181|561332569|FG000|Phase 2, Dose 2|Death during treatment|0|||
155520890|NCT01273181|561332570|FG001|Phase 2, Dose 2|Death during treatment|0|||
155520891|NCT01273181|561332571|FG002|Phase 2, Dose 2|Death during treatment|0|||
155520892|NCT01273181|561332572|FG003|Phase 2, Dose 2|Death during treatment|1|||
155520893|NCT00944697|561332573|FG000|Overall Study|Withdrawal by Subject|1|||
155520894|NCT00944697|561332574|FG001|Overall Study|Withdrawal by Subject|1|||
155520895|NCT00944697|561332573|FG000|Overall Study|Adverse Event|0|||
155520896|NCT00944697|561332574|FG001|Overall Study|Adverse Event|3|||
155520897|NCT00944697|561332573|FG000|Overall Study|Administrative|1|||
155520898|NCT00944697|561332574|FG001|Overall Study|Administrative|1|||
155520899|NCT02468778|561332580|FG000|Overall Study|Death|2|||
155520900|NCT02468778|561332581|FG001|Overall Study|Death|1|||
155520901|NCT02468778|561332582|FG002|Overall Study|Death|0|||
155520902|NCT02468778|561332580|FG000|Overall Study|Lost to Follow-up|1|||
155520903|NCT02468778|561332581|FG001|Overall Study|Lost to Follow-up|2|||
155520904|NCT02468778|561332582|FG002|Overall Study|Lost to Follow-up|2|||
155520905|NCT02468778|561332580|FG000|Overall Study|Withdrawal by Subject|0|||
155520906|NCT02468778|561332581|FG001|Overall Study|Withdrawal by Subject|1|||
155520907|NCT02468778|561332582|FG002|Overall Study|Withdrawal by Subject|1|||
155520908|NCT02458469|561332586|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155520909|NCT02458469|561332587|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155520910|NCT02458469|561332588|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155520911|NCT02458469|561332589|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155520912|NCT02458469|561332590|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155520913|NCT02458469|561332591|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155520914|NCT02458469|561332586|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
155520915|NCT02458469|561332587|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
155520916|NCT02458469|561332588|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
155520917|NCT02458469|561332589|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
155520918|NCT02458469|561332590|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
155520919|NCT02458469|561332591|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
155520920|NCT02458469|561332586|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155520921|NCT02458469|561332587|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155520922|NCT02458469|561332588|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155520923|NCT02458469|561332589|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155520924|NCT02458469|561332590|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155520925|NCT02458469|561332591|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
155520926|NCT03561883|561332593|FG000|Overall Study|Adverse Event|10|||
155520927|NCT03561883|561332594|FG001|Overall Study|Adverse Event|13|||
155520928|NCT03561883|561332593|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155520929|NCT03561883|561332594|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155520930|NCT03561883|561332593|FG000|Overall Study|Protocol Violation|2|||
155520931|NCT03561883|561332594|FG001|Overall Study|Protocol Violation|3|||
155520932|NCT03561883|561332593|FG000|Overall Study|Withdrawal by Subject|14|||
155520933|NCT03561883|561332594|FG001|Overall Study|Withdrawal by Subject|6|||
155520934|NCT03561883|561332593|FG000|Overall Study|Lost to Follow-up|2|||
155520935|NCT03561883|561332594|FG001|Overall Study|Lost to Follow-up|6|||
155520936|NCT03561883|561332593|FG000|Overall Study|Study Terminated by Sponsor|12|||
155520937|NCT03561883|561332594|FG001|Overall Study|Study Terminated by Sponsor|11|||
155520938|NCT03561883|561332593|FG000|Overall Study|Physician Decision|1|||
155520939|NCT03561883|561332594|FG001|Overall Study|Physician Decision|0|||
155520940|NCT03561883|561332593|FG000|Overall Study|Randomized by Mistake|1|||
155520941|NCT03561883|561332594|FG001|Overall Study|Randomized by Mistake|0|||
155520942|NCT03561883|561332593|FG000|Overall Study|Other, Not Specified|3|||
155520943|NCT03561883|561332594|FG001|Overall Study|Other, Not Specified|2|||
155520944|NCT05956665|561332595|FG000|Overall Study|Death|1|||
155520945|NCT05956665|561332595|FG000|Overall Study|Withdrawal by Subject|1|||
155520946|NCT02603952|561332596|FG000|Overall Study|Withdrawal by Subject|1|||
155520947|NCT02603952|561332597|FG001|Overall Study|Withdrawal by Subject|0|||
155520948|NCT02603952|561332598|FG002|Overall Study|Withdrawal by Subject|0|||
155520949|NCT02603952|561332599|FG003|Overall Study|Withdrawal by Subject|0|||
155520950|NCT02603952|561332596|FG000|Overall Study|Received oseltamivir by error|0|||
155520951|NCT02603952|561332597|FG001|Overall Study|Received oseltamivir by error|0|||
155520952|NCT02603952|561332598|FG002|Overall Study|Received oseltamivir by error|0|||
155520953|NCT02603952|561332599|FG003|Overall Study|Received oseltamivir by error|1|||
155520954|NCT04646109|561332603|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
155520955|NCT04646109|561332604|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
155520956|NCT01226797|561332605|FG000|Overall Study|Adverse Event|1|||
155520957|NCT01226797|561332606|FG001|Overall Study|Adverse Event|0|||
155520958|NCT01226797|561332605|FG000|Overall Study|No longer willing to participate|1|||
155520959|NCT01226797|561332606|FG001|Overall Study|No longer willing to participate|0|||
155520960|NCT01226797|561332605|FG000|Overall Study|Protocol Violation|0|||
155520961|NCT01226797|561332606|FG001|Overall Study|Protocol Violation|1|||
155520962|NCT00577460|561332609|FG000|Overall Study|Adverse Event|11|||
155520963|NCT00577460|561332610|FG001|Overall Study|Adverse Event|7|||
155520964|NCT00577460|561332611|FG002|Overall Study|Adverse Event|14|||
155520965|NCT00577460|561332609|FG000|Overall Study|Protocol Violation|0|||
155520966|NCT00577460|561332610|FG001|Overall Study|Protocol Violation|1|||
155520967|NCT00577460|561332611|FG002|Overall Study|Protocol Violation|1|||
155520968|NCT00577460|561332609|FG000|Overall Study|Lost to Follow-up|0|||
155520969|NCT00577460|561332610|FG001|Overall Study|Lost to Follow-up|3|||
155520970|NCT00577460|561332611|FG002|Overall Study|Lost to Follow-up|4|||
155520971|NCT00577460|561332609|FG000|Overall Study|Withdrawal by Subject|5|||
155520972|NCT00577460|561332610|FG001|Overall Study|Withdrawal by Subject|5|||
155520973|NCT00577460|561332611|FG002|Overall Study|Withdrawal by Subject|6|||
155520974|NCT00577460|561332609|FG000|Overall Study|Other|0|||
155520975|NCT00577460|561332610|FG001|Overall Study|Other|3|||
155520976|NCT00577460|561332611|FG002|Overall Study|Other|2|||
155520977|NCT00162123|561332612|FG000|Overall Study|Disease progression|27|||
155520978|NCT00162123|561332613|FG001|Overall Study|Disease progression|19|||
155520979|NCT00162123|561332614|FG002|Overall Study|Disease progression|10|||
155520980|NCT00162123|561332615|FG003|Overall Study|Disease progression|4|||
155520981|NCT00162123|561332616|FG004|Overall Study|Disease progression|8|||
155520982|NCT00162123|561332617|FG005|Overall Study|Disease progression|3|||
155520983|NCT00162123|561332618|FG006|Overall Study|Disease progression|1|||
155520984|NCT00162123|561332619|FG007|Overall Study|Disease progression|0|||
155520985|NCT00162123|561332612|FG000|Overall Study|Study drug toxicity|6|||
155520986|NCT00162123|561332613|FG001|Overall Study|Study drug toxicity|1|||
155520987|NCT00162123|561332614|FG002|Overall Study|Study drug toxicity|5|||
155520988|NCT00162123|561332615|FG003|Overall Study|Study drug toxicity|0|||
155520989|NCT00162123|561332616|FG004|Overall Study|Study drug toxicity|4|||
155520990|NCT00162123|561332617|FG005|Overall Study|Study drug toxicity|1|||
155520991|NCT00162123|561332618|FG006|Overall Study|Study drug toxicity|1|||
155520992|NCT00162123|561332619|FG007|Overall Study|Study drug toxicity|0|||
155520993|NCT00162123|561332612|FG000|Overall Study|Death|3|||
155520994|NCT00162123|561332613|FG001|Overall Study|Death|3|||
155520995|NCT00162123|561332614|FG002|Overall Study|Death|1|||
155520996|NCT00162123|561332615|FG003|Overall Study|Death|1|||
155520997|NCT00162123|561332616|FG004|Overall Study|Death|1|||
155520998|NCT00162123|561332617|FG005|Overall Study|Death|1|||
155520999|NCT00162123|561332618|FG006|Overall Study|Death|0|||
155521000|NCT00162123|561332619|FG007|Overall Study|Death|0|||
155521001|NCT00162123|561332612|FG000|Overall Study|Withdrawal by Subject|2|||
155521002|NCT00162123|561332613|FG001|Overall Study|Withdrawal by Subject|0|||
155521003|NCT00162123|561332614|FG002|Overall Study|Withdrawal by Subject|2|||
155521004|NCT00162123|561332615|FG003|Overall Study|Withdrawal by Subject|1|||
155521005|NCT00162123|561332616|FG004|Overall Study|Withdrawal by Subject|1|||
155521006|NCT00162123|561332617|FG005|Overall Study|Withdrawal by Subject|2|||
155521007|NCT00162123|561332618|FG006|Overall Study|Withdrawal by Subject|1|||
155521008|NCT00162123|561332619|FG007|Overall Study|Withdrawal by Subject|0|||
155521009|NCT00162123|561332612|FG000|Overall Study|Deterioration without progression|2|||
155521010|NCT00162123|561332613|FG001|Overall Study|Deterioration without progression|2|||
155521011|NCT00162123|561332614|FG002|Overall Study|Deterioration without progression|3|||
155521012|NCT00162123|561332615|FG003|Overall Study|Deterioration without progression|0|||
155521013|NCT00162123|561332616|FG004|Overall Study|Deterioration without progression|1|||
155521014|NCT00162123|561332617|FG005|Overall Study|Deterioration without progression|0|||
155521015|NCT00162123|561332618|FG006|Overall Study|Deterioration without progression|0|||
155521016|NCT00162123|561332619|FG007|Overall Study|Deterioration without progression|0|||
155521017|NCT00162123|561332612|FG000|Overall Study|Adverse Event|1|||
155521018|NCT00162123|561332613|FG001|Overall Study|Adverse Event|2|||
155521019|NCT00162123|561332614|FG002|Overall Study|Adverse Event|0|||
155521020|NCT00162123|561332615|FG003|Overall Study|Adverse Event|2|||
155521021|NCT00162123|561332616|FG004|Overall Study|Adverse Event|1|||
155521022|NCT00162123|561332617|FG005|Overall Study|Adverse Event|0|||
155521023|NCT00162123|561332618|FG006|Overall Study|Adverse Event|0|||
155521024|NCT00162123|561332619|FG007|Overall Study|Adverse Event|0|||
155521025|NCT00162123|561332612|FG000|Overall Study|Not specified (before treatment)|2|||
155521026|NCT00162123|561332613|FG001|Overall Study|Not specified (before treatment)|0|||
155521027|NCT00162123|561332614|FG002|Overall Study|Not specified (before treatment)|0|||
155654803|NCT03249558|561828979|FG002|Overall Study|Withdrawal by Subject|7|||
155521028|NCT00162123|561332615|FG003|Overall Study|Not specified (before treatment)|0|||
155521029|NCT00162123|561332616|FG004|Overall Study|Not specified (before treatment)|12|||
155521030|NCT00162123|561332617|FG005|Overall Study|Not specified (before treatment)|1|||
155521031|NCT00162123|561332618|FG006|Overall Study|Not specified (before treatment)|0|||
155521032|NCT00162123|561332619|FG007|Overall Study|Not specified (before treatment)|0|||
155521033|NCT00162123|561332612|FG000|Overall Study|Not specified (after start of treatment)|0|||
155654804|NCT03249558|561828977|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
155485040|NCT04212221|561197516|FG004|Overall Study|Disease progression according to irRECIST|2|||
155485041|NCT04212221|561197517|FG005|Overall Study|Disease progression according to irRECIST|2|||
155485042|NCT04212221|561197518|FG006|Overall Study|Disease progression according to irRECIST|21|||
155485043|NCT04212221|561197519|FG007|Overall Study|Disease progression according to irRECIST|17|||
155485044|NCT04212221|561197512|FG000|Overall Study|Global Deterioration of Health Status|0|||
155485045|NCT04212221|561197513|FG001|Overall Study|Global Deterioration of Health Status|0|||
155485046|NCT04212221|561197514|FG002|Overall Study|Global Deterioration of Health Status|0|||
155485047|NCT04212221|561197515|FG003|Overall Study|Global Deterioration of Health Status|0|||
155485048|NCT04212221|561197516|FG004|Overall Study|Global Deterioration of Health Status|0|||
155485049|NCT04212221|561197517|FG005|Overall Study|Global Deterioration of Health Status|0|||
155485050|NCT04212221|561197518|FG006|Overall Study|Global Deterioration of Health Status|0|||
155485051|NCT04212221|561197519|FG007|Overall Study|Global Deterioration of Health Status|2|||
155485052|NCT04212221|561197512|FG000|Overall Study|Investigator's Decision|0|||
155485053|NCT04212221|561197513|FG001|Overall Study|Investigator's Decision|0|||
155485054|NCT04212221|561197514|FG002|Overall Study|Investigator's Decision|0|||
155485055|NCT04212221|561197515|FG003|Overall Study|Investigator's Decision|1|||
155485056|NCT04212221|561197516|FG004|Overall Study|Investigator's Decision|0|||
155485057|NCT04212221|561197517|FG005|Overall Study|Investigator's Decision|0|||
155485058|NCT04212221|561197518|FG006|Overall Study|Investigator's Decision|3|||
155485059|NCT04212221|561197519|FG007|Overall Study|Investigator's Decision|0|||
155485060|NCT04212221|561197512|FG000|Overall Study|Participant refused to continue treatment|0|||
155485061|NCT04212221|561197513|FG001|Overall Study|Participant refused to continue treatment|1|||
155485062|NCT04212221|561197514|FG002|Overall Study|Participant refused to continue treatment|0|||
155485063|NCT04212221|561197515|FG003|Overall Study|Participant refused to continue treatment|1|||
155485064|NCT04212221|561197516|FG004|Overall Study|Participant refused to continue treatment|1|||
155485065|NCT04212221|561197517|FG005|Overall Study|Participant refused to continue treatment|2|||
155485066|NCT04212221|561197518|FG006|Overall Study|Participant refused to continue treatment|4|||
155485067|NCT04212221|561197519|FG007|Overall Study|Participant refused to continue treatment|2|||
155485068|NCT04212221|561197512|FG000|Overall Study|Protocol Violation|0|||
155485069|NCT04212221|561197513|FG001|Overall Study|Protocol Violation|0|||
155485070|NCT04212221|561197514|FG002|Overall Study|Protocol Violation|0|||
155485071|NCT04212221|561197515|FG003|Overall Study|Protocol Violation|0|||
155485072|NCT04212221|561197516|FG004|Overall Study|Protocol Violation|0|||
155485073|NCT04212221|561197517|FG005|Overall Study|Protocol Violation|0|||
155485074|NCT04212221|561197518|FG006|Overall Study|Protocol Violation|0|||
155485075|NCT04212221|561197519|FG007|Overall Study|Protocol Violation|1|||
155485076|NCT00636506|561197520|FG000|Overall Study|Lost to Follow-up|8|||
155485077|NCT00636506|561197520|FG000|Overall Study|Explanted|1|||
155485078|NCT00636506|561197520|FG000|Overall Study|Withdrawal by Subject|6|||
155485079|NCT00636506|561197520|FG000|Overall Study|Procedure aborted|1|||
155485080|NCT01624974|561197521|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
155485081|NCT01624974|561197522|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
155485082|NCT01624974|561197521|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
155485083|NCT01624974|561197522|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
155485084|NCT01624974|561197521|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
155485085|NCT01624974|561197522|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
155485086|NCT01624974|561197521|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
155485087|NCT01624974|561197522|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
155485088|NCT01624974|561197521|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
155485089|NCT01624974|561197522|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
155485090|NCT01624974|561197521|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
155485091|NCT01624974|561197522|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
155485092|NCT01624974|561197521|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
155485093|NCT01624974|561197522|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
155485094|NCT01624974|561197521|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
155654805|NCT03249558|561828978|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
155521034|NCT00162123|561332613|FG001|Overall Study|Not specified (after start of treatment)|0|||
155521035|NCT00162123|561332614|FG002|Overall Study|Not specified (after start of treatment)|0|||
155521036|NCT00162123|561332615|FG003|Overall Study|Not specified (after start of treatment)|0|||
155521037|NCT00162123|561332616|FG004|Overall Study|Not specified (after start of treatment)|3|||
155521038|NCT00162123|561332617|FG005|Overall Study|Not specified (after start of treatment)|0|||
155521039|NCT00162123|561332618|FG006|Overall Study|Not specified (after start of treatment)|0|||
155521040|NCT00162123|561332619|FG007|Overall Study|Not specified (after start of treatment)|0|||
155521041|NCT00162123|561332612|FG000|Overall Study|Physician Decision|1|||
155521042|NCT00162123|561332613|FG001|Overall Study|Physician Decision|2|||
155521043|NCT00162123|561332614|FG002|Overall Study|Physician Decision|0|||
155521044|NCT00162123|561332615|FG003|Overall Study|Physician Decision|0|||
155521045|NCT00162123|561332616|FG004|Overall Study|Physician Decision|0|||
155521046|NCT00162123|561332617|FG005|Overall Study|Physician Decision|1|||
155521047|NCT00162123|561332618|FG006|Overall Study|Physician Decision|1|||
155521048|NCT00162123|561332619|FG007|Overall Study|Physician Decision|0|||
155521049|NCT00162123|561332612|FG000|Overall Study|Tumor assessment only (not treated)|0|||
155521050|NCT00162123|561332613|FG001|Overall Study|Tumor assessment only (not treated)|0|||
155521051|NCT00162123|561332614|FG002|Overall Study|Tumor assessment only (not treated)|0|||
155521052|NCT00162123|561332615|FG003|Overall Study|Tumor assessment only (not treated)|0|||
155521053|NCT00162123|561332616|FG004|Overall Study|Tumor assessment only (not treated)|0|||
155521054|NCT00162123|561332617|FG005|Overall Study|Tumor assessment only (not treated)|0|||
155521055|NCT00162123|561332618|FG006|Overall Study|Tumor assessment only (not treated)|0|||
155521056|NCT00162123|561332619|FG007|Overall Study|Tumor assessment only (not treated)|1|||
155521057|NCT00162123|561332612|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
155521058|NCT00162123|561332613|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
155521059|NCT00162123|561332614|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
155521060|NCT00162123|561332615|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
155521061|NCT00162123|561332616|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
155521062|NCT00162123|561332617|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
155521063|NCT00162123|561332618|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
155521064|NCT00162123|561332619|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
155521065|NCT01318499|561332621|FG000|Overall Study|Adverse Event|16|||
155521066|NCT01318499|561332622|FG001|Overall Study|Adverse Event|11|||
155521067|NCT01318499|561332623|FG002|Overall Study|Adverse Event|6|||
155521068|NCT01318499|561332621|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
155521069|NCT01318499|561332622|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
155521070|NCT01318499|561332623|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
155521071|NCT01318499|561332621|FG000|Overall Study|Noncompliance|2|||
155521072|NCT01318499|561332622|FG001|Overall Study|Noncompliance|3|||
155521073|NCT01318499|561332623|FG002|Overall Study|Noncompliance|0|||
155521074|NCT01318499|561332621|FG000|Overall Study|Treatment Failure|19|||
155521075|NCT01318499|561332622|FG001|Overall Study|Treatment Failure|19|||
155521076|NCT01318499|561332623|FG002|Overall Study|Treatment Failure|101|||
155521077|NCT01318499|561332621|FG000|Overall Study|Protocol Violation|2|||
155521078|NCT01318499|561332622|FG001|Overall Study|Protocol Violation|4|||
155521079|NCT01318499|561332623|FG002|Overall Study|Protocol Violation|2|||
155521080|NCT01318499|561332621|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
155521081|NCT01318499|561332622|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
155521082|NCT01318499|561332623|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
155521083|NCT01318499|561332621|FG000|Overall Study|Other|7|||
155521084|NCT01318499|561332622|FG001|Overall Study|Other|10|||
155521085|NCT01318499|561332623|FG002|Overall Study|Other|22|||
155521086|NCT01347710|561332626|FG000|Overall Study|Withdrawal by Subject|2|||
155521087|NCT01347710|561332626|FG000|Overall Study|Adverse Event|4|||
155521088|NCT01347710|561332626|FG000|Overall Study|Angio or SPECT not completed|18|||
155521089|NCT01347710|561332626|FG000|Overall Study|issue with vitals prior to dosing|1|||
155521090|NCT01347710|561332626|FG000|Overall Study|Lost to Follow-up|1|||
155521091|NCT01347710|561332626|FG000|Overall Study|Physician Decision|2|||
155521092|NCT01347710|561332626|FG000|Overall Study|Other|3|||
155521093|NCT04591626|561332627|FG000|Overall Study|Adverse Event|4|||
155654806|NCT03249558|561828979|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
155654807|NCT03249558|561828977|FG000|Overall Study|Protocol Violation|1|||
155654808|NCT03249558|561828978|FG001|Overall Study|Protocol Violation|1|||
155521094|NCT04591626|561332628|FG001|Overall Study|Adverse Event|0|||
155521095|NCT04591626|561332627|FG000|Overall Study|Withdrawal by Subject|5|||
155521096|NCT04591626|561332628|FG001|Overall Study|Withdrawal by Subject|3|||
155521097|NCT04591626|561332627|FG000|Overall Study|Physician Decision|0|||
155521098|NCT04591626|561332628|FG001|Overall Study|Physician Decision|1|||
155521099|NCT04591626|561332627|FG000|Overall Study|Death|0|||
155521100|NCT04591626|561332628|FG001|Overall Study|Death|1|||
155521101|NCT04591626|561332627|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155521102|NCT04591626|561332628|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155521103|NCT02003183|561332629|FG000|Overall Study|Lost to Follow-up|0|||
155521104|NCT02003183|561332630|FG001|Overall Study|Lost to Follow-up|2|||
155521105|NCT01759290|561332633|FG000|Overall Study|Subjects withdrawn consent|5|||
155521106|NCT01759290|561332633|FG000|Overall Study|Physician Decision|2|||
155521107|NCT01759290|561332633|FG000|Overall Study|Death|17|||
155521108|NCT01759290|561332633|FG000|Overall Study|Lost to Follow-up|53|||
155521109|NCT01759290|561332633|FG000|Overall Study|Unknown reason|4|||
155521110|NCT00841100|561332634|FG000|Phase 1 (28 Days)|Adverse Event|1|||
155521111|NCT00841100|561332634|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
155521112|NCT03338972|561332637|FG000|Overall Study|Death|1|||
155521113|NCT03338972|561332638|FG001|Overall Study|Death|1|||
155521114|NCT03338972|561332639|FG002|Overall Study|Death|0|||
155521115|NCT03338972|561332640|FG003|Overall Study|Death|0|||
155521116|NCT03338972|561332637|FG000|Overall Study|Withdrawal by Subject|1|||
155521117|NCT03338972|561332638|FG001|Overall Study|Withdrawal by Subject|0|||
155521118|NCT03338972|561332639|FG002|Overall Study|Withdrawal by Subject|0|||
155521119|NCT03338972|561332640|FG003|Overall Study|Withdrawal by Subject|0|||
155521120|NCT06096168|561332643|FG000|Overall Study|Death|30|||
155521121|NCT06096168|561332643|FG000|Overall Study|Revision|2|||
155521122|NCT01868009|561332644|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
155521123|NCT01868009|561332645|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
155521124|NCT01868009|561332644|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
155521125|NCT01868009|561332645|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
155521126|NCT01868009|561332644|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
155521127|NCT01868009|561332645|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
155521128|NCT01046253|561332646|FG000|Second Intervention|Adverse Event|0|||
155521129|NCT01046253|561332647|FG001|Second Intervention|Adverse Event|1|||
155521130|NCT01046253|561332646|FG000|Second Intervention|Protocol Violation|0|||
155521131|NCT01046253|561332647|FG001|Second Intervention|Protocol Violation|1|||
155521132|NCT02339909|561332648|FG000|Overall Study|Became ineligible after randomisation|89|||
155521133|NCT02339909|561332649|FG001|Overall Study|Became ineligible after randomisation|63|||
155521134|NCT02339909|561332650|FG002|Overall Study|Became ineligible after randomisation|71|||
155521135|NCT01054599|561332654|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
155521136|NCT01054599|561332655|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
155521137|NCT01054599|561332654|FG000|Overall Study|Protocol Violation|1|||
155521138|NCT01054599|561332655|FG001|Overall Study|Protocol Violation|0|||
155521139|NCT01054599|561332654|FG000|Overall Study|Spells/seizure-like episodes|1|||
155521140|NCT01054599|561332655|FG001|Overall Study|Spells/seizure-like episodes|1|||
155485095|NCT01624974|561197522|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
155485096|NCT01624974|561197521|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
155485097|NCT01624974|561197522|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
155485098|NCT01624974|561197521|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
155485099|NCT01624974|561197522|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
155485100|NCT01624974|561197521|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
155485101|NCT01624974|561197522|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
155485102|NCT01624974|561197521|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
155485103|NCT01624974|561197522|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
155485104|NCT02607735|561197523|FG000|Primary Study|Randomized but Never Treated|1|||
155485105|NCT02607735|561197524|FG001|Primary Study|Randomized but Never Treated|0|||
155485106|NCT02607735|561197525|FG002|Primary Study|Randomized but Never Treated|0|||
155485107|NCT02607735|561197523|FG000|Primary Study|Lost to Follow-up|4|||
155485108|NCT02607735|561197524|FG001|Primary Study|Lost to Follow-up|0|||
155485109|NCT02607735|561197525|FG002|Primary Study|Lost to Follow-up|0|||
155521141|NCT01054599|561332654|FG000|Overall Study|Timing/scheduling difficulties|1|||
155521142|NCT01054599|561332655|FG001|Overall Study|Timing/scheduling difficulties|1|||
155521143|NCT01054599|561332654|FG000|Overall Study|Visual impairment, WTAR <80|0|||
155521144|NCT01054599|561332655|FG001|Overall Study|Visual impairment, WTAR <80|1|||
155521145|NCT01054599|561332654|FG000|Overall Study|Lost to Follow-up|0|||
155521146|NCT01054599|561332655|FG001|Overall Study|Lost to Follow-up|2|||
155521147|NCT01054599|561332654|FG000|Overall Study|Adverse Event|0|||
155521148|NCT01054599|561332655|FG001|Overall Study|Adverse Event|1|||
155521149|NCT01054599|561332654|FG000|Overall Study|Withdrawal by Subject|0|||
155521150|NCT01054599|561332655|FG001|Overall Study|Withdrawal by Subject|1|||
155521151|NCT01648166|561334023|FG000|Overall Study|inadequate toenail samples|53|||
155485110|NCT02607735|561197523|FG000|Primary Study|Withdrew Consent|2|||
155521152|NCT01648166|561334024|FG001|Overall Study|inadequate toenail samples|100|||
155521153|NCT00883090|561334025|FG000|Overall Study|Sponsor's decision|1|||
155521154|NCT00883090|561334025|FG000|Overall Study|Withdrawal by Subject|1|||
155521155|NCT03831048|561334027|FG000|Overall Study|Protocol Violation|9|||
155521156|NCT03831048|561334028|FG001|Overall Study|Protocol Violation|3|||
155521157|NCT03831048|561334027|FG000|Overall Study|Death|4|||
155521158|NCT03831048|561334028|FG001|Overall Study|Death|9|||
155521159|NCT03831048|561334027|FG000|Overall Study|Re-transplant|0|||
155521160|NCT03831048|561334028|FG001|Overall Study|Re-transplant|2|||
155521161|NCT03831048|561334027|FG000|Overall Study|Protocol violation and death|1|||
155521162|NCT03831048|561334028|FG001|Overall Study|Protocol violation and death|1|||
155521163|NCT01087970|561334029|FG000|Overall Study|Protocol Violation|2|||
155521164|NCT04538170|561334030|FG000|Overall Study|Withdrawal by Subject|104|||
155521165|NCT04538170|561334031|FG001|Overall Study|Withdrawal by Subject|210|||
155521166|NCT01682083|561334033|FG000|Overall Study|Lost to Follow-up|11|||
155521167|NCT01682083|561334034|FG001|Overall Study|Lost to Follow-up|18|||
155521168|NCT01682083|561334033|FG000|Overall Study|Withdrawal by Subject|31|||
155521169|NCT01682083|561334034|FG001|Overall Study|Withdrawal by Subject|40|||
155521170|NCT01682083|561334033|FG000|Overall Study|Death|60|||
155521171|NCT01682083|561334034|FG001|Overall Study|Death|93|||
155521172|NCT01682083|561334033|FG000|Overall Study|Physician Decision|5|||
155521173|NCT01682083|561334034|FG001|Overall Study|Physician Decision|4|||
155521174|NCT02932878|561334035|FG000|Overall Study|Due to Lab Results|2|||
155521175|NCT02932878|561334036|FG001|Overall Study|Due to Lab Results|1|||
155521176|NCT01866319|561334037|FG000|Overall Study|Adverse Event|12|||
155521177|NCT01866319|561334038|FG001|Overall Study|Adverse Event|5|||
155521178|NCT01866319|561334039|FG002|Overall Study|Adverse Event|9|||
155521179|NCT01866319|561334037|FG000|Overall Study|Clinical progression|3|||
155521180|NCT01866319|561334038|FG001|Overall Study|Clinical progression|2|||
155521181|NCT01866319|561334039|FG002|Overall Study|Clinical progression|2|||
155521182|NCT01866319|561334037|FG000|Overall Study|Death|153|||
155521183|NCT01866319|561334038|FG001|Overall Study|Death|154|||
155521184|NCT01866319|561334039|FG002|Overall Study|Death|147|||
155521185|NCT01866319|561334037|FG000|Overall Study|Lost to Follow-up|6|||
155521186|NCT01866319|561334038|FG001|Overall Study|Lost to Follow-up|3|||
155521187|NCT01866319|561334039|FG002|Overall Study|Lost to Follow-up|8|||
155521188|NCT01866319|561334037|FG000|Overall Study|Physician Decision|1|||
155521189|NCT01866319|561334038|FG001|Overall Study|Physician Decision|0|||
155521190|NCT01866319|561334039|FG002|Overall Study|Physician Decision|1|||
155521191|NCT01866319|561334037|FG000|Overall Study|Protocol Violation|0|||
155521192|NCT01866319|561334038|FG001|Overall Study|Protocol Violation|0|||
155521193|NCT01866319|561334039|FG002|Overall Study|Protocol Violation|1|||
155521194|NCT01866319|561334037|FG000|Overall Study|Withdrawal by Subject|32|||
155521195|NCT01866319|561334038|FG001|Overall Study|Withdrawal by Subject|14|||
155521196|NCT01866319|561334039|FG002|Overall Study|Withdrawal by Subject|12|||
155521197|NCT01225146|561334046|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
155521198|NCT01225146|561334047|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
155521199|NCT05150964|561334048|FG000|Overall Study|Lost to Follow-up|2|||
155521200|NCT00623779|561334049|FG000|Overall Study|Adverse Event|1|||
155521201|NCT00623779|561334050|FG001|Overall Study|Adverse Event|3|||
155521202|NCT00623779|561334051|FG002|Overall Study|Adverse Event|0|||
155521203|NCT00623779|561334049|FG000|Overall Study|Criteria from CSR|2|||
155521204|NCT00623779|561334050|FG001|Overall Study|Criteria from CSR|0|||
155521205|NCT00623779|561334051|FG002|Overall Study|Criteria from CSR|1|||
155521206|NCT03912337|561334058|FG000|Overall Study|Withdrawal of Consent From Study|1|||
155521207|NCT03912337|561334059|FG001|Overall Study|Withdrawal of Consent From Study|0|||
155521208|NCT03912337|561334058|FG000|Overall Study|Lost to Follow-up|1|||
155521209|NCT03912337|561334059|FG001|Overall Study|Lost to Follow-up|1|||
155521210|NCT02545998|561334060|FG000|Overall Study|Lost to Follow-up|12|||
155521211|NCT02545998|561334061|FG001|Overall Study|Lost to Follow-up|3|||
155521212|NCT02545998|561334060|FG000|Overall Study|Withdrawal by Subject|3|||
155521213|NCT02545998|561334061|FG001|Overall Study|Withdrawal by Subject|2|||
155521214|NCT00958243|561334068|FG000|Overall Study|Withdrawal by Subject|0|||
155521215|NCT00958243|561334069|FG001|Overall Study|Withdrawal by Subject|1|||
155521216|NCT00958243|561334070|FG002|Overall Study|Withdrawal by Subject|3|||
155521217|NCT00958243|561334071|FG003|Overall Study|Withdrawal by Subject|1|||
155521218|NCT00958243|561334072|FG004|Overall Study|Withdrawal by Subject|1|||
155521219|NCT00958243|561334073|FG005|Overall Study|Withdrawal by Subject|5|||
155521220|NCT00958243|561334068|FG000|Overall Study|Lost to Follow-up|2|||
155521221|NCT00958243|561334069|FG001|Overall Study|Lost to Follow-up|5|||
155521222|NCT00958243|561334070|FG002|Overall Study|Lost to Follow-up|11|||
155521223|NCT00958243|561334071|FG003|Overall Study|Lost to Follow-up|2|||
155521224|NCT00958243|561334072|FG004|Overall Study|Lost to Follow-up|8|||
155521225|NCT00958243|561334073|FG005|Overall Study|Lost to Follow-up|5|||
155521226|NCT06176768|561334074|FG000|Overall Study|Adverse Event|1|||
155521227|NCT06176768|561334075|FG001|Overall Study|Adverse Event|0|||
155521228|NCT06176768|561334074|FG000|Overall Study|Assigned treatment by mistake|1|||
155521229|NCT06176768|561334075|FG001|Overall Study|Assigned treatment by mistake|0|||
155521230|NCT06176768|561334074|FG000|Overall Study|Lost to Follow-up|0|||
155521231|NCT06176768|561334075|FG001|Overall Study|Lost to Follow-up|3|||
155521232|NCT06176768|561334074|FG000|Overall Study|Physician Decision|1|||
155521233|NCT06176768|561334075|FG001|Overall Study|Physician Decision|0|||
155521234|NCT06176768|561334074|FG000|Overall Study|Protocol deviation|3|||
155521235|NCT06176768|561334075|FG001|Overall Study|Protocol deviation|1|||
155521236|NCT06176768|561334074|FG000|Overall Study|Other|1|||
155521237|NCT06176768|561334075|FG001|Overall Study|Other|0|||
155521238|NCT06176768|561334074|FG000|Overall Study|Withdrawal by Subject|6|||
155521239|NCT06176768|561334075|FG001|Overall Study|Withdrawal by Subject|9|||
155521240|NCT02016170|561334076|FG000|Overall Study|Adverse Event|1|||
155521241|NCT02016170|561334077|FG001|Overall Study|Adverse Event|1|||
155521242|NCT02016170|561334078|FG002|Overall Study|Adverse Event|0|||
155521243|NCT02016170|561334076|FG000|Overall Study|Protocol Violation|1|||
155521244|NCT02016170|561334077|FG001|Overall Study|Protocol Violation|0|||
155521245|NCT02016170|561334078|FG002|Overall Study|Protocol Violation|0|||
155521246|NCT01936948|561334081|FG000|Overall Study|no 30-day follow-up data|0|||
155521247|NCT01936948|561334082|FG001|Overall Study|no 30-day follow-up data|3|||
155521248|NCT01936948|561334083|FG002|Overall Study|no 30-day follow-up data|3|||
155521249|NCT01936948|561334084|FG003|Overall Study|no 30-day follow-up data|3|||
155521250|NCT02365207|561334085|FG000|Overall Study|Withdrawal by Subject|1|||
155521251|NCT02365207|561334085|FG000|Overall Study|Physician Decision|1|||
155521252|NCT01395030|561334088|FG000|Overall Study|Did not complete FCH PET/CT|7|||
155521253|NCT01974141|561334092|FG000|Overall Study|Other Reasons|28|||
155521254|NCT01974141|561334093|FG001|Overall Study|Other Reasons|18|||
155521255|NCT01974141|561334092|FG000|Overall Study|Protocol Violation|2|||
155521256|NCT01974141|561334093|FG001|Overall Study|Protocol Violation|6|||
155521257|NCT01974141|561334092|FG000|Overall Study|Personal Reasons|21|||
155521258|NCT01974141|561334093|FG001|Overall Study|Personal Reasons|20|||
155521259|NCT01974141|561334092|FG000|Overall Study|Lost to Follow-up|38|||
155521260|NCT01974141|561334093|FG001|Overall Study|Lost to Follow-up|29|||
155521261|NCT01974141|561334092|FG000|Overall Study|Pregnancy|3|||
155521262|NCT01974141|561334093|FG001|Overall Study|Pregnancy|3|||
155521263|NCT01974141|561334092|FG000|Overall Study|Lack of Efficacy|0|||
155521264|NCT01974141|561334093|FG001|Overall Study|Lack of Efficacy|1|||
155521265|NCT01974141|561334092|FG000|Overall Study|Adverse Event|4|||
155521266|NCT01974141|561334093|FG001|Overall Study|Adverse Event|5|||
155521267|NCT02327130|561334096|FG000|Overall Study|Discharged in less than 5 days|5|||
155521268|NCT02327130|561334096|FG000|Overall Study|Physician Decision|2|||
155521269|NCT02327130|561334096|FG000|Overall Study|Unable to provide breath sample|1|||
155521270|NCT02327130|561334096|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
155521271|NCT02327130|561334096|FG000|Overall Study|Met exclusion criteria|3|||
155521272|NCT05214560|561334098|FG000|Overall Study|Screening Failure|1|||
155521273|NCT05214560|561334098|FG000|Overall Study|Physician Decision|4|||
155521274|NCT05214560|561334098|FG000|Overall Study|Withdrawal by Subject|1|||
155521275|NCT05214560|561334098|FG000|Overall Study|Lost to Follow-up|2|||
155521276|NCT05214560|561334098|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
155521277|NCT05214560|561334098|FG000|Overall Study|Study physician not available for the anesthesia|3|||
155654809|NCT03249558|561828979|FG002|Overall Study|Protocol Violation|2|||
155654810|NCT02657356|561830540|FG000|Overall Study|Death|1|||
155521278|NCT05214560|561334098|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
155521279|NCT05214560|561334098|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
155521280|NCT05214560|561334098|FG000|Overall Study|Surgery not performed|3|||
155521281|NCT04977336|561334099|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
155521282|NCT04977336|561334100|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155521283|NCT04977336|561334101|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155521284|NCT04977336|561334102|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
155521285|NCT04977336|561334103|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
155521286|NCT04977336|561334099|FG000|Overall Study|Lost to Follow-up|0|||
155521287|NCT04977336|561334100|FG001|Overall Study|Lost to Follow-up|0|||
155521288|NCT04977336|561334101|FG002|Overall Study|Lost to Follow-up|1|||
155521289|NCT04977336|561334102|FG003|Overall Study|Lost to Follow-up|0|||
155521290|NCT04977336|561334103|FG004|Overall Study|Lost to Follow-up|0|||
155521291|NCT03298451|561334104|FG000|Overall Study|Death|275|||
155521292|NCT03298451|561334105|FG001|Overall Study|Death|260|||
155521293|NCT03298451|561334106|FG002|Overall Study|Death|122|||
155485111|NCT02607735|561197524|FG001|Primary Study|Withdrew Consent|0|||
155485112|NCT02607735|561197525|FG002|Primary Study|Withdrew Consent|0|||
155485113|NCT02607735|561197523|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
155485114|NCT02607735|561197524|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
155485115|NCT02607735|561197525|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
155485116|NCT02607735|561197523|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
155485117|NCT02607735|561197524|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
155485118|NCT02607735|561197525|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
155485119|NCT01376908|561197526|FG000|Overall Study|Protocol Violation|1|||
155485120|NCT01376908|561197527|FG001|Overall Study|Protocol Violation|1|||
155485121|NCT01376908|561197526|FG000|Overall Study|Withdrawal by Subject|1|||
155485122|NCT01376908|561197527|FG001|Overall Study|Withdrawal by Subject|2|||
155485123|NCT01646255|561197528|FG000|Overall Study|Adverse Event|7|||
155485124|NCT01646255|561197529|FG001|Overall Study|Adverse Event|8|||
155485125|NCT01646255|561197528|FG000|Overall Study|Lack of Efficacy|2|||
155485126|NCT01646255|561197529|FG001|Overall Study|Lack of Efficacy|0|||
155485127|NCT01646255|561197528|FG000|Overall Study|Withdrawal by Subject|10|||
155485128|NCT01646255|561197529|FG001|Overall Study|Withdrawal by Subject|6|||
155485129|NCT01646255|561197528|FG000|Overall Study|Compliance is not well|1|||
155485130|NCT01646255|561197529|FG001|Overall Study|Compliance is not well|0|||
155485131|NCT01646255|561197528|FG000|Overall Study|Inclusion Criteria Deviation|1|||
155485132|NCT01646255|561197529|FG001|Overall Study|Inclusion Criteria Deviation|0|||
155485133|NCT00742391|561197532|FG000|Overall Study|Adverse Event|2|||
155485134|NCT00742391|561197533|FG001|Overall Study|Adverse Event|1|||
155485135|NCT00742391|561197532|FG000|Overall Study|Lost to Follow-up|1|||
155485136|NCT00742391|561197533|FG001|Overall Study|Lost to Follow-up|0|||
155485137|NCT00742391|561197532|FG000|Overall Study|Protocol Violation|1|||
155485138|NCT00742391|561197533|FG001|Overall Study|Protocol Violation|0|||
155485139|NCT01241318|561197536|FG000|Overall Study|Woman: false pregnancies|27|||
155485140|NCT01241318|561197537|FG001|Overall Study|Woman: false pregnancies|15|||
155485141|NCT01241318|561197536|FG000|Overall Study|Woman: miscarriage/abortion|46|||
155485142|NCT01241318|561197537|FG001|Overall Study|Woman: miscarriage/abortion|38|||
155485143|NCT01241318|561197536|FG000|Overall Study|Withdrawal by Subject|175|||
155485144|NCT01241318|561197537|FG001|Overall Study|Withdrawal by Subject|46|||
155485145|NCT01241318|561197536|FG000|Overall Study|Lost to Follow-up|740|||
155485146|NCT01241318|561197537|FG001|Overall Study|Lost to Follow-up|455|||
155485147|NCT01241318|561197536|FG000|Overall Study|Death|2|||
155485148|NCT01241318|561197537|FG001|Overall Study|Death|4|||
155485149|NCT01241318|561197536|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
155485150|NCT01241318|561197537|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
155485151|NCT01241318|561197536|FG000|Overall Study|Woman: Stillborn infant|129|||
155485152|NCT01241318|561197537|FG001|Overall Study|Woman: Stillborn infant|146|||
155485153|NCT02355665|561197538|FG000|Overall Study|Adverse Event|16|||
155485154|NCT02355665|561197539|FG001|Overall Study|Adverse Event|24|||
155485155|NCT02355665|561197538|FG000|Overall Study|Protocol Violation|2|||
155485156|NCT02355665|561197539|FG001|Overall Study|Protocol Violation|0|||
155485157|NCT02355665|561197538|FG000|Overall Study|Withdrawal by Subject|90|||
155485158|NCT02355665|561197539|FG001|Overall Study|Withdrawal by Subject|100|||
155485159|NCT02355665|561197538|FG000|Overall Study|Lost to Follow-up|131|||
155485160|NCT02355665|561197539|FG001|Overall Study|Lost to Follow-up|103|||
155485161|NCT02355665|561197538|FG000|Overall Study|Death|4|||
155485162|NCT02355665|561197539|FG001|Overall Study|Death|2|||
155485163|NCT02355665|561197538|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
155485164|NCT02355665|561197539|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
155485165|NCT02380703|561197540|FG000|Overall Study|Withdrawal by Subject|12|||
155485166|NCT02380703|561197541|FG001|Overall Study|Withdrawal by Subject|9|||
155485167|NCT02380703|561197540|FG000|Overall Study|Lost to Follow-up|12|||
155485168|NCT02380703|561197541|FG001|Overall Study|Lost to Follow-up|12|||
155485169|NCT02380703|561197540|FG000|Overall Study|Caregiver death|1|||
155485170|NCT02380703|561197541|FG001|Overall Study|Caregiver death|0|||
155485171|NCT02380703|561197540|FG000|Overall Study|Person with dementia (PWD) death|7|||
155485172|NCT02380703|561197541|FG001|Overall Study|Person with dementia (PWD) death|8|||
155485173|NCT02380703|561197540|FG000|Overall Study|Entered Long-term Care|4|||
155485174|NCT02380703|561197541|FG001|Overall Study|Entered Long-term Care|7|||
155485175|NCT03607994|561197542|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
155485176|NCT03607994|561197543|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
155485177|NCT01882439|561197552|FG000|Overall Study|Adverse event related to study drug|3|||
155485178|NCT01882439|561197553|FG001|Overall Study|Adverse event related to study drug|8|||
155654811|NCT02657356|561830541|FG001|Overall Study|Death|0|||
155654812|NCT02657356|561830540|FG000|Overall Study|Withdrawal by Subject|5|||
155654813|NCT02657356|561830541|FG001|Overall Study|Withdrawal by Subject|6|||
155521294|NCT03298451|561334107|FG003|Overall Study|Death|280|||
155521295|NCT03298451|561334104|FG000|Overall Study|Lost to Follow-up|1|||
155521296|NCT03298451|561334105|FG001|Overall Study|Lost to Follow-up|1|||
155521297|NCT03298451|561334106|FG002|Overall Study|Lost to Follow-up|0|||
155521298|NCT03298451|561334107|FG003|Overall Study|Lost to Follow-up|7|||
155521299|NCT03298451|561334104|FG000|Overall Study|Withdrawal by Subject|9|||
155521300|NCT03298451|561334105|FG001|Overall Study|Withdrawal by Subject|7|||
155521301|NCT03298451|561334106|FG002|Overall Study|Withdrawal by Subject|1|||
155521302|NCT03298451|561334107|FG003|Overall Study|Withdrawal by Subject|20|||
155521303|NCT02672553|561334110|FG000|Overall Study|Death|3|||
155521304|NCT02672553|561334111|FG001|Overall Study|Death|5|||
155521305|NCT02672553|561334110|FG000|Overall Study|Valve Explant|1|||
155521306|NCT02672553|561334111|FG001|Overall Study|Valve Explant|0|||
155521307|NCT02672553|561334110|FG000|Overall Study|Conversion to Commercial Valve|3|||
155521308|NCT02672553|561334111|FG001|Overall Study|Conversion to Commercial Valve|0|||
155521309|NCT02672553|561334110|FG000|Overall Study|Withdrawal by Subject|3|||
155521310|NCT02672553|561334111|FG001|Overall Study|Withdrawal by Subject|3|||
155521311|NCT02672553|561334110|FG000|Overall Study|Intraoperative screen failure|2|||
155521312|NCT02672553|561334111|FG001|Overall Study|Intraoperative screen failure|0|||
155521313|NCT00970281|561334114|FG000|Overall Study|Lack of Efficacy|1|||
155521314|NCT00970281|561334115|FG001|Overall Study|Lack of Efficacy|14|||
155521315|NCT00970281|561334114|FG000|Overall Study|Withdrawal by Subject|0|||
155521316|NCT00970281|561334115|FG001|Overall Study|Withdrawal by Subject|1|||
155521317|NCT00970281|561334114|FG000|Overall Study|Physician Decision|1|||
155521318|NCT00970281|561334115|FG001|Overall Study|Physician Decision|1|||
155521319|NCT00878995|561334116|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
155521320|NCT00878995|561334117|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
155521321|NCT02480764|561334118|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155521322|NCT02480764|561334119|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
155521323|NCT02480764|561334120|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
155521324|NCT02480764|561334118|FG000|Overall Study|Major Protocol Deviation|1|||
155521325|NCT02480764|561334119|FG001|Overall Study|Major Protocol Deviation|4|||
155521326|NCT02480764|561334120|FG002|Overall Study|Major Protocol Deviation|3|||
155521327|NCT02480764|561334118|FG000|Overall Study|Lost to Follow-up|0|||
155521328|NCT02480764|561334119|FG001|Overall Study|Lost to Follow-up|1|||
155521329|NCT02480764|561334120|FG002|Overall Study|Lost to Follow-up|2|||
155521330|NCT02480764|561334118|FG000|Overall Study|Voluntary Withdrawal|6|||
155521331|NCT02480764|561334119|FG001|Overall Study|Voluntary Withdrawal|5|||
155521332|NCT02480764|561334120|FG002|Overall Study|Voluntary Withdrawal|10|||
155521333|NCT02480764|561334118|FG000|Overall Study|Lack of Efficacy|0|||
155521334|NCT02480764|561334119|FG001|Overall Study|Lack of Efficacy|3|||
155521335|NCT02480764|561334120|FG002|Overall Study|Lack of Efficacy|3|||
155521336|NCT02480764|561334118|FG000|Overall Study|Reason not Specified|0|||
155521337|NCT02480764|561334119|FG001|Overall Study|Reason not Specified|1|||
155521338|NCT02480764|561334120|FG002|Overall Study|Reason not Specified|0|||
155521339|NCT03629249|561334121|FG000|Overall Study|Study terminated by sponsor|197|||
155521340|NCT03629249|561334122|FG001|Overall Study|Study terminated by sponsor|197|||
155521341|NCT03629249|561334123|FG002|Overall Study|Study terminated by sponsor|194|||
155521342|NCT03629249|561334121|FG000|Overall Study|Protocol deviation|0|||
155521343|NCT03629249|561334122|FG001|Overall Study|Protocol deviation|2|||
155521344|NCT03629249|561334123|FG002|Overall Study|Protocol deviation|5|||
155521345|NCT03629249|561334121|FG000|Overall Study|Subject decision|1|||
155521346|NCT03629249|561334122|FG001|Overall Study|Subject decision|1|||
155521347|NCT03629249|561334123|FG002|Overall Study|Subject decision|3|||
155521348|NCT03629249|561334121|FG000|Overall Study|Adverse Event|1|||
155521349|NCT03629249|561334122|FG001|Overall Study|Adverse Event|1|||
155521350|NCT03629249|561334123|FG002|Overall Study|Adverse Event|0|||
155521351|NCT03629249|561334121|FG000|Overall Study|Death|1|||
155521352|NCT03629249|561334122|FG001|Overall Study|Death|0|||
155521353|NCT03629249|561334123|FG002|Overall Study|Death|0|||
155521354|NCT03629249|561334121|FG000|Overall Study|Physician Decision|1|||
155521355|NCT03629249|561334122|FG001|Overall Study|Physician Decision|0|||
155521356|NCT03629249|561334123|FG002|Overall Study|Physician Decision|0|||
155521357|NCT00352690|561334124|FG000|Overall Study|Determined to be ineligible|2|||
155521358|NCT00352690|561334125|FG001|Overall Study|Determined to be ineligible|0|||
155521359|NCT03633721|561334128|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
155521360|NCT03633721|561334129|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
155521361|NCT03633721|561334130|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
155521362|NCT03633721|561334131|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
155521363|NCT01475474|561334135|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
155521364|NCT01475474|561334135|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
155521365|NCT02343120|561334136|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
155521366|NCT02343120|561334137|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
155521367|NCT02343120|561334138|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
155521368|NCT02343120|561334139|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
155521369|NCT02343120|561334140|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
155521370|NCT02343120|561334136|FG000|Part 1: Dose Escalation|Death|1|||
155521371|NCT02343120|561334137|FG001|Part 1: Dose Escalation|Death|2|||
155521372|NCT02343120|561334138|FG002|Part 1: Dose Escalation|Death|2|||
155521373|NCT02343120|561334139|FG003|Part 1: Dose Escalation|Death|2|||
155521374|NCT02343120|561334140|FG004|Part 1: Dose Escalation|Death|1|||
155521375|NCT02343120|561334136|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
155521376|NCT02343120|561334137|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155521377|NCT02343120|561334138|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
155521378|NCT02343120|561334139|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
155521379|NCT02343120|561334140|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
155521380|NCT02343120|561334136|FG000|Part 2: Expansion|Sponsor decision|0|||
155521381|NCT02343120|561334137|FG001|Part 2: Expansion|Sponsor decision|0|||
155521382|NCT02343120|561334138|FG002|Part 2: Expansion|Sponsor decision|0|||
155521383|NCT02343120|561334139|FG003|Part 2: Expansion|Sponsor decision|165|||
155521384|NCT02343120|561334140|FG004|Part 2: Expansion|Sponsor decision|67|||
155521385|NCT02343120|561334136|FG000|Part 2: Expansion|Death|0|||
155521386|NCT02343120|561334137|FG001|Part 2: Expansion|Death|0|||
155521387|NCT02343120|561334138|FG002|Part 2: Expansion|Death|0|||
155521388|NCT02343120|561334139|FG003|Part 2: Expansion|Death|74|||
155521389|NCT02343120|561334140|FG004|Part 2: Expansion|Death|17|||
155521390|NCT02343120|561334136|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
155521391|NCT02343120|561334137|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
155521392|NCT02343120|561334138|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
155521393|NCT02343120|561334139|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
155521394|NCT02343120|561334140|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
155521395|NCT02343120|561334136|FG000|Part 2: Expansion|Lost to Follow-up|0|||
155521396|NCT02343120|561334137|FG001|Part 2: Expansion|Lost to Follow-up|0|||
155654814|NCT02657356|561830540|FG000|Overall Study|Terminated by Sponsor|8|||
155654815|NCT02657356|561830541|FG001|Overall Study|Terminated by Sponsor|5|||
155654816|NCT02657356|561830540|FG000|Overall Study|Rolled over to EAP study|6|||
155521397|NCT02343120|561334138|FG002|Part 2: Expansion|Lost to Follow-up|0|||
155521398|NCT02343120|561334139|FG003|Part 2: Expansion|Lost to Follow-up|5|||
155521399|NCT02343120|561334140|FG004|Part 2: Expansion|Lost to Follow-up|2|||
155521400|NCT02343120|561334136|FG000|Part 2: Expansion|Other|0|||
155521401|NCT02343120|561334137|FG001|Part 2: Expansion|Other|0|||
155521402|NCT02343120|561334138|FG002|Part 2: Expansion|Other|0|||
155521403|NCT02343120|561334139|FG003|Part 2: Expansion|Other|1|||
155521404|NCT02343120|561334140|FG004|Part 2: Expansion|Other|5|||
155521405|NCT02343120|561334136|FG000|Part 2: Expansion|Adverse Event|0|||
155521406|NCT02343120|561334137|FG001|Part 2: Expansion|Adverse Event|0|||
155521407|NCT02343120|561334138|FG002|Part 2: Expansion|Adverse Event|0|||
155521408|NCT02343120|561334139|FG003|Part 2: Expansion|Adverse Event|1|||
155521409|NCT02343120|561334140|FG004|Part 2: Expansion|Adverse Event|1|||
155521410|NCT02534493|561334150|FG000|Overall Study|Lost to Follow-up|1|||
155521411|NCT02534493|561334150|FG000|Overall Study|Withdrawal by Subject|1|||
155521412|NCT01766778|561334155|FG000|Overall Study|Adverse Event|4|||
155521413|NCT01766778|561334156|FG001|Overall Study|Adverse Event|4|||
155521414|NCT01766778|561334155|FG000|Overall Study|Withdrawal by Subject|1|||
155521415|NCT01766778|561334156|FG001|Overall Study|Withdrawal by Subject|0|||
155521416|NCT01104662|561334157|FG000|Overall Study|Adverse Event|2|||
155521417|NCT01104662|561334158|FG001|Overall Study|Adverse Event|2|||
155521418|NCT01104662|561334159|FG002|Overall Study|Adverse Event|0|||
155654817|NCT02657356|561830541|FG001|Overall Study|Rolled over to EAP study|4|||
155654818|NCT03379870|561830542|FG000|Overall Study|Lost to Follow-up|1|||
155654819|NCT03379870|561830543|FG001|Overall Study|Lost to Follow-up|0|||
155521419|NCT01104662|561334160|FG003|Overall Study|Adverse Event|1|||
155521420|NCT01104662|561334161|FG004|Overall Study|Adverse Event|1|||
155521421|NCT01104662|561334162|FG005|Overall Study|Adverse Event|1|||
155521422|NCT01104662|561334163|FG006|Overall Study|Adverse Event|0|||
155521423|NCT01104662|561334164|FG007|Overall Study|Adverse Event|0|||
155521424|NCT01104662|561334157|FG000|Overall Study|Clinical Failure|1|||
155521425|NCT01104662|561334158|FG001|Overall Study|Clinical Failure|0|||
155521426|NCT01104662|561334159|FG002|Overall Study|Clinical Failure|0|||
155521427|NCT01104662|561334160|FG003|Overall Study|Clinical Failure|0|||
155521428|NCT01104662|561334161|FG004|Overall Study|Clinical Failure|0|||
155654820|NCT03379870|561830542|FG000|Overall Study|Protocol Violation|1|||
155521429|NCT01104662|561334162|FG005|Overall Study|Clinical Failure|1|||
155521430|NCT01104662|561334163|FG006|Overall Study|Clinical Failure|0|||
155521431|NCT01104662|561334164|FG007|Overall Study|Clinical Failure|0|||
155654821|NCT03379870|561830543|FG001|Overall Study|Protocol Violation|1|||
155485179|NCT01882439|561197554|FG002|Overall Study|Adverse event related to study drug|1|||
155485180|NCT01882439|561197555|FG003|Overall Study|Adverse event related to study drug|2|||
155485181|NCT01882439|561197552|FG000|Overall Study|Pregnancy|0|||
155485182|NCT01882439|561197553|FG001|Overall Study|Pregnancy|1|||
155485183|NCT01882439|561197554|FG002|Overall Study|Pregnancy|0|||
155485184|NCT01882439|561197555|FG003|Overall Study|Pregnancy|0|||
155485185|NCT01882439|561197552|FG000|Overall Study|Protocol Violation|2|||
155485186|NCT01882439|561197553|FG001|Overall Study|Protocol Violation|2|||
155485187|NCT01882439|561197554|FG002|Overall Study|Protocol Violation|0|||
155485188|NCT01882439|561197555|FG003|Overall Study|Protocol Violation|1|||
155485189|NCT01882439|561197552|FG000|Overall Study|No longer willing to participate|1|||
155485190|NCT01882439|561197553|FG001|Overall Study|No longer willing to participate|4|||
155485191|NCT01882439|561197554|FG002|Overall Study|No longer willing to participate|2|||
155485192|NCT01882439|561197555|FG003|Overall Study|No longer willing to participate|3|||
155485193|NCT01882439|561197552|FG000|Overall Study|Medication error with no associated AE|0|||
155485194|NCT01882439|561197553|FG001|Overall Study|Medication error with no associated AE|0|||
155485195|NCT01882439|561197554|FG002|Overall Study|Medication error with no associated AE|2|||
155485196|NCT01882439|561197555|FG003|Overall Study|Medication error with no associated AE|0|||
155485197|NCT01882439|561197552|FG000|Overall Study|Insufficient clinical response|1|||
155485198|NCT01882439|561197553|FG001|Overall Study|Insufficient clinical response|4|||
155485199|NCT01882439|561197554|FG002|Overall Study|Insufficient clinical response|4|||
155485200|NCT01882439|561197555|FG003|Overall Study|Insufficient clinical response|2|||
155485201|NCT01882439|561197552|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155485202|NCT01882439|561197553|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155485203|NCT01882439|561197554|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155485204|NCT01882439|561197555|FG003|Overall Study|Adverse event unrelated to study drug|1|||
155485205|NCT01775995|561197556|FG000|Overall Study|Lost to Follow-up|1|||
155485206|NCT01775995|561197557|FG001|Overall Study|Lost to Follow-up|1|||
155485207|NCT01997333|561197558|FG000|Randomization and Treatment|Disease Progression|70|||
155485208|NCT01997333|561197559|FG001|Randomization and Treatment|Disease Progression|159|||
155485209|NCT01997333|561197558|FG000|Randomization and Treatment|Adverse Event|10|||
155485210|NCT01997333|561197559|FG001|Randomization and Treatment|Adverse Event|32|||
155485211|NCT01997333|561197558|FG000|Randomization and Treatment|Physician Decision|0|||
155485212|NCT01997333|561197559|FG001|Randomization and Treatment|Physician Decision|4|||
155485213|NCT01997333|561197558|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
155485214|NCT01997333|561197559|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
155485215|NCT01997333|561197558|FG000|Randomization and Treatment|Did not receive treatment|17|||
155485216|NCT01997333|561197559|FG001|Randomization and Treatment|Did not receive treatment|5|||
155485217|NCT01997333|561197558|FG000|Survival Follow up|Withdrawal by Subject|15|||
155485218|NCT01997333|561197559|FG001|Survival Follow up|Withdrawal by Subject|6|||
155485219|NCT01997333|561197558|FG000|Survival Follow up|Lost to Follow-up|0|||
155485220|NCT01997333|561197559|FG001|Survival Follow up|Lost to Follow-up|6|||
155485221|NCT01997333|561197558|FG000|Survival Follow up|Various|1|||
155485222|NCT01997333|561197559|FG001|Survival Follow up|Various|2|||
155485223|NCT03691831|561199778|FG000|Overall Study|Lost to Follow-up|16|||
155485224|NCT03691831|561199779|FG001|Overall Study|Lost to Follow-up|12|||
155485225|NCT03691831|561199778|FG000|Overall Study|Withdrawal by Subject|9|||
155485226|NCT03691831|561199779|FG001|Overall Study|Withdrawal by Subject|17|||
155485227|NCT03691831|561199778|FG000|Overall Study|Investigator Decision|2|||
155485228|NCT03691831|561199779|FG001|Overall Study|Investigator Decision|2|||
155485229|NCT02198040|561199780|FG000|Overall Study|Work reasons|0|||
155485230|NCT02198040|561199781|FG001|Overall Study|Work reasons|1|||
155485231|NCT02198040|561199782|FG002|Overall Study|Work reasons|0|||
155485232|NCT02198040|561199780|FG000|Overall Study|Withdrawal by Subject|0|||
155485233|NCT02198040|561199781|FG001|Overall Study|Withdrawal by Subject|0|||
155485234|NCT02198040|561199782|FG002|Overall Study|Withdrawal by Subject|1|||
155485235|NCT00337935|561199783|FG000|Overall Study|Adverse Event|2|||
155485236|NCT00337935|561199784|FG001|Overall Study|Adverse Event|5|||
155485237|NCT00337935|561199783|FG000|Overall Study|Death|2|||
155485238|NCT00337935|561199784|FG001|Overall Study|Death|8|||
155485239|NCT00337935|561199783|FG000|Overall Study|Physician Decision|1|||
155485240|NCT00337935|561199784|FG001|Overall Study|Physician Decision|1|||
155654822|NCT03058952|561830544|FG000|Overall Study|Adverse Event|1|||
155485241|NCT00337935|561199783|FG000|Overall Study|Lost to Follow-up|0|||
155485242|NCT00337935|561199784|FG001|Overall Study|Lost to Follow-up|1|||
155485243|NCT00337935|561199783|FG000|Overall Study|Protocol Violation|4|||
155485244|NCT00337935|561199784|FG001|Overall Study|Protocol Violation|3|||
155485245|NCT00337935|561199783|FG000|Overall Study|Withdrawal by Subject|1|||
155485246|NCT00337935|561199784|FG001|Overall Study|Withdrawal by Subject|7|||
155485247|NCT00337935|561199783|FG000|Overall Study|Other|0|||
155485248|NCT00337935|561199784|FG001|Overall Study|Other|1|||
155485249|NCT00337935|561199783|FG000|Overall Study|Lack of Efficacy|0|||
155485250|NCT00337935|561199784|FG001|Overall Study|Lack of Efficacy|1|||
155485251|NCT01189201|561199791|FG000|Overall Study|Adverse Event|1|||
155654823|NCT03058952|561830545|FG001|Overall Study|Adverse Event|0|||
155521432|NCT01104662|561334157|FG000|Overall Study|Participant left investigator's care|1|||
155521433|NCT01104662|561334158|FG001|Overall Study|Participant left investigator's care|1|||
155521434|NCT01104662|561334159|FG002|Overall Study|Participant left investigator's care|0|||
155521435|NCT01104662|561334160|FG003|Overall Study|Participant left investigator's care|0|||
155521436|NCT01104662|561334161|FG004|Overall Study|Participant left investigator's care|0|||
155521437|NCT01104662|561334162|FG005|Overall Study|Participant left investigator's care|0|||
155521438|NCT01104662|561334163|FG006|Overall Study|Participant left investigator's care|0|||
155521439|NCT01104662|561334164|FG007|Overall Study|Participant left investigator's care|0|||
155521440|NCT01104662|561334157|FG000|Overall Study|Reason not specified|3|||
155521441|NCT01104662|561334158|FG001|Overall Study|Reason not specified|3|||
155521442|NCT01104662|561334159|FG002|Overall Study|Reason not specified|0|||
155521443|NCT01104662|561334160|FG003|Overall Study|Reason not specified|0|||
155521444|NCT01104662|561334161|FG004|Overall Study|Reason not specified|0|||
155521445|NCT01104662|561334162|FG005|Overall Study|Reason not specified|1|||
155521446|NCT01104662|561334163|FG006|Overall Study|Reason not specified|0|||
155521447|NCT01104662|561334164|FG007|Overall Study|Reason not specified|0|||
155521448|NCT01104662|561334157|FG000|Overall Study|Randomized but not treated|3|||
155521449|NCT01104662|561334158|FG001|Overall Study|Randomized but not treated|4|||
155521450|NCT01104662|561334159|FG002|Overall Study|Randomized but not treated|1|||
155521451|NCT01104662|561334160|FG003|Overall Study|Randomized but not treated|0|||
155521452|NCT01104662|561334161|FG004|Overall Study|Randomized but not treated|0|||
155521453|NCT01104662|561334162|FG005|Overall Study|Randomized but not treated|1|||
155521454|NCT01104662|561334163|FG006|Overall Study|Randomized but not treated|0|||
155521455|NCT01104662|561334164|FG007|Overall Study|Randomized but not treated|0|||
155521456|NCT01478620|561334165|FG000|Overall Study|Lost to Follow-up|6|||
155521457|NCT02514174|561334169|FG000|Overall Study|Patient refused to continue medication|1|||
155521458|NCT02514174|561334169|FG000|Overall Study|Adverse Event|2|||
155521459|NCT02514174|561334169|FG000|Overall Study|Study closed by sponsor|9|||
155521460|NCT02514174|561334169|FG000|Overall Study|Progressive disease|11|||
155521461|NCT02514174|561334169|FG000|Overall Study|Treatment change|1|||
155521462|NCT02514174|561334169|FG000|Overall Study|Treated off study with Afatinib.|1|||
155521463|NCT02888171|561334174|FG000|Overall Study|Lost to Follow-up|2|||
155521464|NCT02888171|561334175|FG001|Overall Study|Lost to Follow-up|1|||
155521465|NCT02888171|561334174|FG000|Overall Study|Withdrawal by Subject|3|||
155521466|NCT02888171|561334175|FG001|Overall Study|Withdrawal by Subject|2|||
155521467|NCT02888171|561334174|FG000|Overall Study|Adverse Event|0|||
155521468|NCT02888171|561334175|FG001|Overall Study|Adverse Event|1|||
155521469|NCT04349917|561335377|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
155521470|NCT04349917|561335378|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
155521471|NCT04349917|561335377|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
155521472|NCT04349917|561335378|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
155521473|NCT00441467|561335383|FG000|Overall Study|Adverse Event|6|||
155521474|NCT00441467|561335383|FG000|Overall Study|Withdrawal by Subject|3|||
155521475|NCT00441467|561335383|FG000|Overall Study|Progressive disease|9|||
155521476|NCT02289963|561335384|FG000|Overall Study|Adverse Event|1|||
155521477|NCT02289963|561335385|FG001|Overall Study|Adverse Event|2|||
155521478|NCT02289963|561335384|FG000|Overall Study|Poor compliance to protocol|1|||
155521479|NCT02289963|561335385|FG001|Overall Study|Poor compliance to protocol|0|||
155521480|NCT02289963|561335384|FG000|Overall Study|Withdrawal by Subject|1|||
155521481|NCT02289963|561335385|FG001|Overall Study|Withdrawal by Subject|0|||
155521482|NCT02289963|561335384|FG000|Overall Study|Last injection missed|2|||
155521483|NCT02289963|561335385|FG001|Overall Study|Last injection missed|2|||
155521484|NCT02289963|561335384|FG000|Overall Study|End treatment visit outside visit window|0|||
155521485|NCT02289963|561335385|FG001|Overall Study|End treatment visit outside visit window|4|||
155521486|NCT02289963|561335384|FG000|Overall Study|Other than specified above|0|||
155521487|NCT02289963|561335385|FG001|Overall Study|Other than specified above|2|||
155521488|NCT01042522|561335387|FG000|Overall Study|Adverse Event|1|||
155521489|NCT01042522|561335388|FG001|Overall Study|Adverse Event|2|||
155521490|NCT01042522|561335387|FG000|Overall Study|Disease Progression|5|||
155521491|NCT01042522|561335388|FG001|Overall Study|Disease Progression|0|||
155521492|NCT01042522|561335387|FG000|Overall Study|Death|1|||
155521493|NCT01042522|561335388|FG001|Overall Study|Death|0|||
155521494|NCT01042522|561335387|FG000|Overall Study|Patient Refused|0|||
155521495|NCT01042522|561335388|FG001|Overall Study|Patient Refused|3|||
155521496|NCT01042522|561335387|FG000|Overall Study|Withdrawal by Subject|1|||
155521497|NCT01042522|561335388|FG001|Overall Study|Withdrawal by Subject|1|||
155521498|NCT00745420|561335390|FG000|Overall Study|Ineligible|1|||
155521499|NCT01941095|561335391|FG000|Overall Study|Insufficient therapeutic response|13|||
155521500|NCT01941095|561335391|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
155521501|NCT01941095|561335391|FG000|Overall Study|Adverse Event|11|||
155521502|NCT01941095|561335391|FG000|Overall Study|Physician Decision|3|||
155521503|NCT01941095|561335391|FG000|Overall Study|Withdrawal by Subject|17|||
155521504|NCT01941095|561335391|FG000|Overall Study|Lost to Follow-up|10|||
155521505|NCT03164772|561335403|FG000|Overall Study|Death|4|||
155521506|NCT03164772|561335404|FG001|Overall Study|Death|2|||
155521507|NCT03164772|561335403|FG000|Overall Study|Adverse Event|1|||
155521508|NCT03164772|561335404|FG001|Overall Study|Adverse Event|4|||
155521509|NCT03164772|561335403|FG000|Overall Study|Progressive Disease|11|||
155521510|NCT03164772|561335404|FG001|Overall Study|Progressive Disease|21|||
155521511|NCT03164772|561335403|FG000|Overall Study|Physician Decision|2|||
155521512|NCT03164772|561335404|FG001|Overall Study|Physician Decision|0|||
155521513|NCT03164772|561335403|FG000|Overall Study|Withdrawal by Subject|0|||
155521514|NCT03164772|561335404|FG001|Overall Study|Withdrawal by Subject|4|||
155521515|NCT00849901|561335409|FG000|Acute Treatment Phase|Adverse Event|9|||
155521516|NCT00849901|561335410|FG001|Acute Treatment Phase|Adverse Event|1|||
155521517|NCT00849901|561335411|FG002|Acute Treatment Phase|Adverse Event|3|||
155521518|NCT00849901|561335409|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
155521519|NCT00849901|561335410|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
155521520|NCT00849901|561335411|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
155521521|NCT00849901|561335409|FG000|Acute Treatment Phase|Protocol Violation|0|||
155521522|NCT00849901|561335410|FG001|Acute Treatment Phase|Protocol Violation|2|||
155521523|NCT00849901|561335411|FG002|Acute Treatment Phase|Protocol Violation|1|||
155521524|NCT00849901|561335409|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
155521525|NCT00849901|561335410|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
155521526|NCT00849901|561335411|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
155521527|NCT00849901|561335409|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
155521528|NCT00849901|561335410|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
155521529|NCT00849901|561335411|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
155521530|NCT00849901|561335409|FG000|Acute Treatment Phase|Physician Decision|1|||
155521531|NCT00849901|561335410|FG001|Acute Treatment Phase|Physician Decision|1|||
155521532|NCT00849901|561335411|FG002|Acute Treatment Phase|Physician Decision|1|||
155521533|NCT00849901|561335409|FG000|Acute Treatment Phase|Sponsor Decision|1|||
155521534|NCT00849901|561335410|FG001|Acute Treatment Phase|Sponsor Decision|0|||
155521535|NCT00849901|561335411|FG002|Acute Treatment Phase|Sponsor Decision|0|||
155521536|NCT00849901|561335409|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
155521537|NCT00849901|561335410|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
155521538|NCT00849901|561335411|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
155521539|NCT00849901|561335409|FG000|Extension Phase|Adverse Event|2|||
155521540|NCT00849901|561335410|FG001|Extension Phase|Adverse Event|8|||
155521541|NCT00849901|561335411|FG002|Extension Phase|Adverse Event|4|||
155521542|NCT00849901|561335409|FG000|Extension Phase|Lost to Follow-up|3|||
155521543|NCT00849901|561335410|FG001|Extension Phase|Lost to Follow-up|0|||
155521544|NCT00849901|561335411|FG002|Extension Phase|Lost to Follow-up|1|||
155521545|NCT00849901|561335409|FG000|Extension Phase|Protocol Violation|2|||
155521546|NCT00849901|561335410|FG001|Extension Phase|Protocol Violation|2|||
155521547|NCT00849901|561335411|FG002|Extension Phase|Protocol Violation|4|||
155521548|NCT00849901|561335409|FG000|Extension Phase|Withdrawal by Subject|7|||
155521549|NCT00849901|561335410|FG001|Extension Phase|Withdrawal by Subject|6|||
155521550|NCT00849901|561335411|FG002|Extension Phase|Withdrawal by Subject|3|||
155521551|NCT00849901|561335409|FG000|Extension Phase|Parent or Caregiver Decision|10|||
155521552|NCT00849901|561335410|FG001|Extension Phase|Parent or Caregiver Decision|4|||
155521553|NCT00849901|561335411|FG002|Extension Phase|Parent or Caregiver Decision|4|||
155521554|NCT00849901|561335409|FG000|Extension Phase|Physician Decision|1|||
155521555|NCT00849901|561335410|FG001|Extension Phase|Physician Decision|2|||
155521556|NCT00849901|561335411|FG002|Extension Phase|Physician Decision|0|||
155521557|NCT00849901|561335409|FG000|Extension Phase|Lack of Efficacy|2|||
155521558|NCT00849901|561335410|FG001|Extension Phase|Lack of Efficacy|4|||
155521559|NCT00849901|561335411|FG002|Extension Phase|Lack of Efficacy|1|||
155521560|NCT00262223|561335414|FG000|Treatment Phase|Withdrawal by Subject|3|||
155521561|NCT00262223|561335415|FG001|Treatment Phase|Withdrawal by Subject|6|||
155521562|NCT00262223|561335414|FG000|Treatment Phase|Adverse Event|1|||
155521563|NCT00262223|561335415|FG001|Treatment Phase|Adverse Event|2|||
155521564|NCT00262223|561335414|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
155521565|NCT00262223|561335415|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
155521566|NCT00262223|561335414|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
155521567|NCT00262223|561335415|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
155521568|NCT00262223|561335414|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
155521569|NCT00262223|561335415|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
155521570|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
155521571|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
155521572|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
155521573|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
155521574|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
155521575|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
155521576|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
155654824|NCT03058952|561830544|FG000|Overall Study|Lost to Follow-up|15|||
155654825|NCT03058952|561830545|FG001|Overall Study|Lost to Follow-up|15|||
155654826|NCT03058952|561830544|FG000|Overall Study|Withdrawal by Subject|7|||
155654827|NCT03058952|561830545|FG001|Overall Study|Withdrawal by Subject|11|||
155485252|NCT01682876|561199792|FG000|Overall Study|Administrative reason|4|||
155485253|NCT01682876|561199793|FG001|Overall Study|Administrative reason|4|||
155485254|NCT01682876|561199794|FG002|Overall Study|Administrative reason|0|||
155485255|NCT01682876|561199795|FG003|Overall Study|Administrative reason|3|||
155485256|NCT01682876|561199792|FG000|Overall Study|Adverse Event|0|||
155485257|NCT01682876|561199793|FG001|Overall Study|Adverse Event|0|||
155485258|NCT01682876|561199794|FG002|Overall Study|Adverse Event|0|||
155485259|NCT01682876|561199795|FG003|Overall Study|Adverse Event|1|||
155485260|NCT01682876|561199792|FG000|Overall Study|Lost to Follow-up|11|||
155485261|NCT01682876|561199793|FG001|Overall Study|Lost to Follow-up|15|||
155485262|NCT01682876|561199794|FG002|Overall Study|Lost to Follow-up|9|||
155485263|NCT01682876|561199795|FG003|Overall Study|Lost to Follow-up|11|||
155485264|NCT01682876|561199792|FG000|Overall Study|Protocol Violation|1|||
155485265|NCT01682876|561199793|FG001|Overall Study|Protocol Violation|1|||
155485266|NCT01682876|561199794|FG002|Overall Study|Protocol Violation|1|||
155485267|NCT01682876|561199795|FG003|Overall Study|Protocol Violation|1|||
155485268|NCT01682876|561199792|FG000|Overall Study|Withdrawal by Subject|4|||
155485269|NCT01682876|561199793|FG001|Overall Study|Withdrawal by Subject|0|||
155485270|NCT01682876|561199794|FG002|Overall Study|Withdrawal by Subject|0|||
155485271|NCT01682876|561199795|FG003|Overall Study|Withdrawal by Subject|2|||
155485272|NCT01682876|561199792|FG000|Overall Study|Other|1|||
155485273|NCT01682876|561199793|FG001|Overall Study|Other|0|||
155485274|NCT01682876|561199794|FG002|Overall Study|Other|1|||
155485275|NCT01682876|561199795|FG003|Overall Study|Other|1|||
155485276|NCT00911508|561199799|FG000|Overall Study|Lost to Follow-up|27|||
155485277|NCT00911508|561199800|FG001|Overall Study|Lost to Follow-up|18|||
155485278|NCT00911508|561199799|FG000|Overall Study|Withdrawal by Subject|79|||
155485279|NCT00911508|561199800|FG001|Overall Study|Withdrawal by Subject|112|||
155485280|NCT00240331|561199803|FG000|Overall Study|Withdrawal by Subject|125|||
155485281|NCT00240331|561199804|FG001|Overall Study|Withdrawal by Subject|132|||
155485282|NCT00240331|561199803|FG000|Overall Study|Option selected by investigator|1|||
155485283|NCT00240331|561199804|FG001|Overall Study|Option selected by investigator|2|||
155485284|NCT01409382|561199805|FG000|Overall Study|Lost to Follow-up|1|||
155485285|NCT01409382|561199806|FG001|Overall Study|Lost to Follow-up|1|||
155485286|NCT01409382|561199805|FG000|Overall Study|Protocol Violation|0|||
155485287|NCT01409382|561199806|FG001|Overall Study|Protocol Violation|3|||
155485288|NCT01409382|561199805|FG000|Overall Study|Multiple pregnancy|2|||
155485289|NCT01409382|561199806|FG001|Overall Study|Multiple pregnancy|4|||
155485290|NCT01409382|561199805|FG000|Overall Study|Still pregnant when study ended|13|||
155485291|NCT01409382|561199806|FG001|Overall Study|Still pregnant when study ended|2|||
155485292|NCT01409382|561199805|FG000|Overall Study|Did not manage to get pregnant|64|||
155485293|NCT01409382|561199806|FG001|Overall Study|Did not manage to get pregnant|70|||
155485294|NCT01409382|561199805|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
155485295|NCT01409382|561199806|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
155485296|NCT04563845|561199807|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485297|NCT04563845|561199808|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485298|NCT04563845|561199809|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485299|NCT04563845|561199810|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485300|NCT04563845|561199811|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485301|NCT04563845|561199812|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485302|NCT04563845|561199813|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485303|NCT04563845|561199814|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
155485304|NCT04563845|561199815|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485305|NCT04563845|561199816|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485306|NCT04563845|561199817|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485307|NCT04563845|561199818|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485308|NCT04563845|561199819|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485309|NCT04563845|561199820|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
155485310|NCT04563845|561199807|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155654828|NCT03768336|561830548|FG000|Overall Study|Lost to Follow-up|3|||
155485311|NCT04563845|561199808|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485312|NCT04563845|561199809|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485313|NCT04563845|561199810|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485314|NCT04563845|561199811|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
155485315|NCT04563845|561199812|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485316|NCT04563845|561199813|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155654829|NCT03768336|561830549|FG001|Overall Study|Lost to Follow-up|2|||
155485317|NCT04563845|561199814|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155654830|NCT03768336|561830548|FG000|Overall Study|Became Ineligible|2|||
155521577|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
155521578|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
155521579|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
155521580|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
155521581|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
155521582|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
155521583|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
155521584|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
155521585|NCT00437658|561335416|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
155521586|NCT00437658|561335417|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
155521587|NCT00437658|561335418|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
155521588|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
155521589|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
155521590|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
155521591|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
155521592|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
155521593|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
155521594|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
155521595|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
155521596|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
155521597|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
155521598|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
155521599|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
155521600|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
155521601|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
155521602|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
155521603|NCT00437658|561335416|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
155521604|NCT00437658|561335417|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
155521605|NCT00437658|561335418|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
155521606|NCT03952143|561335419|FG000|Lead-In Period|Adverse Event|2|||
155521607|NCT03952143|561335420|FG001|Lead-In Period|Adverse Event|0|||
155521608|NCT03952143|561335421|FG002|Lead-In Period|Adverse Event|0|||
155521609|NCT03952143|561335419|FG000|Lead-In Period|Lack of Efficacy|2|||
155521610|NCT03952143|561335420|FG001|Lead-In Period|Lack of Efficacy|0|||
155521611|NCT03952143|561335421|FG002|Lead-In Period|Lack of Efficacy|0|||
155521612|NCT03952143|561335419|FG000|Lead-In Period|Physician Decision|5|||
155521613|NCT03952143|561335420|FG001|Lead-In Period|Physician Decision|0|||
155521614|NCT03952143|561335421|FG002|Lead-In Period|Physician Decision|0|||
155521615|NCT03952143|561335419|FG000|Lead-In Period|Protocol Violation|5|||
155521616|NCT03952143|561335420|FG001|Lead-In Period|Protocol Violation|0|||
155521617|NCT03952143|561335421|FG002|Lead-In Period|Protocol Violation|0|||
155521618|NCT03952143|561335419|FG000|Lead-In Period|Withdrawal by Subject|19|||
155521619|NCT03952143|561335420|FG001|Lead-In Period|Withdrawal by Subject|0|||
155521620|NCT03952143|561335421|FG002|Lead-In Period|Withdrawal by Subject|0|||
155521621|NCT03952143|561335419|FG000|Treatment Period|Adverse Event|0|||
155521622|NCT03952143|561335420|FG001|Treatment Period|Adverse Event|0|||
155521623|NCT03952143|561335421|FG002|Treatment Period|Adverse Event|1|||
155521624|NCT03952143|561335419|FG000|Treatment Period|Lost to Follow-up|0|||
155521625|NCT03952143|561335420|FG001|Treatment Period|Lost to Follow-up|2|||
155521626|NCT03952143|561335421|FG002|Treatment Period|Lost to Follow-up|0|||
155521627|NCT03952143|561335419|FG000|Treatment Period|Physician Decision|0|||
155521628|NCT03952143|561335420|FG001|Treatment Period|Physician Decision|0|||
155521629|NCT03952143|561335421|FG002|Treatment Period|Physician Decision|2|||
155521630|NCT03952143|561335419|FG000|Treatment Period|Protocol Violation|0|||
155521631|NCT03952143|561335420|FG001|Treatment Period|Protocol Violation|0|||
155521632|NCT03952143|561335421|FG002|Treatment Period|Protocol Violation|1|||
155521633|NCT03952143|561335419|FG000|Treatment Period|Withdrawal by Subject|0|||
155521634|NCT03952143|561335420|FG001|Treatment Period|Withdrawal by Subject|5|||
155521635|NCT03952143|561335421|FG002|Treatment Period|Withdrawal by Subject|26|||
155521636|NCT03952143|561335419|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
155521637|NCT03952143|561335420|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
155521638|NCT03952143|561335421|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
155521639|NCT03952143|561335419|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
155521640|NCT03952143|561335420|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
155521641|NCT03952143|561335421|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
155521642|NCT02152566|561335422|FG000|Overall Study|Lost to Follow-up|1|||
155521643|NCT02152566|561335422|FG000|Overall Study|Withdrawal by Subject|2|||
155521644|NCT01328093|561335423|FG000|Double-Blind Phase|Adverse Event|78|||
155521645|NCT01328093|561335424|FG001|Double-Blind Phase|Adverse Event|15|||
155521646|NCT01328093|561335423|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
155521647|NCT01328093|561335424|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
155521648|NCT01328093|561335423|FG000|Double-Blind Phase|Lost to Follow-up|39|||
155521649|NCT01328093|561335424|FG001|Double-Blind Phase|Lost to Follow-up|14|||
155521650|NCT01328093|561335423|FG000|Double-Blind Phase|Protocol Violation|30|||
155521651|NCT01328093|561335424|FG001|Double-Blind Phase|Protocol Violation|10|||
155521652|NCT01328093|561335423|FG000|Double-Blind Phase|Lack of Efficacy|55|||
155521653|NCT01328093|561335424|FG001|Double-Blind Phase|Lack of Efficacy|13|||
155521654|NCT01328093|561335423|FG000|Double-Blind Phase|Sponsor Decision|17|||
155521655|NCT01328093|561335424|FG001|Double-Blind Phase|Sponsor Decision|3|||
155521656|NCT01328093|561335423|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
155521657|NCT01328093|561335424|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
155521658|NCT01328093|561335423|FG000|Double-Blind Phase|Scheduling conflict|8|||
155521659|NCT01328093|561335424|FG001|Double-Blind Phase|Scheduling conflict|3|||
155521660|NCT01328093|561335423|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
155521661|NCT01328093|561335424|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
155521662|NCT01328093|561335423|FG000|Double-Blind Phase|Death|1|||
155521663|NCT01328093|561335424|FG001|Double-Blind Phase|Death|0|||
155521664|NCT01328093|561335423|FG000|Open-Label Phase|Sponsor Decision|98|||
155521665|NCT01328093|561335424|FG001|Open-Label Phase|Sponsor Decision|34|||
155521666|NCT01328093|561335423|FG000|Open-Label Phase|Protocol Violation|8|||
155521667|NCT01328093|561335424|FG001|Open-Label Phase|Protocol Violation|3|||
155521668|NCT01328093|561335423|FG000|Open-Label Phase|Lost to Follow-up|10|||
155521669|NCT01328093|561335424|FG001|Open-Label Phase|Lost to Follow-up|1|||
155521670|NCT01328093|561335423|FG000|Open-Label Phase|Adverse Event|10|||
155521671|NCT01328093|561335424|FG001|Open-Label Phase|Adverse Event|4|||
155521672|NCT01328093|561335423|FG000|Open-Label Phase|Lack of Efficacy|5|||
155521673|NCT01328093|561335424|FG001|Open-Label Phase|Lack of Efficacy|6|||
155521674|NCT01328093|561335423|FG000|Open-Label Phase|Withdrawal by Subject|4|||
155521675|NCT01328093|561335424|FG001|Open-Label Phase|Withdrawal by Subject|1|||
155521676|NCT01328093|561335423|FG000|Open-Label Phase|Scheduling conflict|2|||
155521677|NCT01328093|561335424|FG001|Open-Label Phase|Scheduling conflict|1|||
155521678|NCT01328093|561335423|FG000|Open-Label Phase|Subject is moving or has moved|2|||
155521679|NCT01328093|561335424|FG001|Open-Label Phase|Subject is moving or has moved|0|||
155521680|NCT01328093|561335423|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
155521681|NCT01328093|561335424|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
155521682|NCT00760266|561335427|FG000|Overall Study|Adverse Event|13|||
155521683|NCT00760266|561335428|FG001|Overall Study|Adverse Event|7|||
155521684|NCT00760266|561335427|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155521685|NCT00760266|561335428|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155521686|NCT00760266|561335427|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155521687|NCT00760266|561335428|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155521688|NCT00760266|561335427|FG000|Overall Study|Lack of Efficacy|2|||
155521689|NCT00760266|561335428|FG001|Overall Study|Lack of Efficacy|2|||
155521690|NCT00760266|561335427|FG000|Overall Study|Protocol deviation|2|||
155521691|NCT00760266|561335428|FG001|Overall Study|Protocol deviation|4|||
155521692|NCT00760266|561335427|FG000|Overall Study|Patient withdrew consent|3|||
155521693|NCT00760266|561335428|FG001|Overall Study|Patient withdrew consent|3|||
155521694|NCT00760266|561335427|FG000|Overall Study|Lost to Follow-up|2|||
155521695|NCT00760266|561335428|FG001|Overall Study|Lost to Follow-up|1|||
155521696|NCT00760266|561335427|FG000|Overall Study|Administrative Problems|0|||
155521697|NCT00760266|561335428|FG001|Overall Study|Administrative Problems|1|||
155521698|NCT03657160|561335429|FG000|Overall Study|Adverse Event|5|||
155521699|NCT03657160|561335430|FG001|Overall Study|Adverse Event|6|||
155521700|NCT03657160|561335429|FG000|Overall Study|Protocol Deviation|3|||
155521701|NCT03657160|561335430|FG001|Overall Study|Protocol Deviation|0|||
155521702|NCT03657160|561335429|FG000|Overall Study|Withdrawal by Subject|18|||
155521703|NCT03657160|561335430|FG001|Overall Study|Withdrawal by Subject|16|||
155521704|NCT03657160|561335429|FG000|Overall Study|Site Termination|1|||
155521705|NCT03657160|561335430|FG001|Overall Study|Site Termination|0|||
155521706|NCT03657160|561335429|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
155521707|NCT03657160|561335430|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
155521708|NCT03657160|561335429|FG000|Overall Study|Death|33|||
155521709|NCT03657160|561335430|FG001|Overall Study|Death|26|||
155521710|NCT03657160|561335429|FG000|Overall Study|Death (COVID-19-Related)|1|||
155521711|NCT03657160|561335430|FG001|Overall Study|Death (COVID-19-Related)|0|||
155521712|NCT03657160|561335429|FG000|Overall Study|Reason Not Specified|5|||
155521713|NCT03657160|561335430|FG001|Overall Study|Reason Not Specified|5|||
155521714|NCT03657160|561335429|FG000|Overall Study|Other (COVID-19-Related)|0|||
155521715|NCT03657160|561335430|FG001|Overall Study|Other (COVID-19-Related)|1|||
155521716|NCT00686959|561335432|FG000|Overall Study|Participants censored (no death events)|124|||
155521717|NCT00686959|561335433|FG001|Overall Study|Participants censored (no death events)|117|||
155521718|NCT02191891|561335434|FG000|Overall Study|Withdrawal by Subject|0|||
155521719|NCT02191891|561335435|FG001|Overall Study|Withdrawal by Subject|1|||
155521720|NCT02191891|561335436|FG002|Overall Study|Withdrawal by Subject|0|||
155485318|NCT04563845|561199815|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485319|NCT04563845|561199816|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485320|NCT04563845|561199817|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485321|NCT04563845|561199818|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485322|NCT04563845|561199819|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485323|NCT04563845|561199820|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
155485324|NCT01020812|561199821|FG000|Overall Study|Physician Decision|1|||
155485325|NCT01020812|561199821|FG000|Overall Study|Withdrawal by Subject|1|||
155485326|NCT01020812|561199821|FG000|Overall Study|Protocol Violation|1|||
155485327|NCT00883896|561199838|FG000|Overall Study|Lost to Follow-up|0|||
155485328|NCT00883896|561199839|FG001|Overall Study|Lost to Follow-up|0|||
155485329|NCT00883896|561199840|FG002|Overall Study|Lost to Follow-up|0|||
155485330|NCT00883896|561199841|FG003|Overall Study|Lost to Follow-up|2|||
155485331|NCT00883896|561199838|FG000|Overall Study|Withdrawal by Subject|5|||
155485332|NCT00883896|561199839|FG001|Overall Study|Withdrawal by Subject|0|||
155485333|NCT00883896|561199840|FG002|Overall Study|Withdrawal by Subject|1|||
155485334|NCT00883896|561199841|FG003|Overall Study|Withdrawal by Subject|3|||
155485335|NCT00883896|561199838|FG000|Overall Study|Lack of Efficacy|0|||
155485336|NCT00883896|561199839|FG001|Overall Study|Lack of Efficacy|0|||
155485337|NCT00883896|561199840|FG002|Overall Study|Lack of Efficacy|0|||
155485338|NCT00883896|561199841|FG003|Overall Study|Lack of Efficacy|2|||
155485339|NCT00883896|561199838|FG000|Overall Study|Other|1|||
155485340|NCT00883896|561199839|FG001|Overall Study|Other|0|||
155485341|NCT00883896|561199840|FG002|Overall Study|Other|0|||
155485342|NCT00883896|561199841|FG003|Overall Study|Other|0|||
155485343|NCT02546193|561199842|FG000|Overall Study|Withdrawal by Subject|2|||
155485344|NCT02546193|561199843|FG001|Overall Study|Withdrawal by Subject|0|||
155485345|NCT02546193|561199844|FG002|Overall Study|Withdrawal by Subject|1|||
155485346|NCT02546193|561199845|FG003|Overall Study|Withdrawal by Subject|0|||
155485347|NCT02546193|561199842|FG000|Overall Study|Not eligible at time of induction|4|||
155485348|NCT02546193|561199843|FG001|Overall Study|Not eligible at time of induction|6|||
155485349|NCT02546193|561199844|FG002|Overall Study|Not eligible at time of induction|1|||
155485350|NCT02546193|561199845|FG003|Overall Study|Not eligible at time of induction|0|||
155485351|NCT03339999|561199855|FG000|Overall Study|Adverse Event|1|||
155485352|NCT03339999|561199856|FG001|Overall Study|Adverse Event|2|||
155485353|NCT03339999|561199857|FG002|Overall Study|Adverse Event|2|||
155485354|NCT03339999|561199858|FG003|Overall Study|Adverse Event|1|||
155485355|NCT03339999|561199855|FG000|Overall Study|Lack of Efficacy|0|||
155485356|NCT03339999|561199856|FG001|Overall Study|Lack of Efficacy|1|||
155485357|NCT03339999|561199857|FG002|Overall Study|Lack of Efficacy|0|||
155485358|NCT03339999|561199858|FG003|Overall Study|Lack of Efficacy|0|||
155485359|NCT03339999|561199855|FG000|Overall Study|Lost to Follow-up|0|||
155485360|NCT03339999|561199856|FG001|Overall Study|Lost to Follow-up|0|||
155485361|NCT03339999|561199857|FG002|Overall Study|Lost to Follow-up|0|||
155485362|NCT03339999|561199858|FG003|Overall Study|Lost to Follow-up|1|||
155521721|NCT02191891|561335437|FG003|Overall Study|Withdrawal by Subject|0|||
155654831|NCT03768336|561830549|FG001|Overall Study|Became Ineligible|0|||
155485363|NCT03339999|561199855|FG000|Overall Study|Study Terminated by Sponsor|6|||
155485364|NCT03339999|561199856|FG001|Overall Study|Study Terminated by Sponsor|3|||
155485365|NCT03339999|561199857|FG002|Overall Study|Study Terminated by Sponsor|4|||
155485366|NCT03339999|561199858|FG003|Overall Study|Study Terminated by Sponsor|3|||
155485367|NCT03380091|561199860|FG000|Overall Study|Withdrawal by Subject|2|||
155485368|NCT03380091|561199861|FG001|Overall Study|Withdrawal by Subject|1|||
155485369|NCT03802331|561199862|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
155521722|NCT02191891|561335438|FG004|Overall Study|Withdrawal by Subject|1|||
155521723|NCT02191891|561335434|FG000|Overall Study|Adverse Event|0|||
155521724|NCT02191891|561335435|FG001|Overall Study|Adverse Event|1|||
155521725|NCT02191891|561335436|FG002|Overall Study|Adverse Event|0|||
155521726|NCT02191891|561335437|FG003|Overall Study|Adverse Event|0|||
155521727|NCT02191891|561335438|FG004|Overall Study|Adverse Event|2|||
155521728|NCT02191891|561335434|FG000|Overall Study|Disease Progression|4|||
155521729|NCT02191891|561335435|FG001|Overall Study|Disease Progression|10|||
155521730|NCT02191891|561335436|FG002|Overall Study|Disease Progression|4|||
155521731|NCT02191891|561335437|FG003|Overall Study|Disease Progression|2|||
155521732|NCT02191891|561335438|FG004|Overall Study|Disease Progression|7|||
155521733|NCT01448057|561335442|FG000|Overall Study|Protocol Violation|3|||
155521734|NCT01448057|561335443|FG001|Overall Study|Protocol Violation|2|||
155521735|NCT01448057|561335442|FG000|Overall Study|Lost to Follow-up|3|||
155521736|NCT01448057|561335443|FG001|Overall Study|Lost to Follow-up|0|||
155521737|NCT01448057|561335442|FG000|Overall Study|Adverse Event|0|||
155521738|NCT01448057|561335443|FG001|Overall Study|Adverse Event|2|||
155521739|NCT01448057|561335442|FG000|Overall Study|Withdrawal by Subject|2|||
155521740|NCT01448057|561335443|FG001|Overall Study|Withdrawal by Subject|0|||
155521741|NCT03883906|561335447|FG000|Overall Study|Withdrawal by Subject|2|||
155521742|NCT03883906|561335447|FG000|Overall Study|Physician Decision|5|||
155521743|NCT02107092|561335457|FG000|Overall Study|Miscellaneous|3|||
155521744|NCT02107092|561335457|FG000|Overall Study|Subject compliance|3|||
155485370|NCT03802331|561199863|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
155485371|NCT00368069|561199865|FG000|Overall Study|Adverse Event|5|||
155485372|NCT00368069|561199866|FG001|Overall Study|Adverse Event|2|||
155485373|NCT00368069|561199865|FG000|Overall Study|Lack of Efficacy|0|||
155485374|NCT00368069|561199866|FG001|Overall Study|Lack of Efficacy|1|||
155485375|NCT00368069|561199865|FG000|Overall Study|Lost to Follow-up|1|||
155485376|NCT00368069|561199866|FG001|Overall Study|Lost to Follow-up|0|||
155485377|NCT00368069|561199865|FG000|Overall Study|Protocol Violation|0|||
155485378|NCT00368069|561199866|FG001|Overall Study|Protocol Violation|2|||
155485379|NCT00368069|561199865|FG000|Overall Study|Withdrawal of Consent|2|||
155485380|NCT00368069|561199866|FG001|Overall Study|Withdrawal of Consent|1|||
155485381|NCT00368069|561199865|FG000|Overall Study|no blood sampling possible|0|||
155485382|NCT00368069|561199866|FG001|Overall Study|no blood sampling possible|1|||
155485383|NCT03432819|561199867|FG000|Overall Study|Lost to Follow-up|2|||
155485384|NCT03432819|561199868|FG001|Overall Study|Lost to Follow-up|2|||
155485385|NCT03432819|561199867|FG000|Overall Study|Withdrawal by Subject|5|||
155485386|NCT03432819|561199868|FG001|Overall Study|Withdrawal by Subject|3|||
155485387|NCT00760994|561199869|FG000|Overall Study|Lost to Follow-up|4|||
155485388|NCT00760994|561199870|FG001|Overall Study|Lost to Follow-up|4|||
155485389|NCT00760994|561199871|FG002|Overall Study|Lost to Follow-up|3|||
155485390|NCT00529152|561199874|FG000|Overall Study|Adverse Event|2|||
155485391|NCT00529152|561199874|FG000|Overall Study|Withdrawal by Subject|2|||
155485392|NCT00529152|561199874|FG000|Overall Study|Lost to Follow-up|1|||
155485393|NCT02500706|561199875|FG000|Overall Study|Adverse Event|0|||
155485394|NCT02500706|561199876|FG001|Overall Study|Adverse Event|0|||
155485395|NCT02500706|561199877|FG002|Overall Study|Adverse Event|1|||
155485396|NCT02500706|561199875|FG000|Overall Study|Lost to Follow-up|0|||
155485397|NCT02500706|561199876|FG001|Overall Study|Lost to Follow-up|1|||
155485398|NCT02500706|561199877|FG002|Overall Study|Lost to Follow-up|1|||
155485399|NCT02500706|561199875|FG000|Overall Study|Withdrawal by Subject|4|||
155485400|NCT02500706|561199876|FG001|Overall Study|Withdrawal by Subject|6|||
155485401|NCT02500706|561199877|FG002|Overall Study|Withdrawal by Subject|4|||
155485402|NCT02500706|561199875|FG000|Overall Study|Unclassified|0|||
155485403|NCT02500706|561199876|FG001|Overall Study|Unclassified|0|||
155485404|NCT02500706|561199877|FG002|Overall Study|Unclassified|1|||
155485405|NCT01000311|561199885|FG000|Overall Study|Adverse Event|2|||
155485406|NCT01000311|561199886|FG001|Overall Study|Adverse Event|5|||
155485407|NCT01000311|561199885|FG000|Overall Study|Withdrawal by Subject|16|||
155485408|NCT01000311|561199886|FG001|Overall Study|Withdrawal by Subject|24|||
155485409|NCT01000311|561199885|FG000|Overall Study|Lost to Follow-up|15|||
155485410|NCT01000311|561199886|FG001|Overall Study|Lost to Follow-up|24|||
155485411|NCT01000311|561199885|FG000|Overall Study|Protocol Violation|1|||
155521745|NCT02107092|561335457|FG000|Overall Study|Hypo-or hyperkalemia|2|||
155521746|NCT02107092|561335457|FG000|Overall Study|Met ECG withdrawal criteria|3|||
155521747|NCT02107092|561335457|FG000|Overall Study|Physician Decision|3|||
155485412|NCT01000311|561199886|FG001|Overall Study|Protocol Violation|2|||
155485413|NCT01000311|561199885|FG000|Overall Study|Inappropriate enrollment|2|||
155485414|NCT01000311|561199886|FG001|Overall Study|Inappropriate enrollment|0|||
155485415|NCT01000311|561199885|FG000|Overall Study|Administrative reason|9|||
155485416|NCT01000311|561199886|FG001|Overall Study|Administrative reason|15|||
155485417|NCT04411472|561199890|FG000|Overall Study|Adverse Event|5|||
155485418|NCT04411472|561199891|FG001|Overall Study|Adverse Event|10|||
155521748|NCT02107092|561335457|FG000|Overall Study|Lost to Follow-up|2|||
155485419|NCT04411472|561199892|FG002|Overall Study|Adverse Event|1|||
155485420|NCT04411472|561199893|FG003|Overall Study|Adverse Event|0|||
155485421|NCT04411472|561199894|FG004|Overall Study|Adverse Event|0|||
155485422|NCT04411472|561199895|FG005|Overall Study|Adverse Event|0|||
155485423|NCT04411472|561199890|FG000|Overall Study|Protocol Violation|1|||
155485424|NCT04411472|561199891|FG001|Overall Study|Protocol Violation|0|||
155485425|NCT04411472|561199892|FG002|Overall Study|Protocol Violation|0|||
155485426|NCT04411472|561199893|FG003|Overall Study|Protocol Violation|0|||
155485427|NCT04411472|561199894|FG004|Overall Study|Protocol Violation|0|||
155485428|NCT04411472|561199895|FG005|Overall Study|Protocol Violation|0|||
155485429|NCT04411472|561199890|FG000|Overall Study|Withdrawal by Subject|0|||
155485430|NCT04411472|561199891|FG001|Overall Study|Withdrawal by Subject|1|||
155485431|NCT04411472|561199892|FG002|Overall Study|Withdrawal by Subject|0|||
155485432|NCT04411472|561199893|FG003|Overall Study|Withdrawal by Subject|1|||
155485433|NCT04411472|561199894|FG004|Overall Study|Withdrawal by Subject|0|||
155485434|NCT04411472|561199895|FG005|Overall Study|Withdrawal by Subject|0|||
155485435|NCT04411472|561199890|FG000|Overall Study|Physician Decision|1|||
155485436|NCT04411472|561199891|FG001|Overall Study|Physician Decision|0|||
155485437|NCT04411472|561199892|FG002|Overall Study|Physician Decision|0|||
155485438|NCT04411472|561199893|FG003|Overall Study|Physician Decision|0|||
155485439|NCT04411472|561199894|FG004|Overall Study|Physician Decision|0|||
155485440|NCT04411472|561199895|FG005|Overall Study|Physician Decision|0|||
155485441|NCT04411472|561199890|FG000|Overall Study|Study terminated by sponsor|17|||
155485442|NCT04411472|561199891|FG001|Overall Study|Study terminated by sponsor|20|||
155485443|NCT04411472|561199892|FG002|Overall Study|Study terminated by sponsor|3|||
155485444|NCT04411472|561199893|FG003|Overall Study|Study terminated by sponsor|0|||
155485445|NCT04411472|561199894|FG004|Overall Study|Study terminated by sponsor|0|||
155485446|NCT04411472|561199895|FG005|Overall Study|Study terminated by sponsor|0|||
155485447|NCT05060003|561199896|FG000|Overall Study|ctDNA negative|7|||
155485448|NCT01747655|561199899|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
155485449|NCT01747655|561199900|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
155485450|NCT01747655|561199899|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
155485451|NCT01747655|561199900|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
155485452|NCT01747655|561199899|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
155485453|NCT01747655|561199900|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
155485454|NCT01373294|561199903|FG000|Overall Study|Adverse Event|1|||
155485455|NCT01373294|561199904|FG001|Overall Study|Adverse Event|0|||
155485456|NCT00684073|561199905|FG000|Selection|Selection/non-selection criteria|3|||
155485457|NCT00684073|561199905|FG000|Selection|Death|1|||
155485458|NCT00684073|561199905|FG000|Selection|noncompliance|1|||
155485459|NCT00684073|561199905|FG000|Selection|Lost to Follow-up|1|||
155485460|NCT00684073|561199905|FG000|Selection|request of the sponsor|1|||
155485461|NCT00684073|561199905|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
155485462|NCT01259388|561199907|FG000|Overall Study|Adverse Event|3|||
155485463|NCT01259388|561199908|FG001|Overall Study|Adverse Event|0|||
155485464|NCT01259388|561199907|FG000|Overall Study|Withdrawal by Subject|1|||
155485465|NCT01259388|561199908|FG001|Overall Study|Withdrawal by Subject|1|||
155485466|NCT01259388|561199907|FG000|Overall Study|Physician Decision|1|||
155485467|NCT01259388|561199908|FG001|Overall Study|Physician Decision|0|||
155485468|NCT02728804|561199914|FG000|Overall Study|Ineligible|3|||
155485469|NCT02728804|561199914|FG000|Overall Study|Did not complete baseline questionnaire|9|||
155485470|NCT02728804|561199914|FG000|Overall Study|Death|99|||
155485471|NCT00591786|561199915|FG000|Overall Study|Withdrawal of Informed Consent|0|||
155485472|NCT00591786|561199916|FG001|Overall Study|Withdrawal of Informed Consent|0|||
155485473|NCT00591786|561199917|FG002|Overall Study|Withdrawal of Informed Consent|1|||
155485474|NCT00591786|561199918|FG003|Overall Study|Withdrawal of Informed Consent|0|||
155485475|NCT00591786|561199919|FG004|Overall Study|Withdrawal of Informed Consent|0|||
155485476|NCT00591786|561199920|FG005|Overall Study|Withdrawal of Informed Consent|0|||
155485477|NCT00591786|561199921|FG006|Overall Study|Withdrawal of Informed Consent|0|||
155485478|NCT00591786|561199922|FG007|Overall Study|Withdrawal of Informed Consent|0|||
155485479|NCT00591786|561199923|FG008|Overall Study|Withdrawal of Informed Consent|0|||
155485480|NCT00591786|561199924|FG009|Overall Study|Withdrawal of Informed Consent|0|||
155485481|NCT01920061|561199926|FG000|Overall Study|Death|1|||
155485482|NCT01920061|561199927|FG001|Overall Study|Death|1|||
155485483|NCT01920061|561199928|FG002|Overall Study|Death|0|||
155485484|NCT01920061|561199929|FG003|Overall Study|Death|1|||
155485485|NCT01920061|561199930|FG004|Overall Study|Death|1|||
155485486|NCT01920061|561199931|FG005|Overall Study|Death|0|||
155485487|NCT01920061|561199932|FG006|Overall Study|Death|0|||
155485488|NCT01920061|561199933|FG007|Overall Study|Death|1|||
155485489|NCT01920061|561199934|FG008|Overall Study|Death|0|||
155485490|NCT01920061|561199935|FG009|Overall Study|Death|1|||
155485491|NCT01920061|561199936|FG010|Overall Study|Death|0|||
155485492|NCT01920061|561199937|FG011|Overall Study|Death|1|||
155485493|NCT01920061|561199938|FG012|Overall Study|Death|0|||
155485494|NCT01920061|561199939|FG013|Overall Study|Death|2|||
155485495|NCT01920061|561199940|FG014|Overall Study|Death|0|||
155485496|NCT01920061|561199941|FG015|Overall Study|Death|0|||
155485497|NCT01920061|561199942|FG016|Overall Study|Death|0|||
155485498|NCT01920061|561199943|FG017|Overall Study|Death|0|||
155485499|NCT01920061|561199944|FG018|Overall Study|Death|1|||
155485500|NCT01920061|561199945|FG019|Overall Study|Death|0|||
155485501|NCT01920061|561199926|FG000|Overall Study|Lost to Follow-up|0|||
155485502|NCT01920061|561199927|FG001|Overall Study|Lost to Follow-up|2|||
155485503|NCT01920061|561199928|FG002|Overall Study|Lost to Follow-up|0|||
155485504|NCT01920061|561199929|FG003|Overall Study|Lost to Follow-up|0|||
155485505|NCT01920061|561199930|FG004|Overall Study|Lost to Follow-up|0|||
155485506|NCT01920061|561199931|FG005|Overall Study|Lost to Follow-up|0|||
155485507|NCT01920061|561199932|FG006|Overall Study|Lost to Follow-up|1|||
155485508|NCT01920061|561199933|FG007|Overall Study|Lost to Follow-up|0|||
155485509|NCT01920061|561199934|FG008|Overall Study|Lost to Follow-up|0|||
155485510|NCT01920061|561199935|FG009|Overall Study|Lost to Follow-up|0|||
155485511|NCT01920061|561199936|FG010|Overall Study|Lost to Follow-up|3|||
155485512|NCT01920061|561199937|FG011|Overall Study|Lost to Follow-up|0|||
155485513|NCT01920061|561199938|FG012|Overall Study|Lost to Follow-up|0|||
155485514|NCT01920061|561199939|FG013|Overall Study|Lost to Follow-up|0|||
155485515|NCT01920061|561199940|FG014|Overall Study|Lost to Follow-up|0|||
155485516|NCT01920061|561199941|FG015|Overall Study|Lost to Follow-up|0|||
155485517|NCT01920061|561199942|FG016|Overall Study|Lost to Follow-up|0|||
155485518|NCT01920061|561199943|FG017|Overall Study|Lost to Follow-up|1|||
155485519|NCT01920061|561199944|FG018|Overall Study|Lost to Follow-up|4|||
155485520|NCT01920061|561199945|FG019|Overall Study|Lost to Follow-up|3|||
155485521|NCT01920061|561199926|FG000|Overall Study|Other|1|||
155485522|NCT01920061|561199927|FG001|Overall Study|Other|1|||
155485523|NCT01920061|561199928|FG002|Overall Study|Other|2|||
155485524|NCT01920061|561199929|FG003|Overall Study|Other|1|||
155485525|NCT01920061|561199930|FG004|Overall Study|Other|0|||
155485526|NCT01920061|561199931|FG005|Overall Study|Other|1|||
155485527|NCT01920061|561199932|FG006|Overall Study|Other|0|||
155485528|NCT01920061|561199933|FG007|Overall Study|Other|0|||
155485529|NCT01920061|561199934|FG008|Overall Study|Other|0|||
155485530|NCT01920061|561199935|FG009|Overall Study|Other|1|||
155485531|NCT01920061|561199936|FG010|Overall Study|Other|1|||
155485532|NCT01920061|561199937|FG011|Overall Study|Other|2|||
155485533|NCT01920061|561199938|FG012|Overall Study|Other|1|||
155485534|NCT01920061|561199939|FG013|Overall Study|Other|4|||
155485535|NCT01920061|561199940|FG014|Overall Study|Other|0|||
155485536|NCT01920061|561199941|FG015|Overall Study|Other|1|||
155485537|NCT01920061|561199942|FG016|Overall Study|Other|1|||
155485538|NCT01920061|561199943|FG017|Overall Study|Other|0|||
155485539|NCT01920061|561199944|FG018|Overall Study|Other|1|||
155485540|NCT01920061|561199945|FG019|Overall Study|Other|1|||
155485541|NCT01920061|561199926|FG000|Overall Study|Participant refused further follow-up|0|||
155485542|NCT01920061|561199927|FG001|Overall Study|Participant refused further follow-up|0|||
155485543|NCT01920061|561199928|FG002|Overall Study|Participant refused further follow-up|0|||
155485544|NCT01920061|561199929|FG003|Overall Study|Participant refused further follow-up|0|||
155485545|NCT01920061|561199930|FG004|Overall Study|Participant refused further follow-up|1|||
155485546|NCT01920061|561199931|FG005|Overall Study|Participant refused further follow-up|1|||
155485547|NCT01920061|561199932|FG006|Overall Study|Participant refused further follow-up|0|||
155485548|NCT01920061|561199933|FG007|Overall Study|Participant refused further follow-up|0|||
155485549|NCT01920061|561199934|FG008|Overall Study|Participant refused further follow-up|1|||
155521749|NCT02107092|561335457|FG000|Overall Study|Withdrawal by Subject|9|||
155521750|NCT02107092|561335457|FG000|Overall Study|Adverse Event|7|||
155521751|NCT02107092|561335457|FG000|Overall Study|Expected progression of CKD|12|||
155521752|NCT00537030|561335458|FG000|Overall Study|Physician Decision|2|||
155521753|NCT00537030|561335458|FG000|Overall Study|Withdrawal by Subject|2|||
155654832|NCT03768336|561830548|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
155654833|NCT03768336|561830549|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
155654834|NCT03768336|561830548|FG000|Overall Study|Missed final survey (post-treatment|0|||
155654835|NCT03768336|561830549|FG001|Overall Study|Missed final survey (post-treatment|1|||
155654836|NCT05654181|561830550|FG000|Overall Study|Adverse Event|1|||
155654837|NCT05654181|561830551|FG001|Overall Study|Adverse Event|0|||
155654838|NCT05654181|561830552|FG002|Overall Study|Adverse Event|0|||
155654839|NCT05654181|561830553|FG003|Overall Study|Adverse Event|0|||
155654840|NCT05654181|561830554|FG004|Overall Study|Adverse Event|0|||
155654841|NCT05654181|561830555|FG005|Overall Study|Adverse Event|0|||
155654842|NCT05654181|561830556|FG006|Overall Study|Adverse Event|0|||
155654843|NCT05654181|561830557|FG007|Overall Study|Adverse Event|1|||
155654844|NCT05654181|561830558|FG008|Overall Study|Adverse Event|0|||
155654845|NCT05654181|561830559|FG009|Overall Study|Adverse Event|0|||
155654846|NCT05654181|561830550|FG000|Overall Study|Withdrawal by Subject|0|||
155654847|NCT05654181|561830551|FG001|Overall Study|Withdrawal by Subject|0|||
155654848|NCT05654181|561830552|FG002|Overall Study|Withdrawal by Subject|0|||
155654849|NCT05654181|561830553|FG003|Overall Study|Withdrawal by Subject|0|||
155654850|NCT05654181|561830554|FG004|Overall Study|Withdrawal by Subject|0|||
155654851|NCT05654181|561830555|FG005|Overall Study|Withdrawal by Subject|0|||
155654852|NCT05654181|561830556|FG006|Overall Study|Withdrawal by Subject|0|||
155654853|NCT05654181|561830557|FG007|Overall Study|Withdrawal by Subject|1|||
155654854|NCT05654181|561830558|FG008|Overall Study|Withdrawal by Subject|0|||
155654855|NCT05654181|561830559|FG009|Overall Study|Withdrawal by Subject|0|||
155654856|NCT05654181|561830550|FG000|Overall Study|Other|0|||
155654857|NCT05654181|561830551|FG001|Overall Study|Other|0|||
155654858|NCT05654181|561830552|FG002|Overall Study|Other|0|||
155654859|NCT05654181|561830553|FG003|Overall Study|Other|0|||
155654860|NCT05654181|561830554|FG004|Overall Study|Other|1|||
155521754|NCT00537030|561335458|FG000|Overall Study|≥ Grade 2 allergy|7|||
155521755|NCT00537030|561335458|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
155521756|NCT00537030|561335458|FG000|Overall Study|Ineligible|2|||
155521757|NCT00537030|561335458|FG000|Overall Study|Inevaluable|2|||
155521758|NCT01939197|561335461|FG000|Overall Study|Withdrawal by Subject|1|||
155521759|NCT01939197|561335462|FG001|Overall Study|Withdrawal by Subject|0|||
155521760|NCT01939197|561335463|FG002|Overall Study|Withdrawal by Subject|0|||
155521761|NCT01939197|561335464|FG003|Overall Study|Withdrawal by Subject|0|||
155521762|NCT01939197|561335465|FG004|Overall Study|Withdrawal by Subject|1|||
155521763|NCT01939197|561335466|FG005|Overall Study|Withdrawal by Subject|0|||
155521764|NCT01939197|561335467|FG006|Overall Study|Withdrawal by Subject|0|||
155654861|NCT05654181|561830555|FG005|Overall Study|Other|1|||
155654862|NCT05654181|561830556|FG006|Overall Study|Other|0|||
155654863|NCT05654181|561830557|FG007|Overall Study|Other|0|||
155654864|NCT05654181|561830558|FG008|Overall Study|Other|0|||
155654865|NCT05654181|561830559|FG009|Overall Study|Other|0|||
155654866|NCT04101331|561830560|FG000|Overall Study|Adverse Event|9|||
155654867|NCT04101331|561830560|FG000|Overall Study|Disease progression|82|||
155485550|NCT01920061|561199935|FG009|Overall Study|Participant refused further follow-up|0|||
155485551|NCT01920061|561199936|FG010|Overall Study|Participant refused further follow-up|1|||
155485552|NCT01920061|561199937|FG011|Overall Study|Participant refused further follow-up|0|||
155485553|NCT01920061|561199938|FG012|Overall Study|Participant refused further follow-up|1|||
155485554|NCT01920061|561199939|FG013|Overall Study|Participant refused further follow-up|0|||
155485555|NCT01920061|561199940|FG014|Overall Study|Participant refused further follow-up|1|||
155485556|NCT01920061|561199941|FG015|Overall Study|Participant refused further follow-up|2|||
155485557|NCT01920061|561199942|FG016|Overall Study|Participant refused further follow-up|1|||
155485558|NCT01920061|561199943|FG017|Overall Study|Participant refused further follow-up|1|||
155485559|NCT01920061|561199944|FG018|Overall Study|Participant refused further follow-up|0|||
155521765|NCT01939197|561335461|FG000|Overall Study|Lost to Follow-up|0|||
155654868|NCT04101331|561830560|FG000|Overall Study|Withdrawal by Subject|1|||
155654869|NCT04101331|561830560|FG000|Overall Study|Investigator decision|6|||
155654870|NCT04101331|561830560|FG000|Overall Study|Death|6|||
155654871|NCT04101331|561830560|FG000|Overall Study|Allogenic transplant|1|||
155521766|NCT01939197|561335462|FG001|Overall Study|Lost to Follow-up|1|||
155521767|NCT01939197|561335463|FG002|Overall Study|Lost to Follow-up|0|||
155521768|NCT01939197|561335464|FG003|Overall Study|Lost to Follow-up|1|||
155521769|NCT01939197|561335465|FG004|Overall Study|Lost to Follow-up|3|||
155521770|NCT01939197|561335466|FG005|Overall Study|Lost to Follow-up|1|||
155521771|NCT01939197|561335467|FG006|Overall Study|Lost to Follow-up|2|||
155521772|NCT00680121|561335472|FG000|Overall Study|Lost to Follow-up|27|||
155521773|NCT00680121|561335473|FG001|Overall Study|Lost to Follow-up|23|||
155521774|NCT02849652|561335474|FG000|Overall Study|Lost to Follow-up|104|||
155521775|NCT02849652|561335475|FG001|Overall Study|Lost to Follow-up|35|||
155521776|NCT02849652|561335476|FG002|Overall Study|Lost to Follow-up|116|||
155521777|NCT02849652|561335477|FG003|Overall Study|Lost to Follow-up|22|||
155521778|NCT02849652|561335474|FG000|Overall Study|Withdrawal by Subject|10|||
155521779|NCT02849652|561335475|FG001|Overall Study|Withdrawal by Subject|2|||
155521780|NCT02849652|561335476|FG002|Overall Study|Withdrawal by Subject|8|||
155521781|NCT02849652|561335477|FG003|Overall Study|Withdrawal by Subject|4|||
155521782|NCT00777829|561335479|FG000|Overall Study|Withdrawal by Subject|0|||
155521783|NCT00777829|561335480|FG001|Overall Study|Withdrawal by Subject|2|||
155521784|NCT00408902|561335481|FG000|Overall Study|Lack of Efficacy|7|||
155521785|NCT00408902|561335481|FG000|Overall Study|Adverse Event|3|||
155521786|NCT02457832|561335482|FG000|Training|Lost to Follow-up|10|||
155521787|NCT02457832|561335483|FG001|Training|Lost to Follow-up|6|||
155521788|NCT02457832|561335484|FG002|Training|Lost to Follow-up|3|||
155521789|NCT02457832|561335482|FG000|One Month Washout|Lost to Follow-up|0|||
155521790|NCT02457832|561335483|FG001|One Month Washout|Lost to Follow-up|1|||
155521791|NCT02457832|561335484|FG002|One Month Washout|Lost to Follow-up|1|||
155521792|NCT01030965|561335485|FG000|Overall Study|Lack of Efficacy|3|||
155521793|NCT01030965|561335486|FG001|Overall Study|Lack of Efficacy|2|||
155521794|NCT01030965|561335487|FG002|Overall Study|Lack of Efficacy|0|||
155521795|NCT01030965|561335488|FG003|Overall Study|Lack of Efficacy|3|||
155521796|NCT01030965|561335485|FG000|Overall Study|Protocol Violation|1|||
155521797|NCT01030965|561335486|FG001|Overall Study|Protocol Violation|1|||
155521798|NCT01030965|561335487|FG002|Overall Study|Protocol Violation|1|||
155521799|NCT01030965|561335488|FG003|Overall Study|Protocol Violation|1|||
155521800|NCT01030965|561335485|FG000|Overall Study|Adverse Event|0|||
155521801|NCT01030965|561335486|FG001|Overall Study|Adverse Event|1|||
155521802|NCT01030965|561335487|FG002|Overall Study|Adverse Event|2|||
155521803|NCT01030965|561335488|FG003|Overall Study|Adverse Event|1|||
155521804|NCT01030965|561335485|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
155521805|NCT01030965|561335486|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
155521806|NCT01030965|561335487|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
155521807|NCT01030965|561335488|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
155521808|NCT01030965|561335485|FG000|Overall Study|Withdrawal by Subject|0|||
155521809|NCT01030965|561335486|FG001|Overall Study|Withdrawal by Subject|1|||
155521810|NCT01030965|561335487|FG002|Overall Study|Withdrawal by Subject|0|||
155521811|NCT01030965|561335488|FG003|Overall Study|Withdrawal by Subject|2|||
155521812|NCT02097290|561335489|FG000|Overall Study|Death|6|||
155521813|NCT02097290|561335489|FG000|Overall Study|Total Withdrawals|3|||
155521814|NCT02097290|561335489|FG000|Overall Study|Attempt|8|||
155521815|NCT03069937|561335490|FG000|Overall Study|Second primary malignancy noted|1|||
155521816|NCT00591630|561335496|FG000|Overall Study|Death|0|||
155521817|NCT00591630|561335497|FG001|Overall Study|Death|0|||
155521818|NCT00591630|561335498|FG002|Overall Study|Death|1|||
155521819|NCT00591630|561335499|FG003|Overall Study|Death|0|||
155521820|NCT01691248|561335500|FG000|Overall Study|Protocol Violation|43|||
155654872|NCT01444781|561830561|FG000|Overall Study|Lost to Follow-up|0|||
155654873|NCT01444781|561830562|FG001|Overall Study|Lost to Follow-up|3|||
155654874|NCT01444781|561830563|FG002|Overall Study|Lost to Follow-up|1|||
155654875|NCT01444781|561830561|FG000|Overall Study|Withdrawal by Subject|3|||
155654876|NCT01444781|561830562|FG001|Overall Study|Withdrawal by Subject|1|||
155521821|NCT01691248|561335501|FG001|Overall Study|Protocol Violation|27|||
155654877|NCT01444781|561830563|FG002|Overall Study|Withdrawal by Subject|2|||
155654878|NCT02254291|561830564|FG000|Overall Study|Withdrawal by Subject|0|||
155654879|NCT02254291|561830565|FG001|Overall Study|Withdrawal by Subject|3|||
155521822|NCT01691248|561335500|FG000|Overall Study|Adverse Event|24|||
155521823|NCT01691248|561335501|FG001|Overall Study|Adverse Event|22|||
155521824|NCT01691248|561335500|FG000|Overall Study|Withdrawal by Subject|20|||
155521825|NCT01691248|561335501|FG001|Overall Study|Withdrawal by Subject|18|||
155521826|NCT01691248|561335500|FG000|Overall Study|Confirmed CDAD|14|||
155521827|NCT01691248|561335501|FG001|Overall Study|Confirmed CDAD|31|||
155521828|NCT01691248|561335500|FG000|Overall Study|Lost to Follow-up|2|||
155521829|NCT01691248|561335501|FG001|Overall Study|Lost to Follow-up|5|||
155521830|NCT01691248|561335500|FG000|Overall Study|Reason not provided|4|||
155521831|NCT01691248|561335501|FG001|Overall Study|Reason not provided|4|||
155521832|NCT01691248|561335500|FG000|Overall Study|Not Treated|4|||
155521833|NCT01691248|561335501|FG001|Overall Study|Not Treated|7|||
155521834|NCT02863575|561335502|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
155521835|NCT02863575|561335503|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
155521836|NCT02863575|561335504|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
155521837|NCT02863575|561335502|FG000|Overall Study|Withdrawal by Subject|0|||
155521838|NCT02863575|561335503|FG001|Overall Study|Withdrawal by Subject|1|||
155521839|NCT02863575|561335504|FG002|Overall Study|Withdrawal by Subject|1|||
155521840|NCT02863575|561335502|FG000|Overall Study|Adverse Event|0|||
155521841|NCT02863575|561335503|FG001|Overall Study|Adverse Event|1|||
155521842|NCT02863575|561335504|FG002|Overall Study|Adverse Event|0|||
155521843|NCT01387737|561338072|FG000|Overall Study|Adverse Event|20|||
155521844|NCT01387737|561338073|FG001|Overall Study|Adverse Event|30|||
155521845|NCT01387737|561338072|FG000|Overall Study|Lack of Efficacy|1|||
155521846|NCT01387737|561338073|FG001|Overall Study|Lack of Efficacy|0|||
155521847|NCT01387737|561338072|FG000|Overall Study|Physician Decision|3|||
155521848|NCT01387737|561338073|FG001|Overall Study|Physician Decision|10|||
155521849|NCT01387737|561338072|FG000|Overall Study|Withdrawal by Subject|27|||
155521850|NCT01387737|561338073|FG001|Overall Study|Withdrawal by Subject|31|||
155521851|NCT01387737|561338072|FG000|Overall Study|Clearly not eligible for the study|1|||
155521852|NCT01387737|561338073|FG001|Overall Study|Clearly not eligible for the study|3|||
155521853|NCT01248247|561338074|FG000|Overall Study|Adverse Event|2|||
155521854|NCT01248247|561338075|FG001|Overall Study|Adverse Event|4|||
155521855|NCT01248247|561338076|FG002|Overall Study|Adverse Event|4|||
155521856|NCT01248247|561338077|FG003|Overall Study|Adverse Event|2|||
155521857|NCT01248247|561338074|FG000|Overall Study|Death|0|||
155521858|NCT01248247|561338075|FG001|Overall Study|Death|1|||
155521859|NCT01248247|561338076|FG002|Overall Study|Death|4|||
155521860|NCT01248247|561338077|FG003|Overall Study|Death|7|||
155521861|NCT01248247|561338074|FG000|Overall Study|Lost to Follow-up|0|||
155521862|NCT01248247|561338075|FG001|Overall Study|Lost to Follow-up|1|||
155521863|NCT01248247|561338076|FG002|Overall Study|Lost to Follow-up|1|||
155521864|NCT01248247|561338077|FG003|Overall Study|Lost to Follow-up|0|||
155521865|NCT01248247|561338074|FG000|Overall Study|Alternative treatment|0|||
155521866|NCT01248247|561338075|FG001|Overall Study|Alternative treatment|1|||
155521867|NCT01248247|561338076|FG002|Overall Study|Alternative treatment|0|||
155521868|NCT01248247|561338077|FG003|Overall Study|Alternative treatment|0|||
155521869|NCT01248247|561338074|FG000|Overall Study|Other|2|||
155521870|NCT01248247|561338075|FG001|Overall Study|Other|8|||
155521871|NCT01248247|561338076|FG002|Overall Study|Other|8|||
155521872|NCT01248247|561338077|FG003|Overall Study|Other|5|||
155521873|NCT01248247|561338074|FG000|Overall Study|Progression|18|||
155521874|NCT01248247|561338075|FG001|Overall Study|Progression|27|||
155521875|NCT01248247|561338076|FG002|Overall Study|Progression|56|||
155521876|NCT01248247|561338077|FG003|Overall Study|Progression|44|||
155521877|NCT01248247|561338074|FG000|Overall Study|Refuse further treatment|0|||
155521878|NCT01248247|561338075|FG001|Overall Study|Refuse further treatment|0|||
155521879|NCT01248247|561338076|FG002|Overall Study|Refuse further treatment|1|||
155521880|NCT01248247|561338077|FG003|Overall Study|Refuse further treatment|2|||
155521881|NCT01248247|561338074|FG000|Overall Study|Complicating disease|0|||
155521882|NCT01248247|561338075|FG001|Overall Study|Complicating disease|0|||
155521883|NCT01248247|561338076|FG002|Overall Study|Complicating disease|1|||
155521884|NCT01248247|561338077|FG003|Overall Study|Complicating disease|1|||
155521885|NCT04188106|561338079|FG000|Overall Study|Lost to Follow-up|5|||
155521886|NCT04188106|561338079|FG000|Overall Study|Non-Compliance|1|||
155521887|NCT01746017|561338080|FG000|Period 1|Withdrawal by Subject|0|||
155521888|NCT01746017|561338081|FG001|Period 1|Withdrawal by Subject|0|||
155521889|NCT01746017|561338082|FG002|Period 1|Withdrawal by Subject|0|||
155521890|NCT01746017|561338083|FG003|Period 1|Withdrawal by Subject|0|||
155521891|NCT01746017|561338084|FG004|Period 1|Withdrawal by Subject|0|||
155521892|NCT01746017|561338085|FG005|Period 1|Withdrawal by Subject|0|||
155521893|NCT01746017|561338086|FG006|Period 1|Withdrawal by Subject|1|||
155521894|NCT01746017|561338087|FG007|Period 1|Withdrawal by Subject|0|||
155521895|NCT01746017|561338088|FG008|Period 1|Withdrawal by Subject|0|||
155521896|NCT01746017|561338089|FG009|Period 1|Withdrawal by Subject|0|||
155521897|NCT01746017|561338090|FG010|Period 1|Withdrawal by Subject|0|||
155521898|NCT01746017|561338080|FG000|Period 3|Withdrawal by Subject|0|||
155521899|NCT01746017|561338081|FG001|Period 3|Withdrawal by Subject|0|||
155521900|NCT01746017|561338082|FG002|Period 3|Withdrawal by Subject|0|||
155654880|NCT02254291|561830566|FG002|Overall Study|Withdrawal by Subject|1|||
155521901|NCT01746017|561338083|FG003|Period 3|Withdrawal by Subject|0|||
155521902|NCT01746017|561338084|FG004|Period 3|Withdrawal by Subject|0|||
155654881|NCT02254291|561830564|FG000|Overall Study|Missing follow-up information|0|||
155521903|NCT01746017|561338085|FG005|Period 3|Withdrawal by Subject|1|||
155521904|NCT01746017|561338086|FG006|Period 3|Withdrawal by Subject|0|||
155521905|NCT01746017|561338087|FG007|Period 3|Withdrawal by Subject|0|||
155521906|NCT01746017|561338088|FG008|Period 3|Withdrawal by Subject|0|||
155521907|NCT01746017|561338089|FG009|Period 3|Withdrawal by Subject|0|||
155521908|NCT01746017|561338090|FG010|Period 3|Withdrawal by Subject|0|||
155521909|NCT01507051|561338091|FG000|Overall Study|Withdrawal by Subject|1|||
155521910|NCT01507051|561338092|FG001|Overall Study|Withdrawal by Subject|3|||
155521911|NCT01507051|561338093|FG002|Overall Study|Withdrawal by Subject|1|||
155521912|NCT01507051|561338094|FG003|Overall Study|Withdrawal by Subject|6|||
155521913|NCT01507051|561338091|FG000|Overall Study|Physician Decision|0|||
155521914|NCT01507051|561338092|FG001|Overall Study|Physician Decision|0|||
155521915|NCT01507051|561338093|FG002|Overall Study|Physician Decision|0|||
155521916|NCT01507051|561338094|FG003|Overall Study|Physician Decision|1|||
155521917|NCT01507051|561338091|FG000|Overall Study|Adverse Event|1|||
155521918|NCT01507051|561338092|FG001|Overall Study|Adverse Event|0|||
155521919|NCT01507051|561338093|FG002|Overall Study|Adverse Event|0|||
155521920|NCT01507051|561338094|FG003|Overall Study|Adverse Event|0|||
155521921|NCT02311361|561338095|FG000|Overall Study|Did not receive treatment|0|||
155521922|NCT02311361|561338096|FG001|Overall Study|Did not receive treatment|1|||
155521923|NCT02311361|561338097|FG002|Overall Study|Did not receive treatment|0|||
155521924|NCT02311361|561338098|FG003|Overall Study|Did not receive treatment|1|||
155521925|NCT05628675|561338099|FG000|Overall Study|Lost to Follow-up|2|||
155521926|NCT05628675|561338099|FG000|Overall Study|Withdrawal by Subject|1|||
155521927|NCT04455633|561338100|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
155521928|NCT04455633|561338101|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
155521929|NCT04455633|561338102|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
155521930|NCT04455633|561338100|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
155521931|NCT04455633|561338101|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
155521932|NCT04455633|561338102|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
155521933|NCT04455633|561338100|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
155521934|NCT04455633|561338101|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
155521935|NCT04455633|561338102|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
155521936|NCT04455633|561338100|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
155521937|NCT04455633|561338101|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
155521938|NCT04455633|561338102|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
155521939|NCT02532764|561338103|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521940|NCT02532764|561338104|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521941|NCT02532764|561338105|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521942|NCT02532764|561338106|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521943|NCT02532764|561338107|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521944|NCT02532764|561338108|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521945|NCT02532764|561338109|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
155521946|NCT02532764|561338110|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
155521947|NCT02532764|561338111|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
155521948|NCT02532764|561338112|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
155521949|NCT03527745|561338113|FG000|Overall Study|Lost to Follow-up|3|||
155521950|NCT03527745|561338114|FG001|Overall Study|Lost to Follow-up|6|||
155521951|NCT03527745|561338115|FG002|Overall Study|Lost to Follow-up|7|||
155521952|NCT03527745|561338116|FG003|Overall Study|Lost to Follow-up|9|||
155521953|NCT03527745|561338117|FG004|Overall Study|Lost to Follow-up|0|||
155521954|NCT03527745|561338118|FG005|Overall Study|Lost to Follow-up|2|||
155521955|NCT03527745|561338119|FG006|Overall Study|Lost to Follow-up|3|||
155521956|NCT03527745|561338120|FG007|Overall Study|Lost to Follow-up|2|||
155521957|NCT03527745|561338121|FG008|Overall Study|Lost to Follow-up|3|||
155521958|NCT03527745|561338122|FG009|Overall Study|Lost to Follow-up|2|||
155521959|NCT03527745|561338123|FG010|Overall Study|Lost to Follow-up|1|||
155521960|NCT03527745|561338124|FG011|Overall Study|Lost to Follow-up|1|||
155521961|NCT03527745|561338125|FG012|Overall Study|Lost to Follow-up|0|||
155521962|NCT03527745|561338126|FG013|Overall Study|Lost to Follow-up|0|||
155521963|NCT03527745|561338127|FG014|Overall Study|Lost to Follow-up|0|||
155521964|NCT03527745|561338128|FG015|Overall Study|Lost to Follow-up|0|||
155521965|NCT03527745|561338129|FG016|Overall Study|Lost to Follow-up|1|||
155521966|NCT03527745|561338130|FG017|Overall Study|Lost to Follow-up|0|||
155521967|NCT03527745|561338131|FG018|Overall Study|Lost to Follow-up|0|||
155521968|NCT03527745|561338132|FG019|Overall Study|Lost to Follow-up|1|||
155521969|NCT03527745|561338133|FG020|Overall Study|Lost to Follow-up|1|||
155521970|NCT03527745|561338134|FG021|Overall Study|Lost to Follow-up|5|||
155521971|NCT03527745|561338135|FG022|Overall Study|Lost to Follow-up|6|||
155521972|NCT03527745|561338136|FG023|Overall Study|Lost to Follow-up|8|||
155521973|NCT03527745|561338137|FG024|Overall Study|Lost to Follow-up|1|||
155521974|NCT03527745|561338138|FG025|Overall Study|Lost to Follow-up|3|||
155521975|NCT01475838|561338139|FG000|Randomized Phase|Randomized but Not Treated|0|||
155521976|NCT01475838|561338140|FG001|Randomized Phase|Randomized but Not Treated|5|||
155521977|NCT01475838|561338139|FG000|Randomized Phase|Adverse Event|6|||
155521978|NCT01475838|561338140|FG001|Randomized Phase|Adverse Event|1|||
155521979|NCT01475838|561338139|FG000|Randomized Phase|Pregnancy|0|||
155521980|NCT01475838|561338140|FG001|Randomized Phase|Pregnancy|1|||
155521981|NCT01475838|561338139|FG000|Randomized Phase|Investigators Discretion|1|||
155654882|NCT02254291|561830565|FG001|Overall Study|Missing follow-up information|0|||
155485560|NCT01920061|561199945|FG019|Overall Study|Participant refused further follow-up|0|||
155485561|NCT00554229|561199946|FG000|Overall Study|Lost to Follow-up|3|||
155485562|NCT00554229|561199947|FG001|Overall Study|Lost to Follow-up|6|||
155485563|NCT00554229|561199946|FG000|Overall Study|Withdrawal by Subject|29|||
155485564|NCT00554229|561199947|FG001|Overall Study|Withdrawal by Subject|37|||
155485565|NCT00554229|561199946|FG000|Overall Study|Adverse Event|71|||
155485566|NCT00554229|561199947|FG001|Overall Study|Adverse Event|39|||
155485567|NCT00554229|561199946|FG000|Overall Study|Protocol Violation|3|||
155485568|NCT00554229|561199947|FG001|Overall Study|Protocol Violation|3|||
155485569|NCT00554229|561199946|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
155485570|NCT00554229|561199947|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
155485571|NCT00554229|561199946|FG000|Overall Study|Randomised but no treatment received|1|||
155485572|NCT00554229|561199947|FG001|Overall Study|Randomised but no treatment received|0|||
155485573|NCT03969589|561199948|FG000|Overall Study|Lost to Follow-up|3|||
155485574|NCT03969589|561199949|FG001|Overall Study|Lost to Follow-up|2|||
155485575|NCT03969589|561199948|FG000|Overall Study|Declined Follow-Up|0|||
155485576|NCT03969589|561199949|FG001|Overall Study|Declined Follow-Up|1|||
155485577|NCT03143855|561199950|FG000|Overall Study|Withdrawal by Subject|4|||
155485578|NCT03143855|561199951|FG001|Overall Study|Withdrawal by Subject|3|||
155485579|NCT03143855|561199950|FG000|Overall Study|Protocol Violation|1|||
155485580|NCT03143855|561199951|FG001|Overall Study|Protocol Violation|0|||
155485581|NCT03143855|561199950|FG000|Overall Study|Participant experienced withdrawal|0|||
155485582|NCT03143855|561199951|FG001|Overall Study|Participant experienced withdrawal|1|||
155485583|NCT04823494|561201850|FG000|Overall Study|Programming software malfunction.|1|||
155485584|NCT04823494|561201851|FG001|Overall Study|Programming software malfunction.|0|||
155485585|NCT04823494|561201850|FG000|Overall Study|Withdrawal by Subject|1|||
155485586|NCT04823494|561201851|FG001|Overall Study|Withdrawal by Subject|0|||
155485587|NCT04823494|561201850|FG000|Overall Study|Devices lost|0|||
155485588|NCT04823494|561201851|FG001|Overall Study|Devices lost|1|||
155485589|NCT01884675|561201852|FG000|Overall Study|Study closed/terminated|3|||
155485590|NCT01884675|561201853|FG001|Overall Study|Study closed/terminated|2|||
155485591|NCT01277757|561201854|FG000|Overall Study|Disease Progression|1|||
155485592|NCT01277757|561201854|FG000|Overall Study|Withdrawal by Subject|1|||
155485593|NCT04120116|561201855|FG000|Overall Study|Lost to Follow-up|0|||
155485594|NCT04120116|561201856|FG001|Overall Study|Lost to Follow-up|1|||
155485595|NCT04120116|561201857|FG002|Overall Study|Lost to Follow-up|0|||
155485596|NCT04120116|561201858|FG003|Overall Study|Lost to Follow-up|2|||
155485597|NCT04120116|561201855|FG000|Overall Study|Withdrawal by Subject|1|||
155485598|NCT04120116|561201856|FG001|Overall Study|Withdrawal by Subject|0|||
155485599|NCT04120116|561201857|FG002|Overall Study|Withdrawal by Subject|1|||
155485600|NCT04120116|561201858|FG003|Overall Study|Withdrawal by Subject|1|||
155485601|NCT04120116|561201855|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
155485602|NCT04120116|561201856|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
155485603|NCT04120116|561201857|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
155485604|NCT04120116|561201858|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
155485605|NCT00965458|561201859|FG000|Overall Study|Adverse Event|1|||
155485606|NCT00965458|561201860|FG001|Overall Study|Adverse Event|0|||
155485607|NCT00965458|561201859|FG000|Overall Study|Lost to Follow-up|1|||
155485608|NCT00965458|561201860|FG001|Overall Study|Lost to Follow-up|3|||
155485609|NCT00965458|561201859|FG000|Overall Study|Withdrawal by Subject|0|||
155485610|NCT00965458|561201860|FG001|Overall Study|Withdrawal by Subject|1|||
155485611|NCT01846039|561201861|FG000|Overall Study|Protocol Violation|1|||
155485612|NCT01846039|561201861|FG000|Overall Study|Subject Withdrew Consent|1|||
155485613|NCT02528331|561201872|FG000|Overall Study|Withdrawal by Subject|2|||
155485614|NCT03824704|561201882|FG000|Overall Study|Study Terminated by Sponsor|1|||
155485615|NCT02155660|561201885|FG000|Overall Study|Other Reason|8|||
155485616|NCT02155660|561201886|FG001|Overall Study|Other Reason|6|||
155485617|NCT02155660|561201887|FG002|Overall Study|Other Reason|10|||
155485618|NCT02155660|561201888|FG003|Overall Study|Other Reason|10|||
155485619|NCT02155660|561201885|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155485620|NCT02155660|561201886|FG001|Overall Study|Study-specific withdrawal criteria|1|||
155485621|NCT02155660|561201887|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155485622|NCT02155660|561201888|FG003|Overall Study|Study-specific withdrawal criteria|1|||
155485623|NCT02155660|561201885|FG000|Overall Study|Severe non-compliance|0|||
155485624|NCT02155660|561201886|FG001|Overall Study|Severe non-compliance|4|||
155485625|NCT02155660|561201887|FG002|Overall Study|Severe non-compliance|0|||
155485626|NCT02155660|561201888|FG003|Overall Study|Severe non-compliance|1|||
155485627|NCT02155660|561201885|FG000|Overall Study|Adverse Event|2|||
155485628|NCT02155660|561201886|FG001|Overall Study|Adverse Event|6|||
155485629|NCT02155660|561201887|FG002|Overall Study|Adverse Event|3|||
155485630|NCT02155660|561201888|FG003|Overall Study|Adverse Event|1|||
155485631|NCT02155660|561201885|FG000|Overall Study|Lost to Follow-up|3|||
155485632|NCT02155660|561201886|FG001|Overall Study|Lost to Follow-up|6|||
155485633|NCT02155660|561201887|FG002|Overall Study|Lost to Follow-up|5|||
155485634|NCT02155660|561201888|FG003|Overall Study|Lost to Follow-up|8|||
155485635|NCT02155660|561201885|FG000|Overall Study|Death|17|||
155485636|NCT02155660|561201886|FG001|Overall Study|Death|19|||
155485637|NCT02155660|561201887|FG002|Overall Study|Death|17|||
155485638|NCT02155660|561201888|FG003|Overall Study|Death|19|||
155485639|NCT02155660|561201885|FG000|Overall Study|Withdrawal by Subject|28|||
155485640|NCT02155660|561201886|FG001|Overall Study|Withdrawal by Subject|31|||
155485641|NCT02155660|561201887|FG002|Overall Study|Withdrawal by Subject|24|||
155485642|NCT02155660|561201888|FG003|Overall Study|Withdrawal by Subject|21|||
155485643|NCT03730987|561201889|FG000|Overall Study|Lost to Follow-up|2|||
155485644|NCT03730987|561201890|FG001|Overall Study|Lost to Follow-up|0|||
155485645|NCT03730987|561201891|FG002|Overall Study|Lost to Follow-up|2|||
155485646|NCT03730987|561201892|FG003|Overall Study|Lost to Follow-up|0|||
155485647|NCT02505945|561201893|FG000|Overall Study|Withdrawal by Subject|13|||
155485648|NCT02505945|561201894|FG001|Overall Study|Withdrawal by Subject|2|||
155485649|NCT02505945|561201893|FG000|Overall Study|Adverse Event|1|||
155485650|NCT02505945|561201894|FG001|Overall Study|Adverse Event|0|||
155485651|NCT02505945|561201893|FG000|Overall Study|Physician Decision|2|||
155485652|NCT02505945|561201894|FG001|Overall Study|Physician Decision|1|||
155485653|NCT02505945|561201893|FG000|Overall Study|Lost to Follow-up|6|||
155485654|NCT02505945|561201894|FG001|Overall Study|Lost to Follow-up|1|||
155485655|NCT02406586|561201895|FG000|Overall Study|Lost to Follow-up|0|||
155485656|NCT02406586|561201896|FG001|Overall Study|Lost to Follow-up|4|||
155485657|NCT02406586|561201897|FG002|Overall Study|Lost to Follow-up|2|||
155485658|NCT02406586|561201895|FG000|Overall Study|Withdrawal by Subject|1|||
155485659|NCT02406586|561201896|FG001|Overall Study|Withdrawal by Subject|0|||
155485660|NCT02406586|561201897|FG002|Overall Study|Withdrawal by Subject|0|||
155485661|NCT01072175|561201898|FG000|Part A (Drug-Drug Interaction)|Death|1|||
155485662|NCT01072175|561201899|FG001|Part A (Drug-Drug Interaction)|Death|0|||
155485663|NCT01072175|561201900|FG002|Part A (Drug-Drug Interaction)|Death|0|||
155485664|NCT01072175|561201901|FG003|Part A (Drug-Drug Interaction)|Death|0|||
155485665|NCT01072175|561201902|FG004|Part A (Drug-Drug Interaction)|Death|0|||
155485666|NCT01072175|561201903|FG005|Part A (Drug-Drug Interaction)|Death|0|||
155485667|NCT01072175|561201904|FG006|Part A (Drug-Drug Interaction)|Death|0|||
155485668|NCT01072175|561201905|FG007|Part A (Drug-Drug Interaction)|Death|0|||
155485669|NCT01072175|561201906|FG008|Part A (Drug-Drug Interaction)|Death|0|||
155485670|NCT01072175|561201907|FG009|Part A (Drug-Drug Interaction)|Death|0|||
155485671|NCT01072175|561201908|FG010|Part A (Drug-Drug Interaction)|Death|0|||
155485672|NCT01072175|561201909|FG011|Part A (Drug-Drug Interaction)|Death|0|||
155485673|NCT01072175|561201910|FG012|Part A (Drug-Drug Interaction)|Death|0|||
155485674|NCT01072175|561201898|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
155485675|NCT01072175|561201899|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485676|NCT01072175|561201900|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485677|NCT01072175|561201901|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485678|NCT01072175|561201902|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485679|NCT01072175|561201903|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485680|NCT01072175|561201904|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485681|NCT01072175|561201905|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485682|NCT01072175|561201906|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485683|NCT01072175|561201907|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485684|NCT01072175|561201908|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485685|NCT01072175|561201909|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485686|NCT01072175|561201910|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
155485687|NCT01072175|561201898|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
155485688|NCT01072175|561201899|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485689|NCT01072175|561201900|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485690|NCT01072175|561201901|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485691|NCT01072175|561201902|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485692|NCT01072175|561201903|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485693|NCT01072175|561201904|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485694|NCT01072175|561201905|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485695|NCT01072175|561201906|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485696|NCT01072175|561201907|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485697|NCT01072175|561201908|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485698|NCT01072175|561201909|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485699|NCT01072175|561201910|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155485700|NCT01072175|561201898|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
155485701|NCT01072175|561201899|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
155485702|NCT01072175|561201900|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
155485703|NCT01072175|561201901|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
155485704|NCT01072175|561201902|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
155485705|NCT01072175|561201903|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
155485706|NCT01072175|561201904|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
155485707|NCT01072175|561201905|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
155485708|NCT01072175|561201906|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
155485709|NCT01072175|561201907|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
155485710|NCT01072175|561201908|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
155485711|NCT01072175|561201909|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
155485712|NCT01072175|561201910|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
155485713|NCT01072175|561201898|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485714|NCT01072175|561201899|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485715|NCT01072175|561201900|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
155485716|NCT01072175|561201901|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485717|NCT01072175|561201902|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
155485718|NCT01072175|561201903|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485719|NCT01072175|561201904|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485720|NCT01072175|561201905|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485721|NCT01072175|561201906|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485722|NCT01072175|561201907|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485723|NCT01072175|561201908|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485724|NCT01072175|561201909|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485725|NCT01072175|561201910|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
155485726|NCT01072175|561201898|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485727|NCT01072175|561201899|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
155485728|NCT01072175|561201900|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485729|NCT01072175|561201901|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
155485730|NCT01072175|561201902|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
155485731|NCT01072175|561201903|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485732|NCT01072175|561201904|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485733|NCT01072175|561201905|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485734|NCT01072175|561201906|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485735|NCT01072175|561201907|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485736|NCT01072175|561201908|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485737|NCT01072175|561201909|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485738|NCT01072175|561201910|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
155485739|NCT01072175|561201898|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485740|NCT01072175|561201899|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485741|NCT01072175|561201900|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
155485742|NCT01072175|561201901|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
155485743|NCT01072175|561201902|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
155485744|NCT01072175|561201903|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485745|NCT01072175|561201904|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485746|NCT01072175|561201905|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485747|NCT01072175|561201906|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485748|NCT01072175|561201907|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485749|NCT01072175|561201908|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485750|NCT01072175|561201909|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485751|NCT01072175|561201910|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
155485752|NCT01072175|561201898|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485753|NCT01072175|561201899|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
155485754|NCT01072175|561201900|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485755|NCT01072175|561201901|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
155485756|NCT01072175|561201902|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
155485757|NCT01072175|561201903|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485758|NCT01072175|561201904|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485759|NCT01072175|561201905|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485760|NCT01072175|561201906|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155521982|NCT01475838|561338140|FG001|Randomized Phase|Investigators Discretion|2|||
155521983|NCT01475838|561338139|FG000|Randomized Phase|Withdrew Consent|10|||
155521984|NCT01475838|561338140|FG001|Randomized Phase|Withdrew Consent|14|||
155521985|NCT01475838|561338139|FG000|Randomized Phase|Lost to Follow-up|3|||
155521986|NCT01475838|561338140|FG001|Randomized Phase|Lost to Follow-up|4|||
155521987|NCT01475838|561338139|FG000|Randomized Phase|Participant Noncompliance|1|||
155521988|NCT01475838|561338140|FG001|Randomized Phase|Participant Noncompliance|5|||
155521989|NCT01475838|561338139|FG000|Randomized Phase|Protocol Violation|9|||
155521990|NCT01475838|561338140|FG001|Randomized Phase|Protocol Violation|4|||
155521991|NCT01475838|561338139|FG000|Extension Phase|Participant Noncompliance|1|||
155521992|NCT01475838|561338140|FG001|Extension Phase|Participant Noncompliance|0|||
155521993|NCT01717976|561338146|FG000|Overall Study|Protocol Violation|0|||
155521994|NCT01717976|561338147|FG001|Overall Study|Protocol Violation|1|||
155521995|NCT00048568|561338148|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
155521996|NCT00048568|561338149|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
155521997|NCT00048568|561338150|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
155521998|NCT00048568|561338148|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
155521999|NCT00048568|561338149|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
155522000|NCT00048568|561338150|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
155522001|NCT00048568|561338148|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
155522002|NCT00048568|561338149|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
155522003|NCT00048568|561338150|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
155522004|NCT00048568|561338148|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
155522005|NCT00048568|561338149|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
155522006|NCT00048568|561338150|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
155522007|NCT00048568|561338148|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
155522008|NCT00048568|561338149|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
155522009|NCT00048568|561338150|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
155522010|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Death|1|||
155522011|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Death|1|||
155522012|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Death|0|||
155522013|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
155522014|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
155522015|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
155522016|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
155522017|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
155522018|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
155522019|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
155522020|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
155522021|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
155522022|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
155522023|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
155522024|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
155522025|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
155522026|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
155522027|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
155522028|NCT00048568|561338148|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
155522029|NCT00048568|561338149|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
155522030|NCT00048568|561338150|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
155522031|NCT00048568|561338148|FG000|Open-Label Period|Death|0|||
155522032|NCT00048568|561338149|FG001|Open-Label Period|Death|0|||
155522033|NCT00048568|561338150|FG002|Open-Label Period|Death|13|||
155522034|NCT00048568|561338148|FG000|Open-Label Period|Adverse Event|0|||
155522035|NCT00048568|561338149|FG001|Open-Label Period|Adverse Event|0|||
155522036|NCT00048568|561338150|FG002|Open-Label Period|Adverse Event|49|||
155522037|NCT00048568|561338148|FG000|Open-Label Period|Lack of Efficacy|0|||
155522038|NCT00048568|561338149|FG001|Open-Label Period|Lack of Efficacy|0|||
155522039|NCT00048568|561338150|FG002|Open-Label Period|Lack of Efficacy|32|||
155522040|NCT00048568|561338148|FG000|Open-Label Period|Withdrawal by Subject|0|||
155522041|NCT00048568|561338149|FG001|Open-Label Period|Withdrawal by Subject|0|||
155522042|NCT00048568|561338150|FG002|Open-Label Period|Withdrawal by Subject|26|||
155522043|NCT00048568|561338148|FG000|Open-Label Period|Pregnancy|0|||
155522044|NCT00048568|561338149|FG001|Open-Label Period|Pregnancy|0|||
155522045|NCT00048568|561338150|FG002|Open-Label Period|Pregnancy|5|||
155522046|NCT00048568|561338148|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
155522047|NCT00048568|561338149|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
155522048|NCT00048568|561338150|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
155522049|NCT00048568|561338148|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
155522050|NCT00048568|561338149|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
155522051|NCT00048568|561338150|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
155522052|NCT00048568|561338148|FG000|Open-Label Period|Unknown Reasons|0|||
155522053|NCT00048568|561338149|FG001|Open-Label Period|Unknown Reasons|0|||
155522054|NCT00048568|561338150|FG002|Open-Label Period|Unknown Reasons|25|||
155522055|NCT00048568|561338148|FG000|Open-Label Period|Lost to Follow-up|0|||
155522056|NCT00048568|561338149|FG001|Open-Label Period|Lost to Follow-up|0|||
155522057|NCT00048568|561338150|FG002|Open-Label Period|Lost to Follow-up|7|||
155522058|NCT00560235|561338151|FG000|Phase 1|Discontinued|8|||
155522059|NCT00560235|561338152|FG001|Phase 1|Discontinued|0|||
155522060|NCT00560235|561338153|FG002|Phase 1|Discontinued|0|||
155522061|NCT00560235|561338151|FG000|Phase 1B|Discontinued|0|||
155522062|NCT00560235|561338152|FG001|Phase 1B|Discontinued|19|||
155522063|NCT00560235|561338153|FG002|Phase 1B|Discontinued|0|||
155522064|NCT00560235|561338151|FG000|Phase 2|Discontinued|0|||
155522065|NCT00560235|561338152|FG001|Phase 2|Discontinued|0|||
155522066|NCT00560235|561338153|FG002|Phase 2|Discontinued|96|||
155522067|NCT00560235|561338151|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
155522068|NCT00560235|561338152|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
155522069|NCT00560235|561338153|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
155522070|NCT04015232|561338154|FG000|Overall Study|Withdrawal by Subject|7|||
155522071|NCT04015232|561338155|FG001|Overall Study|Withdrawal by Subject|4|||
155522072|NCT04015232|561338154|FG000|Overall Study|Protocol Violation|1|||
155522073|NCT04015232|561338155|FG001|Overall Study|Protocol Violation|0|||
155522074|NCT04015232|561338154|FG000|Overall Study|Medical Grounds|3|||
155522075|NCT04015232|561338155|FG001|Overall Study|Medical Grounds|3|||
155522076|NCT02896361|561338158|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
155522077|NCT02896361|561338159|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
155522078|NCT02896361|561338160|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
155522079|NCT02896361|561338158|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
155522080|NCT02896361|561338159|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
155522081|NCT02896361|561338160|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
155522082|NCT01029353|561338161|FG000|Overall Study|Lost to Follow-up|4|||
155522083|NCT01029353|561338162|FG001|Overall Study|Lost to Follow-up|5|||
155522084|NCT01029353|561338163|FG002|Overall Study|Lost to Follow-up|5|||
155522085|NCT01029353|561338164|FG003|Overall Study|Lost to Follow-up|4|||
155522086|NCT01029353|561338161|FG000|Overall Study|Consent Withdrawn|2|||
155522087|NCT01029353|561338162|FG001|Overall Study|Consent Withdrawn|0|||
155522088|NCT01029353|561338163|FG002|Overall Study|Consent Withdrawn|0|||
155522089|NCT01029353|561338164|FG003|Overall Study|Consent Withdrawn|0|||
155522090|NCT01029353|561338161|FG000|Overall Study|Primary Outcome Indeterminate|1|||
155522091|NCT01029353|561338162|FG001|Overall Study|Primary Outcome Indeterminate|3|||
155522092|NCT01029353|561338163|FG002|Overall Study|Primary Outcome Indeterminate|2|||
155522093|NCT01029353|561338164|FG003|Overall Study|Primary Outcome Indeterminate|0|||
155522094|NCT00496964|561338169|FG000|Overall Study|Withdrawal by Subject|0|||
155522095|NCT00496964|561338170|FG001|Overall Study|Withdrawal by Subject|1|||
155522096|NCT02942264|561338171|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522097|NCT02942264|561338172|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
155522098|NCT02942264|561338173|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522099|NCT02942264|561338174|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522100|NCT02942264|561338175|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522101|NCT02942264|561338176|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522102|NCT02942264|561338177|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
155522103|NCT02942264|561338178|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522104|NCT02942264|561338179|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155522105|NCT02942264|561338171|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522106|NCT02942264|561338172|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522107|NCT02942264|561338173|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522108|NCT02942264|561338174|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522109|NCT02942264|561338175|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522110|NCT02942264|561338176|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522111|NCT02942264|561338177|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522112|NCT02942264|561338178|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
155522113|NCT02942264|561338179|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
155522114|NCT03980483|561338180|FG000|Overall Study|Adverse Event|13|||
155522115|NCT03980483|561338181|FG001|Overall Study|Adverse Event|29|||
155522116|NCT03980483|561338182|FG002|Overall Study|Adverse Event|11|||
155522117|NCT03980483|561338183|FG003|Overall Study|Adverse Event|2|||
155522118|NCT03980483|561338184|FG004|Overall Study|Adverse Event|2|||
155522119|NCT03980483|561338185|FG005|Overall Study|Adverse Event|2|||
155522120|NCT03980483|561338180|FG000|Overall Study|Lack of Efficacy|7|||
155522121|NCT03980483|561338181|FG001|Overall Study|Lack of Efficacy|6|||
155522122|NCT03980483|561338182|FG002|Overall Study|Lack of Efficacy|0|||
155522123|NCT03980483|561338183|FG003|Overall Study|Lack of Efficacy|3|||
155522124|NCT03980483|561338184|FG004|Overall Study|Lack of Efficacy|1|||
155522125|NCT03980483|561338185|FG005|Overall Study|Lack of Efficacy|1|||
155522126|NCT03980483|561338180|FG000|Overall Study|Lost to Follow-up|2|||
155522127|NCT03980483|561338181|FG001|Overall Study|Lost to Follow-up|4|||
155522128|NCT03980483|561338182|FG002|Overall Study|Lost to Follow-up|2|||
155522129|NCT03980483|561338183|FG003|Overall Study|Lost to Follow-up|1|||
155522130|NCT03980483|561338184|FG004|Overall Study|Lost to Follow-up|2|||
155522131|NCT03980483|561338185|FG005|Overall Study|Lost to Follow-up|0|||
155522132|NCT03980483|561338180|FG000|Overall Study|Protocol Violation|4|||
155522133|NCT03980483|561338181|FG001|Overall Study|Protocol Violation|2|||
155522134|NCT03980483|561338182|FG002|Overall Study|Protocol Violation|1|||
155522135|NCT03980483|561338183|FG003|Overall Study|Protocol Violation|1|||
155522136|NCT03980483|561338184|FG004|Overall Study|Protocol Violation|0|||
155522137|NCT03980483|561338185|FG005|Overall Study|Protocol Violation|0|||
155522138|NCT03980483|561338180|FG000|Overall Study|Physician Decision|14|||
155522139|NCT03980483|561338181|FG001|Overall Study|Physician Decision|10|||
155522140|NCT03980483|561338182|FG002|Overall Study|Physician Decision|7|||
155522141|NCT03980483|561338183|FG003|Overall Study|Physician Decision|4|||
155522142|NCT03980483|561338184|FG004|Overall Study|Physician Decision|4|||
155522143|NCT03980483|561338185|FG005|Overall Study|Physician Decision|2|||
155522144|NCT03980483|561338180|FG000|Overall Study|Withdrawal by Subject|38|||
155522145|NCT03980483|561338181|FG001|Overall Study|Withdrawal by Subject|21|||
155522146|NCT03980483|561338182|FG002|Overall Study|Withdrawal by Subject|15|||
155522147|NCT03980483|561338183|FG003|Overall Study|Withdrawal by Subject|5|||
155522148|NCT03980483|561338184|FG004|Overall Study|Withdrawal by Subject|3|||
155522149|NCT03980483|561338185|FG005|Overall Study|Withdrawal by Subject|4|||
155522150|NCT03980483|561338180|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
155522151|NCT03980483|561338181|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155522152|NCT03980483|561338182|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155522153|NCT03980483|561338183|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155522154|NCT03980483|561338184|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155522155|NCT03980483|561338185|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155522156|NCT03980483|561338180|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
155522157|NCT03980483|561338181|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
155522158|NCT03980483|561338182|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
155522159|NCT03980483|561338183|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
155522160|NCT03980483|561338184|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
155522161|NCT03980483|561338185|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
155522162|NCT03980483|561338180|FG000|Overall Study|Other|0|||
155522163|NCT03980483|561338181|FG001|Overall Study|Other|1|||
155522164|NCT03980483|561338182|FG002|Overall Study|Other|0|||
155522165|NCT03980483|561338183|FG003|Overall Study|Other|0|||
155522166|NCT03980483|561338184|FG004|Overall Study|Other|0|||
155522167|NCT03980483|561338185|FG005|Overall Study|Other|0|||
155522168|NCT01062256|561338188|FG000|Overall Study|Adverse Event|1|||
155522169|NCT01062256|561338189|FG001|Overall Study|Adverse Event|0|||
155522170|NCT01062256|561338190|FG002|Overall Study|Adverse Event|0|||
155522171|NCT01062256|561338188|FG000|Overall Study|Withdrawal by Subject|1|||
155522172|NCT01062256|561338189|FG001|Overall Study|Withdrawal by Subject|1|||
155522173|NCT01062256|561338190|FG002|Overall Study|Withdrawal by Subject|1|||
155522174|NCT01062256|561338188|FG000|Overall Study|Ineligible|1|||
155522175|NCT01062256|561338189|FG001|Overall Study|Ineligible|4|||
155522176|NCT01062256|561338190|FG002|Overall Study|Ineligible|3|||
155522177|NCT01062256|561338188|FG000|Overall Study|Administrative|0|||
155522178|NCT01062256|561338189|FG001|Overall Study|Administrative|2|||
155522179|NCT01062256|561338190|FG002|Overall Study|Administrative|0|||
155522180|NCT03049488|561338191|FG000|Overall Study|Lost to Follow-up|1|||
155522181|NCT03049488|561338192|FG001|Overall Study|Lost to Follow-up|1|||
155522182|NCT03049488|561338193|FG002|Overall Study|Lost to Follow-up|0|||
155522183|NCT03049488|561338194|FG003|Overall Study|Lost to Follow-up|0|||
155522184|NCT03049488|561338195|FG004|Overall Study|Lost to Follow-up|0|||
155522185|NCT03049488|561338196|FG005|Overall Study|Lost to Follow-up|0|||
155522186|NCT03049488|561338191|FG000|Overall Study|Moved from Area|1|||
155522187|NCT03049488|561338192|FG001|Overall Study|Moved from Area|0|||
155522188|NCT03049488|561338193|FG002|Overall Study|Moved from Area|0|||
155522189|NCT03049488|561338194|FG003|Overall Study|Moved from Area|1|||
155522190|NCT03049488|561338195|FG004|Overall Study|Moved from Area|1|||
155522191|NCT03049488|561338196|FG005|Overall Study|Moved from Area|0|||
155522192|NCT03049488|561338191|FG000|Overall Study|Physician Decision|0|||
155522193|NCT03049488|561338192|FG001|Overall Study|Physician Decision|1|||
155522194|NCT03049488|561338193|FG002|Overall Study|Physician Decision|0|||
155522195|NCT03049488|561338194|FG003|Overall Study|Physician Decision|0|||
155654883|NCT02254291|561830566|FG002|Overall Study|Missing follow-up information|1|||
155654884|NCT03033784|561830569|FG000|Overall Study|Anxiety related to MRI scanner|0|||
155654885|NCT03033784|561830570|FG001|Overall Study|Anxiety related to MRI scanner|1|||
155522196|NCT03049488|561338195|FG004|Overall Study|Physician Decision|0|||
155522197|NCT03049488|561338196|FG005|Overall Study|Physician Decision|0|||
155522198|NCT03049488|561338191|FG000|Overall Study|Withdrawal by Subject|0|||
155522199|NCT03049488|561338192|FG001|Overall Study|Withdrawal by Subject|0|||
155522200|NCT03049488|561338193|FG002|Overall Study|Withdrawal by Subject|0|||
155522201|NCT03049488|561338194|FG003|Overall Study|Withdrawal by Subject|1|||
155522202|NCT03049488|561338195|FG004|Overall Study|Withdrawal by Subject|1|||
155522203|NCT03049488|561338196|FG005|Overall Study|Withdrawal by Subject|0|||
155522204|NCT03099538|561338198|FG000|Overall Study|Lack of Efficacy|3|||
155522205|NCT00891293|561338199|FG000|Overall Study|Adverse Event|2|||
155522206|NCT00891293|561338199|FG000|Overall Study|Protocol Violation|2|||
155522207|NCT00891293|561338199|FG000|Overall Study|Laboratory abnormality|4|||
155522208|NCT00891293|561338199|FG000|Overall Study|Lost to Follow-up|7|||
155522209|NCT00891293|561338199|FG000|Overall Study|Subject withdrew consent|7|||
155522210|NCT00891293|561338199|FG000|Overall Study|Sponsor termination|62|||
155522211|NCT00440557|561338200|FG000|Overall Study|Withdrawal by Subject|10|||
155522212|NCT00440557|561338201|FG001|Overall Study|Withdrawal by Subject|5|||
155522213|NCT00440557|561338202|FG002|Overall Study|Withdrawal by Subject|11|||
155522214|NCT00440557|561338200|FG000|Overall Study|Lost to Follow-up|1|||
155522215|NCT00440557|561338201|FG001|Overall Study|Lost to Follow-up|2|||
155522216|NCT00440557|561338202|FG002|Overall Study|Lost to Follow-up|6|||
155522217|NCT00440557|561338200|FG000|Overall Study|Adverse Event|3|||
155522218|NCT00440557|561338201|FG001|Overall Study|Adverse Event|3|||
155522219|NCT00440557|561338202|FG002|Overall Study|Adverse Event|5|||
155522220|NCT00440557|561338200|FG000|Overall Study|Death|2|||
155522221|NCT00440557|561338201|FG001|Overall Study|Death|6|||
155522222|NCT00440557|561338202|FG002|Overall Study|Death|3|||
155522223|NCT00440557|561338200|FG000|Overall Study|Began Dialysis|4|||
155522224|NCT00440557|561338201|FG001|Overall Study|Began Dialysis|1|||
155522225|NCT00440557|561338202|FG002|Overall Study|Began Dialysis|4|||
155522226|NCT00440557|561338200|FG000|Overall Study|Principal Investigator decision|0|||
155522227|NCT00440557|561338201|FG001|Overall Study|Principal Investigator decision|3|||
155522228|NCT00440557|561338202|FG002|Overall Study|Principal Investigator decision|1|||
155522229|NCT00440557|561338200|FG000|Overall Study|Patient moved|1|||
155522230|NCT00440557|561338201|FG001|Overall Study|Patient moved|2|||
155522231|NCT00440557|561338202|FG002|Overall Study|Patient moved|1|||
155522232|NCT00440557|561338200|FG000|Overall Study|Principal Investigator's office closed|3|||
155522233|NCT00440557|561338201|FG001|Overall Study|Principal Investigator's office closed|6|||
155522234|NCT00440557|561338202|FG002|Overall Study|Principal Investigator's office closed|4|||
155522235|NCT00440557|561338200|FG000|Overall Study|Patient transferred to nursing home|0|||
155522236|NCT00440557|561338201|FG001|Overall Study|Patient transferred to nursing home|1|||
155522237|NCT00440557|561338202|FG002|Overall Study|Patient transferred to nursing home|0|||
155522238|NCT00440557|561338200|FG000|Overall Study|Patient had surgery|1|||
155522239|NCT00440557|561338201|FG001|Overall Study|Patient had surgery|0|||
155522240|NCT00440557|561338202|FG002|Overall Study|Patient had surgery|0|||
155522241|NCT01572948|561338203|FG000|Overall Study|Lost to Follow-up|1|||
155522242|NCT01572948|561338204|FG001|Overall Study|Lost to Follow-up|0|||
155522243|NCT01572948|561338203|FG000|Overall Study|unable to contact|0|||
155522244|NCT01572948|561338204|FG001|Overall Study|unable to contact|1|||
155522245|NCT01126736|561338209|FG000|Overall Study|Death|2|||
155522246|NCT01126736|561338210|FG001|Overall Study|Death|2|||
155522247|NCT01126736|561338211|FG002|Overall Study|Death|1|||
155522248|NCT01126736|561338212|FG003|Overall Study|Death|19|||
155522249|NCT01126736|561338213|FG004|Overall Study|Death|19|||
155522250|NCT01126736|561338209|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
155522251|NCT01126736|561338210|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
155522252|NCT01126736|561338211|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
155522253|NCT01126736|561338212|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
155522254|NCT01126736|561338213|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
155522255|NCT01126736|561338209|FG000|Overall Study|Lost to Follow-up|0|||
155522256|NCT01126736|561338210|FG001|Overall Study|Lost to Follow-up|0|||
155522257|NCT01126736|561338211|FG002|Overall Study|Lost to Follow-up|0|||
155522258|NCT01126736|561338212|FG003|Overall Study|Lost to Follow-up|1|||
155522259|NCT01126736|561338213|FG004|Overall Study|Lost to Follow-up|1|||
155522260|NCT01126736|561338209|FG000|Overall Study|Administrative reasons|0|||
155522261|NCT01126736|561338210|FG001|Overall Study|Administrative reasons|0|||
155654886|NCT03033784|561830571|FG002|Overall Study|Anxiety related to MRI scanner|0|||
155654887|NCT03033784|561830572|FG003|Overall Study|Anxiety related to MRI scanner|0|||
155654888|NCT03033784|561830573|FG004|Overall Study|Anxiety related to MRI scanner|0|||
155522262|NCT01126736|561338211|FG002|Overall Study|Administrative reasons|0|||
155522263|NCT01126736|561338212|FG003|Overall Study|Administrative reasons|0|||
155522264|NCT01126736|561338213|FG004|Overall Study|Administrative reasons|1|||
155522265|NCT01126736|561338209|FG000|Overall Study|Progressive disease|0|||
155522266|NCT01126736|561338210|FG001|Overall Study|Progressive disease|0|||
155522267|NCT01126736|561338211|FG002|Overall Study|Progressive disease|0|||
155522268|NCT01126736|561338212|FG003|Overall Study|Progressive disease|2|||
155522269|NCT01126736|561338213|FG004|Overall Study|Progressive disease|1|||
155522270|NCT01126736|561338209|FG000|Overall Study|Withdrawal by Subject|0|||
155522271|NCT01126736|561338210|FG001|Overall Study|Withdrawal by Subject|0|||
155522272|NCT01126736|561338211|FG002|Overall Study|Withdrawal by Subject|0|||
155522273|NCT01126736|561338212|FG003|Overall Study|Withdrawal by Subject|1|||
155522274|NCT01126736|561338213|FG004|Overall Study|Withdrawal by Subject|1|||
155522275|NCT01126736|561338209|FG000|Overall Study|Other|2|||
155522276|NCT01126736|561338210|FG001|Overall Study|Other|4|||
155522277|NCT01126736|561338211|FG002|Overall Study|Other|4|||
155522278|NCT01126736|561338212|FG003|Overall Study|Other|16|||
155522279|NCT01126736|561338213|FG004|Overall Study|Other|15|||
155522280|NCT00874237|561338215|FG000|Overall Study|Physician Decision|0|||
155522281|NCT00874237|561338216|FG001|Overall Study|Physician Decision|1|||
155522282|NCT00874237|561338217|FG002|Overall Study|Physician Decision|0|||
155522283|NCT00874237|561338218|FG003|Overall Study|Physician Decision|0|||
155522284|NCT00874237|561338219|FG004|Overall Study|Physician Decision|0|||
155522285|NCT00874237|561338220|FG005|Overall Study|Physician Decision|0|||
155522286|NCT00874237|561338215|FG000|Overall Study|Withdrawal by Subject|0|||
155522287|NCT00874237|561338216|FG001|Overall Study|Withdrawal by Subject|0|||
155522288|NCT00874237|561338217|FG002|Overall Study|Withdrawal by Subject|1|||
155522289|NCT00874237|561338218|FG003|Overall Study|Withdrawal by Subject|0|||
155522290|NCT00874237|561338219|FG004|Overall Study|Withdrawal by Subject|0|||
155522291|NCT00874237|561338220|FG005|Overall Study|Withdrawal by Subject|0|||
155522292|NCT01496183|561338222|FG000|Overall Study|Physician Decision|3|||
155522293|NCT01496183|561338223|FG001|Overall Study|Physician Decision|1|||
155522294|NCT01496183|561338222|FG000|Overall Study|Withdrawal by Subject|0|||
155522295|NCT01496183|561338223|FG001|Overall Study|Withdrawal by Subject|1|||
155522296|NCT00669864|561338226|FG000|Overall Study|Lost to Follow-up|2|||
155522297|NCT00669864|561338226|FG000|Overall Study|Protocol Violation|2|||
155522298|NCT00669864|561338226|FG000|Overall Study|Withdrawal by Subject|3|||
155522299|NCT00669864|561338226|FG000|Overall Study|Other|2|||
155522300|NCT01629381|561338227|FG000|Overall Study|Withdrawal by Subject|2|||
155522301|NCT01629381|561338228|FG001|Overall Study|Withdrawal by Subject|5|||
155522302|NCT00906347|561338231|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
155522303|NCT00906347|561338232|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
155522304|NCT00906347|561338231|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
155522305|NCT00906347|561338232|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
155522306|NCT00906347|561338231|FG000|Received Study Drug|Refused study drug|1|||
155522307|NCT00906347|561338232|FG001|Received Study Drug|Refused study drug|0|||
155522308|NCT00906347|561338231|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
155522309|NCT00906347|561338232|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
155522310|NCT00472290|561338238|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
155522311|NCT00472290|561338238|FG000|Overall Study|Protocol Specified Criteria|7|||
155522312|NCT00472290|561338238|FG000|Overall Study|Administrative Decision|37|||
155522313|NCT00472290|561338238|FG000|Overall Study|Death|3|||
155522314|NCT00472290|561338238|FG000|Overall Study|Lost to Follow-up|1|||
155522315|NCT00472290|561338238|FG000|Overall Study|Lack of Efficacy|1|||
155522316|NCT00472290|561338238|FG000|Overall Study|Disease Progression|4|||
155522317|NCT00472290|561338238|FG000|Overall Study|Withdrawal by Subject|5|||
155522318|NCT00472290|561338238|FG000|Overall Study|Adverse Event|6|||
155522319|NCT00472290|561338238|FG000|Overall Study|Requirement for alternative therapy|7|||
155522320|NCT00745095|561338243|FG000|Overall Study|Declined to participate|1|||
155522321|NCT00745095|561338244|FG001|Overall Study|Declined to participate|0|||
155522322|NCT00745095|561338245|FG002|Overall Study|Declined to participate|0|||
155522323|NCT00745095|561338246|FG003|Overall Study|Declined to participate|0|||
155522324|NCT00745095|561338247|FG004|Overall Study|Declined to participate|92|||
155522325|NCT00745095|561338248|FG005|Overall Study|Declined to participate|95|||
155522326|NCT00745095|561338243|FG000|Overall Study|Ineligible due to GFR criteria|0|||
155522327|NCT00745095|561338244|FG001|Overall Study|Ineligible due to GFR criteria|2|||
155522328|NCT00745095|561338245|FG002|Overall Study|Ineligible due to GFR criteria|3|||
155522329|NCT00745095|561338246|FG003|Overall Study|Ineligible due to GFR criteria|3|||
155522330|NCT00745095|561338247|FG004|Overall Study|Ineligible due to GFR criteria|30|||
155522331|NCT00745095|561338248|FG005|Overall Study|Ineligible due to GFR criteria|28|||
155522332|NCT05277389|561338253|FG000|Overall Study|Lost to Follow-up|1|||
155522333|NCT05277389|561338254|FG001|Overall Study|Lost to Follow-up|4|||
155522334|NCT03144687|561338255|FG000|Overall Study|Death|0|||
155522335|NCT03144687|561338256|FG001|Overall Study|Death|2|||
155522336|NCT03144687|561338255|FG000|Overall Study|Lost to Follow-up|0|||
155522337|NCT03144687|561338256|FG001|Overall Study|Lost to Follow-up|1|||
155522338|NCT03144687|561338255|FG000|Overall Study|Physician Decision|0|||
155522339|NCT03144687|561338256|FG001|Overall Study|Physician Decision|1|||
155522340|NCT03144687|561338255|FG000|Overall Study|Withdrawal by Subject|1|||
155522341|NCT03144687|561338256|FG001|Overall Study|Withdrawal by Subject|3|||
155522342|NCT03144687|561338255|FG000|Overall Study|Not Reported|2|||
155522343|NCT03144687|561338256|FG001|Overall Study|Not Reported|0|||
155522344|NCT00683293|561338259|FG000|Overall Study|Withdrawal by Subject|2|||
155522345|NCT00683293|561338260|FG001|Overall Study|Withdrawal by Subject|3|||
155522346|NCT00743197|561338263|FG000|Overall Study|Study terminated due to departure of PI.|1|||
155654889|NCT03033784|561830574|FG005|Overall Study|Anxiety related to MRI scanner|0|||
155522347|NCT00743197|561338264|FG001|Overall Study|Study terminated due to departure of PI.|2|||
155522348|NCT00824265|561338265|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
155522349|NCT00824265|561338266|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
155522350|NCT00824265|561338265|FG000|Treatment Phase|Protocol Violation|1|||
155522351|NCT00824265|561338266|FG001|Treatment Phase|Protocol Violation|0|||
155522352|NCT00824265|561338265|FG000|Treatment Phase|Lost to Follow-up|1|||
155522353|NCT00824265|561338266|FG001|Treatment Phase|Lost to Follow-up|1|||
155522354|NCT00824265|561338265|FG000|Treatment Phase|Physician Decision|6|||
155522355|NCT00824265|561338266|FG001|Treatment Phase|Physician Decision|12|||
155522356|NCT00824265|561338265|FG000|Treatment Phase|Withdrawal by Subject|6|||
155522357|NCT00824265|561338266|FG001|Treatment Phase|Withdrawal by Subject|15|||
155522358|NCT00824265|561338265|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
155522359|NCT00824265|561338266|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
155522360|NCT00824265|561338265|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
155522361|NCT00824265|561338266|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
155522362|NCT01411332|561338269|FG000|Enrollment|Protocol Violation|0|||
155522363|NCT01411332|561338270|FG001|Enrollment|Protocol Violation|1|||
155522364|NCT01411332|561338269|FG000|Enrollment|Withdrawal by Subject|0|||
155522365|NCT01411332|561338270|FG001|Enrollment|Withdrawal by Subject|1|||
155522366|NCT01411332|561338269|FG000|Treatment|Lost to Follow-up|1|||
155522367|NCT01411332|561338270|FG001|Treatment|Lost to Follow-up|0|||
155522368|NCT02170688|561338271|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
155522369|NCT02170688|561338272|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
155522370|NCT02170688|561338273|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
155522371|NCT02170688|561338274|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
155522372|NCT02170688|561338275|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
155522373|NCT02170688|561338271|FG000|Overall Study|Full dose not received|0|||
155522374|NCT02170688|561338272|FG001|Overall Study|Full dose not received|1|||
155522375|NCT02170688|561338273|FG002|Overall Study|Full dose not received|0|||
155522376|NCT02170688|561338274|FG003|Overall Study|Full dose not received|0|||
155522377|NCT02170688|561338275|FG004|Overall Study|Full dose not received|0|||
155522378|NCT02170688|561338271|FG000|Overall Study|Physician Decision|0|||
155522379|NCT02170688|561338272|FG001|Overall Study|Physician Decision|0|||
155522380|NCT02170688|561338273|FG002|Overall Study|Physician Decision|1|||
155522381|NCT02170688|561338274|FG003|Overall Study|Physician Decision|0|||
155522382|NCT02170688|561338275|FG004|Overall Study|Physician Decision|0|||
155522383|NCT02079532|561338278|FG000|Overall Study|Adverse Event|7|||
155522384|NCT02079532|561338278|FG000|Overall Study|Additional or changed therapy|2|||
155522385|NCT02079532|561338278|FG000|Overall Study|Lack of Efficacy|9|||
155522386|NCT02079532|561338278|FG000|Overall Study|Protocol Violation|3|||
155522387|NCT02079532|561338278|FG000|Overall Study|Withdrawal by Subject|1|||
155522388|NCT02079532|561338278|FG000|Overall Study|Administrative problems|1|||
155522389|NCT02079532|561338278|FG000|Overall Study|Inclusion into ReFIRST|3|||
155522390|NCT02079532|561338278|FG000|Overall Study|Other|3|||
155522391|NCT02920996|561338279|FG000|Overall Study|Adverse Event|8|||
155522392|NCT02920996|561338280|FG001|Overall Study|Adverse Event|0|||
155522393|NCT02920996|561338279|FG000|Overall Study|Physician Decision|1|||
155522394|NCT02920996|561338280|FG001|Overall Study|Physician Decision|0|||
155522395|NCT02920996|561338279|FG000|Overall Study|Death|1|||
155522396|NCT02920996|561338280|FG001|Overall Study|Death|0|||
155522397|NCT02920996|561338279|FG000|Overall Study|Missing|1|||
155522398|NCT02920996|561338280|FG001|Overall Study|Missing|0|||
155522399|NCT02920996|561338279|FG000|Overall Study|Subject Non-Compliance|1|||
155522400|NCT02920996|561338280|FG001|Overall Study|Subject Non-Compliance|0|||
155522401|NCT01402947|561338281|FG000|First Intervention|Adverse Event|0|||
155522402|NCT01402947|561338282|FG001|First Intervention|Adverse Event|1|||
155522403|NCT01471522|561338284|FG000|Overall Study|Withdrawal by Subject|28|||
155522404|NCT01471522|561338285|FG001|Overall Study|Withdrawal by Subject|22|||
155522405|NCT01471522|561338284|FG000|Overall Study|Lost to Follow-up|36|||
155522406|NCT01471522|561338285|FG001|Overall Study|Lost to Follow-up|26|||
155522407|NCT01432171|561338286|FG000|Overall Study|Death|1|||
155522408|NCT01432171|561338287|FG001|Overall Study|Death|2|||
155522409|NCT01432171|561338286|FG000|Overall Study|Lost to Follow-up|6|||
155522410|NCT01432171|561338287|FG001|Overall Study|Lost to Follow-up|5|||
155522411|NCT01432171|561338286|FG000|Overall Study|Withdrawal by Subject|3|||
155522412|NCT01432171|561338287|FG001|Overall Study|Withdrawal by Subject|1|||
155522413|NCT01432171|561338286|FG000|Overall Study|Noncompliance|2|||
155522414|NCT01432171|561338287|FG001|Overall Study|Noncompliance|3|||
155522415|NCT01432171|561338286|FG000|Overall Study|Insurance denial trial coverage|1|||
155522416|NCT01432171|561338287|FG001|Overall Study|Insurance denial trial coverage|0|||
155522417|NCT01432171|561338286|FG000|Overall Study|Patient moved to palliative care|1|||
155522418|NCT01432171|561338287|FG001|Overall Study|Patient moved to palliative care|0|||
155606779|NCT00412217|561649557|FG000|Overall Study|Study Terminated by Sponsor|26|||
155606780|NCT00412217|561649558|FG001|Overall Study|Study Terminated by Sponsor|33|||
155606781|NCT00412217|561649557|FG000|Overall Study|Other|1|||
155606782|NCT00412217|561649558|FG001|Overall Study|Other|1|||
155606783|NCT01069419|561649559|FG000|Overall Study|Adverse Event|233|||
155606784|NCT01069419|561649559|FG000|Overall Study|Lack of Efficacy|332|||
155606785|NCT01069419|561649559|FG000|Overall Study|Lost to Follow-up|49|||
155606786|NCT01069419|561649559|FG000|Overall Study|Remission of disease|11|||
155606787|NCT01069419|561649559|FG000|Overall Study|Withdrawal by Subject|34|||
155606788|NCT01069419|561649559|FG000|Overall Study|Other Reason|43|||
155606789|NCT01069419|561649559|FG000|Overall Study|Missing termination information|13|||
155606790|NCT03114657|561649568|FG000|Overall Study|Adverse Event|9|||
155606791|NCT03114657|561649569|FG001|Overall Study|Adverse Event|6|||
155606792|NCT03114657|561649568|FG000|Overall Study|Death|4|||
155606793|NCT03114657|561649569|FG001|Overall Study|Death|0|||
155606794|NCT03114657|561649568|FG000|Overall Study|Multiple Reasons|1|||
155606795|NCT03114657|561649569|FG001|Overall Study|Multiple Reasons|2|||
155606796|NCT03114657|561649568|FG000|Overall Study|Physician Decision|2|||
155606797|NCT03114657|561649569|FG001|Overall Study|Physician Decision|2|||
155606798|NCT03114657|561649568|FG000|Overall Study|Study Terminated By Sponsor|355|||
155606799|NCT03114657|561649569|FG001|Overall Study|Study Terminated By Sponsor|374|||
155606800|NCT03114657|561649568|FG000|Overall Study|Symptomatic Deterioration|0|||
155606801|NCT03114657|561649569|FG001|Overall Study|Symptomatic Deterioration|1|||
155606802|NCT03114657|561649568|FG000|Overall Study|Withdrawal by Subject|28|||
155606803|NCT03114657|561649569|FG001|Overall Study|Withdrawal by Subject|22|||
155606804|NCT00115037|561649570|FG000|Phase1|Lost to Follow-up|16|||
155606805|NCT00115037|561649571|FG001|Phase1|Lost to Follow-up|23|||
155606806|NCT00115037|561649572|FG002|Phase1|Lost to Follow-up|0|||
155606807|NCT00115037|561649573|FG003|Phase1|Lost to Follow-up|0|||
155606808|NCT00115037|561649574|FG004|Phase1|Lost to Follow-up|0|||
155606809|NCT00115037|561649575|FG005|Phase1|Lost to Follow-up|0|||
155606810|NCT00115037|561649570|FG000|Phase1|Withdrawal by Subject|9|||
155606811|NCT00115037|561649571|FG001|Phase1|Withdrawal by Subject|4|||
155606812|NCT00115037|561649572|FG002|Phase1|Withdrawal by Subject|0|||
155606813|NCT00115037|561649573|FG003|Phase1|Withdrawal by Subject|0|||
155606814|NCT00115037|561649574|FG004|Phase1|Withdrawal by Subject|0|||
155606815|NCT00115037|561649575|FG005|Phase1|Withdrawal by Subject|0|||
155606816|NCT00115037|561649570|FG000|Phase2|Death|0|||
155606817|NCT00115037|561649571|FG001|Phase2|Death|0|||
155606818|NCT00115037|561649572|FG002|Phase2|Death|1|||
155606819|NCT00115037|561649573|FG003|Phase2|Death|0|||
155606820|NCT00115037|561649574|FG004|Phase2|Death|0|||
155606821|NCT00115037|561649575|FG005|Phase2|Death|1|||
155606822|NCT00115037|561649570|FG000|Phase2|Withdrawal by Subject|0|||
155606823|NCT00115037|561649571|FG001|Phase2|Withdrawal by Subject|0|||
155606824|NCT00115037|561649572|FG002|Phase2|Withdrawal by Subject|2|||
155606825|NCT00115037|561649573|FG003|Phase2|Withdrawal by Subject|1|||
155606826|NCT00115037|561649574|FG004|Phase2|Withdrawal by Subject|2|||
155606827|NCT00115037|561649575|FG005|Phase2|Withdrawal by Subject|1|||
155606828|NCT00115037|561649570|FG000|Phase2|Lost to Follow-up|0|||
155606829|NCT00115037|561649571|FG001|Phase2|Lost to Follow-up|0|||
155606830|NCT00115037|561649572|FG002|Phase2|Lost to Follow-up|12|||
155606831|NCT00115037|561649573|FG003|Phase2|Lost to Follow-up|14|||
155606832|NCT00115037|561649574|FG004|Phase2|Lost to Follow-up|4|||
155606833|NCT00115037|561649575|FG005|Phase2|Lost to Follow-up|10|||
155606834|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
155606835|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
155606836|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
155606837|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
155606838|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
155606839|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
155606840|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
155606841|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
155606842|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
155606843|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
155606844|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
155606845|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
155606846|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2|Death|0|||
155606847|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2|Death|0|||
155606848|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2|Death|1|||
155606849|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2|Death|0|||
155522419|NCT02817841|561339628|FG000|Overall Study|Lost to Follow-up|287|||
155522420|NCT02817841|561339628|FG000|Overall Study|Withdrawal by Subject|183|||
155522421|NCT02817841|561339628|FG000|Overall Study|Adverse event not related to bleeding|131|||
155522422|NCT02817841|561339628|FG000|Overall Study|Adverse event related to bleeding|51|||
155522423|NCT02817841|561339628|FG000|Overall Study|Pregnancy|32|||
155522424|NCT02817841|561339628|FG000|Overall Study|Pregnancy wish|17|||
155522425|NCT02817841|561339628|FG000|Overall Study|Other reasons|53|||
155522426|NCT02817841|561339628|FG000|Overall Study|Protocol Violation|94|||
155522427|NCT00705536|561339629|FG000|Start Period 1|Withdrawal by Subject|0|||
155522428|NCT00705536|561339630|FG001|Start Period 1|Withdrawal by Subject|0|||
155522429|NCT00705536|561339631|FG002|Start Period 1|Withdrawal by Subject|0|||
155522430|NCT00705536|561339632|FG003|Start Period 1|Withdrawal by Subject|1|||
155522431|NCT01675622|561339640|FG000|Overall Study|Withdrawal by Subject|2|||
155522432|NCT01675622|561339641|FG001|Overall Study|Withdrawal by Subject|2|||
155522433|NCT01675622|561339640|FG000|Overall Study|Adverse Event|12|||
155522434|NCT01675622|561339641|FG001|Overall Study|Adverse Event|10|||
155522435|NCT01675622|561339640|FG000|Overall Study|Protocol Violation|4|||
155522436|NCT01675622|561339641|FG001|Overall Study|Protocol Violation|1|||
155654890|NCT03033784|561830575|FG006|Overall Study|Anxiety related to MRI scanner|0|||
155654891|NCT03033784|561830576|FG007|Overall Study|Anxiety related to MRI scanner|0|||
155654892|NCT03033784|561830577|FG008|Overall Study|Anxiety related to MRI scanner|0|||
155654893|NCT03033784|561830578|FG009|Overall Study|Anxiety related to MRI scanner|0|||
155654894|NCT03033784|561830579|FG010|Overall Study|Anxiety related to MRI scanner|0|||
155654895|NCT03033784|561830580|FG011|Overall Study|Anxiety related to MRI scanner|0|||
155654896|NCT03033784|561830581|FG012|Overall Study|Anxiety related to MRI scanner|0|||
155654897|NCT03033784|561830569|FG000|Overall Study|Withdrawal by Subject|0|||
155654898|NCT03033784|561830570|FG001|Overall Study|Withdrawal by Subject|0|||
155654899|NCT03033784|561830571|FG002|Overall Study|Withdrawal by Subject|0|||
155654900|NCT03033784|561830572|FG003|Overall Study|Withdrawal by Subject|0|||
155654901|NCT03033784|561830573|FG004|Overall Study|Withdrawal by Subject|0|||
155654902|NCT03033784|561830574|FG005|Overall Study|Withdrawal by Subject|0|||
155654903|NCT03033784|561830575|FG006|Overall Study|Withdrawal by Subject|0|||
155654904|NCT03033784|561830576|FG007|Overall Study|Withdrawal by Subject|0|||
155654905|NCT03033784|561830577|FG008|Overall Study|Withdrawal by Subject|0|||
155654906|NCT03033784|561830578|FG009|Overall Study|Withdrawal by Subject|0|||
155654907|NCT03033784|561830579|FG010|Overall Study|Withdrawal by Subject|0|||
155654908|NCT03033784|561830580|FG011|Overall Study|Withdrawal by Subject|0|||
155654909|NCT03033784|561830581|FG012|Overall Study|Withdrawal by Subject|2|||
155654910|NCT03257657|561830584|FG000|Overall Study|Lost to Follow-up|0|||
155654911|NCT03257657|561830585|FG001|Overall Study|Lost to Follow-up|3|||
155654912|NCT03257657|561830584|FG000|Overall Study|Withdrawn|0|||
155654913|NCT03257657|561830585|FG001|Overall Study|Withdrawn|1|||
155654914|NCT03257657|561830584|FG000|Overall Study|Noted not eligible right after enrolled|0|||
155654915|NCT03257657|561830585|FG001|Overall Study|Noted not eligible right after enrolled|1|||
155654916|NCT02801578|561830586|FG000|Overall Study|Adverse Event|2|||
155654917|NCT00137449|561830587|FG000|Overall Study|Disease Progression|8|||
155654918|NCT00137449|561830588|FG001|Overall Study|Disease Progression|13|||
155654919|NCT00137449|561830587|FG000|Overall Study|Death|4|||
155654920|NCT00137449|561830588|FG001|Overall Study|Death|3|||
155654921|NCT00137449|561830587|FG000|Overall Study|Adverse Event|3|||
155654922|NCT00137449|561830588|FG001|Overall Study|Adverse Event|1|||
155654923|NCT00137449|561830587|FG000|Overall Study|Withdrawal by Subject|1|||
155654924|NCT00137449|561830588|FG001|Overall Study|Withdrawal by Subject|1|||
155654925|NCT00668642|561830591|FG000|First Off-cycle|Cancer progression|1|||
155654926|NCT00668642|561830592|FG001|First Off-cycle|Cancer progression|0|||
155654927|NCT00668642|561830591|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
155654928|NCT00668642|561830592|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
155654929|NCT03707821|561830597|FG000|Overall Study|Protocol Violation|0|||
155654930|NCT03707821|561830598|FG001|Overall Study|Protocol Violation|1|||
155654931|NCT03707821|561830597|FG000|Overall Study|Unsatisfactory Visual Response|1|||
155654932|NCT03707821|561830598|FG001|Overall Study|Unsatisfactory Visual Response|0|||
155654933|NCT03707821|561830597|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
155654934|NCT03707821|561830598|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
155654935|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
155654936|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
155654937|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
155654938|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
155654939|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
155654940|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
155654941|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
155654942|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
155654943|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
155522437|NCT01675622|561339640|FG000|Overall Study|Lack of Efficacy|2|||
155522438|NCT01675622|561339641|FG001|Overall Study|Lack of Efficacy|4|||
155522439|NCT01675622|561339640|FG000|Overall Study|Lost to Follow-up|1|||
155522440|NCT01675622|561339641|FG001|Overall Study|Lost to Follow-up|3|||
155522441|NCT01675622|561339640|FG000|Overall Study|Other|5|||
155522442|NCT01675622|561339641|FG001|Overall Study|Other|4|||
155522443|NCT04032977|561339642|FG000|Overall Study|Withdrawal by Subject|6|||
155522444|NCT04032977|561339643|FG001|Overall Study|Withdrawal by Subject|1|||
155522445|NCT04032977|561339642|FG000|Overall Study|Lost to Follow-up|2|||
155522446|NCT04032977|561339643|FG001|Overall Study|Lost to Follow-up|7|||
155522447|NCT04032977|561339642|FG000|Overall Study|Pregnancy|1|||
155522448|NCT04032977|561339643|FG001|Overall Study|Pregnancy|0|||
155522449|NCT01101022|561339644|FG000|Overall Study|Adverse Event|6|||
155522450|NCT01101022|561339645|FG001|Overall Study|Adverse Event|2|||
155522451|NCT01101022|561339644|FG000|Overall Study|Protocol Violation|4|||
155522452|NCT01101022|561339645|FG001|Overall Study|Protocol Violation|3|||
155522453|NCT01101022|561339644|FG000|Overall Study|Withdrawal by Subject|3|||
155522454|NCT01101022|561339645|FG001|Overall Study|Withdrawal by Subject|8|||
155522455|NCT01101022|561339644|FG000|Overall Study|Lost to Follow-up|1|||
155522456|NCT01101022|561339645|FG001|Overall Study|Lost to Follow-up|4|||
155522457|NCT01101022|561339644|FG000|Overall Study|Lack of Efficacy|0|||
155522458|NCT01101022|561339645|FG001|Overall Study|Lack of Efficacy|7|||
155522459|NCT01101022|561339644|FG000|Overall Study|Sponsor decision|1|||
155522460|NCT01101022|561339645|FG001|Overall Study|Sponsor decision|1|||
155522461|NCT01101022|561339644|FG000|Overall Study|Non-compliance|1|||
155522462|NCT01101022|561339645|FG001|Overall Study|Non-compliance|0|||
155522463|NCT01101022|561339644|FG000|Overall Study|Work schedule|1|||
155522464|NCT01101022|561339645|FG001|Overall Study|Work schedule|1|||
155522465|NCT01101022|561339644|FG000|Overall Study|Vacation|0|||
155522466|NCT01101022|561339645|FG001|Overall Study|Vacation|1|||
155522467|NCT03075761|561339646|FG000|Overall Study|Lost to Follow-up|1|||
155522468|NCT03075761|561339647|FG001|Overall Study|Lost to Follow-up|6|||
155522469|NCT01519661|561339648|FG000|Overall Study|Protocol deviation|6|||
155522470|NCT01519661|561339648|FG000|Overall Study|Lost to Follow-up|3|||
155522471|NCT01519661|561339648|FG000|Overall Study|Withdrawal by Subject|17|||
155522472|NCT01519661|561339648|FG000|Overall Study|Lack of Efficacy|6|||
155522473|NCT01519661|561339648|FG000|Overall Study|Adverse Event|29|||
155522474|NCT01139047|561339649|FG000|Overall Study|Withdrawal by Subject|1|||
155522475|NCT00420303|561339655|FG000|Overall Study|Serious Adverse Event|1|||
155522476|NCT00420303|561339656|FG001|Overall Study|Serious Adverse Event|0|||
155522477|NCT00420303|561339655|FG000|Overall Study|Lack of Efficacy|0|||
155522478|NCT00420303|561339656|FG001|Overall Study|Lack of Efficacy|3|||
155522479|NCT00420303|561339655|FG000|Overall Study|Physician Decision|0|||
155522480|NCT00420303|561339656|FG001|Overall Study|Physician Decision|1|||
155522481|NCT00840632|561339657|FG000|First Intervention|Withdrawal by Subject|0|||
155522482|NCT00840632|561339658|FG001|First Intervention|Withdrawal by Subject|1|||
155522483|NCT00840632|561339657|FG000|Washout|Withdrawal by Subject|1|||
155522484|NCT00840632|561339658|FG001|Washout|Withdrawal by Subject|1|||
155522485|NCT00485472|561339659|FG000|Overall Study|Adverse Event|8|||
155522486|NCT00485472|561339660|FG001|Overall Study|Adverse Event|5|||
155522487|NCT00485472|561339659|FG000|Overall Study|Lack of Efficacy|5|||
155522488|NCT00485472|561339660|FG001|Overall Study|Lack of Efficacy|4|||
155522489|NCT00485472|561339659|FG000|Overall Study|Withdrawal by Subject|1|||
155522490|NCT00485472|561339660|FG001|Overall Study|Withdrawal by Subject|0|||
155522491|NCT00485472|561339659|FG000|Overall Study|Protocol Violation|0|||
155522492|NCT00485472|561339660|FG001|Overall Study|Protocol Violation|1|||
155522493|NCT00485472|561339659|FG000|Overall Study|Other|2|||
155522494|NCT00485472|561339660|FG001|Overall Study|Other|1|||
155522495|NCT00485472|561339659|FG000|Overall Study|Lost to Follow-up|0|||
155522496|NCT00485472|561339660|FG001|Overall Study|Lost to Follow-up|1|||
155522497|NCT01492361|561339661|FG000|Overall Study|Withdrawal by Subject|281|||
155522498|NCT01492361|561339662|FG001|Overall Study|Withdrawal by Subject|297|||
155522499|NCT01492361|561339661|FG000|Overall Study|Physician Decision|12|||
155522500|NCT01492361|561339662|FG001|Overall Study|Physician Decision|12|||
155522501|NCT01492361|561339661|FG000|Overall Study|Lost to Follow-up|6|||
155522502|NCT01492361|561339662|FG001|Overall Study|Lost to Follow-up|13|||
155522503|NCT01492361|561339661|FG000|Overall Study|Other than specified above|106|||
155522504|NCT01492361|561339662|FG001|Overall Study|Other than specified above|138|||
155522505|NCT03227445|561339667|FG000|Period 1 (28 Days)|Adverse Event|1|||
155522506|NCT03227445|561339668|FG001|Period 1 (28 Days)|Adverse Event|2|||
155522507|NCT03227445|561339669|FG002|Period 1 (28 Days)|Adverse Event|0|||
155522508|NCT03227445|561339670|FG003|Period 1 (28 Days)|Adverse Event|1|||
155522509|NCT03227445|561339667|FG000|Period 1 (28 Days)|Protocol Violation|1|||
155522510|NCT03227445|561339668|FG001|Period 1 (28 Days)|Protocol Violation|0|||
155522511|NCT03227445|561339669|FG002|Period 1 (28 Days)|Protocol Violation|0|||
155522512|NCT03227445|561339670|FG003|Period 1 (28 Days)|Protocol Violation|0|||
155522513|NCT03227445|561339667|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
155522514|NCT03227445|561339668|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
155522515|NCT03227445|561339669|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
155522516|NCT03227445|561339670|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
155522517|NCT03227445|561339667|FG000|Period 2 (28 Days)|Adverse Event|1|||
155522518|NCT03227445|561339668|FG001|Period 2 (28 Days)|Adverse Event|0|||
155522519|NCT03227445|561339669|FG002|Period 2 (28 Days)|Adverse Event|2|||
155522520|NCT03227445|561339670|FG003|Period 2 (28 Days)|Adverse Event|1|||
155522521|NCT03227445|561339667|FG000|Period 2 (28 Days)|Protocol Violation|0|||
155522522|NCT03227445|561339668|FG001|Period 2 (28 Days)|Protocol Violation|0|||
155522523|NCT03227445|561339669|FG002|Period 2 (28 Days)|Protocol Violation|0|||
155522524|NCT03227445|561339670|FG003|Period 2 (28 Days)|Protocol Violation|1|||
155522525|NCT03227445|561339667|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
155522526|NCT03227445|561339668|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
155522527|NCT03227445|561339669|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
155522528|NCT03227445|561339670|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
155522529|NCT00365300|561339673|FG000|Open-label Phase|Adverse Event|4|||
155522530|NCT00365300|561339674|FG001|Open-label Phase|Adverse Event|0|||
155522531|NCT00365300|561339673|FG000|Open-label Phase|Failed to Return|1|||
155522532|NCT00365300|561339674|FG001|Open-label Phase|Failed to Return|0|||
155522533|NCT00365300|561339673|FG000|Open-label Phase|Physician Decision|1|||
155522534|NCT00365300|561339674|FG001|Open-label Phase|Physician Decision|0|||
155522535|NCT00365300|561339673|FG000|Open-label Phase|Noncompliance|9|||
155522536|NCT00365300|561339674|FG001|Open-label Phase|Noncompliance|0|||
155522537|NCT00365300|561339673|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
155522538|NCT00365300|561339674|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
155522539|NCT00365300|561339673|FG000|Open-label Phase|Protocol Violation|1|||
155522540|NCT00365300|561339674|FG001|Open-label Phase|Protocol Violation|0|||
155522541|NCT00365300|561339673|FG000|Open-label Phase|Lack of Efficacy|1|||
155522542|NCT00365300|561339674|FG001|Open-label Phase|Lack of Efficacy|0|||
155522543|NCT00365300|561339673|FG000|Open-label Phase|Patient skipped open label phase|1|||
155522544|NCT00365300|561339674|FG001|Open-label Phase|Patient skipped open label phase|0|||
155522545|NCT00365300|561339673|FG000|Double-blind Phase|Failed to return|1|||
155522546|NCT00365300|561339674|FG001|Double-blind Phase|Failed to return|0|||
155522547|NCT00365300|561339673|FG000|Double-blind Phase|Noncompliance|1|||
155522548|NCT00365300|561339674|FG001|Double-blind Phase|Noncompliance|1|||
155522549|NCT00365300|561339673|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155522550|NCT00365300|561339674|FG001|Double-blind Phase|Withdrawal by Subject|1|||
155522551|NCT00365300|561339673|FG000|Double-blind Phase|Protocol Violation|3|||
155522552|NCT00365300|561339674|FG001|Double-blind Phase|Protocol Violation|1|||
155522553|NCT00365300|561339673|FG000|Double-blind Phase|Lack of Efficacy|6|||
155522554|NCT00365300|561339674|FG001|Double-blind Phase|Lack of Efficacy|6|||
155522555|NCT01991470|561339675|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
155522556|NCT01991470|561339675|FG000|Enlite 1 Period|Adverse Event|1|||
155522557|NCT01991470|561339675|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
155522558|NCT01991470|561339675|FG000|Enlite 3 Period|Lost to Follow-up|1|||
155522559|NCT01991470|561339675|FG000|Enlite 3 Period|Physician Decision|2|||
155522560|NCT01991470|561339675|FG000|Enlite 3 Period|Physician Decision|8|||
155522561|NCT01991470|561339675|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
155522562|NCT00324168|561339676|FG000|Overall Study|Lost to Follow-up|19|||
155522563|NCT00324168|561339677|FG001|Overall Study|Lost to Follow-up|18|||
155522564|NCT00324168|561339676|FG000|Overall Study|Death|3|||
155522565|NCT00324168|561339677|FG001|Overall Study|Death|3|||
155522566|NCT00324168|561339676|FG000|Overall Study|Patient did not visit in f/u window|6|||
155522567|NCT00324168|561339677|FG001|Overall Study|Patient did not visit in f/u window|9|||
155522568|NCT01203878|561339678|FG000|Overall Study|Withdrawal by Subject|0|||
155522569|NCT01203878|561339679|FG001|Overall Study|Withdrawal by Subject|0|||
155522570|NCT01203878|561339680|FG002|Overall Study|Withdrawal by Subject|1|||
155522571|NCT01203878|561339678|FG000|Overall Study|Adverse Event|0|||
155522572|NCT01203878|561339679|FG001|Overall Study|Adverse Event|0|||
155522573|NCT01203878|561339680|FG002|Overall Study|Adverse Event|2|||
155522574|NCT00528606|561339681|FG000|Overall Study|Withdrew consent|4|||
155522575|NCT00528606|561339682|FG001|Overall Study|Withdrew consent|3|||
155522576|NCT00528606|561339681|FG000|Overall Study|Lost to Follow-up|4|||
155522577|NCT00528606|561339682|FG001|Overall Study|Lost to Follow-up|1|||
155522578|NCT00528606|561339681|FG000|Overall Study|Adverse Event|3|||
155522579|NCT00528606|561339682|FG001|Overall Study|Adverse Event|0|||
155522580|NCT00528606|561339681|FG000|Overall Study|Other|2|||
155522581|NCT00528606|561339682|FG001|Overall Study|Other|0|||
155522582|NCT02475954|561339683|FG000|Overall Study|Withdrawal by Subject|2|||
155522583|NCT02475954|561339684|FG001|Overall Study|Withdrawal by Subject|2|||
155522584|NCT02475954|561339683|FG000|Overall Study|Lost to Follow-up|11|||
155522585|NCT02475954|561339684|FG001|Overall Study|Lost to Follow-up|9|||
155522586|NCT02475954|561339683|FG000|Overall Study|Death|1|||
155522587|NCT02475954|561339684|FG001|Overall Study|Death|1|||
155522588|NCT01918397|561339686|FG000|Overall Study|Never started treatment|2|||
155522589|NCT01918397|561339687|FG001|Overall Study|Never started treatment|1|||
155522590|NCT01918397|561339688|FG002|Overall Study|Never started treatment|0|||
155522591|NCT01918397|561339689|FG003|Overall Study|Never started treatment|0|||
155522592|NCT01918397|561339686|FG000|Overall Study|Adverse Event|1|||
155522593|NCT01918397|561339687|FG001|Overall Study|Adverse Event|1|||
155522594|NCT01918397|561339688|FG002|Overall Study|Adverse Event|1|||
155522595|NCT01918397|561339689|FG003|Overall Study|Adverse Event|0|||
155522596|NCT01918397|561339686|FG000|Overall Study|Lack of compliance|2|||
155522597|NCT01918397|561339687|FG001|Overall Study|Lack of compliance|2|||
155522598|NCT01918397|561339688|FG002|Overall Study|Lack of compliance|3|||
155522599|NCT01918397|561339689|FG003|Overall Study|Lack of compliance|0|||
155522600|NCT01918397|561339686|FG000|Overall Study|Pregnancy|0|||
155522601|NCT01918397|561339687|FG001|Overall Study|Pregnancy|1|||
155522602|NCT01918397|561339688|FG002|Overall Study|Pregnancy|0|||
155522603|NCT01918397|561339689|FG003|Overall Study|Pregnancy|0|||
155522604|NCT01918397|561339686|FG000|Overall Study|Rifampin susceptible|0|||
155522605|NCT01918397|561339687|FG001|Overall Study|Rifampin susceptible|0|||
155522606|NCT01918397|561339688|FG002|Overall Study|Rifampin susceptible|0|||
155522607|NCT01918397|561339689|FG003|Overall Study|Rifampin susceptible|2|||
155522608|NCT01918397|561339686|FG000|Overall Study|Treatment failure|0|||
155522609|NCT01918397|561339687|FG001|Overall Study|Treatment failure|0|||
155522610|NCT01918397|561339688|FG002|Overall Study|Treatment failure|0|||
155522611|NCT01918397|561339689|FG003|Overall Study|Treatment failure|1|||
155522612|NCT01918397|561339686|FG000|Overall Study|Withdrawal by Subject|3|||
155522613|NCT01918397|561339687|FG001|Overall Study|Withdrawal by Subject|2|||
155522614|NCT01918397|561339688|FG002|Overall Study|Withdrawal by Subject|1|||
155522615|NCT01918397|561339689|FG003|Overall Study|Withdrawal by Subject|1|||
155522616|NCT01918397|561339686|FG000|Overall Study|XDR at baseline|0|||
155522617|NCT01918397|561339687|FG001|Overall Study|XDR at baseline|0|||
155522618|NCT01918397|561339688|FG002|Overall Study|XDR at baseline|1|||
155522619|NCT01918397|561339689|FG003|Overall Study|XDR at baseline|0|||
155522620|NCT01918397|561339686|FG000|Overall Study|Lost to Follow-up|2|||
155522621|NCT01918397|561339687|FG001|Overall Study|Lost to Follow-up|1|||
155522622|NCT01918397|561339688|FG002|Overall Study|Lost to Follow-up|1|||
155522623|NCT01918397|561339689|FG003|Overall Study|Lost to Follow-up|1|||
155522624|NCT01918397|561339686|FG000|Overall Study|Increased QTc|1|||
155522625|NCT01918397|561339687|FG001|Overall Study|Increased QTc|0|||
155522626|NCT01918397|561339688|FG002|Overall Study|Increased QTc|0|||
155522627|NCT01918397|561339689|FG003|Overall Study|Increased QTc|1|||
155522628|NCT01918397|561339686|FG000|Overall Study|Death|0|||
155522629|NCT01918397|561339687|FG001|Overall Study|Death|0|||
155522630|NCT01918397|561339688|FG002|Overall Study|Death|1|||
155522631|NCT01918397|561339689|FG003|Overall Study|Death|0|||
155522632|NCT01918397|561339686|FG000|Overall Study|Involved in another investigative trial|0|||
155522633|NCT01918397|561339687|FG001|Overall Study|Involved in another investigative trial|0|||
155522634|NCT01918397|561339688|FG002|Overall Study|Involved in another investigative trial|0|||
155522635|NCT01918397|561339689|FG003|Overall Study|Involved in another investigative trial|1|||
155522636|NCT01239121|561339692|FG000|Overall Study|Withdrawal by Subject|2|||
155522637|NCT01239121|561339693|FG001|Overall Study|Withdrawal by Subject|4|||
155522638|NCT01239121|561339694|FG002|Overall Study|Withdrawal by Subject|0|||
155522639|NCT01434693|561339697|FG000|Overall Study|Adverse Event|1|||
155522640|NCT01434693|561339698|FG001|Overall Study|Adverse Event|0|||
155522641|NCT01434693|561339699|FG002|Overall Study|Adverse Event|0|||
155522642|NCT01434693|561339700|FG003|Overall Study|Adverse Event|0|||
155522643|NCT01434693|561339697|FG000|Overall Study|Withdrawal by Subject|1|||
155522644|NCT01434693|561339698|FG001|Overall Study|Withdrawal by Subject|0|||
155522645|NCT01434693|561339699|FG002|Overall Study|Withdrawal by Subject|1|||
155522646|NCT01434693|561339700|FG003|Overall Study|Withdrawal by Subject|1|||
155522647|NCT01434693|561339697|FG000|Overall Study|Lost to Follow-up|1|||
155522648|NCT01434693|561339698|FG001|Overall Study|Lost to Follow-up|0|||
155522649|NCT01434693|561339699|FG002|Overall Study|Lost to Follow-up|0|||
155522650|NCT01434693|561339700|FG003|Overall Study|Lost to Follow-up|0|||
155522651|NCT04006171|561339701|FG000|Overall Study|Withdrawal by Subject|8|||
155522652|NCT04006171|561339702|FG001|Overall Study|Withdrawal by Subject|7|||
155522653|NCT04006171|561339701|FG000|Overall Study|missing serum samples|2|||
155522654|NCT04006171|561339702|FG001|Overall Study|missing serum samples|2|||
155522655|NCT04006171|561339701|FG000|Overall Study|insufficient sample volume|2|||
155522656|NCT04006171|561339702|FG001|Overall Study|insufficient sample volume|3|||
155522657|NCT00912288|561339703|FG000|Overall Study|Death|0|||
155522658|NCT00912288|561339704|FG001|Overall Study|Death|1|||
155522659|NCT00912288|561339703|FG000|Overall Study|Adverse Event|1|||
155522660|NCT00912288|561339704|FG001|Overall Study|Adverse Event|1|||
155522661|NCT00912288|561339703|FG000|Overall Study|Lost to Follow-up|1|||
155522662|NCT00912288|561339704|FG001|Overall Study|Lost to Follow-up|0|||
155522663|NCT00912288|561339703|FG000|Overall Study|Protocol Violation|1|||
155522664|NCT00912288|561339704|FG001|Overall Study|Protocol Violation|0|||
155522665|NCT00912288|561339703|FG000|Overall Study|Withdrawal by Subject|3|||
155522666|NCT00912288|561339704|FG001|Overall Study|Withdrawal by Subject|3|||
155522667|NCT00912288|561339703|FG000|Overall Study|Study terminated by sponsor|34|||
155522668|NCT00912288|561339704|FG001|Overall Study|Study terminated by sponsor|35|||
155522669|NCT00912288|561339703|FG000|Overall Study|Other|1|||
155522670|NCT00912288|561339704|FG001|Overall Study|Other|0|||
155522671|NCT02087904|561339707|FG000|Overall Study|Did Not Receive Study Drug|0|||
155522672|NCT02087904|561339708|FG001|Overall Study|Did Not Receive Study Drug|0|||
155522673|NCT02087904|561339709|FG002|Overall Study|Did Not Receive Study Drug|2|||
155522674|NCT02087904|561339710|FG003|Overall Study|Did Not Receive Study Drug|1|||
155522675|NCT02087904|561339707|FG000|Overall Study|Adverse Event|8|||
155522676|NCT02087904|561339708|FG001|Overall Study|Adverse Event|4|||
155522677|NCT02087904|561339709|FG002|Overall Study|Adverse Event|4|||
155522678|NCT02087904|561339710|FG003|Overall Study|Adverse Event|12|||
155522679|NCT02087904|561339707|FG000|Overall Study|Lack of Efficacy|3|||
155522680|NCT02087904|561339708|FG001|Overall Study|Lack of Efficacy|6|||
155522681|NCT02087904|561339709|FG002|Overall Study|Lack of Efficacy|3|||
155522682|NCT02087904|561339710|FG003|Overall Study|Lack of Efficacy|2|||
155522683|NCT02087904|561339707|FG000|Overall Study|Other|6|||
155522684|NCT02087904|561339708|FG001|Overall Study|Other|2|||
155522685|NCT02087904|561339709|FG002|Overall Study|Other|4|||
155522686|NCT02087904|561339710|FG003|Overall Study|Other|4|||
155522687|NCT02087904|561339707|FG000|Overall Study|Withdrawal by Subject|8|||
155522688|NCT02087904|561339708|FG001|Overall Study|Withdrawal by Subject|3|||
155522689|NCT02087904|561339709|FG002|Overall Study|Withdrawal by Subject|7|||
155522690|NCT02087904|561339710|FG003|Overall Study|Withdrawal by Subject|4|||
155522691|NCT02087904|561339707|FG000|Overall Study|Lost to Follow-up|0|||
155522692|NCT02087904|561339708|FG001|Overall Study|Lost to Follow-up|4|||
155522693|NCT02087904|561339709|FG002|Overall Study|Lost to Follow-up|2|||
155522694|NCT02087904|561339710|FG003|Overall Study|Lost to Follow-up|2|||
155522695|NCT02178722|561339711|FG000|Overall Study|Withdrawal by Subject|0|||
155522696|NCT02178722|561339712|FG001|Overall Study|Withdrawal by Subject|0|||
155522697|NCT02178722|561339713|FG002|Overall Study|Withdrawal by Subject|0|||
155522698|NCT02178722|561339714|FG003|Overall Study|Withdrawal by Subject|2|||
155522699|NCT02178722|561339715|FG004|Overall Study|Withdrawal by Subject|33|||
155522700|NCT02178722|561339711|FG000|Overall Study|Death|2|||
155522701|NCT02178722|561339712|FG001|Overall Study|Death|13|||
155522702|NCT02178722|561339713|FG002|Overall Study|Death|12|||
155522703|NCT02178722|561339714|FG003|Overall Study|Death|12|||
155522704|NCT02178722|561339715|FG004|Overall Study|Death|205|||
155522705|NCT02178722|561339711|FG000|Overall Study|Lost to Follow-up|0|||
155522706|NCT02178722|561339712|FG001|Overall Study|Lost to Follow-up|0|||
155522707|NCT02178722|561339713|FG002|Overall Study|Lost to Follow-up|0|||
155522708|NCT02178722|561339714|FG003|Overall Study|Lost to Follow-up|2|||
155522709|NCT02178722|561339715|FG004|Overall Study|Lost to Follow-up|11|||
155522710|NCT02178722|561339711|FG000|Overall Study|Study terminated by Sponsor|2|||
155522711|NCT02178722|561339712|FG001|Overall Study|Study terminated by Sponsor|7|||
155522712|NCT02178722|561339713|FG002|Overall Study|Study terminated by Sponsor|6|||
155522713|NCT02178722|561339714|FG003|Overall Study|Study terminated by Sponsor|4|||
155522714|NCT02178722|561339715|FG004|Overall Study|Study terminated by Sponsor|128|||
155522715|NCT02178722|561339711|FG000|Overall Study|Physician Decision|0|||
155522716|NCT02178722|561339712|FG001|Overall Study|Physician Decision|0|||
155522717|NCT02178722|561339713|FG002|Overall Study|Physician Decision|0|||
155522718|NCT02178722|561339714|FG003|Overall Study|Physician Decision|0|||
155522719|NCT02178722|561339715|FG004|Overall Study|Physician Decision|3|||
155522720|NCT02178722|561339711|FG000|Overall Study|Other|0|||
155522721|NCT02178722|561339712|FG001|Overall Study|Other|0|||
155522722|NCT02178722|561339713|FG002|Overall Study|Other|0|||
155522723|NCT02178722|561339714|FG003|Overall Study|Other|0|||
155522724|NCT02178722|561339715|FG004|Overall Study|Other|2|||
155522725|NCT03752528|561339716|FG000|Part A|Lost to Follow-up|1|||
155522726|NCT03752528|561339716|FG000|Part A|Protocol Violation|1|||
155522727|NCT03752528|561339716|FG000|Part B|Protocol Violation|1|||
155522728|NCT03752528|561339716|FG000|Part B|Study terminated by sponsor|3|||
155522729|NCT04213326|561339717|FG000|Overall Study|Consent withdrawn|51|||
155522730|NCT04213326|561339718|FG001|Overall Study|Consent withdrawn|241|||
155522731|NCT04213326|561339717|FG000|Overall Study|Lost to Follow-up|50|||
155522732|NCT04213326|561339718|FG001|Overall Study|Lost to Follow-up|902|||
155522733|NCT04213326|561339717|FG000|Overall Study|Protocol Violation|3|||
155522734|NCT04213326|561339718|FG001|Overall Study|Protocol Violation|25|||
155522735|NCT04213326|561339717|FG000|Overall Study|Participant eligibility changed|106|||
155522736|NCT04213326|561339718|FG001|Overall Study|Participant eligibility changed|19|||
155522737|NCT04213326|561339717|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
155522738|NCT04213326|561339718|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
155522739|NCT04213326|561339717|FG000|Overall Study|Incomplete study visit|0|||
155522740|NCT04213326|561339718|FG001|Overall Study|Incomplete study visit|367|||
155522741|NCT00854308|561339725|FG000|Overall Study|Disease progression|42|||
155522742|NCT00854308|561339726|FG001|Overall Study|Disease progression|50|||
155522743|NCT00854308|561339725|FG000|Overall Study|Adverse Event|8|||
155522744|NCT00854308|561339726|FG001|Overall Study|Adverse Event|3|||
155522745|NCT00854308|561339725|FG000|Overall Study|Death|2|||
155522746|NCT00854308|561339726|FG001|Overall Study|Death|5|||
155522747|NCT00854308|561339725|FG000|Overall Study|Physician Decision|6|||
155522748|NCT00854308|561339726|FG001|Overall Study|Physician Decision|6|||
155522749|NCT00854308|561339725|FG000|Overall Study|Withdrawal by Subject|4|||
155522750|NCT00854308|561339726|FG001|Overall Study|Withdrawal by Subject|2|||
155522751|NCT00854308|561339725|FG000|Overall Study|Sponsor's decision to terminate study|0|||
155522752|NCT00854308|561339726|FG001|Overall Study|Sponsor's decision to terminate study|1|||
155522753|NCT02079766|561339729|FG000|Overall Study|Physician Decision|1|||
155522754|NCT02079766|561339730|FG001|Overall Study|Physician Decision|0|||
155522755|NCT02079766|561339729|FG000|Overall Study|Withdrawal by Subject|1|||
155522756|NCT02079766|561339730|FG001|Overall Study|Withdrawal by Subject|0|||
155522757|NCT02781727|561339731|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
155522758|NCT02781727|561339732|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
155522759|NCT02781727|561339731|FG000|Treatment Period|Withdrawal by Subject|1|||
155522760|NCT02781727|561339732|FG001|Treatment Period|Withdrawal by Subject|0|||
155522761|NCT02781727|561339731|FG000|Treatment Period|Lost to Follow-up|0|||
155522762|NCT02781727|561339732|FG001|Treatment Period|Lost to Follow-up|1|||
155522763|NCT01044732|561339734|FG000|Overall Study|Lost to Follow-up|2|||
155522764|NCT01044732|561339735|FG001|Overall Study|Lost to Follow-up|1|||
155522765|NCT01044732|561339734|FG000|Overall Study|Physician Decision|5|||
155522766|NCT01044732|561339735|FG001|Overall Study|Physician Decision|3|||
155522767|NCT01044732|561339734|FG000|Overall Study|Protocol Violation|11|||
155522768|NCT01044732|561339735|FG001|Overall Study|Protocol Violation|12|||
155522769|NCT01044732|561339734|FG000|Overall Study|Withdrawal by Subject|0|||
155522770|NCT01044732|561339735|FG001|Overall Study|Withdrawal by Subject|1|||
155522771|NCT01044732|561339734|FG000|Overall Study|Inadequate bowel preparation|11|||
155522772|NCT01044732|561339735|FG001|Overall Study|Inadequate bowel preparation|17|||
155522773|NCT01044732|561339734|FG000|Overall Study|Inability to reach cecum|5|||
155522774|NCT01044732|561339735|FG001|Overall Study|Inability to reach cecum|2|||
155522775|NCT01044732|561339734|FG000|Overall Study|Technical error or malfunction|15|||
155522776|NCT01044732|561339735|FG001|Overall Study|Technical error or malfunction|14|||
155522777|NCT03991494|561339740|FG000|Overall Study|Progressive Disease|4|||
155522778|NCT02507375|561339745|FG000|Overall Study|Progressive Disease|4|||
155522779|NCT02507375|561339746|FG001|Overall Study|Progressive Disease|5|||
155522780|NCT02507375|561339745|FG000|Overall Study|Death|0|||
155522781|NCT02507375|561339746|FG001|Overall Study|Death|1|||
155522782|NCT02507375|561339745|FG000|Overall Study|Refused treatment|0|||
155522783|NCT02507375|561339746|FG001|Overall Study|Refused treatment|1|||
155522784|NCT02507375|561339745|FG000|Overall Study|Adverse Event|0|||
155522785|NCT02507375|561339746|FG001|Overall Study|Adverse Event|1|||
155522786|NCT01706926|561339747|FG000|Overall Study|Lost to Follow-up|0|||
155522787|NCT01706926|561339748|FG001|Overall Study|Lost to Follow-up|0|||
155522788|NCT01706926|561339749|FG002|Overall Study|Lost to Follow-up|1|||
155522789|NCT01706926|561339750|FG003|Overall Study|Lost to Follow-up|0|||
155522790|NCT01706926|561339747|FG000|Overall Study|Withdrawal by Subject|2|||
155522791|NCT01706926|561339748|FG001|Overall Study|Withdrawal by Subject|0|||
155522792|NCT01706926|561339749|FG002|Overall Study|Withdrawal by Subject|1|||
155522793|NCT01706926|561339750|FG003|Overall Study|Withdrawal by Subject|2|||
155522794|NCT01706926|561339747|FG000|Overall Study|Other|4|||
155522795|NCT01706926|561339748|FG001|Overall Study|Other|4|||
155522796|NCT01706926|561339749|FG002|Overall Study|Other|4|||
155522797|NCT01706926|561339750|FG003|Overall Study|Other|3|||
155522798|NCT00397488|561340940|FG000|Overall Study|Withdrawal by Subject|3|||
155522799|NCT00397488|561340940|FG000|Overall Study|Adverse Event|3|||
155522800|NCT00397488|561340940|FG000|Overall Study|Death|1|||
155522801|NCT02943447|561340942|FG000|Blinded Study Phase|Withdrew Consent|1|||
155522802|NCT02943447|561340943|FG001|Blinded Study Phase|Withdrew Consent|2|||
155522803|NCT02943447|561340944|FG002|Blinded Study Phase|Withdrew Consent|1|||
155522804|NCT02943447|561340942|FG000|Blinded Study Phase|Adverse Event|3|||
155522805|NCT02943447|561340943|FG001|Blinded Study Phase|Adverse Event|0|||
155522806|NCT02943447|561340944|FG002|Blinded Study Phase|Adverse Event|0|||
155522807|NCT02943447|561340942|FG000|Blinded Study Phase|Investigator's discretion|1|||
155522808|NCT02943447|561340943|FG001|Blinded Study Phase|Investigator's discretion|0|||
155522809|NCT02943447|561340944|FG002|Blinded Study Phase|Investigator's discretion|0|||
155522810|NCT02943447|561340942|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
155522811|NCT02943447|561340943|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
155522812|NCT02943447|561340944|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
155522813|NCT02943447|561340942|FG000|Open-Label Extension Phase|Adverse Event|4|||
155522814|NCT02943447|561340943|FG001|Open-Label Extension Phase|Adverse Event|7|||
155522815|NCT02943447|561340944|FG002|Open-Label Extension Phase|Adverse Event|3|||
155522816|NCT02943447|561340942|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
155522817|NCT02943447|561340943|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
155522818|NCT02943447|561340944|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
155522819|NCT02943447|561340942|FG000|Open-Label Extension Phase|Withdrew consent|1|||
155522820|NCT02943447|561340943|FG001|Open-Label Extension Phase|Withdrew consent|1|||
155522821|NCT02943447|561340944|FG002|Open-Label Extension Phase|Withdrew consent|1|||
155522822|NCT02943447|561340942|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155522823|NCT02943447|561340943|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
155522824|NCT02943447|561340944|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155522825|NCT05017480|561340950|FG000|Stage 1 Study|Withdrawal by Subject|8|||
155522826|NCT05017480|561340951|FG001|Stage 1 Study|Withdrawal by Subject|6|||
155522827|NCT05017480|561340952|FG002|Stage 1 Study|Withdrawal by Subject|0|||
155522828|NCT05017480|561340953|FG003|Stage 1 Study|Withdrawal by Subject|0|||
155522829|NCT05017480|561340954|FG004|Stage 1 Study|Withdrawal by Subject|0|||
155522830|NCT05017480|561340950|FG000|Stage 1 Study|Adverse Event|1|||
155522831|NCT05017480|561340951|FG001|Stage 1 Study|Adverse Event|1|||
155522832|NCT05017480|561340952|FG002|Stage 1 Study|Adverse Event|0|||
155522833|NCT05017480|561340953|FG003|Stage 1 Study|Adverse Event|0|||
155522834|NCT05017480|561340954|FG004|Stage 1 Study|Adverse Event|0|||
155522835|NCT05017480|561340950|FG000|Stage 1 Study|Poor Compliance|1|||
155522836|NCT05017480|561340951|FG001|Stage 1 Study|Poor Compliance|1|||
155522837|NCT05017480|561340952|FG002|Stage 1 Study|Poor Compliance|0|||
155522838|NCT05017480|561340953|FG003|Stage 1 Study|Poor Compliance|0|||
155522839|NCT05017480|561340954|FG004|Stage 1 Study|Poor Compliance|0|||
155522840|NCT05017480|561340950|FG000|Stage 1 Study|Physician Decision|0|||
155522841|NCT05017480|561340951|FG001|Stage 1 Study|Physician Decision|1|||
155522842|NCT05017480|561340952|FG002|Stage 1 Study|Physician Decision|0|||
155522843|NCT05017480|561340953|FG003|Stage 1 Study|Physician Decision|0|||
155522844|NCT05017480|561340954|FG004|Stage 1 Study|Physician Decision|0|||
155522845|NCT05017480|561340950|FG000|Stage 2 Study|Withdrawal by Subject|0|||
155522846|NCT05017480|561340951|FG001|Stage 2 Study|Withdrawal by Subject|0|||
155522847|NCT05017480|561340952|FG002|Stage 2 Study|Withdrawal by Subject|6|||
155522848|NCT05017480|561340953|FG003|Stage 2 Study|Withdrawal by Subject|9|||
155522849|NCT05017480|561340954|FG004|Stage 2 Study|Withdrawal by Subject|11|||
155522850|NCT05017480|561340950|FG000|Stage 2 Study|Lost to Follow-up|0|||
155522851|NCT05017480|561340951|FG001|Stage 2 Study|Lost to Follow-up|0|||
155522852|NCT05017480|561340952|FG002|Stage 2 Study|Lost to Follow-up|0|||
155522853|NCT05017480|561340953|FG003|Stage 2 Study|Lost to Follow-up|2|||
155522854|NCT05017480|561340954|FG004|Stage 2 Study|Lost to Follow-up|1|||
155522855|NCT05017480|561340950|FG000|Stage 2 Study|Adverse Event|0|||
155522856|NCT05017480|561340951|FG001|Stage 2 Study|Adverse Event|0|||
155522857|NCT05017480|561340952|FG002|Stage 2 Study|Adverse Event|0|||
155522858|NCT05017480|561340953|FG003|Stage 2 Study|Adverse Event|1|||
155522859|NCT05017480|561340954|FG004|Stage 2 Study|Adverse Event|0|||
155522860|NCT05017480|561340950|FG000|Stage 2 Study|COVID-19|0|||
155522861|NCT05017480|561340951|FG001|Stage 2 Study|COVID-19|0|||
155522862|NCT05017480|561340952|FG002|Stage 2 Study|COVID-19|0|||
155522863|NCT05017480|561340953|FG003|Stage 2 Study|COVID-19|1|||
155522864|NCT05017480|561340954|FG004|Stage 2 Study|COVID-19|0|||
155522865|NCT05017480|561340950|FG000|Stage 2 Study|Pregnancy|0|||
155522866|NCT05017480|561340951|FG001|Stage 2 Study|Pregnancy|0|||
155522867|NCT05017480|561340952|FG002|Stage 2 Study|Pregnancy|0|||
155522868|NCT05017480|561340953|FG003|Stage 2 Study|Pregnancy|0|||
155522869|NCT05017480|561340954|FG004|Stage 2 Study|Pregnancy|1|||
155522870|NCT02653664|561340961|FG000|Post-Treatment|Withdrawal by Subject|6|||
155522871|NCT02653664|561340962|FG001|Post-Treatment|Withdrawal by Subject|5|||
155522872|NCT02653664|561340963|FG002|Post-Treatment|Withdrawal by Subject|7|||
155522873|NCT02653664|561340961|FG000|Post-Treatment|Lost to Follow-up|8|||
155522874|NCT02653664|561340962|FG001|Post-Treatment|Lost to Follow-up|1|||
155522875|NCT02653664|561340963|FG002|Post-Treatment|Lost to Follow-up|7|||
155522876|NCT02653664|561340961|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
155522877|NCT02653664|561340962|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
155522878|NCT02653664|561340963|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
155522879|NCT02653664|561340961|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
155522880|NCT02653664|561340962|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
155522881|NCT02653664|561340963|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
155522882|NCT02653664|561340961|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
155522883|NCT02653664|561340962|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
155522884|NCT02653664|561340963|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
155522885|NCT02653664|561340961|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
155522886|NCT02653664|561340962|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
155522887|NCT02653664|561340963|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
155522888|NCT02653664|561340961|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
155522889|NCT02653664|561340962|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
155522890|NCT02653664|561340963|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
155522891|NCT02653664|561340961|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
155522892|NCT02653664|561340962|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
155522893|NCT02653664|561340963|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
155522894|NCT02653664|561340961|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
155522895|NCT02653664|561340962|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
155522896|NCT02653664|561340963|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
155522897|NCT02653664|561340961|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
155522898|NCT02653664|561340962|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
155522899|NCT02653664|561340963|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
155522900|NCT01315249|561340965|FG000|Overall Study|Adverse Event|22|||
155522901|NCT01315249|561340966|FG001|Overall Study|Adverse Event|26|||
155522902|NCT01315249|561340965|FG000|Overall Study|Withdrawal by Subject|11|||
155522903|NCT01315249|561340966|FG001|Overall Study|Withdrawal by Subject|10|||
155522904|NCT01315249|561340965|FG000|Overall Study|Protocol Violation|8|||
155522905|NCT01315249|561340966|FG001|Overall Study|Protocol Violation|5|||
155522906|NCT01315249|561340965|FG000|Overall Study|Abnormal test results|1|||
155522907|NCT01315249|561340966|FG001|Overall Study|Abnormal test results|2|||
155522908|NCT01315249|561340965|FG000|Overall Study|Administrative problems|1|||
155522909|NCT01315249|561340966|FG001|Overall Study|Administrative problems|0|||
155522910|NCT01315249|561340965|FG000|Overall Study|inability to use device|1|||
155522911|NCT01315249|561340966|FG001|Overall Study|inability to use device|0|||
155522912|NCT01315249|561340965|FG000|Overall Study|Lack of Efficacy|0|||
155522913|NCT01315249|561340966|FG001|Overall Study|Lack of Efficacy|1|||
155522914|NCT01315249|561340965|FG000|Overall Study|Lost to Follow-up|0|||
155522915|NCT01315249|561340966|FG001|Overall Study|Lost to Follow-up|2|||
155522916|NCT01315249|561340965|FG000|Overall Study|Death|0|||
155522917|NCT01315249|561340966|FG001|Overall Study|Death|1|||
155522918|NCT01287013|561340970|FG000|Overall Study|Non-evaluable|3|||
155522919|NCT01287013|561340971|FG001|Overall Study|Non-evaluable|5|||
155522920|NCT01287013|561340972|FG002|Overall Study|Non-evaluable|21|||
155522921|NCT03247556|561340973|FG000|Overall Study|Adverse Event|1|||
155522922|NCT03247556|561340974|FG001|Overall Study|Adverse Event|4|||
155522923|NCT03247556|561340975|FG002|Overall Study|Adverse Event|5|||
155522924|NCT03247556|561340973|FG000|Overall Study|Lost to Follow-up|5|||
155522925|NCT03247556|561340974|FG001|Overall Study|Lost to Follow-up|5|||
155522926|NCT03247556|561340975|FG002|Overall Study|Lost to Follow-up|4|||
155522927|NCT03247556|561340973|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
155522928|NCT03247556|561340974|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
155522929|NCT03247556|561340975|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
155522930|NCT03247556|561340973|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
155522931|NCT03247556|561340974|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
155522932|NCT03247556|561340975|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
155522933|NCT03247556|561340973|FG000|Overall Study|Protocol Violation|2|||
155522934|NCT03247556|561340974|FG001|Overall Study|Protocol Violation|0|||
155522935|NCT03247556|561340975|FG002|Overall Study|Protocol Violation|1|||
155522936|NCT03247556|561340973|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
155522937|NCT03247556|561340974|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
155522938|NCT03247556|561340975|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
155522939|NCT00051025|561340977|FG000|Overall Study|Progressive Disease|1|||
155522940|NCT00051025|561340978|FG001|Overall Study|Progressive Disease|1|||
155522941|NCT00051025|561340977|FG000|Overall Study|Adverse Event|1|||
155522942|NCT00051025|561340978|FG001|Overall Study|Adverse Event|1|||
155522943|NCT00051025|561340977|FG000|Overall Study|Withdrawal by Subject|0|||
155522944|NCT00051025|561340978|FG001|Overall Study|Withdrawal by Subject|1|||
155522945|NCT00051025|561340977|FG000|Overall Study|Death|0|||
155522946|NCT00051025|561340978|FG001|Overall Study|Death|1|||
155522947|NCT01900730|561340979|FG000|Overall Study|Withdrawal by Subject|1|||
155522948|NCT01900730|561340980|FG001|Overall Study|Withdrawal by Subject|0|||
155522949|NCT01900730|561340979|FG000|Overall Study|Screen Failure|1|||
155522950|NCT01900730|561340980|FG001|Overall Study|Screen Failure|0|||
155522951|NCT01179048|561340981|FG000|Overall Study|Withdrawn - does not allow contact|4|||
155522952|NCT01179048|561340982|FG001|Overall Study|Withdrawn - does not allow contact|8|||
155522953|NCT01179048|561340981|FG000|Overall Study|Lost to Follow-up|8|||
155522954|NCT01179048|561340982|FG001|Overall Study|Lost to Follow-up|9|||
155522955|NCT01179048|561340981|FG000|Overall Study|Alive|127|||
155522956|NCT01179048|561340982|FG001|Overall Study|Alive|142|||
155522957|NCT02109042|561340983|FG000|Overall Study|Sponsor Decision|15|||
155522958|NCT03203447|561340984|FG000|Overall Study|Withdrawal by Subject|2|||
155522959|NCT03203447|561340985|FG001|Overall Study|Withdrawal by Subject|1|||
155522960|NCT03203447|561340984|FG000|Overall Study|Lost to Follow-up|1|||
155522961|NCT03203447|561340985|FG001|Overall Study|Lost to Follow-up|10|||
155522962|NCT03203447|561340984|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
155522963|NCT03203447|561340985|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
155522964|NCT00274937|561340990|FG000|Overall Study|Physician Decision|10|||
155522965|NCT00274937|561340990|FG000|Overall Study|Withdrawal by Subject|6|||
155522966|NCT00274937|561340990|FG000|Overall Study|Progressive Disease|4|||
155522967|NCT00445003|561340991|FG000|Overall Study|Death|1|||
155522968|NCT00445003|561340992|FG001|Overall Study|Death|2|||
155522969|NCT00445003|561340993|FG002|Overall Study|Death|1|||
155522970|NCT00445003|561340991|FG000|Overall Study|Missed Visit|3|||
155522971|NCT00445003|561340992|FG001|Overall Study|Missed Visit|5|||
155522972|NCT00445003|561340993|FG002|Overall Study|Missed Visit|1|||
155522973|NCT00445003|561340991|FG000|Overall Study|Dropped|1|||
155522974|NCT00445003|561340992|FG001|Overall Study|Dropped|3|||
155522975|NCT00445003|561340993|FG002|Overall Study|Dropped|2|||
155522976|NCT00880568|561340997|FG000|Overall Study|Disease progression|3|||
155522977|NCT00880568|561340998|FG001|Overall Study|Disease progression|3|||
155522978|NCT00880568|561340999|FG002|Overall Study|Disease progression|3|||
155522979|NCT00880568|561341000|FG003|Overall Study|Disease progression|1|||
155522980|NCT00880568|561341001|FG004|Overall Study|Disease progression|3|||
155522981|NCT00880568|561341002|FG005|Overall Study|Disease progression|3|||
155522982|NCT00880568|561341003|FG006|Overall Study|Disease progression|5|||
155522983|NCT00880568|561341004|FG007|Overall Study|Disease progression|0|||
155522984|NCT00880568|561341005|FG008|Overall Study|Disease progression|3|||
155522985|NCT00880568|561340997|FG000|Overall Study|Adverse Event|0|||
155522986|NCT00880568|561340998|FG001|Overall Study|Adverse Event|0|||
155522987|NCT00880568|561340999|FG002|Overall Study|Adverse Event|0|||
155522988|NCT00880568|561341000|FG003|Overall Study|Adverse Event|0|||
155522989|NCT00880568|561341001|FG004|Overall Study|Adverse Event|0|||
155522990|NCT00880568|561341002|FG005|Overall Study|Adverse Event|0|||
155522991|NCT00880568|561341003|FG006|Overall Study|Adverse Event|1|||
155522992|NCT00880568|561341004|FG007|Overall Study|Adverse Event|1|||
155522993|NCT00880568|561341005|FG008|Overall Study|Adverse Event|0|||
155522994|NCT00880568|561340997|FG000|Overall Study|Withdrawal by Subject|0|||
155522995|NCT00880568|561340998|FG001|Overall Study|Withdrawal by Subject|0|||
155522996|NCT00880568|561340999|FG002|Overall Study|Withdrawal by Subject|0|||
155522997|NCT00880568|561341000|FG003|Overall Study|Withdrawal by Subject|0|||
155522998|NCT00880568|561341001|FG004|Overall Study|Withdrawal by Subject|0|||
155522999|NCT00880568|561341002|FG005|Overall Study|Withdrawal by Subject|0|||
155523000|NCT00880568|561341003|FG006|Overall Study|Withdrawal by Subject|0|||
155523001|NCT00880568|561341004|FG007|Overall Study|Withdrawal by Subject|1|||
155523002|NCT00880568|561341005|FG008|Overall Study|Withdrawal by Subject|0|||
155523003|NCT00620022|561341006|FG000|Treatment Period 1|Adverse Event|4|||
155523004|NCT00620022|561341007|FG001|Treatment Period 1|Adverse Event|6|||
155523005|NCT00620022|561341006|FG000|Treatment Period 1|Subject withdrew consent|1|||
155523006|NCT00620022|561341007|FG001|Treatment Period 1|Subject withdrew consent|0|||
155523007|NCT00620022|561341006|FG000|Treatment Period 2|Adverse Event|2|||
155523008|NCT00620022|561341007|FG001|Treatment Period 2|Adverse Event|2|||
155523009|NCT03478397|561341013|FG000|Overall Study|Refused to participate|31|||
155523010|NCT03478397|561341014|FG001|Overall Study|Refused to participate|7|||
155523011|NCT03988803|561341015|FG000|Period 2|Prematurely discontinued from medication|2|||
155523012|NCT03988803|561341015|FG000|Period 2|Adverse Event|1|||
155523013|NCT01617668|561341016|FG000|Overall Study|Adverse Event|7|||
155523014|NCT01617668|561341017|FG001|Overall Study|Adverse Event|0|||
155523015|NCT01617668|561341018|FG002|Overall Study|Adverse Event|12|||
155523016|NCT01617668|561341019|FG003|Overall Study|Adverse Event|5|||
155523017|NCT01617668|561341016|FG000|Overall Study|Physician Decision|1|||
155523018|NCT01617668|561341017|FG001|Overall Study|Physician Decision|2|||
155523019|NCT01617668|561341018|FG002|Overall Study|Physician Decision|3|||
155523020|NCT01617668|561341019|FG003|Overall Study|Physician Decision|0|||
155523021|NCT01617668|561341016|FG000|Overall Study|Progressive Disease|4|||
155523022|NCT01617668|561341017|FG001|Overall Study|Progressive Disease|4|||
155523023|NCT01617668|561341018|FG002|Overall Study|Progressive Disease|6|||
155523024|NCT01617668|561341019|FG003|Overall Study|Progressive Disease|9|||
155523025|NCT01617668|561341016|FG000|Overall Study|Subject/guardian decision|1|||
155523026|NCT01617668|561341017|FG001|Overall Study|Subject/guardian decision|3|||
155523027|NCT01617668|561341018|FG002|Overall Study|Subject/guardian decision|2|||
155523028|NCT01617668|561341019|FG003|Overall Study|Subject/guardian decision|1|||
155523029|NCT00925769|561341020|FG000|Overall Study|Major toxicity|1|||
155523030|NCT00925769|561341021|FG001|Overall Study|Major toxicity|0|||
155523031|NCT00925769|561341022|FG002|Overall Study|Major toxicity|1|||
155523032|NCT00925769|561341023|FG003|Overall Study|Major toxicity|1|||
155523033|NCT00925769|561341024|FG004|Overall Study|Major toxicity|0|||
155523034|NCT00925769|561341025|FG005|Overall Study|Major toxicity|0|||
155523035|NCT00925769|561341020|FG000|Overall Study|Disease progression|4|||
155523036|NCT00925769|561341021|FG001|Overall Study|Disease progression|5|||
155523037|NCT00925769|561341022|FG002|Overall Study|Disease progression|3|||
155523038|NCT00925769|561341023|FG003|Overall Study|Disease progression|4|||
155523039|NCT00925769|561341024|FG004|Overall Study|Disease progression|2|||
155523040|NCT00925769|561341025|FG005|Overall Study|Disease progression|3|||
155523041|NCT00925769|561341020|FG000|Overall Study|Death|0|||
155523042|NCT00925769|561341021|FG001|Overall Study|Death|0|||
155523043|NCT00925769|561341022|FG002|Overall Study|Death|1|||
155523044|NCT00925769|561341023|FG003|Overall Study|Death|0|||
155523045|NCT00925769|561341024|FG004|Overall Study|Death|0|||
155523046|NCT00925769|561341025|FG005|Overall Study|Death|0|||
155523047|NCT00925769|561341020|FG000|Overall Study|Physician Decision|1|||
155523048|NCT00925769|561341021|FG001|Overall Study|Physician Decision|0|||
155523049|NCT00925769|561341022|FG002|Overall Study|Physician Decision|0|||
155523050|NCT00925769|561341023|FG003|Overall Study|Physician Decision|0|||
155523051|NCT00925769|561341024|FG004|Overall Study|Physician Decision|0|||
155523052|NCT00925769|561341025|FG005|Overall Study|Physician Decision|0|||
155523053|NCT00925769|561341020|FG000|Overall Study|Missing documentation|0|||
155523054|NCT00925769|561341021|FG001|Overall Study|Missing documentation|1|||
155523055|NCT00925769|561341022|FG002|Overall Study|Missing documentation|0|||
155523056|NCT00925769|561341023|FG003|Overall Study|Missing documentation|0|||
155523057|NCT00925769|561341024|FG004|Overall Study|Missing documentation|0|||
155523058|NCT00925769|561341025|FG005|Overall Study|Missing documentation|0|||
155523059|NCT00925769|561341020|FG000|Overall Study|End of study visit not done|0|||
155523060|NCT00925769|561341021|FG001|Overall Study|End of study visit not done|0|||
155523061|NCT00925769|561341022|FG002|Overall Study|End of study visit not done|1|||
155523062|NCT00925769|561341023|FG003|Overall Study|End of study visit not done|0|||
155523063|NCT00925769|561341024|FG004|Overall Study|End of study visit not done|0|||
155523064|NCT00925769|561341025|FG005|Overall Study|End of study visit not done|0|||
155523065|NCT00925769|561341020|FG000|Overall Study|Participant is unable to swallow drug|0|||
155523066|NCT00925769|561341021|FG001|Overall Study|Participant is unable to swallow drug|0|||
155523067|NCT00925769|561341022|FG002|Overall Study|Participant is unable to swallow drug|0|||
155523068|NCT00925769|561341023|FG003|Overall Study|Participant is unable to swallow drug|1|||
155523069|NCT00925769|561341024|FG004|Overall Study|Participant is unable to swallow drug|0|||
155523070|NCT00925769|561341025|FG005|Overall Study|Participant is unable to swallow drug|0|||
155523071|NCT00925769|561341020|FG000|Overall Study|Adverse Event|0|||
155523072|NCT00925769|561341021|FG001|Overall Study|Adverse Event|0|||
155523073|NCT00925769|561341022|FG002|Overall Study|Adverse Event|0|||
155523074|NCT00925769|561341023|FG003|Overall Study|Adverse Event|0|||
155523075|NCT00925769|561341024|FG004|Overall Study|Adverse Event|1|||
155523076|NCT00925769|561341025|FG005|Overall Study|Adverse Event|0|||
155523077|NCT01735630|561341027|FG000|Overall Study|Adverse Event|8|||
155523078|NCT01735630|561341028|FG001|Overall Study|Adverse Event|7|||
155523079|NCT01735630|561341027|FG000|Overall Study|Lost to Follow-up|1|||
155523080|NCT01735630|561341028|FG001|Overall Study|Lost to Follow-up|0|||
155523081|NCT01735630|561341027|FG000|Overall Study|Physician Decision|0|||
155523082|NCT01735630|561341028|FG001|Overall Study|Physician Decision|1|||
155523083|NCT01735630|561341027|FG000|Overall Study|Sponsor Decision|2|||
155523084|NCT01735630|561341028|FG001|Overall Study|Sponsor Decision|1|||
155523085|NCT01735630|561341027|FG000|Overall Study|Withdrawal by Subject|7|||
155523086|NCT01735630|561341028|FG001|Overall Study|Withdrawal by Subject|9|||
155523087|NCT01720264|561341032|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
155523088|NCT01720264|561341032|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
155523089|NCT01720264|561341032|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
155523090|NCT00877032|561341033|FG000|Overall Study|Did not meet entrance criteria|0|||
155523091|NCT00877032|561341034|FG001|Overall Study|Did not meet entrance criteria|0|||
155523092|NCT00877032|561341035|FG002|Overall Study|Did not meet entrance criteria|0|||
155523093|NCT00877032|561341036|FG003|Overall Study|Did not meet entrance criteria|1|||
155523094|NCT00877032|561341037|FG004|Overall Study|Did not meet entrance criteria|0|||
155523095|NCT00877032|561341038|FG005|Overall Study|Did not meet entrance criteria|0|||
155523096|NCT00877032|561341039|FG006|Overall Study|Did not meet entrance criteria|2|||
155523097|NCT00813293|561341040|FG000|Overall Study|Intercurrent illness|1|||
155523098|NCT00813293|561341041|FG001|Overall Study|Intercurrent illness|0|||
155523099|NCT00813293|561341040|FG000|Overall Study|Adverse Event|0|||
155523100|NCT00813293|561341041|FG001|Overall Study|Adverse Event|1|||
155523101|NCT00533273|561341042|FG000|Double-blind|Withdrew consent|0|||
155523102|NCT00533273|561341043|FG001|Double-blind|Withdrew consent|2|||
155523103|NCT00533273|561341042|FG000|Open-label|Withdrawal by Subject|6|||
155523104|NCT00533273|561341043|FG001|Open-label|Withdrawal by Subject|0|||
155523105|NCT02794974|561341046|FG000|Overall Study|Physician Decision|0|||
155523106|NCT02794974|561341047|FG001|Overall Study|Physician Decision|1|||
155523107|NCT01873586|561341049|FG000|Overall Study|Lost to Follow-up|3|||
155523108|NCT02202850|561341050|FG000|Overall Study|Other|2|||
155523109|NCT02202850|561341051|FG001|Overall Study|Other|2|||
155523110|NCT02202850|561341050|FG000|Overall Study|Enbrel treatment discontinued|15|||
155523111|NCT02202850|561341051|FG001|Overall Study|Enbrel treatment discontinued|3|||
155523112|NCT02202850|561341050|FG000|Overall Study|Lost to Follow-up|7|||
155523113|NCT02202850|561341051|FG001|Overall Study|Lost to Follow-up|1|||
155523114|NCT00615069|561341052|FG000|Overall Study|Death|10|||
155523115|NCT00615069|561341052|FG000|Overall Study|Physician Decision|2|||
155523116|NCT00615069|561341052|FG000|Overall Study|Withdrawal by Subject|4|||
155523117|NCT00669942|561341053|FG000|Parts 2 and 3|Adverse Event|0|||
155523118|NCT00669942|561341054|FG001|Parts 2 and 3|Adverse Event|0|||
155523119|NCT00669942|561341055|FG002|Parts 2 and 3|Adverse Event|0|||
155523120|NCT00669942|561341056|FG003|Parts 2 and 3|Adverse Event|0|||
155523121|NCT00669942|561341057|FG004|Parts 2 and 3|Adverse Event|0|||
155523122|NCT00669942|561341058|FG005|Parts 2 and 3|Adverse Event|0|||
155523123|NCT00669942|561341059|FG006|Parts 2 and 3|Adverse Event|0|||
155523124|NCT00669942|561341060|FG007|Parts 2 and 3|Adverse Event|2|||
155523125|NCT00669942|561341061|FG008|Parts 2 and 3|Adverse Event|1|||
155523126|NCT00669942|561341062|FG009|Parts 2 and 3|Adverse Event|0|||
155523127|NCT00669942|561341063|FG010|Parts 2 and 3|Adverse Event|0|||
155523128|NCT00669942|561341064|FG011|Parts 2 and 3|Adverse Event|0|||
155523129|NCT00669942|561341053|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
155523130|NCT00669942|561341054|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
155523131|NCT00669942|561341055|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
155523132|NCT00669942|561341056|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
155523133|NCT00669942|561341057|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
155523134|NCT00669942|561341058|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
155523135|NCT00669942|561341059|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
155523136|NCT00669942|561341060|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
155523137|NCT00669942|561341061|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
155523138|NCT00669942|561341062|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
155523139|NCT00669942|561341063|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
155523140|NCT00669942|561341064|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
155523141|NCT00669942|561341053|FG000|Parts 2 and 3|Protocol Violation|0|||
155523142|NCT00669942|561341054|FG001|Parts 2 and 3|Protocol Violation|0|||
155523143|NCT00669942|561341055|FG002|Parts 2 and 3|Protocol Violation|0|||
155523144|NCT00669942|561341056|FG003|Parts 2 and 3|Protocol Violation|0|||
155523145|NCT00669942|561341057|FG004|Parts 2 and 3|Protocol Violation|0|||
155523146|NCT00669942|561341058|FG005|Parts 2 and 3|Protocol Violation|1|||
155523147|NCT00669942|561341059|FG006|Parts 2 and 3|Protocol Violation|0|||
155523148|NCT00669942|561341060|FG007|Parts 2 and 3|Protocol Violation|0|||
155523149|NCT00669942|561341061|FG008|Parts 2 and 3|Protocol Violation|0|||
155523150|NCT00669942|561341062|FG009|Parts 2 and 3|Protocol Violation|0|||
155523151|NCT00669942|561341063|FG010|Parts 2 and 3|Protocol Violation|0|||
155523152|NCT00669942|561341064|FG011|Parts 2 and 3|Protocol Violation|0|||
155523153|NCT02549092|561341068|FG000|Treatment Period|Adverse Event|2|||
155523154|NCT02549092|561341069|FG001|Treatment Period|Adverse Event|2|||
155523155|NCT02549092|561341068|FG000|Treatment Period|Withdrawal by Subject|1|||
155523156|NCT02549092|561341069|FG001|Treatment Period|Withdrawal by Subject|3|||
155523157|NCT02549092|561341068|FG000|Treatment Period|Lack of Efficacy|0|||
155654944|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
155654945|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
155523158|NCT02549092|561341069|FG001|Treatment Period|Lack of Efficacy|2|||
155523159|NCT02549092|561341068|FG000|Extension/Transition Period|Adverse Event|1|||
155523160|NCT02549092|561341069|FG001|Extension/Transition Period|Adverse Event|1|||
155523161|NCT02549092|561341068|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
155523162|NCT02549092|561341069|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
155523163|NCT02549092|561341068|FG000|Extension/Transition Period|Other, Not Specified|4|||
155523164|NCT02549092|561341069|FG001|Extension/Transition Period|Other, Not Specified|2|||
155523165|NCT03002077|561341075|FG000|Overall Study|Non-compliance with Study Drug|4|||
155523166|NCT03002077|561341075|FG000|Overall Study|Non-compliance w/Background ADT|1|||
155485761|NCT01072175|561201907|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485762|NCT01072175|561201908|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485763|NCT01072175|561201909|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485764|NCT01072175|561201910|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155485765|NCT01072175|561201898|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
155485766|NCT01072175|561201899|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
155485767|NCT01072175|561201900|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
155485768|NCT01072175|561201901|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
155485769|NCT01072175|561201902|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
155485770|NCT01072175|561201903|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
155485771|NCT01072175|561201904|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
155485772|NCT01072175|561201905|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
155485773|NCT01072175|561201906|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
155485774|NCT01072175|561201907|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
155485775|NCT01072175|561201908|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
155485776|NCT01072175|561201909|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
155485777|NCT01072175|561201910|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
155485778|NCT01072175|561201898|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485779|NCT01072175|561201899|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485780|NCT01072175|561201900|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485781|NCT01072175|561201901|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485782|NCT01072175|561201902|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485783|NCT01072175|561201903|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
155485784|NCT01072175|561201904|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
155485785|NCT01072175|561201905|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
155485786|NCT01072175|561201906|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485787|NCT01072175|561201907|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485788|NCT01072175|561201908|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485789|NCT01072175|561201909|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485790|NCT01072175|561201910|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
155485791|NCT01072175|561201898|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485792|NCT01072175|561201899|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485793|NCT01072175|561201900|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485794|NCT01072175|561201901|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485795|NCT01072175|561201902|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485796|NCT01072175|561201903|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485797|NCT01072175|561201904|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
155485798|NCT01072175|561201905|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
155485799|NCT01072175|561201906|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485800|NCT01072175|561201907|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485801|NCT01072175|561201908|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485802|NCT01072175|561201909|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485803|NCT01072175|561201910|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
155485804|NCT01072175|561201898|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485805|NCT01072175|561201899|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485806|NCT01072175|561201900|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485807|NCT01072175|561201901|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485808|NCT01072175|561201902|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485809|NCT01072175|561201903|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
155485810|NCT01072175|561201904|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
155485811|NCT01072175|561201905|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
155485812|NCT01072175|561201906|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485813|NCT01072175|561201907|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485814|NCT01072175|561201908|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485815|NCT01072175|561201909|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485816|NCT01072175|561201910|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155485817|NCT01072175|561201898|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485818|NCT01072175|561201899|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485819|NCT01072175|561201900|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155523167|NCT03002077|561341075|FG000|Overall Study|Study Terminated by Sponsor|257|||
155523168|NCT03002077|561341075|FG000|Overall Study|Site Terminated by Sponsor|5|||
155523169|NCT03002077|561341075|FG000|Overall Study|Miscellaneous Reasons|10|||
155523170|NCT03002077|561341075|FG000|Overall Study|Adverse Event|23|||
155523171|NCT03002077|561341075|FG000|Overall Study|Lack of Efficacy|20|||
155523172|NCT03002077|561341075|FG000|Overall Study|Withdrawal by Subject|72|||
155523173|NCT03002077|561341075|FG000|Overall Study|Lost to Follow-up|21|||
155523174|NCT03002077|561341075|FG000|Overall Study|Pregnancy|4|||
155523175|NCT03002077|561341075|FG000|Overall Study|Protocol Violation|21|||
155523176|NCT04625114|561341080|FG000|Overall Study|Adverse Event|3|||
155523177|NCT04625114|561341081|FG001|Overall Study|Adverse Event|1|||
155523178|NCT04625114|561341080|FG000|Overall Study|Withdrawal by Subject|2|||
155523179|NCT04625114|561341081|FG001|Overall Study|Withdrawal by Subject|0|||
155523180|NCT01390844|561341084|FG000|Treatment Phase|Adverse Event|12|||
155523181|NCT01390844|561341085|FG001|Treatment Phase|Adverse Event|2|||
155523182|NCT01390844|561341086|FG002|Treatment Phase|Adverse Event|3|||
155523183|NCT01390844|561341087|FG003|Treatment Phase|Adverse Event|2|||
155523184|NCT01390844|561341084|FG000|Treatment Phase|Treatment Failure|23|||
155523185|NCT01390844|561341085|FG001|Treatment Phase|Treatment Failure|25|||
155523186|NCT01390844|561341086|FG002|Treatment Phase|Treatment Failure|10|||
155523187|NCT01390844|561341087|FG003|Treatment Phase|Treatment Failure|13|||
155523188|NCT01390844|561341084|FG000|Treatment Phase|Non-Medical Reasons|5|||
155523189|NCT01390844|561341085|FG001|Treatment Phase|Non-Medical Reasons|1|||
155523190|NCT01390844|561341086|FG002|Treatment Phase|Non-Medical Reasons|8|||
155523191|NCT01390844|561341087|FG003|Treatment Phase|Non-Medical Reasons|1|||
155523192|NCT01390844|561341084|FG000|Treatment Phase|Non-GCP Compliant|0|||
155523193|NCT01390844|561341085|FG001|Treatment Phase|Non-GCP Compliant|0|||
155523194|NCT01390844|561341086|FG002|Treatment Phase|Non-GCP Compliant|10|||
155523195|NCT01390844|561341087|FG003|Treatment Phase|Non-GCP Compliant|3|||
155523196|NCT01390844|561341084|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
155523197|NCT01390844|561341085|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
155523198|NCT01390844|561341086|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
155523199|NCT01390844|561341087|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
155523200|NCT03048500|561341092|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
155523201|NCT03048500|561341092|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
155523202|NCT03048500|561341092|FG000|Reached 1st Response/Continued Treatment|Death|1|||
155523203|NCT03048500|561341092|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
155523204|NCT03048500|561341092|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
155523205|NCT03048500|561341092|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
155523206|NCT03048500|561341092|FG000|Follow up for 3 Years|Death|12|||
155523207|NCT03018249|561341094|FG000|Overall Study|Withdrawal by Subject|2|||
155523208|NCT03018249|561341095|FG001|Overall Study|Withdrawal by Subject|2|||
155523209|NCT02158936|561341098|FG000|Overall Study|Study closed/ terminated|57|||
155523210|NCT02158936|561341099|FG001|Overall Study|Study closed/ terminated|77|||
155523211|NCT02158936|561341098|FG000|Overall Study|Azacitidine tx discontinued|53|||
155523212|NCT02158936|561341099|FG001|Overall Study|Azacitidine tx discontinued|46|||
155523213|NCT02158936|561341098|FG000|Overall Study|Adverse Event|39|||
155523214|NCT02158936|561341099|FG001|Overall Study|Adverse Event|24|||
155523215|NCT02158936|561341098|FG000|Overall Study|Withdrawal by Subject|15|||
155523216|NCT02158936|561341099|FG001|Overall Study|Withdrawal by Subject|16|||
155523217|NCT02158936|561341098|FG000|Overall Study|Physician Decision|15|||
155523218|NCT02158936|561341099|FG001|Overall Study|Physician Decision|13|||
155523219|NCT02158936|561341098|FG000|Overall Study|Lost to Follow-up|0|||
155523220|NCT02158936|561341099|FG001|Overall Study|Lost to Follow-up|1|||
155523221|NCT00522457|561341100|FG000|Overall Study|Due to disease progression|16|||
155523222|NCT00522457|561341100|FG000|Overall Study|Adverse Event|2|||
155523223|NCT00549718|561342888|FG000|Overall Study|Insufficient clinical response|20|||
155523224|NCT00549718|561342889|FG001|Overall Study|Insufficient clinical response|7|||
155523225|NCT00549718|561342890|FG002|Overall Study|Insufficient clinical response|18|||
155523226|NCT00549718|561342891|FG003|Overall Study|Insufficient clinical response|32|||
155523227|NCT00549718|561342888|FG000|Overall Study|Adverse Event|6|||
155523228|NCT00549718|561342889|FG001|Overall Study|Adverse Event|8|||
155523229|NCT00549718|561342890|FG002|Overall Study|Adverse Event|7|||
155523230|NCT00549718|561342891|FG003|Overall Study|Adverse Event|3|||
155523231|NCT00549718|561342888|FG000|Overall Study|Lost to Follow-up|4|||
155523232|NCT00549718|561342889|FG001|Overall Study|Lost to Follow-up|2|||
155523233|NCT00549718|561342890|FG002|Overall Study|Lost to Follow-up|0|||
155523234|NCT00549718|561342891|FG003|Overall Study|Lost to Follow-up|6|||
155523235|NCT00549718|561342888|FG000|Overall Study|Withdrawal by Subject|9|||
155523236|NCT00549718|561342889|FG001|Overall Study|Withdrawal by Subject|18|||
155523237|NCT00549718|561342890|FG002|Overall Study|Withdrawal by Subject|12|||
155523238|NCT00549718|561342891|FG003|Overall Study|Withdrawal by Subject|13|||
155523239|NCT00549718|561342888|FG000|Overall Study|Administrative|2|||
155523240|NCT00549718|561342889|FG001|Overall Study|Administrative|2|||
155523241|NCT00549718|561342890|FG002|Overall Study|Administrative|2|||
155523242|NCT00549718|561342891|FG003|Overall Study|Administrative|1|||
155523243|NCT02424097|561342892|FG000|Overall Study|Lost to Follow-up|1|||
155523244|NCT02424097|561342893|FG001|Overall Study|Lost to Follow-up|2|||
155523245|NCT02880761|561342894|FG000|Overall Study|Death|6|||
155523246|NCT02880761|561342895|FG001|Overall Study|Death|8|||
155523247|NCT02880761|561342894|FG000|Overall Study|Withdrawal by Subject|3|||
155523248|NCT02880761|561342895|FG001|Overall Study|Withdrawal by Subject|6|||
155523249|NCT02880761|561342894|FG000|Overall Study|Protocol Violation|4|||
155523250|NCT02880761|561342895|FG001|Overall Study|Protocol Violation|3|||
155523251|NCT02880761|561342894|FG000|Overall Study|Lost to Follow-up|3|||
155523252|NCT02880761|561342895|FG001|Overall Study|Lost to Follow-up|4|||
155523253|NCT03597256|561342896|FG000|Overall Study|Lost to Follow-up|3|||
155523254|NCT03597256|561342897|FG001|Overall Study|Lost to Follow-up|1|||
155523255|NCT03597256|561342896|FG000|Overall Study|Withdrawal by Subject|0|||
155523256|NCT03597256|561342897|FG001|Overall Study|Withdrawal by Subject|1|||
155523257|NCT03597256|561342896|FG000|Overall Study|Could not return for treatment|0|||
155523258|NCT03597256|561342897|FG001|Overall Study|Could not return for treatment|1|||
155523259|NCT03597256|561342896|FG000|Overall Study|Moved from location|0|||
155523260|NCT03597256|561342897|FG001|Overall Study|Moved from location|1|||
155523261|NCT03597256|561342896|FG000|Overall Study|Not accepted the treatment|0|||
155523262|NCT03597256|561342897|FG001|Overall Study|Not accepted the treatment|1|||
155523263|NCT02106156|561342898|FG000|Overall Study|Patient Died|19|||
155523264|NCT02106156|561342899|FG001|Overall Study|Patient Died|0|||
155523265|NCT02106156|561342900|FG002|Overall Study|Patient Died|0|||
155523266|NCT02106156|561342898|FG000|Overall Study|Lack of Tolerability|305|||
155523267|NCT02106156|561342899|FG001|Overall Study|Lack of Tolerability|3|||
155523268|NCT02106156|561342900|FG002|Overall Study|Lack of Tolerability|0|||
155523269|NCT02106156|561342898|FG000|Overall Study|Lack of Virological Response|1044|||
155523270|NCT02106156|561342899|FG001|Overall Study|Lack of Virological Response|8|||
155523271|NCT02106156|561342900|FG002|Overall Study|Lack of Virological Response|0|||
155523272|NCT02106156|561342898|FG000|Overall Study|Concomitant Disease|74|||
155523273|NCT02106156|561342899|FG001|Overall Study|Concomitant Disease|2|||
155523274|NCT02106156|561342900|FG002|Overall Study|Concomitant Disease|0|||
155523275|NCT02106156|561342898|FG000|Overall Study|Lack of Compliance|211|||
155523276|NCT02106156|561342899|FG001|Overall Study|Lack of Compliance|7|||
155523277|NCT02106156|561342900|FG002|Overall Study|Lack of Compliance|0|||
155523278|NCT02106156|561342898|FG000|Overall Study|Patients Request|307|||
155523279|NCT02106156|561342899|FG001|Overall Study|Patients Request|9|||
155523280|NCT02106156|561342900|FG002|Overall Study|Patients Request|0|||
155523281|NCT02106156|561342898|FG000|Overall Study|Lost to Follow-up|451|||
155523282|NCT02106156|561342899|FG001|Overall Study|Lost to Follow-up|8|||
155523283|NCT02106156|561342900|FG002|Overall Study|Lost to Follow-up|0|||
155523284|NCT02106156|561342898|FG000|Overall Study|Unplanned Event|82|||
155523285|NCT02106156|561342899|FG001|Overall Study|Unplanned Event|2|||
155523286|NCT02106156|561342900|FG002|Overall Study|Unplanned Event|0|||
155523287|NCT02106156|561342898|FG000|Overall Study|Change of Laboratory Parameter|10|||
155523288|NCT02106156|561342899|FG001|Overall Study|Change of Laboratory Parameter|0|||
155523289|NCT02106156|561342900|FG002|Overall Study|Change of Laboratory Parameter|0|||
155523290|NCT02106156|561342898|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
155523291|NCT02106156|561342899|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
155523292|NCT02106156|561342900|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
155523293|NCT02106156|561342898|FG000|Overall Study|Relocation/Change of Physician|40|||
155523294|NCT02106156|561342899|FG001|Overall Study|Relocation/Change of Physician|1|||
155523295|NCT02106156|561342900|FG002|Overall Study|Relocation/Change of Physician|0|||
155523296|NCT01136382|561342901|FG000|Overall Study|Other|8|||
155523297|NCT01136382|561342902|FG001|Overall Study|Other|3|||
155523298|NCT01136382|561342901|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
155523299|NCT01136382|561342902|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
155523300|NCT01136382|561342901|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
155523301|NCT01136382|561342902|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155523302|NCT01136382|561342901|FG000|Overall Study|Withdrawal by Subject|4|||
155523303|NCT01136382|561342902|FG001|Overall Study|Withdrawal by Subject|1|||
155523304|NCT01725529|561342910|FG000|Overall Study|Adverse Event|1|||
155523305|NCT01725529|561342911|FG001|Overall Study|Adverse Event|0|||
155523306|NCT01725529|561342912|FG002|Overall Study|Adverse Event|0|||
155523307|NCT01725529|561342910|FG000|Overall Study|Lost to Follow-up|2|||
155523308|NCT01725529|561342911|FG001|Overall Study|Lost to Follow-up|1|||
155523309|NCT01725529|561342912|FG002|Overall Study|Lost to Follow-up|1|||
155523310|NCT01725529|561342910|FG000|Overall Study|Protocol Violation|0|||
155523311|NCT01725529|561342911|FG001|Overall Study|Protocol Violation|1|||
155523312|NCT01725529|561342912|FG002|Overall Study|Protocol Violation|1|||
155523313|NCT01725529|561342910|FG000|Overall Study|Withdrawal by Subject|12|||
155523314|NCT01725529|561342911|FG001|Overall Study|Withdrawal by Subject|14|||
155523315|NCT01725529|561342912|FG002|Overall Study|Withdrawal by Subject|8|||
155523316|NCT00746798|561342914|FG000|Overall Study|Protocol Violation|0|||
155523317|NCT00746798|561342915|FG001|Overall Study|Protocol Violation|1|||
155523318|NCT00746798|561342916|FG002|Overall Study|Protocol Violation|0|||
155523319|NCT00746798|561342917|FG003|Overall Study|Protocol Violation|0|||
155523320|NCT00746798|561342914|FG000|Overall Study|Withdrawal by Subject|0|||
155523321|NCT00746798|561342915|FG001|Overall Study|Withdrawal by Subject|1|||
155523322|NCT00746798|561342916|FG002|Overall Study|Withdrawal by Subject|1|||
155523323|NCT00746798|561342917|FG003|Overall Study|Withdrawal by Subject|0|||
155523324|NCT00746798|561342914|FG000|Overall Study|Death|0|||
155523325|NCT00746798|561342915|FG001|Overall Study|Death|0|||
155523326|NCT00746798|561342916|FG002|Overall Study|Death|2|||
155523327|NCT00746798|561342917|FG003|Overall Study|Death|0|||
155523328|NCT00746798|561342914|FG000|Overall Study|Participant unable to return for visit|1|||
155523329|NCT00746798|561342915|FG001|Overall Study|Participant unable to return for visit|0|||
155523330|NCT00746798|561342916|FG002|Overall Study|Participant unable to return for visit|0|||
155523331|NCT00746798|561342917|FG003|Overall Study|Participant unable to return for visit|0|||
155523332|NCT00633594|561342920|FG000|Overall Study|Adverse Event|0|||
155523333|NCT00633594|561342921|FG001|Overall Study|Adverse Event|4|||
155523334|NCT00633594|561342922|FG002|Overall Study|Adverse Event|7|||
155523335|NCT00633594|561342920|FG000|Overall Study|Death|0|||
155523336|NCT00633594|561342921|FG001|Overall Study|Death|1|||
155523337|NCT00633594|561342922|FG002|Overall Study|Death|2|||
155523338|NCT00633594|561342920|FG000|Overall Study|Disease Progression|0|||
155523339|NCT00633594|561342921|FG001|Overall Study|Disease Progression|0|||
155523340|NCT00633594|561342922|FG002|Overall Study|Disease Progression|1|||
155523341|NCT02028715|561342925|FG000|Overall Study|Adverse Event|2|||
155523342|NCT02028715|561342926|FG001|Overall Study|Adverse Event|2|||
155523343|NCT02028715|561342925|FG000|Overall Study|Physician Decision|1|||
155523344|NCT02028715|561342926|FG001|Overall Study|Physician Decision|0|||
155523345|NCT02028715|561342925|FG000|Overall Study|Did not complete satisfaction surveys|2|||
155523346|NCT02028715|561342926|FG001|Overall Study|Did not complete satisfaction surveys|2|||
155523347|NCT04915755|561342927|FG000|Overall Study|Physician Decision|3|||
155523348|NCT04915755|561342928|FG001|Overall Study|Physician Decision|2|||
155523349|NCT04915755|561342927|FG000|Overall Study|Withdrawal by Subject|1|||
155523350|NCT04915755|561342928|FG001|Overall Study|Withdrawal by Subject|1|||
155523351|NCT04915755|561342927|FG000|Overall Study|Ongoing for PACT|3|||
155523352|NCT04915755|561342928|FG001|Overall Study|Ongoing for PACT|2|||
155523353|NCT04915755|561342927|FG000|Overall Study|Other|7|||
155523354|NCT04915755|561342928|FG001|Overall Study|Other|11|||
155523355|NCT03655106|561342930|FG000|Overall Study|Withdrawal by Subject|3|||
155523356|NCT03655106|561342931|FG001|Overall Study|Withdrawal by Subject|2|||
155523357|NCT03655106|561342930|FG000|Overall Study|Lost to Follow-up|2|||
155523358|NCT03655106|561342931|FG001|Overall Study|Lost to Follow-up|1|||
155523359|NCT03655106|561342930|FG000|Overall Study|Duplicate Enrollment|1|||
155523360|NCT03655106|561342931|FG001|Overall Study|Duplicate Enrollment|1|||
155523361|NCT03655106|561342930|FG000|Overall Study|Protocol Violation|3|||
155523362|NCT03655106|561342931|FG001|Overall Study|Protocol Violation|0|||
155523363|NCT00727571|561342935|FG000|Overall Study|Ineligibility determined|1|||
155523364|NCT00727571|561342936|FG001|Overall Study|Ineligibility determined|1|||
155523365|NCT00727571|561342937|FG002|Overall Study|Ineligibility determined|1|||
155523366|NCT00727571|561342938|FG003|Overall Study|Ineligibility determined|0|||
155523367|NCT00727571|561342935|FG000|Overall Study|Death|0|||
155523368|NCT00727571|561342936|FG001|Overall Study|Death|19|||
155523369|NCT00727571|561342937|FG002|Overall Study|Death|5|||
155523370|NCT00727571|561342938|FG003|Overall Study|Death|1|||
155523371|NCT00727571|561342935|FG000|Overall Study|Physician Decision|0|||
155523372|NCT00727571|561342936|FG001|Overall Study|Physician Decision|5|||
155523373|NCT00727571|561342937|FG002|Overall Study|Physician Decision|0|||
155523374|NCT00727571|561342938|FG003|Overall Study|Physician Decision|0|||
155523375|NCT00727571|561342935|FG000|Overall Study|Withdrawal by Subject|0|||
155523376|NCT00727571|561342936|FG001|Overall Study|Withdrawal by Subject|10|||
155523377|NCT00727571|561342937|FG002|Overall Study|Withdrawal by Subject|11|||
155523378|NCT00727571|561342938|FG003|Overall Study|Withdrawal by Subject|0|||
155523379|NCT00727571|561342935|FG000|Overall Study|Subject Non Compliance|0|||
155523380|NCT00727571|561342936|FG001|Overall Study|Subject Non Compliance|6|||
155523381|NCT00727571|561342937|FG002|Overall Study|Subject Non Compliance|0|||
155523382|NCT00727571|561342938|FG003|Overall Study|Subject Non Compliance|4|||
155523383|NCT00727571|561342935|FG000|Overall Study|Dismissed from nursing home|0|||
155523384|NCT00727571|561342936|FG001|Overall Study|Dismissed from nursing home|9|||
155523385|NCT00727571|561342937|FG002|Overall Study|Dismissed from nursing home|5|||
155523386|NCT00727571|561342938|FG003|Overall Study|Dismissed from nursing home|0|||
155523387|NCT00727571|561342935|FG000|Overall Study|Hospitalization|0|||
155523388|NCT00727571|561342936|FG001|Overall Study|Hospitalization|1|||
155523389|NCT00727571|561342937|FG002|Overall Study|Hospitalization|0|||
155523390|NCT00727571|561342938|FG003|Overall Study|Hospitalization|1|||
155523391|NCT00727571|561342935|FG000|Overall Study|AE not leading to hospitalization|0|||
155523392|NCT00727571|561342936|FG001|Overall Study|AE not leading to hospitalization|0|||
155523393|NCT00727571|561342937|FG002|Overall Study|AE not leading to hospitalization|2|||
155523394|NCT00727571|561342938|FG003|Overall Study|AE not leading to hospitalization|0|||
155523395|NCT00727571|561342935|FG000|Overall Study|Other|0|||
155523396|NCT00727571|561342936|FG001|Overall Study|Other|4|||
155523397|NCT00727571|561342937|FG002|Overall Study|Other|6|||
155523398|NCT00727571|561342938|FG003|Overall Study|Other|0|||
155523399|NCT02189941|561342939|FG000|Overall Study|Non-compliance|0|||
155523400|NCT02189941|561342940|FG001|Overall Study|Non-compliance|0|||
155523401|NCT02189941|561342941|FG002|Overall Study|Non-compliance|1|||
155523402|NCT00358449|561342942|FG000|Overall Study|Adverse Event|1|||
155523403|NCT00358449|561342943|FG001|Overall Study|Adverse Event|0|||
155523404|NCT00358449|561342944|FG002|Overall Study|Adverse Event|1|||
155523405|NCT00358449|561342942|FG000|Overall Study|Lost to Follow-up|1|||
155523406|NCT00358449|561342943|FG001|Overall Study|Lost to Follow-up|0|||
155523407|NCT00358449|561342944|FG002|Overall Study|Lost to Follow-up|0|||
155523408|NCT00358449|561342942|FG000|Overall Study|Withdrawal by Subject|2|||
155523409|NCT00358449|561342943|FG001|Overall Study|Withdrawal by Subject|0|||
155523410|NCT00358449|561342944|FG002|Overall Study|Withdrawal by Subject|0|||
155523411|NCT00358449|561342942|FG000|Overall Study|Lack of Efficacy|0|||
155523412|NCT00358449|561342943|FG001|Overall Study|Lack of Efficacy|1|||
155523413|NCT00358449|561342944|FG002|Overall Study|Lack of Efficacy|0|||
155523414|NCT00358449|561342942|FG000|Overall Study|Steriod Inhaler was Increased|0|||
155523415|NCT00358449|561342943|FG001|Overall Study|Steriod Inhaler was Increased|0|||
155523416|NCT00358449|561342944|FG002|Overall Study|Steriod Inhaler was Increased|1|||
155523417|NCT01804270|561342945|FG000|Overall Study|Withdrawal by Subject|1|||
155523418|NCT01804270|561342946|FG001|Overall Study|Withdrawal by Subject|1|||
155523419|NCT02188303|561342947|FG000|Overall Study|Adverse Event|0|||
155523420|NCT02188303|561342948|FG001|Overall Study|Adverse Event|0|||
155523421|NCT02188303|561342949|FG002|Overall Study|Adverse Event|0|||
155523422|NCT02188303|561342950|FG003|Overall Study|Adverse Event|0|||
155523423|NCT02188303|561342951|FG004|Overall Study|Adverse Event|0|||
155523424|NCT02188303|561342952|FG005|Overall Study|Adverse Event|2|||
155523425|NCT02188303|561342953|FG006|Overall Study|Adverse Event|0|||
155523426|NCT02188303|561342954|FG007|Overall Study|Adverse Event|2|||
155523427|NCT02188303|561342947|FG000|Overall Study|Dose Termination Criteria Met|0|||
155523428|NCT02188303|561342948|FG001|Overall Study|Dose Termination Criteria Met|0|||
155523429|NCT02188303|561342949|FG002|Overall Study|Dose Termination Criteria Met|0|||
155523430|NCT02188303|561342950|FG003|Overall Study|Dose Termination Criteria Met|0|||
155523431|NCT02188303|561342951|FG004|Overall Study|Dose Termination Criteria Met|0|||
155523432|NCT02188303|561342952|FG005|Overall Study|Dose Termination Criteria Met|0|||
155523433|NCT02188303|561342953|FG006|Overall Study|Dose Termination Criteria Met|2|||
155523434|NCT02188303|561342954|FG007|Overall Study|Dose Termination Criteria Met|4|||
155523435|NCT04206332|561342956|FG000|Part A|Lost to Follow-up|0|||
155523436|NCT04206332|561342957|FG001|Part A|Lost to Follow-up|1|||
155523437|NCT04206332|561342958|FG002|Part A|Lost to Follow-up|0|||
155523438|NCT04206332|561342959|FG003|Part A|Lost to Follow-up|0|||
155523439|NCT04206332|561342960|FG004|Part A|Lost to Follow-up|0|||
155523440|NCT04206332|561342961|FG005|Part A|Lost to Follow-up|0|||
155523441|NCT04206332|561342962|FG006|Part A|Lost to Follow-up|0|||
155523442|NCT04206332|561342963|FG007|Part A|Lost to Follow-up|0|||
155523443|NCT04206332|561342964|FG008|Part A|Lost to Follow-up|0|||
155523444|NCT04206332|561342965|FG009|Part A|Lost to Follow-up|0|||
155523445|NCT04206332|561342966|FG010|Part A|Lost to Follow-up|0|||
155523446|NCT04206332|561342967|FG011|Part A|Lost to Follow-up|0|||
155523447|NCT04206332|561342968|FG012|Part A|Lost to Follow-up|0|||
155523448|NCT04206332|561342969|FG013|Part A|Lost to Follow-up|0|||
155523449|NCT04206332|561342970|FG014|Part A|Lost to Follow-up|0|||
155523450|NCT04206332|561342971|FG015|Part A|Lost to Follow-up|0|||
155523451|NCT04206332|561342972|FG016|Part A|Lost to Follow-up|0|||
155523452|NCT04206332|561342956|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523453|NCT04206332|561342957|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523454|NCT04206332|561342958|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523455|NCT04206332|561342959|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523456|NCT04206332|561342960|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523457|NCT04206332|561342961|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
155523458|NCT04206332|561342962|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523459|NCT04206332|561342963|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523460|NCT04206332|561342964|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523461|NCT04206332|561342965|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523462|NCT04206332|561342966|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523463|NCT04206332|561342967|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523464|NCT04206332|561342968|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523465|NCT04206332|561342969|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523466|NCT04206332|561342970|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523467|NCT04206332|561342971|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523468|NCT04206332|561342972|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
155523469|NCT04206332|561342956|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523470|NCT04206332|561342957|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523471|NCT04206332|561342958|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523472|NCT04206332|561342959|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523473|NCT04206332|561342960|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523474|NCT04206332|561342961|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523475|NCT04206332|561342962|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523476|NCT04206332|561342963|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
155523477|NCT04206332|561342964|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523478|NCT04206332|561342965|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523479|NCT04206332|561342966|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
155523480|NCT04206332|561342967|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523481|NCT04206332|561342968|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523482|NCT04206332|561342969|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523483|NCT04206332|561342970|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155485820|NCT01072175|561201901|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485821|NCT01072175|561201902|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485822|NCT01072175|561201903|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
155485823|NCT01072175|561201904|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
155485824|NCT01072175|561201905|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485825|NCT01072175|561201906|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485826|NCT01072175|561201907|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485827|NCT01072175|561201908|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485828|NCT01072175|561201909|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485829|NCT01072175|561201910|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
155485830|NCT01072175|561201898|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485831|NCT01072175|561201899|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485832|NCT01072175|561201900|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485833|NCT01072175|561201901|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485834|NCT01072175|561201902|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485835|NCT01072175|561201903|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485836|NCT01072175|561201904|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485837|NCT01072175|561201905|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485838|NCT01072175|561201906|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
155485839|NCT01072175|561201907|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485840|NCT01072175|561201908|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485841|NCT01072175|561201909|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485842|NCT01072175|561201910|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
155485843|NCT01072175|561201898|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485844|NCT01072175|561201899|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485845|NCT01072175|561201900|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485846|NCT01072175|561201901|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485847|NCT01072175|561201902|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485848|NCT01072175|561201903|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485849|NCT01072175|561201904|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485850|NCT01072175|561201905|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485851|NCT01072175|561201906|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
155485852|NCT01072175|561201907|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485853|NCT01072175|561201908|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485854|NCT01072175|561201909|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155485855|NCT01072175|561201910|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
155523484|NCT04206332|561342971|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523485|NCT04206332|561342972|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523486|NCT04206332|561342956|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523487|NCT04206332|561342957|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523488|NCT04206332|561342958|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523489|NCT04206332|561342959|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523490|NCT04206332|561342960|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523491|NCT04206332|561342961|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523492|NCT04206332|561342962|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523493|NCT04206332|561342963|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523494|NCT04206332|561342964|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523495|NCT04206332|561342965|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523496|NCT04206332|561342966|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523497|NCT04206332|561342967|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523498|NCT04206332|561342968|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523499|NCT04206332|561342969|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523500|NCT04206332|561342970|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523501|NCT04206332|561342971|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155523502|NCT04206332|561342972|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
155523503|NCT04206332|561342956|FG000|Part C|Withdrawal by Subject|0|||
155523504|NCT04206332|561342957|FG001|Part C|Withdrawal by Subject|0|||
155523505|NCT04206332|561342958|FG002|Part C|Withdrawal by Subject|0|||
155523506|NCT04206332|561342959|FG003|Part C|Withdrawal by Subject|0|||
155523507|NCT04206332|561342960|FG004|Part C|Withdrawal by Subject|0|||
155523508|NCT04206332|561342961|FG005|Part C|Withdrawal by Subject|0|||
155523509|NCT04206332|561342962|FG006|Part C|Withdrawal by Subject|0|||
155523510|NCT04206332|561342963|FG007|Part C|Withdrawal by Subject|0|||
155523511|NCT04206332|561342964|FG008|Part C|Withdrawal by Subject|0|||
155523512|NCT04206332|561342965|FG009|Part C|Withdrawal by Subject|0|||
155523513|NCT04206332|561342966|FG010|Part C|Withdrawal by Subject|0|||
155523514|NCT04206332|561342967|FG011|Part C|Withdrawal by Subject|0|||
155523515|NCT04206332|561342968|FG012|Part C|Withdrawal by Subject|0|||
155523516|NCT04206332|561342969|FG013|Part C|Withdrawal by Subject|0|||
155523517|NCT04206332|561342970|FG014|Part C|Withdrawal by Subject|2|||
155523518|NCT04206332|561342971|FG015|Part C|Withdrawal by Subject|0|||
155523519|NCT04206332|561342972|FG016|Part C|Withdrawal by Subject|0|||
155523520|NCT02334722|561342973|FG000|Overall Study|Lost to Follow-up|4|||
155523521|NCT02334722|561342974|FG001|Overall Study|Lost to Follow-up|0|||
155523522|NCT02334722|561342973|FG000|Overall Study|6 week questionnaire not completed|2|||
155523523|NCT02334722|561342974|FG001|Overall Study|6 week questionnaire not completed|0|||
155523524|NCT02334722|561342973|FG000|Overall Study|Unable to obtain medication|1|||
155523525|NCT02334722|561342974|FG001|Overall Study|Unable to obtain medication|1|||
155523526|NCT02334722|561342973|FG000|Overall Study|Withdrawal by Subject|0|||
155523527|NCT02334722|561342974|FG001|Overall Study|Withdrawal by Subject|3|||
155523528|NCT02334722|561342973|FG000|Overall Study|Adverse Event|0|||
155523529|NCT02334722|561342974|FG001|Overall Study|Adverse Event|2|||
155523530|NCT02334722|561342973|FG000|Overall Study|Physician Decision|0|||
155523531|NCT02334722|561342974|FG001|Overall Study|Physician Decision|1|||
155523532|NCT00856388|561342978|FG000|Overall Study|Other|1|||
155523533|NCT02017964|561342982|FG000|Overall Study|Patient deemed ineligible|1|||
155523534|NCT01038856|561342985|FG000|Overall Study|Adverse Event|2|||
155523535|NCT02300103|561342988|FG000|Overall Study|Lack of Efficacy|3|||
155523536|NCT02300103|561342988|FG000|Overall Study|Protocol Violation|1|||
155523537|NCT02300103|561342988|FG000|Overall Study|Withdrew Consent|2|||
155523538|NCT04091971|561342989|FG000|Overall Study|Withdrawal by Subject|1|||
155523539|NCT04091971|561342989|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
155523540|NCT04091971|561342989|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
155523541|NCT01391793|561342990|FG000|Overall Study|Ineligible|3|||
155523542|NCT01391793|561342991|FG001|Overall Study|Ineligible|0|||
155523543|NCT01391793|561342990|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
155523544|NCT01391793|561342991|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
155523545|NCT01391793|561342990|FG000|Overall Study|No DMSA|73|||
155523546|NCT01391793|561342991|FG001|Overall Study|No DMSA|57|||
155523547|NCT00150462|561342992|FG000|Overall Study|Disease Progression or Relapse|3|||
155654946|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
155654947|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
155523548|NCT00150462|561342993|FG001|Overall Study|Disease Progression or Relapse|1|||
155523549|NCT00150462|561342994|FG002|Overall Study|Disease Progression or Relapse|2|||
155523550|NCT00150462|561342995|FG003|Overall Study|Disease Progression or Relapse|1|||
155523551|NCT00150462|561342996|FG004|Overall Study|Disease Progression or Relapse|2|||
155523552|NCT00150462|561342997|FG005|Overall Study|Disease Progression or Relapse|2|||
155523553|NCT00150462|561342998|FG006|Overall Study|Disease Progression or Relapse|3|||
155523554|NCT00150462|561342999|FG007|Overall Study|Disease Progression or Relapse|5|||
155523555|NCT00150462|561343000|FG008|Overall Study|Disease Progression or Relapse|5|||
155523556|NCT00150462|561343001|FG009|Overall Study|Disease Progression or Relapse|3|||
155523557|NCT00150462|561343002|FG010|Overall Study|Disease Progression or Relapse|2|||
155523558|NCT00150462|561342992|FG000|Overall Study|Withdrawal by Subject|0|||
155523559|NCT00150462|561342993|FG001|Overall Study|Withdrawal by Subject|1|||
155523560|NCT00150462|561342994|FG002|Overall Study|Withdrawal by Subject|1|||
155523561|NCT00150462|561342995|FG003|Overall Study|Withdrawal by Subject|0|||
155523562|NCT00150462|561342996|FG004|Overall Study|Withdrawal by Subject|1|||
155523563|NCT00150462|561342997|FG005|Overall Study|Withdrawal by Subject|2|||
155523564|NCT00150462|561342998|FG006|Overall Study|Withdrawal by Subject|0|||
155523565|NCT00150462|561342999|FG007|Overall Study|Withdrawal by Subject|1|||
155523566|NCT00150462|561343000|FG008|Overall Study|Withdrawal by Subject|0|||
155523567|NCT00150462|561343001|FG009|Overall Study|Withdrawal by Subject|1|||
155523568|NCT00150462|561343002|FG010|Overall Study|Withdrawal by Subject|0|||
155523569|NCT00150462|561342992|FG000|Overall Study|Death|0|||
155523570|NCT00150462|561342993|FG001|Overall Study|Death|1|||
155523571|NCT00150462|561342994|FG002|Overall Study|Death|0|||
155523572|NCT00150462|561342995|FG003|Overall Study|Death|0|||
155523573|NCT00150462|561342996|FG004|Overall Study|Death|0|||
155523574|NCT00150462|561342997|FG005|Overall Study|Death|0|||
155523575|NCT00150462|561342998|FG006|Overall Study|Death|0|||
155523576|NCT00150462|561342999|FG007|Overall Study|Death|0|||
155523577|NCT00150462|561343000|FG008|Overall Study|Death|1|||
155523578|NCT00150462|561343001|FG009|Overall Study|Death|0|||
155523579|NCT00150462|561343002|FG010|Overall Study|Death|0|||
155523580|NCT00150462|561342992|FG000|Overall Study|Adverse Event|0|||
155523581|NCT00150462|561342993|FG001|Overall Study|Adverse Event|0|||
155523582|NCT00150462|561342994|FG002|Overall Study|Adverse Event|0|||
155523583|NCT00150462|561342995|FG003|Overall Study|Adverse Event|1|||
155523584|NCT00150462|561342996|FG004|Overall Study|Adverse Event|0|||
155523585|NCT00150462|561342997|FG005|Overall Study|Adverse Event|0|||
155523586|NCT00150462|561342998|FG006|Overall Study|Adverse Event|0|||
155523587|NCT00150462|561342999|FG007|Overall Study|Adverse Event|2|||
155523588|NCT00150462|561343000|FG008|Overall Study|Adverse Event|0|||
155523589|NCT00150462|561343001|FG009|Overall Study|Adverse Event|1|||
155523590|NCT00150462|561343002|FG010|Overall Study|Adverse Event|0|||
155523591|NCT00150462|561342992|FG000|Overall Study|Physician Decision|0|||
155523592|NCT00150462|561342993|FG001|Overall Study|Physician Decision|0|||
155523593|NCT00150462|561342994|FG002|Overall Study|Physician Decision|1|||
155523594|NCT00150462|561342995|FG003|Overall Study|Physician Decision|1|||
155523595|NCT00150462|561342996|FG004|Overall Study|Physician Decision|0|||
155523596|NCT00150462|561342997|FG005|Overall Study|Physician Decision|0|||
155523597|NCT00150462|561342998|FG006|Overall Study|Physician Decision|0|||
155523598|NCT00150462|561342999|FG007|Overall Study|Physician Decision|0|||
155523599|NCT00150462|561343000|FG008|Overall Study|Physician Decision|0|||
155523600|NCT00150462|561343001|FG009|Overall Study|Physician Decision|0|||
155523601|NCT00150462|561343002|FG010|Overall Study|Physician Decision|0|||
155523602|NCT00150462|561342992|FG000|Overall Study|Other|0|||
155523603|NCT00150462|561342993|FG001|Overall Study|Other|0|||
155485856|NCT01072175|561201898|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485857|NCT01072175|561201899|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485858|NCT01072175|561201900|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485859|NCT01072175|561201901|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485860|NCT01072175|561201902|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485861|NCT01072175|561201903|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485862|NCT01072175|561201904|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485863|NCT01072175|561201905|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485864|NCT01072175|561201906|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
155485865|NCT01072175|561201907|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485866|NCT01072175|561201908|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485867|NCT01072175|561201909|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485868|NCT01072175|561201910|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
155485869|NCT01072175|561201898|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485870|NCT01072175|561201899|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485871|NCT01072175|561201900|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485872|NCT01072175|561201901|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155523604|NCT00150462|561342994|FG002|Overall Study|Other|0|||
155523605|NCT00150462|561342995|FG003|Overall Study|Other|0|||
155523606|NCT00150462|561342996|FG004|Overall Study|Other|0|||
155523607|NCT00150462|561342997|FG005|Overall Study|Other|0|||
155523608|NCT00150462|561342998|FG006|Overall Study|Other|0|||
155523609|NCT00150462|561342999|FG007|Overall Study|Other|0|||
155523610|NCT00150462|561343000|FG008|Overall Study|Other|0|||
155523611|NCT00150462|561343001|FG009|Overall Study|Other|1|||
155523612|NCT00150462|561343002|FG010|Overall Study|Other|1|||
155523613|NCT01666730|561343005|FG000|Overall Study|Adverse Event|16|||
155523614|NCT01666730|561343005|FG000|Overall Study|Death|2|||
155523615|NCT01666730|561343005|FG000|Overall Study|Physician Decision|5|||
155523616|NCT01666730|561343005|FG000|Overall Study|Withdrawal by Subject|9|||
155523617|NCT01666730|561343005|FG000|Overall Study|Disease progression/relapse|18|||
155523618|NCT04638153|561343006|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155523619|NCT04638153|561343007|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155523620|NCT04638153|561343008|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155523621|NCT04638153|561343006|FG000|Overall Study|Study terminated by sponsor|4|||
155523622|NCT04638153|561343007|FG001|Overall Study|Study terminated by sponsor|2|||
155523623|NCT04638153|561343008|FG002|Overall Study|Study terminated by sponsor|14|||
155523624|NCT01440283|561343011|FG000|Overall Study|Death|3|||
155523625|NCT01440283|561343011|FG000|Overall Study|Withdrawal by Subject|4|||
155523626|NCT01440283|561343011|FG000|Overall Study|Physician Decision|3|||
155523627|NCT01449630|561343012|FG000|Period 1|Physician Decision|1|||
155523628|NCT01449630|561343013|FG001|Period 1|Physician Decision|0|||
155523629|NCT01449630|561343014|FG002|Period 1|Physician Decision|0|||
155523630|NCT01449630|561343015|FG003|Period 1|Physician Decision|1|||
155523631|NCT01449630|561343016|FG004|Period 1|Physician Decision|0|||
155523632|NCT01449630|561343017|FG005|Period 1|Physician Decision|0|||
155523633|NCT01449630|561343018|FG006|Period 1|Physician Decision|0|||
155523634|NCT01449630|561343019|FG007|Period 1|Physician Decision|0|||
155523635|NCT01449630|561343020|FG008|Period 1|Physician Decision|0|||
155523636|NCT01449630|561343012|FG000|Period 1|Sponsor Decision|0|||
155523637|NCT01449630|561343013|FG001|Period 1|Sponsor Decision|0|||
155523638|NCT01449630|561343014|FG002|Period 1|Sponsor Decision|0|||
155523639|NCT01449630|561343015|FG003|Period 1|Sponsor Decision|0|||
155523640|NCT01449630|561343016|FG004|Period 1|Sponsor Decision|0|||
155523641|NCT01449630|561343017|FG005|Period 1|Sponsor Decision|1|||
155523642|NCT01449630|561343018|FG006|Period 1|Sponsor Decision|0|||
155523643|NCT01449630|561343019|FG007|Period 1|Sponsor Decision|0|||
155523644|NCT01449630|561343020|FG008|Period 1|Sponsor Decision|0|||
155523645|NCT01449630|561343012|FG000|Period 2|Sponsor Decision|0|||
155523646|NCT01449630|561343013|FG001|Period 2|Sponsor Decision|0|||
155523647|NCT01449630|561343014|FG002|Period 2|Sponsor Decision|0|||
155523648|NCT01449630|561343015|FG003|Period 2|Sponsor Decision|0|||
155523649|NCT01449630|561343016|FG004|Period 2|Sponsor Decision|0|||
155523650|NCT01449630|561343017|FG005|Period 2|Sponsor Decision|0|||
155523651|NCT01449630|561343018|FG006|Period 2|Sponsor Decision|1|||
155523652|NCT01449630|561343019|FG007|Period 2|Sponsor Decision|0|||
155523653|NCT01449630|561343020|FG008|Period 2|Sponsor Decision|0|||
155523654|NCT03553823|561343021|FG000|Overall Study|Physician Decision|0|||
155523655|NCT03553823|561343022|FG001|Overall Study|Physician Decision|1|||
155523656|NCT03340727|561343023|FG000|Overall Study|Death|1|||
155523657|NCT03340727|561343024|FG001|Overall Study|Death|0|||
155523658|NCT03340727|561343023|FG000|Overall Study|Lost to Follow-up|31|||
155523659|NCT03340727|561343024|FG001|Overall Study|Lost to Follow-up|35|||
155523660|NCT03340727|561343023|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
155523661|NCT03340727|561343024|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
155523662|NCT03340727|561343023|FG000|Overall Study|Transferred to another facility|10|||
155523663|NCT03340727|561343024|FG001|Overall Study|Transferred to another facility|7|||
155523664|NCT03340727|561343023|FG000|Overall Study|Withdrawal by Subject|28|||
155523665|NCT03340727|561343024|FG001|Overall Study|Withdrawal by Subject|17|||
155523666|NCT01389102|561343025|FG000|Overall Study|Adverse Event|1|||
155523667|NCT01389102|561343026|FG001|Overall Study|Adverse Event|3|||
155654948|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
155523668|NCT01389102|561343027|FG002|Overall Study|Adverse Event|2|||
155523669|NCT01389102|561343028|FG003|Overall Study|Adverse Event|2|||
155523670|NCT01389102|561343029|FG004|Overall Study|Adverse Event|2|||
155523671|NCT01389102|561343030|FG005|Overall Study|Adverse Event|2|||
155523672|NCT01389102|561343025|FG000|Overall Study|Hurricane Katrina|4|||
155523673|NCT01389102|561343026|FG001|Overall Study|Hurricane Katrina|2|||
155523674|NCT01389102|561343027|FG002|Overall Study|Hurricane Katrina|3|||
155523675|NCT01389102|561343028|FG003|Overall Study|Hurricane Katrina|0|||
155523676|NCT01389102|561343029|FG004|Overall Study|Hurricane Katrina|3|||
155654949|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
155523677|NCT01389102|561343030|FG005|Overall Study|Hurricane Katrina|1|||
155523678|NCT01389102|561343025|FG000|Overall Study|Lost to Follow-up|4|||
155523679|NCT01389102|561343026|FG001|Overall Study|Lost to Follow-up|1|||
155523680|NCT01389102|561343027|FG002|Overall Study|Lost to Follow-up|1|||
155523681|NCT01389102|561343028|FG003|Overall Study|Lost to Follow-up|2|||
155523682|NCT01389102|561343029|FG004|Overall Study|Lost to Follow-up|4|||
155523683|NCT01389102|561343030|FG005|Overall Study|Lost to Follow-up|1|||
155523684|NCT01389102|561343025|FG000|Overall Study|Protocol Violation|0|||
155523685|NCT01389102|561343026|FG001|Overall Study|Protocol Violation|0|||
155523686|NCT01389102|561343027|FG002|Overall Study|Protocol Violation|3|||
155523687|NCT01389102|561343028|FG003|Overall Study|Protocol Violation|0|||
155523688|NCT01389102|561343029|FG004|Overall Study|Protocol Violation|1|||
155523689|NCT01389102|561343030|FG005|Overall Study|Protocol Violation|1|||
155523690|NCT01389102|561343025|FG000|Overall Study|Withdrawal by Subject|7|||
155523691|NCT01389102|561343026|FG001|Overall Study|Withdrawal by Subject|4|||
155523692|NCT01389102|561343027|FG002|Overall Study|Withdrawal by Subject|9|||
155523693|NCT01389102|561343028|FG003|Overall Study|Withdrawal by Subject|2|||
155523694|NCT01389102|561343029|FG004|Overall Study|Withdrawal by Subject|3|||
155523695|NCT01389102|561343030|FG005|Overall Study|Withdrawal by Subject|3|||
155523696|NCT01389102|561343025|FG000|Overall Study|Subject Traveling Out of Country|0|||
155523697|NCT01389102|561343026|FG001|Overall Study|Subject Traveling Out of Country|0|||
155523698|NCT01389102|561343027|FG002|Overall Study|Subject Traveling Out of Country|0|||
155523699|NCT01389102|561343028|FG003|Overall Study|Subject Traveling Out of Country|1|||
155523700|NCT01389102|561343029|FG004|Overall Study|Subject Traveling Out of Country|0|||
155523701|NCT01389102|561343030|FG005|Overall Study|Subject Traveling Out of Country|0|||
155523702|NCT01389102|561343025|FG000|Overall Study|Subject Moved|2|||
155523703|NCT01389102|561343026|FG001|Overall Study|Subject Moved|0|||
155523704|NCT01389102|561343027|FG002|Overall Study|Subject Moved|1|||
155523705|NCT01389102|561343028|FG003|Overall Study|Subject Moved|0|||
155523706|NCT01389102|561343029|FG004|Overall Study|Subject Moved|0|||
155523707|NCT01389102|561343030|FG005|Overall Study|Subject Moved|0|||
155523708|NCT01389102|561343025|FG000|Overall Study|Unavailable due to husband's illness|0|||
155523709|NCT01389102|561343026|FG001|Overall Study|Unavailable due to husband's illness|1|||
155523710|NCT01389102|561343027|FG002|Overall Study|Unavailable due to husband's illness|0|||
155523711|NCT01389102|561343028|FG003|Overall Study|Unavailable due to husband's illness|0|||
155523712|NCT01389102|561343029|FG004|Overall Study|Unavailable due to husband's illness|0|||
155523713|NCT01389102|561343030|FG005|Overall Study|Unavailable due to husband's illness|0|||
155523714|NCT01389102|561343025|FG000|Overall Study|Investigator Judgement|0|||
155523715|NCT01389102|561343026|FG001|Overall Study|Investigator Judgement|1|||
155523716|NCT01389102|561343027|FG002|Overall Study|Investigator Judgement|0|||
155523717|NCT01389102|561343028|FG003|Overall Study|Investigator Judgement|0|||
155523718|NCT01389102|561343029|FG004|Overall Study|Investigator Judgement|0|||
155523719|NCT01389102|561343030|FG005|Overall Study|Investigator Judgement|0|||
155523720|NCT01661686|561343033|FG000|Overall Study|Lost to Follow-up|2|||
155523721|NCT01661686|561343034|FG001|Overall Study|Lost to Follow-up|1|||
155523722|NCT01661686|561343033|FG000|Overall Study|did not receive allocated intervention|0|||
155523723|NCT01661686|561343034|FG001|Overall Study|did not receive allocated intervention|1|||
155523724|NCT04869787|561343039|FG000|Screening|Physician Decision|1|||
155523725|NCT04869787|561343039|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
155523726|NCT00454909|561343040|FG000|Overall Study|Withdrawal by Subject|1|||
155523727|NCT00454909|561343041|FG001|Overall Study|Withdrawal by Subject|0|||
155523728|NCT00454909|561343042|FG002|Overall Study|Withdrawal by Subject|0|||
155523729|NCT00454909|561343040|FG000|Overall Study|Migrated/moved from study area|0|||
155523730|NCT00454909|561343041|FG001|Overall Study|Migrated/moved from study area|0|||
155523731|NCT00454909|561343042|FG002|Overall Study|Migrated/moved from study area|1|||
155523732|NCT00454909|561343040|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
155523733|NCT00454909|561343041|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
155523734|NCT00454909|561343042|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
155523735|NCT00454909|561343040|FG000|Overall Study|Others|1|||
155523736|NCT00454909|561343041|FG001|Overall Study|Others|0|||
155523737|NCT00454909|561343042|FG002|Overall Study|Others|0|||
155523738|NCT02996682|561343043|FG000|Overall Study|Death|0|||
155523739|NCT02996682|561343044|FG001|Overall Study|Death|3|||
155523740|NCT01981720|561343045|FG000|Overall Study|Adverse Event|1|||
155523741|NCT01981720|561343045|FG000|Overall Study|Withdrawal by Subject|3|||
155523742|NCT01981720|561343045|FG000|Overall Study|Pregnancy|1|||
155523743|NCT00282048|561343046|FG000|Overall Study|Lack of Efficacy|30|||
155523744|NCT00282048|561343046|FG000|Overall Study|Adverse Event|22|||
155523745|NCT00282048|561343046|FG000|Overall Study|Withdrawal by Subject|1|||
155523746|NCT00282048|561343046|FG000|Overall Study|Other|8|||
155523747|NCT00282048|561343046|FG000|Overall Study|Ongoing|1|||
155523748|NCT00259012|561343048|FG000|Overall Study|Adverse Event|0|||
155523749|NCT00259012|561343049|FG001|Overall Study|Adverse Event|1|||
155523750|NCT00259012|561343048|FG000|Overall Study|Withdrawal by Subject|1|||
155523751|NCT00259012|561343049|FG001|Overall Study|Withdrawal by Subject|0|||
155523752|NCT00259012|561343048|FG000|Overall Study|Physician Decision|0|||
155523753|NCT00259012|561343049|FG001|Overall Study|Physician Decision|1|||
155523754|NCT00259012|561343048|FG000|Overall Study|Lost to Follow-up|0|||
155523755|NCT00259012|561343049|FG001|Overall Study|Lost to Follow-up|1|||
155523756|NCT00259012|561343048|FG000|Overall Study|Protocol Violation|1|||
155523757|NCT00259012|561343049|FG001|Overall Study|Protocol Violation|1|||
155523758|NCT03522675|561343050|FG000|Overall Study|Screen fail|1|||
155523759|NCT03522675|561343050|FG000|Overall Study|Non-reactive to histamine|1|||
155523760|NCT00707161|561343051|FG000|Overall Study|Physician Decision|6|||
155523761|NCT02674477|561343052|FG000|Overall Study|Protocol Violation|8|||
155523762|NCT02674477|561343053|FG001|Overall Study|Protocol Violation|2|||
155523763|NCT02511782|561343057|FG000|Overall Study|Withdrawal by Subject|1|||
155523764|NCT02511782|561343058|FG001|Overall Study|Withdrawal by Subject|0|||
155523765|NCT02511782|561343059|FG002|Overall Study|Withdrawal by Subject|0|||
155523766|NCT01173692|561343060|FG000|Overall Study|Adverse Event|1|||
155523767|NCT01173692|561343061|FG001|Overall Study|Adverse Event|2|||
155523768|NCT01173692|561343060|FG000|Overall Study|Withdrawal by Subject|1|||
155523769|NCT01173692|561343061|FG001|Overall Study|Withdrawal by Subject|3|||
155523770|NCT01479439|561343068|FG000|Overall Study|Adverse Event|1|||
155523771|NCT01479439|561343069|FG001|Overall Study|Adverse Event|0|||
155523772|NCT01479439|561343070|FG002|Overall Study|Adverse Event|0|||
155523773|NCT01479439|561343068|FG000|Overall Study|Lost to Follow-up|0|||
155523774|NCT01479439|561343069|FG001|Overall Study|Lost to Follow-up|1|||
155523775|NCT01479439|561343070|FG002|Overall Study|Lost to Follow-up|0|||
155523776|NCT01479439|561343068|FG000|Overall Study|Protocol Violation|0|||
155523777|NCT01479439|561343069|FG001|Overall Study|Protocol Violation|0|||
155523778|NCT01479439|561343070|FG002|Overall Study|Protocol Violation|2|||
155523779|NCT00870870|561343073|FG000|Overall Study|Withdrawal by Subject|0|||
155523780|NCT00870870|561343074|FG001|Overall Study|Withdrawal by Subject|1|||
155523781|NCT00870870|561343075|FG002|Overall Study|Withdrawal by Subject|1|||
155523782|NCT00870870|561343076|FG003|Overall Study|Withdrawal by Subject|3|||
155523783|NCT00870870|561343073|FG000|Overall Study|Adverse Event|0|||
155523784|NCT00870870|561343074|FG001|Overall Study|Adverse Event|0|||
155523785|NCT00870870|561343075|FG002|Overall Study|Adverse Event|2|||
155523786|NCT00870870|561343076|FG003|Overall Study|Adverse Event|2|||
155523787|NCT01215981|561345197|FG000|Overall Study|Physician Decision|0|||
155523788|NCT01215981|561345198|FG001|Overall Study|Physician Decision|1|||
155523789|NCT01215981|561345197|FG000|Overall Study|Protocol Violation|1|||
155523790|NCT01215981|561345198|FG001|Overall Study|Protocol Violation|0|||
155523791|NCT01215981|561345197|FG000|Overall Study|Withdrawal by Subject|1|||
155523792|NCT01215981|561345198|FG001|Overall Study|Withdrawal by Subject|0|||
155523793|NCT04657770|561345199|FG000|Overall Study|Withdrawal by Subject|3|||
155523794|NCT04657770|561345199|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
155523795|NCT03497897|561345200|FG000|Overall Study|Adverse Event|1|||
155523796|NCT03497897|561345201|FG001|Overall Study|Adverse Event|1|||
155523797|NCT03497897|561345202|FG002|Overall Study|Adverse Event|1|||
155523798|NCT03497897|561345200|FG000|Overall Study|Lost to Follow-up|2|||
155523799|NCT03497897|561345201|FG001|Overall Study|Lost to Follow-up|0|||
155523800|NCT03497897|561345202|FG002|Overall Study|Lost to Follow-up|2|||
155523801|NCT03497897|561345200|FG000|Overall Study|Physician Decision|1|||
155523802|NCT03497897|561345201|FG001|Overall Study|Physician Decision|0|||
155523803|NCT03497897|561345202|FG002|Overall Study|Physician Decision|0|||
155523804|NCT03497897|561345200|FG000|Overall Study|Subject/Guardian Decision|2|||
155523805|NCT03497897|561345201|FG001|Overall Study|Subject/Guardian Decision|1|||
155523806|NCT03497897|561345202|FG002|Overall Study|Subject/Guardian Decision|3|||
155523807|NCT01471093|561345205|FG000|Overall Study|Adverse Event|1|||
155523808|NCT01471093|561345206|FG001|Overall Study|Adverse Event|0|||
155523809|NCT01471093|561345207|FG002|Overall Study|Adverse Event|0|||
155523810|NCT01471093|561345208|FG003|Overall Study|Adverse Event|0|||
155523811|NCT01710657|561345209|FG000|Overall Study|Lost to Follow-up|2|||
155523812|NCT01710657|561345210|FG001|Overall Study|Lost to Follow-up|0|||
155523813|NCT01710657|561345211|FG002|Overall Study|Lost to Follow-up|1|||
155523814|NCT01710657|561345209|FG000|Overall Study|Protocol Violation|2|||
155523815|NCT01710657|561345210|FG001|Overall Study|Protocol Violation|2|||
155523816|NCT01710657|561345211|FG002|Overall Study|Protocol Violation|0|||
155523817|NCT01710657|561345209|FG000|Overall Study|Adverse Event|14|||
155523818|NCT01710657|561345210|FG001|Overall Study|Adverse Event|8|||
155523819|NCT01710657|561345211|FG002|Overall Study|Adverse Event|28|||
155523820|NCT01710657|561345209|FG000|Overall Study|Withdrawal by Subject|0|||
155523821|NCT01710657|561345210|FG001|Overall Study|Withdrawal by Subject|1|||
155523822|NCT01710657|561345211|FG002|Overall Study|Withdrawal by Subject|2|||
155523823|NCT01710657|561345209|FG000|Overall Study|Lack of Efficacy|0|||
155523824|NCT01710657|561345210|FG001|Overall Study|Lack of Efficacy|1|||
155523825|NCT01710657|561345211|FG002|Overall Study|Lack of Efficacy|1|||
155523826|NCT01367457|561345220|FG000|Overall Study|Death|2|||
155523827|NCT01367457|561345221|FG001|Overall Study|Death|0|||
155523828|NCT01367457|561345222|FG002|Overall Study|Death|0|||
155523829|NCT01367457|561345220|FG000|Overall Study|Investigator's decision|2|||
155523830|NCT01367457|561345221|FG001|Overall Study|Investigator's decision|0|||
155523831|NCT01367457|561345222|FG002|Overall Study|Investigator's decision|0|||
155523832|NCT01367457|561345220|FG000|Overall Study|Clinical decline (CD)|2|||
155523833|NCT01367457|561345221|FG001|Overall Study|Clinical decline (CD)|0|||
155523834|NCT01367457|561345222|FG002|Overall Study|Clinical decline (CD)|0|||
155523835|NCT01367457|561345220|FG000|Overall Study|Progression and death|8|||
155523836|NCT01367457|561345221|FG001|Overall Study|Progression and death|0|||
155523837|NCT01367457|561345222|FG002|Overall Study|Progression and death|0|||
155523838|NCT01367457|561345220|FG000|Overall Study|Toxicity|16|||
155523839|NCT01367457|561345221|FG001|Overall Study|Toxicity|0|||
155523840|NCT01367457|561345222|FG002|Overall Study|Toxicity|0|||
155523841|NCT01367457|561345220|FG000|Overall Study|Progression|137|||
155523842|NCT01367457|561345221|FG001|Overall Study|Progression|0|||
155523843|NCT01367457|561345222|FG002|Overall Study|Progression|0|||
155523844|NCT01367457|561345220|FG000|Overall Study|Patient asks for rest + slow progression|1|||
155523845|NCT01367457|561345221|FG001|Overall Study|Patient asks for rest + slow progression|0|||
155523846|NCT01367457|561345222|FG002|Overall Study|Patient asks for rest + slow progression|0|||
155523847|NCT01367457|561345220|FG000|Overall Study|Investigator's opinion, stable disease|1|||
155523848|NCT01367457|561345221|FG001|Overall Study|Investigator's opinion, stable disease|0|||
155523849|NCT01367457|561345222|FG002|Overall Study|Investigator's opinion, stable disease|0|||
155523850|NCT01367457|561345220|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
155523851|NCT01367457|561345221|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
155523852|NCT01367457|561345222|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
155523853|NCT01367457|561345220|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
155523854|NCT01367457|561345221|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
155523855|NCT01367457|561345222|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
155523856|NCT01367457|561345220|FG000|Overall Study|low grade toxicities + stable disease|1|||
155523857|NCT01367457|561345221|FG001|Overall Study|low grade toxicities + stable disease|0|||
155523858|NCT01367457|561345222|FG002|Overall Study|low grade toxicities + stable disease|0|||
155523859|NCT01367457|561345220|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
155523860|NCT01367457|561345221|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
155523861|NCT01367457|561345222|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
155523862|NCT01367457|561345220|FG000|Overall Study|Withdrawal by Subject|1|||
155523863|NCT01367457|561345221|FG001|Overall Study|Withdrawal by Subject|0|||
155523864|NCT01367457|561345222|FG002|Overall Study|Withdrawal by Subject|0|||
155523865|NCT01367457|561345220|FG000|Overall Study|CD, associated leukaemia|1|||
155523866|NCT01367457|561345221|FG001|Overall Study|CD, associated leukaemia|0|||
155523867|NCT01367457|561345222|FG002|Overall Study|CD, associated leukaemia|0|||
155523868|NCT01367457|561345220|FG000|Overall Study|Uncontrolled pain|1|||
155523869|NCT01367457|561345221|FG001|Overall Study|Uncontrolled pain|0|||
155523870|NCT01367457|561345222|FG002|Overall Study|Uncontrolled pain|0|||
155523871|NCT01367457|561345220|FG000|Overall Study|Overall status worsens to grade 4|1|||
155523872|NCT01367457|561345221|FG001|Overall Study|Overall status worsens to grade 4|0|||
155523873|NCT01367457|561345222|FG002|Overall Study|Overall status worsens to grade 4|0|||
155523874|NCT01367457|561345220|FG000|Overall Study|Stabilisation + frequent infections|1|||
155523875|NCT01367457|561345221|FG001|Overall Study|Stabilisation + frequent infections|0|||
155523876|NCT01367457|561345222|FG002|Overall Study|Stabilisation + frequent infections|0|||
155523877|NCT01367457|561345220|FG000|Overall Study|No clinical benefit|1|||
155523878|NCT01367457|561345221|FG001|Overall Study|No clinical benefit|0|||
155523879|NCT01367457|561345222|FG002|Overall Study|No clinical benefit|0|||
155523880|NCT01367457|561345220|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
155523881|NCT01367457|561345221|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
155523882|NCT01367457|561345222|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
155523883|NCT01367457|561345220|FG000|Overall Study|Overall decline|1|||
155523884|NCT01367457|561345221|FG001|Overall Study|Overall decline|0|||
155523885|NCT01367457|561345222|FG002|Overall Study|Overall decline|0|||
155523886|NCT01367457|561345220|FG000|Overall Study|Rejection of treatment|1|||
155523887|NCT01367457|561345221|FG001|Overall Study|Rejection of treatment|0|||
155523888|NCT01367457|561345222|FG002|Overall Study|Rejection of treatment|0|||
155523889|NCT01367457|561345220|FG000|Overall Study|Lost to Follow-up|1|||
155523890|NCT01367457|561345221|FG001|Overall Study|Lost to Follow-up|0|||
155523891|NCT01367457|561345222|FG002|Overall Study|Lost to Follow-up|0|||
155523892|NCT01367457|561345220|FG000|Overall Study|Death from septic shock|1|||
155523893|NCT01367457|561345221|FG001|Overall Study|Death from septic shock|0|||
155523894|NCT01367457|561345222|FG002|Overall Study|Death from septic shock|0|||
155523895|NCT01367457|561345220|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
155523896|NCT01367457|561345221|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
155523897|NCT01367457|561345222|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
155523898|NCT01367457|561345220|FG000|Overall Study|Patient's Wish|1|||
155523899|NCT01367457|561345221|FG001|Overall Study|Patient's Wish|0|||
155523900|NCT01367457|561345222|FG002|Overall Study|Patient's Wish|0|||
155523901|NCT01367457|561345220|FG000|Overall Study|Palliative. Overall decline|1|||
155523902|NCT01367457|561345221|FG001|Overall Study|Palliative. Overall decline|0|||
155523903|NCT01367457|561345222|FG002|Overall Study|Palliative. Overall decline|0|||
155523904|NCT01367457|561345220|FG000|Overall Study|Suspected DP/suspected active infection|1|||
155523905|NCT01367457|561345221|FG001|Overall Study|Suspected DP/suspected active infection|0|||
155485873|NCT01072175|561201902|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485874|NCT01072175|561201903|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485875|NCT01072175|561201904|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485876|NCT01072175|561201905|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485877|NCT01072175|561201906|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
155485878|NCT01072175|561201907|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485879|NCT01072175|561201908|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485880|NCT01072175|561201909|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485881|NCT01072175|561201910|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
155485882|NCT01072175|561201898|FG000|Part D (HPMC Capsules)|Death|0|||
155485883|NCT01072175|561201899|FG001|Part D (HPMC Capsules)|Death|0|||
155485884|NCT01072175|561201900|FG002|Part D (HPMC Capsules)|Death|0|||
155485885|NCT01072175|561201901|FG003|Part D (HPMC Capsules)|Death|0|||
155485886|NCT01072175|561201902|FG004|Part D (HPMC Capsules)|Death|0|||
155485887|NCT01072175|561201903|FG005|Part D (HPMC Capsules)|Death|0|||
155485888|NCT01072175|561201904|FG006|Part D (HPMC Capsules)|Death|0|||
155485889|NCT01072175|561201905|FG007|Part D (HPMC Capsules)|Death|0|||
155485890|NCT01072175|561201906|FG008|Part D (HPMC Capsules)|Death|0|||
155485891|NCT01072175|561201907|FG009|Part D (HPMC Capsules)|Death|10|||
155485892|NCT01072175|561201908|FG010|Part D (HPMC Capsules)|Death|12|||
155485893|NCT01072175|561201909|FG011|Part D (HPMC Capsules)|Death|28|||
155485894|NCT01072175|561201910|FG012|Part D (HPMC Capsules)|Death|26|||
155485895|NCT01072175|561201898|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
155485896|NCT01072175|561201899|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
155485897|NCT01072175|561201900|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
155485898|NCT01072175|561201901|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
155485899|NCT01072175|561201902|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
155485900|NCT01072175|561201903|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
155485901|NCT01072175|561201904|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
155485902|NCT01072175|561201905|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
155485903|NCT01072175|561201906|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
155485904|NCT01072175|561201907|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
155485905|NCT01072175|561201908|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
155485906|NCT01072175|561201909|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
155485907|NCT01072175|561201910|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
155485908|NCT01072175|561201898|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485909|NCT01072175|561201899|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485910|NCT01072175|561201900|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485911|NCT01072175|561201901|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485912|NCT01072175|561201902|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485913|NCT01072175|561201903|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485914|NCT01072175|561201904|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485915|NCT01072175|561201905|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485916|NCT01072175|561201906|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485917|NCT01072175|561201907|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155485918|NCT01072175|561201908|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
155485919|NCT01072175|561201909|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
155485920|NCT01072175|561201910|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
155485921|NCT01072175|561201898|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485922|NCT01072175|561201899|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485923|NCT01072175|561201900|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485924|NCT01072175|561201901|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485925|NCT01072175|561201902|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485926|NCT01072175|561201903|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485927|NCT01072175|561201904|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485928|NCT01072175|561201905|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485929|NCT01072175|561201906|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
155485930|NCT01072175|561201907|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
155485931|NCT01072175|561201908|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
155485932|NCT01072175|561201909|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
155485933|NCT01072175|561201910|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
155485934|NCT01072175|561201898|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485935|NCT01072175|561201899|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485936|NCT01072175|561201900|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485937|NCT01072175|561201901|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485938|NCT01072175|561201902|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485939|NCT01072175|561201903|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485940|NCT01072175|561201904|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485941|NCT01072175|561201905|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485942|NCT01072175|561201906|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485943|NCT01072175|561201907|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485944|NCT01072175|561201908|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
155485945|NCT01072175|561201909|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
155485946|NCT01072175|561201910|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
155485947|NCT02839330|561201911|FG000|Overall Study|Adverse Event|0|||
155485948|NCT02839330|561201912|FG001|Overall Study|Adverse Event|1|||
155485949|NCT02839330|561201913|FG002|Overall Study|Adverse Event|2|||
155485950|NCT02839330|561201914|FG003|Overall Study|Adverse Event|2|||
155485951|NCT02839330|561201911|FG000|Overall Study|Death|4|||
155485952|NCT02839330|561201912|FG001|Overall Study|Death|6|||
155485953|NCT02839330|561201913|FG002|Overall Study|Death|1|||
155485954|NCT02839330|561201914|FG003|Overall Study|Death|1|||
155485955|NCT02839330|561201911|FG000|Overall Study|Withdrawal by Subject|27|||
155485956|NCT02839330|561201912|FG001|Overall Study|Withdrawal by Subject|19|||
155485957|NCT02839330|561201913|FG002|Overall Study|Withdrawal by Subject|11|||
155485958|NCT02839330|561201914|FG003|Overall Study|Withdrawal by Subject|13|||
155485959|NCT02839330|561201911|FG000|Overall Study|Lost to Follow-up|22|||
155485960|NCT02839330|561201912|FG001|Overall Study|Lost to Follow-up|27|||
155485961|NCT02839330|561201913|FG002|Overall Study|Lost to Follow-up|29|||
155485962|NCT02839330|561201914|FG003|Overall Study|Lost to Follow-up|25|||
155485963|NCT02839330|561201911|FG000|Overall Study|Administrative Reason|0|||
155485964|NCT02839330|561201912|FG001|Overall Study|Administrative Reason|0|||
155485965|NCT02839330|561201913|FG002|Overall Study|Administrative Reason|0|||
155485966|NCT02839330|561201914|FG003|Overall Study|Administrative Reason|1|||
155485967|NCT02839330|561201911|FG000|Overall Study|Protocol Violation|1|||
155485968|NCT02839330|561201912|FG001|Overall Study|Protocol Violation|2|||
155485969|NCT02839330|561201913|FG002|Overall Study|Protocol Violation|2|||
155485970|NCT02839330|561201914|FG003|Overall Study|Protocol Violation|3|||
155485971|NCT02839330|561201911|FG000|Overall Study|Other reason, not specified|4|||
155485972|NCT02839330|561201912|FG001|Overall Study|Other reason, not specified|3|||
155485973|NCT02839330|561201913|FG002|Overall Study|Other reason, not specified|3|||
155485974|NCT02839330|561201914|FG003|Overall Study|Other reason, not specified|6|||
155485975|NCT00438815|561201915|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
155485976|NCT00438815|561201915|FG000|Overall Study|3-month follow-up no longer required|12|||
155485977|NCT00438815|561201915|FG000|Overall Study|Noncompliance with protocol requirements|9|||
155485978|NCT00438815|561201915|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
155485979|NCT00438815|561201915|FG000|Overall Study|Lost to Follow-up|6|||
155485980|NCT00438815|561201915|FG000|Overall Study|Withdrawal by Subject|6|||
155485981|NCT00438815|561201915|FG000|Overall Study|Death|1|||
155485982|NCT01733758|561201916|FG000|Overall Study|Adverse Event|5|||
155485983|NCT01733758|561201917|FG001|Overall Study|Adverse Event|7|||
155485984|NCT01733758|561201918|FG002|Overall Study|Adverse Event|8|||
155485985|NCT01733758|561201919|FG003|Overall Study|Adverse Event|1|||
155485986|NCT01733758|561201916|FG000|Overall Study|Withdrawal by Subject|1|||
155485987|NCT01733758|561201917|FG001|Overall Study|Withdrawal by Subject|1|||
155485988|NCT01733758|561201918|FG002|Overall Study|Withdrawal by Subject|5|||
155485989|NCT01733758|561201919|FG003|Overall Study|Withdrawal by Subject|3|||
155485990|NCT01733758|561201916|FG000|Overall Study|Persistent Hyperglycemia|3|||
155485991|NCT01733758|561201917|FG001|Overall Study|Persistent Hyperglycemia|2|||
155485992|NCT01733758|561201918|FG002|Overall Study|Persistent Hyperglycemia|0|||
155485993|NCT01733758|561201919|FG003|Overall Study|Persistent Hyperglycemia|0|||
155485994|NCT01733758|561201916|FG000|Overall Study|Protocol Violation|0|||
155485995|NCT01733758|561201917|FG001|Overall Study|Protocol Violation|1|||
155485996|NCT01733758|561201918|FG002|Overall Study|Protocol Violation|2|||
155485997|NCT01733758|561201919|FG003|Overall Study|Protocol Violation|2|||
155485998|NCT01733758|561201916|FG000|Overall Study|Non-compliance|1|||
155485999|NCT01733758|561201917|FG001|Overall Study|Non-compliance|0|||
155486000|NCT01733758|561201918|FG002|Overall Study|Non-compliance|0|||
155486001|NCT01733758|561201919|FG003|Overall Study|Non-compliance|0|||
155486002|NCT01733758|561201916|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
155486003|NCT01733758|561201917|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
155486004|NCT01733758|561201918|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
155486005|NCT01733758|561201919|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
155486006|NCT01733758|561201916|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
155486007|NCT01733758|561201917|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
155486008|NCT01733758|561201918|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
155486009|NCT01733758|561201919|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
155486010|NCT02545270|561201924|FG000|Overall Study|technical difficulties|0|||
155486011|NCT02545270|561201925|FG001|Overall Study|technical difficulties|1|||
155523906|NCT01367457|561345222|FG002|Overall Study|Suspected DP/suspected active infection|0|||
155523907|NCT02495857|561345223|FG000|Overall Study|Adverse Event|5|||
155523908|NCT02495857|561345224|FG001|Overall Study|Adverse Event|0|||
155523909|NCT02495857|561345225|FG002|Overall Study|Adverse Event|1|||
155523910|NCT02495857|561345223|FG000|Overall Study|Withdrawal by Subject|9|||
155523911|NCT02495857|561345224|FG001|Overall Study|Withdrawal by Subject|6|||
155523912|NCT02495857|561345225|FG002|Overall Study|Withdrawal by Subject|10|||
155523913|NCT02495857|561345223|FG000|Overall Study|Physician Decision|0|||
155523914|NCT02495857|561345224|FG001|Overall Study|Physician Decision|1|||
155523915|NCT02495857|561345225|FG002|Overall Study|Physician Decision|0|||
155523916|NCT02495857|561345223|FG000|Overall Study|Protocol Violation|1|||
155523917|NCT02495857|561345224|FG001|Overall Study|Protocol Violation|1|||
155523918|NCT02495857|561345225|FG002|Overall Study|Protocol Violation|2|||
155523919|NCT02495857|561345223|FG000|Overall Study|Lost to Follow-up|4|||
155523920|NCT02495857|561345224|FG001|Overall Study|Lost to Follow-up|5|||
155523921|NCT02495857|561345225|FG002|Overall Study|Lost to Follow-up|3|||
155523922|NCT02495857|561345223|FG000|Overall Study|Other|3|||
155523923|NCT02495857|561345224|FG001|Overall Study|Other|3|||
155523924|NCT02495857|561345225|FG002|Overall Study|Other|2|||
155523925|NCT04407806|561345226|FG000|Overall Study|Withdrawal by Subject|1|||
155523926|NCT04407806|561345227|FG001|Overall Study|Withdrawal by Subject|2|||
155523927|NCT03447262|561345228|FG000|Overall Study|Adverse Event|7|||
155523928|NCT03447262|561345228|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
155523929|NCT03447262|561345228|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
155523930|NCT03447262|561345228|FG000|Overall Study|Death|2|||
155523931|NCT03447262|561345228|FG000|Overall Study|Study Termination by Sponsor|455|||
155523932|NCT03447262|561345228|FG000|Overall Study|Other|4|||
155523933|NCT02058498|561345229|FG000|Overall Study|Withdrawal by Subject|4|||
155523934|NCT05327491|561345230|FG000|Periods 1 & 2|Miscellaneous|0|||
155523935|NCT05327491|561345231|FG001|Periods 1 & 2|Miscellaneous|1|||
155523936|NCT05327491|561345232|FG002|Periods 1 & 2|Miscellaneous|0|||
155523937|NCT05327491|561345233|FG003|Periods 1 & 2|Miscellaneous|0|||
155523938|NCT05327491|561345230|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
155523939|NCT05327491|561345231|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
155523940|NCT05327491|561345232|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
155523941|NCT05327491|561345233|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
155523942|NCT05612724|561345234|FG000|Overall Study|Lost to Follow-up|4|||
155523943|NCT04000815|561345241|FG000|Overall Study|Lost to Follow-up|9|||
155523944|NCT04000815|561345242|FG001|Overall Study|Lost to Follow-up|2|||
155523945|NCT04000815|561345243|FG002|Overall Study|Lost to Follow-up|3|||
155523946|NCT04000815|561345241|FG000|Overall Study|Withdrawal by Subject|4|||
155523947|NCT04000815|561345242|FG001|Overall Study|Withdrawal by Subject|3|||
155523948|NCT04000815|561345243|FG002|Overall Study|Withdrawal by Subject|2|||
155523949|NCT04000815|561345241|FG000|Overall Study|Right ovarian cyst occured|1|||
155523950|NCT04000815|561345242|FG001|Overall Study|Right ovarian cyst occured|0|||
155523951|NCT04000815|561345243|FG002|Overall Study|Right ovarian cyst occured|0|||
155523952|NCT04000815|561345241|FG000|Overall Study|Hypertension occured on follow up|0|||
155523953|NCT04000815|561345242|FG001|Overall Study|Hypertension occured on follow up|0|||
155523954|NCT04000815|561345243|FG002|Overall Study|Hypertension occured on follow up|2|||
155523955|NCT00239577|561345244|FG000|Primary Phase|Adverse Event|0|||
155523956|NCT00239577|561345245|FG001|Primary Phase|Adverse Event|0|||
155523957|NCT00239577|561345246|FG002|Primary Phase|Adverse Event|1|||
155523958|NCT00239577|561345247|FG003|Primary Phase|Adverse Event|0|||
155523959|NCT00239577|561345244|FG000|Primary Phase|Other|5|||
155523960|NCT00239577|561345245|FG001|Primary Phase|Other|3|||
155523961|NCT00239577|561345246|FG002|Primary Phase|Other|2|||
155523962|NCT00239577|561345247|FG003|Primary Phase|Other|0|||
155523963|NCT02422264|561345250|FG000|Overall Study|Serious Adverse Event|1|||
155523964|NCT02422264|561345251|FG001|Overall Study|Serious Adverse Event|0|||
155654950|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
155523965|NCT02422264|561345250|FG000|Overall Study|Withdrawal by Subject|1|||
155523966|NCT02422264|561345251|FG001|Overall Study|Withdrawal by Subject|2|||
155523967|NCT02422264|561345250|FG000|Overall Study|Migrated/moved from study area|3|||
155523968|NCT02422264|561345251|FG001|Overall Study|Migrated/moved from study area|1|||
155523969|NCT02422264|561345250|FG000|Overall Study|Subject vaccinated outside of the study|0|||
155523970|NCT02422264|561345251|FG001|Overall Study|Subject vaccinated outside of the study|1|||
155523971|NCT03021018|561345253|FG000|Overall Study|Adverse Event|1|||
155523972|NCT03021018|561345254|FG001|Overall Study|Adverse Event|0|||
155523973|NCT03021018|561345255|FG002|Overall Study|Adverse Event|0|||
155523974|NCT03021018|561345253|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
155523975|NCT03021018|561345254|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
155523976|NCT03021018|561345255|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
155523977|NCT00050778|561345268|FG000|Overall Study|Adverse Event|13|||
155523978|NCT00050778|561345269|FG001|Overall Study|Adverse Event|3|||
155523979|NCT00050778|561345270|FG002|Overall Study|Adverse Event|2|||
155523980|NCT00050778|561345268|FG000|Overall Study|Death|0|||
155523981|NCT00050778|561345269|FG001|Overall Study|Death|1|||
155523982|NCT00050778|561345270|FG002|Overall Study|Death|1|||
155523983|NCT00050778|561345268|FG000|Overall Study|Lack of Efficacy|16|||
155523984|NCT00050778|561345269|FG001|Overall Study|Lack of Efficacy|2|||
155523985|NCT00050778|561345270|FG002|Overall Study|Lack of Efficacy|2|||
155523986|NCT00050778|561345268|FG000|Overall Study|Lost to Follow-up|0|||
155523987|NCT00050778|561345269|FG001|Overall Study|Lost to Follow-up|2|||
155523988|NCT00050778|561345270|FG002|Overall Study|Lost to Follow-up|4|||
155523989|NCT00050778|561345268|FG000|Overall Study|Physician Decision|3|||
155523990|NCT00050778|561345269|FG001|Overall Study|Physician Decision|0|||
155523991|NCT00050778|561345270|FG002|Overall Study|Physician Decision|2|||
155523992|NCT00050778|561345268|FG000|Overall Study|Protocol Violation|2|||
155523993|NCT00050778|561345269|FG001|Overall Study|Protocol Violation|0|||
155523994|NCT00050778|561345270|FG002|Overall Study|Protocol Violation|1|||
155523995|NCT00050778|561345268|FG000|Overall Study|Withdrawal by Subject|6|||
155523996|NCT00050778|561345269|FG001|Overall Study|Withdrawal by Subject|8|||
155523997|NCT00050778|561345270|FG002|Overall Study|Withdrawal by Subject|4|||
155523998|NCT00050778|561345268|FG000|Overall Study|Randomized but not treated|4|||
155523999|NCT00050778|561345269|FG001|Overall Study|Randomized but not treated|5|||
155524000|NCT00050778|561345270|FG002|Overall Study|Randomized but not treated|2|||
155524001|NCT00050778|561345268|FG000|Overall Study|Familial and personal reasons|1|||
155524002|NCT00050778|561345269|FG001|Overall Study|Familial and personal reasons|0|||
155524003|NCT00050778|561345270|FG002|Overall Study|Familial and personal reasons|0|||
155524004|NCT01536574|561345271|FG000|Overall Study|Adverse Event|4|||
155524005|NCT01536574|561345272|FG001|Overall Study|Adverse Event|5|||
155524006|NCT01536574|561345271|FG000|Overall Study|Withdrawal by Subject|1|||
155524007|NCT01536574|561345272|FG001|Overall Study|Withdrawal by Subject|2|||
155524008|NCT01536574|561345271|FG000|Overall Study|Lack of Efficacy|1|||
155524009|NCT01536574|561345272|FG001|Overall Study|Lack of Efficacy|0|||
155524010|NCT00834756|561345273|FG000|First Intervention|Adverse Event|1|||
155524011|NCT00834756|561345274|FG001|First Intervention|Adverse Event|0|||
155524012|NCT00834756|561345273|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
155524013|NCT00834756|561345274|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
155524014|NCT02193165|561345277|FG000|4 Week Product Use|Lost to Follow-up|1|||
155524015|NCT02193165|561345278|FG001|4 Week Product Use|Lost to Follow-up|1|||
155524016|NCT02193165|561345279|FG002|4 Week Product Use|Lost to Follow-up|1|||
155524017|NCT02193165|561345277|FG000|6 Week Product Use|Lost to Follow-up|0|||
155524018|NCT02193165|561345278|FG001|6 Week Product Use|Lost to Follow-up|1|||
155524019|NCT02193165|561345279|FG002|6 Week Product Use|Lost to Follow-up|0|||
155524020|NCT00579670|561345280|FG000|Overall Study|Death|1|||
155524021|NCT00579670|561345281|FG001|Overall Study|Death|0|||
155524022|NCT00579670|561345282|FG002|Overall Study|Death|0|||
155524023|NCT00579670|561345283|FG003|Overall Study|Death|0|||
155524024|NCT00579670|561345284|FG004|Overall Study|Death|0|||
155524025|NCT00579670|561345280|FG000|Overall Study|Adverse Event|1|||
155524026|NCT00579670|561345281|FG001|Overall Study|Adverse Event|0|||
155524027|NCT00579670|561345282|FG002|Overall Study|Adverse Event|1|||
155524028|NCT00579670|561345283|FG003|Overall Study|Adverse Event|2|||
155524029|NCT00579670|561345284|FG004|Overall Study|Adverse Event|0|||
155524030|NCT00579670|561345280|FG000|Overall Study|Lack of Efficacy|0|||
155524031|NCT00579670|561345281|FG001|Overall Study|Lack of Efficacy|0|||
155524032|NCT00579670|561345282|FG002|Overall Study|Lack of Efficacy|1|||
155524033|NCT00579670|561345283|FG003|Overall Study|Lack of Efficacy|14|||
155524034|NCT00579670|561345284|FG004|Overall Study|Lack of Efficacy|0|||
155524035|NCT00579670|561345280|FG000|Overall Study|Lost to Follow-up|0|||
155524036|NCT00579670|561345281|FG001|Overall Study|Lost to Follow-up|1|||
155524037|NCT00579670|561345282|FG002|Overall Study|Lost to Follow-up|0|||
155524038|NCT00579670|561345283|FG003|Overall Study|Lost to Follow-up|4|||
155524039|NCT00579670|561345284|FG004|Overall Study|Lost to Follow-up|0|||
155524040|NCT00579670|561345280|FG000|Overall Study|Other|0|||
155524041|NCT00579670|561345281|FG001|Overall Study|Other|0|||
155524042|NCT00579670|561345282|FG002|Overall Study|Other|1|||
155524043|NCT00579670|561345283|FG003|Overall Study|Other|2|||
155524044|NCT00579670|561345284|FG004|Overall Study|Other|0|||
155524045|NCT00579670|561345280|FG000|Overall Study|Withdrawal by Subject|0|||
155524046|NCT00579670|561345281|FG001|Overall Study|Withdrawal by Subject|0|||
155524047|NCT00579670|561345282|FG002|Overall Study|Withdrawal by Subject|1|||
155524048|NCT00579670|561345283|FG003|Overall Study|Withdrawal by Subject|0|||
155524049|NCT00579670|561345284|FG004|Overall Study|Withdrawal by Subject|0|||
155524050|NCT00986245|561345285|FG000|First Intervention|Poor compliance|8|||
155524051|NCT00986245|561345286|FG001|First Intervention|Poor compliance|4|||
155524052|NCT00986245|561345285|FG000|First Intervention|Lack of Efficacy|1|||
155524053|NCT00986245|561345286|FG001|First Intervention|Lack of Efficacy|2|||
155524054|NCT00986245|561345285|FG000|First Intervention|Withdrawal by Subject|0|||
155524055|NCT00986245|561345286|FG001|First Intervention|Withdrawal by Subject|1|||
155524056|NCT00986245|561345285|FG000|First Intervention|Protocol Violation|0|||
155524057|NCT00986245|561345286|FG001|First Intervention|Protocol Violation|1|||
155524058|NCT00986245|561345285|FG000|First Intervention|Out of indication|1|||
155524059|NCT00986245|561345286|FG001|First Intervention|Out of indication|0|||
155524060|NCT00986245|561345285|FG000|Second Intervention|Poor compliance|1|||
155524061|NCT00986245|561345286|FG001|Second Intervention|Poor compliance|0|||
155524062|NCT00986245|561345285|FG000|Second Intervention|Lost to Follow-up|1|||
155524063|NCT00986245|561345286|FG001|Second Intervention|Lost to Follow-up|0|||
155524064|NCT00986245|561345285|FG000|Second Intervention|Protocol Violation|0|||
155524065|NCT00986245|561345286|FG001|Second Intervention|Protocol Violation|1|||
155524066|NCT01941030|561345288|FG000|Overall Study|Death|3|||
155524067|NCT01941030|561345289|FG001|Overall Study|Death|2|||
155524068|NCT01941030|561345288|FG000|Overall Study|Lost to Follow-up|6|||
155524069|NCT01941030|561345289|FG001|Overall Study|Lost to Follow-up|5|||
155524070|NCT01941030|561345288|FG000|Overall Study|Withdrawal by Subject|4|||
155524071|NCT01941030|561345289|FG001|Overall Study|Withdrawal by Subject|6|||
155524072|NCT01722877|561345293|FG000|Overall Study|Death|1|||
155524073|NCT01722877|561345293|FG000|Overall Study|Lost to Follow-up|1|||
155524074|NCT03693430|561345294|FG000|Overall Study|Lost to Follow-up|3|||
155524075|NCT03693430|561345295|FG001|Overall Study|Lost to Follow-up|14|||
155524076|NCT03693430|561345294|FG000|Overall Study|Death|1|||
155524077|NCT03693430|561345295|FG001|Overall Study|Death|0|||
155524078|NCT03693430|561345294|FG000|Overall Study|Withdrawal by Subject|0|||
155524079|NCT03693430|561345295|FG001|Overall Study|Withdrawal by Subject|4|||
155524080|NCT00585689|561345296|FG000|Overall Study|Received different ABI-007 schedule|3|||
155524081|NCT00585689|561345296|FG000|Overall Study|Adverse Event|1|||
155524082|NCT00585689|561345296|FG000|Overall Study|Patient Declined Surgery|1|||
155524083|NCT00585689|561345296|FG000|Overall Study|Patient had unresectable disease|1|||
155524084|NCT00585689|561345296|FG000|Overall Study|Death|1|||
155524085|NCT02930005|561345298|FG000|Overall Study|Lost to Follow-up|1|||
155524086|NCT02930005|561345299|FG001|Overall Study|Lost to Follow-up|5|||
155524087|NCT02373098|561345300|FG000|Overall Study|Lost to Follow-up|1|||
155524088|NCT02373098|561345301|FG001|Overall Study|Lost to Follow-up|0|||
155524089|NCT02373098|561345300|FG000|Overall Study|Protocol Violation|3|||
155524090|NCT02373098|561345301|FG001|Overall Study|Protocol Violation|0|||
155524091|NCT02373098|561345300|FG000|Overall Study|Withdrawal by Subject|5|||
155524092|NCT02373098|561345301|FG001|Overall Study|Withdrawal by Subject|0|||
155524093|NCT02373098|561345300|FG000|Overall Study|Adverse Event|3|||
155524094|NCT02373098|561345301|FG001|Overall Study|Adverse Event|0|||
155524095|NCT05067647|561345302|FG000|Overall Study|Lost to Follow-up|1|||
155524096|NCT03639311|561345309|FG000|Maintenance Phase|Lost to Follow-up|1|||
155524097|NCT03639311|561345310|FG001|Maintenance Phase|Lost to Follow-up|0|||
155524098|NCT03639311|561345311|FG002|Maintenance Phase|Lost to Follow-up|0|||
155524099|NCT03639311|561345309|FG000|Maintenance Phase|Adverse Event|1|||
155524100|NCT03639311|561345310|FG001|Maintenance Phase|Adverse Event|0|||
155524101|NCT03639311|561345311|FG002|Maintenance Phase|Adverse Event|0|||
155524102|NCT03639311|561345309|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
155524103|NCT03639311|561345310|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
155524104|NCT03639311|561345311|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
155524105|NCT03639311|561345309|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
155524106|NCT03639311|561345310|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
155524107|NCT03639311|561345311|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
155524108|NCT03639311|561345309|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
155524109|NCT03639311|561345310|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
155524110|NCT03639311|561345311|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
155524111|NCT03639311|561345309|FG000|Maintenance Phase|Lack of Efficacy|1|||
155524112|NCT03639311|561345310|FG001|Maintenance Phase|Lack of Efficacy|0|||
155524113|NCT03639311|561345311|FG002|Maintenance Phase|Lack of Efficacy|0|||
155524114|NCT00855738|561345318|FG000|Overall Study|Lost to Follow-up|2|||
155524115|NCT00855738|561345318|FG000|Overall Study|Adverse Event|1|||
155524116|NCT00855738|561345318|FG000|Overall Study|Subject Defaulted|1|||
155524117|NCT00855738|561345318|FG000|Overall Study|Death|1|||
155524118|NCT00304083|561345322|FG000|Overall Study|Withdrawal by Subject|4|||
155524119|NCT00304083|561345323|FG001|Overall Study|Withdrawal by Subject|2|||
155524120|NCT00304083|561345322|FG000|Overall Study|Physician Decision|8|||
155524121|NCT00304083|561345323|FG001|Overall Study|Physician Decision|3|||
155524122|NCT00304083|561345322|FG000|Overall Study|Disease Progression|5|||
155524123|NCT00304083|561345323|FG001|Overall Study|Disease Progression|1|||
155524124|NCT00304083|561345322|FG000|Overall Study|Other|5|||
155524125|NCT00304083|561345323|FG001|Overall Study|Other|2|||
155524126|NCT03929393|561345324|FG000|Overall Study|Death|1|||
155524127|NCT03929393|561345325|FG001|Overall Study|Death|0|||
155524128|NCT03929393|561345324|FG000|Overall Study|Time Commitment|2|||
155524129|NCT03929393|561345325|FG001|Overall Study|Time Commitment|5|||
155524130|NCT03929393|561345324|FG000|Overall Study|Motor Vehicle Accident|0|||
155524131|NCT03929393|561345325|FG001|Overall Study|Motor Vehicle Accident|1|||
155524132|NCT03929393|561345324|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
155524133|NCT03929393|561345325|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
155524134|NCT03929393|561345324|FG000|Overall Study|Other|1|||
155524135|NCT03929393|561345325|FG001|Overall Study|Other|3|||
155524136|NCT00694551|561345336|FG000|Overall Study|Disease Progression|1|||
155524137|NCT00694551|561345337|FG001|Overall Study|Disease Progression|0|||
155524138|NCT00694551|561345338|FG002|Overall Study|Disease Progression|1|||
155524139|NCT01569152|561345350|FG000|Phase IIa, Period 1|Early Escape|5|||
155524140|NCT01569152|561345351|FG001|Phase IIa, Period 1|Early Escape|22|||
155524141|NCT01569152|561345352|FG002|Phase IIa, Period 1|Early Escape|0|||
155524142|NCT01569152|561345350|FG000|Phase IIa, Period 1|Adverse Event|4|||
155524143|NCT01569152|561345351|FG001|Phase IIa, Period 1|Adverse Event|0|||
155524144|NCT01569152|561345352|FG002|Phase IIa, Period 1|Adverse Event|0|||
155524145|NCT01569152|561345350|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
155524146|NCT01569152|561345351|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
155524147|NCT01569152|561345352|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
155524148|NCT01569152|561345350|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
155524149|NCT01569152|561345351|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
155524150|NCT01569152|561345352|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
155524151|NCT01569152|561345350|FG000|Phase IIa, Period 1|Protocol Violation|0|||
155524152|NCT01569152|561345351|FG001|Phase IIa, Period 1|Protocol Violation|1|||
155524153|NCT01569152|561345352|FG002|Phase IIa, Period 1|Protocol Violation|0|||
155524154|NCT01569152|561345350|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
155524155|NCT01569152|561345351|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
155524156|NCT01569152|561345352|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
155524157|NCT01569152|561345350|FG000|Safety Extension, Period 3|Adverse Event|0|||
155524158|NCT01569152|561345351|FG001|Safety Extension, Period 3|Adverse Event|0|||
155524159|NCT01569152|561345352|FG002|Safety Extension, Period 3|Adverse Event|4|||
155524160|NCT01569152|561345350|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
155524161|NCT01569152|561345351|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
155524162|NCT01569152|561345352|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
155524163|NCT01569152|561345350|FG000|Safety Extension, Period 3|Physician Decision|0|||
155524164|NCT01569152|561345351|FG001|Safety Extension, Period 3|Physician Decision|0|||
155524165|NCT01569152|561345352|FG002|Safety Extension, Period 3|Physician Decision|2|||
155524166|NCT01569152|561345350|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
155524167|NCT01569152|561345351|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
155524168|NCT01569152|561345352|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
155524169|NCT03262012|561345353|FG000|Overall Study|Withdrawal by Subject|15|||
155524170|NCT03262012|561345354|FG001|Overall Study|Withdrawal by Subject|13|||
155524171|NCT03262012|561345355|FG002|Overall Study|Withdrawal by Subject|8|||
155524172|NCT03262012|561345356|FG003|Overall Study|Withdrawal by Subject|7|||
155524173|NCT03262012|561345353|FG000|Overall Study|Adverse Event|10|||
155524174|NCT03262012|561345354|FG001|Overall Study|Adverse Event|12|||
155524175|NCT03262012|561345355|FG002|Overall Study|Adverse Event|4|||
155524176|NCT03262012|561345356|FG003|Overall Study|Adverse Event|6|||
155524177|NCT03262012|561345353|FG000|Overall Study|Physician Decision|2|||
155524178|NCT03262012|561345354|FG001|Overall Study|Physician Decision|5|||
155524179|NCT03262012|561345355|FG002|Overall Study|Physician Decision|1|||
155524180|NCT03262012|561345356|FG003|Overall Study|Physician Decision|0|||
155524181|NCT03262012|561345353|FG000|Overall Study|Lack of Efficacy|0|||
155524182|NCT03262012|561345354|FG001|Overall Study|Lack of Efficacy|5|||
155524183|NCT03262012|561345355|FG002|Overall Study|Lack of Efficacy|1|||
155524184|NCT03262012|561345356|FG003|Overall Study|Lack of Efficacy|2|||
155524185|NCT03262012|561345353|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
155524186|NCT03262012|561345354|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
155524187|NCT03262012|561345355|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
155524188|NCT03262012|561345356|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
155524189|NCT02682602|561345360|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
155524190|NCT02682602|561345361|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
155524191|NCT02682602|561345360|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
155524192|NCT02682602|561345361|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
155524193|NCT00377260|561346684|FG000|Overall Study|Lost to Follow-up|0|||
155524194|NCT00377260|561346685|FG001|Overall Study|Lost to Follow-up|1|||
155524195|NCT00377260|561346684|FG000|Overall Study|Withdrawal by Subject|2|||
155524196|NCT00377260|561346685|FG001|Overall Study|Withdrawal by Subject|4|||
155524197|NCT01015625|561346686|FG000|Overall Study|Lost to Follow-up|3|||
155524198|NCT01015625|561346687|FG001|Overall Study|Lost to Follow-up|1|||
155524199|NCT01015625|561346686|FG000|Overall Study|Withdrawal by Subject|2|||
155524200|NCT01015625|561346687|FG001|Overall Study|Withdrawal by Subject|3|||
155524201|NCT01015625|561346686|FG000|Overall Study|Physician Decision|2|||
155524202|NCT01015625|561346687|FG001|Overall Study|Physician Decision|0|||
155524203|NCT01015625|561346686|FG000|Overall Study|Death|30|||
155524204|NCT01015625|561346687|FG001|Overall Study|Death|22|||
155524205|NCT00569374|561346688|FG000|Overall Study|Withdrawal by Subject|4|||
155524206|NCT01196052|561346691|FG000|Overall Study|Adverse Event|9|||
155524207|NCT01196052|561346691|FG000|Overall Study|Lost to Follow-up|1|||
155524208|NCT01196052|561346691|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
155524209|NCT01196052|561346691|FG000|Overall Study|Reason not Specified|5|||
155524210|NCT01196052|561346691|FG000|Overall Study|Withdrawal by Subject|6|||
155524211|NCT03603314|561346692|FG000|Overall Study|Lost to Follow-up|0|||
155524212|NCT03603314|561346693|FG001|Overall Study|Lost to Follow-up|3|||
155524213|NCT03603314|561346694|FG002|Overall Study|Lost to Follow-up|0|||
155524214|NCT03603314|561346692|FG000|Overall Study|Protocol Violation|0|||
155524215|NCT03603314|561346693|FG001|Overall Study|Protocol Violation|1|||
155524216|NCT03603314|561346694|FG002|Overall Study|Protocol Violation|0|||
155524217|NCT03603314|561346692|FG000|Overall Study|Adverse Event|2|||
155524218|NCT03603314|561346693|FG001|Overall Study|Adverse Event|0|||
155524219|NCT03603314|561346694|FG002|Overall Study|Adverse Event|0|||
155524220|NCT03603314|561346692|FG000|Overall Study|Physician Decision|1|||
155524221|NCT03603314|561346693|FG001|Overall Study|Physician Decision|1|||
155524222|NCT03603314|561346694|FG002|Overall Study|Physician Decision|0|||
155524223|NCT03603314|561346692|FG000|Overall Study|Withdrawal by Subject|4|||
155524224|NCT03603314|561346693|FG001|Overall Study|Withdrawal by Subject|5|||
155524225|NCT03603314|561346694|FG002|Overall Study|Withdrawal by Subject|3|||
155524226|NCT03603314|561346692|FG000|Overall Study|Other|0|||
155524227|NCT03603314|561346693|FG001|Overall Study|Other|1|||
155524228|NCT03603314|561346694|FG002|Overall Study|Other|0|||
155524229|NCT03450070|561346695|FG000|Overall Study|Withdrawal by Subject|8|||
155524230|NCT02910037|561346696|FG000|Overall Study|Withdrawal by Subject|4|||
155524231|NCT02910037|561346696|FG000|Overall Study|Lost to Follow-up|6|||
155524232|NCT01035060|561346697|FG000|Overall Study|Lost to Follow-up|0|||
155524233|NCT01035060|561346698|FG001|Overall Study|Lost to Follow-up|7|||
155524234|NCT01035060|561346697|FG000|Overall Study|Did not quality after 2nd screening|14|||
155524235|NCT01035060|561346698|FG001|Overall Study|Did not quality after 2nd screening|1|||
155524236|NCT01035060|561346697|FG000|Overall Study|Withdrawal by Subject|8|||
155524237|NCT01035060|561346698|FG001|Overall Study|Withdrawal by Subject|6|||
155524238|NCT01035060|561346697|FG000|Overall Study|Physician Decision|2|||
155524239|NCT01035060|561346698|FG001|Overall Study|Physician Decision|0|||
155524240|NCT02015390|561346699|FG000|Overall Study|Lost to Follow-up|1|||
155524241|NCT02015390|561346700|FG001|Overall Study|Lost to Follow-up|0|||
155524242|NCT02015390|561346699|FG000|Overall Study|Adverse Event|0|||
155524243|NCT02015390|561346700|FG001|Overall Study|Adverse Event|3|||
155524244|NCT02015390|561346699|FG000|Overall Study|Physician Decision|0|||
155524245|NCT02015390|561346700|FG001|Overall Study|Physician Decision|1|||
155524246|NCT00064753|561346701|FG000|Overall Study|Death|251|||
155524247|NCT00064753|561346702|FG001|Overall Study|Death|242|||
155524248|NCT00064753|561346701|FG000|Overall Study|Withdrawal by Subject|198|||
155524249|NCT00064753|561346702|FG001|Overall Study|Withdrawal by Subject|171|||
155524250|NCT00064753|561346701|FG000|Overall Study|Lost to Follow-up|225|||
155524251|NCT00064753|561346702|FG001|Overall Study|Lost to Follow-up|235|||
155524252|NCT02193880|561346705|FG000|Overall Study|patients did not collect enough HPC|3|||
155524253|NCT02914600|561346709|FG000|Overall Study|Adverse Event|298|||
155524254|NCT02914600|561346710|FG001|Overall Study|Adverse Event|35|||
155524255|NCT02914600|561346711|FG002|Overall Study|Adverse Event|25|||
155654951|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
155524256|NCT02914600|561346709|FG000|Overall Study|Sponsors decision|287|||
155524257|NCT02914600|561346710|FG001|Overall Study|Sponsors decision|41|||
155524258|NCT02914600|561346711|FG002|Overall Study|Sponsors decision|12|||
155486012|NCT02545270|561201926|FG002|Overall Study|technical difficulties|0|||
155486013|NCT02545270|561201924|FG000|Overall Study|Videos being too similar to other|0|||
155486014|NCT02545270|561201925|FG001|Overall Study|Videos being too similar to other|0|||
155486015|NCT02545270|561201926|FG002|Overall Study|Videos being too similar to other|2|||
155486016|NCT00661362|561201927|FG000|Overall Study|Adverse Event|5|||
155486017|NCT00661362|561201928|FG001|Overall Study|Adverse Event|4|||
155486018|NCT00661362|561201927|FG000|Overall Study|Incorrect enrollment|2|||
155486019|NCT00661362|561201928|FG001|Overall Study|Incorrect enrollment|0|||
155486020|NCT00661362|561201927|FG000|Overall Study|Study specific discontinuation criteria|4|||
155486021|NCT00661362|561201928|FG001|Overall Study|Study specific discontinuation criteria|11|||
155486022|NCT00661362|561201927|FG000|Overall Study|Withdrawal by Subject|13|||
155486023|NCT00661362|561201928|FG001|Overall Study|Withdrawal by Subject|23|||
155486024|NCT00661362|561201927|FG000|Overall Study|Lost to Follow-up|3|||
155486025|NCT00661362|561201928|FG001|Overall Study|Lost to Follow-up|1|||
155486026|NCT00661362|561201927|FG000|Overall Study|Severe non-compliance to protocol|0|||
155486027|NCT00661362|561201928|FG001|Overall Study|Severe non-compliance to protocol|1|||
155486028|NCT00661362|561201927|FG000|Overall Study|Safety reasons|1|||
155486029|NCT00661362|561201928|FG001|Overall Study|Safety reasons|0|||
155486030|NCT00661362|561201927|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
155486031|NCT00661362|561201928|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
155486032|NCT00535262|561201931|FG000|Overall Study|No funding|3|||
155486033|NCT01707667|561201932|FG000|Period 1|expulsion of colonic sensor catheter|1|||
155486034|NCT01707667|561201933|FG001|Period 1|expulsion of colonic sensor catheter|0|||
155486035|NCT04382066|561201936|FG000|Overall Study|Adverse Event|1|||
155486036|NCT04382066|561201937|FG001|Overall Study|Adverse Event|0|||
155486037|NCT04382066|561201938|FG002|Overall Study|Adverse Event|0|||
155486038|NCT04382066|561201936|FG000|Overall Study|Death|1|||
155486039|NCT04382066|561201937|FG001|Overall Study|Death|0|||
155486040|NCT04382066|561201938|FG002|Overall Study|Death|1|||
155486041|NCT01430559|561201939|FG000|Overall Study|Adverse Event|7|||
155486042|NCT01430559|561201940|FG001|Overall Study|Adverse Event|3|||
155486043|NCT01430559|561201939|FG000|Overall Study|Entry criteria not met|1|||
155486044|NCT01430559|561201940|FG001|Overall Study|Entry criteria not met|1|||
155486045|NCT01430559|561201939|FG000|Overall Study|Lost to Follow-up|1|||
155486046|NCT01430559|561201940|FG001|Overall Study|Lost to Follow-up|0|||
155486047|NCT01430559|561201939|FG000|Overall Study|Medication error|1|||
155486048|NCT01430559|561201940|FG001|Overall Study|Medication error|0|||
155486049|NCT01430559|561201939|FG000|Overall Study|Withdrawal by Subject|3|||
155486050|NCT01430559|561201940|FG001|Overall Study|Withdrawal by Subject|2|||
155486051|NCT01430559|561201939|FG000|Overall Study|Protocol Violation|1|||
155486052|NCT01430559|561201940|FG001|Overall Study|Protocol Violation|0|||
155486053|NCT01430559|561201939|FG000|Overall Study|Other|3|||
155486054|NCT01430559|561201940|FG001|Overall Study|Other|3|||
155486055|NCT01430559|561201939|FG000|Overall Study|Randomized, Not Treated|3|||
155486056|NCT01430559|561201940|FG001|Overall Study|Randomized, Not Treated|3|||
155486057|NCT01220024|561201942|FG000|Overall Study|Lost to Follow-up|1|||
155486058|NCT01220024|561201943|FG001|Overall Study|Lost to Follow-up|1|||
155486059|NCT00174460|561201946|FG000|Overall Study|Withdrawal by Subject|0|||
155486060|NCT00174460|561201947|FG001|Overall Study|Withdrawal by Subject|1|||
155486061|NCT04225026|561201948|FG000|Overall Study|Withdrawal by Subject|4|||
155486062|NCT04225026|561201948|FG000|Overall Study|Adverse Event|1|||
155486063|NCT04225026|561201948|FG000|Overall Study|Other|1|||
155524259|NCT02914600|561346709|FG000|Overall Study|Withdrawal by Subject|158|||
155486064|NCT04225026|561201948|FG000|Overall Study|Death|11|||
155486065|NCT04225026|561201948|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
155486066|NCT00579059|561201949|FG000|Overall Study|Study Canceled at 1 Year|21|||
155486067|NCT00579059|561201950|FG001|Overall Study|Study Canceled at 1 Year|10|||
155486068|NCT04738123|561201953|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
155486069|NCT04738123|561201954|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
155486070|NCT04738123|561201953|FG000|Overall Study|Progressive Disease|0|||
155486071|NCT04738123|561201954|FG001|Overall Study|Progressive Disease|4|||
155524260|NCT02914600|561346710|FG001|Overall Study|Withdrawal by Subject|20|||
155486072|NCT04738123|561201953|FG000|Overall Study|Adverse Event|8|||
155486073|NCT04738123|561201954|FG001|Overall Study|Adverse Event|7|||
155486074|NCT04738123|561201953|FG000|Overall Study|Other Reasons|0|||
155486075|NCT04738123|561201954|FG001|Overall Study|Other Reasons|1|||
155486076|NCT04738123|561201953|FG000|Overall Study|Suicidal or assaultive behavior|0|||
155486077|NCT04738123|561201954|FG001|Overall Study|Suicidal or assaultive behavior|2|||
155524261|NCT02914600|561346711|FG002|Overall Study|Withdrawal by Subject|18|||
155524262|NCT02914600|561346709|FG000|Overall Study|Investigators discretion|169|||
155524263|NCT02914600|561346710|FG001|Overall Study|Investigators discretion|14|||
155524264|NCT02914600|561346711|FG002|Overall Study|Investigators discretion|13|||
155524265|NCT02914600|561346709|FG000|Overall Study|Lost to Follow-up|10|||
155524266|NCT02914600|561346710|FG001|Overall Study|Lost to Follow-up|4|||
155524267|NCT02914600|561346711|FG002|Overall Study|Lost to Follow-up|0|||
155524268|NCT02914600|561346709|FG000|Overall Study|Pregnancy|8|||
155524269|NCT02914600|561346710|FG001|Overall Study|Pregnancy|0|||
155524270|NCT02914600|561346711|FG002|Overall Study|Pregnancy|0|||
155524271|NCT02914600|561346709|FG000|Overall Study|Protocol Violation|5|||
155524272|NCT02914600|561346710|FG001|Overall Study|Protocol Violation|3|||
155524273|NCT02914600|561346711|FG002|Overall Study|Protocol Violation|0|||
155524274|NCT02914600|561346709|FG000|Overall Study|Non-compliance with study drug|6|||
155524275|NCT02914600|561346710|FG001|Overall Study|Non-compliance with study drug|1|||
155524276|NCT02914600|561346711|FG002|Overall Study|Non-compliance with study drug|0|||
155524277|NCT02914600|561346709|FG000|Overall Study|Death|3|||
155524278|NCT02914600|561346710|FG001|Overall Study|Death|1|||
155524279|NCT02914600|561346711|FG002|Overall Study|Death|1|||
155524280|NCT02914600|561346709|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
155524281|NCT02914600|561346710|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
155524282|NCT02914600|561346711|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
155524283|NCT02914600|561346709|FG000|Overall Study|Enrolled but not treated|1|||
155524284|NCT02914600|561346710|FG001|Overall Study|Enrolled but not treated|0|||
155524285|NCT02914600|561346711|FG002|Overall Study|Enrolled but not treated|0|||
155524286|NCT02457520|561346712|FG000|Active Treatment Phase|Adverse Event|10|||
155524287|NCT02457520|561346712|FG000|Active Treatment Phase|Lost to Follow-up|8|||
155524288|NCT02457520|561346712|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
155654952|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
155654953|NCT01432444|561830599|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
155654954|NCT01432444|561830600|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
155654955|NCT01432444|561830601|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
155654956|NCT01432444|561830599|FG000|Treatment Phase|Lost to Follow-up|0|||
155654957|NCT01432444|561830600|FG001|Treatment Phase|Lost to Follow-up|33|||
155654958|NCT01432444|561830601|FG002|Treatment Phase|Lost to Follow-up|0|||
155654959|NCT01432444|561830599|FG000|Treatment Phase|Adverse Event|0|||
155654960|NCT01432444|561830600|FG001|Treatment Phase|Adverse Event|37|||
155654961|NCT01432444|561830601|FG002|Treatment Phase|Adverse Event|0|||
155654962|NCT01432444|561830599|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
155654963|NCT01432444|561830600|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
155654964|NCT01432444|561830601|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
155654965|NCT01432444|561830599|FG000|Treatment Phase|Physician Decision|0|||
155654966|NCT01432444|561830600|FG001|Treatment Phase|Physician Decision|5|||
155654967|NCT01432444|561830601|FG002|Treatment Phase|Physician Decision|0|||
155654968|NCT01432444|561830599|FG000|Treatment Phase|Withdrawal by Subject|0|||
155654969|NCT01432444|561830600|FG001|Treatment Phase|Withdrawal by Subject|41|||
155654970|NCT01432444|561830601|FG002|Treatment Phase|Withdrawal by Subject|0|||
155654971|NCT01432444|561830599|FG000|Treatment Phase|Protocol Deviation|0|||
155654972|NCT01432444|561830600|FG001|Treatment Phase|Protocol Deviation|3|||
155654973|NCT01432444|561830601|FG002|Treatment Phase|Protocol Deviation|0|||
155654974|NCT01432444|561830599|FG000|Treatment Phase|Lack of Efficacy|0|||
155654975|NCT01432444|561830600|FG001|Treatment Phase|Lack of Efficacy|10|||
155654976|NCT01432444|561830601|FG002|Treatment Phase|Lack of Efficacy|0|||
155654977|NCT01432444|561830599|FG000|Extension Phase|Lost to Follow-up|0|||
155654978|NCT01432444|561830600|FG001|Extension Phase|Lost to Follow-up|0|||
155654979|NCT01432444|561830601|FG002|Extension Phase|Lost to Follow-up|17|||
155654980|NCT01432444|561830599|FG000|Extension Phase|Adverse Event|0|||
155654981|NCT01432444|561830600|FG001|Extension Phase|Adverse Event|0|||
155654982|NCT01432444|561830601|FG002|Extension Phase|Adverse Event|10|||
155654983|NCT01432444|561830599|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
155654984|NCT01432444|561830600|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
155654985|NCT01432444|561830601|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
155654986|NCT01432444|561830599|FG000|Extension Phase|Met Withdrawal Criteria|0|||
155654987|NCT01432444|561830600|FG001|Extension Phase|Met Withdrawal Criteria|0|||
155654988|NCT01432444|561830601|FG002|Extension Phase|Met Withdrawal Criteria|144|||
155524289|NCT02457520|561346712|FG000|Active Treatment Phase|other|4|||
155524290|NCT02457520|561346712|FG000|Active Treatment Phase|Physician Decision|1|||
155524291|NCT02457520|561346712|FG000|Active Treatment Phase|Protocol Violation|1|||
155524292|NCT02457520|561346712|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
155524293|NCT02457520|561346712|FG000|Post-treatment Period|Other: Retreatment Required|7|||
155524294|NCT02457520|561346712|FG000|Post-treatment Period|Lost to Follow-up|23|||
155654989|NCT01432444|561830599|FG000|Extension Phase|Physician Decision|0|||
155654990|NCT01432444|561830600|FG001|Extension Phase|Physician Decision|0|||
155654991|NCT01432444|561830601|FG002|Extension Phase|Physician Decision|1|||
155654992|NCT01432444|561830599|FG000|Extension Phase|Withdrawal by Subject|0|||
155486078|NCT04738123|561201953|FG000|Overall Study|Protocol Violation|2|||
155486079|NCT04738123|561201954|FG001|Overall Study|Protocol Violation|2|||
155486080|NCT04738123|561201953|FG000|Overall Study|Consent Withdrawn|35|||
155486081|NCT04738123|561201954|FG001|Overall Study|Consent Withdrawn|22|||
155486082|NCT00779506|561201955|FG000|Overall Study|Screening Failed|2|||
155486083|NCT00779506|561201955|FG000|Overall Study|Adverse Event|4|||
155524295|NCT02457520|561346712|FG000|Post-treatment Period|Other|3|||
155524296|NCT02457520|561346712|FG000|Post-treatment Period|Physician Decision|1|||
155524297|NCT02457520|561346712|FG000|Post-treatment Period|Withdrawal by Subject|14|||
155524298|NCT01772537|561346713|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
155524299|NCT01772537|561346714|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
155524300|NCT01772537|561346715|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
155524301|NCT00450190|561346716|FG000|Overall Study|Withdrawal by Subject|2|||
155524302|NCT01376167|561346717|FG000|Overall Study|Lost to Follow-up|2|||
155524303|NCT01376167|561346718|FG001|Overall Study|Lost to Follow-up|4|||
155524304|NCT01376167|561346719|FG002|Overall Study|Lost to Follow-up|2|||
155524305|NCT01376167|561346717|FG000|Overall Study|Physician Decision|1|||
155524306|NCT01376167|561346718|FG001|Overall Study|Physician Decision|1|||
155524307|NCT01376167|561346719|FG002|Overall Study|Physician Decision|0|||
155524308|NCT01376167|561346717|FG000|Overall Study|Withdrawal by Subject|1|||
155524309|NCT01376167|561346718|FG001|Overall Study|Withdrawal by Subject|5|||
155524310|NCT01376167|561346719|FG002|Overall Study|Withdrawal by Subject|4|||
155524311|NCT00296647|561346723|FG000|Overall Study|Death|4|||
155524312|NCT00296647|561346724|FG001|Overall Study|Death|1|||
155524313|NCT00296647|561346725|FG002|Overall Study|Death|2|||
155524314|NCT00296647|561346726|FG003|Overall Study|Death|1|||
155524315|NCT00296647|561346727|FG004|Overall Study|Death|1|||
155524316|NCT00296647|561346723|FG000|Overall Study|Withdrawal by Subject|28|||
155524317|NCT00296647|561346724|FG001|Overall Study|Withdrawal by Subject|27|||
155524318|NCT00296647|561346725|FG002|Overall Study|Withdrawal by Subject|32|||
155524319|NCT00296647|561346726|FG003|Overall Study|Withdrawal by Subject|16|||
155524320|NCT00296647|561346727|FG004|Overall Study|Withdrawal by Subject|19|||
155524321|NCT01863745|561346728|FG000|Overall Study|Disease Progression|9|||
155524322|NCT01863745|561346728|FG000|Overall Study|Adverse Event|2|||
155524323|NCT01863745|561346728|FG000|Overall Study|Death|1|||
155524324|NCT01863745|561346728|FG000|Overall Study|Withdrawal by Subject|1|||
155524325|NCT00610363|561346731|FG000|Overall Study|Non-compliance with protocol|0|||
155524326|NCT00610363|561346732|FG001|Overall Study|Non-compliance with protocol|1|||
155524327|NCT00610363|561346731|FG000|Overall Study|Adverse Event|3|||
155524328|NCT00610363|561346732|FG001|Overall Study|Adverse Event|1|||
155524329|NCT00610363|561346731|FG000|Overall Study|Lack of Efficacy|2|||
155524330|NCT00610363|561346732|FG001|Overall Study|Lack of Efficacy|0|||
155524331|NCT00610363|561346731|FG000|Overall Study|Lost to Follow-up|4|||
155524332|NCT00610363|561346732|FG001|Overall Study|Lost to Follow-up|0|||
155524333|NCT00610363|561346731|FG000|Overall Study|Withdrawal by Subject|1|||
155524334|NCT00610363|561346732|FG001|Overall Study|Withdrawal by Subject|0|||
155524335|NCT00610363|561346731|FG000|Overall Study|Other than specified above|1|||
155524336|NCT00610363|561346732|FG001|Overall Study|Other than specified above|1|||
155524337|NCT05093205|561346733|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
155524338|NCT05093205|561346734|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
155524339|NCT05093205|561346735|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
155524340|NCT05093205|561346736|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
155486084|NCT00779506|561201955|FG000|Overall Study|Lack of Efficacy|11|||
155486085|NCT00779506|561201955|FG000|Overall Study|Protocol Violation|5|||
155486086|NCT00779506|561201955|FG000|Overall Study|Withdrawal by Subject|6|||
155486087|NCT00779506|561201955|FG000|Overall Study|Lost to Follow-up|1|||
155486088|NCT03982069|561201956|FG000|Overall Study|Lost to Follow-up|5|||
155486089|NCT03982069|561201957|FG001|Overall Study|Lost to Follow-up|5|||
155524341|NCT05093205|561346737|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
155524342|NCT05093205|561346738|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
155524343|NCT05093205|561346739|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
155524344|NCT05093205|561346740|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
155524345|NCT05093205|561346741|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
155524346|NCT05093205|561346742|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
155524347|NCT05093205|561346743|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
155524348|NCT05093205|561346744|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
155524349|NCT05093205|561346745|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
155524350|NCT05093205|561346733|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524351|NCT05093205|561346734|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524352|NCT05093205|561346735|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
155524353|NCT05093205|561346736|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524354|NCT05093205|561346737|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524355|NCT05093205|561346738|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155486090|NCT03982069|561201958|FG002|Overall Study|Lost to Follow-up|3|||
155486091|NCT03982069|561201959|FG003|Overall Study|Lost to Follow-up|5|||
155486092|NCT03982069|561201956|FG000|Overall Study|Physician Decision|0|||
155524356|NCT05093205|561346739|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524357|NCT05093205|561346740|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524358|NCT05093205|561346741|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524359|NCT05093205|561346742|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524360|NCT05093205|561346743|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524361|NCT05093205|561346744|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524362|NCT05093205|561346745|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155524363|NCT05093205|561346733|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
155524364|NCT05093205|561346734|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
155524365|NCT05093205|561346735|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
155524366|NCT05093205|561346736|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
155524367|NCT05093205|561346737|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
155524368|NCT05093205|561346738|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
155524369|NCT05093205|561346739|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
155524370|NCT05093205|561346740|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
155524371|NCT05093205|561346741|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
155524372|NCT05093205|561346742|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
155524373|NCT05093205|561346743|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
155524374|NCT05093205|561346744|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
155524375|NCT05093205|561346745|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
155524376|NCT05093205|561346733|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
155524377|NCT05093205|561346734|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
155524378|NCT05093205|561346735|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
155524379|NCT05093205|561346736|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
155524380|NCT05093205|561346737|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
155524381|NCT05093205|561346738|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
155524382|NCT05093205|561346739|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
155524383|NCT05093205|561346740|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
155524384|NCT05093205|561346741|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
155524385|NCT05093205|561346742|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
155524386|NCT05093205|561346743|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
155524387|NCT05093205|561346744|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
155524388|NCT05093205|561346745|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
155524389|NCT05093205|561346733|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
155524390|NCT05093205|561346734|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
155524391|NCT05093205|561346735|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
155524392|NCT05093205|561346736|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
155524393|NCT05093205|561346737|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
155524394|NCT05093205|561346738|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
155524395|NCT05093205|561346739|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
155524396|NCT05093205|561346740|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
155524397|NCT05093205|561346741|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
155524398|NCT05093205|561346742|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
155524399|NCT05093205|561346743|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
155524400|NCT05093205|561346744|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
155524401|NCT05093205|561346745|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
155524402|NCT05093205|561346733|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
155524403|NCT05093205|561346734|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
155524404|NCT05093205|561346735|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
155524405|NCT05093205|561346736|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
155524406|NCT05093205|561346737|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
155524407|NCT05093205|561346738|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
155524408|NCT05093205|561346739|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
155524409|NCT05093205|561346740|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
155524410|NCT05093205|561346741|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
155524411|NCT05093205|561346742|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
155524412|NCT05093205|561346743|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
155524413|NCT05093205|561346744|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
155524414|NCT05093205|561346745|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
155524415|NCT05093205|561346733|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
155524416|NCT05093205|561346734|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
155524417|NCT05093205|561346735|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
155524418|NCT05093205|561346736|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
155524419|NCT05093205|561346737|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
155524420|NCT05093205|561346738|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
155524421|NCT05093205|561346739|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
155524422|NCT05093205|561346740|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
155524423|NCT05093205|561346741|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
155524424|NCT05093205|561346742|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
155524425|NCT05093205|561346743|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
155524426|NCT05093205|561346744|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
155524427|NCT05093205|561346745|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
155524428|NCT05093205|561346733|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
155524429|NCT05093205|561346734|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
155524430|NCT05093205|561346735|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
155524431|NCT05093205|561346736|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
155524432|NCT05093205|561346737|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
155524433|NCT05093205|561346738|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
155524434|NCT05093205|561346739|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
155524435|NCT05093205|561346740|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
155524436|NCT05093205|561346741|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
155524437|NCT05093205|561346742|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
155524438|NCT05093205|561346743|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
155524439|NCT05093205|561346744|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
155524440|NCT05093205|561346745|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
155524441|NCT05093205|561346733|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524442|NCT05093205|561346734|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524443|NCT05093205|561346735|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524444|NCT05093205|561346736|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524445|NCT05093205|561346737|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524446|NCT05093205|561346738|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524447|NCT05093205|561346739|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524448|NCT05093205|561346740|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524449|NCT05093205|561346741|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524450|NCT05093205|561346742|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
155524451|NCT05093205|561346743|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524452|NCT05093205|561346744|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524453|NCT05093205|561346745|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155524454|NCT05093205|561346733|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
155524455|NCT05093205|561346734|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
155524456|NCT05093205|561346735|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
155524457|NCT05093205|561346736|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
155524458|NCT05093205|561346737|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
155524459|NCT05093205|561346738|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
155524460|NCT05093205|561346739|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
155524461|NCT05093205|561346740|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
155524462|NCT05093205|561346741|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
155524463|NCT05093205|561346742|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
155524464|NCT05093205|561346743|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
155524465|NCT05093205|561346744|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
155524466|NCT05093205|561346745|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
155524467|NCT05093205|561346733|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524468|NCT05093205|561346734|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524469|NCT05093205|561346735|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524470|NCT05093205|561346736|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524471|NCT05093205|561346737|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524472|NCT05093205|561346738|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524473|NCT05093205|561346739|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524474|NCT05093205|561346740|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524475|NCT05093205|561346741|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524476|NCT05093205|561346742|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524477|NCT05093205|561346743|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
155524478|NCT05093205|561346744|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524479|NCT05093205|561346745|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155524480|NCT05093205|561346733|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524481|NCT05093205|561346734|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524482|NCT05093205|561346735|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524483|NCT05093205|561346736|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524484|NCT05093205|561346737|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524485|NCT05093205|561346738|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524486|NCT05093205|561346739|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524487|NCT05093205|561346740|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524488|NCT05093205|561346741|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524489|NCT05093205|561346742|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524490|NCT05093205|561346743|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524491|NCT05093205|561346744|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
155524492|NCT05093205|561346745|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
155524493|NCT05093205|561346733|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
155524494|NCT05093205|561346734|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
155524495|NCT05093205|561346735|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
155524496|NCT05093205|561346736|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
155524497|NCT05093205|561346737|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
155524498|NCT05093205|561346738|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
155524499|NCT05093205|561346739|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
155524500|NCT05093205|561346740|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
155524501|NCT05093205|561346741|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
155524502|NCT05093205|561346742|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
155524503|NCT05093205|561346743|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
155524504|NCT05093205|561346744|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
155524505|NCT05093205|561346745|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
155524506|NCT05093205|561346733|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524507|NCT05093205|561346734|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524508|NCT05093205|561346735|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524509|NCT05093205|561346736|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524510|NCT05093205|561346737|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524511|NCT05093205|561346738|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524512|NCT05093205|561346739|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524513|NCT05093205|561346740|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524514|NCT05093205|561346741|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524515|NCT05093205|561346742|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524516|NCT05093205|561346743|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524517|NCT05093205|561346744|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
155524518|NCT05093205|561346745|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
155524519|NCT03361228|561346755|FG000|Overall Study|Other|1|||
155524520|NCT03361228|561346756|FG001|Overall Study|Other|1|||
155524521|NCT03361228|561346755|FG000|Overall Study|Death|3|||
155524522|NCT03361228|561346756|FG001|Overall Study|Death|0|||
155524523|NCT02979353|561346760|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
155524524|NCT02979353|561346761|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
155524525|NCT02979353|561346760|FG000|Overall Study|Withdrawal by Subject|16|||
155524526|NCT02979353|561346761|FG001|Overall Study|Withdrawal by Subject|12|||
155524527|NCT02979353|561346760|FG000|Overall Study|Death|10|||
155524528|NCT02979353|561346761|FG001|Overall Study|Death|11|||
155524529|NCT02979353|561346760|FG000|Overall Study|Transfer to Hospice Care|19|||
155524530|NCT02979353|561346761|FG001|Overall Study|Transfer to Hospice Care|14|||
155524531|NCT02979353|561346760|FG000|Overall Study|Lost to Follow-up|1|||
155524532|NCT02979353|561346761|FG001|Overall Study|Lost to Follow-up|5|||
155524533|NCT00822926|561346766|FG000|Second Injection Visit|Lost to Follow-up|1|||
155524534|NCT00822926|561346767|FG001|Second Injection Visit|Lost to Follow-up|0|||
155524535|NCT00822926|561346766|FG000|Second Injection Visit|Withdrawal by Subject|0|||
155524536|NCT00822926|561346767|FG001|Second Injection Visit|Withdrawal by Subject|1|||
155524537|NCT01378975|561346768|FG000|Overall Study|Death|77|||
155654993|NCT01432444|561830600|FG001|Extension Phase|Withdrawal by Subject|0|||
155654994|NCT01432444|561830601|FG002|Extension Phase|Withdrawal by Subject|13|||
155654995|NCT02014467|561830602|FG000|Overall Study|Adverse Event|4|||
155524538|NCT01378975|561346769|FG001|Overall Study|Death|46|||
155524539|NCT01378975|561346768|FG000|Overall Study|Investigator Request|1|||
155524540|NCT01378975|561346769|FG001|Overall Study|Investigator Request|0|||
155524541|NCT01378975|561346768|FG000|Overall Study|Lost to Follow-up|4|||
155524542|NCT01378975|561346769|FG001|Overall Study|Lost to Follow-up|1|||
155524543|NCT01378975|561346768|FG000|Overall Study|Withdrew Consent|4|||
155524544|NCT01378975|561346769|FG001|Overall Study|Withdrew Consent|3|||
155524545|NCT03125200|561346776|FG000|Overall Study|Study Termination|0|||
155524546|NCT03125200|561346777|FG001|Overall Study|Study Termination|0|||
155524547|NCT03125200|561346778|FG002|Overall Study|Study Termination|0|||
155486093|NCT03982069|561201957|FG001|Overall Study|Physician Decision|1|||
155486094|NCT03982069|561201958|FG002|Overall Study|Physician Decision|0|||
155486095|NCT03982069|561201959|FG003|Overall Study|Physician Decision|0|||
155486096|NCT03982069|561201956|FG000|Overall Study|Withdrawal by Subject|2|||
155486097|NCT03982069|561201957|FG001|Overall Study|Withdrawal by Subject|1|||
155486098|NCT03982069|561201958|FG002|Overall Study|Withdrawal by Subject|5|||
155486099|NCT03982069|561201959|FG003|Overall Study|Withdrawal by Subject|2|||
155486100|NCT03982069|561201956|FG000|Overall Study|Specimen loss|3|||
155486101|NCT03982069|561201957|FG001|Overall Study|Specimen loss|3|||
155486102|NCT03982069|561201958|FG002|Overall Study|Specimen loss|1|||
155486103|NCT03982069|561201959|FG003|Overall Study|Specimen loss|1|||
155486104|NCT03137433|561201960|FG000|Overall Study|Withdrawal by Subject|11|||
155486105|NCT03137433|561201961|FG001|Overall Study|Withdrawal by Subject|11|||
155486106|NCT03137433|561201960|FG000|Overall Study|Lost to Follow-up|5|||
155486107|NCT03137433|561201961|FG001|Overall Study|Lost to Follow-up|6|||
155486108|NCT03137433|561201960|FG000|Overall Study|Physician Decision|2|||
155486109|NCT03137433|561201961|FG001|Overall Study|Physician Decision|0|||
155486110|NCT03137433|561201960|FG000|Overall Study|Moved out of study area|1|||
155486111|NCT03137433|561201961|FG001|Overall Study|Moved out of study area|0|||
155486112|NCT03137433|561201960|FG000|Overall Study|Too far out of window due to COVID|0|||
155486113|NCT03137433|561201961|FG001|Overall Study|Too far out of window due to COVID|1|||
155486114|NCT00914940|561201962|FG000|D0 to D100 Post-transplant|Death|2|||
155486115|NCT00914940|561201962|FG000|D101 to 2 Years Post-transplant|Death|8|||
155486116|NCT00914940|561201962|FG000|2 Years to 5 Years Post-transplant|Death|3|||
155486117|NCT01853397|561201963|FG000|Overall Study|Withdrawal by Subject|0|||
155486118|NCT01853397|561201964|FG001|Overall Study|Withdrawal by Subject|0|||
155486119|NCT01853397|561201965|FG002|Overall Study|Withdrawal by Subject|0|||
155486120|NCT01853397|561201966|FG003|Overall Study|Withdrawal by Subject|1|||
155486121|NCT01853397|561201963|FG000|Overall Study|Subject Noncompliance|0|||
155486122|NCT01853397|561201964|FG001|Overall Study|Subject Noncompliance|0|||
155486123|NCT01853397|561201965|FG002|Overall Study|Subject Noncompliance|0|||
155486124|NCT01853397|561201966|FG003|Overall Study|Subject Noncompliance|1|||
155486125|NCT01724021|561201967|FG000|Overall Study|Adverse Event|11|||
155486126|NCT01724021|561201968|FG001|Overall Study|Adverse Event|6|||
155486127|NCT01724021|561201967|FG000|Overall Study|Death|46|||
155486128|NCT01724021|561201968|FG001|Overall Study|Death|58|||
155486129|NCT01724021|561201967|FG000|Overall Study|Participant request/ Withdrew consent|18|||
155486130|NCT01724021|561201968|FG001|Overall Study|Participant request/ Withdrew consent|14|||
155486131|NCT01724021|561201967|FG000|Overall Study|Lost to Follow-up|15|||
155486132|NCT01724021|561201968|FG001|Overall Study|Lost to Follow-up|15|||
155486133|NCT01724021|561201967|FG000|Overall Study|Reason Not Specified|36|||
155486134|NCT01724021|561201968|FG001|Overall Study|Reason Not Specified|39|||
155486135|NCT01724021|561201967|FG000|Overall Study|Missing|1|||
155486136|NCT01724021|561201968|FG001|Overall Study|Missing|1|||
155486137|NCT01005875|561201969|FG000|Overall Study|Death|3|||
155486138|NCT00606931|561201970|FG000|Overall Study|Withdrawal by Subject|3|||
155486139|NCT00286234|561201971|FG000|Overall Study|Protocol Violation|1|||
155486140|NCT00286234|561201972|FG001|Overall Study|Protocol Violation|2|||
155486141|NCT00286234|561201973|FG002|Overall Study|Protocol Violation|0|||
155486142|NCT00286234|561201974|FG003|Overall Study|Protocol Violation|1|||
155486143|NCT00286234|561201971|FG000|Overall Study|Physician Decision|1|||
155486144|NCT00286234|561201972|FG001|Overall Study|Physician Decision|0|||
155486145|NCT00286234|561201973|FG002|Overall Study|Physician Decision|0|||
155486146|NCT00286234|561201974|FG003|Overall Study|Physician Decision|1|||
155486147|NCT00286234|561201971|FG000|Overall Study|Adverse Event|0|||
155486148|NCT00286234|561201972|FG001|Overall Study|Adverse Event|0|||
155486149|NCT00286234|561201973|FG002|Overall Study|Adverse Event|0|||
155486150|NCT00286234|561201974|FG003|Overall Study|Adverse Event|1|||
155486151|NCT00286234|561201971|FG000|Overall Study|Adverse Event|0|||
155486152|NCT00286234|561201972|FG001|Overall Study|Adverse Event|0|||
155486153|NCT00286234|561201973|FG002|Overall Study|Adverse Event|0|||
155486154|NCT00286234|561201974|FG003|Overall Study|Adverse Event|1|||
155486155|NCT03742271|561201983|FG000|Overall Study|Unsatisfactory Visual Response|1|||
155486156|NCT03742271|561201983|FG000|Overall Study|Withdrawal by Subject|3|||
155486157|NCT03742271|561201983|FG000|Overall Study|Lost to Follow-up|4|||
155486158|NCT03742271|561201983|FG000|Overall Study|Failed Insertion & removal|3|||
155486159|NCT03742271|561201983|FG000|Overall Study|Protocol Violation|1|||
155486160|NCT01468844|561201984|FG000|Overall Study|Adverse Event|1|||
155486161|NCT01468844|561201985|FG001|Overall Study|Adverse Event|0|||
155486162|NCT01468844|561201984|FG000|Overall Study|Withdrawal by Subject|1|||
155486163|NCT01468844|561201985|FG001|Overall Study|Withdrawal by Subject|0|||
155486164|NCT00266695|561201988|FG000|Overall Study|Adverse Event|1|||
155486165|NCT00266695|561201988|FG000|Overall Study|Death|9|||
155524548|NCT03125200|561346779|FG003|Overall Study|Study Termination|1|||
155524549|NCT03125200|561346780|FG004|Overall Study|Study Termination|1|||
155524550|NCT03125200|561346781|FG005|Overall Study|Study Termination|2|||
155524551|NCT03125200|561346782|FG006|Overall Study|Study Termination|1|||
155524552|NCT03125200|561346776|FG000|Overall Study|Clinical Progression|0|||
155524553|NCT03125200|561346777|FG001|Overall Study|Clinical Progression|0|||
155524554|NCT03125200|561346778|FG002|Overall Study|Clinical Progression|0|||
155524555|NCT03125200|561346779|FG003|Overall Study|Clinical Progression|1|||
155524556|NCT03125200|561346780|FG004|Overall Study|Clinical Progression|0|||
155524557|NCT03125200|561346781|FG005|Overall Study|Clinical Progression|1|||
155524558|NCT03125200|561346782|FG006|Overall Study|Clinical Progression|0|||
155524559|NCT03125200|561346776|FG000|Overall Study|Progressive Disease|2|||
155524560|NCT03125200|561346777|FG001|Overall Study|Progressive Disease|1|||
155524561|NCT03125200|561346778|FG002|Overall Study|Progressive Disease|2|||
155524562|NCT03125200|561346779|FG003|Overall Study|Progressive Disease|1|||
155524563|NCT03125200|561346780|FG004|Overall Study|Progressive Disease|2|||
155524564|NCT03125200|561346781|FG005|Overall Study|Progressive Disease|0|||
155524565|NCT03125200|561346782|FG006|Overall Study|Progressive Disease|1|||
155524566|NCT03125200|561346776|FG000|Overall Study|Lack of Efficacy|0|||
155524567|NCT03125200|561346777|FG001|Overall Study|Lack of Efficacy|0|||
155524568|NCT03125200|561346778|FG002|Overall Study|Lack of Efficacy|0|||
155524569|NCT03125200|561346779|FG003|Overall Study|Lack of Efficacy|1|||
155524570|NCT03125200|561346780|FG004|Overall Study|Lack of Efficacy|0|||
155524571|NCT03125200|561346781|FG005|Overall Study|Lack of Efficacy|0|||
155524572|NCT03125200|561346782|FG006|Overall Study|Lack of Efficacy|0|||
155524573|NCT03125200|561346776|FG000|Overall Study|Toxicity|0|||
155524574|NCT03125200|561346777|FG001|Overall Study|Toxicity|0|||
155524575|NCT03125200|561346778|FG002|Overall Study|Toxicity|0|||
155524576|NCT03125200|561346779|FG003|Overall Study|Toxicity|1|||
155524577|NCT03125200|561346780|FG004|Overall Study|Toxicity|0|||
155524578|NCT03125200|561346781|FG005|Overall Study|Toxicity|0|||
155524579|NCT03125200|561346782|FG006|Overall Study|Toxicity|0|||
155524580|NCT03125200|561346776|FG000|Overall Study|Consent Withdrawn by Subject|0|||
155524581|NCT03125200|561346777|FG001|Overall Study|Consent Withdrawn by Subject|1|||
155524582|NCT03125200|561346778|FG002|Overall Study|Consent Withdrawn by Subject|0|||
155524583|NCT03125200|561346779|FG003|Overall Study|Consent Withdrawn by Subject|0|||
155524584|NCT03125200|561346780|FG004|Overall Study|Consent Withdrawn by Subject|1|||
155524585|NCT03125200|561346781|FG005|Overall Study|Consent Withdrawn by Subject|0|||
155524586|NCT03125200|561346782|FG006|Overall Study|Consent Withdrawn by Subject|1|||
155524587|NCT00119379|561346783|FG000|Overall Study|Adverse Event|4|||
155524588|NCT00119379|561346784|FG001|Overall Study|Adverse Event|1|||
155524589|NCT01937390|561346794|FG000|Overall Study|Death|2|||
155524590|NCT01937390|561346794|FG000|Overall Study|Lost to Follow-up|7|||
155524591|NCT01937390|561346794|FG000|Overall Study|Withdrawal by Subject|5|||
155524592|NCT01937390|561346794|FG000|Overall Study|Fail to return|21|||
155524593|NCT03544138|561346795|FG000|Overall Study|Lost to Follow-up|29|||
155524594|NCT01706536|561346796|FG000|Overall Study|Withdrawal by Subject|1|||
155524595|NCT01706536|561346797|FG001|Overall Study|Withdrawal by Subject|0|||
155524596|NCT01706536|561346798|FG002|Overall Study|Withdrawal by Subject|1|||
155524597|NCT01706536|561346799|FG003|Overall Study|Withdrawal by Subject|0|||
155524598|NCT01706536|561346800|FG004|Overall Study|Withdrawal by Subject|0|||
155524599|NCT01706536|561346796|FG000|Overall Study|Adverse Event|2|||
155524600|NCT01706536|561346797|FG001|Overall Study|Adverse Event|3|||
155524601|NCT01706536|561346798|FG002|Overall Study|Adverse Event|4|||
155524602|NCT01706536|561346799|FG003|Overall Study|Adverse Event|3|||
155524603|NCT01706536|561346800|FG004|Overall Study|Adverse Event|2|||
155524604|NCT01706536|561346796|FG000|Overall Study|Lack of Efficacy|1|||
155524605|NCT01706536|561346797|FG001|Overall Study|Lack of Efficacy|0|||
155524606|NCT01706536|561346798|FG002|Overall Study|Lack of Efficacy|0|||
155524607|NCT01706536|561346799|FG003|Overall Study|Lack of Efficacy|1|||
155524608|NCT01706536|561346800|FG004|Overall Study|Lack of Efficacy|0|||
155524609|NCT01706536|561346796|FG000|Overall Study|non compliance|0|||
155524610|NCT01706536|561346797|FG001|Overall Study|non compliance|1|||
155524611|NCT01706536|561346798|FG002|Overall Study|non compliance|0|||
155524612|NCT01706536|561346799|FG003|Overall Study|non compliance|0|||
155524613|NCT01706536|561346800|FG004|Overall Study|non compliance|0|||
155524614|NCT04753437|561346807|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155524615|NCT04753437|561346808|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155524616|NCT04753437|561346807|FG000|Overall Study|Liver Function Test Abnormalities|2|||
155524617|NCT04753437|561346808|FG001|Overall Study|Liver Function Test Abnormalities|4|||
155524618|NCT00385684|561346809|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
155524619|NCT00385684|561346810|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
155524620|NCT00385684|561346809|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
155524621|NCT00385684|561346810|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
155524622|NCT00385684|561346809|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
155524623|NCT00385684|561346810|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
155524624|NCT00154102|561346811|FG000|Overall Study|investigational study phase ongoing|7|||
155524625|NCT00154102|561346812|FG001|Overall Study|investigational study phase ongoing|2|||
155524626|NCT00463606|561346813|FG000|Overall Study|Adverse Event|21|||
155524627|NCT00463606|561346814|FG001|Overall Study|Adverse Event|18|||
155524628|NCT00463606|561346815|FG002|Overall Study|Adverse Event|11|||
155524629|NCT00463606|561346813|FG000|Overall Study|Withdrawal by Subject|11|||
155524630|NCT00463606|561346814|FG001|Overall Study|Withdrawal by Subject|11|||
155524631|NCT00463606|561346815|FG002|Overall Study|Withdrawal by Subject|5|||
155524632|NCT00463606|561346813|FG000|Overall Study|Lost to Follow-up|2|||
155524633|NCT00463606|561346814|FG001|Overall Study|Lost to Follow-up|2|||
155524634|NCT00463606|561346815|FG002|Overall Study|Lost to Follow-up|3|||
155524635|NCT00463606|561346813|FG000|Overall Study|Subject noncompliance|1|||
155524636|NCT00463606|561346814|FG001|Overall Study|Subject noncompliance|1|||
155524637|NCT00463606|561346815|FG002|Overall Study|Subject noncompliance|0|||
155524638|NCT00463606|561346813|FG000|Overall Study|Subject moved out of town|1|||
155524639|NCT00463606|561346814|FG001|Overall Study|Subject moved out of town|0|||
155524640|NCT00463606|561346815|FG002|Overall Study|Subject moved out of town|0|||
155524641|NCT00463606|561346813|FG000|Overall Study|Physician Decision|0|||
155524642|NCT00463606|561346814|FG001|Overall Study|Physician Decision|1|||
155524643|NCT00463606|561346815|FG002|Overall Study|Physician Decision|0|||
155524644|NCT00463606|561346813|FG000|Overall Study|Sponsor request|0|||
155524645|NCT00463606|561346814|FG001|Overall Study|Sponsor request|1|||
155524646|NCT00463606|561346815|FG002|Overall Study|Sponsor request|0|||
155524647|NCT00463606|561346813|FG000|Overall Study|Exclusion criteria violation|2|||
155524648|NCT00463606|561346814|FG001|Overall Study|Exclusion criteria violation|0|||
155524649|NCT00463606|561346815|FG002|Overall Study|Exclusion criteria violation|0|||
155524650|NCT00463606|561346813|FG000|Overall Study|Coordinator error|1|||
155524651|NCT00463606|561346814|FG001|Overall Study|Coordinator error|0|||
155524652|NCT00463606|561346815|FG002|Overall Study|Coordinator error|0|||
155524653|NCT00463606|561346813|FG000|Overall Study|Patient randomized in error|1|||
155524654|NCT00463606|561346814|FG001|Overall Study|Patient randomized in error|0|||
155524655|NCT00463606|561346815|FG002|Overall Study|Patient randomized in error|0|||
155524656|NCT00463606|561346813|FG000|Overall Study|Participation in another ABT-335 trial|1|||
155524657|NCT00463606|561346814|FG001|Overall Study|Participation in another ABT-335 trial|0|||
155524658|NCT00463606|561346815|FG002|Overall Study|Participation in another ABT-335 trial|0|||
155524659|NCT00463606|561346813|FG000|Overall Study|Protocol Violation|0|||
155524660|NCT00463606|561346814|FG001|Overall Study|Protocol Violation|0|||
155524661|NCT00463606|561346815|FG002|Overall Study|Protocol Violation|1|||
155524662|NCT03567174|561346816|FG000|Overall Study|Death|24|||
155524663|NCT03567174|561346817|FG001|Overall Study|Death|31|||
155524664|NCT03567174|561346816|FG000|Overall Study|Lost to Follow-up|165|||
155524665|NCT03567174|561346817|FG001|Overall Study|Lost to Follow-up|174|||
155524666|NCT02140060|561346818|FG000|Overall Study|Adverse Event|0|||
155524667|NCT02140060|561346819|FG001|Overall Study|Adverse Event|0|||
155524668|NCT02140060|561346820|FG002|Overall Study|Adverse Event|0|||
155524669|NCT02140060|561346821|FG003|Overall Study|Adverse Event|1|||
155524670|NCT02140060|561346822|FG004|Overall Study|Adverse Event|1|||
155524671|NCT02140060|561346823|FG005|Overall Study|Adverse Event|1|||
155524672|NCT02140060|561346818|FG000|Overall Study|Lack of Efficacy|0|||
155524673|NCT02140060|561346819|FG001|Overall Study|Lack of Efficacy|0|||
155524674|NCT02140060|561346820|FG002|Overall Study|Lack of Efficacy|0|||
155524675|NCT02140060|561346821|FG003|Overall Study|Lack of Efficacy|1|||
155524676|NCT02140060|561346822|FG004|Overall Study|Lack of Efficacy|0|||
155524677|NCT02140060|561346823|FG005|Overall Study|Lack of Efficacy|0|||
155524678|NCT00723528|561348506|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524679|NCT00723528|561348507|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524680|NCT00723528|561348508|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
155524681|NCT00723528|561348509|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524682|NCT00723528|561348510|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524683|NCT00723528|561348511|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524684|NCT00723528|561348512|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
155524685|NCT00723528|561348506|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
155524686|NCT00723528|561348507|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524687|NCT00723528|561348508|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524688|NCT00723528|561348509|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524689|NCT00723528|561348510|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524690|NCT00723528|561348511|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524691|NCT00723528|561348512|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155524692|NCT00723528|561348506|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524693|NCT00723528|561348507|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524694|NCT00723528|561348508|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
155524695|NCT00723528|561348509|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524696|NCT00723528|561348510|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524697|NCT00723528|561348511|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524698|NCT00723528|561348512|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
155524699|NCT00723528|561348506|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524700|NCT00723528|561348507|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524701|NCT00723528|561348508|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
155524702|NCT00723528|561348509|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524703|NCT00723528|561348510|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524704|NCT00723528|561348511|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524705|NCT00723528|561348512|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155524706|NCT00723528|561348506|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
155524707|NCT00723528|561348507|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155524708|NCT00723528|561348508|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
155524709|NCT00723528|561348509|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155524710|NCT00723528|561348510|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155524711|NCT00723528|561348511|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155524712|NCT00723528|561348512|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155524713|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
155524714|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
155524715|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
155524716|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
155524717|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
155524718|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
155524719|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
155524720|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524721|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524722|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524723|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524724|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524725|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
155524726|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155524727|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Other|0|||
155524728|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Other|0|||
155524729|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Other|0|||
155524730|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Other|0|||
155524731|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Other|1|||
155524732|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Other|4|||
155524733|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Other|0|||
155524734|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Adverse Event|0|||
155524735|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Adverse Event|0|||
155524736|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Adverse Event|0|||
155524737|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Adverse Event|0|||
155524738|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Adverse Event|1|||
155524739|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Adverse Event|0|||
155524740|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Adverse Event|1|||
155524741|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524742|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524743|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524744|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524745|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524746|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
155524747|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
155524748|NCT00723528|561348506|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524749|NCT00723528|561348507|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524750|NCT00723528|561348508|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524751|NCT00723528|561348509|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524752|NCT00723528|561348510|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524753|NCT00723528|561348511|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
155524754|NCT00723528|561348512|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
155524755|NCT00667862|561348514|FG000|Overall Study|Adverse Event|9|||
155524756|NCT00667862|561348514|FG000|Overall Study|Death|1|||
155524757|NCT00667862|561348514|FG000|Overall Study|Disease Progression|22|||
155524758|NCT00667862|561348514|FG000|Overall Study|Withdrawal by Subject|3|||
155524759|NCT00667095|561348518|FG000|Overall Study|Withdrawal by Subject|0|||
155524760|NCT00667095|561348519|FG001|Overall Study|Withdrawal by Subject|1|||
155524761|NCT01435265|561348523|FG000|Overall Study|Lost to Follow-up|0|||
155524762|NCT01435265|561348524|FG001|Overall Study|Lost to Follow-up|1|||
155524763|NCT04605094|561348525|FG000|Overall Study|Adverse Event|2|||
155524764|NCT04605094|561348526|FG001|Overall Study|Adverse Event|2|||
155524765|NCT04605094|561348525|FG000|Overall Study|Lost to Follow-up|1|||
155524766|NCT04605094|561348526|FG001|Overall Study|Lost to Follow-up|4|||
155524767|NCT04605094|561348525|FG000|Overall Study|Physician Decision|2|||
155524768|NCT04605094|561348526|FG001|Overall Study|Physician Decision|2|||
155524769|NCT04605094|561348525|FG000|Overall Study|Study terminated by Sponsor|31|||
155524770|NCT04605094|561348526|FG001|Overall Study|Study terminated by Sponsor|33|||
155524771|NCT04605094|561348525|FG000|Overall Study|Withdrawal by Subject|22|||
155524772|NCT04605094|561348526|FG001|Overall Study|Withdrawal by Subject|19|||
155524773|NCT04605094|561348525|FG000|Overall Study|Other|1|||
155524774|NCT04605094|561348526|FG001|Overall Study|Other|1|||
155524775|NCT02724462|561348527|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
155524776|NCT02724462|561348528|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
155524777|NCT02724462|561348527|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
155524778|NCT02724462|561348528|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
155524779|NCT02724462|561348527|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
155524780|NCT02724462|561348528|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
155524781|NCT02724462|561348527|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
155524782|NCT02724462|561348528|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
155524783|NCT02724462|561348527|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
155524784|NCT02724462|561348528|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
155524785|NCT02724462|561348527|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
155524786|NCT02724462|561348528|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
155524787|NCT00469417|561348531|FG000|Overall Study|Treatment failure all lesions|18|||
155524788|NCT00469417|561348532|FG001|Overall Study|Treatment failure all lesions|11|||
155524789|NCT00469417|561348531|FG000|Overall Study|Consent withdrawn|1|||
155524790|NCT00469417|561348532|FG001|Overall Study|Consent withdrawn|1|||
155524791|NCT00469417|561348531|FG000|Overall Study|Adverse Event|8|||
155524792|NCT00469417|561348532|FG001|Overall Study|Adverse Event|2|||
155524793|NCT00469417|561348531|FG000|Overall Study|Lost to Follow-up|1|||
155524794|NCT00469417|561348532|FG001|Overall Study|Lost to Follow-up|2|||
155524795|NCT00469417|561348531|FG000|Overall Study|Intercurrent disease|0|||
155524796|NCT00469417|561348532|FG001|Overall Study|Intercurrent disease|1|||
155524797|NCT00469417|561348531|FG000|Overall Study|Randomized but not treated|2|||
155524798|NCT00469417|561348532|FG001|Overall Study|Randomized but not treated|0|||
155524799|NCT05038293|561348535|FG000|Overall Study|device was not operating properly for one subject.|1|||
155524800|NCT05038293|561348536|FG001|Overall Study|device was not operating properly for one subject.|0|||
155524801|NCT05038293|561348535|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
155524802|NCT05038293|561348536|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
155524803|NCT01171989|561348538|FG000|Overall Study|Lost to Follow-up|0|||
155524804|NCT01171989|561348539|FG001|Overall Study|Lost to Follow-up|0|||
155524805|NCT01171989|561348540|FG002|Overall Study|Lost to Follow-up|1|||
155524806|NCT01247701|561348542|FG000|Overall Study|Death|2|||
155524807|NCT01247701|561348542|FG000|Overall Study|Relapsed|8|||
155524808|NCT01034358|561348543|FG000|Overall Study|Withdrawal by Subject|1|||
155524809|NCT01034358|561348543|FG000|Overall Study|Protocol Violation|1|||
155524810|NCT01838941|561348544|FG000|Overall Study|Adverse Event|1|||
155524811|NCT01838941|561348544|FG000|Overall Study|Withdrawal by Subject|1|||
155524812|NCT02822235|561348545|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
155524813|NCT02822235|561348546|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
155524814|NCT02822235|561348545|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
155524815|NCT02822235|561348546|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
155486166|NCT00266695|561201988|FG000|Overall Study|Physician Decision|1|||
155486167|NCT00266695|561201988|FG000|Overall Study|Lost to Follow-up|3|||
155486168|NCT00266695|561201988|FG000|Overall Study|Withdrawal by Subject|15|||
155486169|NCT02853318|561201989|FG000|Overall Study|Withdrawal by Subject|1|||
155486170|NCT04490499|561201990|FG000|Overall Study|Withdrawal by Subject|2|||
155486171|NCT03125902|561201993|FG000|Overall Study|Adverse Event|0|||
155486172|NCT03125902|561201994|FG001|Overall Study|Adverse Event|1|||
155486173|NCT03125902|561201993|FG000|Overall Study|Death|119|||
155486174|NCT03125902|561201994|FG001|Overall Study|Death|229|||
155486175|NCT03125902|561201993|FG000|Overall Study|Lost to Follow-up|4|||
155486176|NCT03125902|561201994|FG001|Overall Study|Lost to Follow-up|13|||
155486177|NCT03125902|561201993|FG000|Overall Study|Other|0|||
155486178|NCT03125902|561201994|FG001|Overall Study|Other|4|||
155486179|NCT03125902|561201993|FG000|Overall Study|Physician Decision|2|||
155486180|NCT03125902|561201994|FG001|Overall Study|Physician Decision|1|||
155486181|NCT03125902|561201993|FG000|Overall Study|Progressive Disease|0|||
155486182|NCT03125902|561201994|FG001|Overall Study|Progressive Disease|3|||
155486183|NCT03125902|561201993|FG000|Overall Study|Study Terminated By Sponsor|74|||
155486184|NCT03125902|561201994|FG001|Overall Study|Study Terminated By Sponsor|143|||
155486185|NCT03125902|561201993|FG000|Overall Study|Withdrawal by Subject|21|||
155486186|NCT03125902|561201994|FG001|Overall Study|Withdrawal by Subject|37|||
155486187|NCT01843933|561201995|FG000|Overall Study|Data lost|6|||
155486188|NCT01843933|561201996|FG001|Overall Study|Data lost|4|||
155486189|NCT00440232|561201999|FG000|Overall Study|Lost to Follow-up|1|||
155486190|NCT00440232|561202000|FG001|Overall Study|Lost to Follow-up|1|||
155486191|NCT00440232|561201999|FG000|Overall Study|Unable to treat within allowed time|0|||
155486192|NCT00440232|561202000|FG001|Overall Study|Unable to treat within allowed time|1|||
155486193|NCT00440232|561201999|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
155486194|NCT00440232|561202000|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
155486195|NCT00819052|561202001|FG000|Overall Study|Adverse Event|0|||
155486196|NCT00819052|561202002|FG001|Overall Study|Adverse Event|5|||
155486197|NCT00819052|561202001|FG000|Overall Study|Protocol Violation|1|||
155486198|NCT00819052|561202002|FG001|Overall Study|Protocol Violation|2|||
155486199|NCT00819052|561202001|FG000|Overall Study|Lost to Follow-up|1|||
155486200|NCT00819052|561202002|FG001|Overall Study|Lost to Follow-up|2|||
155486201|NCT00819052|561202001|FG000|Overall Study|Withdrawal by Subject|1|||
155486202|NCT00819052|561202002|FG001|Overall Study|Withdrawal by Subject|2|||
155486203|NCT00819052|561202001|FG000|Overall Study|Lack of Efficacy|1|||
155486204|NCT00819052|561202002|FG001|Overall Study|Lack of Efficacy|1|||
155486205|NCT00819052|561202001|FG000|Overall Study|Pregnancy|1|||
155486206|NCT00819052|561202002|FG001|Overall Study|Pregnancy|2|||
155486207|NCT00819052|561202001|FG000|Overall Study|Death or events leading to death|1|||
155486208|NCT00819052|561202002|FG001|Overall Study|Death or events leading to death|0|||
155486209|NCT00362297|561202003|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
155486210|NCT00362297|561202004|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
155486211|NCT03512028|561202005|FG000|Overall Study|Withdrawal by Subject|2|||
155486212|NCT03512028|561202006|FG001|Overall Study|Withdrawal by Subject|0|||
155486213|NCT03512028|561202005|FG000|Overall Study|Protocol Violation|2|||
155486214|NCT03512028|561202006|FG001|Overall Study|Protocol Violation|0|||
155486215|NCT03529162|561202007|FG000|Overall Study|Lost to Follow-up|2|||
155486216|NCT03529162|561202008|FG001|Overall Study|Lost to Follow-up|2|||
155486217|NCT00517634|561202011|FG000|Second Treatment Period|Withdrawal by Subject|0|||
155486218|NCT00517634|561202012|FG001|Second Treatment Period|Withdrawal by Subject|0|||
155486219|NCT00517634|561202013|FG002|Second Treatment Period|Withdrawal by Subject|0|||
155654996|NCT02014467|561830603|FG001|Overall Study|Adverse Event|0|||
155486220|NCT00517634|561202014|FG003|Second Treatment Period|Withdrawal by Subject|0|||
155486221|NCT00517634|561202015|FG004|Second Treatment Period|Withdrawal by Subject|1|||
155486222|NCT00517634|561202016|FG005|Second Treatment Period|Withdrawal by Subject|0|||
155486223|NCT00701064|561202017|FG000|Overall Study|Protocol Violation|1|||
155486224|NCT00701064|561202018|FG001|Overall Study|Protocol Violation|1|||
155486225|NCT00701064|561202017|FG000|Overall Study|Withdrawal by Subject|1|||
155486226|NCT00701064|561202018|FG001|Overall Study|Withdrawal by Subject|1|||
155486227|NCT00701064|561202017|FG000|Overall Study|initiated other PTSD treatment|2|||
155486228|NCT00701064|561202018|FG001|Overall Study|initiated other PTSD treatment|2|||
155486229|NCT02098733|561202019|FG000|Overall Study|Data Not Available|5|||
155486230|NCT02098733|561202019|FG000|Overall Study|Lost to Follow-up|5|||
155486231|NCT00939094|561202020|FG000|Overall Study|Adverse Event|9|||
155486232|NCT00939094|561202021|FG001|Overall Study|Adverse Event|0|||
155486233|NCT00939094|561202020|FG000|Overall Study|Withdrawal by Subject|1|||
155486234|NCT00939094|561202021|FG001|Overall Study|Withdrawal by Subject|6|||
155486235|NCT00939094|561202020|FG000|Overall Study|Lost to Follow-up|1|||
155486236|NCT00939094|561202021|FG001|Overall Study|Lost to Follow-up|1|||
155486237|NCT00939094|561202020|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155486238|NCT00939094|561202021|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155486239|NCT00939094|561202020|FG000|Overall Study|Severe non-compliance to protocol|0|||
155486240|NCT00939094|561202021|FG001|Overall Study|Severe non-compliance to protocol|1|||
155486241|NCT00939094|561202020|FG000|Overall Study|Study stopped by sponsor|0|||
155486242|NCT00939094|561202021|FG001|Overall Study|Study stopped by sponsor|2|||
155486243|NCT00939094|561202020|FG000|Overall Study|Abnormal ECG findings|1|||
155486244|NCT00939094|561202021|FG001|Overall Study|Abnormal ECG findings|0|||
155486245|NCT01078389|561203708|FG000|Overall Study|Adverse Event|10|||
155486246|NCT01078389|561203709|FG001|Overall Study|Adverse Event|6|||
155486247|NCT01078389|561203708|FG000|Overall Study|Major Protocol Deviation|2|||
155486248|NCT01078389|561203709|FG001|Overall Study|Major Protocol Deviation|0|||
155486249|NCT01078389|561203708|FG000|Overall Study|Lost to Follow-up|23|||
155486250|NCT01078389|561203709|FG001|Overall Study|Lost to Follow-up|23|||
155486251|NCT01078389|561203708|FG000|Overall Study|Voluntary Withdrawal|20|||
155486252|NCT01078389|561203709|FG001|Overall Study|Voluntary Withdrawal|36|||
155486253|NCT01078389|561203708|FG000|Overall Study|Other|9|||
155486254|NCT01078389|561203709|FG001|Overall Study|Other|2|||
155486255|NCT02361307|561203710|FG000|Overall Study|Unstable medical condition.|0|||
155486256|NCT02361307|561203711|FG001|Overall Study|Unstable medical condition.|1|||
155486257|NCT00421928|561203712|FG000|Overall Study|Adverse Event|61|||
155486258|NCT00421928|561203713|FG001|Overall Study|Adverse Event|140|||
155486259|NCT00421928|561203714|FG002|Overall Study|Adverse Event|22|||
155486260|NCT00421928|561203712|FG000|Overall Study|Lost to Follow-up|5|||
155486261|NCT00421928|561203713|FG001|Overall Study|Lost to Follow-up|0|||
155486262|NCT00421928|561203714|FG002|Overall Study|Lost to Follow-up|3|||
155486263|NCT00421928|561203712|FG000|Overall Study|Withdrawal by Subject|50|||
155486264|NCT00421928|561203713|FG001|Overall Study|Withdrawal by Subject|48|||
155486265|NCT00421928|561203714|FG002|Overall Study|Withdrawal by Subject|43|||
155486266|NCT00421928|561203712|FG000|Overall Study|Lack of Efficacy|15|||
155486267|NCT00421928|561203713|FG001|Overall Study|Lack of Efficacy|7|||
155486268|NCT00421928|561203714|FG002|Overall Study|Lack of Efficacy|35|||
155486269|NCT00421928|561203712|FG000|Overall Study|Study drug non-compliant|6|||
155486270|NCT00421928|561203713|FG001|Overall Study|Study drug non-compliant|7|||
155486271|NCT00421928|561203714|FG002|Overall Study|Study drug non-compliant|4|||
155486272|NCT00421928|561203712|FG000|Overall Study|All other|26|||
155486273|NCT00421928|561203713|FG001|Overall Study|All other|21|||
155486274|NCT00421928|561203714|FG002|Overall Study|All other|27|||
155486275|NCT00421928|561203712|FG000|Overall Study|Death|0|||
155486276|NCT00421928|561203713|FG001|Overall Study|Death|1|||
155486277|NCT00421928|561203714|FG002|Overall Study|Death|0|||
155486278|NCT01545375|561203716|FG000|Overall Study|Adverse Event|2|||
155486279|NCT01545375|561203717|FG001|Overall Study|Adverse Event|1|||
155486280|NCT01545375|561203716|FG000|Overall Study|Lost to Follow-up|34|||
155486281|NCT01545375|561203717|FG001|Overall Study|Lost to Follow-up|31|||
155486282|NCT01545375|561203716|FG000|Overall Study|Protocol Violation|3|||
155486283|NCT01545375|561203717|FG001|Overall Study|Protocol Violation|3|||
155486284|NCT01545375|561203716|FG000|Overall Study|Withdrawal by Subject|58|||
155486285|NCT01545375|561203717|FG001|Overall Study|Withdrawal by Subject|55|||
155486286|NCT04177862|561203719|FG000|Overall Study|Protocol Violation|2|||
155486287|NCT04177862|561203720|FG001|Overall Study|Protocol Violation|7|||
155486288|NCT05637515|561203721|FG000|Overall Study|Withdrawal by Subject|17|||
155486289|NCT05637515|561203722|FG001|Overall Study|Withdrawal by Subject|17|||
155486290|NCT03233009|561203723|FG000|Overall Study|Lost to Follow-up|1|||
155486291|NCT04516291|561203725|FG000|Treatment Period (24 Weeks)|Other|1|||
155486292|NCT04516291|561203726|FG001|Treatment Period (24 Weeks)|Other|0|||
155486293|NCT04516291|561203727|FG002|Treatment Period (24 Weeks)|Other|0|||
155486294|NCT04516291|561203728|FG003|Treatment Period (24 Weeks)|Other|2|||
155486295|NCT04516291|561203729|FG004|Treatment Period (24 Weeks)|Other|2|||
155486296|NCT04516291|561203730|FG005|Treatment Period (24 Weeks)|Other|4|||
155524816|NCT02822235|561348545|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
155524817|NCT02822235|561348546|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
155524818|NCT02822235|561348545|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
155524819|NCT02822235|561348546|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
155486297|NCT04516291|561203731|FG006|Treatment Period (24 Weeks)|Other|2|||
155486298|NCT04516291|561203732|FG007|Treatment Period (24 Weeks)|Other|0|||
155486299|NCT04516291|561203725|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155486300|NCT04516291|561203726|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
155486301|NCT04516291|561203727|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155486302|NCT04516291|561203728|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155486303|NCT04516291|561203729|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155486304|NCT04516291|561203730|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155486305|NCT04516291|561203731|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155486306|NCT04516291|561203732|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155486307|NCT04516291|561203725|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486308|NCT04516291|561203726|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486309|NCT04516291|561203727|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486310|NCT04516291|561203728|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
155486311|NCT04516291|561203729|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486312|NCT04516291|561203730|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486313|NCT04516291|561203731|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486314|NCT04516291|561203732|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
155486315|NCT04516291|561203725|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486316|NCT04516291|561203726|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155486317|NCT04516291|561203727|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486318|NCT04516291|561203728|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486319|NCT04516291|561203729|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486320|NCT04516291|561203730|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486321|NCT04516291|561203731|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486322|NCT04516291|561203732|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155486323|NCT04516291|561203725|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
155486324|NCT04516291|561203726|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
155486325|NCT04516291|561203727|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
155486326|NCT04516291|561203728|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
155486327|NCT04516291|561203729|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
155486328|NCT04516291|561203730|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
155486329|NCT04516291|561203731|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
155486330|NCT04516291|561203732|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
155486331|NCT04516291|561203725|FG000|Follow-up Period (12 Weeks)|Other|0|||
155486332|NCT04516291|561203726|FG001|Follow-up Period (12 Weeks)|Other|1|||
155486333|NCT04516291|561203727|FG002|Follow-up Period (12 Weeks)|Other|0|||
155486334|NCT04516291|561203728|FG003|Follow-up Period (12 Weeks)|Other|2|||
155486335|NCT04516291|561203729|FG004|Follow-up Period (12 Weeks)|Other|0|||
155486336|NCT04516291|561203730|FG005|Follow-up Period (12 Weeks)|Other|0|||
155486337|NCT04516291|561203731|FG006|Follow-up Period (12 Weeks)|Other|0|||
155486338|NCT04516291|561203732|FG007|Follow-up Period (12 Weeks)|Other|0|||
155486339|NCT04516291|561203725|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486340|NCT04516291|561203726|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486341|NCT04516291|561203727|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486342|NCT04516291|561203728|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486343|NCT04516291|561203729|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
155486344|NCT04516291|561203730|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486345|NCT04516291|561203731|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486346|NCT04516291|561203732|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155486347|NCT04516291|561203725|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486348|NCT04516291|561203726|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486349|NCT04516291|561203727|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
155486350|NCT04516291|561203728|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486351|NCT04516291|561203729|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
155486352|NCT04516291|561203730|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486353|NCT04516291|561203731|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486354|NCT04516291|561203732|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
155486355|NCT03039686|561203733|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
155486356|NCT03039686|561203734|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
155486357|NCT03039686|561203735|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
155486358|NCT03039686|561203733|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
155486359|NCT03039686|561203734|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
155486360|NCT03039686|561203735|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
155486361|NCT03039686|561203733|FG000|Double-blind Period|Withdrawal by Subject|2|||
155486362|NCT03039686|561203734|FG001|Double-blind Period|Withdrawal by Subject|2|||
155486363|NCT03039686|561203735|FG002|Double-blind Period|Withdrawal by Subject|1|||
155524820|NCT02822235|561348545|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
155524821|NCT02822235|561348546|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
155524822|NCT02822235|561348545|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
155524823|NCT02822235|561348546|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
155524824|NCT00829530|561348551|FG000|First Intervention|Adverse Event|0|||
155524825|NCT00829530|561348552|FG001|First Intervention|Adverse Event|1|||
155524826|NCT00829530|561348551|FG000|First Intervention|Intolerance to Venopuncture|0|||
155524827|NCT00829530|561348552|FG001|First Intervention|Intolerance to Venopuncture|1|||
155524828|NCT00829530|561348551|FG000|Second Intervention|Intolerance to Venopuncture|1|||
155524829|NCT00829530|561348552|FG001|Second Intervention|Intolerance to Venopuncture|0|||
155524830|NCT04466111|561348555|FG000|Prior to Trial Phase|Physician Decision|1|||
155524831|NCT00105196|561348556|FG000|Overall Study|Lack of Efficacy|2|||
155524832|NCT00105196|561348557|FG001|Overall Study|Lack of Efficacy|3|||
155524833|NCT00105196|561348556|FG000|Overall Study|Adverse Event|11|||
155486364|NCT03039686|561203733|FG000|Double-blind Period|Death|0|||
155486365|NCT03039686|561203734|FG001|Double-blind Period|Death|0|||
155486366|NCT03039686|561203735|FG002|Double-blind Period|Death|1|||
155486367|NCT03039686|561203733|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
155486368|NCT03039686|561203734|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
155486369|NCT03039686|561203735|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
155486370|NCT03039686|561203733|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
155486371|NCT03039686|561203734|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
155486372|NCT03039686|561203735|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
155486373|NCT03039686|561203733|FG000|Open Label Period|Withdrawal by Subject|0|||
155486374|NCT03039686|561203734|FG001|Open Label Period|Withdrawal by Subject|3|||
155486375|NCT03039686|561203735|FG002|Open Label Period|Withdrawal by Subject|1|||
155486376|NCT02158949|561203736|FG000|Overall Study|Withdrawal by Subject|1|||
155486377|NCT02158949|561203737|FG001|Overall Study|Withdrawal by Subject|0|||
155486378|NCT02158949|561203736|FG000|Overall Study|Lost to Follow-up|5|||
155486379|NCT02158949|561203737|FG001|Overall Study|Lost to Follow-up|11|||
155486380|NCT01855607|561203738|FG000|Overall Study|Withdrawal by Subject|1|||
155486381|NCT01855607|561203738|FG000|Overall Study|Study was terminated|11|||
155486382|NCT02181634|561203739|FG000|Overall Study|Lack of Efficacy|33|||
155486383|NCT02181634|561203739|FG000|Overall Study|Adverse Event|17|||
155486384|NCT02181634|561203739|FG000|Overall Study|Physician Decision|8|||
155486385|NCT02181634|561203739|FG000|Overall Study|Withdrawal by Subject|5|||
155486386|NCT02181634|561203739|FG000|Overall Study|Death|2|||
155486387|NCT02181634|561203739|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
155486388|NCT02181634|561203739|FG000|Overall Study|Ineligible|1|||
155486389|NCT02181634|561203739|FG000|Overall Study|Max number of dose reduction|1|||
155486390|NCT02181634|561203739|FG000|Overall Study|Symptomatic progression|1|||
155486391|NCT02181634|561203739|FG000|Overall Study|Patient opted to proceed to surgery|1|||
155486392|NCT02392078|561203747|FG000|Overall Study|Did not have procedure|32|||
155486393|NCT02392078|561203748|FG001|Overall Study|Did not have procedure|43|||
155486394|NCT02392078|561203749|FG002|Overall Study|Did not have procedure|20|||
155486395|NCT02392078|561203750|FG003|Overall Study|Did not have procedure|1|||
155486396|NCT02079077|561203751|FG000|Overall Study|Lost to Follow-up|5|||
155486397|NCT02079077|561203752|FG001|Overall Study|Lost to Follow-up|7|||
155486398|NCT02079077|561203751|FG000|Overall Study|Became STIs Positive|1|||
155486399|NCT02079077|561203752|FG001|Overall Study|Became STIs Positive|2|||
155486400|NCT02087085|561203753|FG000|Overall Study|Adverse Event|10|||
155486401|NCT02087085|561203754|FG001|Overall Study|Adverse Event|14|||
155486402|NCT02087085|561203753|FG000|Overall Study|Lack of Efficacy|4|||
155486403|NCT02087085|561203754|FG001|Overall Study|Lack of Efficacy|3|||
155486404|NCT02087085|561203753|FG000|Overall Study|Lost to Follow-up|6|||
155486405|NCT02087085|561203754|FG001|Overall Study|Lost to Follow-up|4|||
155486406|NCT02087085|561203753|FG000|Overall Study|Withdrawal by Subject|9|||
155486407|NCT02087085|561203754|FG001|Overall Study|Withdrawal by Subject|11|||
155486408|NCT02087085|561203753|FG000|Overall Study|Protocol Violation|1|||
155486409|NCT02087085|561203754|FG001|Overall Study|Protocol Violation|0|||
155486410|NCT02087085|561203753|FG000|Overall Study|Study Terminated by Sponsor|87|||
155486411|NCT02087085|561203754|FG001|Overall Study|Study Terminated by Sponsor|80|||
155486412|NCT02087085|561203753|FG000|Overall Study|Other Miscellaneous Reasons|3|||
155486413|NCT02087085|561203754|FG001|Overall Study|Other Miscellaneous Reasons|4|||
155486414|NCT00635804|561203755|FG000|Overall Study|Adverse Event|0|||
155486415|NCT00635804|561203756|FG001|Overall Study|Adverse Event|0|||
155486416|NCT00635804|561203757|FG002|Overall Study|Adverse Event|0|||
155486417|NCT00635804|561203758|FG003|Overall Study|Adverse Event|0|||
155486418|NCT00635804|561203759|FG004|Overall Study|Adverse Event|0|||
155524834|NCT00105196|561348557|FG001|Overall Study|Adverse Event|3|||
155486419|NCT00635804|561203760|FG005|Overall Study|Adverse Event|1|||
155486420|NCT00635804|561203761|FG006|Overall Study|Adverse Event|0|||
155486421|NCT00635804|561203762|FG007|Overall Study|Adverse Event|0|||
155486422|NCT00635804|561203755|FG000|Overall Study|Withdrawal by Subject|1|||
155486423|NCT00635804|561203756|FG001|Overall Study|Withdrawal by Subject|0|||
155486424|NCT00635804|561203757|FG002|Overall Study|Withdrawal by Subject|0|||
155524835|NCT00105196|561348556|FG000|Overall Study|Withdrawal by Subject|6|||
155524836|NCT00105196|561348557|FG001|Overall Study|Withdrawal by Subject|6|||
155524837|NCT00105196|561348556|FG000|Overall Study|Lost to Follow-up|3|||
155524838|NCT00105196|561348557|FG001|Overall Study|Lost to Follow-up|2|||
155524839|NCT00105196|561348556|FG000|Overall Study|Poor/noncompliance|3|||
155524840|NCT00105196|561348557|FG001|Overall Study|Poor/noncompliance|4|||
155524841|NCT00105196|561348556|FG000|Overall Study|Protocol Violation|5|||
155524842|NCT00105196|561348557|FG001|Overall Study|Protocol Violation|2|||
155524843|NCT00105196|561348556|FG000|Overall Study|pending surgery|0|||
155524844|NCT00105196|561348557|FG001|Overall Study|pending surgery|1|||
155524845|NCT00105196|561348556|FG000|Overall Study|marijuana use|0|||
155524846|NCT00105196|561348557|FG001|Overall Study|marijuana use|1|||
155524847|NCT00105196|561348556|FG000|Overall Study|Subject became unblinded|0|||
155524848|NCT00105196|561348557|FG001|Overall Study|Subject became unblinded|1|||
155524849|NCT00893464|561348558|FG000|Overall Study|Did not complete therapy/experience PD|0|||
155524850|NCT00893464|561348559|FG001|Overall Study|Did not complete therapy/experience PD|0|||
155524851|NCT00893464|561348560|FG002|Overall Study|Did not complete therapy/experience PD|0|||
155524852|NCT00893464|561348561|FG003|Overall Study|Did not complete therapy/experience PD|0|||
155524853|NCT00893464|561348562|FG004|Overall Study|Did not complete therapy/experience PD|0|||
155524854|NCT00893464|561348563|FG005|Overall Study|Did not complete therapy/experience PD|0|||
155524855|NCT00893464|561348564|FG006|Overall Study|Did not complete therapy/experience PD|2|||
155524856|NCT00893464|561348565|FG007|Overall Study|Did not complete therapy/experience PD|2|||
155524857|NCT02661295|561348577|FG000|Overall Study|Death|1|||
155486425|NCT00635804|561203758|FG003|Overall Study|Withdrawal by Subject|0|||
155486426|NCT00635804|561203759|FG004|Overall Study|Withdrawal by Subject|0|||
155486427|NCT00635804|561203760|FG005|Overall Study|Withdrawal by Subject|0|||
155486428|NCT00635804|561203761|FG006|Overall Study|Withdrawal by Subject|0|||
155486429|NCT00635804|561203762|FG007|Overall Study|Withdrawal by Subject|0|||
155486430|NCT01425268|561203770|FG000|Overall Study|Withdrawal by Subject|2|||
155486431|NCT01425268|561203771|FG001|Overall Study|Withdrawal by Subject|0|||
155486432|NCT01425268|561203770|FG000|Overall Study|Sponsor Decision|5|||
155486433|NCT01425268|561203771|FG001|Overall Study|Sponsor Decision|0|||
155486434|NCT01425268|561203770|FG000|Overall Study|Physician Decision|1|||
155486435|NCT01425268|561203771|FG001|Overall Study|Physician Decision|0|||
155486436|NCT00719706|561203772|FG000|Overall Study|Adverse Event|5|||
155486437|NCT00719706|561203773|FG001|Overall Study|Adverse Event|4|||
155486438|NCT00719706|561203772|FG000|Overall Study|Withdrawal by Subject|1|||
155486439|NCT00719706|561203773|FG001|Overall Study|Withdrawal by Subject|2|||
155486440|NCT00719706|561203772|FG000|Overall Study|Protocol Violation|3|||
155486441|NCT00719706|561203773|FG001|Overall Study|Protocol Violation|0|||
155486442|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
155486443|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
155486444|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
155486445|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
155486446|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
155486447|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
155486448|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
155486449|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
155486450|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
155486451|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
155486452|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
155486453|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
155486454|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
155486455|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
155486456|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
155486457|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|Other|6|||
155486458|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|Other|6|||
155486459|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|Other|7|||
155486460|NCT02681094|561203774|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
155486461|NCT02681094|561203775|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
155486462|NCT02681094|561203776|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
155486463|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Participant decision|7|||
155486464|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Participant decision|10|||
155524858|NCT02661295|561348577|FG000|Overall Study|Transferred Out|1|||
155524859|NCT02661295|561348577|FG000|Overall Study|Kidney Transplant|1|||
155524860|NCT02661295|561348577|FG000|Overall Study|Withdrawn due to side effects|8|||
155524861|NCT02661295|561348577|FG000|Overall Study|Withdrawn due to access type|1|||
155524862|NCT02661295|561348577|FG000|Overall Study|Withdrawn due to allergies|1|||
155524863|NCT02661295|561348577|FG000|Overall Study|Withdrawn due to non-compliance|1|||
155524864|NCT02661295|561348577|FG000|Overall Study|Withdrawal by Subject|3|||
155524865|NCT02661295|561348577|FG000|Overall Study|Failed screening|2|||
155524866|NCT02336165|561348578|FG000|Overall Study|Death|3|||
155524867|NCT02336165|561348579|FG001|Overall Study|Death|0|||
155524868|NCT02336165|561348580|FG002|Overall Study|Death|0|||
155524869|NCT02336165|561348581|FG003|Overall Study|Death|0|||
155524870|NCT02336165|561348582|FG004|Overall Study|Death|1|||
155524871|NCT02336165|561348578|FG000|Overall Study|Physician Decision|2|||
155524872|NCT02336165|561348579|FG001|Overall Study|Physician Decision|2|||
155524873|NCT02336165|561348580|FG002|Overall Study|Physician Decision|1|||
155524874|NCT02336165|561348581|FG003|Overall Study|Physician Decision|1|||
155524875|NCT02336165|561348582|FG004|Overall Study|Physician Decision|0|||
155524876|NCT02336165|561348578|FG000|Overall Study|Withdrawal by Subject|0|||
155524877|NCT02336165|561348579|FG001|Overall Study|Withdrawal by Subject|0|||
155524878|NCT02336165|561348580|FG002|Overall Study|Withdrawal by Subject|1|||
155524879|NCT02336165|561348581|FG003|Overall Study|Withdrawal by Subject|0|||
155524880|NCT02336165|561348582|FG004|Overall Study|Withdrawal by Subject|1|||
155524881|NCT02336165|561348578|FG000|Overall Study|Adverse Event|4|||
155524882|NCT02336165|561348579|FG001|Overall Study|Adverse Event|1|||
155524883|NCT02336165|561348580|FG002|Overall Study|Adverse Event|2|||
155524884|NCT02336165|561348581|FG003|Overall Study|Adverse Event|4|||
155524885|NCT02336165|561348582|FG004|Overall Study|Adverse Event|1|||
155524886|NCT02336165|561348578|FG000|Overall Study|Progressive disease|23|||
155524887|NCT02336165|561348579|FG001|Overall Study|Progressive disease|22|||
155524888|NCT02336165|561348580|FG002|Overall Study|Progressive disease|27|||
155524889|NCT02336165|561348581|FG003|Overall Study|Progressive disease|24|||
155524890|NCT02336165|561348582|FG004|Overall Study|Progressive disease|19|||
155524891|NCT02336165|561348578|FG000|Overall Study|Non-compliance|1|||
155524892|NCT02336165|561348579|FG001|Overall Study|Non-compliance|0|||
155524893|NCT02336165|561348580|FG002|Overall Study|Non-compliance|0|||
155524894|NCT02336165|561348581|FG003|Overall Study|Non-compliance|1|||
155524895|NCT02336165|561348582|FG004|Overall Study|Non-compliance|0|||
155524896|NCT02336165|561348578|FG000|Overall Study|Other|1|||
155524897|NCT02336165|561348579|FG001|Overall Study|Other|0|||
155524898|NCT02336165|561348580|FG002|Overall Study|Other|0|||
155524899|NCT02336165|561348581|FG003|Overall Study|Other|1|||
155524900|NCT02336165|561348582|FG004|Overall Study|Other|0|||
155524901|NCT00910663|561348585|FG000|Period 1|Withdrawal by Subject|0|||
155524902|NCT00910663|561348586|FG001|Period 1|Withdrawal by Subject|1|||
155524903|NCT02726581|561348587|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155524904|NCT02726581|561348588|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
155524905|NCT02726581|561348589|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155524906|NCT02726581|561348587|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
155524907|NCT02726581|561348588|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
155524908|NCT02726581|561348589|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
155524909|NCT02726581|561348587|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155524910|NCT02726581|561348588|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155524911|NCT02726581|561348589|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155524912|NCT02726581|561348587|FG000|Treatment Period|Disease progression|47|||
155524913|NCT02726581|561348588|FG001|Treatment Period|Disease progression|50|||
155524914|NCT02726581|561348589|FG002|Treatment Period|Disease progression|16|||
155524915|NCT02726581|561348587|FG000|Treatment Period|Other reasons|9|||
155524916|NCT02726581|561348588|FG001|Treatment Period|Other reasons|8|||
155524917|NCT02726581|561348589|FG002|Treatment Period|Other reasons|2|||
155524918|NCT02726581|561348587|FG000|Treatment Period|Study drug toxicity|6|||
155524919|NCT02726581|561348588|FG001|Treatment Period|Study drug toxicity|3|||
155524920|NCT02726581|561348589|FG002|Treatment Period|Study drug toxicity|2|||
155524921|NCT02726581|561348587|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
155524922|NCT02726581|561348588|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
155524923|NCT02726581|561348589|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
155524924|NCT02726581|561348587|FG000|Treatment Period|Participant withdrew consent|3|||
155524925|NCT02726581|561348588|FG001|Treatment Period|Participant withdrew consent|1|||
155524926|NCT02726581|561348589|FG002|Treatment Period|Participant withdrew consent|1|||
155524927|NCT02726581|561348587|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
155524928|NCT02726581|561348588|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
155524929|NCT02726581|561348589|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
155524930|NCT02726581|561348587|FG000|Treatment Period|Maximum clinical benefit|0|||
155524931|NCT02726581|561348588|FG001|Treatment Period|Maximum clinical benefit|2|||
155524932|NCT02726581|561348589|FG002|Treatment Period|Maximum clinical benefit|0|||
155524933|NCT02726581|561348587|FG000|Treatment Period|Death|1|||
155524934|NCT02726581|561348588|FG001|Treatment Period|Death|0|||
155524935|NCT02726581|561348589|FG002|Treatment Period|Death|0|||
155524936|NCT02726581|561348587|FG000|Treatment Period|Poor/non-compliance|1|||
155524937|NCT02726581|561348588|FG001|Treatment Period|Poor/non-compliance|0|||
155524938|NCT02726581|561348589|FG002|Treatment Period|Poor/non-compliance|0|||
155524939|NCT02726581|561348587|FG000|Treatment Period|Participant no longer meets study criteria|0|||
155524940|NCT02726581|561348588|FG001|Treatment Period|Participant no longer meets study criteria|1|||
155524941|NCT02726581|561348589|FG002|Treatment Period|Participant no longer meets study criteria|0|||
155524942|NCT01844375|561348593|FG000|Overall Study|Protocol Violation|1|||
155524943|NCT01844375|561348594|FG001|Overall Study|Protocol Violation|1|||
155524944|NCT04239872|561348595|FG000|Overall Study|Lost to Follow-up|0|||
155524945|NCT04239872|561348596|FG001|Overall Study|Lost to Follow-up|1|||
155524946|NCT01498120|561348600|FG000|Overall Study|Lost to Follow-up|1|||
155524947|NCT01498120|561348600|FG000|Overall Study|Withdrawal by Subject|5|||
155524948|NCT01498120|561348600|FG000|Overall Study|AE, non-serious non-fatal|3|||
155524949|NCT01498120|561348600|FG000|Overall Study|Other|4|||
155524950|NCT01472341|561348601|FG000|Overall Study|Started insulin therapy|55|||
155524951|NCT01472341|561348601|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
155524952|NCT01472341|561348601|FG000|Overall Study|Withdrawal by Subject|39|||
155524953|NCT01472341|561348601|FG000|Overall Study|Lost to Follow-up|52|||
155524954|NCT01472341|561348601|FG000|Overall Study|Laboratory parameters unavailable|25|||
155524955|NCT01472341|561348601|FG000|Overall Study|Death|9|||
155524956|NCT00112463|561348602|FG000|Overall Study|Physician Decision|1|||
155524957|NCT00112463|561348602|FG000|Overall Study|Progression|30|||
155524958|NCT00112463|561348602|FG000|Overall Study|Second Primary|1|||
155524959|NCT00112463|561348602|FG000|Overall Study|Toxicity|3|||
155524960|NCT00112463|561348602|FG000|Overall Study|Withdrawal by Subject|2|||
155524961|NCT00112463|561348602|FG000|Overall Study|Never started treatment|2|||
155524962|NCT04060147|561348604|FG000|Overall Study|Withdrew consent|1|||
155524963|NCT00565448|561348605|FG000|Overall Study|Adverse Event|1|||
155524964|NCT00565448|561348606|FG001|Overall Study|Adverse Event|2|||
155524965|NCT00565448|561348605|FG000|Overall Study|Disease progression|1|||
155524966|NCT00565448|561348606|FG001|Overall Study|Disease progression|0|||
155524967|NCT00565448|561348605|FG000|Overall Study|Withdrawal by Subject|1|||
155524968|NCT00565448|561348606|FG001|Overall Study|Withdrawal by Subject|0|||
155524969|NCT00193609|561348607|FG000|Overall Study|Lack of Efficacy|2|||
155524970|NCT00193609|561348607|FG000|Overall Study|Adverse Event|2|||
155524971|NCT00735904|561348608|FG000|Overall Study|Adverse Event|3|||
155524972|NCT00735904|561348608|FG000|Overall Study|Death|20|||
155524973|NCT00735904|561348608|FG000|Overall Study|Protocol Violation|1|||
155524974|NCT00735904|561348608|FG000|Overall Study|Withdrawal by Subject|1|||
155524975|NCT00735904|561348608|FG000|Overall Study|Study Terminated by Sponsor|5|||
155524976|NCT00735904|561348608|FG000|Overall Study|Other|8|||
155524977|NCT03204539|561348609|FG000|Overall Study|Loss of funding|0|||
155524978|NCT03204539|561348610|FG001|Overall Study|Loss of funding|1|||
155524979|NCT00550537|561348618|FG000|Overall Study|Death|18|||
155524980|NCT00550537|561348618|FG000|Overall Study|Adverse Event|20|||
155524981|NCT00550537|561348618|FG000|Overall Study|Disease progression before|46|||
155524982|NCT00550537|561348618|FG000|Overall Study|Withdrawal by Subject|7|||
155524983|NCT00550537|561348618|FG000|Overall Study|Change in treatment plan|4|||
155524984|NCT00550537|561348618|FG000|Overall Study|Other complicating ilness|3|||
155524985|NCT00550537|561348618|FG000|Overall Study|Declining performance status|2|||
155524986|NCT00550537|561348618|FG000|Overall Study|Treated closer to home|4|||
155524987|NCT02008565|561348619|FG000|Overall Study|Protocol Violation|1|||
155524988|NCT02008565|561348620|FG001|Overall Study|Protocol Violation|1|||
155524989|NCT02008565|561348621|FG002|Overall Study|Protocol Violation|2|||
155524990|NCT02008565|561348622|FG003|Overall Study|Protocol Violation|0|||
155524991|NCT00268905|561348623|FG000|Overall Study|Adverse Event|3|||
155524992|NCT00268905|561348624|FG001|Overall Study|Adverse Event|0|||
155524993|NCT00268905|561348625|FG002|Overall Study|Adverse Event|4|||
155524994|NCT00268905|561348623|FG000|Overall Study|Lost to Follow-up|0|||
155524995|NCT00268905|561348624|FG001|Overall Study|Lost to Follow-up|1|||
155524996|NCT00268905|561348625|FG002|Overall Study|Lost to Follow-up|0|||
155524997|NCT00268905|561348623|FG000|Overall Study|Withdrawal by Subject|0|||
155524998|NCT00268905|561348624|FG001|Overall Study|Withdrawal by Subject|0|||
155524999|NCT00268905|561348625|FG002|Overall Study|Withdrawal by Subject|3|||
155525000|NCT00268905|561348623|FG000|Overall Study|Progressive Disease|28|||
155525001|NCT00268905|561348624|FG001|Overall Study|Progressive Disease|4|||
155525002|NCT00268905|561348625|FG002|Overall Study|Progressive Disease|3|||
155525003|NCT00268905|561348623|FG000|Overall Study|Physician Decision|3|||
155525004|NCT00268905|561348624|FG001|Overall Study|Physician Decision|0|||
155525005|NCT00268905|561348625|FG002|Overall Study|Physician Decision|1|||
155525006|NCT00268905|561348623|FG000|Overall Study|Clinical Progression|9|||
155525007|NCT00268905|561348624|FG001|Overall Study|Clinical Progression|4|||
155525008|NCT00268905|561348625|FG002|Overall Study|Clinical Progression|1|||
155525009|NCT00617305|561348626|FG000|Overall Study|Adverse Event|4|||
155525010|NCT00617305|561348627|FG001|Overall Study|Adverse Event|0|||
155525011|NCT00617305|561348628|FG002|Overall Study|Adverse Event|0|||
155525012|NCT00617305|561348626|FG000|Overall Study|Death|1|||
155525013|NCT00617305|561348627|FG001|Overall Study|Death|0|||
155525014|NCT00617305|561348628|FG002|Overall Study|Death|0|||
155525015|NCT00617305|561348626|FG000|Overall Study|Physician Decision|1|||
155525016|NCT00617305|561348627|FG001|Overall Study|Physician Decision|0|||
155525017|NCT00617305|561348628|FG002|Overall Study|Physician Decision|0|||
155525018|NCT00617305|561348626|FG000|Overall Study|Protocol Violation|1|||
155525019|NCT00617305|561348627|FG001|Overall Study|Protocol Violation|0|||
155525020|NCT00617305|561348628|FG002|Overall Study|Protocol Violation|1|||
155525021|NCT00617305|561348626|FG000|Overall Study|Withdrawal by Subject|1|||
155525022|NCT00617305|561348627|FG001|Overall Study|Withdrawal by Subject|0|||
155525023|NCT00617305|561348628|FG002|Overall Study|Withdrawal by Subject|0|||
155525024|NCT00857623|561348629|FG000|Overall Study|Adverse Event|5|||
155525025|NCT00857623|561348630|FG001|Overall Study|Adverse Event|2|||
155525026|NCT00857623|561348629|FG000|Overall Study|Study-specific discontinuation criteria|5|||
155525027|NCT00857623|561348630|FG001|Overall Study|Study-specific discontinuation criteria|3|||
155525028|NCT00857623|561348629|FG000|Overall Study|Withdrawal by Subject|2|||
155525029|NCT00857623|561348630|FG001|Overall Study|Withdrawal by Subject|1|||
155525030|NCT00857623|561348629|FG000|Overall Study|Lack of Efficacy|1|||
155525031|NCT00857623|561348630|FG001|Overall Study|Lack of Efficacy|1|||
155525032|NCT00857623|561348629|FG000|Overall Study|Severe non-compliance to protocol|1|||
155525033|NCT00857623|561348630|FG001|Overall Study|Severe non-compliance to protocol|1|||
155525034|NCT00857623|561348629|FG000|Overall Study|Intake of prohibited medication|0|||
155525035|NCT00857623|561348630|FG001|Overall Study|Intake of prohibited medication|1|||
155525036|NCT00857623|561348629|FG000|Overall Study|Positive for HEP C|0|||
155525037|NCT00857623|561348630|FG001|Overall Study|Positive for HEP C|1|||
155525038|NCT04185909|561348631|FG000|Overall Study|Lost to Follow-up|1|||
155525039|NCT02193178|561348632|FG000|Overall Study|Lost to Follow-up|1|||
155525040|NCT02193178|561348632|FG000|Overall Study|Dry eyes|1|||
155525041|NCT04510285|561348633|FG000|Overall Study|Death|1|||
155525042|NCT00048581|561348634|FG000|Double-Blind Period|Adverse Event|9|||
155525043|NCT00048581|561348635|FG001|Double-Blind Period|Adverse Event|5|||
155525044|NCT00048581|561348636|FG002|Double-Blind Period|Adverse Event|0|||
155525045|NCT00048581|561348634|FG000|Double-Blind Period|Lack of Efficacy|14|||
155525046|NCT00048581|561348635|FG001|Double-Blind Period|Lack of Efficacy|27|||
155525047|NCT00048581|561348636|FG002|Double-Blind Period|Lack of Efficacy|0|||
155525048|NCT00048581|561348634|FG000|Double-Blind Period|Lost to Follow-up|5|||
155525049|NCT00048581|561348635|FG001|Double-Blind Period|Lost to Follow-up|0|||
155525050|NCT00048581|561348636|FG002|Double-Blind Period|Lost to Follow-up|0|||
155525051|NCT00048581|561348634|FG000|Double-Blind Period|Withdrawal by Subject|5|||
155525052|NCT00048581|561348635|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155525053|NCT00048581|561348636|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155525054|NCT00048581|561348634|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
155525055|NCT00048581|561348635|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
155525056|NCT00048581|561348636|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
155525057|NCT00048581|561348634|FG000|Double-Blind Period|Investigator Decision|1|||
155525058|NCT00048581|561348635|FG001|Double-Blind Period|Investigator Decision|0|||
155525059|NCT00048581|561348636|FG002|Double-Blind Period|Investigator Decision|0|||
155525060|NCT00048581|561348634|FG000|Open-Label Period|Death|0|||
155525061|NCT00048581|561348635|FG001|Open-Label Period|Death|0|||
155525062|NCT00048581|561348636|FG002|Open-Label Period|Death|4|||
155525063|NCT00048581|561348634|FG000|Open-Label Period|Adverse Event|0|||
155525064|NCT00048581|561348635|FG001|Open-Label Period|Adverse Event|0|||
155525065|NCT00048581|561348636|FG002|Open-Label Period|Adverse Event|37|||
155525066|NCT00048581|561348634|FG000|Open-Label Period|Lack of Efficacy|0|||
155654997|NCT02014467|561830602|FG000|Overall Study|Protocol Violation|3|||
155525067|NCT00048581|561348635|FG001|Open-Label Period|Lack of Efficacy|0|||
155525068|NCT00048581|561348636|FG002|Open-Label Period|Lack of Efficacy|69|||
155525069|NCT00048581|561348634|FG000|Open-Label Period|Lost to Follow-up|0|||
155525070|NCT00048581|561348635|FG001|Open-Label Period|Lost to Follow-up|0|||
155525071|NCT00048581|561348636|FG002|Open-Label Period|Lost to Follow-up|14|||
155525072|NCT00048581|561348634|FG000|Open-Label Period|Withdrawal by Subject|0|||
155525073|NCT00048581|561348635|FG001|Open-Label Period|Withdrawal by Subject|0|||
155525074|NCT00048581|561348636|FG002|Open-Label Period|Withdrawal by Subject|20|||
155525075|NCT00048581|561348634|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
155525076|NCT00048581|561348635|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
155525077|NCT00048581|561348636|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
155525078|NCT00048581|561348634|FG000|Open-Label Period|Poor/Non-compliance|0|||
155525079|NCT00048581|561348635|FG001|Open-Label Period|Poor/Non-compliance|0|||
155525080|NCT00048581|561348636|FG002|Open-Label Period|Poor/Non-compliance|5|||
155525081|NCT00048581|561348634|FG000|Open-Label Period|Pregnancy|0|||
155525082|NCT00048581|561348635|FG001|Open-Label Period|Pregnancy|0|||
155525083|NCT00048581|561348636|FG002|Open-Label Period|Pregnancy|7|||
155525084|NCT00048581|561348634|FG000|Open-Label Period|Study Site Closure|0|||
155525085|NCT00048581|561348635|FG001|Open-Label Period|Study Site Closure|0|||
155525086|NCT00048581|561348636|FG002|Open-Label Period|Study Site Closure|2|||
155525087|NCT00048581|561348634|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
155486465|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Participant decision|9|||
155486466|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
155486467|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
155525088|NCT00048581|561348635|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
155525089|NCT00048581|561348636|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
155525090|NCT00048581|561348634|FG000|Open-Label Period|Problem With Transportation To Site|0|||
155525091|NCT00048581|561348635|FG001|Open-Label Period|Problem With Transportation To Site|0|||
155525092|NCT00048581|561348636|FG002|Open-Label Period|Problem With Transportation To Site|1|||
155486468|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
155486469|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
155486470|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
155486471|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
155486472|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
155486473|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
155486474|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
155486475|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
155486476|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
155486477|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
155486478|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|Other|6|||
155486479|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|Other|6|||
155486480|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|Other|7|||
155486481|NCT02681094|561203774|FG000|2 - Enrolled Participants Set|No treatment given|0|||
155486482|NCT02681094|561203775|FG001|2 - Enrolled Participants Set|No treatment given|1|||
155486483|NCT02681094|561203776|FG002|2 - Enrolled Participants Set|No treatment given|1|||
155486484|NCT00134563|561203777|FG000|Overall Study|Not treated due to protocol violation|0|||
155486485|NCT00134563|561203778|FG001|Overall Study|Not treated due to protocol violation|1|||
155486486|NCT00134563|561203779|FG002|Overall Study|Not treated due to protocol violation|1|||
155486487|NCT00134563|561203777|FG000|Overall Study|Adverse Event|29|||
155486488|NCT00134563|561203778|FG001|Overall Study|Adverse Event|37|||
155486489|NCT00134563|561203779|FG002|Overall Study|Adverse Event|38|||
155486490|NCT00134563|561203777|FG000|Overall Study|Lack of Efficacy|24|||
155486491|NCT00134563|561203778|FG001|Overall Study|Lack of Efficacy|14|||
155486492|NCT00134563|561203779|FG002|Overall Study|Lack of Efficacy|17|||
155486493|NCT00134563|561203777|FG000|Overall Study|Protocol Violation|3|||
155486494|NCT00134563|561203778|FG001|Overall Study|Protocol Violation|2|||
155486495|NCT00134563|561203779|FG002|Overall Study|Protocol Violation|5|||
155486496|NCT00134563|561203777|FG000|Overall Study|Lost to Follow-up|4|||
155486497|NCT00134563|561203778|FG001|Overall Study|Lost to Follow-up|0|||
155486498|NCT00134563|561203779|FG002|Overall Study|Lost to Follow-up|2|||
155486499|NCT00134563|561203777|FG000|Overall Study|progressive disease|11|||
155486500|NCT00134563|561203778|FG001|Overall Study|progressive disease|4|||
155486501|NCT00134563|561203779|FG002|Overall Study|progressive disease|2|||
155486502|NCT00134563|561203777|FG000|Overall Study|did not wish to continue|33|||
155486503|NCT00134563|561203778|FG001|Overall Study|did not wish to continue|32|||
155486504|NCT00134563|561203779|FG002|Overall Study|did not wish to continue|26|||
155486505|NCT00134563|561203777|FG000|Overall Study|Reason other than above|0|||
155486506|NCT00134563|561203778|FG001|Overall Study|Reason other than above|2|||
155486507|NCT00134563|561203779|FG002|Overall Study|Reason other than above|5|||
155525093|NCT00048581|561348634|FG000|Open-Label Period|Primary Investigator Retired|0|||
155525094|NCT00048581|561348635|FG001|Open-Label Period|Primary Investigator Retired|0|||
155525095|NCT00048581|561348636|FG002|Open-Label Period|Primary Investigator Retired|2|||
155486508|NCT03382639|561203780|FG000|Overall Study|Adverse Event|2|||
155486509|NCT03382639|561203781|FG001|Overall Study|Adverse Event|0|||
155486510|NCT03382639|561203782|FG002|Overall Study|Adverse Event|1|||
155486511|NCT03382639|561203783|FG003|Overall Study|Adverse Event|1|||
155486512|NCT03382639|561203780|FG000|Overall Study|Lost to Follow-up|1|||
155486513|NCT03382639|561203781|FG001|Overall Study|Lost to Follow-up|0|||
155486514|NCT03382639|561203782|FG002|Overall Study|Lost to Follow-up|0|||
155525096|NCT00048581|561348634|FG000|Open-Label Period|Study Ended By Sponsor|0|||
155525097|NCT00048581|561348635|FG001|Open-Label Period|Study Ended By Sponsor|0|||
155525098|NCT00048581|561348636|FG002|Open-Label Period|Study Ended By Sponsor|1|||
155525099|NCT03897088|561348637|FG000|Overall Study|Withdrawal by Subject|12|||
155525100|NCT03897088|561348638|FG001|Overall Study|Withdrawal by Subject|12|||
155525101|NCT03897088|561348637|FG000|Overall Study|Lost to Follow-up|7|||
155525102|NCT03897088|561348638|FG001|Overall Study|Lost to Follow-up|15|||
155525103|NCT03897088|561348637|FG000|Overall Study|Sponsor Decision|1|||
155525104|NCT03897088|561348638|FG001|Overall Study|Sponsor Decision|2|||
155525105|NCT03897088|561348637|FG000|Overall Study|COVID-19|2|||
155525106|NCT03897088|561348638|FG001|Overall Study|COVID-19|0|||
155525107|NCT03897088|561348637|FG000|Overall Study|Other|3|||
155525108|NCT03897088|561348638|FG001|Overall Study|Other|0|||
155525109|NCT03897088|561348637|FG000|Overall Study|Non-compliance with Study Drug|1|||
155525110|NCT03897088|561348638|FG001|Overall Study|Non-compliance with Study Drug|1|||
155525111|NCT03897088|561348637|FG000|Overall Study|Pregnancy|0|||
155525112|NCT03897088|561348638|FG001|Overall Study|Pregnancy|1|||
155525113|NCT00319735|561348647|FG000|Overall Study|Death|2|||
155525114|NCT02216071|561348649|FG000|Overall Study|Withdrawal by Subject|7|||
155525115|NCT02216071|561348650|FG001|Overall Study|Withdrawal by Subject|2|||
155525116|NCT02216071|561348649|FG000|Overall Study|Lost to Follow-up|3|||
155525117|NCT02216071|561348650|FG001|Overall Study|Lost to Follow-up|3|||
155525118|NCT02216071|561348649|FG000|Overall Study|Protocol Violation|3|||
155525119|NCT02216071|561348650|FG001|Overall Study|Protocol Violation|5|||
155525120|NCT02216071|561348649|FG000|Overall Study|Other|2|||
155525121|NCT02216071|561348650|FG001|Overall Study|Other|2|||
155525122|NCT01469546|561348653|FG000|Received 5 mg Dose|Adverse Event|13|||
155525123|NCT01469546|561348653|FG000|Received 5 mg Dose|Death|2|||
155525124|NCT01469546|561348653|FG000|Received 5 mg Dose|Protocol Violation|2|||
155525125|NCT01469546|561348653|FG000|Received 5 mg Dose|Progressive Disease|3|||
155525126|NCT01469546|561348653|FG000|Received 5 mg Dose|Physician Decision|3|||
155525127|NCT02801877|561348654|FG000|Overall Study|Lost to Follow-up|1|||
155525128|NCT02801877|561348655|FG001|Overall Study|Lost to Follow-up|1|||
155525129|NCT02801877|561348656|FG002|Overall Study|Lost to Follow-up|2|||
155525130|NCT02801877|561348657|FG003|Overall Study|Lost to Follow-up|0|||
155525131|NCT02801877|561348654|FG000|Overall Study|Never Started Treatment|2|||
155525132|NCT02801877|561348655|FG001|Overall Study|Never Started Treatment|0|||
155525133|NCT02801877|561348656|FG002|Overall Study|Never Started Treatment|4|||
155525134|NCT02801877|561348657|FG003|Overall Study|Never Started Treatment|0|||
155525135|NCT01066143|561350594|FG000|Overall Study|ineligible for the study|8|||
155525136|NCT01294787|561350595|FG000|Period 1|Adverse Event|0|||
155525137|NCT01294787|561350596|FG001|Period 1|Adverse Event|0|||
155525138|NCT01294787|561350597|FG002|Period 1|Adverse Event|0|||
155525139|NCT01294787|561350598|FG003|Period 1|Adverse Event|0|||
155525140|NCT01294787|561350599|FG004|Period 1|Adverse Event|1|||
155525141|NCT01294787|561350600|FG005|Period 1|Adverse Event|0|||
155525142|NCT01294787|561350595|FG000|Period 1|Withdrawal by Subject|0|||
155525143|NCT01294787|561350596|FG001|Period 1|Withdrawal by Subject|0|||
155525144|NCT01294787|561350597|FG002|Period 1|Withdrawal by Subject|0|||
155525145|NCT01294787|561350598|FG003|Period 1|Withdrawal by Subject|1|||
155525146|NCT01294787|561350599|FG004|Period 1|Withdrawal by Subject|1|||
155525147|NCT01294787|561350600|FG005|Period 1|Withdrawal by Subject|1|||
155525148|NCT01294787|561350595|FG000|Period 1|Administrative problem|0|||
155525149|NCT01294787|561350596|FG001|Period 1|Administrative problem|0|||
155525150|NCT01294787|561350597|FG002|Period 1|Administrative problem|1|||
155525151|NCT01294787|561350598|FG003|Period 1|Administrative problem|0|||
155525152|NCT01294787|561350599|FG004|Period 1|Administrative problem|0|||
155525153|NCT01294787|561350600|FG005|Period 1|Administrative problem|1|||
155525154|NCT01294787|561350595|FG000|Period 2|Adverse Event|0|||
155525155|NCT01294787|561350596|FG001|Period 2|Adverse Event|3|||
155525156|NCT01294787|561350597|FG002|Period 2|Adverse Event|0|||
155525157|NCT01294787|561350598|FG003|Period 2|Adverse Event|1|||
155525158|NCT01294787|561350599|FG004|Period 2|Adverse Event|0|||
155525159|NCT01294787|561350600|FG005|Period 2|Adverse Event|0|||
155525160|NCT01294787|561350595|FG000|Period 2|No longer needs study drug|0|||
155525161|NCT01294787|561350596|FG001|Period 2|No longer needs study drug|0|||
155525162|NCT01294787|561350597|FG002|Period 2|No longer needs study drug|0|||
155525163|NCT01294787|561350598|FG003|Period 2|No longer needs study drug|1|||
155525164|NCT01294787|561350599|FG004|Period 2|No longer needs study drug|0|||
155525165|NCT01294787|561350600|FG005|Period 2|No longer needs study drug|0|||
155525166|NCT01294787|561350595|FG000|Period 3|Adverse Event|0|||
155525167|NCT01294787|561350596|FG001|Period 3|Adverse Event|0|||
155525168|NCT01294787|561350597|FG002|Period 3|Adverse Event|0|||
155525169|NCT01294787|561350598|FG003|Period 3|Adverse Event|0|||
155525170|NCT01294787|561350599|FG004|Period 3|Adverse Event|1|||
155525171|NCT01294787|561350600|FG005|Period 3|Adverse Event|0|||
155525172|NCT05376319|561350601|FG000|Overall Study|Funding termination|2|||
155525173|NCT05376319|561350602|FG001|Overall Study|Funding termination|4|||
155525174|NCT01124175|561350603|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
155525175|NCT01124175|561350604|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
155525176|NCT00942968|561350605|FG000|Overall Study|Adverse Event|60|||
155525177|NCT00942968|561350605|FG000|Overall Study|Death|76|||
155525178|NCT00942968|561350605|FG000|Overall Study|Protocol Violation|9|||
155525179|NCT00942968|561350605|FG000|Overall Study|Lost to Follow-up|4|||
155525180|NCT00942968|561350605|FG000|Overall Study|Withdrawal by Subject|44|||
155525181|NCT00942968|561350605|FG000|Overall Study|Sponsor request|5|||
155525182|NCT00942968|561350605|FG000|Overall Study|Physician Decision|11|||
155525183|NCT00942968|561350605|FG000|Overall Study|Progression of disease|12|||
155525184|NCT00942968|561350605|FG000|Overall Study|Inferior vena cava filter placement|4|||
155525185|NCT00942968|561350605|FG000|Overall Study|Pulmonary embolism (PE)|1|||
155525186|NCT00942968|561350605|FG000|Overall Study|Participant required pancreatic biopsy|1|||
155525187|NCT00942968|561350605|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
155525188|NCT01948258|561350606|FG000|Overall Study|Pregnancy|41|||
155525189|NCT01948258|561350606|FG000|Overall Study|Did not complete by cut-off date|35|||
155525190|NCT01948258|561350606|FG000|Overall Study|Lost to Follow-up|27|||
155525191|NCT01948258|561350606|FG000|Overall Study|Withdrawal by SPD|8|||
155525192|NCT01948258|561350606|FG000|Overall Study|Withdrawal by Subject|6|||
155525193|NCT01948258|561350606|FG000|Overall Study|Health Care Professional|43|||
155525194|NCT01948258|561350606|FG000|Overall Study|Removed from statistical analysis|2|||
155525195|NCT01340495|561350613|FG000|Overall Study|Withdrawal by Subject|1|||
155525196|NCT01811953|561350614|FG000|Overall Study|Adverse Event|0|||
155525197|NCT01811953|561350615|FG001|Overall Study|Adverse Event|0|||
155525198|NCT01811953|561350616|FG002|Overall Study|Adverse Event|0|||
155525199|NCT01811953|561350617|FG003|Overall Study|Adverse Event|1|||
155525200|NCT01811953|561350618|FG004|Overall Study|Adverse Event|0|||
155525201|NCT01811953|561350619|FG005|Overall Study|Adverse Event|1|||
155525202|NCT01811953|561350614|FG000|Overall Study|Protocol Violation|0|||
155525203|NCT01811953|561350615|FG001|Overall Study|Protocol Violation|0|||
155525204|NCT01811953|561350616|FG002|Overall Study|Protocol Violation|0|||
155525205|NCT01811953|561350617|FG003|Overall Study|Protocol Violation|0|||
155525206|NCT01811953|561350618|FG004|Overall Study|Protocol Violation|1|||
155525207|NCT01811953|561350619|FG005|Overall Study|Protocol Violation|0|||
155525208|NCT00070291|561350621|FG000|Step 1|Withdrawal by Subject|1|||
155525209|NCT00070291|561350621|FG000|Step 1|Adverse Event|1|||
155525210|NCT00070291|561350621|FG000|Step 2|Adverse Event|1|||
155525211|NCT00520130|561350622|FG000|Overall Study|Disease progression on study|4|||
155525212|NCT00520130|561350623|FG001|Overall Study|Disease progression on study|0|||
155525213|NCT00520130|561350622|FG000|Overall Study|Physician Decision|1|||
155525214|NCT00520130|561350623|FG001|Overall Study|Physician Decision|1|||
155525215|NCT02533258|561350624|FG000|Overall Study|Adverse Event|1|||
155525216|NCT02533258|561350624|FG000|Overall Study|Death|2|||
155525217|NCT02533258|561350624|FG000|Overall Study|Other|1|||
155525218|NCT02533258|561350624|FG000|Overall Study|Economic factor|1|||
155525219|NCT02533258|561350624|FG000|Overall Study|Progression of pleural effusion|1|||
155525220|NCT02533258|561350624|FG000|Overall Study|Lack of Efficacy|2|||
155525221|NCT01520909|561350632|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
155525222|NCT01520909|561350633|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
155525223|NCT01520909|561350634|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
155525224|NCT01520909|561350632|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
155525225|NCT01520909|561350633|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
155525226|NCT01520909|561350634|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
155525227|NCT01520909|561350632|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
155525228|NCT01520909|561350633|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
155525229|NCT01520909|561350634|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
155525230|NCT01520909|561350632|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
155525231|NCT01520909|561350633|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
155525232|NCT01520909|561350634|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
155525233|NCT01882257|561350635|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
155525234|NCT01882257|561350636|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
155525235|NCT01882257|561350637|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
155525236|NCT01882257|561350635|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
155525237|NCT01882257|561350636|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
155525238|NCT01882257|561350637|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
155525239|NCT00830206|561350638|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
155525240|NCT00830206|561350639|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
155525241|NCT03351335|561350642|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
155525242|NCT03351335|561350643|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
155525243|NCT03351335|561350644|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
155525244|NCT01900691|561350645|FG000|Overall Study|Death|7|||
155525245|NCT01900691|561350645|FG000|Overall Study|Lost to Follow-up|4|||
155525246|NCT01900691|561350645|FG000|Overall Study|Study Device Not Placed|3|||
155525247|NCT01900691|561350645|FG000|Overall Study|Non study stent placed|2|||
155525248|NCT01900691|561350645|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
155525249|NCT01900691|561350645|FG000|Overall Study|Complete stent migration through digestive tract|1|||
155525250|NCT01149473|561350646|FG000|First Intervention|Adverse Event|1|||
155525251|NCT01149473|561350647|FG001|First Intervention|Adverse Event|1|||
155525252|NCT01149473|561350646|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155525253|NCT01149473|561350647|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155525254|NCT01954394|561350648|FG000|Overall Study|Enrolled but not treated|1|||
155525255|NCT01954394|561350649|FG001|Overall Study|Enrolled but not treated|0|||
155525256|NCT01954394|561350648|FG000|Overall Study|Adverse Event|10|||
155525257|NCT01954394|561350649|FG001|Overall Study|Adverse Event|23|||
155525258|NCT01954394|561350648|FG000|Overall Study|Poor compliance to protocol|7|||
155525259|NCT01954394|561350649|FG001|Overall Study|Poor compliance to protocol|7|||
155525260|NCT01954394|561350648|FG000|Overall Study|Participant Moved|0|||
155525261|NCT01954394|561350649|FG001|Overall Study|Participant Moved|4|||
155525262|NCT01954394|561350648|FG000|Overall Study|Related to Study Drug administration|2|||
155525263|NCT01954394|561350649|FG001|Overall Study|Related to Study Drug administration|2|||
155525264|NCT01954394|561350648|FG000|Overall Study|Other than specified above|10|||
155525265|NCT01954394|561350649|FG001|Overall Study|Other than specified above|21|||
155525266|NCT02128997|561350650|FG000|Overall Study|Lost to Follow-up|6|||
155525267|NCT02128997|561350651|FG001|Overall Study|Lost to Follow-up|11|||
155525268|NCT04123548|561350652|FG000|Overall Study|Withdrawal by Subject|1|||
155525269|NCT04123548|561350652|FG000|Overall Study|Lost to Follow-up|8|||
155525270|NCT04123548|561350652|FG000|Overall Study|Death|4|||
155525271|NCT04123548|561350652|FG000|Overall Study|Reason Not Specified|1|||
155525272|NCT04166630|561350654|FG000|Overall Study|Withdrawal by Subject|0|||
155525273|NCT04166630|561350655|FG001|Overall Study|Withdrawal by Subject|1|||
155525274|NCT00096447|561350656|FG000|Overall Study|Never treated|1|||
155525275|NCT00627016|561350657|FG000|Overall Study|Adverse Event|1|||
155525276|NCT00627016|561350658|FG001|Overall Study|Adverse Event|1|||
155525277|NCT00627016|561350657|FG000|Overall Study|Protocol Violation|0|||
155525278|NCT00627016|561350658|FG001|Overall Study|Protocol Violation|2|||
155525279|NCT00627016|561350657|FG000|Overall Study|Lost to Follow-up|0|||
155525280|NCT00627016|561350658|FG001|Overall Study|Lost to Follow-up|1|||
155525281|NCT00627016|561350657|FG000|Overall Study|Withdrawal by Subject|2|||
155525282|NCT00627016|561350658|FG001|Overall Study|Withdrawal by Subject|1|||
155525283|NCT00627016|561350657|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155525284|NCT00627016|561350658|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
155525285|NCT00627016|561350657|FG000|Overall Study|Lack of Efficacy|1|||
155525286|NCT00627016|561350658|FG001|Overall Study|Lack of Efficacy|0|||
155525287|NCT00627016|561350657|FG000|Overall Study|Placed on Excluded Drugs|1|||
155525288|NCT00627016|561350658|FG001|Overall Study|Placed on Excluded Drugs|0|||
155525289|NCT00627016|561350657|FG000|Overall Study|Pregnancy|1|||
155525290|NCT00627016|561350658|FG001|Overall Study|Pregnancy|0|||
155525291|NCT01534663|561350659|FG000|Overall Study|Lost to Follow-up|0|||
155525292|NCT01534663|561350660|FG001|Overall Study|Lost to Follow-up|2|||
155525293|NCT01534663|561350659|FG000|Overall Study|Adverse Event|2|||
155525294|NCT01534663|561350660|FG001|Overall Study|Adverse Event|1|||
155525295|NCT04088760|561350661|FG000|Overall Study|Physician Decision|1|||
155525296|NCT04112823|561350666|FG000|Overall Study|Lost to Follow-up|2|||
155525297|NCT04112823|561350667|FG001|Overall Study|Lost to Follow-up|3|||
155525298|NCT03107091|561350668|FG000|Overall Study|Physician Decision|1|||
155525299|NCT00436553|561350671|FG000|Overall Study|Adverse Event|4|||
155525300|NCT00436553|561350672|FG001|Overall Study|Adverse Event|3|||
155525301|NCT00436553|561350673|FG002|Overall Study|Adverse Event|4|||
155525302|NCT00436553|561350671|FG000|Overall Study|Death|3|||
155525303|NCT00436553|561350672|FG001|Overall Study|Death|1|||
155525304|NCT00436553|561350673|FG002|Overall Study|Death|3|||
155525305|NCT00436553|561350671|FG000|Overall Study|Lost to Follow-up|0|||
155525306|NCT00436553|561350672|FG001|Overall Study|Lost to Follow-up|2|||
155525307|NCT00436553|561350673|FG002|Overall Study|Lost to Follow-up|0|||
155525308|NCT00436553|561350671|FG000|Overall Study|Protocol Violation|1|||
155525309|NCT00436553|561350672|FG001|Overall Study|Protocol Violation|0|||
155525310|NCT00436553|561350673|FG002|Overall Study|Protocol Violation|0|||
155525311|NCT00436553|561350671|FG000|Overall Study|Withdrawal by Subject|5|||
155525312|NCT00436553|561350672|FG001|Overall Study|Withdrawal by Subject|6|||
155525313|NCT00436553|561350673|FG002|Overall Study|Withdrawal by Subject|3|||
155525314|NCT00625443|561350678|FG000|Overall Study|Adverse Event|1|||
155525315|NCT00625443|561350679|FG001|Overall Study|Adverse Event|4|||
155525316|NCT00625443|561350680|FG002|Overall Study|Adverse Event|0|||
155525317|NCT00625443|561350678|FG000|Overall Study|Non-compliance with protocol|0|||
155525318|NCT00625443|561350679|FG001|Overall Study|Non-compliance with protocol|1|||
155525319|NCT00625443|561350680|FG002|Overall Study|Non-compliance with protocol|0|||
155525320|NCT00625443|561350678|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
155525321|NCT00625443|561350679|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
155525322|NCT00625443|561350680|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
155525323|NCT00625443|561350678|FG000|Overall Study|Withdrawal by Subject|0|||
155525324|NCT00625443|561350679|FG001|Overall Study|Withdrawal by Subject|1|||
155525325|NCT00625443|561350680|FG002|Overall Study|Withdrawal by Subject|2|||
155525326|NCT00625443|561350678|FG000|Overall Study|Physician Decision|0|||
155525327|NCT00625443|561350679|FG001|Overall Study|Physician Decision|4|||
155525328|NCT00625443|561350680|FG002|Overall Study|Physician Decision|2|||
155525329|NCT00625443|561350678|FG000|Overall Study|Other|0|||
155525330|NCT00625443|561350679|FG001|Overall Study|Other|1|||
155525331|NCT00625443|561350680|FG002|Overall Study|Other|1|||
155525332|NCT02728102|561350681|FG000|Overall Study|Death|3|||
155525333|NCT02728102|561350682|FG001|Overall Study|Death|0|||
155525334|NCT02728102|561350683|FG002|Overall Study|Death|1|||
155525335|NCT02728102|561350681|FG000|Overall Study|Withdrawal by Subject|0|||
155525336|NCT02728102|561350682|FG001|Overall Study|Withdrawal by Subject|2|||
155525337|NCT02728102|561350683|FG002|Overall Study|Withdrawal by Subject|3|||
155525338|NCT02728102|561350681|FG000|Overall Study|Physician Decision|1|||
155525339|NCT02728102|561350682|FG001|Overall Study|Physician Decision|1|||
155525340|NCT02728102|561350683|FG002|Overall Study|Physician Decision|0|||
155525341|NCT02728102|561350681|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
155525342|NCT02728102|561350682|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
155525343|NCT02728102|561350683|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
155525344|NCT02728102|561350681|FG000|Overall Study|Covid|0|||
155525345|NCT02728102|561350682|FG001|Overall Study|Covid|0|||
155525346|NCT02728102|561350683|FG002|Overall Study|Covid|1|||
155525347|NCT02419937|561350688|FG000|Overall Study|Lost to Follow-up|1|||
155525348|NCT02419937|561350689|FG001|Overall Study|Lost to Follow-up|0|||
155525349|NCT00553280|561350690|FG000|Overall Study|Adverse Event|19|||
155525350|NCT00553280|561350690|FG000|Overall Study|Lack of Efficacy|3|||
155525351|NCT00553280|561350690|FG000|Overall Study|Withdrawal by Subject|3|||
155525352|NCT00553280|561350690|FG000|Overall Study|Physician Decision|1|||
155525353|NCT01182415|561350691|FG000|Overall Study|Lost to Follow-up|1|||
155525354|NCT01544127|561350692|FG000|Overall Study|Lost to Follow-up|4|||
155525355|NCT01544127|561350693|FG001|Overall Study|Lost to Follow-up|2|||
155525356|NCT01544127|561350694|FG002|Overall Study|Lost to Follow-up|9|||
155525357|NCT01544127|561350692|FG000|Overall Study|Withdrawal by Subject|2|||
155525358|NCT01544127|561350693|FG001|Overall Study|Withdrawal by Subject|2|||
155525359|NCT01544127|561350694|FG002|Overall Study|Withdrawal by Subject|1|||
155525360|NCT01544127|561350692|FG000|Overall Study|Discharged out of catchment area|1|||
155525361|NCT01544127|561350693|FG001|Overall Study|Discharged out of catchment area|1|||
155525362|NCT01544127|561350694|FG002|Overall Study|Discharged out of catchment area|1|||
155525363|NCT01544127|561350692|FG000|Overall Study|Death|1|||
155525364|NCT01544127|561350693|FG001|Overall Study|Death|0|||
155525365|NCT01544127|561350694|FG002|Overall Study|Death|0|||
155525366|NCT01544127|561350692|FG000|Overall Study|Jail or Prison|1|||
155525367|NCT01544127|561350693|FG001|Overall Study|Jail or Prison|1|||
155525368|NCT01544127|561350694|FG002|Overall Study|Jail or Prison|2|||
155525369|NCT01544127|561350692|FG000|Overall Study|Became Psychotic|1|||
155525370|NCT01544127|561350693|FG001|Overall Study|Became Psychotic|0|||
155525371|NCT01544127|561350694|FG002|Overall Study|Became Psychotic|0|||
155525372|NCT01544127|561350692|FG000|Overall Study|Researcher withdrew|1|||
155525373|NCT01544127|561350693|FG001|Overall Study|Researcher withdrew|0|||
155525374|NCT01544127|561350694|FG002|Overall Study|Researcher withdrew|0|||
155525375|NCT01544127|561350692|FG000|Overall Study|Went active duty|0|||
155525376|NCT01544127|561350693|FG001|Overall Study|Went active duty|0|||
155525377|NCT01544127|561350694|FG002|Overall Study|Went active duty|1|||
155525378|NCT01256684|561350697|FG000|Overall Study|Adverse Event|1|||
155525379|NCT01256684|561350698|FG001|Overall Study|Adverse Event|4|||
155525380|NCT01256684|561350699|FG002|Overall Study|Adverse Event|2|||
155525381|NCT01256684|561350697|FG000|Overall Study|Withdrawal by Subject|4|||
155525382|NCT01256684|561350698|FG001|Overall Study|Withdrawal by Subject|0|||
155525383|NCT01256684|561350699|FG002|Overall Study|Withdrawal by Subject|2|||
155525384|NCT01256684|561350697|FG000|Overall Study|Physician Decision|0|||
155525385|NCT01256684|561350698|FG001|Overall Study|Physician Decision|1|||
155525386|NCT01256684|561350699|FG002|Overall Study|Physician Decision|0|||
155525387|NCT01256684|561350697|FG000|Overall Study|Lack of Efficacy|0|||
155525388|NCT01256684|561350698|FG001|Overall Study|Lack of Efficacy|1|||
155525389|NCT01256684|561350699|FG002|Overall Study|Lack of Efficacy|1|||
155525390|NCT01256684|561350697|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
155525391|NCT01256684|561350698|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
155525392|NCT01256684|561350699|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
155525393|NCT02587962|561350701|FG000|Overall Study|Adverse Event|0|||
155525394|NCT02587962|561350702|FG001|Overall Study|Adverse Event|0|||
155525395|NCT02587962|561350703|FG002|Overall Study|Adverse Event|1|||
155525396|NCT02587962|561350704|FG003|Overall Study|Adverse Event|0|||
155525397|NCT02587962|561350705|FG004|Overall Study|Adverse Event|0|||
155525398|NCT02587962|561350701|FG000|Overall Study|Withdrawal by Subject|0|||
155525399|NCT02587962|561350702|FG001|Overall Study|Withdrawal by Subject|0|||
155525400|NCT02587962|561350703|FG002|Overall Study|Withdrawal by Subject|1|||
155525401|NCT02587962|561350704|FG003|Overall Study|Withdrawal by Subject|1|||
155525402|NCT02587962|561350705|FG004|Overall Study|Withdrawal by Subject|4|||
155525403|NCT02587962|561350701|FG000|Overall Study|Radiological progression|2|||
155525404|NCT02587962|561350702|FG001|Overall Study|Radiological progression|2|||
155525405|NCT02587962|561350703|FG002|Overall Study|Radiological progression|2|||
155525406|NCT02587962|561350704|FG003|Overall Study|Radiological progression|5|||
155525407|NCT02587962|561350705|FG004|Overall Study|Radiological progression|10|||
155525408|NCT02587962|561350701|FG000|Overall Study|Clinical progression|0|||
155525409|NCT02587962|561350702|FG001|Overall Study|Clinical progression|1|||
155525410|NCT02587962|561350703|FG002|Overall Study|Clinical progression|2|||
155525411|NCT02587962|561350704|FG003|Overall Study|Clinical progression|0|||
155525412|NCT02587962|561350705|FG004|Overall Study|Clinical progression|1|||
155525413|NCT00184600|561350706|FG000|Overall Study|Adverse Event|9|||
155525414|NCT00184600|561350707|FG001|Overall Study|Adverse Event|0|||
155525415|NCT00184600|561350708|FG002|Overall Study|Adverse Event|5|||
155525416|NCT00184600|561350706|FG000|Overall Study|Death|3|||
155525417|NCT00184600|561350707|FG001|Overall Study|Death|9|||
155525418|NCT00184600|561350708|FG002|Overall Study|Death|7|||
155525419|NCT00184600|561350706|FG000|Overall Study|Lack of Efficacy|3|||
155525420|NCT00184600|561350707|FG001|Overall Study|Lack of Efficacy|1|||
155525421|NCT00184600|561350708|FG002|Overall Study|Lack of Efficacy|3|||
155525422|NCT00184600|561350706|FG000|Overall Study|Lost to Follow-up|4|||
155525423|NCT00184600|561350707|FG001|Overall Study|Lost to Follow-up|6|||
155525424|NCT00184600|561350708|FG002|Overall Study|Lost to Follow-up|1|||
155525425|NCT00184600|561350706|FG000|Overall Study|Protocol Violation|2|||
155525426|NCT00184600|561350707|FG001|Overall Study|Protocol Violation|2|||
155525427|NCT00184600|561350708|FG002|Overall Study|Protocol Violation|3|||
155525428|NCT00184600|561350706|FG000|Overall Study|Withdrawal by Subject|20|||
155525429|NCT00184600|561350707|FG001|Overall Study|Withdrawal by Subject|28|||
155525430|NCT00184600|561350708|FG002|Overall Study|Withdrawal by Subject|12|||
155525431|NCT00184600|561350706|FG000|Overall Study|Unclassified|4|||
155525432|NCT00184600|561350707|FG001|Overall Study|Unclassified|5|||
155525433|NCT00184600|561350708|FG002|Overall Study|Unclassified|3|||
155525434|NCT00696020|561350711|FG000|Overall Study|Adverse Event|3|||
155525435|NCT00696020|561350712|FG001|Overall Study|Adverse Event|1|||
155525436|NCT00696020|561350713|FG002|Overall Study|Adverse Event|2|||
155525437|NCT00696020|561350714|FG003|Overall Study|Adverse Event|1|||
155525438|NCT00696020|561350711|FG000|Overall Study|Lack of Efficacy|1|||
155525439|NCT00696020|561350712|FG001|Overall Study|Lack of Efficacy|0|||
155525440|NCT00696020|561350713|FG002|Overall Study|Lack of Efficacy|0|||
155525441|NCT00696020|561350714|FG003|Overall Study|Lack of Efficacy|0|||
155525442|NCT00696020|561350711|FG000|Overall Study|Protocol Violation|0|||
155525443|NCT00696020|561350712|FG001|Overall Study|Protocol Violation|0|||
155525444|NCT00696020|561350713|FG002|Overall Study|Protocol Violation|0|||
155525445|NCT00696020|561350714|FG003|Overall Study|Protocol Violation|1|||
155525446|NCT00696020|561350711|FG000|Overall Study|Withdrawal by Subject|0|||
155525447|NCT00696020|561350712|FG001|Overall Study|Withdrawal by Subject|1|||
155525448|NCT00696020|561350713|FG002|Overall Study|Withdrawal by Subject|0|||
155525449|NCT00696020|561350714|FG003|Overall Study|Withdrawal by Subject|1|||
155525450|NCT00696020|561350711|FG000|Overall Study|Other not stated above|0|||
155525451|NCT00696020|561350712|FG001|Overall Study|Other not stated above|0|||
155525452|NCT00696020|561350713|FG002|Overall Study|Other not stated above|1|||
155525453|NCT00696020|561350714|FG003|Overall Study|Other not stated above|1|||
155525454|NCT00624065|561350715|FG000|Overall Study|Adverse Event|5|||
155525455|NCT00624065|561350716|FG001|Overall Study|Adverse Event|6|||
155525456|NCT00624065|561350715|FG000|Overall Study|Lost to Follow-up|4|||
155525457|NCT00624065|561350716|FG001|Overall Study|Lost to Follow-up|1|||
155525458|NCT00624065|561350715|FG000|Overall Study|Consent withdrawn|6|||
155525459|NCT00624065|561350716|FG001|Overall Study|Consent withdrawn|5|||
155654998|NCT02014467|561830603|FG001|Overall Study|Protocol Violation|0|||
155654999|NCT02014467|561830602|FG000|Overall Study|Physician Decision|2|||
155655000|NCT02014467|561830603|FG001|Overall Study|Physician Decision|3|||
155525460|NCT00624065|561350715|FG000|Overall Study|Lack of Efficacy|0|||
155525461|NCT00624065|561350716|FG001|Overall Study|Lack of Efficacy|3|||
155525462|NCT00624065|561350715|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
155525463|NCT00624065|561350716|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
155525464|NCT03627091|561350719|FG000|Overall Study|Adverse Event|0|||
155525465|NCT03627091|561350720|FG001|Overall Study|Adverse Event|0|||
155525466|NCT03627091|561350721|FG002|Overall Study|Adverse Event|2|||
155525467|NCT03627091|561350719|FG000|Overall Study|Withdrawal by Subject|2|||
155525468|NCT03627091|561350720|FG001|Overall Study|Withdrawal by Subject|0|||
155655001|NCT02014467|561830602|FG000|Overall Study|Withdrawal by Subject|16|||
155655002|NCT02014467|561830603|FG001|Overall Study|Withdrawal by Subject|4|||
155525469|NCT03627091|561350721|FG002|Overall Study|Withdrawal by Subject|2|||
155525470|NCT03627091|561350719|FG000|Overall Study|Physician Decision|2|||
155525471|NCT03627091|561350720|FG001|Overall Study|Physician Decision|0|||
155525472|NCT03627091|561350721|FG002|Overall Study|Physician Decision|0|||
155525473|NCT03627091|561350719|FG000|Overall Study|Site terminated by sponsor|0|||
155525474|NCT03627091|561350720|FG001|Overall Study|Site terminated by sponsor|1|||
155525475|NCT03627091|561350721|FG002|Overall Study|Site terminated by sponsor|0|||
155525476|NCT03627091|561350719|FG000|Overall Study|Disease relapse|7|||
155525477|NCT03627091|561350720|FG001|Overall Study|Disease relapse|5|||
155525478|NCT03627091|561350721|FG002|Overall Study|Disease relapse|1|||
155525479|NCT03627091|561350719|FG000|Overall Study|Other|1|||
155525480|NCT03627091|561350720|FG001|Overall Study|Other|0|||
155525481|NCT03627091|561350721|FG002|Overall Study|Other|0|||
155525482|NCT00102440|561350722|FG000|Overall Study|Lost to Follow-up|25|||
155525483|NCT00102440|561350723|FG001|Overall Study|Lost to Follow-up|18|||
155525484|NCT00102440|561350724|FG002|Overall Study|Lost to Follow-up|21|||
155525485|NCT00102440|561350722|FG000|Overall Study|Adverse Event|16|||
155525486|NCT00102440|561350723|FG001|Overall Study|Adverse Event|23|||
155525487|NCT00102440|561350724|FG002|Overall Study|Adverse Event|8|||
155525488|NCT00102440|561350722|FG000|Overall Study|Gout Flare|10|||
155525489|NCT00102440|561350723|FG001|Overall Study|Gout Flare|28|||
155525490|NCT00102440|561350724|FG002|Overall Study|Gout Flare|9|||
155525491|NCT00102440|561350722|FG000|Overall Study|Personal Reason(s)|19|||
155525492|NCT00102440|561350723|FG001|Overall Study|Personal Reason(s)|13|||
155525493|NCT00102440|561350724|FG002|Overall Study|Personal Reason(s)|13|||
155525494|NCT00102440|561350722|FG000|Overall Study|Other|11|||
155525495|NCT00102440|561350723|FG001|Overall Study|Other|14|||
155525496|NCT00102440|561350724|FG002|Overall Study|Other|14|||
155525497|NCT00102440|561350722|FG000|Overall Study|Protocol Violation|7|||
155525498|NCT00102440|561350723|FG001|Overall Study|Protocol Violation|2|||
155525499|NCT00102440|561350724|FG002|Overall Study|Protocol Violation|1|||
155525500|NCT01010542|561350726|FG000|Overall Study|Adverse Event|0|||
155525501|NCT01010542|561350727|FG001|Overall Study|Adverse Event|1|||
155525502|NCT01010542|561350728|FG002|Overall Study|Adverse Event|0|||
155525503|NCT01010542|561350726|FG000|Overall Study|Lost to Follow-up|0|||
155525504|NCT01010542|561350727|FG001|Overall Study|Lost to Follow-up|1|||
155525505|NCT01010542|561350728|FG002|Overall Study|Lost to Follow-up|0|||
155525506|NCT01010542|561350726|FG000|Overall Study|Withdrawal by Subject|0|||
155525507|NCT01010542|561350727|FG001|Overall Study|Withdrawal by Subject|3|||
155525508|NCT01010542|561350728|FG002|Overall Study|Withdrawal by Subject|2|||
155525509|NCT00678639|561350731|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
155525510|NCT00678639|561350732|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
155525511|NCT01546545|561350734|FG000|Overall Study|Withdrawal by Subject|1|||
155525512|NCT01214850|561350735|FG000|Overall Study|Withdrawal by Subject|38|||
155525513|NCT01214850|561350736|FG001|Overall Study|Withdrawal by Subject|31|||
155525514|NCT01214850|561350737|FG002|Overall Study|Withdrawal by Subject|28|||
155525515|NCT01214850|561350735|FG000|Overall Study|Lost to Follow-up|124|||
155525516|NCT01214850|561350736|FG001|Overall Study|Lost to Follow-up|98|||
155525517|NCT01214850|561350737|FG002|Overall Study|Lost to Follow-up|123|||
155525518|NCT01214850|561350735|FG000|Overall Study|Protocol Violation|5|||
155525519|NCT01214850|561350736|FG001|Overall Study|Protocol Violation|5|||
155525520|NCT01214850|561350737|FG002|Overall Study|Protocol Violation|6|||
155525521|NCT01214850|561350735|FG000|Overall Study|Adverse event or death|11|||
155525522|NCT01214850|561350736|FG001|Overall Study|Adverse event or death|8|||
155525523|NCT01214850|561350737|FG002|Overall Study|Adverse event or death|3|||
155525524|NCT01214850|561350735|FG000|Overall Study|Inappropriate enrollment|2|||
155525525|NCT01214850|561350736|FG001|Overall Study|Inappropriate enrollment|1|||
155525526|NCT01214850|561350737|FG002|Overall Study|Inappropriate enrollment|0|||
155525527|NCT01214850|561350735|FG000|Overall Study|Administrative reason|1|||
155525528|NCT01214850|561350736|FG001|Overall Study|Administrative reason|0|||
155655003|NCT00443456|561830605|FG000|Overall Study|Adverse Event|16|||
155525529|NCT01214850|561350737|FG002|Overall Study|Administrative reason|0|||
155525530|NCT01214850|561350735|FG000|Overall Study|Unable to classify|2|||
155525531|NCT01214850|561350736|FG001|Overall Study|Unable to classify|1|||
155525532|NCT01214850|561350737|FG002|Overall Study|Unable to classify|1|||
155525533|NCT01171963|561350741|FG000|Overall Study|Adverse Event|10|||
155525534|NCT01171963|561350742|FG001|Overall Study|Adverse Event|15|||
155525535|NCT01171963|561350741|FG000|Overall Study|Lost to Follow-up|23|||
155655004|NCT00443456|561830605|FG000|Overall Study|Move|1|||
155525536|NCT01171963|561350742|FG001|Overall Study|Lost to Follow-up|24|||
155525537|NCT01171963|561350741|FG000|Overall Study|Other - diarrhoea|1|||
155525538|NCT01171963|561350742|FG001|Overall Study|Other - diarrhoea|0|||
155525539|NCT01171963|561350741|FG000|Overall Study|Withdrawal by Subject|114|||
155525540|NCT01171963|561350742|FG001|Overall Study|Withdrawal by Subject|129|||
155525541|NCT00302952|561350745|FG000|Overall Study|Physician Decision|1|||
155525542|NCT00302952|561350746|FG001|Overall Study|Physician Decision|1|||
155525543|NCT00302952|561350745|FG000|Overall Study|Withdrawal by Subject|2|||
155525544|NCT00302952|561350746|FG001|Overall Study|Withdrawal by Subject|3|||
155525545|NCT00302952|561350745|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
155525546|NCT00302952|561350746|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
155525547|NCT00336479|561350747|FG000|Overall Study|Adverse Event|8|||
155525548|NCT00336479|561350748|FG001|Overall Study|Adverse Event|11|||
155525549|NCT00336479|561350749|FG002|Overall Study|Adverse Event|18|||
155525550|NCT00336479|561350750|FG003|Overall Study|Adverse Event|4|||
155525551|NCT00336479|561350747|FG000|Overall Study|Noncompliant|1|||
155525552|NCT00336479|561350748|FG001|Overall Study|Noncompliant|7|||
155525553|NCT00336479|561350749|FG002|Overall Study|Noncompliant|3|||
155525554|NCT00336479|561350750|FG003|Overall Study|Noncompliant|0|||
155525555|NCT00336479|561350747|FG000|Overall Study|Physician Decision|2|||
155525556|NCT00336479|561350748|FG001|Overall Study|Physician Decision|3|||
155525557|NCT00336479|561350749|FG002|Overall Study|Physician Decision|1|||
155525558|NCT00336479|561350750|FG003|Overall Study|Physician Decision|0|||
155525559|NCT00336479|561350747|FG000|Overall Study|Lost to Follow-up|3|||
155525560|NCT00336479|561350748|FG001|Overall Study|Lost to Follow-up|2|||
155525561|NCT00336479|561350749|FG002|Overall Study|Lost to Follow-up|0|||
155525562|NCT00336479|561350750|FG003|Overall Study|Lost to Follow-up|0|||
155525563|NCT00336479|561350747|FG000|Overall Study|Withdrawal by Subject|3|||
155525564|NCT00336479|561350748|FG001|Overall Study|Withdrawal by Subject|2|||
155525565|NCT00336479|561350749|FG002|Overall Study|Withdrawal by Subject|3|||
155525566|NCT00336479|561350750|FG003|Overall Study|Withdrawal by Subject|0|||
155525567|NCT00336479|561350747|FG000|Overall Study|Other|0|||
155525568|NCT00336479|561350748|FG001|Overall Study|Other|0|||
155525569|NCT00336479|561350749|FG002|Overall Study|Other|1|||
155525570|NCT00336479|561350750|FG003|Overall Study|Other|0|||
155525571|NCT00336479|561350747|FG000|Overall Study|Virologic Stopping Rule|20|||
155525572|NCT00336479|561350748|FG001|Overall Study|Virologic Stopping Rule|0|||
155525573|NCT00336479|561350749|FG002|Overall Study|Virologic Stopping Rule|0|||
155525574|NCT00336479|561350750|FG003|Overall Study|Virologic Stopping Rule|0|||
155525575|NCT03435081|561350753|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
155525576|NCT03435081|561350754|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
155525577|NCT03435081|561350755|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
155525578|NCT03435081|561350753|FG000|Week 0 to Week 16|Adverse Event|2|||
155525579|NCT03435081|561350754|FG001|Week 0 to Week 16|Adverse Event|2|||
155525580|NCT03435081|561350755|FG002|Week 0 to Week 16|Adverse Event|2|||
155525581|NCT03435081|561350753|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
155525582|NCT03435081|561350754|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
155525583|NCT03435081|561350755|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
155525584|NCT03435081|561350753|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
155525585|NCT03435081|561350754|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
155525586|NCT03435081|561350755|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
155525587|NCT03435081|561350753|FG000|Week 0 to Week 16|Pregnancy|1|||
155525588|NCT03435081|561350754|FG001|Week 0 to Week 16|Pregnancy|0|||
155525589|NCT03435081|561350755|FG002|Week 0 to Week 16|Pregnancy|0|||
155525590|NCT03435081|561350753|FG000|Week 0 to Week 16|Non-compliance|1|||
155525591|NCT03435081|561350754|FG001|Week 0 to Week 16|Non-compliance|0|||
155525592|NCT03435081|561350755|FG002|Week 0 to Week 16|Non-compliance|2|||
155525593|NCT03435081|561350753|FG000|Week 0 to Week 16|Inadequate Response|0|||
155525594|NCT03435081|561350754|FG001|Week 0 to Week 16|Inadequate Response|1|||
155525595|NCT03435081|561350755|FG002|Week 0 to Week 16|Inadequate Response|0|||
155525596|NCT03435081|561350753|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
155525597|NCT03435081|561350754|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
155525598|NCT03435081|561350755|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
155525599|NCT03435081|561350753|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
155525600|NCT03435081|561350754|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
155525601|NCT03435081|561350755|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
155525602|NCT03435081|561350753|FG000|Week 16 to Week 104|Adverse Event|1|||
155525603|NCT03435081|561350754|FG001|Week 16 to Week 104|Adverse Event|0|||
155525604|NCT03435081|561350755|FG002|Week 16 to Week 104|Adverse Event|2|||
155525605|NCT03435081|561350753|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
155525606|NCT03435081|561350754|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
155525607|NCT03435081|561350755|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
155525608|NCT03435081|561350753|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
155525609|NCT03435081|561350754|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
155525610|NCT03435081|561350755|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
155525611|NCT03435081|561350753|FG000|Week 16 to Week 104|Non--Compliance|0|||
155525612|NCT03435081|561350754|FG001|Week 16 to Week 104|Non--Compliance|0|||
155525613|NCT03435081|561350755|FG002|Week 16 to Week 104|Non--Compliance|1|||
155525614|NCT02601560|561350756|FG000|Overall Study|Other|0|||
155525615|NCT02601560|561350757|FG001|Overall Study|Other|0|||
155525616|NCT02601560|561350758|FG002|Overall Study|Other|0|||
155525617|NCT02601560|561350759|FG003|Overall Study|Other|0|||
155525618|NCT02601560|561350760|FG004|Overall Study|Other|0|||
155525619|NCT02601560|561350761|FG005|Overall Study|Other|0|||
155525620|NCT02601560|561350762|FG006|Overall Study|Other|1|||
155525621|NCT02601560|561350763|FG007|Overall Study|Other|0|||
155525622|NCT01406795|561350764|FG000|Overall Study|Withdrawal by Subject|1|||
155525623|NCT04320849|561350765|FG000|Overall Study|Withdrawal by Subject|4|||
155525624|NCT04320849|561350765|FG000|Overall Study|Imaging data unavailable|2|||
155525625|NCT04320849|561350765|FG000|Overall Study|Incomplete imaging|2|||
155525626|NCT02421952|561350766|FG000|Overall Study|Diary Not Returned|93|||
155525627|NCT02421952|561350766|FG000|Overall Study|Failed seriation task|13|||
155525628|NCT02421952|561350766|FG000|Overall Study|Subject uncooperative for baseline test|2|||
155525629|NCT02421952|561350766|FG000|Overall Study|Surgery cancelled|1|||
155525630|NCT04934722|561352434|FG000|Overall Study|Death|4|||
155525631|NCT04934722|561352435|FG001|Overall Study|Death|3|||
155525632|NCT04934722|561352434|FG000|Overall Study|Participants Ongoing|88|||
155525633|NCT04934722|561352435|FG001|Overall Study|Participants Ongoing|91|||
155525634|NCT06358820|561352436|FG000|Overall Study|Adverse Event|11|||
155525635|NCT06358820|561352436|FG000|Overall Study|kidney transplantation|3|||
155525636|NCT06358820|561352436|FG000|Overall Study|patient voluntary withdrawal|6|||
155525637|NCT06358820|561352436|FG000|Overall Study|Physician Decision|1|||
155525638|NCT01045096|561352439|FG000|Overall Study|Withdrawal by Subject|2|||
155525639|NCT01045096|561352440|FG001|Overall Study|Withdrawal by Subject|0|||
155525640|NCT01045096|561352441|FG002|Overall Study|Withdrawal by Subject|0|||
155525641|NCT01045096|561352439|FG000|Overall Study|Other|1|||
155525642|NCT01045096|561352440|FG001|Overall Study|Other|0|||
155525643|NCT01045096|561352441|FG002|Overall Study|Other|0|||
155525644|NCT01511939|561352443|FG000|Overall Study|Withdrawal by Subject|2|||
155525645|NCT01511939|561352444|FG001|Overall Study|Withdrawal by Subject|1|||
155525646|NCT01511939|561352445|FG002|Overall Study|Withdrawal by Subject|0|||
155525647|NCT01993030|561352451|FG000|Overall Study|Adverse Event|0|||
155525648|NCT01993030|561352452|FG001|Overall Study|Adverse Event|4|||
155525649|NCT03785548|561352453|FG000|Overall Study|age > 80|1|||
155525650|NCT03785548|561352454|FG001|Overall Study|age > 80|0|||
155525651|NCT03785548|561352453|FG000|Overall Study|no Postop queries|1|||
155525652|NCT03785548|561352454|FG001|Overall Study|no Postop queries|0|||
155525653|NCT01591785|561352456|FG000|Overall Study|worsening condition|1|||
155525654|NCT01591785|561352457|FG001|Overall Study|worsening condition|2|||
155525655|NCT01591785|561352456|FG000|Overall Study|Protocol Violation|2|||
155525656|NCT01591785|561352457|FG001|Overall Study|Protocol Violation|0|||
155525657|NCT01591785|561352456|FG000|Overall Study|Lost to Follow-up|1|||
155525658|NCT01591785|561352457|FG001|Overall Study|Lost to Follow-up|0|||
155525659|NCT00396279|561352459|FG000|Overall Study|Ongoing in study|26|||
155525660|NCT00396279|561352459|FG000|Overall Study|Disease progression|2|||
155525661|NCT00396279|561352459|FG000|Overall Study|Withdrawal by Subject|1|||
155525662|NCT00396279|561352459|FG000|Overall Study|Physician Decision|1|||
155525663|NCT02883452|561352460|FG000|Overall Study|Withdrawal by Subject|1|||
155525664|NCT02883452|561352461|FG001|Overall Study|Withdrawal by Subject|1|||
155525665|NCT02883452|561352462|FG002|Overall Study|Withdrawal by Subject|3|||
155525666|NCT02883452|561352463|FG003|Overall Study|Withdrawal by Subject|0|||
155525667|NCT02883452|561352464|FG004|Overall Study|Withdrawal by Subject|2|||
155525668|NCT02883452|561352465|FG005|Overall Study|Withdrawal by Subject|5|||
155525669|NCT02883452|561352460|FG000|Overall Study|Disease progression|1|||
155525670|NCT02883452|561352461|FG001|Overall Study|Disease progression|0|||
155525671|NCT02883452|561352462|FG002|Overall Study|Disease progression|0|||
155525672|NCT02883452|561352463|FG003|Overall Study|Disease progression|1|||
155525673|NCT02883452|561352464|FG004|Overall Study|Disease progression|4|||
155525674|NCT02883452|561352465|FG005|Overall Study|Disease progression|5|||
155525675|NCT02883452|561352460|FG000|Overall Study|Adverse Event|2|||
155525676|NCT02883452|561352461|FG001|Overall Study|Adverse Event|1|||
155525677|NCT02883452|561352462|FG002|Overall Study|Adverse Event|1|||
155525678|NCT02883452|561352463|FG003|Overall Study|Adverse Event|1|||
155525679|NCT02883452|561352464|FG004|Overall Study|Adverse Event|1|||
155525680|NCT02883452|561352465|FG005|Overall Study|Adverse Event|3|||
155525681|NCT02883452|561352460|FG000|Overall Study|Physician Decision|0|||
155525682|NCT02883452|561352461|FG001|Overall Study|Physician Decision|0|||
155525683|NCT02883452|561352462|FG002|Overall Study|Physician Decision|0|||
155525684|NCT02883452|561352463|FG003|Overall Study|Physician Decision|0|||
155525685|NCT02883452|561352464|FG004|Overall Study|Physician Decision|4|||
155525686|NCT02883452|561352465|FG005|Overall Study|Physician Decision|1|||
155525687|NCT02883452|561352460|FG000|Overall Study|Death|1|||
155525688|NCT02883452|561352461|FG001|Overall Study|Death|0|||
155525689|NCT02883452|561352462|FG002|Overall Study|Death|1|||
155525690|NCT02883452|561352463|FG003|Overall Study|Death|0|||
155525691|NCT02883452|561352464|FG004|Overall Study|Death|0|||
155525692|NCT02883452|561352465|FG005|Overall Study|Death|0|||
155525693|NCT02883452|561352460|FG000|Overall Study|Other|0|||
155525694|NCT02883452|561352461|FG001|Overall Study|Other|0|||
155525695|NCT02883452|561352462|FG002|Overall Study|Other|0|||
155525696|NCT02883452|561352463|FG003|Overall Study|Other|0|||
155525697|NCT02883452|561352464|FG004|Overall Study|Other|0|||
155525698|NCT02883452|561352465|FG005|Overall Study|Other|1|||
155525699|NCT00905346|561352468|FG000|Period 1|Withdrawal by Subject|1|||
155525700|NCT00905346|561352469|FG001|Period 1|Withdrawal by Subject|0|||
155525701|NCT00909610|561352470|FG000|Period: First Intervention|Adverse Event|0|||
155525702|NCT00909610|561352471|FG001|Period: First Intervention|Adverse Event|1|||
155525703|NCT00909610|561352470|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
155525704|NCT00909610|561352471|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
155525705|NCT00909610|561352470|FG000|Period: Second Intervention|Adverse Event|1|||
155525706|NCT00909610|561352471|FG001|Period: Second Intervention|Adverse Event|0|||
155525707|NCT02736721|561352479|FG000|Overall Study|Adverse Event|8|||
155525708|NCT02736721|561352479|FG000|Overall Study|Lost to Follow-up|3|||
155486515|NCT03382639|561203783|FG003|Overall Study|Lost to Follow-up|0|||
155486516|NCT03382639|561203780|FG000|Overall Study|Withdrawal by Subject|4|||
155486517|NCT03382639|561203781|FG001|Overall Study|Withdrawal by Subject|3|||
155486518|NCT03382639|561203782|FG002|Overall Study|Withdrawal by Subject|2|||
155486519|NCT03382639|561203783|FG003|Overall Study|Withdrawal by Subject|3|||
155486520|NCT03382639|561203780|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
155486521|NCT03382639|561203781|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
155486522|NCT03382639|561203782|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
155486523|NCT03382639|561203783|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
155486524|NCT03382639|561203780|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
155486525|NCT03382639|561203781|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
155486526|NCT03382639|561203782|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
155486527|NCT03382639|561203783|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
155486528|NCT03382639|561203780|FG000|Overall Study|Other|2|||
155486529|NCT03382639|561203781|FG001|Overall Study|Other|0|||
155486530|NCT03382639|561203782|FG002|Overall Study|Other|0|||
155486531|NCT03382639|561203783|FG003|Overall Study|Other|3|||
155486532|NCT00682539|561203786|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
155486533|NCT00682539|561203787|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
155486534|NCT00682539|561203788|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
155486535|NCT00682539|561203786|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
155486536|NCT00682539|561203787|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
155486537|NCT00682539|561203788|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
155486538|NCT02477215|561203793|FG000|Dose Escalation Phase|Physician Decision|1|||
155486539|NCT02477215|561203794|FG001|Dose Escalation Phase|Physician Decision|2|||
155486540|NCT02477215|561203795|FG002|Dose Escalation Phase|Physician Decision|0|||
155486541|NCT02477215|561203793|FG000|Fixed Dose Phase|Physician Decision|0|||
155486542|NCT02477215|561203794|FG001|Fixed Dose Phase|Physician Decision|7|||
155486543|NCT02477215|561203795|FG002|Fixed Dose Phase|Physician Decision|0|||
155486544|NCT00285857|561203796|FG000|Overall Study|Withdrawal by Subject|2|||
155486545|NCT00285857|561203796|FG000|Overall Study|Inadequate initial breast cytology|1|||
155486546|NCT00285857|561203796|FG000|Overall Study|Adverse Event|1|||
155486547|NCT00508872|561203797|FG000|Overall Study|Lost to Follow-up|1|||
155486548|NCT00508872|561203797|FG000|Overall Study|Physician Decision|1|||
155486549|NCT02210559|561203802|FG000|Overall Study|Progressive Disease|3|||
155486550|NCT02210559|561203803|FG001|Overall Study|Progressive Disease|2|||
155486551|NCT02210559|561203802|FG000|Overall Study|Adverse Event|2|||
155486552|NCT02210559|561203803|FG001|Overall Study|Adverse Event|2|||
155486553|NCT02210559|561203802|FG000|Overall Study|Physician Decision|1|||
155486554|NCT02210559|561203803|FG001|Overall Study|Physician Decision|0|||
155486555|NCT02210559|561203802|FG000|Overall Study|Withdrawal by Subject|0|||
155486556|NCT02210559|561203803|FG001|Overall Study|Withdrawal by Subject|1|||
155486557|NCT02210559|561203802|FG000|Overall Study|Other than specified|0|||
155486558|NCT02210559|561203803|FG001|Overall Study|Other than specified|1|||
155486559|NCT00310440|561203804|FG000|Overall Study|Lost to Follow-up|17|||
155486560|NCT00310440|561203805|FG001|Overall Study|Lost to Follow-up|8|||
155525709|NCT02736721|561352479|FG000|Overall Study|Other|5|||
155525710|NCT00418184|561352484|FG000|Double-blind Phase|Withdrawal by Subject|22|||
155525711|NCT00418184|561352485|FG001|Double-blind Phase|Withdrawal by Subject|9|||
155525712|NCT00418184|561352484|FG000|Double-blind Phase|Adverse Event|2|||
155525713|NCT00418184|561352485|FG001|Double-blind Phase|Adverse Event|1|||
155525714|NCT00418184|561352484|FG000|Double-blind Phase|Poor compliance|3|||
155525715|NCT00418184|561352485|FG001|Double-blind Phase|Poor compliance|1|||
155525716|NCT00834249|561352486|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155525717|NCT00834249|561352487|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
155525718|NCT00834249|561352486|FG000|Second Intervention|Adverse Event|1|||
155525719|NCT00834249|561352487|FG001|Second Intervention|Adverse Event|0|||
155525720|NCT00851877|561352488|FG000|Phase I-1|Death|1|||
155525721|NCT00851877|561352489|FG001|Phase I-1|Death|0|||
155525722|NCT00851877|561352490|FG002|Phase I-1|Death|0|||
155525723|NCT00851877|561352488|FG000|Phase II|Withdrawal by Subject|0|||
155525724|NCT00851877|561352489|FG001|Phase II|Withdrawal by Subject|0|||
155525725|NCT00851877|561352490|FG002|Phase II|Withdrawal by Subject|3|||
155525726|NCT00620074|561352491|FG000|Overall Study|Adverse Event|1|||
155525727|NCT03025880|561352494|FG000|Overall Study|Adverse Event|1|||
155525728|NCT03025880|561352495|FG001|Overall Study|Adverse Event|0|||
155525729|NCT03025880|561352494|FG000|Overall Study|Death|1|||
155525730|NCT03025880|561352495|FG001|Overall Study|Death|1|||
155525731|NCT03025880|561352494|FG000|Overall Study|Withdrawal by Subject|0|||
155525732|NCT03025880|561352495|FG001|Overall Study|Withdrawal by Subject|1|||
155525733|NCT03025880|561352494|FG000|Overall Study|Physician Decision|0|||
155525734|NCT03025880|561352495|FG001|Overall Study|Physician Decision|1|||
155525735|NCT03025880|561352494|FG000|Overall Study|Progressive Disease|12|||
155525736|NCT03025880|561352495|FG001|Overall Study|Progressive Disease|19|||
155525737|NCT03136380|561352497|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155525738|NCT03136380|561352498|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
155525739|NCT03136380|561352499|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155525740|NCT03136380|561352500|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155525741|NCT03136380|561352501|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155525742|NCT01185548|561352504|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
155525743|NCT00086996|561352505|FG000|Overall Study|Adverse Event|29|||
155525744|NCT00086996|561352505|FG000|Overall Study|Death|4|||
155525745|NCT00086996|561352505|FG000|Overall Study|progression/relapse|7|||
155525746|NCT00086996|561352505|FG000|Overall Study|Withdrawal by Subject|13|||
155525747|NCT00086996|561352505|FG000|Overall Study|Other|6|||
155525748|NCT00086996|561352505|FG000|Overall Study|not eligible|5|||
155525749|NCT01422538|561352507|FG000|Overall Study|Lost to Follow-up|0|||
155525750|NCT01422538|561352508|FG001|Overall Study|Lost to Follow-up|1|||
155525751|NCT01422538|561352509|FG002|Overall Study|Lost to Follow-up|1|||
155525752|NCT01422538|561352507|FG000|Overall Study|Missed visit|0|||
155525753|NCT01422538|561352508|FG001|Overall Study|Missed visit|1|||
155525754|NCT01422538|561352509|FG002|Overall Study|Missed visit|1|||
155525755|NCT02770820|561352510|FG000|Overall Study|Death|1|||
155525756|NCT02770820|561352510|FG000|Overall Study|Physician Decision|2|||
155525757|NCT01387022|561352512|FG000|Overall Study|Death|1|||
155525758|NCT01387022|561352513|FG001|Overall Study|Death|1|||
155525759|NCT01387022|561352512|FG000|Overall Study|Lost to Follow-up|0|||
155525760|NCT01387022|561352513|FG001|Overall Study|Lost to Follow-up|3|||
155525761|NCT02076022|561352514|FG000|Overall Study|Withdrawal by Subject|2|||
155525762|NCT02076022|561352515|FG001|Overall Study|Withdrawal by Subject|0|||
155525763|NCT00286754|561352518|FG000|Overall Study|Adverse Event|2|||
155525764|NCT00286754|561352519|FG001|Overall Study|Adverse Event|2|||
155525765|NCT00286754|561352520|FG002|Overall Study|Adverse Event|3|||
155525766|NCT00286754|561352518|FG000|Overall Study|Withdrawal by Subject|6|||
155525767|NCT00286754|561352519|FG001|Overall Study|Withdrawal by Subject|2|||
155525768|NCT00286754|561352520|FG002|Overall Study|Withdrawal by Subject|0|||
155525769|NCT00286754|561352518|FG000|Overall Study|Lost to Follow-up|12|||
155525770|NCT00286754|561352519|FG001|Overall Study|Lost to Follow-up|14|||
155525771|NCT00286754|561352520|FG002|Overall Study|Lost to Follow-up|6|||
155525772|NCT00286754|561352518|FG000|Overall Study|Moved out of state|0|||
155525773|NCT00286754|561352519|FG001|Overall Study|Moved out of state|0|||
155525774|NCT00286754|561352520|FG002|Overall Study|Moved out of state|1|||
155525775|NCT01536405|561352521|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
155525776|NCT01536405|561352522|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
155525777|NCT01536405|561352521|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
155525778|NCT01536405|561352522|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
155525779|NCT01536405|561352521|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
155525780|NCT01536405|561352522|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
155525781|NCT01536405|561352521|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
155525782|NCT01536405|561352522|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
155525783|NCT01536405|561352521|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
155525784|NCT01536405|561352522|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
155525785|NCT01536405|561352521|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
155525786|NCT01536405|561352522|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
155525787|NCT01536405|561352521|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
155525788|NCT01536405|561352522|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
155525789|NCT01536405|561352521|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
155525790|NCT01536405|561352522|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
155525791|NCT01536405|561352521|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
155525792|NCT01536405|561352522|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
155525793|NCT01536405|561352521|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
155525794|NCT01536405|561352522|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
155525795|NCT01536405|561352521|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
155525796|NCT01536405|561352522|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
155525797|NCT01536405|561352521|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
155525798|NCT01536405|561352522|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
155525799|NCT01536405|561352521|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
155655005|NCT00443456|561830605|FG000|Overall Study|Withdrawal by Subject|1|||
155655006|NCT00557440|561830606|FG000|Treatment Period 1|Adverse Event|0|||
155655007|NCT00557440|561830607|FG001|Treatment Period 1|Adverse Event|0|||
155655008|NCT00557440|561830608|FG002|Treatment Period 1|Adverse Event|1|||
155525800|NCT01536405|561352522|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
155525801|NCT01061866|561352523|FG000|Overall Study|Adverse Event|2|||
155525802|NCT04786184|561352524|FG000|Overall Study|Adverse Event|4|||
155525803|NCT04786184|561352525|FG001|Overall Study|Adverse Event|0|||
155525804|NCT04786184|561352524|FG000|Overall Study|Withdrawal by Subject|3|||
155525805|NCT04786184|561352525|FG001|Overall Study|Withdrawal by Subject|1|||
155525806|NCT04786184|561352524|FG000|Overall Study|Lost to Follow-up|4|||
155525807|NCT04786184|561352525|FG001|Overall Study|Lost to Follow-up|2|||
155525808|NCT01185821|561352529|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155525809|NCT01185821|561352530|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155525810|NCT01185821|561352531|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155525811|NCT01185821|561352532|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155525812|NCT01185821|561352533|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155525813|NCT01185821|561352529|FG000|Overall Study|Protocol Violation|0|||
155525814|NCT01185821|561352530|FG001|Overall Study|Protocol Violation|0|||
155525815|NCT01185821|561352531|FG002|Overall Study|Protocol Violation|0|||
155525816|NCT01185821|561352532|FG003|Overall Study|Protocol Violation|1|||
155525817|NCT01185821|561352533|FG004|Overall Study|Protocol Violation|1|||
155525818|NCT01185821|561352529|FG000|Overall Study|Abnormal test procedure result|0|||
155525819|NCT01185821|561352530|FG001|Overall Study|Abnormal test procedure result|0|||
155525820|NCT01185821|561352531|FG002|Overall Study|Abnormal test procedure result|0|||
155525821|NCT01185821|561352532|FG003|Overall Study|Abnormal test procedure result|0|||
155525822|NCT01185821|561352533|FG004|Overall Study|Abnormal test procedure result|1|||
155525823|NCT01185821|561352529|FG000|Overall Study|Death|0|||
155525824|NCT01185821|561352530|FG001|Overall Study|Death|1|||
155525825|NCT01185821|561352531|FG002|Overall Study|Death|0|||
155525826|NCT01185821|561352532|FG003|Overall Study|Death|0|||
155525827|NCT01185821|561352533|FG004|Overall Study|Death|0|||
155525828|NCT01185821|561352529|FG000|Overall Study|Condition no longer required study drug|0|||
155525829|NCT01185821|561352530|FG001|Overall Study|Condition no longer required study drug|0|||
155525830|NCT01185821|561352531|FG002|Overall Study|Condition no longer required study drug|0|||
155525831|NCT01185821|561352532|FG003|Overall Study|Condition no longer required study drug|0|||
155525832|NCT01185821|561352533|FG004|Overall Study|Condition no longer required study drug|1|||
155655009|NCT02157610|561830609|FG000|Overall Study|Death|4|||
155655010|NCT02157610|561830610|FG001|Overall Study|Death|4|||
155655011|NCT00124657|561830616|FG000|Overall Study|Toxicity|0|||
155655012|NCT00124657|561830617|FG001|Overall Study|Toxicity|0|||
155655013|NCT00124657|561830618|FG002|Overall Study|Toxicity|1|||
155655014|NCT00124657|561830616|FG000|Overall Study|Non-compliance|1|||
155655015|NCT00124657|561830617|FG001|Overall Study|Non-compliance|0|||
155525833|NCT01185821|561352529|FG000|Overall Study|Adverse Event|2|||
155525834|NCT01185821|561352530|FG001|Overall Study|Adverse Event|3|||
155525835|NCT01185821|561352531|FG002|Overall Study|Adverse Event|1|||
155525836|NCT01185821|561352532|FG003|Overall Study|Adverse Event|2|||
155525837|NCT01185821|561352533|FG004|Overall Study|Adverse Event|5|||
155655016|NCT00124657|561830618|FG002|Overall Study|Non-compliance|4|||
155655017|NCT00124657|561830616|FG000|Overall Study|Progressive disease|14|||
155655018|NCT00124657|561830617|FG001|Overall Study|Progressive disease|5|||
155655019|NCT00124657|561830618|FG002|Overall Study|Progressive disease|27|||
155655020|NCT00124657|561830616|FG000|Overall Study|Intercurrent illness|1|||
155655021|NCT00124657|561830617|FG001|Overall Study|Intercurrent illness|0|||
155525838|NCT01185821|561352529|FG000|Overall Study|Lack of Efficacy|0|||
155525839|NCT01185821|561352530|FG001|Overall Study|Lack of Efficacy|0|||
155525840|NCT01185821|561352531|FG002|Overall Study|Lack of Efficacy|3|||
155525841|NCT01185821|561352532|FG003|Overall Study|Lack of Efficacy|0|||
155525842|NCT01185821|561352533|FG004|Overall Study|Lack of Efficacy|9|||
155525843|NCT01185821|561352529|FG000|Overall Study|Withdrawal by Subject|3|||
155525844|NCT01185821|561352530|FG001|Overall Study|Withdrawal by Subject|2|||
155525845|NCT01185821|561352531|FG002|Overall Study|Withdrawal by Subject|2|||
155525846|NCT01185821|561352532|FG003|Overall Study|Withdrawal by Subject|1|||
155525847|NCT01185821|561352533|FG004|Overall Study|Withdrawal by Subject|3|||
155525848|NCT01185821|561352529|FG000|Overall Study|Lost to Follow-up|1|||
155525849|NCT01185821|561352530|FG001|Overall Study|Lost to Follow-up|1|||
155525850|NCT01185821|561352531|FG002|Overall Study|Lost to Follow-up|2|||
155525851|NCT01185821|561352532|FG003|Overall Study|Lost to Follow-up|1|||
155525852|NCT01185821|561352533|FG004|Overall Study|Lost to Follow-up|2|||
155525853|NCT01185821|561352529|FG000|Overall Study|Administrative problems|0|||
155525854|NCT01185821|561352530|FG001|Overall Study|Administrative problems|0|||
155525855|NCT01185821|561352531|FG002|Overall Study|Administrative problems|1|||
155525856|NCT01185821|561352532|FG003|Overall Study|Administrative problems|1|||
155525857|NCT01185821|561352533|FG004|Overall Study|Administrative problems|2|||
155525858|NCT01534520|561352534|FG000|Overall Study|Adverse Event|0|||
155525859|NCT01534520|561352535|FG001|Overall Study|Adverse Event|1|||
155525860|NCT05615935|561352538|FG000|Overall Study|Lost to Follow-up|1|||
155525861|NCT05615935|561352539|FG001|Overall Study|Lost to Follow-up|1|||
155525862|NCT00420238|561352540|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
155525863|NCT00420238|561352541|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
155525864|NCT00420238|561352540|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
155525865|NCT00420238|561352541|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
155525866|NCT00420238|561352540|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
155525867|NCT00420238|561352541|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
155525868|NCT00420238|561352540|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
155525869|NCT00420238|561352541|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
155525870|NCT00420238|561352540|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
155525871|NCT00420238|561352541|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
155525872|NCT00420238|561352540|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
155525873|NCT00420238|561352541|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
155525874|NCT03555305|561352542|FG000|Period 1|Physician Decision|0|||
155525875|NCT03555305|561352543|FG001|Period 1|Physician Decision|1|||
155525876|NCT03555305|561352542|FG000|Period 1|Adverse Event|0|||
155525877|NCT03555305|561352543|FG001|Period 1|Adverse Event|1|||
155525878|NCT03135834|561352546|FG000|Stage 1|Adverse Event|1|||
155525879|NCT03135834|561352547|FG001|Stage 1|Adverse Event|2|||
155525880|NCT03135834|561352548|FG002|Stage 1|Adverse Event|2|||
155525881|NCT03135834|561352549|FG003|Stage 1|Adverse Event|1|||
155525882|NCT03135834|561352546|FG000|Stage 1|Death|1|||
155525883|NCT03135834|561352547|FG001|Stage 1|Death|0|||
155525884|NCT03135834|561352548|FG002|Stage 1|Death|0|||
155525885|NCT03135834|561352549|FG003|Stage 1|Death|0|||
155525886|NCT03135834|561352546|FG000|Stage 1|Lost to Follow-up|17|||
155525887|NCT03135834|561352547|FG001|Stage 1|Lost to Follow-up|24|||
155525888|NCT03135834|561352548|FG002|Stage 1|Lost to Follow-up|21|||
155525889|NCT03135834|561352549|FG003|Stage 1|Lost to Follow-up|38|||
155525890|NCT03135834|561352546|FG000|Stage 1|No longer met eligibility criteria|1|||
155525891|NCT03135834|561352547|FG001|Stage 1|No longer met eligibility criteria|6|||
155525892|NCT03135834|561352548|FG002|Stage 1|No longer met eligibility criteria|2|||
155525893|NCT03135834|561352549|FG003|Stage 1|No longer met eligibility criteria|5|||
155525894|NCT03135834|561352546|FG000|Stage 1|Other|0|||
155525895|NCT03135834|561352547|FG001|Stage 1|Other|2|||
155525896|NCT03135834|561352548|FG002|Stage 1|Other|1|||
155525897|NCT03135834|561352549|FG003|Stage 1|Other|0|||
155525898|NCT03135834|561352546|FG000|Stage 1|Physician Decision|0|||
155525899|NCT03135834|561352547|FG001|Stage 1|Physician Decision|1|||
155525900|NCT03135834|561352548|FG002|Stage 1|Physician Decision|0|||
155525901|NCT03135834|561352549|FG003|Stage 1|Physician Decision|0|||
155525902|NCT03135834|561352546|FG000|Stage 1|Pregnancy|0|||
155525903|NCT03135834|561352547|FG001|Stage 1|Pregnancy|4|||
155525904|NCT03135834|561352548|FG002|Stage 1|Pregnancy|2|||
155525905|NCT03135834|561352549|FG003|Stage 1|Pregnancy|4|||
155525906|NCT03135834|561352546|FG000|Stage 1|Protocol Violation|1|||
155525907|NCT03135834|561352547|FG001|Stage 1|Protocol Violation|1|||
155525908|NCT03135834|561352548|FG002|Stage 1|Protocol Violation|2|||
155525909|NCT03135834|561352549|FG003|Stage 1|Protocol Violation|1|||
155525910|NCT03135834|561352546|FG000|Stage 1|Withdrawal by parent/guardian|2|||
155525911|NCT03135834|561352547|FG001|Stage 1|Withdrawal by parent/guardian|10|||
155525912|NCT03135834|561352548|FG002|Stage 1|Withdrawal by parent/guardian|2|||
155525913|NCT03135834|561352549|FG003|Stage 1|Withdrawal by parent/guardian|1|||
155525914|NCT03135834|561352546|FG000|Stage 1|Withdrawal by Subject|16|||
155525915|NCT03135834|561352547|FG001|Stage 1|Withdrawal by Subject|22|||
155525916|NCT03135834|561352548|FG002|Stage 1|Withdrawal by Subject|7|||
155525917|NCT03135834|561352549|FG003|Stage 1|Withdrawal by Subject|10|||
155525918|NCT03135834|561352546|FG000|Stage 1|Randomized but not Vaccinated|0|||
155525919|NCT03135834|561352547|FG001|Stage 1|Randomized but not Vaccinated|3|||
155525920|NCT03135834|561352548|FG002|Stage 1|Randomized but not Vaccinated|1|||
155525921|NCT03135834|561352549|FG003|Stage 1|Randomized but not Vaccinated|6|||
155525922|NCT03135834|561352546|FG000|Stage 2|Lost to Follow-up|0|||
155525923|NCT03135834|561352547|FG001|Stage 2|Lost to Follow-up|1|||
155525924|NCT03135834|561352548|FG002|Stage 2|Lost to Follow-up|0|||
155525925|NCT03135834|561352549|FG003|Stage 2|Lost to Follow-up|0|||
155525926|NCT03135834|561352546|FG000|Stage 2|Withdrawal by Subject|0|||
155525927|NCT03135834|561352547|FG001|Stage 2|Withdrawal by Subject|1|||
155525928|NCT03135834|561352548|FG002|Stage 2|Withdrawal by Subject|0|||
155525929|NCT03135834|561352549|FG003|Stage 2|Withdrawal by Subject|0|||
155525930|NCT03135834|561352546|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
155525931|NCT03135834|561352547|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
155525932|NCT03135834|561352548|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
155525933|NCT03135834|561352549|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
155525934|NCT03135834|561352546|FG000|Stage 2|Did not receive Booster Vaccination|1|||
155525935|NCT03135834|561352547|FG001|Stage 2|Did not receive Booster Vaccination|1|||
155525936|NCT03135834|561352548|FG002|Stage 2|Did not receive Booster Vaccination|0|||
155525937|NCT03135834|561352549|FG003|Stage 2|Did not receive Booster Vaccination|0|||
155525938|NCT03966365|561352550|FG000|Overall Study|Protocol Violation|1|||
155525939|NCT03966365|561352551|FG001|Overall Study|Protocol Violation|0|||
155525940|NCT00214422|561352552|FG000|Overall Study|Physician Decision|2|||
155525941|NCT00214422|561352553|FG001|Overall Study|Physician Decision|0|||
155525942|NCT00214422|561352554|FG002|Overall Study|Physician Decision|0|||
155525943|NCT00214422|561352552|FG000|Overall Study|Developed esophageal ca|1|||
155525944|NCT00214422|561352553|FG001|Overall Study|Developed esophageal ca|0|||
155525945|NCT00214422|561352554|FG002|Overall Study|Developed esophageal ca|0|||
155525946|NCT00214422|561352552|FG000|Overall Study|Pt taken off study|1|||
155525947|NCT00214422|561352553|FG001|Overall Study|Pt taken off study|1|||
155525948|NCT00214422|561352554|FG002|Overall Study|Pt taken off study|0|||
155525949|NCT00214422|561352552|FG000|Overall Study|Disease progression on study|1|||
155525950|NCT00214422|561352553|FG001|Overall Study|Disease progression on study|0|||
155525951|NCT00214422|561352554|FG002|Overall Study|Disease progression on study|0|||
155525952|NCT00214422|561352552|FG000|Overall Study|Unable to make a radiation treatment|0|||
155525953|NCT00214422|561352553|FG001|Overall Study|Unable to make a radiation treatment|0|||
155525954|NCT00214422|561352554|FG002|Overall Study|Unable to make a radiation treatment|1|||
155525955|NCT01223365|561352559|FG000|Open-label Titration Period|Enrolled but not treated|1|||
155525956|NCT01223365|561352559|FG000|Open-label Titration Period|Adverse Event|23|||
155525957|NCT01223365|561352559|FG000|Open-label Titration Period|Lack of Efficacy|3|||
155525958|NCT01223365|561352559|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
155525959|NCT01223365|561352559|FG000|Open-label Titration Period|Protocol Violation|1|||
155525960|NCT01223365|561352559|FG000|Open-label Titration Period|Lost to Follow-up|2|||
155525961|NCT01223365|561352559|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
155525962|NCT01223365|561352559|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
155525963|NCT01223365|561352559|FG000|Open-label Titration Period|Starting physical therapy|1|||
155525964|NCT01223365|561352559|FG000|Open-label Treatment Period|Adverse Event|39|||
155525965|NCT01223365|561352559|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
155525966|NCT01223365|561352559|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
155525967|NCT01223365|561352559|FG000|Open-label Treatment Period|Protocol Violation|15|||
155525968|NCT01223365|561352559|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
155525969|NCT01223365|561352559|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
155525970|NCT01223365|561352559|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
155525971|NCT01223365|561352559|FG000|Open-label Treatment Period|Moved out of area|2|||
155525972|NCT01223365|561352559|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
155525973|NCT01223365|561352559|FG000|Open-label Treatment Period|"Out of window"|1|||
155525974|NCT01223365|561352559|FG000|Open-label Treatment Period|Starting physical therapy|1|||
155525975|NCT01223365|561352559|FG000|Open-label Treatment Period|Physician Decision|2|||
155525976|NCT02865122|561352560|FG000|Overall Study|Adverse Event|1|||
155525977|NCT02865122|561352561|FG001|Overall Study|Adverse Event|0|||
155525978|NCT02865122|561352562|FG002|Overall Study|Adverse Event|0|||
155525979|NCT05369208|561354213|FG000|Core Phase|Prohibited Medication Required|2|||
155525980|NCT05369208|561354213|FG000|Core Phase|Adverse Event|1|||
155525981|NCT05369208|561354213|FG000|Core Phase|Lack of Efficacy|1|||
155525982|NCT02262377|561354214|FG000|Overall Study|Lost to Follow-up|5|||
155525983|NCT02262377|561354215|FG001|Overall Study|Lost to Follow-up|6|||
155525984|NCT02262377|561354214|FG000|Overall Study|Found ineligible after enrollment|3|||
155525985|NCT02262377|561354215|FG001|Overall Study|Found ineligible after enrollment|0|||
155525986|NCT02262377|561354214|FG000|Overall Study|Withdrawal by Subject|4|||
155525987|NCT02262377|561354215|FG001|Overall Study|Withdrawal by Subject|0|||
155525988|NCT00371839|561354216|FG000|Overall Study|Death|4|||
155525989|NCT00371839|561354217|FG001|Overall Study|Death|0|||
155486561|NCT00310440|561203804|FG000|Overall Study|Withdrawal by Subject|2|||
155486562|NCT00310440|561203805|FG001|Overall Study|Withdrawal by Subject|1|||
155486563|NCT00310440|561203804|FG000|Overall Study|Missed 12 Month Visit|7|||
155486564|NCT00310440|561203805|FG001|Overall Study|Missed 12 Month Visit|4|||
155486565|NCT00792467|561203806|FG000|Overall Study|progression of disease|17|||
155486566|NCT00792467|561203806|FG000|Overall Study|Adverse Event|1|||
155486567|NCT00792467|561203806|FG000|Overall Study|patient request|1|||
155486568|NCT00792467|561203806|FG000|Overall Study|Lost to Follow-up|1|||
155486569|NCT00792467|561203806|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
155486570|NCT00792467|561203806|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
155486571|NCT01287403|561203811|FG000|1st Intervention (1 Day)|Adverse Event|1|||
155486572|NCT01098266|561203812|FG000|Overall Study|Physician Decision|1|||
155486573|NCT01098266|561203813|FG001|Overall Study|Physician Decision|0|||
155486574|NCT01098266|561203812|FG000|Overall Study|Death|3|||
155486575|NCT01098266|561203813|FG001|Overall Study|Death|2|||
155486576|NCT01098266|561203812|FG000|Overall Study|Withdrawal by Subject|3|||
155486577|NCT01098266|561203813|FG001|Overall Study|Withdrawal by Subject|5|||
155486578|NCT00727246|561203817|FG000|Overall Study|could not complete MRI|0|||
155486579|NCT00727246|561203818|FG001|Overall Study|could not complete MRI|1|||
155486580|NCT00727246|561203819|FG002|Overall Study|could not complete MRI|0|||
155486581|NCT00727246|561203820|FG003|Overall Study|could not complete MRI|1|||
155486582|NCT00727246|561203817|FG000|Overall Study|incidental finding|0|||
155486583|NCT00727246|561203818|FG001|Overall Study|incidental finding|0|||
155486584|NCT00727246|561203819|FG002|Overall Study|incidental finding|0|||
155486585|NCT00727246|561203820|FG003|Overall Study|incidental finding|1|||
155486586|NCT00727246|561203817|FG000|Overall Study|withdrawn|0|||
155486587|NCT00727246|561203818|FG001|Overall Study|withdrawn|0|||
155486588|NCT00727246|561203819|FG002|Overall Study|withdrawn|1|||
155486589|NCT00727246|561203820|FG003|Overall Study|withdrawn|0|||
155486590|NCT04594213|561203821|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
155486591|NCT04594213|561203822|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
155486592|NCT04594213|561203823|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
155486593|NCT04594213|561203824|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155486594|NCT04594213|561203825|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155486595|NCT04594213|561203826|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155486596|NCT04594213|561203821|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
155486597|NCT04594213|561203822|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
155486598|NCT04594213|561203823|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
155486599|NCT04594213|561203824|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
155486600|NCT04594213|561203825|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
155486601|NCT04594213|561203826|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
155486602|NCT04594213|561203821|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
155486603|NCT04594213|561203822|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155486604|NCT04594213|561203823|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
155486605|NCT04594213|561203824|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155486606|NCT04594213|561203825|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155486607|NCT04594213|561203826|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155486608|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155486609|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155486610|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155486611|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155486612|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
155486613|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155486614|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155486615|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155486616|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155486617|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
155486618|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
155486619|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
155486620|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155486621|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155486622|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155486623|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155486624|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155486625|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
155486626|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155486627|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155486628|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155486629|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
155486630|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155525990|NCT00371839|561354218|FG002|Overall Study|Death|0|||
155525991|NCT00371839|561354216|FG000|Overall Study|Withdrawal by Subject|7|||
155525992|NCT00371839|561354217|FG001|Overall Study|Withdrawal by Subject|4|||
155525993|NCT00371839|561354218|FG002|Overall Study|Withdrawal by Subject|0|||
155525994|NCT00371839|561354216|FG000|Overall Study|Lost to Follow-up|6|||
155525995|NCT00371839|561354217|FG001|Overall Study|Lost to Follow-up|3|||
155525996|NCT00371839|561354218|FG002|Overall Study|Lost to Follow-up|2|||
155525997|NCT01049334|561354220|FG000|Overall Study|Withdrawal by Subject|5|||
155525998|NCT01049334|561354221|FG001|Overall Study|Withdrawal by Subject|3|||
155525999|NCT01049334|561354220|FG000|Overall Study|Adverse Event|2|||
155526000|NCT01049334|561354221|FG001|Overall Study|Adverse Event|3|||
155526001|NCT01049334|561354220|FG000|Overall Study|Physician Decision|2|||
155526002|NCT01049334|561354221|FG001|Overall Study|Physician Decision|0|||
155526003|NCT01049334|561354220|FG000|Overall Study|Protocol Violation|0|||
155526004|NCT01049334|561354221|FG001|Overall Study|Protocol Violation|1|||
155526005|NCT04089735|561354222|FG000|Overall Study|Adverse Event|1|||
155526006|NCT04089735|561354223|FG001|Overall Study|Adverse Event|0|||
155526007|NCT04089735|561354224|FG002|Overall Study|Adverse Event|1|||
155526008|NCT04089735|561354225|FG003|Overall Study|Adverse Event|1|||
155526009|NCT04089735|561354226|FG004|Overall Study|Adverse Event|0|||
155526010|NCT04089735|561354227|FG005|Overall Study|Adverse Event|0|||
155526011|NCT04089735|561354222|FG000|Overall Study|Physician Decision|0|||
155526012|NCT04089735|561354223|FG001|Overall Study|Physician Decision|3|||
155526013|NCT04089735|561354224|FG002|Overall Study|Physician Decision|0|||
155526014|NCT04089735|561354225|FG003|Overall Study|Physician Decision|0|||
155526015|NCT04089735|561354226|FG004|Overall Study|Physician Decision|0|||
155526016|NCT04089735|561354227|FG005|Overall Study|Physician Decision|0|||
155526017|NCT04089735|561354222|FG000|Overall Study|Withdrawal by Subject|0|||
155526018|NCT04089735|561354223|FG001|Overall Study|Withdrawal by Subject|0|||
155526019|NCT04089735|561354224|FG002|Overall Study|Withdrawal by Subject|1|||
155526020|NCT04089735|561354225|FG003|Overall Study|Withdrawal by Subject|0|||
155526021|NCT04089735|561354226|FG004|Overall Study|Withdrawal by Subject|0|||
155526022|NCT04089735|561354227|FG005|Overall Study|Withdrawal by Subject|0|||
155526023|NCT04089735|561354222|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
155526024|NCT04089735|561354223|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
155526025|NCT04089735|561354224|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
155526026|NCT04089735|561354225|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
155526027|NCT04089735|561354226|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
155526028|NCT04089735|561354227|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
155526029|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
155526030|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
155526031|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Death|2|||
155526032|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Death|1|||
155526033|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
155526034|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
155526035|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
155526036|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
155526037|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Other|8|||
155526038|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Other|13|||
155526039|NCT01439880|561354237|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
155526040|NCT01439880|561354238|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
155526041|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
155526042|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
155526043|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
155526044|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
155526045|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Death|3|||
155526046|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Death|13|||
155526047|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
155526048|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
155526049|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Other|14|||
155526050|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Other|31|||
155526051|NCT01439880|561354237|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
155526052|NCT01439880|561354238|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
155526053|NCT00328926|561354239|FG000|Overall Study|Pregnancy|2|||
155526054|NCT00328926|561354240|FG001|Overall Study|Pregnancy|1|||
155526055|NCT00328926|561354241|FG002|Overall Study|Pregnancy|0|||
155526056|NCT00328926|561354239|FG000|Overall Study|Lost to Follow-up|0|||
155526057|NCT00328926|561354240|FG001|Overall Study|Lost to Follow-up|1|||
155526058|NCT00328926|561354241|FG002|Overall Study|Lost to Follow-up|0|||
155526059|NCT00328926|561354239|FG000|Overall Study|Death|0|||
155526060|NCT00328926|561354240|FG001|Overall Study|Death|0|||
155526061|NCT00328926|561354241|FG002|Overall Study|Death|1|||
155526062|NCT00328926|561354239|FG000|Overall Study|In vitro fertilization treatment|0|||
155526063|NCT00328926|561354240|FG001|Overall Study|In vitro fertilization treatment|0|||
155526064|NCT00328926|561354241|FG002|Overall Study|In vitro fertilization treatment|1|||
155526065|NCT00328926|561354239|FG000|Overall Study|Lack of ovarian response|0|||
155526066|NCT00328926|561354240|FG001|Overall Study|Lack of ovarian response|1|||
155526067|NCT00328926|561354241|FG002|Overall Study|Lack of ovarian response|0|||
155526068|NCT00573066|561354242|FG000|Overall Study|Exclusion criteria|18|||
155526069|NCT00573066|561354242|FG000|Overall Study|IV malfunction|1|||
155526070|NCT00573066|561354242|FG000|Overall Study|Postoperative bleeding|1|||
155526071|NCT02246166|561354245|FG000|Overall Study|Protocol Violation|1|||
155526072|NCT02246166|561354246|FG001|Overall Study|Protocol Violation|0|||
155526073|NCT00834743|561354247|FG000|Second Intervention|Withdrawal by Subject|1|||
155526074|NCT00834743|561354248|FG001|Second Intervention|Withdrawal by Subject|0|||
155526075|NCT00376623|561354251|FG000|Overall Study|Progressive disease|35|||
155526076|NCT00376623|561354252|FG001|Overall Study|Progressive disease|22|||
155526077|NCT00376623|561354253|FG002|Overall Study|Progressive disease|17|||
155526078|NCT00376623|561354251|FG000|Overall Study|Lost to Follow-up|0|||
155526079|NCT00376623|561354252|FG001|Overall Study|Lost to Follow-up|1|||
155526080|NCT00376623|561354253|FG002|Overall Study|Lost to Follow-up|0|||
155526081|NCT00376623|561354251|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
155526082|NCT00376623|561354252|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
155526083|NCT00376623|561354253|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
155526084|NCT00376623|561354251|FG000|Overall Study|Not treated with BI 2536|1|||
155526085|NCT00376623|561354252|FG001|Overall Study|Not treated with BI 2536|0|||
155526086|NCT00376623|561354253|FG002|Overall Study|Not treated with BI 2536|0|||
155526087|NCT00376623|561354251|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
155526088|NCT00376623|561354252|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526089|NCT00376623|561354253|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526090|NCT00376623|561354251|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
155526091|NCT00376623|561354252|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
155526092|NCT00376623|561354253|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
155526093|NCT00376623|561354251|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
155526094|NCT00376623|561354252|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526095|NCT00376623|561354253|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526096|NCT00376623|561354251|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
155526097|NCT00376623|561354252|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
155526098|NCT00376623|561354253|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
155526099|NCT00376623|561354251|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526100|NCT00376623|561354252|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
155526101|NCT00376623|561354253|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
155526102|NCT00376623|561354251|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
155526103|NCT00376623|561354252|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
155526104|NCT00376623|561354253|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
155526105|NCT00376623|561354251|FG000|Overall Study|Increase of tumour markers|0|||
155526106|NCT00376623|561354252|FG001|Overall Study|Increase of tumour markers|1|||
155526107|NCT00376623|561354253|FG002|Overall Study|Increase of tumour markers|0|||
155526108|NCT00376623|561354251|FG000|Overall Study|Bone metastasis|1|||
155526109|NCT00376623|561354252|FG001|Overall Study|Bone metastasis|0|||
155526110|NCT00376623|561354253|FG002|Overall Study|Bone metastasis|0|||
155526111|NCT02331394|561354254|FG000|Overall Study|Disease progression|1|||
155526112|NCT04247282|561354255|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
155526113|NCT04247282|561354256|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
155526114|NCT04247282|561354257|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
155526115|NCT04247282|561354258|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
155526116|NCT04247282|561354255|FG000|Overall Study|Refused further treatment|0|||
155526117|NCT04247282|561354256|FG001|Overall Study|Refused further treatment|1|||
155526118|NCT04247282|561354257|FG002|Overall Study|Refused further treatment|0|||
155526119|NCT04247282|561354258|FG003|Overall Study|Refused further treatment|0|||
155655022|NCT00124657|561830618|FG002|Overall Study|Intercurrent illness|0|||
155655023|NCT00619918|561830623|FG000|Overall Study|Withdrawal by Subject|4|||
155655024|NCT00619918|561830624|FG001|Overall Study|Withdrawal by Subject|3|||
155655025|NCT00619918|561830623|FG000|Overall Study|Physician Decision|2|||
155655026|NCT00619918|561830624|FG001|Overall Study|Physician Decision|4|||
155526120|NCT00301366|561354259|FG000|Overall Study|Adverse Event|1|||
155526121|NCT01313273|561354262|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
155526122|NCT01313273|561354263|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
155526123|NCT01313273|561354262|FG000|Overall Study|Withdrawal by Subject|1|||
155655027|NCT00619918|561830623|FG000|Overall Study|Transfer to outside facility|3|||
155655028|NCT00619918|561830624|FG001|Overall Study|Transfer to outside facility|3|||
155655029|NCT00619918|561830623|FG000|Overall Study|Left before receiving first dose|7|||
155655030|NCT00619918|561830624|FG001|Overall Study|Left before receiving first dose|6|||
155655031|NCT00619918|561830623|FG000|Overall Study|ICU admission|4|||
155655032|NCT00619918|561830624|FG001|Overall Study|ICU admission|6|||
155655033|NCT03533491|561830625|FG000|Overall Study|Lost to Follow-up|2|||
155655034|NCT01969409|561830629|FG000|Overall Study|Death|2|||
155655035|NCT01969409|561830630|FG001|Overall Study|Death|2|||
155655036|NCT01969409|561830629|FG000|Overall Study|Transplant|1|||
155655037|NCT01969409|561830630|FG001|Overall Study|Transplant|1|||
155655038|NCT01969409|561830629|FG000|Overall Study|Withdrawal by Subject|0|||
155655039|NCT01969409|561830630|FG001|Overall Study|Withdrawal by Subject|1|||
155655040|NCT01554904|561830633|FG000|Overall Study|Withdrawal by Subject|3|||
155655041|NCT01554904|561830633|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
155655042|NCT01051661|561830636|FG000|Overall Study|Adverse Event|1|||
155655043|NCT01051661|561830637|FG001|Overall Study|Adverse Event|1|||
155655044|NCT01051661|561830638|FG002|Overall Study|Adverse Event|1|||
155655045|NCT01051661|561830639|FG003|Overall Study|Adverse Event|1|||
155655046|NCT01051661|561830640|FG004|Overall Study|Adverse Event|0|||
155655047|NCT01051661|561830641|FG005|Overall Study|Adverse Event|0|||
155655048|NCT01051661|561830636|FG000|Overall Study|Lost to Follow-up|13|||
155655049|NCT01051661|561830637|FG001|Overall Study|Lost to Follow-up|22|||
155655050|NCT01051661|561830638|FG002|Overall Study|Lost to Follow-up|15|||
155655051|NCT01051661|561830639|FG003|Overall Study|Lost to Follow-up|17|||
155655052|NCT01051661|561830640|FG004|Overall Study|Lost to Follow-up|10|||
155655053|NCT01051661|561830641|FG005|Overall Study|Lost to Follow-up|24|||
155526124|NCT01313273|561354263|FG001|Overall Study|Withdrawal by Subject|0|||
155526125|NCT01313273|561354262|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
155526126|NCT01313273|561354263|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
155526127|NCT02865850|561354268|FG000|Overall Study|Death|15|||
155526128|NCT02865850|561354269|FG001|Overall Study|Death|19|||
155526129|NCT02865850|561354268|FG000|Overall Study|Withdrawal by Subject|3|||
155526130|NCT02865850|561354269|FG001|Overall Study|Withdrawal by Subject|2|||
155526131|NCT02865850|561354268|FG000|Overall Study|Lost to Follow-up|3|||
155526132|NCT02865850|561354269|FG001|Overall Study|Lost to Follow-up|2|||
155526133|NCT00552669|561354270|FG000|Overall Study|Death|3|||
155526134|NCT00552669|561354271|FG001|Overall Study|Death|7|||
155655054|NCT01051661|561830636|FG000|Overall Study|Migrated/moved from study area|1|||
155655055|NCT01051661|561830637|FG001|Overall Study|Migrated/moved from study area|6|||
155655056|NCT01051661|561830638|FG002|Overall Study|Migrated/moved from study area|6|||
155655057|NCT01051661|561830639|FG003|Overall Study|Migrated/moved from study area|8|||
155655058|NCT01051661|561830640|FG004|Overall Study|Migrated/moved from study area|7|||
155655059|NCT01051661|561830641|FG005|Overall Study|Migrated/moved from study area|3|||
155655060|NCT01051661|561830636|FG000|Overall Study|Refused blood sampling|0|||
155526135|NCT03687736|561354272|FG000|Overall Study|Lost to Follow-up|7|||
155526136|NCT03687736|561354272|FG000|Overall Study|Withdrawal by Subject|3|||
155526137|NCT02098876|561354274|FG000|Overall Study|Withdrawal by Subject|5|||
155526138|NCT02098876|561354275|FG001|Overall Study|Withdrawal by Subject|5|||
155655061|NCT01051661|561830637|FG001|Overall Study|Refused blood sampling|0|||
155655062|NCT01051661|561830638|FG002|Overall Study|Refused blood sampling|0|||
155655063|NCT01051661|561830639|FG003|Overall Study|Refused blood sampling|0|||
155526139|NCT03195491|561354276|FG000|Overall Study|Study drug toxicity|25|||
155526140|NCT03195491|561354277|FG001|Overall Study|Study drug toxicity|3|||
155526141|NCT03195491|561354276|FG000|Overall Study|Maximum clinical benefit|5|||
155526142|NCT03195491|561354277|FG001|Overall Study|Maximum clinical benefit|0|||
155526143|NCT03195491|561354276|FG000|Overall Study|Lost to Follow-up|1|||
155526144|NCT03195491|561354277|FG001|Overall Study|Lost to Follow-up|0|||
155526145|NCT03195491|561354276|FG000|Overall Study|Death|3|||
155526146|NCT03195491|561354277|FG001|Overall Study|Death|0|||
155526147|NCT03195491|561354276|FG000|Overall Study|Adverse event unrelated to study drug|19|||
155526148|NCT03195491|561354277|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155526149|NCT03195491|561354276|FG000|Overall Study|Disease progression|266|||
155526150|NCT03195491|561354277|FG001|Overall Study|Disease progression|8|||
155526151|NCT03195491|561354276|FG000|Overall Study|Other reasons|10|||
155526152|NCT03195491|561354277|FG001|Overall Study|Other reasons|0|||
155526153|NCT03195491|561354276|FG000|Overall Study|Participant withdrew consent|8|||
155526154|NCT03195491|561354277|FG001|Overall Study|Participant withdrew consent|1|||
155526155|NCT03195491|561354276|FG000|Overall Study|Participant no longer meets study criteria|0|||
155526156|NCT03195491|561354277|FG001|Overall Study|Participant no longer meets study criteria|1|||
155526157|NCT03195491|561354276|FG000|Overall Study|Participant request to discontinue study treatment|10|||
155526158|NCT03195491|561354277|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155526159|NCT01263704|561354278|FG000|Overall Study|Progressive disease|18|||
155526160|NCT01263704|561354278|FG000|Overall Study|Adverse Event|3|||
155526161|NCT01263704|561354278|FG000|Overall Study|Death|2|||
155526162|NCT01263704|561354278|FG000|Overall Study|Patient withdrew consent|2|||
155526163|NCT01263704|561354278|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
155526164|NCT01263704|561354278|FG000|Overall Study|Lost to Follow-up|1|||
155526165|NCT01263704|561354278|FG000|Overall Study|Colon metastases|1|||
155526166|NCT01263704|561354278|FG000|Overall Study|Principal Investigator (PI) decision|1|||
155526167|NCT02514122|561354279|FG000|Overall Study|Withdrawal by Subject|2|||
155526168|NCT02514122|561354280|FG001|Overall Study|Withdrawal by Subject|0|||
155526169|NCT01792635|561354281|FG000|Part B|Adverse Event|0|||
155526170|NCT01792635|561354282|FG001|Part B|Adverse Event|0|||
155526171|NCT01792635|561354283|FG002|Part B|Adverse Event|1|||
155526172|NCT01792635|561354281|FG000|Part B|Study terminated|0|||
155526173|NCT01792635|561354282|FG001|Part B|Study terminated|4|||
155526174|NCT01792635|561354283|FG002|Part B|Study terminated|3|||
155526175|NCT01118312|561354284|FG000|Overall Study|Lost to Follow-up|33|||
155526176|NCT01118312|561354285|FG001|Overall Study|Lost to Follow-up|32|||
155526177|NCT01118312|561354284|FG000|Overall Study|Withdrawal by Subject|1|||
155526178|NCT01118312|561354285|FG001|Overall Study|Withdrawal by Subject|3|||
155526179|NCT03965091|561354287|FG000|Overall Study|Adverse Event|0|||
155526180|NCT03965091|561354288|FG001|Overall Study|Adverse Event|2|||
155526181|NCT03965091|561354289|FG002|Overall Study|Adverse Event|3|||
155526182|NCT03965091|561354287|FG000|Overall Study|Withdrawal by Subject|11|||
155526183|NCT03965091|561354288|FG001|Overall Study|Withdrawal by Subject|3|||
155526184|NCT03965091|561354289|FG002|Overall Study|Withdrawal by Subject|5|||
155526185|NCT03965091|561354287|FG000|Overall Study|Non-compliance with study drug|0|||
155526186|NCT03965091|561354288|FG001|Overall Study|Non-compliance with study drug|0|||
155526187|NCT03965091|561354289|FG002|Overall Study|Non-compliance with study drug|1|||
155526188|NCT03965091|561354287|FG000|Overall Study|Lost to Follow-up|1|||
155526189|NCT03965091|561354288|FG001|Overall Study|Lost to Follow-up|1|||
155526190|NCT03965091|561354289|FG002|Overall Study|Lost to Follow-up|1|||
155526191|NCT03965091|561354287|FG000|Overall Study|Lack of Efficacy|2|||
155526192|NCT03965091|561354288|FG001|Overall Study|Lack of Efficacy|0|||
155526193|NCT03965091|561354289|FG002|Overall Study|Lack of Efficacy|0|||
155526194|NCT03965091|561354287|FG000|Overall Study|Other than specified|9|||
155526195|NCT03965091|561354288|FG001|Overall Study|Other than specified|11|||
155526196|NCT03965091|561354289|FG002|Overall Study|Other than specified|8|||
155526197|NCT00537979|561354296|FG000|Overall Study|Adverse Event|2|||
155526198|NCT00537979|561354297|FG001|Overall Study|Adverse Event|2|||
155526199|NCT00537979|561354296|FG000|Overall Study|Withdrawal by Subject|1|||
155526200|NCT00537979|561354297|FG001|Overall Study|Withdrawal by Subject|4|||
155526201|NCT00537979|561354296|FG000|Overall Study|Lost to Follow-up|1|||
155526202|NCT00537979|561354297|FG001|Overall Study|Lost to Follow-up|4|||
155526203|NCT00537979|561354296|FG000|Overall Study|Lack of Efficacy|0|||
155526204|NCT00537979|561354297|FG001|Overall Study|Lack of Efficacy|1|||
155526205|NCT00537979|561354296|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
155526206|NCT00537979|561354297|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
155526207|NCT00537979|561354296|FG000|Overall Study|Death|0|||
155526208|NCT00537979|561354297|FG001|Overall Study|Death|3|||
155526209|NCT00537979|561354296|FG000|Overall Study|Kidney transplant|0|||
155526210|NCT00537979|561354297|FG001|Overall Study|Kidney transplant|3|||
155526211|NCT00537979|561354296|FG000|Overall Study|Heart failure|0|||
155526212|NCT00537979|561354297|FG001|Overall Study|Heart failure|1|||
155526213|NCT01417078|561354300|FG000|Overall Study|Withdrawal by Subject|1|||
155526214|NCT00626548|561354301|FG000|Overall Study|Adverse Event|164|||
155526215|NCT00626548|561354302|FG001|Overall Study|Adverse Event|44|||
155526216|NCT00626548|561354301|FG000|Overall Study|Withdrawal by Subject|42|||
155526217|NCT00626548|561354302|FG001|Overall Study|Withdrawal by Subject|46|||
155526218|NCT00626548|561354301|FG000|Overall Study|Protocol Violation|4|||
155526219|NCT00626548|561354302|FG001|Overall Study|Protocol Violation|11|||
155526220|NCT00626548|561354301|FG000|Overall Study|Lost to Follow-up|2|||
155526221|NCT00626548|561354302|FG001|Overall Study|Lost to Follow-up|2|||
155526222|NCT00626548|561354301|FG000|Overall Study|Other termination reason|493|||
155526223|NCT00626548|561354302|FG001|Overall Study|Other termination reason|613|||
155526224|NCT01059903|561354306|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
155526225|NCT01059903|561354307|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
155526226|NCT02392000|561354310|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
155526227|NCT02392000|561354310|FG000|Overall Study|Withdrawal by Subject|1|||
155526228|NCT02392000|561354310|FG000|Overall Study|Lost to Follow-up|8|||
155526229|NCT04384978|561354311|FG000|Overall Study|Withdrawal by Subject|4|||
155526230|NCT04384978|561354312|FG001|Overall Study|Withdrawal by Subject|0|||
155526231|NCT00385593|561354313|FG000|Overall Study|Adverse Event|3|||
155526232|NCT00385593|561354314|FG001|Overall Study|Adverse Event|2|||
155526233|NCT00385593|561354313|FG000|Overall Study|Withdrawal by Subject|17|||
155526234|NCT00385593|561354314|FG001|Overall Study|Withdrawal by Subject|7|||
155526235|NCT00385593|561354313|FG000|Overall Study|Lost to Follow-up|12|||
155526236|NCT00385593|561354314|FG001|Overall Study|Lost to Follow-up|8|||
155526237|NCT00385593|561354313|FG000|Overall Study|Protocol Violation|7|||
155526238|NCT00385593|561354314|FG001|Overall Study|Protocol Violation|4|||
155526239|NCT00385593|561354313|FG000|Overall Study|Several reasons|17|||
155526240|NCT00385593|561354314|FG001|Overall Study|Several reasons|15|||
155526241|NCT00385593|561354313|FG000|Overall Study|Incorrect inclusion|2|||
155526242|NCT00385593|561354314|FG001|Overall Study|Incorrect inclusion|0|||
155526243|NCT00385593|561354313|FG000|Overall Study|Incorrect randomization|0|||
155526244|NCT00385593|561354314|FG001|Overall Study|Incorrect randomization|1|||
155526245|NCT00858845|561354327|FG000|Overall Study|Patient underwent heart transplant.|0|||
155526246|NCT00858845|561354328|FG001|Overall Study|Patient underwent heart transplant.|1|||
155526247|NCT02100228|561354331|FG000|Overall Study|Other|19|||
155526248|NCT02100228|561354332|FG001|Overall Study|Other|19|||
155526249|NCT02100228|561354331|FG000|Overall Study|Administrative reason|0|||
155526250|NCT02100228|561354332|FG001|Overall Study|Administrative reason|1|||
155526251|NCT02100228|561354331|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
155526252|NCT02100228|561354332|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
155526253|NCT02100228|561354331|FG000|Overall Study|Non-compliance|0|||
155526254|NCT02100228|561354332|FG001|Overall Study|Non-compliance|3|||
155526255|NCT02100228|561354331|FG000|Overall Study|Lost to Follow-up|0|||
155526256|NCT02100228|561354332|FG001|Overall Study|Lost to Follow-up|1|||
155526257|NCT02100228|561354331|FG000|Overall Study|Withdrawal by Subject|27|||
155526258|NCT02100228|561354332|FG001|Overall Study|Withdrawal by Subject|37|||
155526259|NCT02100228|561354331|FG000|Overall Study|Adverse Event|16|||
155526260|NCT02100228|561354332|FG001|Overall Study|Adverse Event|12|||
155526261|NCT02100228|561354331|FG000|Overall Study|Death|1|||
155526262|NCT02100228|561354332|FG001|Overall Study|Death|1|||
155526263|NCT00854100|561354341|FG000|Overall Study|Inability to complete the study visits|0|||
155526264|NCT00854100|561354342|FG001|Overall Study|Inability to complete the study visits|0|||
155526265|NCT00854100|561354343|FG002|Overall Study|Inability to complete the study visits|1|||
155526266|NCT00854100|561354341|FG000|Overall Study|Lost to Follow-up|2|||
155526267|NCT00854100|561354342|FG001|Overall Study|Lost to Follow-up|0|||
155526268|NCT00854100|561354343|FG002|Overall Study|Lost to Follow-up|3|||
155526269|NCT00854100|561354341|FG000|Overall Study|Withdrawal by Subject|3|||
155526270|NCT00854100|561354342|FG001|Overall Study|Withdrawal by Subject|1|||
155526271|NCT00854100|561354343|FG002|Overall Study|Withdrawal by Subject|2|||
155526272|NCT00854100|561354341|FG000|Overall Study|Protocol Violation|2|||
155526273|NCT00854100|561354342|FG001|Overall Study|Protocol Violation|4|||
155526274|NCT00854100|561354343|FG002|Overall Study|Protocol Violation|3|||
155526275|NCT00854100|561354341|FG000|Overall Study|Adverse Event|2|||
155526276|NCT00854100|561354342|FG001|Overall Study|Adverse Event|1|||
155526277|NCT00854100|561354343|FG002|Overall Study|Adverse Event|2|||
155526278|NCT00389064|561354345|FG000|Overall Study|Adverse Event|11|||
155526279|NCT00389064|561354346|FG001|Overall Study|Adverse Event|3|||
155526280|NCT00389064|561354345|FG000|Overall Study|Lack of Efficacy|3|||
155526281|NCT00389064|561354346|FG001|Overall Study|Lack of Efficacy|14|||
155526282|NCT00389064|561354345|FG000|Overall Study|Withdrawal by Subject|17|||
155526283|NCT00389064|561354346|FG001|Overall Study|Withdrawal by Subject|27|||
155526284|NCT00389064|561354345|FG000|Overall Study|Physician Decision|2|||
155526285|NCT00389064|561354346|FG001|Overall Study|Physician Decision|2|||
155526286|NCT00389064|561354345|FG000|Overall Study|Lost to Follow-up|1|||
155526287|NCT00389064|561354346|FG001|Overall Study|Lost to Follow-up|2|||
155526288|NCT00389064|561354345|FG000|Overall Study|Protocol Violation|2|||
155526289|NCT00389064|561354346|FG001|Overall Study|Protocol Violation|0|||
155526290|NCT00389064|561354345|FG000|Overall Study|Multiple Reasons|9|||
155526291|NCT00389064|561354346|FG001|Overall Study|Multiple Reasons|11|||
155526292|NCT03616106|561354347|FG000|Overall Study|Removed by PI|6|||
155526293|NCT03616106|561354348|FG001|Overall Study|Removed by PI|0|||
155526294|NCT03616106|561354347|FG000|Overall Study|Withdrawal by Subject|1|||
155526295|NCT03616106|561354348|FG001|Overall Study|Withdrawal by Subject|1|||
155526296|NCT03616106|561354347|FG000|Overall Study|Lost to Follow-up|7|||
155526297|NCT03616106|561354348|FG001|Overall Study|Lost to Follow-up|0|||
155526298|NCT01880593|561354349|FG000|Overall Study|Adverse Event|1|||
155526299|NCT01880593|561354350|FG001|Overall Study|Adverse Event|0|||
155526300|NCT01880593|561354349|FG000|Overall Study|Lack of Efficacy|1|||
155526301|NCT01880593|561354350|FG001|Overall Study|Lack of Efficacy|5|||
155526302|NCT01880593|561354349|FG000|Overall Study|Withdrawal by Subject|6|||
155526303|NCT01880593|561354350|FG001|Overall Study|Withdrawal by Subject|1|||
155526304|NCT05275205|561354354|FG000|Overall Study|Adverse Event|1|||
155526305|NCT05275205|561354355|FG001|Overall Study|Adverse Event|2|||
155526306|NCT05275205|561354354|FG000|Overall Study|Physician Decision|1|||
155526307|NCT05275205|561354355|FG001|Overall Study|Physician Decision|1|||
155526308|NCT05275205|561354354|FG000|Overall Study|Withdrawal by Subject|2|||
155526309|NCT05275205|561354355|FG001|Overall Study|Withdrawal by Subject|3|||
155526310|NCT05275205|561354354|FG000|Overall Study|Death|1|||
155526311|NCT05275205|561354355|FG001|Overall Study|Death|0|||
155526312|NCT05275205|561354354|FG000|Overall Study|Patient unable to attend visits|1|||
155526313|NCT05275205|561354355|FG001|Overall Study|Patient unable to attend visits|0|||
155526314|NCT03041025|561354357|FG000|Overall Study|Adverse Event|0|||
155526315|NCT03041025|561354358|FG001|Overall Study|Adverse Event|0|||
155526316|NCT03041025|561354359|FG002|Overall Study|Adverse Event|1|||
155526317|NCT03041025|561354357|FG000|Overall Study|Lost to Follow-up|1|||
155526318|NCT03041025|561354358|FG001|Overall Study|Lost to Follow-up|0|||
155526319|NCT03041025|561354359|FG002|Overall Study|Lost to Follow-up|0|||
155526320|NCT03041025|561354357|FG000|Overall Study|Withdrawal by Subject|0|||
155526321|NCT03041025|561354358|FG001|Overall Study|Withdrawal by Subject|0|||
155526322|NCT03041025|561354359|FG002|Overall Study|Withdrawal by Subject|1|||
155526323|NCT02963259|561354361|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
155526324|NCT02963259|561354361|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
155526325|NCT02963259|561354361|FG000|Overall Study|Death|1|||
155526326|NCT02963259|561354361|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
155526327|NCT03243630|561354363|FG000|Overall Study|Protocol Violation|1|||
155526328|NCT03243630|561354363|FG000|Overall Study|Physician Decision|1|||
155526329|NCT00939003|561354364|FG000|Double-blind Treatment Period|Adverse Event|1|||
155526330|NCT00939003|561354365|FG001|Double-blind Treatment Period|Adverse Event|1|||
155526331|NCT00939003|561354364|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155526332|NCT00939003|561354365|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
155526333|NCT00939003|561354364|FG000|Double-blind Treatment Period|Pregnancy|0|||
155526334|NCT00939003|561354365|FG001|Double-blind Treatment Period|Pregnancy|1|||
155526335|NCT00939003|561354364|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
155526336|NCT00939003|561354365|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
155526337|NCT00939003|561354364|FG000|Open-label Treatment Period|Adverse Event|4|||
155526338|NCT00939003|561354365|FG001|Open-label Treatment Period|Adverse Event|8|||
155526339|NCT00939003|561354364|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
155526340|NCT00939003|561354365|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
155526341|NCT00939003|561354364|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
155526342|NCT00939003|561354365|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
155526343|NCT00939003|561354364|FG000|Open-label Treatment Period|Pregnancy|1|||
155526344|NCT00939003|561354365|FG001|Open-label Treatment Period|Pregnancy|1|||
155526345|NCT00939003|561354364|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
155526346|NCT00939003|561354365|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
155526347|NCT00939003|561354364|FG000|Open-label Treatment Period|Site Closure|3|||
155526348|NCT00939003|561354365|FG001|Open-label Treatment Period|Site Closure|4|||
155526349|NCT02131129|561354367|FG000|Overall Study|Withdrawal by Subject|1|||
155526350|NCT02131129|561354368|FG001|Overall Study|Withdrawal by Subject|0|||
155526351|NCT03707912|561354369|FG000|Overall Study|Violation of inclusion criteria|1|||
155526352|NCT03707912|561354370|FG001|Overall Study|Violation of inclusion criteria|0|||
155526353|NCT03880266|561354371|FG000|Overall Study|Withdrawal by Subject|0|||
155526354|NCT03880266|561354372|FG001|Overall Study|Withdrawal by Subject|1|||
155526355|NCT03880266|561354373|FG002|Overall Study|Withdrawal by Subject|1|||
155526356|NCT03880266|561354374|FG003|Overall Study|Withdrawal by Subject|0|||
155526357|NCT03880266|561354375|FG004|Overall Study|Withdrawal by Subject|0|||
155526358|NCT03880266|561354376|FG005|Overall Study|Withdrawal by Subject|0|||
155526359|NCT03880266|561354377|FG006|Overall Study|Withdrawal by Subject|0|||
155526360|NCT03880266|561354378|FG007|Overall Study|Withdrawal by Subject|0|||
155526361|NCT00467896|561356023|FG000|Overall Study|Consent Withdrawal|18|||
155526362|NCT00467896|561356023|FG000|Overall Study|Adverse Event|7|||
155526363|NCT00467896|561356023|FG000|Overall Study|Serious Adverse Event|13|||
155526364|NCT00467896|561356023|FG000|Overall Study|Non-compliance|3|||
155526365|NCT00467896|561356023|FG000|Overall Study|Changed therapy|2|||
155526366|NCT00467896|561356023|FG000|Overall Study|Patient received transplant|2|||
155526367|NCT00467896|561356023|FG000|Overall Study|Patient had atrial septostomy|1|||
155526368|NCT00467896|561356023|FG000|Overall Study|Patient weaned off iloprost|1|||
155526369|NCT00467896|561356023|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
155526370|NCT00467896|561356023|FG000|Overall Study|Started intravenous prostacyclin|1|||
155526371|NCT00467896|561356023|FG000|Overall Study|Started inhaled Remodulin|1|||
155526372|NCT00467896|561356023|FG000|Overall Study|Patient had no improvement|1|||
155526373|NCT03818581|561356028|FG000|Overall Study|Adverse Event|1|||
155526374|NCT03818581|561356029|FG001|Overall Study|Adverse Event|0|||
155526375|NCT03818581|561356030|FG002|Overall Study|Adverse Event|0|||
155526376|NCT03818581|561356031|FG003|Overall Study|Adverse Event|0|||
155526377|NCT03818581|561356032|FG004|Overall Study|Adverse Event|0|||
155526378|NCT03818581|561356028|FG000|Overall Study|Covid-19|2|||
155526379|NCT03818581|561356029|FG001|Overall Study|Covid-19|0|||
155526380|NCT03818581|561356030|FG002|Overall Study|Covid-19|0|||
155526381|NCT03818581|561356031|FG003|Overall Study|Covid-19|0|||
155526382|NCT03818581|561356032|FG004|Overall Study|Covid-19|1|||
155526383|NCT03818581|561356028|FG000|Overall Study|Withdrawal by Subject|0|||
155526384|NCT03818581|561356029|FG001|Overall Study|Withdrawal by Subject|0|||
155526385|NCT03818581|561356030|FG002|Overall Study|Withdrawal by Subject|0|||
155526386|NCT03818581|561356031|FG003|Overall Study|Withdrawal by Subject|0|||
155526387|NCT03818581|561356032|FG004|Overall Study|Withdrawal by Subject|1|||
155526388|NCT03818581|561356028|FG000|Overall Study|No longer met study criteria|0|||
155526389|NCT03818581|561356029|FG001|Overall Study|No longer met study criteria|0|||
155526390|NCT03818581|561356030|FG002|Overall Study|No longer met study criteria|0|||
155526391|NCT03818581|561356031|FG003|Overall Study|No longer met study criteria|0|||
155526392|NCT03818581|561356032|FG004|Overall Study|No longer met study criteria|1|||
155526393|NCT01466166|561356038|FG000|Overall Study|Death|1|||
155526394|NCT01466166|561356038|FG000|Overall Study|Lost to Follow-up|7|||
155526395|NCT01466166|561356038|FG000|Overall Study|Infusion Reaction (IR)|27|||
155526396|NCT01466166|561356038|FG000|Overall Study|Adverse Event (Other than IR)|11|||
155526397|NCT01466166|561356038|FG000|Overall Study|Elevated Serum Uric Acid|78|||
155526398|NCT01466166|561356038|FG000|Overall Study|Withdrawal by Subject|13|||
155526399|NCT01466166|561356038|FG000|Overall Study|Sponsor Decision|4|||
155526400|NCT01466166|561356038|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
155526401|NCT01466166|561356038|FG000|Overall Study|Other|20|||
155526402|NCT02096211|561356039|FG000|Overall Study|Death|2|||
155526403|NCT02096211|561356039|FG000|Overall Study|Withdrawal by Subject|8|||
155526404|NCT02096211|561356039|FG000|Overall Study|Revision of implant|7|||
155655064|NCT01051661|561830640|FG004|Overall Study|Refused blood sampling|0|||
155526405|NCT02096211|561356039|FG000|Overall Study|Lost to Follow-up|43|||
155526406|NCT02269657|561356042|FG000|Overall Study|Protocol Violation|3|||
155526407|NCT02956460|561356045|FG000|Lens 1|Lost to Follow-up|1|||
155526408|NCT02956460|561356046|FG001|Lens 1|Lost to Follow-up|0|||
155526409|NCT00829673|561356047|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155526410|NCT00829673|561356048|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155526411|NCT00272779|561356049|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
155526412|NCT00272779|561356050|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
155526413|NCT00272779|561356049|FG000|Baseline Through Week 48|Death before Week 48|4|||
155526414|NCT00272779|561356050|FG001|Baseline Through Week 48|Death before Week 48|4|||
155526415|NCT00272779|561356049|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
155526416|NCT00272779|561356050|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
155526417|NCT00272779|561356049|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
155526418|NCT00272779|561356050|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
155526419|NCT00272779|561356049|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
155526420|NCT00272779|561356050|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
155526421|NCT00272779|561356049|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
155526422|NCT00272779|561356050|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
155526423|NCT00272779|561356049|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
155526424|NCT00272779|561356050|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
155526425|NCT00272779|561356049|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
155526426|NCT00272779|561356050|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
155526427|NCT00272779|561356049|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
155526428|NCT00272779|561356050|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
155526429|NCT00272779|561356049|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
155526430|NCT00272779|561356050|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
155526431|NCT00272779|561356049|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
155526432|NCT00272779|561356050|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
155655065|NCT01051661|561830641|FG005|Overall Study|Refused blood sampling|1|||
155486631|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155486632|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
155486633|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
155486634|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
155486635|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
155486636|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
155486637|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
155486638|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155486639|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155486640|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155486641|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
155486642|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
155486643|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
155486644|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155486645|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155486646|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155486647|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
155486648|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
155486649|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
155486650|NCT04594213|561203821|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
155486651|NCT04594213|561203822|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
155526433|NCT00272779|561356049|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
155526434|NCT00272779|561356050|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
155526435|NCT00272779|561356049|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
155526436|NCT00272779|561356050|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
155526437|NCT00272779|561356049|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
155526438|NCT00272779|561356050|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
155526439|NCT00272779|561356049|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
155526440|NCT00272779|561356050|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
155526441|NCT00272779|561356049|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
155526442|NCT00272779|561356050|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
155526443|NCT00272779|561356049|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
155526444|NCT00272779|561356050|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
155526445|NCT00272779|561356049|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
155526446|NCT00272779|561356050|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
155526447|NCT00272779|561356049|FG000|Baseline Through Week 48|Continuing treatment|385|||
155526448|NCT00272779|561356050|FG001|Baseline Through Week 48|Continuing treatment|368|||
155526449|NCT00272779|561356049|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
155526450|NCT00272779|561356050|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
155526451|NCT00272779|561356049|FG000|Baseline Through Week 48|Never treated|2|||
155526452|NCT00272779|561356050|FG001|Baseline Through Week 48|Never treated|3|||
155526453|NCT00272779|561356049|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
155526454|NCT00272779|561356050|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
155526455|NCT00272779|561356049|FG000|Baseline Through Week 96|Death before Week 96|6|||
155526456|NCT00272779|561356050|FG001|Baseline Through Week 96|Death before Week 96|5|||
155526457|NCT00272779|561356049|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
155526458|NCT00272779|561356050|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
155526459|NCT00272779|561356049|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
155526460|NCT00272779|561356050|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
155526461|NCT00272779|561356049|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
155526462|NCT00272779|561356050|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
155526463|NCT00272779|561356049|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
155526464|NCT00272779|561356050|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
155526465|NCT00272779|561356049|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
155526466|NCT00272779|561356050|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
155526467|NCT00272779|561356049|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
155526468|NCT00272779|561356050|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
155526469|NCT00272779|561356049|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
155526470|NCT00272779|561356050|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
155526471|NCT00272779|561356049|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
155526472|NCT00272779|561356050|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
155526473|NCT00272779|561356049|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
155526474|NCT00272779|561356050|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
155526475|NCT00272779|561356049|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
155526476|NCT00272779|561356050|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
155526477|NCT00272779|561356049|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
155526478|NCT00272779|561356050|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
155526479|NCT00272779|561356049|FG000|Baseline Through Week 96|Never treated|2|||
155526480|NCT00272779|561356050|FG001|Baseline Through Week 96|Never treated|3|||
155526481|NCT00272779|561356049|FG000|Baseline Through Week 96|Continuing on treatment|61|||
155526482|NCT00272779|561356050|FG001|Baseline Through Week 96|Continuing on treatment|38|||
155526483|NCT03450057|561356053|FG000|Overall Study|Death|17|||
155526484|NCT03450057|561356053|FG000|Overall Study|ICF withdrawal|4|||
155526485|NCT03450057|561356053|FG000|Overall Study|Lost to Follow-up|2|||
155526486|NCT04129346|561356054|FG000|Overall Study|Death|1|||
155526487|NCT04129346|561356055|FG001|Overall Study|Death|0|||
155526488|NCT05755282|561356056|FG000|Overall Study|Protocol Violation|0|||
155526489|NCT05755282|561356057|FG001|Overall Study|Protocol Violation|1|||
155526490|NCT02924883|561356058|FG000|Overall Study|Death|39|||
155526491|NCT02924883|561356059|FG001|Overall Study|Death|20|||
155526492|NCT02924883|561356058|FG000|Overall Study|Lost to Follow-up|1|||
155526493|NCT02924883|561356059|FG001|Overall Study|Lost to Follow-up|0|||
155526494|NCT02924883|561356058|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
155526495|NCT02924883|561356059|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
155526496|NCT02924883|561356058|FG000|Overall Study|Protocol Violation|1|||
155526497|NCT02924883|561356059|FG001|Overall Study|Protocol Violation|0|||
155526498|NCT02924883|561356058|FG000|Overall Study|Withdrawal by Subject|22|||
155526499|NCT02924883|561356059|FG001|Overall Study|Withdrawal by Subject|16|||
155526500|NCT02924883|561356058|FG000|Overall Study|Progressive Disease|1|||
155526501|NCT02924883|561356059|FG001|Overall Study|Progressive Disease|0|||
155526502|NCT02924883|561356058|FG000|Overall Study|Study Terminated by Sponsor|69|||
155526503|NCT02924883|561356059|FG001|Overall Study|Study Terminated by Sponsor|32|||
155526504|NCT00004562|561356060|FG000|Overall Study|Lost to Follow-up|102|||
155526505|NCT00004562|561356061|FG001|Overall Study|Lost to Follow-up|91|||
155526506|NCT00312663|561356062|FG000|Immunization Phase|Adverse Event|0|||
155526507|NCT00312663|561356063|FG001|Immunization Phase|Adverse Event|1|||
155526508|NCT00312663|561356064|FG002|Immunization Phase|Adverse Event|0|||
155526509|NCT03496623|561356068|FG000|Run-In Period (2 Weeks)|Death|1|||
155526510|NCT03496623|561356069|FG001|Run-In Period (2 Weeks)|Death|0|||
155526511|NCT03496623|561356070|FG002|Run-In Period (2 Weeks)|Death|0|||
155526512|NCT03496623|561356071|FG003|Run-In Period (2 Weeks)|Death|0|||
155526513|NCT03496623|561356072|FG004|Run-In Period (2 Weeks)|Death|0|||
155526514|NCT03496623|561356068|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
155526515|NCT03496623|561356069|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
155526516|NCT03496623|561356070|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
155526517|NCT03496623|561356071|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
155526518|NCT03496623|561356072|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
155526519|NCT03496623|561356068|FG000|Period 1 (12 Weeks)|Death|0|||
155526520|NCT03496623|561356069|FG001|Period 1 (12 Weeks)|Death|3|||
155526521|NCT03496623|561356070|FG002|Period 1 (12 Weeks)|Death|0|||
155526522|NCT03496623|561356071|FG003|Period 1 (12 Weeks)|Death|0|||
155526523|NCT03496623|561356072|FG004|Period 1 (12 Weeks)|Death|0|||
155526524|NCT03496623|561356068|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
155526525|NCT03496623|561356069|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
155526526|NCT03496623|561356070|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
155526527|NCT03496623|561356071|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
155526528|NCT03496623|561356072|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
155526529|NCT03496623|561356068|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155526530|NCT03496623|561356069|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
155526531|NCT03496623|561356070|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
155526532|NCT03496623|561356071|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155526533|NCT03496623|561356072|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155526534|NCT03496623|561356068|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
155526535|NCT03496623|561356069|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
155526536|NCT03496623|561356070|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
155526537|NCT03496623|561356071|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
155526538|NCT03496623|561356072|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
155526539|NCT03496623|561356068|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155526540|NCT03496623|561356069|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155526541|NCT03496623|561356070|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
155526542|NCT03496623|561356071|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155526543|NCT03496623|561356072|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155526544|NCT03496623|561356068|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
155526545|NCT03496623|561356069|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
155526546|NCT03496623|561356070|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
155526547|NCT03496623|561356071|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
155526548|NCT03496623|561356072|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
155526549|NCT03496623|561356068|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155526550|NCT03496623|561356069|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
155526551|NCT03496623|561356070|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155526552|NCT03496623|561356071|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155526553|NCT03496623|561356072|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155526554|NCT02543203|561356073|FG000|Overall Study|Unpalatable Fragrance|2|||
155526555|NCT02543203|561356074|FG001|Overall Study|Unpalatable Fragrance|2|||
155526556|NCT02543203|561356073|FG000|Overall Study|Lost to Follow-up|1|||
155526557|NCT02543203|561356074|FG001|Overall Study|Lost to Follow-up|0|||
155526558|NCT02543203|561356073|FG000|Overall Study|Increased Irritability|1|||
155526559|NCT02543203|561356074|FG001|Overall Study|Increased Irritability|0|||
155526560|NCT02543203|561356073|FG000|Overall Study|Family|1|||
155526561|NCT02543203|561356074|FG001|Overall Study|Family|2|||
155526562|NCT02543203|561356073|FG000|Overall Study|Negative Behavior|1|||
155526563|NCT02543203|561356074|FG001|Overall Study|Negative Behavior|0|||
155526564|NCT02543203|561356073|FG000|Overall Study|Withdrawal by Subject|0|||
155526565|NCT02543203|561356074|FG001|Overall Study|Withdrawal by Subject|1|||
155526566|NCT01270503|561356075|FG000|Overall Study|Lost to Follow-up|1|||
155526567|NCT02459951|561356076|FG000|Overall Study|Unable to meet holding requirement|1|||
155526568|NCT00772941|561356079|FG000|Overall Study|CRFs not available|195|||
155526569|NCT00772941|561356079|FG000|Overall Study|Study not completed|16|||
155526570|NCT00772941|561356079|FG000|Overall Study|Missed Visits|374|||
155526571|NCT00772941|561356079|FG000|Overall Study|Poor Compliance|7|||
155526572|NCT00772941|561356079|FG000|Overall Study|GPSP Violation|90|||
155526573|NCT02255097|561356080|FG000|Overall Study|Death|151|||
155526574|NCT02255097|561356080|FG000|Overall Study|Lost to Follow-up|5|||
155526575|NCT02255097|561356080|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
155526576|NCT02255097|561356080|FG000|Overall Study|Withdrawal by Subject|7|||
155526577|NCT02255097|561356080|FG000|Overall Study|Allocated but not treated|1|||
155526578|NCT01745120|561356086|FG000|Overall Study|Investigator decision|1|||
155526579|NCT01745120|561356087|FG001|Overall Study|Investigator decision|0|||
155526580|NCT02714062|561356088|FG000|Overall Study|Adverse Event|0|||
155526581|NCT02714062|561356089|FG001|Overall Study|Adverse Event|0|||
155526582|NCT02714062|561356090|FG002|Overall Study|Adverse Event|2|||
155526583|NCT02714062|561356088|FG000|Overall Study|Withdrawal by Subject|1|||
155526584|NCT02714062|561356089|FG001|Overall Study|Withdrawal by Subject|0|||
155526585|NCT02714062|561356090|FG002|Overall Study|Withdrawal by Subject|1|||
155526586|NCT02714062|561356088|FG000|Overall Study|Protocol Violation|0|||
155526587|NCT02714062|561356089|FG001|Overall Study|Protocol Violation|1|||
155526588|NCT02714062|561356090|FG002|Overall Study|Protocol Violation|0|||
155526589|NCT03956862|561356091|FG000|Overall Study|Lost to Follow-up|1|||
155526590|NCT03956862|561356092|FG001|Overall Study|Lost to Follow-up|1|||
155526591|NCT03956862|561356091|FG000|Overall Study|Withdrawal by Subject|1|||
155526592|NCT03956862|561356092|FG001|Overall Study|Withdrawal by Subject|1|||
155526593|NCT02017223|561356103|FG000|Overall Study|Algorithm problems|2|||
155526594|NCT01401647|561356104|FG000|Overall Study|Withdrawal by Subject|1|||
155526595|NCT01401647|561356105|FG001|Overall Study|Withdrawal by Subject|5|||
155526596|NCT01401647|561356106|FG002|Overall Study|Withdrawal by Subject|2|||
155526597|NCT01401647|561356104|FG000|Overall Study|Lost to Follow-up|3|||
155526598|NCT01401647|561356105|FG001|Overall Study|Lost to Follow-up|3|||
155526599|NCT01401647|561356106|FG002|Overall Study|Lost to Follow-up|1|||
155526600|NCT05169710|561356109|FG000|Overall Study|Adverse Event|1|||
155526601|NCT05169710|561356110|FG001|Overall Study|Adverse Event|2|||
155526602|NCT05169710|561356111|FG002|Overall Study|Adverse Event|2|||
155526603|NCT05169710|561356109|FG000|Overall Study|Lost to Follow-up|0|||
155526604|NCT05169710|561356110|FG001|Overall Study|Lost to Follow-up|0|||
155526605|NCT05169710|561356111|FG002|Overall Study|Lost to Follow-up|1|||
155526606|NCT05169710|561356109|FG000|Overall Study|Withdrawal by Subject|2|||
155526607|NCT05169710|561356110|FG001|Overall Study|Withdrawal by Subject|1|||
155526608|NCT05169710|561356111|FG002|Overall Study|Withdrawal by Subject|0|||
155526609|NCT05169710|561356109|FG000|Overall Study|Other Study Discontinuation Reason|0|||
155526610|NCT05169710|561356110|FG001|Overall Study|Other Study Discontinuation Reason|2|||
155526611|NCT05169710|561356111|FG002|Overall Study|Other Study Discontinuation Reason|0|||
155526612|NCT02711852|561356119|FG000|Overall Study|Death|5|||
155526613|NCT02711852|561356119|FG000|Overall Study|Lost to Follow-up|1|||
155526614|NCT02711852|561356119|FG000|Overall Study|Completed follow-up|3|||
155526615|NCT02711852|561356119|FG000|Overall Study|Withdrawal by Subject|1|||
155526616|NCT03459807|561356123|FG000|Overall Study|Withdrawal due to transplant|0|||
155526617|NCT03459807|561356124|FG001|Overall Study|Withdrawal due to transplant|1|||
155526618|NCT03586726|561356127|FG000|Overall Study|Withdrawal by Subject|1|||
155526619|NCT00576056|561356128|FG000|Overall Study|Adverse Event|1|||
155526620|NCT00576056|561356128|FG000|Overall Study|Death|1|||
155526621|NCT00576056|561356128|FG000|Overall Study|Lack of Efficacy|1|||
155526622|NCT00576056|561356128|FG000|Overall Study|Withdrawal by Subject|2|||
155526623|NCT00576056|561356128|FG000|Overall Study|did not meet eligibility criteria|8|||
155526624|NCT00576056|561356128|FG000|Overall Study|Physician Decision|1|||
155526625|NCT03197883|561356129|FG000|Overall Study|Adverse Event|1|||
155526626|NCT03197883|561356130|FG001|Overall Study|Adverse Event|1|||
155526627|NCT03197883|561356129|FG000|Overall Study|Lost to Follow-up|1|||
155526628|NCT03197883|561356130|FG001|Overall Study|Lost to Follow-up|0|||
155526629|NCT03197883|561356129|FG000|Overall Study|Protocol Violation|1|||
155526630|NCT03197883|561356130|FG001|Overall Study|Protocol Violation|0|||
155526631|NCT03197883|561356129|FG000|Overall Study|Other (Not Specified)|0|||
155526632|NCT03197883|561356130|FG001|Overall Study|Other (Not Specified)|5|||
155526633|NCT03031847|561356131|FG000|Overall Study|Death|1|||
155526634|NCT03031847|561356132|FG001|Overall Study|Death|1|||
155526635|NCT03031847|561356133|FG002|Overall Study|Death|2|||
155526636|NCT03031847|561356134|FG003|Overall Study|Death|3|||
155526637|NCT03031847|561356131|FG000|Overall Study|Lost to Follow-up|1|||
155526638|NCT03031847|561356132|FG001|Overall Study|Lost to Follow-up|1|||
155526639|NCT03031847|561356133|FG002|Overall Study|Lost to Follow-up|2|||
155526640|NCT03031847|561356134|FG003|Overall Study|Lost to Follow-up|3|||
155526641|NCT03273153|561356135|FG000|Overall Study|Adverse Event|1|||
155526642|NCT03273153|561356136|FG001|Overall Study|Adverse Event|2|||
155526643|NCT03273153|561356135|FG000|Overall Study|Missing|0|||
155526644|NCT03273153|561356136|FG001|Overall Study|Missing|2|||
155526645|NCT03273153|561356135|FG000|Overall Study|Other|3|||
155526646|NCT03273153|561356136|FG001|Overall Study|Other|2|||
155526647|NCT03273153|561356135|FG000|Overall Study|Symptomatic Deterioration|0|||
155526648|NCT03273153|561356136|FG001|Overall Study|Symptomatic Deterioration|1|||
155526649|NCT03273153|561356135|FG000|Overall Study|Progressive Disease|6|||
155526650|NCT03273153|561356136|FG001|Overall Study|Progressive Disease|5|||
155526651|NCT03273153|561356135|FG000|Overall Study|Physician Decision|1|||
155526652|NCT03273153|561356136|FG001|Overall Study|Physician Decision|3|||
155526653|NCT03273153|561356135|FG000|Overall Study|Study Terminated by Sponsor|112|||
155526654|NCT03273153|561356136|FG001|Overall Study|Study Terminated by Sponsor|102|||
155526655|NCT03273153|561356135|FG000|Overall Study|Withdrawal by Subject|26|||
155526656|NCT03273153|561356136|FG001|Overall Study|Withdrawal by Subject|25|||
155526657|NCT03273153|561356135|FG000|Overall Study|Protocol Deviation|3|||
155526658|NCT03273153|561356136|FG001|Overall Study|Protocol Deviation|0|||
155486652|NCT04594213|561203823|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
155486653|NCT04594213|561203824|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
155486654|NCT04594213|561203825|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
155486655|NCT04594213|561203826|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
155486656|NCT01654666|561203829|FG000|Overall Study|Protocol Violation|7|||
155486657|NCT01654666|561203830|FG001|Overall Study|Protocol Violation|4|||
155486658|NCT01654666|561203831|FG002|Overall Study|Protocol Violation|8|||
155486659|NCT01654666|561203829|FG000|Overall Study|Lost to Follow-up|4|||
155486660|NCT01654666|561203830|FG001|Overall Study|Lost to Follow-up|5|||
155486661|NCT01654666|561203831|FG002|Overall Study|Lost to Follow-up|5|||
155486662|NCT01654666|561203829|FG000|Overall Study|Withdrawal by Subject|4|||
155486663|NCT01654666|561203830|FG001|Overall Study|Withdrawal by Subject|4|||
155486664|NCT01654666|561203831|FG002|Overall Study|Withdrawal by Subject|1|||
155486665|NCT01616173|561203833|FG000|Overall Study|Lost to Follow-up|0|||
155486666|NCT01616173|561203834|FG001|Overall Study|Lost to Follow-up|2|||
155486667|NCT01616173|561203835|FG002|Overall Study|Lost to Follow-up|0|||
155486668|NCT00504595|561203840|FG000|Overall Study|Lack of Efficacy|1|||
155486669|NCT00504595|561203841|FG001|Overall Study|Lack of Efficacy|0|||
155486670|NCT00504595|561203842|FG002|Overall Study|Lack of Efficacy|0|||
155486671|NCT00504595|561203843|FG003|Overall Study|Lack of Efficacy|0|||
155486672|NCT00504595|561203840|FG000|Overall Study|Other|0|||
155486673|NCT00504595|561203841|FG001|Overall Study|Other|0|||
155486674|NCT00504595|561203842|FG002|Overall Study|Other|2|||
155486675|NCT00504595|561203843|FG003|Overall Study|Other|0|||
155486676|NCT01218477|561203848|FG000|Overall Study|Disease progression|2|||
155486677|NCT01218477|561203849|FG001|Overall Study|Disease progression|3|||
155486678|NCT01218477|561203850|FG002|Overall Study|Disease progression|6|||
155486679|NCT01218477|561203851|FG003|Overall Study|Disease progression|2|||
155486680|NCT01218477|561203848|FG000|Overall Study|Study drug toxicity|0|||
155486681|NCT01218477|561203849|FG001|Overall Study|Study drug toxicity|2|||
155486682|NCT01218477|561203850|FG002|Overall Study|Study drug toxicity|5|||
155486683|NCT01218477|561203851|FG003|Overall Study|Study drug toxicity|0|||
155486684|NCT01218477|561203848|FG000|Overall Study|No longer meets study criteria|1|||
155486685|NCT01218477|561203849|FG001|Overall Study|No longer meets study criteria|0|||
155486686|NCT01218477|561203850|FG002|Overall Study|No longer meets study criteria|0|||
155486687|NCT01218477|561203851|FG003|Overall Study|No longer meets study criteria|0|||
155486688|NCT01218477|561203848|FG000|Overall Study|Withdrawal by Subject|0|||
155486689|NCT01218477|561203849|FG001|Overall Study|Withdrawal by Subject|0|||
155526659|NCT03273153|561356135|FG000|Overall Study|Lost to Follow-up|6|||
155526660|NCT03273153|561356136|FG001|Overall Study|Lost to Follow-up|11|||
155526661|NCT03273153|561356135|FG000|Overall Study|Death|66|||
155526662|NCT03273153|561356136|FG001|Overall Study|Death|69|||
155526663|NCT00838539|561356139|FG000|Overall Study|Disease Progression|2|||
155526664|NCT00838539|561356140|FG001|Overall Study|Disease Progression|4|||
155526665|NCT00838539|561356141|FG002|Overall Study|Disease Progression|3|||
155486690|NCT01218477|561203850|FG002|Overall Study|Withdrawal by Subject|1|||
155486691|NCT01218477|561203851|FG003|Overall Study|Withdrawal by Subject|0|||
155486692|NCT01218477|561203848|FG000|Overall Study|Prepared for cell transplantation|0|||
155486693|NCT01218477|561203849|FG001|Overall Study|Prepared for cell transplantation|1|||
155486694|NCT01218477|561203850|FG002|Overall Study|Prepared for cell transplantation|1|||
155486695|NCT01218477|561203851|FG003|Overall Study|Prepared for cell transplantation|0|||
155526666|NCT00838539|561356142|FG003|Overall Study|Disease Progression|2|||
155526667|NCT00838539|561356143|FG004|Overall Study|Disease Progression|4|||
155526668|NCT00838539|561356144|FG005|Overall Study|Disease Progression|2|||
155526669|NCT00838539|561356145|FG006|Overall Study|Disease Progression|3|||
155526670|NCT00838539|561356146|FG007|Overall Study|Disease Progression|4|||
155526671|NCT00838539|561356147|FG008|Overall Study|Disease Progression|4|||
155526672|NCT00838539|561356148|FG009|Overall Study|Disease Progression|5|||
155526673|NCT00838539|561356149|FG010|Overall Study|Disease Progression|1|||
155526674|NCT00838539|561356150|FG011|Overall Study|Disease Progression|4|||
155526675|NCT00838539|561356139|FG000|Overall Study|Adverse Event|1|||
155526676|NCT00838539|561356140|FG001|Overall Study|Adverse Event|1|||
155526677|NCT00838539|561356141|FG002|Overall Study|Adverse Event|1|||
155526678|NCT00838539|561356142|FG003|Overall Study|Adverse Event|1|||
155526679|NCT00838539|561356143|FG004|Overall Study|Adverse Event|2|||
155526680|NCT00838539|561356144|FG005|Overall Study|Adverse Event|1|||
155526681|NCT00838539|561356145|FG006|Overall Study|Adverse Event|0|||
155526682|NCT00838539|561356146|FG007|Overall Study|Adverse Event|2|||
155526683|NCT00838539|561356147|FG008|Overall Study|Adverse Event|0|||
155526684|NCT00838539|561356148|FG009|Overall Study|Adverse Event|1|||
155526685|NCT00838539|561356149|FG010|Overall Study|Adverse Event|2|||
155526686|NCT00838539|561356150|FG011|Overall Study|Adverse Event|0|||
155526687|NCT00838539|561356139|FG000|Overall Study|Withdrawal by Subject|0|||
155526688|NCT00838539|561356140|FG001|Overall Study|Withdrawal by Subject|1|||
155526689|NCT00838539|561356141|FG002|Overall Study|Withdrawal by Subject|0|||
155526690|NCT00838539|561356142|FG003|Overall Study|Withdrawal by Subject|0|||
155526691|NCT00838539|561356143|FG004|Overall Study|Withdrawal by Subject|0|||
155526692|NCT00838539|561356144|FG005|Overall Study|Withdrawal by Subject|0|||
155526693|NCT00838539|561356145|FG006|Overall Study|Withdrawal by Subject|0|||
155526694|NCT00838539|561356146|FG007|Overall Study|Withdrawal by Subject|0|||
155526695|NCT00838539|561356147|FG008|Overall Study|Withdrawal by Subject|0|||
155526696|NCT00838539|561356148|FG009|Overall Study|Withdrawal by Subject|1|||
155526697|NCT00838539|561356149|FG010|Overall Study|Withdrawal by Subject|2|||
155526698|NCT00838539|561356150|FG011|Overall Study|Withdrawal by Subject|0|||
155526699|NCT00838539|561356139|FG000|Overall Study|Death|0|||
155526700|NCT00838539|561356140|FG001|Overall Study|Death|0|||
155526701|NCT00838539|561356141|FG002|Overall Study|Death|0|||
155526702|NCT00838539|561356142|FG003|Overall Study|Death|0|||
155526703|NCT00838539|561356143|FG004|Overall Study|Death|0|||
155526704|NCT00838539|561356144|FG005|Overall Study|Death|0|||
155526705|NCT00838539|561356145|FG006|Overall Study|Death|1|||
155526706|NCT00838539|561356146|FG007|Overall Study|Death|0|||
155526707|NCT00838539|561356147|FG008|Overall Study|Death|0|||
155526708|NCT00838539|561356148|FG009|Overall Study|Death|0|||
155526709|NCT00838539|561356149|FG010|Overall Study|Death|0|||
155526710|NCT00838539|561356150|FG011|Overall Study|Death|0|||
155526711|NCT00838539|561356139|FG000|Overall Study|Physician Decision|0|||
155526712|NCT00838539|561356140|FG001|Overall Study|Physician Decision|0|||
155526713|NCT00838539|561356141|FG002|Overall Study|Physician Decision|0|||
155526714|NCT00838539|561356142|FG003|Overall Study|Physician Decision|0|||
155526715|NCT00838539|561356143|FG004|Overall Study|Physician Decision|0|||
155526716|NCT00838539|561356144|FG005|Overall Study|Physician Decision|0|||
155526717|NCT00838539|561356145|FG006|Overall Study|Physician Decision|0|||
155526718|NCT00838539|561356146|FG007|Overall Study|Physician Decision|0|||
155526719|NCT00838539|561356147|FG008|Overall Study|Physician Decision|1|||
155526720|NCT00838539|561356148|FG009|Overall Study|Physician Decision|0|||
155526721|NCT00838539|561356149|FG010|Overall Study|Physician Decision|0|||
155526722|NCT00838539|561356150|FG011|Overall Study|Physician Decision|0|||
155526723|NCT00838539|561356139|FG000|Overall Study|Clinical Progression|0|||
155526724|NCT00838539|561356140|FG001|Overall Study|Clinical Progression|0|||
155526725|NCT00838539|561356141|FG002|Overall Study|Clinical Progression|0|||
155526726|NCT00838539|561356142|FG003|Overall Study|Clinical Progression|0|||
155526727|NCT00838539|561356143|FG004|Overall Study|Clinical Progression|0|||
155526728|NCT00838539|561356144|FG005|Overall Study|Clinical Progression|0|||
155526729|NCT00838539|561356145|FG006|Overall Study|Clinical Progression|1|||
155526730|NCT00838539|561356146|FG007|Overall Study|Clinical Progression|0|||
155526731|NCT00838539|561356147|FG008|Overall Study|Clinical Progression|0|||
155526732|NCT00838539|561356148|FG009|Overall Study|Clinical Progression|0|||
155526733|NCT00838539|561356149|FG010|Overall Study|Clinical Progression|0|||
155526734|NCT00838539|561356150|FG011|Overall Study|Clinical Progression|0|||
155526735|NCT00838539|561356139|FG000|Overall Study|Symptomatic Deterioration|0|||
155526736|NCT00838539|561356140|FG001|Overall Study|Symptomatic Deterioration|0|||
155526737|NCT00838539|561356141|FG002|Overall Study|Symptomatic Deterioration|1|||
155526738|NCT00838539|561356142|FG003|Overall Study|Symptomatic Deterioration|1|||
155526739|NCT00838539|561356143|FG004|Overall Study|Symptomatic Deterioration|0|||
155526740|NCT00838539|561356144|FG005|Overall Study|Symptomatic Deterioration|1|||
155526741|NCT00838539|561356145|FG006|Overall Study|Symptomatic Deterioration|0|||
155526742|NCT00838539|561356146|FG007|Overall Study|Symptomatic Deterioration|0|||
155526743|NCT00838539|561356147|FG008|Overall Study|Symptomatic Deterioration|0|||
155526744|NCT00838539|561356148|FG009|Overall Study|Symptomatic Deterioration|1|||
155526745|NCT00838539|561356149|FG010|Overall Study|Symptomatic Deterioration|0|||
155526746|NCT00838539|561356150|FG011|Overall Study|Symptomatic Deterioration|0|||
155526747|NCT01908205|561356151|FG000|Overall Study|Lost to Follow-up|2|||
155526748|NCT01908205|561356152|FG001|Overall Study|Lost to Follow-up|0|||
155526749|NCT01908205|561356151|FG000|Overall Study|Withdrawal by Subject|3|||
155526750|NCT01908205|561356152|FG001|Overall Study|Withdrawal by Subject|1|||
155526751|NCT02612337|561356154|FG000|Overall Study|Lack of Efficacy|1|||
155526752|NCT02612337|561356155|FG001|Overall Study|Lack of Efficacy|0|||
155526753|NCT02612337|561356154|FG000|Overall Study|Withdrawal by Subject|2|||
155526754|NCT02612337|561356155|FG001|Overall Study|Withdrawal by Subject|2|||
155526755|NCT02612337|561356154|FG000|Overall Study|Did not receive study drug|0|||
155526756|NCT02612337|561356155|FG001|Overall Study|Did not receive study drug|1|||
155526757|NCT03420300|561356156|FG000|Overall Study|Death|2|||
155526758|NCT02242201|561356163|FG000|Overall Study|preoperative identified neuropathy|2|||
155526759|NCT02242201|561356164|FG001|Overall Study|preoperative identified neuropathy|0|||
155526760|NCT02242201|561356165|FG002|Overall Study|preoperative identified neuropathy|0|||
155526761|NCT02242201|561356163|FG000|Overall Study|planned post-op anticoagulation|1|||
155526762|NCT02242201|561356164|FG001|Overall Study|planned post-op anticoagulation|0|||
155526763|NCT02242201|561356165|FG002|Overall Study|planned post-op anticoagulation|0|||
155526764|NCT02242201|561356163|FG000|Overall Study|changed surgical procedure|1|||
155526765|NCT02242201|561356164|FG001|Overall Study|changed surgical procedure|0|||
155526766|NCT02242201|561356165|FG002|Overall Study|changed surgical procedure|0|||
155526767|NCT02242201|561356163|FG000|Overall Study|postponed surgery|0|||
155526768|NCT02242201|561356164|FG001|Overall Study|postponed surgery|0|||
155526769|NCT02242201|561356165|FG002|Overall Study|postponed surgery|1|||
155526770|NCT02242201|561356163|FG000|Overall Study|preoperative opioid consumption|0|||
155526771|NCT02242201|561356164|FG001|Overall Study|preoperative opioid consumption|1|||
155526772|NCT02242201|561356165|FG002|Overall Study|preoperative opioid consumption|0|||
155526773|NCT01424644|561356168|FG000|Overall Study|Adverse Event|2|||
155526774|NCT01424644|561356169|FG001|Overall Study|Adverse Event|0|||
155526775|NCT01424644|561356168|FG000|Overall Study|Withdrawal by Subject|9|||
155526776|NCT01424644|561356169|FG001|Overall Study|Withdrawal by Subject|12|||
155526777|NCT01424644|561356168|FG000|Overall Study|Lost to Follow-up|16|||
155526778|NCT01424644|561356169|FG001|Overall Study|Lost to Follow-up|12|||
155526779|NCT01424644|561356168|FG000|Overall Study|Protocol Violation|4|||
155526780|NCT01424644|561356169|FG001|Overall Study|Protocol Violation|3|||
155526781|NCT01424644|561356168|FG000|Overall Study|Administrative Reason|1|||
155526782|NCT01424644|561356169|FG001|Overall Study|Administrative Reason|0|||
155526783|NCT01424644|561356168|FG000|Overall Study|Unable to Classify|1|||
155526784|NCT01424644|561356169|FG001|Overall Study|Unable to Classify|0|||
155526785|NCT01577381|561356177|FG000|Overall Study|Discontinued|2|||
155526786|NCT01577381|561356178|FG001|Overall Study|Discontinued|1|||
155526787|NCT01577381|561356179|FG002|Overall Study|Discontinued|2|||
155526788|NCT01577381|561356180|FG003|Overall Study|Discontinued|2|||
155526789|NCT01577381|561356177|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
155526790|NCT01577381|561356178|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
155526791|NCT01577381|561356179|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
155526792|NCT01577381|561356180|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
155526793|NCT05472038|561357570|FG000|Overall Study|Adverse Event|0|||
155526794|NCT05472038|561357571|FG001|Overall Study|Adverse Event|0|||
155526795|NCT05472038|561357572|FG002|Overall Study|Adverse Event|1|||
155526796|NCT05472038|561357573|FG003|Overall Study|Adverse Event|0|||
155526797|NCT05472038|561357574|FG004|Overall Study|Adverse Event|0|||
155526798|NCT05472038|561357575|FG005|Overall Study|Adverse Event|0|||
155526799|NCT05472038|561357576|FG006|Overall Study|Adverse Event|0|||
155526800|NCT05472038|561357577|FG007|Overall Study|Adverse Event|0|||
155526801|NCT05472038|561357578|FG008|Overall Study|Adverse Event|0|||
155526802|NCT05472038|561357579|FG009|Overall Study|Adverse Event|0|||
155526803|NCT05472038|561357580|FG010|Overall Study|Adverse Event|0|||
155526804|NCT05472038|561357581|FG011|Overall Study|Adverse Event|0|||
155526805|NCT05472038|561357570|FG000|Overall Study|Death|0|||
155526806|NCT05472038|561357571|FG001|Overall Study|Death|0|||
155526807|NCT05472038|561357572|FG002|Overall Study|Death|0|||
155526808|NCT05472038|561357573|FG003|Overall Study|Death|0|||
155526809|NCT05472038|561357574|FG004|Overall Study|Death|0|||
155526810|NCT05472038|561357575|FG005|Overall Study|Death|1|||
155526811|NCT05472038|561357576|FG006|Overall Study|Death|0|||
155526812|NCT05472038|561357577|FG007|Overall Study|Death|0|||
155526813|NCT05472038|561357578|FG008|Overall Study|Death|0|||
155526814|NCT05472038|561357579|FG009|Overall Study|Death|0|||
155526815|NCT05472038|561357580|FG010|Overall Study|Death|0|||
155526816|NCT05472038|561357581|FG011|Overall Study|Death|0|||
155526817|NCT05472038|561357570|FG000|Overall Study|Lost to Follow-up|1|||
155526818|NCT05472038|561357571|FG001|Overall Study|Lost to Follow-up|3|||
155526819|NCT05472038|561357572|FG002|Overall Study|Lost to Follow-up|3|||
155526820|NCT05472038|561357573|FG003|Overall Study|Lost to Follow-up|9|||
155526821|NCT05472038|561357574|FG004|Overall Study|Lost to Follow-up|2|||
155526822|NCT05472038|561357575|FG005|Overall Study|Lost to Follow-up|2|||
155526823|NCT05472038|561357576|FG006|Overall Study|Lost to Follow-up|1|||
155526824|NCT05472038|561357577|FG007|Overall Study|Lost to Follow-up|0|||
155526825|NCT05472038|561357578|FG008|Overall Study|Lost to Follow-up|1|||
155526826|NCT05472038|561357579|FG009|Overall Study|Lost to Follow-up|0|||
155526827|NCT05472038|561357580|FG010|Overall Study|Lost to Follow-up|2|||
155526828|NCT05472038|561357581|FG011|Overall Study|Lost to Follow-up|1|||
155526829|NCT05472038|561357570|FG000|Overall Study|Physician Decision|0|||
155526830|NCT05472038|561357571|FG001|Overall Study|Physician Decision|0|||
155526831|NCT05472038|561357572|FG002|Overall Study|Physician Decision|0|||
155526832|NCT05472038|561357573|FG003|Overall Study|Physician Decision|0|||
155526833|NCT05472038|561357574|FG004|Overall Study|Physician Decision|1|||
155526834|NCT05472038|561357575|FG005|Overall Study|Physician Decision|0|||
155526835|NCT05472038|561357576|FG006|Overall Study|Physician Decision|0|||
155526836|NCT05472038|561357577|FG007|Overall Study|Physician Decision|0|||
155526837|NCT05472038|561357578|FG008|Overall Study|Physician Decision|0|||
155526838|NCT05472038|561357579|FG009|Overall Study|Physician Decision|0|||
155526839|NCT05472038|561357580|FG010|Overall Study|Physician Decision|0|||
155526840|NCT05472038|561357581|FG011|Overall Study|Physician Decision|0|||
155526841|NCT05472038|561357570|FG000|Overall Study|Withdrawal by Subject|1|||
155526842|NCT05472038|561357571|FG001|Overall Study|Withdrawal by Subject|3|||
155526843|NCT05472038|561357572|FG002|Overall Study|Withdrawal by Subject|1|||
155526844|NCT05472038|561357573|FG003|Overall Study|Withdrawal by Subject|6|||
155526845|NCT05472038|561357574|FG004|Overall Study|Withdrawal by Subject|1|||
155526846|NCT05472038|561357575|FG005|Overall Study|Withdrawal by Subject|3|||
155526847|NCT05472038|561357576|FG006|Overall Study|Withdrawal by Subject|0|||
155526848|NCT05472038|561357577|FG007|Overall Study|Withdrawal by Subject|2|||
155526849|NCT05472038|561357578|FG008|Overall Study|Withdrawal by Subject|3|||
155526850|NCT05472038|561357579|FG009|Overall Study|Withdrawal by Subject|1|||
155526851|NCT05472038|561357580|FG010|Overall Study|Withdrawal by Subject|2|||
155526852|NCT05472038|561357581|FG011|Overall Study|Withdrawal by Subject|2|||
155526853|NCT05472038|561357570|FG000|Overall Study|Protocol Violation|0|||
155526854|NCT05472038|561357571|FG001|Overall Study|Protocol Violation|0|||
155526855|NCT05472038|561357572|FG002|Overall Study|Protocol Violation|0|||
155526856|NCT05472038|561357573|FG003|Overall Study|Protocol Violation|0|||
155526857|NCT05472038|561357574|FG004|Overall Study|Protocol Violation|0|||
155526858|NCT05472038|561357575|FG005|Overall Study|Protocol Violation|0|||
155526859|NCT05472038|561357576|FG006|Overall Study|Protocol Violation|0|||
155526860|NCT05472038|561357577|FG007|Overall Study|Protocol Violation|1|||
155526861|NCT05472038|561357578|FG008|Overall Study|Protocol Violation|1|||
155526862|NCT05472038|561357579|FG009|Overall Study|Protocol Violation|1|||
155526863|NCT05472038|561357580|FG010|Overall Study|Protocol Violation|1|||
155526864|NCT05472038|561357581|FG011|Overall Study|Protocol Violation|1|||
155526865|NCT05472038|561357570|FG000|Overall Study|Not vaccinated|0|||
155526866|NCT05472038|561357571|FG001|Overall Study|Not vaccinated|0|||
155526867|NCT05472038|561357572|FG002|Overall Study|Not vaccinated|0|||
155526868|NCT05472038|561357573|FG003|Overall Study|Not vaccinated|1|||
155526869|NCT05472038|561357574|FG004|Overall Study|Not vaccinated|0|||
155526870|NCT05472038|561357575|FG005|Overall Study|Not vaccinated|0|||
155526871|NCT05472038|561357576|FG006|Overall Study|Not vaccinated|0|||
155526872|NCT05472038|561357577|FG007|Overall Study|Not vaccinated|0|||
155526873|NCT05472038|561357578|FG008|Overall Study|Not vaccinated|0|||
155526874|NCT05472038|561357579|FG009|Overall Study|Not vaccinated|0|||
155526875|NCT05472038|561357580|FG010|Overall Study|Not vaccinated|0|||
155526876|NCT05472038|561357581|FG011|Overall Study|Not vaccinated|0|||
155526877|NCT03235739|561357584|FG000|Overall Study|Withdrawal by Subject|2|||
155526878|NCT03235739|561357585|FG001|Overall Study|Withdrawal by Subject|2|||
155526879|NCT03235739|561357584|FG000|Overall Study|Physician Decision|0|||
155526880|NCT03235739|561357585|FG001|Overall Study|Physician Decision|1|||
155526881|NCT02378935|561357588|FG000|Overall Study|Lack of Efficacy|10|||
155526882|NCT02378935|561357589|FG001|Overall Study|Lack of Efficacy|0|||
155526883|NCT02378935|561357590|FG002|Overall Study|Lack of Efficacy|2|||
155526884|NCT02378935|561357591|FG003|Overall Study|Lack of Efficacy|6|||
155526885|NCT02378935|561357592|FG004|Overall Study|Lack of Efficacy|0|||
155526886|NCT02378935|561357593|FG005|Overall Study|Lack of Efficacy|0|||
155526887|NCT02378935|561357594|FG006|Overall Study|Lack of Efficacy|0|||
155526888|NCT02378935|561357588|FG000|Overall Study|Death|0|||
155526889|NCT02378935|561357589|FG001|Overall Study|Death|0|||
155526890|NCT02378935|561357590|FG002|Overall Study|Death|1|||
155526891|NCT02378935|561357591|FG003|Overall Study|Death|0|||
155526892|NCT02378935|561357592|FG004|Overall Study|Death|0|||
155526893|NCT02378935|561357593|FG005|Overall Study|Death|0|||
155526894|NCT02378935|561357594|FG006|Overall Study|Death|0|||
155526895|NCT02440711|561357595|FG000|Second Intervention|Lost to Follow-up|1|||
155655066|NCT01051661|561830636|FG000|Overall Study|Data not reliable|1|||
155526896|NCT02440711|561357596|FG001|Second Intervention|Lost to Follow-up|0|||
155526897|NCT00829790|561357600|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
155526898|NCT00829790|561357601|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
155526899|NCT03214952|561357602|FG000|Overall Study|Protocol Deviation|45|||
155526900|NCT03214952|561357602|FG000|Overall Study|Case Report Forms Uncollected|13|||
155526901|NCT03935880|561357603|FG000|Overall Study|Lost to Follow-up|0|||
155526902|NCT03935880|561357604|FG001|Overall Study|Lost to Follow-up|1|||
155526903|NCT02476994|561357605|FG000|Overall Study|Based on feedback from FDA|1|||
155526904|NCT02476994|561357606|FG001|Overall Study|Based on feedback from FDA|0|||
155526905|NCT02563561|561357607|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
155526906|NCT02563561|561357608|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
155526907|NCT02563561|561357609|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
155526908|NCT02563561|561357607|FG000|Overall Study|Withdrew of Consent|1|||
155526909|NCT02563561|561357608|FG001|Overall Study|Withdrew of Consent|1|||
155526910|NCT02563561|561357609|FG002|Overall Study|Withdrew of Consent|2|||
155526911|NCT02563561|561357607|FG000|Overall Study|Lost to Follow-up|1|||
155526912|NCT02563561|561357608|FG001|Overall Study|Lost to Follow-up|1|||
155526913|NCT02563561|561357609|FG002|Overall Study|Lost to Follow-up|0|||
155526914|NCT02563561|561357607|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
155526915|NCT02563561|561357608|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
155526916|NCT02563561|561357609|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
155526917|NCT02563561|561357607|FG000|Overall Study|Investigator Decision|3|||
155526918|NCT02563561|561357608|FG001|Overall Study|Investigator Decision|4|||
155526919|NCT02563561|561357609|FG002|Overall Study|Investigator Decision|2|||
155526920|NCT02563561|561357607|FG000|Overall Study|Sponsor Decision|5|||
155526921|NCT02563561|561357608|FG001|Overall Study|Sponsor Decision|2|||
155526922|NCT02563561|561357609|FG002|Overall Study|Sponsor Decision|4|||
155526923|NCT02563561|561357607|FG000|Overall Study|Other|1|||
155526924|NCT02563561|561357608|FG001|Overall Study|Other|5|||
155526925|NCT02563561|561357609|FG002|Overall Study|Other|2|||
155526926|NCT03122535|561357610|FG000|Overall Study|Lost to Follow-up|68|||
155526927|NCT03122535|561357611|FG001|Overall Study|Lost to Follow-up|68|||
155526928|NCT03122535|561357610|FG000|Overall Study|Physician Decision|3|||
155526929|NCT03122535|561357611|FG001|Overall Study|Physician Decision|3|||
155526930|NCT03122535|561357610|FG000|Overall Study|Withdrawal by Subject|2|||
155526931|NCT03122535|561357611|FG001|Overall Study|Withdrawal by Subject|2|||
155526932|NCT01693523|561357612|FG000|Overall Study|Adverse Event|2|||
155526933|NCT01693523|561357613|FG001|Overall Study|Adverse Event|1|||
155526934|NCT01693523|561357614|FG002|Overall Study|Adverse Event|0|||
155526935|NCT01693523|561357612|FG000|Overall Study|Death|0|||
155526936|NCT01693523|561357613|FG001|Overall Study|Death|1|||
155526937|NCT01693523|561357614|FG002|Overall Study|Death|1|||
155526938|NCT01693523|561357612|FG000|Overall Study|Lost to Follow-up|0|||
155526939|NCT01693523|561357613|FG001|Overall Study|Lost to Follow-up|0|||
155526940|NCT01693523|561357614|FG002|Overall Study|Lost to Follow-up|4|||
155526941|NCT01693523|561357612|FG000|Overall Study|Physician Decision|0|||
155526942|NCT01693523|561357613|FG001|Overall Study|Physician Decision|0|||
155526943|NCT01693523|561357614|FG002|Overall Study|Physician Decision|1|||
155526944|NCT01693523|561357612|FG000|Overall Study|Withdrawal by Subject|1|||
155526945|NCT01693523|561357613|FG001|Overall Study|Withdrawal by Subject|2|||
155526946|NCT01693523|561357614|FG002|Overall Study|Withdrawal by Subject|2|||
155526947|NCT01693523|561357612|FG000|Overall Study|Lack of compliance study medication|1|||
155526948|NCT01693523|561357613|FG001|Overall Study|Lack of compliance study medication|2|||
155526949|NCT01693523|561357614|FG002|Overall Study|Lack of compliance study medication|0|||
155526950|NCT01693523|561357612|FG000|Overall Study|Chemotherapy was held|1|||
155526951|NCT01693523|561357613|FG001|Overall Study|Chemotherapy was held|2|||
155526952|NCT01693523|561357614|FG002|Overall Study|Chemotherapy was held|0|||
155526953|NCT03020615|561357619|FG000|Overall Study|Physician Decision|3|||
155526954|NCT03020615|561357620|FG001|Overall Study|Physician Decision|1|||
155526955|NCT03020615|561357621|FG002|Overall Study|Physician Decision|2|||
155526956|NCT03020615|561357619|FG000|Overall Study|Parent/guardian/patient choice|3|||
155526957|NCT03020615|561357620|FG001|Overall Study|Parent/guardian/patient choice|0|||
155526958|NCT03020615|561357621|FG002|Overall Study|Parent/guardian/patient choice|4|||
155526959|NCT03020615|561357619|FG000|Overall Study|Screen failure|0|||
155526960|NCT03020615|561357620|FG001|Overall Study|Screen failure|0|||
155526961|NCT03020615|561357621|FG002|Overall Study|Screen failure|1|||
155526962|NCT03020615|561357619|FG000|Overall Study|Death|1|||
155526963|NCT03020615|561357620|FG001|Overall Study|Death|0|||
155526964|NCT03020615|561357621|FG002|Overall Study|Death|0|||
155526965|NCT03020615|561357619|FG000|Overall Study|Lost to Follow-up|0|||
155655067|NCT01051661|561830637|FG001|Overall Study|Data not reliable|0|||
155526966|NCT03020615|561357620|FG001|Overall Study|Lost to Follow-up|1|||
155526967|NCT03020615|561357621|FG002|Overall Study|Lost to Follow-up|0|||
155526968|NCT01273805|561357622|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
155526969|NCT01273805|561357623|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
155526970|NCT02647944|561357624|FG000|Overall Study|Withdrawal by Subject|0|||
155526971|NCT02647944|561357625|FG001|Overall Study|Withdrawal by Subject|3|||
155526972|NCT02647944|561357624|FG000|Overall Study|Adverse Event|2|||
155526973|NCT02647944|561357625|FG001|Overall Study|Adverse Event|0|||
155526974|NCT00252720|561357626|FG000|Overall Study|Withdrawal by Subject|95|||
155655068|NCT01051661|561830638|FG002|Overall Study|Data not reliable|0|||
155526975|NCT00252720|561357627|FG001|Overall Study|Withdrawal by Subject|97|||
155526976|NCT00252720|561357626|FG000|Overall Study|Death|7|||
155526977|NCT00252720|561357627|FG001|Overall Study|Death|8|||
155526978|NCT00252720|561357626|FG000|Overall Study|Moving|23|||
155526979|NCT00252720|561357627|FG001|Overall Study|Moving|42|||
155526980|NCT00252720|561357626|FG000|Overall Study|Mainly patients lost to follow-up|7|||
155526981|NCT00252720|561357627|FG001|Overall Study|Mainly patients lost to follow-up|18|||
155526982|NCT02077465|561357631|FG000|Overall Study|Withdrew Consent|0|||
155526983|NCT02077465|561357632|FG001|Overall Study|Withdrew Consent|1|||
155526984|NCT02077465|561357631|FG000|Overall Study|Lost to Follow-up|1|||
155526985|NCT02077465|561357632|FG001|Overall Study|Lost to Follow-up|0|||
155526986|NCT02481830|561357633|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
155526987|NCT02481830|561357634|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
155526988|NCT02481830|561357633|FG000|Pre-treatment|Withdrawal by Subject|0|||
155526989|NCT02481830|561357634|FG001|Pre-treatment|Withdrawal by Subject|10|||
155526990|NCT02481830|561357633|FG000|Pre-treatment|Disease Progression|1|||
155526991|NCT02481830|561357634|FG001|Pre-treatment|Disease Progression|1|||
155526992|NCT02481830|561357633|FG000|Pre-treatment|Other reasons|0|||
155526993|NCT02481830|561357634|FG001|Pre-treatment|Other reasons|1|||
155526994|NCT02481830|561357633|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
155526995|NCT02481830|561357634|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
155526996|NCT02481830|561357633|FG000|Treatment|Disease Progression|233|||
155526997|NCT02481830|561357634|FG001|Treatment|Disease Progression|171|||
155526998|NCT02481830|561357633|FG000|Treatment|Study drug toxicity|18|||
155526999|NCT02481830|561357634|FG001|Treatment|Study drug toxicity|38|||
155527000|NCT02481830|561357633|FG000|Treatment|Death|1|||
155527001|NCT02481830|561357634|FG001|Treatment|Death|1|||
155527002|NCT02481830|561357633|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
155527003|NCT02481830|561357634|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
155527004|NCT02481830|561357633|FG000|Treatment|Participants request to discontinue Study treatment|6|||
155527005|NCT02481830|561357634|FG001|Treatment|Participants request to discontinue Study treatment|34|||
155527006|NCT02481830|561357633|FG000|Treatment|Withdrawal by Subject|2|||
155527007|NCT02481830|561357634|FG001|Treatment|Withdrawal by Subject|3|||
155527008|NCT02481830|561357633|FG000|Treatment|Lost to Follow-up|1|||
155527009|NCT02481830|561357634|FG001|Treatment|Lost to Follow-up|0|||
155527010|NCT02481830|561357633|FG000|Treatment|Maximum Clinical Benefit|0|||
155527011|NCT02481830|561357634|FG001|Treatment|Maximum Clinical Benefit|5|||
155527012|NCT02481830|561357633|FG000|Treatment|Administrative reason by sponsor|1|||
155527013|NCT02481830|561357634|FG001|Treatment|Administrative reason by sponsor|1|||
155527014|NCT02481830|561357633|FG000|Treatment|Other reasons|6|||
155527015|NCT02481830|561357634|FG001|Treatment|Other reasons|1|||
155527016|NCT04627038|561357635|FG000|Overall Study|Adverse Event|36|||
155527017|NCT04627038|561357636|FG001|Overall Study|Adverse Event|8|||
155527018|NCT04627038|561357635|FG000|Overall Study|Lost to Follow-up|1|||
155527019|NCT04627038|561357636|FG001|Overall Study|Lost to Follow-up|0|||
155527020|NCT04627038|561357635|FG000|Overall Study|Physician Decision|0|||
155527021|NCT04627038|561357636|FG001|Overall Study|Physician Decision|1|||
155527022|NCT04627038|561357635|FG000|Overall Study|Protocol Violation|3|||
155527023|NCT04627038|561357636|FG001|Overall Study|Protocol Violation|1|||
155527024|NCT04627038|561357635|FG000|Overall Study|Withdrawal by Subject|13|||
155527025|NCT04627038|561357636|FG001|Overall Study|Withdrawal by Subject|3|||
155527026|NCT04627038|561357635|FG000|Overall Study|Non-compliance with study drug|0|||
155527027|NCT04627038|561357636|FG001|Overall Study|Non-compliance with study drug|1|||
155527028|NCT04627038|561357635|FG000|Overall Study|Prohibited Concomitant Medication|1|||
155527029|NCT04627038|561357636|FG001|Overall Study|Prohibited Concomitant Medication|0|||
155527030|NCT02760368|561357641|FG000|Overall Study|Withdrawal by Subject|8|||
155527031|NCT02760368|561357642|FG001|Overall Study|Withdrawal by Subject|12|||
155527032|NCT02760368|561357643|FG002|Overall Study|Withdrawal by Subject|9|||
155527033|NCT02760368|561357641|FG000|Overall Study|Screen Failure|0|||
155527034|NCT02760368|561357642|FG001|Overall Study|Screen Failure|0|||
155527035|NCT02760368|561357643|FG002|Overall Study|Screen Failure|1|||
155527036|NCT02760368|561357641|FG000|Overall Study|Death|0|||
155527037|NCT02760368|561357642|FG001|Overall Study|Death|1|||
155527038|NCT02760368|561357643|FG002|Overall Study|Death|0|||
155527039|NCT02760368|561357641|FG000|Overall Study|Withdrawal by Sponsor|0|||
155527040|NCT02760368|561357642|FG001|Overall Study|Withdrawal by Sponsor|0|||
155527041|NCT02760368|561357643|FG002|Overall Study|Withdrawal by Sponsor|1|||
155527042|NCT00794963|561357644|FG000|Overall Study|Withdrawal by Subject|1|||
155527043|NCT00794963|561357645|FG001|Overall Study|Withdrawal by Subject|4|||
155527044|NCT01037114|561357646|FG000|Year 20|Others|1|||
155527045|NCT01602419|561357647|FG000|Overall Study|Not treated with Wilate|9|||
155527046|NCT01602419|561357647|FG000|Overall Study|Adverse Drug Reaction|4|||
155527047|NCT01602419|561357647|FG000|Overall Study|Insurance issues|3|||
155527048|NCT01602419|561357647|FG000|Overall Study|Changed treatment centre|1|||
155527049|NCT01602419|561357647|FG000|Overall Study|Treatment centre closed|1|||
155527050|NCT01602419|561357647|FG000|Overall Study|Withdrawal by Subject|5|||
155527051|NCT01602419|561357647|FG000|Overall Study|Lost to Follow-up|6|||
155527052|NCT02294604|561357654|FG000|Overall Study|Did not provide samples for culture|0|||
155527053|NCT02294604|561357655|FG001|Overall Study|Did not provide samples for culture|1|||
155527054|NCT02294604|561357656|FG002|Overall Study|Did not provide samples for culture|0|||
155527055|NCT02294604|561357654|FG000|Overall Study|Culture contamination|1|||
155527056|NCT02294604|561357655|FG001|Overall Study|Culture contamination|2|||
155527057|NCT02294604|561357656|FG002|Overall Study|Culture contamination|0|||
155527058|NCT01675765|561357661|FG000|Overall Study|Progressive disease|4|||
155527059|NCT01675765|561357662|FG001|Overall Study|Progressive disease|4|||
155527060|NCT01675765|561357661|FG000|Overall Study|Adverse Event|1|||
155527061|NCT01675765|561357662|FG001|Overall Study|Adverse Event|2|||
155527062|NCT01675765|561357661|FG000|Overall Study|Withdrawal by Subject|2|||
155527063|NCT01675765|561357662|FG001|Overall Study|Withdrawal by Subject|0|||
155527064|NCT01675765|561357661|FG000|Overall Study|Death|1|||
155527065|NCT01675765|561357662|FG001|Overall Study|Death|0|||
155527066|NCT01675765|561357661|FG000|Overall Study|Clinical progression|3|||
155527067|NCT01675765|561357662|FG001|Overall Study|Clinical progression|2|||
155527068|NCT02057458|561357670|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
155527069|NCT02057458|561357671|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
155527070|NCT02057458|561357672|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
155527071|NCT02057458|561357670|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
155527072|NCT02057458|561357671|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
155527073|NCT02057458|561357672|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
155527074|NCT02057458|561357670|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
155527075|NCT02057458|561357671|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
155527076|NCT02057458|561357672|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
155527077|NCT04263649|561357673|FG000|Overall Study|Adverse Event|53|||
155527078|NCT04263649|561357673|FG000|Overall Study|Lost to Follow-up|3|||
155527079|NCT04263649|561357673|FG000|Overall Study|Death|29|||
155527080|NCT04263649|561357673|FG000|Overall Study|Device deficiency|19|||
155527081|NCT04263649|561357673|FG000|Overall Study|other reasons|11|||
155527082|NCT00836056|561357677|FG000|First Intervention|Adverse Event|1|||
155527083|NCT00836056|561357678|FG001|First Intervention|Adverse Event|0|||
155527084|NCT00846495|561357682|FG000|Overall Study|Lost to Follow-up|1|||
155527085|NCT00846495|561357683|FG001|Overall Study|Lost to Follow-up|0|||
155527086|NCT00846495|561357682|FG000|Overall Study|Adverse Event|5|||
155527087|NCT00846495|561357683|FG001|Overall Study|Adverse Event|1|||
155527088|NCT00846495|561357682|FG000|Overall Study|Lack of Efficacy|1|||
155527089|NCT00846495|561357683|FG001|Overall Study|Lack of Efficacy|2|||
155527090|NCT00846495|561357682|FG000|Overall Study|Physician Decision|1|||
155527091|NCT00846495|561357683|FG001|Overall Study|Physician Decision|0|||
155527092|NCT01079988|561357684|FG000|Overall Study|Lost to Follow-up|0|||
155527093|NCT01079988|561357685|FG001|Overall Study|Lost to Follow-up|0|||
155527094|NCT01079988|561357686|FG002|Overall Study|Lost to Follow-up|0|||
155527095|NCT01079988|561357687|FG003|Overall Study|Lost to Follow-up|1|||
155527096|NCT01079988|561357688|FG004|Overall Study|Lost to Follow-up|0|||
155527097|NCT01079988|561357684|FG000|Overall Study|Lack of Efficacy|1|||
155527098|NCT01079988|561357685|FG001|Overall Study|Lack of Efficacy|0|||
155527099|NCT01079988|561357686|FG002|Overall Study|Lack of Efficacy|0|||
155527100|NCT01079988|561357687|FG003|Overall Study|Lack of Efficacy|0|||
155527101|NCT01079988|561357688|FG004|Overall Study|Lack of Efficacy|0|||
155527102|NCT01079988|561357684|FG000|Overall Study|Other|0|||
155527103|NCT01079988|561357685|FG001|Overall Study|Other|0|||
155527104|NCT01079988|561357686|FG002|Overall Study|Other|0|||
155527105|NCT01079988|561357687|FG003|Overall Study|Other|2|||
155527106|NCT01079988|561357688|FG004|Overall Study|Other|1|||
155527107|NCT03546842|561357689|FG000|Overall Study|Protocol Violation|1|||
155527108|NCT03546842|561357689|FG000|Overall Study|Withdrawal by Subject|2|||
155527109|NCT02158663|561357691|FG000|Overall Study|Withdrawal by Subject|5|||
155527110|NCT02158663|561357692|FG001|Overall Study|Withdrawal by Subject|4|||
155527111|NCT01265056|561357693|FG000|Initial Study Period|Withdrawal by Subject|1|||
155527112|NCT01265056|561357694|FG001|Initial Study Period|Withdrawal by Subject|1|||
155655069|NCT01051661|561830639|FG003|Overall Study|Data not reliable|0|||
155527113|NCT01265056|561357693|FG000|Initial Study Period|Withdrawal by Subject|1|||
155527114|NCT01265056|561357694|FG001|Initial Study Period|Withdrawal by Subject|1|||
155527115|NCT01265056|561357693|FG000|Follow up|Lost to Follow-up|7|||
155527116|NCT01265056|561357694|FG001|Follow up|Lost to Follow-up|3|||
155527117|NCT00965185|561357695|FG000|Overall Study|Lost to Follow-up|2|||
155527118|NCT00965185|561357696|FG001|Overall Study|Lost to Follow-up|0|||
155527119|NCT00965185|561357695|FG000|Overall Study|Withdrawal by Subject|0|||
155527120|NCT00965185|561357696|FG001|Overall Study|Withdrawal by Subject|1|||
155527121|NCT05323396|561357697|FG000|Overall Study|Lost to Follow-up|1|||
155527122|NCT05323396|561357698|FG001|Overall Study|Lost to Follow-up|35|||
155527123|NCT05323396|561357697|FG000|Overall Study|Pregnancy|1|||
155527124|NCT05323396|561357698|FG001|Overall Study|Pregnancy|0|||
155527125|NCT03681470|561357701|FG000|Overall Study|Lack of Efficacy|3|||
155527126|NCT03681470|561357701|FG000|Overall Study|Lost to Follow-up|1|||
155527127|NCT03681470|561357701|FG000|Overall Study|Protocol Violation|3|||
155527128|NCT03681470|561357701|FG000|Overall Study|Withdrawal by Subject|1|||
155527129|NCT03500692|561357706|FG000|Overall Study|Death|163|||
155527130|NCT03500692|561357706|FG000|Overall Study|Lost to Follow-up|75|||
155527131|NCT03500692|561357706|FG000|Overall Study|Termination Reasons|3|||
155527132|NCT04149964|561357707|FG000|Overall Study|Lost to Follow-up|19|||
155527133|NCT04149964|561357708|FG001|Overall Study|Lost to Follow-up|18|||
155527134|NCT01697696|561357709|FG000|Overall Study|Study terminated by sponsor|0|||
155527135|NCT01697696|561357710|FG001|Overall Study|Study terminated by sponsor|3|||
155527136|NCT01697696|561357709|FG000|Overall Study|Protocol deviation|1|||
155527137|NCT01697696|561357710|FG001|Overall Study|Protocol deviation|0|||
155527138|NCT01697696|561357709|FG000|Overall Study|Physician Decision|1|||
155527139|NCT01697696|561357710|FG001|Overall Study|Physician Decision|0|||
155527140|NCT01697696|561357709|FG000|Overall Study|Death|4|||
155527141|NCT01697696|561357710|FG001|Overall Study|Death|2|||
155527142|NCT01697696|561357709|FG000|Overall Study|Lost to Follow-up|10|||
155527143|NCT01697696|561357710|FG001|Overall Study|Lost to Follow-up|7|||
155527144|NCT01697696|561357709|FG000|Overall Study|Subject/guardian decision|31|||
155527145|NCT01697696|561357710|FG001|Overall Study|Subject/guardian decision|35|||
155527146|NCT02066922|561357713|FG000|Overall Study|Adverse Event|1|||
155527147|NCT03238781|561357714|FG000|Overall Study|Adverse Event|1|||
155527148|NCT03238781|561357715|FG001|Overall Study|Adverse Event|1|||
155527149|NCT03238781|561357716|FG002|Overall Study|Adverse Event|2|||
155527150|NCT03238781|561357714|FG000|Overall Study|Lost to Follow-up|2|||
155527151|NCT03238781|561357715|FG001|Overall Study|Lost to Follow-up|1|||
155527152|NCT03238781|561357716|FG002|Overall Study|Lost to Follow-up|2|||
155527153|NCT03238781|561357714|FG000|Overall Study|Withdrawal by Subject|23|||
155527154|NCT03238781|561357715|FG001|Overall Study|Withdrawal by Subject|14|||
155527155|NCT03238781|561357716|FG002|Overall Study|Withdrawal by Subject|16|||
155527156|NCT03238781|561357714|FG000|Overall Study|Decision by sponsor|0|||
155527157|NCT03238781|561357715|FG001|Overall Study|Decision by sponsor|1|||
155527158|NCT03238781|561357716|FG002|Overall Study|Decision by sponsor|0|||
155527159|NCT03161405|561357717|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
155527160|NCT01313780|561357718|FG000|Overall Study|Lack of Efficacy|4|||
155527161|NCT01313780|561357719|FG001|Overall Study|Lack of Efficacy|2|||
155527162|NCT01313780|561357718|FG000|Overall Study|Adverse Event|6|||
155527163|NCT01313780|561357719|FG001|Overall Study|Adverse Event|11|||
155527164|NCT01313780|561357718|FG000|Overall Study|Withdrawal by Subject|2|||
155527165|NCT01313780|561357719|FG001|Overall Study|Withdrawal by Subject|8|||
155527166|NCT01313780|561357718|FG000|Overall Study|Protocol Violation|10|||
155527167|NCT01313780|561357719|FG001|Overall Study|Protocol Violation|4|||
155527168|NCT01313780|561357718|FG000|Overall Study|missing data|3|||
155527169|NCT01313780|561357719|FG001|Overall Study|missing data|3|||
155527170|NCT02847650|561358898|FG000|Overall Study|Adverse Event|2|||
155527171|NCT02847650|561358899|FG001|Overall Study|Adverse Event|4|||
155527172|NCT02847650|561358898|FG000|Overall Study|Lost to Follow-up|1|||
155527173|NCT02847650|561358899|FG001|Overall Study|Lost to Follow-up|0|||
155527174|NCT02847650|561358898|FG000|Overall Study|Protocol Violation|0|||
155527175|NCT02847650|561358899|FG001|Overall Study|Protocol Violation|1|||
155527176|NCT02847650|561358898|FG000|Overall Study|Withdrawal by Subject|1|||
155527177|NCT02847650|561358899|FG001|Overall Study|Withdrawal by Subject|1|||
155527178|NCT03772522|561358900|FG000|Pre-intervention|Withdrawal by Subject|3|||
155527179|NCT03772522|561358901|FG001|Pre-intervention|Withdrawal by Subject|4|||
155527180|NCT03772522|561358900|FG000|Intervention|Withdrawal by Subject|1|||
155527181|NCT03772522|561358901|FG001|Intervention|Withdrawal by Subject|0|||
155527182|NCT03772522|561358900|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
155527183|NCT03772522|561358901|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
155527184|NCT00218257|561358902|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
155527185|NCT00218257|561358903|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
155527186|NCT03255733|561358906|FG000|Overall Study|Lost to Follow-up|4|||
155527187|NCT03769896|561358911|FG000|Open-label Phase|Lack of Efficacy|5|||
155527188|NCT03769896|561358912|FG001|Open-label Phase|Lack of Efficacy|0|||
155527189|NCT03769896|561358911|FG000|Open-label Phase|Adverse Event|3|||
155527190|NCT03769896|561358912|FG001|Open-label Phase|Adverse Event|0|||
155527191|NCT03769896|561358911|FG000|Open-label Phase|Withdrawal by Subject|1|||
155527192|NCT03769896|561358912|FG001|Open-label Phase|Withdrawal by Subject|0|||
155527193|NCT01015703|561358913|FG000|Overall Study|Withdrawal by Subject|0|||
155527194|NCT01015703|561358914|FG001|Overall Study|Withdrawal by Subject|1|||
155527195|NCT01015703|561358915|FG002|Overall Study|Withdrawal by Subject|0|||
155527196|NCT01015703|561358916|FG003|Overall Study|Withdrawal by Subject|0|||
155527197|NCT01015703|561358917|FG004|Overall Study|Withdrawal by Subject|0|||
155527198|NCT01015703|561358913|FG000|Overall Study|Adverse Event|1|||
155527199|NCT01015703|561358914|FG001|Overall Study|Adverse Event|0|||
155527200|NCT01015703|561358915|FG002|Overall Study|Adverse Event|0|||
155527201|NCT01015703|561358916|FG003|Overall Study|Adverse Event|0|||
155527202|NCT01015703|561358917|FG004|Overall Study|Adverse Event|0|||
155527203|NCT01015703|561358913|FG000|Overall Study|Protocol Violation|1|||
155527204|NCT01015703|561358914|FG001|Overall Study|Protocol Violation|0|||
155527205|NCT01015703|561358915|FG002|Overall Study|Protocol Violation|0|||
155527206|NCT01015703|561358916|FG003|Overall Study|Protocol Violation|0|||
155527207|NCT01015703|561358917|FG004|Overall Study|Protocol Violation|0|||
155527208|NCT02646124|561358918|FG000|Overall Study|Lost to Follow-up|0|||
155527209|NCT02646124|561358919|FG001|Overall Study|Lost to Follow-up|2|||
155527210|NCT00857454|561358922|FG000|Overall Study|Withdrawal by Subject|2|||
155527211|NCT00857454|561358922|FG000|Overall Study|Lost to Follow-up|1|||
155527212|NCT00857454|561358922|FG000|Overall Study|Adverse Event|2|||
155527213|NCT00857454|561358922|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
155527214|NCT00857454|561358922|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
155527215|NCT00857454|561358922|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
155527216|NCT00365365|561358923|FG000|Overall Study|Randomized but not treated|0|||
155527217|NCT00365365|561358924|FG001|Overall Study|Randomized but not treated|2|||
155527218|NCT00365365|561358925|FG002|Overall Study|Randomized but not treated|0|||
155527219|NCT00365365|561358923|FG000|Overall Study|Poor compliance to protocol|0|||
155527220|NCT00365365|561358924|FG001|Overall Study|Poor compliance to protocol|1|||
155527221|NCT00365365|561358925|FG002|Overall Study|Poor compliance to protocol|0|||
155527222|NCT00365365|561358923|FG000|Overall Study|Lost to Follow-up|3|||
155527223|NCT00365365|561358924|FG001|Overall Study|Lost to Follow-up|3|||
155527224|NCT00365365|561358925|FG002|Overall Study|Lost to Follow-up|3|||
155527225|NCT00365365|561358923|FG000|Overall Study|Death|1|||
155527226|NCT00365365|561358924|FG001|Overall Study|Death|3|||
155527227|NCT00365365|561358925|FG002|Overall Study|Death|0|||
155527228|NCT00365365|561358923|FG000|Overall Study|Subject's request|11|||
155527229|NCT00365365|561358924|FG001|Overall Study|Subject's request|13|||
155527230|NCT00365365|561358925|FG002|Overall Study|Subject's request|1|||
155527231|NCT00365365|561358923|FG000|Overall Study|Disease progression/relapse|9|||
155527232|NCT00365365|561358924|FG001|Overall Study|Disease progression/relapse|6|||
155527233|NCT00365365|561358925|FG002|Overall Study|Disease progression/relapse|7|||
155527234|NCT00365365|561358923|FG000|Overall Study|Adverse Event|6|||
155527235|NCT00365365|561358924|FG001|Overall Study|Adverse Event|6|||
155527236|NCT00365365|561358925|FG002|Overall Study|Adverse Event|3|||
155527237|NCT00365365|561358923|FG000|Overall Study|Moved|2|||
155527238|NCT00365365|561358924|FG001|Overall Study|Moved|0|||
155527239|NCT00365365|561358925|FG002|Overall Study|Moved|0|||
155527240|NCT00365365|561358923|FG000|Overall Study|New cancer|1|||
155527241|NCT00365365|561358924|FG001|Overall Study|New cancer|0|||
155527242|NCT00365365|561358925|FG002|Overall Study|New cancer|0|||
155527243|NCT00365365|561358923|FG000|Overall Study|Withdrew consent|1|||
155527244|NCT00365365|561358924|FG001|Overall Study|Withdrew consent|1|||
155527245|NCT00365365|561358925|FG002|Overall Study|Withdrew consent|0|||
155527246|NCT00365365|561358923|FG000|Overall Study|Second malignancy|0|||
155527247|NCT00365365|561358924|FG001|Overall Study|Second malignancy|1|||
155527248|NCT00365365|561358925|FG002|Overall Study|Second malignancy|0|||
155527249|NCT00365365|561358923|FG000|Overall Study|Patient/physician decision|0|||
155527250|NCT00365365|561358924|FG001|Overall Study|Patient/physician decision|0|||
155527251|NCT00365365|561358925|FG002|Overall Study|Patient/physician decision|1|||
155527252|NCT00984022|561358926|FG000|Overall Study|Lost to Follow-up|10|||
155527253|NCT00984022|561358927|FG001|Overall Study|Lost to Follow-up|14|||
155527254|NCT00573443|561358931|FG000|Double-Blind Phase|Lost to Follow-up|1|||
155527255|NCT00573443|561358932|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155527256|NCT00573443|561358933|FG002|Double-Blind Phase|Lost to Follow-up|2|||
155527257|NCT00573443|561358931|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
155527258|NCT00573443|561358932|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
155527259|NCT00573443|561358933|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
155527260|NCT00573443|561358931|FG000|Double-Blind Phase|Adverse Event|1|||
155527261|NCT00573443|561358932|FG001|Double-Blind Phase|Adverse Event|5|||
155527262|NCT00573443|561358933|FG002|Double-Blind Phase|Adverse Event|0|||
155527263|NCT00573443|561358931|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
155527264|NCT00573443|561358932|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
155527265|NCT00573443|561358933|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
155527266|NCT00573443|561358931|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
155527267|NCT00573443|561358932|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
155527268|NCT00573443|561358933|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
155527269|NCT00573443|561358931|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155527270|NCT00573443|561358932|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
155527271|NCT00573443|561358933|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
155527272|NCT00573443|561358931|FG000|Double-Blind Phase|Protocol Violation|0|||
155527273|NCT00573443|561358932|FG001|Double-Blind Phase|Protocol Violation|2|||
155527274|NCT00573443|561358933|FG002|Double-Blind Phase|Protocol Violation|1|||
155527275|NCT00573443|561358931|FG000|Double-Blind Phase|Other|0|||
155527276|NCT00573443|561358932|FG001|Double-Blind Phase|Other|2|||
155527277|NCT00573443|561358933|FG002|Double-Blind Phase|Other|3|||
155527278|NCT00573443|561358931|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
155527279|NCT00573443|561358932|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155527280|NCT00573443|561358933|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155527281|NCT00573443|561358931|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
155527282|NCT00573443|561358932|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
155527283|NCT00573443|561358933|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
155527284|NCT00573443|561358931|FG000|Open-Label Extension Phase|Adverse Event|3|||
155527285|NCT00573443|561358932|FG001|Open-Label Extension Phase|Adverse Event|0|||
155527286|NCT00573443|561358933|FG002|Open-Label Extension Phase|Adverse Event|0|||
155527287|NCT00573443|561358931|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
155527288|NCT00573443|561358932|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
155527289|NCT00573443|561358933|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
155527290|NCT00573443|561358931|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
155527291|NCT00573443|561358932|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
155527292|NCT00573443|561358933|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
155527293|NCT00573443|561358931|FG000|Open-Label Extension Phase|Protocol Violation|2|||
155527294|NCT00573443|561358932|FG001|Open-Label Extension Phase|Protocol Violation|0|||
155527295|NCT00573443|561358933|FG002|Open-Label Extension Phase|Protocol Violation|0|||
155527296|NCT00573443|561358931|FG000|Open-Label Extension Phase|Other|2|||
155527297|NCT00573443|561358932|FG001|Open-Label Extension Phase|Other|0|||
155527298|NCT00573443|561358933|FG002|Open-Label Extension Phase|Other|0|||
155527299|NCT00418561|561358934|FG000|Overall Study|Participant's (guardian's) decision|0|||
155527300|NCT00418561|561358935|FG001|Overall Study|Participant's (guardian's) decision|1|||
155527301|NCT00418561|561358936|FG002|Overall Study|Participant's (guardian's) decision|0|||
155527302|NCT01796171|561358937|FG000|Enrolled|Death|0|||
155527303|NCT01796171|561358938|FG001|Enrolled|Death|0|||
155527304|NCT01796171|561358939|FG002|Enrolled|Death|0|||
155527305|NCT01796171|561358940|FG003|Enrolled|Death|0|||
155527306|NCT01796171|561358941|FG004|Enrolled|Death|0|||
155527307|NCT01796171|561358942|FG005|Enrolled|Death|0|||
155527308|NCT01796171|561358943|FG006|Enrolled|Death|0|||
155527309|NCT01796171|561358944|FG007|Enrolled|Death|0|||
155527310|NCT01796171|561358945|FG008|Enrolled|Death|0|||
155527311|NCT01796171|561358946|FG009|Enrolled|Death|0|||
155527312|NCT01796171|561358947|FG010|Enrolled|Death|0|||
155527313|NCT01796171|561358948|FG011|Enrolled|Death|0|||
155527314|NCT01796171|561358949|FG012|Enrolled|Death|0|||
155527315|NCT01796171|561358950|FG013|Enrolled|Death|0|||
155527316|NCT01796171|561358951|FG014|Enrolled|Death|1|||
155527317|NCT01796171|561358937|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
155527318|NCT01796171|561358938|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
155527319|NCT01796171|561358939|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
155527320|NCT01796171|561358940|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
155527321|NCT01796171|561358941|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
155527322|NCT01796171|561358942|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
155527323|NCT01796171|561358943|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
155527324|NCT01796171|561358944|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
155527325|NCT01796171|561358945|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
155527326|NCT01796171|561358946|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
155527327|NCT01796171|561358947|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
155527328|NCT01796171|561358948|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
155527329|NCT01796171|561358949|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
155527330|NCT01796171|561358950|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
155527331|NCT01796171|561358951|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
155527332|NCT01796171|561358937|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527333|NCT01796171|561358938|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527334|NCT01796171|561358939|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527335|NCT01796171|561358940|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527336|NCT01796171|561358941|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527337|NCT01796171|561358942|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527338|NCT01796171|561358943|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527339|NCT01796171|561358944|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527340|NCT01796171|561358945|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527341|NCT01796171|561358946|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527342|NCT01796171|561358947|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527343|NCT01796171|561358948|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527344|NCT01796171|561358949|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527345|NCT01796171|561358950|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
155527346|NCT01796171|561358951|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
155527347|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Progressive disease|0|||
155527348|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Progressive disease|1|||
155527349|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Progressive disease|0|||
155527350|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Progressive disease|0|||
155527351|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Progressive disease|0|||
155527352|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Progressive disease|0|||
155527353|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Progressive disease|0|||
155527354|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Progressive disease|0|||
155527355|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Progressive disease|0|||
155527356|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Progressive disease|0|||
155527357|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Progressive disease|0|||
155527358|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Progressive disease|0|||
155527359|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Progressive disease|0|||
155527360|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Progressive disease|0|||
155527361|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Progressive disease|0|||
155527362|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527363|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527364|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527365|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527366|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527367|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527368|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527369|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527370|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
155527371|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527372|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
155527373|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
155527374|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527375|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527376|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
155527377|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Physician Decision|0|||
155527378|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Physician Decision|0|||
155527379|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Physician Decision|0|||
155527380|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Physician Decision|0|||
155527381|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Physician Decision|0|||
155527382|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Physician Decision|0|||
155527383|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Physician Decision|0|||
155527384|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Physician Decision|0|||
155527385|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Physician Decision|0|||
155527386|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Physician Decision|0|||
155527387|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Physician Decision|5|||
155527388|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Physician Decision|1|||
155527389|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Physician Decision|1|||
155527390|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Physician Decision|0|||
155527391|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Physician Decision|0|||
155527392|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Death|0|||
155527393|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Death|0|||
155527394|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Death|0|||
155527395|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Death|0|||
155527396|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Death|0|||
155527397|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Death|0|||
155527398|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Death|0|||
155527399|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Death|0|||
155527400|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Death|0|||
155527401|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Death|0|||
155527402|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Death|2|||
155527403|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Death|0|||
155527404|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Death|0|||
155527405|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Death|0|||
155527406|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Death|0|||
155527407|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
155527408|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
155527409|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
155527410|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
155527411|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
155527412|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
155527413|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
155527414|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
155527415|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
155527416|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
155527417|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
155527418|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
155527419|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
155527420|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
155527421|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
155527422|NCT01796171|561358937|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527423|NCT01796171|561358938|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527424|NCT01796171|561358939|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527425|NCT01796171|561358940|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527426|NCT01796171|561358941|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527427|NCT01796171|561358942|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527428|NCT01796171|561358943|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527429|NCT01796171|561358944|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527430|NCT01796171|561358945|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527431|NCT01796171|561358946|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527432|NCT01796171|561358947|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
155527433|NCT01796171|561358948|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
155527434|NCT01796171|561358949|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527435|NCT01796171|561358950|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527436|NCT01796171|561358951|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155527437|NCT01796171|561358937|FG000|Follow-up Period|Start of further anticancer therapy|4|||
155527438|NCT01796171|561358938|FG001|Follow-up Period|Start of further anticancer therapy|25|||
155527439|NCT01796171|561358939|FG002|Follow-up Period|Start of further anticancer therapy|2|||
155527440|NCT01796171|561358940|FG003|Follow-up Period|Start of further anticancer therapy|1|||
155527441|NCT01796171|561358941|FG004|Follow-up Period|Start of further anticancer therapy|2|||
155527442|NCT01796171|561358942|FG005|Follow-up Period|Start of further anticancer therapy|2|||
155527443|NCT01796171|561358943|FG006|Follow-up Period|Start of further anticancer therapy|1|||
155527444|NCT01796171|561358944|FG007|Follow-up Period|Start of further anticancer therapy|15|||
155527445|NCT01796171|561358945|FG008|Follow-up Period|Start of further anticancer therapy|2|||
155527446|NCT01796171|561358946|FG009|Follow-up Period|Start of further anticancer therapy|0|||
155527447|NCT01796171|561358947|FG010|Follow-up Period|Start of further anticancer therapy|0|||
155527448|NCT01796171|561358948|FG011|Follow-up Period|Start of further anticancer therapy|0|||
155527449|NCT01796171|561358949|FG012|Follow-up Period|Start of further anticancer therapy|0|||
155527450|NCT01796171|561358950|FG013|Follow-up Period|Start of further anticancer therapy|0|||
155527451|NCT01796171|561358951|FG014|Follow-up Period|Start of further anticancer therapy|0|||
155527452|NCT01796171|561358937|FG000|Follow-up Period|Progressive disease|0|||
155527453|NCT01796171|561358938|FG001|Follow-up Period|Progressive disease|1|||
155527454|NCT01796171|561358939|FG002|Follow-up Period|Progressive disease|0|||
155527455|NCT01796171|561358940|FG003|Follow-up Period|Progressive disease|0|||
155527456|NCT01796171|561358941|FG004|Follow-up Period|Progressive disease|0|||
155527457|NCT01796171|561358942|FG005|Follow-up Period|Progressive disease|0|||
155527458|NCT01796171|561358943|FG006|Follow-up Period|Progressive disease|0|||
155527459|NCT01796171|561358944|FG007|Follow-up Period|Progressive disease|3|||
155527460|NCT01796171|561358945|FG008|Follow-up Period|Progressive disease|0|||
155527461|NCT01796171|561358946|FG009|Follow-up Period|Progressive disease|0|||
155527462|NCT01796171|561358947|FG010|Follow-up Period|Progressive disease|0|||
155527463|NCT01796171|561358948|FG011|Follow-up Period|Progressive disease|0|||
155527464|NCT01796171|561358949|FG012|Follow-up Period|Progressive disease|0|||
155527465|NCT01796171|561358950|FG013|Follow-up Period|Progressive disease|0|||
155527466|NCT01796171|561358951|FG014|Follow-up Period|Progressive disease|0|||
155527467|NCT01796171|561358937|FG000|Follow-up Period|Physician Decision|0|||
155527468|NCT01796171|561358938|FG001|Follow-up Period|Physician Decision|2|||
155527469|NCT01796171|561358939|FG002|Follow-up Period|Physician Decision|0|||
155527470|NCT01796171|561358940|FG003|Follow-up Period|Physician Decision|0|||
155527471|NCT01796171|561358941|FG004|Follow-up Period|Physician Decision|0|||
155527472|NCT01796171|561358942|FG005|Follow-up Period|Physician Decision|0|||
155527473|NCT01796171|561358943|FG006|Follow-up Period|Physician Decision|0|||
155527474|NCT01796171|561358944|FG007|Follow-up Period|Physician Decision|0|||
155527475|NCT01796171|561358945|FG008|Follow-up Period|Physician Decision|0|||
155527476|NCT01796171|561358946|FG009|Follow-up Period|Physician Decision|0|||
155527477|NCT01796171|561358947|FG010|Follow-up Period|Physician Decision|5|||
155527478|NCT01796171|561358948|FG011|Follow-up Period|Physician Decision|0|||
155527479|NCT01796171|561358949|FG012|Follow-up Period|Physician Decision|0|||
155527480|NCT01796171|561358950|FG013|Follow-up Period|Physician Decision|0|||
155527481|NCT01796171|561358951|FG014|Follow-up Period|Physician Decision|0|||
155527482|NCT01796171|561358937|FG000|Follow-up Period|Withdrawal by Subject|0|||
155527483|NCT01796171|561358938|FG001|Follow-up Period|Withdrawal by Subject|1|||
155527484|NCT01796171|561358939|FG002|Follow-up Period|Withdrawal by Subject|0|||
155527485|NCT01796171|561358940|FG003|Follow-up Period|Withdrawal by Subject|0|||
155527486|NCT01796171|561358941|FG004|Follow-up Period|Withdrawal by Subject|0|||
155527487|NCT01796171|561358942|FG005|Follow-up Period|Withdrawal by Subject|1|||
155527488|NCT01796171|561358943|FG006|Follow-up Period|Withdrawal by Subject|0|||
155527489|NCT01796171|561358944|FG007|Follow-up Period|Withdrawal by Subject|0|||
155527490|NCT01796171|561358945|FG008|Follow-up Period|Withdrawal by Subject|0|||
155527491|NCT01796171|561358946|FG009|Follow-up Period|Withdrawal by Subject|0|||
155527492|NCT01796171|561358947|FG010|Follow-up Period|Withdrawal by Subject|3|||
155527493|NCT01796171|561358948|FG011|Follow-up Period|Withdrawal by Subject|1|||
155527494|NCT01796171|561358949|FG012|Follow-up Period|Withdrawal by Subject|0|||
155527495|NCT01796171|561358950|FG013|Follow-up Period|Withdrawal by Subject|0|||
155527496|NCT01796171|561358951|FG014|Follow-up Period|Withdrawal by Subject|0|||
155527497|NCT01796171|561358937|FG000|Follow-up Period|Death|0|||
155527498|NCT01796171|561358938|FG001|Follow-up Period|Death|0|||
155527499|NCT01796171|561358939|FG002|Follow-up Period|Death|0|||
155527500|NCT01796171|561358940|FG003|Follow-up Period|Death|0|||
155527501|NCT01796171|561358941|FG004|Follow-up Period|Death|0|||
155527502|NCT01796171|561358942|FG005|Follow-up Period|Death|0|||
155527503|NCT01796171|561358943|FG006|Follow-up Period|Death|1|||
155527504|NCT01796171|561358944|FG007|Follow-up Period|Death|0|||
155527505|NCT01796171|561358945|FG008|Follow-up Period|Death|0|||
155527506|NCT01796171|561358946|FG009|Follow-up Period|Death|0|||
155527507|NCT01796171|561358947|FG010|Follow-up Period|Death|17|||
155527508|NCT01796171|561358948|FG011|Follow-up Period|Death|9|||
155527509|NCT01796171|561358949|FG012|Follow-up Period|Death|1|||
155527510|NCT01796171|561358950|FG013|Follow-up Period|Death|0|||
155527511|NCT01796171|561358951|FG014|Follow-up Period|Death|0|||
155527512|NCT01796171|561358937|FG000|Follow-up Period|Patient transferred to other hospital|0|||
155527513|NCT01796171|561358938|FG001|Follow-up Period|Patient transferred to other hospital|1|||
155527514|NCT01796171|561358939|FG002|Follow-up Period|Patient transferred to other hospital|0|||
155527515|NCT01796171|561358940|FG003|Follow-up Period|Patient transferred to other hospital|0|||
155527516|NCT01796171|561358941|FG004|Follow-up Period|Patient transferred to other hospital|0|||
155527517|NCT01796171|561358942|FG005|Follow-up Period|Patient transferred to other hospital|0|||
155527518|NCT01796171|561358943|FG006|Follow-up Period|Patient transferred to other hospital|0|||
155527519|NCT01796171|561358944|FG007|Follow-up Period|Patient transferred to other hospital|0|||
155527520|NCT01796171|561358945|FG008|Follow-up Period|Patient transferred to other hospital|0|||
155527521|NCT01796171|561358946|FG009|Follow-up Period|Patient transferred to other hospital|0|||
155527522|NCT01796171|561358947|FG010|Follow-up Period|Patient transferred to other hospital|0|||
155527523|NCT01796171|561358948|FG011|Follow-up Period|Patient transferred to other hospital|0|||
155527524|NCT01796171|561358949|FG012|Follow-up Period|Patient transferred to other hospital|0|||
155527525|NCT01796171|561358950|FG013|Follow-up Period|Patient transferred to other hospital|0|||
155527526|NCT01796171|561358951|FG014|Follow-up Period|Patient transferred to other hospital|0|||
155527527|NCT01796171|561358937|FG000|Follow-up Period|Sponsor Decision|0|||
155527528|NCT01796171|561358938|FG001|Follow-up Period|Sponsor Decision|0|||
155527529|NCT01796171|561358939|FG002|Follow-up Period|Sponsor Decision|0|||
155527530|NCT01796171|561358940|FG003|Follow-up Period|Sponsor Decision|0|||
155527531|NCT01796171|561358941|FG004|Follow-up Period|Sponsor Decision|0|||
155527532|NCT01796171|561358942|FG005|Follow-up Period|Sponsor Decision|0|||
155527533|NCT01796171|561358943|FG006|Follow-up Period|Sponsor Decision|0|||
155527534|NCT01796171|561358944|FG007|Follow-up Period|Sponsor Decision|0|||
155527535|NCT01796171|561358945|FG008|Follow-up Period|Sponsor Decision|0|||
155527536|NCT01796171|561358946|FG009|Follow-up Period|Sponsor Decision|0|||
155527537|NCT01796171|561358947|FG010|Follow-up Period|Sponsor Decision|40|||
155527538|NCT01796171|561358948|FG011|Follow-up Period|Sponsor Decision|15|||
155527539|NCT01796171|561358949|FG012|Follow-up Period|Sponsor Decision|7|||
155527540|NCT01796171|561358950|FG013|Follow-up Period|Sponsor Decision|0|||
155527541|NCT01796171|561358951|FG014|Follow-up Period|Sponsor Decision|0|||
155527542|NCT00829309|561358952|FG000|Washout: 7 Days|Protocol Violation|1|||
155527543|NCT00829309|561358953|FG001|Washout: 7 Days|Protocol Violation|0|||
155527544|NCT01083693|561358956|FG000|Overall Study|Adverse Event|1|||
155527545|NCT01083693|561358957|FG001|Overall Study|Adverse Event|1|||
155527546|NCT01083693|561358958|FG002|Overall Study|Adverse Event|0|||
155527547|NCT01083693|561358956|FG000|Overall Study|Lost to Follow-up|2|||
155527548|NCT01083693|561358957|FG001|Overall Study|Lost to Follow-up|0|||
155527549|NCT01083693|561358958|FG002|Overall Study|Lost to Follow-up|2|||
155527550|NCT01083693|561358956|FG000|Overall Study|Lack of effectiveness|13|||
155527551|NCT01083693|561358957|FG001|Overall Study|Lack of effectiveness|2|||
155527552|NCT01083693|561358958|FG002|Overall Study|Lack of effectiveness|2|||
155527553|NCT01083693|561358956|FG000|Overall Study|Patient Moved|0|||
155527554|NCT01083693|561358957|FG001|Overall Study|Patient Moved|1|||
155527555|NCT01083693|561358958|FG002|Overall Study|Patient Moved|0|||
155527556|NCT01083693|561358956|FG000|Overall Study|Complete remission|0|||
155527557|NCT01083693|561358957|FG001|Overall Study|Complete remission|1|||
155527558|NCT01083693|561358958|FG002|Overall Study|Complete remission|0|||
155527559|NCT01083693|561358956|FG000|Overall Study|Other medical condition/surgery|1|||
155527560|NCT01083693|561358957|FG001|Overall Study|Other medical condition/surgery|1|||
155527561|NCT01083693|561358958|FG002|Overall Study|Other medical condition/surgery|0|||
155527562|NCT01083693|561358956|FG000|Overall Study|Withdrawal by Subject|3|||
155527563|NCT01083693|561358957|FG001|Overall Study|Withdrawal by Subject|0|||
155527564|NCT01083693|561358958|FG002|Overall Study|Withdrawal by Subject|2|||
155527565|NCT01083693|561358956|FG000|Overall Study|Reason unknown|0|||
155527566|NCT01083693|561358957|FG001|Overall Study|Reason unknown|0|||
155527567|NCT01083693|561358958|FG002|Overall Study|Reason unknown|1|||
155527568|NCT00834418|561358959|FG000|Overall Study|Adverse Event|0|||
155527569|NCT00834418|561358960|FG001|Overall Study|Adverse Event|2|||
155527570|NCT04567186|561358962|FG000|Period 1|COVID-19 related|1|||
155527571|NCT04567186|561358963|FG001|Period 1|COVID-19 related|0|||
155527572|NCT04567186|561358962|FG000|Period 1|Protocol Violation|0|||
155527573|NCT04567186|561358963|FG001|Period 1|Protocol Violation|1|||
155527574|NCT04567186|561358962|FG000|Period 1|Adverse Event|0|||
155527575|NCT04567186|561358963|FG001|Period 1|Adverse Event|2|||
155527576|NCT04567186|561358962|FG000|Period 2|COVID-19 Related|0|||
155527577|NCT04567186|561358963|FG001|Period 2|COVID-19 Related|1|||
155527578|NCT04567186|561358962|FG000|Period 2|Protocol Violation|0|||
155527579|NCT04567186|561358963|FG001|Period 2|Protocol Violation|1|||
155527580|NCT04567186|561358962|FG000|Period 2|Lost to Follow-up|0|||
155527581|NCT04567186|561358963|FG001|Period 2|Lost to Follow-up|1|||
155527582|NCT04567186|561358962|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
155527583|NCT04567186|561358963|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
155527584|NCT00448019|561358968|FG000|Overall Study|Withdrawal by Subject|3|||
155527585|NCT00448019|561358968|FG000|Overall Study|Disease progression|1|||
155527586|NCT00448019|561358968|FG000|Overall Study|Death|2|||
155527587|NCT00448019|561358968|FG000|Overall Study|Insurance Issues|1|||
155527588|NCT00089661|561358969|FG000|Overall Study|Adverse Event|0|||
155527589|NCT00089661|561358970|FG001|Overall Study|Adverse Event|2|||
155527590|NCT00089661|561358969|FG000|Overall Study|Death|1|||
155527591|NCT00089661|561358970|FG001|Overall Study|Death|0|||
155527592|NCT00089661|561358969|FG000|Overall Study|Lost to Follow-up|0|||
155527593|NCT00089661|561358970|FG001|Overall Study|Lost to Follow-up|3|||
155527594|NCT00089661|561358969|FG000|Overall Study|Withdrawal by Subject|11|||
155527595|NCT00089661|561358970|FG001|Overall Study|Withdrawal by Subject|9|||
155527596|NCT00089661|561358969|FG000|Overall Study|Disease progression|1|||
155527597|NCT00089661|561358970|FG001|Overall Study|Disease progression|3|||
155527598|NCT00089661|561358969|FG000|Overall Study|Ineligibility determined|4|||
155527599|NCT00089661|561358970|FG001|Overall Study|Ineligibility determined|4|||
155527600|NCT00089661|561358969|FG000|Overall Study|Noncompliance|2|||
155527601|NCT00089661|561358970|FG001|Overall Study|Noncompliance|4|||
155527602|NCT00089661|561358969|FG000|Overall Study|Other|2|||
155527603|NCT00089661|561358970|FG001|Overall Study|Other|1|||
155527604|NCT00850174|561358971|FG000|Washout: One Week|Withdrawal by Subject|0|||
155527605|NCT00850174|561358972|FG001|Washout: One Week|Withdrawal by Subject|2|||
155527606|NCT00850174|561358971|FG000|Second Intervention|Withdrawal by Subject|1|||
155527607|NCT00850174|561358972|FG001|Second Intervention|Withdrawal by Subject|0|||
155527608|NCT01363765|561358973|FG000|Overall Study|non-diagnostic|2621|||
155527609|NCT01363765|561358974|FG001|Overall Study|non-diagnostic|1124|||
155527610|NCT01363765|561358973|FG000|Overall Study|duplicate records|736|||
155527611|NCT01363765|561358974|FG001|Overall Study|duplicate records|3177|||
155527612|NCT01363765|561358973|FG000|Overall Study|non-resident|156|||
155527613|NCT01363765|561358974|FG001|Overall Study|non-resident|76|||
155527614|NCT01363765|561358973|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
155527615|NCT01363765|561358974|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
155527616|NCT01363765|561358973|FG000|Overall Study|smear during intervention|2170|||
155527617|NCT01363765|561358974|FG001|Overall Study|smear during intervention|0|||
155527618|NCT00635492|561358975|FG000|Overall Study|Death|12|||
155527619|NCT00635492|561358976|FG001|Overall Study|Death|40|||
155527620|NCT00635492|561358975|FG000|Overall Study|Lost to Follow-up|151|||
155527621|NCT00635492|561358976|FG001|Overall Study|Lost to Follow-up|172|||
155527622|NCT00635492|561358975|FG000|Overall Study|Physician Decision|32|||
155527623|NCT00635492|561358976|FG001|Overall Study|Physician Decision|22|||
155527624|NCT00635492|561358975|FG000|Overall Study|Sponsor decision|2|||
155527625|NCT00635492|561358976|FG001|Overall Study|Sponsor decision|3|||
155527626|NCT00635492|561358975|FG000|Overall Study|Withdrawal by Subject|82|||
155527627|NCT00635492|561358976|FG001|Overall Study|Withdrawal by Subject|45|||
155527628|NCT02682784|561358982|FG000|Overall Study|Withdrawal by Subject|0|||
155527629|NCT02682784|561358983|FG001|Overall Study|Withdrawal by Subject|2|||
155527630|NCT02682784|561358984|FG002|Overall Study|Withdrawal by Subject|1|||
155527631|NCT02682784|561358985|FG003|Overall Study|Withdrawal by Subject|2|||
155527632|NCT02682784|561358982|FG000|Overall Study|Physician Decision|1|||
155527633|NCT02682784|561358983|FG001|Overall Study|Physician Decision|0|||
155527634|NCT02682784|561358984|FG002|Overall Study|Physician Decision|1|||
155527635|NCT02682784|561358985|FG003|Overall Study|Physician Decision|1|||
155527636|NCT01702987|561358986|FG000|Overall Study|Withdrawal by Subject|1|||
155527637|NCT01702987|561358987|FG001|Overall Study|Withdrawal by Subject|0|||
155527638|NCT00467363|561358988|FG000|Overall Study|Lost to Follow-up|80|||
155527639|NCT00467363|561358989|FG001|Overall Study|Lost to Follow-up|70|||
155527640|NCT04533594|561358990|FG000|Overall Study|Death|26|||
155527641|NCT00473330|561358997|FG000|Core Study|Adverse Event|4|||
155527642|NCT00473330|561358998|FG001|Core Study|Adverse Event|4|||
155527643|NCT00473330|561358999|FG002|Core Study|Adverse Event|1|||
155527644|NCT00473330|561358997|FG000|Core Study|Death|6|||
155527645|NCT00473330|561358998|FG001|Core Study|Death|4|||
155527646|NCT00473330|561358999|FG002|Core Study|Death|4|||
155527647|NCT00473330|561358997|FG000|Core Study|Lost to Follow-up|5|||
155527648|NCT00473330|561358998|FG001|Core Study|Lost to Follow-up|5|||
155527649|NCT00473330|561358999|FG002|Core Study|Lost to Follow-up|10|||
155527650|NCT00473330|561358997|FG000|Core Study|Physician Decision|2|||
155527651|NCT00473330|561358998|FG001|Core Study|Physician Decision|1|||
155527652|NCT00473330|561358999|FG002|Core Study|Physician Decision|3|||
155527653|NCT00473330|561358997|FG000|Core Study|Subject Non-compliance|1|||
155527654|NCT00473330|561358998|FG001|Core Study|Subject Non-compliance|2|||
155527655|NCT00473330|561358999|FG002|Core Study|Subject Non-compliance|1|||
155527656|NCT00473330|561358997|FG000|Core Study|Subject Required Other Therapy|0|||
155527657|NCT00473330|561358998|FG001|Core Study|Subject Required Other Therapy|1|||
155527658|NCT00473330|561358999|FG002|Core Study|Subject Required Other Therapy|3|||
155527659|NCT00473330|561358997|FG000|Core Study|Subject's Decision|9|||
155527660|NCT00473330|561358998|FG001|Core Study|Subject's Decision|8|||
155527661|NCT00473330|561358999|FG002|Core Study|Subject's Decision|19|||
155527662|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
155527663|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
155527664|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
155527665|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Death|2|||
155527666|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Death|0|||
155527667|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Death|0|||
155527668|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
155527669|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
155527670|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
155527671|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
155527672|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
155527673|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
155527674|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
155527675|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
155527676|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
155527677|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
155527678|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
155527679|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
155527680|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
155527681|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
155527682|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
155527683|NCT00473330|561358997|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
155527684|NCT00473330|561358998|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
155527685|NCT00473330|561358999|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
155527686|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
155527687|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
155527688|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
155655070|NCT01051661|561830640|FG004|Overall Study|Data not reliable|0|||
155527689|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Death|2|||
155527690|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Death|2|||
155527691|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Death|1|||
155527692|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
155527693|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
155527694|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
155527695|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
155527696|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
155527697|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
155527698|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
155527699|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
155527700|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
155527701|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
155527702|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
155527703|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
155527704|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
155527705|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
155527706|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
155527707|NCT00473330|561358997|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
155527708|NCT00473330|561358998|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
155527709|NCT00473330|561358999|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
155527710|NCT01975948|561359001|FG000|Overall Study|Withdrawal by Subject|17|||
155527711|NCT01975948|561359002|FG001|Overall Study|Withdrawal by Subject|21|||
155527712|NCT01975948|561359003|FG002|Overall Study|Withdrawal by Subject|7|||
155527713|NCT01975948|561359004|FG003|Overall Study|Withdrawal by Subject|6|||
155527714|NCT00365846|561359005|FG000|Overall Study|Lost to Follow-up|1|||
155527715|NCT00904215|561359006|FG000|Overall Study|Adverse Event|25|||
155527716|NCT00904215|561359006|FG000|Overall Study|Protocol Violation|10|||
155527717|NCT00904215|561359006|FG000|Overall Study|Lost to Follow-up|63|||
155527718|NCT00904215|561359006|FG000|Overall Study|Withdrawal by Subject|9|||
155527719|NCT00904215|561359006|FG000|Overall Study|Other|28|||
155527720|NCT00640562|561359007|FG000|Overall Study|Adverse Event|8|||
155527721|NCT00640562|561359008|FG001|Overall Study|Adverse Event|5|||
155527722|NCT00640562|561359007|FG000|Overall Study|Lack of Efficacy|1|||
155527723|NCT00640562|561359008|FG001|Overall Study|Lack of Efficacy|4|||
155527724|NCT00640562|561359007|FG000|Overall Study|Protocol Violation|2|||
155527725|NCT00640562|561359008|FG001|Overall Study|Protocol Violation|4|||
155527726|NCT00640562|561359007|FG000|Overall Study|Withdrawal by Subject|6|||
155527727|NCT00640562|561359008|FG001|Overall Study|Withdrawal by Subject|10|||
155527728|NCT00640562|561359007|FG000|Overall Study|Known risperidone intolerance|0|||
155527729|NCT00640562|561359008|FG001|Overall Study|Known risperidone intolerance|1|||
155527730|NCT00640562|561359007|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
155527731|NCT00640562|561359008|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
155527732|NCT00640562|561359007|FG000|Overall Study|Low study drug dose|0|||
155527733|NCT00640562|561359008|FG001|Overall Study|Low study drug dose|1|||
155527734|NCT00640562|561359007|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
155527735|NCT00640562|561359008|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
155527736|NCT00448591|561359009|FG000|Overall Study|Withdrawal by Subject|178|||
155527737|NCT00448591|561359009|FG000|Overall Study|Progressive Disease|1382|||
155527738|NCT00448591|561359009|FG000|Overall Study|Adverse Event|382|||
155527739|NCT00448591|561359009|FG000|Overall Study|Protocol Violation|41|||
155527740|NCT00448591|561359009|FG000|Overall Study|Lost to Follow-up|19|||
155527741|NCT00448591|561359009|FG000|Overall Study|Treatment Regimen Completed|70|||
155527742|NCT00448591|561359009|FG000|Overall Study|Other|154|||
155527743|NCT00448591|561359009|FG000|Overall Study|Termination of Study|70|||
155527744|NCT02937870|561359010|FG000|Overall Study|Adverse Event|1|||
155527745|NCT02937870|561359010|FG000|Overall Study|Protocol Deviation|2|||
155527746|NCT00244764|561359011|FG000|Overall Study|Adverse Event|37|||
155527747|NCT00244764|561359011|FG000|Overall Study|Lost to Follow-up|23|||
155527748|NCT00244764|561359011|FG000|Overall Study|Withdrawal by Subject|12|||
155527749|NCT00244764|561359011|FG000|Overall Study|Disease Progression|13|||
155527750|NCT00244764|561359011|FG000|Overall Study|Protocol Violation|2|||
155527751|NCT00244764|561359011|FG000|Overall Study|Death|1|||
155527752|NCT00244764|561359011|FG000|Overall Study|Off Study Medication for >21 Days|1|||
155527753|NCT00244764|561359011|FG000|Overall Study|Declining Performance Status|1|||
155527754|NCT00244764|561359011|FG000|Overall Study|Participant was Hospitalized until Death|1|||
155527755|NCT00244764|561359011|FG000|Overall Study|Primary Investigator Discretion|2|||
155527756|NCT00244764|561359011|FG000|Overall Study|Sponsor Terminated Study|2|||
155527757|NCT00244764|561359011|FG000|Overall Study|Developed Secondary Malignancy|1|||
155527758|NCT04022954|561359014|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
155527759|NCT04022954|561359014|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
155527760|NCT04022954|561359014|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
155527761|NCT03017885|561359015|FG000|Overall Study|Adverse Event|2|||
155527762|NCT03017885|561359016|FG001|Overall Study|Adverse Event|0|||
155527763|NCT03017885|561359017|FG002|Overall Study|Adverse Event|0|||
155527764|NCT03017885|561359018|FG003|Overall Study|Adverse Event|0|||
155527765|NCT03017885|561359019|FG004|Overall Study|Adverse Event|0|||
155527766|NCT03017885|561359020|FG005|Overall Study|Adverse Event|0|||
155527767|NCT03017885|561359015|FG000|Overall Study|Progression of disease|4|||
155527768|NCT03017885|561359016|FG001|Overall Study|Progression of disease|3|||
155527769|NCT03017885|561359017|FG002|Overall Study|Progression of disease|4|||
155527770|NCT03017885|561359018|FG003|Overall Study|Progression of disease|0|||
155527771|NCT03017885|561359019|FG004|Overall Study|Progression of disease|0|||
155527772|NCT03017885|561359020|FG005|Overall Study|Progression of disease|0|||
155527773|NCT03017885|561359015|FG000|Overall Study|Other than listed|1|||
155527774|NCT03017885|561359016|FG001|Overall Study|Other than listed|2|||
155527775|NCT03017885|561359017|FG002|Overall Study|Other than listed|1|||
155527776|NCT03017885|561359018|FG003|Overall Study|Other than listed|0|||
155527777|NCT03017885|561359019|FG004|Overall Study|Other than listed|0|||
155527778|NCT03017885|561359020|FG005|Overall Study|Other than listed|0|||
155527779|NCT03017885|561359015|FG000|Overall Study|Lost to Follow-up|2|||
155527780|NCT03017885|561359016|FG001|Overall Study|Lost to Follow-up|0|||
155527781|NCT03017885|561359017|FG002|Overall Study|Lost to Follow-up|3|||
155527782|NCT03017885|561359018|FG003|Overall Study|Lost to Follow-up|0|||
155527783|NCT03017885|561359019|FG004|Overall Study|Lost to Follow-up|0|||
155527784|NCT03017885|561359020|FG005|Overall Study|Lost to Follow-up|0|||
155527785|NCT03017885|561359015|FG000|Overall Study|Change to other anti-cancer therapy|0|||
155527786|NCT03017885|561359016|FG001|Overall Study|Change to other anti-cancer therapy|0|||
155527787|NCT03017885|561359017|FG002|Overall Study|Change to other anti-cancer therapy|1|||
155527788|NCT03017885|561359018|FG003|Overall Study|Change to other anti-cancer therapy|0|||
155527789|NCT03017885|561359019|FG004|Overall Study|Change to other anti-cancer therapy|0|||
155527790|NCT03017885|561359020|FG005|Overall Study|Change to other anti-cancer therapy|0|||
155527791|NCT04400890|561359021|FG000|Overall Study|Withdrawal by Subject|3|||
155527792|NCT04400890|561359022|FG001|Overall Study|Withdrawal by Subject|2|||
155527793|NCT03925532|561359023|FG000|Overall Study|Lost to Follow-up|1|||
155527794|NCT01001208|561359028|FG000|Overall Study|Adverse Event|10|||
155527795|NCT01001208|561359029|FG001|Overall Study|Adverse Event|5|||
155527796|NCT01001208|561359028|FG000|Overall Study|Lost to Follow-up|5|||
155527797|NCT01001208|561359029|FG001|Overall Study|Lost to Follow-up|9|||
155527798|NCT01001208|561359028|FG000|Overall Study|Physician Decision|1|||
155527799|NCT01001208|561359029|FG001|Overall Study|Physician Decision|0|||
155527800|NCT01001208|561359028|FG000|Overall Study|Withdrawal by Subject|4|||
155527801|NCT01001208|561359029|FG001|Overall Study|Withdrawal by Subject|5|||
155527802|NCT01001208|561359028|FG000|Overall Study|Ineligibility Determined|4|||
155527803|NCT01001208|561359029|FG001|Overall Study|Ineligibility Determined|2|||
155527804|NCT01001208|561359028|FG000|Overall Study|Noncompliance|4|||
155527805|NCT01001208|561359029|FG001|Overall Study|Noncompliance|7|||
155527806|NCT01001208|561359028|FG000|Overall Study|Disease Progression|0|||
155527807|NCT01001208|561359029|FG001|Overall Study|Disease Progression|3|||
155527808|NCT01001208|561359028|FG000|Overall Study|Other|0|||
155527809|NCT01001208|561359029|FG001|Overall Study|Other|2|||
155527810|NCT02739997|561359030|FG000|Overall Study|Death|1|||
155655071|NCT01051661|561830641|FG005|Overall Study|Data not reliable|1|||
155527811|NCT02739997|561359030|FG000|Overall Study|Withdrawal by Subject|1|||
155527812|NCT01723397|561359031|FG000|Study Period 1|Protocol Violation|0|||
155527813|NCT01723397|561359032|FG001|Study Period 1|Protocol Violation|1|||
155527814|NCT01723397|561359031|FG000|Study Period 2|Protocol Violation|0|||
155527815|NCT01723397|561359032|FG001|Study Period 2|Protocol Violation|1|||
155527816|NCT00833937|561359033|FG000|Washout|Withdrawal by Subject|1|||
155527817|NCT00833937|561359034|FG001|Washout|Withdrawal by Subject|0|||
155527818|NCT01353664|561359037|FG000|Overall Study|Other|3|||
155527819|NCT01353664|561359037|FG000|Overall Study|Disease Progression|16|||
155527820|NCT03206177|561359038|FG000|Overall Study|Withdrawal by Subject|1|||
155527821|NCT00837486|561359039|FG000|Blinded-treatment Phase|Physician Decision|1|||
155527822|NCT00837486|561359040|FG001|Blinded-treatment Phase|Physician Decision|0|||
155527823|NCT00837486|561359039|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
155527824|NCT00837486|561359040|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
155527825|NCT00837486|561359039|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
155527826|NCT00837486|561359040|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
155527827|NCT00837486|561359039|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
155527828|NCT00837486|561359040|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
155527829|NCT02655679|561359041|FG000|Overall Study|Adverse Event|0|||
155527830|NCT02655679|561359042|FG001|Overall Study|Adverse Event|1|||
155527831|NCT02655679|561359043|FG002|Overall Study|Adverse Event|0|||
155527832|NCT02655679|561359044|FG003|Overall Study|Adverse Event|0|||
155527833|NCT02655679|561359045|FG004|Overall Study|Adverse Event|0|||
155527834|NCT02655679|561359041|FG000|Overall Study|Withdrawal by Subject|1|||
155527835|NCT02655679|561359042|FG001|Overall Study|Withdrawal by Subject|1|||
155527836|NCT02655679|561359043|FG002|Overall Study|Withdrawal by Subject|0|||
155527837|NCT02655679|561359044|FG003|Overall Study|Withdrawal by Subject|3|||
155527838|NCT02655679|561359045|FG004|Overall Study|Withdrawal by Subject|1|||
155527839|NCT02655679|561359041|FG000|Overall Study|Inability to Comply with the Protocol|1|||
155527840|NCT02655679|561359042|FG001|Overall Study|Inability to Comply with the Protocol|0|||
155527841|NCT02655679|561359043|FG002|Overall Study|Inability to Comply with the Protocol|0|||
155527842|NCT02655679|561359044|FG003|Overall Study|Inability to Comply with the Protocol|0|||
155527843|NCT02655679|561359045|FG004|Overall Study|Inability to Comply with the Protocol|0|||
155527844|NCT02655679|561359041|FG000|Overall Study|Lost to Follow-up|0|||
155527845|NCT02655679|561359042|FG001|Overall Study|Lost to Follow-up|1|||
155527846|NCT02655679|561359043|FG002|Overall Study|Lost to Follow-up|1|||
155527847|NCT02655679|561359044|FG003|Overall Study|Lost to Follow-up|1|||
155527848|NCT02655679|561359045|FG004|Overall Study|Lost to Follow-up|0|||
155527849|NCT02655679|561359041|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155527850|NCT02655679|561359042|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155527851|NCT02655679|561359043|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155527852|NCT02655679|561359044|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155527853|NCT02655679|561359045|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155527854|NCT00731783|561359046|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
155527855|NCT00731783|561359047|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
155527856|NCT00731783|561359046|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
155527857|NCT00731783|561359047|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
155527858|NCT00731783|561359046|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
155527859|NCT00731783|561359047|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
155527860|NCT00731783|561359046|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
155527861|NCT00731783|561359047|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
155527862|NCT03154047|561360271|FG000|Overall Study|Death|1|||
155527863|NCT03154047|561360271|FG000|Overall Study|Study terminated by sponsor|76|||
155527864|NCT03154047|561360271|FG000|Overall Study|Withdrawal by Subject|3|||
155527865|NCT01705574|561360274|FG000|Double-Blind Phase|Lost to Follow-up|12|||
155527866|NCT01705574|561360275|FG001|Double-Blind Phase|Lost to Follow-up|16|||
155527867|NCT01705574|561360276|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155527868|NCT01705574|561360277|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155527869|NCT01705574|561360274|FG000|Double-Blind Phase|Adverse Event|3|||
155527870|NCT01705574|561360275|FG001|Double-Blind Phase|Adverse Event|10|||
155527871|NCT01705574|561360276|FG002|Double-Blind Phase|Adverse Event|0|||
155527872|NCT01705574|561360277|FG003|Double-Blind Phase|Adverse Event|0|||
155527873|NCT01705574|561360274|FG000|Double-Blind Phase|Withdrew Consent|8|||
155527874|NCT01705574|561360275|FG001|Double-Blind Phase|Withdrew Consent|5|||
155527875|NCT01705574|561360276|FG002|Double-Blind Phase|Withdrew Consent|0|||
155527876|NCT01705574|561360277|FG003|Double-Blind Phase|Withdrew Consent|0|||
155527877|NCT01705574|561360274|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
155527878|NCT01705574|561360275|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
155527879|NCT01705574|561360276|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
155527880|NCT01705574|561360277|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
155527881|NCT01705574|561360274|FG000|Double-Blind Phase|Pregnancy|1|||
155527882|NCT01705574|561360275|FG001|Double-Blind Phase|Pregnancy|1|||
155527883|NCT01705574|561360276|FG002|Double-Blind Phase|Pregnancy|0|||
155527884|NCT01705574|561360277|FG003|Double-Blind Phase|Pregnancy|0|||
155527885|NCT01705574|561360274|FG000|Double-Blind Phase|Protocol Violation|1|||
155527886|NCT01705574|561360275|FG001|Double-Blind Phase|Protocol Violation|0|||
155527887|NCT01705574|561360276|FG002|Double-Blind Phase|Protocol Violation|0|||
155527888|NCT01705574|561360277|FG003|Double-Blind Phase|Protocol Violation|0|||
155527889|NCT01705574|561360274|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
155527890|NCT01705574|561360275|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
155527891|NCT01705574|561360276|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
155527892|NCT01705574|561360277|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
155527893|NCT01705574|561360274|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
155527894|NCT01705574|561360275|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155527895|NCT01705574|561360276|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
155527896|NCT01705574|561360277|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
155527897|NCT01705574|561360274|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
155527898|NCT01705574|561360275|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
155527899|NCT01705574|561360276|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
155527900|NCT01705574|561360277|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
155527901|NCT01705574|561360274|FG000|Open-Label Extension Phase|Adverse Event|3|||
155527902|NCT01705574|561360275|FG001|Open-Label Extension Phase|Adverse Event|0|||
155527903|NCT01705574|561360276|FG002|Open-Label Extension Phase|Adverse Event|0|||
155527904|NCT01705574|561360277|FG003|Open-Label Extension Phase|Adverse Event|1|||
155527905|NCT01705574|561360274|FG000|Open-Label Extension Phase|Death|2|||
155527906|NCT01705574|561360275|FG001|Open-Label Extension Phase|Death|0|||
155527907|NCT01705574|561360276|FG002|Open-Label Extension Phase|Death|1|||
155527908|NCT01705574|561360277|FG003|Open-Label Extension Phase|Death|0|||
155527909|NCT01705574|561360274|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
155527910|NCT01705574|561360275|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
155527911|NCT01705574|561360276|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
155527912|NCT01705574|561360277|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
155527913|NCT01705574|561360274|FG000|Open-Label Extension Phase|Physician Decision|0|||
155527914|NCT01705574|561360275|FG001|Open-Label Extension Phase|Physician Decision|0|||
155527915|NCT01705574|561360276|FG002|Open-Label Extension Phase|Physician Decision|2|||
155527916|NCT01705574|561360277|FG003|Open-Label Extension Phase|Physician Decision|0|||
155527917|NCT01705574|561360274|FG000|Open-Label Extension Phase|Pregnancy|0|||
155527918|NCT01705574|561360275|FG001|Open-Label Extension Phase|Pregnancy|0|||
155527919|NCT01705574|561360276|FG002|Open-Label Extension Phase|Pregnancy|1|||
155527920|NCT01705574|561360277|FG003|Open-Label Extension Phase|Pregnancy|1|||
155527921|NCT02472366|561360281|FG000|Overall Study|Lost to Follow-up|1|||
155527922|NCT02472366|561360282|FG001|Overall Study|Lost to Follow-up|0|||
155527923|NCT03699020|561360283|FG000|Overall Study|Withdrawal by Subject|3|||
155527924|NCT03699020|561360284|FG001|Overall Study|Withdrawal by Subject|2|||
155527925|NCT04274686|561360285|FG000|Overall Study|Physician Decision|1|||
155527926|NCT04274686|561360286|FG001|Overall Study|Physician Decision|0|||
155527927|NCT00905840|561360287|FG000|Overall Study|Lost to Follow-up|11|||
155527928|NCT00905840|561360287|FG000|Overall Study|Death|3|||
155527929|NCT00905840|561360287|FG000|Overall Study|Withdrawal by Subject|1|||
155527930|NCT00905840|561360287|FG000|Overall Study|Adverse Event|1|||
155527931|NCT01827163|561360288|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
155527932|NCT01827163|561360288|FG000|Overall Study|Adverse Event|9|||
155527933|NCT03375463|561360289|FG000|Period 1|Lost to Follow-up|0|||
155527934|NCT03375463|561360290|FG001|Period 1|Lost to Follow-up|0|||
155527935|NCT03375463|561360291|FG002|Period 1|Lost to Follow-up|1|||
155527936|NCT03375463|561360292|FG003|Period 1|Lost to Follow-up|0|||
155527937|NCT03375463|561360293|FG004|Period 1|Lost to Follow-up|0|||
155527938|NCT03375463|561360294|FG005|Period 1|Lost to Follow-up|0|||
155527939|NCT03375463|561360289|FG000|Period 1|Adverse Event|0|||
155527940|NCT03375463|561360290|FG001|Period 1|Adverse Event|0|||
155527941|NCT03375463|561360291|FG002|Period 1|Adverse Event|0|||
155527942|NCT03375463|561360292|FG003|Period 1|Adverse Event|0|||
155527943|NCT03375463|561360293|FG004|Period 1|Adverse Event|1|||
155527944|NCT03375463|561360294|FG005|Period 1|Adverse Event|0|||
155527945|NCT03375463|561360289|FG000|Period 2|Lost to Follow-up|1|||
155527946|NCT03375463|561360290|FG001|Period 2|Lost to Follow-up|1|||
155527947|NCT03375463|561360291|FG002|Period 2|Lost to Follow-up|0|||
155527948|NCT03375463|561360292|FG003|Period 2|Lost to Follow-up|0|||
155527949|NCT03375463|561360293|FG004|Period 2|Lost to Follow-up|0|||
155527950|NCT03375463|561360294|FG005|Period 2|Lost to Follow-up|0|||
155527951|NCT03620747|561360297|FG000|Overall Study|Participant decision|7|||
155527952|NCT03620747|561360297|FG000|Overall Study|Adverse Event|6|||
155527953|NCT03620747|561360297|FG000|Overall Study|Lack of Efficacy|1|||
155527954|NCT03620747|561360297|FG000|Overall Study|Poor compliance to protocol|2|||
155527955|NCT03620747|561360297|FG000|Overall Study|Other-unspecified|3|||
155527956|NCT01513174|561360307|FG000|Overall Study|Inclusion Error|1|||
155527957|NCT01513174|561360308|FG001|Overall Study|Inclusion Error|7|||
155527958|NCT01513174|561360307|FG000|Overall Study|Not receive study treatment|3|||
155527959|NCT01513174|561360308|FG001|Overall Study|Not receive study treatment|1|||
155527960|NCT01900626|561360311|FG000|Overall Study|study was closed due to low enrollment|1|||
155527961|NCT01900626|561360312|FG001|Overall Study|study was closed due to low enrollment|1|||
155527962|NCT03181594|561360313|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
155527963|NCT03181594|561360313|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
155527964|NCT03181594|561360313|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
155527965|NCT03181594|561360313|FG000|Initial Study Protocol (12-month FU)|Death|1|||
155527966|NCT03181594|561360313|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
155527967|NCT03181594|561360313|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
155527968|NCT01200810|561360314|FG000|Overall Study|Physician Decision|1|||
155527969|NCT01200810|561360315|FG001|Overall Study|Physician Decision|0|||
155527970|NCT01200810|561360314|FG000|Overall Study|Withdrawal by Subject|1|||
155527971|NCT01200810|561360315|FG001|Overall Study|Withdrawal by Subject|2|||
155527972|NCT01200810|561360314|FG000|Overall Study|Sponsor stopped making study drug|3|||
155527973|NCT01200810|561360315|FG001|Overall Study|Sponsor stopped making study drug|3|||
155527974|NCT00003659|561360317|FG000|Overall Study|Withdrawal by Subject|3|||
155527975|NCT04405570|561360318|FG000|Overall Study|Adverse Event|0|||
155527976|NCT04405570|561360319|FG001|Overall Study|Adverse Event|1|||
155527977|NCT04405570|561360320|FG002|Overall Study|Adverse Event|1|||
155527978|NCT04405570|561360321|FG003|Overall Study|Adverse Event|1|||
155527979|NCT04405570|561360318|FG000|Overall Study|Lost to Follow-up|0|||
155527980|NCT04405570|561360319|FG001|Overall Study|Lost to Follow-up|1|||
155527981|NCT04405570|561360320|FG002|Overall Study|Lost to Follow-up|0|||
155527982|NCT04405570|561360321|FG003|Overall Study|Lost to Follow-up|0|||
155527983|NCT04405570|561360318|FG000|Overall Study|Physician Decision|0|||
155527984|NCT04405570|561360319|FG001|Overall Study|Physician Decision|0|||
155527985|NCT04405570|561360320|FG002|Overall Study|Physician Decision|1|||
155527986|NCT04405570|561360321|FG003|Overall Study|Physician Decision|0|||
155527987|NCT04405570|561360318|FG000|Overall Study|Withdrawal by Subject|0|||
155527988|NCT04405570|561360319|FG001|Overall Study|Withdrawal by Subject|1|||
155527989|NCT04405570|561360320|FG002|Overall Study|Withdrawal by Subject|1|||
155527990|NCT04405570|561360321|FG003|Overall Study|Withdrawal by Subject|0|||
155527991|NCT04405570|561360318|FG000|Overall Study|Randomized not dosed|0|||
155527992|NCT04405570|561360319|FG001|Overall Study|Randomized not dosed|2|||
155527993|NCT04405570|561360320|FG002|Overall Study|Randomized not dosed|0|||
155527994|NCT04405570|561360321|FG003|Overall Study|Randomized not dosed|0|||
155527995|NCT00723710|561360322|FG000|Overall Study|Disease progression|48|||
155527996|NCT00723710|561360322|FG000|Overall Study|Adverse Event|88|||
155527997|NCT00723710|561360322|FG000|Overall Study|Withdrawal by Subject|36|||
155527998|NCT00723710|561360322|FG000|Overall Study|Physician Decision|2|||
155527999|NCT04499963|561360323|FG000|Overall Study|Adverse Event|3|||
155528000|NCT04499963|561360324|FG001|Overall Study|Adverse Event|0|||
155528001|NCT04499963|561360323|FG000|Overall Study|Death|3|||
155528002|NCT04499963|561360324|FG001|Overall Study|Death|0|||
155528003|NCT04499963|561360323|FG000|Overall Study|Lack of Efficacy|7|||
155528004|NCT04499963|561360324|FG001|Overall Study|Lack of Efficacy|0|||
155528005|NCT04499963|561360323|FG000|Overall Study|Lost to Follow-up|2|||
155528006|NCT04499963|561360324|FG001|Overall Study|Lost to Follow-up|0|||
155528007|NCT00359281|561360328|FG000|Overall Study|Adverse Event|1|||
155528008|NCT00359281|561360329|FG001|Overall Study|Adverse Event|0|||
155528009|NCT00359281|561360330|FG002|Overall Study|Adverse Event|0|||
155528010|NCT00359281|561360331|FG003|Overall Study|Adverse Event|0|||
155528011|NCT00359281|561360332|FG004|Overall Study|Adverse Event|0|||
155528012|NCT00359281|561360333|FG005|Overall Study|Adverse Event|0|||
155528013|NCT00359281|561360334|FG006|Overall Study|Adverse Event|1|||
155528014|NCT00359281|561360335|FG007|Overall Study|Adverse Event|0|||
155528015|NCT00359281|561360336|FG008|Overall Study|Adverse Event|0|||
155528016|NCT00359281|561360328|FG000|Overall Study|Withdrawal by Subject|0|||
155528017|NCT00359281|561360329|FG001|Overall Study|Withdrawal by Subject|0|||
155528018|NCT00359281|561360330|FG002|Overall Study|Withdrawal by Subject|0|||
155528019|NCT00359281|561360331|FG003|Overall Study|Withdrawal by Subject|0|||
155528020|NCT00359281|561360332|FG004|Overall Study|Withdrawal by Subject|0|||
155528021|NCT00359281|561360333|FG005|Overall Study|Withdrawal by Subject|0|||
155528022|NCT00359281|561360334|FG006|Overall Study|Withdrawal by Subject|1|||
155528023|NCT00359281|561360335|FG007|Overall Study|Withdrawal by Subject|0|||
155528024|NCT00359281|561360336|FG008|Overall Study|Withdrawal by Subject|0|||
155528025|NCT04419311|561360337|FG000|Overall Study|Lost to Follow-up|1|||
155528026|NCT04419311|561360338|FG001|Overall Study|Lost to Follow-up|0|||
155528027|NCT01302548|561360351|FG000|Overall Study|Lost to Follow-up|2|||
155528028|NCT01302548|561360352|FG001|Overall Study|Lost to Follow-up|1|||
155528029|NCT01237054|561360353|FG000|Overall Study|imaging 10C0096|1|||
155528030|NCT02089997|561360367|FG000|Overall Study|Case report forms uncollected|99|||
155528031|NCT02089997|561360367|FG000|Overall Study|Protocol Violation|147|||
155528032|NCT00095212|561360370|FG000|Overall Study|Withdrawal by Subject|1|||
155528033|NCT00095212|561360371|FG001|Overall Study|Withdrawal by Subject|3|||
155528034|NCT02374853|561360374|FG000|Overall Study|Surgery Cancelled|5|||
155528035|NCT02374853|561360375|FG001|Overall Study|Surgery Cancelled|11|||
155528036|NCT02281084|561360377|FG000|Overall Study|Death|21|||
155528037|NCT02281084|561360378|FG001|Overall Study|Death|18|||
155528038|NCT02281084|561360379|FG002|Overall Study|Death|3|||
155528039|NCT02281084|561360380|FG003|Overall Study|Death|5|||
155528040|NCT02281084|561360377|FG000|Overall Study|Adverse Event|1|||
155528041|NCT02281084|561360378|FG001|Overall Study|Adverse Event|0|||
155528042|NCT02281084|561360379|FG002|Overall Study|Adverse Event|0|||
155528043|NCT02281084|561360380|FG003|Overall Study|Adverse Event|0|||
155528044|NCT02281084|561360377|FG000|Overall Study|Withdrawal by Subject|2|||
155528045|NCT02281084|561360378|FG001|Overall Study|Withdrawal by Subject|2|||
155528046|NCT02281084|561360379|FG002|Overall Study|Withdrawal by Subject|0|||
155528047|NCT02281084|561360380|FG003|Overall Study|Withdrawal by Subject|0|||
155528048|NCT02281084|561360377|FG000|Overall Study|Site Closure by Sponsor|5|||
155528049|NCT02281084|561360378|FG001|Overall Study|Site Closure by Sponsor|1|||
155528050|NCT02281084|561360379|FG002|Overall Study|Site Closure by Sponsor|2|||
155528051|NCT02281084|561360380|FG003|Overall Study|Site Closure by Sponsor|0|||
155528052|NCT02305758|561360381|FG000|Overall Study|Death|27|||
155528053|NCT02305758|561360382|FG001|Overall Study|Death|27|||
155528054|NCT02305758|561360381|FG000|Overall Study|Withdrew consent|9|||
155528055|NCT02305758|561360382|FG001|Overall Study|Withdrew consent|2|||
155528056|NCT02305758|561360381|FG000|Overall Study|Lost to Follow-up|6|||
155528057|NCT02305758|561360382|FG001|Overall Study|Lost to Follow-up|1|||
155528058|NCT02305758|561360381|FG000|Overall Study|Study Terminated by Sponsor|21|||
155528059|NCT02305758|561360382|FG001|Overall Study|Study Terminated by Sponsor|34|||
155528060|NCT02305758|561360381|FG000|Overall Study|Other, not specified|2|||
155528061|NCT02305758|561360382|FG001|Overall Study|Other, not specified|1|||
155528062|NCT05593965|561360383|FG000|1st Intervention (1 Day)|Technical error|1|||
155528063|NCT05593965|561360384|FG001|1st Intervention (1 Day)|Technical error|0|||
155528064|NCT02272777|561360385|FG000|Overall Study|Adverse Event|0|||
155528065|NCT02272777|561360386|FG001|Overall Study|Adverse Event|1|||
155528066|NCT02272777|561360385|FG000|Overall Study|Withdrawal by Subject|0|||
155528067|NCT02272777|561360386|FG001|Overall Study|Withdrawal by Subject|3|||
155528068|NCT02272777|561360385|FG000|Overall Study|Lost to Follow-up|2|||
155528069|NCT02272777|561360386|FG001|Overall Study|Lost to Follow-up|0|||
155528070|NCT02272777|561360385|FG000|Overall Study|Other|2|||
155528071|NCT02272777|561360386|FG001|Overall Study|Other|0|||
155528072|NCT00440297|561360387|FG000|Overall Study|Adverse Event|8|||
155528073|NCT00440297|561360388|FG001|Overall Study|Adverse Event|5|||
155528074|NCT00440297|561360387|FG000|Overall Study|Lost to Follow-up|1|||
155528075|NCT00440297|561360388|FG001|Overall Study|Lost to Follow-up|0|||
155528076|NCT00440297|561360387|FG000|Overall Study|Physician Decision|1|||
155528077|NCT00440297|561360388|FG001|Overall Study|Physician Decision|0|||
155528078|NCT00440297|561360387|FG000|Overall Study|Protocol Violation|11|||
155528079|NCT00440297|561360388|FG001|Overall Study|Protocol Violation|7|||
155528080|NCT00440297|561360387|FG000|Overall Study|Withdrawal by Subject|1|||
155528081|NCT00440297|561360388|FG001|Overall Study|Withdrawal by Subject|6|||
155528082|NCT00440297|561360387|FG000|Overall Study|Randomized by mistake|1|||
155528083|NCT00440297|561360388|FG001|Overall Study|Randomized by mistake|0|||
155528084|NCT02445339|561360389|FG000|Overall Study|Physician Decision|1|||
155528085|NCT02445339|561360390|FG001|Overall Study|Physician Decision|0|||
155528086|NCT02445339|561360389|FG000|Overall Study|Lost to Follow-up|11|||
155528087|NCT02445339|561360390|FG001|Overall Study|Lost to Follow-up|15|||
155528088|NCT02024932|561360391|FG000|Overall Study|Adverse Event|2|||
155528089|NCT02024932|561360392|FG001|Overall Study|Adverse Event|3|||
155528090|NCT02024932|561360393|FG002|Overall Study|Adverse Event|0|||
155528091|NCT02024932|561360394|FG003|Overall Study|Adverse Event|0|||
155528092|NCT02024932|561360395|FG004|Overall Study|Adverse Event|2|||
155528093|NCT02024932|561360396|FG005|Overall Study|Adverse Event|0|||
155528094|NCT02024932|561360391|FG000|Overall Study|Abnormal laboratory value|0|||
155528095|NCT02024932|561360392|FG001|Overall Study|Abnormal laboratory value|0|||
155528096|NCT02024932|561360393|FG002|Overall Study|Abnormal laboratory value|0|||
155528097|NCT02024932|561360394|FG003|Overall Study|Abnormal laboratory value|2|||
155528098|NCT02024932|561360395|FG004|Overall Study|Abnormal laboratory value|0|||
155528099|NCT02024932|561360396|FG005|Overall Study|Abnormal laboratory value|0|||
155528100|NCT03020641|561360397|FG000|Overall Study|Lost to Follow-up|0|||
155528101|NCT03020641|561360398|FG001|Overall Study|Lost to Follow-up|1|||
155528102|NCT03020641|561360397|FG000|Overall Study|Converted to open surgery|2|||
155528103|NCT03020641|561360398|FG001|Overall Study|Converted to open surgery|1|||
155528104|NCT03020641|561360397|FG000|Overall Study|for surgery not performed|0|||
155528105|NCT03020641|561360398|FG001|Overall Study|for surgery not performed|1|||
155528106|NCT00727961|561360400|FG000|Overall Study|Lost to Follow-up|1|||
155528107|NCT00727961|561360400|FG000|Overall Study|Adverse Event|4|||
155528108|NCT00727961|561360400|FG000|Overall Study|Patient's refusal|2|||
155528109|NCT00727961|561360400|FG000|Overall Study|Progression|30|||
155528110|NCT01421277|561360401|FG000|Overall Study|Lack of qualifying event|0|||
155528111|NCT01421277|561360402|FG001|Overall Study|Lack of qualifying event|61|||
155528112|NCT01421277|561360401|FG000|Overall Study|Incomplete baseline data|0|||
155528113|NCT01421277|561360402|FG001|Overall Study|Incomplete baseline data|31|||
155528114|NCT02186821|561360403|FG000|Overall Study|Adverse Event|9|||
155528115|NCT02186821|561360403|FG000|Overall Study|Death|2|||
155528116|NCT02186821|561360403|FG000|Overall Study|Disease progression|32|||
155528117|NCT02186821|561360403|FG000|Overall Study|Protocol Violation|1|||
155528118|NCT02186821|561360403|FG000|Overall Study|Physician Decision|1|||
155528119|NCT02186821|561360403|FG000|Overall Study|Study terminated by sponsor|2|||
155528120|NCT02039908|561360404|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
155528121|NCT02039908|561360405|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
155528122|NCT02039908|561360406|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
155528123|NCT02039908|561360407|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
155528124|NCT02039908|561360404|FG000|Phase 1-Summer|Protocol Violation|6|||
155528125|NCT02039908|561360405|FG001|Phase 1-Summer|Protocol Violation|0|||
155528126|NCT02039908|561360406|FG002|Phase 1-Summer|Protocol Violation|0|||
155528127|NCT02039908|561360407|FG003|Phase 1-Summer|Protocol Violation|0|||
155528128|NCT02039908|561360404|FG000|Phase 2-School Year|Lost to Follow-up|0|||
155528129|NCT02039908|561360405|FG001|Phase 2-School Year|Lost to Follow-up|0|||
155528130|NCT02039908|561360406|FG002|Phase 2-School Year|Lost to Follow-up|1|||
155528131|NCT02039908|561360407|FG003|Phase 2-School Year|Lost to Follow-up|3|||
155528132|NCT02039908|561360404|FG000|Phase 2-School Year|Protocol Violation|0|||
155528133|NCT02039908|561360405|FG001|Phase 2-School Year|Protocol Violation|0|||
155528134|NCT02039908|561360406|FG002|Phase 2-School Year|Protocol Violation|3|||
155528135|NCT02039908|561360407|FG003|Phase 2-School Year|Protocol Violation|0|||
155528136|NCT02039908|561360404|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
155528137|NCT02039908|561360405|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
155528138|NCT02039908|561360406|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
155528139|NCT02039908|561360407|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
155528140|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
155528141|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
155528142|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
155528143|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
155528144|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528145|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528146|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528147|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528148|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528149|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528150|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528151|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528152|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528153|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528154|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528155|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528156|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528157|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528158|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528159|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528160|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
155528161|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
155528162|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
155528163|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
155528164|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
155528165|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528166|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528167|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528168|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528169|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528170|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528171|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528172|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528173|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528174|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528175|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528176|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528177|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528178|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528179|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528180|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528181|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155528182|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
155528183|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
155528184|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
155528185|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
155528186|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528187|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528188|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528189|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528190|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528191|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528192|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528193|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528194|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528195|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528196|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528197|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528198|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528199|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528200|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528201|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528202|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
155528203|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
155528204|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
155528205|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
155528206|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528207|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528208|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528209|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528210|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528211|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528212|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528213|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528214|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528215|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528216|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528217|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528218|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528219|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528220|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528221|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528222|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528223|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155528224|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
155528225|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528226|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528227|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
155528228|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528229|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528230|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528231|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528232|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528233|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528234|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528235|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528236|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528237|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528238|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528239|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528240|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528241|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528242|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528243|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528244|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155528245|NCT01597245|561360408|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
155528246|NCT01597245|561360409|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
155528247|NCT01597245|561360410|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
155528248|NCT01597245|561360411|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528249|NCT01597245|561360412|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528250|NCT01597245|561360413|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528251|NCT01597245|561360414|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528252|NCT01597245|561360415|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528253|NCT01597245|561360416|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528254|NCT01597245|561360417|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528255|NCT01597245|561360418|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528256|NCT01597245|561360419|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528257|NCT01597245|561360420|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155655072|NCT01051661|561830636|FG000|Overall Study|Unable to attend visit(s)|2|||
155655073|NCT01051661|561830637|FG001|Overall Study|Unable to attend visit(s)|4|||
155528258|NCT01597245|561360421|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528259|NCT01597245|561360422|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528260|NCT01597245|561360423|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528261|NCT01597245|561360424|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155655074|NCT01051661|561830638|FG002|Overall Study|Unable to attend visit(s)|2|||
155655075|NCT01051661|561830639|FG003|Overall Study|Unable to attend visit(s)|1|||
155655076|NCT01051661|561830640|FG004|Overall Study|Unable to attend visit(s)|3|||
155655077|NCT01051661|561830641|FG005|Overall Study|Unable to attend visit(s)|2|||
155655078|NCT01051661|561830636|FG000|Overall Study|Consent not received from both parents|0|||
155528262|NCT01597245|561360425|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528263|NCT01597245|561360426|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528264|NCT01597245|561360427|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528265|NCT01597245|561360428|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155528266|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528267|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528268|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528269|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528270|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528271|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
155528272|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
155528273|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528274|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528275|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528276|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528277|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528278|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528279|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528280|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528281|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528282|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528283|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528284|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528285|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528286|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155528287|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528288|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528289|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528290|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528291|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
155528292|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
155528293|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
155528294|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
155528295|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528296|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
155528297|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528298|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528299|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528300|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528301|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528302|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528303|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528304|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528305|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528306|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528307|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
155528308|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528309|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528310|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528311|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528312|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528313|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
155528314|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528315|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528316|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
155655079|NCT01051661|561830637|FG001|Overall Study|Consent not received from both parents|0|||
155655080|NCT01051661|561830638|FG002|Overall Study|Consent not received from both parents|0|||
155528317|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528318|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
155528319|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
155528320|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
155528321|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528322|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528323|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528324|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528325|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528326|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528327|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528328|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155528329|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528330|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528331|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528332|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528333|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
155528334|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
155528335|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
155528336|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
155528337|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
155528338|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
155528339|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
155528340|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
155528341|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
155528342|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528343|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528344|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528345|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528346|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528347|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528348|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528349|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155528350|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528351|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528352|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528353|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528354|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
155528355|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
155528356|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
155528357|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528358|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
155528359|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
155528360|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
155528361|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
155528362|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
155528363|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528364|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528365|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528366|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528367|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528368|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528369|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528370|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155528371|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528372|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528373|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528374|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528375|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
155528376|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528377|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528378|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528379|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
155528380|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
155528381|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
155528382|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528383|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
155528384|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528385|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528386|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528387|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528388|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528389|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528390|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528391|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155528392|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528393|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528394|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528395|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528396|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
155528397|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
155528398|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
155528399|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528400|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
155528401|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
155528402|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
155528403|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
155528404|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
155528405|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528406|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528407|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528408|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528409|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528410|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528411|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528412|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
155528413|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528414|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528415|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528416|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528417|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528418|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
155528419|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528420|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528421|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
155528422|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
155528423|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
155528424|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
155528425|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528426|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528427|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528428|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528429|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528430|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155655081|NCT01051661|561830639|FG003|Overall Study|Consent not received from both parents|0|||
155655082|NCT01051661|561830640|FG004|Overall Study|Consent not received from both parents|0|||
155655083|NCT01051661|561830641|FG005|Overall Study|Consent not received from both parents|1|||
155655084|NCT01051661|561830636|FG000|Overall Study|Failure to comply with protocol|0|||
155655085|NCT01051661|561830637|FG001|Overall Study|Failure to comply with protocol|0|||
155655086|NCT01051661|561830638|FG002|Overall Study|Failure to comply with protocol|2|||
155528431|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528432|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528433|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
155528434|NCT01597245|561360408|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528435|NCT01597245|561360409|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528436|NCT01597245|561360410|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528437|NCT01597245|561360411|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528438|NCT01597245|561360412|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528439|NCT01597245|561360413|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528440|NCT01597245|561360414|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528441|NCT01597245|561360415|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528442|NCT01597245|561360416|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528443|NCT01597245|561360417|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528444|NCT01597245|561360418|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
155528445|NCT01597245|561360419|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528446|NCT01597245|561360420|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528447|NCT01597245|561360421|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528448|NCT01597245|561360422|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528449|NCT01597245|561360423|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528450|NCT01597245|561360424|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528451|NCT01597245|561360425|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528452|NCT01597245|561360426|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528453|NCT01597245|561360427|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528454|NCT01597245|561360428|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
155528455|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528456|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528457|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528458|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528459|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528460|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528461|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528462|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528463|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528464|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528465|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528466|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528467|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528468|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
155528469|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
155528470|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
155528471|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528472|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528473|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528474|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528475|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155528476|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528477|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528478|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528479|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528480|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528481|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528482|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528483|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528484|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528485|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528486|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528487|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528488|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528489|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
155528490|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
155528491|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
155528492|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528493|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528494|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528495|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528496|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
155528497|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528498|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528499|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528500|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528501|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528502|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528503|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528504|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528505|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528506|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528507|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528508|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528509|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528510|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528511|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
155528512|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
155528513|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528514|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528515|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528516|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528517|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
155528518|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528519|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528520|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528521|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528522|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528523|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528524|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528525|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528526|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528527|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528528|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528529|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528530|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528531|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528532|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
155528533|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
155528534|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528535|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528536|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528537|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528538|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155528539|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528540|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528541|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528542|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528543|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528544|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528545|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528546|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528547|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528548|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528549|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528550|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528551|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528552|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
155528553|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
155528554|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
155528555|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155655087|NCT01051661|561830639|FG003|Overall Study|Failure to comply with protocol|0|||
155528556|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528557|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528558|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528559|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155528560|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528561|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528562|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528563|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528564|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528565|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528566|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528567|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528568|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528569|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528570|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528571|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528572|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528573|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528574|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
155528575|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
155528576|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528577|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528578|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528579|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528580|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
155528581|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528582|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528583|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528584|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528585|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528586|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528587|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528588|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528589|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528590|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528591|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528592|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528593|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528594|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528595|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
155528596|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
155528597|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528598|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528599|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528600|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528601|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
155528602|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528603|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528604|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528605|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528606|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528607|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528608|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528609|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528610|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528611|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528612|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528613|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528614|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528615|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528616|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
155528617|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
155528618|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528619|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528620|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528621|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528622|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
155528623|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528624|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528625|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528626|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528627|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528628|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528629|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528630|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528631|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528632|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528633|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528634|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528635|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528636|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528637|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
155528638|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
155528639|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528640|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528641|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528642|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528643|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155528644|NCT01597245|561360408|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528645|NCT01597245|561360409|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528646|NCT01597245|561360410|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528647|NCT01597245|561360411|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528648|NCT01597245|561360412|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528649|NCT01597245|561360413|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528650|NCT01597245|561360414|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528651|NCT01597245|561360415|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528652|NCT01597245|561360416|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528653|NCT01597245|561360417|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528654|NCT01597245|561360418|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528655|NCT01597245|561360419|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528656|NCT01597245|561360420|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528657|NCT01597245|561360421|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
155528658|NCT01597245|561360422|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528659|NCT01597245|561360423|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528660|NCT01597245|561360424|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528661|NCT01597245|561360425|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528662|NCT01597245|561360426|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528663|NCT01597245|561360427|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528664|NCT01597245|561360428|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155528665|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528666|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528667|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528668|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528669|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528670|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528671|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528672|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528673|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528674|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528675|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528676|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528677|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528678|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528679|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528680|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155528681|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
155528682|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
155528683|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
155528684|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
155528685|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
155528686|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528687|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528688|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528689|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528690|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528691|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528692|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528693|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528694|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528695|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528696|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528697|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528698|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528699|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528700|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528701|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528702|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155528703|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
155528704|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
155528705|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
155528706|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
155528707|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528708|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528709|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528710|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528711|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528712|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528713|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528714|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528715|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528716|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528717|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528718|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528719|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528720|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528721|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528722|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528723|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
155528724|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528725|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155528726|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
155528727|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
155528728|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528729|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528730|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528731|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528732|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528733|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528734|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528735|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528736|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528737|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528738|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528739|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528740|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528741|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528742|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528743|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528744|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528745|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155528746|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
155528747|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
155528748|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
155528749|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528750|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528751|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528752|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528753|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528754|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528755|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528756|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528757|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528758|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528759|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528760|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528761|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528762|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528763|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528764|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528765|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
155528766|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528767|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155528768|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
155528769|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
155528770|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528771|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528772|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528773|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528774|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528775|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528776|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528777|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528778|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528779|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528780|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528781|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528782|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528783|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528784|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528785|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528786|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
155528787|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528788|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
155528789|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
155528790|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
155528791|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528792|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528793|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528794|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528795|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528796|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528797|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528798|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528799|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528800|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528801|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528802|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528803|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528804|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528805|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528806|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528807|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
155528808|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528809|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528810|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
155528811|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
155528812|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528813|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528814|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528815|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528816|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528817|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528818|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528819|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528820|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528821|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528822|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528823|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528824|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528825|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528826|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528827|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528828|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
155528829|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528830|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528831|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
155528832|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155528833|NCT01597245|561360408|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528834|NCT01597245|561360409|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528835|NCT01597245|561360410|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528836|NCT01597245|561360411|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528837|NCT01597245|561360412|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528838|NCT01597245|561360413|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528839|NCT01597245|561360414|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528840|NCT01597245|561360415|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528841|NCT01597245|561360416|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528842|NCT01597245|561360417|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528843|NCT01597245|561360418|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528844|NCT01597245|561360419|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528845|NCT01597245|561360420|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528846|NCT01597245|561360421|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528847|NCT01597245|561360422|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528848|NCT01597245|561360423|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528849|NCT01597245|561360424|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528850|NCT01597245|561360425|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528851|NCT01597245|561360426|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528852|NCT01597245|561360427|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
155528853|NCT01597245|561360428|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
155528854|NCT01802320|561360429|FG000|Overall Study|Death|1|||
155528855|NCT01802320|561360429|FG000|Overall Study|Withdrawal by Subject|1|||
155528856|NCT04115293|561362188|FG000|Overall Study|Adverse Event|0|||
155528857|NCT04115293|561362189|FG001|Overall Study|Adverse Event|2|||
155528858|NCT04115293|561362188|FG000|Overall Study|Withdrawal by Subject|2|||
155528859|NCT04115293|561362189|FG001|Overall Study|Withdrawal by Subject|1|||
155528860|NCT04115293|561362188|FG000|Overall Study|Physician Decision|1|||
155528861|NCT04115293|561362189|FG001|Overall Study|Physician Decision|0|||
155528862|NCT04115293|561362188|FG000|Overall Study|Death|1|||
155528863|NCT04115293|561362189|FG001|Overall Study|Death|1|||
155528864|NCT02674152|561362190|FG000|Overall Study|Personal Reasons|1|||
155528865|NCT02674152|561362191|FG001|Overall Study|Personal Reasons|0|||
155528866|NCT02674152|561362192|FG002|Overall Study|Personal Reasons|0|||
155528867|NCT02674152|561362193|FG003|Overall Study|Personal Reasons|1|||
155528868|NCT02674152|561362194|FG004|Overall Study|Personal Reasons|1|||
155528869|NCT02674152|561362190|FG000|Overall Study|Other adverse event or clinical progression|0|||
155528870|NCT02674152|561362191|FG001|Overall Study|Other adverse event or clinical progression|1|||
155528871|NCT02674152|561362192|FG002|Overall Study|Other adverse event or clinical progression|0|||
155528872|NCT02674152|561362193|FG003|Overall Study|Other adverse event or clinical progression|3|||
155528873|NCT02674152|561362194|FG004|Overall Study|Other adverse event or clinical progression|0|||
155528874|NCT02674152|561362190|FG000|Overall Study|Dose-limiting toxicity|0|||
155528875|NCT02674152|561362191|FG001|Overall Study|Dose-limiting toxicity|0|||
155528876|NCT02674152|561362192|FG002|Overall Study|Dose-limiting toxicity|0|||
155528877|NCT02674152|561362193|FG003|Overall Study|Dose-limiting toxicity|0|||
155528878|NCT02674152|561362194|FG004|Overall Study|Dose-limiting toxicity|1|||
155528879|NCT02674152|561362190|FG000|Overall Study|Progressive Disease|2|||
155528880|NCT02674152|561362191|FG001|Overall Study|Progressive Disease|1|||
155528881|NCT02674152|561362192|FG002|Overall Study|Progressive Disease|1|||
155528882|NCT02674152|561362193|FG003|Overall Study|Progressive Disease|13|||
155528883|NCT02674152|561362194|FG004|Overall Study|Progressive Disease|2|||
155528884|NCT02674152|561362190|FG000|Overall Study|Adverse Event|0|||
155528885|NCT02674152|561362191|FG001|Overall Study|Adverse Event|0|||
155528886|NCT02674152|561362192|FG002|Overall Study|Adverse Event|1|||
155528887|NCT02674152|561362193|FG003|Overall Study|Adverse Event|0|||
155528888|NCT02674152|561362194|FG004|Overall Study|Adverse Event|1|||
155528889|NCT02571907|561362195|FG000|Overall Study|Death|4|||
155528890|NCT02571907|561362195|FG000|Overall Study|Lost to Follow-up|3|||
155528891|NCT02571907|561362195|FG000|Overall Study|Withdrawal by Subject|3|||
155528892|NCT03071575|561362196|FG000|Overall Study|Death|0|||
155528893|NCT03071575|561362197|FG001|Overall Study|Death|1|||
155528894|NCT03071575|561362196|FG000|Overall Study|Lost to Follow-up|5|||
155528895|NCT03071575|561362197|FG001|Overall Study|Lost to Follow-up|11|||
155528896|NCT03071575|561362196|FG000|Overall Study|Withdrawal by Subject|4|||
155528897|NCT03071575|561362197|FG001|Overall Study|Withdrawal by Subject|2|||
155528898|NCT00579345|561362198|FG000|Overall Study|Withdrawal by Subject|2|||
155528899|NCT00579345|561362199|FG001|Overall Study|Withdrawal by Subject|0|||
155528900|NCT00579345|561362200|FG002|Overall Study|Withdrawal by Subject|0|||
155528901|NCT00579345|561362201|FG003|Overall Study|Withdrawal by Subject|0|||
155528902|NCT00579345|561362202|FG004|Overall Study|Withdrawal by Subject|0|||
155528903|NCT00579345|561362203|FG005|Overall Study|Withdrawal by Subject|0|||
155528904|NCT00579345|561362204|FG006|Overall Study|Withdrawal by Subject|0|||
155528905|NCT00579345|561362205|FG007|Overall Study|Withdrawal by Subject|1|||
155528906|NCT00579345|561362198|FG000|Overall Study|Lost to Follow-up|1|||
155528907|NCT00579345|561362199|FG001|Overall Study|Lost to Follow-up|0|||
155528908|NCT00579345|561362200|FG002|Overall Study|Lost to Follow-up|0|||
155528909|NCT00579345|561362201|FG003|Overall Study|Lost to Follow-up|0|||
155528910|NCT00579345|561362202|FG004|Overall Study|Lost to Follow-up|0|||
155528911|NCT00579345|561362203|FG005|Overall Study|Lost to Follow-up|0|||
155528912|NCT00579345|561362204|FG006|Overall Study|Lost to Follow-up|0|||
155528913|NCT00579345|561362205|FG007|Overall Study|Lost to Follow-up|0|||
155528914|NCT00579345|561362198|FG000|Overall Study|Adverse Event|0|||
155528915|NCT00579345|561362199|FG001|Overall Study|Adverse Event|0|||
155528916|NCT00579345|561362200|FG002|Overall Study|Adverse Event|1|||
155528917|NCT00579345|561362201|FG003|Overall Study|Adverse Event|0|||
155528918|NCT00579345|561362202|FG004|Overall Study|Adverse Event|0|||
155528919|NCT00579345|561362203|FG005|Overall Study|Adverse Event|0|||
155528920|NCT00579345|561362204|FG006|Overall Study|Adverse Event|0|||
155528921|NCT00579345|561362205|FG007|Overall Study|Adverse Event|0|||
155528922|NCT00579345|561362198|FG000|Overall Study|Protocol Violation|1|||
155528923|NCT00579345|561362199|FG001|Overall Study|Protocol Violation|0|||
155528924|NCT00579345|561362200|FG002|Overall Study|Protocol Violation|0|||
155528925|NCT00579345|561362201|FG003|Overall Study|Protocol Violation|0|||
155528926|NCT00579345|561362202|FG004|Overall Study|Protocol Violation|0|||
155528927|NCT00579345|561362203|FG005|Overall Study|Protocol Violation|0|||
155528928|NCT00579345|561362204|FG006|Overall Study|Protocol Violation|0|||
155528929|NCT00579345|561362205|FG007|Overall Study|Protocol Violation|1|||
155528930|NCT00579345|561362198|FG000|Overall Study|Death|1|||
155528931|NCT00579345|561362199|FG001|Overall Study|Death|1|||
155528932|NCT00579345|561362200|FG002|Overall Study|Death|1|||
155528933|NCT00579345|561362201|FG003|Overall Study|Death|1|||
155528934|NCT00579345|561362202|FG004|Overall Study|Death|0|||
155528935|NCT00579345|561362203|FG005|Overall Study|Death|0|||
155528936|NCT00579345|561362204|FG006|Overall Study|Death|0|||
155528937|NCT00579345|561362205|FG007|Overall Study|Death|0|||
155528938|NCT00462345|561362209|FG000|Overall Study|Withdrawal by Subject|2|||
155528939|NCT00462345|561362209|FG000|Overall Study|Did not complete second course|1|||
155528940|NCT02267187|561362213|FG000|Overall Study|Physician Decision|2|||
155528941|NCT02267187|561362213|FG000|Overall Study|Screen fail|3|||
155528942|NCT00508651|561362214|FG000|Overall Study|Lost to Follow-up|3|||
155528943|NCT00508651|561362215|FG001|Overall Study|Lost to Follow-up|1|||
155528944|NCT00508651|561362214|FG000|Overall Study|Withdrawal by Subject|1|||
155528945|NCT00508651|561362215|FG001|Overall Study|Withdrawal by Subject|1|||
155528946|NCT03874715|561362220|FG000|Overall Study|Adverse Event|2|||
155528947|NCT03874715|561362221|FG001|Overall Study|Adverse Event|0|||
155528948|NCT03874715|561362220|FG000|Overall Study|Poor compliance to protocol|5|||
155528949|NCT03874715|561362221|FG001|Overall Study|Poor compliance to protocol|1|||
155528950|NCT03874715|561362220|FG000|Overall Study|Withdrawal by Subject|1|||
155528951|NCT03874715|561362221|FG001|Overall Study|Withdrawal by Subject|0|||
155528952|NCT03874715|561362220|FG000|Overall Study|Other-unspecified|1|||
155528953|NCT03874715|561362221|FG001|Overall Study|Other-unspecified|0|||
155528954|NCT00461786|561362222|FG000|Overall Study|Entry Criteria Not Met|2|||
155528955|NCT00461786|561362222|FG000|Overall Study|Inevaluable (Never Treated)|1|||
155528956|NCT00934050|561362223|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
155528957|NCT00934050|561362224|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155528958|NCT00934050|561362225|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155528959|NCT00934050|561362226|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
155528960|NCT00934050|561362227|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155528961|NCT00934050|561362228|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155528962|NCT00934050|561362223|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
155528963|NCT00934050|561362224|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
155528964|NCT00934050|561362225|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
155528965|NCT00934050|561362226|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
155528966|NCT00934050|561362227|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
155528967|NCT00934050|561362228|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
155528968|NCT00934050|561362223|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155528969|NCT00934050|561362224|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155528970|NCT00934050|561362225|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
155528971|NCT00934050|561362226|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155655088|NCT01051661|561830640|FG004|Overall Study|Failure to comply with protocol|0|||
155528972|NCT00934050|561362227|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155528973|NCT00934050|561362228|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155528974|NCT00934050|561362223|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
155528975|NCT00934050|561362224|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
155528976|NCT00934050|561362225|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
155528977|NCT00934050|561362226|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
155528978|NCT00934050|561362227|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
155655089|NCT01051661|561830641|FG005|Overall Study|Failure to comply with protocol|0|||
155528979|NCT00934050|561362228|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
155528980|NCT00934050|561362223|FG000|Enrolled After 15 Dec 2009|Death|0|||
155528981|NCT00934050|561362224|FG001|Enrolled After 15 Dec 2009|Death|0|||
155528982|NCT00934050|561362225|FG002|Enrolled After 15 Dec 2009|Death|0|||
155528983|NCT00934050|561362226|FG003|Enrolled After 15 Dec 2009|Death|0|||
155528984|NCT00934050|561362227|FG004|Enrolled After 15 Dec 2009|Death|0|||
155528985|NCT00934050|561362228|FG005|Enrolled After 15 Dec 2009|Death|1|||
155528986|NCT00934050|561362223|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155528987|NCT00934050|561362224|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155528988|NCT00934050|561362225|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155528989|NCT00934050|561362226|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155528990|NCT00934050|561362227|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155528991|NCT00934050|561362228|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
155528992|NCT00934050|561362223|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
155528993|NCT00934050|561362224|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
155528994|NCT00934050|561362225|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
155528995|NCT00934050|561362226|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
155528996|NCT00934050|561362227|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
155528997|NCT00934050|561362228|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
155528998|NCT00835991|561362231|FG000|First Intervention|Adverse Event|0|||
155528999|NCT00835991|561362232|FG001|First Intervention|Adverse Event|1|||
155529000|NCT00835991|561362231|FG000|Washout|Protocol Violation|0|||
155529001|NCT00835991|561362232|FG001|Washout|Protocol Violation|2|||
155529002|NCT00835991|561362231|FG000|Washout|Withdrawal by Subject|3|||
155529003|NCT00835991|561362232|FG001|Washout|Withdrawal by Subject|1|||
155529004|NCT03570749|561362233|FG000|Overall Study|Ongoing|26|||
155529005|NCT03570749|561362234|FG001|Overall Study|Ongoing|25|||
155529006|NCT03570749|561362235|FG002|Overall Study|Ongoing|25|||
155529007|NCT03570749|561362236|FG003|Overall Study|Ongoing|26|||
155529008|NCT03570749|561362237|FG004|Overall Study|Ongoing|140|||
155529009|NCT03570749|561362238|FG005|Overall Study|Ongoing|142|||
155529010|NCT03570749|561362239|FG006|Overall Study|Ongoing|220|||
155529011|NCT03570749|561362233|FG000|Overall Study|Adverse Event|0|||
155529012|NCT03570749|561362234|FG001|Overall Study|Adverse Event|0|||
155529013|NCT03570749|561362235|FG002|Overall Study|Adverse Event|0|||
155529014|NCT03570749|561362236|FG003|Overall Study|Adverse Event|0|||
155529015|NCT03570749|561362237|FG004|Overall Study|Adverse Event|2|||
155529016|NCT03570749|561362238|FG005|Overall Study|Adverse Event|3|||
155529017|NCT03570749|561362239|FG006|Overall Study|Adverse Event|6|||
155529018|NCT03570749|561362233|FG000|Overall Study|Lack of Efficacy|0|||
155529019|NCT03570749|561362234|FG001|Overall Study|Lack of Efficacy|0|||
155529020|NCT03570749|561362235|FG002|Overall Study|Lack of Efficacy|0|||
155529021|NCT03570749|561362236|FG003|Overall Study|Lack of Efficacy|0|||
155529022|NCT03570749|561362237|FG004|Overall Study|Lack of Efficacy|8|||
155529023|NCT03570749|561362238|FG005|Overall Study|Lack of Efficacy|2|||
155529024|NCT03570749|561362239|FG006|Overall Study|Lack of Efficacy|7|||
155529025|NCT03570749|561362233|FG000|Overall Study|Lost to Follow-up|0|||
155529026|NCT03570749|561362234|FG001|Overall Study|Lost to Follow-up|0|||
155529027|NCT03570749|561362235|FG002|Overall Study|Lost to Follow-up|0|||
155529028|NCT03570749|561362236|FG003|Overall Study|Lost to Follow-up|0|||
155529029|NCT03570749|561362237|FG004|Overall Study|Lost to Follow-up|5|||
155529030|NCT03570749|561362238|FG005|Overall Study|Lost to Follow-up|10|||
155529031|NCT03570749|561362239|FG006|Overall Study|Lost to Follow-up|10|||
155529032|NCT03570749|561362233|FG000|Overall Study|Pregnancy|0|||
155529033|NCT03570749|561362234|FG001|Overall Study|Pregnancy|0|||
155529034|NCT03570749|561362235|FG002|Overall Study|Pregnancy|0|||
155529035|NCT03570749|561362236|FG003|Overall Study|Pregnancy|0|||
155529036|NCT03570749|561362237|FG004|Overall Study|Pregnancy|0|||
155529037|NCT03570749|561362238|FG005|Overall Study|Pregnancy|1|||
155529038|NCT03570749|561362239|FG006|Overall Study|Pregnancy|1|||
155529039|NCT03570749|561362233|FG000|Overall Study|Screen Fail|0|||
155529040|NCT03570749|561362234|FG001|Overall Study|Screen Fail|0|||
155529041|NCT03570749|561362235|FG002|Overall Study|Screen Fail|0|||
155529042|NCT03570749|561362236|FG003|Overall Study|Screen Fail|0|||
155529043|NCT03570749|561362237|FG004|Overall Study|Screen Fail|0|||
155529044|NCT03570749|561362238|FG005|Overall Study|Screen Fail|0|||
155529045|NCT03570749|561362239|FG006|Overall Study|Screen Fail|1|||
155529046|NCT03570749|561362233|FG000|Overall Study|Withdrawal by Subject|2|||
155529047|NCT03570749|561362234|FG001|Overall Study|Withdrawal by Subject|3|||
155529048|NCT03570749|561362235|FG002|Overall Study|Withdrawal by Subject|2|||
155529049|NCT03570749|561362236|FG003|Overall Study|Withdrawal by Subject|1|||
155529050|NCT03570749|561362237|FG004|Overall Study|Withdrawal by Subject|17|||
155529051|NCT03570749|561362238|FG005|Overall Study|Withdrawal by Subject|12|||
155529052|NCT03570749|561362239|FG006|Overall Study|Withdrawal by Subject|15|||
155529053|NCT03570749|561362233|FG000|Overall Study|Other|0|||
155529054|NCT03570749|561362234|FG001|Overall Study|Other|0|||
155529055|NCT03570749|561362235|FG002|Overall Study|Other|0|||
155529056|NCT03570749|561362236|FG003|Overall Study|Other|0|||
155529057|NCT03570749|561362237|FG004|Overall Study|Other|17|||
155529058|NCT03570749|561362238|FG005|Overall Study|Other|14|||
155529059|NCT03570749|561362239|FG006|Overall Study|Other|21|||
155529060|NCT02146105|561362240|FG000|Overall Study|Adverse Event|1|||
155529061|NCT02146105|561362240|FG000|Overall Study|Withdrawal by Subject|5|||
155529062|NCT02718326|561362243|FG000|Overall Study|Adverse Event|4|||
155529063|NCT02718326|561362244|FG001|Overall Study|Adverse Event|9|||
155529064|NCT02718326|561362245|FG002|Overall Study|Adverse Event|0|||
155529065|NCT02718326|561362243|FG000|Overall Study|Death|8|||
155529066|NCT02718326|561362244|FG001|Overall Study|Death|1|||
155529067|NCT02718326|561362245|FG002|Overall Study|Death|2|||
155529068|NCT02718326|561362243|FG000|Overall Study|Withdrawal by Subject|4|||
155529069|NCT02718326|561362244|FG001|Overall Study|Withdrawal by Subject|9|||
155529070|NCT02718326|561362245|FG002|Overall Study|Withdrawal by Subject|6|||
155529071|NCT02718326|561362243|FG000|Overall Study|Lost to Follow-up|18|||
155529072|NCT02718326|561362244|FG001|Overall Study|Lost to Follow-up|5|||
155529073|NCT02718326|561362245|FG002|Overall Study|Lost to Follow-up|14|||
155529074|NCT02718326|561362243|FG000|Overall Study|Protocol Deviation|1|||
155529075|NCT02718326|561362244|FG001|Overall Study|Protocol Deviation|0|||
155529076|NCT02718326|561362245|FG002|Overall Study|Protocol Deviation|0|||
155529077|NCT02718326|561362243|FG000|Overall Study|Pregnancy|1|||
155529078|NCT02718326|561362244|FG001|Overall Study|Pregnancy|0|||
155529079|NCT02718326|561362245|FG002|Overall Study|Pregnancy|0|||
155529080|NCT00583453|561362249|FG000|Overall Study|discontinued intervention|0|||
155529081|NCT00583453|561362250|FG001|Overall Study|discontinued intervention|2|||
155529082|NCT00455312|561362251|FG000|Overall Study|Death|0|||
155529083|NCT00455312|561362252|FG001|Overall Study|Death|1|||
155529084|NCT03868891|561362253|FG000|Overall Study|Adverse Event|1|||
155529085|NCT03868891|561362254|FG001|Overall Study|Adverse Event|0|||
155529086|NCT03868891|561362253|FG000|Overall Study|Lost to Follow-up|2|||
155529087|NCT03868891|561362254|FG001|Overall Study|Lost to Follow-up|1|||
155529088|NCT03868891|561362253|FG000|Overall Study|COVID-19 Restrictions|1|||
155529089|NCT03868891|561362254|FG001|Overall Study|COVID-19 Restrictions|2|||
155529090|NCT00777023|561362255|FG000|Overall Study|Adverse Event|15|||
155529091|NCT00777023|561362256|FG001|Overall Study|Adverse Event|21|||
155529092|NCT00777023|561362257|FG002|Overall Study|Adverse Event|8|||
155529093|NCT00777023|561362255|FG000|Overall Study|Lack of Efficacy|1|||
155529094|NCT00777023|561362256|FG001|Overall Study|Lack of Efficacy|0|||
155529095|NCT00777023|561362257|FG002|Overall Study|Lack of Efficacy|14|||
155529096|NCT00777023|561362255|FG000|Overall Study|Protocol Violation|2|||
155529097|NCT00777023|561362256|FG001|Overall Study|Protocol Violation|1|||
155529098|NCT00777023|561362257|FG002|Overall Study|Protocol Violation|1|||
155529099|NCT00777023|561362255|FG000|Overall Study|Lost to Follow-up|2|||
155529100|NCT00777023|561362256|FG001|Overall Study|Lost to Follow-up|3|||
155529101|NCT00777023|561362257|FG002|Overall Study|Lost to Follow-up|3|||
155529102|NCT00777023|561362255|FG000|Overall Study|Death|0|||
155529103|NCT00777023|561362256|FG001|Overall Study|Death|1|||
155529104|NCT00777023|561362257|FG002|Overall Study|Death|0|||
155529105|NCT00777023|561362255|FG000|Overall Study|Withdrawal by Subject|7|||
155529106|NCT00777023|561362256|FG001|Overall Study|Withdrawal by Subject|7|||
155529107|NCT00777023|561362257|FG002|Overall Study|Withdrawal by Subject|8|||
155529108|NCT00777023|561362255|FG000|Overall Study|Missing data|1|||
155529109|NCT00777023|561362256|FG001|Overall Study|Missing data|1|||
155529110|NCT00777023|561362257|FG002|Overall Study|Missing data|0|||
155529111|NCT00777023|561362255|FG000|Overall Study|Reasons not specified|4|||
155529112|NCT00777023|561362256|FG001|Overall Study|Reasons not specified|4|||
155529113|NCT00777023|561362257|FG002|Overall Study|Reasons not specified|2|||
155529114|NCT00777023|561362255|FG000|Overall Study|Last dose date unknown|3|||
155529115|NCT00777023|561362256|FG001|Overall Study|Last dose date unknown|3|||
155529116|NCT00777023|561362257|FG002|Overall Study|Last dose date unknown|1|||
155529117|NCT02659150|561362258|FG000|Subject Enrollment|Physician Decision|3|||
155529118|NCT02659150|561362258|FG000|Subject Enrollment|Withdrawal by Subject|2|||
155529119|NCT02659150|561362258|FG000|Baseline Imaging|Withdrawal by Subject|1|||
155529120|NCT02659150|561362258|FG000|Baseline Imaging|Physician Decision|1|||
155529121|NCT02659150|561362258|FG000|Study Drug Dosing|Adverse Event|1|||
155529122|NCT02246920|561362259|FG000|Overall Study|Adverse Event|3|||
155529123|NCT02246920|561362260|FG001|Overall Study|Adverse Event|1|||
155529124|NCT02246920|561362261|FG002|Overall Study|Adverse Event|1|||
155529125|NCT02246920|561362259|FG000|Overall Study|Lost to Follow-up|2|||
155529126|NCT02246920|561362260|FG001|Overall Study|Lost to Follow-up|1|||
155529127|NCT02246920|561362261|FG002|Overall Study|Lost to Follow-up|0|||
155529128|NCT02246920|561362259|FG000|Overall Study|Protocol Violation|2|||
155529129|NCT02246920|561362260|FG001|Overall Study|Protocol Violation|5|||
155655090|NCT01051661|561830636|FG000|Overall Study|Subject lost legal representation|0|||
155529130|NCT02246920|561362261|FG002|Overall Study|Protocol Violation|1|||
155529131|NCT02246920|561362259|FG000|Overall Study|Withdrawal by Subject|0|||
155529132|NCT02246920|561362260|FG001|Overall Study|Withdrawal by Subject|0|||
155529133|NCT02246920|561362261|FG002|Overall Study|Withdrawal by Subject|1|||
155529134|NCT02678286|561362262|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
155529135|NCT02678286|561362263|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
155529136|NCT02678286|561362262|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
155529137|NCT02678286|561362263|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
155529138|NCT02678286|561362262|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
155529139|NCT02678286|561362263|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
155529140|NCT02678286|561362262|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
155529141|NCT02678286|561362263|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
155529142|NCT02678286|561362262|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
155529143|NCT02678286|561362263|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
155529144|NCT02909907|561362270|FG000|Overall Study|Withdrawal by Subject|0|||
155529145|NCT02909907|561362271|FG001|Overall Study|Withdrawal by Subject|1|||
155529146|NCT02902211|561362272|FG000|First Three Months|Withdrawal by Subject|7|||
155529147|NCT02902211|561362273|FG001|First Three Months|Withdrawal by Subject|3|||
155529148|NCT02576938|561362276|FG000|Overall Study|Adverse Event|5|||
155529149|NCT02576938|561362277|FG001|Overall Study|Adverse Event|3|||
155529150|NCT02576938|561362278|FG002|Overall Study|Adverse Event|6|||
155529151|NCT02576938|561362276|FG000|Overall Study|Protocol Violation|1|||
155529152|NCT02576938|561362277|FG001|Overall Study|Protocol Violation|1|||
155529153|NCT02576938|561362278|FG002|Overall Study|Protocol Violation|1|||
155529154|NCT02576938|561362276|FG000|Overall Study|Withdrawal by Subject|3|||
155529155|NCT02576938|561362277|FG001|Overall Study|Withdrawal by Subject|2|||
155529156|NCT02576938|561362278|FG002|Overall Study|Withdrawal by Subject|4|||
155529157|NCT02576938|561362276|FG000|Overall Study|Lack of Efficacy|9|||
155529158|NCT02576938|561362277|FG001|Overall Study|Lack of Efficacy|4|||
155529159|NCT02576938|561362278|FG002|Overall Study|Lack of Efficacy|0|||
155529160|NCT02576938|561362276|FG000|Overall Study|Lost to Follow-up|2|||
155529161|NCT02576938|561362277|FG001|Overall Study|Lost to Follow-up|0|||
155529162|NCT02576938|561362278|FG002|Overall Study|Lost to Follow-up|1|||
155529163|NCT02576938|561362276|FG000|Overall Study|Physician Decision|0|||
155529164|NCT02576938|561362277|FG001|Overall Study|Physician Decision|1|||
155529165|NCT02576938|561362278|FG002|Overall Study|Physician Decision|0|||
155529166|NCT02576938|561362276|FG000|Overall Study|Met Exclusion Criteria|0|||
155529167|NCT02576938|561362277|FG001|Overall Study|Met Exclusion Criteria|1|||
155529168|NCT02576938|561362278|FG002|Overall Study|Met Exclusion Criteria|0|||
155529169|NCT03500341|561362279|FG000|Overall Study|Withdrawn prior to Completion|2|||
155529170|NCT00838630|561362284|FG000|First Intervention|Adverse Event|1|||
155529171|NCT00838630|561362285|FG001|First Intervention|Adverse Event|0|||
155529172|NCT00838630|561362284|FG000|Washout: 7 Days|Protocol Violation|1|||
155529173|NCT00838630|561362285|FG001|Washout: 7 Days|Protocol Violation|0|||
155529174|NCT02699866|561362286|FG000|Overall Study|Withdrawal by Subject|3|||
155529175|NCT02699866|561362286|FG000|Overall Study|Physician Decision|2|||
155529176|NCT02699866|561362286|FG000|Overall Study|Adverse Event|3|||
155529177|NCT03098394|561362290|FG000|Overall Study|Pregnancy|0|||
155529178|NCT03098394|561362291|FG001|Overall Study|Pregnancy|1|||
155529179|NCT01518972|561362294|FG000|Overall Study|Lost to Follow-up|2|||
155529180|NCT01518972|561362295|FG001|Overall Study|Lost to Follow-up|1|||
155529181|NCT01518972|561362294|FG000|Overall Study|Withdrawal by Subject|1|||
155529182|NCT01518972|561362295|FG001|Overall Study|Withdrawal by Subject|0|||
155529183|NCT01518972|561362294|FG000|Overall Study|Moved from area|1|||
155529184|NCT01518972|561362295|FG001|Overall Study|Moved from area|0|||
155529185|NCT01518972|561362294|FG000|Overall Study|Transportation problems|1|||
155529186|NCT01518972|561362295|FG001|Overall Study|Transportation problems|0|||
155529187|NCT01518972|561362294|FG000|Overall Study|Exclusionary medical condition|1|||
155529188|NCT01518972|561362295|FG001|Overall Study|Exclusionary medical condition|0|||
155529189|NCT01518972|561362294|FG000|Overall Study|Missed safety visits|0|||
155529190|NCT01518972|561362295|FG001|Overall Study|Missed safety visits|1|||
155529191|NCT01518972|561362294|FG000|Overall Study|Exclusionary medication|0|||
155529192|NCT01518972|561362295|FG001|Overall Study|Exclusionary medication|1|||
155529193|NCT01518972|561362294|FG000|Overall Study|Declined medication starting on day 12|0|||
155529194|NCT01518972|561362295|FG001|Overall Study|Declined medication starting on day 12|1|||
155529195|NCT01294917|561362298|FG000|Overall Study|Relocation|5|||
155529196|NCT01294917|561362298|FG000|Overall Study|Inconvenience|1|||
155529197|NCT02159950|561362302|FG000|Overall Study|Adverse Event|0|||
155529198|NCT02159950|561362303|FG001|Overall Study|Adverse Event|1|||
155529199|NCT02159950|561362302|FG000|Overall Study|Progression|0|||
155529200|NCT02159950|561362303|FG001|Overall Study|Progression|1|||
155529201|NCT03285594|561362307|FG000|Overall Study|At the Participant's Own Request|10|||
155529202|NCT03285594|561362308|FG001|Overall Study|At the Participant's Own Request|5|||
155529203|NCT03285594|561362309|FG002|Overall Study|At the Participant's Own Request|21|||
155529204|NCT03285594|561362307|FG000|Overall Study|Adverse Event|2|||
155529205|NCT03285594|561362308|FG001|Overall Study|Adverse Event|2|||
155529206|NCT03285594|561362309|FG002|Overall Study|Adverse Event|6|||
155529207|NCT03285594|561362307|FG000|Overall Study|Poor Compliance to Protocol|0|||
155529208|NCT03285594|561362308|FG001|Overall Study|Poor Compliance to Protocol|0|||
155529209|NCT03285594|561362309|FG002|Overall Study|Poor Compliance to Protocol|1|||
155529210|NCT03285594|561362307|FG000|Overall Study|Lost to Follow-up|0|||
155529211|NCT03285594|561362308|FG001|Overall Study|Lost to Follow-up|0|||
155529212|NCT03285594|561362309|FG002|Overall Study|Lost to Follow-up|1|||
155529213|NCT03285594|561362307|FG000|Overall Study|Reason Not Specified|3|||
155529214|NCT03285594|561362308|FG001|Overall Study|Reason Not Specified|4|||
155529215|NCT03285594|561362309|FG002|Overall Study|Reason Not Specified|8|||
155529216|NCT03733444|561362313|FG000|Overall Study|Adverse Event|8|||
155529217|NCT03733444|561362314|FG001|Overall Study|Adverse Event|10|||
155529218|NCT03733444|561362315|FG002|Overall Study|Adverse Event|5|||
155529219|NCT03733444|561362313|FG000|Overall Study|Death|20|||
155529220|NCT03733444|561362314|FG001|Overall Study|Death|19|||
155529221|NCT03733444|561362315|FG002|Overall Study|Death|11|||
155529222|NCT03733444|561362313|FG000|Overall Study|Lost to Follow-up|3|||
155529223|NCT03733444|561362314|FG001|Overall Study|Lost to Follow-up|0|||
155529224|NCT03733444|561362315|FG002|Overall Study|Lost to Follow-up|1|||
155529225|NCT03733444|561362313|FG000|Overall Study|Lack of Efficacy|0|||
155529226|NCT03733444|561362314|FG001|Overall Study|Lack of Efficacy|1|||
155529227|NCT03733444|561362315|FG002|Overall Study|Lack of Efficacy|1|||
155529228|NCT03733444|561362313|FG000|Overall Study|Physician Decision|2|||
155529229|NCT03733444|561362314|FG001|Overall Study|Physician Decision|1|||
155529230|NCT03733444|561362315|FG002|Overall Study|Physician Decision|0|||
155529231|NCT03733444|561362313|FG000|Overall Study|Protocol Violation|2|||
155529232|NCT03733444|561362314|FG001|Overall Study|Protocol Violation|1|||
155529233|NCT03733444|561362315|FG002|Overall Study|Protocol Violation|0|||
155529234|NCT03733444|561362313|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
155529235|NCT03733444|561362314|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
155529236|NCT03733444|561362315|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
155529237|NCT03733444|561362313|FG000|Overall Study|Study Terminated by Sponsor|203|||
155529238|NCT03733444|561362314|FG001|Overall Study|Study Terminated by Sponsor|209|||
155529239|NCT03733444|561362315|FG002|Overall Study|Study Terminated by Sponsor|221|||
155529240|NCT03733444|561362313|FG000|Overall Study|Withdrawal by Subject|19|||
155529241|NCT03733444|561362314|FG001|Overall Study|Withdrawal by Subject|18|||
155529242|NCT03733444|561362315|FG002|Overall Study|Withdrawal by Subject|16|||
155529243|NCT03733444|561362313|FG000|Overall Study|Miscellaneous|1|||
155529244|NCT03733444|561362314|FG001|Overall Study|Miscellaneous|0|||
155529245|NCT03733444|561362315|FG002|Overall Study|Miscellaneous|1|||
155529246|NCT03733444|561362313|FG000|Overall Study|Not Treated|1|||
155529247|NCT03733444|561362314|FG001|Overall Study|Not Treated|2|||
155529248|NCT03733444|561362315|FG002|Overall Study|Not Treated|1|||
155529249|NCT02648438|561362316|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155529250|NCT02648438|561362317|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155529251|NCT02648438|561362318|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155529252|NCT02648438|561362316|FG000|Overall Study|Protocol Violation|2|||
155529253|NCT02648438|561362317|FG001|Overall Study|Protocol Violation|0|||
155529254|NCT02648438|561362318|FG002|Overall Study|Protocol Violation|0|||
155529255|NCT02648438|561362316|FG000|Overall Study|Withdrawal by Subject|1|||
155529256|NCT02648438|561362317|FG001|Overall Study|Withdrawal by Subject|1|||
155529257|NCT02648438|561362318|FG002|Overall Study|Withdrawal by Subject|0|||
155529258|NCT03138967|561362319|FG000|Overall Study|Death|0|||
155529259|NCT03138967|561362320|FG001|Overall Study|Death|1|||
155529260|NCT03138967|561362319|FG000|Overall Study|Physician Decision|1|||
155529261|NCT03138967|561362320|FG001|Overall Study|Physician Decision|3|||
155529262|NCT04604275|561362323|FG000|Washout-1 Week|Withdrawal by Subject|1|||
155529263|NCT04604275|561362324|FG001|Washout-1 Week|Withdrawal by Subject|0|||
155529264|NCT02258074|561362325|FG000|Overall Study|Withdrawal by Subject|1|||
155529265|NCT02258074|561362326|FG001|Overall Study|Withdrawal by Subject|0|||
155529266|NCT02258074|561362327|FG002|Overall Study|Withdrawal by Subject|0|||
155529267|NCT02258074|561362328|FG003|Overall Study|Withdrawal by Subject|0|||
155529268|NCT05446870|561362329|FG000|Overall Study|Death|6|||
155529269|NCT05446870|561362330|FG001|Overall Study|Death|5|||
155529270|NCT05446870|561362329|FG000|Overall Study|Lost to Follow-up|0|||
155529271|NCT05446870|561362330|FG001|Overall Study|Lost to Follow-up|1|||
155655091|NCT01051661|561830637|FG001|Overall Study|Subject lost legal representation|0|||
155655092|NCT01051661|561830638|FG002|Overall Study|Subject lost legal representation|0|||
155655093|NCT01051661|561830639|FG003|Overall Study|Subject lost legal representation|0|||
155655094|NCT01051661|561830640|FG004|Overall Study|Subject lost legal representation|1|||
155655095|NCT01051661|561830641|FG005|Overall Study|Subject lost legal representation|0|||
155655096|NCT01051661|561830636|FG000|Overall Study|Protocol Violation|0|||
155655097|NCT01051661|561830637|FG001|Overall Study|Protocol Violation|0|||
155655098|NCT01051661|561830638|FG002|Overall Study|Protocol Violation|0|||
155655099|NCT01051661|561830639|FG003|Overall Study|Protocol Violation|1|||
155655100|NCT01051661|561830640|FG004|Overall Study|Protocol Violation|2|||
155655101|NCT01051661|561830641|FG005|Overall Study|Protocol Violation|1|||
155655102|NCT01051661|561830636|FG000|Overall Study|Withdrawal by Subject|16|||
155655103|NCT01051661|561830637|FG001|Overall Study|Withdrawal by Subject|30|||
155655104|NCT01051661|561830638|FG002|Overall Study|Withdrawal by Subject|13|||
155529272|NCT05446870|561362329|FG000|Overall Study|Physician Decision|52|||
155529273|NCT05446870|561362330|FG001|Overall Study|Physician Decision|53|||
155529274|NCT05446870|561362329|FG000|Overall Study|Withdrawal by Subject|3|||
155529275|NCT05446870|561362330|FG001|Overall Study|Withdrawal by Subject|3|||
155529276|NCT01208337|561362333|FG000|Overall Study|Death|3|||
155529277|NCT00984126|561362337|FG000|Overall Study|Protocol Violation|0|||
155529278|NCT00984126|561362338|FG001|Overall Study|Protocol Violation|0|||
155529279|NCT00984126|561362339|FG002|Overall Study|Protocol Violation|1|||
155529280|NCT00984126|561362340|FG003|Overall Study|Protocol Violation|2|||
155529281|NCT00984126|561362337|FG000|Overall Study|Adverse Event|0|||
155529282|NCT00984126|561362338|FG001|Overall Study|Adverse Event|0|||
155529283|NCT00984126|561362339|FG002|Overall Study|Adverse Event|0|||
155529284|NCT00984126|561362340|FG003|Overall Study|Adverse Event|2|||
155529285|NCT00984126|561362337|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
155529286|NCT00984126|561362338|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
155529287|NCT00984126|561362339|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
155529288|NCT00984126|561362340|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
155529289|NCT00984126|561362337|FG000|Overall Study|Withdrawal criteria|0|||
155529290|NCT00984126|561362338|FG001|Overall Study|Withdrawal criteria|1|||
155529291|NCT00984126|561362339|FG002|Overall Study|Withdrawal criteria|3|||
155529292|NCT00984126|561362340|FG003|Overall Study|Withdrawal criteria|9|||
155529293|NCT01029340|561362341|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
155529294|NCT01029340|561362342|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
155529295|NCT01029340|561362343|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
155529296|NCT01029340|561362344|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
155529297|NCT01029340|561362345|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
155529298|NCT01029340|561362346|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
155529299|NCT01029340|561362341|FG000|Part B Treatment Period|Protocol Violation|0|||
155529300|NCT01029340|561362342|FG001|Part B Treatment Period|Protocol Violation|0|||
155529301|NCT01029340|561362343|FG002|Part B Treatment Period|Protocol Violation|1|||
155529302|NCT01029340|561362344|FG003|Part B Treatment Period|Protocol Violation|0|||
155529303|NCT01029340|561362345|FG004|Part B Treatment Period|Protocol Violation|0|||
155529304|NCT01029340|561362346|FG005|Part B Treatment Period|Protocol Violation|0|||
155529305|NCT01029340|561362341|FG000|Extension Period|Adverse Event|0|||
155529306|NCT01029340|561362342|FG001|Extension Period|Adverse Event|0|||
155529307|NCT01029340|561362343|FG002|Extension Period|Adverse Event|0|||
155529308|NCT01029340|561362344|FG003|Extension Period|Adverse Event|0|||
155529309|NCT01029340|561362345|FG004|Extension Period|Adverse Event|0|||
155529310|NCT01029340|561362346|FG005|Extension Period|Adverse Event|1|||
155529311|NCT01029340|561362341|FG000|Extension Period|starting another study|0|||
155529312|NCT01029340|561362342|FG001|Extension Period|starting another study|0|||
155529313|NCT01029340|561362343|FG002|Extension Period|starting another study|0|||
155529314|NCT01029340|561362344|FG003|Extension Period|starting another study|0|||
155529315|NCT01029340|561362345|FG004|Extension Period|starting another study|0|||
155529316|NCT01029340|561362346|FG005|Extension Period|starting another study|8|||
155529317|NCT01029340|561362341|FG000|Extension Period|non-compliance|0|||
155529318|NCT01029340|561362342|FG001|Extension Period|non-compliance|0|||
155529319|NCT01029340|561362343|FG002|Extension Period|non-compliance|0|||
155529320|NCT01029340|561362344|FG003|Extension Period|non-compliance|0|||
155529321|NCT01029340|561362345|FG004|Extension Period|non-compliance|0|||
155529322|NCT01029340|561362346|FG005|Extension Period|non-compliance|1|||
155529323|NCT01029340|561362341|FG000|Extension Period|Withdrawal by Subject|0|||
155529324|NCT01029340|561362342|FG001|Extension Period|Withdrawal by Subject|0|||
155529325|NCT01029340|561362343|FG002|Extension Period|Withdrawal by Subject|0|||
155529326|NCT01029340|561362344|FG003|Extension Period|Withdrawal by Subject|0|||
155529327|NCT01029340|561362345|FG004|Extension Period|Withdrawal by Subject|0|||
155529328|NCT01029340|561362346|FG005|Extension Period|Withdrawal by Subject|1|||
155529329|NCT01029340|561362341|FG000|Extension Period|Physician Decision|0|||
155529330|NCT01029340|561362342|FG001|Extension Period|Physician Decision|0|||
155529331|NCT01029340|561362343|FG002|Extension Period|Physician Decision|0|||
155529332|NCT01029340|561362344|FG003|Extension Period|Physician Decision|0|||
155529333|NCT01029340|561362345|FG004|Extension Period|Physician Decision|0|||
155529334|NCT01029340|561362346|FG005|Extension Period|Physician Decision|1|||
155529335|NCT02648347|561362347|FG000|Overall Study|Death|174|||
155529336|NCT02648347|561362348|FG001|Overall Study|Death|167|||
155529337|NCT02648347|561362347|FG000|Overall Study|Withdrawal by Subject|16|||
155529338|NCT02648347|561362348|FG001|Overall Study|Withdrawal by Subject|9|||
155529339|NCT02648347|561362347|FG000|Overall Study|Lost to Follow-up|18|||
155529340|NCT02648347|561362348|FG001|Overall Study|Lost to Follow-up|21|||
155529341|NCT02648347|561362347|FG000|Overall Study|Missing|1|||
155529342|NCT02648347|561362348|FG001|Overall Study|Missing|0|||
155529343|NCT02196675|561362355|FG000|Overall Study|Withdrawal by Subject|1|||
155529344|NCT02196675|561362356|FG001|Overall Study|Withdrawal by Subject|0|||
155529345|NCT02196675|561362357|FG002|Overall Study|Withdrawal by Subject|0|||
155529346|NCT02196675|561362355|FG000|Overall Study|Intra-operative surgical exclusion|1|||
155529347|NCT02196675|561362356|FG001|Overall Study|Intra-operative surgical exclusion|1|||
155529348|NCT02196675|561362357|FG002|Overall Study|Intra-operative surgical exclusion|0|||
155529349|NCT02196675|561362355|FG000|Overall Study|Protocol Violation|0|||
155529350|NCT02196675|561362356|FG001|Overall Study|Protocol Violation|1|||
155529351|NCT02196675|561362357|FG002|Overall Study|Protocol Violation|0|||
155529352|NCT02196675|561362355|FG000|Overall Study|Death|0|||
155529353|NCT02196675|561362356|FG001|Overall Study|Death|0|||
155529354|NCT02196675|561362357|FG002|Overall Study|Death|1|||
155529355|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
155529356|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
155529357|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
155529358|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
155529359|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
155529360|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
155529361|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
155529362|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
155529363|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
155529364|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
155529365|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
155529366|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
155529367|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
155529368|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
155529369|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
155529370|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
155529371|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
155529372|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
155529373|NCT02009163|561362358|FG000|Open-label Period (Non-randomized)|Other|13|||
155529374|NCT02009163|561362359|FG001|Open-label Period (Non-randomized)|Other|0|||
155529375|NCT02009163|561362360|FG002|Open-label Period (Non-randomized)|Other|0|||
155529376|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
155529377|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
155529378|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
155529379|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
155529380|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
155529381|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
155529382|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Adverse Event|0|||
155529383|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Adverse Event|0|||
155529384|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Adverse Event|6|||
155529385|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
155529386|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
155529387|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
155529388|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
155529389|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
155529390|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
155529391|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Pregnancy|0|||
155529392|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Pregnancy|0|||
155529393|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Pregnancy|2|||
155529394|NCT02009163|561362358|FG000|Randomized-withdrawal Period|Other|0|||
155529395|NCT02009163|561362359|FG001|Randomized-withdrawal Period|Other|9|||
155529396|NCT02009163|561362360|FG002|Randomized-withdrawal Period|Other|5|||
155529397|NCT01415986|561362361|FG000|Overall Study|Lost to Follow-up|1|||
155529398|NCT03122457|561362362|FG000|Overall Study|Withdrawal by Subject|6|||
155529399|NCT03686033|561362364|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
155529400|NCT03686033|561362365|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
155529401|NCT03686033|561362366|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
155529402|NCT03686033|561362367|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
155529403|NCT03686033|561362368|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
155529404|NCT03686033|561362369|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
155529405|NCT02335658|561362370|FG000|Overall Study|Adverse Event|18|||
155529406|NCT02335658|561362371|FG001|Overall Study|Adverse Event|12|||
155529407|NCT02335658|561362370|FG000|Overall Study|Lack of Efficacy|4|||
155529408|NCT02335658|561362371|FG001|Overall Study|Lack of Efficacy|5|||
155529409|NCT02335658|561362370|FG000|Overall Study|Pregnancy|1|||
155529410|NCT02335658|561362371|FG001|Overall Study|Pregnancy|0|||
155529411|NCT02335658|561362370|FG000|Overall Study|Withdrawal by Subject|13|||
155529412|NCT02335658|561362371|FG001|Overall Study|Withdrawal by Subject|21|||
155529413|NCT02335658|561362370|FG000|Overall Study|non-compliance|2|||
155529414|NCT02335658|561362371|FG001|Overall Study|non-compliance|3|||
155529415|NCT02335658|561362370|FG000|Overall Study|other reason|2|||
155529416|NCT02335658|561362371|FG001|Overall Study|other reason|3|||
155529417|NCT02032888|561362372|FG000|Treatment Period|Poor compliance/noncompliance|1|||
155529418|NCT02032888|561362373|FG001|Treatment Period|Poor compliance/noncompliance|1|||
155529419|NCT02032888|561362374|FG002|Treatment Period|Poor compliance/noncompliance|0|||
155529420|NCT02032888|561362372|FG000|Treatment Period|Other|1|||
155529421|NCT02032888|561362373|FG001|Treatment Period|Other|1|||
155529422|NCT02032888|561362374|FG002|Treatment Period|Other|0|||
155529423|NCT02032888|561362372|FG000|Follow-up Period|Lost to Follow-up|1|||
155529424|NCT02032888|561362373|FG001|Follow-up Period|Lost to Follow-up|1|||
155529425|NCT02032888|561362374|FG002|Follow-up Period|Lost to Follow-up|0|||
155486696|NCT01218477|561203848|FG000|Overall Study|Administrative reason by sponsor|0|||
155486697|NCT01218477|561203849|FG001|Overall Study|Administrative reason by sponsor|0|||
155486698|NCT01218477|561203850|FG002|Overall Study|Administrative reason by sponsor|1|||
155486699|NCT01218477|561203851|FG003|Overall Study|Administrative reason by sponsor|0|||
155486700|NCT01218477|561203848|FG000|Overall Study|Maximum clinical benefit|0|||
155486701|NCT01218477|561203849|FG001|Overall Study|Maximum clinical benefit|2|||
155486702|NCT01218477|561203850|FG002|Overall Study|Maximum clinical benefit|0|||
155486703|NCT01218477|561203851|FG003|Overall Study|Maximum clinical benefit|0|||
155486704|NCT00787527|561203852|FG000|Overall Study|Toxicity|3|||
155486705|NCT02132312|561203863|FG000|Overall Study|Adverse Event|2|||
155486706|NCT02132312|561203864|FG001|Overall Study|Adverse Event|0|||
155486707|NCT02132312|561203863|FG000|Overall Study|Physician Decision|1|||
155486708|NCT02132312|561203864|FG001|Overall Study|Physician Decision|1|||
155486709|NCT02132312|561203863|FG000|Overall Study|Protocol Violation|0|||
155486710|NCT02132312|561203864|FG001|Overall Study|Protocol Violation|1|||
155486711|NCT02132312|561203863|FG000|Overall Study|Withdrawal by Subject|1|||
155486712|NCT02132312|561203864|FG001|Overall Study|Withdrawal by Subject|0|||
155486713|NCT02132312|561203863|FG000|Overall Study|Lost to Follow-up|2|||
155486714|NCT02132312|561203864|FG001|Overall Study|Lost to Follow-up|1|||
155486715|NCT00089505|561203865|FG000|Overall Study|Death|4|||
155486716|NCT00089505|561203866|FG001|Overall Study|Death|1|||
155486717|NCT00089505|561203867|FG002|Overall Study|Death|5|||
155486718|NCT00089505|561203868|FG003|Overall Study|Death|8|||
155486719|NCT00089505|561203865|FG000|Overall Study|Withdrawal by Subject|3|||
155486720|NCT00089505|561203866|FG001|Overall Study|Withdrawal by Subject|0|||
155486721|NCT00089505|561203867|FG002|Overall Study|Withdrawal by Subject|6|||
155486722|NCT00089505|561203868|FG003|Overall Study|Withdrawal by Subject|6|||
155486723|NCT00089505|561203865|FG000|Overall Study|Lost to Follow-up|1|||
155486724|NCT00089505|561203866|FG001|Overall Study|Lost to Follow-up|1|||
155486725|NCT00089505|561203867|FG002|Overall Study|Lost to Follow-up|9|||
155486726|NCT00089505|561203868|FG003|Overall Study|Lost to Follow-up|7|||
155486727|NCT00089505|561203865|FG000|Overall Study|Physician Decision|1|||
155486728|NCT00089505|561203866|FG001|Overall Study|Physician Decision|0|||
155486729|NCT00089505|561203867|FG002|Overall Study|Physician Decision|0|||
155486730|NCT00089505|561203868|FG003|Overall Study|Physician Decision|0|||
155486731|NCT00089505|561203865|FG000|Overall Study|Protocol Violation|0|||
155486732|NCT00089505|561203866|FG001|Overall Study|Protocol Violation|0|||
155486733|NCT00089505|561203867|FG002|Overall Study|Protocol Violation|1|||
155486734|NCT00089505|561203868|FG003|Overall Study|Protocol Violation|0|||
155486735|NCT02543918|561203869|FG000|Overall Study|Never treated|0|||
155486736|NCT02543918|561203870|FG001|Overall Study|Never treated|1|||
155486737|NCT02543918|561203869|FG000|Overall Study|Lost to Follow-up|1|||
155486738|NCT02543918|561203870|FG001|Overall Study|Lost to Follow-up|1|||
155486739|NCT02543918|561203869|FG000|Overall Study|Withdrawal by Subject|1|||
155486740|NCT02543918|561203870|FG001|Overall Study|Withdrawal by Subject|1|||
155486741|NCT02543918|561203869|FG000|Overall Study|Adverse Event|1|||
155486742|NCT02543918|561203870|FG001|Overall Study|Adverse Event|1|||
155486743|NCT00486720|561203873|FG000|Overall Study|Adverse Event|1|||
155486744|NCT00486720|561203874|FG001|Overall Study|Adverse Event|2|||
155486745|NCT00486720|561203873|FG000|Overall Study|Lack of Efficacy|4|||
155486746|NCT00486720|561203874|FG001|Overall Study|Lack of Efficacy|6|||
155486747|NCT00486720|561203873|FG000|Overall Study|Physician Decision|1|||
155486748|NCT00486720|561203874|FG001|Overall Study|Physician Decision|2|||
155486749|NCT00486720|561203873|FG000|Overall Study|Protocol Violation|1|||
155486750|NCT00486720|561203874|FG001|Overall Study|Protocol Violation|0|||
155486751|NCT00486720|561203873|FG000|Overall Study|Withdrawal by Subject|3|||
155486752|NCT00486720|561203874|FG001|Overall Study|Withdrawal by Subject|1|||
155486753|NCT00486720|561203873|FG000|Overall Study|Progressive Disease|0|||
155486754|NCT00486720|561203874|FG001|Overall Study|Progressive Disease|1|||
155486755|NCT00252499|561203879|FG000|Overall Study|Lost to Follow-up|1|||
155486756|NCT00252499|561203880|FG001|Overall Study|Lost to Follow-up|0|||
155486757|NCT00252499|561203881|FG002|Overall Study|Lost to Follow-up|0|||
155486758|NCT03137173|561203882|FG000|Overall Study|Withdrawal by Subject|8|||
155486759|NCT03137173|561203883|FG001|Overall Study|Withdrawal by Subject|13|||
155486760|NCT03137173|561203882|FG000|Overall Study|Death|1|||
155486761|NCT03137173|561203883|FG001|Overall Study|Death|3|||
155486762|NCT03137173|561203882|FG000|Overall Study|Physician Decision|1|||
155486763|NCT03137173|561203883|FG001|Overall Study|Physician Decision|0|||
155486764|NCT03137173|561203882|FG000|Overall Study|Lost to Follow-up|13|||
155486765|NCT03137173|561203883|FG001|Overall Study|Lost to Follow-up|18|||
155486766|NCT03137173|561203882|FG000|Overall Study|Other reasons|3|||
155486767|NCT03137173|561203883|FG001|Overall Study|Other reasons|2|||
155486768|NCT00423267|561203884|FG000|Period A|Withdrawal by Subject|0|||
155486769|NCT00423267|561203885|FG001|Period A|Withdrawal by Subject|1|||
155486770|NCT00423267|561203884|FG000|Period A|Non-compliance with protocol|1|||
155486771|NCT00423267|561203885|FG001|Period A|Non-compliance with protocol|0|||
155486772|NCT00423267|561203884|FG000|Period A|Administrative|1|||
155486773|NCT00423267|561203885|FG001|Period A|Administrative|0|||
155529426|NCT02032888|561362372|FG000|Follow-up Period|Death|1|||
155529427|NCT02032888|561362373|FG001|Follow-up Period|Death|1|||
155529428|NCT02032888|561362374|FG002|Follow-up Period|Death|0|||
155529429|NCT02032888|561362372|FG000|Follow-up Period|Other|1|||
155529430|NCT02032888|561362373|FG001|Follow-up Period|Other|0|||
155529431|NCT02032888|561362374|FG002|Follow-up Period|Other|0|||
155529432|NCT01754597|561362377|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
155529433|NCT01754597|561362378|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
155529434|NCT00819741|561362379|FG000|Overall Study|Adverse Event|5|||
155529435|NCT00819741|561362380|FG001|Overall Study|Adverse Event|2|||
155529436|NCT00819741|561362379|FG000|Overall Study|Lack of Efficacy|0|||
155529437|NCT00819741|561362380|FG001|Overall Study|Lack of Efficacy|2|||
155529438|NCT00819741|561362379|FG000|Overall Study|Lost to Follow-up|3|||
155529439|NCT00819741|561362380|FG001|Overall Study|Lost to Follow-up|1|||
155529440|NCT00819741|561362379|FG000|Overall Study|Protocol Violation|3|||
155529441|NCT00819741|561362380|FG001|Overall Study|Protocol Violation|4|||
155529442|NCT00819741|561362379|FG000|Overall Study|Withdrawal by Subject|2|||
155529443|NCT00819741|561362380|FG001|Overall Study|Withdrawal by Subject|2|||
155529444|NCT00819741|561362379|FG000|Overall Study|Unclassified|6|||
155529445|NCT00819741|561362380|FG001|Overall Study|Unclassified|0|||
155529446|NCT00819741|561362379|FG000|Overall Study|Reasons unknown|3|||
155529447|NCT00819741|561362380|FG001|Overall Study|Reasons unknown|3|||
155529448|NCT03447353|561363893|FG000|Overall Study|Failure at Screening Visit|2|||
155529449|NCT03447353|561363893|FG000|Overall Study|Lost to Follow-up|4|||
155529450|NCT03447353|561363893|FG000|Overall Study|Scheduling Conflicts|3|||
155529451|NCT03447353|561363893|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
155529452|NCT02175095|561363894|FG000|Overall Study|Withdrawal by Subject|3|||
155529453|NCT02635750|561363895|FG000|Part 1, Period 2|Adverse Event|1|||
155529454|NCT02635750|561363896|FG001|Part 1, Period 2|Adverse Event|0|||
155529455|NCT02635750|561363897|FG002|Part 1, Period 2|Adverse Event|0|||
155529456|NCT02642653|561363899|FG000|Overall Study|Adverse Event|2|||
155529457|NCT02642653|561363900|FG001|Overall Study|Adverse Event|0|||
155529458|NCT02875392|561363901|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
155529459|NCT02875392|561363902|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
155529460|NCT01660243|561363908|FG000|Overall Study|Adverse Event|1|||
155529461|NCT01660243|561363909|FG001|Overall Study|Adverse Event|0|||
155529462|NCT01660243|561363910|FG002|Overall Study|Adverse Event|1|||
155529463|NCT01660243|561363911|FG003|Overall Study|Adverse Event|0|||
155529464|NCT01660243|561363908|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
155529465|NCT01660243|561363909|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
155529466|NCT01660243|561363910|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
155529467|NCT01660243|561363911|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
155529468|NCT01660243|561363908|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
155529469|NCT01660243|561363909|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
155529470|NCT01660243|561363910|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
155529471|NCT01660243|561363911|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
155529472|NCT01660243|561363908|FG000|Overall Study|Randomization error|0|||
155529473|NCT01660243|561363909|FG001|Overall Study|Randomization error|0|||
155529474|NCT01660243|561363910|FG002|Overall Study|Randomization error|0|||
155529475|NCT01660243|561363911|FG003|Overall Study|Randomization error|1|||
155529476|NCT04299087|561363912|FG000|Overall Study|Lost to Follow-up|2|||
155529477|NCT04299087|561363913|FG001|Overall Study|Lost to Follow-up|1|||
155529478|NCT03025087|561363914|FG000|Overall Study|Physician Decision|3|||
155529479|NCT03025087|561363915|FG001|Overall Study|Physician Decision|3|||
155529480|NCT03025087|561363916|FG002|Overall Study|Physician Decision|0|||
155529481|NCT03025087|561363917|FG003|Overall Study|Physician Decision|0|||
155529482|NCT03025087|561363918|FG004|Overall Study|Physician Decision|0|||
155529483|NCT03025087|561363914|FG000|Overall Study|Withdrawal by Subject|1|||
155529484|NCT03025087|561363915|FG001|Overall Study|Withdrawal by Subject|1|||
155529485|NCT03025087|561363916|FG002|Overall Study|Withdrawal by Subject|0|||
155529486|NCT03025087|561363917|FG003|Overall Study|Withdrawal by Subject|0|||
155529487|NCT03025087|561363918|FG004|Overall Study|Withdrawal by Subject|0|||
155655105|NCT01051661|561830639|FG003|Overall Study|Withdrawal by Subject|28|||
155529488|NCT03025087|561363914|FG000|Overall Study|Unable to complete MRI|2|||
155529489|NCT03025087|561363915|FG001|Overall Study|Unable to complete MRI|2|||
155529490|NCT03025087|561363916|FG002|Overall Study|Unable to complete MRI|0|||
155529491|NCT03025087|561363917|FG003|Overall Study|Unable to complete MRI|0|||
155529492|NCT03025087|561363918|FG004|Overall Study|Unable to complete MRI|0|||
155529493|NCT00594035|561363919|FG000|Overall Study|Lost to Follow-up|1|||
155529494|NCT00594035|561363920|FG001|Overall Study|Lost to Follow-up|1|||
155529495|NCT00594035|561363919|FG000|Overall Study|Withdrawal by Subject|1|||
155529496|NCT00594035|561363920|FG001|Overall Study|Withdrawal by Subject|0|||
155529497|NCT00594035|561363919|FG000|Overall Study|Subject transferred to nursing home|0|||
155529498|NCT00594035|561363920|FG001|Overall Study|Subject transferred to nursing home|1|||
155529499|NCT00594035|561363919|FG000|Overall Study|Subject couldn't return due to job|0|||
155529500|NCT00594035|561363920|FG001|Overall Study|Subject couldn't return due to job|1|||
155529501|NCT00795821|561363921|FG000|Acute Treatment Phase|Adverse Event|23|||
155529502|NCT00795821|561363922|FG001|Acute Treatment Phase|Adverse Event|4|||
155529503|NCT00795821|561363921|FG000|Acute Treatment Phase|Death|1|||
155529504|NCT00795821|561363922|FG001|Acute Treatment Phase|Death|0|||
155529505|NCT00795821|561363921|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
155529506|NCT00795821|561363922|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
155529507|NCT00795821|561363921|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
155529508|NCT00795821|561363922|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
155529509|NCT00795821|561363921|FG000|Acute Treatment Phase|Physician Decision|1|||
155529510|NCT00795821|561363922|FG001|Acute Treatment Phase|Physician Decision|1|||
155529511|NCT00795821|561363921|FG000|Acute Treatment Phase|Protocol Violation|1|||
155529512|NCT00795821|561363922|FG001|Acute Treatment Phase|Protocol Violation|2|||
155529513|NCT00795821|561363921|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
155529514|NCT00795821|561363922|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
155529515|NCT00795821|561363921|FG000|Long-term Extension Phase|Adverse Event|25|||
155529516|NCT00795821|561363922|FG001|Long-term Extension Phase|Adverse Event|32|||
155529517|NCT00795821|561363921|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
155529518|NCT00795821|561363922|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
155529519|NCT00795821|561363921|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
155529520|NCT00795821|561363922|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
155529521|NCT00795821|561363921|FG000|Long-term Extension Phase|Physician Decision|1|||
155529522|NCT00795821|561363922|FG001|Long-term Extension Phase|Physician Decision|2|||
155529523|NCT00795821|561363921|FG000|Long-term Extension Phase|Protocol Violation|3|||
155529524|NCT00795821|561363922|FG001|Long-term Extension Phase|Protocol Violation|5|||
155529525|NCT00795821|561363921|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
155529526|NCT00795821|561363922|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
155529527|NCT00795821|561363921|FG000|Taper Phase|Adverse Event|2|||
155529528|NCT00795821|561363922|FG001|Taper Phase|Adverse Event|0|||
155529529|NCT00795821|561363921|FG000|Taper Phase|Lost to Follow-up|1|||
155529530|NCT00795821|561363922|FG001|Taper Phase|Lost to Follow-up|0|||
155529531|NCT00795821|561363921|FG000|Taper Phase|Physician Decision|2|||
155529532|NCT00795821|561363922|FG001|Taper Phase|Physician Decision|0|||
155529533|NCT00795821|561363921|FG000|Taper Phase|Withdrawal by Subject|4|||
155529534|NCT00795821|561363922|FG001|Taper Phase|Withdrawal by Subject|0|||
155529535|NCT00712959|561363929|FG000|Overall Study|Protocol Violation|3|||
155529536|NCT00712959|561363930|FG001|Overall Study|Protocol Violation|1|||
155529537|NCT00712959|561363929|FG000|Overall Study|Lost to Follow-up|13|||
155529538|NCT00712959|561363930|FG001|Overall Study|Lost to Follow-up|2|||
155529539|NCT00712959|561363929|FG000|Overall Study|Withdrawal by Subject|3|||
155529540|NCT00712959|561363930|FG001|Overall Study|Withdrawal by Subject|0|||
155529541|NCT00905606|561363931|FG000|Period 1|Adverse Event|0|||
155529542|NCT00905606|561363932|FG001|Period 1|Adverse Event|1|||
155529543|NCT00905606|561363931|FG000|Washout|Withdrawal by Subject|1|||
155529544|NCT00905606|561363932|FG001|Washout|Withdrawal by Subject|0|||
155529545|NCT01558635|561363933|FG000|Overall Study|Death|1|||
155529546|NCT01558635|561363933|FG000|Overall Study|Withdrawal by Subject|2|||
155529547|NCT01558635|561363933|FG000|Overall Study|Physician Decision|1|||
155529548|NCT01558635|561363933|FG000|Overall Study|Subject received other treatment|1|||
155529549|NCT01558635|561363933|FG000|Overall Study|Reveal XT was explanted|1|||
155529550|NCT03247972|561363937|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
155529551|NCT03247972|561363937|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
155529552|NCT00968812|561363938|FG000|Overall Study|Adverse Event|30|||
155529553|NCT00968812|561363939|FG001|Overall Study|Adverse Event|46|||
155529554|NCT00968812|561363940|FG002|Overall Study|Adverse Event|33|||
155529555|NCT00968812|561363938|FG000|Overall Study|Death|2|||
155529556|NCT00968812|561363939|FG001|Overall Study|Death|2|||
155529557|NCT00968812|561363940|FG002|Overall Study|Death|1|||
155529558|NCT00968812|561363938|FG000|Overall Study|Lack of Efficacy|9|||
155529559|NCT00968812|561363939|FG001|Overall Study|Lack of Efficacy|7|||
155529560|NCT00968812|561363940|FG002|Overall Study|Lack of Efficacy|16|||
155529561|NCT00968812|561363938|FG000|Overall Study|Lost to Follow-up|17|||
155529562|NCT00968812|561363939|FG001|Overall Study|Lost to Follow-up|12|||
155529563|NCT00968812|561363940|FG002|Overall Study|Lost to Follow-up|11|||
155529564|NCT00968812|561363938|FG000|Overall Study|Physician Decision|8|||
155529565|NCT00968812|561363939|FG001|Overall Study|Physician Decision|5|||
155529566|NCT00968812|561363940|FG002|Overall Study|Physician Decision|9|||
155529567|NCT00968812|561363938|FG000|Overall Study|Protocol Violation|7|||
155529568|NCT00968812|561363939|FG001|Overall Study|Protocol Violation|4|||
155529569|NCT00968812|561363940|FG002|Overall Study|Protocol Violation|3|||
155529570|NCT00968812|561363938|FG000|Overall Study|Withdrawal by Subject|17|||
155529571|NCT00968812|561363939|FG001|Overall Study|Withdrawal by Subject|23|||
155529572|NCT00968812|561363940|FG002|Overall Study|Withdrawal by Subject|25|||
155529573|NCT00968812|561363938|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
155529574|NCT00968812|561363939|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
155529575|NCT00968812|561363940|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
155529576|NCT00968812|561363938|FG000|Overall Study|Noncompliance with study drug|4|||
155529577|NCT00968812|561363939|FG001|Overall Study|Noncompliance with study drug|1|||
155529578|NCT00968812|561363940|FG002|Overall Study|Noncompliance with study drug|6|||
155529579|NCT00968812|561363938|FG000|Overall Study|Unable to take rescue therapy|12|||
155529580|NCT00968812|561363939|FG001|Overall Study|Unable to take rescue therapy|12|||
155529581|NCT00968812|561363940|FG002|Overall Study|Unable to take rescue therapy|17|||
155529582|NCT00968812|561363938|FG000|Overall Study|Other|25|||
155529583|NCT00968812|561363939|FG001|Overall Study|Other|37|||
155529584|NCT00968812|561363940|FG002|Overall Study|Other|40|||
155529585|NCT00609674|561363941|FG000|Overall Study|Adverse Event|1|||
155529586|NCT00609674|561363942|FG001|Overall Study|Adverse Event|1|||
155529587|NCT00609674|561363941|FG000|Overall Study|Protocol Violation|3|||
155529588|NCT00609674|561363942|FG001|Overall Study|Protocol Violation|5|||
155529589|NCT00609674|561363941|FG000|Overall Study|Lost to Follow-up|1|||
155529590|NCT00609674|561363942|FG001|Overall Study|Lost to Follow-up|0|||
155529591|NCT00609674|561363941|FG000|Overall Study|Withdrew consent|2|||
155529592|NCT00609674|561363942|FG001|Overall Study|Withdrew consent|1|||
155529593|NCT00571064|561363943|FG000|Overall Study|Adverse Event|13|||
155529594|NCT00571064|561363943|FG000|Overall Study|Protocol Violation|4|||
155529595|NCT00571064|561363943|FG000|Overall Study|Withdrawal by Subject|2|||
155529596|NCT00571064|561363943|FG000|Overall Study|Other|2|||
155529597|NCT03872128|561363954|FG000|Overall Study|Dropped out before treatment|1|||
155529598|NCT03872128|561363955|FG001|Overall Study|Dropped out before treatment|0|||
155529599|NCT03872128|561363956|FG002|Overall Study|Dropped out before treatment|4|||
155529600|NCT03872128|561363954|FG000|Overall Study|Lost to Follow-up|2|||
155529601|NCT03872128|561363955|FG001|Overall Study|Lost to Follow-up|5|||
155529602|NCT03872128|561363956|FG002|Overall Study|Lost to Follow-up|8|||
155529603|NCT00834431|561363964|FG000|First Intervention|Adverse Event|0|||
155529604|NCT00834431|561363965|FG001|First Intervention|Adverse Event|1|||
155529605|NCT00834431|561363964|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
155529606|NCT00834431|561363965|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155529607|NCT03637764|561363968|FG000|Overall Study|Adverse Event|2|||
155529608|NCT03637764|561363969|FG001|Overall Study|Adverse Event|0|||
155529609|NCT03637764|561363970|FG002|Overall Study|Adverse Event|0|||
155529610|NCT03637764|561363971|FG003|Overall Study|Adverse Event|1|||
155529611|NCT03637764|561363968|FG000|Overall Study|Progressive Disease|23|||
155529612|NCT03637764|561363969|FG001|Overall Study|Progressive Disease|23|||
155529613|NCT03637764|561363970|FG002|Overall Study|Progressive Disease|18|||
155529614|NCT03637764|561363971|FG003|Overall Study|Progressive Disease|31|||
155529615|NCT03637764|561363968|FG000|Overall Study|Withdrawal by Subject|1|||
155529616|NCT03637764|561363969|FG001|Overall Study|Withdrawal by Subject|3|||
155529617|NCT03637764|561363970|FG002|Overall Study|Withdrawal by Subject|0|||
155529618|NCT03637764|561363971|FG003|Overall Study|Withdrawal by Subject|1|||
155529619|NCT02689505|561363972|FG000|Overall Study|Progressive disease|2|||
155529620|NCT02689505|561363973|FG001|Overall Study|Progressive disease|2|||
155529621|NCT02689505|561363974|FG002|Overall Study|Progressive disease|3|||
155529622|NCT02689505|561363975|FG003|Overall Study|Progressive disease|9|||
155655106|NCT01051661|561830640|FG004|Overall Study|Withdrawal by Subject|12|||
155529623|NCT02689505|561363976|FG004|Overall Study|Progressive disease|1|||
155529624|NCT02689505|561363972|FG000|Overall Study|Dose Limiting Toxicity|0|||
155529625|NCT02689505|561363973|FG001|Overall Study|Dose Limiting Toxicity|1|||
155529626|NCT02689505|561363974|FG002|Overall Study|Dose Limiting Toxicity|0|||
155529627|NCT02689505|561363975|FG003|Overall Study|Dose Limiting Toxicity|0|||
155529628|NCT02689505|561363976|FG004|Overall Study|Dose Limiting Toxicity|2|||
155529629|NCT02689505|561363972|FG000|Overall Study|Other AE or clinical progression|0|||
155529630|NCT02689505|561363973|FG001|Overall Study|Other AE or clinical progression|2|||
155529631|NCT02689505|561363974|FG002|Overall Study|Other AE or clinical progression|0|||
155529632|NCT02689505|561363975|FG003|Overall Study|Other AE or clinical progression|2|||
155529633|NCT02689505|561363976|FG004|Overall Study|Other AE or clinical progression|0|||
155529634|NCT04108858|561363977|FG000|Overall Study|Adverse Event|1|||
155529635|NCT03663179|561363980|FG000|Overall Study|Withdrawal by Subject|2|||
155529636|NCT03663179|561363981|FG001|Overall Study|Withdrawal by Subject|0|||
155529637|NCT03663179|561363980|FG000|Overall Study|Lost to Follow-up|1|||
155529638|NCT03663179|561363981|FG001|Overall Study|Lost to Follow-up|1|||
155529639|NCT03663179|561363980|FG000|Overall Study|Revealed exclusionary condition|1|||
155529640|NCT03663179|561363981|FG001|Overall Study|Revealed exclusionary condition|0|||
155529641|NCT01615198|561363982|FG000|Overall Study|Withdrawal by Subject|5|||
155529642|NCT01615198|561363983|FG001|Overall Study|Withdrawal by Subject|5|||
155529643|NCT01615198|561363982|FG000|Overall Study|Protocol deviation|1|||
155529644|NCT01615198|561363983|FG001|Overall Study|Protocol deviation|1|||
155529645|NCT01615198|561363982|FG000|Overall Study|Physician Decision|5|||
155529646|NCT01615198|561363983|FG001|Overall Study|Physician Decision|1|||
155529647|NCT01615198|561363982|FG000|Overall Study|Lost to Follow-up|1|||
155529648|NCT01615198|561363983|FG001|Overall Study|Lost to Follow-up|1|||
155529649|NCT01615198|561363982|FG000|Overall Study|Lack of Efficacy|1|||
155529650|NCT01615198|561363983|FG001|Overall Study|Lack of Efficacy|6|||
155529651|NCT01615198|561363982|FG000|Overall Study|Adverse Event|11|||
155529652|NCT01615198|561363983|FG001|Overall Study|Adverse Event|5|||
155529653|NCT01686438|561363984|FG000|Overall Study|Lost to Follow-up|8|||
155529654|NCT01686438|561363985|FG001|Overall Study|Lost to Follow-up|9|||
155529655|NCT01686438|561363986|FG002|Overall Study|Lost to Follow-up|10|||
155529656|NCT01686438|561363984|FG000|Overall Study|Adverse Event|0|||
155529657|NCT01686438|561363985|FG001|Overall Study|Adverse Event|0|||
155529658|NCT01686438|561363986|FG002|Overall Study|Adverse Event|1|||
155529659|NCT01686438|561363984|FG000|Overall Study|Protocol Violation|0|||
155529660|NCT01686438|561363985|FG001|Overall Study|Protocol Violation|0|||
155529661|NCT01686438|561363986|FG002|Overall Study|Protocol Violation|1|||
155529662|NCT01686438|561363984|FG000|Overall Study|Withdrawal by Subject|0|||
155529663|NCT01686438|561363985|FG001|Overall Study|Withdrawal by Subject|0|||
155529664|NCT01686438|561363986|FG002|Overall Study|Withdrawal by Subject|1|||
155529665|NCT01864174|561363989|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
155529666|NCT01864174|561363990|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
155529667|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
155529668|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
155529669|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
155529670|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
155529671|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
155529672|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
155529673|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Death|1|||
155529674|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Death|0|||
155529675|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
155529676|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
155529677|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
155529678|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
155529679|NCT01864174|561363989|FG000|Double Blind - Compliant Randomized|Other|6|||
155529680|NCT01864174|561363990|FG001|Double Blind - Compliant Randomized|Other|10|||
155655107|NCT01051661|561830641|FG005|Overall Study|Withdrawal by Subject|34|||
155655108|NCT01681849|561830642|FG000|Overall Study|Protocol Violation|2|||
155655109|NCT01681849|561830643|FG001|Overall Study|Protocol Violation|0|||
155655110|NCT01681849|561830644|FG002|Overall Study|Protocol Violation|0|||
155655111|NCT01681849|561830642|FG000|Overall Study|Withdrawal by Subject|3|||
155655112|NCT01681849|561830643|FG001|Overall Study|Withdrawal by Subject|5|||
155655113|NCT01681849|561830644|FG002|Overall Study|Withdrawal by Subject|33|||
155655114|NCT01681849|561830642|FG000|Overall Study|Lost to Follow-up|3|||
155655115|NCT01681849|561830643|FG001|Overall Study|Lost to Follow-up|2|||
155655116|NCT01681849|561830644|FG002|Overall Study|Lost to Follow-up|6|||
155529681|NCT01864174|561363989|FG000|Off Treatment Follow-Up|Other|2|||
155529682|NCT01864174|561363990|FG001|Off Treatment Follow-Up|Other|0|||
155529683|NCT01864174|561363989|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
155529684|NCT01864174|561363990|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
155529685|NCT00468286|561363991|FG000|Overall Study|Adverse Event|1|||
155529686|NCT00468286|561363992|FG001|Overall Study|Adverse Event|6|||
155529687|NCT00468286|561363991|FG000|Overall Study|Protocol Violation|2|||
155529688|NCT00468286|561363992|FG001|Overall Study|Protocol Violation|2|||
155529689|NCT00468286|561363991|FG000|Overall Study|Withdrawal by Subject|4|||
155529690|NCT00468286|561363992|FG001|Overall Study|Withdrawal by Subject|3|||
155486774|NCT03702166|561203886|FG000|Overall Study|Lost to Follow-up|1|||
155486775|NCT03702166|561203886|FG000|Overall Study|Withdrawal by Subject|1|||
155486776|NCT01333865|561203887|FG000|Overall Study|Adverse Event|2|||
155486777|NCT00784836|561203891|FG000|Overall Study|Early Study Termination|3|||
155486778|NCT03417999|561203893|FG000|Overall Study|Withdrawal by Subject|1|||
155486779|NCT03417999|561203894|FG001|Overall Study|Withdrawal by Subject|0|||
155486780|NCT03417999|561203895|FG002|Overall Study|Withdrawal by Subject|0|||
155486781|NCT03417999|561203893|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
155486782|NCT03417999|561203894|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
155486783|NCT03417999|561203895|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
155486784|NCT03417999|561203893|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
155486785|NCT03417999|561203894|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
155486786|NCT03417999|561203895|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
155486787|NCT03417999|561203893|FG000|Overall Study|Inadequate study staff available to process samples|0|||
155486788|NCT03417999|561203894|FG001|Overall Study|Inadequate study staff available to process samples|0|||
155486789|NCT03417999|561203895|FG002|Overall Study|Inadequate study staff available to process samples|1|||
155486790|NCT02613910|561203896|FG000|Overall Study|Termination of study|1|||
155486791|NCT00695318|561203897|FG000|Overall Study|Lost to Follow-up|1|||
155486792|NCT00695318|561203898|FG001|Overall Study|Lost to Follow-up|0|||
155486793|NCT00695318|561203897|FG000|Overall Study|Withdrawal by Subject|2|||
155486794|NCT00695318|561203898|FG001|Overall Study|Withdrawal by Subject|0|||
155486795|NCT00695318|561203897|FG000|Overall Study|Death|1|||
155486796|NCT00695318|561203898|FG001|Overall Study|Death|1|||
155486797|NCT00695318|561203897|FG000|Overall Study|Study Terminated|1|||
155486798|NCT00695318|561203898|FG001|Overall Study|Study Terminated|0|||
155486799|NCT03726320|561205707|FG000|Overall Study|Lost to Follow-up|2|||
155486800|NCT03726320|561205708|FG001|Overall Study|Lost to Follow-up|4|||
155486801|NCT03726320|561205709|FG002|Overall Study|Lost to Follow-up|0|||
155486802|NCT03726320|561205707|FG000|Overall Study|Time Constraints|4|||
155486803|NCT03726320|561205708|FG001|Overall Study|Time Constraints|1|||
155486804|NCT03726320|561205709|FG002|Overall Study|Time Constraints|0|||
155486805|NCT03726320|561205707|FG000|Overall Study|Ineligible after enrollment|3|||
155486806|NCT03726320|561205708|FG001|Overall Study|Ineligible after enrollment|3|||
155486807|NCT03726320|561205709|FG002|Overall Study|Ineligible after enrollment|0|||
155486808|NCT03726320|561205707|FG000|Overall Study|Clinic / insurance issue|2|||
155486809|NCT03726320|561205708|FG001|Overall Study|Clinic / insurance issue|0|||
155486810|NCT03726320|561205709|FG002|Overall Study|Clinic / insurance issue|0|||
155486811|NCT03726320|561205707|FG000|Overall Study|Language barrier|1|||
155486812|NCT03726320|561205708|FG001|Overall Study|Language barrier|0|||
155486813|NCT03726320|561205709|FG002|Overall Study|Language barrier|0|||
155486814|NCT03726320|561205707|FG000|Overall Study|Provider left the clinic|0|||
155486815|NCT03726320|561205708|FG001|Overall Study|Provider left the clinic|0|||
155486816|NCT03726320|561205709|FG002|Overall Study|Provider left the clinic|1|||
155486817|NCT02028182|561205712|FG000|Overall Study|Protocol Violation|2|||
155486818|NCT01684930|561205715|FG000|Overall Study|Withdrawal by Subject|3|||
155486819|NCT01684930|561205716|FG001|Overall Study|Withdrawal by Subject|1|||
155486820|NCT01336647|561205717|FG000|Overall Study|Lost to Follow-up|4|||
155486821|NCT01336647|561205718|FG001|Overall Study|Lost to Follow-up|1|||
155486822|NCT01336647|561205719|FG002|Overall Study|Lost to Follow-up|3|||
155486823|NCT03808298|561205720|FG000|Overall Study|Adverse Event|3|||
155486824|NCT03808298|561205720|FG000|Overall Study|Physician Decision|1|||
155486825|NCT03808298|561205720|FG000|Overall Study|Withdrawal by Subject|1|||
155486826|NCT03808298|561205720|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
155486827|NCT01004822|561205721|FG000|Overall Study|Objective progression or relapse|3|||
155486828|NCT01004822|561205722|FG001|Overall Study|Objective progression or relapse|3|||
155486829|NCT01004822|561205723|FG002|Overall Study|Objective progression or relapse|0|||
155486830|NCT01004822|561205724|FG003|Overall Study|Objective progression or relapse|1|||
155486831|NCT01004822|561205725|FG004|Overall Study|Objective progression or relapse|2|||
155486832|NCT01004822|561205726|FG005|Overall Study|Objective progression or relapse|2|||
155486833|NCT01004822|561205727|FG006|Overall Study|Objective progression or relapse|1|||
155486834|NCT01004822|561205728|FG007|Overall Study|Objective progression or relapse|4|||
155486835|NCT01004822|561205721|FG000|Overall Study|Global deterioration of health status|0|||
155486836|NCT01004822|561205722|FG001|Overall Study|Global deterioration of health status|0|||
155655117|NCT04525183|561830648|FG000|Overall Study|Withdrawal by Subject|0|||
155655118|NCT04525183|561830649|FG001|Overall Study|Withdrawal by Subject|0|||
155655119|NCT04525183|561830650|FG002|Overall Study|Withdrawal by Subject|3|||
155655120|NCT04525183|561830648|FG000|Overall Study|Study non-compliance|0|||
155486837|NCT01004822|561205723|FG002|Overall Study|Global deterioration of health status|0|||
155486838|NCT01004822|561205724|FG003|Overall Study|Global deterioration of health status|1|||
155486839|NCT01004822|561205725|FG004|Overall Study|Global deterioration of health status|0|||
155486840|NCT01004822|561205726|FG005|Overall Study|Global deterioration of health status|0|||
155486841|NCT01004822|561205727|FG006|Overall Study|Global deterioration of health status|1|||
155486842|NCT01004822|561205728|FG007|Overall Study|Global deterioration of health status|0|||
155486843|NCT01004822|561205721|FG000|Overall Study|No longer willing to continue|0|||
155486844|NCT01004822|561205722|FG001|Overall Study|No longer willing to continue|0|||
155486845|NCT01004822|561205723|FG002|Overall Study|No longer willing to continue|0|||
155486846|NCT01004822|561205724|FG003|Overall Study|No longer willing to continue|1|||
155486847|NCT01004822|561205725|FG004|Overall Study|No longer willing to continue|2|||
155486848|NCT01004822|561205726|FG005|Overall Study|No longer willing to continue|1|||
155486849|NCT01004822|561205727|FG006|Overall Study|No longer willing to continue|1|||
155486850|NCT01004822|561205728|FG007|Overall Study|No longer willing to continue|0|||
155486851|NCT01004822|561205721|FG000|Overall Study|Adverse Event|0|||
155486852|NCT01004822|561205722|FG001|Overall Study|Adverse Event|0|||
155486853|NCT01004822|561205723|FG002|Overall Study|Adverse Event|0|||
155486854|NCT01004822|561205724|FG003|Overall Study|Adverse Event|0|||
155486855|NCT01004822|561205725|FG004|Overall Study|Adverse Event|0|||
155486856|NCT01004822|561205726|FG005|Overall Study|Adverse Event|0|||
155486857|NCT01004822|561205727|FG006|Overall Study|Adverse Event|1|||
155486858|NCT01004822|561205728|FG007|Overall Study|Adverse Event|1|||
155486859|NCT01004822|561205721|FG000|Overall Study|Other|0|||
155486860|NCT01004822|561205722|FG001|Overall Study|Other|0|||
155486861|NCT01004822|561205723|FG002|Overall Study|Other|4|||
155486862|NCT01004822|561205724|FG003|Overall Study|Other|1|||
155486863|NCT01004822|561205725|FG004|Overall Study|Other|0|||
155486864|NCT01004822|561205726|FG005|Overall Study|Other|1|||
155486865|NCT01004822|561205727|FG006|Overall Study|Other|0|||
155486866|NCT01004822|561205728|FG007|Overall Study|Other|0|||
155486867|NCT01858701|561205729|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
155486868|NCT01858701|561205730|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
155486869|NCT01858701|561205729|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
155486870|NCT01858701|561205730|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
155486871|NCT01858701|561205729|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
155486872|NCT01858701|561205730|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
155486873|NCT01858701|561205729|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
155486874|NCT01858701|561205730|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
155486875|NCT01674010|561205731|FG000|Open Treatment Phase 1|Adverse Event|10|||
155486876|NCT01674010|561205732|FG001|Open Treatment Phase 1|Adverse Event|0|||
155486877|NCT01674010|561205733|FG002|Open Treatment Phase 1|Adverse Event|0|||
155486878|NCT01674010|561205731|FG000|Open Treatment Phase 1|Death|1|||
155486879|NCT01674010|561205732|FG001|Open Treatment Phase 1|Death|0|||
155486880|NCT01674010|561205733|FG002|Open Treatment Phase 1|Death|0|||
155486881|NCT01674010|561205731|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
155486882|NCT01674010|561205732|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
155486883|NCT01674010|561205733|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
155486884|NCT01674010|561205731|FG000|Open Treatment Phase 1|Physician Decision|9|||
155486885|NCT01674010|561205732|FG001|Open Treatment Phase 1|Physician Decision|0|||
155486886|NCT01674010|561205733|FG002|Open Treatment Phase 1|Physician Decision|0|||
155486887|NCT01674010|561205731|FG000|Open Treatment Phase 1|Protocol Violation|7|||
155486888|NCT01674010|561205732|FG001|Open Treatment Phase 1|Protocol Violation|0|||
155486889|NCT01674010|561205733|FG002|Open Treatment Phase 1|Protocol Violation|0|||
155486890|NCT01674010|561205731|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
155486891|NCT01674010|561205732|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
155486892|NCT01674010|561205733|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
155486893|NCT01674010|561205731|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
155486894|NCT01674010|561205732|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
155486895|NCT01674010|561205733|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
155486896|NCT01674010|561205731|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
155486897|NCT01674010|561205732|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
155486898|NCT01674010|561205733|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
155486899|NCT01674010|561205731|FG000|Randomization Phase 2|Adverse Event|0|||
155486900|NCT01674010|561205732|FG001|Randomization Phase 2|Adverse Event|1|||
155486901|NCT01674010|561205733|FG002|Randomization Phase 2|Adverse Event|1|||
155486902|NCT01674010|561205731|FG000|Randomization Phase 2|Lost to Follow-up|0|||
155486903|NCT01674010|561205732|FG001|Randomization Phase 2|Lost to Follow-up|1|||
155486904|NCT01674010|561205733|FG002|Randomization Phase 2|Lost to Follow-up|2|||
155486905|NCT01674010|561205731|FG000|Randomization Phase 2|Mood episode recurrence|0|||
155486906|NCT01674010|561205732|FG001|Randomization Phase 2|Mood episode recurrence|8|||
155529691|NCT00468286|561363991|FG000|Overall Study|Physician Decision|0|||
155529692|NCT00468286|561363992|FG001|Overall Study|Physician Decision|1|||
155529693|NCT02453386|561363996|FG000|Overall Study|Adverse Event|22|||
155529694|NCT02453386|561363997|FG001|Overall Study|Adverse Event|30|||
155529695|NCT02453386|561363998|FG002|Overall Study|Adverse Event|15|||
155529696|NCT02453386|561363996|FG000|Overall Study|Protocol Violation|1|||
155529697|NCT02453386|561363997|FG001|Overall Study|Protocol Violation|0|||
155529698|NCT02453386|561363998|FG002|Overall Study|Protocol Violation|1|||
155529699|NCT02453386|561363996|FG000|Overall Study|Withdrawal by Subject|10|||
155529700|NCT02453386|561363997|FG001|Overall Study|Withdrawal by Subject|9|||
155529701|NCT02453386|561363998|FG002|Overall Study|Withdrawal by Subject|9|||
155529702|NCT02453386|561363996|FG000|Overall Study|Sponsor Terminated Study|14|||
155529703|NCT02453386|561363997|FG001|Overall Study|Sponsor Terminated Study|8|||
155529704|NCT02453386|561363998|FG002|Overall Study|Sponsor Terminated Study|11|||
155529705|NCT02453386|561363996|FG000|Overall Study|Subject Terminated by Sponsor|1|||
155529706|NCT02453386|561363997|FG001|Overall Study|Subject Terminated by Sponsor|1|||
155529707|NCT02453386|561363998|FG002|Overall Study|Subject Terminated by Sponsor|1|||
155529708|NCT02453386|561363996|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
155529709|NCT02453386|561363997|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
155529710|NCT02453386|561363998|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
155529711|NCT02453386|561363996|FG000|Overall Study|Lost to Follow-up|0|||
155529712|NCT02453386|561363997|FG001|Overall Study|Lost to Follow-up|0|||
155529713|NCT02453386|561363998|FG002|Overall Study|Lost to Follow-up|1|||
155529714|NCT02453386|561363996|FG000|Overall Study|Other|1|||
155529715|NCT02453386|561363997|FG001|Overall Study|Other|0|||
155529716|NCT02453386|561363998|FG002|Overall Study|Other|1|||
155529717|NCT02601625|561363999|FG000|Overall Study|Lost to Follow-up|0|||
155529718|NCT02601625|561364000|FG001|Overall Study|Lost to Follow-up|0|||
155529719|NCT02601625|561364001|FG002|Overall Study|Lost to Follow-up|1|||
155529720|NCT02601625|561364002|FG003|Overall Study|Lost to Follow-up|1|||
155529721|NCT01289262|561364005|FG000|Overall Study|Lost to Follow-up|29|||
155529722|NCT01289262|561364006|FG001|Overall Study|Lost to Follow-up|16|||
155529723|NCT01289262|561364005|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
155529724|NCT01289262|561364006|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
155529725|NCT00838279|561364009|FG000|Washout|Protocol Violation|1|||
155529726|NCT00838279|561364010|FG001|Washout|Protocol Violation|0|||
155529727|NCT00838279|561364009|FG000|Washout|Withdrawal by Subject|0|||
155529728|NCT00838279|561364010|FG001|Washout|Withdrawal by Subject|1|||
155529729|NCT04608188|561364011|FG000|Overall Study|Withdrawal by Subject|4|||
155529730|NCT04608188|561364012|FG001|Overall Study|Withdrawal by Subject|8|||
155529731|NCT01474551|561364016|FG000|Overall Study|Death|1|||
155529732|NCT01921062|561364017|FG000|Overall Study|Withdrawal by Subject|0|||
155529733|NCT01921062|561364018|FG001|Overall Study|Withdrawal by Subject|7|||
155529734|NCT01921062|561364017|FG000|Overall Study|Adverse Event|5|||
155529735|NCT01921062|561364018|FG001|Overall Study|Adverse Event|6|||
155529736|NCT01921062|561364017|FG000|Overall Study|Protocol Violation|0|||
155529737|NCT01921062|561364018|FG001|Overall Study|Protocol Violation|1|||
155529738|NCT01921062|561364017|FG000|Overall Study|VMIQ score > 72|4|||
155529739|NCT01921062|561364018|FG001|Overall Study|VMIQ score > 72|1|||
155529740|NCT01921062|561364017|FG000|Overall Study|Logistic error|0|||
155529741|NCT01921062|561364018|FG001|Overall Study|Logistic error|1|||
155529742|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
155529743|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
155529744|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
155529745|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
155529746|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
155529747|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
155529748|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
155529749|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
155529750|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
155529751|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
155529752|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
155529753|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
155529754|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
155529755|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
155529756|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
155529757|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
155529758|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
155529759|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
155529760|NCT01045161|561364019|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
155529761|NCT01045161|561364020|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
155529762|NCT01045161|561364021|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
155529763|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
155529764|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
155529765|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
155529766|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
155529767|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
155529768|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
155529769|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
155529770|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
155529771|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
155529772|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
155529773|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
155529774|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
155529775|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
155529776|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
155529777|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
155529778|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
155529779|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
155529780|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
155529781|NCT01045161|561364019|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
155529782|NCT01045161|561364020|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
155529783|NCT01045161|561364021|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
155529784|NCT01854047|561364022|FG000|Overall Study|Lack of Efficacy|1|||
155529785|NCT01854047|561364023|FG001|Overall Study|Lack of Efficacy|0|||
155529786|NCT01854047|561364024|FG002|Overall Study|Lack of Efficacy|0|||
155529787|NCT01854047|561364025|FG003|Overall Study|Lack of Efficacy|0|||
155529788|NCT01854047|561364026|FG004|Overall Study|Lack of Efficacy|0|||
155529789|NCT01854047|561364022|FG000|Overall Study|Poor compliance to protocol|3|||
155529790|NCT01854047|561364023|FG001|Overall Study|Poor compliance to protocol|0|||
155529791|NCT01854047|561364024|FG002|Overall Study|Poor compliance to protocol|2|||
155529792|NCT01854047|561364025|FG003|Overall Study|Poor compliance to protocol|0|||
155529793|NCT01854047|561364026|FG004|Overall Study|Poor compliance to protocol|0|||
155529794|NCT01854047|561364022|FG000|Overall Study|Adverse Event|5|||
155529795|NCT01854047|561364023|FG001|Overall Study|Adverse Event|4|||
155529796|NCT01854047|561364024|FG002|Overall Study|Adverse Event|6|||
155529797|NCT01854047|561364025|FG003|Overall Study|Adverse Event|10|||
155529798|NCT01854047|561364026|FG004|Overall Study|Adverse Event|7|||
155529799|NCT01854047|561364022|FG000|Overall Study|Randomized but not treated|0|||
155529800|NCT01854047|561364023|FG001|Overall Study|Randomized but not treated|1|||
155529801|NCT01854047|561364024|FG002|Overall Study|Randomized but not treated|2|||
155529802|NCT01854047|561364025|FG003|Overall Study|Randomized but not treated|0|||
155529803|NCT01854047|561364026|FG004|Overall Study|Randomized but not treated|4|||
155529804|NCT01854047|561364022|FG000|Overall Study|Other than specified above|3|||
155529805|NCT01854047|561364023|FG001|Overall Study|Other than specified above|3|||
155529806|NCT01854047|561364024|FG002|Overall Study|Other than specified above|3|||
155529807|NCT01854047|561364025|FG003|Overall Study|Other than specified above|5|||
155529808|NCT01854047|561364026|FG004|Overall Study|Other than specified above|8|||
155529809|NCT00773253|561364027|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
155529810|NCT00773253|561364028|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
155529811|NCT03173547|561364032|FG000|Overall Study|Adverse Event|2|||
155529812|NCT03173547|561364033|FG001|Overall Study|Adverse Event|0|||
155529813|NCT03173547|561364032|FG000|Overall Study|Withdrawal by Subject|2|||
155529814|NCT03173547|561364033|FG001|Overall Study|Withdrawal by Subject|2|||
155529815|NCT00657553|561364034|FG000|Overall Study|low accrual, no analysis run|5|||
155529816|NCT00657553|561364035|FG001|Overall Study|low accrual, no analysis run|5|||
155529817|NCT01169558|561364036|FG000|Overall Study|Disease progression|98|||
155529818|NCT01169558|561364036|FG000|Overall Study|Adverse Event|25|||
155529819|NCT01169558|561364036|FG000|Overall Study|Withdrawal of Consent|8|||
155529820|NCT01169558|561364036|FG000|Overall Study|Medical Decision|7|||
155529821|NCT01169558|561364036|FG000|Overall Study|Stable Disease|4|||
155529822|NCT01169558|561364036|FG000|Overall Study|Lost to Follow-up|4|||
155529823|NCT01169558|561364036|FG000|Overall Study|Need for Surgery|4|||
155529824|NCT01169558|561364036|FG000|Overall Study|Non-compliance|2|||
155529825|NCT01169558|561364036|FG000|Overall Study|Protocol Violation|2|||
155529826|NCT01169558|561364036|FG000|Overall Study|Partial response|2|||
155529827|NCT02911701|561364037|FG000|Overall Study|Withdrawal by Subject|2|||
155529828|NCT02911701|561364038|FG001|Overall Study|Withdrawal by Subject|4|||
155529829|NCT02911701|561364037|FG000|Overall Study|Adverse Event|1|||
155529830|NCT02911701|561364038|FG001|Overall Study|Adverse Event|0|||
155529831|NCT02409355|561364041|FG000|Overall Study|Withdrawal by Subject|1|||
155529832|NCT02409355|561364042|FG001|Overall Study|Withdrawal by Subject|0|||
155529833|NCT02409355|561364041|FG000|Overall Study|Death|1|||
155529834|NCT02409355|561364042|FG001|Overall Study|Death|1|||
155529835|NCT02409355|561364041|FG000|Overall Study|Study terminated by Sponsor|2|||
155529836|NCT02409355|561364042|FG001|Overall Study|Study terminated by Sponsor|3|||
155486907|NCT01674010|561205733|FG002|Randomization Phase 2|Mood episode recurrence|2|||
155486908|NCT01674010|561205731|FG000|Randomization Phase 2|Physician Decision|0|||
155486909|NCT01674010|561205732|FG001|Randomization Phase 2|Physician Decision|0|||
155486910|NCT01674010|561205733|FG002|Randomization Phase 2|Physician Decision|2|||
155486911|NCT01674010|561205731|FG000|Randomization Phase 2|Pregnancy|0|||
155486912|NCT01674010|561205732|FG001|Randomization Phase 2|Pregnancy|1|||
155486913|NCT01674010|561205733|FG002|Randomization Phase 2|Pregnancy|1|||
155486914|NCT01674010|561205731|FG000|Randomization Phase 2|Protocol Violation|0|||
155486915|NCT01674010|561205732|FG001|Randomization Phase 2|Protocol Violation|1|||
155486916|NCT01674010|561205733|FG002|Randomization Phase 2|Protocol Violation|1|||
155486917|NCT01674010|561205731|FG000|Randomization Phase 2|Sponsor Decision|0|||
155486918|NCT01674010|561205732|FG001|Randomization Phase 2|Sponsor Decision|42|||
155486919|NCT01674010|561205733|FG002|Randomization Phase 2|Sponsor Decision|45|||
155486920|NCT01674010|561205731|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
155486921|NCT01674010|561205732|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
155486922|NCT01674010|561205733|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
155486923|NCT01801475|561205740|FG000|Overall Study|Withdrawal by Subject|0|||
155486924|NCT01801475|561205741|FG001|Overall Study|Withdrawal by Subject|0|||
155486925|NCT01801475|561205742|FG002|Overall Study|Withdrawal by Subject|0|||
155486926|NCT01801475|561205743|FG003|Overall Study|Withdrawal by Subject|0|||
155486927|NCT01801475|561205744|FG004|Overall Study|Withdrawal by Subject|1|||
155486928|NCT01786707|561205747|FG000|Overall Study|Lost to Follow-up|1|||
155486929|NCT01786707|561205748|FG001|Overall Study|Lost to Follow-up|1|||
155486930|NCT00346775|561205755|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
155486931|NCT00346775|561205756|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
155486932|NCT00346775|561205755|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
155486933|NCT00346775|561205756|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
155486934|NCT00346775|561205755|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
155486935|NCT00346775|561205756|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
155486936|NCT02946515|561205757|FG000|Overall Study|Lost to Follow-up|2|||
155486937|NCT02946515|561205758|FG001|Overall Study|Lost to Follow-up|1|||
155486938|NCT01096017|561205765|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
155486939|NCT01096017|561205766|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
155486940|NCT02600559|561205767|FG000|Overall Study|Withdrawal by Subject|3|||
155486941|NCT02600559|561205767|FG000|Overall Study|Lost to Follow-up|20|||
155486942|NCT00594958|561205771|FG000|Overall Study|Withdrawal by Subject|1|||
155486943|NCT00594958|561205772|FG001|Overall Study|Withdrawal by Subject|0|||
155486944|NCT00594958|561205773|FG002|Overall Study|Withdrawal by Subject|1|||
155486945|NCT00594958|561205771|FG000|Overall Study|Adverse Event|4|||
155486946|NCT00594958|561205772|FG001|Overall Study|Adverse Event|1|||
155486947|NCT00594958|561205773|FG002|Overall Study|Adverse Event|2|||
155486948|NCT00594958|561205771|FG000|Overall Study|Pregnancy|0|||
155486949|NCT00594958|561205772|FG001|Overall Study|Pregnancy|2|||
155486950|NCT00594958|561205773|FG002|Overall Study|Pregnancy|0|||
155486951|NCT00594958|561205771|FG000|Overall Study|Protocol Violation|1|||
155486952|NCT00594958|561205772|FG001|Overall Study|Protocol Violation|0|||
155486953|NCT00594958|561205773|FG002|Overall Study|Protocol Violation|2|||
155486954|NCT00594958|561205771|FG000|Overall Study|Lost to Follow-up|5|||
155486955|NCT00594958|561205772|FG001|Overall Study|Lost to Follow-up|0|||
155486956|NCT00594958|561205773|FG002|Overall Study|Lost to Follow-up|3|||
155486957|NCT00594958|561205771|FG000|Overall Study|administrative|3|||
155486958|NCT00594958|561205772|FG001|Overall Study|administrative|0|||
155486959|NCT00594958|561205773|FG002|Overall Study|administrative|2|||
155486960|NCT00408408|561205781|FG000|Overall Study|No follow up data|2|||
155486961|NCT00408408|561205782|FG001|Overall Study|No follow up data|3|||
155486962|NCT00408408|561205783|FG002|Overall Study|No follow up data|0|||
155486963|NCT00408408|561205784|FG003|Overall Study|No follow up data|7|||
155486964|NCT00408408|561205785|FG004|Overall Study|No follow up data|5|||
155486965|NCT00408408|561205786|FG005|Overall Study|No follow up data|3|||
155486966|NCT00917553|561205787|FG000|Overall Study|Lost to Follow-up|2|||
155486967|NCT00917553|561205788|FG001|Overall Study|Lost to Follow-up|1|||
155486968|NCT03172026|561205790|FG000|Overall Study|Withdrawal by Subject|1|||
155486969|NCT03172026|561205791|FG001|Overall Study|Withdrawal by Subject|0|||
155486970|NCT03172026|561205790|FG000|Overall Study|COVID restrictions|1|||
155486971|NCT03172026|561205791|FG001|Overall Study|COVID restrictions|0|||
155486972|NCT01177943|561205792|FG000|First Intervention|Withdrawal by Subject|2|||
155486973|NCT01177943|561205793|FG001|First Intervention|Withdrawal by Subject|0|||
155486974|NCT00779142|561205795|FG000|Overall Study|Screen Failures|3|||
155486975|NCT01303159|561205799|FG000|Overall Study|Death|16|||
155486976|NCT01303159|561205799|FG000|Overall Study|Study Termination|7|||
155486977|NCT00496782|561205800|FG000|Overall Study|Protocol Violation|1|||
155486978|NCT00496782|561205801|FG001|Overall Study|Protocol Violation|2|||
155486979|NCT01288911|561205802|FG000|Double-blind Period|Death|11|||
155486980|NCT01288911|561205803|FG001|Double-blind Period|Death|7|||
155486981|NCT01288911|561205802|FG000|Double-blind Period|Lost to Follow-up|0|||
155486982|NCT01288911|561205803|FG001|Double-blind Period|Lost to Follow-up|2|||
155486983|NCT01288911|561205802|FG000|Double-blind Period|Progressive Disease|75|||
155486984|NCT01288911|561205803|FG001|Double-blind Period|Progressive Disease|103|||
155486985|NCT01288911|561205802|FG000|Double-blind Period|Protocol Violation|1|||
155486986|NCT01288911|561205803|FG001|Double-blind Period|Protocol Violation|0|||
155486987|NCT01288911|561205802|FG000|Double-blind Period|Withdrawal by Subject|25|||
155486988|NCT01288911|561205803|FG001|Double-blind Period|Withdrawal by Subject|26|||
155486989|NCT01288911|561205802|FG000|Double-blind Period|Miscellaneous Reason|29|||
155486990|NCT01288911|561205803|FG001|Double-blind Period|Miscellaneous Reason|42|||
155486991|NCT01288911|561205802|FG000|Double-blind Period|Randomized but never received study drug|1|||
155486992|NCT01288911|561205803|FG001|Double-blind Period|Randomized but never received study drug|2|||
155486993|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Death|0|||
155486994|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Death|1|||
155486995|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
155486996|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
155486997|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
155486998|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
155486999|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
155487000|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
155487001|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
155487002|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
155487003|NCT01288911|561205802|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
155487004|NCT01288911|561205803|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
155487005|NCT01632345|561205804|FG000|Treatment: Part I|Adverse Event|1|||
155487006|NCT01632345|561205805|FG001|Treatment: Part I|Adverse Event|4|||
155487007|NCT01632345|561205806|FG002|Treatment: Part I|Adverse Event|2|||
155487008|NCT01632345|561205807|FG003|Treatment: Part I|Adverse Event|1|||
155487009|NCT01632345|561205808|FG004|Treatment: Part I|Adverse Event|3|||
155487010|NCT01632345|561205809|FG005|Treatment: Part I|Adverse Event|0|||
155487011|NCT01632345|561205810|FG006|Treatment: Part I|Adverse Event|0|||
155487012|NCT01632345|561205804|FG000|Treatment: Part I|Lack of Efficacy|0|||
155487013|NCT01632345|561205805|FG001|Treatment: Part I|Lack of Efficacy|1|||
155487014|NCT01632345|561205806|FG002|Treatment: Part I|Lack of Efficacy|0|||
155487015|NCT01632345|561205807|FG003|Treatment: Part I|Lack of Efficacy|1|||
155487016|NCT01632345|561205808|FG004|Treatment: Part I|Lack of Efficacy|1|||
155487017|NCT01632345|561205809|FG005|Treatment: Part I|Lack of Efficacy|0|||
155487018|NCT01632345|561205810|FG006|Treatment: Part I|Lack of Efficacy|0|||
155487019|NCT01632345|561205804|FG000|Treatment: Part I|Lost to Follow-up|3|||
155487020|NCT01632345|561205805|FG001|Treatment: Part I|Lost to Follow-up|2|||
155487021|NCT01632345|561205806|FG002|Treatment: Part I|Lost to Follow-up|1|||
155487022|NCT01632345|561205807|FG003|Treatment: Part I|Lost to Follow-up|3|||
155487023|NCT01632345|561205808|FG004|Treatment: Part I|Lost to Follow-up|4|||
155487024|NCT01632345|561205809|FG005|Treatment: Part I|Lost to Follow-up|0|||
155487025|NCT01632345|561205810|FG006|Treatment: Part I|Lost to Follow-up|0|||
155487026|NCT01632345|561205804|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
155487027|NCT01632345|561205805|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
155487028|NCT01632345|561205806|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
155487029|NCT01632345|561205807|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
155487030|NCT01632345|561205808|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
155487031|NCT01632345|561205809|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
155487032|NCT01632345|561205810|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
155487033|NCT01632345|561205804|FG000|Treatment: Part I|Physician Decision|2|||
155487034|NCT01632345|561205805|FG001|Treatment: Part I|Physician Decision|1|||
155487035|NCT01632345|561205806|FG002|Treatment: Part I|Physician Decision|0|||
155487036|NCT01632345|561205807|FG003|Treatment: Part I|Physician Decision|0|||
155487037|NCT01632345|561205808|FG004|Treatment: Part I|Physician Decision|1|||
155487038|NCT01632345|561205809|FG005|Treatment: Part I|Physician Decision|0|||
155529837|NCT03134222|561364043|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
155529838|NCT03134222|561364044|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
155529839|NCT03134222|561364045|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
155529840|NCT03134222|561364046|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
155529841|NCT03134222|561364047|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
155529842|NCT03134222|561364043|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
155529843|NCT03134222|561364044|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
155529844|NCT03134222|561364045|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
155529845|NCT03134222|561364046|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
155529846|NCT03134222|561364047|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
155529847|NCT03134222|561364043|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
155529848|NCT03134222|561364044|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
155529849|NCT03134222|561364045|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
155529850|NCT03134222|561364046|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
155529851|NCT03134222|561364047|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
155529852|NCT03134222|561364043|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
155529853|NCT03134222|561364044|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
155529854|NCT03134222|561364045|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
155529855|NCT03134222|561364046|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
155529856|NCT03134222|561364047|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
155529857|NCT03134222|561364043|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
155529858|NCT03134222|561364044|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
155529859|NCT03134222|561364045|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
155529860|NCT03134222|561364046|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
155529861|NCT03134222|561364047|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
155529862|NCT03134222|561364043|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
155529863|NCT03134222|561364044|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
155529864|NCT03134222|561364045|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
155529865|NCT03134222|561364046|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
155529866|NCT03134222|561364047|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
155529867|NCT03134222|561364043|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
155529868|NCT03134222|561364044|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
155529869|NCT03134222|561364045|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
155529870|NCT03134222|561364046|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
155529871|NCT03134222|561364047|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
155529872|NCT03134222|561364043|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
155529873|NCT03134222|561364044|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
155529874|NCT03134222|561364045|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
155529875|NCT03134222|561364046|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
155529876|NCT03134222|561364047|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
155529877|NCT03482882|561364048|FG000|Overall Study|Adverse Event|3|||
155529878|NCT03482882|561364048|FG000|Overall Study|Lost to Follow-up|1|||
155529879|NCT03482882|561364048|FG000|Overall Study|Protocol Violation|2|||
155529880|NCT03482882|561364048|FG000|Overall Study|Not further specified|1|||
155529881|NCT01110005|561364051|FG000|Overall Study|ineligible|1|||
155529882|NCT01110005|561364052|FG001|Overall Study|ineligible|2|||
155529883|NCT01110005|561364051|FG000|Overall Study|missing consent|3|||
155529884|NCT01110005|561364052|FG001|Overall Study|missing consent|2|||
155529885|NCT01110005|561364051|FG000|Overall Study|Withdrawal by Subject|0|||
155529886|NCT01110005|561364052|FG001|Overall Study|Withdrawal by Subject|1|||
155529887|NCT02957942|561364053|FG000|Overall Study|Withdrawal by Subject|0|||
155529888|NCT02957942|561364054|FG001|Overall Study|Withdrawal by Subject|1|||
155529889|NCT02957942|561364053|FG000|Overall Study|Practicing experiment protocol|0|||
155529890|NCT02957942|561364054|FG001|Overall Study|Practicing experiment protocol|6|||
155529891|NCT04611789|561364057|FG000|Overall Study|Lost to Follow-up|1|||
155529892|NCT04611789|561364058|FG001|Overall Study|Lost to Follow-up|0|||
155529893|NCT04611789|561364059|FG002|Overall Study|Lost to Follow-up|0|||
155529894|NCT02820350|561364062|FG000|Overall Study|Withdrawal by Subject|3|||
155529895|NCT02820350|561364062|FG000|Overall Study|Death|4|||
155529896|NCT03801707|561364063|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
155529897|NCT05265624|561365836|FG000|Overall Study|Lost to Follow-up|3|||
155529898|NCT05265624|561365837|FG001|Overall Study|Lost to Follow-up|0|||
155529899|NCT05265624|561365836|FG000|Overall Study|Withdrawal by Subject|1|||
155529900|NCT05265624|561365837|FG001|Overall Study|Withdrawal by Subject|0|||
155529901|NCT00001703|561365838|FG000|Overall Study|progressed disease|2|||
155529902|NCT00001703|561365838|FG000|Overall Study|No evidence of disease|1|||
155529903|NCT00001703|561365838|FG000|Overall Study|recurrent disease|2|||
155529904|NCT02286739|561365843|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
155529905|NCT02286739|561365844|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
155529906|NCT02286739|561365843|FG000|Overall Study|No Verasense type documented|0|||
155529907|NCT02286739|561365844|FG001|Overall Study|No Verasense type documented|23|||
155529908|NCT02286739|561365843|FG000|Overall Study|Adverse Event|1|||
155529909|NCT02286739|561365844|FG001|Overall Study|Adverse Event|2|||
155529910|NCT02286739|561365843|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
155529911|NCT02286739|561365844|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
155529912|NCT00834795|561365845|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
155529913|NCT00834795|561365846|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
155529914|NCT00834795|561365845|FG000|Second Intervention|Adverse Event|1|||
155529915|NCT00834795|561365846|FG001|Second Intervention|Adverse Event|0|||
155529916|NCT02057835|561365853|FG000|Overall Study|Withdrawal by Subject|0|||
155529917|NCT02057835|561365854|FG001|Overall Study|Withdrawal by Subject|2|||
155529918|NCT02057835|561365855|FG002|Overall Study|Withdrawal by Subject|0|||
155529919|NCT02057835|561365856|FG003|Overall Study|Withdrawal by Subject|0|||
155529920|NCT02057835|561365857|FG004|Overall Study|Withdrawal by Subject|0|||
155529921|NCT02057835|561365858|FG005|Overall Study|Withdrawal by Subject|0|||
155529922|NCT02057835|561365859|FG006|Overall Study|Withdrawal by Subject|0|||
155529923|NCT02057835|561365860|FG007|Overall Study|Withdrawal by Subject|0|||
155529924|NCT02057835|561365861|FG008|Overall Study|Withdrawal by Subject|0|||
155529925|NCT02057835|561365862|FG009|Overall Study|Withdrawal by Subject|0|||
155529926|NCT00834717|561365863|FG000|First Intervention|Adverse Event|1|||
155529927|NCT00834717|561365864|FG001|First Intervention|Adverse Event|0|||
155529928|NCT00834717|561365863|FG000|First Intervention|Withdrawal by Subject|0|||
155529929|NCT00834717|561365864|FG001|First Intervention|Withdrawal by Subject|1|||
155529930|NCT02222818|561365865|FG000|Period 1|Eligibility criteria not met|0|||
155529931|NCT02222818|561365866|FG001|Period 1|Eligibility criteria not met|3|||
155529932|NCT06284525|561365868|FG000|Overall Study|Withdrawal by Subject|1|||
155529933|NCT02149420|561365869|FG000|Core Study|Administrative problems|0|||
155529934|NCT02149420|561365870|FG001|Core Study|Administrative problems|1|||
155529935|NCT02149420|561365871|FG002|Core Study|Administrative problems|2|||
155529936|NCT02149420|561365869|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
155529937|NCT02149420|561365870|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
155529938|NCT02149420|561365871|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
155529939|NCT00834067|561365874|FG000|Washout of 21 Days|Protocol Violation|0|||
155529940|NCT00834067|561365875|FG001|Washout of 21 Days|Protocol Violation|1|||
155655121|NCT04525183|561830649|FG001|Overall Study|Study non-compliance|0|||
155655122|NCT04525183|561830650|FG002|Overall Study|Study non-compliance|1|||
155655123|NCT04525183|561830648|FG000|Overall Study|Recurrent disease before starting on study|0|||
155655124|NCT04525183|561830649|FG001|Overall Study|Recurrent disease before starting on study|0|||
155655125|NCT04525183|561830650|FG002|Overall Study|Recurrent disease before starting on study|1|||
155655126|NCT05142306|561830652|FG000|Overall Study|Withdrawal by Subject|0|||
155529941|NCT00440518|561365876|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
155529942|NCT00440518|561365877|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
155529943|NCT00440518|561365878|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
155529944|NCT00440518|561365876|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
155529945|NCT00440518|561365877|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
155529946|NCT00440518|561365878|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
155529947|NCT00440518|561365876|FG000|Randomized /Titration Period|Protocol Deviation|1|||
155529948|NCT00440518|561365877|FG001|Randomized /Titration Period|Protocol Deviation|0|||
155655127|NCT05142306|561830653|FG001|Overall Study|Withdrawal by Subject|0|||
155529949|NCT00440518|561365878|FG002|Randomized /Titration Period|Protocol Deviation|0|||
155529950|NCT00440518|561365876|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
155529951|NCT00440518|561365877|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
155529952|NCT00440518|561365878|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
155529953|NCT00440518|561365876|FG000|Randomized /Titration Period|Other|1|||
155529954|NCT00440518|561365877|FG001|Randomized /Titration Period|Other|0|||
155529955|NCT00440518|561365878|FG002|Randomized /Titration Period|Other|0|||
155529956|NCT00440518|561365876|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
155529957|NCT00440518|561365877|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
155529958|NCT00440518|561365878|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
155529959|NCT00440518|561365876|FG000|Randomized /Titration Period|Adverse Event|2|||
155529960|NCT00440518|561365877|FG001|Randomized /Titration Period|Adverse Event|3|||
155529961|NCT00440518|561365878|FG002|Randomized /Titration Period|Adverse Event|0|||
155529962|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
155529963|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
155529964|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
155529965|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
155529966|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
155529967|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
155529968|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
155529969|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
155529970|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
155529971|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
155529972|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
155529973|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
155529974|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
155529975|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
155529976|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
155529977|NCT00440518|561365876|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
155529978|NCT00440518|561365877|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
155529979|NCT00440518|561365878|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
155529980|NCT00561015|561365879|FG000|Overall Study|Adverse Event|0|||
155529981|NCT00561015|561365880|FG001|Overall Study|Adverse Event|0|||
155529982|NCT00561015|561365881|FG002|Overall Study|Adverse Event|0|||
155529983|NCT00561015|561365882|FG003|Overall Study|Adverse Event|0|||
155529984|NCT00561015|561365883|FG004|Overall Study|Adverse Event|1|||
155529985|NCT00561015|561365884|FG005|Overall Study|Adverse Event|0|||
155529986|NCT00561015|561365879|FG000|Overall Study|Lost to Follow-up|2|||
155529987|NCT00561015|561365880|FG001|Overall Study|Lost to Follow-up|0|||
155529988|NCT00561015|561365881|FG002|Overall Study|Lost to Follow-up|0|||
155529989|NCT00561015|561365882|FG003|Overall Study|Lost to Follow-up|1|||
155529990|NCT00561015|561365883|FG004|Overall Study|Lost to Follow-up|0|||
155529991|NCT00561015|561365884|FG005|Overall Study|Lost to Follow-up|3|||
155529992|NCT00561015|561365879|FG000|Overall Study|Participant non-compliance|2|||
155529993|NCT00561015|561365880|FG001|Overall Study|Participant non-compliance|0|||
155529994|NCT00561015|561365881|FG002|Overall Study|Participant non-compliance|0|||
155529995|NCT00561015|561365882|FG003|Overall Study|Participant non-compliance|0|||
155529996|NCT00561015|561365883|FG004|Overall Study|Participant non-compliance|0|||
155529997|NCT00561015|561365884|FG005|Overall Study|Participant non-compliance|0|||
155529998|NCT03616535|561365885|FG000|Overall Study|Death|2|||
155529999|NCT03616535|561365886|FG001|Overall Study|Death|0|||
155530000|NCT03616535|561365887|FG002|Overall Study|Death|0|||
155530001|NCT03616535|561365888|FG003|Overall Study|Death|1|||
155530002|NCT03616535|561365885|FG000|Overall Study|Lost to Follow-up|2|||
155530003|NCT03616535|561365886|FG001|Overall Study|Lost to Follow-up|1|||
155530004|NCT03616535|561365887|FG002|Overall Study|Lost to Follow-up|0|||
155530005|NCT03616535|561365888|FG003|Overall Study|Lost to Follow-up|2|||
155530006|NCT03616535|561365885|FG000|Overall Study|Withdrawal by Subject|1|||
155530007|NCT03616535|561365886|FG001|Overall Study|Withdrawal by Subject|2|||
155530008|NCT03616535|561365887|FG002|Overall Study|Withdrawal by Subject|5|||
155530009|NCT03616535|561365888|FG003|Overall Study|Withdrawal by Subject|1|||
155530010|NCT03616535|561365885|FG000|Overall Study|Not specified or change in eligibility|2|||
155530011|NCT03616535|561365886|FG001|Overall Study|Not specified or change in eligibility|3|||
155530012|NCT03616535|561365887|FG002|Overall Study|Not specified or change in eligibility|3|||
155530013|NCT03616535|561365888|FG003|Overall Study|Not specified or change in eligibility|1|||
155530014|NCT03086460|561365891|FG000|Study Participants|Lost to Follow-up|2|||
155655128|NCT05142306|561830654|FG002|Overall Study|Withdrawal by Subject|1|||
155530015|NCT03086460|561365891|FG000|Study Participants|Protocol Violation|1|||
155530016|NCT03086460|561365891|FG000|Study Participants|Withdrawal by Subject|6|||
155530017|NCT03086460|561365891|FG000|Treatment A|Lost to Follow-up|1|||
155530018|NCT03086460|561365891|FG000|Treatment A|Protocol Violation|1|||
155530019|NCT03086460|561365891|FG000|Treatment A|Withdrawal by Subject|2|||
155530020|NCT03086460|561365891|FG000|Treatment C|Withdrawal by Subject|2|||
155530021|NCT03086460|561365891|FG000|Treatment E|Lost to Follow-up|1|||
155530022|NCT03086460|561365891|FG000|Treatment E|Withdrawal by Subject|3|||
155530023|NCT02436005|561365892|FG000|Second Intervention|Adverse Event|0|||
155530024|NCT02436005|561365893|FG001|Second Intervention|Adverse Event|1|||
155530025|NCT00804856|561365896|FG000|Overall Study|Progressive Disease|3|||
155530026|NCT00804856|561365897|FG001|Overall Study|Progressive Disease|2|||
155530027|NCT00804856|561365898|FG002|Overall Study|Progressive Disease|4|||
155530028|NCT00804856|561365899|FG003|Overall Study|Progressive Disease|6|||
155530029|NCT00804856|561365900|FG004|Overall Study|Progressive Disease|4|||
155530030|NCT00804856|561365901|FG005|Overall Study|Progressive Disease|1|||
155530031|NCT00804856|561365902|FG006|Overall Study|Progressive Disease|8|||
155530032|NCT00804856|561365903|FG007|Overall Study|Progressive Disease|2|||
155530033|NCT00804856|561365904|FG008|Overall Study|Progressive Disease|4|||
155530034|NCT00804856|561365905|FG009|Overall Study|Progressive Disease|5|||
155530035|NCT00804856|561365906|FG010|Overall Study|Progressive Disease|12|||
155530036|NCT00804856|561365907|FG011|Overall Study|Progressive Disease|2|||
155530037|NCT00804856|561365908|FG012|Overall Study|Progressive Disease|2|||
155530038|NCT00804856|561365909|FG013|Overall Study|Progressive Disease|26|||
155530039|NCT00804856|561365910|FG014|Overall Study|Progressive Disease|20|||
155530040|NCT00804856|561365896|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530041|NCT00804856|561365897|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530042|NCT00804856|561365898|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530043|NCT00804856|561365899|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530044|NCT00804856|561365900|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155530045|NCT00804856|561365901|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530046|NCT00804856|561365902|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530047|NCT00804856|561365903|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530048|NCT00804856|561365904|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530049|NCT00804856|561365905|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530050|NCT00804856|561365906|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530051|NCT00804856|561365907|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530052|NCT00804856|561365908|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530053|NCT00804856|561365909|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155530054|NCT00804856|561365910|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155530055|NCT00804856|561365896|FG000|Overall Study|Other Adverse Event|1|||
155530056|NCT00804856|561365897|FG001|Overall Study|Other Adverse Event|1|||
155530057|NCT00804856|561365898|FG002|Overall Study|Other Adverse Event|1|||
155530058|NCT00804856|561365899|FG003|Overall Study|Other Adverse Event|2|||
155530059|NCT00804856|561365900|FG004|Overall Study|Other Adverse Event|2|||
155530060|NCT00804856|561365901|FG005|Overall Study|Other Adverse Event|1|||
155530061|NCT00804856|561365902|FG006|Overall Study|Other Adverse Event|3|||
155530062|NCT00804856|561365903|FG007|Overall Study|Other Adverse Event|0|||
155530063|NCT00804856|561365904|FG008|Overall Study|Other Adverse Event|0|||
155530064|NCT00804856|561365905|FG009|Overall Study|Other Adverse Event|1|||
155530065|NCT00804856|561365906|FG010|Overall Study|Other Adverse Event|5|||
155530066|NCT00804856|561365907|FG011|Overall Study|Other Adverse Event|2|||
155530067|NCT00804856|561365908|FG012|Overall Study|Other Adverse Event|0|||
155530068|NCT00804856|561365909|FG013|Overall Study|Other Adverse Event|6|||
155530069|NCT00804856|561365910|FG014|Overall Study|Other Adverse Event|13|||
155530070|NCT00804856|561365896|FG000|Overall Study|Non compliance with protocol|0|||
155530071|NCT00804856|561365897|FG001|Overall Study|Non compliance with protocol|0|||
155530072|NCT00804856|561365898|FG002|Overall Study|Non compliance with protocol|0|||
155530073|NCT00804856|561365899|FG003|Overall Study|Non compliance with protocol|0|||
155530074|NCT00804856|561365900|FG004|Overall Study|Non compliance with protocol|0|||
155530075|NCT00804856|561365901|FG005|Overall Study|Non compliance with protocol|0|||
155530076|NCT00804856|561365902|FG006|Overall Study|Non compliance with protocol|0|||
155530077|NCT00804856|561365903|FG007|Overall Study|Non compliance with protocol|0|||
155530078|NCT00804856|561365904|FG008|Overall Study|Non compliance with protocol|0|||
155530079|NCT00804856|561365905|FG009|Overall Study|Non compliance with protocol|0|||
155530080|NCT00804856|561365906|FG010|Overall Study|Non compliance with protocol|0|||
155530081|NCT00804856|561365907|FG011|Overall Study|Non compliance with protocol|0|||
155530082|NCT00804856|561365908|FG012|Overall Study|Non compliance with protocol|0|||
155530083|NCT00804856|561365909|FG013|Overall Study|Non compliance with protocol|2|||
155530084|NCT00804856|561365910|FG014|Overall Study|Non compliance with protocol|0|||
155530085|NCT00804856|561365896|FG000|Overall Study|Refused to continue medication|0|||
155530086|NCT00804856|561365897|FG001|Overall Study|Refused to continue medication|0|||
155530087|NCT00804856|561365898|FG002|Overall Study|Refused to continue medication|0|||
155530088|NCT00804856|561365899|FG003|Overall Study|Refused to continue medication|1|||
155530089|NCT00804856|561365900|FG004|Overall Study|Refused to continue medication|1|||
155530090|NCT00804856|561365901|FG005|Overall Study|Refused to continue medication|0|||
155530091|NCT00804856|561365902|FG006|Overall Study|Refused to continue medication|0|||
155530092|NCT00804856|561365903|FG007|Overall Study|Refused to continue medication|0|||
155530093|NCT00804856|561365904|FG008|Overall Study|Refused to continue medication|0|||
155530094|NCT00804856|561365905|FG009|Overall Study|Refused to continue medication|0|||
155530095|NCT00804856|561365906|FG010|Overall Study|Refused to continue medication|3|||
155530096|NCT00804856|561365907|FG011|Overall Study|Refused to continue medication|0|||
155530097|NCT00804856|561365908|FG012|Overall Study|Refused to continue medication|1|||
155530098|NCT00804856|561365909|FG013|Overall Study|Refused to continue medication|1|||
155530099|NCT00804856|561365910|FG014|Overall Study|Refused to continue medication|5|||
155530100|NCT00804856|561365896|FG000|Overall Study|Other reason than listed above|0|||
155530101|NCT00804856|561365897|FG001|Overall Study|Other reason than listed above|0|||
155530102|NCT00804856|561365898|FG002|Overall Study|Other reason than listed above|0|||
155530103|NCT00804856|561365899|FG003|Overall Study|Other reason than listed above|0|||
155530104|NCT00804856|561365900|FG004|Overall Study|Other reason than listed above|0|||
155530105|NCT00804856|561365901|FG005|Overall Study|Other reason than listed above|1|||
155655129|NCT04042311|561830661|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
155655130|NCT04042311|561830661|FG000|Overall Study|Unable to tolerate|4|||
155655131|NCT04042311|561830661|FG000|Overall Study|Concurrent illness|2|||
155530106|NCT00804856|561365902|FG006|Overall Study|Other reason than listed above|0|||
155530107|NCT00804856|561365903|FG007|Overall Study|Other reason than listed above|0|||
155530108|NCT00804856|561365904|FG008|Overall Study|Other reason than listed above|1|||
155530109|NCT00804856|561365905|FG009|Overall Study|Other reason than listed above|0|||
155530110|NCT00804856|561365906|FG010|Overall Study|Other reason than listed above|3|||
155530111|NCT00804856|561365907|FG011|Overall Study|Other reason than listed above|1|||
155530112|NCT00804856|561365908|FG012|Overall Study|Other reason than listed above|1|||
155655132|NCT04042311|561830661|FG000|Overall Study|Adverse Event|2|||
155530113|NCT00804856|561365909|FG013|Overall Study|Other reason than listed above|10|||
155530114|NCT00804856|561365910|FG014|Overall Study|Other reason than listed above|3|||
155530115|NCT04994535|561365911|FG000|Overall Study|Lost to Follow-up|7|||
155530116|NCT04994535|561365912|FG001|Overall Study|Lost to Follow-up|7|||
155530117|NCT04994535|561365911|FG000|Overall Study|Withdrawal by Subject|10|||
155530118|NCT04994535|561365912|FG001|Overall Study|Withdrawal by Subject|7|||
155530119|NCT04994535|561365911|FG000|Overall Study|Other|1|||
155530120|NCT04994535|561365912|FG001|Overall Study|Other|1|||
155530121|NCT01158118|561365913|FG000|Overall Study|Screen failure|1|||
155530122|NCT01158118|561365914|FG001|Overall Study|Screen failure|0|||
155530123|NCT01158118|561365913|FG000|Overall Study|Donor match was a screen failure|0|||
155530124|NCT01158118|561365914|FG001|Overall Study|Donor match was a screen failure|1|||
155530125|NCT01158118|561365913|FG000|Overall Study|Suffered stroke prior to transplant|0|||
155530126|NCT01158118|561365914|FG001|Overall Study|Suffered stroke prior to transplant|1|||
155530127|NCT01158118|561365913|FG000|Overall Study|Death|0|||
155530128|NCT01158118|561365914|FG001|Overall Study|Death|1|||
155530129|NCT04238754|561365916|FG000|Washout - 1 Week|Lost to Follow-up|1|||
155530130|NCT04238754|561365917|FG001|Washout - 1 Week|Lost to Follow-up|0|||
155530131|NCT01175018|561365918|FG000|Overall Study|Adverse Event|3|||
155530132|NCT01175018|561365919|FG001|Overall Study|Adverse Event|1|||
155530133|NCT02558491|561365920|FG000|First Invention|Withdrawal by Subject|3|||
155530134|NCT02558491|561365921|FG001|First Invention|Withdrawal by Subject|1|||
155530135|NCT02558491|561365920|FG000|First Invention|Data collection issues|1|||
155530136|NCT02558491|561365921|FG001|First Invention|Data collection issues|0|||
155530137|NCT02558491|561365920|FG000|First Invention|Stopping criteria|0|||
155530138|NCT02558491|561365921|FG001|First Invention|Stopping criteria|1|||
155530139|NCT02558491|561365920|FG000|First Invention|Changed parameters during trial|1|||
155530140|NCT02558491|561365921|FG001|First Invention|Changed parameters during trial|0|||
155530141|NCT02558491|561365920|FG000|Second Intervention|Withdrawal by Subject|1|||
155530142|NCT02558491|561365921|FG001|Second Intervention|Withdrawal by Subject|0|||
155530143|NCT02558491|561365920|FG000|Second Intervention|Stopping Criteria|1|||
155530144|NCT02558491|561365921|FG001|Second Intervention|Stopping Criteria|0|||
155530145|NCT01788423|561365922|FG000|Overall Study|See Comments in Completed (above)|0|||
155530146|NCT01788423|561365923|FG001|Overall Study|See Comments in Completed (above)|4|||
155530147|NCT01788423|561365924|FG002|Overall Study|See Comments in Completed (above)|5|||
155530148|NCT03792477|561365928|FG000|Overall Study|Adverse Event|0|||
155530149|NCT03792477|561365929|FG001|Overall Study|Adverse Event|0|||
155530150|NCT03792477|561365930|FG002|Overall Study|Adverse Event|0|||
155530151|NCT03792477|561365931|FG003|Overall Study|Adverse Event|1|||
155530152|NCT03792477|561365932|FG004|Overall Study|Adverse Event|0|||
155530153|NCT03792477|561365928|FG000|Overall Study|Lost to Follow-up|0|||
155530154|NCT03792477|561365929|FG001|Overall Study|Lost to Follow-up|0|||
155530155|NCT03792477|561365930|FG002|Overall Study|Lost to Follow-up|2|||
155530156|NCT03792477|561365931|FG003|Overall Study|Lost to Follow-up|0|||
155530157|NCT03792477|561365932|FG004|Overall Study|Lost to Follow-up|0|||
155530158|NCT03792477|561365928|FG000|Overall Study|Other|0|||
155530159|NCT03792477|561365929|FG001|Overall Study|Other|0|||
155530160|NCT03792477|561365930|FG002|Overall Study|Other|0|||
155530161|NCT03792477|561365931|FG003|Overall Study|Other|0|||
155530162|NCT03792477|561365932|FG004|Overall Study|Other|1|||
155530163|NCT00840411|561365934|FG000|First Intervention|Adverse Event|1|||
155530164|NCT00840411|561365935|FG001|First Intervention|Adverse Event|0|||
155530165|NCT00840411|561365934|FG000|Washout|Withdrawal by Subject|1|||
155530166|NCT00840411|561365935|FG001|Washout|Withdrawal by Subject|0|||
155530167|NCT01576042|561365938|FG000|Overall Study|Physician Decision|2|||
155530168|NCT01576042|561365939|FG001|Overall Study|Physician Decision|0|||
155530169|NCT03233724|561365940|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
155530170|NCT03233724|561365941|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
155530171|NCT03233724|561365942|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
155530172|NCT03233724|561365943|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
155530173|NCT03233724|561365944|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
155530174|NCT03233724|561365940|FG000|Phase I Dose Escalation|Best interest of participant|1|||
155530175|NCT03233724|561365941|FG001|Phase I Dose Escalation|Best interest of participant|1|||
155530176|NCT03233724|561365942|FG002|Phase I Dose Escalation|Best interest of participant|1|||
155530177|NCT03233724|561365943|FG003|Phase I Dose Escalation|Best interest of participant|0|||
155530178|NCT03233724|561365944|FG004|Phase I Dose Escalation|Best interest of participant|0|||
155530179|NCT03233724|561365940|FG000|Phase I Dose Escalation|Physician Decision|0|||
155530180|NCT03233724|561365941|FG001|Phase I Dose Escalation|Physician Decision|0|||
155530181|NCT03233724|561365942|FG002|Phase I Dose Escalation|Physician Decision|1|||
155530182|NCT03233724|561365943|FG003|Phase I Dose Escalation|Physician Decision|0|||
155530183|NCT03233724|561365944|FG004|Phase I Dose Escalation|Physician Decision|0|||
155530184|NCT03233724|561365940|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155530185|NCT03233724|561365941|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155530186|NCT03233724|561365942|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
155530187|NCT03233724|561365943|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155530188|NCT03233724|561365944|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155530189|NCT00651820|561365947|FG000|Overall Study|Lost to Follow-up|2|||
155530190|NCT02388191|561365948|FG000|Overall Study|Patient did not receive IUD|1|||
155530191|NCT02388191|561365949|FG001|Overall Study|Patient did not receive IUD|0|||
155530192|NCT01911676|561365950|FG000|Period 1 of Study|Withdrawal by Subject|4|||
155530193|NCT01911676|561365951|FG001|Period 1 of Study|Withdrawal by Subject|2|||
155530194|NCT01911676|561365952|FG002|Period 1 of Study|Withdrawal by Subject|1|||
155530195|NCT01911676|561365953|FG003|Period 1 of Study|Withdrawal by Subject|2|||
155530196|NCT01911676|561365950|FG000|Period 1 of Study|Physician Decision|2|||
155530197|NCT01911676|561365951|FG001|Period 1 of Study|Physician Decision|0|||
155530198|NCT01911676|561365952|FG002|Period 1 of Study|Physician Decision|0|||
155530199|NCT01911676|561365953|FG003|Period 1 of Study|Physician Decision|1|||
155530200|NCT01911676|561365950|FG000|Period 2 of Study|Physician Decision|2|||
155530201|NCT01911676|561365951|FG001|Period 2 of Study|Physician Decision|0|||
155530202|NCT01911676|561365952|FG002|Period 2 of Study|Physician Decision|0|||
155530203|NCT01911676|561365953|FG003|Period 2 of Study|Physician Decision|1|||
155530204|NCT01911676|561365950|FG000|Period 2 of Study|Lost to Follow-up|0|||
155530205|NCT01911676|561365951|FG001|Period 2 of Study|Lost to Follow-up|0|||
155530206|NCT01911676|561365952|FG002|Period 2 of Study|Lost to Follow-up|0|||
155530207|NCT01911676|561365953|FG003|Period 2 of Study|Lost to Follow-up|1|||
155530208|NCT01566721|561365954|FG000|Treatment Period|Withdrawal by Subject|35|||
155530209|NCT01566721|561365955|FG001|Treatment Period|Withdrawal by Subject|9|||
155530210|NCT01566721|561365954|FG000|Treatment Period|Disease Progression/Recurrence|37|||
155530211|NCT01566721|561365955|FG001|Treatment Period|Disease Progression/Recurrence|13|||
155530212|NCT01566721|561365954|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
155530213|NCT01566721|561365955|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
155530214|NCT01566721|561365954|FG000|Treatment Period|Other|13|||
155530215|NCT01566721|561365955|FG001|Treatment Period|Other|2|||
155530216|NCT01566721|561365954|FG000|Treatment Period|Lack of Compliance|5|||
155530217|NCT01566721|561365955|FG001|Treatment Period|Lack of Compliance|1|||
155530218|NCT01566721|561365954|FG000|Treatment Period|Adverse Event|100|||
155530219|NCT01566721|561365955|FG001|Treatment Period|Adverse Event|30|||
155530220|NCT01566721|561365954|FG000|Treatment Period|Pregnancy|1|||
155530221|NCT01566721|561365955|FG001|Treatment Period|Pregnancy|0|||
155530222|NCT01566721|561365954|FG000|Safety Follow-up|Physician Decision|6|||
155530223|NCT01566721|561365955|FG001|Safety Follow-up|Physician Decision|4|||
155530224|NCT01566721|561365954|FG000|Safety Follow-up|Lost to Follow-up|101|||
155530225|NCT01566721|561365955|FG001|Safety Follow-up|Lost to Follow-up|48|||
155530226|NCT01566721|561365954|FG000|Safety Follow-up|Withdrawal by Subject|155|||
155530227|NCT01566721|561365955|FG001|Safety Follow-up|Withdrawal by Subject|49|||
155530228|NCT01566721|561365954|FG000|Safety Follow-up|Death|28|||
155530229|NCT01566721|561365955|FG001|Safety Follow-up|Death|4|||
155530230|NCT01566721|561365954|FG000|Safety Follow-up|Non-compliance|7|||
155530231|NCT01566721|561365955|FG001|Safety Follow-up|Non-compliance|3|||
155530232|NCT01566721|561365954|FG000|Safety Follow-up|Protocol Violation|7|||
155530233|NCT01566721|561365955|FG001|Safety Follow-up|Protocol Violation|0|||
155530234|NCT01566721|561365954|FG000|Safety Follow-up|Site closure|2|||
155530235|NCT01566721|561365955|FG001|Safety Follow-up|Site closure|3|||
155530236|NCT01566721|561365954|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
155530237|NCT01566721|561365955|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
155530238|NCT01566721|561365954|FG000|Safety Follow-up|Missing|7|||
155530239|NCT01566721|561365955|FG001|Safety Follow-up|Missing|2|||
155530240|NCT01566721|561365954|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
155530241|NCT01566721|561365955|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
155530242|NCT01566721|561365954|FG000|Safety Follow-up|Sponsor decision|1|||
155530243|NCT01566721|561365955|FG001|Safety Follow-up|Sponsor decision|0|||
155530244|NCT01566721|561365954|FG000|Safety Follow-up|Adverse Event|8|||
155530245|NCT01566721|561365955|FG001|Safety Follow-up|Adverse Event|4|||
155530246|NCT00446563|561365956|FG000|Overall Study|Adverse Event|4|||
155530247|NCT00446563|561365957|FG001|Overall Study|Adverse Event|3|||
155530248|NCT00446563|561365956|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155530249|NCT00446563|561365957|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155530250|NCT00446563|561365956|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155530251|NCT00446563|561365957|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155530252|NCT00446563|561365956|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155530253|NCT00446563|561365957|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155655133|NCT04042311|561830661|FG000|Overall Study|No longer meeting inclusion criteria|2|||
155530254|NCT00446563|561365956|FG000|Overall Study|Withdrawal by Subject|2|||
155530255|NCT00446563|561365957|FG001|Overall Study|Withdrawal by Subject|1|||
155530256|NCT00446563|561365956|FG000|Overall Study|Administrative problems|0|||
155530257|NCT00446563|561365957|FG001|Overall Study|Administrative problems|1|||
155530258|NCT03769025|561365958|FG000|Overall Study|Withdrawal by Subject|1|||
155530259|NCT03769025|561365959|FG001|Overall Study|Withdrawal by Subject|1|||
155530260|NCT03769025|561365958|FG000|Overall Study|Lost to Follow-up|4|||
155530261|NCT03769025|561365959|FG001|Overall Study|Lost to Follow-up|3|||
155530262|NCT04659603|561365970|FG000|Overall Study|Study terminated by sponsor|0|||
155530263|NCT04659603|561365971|FG001|Overall Study|Study terminated by sponsor|0|||
155530264|NCT04659603|561365972|FG002|Overall Study|Study terminated by sponsor|2|||
155530265|NCT04659603|561365970|FG000|Overall Study|Withdrawal by Subject|0|||
155530266|NCT04659603|561365971|FG001|Overall Study|Withdrawal by Subject|5|||
155530267|NCT04659603|561365972|FG002|Overall Study|Withdrawal by Subject|0|||
155530268|NCT04659603|561365970|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
155530269|NCT04659603|561365971|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
155530270|NCT04659603|561365972|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
155530271|NCT04646213|561365973|FG000|Overall Study|Physician Decision|3|||
155530272|NCT04646213|561365973|FG000|Overall Study|Withdrawal by Subject|2|||
155530273|NCT02441309|561365976|FG000|Overall Study|Disease progression|2|||
155530274|NCT02441309|561365977|FG001|Overall Study|Disease progression|1|||
155530275|NCT02441309|561365978|FG002|Overall Study|Disease progression|2|||
155530276|NCT02441309|561365976|FG000|Overall Study|Adverse Event|0|||
155530277|NCT02441309|561365977|FG001|Overall Study|Adverse Event|1|||
155530278|NCT02441309|561365978|FG002|Overall Study|Adverse Event|0|||
155530279|NCT02441309|561365976|FG000|Overall Study|Withdrawal by Subject|1|||
155530280|NCT02441309|561365977|FG001|Overall Study|Withdrawal by Subject|0|||
155530281|NCT02441309|561365978|FG002|Overall Study|Withdrawal by Subject|1|||
155530282|NCT03290781|561365984|FG000|Overall Study|Adverse Event|5|||
155530283|NCT03290781|561365985|FG001|Overall Study|Adverse Event|7|||
155530284|NCT03290781|561365986|FG002|Overall Study|Adverse Event|4|||
155530285|NCT03290781|561365987|FG003|Overall Study|Adverse Event|1|||
155530286|NCT03290781|561365988|FG004|Overall Study|Adverse Event|0|||
155530287|NCT03290781|561365989|FG005|Overall Study|Adverse Event|0|||
155530288|NCT03290781|561365990|FG006|Overall Study|Adverse Event|0|||
155530289|NCT03290781|561365984|FG000|Overall Study|Death|0|||
155655134|NCT04042311|561830661|FG000|Overall Study|No reason given|1|||
155655135|NCT04042311|561830661|FG000|Overall Study|Withdrawal by Subject|4|||
155655136|NCT03518060|561830662|FG000|Overall Study|Death|1|||
155530290|NCT03290781|561365985|FG001|Overall Study|Death|0|||
155530291|NCT03290781|561365986|FG002|Overall Study|Death|1|||
155530292|NCT03290781|561365987|FG003|Overall Study|Death|0|||
155530293|NCT03290781|561365988|FG004|Overall Study|Death|1|||
155530294|NCT03290781|561365989|FG005|Overall Study|Death|0|||
155530295|NCT03290781|561365990|FG006|Overall Study|Death|0|||
155530296|NCT03290781|561365984|FG000|Overall Study|Withdrawal by Subject|6|||
155530297|NCT03290781|561365985|FG001|Overall Study|Withdrawal by Subject|5|||
155530298|NCT03290781|561365986|FG002|Overall Study|Withdrawal by Subject|9|||
155530299|NCT03290781|561365987|FG003|Overall Study|Withdrawal by Subject|10|||
155530300|NCT03290781|561365988|FG004|Overall Study|Withdrawal by Subject|1|||
155530301|NCT03290781|561365989|FG005|Overall Study|Withdrawal by Subject|2|||
155530302|NCT03290781|561365990|FG006|Overall Study|Withdrawal by Subject|0|||
155530303|NCT03290781|561365984|FG000|Overall Study|Physician Decision|0|||
155655137|NCT03518060|561830662|FG000|Overall Study|Poor adherence|1|||
155530304|NCT03290781|561365985|FG001|Overall Study|Physician Decision|1|||
155530305|NCT03290781|561365986|FG002|Overall Study|Physician Decision|0|||
155530306|NCT03290781|561365987|FG003|Overall Study|Physician Decision|0|||
155530307|NCT03290781|561365988|FG004|Overall Study|Physician Decision|0|||
155530308|NCT03290781|561365989|FG005|Overall Study|Physician Decision|0|||
155530309|NCT03290781|561365990|FG006|Overall Study|Physician Decision|0|||
155530310|NCT03290781|561365984|FG000|Overall Study|Site Terminated by Sponsor|1|||
155530311|NCT03290781|561365985|FG001|Overall Study|Site Terminated by Sponsor|0|||
155530312|NCT03290781|561365986|FG002|Overall Study|Site Terminated by Sponsor|2|||
155530313|NCT03290781|561365987|FG003|Overall Study|Site Terminated by Sponsor|1|||
155530314|NCT03290781|561365988|FG004|Overall Study|Site Terminated by Sponsor|0|||
155530315|NCT03290781|561365989|FG005|Overall Study|Site Terminated by Sponsor|0|||
155530316|NCT03290781|561365990|FG006|Overall Study|Site Terminated by Sponsor|0|||
155530317|NCT03290781|561365984|FG000|Overall Study|Lost to Follow-up|0|||
155530318|NCT03290781|561365985|FG001|Overall Study|Lost to Follow-up|0|||
155530319|NCT03290781|561365986|FG002|Overall Study|Lost to Follow-up|0|||
155530320|NCT03290781|561365987|FG003|Overall Study|Lost to Follow-up|1|||
155530321|NCT03290781|561365988|FG004|Overall Study|Lost to Follow-up|0|||
155530322|NCT03290781|561365989|FG005|Overall Study|Lost to Follow-up|0|||
155530323|NCT03290781|561365990|FG006|Overall Study|Lost to Follow-up|0|||
155530324|NCT03290781|561365984|FG000|Overall Study|Protocol Deviation|2|||
155530325|NCT03290781|561365985|FG001|Overall Study|Protocol Deviation|0|||
155530326|NCT03290781|561365986|FG002|Overall Study|Protocol Deviation|0|||
155530327|NCT03290781|561365987|FG003|Overall Study|Protocol Deviation|1|||
155530328|NCT03290781|561365988|FG004|Overall Study|Protocol Deviation|0|||
155530329|NCT03290781|561365989|FG005|Overall Study|Protocol Deviation|0|||
155530330|NCT03290781|561365990|FG006|Overall Study|Protocol Deviation|0|||
155530331|NCT03290781|561365984|FG000|Overall Study|Disease Relapse|32|||
155530332|NCT03290781|561365985|FG001|Overall Study|Disease Relapse|5|||
155530333|NCT03290781|561365986|FG002|Overall Study|Disease Relapse|38|||
155530334|NCT03290781|561365987|FG003|Overall Study|Disease Relapse|7|||
155530335|NCT03290781|561365988|FG004|Overall Study|Disease Relapse|3|||
155530336|NCT03290781|561365989|FG005|Overall Study|Disease Relapse|1|||
155530337|NCT03290781|561365990|FG006|Overall Study|Disease Relapse|4|||
155655138|NCT03518060|561830662|FG000|Overall Study|Withdrawal of informed consent|2|||
155655139|NCT03518060|561830662|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
155655140|NCT03518060|561830662|FG000|Overall Study|Physician Decision|7|||
155655141|NCT03518060|561830662|FG000|Overall Study|Adverse drug reactions|23|||
155655142|NCT03518060|561830662|FG000|Overall Study|Withdrawal by Subject|25|||
155655143|NCT03518060|561830662|FG000|Overall Study|Lost to Follow-up|13|||
155655144|NCT04903093|561830664|FG000|Overall Study|Withdrawal by Subject|0|||
155655145|NCT04903093|561830665|FG001|Overall Study|Withdrawal by Subject|0|||
155655146|NCT04903093|561830666|FG002|Overall Study|Withdrawal by Subject|0|||
155655147|NCT04903093|561830667|FG003|Overall Study|Withdrawal by Subject|1|||
155655148|NCT04903093|561830668|FG004|Overall Study|Withdrawal by Subject|0|||
155655149|NCT04903093|561830669|FG005|Overall Study|Withdrawal by Subject|0|||
155655150|NCT03204812|561830670|FG000|Overall Study|Adverse Event|3|||
155655151|NCT02412436|561830671|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
155655152|NCT02412436|561830671|FG000|Overall Study|Lost to Follow-up|6|||
155655153|NCT02412436|561830671|FG000|Overall Study|Unable to get to clinic|3|||
155655154|NCT02412436|561830671|FG000|Overall Study|Death|1|||
155655155|NCT02412436|561830671|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
155655156|NCT02544763|561830672|FG000|Overall Study|Adverse Event|8|||
155655157|NCT02544763|561830673|FG001|Overall Study|Adverse Event|8|||
155655158|NCT02544763|561830674|FG002|Overall Study|Adverse Event|0|||
155655159|NCT02544763|561830672|FG000|Overall Study|Withdrawn by parent/guardian|1|||
155655160|NCT02544763|561830673|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155655161|NCT02544763|561830674|FG002|Overall Study|Withdrawn by parent/guardian|1|||
155655162|NCT02544763|561830672|FG000|Overall Study|Met withdrawal criteria|0|||
155655163|NCT02544763|561830673|FG001|Overall Study|Met withdrawal criteria|2|||
155655164|NCT02544763|561830674|FG002|Overall Study|Met withdrawal criteria|0|||
155655165|NCT02544763|561830672|FG000|Overall Study|Physician Decision|0|||
155655166|NCT02544763|561830673|FG001|Overall Study|Physician Decision|1|||
155655167|NCT02544763|561830674|FG002|Overall Study|Physician Decision|0|||
155655168|NCT02544763|561830672|FG000|Overall Study|Difficulties taking IMP|1|||
155655169|NCT02544763|561830673|FG001|Overall Study|Difficulties taking IMP|0|||
155655170|NCT02544763|561830674|FG002|Overall Study|Difficulties taking IMP|0|||
155655171|NCT02528305|561830675|FG000|Overall Study|Withdrawal by Subject|1|||
155655172|NCT02528305|561830675|FG000|Overall Study|Adverse Event|1|||
155655173|NCT02528305|561830675|FG000|Overall Study|Physician Decision|1|||
155655174|NCT01852214|561830676|FG000|Period 1|Adverse Event|1|||
155655175|NCT01852214|561830677|FG001|Period 1|Adverse Event|2|||
155655176|NCT01852214|561830676|FG000|Period 1|Withdrawal by Subject|0|||
155655177|NCT01852214|561830677|FG001|Period 1|Withdrawal by Subject|1|||
155655178|NCT01852214|561830676|FG000|Washout Period|Withdrawal by Subject|0|||
155655179|NCT01852214|561830677|FG001|Washout Period|Withdrawal by Subject|1|||
155530338|NCT03290781|561365984|FG000|Overall Study|Other|3|||
155530339|NCT03290781|561365985|FG001|Overall Study|Other|0|||
155655180|NCT00421408|561830678|FG000|Overall Study|Lost to Follow-up|30|||
155655181|NCT00421408|561830679|FG001|Overall Study|Lost to Follow-up|20|||
155655182|NCT00421408|561830678|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
155530340|NCT03290781|561365986|FG002|Overall Study|Other|2|||
155530341|NCT03290781|561365987|FG003|Overall Study|Other|2|||
155530342|NCT03290781|561365988|FG004|Overall Study|Other|0|||
155655183|NCT00421408|561830679|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
155655184|NCT00773461|561830683|FG000|Overall Study|Adverse Event|1|||
155655185|NCT00773461|561830684|FG001|Overall Study|Adverse Event|3|||
155655186|NCT00773461|561830683|FG000|Overall Study|Withdrawal by Subject|4|||
155530343|NCT03290781|561365989|FG005|Overall Study|Other|0|||
155530344|NCT03290781|561365990|FG006|Overall Study|Other|0|||
155530345|NCT00811655|561366008|FG000|Overall Study|Physician Decision|1|||
155530346|NCT00119015|561366016|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
155530347|NCT00119015|561366017|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
155530348|NCT00119015|561366018|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
155530349|NCT02255149|561367285|FG000|Overall Study|Lost to Follow-up|2|||
155530350|NCT02255149|561367285|FG000|Overall Study|Withdrawal by Subject|1|||
155530351|NCT02255149|561367285|FG000|Overall Study|Withdrawal by PI|1|||
155530352|NCT02255149|561367285|FG000|Overall Study|Implant Failure|1|||
155530353|NCT01376037|561367286|FG000|Overall Study|Lost to Follow-up|0|||
155530354|NCT01376037|561367287|FG001|Overall Study|Lost to Follow-up|2|||
155530355|NCT02328040|561367288|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
155530356|NCT02328040|561367289|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
155530357|NCT05604170|561367291|FG000|Overall Study|Lack of Efficacy|5|||
155530358|NCT05604170|561367291|FG000|Overall Study|Adverse Event|6|||
155530359|NCT05604170|561367291|FG000|Overall Study|Physician Decision|6|||
155530360|NCT05604170|561367291|FG000|Overall Study|Lost to Follow-up|6|||
155530361|NCT05604170|561367291|FG000|Overall Study|Withdrawal by Subject|11|||
155530362|NCT05604170|561367291|FG000|Overall Study|Early study termination by sponsor|77|||
155530363|NCT05604170|561367291|FG000|Overall Study|Other|6|||
155530364|NCT03697109|561367296|FG000|Open-label (OL) Phase|Adverse Event|24|||
155530365|NCT03697109|561367297|FG001|Open-label (OL) Phase|Adverse Event|0|||
155530366|NCT03697109|561367298|FG002|Open-label (OL) Phase|Adverse Event|0|||
155530367|NCT03697109|561367296|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
155530368|NCT03697109|561367297|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
155530369|NCT03697109|561367298|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
155530370|NCT03697109|561367296|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
155530371|NCT03697109|561367297|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
155530372|NCT03697109|561367298|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
155530373|NCT03697109|561367296|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
155530374|NCT03697109|561367297|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
155530375|NCT03697109|561367298|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
155530376|NCT03697109|561367296|FG000|Open-label (OL) Phase|Physician Decision|2|||
155530377|NCT03697109|561367297|FG001|Open-label (OL) Phase|Physician Decision|0|||
155530378|NCT03697109|561367298|FG002|Open-label (OL) Phase|Physician Decision|0|||
155530379|NCT03697109|561367296|FG000|Open-label (OL) Phase|Death|2|||
155530380|NCT03697109|561367297|FG001|Open-label (OL) Phase|Death|0|||
155530381|NCT03697109|561367298|FG002|Open-label (OL) Phase|Death|0|||
155530382|NCT03697109|561367296|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
155530383|NCT03697109|561367297|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
155530384|NCT03697109|561367298|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
155530385|NCT03697109|561367296|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
155530386|NCT03697109|561367297|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
155530387|NCT03697109|561367298|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
155530388|NCT03697109|561367296|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
155530389|NCT03697109|561367297|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
155530390|NCT03697109|561367298|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
155530391|NCT03032172|561367299|FG000|Treatment Period|Adverse Event|0|||
155530392|NCT03032172|561367300|FG001|Treatment Period|Adverse Event|1|||
155530393|NCT03032172|561367301|FG002|Treatment Period|Adverse Event|0|||
155530394|NCT03032172|561367302|FG003|Treatment Period|Adverse Event|0|||
155530395|NCT03032172|561367303|FG004|Treatment Period|Adverse Event|0|||
155530396|NCT03032172|561367304|FG005|Treatment Period|Adverse Event|0|||
155530397|NCT03032172|561367305|FG006|Treatment Period|Adverse Event|0|||
155530398|NCT03032172|561367306|FG007|Treatment Period|Adverse Event|0|||
155530399|NCT03032172|561367299|FG000|Treatment Period|Lack of Efficacy|0|||
155530400|NCT03032172|561367300|FG001|Treatment Period|Lack of Efficacy|1|||
155530401|NCT03032172|561367301|FG002|Treatment Period|Lack of Efficacy|0|||
155530402|NCT03032172|561367302|FG003|Treatment Period|Lack of Efficacy|0|||
155530403|NCT03032172|561367303|FG004|Treatment Period|Lack of Efficacy|0|||
155530404|NCT03032172|561367304|FG005|Treatment Period|Lack of Efficacy|0|||
155530405|NCT03032172|561367305|FG006|Treatment Period|Lack of Efficacy|0|||
155530406|NCT03032172|561367306|FG007|Treatment Period|Lack of Efficacy|0|||
155530407|NCT03032172|561367299|FG000|Treatment Period|Non-compliance With Study Drug|0|||
155530408|NCT03032172|561367300|FG001|Treatment Period|Non-compliance With Study Drug|1|||
155530409|NCT03032172|561367301|FG002|Treatment Period|Non-compliance With Study Drug|0|||
155530410|NCT03032172|561367302|FG003|Treatment Period|Non-compliance With Study Drug|0|||
155530411|NCT03032172|561367303|FG004|Treatment Period|Non-compliance With Study Drug|0|||
155530412|NCT03032172|561367304|FG005|Treatment Period|Non-compliance With Study Drug|0|||
155530413|NCT03032172|561367305|FG006|Treatment Period|Non-compliance With Study Drug|0|||
155530414|NCT03032172|561367306|FG007|Treatment Period|Non-compliance With Study Drug|0|||
155530415|NCT03032172|561367299|FG000|Treatment Period|Reason Not Specified|0|||
155530416|NCT03032172|561367300|FG001|Treatment Period|Reason Not Specified|4|||
155530417|NCT03032172|561367301|FG002|Treatment Period|Reason Not Specified|1|||
155530418|NCT03032172|561367302|FG003|Treatment Period|Reason Not Specified|0|||
155530419|NCT03032172|561367303|FG004|Treatment Period|Reason Not Specified|0|||
155530420|NCT03032172|561367304|FG005|Treatment Period|Reason Not Specified|0|||
155530421|NCT03032172|561367305|FG006|Treatment Period|Reason Not Specified|0|||
155530422|NCT03032172|561367306|FG007|Treatment Period|Reason Not Specified|0|||
155530423|NCT03032172|561367299|FG000|Treatment Period|Physician Decision|0|||
155530424|NCT03032172|561367300|FG001|Treatment Period|Physician Decision|2|||
155530425|NCT03032172|561367301|FG002|Treatment Period|Physician Decision|1|||
155530426|NCT03032172|561367302|FG003|Treatment Period|Physician Decision|0|||
155530427|NCT03032172|561367303|FG004|Treatment Period|Physician Decision|0|||
155530428|NCT03032172|561367304|FG005|Treatment Period|Physician Decision|0|||
155530429|NCT03032172|561367305|FG006|Treatment Period|Physician Decision|0|||
155530430|NCT03032172|561367306|FG007|Treatment Period|Physician Decision|0|||
155530431|NCT03032172|561367299|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
155530432|NCT03032172|561367300|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
155530433|NCT03032172|561367301|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
155530434|NCT03032172|561367302|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
155530435|NCT03032172|561367303|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
155530436|NCT03032172|561367304|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
155530437|NCT03032172|561367305|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
155530438|NCT03032172|561367306|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
155530439|NCT03032172|561367299|FG000|Treatment Period|Withdrawal by Subject|2|||
155530440|NCT03032172|561367300|FG001|Treatment Period|Withdrawal by Subject|0|||
155530441|NCT03032172|561367301|FG002|Treatment Period|Withdrawal by Subject|3|||
155530442|NCT03032172|561367302|FG003|Treatment Period|Withdrawal by Subject|0|||
155530443|NCT03032172|561367303|FG004|Treatment Period|Withdrawal by Subject|0|||
155530444|NCT03032172|561367304|FG005|Treatment Period|Withdrawal by Subject|0|||
155530445|NCT03032172|561367305|FG006|Treatment Period|Withdrawal by Subject|0|||
155530446|NCT03032172|561367306|FG007|Treatment Period|Withdrawal by Subject|0|||
155655187|NCT00773461|561830684|FG001|Overall Study|Withdrawal by Subject|1|||
155655188|NCT00913835|561830685|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
155655189|NCT00913835|561830686|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
155655190|NCT00913835|561830685|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
155655191|NCT00913835|561830686|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
155655192|NCT00913835|561830685|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
155655193|NCT00913835|561830686|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
155655194|NCT00913835|561830685|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
155655195|NCT00913835|561830686|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
155655196|NCT00913835|561830685|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
155655197|NCT00913835|561830686|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
155655198|NCT03345550|561832137|FG000|Overall Study|Withdrawal by Subject|1|||
155655199|NCT03345550|561832138|FG001|Overall Study|Withdrawal by Subject|0|||
155655200|NCT03345550|561832137|FG000|Overall Study|Lost to Follow-up|4|||
155655201|NCT03345550|561832138|FG001|Overall Study|Lost to Follow-up|5|||
155655202|NCT01149460|561832142|FG000|Overall Study|Withdrawal by Subject|0|||
155655203|NCT01149460|561832143|FG001|Overall Study|Withdrawal by Subject|2|||
155655204|NCT03014089|561832144|FG000|Overall Study|Withdrawal by Subject|0|||
155655205|NCT03014089|561832145|FG001|Overall Study|Withdrawal by Subject|1|||
155655206|NCT03014089|561832146|FG002|Overall Study|Withdrawal by Subject|1|||
155655207|NCT03014089|561832147|FG003|Overall Study|Withdrawal by Subject|1|||
155655208|NCT03014089|561832144|FG000|Overall Study|Lost to Follow-up|1|||
155655209|NCT03014089|561832145|FG001|Overall Study|Lost to Follow-up|0|||
155655210|NCT03014089|561832146|FG002|Overall Study|Lost to Follow-up|0|||
155655211|NCT03014089|561832147|FG003|Overall Study|Lost to Follow-up|0|||
155655212|NCT03014089|561832144|FG000|Overall Study|Adverse Event|1|||
155655213|NCT03014089|561832145|FG001|Overall Study|Adverse Event|0|||
155655214|NCT03014089|561832146|FG002|Overall Study|Adverse Event|1|||
155655215|NCT03014089|561832147|FG003|Overall Study|Adverse Event|0|||
155655216|NCT00321932|561832148|FG000|Overall Study|Death|3|||
155655217|NCT00321932|561832149|FG001|Overall Study|Death|6|||
155655218|NCT00321932|561832148|FG000|Overall Study|Withdrawal by Subject|3|||
155530447|NCT03032172|561367299|FG000|Open-label Extension Period|Death|0|||
155530448|NCT03032172|561367300|FG001|Open-label Extension Period|Death|0|||
155530449|NCT03032172|561367301|FG002|Open-label Extension Period|Death|0|||
155530450|NCT03032172|561367302|FG003|Open-label Extension Period|Death|0|||
155530451|NCT03032172|561367303|FG004|Open-label Extension Period|Death|0|||
155530452|NCT03032172|561367304|FG005|Open-label Extension Period|Death|0|||
155530453|NCT03032172|561367305|FG006|Open-label Extension Period|Death|0|||
155530454|NCT03032172|561367306|FG007|Open-label Extension Period|Death|2|||
155530455|NCT03032172|561367299|FG000|Open-label Extension Period|Reason Not Specified|0|||
155530456|NCT03032172|561367300|FG001|Open-label Extension Period|Reason Not Specified|0|||
155530457|NCT03032172|561367301|FG002|Open-label Extension Period|Reason Not Specified|0|||
155530458|NCT03032172|561367302|FG003|Open-label Extension Period|Reason Not Specified|0|||
155530459|NCT03032172|561367303|FG004|Open-label Extension Period|Reason Not Specified|0|||
155530460|NCT03032172|561367304|FG005|Open-label Extension Period|Reason Not Specified|5|||
155530461|NCT03032172|561367305|FG006|Open-label Extension Period|Reason Not Specified|3|||
155530462|NCT03032172|561367306|FG007|Open-label Extension Period|Reason Not Specified|0|||
155530463|NCT03032172|561367299|FG000|Open-label Extension Period|Pregnancy|0|||
155530464|NCT03032172|561367300|FG001|Open-label Extension Period|Pregnancy|0|||
155530465|NCT03032172|561367301|FG002|Open-label Extension Period|Pregnancy|0|||
155530466|NCT03032172|561367302|FG003|Open-label Extension Period|Pregnancy|0|||
155530467|NCT03032172|561367303|FG004|Open-label Extension Period|Pregnancy|0|||
155530468|NCT03032172|561367304|FG005|Open-label Extension Period|Pregnancy|0|||
155530469|NCT03032172|561367305|FG006|Open-label Extension Period|Pregnancy|1|||
155530470|NCT03032172|561367306|FG007|Open-label Extension Period|Pregnancy|0|||
155530471|NCT03032172|561367299|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155530472|NCT03032172|561367300|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155530473|NCT03032172|561367301|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
155530474|NCT03032172|561367302|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
155530475|NCT03032172|561367303|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
155530476|NCT03032172|561367304|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
155530477|NCT03032172|561367305|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
155530478|NCT03032172|561367306|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
155530479|NCT04516967|561367308|FG000|Core Phase|Adverse Event|2|||
155530480|NCT04516967|561367309|FG001|Core Phase|Adverse Event|1|||
155530481|NCT04516967|561367310|FG002|Core Phase|Adverse Event|0|||
155530482|NCT04516967|561367308|FG000|Core Phase|Physician Decision|1|||
155530483|NCT04516967|561367309|FG001|Core Phase|Physician Decision|1|||
155530484|NCT04516967|561367310|FG002|Core Phase|Physician Decision|0|||
155530485|NCT04516967|561367308|FG000|Core Phase|Lack of Efficacy|7|||
155530486|NCT04516967|561367309|FG001|Core Phase|Lack of Efficacy|18|||
155530487|NCT04516967|561367310|FG002|Core Phase|Lack of Efficacy|0|||
155530488|NCT00519194|561367311|FG000|Overall Study|Withdrawal by Subject|9|||
155530489|NCT00519194|561367311|FG000|Overall Study|Death|9|||
155530490|NCT00519194|561367311|FG000|Overall Study|Lost to Follow-up|3|||
155530491|NCT03165994|561367312|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
155530492|NCT03165994|561367312|FG000|Overall Study|Death|2|||
155530493|NCT03165994|561367312|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
155530494|NCT03165994|561367312|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
155530495|NCT03165994|561367312|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
155530496|NCT03165994|561367312|FG000|Overall Study|Miscellaneous|1|||
155530497|NCT02301975|561367315|FG000|Overall Study|Adverse Event|8|||
155530498|NCT02301975|561367316|FG001|Overall Study|Adverse Event|3|||
155530499|NCT02301975|561367317|FG002|Overall Study|Adverse Event|2|||
155530500|NCT02301975|561367315|FG000|Overall Study|Lack of Efficacy|1|||
155530501|NCT02301975|561367316|FG001|Overall Study|Lack of Efficacy|1|||
155530502|NCT02301975|561367317|FG002|Overall Study|Lack of Efficacy|1|||
155530503|NCT02301975|561367315|FG000|Overall Study|Protocol Violation|3|||
155530504|NCT02301975|561367316|FG001|Overall Study|Protocol Violation|5|||
155530505|NCT02301975|561367317|FG002|Overall Study|Protocol Violation|3|||
155530506|NCT02301975|561367315|FG000|Overall Study|Lost to Follow-up|0|||
155530507|NCT02301975|561367316|FG001|Overall Study|Lost to Follow-up|2|||
155530508|NCT02301975|561367317|FG002|Overall Study|Lost to Follow-up|2|||
155530509|NCT02301975|561367315|FG000|Overall Study|Physician Decision|4|||
155530510|NCT02301975|561367316|FG001|Overall Study|Physician Decision|2|||
155530511|NCT02301975|561367317|FG002|Overall Study|Physician Decision|3|||
155530512|NCT02301975|561367315|FG000|Overall Study|Withdrawal by Subject|15|||
155530513|NCT02301975|561367316|FG001|Overall Study|Withdrawal by Subject|12|||
155530514|NCT02301975|561367317|FG002|Overall Study|Withdrawal by Subject|11|||
155530515|NCT01111461|561367319|FG000|Overall Study|Adverse Event|32|||
155530516|NCT01111461|561367319|FG000|Overall Study|Participant choice|11|||
155530517|NCT01111461|561367319|FG000|Overall Study|Lost to Follow-up|1|||
155530518|NCT01111461|561367319|FG000|Overall Study|Withdrawal by Subject|1|||
155530519|NCT01111461|561367319|FG000|Overall Study|Other|6|||
155530520|NCT04278560|561367320|FG000|Overall Study|Adverse Event|1|||
155530521|NCT04278560|561367321|FG001|Overall Study|Adverse Event|2|||
155530522|NCT04278560|561367320|FG000|Overall Study|Withdrawal by Subject|0|||
155530523|NCT04278560|561367321|FG001|Overall Study|Withdrawal by Subject|1|||
155530524|NCT00163657|561367323|FG000|Overall Study|Death|12|||
155530525|NCT00163657|561367324|FG001|Overall Study|Death|14|||
155530526|NCT00163657|561367325|FG002|Overall Study|Death|19|||
155530527|NCT00163657|561367323|FG000|Overall Study|graft loss|4|||
155530528|NCT00163657|561367324|FG001|Overall Study|graft loss|1|||
155530529|NCT00163657|561367325|FG002|Overall Study|graft loss|2|||
155530530|NCT00163657|561367323|FG000|Overall Study|Withdrawal by Subject|2|||
155530531|NCT00163657|561367324|FG001|Overall Study|Withdrawal by Subject|3|||
155530532|NCT00163657|561367325|FG002|Overall Study|Withdrawal by Subject|2|||
155530533|NCT00163657|561367323|FG000|Overall Study|Physician Decision|0|||
155530534|NCT00163657|561367324|FG001|Overall Study|Physician Decision|1|||
155530535|NCT00163657|561367325|FG002|Overall Study|Physician Decision|1|||
155530536|NCT00163657|561367323|FG000|Overall Study|Non Compliance|1|||
155530537|NCT00163657|561367324|FG001|Overall Study|Non Compliance|0|||
155530538|NCT00163657|561367325|FG002|Overall Study|Non Compliance|0|||
155530539|NCT00163657|561367323|FG000|Overall Study|Lost to Follow-up|1|||
155530540|NCT00163657|561367324|FG001|Overall Study|Lost to Follow-up|3|||
155530541|NCT00163657|561367325|FG002|Overall Study|Lost to Follow-up|10|||
155530542|NCT00163657|561367323|FG000|Overall Study|Other reason|0|||
155530543|NCT00163657|561367324|FG001|Overall Study|Other reason|1|||
155530544|NCT00163657|561367325|FG002|Overall Study|Other reason|3|||
155530545|NCT01319383|561367326|FG000|Overall Study|No ex vivo or in vivo response|4|||
155530546|NCT01319383|561367327|FG001|Overall Study|No ex vivo or in vivo response|0|||
155530547|NCT01319383|561367326|FG000|Overall Study|Physician Decision|3|||
155530548|NCT01319383|561367327|FG001|Overall Study|Physician Decision|0|||
155530549|NCT01319383|561367326|FG000|Overall Study|Lack of Efficacy|5|||
155530550|NCT01319383|561367327|FG001|Overall Study|Lack of Efficacy|9|||
155530551|NCT01319383|561367326|FG000|Overall Study|No in vivo response to interval doses|0|||
155530552|NCT01319383|561367327|FG001|Overall Study|No in vivo response to interval doses|1|||
155530553|NCT01531894|561367330|FG000|Overall Study|Physician Decision|8|||
155530554|NCT01531894|561367330|FG000|Overall Study|Death|1|||
155530555|NCT06195579|561367331|FG000|Overall Study|Withdrawal by Subject|1|||
155530556|NCT02545283|561367332|FG000|Overall Study|Lost to Follow-up|2|||
155530557|NCT02545283|561367333|FG001|Overall Study|Lost to Follow-up|4|||
155530558|NCT02545283|561367332|FG000|Overall Study|Withdrawal by Subject|5|||
155530559|NCT02545283|561367333|FG001|Overall Study|Withdrawal by Subject|9|||
155530560|NCT02545283|561367332|FG000|Overall Study|Death|109|||
155530561|NCT02545283|561367333|FG001|Overall Study|Death|211|||
155530562|NCT02545283|561367332|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
155530563|NCT02545283|561367333|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
155530564|NCT02545283|561367332|FG000|Overall Study|Study Terminated By Sponsor|33|||
155530565|NCT02545283|561367333|FG001|Overall Study|Study Terminated By Sponsor|71|||
155530566|NCT03343535|561367335|FG000|Overall Study|Lost to Follow-up|1|||
155530567|NCT03343535|561367335|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
155530568|NCT03343535|561367335|FG000|Overall Study|Death|12|||
155530569|NCT00604162|561367336|FG000|Overall Study|Physician Decision|3|||
155530570|NCT00604162|561367336|FG000|Overall Study|Withdrawal by Subject|1|||
155530571|NCT00736190|561367339|FG000|Overall Study|Pregnancy|1|||
155530572|NCT00736190|561367339|FG000|Overall Study|Withdrawal by Subject|1|||
155530573|NCT00736190|561367339|FG000|Overall Study|Adverse Event|1|||
155530574|NCT05014828|561367340|FG000|Overall Study|Study Completed by Sponsor|16|||
155530575|NCT05014828|561367341|FG001|Overall Study|Study Completed by Sponsor|16|||
155530576|NCT05014828|561367342|FG002|Overall Study|Study Completed by Sponsor|3|||
155530577|NCT05014828|561367343|FG003|Overall Study|Study Completed by Sponsor|3|||
155530578|NCT05014828|561367340|FG000|Overall Study|Death|11|||
155530579|NCT05014828|561367341|FG001|Overall Study|Death|6|||
155530580|NCT05014828|561367342|FG002|Overall Study|Death|0|||
155530581|NCT05014828|561367343|FG003|Overall Study|Death|0|||
155530582|NCT05014828|561367340|FG000|Overall Study|Lost to Follow-up|0|||
155530583|NCT05014828|561367341|FG001|Overall Study|Lost to Follow-up|0|||
155530584|NCT05014828|561367342|FG002|Overall Study|Lost to Follow-up|2|||
155530585|NCT05014828|561367343|FG003|Overall Study|Lost to Follow-up|0|||
155530586|NCT05014828|561367340|FG000|Overall Study|Miscellaneous.|0|||
155530587|NCT05014828|561367341|FG001|Overall Study|Miscellaneous.|1|||
155530588|NCT05014828|561367342|FG002|Overall Study|Miscellaneous.|0|||
155530589|NCT05014828|561367343|FG003|Overall Study|Miscellaneous.|0|||
155530590|NCT01370317|561367347|FG000|Overall Study|Participant withdrew consent|1|||
155530591|NCT01370317|561367348|FG001|Overall Study|Participant withdrew consent|0|||
155530592|NCT01370317|561367347|FG000|Overall Study|Protocol deviation|0|||
155530593|NCT01370317|561367348|FG001|Overall Study|Protocol deviation|1|||
155530594|NCT00075478|561367349|FG000|Overall Study|not eligible|1|||
155530595|NCT00075478|561367350|FG001|Overall Study|not eligible|0|||
155530596|NCT00075478|561367349|FG000|Overall Study|Physician Decision|0|||
155530597|NCT00075478|561367350|FG001|Overall Study|Physician Decision|1|||
155530598|NCT00960297|561367352|FG000|Overall Study|Physician Decision|1|||
155530599|NCT00960297|561367352|FG000|Overall Study|Venous port infection|1|||
155530600|NCT00960297|561367352|FG000|Overall Study|Disease progression|1|||
155530601|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
155530602|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
155530603|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
155530604|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
155530605|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
155530606|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
155530607|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
155530608|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
155530609|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
155530610|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
155530611|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
155530612|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
155530613|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
155530614|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
155530615|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
155530616|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
155530617|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
155530618|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
155530619|NCT01667679|561367360|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
155530620|NCT01667679|561367361|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
155530621|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
155530622|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
155530623|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
155655219|NCT00321932|561832149|FG001|Overall Study|Withdrawal by Subject|6|||
155655220|NCT00321932|561832148|FG000|Overall Study|Early relapse|2|||
155655221|NCT00321932|561832149|FG001|Overall Study|Early relapse|8|||
155655222|NCT00321932|561832148|FG000|Overall Study|Missing data|2|||
155655223|NCT00321932|561832149|FG001|Overall Study|Missing data|1|||
155655224|NCT02378480|561832150|FG000|Overall Study|Physician Decision|1|||
155655225|NCT02378480|561832151|FG001|Overall Study|Physician Decision|1|||
155655226|NCT02378480|561832150|FG000|Overall Study|Death|1|||
155655227|NCT02378480|561832151|FG001|Overall Study|Death|2|||
155655228|NCT02378480|561832150|FG000|Overall Study|Randomized, but Not Treated|6|||
155655229|NCT02378480|561832151|FG001|Overall Study|Randomized, but Not Treated|4|||
155655230|NCT02378480|561832150|FG000|Overall Study|Adverse Event|0|||
155655231|NCT02378480|561832151|FG001|Overall Study|Adverse Event|1|||
155655232|NCT02378480|561832150|FG000|Overall Study|Missed EOT/PTE Visit|1|||
155655233|NCT02378480|561832151|FG001|Overall Study|Missed EOT/PTE Visit|2|||
155655234|NCT02378480|561832150|FG000|Overall Study|Withdrawal by Subject|9|||
155655235|NCT02378480|561832151|FG001|Overall Study|Withdrawal by Subject|4|||
155655236|NCT02378480|561832150|FG000|Overall Study|Lost to Follow-up|10|||
155655237|NCT02378480|561832151|FG001|Overall Study|Lost to Follow-up|18|||
155655238|NCT01217892|561832152|FG000|Overall Study|Adverse Event|1|||
155487039|NCT01632345|561205810|FG006|Treatment: Part I|Physician Decision|0|||
155487040|NCT01632345|561205804|FG000|Treatment: Part I|Pregnancy|0|||
155487041|NCT01632345|561205805|FG001|Treatment: Part I|Pregnancy|1|||
155487042|NCT01632345|561205806|FG002|Treatment: Part I|Pregnancy|0|||
155487043|NCT01632345|561205807|FG003|Treatment: Part I|Pregnancy|0|||
155487044|NCT01632345|561205808|FG004|Treatment: Part I|Pregnancy|0|||
155487045|NCT01632345|561205809|FG005|Treatment: Part I|Pregnancy|0|||
155487046|NCT01632345|561205810|FG006|Treatment: Part I|Pregnancy|0|||
155487047|NCT01632345|561205804|FG000|Treatment: Part I|Protocol Deviation|0|||
155487048|NCT01632345|561205805|FG001|Treatment: Part I|Protocol Deviation|0|||
155487049|NCT01632345|561205806|FG002|Treatment: Part I|Protocol Deviation|1|||
155487050|NCT01632345|561205807|FG003|Treatment: Part I|Protocol Deviation|1|||
155487051|NCT01632345|561205808|FG004|Treatment: Part I|Protocol Deviation|0|||
155487052|NCT01632345|561205809|FG005|Treatment: Part I|Protocol Deviation|0|||
155487053|NCT01632345|561205810|FG006|Treatment: Part I|Protocol Deviation|0|||
155655239|NCT01217892|561832153|FG001|Overall Study|Adverse Event|1|||
155655240|NCT01217892|561832154|FG002|Overall Study|Adverse Event|1|||
155530624|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
155530625|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
155530626|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
155530627|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
155530628|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
155530629|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
155530630|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
155530631|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
155530632|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
155530633|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
155530634|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
155530635|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
155530636|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
155530637|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
155530638|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
155530639|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
155530640|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
155530641|NCT01667679|561367360|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
155530642|NCT01667679|561367361|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
155530643|NCT00835263|561367367|FG000|Second Intervention|Adverse Event|1|||
155530644|NCT00835263|561367368|FG001|Second Intervention|Adverse Event|0|||
155530645|NCT03987191|561367371|FG000|Overall Study|COVID-19 related research disruption|0|||
155530646|NCT03987191|561367372|FG001|Overall Study|COVID-19 related research disruption|2|||
155530647|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
155530648|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
155530649|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
155530650|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
155530651|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
155530652|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
155530653|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155530654|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155530655|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
155530656|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
155530657|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
155530658|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
155530659|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
155530660|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
155530661|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155530662|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155530663|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
155530664|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
155530665|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
155530666|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
155530667|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Death|0|||
155530668|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Death|1|||
155530669|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Death|0|||
155530670|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Death|0|||
155530671|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
155530672|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
155530673|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
155530674|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
155530675|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
155530676|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
155530677|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
155530678|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
155530679|NCT01940341|561367380|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155530680|NCT01940341|561367381|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
155530681|NCT01940341|561367382|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155530682|NCT01940341|561367383|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155530683|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155530684|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155530685|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
155530686|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
155530687|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155530688|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155655241|NCT01217892|561832155|FG003|Overall Study|Adverse Event|0|||
155530689|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
155530690|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
155530691|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155655242|NCT01217892|561832152|FG000|Overall Study|Withdrawal by Subject|0|||
155655243|NCT01217892|561832153|FG001|Overall Study|Withdrawal by Subject|2|||
155655244|NCT01217892|561832154|FG002|Overall Study|Withdrawal by Subject|1|||
155655245|NCT01217892|561832155|FG003|Overall Study|Withdrawal by Subject|0|||
155655246|NCT01217892|561832152|FG000|Overall Study|Lab value|1|||
155655247|NCT01217892|561832153|FG001|Overall Study|Lab value|0|||
155655248|NCT01217892|561832154|FG002|Overall Study|Lab value|1|||
155655249|NCT01217892|561832155|FG003|Overall Study|Lab value|0|||
155655250|NCT01217892|561832152|FG000|Overall Study|Subject no longer meets study criteria|5|||
155655251|NCT01217892|561832153|FG001|Overall Study|Subject no longer meets study criteria|2|||
155655252|NCT01217892|561832154|FG002|Overall Study|Subject no longer meets study criteria|4|||
155655253|NCT01217892|561832155|FG003|Overall Study|Subject no longer meets study criteria|8|||
155655254|NCT01217892|561832152|FG000|Overall Study|Incorrect enrollment|0|||
155655255|NCT01217892|561832153|FG001|Overall Study|Incorrect enrollment|1|||
155655256|NCT01217892|561832154|FG002|Overall Study|Incorrect enrollment|1|||
155655257|NCT01217892|561832155|FG003|Overall Study|Incorrect enrollment|0|||
155655258|NCT01217892|561832152|FG000|Overall Study|Poor/Non-Compliance|0|||
155655259|NCT01217892|561832153|FG001|Overall Study|Poor/Non-Compliance|0|||
155655260|NCT01217892|561832154|FG002|Overall Study|Poor/Non-Compliance|1|||
155655261|NCT01217892|561832155|FG003|Overall Study|Poor/Non-Compliance|0|||
155655262|NCT00480532|561832158|FG000|Overall Study|Withdrawal by Subject|2|||
155655263|NCT00480532|561832159|FG001|Overall Study|Withdrawal by Subject|4|||
155655264|NCT00480532|561832160|FG002|Overall Study|Withdrawal by Subject|3|||
155655265|NCT00480532|561832161|FG003|Overall Study|Withdrawal by Subject|1|||
155655266|NCT00480532|561832158|FG000|Overall Study|Protocol Violation|0|||
155655267|NCT00480532|561832159|FG001|Overall Study|Protocol Violation|0|||
155655268|NCT00480532|561832160|FG002|Overall Study|Protocol Violation|1|||
155655269|NCT00480532|561832161|FG003|Overall Study|Protocol Violation|0|||
155655270|NCT01592747|561832162|FG000|Overall Study|Loss of Therapeutic Response|107|||
155655271|NCT01592747|561832163|FG001|Overall Study|Loss of Therapeutic Response|108|||
155655272|NCT01592747|561832164|FG002|Overall Study|Loss of Therapeutic Response|100|||
155487054|NCT01632345|561205804|FG000|Treatment: Part I|Withdrawal by Subject|3|||
155487055|NCT01632345|561205805|FG001|Treatment: Part I|Withdrawal by Subject|4|||
155487056|NCT01632345|561205806|FG002|Treatment: Part I|Withdrawal by Subject|4|||
155487057|NCT01632345|561205807|FG003|Treatment: Part I|Withdrawal by Subject|1|||
155487058|NCT01632345|561205808|FG004|Treatment: Part I|Withdrawal by Subject|4|||
155487059|NCT01632345|561205809|FG005|Treatment: Part I|Withdrawal by Subject|0|||
155487060|NCT01632345|561205810|FG006|Treatment: Part I|Withdrawal by Subject|0|||
155487061|NCT01632345|561205804|FG000|Treatment: Part II|Adverse Event|0|||
155487062|NCT01632345|561205805|FG001|Treatment: Part II|Adverse Event|0|||
155487063|NCT01632345|561205806|FG002|Treatment: Part II|Adverse Event|0|||
155487064|NCT01632345|561205807|FG003|Treatment: Part II|Adverse Event|0|||
155487065|NCT01632345|561205808|FG004|Treatment: Part II|Adverse Event|0|||
155487066|NCT01632345|561205809|FG005|Treatment: Part II|Adverse Event|3|||
155487067|NCT01632345|561205810|FG006|Treatment: Part II|Adverse Event|8|||
155487068|NCT01632345|561205804|FG000|Treatment: Part II|Lost to Follow-up|0|||
155487069|NCT01632345|561205805|FG001|Treatment: Part II|Lost to Follow-up|0|||
155487070|NCT01632345|561205806|FG002|Treatment: Part II|Lost to Follow-up|0|||
155487071|NCT01632345|561205807|FG003|Treatment: Part II|Lost to Follow-up|0|||
155487072|NCT01632345|561205808|FG004|Treatment: Part II|Lost to Follow-up|0|||
155487073|NCT01632345|561205809|FG005|Treatment: Part II|Lost to Follow-up|3|||
155487074|NCT01632345|561205810|FG006|Treatment: Part II|Lost to Follow-up|1|||
155487075|NCT01632345|561205804|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487076|NCT01632345|561205805|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487077|NCT01632345|561205806|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487078|NCT01632345|561205807|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487079|NCT01632345|561205808|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487080|NCT01632345|561205809|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
155487081|NCT01632345|561205810|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
155487082|NCT01632345|561205804|FG000|Treatment: Part II|Withdrawal by Subject|0|||
155487083|NCT01632345|561205805|FG001|Treatment: Part II|Withdrawal by Subject|0|||
155487084|NCT01632345|561205806|FG002|Treatment: Part II|Withdrawal by Subject|0|||
155487085|NCT01632345|561205807|FG003|Treatment: Part II|Withdrawal by Subject|0|||
155487086|NCT01632345|561205808|FG004|Treatment: Part II|Withdrawal by Subject|0|||
155487087|NCT01632345|561205809|FG005|Treatment: Part II|Withdrawal by Subject|2|||
155655273|NCT01592747|561832162|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155655274|NCT01592747|561832163|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155655275|NCT01592747|561832164|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
155655276|NCT01592747|561832162|FG000|Overall Study|Adverse Event|1|||
155530692|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155530693|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
155530694|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155530695|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
155530696|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
155530697|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
155530698|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
155530699|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155530700|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155530701|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
155530702|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155530703|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
155530704|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
155530705|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
155530706|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
155530707|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155530708|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155530709|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
155530710|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155530711|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155530712|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155530713|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155530714|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
155530715|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155530716|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155530717|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155530718|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
155530719|NCT01940341|561367380|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
155530720|NCT01940341|561367381|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
155530721|NCT01940341|561367382|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
155530722|NCT01940341|561367383|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
155530723|NCT03552393|561367384|FG000|Core Period|Kidney Transplant|1|||
155530724|NCT03552393|561367384|FG000|Core Period|Prohibited Medication|1|||
155530725|NCT03552393|561367384|FG000|Safety Extension Period|Kidney Transplant|4|||
155530726|NCT05646251|561367385|FG000|Overall Study|Physician Decision|1|||
155530727|NCT05646251|561367386|FG001|Overall Study|Physician Decision|0|||
155530728|NCT05646251|561367387|FG002|Overall Study|Physician Decision|2|||
155530729|NCT00465270|561367388|FG000|Overall Study|Death|7|||
155530730|NCT00465270|561367389|FG001|Overall Study|Death|11|||
155530731|NCT00465270|561367388|FG000|Overall Study|Withdrawal by Subject|34|||
155530732|NCT00465270|561367389|FG001|Overall Study|Withdrawal by Subject|78|||
155530733|NCT00465270|561367388|FG000|Overall Study|Lost to Follow-up|60|||
155530734|NCT00465270|561367389|FG001|Overall Study|Lost to Follow-up|67|||
155530735|NCT00465270|561367388|FG000|Overall Study|Investigator request|3|||
155530736|NCT00465270|561367389|FG001|Overall Study|Investigator request|4|||
155530737|NCT02605928|561367393|FG000|Overall Study|Model tuning phase|28|||
155530738|NCT02605928|561367393|FG000|Overall Study|Lack of Efficacy|5|||
155530739|NCT01231906|561367394|FG000|Overall Study|Lack of Efficacy|75|||
155530740|NCT01231906|561367395|FG001|Overall Study|Lack of Efficacy|68|||
155530741|NCT01231906|561367394|FG000|Overall Study|Lost to Follow-up|1|||
155530742|NCT01231906|561367395|FG001|Overall Study|Lost to Follow-up|0|||
155530743|NCT01231906|561367394|FG000|Overall Study|Physician Decision|34|||
155530744|NCT01231906|561367395|FG001|Overall Study|Physician Decision|24|||
155530745|NCT01231906|561367394|FG000|Overall Study|Withdrawal by Subject|0|||
155530746|NCT01231906|561367395|FG001|Overall Study|Withdrawal by Subject|4|||
155530747|NCT01231906|561367394|FG000|Overall Study|Ineligible|10|||
155530748|NCT01231906|561367395|FG001|Overall Study|Ineligible|3|||
155530749|NCT01231906|561367394|FG000|Overall Study|No treatment|1|||
155530750|NCT01231906|561367395|FG001|Overall Study|No treatment|2|||
155530751|NCT05341622|561367396|FG000|Overall Study|Death|0|||
155530752|NCT05341622|561367397|FG001|Overall Study|Death|0|||
155530753|NCT05341622|561367398|FG002|Overall Study|Death|0|||
155530754|NCT05341622|561367399|FG003|Overall Study|Death|0|||
155530755|NCT05341622|561367400|FG004|Overall Study|Death|1|||
155530756|NCT05341622|561367401|FG005|Overall Study|Death|0|||
155530757|NCT05341622|561367402|FG006|Overall Study|Death|0|||
155530758|NCT05341622|561367403|FG007|Overall Study|Death|1|||
155530759|NCT05341622|561367396|FG000|Overall Study|Invalid Address|0|||
155655277|NCT01592747|561832163|FG001|Overall Study|Adverse Event|0|||
155530760|NCT05341622|561367397|FG001|Overall Study|Invalid Address|1|||
155530761|NCT05341622|561367398|FG002|Overall Study|Invalid Address|0|||
155530762|NCT05341622|561367399|FG003|Overall Study|Invalid Address|0|||
155530763|NCT05341622|561367400|FG004|Overall Study|Invalid Address|0|||
155530764|NCT05341622|561367401|FG005|Overall Study|Invalid Address|0|||
155530765|NCT05341622|561367402|FG006|Overall Study|Invalid Address|0|||
155530766|NCT05341622|561367403|FG007|Overall Study|Invalid Address|0|||
155530767|NCT05341622|561367396|FG000|Overall Study|Ineligible|26|||
155530768|NCT05341622|561367397|FG001|Overall Study|Ineligible|21|||
155530769|NCT05341622|561367398|FG002|Overall Study|Ineligible|28|||
155530770|NCT05341622|561367399|FG003|Overall Study|Ineligible|24|||
155530771|NCT05341622|561367400|FG004|Overall Study|Ineligible|29|||
155530772|NCT05341622|561367401|FG005|Overall Study|Ineligible|31|||
155530773|NCT05341622|561367402|FG006|Overall Study|Ineligible|28|||
155530774|NCT05341622|561367403|FG007|Overall Study|Ineligible|26|||
155530775|NCT02658084|561367404|FG000|Overall Study|Withdrawal by Subject|1|||
155530776|NCT02658084|561367405|FG001|Overall Study|Withdrawal by Subject|0|||
155530777|NCT02658084|561367404|FG000|Overall Study|Study Termination|1|||
155530778|NCT02658084|561367405|FG001|Overall Study|Study Termination|0|||
155530779|NCT03600805|561369104|FG000|Overall Study|Adverse Event|2|||
155530780|NCT03600805|561369105|FG001|Overall Study|Adverse Event|1|||
155530781|NCT03600805|561369106|FG002|Overall Study|Adverse Event|1|||
155530782|NCT03600805|561369107|FG003|Overall Study|Adverse Event|7|||
155530783|NCT03600805|561369104|FG000|Overall Study|Lack of Efficacy|2|||
155530784|NCT03600805|561369105|FG001|Overall Study|Lack of Efficacy|1|||
155530785|NCT03600805|561369106|FG002|Overall Study|Lack of Efficacy|0|||
155530786|NCT03600805|561369107|FG003|Overall Study|Lack of Efficacy|0|||
155530787|NCT03600805|561369104|FG000|Overall Study|Withdrawal by Subject|1|||
155530788|NCT03600805|561369105|FG001|Overall Study|Withdrawal by Subject|0|||
155530789|NCT03600805|561369106|FG002|Overall Study|Withdrawal by Subject|0|||
155530790|NCT03600805|561369107|FG003|Overall Study|Withdrawal by Subject|1|||
155530791|NCT03600805|561369104|FG000|Overall Study|Other unspecified|14|||
155530792|NCT03600805|561369105|FG001|Overall Study|Other unspecified|6|||
155530793|NCT03600805|561369106|FG002|Overall Study|Other unspecified|7|||
155530794|NCT03600805|561369107|FG003|Overall Study|Other unspecified|11|||
155530795|NCT03635320|561369108|FG000|Overall Study|not implanted the device|1|||
155530796|NCT03635320|561369109|FG001|Overall Study|not implanted the device|2|||
155530797|NCT03635320|561369108|FG000|Overall Study|Withdrawal by Subject|11|||
155530798|NCT03635320|561369109|FG001|Overall Study|Withdrawal by Subject|6|||
155530799|NCT03049748|561369110|FG000|Overall Study|Lost to Follow-up|1|||
155530800|NCT03049748|561369111|FG001|Overall Study|Lost to Follow-up|0|||
155530801|NCT03049748|561369110|FG000|Overall Study|Death|3|||
155530802|NCT03049748|561369111|FG001|Overall Study|Death|0|||
155530803|NCT03049748|561369110|FG000|Overall Study|Withdrawal by Subject|0|||
155530804|NCT03049748|561369111|FG001|Overall Study|Withdrawal by Subject|3|||
155530805|NCT03049748|561369110|FG000|Overall Study|Protocol Violation|0|||
155530806|NCT03049748|561369111|FG001|Overall Study|Protocol Violation|2|||
155530807|NCT03049748|561369110|FG000|Overall Study|Moved out of state (relocation)|0|||
155530808|NCT03049748|561369111|FG001|Overall Study|Moved out of state (relocation)|1|||
155530809|NCT01471353|561369112|FG000|Overall Study|remain on study|3|||
155530810|NCT01735994|561369113|FG000|Overall Study|Withdrawal by Subject|6|||
155530811|NCT01735994|561369114|FG001|Overall Study|Withdrawal by Subject|4|||
155530812|NCT01735994|561369113|FG000|Overall Study|Injury|2|||
155530813|NCT01735994|561369114|FG001|Overall Study|Injury|0|||
155530814|NCT01735994|561369113|FG000|Overall Study|Kicked off team|5|||
155530815|NCT01735994|561369114|FG001|Overall Study|Kicked off team|0|||
155530816|NCT01735994|561369113|FG000|Overall Study|Lost to Follow-up|50|||
155530817|NCT01735994|561369114|FG001|Overall Study|Lost to Follow-up|62|||
155530818|NCT03123094|561369115|FG000|Overall Study|Withdrawal by Subject|0|||
155530819|NCT03123094|561369116|FG001|Overall Study|Withdrawal by Subject|2|||
155530820|NCT03123094|561369117|FG002|Overall Study|Withdrawal by Subject|1|||
155530821|NCT03123094|561369118|FG003|Overall Study|Withdrawal by Subject|0|||
155530822|NCT03123094|561369119|FG004|Overall Study|Withdrawal by Subject|1|||
155530823|NCT02682238|561369125|FG000|Overall Study|Lost to Follow-up|0|||
155530824|NCT02682238|561369126|FG001|Overall Study|Lost to Follow-up|2|||
155530825|NCT02682238|561369125|FG000|Overall Study|Withdrawal by Subject|1|||
155530826|NCT02682238|561369126|FG001|Overall Study|Withdrawal by Subject|0|||
155530827|NCT02682238|561369125|FG000|Overall Study|Adverse Event|1|||
155530828|NCT02682238|561369126|FG001|Overall Study|Adverse Event|0|||
155530829|NCT02682238|561369125|FG000|Overall Study|Non-compliance with Study Drug|1|||
155530830|NCT02682238|561369126|FG001|Overall Study|Non-compliance with Study Drug|0|||
155530831|NCT02682238|561369125|FG000|Overall Study|Non-compliance with Protocol|0|||
155530832|NCT02682238|561369126|FG001|Overall Study|Non-compliance with Protocol|2|||
155530833|NCT00824291|561369131|FG000|Overall Study|Adverse Event|15|||
155530834|NCT00824291|561369132|FG001|Overall Study|Adverse Event|6|||
155530835|NCT00824291|561369131|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
155530836|NCT00824291|561369132|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
155530837|NCT00824291|561369131|FG000|Overall Study|Lost to Follow-up|11|||
155530838|NCT00824291|561369132|FG001|Overall Study|Lost to Follow-up|9|||
155530839|NCT00824291|561369131|FG000|Overall Study|Non-compliance|1|||
155530840|NCT00824291|561369132|FG001|Overall Study|Non-compliance|1|||
155530841|NCT00824291|561369131|FG000|Overall Study|Protocol Violation|4|||
155530842|NCT00824291|561369132|FG001|Overall Study|Protocol Violation|1|||
155530843|NCT00824291|561369131|FG000|Overall Study|Withdrawal by Subject|14|||
155530844|NCT00824291|561369132|FG001|Overall Study|Withdrawal by Subject|8|||
155530845|NCT00824291|561369131|FG000|Overall Study|Lack of Efficacy|7|||
155530846|NCT00824291|561369132|FG001|Overall Study|Lack of Efficacy|8|||
155530847|NCT00824291|561369131|FG000|Overall Study|Participant on prohibited medication|1|||
155530848|NCT00824291|561369132|FG001|Overall Study|Participant on prohibited medication|0|||
155530849|NCT02849457|561369136|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
155530850|NCT02849457|561369137|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
155530851|NCT02849457|561369138|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
155530852|NCT02849457|561369139|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
155530853|NCT00392665|561369140|FG000|Overall Study|Death|16|||
155530854|NCT00392665|561369141|FG001|Overall Study|Death|14|||
155530855|NCT00392665|561369140|FG000|Overall Study|Lost to Follow-up|1|||
155530856|NCT00392665|561369141|FG001|Overall Study|Lost to Follow-up|1|||
155530857|NCT03673670|561369145|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
155530858|NCT03673670|561369146|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155530859|NCT03673670|561369147|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155530860|NCT03673670|561369148|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155530861|NCT03673670|561369149|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155530862|NCT03673670|561369150|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155530863|NCT03673670|561369145|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
155530864|NCT03673670|561369146|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
155530865|NCT03673670|561369147|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
155530866|NCT03673670|561369148|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
155530867|NCT03673670|561369149|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
155530868|NCT03673670|561369150|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
155530869|NCT03673670|561369145|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
155530870|NCT03673670|561369146|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
155530871|NCT03673670|561369147|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
155530872|NCT03673670|561369148|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
155530873|NCT03673670|561369149|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
155530874|NCT03673670|561369150|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
155530875|NCT03673670|561369145|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
155530876|NCT03673670|561369146|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
155530877|NCT03673670|561369147|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
155530878|NCT03673670|561369148|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
155530879|NCT03673670|561369149|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
155530880|NCT03673670|561369150|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
155530881|NCT03673670|561369145|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
155530882|NCT03673670|561369146|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
155530883|NCT03673670|561369147|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
155530884|NCT03673670|561369148|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
155530885|NCT03673670|561369149|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
155530886|NCT03673670|561369150|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
155530887|NCT03673670|561369145|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
155530888|NCT03673670|561369146|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
155530889|NCT03673670|561369147|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
155530890|NCT03673670|561369148|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
155530891|NCT03673670|561369149|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
155530892|NCT03673670|561369150|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
155530893|NCT03673670|561369145|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
155530894|NCT03673670|561369146|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
155530895|NCT03673670|561369147|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
155530896|NCT03673670|561369148|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
155530897|NCT03673670|561369149|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
155530898|NCT03673670|561369150|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
155530899|NCT04408794|561369151|FG000|Overall Study|Adverse Event|43|||
155530900|NCT04408794|561369151|FG000|Overall Study|Infrequent study drug usage|43|||
155530901|NCT04408794|561369151|FG000|Overall Study|Lack of Efficacy|61|||
155530902|NCT04408794|561369151|FG000|Overall Study|Lost to Follow-up|33|||
155530903|NCT04408794|561369151|FG000|Overall Study|Non-compliance|6|||
155530904|NCT04408794|561369151|FG000|Overall Study|Physician Decision|1|||
155530905|NCT04408794|561369151|FG000|Overall Study|Pregnancy|6|||
155530906|NCT04408794|561369151|FG000|Overall Study|Protocol Deviation|9|||
155530907|NCT04408794|561369151|FG000|Overall Study|Sheehan-STS Result|1|||
155530908|NCT04408794|561369151|FG000|Overall Study|Withdrawal by Subject|57|||
155530909|NCT04408794|561369151|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
155530910|NCT04408794|561369151|FG000|Overall Study|Never Treated Migraine|5|||
155530911|NCT03437265|561369154|FG000|Overall Study|Protocol Violation|6|||
155530912|NCT02294786|561369157|FG000|Overall Study|Withdrawal by Subject|0|||
155530913|NCT02294786|561369158|FG001|Overall Study|Withdrawal by Subject|1|||
155530914|NCT02294786|561369157|FG000|Overall Study|Physician Decision|6|||
155530915|NCT02294786|561369158|FG001|Overall Study|Physician Decision|7|||
155530916|NCT02294786|561369157|FG000|Overall Study|Lost to Follow-up|1|||
155530917|NCT02294786|561369158|FG001|Overall Study|Lost to Follow-up|2|||
155530918|NCT02294786|561369157|FG000|Overall Study|Protocol Violation|1|||
155530919|NCT02294786|561369158|FG001|Overall Study|Protocol Violation|0|||
155530920|NCT02294786|561369157|FG000|Overall Study|Adverse Event|1|||
155530921|NCT02294786|561369158|FG001|Overall Study|Adverse Event|1|||
155530922|NCT02294786|561369157|FG000|Overall Study|Death|2|||
155530923|NCT02294786|561369158|FG001|Overall Study|Death|3|||
155530924|NCT01778010|561369159|FG000|Overall Study|Withdrawal by Subject|2|||
155530925|NCT01778010|561369159|FG000|Overall Study|abnormal ECG before meds|1|||
155530926|NCT01778010|561369159|FG000|Overall Study|Arrested|1|||
155530927|NCT01778010|561369159|FG000|Overall Study|rash while on placebo|1|||
155530928|NCT00840073|561369164|FG000|Second Intervention|Missed 72 hour blood draw|1|||
155530929|NCT00840073|561369165|FG001|Second Intervention|Missed 72 hour blood draw|1|||
155530930|NCT00556322|561369166|FG000|Overall Study|Insufficient therapeutic response|158|||
155530931|NCT00556322|561369167|FG001|Overall Study|Insufficient therapeutic response|168|||
155530932|NCT00556322|561369166|FG000|Overall Study|Adverse Event|7|||
155530933|NCT00556322|561369167|FG001|Overall Study|Adverse Event|4|||
155530934|NCT00556322|561369166|FG000|Overall Study|Other|4|||
155530935|NCT00556322|561369167|FG001|Overall Study|Other|1|||
155530936|NCT00556322|561369166|FG000|Overall Study|Lost to Follow-up|5|||
155530937|NCT00556322|561369167|FG001|Overall Study|Lost to Follow-up|3|||
155530938|NCT00556322|561369166|FG000|Overall Study|Withdrawal by Subject|19|||
155530939|NCT00556322|561369167|FG001|Overall Study|Withdrawal by Subject|7|||
155530940|NCT00556322|561369166|FG000|Overall Study|Protocol Violation|5|||
155530941|NCT00556322|561369167|FG001|Overall Study|Protocol Violation|1|||
155530942|NCT00556322|561369166|FG000|Overall Study|Ongoing at data cutoff|3|||
155530943|NCT00556322|561369167|FG001|Overall Study|Ongoing at data cutoff|5|||
155530944|NCT00556322|561369166|FG000|Overall Study|Death|20|||
155530945|NCT00556322|561369167|FG001|Overall Study|Death|14|||
155530946|NCT03249454|561369168|FG000|Overall Study|Withdrawal by Subject|0|||
155530947|NCT03249454|561369169|FG001|Overall Study|Withdrawal by Subject|0|||
155530948|NCT03249454|561369170|FG002|Overall Study|Withdrawal by Subject|0|||
155530949|NCT03249454|561369171|FG003|Overall Study|Withdrawal by Subject|0|||
155530950|NCT03249454|561369172|FG004|Overall Study|Withdrawal by Subject|0|||
155530951|NCT03249454|561369173|FG005|Overall Study|Withdrawal by Subject|0|||
155530952|NCT03249454|561369174|FG006|Overall Study|Withdrawal by Subject|0|||
155530953|NCT03249454|561369175|FG007|Overall Study|Withdrawal by Subject|0|||
155530954|NCT03249454|561369176|FG008|Overall Study|Withdrawal by Subject|0|||
155530955|NCT03249454|561369177|FG009|Overall Study|Withdrawal by Subject|1|||
155530956|NCT03249454|561369178|FG010|Overall Study|Withdrawal by Subject|1|||
155530957|NCT01913405|561369179|FG000|Overall Study|Withdrawal by Subject|1|||
155530958|NCT01913405|561369179|FG000|Overall Study|Adverse Event|1|||
155530959|NCT01020474|561369180|FG000|Overall Study|Adverse Event|4|||
155530960|NCT01020474|561369181|FG001|Overall Study|Adverse Event|4|||
155530961|NCT01020474|561369180|FG000|Overall Study|Protocol Violation|0|||
155530962|NCT01020474|561369181|FG001|Overall Study|Protocol Violation|2|||
155530963|NCT01020474|561369180|FG000|Overall Study|Withdrawal by Subject|5|||
155530964|NCT01020474|561369181|FG001|Overall Study|Withdrawal by Subject|7|||
155530965|NCT01020474|561369180|FG000|Overall Study|Other Reasons|1|||
155530966|NCT01020474|561369181|FG001|Overall Study|Other Reasons|1|||
155530967|NCT01020474|561369180|FG000|Overall Study|Insufficient Clinical Response|0|||
155530968|NCT01020474|561369181|FG001|Overall Study|Insufficient Clinical Response|3|||
155530969|NCT01103713|561369183|FG000|Overall Study|Lost to Follow-up|2|||
155530970|NCT01103713|561369183|FG000|Overall Study|Withdrawal by Subject|8|||
155530971|NCT01103713|561369183|FG000|Overall Study|Study terminated by sponsor|2|||
155530972|NCT01103713|561369183|FG000|Overall Study|Other|1|||
155530973|NCT02645409|561369184|FG000|Overall Study|Withdrawal by Subject|3|||
155530974|NCT02645409|561369185|FG001|Overall Study|Withdrawal by Subject|0|||
155530975|NCT02645409|561369184|FG000|Overall Study|Physician Decision|1|||
155530976|NCT02645409|561369185|FG001|Overall Study|Physician Decision|0|||
155530977|NCT02089685|561369186|FG000|Overall Study|Adverse Event|1|||
155530978|NCT02089685|561369187|FG001|Overall Study|Adverse Event|0|||
155530979|NCT02089685|561369188|FG002|Overall Study|Adverse Event|0|||
155530980|NCT02089685|561369189|FG003|Overall Study|Adverse Event|0|||
155530981|NCT02089685|561369190|FG004|Overall Study|Adverse Event|1|||
155530982|NCT02089685|561369191|FG005|Overall Study|Adverse Event|0|||
155530983|NCT02089685|561369186|FG000|Overall Study|Clinical Progression|4|||
155530984|NCT02089685|561369187|FG001|Overall Study|Clinical Progression|0|||
155530985|NCT02089685|561369188|FG002|Overall Study|Clinical Progression|0|||
155530986|NCT02089685|561369189|FG003|Overall Study|Clinical Progression|5|||
155530987|NCT02089685|561369190|FG004|Overall Study|Clinical Progression|1|||
155530988|NCT02089685|561369191|FG005|Overall Study|Clinical Progression|2|||
155530989|NCT02089685|561369186|FG000|Overall Study|Excluded Medication|1|||
155530990|NCT02089685|561369187|FG001|Overall Study|Excluded Medication|0|||
155530991|NCT02089685|561369188|FG002|Overall Study|Excluded Medication|0|||
155530992|NCT02089685|561369189|FG003|Overall Study|Excluded Medication|11|||
155530993|NCT02089685|561369190|FG004|Overall Study|Excluded Medication|2|||
155530994|NCT02089685|561369191|FG005|Overall Study|Excluded Medication|1|||
155530995|NCT02089685|561369186|FG000|Overall Study|Progressive disease|13|||
155530996|NCT02089685|561369187|FG001|Overall Study|Progressive disease|10|||
155530997|NCT02089685|561369188|FG002|Overall Study|Progressive disease|3|||
155530998|NCT02089685|561369189|FG003|Overall Study|Progressive disease|51|||
155530999|NCT02089685|561369190|FG004|Overall Study|Progressive disease|17|||
155531000|NCT02089685|561369191|FG005|Overall Study|Progressive disease|12|||
155531001|NCT02089685|561369186|FG000|Overall Study|Follow up ended by sponsor|2|||
155531002|NCT02089685|561369187|FG001|Overall Study|Follow up ended by sponsor|2|||
155531003|NCT02089685|561369188|FG002|Overall Study|Follow up ended by sponsor|0|||
155531004|NCT02089685|561369189|FG003|Overall Study|Follow up ended by sponsor|70|||
155655278|NCT01592747|561832164|FG002|Overall Study|Adverse Event|0|||
155655279|NCT01592747|561832162|FG000|Overall Study|Protocol Violation|4|||
155655280|NCT01592747|561832163|FG001|Overall Study|Protocol Violation|0|||
155531005|NCT02089685|561369190|FG004|Overall Study|Follow up ended by sponsor|26|||
155531006|NCT02089685|561369191|FG005|Overall Study|Follow up ended by sponsor|26|||
155531007|NCT02089685|561369186|FG000|Overall Study|Withdrawal by Subject|0|||
155531008|NCT02089685|561369187|FG001|Overall Study|Withdrawal by Subject|2|||
155531009|NCT02089685|561369188|FG002|Overall Study|Withdrawal by Subject|0|||
155531010|NCT02089685|561369189|FG003|Overall Study|Withdrawal by Subject|8|||
155531011|NCT02089685|561369190|FG004|Overall Study|Withdrawal by Subject|1|||
155655281|NCT01592747|561832164|FG002|Overall Study|Protocol Violation|4|||
155531012|NCT02089685|561369191|FG005|Overall Study|Withdrawal by Subject|1|||
155531013|NCT02089685|561369186|FG000|Overall Study|Status not recorded|1|||
155531014|NCT02089685|561369187|FG001|Overall Study|Status not recorded|0|||
155531015|NCT02089685|561369188|FG002|Overall Study|Status not recorded|0|||
155531016|NCT02089685|561369189|FG003|Overall Study|Status not recorded|0|||
155531017|NCT02089685|561369190|FG004|Overall Study|Status not recorded|1|||
155531018|NCT02089685|561369191|FG005|Overall Study|Status not recorded|0|||
155531019|NCT02089685|561369186|FG000|Overall Study|Death|0|||
155531020|NCT02089685|561369187|FG001|Overall Study|Death|0|||
155531021|NCT02089685|561369188|FG002|Overall Study|Death|0|||
155531022|NCT02089685|561369189|FG003|Overall Study|Death|7|||
155531023|NCT02089685|561369190|FG004|Overall Study|Death|2|||
155531024|NCT02089685|561369191|FG005|Overall Study|Death|5|||
155531025|NCT02089685|561369186|FG000|Overall Study|Lost to Follow-up|0|||
155531026|NCT02089685|561369187|FG001|Overall Study|Lost to Follow-up|0|||
155531027|NCT02089685|561369188|FG002|Overall Study|Lost to Follow-up|0|||
155531028|NCT02089685|561369189|FG003|Overall Study|Lost to Follow-up|1|||
155531029|NCT02089685|561369190|FG004|Overall Study|Lost to Follow-up|0|||
155531030|NCT02089685|561369191|FG005|Overall Study|Lost to Follow-up|0|||
155531031|NCT02089685|561369186|FG000|Overall Study|Physician Decision|0|||
155531032|NCT02089685|561369187|FG001|Overall Study|Physician Decision|0|||
155531033|NCT02089685|561369188|FG002|Overall Study|Physician Decision|0|||
155531034|NCT02089685|561369189|FG003|Overall Study|Physician Decision|0|||
155531035|NCT02089685|561369190|FG004|Overall Study|Physician Decision|0|||
155531036|NCT02089685|561369191|FG005|Overall Study|Physician Decision|4|||
155531037|NCT02089685|561369186|FG000|Overall Study|Screen failure|1|||
155531038|NCT02089685|561369187|FG001|Overall Study|Screen failure|0|||
155531039|NCT02089685|561369188|FG002|Overall Study|Screen failure|0|||
155531040|NCT02089685|561369189|FG003|Overall Study|Screen failure|0|||
155531041|NCT02089685|561369190|FG004|Overall Study|Screen failure|0|||
155531042|NCT02089685|561369191|FG005|Overall Study|Screen failure|0|||
155531043|NCT04887415|561369197|FG000|Overall Study|Lost to Follow-up|2|||
155531044|NCT00841698|561369198|FG000|First Intervention|Withdrawal by Subject|1|||
155531045|NCT00841698|561369199|FG001|First Intervention|Withdrawal by Subject|0|||
155531046|NCT00191815|561369200|FG000|Overall Study|Adverse Event|2|||
155531047|NCT00191815|561369200|FG000|Overall Study|Disease progression or relapse|24|||
155531048|NCT00191815|561369200|FG000|Overall Study|Death|2|||
155531049|NCT00191815|561369200|FG000|Overall Study|Protocol Violation|3|||
155531050|NCT00191815|561369200|FG000|Overall Study|Physician Decision|2|||
155531051|NCT00191815|561369200|FG000|Overall Study|Withdrawal by Subject|7|||
155531052|NCT01218867|561369203|FG000|Overall Study|Death during treatment|0|||
155531053|NCT01218867|561369204|FG001|Overall Study|Death during treatment|0|||
155531054|NCT01218867|561369205|FG002|Overall Study|Death during treatment|0|||
155531055|NCT01218867|561369206|FG003|Overall Study|Death during treatment|0|||
155531056|NCT01218867|561369207|FG004|Overall Study|Death during treatment|0|||
155531057|NCT01218867|561369208|FG005|Overall Study|Death during treatment|0|||
155531058|NCT01218867|561369209|FG006|Overall Study|Death during treatment|1|||
155531059|NCT01218867|561369210|FG007|Overall Study|Death during treatment|0|||
155531060|NCT01218867|561369211|FG008|Overall Study|Death during treatment|0|||
155531061|NCT01218867|561369212|FG009|Overall Study|Death during treatment|0|||
155531062|NCT01218867|561369213|FG010|Overall Study|Death during treatment|0|||
155531063|NCT00251979|561369214|FG000|Overall Study|Protocol Violation|3|||
155531064|NCT00251979|561369215|FG001|Overall Study|Protocol Violation|5|||
155531065|NCT00251979|561369214|FG000|Overall Study|Adverse Event|11|||
155531066|NCT00251979|561369215|FG001|Overall Study|Adverse Event|17|||
155655282|NCT01592747|561832162|FG000|Overall Study|Lack of Efficacy|0|||
155655283|NCT01592747|561832163|FG001|Overall Study|Lack of Efficacy|1|||
155655284|NCT01592747|561832164|FG002|Overall Study|Lack of Efficacy|0|||
155531067|NCT00251979|561369214|FG000|Overall Study|Withdrawal by Subject|13|||
155531068|NCT00251979|561369215|FG001|Overall Study|Withdrawal by Subject|7|||
155531069|NCT00251979|561369214|FG000|Overall Study|Lost to Follow-up|8|||
155531070|NCT00251979|561369215|FG001|Overall Study|Lost to Follow-up|6|||
155531071|NCT00251979|561369214|FG000|Overall Study|Death|3|||
155531072|NCT00251979|561369215|FG001|Overall Study|Death|5|||
155531073|NCT01878292|561369223|FG000|Randomized|Protocol Violation|1|||
155531074|NCT01878292|561369224|FG001|Randomized|Protocol Violation|0|||
155531075|NCT01878292|561369225|FG002|Randomized|Protocol Violation|0|||
155531076|NCT01878292|561369223|FG000|Randomized|Lost to Follow-up|1|||
155531077|NCT01878292|561369224|FG001|Randomized|Lost to Follow-up|0|||
155655285|NCT01592747|561832162|FG000|Overall Study|Withdrawal by Subject|2|||
155531078|NCT01878292|561369225|FG002|Randomized|Lost to Follow-up|0|||
155531079|NCT01878292|561369223|FG000|Randomized|Adverse Event|1|||
155531080|NCT01878292|561369224|FG001|Randomized|Adverse Event|0|||
155531081|NCT01878292|561369225|FG002|Randomized|Adverse Event|0|||
155531082|NCT01878292|561369223|FG000|Double-blind Treatment Period|Other Reasons|2|||
155531083|NCT01878292|561369224|FG001|Double-blind Treatment Period|Other Reasons|0|||
155531084|NCT01878292|561369225|FG002|Double-blind Treatment Period|Other Reasons|0|||
155531085|NCT01878292|561369223|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
155531086|NCT01878292|561369224|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
155531087|NCT01878292|561369225|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155531088|NCT01878292|561369223|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
155531089|NCT01878292|561369224|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
155531090|NCT01878292|561369225|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
155531091|NCT01878292|561369223|FG000|Double-blind Treatment Period|Protocol Violation|3|||
155531092|NCT01878292|561369224|FG001|Double-blind Treatment Period|Protocol Violation|4|||
155531093|NCT01878292|561369225|FG002|Double-blind Treatment Period|Protocol Violation|2|||
155531094|NCT01878292|561369223|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
155531095|NCT01878292|561369224|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
155531096|NCT01878292|561369225|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155531097|NCT01878292|561369223|FG000|Double-blind Treatment Period|Adverse Event|4|||
155531098|NCT01878292|561369224|FG001|Double-blind Treatment Period|Adverse Event|9|||
155531099|NCT01878292|561369225|FG002|Double-blind Treatment Period|Adverse Event|8|||
155531100|NCT01878292|561369223|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
155531101|NCT01878292|561369224|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
155531102|NCT01878292|561369225|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
155531103|NCT02530905|561369226|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
155531104|NCT02530905|561369227|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
155531105|NCT02530905|561369228|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
155531106|NCT00415363|561369234|FG000|Overall Study|Withdrawal by Subject|4|||
155531107|NCT00415363|561369235|FG001|Overall Study|Withdrawal by Subject|4|||
155531108|NCT00415363|561369234|FG000|Overall Study|Adverse Event|4|||
155531109|NCT00415363|561369235|FG001|Overall Study|Adverse Event|4|||
155531110|NCT00415363|561369234|FG000|Overall Study|Lost to Follow-up|2|||
155531111|NCT00415363|561369235|FG001|Overall Study|Lost to Follow-up|1|||
155531112|NCT00415363|561369234|FG000|Overall Study|Physician Decision|3|||
155531113|NCT00415363|561369235|FG001|Overall Study|Physician Decision|1|||
155531114|NCT00415363|561369234|FG000|Overall Study|Death|16|||
155531115|NCT00415363|561369235|FG001|Overall Study|Death|12|||
155531116|NCT00415363|561369234|FG000|Overall Study|Progressive disease|26|||
155531117|NCT00415363|561369235|FG001|Overall Study|Progressive disease|32|||
155531118|NCT03123471|561369236|FG000|Placebo-controlled Phase|Adverse Event|3|||
155531119|NCT03123471|561369237|FG001|Placebo-controlled Phase|Adverse Event|8|||
155531120|NCT03123471|561369236|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
155531121|NCT03123471|561369237|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
155531122|NCT03123471|561369236|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
155531123|NCT03123471|561369237|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
155531124|NCT03123471|561369236|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
155531125|NCT03123471|561369237|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
155531126|NCT03123471|561369236|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
155531127|NCT03123471|561369237|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
155531128|NCT03123471|561369236|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
155531129|NCT03123471|561369237|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
155531130|NCT03123471|561369236|FG000|Placebo-controlled Phase|Miscellaneous|0|||
155531131|NCT03123471|561369237|FG001|Placebo-controlled Phase|Miscellaneous|1|||
155531132|NCT03123471|561369236|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
155531133|NCT03123471|561369237|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
155531134|NCT03123471|561369236|FG000|Apremilast Extension Phase|Adverse Event|1|||
155531135|NCT03123471|561369237|FG001|Apremilast Extension Phase|Adverse Event|5|||
155531136|NCT03123471|561369236|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
155531137|NCT03123471|561369237|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
155531138|NCT03123471|561369236|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
155531139|NCT03123471|561369237|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
155531140|NCT01136174|561369241|FG000|Overall Study|Adverse Event|0|||
155531141|NCT01136174|561369242|FG001|Overall Study|Adverse Event|0|||
155531142|NCT01136174|561369243|FG002|Overall Study|Adverse Event|0|||
155531143|NCT01136174|561369244|FG003|Overall Study|Adverse Event|4|||
155531144|NCT01249651|561369248|FG000|Overall Study|Withdrawal by Subject|4|||
155531145|NCT01249651|561369248|FG000|Overall Study|Adverse Event|1|||
155531146|NCT01249651|561369248|FG000|Overall Study|Protocol Violation|1|||
155531147|NCT01249651|561369248|FG000|Overall Study|Sponsor Decision|1|||
155531148|NCT00813592|561369253|FG000|Overall Study|Disease assessment was not completed per|2|||
155531149|NCT01588236|561369258|FG000|Overall Study|Adverse Event|5|||
155531150|NCT01588236|561369259|FG001|Overall Study|Adverse Event|4|||
155531151|NCT01588236|561369260|FG002|Overall Study|Adverse Event|1|||
155531152|NCT01588236|561369258|FG000|Overall Study|Lost to Follow-up|8|||
155531153|NCT01588236|561369259|FG001|Overall Study|Lost to Follow-up|13|||
155531154|NCT01588236|561369260|FG002|Overall Study|Lost to Follow-up|6|||
155531155|NCT01588236|561369258|FG000|Overall Study|Physician Decision|1|||
155531156|NCT01588236|561369259|FG001|Overall Study|Physician Decision|2|||
155531157|NCT01588236|561369260|FG002|Overall Study|Physician Decision|0|||
155531158|NCT01588236|561369258|FG000|Overall Study|Protocol Violation|0|||
155531159|NCT01588236|561369259|FG001|Overall Study|Protocol Violation|1|||
155531160|NCT01588236|561369260|FG002|Overall Study|Protocol Violation|1|||
155531161|NCT01588236|561369258|FG000|Overall Study|Withdrawal by Subject|14|||
155531162|NCT01588236|561369259|FG001|Overall Study|Withdrawal by Subject|16|||
155531163|NCT01588236|561369260|FG002|Overall Study|Withdrawal by Subject|18|||
155531164|NCT01588236|561369258|FG000|Overall Study|Exclusion Criteria met during study|2|||
155531165|NCT01588236|561369259|FG001|Overall Study|Exclusion Criteria met during study|1|||
155531166|NCT01588236|561369260|FG002|Overall Study|Exclusion Criteria met during study|0|||
155531167|NCT01588236|561369258|FG000|Overall Study|sponsor decision|1|||
155531168|NCT01588236|561369259|FG001|Overall Study|sponsor decision|6|||
155531169|NCT01588236|561369260|FG002|Overall Study|sponsor decision|2|||
155531170|NCT03873272|561369261|FG000|Overall Study|Withdrawal by Subject|2|||
155531171|NCT03873272|561369262|FG001|Overall Study|Withdrawal by Subject|0|||
155531172|NCT03873272|561369263|FG002|Overall Study|Withdrawal by Subject|1|||
155531173|NCT03873272|561369261|FG000|Overall Study|Death|0|||
155531174|NCT03873272|561369262|FG001|Overall Study|Death|2|||
155531175|NCT03873272|561369263|FG002|Overall Study|Death|1|||
155531176|NCT00787254|561369264|FG000|Overall Study|Adverse Event|24|||
155531177|NCT00787254|561369265|FG001|Overall Study|Adverse Event|23|||
155531178|NCT00787254|561369264|FG000|Overall Study|Protocol Violation|26|||
155531179|NCT00787254|561369265|FG001|Overall Study|Protocol Violation|23|||
155531180|NCT00787254|561369264|FG000|Overall Study|Withdrawal by Subject|16|||
155531181|NCT00787254|561369265|FG001|Overall Study|Withdrawal by Subject|11|||
155531182|NCT00787254|561369264|FG000|Overall Study|Lack of Efficacy|4|||
155531183|NCT00787254|561369265|FG001|Overall Study|Lack of Efficacy|15|||
155531184|NCT00787254|561369264|FG000|Overall Study|NSAIDs discontinuation|1|||
155531185|NCT00787254|561369265|FG001|Overall Study|NSAIDs discontinuation|2|||
155531186|NCT00787254|561369264|FG000|Overall Study|Institution closed|1|||
155531187|NCT00787254|561369265|FG001|Overall Study|Institution closed|0|||
155531188|NCT00787254|561369264|FG000|Overall Study|Physician Decision|4|||
155531189|NCT00787254|561369265|FG001|Overall Study|Physician Decision|8|||
155531190|NCT03761173|561369270|FG000|Overall Study|Lost to Follow-up|93|||
155531191|NCT03761173|561369270|FG000|Overall Study|Withdrawal by Subject|74|||
155531192|NCT03761173|561369270|FG000|Overall Study|Death|45|||
155531193|NCT03761173|561369270|FG000|Overall Study|Withdrawal for Other Reasons|29|||
155531194|NCT03761173|561369270|FG000|Overall Study|Protocol Violation|1|||
155531195|NCT00316186|561369271|FG000|Overall Study|Adverse Event|6|||
155531196|NCT00316186|561369271|FG000|Overall Study|Disease Progression|4|||
155531197|NCT00316186|561369271|FG000|Overall Study|Lost to Follow-up|1|||
155531198|NCT00316186|561369271|FG000|Overall Study|Other|1|||
155531199|NCT00859430|561369273|FG000|First Intervention|Withdrawal by Subject|0|||
155531200|NCT00859430|561369274|FG001|First Intervention|Withdrawal by Subject|1|||
155531201|NCT00373256|561371211|FG000|Overall Study|Adverse Event (AE)|1|||
155531202|NCT00373256|561371212|FG001|Overall Study|Adverse Event (AE)|5|||
155531203|NCT00373256|561371211|FG000|Overall Study|Lost to Follow-up|2|||
155531204|NCT00373256|561371212|FG001|Overall Study|Lost to Follow-up|1|||
155531205|NCT00373256|561371211|FG000|Overall Study|Death|9|||
155531206|NCT00373256|561371212|FG001|Overall Study|Death|8|||
155531207|NCT00373256|561371211|FG000|Overall Study|Objective Progression or Relapse|111|||
155531208|NCT00373256|561371212|FG001|Overall Study|Objective Progression or Relapse|104|||
155531209|NCT00373256|561371211|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
155531210|NCT00373256|561371212|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
155531211|NCT00373256|561371211|FG000|Overall Study|Other|73|||
155531212|NCT00373256|561371212|FG001|Overall Study|Other|107|||
155531213|NCT00373256|561371211|FG000|Overall Study|Protocol Violation|0|||
155531214|NCT00373256|561371212|FG001|Overall Study|Protocol Violation|2|||
155531215|NCT00373256|561371211|FG000|Overall Study|Study Terminated by Sponsor|41|||
155531216|NCT00373256|561371212|FG001|Overall Study|Study Terminated by Sponsor|13|||
155531217|NCT00834522|561371218|FG000|Washout|Adverse Event|1|||
155531218|NCT00834522|561371219|FG001|Washout|Adverse Event|0|||
155531219|NCT00834522|561371218|FG000|Washout|Withdrawal by Subject|2|||
155531220|NCT00834522|561371219|FG001|Washout|Withdrawal by Subject|1|||
155531221|NCT03128723|561371232|FG000|Overall Study|Withdrawal by Subject|2|||
155531222|NCT00673660|561371234|FG000|Overall Study|Lost to Follow-up|107|||
155531223|NCT00123734|561371235|FG000|Overall Study|Death|3|||
155531224|NCT00123734|561371235|FG000|Overall Study|Lost to Follow-up|3|||
155531225|NCT00123734|561371235|FG000|Overall Study|Dropout|1|||
155531226|NCT00123734|561371235|FG000|Overall Study|Withdrawal by Subject|1|||
155531227|NCT00113386|561371236|FG000|Overall Study|Withdrawal by Subject|1|||
155531228|NCT00113386|561371237|FG001|Overall Study|Withdrawal by Subject|0|||
155531229|NCT00113386|561371236|FG000|Overall Study|Physician Decision|0|||
155531230|NCT00113386|561371237|FG001|Overall Study|Physician Decision|1|||
155531231|NCT00113386|561371236|FG000|Overall Study|Toxicity|3|||
155531232|NCT00113386|561371237|FG001|Overall Study|Toxicity|0|||
155531233|NCT00113386|561371236|FG000|Overall Study|Ineligible|1|||
155531234|NCT00113386|561371237|FG001|Overall Study|Ineligible|2|||
155531235|NCT00113386|561371236|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
155531236|NCT00113386|561371237|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
155531237|NCT00834340|561371238|FG000|Washout|Adverse Event|1|||
155531238|NCT00834340|561371239|FG001|Washout|Adverse Event|0|||
155531239|NCT00834340|561371238|FG000|Washout|Withdrawal by Subject|1|||
155531240|NCT00834340|561371239|FG001|Washout|Withdrawal by Subject|0|||
155531241|NCT00395694|561371240|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
155531242|NCT00395694|561371241|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
155531243|NCT00395694|561371240|FG000|Continuation Phase|Adverse Event|1|||
155531244|NCT00395694|561371241|FG001|Continuation Phase|Adverse Event|0|||
155531245|NCT00395694|561371240|FG000|Continuation Phase|Lack of Efficacy|12|||
155531246|NCT00395694|561371241|FG001|Continuation Phase|Lack of Efficacy|11|||
155531247|NCT00395694|561371240|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
155531248|NCT00395694|561371241|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
155531249|NCT00395694|561371240|FG000|Continuation Phase|Poor Compliance|1|||
155531250|NCT00395694|561371241|FG001|Continuation Phase|Poor Compliance|0|||
155531251|NCT00395694|561371240|FG000|Continuation Phase|Withdrawal by Subject|0|||
155531252|NCT00395694|561371241|FG001|Continuation Phase|Withdrawal by Subject|2|||
155531253|NCT02159183|561371246|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
155531254|NCT02159183|561371247|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
155531255|NCT02159183|561371246|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
155531256|NCT02159183|561371247|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
155531257|NCT02159183|561371246|FG000|Analysis After the 36 Months Follow-up|Death|0|||
155531258|NCT02159183|561371247|FG001|Analysis After the 36 Months Follow-up|Death|1|||
155531259|NCT02159183|561371246|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
155531260|NCT02159183|561371247|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
155531261|NCT02159183|561371246|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
155531262|NCT02159183|561371247|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
155531263|NCT01444378|561371253|FG000|Overall Study|Lost to Follow-up|1|||
155531264|NCT01444378|561371253|FG000|Overall Study|Withdrawal by Subject|1|||
155531265|NCT01444378|561371253|FG000|Overall Study|Death|3|||
155531266|NCT01444378|561371253|FG000|Overall Study|Administrative Closure Of The Study|2|||
155531267|NCT01444378|561371253|FG000|Overall Study|Missed Visits|10|||
155531268|NCT01244620|561371254|FG000|Overall Study|Study terminated|4|||
155531269|NCT01244620|561371255|FG001|Overall Study|Study terminated|4|||
155531270|NCT01244620|561371256|FG002|Overall Study|Study terminated|4|||
155531271|NCT01244620|561371257|FG003|Overall Study|Study terminated|4|||
155531272|NCT01663233|561371258|FG000|Overall Study|Withdrawal by Subject|3|||
155531273|NCT01663233|561371259|FG001|Overall Study|Withdrawal by Subject|2|||
155531274|NCT01663233|561371258|FG000|Overall Study|Protocol Deviation|1|||
155531275|NCT01663233|561371259|FG001|Overall Study|Protocol Deviation|4|||
155531276|NCT01663233|561371258|FG000|Overall Study|Lost to Follow-up|0|||
155531277|NCT01663233|561371259|FG001|Overall Study|Lost to Follow-up|1|||
155531278|NCT02321098|561371260|FG000|12 Weeks Treament|Lost to Follow-up|1|||
155531279|NCT02321098|561371261|FG001|12 Weeks Treament|Lost to Follow-up|1|||
155531280|NCT02321098|561371262|FG002|12 Weeks Treament|Lost to Follow-up|0|||
155531281|NCT02321098|561371260|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
155531282|NCT02321098|561371261|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
155531283|NCT02321098|561371262|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
155531284|NCT02321098|561371260|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
155531285|NCT02321098|561371261|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
155531286|NCT02321098|561371262|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
155531287|NCT02321098|561371260|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
155531288|NCT02321098|561371261|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
155531289|NCT02321098|561371262|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
155531290|NCT00796328|561371265|FG000|Overall Study|experienced hypotension requiring tx|6|||
155531291|NCT03261167|561371266|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
155531292|NCT03261167|561371267|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
155531293|NCT03261167|561371266|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
155531294|NCT03261167|561371267|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
155531295|NCT03261167|561371266|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
155531296|NCT03261167|561371267|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
155655286|NCT01592747|561832163|FG001|Overall Study|Withdrawal by Subject|0|||
155655287|NCT01592747|561832164|FG002|Overall Study|Withdrawal by Subject|2|||
155655288|NCT01592747|561832162|FG000|Overall Study|Lost to Follow-up|1|||
155655289|NCT01592747|561832163|FG001|Overall Study|Lost to Follow-up|0|||
155655290|NCT01592747|561832164|FG002|Overall Study|Lost to Follow-up|1|||
155655291|NCT01592747|561832162|FG000|Overall Study|Other Reasons|1|||
155531297|NCT03261167|561371266|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
155531298|NCT03261167|561371267|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
155531299|NCT03261167|561371266|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
155531300|NCT03261167|561371267|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
155531301|NCT03669861|561371270|FG000|Overall Study|Disease Flare|5|||
155531302|NCT03669861|561371270|FG000|Overall Study|Lack of Efficacy|2|||
155531303|NCT02760927|561371275|FG000|Overall Study|Tube Slippage from Device|1|||
155531304|NCT03406156|561371285|FG000|Overall Study|Death|9|||
155531305|NCT03406156|561371286|FG001|Overall Study|Death|3|||
155655292|NCT01592747|561832163|FG001|Overall Study|Other Reasons|1|||
155655293|NCT01592747|561832164|FG002|Overall Study|Other Reasons|0|||
155655294|NCT02367885|561832165|FG000|Overall Study|Lost to Follow-up|1|||
155531306|NCT03406156|561371285|FG000|Overall Study|Withdrawal by Subject|1|||
155531307|NCT03406156|561371286|FG001|Overall Study|Withdrawal by Subject|2|||
155531308|NCT03406156|561371285|FG000|Overall Study|COVID-19 infection|1|||
155531309|NCT03406156|561371286|FG001|Overall Study|COVID-19 infection|0|||
155531310|NCT03406156|561371285|FG000|Overall Study|Non-compliance with study procedures|1|||
155531311|NCT03406156|561371286|FG001|Overall Study|Non-compliance with study procedures|1|||
155531312|NCT03406156|561371285|FG000|Overall Study|Lost to Follow-up|0|||
155531313|NCT03406156|561371286|FG001|Overall Study|Lost to Follow-up|2|||
155531314|NCT03406156|561371285|FG000|Overall Study|Other, not specified|72|||
155531315|NCT03406156|561371286|FG001|Overall Study|Other, not specified|28|||
155531316|NCT02838420|561371288|FG000|Overall Study|Ongoing in Study|113|||
155531317|NCT02838420|561371289|FG001|Overall Study|Ongoing in Study|45|||
155531318|NCT02838420|561371288|FG000|Overall Study|Lost to Follow-up|1|||
155531319|NCT02838420|561371289|FG001|Overall Study|Lost to Follow-up|0|||
155531320|NCT02838420|561371288|FG000|Overall Study|Withdrawal by Subject|3|||
155531321|NCT02838420|561371289|FG001|Overall Study|Withdrawal by Subject|4|||
155531322|NCT02838420|561371288|FG000|Overall Study|Death|8|||
155531323|NCT02838420|561371289|FG001|Overall Study|Death|13|||
155531324|NCT02964039|561371290|FG000|Overall Study|Medical reason unrelated to study participation|1|||
155531325|NCT02964039|561371291|FG001|Overall Study|Medical reason unrelated to study participation|0|||
155531326|NCT02964039|561371292|FG002|Overall Study|Medical reason unrelated to study participation|3|||
155531327|NCT02964039|561371290|FG000|Overall Study|Research shutdown due to pandemic|2|||
155531328|NCT02964039|561371291|FG001|Overall Study|Research shutdown due to pandemic|0|||
155531329|NCT02964039|561371292|FG002|Overall Study|Research shutdown due to pandemic|1|||
155531330|NCT02964039|561371290|FG000|Overall Study|Withdrawal by Subject|0|||
155531331|NCT02964039|561371291|FG001|Overall Study|Withdrawal by Subject|1|||
155531332|NCT02964039|561371292|FG002|Overall Study|Withdrawal by Subject|0|||
155531333|NCT02964039|561371290|FG000|Overall Study|Lost to Follow-up|1|||
155531334|NCT02964039|561371291|FG001|Overall Study|Lost to Follow-up|0|||
155531335|NCT02964039|561371292|FG002|Overall Study|Lost to Follow-up|1|||
155531336|NCT05479058|561371293|FG000|Overall Study|Withdrawal by Subject|1|||
155531337|NCT05479058|561371294|FG001|Overall Study|Withdrawal by Subject|1|||
155531338|NCT05479058|561371293|FG000|Overall Study|Study terminated by sponsor|10|||
155531339|NCT05479058|561371294|FG001|Overall Study|Study terminated by sponsor|10|||
155531340|NCT05630885|561371295|FG000|Study Completion|Took prohibited medications|2|||
155531341|NCT05630885|561371296|FG001|Study Completion|Took prohibited medications|0|||
155531342|NCT05630885|561371295|FG000|Study Completion|Non-compliance with study drug|1|||
155531343|NCT05630885|561371296|FG001|Study Completion|Non-compliance with study drug|0|||
155531344|NCT05630885|561371295|FG000|Study Completion|Adverse Event|1|||
155531345|NCT05630885|561371296|FG001|Study Completion|Adverse Event|0|||
155531346|NCT05630885|561371295|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
155531347|NCT05630885|561371296|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
155531348|NCT05630885|561371295|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
155531349|NCT05630885|561371296|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
155655295|NCT02367885|561832166|FG001|Overall Study|Lost to Follow-up|0|||
155487088|NCT01632345|561205810|FG006|Treatment: Part II|Withdrawal by Subject|2|||
155487089|NCT02431559|561205811|FG000|Overall Study|Adverse Event|0|||
155487090|NCT02431559|561205812|FG001|Overall Study|Adverse Event|1|||
155487091|NCT02431559|561205813|FG002|Overall Study|Adverse Event|0|||
155487092|NCT02431559|561205814|FG003|Overall Study|Adverse Event|4|||
155487093|NCT02431559|561205811|FG000|Overall Study|Progressive disease|2|||
155487094|NCT02431559|561205812|FG001|Overall Study|Progressive disease|1|||
155487095|NCT02431559|561205813|FG002|Overall Study|Progressive disease|4|||
155487096|NCT02431559|561205814|FG003|Overall Study|Progressive disease|22|||
155487097|NCT02431559|561205811|FG000|Overall Study|Withdrawal by Subject|0|||
155487098|NCT02431559|561205812|FG001|Overall Study|Withdrawal by Subject|1|||
155487099|NCT02431559|561205813|FG002|Overall Study|Withdrawal by Subject|0|||
155487100|NCT02431559|561205814|FG003|Overall Study|Withdrawal by Subject|4|||
155487101|NCT02431559|561205811|FG000|Overall Study|Physician Decision|0|||
155487102|NCT02431559|561205812|FG001|Overall Study|Physician Decision|0|||
155487103|NCT02431559|561205813|FG002|Overall Study|Physician Decision|0|||
155487104|NCT02431559|561205814|FG003|Overall Study|Physician Decision|1|||
155487105|NCT02452892|561205817|FG000|Week 1 Initial Randommization|Adverse Event|1|||
155487106|NCT02452892|561205818|FG001|Week 1 Initial Randommization|Adverse Event|0|||
155487107|NCT02452892|561205819|FG002|Week 1 Initial Randommization|Adverse Event|0|||
155487108|NCT02452892|561205820|FG003|Week 1 Initial Randommization|Adverse Event|0|||
155487109|NCT02452892|561205817|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
155487110|NCT02452892|561205818|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
155487111|NCT02452892|561205819|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
155487112|NCT02452892|561205820|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
155487113|NCT02452892|561205817|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
155487114|NCT02452892|561205818|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
155487115|NCT02452892|561205819|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
155487116|NCT02452892|561205820|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
155487117|NCT02452892|561205817|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
155487118|NCT02452892|561205818|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
155487119|NCT02452892|561205819|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
155487120|NCT02452892|561205820|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
155487121|NCT02452892|561205817|FG000|Follow-up|Withdrawal by Subject|0|||
155487122|NCT02452892|561205818|FG001|Follow-up|Withdrawal by Subject|0|||
155487123|NCT02452892|561205819|FG002|Follow-up|Withdrawal by Subject|0|||
155487124|NCT02452892|561205820|FG003|Follow-up|Withdrawal by Subject|1|||
155487125|NCT02452892|561205817|FG000|Follow-up|Subject left town on Day 42|1|||
155487126|NCT02452892|561205818|FG001|Follow-up|Subject left town on Day 42|0|||
155487127|NCT02452892|561205819|FG002|Follow-up|Subject left town on Day 42|0|||
155487128|NCT02452892|561205820|FG003|Follow-up|Subject left town on Day 42|0|||
155531350|NCT03419403|561371297|FG000|Overall Study|Withdrawal by Subject|5|||
155531351|NCT03419403|561371298|FG001|Overall Study|Withdrawal by Subject|2|||
155531352|NCT03419403|561371299|FG002|Overall Study|Withdrawal by Subject|5|||
155531353|NCT03419403|561371300|FG003|Overall Study|Withdrawal by Subject|1|||
155531354|NCT03419403|561371297|FG000|Overall Study|Progressive disease (per protocol)|0|||
155531355|NCT03419403|561371298|FG001|Overall Study|Progressive disease (per protocol)|2|||
155531356|NCT03419403|561371299|FG002|Overall Study|Progressive disease (per protocol)|2|||
155531357|NCT03419403|561371300|FG003|Overall Study|Progressive disease (per protocol)|0|||
155531358|NCT03419403|561371297|FG000|Overall Study|Other, not specified|6|||
155531359|NCT03419403|561371298|FG001|Overall Study|Other, not specified|4|||
155531360|NCT03419403|561371299|FG002|Overall Study|Other, not specified|5|||
155531361|NCT03419403|561371300|FG003|Overall Study|Other, not specified|1|||
155531362|NCT03419403|561371297|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
155531363|NCT03419403|561371298|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
155531364|NCT03419403|561371299|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
155531365|NCT03419403|561371300|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
155531366|NCT00796653|561371303|FG000|Overall Study|Adverse Event|19|||
155531367|NCT00796653|561371304|FG001|Overall Study|Adverse Event|16|||
155531368|NCT00796653|561371305|FG002|Overall Study|Adverse Event|16|||
155531369|NCT00796653|561371306|FG003|Overall Study|Adverse Event|16|||
155531370|NCT00796653|561371303|FG000|Overall Study|Lost to Follow-up|2|||
155531371|NCT00796653|561371304|FG001|Overall Study|Lost to Follow-up|1|||
155531372|NCT00796653|561371305|FG002|Overall Study|Lost to Follow-up|2|||
155531373|NCT00796653|561371306|FG003|Overall Study|Lost to Follow-up|3|||
155531374|NCT00796653|561371303|FG000|Overall Study|Withdrawal by Subject|16|||
155531375|NCT00796653|561371304|FG001|Overall Study|Withdrawal by Subject|8|||
155531376|NCT00796653|561371305|FG002|Overall Study|Withdrawal by Subject|8|||
155531377|NCT00796653|561371306|FG003|Overall Study|Withdrawal by Subject|13|||
155531378|NCT00796653|561371303|FG000|Overall Study|Lack of Efficacy|8|||
155531379|NCT00796653|561371304|FG001|Overall Study|Lack of Efficacy|1|||
155531380|NCT00796653|561371305|FG002|Overall Study|Lack of Efficacy|3|||
155531381|NCT00796653|561371306|FG003|Overall Study|Lack of Efficacy|2|||
155531382|NCT00796653|561371303|FG000|Overall Study|Non compliance with protocol|2|||
155531383|NCT00796653|561371304|FG001|Overall Study|Non compliance with protocol|2|||
155531384|NCT00796653|561371305|FG002|Overall Study|Non compliance with protocol|0|||
155531385|NCT00796653|561371306|FG003|Overall Study|Non compliance with protocol|2|||
155531386|NCT00796653|561371303|FG000|Overall Study|Other reason not described above|4|||
155531387|NCT00796653|561371304|FG001|Overall Study|Other reason not described above|9|||
155531388|NCT00796653|561371305|FG002|Overall Study|Other reason not described above|7|||
155531389|NCT00796653|561371306|FG003|Overall Study|Other reason not described above|4|||
155531390|NCT02414152|561371307|FG000|Overall Study|Withdrawal by Subject|1|||
155531391|NCT02414152|561371307|FG000|Overall Study|Lack of Efficacy|1|||
155531392|NCT01250912|561371310|FG000|Overall Study|Lost to Follow-up|1|||
155531393|NCT01348789|561371311|FG000|Overall Study|Protocol Violation|2|||
155531394|NCT01348789|561371311|FG000|Overall Study|Withdrawal by Subject|2|||
155531395|NCT00323882|561371312|FG000|Overall Study|Adverse Event|2|||
155531396|NCT00323882|561371313|FG001|Overall Study|Adverse Event|1|||
155531397|NCT00323882|561371314|FG002|Overall Study|Adverse Event|1|||
155531398|NCT00323882|561371315|FG003|Overall Study|Adverse Event|1|||
155531399|NCT00323882|561371316|FG004|Overall Study|Adverse Event|3|||
155531400|NCT00323882|561371312|FG000|Overall Study|Disease Progression|6|||
155531401|NCT00323882|561371313|FG001|Overall Study|Disease Progression|4|||
155531402|NCT00323882|561371314|FG002|Overall Study|Disease Progression|10|||
155531403|NCT00323882|561371315|FG003|Overall Study|Disease Progression|5|||
155531404|NCT00323882|561371316|FG004|Overall Study|Disease Progression|22|||
155531405|NCT00323882|561371312|FG000|Overall Study|Death|0|||
155531406|NCT00323882|561371313|FG001|Overall Study|Death|1|||
155531407|NCT00323882|561371314|FG002|Overall Study|Death|1|||
155531408|NCT00323882|561371315|FG003|Overall Study|Death|0|||
155531409|NCT00323882|561371316|FG004|Overall Study|Death|5|||
155531410|NCT00323882|561371312|FG000|Overall Study|Lost to Follow-up|0|||
155531411|NCT00323882|561371313|FG001|Overall Study|Lost to Follow-up|0|||
155531412|NCT00323882|561371314|FG002|Overall Study|Lost to Follow-up|1|||
155531413|NCT00323882|561371315|FG003|Overall Study|Lost to Follow-up|0|||
155531414|NCT00323882|561371316|FG004|Overall Study|Lost to Follow-up|1|||
155531415|NCT00323882|561371312|FG000|Overall Study|Other|0|||
155531416|NCT00323882|561371313|FG001|Overall Study|Other|0|||
155531417|NCT00323882|561371314|FG002|Overall Study|Other|0|||
155531418|NCT00323882|561371315|FG003|Overall Study|Other|1|||
155531419|NCT00323882|561371316|FG004|Overall Study|Other|1|||
155531420|NCT04544410|561371317|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155531421|NCT04544410|561371318|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155531422|NCT04544410|561371317|FG000|Double-blind Treatment Period|Adverse Event|1|||
155531423|NCT04544410|561371318|FG001|Double-blind Treatment Period|Adverse Event|0|||
155531424|NCT04544410|561371317|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155531425|NCT04544410|561371318|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155531426|NCT04544410|561371317|FG000|Double-blind Treatment Period|Protocol Violation|1|||
155531427|NCT04544410|561371318|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155531428|NCT04544410|561371317|FG000|Open-Label Treatment Period|Study Terminated|15|||
155531429|NCT04544410|561371318|FG001|Open-Label Treatment Period|Study Terminated|19|||
155531430|NCT04544410|561371317|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
155531431|NCT04544410|561371318|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
155531432|NCT04544410|561371317|FG000|Open-Label Treatment Period|Adverse Event|0|||
155531433|NCT04544410|561371318|FG001|Open-Label Treatment Period|Adverse Event|1|||
155531434|NCT04544410|561371317|FG000|Open-Label Treatment Period|Physician Decision|1|||
155531435|NCT04544410|561371318|FG001|Open-Label Treatment Period|Physician Decision|0|||
155531436|NCT04544410|561371317|FG000|Open-Label Treatment Period|Other|0|||
155531437|NCT04544410|561371318|FG001|Open-Label Treatment Period|Other|1|||
155531438|NCT01030133|561371319|FG000|Overall Study|failed to experience pain at level 7/10|2|||
155531439|NCT01030133|561371320|FG001|Overall Study|failed to experience pain at level 7/10|2|||
155531440|NCT04493684|561371322|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
155531441|NCT04493684|561371323|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531442|NCT04493684|561371324|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
155531443|NCT04493684|561371325|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531444|NCT04493684|561371326|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531445|NCT04493684|561371327|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
155531446|NCT04493684|561371328|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531447|NCT04493684|561371329|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531448|NCT04493684|561371330|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531449|NCT04493684|561371331|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531450|NCT04493684|561371332|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531451|NCT04493684|561371333|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531452|NCT04493684|561371334|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531453|NCT04493684|561371335|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531454|NCT04493684|561371336|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531455|NCT04493684|561371337|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531456|NCT04493684|561371338|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155531457|NCT04493684|561371322|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
155531458|NCT04493684|561371323|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531459|NCT04493684|561371324|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531460|NCT04493684|561371325|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531461|NCT04493684|561371326|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531462|NCT04493684|561371327|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531463|NCT04493684|561371328|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531464|NCT04493684|561371329|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531465|NCT04493684|561371330|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531466|NCT04493684|561371331|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531467|NCT04493684|561371332|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531468|NCT04493684|561371333|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531469|NCT04493684|561371334|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531470|NCT04493684|561371335|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531471|NCT04493684|561371336|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155655296|NCT02367885|561832167|FG002|Overall Study|Lost to Follow-up|0|||
155655297|NCT02367885|561832165|FG000|Overall Study|Withdrawal by Subject|1|||
155655298|NCT02367885|561832166|FG001|Overall Study|Withdrawal by Subject|0|||
155531472|NCT04493684|561371337|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531473|NCT04493684|561371338|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155531474|NCT04493684|561371322|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531475|NCT04493684|561371323|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531476|NCT04493684|561371324|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531477|NCT04493684|561371325|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531478|NCT04493684|561371326|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531479|NCT04493684|561371327|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531480|NCT04493684|561371328|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
155531481|NCT04493684|561371329|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531482|NCT04493684|561371330|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531483|NCT04493684|561371331|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531484|NCT04493684|561371332|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531485|NCT04493684|561371333|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531486|NCT04493684|561371334|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531487|NCT04493684|561371335|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531488|NCT04493684|561371336|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531489|NCT04493684|561371337|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531490|NCT04493684|561371338|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155531491|NCT04493684|561371322|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
155531492|NCT04493684|561371323|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531493|NCT04493684|561371324|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531494|NCT04493684|561371325|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531495|NCT04493684|561371326|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531496|NCT04493684|561371327|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531497|NCT04493684|561371328|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531498|NCT04493684|561371329|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531499|NCT04493684|561371330|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531500|NCT04493684|561371331|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531501|NCT04493684|561371332|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531502|NCT04493684|561371333|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531503|NCT04493684|561371334|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531504|NCT04493684|561371335|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531505|NCT04493684|561371336|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531506|NCT04493684|561371337|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531507|NCT04493684|561371338|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155531508|NCT04493684|561371322|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531509|NCT04493684|561371323|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531510|NCT04493684|561371324|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531511|NCT04493684|561371325|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531512|NCT04493684|561371326|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531513|NCT04493684|561371327|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
155531514|NCT04493684|561371328|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531515|NCT04493684|561371329|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531516|NCT04493684|561371330|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531517|NCT04493684|561371331|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531518|NCT04493684|561371332|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531519|NCT04493684|561371333|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531520|NCT04493684|561371334|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531521|NCT04493684|561371335|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531522|NCT04493684|561371336|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531523|NCT04493684|561371337|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531524|NCT04493684|561371338|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155531525|NCT04493684|561371322|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531526|NCT04493684|561371323|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531527|NCT04493684|561371324|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531528|NCT04493684|561371325|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531529|NCT04493684|561371326|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531530|NCT04493684|561371327|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531531|NCT04493684|561371328|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531532|NCT04493684|561371329|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531533|NCT04493684|561371330|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531534|NCT04493684|561371331|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531535|NCT04493684|561371332|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531536|NCT04493684|561371333|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
155531537|NCT04493684|561371334|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531538|NCT04493684|561371335|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531539|NCT04493684|561371336|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531540|NCT04493684|561371337|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531541|NCT04493684|561371338|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155531542|NCT04493684|561371322|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531543|NCT04493684|561371323|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531544|NCT04493684|561371324|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531545|NCT04493684|561371325|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531546|NCT04493684|561371326|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531547|NCT04493684|561371327|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531548|NCT04493684|561371328|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531549|NCT04493684|561371329|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531550|NCT04493684|561371330|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531551|NCT04493684|561371331|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531552|NCT04493684|561371332|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531553|NCT04493684|561371333|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531554|NCT04493684|561371334|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531555|NCT04493684|561371335|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531556|NCT04493684|561371336|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531557|NCT04493684|561371337|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
155531558|NCT04493684|561371338|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
155531559|NCT04493684|561371322|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531560|NCT04493684|561371323|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531561|NCT04493684|561371324|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531562|NCT04493684|561371325|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531563|NCT04493684|561371326|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531564|NCT04493684|561371327|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531565|NCT04493684|561371328|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531566|NCT04493684|561371329|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531567|NCT04493684|561371330|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531568|NCT04493684|561371331|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531569|NCT04493684|561371332|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531570|NCT04493684|561371333|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531571|NCT04493684|561371334|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531572|NCT04493684|561371335|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531573|NCT04493684|561371336|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531574|NCT04493684|561371337|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
155531575|NCT04493684|561371338|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155531576|NCT05152576|561371345|FG000|Overall Study|Lost to Follow-up|3|||
155531577|NCT05152576|561371346|FG001|Overall Study|Lost to Follow-up|0|||
155531578|NCT05152576|561371347|FG002|Overall Study|Lost to Follow-up|0|||
155531579|NCT05152576|561371348|FG003|Overall Study|Lost to Follow-up|1|||
155531580|NCT05152576|561371345|FG000|Overall Study|Withdrawal by Subject|0|||
155531581|NCT05152576|561371346|FG001|Overall Study|Withdrawal by Subject|1|||
155531582|NCT05152576|561371347|FG002|Overall Study|Withdrawal by Subject|0|||
155531583|NCT05152576|561371348|FG003|Overall Study|Withdrawal by Subject|1|||
155531584|NCT05152576|561371345|FG000|Overall Study|Other|2|||
155531585|NCT05152576|561371346|FG001|Overall Study|Other|0|||
155531586|NCT05152576|561371347|FG002|Overall Study|Other|0|||
155531587|NCT05152576|561371348|FG003|Overall Study|Other|0|||
155531588|NCT01952691|561372923|FG000|Overall Study|Lost to Follow-up|2|||
155531589|NCT00199901|561372924|FG000|Overall Study|Protocol Violation|2|||
155531590|NCT00199901|561372925|FG001|Overall Study|Protocol Violation|0|||
155531591|NCT00199901|561372924|FG000|Overall Study|Withdrawal by Subject|1|||
155655299|NCT02367885|561832167|FG002|Overall Study|Withdrawal by Subject|0|||
155655300|NCT01602484|561832168|FG000|Overall Study|Airway issues unrelated to study|0|||
155531592|NCT00199901|561372925|FG001|Overall Study|Withdrawal by Subject|0|||
155531593|NCT00199901|561372924|FG000|Overall Study|Progressive Disease|24|||
155531594|NCT00199901|561372925|FG001|Overall Study|Progressive Disease|24|||
155531595|NCT05776901|561372928|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
155531596|NCT01958294|561372936|FG000|Overall Study|Clinical Circumstances|2|||
155531597|NCT00682461|561372937|FG000|Overall Study|Adverse Event|5|||
155531598|NCT00682461|561372938|FG001|Overall Study|Adverse Event|7|||
155531599|NCT00682461|561372937|FG000|Overall Study|Lost to Follow-up|8|||
155531600|NCT00682461|561372938|FG001|Overall Study|Lost to Follow-up|5|||
155531601|NCT00682461|561372937|FG000|Overall Study|Withdrawal by Subject|12|||
155531602|NCT00682461|561372938|FG001|Overall Study|Withdrawal by Subject|19|||
155531603|NCT00665925|561372940|FG000|Overall Study|Lack of Efficacy|10|||
155531604|NCT00665925|561372941|FG001|Overall Study|Lack of Efficacy|8|||
155531605|NCT00665925|561372942|FG002|Overall Study|Lack of Efficacy|9|||
155531606|NCT00665925|561372943|FG003|Overall Study|Lack of Efficacy|8|||
155531607|NCT00665925|561372940|FG000|Overall Study|Lost to Follow-up|1|||
155531608|NCT00665925|561372941|FG001|Overall Study|Lost to Follow-up|2|||
155531609|NCT00665925|561372942|FG002|Overall Study|Lost to Follow-up|2|||
155531610|NCT00665925|561372943|FG003|Overall Study|Lost to Follow-up|2|||
155531611|NCT00665925|561372940|FG000|Overall Study|Withdrawal by Subject|2|||
155531612|NCT00665925|561372941|FG001|Overall Study|Withdrawal by Subject|2|||
155531613|NCT00665925|561372942|FG002|Overall Study|Withdrawal by Subject|3|||
155531614|NCT00665925|561372943|FG003|Overall Study|Withdrawal by Subject|2|||
155531615|NCT00665925|561372940|FG000|Overall Study|Physician Decision|0|||
155531616|NCT00665925|561372941|FG001|Overall Study|Physician Decision|0|||
155531617|NCT00665925|561372942|FG002|Overall Study|Physician Decision|1|||
155531618|NCT00665925|561372943|FG003|Overall Study|Physician Decision|2|||
155531619|NCT00665925|561372940|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
155531620|NCT00665925|561372941|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
155531621|NCT00665925|561372942|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
155531622|NCT00665925|561372943|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
155531623|NCT00665925|561372940|FG000|Overall Study|Adverse Event|1|||
155531624|NCT00665925|561372941|FG001|Overall Study|Adverse Event|5|||
155531625|NCT00665925|561372942|FG002|Overall Study|Adverse Event|10|||
155531626|NCT00665925|561372943|FG003|Overall Study|Adverse Event|5|||
155531627|NCT00665925|561372940|FG000|Overall Study|Enrolled by mistake|0|||
155531628|NCT00665925|561372941|FG001|Overall Study|Enrolled by mistake|0|||
155531629|NCT00665925|561372942|FG002|Overall Study|Enrolled by mistake|0|||
155531630|NCT00665925|561372943|FG003|Overall Study|Enrolled by mistake|1|||
155531631|NCT00665925|561372940|FG000|Overall Study|Due to exclusion criteria|1|||
155531632|NCT00665925|561372941|FG001|Overall Study|Due to exclusion criteria|0|||
155531633|NCT00665925|561372942|FG002|Overall Study|Due to exclusion criteria|0|||
155531634|NCT00665925|561372943|FG003|Overall Study|Due to exclusion criteria|0|||
155531635|NCT04035187|561372944|FG000|Overall Study|Withdrawal by Subject|2|||
155531636|NCT04035187|561372945|FG001|Overall Study|Withdrawal by Subject|1|||
155531637|NCT04035187|561372946|FG002|Overall Study|Withdrawal by Subject|0|||
155531638|NCT04035187|561372947|FG003|Overall Study|Withdrawal by Subject|0|||
155531639|NCT04035187|561372944|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
155531640|NCT04035187|561372945|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
155531641|NCT04035187|561372946|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
155531642|NCT04035187|561372947|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
155531643|NCT06144424|561372950|FG000|Overall Study|Withdrawal by Subject|2|||
155531644|NCT06144424|561372951|FG001|Overall Study|Withdrawal by Subject|0|||
155531645|NCT06144424|561372950|FG000|Overall Study|Incarceration|1|||
155531646|NCT06144424|561372951|FG001|Overall Study|Incarceration|0|||
155531647|NCT00835575|561372954|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
155531648|NCT00835575|561372955|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
155531649|NCT03415308|561372968|FG000|Overall Study|Lost to Follow-up|0|||
155531650|NCT03415308|561372969|FG001|Overall Study|Lost to Follow-up|0|||
155531651|NCT03415308|561372970|FG002|Overall Study|Lost to Follow-up|1|||
155531652|NCT03415308|561372968|FG000|Overall Study|Scheduling Conflicts|0|||
155531653|NCT03415308|561372969|FG001|Overall Study|Scheduling Conflicts|0|||
155531654|NCT03415308|561372970|FG002|Overall Study|Scheduling Conflicts|7|||
155531655|NCT00836472|561372971|FG000|Washout|Adverse Event|1|||
155531656|NCT00836472|561372972|FG001|Washout|Adverse Event|2|||
155531657|NCT00836472|561372971|FG000|Washout|Withdrawal by Subject|1|||
155531658|NCT00836472|561372972|FG001|Washout|Withdrawal by Subject|1|||
155531659|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
155531660|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
155531661|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
155531662|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
155531663|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531664|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531665|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531666|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531667|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531668|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531669|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531670|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531671|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155531672|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155655301|NCT01602484|561832169|FG001|Overall Study|Airway issues unrelated to study|1|||
155531673|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
155531674|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
155531675|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
155531676|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
155531677|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531678|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531679|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531680|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531681|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531682|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531683|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531684|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531685|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531686|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155531687|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
155531688|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531689|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
155531690|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531691|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531692|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531693|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531694|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531695|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531696|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531697|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531698|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531699|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531700|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155531701|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
155531702|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155531703|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155531704|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531705|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531706|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531707|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531708|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531709|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531710|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531711|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531712|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531713|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531714|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155531715|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
155531716|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531717|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
155531718|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531719|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531720|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531721|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531722|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531723|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531724|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531725|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531726|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531727|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155655302|NCT01378195|561832170|FG000|Overall Study|Lost to Follow-up|29|||
155655303|NCT01378195|561832171|FG001|Overall Study|Lost to Follow-up|18|||
155655304|NCT00425555|561832172|FG000|Overall Study|Withdrawal by Subject|11|||
155531728|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
155531729|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155531730|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531731|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155531732|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531733|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531734|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531735|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531736|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531737|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531738|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531739|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531740|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531741|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531742|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155531743|NCT01695239|561372973|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
155531744|NCT01695239|561372974|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531745|NCT01695239|561372975|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531746|NCT01695239|561372976|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531747|NCT01695239|561372977|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531748|NCT01695239|561372978|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531749|NCT01695239|561372979|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531750|NCT01695239|561372980|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531751|NCT01695239|561372981|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531752|NCT01695239|561372982|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531753|NCT01695239|561372983|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531754|NCT01695239|561372984|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531755|NCT01695239|561372985|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531756|NCT01695239|561372986|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
155531757|NCT01695239|561372973|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531758|NCT01695239|561372974|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531759|NCT01695239|561372975|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531760|NCT01695239|561372976|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531761|NCT01695239|561372977|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531762|NCT01695239|561372978|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531763|NCT01695239|561372979|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531764|NCT01695239|561372980|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
155531765|NCT01695239|561372981|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531766|NCT01695239|561372982|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531767|NCT01695239|561372983|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531768|NCT01695239|561372984|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531769|NCT01695239|561372985|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531770|NCT01695239|561372986|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155531771|NCT01695239|561372973|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531772|NCT01695239|561372974|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531773|NCT01695239|561372975|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531774|NCT01695239|561372976|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531775|NCT01695239|561372977|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531776|NCT01695239|561372978|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531777|NCT01695239|561372979|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531778|NCT01695239|561372980|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
155531779|NCT01695239|561372981|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531780|NCT01695239|561372982|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531781|NCT01695239|561372983|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531782|NCT01695239|561372984|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531783|NCT01695239|561372985|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531784|NCT01695239|561372986|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
155531785|NCT01695239|561372973|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531786|NCT01695239|561372974|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531787|NCT01695239|561372975|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531788|NCT01695239|561372976|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531789|NCT01695239|561372977|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531790|NCT01695239|561372978|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155655305|NCT00425555|561832173|FG001|Overall Study|Withdrawal by Subject|8|||
155655306|NCT00425555|561832172|FG000|Overall Study|Lost to Follow-up|0|||
155655307|NCT00425555|561832173|FG001|Overall Study|Lost to Follow-up|1|||
155531791|NCT01695239|561372979|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531792|NCT01695239|561372980|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
155531793|NCT01695239|561372981|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531794|NCT01695239|561372982|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531795|NCT01695239|561372983|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531796|NCT01695239|561372984|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531797|NCT01695239|561372985|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531798|NCT01695239|561372986|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
155531799|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531800|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531801|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531802|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531803|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531804|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531805|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531806|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531807|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
155531808|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
155531809|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531810|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531811|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531812|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
155531813|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
155531814|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
155531815|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
155531816|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
155531817|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
155531818|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
155531819|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
155531820|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
155531821|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
155531822|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
155531823|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
155531824|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
155531825|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
155531826|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
155531827|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531828|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531829|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531830|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531831|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531832|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531833|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531834|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531835|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
155531836|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
155531837|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531838|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531839|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531840|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
155531841|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
155531842|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
155531843|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
155531844|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
155531845|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
155531846|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
155531847|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
155531848|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
155531849|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
155531850|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
155531851|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
155531852|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
155531853|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
155531854|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
155531855|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531856|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531857|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531858|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531859|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531860|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531861|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531862|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531863|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
155531864|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
155531865|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531866|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531867|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531868|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155531869|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531870|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531871|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531872|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531873|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531874|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531875|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531876|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531877|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
155531878|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
155531879|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531880|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531881|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531882|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
155531883|NCT01695239|561372973|FG000|Extension Long-Term Extension Periods|Death|0|||
155531884|NCT01695239|561372974|FG001|Extension Long-Term Extension Periods|Death|0|||
155531885|NCT01695239|561372975|FG002|Extension Long-Term Extension Periods|Death|0|||
155531886|NCT01695239|561372976|FG003|Extension Long-Term Extension Periods|Death|0|||
155531887|NCT01695239|561372977|FG004|Extension Long-Term Extension Periods|Death|0|||
155531888|NCT01695239|561372978|FG005|Extension Long-Term Extension Periods|Death|0|||
155531889|NCT01695239|561372979|FG006|Extension Long-Term Extension Periods|Death|0|||
155531890|NCT01695239|561372980|FG007|Extension Long-Term Extension Periods|Death|0|||
155531891|NCT01695239|561372981|FG008|Extension Long-Term Extension Periods|Death|1|||
155531892|NCT01695239|561372982|FG009|Extension Long-Term Extension Periods|Death|0|||
155531893|NCT01695239|561372983|FG010|Extension Long-Term Extension Periods|Death|0|||
155531894|NCT01695239|561372984|FG011|Extension Long-Term Extension Periods|Death|0|||
155531895|NCT01695239|561372985|FG012|Extension Long-Term Extension Periods|Death|0|||
155531896|NCT01695239|561372986|FG013|Extension Long-Term Extension Periods|Death|0|||
155531897|NCT01695239|561372973|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531898|NCT01695239|561372974|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531899|NCT01695239|561372975|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531900|NCT01695239|561372976|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531901|NCT01695239|561372977|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531902|NCT01695239|561372978|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531903|NCT01695239|561372979|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531904|NCT01695239|561372980|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531905|NCT01695239|561372981|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531906|NCT01695239|561372982|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531907|NCT01695239|561372983|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155531908|NCT01695239|561372984|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
155531909|NCT01695239|561372985|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
155531910|NCT01695239|561372986|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
155531911|NCT01695239|561372973|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531912|NCT01695239|561372974|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531913|NCT01695239|561372975|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155655308|NCT00425555|561832172|FG000|Overall Study|Administrative problems|3|||
155655309|NCT00425555|561832173|FG001|Overall Study|Administrative problems|0|||
155531914|NCT01695239|561372976|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531915|NCT01695239|561372977|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531916|NCT01695239|561372978|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531917|NCT01695239|561372979|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531918|NCT01695239|561372980|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531919|NCT01695239|561372981|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531920|NCT01695239|561372982|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531921|NCT01695239|561372983|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531922|NCT01695239|561372984|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155531923|NCT01695239|561372985|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
155531924|NCT01695239|561372986|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
155531925|NCT01695239|561372973|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531926|NCT01695239|561372974|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531927|NCT01695239|561372975|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531928|NCT01695239|561372976|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531929|NCT01695239|561372977|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531930|NCT01695239|561372978|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531931|NCT01695239|561372979|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531932|NCT01695239|561372980|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531933|NCT01695239|561372981|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531934|NCT01695239|561372982|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531935|NCT01695239|561372983|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531936|NCT01695239|561372984|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531937|NCT01695239|561372985|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
155531938|NCT01695239|561372986|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
155531939|NCT01695239|561372973|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531940|NCT01695239|561372974|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531941|NCT01695239|561372975|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531942|NCT01695239|561372976|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531943|NCT01695239|561372977|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531944|NCT01695239|561372978|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531945|NCT01695239|561372979|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531946|NCT01695239|561372980|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531947|NCT01695239|561372981|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531948|NCT01695239|561372982|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531949|NCT01695239|561372983|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531950|NCT01695239|561372984|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531951|NCT01695239|561372985|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155531952|NCT01695239|561372986|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
155531953|NCT03502811|561372988|FG000|Overall Study|Death|157|||
155531954|NCT03502811|561372988|FG000|Overall Study|Withdrawal by Subject|105|||
155531955|NCT03502811|561372988|FG000|Overall Study|Lost to Follow-up|26|||
155531956|NCT03502811|561372988|FG000|Overall Study|No Visits (Missed)|31|||
155531957|NCT05239195|561372989|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
155531958|NCT05239195|561372990|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
155531959|NCT00933686|561372994|FG000|Overall Study|Protocol Violation|0|||
155531960|NCT00933686|561372995|FG001|Overall Study|Protocol Violation|1|||
155531961|NCT00933686|561372994|FG000|Overall Study|Lost to Follow-up|2|||
155531962|NCT00933686|561372995|FG001|Overall Study|Lost to Follow-up|2|||
155531963|NCT00933686|561372994|FG000|Overall Study|Withdrawal by Subject|6|||
155531964|NCT00933686|561372995|FG001|Overall Study|Withdrawal by Subject|5|||
155531965|NCT00933686|561372994|FG000|Overall Study|Adverse Event|1|||
155531966|NCT00933686|561372995|FG001|Overall Study|Adverse Event|1|||
155531967|NCT00933686|561372994|FG000|Overall Study|Physician Decision|1|||
155531968|NCT00933686|561372995|FG001|Overall Study|Physician Decision|0|||
155531969|NCT00933686|561372994|FG000|Overall Study|Failure to show up at endpoint visits|0|||
155531970|NCT00933686|561372995|FG001|Overall Study|Failure to show up at endpoint visits|2|||
155531971|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Adverse Event|8|||
155655310|NCT00425555|561832172|FG000|Overall Study|Death|1|||
155655311|NCT00425555|561832173|FG001|Overall Study|Death|2|||
155655312|NCT00425555|561832172|FG000|Overall Study|New cancer therapy|2|||
155655313|NCT00425555|561832173|FG001|Overall Study|New cancer therapy|1|||
155655314|NCT00425555|561832172|FG000|Overall Study|Disease progression|36|||
155655315|NCT00425555|561832173|FG001|Overall Study|Disease progression|33|||
155655316|NCT00425555|561832172|FG000|Overall Study|Adverse Event|25|||
155655317|NCT00425555|561832173|FG001|Overall Study|Adverse Event|15|||
155531972|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Adverse Event|15|||
155531973|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Adverse Event|25|||
155655318|NCT00425555|561832172|FG000|Overall Study|Protocol Violation|1|||
155655319|NCT00425555|561832173|FG001|Overall Study|Protocol Violation|0|||
155655320|NCT03787615|561832174|FG000|Overall Study|Withdrawal by Subject|2|||
155531974|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
155531975|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
155531976|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
155531977|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
155531978|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
155531979|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
155531980|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
155531981|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
155531982|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
155531983|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155531984|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
155531985|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
155531986|NCT01058668|561372996|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
155531987|NCT01058668|561372997|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
155531988|NCT01058668|561372998|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
155531989|NCT02911792|561372999|FG000|Overall Study|Lost to Follow-up|3|||
155531990|NCT02911792|561373000|FG001|Overall Study|Lost to Follow-up|3|||
155531991|NCT02911792|561373001|FG002|Overall Study|Lost to Follow-up|3|||
155531992|NCT02911792|561373002|FG003|Overall Study|Lost to Follow-up|3|||
155531993|NCT00705666|561373003|FG000|Overall Study|No post-treatment questionnaire|279|||
155531994|NCT00705666|561373003|FG000|Overall Study|Withdrawal by Subject|21|||
155531995|NCT00705666|561373003|FG000|Overall Study|Physician Decision|7|||
155531996|NCT00705666|561373003|FG000|Overall Study|Lost to Follow-up|5|||
155531997|NCT00705666|561373003|FG000|Overall Study|Death|1|||
155531998|NCT00705666|561373003|FG000|Overall Study|Adverse Event|4|||
155531999|NCT00705666|561373003|FG000|Overall Study|Other|12|||
155532000|NCT00705666|561373003|FG000|Overall Study|Other|2|||
155532001|NCT00705666|561373003|FG000|Overall Study|Lack of data|3|||
155532002|NCT00705666|561373003|FG000|Overall Study|Untreated|5|||
155532003|NCT02105272|561373005|FG000|Overall Study|Adverse Event|1|||
155532004|NCT02105272|561373006|FG001|Overall Study|Adverse Event|2|||
155532005|NCT02105272|561373005|FG000|Overall Study|Physician Decision|0|||
155532006|NCT02105272|561373006|FG001|Overall Study|Physician Decision|1|||
155532007|NCT02105272|561373005|FG000|Overall Study|Protocol Violation|2|||
155532008|NCT02105272|561373006|FG001|Overall Study|Protocol Violation|0|||
155532009|NCT02105272|561373005|FG000|Overall Study|Withdrawal by Subject|2|||
155532010|NCT02105272|561373006|FG001|Overall Study|Withdrawal by Subject|0|||
155532011|NCT03256695|561373007|FG000|Overall Study|Adverse Event|8|||
155532012|NCT03256695|561373007|FG000|Overall Study|Death|2|||
155532013|NCT03256695|561373007|FG000|Overall Study|Withdrawal by Subject|14|||
155532014|NCT03256695|561373007|FG000|Overall Study|Non-compliance with study drug|1|||
155532015|NCT03256695|561373007|FG000|Overall Study|Lost to Follow-up|3|||
155532016|NCT03256695|561373007|FG000|Overall Study|Lack of Efficacy|3|||
155532017|NCT03256695|561373007|FG000|Overall Study|Protocol Violation|5|||
155532018|NCT03256695|561373007|FG000|Overall Study|Other than specified|3|||
155532019|NCT04078022|561373016|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
155532020|NCT04078022|561373017|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
155532021|NCT01929863|561373018|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
155532022|NCT01929863|561373019|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
155532023|NCT01929863|561373018|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
155532024|NCT01929863|561373019|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
155532025|NCT01929863|561373018|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
155532026|NCT01929863|561373019|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
155532027|NCT00429416|561373022|FG000|Overall Study|Death|1|||
155532028|NCT02152163|561373023|FG000|Overall Study|Physician Decision|12|||
155532029|NCT02152163|561373024|FG001|Overall Study|Physician Decision|13|||
155532030|NCT02358538|561373025|FG000|Through Week 26|Adverse Event|0|||
155532031|NCT02358538|561373026|FG001|Through Week 26|Adverse Event|1|||
155532032|NCT02358538|561373027|FG002|Through Week 26|Adverse Event|1|||
155532033|NCT02358538|561373028|FG003|Through Week 26|Adverse Event|2|||
155532034|NCT02358538|561373025|FG000|Through Week 26|Lack of Efficacy|1|||
155532035|NCT02358538|561373026|FG001|Through Week 26|Lack of Efficacy|1|||
155532036|NCT02358538|561373027|FG002|Through Week 26|Lack of Efficacy|3|||
155532037|NCT02358538|561373028|FG003|Through Week 26|Lack of Efficacy|3|||
155532038|NCT02358538|561373025|FG000|Through Week 26|Withdrawal by Subject|1|||
155532039|NCT02358538|561373026|FG001|Through Week 26|Withdrawal by Subject|0|||
155532040|NCT02358538|561373027|FG002|Through Week 26|Withdrawal by Subject|0|||
155532041|NCT02358538|561373028|FG003|Through Week 26|Withdrawal by Subject|0|||
155532042|NCT02358538|561373025|FG000|Through Week 26|Non-Compliance|0|||
155532043|NCT02358538|561373026|FG001|Through Week 26|Non-Compliance|0|||
155532044|NCT02358538|561373027|FG002|Through Week 26|Non-Compliance|1|||
155532045|NCT02358538|561373028|FG003|Through Week 26|Non-Compliance|0|||
155532046|NCT02358538|561373025|FG000|Through Week 26|Family did not see benefit from IP|1|||
155532047|NCT02358538|561373026|FG001|Through Week 26|Family did not see benefit from IP|0|||
155532048|NCT02358538|561373027|FG002|Through Week 26|Family did not see benefit from IP|0|||
155532049|NCT02358538|561373028|FG003|Through Week 26|Family did not see benefit from IP|0|||
155532050|NCT02358538|561373025|FG000|52 Week Extension Period|Lack of Efficacy|0|||
155532051|NCT02358538|561373026|FG001|52 Week Extension Period|Lack of Efficacy|0|||
155532052|NCT02358538|561373027|FG002|52 Week Extension Period|Lack of Efficacy|2|||
155532053|NCT02358538|561373028|FG003|52 Week Extension Period|Lack of Efficacy|4|||
155532054|NCT01686477|561373029|FG000|Feeding Intervention|Death|1|||
155532055|NCT01686477|561373030|FG001|Feeding Intervention|Death|0|||
155532056|NCT01686477|561373031|FG002|Feeding Intervention|Death|1|||
155532057|NCT01686477|561373029|FG000|Feeding Intervention|Withdrawal by Subject|0|||
155532058|NCT01686477|561373030|FG001|Feeding Intervention|Withdrawal by Subject|6|||
155532059|NCT01686477|561373031|FG002|Feeding Intervention|Withdrawal by Subject|0|||
155532060|NCT01686477|561373029|FG000|Feeding Intervention|Physician Decision|1|||
155532061|NCT01686477|561373030|FG001|Feeding Intervention|Physician Decision|2|||
155532062|NCT01686477|561373031|FG002|Feeding Intervention|Physician Decision|0|||
155532063|NCT01686477|561373029|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
155532064|NCT01686477|561373030|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
155532065|NCT01686477|561373031|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
155532066|NCT01686477|561373029|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
155532067|NCT01686477|561373030|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
155532068|NCT01686477|561373031|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
155532069|NCT01686477|561373029|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
155532070|NCT01686477|561373030|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
155532071|NCT01686477|561373031|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
155532072|NCT01686477|561373029|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
155532073|NCT01686477|561373030|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
155532074|NCT01686477|561373031|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
155655321|NCT03787615|561832174|FG000|Overall Study|Lost to Follow-up|2|||
155655322|NCT04661839|561832176|FG000|Overall Study|Not Treated|0|||
155655323|NCT04661839|561832177|FG001|Overall Study|Not Treated|0|||
155532075|NCT01686477|561373029|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
155655324|NCT04661839|561832178|FG002|Overall Study|Not Treated|1|||
155532076|NCT01686477|561373030|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
155532077|NCT01686477|561373031|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
155532078|NCT01686477|561373029|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
155532079|NCT01686477|561373030|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
155532080|NCT01686477|561373031|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
155532081|NCT01686477|561373029|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
155532082|NCT01686477|561373030|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
155532083|NCT01686477|561373031|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
155532084|NCT06999265|561373032|FG000|Overall Study|Lost to Follow-up|1|||
155532085|NCT06999265|561373033|FG001|Overall Study|Lost to Follow-up|1|||
155532086|NCT00730691|561373034|FG000|Overall Study|Adverse Event|4|||
155532087|NCT00730691|561373035|FG001|Overall Study|Adverse Event|8|||
155532088|NCT00730691|561373036|FG002|Overall Study|Adverse Event|11|||
155532089|NCT00730691|561373037|FG003|Overall Study|Adverse Event|11|||
155532090|NCT00730691|561373038|FG004|Overall Study|Adverse Event|23|||
155532091|NCT00730691|561373034|FG000|Overall Study|Lack of Efficacy|4|||
155532092|NCT00730691|561373035|FG001|Overall Study|Lack of Efficacy|4|||
155532093|NCT00730691|561373036|FG002|Overall Study|Lack of Efficacy|2|||
155532094|NCT00730691|561373037|FG003|Overall Study|Lack of Efficacy|1|||
155532095|NCT00730691|561373038|FG004|Overall Study|Lack of Efficacy|1|||
155532096|NCT00730691|561373034|FG000|Overall Study|Non-compliance with Study Drug|6|||
155532097|NCT00730691|561373035|FG001|Overall Study|Non-compliance with Study Drug|1|||
155532098|NCT00730691|561373036|FG002|Overall Study|Non-compliance with Study Drug|6|||
155532099|NCT00730691|561373037|FG003|Overall Study|Non-compliance with Study Drug|3|||
155532100|NCT00730691|561373038|FG004|Overall Study|Non-compliance with Study Drug|3|||
155532101|NCT00730691|561373034|FG000|Overall Study|Protocol Deviations|3|||
155532102|NCT00730691|561373035|FG001|Overall Study|Protocol Deviations|5|||
155532103|NCT00730691|561373036|FG002|Overall Study|Protocol Deviations|3|||
155532104|NCT00730691|561373037|FG003|Overall Study|Protocol Deviations|7|||
155532105|NCT00730691|561373038|FG004|Overall Study|Protocol Deviations|5|||
155532106|NCT00730691|561373034|FG000|Overall Study|Withdrawal of Consent|7|||
155532107|NCT00730691|561373035|FG001|Overall Study|Withdrawal of Consent|9|||
155532108|NCT00730691|561373036|FG002|Overall Study|Withdrawal of Consent|3|||
155532109|NCT00730691|561373037|FG003|Overall Study|Withdrawal of Consent|6|||
155532110|NCT00730691|561373038|FG004|Overall Study|Withdrawal of Consent|3|||
155532111|NCT00730691|561373034|FG000|Overall Study|Lost to Follow-up|11|||
155532112|NCT00730691|561373035|FG001|Overall Study|Lost to Follow-up|8|||
155532113|NCT00730691|561373036|FG002|Overall Study|Lost to Follow-up|13|||
155532114|NCT00730691|561373037|FG003|Overall Study|Lost to Follow-up|15|||
155532115|NCT00730691|561373038|FG004|Overall Study|Lost to Follow-up|13|||
155532116|NCT00730691|561373034|FG000|Overall Study|Other|1|||
155532117|NCT00730691|561373035|FG001|Overall Study|Other|1|||
155532118|NCT00730691|561373036|FG002|Overall Study|Other|1|||
155532119|NCT00730691|561373037|FG003|Overall Study|Other|2|||
155532120|NCT00730691|561373038|FG004|Overall Study|Other|2|||
155532121|NCT02178787|561373039|FG000|Overall Study|Lost to Follow-up|1|||
155532122|NCT02178787|561373040|FG001|Overall Study|Lost to Follow-up|0|||
155532123|NCT02178787|561373039|FG000|Overall Study|Withdrawal by Subject|0|||
155532124|NCT02178787|561373040|FG001|Overall Study|Withdrawal by Subject|2|||
155532125|NCT02178787|561373039|FG000|Overall Study|No TCD window|3|||
155532126|NCT02178787|561373040|FG001|Overall Study|No TCD window|7|||
155532127|NCT02178787|561373039|FG000|Overall Study|Physician Decision|1|||
155532128|NCT02178787|561373040|FG001|Overall Study|Physician Decision|0|||
155532129|NCT02554890|561373041|FG000|Double-blind|Adverse Event|45|||
155532130|NCT02554890|561373042|FG001|Double-blind|Adverse Event|51|||
155532131|NCT02554890|561373041|FG000|Double-blind|Death|6|||
155532132|NCT02554890|561373042|FG001|Double-blind|Death|4|||
155532133|NCT02554890|561373041|FG000|Double-blind|Protocol Violation|1|||
155532134|NCT02554890|561373042|FG001|Double-blind|Protocol Violation|1|||
155532135|NCT02554890|561373041|FG000|Double-blind|Physician Decision|4|||
155532136|NCT02554890|561373042|FG001|Double-blind|Physician Decision|3|||
155532137|NCT02554890|561373041|FG000|Double-blind|Subject/Guardian decision|21|||
155532138|NCT02554890|561373042|FG001|Double-blind|Subject/Guardian decision|16|||
155532139|NCT02554890|561373041|FG000|Double-blind|Lost to Follow-up|7|||
155532140|NCT02554890|561373042|FG001|Double-blind|Lost to Follow-up|5|||
155532141|NCT02554890|561373041|FG000|Double-blind|Technical problems|1|||
155532142|NCT02554890|561373042|FG001|Double-blind|Technical problems|0|||
155532143|NCT02554890|561373041|FG000|Double-blind|Withdrawal by Subject|5|||
155532144|NCT02554890|561373042|FG001|Double-blind|Withdrawal by Subject|6|||
155532145|NCT02554890|561373041|FG000|Double-blind|Noncompliance with study treatment|6|||
155532146|NCT02554890|561373042|FG001|Double-blind|Noncompliance with study treatment|5|||
155532147|NCT02554890|561373041|FG000|Open-label|Adverse Event|0|||
155532148|NCT02554890|561373042|FG001|Open-label|Adverse Event|30|||
155532149|NCT02554890|561373041|FG000|Open-label|Death|0|||
155532150|NCT02554890|561373042|FG001|Open-label|Death|1|||
155532151|NCT02554890|561373041|FG000|Open-label|Physician Decision|0|||
155532152|NCT02554890|561373042|FG001|Open-label|Physician Decision|1|||
155532153|NCT02554890|561373041|FG000|Open-label|Subject/Guardian decision|0|||
155532154|NCT02554890|561373042|FG001|Open-label|Subject/Guardian decision|11|||
155532155|NCT02554890|561373041|FG000|Open-label|Lost to Follow-up|0|||
155532156|NCT02554890|561373042|FG001|Open-label|Lost to Follow-up|7|||
155532157|NCT02554890|561373041|FG000|Open-label|Technical problems|0|||
155532158|NCT02554890|561373042|FG001|Open-label|Technical problems|1|||
155532159|NCT02554890|561373041|FG000|Open-label|Withdrawal by Subject|0|||
155532160|NCT02554890|561373042|FG001|Open-label|Withdrawal by Subject|1|||
155532161|NCT03649477|561373048|FG000|Overall Study|Adverse Event|2|||
155532162|NCT03649477|561373049|FG001|Overall Study|Adverse Event|0|||
155532163|NCT03649477|561373050|FG002|Overall Study|Adverse Event|0|||
155532164|NCT02430480|561373051|FG000|Overall Study|Death|1|||
155532165|NCT02430480|561373051|FG000|Overall Study|Anesthesia concerns|1|||
155532166|NCT02430480|561373051|FG000|Overall Study|Progressed on treatment|1|||
155532167|NCT01097577|561373052|FG000|Overall Study|Adverse Event|0|||
155532168|NCT01097577|561373053|FG001|Overall Study|Adverse Event|1|||
155532169|NCT01963728|561373063|FG000|Overall Study|Study terminated early|0|||
155532170|NCT01963728|561373064|FG001|Overall Study|Study terminated early|1|||
155532171|NCT06298396|561374486|FG000|Default MAP|Protocol Violation|1|||
155532172|NCT06137781|561374487|FG000|Baseline measurements|Lost to Follow-up|2|||
155532173|NCT06137781|561374487|FG000|Baseline measurements|Withdrawal by Subject|1|||
155532174|NCT06137781|561374487|FG000|Baseline measurements|Expedited surgery|1|||
155532175|NCT06137781|561374487|FG000|Intervention period|Lost to Follow-up|2|||
155532176|NCT06137781|561374487|FG000|Intervention period|Withdrawal by Subject|3|||
155532177|NCT06137781|561374487|FG000|Intervention period|Expedited surgery|1|||
155532178|NCT06137781|561374487|FG000|Intervention period|Adverse Event|1|||
155532179|NCT02591420|561374488|FG000|Overall Study|Lost to Follow-up|0|||
155532180|NCT02591420|561374489|FG001|Overall Study|Lost to Follow-up|1|||
155532181|NCT02591420|561374490|FG002|Overall Study|Lost to Follow-up|2|||
155532182|NCT03056755|561374491|FG000|Core Phase|Progressive disease|89|||
155532183|NCT03056755|561374492|FG001|Core Phase|Progressive disease|88|||
155532184|NCT03056755|561374493|FG002|Core Phase|Progressive disease|90|||
155532185|NCT03056755|561374491|FG000|Core Phase|Adverse Event|20|||
155532186|NCT03056755|561374492|FG001|Core Phase|Adverse Event|14|||
155532187|NCT03056755|561374493|FG002|Core Phase|Adverse Event|13|||
155532188|NCT03056755|561374491|FG000|Core Phase|Physician Decision|7|||
155532189|NCT03056755|561374492|FG001|Core Phase|Physician Decision|13|||
155532190|NCT03056755|561374493|FG002|Core Phase|Physician Decision|5|||
155532191|NCT03056755|561374491|FG000|Core Phase|Subject/guardian decision|5|||
155532192|NCT03056755|561374492|FG001|Core Phase|Subject/guardian decision|8|||
155532193|NCT03056755|561374493|FG002|Core Phase|Subject/guardian decision|4|||
155532194|NCT03056755|561374491|FG000|Core Phase|Death|3|||
155532195|NCT03056755|561374492|FG001|Core Phase|Death|2|||
155532196|NCT03056755|561374493|FG002|Core Phase|Death|4|||
155532197|NCT03056755|561374491|FG000|Core Phase|Protocol deviation|1|||
155532198|NCT03056755|561374492|FG001|Core Phase|Protocol deviation|1|||
155532199|NCT03056755|561374493|FG002|Core Phase|Protocol deviation|0|||
155532200|NCT03056755|561374491|FG000|Core Phase|Technical problems|1|||
155532201|NCT03056755|561374492|FG001|Core Phase|Technical problems|0|||
155532202|NCT03056755|561374493|FG002|Core Phase|Technical problems|0|||
155532203|NCT03056755|561374491|FG000|Extension Phase|Physician Decision|1|||
155532204|NCT03056755|561374492|FG001|Extension Phase|Physician Decision|0|||
155532205|NCT03056755|561374493|FG002|Extension Phase|Physician Decision|3|||
155532206|NCT03056755|561374491|FG000|Extension Phase|Adverse Event|0|||
155532207|NCT03056755|561374492|FG001|Extension Phase|Adverse Event|0|||
155532208|NCT03056755|561374493|FG002|Extension Phase|Adverse Event|1|||
155532209|NCT03056755|561374491|FG000|Extension Phase|Subject/guardian decision|0|||
155532210|NCT03056755|561374492|FG001|Extension Phase|Subject/guardian decision|0|||
155532211|NCT03056755|561374493|FG002|Extension Phase|Subject/guardian decision|1|||
155532212|NCT01528696|561374496|FG000|Overall Study|See detailed description|18|||
155532213|NCT01528696|561374497|FG001|Overall Study|See detailed description|19|||
155532214|NCT01056484|561374498|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
155532215|NCT01056484|561374499|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
155532216|NCT01056484|561374498|FG000|Randomized Controlled Trial|Physician Decision|1|||
155532217|NCT01056484|561374499|FG001|Randomized Controlled Trial|Physician Decision|0|||
155532218|NCT01056484|561374498|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
155532219|NCT01056484|561374499|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
155532220|NCT00446966|561374500|FG000|Overall Study|Lost to Follow-up|10|||
155532221|NCT00446966|561374501|FG001|Overall Study|Lost to Follow-up|7|||
155532222|NCT01547286|561374502|FG000|Overall Study|Did not meet all eligibility criteria|1|||
155532223|NCT01547286|561374502|FG000|Overall Study|Physician Decision|1|||
155532224|NCT02241551|561374506|FG000|Overall Study|Adverse Event|1|||
155532225|NCT02241551|561374507|FG001|Overall Study|Adverse Event|0|||
155532226|NCT00081653|561374508|FG000|Overall Study|Adverse Event|23|||
155532227|NCT00081653|561374509|FG001|Overall Study|Adverse Event|17|||
155532228|NCT00081653|561374508|FG000|Overall Study|Lost to Follow-up|2|||
155532229|NCT00081653|561374509|FG001|Overall Study|Lost to Follow-up|4|||
155532230|NCT00081653|561374508|FG000|Overall Study|Refused Treatment|18|||
155532231|NCT00081653|561374509|FG001|Overall Study|Refused Treatment|14|||
155532232|NCT00081653|561374508|FG000|Overall Study|Low bone mineral density|1|||
155532233|NCT00081653|561374509|FG001|Overall Study|Low bone mineral density|0|||
155532234|NCT00081653|561374508|FG000|Overall Study|Bone loss|2|||
155532235|NCT00081653|561374509|FG001|Overall Study|Bone loss|0|||
155532236|NCT00081653|561374508|FG000|Overall Study|Participant leaving country|1|||
155532237|NCT00081653|561374509|FG001|Overall Study|Participant leaving country|0|||
155532238|NCT00081653|561374508|FG000|Overall Study|Loss of bone mass|0|||
155532239|NCT00081653|561374509|FG001|Overall Study|Loss of bone mass|2|||
155532240|NCT03246503|561374512|FG000|Overall Study|Lost to Follow-up|23|||
155532241|NCT03246503|561374512|FG000|Overall Study|Withdrawal by Subject|20|||
155532242|NCT03246503|561374512|FG000|Overall Study|Physician Decision|5|||
155532243|NCT03246503|561374512|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
155532244|NCT02751424|561374520|FG000|Part 2|Adverse Event|0|||
155532245|NCT02751424|561374521|FG001|Part 2|Adverse Event|0|||
155532246|NCT02751424|561374522|FG002|Part 2|Adverse Event|0|||
155532247|NCT02751424|561374523|FG003|Part 2|Adverse Event|0|||
155532248|NCT02751424|561374524|FG004|Part 2|Adverse Event|0|||
155532249|NCT02751424|561374525|FG005|Part 2|Adverse Event|0|||
155532250|NCT02751424|561374526|FG006|Part 2|Adverse Event|0|||
155532251|NCT02751424|561374527|FG007|Part 2|Adverse Event|5|||
155532252|NCT02751424|561374528|FG008|Part 2|Adverse Event|0|||
155532253|NCT02197416|561374529|FG000|Overall Study|Other reasons|0|||
155532254|NCT02197416|561374530|FG001|Overall Study|Other reasons|2|||
155532255|NCT02197416|561374531|FG002|Overall Study|Other reasons|5|||
155532256|NCT02197416|561374529|FG000|Overall Study|Withdrawal by Subject|0|||
155532257|NCT02197416|561374530|FG001|Overall Study|Withdrawal by Subject|2|||
155532258|NCT02197416|561374531|FG002|Overall Study|Withdrawal by Subject|1|||
155532259|NCT02197416|561374529|FG000|Overall Study|Protocol Violation|1|||
155532260|NCT02197416|561374530|FG001|Overall Study|Protocol Violation|0|||
155532261|NCT02197416|561374531|FG002|Overall Study|Protocol Violation|1|||
155532262|NCT02197416|561374529|FG000|Overall Study|Adverse Event|0|||
155532263|NCT02197416|561374530|FG001|Overall Study|Adverse Event|0|||
155532264|NCT02197416|561374531|FG002|Overall Study|Adverse Event|1|||
155532265|NCT01492439|561374532|FG000|Overall Study|Withdrew from RTE|4|||
155532266|NCT01492439|561374533|FG001|Overall Study|Withdrew from RTE|9|||
155532267|NCT00716625|561374534|FG000|Overall Study|Safety was not Assessable|1|||
155532268|NCT01204294|561374535|FG000|Overall Study|Adverse Event|2|||
155532269|NCT01204294|561374536|FG001|Overall Study|Adverse Event|6|||
155532270|NCT01204294|561374537|FG002|Overall Study|Adverse Event|0|||
155655325|NCT04661839|561832179|FG003|Overall Study|Not Treated|0|||
155655326|NCT04661839|561832176|FG000|Overall Study|Lost to Follow-up|1|||
155532271|NCT01204294|561374538|FG003|Overall Study|Adverse Event|7|||
155532272|NCT01204294|561374539|FG004|Overall Study|Adverse Event|1|||
155532273|NCT01204294|561374540|FG005|Overall Study|Adverse Event|4|||
155532274|NCT01204294|561374541|FG006|Overall Study|Adverse Event|0|||
155532275|NCT01204294|561374535|FG000|Overall Study|Protocol Violation|1|||
155532276|NCT01204294|561374536|FG001|Overall Study|Protocol Violation|0|||
155532277|NCT01204294|561374537|FG002|Overall Study|Protocol Violation|2|||
155532278|NCT01204294|561374538|FG003|Overall Study|Protocol Violation|1|||
155532279|NCT01204294|561374539|FG004|Overall Study|Protocol Violation|0|||
155655327|NCT04661839|561832177|FG001|Overall Study|Lost to Follow-up|0|||
155532280|NCT01204294|561374540|FG005|Overall Study|Protocol Violation|0|||
155532281|NCT01204294|561374541|FG006|Overall Study|Protocol Violation|0|||
155532282|NCT01204294|561374535|FG000|Overall Study|Withdrawal by Subject|0|||
155532283|NCT01204294|561374536|FG001|Overall Study|Withdrawal by Subject|2|||
155532284|NCT01204294|561374537|FG002|Overall Study|Withdrawal by Subject|2|||
155532285|NCT01204294|561374538|FG003|Overall Study|Withdrawal by Subject|1|||
155532286|NCT01204294|561374539|FG004|Overall Study|Withdrawal by Subject|1|||
155532287|NCT01204294|561374540|FG005|Overall Study|Withdrawal by Subject|1|||
155532288|NCT01204294|561374541|FG006|Overall Study|Withdrawal by Subject|2|||
155532289|NCT01204294|561374535|FG000|Overall Study|Lack of Efficacy|0|||
155532290|NCT01204294|561374536|FG001|Overall Study|Lack of Efficacy|0|||
155532291|NCT01204294|561374537|FG002|Overall Study|Lack of Efficacy|0|||
155532292|NCT01204294|561374538|FG003|Overall Study|Lack of Efficacy|2|||
155532293|NCT01204294|561374539|FG004|Overall Study|Lack of Efficacy|0|||
155532294|NCT01204294|561374540|FG005|Overall Study|Lack of Efficacy|0|||
155532295|NCT01204294|561374541|FG006|Overall Study|Lack of Efficacy|0|||
155532296|NCT01204294|561374535|FG000|Overall Study|Other (house moving)|0|||
155532297|NCT01204294|561374536|FG001|Overall Study|Other (house moving)|0|||
155532298|NCT01204294|561374537|FG002|Overall Study|Other (house moving)|1|||
155532299|NCT01204294|561374538|FG003|Overall Study|Other (house moving)|0|||
155532300|NCT01204294|561374539|FG004|Overall Study|Other (house moving)|0|||
155532301|NCT01204294|561374540|FG005|Overall Study|Other (house moving)|0|||
155532302|NCT01204294|561374541|FG006|Overall Study|Other (house moving)|0|||
155532303|NCT02075463|561374542|FG000|Overall Study|Adverse Event|3|||
155532304|NCT02075463|561374542|FG000|Overall Study|Par. reached stopping criteria|4|||
155532305|NCT02075463|561374542|FG000|Overall Study|Withdrawal by Subject|1|||
155532306|NCT01527006|561374543|FG000|Core Study|Adverse Event|0|||
155532307|NCT01527006|561374544|FG001|Core Study|Adverse Event|2|||
155532308|NCT01527006|561374543|FG000|Core Study|Lost to Follow-up|0|||
155532309|NCT01527006|561374544|FG001|Core Study|Lost to Follow-up|1|||
155532310|NCT01527006|561374543|FG000|Core Study|Subject Choice|1|||
155532311|NCT01527006|561374544|FG001|Core Study|Subject Choice|0|||
155532312|NCT01527006|561374543|FG000|Core Study|Inadequate Therapeutic Effect|1|||
155532313|NCT01527006|561374544|FG001|Core Study|Inadequate Therapeutic Effect|0|||
155532314|NCT01527006|561374543|FG000|Core Study|Withdrawal by Subject|0|||
155532315|NCT01527006|561374544|FG001|Core Study|Withdrawal by Subject|1|||
155532316|NCT01527006|561374543|FG000|Core Study|Other|0|||
155532317|NCT01527006|561374544|FG001|Core Study|Other|2|||
155532318|NCT01527006|561374543|FG000|Extension Phase|Adverse Event|4|||
155532319|NCT01527006|561374544|FG001|Extension Phase|Adverse Event|2|||
155532320|NCT01527006|561374543|FG000|Extension Phase|Lost to Follow-up|0|||
155532321|NCT01527006|561374544|FG001|Extension Phase|Lost to Follow-up|1|||
155532322|NCT01527006|561374543|FG000|Extension Phase|Subject Choice|1|||
155532323|NCT01527006|561374544|FG001|Extension Phase|Subject Choice|1|||
155532324|NCT01527006|561374543|FG000|Extension Phase|Inadequate therapeutic effect|1|||
155532325|NCT01527006|561374544|FG001|Extension Phase|Inadequate therapeutic effect|1|||
155532326|NCT01527006|561374543|FG000|Extension Phase|Other|0|||
155532327|NCT01527006|561374544|FG001|Extension Phase|Other|3|||
155532328|NCT01383486|561374545|FG000|Overall Study|Lost to Follow-up|10|||
155532329|NCT01383486|561374545|FG000|Overall Study|Incomplete information for analysis|2|||
155532330|NCT01383486|561374545|FG000|Overall Study|Did not take any product|6|||
155532331|NCT00245063|561374546|FG000|Overall Study|Adverse Event|6|||
155532332|NCT00245063|561374547|FG001|Overall Study|Adverse Event|5|||
155532333|NCT00245063|561374546|FG000|Overall Study|Death|1|||
155532334|NCT00245063|561374547|FG001|Overall Study|Death|0|||
155532335|NCT01839279|561374550|FG000|Overall Study|Adverse Event|4|||
155532336|NCT01839279|561374551|FG001|Overall Study|Adverse Event|1|||
155532337|NCT01839279|561374552|FG002|Overall Study|Adverse Event|1|||
155532338|NCT01839279|561374550|FG000|Overall Study|Withdrawal by Subject|4|||
155532339|NCT01839279|561374551|FG001|Overall Study|Withdrawal by Subject|1|||
155532340|NCT01839279|561374552|FG002|Overall Study|Withdrawal by Subject|1|||
155532341|NCT01839279|561374550|FG000|Overall Study|Classified as 'Other'|5|||
155532342|NCT01839279|561374551|FG001|Overall Study|Classified as 'Other'|0|||
155532343|NCT01839279|561374552|FG002|Overall Study|Classified as 'Other'|0|||
155532344|NCT00466167|561374563|FG000|Overall Study|Adverse Event|8|||
155532345|NCT00466167|561374564|FG001|Overall Study|Adverse Event|8|||
155532346|NCT00466167|561374565|FG002|Overall Study|Adverse Event|7|||
155532347|NCT00466167|561374563|FG000|Overall Study|Lack of Efficacy|2|||
155532348|NCT00466167|561374564|FG001|Overall Study|Lack of Efficacy|0|||
155532349|NCT00466167|561374565|FG002|Overall Study|Lack of Efficacy|3|||
155532350|NCT00466167|561374563|FG000|Overall Study|Protocol Violation|1|||
155532351|NCT00466167|561374564|FG001|Overall Study|Protocol Violation|1|||
155532352|NCT00466167|561374565|FG002|Overall Study|Protocol Violation|2|||
155532353|NCT00466167|561374563|FG000|Overall Study|Lost to Follow-up|3|||
155532354|NCT00466167|561374564|FG001|Overall Study|Lost to Follow-up|2|||
155532355|NCT00466167|561374565|FG002|Overall Study|Lost to Follow-up|2|||
155532356|NCT00466167|561374563|FG000|Overall Study|Withdrawal by Subject|4|||
155532357|NCT00466167|561374564|FG001|Overall Study|Withdrawal by Subject|1|||
155532358|NCT00466167|561374565|FG002|Overall Study|Withdrawal by Subject|6|||
155532359|NCT00466167|561374563|FG000|Overall Study|patient did not meet inclusion criteria|1|||
155532360|NCT00466167|561374564|FG001|Overall Study|patient did not meet inclusion criteria|0|||
155532361|NCT00466167|561374565|FG002|Overall Study|patient did not meet inclusion criteria|1|||
155532362|NCT00466167|561374563|FG000|Overall Study|Not treated|1|||
155532363|NCT00466167|561374564|FG001|Overall Study|Not treated|0|||
155532364|NCT00466167|561374565|FG002|Overall Study|Not treated|0|||
155532365|NCT03199963|561374566|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
155532366|NCT03199963|561374567|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
155532367|NCT03199963|561374566|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
155532368|NCT03199963|561374567|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
155532369|NCT03199963|561374566|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
155532370|NCT03199963|561374567|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
155532371|NCT03199963|561374566|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
155532372|NCT03199963|561374567|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
155532373|NCT03199963|561374566|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
155532374|NCT03199963|561374567|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
155532375|NCT03199963|561374566|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
155532376|NCT03199963|561374567|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
155532377|NCT00107991|561374570|FG000|Eligibility Assessment|Disease not severe enough|7|||
155532378|NCT00107991|561374570|FG000|Eligibility Assessment|Unwilling to participate|7|||
155532379|NCT00107991|561374570|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
155532380|NCT00107991|561374570|FG000|Eligibility Assessment|Abnormal labs|2|||
155532381|NCT00107991|561374570|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
155532382|NCT00107991|561374570|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
155532383|NCT00107991|561374570|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
155532384|NCT00107991|561374570|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
155532385|NCT00107991|561374570|FG000|12 Week Treatment Period|Adverse Event|1|||
155532386|NCT00107991|561374570|FG000|12 Week Treatment Period|Protocol Violation|1|||
155532387|NCT00107991|561374570|FG000|12 Week Treatment Period|Incarcerated|1|||
155532388|NCT00107991|561374570|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
155532389|NCT03930732|561374571|FG000|Overall Study|Adverse Event|9|||
155532390|NCT03930732|561374572|FG001|Overall Study|Adverse Event|7|||
155532391|NCT03930732|561374571|FG000|Overall Study|Poor compliance to protocol|0|||
155532392|NCT03930732|561374572|FG001|Overall Study|Poor compliance to protocol|1|||
155532393|NCT03930732|561374571|FG000|Overall Study|Withdrawal by Subject|23|||
155532394|NCT03930732|561374572|FG001|Overall Study|Withdrawal by Subject|11|||
155532395|NCT03930732|561374571|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
155532396|NCT03930732|561374572|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
155532397|NCT03930732|561374571|FG000|Overall Study|Other reason not related to COVID-19|5|||
155532398|NCT03930732|561374572|FG001|Overall Study|Other reason not related to COVID-19|8|||
155532399|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Adverse Event|11|||
155532400|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Adverse Event|23|||
155532401|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Adverse Event|29|||
155532402|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Adverse Event|2|||
155532403|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Adverse Event|8|||
155532404|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
155532405|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
155532406|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
155532407|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
155532408|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
155532409|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
155532410|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
155532411|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
155532412|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
155532413|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
155532414|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
155532415|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
155532416|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
155532417|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
155532418|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
155532419|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
155532420|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
155532421|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
155532422|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
155532423|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
155532424|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
155532425|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
155655328|NCT04661839|561832178|FG002|Overall Study|Lost to Follow-up|0|||
155655329|NCT04661839|561832179|FG003|Overall Study|Lost to Follow-up|1|||
155532426|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
155532427|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
155532428|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
155532429|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
155532430|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
155532431|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
155532432|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
155532433|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
155532434|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Move|0|||
155532435|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Move|1|||
155532436|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Move|0|||
155532437|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Move|0|||
155532438|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Move|0|||
155532439|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
155532440|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
155532441|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
155532442|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
155532443|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
155532444|NCT00318461|561374579|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
155532445|NCT00318461|561374580|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
155532446|NCT00318461|561374581|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
155532447|NCT00318461|561374582|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
155532448|NCT00318461|561374583|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
155532449|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Work commitment|0|||
155532450|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Work commitment|0|||
155532451|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Work commitment|0|||
155532452|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Work commitment|0|||
155532453|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Work commitment|1|||
155532454|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Investigator decision|0|||
155532455|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Investigator decision|0|||
155532456|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Investigator decision|0|||
155532457|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Investigator decision|0|||
155532458|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Investigator decision|1|||
155532459|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Lack of time|1|||
155532460|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Lack of time|0|||
155532461|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Lack of time|0|||
155532462|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Lack of time|0|||
155532463|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Lack of time|0|||
155532464|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
155532465|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
155532466|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
155532467|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
155532468|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
155532469|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
155532470|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
155532471|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
155532472|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
155532473|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
155532474|NCT00318461|561374579|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
155532475|NCT00318461|561374580|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
155532476|NCT00318461|561374581|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
155532477|NCT00318461|561374582|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
155532478|NCT00318461|561374583|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
155532479|NCT00318461|561374579|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
155532480|NCT00318461|561374580|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
155532481|NCT00318461|561374581|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
155655330|NCT01946880|561832180|FG000|Overall Study|Lost to Follow-up|1|||
155655331|NCT01946880|561832181|FG001|Overall Study|Lost to Follow-up|0|||
155655332|NCT01946880|561832180|FG000|Overall Study|Physician Decision|1|||
155655333|NCT01946880|561832181|FG001|Overall Study|Physician Decision|1|||
155655334|NCT01946880|561832180|FG000|Overall Study|Withdrawal by Subject|3|||
155655335|NCT01946880|561832181|FG001|Overall Study|Withdrawal by Subject|2|||
155655336|NCT01946880|561832180|FG000|Overall Study|Met Primary Endpoint|1|||
155655337|NCT01946880|561832181|FG001|Overall Study|Met Primary Endpoint|0|||
155655338|NCT01946880|561832180|FG000|Overall Study|Personal and Family Issues|1|||
155655339|NCT01946880|561832181|FG001|Overall Study|Personal and Family Issues|0|||
155655340|NCT02609503|561832182|FG000|Overall Study|Adverse Event|1|||
155655341|NCT02609503|561832182|FG000|Overall Study|Death|1|||
155655342|NCT02609503|561832182|FG000|Overall Study|Withdrawal by Subject|1|||
155655343|NCT02609503|561832182|FG000|Overall Study|Disease progression|1|||
155655344|NCT02034565|561832183|FG000|Overall Study|Adverse Event|1|||
155532482|NCT00318461|561374582|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
155532483|NCT00318461|561374583|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
155532484|NCT00318461|561374579|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
155532485|NCT00318461|561374580|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
155532486|NCT00318461|561374581|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
155532487|NCT00318461|561374582|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
155532488|NCT00318461|561374583|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
155532489|NCT00318461|561374579|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
155532490|NCT00318461|561374580|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
155532491|NCT00318461|561374581|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
155532492|NCT00318461|561374582|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
155532493|NCT00318461|561374583|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
155532494|NCT00318461|561374579|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
155532495|NCT00318461|561374580|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
155532496|NCT00318461|561374581|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
155532497|NCT00318461|561374582|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
155532498|NCT00318461|561374583|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
155532499|NCT00318461|561374579|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
155532500|NCT00318461|561374580|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
155532501|NCT00318461|561374581|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
155532502|NCT00318461|561374582|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
155532503|NCT00318461|561374583|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
155532504|NCT03084471|561374584|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
155532505|NCT03084471|561374584|FG000|Overall Study|Condition under investigation worsened|84|||
155532506|NCT03084471|561374584|FG000|Overall Study|Lack of therapeutic response|2|||
155532507|NCT03084471|561374584|FG000|Overall Study|Protocol Violation|1|||
155532508|NCT03084471|561374584|FG000|Overall Study|Adverse Event|73|||
155532509|NCT03084471|561374584|FG000|Overall Study|Withdrawal by Subject|12|||
155532510|NCT03084471|561374584|FG000|Overall Study|Disease relapse|181|||
155532511|NCT03084471|561374584|FG000|Overall Study|Subjective disease progression|359|||
155532512|NCT03084471|561374584|FG000|Overall Study|Other (as recorded)|33|||
155532513|NCT03084471|561374584|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
155532514|NCT00505622|561374585|FG000|Overall Study|Adverse Event|5|||
155532515|NCT00505622|561374586|FG001|Overall Study|Adverse Event|6|||
155532516|NCT00505622|561374587|FG002|Overall Study|Adverse Event|4|||
155532517|NCT00505622|561374585|FG000|Overall Study|Protocol Violation|1|||
155532518|NCT00505622|561374586|FG001|Overall Study|Protocol Violation|1|||
155532519|NCT00505622|561374587|FG002|Overall Study|Protocol Violation|0|||
155532520|NCT00505622|561374585|FG000|Overall Study|Withdrawal by Subject|0|||
155532521|NCT00505622|561374586|FG001|Overall Study|Withdrawal by Subject|3|||
155532522|NCT00505622|561374587|FG002|Overall Study|Withdrawal by Subject|2|||
155532523|NCT00505622|561374585|FG000|Overall Study|Study termination by sponsor|115|||
155532524|NCT00505622|561374586|FG001|Overall Study|Study termination by sponsor|98|||
155532525|NCT00505622|561374587|FG002|Overall Study|Study termination by sponsor|90|||
155532526|NCT01757392|561374598|FG000|Overall Study|Withdrawal by Subject|1|||
155532527|NCT01757392|561374598|FG000|Overall Study|Screen Fail|3|||
155532528|NCT00207090|561374601|FG000|Overall Study|Study drug toxicity|3|||
155532529|NCT00207090|561374601|FG000|Overall Study|Chest wall mass larger|1|||
155532530|NCT00207090|561374601|FG000|Overall Study|Disease progression/relapse|2|||
155532531|NCT00207090|561374601|FG000|Overall Study|Physician Decision|1|||
155532532|NCT00835692|561374602|FG000|First Intervention|Withdrawal by Subject|1|||
155532533|NCT00835692|561374603|FG001|First Intervention|Withdrawal by Subject|0|||
155532534|NCT03644550|561374608|FG000|Overall Study|Withdrawal by Subject|3|||
155532535|NCT03644550|561374608|FG000|Overall Study|Progressive disease|15|||
155532536|NCT00835536|561374611|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
155532537|NCT00835536|561374612|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
155532538|NCT00830024|561374617|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155532539|NCT00830024|561374618|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155532540|NCT00950989|561374619|FG000|Overall Study|Death|0|||
155532541|NCT00950989|561374620|FG001|Overall Study|Death|0|||
155532542|NCT00950989|561374621|FG002|Overall Study|Death|1|||
155655345|NCT02034565|561832184|FG001|Overall Study|Adverse Event|0|||
155655346|NCT00721110|561832189|FG000|Overall Study|Ultram use|1|||
155655347|NCT00721110|561832190|FG001|Overall Study|Ultram use|0|||
155655348|NCT00721110|561832191|FG002|Overall Study|Ultram use|0|||
155655349|NCT00721110|561832192|FG003|Overall Study|Ultram use|0|||
155655350|NCT00721110|561832189|FG000|Overall Study|vertical incision|0|||
155655351|NCT00721110|561832190|FG001|Overall Study|vertical incision|0|||
155655352|NCT00721110|561832191|FG002|Overall Study|vertical incision|1|||
155532543|NCT00950989|561374622|FG003|Overall Study|Death|0|||
155655353|NCT00721110|561832192|FG003|Overall Study|vertical incision|0|||
155532544|NCT00950989|561374619|FG000|Overall Study|Administrative Decision|0|||
155532545|NCT00950989|561374620|FG001|Overall Study|Administrative Decision|1|||
155532546|NCT00950989|561374621|FG002|Overall Study|Administrative Decision|0|||
155532547|NCT00950989|561374622|FG003|Overall Study|Administrative Decision|0|||
155532548|NCT00950989|561374619|FG000|Overall Study|Disease Progression|0|||
155532549|NCT00950989|561374620|FG001|Overall Study|Disease Progression|0|||
155532550|NCT00950989|561374621|FG002|Overall Study|Disease Progression|1|||
155532551|NCT00950989|561374622|FG003|Overall Study|Disease Progression|0|||
155532552|NCT00950989|561374619|FG000|Overall Study|Withdrawal by Subject|2|||
155532553|NCT00950989|561374620|FG001|Overall Study|Withdrawal by Subject|1|||
155532554|NCT00950989|561374621|FG002|Overall Study|Withdrawal by Subject|0|||
155532555|NCT00950989|561374622|FG003|Overall Study|Withdrawal by Subject|0|||
155532556|NCT00950989|561374619|FG000|Overall Study|Adverse Event|2|||
155532557|NCT00950989|561374620|FG001|Overall Study|Adverse Event|1|||
155532558|NCT00950989|561374621|FG002|Overall Study|Adverse Event|1|||
155532559|NCT00950989|561374622|FG003|Overall Study|Adverse Event|0|||
155532560|NCT03804983|561374623|FG000|Overall Study|Adverse Event|0|||
155532561|NCT03804983|561374624|FG001|Overall Study|Adverse Event|1|||
155532562|NCT03804983|561374623|FG000|Overall Study|Family Obligation|1|||
155532563|NCT03804983|561374624|FG001|Overall Study|Family Obligation|0|||
155532564|NCT04825275|561375624|FG000|Overall Study|Withdrawal by Subject|1|||
155532565|NCT04825275|561375625|FG001|Overall Study|Withdrawal by Subject|0|||
155532566|NCT02566850|561375626|FG000|Overall Study|Protocol Violation|1|||
155532567|NCT05005442|561375627|FG000|Overall Study|Death|14|||
155532568|NCT05005442|561375628|FG001|Overall Study|Death|10|||
155532569|NCT05005442|561375629|FG002|Overall Study|Death|8|||
155532570|NCT05005442|561375630|FG003|Overall Study|Death|22|||
155532571|NCT05005442|561375631|FG004|Overall Study|Death|13|||
155532572|NCT05005442|561375632|FG005|Overall Study|Death|15|||
155532573|NCT05005442|561375627|FG000|Overall Study|Lost to Follow-up|0|||
155532574|NCT05005442|561375628|FG001|Overall Study|Lost to Follow-up|2|||
155532575|NCT05005442|561375629|FG002|Overall Study|Lost to Follow-up|0|||
155532576|NCT05005442|561375630|FG003|Overall Study|Lost to Follow-up|0|||
155532577|NCT05005442|561375631|FG004|Overall Study|Lost to Follow-up|1|||
155532578|NCT05005442|561375632|FG005|Overall Study|Lost to Follow-up|0|||
155532579|NCT05005442|561375627|FG000|Overall Study|Physician Decision|0|||
155532580|NCT05005442|561375628|FG001|Overall Study|Physician Decision|0|||
155532581|NCT05005442|561375629|FG002|Overall Study|Physician Decision|1|||
155532582|NCT05005442|561375630|FG003|Overall Study|Physician Decision|0|||
155532583|NCT05005442|561375631|FG004|Overall Study|Physician Decision|2|||
155532584|NCT05005442|561375632|FG005|Overall Study|Physician Decision|0|||
155532585|NCT05005442|561375627|FG000|Overall Study|Sponsor decision|26|||
155532586|NCT05005442|561375628|FG001|Overall Study|Sponsor decision|26|||
155532587|NCT05005442|561375629|FG002|Overall Study|Sponsor decision|10|||
155532588|NCT05005442|561375630|FG003|Overall Study|Sponsor decision|5|||
155532589|NCT05005442|561375631|FG004|Overall Study|Sponsor decision|9|||
155532590|NCT05005442|561375632|FG005|Overall Study|Sponsor decision|12|||
155532591|NCT05005442|561375627|FG000|Overall Study|Withdrawal by Subject|2|||
155532592|NCT05005442|561375628|FG001|Overall Study|Withdrawal by Subject|2|||
155532593|NCT05005442|561375629|FG002|Overall Study|Withdrawal by Subject|1|||
155532594|NCT05005442|561375630|FG003|Overall Study|Withdrawal by Subject|3|||
155532595|NCT05005442|561375631|FG004|Overall Study|Withdrawal by Subject|0|||
155532596|NCT05005442|561375632|FG005|Overall Study|Withdrawal by Subject|5|||
155532597|NCT05005442|561375627|FG000|Overall Study|Site terminated by sponsor|0|||
155532598|NCT05005442|561375628|FG001|Overall Study|Site terminated by sponsor|2|||
155532599|NCT05005442|561375629|FG002|Overall Study|Site terminated by sponsor|0|||
155532600|NCT05005442|561375630|FG003|Overall Study|Site terminated by sponsor|0|||
155532601|NCT05005442|561375631|FG004|Overall Study|Site terminated by sponsor|0|||
155532602|NCT05005442|561375632|FG005|Overall Study|Site terminated by sponsor|1|||
155532603|NCT03696160|561375639|FG000|Overall Study|Withdrew before IMP dosing|2|||
155532604|NCT03696160|561375640|FG001|Overall Study|Withdrew before IMP dosing|3|||
155532605|NCT04970810|561375643|FG000|Overall Study|deemed ineligible after randomization|3|||
155532606|NCT04970810|561375644|FG001|Overall Study|deemed ineligible after randomization|0|||
155532607|NCT04970810|561375645|FG002|Overall Study|deemed ineligible after randomization|4|||
155532608|NCT04742491|561375648|FG000|Overall Study|Death|2|||
155532609|NCT04742491|561375649|FG001|Overall Study|Death|0|||
155532610|NCT04742491|561375648|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
155532611|NCT04742491|561375649|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
155532612|NCT04742491|561375648|FG000|Overall Study|Lost to Follow-up|6|||
155532613|NCT04742491|561375649|FG001|Overall Study|Lost to Follow-up|8|||
155532614|NCT04742491|561375648|FG000|Overall Study|Withdrawal by Subject|4|||
155532615|NCT04742491|561375649|FG001|Overall Study|Withdrawal by Subject|2|||
155532616|NCT04742491|561375648|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
155532617|NCT04742491|561375649|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
155532618|NCT04742491|561375648|FG000|Overall Study|Participant refused further participation|2|||
155532619|NCT04742491|561375649|FG001|Overall Study|Participant refused further participation|7|||
155532620|NCT04742491|561375648|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
155532621|NCT04742491|561375649|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
155532622|NCT04742491|561375648|FG000|Overall Study|Other reasons|3|||
155532623|NCT04742491|561375649|FG001|Overall Study|Other reasons|4|||
155532624|NCT03317899|561375653|FG000|Overall Study|Death|6|||
155532625|NCT03317899|561375654|FG001|Overall Study|Death|9|||
155532626|NCT01440803|561375656|FG000|Overall Study|Met study stopping rule|2|||
155532627|NCT01440803|561375657|FG001|Overall Study|Met study stopping rule|1|||
155532628|NCT01440803|561375656|FG000|Overall Study|Lost to Follow-up|0|||
155532629|NCT01440803|561375657|FG001|Overall Study|Lost to Follow-up|2|||
155532630|NCT01440803|561375656|FG000|Overall Study|Withdrawal by Subject|0|||
155655354|NCT04079920|561832199|FG000|Overall Study|Adverse event, not related to study drug|2|||
155655355|NCT04079920|561832199|FG000|Overall Study|Adverse event related to study drug|10|||
155655356|NCT04079920|561832199|FG000|Overall Study|Death|2|||
155655357|NCT04079920|561832199|FG000|Overall Study|Lost to Follow-up|22|||
155655358|NCT04079920|561832199|FG000|Overall Study|Physician Decision|1|||
155655359|NCT04079920|561832199|FG000|Overall Study|Withdrawal by Subject|11|||
155655360|NCT03760068|561832200|FG000|Overall Study|Withdrawal by Subject|7|||
155655361|NCT03760068|561832201|FG001|Overall Study|Withdrawal by Subject|8|||
155655362|NCT03760068|561832200|FG000|Overall Study|Adverse Event|1|||
155655363|NCT03760068|561832201|FG001|Overall Study|Adverse Event|2|||
155655364|NCT03760068|561832200|FG000|Overall Study|Administrative Decision by Sponsor|0|||
155655365|NCT03760068|561832201|FG001|Overall Study|Administrative Decision by Sponsor|2|||
155655366|NCT03760068|561832200|FG000|Overall Study|Physician Decision|1|||
155655367|NCT03760068|561832201|FG001|Overall Study|Physician Decision|2|||
155655368|NCT03760068|561832200|FG000|Overall Study|Lost to Follow-up|4|||
155655369|NCT03760068|561832201|FG001|Overall Study|Lost to Follow-up|9|||
155655370|NCT03760068|561832200|FG000|Overall Study|Subject Moved Out of State|1|||
155655371|NCT03760068|561832201|FG001|Overall Study|Subject Moved Out of State|0|||
155655372|NCT01618708|561832202|FG000|Overall Study|Adverse Event|10|||
155655373|NCT01618708|561832203|FG001|Overall Study|Adverse Event|10|||
155655374|NCT01618708|561832202|FG000|Overall Study|Lost to Follow-up|3|||
155655375|NCT01618708|561832203|FG001|Overall Study|Lost to Follow-up|3|||
155655376|NCT01618708|561832202|FG000|Overall Study|Withdrawal by Subject|17|||
155655377|NCT01618708|561832203|FG001|Overall Study|Withdrawal by Subject|22|||
155655378|NCT01618708|561832202|FG000|Overall Study|Lack of Efficacy|8|||
155655379|NCT01618708|561832203|FG001|Overall Study|Lack of Efficacy|8|||
155655380|NCT01618708|561832202|FG000|Overall Study|Technical problems|2|||
155655381|NCT01618708|561832203|FG001|Overall Study|Technical problems|0|||
155655382|NCT01618708|561832202|FG000|Overall Study|Other than specified above|1|||
155655383|NCT01618708|561832203|FG001|Overall Study|Other than specified above|1|||
155655384|NCT01618708|561832202|FG000|Overall Study|Randomized but not treated|3|||
155655385|NCT01618708|561832203|FG001|Overall Study|Randomized but not treated|2|||
155655386|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
155655387|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
155655388|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
155655389|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
155655390|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
155655391|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
155655392|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
155655393|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
155655394|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
155655395|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
155655396|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155655397|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155655398|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
155655399|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
155655400|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
155655401|NCT05014919|561832206|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
155655402|NCT05014919|561832207|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
155655403|NCT05014919|561832208|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
155655404|NCT05014919|561832206|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
155655405|NCT05014919|561832207|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
155655406|NCT05014919|561832208|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
155532631|NCT01440803|561375657|FG001|Overall Study|Withdrawal by Subject|1|||
155532632|NCT03913377|561375659|FG000|Period 1|Test Article no longer available|0|||
155655407|NCT05014919|561832206|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155655408|NCT05014919|561832207|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
155655409|NCT05014919|561832208|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
155532633|NCT03913377|561375660|FG001|Period 1|Test Article no longer available|1|||
155532634|NCT03913377|561375661|FG002|Period 1|Test Article no longer available|0|||
155532635|NCT03913377|561375659|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
155532636|NCT03913377|561375660|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
155532637|NCT03913377|561375661|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
155532638|NCT04349267|561375662|FG000|Overall Study|Adverse Event|0|||
155532639|NCT04349267|561375663|FG001|Overall Study|Adverse Event|0|||
155532640|NCT04349267|561375664|FG002|Overall Study|Adverse Event|0|||
155532641|NCT04349267|561375665|FG003|Overall Study|Adverse Event|0|||
155532642|NCT04349267|561375666|FG004|Overall Study|Adverse Event|0|||
155532643|NCT04349267|561375667|FG005|Overall Study|Adverse Event|1|||
155532644|NCT04349267|561375668|FG006|Overall Study|Adverse Event|0|||
155532645|NCT04349267|561375662|FG000|Overall Study|Other reason|0|||
155532646|NCT04349267|561375663|FG001|Overall Study|Other reason|1|||
155532647|NCT04349267|561375664|FG002|Overall Study|Other reason|0|||
155532648|NCT04349267|561375665|FG003|Overall Study|Other reason|0|||
155532649|NCT04349267|561375666|FG004|Overall Study|Other reason|1|||
155532650|NCT04349267|561375667|FG005|Overall Study|Other reason|1|||
155532651|NCT04349267|561375668|FG006|Overall Study|Other reason|1|||
155532652|NCT04349267|561375662|FG000|Overall Study|Disease Progression|2|||
155532653|NCT04349267|561375663|FG001|Overall Study|Disease Progression|0|||
155532654|NCT04349267|561375664|FG002|Overall Study|Disease Progression|2|||
155532655|NCT04349267|561375665|FG003|Overall Study|Disease Progression|3|||
155532656|NCT04349267|561375666|FG004|Overall Study|Disease Progression|3|||
155532657|NCT04349267|561375667|FG005|Overall Study|Disease Progression|7|||
155532658|NCT04349267|561375668|FG006|Overall Study|Disease Progression|10|||
155532659|NCT04349267|561375662|FG000|Overall Study|Participant withdrew consent|0|||
155532660|NCT04349267|561375663|FG001|Overall Study|Participant withdrew consent|1|||
155532661|NCT04349267|561375664|FG002|Overall Study|Participant withdrew consent|0|||
155532662|NCT04349267|561375665|FG003|Overall Study|Participant withdrew consent|0|||
155532663|NCT04349267|561375666|FG004|Overall Study|Participant withdrew consent|0|||
155532664|NCT04349267|561375667|FG005|Overall Study|Participant withdrew consent|0|||
155532665|NCT04349267|561375668|FG006|Overall Study|Participant withdrew consent|1|||
155532666|NCT03689400|561375669|FG000|Overall Study|Lost to Follow-up|4|||
155532667|NCT04618211|561375670|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
155532668|NCT04618211|561375671|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
155532669|NCT04618211|561375672|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
155532670|NCT04618211|561375670|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
155532671|NCT04618211|561375671|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
155532672|NCT04618211|561375672|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
155532673|NCT04618211|561375670|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
155532674|NCT04618211|561375671|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
155532675|NCT04618211|561375672|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
155532676|NCT01648582|561375673|FG000|Overall Study|Adverse Event|6|||
155532677|NCT01648582|561375674|FG001|Overall Study|Adverse Event|11|||
155532678|NCT01648582|561375675|FG002|Overall Study|Adverse Event|2|||
155532679|NCT01648582|561375673|FG000|Overall Study|Lost to Follow-up|9|||
155532680|NCT01648582|561375674|FG001|Overall Study|Lost to Follow-up|6|||
155532681|NCT01648582|561375675|FG002|Overall Study|Lost to Follow-up|8|||
155655410|NCT00680914|561832209|FG000|Overall Study|Consent withdrawal|6|||
155655411|NCT00680914|561832210|FG001|Overall Study|Consent withdrawal|3|||
155655412|NCT00680914|561832209|FG000|Overall Study|Lost to Follow-up|4|||
155655413|NCT00680914|561832210|FG001|Overall Study|Lost to Follow-up|0|||
155655414|NCT00680914|561832209|FG000|Overall Study|serious adverse event (SAE)|0|||
155655415|NCT00680914|561832210|FG001|Overall Study|serious adverse event (SAE)|1|||
155532682|NCT01648582|561375673|FG000|Overall Study|Protocol Violation|1|||
155532683|NCT01648582|561375674|FG001|Overall Study|Protocol Violation|2|||
155532684|NCT01648582|561375675|FG002|Overall Study|Protocol Violation|1|||
155532685|NCT01648582|561375673|FG000|Overall Study|Withdrawal by Subject|15|||
155532686|NCT01648582|561375674|FG001|Overall Study|Withdrawal by Subject|17|||
155532687|NCT01648582|561375675|FG002|Overall Study|Withdrawal by Subject|17|||
155532688|NCT01648582|561375673|FG000|Overall Study|Physician Decision|0|||
155532689|NCT01648582|561375674|FG001|Overall Study|Physician Decision|1|||
155532690|NCT01648582|561375675|FG002|Overall Study|Physician Decision|3|||
155532691|NCT01648582|561375673|FG000|Overall Study|Death|1|||
155532692|NCT01648582|561375674|FG001|Overall Study|Death|0|||
155532693|NCT01648582|561375675|FG002|Overall Study|Death|0|||
155532694|NCT01648582|561375673|FG000|Overall Study|Sponsor Decision|0|||
155532695|NCT01648582|561375674|FG001|Overall Study|Sponsor Decision|1|||
155532696|NCT01648582|561375675|FG002|Overall Study|Sponsor Decision|1|||
155532697|NCT03534193|561375680|FG000|Overall Study|Lost to Follow-up|1|||
155532698|NCT03534193|561375681|FG001|Overall Study|Lost to Follow-up|3|||
155532699|NCT06539676|561375684|FG000|Overall Study|Early study termination|1|||
155655416|NCT01848457|561832211|FG000|Overall Study|Death|1|||
155655417|NCT01848457|561832212|FG001|Overall Study|Death|0|||
155532700|NCT06539676|561375685|FG001|Overall Study|Early study termination|0|||
155532701|NCT06539676|561375686|FG002|Overall Study|Early study termination|6|||
155532702|NCT01154231|561375692|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
155532703|NCT01154231|561375692|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
155532704|NCT05710718|561376313|FG000|Overall Study|Withdrawal by Subject|5|||
155532705|NCT05710718|561376314|FG001|Overall Study|Withdrawal by Subject|1|||
155532706|NCT05710718|561376313|FG000|Overall Study|Lost to Follow-up|0|||
155532707|NCT05710718|561376314|FG001|Overall Study|Lost to Follow-up|1|||
155532708|NCT05710718|561376313|FG000|Overall Study|Death|0|||
155532709|NCT05710718|561376314|FG001|Overall Study|Death|1|||
155532710|NCT04372238|561376315|FG000|Overall Study|Duplicate|3|||
155532711|NCT04372238|561376316|FG001|Overall Study|Duplicate|3|||
155532712|NCT04372238|561376315|FG000|Overall Study|Did not consent for data linkage|6|||
155532713|NCT04372238|561376316|FG001|Overall Study|Did not consent for data linkage|10|||
155532714|NCT04241458|561376317|FG000|Overall Study|Withdrawal by Subject|0|||
155532715|NCT04241458|561376318|FG001|Overall Study|Withdrawal by Subject|0|||
155532716|NCT04241458|561376319|FG002|Overall Study|Withdrawal by Subject|0|||
155532717|NCT04241458|561376320|FG003|Overall Study|Withdrawal by Subject|0|||
155532718|NCT04241458|561376321|FG004|Overall Study|Withdrawal by Subject|1|||
155532719|NCT00334815|561376322|FG000|Overall Study|Adverse Event|3|||
155532720|NCT00334815|561376323|FG001|Overall Study|Adverse Event|2|||
155532721|NCT00334815|561376322|FG000|Overall Study|Death|0|||
155532722|NCT00334815|561376323|FG001|Overall Study|Death|2|||
155532723|NCT00334815|561376322|FG000|Overall Study|Progression|1|||
155532724|NCT00334815|561376323|FG001|Overall Study|Progression|0|||
155532725|NCT00334815|561376322|FG000|Overall Study|ineligible|1|||
155532726|NCT00334815|561376323|FG001|Overall Study|ineligible|1|||
155532727|NCT00334815|561376322|FG000|Overall Study|patient refused treatment|0|||
155532728|NCT00334815|561376323|FG001|Overall Study|patient refused treatment|1|||
155532729|NCT00334815|561376322|FG000|Overall Study|Physician Decision|2|||
155532730|NCT00334815|561376323|FG001|Overall Study|Physician Decision|4|||
155532731|NCT05919823|561376324|FG000|Pre-Treatment Period|Screen failure|1|||
155532732|NCT05919823|561376325|FG001|Pre-Treatment Period|Screen failure|0|||
155532733|NCT05919823|561376326|FG002|Pre-Treatment Period|Screen failure|0|||
155532734|NCT05919823|561376327|FG003|Pre-Treatment Period|Screen failure|0|||
155532735|NCT05919823|561376324|FG000|Pre-Treatment Period|Protocol Violation|0|||
155532736|NCT05919823|561376325|FG001|Pre-Treatment Period|Protocol Violation|1|||
155532737|NCT05919823|561376326|FG002|Pre-Treatment Period|Protocol Violation|0|||
155532738|NCT05919823|561376327|FG003|Pre-Treatment Period|Protocol Violation|0|||
155532739|NCT05919823|561376324|FG000|Double-Blind Period|Adverse Event|8|||
155532740|NCT05919823|561376325|FG001|Double-Blind Period|Adverse Event|9|||
155532741|NCT05919823|561376326|FG002|Double-Blind Period|Adverse Event|0|||
155532742|NCT05919823|561376327|FG003|Double-Blind Period|Adverse Event|0|||
155532743|NCT05919823|561376324|FG000|Double-Blind Period|Protocol Violation|2|||
155532744|NCT05919823|561376325|FG001|Double-Blind Period|Protocol Violation|1|||
155532745|NCT05919823|561376326|FG002|Double-Blind Period|Protocol Violation|0|||
155532746|NCT05919823|561376327|FG003|Double-Blind Period|Protocol Violation|0|||
155532747|NCT05919823|561376324|FG000|Double-Blind Period|Participant withdrew consent|11|||
155532748|NCT05919823|561376325|FG001|Double-Blind Period|Participant withdrew consent|7|||
155532749|NCT05919823|561376326|FG002|Double-Blind Period|Participant withdrew consent|0|||
155532750|NCT05919823|561376327|FG003|Double-Blind Period|Participant withdrew consent|0|||
155532751|NCT05919823|561376324|FG000|Double-Blind Period|Other reasons|2|||
155532752|NCT05919823|561376325|FG001|Double-Blind Period|Other reasons|3|||
155532753|NCT05919823|561376326|FG002|Double-Blind Period|Other reasons|0|||
155532754|NCT05919823|561376327|FG003|Double-Blind Period|Other reasons|0|||
155532755|NCT05919823|561376324|FG000|Open Label Period|Adverse Event|0|||
155532756|NCT05919823|561376325|FG001|Open Label Period|Adverse Event|0|||
155532757|NCT05919823|561376326|FG002|Open Label Period|Adverse Event|2|||
155532758|NCT05919823|561376327|FG003|Open Label Period|Adverse Event|4|||
155532759|NCT05919823|561376324|FG000|Open Label Period|Lost to Follow-up|0|||
155532760|NCT05919823|561376325|FG001|Open Label Period|Lost to Follow-up|0|||
155532761|NCT05919823|561376326|FG002|Open Label Period|Lost to Follow-up|1|||
155532762|NCT05919823|561376327|FG003|Open Label Period|Lost to Follow-up|0|||
155532763|NCT05919823|561376324|FG000|Open Label Period|Protocol Violation|0|||
155532764|NCT05919823|561376325|FG001|Open Label Period|Protocol Violation|0|||
155532765|NCT05919823|561376326|FG002|Open Label Period|Protocol Violation|0|||
155532766|NCT05919823|561376327|FG003|Open Label Period|Protocol Violation|1|||
155532767|NCT05919823|561376324|FG000|Open Label Period|Participant withdrew consent|0|||
155532768|NCT05919823|561376325|FG001|Open Label Period|Participant withdrew consent|0|||
155532769|NCT05919823|561376326|FG002|Open Label Period|Participant withdrew consent|8|||
155532770|NCT05919823|561376327|FG003|Open Label Period|Participant withdrew consent|6|||
155532771|NCT05919823|561376324|FG000|Open Label Period|Death|0|||
155532772|NCT05919823|561376325|FG001|Open Label Period|Death|0|||
155532773|NCT05919823|561376326|FG002|Open Label Period|Death|0|||
155532774|NCT05919823|561376327|FG003|Open Label Period|Death|1|||
155532775|NCT05919823|561376324|FG000|Open Label Period|Other reasons|0|||
155532776|NCT05919823|561376325|FG001|Open Label Period|Other reasons|0|||
155532777|NCT05919823|561376326|FG002|Open Label Period|Other reasons|9|||
155532778|NCT05919823|561376327|FG003|Open Label Period|Other reasons|5|||
155655418|NCT01848457|561832213|FG002|Overall Study|Death|0|||
155655419|NCT01848457|561832214|FG003|Overall Study|Death|0|||
155655420|NCT02940223|561832215|FG000|Overall Study|Failed Requirement|2|||
155655421|NCT02940223|561832216|FG001|Overall Study|Failed Requirement|0|||
155532779|NCT04414930|561376332|FG000|Overall Study|Withdrawal by Subject|1|||
155532780|NCT04414930|561376333|FG001|Overall Study|Withdrawal by Subject|3|||
155532781|NCT05470699|561376334|FG000|Overall Study|Did not receive intervention|13|||
155532782|NCT05470699|561376334|FG000|Overall Study|Ineligible|1|||
155532783|NCT04128761|561376335|FG000|Overall Study|Lost to Follow-up|5|||
155532784|NCT04128761|561376336|FG001|Overall Study|Lost to Follow-up|6|||
155532785|NCT01848938|561376343|FG000|Overall Study|Lost to Follow-up|1|||
155532786|NCT01848938|561376344|FG001|Overall Study|Lost to Follow-up|1|||
155532787|NCT01983969|561376348|FG000|Overall Study|Disease Progression|0|||
155532788|NCT01983969|561376349|FG001|Overall Study|Disease Progression|1|||
155532789|NCT01983969|561376350|FG002|Overall Study|Disease Progression|0|||
155532790|NCT02619682|561376351|FG000|Overall Study|Withdrawal by Subject|3|||
155532791|NCT02619682|561376351|FG000|Overall Study|Lack of Efficacy|8|||
155532792|NCT02619682|561376351|FG000|Overall Study|new secondary cancer|1|||
155532793|NCT02619682|561376351|FG000|Overall Study|post surgery complications|2|||
155532794|NCT00268203|561376352|FG000|Overall Study|Lost to Follow-up|92|||
155532795|NCT00268203|561376352|FG000|Overall Study|Withdrawal by Subject|9|||
155532796|NCT00268203|561376352|FG000|Overall Study|Received Other NHL Therapy|7|||
155532797|NCT00268203|561376352|FG000|Overall Study|Progressive Disease|359|||
155532798|NCT00268203|561376352|FG000|Overall Study|Death|84|||
155532799|NCT00268203|561376352|FG000|Overall Study|Reason Not Specified|34|||
155532800|NCT00268203|561376352|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
155532801|NCT04589650|561376353|FG000|Overall Study|Subject decision|6|||
155532802|NCT04589650|561376354|FG001|Overall Study|Subject decision|2|||
155532803|NCT04589650|561376355|FG002|Overall Study|Subject decision|2|||
155532804|NCT04589650|561376356|FG003|Overall Study|Subject decision|0|||
155532805|NCT04589650|561376357|FG004|Overall Study|Subject decision|0|||
155532806|NCT04589650|561376358|FG005|Overall Study|Subject decision|0|||
155532807|NCT04589650|561376353|FG000|Overall Study|Adverse Event|3|||
155532808|NCT04589650|561376354|FG001|Overall Study|Adverse Event|1|||
155532809|NCT04589650|561376355|FG002|Overall Study|Adverse Event|1|||
155532810|NCT04589650|561376356|FG003|Overall Study|Adverse Event|1|||
155532811|NCT04589650|561376357|FG004|Overall Study|Adverse Event|0|||
155532812|NCT04589650|561376358|FG005|Overall Study|Adverse Event|1|||
155532813|NCT04589650|561376353|FG000|Overall Study|Physician Decision|1|||
155532814|NCT04589650|561376354|FG001|Overall Study|Physician Decision|1|||
155532815|NCT04589650|561376355|FG002|Overall Study|Physician Decision|0|||
155532816|NCT04589650|561376356|FG003|Overall Study|Physician Decision|0|||
155532817|NCT04589650|561376357|FG004|Overall Study|Physician Decision|0|||
155532818|NCT04589650|561376358|FG005|Overall Study|Physician Decision|0|||
155532819|NCT04589650|561376353|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155532820|NCT04589650|561376354|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155532821|NCT04589650|561376355|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155532822|NCT04589650|561376356|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155532823|NCT04589650|561376357|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
155532824|NCT04589650|561376358|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
155532825|NCT04589650|561376353|FG000|Overall Study|Death|0|||
155532826|NCT04589650|561376354|FG001|Overall Study|Death|0|||
155532827|NCT04589650|561376355|FG002|Overall Study|Death|0|||
155532828|NCT04589650|561376356|FG003|Overall Study|Death|1|||
155532829|NCT04589650|561376357|FG004|Overall Study|Death|0|||
155532830|NCT04589650|561376358|FG005|Overall Study|Death|0|||
155532831|NCT04589650|561376353|FG000|Overall Study|Guardian Decision|0|||
155532832|NCT04589650|561376354|FG001|Overall Study|Guardian Decision|0|||
155532833|NCT04589650|561376355|FG002|Overall Study|Guardian Decision|0|||
155532834|NCT04589650|561376356|FG003|Overall Study|Guardian Decision|1|||
155532835|NCT04589650|561376357|FG004|Overall Study|Guardian Decision|0|||
155532836|NCT04589650|561376358|FG005|Overall Study|Guardian Decision|0|||
155532837|NCT03600376|561376359|FG000|Overall Study|Adverse Event|1|||
155532838|NCT03600376|561376360|FG001|Overall Study|Adverse Event|1|||
155655422|NCT03773562|561832220|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
155532839|NCT03600376|561376359|FG000|Overall Study|Transferred to other facility|1|||
155532840|NCT03600376|561376360|FG001|Overall Study|Transferred to other facility|0|||
155532841|NCT03600376|561376359|FG000|Overall Study|Investigator Decision|0|||
155532842|NCT03600376|561376360|FG001|Overall Study|Investigator Decision|4|||
155532843|NCT03600376|561376359|FG000|Overall Study|Determined to be ineligible for study|0|||
155532844|NCT03600376|561376360|FG001|Overall Study|Determined to be ineligible for study|1|||
155532845|NCT05655520|561376364|FG000|Overall Study|Adverse Event|2|||
155532846|NCT05655520|561376365|FG001|Overall Study|Adverse Event|3|||
155532847|NCT05655520|561376364|FG000|Overall Study|Physician Decision|2|||
155532848|NCT05655520|561376365|FG001|Overall Study|Physician Decision|0|||
155532849|NCT05655520|561376364|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155532850|NCT05655520|561376365|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155532851|NCT05655520|561376364|FG000|Overall Study|Lost to Follow-up|1|||
155532852|NCT05655520|561376365|FG001|Overall Study|Lost to Follow-up|0|||
155532853|NCT05655520|561376364|FG000|Overall Study|Withdrawal by Subject|4|||
155532854|NCT05655520|561376365|FG001|Overall Study|Withdrawal by Subject|4|||
155532855|NCT05655520|561376364|FG000|Overall Study|Study Terminated by Sponsor|61|||
155532856|NCT05655520|561376365|FG001|Overall Study|Study Terminated by Sponsor|68|||
155532857|NCT03114891|561376368|FG000|First Treatment Round|Lost to Follow-up|0|||
155532858|NCT03114891|561376369|FG001|First Treatment Round|Lost to Follow-up|1|||
155532859|NCT03114891|561376370|FG002|First Treatment Round|Lost to Follow-up|1|||
155532860|NCT03114891|561376371|FG003|First Treatment Round|Lost to Follow-up|0|||
155532861|NCT03114891|561376368|FG000|First Treatment Round|Withdrawal by Subject|0|||
155532862|NCT03114891|561376369|FG001|First Treatment Round|Withdrawal by Subject|2|||
155532863|NCT03114891|561376370|FG002|First Treatment Round|Withdrawal by Subject|0|||
155532864|NCT03114891|561376371|FG003|First Treatment Round|Withdrawal by Subject|1|||
155532865|NCT03114891|561376368|FG000|3 Week Break|Lost to Follow-up|1|||
155532866|NCT03114891|561376369|FG001|3 Week Break|Lost to Follow-up|0|||
155532867|NCT03114891|561376370|FG002|3 Week Break|Lost to Follow-up|0|||
155532868|NCT03114891|561376371|FG003|3 Week Break|Lost to Follow-up|1|||
155532869|NCT03114891|561376368|FG000|3 Week Break|Withdrawal by Subject|0|||
155532870|NCT03114891|561376369|FG001|3 Week Break|Withdrawal by Subject|1|||
155532871|NCT03114891|561376370|FG002|3 Week Break|Withdrawal by Subject|0|||
155532872|NCT03114891|561376371|FG003|3 Week Break|Withdrawal by Subject|0|||
155532873|NCT03114891|561376368|FG000|Second Treatment Round|Lost to Follow-up|1|||
155532874|NCT03114891|561376369|FG001|Second Treatment Round|Lost to Follow-up|0|||
155532875|NCT03114891|561376370|FG002|Second Treatment Round|Lost to Follow-up|0|||
155532876|NCT03114891|561376371|FG003|Second Treatment Round|Lost to Follow-up|0|||
155532877|NCT03114891|561376368|FG000|Second Treatment Round|Physician Decision|1|||
155532878|NCT03114891|561376369|FG001|Second Treatment Round|Physician Decision|0|||
155532879|NCT03114891|561376370|FG002|Second Treatment Round|Physician Decision|0|||
155532880|NCT03114891|561376371|FG003|Second Treatment Round|Physician Decision|0|||
155532881|NCT02294981|561376996|FG000|Overall Study|Lost to Follow-up|1|||
155532882|NCT00909753|561376999|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
155532883|NCT00909753|561377000|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
155532884|NCT00909753|561376999|FG000|Period: Second Intervention|Protocol Violation|1|||
155532885|NCT00909753|561377000|FG001|Period: Second Intervention|Protocol Violation|0|||
155532886|NCT00185458|561377003|FG000|Contraception Phase|Adverse Event|37|||
155532887|NCT00185458|561377003|FG000|Contraception Phase|Lost to Follow-up|10|||
155532888|NCT00185458|561377003|FG000|Contraception Phase|Protocol Violation|2|||
155532889|NCT00185458|561377003|FG000|Contraception Phase|Physician Decision|2|||
155532890|NCT00185458|561377003|FG000|Contraception Phase|Withdrawal by Subject|7|||
155532891|NCT00185458|561377003|FG000|HRT Phase|Adverse Event|18|||
155532892|NCT00185458|561377003|FG000|HRT Phase|Lost to Follow-up|4|||
155532893|NCT00185458|561377003|FG000|HRT Phase|Protocol Violation|2|||
155532894|NCT00185458|561377003|FG000|HRT Phase|Withdrawal by Subject|3|||
155532895|NCT01838681|561377010|FG000|Period A|Adverse Event|39|||
155532896|NCT01838681|561377011|FG001|Period A|Adverse Event|0|||
155532897|NCT01838681|561377012|FG002|Period A|Adverse Event|0|||
155532898|NCT01838681|561377013|FG003|Period A|Adverse Event|0|||
155532899|NCT01838681|561377010|FG000|Period A|Lack of Efficacy|21|||
155532900|NCT01838681|561377011|FG001|Period A|Lack of Efficacy|0|||
155532901|NCT01838681|561377012|FG002|Period A|Lack of Efficacy|0|||
155532902|NCT01838681|561377013|FG003|Period A|Lack of Efficacy|0|||
155532903|NCT01838681|561377010|FG000|Period A|Early response|148|||
155532904|NCT01838681|561377011|FG001|Period A|Early response|0|||
155532905|NCT01838681|561377012|FG002|Period A|Early response|0|||
155532906|NCT01838681|561377013|FG003|Period A|Early response|0|||
155532907|NCT01838681|561377010|FG000|Period A|Withdrawal by Subject|70|||
155532908|NCT01838681|561377011|FG001|Period A|Withdrawal by Subject|0|||
155532909|NCT01838681|561377012|FG002|Period A|Withdrawal by Subject|0|||
155532910|NCT01838681|561377013|FG003|Period A|Withdrawal by Subject|0|||
155532911|NCT01838681|561377010|FG000|Period A|Protocol Violation|16|||
155532912|NCT01838681|561377011|FG001|Period A|Protocol Violation|0|||
155532913|NCT01838681|561377012|FG002|Period A|Protocol Violation|0|||
155532914|NCT01838681|561377013|FG003|Period A|Protocol Violation|0|||
155532915|NCT01838681|561377010|FG000|Period A|Non-compliance with IMP|6|||
155532916|NCT01838681|561377011|FG001|Period A|Non-compliance with IMP|0|||
155532917|NCT01838681|561377012|FG002|Period A|Non-compliance with IMP|0|||
155532918|NCT01838681|561377013|FG003|Period A|Non-compliance with IMP|0|||
155532919|NCT01838681|561377010|FG000|Period A|Lost to Follow-up|4|||
155532920|NCT01838681|561377011|FG001|Period A|Lost to Follow-up|0|||
155532921|NCT01838681|561377012|FG002|Period A|Lost to Follow-up|0|||
155532922|NCT01838681|561377013|FG003|Period A|Lost to Follow-up|0|||
155532923|NCT01838681|561377010|FG000|Period A|Withdrawal before treatment|4|||
155532924|NCT01838681|561377011|FG001|Period A|Withdrawal before treatment|0|||
155532925|NCT01838681|561377012|FG002|Period A|Withdrawal before treatment|0|||
155532926|NCT01838681|561377013|FG003|Period A|Withdrawal before treatment|0|||
155532927|NCT01838681|561377010|FG000|Period A|Administrative or other reasons|17|||
155532928|NCT01838681|561377011|FG001|Period A|Administrative or other reasons|0|||
155532929|NCT01838681|561377012|FG002|Period A|Administrative or other reasons|0|||
155532930|NCT01838681|561377013|FG003|Period A|Administrative or other reasons|0|||
155532931|NCT01838681|561377010|FG000|Period B/A+|Adverse Event|0|||
155532932|NCT01838681|561377011|FG001|Period B/A+|Adverse Event|13|||
155532933|NCT01838681|561377012|FG002|Period B/A+|Adverse Event|27|||
155532934|NCT01838681|561377013|FG003|Period B/A+|Adverse Event|16|||
155532935|NCT01838681|561377010|FG000|Period B/A+|Lack of Efficacy|0|||
155532936|NCT01838681|561377011|FG001|Period B/A+|Lack of Efficacy|9|||
155532937|NCT01838681|561377012|FG002|Period B/A+|Lack of Efficacy|11|||
155532938|NCT01838681|561377013|FG003|Period B/A+|Lack of Efficacy|6|||
155532939|NCT01838681|561377010|FG000|Period B/A+|Withdrawal by Subject|0|||
155532940|NCT01838681|561377011|FG001|Period B/A+|Withdrawal by Subject|28|||
155532941|NCT01838681|561377012|FG002|Period B/A+|Withdrawal by Subject|35|||
155532942|NCT01838681|561377013|FG003|Period B/A+|Withdrawal by Subject|47|||
155532943|NCT01838681|561377010|FG000|Period B/A+|Protocol Violation|0|||
155532944|NCT01838681|561377011|FG001|Period B/A+|Protocol Violation|1|||
155532945|NCT01838681|561377012|FG002|Period B/A+|Protocol Violation|4|||
155532946|NCT01838681|561377013|FG003|Period B/A+|Protocol Violation|6|||
155532947|NCT01838681|561377010|FG000|Period B/A+|Non-compliance with IMP|0|||
155532948|NCT01838681|561377011|FG001|Period B/A+|Non-compliance with IMP|2|||
155532949|NCT01838681|561377012|FG002|Period B/A+|Non-compliance with IMP|3|||
155532950|NCT01838681|561377013|FG003|Period B/A+|Non-compliance with IMP|3|||
155532951|NCT01838681|561377010|FG000|Period B/A+|Lost to Follow-up|0|||
155532952|NCT01838681|561377011|FG001|Period B/A+|Lost to Follow-up|2|||
155532953|NCT01838681|561377012|FG002|Period B/A+|Lost to Follow-up|5|||
155532954|NCT01838681|561377013|FG003|Period B/A+|Lost to Follow-up|11|||
155532955|NCT01838681|561377010|FG000|Period B/A+|Withdrawal before treatment|0|||
155532956|NCT01838681|561377011|FG001|Period B/A+|Withdrawal before treatment|1|||
155532957|NCT01838681|561377012|FG002|Period B/A+|Withdrawal before treatment|0|||
155532958|NCT01838681|561377013|FG003|Period B/A+|Withdrawal before treatment|0|||
155532959|NCT01838681|561377010|FG000|Period B/A+|Administrative or other reasons|0|||
155532960|NCT01838681|561377011|FG001|Period B/A+|Administrative or other reasons|6|||
155532961|NCT01838681|561377012|FG002|Period B/A+|Administrative or other reasons|10|||
155532962|NCT01838681|561377013|FG003|Period B/A+|Administrative or other reasons|28|||
155532963|NCT00796562|561377014|FG000|Overall Study|Death|49|||
155532964|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
155532965|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
155532966|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
155532967|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
155532968|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
155532969|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
155532970|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
155532971|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
155532972|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
155532973|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
155532974|NCT00424047|561377015|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
155532975|NCT00424047|561377016|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
155532976|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Adverse Event|22|||
155532977|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Adverse Event|12|||
155532978|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Progression of disease|92|||
155532979|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Progression of disease|128|||
155532980|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
155532981|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
155532982|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
155532983|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
155532984|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Death|11|||
155532985|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Death|11|||
155532986|NCT00424047|561377015|FG000|On Study at Time of Unblinding|Other|5|||
155532987|NCT00424047|561377016|FG001|On Study at Time of Unblinding|Other|4|||
155532988|NCT00424047|561377015|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
155532989|NCT00424047|561377016|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
155532990|NCT00424047|561377015|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
155532991|NCT00424047|561377016|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
155532992|NCT00424047|561377015|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
155532993|NCT00424047|561377016|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
155655423|NCT03773562|561832220|FG000|Overall Study|Lost to Follow-up|10|||
155655424|NCT03773562|561832220|FG000|Overall Study|Withdrawal by Subject|1|||
155532994|NCT00424047|561377015|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
155532995|NCT00424047|561377016|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
155532996|NCT00424047|561377015|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
155655425|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
155487129|NCT05047601|561205826|FG000|Overall Study|Lost to Follow-up|9|||
155487130|NCT05047601|561205827|FG001|Overall Study|Lost to Follow-up|11|||
155487131|NCT05047601|561205828|FG002|Overall Study|Lost to Follow-up|7|||
155487132|NCT05047601|561205826|FG000|Overall Study|Withdrawal by Subject|25|||
155487133|NCT05047601|561205827|FG001|Overall Study|Withdrawal by Subject|36|||
155487134|NCT05047601|561205828|FG002|Overall Study|Withdrawal by Subject|23|||
155487135|NCT05047601|561205826|FG000|Overall Study|Other|10|||
155487136|NCT05047601|561205827|FG001|Overall Study|Other|6|||
155487137|NCT05047601|561205828|FG002|Overall Study|Other|5|||
155487138|NCT00302731|561205841|FG000|Overall Study|Lost to Follow-up|1|||
155487139|NCT00302731|561205842|FG001|Overall Study|Lost to Follow-up|2|||
155487140|NCT00302731|561205843|FG002|Overall Study|Lost to Follow-up|0|||
155487141|NCT00302731|561205844|FG003|Overall Study|Lost to Follow-up|0|||
155487142|NCT00302731|561205841|FG000|Overall Study|Adverse Event|0|||
155487143|NCT00302731|561205842|FG001|Overall Study|Adverse Event|2|||
155487144|NCT00302731|561205843|FG002|Overall Study|Adverse Event|2|||
155487145|NCT00302731|561205844|FG003|Overall Study|Adverse Event|0|||
155487146|NCT00302731|561205841|FG000|Overall Study|Withdrawal by Subject|1|||
155487147|NCT00302731|561205842|FG001|Overall Study|Withdrawal by Subject|1|||
155487148|NCT00302731|561205843|FG002|Overall Study|Withdrawal by Subject|0|||
155487149|NCT00302731|561205844|FG003|Overall Study|Withdrawal by Subject|0|||
155487150|NCT00302731|561205841|FG000|Overall Study|Protocol Violation|1|||
155487151|NCT00302731|561205842|FG001|Overall Study|Protocol Violation|0|||
155487152|NCT00302731|561205843|FG002|Overall Study|Protocol Violation|0|||
155487153|NCT00302731|561205844|FG003|Overall Study|Protocol Violation|0|||
155487154|NCT00302731|561205841|FG000|Overall Study|cancer unrelated to study discovered|1|||
155487155|NCT00302731|561205842|FG001|Overall Study|cancer unrelated to study discovered|0|||
155487156|NCT00302731|561205843|FG002|Overall Study|cancer unrelated to study discovered|1|||
155487157|NCT00302731|561205844|FG003|Overall Study|cancer unrelated to study discovered|0|||
155487158|NCT01535638|561205845|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
155487159|NCT01535638|561205846|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
155487160|NCT01535638|561205847|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
155487161|NCT01535638|561205848|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
155487162|NCT01535638|561205849|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
155487163|NCT01535638|561205850|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
155487164|NCT01535638|561205845|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
155487165|NCT01535638|561205846|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
155487166|NCT01535638|561205847|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
155532997|NCT00424047|561377016|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
155532998|NCT05248204|561377018|FG000|Overall Study|Lost to Follow-up|13|||
155532999|NCT05248204|561377019|FG001|Overall Study|Lost to Follow-up|13|||
155533000|NCT05248204|561377018|FG000|Overall Study|Protocol Violation|1|||
155533001|NCT05248204|561377019|FG001|Overall Study|Protocol Violation|0|||
155533002|NCT03100344|561377020|FG000|Overall Study|Adverse Event|0|||
155533003|NCT03100344|561377021|FG001|Overall Study|Adverse Event|3|||
155533004|NCT03100344|561377022|FG002|Overall Study|Adverse Event|2|||
155533005|NCT03100344|561377023|FG003|Overall Study|Adverse Event|3|||
155533006|NCT03100344|561377020|FG000|Overall Study|Lack of Efficacy|2|||
155533007|NCT03100344|561377021|FG001|Overall Study|Lack of Efficacy|0|||
155533008|NCT03100344|561377022|FG002|Overall Study|Lack of Efficacy|0|||
155533009|NCT03100344|561377023|FG003|Overall Study|Lack of Efficacy|0|||
155533010|NCT03100344|561377020|FG000|Overall Study|Protocol Violation|1|||
155533011|NCT03100344|561377021|FG001|Overall Study|Protocol Violation|0|||
155533012|NCT03100344|561377022|FG002|Overall Study|Protocol Violation|0|||
155533013|NCT03100344|561377023|FG003|Overall Study|Protocol Violation|0|||
155533014|NCT03100344|561377020|FG000|Overall Study|Withdrawal by Subject|10|||
155533015|NCT03100344|561377021|FG001|Overall Study|Withdrawal by Subject|7|||
155533016|NCT03100344|561377022|FG002|Overall Study|Withdrawal by Subject|4|||
155533017|NCT03100344|561377023|FG003|Overall Study|Withdrawal by Subject|8|||
155533018|NCT03100344|561377020|FG000|Overall Study|Lost to Follow-up|1|||
155533019|NCT03100344|561377021|FG001|Overall Study|Lost to Follow-up|1|||
155533020|NCT03100344|561377022|FG002|Overall Study|Lost to Follow-up|1|||
155533021|NCT03100344|561377023|FG003|Overall Study|Lost to Follow-up|1|||
155533022|NCT01010503|561377024|FG000|Overall Study|Adverse Event|1|||
155533023|NCT01010503|561377024|FG000|Overall Study|Death|1|||
155533024|NCT06336356|561377025|FG000|Overall Study|Withdrawal by Subject|1|||
155533025|NCT06336356|561377026|FG001|Overall Study|Withdrawal by Subject|0|||
155533026|NCT06336356|561377025|FG000|Overall Study|Lost to Follow Up|1|||
155533027|NCT06336356|561377026|FG001|Overall Study|Lost to Follow Up|0|||
155533028|NCT04827394|561377027|FG000|Overall Study|Physician Decision|0|||
155533029|NCT04827394|561377028|FG001|Overall Study|Physician Decision|2|||
155533030|NCT05871151|561377029|FG000|Overall Study|Lost to Follow-up|1|||
155533031|NCT05871151|561377030|FG001|Overall Study|Lost to Follow-up|0|||
155533032|NCT05871151|561377029|FG000|Overall Study|Unrelated illness|0|||
155533033|NCT05871151|561377030|FG001|Overall Study|Unrelated illness|1|||
155533034|NCT06041256|561377031|FG000|Overall Study|Withdrawal by Subject|1|||
155533035|NCT06041256|561377032|FG001|Overall Study|Withdrawal by Subject|0|||
155533036|NCT06041256|561377033|FG002|Overall Study|Withdrawal by Subject|3|||
155533037|NCT06041256|561377034|FG003|Overall Study|Withdrawal by Subject|1|||
155533038|NCT06041256|561377035|FG004|Overall Study|Withdrawal by Subject|1|||
155533039|NCT06041256|561377031|FG000|Overall Study|Rescue|17|||
155533040|NCT06041256|561377032|FG001|Overall Study|Rescue|6|||
155533041|NCT06041256|561377033|FG002|Overall Study|Rescue|9|||
155533042|NCT06041256|561377034|FG003|Overall Study|Rescue|6|||
155533043|NCT06041256|561377035|FG004|Overall Study|Rescue|2|||
155533044|NCT03215706|561377036|FG000|Randomization|Adverse Event unrelated to study drug|1|||
155533045|NCT03215706|561377037|FG001|Randomization|Adverse Event unrelated to study drug|0|||
155533046|NCT03215706|561377036|FG000|Randomization|participant withdrew consent|1|||
155533047|NCT03215706|561377037|FG001|Randomization|participant withdrew consent|3|||
155533048|NCT03215706|561377036|FG000|Randomization|no longer meets study criteria|1|||
155533049|NCT03215706|561377037|FG001|Randomization|no longer meets study criteria|4|||
155533050|NCT03215706|561377036|FG000|Randomization|other reasons|0|||
155533051|NCT03215706|561377037|FG001|Randomization|other reasons|2|||
155533052|NCT03215706|561377036|FG000|Treatment Period|Disease Progression|184|||
155533053|NCT03215706|561377037|FG001|Treatment Period|Disease Progression|174|||
155533054|NCT03215706|561377036|FG000|Treatment Period|Study Drug Toxicity|70|||
155533055|NCT03215706|561377037|FG001|Treatment Period|Study Drug Toxicity|24|||
155533056|NCT03215706|561377036|FG000|Treatment Period|Death|7|||
155533057|NCT03215706|561377037|FG001|Treatment Period|Death|1|||
155655426|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155533058|NCT03215706|561377036|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
155533059|NCT03215706|561377037|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
155533060|NCT03215706|561377036|FG000|Treatment Period|Request to D/C treatment|2|||
155655427|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155655428|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155533061|NCT03215706|561377037|FG001|Treatment Period|Request to D/C treatment|10|||
155533062|NCT03215706|561377036|FG000|Treatment Period|Participant withdrew consent|4|||
155533063|NCT03215706|561377037|FG001|Treatment Period|Participant withdrew consent|5|||
155533064|NCT03215706|561377036|FG000|Treatment Period|Lost to Follow-up|0|||
155533065|NCT03215706|561377037|FG001|Treatment Period|Lost to Follow-up|1|||
155533066|NCT03215706|561377036|FG000|Treatment Period|Administrative reason by sponsor|0|||
155533067|NCT03215706|561377037|FG001|Treatment Period|Administrative reason by sponsor|2|||
155533068|NCT03215706|561377036|FG000|Treatment Period|other reasons|10|||
155533069|NCT03215706|561377037|FG001|Treatment Period|other reasons|5|||
155533070|NCT03215706|561377036|FG000|Treatment Period|Not reported|1|||
155533071|NCT03215706|561377037|FG001|Treatment Period|Not reported|0|||
155533072|NCT00640341|561378663|FG000|Overall Study|Adverse Event|0|||
155533073|NCT00640341|561378664|FG001|Overall Study|Adverse Event|0|||
155533074|NCT00640341|561378665|FG002|Overall Study|Adverse Event|1|||
155533075|NCT00640341|561378663|FG000|Overall Study|Positive Slit Lamp Findings|0|||
155533076|NCT00640341|561378664|FG001|Overall Study|Positive Slit Lamp Findings|0|||
155533077|NCT00640341|561378665|FG002|Overall Study|Positive Slit Lamp Findings|1|||
155533078|NCT00640341|561378663|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
155533079|NCT00640341|561378664|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
155533080|NCT00640341|561378665|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
155533081|NCT00640341|561378663|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
155533082|NCT00640341|561378664|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
155533083|NCT00640341|561378665|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
155533084|NCT00640341|561378663|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
155533085|NCT00640341|561378664|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
155533086|NCT00640341|561378665|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
155533087|NCT00640341|561378663|FG000|Overall Study|Lost to Follow-up|2|||
155533088|NCT00640341|561378664|FG001|Overall Study|Lost to Follow-up|0|||
155533089|NCT00640341|561378665|FG002|Overall Study|Lost to Follow-up|0|||
155533090|NCT00640341|561378663|FG000|Overall Study|Withdrawal by Subject|4|||
155533091|NCT00640341|561378664|FG001|Overall Study|Withdrawal by Subject|0|||
155533092|NCT00640341|561378665|FG002|Overall Study|Withdrawal by Subject|1|||
155533093|NCT00640341|561378663|FG000|Overall Study|Unacceptable Lens Movement|1|||
155533094|NCT00640341|561378664|FG001|Overall Study|Unacceptable Lens Movement|0|||
155533095|NCT00640341|561378665|FG002|Overall Study|Unacceptable Lens Movement|0|||
155655429|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155487167|NCT01535638|561205848|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
155487168|NCT01535638|561205849|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
155487169|NCT01535638|561205850|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
155487170|NCT03524664|561205851|FG000|Overall Study|Withdrawal by Subject|1|||
155487171|NCT03524664|561205852|FG001|Overall Study|Withdrawal by Subject|2|||
155487172|NCT03524664|561205851|FG000|Overall Study|Lost to Follow-up|4|||
155487173|NCT03524664|561205852|FG001|Overall Study|Lost to Follow-up|13|||
155487174|NCT03077646|561205856|FG000|Overall Study|Lost to Follow-up|29|||
155487175|NCT03077646|561205857|FG001|Overall Study|Lost to Follow-up|30|||
155487176|NCT03077646|561205858|FG002|Overall Study|Lost to Follow-up|31|||
155487177|NCT00434876|561205859|FG000|Overall Study|Lost to Follow-up|1|||
155487178|NCT00434876|561205860|FG001|Overall Study|Lost to Follow-up|1|||
155487179|NCT03159455|561208146|FG000|Overall Study|Adverse Event|0|||
155487180|NCT03159455|561208147|FG001|Overall Study|Adverse Event|0|||
155487181|NCT03159455|561208148|FG002|Overall Study|Adverse Event|0|||
155487182|NCT03159455|561208149|FG003|Overall Study|Adverse Event|0|||
155487183|NCT03159455|561208150|FG004|Overall Study|Adverse Event|0|||
155487184|NCT03159455|561208151|FG005|Overall Study|Adverse Event|1|||
155487185|NCT02713490|561208154|FG000|Overall Study|Withdrawal by Subject|2|||
155487186|NCT02713490|561208155|FG001|Overall Study|Withdrawal by Subject|1|||
155487187|NCT02713490|561208154|FG000|Overall Study|Did not receive study drug|1|||
155487188|NCT02713490|561208155|FG001|Overall Study|Did not receive study drug|0|||
155487189|NCT02713490|561208154|FG000|Overall Study|Met exclusion criteria|0|||
155487190|NCT02713490|561208155|FG001|Overall Study|Met exclusion criteria|1|||
155487191|NCT01714726|561208156|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
155487192|NCT01714726|561208157|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
155487193|NCT01714726|561208158|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
155487194|NCT01714726|561208159|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
155487195|NCT01714726|561208156|FG000|Double-Blinded Induction Period|Adverse Event|0|||
155487196|NCT01714726|561208157|FG001|Double-Blinded Induction Period|Adverse Event|1|||
155487197|NCT01714726|561208158|FG002|Double-Blinded Induction Period|Adverse Event|0|||
155487198|NCT01714726|561208159|FG003|Double-Blinded Induction Period|Adverse Event|0|||
155487199|NCT01714726|561208156|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
155487200|NCT01714726|561208157|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
155487201|NCT01714726|561208158|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
155487202|NCT01714726|561208159|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
155487203|NCT01714726|561208156|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
155487204|NCT01714726|561208157|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
155487205|NCT01714726|561208158|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
155487206|NCT01714726|561208159|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
155487207|NCT01714726|561208156|FG000|Open-Label Period|Other|0|||
155487208|NCT01714726|561208157|FG001|Open-Label Period|Other|0|||
155487209|NCT01714726|561208158|FG002|Open-Label Period|Other|1|||
155487210|NCT01714726|561208159|FG003|Open-Label Period|Other|3|||
155487211|NCT01714726|561208156|FG000|Open-Label Period|Adverse Event|0|||
155533096|NCT00640341|561378663|FG000|Overall Study|Poor fit/Uncomfortable|4|||
155533097|NCT00640341|561378664|FG001|Overall Study|Poor fit/Uncomfortable|0|||
155533098|NCT00640341|561378665|FG002|Overall Study|Poor fit/Uncomfortable|0|||
155533099|NCT00640341|561378663|FG000|Overall Study|Ineligable at Baseline|5|||
155533100|NCT00640341|561378664|FG001|Overall Study|Ineligable at Baseline|3|||
155533101|NCT00640341|561378665|FG002|Overall Study|Ineligable at Baseline|2|||
155533102|NCT00640341|561378663|FG000|Overall Study|Adverse event and positive slit lamp|1|||
155533103|NCT00640341|561378664|FG001|Overall Study|Adverse event and positive slit lamp|0|||
155533104|NCT00640341|561378665|FG002|Overall Study|Adverse event and positive slit lamp|0|||
155533105|NCT03578809|561378666|FG000|Overall Study|Death|0|||
155533106|NCT03578809|561378667|FG001|Overall Study|Death|2|||
155533107|NCT03578809|561378668|FG002|Overall Study|Death|0|||
155533108|NCT03578809|561378669|FG003|Overall Study|Death|1|||
155533109|NCT03578809|561378666|FG000|Overall Study|Lost to Follow-up|0|||
155533110|NCT03578809|561378667|FG001|Overall Study|Lost to Follow-up|1|||
155533111|NCT03578809|561378668|FG002|Overall Study|Lost to Follow-up|0|||
155533112|NCT03578809|561378669|FG003|Overall Study|Lost to Follow-up|0|||
155533113|NCT03578809|561378666|FG000|Overall Study|Withdrawal by Subject|3|||
155533114|NCT03578809|561378667|FG001|Overall Study|Withdrawal by Subject|5|||
155533115|NCT03578809|561378668|FG002|Overall Study|Withdrawal by Subject|2|||
155533116|NCT03578809|561378669|FG003|Overall Study|Withdrawal by Subject|0|||
155533117|NCT03578809|561378666|FG000|Overall Study|Other|3|||
155533118|NCT03578809|561378667|FG001|Overall Study|Other|6|||
155533119|NCT03578809|561378668|FG002|Overall Study|Other|2|||
155533120|NCT03578809|561378669|FG003|Overall Study|Other|8|||
155533121|NCT00830258|561378670|FG000|First Intervention|Adverse Event|1|||
155533122|NCT00830258|561378671|FG001|First Intervention|Adverse Event|0|||
155533123|NCT00830258|561378670|FG000|Washout: 7 Days|Protocol Violation|1|||
155533124|NCT00830258|561378671|FG001|Washout: 7 Days|Protocol Violation|0|||
155533125|NCT00798603|561378672|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
155533126|NCT00798603|561378672|FG000|Overall Study|Withdrawal by Subject|10|||
155533127|NCT00798603|561378672|FG000|Overall Study|Adverse Event|22|||
155533128|NCT00798603|561378672|FG000|Overall Study|Physician Decision|1|||
155533129|NCT00798603|561378672|FG000|Overall Study|Lack of insurance coverage|1|||
155533130|NCT00835705|561378673|FG000|First Intervention|Difficulty with vein|1|||
155533131|NCT00835705|561378674|FG001|First Intervention|Difficulty with vein|0|||
155533132|NCT00835705|561378673|FG000|Second Intervention|Difficulty with vein|1|||
155533133|NCT00835705|561378674|FG001|Second Intervention|Difficulty with vein|0|||
155533134|NCT01750294|561378675|FG000|Overall Study|Withdrawal by Subject|1|||
155533135|NCT01750294|561378675|FG000|Overall Study|Safety Endpoint|1|||
155533136|NCT01116739|561378678|FG000|Overall Study|Child had 2 years of HS|110|||
155533137|NCT01116739|561378679|FG001|Overall Study|Child had 2 years of HS|128|||
155533138|NCT01116739|561378678|FG000|Overall Study|Withdrawal by Subject|6|||
155533139|NCT01116739|561378679|FG001|Overall Study|Withdrawal by Subject|0|||
155533140|NCT01116739|561378678|FG000|Overall Study|child too young|2|||
155533141|NCT01116739|561378679|FG001|Overall Study|child too young|6|||
155533142|NCT01116739|561378678|FG000|Overall Study|child not enrolled in head start|10|||
155533143|NCT01116739|561378679|FG001|Overall Study|child not enrolled in head start|2|||
155533144|NCT01116739|561378678|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
155533145|NCT01116739|561378679|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
155533146|NCT01624233|561378680|FG000|Period 2 - Induction|Adverse Event|1|||
155533147|NCT01624233|561378680|FG000|Period 3 - Maintenance|Adverse Event|2|||
155533148|NCT01624233|561378680|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
155533149|NCT01624233|561378680|FG000|Period 3 - Maintenance|Physician Decision|2|||
155533150|NCT01624233|561378680|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
155533151|NCT01624233|561378680|FG000|Period 4 - Drug Free Period|Relapsed|61|||
155533152|NCT01624233|561378680|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
155533153|NCT01624233|561378680|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
155533154|NCT01624233|561378680|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
155533155|NCT01624233|561378680|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
155533156|NCT01624233|561378680|FG000|Period 6: Follow-up|Adverse Event|3|||
155533157|NCT01624233|561378680|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
155533158|NCT01624233|561378680|FG000|Period 6: Follow-up|Physician Decision|1|||
155533159|NCT01624233|561378680|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
155533160|NCT05090839|561378681|FG000|Overall Study|Lost to Follow-up|2|||
155533161|NCT05090839|561378682|FG001|Overall Study|Lost to Follow-up|3|||
155533162|NCT05090839|561378683|FG002|Overall Study|Lost to Follow-up|1|||
155533163|NCT05090839|561378684|FG003|Overall Study|Lost to Follow-up|1|||
155533164|NCT03121586|561378687|FG000|Overall Study|Study terminated by sponsor|0|||
155533165|NCT03121586|561378688|FG001|Overall Study|Study terminated by sponsor|0|||
155533166|NCT03121586|561378689|FG002|Overall Study|Study terminated by sponsor|99|||
155533167|NCT03121586|561378687|FG000|Overall Study|Withdrawal by Subject|37|||
155533168|NCT03121586|561378688|FG001|Overall Study|Withdrawal by Subject|14|||
155533169|NCT03121586|561378689|FG002|Overall Study|Withdrawal by Subject|9|||
155533170|NCT03121586|561378687|FG000|Overall Study|Not further specified|6|||
155533171|NCT03121586|561378688|FG001|Overall Study|Not further specified|11|||
155533172|NCT03121586|561378689|FG002|Overall Study|Not further specified|10|||
155533173|NCT03121586|561378687|FG000|Overall Study|Adverse Event|16|||
155533174|NCT03121586|561378688|FG001|Overall Study|Adverse Event|5|||
155533175|NCT03121586|561378689|FG002|Overall Study|Adverse Event|6|||
155533176|NCT03121586|561378687|FG000|Overall Study|Protocol Violation|0|||
155533177|NCT03121586|561378688|FG001|Overall Study|Protocol Violation|5|||
155533178|NCT03121586|561378689|FG002|Overall Study|Protocol Violation|0|||
155533179|NCT03121586|561378687|FG000|Overall Study|Lack of Efficacy|3|||
155533180|NCT03121586|561378688|FG001|Overall Study|Lack of Efficacy|3|||
155533181|NCT03121586|561378689|FG002|Overall Study|Lack of Efficacy|1|||
155533182|NCT03121586|561378687|FG000|Overall Study|Physician Decision|2|||
155533183|NCT03121586|561378688|FG001|Overall Study|Physician Decision|2|||
155533184|NCT03121586|561378689|FG002|Overall Study|Physician Decision|0|||
155533185|NCT03121586|561378687|FG000|Overall Study|Noncompliance with study drug|5|||
155533186|NCT03121586|561378688|FG001|Overall Study|Noncompliance with study drug|3|||
155533187|NCT03121586|561378689|FG002|Overall Study|Noncompliance with study drug|5|||
155533188|NCT03121586|561378687|FG000|Overall Study|Lost to Follow-up|4|||
155533189|NCT03121586|561378688|FG001|Overall Study|Lost to Follow-up|2|||
155533190|NCT03121586|561378689|FG002|Overall Study|Lost to Follow-up|0|||
155533191|NCT03121586|561378687|FG000|Overall Study|Death|2|||
155533192|NCT03121586|561378688|FG001|Overall Study|Death|0|||
155533193|NCT03121586|561378689|FG002|Overall Study|Death|0|||
155533194|NCT06381102|561378690|FG000|Washout 5 Days|Withdrawal by Subject|0|||
155533195|NCT06381102|561378691|FG001|Washout 5 Days|Withdrawal by Subject|2|||
155533196|NCT02832063|561378693|FG000|Overall Study|Adverse Event|2|||
155533197|NCT02832063|561378694|FG001|Overall Study|Adverse Event|1|||
155533198|NCT02832063|561378693|FG000|Overall Study|Physician Decision|5|||
155533199|NCT02832063|561378694|FG001|Overall Study|Physician Decision|7|||
155533200|NCT02832063|561378693|FG000|Overall Study|Lost to Follow-up|15|||
155533201|NCT02832063|561378694|FG001|Overall Study|Lost to Follow-up|8|||
155533202|NCT02832063|561378693|FG000|Overall Study|Withdrawal by Subject|10|||
155533203|NCT02832063|561378694|FG001|Overall Study|Withdrawal by Subject|21|||
155533204|NCT02832063|561378693|FG000|Overall Study|Other|2|||
155533205|NCT02832063|561378694|FG001|Overall Study|Other|1|||
155533206|NCT03733730|561378695|FG000|Overall Study|Lost to Follow-up|1|||
155533207|NCT03733730|561378696|FG001|Overall Study|Lost to Follow-up|32|||
155533208|NCT03733730|561378695|FG000|Overall Study|Other|1|||
155533209|NCT03733730|561378696|FG001|Overall Study|Other|0|||
155533210|NCT03733730|561378695|FG000|Overall Study|Adverse Event|0|||
155533211|NCT03733730|561378696|FG001|Overall Study|Adverse Event|4|||
155533212|NCT03733730|561378695|FG000|Overall Study|Death|0|||
155533213|NCT03733730|561378696|FG001|Overall Study|Death|5|||
155533214|NCT03733730|561378695|FG000|Overall Study|Withdrawal by Subject|0|||
155533215|NCT03733730|561378696|FG001|Overall Study|Withdrawal by Subject|8|||
155533216|NCT01987765|561378697|FG000|Overall Study|Protocol Violation|65|||
155533217|NCT01987765|561378697|FG000|Overall Study|Lost to Follow-up|37|||
155533218|NCT00772603|561378698|FG000|Overall Study|Withdrawal by Subject|11|||
155533219|NCT00772603|561378699|FG001|Overall Study|Withdrawal by Subject|10|||
155533220|NCT00772603|561378700|FG002|Overall Study|Withdrawal by Subject|6|||
155533221|NCT00772603|561378698|FG000|Overall Study|Adverse Event|37|||
155533222|NCT00772603|561378699|FG001|Overall Study|Adverse Event|18|||
155533223|NCT00772603|561378700|FG002|Overall Study|Adverse Event|10|||
155533224|NCT00772603|561378698|FG000|Overall Study|Subject Non-compliance|1|||
155533225|NCT00772603|561378699|FG001|Overall Study|Subject Non-compliance|6|||
155533226|NCT00772603|561378700|FG002|Overall Study|Subject Non-compliance|4|||
155533227|NCT00772603|561378698|FG000|Overall Study|Protocol Violation|0|||
155533228|NCT00772603|561378699|FG001|Overall Study|Protocol Violation|1|||
155533229|NCT00772603|561378700|FG002|Overall Study|Protocol Violation|1|||
155533230|NCT00772603|561378698|FG000|Overall Study|Lost to Follow-up|1|||
155533231|NCT00772603|561378699|FG001|Overall Study|Lost to Follow-up|5|||
155533232|NCT00772603|561378700|FG002|Overall Study|Lost to Follow-up|2|||
155533233|NCT00772603|561378698|FG000|Overall Study|Physician Decision|0|||
155533234|NCT00772603|561378699|FG001|Overall Study|Physician Decision|0|||
155533235|NCT00772603|561378700|FG002|Overall Study|Physician Decision|1|||
155533236|NCT00772603|561378698|FG000|Overall Study|Other|2|||
155533237|NCT00772603|561378699|FG001|Overall Study|Other|0|||
155533238|NCT00772603|561378700|FG002|Overall Study|Other|2|||
155533239|NCT00443651|561378701|FG000|Overall Study|Death|1|||
155533240|NCT00443651|561378702|FG001|Overall Study|Death|5|||
155533241|NCT00443651|561378701|FG000|Overall Study|Adverse Event|5|||
155533242|NCT00443651|561378702|FG001|Overall Study|Adverse Event|6|||
155533243|NCT00443651|561378701|FG000|Overall Study|Lost to Follow-up|18|||
155533244|NCT00443651|561378702|FG001|Overall Study|Lost to Follow-up|12|||
155533245|NCT00443651|561378701|FG000|Overall Study|Patient's/Guardian's Decision|58|||
155533246|NCT00443651|561378702|FG001|Overall Study|Patient's/Guardian's Decision|30|||
155533247|NCT00443651|561378701|FG000|Overall Study|Physician Decision|13|||
155533248|NCT00443651|561378702|FG001|Overall Study|Physician Decision|4|||
155533249|NCT00443651|561378701|FG000|Overall Study|Pregnancy|0|||
155533250|NCT00443651|561378702|FG001|Overall Study|Pregnancy|1|||
155533251|NCT01564394|561378703|FG000|Overall Study|Withdrawal by Subject|6|||
155533252|NCT01564394|561378704|FG001|Overall Study|Withdrawal by Subject|10|||
155533253|NCT03606174|561378709|FG000|Overall Study|Death|37|||
155533254|NCT03606174|561378710|FG001|Overall Study|Death|15|||
155533255|NCT03606174|561378711|FG002|Overall Study|Death|15|||
155533256|NCT03606174|561378712|FG003|Overall Study|Death|7|||
155533257|NCT03606174|561378713|FG004|Overall Study|Death|35|||
155533258|NCT03606174|561378714|FG005|Overall Study|Death|12|||
155533259|NCT03606174|561378715|FG006|Overall Study|Death|35|||
155533260|NCT03606174|561378716|FG007|Overall Study|Death|8|||
155533261|NCT03606174|561378717|FG008|Overall Study|Death|5|||
155533262|NCT03606174|561378718|FG009|Overall Study|Death|3|||
155655430|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
155533263|NCT03606174|561378719|FG010|Overall Study|Death|0|||
155533264|NCT03606174|561378709|FG000|Overall Study|Lost to Follow-up|0|||
155533265|NCT03606174|561378710|FG001|Overall Study|Lost to Follow-up|0|||
155533266|NCT03606174|561378711|FG002|Overall Study|Lost to Follow-up|0|||
155533267|NCT03606174|561378712|FG003|Overall Study|Lost to Follow-up|0|||
155533268|NCT03606174|561378713|FG004|Overall Study|Lost to Follow-up|1|||
155533269|NCT03606174|561378714|FG005|Overall Study|Lost to Follow-up|1|||
155533270|NCT03606174|561378715|FG006|Overall Study|Lost to Follow-up|0|||
155533271|NCT03606174|561378716|FG007|Overall Study|Lost to Follow-up|0|||
155533272|NCT03606174|561378717|FG008|Overall Study|Lost to Follow-up|0|||
155533273|NCT03606174|561378718|FG009|Overall Study|Lost to Follow-up|0|||
155533274|NCT03606174|561378719|FG010|Overall Study|Lost to Follow-up|0|||
155533275|NCT03606174|561378709|FG000|Overall Study|Withdrawal by Subject|6|||
155533276|NCT03606174|561378710|FG001|Overall Study|Withdrawal by Subject|0|||
155533277|NCT03606174|561378711|FG002|Overall Study|Withdrawal by Subject|0|||
155533278|NCT03606174|561378712|FG003|Overall Study|Withdrawal by Subject|1|||
155533279|NCT03606174|561378713|FG004|Overall Study|Withdrawal by Subject|2|||
155533280|NCT03606174|561378714|FG005|Overall Study|Withdrawal by Subject|1|||
155533281|NCT03606174|561378715|FG006|Overall Study|Withdrawal by Subject|4|||
155533282|NCT03606174|561378716|FG007|Overall Study|Withdrawal by Subject|0|||
155533283|NCT03606174|561378717|FG008|Overall Study|Withdrawal by Subject|0|||
155533284|NCT03606174|561378718|FG009|Overall Study|Withdrawal by Subject|0|||
155533285|NCT03606174|561378719|FG010|Overall Study|Withdrawal by Subject|1|||
155533286|NCT03606174|561378709|FG000|Overall Study|Study Terminated by Sponsor|5|||
155533287|NCT03606174|561378710|FG001|Overall Study|Study Terminated by Sponsor|7|||
155533288|NCT03606174|561378711|FG002|Overall Study|Study Terminated by Sponsor|3|||
155533289|NCT03606174|561378712|FG003|Overall Study|Study Terminated by Sponsor|0|||
155533290|NCT03606174|561378713|FG004|Overall Study|Study Terminated by Sponsor|11|||
155533291|NCT03606174|561378714|FG005|Overall Study|Study Terminated by Sponsor|6|||
155533292|NCT03606174|561378715|FG006|Overall Study|Study Terminated by Sponsor|12|||
155533293|NCT03606174|561378716|FG007|Overall Study|Study Terminated by Sponsor|1|||
155533294|NCT03606174|561378717|FG008|Overall Study|Study Terminated by Sponsor|3|||
155533295|NCT03606174|561378718|FG009|Overall Study|Study Terminated by Sponsor|1|||
155533296|NCT03606174|561378719|FG010|Overall Study|Study Terminated by Sponsor|2|||
155533297|NCT03606174|561378709|FG000|Overall Study|Miscellaneous|1|||
155533298|NCT03606174|561378710|FG001|Overall Study|Miscellaneous|1|||
155533299|NCT03606174|561378711|FG002|Overall Study|Miscellaneous|0|||
155533300|NCT03606174|561378712|FG003|Overall Study|Miscellaneous|1|||
155533301|NCT03606174|561378713|FG004|Overall Study|Miscellaneous|4|||
155533302|NCT03606174|561378714|FG005|Overall Study|Miscellaneous|7|||
155533303|NCT03606174|561378715|FG006|Overall Study|Miscellaneous|5|||
155533304|NCT03606174|561378716|FG007|Overall Study|Miscellaneous|0|||
155533305|NCT03606174|561378717|FG008|Overall Study|Miscellaneous|0|||
155533306|NCT03606174|561378718|FG009|Overall Study|Miscellaneous|0|||
155533307|NCT03606174|561378719|FG010|Overall Study|Miscellaneous|1|||
155533308|NCT00859521|561378720|FG000|Washout|Withdrawal by Subject|0|||
155533309|NCT00859521|561378721|FG001|Washout|Withdrawal by Subject|1|||
155533310|NCT02125461|561378722|FG000|Overall Study|Withdrawal by Subject|30|||
155533311|NCT02125461|561378723|FG001|Overall Study|Withdrawal by Subject|16|||
155533312|NCT02125461|561378722|FG000|Overall Study|Lost to Follow-up|8|||
155533313|NCT02125461|561378723|FG001|Overall Study|Lost to Follow-up|3|||
155533314|NCT02125461|561378722|FG000|Overall Study|Death|260|||
155533315|NCT02125461|561378723|FG001|Overall Study|Death|149|||
155533316|NCT02125461|561378722|FG000|Overall Study|Missing Termination Reason|0|||
155533317|NCT02125461|561378723|FG001|Overall Study|Missing Termination Reason|1|||
155533318|NCT03552484|561378728|FG000|Overall Study|Death|6|||
155533319|NCT03552484|561378729|FG001|Overall Study|Death|4|||
155533320|NCT03552484|561378728|FG000|Overall Study|Lost to Follow-up|0|||
155533321|NCT03552484|561378729|FG001|Overall Study|Lost to Follow-up|16|||
155533322|NCT03499353|561378730|FG000|Treatment|Adverse Event|3|||
155533323|NCT03499353|561378730|FG000|Treatment|Progressive Disease|10|||
155533324|NCT03499353|561378730|FG000|Treatment|Other|1|||
155533325|NCT03499353|561378730|FG000|Treatment|Withdrawal by Subject|2|||
155533326|NCT03499353|561378730|FG000|Long-Term Follow-up|Death|2|||
155533327|NCT03499353|561378730|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
155533328|NCT03499353|561378730|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
155533329|NCT01592240|561378731|FG000|Overall Study|Adverse Event|1|||
155533330|NCT01592240|561378732|FG001|Overall Study|Adverse Event|0|||
155533331|NCT01592240|561378733|FG002|Overall Study|Adverse Event|0|||
155533332|NCT01592240|561378734|FG003|Overall Study|Adverse Event|1|||
155533333|NCT01592240|561378735|FG004|Overall Study|Adverse Event|1|||
155533334|NCT01592240|561378736|FG005|Overall Study|Adverse Event|0|||
155533335|NCT01592240|561378737|FG006|Overall Study|Adverse Event|0|||
155533336|NCT01592240|561378731|FG000|Overall Study|Death|0|||
155533337|NCT01592240|561378732|FG001|Overall Study|Death|1|||
155533338|NCT01592240|561378733|FG002|Overall Study|Death|0|||
155533339|NCT01592240|561378734|FG003|Overall Study|Death|0|||
155533340|NCT01592240|561378735|FG004|Overall Study|Death|0|||
155533341|NCT01592240|561378736|FG005|Overall Study|Death|0|||
155533342|NCT01592240|561378737|FG006|Overall Study|Death|0|||
155533343|NCT01592240|561378731|FG000|Overall Study|Lost to Follow-up|1|||
155533344|NCT01592240|561378732|FG001|Overall Study|Lost to Follow-up|3|||
155533345|NCT01592240|561378733|FG002|Overall Study|Lost to Follow-up|1|||
155533346|NCT01592240|561378734|FG003|Overall Study|Lost to Follow-up|0|||
155533347|NCT01592240|561378735|FG004|Overall Study|Lost to Follow-up|3|||
155533348|NCT01592240|561378736|FG005|Overall Study|Lost to Follow-up|2|||
155533349|NCT01592240|561378737|FG006|Overall Study|Lost to Follow-up|0|||
155533350|NCT01592240|561378731|FG000|Overall Study|Protocol Violation|0|||
155533351|NCT01592240|561378732|FG001|Overall Study|Protocol Violation|0|||
155533352|NCT01592240|561378733|FG002|Overall Study|Protocol Violation|0|||
155533353|NCT01592240|561378734|FG003|Overall Study|Protocol Violation|0|||
155533354|NCT01592240|561378735|FG004|Overall Study|Protocol Violation|0|||
155533355|NCT01592240|561378736|FG005|Overall Study|Protocol Violation|1|||
155533356|NCT01592240|561378737|FG006|Overall Study|Protocol Violation|0|||
155533357|NCT01592240|561378731|FG000|Overall Study|Withdrawal by Subject|0|||
155533358|NCT01592240|561378732|FG001|Overall Study|Withdrawal by Subject|4|||
155533359|NCT01592240|561378733|FG002|Overall Study|Withdrawal by Subject|4|||
155533360|NCT01592240|561378734|FG003|Overall Study|Withdrawal by Subject|1|||
155533361|NCT01592240|561378735|FG004|Overall Study|Withdrawal by Subject|3|||
155533362|NCT01592240|561378736|FG005|Overall Study|Withdrawal by Subject|0|||
155533363|NCT01592240|561378737|FG006|Overall Study|Withdrawal by Subject|2|||
155533364|NCT01592240|561378731|FG000|Overall Study|Other|0|||
155533365|NCT01592240|561378732|FG001|Overall Study|Other|3|||
155533366|NCT01592240|561378733|FG002|Overall Study|Other|1|||
155533367|NCT01592240|561378734|FG003|Overall Study|Other|1|||
155533368|NCT01592240|561378735|FG004|Overall Study|Other|0|||
155533369|NCT01592240|561378736|FG005|Overall Study|Other|0|||
155533370|NCT01592240|561378737|FG006|Overall Study|Other|1|||
155533371|NCT01592240|561378731|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155533372|NCT01592240|561378732|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
155533373|NCT01592240|561378733|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
155533374|NCT01592240|561378734|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
155533375|NCT01592240|561378735|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
155533376|NCT01592240|561378736|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
155533377|NCT01592240|561378737|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
155533378|NCT00469898|561378742|FG000|Overall Study|Adverse Event|7|||
155533379|NCT00469898|561378742|FG000|Overall Study|Withdrawal by Subject|4|||
155533380|NCT00469898|561378742|FG000|Overall Study|Death|4|||
155533381|NCT00469898|561378742|FG000|Overall Study|Disease progression|9|||
155533382|NCT00469898|561378742|FG000|Overall Study|Decreased performance status|1|||
155533383|NCT01205035|561378745|FG000|Overall Study|Withdrawal by Subject|1|||
155533384|NCT01205035|561378746|FG001|Overall Study|Withdrawal by Subject|0|||
155533385|NCT01205035|561378745|FG000|Overall Study|Physician Decision|1|||
155533386|NCT01205035|561378746|FG001|Overall Study|Physician Decision|0|||
155533387|NCT02663349|561378747|FG000|Overall Study|Withdrawal by Subject|6|||
155533388|NCT01896934|561378748|FG000|Overall Study|Adverse Event|1|||
155533389|NCT01896934|561378748|FG000|Overall Study|Withdrawal by Subject|1|||
155533390|NCT01557751|561378749|FG000|Overall Study|Physician Decision|3|||
155533391|NCT04590027|561378751|FG000|Overall Study|Lost to Follow-up|17|||
155533392|NCT04590027|561378752|FG001|Overall Study|Lost to Follow-up|14|||
155533393|NCT04590027|561378751|FG000|Overall Study|Protocol Violation|0|||
155533394|NCT04590027|561378752|FG001|Overall Study|Protocol Violation|3|||
155533395|NCT03276754|561378753|FG000|Overall Study|Withdrawal of informed consent|4|||
155533396|NCT03276754|561378753|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
155533397|NCT03276754|561378753|FG000|Overall Study|Lost to Follow-up|27|||
155533398|NCT03276754|561378753|FG000|Overall Study|No data reported at Month 24|31|||
155533399|NCT03276754|561378753|FG000|Overall Study|Death|39|||
155533400|NCT00316277|561378754|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
155533401|NCT00316277|561378755|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
155533402|NCT00316277|561378754|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
155533403|NCT00316277|561378755|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
155533404|NCT00316277|561378754|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
155533405|NCT00316277|561378755|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
155533406|NCT00316277|561378754|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
155533407|NCT00316277|561378755|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
155533408|NCT00316277|561378754|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
155533409|NCT00316277|561378755|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
155533410|NCT00848536|561378756|FG000|Overall Study|Adverse Event|2|||
155533411|NCT00848536|561378757|FG001|Overall Study|Adverse Event|2|||
155533412|NCT00848536|561378756|FG000|Overall Study|Withdrawal by Subject|0|||
155533413|NCT00848536|561378757|FG001|Overall Study|Withdrawal by Subject|1|||
155533414|NCT00848536|561378756|FG000|Overall Study|Protocol Violation|0|||
155533415|NCT00848536|561378757|FG001|Overall Study|Protocol Violation|1|||
155533416|NCT00848536|561378756|FG000|Overall Study|Noncompliance|1|||
155533417|NCT00848536|561378757|FG001|Overall Study|Noncompliance|0|||
155533418|NCT00848536|561378756|FG000|Overall Study|Inadequate Control of IOP|1|||
155533419|NCT00848536|561378757|FG001|Overall Study|Inadequate Control of IOP|1|||
155533420|NCT00848536|561378756|FG000|Overall Study|Patient Moved|0|||
155533421|NCT00848536|561378757|FG001|Overall Study|Patient Moved|2|||
155533422|NCT04089553|561378758|FG000|Overall Study|Death|1|||
155533423|NCT04089553|561378759|FG001|Overall Study|Death|1|||
155533424|NCT04089553|561378758|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
155533425|NCT04089553|561378759|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
155533426|NCT04089553|561378758|FG000|Overall Study|Withdrawal by Subject|3|||
155533427|NCT04089553|561378759|FG001|Overall Study|Withdrawal by Subject|3|||
155533428|NCT04089553|561378758|FG000|Overall Study|Physician Decision|1|||
155533429|NCT04089553|561378759|FG001|Overall Study|Physician Decision|0|||
155533430|NCT04089553|561378758|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
155533431|NCT04089553|561378759|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
155533432|NCT04089553|561378758|FG000|Overall Study|Other|1|||
155533433|NCT04089553|561378759|FG001|Overall Study|Other|0|||
155533434|NCT04089553|561378758|FG000|Overall Study|Adverse Event|1|||
155533435|NCT04089553|561378759|FG001|Overall Study|Adverse Event|1|||
155533436|NCT01175135|561378760|FG000|Overall Study|Adverse Event|2|||
155533437|NCT01175135|561378761|FG001|Overall Study|Adverse Event|5|||
155533438|NCT01175135|561378762|FG002|Overall Study|Adverse Event|3|||
155533439|NCT01175135|561378763|FG003|Overall Study|Adverse Event|4|||
155533440|NCT01175135|561378760|FG000|Overall Study|Death|1|||
155533441|NCT01175135|561378761|FG001|Overall Study|Death|0|||
155533442|NCT01175135|561378762|FG002|Overall Study|Death|0|||
155533443|NCT01175135|561378763|FG003|Overall Study|Death|0|||
155533444|NCT01175135|561378760|FG000|Overall Study|Lack of Efficacy|4|||
155533445|NCT01175135|561378761|FG001|Overall Study|Lack of Efficacy|5|||
155533446|NCT01175135|561378762|FG002|Overall Study|Lack of Efficacy|0|||
155533447|NCT01175135|561378763|FG003|Overall Study|Lack of Efficacy|5|||
155533448|NCT01175135|561378760|FG000|Overall Study|Lost to Follow-up|1|||
155533449|NCT01175135|561378761|FG001|Overall Study|Lost to Follow-up|2|||
155533450|NCT01175135|561378762|FG002|Overall Study|Lost to Follow-up|0|||
155533451|NCT01175135|561378763|FG003|Overall Study|Lost to Follow-up|0|||
155533452|NCT01175135|561378760|FG000|Overall Study|Protocol Violation|1|||
155533453|NCT01175135|561378761|FG001|Overall Study|Protocol Violation|1|||
155533454|NCT01175135|561378762|FG002|Overall Study|Protocol Violation|0|||
155533455|NCT01175135|561378763|FG003|Overall Study|Protocol Violation|0|||
155533456|NCT01175135|561378760|FG000|Overall Study|Withdrawal by Subject|4|||
155533457|NCT01175135|561378761|FG001|Overall Study|Withdrawal by Subject|8|||
155533458|NCT01175135|561378762|FG002|Overall Study|Withdrawal by Subject|5|||
155533459|NCT01175135|561378763|FG003|Overall Study|Withdrawal by Subject|5|||
155533460|NCT01175135|561378760|FG000|Overall Study|Other|3|||
155533461|NCT01175135|561378761|FG001|Overall Study|Other|1|||
155533462|NCT01175135|561378762|FG002|Overall Study|Other|3|||
155533463|NCT01175135|561378763|FG003|Overall Study|Other|0|||
155533464|NCT01175135|561378760|FG000|Overall Study|Randomized But Not Treated|0|||
155533465|NCT01175135|561378761|FG001|Overall Study|Randomized But Not Treated|0|||
155533466|NCT01175135|561378762|FG002|Overall Study|Randomized But Not Treated|1|||
155655431|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155533467|NCT01175135|561378763|FG003|Overall Study|Randomized But Not Treated|0|||
155533468|NCT01572662|561378766|FG000|Overall Study|Withdrawal by Subject|1|||
155533469|NCT01572662|561378767|FG001|Overall Study|Withdrawal by Subject|0|||
155533470|NCT01572662|561378766|FG000|Overall Study|Physician Decision|0|||
155533471|NCT01572662|561378767|FG001|Overall Study|Physician Decision|1|||
155533472|NCT03364192|561378768|FG000|Overall Study|Ineligible|10|||
155533473|NCT03364192|561378768|FG000|Overall Study|Withdrawal by Subject|5|||
155533474|NCT03364192|561378768|FG000|Overall Study|Lost to Follow-up|1|||
155533475|NCT04692155|561378771|FG000|Overall Study|Death|1|||
155533476|NCT04547192|561378772|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
155533477|NCT04547192|561378773|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
155655432|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155533478|NCT04547192|561378774|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
155533479|NCT04547192|561378775|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
155533480|NCT04547192|561378772|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
155533481|NCT04547192|561378773|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
155533482|NCT04547192|561378774|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
155533483|NCT04547192|561378775|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
155533484|NCT04547192|561378772|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
155533485|NCT04547192|561378773|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
155533486|NCT04547192|561378774|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
155533487|NCT04547192|561378775|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
155533488|NCT04547192|561378772|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
155533489|NCT04547192|561378773|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
155533490|NCT04547192|561378774|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
155533491|NCT04547192|561378775|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
155533492|NCT04547192|561378772|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
155533493|NCT04547192|561378773|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
155533494|NCT04547192|561378774|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
155533495|NCT04547192|561378775|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
155533496|NCT01535222|561378776|FG000|Overall Study|Inclusion/exclusion|0|||
155533497|NCT01535222|561378777|FG001|Overall Study|Inclusion/exclusion|0|||
155533498|NCT01535222|561378778|FG002|Overall Study|Inclusion/exclusion|1|||
155533499|NCT01535222|561378779|FG003|Overall Study|Inclusion/exclusion|0|||
155533500|NCT01535222|561378780|FG004|Overall Study|Inclusion/exclusion|0|||
155533501|NCT01535222|561378781|FG005|Overall Study|Inclusion/exclusion|0|||
155533502|NCT00935012|561378784|FG000|Overall Study|Death|19|||
155533503|NCT00935012|561378784|FG000|Overall Study|Withdrawal by Subject|3|||
155533504|NCT00935012|561378784|FG000|Overall Study|Other|5|||
155533505|NCT00935012|561378784|FG000|Overall Study|Adverse Event|2|||
155533506|NCT01442155|561378785|FG000|Overall Study|Complete remission|35|||
155533507|NCT01442155|561378785|FG000|Overall Study|Recurrence|26|||
155533508|NCT01442155|561378785|FG000|Overall Study|Adverse Event|2|||
155533509|NCT01442155|561378785|FG000|Overall Study|Lost to Follow-up|2|||
155533510|NCT01590563|561378792|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
155533511|NCT02699463|561378793|FG000|Overall Study|Lost to Follow-up|11|||
155533512|NCT02699463|561378794|FG001|Overall Study|Lost to Follow-up|8|||
155533513|NCT02699463|561378793|FG000|Overall Study|Withdrawal by Subject|4|||
155533514|NCT02699463|561378794|FG001|Overall Study|Withdrawal by Subject|1|||
155533515|NCT02488239|561378797|FG000|Overall Study|Death|3|||
155533516|NCT02488239|561378797|FG000|Overall Study|Withdrawal by Subject|3|||
155533517|NCT02488239|561378797|FG000|Overall Study|Physician Decision|2|||
155533518|NCT02488239|561378797|FG000|Overall Study|Consent ineligible|1|||
155533519|NCT02488239|561378797|FG000|Overall Study|Did not undergo implant procedure|1|||
155533520|NCT01370733|561378801|FG000|Overall Study|Withdrawal by Subject|8|||
155533521|NCT01370733|561378802|FG001|Overall Study|Withdrawal by Subject|8|||
155533522|NCT01370733|561378801|FG000|Overall Study|Lost to Follow-up|3|||
155533523|NCT01370733|561378802|FG001|Overall Study|Lost to Follow-up|0|||
155533524|NCT01370733|561378801|FG000|Overall Study|Adverse Event|2|||
155533525|NCT01370733|561378802|FG001|Overall Study|Adverse Event|4|||
155533526|NCT01370733|561378801|FG000|Overall Study|Lack of Efficacy|3|||
155533527|NCT01370733|561378802|FG001|Overall Study|Lack of Efficacy|5|||
155533528|NCT01370733|561378801|FG000|Overall Study|Physician Decision|0|||
155533529|NCT01370733|561378802|FG001|Overall Study|Physician Decision|2|||
155533530|NCT01370733|561378801|FG000|Overall Study|Protocol Violation|1|||
155533531|NCT01370733|561378802|FG001|Overall Study|Protocol Violation|3|||
155533532|NCT03325881|561378803|FG000|Overall Study|Protocol Violation|0|||
155533533|NCT03325881|561378804|FG001|Overall Study|Protocol Violation|1|||
155533534|NCT03325881|561378803|FG000|Overall Study|Withdrawal by Subject|0|||
155533535|NCT03325881|561378804|FG001|Overall Study|Withdrawal by Subject|2|||
155533536|NCT03325881|561378803|FG000|Overall Study|Lack of Efficacy|2|||
155533537|NCT03325881|561378804|FG001|Overall Study|Lack of Efficacy|0|||
155533538|NCT03325881|561378803|FG000|Overall Study|Not treated|1|||
155533539|NCT03325881|561378804|FG001|Overall Study|Not treated|0|||
155533540|NCT03676634|561378805|FG000|Overall Study|Red blood cell loss|1|||
155533541|NCT03676634|561378805|FG000|Overall Study|Out-of-limit pulse|2|||
155533542|NCT00909038|561378808|FG000|Overall Study|Protocol Violation|187|||
155533543|NCT00909038|561378808|FG000|Overall Study|Non-evaluable Subjects|230|||
155533544|NCT01895335|561378815|FG000|Overall Study|Adverse Event|106|||
155533545|NCT01895335|561378815|FG000|Overall Study|Lack of Efficacy|53|||
155533546|NCT01895335|561378815|FG000|Overall Study|Poor Compliance to Protocol|11|||
155533547|NCT01895335|561378815|FG000|Overall Study|Included But Not treated|1|||
155533548|NCT01895335|561378815|FG000|Overall Study|Other than Specified Above|44|||
155533549|NCT03480763|561378816|FG000|Overall Study|Withdrawal by Subject|18|||
155533550|NCT03480763|561378817|FG001|Overall Study|Withdrawal by Subject|10|||
155533551|NCT03480763|561378816|FG000|Overall Study|Lost to Follow-up|4|||
155533552|NCT03480763|561378817|FG001|Overall Study|Lost to Follow-up|7|||
155533553|NCT03480763|561378816|FG000|Overall Study|non-study pneumococcal vaccine|1|||
155533554|NCT03480763|561378817|FG001|Overall Study|non-study pneumococcal vaccine|0|||
155533555|NCT03480763|561378816|FG000|Overall Study|oncological treatment|0|||
155533556|NCT03480763|561378817|FG001|Overall Study|oncological treatment|2|||
155533557|NCT03480763|561378816|FG000|Overall Study|pain with vaccination|1|||
155533558|NCT03480763|561378817|FG001|Overall Study|pain with vaccination|0|||
155533559|NCT01647828|561378818|FG000|Overall Study|Death|3|||
155533560|NCT01647828|561378819|FG001|Overall Study|Death|4|||
155533561|NCT01647828|561378820|FG002|Overall Study|Death|4|||
155533562|NCT01647828|561378821|FG003|Overall Study|Death|5|||
155533563|NCT01647828|561378822|FG004|Overall Study|Death|6|||
155533564|NCT01647828|561378823|FG005|Overall Study|Death|3|||
155533565|NCT01647828|561378824|FG006|Overall Study|Death|10|||
155533566|NCT01647828|561378825|FG007|Overall Study|Death|60|||
155533567|NCT01647828|561378826|FG008|Overall Study|Death|71|||
155533568|NCT01647828|561378818|FG000|Overall Study|Withdrawal by Subject|2|||
155533569|NCT01647828|561378819|FG001|Overall Study|Withdrawal by Subject|0|||
155533570|NCT01647828|561378820|FG002|Overall Study|Withdrawal by Subject|0|||
155533571|NCT01647828|561378821|FG003|Overall Study|Withdrawal by Subject|1|||
155533572|NCT01647828|561378822|FG004|Overall Study|Withdrawal by Subject|0|||
155533573|NCT01647828|561378823|FG005|Overall Study|Withdrawal by Subject|0|||
155533574|NCT01647828|561378824|FG006|Overall Study|Withdrawal by Subject|1|||
155533575|NCT01647828|561378825|FG007|Overall Study|Withdrawal by Subject|0|||
155533576|NCT01647828|561378826|FG008|Overall Study|Withdrawal by Subject|2|||
155533577|NCT01647828|561378818|FG000|Overall Study|Study terminated by Sponsor|0|||
155533578|NCT01647828|561378819|FG001|Overall Study|Study terminated by Sponsor|0|||
155533579|NCT01647828|561378820|FG002|Overall Study|Study terminated by Sponsor|0|||
155533580|NCT01647828|561378821|FG003|Overall Study|Study terminated by Sponsor|0|||
155533581|NCT01647828|561378822|FG004|Overall Study|Study terminated by Sponsor|0|||
155533582|NCT01647828|561378823|FG005|Overall Study|Study terminated by Sponsor|0|||
155533583|NCT01647828|561378824|FG006|Overall Study|Study terminated by Sponsor|1|||
155533584|NCT01647828|561378825|FG007|Overall Study|Study terminated by Sponsor|26|||
155533585|NCT01647828|561378826|FG008|Overall Study|Study terminated by Sponsor|16|||
155533586|NCT01647828|561378818|FG000|Overall Study|Lost to Follow-up|0|||
155533587|NCT01647828|561378819|FG001|Overall Study|Lost to Follow-up|0|||
155533588|NCT01647828|561378820|FG002|Overall Study|Lost to Follow-up|0|||
155533589|NCT01647828|561378821|FG003|Overall Study|Lost to Follow-up|0|||
155533590|NCT01647828|561378822|FG004|Overall Study|Lost to Follow-up|0|||
155533591|NCT01647828|561378823|FG005|Overall Study|Lost to Follow-up|0|||
155533592|NCT01647828|561378824|FG006|Overall Study|Lost to Follow-up|0|||
155533593|NCT01647828|561378825|FG007|Overall Study|Lost to Follow-up|2|||
155533594|NCT01647828|561378826|FG008|Overall Study|Lost to Follow-up|0|||
155533595|NCT00115063|561378829|FG000|Overall Study|Lost to Follow-up|98|||
155533596|NCT00115063|561378830|FG001|Overall Study|Lost to Follow-up|104|||
155533597|NCT00115063|561378829|FG000|Overall Study|Death|1|||
155533598|NCT00115063|561378830|FG001|Overall Study|Death|0|||
155533599|NCT03808376|561378831|FG000|Overall Study|Withdrawal by Subject|10|||
155533600|NCT03503318|561378834|FG000|Overall Study|Death|1|||
155533601|NCT03503318|561378835|FG001|Overall Study|Death|0|||
155533602|NCT03503318|561378836|FG002|Overall Study|Death|4|||
155533603|NCT03503318|561378834|FG000|Overall Study|Adverse Event|3|||
155533604|NCT03503318|561378835|FG001|Overall Study|Adverse Event|4|||
155533605|NCT03503318|561378836|FG002|Overall Study|Adverse Event|2|||
155533606|NCT03503318|561378834|FG000|Overall Study|Withdrawal by Subject|12|||
155533607|NCT03503318|561378835|FG001|Overall Study|Withdrawal by Subject|17|||
155533608|NCT03503318|561378836|FG002|Overall Study|Withdrawal by Subject|16|||
155533609|NCT03503318|561378834|FG000|Overall Study|Protocol Violation|5|||
155533610|NCT03503318|561378835|FG001|Overall Study|Protocol Violation|0|||
155533611|NCT03503318|561378836|FG002|Overall Study|Protocol Violation|3|||
155533612|NCT03503318|561378834|FG000|Overall Study|Lost to Follow-up|17|||
155533613|NCT03503318|561378835|FG001|Overall Study|Lost to Follow-up|15|||
155655433|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155655434|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155655435|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
155533614|NCT03503318|561378836|FG002|Overall Study|Lost to Follow-up|12|||
155533615|NCT03503318|561378834|FG000|Overall Study|Other than specified|1|||
155533616|NCT03503318|561378835|FG001|Overall Study|Other than specified|3|||
155533617|NCT03503318|561378836|FG002|Overall Study|Other than specified|3|||
155533618|NCT01541215|561380783|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
155533619|NCT01541215|561380784|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
155533620|NCT01541215|561380783|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
155655436|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155655437|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155655438|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155655439|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155655440|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
155655441|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155655442|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155655443|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155655444|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155655445|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
155655446|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155655447|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155655448|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155655449|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155655450|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
155655451|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155655452|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155655453|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155655454|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155655455|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
155655456|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155655457|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155655458|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155655459|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155655460|NCT01111552|561832226|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
155655461|NCT01111552|561832227|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155655462|NCT01111552|561832228|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155655463|NCT01111552|561832229|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155655464|NCT01111552|561832230|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155655465|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155655466|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155655467|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155655468|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
155655469|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155655470|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
155533621|NCT01541215|561380784|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
155533622|NCT01541215|561380783|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
155533623|NCT01541215|561380784|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
155655471|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155655472|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
155655473|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155655474|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155655475|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155655476|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
155655477|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155655478|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155655479|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155655480|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155655481|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
155655482|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155655483|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155655484|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155655485|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155655486|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
155655487|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155655488|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155655489|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155655490|NCT01111552|561832226|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155655491|NCT01111552|561832227|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155655492|NCT01111552|561832228|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
155655493|NCT01111552|561832229|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155655494|NCT01111552|561832230|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155655495|NCT02097225|561832231|FG000|Dose Level 4|Adverse Event|0|||
155655496|NCT02097225|561832232|FG001|Dose Level 4|Adverse Event|0|||
155655497|NCT02097225|561832233|FG002|Dose Level 4|Adverse Event|0|||
155655498|NCT02097225|561832234|FG003|Dose Level 4|Adverse Event|0|||
155655499|NCT02097225|561832235|FG004|Dose Level 4|Adverse Event|1|||
155655500|NCT01027351|561832237|FG000|Overall Study|Withdrawal by Subject|1|||
155655501|NCT01027351|561832238|FG001|Overall Study|Withdrawal by Subject|0|||
155655502|NCT01027351|561832239|FG002|Overall Study|Withdrawal by Subject|1|||
155655503|NCT01027351|561832240|FG003|Overall Study|Withdrawal by Subject|0|||
155655504|NCT01027351|561832241|FG004|Overall Study|Withdrawal by Subject|3|||
155655505|NCT01027351|561832242|FG005|Overall Study|Withdrawal by Subject|5|||
155655506|NCT01027351|561832237|FG000|Overall Study|Lost to Follow-up|1|||
155655507|NCT01027351|561832238|FG001|Overall Study|Lost to Follow-up|1|||
155655508|NCT01027351|561832239|FG002|Overall Study|Lost to Follow-up|0|||
155655509|NCT01027351|561832240|FG003|Overall Study|Lost to Follow-up|1|||
155655510|NCT01027351|561832241|FG004|Overall Study|Lost to Follow-up|6|||
155655511|NCT01027351|561832242|FG005|Overall Study|Lost to Follow-up|0|||
155655512|NCT01027351|561832237|FG000|Overall Study|Inappropriate enrollment|0|||
155655513|NCT01027351|561832238|FG001|Overall Study|Inappropriate enrollment|0|||
155655514|NCT01027351|561832239|FG002|Overall Study|Inappropriate enrollment|0|||
155655515|NCT01027351|561832240|FG003|Overall Study|Inappropriate enrollment|0|||
155655516|NCT01027351|561832241|FG004|Overall Study|Inappropriate enrollment|1|||
155655517|NCT01027351|561832242|FG005|Overall Study|Inappropriate enrollment|0|||
155655518|NCT01027351|561832237|FG000|Overall Study|Protocol Violation|1|||
155533624|NCT01541215|561380783|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
155533625|NCT01541215|561380784|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
155533626|NCT01541215|561380783|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
155533627|NCT01541215|561380784|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
155533628|NCT01541215|561380783|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
155533629|NCT01541215|561380784|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
155533630|NCT03599193|561380785|FG000|Overall Study|Adverse Event|0|||
155533631|NCT03599193|561380786|FG001|Overall Study|Adverse Event|2|||
155533632|NCT03599193|561380785|FG000|Overall Study|Withdrawal by Subject|1|||
155533633|NCT03599193|561380786|FG001|Overall Study|Withdrawal by Subject|0|||
155533634|NCT03599193|561380785|FG000|Overall Study|Protocol Violation|1|||
155533635|NCT03599193|561380786|FG001|Overall Study|Protocol Violation|0|||
155533636|NCT03599193|561380785|FG000|Overall Study|Lost to Follow-up|0|||
155533637|NCT03599193|561380786|FG001|Overall Study|Lost to Follow-up|1|||
155533638|NCT05511935|561380787|FG000|Overall Study|Lost to Follow-up|9|||
155533639|NCT05511935|561380788|FG001|Overall Study|Lost to Follow-up|27|||
155533640|NCT04102345|561380789|FG000|Overall Study|Withdrawal by Subject|1|||
155533641|NCT04102345|561380790|FG001|Overall Study|Withdrawal by Subject|0|||
155533642|NCT01609257|561380793|FG000|Overall Study|Lost to Follow-up|2|||
155533643|NCT01609257|561380794|FG001|Overall Study|Lost to Follow-up|1|||
155533644|NCT01609257|561380793|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
155533645|NCT01609257|561380794|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
155533646|NCT01609257|561380793|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
155533647|NCT01609257|561380794|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
155533648|NCT01015287|561380801|FG000|Overall Study|Death|21|||
155533649|NCT01015287|561380802|FG001|Overall Study|Death|16|||
155533650|NCT01015287|561380801|FG000|Overall Study|Adverse Event|1|||
155533651|NCT01015287|561380802|FG001|Overall Study|Adverse Event|0|||
155533652|NCT01015287|561380801|FG000|Overall Study|Sponsor Decision|3|||
155533653|NCT01015287|561380802|FG001|Overall Study|Sponsor Decision|7|||
155533654|NCT01015287|561380801|FG000|Overall Study|Physician Decision|19|||
155533655|NCT01015287|561380802|FG001|Overall Study|Physician Decision|21|||
155533656|NCT01015287|561380801|FG000|Overall Study|Withdrawal by Subject|14|||
155533657|NCT01015287|561380802|FG001|Overall Study|Withdrawal by Subject|19|||
155533658|NCT01015287|561380801|FG000|Overall Study|Entry Criteria not Met|11|||
155533659|NCT01015287|561380802|FG001|Overall Study|Entry Criteria not Met|14|||
155533660|NCT01015287|561380801|FG000|Overall Study|Lost to Follow-up|2|||
155533661|NCT01015287|561380802|FG001|Overall Study|Lost to Follow-up|1|||
155533662|NCT01015287|561380801|FG000|Overall Study|Protocol Violation|1|||
155533663|NCT01015287|561380802|FG001|Overall Study|Protocol Violation|1|||
155533664|NCT01117623|561380803|FG000|Overall Study|Adverse Event|0|||
155533665|NCT01117623|561380804|FG001|Overall Study|Adverse Event|2|||
155533666|NCT01117623|561380805|FG002|Overall Study|Adverse Event|4|||
155533667|NCT01117623|561380806|FG003|Overall Study|Adverse Event|0|||
155533668|NCT01117623|561380807|FG004|Overall Study|Adverse Event|2|||
155533669|NCT01117623|561380808|FG005|Overall Study|Adverse Event|0|||
155533670|NCT01117623|561380809|FG006|Overall Study|Adverse Event|0|||
155533671|NCT01117623|561380810|FG007|Overall Study|Adverse Event|2|||
155533672|NCT01117623|561380803|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
155533673|NCT01117623|561380804|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
155533674|NCT01117623|561380805|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
155533675|NCT01117623|561380806|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
155533676|NCT01117623|561380807|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
155533677|NCT01117623|561380808|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
155533678|NCT01117623|561380809|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
155533679|NCT01117623|561380810|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
155533680|NCT01117623|561380803|FG000|Overall Study|Withdrawal by Subject|0|||
155533681|NCT01117623|561380804|FG001|Overall Study|Withdrawal by Subject|0|||
155533682|NCT01117623|561380805|FG002|Overall Study|Withdrawal by Subject|2|||
155533683|NCT01117623|561380806|FG003|Overall Study|Withdrawal by Subject|0|||
155533684|NCT01117623|561380807|FG004|Overall Study|Withdrawal by Subject|0|||
155533685|NCT01117623|561380808|FG005|Overall Study|Withdrawal by Subject|1|||
155533686|NCT01117623|561380809|FG006|Overall Study|Withdrawal by Subject|1|||
155533687|NCT01117623|561380810|FG007|Overall Study|Withdrawal by Subject|1|||
155533688|NCT01117623|561380803|FG000|Overall Study|Non-compliance with study medication|0|||
155533689|NCT01117623|561380804|FG001|Overall Study|Non-compliance with study medication|0|||
155533690|NCT01117623|561380805|FG002|Overall Study|Non-compliance with study medication|0|||
155533691|NCT01117623|561380806|FG003|Overall Study|Non-compliance with study medication|0|||
155533692|NCT01117623|561380807|FG004|Overall Study|Non-compliance with study medication|0|||
155533693|NCT01117623|561380808|FG005|Overall Study|Non-compliance with study medication|0|||
155533694|NCT01117623|561380809|FG006|Overall Study|Non-compliance with study medication|0|||
155533695|NCT01117623|561380810|FG007|Overall Study|Non-compliance with study medication|1|||
155533696|NCT01117623|561380803|FG000|Overall Study|Invest. text: completed all planned txs|0|||
155533697|NCT01117623|561380804|FG001|Overall Study|Invest. text: completed all planned txs|0|||
155533698|NCT01117623|561380805|FG002|Overall Study|Invest. text: completed all planned txs|0|||
155533699|NCT01117623|561380806|FG003|Overall Study|Invest. text: completed all planned txs|0|||
155533700|NCT01117623|561380807|FG004|Overall Study|Invest. text: completed all planned txs|0|||
155533701|NCT01117623|561380808|FG005|Overall Study|Invest. text: completed all planned txs|1|||
155533702|NCT01117623|561380809|FG006|Overall Study|Invest. text: completed all planned txs|0|||
155533703|NCT01117623|561380810|FG007|Overall Study|Invest. text: completed all planned txs|0|||
155533704|NCT02727192|561380815|FG000|Overall Study|Lost to Follow-up|1|||
155533705|NCT02727192|561380816|FG001|Overall Study|Lost to Follow-up|0|||
155533706|NCT02727192|561380817|FG002|Overall Study|Lost to Follow-up|0|||
155533707|NCT00928057|561380818|FG000|Overall Study|Adverse Event|1|||
155533708|NCT00928057|561380819|FG001|Overall Study|Adverse Event|2|||
155533709|NCT00928057|561380818|FG000|Overall Study|Withdrawal by Subject|1|||
155533710|NCT00928057|561380819|FG001|Overall Study|Withdrawal by Subject|0|||
155533711|NCT00928057|561380818|FG000|Overall Study|Lost to Follow-up|0|||
155533712|NCT00928057|561380819|FG001|Overall Study|Lost to Follow-up|1|||
155533713|NCT00928057|561380818|FG000|Overall Study|Protocol Violation|0|||
155533714|NCT00928057|561380819|FG001|Overall Study|Protocol Violation|1|||
155533715|NCT03206749|561380820|FG000|Overall Study|Withdrawal of consent|5|||
155533716|NCT03206749|561380821|FG001|Overall Study|Withdrawal of consent|3|||
155533717|NCT03206749|561380822|FG002|Overall Study|Withdrawal of consent|6|||
155533718|NCT03206749|561380820|FG000|Overall Study|Lost to Follow-up|0|||
155533719|NCT03206749|561380821|FG001|Overall Study|Lost to Follow-up|0|||
155533720|NCT03206749|561380822|FG002|Overall Study|Lost to Follow-up|1|||
155533721|NCT02451696|561380823|FG000|Overall Study|Surgery postponed|1|||
155533722|NCT02451696|561380824|FG001|Overall Study|Surgery postponed|0|||
155533723|NCT03674892|561380825|FG000|Overall Study|Lack of Efficacy|5|||
155533724|NCT03674892|561380825|FG000|Overall Study|Lost to Follow-up|3|||
155533725|NCT03674892|561380825|FG000|Overall Study|Migraine|2|||
155533726|NCT03674892|561380825|FG000|Overall Study|Excessive Tearing|1|||
155533727|NCT03674892|561380825|FG000|Overall Study|Increased Eye Pain|1|||
155533728|NCT03674892|561380825|FG000|Overall Study|Increased Facial Pain|1|||
155533729|NCT03674892|561380825|FG000|Overall Study|Sinus Irritation|1|||
155533730|NCT03674892|561380825|FG000|Overall Study|Sinus Infection|1|||
155533731|NCT05099380|561380826|FG000|Overall Study|Subject enrolled in error|1|||
155533732|NCT05099380|561380827|FG001|Overall Study|Subject enrolled in error|0|||
155533733|NCT05099380|561380826|FG000|Overall Study|Study Procedure|1|||
155533734|NCT05099380|561380827|FG001|Overall Study|Study Procedure|0|||
155533735|NCT05099380|561380826|FG000|Overall Study|Protocol Violation|1|||
155533736|NCT05099380|561380827|FG001|Overall Study|Protocol Violation|0|||
155533737|NCT05099380|561380826|FG000|Overall Study|Adverse Event|1|||
155533738|NCT05099380|561380827|FG001|Overall Study|Adverse Event|1|||
155533739|NCT05099380|561380826|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
155533740|NCT05099380|561380827|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
155533741|NCT01959672|561380833|FG000|Overall Study|Death|1|||
155533742|NCT02392195|561380834|FG000|Overall Study|Lost to Follow-up|4|||
155533743|NCT02392195|561380834|FG000|Overall Study|Withdrawal by Subject|4|||
155533744|NCT00840216|561380835|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155533745|NCT00840216|561380836|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155533746|NCT00545792|561380839|FG000|Overall Study|Withdrawal by Subject|1|||
155533747|NCT05041361|561380841|FG000|Overall Study|Lost to Follow-up|1|||
155533748|NCT05041361|561380842|FG001|Overall Study|Lost to Follow-up|3|||
155533749|NCT01642277|561380843|FG000|Overall Study|Adverse Event|10|||
155533750|NCT01642277|561380844|FG001|Overall Study|Adverse Event|0|||
155533751|NCT01642277|561380843|FG000|Overall Study|Physician Decision|2|||
155533752|NCT01642277|561380844|FG001|Overall Study|Physician Decision|0|||
155533753|NCT01642277|561380843|FG000|Overall Study|Protocol Violation|1|||
155533754|NCT01642277|561380844|FG001|Overall Study|Protocol Violation|0|||
155533755|NCT01642277|561380843|FG000|Overall Study|Withdrawal by Subject|11|||
155533756|NCT01642277|561380844|FG001|Overall Study|Withdrawal by Subject|0|||
155533757|NCT03679598|561380845|FG000|Overall Study|Adverse Event|2|||
155533758|NCT03679598|561380846|FG001|Overall Study|Adverse Event|0|||
155533759|NCT00927069|561380847|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
155533760|NCT00927069|561380848|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
155533761|NCT00927069|561380849|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
155533762|NCT00927069|561380850|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
155533763|NCT00927069|561380847|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
155533764|NCT00927069|561380848|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
155533765|NCT00927069|561380849|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
155533766|NCT00927069|561380850|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
155533767|NCT00927069|561380847|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
155533768|NCT00927069|561380848|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
155533769|NCT00927069|561380849|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
155533770|NCT00927069|561380850|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
155533771|NCT00927069|561380847|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
155533772|NCT00927069|561380848|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
155533773|NCT00927069|561380849|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
155533774|NCT00927069|561380850|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
155487212|NCT01714726|561208157|FG001|Open-Label Period|Adverse Event|0|||
155487213|NCT01714726|561208158|FG002|Open-Label Period|Adverse Event|1|||
155487214|NCT01714726|561208159|FG003|Open-Label Period|Adverse Event|0|||
155487215|NCT01714726|561208156|FG000|Open-Label Period|Withdrawal by Subject|0|||
155487216|NCT01714726|561208157|FG001|Open-Label Period|Withdrawal by Subject|0|||
155487217|NCT01714726|561208158|FG002|Open-Label Period|Withdrawal by Subject|9|||
155487218|NCT01714726|561208159|FG003|Open-Label Period|Withdrawal by Subject|19|||
155487219|NCT01714726|561208156|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
155487220|NCT01714726|561208157|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
155487221|NCT01714726|561208158|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
155487222|NCT01714726|561208159|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
155487223|NCT01714726|561208156|FG000|Open-Label Period|Lost to Follow-up|0|||
155487224|NCT01714726|561208157|FG001|Open-Label Period|Lost to Follow-up|0|||
155487225|NCT01714726|561208158|FG002|Open-Label Period|Lost to Follow-up|3|||
155487226|NCT01714726|561208159|FG003|Open-Label Period|Lost to Follow-up|4|||
155487227|NCT00501969|561208160|FG000|Overall Study|Major Protocol Violation|4|||
155487228|NCT00501969|561208160|FG000|Overall Study|Lack of Efficacy|29|||
155487229|NCT00501969|561208160|FG000|Overall Study|Adverse Event|76|||
155487230|NCT00501969|561208160|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
155487231|NCT00501969|561208160|FG000|Overall Study|Subject withdrew consent|51|||
155487232|NCT00501969|561208160|FG000|Overall Study|Lost to Follow-up|4|||
155487233|NCT00501969|561208160|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
155487234|NCT00501969|561208160|FG000|Overall Study|Other: Sponsors Request|10|||
155487235|NCT00501969|561208160|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
155487236|NCT00501969|561208160|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
155487237|NCT00501969|561208160|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
155487238|NCT00501969|561208160|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
155487239|NCT00501969|561208160|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
155487240|NCT00501969|561208160|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
155487241|NCT00501969|561208160|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
155487242|NCT00501969|561208160|FG000|Overall Study|Other: As Required by Local EC|2|||
155487243|NCT00501969|561208160|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
155487244|NCT00501969|561208160|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
155487245|NCT00665366|561208163|FG000|Overall Study|Lack of Efficacy|11|||
155487246|NCT00665366|561208164|FG001|Overall Study|Lack of Efficacy|10|||
155487247|NCT00665366|561208163|FG000|Overall Study|Adverse Event|25|||
155487248|NCT00665366|561208164|FG001|Overall Study|Adverse Event|23|||
155487249|NCT00665366|561208163|FG000|Overall Study|Withdrawal by Subject|11|||
155487250|NCT00665366|561208164|FG001|Overall Study|Withdrawal by Subject|14|||
155487251|NCT00665366|561208163|FG000|Overall Study|Lost to Follow-up|3|||
155487252|NCT00665366|561208164|FG001|Overall Study|Lost to Follow-up|5|||
155487253|NCT00665366|561208163|FG000|Overall Study|Poor compliance/noncompliance|3|||
155487254|NCT00665366|561208164|FG001|Overall Study|Poor compliance/noncompliance|5|||
155487255|NCT00665366|561208163|FG000|Overall Study|Pregnancy|1|||
155487256|NCT00665366|561208164|FG001|Overall Study|Pregnancy|0|||
155487257|NCT00665366|561208163|FG000|Overall Study|No longer meets study criteria|0|||
155487258|NCT00665366|561208164|FG001|Overall Study|No longer meets study criteria|1|||
155487259|NCT00665366|561208163|FG000|Overall Study|Other reasons|4|||
155487260|NCT00665366|561208164|FG001|Overall Study|Other reasons|1|||
155487261|NCT03628781|561208165|FG000|Overall Study|Lost to Follow-up|16|||
155487262|NCT03628781|561208166|FG001|Overall Study|Lost to Follow-up|8|||
155487263|NCT03628781|561208165|FG000|Overall Study|Withdrawal by Subject|16|||
155487264|NCT03628781|561208166|FG001|Overall Study|Withdrawal by Subject|1|||
155487265|NCT02687815|561208170|FG000|Overall Study|Lost to Follow-up|2|||
155487266|NCT02687815|561208171|FG001|Overall Study|Lost to Follow-up|4|||
155487267|NCT02687815|561208170|FG000|Overall Study|Withdrawal by Subject|2|||
155487268|NCT02687815|561208171|FG001|Overall Study|Withdrawal by Subject|4|||
155487269|NCT00379639|561208172|FG000|Overall Study|Disease Progression|3|||
155487270|NCT00379639|561208173|FG001|Overall Study|Disease Progression|3|||
155487271|NCT00379639|561208174|FG002|Overall Study|Disease Progression|3|||
155487272|NCT00379639|561208175|FG003|Overall Study|Disease Progression|4|||
155487273|NCT00379639|561208176|FG004|Overall Study|Disease Progression|4|||
155487274|NCT00379639|561208172|FG000|Overall Study|Physician Decision|0|||
155487275|NCT00379639|561208173|FG001|Overall Study|Physician Decision|2|||
155487276|NCT00379639|561208174|FG002|Overall Study|Physician Decision|1|||
155487277|NCT00379639|561208175|FG003|Overall Study|Physician Decision|1|||
155487278|NCT00379639|561208176|FG004|Overall Study|Physician Decision|0|||
155487279|NCT00379639|561208172|FG000|Overall Study|Symptomatic Deterioration|0|||
155487280|NCT00379639|561208173|FG001|Overall Study|Symptomatic Deterioration|0|||
155487281|NCT00379639|561208174|FG002|Overall Study|Symptomatic Deterioration|1|||
155487282|NCT00379639|561208175|FG003|Overall Study|Symptomatic Deterioration|0|||
155533775|NCT00927069|561380847|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
155533776|NCT00927069|561380848|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
155533777|NCT00927069|561380849|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
155533778|NCT00927069|561380850|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
155533779|NCT02842853|561380853|FG000|Overall Study|Non-compliance with the protocol|3|||
155533780|NCT02842853|561380854|FG001|Overall Study|Non-compliance with the protocol|7|||
155533781|NCT02842853|561380855|FG002|Overall Study|Non-compliance with the protocol|2|||
155533782|NCT02842853|561380856|FG003|Overall Study|Non-compliance with the protocol|5|||
155533783|NCT02842853|561380853|FG000|Overall Study|Subject met exclusion criteria|0|||
155533784|NCT02842853|561380854|FG001|Overall Study|Subject met exclusion criteria|1|||
155533785|NCT02842853|561380855|FG002|Overall Study|Subject met exclusion criteria|0|||
155533786|NCT02842853|561380856|FG003|Overall Study|Subject met exclusion criteria|0|||
155533787|NCT02842853|561380853|FG000|Overall Study|Withdrawal by Subject|11|||
155533788|NCT02842853|561380854|FG001|Overall Study|Withdrawal by Subject|13|||
155533789|NCT02842853|561380855|FG002|Overall Study|Withdrawal by Subject|9|||
155533790|NCT02842853|561380856|FG003|Overall Study|Withdrawal by Subject|8|||
155533791|NCT02842853|561380853|FG000|Overall Study|Lost to Follow-up|9|||
155533792|NCT02842853|561380854|FG001|Overall Study|Lost to Follow-up|13|||
155533793|NCT02842853|561380855|FG002|Overall Study|Lost to Follow-up|10|||
155533794|NCT02842853|561380856|FG003|Overall Study|Lost to Follow-up|11|||
155533795|NCT01403194|561380864|FG000|Overall Study|Screen Failure|2|||
155533796|NCT01403194|561380864|FG000|Overall Study|Lost to Follow-up|8|||
155533797|NCT03428750|561380865|FG000|Overall Study|Withdrawal by Subject|11|||
155533798|NCT03428750|561380866|FG001|Overall Study|Withdrawal by Subject|10|||
155533799|NCT03428750|561380865|FG000|Overall Study|Lost to Follow-up|3|||
155533800|NCT03428750|561380866|FG001|Overall Study|Lost to Follow-up|9|||
155533801|NCT03428750|561380865|FG000|Overall Study|Adverse Event|9|||
155533802|NCT03428750|561380866|FG001|Overall Study|Adverse Event|1|||
155533803|NCT03428750|561380865|FG000|Overall Study|Protocol Violation|1|||
155533804|NCT03428750|561380866|FG001|Overall Study|Protocol Violation|0|||
155533805|NCT03428750|561380865|FG000|Overall Study|Administrative|0|||
155533806|NCT03428750|561380866|FG001|Overall Study|Administrative|1|||
155533807|NCT00274651|561380869|FG000|Overall Study|Adverse Event|6|||
155533808|NCT00274651|561380870|FG001|Overall Study|Adverse Event|3|||
155533809|NCT00274651|561380869|FG000|Overall Study|Lack of Efficacy|13|||
155533810|NCT00274651|561380870|FG001|Overall Study|Lack of Efficacy|6|||
155533811|NCT00274651|561380869|FG000|Overall Study|Death|1|||
155533812|NCT00274651|561380870|FG001|Overall Study|Death|3|||
155533813|NCT00274651|561380869|FG000|Overall Study|Withdrawal by Subject|0|||
155533814|NCT00274651|561380870|FG001|Overall Study|Withdrawal by Subject|1|||
155533815|NCT00274651|561380869|FG000|Overall Study|Physician Decision|8|||
155533816|NCT00274651|561380870|FG001|Overall Study|Physician Decision|7|||
155533817|NCT05133180|561380871|FG000|Overall Study|Withdrawal of consent|1|||
155533818|NCT05133180|561380872|FG001|Overall Study|Withdrawal of consent|1|||
155533819|NCT05133180|561380871|FG000|Overall Study|Lost to Follow-up|1|||
155533820|NCT05133180|561380872|FG001|Overall Study|Lost to Follow-up|1|||
155533821|NCT05133180|561380871|FG000|Overall Study|Documented disease progression|0|||
155533822|NCT05133180|561380872|FG001|Overall Study|Documented disease progression|1|||
155533823|NCT01188681|561380875|FG000|Overall Study|bladder cancer|0|||
155533824|NCT01188681|561380876|FG001|Overall Study|bladder cancer|0|||
155533825|NCT01188681|561380877|FG002|Overall Study|bladder cancer|1|||
155533826|NCT01188681|561380878|FG003|Overall Study|bladder cancer|0|||
155533827|NCT01188681|561380875|FG000|Overall Study|Withdrawal by Subject|0|||
155533828|NCT01188681|561380876|FG001|Overall Study|Withdrawal by Subject|0|||
155533829|NCT01188681|561380877|FG002|Overall Study|Withdrawal by Subject|0|||
155533830|NCT01188681|561380878|FG003|Overall Study|Withdrawal by Subject|1|||
155533831|NCT04345653|561380879|FG000|Overall Study|Withdrawal by Subject|2|||
155533832|NCT03214588|561380880|FG000|Overall Study|Adverse Event|1|||
155533833|NCT03214588|561380881|FG001|Overall Study|Adverse Event|0|||
155533834|NCT03214588|561380882|FG002|Overall Study|Adverse Event|2|||
155533835|NCT03214588|561380880|FG000|Overall Study|Reason Not Specified|0|||
155533836|NCT03214588|561380881|FG001|Overall Study|Reason Not Specified|1|||
155533837|NCT03214588|561380882|FG002|Overall Study|Reason Not Specified|0|||
155533838|NCT00418938|561380883|FG000|Overall Study|Reimbursement|1|||
155533839|NCT00418938|561380884|FG001|Overall Study|Reimbursement|0|||
155533840|NCT00418938|561380883|FG000|Overall Study|Administrative decision|3|||
155533841|NCT00418938|561380884|FG001|Overall Study|Administrative decision|3|||
155533842|NCT00418938|561380883|FG000|Overall Study|Withdrawal by Subject|16|||
155533843|NCT00418938|561380884|FG001|Overall Study|Withdrawal by Subject|15|||
155533844|NCT00418938|561380883|FG000|Overall Study|Lost to Follow-up|1|||
155533845|NCT00418938|561380884|FG001|Overall Study|Lost to Follow-up|3|||
155533846|NCT00418938|561380883|FG000|Overall Study|Adverse Event|1|||
155533847|NCT00418938|561380884|FG001|Overall Study|Adverse Event|1|||
155533848|NCT00418938|561380883|FG000|Overall Study|On-going|1|||
155533849|NCT00418938|561380884|FG001|Overall Study|On-going|1|||
155533850|NCT00418938|561380883|FG000|Overall Study|Ineligibility Determined|1|||
155533851|NCT00418938|561380884|FG001|Overall Study|Ineligibility Determined|0|||
155533852|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
155533853|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
155533854|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
155533855|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
155533856|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
155533857|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
155533858|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Death|9|||
155533859|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Death|7|||
155533860|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Death|14|||
155533861|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Death|7|||
155533862|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Death|0|||
155533863|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Death|0|||
155533864|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
155533865|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
155533866|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
155533867|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
155533868|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
155533869|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
155533870|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Other Event|49|||
155533871|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Other Event|52|||
155533872|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Other Event|41|||
155533873|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Other Event|58|||
155533874|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Other Event|0|||
155533875|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Other Event|0|||
155533876|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
155533877|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
155533878|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
155533879|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
155533880|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
155533881|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
155533882|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
155533883|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
155533884|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
155533885|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
155533886|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
155533887|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
155533888|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
155533889|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
155533890|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
155533891|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
155533892|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
155533893|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
155533894|NCT00205777|561380885|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
155533895|NCT00205777|561380886|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
155533896|NCT00205777|561380887|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
155533897|NCT00205777|561380888|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
155533898|NCT00205777|561380889|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
155533899|NCT00205777|561380890|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
155533900|NCT00205777|561380885|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
155533901|NCT00205777|561380886|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
155533902|NCT00205777|561380887|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
155533903|NCT00205777|561380888|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
155533904|NCT00205777|561380889|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
155533905|NCT00205777|561380890|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
155533906|NCT00205777|561380885|FG000|Completed Core Study, Entered SE I|Other Event|52|||
155533907|NCT00205777|561380886|FG001|Completed Core Study, Entered SE I|Other Event|46|||
155533908|NCT00205777|561380887|FG002|Completed Core Study, Entered SE I|Other Event|47|||
155533909|NCT00205777|561380888|FG003|Completed Core Study, Entered SE I|Other Event|50|||
155533910|NCT00205777|561380889|FG004|Completed Core Study, Entered SE I|Other Event|0|||
155533911|NCT00205777|561380890|FG005|Completed Core Study, Entered SE I|Other Event|0|||
155533912|NCT00205777|561380885|FG000|Study Extension I|Adverse Event|57|||
155655519|NCT01027351|561832238|FG001|Overall Study|Protocol Violation|0|||
155655520|NCT01027351|561832239|FG002|Overall Study|Protocol Violation|0|||
155655521|NCT01027351|561832240|FG003|Overall Study|Protocol Violation|1|||
155655522|NCT01027351|561832241|FG004|Overall Study|Protocol Violation|1|||
155655523|NCT01027351|561832242|FG005|Overall Study|Protocol Violation|0|||
155533913|NCT00205777|561380886|FG001|Study Extension I|Adverse Event|0|||
155533914|NCT00205777|561380887|FG002|Study Extension I|Adverse Event|0|||
155533915|NCT00205777|561380888|FG003|Study Extension I|Adverse Event|61|||
155533916|NCT00205777|561380889|FG004|Study Extension I|Adverse Event|58|||
155533917|NCT00205777|561380890|FG005|Study Extension I|Adverse Event|0|||
155533918|NCT00205777|561380885|FG000|Study Extension I|Death|5|||
155533919|NCT00205777|561380886|FG001|Study Extension I|Death|0|||
155533920|NCT00205777|561380887|FG002|Study Extension I|Death|0|||
155533921|NCT00205777|561380888|FG003|Study Extension I|Death|1|||
155533922|NCT00205777|561380889|FG004|Study Extension I|Death|2|||
155533923|NCT00205777|561380890|FG005|Study Extension I|Death|0|||
155533924|NCT00205777|561380885|FG000|Study Extension I|Withdrawal by Subject|99|||
155533925|NCT00205777|561380886|FG001|Study Extension I|Withdrawal by Subject|0|||
155533926|NCT00205777|561380887|FG002|Study Extension I|Withdrawal by Subject|0|||
155533927|NCT00205777|561380888|FG003|Study Extension I|Withdrawal by Subject|106|||
155533928|NCT00205777|561380889|FG004|Study Extension I|Withdrawal by Subject|89|||
155533929|NCT00205777|561380890|FG005|Study Extension I|Withdrawal by Subject|0|||
155533930|NCT00205777|561380885|FG000|Study Extension I|Protocol Violation|4|||
155533931|NCT00205777|561380886|FG001|Study Extension I|Protocol Violation|0|||
155533932|NCT00205777|561380887|FG002|Study Extension I|Protocol Violation|0|||
155533933|NCT00205777|561380888|FG003|Study Extension I|Protocol Violation|8|||
155533934|NCT00205777|561380889|FG004|Study Extension I|Protocol Violation|8|||
155533935|NCT00205777|561380890|FG005|Study Extension I|Protocol Violation|0|||
155533936|NCT00205777|561380885|FG000|Study Extension I|Lack of Efficacy|0|||
155533937|NCT00205777|561380886|FG001|Study Extension I|Lack of Efficacy|0|||
155533938|NCT00205777|561380887|FG002|Study Extension I|Lack of Efficacy|0|||
155533939|NCT00205777|561380888|FG003|Study Extension I|Lack of Efficacy|1|||
155533940|NCT00205777|561380889|FG004|Study Extension I|Lack of Efficacy|2|||
155533941|NCT00205777|561380890|FG005|Study Extension I|Lack of Efficacy|0|||
155533942|NCT00205777|561380885|FG000|Study Extension I|Failed to return|15|||
155533943|NCT00205777|561380886|FG001|Study Extension I|Failed to return|0|||
155533944|NCT00205777|561380887|FG002|Study Extension I|Failed to return|0|||
155533945|NCT00205777|561380888|FG003|Study Extension I|Failed to return|17|||
155533946|NCT00205777|561380889|FG004|Study Extension I|Failed to return|13|||
155533947|NCT00205777|561380890|FG005|Study Extension I|Failed to return|0|||
155533948|NCT00205777|561380885|FG000|Study Extension I|Other Event|34|||
155533949|NCT00205777|561380886|FG001|Study Extension I|Other Event|0|||
155533950|NCT00205777|561380887|FG002|Study Extension I|Other Event|0|||
155533951|NCT00205777|561380888|FG003|Study Extension I|Other Event|34|||
155533952|NCT00205777|561380889|FG004|Study Extension I|Other Event|29|||
155533953|NCT00205777|561380890|FG005|Study Extension I|Other Event|0|||
155533954|NCT00205777|561380885|FG000|Study Extension I|Withdrawn as per protocol|0|||
155533955|NCT00205777|561380886|FG001|Study Extension I|Withdrawn as per protocol|0|||
155533956|NCT00205777|561380887|FG002|Study Extension I|Withdrawn as per protocol|1070|||
155533957|NCT00205777|561380888|FG003|Study Extension I|Withdrawn as per protocol|0|||
155533958|NCT00205777|561380889|FG004|Study Extension I|Withdrawn as per protocol|0|||
155533959|NCT00205777|561380890|FG005|Study Extension I|Withdrawn as per protocol|0|||
155533960|NCT00205777|561380885|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
155533961|NCT00205777|561380886|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
155533962|NCT00205777|561380887|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
155533963|NCT00205777|561380888|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
155533964|NCT00205777|561380889|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
155533965|NCT00205777|561380890|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
155533966|NCT00205777|561380885|FG000|Study Extension II|Adverse Event|0|||
155533967|NCT00205777|561380886|FG001|Study Extension II|Adverse Event|0|||
155533968|NCT00205777|561380887|FG002|Study Extension II|Adverse Event|0|||
155533969|NCT00205777|561380888|FG003|Study Extension II|Adverse Event|14|||
155533970|NCT00205777|561380889|FG004|Study Extension II|Adverse Event|0|||
155533971|NCT00205777|561380890|FG005|Study Extension II|Adverse Event|30|||
155533972|NCT00205777|561380885|FG000|Study Extension II|Death|0|||
155533973|NCT00205777|561380886|FG001|Study Extension II|Death|0|||
155533974|NCT00205777|561380887|FG002|Study Extension II|Death|0|||
155533975|NCT00205777|561380888|FG003|Study Extension II|Death|2|||
155533976|NCT00205777|561380889|FG004|Study Extension II|Death|0|||
155533977|NCT00205777|561380890|FG005|Study Extension II|Death|5|||
155533978|NCT00205777|561380885|FG000|Study Extension II|Withdrawal by Subject|0|||
155533979|NCT00205777|561380886|FG001|Study Extension II|Withdrawal by Subject|0|||
155655524|NCT04650893|561832243|FG000|Overall Study|Lost to Follow-up|11|||
155655525|NCT04650893|561832244|FG001|Overall Study|Lost to Follow-up|10|||
155655526|NCT04650893|561832245|FG002|Overall Study|Lost to Follow-up|11|||
155655527|NCT04091438|561832246|FG000|Treatment Period 1 (1 Day)|Other|1|||
155655528|NCT04091438|561832247|FG001|Treatment Period 1 (1 Day)|Other|0|||
155533980|NCT00205777|561380887|FG002|Study Extension II|Withdrawal by Subject|0|||
155533981|NCT00205777|561380888|FG003|Study Extension II|Withdrawal by Subject|35|||
155533982|NCT00205777|561380889|FG004|Study Extension II|Withdrawal by Subject|0|||
155533983|NCT00205777|561380890|FG005|Study Extension II|Withdrawal by Subject|59|||
155533984|NCT00205777|561380885|FG000|Study Extension II|Protocol Violation|0|||
155533985|NCT00205777|561380886|FG001|Study Extension II|Protocol Violation|0|||
155533986|NCT00205777|561380887|FG002|Study Extension II|Protocol Violation|0|||
155533987|NCT00205777|561380888|FG003|Study Extension II|Protocol Violation|1|||
155533988|NCT00205777|561380889|FG004|Study Extension II|Protocol Violation|0|||
155533989|NCT00205777|561380890|FG005|Study Extension II|Protocol Violation|10|||
155655529|NCT04091438|561832246|FG000|Washout Period (1 Day)|Protocol deviation|0|||
155533990|NCT00205777|561380885|FG000|Study Extension II|Lack of Efficacy|0|||
155533991|NCT00205777|561380886|FG001|Study Extension II|Lack of Efficacy|0|||
155533992|NCT00205777|561380887|FG002|Study Extension II|Lack of Efficacy|0|||
155533993|NCT00205777|561380888|FG003|Study Extension II|Lack of Efficacy|0|||
155533994|NCT00205777|561380889|FG004|Study Extension II|Lack of Efficacy|0|||
155533995|NCT00205777|561380890|FG005|Study Extension II|Lack of Efficacy|1|||
155533996|NCT00205777|561380885|FG000|Study Extension II|Failed to return|0|||
155533997|NCT00205777|561380886|FG001|Study Extension II|Failed to return|0|||
155533998|NCT00205777|561380887|FG002|Study Extension II|Failed to return|0|||
155533999|NCT00205777|561380888|FG003|Study Extension II|Failed to return|14|||
155534000|NCT00205777|561380889|FG004|Study Extension II|Failed to return|0|||
155534001|NCT00205777|561380890|FG005|Study Extension II|Failed to return|26|||
155534002|NCT00205777|561380885|FG000|Study Extension II|Other Event|0|||
155534003|NCT00205777|561380886|FG001|Study Extension II|Other Event|0|||
155534004|NCT00205777|561380887|FG002|Study Extension II|Other Event|0|||
155534005|NCT00205777|561380888|FG003|Study Extension II|Other Event|12|||
155534006|NCT00205777|561380889|FG004|Study Extension II|Other Event|0|||
155534007|NCT00205777|561380890|FG005|Study Extension II|Other Event|20|||
155534008|NCT00205777|561380885|FG000|Study Extension II|Enrolled but not treated|0|||
155534009|NCT00205777|561380886|FG001|Study Extension II|Enrolled but not treated|0|||
155534010|NCT00205777|561380887|FG002|Study Extension II|Enrolled but not treated|0|||
155534011|NCT00205777|561380888|FG003|Study Extension II|Enrolled but not treated|71|||
155534012|NCT00205777|561380889|FG004|Study Extension II|Enrolled but not treated|0|||
155534013|NCT00205777|561380890|FG005|Study Extension II|Enrolled but not treated|131|||
155534014|NCT00700739|561380894|FG000|Overall Study|Lost to Follow-up|4|||
155534015|NCT00700739|561380895|FG001|Overall Study|Lost to Follow-up|4|||
155534016|NCT01794845|561380897|FG000|Overall Study|Withdrawal by Subject|1|||
155534017|NCT02139826|561380898|FG000|Overall Study|Adverse Event|1|||
155534018|NCT01004510|561380902|FG000|Overall Study|Adverse Event|1|||
155534019|NCT01824576|561380904|FG000|Overall Study|Device deficiency|2|||
155534020|NCT02911025|561380906|FG000|Overall Study|Lost to Follow-up|3|||
155534021|NCT03719040|561380907|FG000|Overall Study|Withdrawal by Subject|177|||
155534022|NCT03719040|561380907|FG000|Overall Study|Lost to Follow-up|26|||
155534023|NCT06647173|561380908|FG000|Overall Study|Lost to Follow-up|24|||
155534024|NCT02923349|561380909|FG000|Overall Study|Other|1|||
155534025|NCT02923349|561380910|FG001|Overall Study|Other|2|||
155534026|NCT02923349|561380911|FG002|Overall Study|Other|4|||
155534027|NCT02923349|561380912|FG003|Overall Study|Other|1|||
155534028|NCT02923349|561380913|FG004|Overall Study|Other|3|||
155534029|NCT02923349|561380914|FG005|Overall Study|Other|0|||
155534030|NCT02923349|561380915|FG006|Overall Study|Other|1|||
155534031|NCT02923349|561380909|FG000|Overall Study|Withdrawal by Subject|2|||
155534032|NCT02923349|561380910|FG001|Overall Study|Withdrawal by Subject|2|||
155534033|NCT02923349|561380911|FG002|Overall Study|Withdrawal by Subject|8|||
155534034|NCT02923349|561380912|FG003|Overall Study|Withdrawal by Subject|10|||
155534035|NCT02923349|561380913|FG004|Overall Study|Withdrawal by Subject|12|||
155534036|NCT02923349|561380914|FG005|Overall Study|Withdrawal by Subject|3|||
155534037|NCT02923349|561380915|FG006|Overall Study|Withdrawal by Subject|0|||
155534038|NCT02923349|561380909|FG000|Overall Study|Physician Decision|0|||
155534039|NCT02923349|561380910|FG001|Overall Study|Physician Decision|0|||
155534040|NCT02923349|561380911|FG002|Overall Study|Physician Decision|0|||
155534041|NCT02923349|561380912|FG003|Overall Study|Physician Decision|1|||
155534042|NCT02923349|561380913|FG004|Overall Study|Physician Decision|1|||
155534043|NCT02923349|561380914|FG005|Overall Study|Physician Decision|0|||
155534044|NCT02923349|561380915|FG006|Overall Study|Physician Decision|2|||
155534045|NCT02923349|561380909|FG000|Overall Study|Lost to Follow-up|0|||
155534046|NCT02923349|561380910|FG001|Overall Study|Lost to Follow-up|0|||
155534047|NCT02923349|561380911|FG002|Overall Study|Lost to Follow-up|3|||
155534048|NCT02923349|561380912|FG003|Overall Study|Lost to Follow-up|0|||
155655530|NCT04091438|561832247|FG001|Washout Period (1 Day)|Protocol deviation|1|||
155655531|NCT04091438|561832246|FG000|Washout Period (1 Day)|Other|0|||
155534049|NCT02923349|561380913|FG004|Overall Study|Lost to Follow-up|1|||
155534050|NCT02923349|561380914|FG005|Overall Study|Lost to Follow-up|1|||
155534051|NCT02923349|561380915|FG006|Overall Study|Lost to Follow-up|0|||
155534052|NCT02923349|561380909|FG000|Overall Study|Death|1|||
155534053|NCT02923349|561380910|FG001|Overall Study|Death|0|||
155534054|NCT02923349|561380911|FG002|Overall Study|Death|2|||
155534055|NCT02923349|561380912|FG003|Overall Study|Death|4|||
155534056|NCT02923349|561380913|FG004|Overall Study|Death|2|||
155534057|NCT02923349|561380914|FG005|Overall Study|Death|3|||
155534058|NCT02923349|561380915|FG006|Overall Study|Death|0|||
155534059|NCT01120028|561380918|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
155534060|NCT01120028|561380919|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
155534061|NCT01120028|561380920|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
155534062|NCT01120028|561380921|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
155534063|NCT01120028|561380918|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
155534064|NCT01120028|561380919|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
155534065|NCT01120028|561380920|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
155534066|NCT01120028|561380921|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
155534067|NCT01248728|561380922|FG000|Overall Study|Adverse Event|1|||
155534068|NCT01248728|561380923|FG001|Overall Study|Adverse Event|1|||
155534069|NCT01248728|561380922|FG000|Overall Study|Withdrawal by Subject|2|||
155534070|NCT01248728|561380923|FG001|Overall Study|Withdrawal by Subject|1|||
155534071|NCT01248728|561380922|FG000|Overall Study|Lack of Efficacy|1|||
155534072|NCT01248728|561380923|FG001|Overall Study|Lack of Efficacy|0|||
155534073|NCT01841554|561380924|FG000|Overall Study|Death|7|||
155534074|NCT01841554|561380924|FG000|Overall Study|No Implantation|1|||
155534075|NCT01841554|561380924|FG000|Overall Study|Discontinued Follow Up|5|||
155534076|NCT01841554|561380924|FG000|Overall Study|Study exit due to secondary intervention|6|||
155534077|NCT00312897|561380925|FG000|Overall Study|Adverse Event|1|||
155534078|NCT00312897|561380926|FG001|Overall Study|Adverse Event|0|||
155534079|NCT00312897|561380925|FG000|Overall Study|Lost to Follow-up|2|||
155534080|NCT00312897|561380926|FG001|Overall Study|Lost to Follow-up|0|||
155534081|NCT00312897|561380925|FG000|Overall Study|Physician Decision|1|||
155534082|NCT00312897|561380926|FG001|Overall Study|Physician Decision|0|||
155534083|NCT00312897|561380925|FG000|Overall Study|Withdrawal by Subject|1|||
155534084|NCT00312897|561380926|FG001|Overall Study|Withdrawal by Subject|3|||
155534085|NCT00312897|561380925|FG000|Overall Study|Pregnancy|1|||
155534086|NCT00312897|561380926|FG001|Overall Study|Pregnancy|0|||
155534087|NCT00312897|561380925|FG000|Overall Study|discontinued prior to getting treatment|0|||
155534088|NCT00312897|561380926|FG001|Overall Study|discontinued prior to getting treatment|3|||
155534089|NCT00725322|561380927|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
155534090|NCT00725322|561380928|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
155534091|NCT00725322|561380927|FG000|Washout (28 Days)|Protocol Violation|0|||
155534092|NCT00725322|561380928|FG001|Washout (28 Days)|Protocol Violation|1|||
155534093|NCT00258856|561382155|FG000|Overall Study|Lost to Follow-up|1|||
155534094|NCT00258856|561382156|FG001|Overall Study|Lost to Follow-up|0|||
155534095|NCT00258856|561382157|FG002|Overall Study|Lost to Follow-up|2|||
155534096|NCT00258856|561382158|FG003|Overall Study|Lost to Follow-up|0|||
155534097|NCT00258856|561382155|FG000|Overall Study|Non-compliance|2|||
155534098|NCT00258856|561382156|FG001|Overall Study|Non-compliance|0|||
155534099|NCT00258856|561382157|FG002|Overall Study|Non-compliance|0|||
155534100|NCT00258856|561382158|FG003|Overall Study|Non-compliance|1|||
155534101|NCT03247686|561382159|FG000|Overall Study|Withdrawal by Subject|1|||
155534102|NCT03247686|561382160|FG001|Overall Study|Withdrawal by Subject|2|||
155534103|NCT02488109|561382166|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
155534104|NCT02488109|561382167|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
155534105|NCT02488109|561382166|FG000|12-month Follow-Up|Lost to Follow-up|4|||
155534106|NCT02488109|561382167|FG001|12-month Follow-Up|Lost to Follow-up|7|||
155534107|NCT02302716|561382168|FG000|Overall Study|Adverse Event|1|||
155534108|NCT02302716|561382169|FG001|Overall Study|Adverse Event|1|||
155534109|NCT02302716|561382168|FG000|Overall Study|Death|0|||
155534110|NCT02302716|561382169|FG001|Overall Study|Death|1|||
155534111|NCT02302716|561382168|FG000|Overall Study|Lack of Efficacy|0|||
155534112|NCT02302716|561382169|FG001|Overall Study|Lack of Efficacy|1|||
155534113|NCT02302716|561382168|FG000|Overall Study|Lost to Follow-up|2|||
155534114|NCT02302716|561382169|FG001|Overall Study|Lost to Follow-up|4|||
155534115|NCT02302716|561382168|FG000|Overall Study|Physician Decision|3|||
155534116|NCT02302716|561382169|FG001|Overall Study|Physician Decision|4|||
155534117|NCT02302716|561382168|FG000|Overall Study|Withdrawal by Subject|13|||
155534118|NCT02302716|561382169|FG001|Overall Study|Withdrawal by Subject|7|||
155534119|NCT02302716|561382168|FG000|Overall Study|Protocol Violation|0|||
155534120|NCT02302716|561382169|FG001|Overall Study|Protocol Violation|1|||
155534121|NCT00557245|561382177|FG000|Overall Study|Lost to Follow-up|7|||
155534122|NCT00557245|561382178|FG001|Overall Study|Lost to Follow-up|8|||
155534123|NCT00557245|561382179|FG002|Overall Study|Lost to Follow-up|10|||
155534124|NCT00557245|561382177|FG000|Overall Study|Ineligible|5|||
155534125|NCT00557245|561382178|FG001|Overall Study|Ineligible|4|||
155534126|NCT00557245|561382179|FG002|Overall Study|Ineligible|2|||
155534127|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Subject request|8|||
155534128|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Subject request|11|||
155534129|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
155534130|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
155534131|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
155534132|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
155534133|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
155534134|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
155534135|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
155534136|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
155534137|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
155534138|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
155534139|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Death|1|||
155534140|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Death|0|||
155534141|NCT00521586|561382183|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
155534142|NCT00521586|561382184|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
155534143|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
155534144|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
155534145|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
155534146|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
155534147|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
155534148|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
155534149|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
155534150|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
155534151|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
155534152|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
155534153|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
155534154|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
155534155|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
155534156|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
155534157|NCT00521586|561382183|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
155534158|NCT00521586|561382184|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
155534159|NCT00521586|561382183|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
155534160|NCT00521586|561382184|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
155534161|NCT00521586|561382183|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
155534162|NCT00521586|561382184|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
155534163|NCT00521586|561382183|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
155534164|NCT00521586|561382184|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
155534165|NCT00828321|561382185|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
155534166|NCT00828321|561382186|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
155534167|NCT00828321|561382185|FG000|Second Intervention|Protocol Violation|0|||
155534168|NCT00828321|561382186|FG001|Second Intervention|Protocol Violation|1|||
155534169|NCT04406194|561382189|FG000|Period 1|Withdrawal by Subject|0|||
155534170|NCT04406194|561382190|FG001|Period 1|Withdrawal by Subject|1|||
155534171|NCT02888756|561382191|FG000|Analytical Treatment Interruption|Physician Decision|10|||
155534172|NCT02888756|561382192|FG001|Analytical Treatment Interruption|Physician Decision|6|||
155534173|NCT02888756|561382193|FG002|Analytical Treatment Interruption|Physician Decision|5|||
155534174|NCT02752074|561382200|FG000|Overall Study|Lost to Follow-up|1|||
155534175|NCT02752074|561382201|FG001|Overall Study|Lost to Follow-up|4|||
155534176|NCT02752074|561382200|FG000|Overall Study|Death|146|||
155534177|NCT02752074|561382201|FG001|Overall Study|Death|129|||
155534178|NCT02752074|561382200|FG000|Overall Study|Withdrawal by Subject|9|||
155534179|NCT02752074|561382201|FG001|Overall Study|Withdrawal by Subject|10|||
155534180|NCT00488774|561382202|FG000|Overall Study|Withdrawal of consent|2|||
155534181|NCT00488774|561382203|FG001|Overall Study|Withdrawal of consent|2|||
155534182|NCT00488774|561382204|FG002|Overall Study|Withdrawal of consent|2|||
155534183|NCT00488774|561382205|FG003|Overall Study|Withdrawal of consent|0|||
155534184|NCT00488774|561382202|FG000|Overall Study|Other|6|||
155534185|NCT00488774|561382203|FG001|Overall Study|Other|3|||
155534186|NCT00488774|561382204|FG002|Overall Study|Other|2|||
155534187|NCT00488774|561382205|FG003|Overall Study|Other|2|||
155534188|NCT00488774|561382202|FG000|Overall Study|Lost to Follow-up|0|||
155534189|NCT00488774|561382203|FG001|Overall Study|Lost to Follow-up|0|||
155534190|NCT00488774|561382204|FG002|Overall Study|Lost to Follow-up|1|||
155534191|NCT00488774|561382205|FG003|Overall Study|Lost to Follow-up|1|||
155534192|NCT03605342|561382206|FG000|Overall Study|Withdrawal by Subject|9|||
155534193|NCT03605342|561382207|FG001|Overall Study|Withdrawal by Subject|7|||
155534194|NCT03605342|561382206|FG000|Overall Study|Lost to Follow-up|1|||
155534195|NCT03605342|561382207|FG001|Overall Study|Lost to Follow-up|1|||
155534196|NCT01604941|561382208|FG000|Overall Study|Adverse Event|1|||
155534197|NCT01604941|561382209|FG001|Overall Study|Adverse Event|2|||
155534198|NCT01604941|561382210|FG002|Overall Study|Adverse Event|0|||
155534199|NCT01604941|561382211|FG003|Overall Study|Adverse Event|0|||
155534200|NCT01604941|561382212|FG004|Overall Study|Adverse Event|1|||
155534201|NCT01604941|561382213|FG005|Overall Study|Adverse Event|5|||
155534202|NCT01604941|561382208|FG000|Overall Study|Non-compliance|1|||
155534203|NCT01604941|561382209|FG001|Overall Study|Non-compliance|0|||
155534204|NCT01604941|561382210|FG002|Overall Study|Non-compliance|0|||
155534205|NCT01604941|561382211|FG003|Overall Study|Non-compliance|0|||
155534206|NCT01604941|561382212|FG004|Overall Study|Non-compliance|0|||
155534207|NCT01604941|561382213|FG005|Overall Study|Non-compliance|0|||
155534208|NCT01604941|561382208|FG000|Overall Study|Participant Decision|0|||
155534209|NCT01604941|561382209|FG001|Overall Study|Participant Decision|0|||
155534210|NCT01604941|561382210|FG002|Overall Study|Participant Decision|0|||
155534211|NCT01604941|561382211|FG003|Overall Study|Participant Decision|0|||
155534212|NCT01604941|561382212|FG004|Overall Study|Participant Decision|0|||
155534213|NCT01604941|561382213|FG005|Overall Study|Participant Decision|2|||
155534214|NCT01604941|561382208|FG000|Overall Study|Early Study Termination|9|||
155534215|NCT01604941|561382209|FG001|Overall Study|Early Study Termination|2|||
155534216|NCT01604941|561382210|FG002|Overall Study|Early Study Termination|3|||
155534217|NCT01604941|561382211|FG003|Overall Study|Early Study Termination|3|||
155534218|NCT01604941|561382212|FG004|Overall Study|Early Study Termination|0|||
155534219|NCT01604941|561382213|FG005|Overall Study|Early Study Termination|0|||
155534220|NCT03366792|561382214|FG000|Overall Study|Withdrawal by Subject|7|||
155534221|NCT03366792|561382214|FG000|Overall Study|Lost to Follow-up|2|||
155534222|NCT03366792|561382214|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
155534223|NCT03366792|561382214|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
155534224|NCT03497130|561382215|FG000|Overall Study|Lost to Follow-up|1|||
155534225|NCT03497130|561382216|FG001|Overall Study|Lost to Follow-up|1|||
155534226|NCT01484912|561382218|FG000|Overall Study|Withdrawal by Subject|1|||
155534227|NCT01484912|561382219|FG001|Overall Study|Withdrawal by Subject|0|||
155534228|NCT01484912|561382218|FG000|Overall Study|Physician Decision|0|||
155534229|NCT01484912|561382219|FG001|Overall Study|Physician Decision|1|||
155534230|NCT00829712|561382220|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
155534231|NCT00829712|561382221|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155534232|NCT00003470|561382223|FG000|Overall Study|Not evaluable|6|||
155534233|NCT00867360|561382226|FG000|Overall Study|Withdrawal by Subject|1|||
155534234|NCT00867360|561382227|FG001|Overall Study|Withdrawal by Subject|0|||
155534235|NCT00867360|561382226|FG000|Overall Study|Physician Decision|0|||
155534236|NCT00867360|561382227|FG001|Overall Study|Physician Decision|1|||
155534237|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
155534238|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
155487283|NCT00379639|561208176|FG004|Overall Study|Symptomatic Deterioration|1|||
155487284|NCT00379639|561208172|FG000|Overall Study|Adverse Event|0|||
155487285|NCT00379639|561208173|FG001|Overall Study|Adverse Event|0|||
155487286|NCT00379639|561208174|FG002|Overall Study|Adverse Event|1|||
155487287|NCT00379639|561208175|FG003|Overall Study|Adverse Event|0|||
155487288|NCT00379639|561208176|FG004|Overall Study|Adverse Event|1|||
155487289|NCT00379639|561208172|FG000|Overall Study|Lost to Follow-up|0|||
155487290|NCT00379639|561208173|FG001|Overall Study|Lost to Follow-up|0|||
155487291|NCT00379639|561208174|FG002|Overall Study|Lost to Follow-up|0|||
155487292|NCT00379639|561208175|FG003|Overall Study|Lost to Follow-up|1|||
155487293|NCT00379639|561208176|FG004|Overall Study|Lost to Follow-up|0|||
155487294|NCT00379639|561208172|FG000|Overall Study|Other|0|||
155487295|NCT00379639|561208173|FG001|Overall Study|Other|0|||
155487296|NCT00379639|561208174|FG002|Overall Study|Other|3|||
155487297|NCT00379639|561208175|FG003|Overall Study|Other|0|||
155487298|NCT00379639|561208176|FG004|Overall Study|Other|0|||
155487299|NCT01238861|561208179|FG000|Overall Study|Lost to Follow-up|4|||
155487300|NCT01238861|561208180|FG001|Overall Study|Lost to Follow-up|2|||
155487301|NCT01238861|561208181|FG002|Overall Study|Lost to Follow-up|3|||
155487302|NCT01238861|561208182|FG003|Overall Study|Lost to Follow-up|1|||
155487303|NCT01238861|561208183|FG004|Overall Study|Lost to Follow-up|1|||
155487304|NCT01238861|561208184|FG005|Overall Study|Lost to Follow-up|2|||
155487305|NCT01238861|561208179|FG000|Overall Study|Unplanned surgery|1|||
155487306|NCT01238861|561208180|FG001|Overall Study|Unplanned surgery|0|||
155487307|NCT01238861|561208181|FG002|Overall Study|Unplanned surgery|0|||
155487308|NCT01238861|561208182|FG003|Overall Study|Unplanned surgery|0|||
155487309|NCT01238861|561208183|FG004|Overall Study|Unplanned surgery|0|||
155487310|NCT01238861|561208184|FG005|Overall Study|Unplanned surgery|0|||
155487311|NCT01238861|561208179|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
155487312|NCT01238861|561208180|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
155487313|NCT01238861|561208181|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
155487314|NCT01238861|561208182|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
155487315|NCT01238861|561208183|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
155487316|NCT01238861|561208184|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
155487317|NCT01238861|561208179|FG000|Overall Study|Incorrect enrollment/randomization|0|||
155487318|NCT01238861|561208180|FG001|Overall Study|Incorrect enrollment/randomization|0|||
155487319|NCT01238861|561208181|FG002|Overall Study|Incorrect enrollment/randomization|1|||
155487320|NCT01238861|561208182|FG003|Overall Study|Incorrect enrollment/randomization|0|||
155487321|NCT01238861|561208183|FG004|Overall Study|Incorrect enrollment/randomization|1|||
155487322|NCT01238861|561208184|FG005|Overall Study|Incorrect enrollment/randomization|0|||
155487323|NCT01238861|561208179|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
155487324|NCT01238861|561208180|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
155487325|NCT01238861|561208181|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
155487326|NCT01238861|561208182|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
155487327|NCT01238861|561208183|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
155487328|NCT01238861|561208184|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
155487329|NCT01238861|561208179|FG000|Overall Study|Subject moved out of state/area|0|||
155487330|NCT01238861|561208180|FG001|Overall Study|Subject moved out of state/area|0|||
155487331|NCT01238861|561208181|FG002|Overall Study|Subject moved out of state/area|1|||
155487332|NCT01238861|561208182|FG003|Overall Study|Subject moved out of state/area|1|||
155487333|NCT01238861|561208183|FG004|Overall Study|Subject moved out of state/area|0|||
155487334|NCT01238861|561208184|FG005|Overall Study|Subject moved out of state/area|0|||
155487335|NCT01238861|561208179|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
155487336|NCT01238861|561208180|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
155487337|NCT01238861|561208181|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
155487338|NCT01238861|561208182|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
155487339|NCT01238861|561208183|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
155487340|NCT01238861|561208184|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
155487341|NCT01238861|561208179|FG000|Overall Study|Personal problems|0|||
155487342|NCT01238861|561208180|FG001|Overall Study|Personal problems|0|||
155534239|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
155487343|NCT01238861|561208181|FG002|Overall Study|Personal problems|0|||
155487344|NCT01238861|561208182|FG003|Overall Study|Personal problems|1|||
155534240|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
155487345|NCT01238861|561208183|FG004|Overall Study|Personal problems|0|||
155487346|NCT01238861|561208184|FG005|Overall Study|Personal problems|0|||
155487347|NCT01238861|561208179|FG000|Overall Study|Unable to continue visits|0|||
155487348|NCT01238861|561208180|FG001|Overall Study|Unable to continue visits|0|||
155487349|NCT01238861|561208181|FG002|Overall Study|Unable to continue visits|0|||
155487350|NCT01238861|561208182|FG003|Overall Study|Unable to continue visits|1|||
155487351|NCT01238861|561208183|FG004|Overall Study|Unable to continue visits|0|||
155487352|NCT01238861|561208184|FG005|Overall Study|Unable to continue visits|1|||
155487353|NCT01238861|561208179|FG000|Overall Study|Serious adverse event|0|||
155487354|NCT01238861|561208180|FG001|Overall Study|Serious adverse event|0|||
155487355|NCT01238861|561208181|FG002|Overall Study|Serious adverse event|0|||
155487356|NCT01238861|561208182|FG003|Overall Study|Serious adverse event|0|||
155487357|NCT01238861|561208183|FG004|Overall Study|Serious adverse event|0|||
155487358|NCT01238861|561208184|FG005|Overall Study|Serious adverse event|1|||
155487359|NCT01238861|561208179|FG000|Overall Study|Lack of compliance|0|||
155487360|NCT01238861|561208180|FG001|Overall Study|Lack of compliance|0|||
155487361|NCT01238861|561208181|FG002|Overall Study|Lack of compliance|0|||
155487362|NCT01238861|561208182|FG003|Overall Study|Lack of compliance|0|||
155487363|NCT01238861|561208183|FG004|Overall Study|Lack of compliance|0|||
155487364|NCT01238861|561208184|FG005|Overall Study|Lack of compliance|1|||
155487365|NCT01238861|561208179|FG000|Overall Study|Adverse Event|0|||
155487366|NCT01238861|561208180|FG001|Overall Study|Adverse Event|1|||
155487367|NCT01238861|561208181|FG002|Overall Study|Adverse Event|0|||
155487368|NCT01238861|561208182|FG003|Overall Study|Adverse Event|0|||
155487369|NCT01238861|561208183|FG004|Overall Study|Adverse Event|0|||
155487370|NCT01238861|561208184|FG005|Overall Study|Adverse Event|0|||
155487371|NCT01238861|561208179|FG000|Overall Study|Withdrawal by Subject|6|||
155487372|NCT01238861|561208180|FG001|Overall Study|Withdrawal by Subject|5|||
155487373|NCT01238861|561208181|FG002|Overall Study|Withdrawal by Subject|4|||
155487374|NCT01238861|561208182|FG003|Overall Study|Withdrawal by Subject|8|||
155487375|NCT01238861|561208183|FG004|Overall Study|Withdrawal by Subject|10|||
155487376|NCT01238861|561208184|FG005|Overall Study|Withdrawal by Subject|9|||
155487377|NCT03868410|561208185|FG000|Overall Study|Physician Decision|0|||
155487378|NCT03868410|561208186|FG001|Overall Study|Physician Decision|1|||
155487379|NCT02452320|561208190|FG000|Overall Study|Adverse Event|0|||
155487380|NCT02452320|561208191|FG001|Overall Study|Adverse Event|1|||
155487381|NCT03737812|561208192|FG000|Overall Study|Withdrawal by Subject|1|||
155487382|NCT03737812|561208193|FG001|Overall Study|Withdrawal by Subject|2|||
155487383|NCT03737812|561208194|FG002|Overall Study|Withdrawal by Subject|1|||
155487384|NCT03737812|561208192|FG000|Overall Study|Sponsor Discontinued the Study|4|||
155487385|NCT03737812|561208193|FG001|Overall Study|Sponsor Discontinued the Study|3|||
155487386|NCT03737812|561208194|FG002|Overall Study|Sponsor Discontinued the Study|2|||
155487387|NCT03737812|561208192|FG000|Overall Study|Adverse Event|0|||
155487388|NCT03737812|561208193|FG001|Overall Study|Adverse Event|1|||
155487389|NCT03737812|561208194|FG002|Overall Study|Adverse Event|0|||
155487390|NCT03737812|561208192|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
155487391|NCT03737812|561208193|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
155487392|NCT03737812|561208194|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
155487393|NCT02624713|561208195|FG000|Overall Study|Lost to Follow-up|14|||
155487394|NCT02624713|561208196|FG001|Overall Study|Lost to Follow-up|0|||
155487395|NCT06104423|561208197|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
155487396|NCT06104423|561208198|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
155487397|NCT06104423|561208199|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
155487398|NCT06104423|561208197|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
155487399|NCT06104423|561208198|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
155487400|NCT06104423|561208199|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
155487401|NCT03814499|561208200|FG000|Overall Study|Lost to Follow-up|3|||
155487402|NCT00462501|561208206|FG000|Overall Study|Not treated|3|||
155534241|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
155534242|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534243|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534244|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534245|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534246|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534247|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534248|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534249|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534250|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534251|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534252|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534253|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
155655532|NCT04091438|561832247|FG001|Washout Period (1 Day)|Other|1|||
155655533|NCT04309500|561832248|FG000|Overall Study|Lost to Follow-up|1|||
155655534|NCT04309500|561832249|FG001|Overall Study|Lost to Follow-up|0|||
155655535|NCT04309500|561832250|FG002|Overall Study|Lost to Follow-up|0|||
155655536|NCT04309500|561832251|FG003|Overall Study|Lost to Follow-up|0|||
155655537|NCT00637156|561832252|FG000|Overall Study|Withdrawal by Subject|0|||
155655538|NCT00637156|561832253|FG001|Overall Study|Withdrawal by Subject|7|||
155655539|NCT00637156|561832252|FG000|Overall Study|Death|0|||
155655540|NCT00637156|561832253|FG001|Overall Study|Death|1|||
155487403|NCT00462501|561208206|FG000|Overall Study|Adverse Event|2|||
155487404|NCT03764813|561208208|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
155487405|NCT03764813|561208209|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
155487406|NCT03764813|561208210|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
155487407|NCT03764813|561208211|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
155487408|NCT02898662|561208216|FG000|Overall Study|Adverse Event|1|||
155487409|NCT02898662|561208217|FG001|Overall Study|Adverse Event|0|||
155487410|NCT02898662|561208216|FG000|Overall Study|Loss of asthma control|23|||
155487411|NCT02898662|561208217|FG001|Overall Study|Loss of asthma control|24|||
155487412|NCT02898662|561208216|FG000|Overall Study|Withdrawal by Subject|4|||
155487413|NCT02898662|561208217|FG001|Overall Study|Withdrawal by Subject|1|||
155487414|NCT02898662|561208216|FG000|Overall Study|Technical issue|0|||
155487415|NCT02898662|561208217|FG001|Overall Study|Technical issue|1|||
155487416|NCT02898662|561208216|FG000|Overall Study|Randomized in error|0|||
155487417|NCT02898662|561208217|FG001|Overall Study|Randomized in error|1|||
155487418|NCT02898662|561208216|FG000|Overall Study|Subject decision|1|||
155487419|NCT02898662|561208217|FG001|Overall Study|Subject decision|0|||
155487420|NCT02898662|561208216|FG000|Overall Study|Other|0|||
155487421|NCT02898662|561208217|FG001|Overall Study|Other|1|||
155487422|NCT00399542|561208218|FG000|Overall Study|Adverse Event|18|||
155487423|NCT00399542|561208219|FG001|Overall Study|Adverse Event|15|||
155487424|NCT00399542|561208218|FG000|Overall Study|Protocol Violation|13|||
155487425|NCT00399542|561208219|FG001|Overall Study|Protocol Violation|3|||
155487426|NCT00399542|561208218|FG000|Overall Study|Withdrawal by Subject|28|||
155487427|NCT00399542|561208219|FG001|Overall Study|Withdrawal by Subject|10|||
155487428|NCT00399542|561208218|FG000|Overall Study|Lack of Efficacy|18|||
155487429|NCT00399542|561208219|FG001|Overall Study|Lack of Efficacy|8|||
155487430|NCT00399542|561208218|FG000|Overall Study|Lost to Follow-up|6|||
155487431|NCT00399542|561208219|FG001|Overall Study|Lost to Follow-up|6|||
155487432|NCT00399542|561208218|FG000|Overall Study|Other|1|||
155487433|NCT00399542|561208219|FG001|Overall Study|Other|0|||
155487434|NCT00399542|561208218|FG000|Overall Study|Physician Decision|0|||
155487435|NCT00399542|561208219|FG001|Overall Study|Physician Decision|1|||
155487436|NCT04652245|561208220|FG000|Wash-Out Period|Adverse Event|0|||
155487437|NCT04652245|561208221|FG001|Wash-Out Period|Adverse Event|2|||
155487438|NCT04652245|561208220|FG000|Wash-Out Period|Withdrawal by Subject|0|||
155487439|NCT04652245|561208221|FG001|Wash-Out Period|Withdrawal by Subject|2|||
155487440|NCT00851721|561208226|FG000|Overall Study|planned surgery|1|||
155487441|NCT00851721|561208227|FG001|Overall Study|planned surgery|0|||
155487442|NCT00851721|561208226|FG000|Overall Study|Death|1|||
155487443|NCT00851721|561208227|FG001|Overall Study|Death|0|||
155487444|NCT00851721|561208226|FG000|Overall Study|Adverse Event|0|||
155487445|NCT00851721|561208227|FG001|Overall Study|Adverse Event|1|||
155487446|NCT04047472|561208228|FG000|Overall Study|Adverse Event|3|||
155487447|NCT04047472|561208229|FG001|Overall Study|Adverse Event|3|||
155487448|NCT04047472|561208228|FG000|Overall Study|Death|0|||
155487449|NCT04047472|561208229|FG001|Overall Study|Death|1|||
155487450|NCT04047472|561208228|FG000|Overall Study|Lost to Follow-up|1|||
155487451|NCT04047472|561208229|FG001|Overall Study|Lost to Follow-up|0|||
155487452|NCT04047472|561208228|FG000|Overall Study|Physician Decision|1|||
155534254|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534255|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534256|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534257|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534258|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534259|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534260|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534261|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534262|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
155534263|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534264|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
155534265|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534266|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534267|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534268|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534269|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534270|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534271|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534272|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534273|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534274|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534275|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534276|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534277|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534278|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534279|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534280|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534281|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534282|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534283|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534284|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534285|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534286|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534287|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534288|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155534289|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534290|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
155534291|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534292|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534293|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534294|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534295|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534296|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534297|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534298|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534299|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534300|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534301|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534302|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534303|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534304|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534305|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534306|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534307|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534308|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534309|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534310|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534311|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534312|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534313|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534314|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155534315|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
155534316|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534317|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
155534318|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
155534319|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
155534320|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534321|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534322|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534323|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534324|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534325|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534326|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534327|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534328|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534329|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534330|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534331|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534332|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534333|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534334|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534335|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534336|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534337|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534338|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534339|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534340|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155534341|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
155534342|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
155534343|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
155534344|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
155534345|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
155534346|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534347|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534348|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534349|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534350|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534351|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534352|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534353|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534354|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534355|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534356|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534357|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534358|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534359|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534360|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534361|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534362|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534363|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534364|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534365|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534366|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155534367|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|moved|0|||
155534368|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|moved|1|||
155534369|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|moved|1|||
155534370|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|moved|0|||
155534371|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|moved|0|||
155534372|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|moved|0|||
155534373|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|moved|0|||
155534374|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|moved|0|||
155534375|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|moved|0|||
155534376|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|moved|0|||
155534377|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|moved|0|||
155534378|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|moved|0|||
155534379|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|moved|0|||
155534380|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|moved|0|||
155534381|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|moved|0|||
155534382|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|moved|0|||
155534383|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|moved|0|||
155534384|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|moved|0|||
155534385|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|moved|0|||
155534386|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|moved|0|||
155534387|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|moved|0|||
155534388|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|moved|0|||
155534389|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|moved|0|||
155534390|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|moved|0|||
155534391|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|moved|0|||
155534392|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|moved|0|||
155534393|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534394|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534395|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534396|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
155534397|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534398|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534399|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534400|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534401|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534402|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534403|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534404|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534405|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534406|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534407|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534408|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534409|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534410|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534411|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534412|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534413|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534414|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534415|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534416|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534417|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534418|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155534419|NCT00112437|561382230|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534420|NCT00112437|561382231|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534421|NCT00112437|561382232|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534422|NCT00112437|561382233|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534423|NCT00112437|561382234|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
155534424|NCT00112437|561382235|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534425|NCT00112437|561382236|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534426|NCT00112437|561382237|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534427|NCT00112437|561382238|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155655541|NCT00637156|561832252|FG000|Overall Study|Lost to Follow-up|10|||
155534428|NCT00112437|561382239|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534429|NCT00112437|561382240|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534430|NCT00112437|561382241|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534431|NCT00112437|561382242|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534432|NCT00112437|561382243|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534433|NCT00112437|561382244|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534434|NCT00112437|561382245|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534435|NCT00112437|561382246|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534436|NCT00112437|561382247|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534437|NCT00112437|561382248|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534438|NCT00112437|561382249|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534439|NCT00112437|561382250|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534440|NCT00112437|561382251|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534441|NCT00112437|561382252|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534442|NCT00112437|561382253|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534443|NCT00112437|561382254|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534444|NCT00112437|561382255|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155534445|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
155534446|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
155534447|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
155534448|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
155534449|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
155534450|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
155534451|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
155534452|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
155534453|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
155534454|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
155534455|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
155534456|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
155534457|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
155534458|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
155534459|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
155534460|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
155534461|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
155534462|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
155534463|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
155534464|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
155534465|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
155534466|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
155534467|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
155534468|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
155534469|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
155534470|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
155534471|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534472|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534473|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534474|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534475|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534476|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
155534477|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
155534478|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534479|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534480|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
155534481|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534482|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534483|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534484|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534485|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534486|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534487|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534488|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534489|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534490|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534491|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534492|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534493|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534494|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534495|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534496|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155534497|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534498|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534499|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534500|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534501|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534502|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534503|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534504|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534505|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
155534506|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534507|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534508|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534509|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534510|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534511|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534512|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534513|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534514|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534515|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534516|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534517|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534518|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534519|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534520|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534521|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534522|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155534523|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534524|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534525|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534526|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534527|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534528|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534529|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534530|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534531|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
155534532|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534533|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534534|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534535|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534536|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534537|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534538|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534539|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534540|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534541|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534542|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534543|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534544|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534545|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534546|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534547|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534548|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
155534549|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534550|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534551|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534552|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534553|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534554|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
155534555|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
155534556|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
155534557|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
155534558|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
155534559|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534560|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534561|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534562|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534563|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155655542|NCT00637156|561832253|FG001|Overall Study|Lost to Follow-up|16|||
155655543|NCT00461812|561832254|FG000|Overall Study|study terminated|10|||
155655544|NCT02679274|561832255|FG000|Overall Study|Withdrawal by Subject|1|||
155534564|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534565|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534566|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534567|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534568|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534569|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534570|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534571|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534572|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534573|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534574|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155534575|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534576|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534577|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534578|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534579|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534580|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534581|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534582|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534583|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534584|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
155534585|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534586|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534587|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534588|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534589|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534590|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534591|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534592|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534593|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534594|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534595|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534596|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534597|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534598|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534599|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534600|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155534601|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534602|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534603|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534604|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534605|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534606|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534607|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534608|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534609|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534610|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
155534611|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534612|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534613|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534614|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534615|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534616|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534617|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
155655545|NCT02679274|561832256|FG001|Overall Study|Withdrawal by Subject|0|||
155655546|NCT01308788|561832257|FG000|2-year Treatment|medication change by treating physician|4|||
155655547|NCT01308788|561832258|FG001|2-year Treatment|medication change by treating physician|11|||
155655548|NCT00322218|561832259|FG000|Overall Study|Death|3|||
155655549|NCT00322218|561832260|FG001|Overall Study|Death|6|||
155655550|NCT04976855|561832267|FG000|Part I|Withdrawal by Subject|0|||
155655551|NCT04976855|561832268|FG001|Part I|Withdrawal by Subject|1|||
155534618|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534619|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534620|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534621|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534622|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534623|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534624|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534625|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534626|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
155534627|NCT00112437|561382230|FG000|Year 2 (12-Month Extension)|Moved|0|||
155534628|NCT00112437|561382231|FG001|Year 2 (12-Month Extension)|Moved|0|||
155534629|NCT00112437|561382232|FG002|Year 2 (12-Month Extension)|Moved|0|||
155534630|NCT00112437|561382233|FG003|Year 2 (12-Month Extension)|Moved|0|||
155534631|NCT00112437|561382234|FG004|Year 2 (12-Month Extension)|Moved|0|||
155534632|NCT00112437|561382235|FG005|Year 2 (12-Month Extension)|Moved|0|||
155534633|NCT00112437|561382236|FG006|Year 2 (12-Month Extension)|Moved|0|||
155534634|NCT00112437|561382237|FG007|Year 2 (12-Month Extension)|Moved|0|||
155534635|NCT00112437|561382238|FG008|Year 2 (12-Month Extension)|Moved|0|||
155534636|NCT00112437|561382239|FG009|Year 2 (12-Month Extension)|Moved|1|||
155534637|NCT00112437|561382240|FG010|Year 2 (12-Month Extension)|Moved|0|||
155534638|NCT00112437|561382241|FG011|Year 2 (12-Month Extension)|Moved|0|||
155534639|NCT00112437|561382242|FG012|Year 2 (12-Month Extension)|Moved|0|||
155534640|NCT00112437|561382243|FG013|Year 2 (12-Month Extension)|Moved|0|||
155534641|NCT00112437|561382244|FG014|Year 2 (12-Month Extension)|Moved|0|||
155534642|NCT00112437|561382245|FG015|Year 2 (12-Month Extension)|Moved|0|||
155534643|NCT00112437|561382246|FG016|Year 2 (12-Month Extension)|Moved|0|||
155534644|NCT00112437|561382247|FG017|Year 2 (12-Month Extension)|Moved|0|||
155534645|NCT00112437|561382248|FG018|Year 2 (12-Month Extension)|Moved|0|||
155534646|NCT00112437|561382249|FG019|Year 2 (12-Month Extension)|Moved|0|||
155534647|NCT00112437|561382250|FG020|Year 2 (12-Month Extension)|Moved|0|||
155534648|NCT00112437|561382251|FG021|Year 2 (12-Month Extension)|Moved|0|||
155534649|NCT00112437|561382252|FG022|Year 2 (12-Month Extension)|Moved|0|||
155534650|NCT00112437|561382253|FG023|Year 2 (12-Month Extension)|Moved|0|||
155534651|NCT00112437|561382254|FG024|Year 2 (12-Month Extension)|Moved|0|||
155534652|NCT00112437|561382255|FG025|Year 2 (12-Month Extension)|Moved|0|||
155534653|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
155534654|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
155534655|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
155534656|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
155534657|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
155534658|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
155534659|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
155534660|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
155534661|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
155534662|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
155534663|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
155534664|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
155534665|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
155534666|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
155534667|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
155534668|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
155534669|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
155534670|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
155534671|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
155534672|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
155534673|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
155534674|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
155534675|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
155534676|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
155534677|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
155534678|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
155534679|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534680|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534681|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155655552|NCT04976855|561832269|FG002|Part I|Withdrawal by Subject|0|||
155534682|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534683|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534684|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534685|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534686|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534687|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534688|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155655553|NCT04976855|561832270|FG003|Part I|Withdrawal by Subject|0|||
155487453|NCT04047472|561208229|FG001|Overall Study|Physician Decision|2|||
155534689|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534690|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
155534691|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534692|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
155534693|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534694|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
155534695|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534696|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534697|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
155534698|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155487454|NCT04047472|561208228|FG000|Overall Study|Protocol Violation|1|||
155487455|NCT04047472|561208229|FG001|Overall Study|Protocol Violation|0|||
155487456|NCT04047472|561208228|FG000|Overall Study|Withdrawal by Subject|10|||
155487457|NCT04047472|561208229|FG001|Overall Study|Withdrawal by Subject|10|||
155487458|NCT01333501|561208230|FG000|Overall Study|Adverse Event|3|||
155487459|NCT01333501|561208231|FG001|Overall Study|Adverse Event|1|||
155487460|NCT01333501|561208230|FG000|Overall Study|Abnormal laboratory value|2|||
155487461|NCT01333501|561208231|FG001|Overall Study|Abnormal laboratory value|1|||
155487462|NCT01333501|561208230|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155487463|NCT01333501|561208231|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
155487464|NCT01333501|561208230|FG000|Overall Study|Withdrawn consent|3|||
155487465|NCT01333501|561208231|FG001|Overall Study|Withdrawn consent|12|||
155487466|NCT01016912|561208232|FG000|End of Treatment Period|Lack of Efficacy|0|||
155487467|NCT01016912|561208233|FG001|End of Treatment Period|Lack of Efficacy|1|||
155487468|NCT01016912|561208234|FG002|End of Treatment Period|Lack of Efficacy|0|||
155487469|NCT01016912|561208235|FG003|End of Treatment Period|Lack of Efficacy|4|||
155487470|NCT01016912|561208236|FG004|End of Treatment Period|Lack of Efficacy|4|||
155487471|NCT01016912|561208232|FG000|End of Treatment Period|Adverse Event|0|||
155487472|NCT01016912|561208233|FG001|End of Treatment Period|Adverse Event|1|||
155487473|NCT01016912|561208234|FG002|End of Treatment Period|Adverse Event|1|||
155487474|NCT01016912|561208235|FG003|End of Treatment Period|Adverse Event|0|||
155487475|NCT01016912|561208236|FG004|End of Treatment Period|Adverse Event|0|||
155487476|NCT01016912|561208232|FG000|End of Treatment Period|Completed double-blind period only|0|||
155487477|NCT01016912|561208233|FG001|End of Treatment Period|Completed double-blind period only|1|||
155487478|NCT01016912|561208234|FG002|End of Treatment Period|Completed double-blind period only|0|||
155487479|NCT01016912|561208235|FG003|End of Treatment Period|Completed double-blind period only|0|||
155487480|NCT01016912|561208236|FG004|End of Treatment Period|Completed double-blind period only|0|||
155487481|NCT01016912|561208232|FG000|Follow-up Period|Other reason|0|||
155487482|NCT01016912|561208233|FG001|Follow-up Period|Other reason|0|||
155487483|NCT01016912|561208234|FG002|Follow-up Period|Other reason|1|||
155487484|NCT01016912|561208235|FG003|Follow-up Period|Other reason|1|||
155487485|NCT01016912|561208236|FG004|Follow-up Period|Other reason|0|||
155487486|NCT00955682|561208237|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
155487487|NCT00955682|561208238|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
155487488|NCT02924129|561208245|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
155487489|NCT02924129|561208246|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
155487490|NCT02924129|561208245|FG000|Overall Study|Withdrawal by Subject|2|||
155487491|NCT02924129|561208246|FG001|Overall Study|Withdrawal by Subject|2|||
155487492|NCT02924129|561208245|FG000|Overall Study|Physician Decision|1|||
155487493|NCT02924129|561208246|FG001|Overall Study|Physician Decision|0|||
155487494|NCT02924129|561208245|FG000|Overall Study|Missed Visit|0|||
155487495|NCT02924129|561208246|FG001|Overall Study|Missed Visit|1|||
155487496|NCT01348828|561208248|FG000|Overall Study|Death|20|||
155487497|NCT01348828|561208248|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
155487498|NCT01348828|561208248|FG000|Overall Study|Conversion|2|||
155487499|NCT01348828|561208248|FG000|Overall Study|missed visit|1|||
155487500|NCT02442284|561208249|FG000|Overall Study|Adverse Event|1|||
155487501|NCT02442284|561208249|FG000|Overall Study|Withdrew Consent|2|||
155487502|NCT02442284|561208249|FG000|Overall Study|Lost to Follow-up|3|||
155487503|NCT02442284|561208249|FG000|Overall Study|Other|1|||
155487504|NCT01610752|561208250|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
155487505|NCT01610752|561208251|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
155487506|NCT01610752|561208252|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
155487507|NCT00283062|561208253|FG000|Overall Study|Did not receive any study medication|5|||
155487508|NCT00283062|561208254|FG001|Overall Study|Did not receive any study medication|4|||
155487509|NCT00283062|561208255|FG002|Overall Study|Did not receive any study medication|36|||
155487510|NCT00283062|561208256|FG003|Overall Study|Did not receive any study medication|45|||
155487511|NCT00283062|561208253|FG000|Overall Study|Adverse Event|2|||
155487512|NCT00283062|561208254|FG001|Overall Study|Adverse Event|0|||
155487513|NCT00283062|561208255|FG002|Overall Study|Adverse Event|1|||
155487514|NCT00283062|561208256|FG003|Overall Study|Adverse Event|0|||
155534699|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534700|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534701|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534702|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534703|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534704|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155534705|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534706|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534707|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534708|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534709|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534710|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534711|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534712|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534713|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534714|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534715|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534716|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534717|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534718|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534719|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534720|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
155534721|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534722|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534723|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534724|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534725|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534726|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534727|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534728|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534729|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534730|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155534731|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534732|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534733|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534734|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534735|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534736|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534737|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534738|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534739|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534740|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534741|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534742|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534743|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534744|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534745|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534746|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
155534747|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534748|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534749|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534750|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534751|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534752|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534753|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534754|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534755|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534756|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
155534757|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534758|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534759|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155655554|NCT04976855|561832271|FG004|Part I|Withdrawal by Subject|0|||
155655555|NCT04976855|561832272|FG005|Part I|Withdrawal by Subject|0|||
155487515|NCT00283062|561208253|FG000|Overall Study|Lost to Follow-up|1|||
155487516|NCT00283062|561208254|FG001|Overall Study|Lost to Follow-up|0|||
155487517|NCT00283062|561208255|FG002|Overall Study|Lost to Follow-up|1|||
155487518|NCT00283062|561208256|FG003|Overall Study|Lost to Follow-up|0|||
155487519|NCT00283062|561208253|FG000|Overall Study|Progressive disease|0|||
155487520|NCT00283062|561208254|FG001|Overall Study|Progressive disease|0|||
155487521|NCT00283062|561208255|FG002|Overall Study|Progressive disease|1|||
155487522|NCT00283062|561208256|FG003|Overall Study|Progressive disease|0|||
155487523|NCT00283062|561208253|FG000|Overall Study|Participant did not wish to continue|3|||
155487524|NCT00283062|561208254|FG001|Overall Study|Participant did not wish to continue|2|||
155487525|NCT00283062|561208255|FG002|Overall Study|Participant did not wish to continue|1|||
155487526|NCT00283062|561208256|FG003|Overall Study|Participant did not wish to continue|0|||
155487527|NCT00283062|561208253|FG000|Overall Study|Undefined|0|||
155487528|NCT00283062|561208254|FG001|Overall Study|Undefined|1|||
155487529|NCT00283062|561208255|FG002|Overall Study|Undefined|1|||
155487530|NCT00283062|561208256|FG003|Overall Study|Undefined|4|||
155487531|NCT00283062|561208253|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
155487532|NCT00283062|561208254|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
155487533|NCT00283062|561208255|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
155487534|NCT00283062|561208256|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
155487535|NCT01482598|561208257|FG000|Overall Study|Death|7|||
155487536|NCT01482598|561208258|FG001|Overall Study|Death|10|||
155487537|NCT01482598|561208257|FG000|Overall Study|Physician Decision|0|||
155487538|NCT01482598|561208258|FG001|Overall Study|Physician Decision|3|||
155487539|NCT01482598|561208257|FG000|Overall Study|Withdrawal by Subject|4|||
155487540|NCT01482598|561208258|FG001|Overall Study|Withdrawal by Subject|5|||
155487541|NCT01482598|561208257|FG000|Overall Study|Lost to Follow-up|5|||
155487542|NCT01482598|561208258|FG001|Overall Study|Lost to Follow-up|4|||
155487543|NCT02694562|561208259|FG000|Overall Study|Death|8|||
155487544|NCT02694562|561208259|FG000|Overall Study|Protocol Violation|4|||
155487545|NCT02694562|561208259|FG000|Overall Study|Lost to Follow-up|3|||
155487546|NCT02694562|561208259|FG000|Overall Study|Screen Failure|2|||
155487547|NCT02694562|561208259|FG000|Overall Study|Physician Decision|1|||
155487548|NCT00827112|561208260|FG000|Overall Study|Adverse Event|2|||
155487549|NCT00827112|561208261|FG001|Overall Study|Adverse Event|0|||
155487550|NCT00827112|561208260|FG000|Overall Study|Lack of Efficacy|2|||
155487551|NCT00827112|561208261|FG001|Overall Study|Lack of Efficacy|0|||
155487552|NCT00827112|561208260|FG000|Overall Study|Lost to Follow-up|3|||
155487553|NCT00827112|561208261|FG001|Overall Study|Lost to Follow-up|2|||
155487554|NCT00827112|561208260|FG000|Overall Study|Pregnancy|0|||
155487555|NCT00827112|561208261|FG001|Overall Study|Pregnancy|1|||
155487556|NCT00827112|561208260|FG000|Overall Study|Protocol Violation|0|||
155487557|NCT00827112|561208261|FG001|Overall Study|Protocol Violation|2|||
155487558|NCT00827112|561208260|FG000|Overall Study|Withdrawal by Subject|2|||
155487559|NCT00827112|561208261|FG001|Overall Study|Withdrawal by Subject|1|||
155487560|NCT00827112|561208260|FG000|Overall Study|Randomized but not treated|5|||
155487561|NCT00827112|561208261|FG001|Overall Study|Randomized but not treated|3|||
155487562|NCT00827112|561208260|FG000|Overall Study|Other|1|||
155487563|NCT00827112|561208261|FG001|Overall Study|Other|3|||
155487564|NCT01521494|561208264|FG000|Overall Study|Adverse Event|1|||
155487565|NCT01521494|561208265|FG001|Overall Study|Adverse Event|2|||
155487566|NCT01521494|561208266|FG002|Overall Study|Adverse Event|9|||
155487567|NCT01521494|561208267|FG003|Overall Study|Adverse Event|6|||
155487568|NCT01521494|561208268|FG004|Overall Study|Adverse Event|2|||
155487569|NCT01521494|561208264|FG000|Overall Study|Lack of Efficacy|0|||
155487570|NCT01521494|561208265|FG001|Overall Study|Lack of Efficacy|0|||
155487571|NCT01521494|561208266|FG002|Overall Study|Lack of Efficacy|0|||
155487572|NCT01521494|561208267|FG003|Overall Study|Lack of Efficacy|0|||
155487573|NCT01521494|561208268|FG004|Overall Study|Lack of Efficacy|2|||
155487574|NCT01521494|561208264|FG000|Overall Study|Withdrawal by Subject|1|||
155487575|NCT01521494|561208265|FG001|Overall Study|Withdrawal by Subject|1|||
155487576|NCT01521494|561208266|FG002|Overall Study|Withdrawal by Subject|0|||
155487577|NCT01521494|561208267|FG003|Overall Study|Withdrawal by Subject|2|||
155487578|NCT01521494|561208268|FG004|Overall Study|Withdrawal by Subject|0|||
155487579|NCT01521494|561208264|FG000|Overall Study|Decrease in serum phosphate|0|||
155487580|NCT01521494|561208265|FG001|Overall Study|Decrease in serum phosphate|2|||
155487581|NCT01521494|561208266|FG002|Overall Study|Decrease in serum phosphate|3|||
155534760|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534761|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534762|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534763|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534764|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534765|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534766|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534767|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534768|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
155534769|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534770|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534771|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
155534772|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534773|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534774|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534775|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534776|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534777|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534778|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534779|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534780|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534781|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534782|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155534783|NCT00112437|561382230|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534784|NCT00112437|561382231|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534785|NCT00112437|561382232|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534786|NCT00112437|561382233|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534787|NCT00112437|561382234|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534788|NCT00112437|561382235|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534789|NCT00112437|561382236|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534790|NCT00112437|561382237|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534791|NCT00112437|561382238|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534792|NCT00112437|561382239|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534793|NCT00112437|561382240|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
155534794|NCT00112437|561382241|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
155534795|NCT00112437|561382242|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534796|NCT00112437|561382243|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534797|NCT00112437|561382244|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534798|NCT00112437|561382245|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534799|NCT00112437|561382246|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534800|NCT00112437|561382247|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534801|NCT00112437|561382248|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534802|NCT00112437|561382249|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534803|NCT00112437|561382250|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534804|NCT00112437|561382251|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534805|NCT00112437|561382252|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534806|NCT00112437|561382253|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534807|NCT00112437|561382254|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534808|NCT00112437|561382255|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155534809|NCT00112437|561382230|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534810|NCT00112437|561382231|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534811|NCT00112437|561382232|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534812|NCT00112437|561382233|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534813|NCT00112437|561382234|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534814|NCT00112437|561382235|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534815|NCT00112437|561382236|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534816|NCT00112437|561382237|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534817|NCT00112437|561382238|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534818|NCT00112437|561382239|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534819|NCT00112437|561382240|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155655556|NCT04976855|561832273|FG006|Part I|Withdrawal by Subject|0|||
155534820|NCT00112437|561382241|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534821|NCT00112437|561382242|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534822|NCT00112437|561382243|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534823|NCT00112437|561382244|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534824|NCT00112437|561382245|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534825|NCT00112437|561382246|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534826|NCT00112437|561382247|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534827|NCT00112437|561382248|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534828|NCT00112437|561382249|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534829|NCT00112437|561382250|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
155534830|NCT00112437|561382251|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
155534831|NCT00112437|561382252|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534832|NCT00112437|561382253|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534833|NCT00112437|561382254|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534834|NCT00112437|561382255|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
155534835|NCT00112437|561382230|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534836|NCT00112437|561382231|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534837|NCT00112437|561382232|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534838|NCT00112437|561382233|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534839|NCT00112437|561382234|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534840|NCT00112437|561382235|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534841|NCT00112437|561382236|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534842|NCT00112437|561382237|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534843|NCT00112437|561382238|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534844|NCT00112437|561382239|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534845|NCT00112437|561382240|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534846|NCT00112437|561382241|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534847|NCT00112437|561382242|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534848|NCT00112437|561382243|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534849|NCT00112437|561382244|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534850|NCT00112437|561382245|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534851|NCT00112437|561382246|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534852|NCT00112437|561382247|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534853|NCT00112437|561382248|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534854|NCT00112437|561382249|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534855|NCT00112437|561382250|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
155534856|NCT00112437|561382251|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534857|NCT00112437|561382252|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534858|NCT00112437|561382253|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534859|NCT00112437|561382254|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534860|NCT00112437|561382255|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155534861|NCT00112437|561382230|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534862|NCT00112437|561382231|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534863|NCT00112437|561382232|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534864|NCT00112437|561382233|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534865|NCT00112437|561382234|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534866|NCT00112437|561382235|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534867|NCT00112437|561382236|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534868|NCT00112437|561382237|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534869|NCT00112437|561382238|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534870|NCT00112437|561382239|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534871|NCT00112437|561382240|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534872|NCT00112437|561382241|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534873|NCT00112437|561382242|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534874|NCT00112437|561382243|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534875|NCT00112437|561382244|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534876|NCT00112437|561382245|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534877|NCT00112437|561382246|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534878|NCT00112437|561382247|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534879|NCT00112437|561382248|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534880|NCT00112437|561382249|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534881|NCT00112437|561382250|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534882|NCT00112437|561382251|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
155534883|NCT00112437|561382252|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534884|NCT00112437|561382253|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534885|NCT00112437|561382254|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534886|NCT00112437|561382255|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155534887|NCT00112437|561382230|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534888|NCT00112437|561382231|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534889|NCT00112437|561382232|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534890|NCT00112437|561382233|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534891|NCT00112437|561382234|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534892|NCT00112437|561382235|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534893|NCT00112437|561382236|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534894|NCT00112437|561382237|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534895|NCT00112437|561382238|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534896|NCT00112437|561382239|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534897|NCT00112437|561382240|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534898|NCT00112437|561382241|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534899|NCT00112437|561382242|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534900|NCT00112437|561382243|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534901|NCT00112437|561382244|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534902|NCT00112437|561382245|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534903|NCT00112437|561382246|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534904|NCT00112437|561382247|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534905|NCT00112437|561382248|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534906|NCT00112437|561382249|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534907|NCT00112437|561382250|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534908|NCT00112437|561382251|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
155534909|NCT00112437|561382252|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534910|NCT00112437|561382253|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534911|NCT00112437|561382254|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534912|NCT00112437|561382255|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
155534913|NCT00112437|561382230|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534914|NCT00112437|561382231|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534915|NCT00112437|561382232|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534916|NCT00112437|561382233|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534917|NCT00112437|561382234|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534918|NCT00112437|561382235|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534919|NCT00112437|561382236|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534920|NCT00112437|561382237|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534921|NCT00112437|561382238|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534922|NCT00112437|561382239|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534923|NCT00112437|561382240|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534924|NCT00112437|561382241|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534925|NCT00112437|561382242|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534926|NCT00112437|561382243|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534927|NCT00112437|561382244|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534928|NCT00112437|561382245|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534929|NCT00112437|561382246|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534930|NCT00112437|561382247|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534931|NCT00112437|561382248|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534932|NCT00112437|561382249|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534933|NCT00112437|561382250|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
155534934|NCT00112437|561382251|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
155534935|NCT00112437|561382252|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534936|NCT00112437|561382253|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534937|NCT00112437|561382254|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155534938|NCT00112437|561382255|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155655557|NCT04976855|561832267|FG000|Part II|Adverse Event|0|||
155534939|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534940|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534941|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534942|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534943|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534944|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534945|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534946|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534947|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534948|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534949|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534950|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534951|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534952|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534953|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534954|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534955|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534956|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534957|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534958|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534959|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534960|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534961|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
155534962|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
155534963|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
155534964|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
155534965|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Death|0|||
155534966|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Death|0|||
155534967|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Death|0|||
155534968|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Death|0|||
155534969|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Death|0|||
155534970|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Death|0|||
155534971|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Death|0|||
155534972|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Death|0|||
155534973|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Death|0|||
155534974|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Death|0|||
155534975|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Death|0|||
155534976|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Death|0|||
155534977|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Death|0|||
155534978|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Death|0|||
155534979|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Death|0|||
155534980|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Death|0|||
155534981|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Death|0|||
155534982|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Death|0|||
155534983|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Death|0|||
155534984|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Death|0|||
155534985|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Death|0|||
155534986|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Death|0|||
155534987|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Death|0|||
155534988|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Death|2|||
155534989|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Death|0|||
155534990|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Death|0|||
155534991|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534992|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155655558|NCT04976855|561832268|FG001|Part II|Adverse Event|0|||
155655559|NCT04976855|561832269|FG002|Part II|Adverse Event|0|||
155655560|NCT04976855|561832270|FG003|Part II|Adverse Event|1|||
155655561|NCT04976855|561832271|FG004|Part II|Adverse Event|0|||
155655562|NCT04976855|561832272|FG005|Part II|Adverse Event|0|||
155655563|NCT04976855|561832273|FG006|Part II|Adverse Event|0|||
155655564|NCT04976855|561832267|FG000|Part II|Withdrawal by Subject|0|||
155655565|NCT04976855|561832268|FG001|Part II|Withdrawal by Subject|0|||
155655566|NCT04976855|561832269|FG002|Part II|Withdrawal by Subject|0|||
155655567|NCT04976855|561832270|FG003|Part II|Withdrawal by Subject|0|||
155534993|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534994|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534995|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534996|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534997|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155534998|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155655568|NCT04976855|561832271|FG004|Part II|Withdrawal by Subject|1|||
155655569|NCT04976855|561832272|FG005|Part II|Withdrawal by Subject|0|||
155655570|NCT04976855|561832273|FG006|Part II|Withdrawal by Subject|0|||
155655571|NCT04976855|561832267|FG000|Part II|Lost to Follow-up|0|||
155534999|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535000|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535001|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535002|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535003|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535004|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535005|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535006|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535007|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535008|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535009|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535010|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535011|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535012|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535013|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535014|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535015|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155535016|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
155535017|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Other|0|||
155535018|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Other|0|||
155535019|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Other|0|||
155535020|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Other|0|||
155535021|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Other|0|||
155535022|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Other|0|||
155535023|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Other|0|||
155535024|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Other|0|||
155535025|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Other|0|||
155535026|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Other|0|||
155535027|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Other|0|||
155535028|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Other|0|||
155535029|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Other|0|||
155535030|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Other|0|||
155535031|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Other|0|||
155535032|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Other|0|||
155535033|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Other|0|||
155535034|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Other|0|||
155535035|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Other|0|||
155535036|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Other|0|||
155535037|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Other|0|||
155535038|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Other|0|||
155535039|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Other|0|||
155535040|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Other|0|||
155535041|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Other|1|||
155535042|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Other|0|||
155535043|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535044|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535045|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535046|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535047|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535048|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535049|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535050|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535051|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535052|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535053|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535054|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535055|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535056|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535057|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535058|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535059|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535060|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535061|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535062|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535063|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535064|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535065|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535066|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
155535067|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535068|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155535069|NCT00112437|561382230|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535070|NCT00112437|561382231|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535071|NCT00112437|561382232|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535072|NCT00112437|561382233|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535073|NCT00112437|561382234|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535074|NCT00112437|561382235|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535075|NCT00112437|561382236|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535076|NCT00112437|561382237|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535077|NCT00112437|561382238|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535078|NCT00112437|561382239|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535079|NCT00112437|561382240|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535080|NCT00112437|561382241|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535081|NCT00112437|561382242|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535082|NCT00112437|561382243|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535083|NCT00112437|561382244|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535084|NCT00112437|561382245|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535085|NCT00112437|561382246|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535086|NCT00112437|561382247|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535087|NCT00112437|561382248|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535088|NCT00112437|561382249|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535089|NCT00112437|561382250|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535090|NCT00112437|561382251|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535091|NCT00112437|561382252|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
155535092|NCT00112437|561382253|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
155535093|NCT00112437|561382254|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
155535094|NCT00112437|561382255|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
155535095|NCT03218787|561382261|FG000|Overall Study|Lost to Follow-up|12|||
155535096|NCT03218787|561382261|FG000|Overall Study|Withdrawal by Subject|72|||
155535097|NCT03218787|561382261|FG000|Overall Study|Physician Decision|11|||
155535098|NCT03218787|561382261|FG000|Overall Study|Death|111|||
155535099|NCT00436163|561382262|FG000|Overall Study|Lost to Follow-up|2|||
155535100|NCT00436163|561382262|FG000|Overall Study|Adverse Event|1|||
155535101|NCT03250117|561382264|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
155535102|NCT03250117|561382265|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
155535103|NCT03250117|561382266|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
155535104|NCT03250117|561382267|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
155535105|NCT04063878|561382268|FG000|Overall Study|Withdrawal by Subject|2|||
155535106|NCT04063878|561382268|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
155535107|NCT02751827|561382269|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
155535108|NCT02751827|561382270|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
155535109|NCT02751827|561382271|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
155535110|NCT01229150|561382274|FG000|Overall Study|Toxicity|2|||
155535111|NCT01229150|561382275|FG001|Overall Study|Toxicity|2|||
155535112|NCT01229150|561382276|FG002|Overall Study|Toxicity|0|||
155535113|NCT01229150|561382277|FG003|Overall Study|Toxicity|0|||
155535114|NCT04633564|561382278|FG000|Period 1|Adverse Event|28|||
155535115|NCT04633564|561382279|FG001|Period 1|Adverse Event|19|||
155535116|NCT04633564|561382278|FG000|Period 1|Death|8|||
155535117|NCT04633564|561382279|FG001|Period 1|Death|7|||
155535118|NCT04633564|561382278|FG000|Period 1|Lost to Follow-up|3|||
155535119|NCT04633564|561382279|FG001|Period 1|Lost to Follow-up|5|||
155535120|NCT04633564|561382278|FG000|Period 1|Physician Decision|4|||
155535121|NCT04633564|561382279|FG001|Period 1|Physician Decision|12|||
155535122|NCT04633564|561382278|FG000|Period 1|Protocol Violation|0|||
155535123|NCT04633564|561382279|FG001|Period 1|Protocol Violation|1|||
155535124|NCT04633564|561382278|FG000|Period 1|Withdrawal by Subject|10|||
155535125|NCT04633564|561382279|FG001|Period 1|Withdrawal by Subject|8|||
155535126|NCT04633564|561382278|FG000|Period 1|Progressive disease|47|||
155535127|NCT04633564|561382279|FG001|Period 1|Progressive disease|51|||
155535128|NCT04633564|561382278|FG000|Period 1|Terminated by Sponsor|8|||
155535129|NCT04633564|561382279|FG001|Period 1|Terminated by Sponsor|6|||
155535130|NCT04633564|561382278|FG000|Period 2|Adverse Event|3|||
155535131|NCT04633564|561382279|FG001|Period 2|Adverse Event|4|||
155535132|NCT04633564|561382278|FG000|Period 2|Death|0|||
155535133|NCT04633564|561382279|FG001|Period 2|Death|2|||
155535134|NCT04633564|561382278|FG000|Period 2|Lost to Follow-up|0|||
155535135|NCT04633564|561382279|FG001|Period 2|Lost to Follow-up|1|||
155535136|NCT04633564|561382278|FG000|Period 2|Physician Decision|2|||
155535137|NCT04633564|561382279|FG001|Period 2|Physician Decision|4|||
155535138|NCT04633564|561382278|FG000|Period 2|Withdrawal by Subject|5|||
155535139|NCT04633564|561382279|FG001|Period 2|Withdrawal by Subject|1|||
155535140|NCT04633564|561382278|FG000|Period 2|Progressive Disease|74|||
155535141|NCT04633564|561382279|FG001|Period 2|Progressive Disease|82|||
155535142|NCT04633564|561382278|FG000|Period 2|Terminated by Sponsor|9|||
155535143|NCT04633564|561382279|FG001|Period 2|Terminated by Sponsor|3|||
155535144|NCT01279486|561382280|FG000|Overall Study|Lost to Follow-up|1|||
155535145|NCT04198363|561382283|FG000|Overall Study|Adverse Event|1|||
155535146|NCT04198363|561382284|FG001|Overall Study|Adverse Event|1|||
155535147|NCT04198363|561382283|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
155535148|NCT04198363|561382284|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
155535149|NCT04198363|561382283|FG000|Overall Study|Reason not Specified|1|||
155535150|NCT04198363|561382284|FG001|Overall Study|Reason not Specified|0|||
155535151|NCT03067987|561382287|FG000|Overall Study|Lost to Follow-up|7|||
155535152|NCT03067987|561382288|FG001|Overall Study|Lost to Follow-up|10|||
155535153|NCT03067987|561382287|FG000|Overall Study|Protocol Violation|1|||
155535154|NCT03067987|561382288|FG001|Overall Study|Protocol Violation|2|||
155535155|NCT03067987|561382287|FG000|Overall Study|Withdrawal by Subject|2|||
155535156|NCT03067987|561382288|FG001|Overall Study|Withdrawal by Subject|1|||
155535157|NCT03500094|561382292|FG000|Overall Study|Withdrawal by Subject|1|||
155535158|NCT03500094|561382292|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
155535159|NCT03500094|561382292|FG000|Overall Study|Lost to Follow-up|1|||
155535160|NCT03506633|561384640|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
155535161|NCT03506633|561384641|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
155535162|NCT02997176|561384642|FG000|Overall Study|Adverse Event|0|||
155535163|NCT02997176|561384643|FG001|Overall Study|Adverse Event|0|||
155535164|NCT02997176|561384644|FG002|Overall Study|Adverse Event|0|||
155535165|NCT02997176|561384645|FG003|Overall Study|Adverse Event|8|||
155535166|NCT02997176|561384642|FG000|Overall Study|Progressive Disease|1|||
155535167|NCT02997176|561384643|FG001|Overall Study|Progressive Disease|0|||
155535168|NCT02997176|561384644|FG002|Overall Study|Progressive Disease|1|||
155535169|NCT02997176|561384645|FG003|Overall Study|Progressive Disease|1|||
155535170|NCT02997176|561384642|FG000|Overall Study|Death|0|||
155535171|NCT02997176|561384643|FG001|Overall Study|Death|0|||
155535172|NCT02997176|561384644|FG002|Overall Study|Death|1|||
155535173|NCT02997176|561384645|FG003|Overall Study|Death|1|||
155535174|NCT02997176|561384642|FG000|Overall Study|Withdrawal by Subject|0|||
155535175|NCT02997176|561384643|FG001|Overall Study|Withdrawal by Subject|2|||
155655572|NCT04976855|561832268|FG001|Part II|Lost to Follow-up|0|||
155655573|NCT04976855|561832269|FG002|Part II|Lost to Follow-up|0|||
155655574|NCT04976855|561832270|FG003|Part II|Lost to Follow-up|0|||
155655575|NCT04976855|561832271|FG004|Part II|Lost to Follow-up|0|||
155655576|NCT04976855|561832272|FG005|Part II|Lost to Follow-up|1|||
155655577|NCT04976855|561832273|FG006|Part II|Lost to Follow-up|0|||
155655578|NCT05487378|561832274|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
155655579|NCT05487378|561832275|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
155655580|NCT05487378|561832274|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
155655581|NCT05487378|561832275|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
155655582|NCT00908141|561832299|FG000|Overall Study|Withdrawal by Subject|0|||
155655583|NCT00908141|561832300|FG001|Overall Study|Withdrawal by Subject|1|||
155655584|NCT00003645|561833539|FG000|Overall Study|Death|4|||
155655585|NCT00003645|561833540|FG001|Overall Study|Death|1|||
155655586|NCT00003645|561833539|FG000|Overall Study|Lost to Follow-up|7|||
155535176|NCT02997176|561384644|FG002|Overall Study|Withdrawal by Subject|0|||
155535177|NCT02997176|561384645|FG003|Overall Study|Withdrawal by Subject|1|||
155535178|NCT01630616|561384649|FG000|Overall Study|Adverse Event|0|||
155535179|NCT01630616|561384650|FG001|Overall Study|Adverse Event|0|||
155535180|NCT01630616|561384651|FG002|Overall Study|Adverse Event|0|||
155535181|NCT01630616|561384652|FG003|Overall Study|Adverse Event|1|||
155535182|NCT01630616|561384653|FG004|Overall Study|Adverse Event|0|||
155655587|NCT00003645|561833540|FG001|Overall Study|Lost to Follow-up|8|||
155655588|NCT00003645|561833539|FG000|Overall Study|Withdrawal by Subject|1|||
155655589|NCT00003645|561833540|FG001|Overall Study|Withdrawal by Subject|3|||
155535183|NCT01630616|561384654|FG005|Overall Study|Adverse Event|0|||
155535184|NCT01630616|561384649|FG000|Overall Study|Withdrawal by Subject|0|||
155535185|NCT01630616|561384650|FG001|Overall Study|Withdrawal by Subject|0|||
155535186|NCT01630616|561384651|FG002|Overall Study|Withdrawal by Subject|0|||
155535187|NCT01630616|561384652|FG003|Overall Study|Withdrawal by Subject|2|||
155535188|NCT01630616|561384653|FG004|Overall Study|Withdrawal by Subject|0|||
155535189|NCT01630616|561384654|FG005|Overall Study|Withdrawal by Subject|0|||
155535190|NCT01993186|561384655|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
155535191|NCT01993186|561384656|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
155535192|NCT01993186|561384655|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
155535193|NCT01993186|561384656|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
155535194|NCT01993186|561384655|FG000|Open-Label Extension Period|Other, Not Specified|0|||
155535195|NCT01993186|561384656|FG001|Open-Label Extension Period|Other, Not Specified|1|||
155535196|NCT01993186|561384655|FG000|Open-Label Extension Period|Adverse Event|1|||
155535197|NCT01993186|561384656|FG001|Open-Label Extension Period|Adverse Event|0|||
155535198|NCT01993186|561384655|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
155535199|NCT01993186|561384656|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
155535200|NCT01993186|561384655|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
155535201|NCT01993186|561384656|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
155535202|NCT01993186|561384655|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
155535203|NCT01993186|561384656|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
155535204|NCT00691704|561384657|FG000|Induction Therapy|Disease Progression|1|||
155535205|NCT00691704|561384657|FG000|Induction Therapy|Active Hepatitis|1|||
155535206|NCT00691704|561384657|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
155535207|NCT00691704|561384657|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
155535208|NCT00691704|561384657|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
155535209|NCT04523480|561384658|FG000|Overall Study|Lost to Follow-up|30|||
155535210|NCT04523480|561384659|FG001|Overall Study|Lost to Follow-up|35|||
155535211|NCT04523480|561384660|FG002|Overall Study|Lost to Follow-up|0|||
155535212|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
155535213|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
155535214|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
155535215|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
155535216|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
155535217|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
155535218|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
155535219|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
155535220|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
155535221|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
155535222|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
155535223|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
155535224|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
155535225|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
155535226|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
155535227|NCT00385736|561384662|FG000|Efficacy Analysis Set - Induction|Other|0|||
155535228|NCT00385736|561384663|FG001|Efficacy Analysis Set - Induction|Other|0|||
155535229|NCT00385736|561384664|FG002|Efficacy Analysis Set - Induction|Other|1|||
155535230|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
155535231|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
155535232|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
155535233|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
155535234|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
155535235|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
155535236|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
155535237|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
155535238|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
155535239|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
155535240|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
155535241|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
155535242|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
155535243|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
155535244|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
155535245|NCT00385736|561384662|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
155535246|NCT00385736|561384663|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
155535247|NCT00385736|561384664|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
155535248|NCT00385736|561384662|FG000|Safety Analysis Set|Adverse Event|23|||
155535249|NCT00385736|561384663|FG001|Safety Analysis Set|Adverse Event|15|||
155535250|NCT00385736|561384664|FG002|Safety Analysis Set|Adverse Event|23|||
155535251|NCT00385736|561384662|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
155535252|NCT00385736|561384663|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
155535253|NCT00385736|561384664|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
155535254|NCT00385736|561384662|FG000|Safety Analysis Set|Lost to Follow-up|0|||
155535255|NCT00385736|561384663|FG001|Safety Analysis Set|Lost to Follow-up|2|||
155535256|NCT00385736|561384664|FG002|Safety Analysis Set|Lost to Follow-up|2|||
155535257|NCT00385736|561384662|FG000|Safety Analysis Set|Lack of Efficacy|38|||
155535258|NCT00385736|561384663|FG001|Safety Analysis Set|Lack of Efficacy|16|||
155535259|NCT00385736|561384664|FG002|Safety Analysis Set|Lack of Efficacy|31|||
155535260|NCT00385736|561384662|FG000|Safety Analysis Set|Protocol Violation|2|||
155535261|NCT00385736|561384663|FG001|Safety Analysis Set|Protocol Violation|1|||
155535262|NCT00385736|561384664|FG002|Safety Analysis Set|Protocol Violation|6|||
155535263|NCT00385736|561384662|FG000|Safety Analysis Set|Other|1|||
155535264|NCT00385736|561384663|FG001|Safety Analysis Set|Other|4|||
155535265|NCT00385736|561384664|FG002|Safety Analysis Set|Other|4|||
155535266|NCT05497557|561384670|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
155535267|NCT05497557|561384671|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
155535268|NCT05497557|561384672|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
155535269|NCT00198133|561384675|FG000|Overall Study|Disease progression|2|||
155535270|NCT00198133|561384676|FG001|Overall Study|Disease progression|5|||
155535271|NCT00198133|561384675|FG000|Overall Study|Adverse Event|1|||
155535272|NCT00198133|561384676|FG001|Overall Study|Adverse Event|3|||
155535273|NCT00198133|561384675|FG000|Overall Study|Withdrawal by Subject|1|||
155535274|NCT00198133|561384676|FG001|Overall Study|Withdrawal by Subject|0|||
155535275|NCT00198133|561384675|FG000|Overall Study|Physician Decision|1|||
155535276|NCT00198133|561384676|FG001|Overall Study|Physician Decision|0|||
155535277|NCT05523895|561384677|FG000|Overall Study|Adverse Event|2|||
155535278|NCT05523895|561384678|FG001|Overall Study|Adverse Event|1|||
155535279|NCT05523895|561384679|FG002|Overall Study|Adverse Event|1|||
155535280|NCT05523895|561384677|FG000|Overall Study|Lost to Follow-up|0|||
155535281|NCT05523895|561384678|FG001|Overall Study|Lost to Follow-up|1|||
155535282|NCT05523895|561384679|FG002|Overall Study|Lost to Follow-up|2|||
155535283|NCT05523895|561384677|FG000|Overall Study|Noncompliance with study drug|1|||
155535284|NCT05523895|561384678|FG001|Overall Study|Noncompliance with study drug|1|||
155535285|NCT05523895|561384679|FG002|Overall Study|Noncompliance with study drug|1|||
155535286|NCT05523895|561384677|FG000|Overall Study|Protocol Violation|0|||
155535287|NCT05523895|561384678|FG001|Overall Study|Protocol Violation|2|||
155535288|NCT05523895|561384679|FG002|Overall Study|Protocol Violation|0|||
155535289|NCT05523895|561384677|FG000|Overall Study|Withdrawal by Subject|1|||
155535290|NCT05523895|561384678|FG001|Overall Study|Withdrawal by Subject|3|||
155535291|NCT05523895|561384679|FG002|Overall Study|Withdrawal by Subject|1|||
155535292|NCT05523895|561384677|FG000|Overall Study|Not further specified|0|||
155535293|NCT05523895|561384678|FG001|Overall Study|Not further specified|3|||
155535294|NCT05523895|561384679|FG002|Overall Study|Not further specified|1|||
155535295|NCT01380782|561384680|FG000|Overall Study|Adverse Event|0|||
155535296|NCT01380782|561384681|FG001|Overall Study|Adverse Event|1|||
155535297|NCT01380782|561384682|FG002|Overall Study|Adverse Event|0|||
155535298|NCT01380782|561384683|FG003|Overall Study|Adverse Event|0|||
155535299|NCT01380782|561384680|FG000|Overall Study|Death|1|||
155535300|NCT01380782|561384681|FG001|Overall Study|Death|0|||
155535301|NCT01380782|561384682|FG002|Overall Study|Death|0|||
155535302|NCT01380782|561384683|FG003|Overall Study|Death|0|||
155535303|NCT01380782|561384680|FG000|Overall Study|Lack of Efficacy|10|||
155535304|NCT01380782|561384681|FG001|Overall Study|Lack of Efficacy|9|||
155535305|NCT01380782|561384682|FG002|Overall Study|Lack of Efficacy|10|||
155535306|NCT01380782|561384683|FG003|Overall Study|Lack of Efficacy|3|||
155535307|NCT01380782|561384680|FG000|Overall Study|Physician Decision|1|||
155535308|NCT01380782|561384681|FG001|Overall Study|Physician Decision|0|||
155535309|NCT01380782|561384682|FG002|Overall Study|Physician Decision|0|||
155535310|NCT01380782|561384683|FG003|Overall Study|Physician Decision|0|||
155535311|NCT01380782|561384680|FG000|Overall Study|Withdrawal by Subject|0|||
155535312|NCT01380782|561384681|FG001|Overall Study|Withdrawal by Subject|0|||
155535313|NCT01380782|561384682|FG002|Overall Study|Withdrawal by Subject|1|||
155535314|NCT01380782|561384683|FG003|Overall Study|Withdrawal by Subject|1|||
155535315|NCT01701063|561384684|FG000|Overall Study|Lost to Follow-up|0|||
155535316|NCT01701063|561384685|FG001|Overall Study|Lost to Follow-up|1|||
155535317|NCT01701063|561384686|FG002|Overall Study|Lost to Follow-up|0|||
155535318|NCT01701063|561384684|FG000|Overall Study|Withdrawal by Subject|0|||
155535319|NCT01701063|561384685|FG001|Overall Study|Withdrawal by Subject|0|||
155535320|NCT01701063|561384686|FG002|Overall Study|Withdrawal by Subject|1|||
155535321|NCT01701063|561384684|FG000|Overall Study|Other|0|||
155535322|NCT01701063|561384685|FG001|Overall Study|Other|0|||
155535323|NCT01701063|561384686|FG002|Overall Study|Other|1|||
155535324|NCT01919112|561384687|FG000|Secondary Analysis-day 30|Death|1|||
155535325|NCT01919112|561384688|FG001|Secondary Analysis-day 30|Death|1|||
155535326|NCT01919112|561384689|FG002|Secondary Analysis-day 30|Death|1|||
155535327|NCT01919112|561384687|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
155535328|NCT01919112|561384688|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
155535329|NCT01919112|561384689|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
155535330|NCT02043132|561384690|FG000|Overall Study|Lost to Follow-up|1|||
155535331|NCT02043132|561384691|FG001|Overall Study|Lost to Follow-up|1|||
155535332|NCT02043132|561384690|FG000|Overall Study|screen failures|4|||
155535333|NCT02043132|561384691|FG001|Overall Study|screen failures|8|||
155535334|NCT04474405|561384692|FG000|Overall Study|Withdrawal by Subject|0|||
155535335|NCT04474405|561384693|FG001|Overall Study|Withdrawal by Subject|0|||
155535336|NCT04474405|561384694|FG002|Overall Study|Withdrawal by Subject|1|||
155535337|NCT04474405|561384695|FG003|Overall Study|Withdrawal by Subject|0|||
155535338|NCT04474405|561384696|FG004|Overall Study|Withdrawal by Subject|1|||
155535339|NCT04474405|561384697|FG005|Overall Study|Withdrawal by Subject|0|||
155535340|NCT04474405|561384692|FG000|Overall Study|Other|0|||
155535341|NCT04474405|561384693|FG001|Overall Study|Other|0|||
155535342|NCT04474405|561384694|FG002|Overall Study|Other|0|||
155535343|NCT04474405|561384695|FG003|Overall Study|Other|0|||
155535344|NCT04474405|561384696|FG004|Overall Study|Other|3|||
155535345|NCT04474405|561384697|FG005|Overall Study|Other|0|||
155535346|NCT00918645|561384700|FG000|Overall Study|Withdrawal by Subject|1|||
155535347|NCT03446768|561384701|FG000|Overall Study|Withdrawal by Subject|0|||
155535348|NCT03446768|561384702|FG001|Overall Study|Withdrawal by Subject|1|||
155535349|NCT00635648|561384703|FG000|Overall Study|Adverse Event|12|||
155535350|NCT00635648|561384703|FG000|Overall Study|Withdrawal by Subject|9|||
155535351|NCT00635648|561384703|FG000|Overall Study|Physician Decision|4|||
155535352|NCT00635648|561384703|FG000|Overall Study|Rapid progression of baseline disease|4|||
155535353|NCT00635648|561384703|FG000|Overall Study|Use of other antifungal agent needed|1|||
155535354|NCT00635648|561384703|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
155535355|NCT00635648|561384703|FG000|Overall Study|Noncompliance with protocol|1|||
155535356|NCT00635648|561384703|FG000|Overall Study|Other reason|2|||
155535357|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
155535358|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
155535359|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
155535360|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
155535361|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
155535362|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
155535363|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
155535364|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
155535365|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
155535366|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
155535367|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
155535368|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
155535369|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
155535370|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
155535371|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
155535372|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
155535373|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
155535374|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
155535375|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
155535376|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
155535377|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
155535378|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
155535379|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
155535380|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
155535381|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
155535382|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
155535383|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
155535384|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
155535385|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
155535386|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
155535387|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
155535388|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
155535389|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
155535390|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
155535391|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
155535392|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
155535393|NCT04194801|561384704|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
155535394|NCT04194801|561384705|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
155535395|NCT04194801|561384706|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
155535396|NCT04194801|561384704|FG000|Part Ib/II End of Study|Death|2|||
155535397|NCT04194801|561384705|FG001|Part Ib/II End of Study|Death|3|||
155535398|NCT04194801|561384706|FG002|Part Ib/II End of Study|Death|3|||
155535399|NCT04194801|561384704|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
155535400|NCT04194801|561384705|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
155535401|NCT04194801|561384706|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
155535402|NCT04194801|561384704|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
155535403|NCT04194801|561384705|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
155535404|NCT04194801|561384706|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
155535405|NCT04194801|561384704|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
155535406|NCT04194801|561384705|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
155535407|NCT04194801|561384706|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
155535408|NCT04194801|561384704|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
155535409|NCT04194801|561384705|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
155535410|NCT04194801|561384706|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
155535411|NCT03827395|561384710|FG000|Overall Study|Lost to Follow-up|1|||
155535412|NCT03827395|561384711|FG001|Overall Study|Lost to Follow-up|0|||
155535413|NCT03827395|561384710|FG000|Overall Study|Protocol Violation|1|||
155535414|NCT03827395|561384711|FG001|Overall Study|Protocol Violation|0|||
155535415|NCT03827395|561384710|FG000|Overall Study|Became ineligible after enrollment|1|||
155535416|NCT03827395|561384711|FG001|Overall Study|Became ineligible after enrollment|2|||
155535417|NCT04723693|561384712|FG000|Overall Study|Withdrawal by Subject|2|||
155535418|NCT00294047|561384713|FG000|Month 48|Adverse Event|28|||
155535419|NCT00294047|561384714|FG001|Month 48|Adverse Event|13|||
155535420|NCT00294047|561384713|FG000|Month 48|Protocol Violation|4|||
155535421|NCT00294047|561384714|FG001|Month 48|Protocol Violation|4|||
155535422|NCT00294047|561384713|FG000|Month 48|Withdrawal by Subject|111|||
155535423|NCT00294047|561384714|FG001|Month 48|Withdrawal by Subject|115|||
155535424|NCT00294047|561384713|FG000|Month 48|Lost to Follow-up|272|||
155535425|NCT00294047|561384714|FG001|Month 48|Lost to Follow-up|287|||
155535426|NCT00294047|561384713|FG000|Month 48|Other|10|||
155535427|NCT00294047|561384714|FG001|Month 48|Other|14|||
155535428|NCT00294047|561384713|FG000|Month 84|Adverse Event|4|||
155535429|NCT00294047|561384714|FG001|Month 84|Adverse Event|2|||
155535430|NCT00294047|561384713|FG000|Month 84|Protocol Violation|1|||
155535431|NCT00294047|561384714|FG001|Month 84|Protocol Violation|1|||
155535432|NCT00294047|561384713|FG000|Month 84|Withdrawal by Subject|33|||
155535433|NCT00294047|561384714|FG001|Month 84|Withdrawal by Subject|31|||
155535434|NCT00294047|561384713|FG000|Month 84|Lost to Follow-up|187|||
155535435|NCT00294047|561384714|FG001|Month 84|Lost to Follow-up|190|||
155535436|NCT00294047|561384713|FG000|Month 84|Absent Cervix|2|||
155535437|NCT00294047|561384714|FG001|Month 84|Absent Cervix|0|||
155535438|NCT00294047|561384713|FG000|Month 84|Work related reasons|4|||
155535439|NCT00294047|561384714|FG001|Month 84|Work related reasons|2|||
155535440|NCT00294047|561384713|FG000|Month 84|Center closed, subject did not transfer|1|||
155535441|NCT00294047|561384714|FG001|Month 84|Center closed, subject did not transfer|0|||
155535442|NCT00294047|561384713|FG000|Month 84|Family problems|2|||
155535443|NCT00294047|561384714|FG001|Month 84|Family problems|2|||
155535444|NCT00294047|561384713|FG000|Month 84|Lack of time|3|||
155535445|NCT00294047|561384714|FG001|Month 84|Lack of time|1|||
155535446|NCT00294047|561384713|FG000|Month 84|Personal reason|2|||
155535447|NCT00294047|561384714|FG001|Month 84|Personal reason|4|||
155535448|NCT00294047|561384713|FG000|Month 84|Subject does not want male physician|1|||
155535449|NCT00294047|561384714|FG001|Month 84|Subject does not want male physician|0|||
155535450|NCT00294047|561384713|FG000|Month 84|Transport reimbursement delayed|0|||
155535451|NCT00294047|561384714|FG001|Month 84|Transport reimbursement delayed|1|||
155535452|NCT00294047|561384713|FG000|Month 84|Unable to reach study site|1|||
155535453|NCT00294047|561384714|FG001|Month 84|Unable to reach study site|0|||
155535454|NCT00294047|561384713|FG000|Month 84|Under investigation locally|1|||
155535455|NCT00294047|561384714|FG001|Month 84|Under investigation locally|0|||
155535456|NCT00294047|561384713|FG000|Month 84|Visit missed|0|||
155535457|NCT00294047|561384714|FG001|Month 84|Visit missed|1|||
155535458|NCT00294047|561384713|FG000|Month 84|No consent for Month 84 Follow-up|731|||
155535459|NCT00294047|561384714|FG001|Month 84|No consent for Month 84 Follow-up|754|||
155535460|NCT02157974|561384715|FG000|Overall Study|Withdrawal by Subject|0|||
155535461|NCT02157974|561384716|FG001|Overall Study|Withdrawal by Subject|1|||
155535462|NCT02157974|561384717|FG002|Overall Study|Withdrawal by Subject|0|||
155535463|NCT02157974|561384718|FG003|Overall Study|Withdrawal by Subject|0|||
155535464|NCT02157974|561384719|FG004|Overall Study|Withdrawal by Subject|0|||
155535465|NCT02157974|561384715|FG000|Overall Study|Screen Failure|0|||
155535466|NCT02157974|561384716|FG001|Overall Study|Screen Failure|1|||
155535467|NCT02157974|561384717|FG002|Overall Study|Screen Failure|0|||
155535468|NCT02157974|561384718|FG003|Overall Study|Screen Failure|0|||
155535469|NCT02157974|561384719|FG004|Overall Study|Screen Failure|0|||
155535470|NCT02157974|561384715|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
155535471|NCT02157974|561384716|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
155535472|NCT02157974|561384717|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
155535473|NCT02157974|561384718|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
155535474|NCT02157974|561384719|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
155535475|NCT00506831|561384722|FG000|Overall Study|Death|1|||
155535476|NCT00506831|561384722|FG000|Overall Study|Withdrawal by Subject|1|||
155535477|NCT01410227|561384726|FG000|Overall Study|Adverse Event|1|||
155535478|NCT01410227|561384727|FG001|Overall Study|Adverse Event|0|||
155535479|NCT01410227|561384728|FG002|Overall Study|Adverse Event|0|||
155535480|NCT01410227|561384729|FG003|Overall Study|Adverse Event|0|||
155535481|NCT01410227|561384726|FG000|Overall Study|Withdrawal by Subject|3|||
155535482|NCT01410227|561384727|FG001|Overall Study|Withdrawal by Subject|0|||
155535483|NCT01410227|561384728|FG002|Overall Study|Withdrawal by Subject|1|||
155535484|NCT01410227|561384729|FG003|Overall Study|Withdrawal by Subject|0|||
155535485|NCT01410227|561384726|FG000|Overall Study|Pregnancy|0|||
155535486|NCT01410227|561384727|FG001|Overall Study|Pregnancy|0|||
155535487|NCT01410227|561384728|FG002|Overall Study|Pregnancy|0|||
155535488|NCT01410227|561384729|FG003|Overall Study|Pregnancy|1|||
155535489|NCT01410227|561384726|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
155535490|NCT01410227|561384727|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
155535491|NCT01410227|561384728|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
155535492|NCT01410227|561384729|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
155535493|NCT00606281|561384731|FG000|Overall Study|Adverse Event|11|||
155535494|NCT00606281|561384732|FG001|Overall Study|Adverse Event|12|||
155535495|NCT00606281|561384731|FG000|Overall Study|Death|1|||
155535496|NCT00606281|561384732|FG001|Overall Study|Death|0|||
155535497|NCT00606281|561384731|FG000|Overall Study|Lack of Efficacy|28|||
155535498|NCT00606281|561384732|FG001|Overall Study|Lack of Efficacy|35|||
155535499|NCT00606281|561384731|FG000|Overall Study|Physician Decision|0|||
155535500|NCT00606281|561384732|FG001|Overall Study|Physician Decision|1|||
155535501|NCT00606281|561384731|FG000|Overall Study|Protocol Violation|3|||
155535502|NCT00606281|561384732|FG001|Overall Study|Protocol Violation|3|||
155535503|NCT00606281|561384731|FG000|Overall Study|Withdrawal by Subject|11|||
155535504|NCT00606281|561384732|FG001|Overall Study|Withdrawal by Subject|13|||
155535505|NCT00606281|561384731|FG000|Overall Study|Progression to depressive phase|1|||
155535506|NCT00606281|561384732|FG001|Overall Study|Progression to depressive phase|1|||
155535507|NCT00606281|561384731|FG000|Overall Study|Change of residence or other commitments|1|||
155535508|NCT00606281|561384732|FG001|Overall Study|Change of residence or other commitments|1|||
155535509|NCT03131895|561384734|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
155535510|NCT03131895|561384735|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
155535511|NCT03131895|561384736|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
155535512|NCT03131895|561384737|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
155535513|NCT03131895|561384734|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155535514|NCT03131895|561384735|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
155535515|NCT03131895|561384736|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
155535516|NCT03131895|561384737|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
155535517|NCT03131895|561384734|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155535518|NCT03131895|561384735|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
155535519|NCT03131895|561384736|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155535520|NCT03131895|561384737|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
155535521|NCT03131895|561384734|FG000|Washout Period (at Least 5 Days)|Other|0|||
155535522|NCT03131895|561384735|FG001|Washout Period (at Least 5 Days)|Other|0|||
155535523|NCT03131895|561384736|FG002|Washout Period (at Least 5 Days)|Other|2|||
155535524|NCT03131895|561384737|FG003|Washout Period (at Least 5 Days)|Other|0|||
155535525|NCT03131895|561384734|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
155535526|NCT03131895|561384735|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
155535527|NCT03131895|561384736|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
155535528|NCT03131895|561384737|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
155535529|NCT03131895|561384734|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
155535530|NCT03131895|561384735|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
155535531|NCT03131895|561384736|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
155535532|NCT03131895|561384737|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
155535533|NCT00540423|561384738|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155535534|NCT00540423|561384739|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155535535|NCT00540423|561384740|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155535536|NCT00540423|561384738|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
155535537|NCT00540423|561384739|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155535538|NCT00540423|561384740|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
155535539|NCT02213263|561384745|FG000|Overall Study|Insufficient clinical response|4|||
155535540|NCT02213263|561384746|FG001|Overall Study|Insufficient clinical response|3|||
155535541|NCT02213263|561384745|FG000|Overall Study|Lost to Follow-up|0|||
155535542|NCT02213263|561384746|FG001|Overall Study|Lost to Follow-up|1|||
155535543|NCT02213263|561384745|FG000|Overall Study|No longer willing to participate|3|||
155535544|NCT02213263|561384746|FG001|Overall Study|No longer willing to participate|4|||
155535545|NCT02213263|561384745|FG000|Overall Study|Progressive disease|20|||
155535546|NCT02213263|561384746|FG001|Overall Study|Progressive disease|14|||
155535547|NCT02213263|561384745|FG000|Overall Study|Protocol Violation|0|||
155535548|NCT02213263|561384746|FG001|Overall Study|Protocol Violation|1|||
155535549|NCT02213263|561384745|FG000|Overall Study|Adverse Event|1|||
155535550|NCT02213263|561384746|FG001|Overall Study|Adverse Event|3|||
155535551|NCT00263588|561384747|FG000|Overall Study|Death|54|||
155535552|NCT00263588|561384748|FG001|Overall Study|Death|90|||
155535553|NCT00263588|561384747|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
155535554|NCT00263588|561384748|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
155535555|NCT00263588|561384747|FG000|Overall Study|Lost to Follow-up|7|||
155535556|NCT00263588|561384748|FG001|Overall Study|Lost to Follow-up|10|||
155535557|NCT00263588|561384747|FG000|Overall Study|Withdrawal by Subject|3|||
155535558|NCT00263588|561384748|FG001|Overall Study|Withdrawal by Subject|4|||
155535559|NCT00263588|561384747|FG000|Overall Study|Protocol Violation|0|||
155535560|NCT00263588|561384748|FG001|Overall Study|Protocol Violation|1|||
155535561|NCT00263588|561384747|FG000|Overall Study|Investigator decision|7|||
155535562|NCT00263588|561384748|FG001|Overall Study|Investigator decision|15|||
155535563|NCT00263588|561384747|FG000|Overall Study|Sponsor terminated study|0|||
155535564|NCT00263588|561384748|FG001|Overall Study|Sponsor terminated study|1|||
155535565|NCT00918684|561384750|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
155535566|NCT00918684|561384750|FG000|Treatment Phase|Lack of Efficacy|6|||
155535567|NCT00918684|561384750|FG000|Treatment Phase|Lost to Follow-up|2|||
155535568|NCT00918684|561384750|FG000|Treatment Phase|Physician Decision|8|||
155535569|NCT00918684|561384750|FG000|Treatment Phase|Protocol Violation|1|||
155535570|NCT00918684|561384750|FG000|Treatment Phase|Withdrawal by Subject|8|||
155535571|NCT03629054|561384751|FG000|Period 2 (4 Days)|Not treated|0|||
155535572|NCT03629054|561384752|FG001|Period 2 (4 Days)|Not treated|1|||
155535573|NCT00924638|561384756|FG000|Overall Study|Death|3|||
155535574|NCT00924638|561384757|FG001|Overall Study|Death|2|||
155535575|NCT00924638|561384756|FG000|Overall Study|Lost to Follow-up|1|||
155535576|NCT00924638|561384757|FG001|Overall Study|Lost to Follow-up|1|||
155535577|NCT00924638|561384756|FG000|Overall Study|Withdrawal by Subject|5|||
155535578|NCT00924638|561384757|FG001|Overall Study|Withdrawal by Subject|7|||
155535579|NCT00924638|561384756|FG000|Overall Study|Physician Decision|3|||
155535580|NCT00924638|561384757|FG001|Overall Study|Physician Decision|3|||
155535581|NCT01316055|561384758|FG000|Overall Study|Lost to Follow-up|1|||
155535582|NCT01316055|561384759|FG001|Overall Study|Lost to Follow-up|0|||
155535583|NCT01316055|561384760|FG002|Overall Study|Lost to Follow-up|0|||
155535584|NCT02679729|561384762|FG000|Overall Study|Lost to Follow-up|0|||
155535585|NCT02679729|561384763|FG001|Overall Study|Lost to Follow-up|1|||
155535586|NCT02679729|561384764|FG002|Overall Study|Lost to Follow-up|0|||
155535587|NCT02679729|561384765|FG003|Overall Study|Lost to Follow-up|0|||
155535588|NCT02679729|561384766|FG004|Overall Study|Lost to Follow-up|1|||
155535589|NCT02679729|561384767|FG005|Overall Study|Lost to Follow-up|0|||
155535590|NCT02679729|561384768|FG006|Overall Study|Lost to Follow-up|0|||
155535591|NCT02679729|561384769|FG007|Overall Study|Lost to Follow-up|0|||
155535592|NCT02679729|561384770|FG008|Overall Study|Lost to Follow-up|0|||
155535593|NCT02679729|561384762|FG000|Overall Study|Participant decision|0|||
155535594|NCT02679729|561384763|FG001|Overall Study|Participant decision|1|||
155535595|NCT02679729|561384764|FG002|Overall Study|Participant decision|0|||
155535596|NCT02679729|561384765|FG003|Overall Study|Participant decision|0|||
155535597|NCT02679729|561384766|FG004|Overall Study|Participant decision|0|||
155535598|NCT02679729|561384767|FG005|Overall Study|Participant decision|0|||
155535599|NCT02679729|561384768|FG006|Overall Study|Participant decision|1|||
155535600|NCT02679729|561384769|FG007|Overall Study|Participant decision|0|||
155535601|NCT02679729|561384770|FG008|Overall Study|Participant decision|0|||
155535602|NCT00748566|561384771|FG000|Overall Study|Adverse Event|49|||
155535603|NCT00748566|561384771|FG000|Overall Study|Death|1|||
155535604|NCT00748566|561384771|FG000|Overall Study|Lack of Efficacy|12|||
155535605|NCT00748566|561384771|FG000|Overall Study|Lost to Follow-up|1|||
155535606|NCT00748566|561384771|FG000|Overall Study|Protocol Violation|13|||
155535607|NCT00748566|561384771|FG000|Overall Study|Withdrawal by Subject|22|||
155535608|NCT00748566|561384771|FG000|Overall Study|Study terminated by sponsor|5|||
155535609|NCT00748566|561384771|FG000|Overall Study|Other|9|||
155535610|NCT01442376|561384778|FG000|Overall Study|Adverse Event|0|||
155535611|NCT01442376|561384779|FG001|Overall Study|Adverse Event|3|||
155535612|NCT01442376|561384780|FG002|Overall Study|Adverse Event|2|||
155535613|NCT01442376|561384778|FG000|Overall Study|Death|0|||
155535614|NCT01442376|561384779|FG001|Overall Study|Death|1|||
155535615|NCT01442376|561384780|FG002|Overall Study|Death|1|||
155535616|NCT01442376|561384778|FG000|Overall Study|Withdrawal of consent|0|||
155535617|NCT01442376|561384779|FG001|Overall Study|Withdrawal of consent|0|||
155535618|NCT01442376|561384780|FG002|Overall Study|Withdrawal of consent|1|||
155535619|NCT01442376|561384778|FG000|Overall Study|Patients not treated|2|||
155535620|NCT01442376|561384779|FG001|Overall Study|Patients not treated|3|||
155535621|NCT01442376|561384780|FG002|Overall Study|Patients not treated|1|||
155535622|NCT01442376|561384778|FG000|Overall Study|Not eligible for subsequent cycles|1|||
155535623|NCT01442376|561384779|FG001|Overall Study|Not eligible for subsequent cycles|2|||
155535624|NCT01442376|561384780|FG002|Overall Study|Not eligible for subsequent cycles|0|||
155535625|NCT04404725|561384781|FG000|First Intervention|Withdrawal by Subject|0|||
155535626|NCT04404725|561384782|FG001|First Intervention|Withdrawal by Subject|2|||
155535627|NCT04404725|561384781|FG000|Second Intervention|Adverse Event|1|||
155535628|NCT04404725|561384782|FG001|Second Intervention|Adverse Event|1|||
155535629|NCT04404725|561384781|FG000|Second Intervention|Withdrawal by Subject|0|||
155535630|NCT04404725|561384782|FG001|Second Intervention|Withdrawal by Subject|1|||
155535631|NCT01075516|561384783|FG000|Overall Study|Death|5|||
155535632|NCT01075516|561384784|FG001|Overall Study|Death|9|||
155535633|NCT01075516|561384783|FG000|Overall Study|Lost to Follow-up|10|||
155535634|NCT01075516|561384784|FG001|Overall Study|Lost to Follow-up|2|||
155535635|NCT01075516|561384783|FG000|Overall Study|Withdrawal by Subject|3|||
155535636|NCT01075516|561384784|FG001|Overall Study|Withdrawal by Subject|5|||
155535637|NCT02252016|561384785|FG000|Overall Study|Lost to Follow-up|2|||
155535638|NCT02252016|561384786|FG001|Overall Study|Lost to Follow-up|1|||
155535639|NCT02252016|561384785|FG000|Overall Study|Physician Decision|1|||
155535640|NCT02252016|561384786|FG001|Overall Study|Physician Decision|0|||
155535641|NCT02252016|561384785|FG000|Overall Study|Withdrawal by Subject|0|||
155535642|NCT02252016|561384786|FG001|Overall Study|Withdrawal by Subject|2|||
155535643|NCT04631562|561384787|FG000|Overall Study|Withdrawal by Subject|0|||
155535644|NCT04631562|561384788|FG001|Overall Study|Withdrawal by Subject|0|||
155535645|NCT04631562|561384789|FG002|Overall Study|Withdrawal by Subject|0|||
155535646|NCT04631562|561384790|FG003|Overall Study|Withdrawal by Subject|0|||
155535647|NCT04631562|561384791|FG004|Overall Study|Withdrawal by Subject|0|||
155535648|NCT04631562|561384792|FG005|Overall Study|Withdrawal by Subject|0|||
155535649|NCT04631562|561384793|FG006|Overall Study|Withdrawal by Subject|0|||
155535650|NCT04631562|561384794|FG007|Overall Study|Withdrawal by Subject|1|||
155535651|NCT04631562|561384795|FG008|Overall Study|Withdrawal by Subject|0|||
155535652|NCT04631562|561384787|FG000|Overall Study|Other|0|||
155535653|NCT04631562|561384788|FG001|Overall Study|Other|0|||
155535654|NCT04631562|561384789|FG002|Overall Study|Other|0|||
155535655|NCT04631562|561384790|FG003|Overall Study|Other|0|||
155535656|NCT04631562|561384791|FG004|Overall Study|Other|0|||
155535657|NCT04631562|561384792|FG005|Overall Study|Other|0|||
155535658|NCT04631562|561384793|FG006|Overall Study|Other|0|||
155535659|NCT04631562|561384794|FG007|Overall Study|Other|0|||
155535660|NCT04631562|561384795|FG008|Overall Study|Other|1|||
155535661|NCT04631562|561384787|FG000|Overall Study|Lost to Follow-up|0|||
155535662|NCT04631562|561384788|FG001|Overall Study|Lost to Follow-up|0|||
155535663|NCT04631562|561384789|FG002|Overall Study|Lost to Follow-up|0|||
155535664|NCT04631562|561384790|FG003|Overall Study|Lost to Follow-up|1|||
155535665|NCT04631562|561384791|FG004|Overall Study|Lost to Follow-up|0|||
155535666|NCT04631562|561384792|FG005|Overall Study|Lost to Follow-up|0|||
155535667|NCT04631562|561384793|FG006|Overall Study|Lost to Follow-up|0|||
155535668|NCT04631562|561384794|FG007|Overall Study|Lost to Follow-up|0|||
155535669|NCT04631562|561384795|FG008|Overall Study|Lost to Follow-up|0|||
155535670|NCT04631562|561384787|FG000|Overall Study|Adverse Event|0|||
155535671|NCT04631562|561384788|FG001|Overall Study|Adverse Event|0|||
155535672|NCT04631562|561384789|FG002|Overall Study|Adverse Event|0|||
155535673|NCT04631562|561384790|FG003|Overall Study|Adverse Event|0|||
155535674|NCT04631562|561384791|FG004|Overall Study|Adverse Event|0|||
155535675|NCT04631562|561384792|FG005|Overall Study|Adverse Event|0|||
155535676|NCT04631562|561384793|FG006|Overall Study|Adverse Event|1|||
155535677|NCT04631562|561384794|FG007|Overall Study|Adverse Event|0|||
155535678|NCT04631562|561384795|FG008|Overall Study|Adverse Event|0|||
155535679|NCT01825798|561384797|FG000|Overall Study|Adverse Event|1|||
155535680|NCT01825798|561384798|FG001|Overall Study|Adverse Event|5|||
155535681|NCT01825798|561384797|FG000|Overall Study|Lost to Follow-up|1|||
155535682|NCT01825798|561384798|FG001|Overall Study|Lost to Follow-up|0|||
155535683|NCT00834873|561384804|FG000|First Intervention|Adverse Event|0|||
155535684|NCT00834873|561384805|FG001|First Intervention|Adverse Event|1|||
155535685|NCT02055547|561384806|FG000|Overall Study|Protocol Violation|0|||
155535686|NCT02055547|561384807|FG001|Overall Study|Protocol Violation|0|||
155535687|NCT02055547|561384808|FG002|Overall Study|Protocol Violation|1|||
155535688|NCT02055547|561384809|FG003|Overall Study|Protocol Violation|0|||
155535689|NCT02055547|561384810|FG004|Overall Study|Protocol Violation|0|||
155535690|NCT02055547|561384811|FG005|Overall Study|Protocol Violation|0|||
155535691|NCT02055547|561384812|FG006|Overall Study|Protocol Violation|1|||
155535692|NCT02055547|561384813|FG007|Overall Study|Protocol Violation|0|||
155535693|NCT02055547|561384814|FG008|Overall Study|Protocol Violation|0|||
155535694|NCT02055547|561384815|FG009|Overall Study|Protocol Violation|0|||
155535695|NCT02055547|561384816|FG010|Overall Study|Protocol Violation|0|||
155535696|NCT02055547|561384817|FG011|Overall Study|Protocol Violation|0|||
155535697|NCT02055547|561384818|FG012|Overall Study|Protocol Violation|0|||
155535698|NCT02055547|561384819|FG013|Overall Study|Protocol Violation|0|||
155535699|NCT02055547|561384820|FG014|Overall Study|Protocol Violation|0|||
155535700|NCT02055547|561384821|FG015|Overall Study|Protocol Violation|0|||
155535701|NCT02055547|561384822|FG016|Overall Study|Protocol Violation|0|||
155535702|NCT02055547|561384823|FG017|Overall Study|Protocol Violation|0|||
155535703|NCT02055547|561384824|FG018|Overall Study|Protocol Violation|0|||
155535704|NCT02055547|561384806|FG000|Overall Study|Physician Decision|0|||
155535705|NCT02055547|561384807|FG001|Overall Study|Physician Decision|1|||
155535706|NCT02055547|561384808|FG002|Overall Study|Physician Decision|1|||
155535707|NCT02055547|561384809|FG003|Overall Study|Physician Decision|0|||
155535708|NCT02055547|561384810|FG004|Overall Study|Physician Decision|1|||
155535709|NCT02055547|561384811|FG005|Overall Study|Physician Decision|0|||
155535710|NCT02055547|561384812|FG006|Overall Study|Physician Decision|0|||
155535711|NCT02055547|561384813|FG007|Overall Study|Physician Decision|0|||
155535712|NCT02055547|561384814|FG008|Overall Study|Physician Decision|0|||
155535713|NCT02055547|561384815|FG009|Overall Study|Physician Decision|1|||
155535714|NCT02055547|561384816|FG010|Overall Study|Physician Decision|1|||
155535715|NCT02055547|561384817|FG011|Overall Study|Physician Decision|0|||
155535716|NCT02055547|561384818|FG012|Overall Study|Physician Decision|0|||
155535717|NCT02055547|561384819|FG013|Overall Study|Physician Decision|0|||
155535718|NCT02055547|561384820|FG014|Overall Study|Physician Decision|0|||
155535719|NCT02055547|561384821|FG015|Overall Study|Physician Decision|0|||
155535720|NCT02055547|561384822|FG016|Overall Study|Physician Decision|0|||
155535721|NCT02055547|561384823|FG017|Overall Study|Physician Decision|0|||
155535722|NCT02055547|561384824|FG018|Overall Study|Physician Decision|0|||
155535723|NCT02055547|561384806|FG000|Overall Study|Adverse Event|0|||
155535724|NCT02055547|561384807|FG001|Overall Study|Adverse Event|0|||
155535725|NCT02055547|561384808|FG002|Overall Study|Adverse Event|0|||
155535726|NCT02055547|561384809|FG003|Overall Study|Adverse Event|0|||
155535727|NCT02055547|561384810|FG004|Overall Study|Adverse Event|0|||
155535728|NCT02055547|561384811|FG005|Overall Study|Adverse Event|0|||
155535729|NCT02055547|561384812|FG006|Overall Study|Adverse Event|1|||
155535730|NCT02055547|561384813|FG007|Overall Study|Adverse Event|0|||
155535731|NCT02055547|561384814|FG008|Overall Study|Adverse Event|1|||
155535732|NCT02055547|561384815|FG009|Overall Study|Adverse Event|0|||
155535733|NCT02055547|561384816|FG010|Overall Study|Adverse Event|0|||
155535734|NCT02055547|561384817|FG011|Overall Study|Adverse Event|0|||
155535735|NCT02055547|561384818|FG012|Overall Study|Adverse Event|0|||
155535736|NCT02055547|561384819|FG013|Overall Study|Adverse Event|0|||
155535737|NCT02055547|561384820|FG014|Overall Study|Adverse Event|0|||
155535738|NCT02055547|561384821|FG015|Overall Study|Adverse Event|0|||
155535739|NCT02055547|561384822|FG016|Overall Study|Adverse Event|0|||
155535740|NCT02055547|561384823|FG017|Overall Study|Adverse Event|0|||
155535741|NCT02055547|561384824|FG018|Overall Study|Adverse Event|0|||
155535742|NCT02055547|561384806|FG000|Overall Study|Withdrawal by Subject|0|||
155535743|NCT02055547|561384807|FG001|Overall Study|Withdrawal by Subject|0|||
155535744|NCT02055547|561384808|FG002|Overall Study|Withdrawal by Subject|0|||
155535745|NCT02055547|561384809|FG003|Overall Study|Withdrawal by Subject|0|||
155535746|NCT02055547|561384810|FG004|Overall Study|Withdrawal by Subject|0|||
155535747|NCT02055547|561384811|FG005|Overall Study|Withdrawal by Subject|1|||
155535748|NCT02055547|561384812|FG006|Overall Study|Withdrawal by Subject|0|||
155535749|NCT02055547|561384813|FG007|Overall Study|Withdrawal by Subject|0|||
155535750|NCT02055547|561384814|FG008|Overall Study|Withdrawal by Subject|1|||
155535751|NCT02055547|561384815|FG009|Overall Study|Withdrawal by Subject|0|||
155535752|NCT02055547|561384816|FG010|Overall Study|Withdrawal by Subject|0|||
155535753|NCT02055547|561384817|FG011|Overall Study|Withdrawal by Subject|0|||
155535754|NCT02055547|561384818|FG012|Overall Study|Withdrawal by Subject|0|||
155535755|NCT02055547|561384819|FG013|Overall Study|Withdrawal by Subject|1|||
155535756|NCT02055547|561384820|FG014|Overall Study|Withdrawal by Subject|0|||
155535757|NCT02055547|561384821|FG015|Overall Study|Withdrawal by Subject|1|||
155535758|NCT02055547|561384822|FG016|Overall Study|Withdrawal by Subject|0|||
155535759|NCT02055547|561384823|FG017|Overall Study|Withdrawal by Subject|0|||
155535760|NCT02055547|561384824|FG018|Overall Study|Withdrawal by Subject|0|||
155535761|NCT02055547|561384806|FG000|Overall Study|Lost to Follow-up|0|||
155535762|NCT02055547|561384807|FG001|Overall Study|Lost to Follow-up|0|||
155535763|NCT02055547|561384808|FG002|Overall Study|Lost to Follow-up|1|||
155535764|NCT02055547|561384809|FG003|Overall Study|Lost to Follow-up|0|||
155535765|NCT02055547|561384810|FG004|Overall Study|Lost to Follow-up|0|||
155535766|NCT02055547|561384811|FG005|Overall Study|Lost to Follow-up|0|||
155535767|NCT02055547|561384812|FG006|Overall Study|Lost to Follow-up|0|||
155535768|NCT02055547|561384813|FG007|Overall Study|Lost to Follow-up|0|||
155535769|NCT02055547|561384814|FG008|Overall Study|Lost to Follow-up|0|||
155535770|NCT02055547|561384815|FG009|Overall Study|Lost to Follow-up|0|||
155535771|NCT02055547|561384816|FG010|Overall Study|Lost to Follow-up|0|||
155535772|NCT02055547|561384817|FG011|Overall Study|Lost to Follow-up|0|||
155535773|NCT02055547|561384818|FG012|Overall Study|Lost to Follow-up|0|||
155535774|NCT02055547|561384819|FG013|Overall Study|Lost to Follow-up|0|||
155535775|NCT02055547|561384820|FG014|Overall Study|Lost to Follow-up|0|||
155535776|NCT02055547|561384821|FG015|Overall Study|Lost to Follow-up|0|||
155535777|NCT02055547|561384822|FG016|Overall Study|Lost to Follow-up|0|||
155535778|NCT02055547|561384823|FG017|Overall Study|Lost to Follow-up|0|||
155535779|NCT02055547|561384824|FG018|Overall Study|Lost to Follow-up|0|||
155535780|NCT03498560|561384826|FG000|Overall Study|Found Ineligible|2|||
155535781|NCT03498560|561384826|FG000|Overall Study|Withdrawal by Subject|14|||
155535782|NCT03498560|561384826|FG000|Overall Study|Lost to Follow-up|4|||
155535783|NCT03498560|561384826|FG000|Overall Study|Death|1|||
155535784|NCT02896296|561384827|FG000|Overall Study|Adverse Event|1|||
155535785|NCT02896296|561384827|FG000|Overall Study|Lost to Follow-up|19|||
155535786|NCT02896296|561384827|FG000|Overall Study|Pregnancy|1|||
155535787|NCT02896296|561384827|FG000|Overall Study|Physician Decision|2|||
155535788|NCT02896296|561384827|FG000|Overall Study|Withdrawal by Subject|10|||
155535789|NCT02896296|561384827|FG000|Overall Study|Site closing|7|||
155535790|NCT02896296|561384827|FG000|Overall Study|Incarceration|1|||
155535791|NCT02896296|561384827|FG000|Overall Study|Relocation|1|||
155535792|NCT02597049|561384828|FG000|Overall Study|Lost to Follow-up|0|||
155535793|NCT02597049|561384829|FG001|Overall Study|Lost to Follow-up|3|||
155535794|NCT02597049|561384830|FG002|Overall Study|Lost to Follow-up|2|||
155535795|NCT02597049|561384828|FG000|Overall Study|Withdrawal by Subject|2|||
155535796|NCT02597049|561384829|FG001|Overall Study|Withdrawal by Subject|2|||
155535797|NCT02597049|561384830|FG002|Overall Study|Withdrawal by Subject|1|||
155535798|NCT02597049|561384828|FG000|Overall Study|Adverse Event|2|||
155535799|NCT02597049|561384829|FG001|Overall Study|Adverse Event|0|||
155535800|NCT02597049|561384830|FG002|Overall Study|Adverse Event|0|||
155535801|NCT02597049|561384828|FG000|Overall Study|Death|2|||
155535802|NCT02597049|561384829|FG001|Overall Study|Death|0|||
155535803|NCT02597049|561384830|FG002|Overall Study|Death|0|||
155535804|NCT02597049|561384828|FG000|Overall Study|Noncompliant with Study Visits|1|||
155535805|NCT02597049|561384829|FG001|Overall Study|Noncompliant with Study Visits|0|||
155535806|NCT02597049|561384830|FG002|Overall Study|Noncompliant with Study Visits|0|||
155535807|NCT00227370|561384834|FG000|Overall Study|Withdrawal by Subject|1|||
155535808|NCT00227370|561384835|FG001|Overall Study|Withdrawal by Subject|2|||
155535809|NCT00227370|561384834|FG000|Overall Study|Death|3|||
155535810|NCT00227370|561384835|FG001|Overall Study|Death|4|||
155535811|NCT00227370|561384834|FG000|Overall Study|Adverse Event|6|||
155535812|NCT00227370|561384835|FG001|Overall Study|Adverse Event|11|||
155535813|NCT00227370|561384834|FG000|Overall Study|Physician Decision|9|||
155535814|NCT00227370|561384835|FG001|Overall Study|Physician Decision|6|||
155535815|NCT00227370|561384834|FG000|Overall Study|Other reasons|2|||
155535816|NCT00227370|561384835|FG001|Overall Study|Other reasons|1|||
155535817|NCT00147498|561384836|FG000|Overall Study|Adverse Event|1|||
155535818|NCT00147498|561384837|FG001|Overall Study|Adverse Event|6|||
155535819|NCT00147498|561384838|FG002|Overall Study|Adverse Event|7|||
155535820|NCT00147498|561384839|FG003|Overall Study|Adverse Event|3|||
155535821|NCT00147498|561384836|FG000|Overall Study|Lack of Efficacy|1|||
155535822|NCT00147498|561384837|FG001|Overall Study|Lack of Efficacy|1|||
155535823|NCT00147498|561384838|FG002|Overall Study|Lack of Efficacy|1|||
155535824|NCT00147498|561384839|FG003|Overall Study|Lack of Efficacy|8|||
155535825|NCT00147498|561384836|FG000|Overall Study|Laboratory abnormality|0|||
155535826|NCT00147498|561384837|FG001|Overall Study|Laboratory abnormality|0|||
155535827|NCT00147498|561384838|FG002|Overall Study|Laboratory abnormality|2|||
155535828|NCT00147498|561384839|FG003|Overall Study|Laboratory abnormality|0|||
155535829|NCT00147498|561384836|FG000|Overall Study|Participant defaulted|0|||
155535830|NCT00147498|561384837|FG001|Overall Study|Participant defaulted|1|||
155535831|NCT00147498|561384838|FG002|Overall Study|Participant defaulted|4|||
155535832|NCT00147498|561384839|FG003|Overall Study|Participant defaulted|3|||
155535833|NCT00147498|561384836|FG000|Overall Study|Other|1|||
155535834|NCT00147498|561384837|FG001|Overall Study|Other|1|||
155535835|NCT00147498|561384838|FG002|Overall Study|Other|3|||
155535836|NCT00147498|561384839|FG003|Overall Study|Other|3|||
155535837|NCT01473953|561384843|FG000|Overall Study|Other|1|||
155535838|NCT01473953|561384844|FG001|Overall Study|Other|0|||
155535839|NCT01473953|561384845|FG002|Overall Study|Other|0|||
155535840|NCT01473953|561384846|FG003|Overall Study|Other|0|||
155535841|NCT01473953|561384847|FG004|Overall Study|Other|0|||
155535842|NCT02011945|561384850|FG000|Overall Study|Participant requested to Discontinue|0|||
155535843|NCT02011945|561384851|FG001|Overall Study|Participant requested to Discontinue|1|||
155535844|NCT02011945|561384852|FG002|Overall Study|Participant requested to Discontinue|1|||
155535845|NCT02011945|561384850|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
155535846|NCT02011945|561384851|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
155535847|NCT02011945|561384852|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
155535848|NCT02011945|561384850|FG000|Overall Study|Study Drug Toxicity|0|||
155535849|NCT02011945|561384851|FG001|Overall Study|Study Drug Toxicity|0|||
155535850|NCT02011945|561384852|FG002|Overall Study|Study Drug Toxicity|1|||
155535851|NCT02011945|561384850|FG000|Overall Study|Treatment Failure|0|||
155535852|NCT02011945|561384851|FG001|Overall Study|Treatment Failure|7|||
155535853|NCT02011945|561384852|FG002|Overall Study|Treatment Failure|6|||
155535854|NCT02011945|561384850|FG000|Overall Study|No Longer Meets Study Criteria|1|||
155535855|NCT02011945|561384851|FG001|Overall Study|No Longer Meets Study Criteria|0|||
155535856|NCT02011945|561384852|FG002|Overall Study|No Longer Meets Study Criteria|0|||
155535857|NCT02011945|561384850|FG000|Overall Study|Proceeded to stem cell transplant|0|||
155535858|NCT02011945|561384851|FG001|Overall Study|Proceeded to stem cell transplant|0|||
155535859|NCT02011945|561384852|FG002|Overall Study|Proceeded to stem cell transplant|1|||
155535860|NCT02011945|561384850|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
155535861|NCT02011945|561384851|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
155535862|NCT02011945|561384852|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
155535863|NCT00902538|561384853|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
155535864|NCT00902538|561384854|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155535865|NCT00902538|561384855|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155535866|NCT00902538|561384856|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155535867|NCT00902538|561384857|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155535868|NCT00902538|561384858|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155535869|NCT00902538|561384853|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
155535870|NCT00902538|561384854|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155535871|NCT00902538|561384855|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155535872|NCT00902538|561384856|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155535873|NCT00902538|561384857|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155535874|NCT00902538|561384858|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155535875|NCT00902538|561384853|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
155535876|NCT00902538|561384854|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155535877|NCT00902538|561384855|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155535878|NCT00902538|561384856|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155535879|NCT00902538|561384857|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155535880|NCT00902538|561384858|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155535881|NCT00902538|561384853|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
155535882|NCT00902538|561384854|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
155535883|NCT00902538|561384855|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
155535884|NCT00902538|561384856|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
155535885|NCT00902538|561384857|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
155655590|NCT01397253|561833543|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
155655591|NCT01397253|561833544|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
155655592|NCT00980044|561833547|FG000|Overall Study|Withdrawal by Subject|5|||
155655593|NCT00980044|561833548|FG001|Overall Study|Withdrawal by Subject|7|||
155655594|NCT00980044|561833549|FG002|Overall Study|Withdrawal by Subject|3|||
155655595|NCT00980044|561833547|FG000|Overall Study|Protocol Violation|0|||
155655596|NCT00980044|561833548|FG001|Overall Study|Protocol Violation|0|||
155655597|NCT00980044|561833549|FG002|Overall Study|Protocol Violation|2|||
155655598|NCT00500331|561833551|FG000|Overall Study|Adverse Event|0|||
155655599|NCT00500331|561833552|FG001|Overall Study|Adverse Event|2|||
155655600|NCT00500331|561833553|FG002|Overall Study|Adverse Event|0|||
155655601|NCT00500331|561833554|FG003|Overall Study|Adverse Event|1|||
155655602|NCT00500331|561833555|FG004|Overall Study|Adverse Event|2|||
155655603|NCT00500331|561833556|FG005|Overall Study|Adverse Event|2|||
155655604|NCT00500331|561833557|FG006|Overall Study|Adverse Event|0|||
155655605|NCT00500331|561833551|FG000|Overall Study|Lost to Follow-up|1|||
155655606|NCT00500331|561833552|FG001|Overall Study|Lost to Follow-up|1|||
155655607|NCT00500331|561833553|FG002|Overall Study|Lost to Follow-up|1|||
155535886|NCT00902538|561384858|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
155535887|NCT00902538|561384853|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
155535888|NCT00902538|561384854|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
155535889|NCT00902538|561384855|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
155535890|NCT00902538|561384856|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
155535891|NCT00902538|561384857|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
155535892|NCT00902538|561384858|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
155535893|NCT00902538|561384853|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
155535894|NCT00902538|561384854|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
155535895|NCT00902538|561384855|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
155535896|NCT00902538|561384856|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
155535897|NCT00902538|561384857|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
155535898|NCT00902538|561384858|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
155535899|NCT00902538|561384853|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
155535900|NCT00902538|561384854|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
155655608|NCT00500331|561833554|FG003|Overall Study|Lost to Follow-up|2|||
155655609|NCT00500331|561833555|FG004|Overall Study|Lost to Follow-up|1|||
155655610|NCT00500331|561833556|FG005|Overall Study|Lost to Follow-up|0|||
155655611|NCT00500331|561833557|FG006|Overall Study|Lost to Follow-up|0|||
155655612|NCT00500331|561833551|FG000|Overall Study|Protocol Violation|3|||
155535901|NCT00902538|561384855|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
155655613|NCT00500331|561833552|FG001|Overall Study|Protocol Violation|1|||
155535902|NCT00902538|561384856|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
155535903|NCT00902538|561384857|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
155535904|NCT00902538|561384858|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
155535905|NCT00902538|561384853|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
155535906|NCT00902538|561384854|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
155535907|NCT00902538|561384855|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
155535908|NCT00902538|561384856|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
155535909|NCT00902538|561384857|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
155535910|NCT00902538|561384858|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
155535911|NCT00902538|561384853|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
155535912|NCT00902538|561384854|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
155535913|NCT00902538|561384855|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
155535914|NCT00902538|561384856|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
155535915|NCT00902538|561384857|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
155535916|NCT00902538|561384858|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
155535917|NCT00902538|561384853|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
155535918|NCT00902538|561384854|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
155535919|NCT00902538|561384855|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
155535920|NCT00902538|561384856|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
155535921|NCT00902538|561384857|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
155535922|NCT00902538|561384858|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
155535923|NCT00902538|561384853|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
155535924|NCT00902538|561384854|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
155535925|NCT00902538|561384855|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
155535926|NCT00902538|561384856|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
155535927|NCT00902538|561384857|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
155535928|NCT00902538|561384858|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
155535929|NCT00902538|561384853|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
155535930|NCT00902538|561384854|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
155535931|NCT00902538|561384855|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
155535932|NCT00902538|561384856|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
155535933|NCT00902538|561384857|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
155535934|NCT00902538|561384858|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
155535935|NCT00902538|561384853|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
155535936|NCT00902538|561384854|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
155535937|NCT00902538|561384855|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
155535938|NCT00902538|561384856|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
155535939|NCT00902538|561384857|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
155535940|NCT00902538|561384858|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
155535941|NCT00902538|561384853|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155535942|NCT00902538|561384854|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
155535943|NCT00902538|561384855|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155535944|NCT00902538|561384856|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155535945|NCT00902538|561384857|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155535946|NCT00902538|561384858|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155655614|NCT00500331|561833553|FG002|Overall Study|Protocol Violation|1|||
155655615|NCT00500331|561833554|FG003|Overall Study|Protocol Violation|0|||
155655616|NCT00500331|561833555|FG004|Overall Study|Protocol Violation|1|||
155655617|NCT00500331|561833556|FG005|Overall Study|Protocol Violation|1|||
155655618|NCT00500331|561833557|FG006|Overall Study|Protocol Violation|1|||
155655619|NCT00500331|561833551|FG000|Overall Study|Withdrawal by Subject|4|||
155655620|NCT00500331|561833552|FG001|Overall Study|Withdrawal by Subject|0|||
155655621|NCT00500331|561833553|FG002|Overall Study|Withdrawal by Subject|1|||
155655622|NCT00500331|561833554|FG003|Overall Study|Withdrawal by Subject|5|||
155655623|NCT00500331|561833555|FG004|Overall Study|Withdrawal by Subject|0|||
155655624|NCT00500331|561833556|FG005|Overall Study|Withdrawal by Subject|1|||
155655625|NCT00500331|561833557|FG006|Overall Study|Withdrawal by Subject|1|||
155655626|NCT00500331|561833551|FG000|Overall Study|Lack of Efficacy|3|||
155655627|NCT00500331|561833552|FG001|Overall Study|Lack of Efficacy|1|||
155655628|NCT00500331|561833553|FG002|Overall Study|Lack of Efficacy|0|||
155655629|NCT00500331|561833554|FG003|Overall Study|Lack of Efficacy|0|||
155535947|NCT00902538|561384853|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
155655630|NCT00500331|561833555|FG004|Overall Study|Lack of Efficacy|0|||
155655631|NCT00500331|561833556|FG005|Overall Study|Lack of Efficacy|0|||
155655632|NCT00500331|561833557|FG006|Overall Study|Lack of Efficacy|0|||
155535948|NCT00902538|561384854|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
155535949|NCT00902538|561384855|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
155655633|NCT00500331|561833551|FG000|Overall Study|Liver function test abnormality|0|||
155655634|NCT00500331|561833552|FG001|Overall Study|Liver function test abnormality|0|||
155535950|NCT00902538|561384856|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
155535951|NCT00902538|561384857|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
155535952|NCT00902538|561384858|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
155535953|NCT00902538|561384853|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
155535954|NCT00902538|561384854|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
155535955|NCT00902538|561384855|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
155535956|NCT00902538|561384856|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
155535957|NCT00902538|561384857|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
155535958|NCT00902538|561384858|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
155535959|NCT00902538|561384853|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
155535960|NCT00902538|561384854|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
155535961|NCT00902538|561384855|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
155535962|NCT00902538|561384856|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
155535963|NCT00902538|561384857|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
155535964|NCT00902538|561384858|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
155535965|NCT03531827|561384859|FG000|Overall Study|Adverse Event|2|||
155535966|NCT03531827|561384860|FG001|Overall Study|Adverse Event|0|||
155535967|NCT03531827|561384859|FG000|Overall Study|Progressive disease|1|||
155535968|NCT03531827|561384860|FG001|Overall Study|Progressive disease|0|||
155535969|NCT01494532|561384863|FG000|Overall Study|Adverse Event|4|||
155535970|NCT01494532|561384864|FG001|Overall Study|Adverse Event|1|||
155535971|NCT01494532|561384865|FG002|Overall Study|Adverse Event|8|||
155535972|NCT01494532|561384866|FG003|Overall Study|Adverse Event|6|||
155535973|NCT01494532|561384867|FG004|Overall Study|Adverse Event|5|||
155535974|NCT01494532|561384868|FG005|Overall Study|Adverse Event|0|||
155535975|NCT01494532|561384863|FG000|Overall Study|Lack of Efficacy|0|||
155535976|NCT01494532|561384864|FG001|Overall Study|Lack of Efficacy|0|||
155535977|NCT01494532|561384865|FG002|Overall Study|Lack of Efficacy|0|||
155535978|NCT01494532|561384866|FG003|Overall Study|Lack of Efficacy|0|||
155535979|NCT01494532|561384867|FG004|Overall Study|Lack of Efficacy|2|||
155535980|NCT01494532|561384868|FG005|Overall Study|Lack of Efficacy|0|||
155535981|NCT01494532|561384863|FG000|Overall Study|Protocol deviation|2|||
155535982|NCT01494532|561384864|FG001|Overall Study|Protocol deviation|1|||
155535983|NCT01494532|561384865|FG002|Overall Study|Protocol deviation|3|||
155535984|NCT01494532|561384866|FG003|Overall Study|Protocol deviation|2|||
155535985|NCT01494532|561384867|FG004|Overall Study|Protocol deviation|3|||
155535986|NCT01494532|561384868|FG005|Overall Study|Protocol deviation|0|||
155535987|NCT01494532|561384863|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155535988|NCT01494532|561384864|FG001|Overall Study|Protocol-defined stopping criteria|0|||
155535989|NCT01494532|561384865|FG002|Overall Study|Protocol-defined stopping criteria|1|||
155535990|NCT01494532|561384866|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155535991|NCT01494532|561384867|FG004|Overall Study|Protocol-defined stopping criteria|0|||
155535992|NCT01494532|561384868|FG005|Overall Study|Protocol-defined stopping criteria|0|||
155535993|NCT01494532|561384863|FG000|Overall Study|Lost to Follow-up|1|||
155535994|NCT01494532|561384864|FG001|Overall Study|Lost to Follow-up|0|||
155535995|NCT01494532|561384865|FG002|Overall Study|Lost to Follow-up|0|||
155535996|NCT01494532|561384866|FG003|Overall Study|Lost to Follow-up|2|||
155535997|NCT01494532|561384867|FG004|Overall Study|Lost to Follow-up|0|||
155535998|NCT01494532|561384868|FG005|Overall Study|Lost to Follow-up|0|||
155535999|NCT01494532|561384863|FG000|Overall Study|Physician Decision|0|||
155536000|NCT01494532|561384864|FG001|Overall Study|Physician Decision|1|||
155536001|NCT01494532|561384865|FG002|Overall Study|Physician Decision|1|||
155536002|NCT01494532|561384866|FG003|Overall Study|Physician Decision|2|||
155536003|NCT01494532|561384867|FG004|Overall Study|Physician Decision|0|||
155536004|NCT01494532|561384868|FG005|Overall Study|Physician Decision|0|||
155536005|NCT01494532|561384863|FG000|Overall Study|Withdrawal by Subject|3|||
155536006|NCT01494532|561384864|FG001|Overall Study|Withdrawal by Subject|1|||
155536007|NCT01494532|561384865|FG002|Overall Study|Withdrawal by Subject|4|||
155536008|NCT01494532|561384866|FG003|Overall Study|Withdrawal by Subject|3|||
155536009|NCT01494532|561384867|FG004|Overall Study|Withdrawal by Subject|2|||
155536010|NCT01494532|561384868|FG005|Overall Study|Withdrawal by Subject|0|||
155536011|NCT00849797|561384869|FG000|First Intervention|bad veins|1|||
155536012|NCT00849797|561384870|FG001|First Intervention|bad veins|0|||
155536013|NCT00849797|561384869|FG000|First Intervention|Adverse Event|0|||
155536014|NCT00849797|561384870|FG001|First Intervention|Adverse Event|1|||
155536015|NCT00849797|561384869|FG000|Washout: One Week|Withdrawal by Subject|0|||
155536016|NCT00849797|561384870|FG001|Washout: One Week|Withdrawal by Subject|2|||
155536017|NCT00679081|561384871|FG000|Overall Study|Lost to Follow-up|1|||
155536018|NCT01404988|561384872|FG000|Overall Study|Death|2|||
155536019|NCT01404988|561384873|FG001|Overall Study|Death|0|||
155536020|NCT01404988|561384874|FG002|Overall Study|Death|2|||
155536021|NCT01404988|561384872|FG000|Overall Study|Adverse Event|1|||
155536022|NCT01404988|561384873|FG001|Overall Study|Adverse Event|0|||
155536023|NCT01404988|561384874|FG002|Overall Study|Adverse Event|0|||
155536024|NCT01404988|561384872|FG000|Overall Study|Withdrawal by Subject|2|||
155536025|NCT01404988|561384873|FG001|Overall Study|Withdrawal by Subject|2|||
155536026|NCT01404988|561384874|FG002|Overall Study|Withdrawal by Subject|0|||
155536027|NCT01404988|561384872|FG000|Overall Study|Lost to Follow-up|1|||
155536028|NCT01404988|561384873|FG001|Overall Study|Lost to Follow-up|2|||
155536029|NCT01404988|561384874|FG002|Overall Study|Lost to Follow-up|1|||
155536030|NCT00829764|561384875|FG000|First Intervention|Adverse Event|1|||
155536031|NCT00829764|561384876|FG001|First Intervention|Adverse Event|0|||
155536032|NCT00829764|561384875|FG000|First Intervention|Withdrawal by Subject|1|||
155536033|NCT00829764|561384876|FG001|First Intervention|Withdrawal by Subject|1|||
155536034|NCT00754052|561386687|FG000|Overall Study|Study terminated by Sponsor|5|||
155536035|NCT00754052|561386688|FG001|Overall Study|Study terminated by Sponsor|3|||
155536036|NCT02485158|561386693|FG000|Overall Study|Withdrawal by Subject|3|||
155536037|NCT02485158|561386693|FG000|Overall Study|expected drug side effect|1|||
155536038|NCT01098851|561386694|FG000|Overall Study|Equipment failure|1|||
155536039|NCT01098851|561386695|FG001|Overall Study|Equipment failure|0|||
155536040|NCT02316223|561386697|FG000|Overall Study|Lack of Efficacy|0|||
155536041|NCT02316223|561386698|FG001|Overall Study|Lack of Efficacy|1|||
155536042|NCT02316223|561386699|FG002|Overall Study|Lack of Efficacy|1|||
155536043|NCT02316223|561386697|FG000|Overall Study|Lost to Follow-up|27|||
155536044|NCT02316223|561386698|FG001|Overall Study|Lost to Follow-up|34|||
155536045|NCT02316223|561386699|FG002|Overall Study|Lost to Follow-up|36|||
155536046|NCT02316223|561386697|FG000|Overall Study|COPD Diagnosis|3|||
155536047|NCT02316223|561386698|FG001|Overall Study|COPD Diagnosis|2|||
155536048|NCT02316223|561386699|FG002|Overall Study|COPD Diagnosis|3|||
155536049|NCT02316223|561386697|FG000|Overall Study|Reside outside study area|1|||
155536050|NCT02316223|561386698|FG001|Overall Study|Reside outside study area|1|||
155536051|NCT02316223|561386699|FG002|Overall Study|Reside outside study area|1|||
155536052|NCT02316223|561386697|FG000|Overall Study|No asthma|2|||
155536053|NCT02316223|561386698|FG001|Overall Study|No asthma|0|||
155536054|NCT02316223|561386699|FG002|Overall Study|No asthma|0|||
155536055|NCT02316223|561386697|FG000|Overall Study|Discontinued by PI|11|||
155536056|NCT02316223|561386698|FG001|Overall Study|Discontinued by PI|19|||
155536057|NCT02316223|561386699|FG002|Overall Study|Discontinued by PI|3|||
155536058|NCT00529763|561386700|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155536059|NCT00529763|561386701|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
155536060|NCT00529763|561386702|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155536061|NCT00529763|561386700|FG000|Overall Study|Death|1|||
155536062|NCT00529763|561386701|FG001|Overall Study|Death|1|||
155536063|NCT00529763|561386702|FG002|Overall Study|Death|1|||
155536064|NCT00529763|561386700|FG000|Overall Study|Disease Progression|10|||
155536065|NCT00529763|561386701|FG001|Overall Study|Disease Progression|16|||
155536066|NCT00529763|561386702|FG002|Overall Study|Disease Progression|11|||
155536067|NCT00529763|561386700|FG000|Overall Study|Lost to Follow-up|1|||
155536068|NCT00529763|561386701|FG001|Overall Study|Lost to Follow-up|2|||
155536069|NCT00529763|561386702|FG002|Overall Study|Lost to Follow-up|3|||
155536070|NCT00529763|561386700|FG000|Overall Study|Stem Cell Transplant|0|||
155536071|NCT00529763|561386701|FG001|Overall Study|Stem Cell Transplant|3|||
155536072|NCT00529763|561386702|FG002|Overall Study|Stem Cell Transplant|1|||
155536073|NCT00529763|561386700|FG000|Overall Study|Study Drug Toxicity|3|||
155536074|NCT00529763|561386701|FG001|Overall Study|Study Drug Toxicity|6|||
155536075|NCT00529763|561386702|FG002|Overall Study|Study Drug Toxicity|4|||
155536076|NCT00529763|561386700|FG000|Overall Study|Participant Withdrew Consent|2|||
155536077|NCT00529763|561386701|FG001|Overall Study|Participant Withdrew Consent|3|||
155536078|NCT00529763|561386702|FG002|Overall Study|Participant Withdrew Consent|4|||
155536079|NCT00529763|561386700|FG000|Overall Study|Other reasons|2|||
155536080|NCT00529763|561386701|FG001|Overall Study|Other reasons|0|||
155536081|NCT00529763|561386702|FG002|Overall Study|Other reasons|2|||
155655635|NCT00500331|561833553|FG002|Overall Study|Liver function test abnormality|1|||
155655636|NCT00500331|561833554|FG003|Overall Study|Liver function test abnormality|0|||
155655637|NCT00500331|561833555|FG004|Overall Study|Liver function test abnormality|0|||
155655638|NCT00500331|561833556|FG005|Overall Study|Liver function test abnormality|0|||
155536082|NCT00529763|561386700|FG000|Overall Study|Participant request to discontinue treatment|1|||
155536083|NCT00529763|561386701|FG001|Overall Study|Participant request to discontinue treatment|1|||
155536084|NCT00529763|561386702|FG002|Overall Study|Participant request to discontinue treatment|3|||
155655639|NCT00500331|561833557|FG006|Overall Study|Liver function test abnormality|0|||
155536085|NCT03669250|561386703|FG000|Overall Study|Adverse Event|0|||
155536086|NCT03669250|561386704|FG001|Overall Study|Adverse Event|0|||
155536087|NCT03669250|561386705|FG002|Overall Study|Adverse Event|0|||
155536088|NCT03669250|561386706|FG003|Overall Study|Adverse Event|0|||
155536089|NCT03669250|561386707|FG004|Overall Study|Adverse Event|1|||
155536090|NCT03669250|561386708|FG005|Overall Study|Adverse Event|0|||
155536091|NCT03669250|561386703|FG000|Overall Study|Withdrawal by Subject|0|||
155536092|NCT03669250|561386704|FG001|Overall Study|Withdrawal by Subject|1|||
155536093|NCT03669250|561386705|FG002|Overall Study|Withdrawal by Subject|0|||
155536094|NCT03669250|561386706|FG003|Overall Study|Withdrawal by Subject|1|||
155536095|NCT03669250|561386707|FG004|Overall Study|Withdrawal by Subject|0|||
155536096|NCT03669250|561386708|FG005|Overall Study|Withdrawal by Subject|0|||
155536097|NCT03234907|561386711|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
155536098|NCT03234907|561386712|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
155536099|NCT03234907|561386713|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
155536100|NCT03234907|561386714|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
155536101|NCT03234907|561386715|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
155536102|NCT03234907|561386716|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
155536103|NCT03234907|561386711|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
155536104|NCT03234907|561386712|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
155536105|NCT03234907|561386713|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
155536106|NCT03234907|561386714|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
155536107|NCT03234907|561386715|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
155536108|NCT03234907|561386716|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
155536109|NCT03234907|561386711|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
155536110|NCT03234907|561386712|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
155536111|NCT03234907|561386713|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
155536112|NCT03234907|561386714|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
155536113|NCT03234907|561386715|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
155536114|NCT03234907|561386716|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
155536115|NCT03234907|561386711|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
155536116|NCT03234907|561386712|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
155536117|NCT03234907|561386713|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
155536118|NCT03234907|561386714|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
155536119|NCT03234907|561386715|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
155536120|NCT03234907|561386716|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
155536121|NCT03234907|561386711|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
155536122|NCT03234907|561386712|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
155536123|NCT03234907|561386713|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
155536124|NCT03234907|561386714|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
155536125|NCT03234907|561386715|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
155536126|NCT03234907|561386716|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
155536127|NCT03234907|561386711|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
155536128|NCT03234907|561386712|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
155536129|NCT03234907|561386713|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
155536130|NCT03234907|561386714|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
155536131|NCT03234907|561386715|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
155536132|NCT03234907|561386716|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
155536133|NCT03234907|561386711|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
155536134|NCT03234907|561386712|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
155536135|NCT03234907|561386713|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
155536136|NCT03234907|561386714|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
155536137|NCT03234907|561386715|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
155536138|NCT03234907|561386716|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
155536139|NCT00414726|561386717|FG000|Overall Study|Withdrawal by Subject|0|||
155536140|NCT00414726|561386718|FG001|Overall Study|Withdrawal by Subject|1|||
155536141|NCT02107196|561386719|FG000|12-week Treatment Period|Adverse Event|6|||
155536142|NCT02107196|561386720|FG001|12-week Treatment Period|Adverse Event|3|||
155536143|NCT02107196|561386719|FG000|12-week Treatment Period|Lack of Efficacy|2|||
155536144|NCT02107196|561386720|FG001|12-week Treatment Period|Lack of Efficacy|1|||
155536145|NCT02107196|561386719|FG000|12-week Treatment Period|Lost to Follow-up|3|||
155536146|NCT02107196|561386720|FG001|12-week Treatment Period|Lost to Follow-up|6|||
155536147|NCT02107196|561386719|FG000|12-week Treatment Period|Physician Decision|0|||
155536148|NCT02107196|561386720|FG001|12-week Treatment Period|Physician Decision|1|||
155536149|NCT02107196|561386719|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
155536150|NCT02107196|561386720|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
155536151|NCT02107196|561386719|FG000|12-week Treatment Period|Protocol Violation|7|||
155536152|NCT02107196|561386720|FG001|12-week Treatment Period|Protocol Violation|8|||
155536153|NCT02107196|561386719|FG000|12-week Treatment Period|Reason Missing|11|||
155536154|NCT02107196|561386720|FG001|12-week Treatment Period|Reason Missing|8|||
155536155|NCT02107196|561386719|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
155536156|NCT02107196|561386720|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
155536157|NCT02107196|561386719|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
155655640|NCT00500331|561833551|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
155655641|NCT00500331|561833552|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
155536158|NCT02107196|561386720|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155536159|NCT02107196|561386719|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
155536160|NCT02107196|561386720|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
155536161|NCT02107196|561386719|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
155536162|NCT02107196|561386720|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
155536163|NCT04158687|561386721|FG000|Overall Study|Adverse Event|2|||
155536164|NCT04158687|561386722|FG001|Overall Study|Adverse Event|3|||
155536165|NCT04158687|561386723|FG002|Overall Study|Adverse Event|0|||
155536166|NCT04158687|561386724|FG003|Overall Study|Adverse Event|3|||
155536167|NCT04158687|561386721|FG000|Overall Study|Lost to Follow-up|5|||
155536168|NCT04158687|561386722|FG001|Overall Study|Lost to Follow-up|12|||
155536169|NCT04158687|561386723|FG002|Overall Study|Lost to Follow-up|4|||
155536170|NCT04158687|561386724|FG003|Overall Study|Lost to Follow-up|5|||
155536171|NCT04158687|561386721|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
155536172|NCT04158687|561386722|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
155536173|NCT04158687|561386723|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
155536174|NCT04158687|561386724|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
155536175|NCT04158687|561386721|FG000|Overall Study|Non-Compliance with Study Medication|2|||
155536176|NCT04158687|561386722|FG001|Overall Study|Non-Compliance with Study Medication|2|||
155536177|NCT04158687|561386723|FG002|Overall Study|Non-Compliance with Study Medication|3|||
155536178|NCT04158687|561386724|FG003|Overall Study|Non-Compliance with Study Medication|0|||
155536179|NCT04158687|561386721|FG000|Overall Study|Investigator Decision|0|||
155536180|NCT04158687|561386722|FG001|Overall Study|Investigator Decision|0|||
155536181|NCT04158687|561386723|FG002|Overall Study|Investigator Decision|2|||
155536182|NCT04158687|561386724|FG003|Overall Study|Investigator Decision|0|||
155536183|NCT04158687|561386721|FG000|Overall Study|Protocol Violation|0|||
155536184|NCT04158687|561386722|FG001|Overall Study|Protocol Violation|2|||
155536185|NCT04158687|561386723|FG002|Overall Study|Protocol Violation|1|||
155536186|NCT04158687|561386724|FG003|Overall Study|Protocol Violation|0|||
155536187|NCT04158687|561386721|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
155536188|NCT04158687|561386722|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
155536189|NCT04158687|561386723|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
155536190|NCT04158687|561386724|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
155536191|NCT04158687|561386721|FG000|Overall Study|Reason not Specified|3|||
155536192|NCT04158687|561386722|FG001|Overall Study|Reason not Specified|2|||
155536193|NCT04158687|561386723|FG002|Overall Study|Reason not Specified|4|||
155536194|NCT04158687|561386724|FG003|Overall Study|Reason not Specified|4|||
155536195|NCT00640393|561386725|FG000|Part 1|Lost to Follow-up|2|||
155536196|NCT00640393|561386726|FG001|Part 1|Lost to Follow-up|0|||
155536197|NCT00640393|561386727|FG002|Part 1|Lost to Follow-up|0|||
155536198|NCT00640393|561386725|FG000|Part 1|Withdrawal by Subject|3|||
155536199|NCT00640393|561386726|FG001|Part 1|Withdrawal by Subject|0|||
155536200|NCT00640393|561386727|FG002|Part 1|Withdrawal by Subject|0|||
155536201|NCT00640393|561386725|FG000|Randomization|Withdrawn per protocol|17|||
155536202|NCT00640393|561386726|FG001|Randomization|Withdrawn per protocol|0|||
155536203|NCT00640393|561386727|FG002|Randomization|Withdrawn per protocol|0|||
155536204|NCT00640393|561386725|FG000|Randomization|Never randomized by site|2|||
155536205|NCT00640393|561386726|FG001|Randomization|Never randomized by site|0|||
155536206|NCT00640393|561386727|FG002|Randomization|Never randomized by site|0|||
155536207|NCT00640393|561386725|FG000|Part 2|Lost to Follow-up|0|||
155536208|NCT00640393|561386726|FG001|Part 2|Lost to Follow-up|2|||
155536209|NCT00640393|561386727|FG002|Part 2|Lost to Follow-up|2|||
155536210|NCT00640393|561386725|FG000|Part 2|Withdrawal by Subject|0|||
155536211|NCT00640393|561386726|FG001|Part 2|Withdrawal by Subject|6|||
155536212|NCT00640393|561386727|FG002|Part 2|Withdrawal by Subject|1|||
155536213|NCT00640393|561386725|FG000|Part 2|Non-adherence|0|||
155536214|NCT00640393|561386726|FG001|Part 2|Non-adherence|1|||
155536215|NCT00640393|561386727|FG002|Part 2|Non-adherence|0|||
155536216|NCT00640393|561386725|FG000|Part 2|Adverse Event|0|||
155536217|NCT00640393|561386726|FG001|Part 2|Adverse Event|1|||
155536218|NCT00640393|561386727|FG002|Part 2|Adverse Event|0|||
155536219|NCT02554877|561386728|FG000|Overall Study|Adverse Event|2|||
155536220|NCT02554877|561386729|FG001|Overall Study|Adverse Event|0|||
155536221|NCT02554877|561386730|FG002|Overall Study|Adverse Event|0|||
155536222|NCT02554877|561386731|FG003|Overall Study|Adverse Event|1|||
155536223|NCT02554877|561386728|FG000|Overall Study|Lost to Follow-up|1|||
155536224|NCT02554877|561386729|FG001|Overall Study|Lost to Follow-up|1|||
155536225|NCT02554877|561386730|FG002|Overall Study|Lost to Follow-up|1|||
155536226|NCT02554877|561386731|FG003|Overall Study|Lost to Follow-up|2|||
155536227|NCT02554877|561386728|FG000|Overall Study|Did not meet entrance criteria|0|||
155536228|NCT02554877|561386729|FG001|Overall Study|Did not meet entrance criteria|0|||
155536229|NCT02554877|561386730|FG002|Overall Study|Did not meet entrance criteria|1|||
155536230|NCT02554877|561386731|FG003|Overall Study|Did not meet entrance criteria|0|||
155536231|NCT02554877|561386728|FG000|Overall Study|No longer met eligibility criteria|1|||
155536232|NCT02554877|561386729|FG001|Overall Study|No longer met eligibility criteria|0|||
155536233|NCT02554877|561386730|FG002|Overall Study|No longer met eligibility criteria|1|||
155536234|NCT02554877|561386731|FG003|Overall Study|No longer met eligibility criteria|1|||
155536235|NCT02554877|561386728|FG000|Overall Study|Protocol Violation|3|||
155536236|NCT02554877|561386729|FG001|Overall Study|Protocol Violation|1|||
155536237|NCT02554877|561386730|FG002|Overall Study|Protocol Violation|1|||
155536238|NCT02554877|561386731|FG003|Overall Study|Protocol Violation|0|||
155536239|NCT02554877|561386728|FG000|Overall Study|Other|1|||
155536240|NCT02554877|561386729|FG001|Overall Study|Other|3|||
155536241|NCT02554877|561386730|FG002|Overall Study|Other|0|||
155536242|NCT02554877|561386731|FG003|Overall Study|Other|3|||
155536243|NCT02554877|561386728|FG000|Overall Study|Insufficient clinical response|4|||
155536244|NCT02554877|561386729|FG001|Overall Study|Insufficient clinical response|0|||
155536245|NCT02554877|561386730|FG002|Overall Study|Insufficient clinical response|0|||
155536246|NCT02554877|561386731|FG003|Overall Study|Insufficient clinical response|0|||
155536247|NCT02554877|561386728|FG000|Overall Study|No longer willing to participate|0|||
155536248|NCT02554877|561386729|FG001|Overall Study|No longer willing to participate|2|||
155536249|NCT02554877|561386730|FG002|Overall Study|No longer willing to participate|2|||
155536250|NCT02554877|561386731|FG003|Overall Study|No longer willing to participate|0|||
155536251|NCT00835666|561386732|FG000|Washout|Protocol Violation|1|||
155536252|NCT00835666|561386733|FG001|Washout|Protocol Violation|0|||
155536253|NCT00835666|561386732|FG000|Washout|Withdrawal by Subject|1|||
155536254|NCT00835666|561386733|FG001|Washout|Withdrawal by Subject|0|||
155536255|NCT01537887|561386734|FG000|Period 1|Physician Decision|0|||
155536256|NCT01537887|561386735|FG001|Period 1|Physician Decision|0|||
155536257|NCT01537887|561386736|FG002|Period 1|Physician Decision|0|||
155536258|NCT01537887|561386737|FG003|Period 1|Physician Decision|0|||
155536259|NCT01537887|561386738|FG004|Period 1|Physician Decision|1|||
155536260|NCT01537887|561386739|FG005|Period 1|Physician Decision|1|||
155536261|NCT01537887|561386734|FG000|Period 1|Did not receive treatment|0|||
155536262|NCT01537887|561386735|FG001|Period 1|Did not receive treatment|0|||
155536263|NCT01537887|561386736|FG002|Period 1|Did not receive treatment|1|||
155536264|NCT01537887|561386737|FG003|Period 1|Did not receive treatment|0|||
155536265|NCT01537887|561386738|FG004|Period 1|Did not receive treatment|0|||
155536266|NCT01537887|561386739|FG005|Period 1|Did not receive treatment|0|||
155536267|NCT01537887|561386734|FG000|Period 2|Withdrawal by Subject|0|||
155536268|NCT01537887|561386735|FG001|Period 2|Withdrawal by Subject|1|||
155536269|NCT01537887|561386736|FG002|Period 2|Withdrawal by Subject|0|||
155536270|NCT01537887|561386737|FG003|Period 2|Withdrawal by Subject|0|||
155536271|NCT01537887|561386738|FG004|Period 2|Withdrawal by Subject|0|||
155536272|NCT01537887|561386739|FG005|Period 2|Withdrawal by Subject|0|||
155536273|NCT01537887|561386734|FG000|Period 3|Adverse Event|0|||
155536274|NCT01537887|561386735|FG001|Period 3|Adverse Event|0|||
155536275|NCT01537887|561386736|FG002|Period 3|Adverse Event|1|||
155536276|NCT01537887|561386737|FG003|Period 3|Adverse Event|0|||
155536277|NCT01537887|561386738|FG004|Period 3|Adverse Event|0|||
155536278|NCT01537887|561386739|FG005|Period 3|Adverse Event|0|||
155536279|NCT01537887|561386734|FG000|Period 3|Withdrawal by Subject|0|||
155536280|NCT01537887|561386735|FG001|Period 3|Withdrawal by Subject|1|||
155536281|NCT01537887|561386736|FG002|Period 3|Withdrawal by Subject|0|||
155536282|NCT01537887|561386737|FG003|Period 3|Withdrawal by Subject|0|||
155536283|NCT01537887|561386738|FG004|Period 3|Withdrawal by Subject|0|||
155536284|NCT01537887|561386739|FG005|Period 3|Withdrawal by Subject|0|||
155536285|NCT01808651|561386740|FG000|Study Period 1|Lost to Follow-up|1|||
155536286|NCT01808651|561386741|FG001|Study Period 1|Lost to Follow-up|3|||
155536287|NCT01808651|561386742|FG002|Study Period 1|Lost to Follow-up|0|||
155536288|NCT01808651|561386740|FG000|Study Period 1|Protocol Violation|1|||
155536289|NCT01808651|561386741|FG001|Study Period 1|Protocol Violation|0|||
155536290|NCT01808651|561386742|FG002|Study Period 1|Protocol Violation|1|||
155536291|NCT01808651|561386740|FG000|Study Period 1|Physician Decision|3|||
155536292|NCT01808651|561386741|FG001|Study Period 1|Physician Decision|2|||
155536293|NCT01808651|561386742|FG002|Study Period 1|Physician Decision|0|||
155536294|NCT01808651|561386740|FG000|Study Period 1|Lack of Efficacy|2|||
155536295|NCT01808651|561386741|FG001|Study Period 1|Lack of Efficacy|1|||
155536296|NCT01808651|561386742|FG002|Study Period 1|Lack of Efficacy|0|||
155536297|NCT01808651|561386740|FG000|Study Period 1|Adverse Event|10|||
155536298|NCT01808651|561386741|FG001|Study Period 1|Adverse Event|4|||
155536299|NCT01808651|561386742|FG002|Study Period 1|Adverse Event|1|||
155536300|NCT01808651|561386740|FG000|Study Period 1|Participant Decision|9|||
155536301|NCT01808651|561386741|FG001|Study Period 1|Participant Decision|7|||
155536302|NCT01808651|561386742|FG002|Study Period 1|Participant Decision|3|||
155536303|NCT00585286|561386743|FG000|Overall Study|Lost to Follow-up|1|||
155536304|NCT00608322|561386747|FG000|Overall Study|Death|2|||
155536305|NCT00608322|561386748|FG001|Overall Study|Death|1|||
155536306|NCT04002648|561386749|FG000|Overall Study|Lost to Follow-up|2|||
155536307|NCT04002648|561386750|FG001|Overall Study|Lost to Follow-up|0|||
155536308|NCT05752721|561386755|FG000|Overall Study|Lost to Follow-up|22|||
155536309|NCT05752721|561386756|FG001|Overall Study|Lost to Follow-up|20|||
155536310|NCT05752721|561386755|FG000|Overall Study|Withdrawal by Subject|15|||
155536311|NCT05752721|561386756|FG001|Overall Study|Withdrawal by Subject|12|||
155536312|NCT00216736|561386763|FG000|Overall Study|Lost to Follow-up|1|||
155536313|NCT00216736|561386764|FG001|Overall Study|Lost to Follow-up|1|||
155536314|NCT00807495|561386766|FG000|Overall Study|Adverse Event|6|||
155536315|NCT00807495|561386767|FG001|Overall Study|Adverse Event|3|||
155536316|NCT00807495|561386768|FG002|Overall Study|Adverse Event|1|||
155536317|NCT00807495|561386769|FG003|Overall Study|Adverse Event|1|||
155536318|NCT00807495|561386770|FG004|Overall Study|Adverse Event|2|||
155536319|NCT00807495|561386766|FG000|Overall Study|Withdrawal by Patient|2|||
155536320|NCT00807495|561386767|FG001|Overall Study|Withdrawal by Patient|0|||
155536321|NCT00807495|561386768|FG002|Overall Study|Withdrawal by Patient|1|||
155536322|NCT00807495|561386769|FG003|Overall Study|Withdrawal by Patient|0|||
155536323|NCT00807495|561386770|FG004|Overall Study|Withdrawal by Patient|0|||
155536324|NCT00807495|561386766|FG000|Overall Study|Reason Not Specified|0|||
155536325|NCT00807495|561386767|FG001|Overall Study|Reason Not Specified|3|||
155536326|NCT00807495|561386768|FG002|Overall Study|Reason Not Specified|2|||
155536327|NCT00807495|561386769|FG003|Overall Study|Reason Not Specified|0|||
155536328|NCT00807495|561386770|FG004|Overall Study|Reason Not Specified|3|||
155536329|NCT00841542|561386771|FG000|Period 1|Adverse Event|1|||
155536330|NCT00841542|561386772|FG001|Period 1|Adverse Event|0|||
155536331|NCT01906372|561386773|FG000|Overall Study|Withdrawal by Subject|2|||
155536332|NCT02462837|561386774|FG000|Overall Study|pt developed hives|1|||
155536333|NCT02462837|561386775|FG001|Overall Study|pt developed hives|0|||
155536334|NCT02462837|561386774|FG000|Overall Study|Withdrawal by Subject|1|||
155536335|NCT02462837|561386775|FG001|Overall Study|Withdrawal by Subject|0|||
155536336|NCT00906399|561386776|FG000|Year 1|Randomized But Not Treated|0|||
155536337|NCT00906399|561386777|FG001|Year 1|Randomized But Not Treated|1|||
155536338|NCT00906399|561386778|FG002|Year 1|Randomized But Not Treated|3|||
155536339|NCT00906399|561386779|FG003|Year 1|Randomized But Not Treated|0|||
155536340|NCT00906399|561386780|FG004|Year 1|Randomized But Not Treated|0|||
155536341|NCT00906399|561386781|FG005|Year 1|Randomized But Not Treated|0|||
155536342|NCT00906399|561386782|FG006|Year 1|Randomized But Not Treated|0|||
155536343|NCT00906399|561386776|FG000|Year 1|Adverse Event|4|||
155536344|NCT00906399|561386777|FG001|Year 1|Adverse Event|22|||
155536345|NCT00906399|561386778|FG002|Year 1|Adverse Event|24|||
155536346|NCT00906399|561386779|FG003|Year 1|Adverse Event|0|||
155536347|NCT00906399|561386780|FG004|Year 1|Adverse Event|0|||
155536348|NCT00906399|561386781|FG005|Year 1|Adverse Event|0|||
155536349|NCT00906399|561386782|FG006|Year 1|Adverse Event|0|||
155536350|NCT00906399|561386776|FG000|Year 1|Lost to Follow-up|4|||
155536351|NCT00906399|561386777|FG001|Year 1|Lost to Follow-up|4|||
155536352|NCT00906399|561386778|FG002|Year 1|Lost to Follow-up|2|||
155536353|NCT00906399|561386779|FG003|Year 1|Lost to Follow-up|0|||
155536354|NCT00906399|561386780|FG004|Year 1|Lost to Follow-up|0|||
155536355|NCT00906399|561386781|FG005|Year 1|Lost to Follow-up|0|||
155536356|NCT00906399|561386782|FG006|Year 1|Lost to Follow-up|0|||
155536357|NCT00906399|561386776|FG000|Year 1|Withdrawal by Subject|30|||
155536358|NCT00906399|561386777|FG001|Year 1|Withdrawal by Subject|32|||
155536359|NCT00906399|561386778|FG002|Year 1|Withdrawal by Subject|36|||
155536360|NCT00906399|561386779|FG003|Year 1|Withdrawal by Subject|0|||
155536361|NCT00906399|561386780|FG004|Year 1|Withdrawal by Subject|0|||
155536362|NCT00906399|561386781|FG005|Year 1|Withdrawal by Subject|0|||
155536363|NCT00906399|561386782|FG006|Year 1|Withdrawal by Subject|0|||
155536364|NCT00906399|561386776|FG000|Year 1|Physician Decision|0|||
155536365|NCT00906399|561386777|FG001|Year 1|Physician Decision|1|||
155536366|NCT00906399|561386778|FG002|Year 1|Physician Decision|3|||
155536367|NCT00906399|561386779|FG003|Year 1|Physician Decision|0|||
155536368|NCT00906399|561386780|FG004|Year 1|Physician Decision|0|||
155536369|NCT00906399|561386781|FG005|Year 1|Physician Decision|0|||
155536370|NCT00906399|561386782|FG006|Year 1|Physician Decision|0|||
155536371|NCT00906399|561386776|FG000|Year 1|Death|2|||
155536372|NCT00906399|561386777|FG001|Year 1|Death|1|||
155536373|NCT00906399|561386778|FG002|Year 1|Death|1|||
155536374|NCT00906399|561386779|FG003|Year 1|Death|0|||
155536375|NCT00906399|561386780|FG004|Year 1|Death|0|||
155536376|NCT00906399|561386781|FG005|Year 1|Death|0|||
155536377|NCT00906399|561386782|FG006|Year 1|Death|0|||
155536378|NCT00906399|561386776|FG000|Year 1|Other|4|||
155536379|NCT00906399|561386777|FG001|Year 1|Other|2|||
155536380|NCT00906399|561386778|FG002|Year 1|Other|7|||
155536381|NCT00906399|561386779|FG003|Year 1|Other|0|||
155536382|NCT00906399|561386780|FG004|Year 1|Other|0|||
155536383|NCT00906399|561386781|FG005|Year 1|Other|0|||
155536384|NCT00906399|561386782|FG006|Year 1|Other|0|||
155536385|NCT00906399|561386776|FG000|Year 2|Adverse Event|0|||
155536386|NCT00906399|561386777|FG001|Year 2|Adverse Event|0|||
155536387|NCT00906399|561386778|FG002|Year 2|Adverse Event|0|||
155536388|NCT00906399|561386779|FG003|Year 2|Adverse Event|9|||
155536389|NCT00906399|561386780|FG004|Year 2|Adverse Event|8|||
155536390|NCT00906399|561386781|FG005|Year 2|Adverse Event|11|||
155536391|NCT00906399|561386782|FG006|Year 2|Adverse Event|6|||
155536392|NCT00906399|561386776|FG000|Year 2|Lost to Follow-up|0|||
155536393|NCT00906399|561386777|FG001|Year 2|Lost to Follow-up|0|||
155536394|NCT00906399|561386778|FG002|Year 2|Lost to Follow-up|0|||
155536395|NCT00906399|561386779|FG003|Year 2|Lost to Follow-up|1|||
155536396|NCT00906399|561386780|FG004|Year 2|Lost to Follow-up|4|||
155536397|NCT00906399|561386781|FG005|Year 2|Lost to Follow-up|2|||
155536398|NCT00906399|561386782|FG006|Year 2|Lost to Follow-up|4|||
155536399|NCT00906399|561386776|FG000|Year 2|Withdrawal by Subject|0|||
155536400|NCT00906399|561386777|FG001|Year 2|Withdrawal by Subject|0|||
155536401|NCT00906399|561386778|FG002|Year 2|Withdrawal by Subject|0|||
155536402|NCT00906399|561386779|FG003|Year 2|Withdrawal by Subject|17|||
155536403|NCT00906399|561386780|FG004|Year 2|Withdrawal by Subject|18|||
155536404|NCT00906399|561386781|FG005|Year 2|Withdrawal by Subject|27|||
155536405|NCT00906399|561386782|FG006|Year 2|Withdrawal by Subject|13|||
155536406|NCT00906399|561386776|FG000|Year 2|Physician Decision|0|||
155536407|NCT00906399|561386777|FG001|Year 2|Physician Decision|0|||
155536408|NCT00906399|561386778|FG002|Year 2|Physician Decision|0|||
155536409|NCT00906399|561386779|FG003|Year 2|Physician Decision|0|||
155536410|NCT00906399|561386780|FG004|Year 2|Physician Decision|2|||
155536411|NCT00906399|561386781|FG005|Year 2|Physician Decision|6|||
155536412|NCT00906399|561386782|FG006|Year 2|Physician Decision|3|||
155536413|NCT00906399|561386776|FG000|Year 2|Death|0|||
155536414|NCT00906399|561386777|FG001|Year 2|Death|0|||
155536415|NCT00906399|561386778|FG002|Year 2|Death|0|||
155536416|NCT00906399|561386779|FG003|Year 2|Death|1|||
155536417|NCT00906399|561386780|FG004|Year 2|Death|0|||
155536418|NCT00906399|561386781|FG005|Year 2|Death|0|||
155536419|NCT00906399|561386782|FG006|Year 2|Death|3|||
155536420|NCT00906399|561386776|FG000|Year 2|Other|0|||
155536421|NCT00906399|561386777|FG001|Year 2|Other|0|||
155536422|NCT00906399|561386778|FG002|Year 2|Other|0|||
155536423|NCT00906399|561386779|FG003|Year 2|Other|2|||
155536424|NCT00906399|561386780|FG004|Year 2|Other|3|||
155536425|NCT00906399|561386781|FG005|Year 2|Other|1|||
155536426|NCT00906399|561386782|FG006|Year 2|Other|0|||
155536427|NCT00624286|561386783|FG000|Overall Study|Protocol Deviation|7|||
155536428|NCT00624286|561386784|FG001|Overall Study|Protocol Deviation|9|||
155536429|NCT00624286|561386783|FG000|Overall Study|Adverse Event|6|||
155536430|NCT00624286|561386784|FG001|Overall Study|Adverse Event|3|||
155536431|NCT00624286|561386783|FG000|Overall Study|Withdrawal by Subject|5|||
155536432|NCT00624286|561386784|FG001|Overall Study|Withdrawal by Subject|4|||
155536433|NCT00624286|561386783|FG000|Overall Study|Lost to Follow-up|3|||
155536434|NCT00624286|561386784|FG001|Overall Study|Lost to Follow-up|2|||
155536435|NCT00624286|561386783|FG000|Overall Study|Administrative problems|3|||
155536436|NCT00624286|561386784|FG001|Overall Study|Administrative problems|0|||
155536437|NCT00624286|561386783|FG000|Overall Study|Lack of Efficacy|1|||
155536438|NCT00624286|561386784|FG001|Overall Study|Lack of Efficacy|6|||
155536439|NCT00624286|561386783|FG000|Overall Study|Not stated|0|||
155536440|NCT00624286|561386784|FG001|Overall Study|Not stated|1|||
155536441|NCT00624286|561386783|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155536442|NCT00624286|561386784|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155536443|NCT00624286|561386783|FG000|Overall Study|Death|0|||
155536444|NCT00624286|561386784|FG001|Overall Study|Death|1|||
155536445|NCT02845336|561386788|FG000|Overall Study|Lost to Follow-up|3|||
155536446|NCT02845336|561386789|FG001|Overall Study|Lost to Follow-up|1|||
155536447|NCT02845336|561386788|FG000|Overall Study|Inability to get medication|2|||
155536448|NCT02845336|561386789|FG001|Overall Study|Inability to get medication|0|||
155536449|NCT03488108|561386791|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
155536450|NCT03488108|561386792|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155536451|NCT03488108|561386791|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
155536452|NCT03488108|561386792|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
155536453|NCT00863330|561386793|FG000|Overall Study|study terminated early due to administra|6|||
155536454|NCT00674128|561386796|FG000|Overall Study|Withdrawal by Subject|25|||
155536455|NCT00674128|561386797|FG001|Overall Study|Withdrawal by Subject|23|||
155536456|NCT02615249|561386806|FG000|Overall Study|Withdrawal by Subject|1|||
155536457|NCT02471807|561386811|FG000|Overall Study|Death|14|||
155536458|NCT02471807|561386811|FG000|Overall Study|Withdrawal by Subject|2|||
155536459|NCT02471807|561386811|FG000|Overall Study|Explant|5|||
155536460|NCT02471807|561386811|FG000|Overall Study|Lost to Follow-up|1|||
155536461|NCT01559363|561386812|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
155536462|NCT01559363|561386813|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
155536463|NCT01559363|561386814|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
155536464|NCT01559363|561386815|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
155536465|NCT01559363|561386816|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
155536466|NCT01559363|561386817|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
155536467|NCT01559363|561386812|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
155536468|NCT01559363|561386813|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
155536469|NCT01559363|561386814|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
155536470|NCT01559363|561386815|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
155536471|NCT01559363|561386816|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
155536472|NCT01559363|561386817|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
155536473|NCT01559363|561386812|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
155536474|NCT01559363|561386813|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
155536475|NCT01559363|561386814|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
155536476|NCT01559363|561386815|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
155536477|NCT01559363|561386816|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
155536478|NCT01559363|561386817|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
155536479|NCT01559363|561386812|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
155536480|NCT01559363|561386813|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
155536481|NCT01559363|561386814|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
155536482|NCT01559363|561386815|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
155536483|NCT01559363|561386816|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
155536484|NCT01559363|561386817|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
155536485|NCT01559363|561386812|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
155536486|NCT01559363|561386813|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
155536487|NCT01559363|561386814|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
155536488|NCT01559363|561386815|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
155536489|NCT01559363|561386816|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
155536490|NCT01559363|561386817|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
155536491|NCT01559363|561386812|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
155536492|NCT01559363|561386813|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
155536493|NCT01559363|561386814|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
155536494|NCT01559363|561386815|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
155536495|NCT01559363|561386816|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
155536496|NCT01559363|561386817|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
155536497|NCT01559363|561386812|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
155655642|NCT00500331|561833553|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
155655643|NCT00500331|561833554|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
155536498|NCT01559363|561386813|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
155536499|NCT01559363|561386814|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
155536500|NCT01559363|561386815|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
155536501|NCT01559363|561386816|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
155536502|NCT01559363|561386817|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
155536503|NCT05098743|561386822|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
155536504|NCT05098743|561386823|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
155536505|NCT05098743|561386822|FG000|Overall Study|Lost to Follow-up|1|||
155536506|NCT05098743|561386823|FG001|Overall Study|Lost to Follow-up|2|||
155536507|NCT01456221|561386824|FG000|Overall Study|Withdrawal by Subject|56|||
155536508|NCT01456221|561386825|FG001|Overall Study|Withdrawal by Subject|49|||
155536509|NCT01456221|561386824|FG000|Overall Study|Lost to Follow-up|1|||
155536510|NCT01456221|561386825|FG001|Overall Study|Lost to Follow-up|4|||
155536511|NCT01456221|561386824|FG000|Overall Study|Received medication|3|||
155536512|NCT01456221|561386825|FG001|Overall Study|Received medication|2|||
155536513|NCT01456221|561386824|FG000|Overall Study|Incomplete data|4|||
155536514|NCT01456221|561386825|FG001|Overall Study|Incomplete data|2|||
155536515|NCT02272803|561386826|FG000|Overall Study|Disease progression|16|||
155536516|NCT02272803|561386827|FG001|Overall Study|Disease progression|8|||
155536517|NCT02272803|561386826|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
155536518|NCT02272803|561386827|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
155536519|NCT02272803|561386826|FG000|Overall Study|Study drug toxicity|4|||
155536520|NCT02272803|561386827|FG001|Overall Study|Study drug toxicity|9|||
155536521|NCT02272803|561386826|FG000|Overall Study|Participant request to discontinue study treatment|3|||
155536522|NCT02272803|561386827|FG001|Overall Study|Participant request to discontinue study treatment|7|||
155536523|NCT02272803|561386826|FG000|Overall Study|Maximum clinical benefit|4|||
155536524|NCT02272803|561386827|FG001|Overall Study|Maximum clinical benefit|2|||
155536525|NCT02272803|561386826|FG000|Overall Study|Poor/non-compliance|2|||
155536526|NCT02272803|561386827|FG001|Overall Study|Poor/non-compliance|2|||
155536527|NCT02272803|561386826|FG000|Overall Study|Withdrawal by Subject|2|||
155536528|NCT02272803|561386827|FG001|Overall Study|Withdrawal by Subject|1|||
155536529|NCT02272803|561386826|FG000|Overall Study|Death|0|||
155536530|NCT02272803|561386827|FG001|Overall Study|Death|1|||
155536531|NCT02272803|561386826|FG000|Overall Study|Other reasons|1|||
155536532|NCT02272803|561386827|FG001|Overall Study|Other reasons|3|||
155536533|NCT02272803|561386826|FG000|Overall Study|Administrative reason by sponsor|5|||
155536534|NCT02272803|561386827|FG001|Overall Study|Administrative reason by sponsor|4|||
155536535|NCT02611323|561386828|FG000|Overall Study|Death|3|||
155536536|NCT02611323|561386829|FG001|Overall Study|Death|1|||
155536537|NCT02611323|561386830|FG002|Overall Study|Death|0|||
155536538|NCT02611323|561386831|FG003|Overall Study|Death|0|||
155536539|NCT02611323|561386832|FG004|Overall Study|Death|1|||
155536540|NCT02611323|561386833|FG005|Overall Study|Death|1|||
155536541|NCT02611323|561386834|FG006|Overall Study|Death|8|||
155536542|NCT02611323|561386835|FG007|Overall Study|Death|0|||
155536543|NCT02611323|561386836|FG008|Overall Study|Death|4|||
155536544|NCT02611323|561386837|FG009|Overall Study|Death|6|||
155536545|NCT02611323|561386838|FG010|Overall Study|Death|26|||
155536546|NCT02611323|561386828|FG000|Overall Study|Lost to Follow-up|1|||
155536547|NCT02611323|561386829|FG001|Overall Study|Lost to Follow-up|0|||
155536548|NCT02611323|561386830|FG002|Overall Study|Lost to Follow-up|0|||
155536549|NCT02611323|561386831|FG003|Overall Study|Lost to Follow-up|0|||
155536550|NCT02611323|561386832|FG004|Overall Study|Lost to Follow-up|0|||
155536551|NCT02611323|561386833|FG005|Overall Study|Lost to Follow-up|0|||
155536552|NCT02611323|561386834|FG006|Overall Study|Lost to Follow-up|3|||
155536553|NCT02611323|561386835|FG007|Overall Study|Lost to Follow-up|0|||
155536554|NCT02611323|561386836|FG008|Overall Study|Lost to Follow-up|0|||
155536555|NCT02611323|561386837|FG009|Overall Study|Lost to Follow-up|0|||
155536556|NCT02611323|561386838|FG010|Overall Study|Lost to Follow-up|2|||
155536557|NCT02611323|561386828|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536558|NCT02611323|561386829|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536559|NCT02611323|561386830|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536560|NCT02611323|561386831|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536561|NCT02611323|561386832|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536562|NCT02611323|561386833|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536563|NCT02611323|561386834|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536564|NCT02611323|561386835|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536565|NCT02611323|561386836|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536566|NCT02611323|561386837|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
155536567|NCT02611323|561386838|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
155536568|NCT02611323|561386828|FG000|Overall Study|Progressive Disease|0|||
155536569|NCT02611323|561386829|FG001|Overall Study|Progressive Disease|0|||
155536570|NCT02611323|561386830|FG002|Overall Study|Progressive Disease|0|||
155536571|NCT02611323|561386831|FG003|Overall Study|Progressive Disease|0|||
155536572|NCT02611323|561386832|FG004|Overall Study|Progressive Disease|0|||
155536573|NCT02611323|561386833|FG005|Overall Study|Progressive Disease|0|||
155536574|NCT02611323|561386834|FG006|Overall Study|Progressive Disease|0|||
155536575|NCT02611323|561386835|FG007|Overall Study|Progressive Disease|0|||
155536576|NCT02611323|561386836|FG008|Overall Study|Progressive Disease|0|||
155536577|NCT02611323|561386837|FG009|Overall Study|Progressive Disease|0|||
155536578|NCT02611323|561386838|FG010|Overall Study|Progressive Disease|1|||
155536579|NCT02611323|561386828|FG000|Overall Study|Withdrawal by Subject|1|||
155536580|NCT02611323|561386829|FG001|Overall Study|Withdrawal by Subject|0|||
155536581|NCT02611323|561386830|FG002|Overall Study|Withdrawal by Subject|0|||
155536582|NCT02611323|561386831|FG003|Overall Study|Withdrawal by Subject|0|||
155536583|NCT02611323|561386832|FG004|Overall Study|Withdrawal by Subject|0|||
155536584|NCT02611323|561386833|FG005|Overall Study|Withdrawal by Subject|0|||
155536585|NCT02611323|561386834|FG006|Overall Study|Withdrawal by Subject|0|||
155536586|NCT02611323|561386835|FG007|Overall Study|Withdrawal by Subject|1|||
155536587|NCT02611323|561386836|FG008|Overall Study|Withdrawal by Subject|0|||
155536588|NCT02611323|561386837|FG009|Overall Study|Withdrawal by Subject|1|||
155536589|NCT02611323|561386838|FG010|Overall Study|Withdrawal by Subject|0|||
155536590|NCT01899053|561386840|FG000|Overall Study|Progressive Disease|4|||
155536591|NCT01899053|561386841|FG001|Overall Study|Progressive Disease|0|||
155536592|NCT01899053|561386842|FG002|Overall Study|Progressive Disease|3|||
155536593|NCT01899053|561386843|FG003|Overall Study|Progressive Disease|0|||
155536594|NCT01899053|561386844|FG004|Overall Study|Progressive Disease|3|||
155536595|NCT01899053|561386845|FG005|Overall Study|Progressive Disease|1|||
155536596|NCT01899053|561386846|FG006|Overall Study|Progressive Disease|1|||
155536597|NCT01899053|561386847|FG007|Overall Study|Progressive Disease|1|||
155536598|NCT01899053|561386848|FG008|Overall Study|Progressive Disease|4|||
155536599|NCT01899053|561386849|FG009|Overall Study|Progressive Disease|3|||
155536600|NCT01899053|561386850|FG010|Overall Study|Progressive Disease|12|||
155536601|NCT01899053|561386851|FG011|Overall Study|Progressive Disease|5|||
155536602|NCT01899053|561386852|FG012|Overall Study|Progressive Disease|8|||
155536603|NCT01899053|561386853|FG013|Overall Study|Progressive Disease|17|||
155536604|NCT01899053|561386840|FG000|Overall Study|Adverse Event|1|||
155536605|NCT01899053|561386841|FG001|Overall Study|Adverse Event|1|||
155536606|NCT01899053|561386842|FG002|Overall Study|Adverse Event|1|||
155536607|NCT01899053|561386843|FG003|Overall Study|Adverse Event|3|||
155536608|NCT01899053|561386844|FG004|Overall Study|Adverse Event|1|||
155536609|NCT01899053|561386845|FG005|Overall Study|Adverse Event|1|||
155536610|NCT01899053|561386846|FG006|Overall Study|Adverse Event|1|||
155536611|NCT01899053|561386847|FG007|Overall Study|Adverse Event|0|||
155536612|NCT01899053|561386848|FG008|Overall Study|Adverse Event|2|||
155536613|NCT01899053|561386849|FG009|Overall Study|Adverse Event|0|||
155536614|NCT01899053|561386850|FG010|Overall Study|Adverse Event|3|||
155536615|NCT01899053|561386851|FG011|Overall Study|Adverse Event|1|||
155536616|NCT01899053|561386852|FG012|Overall Study|Adverse Event|2|||
155536617|NCT01899053|561386853|FG013|Overall Study|Adverse Event|2|||
155536618|NCT01899053|561386840|FG000|Overall Study|Reason Not Specified|0|||
155536619|NCT01899053|561386841|FG001|Overall Study|Reason Not Specified|0|||
155536620|NCT01899053|561386842|FG002|Overall Study|Reason Not Specified|0|||
155536621|NCT01899053|561386843|FG003|Overall Study|Reason Not Specified|0|||
155536622|NCT01899053|561386844|FG004|Overall Study|Reason Not Specified|0|||
155536623|NCT01899053|561386845|FG005|Overall Study|Reason Not Specified|0|||
155536624|NCT01899053|561386846|FG006|Overall Study|Reason Not Specified|1|||
155536625|NCT01899053|561386847|FG007|Overall Study|Reason Not Specified|0|||
155536626|NCT01899053|561386848|FG008|Overall Study|Reason Not Specified|0|||
155536627|NCT01899053|561386849|FG009|Overall Study|Reason Not Specified|0|||
155536628|NCT01899053|561386850|FG010|Overall Study|Reason Not Specified|0|||
155536629|NCT01899053|561386851|FG011|Overall Study|Reason Not Specified|0|||
155536630|NCT01899053|561386852|FG012|Overall Study|Reason Not Specified|1|||
155536631|NCT01899053|561386853|FG013|Overall Study|Reason Not Specified|0|||
155536632|NCT01899053|561386840|FG000|Overall Study|Withdrawal by Subject|1|||
155536633|NCT01899053|561386841|FG001|Overall Study|Withdrawal by Subject|1|||
155536634|NCT01899053|561386842|FG002|Overall Study|Withdrawal by Subject|2|||
155536635|NCT01899053|561386843|FG003|Overall Study|Withdrawal by Subject|0|||
155536636|NCT01899053|561386844|FG004|Overall Study|Withdrawal by Subject|2|||
155536637|NCT01899053|561386845|FG005|Overall Study|Withdrawal by Subject|0|||
155536638|NCT01899053|561386846|FG006|Overall Study|Withdrawal by Subject|0|||
155536639|NCT01899053|561386847|FG007|Overall Study|Withdrawal by Subject|1|||
155536640|NCT01899053|561386848|FG008|Overall Study|Withdrawal by Subject|0|||
155536641|NCT01899053|561386849|FG009|Overall Study|Withdrawal by Subject|0|||
155536642|NCT01899053|561386850|FG010|Overall Study|Withdrawal by Subject|0|||
155536643|NCT01899053|561386851|FG011|Overall Study|Withdrawal by Subject|0|||
155536644|NCT01899053|561386852|FG012|Overall Study|Withdrawal by Subject|1|||
155536645|NCT01899053|561386853|FG013|Overall Study|Withdrawal by Subject|1|||
155536646|NCT01899053|561386840|FG000|Overall Study|Protocol Violation|0|||
155536647|NCT01899053|561386841|FG001|Overall Study|Protocol Violation|0|||
155536648|NCT01899053|561386842|FG002|Overall Study|Protocol Violation|1|||
155536649|NCT01899053|561386843|FG003|Overall Study|Protocol Violation|0|||
155655644|NCT00500331|561833555|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
155536650|NCT01899053|561386844|FG004|Overall Study|Protocol Violation|0|||
155536651|NCT01899053|561386845|FG005|Overall Study|Protocol Violation|0|||
155536652|NCT01899053|561386846|FG006|Overall Study|Protocol Violation|0|||
155536653|NCT01899053|561386847|FG007|Overall Study|Protocol Violation|0|||
155536654|NCT01899053|561386848|FG008|Overall Study|Protocol Violation|0|||
155536655|NCT01899053|561386849|FG009|Overall Study|Protocol Violation|0|||
155536656|NCT01899053|561386850|FG010|Overall Study|Protocol Violation|0|||
155536657|NCT01899053|561386851|FG011|Overall Study|Protocol Violation|0|||
155536658|NCT01899053|561386852|FG012|Overall Study|Protocol Violation|0|||
155536659|NCT01899053|561386853|FG013|Overall Study|Protocol Violation|0|||
155536660|NCT01899053|561386840|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
155655645|NCT00500331|561833556|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
155655646|NCT00500331|561833557|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
155655647|NCT00500331|561833551|FG000|Overall Study|Didn't return for continuation of study|1|||
155655648|NCT00500331|561833552|FG001|Overall Study|Didn't return for continuation of study|0|||
155655649|NCT00500331|561833553|FG002|Overall Study|Didn't return for continuation of study|0|||
155655650|NCT00500331|561833554|FG003|Overall Study|Didn't return for continuation of study|0|||
155655651|NCT00500331|561833555|FG004|Overall Study|Didn't return for continuation of study|0|||
155655652|NCT00500331|561833556|FG005|Overall Study|Didn't return for continuation of study|0|||
155655653|NCT00500331|561833557|FG006|Overall Study|Didn't return for continuation of study|0|||
155655654|NCT00500331|561833551|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
155655655|NCT00500331|561833552|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
155655656|NCT00500331|561833553|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
155536661|NCT01899053|561386841|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
155536662|NCT01899053|561386842|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536663|NCT01899053|561386843|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536664|NCT01899053|561386844|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536665|NCT01899053|561386845|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536666|NCT01899053|561386846|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536667|NCT01899053|561386847|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536668|NCT01899053|561386848|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536669|NCT01899053|561386849|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536670|NCT01899053|561386850|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
155536671|NCT01899053|561386851|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536672|NCT01899053|561386852|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536673|NCT01899053|561386853|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
155536674|NCT01899053|561386840|FG000|Overall Study|Symptomatic Deterioration|0|||
155536675|NCT01899053|561386841|FG001|Overall Study|Symptomatic Deterioration|0|||
155536676|NCT01899053|561386842|FG002|Overall Study|Symptomatic Deterioration|0|||
155536677|NCT01899053|561386843|FG003|Overall Study|Symptomatic Deterioration|0|||
155536678|NCT01899053|561386844|FG004|Overall Study|Symptomatic Deterioration|0|||
155536679|NCT01899053|561386845|FG005|Overall Study|Symptomatic Deterioration|1|||
155536680|NCT01899053|561386846|FG006|Overall Study|Symptomatic Deterioration|0|||
155536681|NCT01899053|561386847|FG007|Overall Study|Symptomatic Deterioration|1|||
155536682|NCT01899053|561386848|FG008|Overall Study|Symptomatic Deterioration|0|||
155536683|NCT01899053|561386849|FG009|Overall Study|Symptomatic Deterioration|0|||
155536684|NCT01899053|561386850|FG010|Overall Study|Symptomatic Deterioration|0|||
155536685|NCT01899053|561386851|FG011|Overall Study|Symptomatic Deterioration|1|||
155536686|NCT01899053|561386852|FG012|Overall Study|Symptomatic Deterioration|2|||
155536687|NCT01899053|561386853|FG013|Overall Study|Symptomatic Deterioration|0|||
155536688|NCT02452463|561386855|FG000|Overall Study|Death|1|||
155536689|NCT02452463|561386856|FG001|Overall Study|Death|0|||
155536690|NCT02452463|561386857|FG002|Overall Study|Death|0|||
155536691|NCT02452463|561386855|FG000|Overall Study|Study Suspended|1|||
155536692|NCT02452463|561386856|FG001|Overall Study|Study Suspended|0|||
155536693|NCT02452463|561386857|FG002|Overall Study|Study Suspended|0|||
155536694|NCT02452463|561386855|FG000|Overall Study|Recommended by DSMB|0|||
155536695|NCT02452463|561386856|FG001|Overall Study|Recommended by DSMB|1|||
155536696|NCT02452463|561386857|FG002|Overall Study|Recommended by DSMB|0|||
155536697|NCT02452463|561386855|FG000|Overall Study|Withdrawal by Subject|0|||
155536698|NCT02452463|561386856|FG001|Overall Study|Withdrawal by Subject|1|||
155536699|NCT02452463|561386857|FG002|Overall Study|Withdrawal by Subject|0|||
155536700|NCT01073631|561386858|FG000|Overall Study|Death|82|||
155536701|NCT01073631|561386858|FG000|Overall Study|Adverse Event|24|||
155536702|NCT01073631|561386858|FG000|Overall Study|Other|63|||
155536703|NCT04594252|561386864|FG000|Overall Study|Adverse Event|0|||
155536704|NCT04594252|561386865|FG001|Overall Study|Adverse Event|2|||
155536705|NCT00477594|561386866|FG000|Year 1 and Year 2|Adverse Event|4|||
155655657|NCT00500331|561833554|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
155655658|NCT00500331|561833555|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
155655659|NCT00500331|561833556|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
155536706|NCT00477594|561386867|FG001|Year 1 and Year 2|Adverse Event|2|||
155536707|NCT00477594|561386866|FG000|Year 1 and Year 2|Physician Decision|2|||
155536708|NCT00477594|561386867|FG001|Year 1 and Year 2|Physician Decision|1|||
155536709|NCT00477594|561386866|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
155536710|NCT00477594|561386867|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
155536711|NCT00477594|561386866|FG000|Year 1 and Year 2|Other|1|||
155536712|NCT00477594|561386867|FG001|Year 1 and Year 2|Other|0|||
155536713|NCT00477594|561386866|FG000|Year 3|Adverse Event|1|||
155536714|NCT00477594|561386867|FG001|Year 3|Adverse Event|0|||
155536715|NCT00477594|561386866|FG000|Year 3|Withdrawal by Subject|1|||
155536716|NCT00477594|561386867|FG001|Year 3|Withdrawal by Subject|0|||
155536717|NCT00477594|561386866|FG000|Follow-up Period|Withdrawal by Subject|2|||
155536718|NCT00477594|561386867|FG001|Follow-up Period|Withdrawal by Subject|1|||
155536719|NCT00477594|561386866|FG000|Follow-up Period|Other|1|||
155536720|NCT00477594|561386867|FG001|Follow-up Period|Other|0|||
155536721|NCT01109849|561388824|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
155536722|NCT01109849|561388825|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
155536723|NCT01109849|561388826|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
155536724|NCT01109849|561388827|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
155536725|NCT01109849|561388828|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
155536726|NCT01109849|561388824|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
155536727|NCT01109849|561388825|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
155536728|NCT01109849|561388826|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
155536729|NCT01109849|561388827|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
155536730|NCT01109849|561388828|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
155536731|NCT01109849|561388824|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
155536732|NCT01109849|561388825|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
155536733|NCT01109849|561388826|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
155536734|NCT01109849|561388827|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
155536735|NCT01109849|561388828|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
155536736|NCT01109849|561388824|FG000|Initial Randomization: ADHD Treatment|move away|2|||
155536737|NCT01109849|561388825|FG001|Initial Randomization: ADHD Treatment|move away|7|||
155536738|NCT01109849|561388826|FG002|Initial Randomization: ADHD Treatment|move away|0|||
155536739|NCT01109849|561388827|FG003|Initial Randomization: ADHD Treatment|move away|0|||
155536740|NCT01109849|561388828|FG004|Initial Randomization: ADHD Treatment|move away|0|||
155536741|NCT01109849|561388824|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
155536742|NCT01109849|561388825|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
155536743|NCT01109849|561388826|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
155536744|NCT01109849|561388827|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
155536745|NCT01109849|561388828|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
155536746|NCT01109849|561388824|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
155536747|NCT01109849|561388825|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
155536748|NCT01109849|561388826|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
155536749|NCT01109849|561388827|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
155536750|NCT01109849|561388828|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
155536751|NCT03969641|561388829|FG000|Overall Study|Lost to Follow-up|5|||
155536752|NCT03969641|561388830|FG001|Overall Study|Lost to Follow-up|3|||
155536753|NCT03969641|561388829|FG000|Overall Study|Withdrawal by Subject|1|||
155536754|NCT03969641|561388830|FG001|Overall Study|Withdrawal by Subject|2|||
155536755|NCT03969641|561388829|FG000|Overall Study|Found to be ineligible|1|||
155536756|NCT03969641|561388830|FG001|Overall Study|Found to be ineligible|1|||
155536757|NCT03969641|561388829|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
155536758|NCT03969641|561388830|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
155536759|NCT03969641|561388829|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
155536760|NCT03969641|561388830|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
155536761|NCT03969641|561388829|FG000|Overall Study|Elective termination|0|||
155536762|NCT03969641|561388830|FG001|Overall Study|Elective termination|1|||
155536763|NCT02658019|561388838|FG000|Overall Study|Adverse Event|1|||
155536764|NCT03087786|561388839|FG000|Overall Study|Withdrawal by Subject|2|||
155536765|NCT03087786|561388840|FG001|Overall Study|Withdrawal by Subject|0|||
155536766|NCT02986139|561388841|FG000|Overall Study|Sponsor Decision|1|||
155536767|NCT02986139|561388842|FG001|Overall Study|Sponsor Decision|2|||
155536768|NCT02986139|561388841|FG000|Overall Study|Withdrawal by Subject|0|||
155536769|NCT02986139|561388842|FG001|Overall Study|Withdrawal by Subject|1|||
155536770|NCT02986139|561388841|FG000|Overall Study|Lost to Follow-up|0|||
155536771|NCT02986139|561388842|FG001|Overall Study|Lost to Follow-up|1|||
155536772|NCT00660660|561388843|FG000|Overall Study|Adverse Event|1|||
155536773|NCT00660660|561388844|FG001|Overall Study|Adverse Event|0|||
155536774|NCT00660660|561388843|FG000|Overall Study|Lost to Follow-up|0|||
155536775|NCT00660660|561388844|FG001|Overall Study|Lost to Follow-up|6|||
155536776|NCT00660660|561388843|FG000|Overall Study|Lack of Efficacy|0|||
155536777|NCT00660660|561388844|FG001|Overall Study|Lack of Efficacy|2|||
155536778|NCT00660660|561388843|FG000|Overall Study|Withdrawal by Subject|3|||
155536779|NCT00660660|561388844|FG001|Overall Study|Withdrawal by Subject|0|||
155536780|NCT00660660|561388843|FG000|Overall Study|Incorrect enrollment and other|0|||
155536781|NCT00660660|561388844|FG001|Overall Study|Incorrect enrollment and other|1|||
155536782|NCT00660660|561388843|FG000|Overall Study|New medication after randomization|1|||
155536783|NCT00660660|561388844|FG001|Overall Study|New medication after randomization|0|||
155536784|NCT02313558|561388846|FG000|Overall Study|Withdrawal by Subject|2|||
155536785|NCT02313558|561388847|FG001|Overall Study|Withdrawal by Subject|0|||
155536786|NCT02313558|561388846|FG000|Overall Study|Lost to Follow-up|4|||
155536787|NCT02313558|561388847|FG001|Overall Study|Lost to Follow-up|4|||
155536788|NCT01370083|561388850|FG000|Overall Study|Lost to Follow-up|2|||
155536789|NCT01370083|561388851|FG001|Overall Study|Lost to Follow-up|0|||
155536790|NCT01370083|561388850|FG000|Overall Study|Adverse Event|0|||
155536791|NCT01370083|561388851|FG001|Overall Study|Adverse Event|1|||
155536792|NCT02450539|561388852|FG000|Overall Study|Withdrawal by Subject|12|||
155536793|NCT02450539|561388853|FG001|Overall Study|Withdrawal by Subject|6|||
155536794|NCT02450539|561388852|FG000|Overall Study|Lost to Follow-up|4|||
155536795|NCT02450539|561388853|FG001|Overall Study|Lost to Follow-up|1|||
155536796|NCT00731939|561388864|FG000|Overall Study|Adverse Event|6|||
155536797|NCT00731939|561388864|FG000|Overall Study|Lost to Follow-up|15|||
155536798|NCT00731939|561388864|FG000|Overall Study|Not implanted with study device|9|||
155536799|NCT00731939|561388864|FG000|Overall Study|Withdrawal by Subject|2|||
155536800|NCT00731939|561388864|FG000|Overall Study|Did not meet enrollment criteria|2|||
155536801|NCT02280863|561388865|FG000|Integrated Platform|Met stopping criteria|0|||
155536802|NCT02280863|561388866|FG001|Integrated Platform|Met stopping criteria|1|||
155536803|NCT02890992|561388869|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536804|NCT02890992|561388870|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
155536805|NCT02890992|561388871|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536806|NCT02890992|561388872|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536807|NCT02890992|561388873|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536808|NCT02890992|561388874|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536809|NCT02890992|561388875|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536810|NCT02890992|561388876|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155536811|NCT02890992|561388869|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536812|NCT02890992|561388870|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536813|NCT02890992|561388871|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536814|NCT02890992|561388872|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536815|NCT02890992|561388873|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536816|NCT02890992|561388874|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
155536817|NCT02890992|561388875|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
155536818|NCT02890992|561388876|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
155536819|NCT02890992|561388869|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536820|NCT02890992|561388870|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
155536821|NCT02890992|561388871|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536822|NCT02890992|561388872|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536823|NCT02890992|561388873|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536824|NCT02890992|561388874|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536825|NCT02890992|561388875|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536826|NCT02890992|561388876|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
155536827|NCT02622386|561388877|FG000|First Assignment|Withdrawal by Subject|3|||
155536828|NCT02622386|561388878|FG001|First Assignment|Withdrawal by Subject|2|||
155536829|NCT02622386|561388877|FG000|Washout|Withdrawal by Subject|4|||
155536830|NCT02622386|561388878|FG001|Washout|Withdrawal by Subject|4|||
155536831|NCT02622386|561388877|FG000|Second Assignment|Withdrawal by Subject|0|||
155536832|NCT02622386|561388878|FG001|Second Assignment|Withdrawal by Subject|2|||
155536833|NCT03236311|561388879|FG000|Overall Study|Study terminated by sponsor|0|||
155536834|NCT03236311|561388880|FG001|Overall Study|Study terminated by sponsor|2|||
155536835|NCT03236311|561388879|FG000|Overall Study|Adverse Event|0|||
155536836|NCT03236311|561388880|FG001|Overall Study|Adverse Event|1|||
155536837|NCT00669162|561388881|FG000|Overall Study|Withdrawal by Subject|1|||
155536838|NCT02704091|561388882|FG000|Overall Study|Adverse Event|4|||
155536839|NCT02704091|561388883|FG001|Overall Study|Adverse Event|3|||
155536840|NCT02704091|561388882|FG000|Overall Study|Protocol Violation|5|||
155536841|NCT02704091|561388883|FG001|Overall Study|Protocol Violation|3|||
155536842|NCT02704091|561388882|FG000|Overall Study|Consent withdrawn|4|||
155536843|NCT02704091|561388883|FG001|Overall Study|Consent withdrawn|4|||
155536844|NCT02704091|561388882|FG000|Overall Study|Lost to Follow-up|13|||
155536845|NCT02704091|561388883|FG001|Overall Study|Lost to Follow-up|5|||
155536846|NCT02704091|561388882|FG000|Overall Study|Other|2|||
155536847|NCT02704091|561388883|FG001|Overall Study|Other|8|||
155536848|NCT00985439|561388884|FG000|Overall Study|Adverse Event|0|||
155536849|NCT00985439|561388885|FG001|Overall Study|Adverse Event|0|||
155536850|NCT00985439|561388886|FG002|Overall Study|Adverse Event|1|||
155536851|NCT00985439|561388887|FG003|Overall Study|Adverse Event|0|||
155536852|NCT05274763|561388888|FG000|Overall Study|Lost to Follow-up|1|||
155536853|NCT01174186|561388889|FG000|Overall Study|Lost to Follow-up|0|||
155536854|NCT01174186|561388890|FG001|Overall Study|Lost to Follow-up|1|||
155536855|NCT01174186|561388889|FG000|Overall Study|Withdrawal by Subject|0|||
155536856|NCT01174186|561388890|FG001|Overall Study|Withdrawal by Subject|2|||
155536857|NCT01051349|561388891|FG000|Overall Study|Adverse Event|88|||
155536858|NCT01051349|561388891|FG000|Overall Study|Consent Withdrawn|54|||
155536859|NCT01051349|561388891|FG000|Overall Study|Investigator Decision|6|||
155536860|NCT01051349|561388891|FG000|Overall Study|Lost to Follow-up|6|||
155536861|NCT01051349|561388891|FG000|Overall Study|Subject non-compliance|7|||
155536862|NCT01051349|561388891|FG000|Overall Study|Reason not Specified|12|||
155536863|NCT00402103|561388892|FG000|Overall Study|Adverse Event|60|||
155536864|NCT00402103|561388893|FG001|Overall Study|Adverse Event|7|||
155536865|NCT00402103|561388892|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155536866|NCT00402103|561388893|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155536867|NCT00402103|561388892|FG000|Overall Study|Condition no longer requires study drug|2|||
155536868|NCT00402103|561388893|FG001|Overall Study|Condition no longer requires study drug|0|||
155536869|NCT00402103|561388892|FG000|Overall Study|Protocol Deviation|8|||
155536870|NCT00402103|561388893|FG001|Overall Study|Protocol Deviation|0|||
155536871|NCT00402103|561388892|FG000|Overall Study|Patient withdrew consent|12|||
155536872|NCT00402103|561388893|FG001|Overall Study|Patient withdrew consent|1|||
155536873|NCT00402103|561388892|FG000|Overall Study|Lost to Follow-up|6|||
155536874|NCT00402103|561388893|FG001|Overall Study|Lost to Follow-up|3|||
155536875|NCT00402103|561388892|FG000|Overall Study|Administrative problems|2|||
155536876|NCT00402103|561388893|FG001|Overall Study|Administrative problems|0|||
155536877|NCT00484679|561388894|FG000|Overall Study|Withdrawal by Subject|3|||
155536878|NCT00418145|561388897|FG000|Overall Study|study terminated|6|||
155536879|NCT00425308|561388898|FG000|Overall Study|Adverse Event|2|||
155536880|NCT00425308|561388899|FG001|Overall Study|Adverse Event|1|||
155536881|NCT00425308|561388898|FG000|Overall Study|Withdrawal by Subject|1|||
155536882|NCT00425308|561388899|FG001|Overall Study|Withdrawal by Subject|0|||
155536883|NCT00425308|561388898|FG000|Overall Study|Death|1|||
155536884|NCT00425308|561388899|FG001|Overall Study|Death|0|||
155536885|NCT00463684|561388904|FG000|Overall Study|Withdrawal by Subject|1|||
155536886|NCT00463684|561388904|FG000|Overall Study|Lost to Follow-up|3|||
155536887|NCT01075282|561388906|FG000|Overall Study|Withdrawal by Subject|11|||
155536888|NCT01075282|561388907|FG001|Overall Study|Withdrawal by Subject|7|||
155536889|NCT01075282|561388908|FG002|Overall Study|Withdrawal by Subject|11|||
155536890|NCT01075282|561388906|FG000|Overall Study|Adverse Event|9|||
155536891|NCT01075282|561388907|FG001|Overall Study|Adverse Event|8|||
155536892|NCT01075282|561388908|FG002|Overall Study|Adverse Event|5|||
155536893|NCT01075282|561388906|FG000|Overall Study|Entry Criteria Not Met|3|||
155536894|NCT01075282|561388907|FG001|Overall Study|Entry Criteria Not Met|2|||
155536895|NCT01075282|561388908|FG002|Overall Study|Entry Criteria Not Met|0|||
155536896|NCT01075282|561388906|FG000|Overall Study|Lost to Follow-up|3|||
155536897|NCT01075282|561388907|FG001|Overall Study|Lost to Follow-up|3|||
155536898|NCT01075282|561388908|FG002|Overall Study|Lost to Follow-up|3|||
155536899|NCT01075282|561388906|FG000|Overall Study|Physician Decision|3|||
155536900|NCT01075282|561388907|FG001|Overall Study|Physician Decision|3|||
155536901|NCT01075282|561388908|FG002|Overall Study|Physician Decision|3|||
155536902|NCT01075282|561388906|FG000|Overall Study|Lack of Efficacy|1|||
155536903|NCT01075282|561388907|FG001|Overall Study|Lack of Efficacy|1|||
155536904|NCT01075282|561388908|FG002|Overall Study|Lack of Efficacy|0|||
155536905|NCT01075282|561388906|FG000|Overall Study|Treatment Non-compliance|1|||
155536906|NCT01075282|561388907|FG001|Overall Study|Treatment Non-compliance|2|||
155536907|NCT01075282|561388908|FG002|Overall Study|Treatment Non-compliance|2|||
155536908|NCT01075282|561388906|FG000|Overall Study|Protocol Violation|0|||
155536909|NCT01075282|561388907|FG001|Overall Study|Protocol Violation|2|||
155536910|NCT01075282|561388908|FG002|Overall Study|Protocol Violation|1|||
155655660|NCT00500331|561833557|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
155536911|NCT01075282|561388906|FG000|Overall Study|Death|0|||
155536912|NCT01075282|561388907|FG001|Overall Study|Death|1|||
155536913|NCT01075282|561388908|FG002|Overall Study|Death|2|||
155536914|NCT00367133|561388909|FG000|2 Years|Death|20|||
155536915|NCT00367133|561388910|FG001|2 Years|Death|12|||
155536916|NCT00367133|561388911|FG002|2 Years|Death|12|||
155536917|NCT00367133|561388909|FG000|2 Years|Dropped|34|||
155655661|NCT00500331|561833551|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
155536918|NCT00367133|561388910|FG001|2 Years|Dropped|19|||
155536919|NCT00367133|561388911|FG002|2 Years|Dropped|33|||
155536920|NCT00367133|561388909|FG000|2 Years|Missed visit|4|||
155536921|NCT00367133|561388910|FG001|2 Years|Missed visit|5|||
155536922|NCT00367133|561388911|FG002|2 Years|Missed visit|4|||
155536923|NCT00847535|561388912|FG000|Overall Study|Withdrawal by Subject|2|||
155536924|NCT00847535|561388913|FG001|Overall Study|Withdrawal by Subject|1|||
155536925|NCT00847535|561388914|FG002|Overall Study|Withdrawal by Subject|1|||
155536926|NCT00847535|561388912|FG000|Overall Study|Lost to Follow-up|0|||
155536927|NCT00847535|561388913|FG001|Overall Study|Lost to Follow-up|1|||
155536928|NCT00847535|561388914|FG002|Overall Study|Lost to Follow-up|0|||
155536929|NCT01252953|561388915|FG000|Overall Study|Withdrawal by Subject|16|||
155536930|NCT01252953|561388916|FG001|Overall Study|Withdrawal by Subject|17|||
155536931|NCT01252953|561388915|FG000|Overall Study|Lost to Follow-up|22|||
155536932|NCT01252953|561388916|FG001|Overall Study|Lost to Follow-up|21|||
155536933|NCT00840203|561388917|FG000|First Intervention|Protocol Violation|1|||
155536934|NCT00840203|561388918|FG001|First Intervention|Protocol Violation|1|||
155536935|NCT00840203|561388917|FG000|Washout|Protocol Violation|1|||
155536936|NCT00840203|561388918|FG001|Washout|Protocol Violation|0|||
155536937|NCT00989950|561388923|FG000|Randomized Phase|Protocol Violation|1|||
155536938|NCT00989950|561388924|FG001|Randomized Phase|Protocol Violation|0|||
155536939|NCT00989950|561388925|FG002|Randomized Phase|Protocol Violation|0|||
155536940|NCT00989950|561388926|FG003|Randomized Phase|Protocol Violation|0|||
155536941|NCT00989950|561388923|FG000|Randomized Phase|Adverse Event|0|||
155536942|NCT00989950|561388924|FG001|Randomized Phase|Adverse Event|1|||
155536943|NCT00989950|561388925|FG002|Randomized Phase|Adverse Event|0|||
155536944|NCT00989950|561388926|FG003|Randomized Phase|Adverse Event|0|||
155536945|NCT00101439|561388927|FG000|Period 2|Withdrawal by Subject|0|||
155536946|NCT00101439|561388928|FG001|Period 2|Withdrawal by Subject|2|||
155536947|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
155536948|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
155536949|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
155536950|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
155536951|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
155536952|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
155536953|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
155536954|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
155536955|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
155536956|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
155536957|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
155536958|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
155655662|NCT00500331|561833552|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
155655663|NCT00500331|561833553|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
155655664|NCT00500331|561833554|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
155655665|NCT00500331|561833555|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
155655666|NCT00500331|561833556|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
155655667|NCT00500331|561833557|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
155655668|NCT00500331|561833551|FG000|Overall Study|Participant was randomized by mistake|1|||
155655669|NCT00500331|561833552|FG001|Overall Study|Participant was randomized by mistake|0|||
155655670|NCT00500331|561833553|FG002|Overall Study|Participant was randomized by mistake|0|||
155655671|NCT00500331|561833554|FG003|Overall Study|Participant was randomized by mistake|0|||
155655672|NCT00500331|561833555|FG004|Overall Study|Participant was randomized by mistake|0|||
155655673|NCT00500331|561833556|FG005|Overall Study|Participant was randomized by mistake|0|||
155655674|NCT00500331|561833557|FG006|Overall Study|Participant was randomized by mistake|0|||
155655675|NCT00500331|561833551|FG000|Overall Study|Diabetologist nurse in the study|0|||
155655676|NCT00500331|561833552|FG001|Overall Study|Diabetologist nurse in the study|0|||
155655677|NCT00500331|561833553|FG002|Overall Study|Diabetologist nurse in the study|1|||
155655678|NCT00500331|561833554|FG003|Overall Study|Diabetologist nurse in the study|0|||
155655679|NCT00500331|561833555|FG004|Overall Study|Diabetologist nurse in the study|0|||
155655680|NCT00500331|561833556|FG005|Overall Study|Diabetologist nurse in the study|0|||
155655681|NCT00500331|561833557|FG006|Overall Study|Diabetologist nurse in the study|0|||
155655682|NCT00500331|561833551|FG000|Overall Study|State ban of biological samples export|0|||
155655683|NCT00500331|561833552|FG001|Overall Study|State ban of biological samples export|0|||
155655684|NCT00500331|561833553|FG002|Overall Study|State ban of biological samples export|0|||
155655685|NCT00500331|561833554|FG003|Overall Study|State ban of biological samples export|1|||
155655686|NCT00500331|561833555|FG004|Overall Study|State ban of biological samples export|0|||
155655687|NCT00500331|561833556|FG005|Overall Study|State ban of biological samples export|0|||
155655688|NCT00500331|561833557|FG006|Overall Study|State ban of biological samples export|0|||
155536959|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
155536960|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
155536961|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
155536962|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
155655689|NCT00500331|561833551|FG000|Overall Study|Protocol violated|0|||
155536963|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
155536964|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
155487582|NCT01521494|561208267|FG003|Overall Study|Decrease in serum phosphate|12|||
155487583|NCT01521494|561208268|FG004|Overall Study|Decrease in serum phosphate|0|||
155487584|NCT01521494|561208264|FG000|Overall Study|Decrease in serum calcium|0|||
155487585|NCT01521494|561208265|FG001|Overall Study|Decrease in serum calcium|0|||
155487586|NCT01521494|561208266|FG002|Overall Study|Decrease in serum calcium|0|||
155487587|NCT01521494|561208267|FG003|Overall Study|Decrease in serum calcium|1|||
155487588|NCT01521494|561208268|FG004|Overall Study|Decrease in serum calcium|1|||
155487589|NCT01521494|561208264|FG000|Overall Study|Physician Decision|0|||
155487590|NCT01521494|561208265|FG001|Overall Study|Physician Decision|0|||
155487591|NCT01521494|561208266|FG002|Overall Study|Physician Decision|0|||
155487592|NCT01521494|561208267|FG003|Overall Study|Physician Decision|0|||
155487593|NCT01521494|561208268|FG004|Overall Study|Physician Decision|2|||
155487594|NCT00877929|561208269|FG000|Overall Study|Adverse Event|11|||
155487595|NCT00877929|561208270|FG001|Overall Study|Adverse Event|20|||
155487596|NCT00877929|561208269|FG000|Overall Study|Protocol Violation|3|||
155487597|NCT00877929|561208270|FG001|Overall Study|Protocol Violation|3|||
155487598|NCT00877929|561208269|FG000|Overall Study|Lost to Follow-up|0|||
155487599|NCT00877929|561208270|FG001|Overall Study|Lost to Follow-up|1|||
155487600|NCT00877929|561208269|FG000|Overall Study|Withdrawal by Subject|4|||
155487601|NCT00877929|561208270|FG001|Overall Study|Withdrawal by Subject|4|||
155487602|NCT00877929|561208269|FG000|Overall Study|Lack of Efficacy|0|||
155487603|NCT00877929|561208270|FG001|Overall Study|Lack of Efficacy|1|||
155487604|NCT00877929|561208269|FG000|Overall Study|Other reason (not specified)|2|||
155487605|NCT00877929|561208270|FG001|Overall Study|Other reason (not specified)|6|||
155487606|NCT01140646|561208271|FG000|Overall Study|Adverse Event|4|||
155487607|NCT01140646|561208271|FG000|Overall Study|Refused Further Treatment|5|||
155487608|NCT00689728|561208274|FG000|Double-Blind Treatment|Adverse Event|1|||
155487609|NCT00689728|561208275|FG001|Double-Blind Treatment|Adverse Event|0|||
155487610|NCT00689728|561208276|FG002|Double-Blind Treatment|Adverse Event|0|||
155487611|NCT00689728|561208274|FG000|Double-Blind Treatment|Protocol Violation|0|||
155487612|NCT00689728|561208275|FG001|Double-Blind Treatment|Protocol Violation|0|||
155487613|NCT00689728|561208276|FG002|Double-Blind Treatment|Protocol Violation|1|||
155487614|NCT00689728|561208274|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
155487615|NCT00689728|561208275|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
155487616|NCT00689728|561208276|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
155487617|NCT00689728|561208274|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
155487618|NCT00689728|561208275|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
155487619|NCT00689728|561208276|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
155487620|NCT00689728|561208274|FG000|Rescue|Adverse Event|0|||
155487621|NCT00689728|561208275|FG001|Rescue|Adverse Event|1|||
155487622|NCT00689728|561208276|FG002|Rescue|Adverse Event|0|||
155487623|NCT00689728|561208274|FG000|Rescue|Withdrawal by Subject|1|||
155487624|NCT00689728|561208275|FG001|Rescue|Withdrawal by Subject|1|||
155487625|NCT00689728|561208276|FG002|Rescue|Withdrawal by Subject|1|||
155487626|NCT00689728|561208274|FG000|Optional Follow-Up|Adverse Event|1|||
155487627|NCT00689728|561208275|FG001|Optional Follow-Up|Adverse Event|0|||
155487628|NCT00689728|561208276|FG002|Optional Follow-Up|Adverse Event|0|||
155487629|NCT00689728|561208274|FG000|Optional Follow-Up|Lack of Efficacy|0|||
155487630|NCT00689728|561208275|FG001|Optional Follow-Up|Lack of Efficacy|1|||
155487631|NCT00689728|561208276|FG002|Optional Follow-Up|Lack of Efficacy|1|||
155487632|NCT00689728|561208274|FG000|Optional Follow-Up|Lost to Follow-up|0|||
155487633|NCT00689728|561208275|FG001|Optional Follow-Up|Lost to Follow-up|1|||
155487634|NCT00689728|561208276|FG002|Optional Follow-Up|Lost to Follow-up|1|||
155487635|NCT00689728|561208274|FG000|Optional Follow-Up|Protocol Violation|0|||
155487636|NCT00689728|561208275|FG001|Optional Follow-Up|Protocol Violation|0|||
155487637|NCT00689728|561208276|FG002|Optional Follow-Up|Protocol Violation|1|||
155487638|NCT00689728|561208274|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
155487639|NCT00689728|561208275|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
155487640|NCT00689728|561208276|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
155487641|NCT00842829|561208281|FG000|Dose Titration Period|Adverse Event|11|||
155487642|NCT00842829|561208282|FG001|Dose Titration Period|Adverse Event|10|||
155487643|NCT00842829|561208283|FG002|Dose Titration Period|Adverse Event|0|||
155487644|NCT00842829|561208281|FG000|Dose Titration Period|Lack of Efficacy|4|||
155487645|NCT00842829|561208282|FG001|Dose Titration Period|Lack of Efficacy|1|||
155487646|NCT00842829|561208283|FG002|Dose Titration Period|Lack of Efficacy|0|||
155487647|NCT00842829|561208281|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
155536965|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
155536966|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
155536967|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
155536968|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
155536969|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
155536970|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
155536971|NCT00073307|561388932|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
155536972|NCT00073307|561388933|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
155536973|NCT00073307|561388934|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
155536974|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
155536975|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
155536976|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
155536977|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
155536978|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
155536979|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
155536980|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
155536981|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
155536982|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
155536983|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
155536984|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
155536985|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
155536986|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
155536987|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
155536988|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
155536989|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
155536990|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
155536991|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
155536992|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
155536993|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
155536994|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
155536995|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
155536996|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
155536997|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
155536998|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
155536999|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
155537000|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
155537001|NCT00073307|561388932|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
155537002|NCT00073307|561388933|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
155537003|NCT00073307|561388934|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
155537004|NCT00858780|561388935|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
155537005|NCT00858780|561388936|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
155537006|NCT00858780|561388937|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
155537007|NCT00858780|561388938|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
155537008|NCT00858780|561388939|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
155537009|NCT00858780|561388935|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
155537010|NCT00858780|561388936|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
155537011|NCT00858780|561388937|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
155537012|NCT00858780|561388938|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
155537013|NCT00858780|561388939|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
155537014|NCT00858780|561388935|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
155537015|NCT00858780|561388936|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
155537016|NCT00858780|561388937|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
155537017|NCT00858780|561388938|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
155537018|NCT00858780|561388939|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
155537019|NCT00858780|561388935|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
155537020|NCT00858780|561388936|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
155537021|NCT00858780|561388937|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
155537022|NCT00858780|561388938|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
155537023|NCT00858780|561388939|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
155537024|NCT00858780|561388935|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
155537025|NCT00858780|561388936|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
155537026|NCT00858780|561388937|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
155537027|NCT00858780|561388938|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
155537028|NCT00858780|561388939|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
155537029|NCT00858780|561388935|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
155537030|NCT00858780|561388936|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
155537031|NCT00858780|561388937|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
155537032|NCT00858780|561388938|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
155537033|NCT00858780|561388939|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
155537034|NCT01964950|561388940|FG000|Overall Study|Protocol Violation|25|||
155537035|NCT03499873|561388941|FG000|Overall Study|Withdrawal by Subject|4|||
155537036|NCT03499873|561388942|FG001|Overall Study|Withdrawal by Subject|6|||
155537037|NCT03499873|561388943|FG002|Overall Study|Withdrawal by Subject|1|||
155537038|NCT03499873|561388941|FG000|Overall Study|Subjects condition worsened|0|||
155537039|NCT03499873|561388942|FG001|Overall Study|Subjects condition worsened|3|||
155537040|NCT03499873|561388943|FG002|Overall Study|Subjects condition worsened|11|||
155537041|NCT03499873|561388941|FG000|Overall Study|Adverse Event|8|||
155537042|NCT03499873|561388942|FG001|Overall Study|Adverse Event|3|||
155537043|NCT03499873|561388943|FG002|Overall Study|Adverse Event|6|||
155537044|NCT03499873|561388941|FG000|Overall Study|Physician Decision|1|||
155537045|NCT03499873|561388942|FG001|Overall Study|Physician Decision|0|||
155537046|NCT03499873|561388943|FG002|Overall Study|Physician Decision|0|||
155537047|NCT03499873|561388941|FG000|Overall Study|Administrative reasons|0|||
155537048|NCT03499873|561388942|FG001|Overall Study|Administrative reasons|1|||
155537049|NCT03499873|561388943|FG002|Overall Study|Administrative reasons|0|||
155537050|NCT03499873|561388941|FG000|Overall Study|Concomitant therapy|5|||
155537051|NCT03499873|561388942|FG001|Overall Study|Concomitant therapy|4|||
155537052|NCT03499873|561388943|FG002|Overall Study|Concomitant therapy|7|||
155537053|NCT03499873|561388941|FG000|Overall Study|Miscellaneous|1|||
155537054|NCT03499873|561388942|FG001|Overall Study|Miscellaneous|2|||
155537055|NCT03499873|561388943|FG002|Overall Study|Miscellaneous|2|||
155537056|NCT03499873|561388941|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
155537057|NCT03499873|561388942|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
155537058|NCT03499873|561388943|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
155537059|NCT01149057|561388944|FG000|Overall Study|Lack of Efficacy|16|||
155537060|NCT01149057|561388944|FG000|Overall Study|Adverse Event|13|||
155537061|NCT01149057|561388944|FG000|Overall Study|Withdrawal by Subject|9|||
155537062|NCT01149057|561388944|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
155537063|NCT01149057|561388944|FG000|Overall Study|B Cell Depletion|4|||
155537064|NCT01149057|561388944|FG000|Overall Study|Participant Non-Compliance|2|||
155537065|NCT01149057|561388944|FG000|Overall Study|Lost to Follow-up|1|||
155537066|NCT01149057|561388944|FG000|Overall Study|High Parathyroid Hormone Value|1|||
155537067|NCT01149057|561388944|FG000|Overall Study|Other|6|||
155537068|NCT01297504|561388945|FG000|Overall Study|Invalid Consent|1|||
155537069|NCT01297504|561388945|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
155537070|NCT01297504|561388945|FG000|Overall Study|No Study Visits|4|||
155537071|NCT01297504|561388945|FG000|Overall Study|Death|3|||
155537072|NCT01297504|561388945|FG000|Overall Study|Lost to Follow-up|43|||
155537073|NCT01297504|561388945|FG000|Overall Study|Withdrawal by Subject|9|||
155537074|NCT01297504|561388945|FG000|Overall Study|Site Closure|3|||
155537075|NCT01297504|561388945|FG000|Overall Study|Protocol Violation|3|||
155537076|NCT03602339|561388946|FG000|Overall Study|Withdrawal by Subject|9|||
155537077|NCT03602339|561388946|FG000|Overall Study|Physician Decision|2|||
155537078|NCT03602339|561388946|FG000|Overall Study|Other reason|4|||
155537079|NCT04025021|561388949|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
155537080|NCT04025021|561388950|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
155537081|NCT01986647|561388952|FG000|Overall Study|Lost to Follow-up|4|||
155537082|NCT01986647|561388953|FG001|Overall Study|Lost to Follow-up|1|||
155537083|NCT01986647|561388954|FG002|Overall Study|Lost to Follow-up|4|||
155537084|NCT01986647|561388955|FG003|Overall Study|Lost to Follow-up|4|||
155537085|NCT01986647|561388952|FG000|Overall Study|Withdrawal by Subject|1|||
155537086|NCT01986647|561388953|FG001|Overall Study|Withdrawal by Subject|3|||
155537087|NCT01986647|561388954|FG002|Overall Study|Withdrawal by Subject|2|||
155537088|NCT01986647|561388955|FG003|Overall Study|Withdrawal by Subject|3|||
155537089|NCT01986647|561388952|FG000|Overall Study|Health|5|||
155537090|NCT01986647|561388953|FG001|Overall Study|Health|3|||
155537091|NCT01986647|561388954|FG002|Overall Study|Health|6|||
155537092|NCT01986647|561388955|FG003|Overall Study|Health|4|||
155537093|NCT00868998|561388956|FG000|Overall Study|Screen Failure|1|||
155537094|NCT00868998|561388956|FG000|Overall Study|Withdrawal by Subject|1|||
155537095|NCT00868998|561388956|FG000|Overall Study|Progression of disease|2|||
155537096|NCT00868998|561388956|FG000|Overall Study|Death|1|||
155537097|NCT01483820|561388957|FG000|Overall Study|Lack of Efficacy|6|||
155537098|NCT01483820|561388957|FG000|Overall Study|Adverse Event|1|||
155537099|NCT01483820|561388957|FG000|Overall Study|Death|1|||
155537100|NCT01507662|561388962|FG000|Overall Study|Death|26|||
155537101|NCT01507662|561388963|FG001|Overall Study|Death|18|||
155537102|NCT01507662|561388962|FG000|Overall Study|Withdrawal by Subject|290|||
155537103|NCT01507662|561388963|FG001|Overall Study|Withdrawal by Subject|287|||
155537104|NCT01507662|561388962|FG000|Overall Study|Lost to Follow-up|498|||
155537105|NCT01507662|561388963|FG001|Overall Study|Lost to Follow-up|523|||
155537106|NCT01507662|561388962|FG000|Overall Study|Proxy interview done|2|||
155537107|NCT01507662|561388963|FG001|Overall Study|Proxy interview done|3|||
155537108|NCT03541252|561388970|FG000|Overall Study|Withdrawal by Subject|1|||
155537109|NCT01960296|561388977|FG000|Overall Study|Postponed surgery|1|||
155537110|NCT01960296|561388978|FG001|Overall Study|Postponed surgery|0|||
155537111|NCT01960296|561388977|FG000|Overall Study|Received different procedure|1|||
155537112|NCT01960296|561388978|FG001|Overall Study|Received different procedure|3|||
155537113|NCT02003391|561388979|FG000|Overall Study|Withdrawal by Subject|2|||
155537114|NCT02003391|561388980|FG001|Overall Study|Withdrawal by Subject|1|||
155537115|NCT02003391|561388979|FG000|Overall Study|Protocol Violation|0|||
155537116|NCT02003391|561388980|FG001|Overall Study|Protocol Violation|1|||
155537117|NCT02003391|561388979|FG000|Overall Study|Adverse Event|1|||
155537118|NCT02003391|561388980|FG001|Overall Study|Adverse Event|0|||
155537119|NCT00858403|561388981|FG000|Overall Study|Withdrawal by Subject|1|||
155537120|NCT00858403|561388981|FG000|Overall Study|Death|3|||
155537121|NCT00858403|561388981|FG000|Overall Study|Disease Progression|1|||
155537122|NCT00243347|561388982|FG000|Overall Study|Lack of Efficacy|4|||
155537123|NCT00243347|561388982|FG000|Overall Study|Adverse Event|2|||
155537124|NCT00243347|561388982|FG000|Overall Study|Death|1|||
155537125|NCT00243347|561388982|FG000|Overall Study|Withdrawal by Subject|5|||
155537126|NCT00243347|561388982|FG000|Overall Study|Condition worsened|7|||
155537127|NCT02264977|561388983|FG000|Overall Study|Death|3|||
155537128|NCT02264977|561388983|FG000|Overall Study|Physician Decision|1|||
155537129|NCT02264977|561388983|FG000|Overall Study|Refuse to return|1|||
155537130|NCT03573544|561388984|FG000|Overall Study|Adverse Event|0|||
155537131|NCT03573544|561388985|FG001|Overall Study|Adverse Event|0|||
155537132|NCT03573544|561388986|FG002|Overall Study|Adverse Event|0|||
155537133|NCT03573544|561388987|FG003|Overall Study|Adverse Event|3|||
155537134|NCT03573544|561388988|FG004|Overall Study|Adverse Event|1|||
155537135|NCT03573544|561388989|FG005|Overall Study|Adverse Event|0|||
155537136|NCT03573544|561388990|FG006|Overall Study|Adverse Event|2|||
155537137|NCT03573544|561388991|FG007|Overall Study|Adverse Event|0|||
155537138|NCT03573544|561388984|FG000|Overall Study|Physician Decision|0|||
155537139|NCT03573544|561388985|FG001|Overall Study|Physician Decision|0|||
155537140|NCT03573544|561388986|FG002|Overall Study|Physician Decision|0|||
155537141|NCT03573544|561388987|FG003|Overall Study|Physician Decision|0|||
155537142|NCT03573544|561388988|FG004|Overall Study|Physician Decision|0|||
155537143|NCT03573544|561388989|FG005|Overall Study|Physician Decision|0|||
155537144|NCT03573544|561388990|FG006|Overall Study|Physician Decision|1|||
155537145|NCT03573544|561388991|FG007|Overall Study|Physician Decision|0|||
155537146|NCT03573544|561388984|FG000|Overall Study|Withdrawal by Subject|2|||
155537147|NCT03573544|561388985|FG001|Overall Study|Withdrawal by Subject|0|||
155537148|NCT03573544|561388986|FG002|Overall Study|Withdrawal by Subject|0|||
155537149|NCT03573544|561388987|FG003|Overall Study|Withdrawal by Subject|1|||
155537150|NCT03573544|561388988|FG004|Overall Study|Withdrawal by Subject|1|||
155537151|NCT03573544|561388989|FG005|Overall Study|Withdrawal by Subject|1|||
155537152|NCT03573544|561388990|FG006|Overall Study|Withdrawal by Subject|0|||
155537153|NCT03573544|561388991|FG007|Overall Study|Withdrawal by Subject|1|||
155537154|NCT03573544|561388984|FG000|Overall Study|Disease progression|3|||
155537155|NCT03573544|561388985|FG001|Overall Study|Disease progression|3|||
155537156|NCT03573544|561388986|FG002|Overall Study|Disease progression|6|||
155537157|NCT03573544|561388987|FG003|Overall Study|Disease progression|4|||
155537158|NCT03573544|561388988|FG004|Overall Study|Disease progression|5|||
155537159|NCT03573544|561388989|FG005|Overall Study|Disease progression|7|||
155537160|NCT03573544|561388990|FG006|Overall Study|Disease progression|6|||
155537161|NCT03573544|561388991|FG007|Overall Study|Disease progression|7|||
155537162|NCT03846193|561388994|FG000|Overall Study|Physician Decision|0|||
155537163|NCT03846193|561388995|FG001|Overall Study|Physician Decision|0|||
155537164|NCT03846193|561388996|FG002|Overall Study|Physician Decision|1|||
155537165|NCT03846193|561388997|FG003|Overall Study|Physician Decision|0|||
155537166|NCT03846193|561388998|FG004|Overall Study|Physician Decision|0|||
155487648|NCT00842829|561208282|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
155487649|NCT00842829|561208283|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
155487650|NCT00842829|561208281|FG000|Dose Titration Period|Withdrawal by Subject|2|||
155487651|NCT00842829|561208282|FG001|Dose Titration Period|Withdrawal by Subject|6|||
155487652|NCT00842829|561208283|FG002|Dose Titration Period|Withdrawal by Subject|0|||
155487653|NCT00842829|561208281|FG000|Dose Titration Period|Other|5|||
155487654|NCT00842829|561208282|FG001|Dose Titration Period|Other|4|||
155487655|NCT00842829|561208283|FG002|Dose Titration Period|Other|0|||
155487656|NCT00842829|561208281|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
155487657|NCT00842829|561208282|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
155487658|NCT00842829|561208283|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
155487659|NCT00842829|561208281|FG000|Dose Titration Period|Non-compliance to study drug|2|||
155487660|NCT00842829|561208282|FG001|Dose Titration Period|Non-compliance to study drug|1|||
155487661|NCT00842829|561208283|FG002|Dose Titration Period|Non-compliance to study drug|0|||
155487662|NCT00842829|561208281|FG000|Treatment Period|Adverse Event|0|||
155487663|NCT00842829|561208282|FG001|Treatment Period|Adverse Event|0|||
155487664|NCT00842829|561208283|FG002|Treatment Period|Adverse Event|15|||
155487665|NCT00842829|561208281|FG000|Treatment Period|Lack of Efficacy|0|||
155487666|NCT00842829|561208282|FG001|Treatment Period|Lack of Efficacy|0|||
155487667|NCT00842829|561208283|FG002|Treatment Period|Lack of Efficacy|6|||
155487668|NCT00842829|561208281|FG000|Treatment Period|Unstable persistent cancer pain|0|||
155487669|NCT00842829|561208282|FG001|Treatment Period|Unstable persistent cancer pain|0|||
155487670|NCT00842829|561208283|FG002|Treatment Period|Unstable persistent cancer pain|5|||
155487671|NCT00842829|561208281|FG000|Treatment Period|Withdrawal by Subject|0|||
155487672|NCT00842829|561208282|FG001|Treatment Period|Withdrawal by Subject|0|||
155487673|NCT00842829|561208283|FG002|Treatment Period|Withdrawal by Subject|11|||
155487674|NCT00842829|561208281|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
155487675|NCT00842829|561208282|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
155487676|NCT00842829|561208283|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
155487677|NCT00842829|561208281|FG000|Treatment Period|Protocol Violation|0|||
155487678|NCT00842829|561208282|FG001|Treatment Period|Protocol Violation|0|||
155487679|NCT00842829|561208283|FG002|Treatment Period|Protocol Violation|2|||
155487680|NCT00842829|561208281|FG000|Treatment Period|Other|0|||
155487681|NCT00842829|561208282|FG001|Treatment Period|Other|0|||
155487682|NCT00842829|561208283|FG002|Treatment Period|Other|18|||
155487683|NCT00842829|561208281|FG000|Treatment Period|Non-compliance to study procedures|0|||
155487684|NCT00842829|561208282|FG001|Treatment Period|Non-compliance to study procedures|0|||
155487685|NCT00842829|561208283|FG002|Treatment Period|Non-compliance to study procedures|4|||
155487686|NCT00842829|561208281|FG000|Treatment Period|Unclear completion status|0|||
155487687|NCT00842829|561208282|FG001|Treatment Period|Unclear completion status|0|||
155487688|NCT00842829|561208283|FG002|Treatment Period|Unclear completion status|1|||
155537167|NCT03846193|561388994|FG000|Overall Study|Lost to Follow-up|0|||
155537168|NCT03846193|561388995|FG001|Overall Study|Lost to Follow-up|0|||
155537169|NCT03846193|561388996|FG002|Overall Study|Lost to Follow-up|0|||
155537170|NCT03846193|561388997|FG003|Overall Study|Lost to Follow-up|0|||
155537171|NCT03846193|561388998|FG004|Overall Study|Lost to Follow-up|1|||
155537172|NCT03846193|561388994|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
155537173|NCT03846193|561388995|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
155537174|NCT03846193|561388996|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
155537175|NCT03846193|561388997|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
155537176|NCT03846193|561388998|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
155537177|NCT01891357|561389004|FG000|Overall Study|Protocol Violation|3|||
155537178|NCT03733145|561389005|FG000|Overall Study|screenfail|3|||
155537179|NCT03733145|561389006|FG001|Overall Study|screenfail|3|||
155537180|NCT03733145|561389007|FG002|Overall Study|screenfail|2|||
155537181|NCT02583048|561390909|FG000|Overall Study|Withdrawal by Subject|0|||
155537182|NCT02583048|561390910|FG001|Overall Study|Withdrawal by Subject|1|||
155537183|NCT02583048|561390911|FG002|Overall Study|Withdrawal by Subject|0|||
155537184|NCT02583048|561390909|FG000|Overall Study|Failed to meet eligibility criterion|0|||
155537185|NCT02583048|561390910|FG001|Overall Study|Failed to meet eligibility criterion|0|||
155537186|NCT02583048|561390911|FG002|Overall Study|Failed to meet eligibility criterion|1|||
155537187|NCT00516295|561390915|FG000|Overall Study|Lack of Efficacy|2|||
155537188|NCT00516295|561390916|FG001|Overall Study|Lack of Efficacy|0|||
155537189|NCT00516295|561390917|FG002|Overall Study|Lack of Efficacy|0|||
155537190|NCT00516295|561390915|FG000|Overall Study|Ineligible|1|||
155537191|NCT00516295|561390916|FG001|Overall Study|Ineligible|0|||
155537192|NCT00516295|561390917|FG002|Overall Study|Ineligible|0|||
155537193|NCT01911429|561390922|FG000|Overall Study|Adverse Event|5|||
155537194|NCT01911429|561390923|FG001|Overall Study|Adverse Event|3|||
155537195|NCT01911429|561390924|FG002|Overall Study|Adverse Event|9|||
155537196|NCT01911429|561390922|FG000|Overall Study|Lack of Efficacy|1|||
155537197|NCT01911429|561390923|FG001|Overall Study|Lack of Efficacy|2|||
155537198|NCT01911429|561390924|FG002|Overall Study|Lack of Efficacy|4|||
155537199|NCT01911429|561390922|FG000|Overall Study|Lost to Follow-up|0|||
155537200|NCT01911429|561390923|FG001|Overall Study|Lost to Follow-up|0|||
155537201|NCT01911429|561390924|FG002|Overall Study|Lost to Follow-up|1|||
155537202|NCT01911429|561390922|FG000|Overall Study|Protocol Violation|0|||
155537203|NCT01911429|561390923|FG001|Overall Study|Protocol Violation|0|||
155537204|NCT01911429|561390924|FG002|Overall Study|Protocol Violation|1|||
155537205|NCT01911429|561390922|FG000|Overall Study|Withdrawal by Subject|5|||
155537206|NCT01911429|561390923|FG001|Overall Study|Withdrawal by Subject|5|||
155537207|NCT01911429|561390924|FG002|Overall Study|Withdrawal by Subject|4|||
155537208|NCT01911429|561390922|FG000|Overall Study|Accidental randomization|0|||
155537209|NCT01911429|561390923|FG001|Overall Study|Accidental randomization|0|||
155537210|NCT01911429|561390924|FG002|Overall Study|Accidental randomization|1|||
155537211|NCT01911429|561390922|FG000|Overall Study|subject left study|1|||
155537212|NCT01911429|561390923|FG001|Overall Study|subject left study|0|||
155537213|NCT01911429|561390924|FG002|Overall Study|subject left study|0|||
155537214|NCT03540160|561390925|FG000|Overall Study|Protocol Violation|1|||
155537215|NCT03540160|561390925|FG000|Overall Study|Physician Decision|8|||
155537216|NCT03540160|561390925|FG000|Overall Study|Lack of Efficacy|60|||
155537217|NCT03540160|561390925|FG000|Overall Study|Pregnancy|1|||
155537218|NCT03540160|561390925|FG000|Overall Study|Adverse Event|20|||
155537219|NCT03540160|561390925|FG000|Overall Study|Withdrawal by Subject|68|||
155537220|NCT03540160|561390925|FG000|Overall Study|COVID-19|2|||
155537221|NCT03540160|561390925|FG000|Overall Study|Study Closure|10|||
155537222|NCT03540160|561390925|FG000|Overall Study|Lost to Follow-up|18|||
155537223|NCT03540160|561390925|FG000|Overall Study|Sponsor decision|191|||
155537224|NCT03599362|561390930|FG000|Overall Study|Screen Failure|3|||
155537225|NCT01923740|561390931|FG000|Overall Study|Lost to Follow-up|4|||
155537226|NCT01923740|561390932|FG001|Overall Study|Lost to Follow-up|9|||
155537227|NCT01923740|561390931|FG000|Overall Study|Withdrawal by Subject|2|||
155537228|NCT01923740|561390932|FG001|Overall Study|Withdrawal by Subject|0|||
155537229|NCT03707587|561390933|FG000|Overall Study|Death|0|||
155537230|NCT03707587|561390934|FG001|Overall Study|Death|1|||
155537231|NCT00834444|561390935|FG000|First Intervention|Adverse Event|1|||
155537232|NCT00834444|561390936|FG001|First Intervention|Adverse Event|0|||
155537233|NCT00834444|561390935|FG000|First Intervention|Intolerance to Venopuncture|0|||
155537234|NCT00834444|561390936|FG001|First Intervention|Intolerance to Venopuncture|1|||
155537235|NCT00834444|561390935|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
155537236|NCT00834444|561390936|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155537237|NCT00834444|561390935|FG000|Second Intervention|Adverse Event|1|||
155537238|NCT00834444|561390936|FG001|Second Intervention|Adverse Event|0|||
155537239|NCT03158727|561390939|FG000|Overall Study|Withdrawal by Subject|2|||
155537240|NCT03158727|561390940|FG001|Overall Study|Withdrawal by Subject|6|||
155537241|NCT03158727|561390939|FG000|Overall Study|Death|11|||
155537242|NCT03158727|561390940|FG001|Overall Study|Death|12|||
155537243|NCT03158727|561390939|FG000|Overall Study|Lost to Follow-up|1|||
155537244|NCT03158727|561390940|FG001|Overall Study|Lost to Follow-up|0|||
155537245|NCT03158727|561390939|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
155537246|NCT03158727|561390940|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
155537247|NCT03158727|561390939|FG000|Overall Study|Visit 11 not done by mistake|0|||
155537248|NCT03158727|561390940|FG001|Overall Study|Visit 11 not done by mistake|1|||
155537249|NCT03158727|561390939|FG000|Overall Study|Enrolled, not treated|1|||
155537250|NCT03158727|561390940|FG001|Overall Study|Enrolled, not treated|0|||
155537251|NCT02412852|561390941|FG000|Overall Study|Withdrawal by Subject|0|||
155537252|NCT02412852|561390942|FG001|Overall Study|Withdrawal by Subject|1|||
155537253|NCT02412852|561390943|FG002|Overall Study|Withdrawal by Subject|0|||
155537254|NCT02412852|561390944|FG003|Overall Study|Withdrawal by Subject|0|||
155537255|NCT02412852|561390941|FG000|Overall Study|Physician Decision|0|||
155537256|NCT02412852|561390942|FG001|Overall Study|Physician Decision|0|||
155537257|NCT02412852|561390943|FG002|Overall Study|Physician Decision|0|||
155537258|NCT02412852|561390944|FG003|Overall Study|Physician Decision|1|||
155537259|NCT00472212|561390945|FG000|Overall Study|Lost to Follow-up|6|||
155537260|NCT00472212|561390946|FG001|Overall Study|Lost to Follow-up|4|||
155537261|NCT02336074|561390952|FG000|Overall Study|Adverse Event|0|||
155537262|NCT02336074|561390953|FG001|Overall Study|Adverse Event|2|||
155537263|NCT00958724|561390956|FG000|Overall Study|Disease Progression|6|||
155537264|NCT05604014|561390974|FG000|Overall Study|Lost to Follow-up|13|||
155537265|NCT02121184|561390979|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
155537266|NCT02121184|561390980|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
155537267|NCT02121184|561390979|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
155537268|NCT02121184|561390980|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
155537269|NCT02121184|561390979|FG000|Overall Study|Emergency cesarean section required|0|||
155537270|NCT02121184|561390980|FG001|Overall Study|Emergency cesarean section required|2|||
155537271|NCT02121184|561390979|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
155537272|NCT02121184|561390980|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
155537273|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Refused|1|||
155537274|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Refused|3|||
155537275|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Medical|0|||
155537276|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Medical|1|||
155537277|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
155537278|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
155537279|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
155537280|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
155537281|NCT02054715|561390987|FG000|Baseline/Follow-up 1|No Reason|0|||
155537282|NCT02054715|561390988|FG001|Baseline/Follow-up 1|No Reason|1|||
155537283|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
155537284|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
155537285|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Ineligible|3|||
155537286|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Ineligible|0|||
155537287|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Hospitalization|1|||
155537288|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Hospitalization|0|||
155537289|NCT02054715|561390987|FG000|Baseline/Follow-up 1|Changed Mind|1|||
155537290|NCT02054715|561390988|FG001|Baseline/Follow-up 1|Changed Mind|0|||
155537291|NCT02054715|561390987|FG000|Follow-up 2|Lost to Followup|3|||
155537292|NCT02054715|561390988|FG001|Follow-up 2|Lost to Followup|1|||
155537293|NCT02054715|561390987|FG000|Follow-up 2|Refused|3|||
155537294|NCT02054715|561390988|FG001|Follow-up 2|Refused|2|||
155537295|NCT02054715|561390987|FG000|Follow-up 2|Followup Not Completed|3|||
155537296|NCT02054715|561390988|FG001|Follow-up 2|Followup Not Completed|4|||
155655690|NCT00500331|561833552|FG001|Overall Study|Protocol violated|0|||
155655691|NCT00500331|561833553|FG002|Overall Study|Protocol violated|0|||
155655692|NCT00500331|561833554|FG003|Overall Study|Protocol violated|1|||
155537297|NCT02054715|561390987|FG000|Follow-up 2|Ineligible|4|||
155537298|NCT02054715|561390988|FG001|Follow-up 2|Ineligible|5|||
155537299|NCT02054715|561390987|FG000|Follow-up 2|Death|3|||
155537300|NCT02054715|561390988|FG001|Follow-up 2|Death|3|||
155537301|NCT02054715|561390987|FG000|Follow-up 2|Hospitalization|0|||
155537302|NCT02054715|561390988|FG001|Follow-up 2|Hospitalization|2|||
155537303|NCT02054715|561390987|FG000|Follow-up 2|Changed MD/Facility|0|||
155537304|NCT02054715|561390988|FG001|Follow-up 2|Changed MD/Facility|1|||
155537305|NCT02054715|561390987|FG000|Follow-up 2|Changed Mind|0|||
155537306|NCT02054715|561390988|FG001|Follow-up 2|Changed Mind|1|||
155537307|NCT02054715|561390987|FG000|Follow-up 2|No Reason|2|||
155537308|NCT02054715|561390988|FG001|Follow-up 2|No Reason|0|||
155537309|NCT02054715|561390987|FG000|Follow-up 2|Treatment Change or Delay|1|||
155537310|NCT02054715|561390988|FG001|Follow-up 2|Treatment Change or Delay|0|||
155537311|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
155537312|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
155537313|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
155537314|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
155537315|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
155537316|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
155537317|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
155537318|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
155537319|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
155537320|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
155537321|NCT01438060|561390991|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
155537322|NCT01438060|561390992|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
155537323|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
155537324|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
155537325|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
155537326|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
155537327|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
155537328|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
155537329|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
155537330|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
155537331|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
155537332|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
155537333|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
155537334|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
155537335|NCT01438060|561390991|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
155537336|NCT01438060|561390992|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
155537337|NCT01438060|561390991|FG000|On Study Beyond Week 140|Adverse Event|0|||
155537338|NCT01438060|561390992|FG001|On Study Beyond Week 140|Adverse Event|2|||
155537339|NCT01438060|561390991|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
155537340|NCT01438060|561390992|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
155537341|NCT01438060|561390991|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
155537342|NCT01438060|561390992|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
155537343|NCT01438060|561390991|FG000|On Study Beyond Week 140|Death|0|||
155537344|NCT01438060|561390992|FG001|On Study Beyond Week 140|Death|1|||
155537345|NCT01438060|561390991|FG000|On Study Beyond Week 140|Other Reason|0|||
155537346|NCT01438060|561390992|FG001|On Study Beyond Week 140|Other Reason|3|||
155537347|NCT01190865|561390999|FG000|Overall Study|Withdrawal by Subject|1|||
155537348|NCT01190865|561390999|FG000|Overall Study|Non-compliance|2|||
155537349|NCT00574847|561391002|FG000|Overall Study|Adverse Event|2|||
155537350|NCT00574847|561391003|FG001|Overall Study|Adverse Event|0|||
155537351|NCT00574847|561391002|FG000|Overall Study|Death|1|||
155537352|NCT00574847|561391003|FG001|Overall Study|Death|0|||
155537353|NCT00574847|561391002|FG000|Overall Study|Withdrawal by Subject|2|||
155537354|NCT00574847|561391003|FG001|Overall Study|Withdrawal by Subject|2|||
155537355|NCT00574847|561391002|FG000|Overall Study|Physician Decision|1|||
155537356|NCT00574847|561391003|FG001|Overall Study|Physician Decision|0|||
155537357|NCT00574847|561391002|FG000|Overall Study|Did not receive medication (declined)|2|||
155537358|NCT00574847|561391003|FG001|Overall Study|Did not receive medication (declined)|5|||
155537359|NCT00881751|561391004|FG000|Overall Study|Physician Decision|0|||
155537360|NCT00881751|561391005|FG001|Overall Study|Physician Decision|1|||
155537361|NCT00881751|561391004|FG000|Overall Study|Adverse Event|0|||
155537362|NCT00881751|561391005|FG001|Overall Study|Adverse Event|2|||
155537363|NCT00881751|561391004|FG000|Overall Study|Withdrawal by Subject|0|||
155537364|NCT00881751|561391005|FG001|Overall Study|Withdrawal by Subject|2|||
155537365|NCT00957021|561391006|FG000|Overall Study|Death|5|||
155537366|NCT00957021|561391006|FG000|Overall Study|Lost to Follow-up|8|||
155537367|NCT00957021|561391006|FG000|Overall Study|Withdrawal by Subject|34|||
155537368|NCT00957021|561391006|FG000|Overall Study|No 2 yr ROM data|35|||
155537369|NCT00957021|561391006|FG000|Overall Study|Revised study component by 2 yr visit|8|||
155537370|NCT00957021|561391006|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
155537371|NCT00957021|561391006|FG000|Overall Study|Surgery Cancelled|9|||
155537372|NCT00957021|561391006|FG000|Overall Study|Termination due to language issue|2|||
155537373|NCT01087502|561391019|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
155537374|NCT01087502|561391020|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
155537375|NCT01087502|561391019|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
155537376|NCT01087502|561391020|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
155537377|NCT01087502|561391019|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
155537378|NCT01087502|561391020|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
155537379|NCT01087502|561391019|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
155537380|NCT01087502|561391020|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
155537381|NCT01087502|561391019|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
155537382|NCT01087502|561391020|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
155537383|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
155537384|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
155537385|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
155537386|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
155537387|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
155537388|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
155537389|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
155537390|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
155537391|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
155537392|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
155537393|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
155537394|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
155537395|NCT01087502|561391019|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
155537396|NCT01087502|561391020|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
155537397|NCT01653704|561391021|FG000|Overall Study|Technical failure during recording|1|||
155537398|NCT01653704|561391022|FG001|Overall Study|Technical failure during recording|1|||
155655693|NCT00500331|561833555|FG004|Overall Study|Protocol violated|0|||
155655694|NCT00500331|561833556|FG005|Overall Study|Protocol violated|0|||
155655695|NCT00500331|561833557|FG006|Overall Study|Protocol violated|0|||
155655696|NCT00734032|561833558|FG000|Overall Study|Adverse Event|0|||
155655697|NCT00734032|561833559|FG001|Overall Study|Adverse Event|1|||
155655698|NCT00734032|561833560|FG002|Overall Study|Adverse Event|0|||
155655699|NCT00734032|561833561|FG003|Overall Study|Adverse Event|0|||
155655700|NCT02489279|561833562|FG000|Overall Study|Lost to Follow-up|12|||
155655701|NCT02489279|561833563|FG001|Overall Study|Lost to Follow-up|10|||
155655702|NCT02263547|561833564|FG000|Overall Study|Adverse Event|1|||
155655703|NCT02263547|561833564|FG000|Overall Study|Lost to Follow-up|2|||
155655704|NCT00856557|561833565|FG000|Overall Study|No patients with contextual flags|12|||
155655705|NCT00856557|561833566|FG001|Overall Study|No patients with contextual flags|16|||
155655706|NCT02301897|561833567|FG000|Treatment Course 1|Non-Compliance|0|||
155655707|NCT02301897|561833568|FG001|Treatment Course 1|Non-Compliance|0|||
155655708|NCT02301897|561833569|FG002|Treatment Course 1|Non-Compliance|1|||
155655709|NCT02301897|561833567|FG000|Treatment Course 1|Adverse Event|1|||
155655710|NCT02301897|561833568|FG001|Treatment Course 1|Adverse Event|1|||
155655711|NCT02301897|561833569|FG002|Treatment Course 1|Adverse Event|0|||
155655712|NCT02301897|561833567|FG000|Treatment Course 1|Lost to Follow-up|1|||
155655713|NCT02301897|561833568|FG001|Treatment Course 1|Lost to Follow-up|2|||
155487689|NCT00842829|561208281|FG000|Continuation Period|Adverse Event|0|||
155487690|NCT00842829|561208282|FG001|Continuation Period|Adverse Event|0|||
155487691|NCT00842829|561208283|FG002|Continuation Period|Adverse Event|32|||
155487692|NCT00842829|561208281|FG000|Continuation Period|Lack of Efficacy|0|||
155487693|NCT00842829|561208282|FG001|Continuation Period|Lack of Efficacy|0|||
155487694|NCT00842829|561208283|FG002|Continuation Period|Lack of Efficacy|6|||
155487695|NCT00842829|561208281|FG000|Continuation Period|Unstable persistent cancer pain|0|||
155487696|NCT00842829|561208282|FG001|Continuation Period|Unstable persistent cancer pain|0|||
155487697|NCT00842829|561208283|FG002|Continuation Period|Unstable persistent cancer pain|3|||
155487698|NCT00842829|561208281|FG000|Continuation Period|Withdrawal by Subject|0|||
155537399|NCT01653704|561391021|FG000|Overall Study|Performance not reflective of training|1|||
155537400|NCT01653704|561391022|FG001|Overall Study|Performance not reflective of training|0|||
155537401|NCT02705716|561391023|FG000|Overall Study|Adverse Event|0|||
155537402|NCT02705716|561391024|FG001|Overall Study|Adverse Event|1|||
155537403|NCT02705716|561391023|FG000|Overall Study|Protocol Violation|3|||
155537404|NCT02705716|561391024|FG001|Overall Study|Protocol Violation|0|||
155537405|NCT02705716|561391023|FG000|Overall Study|Withdrawal of Consent|1|||
155537406|NCT02705716|561391024|FG001|Overall Study|Withdrawal of Consent|1|||
155537407|NCT00562718|561391025|FG000|Overall Study|Death|1|||
155537408|NCT00562718|561391025|FG000|Overall Study|Withdrawal by Subject|3|||
155537409|NCT00562718|561391025|FG000|Overall Study|Adverse Event|4|||
155537410|NCT00562718|561391025|FG000|Overall Study|Lack of Efficacy|2|||
155537411|NCT00562718|561391025|FG000|Overall Study|not stated|1|||
155537412|NCT01151618|561391026|FG000|Overall Study|Adverse Event|2|||
155537413|NCT01151618|561391026|FG000|Overall Study|Withdrawal by Subject|7|||
155537414|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
155537415|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
155537416|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
155537417|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
155537418|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
155537419|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
155537420|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
155537421|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
155537422|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
155537423|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
155537424|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
155537425|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
155537426|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
155537427|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
155537428|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
155537429|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
155537430|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
155537431|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
155537432|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
155537433|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
155537434|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
155537435|NCT02227238|561391027|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
155537436|NCT02227238|561391028|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
155537437|NCT02227238|561391029|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
155537438|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
155537439|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
155537440|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
155537441|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
155537442|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
155537443|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
155537444|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
155537445|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
155537446|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
155537447|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
155537448|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
155537449|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
155537450|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
155537451|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
155537452|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
155537453|NCT02227238|561391027|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
155537454|NCT02227238|561391028|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
155537455|NCT02227238|561391029|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
155537456|NCT03966911|561391031|FG000|Overall Study|Adverse Event|1|||
155537457|NCT03966911|561391032|FG001|Overall Study|Adverse Event|1|||
155537458|NCT03966911|561391031|FG000|Overall Study|Withdrawal by Subject|8|||
155537459|NCT03966911|561391032|FG001|Overall Study|Withdrawal by Subject|2|||
155537460|NCT03966911|561391031|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
155537461|NCT03966911|561391032|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
155537462|NCT00985751|561391033|FG000|Overall Study|Adverse Event|0|||
155537463|NCT00985751|561391034|FG001|Overall Study|Adverse Event|0|||
155537464|NCT00985751|561391035|FG002|Overall Study|Adverse Event|0|||
155537465|NCT00985751|561391036|FG003|Overall Study|Adverse Event|0|||
155537466|NCT00985751|561391037|FG004|Overall Study|Adverse Event|1|||
155537467|NCT01663896|561391038|FG000|Overall Study|Various reasons|43|||
155537468|NCT00474188|561391041|FG000|Overall Study|Withdrawal by Subject|1|||
155537469|NCT00474188|561391041|FG000|Overall Study|Study discontinued by sponsor|5|||
155537470|NCT05412121|561391044|FG000|Overall Study|Withdrawal by Subject|4|||
155537471|NCT05412121|561391044|FG000|Overall Study|Physician Decision|1|||
155537472|NCT05412121|561391044|FG000|Overall Study|Lost to Follow-up|5|||
155537473|NCT04476277|561391045|FG000|Overall Study|Withdrawal by Subject|0|||
155537474|NCT04476277|561391046|FG001|Overall Study|Withdrawal by Subject|0|||
155537475|NCT04476277|561391047|FG002|Overall Study|Withdrawal by Subject|1|||
155537476|NCT04476277|561391048|FG003|Overall Study|Withdrawal by Subject|0|||
155537477|NCT01962298|561391049|FG000|Overall Study|Protocol Violation|1|||
155537478|NCT01962298|561391050|FG001|Overall Study|Protocol Violation|0|||
155537479|NCT01962298|561391051|FG002|Overall Study|Protocol Violation|1|||
155537480|NCT01962298|561391052|FG003|Overall Study|Protocol Violation|1|||
155537481|NCT01962298|561391053|FG004|Overall Study|Protocol Violation|0|||
155537482|NCT01962298|561391049|FG000|Overall Study|Data quality insufficient|2|||
155537483|NCT01962298|561391050|FG001|Overall Study|Data quality insufficient|0|||
155537484|NCT01962298|561391051|FG002|Overall Study|Data quality insufficient|3|||
155537485|NCT01962298|561391052|FG003|Overall Study|Data quality insufficient|1|||
155537486|NCT01962298|561391053|FG004|Overall Study|Data quality insufficient|4|||
155537487|NCT01962298|561391049|FG000|Overall Study|Insufficient data|0|||
155537488|NCT01962298|561391050|FG001|Overall Study|Insufficient data|2|||
155537489|NCT01962298|561391051|FG002|Overall Study|Insufficient data|1|||
155655714|NCT02301897|561833569|FG002|Treatment Course 1|Lost to Follow-up|1|||
155537490|NCT01962298|561391052|FG003|Overall Study|Insufficient data|0|||
155537491|NCT01962298|561391053|FG004|Overall Study|Insufficient data|1|||
155537492|NCT01962298|561391049|FG000|Overall Study|Incorrect data recorded|0|||
155537493|NCT01962298|561391050|FG001|Overall Study|Incorrect data recorded|1|||
155537494|NCT01962298|561391051|FG002|Overall Study|Incorrect data recorded|0|||
155537495|NCT01962298|561391052|FG003|Overall Study|Incorrect data recorded|0|||
155537496|NCT01962298|561391053|FG004|Overall Study|Incorrect data recorded|0|||
155537497|NCT01962298|561391049|FG000|Overall Study|Physician Decision|0|||
155537498|NCT01962298|561391050|FG001|Overall Study|Physician Decision|1|||
155537499|NCT01962298|561391051|FG002|Overall Study|Physician Decision|0|||
155537500|NCT01962298|561391052|FG003|Overall Study|Physician Decision|0|||
155537501|NCT01962298|561391053|FG004|Overall Study|Physician Decision|1|||
155537502|NCT01576705|561391054|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
155537503|NCT01576705|561391055|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
155537504|NCT01576705|561391056|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
155537505|NCT01576705|561391057|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
155537506|NCT01576705|561391054|FG000|Overall Study|invalid ICF|0|||
155537507|NCT01576705|561391055|FG001|Overall Study|invalid ICF|1|||
155537508|NCT01576705|561391056|FG002|Overall Study|invalid ICF|0|||
155537509|NCT01576705|561391057|FG003|Overall Study|invalid ICF|0|||
155537510|NCT03727139|561391058|FG000|Overall Study|Protocol Violation|60|||
155537511|NCT00566722|561391059|FG000|Overall Study|Adverse Event|0|||
155537512|NCT00566722|561391060|FG001|Overall Study|Adverse Event|1|||
155537513|NCT00566722|561391061|FG002|Overall Study|Adverse Event|0|||
155537514|NCT00566722|561391059|FG000|Overall Study|Withdrawal by Subject|0|||
155537515|NCT00566722|561391060|FG001|Overall Study|Withdrawal by Subject|0|||
155537516|NCT00566722|561391061|FG002|Overall Study|Withdrawal by Subject|1|||
155537517|NCT00566722|561391059|FG000|Overall Study|Lost to Follow-up|1|||
155537518|NCT00566722|561391060|FG001|Overall Study|Lost to Follow-up|1|||
155537519|NCT00566722|561391061|FG002|Overall Study|Lost to Follow-up|1|||
155537520|NCT00566722|561391059|FG000|Overall Study|Lack of Efficacy|1|||
155537521|NCT00566722|561391060|FG001|Overall Study|Lack of Efficacy|2|||
155537522|NCT00566722|561391061|FG002|Overall Study|Lack of Efficacy|4|||
155537523|NCT00566722|561391059|FG000|Overall Study|Did not meet exclusion criteria|0|||
155537524|NCT00566722|561391060|FG001|Overall Study|Did not meet exclusion criteria|0|||
155537525|NCT00566722|561391061|FG002|Overall Study|Did not meet exclusion criteria|2|||
155537526|NCT00566722|561391059|FG000|Overall Study|Serious adverse event|0|||
155537527|NCT00566722|561391060|FG001|Overall Study|Serious adverse event|1|||
155537528|NCT00566722|561391061|FG002|Overall Study|Serious adverse event|0|||
155537529|NCT00566722|561391059|FG000|Overall Study|Noncompliant with drug administration|0|||
155537530|NCT00566722|561391060|FG001|Overall Study|Noncompliant with drug administration|0|||
155537531|NCT00566722|561391061|FG002|Overall Study|Noncompliant with drug administration|1|||
155537532|NCT03961204|561391062|FG000|Overall Study|Withdrawal by Subject|2|||
155537533|NCT03961204|561391062|FG000|Overall Study|Lost to Follow-up|3|||
155537534|NCT03961204|561391062|FG000|Overall Study|Other|1|||
155537535|NCT03961204|561391062|FG000|Overall Study|Missing|1|||
155537536|NCT02218216|561391063|FG000|Overall Study|Study terminated before completed|6|||
155537537|NCT02218216|561391064|FG001|Overall Study|Study terminated before completed|0|||
155537538|NCT02218216|561391065|FG002|Overall Study|Study terminated before completed|0|||
155537539|NCT05740098|561391070|FG000|Overall Study|Lost to Follow-up|26|||
155537540|NCT05740098|561391071|FG001|Overall Study|Lost to Follow-up|17|||
155537541|NCT05740098|561391072|FG002|Overall Study|Lost to Follow-up|21|||
155537542|NCT01131260|561391073|FG000|Overall Study|Randomization error|5|||
155537543|NCT01131260|561391074|FG001|Overall Study|Randomization error|1|||
155537544|NCT01131260|561391073|FG000|Overall Study|Declined to continue participation|8|||
155537545|NCT01131260|561391074|FG001|Overall Study|Declined to continue participation|13|||
155537546|NCT01131260|561391073|FG000|Overall Study|Physician Decision|22|||
155537547|NCT01131260|561391074|FG001|Overall Study|Physician Decision|24|||
155537548|NCT01131260|561391073|FG000|Overall Study|Technical problems|7|||
155537549|NCT01131260|561391074|FG001|Overall Study|Technical problems|6|||
155537550|NCT01131260|561391073|FG000|Overall Study|Staff error|2|||
155537551|NCT01131260|561391074|FG001|Overall Study|Staff error|1|||
155537552|NCT01131260|561391073|FG000|Overall Study|Ineligible|0|||
155537553|NCT01131260|561391074|FG001|Overall Study|Ineligible|2|||
155537554|NCT01968031|561391080|FG000|Overall Study|Adverse Event|13|||
155537555|NCT01968031|561391081|FG001|Overall Study|Adverse Event|10|||
155537556|NCT01968031|561391082|FG002|Overall Study|Adverse Event|22|||
155537557|NCT01968031|561391080|FG000|Overall Study|Withdrawal by Subject|3|||
155537558|NCT01968031|561391081|FG001|Overall Study|Withdrawal by Subject|7|||
155537559|NCT01968031|561391082|FG002|Overall Study|Withdrawal by Subject|3|||
155537560|NCT01968031|561391080|FG000|Overall Study|Did not meet entry criteria|1|||
155537561|NCT01968031|561391081|FG001|Overall Study|Did not meet entry criteria|1|||
155537562|NCT01968031|561391082|FG002|Overall Study|Did not meet entry criteria|1|||
155537563|NCT01968031|561391080|FG000|Overall Study|Noncompliance|0|||
155537564|NCT01968031|561391081|FG001|Overall Study|Noncompliance|0|||
155537565|NCT01968031|561391082|FG002|Overall Study|Noncompliance|2|||
155537566|NCT01968031|561391080|FG000|Overall Study|Failed inclusion criteria|0|||
155537567|NCT01968031|561391081|FG001|Overall Study|Failed inclusion criteria|2|||
155537568|NCT01968031|561391082|FG002|Overall Study|Failed inclusion criteria|0|||
155537569|NCT01968031|561391080|FG000|Overall Study|Death|0|||
155537570|NCT01968031|561391081|FG001|Overall Study|Death|0|||
155537571|NCT01968031|561391082|FG002|Overall Study|Death|1|||
155537572|NCT01968031|561391080|FG000|Overall Study|Prohibited concomitant medication|1|||
155537573|NCT01968031|561391081|FG001|Overall Study|Prohibited concomitant medication|0|||
155537574|NCT01968031|561391082|FG002|Overall Study|Prohibited concomitant medication|0|||
155537575|NCT04573309|561392460|FG000|Overall Study|Protocol Violation|1|||
155537576|NCT04573309|561392461|FG001|Overall Study|Protocol Violation|0|||
155537577|NCT01691430|561392464|FG000|Overall Study|Death|17|||
155537578|NCT01691430|561392465|FG001|Overall Study|Death|16|||
155537579|NCT01691430|561392464|FG000|Overall Study|Withdrawal by Subject|5|||
155537580|NCT01691430|561392465|FG001|Overall Study|Withdrawal by Subject|1|||
155537581|NCT01691430|561392464|FG000|Overall Study|Lost to Follow-up|0|||
155537582|NCT01691430|561392465|FG001|Overall Study|Lost to Follow-up|3|||
155537583|NCT01894230|561392466|FG000|Overall Study|Lost to Follow-up|2|||
155537584|NCT01894230|561392467|FG001|Overall Study|Lost to Follow-up|2|||
155537585|NCT01894230|561392466|FG000|Overall Study|Withdrawal by Subject|4|||
155537586|NCT01894230|561392467|FG001|Overall Study|Withdrawal by Subject|4|||
155537587|NCT01894230|561392466|FG000|Overall Study|Non-adherent|0|||
155537588|NCT01894230|561392467|FG001|Overall Study|Non-adherent|1|||
155537589|NCT01894230|561392466|FG000|Overall Study|Death|1|||
155537590|NCT01894230|561392467|FG001|Overall Study|Death|0|||
155537591|NCT02219009|561392470|FG000|Overall Study|Withdrawal by Subject|5|||
155537592|NCT02219009|561392471|FG001|Overall Study|Withdrawal by Subject|1|||
155537593|NCT02219009|561392470|FG000|Overall Study|Adverse Event|2|||
155537594|NCT02219009|561392471|FG001|Overall Study|Adverse Event|4|||
155537595|NCT02219009|561392470|FG000|Overall Study|Lost to Follow-up|2|||
155537596|NCT02219009|561392471|FG001|Overall Study|Lost to Follow-up|2|||
155537597|NCT02219009|561392470|FG000|Overall Study|Protocol deviation|1|||
155537598|NCT02219009|561392471|FG001|Overall Study|Protocol deviation|0|||
155537599|NCT02219009|561392470|FG000|Overall Study|Physician Decision|0|||
155537600|NCT02219009|561392471|FG001|Overall Study|Physician Decision|1|||
155537601|NCT00660387|561392472|FG000|Overall Study|Adverse Event|1|||
155537602|NCT00660387|561392473|FG001|Overall Study|Adverse Event|2|||
155537603|NCT00660387|561392472|FG000|Overall Study|Lack of Efficacy|0|||
155537604|NCT00660387|561392473|FG001|Overall Study|Lack of Efficacy|1|||
155537605|NCT00660387|561392472|FG000|Overall Study|Protocol Violation|1|||
155537606|NCT00660387|561392473|FG001|Overall Study|Protocol Violation|0|||
155537607|NCT02259348|561392474|FG000|Overall Study|Donors|6|||
155537608|NCT02259348|561392474|FG000|Overall Study|Death|4|||
155537609|NCT01622660|561392475|FG000|Overall Study|Adverse Event|1|||
155537610|NCT04211766|561392476|FG000|Overall Study|Withdrawal by Subject|5|||
155537611|NCT04211766|561392477|FG001|Overall Study|Withdrawal by Subject|1|||
155537612|NCT00642993|561392478|FG000|Overall Study|Adverse Event|85|||
155537613|NCT00642993|561392479|FG001|Overall Study|Adverse Event|4|||
155537614|NCT00642993|561392478|FG000|Overall Study|Lost to Follow-up|8|||
155537615|NCT00642993|561392479|FG001|Overall Study|Lost to Follow-up|4|||
155537616|NCT00642993|561392478|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
155537617|NCT00642993|561392479|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
155537618|NCT00642993|561392478|FG000|Overall Study|Protocol Violation|1|||
155537619|NCT00642993|561392479|FG001|Overall Study|Protocol Violation|4|||
155537620|NCT00642993|561392478|FG000|Overall Study|Did not meet protocol eligibility|0|||
155537621|NCT00642993|561392479|FG001|Overall Study|Did not meet protocol eligibility|1|||
155537622|NCT00642993|561392478|FG000|Overall Study|Administrative|1|||
155537623|NCT00642993|561392479|FG001|Overall Study|Administrative|0|||
155537624|NCT04661202|561392480|FG000|Overall Study|Withdrawal by Subject|1|||
155537625|NCT04661202|561392481|FG001|Overall Study|Withdrawal by Subject|1|||
155537626|NCT04661202|561392480|FG000|Overall Study|Lack of Efficacy|2|||
155537627|NCT04661202|561392481|FG001|Overall Study|Lack of Efficacy|0|||
155537628|NCT02725515|561392482|FG000|Overall Study|Refused infusion (no study treatment)|1|||
155537629|NCT02725515|561392483|FG001|Overall Study|Refused infusion (no study treatment)|0|||
155537630|NCT02725515|561392482|FG000|Overall Study|Loss of Improvement per Protocol|14|||
155537631|NCT02725515|561392483|FG001|Overall Study|Loss of Improvement per Protocol|25|||
155537632|NCT02725515|561392482|FG000|Overall Study|Withdrawal by Subject|2|||
155537633|NCT02725515|561392483|FG001|Overall Study|Withdrawal by Subject|1|||
155537634|NCT02725515|561392482|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155537635|NCT02725515|561392483|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155537636|NCT02725515|561392482|FG000|Overall Study|Lost to Follow-up|1|||
155537637|NCT02725515|561392483|FG001|Overall Study|Lost to Follow-up|1|||
155537638|NCT02725515|561392482|FG000|Overall Study|Adverse Event|7|||
155537639|NCT02725515|561392483|FG001|Overall Study|Adverse Event|2|||
155537640|NCT02725515|561392482|FG000|Overall Study|No Documented Disease Improvement|0|||
155537641|NCT02725515|561392483|FG001|Overall Study|No Documented Disease Improvement|1|||
155537642|NCT02725515|561392482|FG000|Overall Study|Completed Study Under Original Protocol|0|||
155537643|NCT02725515|561392483|FG001|Overall Study|Completed Study Under Original Protocol|1|||
155537644|NCT02725515|561392482|FG000|Overall Study|Lack of Response|0|||
155537645|NCT02725515|561392483|FG001|Overall Study|Lack of Response|1|||
155537646|NCT00183196|561392488|FG000|Overall Study|Withdrawal by Subject|18|||
155537647|NCT00183196|561392489|FG001|Overall Study|Withdrawal by Subject|11|||
155537648|NCT00183196|561392490|FG002|Overall Study|Withdrawal by Subject|13|||
155537649|NCT00183196|561392488|FG000|Overall Study|Adverse Event|1|||
155537650|NCT00183196|561392489|FG001|Overall Study|Adverse Event|2|||
155537651|NCT00183196|561392490|FG002|Overall Study|Adverse Event|2|||
155537652|NCT00183196|561392488|FG000|Overall Study|Legal event|1|||
155537653|NCT00183196|561392489|FG001|Overall Study|Legal event|1|||
155537654|NCT00183196|561392490|FG002|Overall Study|Legal event|1|||
155537655|NCT00183196|561392488|FG000|Overall Study|Required more intensive care|0|||
155537656|NCT00183196|561392489|FG001|Overall Study|Required more intensive care|1|||
155537657|NCT00183196|561392490|FG002|Overall Study|Required more intensive care|2|||
155537658|NCT01944722|561392491|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
155537659|NCT01944722|561392491|FG000|Overall Study|Specimen Shipping Issues|34|||
155537660|NCT01944722|561392491|FG000|Overall Study|Improper Storage/Transport|5|||
155537661|NCT01944722|561392491|FG000|Overall Study|Insufficient Volume for Test|1|||
155537662|NCT01944722|561392491|FG000|Overall Study|Missing Specimens|3|||
155537663|NCT01944722|561392491|FG000|Overall Study|Specimens Mislabeled|2|||
155537664|NCT01944722|561392491|FG000|Overall Study|Withdrawal by Subject|8|||
155537665|NCT01944722|561392491|FG000|Overall Study|NILM Subjects <30 years old|8106|||
155537666|NCT01944722|561392491|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
155537667|NCT01944722|561392491|FG000|Overall Study|>ASCUS Cytology|1122|||
155537668|NCT02906917|561392495|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
155537669|NCT02906917|561392496|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
155537670|NCT02906917|561392495|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
155537671|NCT02906917|561392496|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
155537672|NCT02906917|561392495|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
155537673|NCT02906917|561392496|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
155537674|NCT02906917|561392495|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
155537675|NCT02906917|561392496|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
155537676|NCT02906917|561392495|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
155537677|NCT02906917|561392496|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
155537678|NCT02906917|561392495|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
155537679|NCT02906917|561392496|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
155537680|NCT02906917|561392495|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
155537681|NCT02906917|561392496|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
155537682|NCT02906917|561392495|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
155537683|NCT02906917|561392496|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
155537684|NCT00687739|561392497|FG000|Overall Study|Lost to Follow-up|2|||
155537685|NCT00687739|561392498|FG001|Overall Study|Lost to Follow-up|2|||
155537686|NCT00687739|561392499|FG002|Overall Study|Lost to Follow-up|1|||
155537687|NCT00687739|561392500|FG003|Overall Study|Lost to Follow-up|2|||
155537688|NCT00687739|561392497|FG000|Overall Study|Adverse Event|0|||
155537689|NCT00687739|561392498|FG001|Overall Study|Adverse Event|1|||
155537690|NCT00687739|561392499|FG002|Overall Study|Adverse Event|1|||
155537691|NCT00687739|561392500|FG003|Overall Study|Adverse Event|0|||
155537692|NCT03358147|561392507|FG000|Overall Study|Withdrawal by Subject|13|||
155537693|NCT03358147|561392508|FG001|Overall Study|Withdrawal by Subject|19|||
155537694|NCT03358147|561392509|FG002|Overall Study|Withdrawal by Subject|16|||
155537695|NCT03358147|561392510|FG003|Overall Study|Withdrawal by Subject|10|||
155537696|NCT03358147|561392511|FG004|Overall Study|Withdrawal by Subject|5|||
155537697|NCT03358147|561392507|FG000|Overall Study|Adverse Event|3|||
155537698|NCT03358147|561392508|FG001|Overall Study|Adverse Event|9|||
155537699|NCT03358147|561392509|FG002|Overall Study|Adverse Event|7|||
155537700|NCT03358147|561392510|FG003|Overall Study|Adverse Event|5|||
155537701|NCT03358147|561392511|FG004|Overall Study|Adverse Event|2|||
155537702|NCT03358147|561392507|FG000|Overall Study|Lost to Follow-up|4|||
155537703|NCT03358147|561392508|FG001|Overall Study|Lost to Follow-up|3|||
155537704|NCT03358147|561392509|FG002|Overall Study|Lost to Follow-up|7|||
155537705|NCT03358147|561392510|FG003|Overall Study|Lost to Follow-up|6|||
155537706|NCT03358147|561392511|FG004|Overall Study|Lost to Follow-up|4|||
155537707|NCT03358147|561392507|FG000|Overall Study|Major Protocol Deviation|11|||
155537708|NCT03358147|561392508|FG001|Overall Study|Major Protocol Deviation|3|||
155537709|NCT03358147|561392509|FG002|Overall Study|Major Protocol Deviation|2|||
155537710|NCT03358147|561392510|FG003|Overall Study|Major Protocol Deviation|3|||
155537711|NCT03358147|561392511|FG004|Overall Study|Major Protocol Deviation|1|||
155537712|NCT03358147|561392507|FG000|Overall Study|Protocol specified criteria|2|||
155537713|NCT03358147|561392508|FG001|Overall Study|Protocol specified criteria|3|||
155537714|NCT03358147|561392509|FG002|Overall Study|Protocol specified criteria|0|||
155537715|NCT03358147|561392510|FG003|Overall Study|Protocol specified criteria|3|||
155537716|NCT03358147|561392511|FG004|Overall Study|Protocol specified criteria|1|||
155537717|NCT03358147|561392507|FG000|Overall Study|Physician Decision|1|||
155537718|NCT03358147|561392508|FG001|Overall Study|Physician Decision|0|||
155537719|NCT03358147|561392509|FG002|Overall Study|Physician Decision|1|||
155537720|NCT03358147|561392510|FG003|Overall Study|Physician Decision|6|||
155537721|NCT03358147|561392511|FG004|Overall Study|Physician Decision|1|||
155537722|NCT03358147|561392507|FG000|Overall Study|Administrative reasons|0|||
155537723|NCT03358147|561392508|FG001|Overall Study|Administrative reasons|1|||
155537724|NCT03358147|561392509|FG002|Overall Study|Administrative reasons|0|||
155537725|NCT03358147|561392510|FG003|Overall Study|Administrative reasons|3|||
155537726|NCT03358147|561392511|FG004|Overall Study|Administrative reasons|0|||
155537727|NCT03358147|561392507|FG000|Overall Study|Lack of Efficacy|0|||
155537728|NCT03358147|561392508|FG001|Overall Study|Lack of Efficacy|1|||
155537729|NCT03358147|561392509|FG002|Overall Study|Lack of Efficacy|1|||
155537730|NCT03358147|561392510|FG003|Overall Study|Lack of Efficacy|0|||
155537731|NCT03358147|561392511|FG004|Overall Study|Lack of Efficacy|0|||
155537732|NCT02072096|561392512|FG000|Overall Study|Lack of Efficacy|18|||
155537733|NCT02072096|561392513|FG001|Overall Study|Lack of Efficacy|29|||
155537734|NCT02072096|561392512|FG000|Overall Study|Protocol Violation|7|||
155537735|NCT02072096|561392513|FG001|Overall Study|Protocol Violation|7|||
155537736|NCT02072096|561392512|FG000|Overall Study|Withdrawal by Subject|5|||
155537737|NCT02072096|561392513|FG001|Overall Study|Withdrawal by Subject|7|||
155537738|NCT02072096|561392512|FG000|Overall Study|Adverse Event|5|||
155537739|NCT02072096|561392513|FG001|Overall Study|Adverse Event|2|||
155537740|NCT02072096|561392512|FG000|Overall Study|No Reason Provided|4|||
155537741|NCT02072096|561392513|FG001|Overall Study|No Reason Provided|2|||
155537742|NCT02072096|561392512|FG000|Overall Study|Death|2|||
155537743|NCT02072096|561392513|FG001|Overall Study|Death|0|||
155537744|NCT02072096|561392512|FG000|Overall Study|Physician Decision|0|||
155537745|NCT02072096|561392513|FG001|Overall Study|Physician Decision|1|||
155537746|NCT02072096|561392512|FG000|Overall Study|Study Terminated by Sponsor|43|||
155537747|NCT02072096|561392513|FG001|Overall Study|Study Terminated by Sponsor|30|||
155537748|NCT02072096|561392512|FG000|Overall Study|Lost to Follow-up|1|||
155537749|NCT02072096|561392513|FG001|Overall Study|Lost to Follow-up|0|||
155537750|NCT01634139|561392514|FG000|Overall Study|Non compliant with protocol|1|||
155537751|NCT01634139|561392515|FG001|Overall Study|Non compliant with protocol|0|||
155537752|NCT01634139|561392516|FG002|Overall Study|Non compliant with protocol|0|||
155537753|NCT01634139|561392514|FG000|Overall Study|Consent withdrawn not due to AE|4|||
155537754|NCT01634139|561392515|FG001|Overall Study|Consent withdrawn not due to AE|3|||
155537755|NCT01634139|561392516|FG002|Overall Study|Consent withdrawn not due to AE|2|||
155537756|NCT01634139|561392514|FG000|Overall Study|Other|4|||
155537757|NCT01634139|561392515|FG001|Overall Study|Other|0|||
155537758|NCT01634139|561392516|FG002|Overall Study|Other|3|||
155537759|NCT01634139|561392514|FG000|Overall Study|Lost to Follow-up|0|||
155537760|NCT01634139|561392515|FG001|Overall Study|Lost to Follow-up|2|||
155537761|NCT01634139|561392516|FG002|Overall Study|Lost to Follow-up|0|||
155537762|NCT01634139|561392514|FG000|Overall Study|Not treated|1|||
155537763|NCT01634139|561392515|FG001|Overall Study|Not treated|1|||
155537764|NCT01634139|561392516|FG002|Overall Study|Not treated|0|||
155537765|NCT04567329|561392527|FG000|Overall Study|Withdrawal by Subject|5|||
155537766|NCT04567329|561392528|FG001|Overall Study|Withdrawal by Subject|6|||
155537767|NCT04567329|561392527|FG000|Overall Study|Protocol Violation|2|||
155537768|NCT04567329|561392528|FG001|Overall Study|Protocol Violation|3|||
155537769|NCT04567329|561392527|FG000|Overall Study|Discontinued|2|||
155537770|NCT04567329|561392528|FG001|Overall Study|Discontinued|2|||
155537771|NCT04567329|561392527|FG000|Overall Study|Lost to Follow-up|0|||
155537772|NCT04567329|561392528|FG001|Overall Study|Lost to Follow-up|1|||
155537773|NCT04567329|561392527|FG000|Overall Study|Lack of Efficacy|0|||
155537774|NCT04567329|561392528|FG001|Overall Study|Lack of Efficacy|1|||
155537775|NCT02933060|561392529|FG000|Overall Study|Withdrawal by Subject|0|||
155537776|NCT02933060|561392530|FG001|Overall Study|Withdrawal by Subject|1|||
155537777|NCT01945580|561392531|FG000|Overall Study|Withdrawal by Subject|13|||
155537778|NCT01945580|561392532|FG001|Overall Study|Withdrawal by Subject|35|||
155537779|NCT01945580|561392531|FG000|Overall Study|Physician Decision|3|||
155537780|NCT01945580|561392532|FG001|Overall Study|Physician Decision|2|||
155537781|NCT01945580|561392531|FG000|Overall Study|Lost to Follow-up|26|||
155537782|NCT01945580|561392532|FG001|Overall Study|Lost to Follow-up|39|||
155537783|NCT01945580|561392531|FG000|Overall Study|Death|7|||
155537784|NCT01945580|561392532|FG001|Overall Study|Death|2|||
155537785|NCT01945580|561392531|FG000|Overall Study|Patient moved out of state|0|||
155537786|NCT01945580|561392532|FG001|Overall Study|Patient moved out of state|1|||
155537787|NCT01945580|561392531|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
155537788|NCT01945580|561392532|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
155537789|NCT01945580|561392531|FG000|Overall Study|Family illness - unable to return|0|||
155537790|NCT01945580|561392532|FG001|Overall Study|Family illness - unable to return|1|||
155537791|NCT01945580|561392531|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
155537792|NCT01945580|561392532|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
155537793|NCT01945580|561392531|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
155537794|NCT01945580|561392532|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
155537795|NCT01945580|561392531|FG000|Overall Study|Noncompliance with 36 month visit|1|||
155537796|NCT01945580|561392532|FG001|Overall Study|Noncompliance with 36 month visit|0|||
155537797|NCT01945580|561392531|FG000|Overall Study|The patient moved.|1|||
155537798|NCT01945580|561392532|FG001|Overall Study|The patient moved.|0|||
155537799|NCT01945580|561392531|FG000|Overall Study|No data available|0|||
155537800|NCT01945580|561392532|FG001|Overall Study|No data available|2|||
155537801|NCT04411680|561392533|FG000|Treatment Period|Adverse Event|3|||
155537802|NCT04411680|561392534|FG001|Treatment Period|Adverse Event|0|||
155537803|NCT04411680|561392533|FG000|Treatment Period|Discharged from hospital|18|||
155537804|NCT04411680|561392534|FG001|Treatment Period|Discharged from hospital|7|||
155537805|NCT04411680|561392533|FG000|Treatment Period|Missed 1 or more doses|8|||
155537806|NCT04411680|561392534|FG001|Treatment Period|Missed 1 or more doses|0|||
155537807|NCT04411680|561392533|FG000|Treatment Period|Transferred to another hospital|0|||
155537808|NCT04411680|561392534|FG001|Treatment Period|Transferred to another hospital|1|||
155537809|NCT04411680|561392533|FG000|Follow up Period|Withdrawal by Subject|2|||
155537810|NCT04411680|561392534|FG001|Follow up Period|Withdrawal by Subject|0|||
155537811|NCT04411680|561392533|FG000|Follow up Period|Lost to Follow-up|5|||
155537812|NCT04411680|561392534|FG001|Follow up Period|Lost to Follow-up|6|||
155537813|NCT04411680|561392533|FG000|Follow up Period|Death|11|||
155537814|NCT04411680|561392534|FG001|Follow up Period|Death|8|||
155537815|NCT05034874|561392535|FG000|Overall Study|Withdrawal by Subject|6|||
155537816|NCT05034874|561392536|FG001|Overall Study|Withdrawal by Subject|6|||
155537817|NCT05034874|561392535|FG000|Overall Study|Lost to Follow-up|18|||
155537818|NCT05034874|561392536|FG001|Overall Study|Lost to Follow-up|8|||
155537819|NCT05034874|561392535|FG000|Overall Study|Physician Decision|0|||
155537820|NCT05034874|561392536|FG001|Overall Study|Physician Decision|1|||
155537821|NCT05034874|561392535|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
155537822|NCT05034874|561392536|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
155537823|NCT02426918|561392537|FG000|Overall Study|Adverse Event|2|||
155537824|NCT02426918|561392538|FG001|Overall Study|Adverse Event|2|||
155537825|NCT02426918|561392539|FG002|Overall Study|Adverse Event|0|||
155537826|NCT02426918|561392537|FG000|Overall Study|Physician Decision|1|||
155537827|NCT02426918|561392538|FG001|Overall Study|Physician Decision|1|||
155537828|NCT02426918|561392539|FG002|Overall Study|Physician Decision|1|||
155537829|NCT02426918|561392537|FG000|Overall Study|Withdrawal by Subject|5|||
155537830|NCT02426918|561392538|FG001|Overall Study|Withdrawal by Subject|5|||
155537831|NCT02426918|561392539|FG002|Overall Study|Withdrawal by Subject|4|||
155537832|NCT02426918|561392537|FG000|Overall Study|Other|9|||
155537833|NCT02426918|561392538|FG001|Overall Study|Other|11|||
155537834|NCT02426918|561392539|FG002|Overall Study|Other|9|||
155537835|NCT01496118|561392540|FG000|Overall Study|Disease progression|3|||
155537836|NCT01496118|561392541|FG001|Overall Study|Disease progression|2|||
155537837|NCT01496118|561392542|FG002|Overall Study|Disease progression|3|||
155537838|NCT01496118|561392543|FG003|Overall Study|Disease progression|1|||
155537839|NCT01496118|561392544|FG004|Overall Study|Disease progression|2|||
155537840|NCT01496118|561392545|FG005|Overall Study|Disease progression|2|||
155537841|NCT01496118|561392546|FG006|Overall Study|Disease progression|14|||
155537842|NCT01496118|561392547|FG007|Overall Study|Disease progression|10|||
155537843|NCT01496118|561392540|FG000|Overall Study|Physician Decision|0|||
155537844|NCT01496118|561392541|FG001|Overall Study|Physician Decision|0|||
155537845|NCT01496118|561392542|FG002|Overall Study|Physician Decision|0|||
155537846|NCT01496118|561392543|FG003|Overall Study|Physician Decision|0|||
155537847|NCT01496118|561392544|FG004|Overall Study|Physician Decision|1|||
155537848|NCT01496118|561392545|FG005|Overall Study|Physician Decision|0|||
155655715|NCT02301897|561833567|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
155537849|NCT01496118|561392546|FG006|Overall Study|Physician Decision|3|||
155537850|NCT01496118|561392547|FG007|Overall Study|Physician Decision|6|||
155537851|NCT01496118|561392540|FG000|Overall Study|Adverse Event|1|||
155537852|NCT01496118|561392541|FG001|Overall Study|Adverse Event|1|||
155537853|NCT01496118|561392542|FG002|Overall Study|Adverse Event|0|||
155537854|NCT01496118|561392543|FG003|Overall Study|Adverse Event|0|||
155537855|NCT01496118|561392544|FG004|Overall Study|Adverse Event|0|||
155537856|NCT01496118|561392545|FG005|Overall Study|Adverse Event|0|||
155537857|NCT01496118|561392546|FG006|Overall Study|Adverse Event|6|||
155537858|NCT01496118|561392547|FG007|Overall Study|Adverse Event|10|||
155537859|NCT01496118|561392540|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537860|NCT01496118|561392541|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537861|NCT01496118|561392542|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537862|NCT01496118|561392543|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537863|NCT01496118|561392544|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537864|NCT01496118|561392545|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537865|NCT01496118|561392546|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
155537866|NCT01496118|561392547|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
155537867|NCT01496118|561392540|FG000|Overall Study|Death|0|||
155537868|NCT01496118|561392541|FG001|Overall Study|Death|0|||
155537869|NCT01496118|561392542|FG002|Overall Study|Death|0|||
155537870|NCT01496118|561392543|FG003|Overall Study|Death|0|||
155537871|NCT01496118|561392544|FG004|Overall Study|Death|0|||
155537872|NCT01496118|561392545|FG005|Overall Study|Death|0|||
155537873|NCT01496118|561392546|FG006|Overall Study|Death|1|||
155537874|NCT01496118|561392547|FG007|Overall Study|Death|1|||
155537875|NCT01496118|561392540|FG000|Overall Study|Withdrawal by Subject|0|||
155537876|NCT01496118|561392541|FG001|Overall Study|Withdrawal by Subject|0|||
155537877|NCT01496118|561392542|FG002|Overall Study|Withdrawal by Subject|0|||
155537878|NCT01496118|561392543|FG003|Overall Study|Withdrawal by Subject|2|||
155537879|NCT01496118|561392544|FG004|Overall Study|Withdrawal by Subject|0|||
155537880|NCT01496118|561392545|FG005|Overall Study|Withdrawal by Subject|1|||
155537881|NCT01496118|561392546|FG006|Overall Study|Withdrawal by Subject|6|||
155537882|NCT01496118|561392547|FG007|Overall Study|Withdrawal by Subject|3|||
155537883|NCT04608448|561392549|FG000|Overall Study|Withdrawal by Subject|1|||
155537884|NCT04608448|561392549|FG000|Overall Study|Adverse Event|1|||
155537885|NCT04060251|561392552|FG000|Overall Study|Study terminated due to low enrollment.|7|||
155537886|NCT04060251|561392553|FG001|Overall Study|Study terminated due to low enrollment.|5|||
155537887|NCT04060251|561392554|FG002|Overall Study|Study terminated due to low enrollment.|7|||
155537888|NCT04060251|561392552|FG000|Overall Study|Adverse Event|1|||
155537889|NCT04060251|561392553|FG001|Overall Study|Adverse Event|1|||
155537890|NCT04060251|561392554|FG002|Overall Study|Adverse Event|0|||
155537891|NCT00487435|561392555|FG000|Overall Study|Adverse Event|146|||
155537892|NCT00487435|561392555|FG000|Overall Study|Death|2|||
155537893|NCT00487435|561392555|FG000|Overall Study|Lack of Efficacy|33|||
155537894|NCT00487435|561392555|FG000|Overall Study|Lost to Follow-up|54|||
155537895|NCT00487435|561392555|FG000|Overall Study|Pregnancy|2|||
155537896|NCT00487435|561392555|FG000|Overall Study|Withdrawal by Subject|132|||
155537897|NCT00487435|561392555|FG000|Overall Study|Resolution Of Pain|1|||
155537898|NCT00487435|561392555|FG000|Overall Study|Study Medication Non-Compliant|32|||
155537899|NCT00487435|561392555|FG000|Overall Study|Other|83|||
155537900|NCT01155531|561392556|FG000|Overall Study|Adverse Event|0|||
155537901|NCT01155531|561392557|FG001|Overall Study|Adverse Event|0|||
155537902|NCT01155531|561392558|FG002|Overall Study|Adverse Event|1|||
155537903|NCT01155531|561392559|FG003|Overall Study|Adverse Event|0|||
155537904|NCT01155531|561392556|FG000|Overall Study|Lost to Follow-up|0|||
155537905|NCT01155531|561392557|FG001|Overall Study|Lost to Follow-up|0|||
155537906|NCT01155531|561392558|FG002|Overall Study|Lost to Follow-up|0|||
155537907|NCT01155531|561392559|FG003|Overall Study|Lost to Follow-up|1|||
155537908|NCT01155531|561392556|FG000|Overall Study|Withdrawal by Subject|1|||
155537909|NCT01155531|561392557|FG001|Overall Study|Withdrawal by Subject|0|||
155537910|NCT01155531|561392558|FG002|Overall Study|Withdrawal by Subject|1|||
155537911|NCT01155531|561392559|FG003|Overall Study|Withdrawal by Subject|0|||
155537912|NCT00999687|561392562|FG000|First Intervention|Withdrawal by Subject|1|||
155537913|NCT00999687|561392562|FG000|Second Intervention|Withdrawal by Subject|2|||
155537914|NCT00999687|561392562|FG000|Second Intervention|Lack of Efficacy|1|||
155537915|NCT03614728|561392563|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
155537916|NCT03614728|561392564|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
155537917|NCT03614728|561392565|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
155537918|NCT03614728|561392566|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
155537919|NCT03614728|561392563|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
155537920|NCT03614728|561392564|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
155537921|NCT03614728|561392565|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
155537922|NCT03614728|561392566|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
155537923|NCT00842309|561392569|FG000|Overall Study|Withdrawal by Subject|3|||
155537924|NCT00842309|561392570|FG001|Overall Study|Withdrawal by Subject|1|||
155537925|NCT03105297|561392571|FG000|Baseline Phase (Day 1)|Other|21|||
155537926|NCT03105297|561392571|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
155537927|NCT03105297|561392571|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
155537928|NCT01390948|561392572|FG000|Overall Study|End of Study|1|||
155537929|NCT01390948|561392573|FG001|Overall Study|End of Study|0|||
155537930|NCT01390948|561392574|FG002|Overall Study|End of Study|0|||
155537931|NCT01390948|561392572|FG000|Overall Study|Withdrew consent|2|||
155537932|NCT01390948|561392573|FG001|Overall Study|Withdrew consent|2|||
155537933|NCT01390948|561392574|FG002|Overall Study|Withdrew consent|0|||
155537934|NCT01390948|561392572|FG000|Overall Study|Progressive Disease|2|||
155537935|NCT01390948|561392573|FG001|Overall Study|Progressive Disease|5|||
155537936|NCT01390948|561392574|FG002|Overall Study|Progressive Disease|0|||
155487699|NCT00842829|561208282|FG001|Continuation Period|Withdrawal by Subject|0|||
155487700|NCT00842829|561208283|FG002|Continuation Period|Withdrawal by Subject|10|||
155487701|NCT00842829|561208281|FG000|Continuation Period|Other|0|||
155487702|NCT00842829|561208282|FG001|Continuation Period|Other|0|||
155487703|NCT00842829|561208283|FG002|Continuation Period|Other|7|||
155487704|NCT00842829|561208281|FG000|Continuation Period|Non-compliance to study procedures|0|||
155487705|NCT00842829|561208282|FG001|Continuation Period|Non-compliance to study procedures|0|||
155487706|NCT00842829|561208283|FG002|Continuation Period|Non-compliance to study procedures|2|||
155487707|NCT00842829|561208281|FG000|Continuation Period|Non-compliance to study drug|0|||
155487708|NCT00842829|561208282|FG001|Continuation Period|Non-compliance to study drug|0|||
155487709|NCT00842829|561208283|FG002|Continuation Period|Non-compliance to study drug|1|||
155487710|NCT02612194|561208290|FG000|Overall Study|Death|5|||
155487711|NCT02612194|561208291|FG001|Overall Study|Death|0|||
155487712|NCT02612194|561208292|FG002|Overall Study|Death|2|||
155487713|NCT02612194|561208290|FG000|Overall Study|Early Study Termination|1|||
155487714|NCT02612194|561208291|FG001|Overall Study|Early Study Termination|0|||
155487715|NCT02612194|561208292|FG002|Overall Study|Early Study Termination|0|||
155487716|NCT02539160|561208293|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
155487717|NCT02539160|561208294|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
155487718|NCT02539160|561208295|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
155487719|NCT02539160|561208296|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
155487720|NCT02539160|561208293|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
155487721|NCT02539160|561208294|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
155537937|NCT01390948|561392572|FG000|Overall Study|Death during follow-up|10|||
155537938|NCT01390948|561392573|FG001|Overall Study|Death during follow-up|11|||
155537939|NCT01390948|561392574|FG002|Overall Study|Death during follow-up|1|||
155537940|NCT03867760|561392579|FG000|Overall Study|Lost to Follow-up|2|||
155537941|NCT03867760|561392580|FG001|Overall Study|Lost to Follow-up|3|||
155537942|NCT03867760|561392579|FG000|Overall Study|Withdrawal by Subject|1|||
155537943|NCT03867760|561392580|FG001|Overall Study|Withdrawal by Subject|2|||
155537944|NCT03867760|561392579|FG000|Overall Study|subject could not meet study logistics|3|||
155537945|NCT03867760|561392580|FG001|Overall Study|subject could not meet study logistics|3|||
155537946|NCT01401062|561392583|FG000|Overall Study|Death|9|||
155537947|NCT01401062|561392584|FG001|Overall Study|Death|7|||
155537948|NCT01401062|561392583|FG000|Overall Study|Physician Decision|1|||
155537949|NCT01401062|561392584|FG001|Overall Study|Physician Decision|0|||
155537950|NCT01401062|561392583|FG000|Overall Study|Withdrawal by Subject|1|||
155537951|NCT01401062|561392584|FG001|Overall Study|Withdrawal by Subject|1|||
155537952|NCT03684928|561392590|FG000|First Intervention|Lost to Follow-up|0|||
155537953|NCT03684928|561392591|FG001|First Intervention|Lost to Follow-up|1|||
155537954|NCT03684928|561392590|FG000|First Intervention|Withdrawal by Subject|0|||
155537955|NCT03684928|561392591|FG001|First Intervention|Withdrawal by Subject|2|||
155537956|NCT03684928|561392590|FG000|Second Intervention|Soft Tissue Injury|1|||
155537957|NCT03684928|561392591|FG001|Second Intervention|Soft Tissue Injury|0|||
155537958|NCT01018862|561392592|FG000|Overall Study|Adverse Event|2|||
155537959|NCT01018862|561392593|FG001|Overall Study|Adverse Event|0|||
155537960|NCT01018862|561392594|FG002|Overall Study|Adverse Event|6|||
155537961|NCT01018862|561392592|FG000|Overall Study|Lack of Efficacy|1|||
155537962|NCT01018862|561392593|FG001|Overall Study|Lack of Efficacy|0|||
155537963|NCT01018862|561392594|FG002|Overall Study|Lack of Efficacy|2|||
155537964|NCT01018862|561392592|FG000|Overall Study|Lost to Follow-up|3|||
155537965|NCT01018862|561392593|FG001|Overall Study|Lost to Follow-up|1|||
155537966|NCT01018862|561392594|FG002|Overall Study|Lost to Follow-up|0|||
155537967|NCT01018862|561392592|FG000|Overall Study|Protocol Violation|1|||
155537968|NCT01018862|561392593|FG001|Overall Study|Protocol Violation|3|||
155537969|NCT01018862|561392594|FG002|Overall Study|Protocol Violation|3|||
155537970|NCT01018862|561392592|FG000|Overall Study|Withdrawal by Subject|1|||
155537971|NCT01018862|561392593|FG001|Overall Study|Withdrawal by Subject|2|||
155537972|NCT01018862|561392594|FG002|Overall Study|Withdrawal by Subject|1|||
155537973|NCT01018862|561392592|FG000|Overall Study|administrative problems|5|||
155537974|NCT01018862|561392593|FG001|Overall Study|administrative problems|4|||
155537975|NCT01018862|561392594|FG002|Overall Study|administrative problems|4|||
155537976|NCT00840879|561392595|FG000|Second Intervention|Withdrawal by Subject|1|||
155537977|NCT00840879|561392596|FG001|Second Intervention|Withdrawal by Subject|0|||
155537978|NCT03086135|561393880|FG000|Overall Study|Adverse Event|1|||
155537979|NCT03086135|561393880|FG000|Overall Study|Lost to Follow-up|2|||
155537980|NCT00960154|561393881|FG000|Overall Study|Study termination|25|||
155537981|NCT00960154|561393882|FG001|Overall Study|Study termination|25|||
155537982|NCT00757705|561393883|FG000|Overall Study|Adverse Event|19|||
155537983|NCT00757705|561393883|FG000|Overall Study|Lost to Follow-up|16|||
155537984|NCT00757705|561393883|FG000|Overall Study|Withdrawal by Subject|25|||
155537985|NCT00757705|561393883|FG000|Overall Study|Insufficient Response|26|||
155537986|NCT00757705|561393883|FG000|Overall Study|Ineligible to continue|8|||
155537987|NCT00757705|561393883|FG000|Overall Study|Non-compliant|9|||
155537988|NCT00757705|561393883|FG000|Overall Study|Other|18|||
155537989|NCT02651987|561393887|FG000|Overall Study|Adverse Event|2|||
155537990|NCT02651987|561393888|FG001|Overall Study|Adverse Event|2|||
155537991|NCT02651987|561393887|FG000|Overall Study|Consent Withdrawn|2|||
155537992|NCT02651987|561393888|FG001|Overall Study|Consent Withdrawn|0|||
155537993|NCT02651987|561393887|FG000|Overall Study|Local PD|0|||
155537994|NCT02651987|561393888|FG001|Overall Study|Local PD|2|||
155537995|NCT02651987|561393887|FG000|Overall Study|Investigator Decision|1|||
155537996|NCT02651987|561393888|FG001|Overall Study|Investigator Decision|1|||
155537997|NCT04408924|561393889|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
155537998|NCT04408924|561393889|FG000|Overall Study|Lost to Follow-up|3|||
155537999|NCT04408924|561393889|FG000|Overall Study|Withdrawal by Subject|5|||
155538000|NCT04408924|561393889|FG000|Overall Study|Sponsor Decision|2|||
155538001|NCT00486434|561393890|FG000|Overall Study|Withdrawal by Subject|34|||
155538002|NCT00486434|561393891|FG001|Overall Study|Withdrawal by Subject|39|||
155538003|NCT00486434|561393890|FG000|Overall Study|Adverse Event|118|||
155538004|NCT00486434|561393891|FG001|Overall Study|Adverse Event|44|||
155538005|NCT00486434|561393890|FG000|Overall Study|Protocol Violation|22|||
155538006|NCT00486434|561393891|FG001|Overall Study|Protocol Violation|21|||
155538007|NCT00486434|561393890|FG000|Overall Study|Lack of Efficacy|12|||
155538008|NCT00486434|561393891|FG001|Overall Study|Lack of Efficacy|19|||
155538009|NCT00486434|561393890|FG000|Overall Study|Lost to Follow-up|2|||
155538010|NCT00486434|561393891|FG001|Overall Study|Lost to Follow-up|3|||
155538011|NCT00486434|561393890|FG000|Overall Study|Death|1|||
155538012|NCT00486434|561393891|FG001|Overall Study|Death|2|||
155538013|NCT00486434|561393890|FG000|Overall Study|Personal reasons|5|||
155538014|NCT00486434|561393891|FG001|Overall Study|Personal reasons|6|||
155538015|NCT02218541|561393892|FG000|Overall Study|Lost to Follow-up|2|||
155538016|NCT02218541|561393893|FG001|Overall Study|Lost to Follow-up|1|||
155538017|NCT02218541|561393892|FG000|Overall Study|Implant Failure|4|||
155538018|NCT02218541|561393893|FG001|Overall Study|Implant Failure|1|||
155538019|NCT00856349|561393894|FG000|Overall Study|Death|418|||
155538020|NCT00856349|561393894|FG000|Overall Study|Withdrawal by Subject|116|||
155538021|NCT00856349|561393894|FG000|Overall Study|Lost to Follow-up|91|||
155538022|NCT00856349|561393894|FG000|Overall Study|Protocol Violation|38|||
155538023|NCT00856349|561393894|FG000|Overall Study|Physician Decision|13|||
155538024|NCT00856349|561393894|FG000|Overall Study|Subject relocation|104|||
155538025|NCT00856349|561393894|FG000|Overall Study|Device explant|33|||
155538026|NCT00856349|561393894|FG000|Overall Study|Site closure|78|||
155538027|NCT00856349|561393894|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
155538028|NCT02578641|561393895|FG000|Overall Study|Adverse Event|5|||
155538029|NCT02578641|561393896|FG001|Overall Study|Adverse Event|15|||
155538030|NCT02578641|561393895|FG000|Overall Study|Death|16|||
155538031|NCT02578641|561393896|FG001|Overall Study|Death|8|||
155538032|NCT02578641|561393895|FG000|Overall Study|Lost to Follow-up|0|||
155538033|NCT02578641|561393896|FG001|Overall Study|Lost to Follow-up|1|||
155538034|NCT02578641|561393895|FG000|Overall Study|Withdrawal by Subject|14|||
155538035|NCT02578641|561393896|FG001|Overall Study|Withdrawal by Subject|7|||
155538036|NCT02578641|561393895|FG000|Overall Study|Progressive Disease|69|||
155538037|NCT02578641|561393896|FG001|Overall Study|Progressive Disease|21|||
155538038|NCT02578641|561393895|FG000|Overall Study|No Study Drug|2|||
155538039|NCT02578641|561393896|FG001|Overall Study|No Study Drug|0|||
155538040|NCT02578641|561393895|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
155538041|NCT02578641|561393896|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
155538042|NCT02578641|561393895|FG000|Overall Study|Non-compliance with Study Schedule|1|||
155538043|NCT02578641|561393896|FG001|Overall Study|Non-compliance with Study Schedule|0|||
155538044|NCT02578641|561393895|FG000|Overall Study|Other|1|||
155538045|NCT02578641|561393896|FG001|Overall Study|Other|10|||
155538046|NCT02578641|561393895|FG000|Overall Study|Not treated|1|||
155538047|NCT02578641|561393896|FG001|Overall Study|Not treated|4|||
155538048|NCT02694536|561393898|FG000|Overall Study|Progressive Disease|40|||
155538049|NCT02694536|561393898|FG000|Overall Study|Lost to Follow-up|1|||
155538050|NCT02694536|561393898|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
155538051|NCT02694536|561393898|FG000|Overall Study|Withdrawal by Subject|8|||
155538052|NCT02694536|561393898|FG000|Overall Study|Death|8|||
155538053|NCT02694536|561393898|FG000|Overall Study|Other|22|||
155538054|NCT01168856|561393905|FG000|Overall Study|Lost to Follow-up|4|||
155538055|NCT01168856|561393906|FG001|Overall Study|Lost to Follow-up|34|||
155538056|NCT01168856|561393905|FG000|Overall Study|Withdrawal by Subject|6|||
155538057|NCT01168856|561393906|FG001|Overall Study|Withdrawal by Subject|8|||
155538058|NCT01168856|561393905|FG000|Overall Study|Physician Decision|2|||
155538059|NCT01168856|561393906|FG001|Overall Study|Physician Decision|1|||
155538060|NCT01168856|561393905|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
155538061|NCT01168856|561393906|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
155538062|NCT01168856|561393905|FG000|Overall Study|Participant received anti-HCV treatment|1|||
155538063|NCT01168856|561393906|FG001|Overall Study|Participant received anti-HCV treatment|0|||
155538064|NCT01168856|561393905|FG000|Overall Study|Death|0|||
155538065|NCT01168856|561393906|FG001|Overall Study|Death|2|||
155538066|NCT01168856|561393905|FG000|Overall Study|Other|1|||
155538067|NCT01168856|561393906|FG001|Overall Study|Other|291|||
155538068|NCT01168856|561393905|FG000|Overall Study|Protocol Violation|4|||
155538069|NCT01168856|561393906|FG001|Overall Study|Protocol Violation|6|||
155538070|NCT01266902|561393907|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
155538071|NCT01266902|561393908|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
155538072|NCT01266902|561393909|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
155538073|NCT01266902|561393907|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
155538074|NCT01266902|561393908|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
155538075|NCT01266902|561393909|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
155538076|NCT01266902|561393907|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
155538077|NCT01266902|561393908|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
155655716|NCT02301897|561833568|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
155538078|NCT01266902|561393909|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
155538079|NCT01266902|561393907|FG000|Period 1 (Main Study)|Adverse Event|3|||
155538080|NCT01266902|561393908|FG001|Period 1 (Main Study)|Adverse Event|11|||
155538081|NCT01266902|561393909|FG002|Period 1 (Main Study)|Adverse Event|0|||
155538082|NCT01266902|561393907|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
155538083|NCT01266902|561393908|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
155538084|NCT01266902|561393909|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
155538085|NCT01266902|561393907|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
155538086|NCT01266902|561393908|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
155538087|NCT01266902|561393909|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
155538088|NCT01266902|561393907|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
155538089|NCT01266902|561393908|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
155538090|NCT01266902|561393909|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
155538091|NCT01266902|561393907|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
155538092|NCT01266902|561393908|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
155538093|NCT01266902|561393909|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
155538094|NCT01266902|561393907|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
155538095|NCT01266902|561393908|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
155538096|NCT01266902|561393909|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
155538097|NCT01266902|561393907|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
155538098|NCT01266902|561393908|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
155538099|NCT01266902|561393909|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
155538100|NCT05562011|561393916|FG000|Overall Study|Withdrawal by Subject|3|||
155538101|NCT05562011|561393916|FG000|Overall Study|Lost to Follow-up|1|||
155538102|NCT05562011|561393916|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
155538103|NCT05562011|561393916|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
155538104|NCT05562011|561393916|FG000|Overall Study|Device malfunction|13|||
155538105|NCT00387153|561393917|FG000|Overall Study|Adverse Event|1|||
155538106|NCT00387153|561393917|FG000|Overall Study|Disease Progression|3|||
155538107|NCT00387153|561393917|FG000|Overall Study|Lack of Response|4|||
155538108|NCT01867658|561393922|FG000|Overall Study|Withdrawal by Subject|6|||
155538109|NCT01867658|561393922|FG000|Overall Study|Death|2|||
155538110|NCT01867658|561393922|FG000|Overall Study|Subject could not be contacted|1|||
155538111|NCT03101358|561393923|FG000|Overall Study|Non-compliance with study schedule|1|||
155538112|NCT03101358|561393924|FG001|Overall Study|Non-compliance with study schedule|0|||
155538113|NCT03101358|561393925|FG002|Overall Study|Non-compliance with study schedule|0|||
155538114|NCT03101358|561393926|FG003|Overall Study|Non-compliance with study schedule|1|||
155538115|NCT03101358|561393923|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
155538116|NCT03101358|561393924|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
155538117|NCT03101358|561393925|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
155538118|NCT03101358|561393926|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
155538119|NCT03101358|561393923|FG000|Overall Study|Physician Decision|1|||
155538120|NCT03101358|561393924|FG001|Overall Study|Physician Decision|0|||
155538121|NCT03101358|561393925|FG002|Overall Study|Physician Decision|0|||
155538122|NCT03101358|561393926|FG003|Overall Study|Physician Decision|3|||
155538123|NCT03101358|561393923|FG000|Overall Study|Adverse Event|0|||
155538124|NCT03101358|561393924|FG001|Overall Study|Adverse Event|0|||
155538125|NCT03101358|561393925|FG002|Overall Study|Adverse Event|1|||
155538126|NCT03101358|561393926|FG003|Overall Study|Adverse Event|0|||
155538127|NCT03101358|561393923|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
155538128|NCT03101358|561393924|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
155538129|NCT03101358|561393925|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
155538130|NCT03101358|561393926|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
155538131|NCT03101358|561393923|FG000|Overall Study|Lost to Follow-up|1|||
155538132|NCT03101358|561393924|FG001|Overall Study|Lost to Follow-up|0|||
155538133|NCT03101358|561393925|FG002|Overall Study|Lost to Follow-up|0|||
155538134|NCT03101358|561393926|FG003|Overall Study|Lost to Follow-up|1|||
155538135|NCT00474058|561393927|FG000|Overall Study|Adverse Event|11|||
155538136|NCT00474058|561393928|FG001|Overall Study|Adverse Event|6|||
155538137|NCT00474058|561393927|FG000|Overall Study|Lack of Efficacy|0|||
155538138|NCT00474058|561393928|FG001|Overall Study|Lack of Efficacy|4|||
155538139|NCT00474058|561393927|FG000|Overall Study|Withdrawal by Subject|11|||
155538140|NCT00474058|561393928|FG001|Overall Study|Withdrawal by Subject|7|||
155538141|NCT00474058|561393927|FG000|Overall Study|Other|2|||
155538142|NCT00474058|561393928|FG001|Overall Study|Other|0|||
155538143|NCT02640235|561393929|FG000|Overall Study|Withdrawal by Subject|7|||
155538144|NCT02640235|561393930|FG001|Overall Study|Withdrawal by Subject|6|||
155538145|NCT02640235|561393929|FG000|Overall Study|Lost to Follow-up|4|||
155538146|NCT02640235|561393930|FG001|Overall Study|Lost to Follow-up|3|||
155538147|NCT02640235|561393929|FG000|Overall Study|Death|2|||
155538148|NCT02640235|561393930|FG001|Overall Study|Death|3|||
155538149|NCT02640235|561393929|FG000|Overall Study|Other|1|||
155538150|NCT02640235|561393930|FG001|Overall Study|Other|2|||
155538151|NCT00841659|561393935|FG000|Washout: 2 Weeks|Protocol Violation|1|||
155538152|NCT00841659|561393936|FG001|Washout: 2 Weeks|Protocol Violation|0|||
155538153|NCT00654186|561393940|FG000|Overall Study|Withdrawal by Subject|5|||
155538154|NCT05616728|561393941|FG000|Overall Study|Lost to Follow-up|0|||
155538155|NCT05616728|561393942|FG001|Overall Study|Lost to Follow-up|0|||
155538156|NCT05616728|561393943|FG002|Overall Study|Lost to Follow-up|1|||
155538157|NCT05616728|561393941|FG000|Overall Study|Withdrawal by Subject|1|||
155538158|NCT05616728|561393942|FG001|Overall Study|Withdrawal by Subject|1|||
155538159|NCT05616728|561393943|FG002|Overall Study|Withdrawal by Subject|0|||
155538160|NCT05616728|561393941|FG000|Overall Study|Physician Decision|1|||
155538161|NCT05616728|561393942|FG001|Overall Study|Physician Decision|1|||
155538162|NCT05616728|561393943|FG002|Overall Study|Physician Decision|1|||
155538163|NCT05616728|561393941|FG000|Overall Study|Other|0|||
155538164|NCT05616728|561393942|FG001|Overall Study|Other|2|||
155538165|NCT05616728|561393943|FG002|Overall Study|Other|0|||
155538166|NCT01024855|561393946|FG000|Overall Study|Inclusion/exclusion criteria|1|||
155538167|NCT03306277|561393948|FG000|Overall Study|Death|1|||
155538168|NCT03306277|561393948|FG000|Overall Study|Adverse Event|1|||
155538169|NCT03306277|561393948|FG000|Overall Study|Withdrawal by Subject|1|||
155538170|NCT00875524|561393955|FG000|Overall Study|Serious adverse event|0|||
155538171|NCT00875524|561393956|FG001|Overall Study|Serious adverse event|1|||
155538172|NCT00875524|561393955|FG000|Overall Study|Protocol Violation|4|||
155538173|NCT00875524|561393956|FG001|Overall Study|Protocol Violation|0|||
155538174|NCT00875524|561393955|FG000|Overall Study|Lost to Follow-up|1|||
155538175|NCT00875524|561393956|FG001|Overall Study|Lost to Follow-up|0|||
155538176|NCT00875524|561393955|FG000|Overall Study|Withdrawal by Subject|3|||
155538177|NCT00875524|561393956|FG001|Overall Study|Withdrawal by Subject|5|||
155538178|NCT00829452|561393957|FG000|First Intervention|Withdrawal by Subject|0|||
155538179|NCT00829452|561393958|FG001|First Intervention|Withdrawal by Subject|1|||
155538180|NCT00829452|561393957|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
155538181|NCT00829452|561393958|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
155538182|NCT00829452|561393957|FG000|Second Intervention|Physician Decision|0|||
155538183|NCT00829452|561393958|FG001|Second Intervention|Physician Decision|1|||
155538184|NCT01370863|561393959|FG000|Overall Study|Adverse Event|1|||
155538185|NCT01370863|561393960|FG001|Overall Study|Adverse Event|1|||
155538186|NCT01370863|561393959|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
155538187|NCT01370863|561393960|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
155538188|NCT01370863|561393959|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155538189|NCT01370863|561393960|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155538190|NCT02436200|561393969|FG000|Overall Study|Significant outlier|1|||
155538191|NCT01968551|561393974|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
155538192|NCT01968551|561393975|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
155538193|NCT01968551|561393976|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
155538194|NCT01968551|561393974|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
155538195|NCT01968551|561393975|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
155538196|NCT01968551|561393976|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
155538197|NCT01968551|561393974|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
155538198|NCT01968551|561393975|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
155538199|NCT01968551|561393976|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
155538200|NCT01968551|561393974|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
155538201|NCT01968551|561393975|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
155538202|NCT01968551|561393976|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
155538203|NCT01968551|561393974|FG000|Extension Phase|Adverse Event|0|||
155538204|NCT01968551|561393975|FG001|Extension Phase|Adverse Event|0|||
155538205|NCT01968551|561393976|FG002|Extension Phase|Adverse Event|2|||
155538206|NCT01968551|561393974|FG000|Extension Phase|Death|0|||
155538207|NCT01968551|561393975|FG001|Extension Phase|Death|1|||
155538208|NCT01968551|561393976|FG002|Extension Phase|Death|0|||
155538209|NCT01968551|561393974|FG000|Extension Phase|Withdrew Consent|0|||
155538210|NCT01968551|561393975|FG001|Extension Phase|Withdrew Consent|0|||
155538211|NCT01968551|561393976|FG002|Extension Phase|Withdrew Consent|1|||
155538212|NCT01968551|561393974|FG000|Extension Phase|Lost to Follow-up|1|||
155655717|NCT02301897|561833569|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
155655718|NCT02301897|561833567|FG000|Treatment Course 1|Withdrawal by Subject|0|||
155655719|NCT02301897|561833568|FG001|Treatment Course 1|Withdrawal by Subject|0|||
155655720|NCT02301897|561833569|FG002|Treatment Course 1|Withdrawal by Subject|2|||
155655721|NCT02301897|561833567|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
155655722|NCT02301897|561833568|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
155655723|NCT02301897|561833569|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
155655724|NCT02301897|561833567|FG000|Treatment Course 2|Lost to Follow-up|0|||
155655725|NCT02301897|561833568|FG001|Treatment Course 2|Lost to Follow-up|2|||
155655726|NCT02301897|561833569|FG002|Treatment Course 2|Lost to Follow-up|0|||
155655727|NCT02301897|561833567|FG000|Treatment Course 2|Pregnancy|0|||
155655728|NCT02301897|561833568|FG001|Treatment Course 2|Pregnancy|1|||
155655729|NCT02301897|561833569|FG002|Treatment Course 2|Pregnancy|1|||
155655730|NCT02301897|561833567|FG000|Treatment Course 2|Withdrawal by Subject|0|||
155655731|NCT02301897|561833568|FG001|Treatment Course 2|Withdrawal by Subject|2|||
155655732|NCT02301897|561833569|FG002|Treatment Course 2|Withdrawal by Subject|0|||
155655733|NCT02301897|561833567|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
155655734|NCT02301897|561833568|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
155655735|NCT02301897|561833569|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
155655736|NCT03673176|561833570|FG000|Overall Study|Death prior to intervention|1|||
155655737|NCT03673176|561833570|FG000|Overall Study|Death following intervention|3|||
155655738|NCT03673176|561833570|FG000|Overall Study|Withdrawal by Subject|1|||
155655739|NCT00337168|561833571|FG000|Overall Study|Death|5|||
155655740|NCT00337168|561833571|FG000|Overall Study|Not protocol specified|2|||
155655741|NCT00337168|561833571|FG000|Overall Study|Did not start therapy|1|||
155655742|NCT01230060|561833575|FG000|Overall Study|Withdrawal by Subject|1|||
155655743|NCT03802916|561833576|FG000|Overall Study|Adverse Event|0|||
155655744|NCT03802916|561833577|FG001|Overall Study|Adverse Event|1|||
155655745|NCT03802916|561833576|FG000|Overall Study|Withdrawal by Subject|0|||
155655746|NCT03802916|561833577|FG001|Overall Study|Withdrawal by Subject|1|||
155655747|NCT01285102|561833578|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
155655748|NCT03524157|561833588|FG000|Overall Study|cytology not readable|0|||
155655749|NCT03524157|561833589|FG001|Overall Study|cytology not readable|0|||
155655750|NCT03524157|561833590|FG002|Overall Study|cytology not readable|1|||
155655751|NCT04507763|561833591|FG000|Overall Study|Participants did not meet entrance criteria|201|||
155655752|NCT03322566|561833592|FG000|Overall Study|Death|34|||
155655753|NCT03322566|561833593|FG001|Overall Study|Death|35|||
155655754|NCT03322566|561833594|FG002|Overall Study|Death|23|||
155655755|NCT03322566|561833592|FG000|Overall Study|Physician Decision|6|||
155655756|NCT03322566|561833593|FG001|Overall Study|Physician Decision|7|||
155538213|NCT01968551|561393975|FG001|Extension Phase|Lost to Follow-up|0|||
155655757|NCT03322566|561833594|FG002|Overall Study|Physician Decision|2|||
155655758|NCT03322566|561833592|FG000|Overall Study|Withdrawal by Subject|4|||
155655759|NCT03322566|561833593|FG001|Overall Study|Withdrawal by Subject|3|||
155538214|NCT01968551|561393976|FG002|Extension Phase|Lost to Follow-up|1|||
155538215|NCT00645853|561393977|FG000|Overall Study|Adverse Event|18|||
155655760|NCT03322566|561833594|FG002|Overall Study|Withdrawal by Subject|6|||
155655761|NCT03322566|561833592|FG000|Overall Study|Lost to Follow-up|0|||
155655762|NCT03322566|561833593|FG001|Overall Study|Lost to Follow-up|0|||
155655763|NCT03322566|561833594|FG002|Overall Study|Lost to Follow-up|1|||
155538216|NCT00645853|561393978|FG001|Overall Study|Adverse Event|7|||
155538217|NCT00645853|561393977|FG000|Overall Study|AZ study closure in Hungary|60|||
155538218|NCT00645853|561393978|FG001|Overall Study|AZ study closure in Hungary|40|||
155538219|NCT00645853|561393977|FG000|Overall Study|Withdrawal by Subject|5|||
155538220|NCT00645853|561393978|FG001|Overall Study|Withdrawal by Subject|2|||
155538221|NCT00645853|561393977|FG000|Overall Study|Protocol Violation|0|||
155538222|NCT00645853|561393978|FG001|Overall Study|Protocol Violation|2|||
155538223|NCT00645853|561393977|FG000|Overall Study|Discontinuation criteria|2|||
155538224|NCT00645853|561393978|FG001|Overall Study|Discontinuation criteria|2|||
155538225|NCT00645853|561393977|FG000|Overall Study|recall of ICF, planned operation, death|7|||
155538226|NCT00645853|561393978|FG001|Overall Study|recall of ICF, planned operation, death|4|||
155538227|NCT00819169|561393979|FG000|Overall Study|Withdrawal by Subject|2|||
155538228|NCT00819169|561393980|FG001|Overall Study|Withdrawal by Subject|0|||
155538229|NCT00819169|561393981|FG002|Overall Study|Withdrawal by Subject|0|||
155538230|NCT00819169|561393982|FG003|Overall Study|Withdrawal by Subject|1|||
155538231|NCT00819169|561393983|FG004|Overall Study|Withdrawal by Subject|1|||
155538232|NCT00819169|561393984|FG005|Overall Study|Withdrawal by Subject|1|||
155538233|NCT00819169|561393985|FG006|Overall Study|Withdrawal by Subject|5|||
155538234|NCT00819169|561393986|FG007|Overall Study|Withdrawal by Subject|1|||
155538235|NCT00819169|561393987|FG008|Overall Study|Withdrawal by Subject|4|||
155538236|NCT00819169|561393979|FG000|Overall Study|Lost to Follow-up|0|||
155538237|NCT00819169|561393980|FG001|Overall Study|Lost to Follow-up|2|||
155538238|NCT00819169|561393981|FG002|Overall Study|Lost to Follow-up|0|||
155538239|NCT00819169|561393982|FG003|Overall Study|Lost to Follow-up|1|||
155538240|NCT00819169|561393983|FG004|Overall Study|Lost to Follow-up|0|||
155538241|NCT00819169|561393984|FG005|Overall Study|Lost to Follow-up|6|||
155538242|NCT00819169|561393985|FG006|Overall Study|Lost to Follow-up|2|||
155538243|NCT00819169|561393986|FG007|Overall Study|Lost to Follow-up|2|||
155538244|NCT00819169|561393987|FG008|Overall Study|Lost to Follow-up|1|||
155538245|NCT00819169|561393979|FG000|Overall Study|Death|1|||
155538246|NCT00819169|561393980|FG001|Overall Study|Death|1|||
155538247|NCT00819169|561393981|FG002|Overall Study|Death|3|||
155538248|NCT00819169|561393982|FG003|Overall Study|Death|8|||
155538249|NCT00819169|561393983|FG004|Overall Study|Death|5|||
155538250|NCT00819169|561393984|FG005|Overall Study|Death|7|||
155538251|NCT00819169|561393985|FG006|Overall Study|Death|9|||
155538252|NCT00819169|561393986|FG007|Overall Study|Death|4|||
155538253|NCT00819169|561393987|FG008|Overall Study|Death|7|||
155538254|NCT00819169|561393979|FG000|Overall Study|Ineligibility determined|0|||
155655764|NCT03322566|561833592|FG000|Overall Study|Study terminated by sponsor|1|||
155655765|NCT03322566|561833593|FG001|Overall Study|Study terminated by sponsor|0|||
155655766|NCT03322566|561833594|FG002|Overall Study|Study terminated by sponsor|1|||
155538255|NCT00819169|561393980|FG001|Overall Study|Ineligibility determined|0|||
155538256|NCT00819169|561393981|FG002|Overall Study|Ineligibility determined|0|||
155538257|NCT00819169|561393982|FG003|Overall Study|Ineligibility determined|2|||
155538258|NCT00819169|561393983|FG004|Overall Study|Ineligibility determined|0|||
155538259|NCT00819169|561393984|FG005|Overall Study|Ineligibility determined|0|||
155538260|NCT00819169|561393985|FG006|Overall Study|Ineligibility determined|0|||
155538261|NCT00819169|561393986|FG007|Overall Study|Ineligibility determined|0|||
155538262|NCT00819169|561393987|FG008|Overall Study|Ineligibility determined|1|||
155538263|NCT00819169|561393979|FG000|Overall Study|Adverse Event|0|||
155538264|NCT00819169|561393980|FG001|Overall Study|Adverse Event|0|||
155538265|NCT00819169|561393981|FG002|Overall Study|Adverse Event|0|||
155538266|NCT00819169|561393982|FG003|Overall Study|Adverse Event|0|||
155538267|NCT00819169|561393983|FG004|Overall Study|Adverse Event|1|||
155538268|NCT00819169|561393984|FG005|Overall Study|Adverse Event|0|||
155655767|NCT05763381|561833598|FG000|Overall Study|Lost to Follow-up|2|||
155655768|NCT05763381|561833599|FG001|Overall Study|Lost to Follow-up|3|||
155655769|NCT05763381|561833598|FG000|Overall Study|Withdrawal by Subject|1|||
155655770|NCT05763381|561833599|FG001|Overall Study|Withdrawal by Subject|2|||
155655771|NCT00841815|561833600|FG000|Washout|Withdrawal by Subject|0|||
155655772|NCT00841815|561833601|FG001|Washout|Withdrawal by Subject|1|||
155655773|NCT03729609|561833602|FG000|Overall Study|Protocol Violation|1|||
155655774|NCT02327169|561833608|FG000|Overall Study|Progressive Disease|1|||
155655775|NCT02327169|561833609|FG001|Overall Study|Progressive Disease|3|||
155538269|NCT00819169|561393985|FG006|Overall Study|Adverse Event|0|||
155538270|NCT00819169|561393986|FG007|Overall Study|Adverse Event|0|||
155538271|NCT00819169|561393987|FG008|Overall Study|Adverse Event|0|||
155538272|NCT00819169|561393979|FG000|Overall Study|Administrative Decision|0|||
155538273|NCT00819169|561393980|FG001|Overall Study|Administrative Decision|0|||
155538274|NCT00819169|561393981|FG002|Overall Study|Administrative Decision|0|||
155538275|NCT00819169|561393982|FG003|Overall Study|Administrative Decision|0|||
155538276|NCT00819169|561393983|FG004|Overall Study|Administrative Decision|1|||
155538277|NCT00819169|561393984|FG005|Overall Study|Administrative Decision|2|||
155538278|NCT00819169|561393985|FG006|Overall Study|Administrative Decision|0|||
155538279|NCT00819169|561393986|FG007|Overall Study|Administrative Decision|2|||
155538280|NCT00819169|561393987|FG008|Overall Study|Administrative Decision|0|||
155538281|NCT03885934|561393992|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
155538282|NCT03885934|561393993|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
155538283|NCT03885934|561393994|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
155538284|NCT03885934|561393995|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
155538285|NCT03885934|561393996|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
155538286|NCT03885934|561393997|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
155538287|NCT00406393|561393998|FG000|Overall Study|Did not undergo transplantation|2|||
155538288|NCT00406393|561393999|FG001|Overall Study|Did not undergo transplantation|1|||
155538289|NCT00380588|561394000|FG000|Overall Study|Unequivocal Disease Progression|25|||
155538290|NCT00380588|561394001|FG001|Overall Study|Unequivocal Disease Progression|34|||
155538291|NCT00380588|561394000|FG000|Overall Study|Next Cycle Not Started|4|||
155538292|NCT00380588|561394001|FG001|Overall Study|Next Cycle Not Started|0|||
155538293|NCT00380588|561394000|FG000|Overall Study|Adverse Event|7|||
155538294|NCT00380588|561394001|FG001|Overall Study|Adverse Event|3|||
155538295|NCT00380588|561394000|FG000|Overall Study|Withdrawal by Subject|1|||
155538296|NCT00380588|561394001|FG001|Overall Study|Withdrawal by Subject|3|||
155538297|NCT00380588|561394000|FG000|Overall Study|Physician Decision|2|||
155538298|NCT00380588|561394001|FG001|Overall Study|Physician Decision|0|||
155538299|NCT02096705|561394002|FG000|Treatment|Adverse Event|6|||
155538300|NCT02096705|561394003|FG001|Treatment|Adverse Event|3|||
155538301|NCT02096705|561394002|FG000|Treatment|Subject request to discontinue treatment|1|||
155538302|NCT02096705|561394003|FG001|Treatment|Subject request to discontinue treatment|1|||
155538303|NCT02096705|561394002|FG000|Treatment|Withdrawal by Subject|1|||
155538304|NCT02096705|561394003|FG001|Treatment|Withdrawal by Subject|0|||
155538305|NCT02096705|561394002|FG000|Treatment|Other|1|||
155655776|NCT02327169|561833610|FG002|Overall Study|Progressive Disease|4|||
155655777|NCT02327169|561833611|FG003|Overall Study|Progressive Disease|3|||
155655778|NCT02327169|561833612|FG004|Overall Study|Progressive Disease|4|||
155655779|NCT02327169|561833613|FG005|Overall Study|Progressive Disease|3|||
155655780|NCT02327169|561833614|FG006|Overall Study|Progressive Disease|3|||
155655781|NCT02327169|561833615|FG007|Overall Study|Progressive Disease|3|||
155655782|NCT02327169|561833616|FG008|Overall Study|Progressive Disease|4|||
155655783|NCT02327169|561833617|FG009|Overall Study|Progressive Disease|4|||
155655784|NCT02327169|561833618|FG010|Overall Study|Progressive Disease|4|||
155655785|NCT02327169|561833619|FG011|Overall Study|Progressive Disease|3|||
155655786|NCT02327169|561833620|FG012|Overall Study|Progressive Disease|1|||
155655787|NCT02327169|561833621|FG013|Overall Study|Progressive Disease|3|||
155655788|NCT02327169|561833622|FG014|Overall Study|Progressive Disease|3|||
155655789|NCT02327169|561833608|FG000|Overall Study|Adverse Event|2|||
155655790|NCT02327169|561833609|FG001|Overall Study|Adverse Event|0|||
155655791|NCT02327169|561833610|FG002|Overall Study|Adverse Event|1|||
155655792|NCT02327169|561833611|FG003|Overall Study|Adverse Event|0|||
155655793|NCT02327169|561833612|FG004|Overall Study|Adverse Event|1|||
155655794|NCT02327169|561833613|FG005|Overall Study|Adverse Event|0|||
155655795|NCT02327169|561833614|FG006|Overall Study|Adverse Event|0|||
155655796|NCT02327169|561833615|FG007|Overall Study|Adverse Event|0|||
155655797|NCT02327169|561833616|FG008|Overall Study|Adverse Event|0|||
155655798|NCT02327169|561833617|FG009|Overall Study|Adverse Event|2|||
155655799|NCT02327169|561833618|FG010|Overall Study|Adverse Event|0|||
155655800|NCT02327169|561833619|FG011|Overall Study|Adverse Event|3|||
155655801|NCT02327169|561833620|FG012|Overall Study|Adverse Event|0|||
155655802|NCT02327169|561833621|FG013|Overall Study|Adverse Event|2|||
155655803|NCT02327169|561833622|FG014|Overall Study|Adverse Event|1|||
155655804|NCT02327169|561833608|FG000|Overall Study|Symptomatic Deterioration|0|||
155655805|NCT02327169|561833609|FG001|Overall Study|Symptomatic Deterioration|0|||
155655806|NCT02327169|561833610|FG002|Overall Study|Symptomatic Deterioration|1|||
155655807|NCT02327169|561833611|FG003|Overall Study|Symptomatic Deterioration|0|||
155655808|NCT02327169|561833612|FG004|Overall Study|Symptomatic Deterioration|1|||
155655809|NCT02327169|561833613|FG005|Overall Study|Symptomatic Deterioration|1|||
155655810|NCT02327169|561833614|FG006|Overall Study|Symptomatic Deterioration|0|||
155655811|NCT02327169|561833615|FG007|Overall Study|Symptomatic Deterioration|0|||
155655812|NCT02327169|561833616|FG008|Overall Study|Symptomatic Deterioration|2|||
155655813|NCT02327169|561833617|FG009|Overall Study|Symptomatic Deterioration|1|||
155655814|NCT02327169|561833618|FG010|Overall Study|Symptomatic Deterioration|0|||
155655815|NCT02327169|561833619|FG011|Overall Study|Symptomatic Deterioration|0|||
155655816|NCT02327169|561833620|FG012|Overall Study|Symptomatic Deterioration|0|||
155655817|NCT02327169|561833621|FG013|Overall Study|Symptomatic Deterioration|2|||
155655818|NCT02327169|561833622|FG014|Overall Study|Symptomatic Deterioration|1|||
155655819|NCT02327169|561833608|FG000|Overall Study|Reason Not Specified|0|||
155655820|NCT02327169|561833609|FG001|Overall Study|Reason Not Specified|0|||
155655821|NCT02327169|561833610|FG002|Overall Study|Reason Not Specified|1|||
155655822|NCT02327169|561833611|FG003|Overall Study|Reason Not Specified|0|||
155538306|NCT02096705|561394003|FG001|Treatment|Other|1|||
155538307|NCT02096705|561394002|FG000|Follow-up|Withdrawal by Subject|1|||
155655823|NCT02327169|561833612|FG004|Overall Study|Reason Not Specified|0|||
155538308|NCT02096705|561394003|FG001|Follow-up|Withdrawal by Subject|0|||
155538309|NCT02096705|561394002|FG000|Follow-up|Adverse Event|2|||
155655824|NCT02327169|561833613|FG005|Overall Study|Reason Not Specified|0|||
155538310|NCT02096705|561394003|FG001|Follow-up|Adverse Event|2|||
155538311|NCT02096705|561394002|FG000|Follow-up|Subjects not reporting status|1|||
155538312|NCT02096705|561394003|FG001|Follow-up|Subjects not reporting status|2|||
155538313|NCT02905435|561394004|FG000|Overall Study|Death|2|||
155538314|NCT02905435|561394004|FG000|Overall Study|Physician Decision|1|||
155538315|NCT02905435|561394004|FG000|Overall Study|Lost to Follow-up|4|||
155538316|NCT02377349|561394008|FG000|Overall Study|Serious Adverse Event|1|||
155538317|NCT02377349|561394009|FG001|Overall Study|Serious Adverse Event|0|||
155538318|NCT02377349|561394008|FG000|Overall Study|Protocol Violation|3|||
155538319|NCT02377349|561394009|FG001|Overall Study|Protocol Violation|2|||
155538320|NCT02377349|561394008|FG000|Overall Study|Withdrawal by Subject|5|||
155538321|NCT02377349|561394009|FG001|Overall Study|Withdrawal by Subject|3|||
155538322|NCT02377349|561394008|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
155538323|NCT02377349|561394009|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
155538324|NCT02377349|561394008|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
155538325|NCT02377349|561394009|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
155538326|NCT02377349|561394008|FG000|Overall Study|Other|0|||
155538327|NCT02377349|561394009|FG001|Overall Study|Other|1|||
155538328|NCT01395017|561394012|FG000|Overall Study|Lost to Follow-up|1|||
155538329|NCT01395017|561394013|FG001|Overall Study|Lost to Follow-up|0|||
155538330|NCT01395017|561394012|FG000|Overall Study|Adverse Event|26|||
155538331|NCT01395017|561394013|FG001|Overall Study|Adverse Event|12|||
155538332|NCT01395017|561394012|FG000|Overall Study|Physician Decision|11|||
155538333|NCT01395017|561394013|FG001|Overall Study|Physician Decision|15|||
155538334|NCT01395017|561394012|FG000|Overall Study|Withdrawal by Subject|14|||
155538335|NCT01395017|561394013|FG001|Overall Study|Withdrawal by Subject|8|||
155538336|NCT01395017|561394012|FG000|Overall Study|Protocol deviation|1|||
155538337|NCT01395017|561394013|FG001|Overall Study|Protocol deviation|2|||
155538338|NCT01395017|561394012|FG000|Overall Study|Death|4|||
155538339|NCT01395017|561394013|FG001|Overall Study|Death|3|||
155538340|NCT01395017|561394012|FG000|Overall Study|Disease progression|42|||
155538341|NCT01395017|561394013|FG001|Overall Study|Disease progression|58|||
155538342|NCT01395017|561394012|FG000|Overall Study|Sponsor discontinued study|1|||
155538343|NCT01395017|561394013|FG001|Overall Study|Sponsor discontinued study|4|||
155538344|NCT03366428|561394016|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
155538345|NCT03366428|561394016|FG000|Overall Study|Adverse Event|12|||
155538346|NCT03366428|561394016|FG000|Overall Study|Clinical progression|2|||
155538347|NCT03366428|561394016|FG000|Overall Study|Withdrawal by Subject|4|||
155538348|NCT01046084|561394020|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
155538349|NCT01046084|561394021|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
155538350|NCT02166606|561394022|FG000|Overall Study|Adverse Event|3|||
155538351|NCT02166606|561394022|FG000|Overall Study|Death|31|||
155538352|NCT02166606|561394022|FG000|Overall Study|Protocol Violation|7|||
155538353|NCT02166606|561394022|FG000|Overall Study|Lost to Follow-up|30|||
155538354|NCT02166606|561394022|FG000|Overall Study|Withdrawal by Subject|1|||
155538355|NCT02166606|561394022|FG000|Overall Study|Physician Decision|1|||
155655825|NCT02327169|561833614|FG006|Overall Study|Reason Not Specified|0|||
155655826|NCT02327169|561833615|FG007|Overall Study|Reason Not Specified|0|||
155655827|NCT02327169|561833616|FG008|Overall Study|Reason Not Specified|0|||
155655828|NCT02327169|561833617|FG009|Overall Study|Reason Not Specified|1|||
155655829|NCT02327169|561833618|FG010|Overall Study|Reason Not Specified|2|||
155655830|NCT02327169|561833619|FG011|Overall Study|Reason Not Specified|1|||
155655831|NCT02327169|561833620|FG012|Overall Study|Reason Not Specified|0|||
155655832|NCT02327169|561833621|FG013|Overall Study|Reason Not Specified|0|||
155655833|NCT02327169|561833622|FG014|Overall Study|Reason Not Specified|2|||
155655834|NCT02327169|561833608|FG000|Overall Study|Withdrawal by Subject|1|||
155655835|NCT02327169|561833609|FG001|Overall Study|Withdrawal by Subject|0|||
155655836|NCT02327169|561833610|FG002|Overall Study|Withdrawal by Subject|0|||
155655837|NCT02327169|561833611|FG003|Overall Study|Withdrawal by Subject|0|||
155655838|NCT02327169|561833612|FG004|Overall Study|Withdrawal by Subject|1|||
155655839|NCT02327169|561833613|FG005|Overall Study|Withdrawal by Subject|0|||
155655840|NCT02327169|561833614|FG006|Overall Study|Withdrawal by Subject|0|||
155655841|NCT02327169|561833615|FG007|Overall Study|Withdrawal by Subject|1|||
155655842|NCT02327169|561833616|FG008|Overall Study|Withdrawal by Subject|0|||
155538356|NCT02166606|561394022|FG000|Overall Study|Device upgrade|1|||
155538357|NCT02166606|561394022|FG000|Overall Study|Enrolled after End of Enrollment|4|||
155538358|NCT01958476|561394025|FG000|Overall Study|Parent requested exclusion from analysis|1|||
155538359|NCT01958476|561394026|FG001|Overall Study|Parent requested exclusion from analysis|0|||
155538360|NCT02670551|561394027|FG000|Overall Study|Adverse Event|4|||
155538361|NCT02670551|561394028|FG001|Overall Study|Adverse Event|7|||
155538362|NCT02670551|561394029|FG002|Overall Study|Adverse Event|9|||
155655843|NCT02327169|561833617|FG009|Overall Study|Withdrawal by Subject|0|||
155655844|NCT02327169|561833618|FG010|Overall Study|Withdrawal by Subject|0|||
155655845|NCT02327169|561833619|FG011|Overall Study|Withdrawal by Subject|0|||
155538363|NCT02670551|561394027|FG000|Overall Study|Lack of Efficacy|2|||
155538364|NCT02670551|561394028|FG001|Overall Study|Lack of Efficacy|0|||
155538365|NCT02670551|561394029|FG002|Overall Study|Lack of Efficacy|3|||
155538366|NCT02670551|561394027|FG000|Overall Study|Withdrawal of Consent|6|||
155538367|NCT02670551|561394028|FG001|Overall Study|Withdrawal of Consent|3|||
155538368|NCT02670551|561394029|FG002|Overall Study|Withdrawal of Consent|8|||
155538369|NCT02670551|561394027|FG000|Overall Study|Lost to Follow-up|5|||
155538370|NCT02670551|561394028|FG001|Overall Study|Lost to Follow-up|7|||
155538371|NCT02670551|561394029|FG002|Overall Study|Lost to Follow-up|6|||
155538372|NCT02670551|561394027|FG000|Overall Study|Protocol Violation|1|||
155538373|NCT02670551|561394028|FG001|Overall Study|Protocol Violation|0|||
155538374|NCT02670551|561394029|FG002|Overall Study|Protocol Violation|0|||
155538375|NCT02670551|561394027|FG000|Overall Study|Noncompliance with study drug|3|||
155538376|NCT02670551|561394028|FG001|Overall Study|Noncompliance with study drug|3|||
155538377|NCT02670551|561394029|FG002|Overall Study|Noncompliance with study drug|2|||
155538378|NCT02670551|561394027|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155538379|NCT02670551|561394028|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155538380|NCT02670551|561394029|FG002|Overall Study|Other Miscellaneous Reasons|3|||
155538381|NCT02670551|561394027|FG000|Overall Study|Did Not Receive Treatment|5|||
155538382|NCT02670551|561394028|FG001|Overall Study|Did Not Receive Treatment|3|||
155538383|NCT02670551|561394029|FG002|Overall Study|Did Not Receive Treatment|0|||
155538384|NCT01971645|561394030|FG000|Overall Study|Adverse Event|1|||
155538385|NCT01971645|561394031|FG001|Overall Study|Adverse Event|0|||
155538386|NCT01971645|561394032|FG002|Overall Study|Adverse Event|0|||
155538387|NCT01971645|561394030|FG000|Overall Study|Lost to Follow-up|1|||
155538388|NCT01971645|561394031|FG001|Overall Study|Lost to Follow-up|0|||
155538389|NCT01971645|561394032|FG002|Overall Study|Lost to Follow-up|1|||
155538390|NCT01971645|561394030|FG000|Overall Study|Protocol Violation|0|||
155538391|NCT01971645|561394031|FG001|Overall Study|Protocol Violation|0|||
155538392|NCT01971645|561394032|FG002|Overall Study|Protocol Violation|1|||
155538393|NCT00714051|561394033|FG000|Overall Study|Withdrawal by Subject|1|||
155538394|NCT00714051|561394034|FG001|Overall Study|Withdrawal by Subject|0|||
155538395|NCT00714051|561394033|FG000|Overall Study|Death|0|||
155538396|NCT00714051|561394034|FG001|Overall Study|Death|1|||
155538397|NCT03868631|561394035|FG000|Baseline to Week 6|Adverse Event|0|||
155538398|NCT03868631|561394036|FG001|Baseline to Week 6|Adverse Event|3|||
155538399|NCT03868631|561394035|FG000|Baseline to Week 6|Protocol Violation|1|||
155538400|NCT03868631|561394036|FG001|Baseline to Week 6|Protocol Violation|1|||
155538401|NCT03868631|561394035|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
155538402|NCT03868631|561394036|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
155538403|NCT03868631|561394035|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
155538404|NCT03868631|561394036|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
155538405|NCT03868631|561394035|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
155538406|NCT03868631|561394036|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
155538407|NCT03868631|561394035|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
155538408|NCT03868631|561394036|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
155538409|NCT02286466|561394037|FG000|Overall Study|Death|1|||
155538410|NCT02286466|561394038|FG001|Overall Study|Death|3|||
155538411|NCT02286466|561394037|FG000|Overall Study|Withdrawal by Subject|5|||
155538412|NCT02286466|561394038|FG001|Overall Study|Withdrawal by Subject|2|||
155538413|NCT02286466|561394037|FG000|Overall Study|Lost to Follow-up|1|||
155538414|NCT02286466|561394038|FG001|Overall Study|Lost to Follow-up|4|||
155538415|NCT02286466|561394037|FG000|Overall Study|Declined Clinician Assessment|0|||
155538416|NCT02286466|561394038|FG001|Overall Study|Declined Clinician Assessment|1|||
155538417|NCT00835081|561394039|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155538418|NCT00835081|561394040|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155538419|NCT01675596|561394041|FG000|Overall Study|Death|6|||
155538420|NCT01675596|561394041|FG000|Overall Study|Exit with other reason|1|||
155538421|NCT01675596|561394041|FG000|Overall Study|Missed Visit|1|||
155538422|NCT04236596|561394042|FG000|Overall Study|Withdrawal by Subject|1|||
155538423|NCT04236596|561394042|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
155538424|NCT04236596|561394042|FG000|Overall Study|Participants did not receive implant at all|4|||
155538425|NCT01520987|561395616|FG000|Overall Study|Withdrawal by Subject|1|||
155538426|NCT01520987|561395617|FG001|Overall Study|Withdrawal by Subject|0|||
155538427|NCT01520987|561395618|FG002|Overall Study|Withdrawal by Subject|0|||
155538428|NCT01520987|561395619|FG003|Overall Study|Withdrawal by Subject|0|||
155538429|NCT01520987|561395620|FG004|Overall Study|Withdrawal by Subject|0|||
155538430|NCT01520987|561395621|FG005|Overall Study|Withdrawal by Subject|1|||
155538431|NCT01520987|561395622|FG006|Overall Study|Withdrawal by Subject|0|||
155538432|NCT01520987|561395623|FG007|Overall Study|Withdrawal by Subject|0|||
155538433|NCT02005562|561395624|FG000|Overall Study|Death|2|||
155538434|NCT02005562|561395625|FG001|Overall Study|Death|2|||
155538435|NCT02005562|561395624|FG000|Overall Study|Graft loss|7|||
155538436|NCT02005562|561395625|FG001|Overall Study|Graft loss|6|||
155538437|NCT02005562|561395624|FG000|Overall Study|Withdrawal by Subject|2|||
155538438|NCT02005562|561395625|FG001|Overall Study|Withdrawal by Subject|2|||
155538439|NCT02005562|561395624|FG000|Overall Study|No transplant|1|||
155538440|NCT02005562|561395625|FG001|Overall Study|No transplant|4|||
155538441|NCT02005562|561395624|FG000|Overall Study|Physician Decision|0|||
155538442|NCT02005562|561395625|FG001|Overall Study|Physician Decision|1|||
155538443|NCT02300987|561395626|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
155538444|NCT02300987|561395627|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
155538445|NCT02300987|561395626|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
155538446|NCT02300987|561395627|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
155538447|NCT02300987|561395626|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
155538448|NCT02300987|561395627|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
155538449|NCT02300987|561395626|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
155538450|NCT02300987|561395627|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
155538451|NCT02300987|561395626|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
155538452|NCT02300987|561395627|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
155538453|NCT01023061|561395628|FG000|Overall Study|Withdrawal prior to treatment|2|||
155538454|NCT02966340|561395629|FG000|Overall Study|Adverse Event|0|||
155538455|NCT02966340|561395630|FG001|Overall Study|Adverse Event|1|||
155538456|NCT02966340|561395629|FG000|Overall Study|Lost to Follow-up|0|||
155538457|NCT02966340|561395630|FG001|Overall Study|Lost to Follow-up|1|||
155538458|NCT02966340|561395629|FG000|Overall Study|Withdrawal by Subject|1|||
155538459|NCT02966340|561395630|FG001|Overall Study|Withdrawal by Subject|0|||
155538460|NCT02966340|561395629|FG000|Overall Study|data acquisition error|1|||
155538461|NCT02966340|561395630|FG001|Overall Study|data acquisition error|0|||
155538462|NCT02966340|561395629|FG000|Overall Study|startle non-responder|1|||
155538463|NCT02966340|561395630|FG001|Overall Study|startle non-responder|1|||
155538464|NCT02664415|561395632|FG000|Overall Study|Adverse Event|1|||
155538465|NCT02664415|561395633|FG001|Overall Study|Adverse Event|0|||
155538466|NCT02034513|561395637|FG000|Overall Study|Adverse Event|11|||
155538467|NCT02034513|561395638|FG001|Overall Study|Adverse Event|10|||
155538468|NCT02034513|561395637|FG000|Overall Study|Lack of Efficacy|0|||
155538469|NCT02034513|561395638|FG001|Overall Study|Lack of Efficacy|1|||
155538470|NCT02034513|561395637|FG000|Overall Study|Lost to Follow-up|6|||
155538471|NCT02034513|561395638|FG001|Overall Study|Lost to Follow-up|7|||
155538472|NCT02034513|561395637|FG000|Overall Study|Pregnancy|0|||
155538473|NCT02034513|561395638|FG001|Overall Study|Pregnancy|3|||
155538474|NCT02034513|561395637|FG000|Overall Study|Protocol Violation|7|||
155538475|NCT02034513|561395638|FG001|Overall Study|Protocol Violation|10|||
155538476|NCT02034513|561395637|FG000|Overall Study|Withdrawal by Subject|25|||
155538477|NCT02034513|561395638|FG001|Overall Study|Withdrawal by Subject|25|||
155538478|NCT02034513|561395637|FG000|Overall Study|Unclassified|0|||
155538479|NCT02034513|561395638|FG001|Overall Study|Unclassified|1|||
155538480|NCT02308241|561395639|FG000|Overall Study|Withdrawal by Subject|3|||
155538481|NCT00659815|561395640|FG000|Overall Study|Study related symptoms and complaints|2|||
155538482|NCT00659815|561395641|FG001|Overall Study|Study related symptoms and complaints|1|||
155538483|NCT00659815|561395640|FG000|Overall Study|Inability to maintain wearing schedule|1|||
155538484|NCT00659815|561395641|FG001|Overall Study|Inability to maintain wearing schedule|2|||
155538485|NCT00659815|561395640|FG000|Overall Study|Withdrawal by Subject|1|||
155538486|NCT00659815|561395641|FG001|Overall Study|Withdrawal by Subject|1|||
155538487|NCT02998541|561395647|FG000|Overall Study|Adverse Event|4|||
155538488|NCT02998541|561395648|FG001|Overall Study|Adverse Event|5|||
155538489|NCT02998541|561395649|FG002|Overall Study|Adverse Event|1|||
155538490|NCT02998541|561395647|FG000|Overall Study|Protocol Violation|1|||
155538491|NCT02998541|561395648|FG001|Overall Study|Protocol Violation|0|||
155538492|NCT02998541|561395649|FG002|Overall Study|Protocol Violation|0|||
155538493|NCT02998541|561395647|FG000|Overall Study|Withdrawal by Subject|3|||
155538494|NCT02998541|561395648|FG001|Overall Study|Withdrawal by Subject|1|||
155538495|NCT02998541|561395649|FG002|Overall Study|Withdrawal by Subject|0|||
155538496|NCT02998541|561395647|FG000|Overall Study|Lost to Follow-up|0|||
155538497|NCT02998541|561395648|FG001|Overall Study|Lost to Follow-up|3|||
155538498|NCT02998541|561395649|FG002|Overall Study|Lost to Follow-up|1|||
155538499|NCT02998541|561395647|FG000|Overall Study|Physician Decision|0|||
155538500|NCT02998541|561395648|FG001|Overall Study|Physician Decision|0|||
155538501|NCT02998541|561395649|FG002|Overall Study|Physician Decision|3|||
155538502|NCT02998541|561395647|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155538503|NCT02998541|561395648|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155538504|NCT02998541|561395649|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
155538505|NCT01513239|561395657|FG000|Period 1: Main Phase|Adverse Event|1|||
155538506|NCT01513239|561395658|FG001|Period 1: Main Phase|Adverse Event|1|||
155538507|NCT01513239|561395659|FG002|Period 1: Main Phase|Adverse Event|2|||
155538508|NCT01513239|561395660|FG003|Period 1: Main Phase|Adverse Event|0|||
155538509|NCT01513239|561395661|FG004|Period 1: Main Phase|Adverse Event|0|||
155538510|NCT01513239|561395662|FG005|Period 1: Main Phase|Adverse Event|0|||
155538511|NCT01513239|561395657|FG000|Period 1: Main Phase|Death|29|||
155538512|NCT01513239|561395658|FG001|Period 1: Main Phase|Death|22|||
155538513|NCT01513239|561395659|FG002|Period 1: Main Phase|Death|32|||
155538514|NCT01513239|561395660|FG003|Period 1: Main Phase|Death|0|||
155538515|NCT01513239|561395661|FG004|Period 1: Main Phase|Death|0|||
155538516|NCT01513239|561395662|FG005|Period 1: Main Phase|Death|0|||
155538517|NCT01513239|561395657|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
155538518|NCT01513239|561395658|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
155538519|NCT01513239|561395659|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
155538520|NCT01513239|561395660|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
155538521|NCT01513239|561395661|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
155538522|NCT01513239|561395662|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
155538523|NCT01513239|561395657|FG000|Period 1: Main Phase|Physician Decision|4|||
155538524|NCT01513239|561395658|FG001|Period 1: Main Phase|Physician Decision|4|||
155538525|NCT01513239|561395659|FG002|Period 1: Main Phase|Physician Decision|4|||
155538526|NCT01513239|561395660|FG003|Period 1: Main Phase|Physician Decision|0|||
155538527|NCT01513239|561395661|FG004|Period 1: Main Phase|Physician Decision|0|||
155538528|NCT01513239|561395662|FG005|Period 1: Main Phase|Physician Decision|0|||
155538529|NCT01513239|561395657|FG000|Period 1: Main Phase|Protocol Violation|2|||
155538530|NCT01513239|561395658|FG001|Period 1: Main Phase|Protocol Violation|2|||
155538531|NCT01513239|561395659|FG002|Period 1: Main Phase|Protocol Violation|2|||
155538532|NCT01513239|561395660|FG003|Period 1: Main Phase|Protocol Violation|0|||
155538533|NCT01513239|561395661|FG004|Period 1: Main Phase|Protocol Violation|0|||
155538534|NCT01513239|561395662|FG005|Period 1: Main Phase|Protocol Violation|0|||
155538535|NCT01513239|561395657|FG000|Period 1: Main Phase|Technical Problems|1|||
155538536|NCT01513239|561395658|FG001|Period 1: Main Phase|Technical Problems|2|||
155538537|NCT01513239|561395659|FG002|Period 1: Main Phase|Technical Problems|0|||
155655846|NCT02327169|561833620|FG012|Overall Study|Withdrawal by Subject|0|||
155655847|NCT02327169|561833621|FG013|Overall Study|Withdrawal by Subject|0|||
155655848|NCT02327169|561833622|FG014|Overall Study|Withdrawal by Subject|3|||
155655849|NCT02327169|561833608|FG000|Overall Study|Lost to Follow-up|0|||
155655850|NCT02327169|561833609|FG001|Overall Study|Lost to Follow-up|0|||
155655851|NCT02327169|561833610|FG002|Overall Study|Lost to Follow-up|0|||
155655852|NCT02327169|561833611|FG003|Overall Study|Lost to Follow-up|0|||
155655853|NCT02327169|561833612|FG004|Overall Study|Lost to Follow-up|1|||
155655854|NCT02327169|561833613|FG005|Overall Study|Lost to Follow-up|0|||
155655855|NCT02327169|561833614|FG006|Overall Study|Lost to Follow-up|0|||
155655856|NCT02327169|561833615|FG007|Overall Study|Lost to Follow-up|0|||
155655857|NCT02327169|561833616|FG008|Overall Study|Lost to Follow-up|0|||
155655858|NCT02327169|561833617|FG009|Overall Study|Lost to Follow-up|0|||
155655859|NCT02327169|561833618|FG010|Overall Study|Lost to Follow-up|0|||
155655860|NCT02327169|561833619|FG011|Overall Study|Lost to Follow-up|0|||
155655861|NCT02327169|561833620|FG012|Overall Study|Lost to Follow-up|0|||
155655862|NCT02327169|561833621|FG013|Overall Study|Lost to Follow-up|0|||
155655863|NCT02327169|561833622|FG014|Overall Study|Lost to Follow-up|0|||
155538538|NCT01513239|561395660|FG003|Period 1: Main Phase|Technical Problems|0|||
155538539|NCT01513239|561395661|FG004|Period 1: Main Phase|Technical Problems|0|||
155538540|NCT01513239|561395662|FG005|Period 1: Main Phase|Technical Problems|0|||
155538541|NCT01513239|561395657|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
155538542|NCT01513239|561395658|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
155538543|NCT01513239|561395659|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
155538544|NCT01513239|561395660|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
155538545|NCT01513239|561395661|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
155538546|NCT01513239|561395662|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
155538547|NCT01513239|561395657|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
155538548|NCT01513239|561395658|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
155538549|NCT01513239|561395659|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
155538550|NCT01513239|561395660|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
155538551|NCT01513239|561395661|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
155538552|NCT01513239|561395662|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
155538553|NCT01513239|561395657|FG000|Period 2: 9 Month Extension Phase|Death|0|||
155538554|NCT01513239|561395658|FG001|Period 2: 9 Month Extension Phase|Death|0|||
155538555|NCT01513239|561395659|FG002|Period 2: 9 Month Extension Phase|Death|0|||
155538556|NCT01513239|561395660|FG003|Period 2: 9 Month Extension Phase|Death|2|||
155538557|NCT01513239|561395661|FG004|Period 2: 9 Month Extension Phase|Death|5|||
155538558|NCT01513239|561395662|FG005|Period 2: 9 Month Extension Phase|Death|2|||
155538559|NCT01513239|561395657|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
155538560|NCT01513239|561395658|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
155655864|NCT06582732|561833625|FG000|Initial Study Period|Adverse Event|0|||
155655865|NCT06582732|561833626|FG001|Initial Study Period|Adverse Event|0|||
155655866|NCT06582732|561833627|FG002|Initial Study Period|Adverse Event|0|||
155655867|NCT06582732|561833628|FG003|Initial Study Period|Adverse Event|2|||
155655868|NCT06582732|561833629|FG004|Initial Study Period|Adverse Event|0|||
155655869|NCT06582732|561833630|FG005|Initial Study Period|Adverse Event|0|||
155655870|NCT06582732|561833631|FG006|Initial Study Period|Adverse Event|0|||
155655871|NCT06582732|561833625|FG000|Initial Study Period|Death|1|||
155655872|NCT06582732|561833626|FG001|Initial Study Period|Death|0|||
155538561|NCT01513239|561395659|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
155538562|NCT01513239|561395660|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
155538563|NCT01513239|561395661|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
155538564|NCT01513239|561395662|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
155538565|NCT01513239|561395657|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
155538566|NCT01513239|561395658|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
155538567|NCT01513239|561395659|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
155538568|NCT01513239|561395660|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
155538569|NCT01513239|561395661|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
155538570|NCT01513239|561395662|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
155538571|NCT01513239|561395657|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
155538572|NCT01513239|561395658|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
155538573|NCT01513239|561395659|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
155538574|NCT01513239|561395660|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
155538575|NCT01513239|561395661|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
155538576|NCT01513239|561395662|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
155538577|NCT00396162|561395663|FG000|Overall Study|Withdrawal by Subject|2|||
155655873|NCT06582732|561833627|FG002|Initial Study Period|Death|0|||
155655874|NCT06582732|561833628|FG003|Initial Study Period|Death|0|||
155655875|NCT06582732|561833629|FG004|Initial Study Period|Death|1|||
155655876|NCT06582732|561833630|FG005|Initial Study Period|Death|0|||
155655877|NCT06582732|561833631|FG006|Initial Study Period|Death|0|||
155655878|NCT06582732|561833625|FG000|Initial Study Period|Lost to Follow-up|0|||
155655879|NCT06582732|561833626|FG001|Initial Study Period|Lost to Follow-up|0|||
155655880|NCT06582732|561833627|FG002|Initial Study Period|Lost to Follow-up|2|||
155655881|NCT06582732|561833628|FG003|Initial Study Period|Lost to Follow-up|0|||
155655882|NCT06582732|561833629|FG004|Initial Study Period|Lost to Follow-up|0|||
155655883|NCT06582732|561833630|FG005|Initial Study Period|Lost to Follow-up|0|||
155655884|NCT06582732|561833631|FG006|Initial Study Period|Lost to Follow-up|0|||
155655885|NCT06582732|561833625|FG000|Initial Study Period|Withdrawal by Subject|0|||
155655886|NCT06582732|561833626|FG001|Initial Study Period|Withdrawal by Subject|1|||
155655887|NCT06582732|561833627|FG002|Initial Study Period|Withdrawal by Subject|0|||
155655888|NCT06582732|561833628|FG003|Initial Study Period|Withdrawal by Subject|1|||
155655889|NCT06582732|561833629|FG004|Initial Study Period|Withdrawal by Subject|3|||
155655890|NCT06582732|561833630|FG005|Initial Study Period|Withdrawal by Subject|1|||
155655891|NCT06582732|561833631|FG006|Initial Study Period|Withdrawal by Subject|2|||
155655892|NCT06582732|561833625|FG000|Initial Study Period|Moved Away|0|||
155655893|NCT06582732|561833626|FG001|Initial Study Period|Moved Away|0|||
155655894|NCT06582732|561833627|FG002|Initial Study Period|Moved Away|0|||
155655895|NCT06582732|561833628|FG003|Initial Study Period|Moved Away|0|||
155655896|NCT06582732|561833629|FG004|Initial Study Period|Moved Away|1|||
155655897|NCT06582732|561833630|FG005|Initial Study Period|Moved Away|0|||
155655898|NCT06582732|561833631|FG006|Initial Study Period|Moved Away|0|||
155655899|NCT03931330|561833632|FG000|Overall Study|Physician Decision|1|||
155655900|NCT03412929|561833633|FG000|Overall Study|Protocol Violation|3|||
155655901|NCT00581919|561833639|FG000|Overall Study|Adverse Event|8|||
155655902|NCT00581919|561833639|FG000|Overall Study|Death|1|||
155655903|NCT00581919|561833639|FG000|Overall Study|Disease Progression|10|||
155655904|NCT00581919|561833639|FG000|Overall Study|Physician Decision|1|||
155655905|NCT00581919|561833639|FG000|Overall Study|Other Complicating Disease|1|||
155655906|NCT00581919|561833639|FG000|Overall Study|Started Non-Protocol Therapy|2|||
155655907|NCT00581919|561833639|FG000|Overall Study|Withdrawal by Subject|1|||
155655908|NCT03900650|561833640|FG000|Overall Study|Withdrawal by Subject|1|||
155655909|NCT03900650|561833641|FG001|Overall Study|Withdrawal by Subject|1|||
155655910|NCT03900650|561833642|FG002|Overall Study|Withdrawal by Subject|0|||
155655911|NCT03900650|561833643|FG003|Overall Study|Withdrawal by Subject|0|||
155655912|NCT03900650|561833640|FG000|Overall Study|Withdrawn by staff|1|||
155655913|NCT03900650|561833641|FG001|Overall Study|Withdrawn by staff|0|||
155655914|NCT03900650|561833642|FG002|Overall Study|Withdrawn by staff|0|||
155655915|NCT03900650|561833643|FG003|Overall Study|Withdrawn by staff|0|||
155538578|NCT00396162|561395664|FG001|Overall Study|Withdrawal by Subject|3|||
155538579|NCT01741545|561395668|FG000|Treatment Period|Lack of Efficacy|0|||
155538580|NCT01741545|561395669|FG001|Treatment Period|Lack of Efficacy|1|||
155655916|NCT02014376|561833646|FG000|Overall Study|Adverse Event|1|||
155655917|NCT02014376|561833647|FG001|Overall Study|Adverse Event|1|||
155655918|NCT02014376|561833648|FG002|Overall Study|Adverse Event|0|||
155655919|NCT02014376|561833646|FG000|Overall Study|Lost to Follow-up|2|||
155655920|NCT02014376|561833647|FG001|Overall Study|Lost to Follow-up|0|||
155655921|NCT02014376|561833648|FG002|Overall Study|Lost to Follow-up|0|||
155655922|NCT02298946|561833651|FG000|Overall Study|Did not receive treatment|2|||
155655923|NCT02298946|561833652|FG001|Overall Study|Did not receive treatment|0|||
155655924|NCT02298946|561833651|FG000|Overall Study|Unevaluable|2|||
155655925|NCT02298946|561833652|FG001|Overall Study|Unevaluable|1|||
155655926|NCT04197583|561833653|FG000|Overall Study|Study Stent Replacement|34|||
155655927|NCT04197583|561833654|FG001|Overall Study|Study Stent Replacement|8|||
155655928|NCT04197583|561833653|FG000|Overall Study|Lost to Follow-up|14|||
155655929|NCT04197583|561833654|FG001|Overall Study|Lost to Follow-up|3|||
155655930|NCT04197583|561833653|FG000|Overall Study|Death|3|||
155655931|NCT04197583|561833654|FG001|Overall Study|Death|0|||
155655932|NCT04197583|561833653|FG000|Overall Study|Physician Decision|1|||
155655933|NCT04197583|561833654|FG001|Overall Study|Physician Decision|0|||
155655934|NCT04197583|561833653|FG000|Overall Study|Withdrawal by Subject|1|||
155655935|NCT04197583|561833654|FG001|Overall Study|Withdrawal by Subject|1|||
155655936|NCT04197583|561833653|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
155655937|NCT04197583|561833654|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
155655938|NCT04197583|561833653|FG000|Overall Study|Screen Failure|0|||
155655939|NCT04197583|561833654|FG001|Overall Study|Screen Failure|20|||
155655940|NCT03193437|561833655|FG000|Overall Study|Adverse Event|4|||
155655941|NCT03193437|561833655|FG000|Overall Study|Withdrawal by Subject|2|||
155655942|NCT03193437|561833655|FG000|Overall Study|Disease Progression|2|||
155655943|NCT01385995|561833656|FG000|Period 1, 2 Months|Physician Decision|1|||
155655944|NCT01385995|561833657|FG001|Period 1, 2 Months|Physician Decision|0|||
155655945|NCT02414841|561833658|FG000|Overall Study|Withdrawal by Subject|7|||
155655946|NCT02414841|561833659|FG001|Overall Study|Withdrawal by Subject|5|||
155655947|NCT02414841|561833658|FG000|Overall Study|Lost to Follow-up|13|||
155655948|NCT02414841|561833659|FG001|Overall Study|Lost to Follow-up|6|||
155655949|NCT02414841|561833658|FG000|Overall Study|Death|17|||
155655950|NCT02414841|561833659|FG001|Overall Study|Death|14|||
155655951|NCT02414841|561833658|FG000|Overall Study|Received a Kidney Transplant|13|||
155655952|NCT02414841|561833659|FG001|Overall Study|Received a Kidney Transplant|4|||
155655953|NCT02414841|561833658|FG000|Overall Study|Randomized But Not Treated|6|||
155655954|NCT02414841|561833659|FG001|Overall Study|Randomized But Not Treated|4|||
155655955|NCT00112385|561833660|FG000|Overall Study|Lost to Follow-up|1|||
155655956|NCT00112385|561833661|FG001|Overall Study|Lost to Follow-up|0|||
155655957|NCT00112385|561833660|FG000|Overall Study|Withdrawal by Subject|0|||
155655958|NCT00112385|561833661|FG001|Overall Study|Withdrawal by Subject|1|||
155655959|NCT01373281|561835070|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
155655960|NCT01373281|561835071|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
155655961|NCT01373281|561835070|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
155655962|NCT01373281|561835071|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
155655963|NCT01373281|561835070|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
155655964|NCT01373281|561835071|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
155655965|NCT01373281|561835070|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
155655966|NCT01373281|561835071|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
155655967|NCT01373281|561835070|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
155538581|NCT01741545|561395668|FG000|Treatment Period|Adverse event, non-fatal|1|||
155538582|NCT01741545|561395669|FG001|Treatment Period|Adverse event, non-fatal|3|||
155538583|NCT01741545|561395668|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
155538584|NCT01741545|561395669|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
155538585|NCT01741545|561395668|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
155538586|NCT01741545|561395669|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
155538587|NCT01456962|561395670|FG000|Overall Study|Lost to Follow-up|2|||
155538588|NCT01456962|561395671|FG001|Overall Study|Lost to Follow-up|1|||
155538589|NCT03387462|561395672|FG000|Overall Study|Lost to Follow-up|1|||
155538590|NCT01460628|561395673|FG000|Overall Study|Adverse Event|3|||
155538591|NCT01460628|561395673|FG000|Overall Study|Withdrawal by Subject|2|||
155538592|NCT01664039|561395677|FG000|Overall Study|Adverse Event|3|||
155538593|NCT01664039|561395678|FG001|Overall Study|Adverse Event|4|||
155538594|NCT01664039|561395677|FG000|Overall Study|Lost to Follow-up|1|||
155538595|NCT01664039|561395678|FG001|Overall Study|Lost to Follow-up|1|||
155538596|NCT01664039|561395677|FG000|Overall Study|Withdrawal by Subject|1|||
155538597|NCT01664039|561395678|FG001|Overall Study|Withdrawal by Subject|3|||
155538598|NCT01664039|561395677|FG000|Overall Study|Noncompliance|1|||
155538599|NCT01664039|561395678|FG001|Overall Study|Noncompliance|1|||
155538600|NCT01853176|561395679|FG000|Overall Study|Study terminated|4|||
155655968|NCT01373281|561835071|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
155655969|NCT01373281|561835070|FG000|Surveillance Expansion Period|Protocol Violation|9|||
155655970|NCT01373281|561835071|FG001|Surveillance Expansion Period|Protocol Violation|1|||
155655971|NCT01373281|561835070|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
155655972|NCT01373281|561835071|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
155538601|NCT01853176|561395680|FG001|Overall Study|Study terminated|0|||
155538602|NCT00874822|561395682|FG000|Overall Study|excluded by criteria|8|||
155538603|NCT02854800|561395683|FG000|Overall Study|Protocol Violation|16|||
155538604|NCT02854800|561395684|FG001|Overall Study|Protocol Violation|11|||
155538605|NCT02854800|561395685|FG002|Overall Study|Protocol Violation|3|||
155538606|NCT02854800|561395683|FG000|Overall Study|Withdrawal by Subject|4|||
155538607|NCT02854800|561395684|FG001|Overall Study|Withdrawal by Subject|2|||
155538608|NCT02854800|561395685|FG002|Overall Study|Withdrawal by Subject|3|||
155538609|NCT04442503|561395686|FG000|Overall Study|Adverse Event|1|||
155538610|NCT04442503|561395687|FG001|Overall Study|Adverse Event|1|||
155538611|NCT04442503|561395686|FG000|Overall Study|Lost to Follow-up|8|||
155538612|NCT04442503|561395687|FG001|Overall Study|Lost to Follow-up|6|||
155538613|NCT04442503|561395686|FG000|Overall Study|Physician Decision|0|||
155538614|NCT04442503|561395687|FG001|Overall Study|Physician Decision|2|||
155538615|NCT04442503|561395686|FG000|Overall Study|Withdrawal by Subject|3|||
155538616|NCT04442503|561395687|FG001|Overall Study|Withdrawal by Subject|4|||
155538617|NCT04442503|561395686|FG000|Overall Study|Reason not Specified|0|||
155538618|NCT04442503|561395687|FG001|Overall Study|Reason not Specified|1|||
155538619|NCT04442503|561395686|FG000|Overall Study|Randomized but not Treated|3|||
155538620|NCT04442503|561395687|FG001|Overall Study|Randomized but not Treated|1|||
155538621|NCT02420353|561395698|FG000|Overall Study|Withdrawal by Subject|0|||
155538622|NCT02420353|561395699|FG001|Overall Study|Withdrawal by Subject|1|||
155538623|NCT00503867|561395700|FG000|Overall Study|Lost to Follow-up|1|||
155538624|NCT00503867|561395700|FG000|Overall Study|Adverse Event|1|||
155655973|NCT01373281|561835070|FG000|Surveillance Expansion Period|Serious adverse event|3|||
155655974|NCT01373281|561835071|FG001|Surveillance Expansion Period|Serious adverse event|4|||
155655975|NCT02296476|561835072|FG000|Overall Study|Disease Progression|6|||
155655976|NCT02296476|561835073|FG001|Overall Study|Disease Progression|4|||
155655977|NCT02296476|561835074|FG002|Overall Study|Disease Progression|2|||
155655978|NCT03502681|561835079|FG000|Overall Study|Adverse Event|1|||
155655979|NCT03502681|561835080|FG001|Overall Study|Adverse Event|1|||
155655980|NCT03502681|561835079|FG000|Overall Study|Disease Progression|2|||
155655981|NCT03502681|561835080|FG001|Overall Study|Disease Progression|1|||
155655982|NCT00442702|561835081|FG000|Titration Period|Adverse Event|2|||
155655983|NCT00442702|561835082|FG001|Titration Period|Adverse Event|0|||
155655984|NCT00442702|561835081|FG000|Titration Period|Death|3|||
155655985|NCT00442702|561835082|FG001|Titration Period|Death|2|||
155655986|NCT00442702|561835081|FG000|Titration Period|Insufficient Therapeutic Response|1|||
155655987|NCT00442702|561835082|FG001|Titration Period|Insufficient Therapeutic Response|0|||
155655988|NCT00442702|561835081|FG000|Titration Period|Refused Treatment|4|||
155655989|NCT00442702|561835082|FG001|Titration Period|Refused Treatment|1|||
155655990|NCT00442702|561835081|FG000|Titration Period|Failure to return|1|||
155655991|NCT00442702|561835082|FG001|Titration Period|Failure to return|0|||
155487722|NCT02539160|561208295|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
155487723|NCT02539160|561208296|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
155487724|NCT02539160|561208293|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
155487725|NCT02539160|561208294|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
155487726|NCT02539160|561208295|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
155487727|NCT02539160|561208296|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
155487728|NCT01681004|561208297|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
155487729|NCT01681004|561208298|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
155487730|NCT01681004|561208297|FG000|Study Completion|Lost to Follow-up|8|||
155487731|NCT01681004|561208298|FG001|Study Completion|Lost to Follow-up|3|||
155487732|NCT01681004|561208297|FG000|Study Completion|Physician Decision|1|||
155487733|NCT01681004|561208298|FG001|Study Completion|Physician Decision|3|||
155487734|NCT01681004|561208297|FG000|Study Completion|Site Termination|2|||
155487735|NCT01681004|561208298|FG001|Study Completion|Site Termination|1|||
155487736|NCT01681004|561208297|FG000|Study Completion|Death|1|||
155487737|NCT01681004|561208298|FG001|Study Completion|Death|1|||
155487738|NCT00372905|561208299|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
155487739|NCT00372905|561208300|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
155487740|NCT00372905|561208301|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
155487741|NCT00372905|561208302|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
155487742|NCT00372905|561208299|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
155487743|NCT00372905|561208300|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
155487744|NCT00372905|561208301|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
155487745|NCT00372905|561208302|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
155487746|NCT00372905|561208299|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
155538625|NCT00577655|561395701|FG000|Overall Study|Patient Request|0|||
155655992|NCT00442702|561835081|FG000|Titration Period|Hospitalized in another hospital|1|||
155487747|NCT00372905|561208300|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
155487748|NCT00372905|561208301|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
155655993|NCT00442702|561835082|FG001|Titration Period|Hospitalized in another hospital|0|||
155655994|NCT00442702|561835081|FG000|Evaluation Period|Adverse Event|1|||
155655995|NCT00442702|561835082|FG001|Evaluation Period|Adverse Event|0|||
155655996|NCT00442702|561835081|FG000|Evaluation Period|Death|1|||
155655997|NCT00442702|561835082|FG001|Evaluation Period|Death|1|||
155655998|NCT00442702|561835081|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
155655999|NCT00442702|561835082|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
155656000|NCT00442702|561835081|FG000|Evaluation Period|Refused treatment|1|||
155656001|NCT00442702|561835082|FG001|Evaluation Period|Refused treatment|1|||
155656002|NCT00442702|561835081|FG000|Evaluation Period|Renal transplant|0|||
155656003|NCT00442702|561835082|FG001|Evaluation Period|Renal transplant|1|||
155656004|NCT00442702|561835081|FG000|Evaluation Period|Failure to return|1|||
155656005|NCT00442702|561835082|FG001|Evaluation Period|Failure to return|0|||
155656006|NCT00442702|561835081|FG000|Evaluation Period|Site closure|0|||
155656007|NCT00442702|561835082|FG001|Evaluation Period|Site closure|1|||
155656008|NCT03436732|561835090|FG000|Overall Study|Not treated-enrolled in different study|1|||
155656009|NCT03436732|561835091|FG001|Overall Study|Not treated-enrolled in different study|0|||
155656010|NCT03436732|561835090|FG000|Overall Study|Off study after cycle 1|1|||
155656011|NCT03436732|561835091|FG001|Overall Study|Off study after cycle 1|0|||
155656012|NCT03436732|561835090|FG000|Overall Study|Adverse Event|2|||
155656013|NCT03436732|561835091|FG001|Overall Study|Adverse Event|0|||
155656014|NCT03436732|561835090|FG000|Overall Study|Death|0|||
155656015|NCT03436732|561835091|FG001|Overall Study|Death|1|||
155656016|NCT00267488|561835092|FG000|Overall Study|Sponsor Terminated Study|9|||
155656017|NCT00267488|561835092|FG000|Overall Study|Protocol Violation|1|||
155656018|NCT00267488|561835092|FG000|Overall Study|Other (Disease Progression)|1|||
155656019|NCT02093520|561835093|FG000|Overall Study|Not treated|6|||
155656020|NCT02093520|561835094|FG001|Overall Study|Not treated|22|||
155656021|NCT00851084|561835095|FG000|Overall Study|Randomized but not treated|1|||
155656022|NCT00851084|561835096|FG001|Overall Study|Randomized but not treated|0|||
155656023|NCT00851084|561835095|FG000|Overall Study|Adverse Event|26|||
155656024|NCT00851084|561835096|FG001|Overall Study|Adverse Event|36|||
155656025|NCT00851084|561835095|FG000|Overall Study|Disease progression|52|||
155656026|NCT00851084|561835096|FG001|Overall Study|Disease progression|47|||
155656027|NCT00851084|561835095|FG000|Overall Study|Poor compliance to protocol|1|||
155656028|NCT00851084|561835096|FG001|Overall Study|Poor compliance to protocol|1|||
155656029|NCT00851084|561835095|FG000|Overall Study|Physician Decision|13|||
155656030|NCT00851084|561835096|FG001|Overall Study|Physician Decision|14|||
155656031|NCT00851084|561835095|FG000|Overall Study|Consent withdrawn|0|||
155656032|NCT00851084|561835096|FG001|Overall Study|Consent withdrawn|2|||
155538626|NCT00577655|561395702|FG001|Overall Study|Patient Request|2|||
155538627|NCT00577655|561395701|FG000|Overall Study|Protocol Violation|0|||
155538628|NCT00577655|561395702|FG001|Overall Study|Protocol Violation|1|||
155538629|NCT00577655|561395701|FG000|Overall Study|Lost to Follow-up|1|||
155538630|NCT00577655|561395702|FG001|Overall Study|Lost to Follow-up|1|||
155538631|NCT02761915|561395707|FG000|Overall Study|Death|3|||
155538632|NCT02761915|561395708|FG001|Overall Study|Death|1|||
155538633|NCT02761915|561395709|FG002|Overall Study|Death|1|||
155538634|NCT02761915|561395710|FG003|Overall Study|Death|1|||
155538635|NCT02761915|561395711|FG004|Overall Study|Death|0|||
155538636|NCT02761915|561395712|FG005|Overall Study|Death|1|||
155538637|NCT02761915|561395707|FG000|Overall Study|Withdrawal by Subject|1|||
155538638|NCT02761915|561395708|FG001|Overall Study|Withdrawal by Subject|0|||
155538639|NCT02761915|561395709|FG002|Overall Study|Withdrawal by Subject|0|||
155538640|NCT02761915|561395710|FG003|Overall Study|Withdrawal by Subject|0|||
155538641|NCT02761915|561395711|FG004|Overall Study|Withdrawal by Subject|1|||
155538642|NCT02761915|561395712|FG005|Overall Study|Withdrawal by Subject|2|||
155538643|NCT02761915|561395707|FG000|Overall Study|Disease Progression|0|||
155538644|NCT02761915|561395708|FG001|Overall Study|Disease Progression|0|||
155538645|NCT02761915|561395709|FG002|Overall Study|Disease Progression|0|||
155538646|NCT02761915|561395710|FG003|Overall Study|Disease Progression|2|||
155538647|NCT02761915|561395711|FG004|Overall Study|Disease Progression|2|||
155538648|NCT02761915|561395712|FG005|Overall Study|Disease Progression|2|||
155656033|NCT00851084|561835095|FG000|Overall Study|Withdrawal by Subject|11|||
155538649|NCT01926119|561395719|FG000|Overall Study|Withdrawal by Subject|1|||
155538650|NCT00009945|561395723|FG000|Overall Study|no follow up data|7|||
155656034|NCT00851084|561835096|FG001|Overall Study|Withdrawal by Subject|12|||
155538651|NCT00009945|561395724|FG001|Overall Study|no follow up data|5|||
155656035|NCT00851084|561835095|FG000|Overall Study|Metastatic surgery|6|||
155656036|NCT00851084|561835096|FG001|Overall Study|Metastatic surgery|6|||
155656037|NCT00851084|561835095|FG000|Overall Study|Other|7|||
155656038|NCT00851084|561835096|FG001|Overall Study|Other|1|||
155656039|NCT03468998|561835097|FG000|Overall Study|Withdrawal by Subject|1|||
155656040|NCT03468998|561835098|FG001|Overall Study|Withdrawal by Subject|1|||
155656041|NCT03468998|561835099|FG002|Overall Study|Withdrawal by Subject|0|||
155538652|NCT02654145|561395725|FG000|Overall Study|Lack of Efficacy|1|||
155538653|NCT02654145|561395725|FG000|Overall Study|Protocol Violation|1|||
155538654|NCT02654145|561395725|FG000|Overall Study|Withdrawal by Subject|5|||
155538655|NCT00672984|561395726|FG000|First Intervention|Adverse Event|5|||
155656042|NCT03468998|561835100|FG003|Overall Study|Withdrawal by Subject|4|||
155656043|NCT03468998|561835101|FG004|Overall Study|Withdrawal by Subject|1|||
155538656|NCT00672984|561395727|FG001|First Intervention|Adverse Event|0|||
155538657|NCT00672984|561395728|FG002|First Intervention|Adverse Event|0|||
155538658|NCT00672984|561395726|FG000|First Intervention|Withdrawal by Subject|1|||
155538659|NCT00672984|561395727|FG001|First Intervention|Withdrawal by Subject|2|||
155538660|NCT00672984|561395728|FG002|First Intervention|Withdrawal by Subject|2|||
155538661|NCT00672984|561395726|FG000|First Intervention|Sponsor decision|3|||
155538662|NCT00672984|561395727|FG001|First Intervention|Sponsor decision|0|||
155538663|NCT00672984|561395728|FG002|First Intervention|Sponsor decision|0|||
155538664|NCT00672984|561395726|FG000|Second Intervention|Non-compliance with facility policies|0|||
155538665|NCT00672984|561395727|FG001|Second Intervention|Non-compliance with facility policies|2|||
155538666|NCT00672984|561395728|FG002|Second Intervention|Non-compliance with facility policies|0|||
155538667|NCT00672984|561395726|FG000|Second Intervention|Withdrawal by Subject|0|||
155538668|NCT00672984|561395727|FG001|Second Intervention|Withdrawal by Subject|3|||
155538669|NCT00672984|561395728|FG002|Second Intervention|Withdrawal by Subject|0|||
155538670|NCT00672984|561395726|FG000|Second Intervention|Protocol Violation|0|||
155538671|NCT00672984|561395727|FG001|Second Intervention|Protocol Violation|1|||
155538672|NCT00672984|561395728|FG002|Second Intervention|Protocol Violation|1|||
155538673|NCT00672984|561395726|FG000|Third Intervention|Adverse Event|1|||
155538674|NCT00672984|561395727|FG001|Third Intervention|Adverse Event|0|||
155538675|NCT00672984|561395728|FG002|Third Intervention|Adverse Event|1|||
155538676|NCT00354835|561395729|FG000|Overall Study|Death|1|||
155538677|NCT00354835|561395730|FG001|Overall Study|Death|1|||
155538678|NCT00354835|561395729|FG000|Overall Study|Physician Decision|8|||
155538679|NCT00354835|561395730|FG001|Overall Study|Physician Decision|13|||
155538680|NCT00354835|561395729|FG000|Overall Study|Withdrawal by Subject|2|||
155538681|NCT00354835|561395730|FG001|Overall Study|Withdrawal by Subject|1|||
155538682|NCT00354835|561395729|FG000|Overall Study|Ineligible|17|||
155538683|NCT00354835|561395730|FG001|Overall Study|Ineligible|16|||
155538684|NCT00354835|561395729|FG000|Overall Study|Disease progression or relapse|15|||
155538685|NCT00354835|561395730|FG001|Overall Study|Disease progression or relapse|22|||
155538686|NCT00354835|561395729|FG000|Overall Study|Adverse Event|6|||
155538687|NCT00354835|561395730|FG001|Overall Study|Adverse Event|0|||
155538688|NCT00354835|561395729|FG000|Overall Study|Refusal of further therapy|3|||
155538689|NCT00354835|561395730|FG001|Overall Study|Refusal of further therapy|8|||
155538690|NCT02637141|561395733|FG000|Overall Study|Adverse Event|1|||
155538691|NCT02637141|561395734|FG001|Overall Study|Adverse Event|1|||
155538692|NCT02637141|561395735|FG002|Overall Study|Adverse Event|0|||
155538693|NCT02637141|561395733|FG000|Overall Study|Withdrawal by Subject|1|||
155538694|NCT02637141|561395734|FG001|Overall Study|Withdrawal by Subject|1|||
155538695|NCT02637141|561395735|FG002|Overall Study|Withdrawal by Subject|1|||
155538696|NCT00379353|561395738|FG000|Overall Study|Hospitalization|3|||
155538697|NCT00379353|561395739|FG001|Overall Study|Hospitalization|3|||
155538698|NCT00379353|561395738|FG000|Overall Study|Withdrawal by Subject|5|||
155538699|NCT00379353|561395739|FG001|Overall Study|Withdrawal by Subject|2|||
155538700|NCT00379353|561395738|FG000|Overall Study|Death|1|||
155538701|NCT00379353|561395739|FG001|Overall Study|Death|0|||
155538702|NCT00379353|561395738|FG000|Overall Study|Cardiac Tamponade|1|||
155538703|NCT00379353|561395739|FG001|Overall Study|Cardiac Tamponade|0|||
155538704|NCT00379353|561395738|FG000|Overall Study|Non-compliance|1|||
155538705|NCT00379353|561395739|FG001|Overall Study|Non-compliance|0|||
155538706|NCT00379353|561395738|FG000|Overall Study|Conflicting drug treatment|0|||
155538707|NCT00379353|561395739|FG001|Overall Study|Conflicting drug treatment|1|||
155538708|NCT02943096|561395742|FG000|Overall Study|Lack of Efficacy|0|||
155538709|NCT02943096|561395743|FG001|Overall Study|Lack of Efficacy|1|||
155538710|NCT05065619|561395744|FG000|Up to Day 42|Lost to Follow-up|1|||
155538711|NCT05065619|561395745|FG001|Up to Day 42|Lost to Follow-up|0|||
155538712|NCT05065619|561395744|FG000|Up to Day 42|Withdrawal by Subject|1|||
155538713|NCT05065619|561395745|FG001|Up to Day 42|Withdrawal by Subject|0|||
155538714|NCT05065619|561395744|FG000|After Day 43|Lost to Follow-up|1|||
155538715|NCT05065619|561395745|FG001|After Day 43|Lost to Follow-up|0|||
155538716|NCT05065619|561395744|FG000|After Day 43|Physician Decision|3|||
155538717|NCT05065619|561395745|FG001|After Day 43|Physician Decision|0|||
155538718|NCT05065619|561395744|FG000|After Day 43|Withdrawal by Subject|1|||
155538719|NCT05065619|561395745|FG001|After Day 43|Withdrawal by Subject|2|||
155538720|NCT05065619|561395744|FG000|After Day 43|Public vaccination|6|||
155538721|NCT05065619|561395745|FG001|After Day 43|Public vaccination|8|||
155538722|NCT05065619|561395744|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
155538723|NCT05065619|561395745|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
155538724|NCT05065619|561395744|FG000|After Day 43|Study Terminated by Sponsor|88|||
155538725|NCT05065619|561395745|FG001|After Day 43|Study Terminated by Sponsor|16|||
155538726|NCT00570128|561395746|FG000|Overall Study|Adverse Event|1|||
155538727|NCT00570128|561395747|FG001|Overall Study|Adverse Event|0|||
155538728|NCT00570128|561395746|FG000|Overall Study|Lost to Follow-up|1|||
155538729|NCT00570128|561395747|FG001|Overall Study|Lost to Follow-up|0|||
155538730|NCT00570128|561395746|FG000|Overall Study|Withdrawal by Subject|2|||
155538731|NCT00570128|561395747|FG001|Overall Study|Withdrawal by Subject|0|||
155538732|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
155538733|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
155538734|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
155538735|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
155538736|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
155538737|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
155538738|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
155487749|NCT00372905|561208302|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
155487750|NCT00372905|561208299|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
155487751|NCT00372905|561208300|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
155487752|NCT00372905|561208301|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
155487753|NCT00372905|561208302|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
155487754|NCT00372905|561208299|FG000|Follow up Until Relapse or Progression|Study closed|0|||
155487755|NCT00372905|561208300|FG001|Follow up Until Relapse or Progression|Study closed|0|||
155487756|NCT00372905|561208301|FG002|Follow up Until Relapse or Progression|Study closed|0|||
155487757|NCT00372905|561208302|FG003|Follow up Until Relapse or Progression|Study closed|3|||
155487758|NCT00372905|561208299|FG000|Follow up Until Relapse or Progression|Other|0|||
155487759|NCT00372905|561208300|FG001|Follow up Until Relapse or Progression|Other|1|||
155487760|NCT00372905|561208301|FG002|Follow up Until Relapse or Progression|Other|0|||
155487761|NCT00372905|561208302|FG003|Follow up Until Relapse or Progression|Other|0|||
155487762|NCT01728454|561208303|FG000|Stage 1 and 2|Pregnancy|1|||
155487763|NCT01728454|561208304|FG001|Stage 1 and 2|Pregnancy|0|||
155487764|NCT01728454|561208305|FG002|Stage 1 and 2|Pregnancy|0|||
155487765|NCT01728454|561208303|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
155487766|NCT01728454|561208304|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
155487767|NCT01728454|561208305|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
155487768|NCT01728454|561208303|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
155487769|NCT01728454|561208304|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
155487770|NCT01728454|561208305|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
155487771|NCT01728454|561208303|FG000|Stage 1 and 2|Lost to Follow-up|1|||
155487772|NCT01728454|561208304|FG001|Stage 1 and 2|Lost to Follow-up|1|||
155487773|NCT01728454|561208305|FG002|Stage 1 and 2|Lost to Follow-up|0|||
155487774|NCT01728454|561208303|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
155487775|NCT01728454|561208304|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
155487776|NCT01728454|561208305|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
155487777|NCT01728454|561208303|FG000|Stage 3|Reason Missing|0|||
155487778|NCT01728454|561208304|FG001|Stage 3|Reason Missing|0|||
155487779|NCT01728454|561208305|FG002|Stage 3|Reason Missing|1|||
155487780|NCT01728454|561208303|FG000|Stage 3|Subject Required Other Treatment|0|||
155487781|NCT01728454|561208304|FG001|Stage 3|Subject Required Other Treatment|1|||
155487782|NCT01728454|561208305|FG002|Stage 3|Subject Required Other Treatment|0|||
155487783|NCT01728454|561208303|FG000|Stage 3|Pregnancy|1|||
155487784|NCT01728454|561208304|FG001|Stage 3|Pregnancy|0|||
155487785|NCT01728454|561208305|FG002|Stage 3|Pregnancy|0|||
155487786|NCT01728454|561208303|FG000|Stage 3|Withdrew Consent|1|||
155487787|NCT01728454|561208304|FG001|Stage 3|Withdrew Consent|0|||
155487788|NCT01728454|561208305|FG002|Stage 3|Withdrew Consent|1|||
155487789|NCT01728454|561208303|FG000|Stage 3|Non-compliance with Protocol|0|||
155487790|NCT01728454|561208304|FG001|Stage 3|Non-compliance with Protocol|0|||
155487791|NCT01728454|561208305|FG002|Stage 3|Non-compliance with Protocol|1|||
155487792|NCT01728454|561208303|FG000|Stage 3|Lost to Follow-up|0|||
155487793|NCT01728454|561208304|FG001|Stage 3|Lost to Follow-up|3|||
155487794|NCT01728454|561208305|FG002|Stage 3|Lost to Follow-up|1|||
155487795|NCT01728454|561208303|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
155487796|NCT01728454|561208304|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
155487797|NCT01728454|561208305|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
155487798|NCT00689299|561208308|FG000|Overall Study|Adverse Event|2|||
155487799|NCT00689299|561208309|FG001|Overall Study|Adverse Event|1|||
155487800|NCT00689299|561208310|FG002|Overall Study|Adverse Event|1|||
155487801|NCT00689299|561208308|FG000|Overall Study|Lost to Follow-up|0|||
155487802|NCT00689299|561208309|FG001|Overall Study|Lost to Follow-up|1|||
155487803|NCT00689299|561208310|FG002|Overall Study|Lost to Follow-up|1|||
155487804|NCT00689299|561208308|FG000|Overall Study|Withdrawal by Subject|4|||
155487805|NCT00689299|561208309|FG001|Overall Study|Withdrawal by Subject|1|||
155487806|NCT00689299|561208310|FG002|Overall Study|Withdrawal by Subject|3|||
155487807|NCT00689299|561208308|FG000|Overall Study|Protocol Violation|1|||
155487808|NCT00689299|561208309|FG001|Overall Study|Protocol Violation|0|||
155487809|NCT00689299|561208310|FG002|Overall Study|Protocol Violation|0|||
155487810|NCT01190839|561208311|FG000|Overall Study|Adverse Event|32|||
155487811|NCT01190839|561208312|FG001|Overall Study|Adverse Event|41|||
155487812|NCT01190839|561208311|FG000|Overall Study|Protocol Violation|2|||
155487813|NCT01190839|561208312|FG001|Overall Study|Protocol Violation|2|||
155487814|NCT01190839|561208311|FG000|Overall Study|Lost to Follow-up|7|||
155487815|NCT01190839|561208312|FG001|Overall Study|Lost to Follow-up|1|||
155487816|NCT01190839|561208311|FG000|Overall Study|Death|1|||
155487817|NCT01190839|561208312|FG001|Overall Study|Death|0|||
155487818|NCT01190839|561208311|FG000|Overall Study|Trial stopped by Sponsor|71|||
155487819|NCT01190839|561208312|FG001|Overall Study|Trial stopped by Sponsor|68|||
155487820|NCT01190839|561208311|FG000|Overall Study|Undefined|35|||
155487821|NCT01190839|561208312|FG001|Overall Study|Undefined|31|||
155487822|NCT01190839|561208311|FG000|Overall Study|Randomized but not treated|2|||
155487823|NCT01190839|561208312|FG001|Overall Study|Randomized but not treated|4|||
155487824|NCT00765726|561208319|FG000|Overall Study|Withdrawal by Subject|1|||
155487825|NCT00765726|561208319|FG000|Overall Study|Discontinuation of study by sponsor|8|||
155538739|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
155538740|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
155538741|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
155538742|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
155538743|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
155538744|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
155538745|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
155538746|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
155538747|NCT01139762|561395748|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
155538748|NCT01139762|561395749|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
155538749|NCT01139762|561395750|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
155538750|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
155538751|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
155538752|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
155538753|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Death|0|||
155538754|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Death|1|||
155538755|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Death|1|||
155538756|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
155538757|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
155538758|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
155538759|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
155538760|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
155538761|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
155538762|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
155538763|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
155538764|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
155538765|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
155538766|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
155538767|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
155538768|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
155538769|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
155538770|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
155538771|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
155538772|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
155538773|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
155538774|NCT01139762|561395748|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
155538775|NCT01139762|561395749|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
155538776|NCT01139762|561395750|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
155538777|NCT00874276|561395751|FG000|Overall Study|Withdrawal by Subject|1|||
155538778|NCT00874276|561395752|FG001|Overall Study|Withdrawal by Subject|1|||
155538779|NCT02957331|561395755|FG000|Overall Study|Protocol Violation|1|||
155538780|NCT02957331|561395756|FG001|Overall Study|Protocol Violation|0|||
155538781|NCT02588339|561395757|FG000|Overall Study|Withdrawal by Subject|1|||
155538782|NCT02588339|561395757|FG000|Overall Study|GVHD Progression prior to treatment|2|||
155538783|NCT04590781|561396887|FG000|Overall Study|Death|0|||
155538784|NCT04590781|561396888|FG001|Overall Study|Death|2|||
155538785|NCT04590781|561396887|FG000|Overall Study|Withdrawal by Subject|2|||
155538786|NCT04590781|561396888|FG001|Overall Study|Withdrawal by Subject|0|||
155538787|NCT01120899|561396894|FG000|Overall Study|Withdrawal by Subject|3|||
155538788|NCT00452348|561396895|FG000|Overall Study|Adverse Event|6|||
155538789|NCT00452348|561396896|FG001|Overall Study|Adverse Event|9|||
155538790|NCT00452348|561396895|FG000|Overall Study|Lack of Efficacy|10|||
155538791|NCT00452348|561396896|FG001|Overall Study|Lack of Efficacy|9|||
155538792|NCT00452348|561396895|FG000|Overall Study|Lost to Follow-up|14|||
155538793|NCT00452348|561396896|FG001|Overall Study|Lost to Follow-up|8|||
155656044|NCT03468998|561835102|FG005|Overall Study|Withdrawal by Subject|0|||
155538794|NCT00452348|561396895|FG000|Overall Study|Protocol Violation|22|||
155538795|NCT00452348|561396896|FG001|Overall Study|Protocol Violation|28|||
155538796|NCT00452348|561396895|FG000|Overall Study|Withdrawal by Subject|18|||
155538797|NCT00452348|561396896|FG001|Overall Study|Withdrawal by Subject|21|||
155538798|NCT00452348|561396895|FG000|Overall Study|Other|9|||
155538799|NCT00452348|561396896|FG001|Overall Study|Other|9|||
155538800|NCT01490190|561396897|FG000|Overall Study|Withdrawal by Subject|9|||
155538801|NCT01490190|561396897|FG000|Overall Study|Adverse Event|17|||
155538802|NCT01490190|561396897|FG000|Overall Study|Protocol Violation|5|||
155538803|NCT01490190|561396897|FG000|Overall Study|Lost to Follow-up|13|||
155538804|NCT01490190|561396897|FG000|Overall Study|Relocation|1|||
155538805|NCT01490190|561396897|FG000|Overall Study|Inconvenience|1|||
155538806|NCT01490190|561396897|FG000|Overall Study|Ring expulsion|2|||
155538807|NCT03119662|561396898|FG000|Overall Study|Withdrawal by Subject|0|||
155538808|NCT03119662|561396899|FG001|Overall Study|Withdrawal by Subject|1|||
155538809|NCT02817828|561396900|FG000|Overall Study|Lost to Follow-up|41|||
155538810|NCT02817828|561396900|FG000|Overall Study|Adverse event not related to bleeding|104|||
155538811|NCT02817828|561396900|FG000|Overall Study|Adverse event related to bleeding|53|||
155538812|NCT02817828|561396900|FG000|Overall Study|Protocol Violation|11|||
155538813|NCT02817828|561396900|FG000|Overall Study|Pregnancy|7|||
155538814|NCT02817828|561396900|FG000|Overall Study|Pregnancy wish|15|||
155538815|NCT02817828|561396900|FG000|Overall Study|Withdrawal by Subject|78|||
155538816|NCT02817828|561396900|FG000|Overall Study|Other|26|||
155538817|NCT01186458|561396904|FG000|Overall Study|Adverse Event|1|||
155538818|NCT04281472|561396905|FG000|Stage A|Lack of Efficacy|8|||
155538819|NCT04281472|561396906|FG001|Stage A|Lack of Efficacy|0|||
155538820|NCT04281472|561396907|FG002|Stage A|Lack of Efficacy|0|||
155538821|NCT04281472|561396905|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
155538822|NCT04281472|561396906|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
155538823|NCT04281472|561396907|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
155538824|NCT04281472|561396905|FG000|Stage A|Adverse Event|20|||
155538825|NCT04281472|561396906|FG001|Stage A|Adverse Event|0|||
155538826|NCT04281472|561396907|FG002|Stage A|Adverse Event|0|||
155656045|NCT01892189|561835103|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155656046|NCT01892189|561835104|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
155656047|NCT01892189|561835105|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155656048|NCT01892189|561835106|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
155656049|NCT01892189|561835107|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
155656050|NCT01892189|561835108|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
155656051|NCT01892189|561835109|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
155656052|NCT01892189|561835110|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
155656053|NCT01892189|561835111|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
155656054|NCT01892189|561835103|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155538827|NCT04281472|561396905|FG000|Stage A|Death|1|||
155538828|NCT04281472|561396906|FG001|Stage A|Death|0|||
155538829|NCT04281472|561396907|FG002|Stage A|Death|0|||
155538830|NCT04281472|561396905|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
155538831|NCT04281472|561396906|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
155538832|NCT04281472|561396907|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
155538833|NCT04281472|561396905|FG000|Stage A|Lost to Follow-up|2|||
155538834|NCT04281472|561396906|FG001|Stage A|Lost to Follow-up|0|||
155538835|NCT04281472|561396907|FG002|Stage A|Lost to Follow-up|0|||
155538836|NCT04281472|561396905|FG000|Stage A|Non-compliance with study drug|1|||
155538837|NCT04281472|561396906|FG001|Stage A|Non-compliance with study drug|0|||
155538838|NCT04281472|561396907|FG002|Stage A|Non-compliance with study drug|0|||
155538839|NCT04281472|561396905|FG000|Stage A|Physician Decision|1|||
155538840|NCT04281472|561396906|FG001|Stage A|Physician Decision|0|||
155538841|NCT04281472|561396907|FG002|Stage A|Physician Decision|0|||
155538842|NCT04281472|561396905|FG000|Stage A|Prohibited medications|2|||
155538843|NCT04281472|561396906|FG001|Stage A|Prohibited medications|0|||
155538844|NCT04281472|561396907|FG002|Stage A|Prohibited medications|0|||
155538845|NCT04281472|561396905|FG000|Stage A|Withdrawal by Subject|11|||
155538846|NCT04281472|561396906|FG001|Stage A|Withdrawal by Subject|0|||
155538847|NCT04281472|561396907|FG002|Stage A|Withdrawal by Subject|0|||
155538848|NCT04281472|561396905|FG000|Stage A|Other|5|||
155538849|NCT04281472|561396906|FG001|Stage A|Other|0|||
155538850|NCT04281472|561396907|FG002|Stage A|Other|0|||
155538851|NCT04281472|561396905|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
155656055|NCT01892189|561835104|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155656056|NCT01892189|561835105|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
155538852|NCT04281472|561396906|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
155538853|NCT04281472|561396907|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
155538854|NCT04281472|561396905|FG000|Stage B|Adverse Event|0|||
155538855|NCT04281472|561396906|FG001|Stage B|Adverse Event|3|||
155538856|NCT04281472|561396907|FG002|Stage B|Adverse Event|0|||
155538857|NCT04281472|561396905|FG000|Stage B|Death|0|||
155538858|NCT04281472|561396906|FG001|Stage B|Death|0|||
155656057|NCT01892189|561835106|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155538859|NCT04281472|561396907|FG002|Stage B|Death|1|||
155538860|NCT04281472|561396905|FG000|Stage B|Lack of Efficacy|0|||
155538861|NCT04281472|561396906|FG001|Stage B|Lack of Efficacy|0|||
155538862|NCT04281472|561396907|FG002|Stage B|Lack of Efficacy|1|||
155538863|NCT04281472|561396905|FG000|Stage B|Lost to Follow-up|0|||
155538864|NCT04281472|561396906|FG001|Stage B|Lost to Follow-up|0|||
155538865|NCT04281472|561396907|FG002|Stage B|Lost to Follow-up|2|||
155538866|NCT04281472|561396905|FG000|Stage B|Prohibited medications|0|||
155538867|NCT04281472|561396906|FG001|Stage B|Prohibited medications|2|||
155538868|NCT04281472|561396907|FG002|Stage B|Prohibited medications|1|||
155538869|NCT04281472|561396905|FG000|Stage B|Protocol Violation|0|||
155538870|NCT04281472|561396906|FG001|Stage B|Protocol Violation|1|||
155538871|NCT04281472|561396907|FG002|Stage B|Protocol Violation|1|||
155538872|NCT04281472|561396905|FG000|Stage B|Sponsor decision|0|||
155538873|NCT04281472|561396906|FG001|Stage B|Sponsor decision|0|||
155538874|NCT04281472|561396907|FG002|Stage B|Sponsor decision|1|||
155538875|NCT04281472|561396905|FG000|Stage B|Withdrawal by Subject|0|||
155538876|NCT04281472|561396906|FG001|Stage B|Withdrawal by Subject|3|||
155538877|NCT04281472|561396907|FG002|Stage B|Withdrawal by Subject|3|||
155538878|NCT04281472|561396905|FG000|Stage B|Other|0|||
155538879|NCT04281472|561396906|FG001|Stage B|Other|3|||
155538880|NCT04281472|561396907|FG002|Stage B|Other|0|||
155538881|NCT04697173|561396911|FG000|Overall Study|Withdrawal by Subject|34|||
155538882|NCT04697173|561396912|FG001|Overall Study|Withdrawal by Subject|38|||
155538883|NCT01717313|561396917|FG000|Phase A (Weeks 0 to 24)|Death|0|||
155538884|NCT01717313|561396918|FG001|Phase A (Weeks 0 to 24)|Death|1|||
155538885|NCT01717313|561396917|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
155538886|NCT01717313|561396918|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
155538887|NCT01717313|561396917|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
155538888|NCT01717313|561396918|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
155538889|NCT01717313|561396917|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
155538890|NCT01717313|561396918|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
155538891|NCT01717313|561396917|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
155538892|NCT01717313|561396918|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
155538893|NCT01717313|561396917|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
155538894|NCT01717313|561396918|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
155538895|NCT01717313|561396917|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
155538896|NCT01717313|561396918|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
155538897|NCT01717313|561396917|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
155538898|NCT01717313|561396918|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
155538899|NCT01717313|561396917|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
155538900|NCT01717313|561396918|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
155538901|NCT05004649|561396919|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
155538902|NCT05004649|561396919|FG000|Overall Study|Lost to Follow-up|1|||
155538903|NCT05004649|561396919|FG000|Overall Study|Withdrawal by Subject|2|||
155538904|NCT05004649|561396919|FG000|Overall Study|COVID-19|1|||
155538905|NCT00301964|561396920|FG000|Overall Study|Second primary|2|||
155538906|NCT00301964|561396920|FG000|Overall Study|Wrong primary|1|||
155538907|NCT00301964|561396920|FG000|Overall Study|Inadequate pathology|1|||
155538908|NCT02385708|561396921|FG000|Overall Study|Withdrawal by Subject|0|||
155538909|NCT02385708|561396922|FG001|Overall Study|Withdrawal by Subject|2|||
155538910|NCT02385708|561396921|FG000|Overall Study|Withdrawn - surgery canceled|2|||
155538911|NCT02385708|561396922|FG001|Overall Study|Withdrawn - surgery canceled|5|||
155538912|NCT02385708|561396921|FG000|Overall Study|Investigator decision|5|||
155538913|NCT02385708|561396922|FG001|Overall Study|Investigator decision|7|||
155538914|NCT02385708|561396921|FG000|Overall Study|Protocol Violation|1|||
155538915|NCT02385708|561396922|FG001|Overall Study|Protocol Violation|1|||
155538916|NCT03504085|561396924|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
155538917|NCT03504085|561396925|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
155538918|NCT03504085|561396924|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
155538919|NCT03504085|561396925|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
155538920|NCT01143337|561396926|FG000|Overall Study|Adverse Event|3|||
155538921|NCT01143337|561396927|FG001|Overall Study|Adverse Event|9|||
155538922|NCT01143337|561396928|FG002|Overall Study|Adverse Event|5|||
155538923|NCT01143337|561396926|FG000|Overall Study|Lack of Efficacy|6|||
155538924|NCT01143337|561396927|FG001|Overall Study|Lack of Efficacy|2|||
155538925|NCT01143337|561396928|FG002|Overall Study|Lack of Efficacy|1|||
155538926|NCT01143337|561396926|FG000|Overall Study|Protocol Violation|1|||
155538927|NCT01143337|561396927|FG001|Overall Study|Protocol Violation|0|||
155538928|NCT01143337|561396928|FG002|Overall Study|Protocol Violation|0|||
155538929|NCT01143337|561396926|FG000|Overall Study|Withdrawal by Subject|0|||
155538930|NCT01143337|561396927|FG001|Overall Study|Withdrawal by Subject|0|||
155538931|NCT01143337|561396928|FG002|Overall Study|Withdrawal by Subject|1|||
155538932|NCT01143337|561396926|FG000|Overall Study|Other reason|0|||
155538933|NCT01143337|561396927|FG001|Overall Study|Other reason|0|||
155538934|NCT01143337|561396928|FG002|Overall Study|Other reason|5|||
155538935|NCT04133311|561396929|FG000|Period 1 Double Masked Treatment Period|Death|1|||
155538936|NCT04133311|561396930|FG001|Period 1 Double Masked Treatment Period|Death|0|||
155538937|NCT04133311|561396931|FG002|Period 1 Double Masked Treatment Period|Death|0|||
155538938|NCT04133311|561396932|FG003|Period 1 Double Masked Treatment Period|Death|0|||
155538939|NCT04133311|561396929|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
155538940|NCT04133311|561396930|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
155538941|NCT04133311|561396931|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
155538942|NCT04133311|561396932|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
155538943|NCT04133311|561396929|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
155538944|NCT04133311|561396930|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
155538945|NCT04133311|561396931|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
155538946|NCT04133311|561396932|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
155538947|NCT04133311|561396929|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
155538948|NCT04133311|561396930|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
155538949|NCT04133311|561396931|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
155538950|NCT04133311|561396932|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
155538951|NCT04133311|561396929|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
155538952|NCT04133311|561396930|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
155538953|NCT04133311|561396931|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
155538954|NCT04133311|561396932|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
155538955|NCT04133311|561396929|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
155538956|NCT04133311|561396930|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
155538957|NCT04133311|561396931|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
155538958|NCT04133311|561396932|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
155538959|NCT04133311|561396929|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
155538960|NCT04133311|561396930|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
155538961|NCT04133311|561396931|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
155538962|NCT04133311|561396932|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
155538963|NCT04133311|561396929|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
155538964|NCT04133311|561396930|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
155538965|NCT04133311|561396931|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
155538966|NCT04133311|561396932|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
155538967|NCT00728754|561396941|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
155538968|NCT00728754|561396942|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
155538969|NCT00728754|561396941|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
155538970|NCT00728754|561396942|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
155538971|NCT00728754|561396941|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
155538972|NCT00728754|561396942|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
155538973|NCT01859598|561396943|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
155538974|NCT00573313|561396948|FG000|Overall Study|Protocol Violation|5|||
155538975|NCT00573313|561396949|FG001|Overall Study|Protocol Violation|0|||
155538976|NCT00573313|561396950|FG002|Overall Study|Protocol Violation|6|||
155538977|NCT00573313|561396951|FG003|Overall Study|Protocol Violation|0|||
155538978|NCT03255980|561396954|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
155538979|NCT03255980|561396955|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
155538980|NCT03255980|561396956|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
155538981|NCT03255980|561396957|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
155538982|NCT03255980|561396954|FG000|Overall Study|Adverse Event|1|||
155538983|NCT03255980|561396955|FG001|Overall Study|Adverse Event|1|||
155538984|NCT03255980|561396956|FG002|Overall Study|Adverse Event|0|||
155538985|NCT03255980|561396957|FG003|Overall Study|Adverse Event|1|||
155538986|NCT03255980|561396954|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
155538987|NCT03255980|561396955|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
155538988|NCT03255980|561396956|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
155538989|NCT03255980|561396957|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
155538990|NCT03255980|561396954|FG000|Overall Study|Lost to Follow-up|1|||
155538991|NCT03255980|561396955|FG001|Overall Study|Lost to Follow-up|1|||
155538992|NCT03255980|561396956|FG002|Overall Study|Lost to Follow-up|0|||
155538993|NCT03255980|561396957|FG003|Overall Study|Lost to Follow-up|3|||
155538994|NCT03255980|561396954|FG000|Overall Study|Withdrawal by Subject|0|||
155538995|NCT03255980|561396955|FG001|Overall Study|Withdrawal by Subject|1|||
155538996|NCT03255980|561396956|FG002|Overall Study|Withdrawal by Subject|0|||
155538997|NCT03255980|561396957|FG003|Overall Study|Withdrawal by Subject|3|||
155538998|NCT01597791|561396958|FG000|Overall Study|Physician Decision|2|||
155538999|NCT01597791|561396959|FG001|Overall Study|Physician Decision|1|||
155539000|NCT01597791|561396958|FG000|Overall Study|Cesarean Section|6|||
155539001|NCT01597791|561396959|FG001|Overall Study|Cesarean Section|7|||
155539002|NCT01597791|561396958|FG000|Overall Study|Subject withdrawal|0|||
155539003|NCT01597791|561396959|FG001|Overall Study|Subject withdrawal|1|||
155539004|NCT01597791|561396958|FG000|Overall Study|Protocol Violation|0|||
155539005|NCT01597791|561396959|FG001|Overall Study|Protocol Violation|1|||
155539006|NCT02611362|561396960|FG000|Overall Study|Withdrawal by Subject|7|||
155539007|NCT02611362|561396961|FG001|Overall Study|Withdrawal by Subject|2|||
155539008|NCT02611362|561396960|FG000|Overall Study|Lost to Follow-up|2|||
155539009|NCT02611362|561396961|FG001|Overall Study|Lost to Follow-up|4|||
155539010|NCT00354159|561396962|FG000|Randomized Study Period|Withdrawal by Subject|5|||
155539011|NCT00354159|561396963|FG001|Randomized Study Period|Withdrawal by Subject|3|||
155539012|NCT00354159|561396962|FG000|Randomized Study Period|Physician Decision|6|||
155539013|NCT00354159|561396963|FG001|Randomized Study Period|Physician Decision|10|||
155539014|NCT00354159|561396962|FG000|Randomized Study Period|Lost to Follow-up|4|||
155539015|NCT00354159|561396963|FG001|Randomized Study Period|Lost to Follow-up|0|||
155539016|NCT00354159|561396962|FG000|Randomized Study Period|Death|7|||
155539017|NCT00354159|561396963|FG001|Randomized Study Period|Death|9|||
155539018|NCT00354159|561396962|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
155539019|NCT00354159|561396963|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
155539020|NCT00354159|561396962|FG000|Long-term Follow-up|Physician Decision|127|||
155539021|NCT00354159|561396963|FG001|Long-term Follow-up|Physician Decision|122|||
155539022|NCT00354159|561396962|FG000|Long-term Follow-up|Lost to Follow-up|1|||
155539023|NCT00354159|561396963|FG001|Long-term Follow-up|Lost to Follow-up|0|||
155539024|NCT00354159|561396962|FG000|Long-term Follow-up|Death|14|||
155539025|NCT00354159|561396963|FG001|Long-term Follow-up|Death|11|||
155539026|NCT00354159|561396962|FG000|Long-term Follow-up|Study Closed|29|||
155539027|NCT00354159|561396963|FG001|Long-term Follow-up|Study Closed|34|||
155539028|NCT02229084|561396964|FG000|Overall Study|Adverse Event|1|||
155539029|NCT02229084|561396965|FG001|Overall Study|Adverse Event|0|||
155539030|NCT02229084|561396966|FG002|Overall Study|Adverse Event|0|||
155539031|NCT02229084|561396967|FG003|Overall Study|Adverse Event|0|||
155539032|NCT02229084|561396968|FG004|Overall Study|Adverse Event|0|||
155539033|NCT02229084|561396969|FG005|Overall Study|Adverse Event|0|||
155539034|NCT02229084|561396970|FG006|Overall Study|Adverse Event|0|||
155539035|NCT02229084|561396964|FG000|Overall Study|Lost to Follow-up|0|||
155539036|NCT02229084|561396965|FG001|Overall Study|Lost to Follow-up|0|||
155539037|NCT02229084|561396966|FG002|Overall Study|Lost to Follow-up|1|||
155539038|NCT02229084|561396967|FG003|Overall Study|Lost to Follow-up|1|||
155539039|NCT02229084|561396968|FG004|Overall Study|Lost to Follow-up|0|||
155539040|NCT02229084|561396969|FG005|Overall Study|Lost to Follow-up|0|||
155539041|NCT02229084|561396970|FG006|Overall Study|Lost to Follow-up|1|||
155539042|NCT02229084|561396964|FG000|Overall Study|Physician Decision|0|||
155539043|NCT02229084|561396965|FG001|Overall Study|Physician Decision|0|||
155539044|NCT02229084|561396966|FG002|Overall Study|Physician Decision|0|||
155539045|NCT02229084|561396967|FG003|Overall Study|Physician Decision|1|||
155539046|NCT02229084|561396968|FG004|Overall Study|Physician Decision|3|||
155539047|NCT02229084|561396969|FG005|Overall Study|Physician Decision|0|||
155539048|NCT02229084|561396970|FG006|Overall Study|Physician Decision|1|||
155539049|NCT02229084|561396964|FG000|Overall Study|Withdrawal by Subject|0|||
155539050|NCT02229084|561396965|FG001|Overall Study|Withdrawal by Subject|0|||
155539051|NCT02229084|561396966|FG002|Overall Study|Withdrawal by Subject|1|||
155539052|NCT02229084|561396967|FG003|Overall Study|Withdrawal by Subject|0|||
155539053|NCT02229084|561396968|FG004|Overall Study|Withdrawal by Subject|1|||
155539054|NCT02229084|561396969|FG005|Overall Study|Withdrawal by Subject|1|||
155656058|NCT01892189|561835107|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155656059|NCT01892189|561835108|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155656060|NCT01892189|561835109|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155656061|NCT01892189|561835110|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155656062|NCT01892189|561835111|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155656063|NCT01892189|561835103|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656064|NCT01892189|561835104|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656065|NCT01892189|561835105|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155539055|NCT02229084|561396970|FG006|Overall Study|Withdrawal by Subject|1|||
155539056|NCT02229084|561396964|FG000|Overall Study|Death|0|||
155539057|NCT02229084|561396965|FG001|Overall Study|Death|0|||
155539058|NCT02229084|561396966|FG002|Overall Study|Death|0|||
155539059|NCT02229084|561396967|FG003|Overall Study|Death|0|||
155539060|NCT02229084|561396968|FG004|Overall Study|Death|0|||
155539061|NCT02229084|561396969|FG005|Overall Study|Death|0|||
155539062|NCT02229084|561396970|FG006|Overall Study|Death|1|||
155539063|NCT01728116|561396973|FG000|Overall Study|Sponsor Terminated Study|106|||
155539064|NCT01728116|561396974|FG001|Overall Study|Sponsor Terminated Study|35|||
155539065|NCT01728116|561396973|FG000|Overall Study|Withdrawal by Subject|16|||
155539066|NCT01728116|561396974|FG001|Overall Study|Withdrawal by Subject|9|||
155539067|NCT01728116|561396973|FG000|Overall Study|Adverse Event|13|||
155539068|NCT01728116|561396974|FG001|Overall Study|Adverse Event|0|||
155539069|NCT01728116|561396973|FG000|Overall Study|Procedure/device failure|7|||
155539070|NCT01728116|561396974|FG001|Overall Study|Procedure/device failure|0|||
155539071|NCT01728116|561396973|FG000|Overall Study|Lost to Follow-up|9|||
155539072|NCT01728116|561396974|FG001|Overall Study|Lost to Follow-up|2|||
155539073|NCT01728116|561396973|FG000|Overall Study|Physician Decision|2|||
155539074|NCT01728116|561396974|FG001|Overall Study|Physician Decision|0|||
155539075|NCT01728116|561396973|FG000|Overall Study|Subject Non-Compliance|2|||
155539076|NCT01728116|561396974|FG001|Overall Study|Subject Non-Compliance|0|||
155539077|NCT01728116|561396973|FG000|Overall Study|Inter-current finding at procedure|1|||
155539078|NCT01728116|561396974|FG001|Overall Study|Inter-current finding at procedure|0|||
155539079|NCT01728116|561396973|FG000|Overall Study|Incorrectly enrolled in Study|0|||
155539080|NCT01728116|561396974|FG001|Overall Study|Incorrectly enrolled in Study|1|||
155539081|NCT01728116|561396973|FG000|Overall Study|various not noted previously|5|||
155539082|NCT01728116|561396974|FG001|Overall Study|various not noted previously|0|||
155539083|NCT03277248|561396975|FG000|Overall Study|Adverse Event|3|||
155539084|NCT03277248|561396976|FG001|Overall Study|Adverse Event|1|||
155539085|NCT03277248|561396975|FG000|Overall Study|Subject Withdrawal of Consent|6|||
155539086|NCT03277248|561396976|FG001|Overall Study|Subject Withdrawal of Consent|23|||
155539087|NCT03277248|561396975|FG000|Overall Study|Investigator/Sponsor Decision|2|||
155539088|NCT03277248|561396976|FG001|Overall Study|Investigator/Sponsor Decision|2|||
155539089|NCT03277248|561396975|FG000|Overall Study|Pregnancy|4|||
155539090|NCT03277248|561396976|FG001|Overall Study|Pregnancy|1|||
155539091|NCT03277248|561396975|FG000|Overall Study|Lost to Follow-up|0|||
155539092|NCT03277248|561396976|FG001|Overall Study|Lost to Follow-up|2|||
155539093|NCT03277248|561396975|FG000|Overall Study|Lack of Efficacy|0|||
155539094|NCT03277248|561396976|FG001|Overall Study|Lack of Efficacy|2|||
155539095|NCT03277248|561396975|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
155539096|NCT03277248|561396976|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
155539097|NCT01993940|561396983|FG000|Overall Study|Adverse Event|16|||
155539098|NCT01993940|561396984|FG001|Overall Study|Adverse Event|11|||
155539099|NCT01993940|561396983|FG000|Overall Study|Withdrawal by Subject|15|||
155539100|NCT01993940|561396984|FG001|Overall Study|Withdrawal by Subject|19|||
155539101|NCT01993940|561396983|FG000|Overall Study|Lost to Follow-up|2|||
155539102|NCT01993940|561396984|FG001|Overall Study|Lost to Follow-up|5|||
155539103|NCT01993940|561396983|FG000|Overall Study|Protocol Violation|5|||
155539104|NCT01993940|561396984|FG001|Overall Study|Protocol Violation|8|||
155539105|NCT01993940|561396983|FG000|Overall Study|Death|1|||
155539106|NCT01993940|561396984|FG001|Overall Study|Death|0|||
155539107|NCT01993940|561396983|FG000|Overall Study|Other - Miscellaneous|1|||
155539108|NCT01993940|561396984|FG001|Overall Study|Other - Miscellaneous|1|||
155539109|NCT03922750|561396985|FG000|Overall Study|Unclassified|0|||
155539110|NCT03922750|561396986|FG001|Overall Study|Unclassified|0|||
155539111|NCT03922750|561396987|FG002|Overall Study|Unclassified|1|||
155539112|NCT03922750|561396985|FG000|Overall Study|Adverse Event|0|||
155539113|NCT03922750|561396986|FG001|Overall Study|Adverse Event|1|||
155539114|NCT03922750|561396987|FG002|Overall Study|Adverse Event|0|||
155539115|NCT01451541|561396988|FG000|Overall Study|Adverse Event|4|||
155539116|NCT01451541|561396989|FG001|Overall Study|Adverse Event|3|||
155539117|NCT01451541|561396990|FG002|Overall Study|Adverse Event|6|||
155539118|NCT01451541|561396988|FG000|Overall Study|Lack of Efficacy|2|||
155539119|NCT01451541|561396989|FG001|Overall Study|Lack of Efficacy|0|||
155539120|NCT01451541|561396990|FG002|Overall Study|Lack of Efficacy|0|||
155539121|NCT01451541|561396988|FG000|Overall Study|Lost to Follow-up|4|||
155656066|NCT01892189|561835106|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656067|NCT01892189|561835107|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656068|NCT01892189|561835108|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
155656069|NCT01892189|561835109|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656070|NCT01892189|561835110|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656071|NCT01892189|561835111|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155656072|NCT03440411|561835116|FG000|Overall Study|Adverse Event|0|||
155656073|NCT03440411|561835117|FG001|Overall Study|Adverse Event|0|||
155539122|NCT01451541|561396989|FG001|Overall Study|Lost to Follow-up|4|||
155539123|NCT01451541|561396990|FG002|Overall Study|Lost to Follow-up|7|||
155539124|NCT01451541|561396988|FG000|Overall Study|Withdrawal by Subject|15|||
155539125|NCT01451541|561396989|FG001|Overall Study|Withdrawal by Subject|8|||
155656074|NCT03440411|561835118|FG002|Overall Study|Adverse Event|1|||
155539126|NCT01451541|561396990|FG002|Overall Study|Withdrawal by Subject|6|||
155539127|NCT01451541|561396988|FG000|Overall Study|randomization error, noncompliance|11|||
155539128|NCT01451541|561396989|FG001|Overall Study|randomization error, noncompliance|10|||
155656075|NCT03440411|561835119|FG003|Overall Study|Adverse Event|0|||
155539129|NCT01451541|561396990|FG002|Overall Study|randomization error, noncompliance|8|||
155539130|NCT04164758|561396991|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
155539131|NCT04164758|561396992|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
155539132|NCT04164758|561396993|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
155539133|NCT04164758|561396991|FG000|Overall Study|Adverse Event|0|||
155539134|NCT04164758|561396992|FG001|Overall Study|Adverse Event|1|||
155539135|NCT04164758|561396993|FG002|Overall Study|Adverse Event|0|||
155539136|NCT00533507|561396997|FG000|Overall Study|Withdrawal by Subject|1|||
155539137|NCT01050764|561396998|FG000|Overall Study|Death, before HSCT|1|||
155539138|NCT01050764|561396998|FG000|Overall Study|Donor mobilization failure, death|1|||
155539139|NCT01050764|561396998|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
155539140|NCT03555695|561397012|FG000|Overall Study|Withdrawal by Subject|1|||
155539141|NCT03555695|561397012|FG000|Overall Study|Lost to Follow-up|1|||
155539142|NCT03555695|561397012|FG000|Overall Study|appendicitis (unrelated)|1|||
155539143|NCT03555695|561397012|FG000|Overall Study|pre-existing sciatica|1|||
155539144|NCT01426854|561397015|FG000|Overall Study|Adverse Event|1|||
155539145|NCT01426854|561397016|FG001|Overall Study|Adverse Event|5|||
155539146|NCT01426854|561397015|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
155539147|NCT01426854|561397016|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
155539148|NCT01426854|561397015|FG000|Overall Study|Lost to Follow-up|3|||
155539149|NCT01426854|561397016|FG001|Overall Study|Lost to Follow-up|0|||
155539150|NCT01426854|561397015|FG000|Overall Study|Noncompliance|0|||
155539151|NCT01426854|561397016|FG001|Overall Study|Noncompliance|1|||
155539152|NCT01426854|561397015|FG000|Overall Study|Treatment Failure|0|||
155539153|NCT01426854|561397016|FG001|Overall Study|Treatment Failure|16|||
155539154|NCT01426854|561397015|FG000|Overall Study|Protocol Deviation|0|||
155539155|NCT01426854|561397016|FG001|Overall Study|Protocol Deviation|1|||
155539156|NCT01426854|561397015|FG000|Overall Study|Other|3|||
155539157|NCT01426854|561397016|FG001|Overall Study|Other|2|||
155539158|NCT04203823|561397019|FG000|Overall Study|Withdrawal by Subject|2|||
155539159|NCT04203823|561397020|FG001|Overall Study|Withdrawal by Subject|2|||
155539160|NCT04203823|561397019|FG000|Overall Study|Adverse Event|1|||
155539161|NCT04203823|561397020|FG001|Overall Study|Adverse Event|1|||
155539162|NCT04203823|561397019|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155539163|NCT04203823|561397020|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
155539164|NCT03193021|561397021|FG000|Overall Study|Lost to Follow-up|1|||
155539165|NCT03193021|561397022|FG001|Overall Study|Lost to Follow-up|1|||
155539166|NCT00685334|561397028|FG000|Overall Study|Withdrawal by Subject|5|||
155539167|NCT00685334|561397029|FG001|Overall Study|Withdrawal by Subject|6|||
155539168|NCT00685334|561397028|FG000|Overall Study|Lost to Follow-up|4|||
155539169|NCT00685334|561397029|FG001|Overall Study|Lost to Follow-up|0|||
155539170|NCT00685334|561397028|FG000|Overall Study|Chose to enter hospital|1|||
155539171|NCT00685334|561397029|FG001|Overall Study|Chose to enter hospital|1|||
155539172|NCT00820599|561398612|FG000|Overall Study|Death|129|||
155539173|NCT00820599|561398612|FG000|Overall Study|Withdrawal by Subject|2|||
155539174|NCT03686215|561398613|FG000|Overall Study|Adverse Event|0|||
155539175|NCT03686215|561398614|FG001|Overall Study|Adverse Event|0|||
155539176|NCT03686215|561398615|FG002|Overall Study|Adverse Event|7|||
155539177|NCT03686215|561398613|FG000|Overall Study|Physician Decision|0|||
155539178|NCT03686215|561398614|FG001|Overall Study|Physician Decision|0|||
155539179|NCT03686215|561398615|FG002|Overall Study|Physician Decision|1|||
155539180|NCT03686215|561398613|FG000|Overall Study|Protocol Violation|0|||
155539181|NCT03686215|561398614|FG001|Overall Study|Protocol Violation|0|||
155539182|NCT03686215|561398615|FG002|Overall Study|Protocol Violation|4|||
155539183|NCT03686215|561398613|FG000|Overall Study|Device issue|1|||
155539184|NCT03686215|561398614|FG001|Overall Study|Device issue|0|||
155539185|NCT03686215|561398615|FG002|Overall Study|Device issue|2|||
155539186|NCT00202839|561398616|FG000|Overall Study|Adverse Event|1|||
155539187|NCT00202839|561398617|FG001|Overall Study|Adverse Event|5|||
155539188|NCT00202839|561398616|FG000|Overall Study|Physician Decision|12|||
155539189|NCT00202839|561398617|FG001|Overall Study|Physician Decision|0|||
155539190|NCT00202839|561398616|FG000|Overall Study|Withdrawal by Subject|6|||
155539191|NCT00202839|561398617|FG001|Overall Study|Withdrawal by Subject|2|||
155656076|NCT03440411|561835116|FG000|Overall Study|PD|2|||
155656077|NCT03440411|561835117|FG001|Overall Study|PD|1|||
155539192|NCT00202839|561398616|FG000|Overall Study|Protocol Violation|2|||
155539193|NCT00202839|561398617|FG001|Overall Study|Protocol Violation|1|||
155539194|NCT00202839|561398616|FG000|Overall Study|Lost to Follow-up|3|||
155539195|NCT00202839|561398617|FG001|Overall Study|Lost to Follow-up|2|||
155539196|NCT04768296|561398618|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
155539197|NCT04768296|561398619|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
155539198|NCT00522041|561398620|FG000|Overall Study|Adverse Event|9|||
155539199|NCT00522041|561398621|FG001|Overall Study|Adverse Event|3|||
155539200|NCT00522041|561398620|FG000|Overall Study|Protocol Violation|2|||
155539201|NCT00522041|561398621|FG001|Overall Study|Protocol Violation|0|||
155539202|NCT00522041|561398620|FG000|Overall Study|Lost to Follow-up|1|||
155539203|NCT00522041|561398621|FG001|Overall Study|Lost to Follow-up|4|||
155539204|NCT00522041|561398620|FG000|Overall Study|Voluntary withdrawal|5|||
155539205|NCT00522041|561398621|FG001|Overall Study|Voluntary withdrawal|4|||
155539206|NCT00522041|561398620|FG000|Overall Study|Did not receive treatment|0|||
155539207|NCT00522041|561398621|FG001|Overall Study|Did not receive treatment|1|||
155539208|NCT00544167|561398622|FG000|Overall Study|Adverse Event|21|||
155539209|NCT00544167|561398622|FG000|Overall Study|Physician Decision|8|||
155539210|NCT00874549|561398623|FG000|Overall Study|Adverse Event|0|||
155539211|NCT00874549|561398624|FG001|Overall Study|Adverse Event|0|||
155539212|NCT00874549|561398625|FG002|Overall Study|Adverse Event|1|||
155539213|NCT00874549|561398626|FG003|Overall Study|Adverse Event|0|||
155539214|NCT00874549|561398623|FG000|Overall Study|Protocol Violation|1|||
155539215|NCT00874549|561398624|FG001|Overall Study|Protocol Violation|0|||
155539216|NCT00874549|561398625|FG002|Overall Study|Protocol Violation|2|||
155539217|NCT00874549|561398626|FG003|Overall Study|Protocol Violation|1|||
155539218|NCT00874549|561398623|FG000|Overall Study|Lost to Follow-up|0|||
155539219|NCT00874549|561398624|FG001|Overall Study|Lost to Follow-up|0|||
155539220|NCT00874549|561398625|FG002|Overall Study|Lost to Follow-up|1|||
155539221|NCT00874549|561398626|FG003|Overall Study|Lost to Follow-up|0|||
155539222|NCT00874549|561398623|FG000|Overall Study|Withdrawal by Subject|0|||
155539223|NCT00874549|561398624|FG001|Overall Study|Withdrawal by Subject|1|||
155539224|NCT00874549|561398625|FG002|Overall Study|Withdrawal by Subject|0|||
155539225|NCT00874549|561398626|FG003|Overall Study|Withdrawal by Subject|1|||
155539226|NCT03343639|561398627|FG000|Overall Study|Withdrawal by Subject|10|||
155539227|NCT03343639|561398628|FG001|Overall Study|Withdrawal by Subject|6|||
155539228|NCT03343639|561398627|FG000|Overall Study|Lost to Follow-up|4|||
155539229|NCT03343639|561398628|FG001|Overall Study|Lost to Follow-up|5|||
155539230|NCT03343639|561398627|FG000|Overall Study|Protocol Violation|0|||
155539231|NCT03343639|561398628|FG001|Overall Study|Protocol Violation|1|||
155539232|NCT00735696|561398629|FG000|Overall Study|Withdrawal by Subject|1|||
155539233|NCT00735696|561398629|FG000|Overall Study|Enrolled but never Treated|1|||
155539234|NCT00084864|561398630|FG000|Overall Study|Adverse Event|1|||
155539235|NCT00084864|561398631|FG001|Overall Study|Adverse Event|0|||
155539236|NCT00084864|561398632|FG002|Overall Study|Adverse Event|0|||
155539237|NCT00084864|561398633|FG003|Overall Study|Adverse Event|0|||
155539238|NCT02655224|561398636|FG000|Overall Study|Adverse Event|1|||
155539239|NCT02655224|561398637|FG001|Overall Study|Adverse Event|1|||
155539240|NCT00063258|561398646|FG000|Overall Study|Physician Decision|2|||
155539241|NCT00063258|561398647|FG001|Overall Study|Physician Decision|0|||
155539242|NCT00063258|561398646|FG000|Overall Study|Lack of Efficacy|2|||
155539243|NCT00063258|561398647|FG001|Overall Study|Lack of Efficacy|0|||
155539244|NCT02754492|561398648|FG000|Overall Study|Protocol Violation|2|||
155539245|NCT02754492|561398649|FG001|Overall Study|Protocol Violation|2|||
155539246|NCT02754492|561398650|FG002|Overall Study|Protocol Violation|0|||
155539247|NCT02754492|561398651|FG003|Overall Study|Protocol Violation|1|||
155539248|NCT02754492|561398648|FG000|Overall Study|Withdrawal by Subject|2|||
155539249|NCT02754492|561398649|FG001|Overall Study|Withdrawal by Subject|0|||
155539250|NCT02754492|561398650|FG002|Overall Study|Withdrawal by Subject|0|||
155656078|NCT03440411|561835118|FG002|Overall Study|PD|1|||
155656079|NCT03440411|561835119|FG003|Overall Study|PD|1|||
155656080|NCT03440411|561835116|FG000|Overall Study|Withdrawal by Subject|1|||
155656081|NCT03440411|561835117|FG001|Overall Study|Withdrawal by Subject|0|||
155656082|NCT03440411|561835118|FG002|Overall Study|Withdrawal by Subject|0|||
155656083|NCT03440411|561835119|FG003|Overall Study|Withdrawal by Subject|0|||
155656084|NCT03440411|561835116|FG000|Overall Study|Closed study by sponsor|0|||
155656085|NCT03440411|561835117|FG001|Overall Study|Closed study by sponsor|0|||
155656086|NCT03440411|561835118|FG002|Overall Study|Closed study by sponsor|0|||
155656087|NCT03440411|561835119|FG003|Overall Study|Closed study by sponsor|1|||
155656088|NCT01052779|561835121|FG000|Overall Study|Adverse Event|1|||
155656089|NCT01052779|561835122|FG001|Overall Study|Adverse Event|4|||
155656090|NCT01052779|561835121|FG000|Overall Study|Withdrawal by Subject|1|||
155656091|NCT01052779|561835122|FG001|Overall Study|Withdrawal by Subject|2|||
155656092|NCT01052779|561835121|FG000|Overall Study|Other-Protocol Violation|1|||
155656093|NCT01052779|561835122|FG001|Overall Study|Other-Protocol Violation|1|||
155656094|NCT01052779|561835121|FG000|Overall Study|Other-Surgery|0|||
155539251|NCT02754492|561398651|FG003|Overall Study|Withdrawal by Subject|0|||
155539252|NCT02754492|561398648|FG000|Overall Study|Equipment malfuntion|0|||
155539253|NCT02754492|561398649|FG001|Overall Study|Equipment malfuntion|0|||
155539254|NCT02754492|561398650|FG002|Overall Study|Equipment malfuntion|2|||
155539255|NCT02754492|561398651|FG003|Overall Study|Equipment malfuntion|5|||
155539256|NCT02754492|561398648|FG000|Overall Study|Adverse Event|0|||
155539257|NCT02754492|561398649|FG001|Overall Study|Adverse Event|0|||
155539258|NCT02754492|561398650|FG002|Overall Study|Adverse Event|0|||
155539259|NCT02754492|561398651|FG003|Overall Study|Adverse Event|13|||
155539260|NCT02754492|561398648|FG000|Overall Study|Venous access issues not resulting in AE|0|||
155656095|NCT01052779|561835122|FG001|Overall Study|Other-Surgery|2|||
155656096|NCT01052779|561835121|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
155656097|NCT01052779|561835122|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
155656098|NCT03663582|561835123|FG000|Overall Study|Physician Decision|1|||
155539261|NCT02754492|561398649|FG001|Overall Study|Venous access issues not resulting in AE|0|||
155539262|NCT02754492|561398650|FG002|Overall Study|Venous access issues not resulting in AE|0|||
155539263|NCT02754492|561398651|FG003|Overall Study|Venous access issues not resulting in AE|4|||
155539264|NCT05387408|561398654|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
155539265|NCT02786953|561398665|FG000|Overall Study|Withdrawal by Subject|3|||
155539266|NCT02786953|561398666|FG001|Overall Study|Withdrawal by Subject|0|||
155539267|NCT02786953|561398665|FG000|Overall Study|Physician Decision|0|||
155539268|NCT02786953|561398666|FG001|Overall Study|Physician Decision|1|||
155539269|NCT02627963|561398672|FG000|Overall Study|Randomized but not treated|2|||
155539270|NCT02627963|561398673|FG001|Overall Study|Randomized but not treated|6|||
155539271|NCT03073798|561398674|FG000|Overall Study|Adverse Event|1|||
155539272|NCT03073798|561398674|FG000|Overall Study|Withdrawal by Subject|1|||
155539273|NCT05278858|561398675|FG000|Overall Study|Withdrawal by Subject|1|||
155539274|NCT00840658|561398676|FG000|Overall Study|Death|2|||
155539275|NCT00840658|561398677|FG001|Overall Study|Death|2|||
155539276|NCT00840658|561398678|FG002|Overall Study|Death|3|||
155539277|NCT00840658|561398679|FG003|Overall Study|Death|3|||
155539278|NCT00840658|561398676|FG000|Overall Study|Lost to Follow-up|3|||
155539279|NCT00840658|561398677|FG001|Overall Study|Lost to Follow-up|1|||
155539280|NCT00840658|561398678|FG002|Overall Study|Lost to Follow-up|2|||
155539281|NCT00840658|561398679|FG003|Overall Study|Lost to Follow-up|1|||
155539282|NCT02372006|561398680|FG000|Overall Study|Progressive disease|8|||
155539283|NCT02372006|561398681|FG001|Overall Study|Progressive disease|7|||
155539284|NCT02372006|561398682|FG002|Overall Study|Progressive disease|34|||
155539285|NCT02372006|561398680|FG000|Overall Study|Dose limiting toxicity|0|||
155539286|NCT02372006|561398681|FG001|Overall Study|Dose limiting toxicity|1|||
155539287|NCT02372006|561398682|FG002|Overall Study|Dose limiting toxicity|0|||
155539288|NCT02372006|561398680|FG000|Overall Study|Adverse Event|0|||
155539289|NCT02372006|561398681|FG001|Overall Study|Adverse Event|0|||
155539290|NCT02372006|561398682|FG002|Overall Study|Adverse Event|3|||
155539291|NCT02372006|561398680|FG000|Overall Study|Withdrawal by Subject|0|||
155539292|NCT02372006|561398681|FG001|Overall Study|Withdrawal by Subject|1|||
155539293|NCT02372006|561398682|FG002|Overall Study|Withdrawal by Subject|1|||
155539294|NCT02372006|561398680|FG000|Overall Study|Other reason for not completing|0|||
155539295|NCT02372006|561398681|FG001|Overall Study|Other reason for not completing|0|||
155539296|NCT02372006|561398682|FG002|Overall Study|Other reason for not completing|1|||
155539297|NCT01055834|561398683|FG000|Treatment Period I|Adverse Event|1|||
155539298|NCT01055834|561398684|FG001|Treatment Period I|Adverse Event|0|||
155539299|NCT00295490|561398685|FG000|Overall Study|Protocol Violation|0|||
155539300|NCT00295490|561398686|FG001|Overall Study|Protocol Violation|0|||
155539301|NCT00295490|561398687|FG002|Overall Study|Protocol Violation|3|||
155539302|NCT00295490|561398688|FG003|Overall Study|Protocol Violation|3|||
155539303|NCT00295490|561398685|FG000|Overall Study|Withdrawal by Subject|0|||
155539304|NCT00295490|561398686|FG001|Overall Study|Withdrawal by Subject|2|||
155539305|NCT00295490|561398687|FG002|Overall Study|Withdrawal by Subject|0|||
155539306|NCT00295490|561398688|FG003|Overall Study|Withdrawal by Subject|1|||
155539307|NCT00295490|561398685|FG000|Overall Study|Lost to Follow-up|0|||
155539308|NCT00295490|561398686|FG001|Overall Study|Lost to Follow-up|0|||
155539309|NCT00295490|561398687|FG002|Overall Study|Lost to Follow-up|1|||
155539310|NCT00295490|561398688|FG003|Overall Study|Lost to Follow-up|0|||
155539311|NCT00295490|561398685|FG000|Overall Study|Adverse Event|1|||
155539312|NCT00295490|561398686|FG001|Overall Study|Adverse Event|0|||
155539313|NCT00295490|561398687|FG002|Overall Study|Adverse Event|0|||
155539314|NCT00295490|561398688|FG003|Overall Study|Adverse Event|0|||
155539315|NCT00295490|561398685|FG000|Overall Study|Other|0|||
155539316|NCT00295490|561398686|FG001|Overall Study|Other|2|||
155539317|NCT00295490|561398687|FG002|Overall Study|Other|0|||
155539318|NCT00295490|561398688|FG003|Overall Study|Other|1|||
155539319|NCT01559116|561398702|FG000|Overall Study|Adverse Event|10|||
155539320|NCT01559116|561398702|FG000|Overall Study|Lack of Efficacy|1|||
155539321|NCT01559116|561398702|FG000|Overall Study|Lost to Follow-up|1|||
155539322|NCT01559116|561398702|FG000|Overall Study|Protocol Violation|1|||
155539323|NCT01559116|561398702|FG000|Overall Study|Withdrawal by Subject|4|||
155539324|NCT01559116|561398702|FG000|Overall Study|other than stated above|9|||
155539325|NCT01532908|561398703|FG000|Overall Study|Not Transplanted|1|||
155539326|NCT01532908|561398704|FG001|Overall Study|Not Transplanted|0|||
155539327|NCT01868243|561398705|FG000|Overall Study|Death|0|||
155539328|NCT01868243|561398706|FG001|Overall Study|Death|1|||
155539329|NCT01632306|561398707|FG000|Overall Study|Protocol Violation|1|||
155539330|NCT01632306|561398708|FG001|Overall Study|Protocol Violation|0|||
155539331|NCT01632306|561398709|FG002|Overall Study|Protocol Violation|0|||
155539332|NCT00467597|561398711|FG000|Overall Study|Withdrawal by Subject|2|||
155539333|NCT00467597|561398712|FG001|Overall Study|Withdrawal by Subject|0|||
155539334|NCT01745094|561398715|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
155539335|NCT01745094|561398716|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
155539336|NCT01745094|561398717|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
155539337|NCT01745094|561398718|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
155539338|NCT01745094|561398715|FG000|Overall Study|Adverse Event|0|||
155539339|NCT01745094|561398716|FG001|Overall Study|Adverse Event|0|||
155539340|NCT01745094|561398717|FG002|Overall Study|Adverse Event|3|||
155539341|NCT01745094|561398718|FG003|Overall Study|Adverse Event|0|||
155539342|NCT01745094|561398715|FG000|Overall Study|Withdrawal by Subject|2|||
155539343|NCT01745094|561398716|FG001|Overall Study|Withdrawal by Subject|0|||
155539344|NCT01745094|561398717|FG002|Overall Study|Withdrawal by Subject|1|||
155539345|NCT01745094|561398718|FG003|Overall Study|Withdrawal by Subject|2|||
155539346|NCT01745094|561398715|FG000|Overall Study|Protocol Violation|1|||
155539347|NCT01745094|561398716|FG001|Overall Study|Protocol Violation|0|||
155539348|NCT01745094|561398717|FG002|Overall Study|Protocol Violation|3|||
155539349|NCT01745094|561398718|FG003|Overall Study|Protocol Violation|1|||
155539350|NCT01745094|561398715|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
155539351|NCT01745094|561398716|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
155539352|NCT01745094|561398717|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
155539353|NCT01745094|561398718|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
155539354|NCT01745094|561398715|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
155539355|NCT01745094|561398716|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
155539356|NCT01745094|561398717|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
155539357|NCT01745094|561398718|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
155539358|NCT01745094|561398715|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
155539359|NCT01745094|561398716|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
155539360|NCT01745094|561398717|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
155539361|NCT01745094|561398718|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
155539362|NCT04610580|561398719|FG000|Two-way Crossover Period|Adverse Event|1|||
155539363|NCT04610580|561398720|FG001|Two-way Crossover Period|Adverse Event|0|||
155539364|NCT04610580|561398721|FG002|Two-way Crossover Period|Adverse Event|0|||
155539365|NCT04610580|561398722|FG003|Two-way Crossover Period|Adverse Event|0|||
155539366|NCT04610580|561398723|FG004|Two-way Crossover Period|Adverse Event|0|||
155539367|NCT04610580|561398724|FG005|Two-way Crossover Period|Adverse Event|0|||
155539368|NCT04610580|561398719|FG000|Two-way Crossover Period|Physician Decision|1|||
155539369|NCT04610580|561398720|FG001|Two-way Crossover Period|Physician Decision|0|||
155539370|NCT04610580|561398721|FG002|Two-way Crossover Period|Physician Decision|0|||
155539371|NCT04610580|561398722|FG003|Two-way Crossover Period|Physician Decision|0|||
155539372|NCT04610580|561398723|FG004|Two-way Crossover Period|Physician Decision|0|||
155539373|NCT04610580|561398724|FG005|Two-way Crossover Period|Physician Decision|0|||
155539374|NCT04610580|561398719|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
155539375|NCT04610580|561398720|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
155539376|NCT04610580|561398721|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
155539377|NCT04610580|561398722|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
155539378|NCT04610580|561398723|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
155539379|NCT04610580|561398724|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
155539380|NCT04610580|561398719|FG000|Two-way Crossover Period|Other than specified|0|||
155539381|NCT04610580|561398720|FG001|Two-way Crossover Period|Other than specified|1|||
155539382|NCT04610580|561398721|FG002|Two-way Crossover Period|Other than specified|0|||
155539383|NCT04610580|561398722|FG003|Two-way Crossover Period|Other than specified|0|||
155539384|NCT04610580|561398723|FG004|Two-way Crossover Period|Other than specified|0|||
155539385|NCT04610580|561398724|FG005|Two-way Crossover Period|Other than specified|0|||
155539386|NCT04610580|561398719|FG000|Washout Before Extension Period|Other than specified|0|||
155539387|NCT04610580|561398720|FG001|Washout Before Extension Period|Other than specified|1|||
155539388|NCT04610580|561398721|FG002|Washout Before Extension Period|Other than specified|0|||
155539389|NCT04610580|561398722|FG003|Washout Before Extension Period|Other than specified|0|||
155539390|NCT04610580|561398723|FG004|Washout Before Extension Period|Other than specified|0|||
155539391|NCT04610580|561398724|FG005|Washout Before Extension Period|Other than specified|0|||
155539392|NCT04610580|561398719|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
155539393|NCT04610580|561398720|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
155539394|NCT04610580|561398721|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
155539395|NCT04610580|561398722|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
155539396|NCT04610580|561398723|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
155539397|NCT04610580|561398724|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
155539398|NCT04610580|561398719|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
155539399|NCT04610580|561398720|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
155539400|NCT04610580|561398721|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
155539401|NCT04610580|561398722|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
155539402|NCT04610580|561398723|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
155539403|NCT04610580|561398724|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
155539404|NCT03480022|561398726|FG000|Overall Study|Pregnancy|2|||
155539405|NCT03480022|561398727|FG001|Overall Study|Pregnancy|0|||
155539406|NCT03480022|561398726|FG000|Overall Study|Adverse Event|6|||
155539407|NCT03480022|561398727|FG001|Overall Study|Adverse Event|0|||
155539408|NCT03480022|561398726|FG000|Overall Study|Lack of Efficacy|0|||
155539409|NCT03480022|561398727|FG001|Overall Study|Lack of Efficacy|2|||
155539410|NCT03480022|561398726|FG000|Overall Study|Physician Decision|0|||
155539411|NCT03480022|561398727|FG001|Overall Study|Physician Decision|1|||
155539412|NCT03480022|561398726|FG000|Overall Study|Withdrawal by Subject|2|||
155539413|NCT03480022|561398727|FG001|Overall Study|Withdrawal by Subject|0|||
155539414|NCT03480022|561398726|FG000|Overall Study|Medication concerns|1|||
155539415|NCT03480022|561398727|FG001|Overall Study|Medication concerns|0|||
155539416|NCT03480022|561398726|FG000|Overall Study|Family member COVID exposure|0|||
155539417|NCT03480022|561398727|FG001|Overall Study|Family member COVID exposure|1|||
155539418|NCT00881569|561398728|FG000|Overall Study|Disease progression|1|||
155539419|NCT00881569|561398729|FG001|Overall Study|Disease progression|1|||
155539420|NCT00668395|561398734|FG000|Overall Study|Withdrawal by Subject|4|||
155539421|NCT00668395|561398735|FG001|Overall Study|Withdrawal by Subject|4|||
155539422|NCT00668395|561398736|FG002|Overall Study|Withdrawal by Subject|1|||
155539423|NCT00668395|561398734|FG000|Overall Study|Adverse Event|1|||
155539424|NCT00668395|561398735|FG001|Overall Study|Adverse Event|1|||
155539425|NCT00668395|561398736|FG002|Overall Study|Adverse Event|0|||
155539426|NCT00668395|561398734|FG000|Overall Study|Physician Decision|1|||
155539427|NCT00668395|561398735|FG001|Overall Study|Physician Decision|1|||
155539428|NCT00668395|561398736|FG002|Overall Study|Physician Decision|0|||
155539429|NCT01670097|561398741|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
155539430|NCT01670097|561398742|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
155539431|NCT01670097|561398741|FG000|Overall Study|Study burden|1|||
155539432|NCT01670097|561398742|FG001|Overall Study|Study burden|0|||
155539433|NCT01670097|561398741|FG000|Overall Study|COPD exacerbation|0|||
155539434|NCT01670097|561398742|FG001|Overall Study|COPD exacerbation|1|||
155539435|NCT01670097|561398741|FG000|Overall Study|Neutropenia|0|||
155539436|NCT01670097|561398742|FG001|Overall Study|Neutropenia|1|||
155539437|NCT01670097|561398741|FG000|Overall Study|Clinical deterioration|0|||
155539438|NCT01670097|561398742|FG001|Overall Study|Clinical deterioration|1|||
155539439|NCT01670097|561398741|FG000|Overall Study|Disease progression|0|||
155539440|NCT01670097|561398742|FG001|Overall Study|Disease progression|1|||
155539441|NCT01949532|561398743|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
155539442|NCT01949532|561398744|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
155539443|NCT05665387|561398745|FG000|Overall Study|Withdrawal by Subject|1|||
155539444|NCT05665387|561398746|FG001|Overall Study|Withdrawal by Subject|0|||
155539445|NCT05665387|561398747|FG002|Overall Study|Withdrawal by Subject|1|||
155539446|NCT01824498|561398748|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
155539447|NCT01824498|561398749|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
155539448|NCT01824498|561398750|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
155539449|NCT01824498|561398751|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
155539450|NCT01824498|561398752|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
155539451|NCT01824498|561398753|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
155539452|NCT01567527|561398754|FG000|Conversion Phase.|Protocol deviation|3|||
155539453|NCT01567527|561398755|FG001|Conversion Phase.|Protocol deviation|0|||
155539454|NCT01567527|561398756|FG002|Conversion Phase.|Protocol deviation|0|||
155539455|NCT01567527|561398757|FG003|Conversion Phase.|Protocol deviation|0|||
155539456|NCT01567527|561398758|FG004|Conversion Phase.|Protocol deviation|0|||
155539457|NCT01567527|561398754|FG000|Conversion Phase.|Met withdrawal criteria|10|||
155539458|NCT01567527|561398755|FG001|Conversion Phase.|Met withdrawal criteria|0|||
155539459|NCT01567527|561398756|FG002|Conversion Phase.|Met withdrawal criteria|0|||
155539460|NCT01567527|561398757|FG003|Conversion Phase.|Met withdrawal criteria|0|||
155539461|NCT01567527|561398758|FG004|Conversion Phase.|Met withdrawal criteria|0|||
155539462|NCT01567527|561398754|FG000|Conversion Phase.|Withdrawal by Subject|32|||
155539463|NCT01567527|561398755|FG001|Conversion Phase.|Withdrawal by Subject|0|||
155539464|NCT01567527|561398756|FG002|Conversion Phase.|Withdrawal by Subject|0|||
155539465|NCT01567527|561398757|FG003|Conversion Phase.|Withdrawal by Subject|0|||
155539466|NCT01567527|561398758|FG004|Conversion Phase.|Withdrawal by Subject|0|||
155539467|NCT01567527|561398754|FG000|Conversion Phase.|Lost to Follow-up|16|||
155539468|NCT01567527|561398755|FG001|Conversion Phase.|Lost to Follow-up|0|||
155539469|NCT01567527|561398756|FG002|Conversion Phase.|Lost to Follow-up|0|||
155539470|NCT01567527|561398757|FG003|Conversion Phase.|Lost to Follow-up|0|||
155539471|NCT01567527|561398758|FG004|Conversion Phase.|Lost to Follow-up|0|||
155539472|NCT01567527|561398754|FG000|Conversion Phase.|Lack of Efficacy|2|||
155539473|NCT01567527|561398755|FG001|Conversion Phase.|Lack of Efficacy|0|||
155539474|NCT01567527|561398756|FG002|Conversion Phase.|Lack of Efficacy|0|||
155539475|NCT01567527|561398757|FG003|Conversion Phase.|Lack of Efficacy|0|||
155539476|NCT01567527|561398758|FG004|Conversion Phase.|Lack of Efficacy|0|||
155539477|NCT01567527|561398754|FG000|Conversion Phase.|Adverse Event|33|||
155539478|NCT01567527|561398755|FG001|Conversion Phase.|Adverse Event|0|||
155539479|NCT01567527|561398756|FG002|Conversion Phase.|Adverse Event|0|||
155539480|NCT01567527|561398757|FG003|Conversion Phase.|Adverse Event|0|||
155539481|NCT01567527|561398758|FG004|Conversion Phase.|Adverse Event|0|||
155539482|NCT01567527|561398754|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
155539483|NCT01567527|561398755|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
155539484|NCT01567527|561398756|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
155539485|NCT01567527|561398757|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
155539486|NCT01567527|561398758|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
155539487|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
155539488|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
155539489|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
155539490|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
155539491|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
155539492|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155539493|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
155539494|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155539495|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155539496|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155539497|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
155539498|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
155539499|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
155539500|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
155539501|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
155539502|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
155539503|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
155539504|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
155539505|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
155539506|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
155539507|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155539508|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
155539509|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155539510|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155539511|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155539512|NCT01567527|561398754|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
155539513|NCT01567527|561398755|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
155539514|NCT01567527|561398756|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
155539515|NCT01567527|561398757|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
155539516|NCT01567527|561398758|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
155539517|NCT01567527|561398754|FG000|IM Depot Stabilization.|Protocol deviation|0|||
155539518|NCT01567527|561398755|FG001|IM Depot Stabilization.|Protocol deviation|0|||
155539519|NCT01567527|561398756|FG002|IM Depot Stabilization.|Protocol deviation|5|||
155539520|NCT01567527|561398757|FG003|IM Depot Stabilization.|Protocol deviation|0|||
155539521|NCT01567527|561398758|FG004|IM Depot Stabilization.|Protocol deviation|0|||
155539522|NCT01567527|561398754|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
155539523|NCT01567527|561398755|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
155539524|NCT01567527|561398756|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
155539525|NCT01567527|561398757|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
155539526|NCT01567527|561398758|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
155539527|NCT01567527|561398754|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
155539528|NCT01567527|561398755|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
155539529|NCT01567527|561398756|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
155539530|NCT01567527|561398757|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
155539531|NCT01567527|561398758|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
155539532|NCT01567527|561398754|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
155539533|NCT01567527|561398755|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
155539534|NCT01567527|561398756|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
155539535|NCT01567527|561398757|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
155539536|NCT01567527|561398758|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
155539537|NCT01567527|561398754|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
155539538|NCT01567527|561398755|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
155539539|NCT01567527|561398756|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
155539540|NCT01567527|561398757|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
155539541|NCT01567527|561398758|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
155539542|NCT01567527|561398754|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
155539543|NCT01567527|561398755|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
155539544|NCT01567527|561398756|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
155539545|NCT01567527|561398757|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
155539546|NCT01567527|561398758|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
155539547|NCT01567527|561398754|FG000|IM Depot Stabilization.|Adverse Event|0|||
155539548|NCT01567527|561398755|FG001|IM Depot Stabilization.|Adverse Event|0|||
155539549|NCT01567527|561398756|FG002|IM Depot Stabilization.|Adverse Event|37|||
155539550|NCT01567527|561398757|FG003|IM Depot Stabilization.|Adverse Event|0|||
155539551|NCT01567527|561398758|FG004|IM Depot Stabilization.|Adverse Event|0|||
155539552|NCT01567527|561398754|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
155539553|NCT01567527|561398755|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
155539554|NCT01567527|561398756|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
155539555|NCT01567527|561398757|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
155539556|NCT01567527|561398758|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
155539557|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
155539558|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
155539559|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
155539560|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
155539561|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
155539562|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
155539563|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
155539564|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
155539565|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
155539566|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
155539567|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
155539568|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
155539569|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
155539570|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
155539571|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
155539572|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
155539573|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
155539574|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
155539575|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
155539576|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
155539577|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155539578|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155539579|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155539580|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
155539581|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
155539582|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
155539583|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
155539584|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
155539585|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
155539586|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
155539587|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
155539588|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
155539589|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
155539590|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
155539591|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
155539592|NCT01567527|561398754|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155539593|NCT01567527|561398755|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155539594|NCT01567527|561398756|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155539595|NCT01567527|561398757|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
155539596|NCT01567527|561398758|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
155539597|NCT02311894|561398759|FG000|Overall Study|Discontinued in error|1|||
155539598|NCT02311894|561398759|FG000|Overall Study|Lost to Follow-up|1|||
155539599|NCT02311894|561398759|FG000|Overall Study|Adverse Event|1|||
155539600|NCT02311894|561398759|FG000|Overall Study|Withdrawal by Subject|1|||
155539601|NCT00884390|561398760|FG000|Overall Study|Adverse Event|0|||
155539602|NCT00884390|561398761|FG001|Overall Study|Adverse Event|1|||
155539603|NCT00884390|561398760|FG000|Overall Study|Lost to Follow-up|0|||
155539604|NCT00884390|561398761|FG001|Overall Study|Lost to Follow-up|1|||
155539605|NCT00884390|561398760|FG000|Overall Study|Physician Decision|2|||
155539606|NCT00884390|561398761|FG001|Overall Study|Physician Decision|1|||
155539607|NCT00884390|561398760|FG000|Overall Study|Protocol Violation|4|||
155539608|NCT00884390|561398761|FG001|Overall Study|Protocol Violation|1|||
155539609|NCT00884390|561398760|FG000|Overall Study|Withdrawal by Subject|4|||
155539610|NCT00884390|561398761|FG001|Overall Study|Withdrawal by Subject|1|||
155539611|NCT00884390|561398760|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
155539612|NCT00884390|561398761|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
155539613|NCT00884390|561398760|FG000|Overall Study|Other|11|||
155539614|NCT00884390|561398761|FG001|Overall Study|Other|1|||
155539615|NCT01691612|561398764|FG000|Overall Study|deemed ineligible after 1st visit|6|||
155539616|NCT01691612|561398764|FG000|Overall Study|Adverse Event|1|||
155539617|NCT00939523|561398767|FG000|Overall Study|Lack of Efficacy|1|||
155539618|NCT00939523|561398767|FG000|Overall Study|Physician Decision|2|||
155539619|NCT02119936|561398772|FG000|Overall Study|Lost to Follow-up|10|||
155539620|NCT00757172|561398774|FG000|Overall Study|Withdrawal by Subject|4|||
155539621|NCT00757172|561398774|FG000|Overall Study|Physician Decision|3|||
155539622|NCT00757172|561398774|FG000|Overall Study|Progression|4|||
155539623|NCT01971554|561398775|FG000|Overall Study|Lost to Follow-up|1|||
155539624|NCT01971554|561398776|FG001|Overall Study|Lost to Follow-up|0|||
155539625|NCT01971554|561398777|FG002|Overall Study|Lost to Follow-up|0|||
155539626|NCT01971554|561398778|FG003|Overall Study|Lost to Follow-up|0|||
155539627|NCT01942135|561398780|FG000|Overall Study|Adverse Event|21|||
155539628|NCT01942135|561398781|FG001|Overall Study|Adverse Event|7|||
155539629|NCT01942135|561398780|FG000|Overall Study|Global Deterioration of Health Status|9|||
155539630|NCT01942135|561398781|FG001|Overall Study|Global Deterioration of Health Status|6|||
155539631|NCT01942135|561398780|FG000|Overall Study|Randomized Not Treated|2|||
155539632|NCT01942135|561398781|FG001|Overall Study|Randomized Not Treated|2|||
155539633|NCT01942135|561398780|FG000|Overall Study|Death|2|||
155539634|NCT01942135|561398781|FG001|Overall Study|Death|1|||
155539635|NCT01942135|561398780|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
155539636|NCT01942135|561398781|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
155539637|NCT01942135|561398780|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
155539638|NCT01942135|561398781|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
155539639|NCT01942135|561398780|FG000|Overall Study|Withdrawal by Subject|4|||
155539640|NCT01942135|561398781|FG001|Overall Study|Withdrawal by Subject|3|||
155539641|NCT01942135|561398780|FG000|Overall Study|Protocol Violation|1|||
155539642|NCT01942135|561398781|FG001|Overall Study|Protocol Violation|0|||
155539643|NCT01942135|561398780|FG000|Overall Study|Other|19|||
155539644|NCT01942135|561398781|FG001|Overall Study|Other|4|||
155539645|NCT01499043|561398782|FG000|Overall Study|Progressive disease (radiographic)|2|||
155539646|NCT01499043|561398782|FG000|Overall Study|Progressive disease (clinical)|1|||
155539647|NCT01499043|561398782|FG000|Overall Study|Withdrawal by Subject|2|||
155539648|NCT01499043|561398782|FG000|Overall Study|Adverse Event|1|||
155539649|NCT01912807|561398783|FG000|Overall Study|Did not meet elegibility criteria|6|||
155539650|NCT01912807|561398784|FG001|Overall Study|Did not meet elegibility criteria|4|||
155539651|NCT01912807|561398783|FG000|Overall Study|Lost to Follow-up|36|||
155539652|NCT01912807|561398784|FG001|Overall Study|Lost to Follow-up|37|||
155539653|NCT04750239|561398785|FG000|Overall Study|Withdrawal by Subject|2|||
155539654|NCT04750239|561398785|FG000|Overall Study|Trial terminated by sponsor|1|||
155539655|NCT00903877|561398786|FG000|Overall Study|Did not meet study criteria|33|||
155539656|NCT00903877|561398786|FG000|Overall Study|Withdrawal by Subject|3|||
155539657|NCT00903877|561398786|FG000|Overall Study|Adverse Event|2|||
155539658|NCT00903877|561398786|FG000|Overall Study|Lost to Follow-up|1|||
155539659|NCT00903877|561398786|FG000|Overall Study|Participation put on hold|4|||
155539660|NCT02535923|561398787|FG000|Overall Study|Lost to Follow-up|5|||
155539661|NCT02535923|561398788|FG001|Overall Study|Lost to Follow-up|5|||
155539662|NCT02535923|561398787|FG000|Overall Study|Withdrawal by Subject|4|||
155539663|NCT02535923|561398788|FG001|Overall Study|Withdrawal by Subject|3|||
155539664|NCT04729101|561400379|FG000|Overall Study|Adverse Event|1|||
155539665|NCT04729101|561400380|FG001|Overall Study|Adverse Event|0|||
155539666|NCT04729101|561400379|FG000|Overall Study|Physician Decision|1|||
155539667|NCT04729101|561400380|FG001|Overall Study|Physician Decision|0|||
155539668|NCT04729101|561400379|FG000|Overall Study|Withdrawal by Subject|1|||
155539669|NCT04729101|561400380|FG001|Overall Study|Withdrawal by Subject|0|||
155539670|NCT00274625|561400381|FG000|Overall Study|Lost to Follow-up|46|||
155539671|NCT00274625|561400382|FG001|Overall Study|Lost to Follow-up|54|||
155539672|NCT00274625|561400381|FG000|Overall Study|Excluded from analysis|14|||
155539673|NCT00274625|561400382|FG001|Overall Study|Excluded from analysis|8|||
155539674|NCT00762411|561400385|FG000|Initial Treatment|Death|7|||
155539675|NCT00762411|561400386|FG001|Initial Treatment|Death|6|||
155539676|NCT00762411|561400385|FG000|Initial Treatment|Adverse Event|132|||
155539677|NCT00762411|561400386|FG001|Initial Treatment|Adverse Event|40|||
155539678|NCT00762411|561400385|FG000|Initial Treatment|Protocol Violation|4|||
155539679|NCT00762411|561400386|FG001|Initial Treatment|Protocol Violation|1|||
155539680|NCT00762411|561400385|FG000|Initial Treatment|Withdrawal by Subject|65|||
155539681|NCT00762411|561400386|FG001|Initial Treatment|Withdrawal by Subject|52|||
155539682|NCT00762411|561400385|FG000|Initial Treatment|Physician Decision|1|||
155539683|NCT00762411|561400386|FG001|Initial Treatment|Physician Decision|0|||
155539684|NCT00762411|561400385|FG000|Initial Treatment|Sponsor Decision|293|||
155539685|NCT00762411|561400386|FG001|Initial Treatment|Sponsor Decision|401|||
155539686|NCT00762411|561400385|FG000|Initial Treatment|Lost to Follow-up|5|||
155539687|NCT00762411|561400386|FG001|Initial Treatment|Lost to Follow-up|0|||
155539688|NCT00762411|561400385|FG000|Initial Treatment|Caregiver Decision|21|||
155539689|NCT00762411|561400386|FG001|Initial Treatment|Caregiver Decision|16|||
155539690|NCT00762411|561400385|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
155539691|NCT00762411|561400386|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
155539692|NCT00762411|561400385|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
155539693|NCT00762411|561400386|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
155539694|NCT00762411|561400385|FG000|Delayed Start|Adverse Event|0|||
155539695|NCT00762411|561400386|FG001|Delayed Start|Adverse Event|4|||
155539696|NCT00762411|561400385|FG000|Delayed Start|Protocol Violation|0|||
155539697|NCT00762411|561400386|FG001|Delayed Start|Protocol Violation|1|||
155539698|NCT00762411|561400385|FG000|Delayed Start|Sponsor Decision|16|||
155539699|NCT00762411|561400386|FG001|Delayed Start|Sponsor Decision|20|||
155539700|NCT00762411|561400385|FG000|Delayed Start|Caregiver Decision|1|||
155539701|NCT00762411|561400386|FG001|Delayed Start|Caregiver Decision|1|||
155539702|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
155539703|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
155539704|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
155539705|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
155539706|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
155539707|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
155539708|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
155539709|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
155539710|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
155539711|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
155539712|NCT00762411|561400385|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
155539713|NCT00762411|561400386|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
155539714|NCT02710214|561400390|FG000|Overall Study|Lost to Follow-up|1|||
155539715|NCT02710214|561400391|FG001|Overall Study|Lost to Follow-up|0|||
155539716|NCT02710214|561400390|FG000|Overall Study|Lack of Efficacy|0|||
155539717|NCT02710214|561400391|FG001|Overall Study|Lack of Efficacy|1|||
155539718|NCT02710214|561400390|FG000|Overall Study|Death|0|||
155539719|NCT02710214|561400391|FG001|Overall Study|Death|1|||
155539720|NCT02832167|561400392|FG000|Treatment Period 1|Disease progression|90|||
155539721|NCT02832167|561400392|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
155539722|NCT02832167|561400392|FG000|Treatment Period 1|Death|2|||
155539723|NCT02832167|561400392|FG000|Treatment Period 1|Study Drug Toxicity|6|||
155539724|NCT02832167|561400392|FG000|Treatment Period 1|Participant request to discontinue|9|||
155539725|NCT02832167|561400392|FG000|Treatment Period 1|No longer meet study criteria|1|||
155539726|NCT02832167|561400392|FG000|Treatment Period 1|Participant withdrew consent|3|||
155539727|NCT02832167|561400392|FG000|Treatment Period 1|Other reasons|6|||
155539728|NCT02832167|561400392|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
155539729|NCT02832167|561400392|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
155539730|NCT02832167|561400392|FG000|Transition From Period 1 to Period 2|Death|2|||
155539731|NCT02832167|561400392|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
155539732|NCT02832167|561400392|FG000|Treatment Period 2|Disease progression|69|||
155539733|NCT02832167|561400392|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
155539734|NCT02832167|561400392|FG000|Treatment Period 2|Maximum clinical benefit|1|||
155539735|NCT02832167|561400392|FG000|Treatment Period 2|Study Drug Toxicity|5|||
155539736|NCT02832167|561400392|FG000|Treatment Period 2|Participant request to discontinue|2|||
155539737|NCT02832167|561400392|FG000|Treatment Period 2|Participant withdrew consent|3|||
155539738|NCT02832167|561400392|FG000|Treatment Period 2|Other reasons|3|||
155539739|NCT01754376|561400393|FG000|Overall Study|Adverse Event|1|||
155539740|NCT01754376|561400393|FG000|Overall Study|Lack of Efficacy|2|||
155539741|NCT04556734|561400394|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
155539742|NCT04556734|561400395|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155539743|NCT04556734|561400396|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
155539744|NCT04556734|561400397|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155539745|NCT04556734|561400398|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155539746|NCT04556734|561400399|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155539747|NCT04556734|561400400|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155539748|NCT04556734|561400401|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155539749|NCT04556734|561400394|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
155539750|NCT04556734|561400395|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539751|NCT04556734|561400396|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539752|NCT04556734|561400397|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539753|NCT04556734|561400398|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539754|NCT04556734|561400399|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539755|NCT04556734|561400400|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539756|NCT04556734|561400401|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155539757|NCT04556734|561400394|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155539758|NCT04556734|561400395|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539759|NCT04556734|561400396|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155539760|NCT04556734|561400397|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539761|NCT04556734|561400398|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539762|NCT04556734|561400399|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539763|NCT04556734|561400400|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539764|NCT04556734|561400401|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155539765|NCT04556734|561400394|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
155539766|NCT04556734|561400395|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539767|NCT04556734|561400396|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539768|NCT04556734|561400397|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539769|NCT04556734|561400398|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539770|NCT04556734|561400399|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539771|NCT04556734|561400400|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539772|NCT04556734|561400401|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155539773|NCT04556734|561400394|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539774|NCT04556734|561400395|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539775|NCT04556734|561400396|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
155539776|NCT04556734|561400397|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539777|NCT04556734|561400398|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539778|NCT04556734|561400399|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539779|NCT04556734|561400400|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539780|NCT04556734|561400401|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
155539781|NCT04556734|561400394|FG000|OLE Period (28 Weeks)|Not reported|0|||
155539782|NCT04556734|561400395|FG001|OLE Period (28 Weeks)|Not reported|0|||
155539783|NCT04556734|561400396|FG002|OLE Period (28 Weeks)|Not reported|0|||
155539784|NCT04556734|561400397|FG003|OLE Period (28 Weeks)|Not reported|0|||
155539785|NCT04556734|561400398|FG004|OLE Period (28 Weeks)|Not reported|0|||
155539786|NCT04556734|561400399|FG005|OLE Period (28 Weeks)|Not reported|1|||
155539787|NCT04556734|561400400|FG006|OLE Period (28 Weeks)|Not reported|0|||
155539788|NCT04556734|561400401|FG007|OLE Period (28 Weeks)|Not reported|0|||
155539789|NCT04556734|561400394|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539790|NCT04556734|561400395|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539791|NCT04556734|561400396|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539792|NCT04556734|561400397|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539793|NCT04556734|561400398|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539794|NCT04556734|561400399|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539795|NCT04556734|561400400|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155539796|NCT04556734|561400401|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
155539797|NCT04556734|561400394|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
155539798|NCT04556734|561400395|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
155539799|NCT04556734|561400396|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
155539800|NCT04556734|561400397|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
155539801|NCT04556734|561400398|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
155487826|NCT02058966|561208320|FG000|Open-Label Methamphetamine|Adverse Event|1|||
155487827|NCT02058966|561208320|FG000|First Intervention|Withdrawal by Subject|1|||
155487828|NCT02993731|561208321|FG000|Overall Study|Study Termination|101|||
155487829|NCT02993731|561208322|FG001|Overall Study|Study Termination|105|||
155487830|NCT01265511|561208323|FG000|Overall Study|Lack of Efficacy|2|||
155487831|NCT01265511|561208324|FG001|Overall Study|Lack of Efficacy|1|||
155487832|NCT01265511|561208323|FG000|Overall Study|Met stopping rules|0|||
155487833|NCT01265511|561208324|FG001|Overall Study|Met stopping rules|2|||
155487834|NCT01362062|561208325|FG000|Overall Study|Adverse Event|1|||
155487835|NCT01362062|561208326|FG001|Overall Study|Adverse Event|0|||
155487836|NCT01362062|561208325|FG000|Overall Study|Lost to Follow-up|11|||
155487837|NCT01362062|561208326|FG001|Overall Study|Lost to Follow-up|0|||
155487838|NCT01362062|561208325|FG000|Overall Study|Withdrawal by Subject|2|||
155487839|NCT01362062|561208326|FG001|Overall Study|Withdrawal by Subject|0|||
155487840|NCT01362062|561208325|FG000|Overall Study|Non-compliant participant|2|||
155487841|NCT01362062|561208326|FG001|Overall Study|Non-compliant participant|0|||
155487842|NCT01362062|561208325|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
155487843|NCT01362062|561208326|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
155487844|NCT01362062|561208325|FG000|Overall Study|Had significant improvement|9|||
155487845|NCT01362062|561208326|FG001|Overall Study|Had significant improvement|0|||
155487846|NCT02545504|561208328|FG000|Overall Study|Death|174|||
155487847|NCT02545504|561208329|FG001|Overall Study|Death|168|||
155487848|NCT02545504|561208328|FG000|Overall Study|Unknown reason|30|||
155487849|NCT02545504|561208329|FG001|Overall Study|Unknown reason|32|||
155487850|NCT02545504|561208328|FG000|Overall Study|Withdrew consent|9|||
155487851|NCT02545504|561208329|FG001|Overall Study|Withdrew consent|11|||
155487852|NCT02545504|561208328|FG000|Overall Study|Investigator's discretion|3|||
155487853|NCT02545504|561208329|FG001|Overall Study|Investigator's discretion|1|||
155487854|NCT02545504|561208328|FG000|Overall Study|Lost to Follow-up|2|||
155487855|NCT02545504|561208329|FG001|Overall Study|Lost to Follow-up|2|||
155487856|NCT00758394|561208332|FG000|2nd Intervention Order|Lost to Follow-up|0|||
155487857|NCT00758394|561208333|FG001|2nd Intervention Order|Lost to Follow-up|1|||
155487858|NCT00758394|561208334|FG002|2nd Intervention Order|Lost to Follow-up|0|||
155487859|NCT00758394|561208335|FG003|2nd Intervention Order|Lost to Follow-up|0|||
155487860|NCT00758394|561208332|FG000|3rd Intervention|Lost to Follow-up|1|||
155487861|NCT00758394|561208333|FG001|3rd Intervention|Lost to Follow-up|0|||
155487862|NCT00758394|561208334|FG002|3rd Intervention|Lost to Follow-up|0|||
155487863|NCT00758394|561208335|FG003|3rd Intervention|Lost to Follow-up|1|||
155487864|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
155487865|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
155487866|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
155487867|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
155487868|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
155487869|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
155487870|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
155487871|NCT00950755|561208341|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
155487872|NCT00950755|561208341|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
155487873|NCT00950755|561208341|FG000|Long-Term Follow-Up|Death|8|||
155487874|NCT00508820|561208342|FG000|Overall Study|Adverse Event|6|||
155487875|NCT00508820|561208343|FG001|Overall Study|Adverse Event|10|||
155487876|NCT00508820|561208342|FG000|Overall Study|Death|6|||
155487877|NCT00508820|561208343|FG001|Overall Study|Death|8|||
155487878|NCT00508820|561208342|FG000|Overall Study|Lost to Follow-up|1|||
155487879|NCT00508820|561208343|FG001|Overall Study|Lost to Follow-up|1|||
155487880|NCT00508820|561208342|FG000|Overall Study|Physician Decision|8|||
155487881|NCT00508820|561208343|FG001|Overall Study|Physician Decision|2|||
155487882|NCT00508820|561208342|FG000|Overall Study|Pregnancy|0|||
155487883|NCT00508820|561208343|FG001|Overall Study|Pregnancy|2|||
155487884|NCT00508820|561208342|FG000|Overall Study|Protocol Violation|2|||
155487885|NCT00508820|561208343|FG001|Overall Study|Protocol Violation|0|||
155487886|NCT00508820|561208342|FG000|Overall Study|Withdrawal by Subject|10|||
155487887|NCT00508820|561208343|FG001|Overall Study|Withdrawal by Subject|12|||
155487888|NCT00508820|561208342|FG000|Overall Study|Other|11|||
155487889|NCT00508820|561208343|FG001|Overall Study|Other|2|||
155487890|NCT00508820|561208342|FG000|Overall Study|Noncompliance|1|||
155487891|NCT00508820|561208343|FG001|Overall Study|Noncompliance|0|||
155487892|NCT00508820|561208342|FG000|Overall Study|Requirement for alternative therapy|7|||
155487893|NCT00508820|561208343|FG001|Overall Study|Requirement for alternative therapy|15|||
155487894|NCT00508820|561208342|FG000|Overall Study|Protocol-specified Criteria|3|||
155487895|NCT00508820|561208343|FG001|Overall Study|Protocol-specified Criteria|12|||
155487896|NCT01002573|561209742|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
155487897|NCT01002573|561209743|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
155487898|NCT00690612|561209744|FG000|Overall Study|Adverse Event|1|||
155487899|NCT00690612|561209744|FG000|Overall Study|Withdrawal by Subject|2|||
155487900|NCT02926833|561209745|FG000|Overall Study|Death|1|||
155487901|NCT02926833|561209746|FG001|Overall Study|Death|1|||
155539802|NCT04556734|561400399|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
155539803|NCT04556734|561400400|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
155539804|NCT04556734|561400401|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
155539805|NCT04556734|561400394|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155539806|NCT04556734|561400395|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155539807|NCT04556734|561400396|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155539808|NCT04556734|561400397|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
155539809|NCT04556734|561400398|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
155539810|NCT04556734|561400399|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
155539811|NCT04556734|561400400|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
155539812|NCT04556734|561400401|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
155539813|NCT04264819|561400407|FG000|Overall Study|Physician Decision|19|||
155539814|NCT04264819|561400407|FG000|Overall Study|Adverse Event|12|||
155539815|NCT04264819|561400407|FG000|Overall Study|Withdrawal by Subject|11|||
155539816|NCT04264819|561400407|FG000|Overall Study|Lost to Follow-up|2|||
155539817|NCT04264819|561400407|FG000|Overall Study|Death|2|||
155539818|NCT01662024|561400414|FG000|Overall Study|Pregnancy|2|||
155539819|NCT01662024|561400414|FG000|Overall Study|Withdrawal by Subject|3|||
155539820|NCT00108628|561400415|FG000|Overall Study|Withdrawal by Subject|17|||
155539821|NCT00108628|561400416|FG001|Overall Study|Withdrawal by Subject|9|||
155539822|NCT00108628|561400415|FG000|Overall Study|Lack of Efficacy|2|||
155539823|NCT00108628|561400416|FG001|Overall Study|Lack of Efficacy|1|||
155539824|NCT00108628|561400415|FG000|Overall Study|Death|1|||
155539825|NCT00108628|561400416|FG001|Overall Study|Death|0|||
155539826|NCT01151280|561400419|FG000|Overall Study|Adverse Event|1|||
155539827|NCT01151280|561400419|FG000|Overall Study|Lack of Efficacy|3|||
155539828|NCT02435433|561400420|FG000|Overall Study|Withdrawal by Subject|2|||
155539829|NCT02435433|561400421|FG001|Overall Study|Withdrawal by Subject|3|||
155539830|NCT02435433|561400422|FG002|Overall Study|Withdrawal by Subject|1|||
155539831|NCT02435433|561400423|FG003|Overall Study|Withdrawal by Subject|0|||
155539832|NCT02435433|561400424|FG004|Overall Study|Withdrawal by Subject|0|||
155539833|NCT02435433|561400420|FG000|Overall Study|Lost to Follow-up|2|||
155539834|NCT02435433|561400421|FG001|Overall Study|Lost to Follow-up|2|||
155539835|NCT02435433|561400422|FG002|Overall Study|Lost to Follow-up|4|||
155539836|NCT02435433|561400423|FG003|Overall Study|Lost to Follow-up|1|||
155539837|NCT02435433|561400424|FG004|Overall Study|Lost to Follow-up|0|||
155656099|NCT03427619|561835124|FG000|Overall Study|Physician Decision|3|||
155656100|NCT03427619|561835124|FG000|Overall Study|Withdrawal by Subject|4|||
155656101|NCT03427619|561835124|FG000|Overall Study|Lost to Follow-up|5|||
155656102|NCT03427619|561835124|FG000|Overall Study|Administrative|4|||
155656103|NCT03427619|561835124|FG000|Overall Study|Other|2|||
155656104|NCT03427619|561835124|FG000|Overall Study|Unknown or Missing Completion Status|48|||
155656105|NCT02853136|561835125|FG000|Wash-out|Adverse Event|0|||
155656106|NCT02853136|561835126|FG001|Wash-out|Adverse Event|0|||
155656107|NCT02853136|561835127|FG002|Wash-out|Adverse Event|0|||
155539838|NCT02460835|561400434|FG000|Overall Study|Disease progression prior to treatment|3|||
155539839|NCT02460835|561400434|FG000|Overall Study|Unable to complete planning scans|2|||
155539840|NCT02460835|561400434|FG000|Overall Study|Decrease in performance status|1|||
155539841|NCT02460835|561400434|FG000|Overall Study|Withdrawal by Subject|3|||
155539842|NCT02460835|561400434|FG000|Overall Study|Underwent fractionated RT|10|||
155539843|NCT02460835|561400434|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
155539844|NCT02483416|561400438|FG000|Overall Study|Other reason|0|||
155539845|NCT02483416|561400439|FG001|Overall Study|Other reason|1|||
155539846|NCT02483416|561400438|FG000|Overall Study|Treatment stop|3|||
155539847|NCT02483416|561400439|FG001|Overall Study|Treatment stop|0|||
155539848|NCT02587143|561400441|FG000|Overall Study|Adverse Event|1|||
155539849|NCT02587143|561400442|FG001|Overall Study|Adverse Event|0|||
155539850|NCT01119625|561400443|FG000|Overall Study|Lost to Follow-up|1|||
155539851|NCT01119625|561400444|FG001|Overall Study|Lost to Follow-up|2|||
155539852|NCT01119625|561400443|FG000|Overall Study|Withdrawal by Subject|2|||
155539853|NCT01119625|561400444|FG001|Overall Study|Withdrawal by Subject|1|||
155539854|NCT01119625|561400443|FG000|Overall Study|Other|0|||
155656108|NCT02853136|561835128|FG003|Wash-out|Adverse Event|1|||
155539855|NCT01119625|561400444|FG001|Overall Study|Other|1|||
155539856|NCT01721772|561400449|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
155539857|NCT01721772|561400450|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
155539858|NCT01721772|561400449|FG000|Pre-Treatment|Poor/non-compliance|0|||
155539859|NCT01721772|561400450|FG001|Pre-Treatment|Poor/non-compliance|1|||
155539860|NCT01721772|561400449|FG000|Pre-Treatment|Participant withdrew consent|0|||
155539861|NCT01721772|561400450|FG001|Pre-Treatment|Participant withdrew consent|1|||
155539862|NCT01721772|561400449|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
155539863|NCT01721772|561400450|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
155539864|NCT01721772|561400449|FG000|Treatment|Disease progression|119|||
155539865|NCT01721772|561400450|FG001|Treatment|Disease progression|168|||
155539866|NCT01721772|561400449|FG000|Treatment|Study drug toxicity|19|||
155539867|NCT01721772|561400450|FG001|Treatment|Study drug toxicity|10|||
155539868|NCT01721772|561400449|FG000|Treatment|Adverse event unrelated to study drug|7|||
155539869|NCT01721772|561400450|FG001|Treatment|Adverse event unrelated to study drug|7|||
155539870|NCT01721772|561400449|FG000|Treatment|Maximum clinical benefit|16|||
155539871|NCT01721772|561400450|FG001|Treatment|Maximum clinical benefit|4|||
155539872|NCT01721772|561400449|FG000|Treatment|Other|19|||
155539873|NCT01721772|561400450|FG001|Treatment|Other|2|||
155539874|NCT01721772|561400449|FG000|Treatment|Participant withdrew consent|2|||
155539875|NCT01721772|561400450|FG001|Treatment|Participant withdrew consent|5|||
155539876|NCT01721772|561400449|FG000|Treatment|Participant request to discontinue study treatment|21|||
155539877|NCT01721772|561400450|FG001|Treatment|Participant request to discontinue study treatment|8|||
155539878|NCT01721772|561400449|FG000|Treatment|Death|1|||
155539879|NCT01721772|561400450|FG001|Treatment|Death|0|||
155539880|NCT01721772|561400449|FG000|Treatment|Not reported|1|||
155539881|NCT01721772|561400450|FG001|Treatment|Not reported|0|||
155539882|NCT01721772|561400449|FG000|Treatment|Poor/non-compliance|1|||
155539883|NCT01721772|561400450|FG001|Treatment|Poor/non-compliance|0|||
155539884|NCT01721772|561400449|FG000|Treatment|Lost to Follow-up|0|||
155539885|NCT01721772|561400450|FG001|Treatment|Lost to Follow-up|1|||
155539886|NCT04542694|561400451|FG000|Overall Study|The need for prohibited therapy|2|||
155539887|NCT04542694|561400452|FG001|Overall Study|The need for prohibited therapy|0|||
155539888|NCT04542694|561400451|FG000|Overall Study|Adverse Event|1|||
155539889|NCT04542694|561400452|FG001|Overall Study|Adverse Event|0|||
155539890|NCT04542694|561400451|FG000|Overall Study|Protocol Violation|1|||
155539891|NCT04542694|561400452|FG001|Overall Study|Protocol Violation|0|||
155539892|NCT00969124|561400453|FG000|Overall Study|Protocol Violation|2|||
155539893|NCT00969124|561400453|FG000|Overall Study|Inadequate bowel preparation|15|||
155539894|NCT00969124|561400453|FG000|Overall Study|Inability to reach cecum|9|||
155539895|NCT00969124|561400453|FG000|Overall Study|Previously unrecognized disease|3|||
155539896|NCT00969124|561400453|FG000|Overall Study|Technical error|1|||
155539897|NCT00210639|561400454|FG000|Overall Study|Lost to Follow-up|37|||
155539898|NCT00210639|561400455|FG001|Overall Study|Lost to Follow-up|29|||
155539899|NCT00210639|561400454|FG000|Overall Study|Withdrawal by Subject|8|||
155539900|NCT00210639|561400455|FG001|Overall Study|Withdrawal by Subject|1|||
155539901|NCT00210639|561400454|FG000|Overall Study|Other|18|||
155539902|NCT00210639|561400455|FG001|Overall Study|Other|12|||
155539903|NCT00743145|561400458|FG000|Overall Study|Withdrawal by Subject|1|||
155539904|NCT00743145|561400458|FG000|Overall Study|Adverse Event|2|||
155539905|NCT00743145|561400458|FG000|Overall Study|Pregnancy|1|||
155539906|NCT01211262|561400460|FG000|Overall Study|Progressive Disease|18|||
155539907|NCT01211262|561400461|FG001|Overall Study|Progressive Disease|9|||
155539908|NCT01211262|561400460|FG000|Overall Study|Adverse Event|4|||
155539909|NCT01211262|561400461|FG001|Overall Study|Adverse Event|0|||
155539910|NCT01211262|561400460|FG000|Overall Study|Withdrawal of Consent|1|||
155539911|NCT01211262|561400461|FG001|Overall Study|Withdrawal of Consent|0|||
155539912|NCT01211262|561400460|FG000|Overall Study|Other|0|||
155539913|NCT01211262|561400461|FG001|Overall Study|Other|1|||
155539914|NCT01277510|561400462|FG000|Double-blind Phase|Non-compliance|0|||
155539915|NCT01277510|561400463|FG001|Double-blind Phase|Non-compliance|1|||
155539916|NCT01277510|561400462|FG000|Double-blind Phase|Adverse Event|1|||
155539917|NCT01277510|561400463|FG001|Double-blind Phase|Adverse Event|0|||
155539918|NCT01277510|561400462|FG000|Double-blind Phase|Withdrawal by Subject|2|||
155539919|NCT01277510|561400463|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155539920|NCT01277510|561400462|FG000|Double-blind Phase|Administrative decision|7|||
155539921|NCT01277510|561400463|FG001|Double-blind Phase|Administrative decision|9|||
155539922|NCT01277510|561400462|FG000|Double-blind Phase|Death|0|||
155539923|NCT01277510|561400463|FG001|Double-blind Phase|Death|1|||
155539924|NCT01277510|561400462|FG000|Double-blind Phase|Protocol-specified criteria|2|||
155539925|NCT01277510|561400463|FG001|Double-blind Phase|Protocol-specified criteria|6|||
155539926|NCT01277510|561400462|FG000|Double-blind Phase|Other|1|||
155539927|NCT01277510|561400463|FG001|Double-blind Phase|Other|1|||
155539928|NCT01277510|561400462|FG000|Open-label Phase|Administrative decision|4|||
155539929|NCT01277510|561400463|FG001|Open-label Phase|Administrative decision|3|||
155539930|NCT01277510|561400462|FG000|Open-label Phase|Protocol-specified criteria|1|||
155539931|NCT01277510|561400463|FG001|Open-label Phase|Protocol-specified criteria|0|||
155539932|NCT01277510|561400462|FG000|Open-label Phase|Never received investigational product|2|||
155539933|NCT01277510|561400463|FG001|Open-label Phase|Never received investigational product|0|||
155539934|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
155539935|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
155539936|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
155539937|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
155656109|NCT00605189|561835129|FG000|Overall Study|Adverse Event|1|||
155656110|NCT00605189|561835130|FG001|Overall Study|Adverse Event|0|||
155656111|NCT00605189|561835131|FG002|Overall Study|Adverse Event|0|||
155656112|NCT00605189|561835129|FG000|Overall Study|Other|2|||
155656113|NCT00605189|561835130|FG001|Overall Study|Other|2|||
155656114|NCT00605189|561835131|FG002|Overall Study|Other|0|||
155656115|NCT02697448|561835132|FG000|Overall Study|Protocol Violation|2|||
155656116|NCT02697448|561835133|FG001|Overall Study|Protocol Violation|4|||
155539938|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|Death|3|||
155539939|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|Death|1|||
155539940|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
155539941|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
155539942|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
155539943|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
155539944|NCT00537095|561400465|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
155539945|NCT00537095|561400466|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
155539946|NCT00537095|561400465|FG000|Open-label Period (590 Days)|Adverse Event|2|||
155539947|NCT00537095|561400466|FG001|Open-label Period (590 Days)|Adverse Event|11|||
155539948|NCT00537095|561400465|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
155539949|NCT00537095|561400466|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
155539950|NCT00537095|561400465|FG000|Open-label Period (590 Days)|Death|2|||
155539951|NCT00537095|561400466|FG001|Open-label Period (590 Days)|Death|2|||
155539952|NCT00537095|561400465|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
155539953|NCT00537095|561400466|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
155539954|NCT00537095|561400465|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
155539955|NCT00537095|561400466|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
155539956|NCT00021541|561400467|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
155539957|NCT00021541|561400468|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
155539958|NCT00021541|561400467|FG000|Period 1-First Treatment|Adverse Event|2|||
155539959|NCT00021541|561400468|FG001|Period 1-First Treatment|Adverse Event|1|||
155539960|NCT00021541|561400467|FG000|Period 1-First Treatment|non-adherence|3|||
155539961|NCT00021541|561400468|FG001|Period 1-First Treatment|non-adherence|0|||
155539962|NCT00021541|561400467|FG000|Period 1-First Treatment|Death|1|||
155539963|NCT00021541|561400468|FG001|Period 1-First Treatment|Death|0|||
155539964|NCT00021541|561400467|FG000|Period 1-First Treatment|Pts that did not progress|2|||
155539965|NCT00021541|561400468|FG001|Period 1-First Treatment|Pts that did not progress|2|||
155539966|NCT00021541|561400467|FG000|Period 1-First Treatment|Ineligible|0|||
155539967|NCT00021541|561400468|FG001|Period 1-First Treatment|Ineligible|2|||
155539968|NCT00021541|561400467|FG000|Period 2-crossover|refused phase B|2|||
155539969|NCT00021541|561400468|FG001|Period 2-crossover|refused phase B|2|||
155539970|NCT00021541|561400467|FG000|Period 2-crossover|Withdrawal by Subject|3|||
155539971|NCT00021541|561400468|FG001|Period 2-crossover|Withdrawal by Subject|4|||
155539972|NCT00021541|561400467|FG000|Period 2-crossover|Adverse Event|2|||
155539973|NCT00021541|561400468|FG001|Period 2-crossover|Adverse Event|2|||
155539974|NCT00021541|561400467|FG000|Period 2-crossover|non-adherence|1|||
155539975|NCT00021541|561400468|FG001|Period 2-crossover|non-adherence|0|||
155539976|NCT00021541|561400467|FG000|Period 2-crossover|Pts that did not progress|2|||
155539977|NCT00021541|561400468|FG001|Period 2-crossover|Pts that did not progress|3|||
155539978|NCT01874535|561400469|FG000|Overall Study|Lost to Follow-up|10|||
155539979|NCT01874535|561400470|FG001|Overall Study|Lost to Follow-up|9|||
155539980|NCT01874535|561400469|FG000|Overall Study|incomplete symptom resolution|45|||
155539981|NCT01874535|561400470|FG001|Overall Study|incomplete symptom resolution|35|||
155539982|NCT05263505|561400471|FG000|Overall Study|Adverse Event|0|||
155539983|NCT05263505|561400472|FG001|Overall Study|Adverse Event|1|||
155539984|NCT02616380|561400473|FG000|Overall Study|Lost to Follow-up|1|||
155539985|NCT02616380|561400473|FG000|Overall Study|Other|2|||
155539986|NCT01929681|561400474|FG000|Overall Study|Withdrawal by Subject|1|||
155656117|NCT02697448|561835132|FG000|Overall Study|Clinical concerns during ablation|1|||
155656118|NCT02697448|561835133|FG001|Overall Study|Clinical concerns during ablation|1|||
155539987|NCT01929681|561400475|FG001|Overall Study|Withdrawal by Subject|0|||
155539988|NCT01929681|561400474|FG000|Overall Study|Physician Decision|1|||
155539989|NCT01929681|561400475|FG001|Overall Study|Physician Decision|1|||
155539990|NCT05315713|561400476|FG000|Overall Study|Death|5|||
155656119|NCT02697448|561835132|FG000|Overall Study|No data collected|2|||
155656120|NCT02697448|561835133|FG001|Overall Study|No data collected|0|||
155539991|NCT05315713|561400476|FG000|Overall Study|Progressive disease|1|||
155539992|NCT05315713|561400476|FG000|Overall Study|Withdrawal by Subject|1|||
155539993|NCT05315713|561400476|FG000|Overall Study|Study terminated by sponsor|1|||
155539994|NCT01528735|561400477|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
155539995|NCT01528735|561400478|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
155539996|NCT01528735|561400477|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
155539997|NCT01528735|561400478|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
155539998|NCT00556673|561400479|FG000|Overall Study|Protocol deviation|3|||
155539999|NCT00556673|561400480|FG001|Overall Study|Protocol deviation|2|||
155540000|NCT01717040|561400481|FG000|Overall Study|Lost to Follow-up|2|||
155540001|NCT01717040|561400482|FG001|Overall Study|Lost to Follow-up|3|||
155540002|NCT01717040|561400481|FG000|Overall Study|Lack of Efficacy|1|||
155540003|NCT01717040|561400482|FG001|Overall Study|Lack of Efficacy|1|||
155656121|NCT02919618|561835138|FG000|Overall Study|Death|1|||
155656122|NCT01674062|561835146|FG000|Overall Study|Insufficient Therapeutic Response|56|||
155656123|NCT01674062|561835147|FG001|Overall Study|Insufficient Therapeutic Response|26|||
155487902|NCT02926833|561209747|FG002|Overall Study|Death|2|||
155487903|NCT02926833|561209748|FG003|Overall Study|Death|13|||
155487904|NCT02926833|561209745|FG000|Overall Study|Lost to Follow-up|1|||
155487905|NCT02926833|561209746|FG001|Overall Study|Lost to Follow-up|2|||
155487906|NCT02926833|561209747|FG002|Overall Study|Lost to Follow-up|0|||
155487907|NCT02926833|561209748|FG003|Overall Study|Lost to Follow-up|3|||
155487908|NCT02926833|561209745|FG000|Overall Study|Full Consent Withdrawal|0|||
155487909|NCT02926833|561209746|FG001|Overall Study|Full Consent Withdrawal|0|||
155487910|NCT02926833|561209747|FG002|Overall Study|Full Consent Withdrawal|0|||
155487911|NCT02926833|561209748|FG003|Overall Study|Full Consent Withdrawal|2|||
155487912|NCT02926833|561209745|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
155487913|NCT02926833|561209746|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
155487914|NCT02926833|561209747|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
155487915|NCT02926833|561209748|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
155487916|NCT02926833|561209745|FG000|Overall Study|Investigator Decision|0|||
155487917|NCT02926833|561209746|FG001|Overall Study|Investigator Decision|1|||
155487918|NCT02926833|561209747|FG002|Overall Study|Investigator Decision|0|||
155487919|NCT02926833|561209748|FG003|Overall Study|Investigator Decision|0|||
155487920|NCT02926833|561209745|FG000|Overall Study|Adverse Event|0|||
155487921|NCT02926833|561209746|FG001|Overall Study|Adverse Event|0|||
155487922|NCT02926833|561209747|FG002|Overall Study|Adverse Event|1|||
155487923|NCT02926833|561209748|FG003|Overall Study|Adverse Event|0|||
155487924|NCT02926833|561209745|FG000|Overall Study|Partial Withdrawal of Consent|0|||
155487925|NCT02926833|561209746|FG001|Overall Study|Partial Withdrawal of Consent|0|||
155487926|NCT02926833|561209747|FG002|Overall Study|Partial Withdrawal of Consent|0|||
155487927|NCT02926833|561209748|FG003|Overall Study|Partial Withdrawal of Consent|1|||
155487928|NCT01945866|561209749|FG000|Overall Study|Eyes did not complete or were dropped|2|||
155487929|NCT01945866|561209750|FG001|Overall Study|Eyes did not complete or were dropped|0|||
155487930|NCT02930889|561209754|FG000|Overall Study|Lost to Follow-up|2|||
155487931|NCT02930889|561209754|FG000|Overall Study|Withdrawal by Subject|6|||
155487932|NCT02930889|561209754|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
155487933|NCT04398030|561209755|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
155487934|NCT04398030|561209756|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
155487935|NCT04398030|561209755|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
155487936|NCT04398030|561209756|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
155487937|NCT03799198|561209762|FG000|Overall Study|Lost to Follow-up|4|||
155487938|NCT03799198|561209763|FG001|Overall Study|Lost to Follow-up|8|||
155487939|NCT03799198|561209762|FG000|Overall Study|Death|0|||
155487940|NCT03799198|561209763|FG001|Overall Study|Death|1|||
155487941|NCT02501642|561209765|FG000|Overall Study|Lost to Follow-up|7|||
155487942|NCT02501642|561209766|FG001|Overall Study|Lost to Follow-up|11|||
155487943|NCT00548340|561209771|FG000|Overall Study|Protocol Violation|2|||
155487944|NCT00548340|561209772|FG001|Overall Study|Protocol Violation|3|||
155487945|NCT00548340|561209773|FG002|Overall Study|Protocol Violation|3|||
155487946|NCT00548340|561209771|FG000|Overall Study|Adverse Event|2|||
155487947|NCT00548340|561209772|FG001|Overall Study|Adverse Event|2|||
155487948|NCT00548340|561209773|FG002|Overall Study|Adverse Event|2|||
155487949|NCT00548340|561209771|FG000|Overall Study|Lost to Follow-up|1|||
155487950|NCT00548340|561209772|FG001|Overall Study|Lost to Follow-up|1|||
155487951|NCT00548340|561209773|FG002|Overall Study|Lost to Follow-up|0|||
155487952|NCT00548340|561209771|FG000|Overall Study|Withdrawal by Subject|2|||
155487953|NCT00548340|561209772|FG001|Overall Study|Withdrawal by Subject|4|||
155487954|NCT00548340|561209773|FG002|Overall Study|Withdrawal by Subject|3|||
155487955|NCT00548340|561209771|FG000|Overall Study|Other|1|||
155487956|NCT00548340|561209772|FG001|Overall Study|Other|1|||
155487957|NCT00548340|561209773|FG002|Overall Study|Other|1|||
155487958|NCT03410693|561209774|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
155487959|NCT03410693|561209775|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
155540004|NCT01717040|561400481|FG000|Overall Study|Adverse Event|1|||
155540005|NCT01717040|561400482|FG001|Overall Study|Adverse Event|0|||
155540006|NCT01717040|561400481|FG000|Overall Study|Required Medication Change|0|||
155540007|NCT01717040|561400482|FG001|Overall Study|Required Medication Change|1|||
155540008|NCT01717040|561400481|FG000|Overall Study|New Substance Use Disorder|1|||
155540009|NCT01717040|561400482|FG001|Overall Study|New Substance Use Disorder|0|||
155540010|NCT01596127|561400484|FG000|Overall Study|Patient Ineligible|1|||
155540011|NCT01566435|561400485|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
155540012|NCT00438633|561400486|FG000|Overall Study|Withdrawal by Subject|1|||
155540013|NCT00438633|561400487|FG001|Overall Study|Withdrawal by Subject|0|||
155540014|NCT00438633|561400486|FG000|Overall Study|Lost to Follow-up|15|||
155540015|NCT00438633|561400487|FG001|Overall Study|Lost to Follow-up|17|||
155540016|NCT00421304|561400488|FG000|Overall Study|Lost to Follow-up|5|||
155540017|NCT00421304|561400489|FG001|Overall Study|Lost to Follow-up|2|||
155540018|NCT00421304|561400490|FG002|Overall Study|Lost to Follow-up|5|||
155540019|NCT00421304|561400488|FG000|Overall Study|Withdrawal by Subject|2|||
155540020|NCT00421304|561400489|FG001|Overall Study|Withdrawal by Subject|2|||
155540021|NCT00421304|561400490|FG002|Overall Study|Withdrawal by Subject|2|||
155540022|NCT00421304|561400488|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
155540023|NCT00421304|561400489|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
155540024|NCT00421304|561400490|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
155540025|NCT00421304|561400488|FG000|Overall Study|Did not attend Day 360 visit|0|||
155540026|NCT00421304|561400489|FG001|Overall Study|Did not attend Day 360 visit|0|||
155540027|NCT00421304|561400490|FG002|Overall Study|Did not attend Day 360 visit|1|||
155540028|NCT03196284|561400491|FG000|Main Part|Withdrawal by Subject|0|||
155540029|NCT03196284|561400492|FG001|Main Part|Withdrawal by Subject|1|||
155540030|NCT03196284|561400493|FG002|Main Part|Withdrawal by Subject|0|||
155540031|NCT03196284|561400491|FG000|Extension Part|Lack of Efficacy|0|||
155540032|NCT03196284|561400492|FG001|Extension Part|Lack of Efficacy|0|||
155540033|NCT03196284|561400493|FG002|Extension Part|Lack of Efficacy|1|||
155540034|NCT03196284|561400491|FG000|Extension Part|Withdrawal by Subject|0|||
155540035|NCT03196284|561400492|FG001|Extension Part|Withdrawal by Subject|0|||
155540036|NCT03196284|561400493|FG002|Extension Part|Withdrawal by Subject|1|||
155540037|NCT03196284|561400491|FG000|Extension Part|Physician Decision|0|||
155540038|NCT03196284|561400492|FG001|Extension Part|Physician Decision|0|||
155540039|NCT03196284|561400493|FG002|Extension Part|Physician Decision|1|||
155540040|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Adverse Event|8|||
155540041|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Adverse Event|5|||
155540042|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Adverse Event|9|||
155540043|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Adverse Event|0|||
155540044|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Adverse Event|0|||
155540045|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Adverse Event|0|||
155540046|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
155540047|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
155540048|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
155540049|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
155540050|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
155540051|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
155656124|NCT01674062|561835146|FG000|Overall Study|Other|8|||
155656125|NCT01674062|561835147|FG001|Overall Study|Other|1|||
155656126|NCT01674062|561835146|FG000|Overall Study|Adverse Event|1|||
155656127|NCT01674062|561835147|FG001|Overall Study|Adverse Event|1|||
155656128|NCT01674062|561835146|FG000|Overall Study|Death|0|||
155656129|NCT01674062|561835147|FG001|Overall Study|Death|1|||
155656130|NCT01674062|561835146|FG000|Overall Study|Programming Error|1|||
155656131|NCT01674062|561835147|FG001|Overall Study|Programming Error|0|||
155656132|NCT03895372|561835148|FG000|Investigational Treatment Period|Adverse Event|1|||
155656133|NCT03895372|561835149|FG001|Investigational Treatment Period|Adverse Event|0|||
155656134|NCT03895372|561835150|FG002|Investigational Treatment Period|Adverse Event|0|||
155656135|NCT03895372|561835151|FG003|Investigational Treatment Period|Adverse Event|0|||
155656136|NCT03895372|561835152|FG004|Investigational Treatment Period|Adverse Event|0|||
155656137|NCT03895372|561835153|FG005|Investigational Treatment Period|Adverse Event|0|||
155540052|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
155540053|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
155540054|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
155540055|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
155656138|NCT03895372|561835154|FG006|Investigational Treatment Period|Adverse Event|4|||
155540056|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
155540057|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
155540058|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Physician Decision|4|||
155540059|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Physician Decision|0|||
155540060|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Physician Decision|2|||
155540061|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Physician Decision|0|||
155540062|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Physician Decision|0|||
155540063|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Physician Decision|0|||
155540064|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Pregnancy|1|||
155540065|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Pregnancy|2|||
155540066|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Pregnancy|0|||
155540067|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Pregnancy|0|||
155540068|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Pregnancy|0|||
155540069|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Pregnancy|0|||
155540070|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
155540071|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
155540072|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
155540073|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
155540074|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
155540075|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
155540076|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
155540077|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
155540078|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
155540079|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
155540080|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
155540081|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
155540082|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
155540083|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
155540084|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
155540085|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
155540086|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155540087|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155540088|NCT02614196|561400494|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
155540089|NCT02614196|561400495|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
155540090|NCT02614196|561400496|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
155540091|NCT02614196|561400497|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
155540092|NCT02614196|561400498|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
155540093|NCT02614196|561400499|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
155540094|NCT02614196|561400494|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
155540095|NCT02614196|561400495|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
155540096|NCT02614196|561400496|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
155540097|NCT02614196|561400497|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
155540098|NCT02614196|561400498|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
155540099|NCT02614196|561400499|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
155540100|NCT02614196|561400494|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
155540101|NCT02614196|561400495|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
155540102|NCT02614196|561400496|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
155540103|NCT02614196|561400497|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
155540104|NCT02614196|561400498|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
155540105|NCT02614196|561400499|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
155540106|NCT02614196|561400494|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
155540107|NCT02614196|561400495|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
155540108|NCT02614196|561400496|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
155540109|NCT02614196|561400497|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
155540110|NCT02614196|561400498|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
155540111|NCT02614196|561400499|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
155540112|NCT02614196|561400494|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
155540113|NCT02614196|561400495|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
155540114|NCT02614196|561400496|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
155540115|NCT02614196|561400497|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
155540116|NCT02614196|561400498|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
155540117|NCT02614196|561400499|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
155540118|NCT00919711|561400500|FG000|Overall Study|Withdrawal by Subject|15|||
155540119|NCT00919711|561400501|FG001|Overall Study|Withdrawal by Subject|7|||
155540120|NCT00919711|561400500|FG000|Overall Study|Adverse Event|13|||
155540121|NCT00919711|561400501|FG001|Overall Study|Adverse Event|3|||
155540122|NCT00919711|561400500|FG000|Overall Study|Other|1|||
155540123|NCT00919711|561400501|FG001|Overall Study|Other|2|||
155540124|NCT00919711|561400500|FG000|Overall Study|Administrative Decision|0|||
155540125|NCT00919711|561400501|FG001|Overall Study|Administrative Decision|1|||
155540126|NCT00919711|561400500|FG000|Overall Study|Lost to Follow-up|2|||
155540127|NCT00919711|561400501|FG001|Overall Study|Lost to Follow-up|0|||
155540128|NCT00919711|561400500|FG000|Overall Study|Death|1|||
155540129|NCT00919711|561400501|FG001|Overall Study|Death|0|||
155540130|NCT00919711|561400500|FG000|Overall Study|Noncompliance|1|||
155540131|NCT00919711|561400501|FG001|Overall Study|Noncompliance|0|||
155540132|NCT00087529|561400503|FG000|Overall Study|Death|1|||
155656139|NCT03895372|561835155|FG007|Investigational Treatment Period|Adverse Event|3|||
155540133|NCT00087529|561400504|FG001|Overall Study|Death|0|||
155540134|NCT00087529|561400503|FG000|Overall Study|Adverse Event|0|||
155540135|NCT00087529|561400504|FG001|Overall Study|Adverse Event|8|||
155540136|NCT00087529|561400503|FG000|Overall Study|Pregnancy|0|||
155540137|NCT00087529|561400504|FG001|Overall Study|Pregnancy|1|||
155540138|NCT00087529|561400503|FG000|Overall Study|Lost to Follow-up|2|||
155540139|NCT00087529|561400504|FG001|Overall Study|Lost to Follow-up|3|||
155540140|NCT00087529|561400503|FG000|Overall Study|Participant Decision|14|||
155540141|NCT00087529|561400504|FG001|Overall Study|Participant Decision|37|||
155540142|NCT00087529|561400503|FG000|Overall Study|Physician Decision|4|||
155540143|NCT00087529|561400504|FG001|Overall Study|Physician Decision|8|||
155540144|NCT00087529|561400503|FG000|Overall Study|Initiation of Excluded Therapy|0|||
155540145|NCT00087529|561400504|FG001|Overall Study|Initiation of Excluded Therapy|1|||
155540146|NCT00087529|561400503|FG000|Overall Study|Participant Noncompliance|0|||
155540147|NCT00087529|561400504|FG001|Overall Study|Participant Noncompliance|1|||
155540148|NCT00087529|561400503|FG000|Overall Study|Disease Progression|5|||
155540149|NCT00087529|561400504|FG001|Overall Study|Disease Progression|4|||
155540150|NCT00087529|561400503|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
155540151|NCT00087529|561400504|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
155540152|NCT01562613|561400505|FG000|Overall Study|Lost to Follow-up|2|||
155540153|NCT01562613|561400505|FG000|Overall Study|Withdrawal by Subject|2|||
155540154|NCT04388787|561400506|FG000|Blinded Period|Patient could not follow instructions|1|||
155540155|NCT04388787|561400506|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
155540156|NCT00663234|561400507|FG000|Overall Study|Not willing to adhere to requirements|1|||
155540157|NCT01253564|561400510|FG000|Overall Study|Disease Progression|22|||
155540158|NCT01253564|561400510|FG000|Overall Study|Withdrawal by Subject|1|||
155540159|NCT01253564|561400510|FG000|Overall Study|Serious Adverse Event|1|||
155540160|NCT03694197|561400513|FG000|Overall Study|Adverse Event|9|||
155540161|NCT03694197|561400513|FG000|Overall Study|Protocol became inconvenient to participate|1|||
155540162|NCT03694197|561400513|FG000|Overall Study|Physician Decision|4|||
155540163|NCT03694197|561400513|FG000|Overall Study|Study terminated by sponsor|1350|||
155540164|NCT03694197|561400513|FG000|Overall Study|Participant moved|5|||
155540165|NCT03694197|561400513|FG000|Overall Study|Participant withdrew consent|10|||
155540166|NCT03694197|561400513|FG000|Overall Study|Related to IMP administration|1|||
155540167|NCT03694197|561400513|FG000|Overall Study|Not disclosed|5|||
155540168|NCT02940522|561402295|FG000|Overall Study|Lost to Follow-up|1|||
155540169|NCT02940522|561402296|FG001|Overall Study|Lost to Follow-up|2|||
155540170|NCT02940522|561402295|FG000|Overall Study|Withdrawal by Subject|1|||
155540171|NCT02940522|561402296|FG001|Overall Study|Withdrawal by Subject|0|||
155540172|NCT05135273|561402297|FG000|Overall Study|Recruited into the army|0|||
155540173|NCT05135273|561402298|FG001|Overall Study|Recruited into the army|0|||
155540174|NCT05135273|561402299|FG002|Overall Study|Recruited into the army|0|||
155540175|NCT05135273|561402300|FG003|Overall Study|Recruited into the army|0|||
155540176|NCT05135273|561402301|FG004|Overall Study|Recruited into the army|1|||
155540177|NCT05135273|561402302|FG005|Overall Study|Recruited into the army|0|||
155540178|NCT05135273|561402303|FG006|Overall Study|Recruited into the army|0|||
155540179|NCT05135273|561402304|FG007|Overall Study|Recruited into the army|0|||
155540180|NCT05135273|561402297|FG000|Overall Study|Moved away from study site|0|||
155540181|NCT05135273|561402298|FG001|Overall Study|Moved away from study site|0|||
155540182|NCT05135273|561402299|FG002|Overall Study|Moved away from study site|0|||
155540183|NCT05135273|561402300|FG003|Overall Study|Moved away from study site|0|||
155540184|NCT05135273|561402301|FG004|Overall Study|Moved away from study site|0|||
155656140|NCT03895372|561835148|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
155656141|NCT03895372|561835149|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
155656142|NCT03895372|561835150|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
155656143|NCT03895372|561835151|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
155656144|NCT03895372|561835152|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
155540185|NCT05135273|561402302|FG005|Overall Study|Moved away from study site|1|||
155540186|NCT05135273|561402303|FG006|Overall Study|Moved away from study site|1|||
155540187|NCT05135273|561402304|FG007|Overall Study|Moved away from study site|0|||
155540188|NCT05135273|561402297|FG000|Overall Study|Travel|0|||
155540189|NCT05135273|561402298|FG001|Overall Study|Travel|0|||
155540190|NCT05135273|561402299|FG002|Overall Study|Travel|0|||
155540191|NCT05135273|561402300|FG003|Overall Study|Travel|0|||
155656145|NCT03895372|561835153|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
155540192|NCT05135273|561402301|FG004|Overall Study|Travel|0|||
155540193|NCT05135273|561402302|FG005|Overall Study|Travel|0|||
155540194|NCT05135273|561402303|FG006|Overall Study|Travel|0|||
155540195|NCT05135273|561402304|FG007|Overall Study|Travel|1|||
155540196|NCT01680016|561402305|FG000|Overall Study|Adverse Event|0|||
155540197|NCT01680016|561402306|FG001|Overall Study|Adverse Event|0|||
155540198|NCT01680016|561402307|FG002|Overall Study|Adverse Event|1|||
155540199|NCT01680016|561402308|FG003|Overall Study|Adverse Event|4|||
155540200|NCT01680016|561402305|FG000|Overall Study|The Subject went out of The Trial|1|||
155540201|NCT01680016|561402306|FG001|Overall Study|The Subject went out of The Trial|0|||
155540202|NCT01680016|561402307|FG002|Overall Study|The Subject went out of The Trial|3|||
155540203|NCT01680016|561402308|FG003|Overall Study|The Subject went out of The Trial|0|||
155540204|NCT01680016|561402305|FG000|Overall Study|Protocol Violation|0|||
155540205|NCT01680016|561402306|FG001|Overall Study|Protocol Violation|1|||
155540206|NCT01680016|561402307|FG002|Overall Study|Protocol Violation|0|||
155540207|NCT01680016|561402308|FG003|Overall Study|Protocol Violation|0|||
155540208|NCT01680016|561402305|FG000|Overall Study|Withdrawal by Subject|5|||
155540209|NCT01680016|561402306|FG001|Overall Study|Withdrawal by Subject|7|||
155540210|NCT01680016|561402307|FG002|Overall Study|Withdrawal by Subject|1|||
155540211|NCT01680016|561402308|FG003|Overall Study|Withdrawal by Subject|1|||
155540212|NCT01958060|561402312|FG000|Overall Study|Not treated|2|||
155540213|NCT01958060|561402313|FG001|Overall Study|Not treated|0|||
155540214|NCT01958060|561402314|FG002|Overall Study|Not treated|0|||
155540215|NCT01958060|561402315|FG003|Overall Study|Not treated|0|||
155540216|NCT01958060|561402316|FG004|Overall Study|Not treated|1|||
155540217|NCT01958060|561402317|FG005|Overall Study|Not treated|0|||
155540218|NCT04980456|561402323|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
155540219|NCT04980456|561402324|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
155540220|NCT04980456|561402323|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
155540221|NCT04980456|561402324|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
155540222|NCT04980456|561402323|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
155540223|NCT04980456|561402324|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
155540224|NCT04980456|561402323|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
155540225|NCT04980456|561402324|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
155540226|NCT02846883|561402327|FG000|Overall Study|Death|0|||
155540227|NCT02846883|561402328|FG001|Overall Study|Death|1|||
155540228|NCT02846883|561402329|FG002|Overall Study|Death|1|||
155540229|NCT02846883|561402327|FG000|Overall Study|Lost to Follow-up|0|||
155540230|NCT02846883|561402328|FG001|Overall Study|Lost to Follow-up|0|||
155540231|NCT02846883|561402329|FG002|Overall Study|Lost to Follow-up|1|||
155540232|NCT02846883|561402327|FG000|Overall Study|Withdrawal by Subject|1|||
155540233|NCT02846883|561402328|FG001|Overall Study|Withdrawal by Subject|0|||
155540234|NCT02846883|561402329|FG002|Overall Study|Withdrawal by Subject|0|||
155540235|NCT02846883|561402327|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
155540236|NCT02846883|561402328|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
155540237|NCT02846883|561402329|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
155540238|NCT02846883|561402327|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
155540239|NCT02846883|561402328|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
155540240|NCT02846883|561402329|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
155540241|NCT00927251|561402330|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
155540242|NCT00442351|561402334|FG000|Overall Study|Administrative|6|||
155540243|NCT00442351|561402335|FG001|Overall Study|Administrative|5|||
155540244|NCT00442351|561402334|FG000|Overall Study|Did not meet protocol eligibility|1|||
155540245|NCT00442351|561402335|FG001|Overall Study|Did not meet protocol eligibility|0|||
155540246|NCT00442351|561402334|FG000|Overall Study|Other|0|||
155540247|NCT00442351|561402335|FG001|Overall Study|Other|1|||
155540248|NCT01074008|561402343|FG000|Overall Study|Adverse Event|0|||
155540249|NCT01074008|561402344|FG001|Overall Study|Adverse Event|1|||
155540250|NCT01074008|561402345|FG002|Overall Study|Adverse Event|0|||
155540251|NCT01074008|561402346|FG003|Overall Study|Adverse Event|0|||
155540252|NCT01074008|561402347|FG004|Overall Study|Adverse Event|0|||
155540253|NCT01074008|561402348|FG005|Overall Study|Adverse Event|0|||
155540254|NCT01074008|561402349|FG006|Overall Study|Adverse Event|0|||
155540255|NCT01074008|561402350|FG007|Overall Study|Adverse Event|0|||
155540256|NCT01074008|561402351|FG008|Overall Study|Adverse Event|0|||
155540257|NCT01074008|561402343|FG000|Overall Study|Withdrawal by Subject|1|||
155540258|NCT01074008|561402344|FG001|Overall Study|Withdrawal by Subject|1|||
155540259|NCT01074008|561402345|FG002|Overall Study|Withdrawal by Subject|1|||
155540260|NCT01074008|561402346|FG003|Overall Study|Withdrawal by Subject|0|||
155540261|NCT01074008|561402347|FG004|Overall Study|Withdrawal by Subject|1|||
155540262|NCT01074008|561402348|FG005|Overall Study|Withdrawal by Subject|0|||
155540263|NCT01074008|561402349|FG006|Overall Study|Withdrawal by Subject|0|||
155540264|NCT01074008|561402350|FG007|Overall Study|Withdrawal by Subject|0|||
155540265|NCT01074008|561402351|FG008|Overall Study|Withdrawal by Subject|0|||
155540266|NCT01074008|561402343|FG000|Overall Study|Lost to Follow-up|0|||
155540267|NCT01074008|561402344|FG001|Overall Study|Lost to Follow-up|1|||
155540268|NCT01074008|561402345|FG002|Overall Study|Lost to Follow-up|1|||
155540269|NCT01074008|561402346|FG003|Overall Study|Lost to Follow-up|1|||
155540270|NCT01074008|561402347|FG004|Overall Study|Lost to Follow-up|1|||
155540271|NCT01074008|561402348|FG005|Overall Study|Lost to Follow-up|0|||
155540272|NCT01074008|561402349|FG006|Overall Study|Lost to Follow-up|1|||
155540273|NCT01074008|561402350|FG007|Overall Study|Lost to Follow-up|0|||
155540274|NCT01074008|561402351|FG008|Overall Study|Lost to Follow-up|4|||
155540275|NCT01453153|561402361|FG000|Overall Study|Physician Decision|0|||
155540276|NCT01453153|561402362|FG001|Overall Study|Physician Decision|0|||
155540277|NCT01453153|561402363|FG002|Overall Study|Physician Decision|1|||
155540278|NCT01453153|561402361|FG000|Overall Study|Progressive Disease|3|||
155540279|NCT01453153|561402362|FG001|Overall Study|Progressive Disease|2|||
155540280|NCT01453153|561402363|FG002|Overall Study|Progressive Disease|16|||
155540281|NCT01453153|561402361|FG000|Overall Study|Withdrawal by Subject|0|||
155540282|NCT01453153|561402362|FG001|Overall Study|Withdrawal by Subject|1|||
155540283|NCT01453153|561402363|FG002|Overall Study|Withdrawal by Subject|2|||
155540284|NCT01453153|561402361|FG000|Overall Study|Adverse Event|1|||
155540285|NCT01453153|561402362|FG001|Overall Study|Adverse Event|1|||
155540286|NCT01453153|561402363|FG002|Overall Study|Adverse Event|1|||
155540287|NCT01350934|561402364|FG000|Base Study|Adverse Event|6|||
155540288|NCT01350934|561402365|FG001|Base Study|Adverse Event|0|||
155540289|NCT01350934|561402364|FG000|Base Study|Lost to Follow-up|1|||
155540290|NCT01350934|561402365|FG001|Base Study|Lost to Follow-up|0|||
155540291|NCT01350934|561402364|FG000|Base Study|Protocol Violation|1|||
155540292|NCT01350934|561402365|FG001|Base Study|Protocol Violation|1|||
155540293|NCT01350934|561402364|FG000|Base Study|Withdrawal by Subject|1|||
155540294|NCT01350934|561402365|FG001|Base Study|Withdrawal by Subject|2|||
155540295|NCT01350934|561402364|FG000|Base Study|Non-Compliance With Study Drug|2|||
155540296|NCT01350934|561402365|FG001|Base Study|Non-Compliance With Study Drug|0|||
155540297|NCT01350934|561402364|FG000|Extension Study|Adverse Event|2|||
155540298|NCT01350934|561402365|FG001|Extension Study|Adverse Event|1|||
155540299|NCT01350934|561402364|FG000|Extension Study|Lost to Follow-up|2|||
155540300|NCT01350934|561402365|FG001|Extension Study|Lost to Follow-up|0|||
155540301|NCT01350934|561402364|FG000|Extension Study|Protocol Violation|1|||
155540302|NCT01350934|561402365|FG001|Extension Study|Protocol Violation|1|||
155540303|NCT01350934|561402364|FG000|Extension Study|Lack of Efficacy|0|||
155540304|NCT01350934|561402365|FG001|Extension Study|Lack of Efficacy|1|||
155540305|NCT01350934|561402364|FG000|Extension Study|Withdrawal by Subject|0|||
155540306|NCT01350934|561402365|FG001|Extension Study|Withdrawal by Subject|1|||
155540307|NCT03547635|561402366|FG000|Overall Study|Adverse Event|5|||
155540308|NCT03547635|561402367|FG001|Overall Study|Adverse Event|2|||
155540309|NCT03547635|561402368|FG002|Overall Study|Adverse Event|3|||
155540310|NCT03547635|561402366|FG000|Overall Study|Lost to Follow-up|1|||
155540311|NCT03547635|561402367|FG001|Overall Study|Lost to Follow-up|3|||
155540312|NCT03547635|561402368|FG002|Overall Study|Lost to Follow-up|4|||
155540313|NCT03547635|561402366|FG000|Overall Study|Withdrawal by Subject|1|||
155540314|NCT03547635|561402367|FG001|Overall Study|Withdrawal by Subject|0|||
155540315|NCT03547635|561402368|FG002|Overall Study|Withdrawal by Subject|0|||
155540316|NCT03547635|561402366|FG000|Overall Study|Withdrawal By PI|0|||
155540317|NCT03547635|561402367|FG001|Overall Study|Withdrawal By PI|1|||
155540318|NCT03547635|561402368|FG002|Overall Study|Withdrawal By PI|0|||
155540319|NCT03547635|561402366|FG000|Overall Study|Withdrawal by Sponsor|0|||
155540320|NCT03547635|561402367|FG001|Overall Study|Withdrawal by Sponsor|0|||
155540321|NCT03547635|561402368|FG002|Overall Study|Withdrawal by Sponsor|1|||
155540322|NCT03547635|561402366|FG000|Overall Study|Errant Randomization before Treatment|0|||
155540323|NCT03547635|561402367|FG001|Overall Study|Errant Randomization before Treatment|1|||
155540324|NCT03547635|561402368|FG002|Overall Study|Errant Randomization before Treatment|0|||
155540325|NCT03547635|561402366|FG000|Overall Study|Withdrawal by Subject|1|||
155540326|NCT03547635|561402367|FG001|Overall Study|Withdrawal by Subject|0|||
155540327|NCT03547635|561402368|FG002|Overall Study|Withdrawal by Subject|0|||
155540328|NCT01813435|561402369|FG000|Overall Study|did not finish experimental regimen|1902|||
155540329|NCT01813435|561402370|FG001|Overall Study|did not finish experimental regimen|770|||
155540330|NCT01813435|561402369|FG000|Overall Study|Lost to Follow-up|268|||
155540331|NCT01813435|561402370|FG001|Overall Study|Lost to Follow-up|237|||
155540332|NCT01011335|561402373|FG000|Overall Study|Lost to Follow-up|0|||
155540333|NCT01011335|561402374|FG001|Overall Study|Lost to Follow-up|0|||
155540334|NCT01011335|561402375|FG002|Overall Study|Lost to Follow-up|1|||
155540335|NCT01011335|561402376|FG003|Overall Study|Lost to Follow-up|1|||
155540336|NCT01011335|561402377|FG004|Overall Study|Lost to Follow-up|1|||
155540337|NCT01011335|561402378|FG005|Overall Study|Lost to Follow-up|1|||
155540338|NCT01011335|561402379|FG006|Overall Study|Lost to Follow-up|2|||
155540339|NCT01011335|561402380|FG007|Overall Study|Lost to Follow-up|2|||
155540340|NCT01011335|561402381|FG008|Overall Study|Lost to Follow-up|1|||
155540341|NCT01011335|561402382|FG009|Overall Study|Lost to Follow-up|0|||
155540342|NCT01011335|561402383|FG010|Overall Study|Lost to Follow-up|0|||
155540343|NCT01011335|561402384|FG011|Overall Study|Lost to Follow-up|1|||
155540344|NCT01011335|561402385|FG012|Overall Study|Lost to Follow-up|2|||
155540345|NCT01011335|561402373|FG000|Overall Study|Protocol Violation|0|||
155540346|NCT01011335|561402374|FG001|Overall Study|Protocol Violation|1|||
155540347|NCT01011335|561402375|FG002|Overall Study|Protocol Violation|0|||
155540348|NCT01011335|561402376|FG003|Overall Study|Protocol Violation|0|||
155540349|NCT01011335|561402377|FG004|Overall Study|Protocol Violation|0|||
155540350|NCT01011335|561402378|FG005|Overall Study|Protocol Violation|0|||
155540351|NCT01011335|561402379|FG006|Overall Study|Protocol Violation|0|||
155540352|NCT01011335|561402380|FG007|Overall Study|Protocol Violation|0|||
155540353|NCT01011335|561402381|FG008|Overall Study|Protocol Violation|0|||
155540354|NCT01011335|561402382|FG009|Overall Study|Protocol Violation|0|||
155540355|NCT01011335|561402383|FG010|Overall Study|Protocol Violation|0|||
155540356|NCT01011335|561402384|FG011|Overall Study|Protocol Violation|0|||
155540357|NCT01011335|561402385|FG012|Overall Study|Protocol Violation|0|||
155540358|NCT01011335|561402373|FG000|Overall Study|Moved/deployed or no booster|1|||
155540359|NCT01011335|561402374|FG001|Overall Study|Moved/deployed or no booster|0|||
155540360|NCT01011335|561402375|FG002|Overall Study|Moved/deployed or no booster|0|||
155540361|NCT01011335|561402376|FG003|Overall Study|Moved/deployed or no booster|1|||
155540362|NCT01011335|561402377|FG004|Overall Study|Moved/deployed or no booster|0|||
155540363|NCT01011335|561402378|FG005|Overall Study|Moved/deployed or no booster|0|||
155540364|NCT01011335|561402379|FG006|Overall Study|Moved/deployed or no booster|1|||
155540365|NCT01011335|561402380|FG007|Overall Study|Moved/deployed or no booster|0|||
155540366|NCT01011335|561402381|FG008|Overall Study|Moved/deployed or no booster|1|||
155540367|NCT01011335|561402382|FG009|Overall Study|Moved/deployed or no booster|0|||
155540368|NCT01011335|561402383|FG010|Overall Study|Moved/deployed or no booster|2|||
155540369|NCT01011335|561402384|FG011|Overall Study|Moved/deployed or no booster|0|||
155540370|NCT01011335|561402385|FG012|Overall Study|Moved/deployed or no booster|0|||
155540371|NCT01011335|561402373|FG000|Overall Study|Adverse Event|0|||
155540372|NCT01011335|561402374|FG001|Overall Study|Adverse Event|0|||
155540373|NCT01011335|561402375|FG002|Overall Study|Adverse Event|0|||
155540374|NCT01011335|561402376|FG003|Overall Study|Adverse Event|0|||
155540375|NCT01011335|561402377|FG004|Overall Study|Adverse Event|0|||
155540376|NCT01011335|561402378|FG005|Overall Study|Adverse Event|0|||
155540377|NCT01011335|561402379|FG006|Overall Study|Adverse Event|0|||
155540378|NCT01011335|561402380|FG007|Overall Study|Adverse Event|0|||
155540379|NCT01011335|561402381|FG008|Overall Study|Adverse Event|0|||
155540380|NCT01011335|561402382|FG009|Overall Study|Adverse Event|0|||
155540381|NCT01011335|561402383|FG010|Overall Study|Adverse Event|4|||
155540382|NCT01011335|561402384|FG011|Overall Study|Adverse Event|0|||
155540383|NCT01011335|561402385|FG012|Overall Study|Adverse Event|1|||
155540384|NCT02415387|561402391|FG000|Overall Study|Withdrawal by Subject|6|||
155540385|NCT02415387|561402392|FG001|Overall Study|Withdrawal by Subject|1|||
155540386|NCT02415387|561402391|FG000|Overall Study|blood draw problem|0|||
155540387|NCT02415387|561402392|FG001|Overall Study|blood draw problem|1|||
155540388|NCT02415387|561402391|FG000|Overall Study|Protocol Violation|1|||
155540389|NCT02415387|561402392|FG001|Overall Study|Protocol Violation|0|||
155540390|NCT01765751|561402395|FG000|Overall Study|Lost to Follow-up|0|||
155540391|NCT01765751|561402396|FG001|Overall Study|Lost to Follow-up|2|||
155540392|NCT01765751|561402397|FG002|Overall Study|Lost to Follow-up|1|||
155540393|NCT01243151|561402398|FG000|Overall Study|Adverse Event|0|||
155540394|NCT01243151|561402399|FG001|Overall Study|Adverse Event|1|||
155540395|NCT01243151|561402400|FG002|Overall Study|Adverse Event|0|||
155540396|NCT01243151|561402401|FG003|Overall Study|Adverse Event|0|||
155540397|NCT01243151|561402402|FG004|Overall Study|Adverse Event|0|||
155540398|NCT01243151|561402398|FG000|Overall Study|Protocol Violation|0|||
155540399|NCT01243151|561402399|FG001|Overall Study|Protocol Violation|0|||
155540400|NCT01243151|561402400|FG002|Overall Study|Protocol Violation|1|||
155540401|NCT01243151|561402401|FG003|Overall Study|Protocol Violation|0|||
155540402|NCT01243151|561402402|FG004|Overall Study|Protocol Violation|0|||
155540403|NCT01243151|561402398|FG000|Overall Study|Other|0|||
155540404|NCT01243151|561402399|FG001|Overall Study|Other|0|||
155540405|NCT01243151|561402400|FG002|Overall Study|Other|0|||
155540406|NCT01243151|561402401|FG003|Overall Study|Other|1|||
155540407|NCT01243151|561402402|FG004|Overall Study|Other|0|||
155540408|NCT01243151|561402398|FG000|Overall Study|Randomized but not treated|0|||
155540409|NCT01243151|561402399|FG001|Overall Study|Randomized but not treated|0|||
155540410|NCT01243151|561402400|FG002|Overall Study|Randomized but not treated|0|||
155540411|NCT01243151|561402401|FG003|Overall Study|Randomized but not treated|1|||
155540412|NCT01243151|561402402|FG004|Overall Study|Randomized but not treated|0|||
155540413|NCT01579006|561402404|FG000|Overall Study|Lack of Efficacy|10|||
155540414|NCT01579006|561402404|FG000|Overall Study|Adverse Event|13|||
155540415|NCT01579006|561402404|FG000|Overall Study|Withdrawal by Subject|5|||
155540416|NCT01579006|561402404|FG000|Overall Study|Non-compliance|3|||
155540417|NCT01579006|561402404|FG000|Overall Study|Due to participant's health fund|1|||
155540418|NCT01579006|561402404|FG000|Overall Study|Scheduled surgery|1|||
155540419|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
155540420|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
155540421|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
155540422|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
155540423|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
155540424|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
155540425|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
155540426|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
155540427|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
155540428|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
155540429|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
155540430|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
155540431|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
155540432|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
155540433|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
155540434|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
155540435|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
155540436|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
155540437|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
155540438|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
155540439|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
155540440|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
155540441|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
155540442|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
155540443|NCT01710358|561402405|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
155540444|NCT01710358|561402406|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
155540445|NCT01710358|561402407|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
155540446|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
155540447|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
155540448|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
155540449|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
155540450|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
155540451|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
155540452|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
155540453|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
155540454|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
155540455|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
155540456|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
155540457|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
155540458|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
155540459|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
155540460|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
155540461|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
155540462|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
155540463|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
155540464|NCT01710358|561402405|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
155540465|NCT01710358|561402406|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
155540466|NCT01710358|561402407|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
155540467|NCT01710358|561402405|FG000|Rescue Period|Adverse Event|0|||
155540468|NCT01710358|561402406|FG001|Rescue Period|Adverse Event|15|||
155540469|NCT01710358|561402407|FG002|Rescue Period|Adverse Event|0|||
155540470|NCT01710358|561402405|FG000|Rescue Period|Death|0|||
155540471|NCT01710358|561402406|FG001|Rescue Period|Death|1|||
155540472|NCT01710358|561402407|FG002|Rescue Period|Death|0|||
155540473|NCT01710358|561402405|FG000|Rescue Period|Lack of Efficacy|0|||
155540474|NCT01710358|561402406|FG001|Rescue Period|Lack of Efficacy|7|||
155540475|NCT01710358|561402407|FG002|Rescue Period|Lack of Efficacy|0|||
155656146|NCT03895372|561835154|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
155540476|NCT01710358|561402405|FG000|Rescue Period|Withdrawal by Subject|0|||
155540477|NCT01710358|561402406|FG001|Rescue Period|Withdrawal by Subject|8|||
155540478|NCT01710358|561402407|FG002|Rescue Period|Withdrawal by Subject|0|||
155540479|NCT00799708|561402409|FG000|Overall Study|non-compliance|1|||
155540480|NCT00799708|561402410|FG001|Overall Study|non-compliance|0|||
155540481|NCT00799708|561402411|FG002|Overall Study|non-compliance|0|||
155540482|NCT00880334|561402412|FG000|Randomized Phase|Physician Decision|1|||
155540483|NCT00880334|561402413|FG001|Randomized Phase|Physician Decision|0|||
155540484|NCT00880334|561402412|FG000|Randomized Phase|Withdrawal by Subject|2|||
155540485|NCT00880334|561402413|FG001|Randomized Phase|Withdrawal by Subject|1|||
155540486|NCT00880334|561402412|FG000|Randomized Phase|Inadequate Labs|1|||
155540487|NCT00880334|561402413|FG001|Randomized Phase|Inadequate Labs|1|||
155540488|NCT00880334|561402412|FG000|Randomized Phase|Brain Metastasis|0|||
155540489|NCT00880334|561402413|FG001|Randomized Phase|Brain Metastasis|1|||
155540490|NCT00880334|561402412|FG000|Randomized Phase|Crossover Participants|0|||
155540491|NCT00880334|561402413|FG001|Randomized Phase|Crossover Participants|37|||
155540492|NCT02274558|561402418|FG000|Overall Study|Adverse Event|2|||
155540493|NCT02274558|561402419|FG001|Overall Study|Adverse Event|4|||
155540494|NCT02274558|561402420|FG002|Overall Study|Adverse Event|2|||
155540495|NCT02274558|561402418|FG000|Overall Study|Non-compliance|2|||
155540496|NCT02274558|561402419|FG001|Overall Study|Non-compliance|1|||
155540497|NCT02274558|561402420|FG002|Overall Study|Non-compliance|0|||
155540498|NCT02274558|561402418|FG000|Overall Study|Withdrawal by Subject|1|||
155540499|NCT02274558|561402419|FG001|Overall Study|Withdrawal by Subject|5|||
155540500|NCT02274558|561402420|FG002|Overall Study|Withdrawal by Subject|4|||
155540501|NCT02274558|561402418|FG000|Overall Study|Death|0|||
155540502|NCT02274558|561402419|FG001|Overall Study|Death|0|||
155540503|NCT02274558|561402420|FG002|Overall Study|Death|1|||
155540504|NCT02274558|561402418|FG000|Overall Study|Lost to Follow-up|2|||
155540505|NCT02274558|561402419|FG001|Overall Study|Lost to Follow-up|1|||
155540506|NCT02274558|561402420|FG002|Overall Study|Lost to Follow-up|1|||
155540507|NCT02274558|561402418|FG000|Overall Study|Physician Decision|0|||
155540508|NCT02274558|561402419|FG001|Overall Study|Physician Decision|2|||
155540509|NCT02274558|561402420|FG002|Overall Study|Physician Decision|1|||
155540510|NCT03167606|561402424|FG000|Overall Study|Lost to Follow-up|73|||
155540511|NCT03167606|561402425|FG001|Overall Study|Lost to Follow-up|64|||
155540512|NCT03167606|561402424|FG000|Overall Study|Withdrawal by Subject|6|||
155540513|NCT03167606|561402425|FG001|Overall Study|Withdrawal by Subject|5|||
155540514|NCT03167606|561402424|FG000|Overall Study|Withdrawal by Investigator|0|||
155540515|NCT03167606|561402425|FG001|Overall Study|Withdrawal by Investigator|2|||
155540516|NCT03314857|561402426|FG000|Overall Study|Death|4|||
155540517|NCT03314857|561402426|FG000|Overall Study|Physician Decision|1|||
155540518|NCT00397254|561402429|FG000|Overall Study|Lost to Follow-up|2|||
155540519|NCT00397254|561402430|FG001|Overall Study|Lost to Follow-up|2|||
155540520|NCT00152451|561402434|FG000|Overall Study|Adverse Event|4|||
155540521|NCT00323258|561402437|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
155540522|NCT00323258|561402438|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
155540523|NCT00323258|561402437|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
155540524|NCT00323258|561402438|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
155540525|NCT00323258|561402437|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
155540526|NCT00323258|561402438|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
155540527|NCT00323258|561402437|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
155540528|NCT00323258|561402438|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
155540529|NCT00323258|561402437|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
155540530|NCT00323258|561402438|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
155540531|NCT00323258|561402437|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
155540532|NCT00323258|561402438|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
155540533|NCT00323258|561402437|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
155540534|NCT00323258|561402438|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
155540535|NCT01943435|561402439|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
155540536|NCT01943435|561402440|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
155540537|NCT01943435|561402441|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
155540538|NCT01943435|561402439|FG000|Intervention Period|Withdrawal by Subject|3|||
155540539|NCT01943435|561402440|FG001|Intervention Period|Withdrawal by Subject|3|||
155540540|NCT01943435|561402441|FG002|Intervention Period|Withdrawal by Subject|4|||
155540541|NCT01943435|561402439|FG000|2 Month Follow up|Lost to Follow-up|2|||
155540542|NCT01943435|561402440|FG001|2 Month Follow up|Lost to Follow-up|3|||
155540543|NCT01943435|561402441|FG002|2 Month Follow up|Lost to Follow-up|0|||
155540544|NCT01943435|561402439|FG000|6 Month Follow up|Lost to Follow-up|12|||
155540545|NCT01943435|561402440|FG001|6 Month Follow up|Lost to Follow-up|7|||
155540546|NCT01943435|561402441|FG002|6 Month Follow up|Lost to Follow-up|15|||
155540547|NCT04473326|561402450|FG000|Overall Study|Death|0|||
155540548|NCT04473326|561402451|FG001|Overall Study|Death|1|||
155656147|NCT03895372|561835155|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
155540549|NCT04473326|561402450|FG000|Overall Study|Withdrawal by Subject|1|||
155540550|NCT04473326|561402451|FG001|Overall Study|Withdrawal by Subject|2|||
155540551|NCT02046122|561402452|FG000|Overall Study|Physician Decision|8|||
155540552|NCT02046122|561402452|FG000|Overall Study|Withdrawal by Subject|1|||
155540553|NCT04535986|561402453|FG000|Overall Study|Death|4|||
155540554|NCT04535986|561402454|FG001|Overall Study|Death|5|||
155540555|NCT04535986|561402453|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
155540556|NCT04535986|561402454|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
155540557|NCT04535986|561402453|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
155540558|NCT04535986|561402454|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
155540559|NCT04535986|561402453|FG000|Overall Study|Adverse Event|10|||
155540560|NCT04535986|561402454|FG001|Overall Study|Adverse Event|1|||
155540561|NCT04535986|561402453|FG000|Overall Study|Lack of Efficacy|3|||
155540562|NCT04535986|561402454|FG001|Overall Study|Lack of Efficacy|2|||
155540563|NCT04535986|561402453|FG000|Overall Study|Investigator discretion|3|||
155540564|NCT04535986|561402454|FG001|Overall Study|Investigator discretion|0|||
155540565|NCT04535986|561402453|FG000|Overall Study|Withdrawal by Subject|32|||
155540566|NCT04535986|561402454|FG001|Overall Study|Withdrawal by Subject|14|||
155540567|NCT04535986|561402453|FG000|Overall Study|Lost to Follow-up|5|||
155540568|NCT04535986|561402454|FG001|Overall Study|Lost to Follow-up|3|||
155540569|NCT04535986|561402453|FG000|Overall Study|Other|7|||
155540570|NCT04535986|561402454|FG001|Overall Study|Other|3|||
155540571|NCT00252564|561402457|FG000|Overall Study|Adverse Event|17|||
155540572|NCT00252564|561402458|FG001|Overall Study|Adverse Event|13|||
155540573|NCT00252564|561402457|FG000|Overall Study|Unrelated Complication|2|||
155540574|NCT00252564|561402458|FG001|Overall Study|Unrelated Complication|1|||
155540575|NCT00252564|561402457|FG000|Overall Study|Disease Progression|14|||
155540576|NCT00252564|561402458|FG001|Overall Study|Disease Progression|20|||
155540577|NCT00252564|561402457|FG000|Overall Study|Death|0|||
155540578|NCT00252564|561402458|FG001|Overall Study|Death|3|||
155540579|NCT00252564|561402457|FG000|Overall Study|Physician Decision|1|||
155540580|NCT00252564|561402458|FG001|Overall Study|Physician Decision|0|||
155540581|NCT00252564|561402457|FG000|Overall Study|Lost to Follow-up|1|||
155540582|NCT00252564|561402458|FG001|Overall Study|Lost to Follow-up|0|||
155540583|NCT00252564|561402457|FG000|Overall Study|Patient Request|4|||
155540584|NCT00252564|561402458|FG001|Overall Study|Patient Request|5|||
155540585|NCT00252564|561402457|FG000|Overall Study|Withdrawal by Subject|0|||
155540586|NCT00252564|561402458|FG001|Overall Study|Withdrawal by Subject|2|||
155540587|NCT01097694|561402459|FG000|Overall Study|Adverse Event|5|||
155540588|NCT01097694|561402460|FG001|Overall Study|Adverse Event|0|||
155540589|NCT01097694|561402459|FG000|Overall Study|Lost to Follow-up|0|||
155540590|NCT01097694|561402460|FG001|Overall Study|Lost to Follow-up|3|||
155540591|NCT01097694|561402459|FG000|Overall Study|Withdrawal by Subject|3|||
155540592|NCT01097694|561402460|FG001|Overall Study|Withdrawal by Subject|1|||
155540593|NCT02179190|561402461|FG000|Enrollment|Exit Prior to Device Attempt|11|||
155540594|NCT02179190|561402461|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
155540595|NCT02179190|561402461|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
155540596|NCT02179190|561402461|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
155540597|NCT02179190|561402461|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
155540598|NCT02179190|561402461|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
155540599|NCT00697827|561402463|FG000|Overall Study|enrolled but not treated|2|||
155540600|NCT00697827|561402464|FG001|Overall Study|enrolled but not treated|1|||
155540601|NCT04049097|561402467|FG000|Overall Study|Adverse Event|18|||
155540602|NCT04049097|561402467|FG000|Overall Study|Death|2|||
155540603|NCT04049097|561402467|FG000|Overall Study|Lost to Follow-up|1|||
155540604|NCT04049097|561402467|FG000|Overall Study|Physician Decision|2|||
155540605|NCT04049097|561402467|FG000|Overall Study|Withdrawal by Subject|9|||
155540606|NCT04049097|561402467|FG000|Overall Study|Protocol Violation|2|||
155540607|NCT04049097|561402467|FG000|Overall Study|Other|1|||
155540608|NCT04049097|561402467|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
155540609|NCT04194151|561402468|FG000|Overall Study|Physician Decision|1|||
155540610|NCT04194151|561402469|FG001|Overall Study|Physician Decision|1|||
155540611|NCT04194151|561402470|FG002|Overall Study|Physician Decision|1|||
155540612|NCT04194151|561402471|FG003|Overall Study|Physician Decision|1|||
155540613|NCT04194151|561402472|FG004|Overall Study|Physician Decision|0|||
155540614|NCT04194151|561402473|FG005|Overall Study|Physician Decision|1|||
155540615|NCT04194151|561402468|FG000|Overall Study|Monitorization problem|0|||
155540616|NCT04194151|561402469|FG001|Overall Study|Monitorization problem|1|||
155540617|NCT04194151|561402470|FG002|Overall Study|Monitorization problem|0|||
155540618|NCT04194151|561402471|FG003|Overall Study|Monitorization problem|0|||
155540619|NCT04194151|561402472|FG004|Overall Study|Monitorization problem|0|||
155540620|NCT04194151|561402473|FG005|Overall Study|Monitorization problem|0|||
155540621|NCT01188226|561404203|FG000|Overall Study|Withdrawal by Subject|4|||
155540622|NCT02293460|561404204|FG000|Overall Study|Protocol Violation|1|||
155540623|NCT02293460|561404204|FG000|Overall Study|Lack of Efficacy|2|||
155540624|NCT02293460|561404204|FG000|Overall Study|Adverse Event|2|||
155540625|NCT02293460|561404204|FG000|Overall Study|Withdrawal by Subject|1|||
155540626|NCT00500318|561404206|FG000|Overall Study|Adverse Event|3|||
155540627|NCT00500318|561404207|FG001|Overall Study|Adverse Event|8|||
155540628|NCT00500318|561404206|FG000|Overall Study|Protocol Violation|1|||
155540629|NCT00500318|561404207|FG001|Overall Study|Protocol Violation|3|||
155540630|NCT00500318|561404206|FG000|Overall Study|Withdrawal by Subject|1|||
155540631|NCT00500318|561404207|FG001|Overall Study|Withdrawal by Subject|2|||
155540632|NCT00500318|561404206|FG000|Overall Study|Lack of Efficacy|0|||
155540633|NCT00500318|561404207|FG001|Overall Study|Lack of Efficacy|3|||
155540634|NCT00500318|561404206|FG000|Overall Study|Other Reason|0|||
155540635|NCT00500318|561404207|FG001|Overall Study|Other Reason|1|||
155540636|NCT00224484|561404228|FG000|Overall Study|Serious Adverse Event|1|||
155540637|NCT00224484|561404229|FG001|Overall Study|Serious Adverse Event|1|||
155540638|NCT00224484|561404230|FG002|Overall Study|Serious Adverse Event|0|||
155540639|NCT00224484|561404228|FG000|Overall Study|Non-Serious Adverse Event|5|||
155540640|NCT00224484|561404229|FG001|Overall Study|Non-Serious Adverse Event|7|||
155540641|NCT00224484|561404230|FG002|Overall Study|Non-Serious Adverse Event|3|||
155540642|NCT00224484|561404228|FG000|Overall Study|Protocol Violation|2|||
155540643|NCT00224484|561404229|FG001|Overall Study|Protocol Violation|2|||
155540644|NCT00224484|561404230|FG002|Overall Study|Protocol Violation|0|||
155540645|NCT00224484|561404228|FG000|Overall Study|Withdrawal by Subject|49|||
155540646|NCT00224484|561404229|FG001|Overall Study|Withdrawal by Subject|18|||
155540647|NCT00224484|561404230|FG002|Overall Study|Withdrawal by Subject|16|||
155540648|NCT00224484|561404228|FG000|Overall Study|Migrated/moved from study area|18|||
155540649|NCT00224484|561404229|FG001|Overall Study|Migrated/moved from study area|5|||
155540650|NCT00224484|561404230|FG002|Overall Study|Migrated/moved from study area|5|||
155540651|NCT00224484|561404228|FG000|Overall Study|Lost to Follow-up|66|||
155540652|NCT00224484|561404229|FG001|Overall Study|Lost to Follow-up|28|||
155540653|NCT00224484|561404230|FG002|Overall Study|Lost to Follow-up|36|||
155540654|NCT00224484|561404228|FG000|Overall Study|Reason not specified|5|||
155540655|NCT00224484|561404229|FG001|Overall Study|Reason not specified|4|||
155540656|NCT00224484|561404230|FG002|Overall Study|Reason not specified|2|||
155540657|NCT02805309|561404231|FG000|Overall Study|Lost to Follow-up|2|||
155540658|NCT02805309|561404232|FG001|Overall Study|Lost to Follow-up|2|||
155540659|NCT02805309|561404233|FG002|Overall Study|Lost to Follow-up|2|||
155540660|NCT02805309|561404231|FG000|Overall Study|Post-Randomization Exclusion|0|||
155540661|NCT02805309|561404232|FG001|Overall Study|Post-Randomization Exclusion|2|||
155540662|NCT02805309|561404233|FG002|Overall Study|Post-Randomization Exclusion|1|||
155540663|NCT01636934|561404236|FG000|Overall Study|Withdrawal by Subject|3|||
155540664|NCT01636934|561404237|FG001|Overall Study|Withdrawal by Subject|2|||
155540665|NCT01636934|561404236|FG000|Overall Study|Chemo cancel|1|||
155540666|NCT01636934|561404237|FG001|Overall Study|Chemo cancel|0|||
155540667|NCT01636934|561404236|FG000|Overall Study|Too ill to continue|1|||
155540668|NCT01636934|561404237|FG001|Overall Study|Too ill to continue|0|||
155540669|NCT01636934|561404236|FG000|Overall Study|Never started study medication|1|||
155540670|NCT01636934|561404237|FG001|Overall Study|Never started study medication|1|||
155540671|NCT03035890|561404242|FG000|Overall Study|Death|1|||
155540672|NCT03243396|561404243|FG000|Overall Study|Lost to Follow-up|2|||
155540673|NCT03243396|561404244|FG001|Overall Study|Lost to Follow-up|3|||
155540674|NCT03243396|561404245|FG002|Overall Study|Lost to Follow-up|15|||
155540675|NCT03243396|561404246|FG003|Overall Study|Lost to Follow-up|8|||
155540676|NCT03243396|561404247|FG004|Overall Study|Lost to Follow-up|1|||
155540677|NCT03243396|561404248|FG005|Overall Study|Lost to Follow-up|4|||
155540678|NCT03243396|561404249|FG006|Overall Study|Lost to Follow-up|9|||
155540679|NCT03687242|561404250|FG000|Overall Study|Adverse Event|1|||
155540680|NCT00288704|561404254|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
155540681|NCT00288704|561404255|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
155540682|NCT00288704|561404256|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
155540683|NCT00288704|561404254|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
155540684|NCT00288704|561404255|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
155540685|NCT00288704|561404256|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
155540686|NCT00288704|561404254|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
155540687|NCT00288704|561404255|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
155540688|NCT00288704|561404256|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
155540689|NCT00288704|561404254|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
155540690|NCT00288704|561404255|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
155540691|NCT00288704|561404256|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
155540692|NCT00288704|561404254|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
155540693|NCT00288704|561404255|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
155540694|NCT00288704|561404256|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
155540695|NCT00288704|561404254|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
155540696|NCT00288704|561404255|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
155540697|NCT00288704|561404256|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
155540698|NCT00288704|561404254|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
155540699|NCT00288704|561404255|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
155540700|NCT00288704|561404256|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
155540701|NCT02473393|561404257|FG000|Overall Study|Adverse Event|0|||
155540702|NCT02473393|561404258|FG001|Overall Study|Adverse Event|0|||
155540703|NCT02473393|561404259|FG002|Overall Study|Adverse Event|1|||
155540704|NCT02473393|561404260|FG003|Overall Study|Adverse Event|0|||
155540705|NCT02473393|561404257|FG000|Overall Study|Withdrawal by Subject|0|||
155540706|NCT02473393|561404258|FG001|Overall Study|Withdrawal by Subject|0|||
155540707|NCT02473393|561404259|FG002|Overall Study|Withdrawal by Subject|1|||
155540708|NCT02473393|561404260|FG003|Overall Study|Withdrawal by Subject|1|||
155540709|NCT01257581|561404262|FG000|Overall Study|Early Termination|3|||
155540710|NCT01257581|561404263|FG001|Overall Study|Early Termination|1|||
155540711|NCT01257581|561404264|FG002|Overall Study|Early Termination|2|||
155540712|NCT01257581|561404262|FG000|Overall Study|Death|2|||
155540713|NCT01257581|561404263|FG001|Overall Study|Death|2|||
155540714|NCT01257581|561404264|FG002|Overall Study|Death|4|||
155540715|NCT01157234|561404265|FG000|Overall Study|Withdrawal by Subject|1|||
155540716|NCT01157234|561404266|FG001|Overall Study|Withdrawal by Subject|0|||
155540717|NCT02733627|561404277|FG000|Overall Study|Adverse Event|0|||
155540718|NCT02733627|561404278|FG001|Overall Study|Adverse Event|1|||
155540719|NCT02733627|561404279|FG002|Overall Study|Adverse Event|1|||
155540720|NCT02733627|561404280|FG003|Overall Study|Adverse Event|0|||
155540721|NCT02733627|561404277|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
155540722|NCT02733627|561404278|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
155540723|NCT02733627|561404279|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
155540724|NCT02733627|561404280|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
155540725|NCT00059332|561404281|FG000|Overall Study|Withdrawal by Subject|2|||
155540726|NCT00059332|561404282|FG001|Overall Study|Withdrawal by Subject|1|||
155540727|NCT00059332|561404281|FG000|Overall Study|Lost to Follow-up|1|||
155540728|NCT00059332|561404282|FG001|Overall Study|Lost to Follow-up|1|||
155540729|NCT01408888|561404285|FG000|First Intervention|Adverse Event|0|||
155540730|NCT01408888|561404286|FG001|First Intervention|Adverse Event|1|||
155540731|NCT01408888|561404285|FG000|First Intervention|Withdrawal by Subject|0|||
155540732|NCT01408888|561404286|FG001|First Intervention|Withdrawal by Subject|2|||
155540733|NCT01408888|561404285|FG000|Second Intervention|Withdrawal by Subject|1|||
155540734|NCT01408888|561404286|FG001|Second Intervention|Withdrawal by Subject|0|||
155540735|NCT01408888|561404285|FG000|Second Intervention|Adverse Event|1|||
155540736|NCT01408888|561404286|FG001|Second Intervention|Adverse Event|0|||
155540737|NCT01698554|561404301|FG000|Overall Study|Adverse Event|2|||
155540738|NCT01698554|561404302|FG001|Overall Study|Adverse Event|5|||
155540739|NCT01698554|561404303|FG002|Overall Study|Adverse Event|0|||
155540740|NCT01698554|561404304|FG003|Overall Study|Adverse Event|1|||
155540741|NCT01698554|561404301|FG000|Overall Study|Lost to Follow-up|1|||
155540742|NCT01698554|561404302|FG001|Overall Study|Lost to Follow-up|0|||
155540743|NCT01698554|561404303|FG002|Overall Study|Lost to Follow-up|0|||
155540744|NCT01698554|561404304|FG003|Overall Study|Lost to Follow-up|0|||
155540745|NCT01698554|561404301|FG000|Overall Study|Personal Reasons|0|||
155540746|NCT01698554|561404302|FG001|Overall Study|Personal Reasons|5|||
155540747|NCT01698554|561404303|FG002|Overall Study|Personal Reasons|1|||
155540748|NCT01698554|561404304|FG003|Overall Study|Personal Reasons|1|||
155540749|NCT01698554|561404301|FG000|Overall Study|Protocol Violation|2|||
155540750|NCT01698554|561404302|FG001|Overall Study|Protocol Violation|0|||
155540751|NCT01698554|561404303|FG002|Overall Study|Protocol Violation|1|||
155540752|NCT01698554|561404304|FG003|Overall Study|Protocol Violation|0|||
155540753|NCT01698554|561404301|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155540754|NCT01698554|561404302|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155540755|NCT01698554|561404303|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155540756|NCT01698554|561404304|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155540757|NCT01617096|561404305|FG000|Overall Study|Withdrawal by Subject|96|||
155540758|NCT01617096|561404306|FG001|Overall Study|Withdrawal by Subject|81|||
155540759|NCT01617096|561404305|FG000|Overall Study|Lost to Follow-up|37|||
155540760|NCT01617096|561404306|FG001|Overall Study|Lost to Follow-up|32|||
155540761|NCT01617096|561404305|FG000|Overall Study|Physician Decision|10|||
155540762|NCT01617096|561404306|FG001|Overall Study|Physician Decision|18|||
155540763|NCT01617096|561404305|FG000|Overall Study|Death|4|||
155540764|NCT01617096|561404306|FG001|Overall Study|Death|3|||
155540765|NCT01617096|561404305|FG000|Overall Study|Other|1|||
155540766|NCT01617096|561404306|FG001|Overall Study|Other|3|||
155540767|NCT01196390|561404311|FG000|Overall Study|Protocol Violation|4|||
155540768|NCT01196390|561404312|FG001|Overall Study|Protocol Violation|5|||
155540769|NCT03141151|561404321|FG000|Overall Study|Lost to Follow-up|3|||
155540770|NCT03141151|561404322|FG001|Overall Study|Lost to Follow-up|2|||
155540771|NCT03141151|561404321|FG000|Overall Study|Withdrawal by Subject|3|||
155540772|NCT03141151|561404322|FG001|Overall Study|Withdrawal by Subject|2|||
155540773|NCT04561115|561404323|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
155540774|NCT04561115|561404324|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
155540775|NCT04561115|561404323|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
155540776|NCT04561115|561404324|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
155540777|NCT04561115|561404323|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
155540778|NCT04561115|561404324|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
155540779|NCT03259165|561404325|FG000|Overall Study|COVID 19 pandemic|1|||
155540780|NCT03259165|561404326|FG001|Overall Study|COVID 19 pandemic|1|||
155540781|NCT03732833|561404331|FG000|Overall Study|Adverse Event|0|||
155540782|NCT03732833|561404332|FG001|Overall Study|Adverse Event|3|||
155540783|NCT03732833|561404333|FG002|Overall Study|Adverse Event|1|||
155540784|NCT03732833|561404331|FG000|Overall Study|Withdrawal by Subject|11|||
155540785|NCT03732833|561404332|FG001|Overall Study|Withdrawal by Subject|13|||
155540786|NCT03732833|561404333|FG002|Overall Study|Withdrawal by Subject|8|||
155540787|NCT03732833|561404331|FG000|Overall Study|Lost to Follow-up|3|||
155540788|NCT03732833|561404332|FG001|Overall Study|Lost to Follow-up|5|||
155540789|NCT03732833|561404333|FG002|Overall Study|Lost to Follow-up|4|||
155540790|NCT03732833|561404331|FG000|Overall Study|Pregnancy|0|||
155540791|NCT03732833|561404332|FG001|Overall Study|Pregnancy|2|||
155540792|NCT03732833|561404333|FG002|Overall Study|Pregnancy|0|||
155540793|NCT03732833|561404331|FG000|Overall Study|Physician Decision|2|||
155540794|NCT03732833|561404332|FG001|Overall Study|Physician Decision|3|||
155540795|NCT03732833|561404333|FG002|Overall Study|Physician Decision|1|||
155540796|NCT03732833|561404331|FG000|Overall Study|Covid-19 related and other reasons|2|||
155540797|NCT03732833|561404332|FG001|Overall Study|Covid-19 related and other reasons|7|||
155540798|NCT03732833|561404333|FG002|Overall Study|Covid-19 related and other reasons|3|||
155540799|NCT02004691|561404336|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
155540800|NCT02004691|561404337|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
155540801|NCT02004691|561404336|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
155540802|NCT02004691|561404337|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
155540803|NCT02004691|561404336|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
155540804|NCT02004691|561404337|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
155540805|NCT02004691|561404336|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
155540806|NCT02004691|561404337|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
155540807|NCT02004691|561404336|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
155540808|NCT02004691|561404337|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
155540809|NCT02004691|561404336|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
155540810|NCT02004691|561404337|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
155540811|NCT02623218|561404338|FG000|Overall Study|Lost to Follow-up|0|||
155540812|NCT02623218|561404339|FG001|Overall Study|Lost to Follow-up|1|||
155540813|NCT02623218|561404340|FG002|Overall Study|Lost to Follow-up|0|||
155540814|NCT02623218|561404341|FG003|Overall Study|Lost to Follow-up|0|||
155540815|NCT02623218|561404342|FG004|Overall Study|Lost to Follow-up|0|||
155540816|NCT01726803|561404343|FG000|Overall Study|Lost to Follow-up|6|||
155540817|NCT01726803|561404344|FG001|Overall Study|Lost to Follow-up|1|||
155540818|NCT01726803|561404343|FG000|Overall Study|Withdrawal by Subject|1|||
155540819|NCT01726803|561404344|FG001|Overall Study|Withdrawal by Subject|0|||
155540820|NCT01970592|561404347|FG000|Overall Study|Withdrawal by Subject|4|||
155540821|NCT01970592|561404347|FG000|Overall Study|Physician Decision|1|||
155540822|NCT01970592|561404347|FG000|Overall Study|Adverse Event|1|||
155540823|NCT03980522|561404350|FG000|Treatment Period|Adverse Event|1|||
155540824|NCT03980522|561404351|FG001|Treatment Period|Adverse Event|0|||
155540825|NCT03980522|561404352|FG002|Treatment Period|Adverse Event|0|||
155540826|NCT03980522|561404353|FG003|Treatment Period|Adverse Event|0|||
155540827|NCT03980522|561404354|FG004|Treatment Period|Adverse Event|0|||
155540828|NCT01320722|561404355|FG000|Overall Study|Did not Receive Intervention|3|||
155540829|NCT01320722|561404356|FG001|Overall Study|Did not Receive Intervention|2|||
155540830|NCT01320722|561404357|FG002|Overall Study|Did not Receive Intervention|1|||
155540831|NCT01320722|561404358|FG003|Overall Study|Did not Receive Intervention|1|||
155540832|NCT01320722|561404359|FG004|Overall Study|Did not Receive Intervention|2|||
155540833|NCT01320722|561404355|FG000|Overall Study|Lost to Follow-up|0|||
155540834|NCT01320722|561404356|FG001|Overall Study|Lost to Follow-up|1|||
155540835|NCT01320722|561404357|FG002|Overall Study|Lost to Follow-up|0|||
155540836|NCT01320722|561404358|FG003|Overall Study|Lost to Follow-up|1|||
155540837|NCT01320722|561404359|FG004|Overall Study|Lost to Follow-up|3|||
155540838|NCT01320722|561404355|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
155540839|NCT01320722|561404356|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
155540840|NCT01320722|561404357|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
155540841|NCT01320722|561404358|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
155540842|NCT01320722|561404359|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
155540843|NCT01320722|561404355|FG000|Overall Study|Participant Developed a Rash|0|||
155540844|NCT01320722|561404356|FG001|Overall Study|Participant Developed a Rash|0|||
155540845|NCT01320722|561404357|FG002|Overall Study|Participant Developed a Rash|2|||
155540846|NCT01320722|561404358|FG003|Overall Study|Participant Developed a Rash|1|||
155540847|NCT01320722|561404359|FG004|Overall Study|Participant Developed a Rash|1|||
155540848|NCT01320722|561404355|FG000|Overall Study|Non-compliant with Medication|0|||
155540849|NCT01320722|561404356|FG001|Overall Study|Non-compliant with Medication|0|||
155540850|NCT01320722|561404357|FG002|Overall Study|Non-compliant with Medication|1|||
155540851|NCT01320722|561404358|FG003|Overall Study|Non-compliant with Medication|0|||
155540852|NCT01320722|561404359|FG004|Overall Study|Non-compliant with Medication|0|||
155540853|NCT01320722|561404355|FG000|Overall Study|Adverse Event|0|||
155540854|NCT01320722|561404356|FG001|Overall Study|Adverse Event|0|||
155540855|NCT01320722|561404357|FG002|Overall Study|Adverse Event|3|||
155540856|NCT01320722|561404358|FG003|Overall Study|Adverse Event|6|||
155540857|NCT01320722|561404359|FG004|Overall Study|Adverse Event|0|||
155540858|NCT01320722|561404355|FG000|Overall Study|Not Compliant with Study Procedures|0|||
155540859|NCT01320722|561404356|FG001|Overall Study|Not Compliant with Study Procedures|0|||
155540860|NCT01320722|561404357|FG002|Overall Study|Not Compliant with Study Procedures|0|||
155540861|NCT01320722|561404358|FG003|Overall Study|Not Compliant with Study Procedures|4|||
155540862|NCT01320722|561404359|FG004|Overall Study|Not Compliant with Study Procedures|0|||
155540863|NCT01320722|561404355|FG000|Overall Study|Pregnancy|0|||
155540864|NCT01320722|561404356|FG001|Overall Study|Pregnancy|0|||
155540865|NCT01320722|561404357|FG002|Overall Study|Pregnancy|0|||
155540866|NCT01320722|561404358|FG003|Overall Study|Pregnancy|1|||
155540867|NCT01320722|561404359|FG004|Overall Study|Pregnancy|0|||
155540868|NCT01320722|561404355|FG000|Overall Study|Started an Exclusionary Medication|0|||
155540869|NCT01320722|561404356|FG001|Overall Study|Started an Exclusionary Medication|0|||
155540870|NCT01320722|561404357|FG002|Overall Study|Started an Exclusionary Medication|0|||
155540871|NCT01320722|561404358|FG003|Overall Study|Started an Exclusionary Medication|0|||
155540872|NCT01320722|561404359|FG004|Overall Study|Started an Exclusionary Medication|1|||
155540873|NCT01320722|561404355|FG000|Overall Study|Withdrew due to Health Condition|0|||
155540874|NCT01320722|561404356|FG001|Overall Study|Withdrew due to Health Condition|0|||
155540875|NCT01320722|561404357|FG002|Overall Study|Withdrew due to Health Condition|0|||
155540876|NCT01320722|561404358|FG003|Overall Study|Withdrew due to Health Condition|0|||
155540877|NCT01320722|561404359|FG004|Overall Study|Withdrew due to Health Condition|1|||
155540878|NCT01091363|561404360|FG000|Overall Study|Withdrawal by Subject|11|||
155540879|NCT01091363|561404361|FG001|Overall Study|Withdrawal by Subject|15|||
155540880|NCT01091363|561404360|FG000|Overall Study|Lost to Follow-up|2|||
155540881|NCT01091363|561404361|FG001|Overall Study|Lost to Follow-up|2|||
155540882|NCT01215721|561404366|FG000|Overall Study|Adverse Event|2|||
155540883|NCT00045162|561404367|FG000|Overall Study|Ineligible|12|||
155540884|NCT00045162|561404368|FG001|Overall Study|Ineligible|8|||
155540885|NCT00045162|561404367|FG000|Overall Study|Not treated|7|||
155540886|NCT00045162|561404368|FG001|Overall Study|Not treated|2|||
155540887|NCT00045162|561404367|FG000|Overall Study|Adverse Event|55|||
155540888|NCT00045162|561404368|FG001|Overall Study|Adverse Event|50|||
155540889|NCT00045162|561404367|FG000|Overall Study|Lack of Efficacy|32|||
155540890|NCT00045162|561404368|FG001|Overall Study|Lack of Efficacy|29|||
155540891|NCT00045162|561404367|FG000|Overall Study|Death|10|||
155540892|NCT00045162|561404368|FG001|Overall Study|Death|10|||
155540893|NCT00045162|561404367|FG000|Overall Study|Withdrawal by Subject|5|||
155540894|NCT00045162|561404368|FG001|Overall Study|Withdrawal by Subject|3|||
155540895|NCT00045162|561404367|FG000|Overall Study|Other|21|||
155540896|NCT00045162|561404368|FG001|Overall Study|Other|16|||
155540897|NCT01044433|561404369|FG000|Overall Study|Lost to Follow-up|3|||
155540898|NCT01044433|561404369|FG000|Overall Study|Withdrawal by Subject|3|||
155540899|NCT00826241|561404370|FG000|Overall Study|Withdrawal from Follow-up|1|||
155540900|NCT00826241|561404370|FG000|Overall Study|Withdrew consent|2|||
155540901|NCT00826241|561404370|FG000|Overall Study|Death|4|||
155540902|NCT00826241|561404370|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
155540903|NCT00826241|561404370|FG000|Overall Study|Non-compliance|1|||
155540904|NCT00826241|561404370|FG000|Overall Study|Progression of disease|1|||
155540905|NCT00826241|561404370|FG000|Overall Study|Patient refused follow-up|3|||
155540906|NCT00826241|561404370|FG000|Overall Study|Lost to Follow-up|9|||
155540907|NCT00826241|561404370|FG000|Overall Study|Could not obtain records|1|||
155540908|NCT00826241|561404370|FG000|Overall Study|Screen failure|2|||
155540909|NCT00826241|561404370|FG000|Overall Study|Pt unable to proceed to registration|1|||
155540910|NCT00826241|561404370|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
155540911|NCT03407729|561404371|FG000|Overall Study|Lost to Follow-up|2|||
155540912|NCT03407729|561404372|FG001|Overall Study|Lost to Follow-up|0|||
155540913|NCT03407729|561404371|FG000|Overall Study|Unable to schedule|0|||
155540914|NCT03407729|561404372|FG001|Overall Study|Unable to schedule|3|||
155540915|NCT00830167|561404375|FG000|Overall Study|Lack of Efficacy|26|||
155540916|NCT00830167|561404376|FG001|Overall Study|Lack of Efficacy|10|||
155540917|NCT00830167|561404375|FG000|Overall Study|Adverse Event|8|||
155540918|NCT00830167|561404376|FG001|Overall Study|Adverse Event|24|||
155540919|NCT00830167|561404375|FG000|Overall Study|Not meeting entrance criteria|2|||
155540920|NCT00830167|561404376|FG001|Overall Study|Not meeting entrance criteria|5|||
155540921|NCT00830167|561404375|FG000|Overall Study|Withdrawal by Subject|2|||
155540922|NCT00830167|561404376|FG001|Overall Study|Withdrawal by Subject|0|||
155540923|NCT00830167|561404375|FG000|Overall Study|Lost to Follow-up|0|||
155540924|NCT00830167|561404376|FG001|Overall Study|Lost to Follow-up|1|||
155540925|NCT00830167|561404375|FG000|Overall Study|Protocol Violation|0|||
155540926|NCT00830167|561404376|FG001|Overall Study|Protocol Violation|1|||
155540927|NCT00830167|561404375|FG000|Overall Study|Other|2|||
155540928|NCT00830167|561404376|FG001|Overall Study|Other|2|||
155540929|NCT00494013|561404377|FG000|Overall Study|Adverse Event|0|||
155540930|NCT00494013|561404378|FG001|Overall Study|Adverse Event|1|||
155540931|NCT00494013|561404377|FG000|Overall Study|Entry Criteria Not Met|1|||
155540932|NCT00494013|561404378|FG001|Overall Study|Entry Criteria Not Met|4|||
155540933|NCT00494013|561404377|FG000|Overall Study|Lost to Follow-up|5|||
155540934|NCT00494013|561404378|FG001|Overall Study|Lost to Follow-up|6|||
155540935|NCT00494013|561404377|FG000|Overall Study|Physician Decision|3|||
155540936|NCT00494013|561404378|FG001|Overall Study|Physician Decision|5|||
155540937|NCT00494013|561404377|FG000|Overall Study|Protocol Violation|8|||
155540938|NCT00494013|561404378|FG001|Overall Study|Protocol Violation|5|||
155540939|NCT00494013|561404377|FG000|Overall Study|Withdrawal by Subject|13|||
155540940|NCT00494013|561404378|FG001|Overall Study|Withdrawal by Subject|14|||
155540941|NCT00494013|561404377|FG000|Overall Study|Sponsor Decision|0|||
155540942|NCT00494013|561404378|FG001|Overall Study|Sponsor Decision|1|||
155540943|NCT01539239|561404379|FG000|Overall Study|Death|5|||
155540944|NCT01539239|561404380|FG001|Overall Study|Death|5|||
155540945|NCT01539239|561404379|FG000|Overall Study|Lost to Follow-up|7|||
155540946|NCT01539239|561404380|FG001|Overall Study|Lost to Follow-up|12|||
155540947|NCT00633022|561404383|FG000|Overall Study|Adverse Event|1|||
155540948|NCT00633022|561404384|FG001|Overall Study|Adverse Event|0|||
155540949|NCT00633022|561404385|FG002|Overall Study|Adverse Event|5|||
155540950|NCT00633022|561404383|FG000|Overall Study|Physician Decision|0|||
155540951|NCT00633022|561404384|FG001|Overall Study|Physician Decision|1|||
155540952|NCT00633022|561404385|FG002|Overall Study|Physician Decision|0|||
155540953|NCT01751087|561404389|FG000|Overall Study|Withdrawal by Subject|1|||
155540954|NCT01751087|561404390|FG001|Overall Study|Withdrawal by Subject|0|||
155540955|NCT01751087|561404391|FG002|Overall Study|Withdrawal by Subject|0|||
155540956|NCT01751087|561404389|FG000|Overall Study|Physician Decision|0|||
155540957|NCT01751087|561404390|FG001|Overall Study|Physician Decision|0|||
155540958|NCT01751087|561404391|FG002|Overall Study|Physician Decision|1|||
155540959|NCT05393271|561405759|FG000|Overall Study|Physician Decision|0|||
155540960|NCT05393271|561405760|FG001|Overall Study|Physician Decision|0|||
155540961|NCT05393271|561405761|FG002|Overall Study|Physician Decision|0|||
155540962|NCT05393271|561405762|FG003|Overall Study|Physician Decision|0|||
155540963|NCT05393271|561405763|FG004|Overall Study|Physician Decision|0|||
155540964|NCT05393271|561405764|FG005|Overall Study|Physician Decision|0|||
155540965|NCT05393271|561405765|FG006|Overall Study|Physician Decision|1|||
155540966|NCT05393271|561405766|FG007|Overall Study|Physician Decision|0|||
155540967|NCT05393271|561405767|FG008|Overall Study|Physician Decision|0|||
155540968|NCT05393271|561405768|FG009|Overall Study|Physician Decision|0|||
155540969|NCT05393271|561405769|FG010|Overall Study|Physician Decision|0|||
155540970|NCT02048813|561405770|FG000|Overall Study|Still on treatment|279|||
155540971|NCT02048813|561405771|FG001|Overall Study|Still on treatment|0|||
155540972|NCT02048813|561405770|FG000|Overall Study|Adverse Event|40|||
155540973|NCT02048813|561405771|FG001|Overall Study|Adverse Event|38|||
155540974|NCT02048813|561405770|FG000|Overall Study|Disease progression|13|||
155540975|NCT02048813|561405771|FG001|Overall Study|Disease progression|3|||
155540976|NCT02048813|561405770|FG000|Overall Study|Withdrawal by Subject|7|||
155540977|NCT02048813|561405771|FG001|Overall Study|Withdrawal by Subject|8|||
155540978|NCT02048813|561405770|FG000|Overall Study|Death|2|||
155540979|NCT02048813|561405771|FG001|Overall Study|Death|1|||
155540980|NCT02048813|561405770|FG000|Overall Study|Complication|2|||
155540981|NCT02048813|561405771|FG001|Overall Study|Complication|2|||
155540982|NCT02048813|561405770|FG000|Overall Study|Non-protocol therapy|0|||
155540983|NCT02048813|561405771|FG001|Overall Study|Non-protocol therapy|1|||
155540984|NCT02048813|561405770|FG000|Overall Study|Second primary cancer|2|||
155540985|NCT02048813|561405771|FG001|Overall Study|Second primary cancer|0|||
155540986|NCT02048813|561405770|FG000|Overall Study|Insurance|2|||
155540987|NCT02048813|561405771|FG001|Overall Study|Insurance|0|||
155540988|NCT02048813|561405770|FG000|Overall Study|Wound infection/healing|2|||
155540989|NCT02048813|561405771|FG001|Overall Study|Wound infection/healing|0|||
155540990|NCT02048813|561405770|FG000|Overall Study|Missed appointment|3|||
155540991|NCT02048813|561405771|FG001|Overall Study|Missed appointment|0|||
155540992|NCT02048813|561405770|FG000|Overall Study|Never started treatment|2|||
155540993|NCT02048813|561405771|FG001|Overall Study|Never started treatment|17|||
155540994|NCT01708954|561405772|FG000|Step 1|Disease progression|26|||
155540995|NCT01708954|561405773|FG001|Step 1|Disease progression|17|||
155540996|NCT01708954|561405774|FG002|Step 1|Disease progression|14|||
155540997|NCT01708954|561405772|FG000|Step 1|Adverse Event|3|||
155540998|NCT01708954|561405773|FG001|Step 1|Adverse Event|11|||
155540999|NCT01708954|561405774|FG002|Step 1|Adverse Event|13|||
155541000|NCT01708954|561405772|FG000|Step 1|Death|3|||
155541001|NCT01708954|561405773|FG001|Step 1|Death|2|||
155541002|NCT01708954|561405774|FG002|Step 1|Death|3|||
155541003|NCT01708954|561405772|FG000|Step 1|Withdrawal by Subject|2|||
155541004|NCT01708954|561405773|FG001|Step 1|Withdrawal by Subject|5|||
155541005|NCT01708954|561405774|FG002|Step 1|Withdrawal by Subject|3|||
155541006|NCT01708954|561405772|FG000|Step 1|Other complicating disease|0|||
155541007|NCT01708954|561405773|FG001|Step 1|Other complicating disease|2|||
155541008|NCT01708954|561405774|FG002|Step 1|Other complicating disease|0|||
155541009|NCT01708954|561405772|FG000|Step 1|Crossed over to Step 2|2|||
155541010|NCT01708954|561405773|FG001|Step 1|Crossed over to Step 2|0|||
155541011|NCT01708954|561405774|FG002|Step 1|Crossed over to Step 2|0|||
155541012|NCT01708954|561405772|FG000|Step 1|Symptomatic deterioration|1|||
155541013|NCT01708954|561405773|FG001|Step 1|Symptomatic deterioration|0|||
155541014|NCT01708954|561405774|FG002|Step 1|Symptomatic deterioration|1|||
155541015|NCT01708954|561405772|FG000|Step 1|Off-treatment reason not submitted|1|||
155541016|NCT01708954|561405773|FG001|Step 1|Off-treatment reason not submitted|1|||
155541017|NCT01708954|561405774|FG002|Step 1|Off-treatment reason not submitted|1|||
155541018|NCT01708954|561405772|FG000|Step 1|Ineligible or never received treatment|4|||
155541019|NCT01708954|561405773|FG001|Step 1|Ineligible or never received treatment|2|||
155541020|NCT01708954|561405774|FG002|Step 1|Ineligible or never received treatment|8|||
155541021|NCT01708954|561405772|FG000|Step 2|Disease progression|9|||
155541022|NCT01708954|561405773|FG001|Step 2|Disease progression|4|||
155541023|NCT01708954|561405774|FG002|Step 2|Disease progression|0|||
155541024|NCT01708954|561405772|FG000|Step 2|Adverse Event|3|||
155541025|NCT01708954|561405773|FG001|Step 2|Adverse Event|2|||
155541026|NCT01708954|561405774|FG002|Step 2|Adverse Event|0|||
155541027|NCT01708954|561405772|FG000|Step 2|Withdrawal by Subject|1|||
155541028|NCT01708954|561405773|FG001|Step 2|Withdrawal by Subject|1|||
155541029|NCT01708954|561405774|FG002|Step 2|Withdrawal by Subject|0|||
155541030|NCT05996198|561405775|FG000|Overall Study|Withdrawal by Subject|1|||
155541031|NCT05996198|561405776|FG001|Overall Study|Withdrawal by Subject|0|||
155541032|NCT01192776|561405777|FG000|Overall Study|Death|8|||
155541033|NCT01192776|561405778|FG001|Overall Study|Death|15|||
155541034|NCT01192776|561405779|FG002|Overall Study|Death|18|||
155541035|NCT01192776|561405780|FG003|Overall Study|Death|15|||
155541036|NCT01192776|561405777|FG000|Overall Study|Lost to Follow-up|3|||
155541037|NCT01192776|561405778|FG001|Overall Study|Lost to Follow-up|6|||
155541038|NCT01192776|561405779|FG002|Overall Study|Lost to Follow-up|3|||
155541039|NCT01192776|561405780|FG003|Overall Study|Lost to Follow-up|5|||
155541040|NCT00413049|561405784|FG000|Overall Study|Adverse Event|10|||
155541041|NCT00413049|561405785|FG001|Overall Study|Adverse Event|8|||
155541042|NCT00413049|561405784|FG000|Overall Study|Withdrawal by Subject|7|||
155541043|NCT00413049|561405785|FG001|Overall Study|Withdrawal by Subject|5|||
155541044|NCT00413049|561405784|FG000|Overall Study|Lost to Follow-up|2|||
155541045|NCT00413049|561405785|FG001|Overall Study|Lost to Follow-up|3|||
155541046|NCT00413049|561405784|FG000|Overall Study|Protocol Violation|3|||
155541047|NCT00413049|561405785|FG001|Overall Study|Protocol Violation|1|||
155541048|NCT00413049|561405784|FG000|Overall Study|Subject no longer requires study drug|0|||
155541049|NCT00413049|561405785|FG001|Overall Study|Subject no longer requires study drug|1|||
155541050|NCT00413049|561405784|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155541051|NCT00413049|561405785|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155541052|NCT00413049|561405784|FG000|Overall Study|Lack of Efficacy|1|||
155541053|NCT00413049|561405785|FG001|Overall Study|Lack of Efficacy|0|||
155541054|NCT00487695|561405790|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
155541055|NCT00487695|561405791|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
155541056|NCT00487695|561405790|FG000|First Procedure|active wheezing (did not have procedure)|1|||
155541057|NCT00487695|561405791|FG001|First Procedure|active wheezing (did not have procedure)|0|||
155541058|NCT00487695|561405790|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
155541059|NCT00487695|561405791|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
155541060|NCT00487695|561405790|FG000|Second Procedure|active wheezing|0|||
155541061|NCT00487695|561405791|FG001|Second Procedure|active wheezing|1|||
155541062|NCT00487695|561405790|FG000|Second Procedure|Withdrawal by Subject|1|||
155541063|NCT00487695|561405791|FG001|Second Procedure|Withdrawal by Subject|2|||
155656148|NCT03895372|561835148|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
155656149|NCT03895372|561835149|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
155541064|NCT02104817|561405792|FG000|Overall Study|Death|363|||
155541065|NCT02104817|561405793|FG001|Overall Study|Death|330|||
155541066|NCT02104817|561405792|FG000|Overall Study|Lost to Follow-up|3|||
155541067|NCT02104817|561405793|FG001|Overall Study|Lost to Follow-up|2|||
155541068|NCT02104817|561405792|FG000|Overall Study|Protocol Violation|0|||
155656150|NCT03895372|561835150|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
155541069|NCT02104817|561405793|FG001|Overall Study|Protocol Violation|1|||
155656151|NCT03895372|561835151|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
155541070|NCT02104817|561405792|FG000|Overall Study|Study terminated by sponsor|5854|||
155541071|NCT02104817|561405793|FG001|Overall Study|Study terminated by sponsor|5901|||
155541072|NCT02104817|561405792|FG000|Overall Study|Withdrawal by Subject|111|||
155541073|NCT02104817|561405793|FG001|Overall Study|Withdrawal by Subject|78|||
155541074|NCT02104817|561405792|FG000|Overall Study|Other reasons|128|||
155541075|NCT02104817|561405793|FG001|Overall Study|Other reasons|135|||
155541076|NCT04633642|561405794|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
155541077|NCT04633642|561405795|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
155541078|NCT00611884|561405796|FG000|Overall Study|Adverse Event|1|||
155541079|NCT00611884|561405797|FG001|Overall Study|Adverse Event|0|||
155541080|NCT00611884|561405798|FG002|Overall Study|Adverse Event|0|||
155541081|NCT00611884|561405799|FG003|Overall Study|Adverse Event|1|||
155541082|NCT00611884|561405796|FG000|Overall Study|Non-Compliance|1|||
155541083|NCT00611884|561405797|FG001|Overall Study|Non-Compliance|4|||
155541084|NCT00611884|561405798|FG002|Overall Study|Non-Compliance|2|||
155541085|NCT00611884|561405799|FG003|Overall Study|Non-Compliance|2|||
155541086|NCT00611884|561405796|FG000|Overall Study|Lack of Efficacy|0|||
155541087|NCT00611884|561405797|FG001|Overall Study|Lack of Efficacy|1|||
155541088|NCT00611884|561405798|FG002|Overall Study|Lack of Efficacy|0|||
155541089|NCT00611884|561405799|FG003|Overall Study|Lack of Efficacy|0|||
155541090|NCT00611884|561405796|FG000|Overall Study|Unclassified|7|||
155541091|NCT00611884|561405797|FG001|Overall Study|Unclassified|4|||
155541092|NCT00611884|561405798|FG002|Overall Study|Unclassified|2|||
155541093|NCT00611884|561405799|FG003|Overall Study|Unclassified|3|||
155541094|NCT00981799|561405800|FG000|Overall Study|Adverse Event|1|||
155541095|NCT00981799|561405801|FG001|Overall Study|Adverse Event|1|||
155541096|NCT00981799|561405802|FG002|Overall Study|Adverse Event|0|||
155541097|NCT00981799|561405803|FG003|Overall Study|Adverse Event|0|||
155541098|NCT00160524|561405804|FG000|Overall Study|Adverse Event|119|||
155541099|NCT00160524|561405804|FG000|Overall Study|Adverse Event and Other|94|||
155541100|NCT00160524|561405804|FG000|Overall Study|Protocol Violation|16|||
155541101|NCT00160524|561405804|FG000|Overall Study|Protocol Violation and Other|2|||
155541102|NCT00160524|561405804|FG000|Overall Study|Withdrawal by Subject|141|||
155541103|NCT00160524|561405804|FG000|Overall Study|Withdrawal by Subject and Other|17|||
155541104|NCT00160524|561405804|FG000|Overall Study|Physician Decision|27|||
155541105|NCT00160524|561405804|FG000|Overall Study|Physician Decision and Other|6|||
155541106|NCT00160524|561405804|FG000|Overall Study|Lost to Follow-up|13|||
155541107|NCT00160524|561405804|FG000|Overall Study|Lost to Follow-up and Other|1|||
155541108|NCT00160524|561405804|FG000|Overall Study|Lack of Efficacy|21|||
155541109|NCT00160524|561405804|FG000|Overall Study|Lack of Efficacy and Other|1|||
155541110|NCT00160524|561405804|FG000|Overall Study|Other|20|||
155541111|NCT04892147|561405805|FG000|Overall Study|Withdrawal by Subject|2|||
155541112|NCT04892147|561405806|FG001|Overall Study|Withdrawal by Subject|0|||
155541113|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
155541114|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
155541115|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
155541116|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
155541117|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
155541118|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
155541119|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
155541120|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
155541121|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
155541122|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
155541123|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
155541124|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
155541125|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
155541126|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
155541127|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
155541128|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
155541129|NCT01067521|561405808|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
155541130|NCT01067521|561405809|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
155541131|NCT01067521|561405808|FG000|Open-Label Period|Death|3|||
155541132|NCT01067521|561405809|FG001|Open-Label Period|Death|1|||
155541133|NCT01067521|561405808|FG000|Open-Label Period|Adverse Event|30|||
155541134|NCT01067521|561405809|FG001|Open-Label Period|Adverse Event|28|||
155541135|NCT01067521|561405808|FG000|Open-Label Period|Withdrawal by Subject|160|||
155541136|NCT01067521|561405809|FG001|Open-Label Period|Withdrawal by Subject|88|||
155541137|NCT01067521|561405808|FG000|Open-Label Period|Physician Decision|13|||
155541138|NCT01067521|561405809|FG001|Open-Label Period|Physician Decision|11|||
155541139|NCT01067521|561405808|FG000|Open-Label Period|Non-compliance with study drug|5|||
155541140|NCT01067521|561405809|FG001|Open-Label Period|Non-compliance with study drug|0|||
155541141|NCT01067521|561405808|FG000|Open-Label Period|Protocol Violation|3|||
155541142|NCT01067521|561405809|FG001|Open-Label Period|Protocol Violation|0|||
155541143|NCT01067521|561405808|FG000|Open-Label Period|Pregnancy|14|||
155541144|NCT01067521|561405809|FG001|Open-Label Period|Pregnancy|8|||
155541145|NCT01067521|561405808|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
155541146|NCT01067521|561405809|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
155541147|NCT01067521|561405808|FG000|Open-Label Period|Lost to Follow-up|21|||
155541148|NCT01067521|561405809|FG001|Open-Label Period|Lost to Follow-up|20|||
155541149|NCT01547728|561405813|FG000|Overall Study|Change in procedure and equipment|1|||
155541150|NCT01547728|561405813|FG000|Overall Study|Drug not ready for subject|1|||
155541151|NCT01547728|561405813|FG000|Overall Study|Screen failure|39|||
155541152|NCT03828539|561405814|FG000|Overall Study|Adverse Event|3|||
155541153|NCT03828539|561405815|FG001|Overall Study|Adverse Event|12|||
155541154|NCT03828539|561405814|FG000|Overall Study|Patient's/guardian's decision|3|||
155541155|NCT03828539|561405815|FG001|Overall Study|Patient's/guardian's decision|5|||
155541156|NCT03828539|561405814|FG000|Overall Study|Lost to Follow-up|4|||
155541157|NCT03828539|561405815|FG001|Overall Study|Lost to Follow-up|2|||
155541158|NCT03828539|561405814|FG000|Overall Study|Protocol Violation|3|||
155541159|NCT03828539|561405815|FG001|Overall Study|Protocol Violation|2|||
155541160|NCT03828539|561405814|FG000|Overall Study|Withdrawal of informed consent|2|||
155541161|NCT03828539|561405815|FG001|Overall Study|Withdrawal of informed consent|1|||
155541162|NCT03828539|561405814|FG000|Overall Study|New therapy for study indication|1|||
155541163|NCT03828539|561405815|FG001|Overall Study|New therapy for study indication|0|||
155541164|NCT01341405|561405816|FG000|Overall Study|Adverse Event|0|||
155541165|NCT01341405|561405817|FG001|Overall Study|Adverse Event|1|||
155541166|NCT01341405|561405818|FG002|Overall Study|Adverse Event|1|||
155541167|NCT01341405|561405816|FG000|Overall Study|Withdrawal by Subject|3|||
155541168|NCT01341405|561405817|FG001|Overall Study|Withdrawal by Subject|2|||
155541169|NCT01341405|561405818|FG002|Overall Study|Withdrawal by Subject|1|||
155541170|NCT02760433|561405819|FG000|Overall Study|Lost to Follow-up|1|||
155541171|NCT02760433|561405820|FG001|Overall Study|Lost to Follow-up|0|||
155541172|NCT02760433|561405821|FG002|Overall Study|Lost to Follow-up|1|||
155541173|NCT02760433|561405822|FG003|Overall Study|Lost to Follow-up|0|||
155541174|NCT02760433|561405823|FG004|Overall Study|Lost to Follow-up|0|||
155541175|NCT02760433|561405819|FG000|Overall Study|Withdrawal by Subject|23|||
155541176|NCT02760433|561405820|FG001|Overall Study|Withdrawal by Subject|9|||
155541177|NCT02760433|561405821|FG002|Overall Study|Withdrawal by Subject|0|||
155541178|NCT02760433|561405822|FG003|Overall Study|Withdrawal by Subject|2|||
155541179|NCT02760433|561405823|FG004|Overall Study|Withdrawal by Subject|9|||
155541180|NCT02760433|561405819|FG000|Overall Study|Lack of Response At Week 14|0|||
155541181|NCT02760433|561405820|FG001|Overall Study|Lack of Response At Week 14|0|||
155541182|NCT02760433|561405821|FG002|Overall Study|Lack of Response At Week 14|0|||
155541183|NCT02760433|561405822|FG003|Overall Study|Lack of Response At Week 14|0|||
155541184|NCT02760433|561405823|FG004|Overall Study|Lack of Response At Week 14|1|||
155541185|NCT02760433|561405819|FG000|Overall Study|Subject refused to continue the study|1|||
155541186|NCT02760433|561405820|FG001|Overall Study|Subject refused to continue the study|0|||
155541187|NCT02760433|561405821|FG002|Overall Study|Subject refused to continue the study|0|||
155541188|NCT02760433|561405822|FG003|Overall Study|Subject refused to continue the study|0|||
155541189|NCT02760433|561405823|FG004|Overall Study|Subject refused to continue the study|0|||
155541190|NCT02760433|561405819|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
155541191|NCT02760433|561405820|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
155541192|NCT02760433|561405821|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
155541193|NCT02760433|561405822|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
155541194|NCT02760433|561405823|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
155541195|NCT02760433|561405819|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
155541196|NCT02760433|561405820|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
155541197|NCT02760433|561405821|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
155541198|NCT02760433|561405822|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
155541199|NCT02760433|561405823|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
155541200|NCT00766493|561405824|FG000|30 Days Post-Procedure|Discontinued|7|||
155541201|NCT00766493|561405824|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
155541202|NCT00766493|561405824|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
155541203|NCT01849458|561405826|FG000|Overall Study|Lost to Follow-up|4|||
155541204|NCT00024258|561405829|FG000|Overall Study|Withdrawal by Subject|1|||
155541205|NCT00024258|561405829|FG000|Overall Study|Disease Progression|8|||
155541206|NCT03950674|561405830|FG000|Overall Study|Death|16|||
155541207|NCT03950674|561405831|FG001|Overall Study|Death|15|||
155541208|NCT03950674|561405830|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
155541209|NCT03950674|561405831|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
155541210|NCT02224053|561405832|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
155541211|NCT02224053|561405832|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
155541212|NCT02224053|561405832|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
155541213|NCT02224053|561405832|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
155541214|NCT02224053|561405832|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
155541215|NCT01898598|561405833|FG000|Overall Study|Adverse Event|1|||
155541216|NCT01898598|561405834|FG001|Overall Study|Adverse Event|0|||
155541217|NCT01898598|561405833|FG000|Overall Study|Withdrawal by Subject|3|||
155541218|NCT01898598|561405834|FG001|Overall Study|Withdrawal by Subject|0|||
155541219|NCT01898598|561405833|FG000|Overall Study|Lost to Follow-up|0|||
155541220|NCT01898598|561405834|FG001|Overall Study|Lost to Follow-up|1|||
155541221|NCT01898598|561405833|FG000|Overall Study|Other|0|||
155541222|NCT01898598|561405834|FG001|Overall Study|Other|1|||
155541223|NCT03833427|561405835|FG000|Overall Study|Death|4|||
155541224|NCT03833427|561405836|FG001|Overall Study|Death|2|||
155541225|NCT03833427|561405837|FG002|Overall Study|Death|9|||
155541226|NCT03833427|561405838|FG003|Overall Study|Death|11|||
155541227|NCT03833427|561405839|FG004|Overall Study|Death|0|||
155541228|NCT03833427|561405840|FG005|Overall Study|Death|0|||
155541229|NCT03833427|561405841|FG006|Overall Study|Death|0|||
155541230|NCT03833427|561405835|FG000|Overall Study|Withdrawal by Subject|0|||
155541231|NCT03833427|561405836|FG001|Overall Study|Withdrawal by Subject|1|||
155541232|NCT03833427|561405837|FG002|Overall Study|Withdrawal by Subject|1|||
155541233|NCT03833427|561405838|FG003|Overall Study|Withdrawal by Subject|0|||
155541234|NCT03833427|561405839|FG004|Overall Study|Withdrawal by Subject|0|||
155541235|NCT03833427|561405840|FG005|Overall Study|Withdrawal by Subject|0|||
155541236|NCT03833427|561405841|FG006|Overall Study|Withdrawal by Subject|0|||
155541237|NCT03833427|561405835|FG000|Overall Study|Sponsor Decision|0|||
155541238|NCT03833427|561405836|FG001|Overall Study|Sponsor Decision|0|||
155541239|NCT03833427|561405837|FG002|Overall Study|Sponsor Decision|1|||
155541240|NCT03833427|561405838|FG003|Overall Study|Sponsor Decision|3|||
155541241|NCT03833427|561405839|FG004|Overall Study|Sponsor Decision|0|||
155541242|NCT03833427|561405840|FG005|Overall Study|Sponsor Decision|0|||
155541243|NCT03833427|561405841|FG006|Overall Study|Sponsor Decision|0|||
155541244|NCT03448692|561405843|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
155541245|NCT03448692|561405844|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
155541246|NCT03448692|561405843|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
155541247|NCT03448692|561405844|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
155541248|NCT03448692|561405843|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
155541249|NCT03448692|561405844|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
155541250|NCT03448692|561405843|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
155541251|NCT03448692|561405844|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
155541252|NCT03448692|561405843|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
155541253|NCT03448692|561405844|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
155541254|NCT03428945|561405847|FG000|Overall Study|Lost to Follow-up|5|||
155541255|NCT03428945|561405848|FG001|Overall Study|Lost to Follow-up|3|||
155541256|NCT03428945|561405847|FG000|Overall Study|Withdrawal by Subject|10|||
155541257|NCT03428945|561405848|FG001|Overall Study|Withdrawal by Subject|10|||
155541258|NCT00982228|561405849|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
155541259|NCT00982228|561405850|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
155541260|NCT00982228|561405849|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
155541261|NCT00982228|561405850|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
155541262|NCT00982228|561405849|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
155541263|NCT00982228|561405850|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
155541264|NCT00982228|561405849|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
155541265|NCT00982228|561405850|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
155541266|NCT00982228|561405849|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
155541267|NCT00982228|561405850|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
155541268|NCT00982228|561405849|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
155541269|NCT00982228|561405850|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
155541270|NCT00982228|561405849|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
155541271|NCT00982228|561405850|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
155541272|NCT00982228|561405849|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
155541273|NCT00982228|561405850|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
155541274|NCT00982228|561405849|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
155541275|NCT00982228|561405850|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
155541276|NCT00982228|561405849|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
155541277|NCT00982228|561405850|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
155541278|NCT00360490|561405854|FG000|Overall Study|Adverse Event|4|||
155541279|NCT00360490|561405855|FG001|Overall Study|Adverse Event|2|||
155541280|NCT00360490|561405854|FG000|Overall Study|Lost to Follow-up|2|||
155541281|NCT00360490|561405855|FG001|Overall Study|Lost to Follow-up|1|||
155541282|NCT00360490|561405854|FG000|Overall Study|Physician Decision|2|||
155541283|NCT00360490|561405855|FG001|Overall Study|Physician Decision|1|||
155541284|NCT00360490|561405854|FG000|Overall Study|Protocol Violation|0|||
155541285|NCT00360490|561405855|FG001|Overall Study|Protocol Violation|4|||
155541286|NCT00360490|561405854|FG000|Overall Study|Withdrawal by Subject|1|||
155541287|NCT00360490|561405855|FG001|Overall Study|Withdrawal by Subject|3|||
155541288|NCT02289820|561405856|FG000|Overall Study|Withdrawal by Subject|2|||
155541289|NCT02289820|561405857|FG001|Overall Study|Withdrawal by Subject|1|||
155541290|NCT02289820|561405858|FG002|Overall Study|Withdrawal by Subject|2|||
155541291|NCT02289820|561405859|FG003|Overall Study|Withdrawal by Subject|1|||
155541292|NCT02289820|561405860|FG004|Overall Study|Withdrawal by Subject|0|||
155541293|NCT02289820|561405861|FG005|Overall Study|Withdrawal by Subject|0|||
155541294|NCT02289820|561405862|FG006|Overall Study|Withdrawal by Subject|1|||
155541295|NCT02289820|561405856|FG000|Overall Study|Death|0|||
155541296|NCT02289820|561405857|FG001|Overall Study|Death|0|||
155541297|NCT02289820|561405858|FG002|Overall Study|Death|1|||
155541298|NCT02289820|561405859|FG003|Overall Study|Death|0|||
155541299|NCT02289820|561405860|FG004|Overall Study|Death|0|||
155541300|NCT02289820|561405861|FG005|Overall Study|Death|0|||
155541301|NCT02289820|561405862|FG006|Overall Study|Death|0|||
155541302|NCT02289820|561405856|FG000|Overall Study|Lost to Follow-up|0|||
155541303|NCT02289820|561405857|FG001|Overall Study|Lost to Follow-up|0|||
155541304|NCT02289820|561405858|FG002|Overall Study|Lost to Follow-up|3|||
155541305|NCT02289820|561405859|FG003|Overall Study|Lost to Follow-up|1|||
155541306|NCT02289820|561405860|FG004|Overall Study|Lost to Follow-up|0|||
155541307|NCT02289820|561405861|FG005|Overall Study|Lost to Follow-up|1|||
155541308|NCT02289820|561405862|FG006|Overall Study|Lost to Follow-up|1|||
155541309|NCT02289820|561405856|FG000|Overall Study|withdrawal of consent|0|||
155541310|NCT02289820|561405857|FG001|Overall Study|withdrawal of consent|1|||
155541311|NCT02289820|561405858|FG002|Overall Study|withdrawal of consent|0|||
155541312|NCT02289820|561405859|FG003|Overall Study|withdrawal of consent|0|||
155541313|NCT02289820|561405860|FG004|Overall Study|withdrawal of consent|0|||
155541314|NCT02289820|561405861|FG005|Overall Study|withdrawal of consent|0|||
155541315|NCT02289820|561405862|FG006|Overall Study|withdrawal of consent|0|||
155541316|NCT02005276|561405863|FG000|Overall Study|No longer interested|5|||
155541317|NCT02005276|561405864|FG001|Overall Study|No longer interested|2|||
155541318|NCT02005276|561405865|FG002|Overall Study|No longer interested|3|||
155541319|NCT02005276|561405866|FG003|Overall Study|No longer interested|3|||
155541320|NCT02786927|561405873|FG000|Overall Study|Adverse Event|1|||
155541321|NCT02786927|561405873|FG000|Overall Study|Protocol Violation|4|||
155541322|NCT01801917|561405874|FG000|Period 1 - Randomized|Adverse Event|1|||
155541323|NCT01801917|561405875|FG001|Period 1 - Randomized|Adverse Event|0|||
155541324|NCT01801917|561405876|FG002|Period 1 - Randomized|Adverse Event|1|||
155541325|NCT01801917|561405877|FG003|Period 1 - Randomized|Adverse Event|0|||
155541326|NCT01924364|561405878|FG000|Overall Study|Physician Decision|3|||
155541327|NCT00265785|561405879|FG000|Overall Study|Adverse Event|4|||
155541328|NCT00265785|561405879|FG000|Overall Study|Withdrawal by Subject|3|||
155541329|NCT00265785|561405879|FG000|Overall Study|Progression/Relapse|15|||
155541330|NCT00265785|561405879|FG000|Overall Study|Not protocol specified|2|||
155541331|NCT00265785|561405879|FG000|Overall Study|Ineligible|1|||
155541332|NCT00265785|561405879|FG000|Overall Study|Did not receive protocol treatment|2|||
155541333|NCT03919695|561405880|FG000|3-month Follow-up|Death|1|||
155541334|NCT03919695|561405881|FG001|3-month Follow-up|Death|1|||
155541335|NCT03919695|561405880|FG000|3-month Follow-up|unable to contact|0|||
155541336|NCT03919695|561405881|FG001|3-month Follow-up|unable to contact|3|||
155541337|NCT03919695|561405880|FG000|3-month Follow-up|in prison|0|||
155541338|NCT03919695|561405881|FG001|3-month Follow-up|in prison|1|||
155541339|NCT03919695|561405880|FG000|6-month Follow-up|Death|0|||
155541340|NCT03919695|561405881|FG001|6-month Follow-up|Death|1|||
155541341|NCT03919695|561405880|FG000|6-month Follow-up|Lost to Follow-up|1|||
155541342|NCT03919695|561405881|FG001|6-month Follow-up|Lost to Follow-up|2|||
155541343|NCT03919695|561405880|FG000|6-month Follow-up|in prison|0|||
155541344|NCT03919695|561405881|FG001|6-month Follow-up|in prison|2|||
155541345|NCT03919695|561405880|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
155541346|NCT03919695|561405881|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
155541347|NCT03919695|561405880|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
155541348|NCT03919695|561405881|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
155541349|NCT01688882|561405882|FG000|Overall Study|Adverse Event|1|||
155541350|NCT01688882|561405883|FG001|Overall Study|Adverse Event|0|||
155541351|NCT01688882|561405882|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155541352|NCT01688882|561405883|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155541353|NCT01688882|561405882|FG000|Overall Study|Administrative problems|1|||
155541354|NCT01688882|561405883|FG001|Overall Study|Administrative problems|0|||
155541355|NCT02416934|561405885|FG000|Overall Study|given steroids|1|||
155541356|NCT02416934|561405886|FG001|Overall Study|given steroids|2|||
155541357|NCT02416934|561405885|FG000|Overall Study|Lost to Follow-up|0|||
155541358|NCT02416934|561405886|FG001|Overall Study|Lost to Follow-up|2|||
155541359|NCT02416934|561405885|FG000|Overall Study|Withdrawal by Subject|1|||
155541360|NCT02416934|561405886|FG001|Overall Study|Withdrawal by Subject|0|||
155541361|NCT02416934|561405885|FG000|Overall Study|recruited during continuing renewal proc|0|||
155541362|NCT02416934|561405886|FG001|Overall Study|recruited during continuing renewal proc|1|||
155541363|NCT02416934|561405885|FG000|Overall Study|Protocol Violation|0|||
155541364|NCT02416934|561405886|FG001|Overall Study|Protocol Violation|1|||
155541365|NCT02416934|561405885|FG000|Overall Study|surgery started late|0|||
155541366|NCT02416934|561405886|FG001|Overall Study|surgery started late|1|||
155541367|NCT02416934|561405885|FG000|Overall Study|re-operation|1|||
155541368|NCT02416934|561405886|FG001|Overall Study|re-operation|0|||
155541369|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
155541370|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
155541371|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
155541372|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
155541373|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
155541374|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
155541375|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
155541376|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
155541377|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
155541378|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
155541379|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
155541380|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
155541381|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
155541382|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
155541383|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
155541384|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
155541385|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
155541386|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
155541387|NCT00950300|561405889|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
155541388|NCT00950300|561405890|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
155541389|NCT00950300|561405889|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
155541390|NCT00950300|561405890|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
155541391|NCT00950300|561405889|FG000|TFFU Period|Death|4|||
155541392|NCT00950300|561405890|FG001|TFFU Period|Death|1|||
155541393|NCT00950300|561405889|FG000|TFFU Period|Refused Treatment|10|||
155541394|NCT00950300|561405890|FG001|TFFU Period|Refused Treatment|11|||
155541395|NCT00950300|561405889|FG000|TFFU Period|Failure to Return|16|||
155541396|NCT00950300|561405890|FG001|TFFU Period|Failure to Return|16|||
155541397|NCT00950300|561405889|FG000|TFFU Period|Recurrence of Disease|63|||
155656152|NCT03895372|561835152|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
155656153|NCT03895372|561835153|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
155656154|NCT03895372|561835154|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
155656155|NCT03895372|561835155|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
155656156|NCT03895372|561835148|FG000|Investigational Treatment Period|Other|0|||
155656157|NCT03895372|561835149|FG001|Investigational Treatment Period|Other|0|||
155656158|NCT03895372|561835150|FG002|Investigational Treatment Period|Other|0|||
155656159|NCT03895372|561835151|FG003|Investigational Treatment Period|Other|0|||
155656160|NCT03895372|561835152|FG004|Investigational Treatment Period|Other|0|||
155541398|NCT00950300|561405890|FG001|TFFU Period|Recurrence of Disease|72|||
155541399|NCT00950300|561405889|FG000|TFFU Period|Other|4|||
155541400|NCT00950300|561405890|FG001|TFFU Period|Other|3|||
155541401|NCT00950300|561405889|FG000|SFU Period|Death|44|||
155541402|NCT00950300|561405890|FG001|SFU Period|Death|42|||
155541403|NCT00950300|561405889|FG000|SFU Period|Lost to Follow-up|30|||
155541404|NCT00950300|561405890|FG001|SFU Period|Lost to Follow-up|28|||
155541405|NCT00950300|561405889|FG000|SFU Period|Withdrawal by Subject|4|||
155541406|NCT00950300|561405890|FG001|SFU Period|Withdrawal by Subject|8|||
155656161|NCT03895372|561835153|FG005|Investigational Treatment Period|Other|1|||
155541407|NCT00124618|561405891|FG000|Overall Study|Ineligible|1|||
155541408|NCT03201003|561405896|FG000|Overall Study|Adverse Event|14|||
155541409|NCT03201003|561405897|FG001|Overall Study|Adverse Event|1|||
155541410|NCT03201003|561405896|FG000|Overall Study|Other reasons|5|||
155541411|NCT03201003|561405897|FG001|Overall Study|Other reasons|1|||
155541412|NCT03201003|561405896|FG000|Overall Study|Withdrawal by Subject|4|||
155541413|NCT03201003|561405897|FG001|Overall Study|Withdrawal by Subject|1|||
155541414|NCT03201003|561405896|FG000|Overall Study|Lost to Follow-up|2|||
155541415|NCT03201003|561405897|FG001|Overall Study|Lost to Follow-up|0|||
155541416|NCT03201003|561405896|FG000|Overall Study|Protocol Violation|1|||
155541417|NCT03201003|561405897|FG001|Overall Study|Protocol Violation|0|||
155541418|NCT00834613|561405898|FG000|First Intervention|Protocol Violation|1|||
155541419|NCT00834613|561405899|FG001|First Intervention|Protocol Violation|0|||
155541420|NCT01709903|561405903|FG000|Overall Study|administrative problems|2|||
155541421|NCT01709903|561405904|FG001|Overall Study|administrative problems|6|||
155541422|NCT01709903|561405903|FG000|Overall Study|Abnormal test procedure results|1|||
155541423|NCT01709903|561405904|FG001|Overall Study|Abnormal test procedure results|0|||
155541424|NCT01709903|561405903|FG000|Overall Study|In ability to use device|1|||
155541425|NCT01709903|561405904|FG001|Overall Study|In ability to use device|1|||
155541426|NCT01709903|561405903|FG000|Overall Study|no longer needed study drug|0|||
155541427|NCT01709903|561405904|FG001|Overall Study|no longer needed study drug|1|||
155541428|NCT01709903|561405903|FG000|Overall Study|Lost to Follow-up|0|||
155541429|NCT01709903|561405904|FG001|Overall Study|Lost to Follow-up|2|||
155541430|NCT01709903|561405903|FG000|Overall Study|Death|2|||
155541431|NCT01709903|561405904|FG001|Overall Study|Death|0|||
155541432|NCT01709903|561405903|FG000|Overall Study|Protocol Violation|3|||
155541433|NCT01709903|561405904|FG001|Overall Study|Protocol Violation|2|||
155541434|NCT01709903|561405903|FG000|Overall Study|Lack of Efficacy|3|||
155541435|NCT01709903|561405904|FG001|Overall Study|Lack of Efficacy|3|||
155541436|NCT01709903|561405903|FG000|Overall Study|Withdrawal by Subject|6|||
155541437|NCT01709903|561405904|FG001|Overall Study|Withdrawal by Subject|6|||
155541438|NCT01709903|561405903|FG000|Overall Study|Adverse Event|11|||
155541439|NCT01709903|561405904|FG001|Overall Study|Adverse Event|18|||
155541440|NCT00697619|561405906|FG000|Overall Study|Lack of Efficacy|2|||
155541441|NCT00697619|561405907|FG001|Overall Study|Lack of Efficacy|2|||
155541442|NCT00697619|561405906|FG000|Overall Study|Adverse Event|4|||
155541443|NCT00697619|561405907|FG001|Overall Study|Adverse Event|6|||
155541444|NCT04662710|561407168|FG000|Overall Study|Death|14|||
155541445|NCT04662710|561407169|FG001|Overall Study|Death|331|||
155541446|NCT04662710|561407170|FG002|Overall Study|Death|367|||
155541447|NCT04662710|561407168|FG000|Overall Study|Ongoing|1|||
155541448|NCT04662710|561407169|FG001|Overall Study|Ongoing|109|||
155541449|NCT04662710|561407170|FG002|Overall Study|Ongoing|56|||
155541450|NCT04662710|561407168|FG000|Overall Study|Withdrawal by Subject|0|||
155541451|NCT04662710|561407169|FG001|Overall Study|Withdrawal by Subject|3|||
155541452|NCT04662710|561407170|FG002|Overall Study|Withdrawal by Subject|14|||
155541453|NCT02722616|561407171|FG000|Overall Study|Sponsor closed study after one month|2|||
155541454|NCT02722616|561407172|FG001|Overall Study|Sponsor closed study after one month|0|||
155541455|NCT02722616|561407173|FG002|Overall Study|Sponsor closed study after one month|0|||
155541456|NCT01705717|561407174|FG000|Overall Study|Adverse Event|2|||
155541457|NCT01705717|561407175|FG001|Overall Study|Adverse Event|2|||
155541458|NCT01705717|561407174|FG000|Overall Study|Lack of Efficacy|0|||
155541459|NCT01705717|561407175|FG001|Overall Study|Lack of Efficacy|1|||
155541460|NCT01705717|561407174|FG000|Overall Study|Other|0|||
155541461|NCT01705717|561407175|FG001|Overall Study|Other|2|||
155541462|NCT00517192|561407180|FG000|Overall Study|Adverse Event|1|||
155541463|NCT00517192|561407181|FG001|Overall Study|Adverse Event|1|||
155541464|NCT00517192|561407180|FG000|Overall Study|Lost to Follow-up|1|||
155541465|NCT00517192|561407181|FG001|Overall Study|Lost to Follow-up|1|||
155541466|NCT00517192|561407180|FG000|Overall Study|Withdrawal by Subject|1|||
155541467|NCT00517192|561407181|FG001|Overall Study|Withdrawal by Subject|0|||
155541468|NCT00517192|561407180|FG000|Overall Study|Early termination of the trial|16|||
155541469|NCT00517192|561407181|FG001|Overall Study|Early termination of the trial|18|||
155541470|NCT02246764|561407183|FG000|Overall Study|Adverse Event|15|||
155541471|NCT02246764|561407184|FG001|Overall Study|Adverse Event|29|||
155541472|NCT02246764|561407185|FG002|Overall Study|Adverse Event|1|||
155541473|NCT02246764|561407183|FG000|Overall Study|Withdrawal by Subject|0|||
155541474|NCT02246764|561407184|FG001|Overall Study|Withdrawal by Subject|0|||
155541475|NCT02246764|561407185|FG002|Overall Study|Withdrawal by Subject|1|||
155541476|NCT02246764|561407183|FG000|Overall Study|Disallowed Concomitant Medication|1|||
155541477|NCT02246764|561407184|FG001|Overall Study|Disallowed Concomitant Medication|0|||
155541478|NCT02246764|561407185|FG002|Overall Study|Disallowed Concomitant Medication|0|||
155541479|NCT02246764|561407183|FG000|Overall Study|Physician Decision|0|||
155541480|NCT02246764|561407184|FG001|Overall Study|Physician Decision|2|||
155541481|NCT02246764|561407185|FG002|Overall Study|Physician Decision|1|||
155541482|NCT02246764|561407183|FG000|Overall Study|Protocol Violation|2|||
155541483|NCT02246764|561407184|FG001|Overall Study|Protocol Violation|1|||
155541484|NCT02246764|561407185|FG002|Overall Study|Protocol Violation|1|||
155541485|NCT03433703|561407186|FG000|Overall Study|Study terminated by Sponsor|2|||
155541486|NCT03223909|561407187|FG000|Overall Study|Protocol Violation|48|||
155541487|NCT03223909|561407188|FG001|Overall Study|Protocol Violation|45|||
155541488|NCT03223909|561407189|FG002|Overall Study|Protocol Violation|16|||
155541489|NCT00098475|561407192|FG000|Step 1|Progressive disease|33|||
155541490|NCT00098475|561407193|FG001|Step 1|Progressive disease|35|||
155541491|NCT00098475|561407194|FG002|Step 1|Progressive disease|2|||
155541492|NCT00098475|561407195|FG003|Step 1|Progressive disease|1|||
155541493|NCT00098475|561407192|FG000|Step 1|Adverse Event|56|||
155541494|NCT00098475|561407193|FG001|Step 1|Adverse Event|37|||
155541495|NCT00098475|561407194|FG002|Step 1|Adverse Event|0|||
155541496|NCT00098475|561407195|FG003|Step 1|Adverse Event|1|||
155541497|NCT00098475|561407192|FG000|Step 1|Death|8|||
155541498|NCT00098475|561407193|FG001|Step 1|Death|5|||
155541499|NCT00098475|561407194|FG002|Step 1|Death|0|||
155541500|NCT00098475|561407195|FG003|Step 1|Death|1|||
155541501|NCT00098475|561407192|FG000|Step 1|Withdrawal by Subject|14|||
155541502|NCT00098475|561407193|FG001|Step 1|Withdrawal by Subject|11|||
155541503|NCT00098475|561407194|FG002|Step 1|Withdrawal by Subject|0|||
155541504|NCT00098475|561407195|FG003|Step 1|Withdrawal by Subject|0|||
155541505|NCT00098475|561407192|FG000|Step 1|Physician Decision|5|||
155541506|NCT00098475|561407193|FG001|Step 1|Physician Decision|2|||
155541507|NCT00098475|561407194|FG002|Step 1|Physician Decision|0|||
155541508|NCT00098475|561407195|FG003|Step 1|Physician Decision|0|||
155541509|NCT00098475|561407192|FG000|Step 1|Alternative therapy|31|||
155541510|NCT00098475|561407193|FG001|Step 1|Alternative therapy|43|||
155541511|NCT00098475|561407194|FG002|Step 1|Alternative therapy|1|||
155541512|NCT00098475|561407195|FG003|Step 1|Alternative therapy|0|||
155541513|NCT00098475|561407192|FG000|Step 1|Other disease|2|||
155541514|NCT00098475|561407193|FG001|Step 1|Other disease|1|||
155541515|NCT00098475|561407194|FG002|Step 1|Other disease|1|||
155541516|NCT00098475|561407195|FG003|Step 1|Other disease|0|||
155541517|NCT00098475|561407192|FG000|Step 1|Never started treatment|0|||
155541518|NCT00098475|561407193|FG001|Step 1|Never started treatment|2|||
155541519|NCT00098475|561407194|FG002|Step 1|Never started treatment|0|||
155541520|NCT00098475|561407195|FG003|Step 1|Never started treatment|0|||
155541521|NCT00098475|561407192|FG000|Step 1|Still on treatment as of this analysis|14|||
155541522|NCT00098475|561407193|FG001|Step 1|Still on treatment as of this analysis|27|||
155541523|NCT00098475|561407194|FG002|Step 1|Still on treatment as of this analysis|0|||
155541524|NCT00098475|561407195|FG003|Step 1|Still on treatment as of this analysis|0|||
155541525|NCT00098475|561407192|FG000|Step 1|Knee surgery|1|||
155541526|NCT00098475|561407193|FG001|Step 1|Knee surgery|0|||
155541527|NCT00098475|561407194|FG002|Step 1|Knee surgery|0|||
155541528|NCT00098475|561407195|FG003|Step 1|Knee surgery|0|||
155541529|NCT00098475|561407192|FG000|Step 1|Complications|1|||
155541530|NCT00098475|561407193|FG001|Step 1|Complications|0|||
155541531|NCT00098475|561407194|FG002|Step 1|Complications|0|||
155541532|NCT00098475|561407195|FG003|Step 1|Complications|0|||
155541533|NCT00098475|561407192|FG000|Step 1|Cannot comply due to other tx|0|||
155541534|NCT00098475|561407193|FG001|Step 1|Cannot comply due to other tx|1|||
155541535|NCT00098475|561407194|FG002|Step 1|Cannot comply due to other tx|0|||
155541536|NCT00098475|561407195|FG003|Step 1|Cannot comply due to other tx|0|||
155541537|NCT00098475|561407192|FG000|Step 1|Both patient and physician's decision|2|||
155541538|NCT00098475|561407193|FG001|Step 1|Both patient and physician's decision|1|||
155541539|NCT00098475|561407194|FG002|Step 1|Both patient and physician's decision|0|||
155541540|NCT00098475|561407195|FG003|Step 1|Both patient and physician's decision|0|||
155541541|NCT00098475|561407192|FG000|Step 1|Incorrect disease assessment|2|||
155541542|NCT00098475|561407193|FG001|Step 1|Incorrect disease assessment|0|||
155541543|NCT00098475|561407194|FG002|Step 1|Incorrect disease assessment|0|||
155541544|NCT00098475|561407195|FG003|Step 1|Incorrect disease assessment|0|||
155541545|NCT00098475|561407192|FG000|Step 1|Off treatment for > specified timeframe|1|||
155541546|NCT00098475|561407193|FG001|Step 1|Off treatment for > specified timeframe|1|||
155541547|NCT00098475|561407194|FG002|Step 1|Off treatment for > specified timeframe|0|||
155541548|NCT00098475|561407195|FG003|Step 1|Off treatment for > specified timeframe|0|||
155541549|NCT00098475|561407192|FG000|Step 1|Declining performance status|0|||
155541550|NCT00098475|561407193|FG001|Step 1|Declining performance status|1|||
155541551|NCT00098475|561407194|FG002|Step 1|Declining performance status|0|||
155541552|NCT00098475|561407195|FG003|Step 1|Declining performance status|0|||
155541553|NCT00098475|561407192|FG000|Step 1|Insurance issue|0|||
155541554|NCT00098475|561407193|FG001|Step 1|Insurance issue|1|||
155541555|NCT00098475|561407194|FG002|Step 1|Insurance issue|0|||
155541556|NCT00098475|561407195|FG003|Step 1|Insurance issue|0|||
155541557|NCT00098475|561407192|FG000|Step 1|Rising paraprotein|0|||
155541558|NCT00098475|561407193|FG001|Step 1|Rising paraprotein|1|||
155541559|NCT00098475|561407194|FG002|Step 1|Rising paraprotein|0|||
155541560|NCT00098475|561407195|FG003|Step 1|Rising paraprotein|0|||
155541561|NCT00098475|561407192|FG000|Step 1|Referred to other physicians|0|||
155541562|NCT00098475|561407193|FG001|Step 1|Referred to other physicians|1|||
155541563|NCT00098475|561407194|FG002|Step 1|Referred to other physicians|0|||
155541564|NCT00098475|561407195|FG003|Step 1|Referred to other physicians|0|||
155541565|NCT00098475|561407192|FG000|Step 1|Criteria to continue treatment not met|0|||
155541566|NCT00098475|561407193|FG001|Step 1|Criteria to continue treatment not met|1|||
155541567|NCT00098475|561407194|FG002|Step 1|Criteria to continue treatment not met|0|||
155541568|NCT00098475|561407195|FG003|Step 1|Criteria to continue treatment not met|0|||
155541569|NCT00098475|561407192|FG000|Step 1|Misinterpretation of lab data|0|||
155541570|NCT00098475|561407193|FG001|Step 1|Misinterpretation of lab data|1|||
155541571|NCT00098475|561407194|FG002|Step 1|Misinterpretation of lab data|0|||
155541572|NCT00098475|561407195|FG003|Step 1|Misinterpretation of lab data|0|||
155541573|NCT00098475|561407192|FG000|Step 1|Patient fell with fracture|1|||
155541574|NCT00098475|561407193|FG001|Step 1|Patient fell with fracture|0|||
155541575|NCT00098475|561407194|FG002|Step 1|Patient fell with fracture|0|||
155541576|NCT00098475|561407195|FG003|Step 1|Patient fell with fracture|0|||
155541577|NCT00098475|561407192|FG000|Step 1|Not documented|0|||
155541578|NCT00098475|561407193|FG001|Step 1|Not documented|1|||
155541579|NCT00098475|561407194|FG002|Step 1|Not documented|0|||
155541580|NCT00098475|561407195|FG003|Step 1|Not documented|0|||
155541581|NCT00098475|561407192|FG000|Step 2|Disease progression|1|||
155541582|NCT00098475|561407193|FG001|Step 2|Disease progression|4|||
155541583|NCT00098475|561407194|FG002|Step 2|Disease progression|0|||
155541584|NCT00098475|561407195|FG003|Step 2|Disease progression|0|||
155541585|NCT00098475|561407192|FG000|Step 2|Adverse Event|2|||
155541586|NCT00098475|561407193|FG001|Step 2|Adverse Event|0|||
155541587|NCT00098475|561407194|FG002|Step 2|Adverse Event|0|||
155541588|NCT00098475|561407195|FG003|Step 2|Adverse Event|0|||
155541589|NCT00098475|561407192|FG000|Step 2|Withdrawal by Subject|0|||
155541590|NCT00098475|561407193|FG001|Step 2|Withdrawal by Subject|2|||
155541591|NCT00098475|561407194|FG002|Step 2|Withdrawal by Subject|0|||
155541592|NCT00098475|561407195|FG003|Step 2|Withdrawal by Subject|0|||
155541593|NCT00098475|561407192|FG000|Step 2|Physician Decision|0|||
155541594|NCT00098475|561407193|FG001|Step 2|Physician Decision|1|||
155541595|NCT00098475|561407194|FG002|Step 2|Physician Decision|0|||
155541596|NCT00098475|561407195|FG003|Step 2|Physician Decision|0|||
155541597|NCT00098475|561407192|FG000|Step 2|Alternative therapy|1|||
155541598|NCT00098475|561407193|FG001|Step 2|Alternative therapy|2|||
155541599|NCT00098475|561407194|FG002|Step 2|Alternative therapy|0|||
155541600|NCT00098475|561407195|FG003|Step 2|Alternative therapy|0|||
155541601|NCT00098475|561407192|FG000|Step 2|Never started treatment|1|||
155541602|NCT00098475|561407193|FG001|Step 2|Never started treatment|1|||
155541603|NCT00098475|561407194|FG002|Step 2|Never started treatment|0|||
155541604|NCT00098475|561407195|FG003|Step 2|Never started treatment|0|||
155541605|NCT03422068|561407196|FG000|Overall Study|Adverse Event|0|||
155541606|NCT03422068|561407197|FG001|Overall Study|Adverse Event|1|||
155541607|NCT03422068|561407196|FG000|Overall Study|Inconvenience to frequent study visits|0|||
155541608|NCT03422068|561407197|FG001|Overall Study|Inconvenience to frequent study visits|1|||
155541609|NCT01583530|561407198|FG000|Overall Study|Adverse Event|0|||
155541610|NCT01583530|561407199|FG001|Overall Study|Adverse Event|0|||
155541611|NCT01583530|561407200|FG002|Overall Study|Adverse Event|0|||
155541612|NCT01583530|561407201|FG003|Overall Study|Adverse Event|0|||
155541613|NCT01583530|561407202|FG004|Overall Study|Adverse Event|0|||
155541614|NCT01583530|561407203|FG005|Overall Study|Adverse Event|1|||
155541615|NCT01583530|561407198|FG000|Overall Study|Withdrawal by Subject|0|||
155541616|NCT01583530|561407199|FG001|Overall Study|Withdrawal by Subject|3|||
155541617|NCT01583530|561407200|FG002|Overall Study|Withdrawal by Subject|0|||
155541618|NCT01583530|561407201|FG003|Overall Study|Withdrawal by Subject|1|||
155541619|NCT01583530|561407202|FG004|Overall Study|Withdrawal by Subject|1|||
155541620|NCT01583530|561407203|FG005|Overall Study|Withdrawal by Subject|2|||
155541621|NCT01583530|561407198|FG000|Overall Study|Lost to Follow-up|0|||
155541622|NCT01583530|561407199|FG001|Overall Study|Lost to Follow-up|0|||
155541623|NCT01583530|561407200|FG002|Overall Study|Lost to Follow-up|0|||
155541624|NCT01583530|561407201|FG003|Overall Study|Lost to Follow-up|0|||
155541625|NCT01583530|561407202|FG004|Overall Study|Lost to Follow-up|3|||
155541626|NCT01583530|561407203|FG005|Overall Study|Lost to Follow-up|0|||
155541627|NCT01583530|561407198|FG000|Overall Study|Lack of compliance|0|||
155541628|NCT01583530|561407199|FG001|Overall Study|Lack of compliance|0|||
155541629|NCT01583530|561407200|FG002|Overall Study|Lack of compliance|0|||
155541630|NCT01583530|561407201|FG003|Overall Study|Lack of compliance|0|||
155541631|NCT01583530|561407202|FG004|Overall Study|Lack of compliance|1|||
155541632|NCT01583530|561407203|FG005|Overall Study|Lack of compliance|0|||
155541633|NCT02416180|561407204|FG000|Overall Study|Withdrawal by Subject|1|||
155541634|NCT02985398|561407205|FG000|Overall Study|Adverse Event|1|||
155541635|NCT02985398|561407205|FG000|Overall Study|Lost to Follow-up|4|||
155541636|NCT02985398|561407205|FG000|Overall Study|Withdrawal by Subject|8|||
155541637|NCT02985398|561407205|FG000|Overall Study|Study Burden|9|||
155541638|NCT00046839|561407210|FG000|Overall Study|Ineligible / No protocol treatment|0|||
155541639|NCT00046839|561407211|FG001|Overall Study|Ineligible / No protocol treatment|2|||
155541640|NCT00046839|561407210|FG000|Overall Study|Withdrawal of consent|1|||
155541641|NCT00046839|561407211|FG001|Overall Study|Withdrawal of consent|0|||
155541642|NCT02472639|561407212|FG000|Overall Study|Physician Decision|4|||
155541643|NCT02472639|561407213|FG001|Overall Study|Physician Decision|3|||
155541644|NCT00751023|561407216|FG000|Overall Study|Lost to Follow-up|11|||
155541645|NCT00751023|561407217|FG001|Overall Study|Lost to Follow-up|7|||
155541646|NCT02050321|561407218|FG000|Overall Study|Withdrawal by Subject|1|||
155541647|NCT02050321|561407218|FG000|Overall Study|Adverse Event|1|||
155541648|NCT04768114|561407220|FG000|Overall Study|Lost to Follow-up|5|||
155541649|NCT04768114|561407221|FG001|Overall Study|Lost to Follow-up|10|||
155541650|NCT04768114|561407220|FG000|Overall Study|Withdrawal by Subject|0|||
155541651|NCT04768114|561407221|FG001|Overall Study|Withdrawal by Subject|1|||
155541652|NCT00715676|561407229|FG000|Overall Study|Adverse Event|3|||
155541653|NCT00715676|561407230|FG001|Overall Study|Adverse Event|5|||
155541654|NCT00715676|561407231|FG002|Overall Study|Adverse Event|21|||
155541655|NCT00715676|561407229|FG000|Overall Study|Withdrawal by Subject|1|||
155541656|NCT00715676|561407230|FG001|Overall Study|Withdrawal by Subject|3|||
155541657|NCT00715676|561407231|FG002|Overall Study|Withdrawal by Subject|8|||
155541658|NCT00715676|561407229|FG000|Overall Study|Lost to Follow-up|1|||
155541659|NCT00715676|561407230|FG001|Overall Study|Lost to Follow-up|2|||
155541660|NCT00715676|561407231|FG002|Overall Study|Lost to Follow-up|1|||
155541661|NCT00715676|561407229|FG000|Overall Study|Terminated by Sponsor|1|||
155541662|NCT00715676|561407230|FG001|Overall Study|Terminated by Sponsor|0|||
155541663|NCT00715676|561407231|FG002|Overall Study|Terminated by Sponsor|0|||
155541664|NCT00715676|561407229|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
155541665|NCT00715676|561407230|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
155541666|NCT00715676|561407231|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
155541667|NCT00715676|561407229|FG000|Overall Study|Use of Exclusionary Medication|0|||
155541668|NCT00715676|561407230|FG001|Overall Study|Use of Exclusionary Medication|0|||
155541669|NCT00715676|561407231|FG002|Overall Study|Use of Exclusionary Medication|1|||
155541670|NCT00715676|561407229|FG000|Overall Study|Elevated Blood Glucose|0|||
155541671|NCT00715676|561407230|FG001|Overall Study|Elevated Blood Glucose|1|||
155541672|NCT00715676|561407231|FG002|Overall Study|Elevated Blood Glucose|0|||
155541673|NCT01963260|561407232|FG000|Overall Study|Withdrawal by Subject|2|||
155541674|NCT01963260|561407233|FG001|Overall Study|Withdrawal by Subject|0|||
155541675|NCT01963260|561407234|FG002|Overall Study|Withdrawal by Subject|0|||
155541676|NCT01963260|561407235|FG003|Overall Study|Withdrawal by Subject|1|||
155541677|NCT01963260|561407236|FG004|Overall Study|Withdrawal by Subject|2|||
155541678|NCT01963260|561407237|FG005|Overall Study|Withdrawal by Subject|0|||
155541679|NCT01963260|561407238|FG006|Overall Study|Withdrawal by Subject|0|||
155541680|NCT01963260|561407239|FG007|Overall Study|Withdrawal by Subject|0|||
155541681|NCT01963260|561407240|FG008|Overall Study|Withdrawal by Subject|0|||
155541682|NCT01963260|561407241|FG009|Overall Study|Withdrawal by Subject|0|||
155541683|NCT00057941|561407242|FG000|Overall Study|Death|1|||
155541684|NCT00057941|561407243|FG001|Overall Study|Death|2|||
155541685|NCT00057941|561407242|FG000|Overall Study|Adverse Event|7|||
155541686|NCT00057941|561407243|FG001|Overall Study|Adverse Event|9|||
155541687|NCT00057941|561407242|FG000|Overall Study|Lack of Efficacy|54|||
155541688|NCT00057941|561407243|FG001|Overall Study|Lack of Efficacy|53|||
155541689|NCT00057941|561407242|FG000|Overall Study|Withdrawal by Subject|6|||
155541690|NCT00057941|561407243|FG001|Overall Study|Withdrawal by Subject|1|||
155541691|NCT00057941|561407242|FG000|Overall Study|still on treatment|3|||
155541692|NCT00057941|561407243|FG001|Overall Study|still on treatment|1|||
155541693|NCT00057941|561407242|FG000|Overall Study|insurance, symptomatic deterioration|1|||
155541694|NCT00057941|561407243|FG001|Overall Study|insurance, symptomatic deterioration|3|||
155541695|NCT00057941|561407242|FG000|Overall Study|Ineligible|2|||
155541696|NCT00057941|561407243|FG001|Overall Study|Ineligible|5|||
155541697|NCT01863433|561407246|FG000|Overall Study|Protocol Violation|1|||
155541698|NCT00860262|561407251|FG000|Overall Study|Adverse Event|9|||
155541699|NCT00860262|561407252|FG001|Overall Study|Adverse Event|6|||
155541700|NCT00860262|561407253|FG002|Overall Study|Adverse Event|7|||
155541701|NCT00860262|561407251|FG000|Overall Study|Protocol Violation|0|||
155541702|NCT00860262|561407252|FG001|Overall Study|Protocol Violation|1|||
155541703|NCT00860262|561407253|FG002|Overall Study|Protocol Violation|0|||
155541704|NCT00860262|561407251|FG000|Overall Study|Lost to Follow-up|2|||
155541705|NCT00860262|561407252|FG001|Overall Study|Lost to Follow-up|0|||
155541706|NCT00860262|561407253|FG002|Overall Study|Lost to Follow-up|1|||
155541707|NCT00860262|561407251|FG000|Overall Study|Withdrawal by Subject|4|||
155541708|NCT00860262|561407252|FG001|Overall Study|Withdrawal by Subject|8|||
155541709|NCT00860262|561407253|FG002|Overall Study|Withdrawal by Subject|6|||
155541710|NCT00860262|561407251|FG000|Overall Study|Lack of Efficacy|0|||
155541711|NCT00860262|561407252|FG001|Overall Study|Lack of Efficacy|4|||
155541712|NCT00860262|561407253|FG002|Overall Study|Lack of Efficacy|3|||
155541713|NCT00860262|561407251|FG000|Overall Study|Other|5|||
155541714|NCT00860262|561407252|FG001|Overall Study|Other|3|||
155541715|NCT00860262|561407253|FG002|Overall Study|Other|1|||
155541716|NCT05467540|561407254|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
155541717|NCT05467540|561407254|FG000|3-Month Follow-up|Lost to Follow-up|4|||
155541718|NCT05467540|561407254|FG000|3-Month Follow-up|Death|5|||
155541719|NCT05467540|561407254|FG000|12-Month Follow-up|Lost to Follow-up|6|||
155541720|NCT05467540|561407254|FG000|12-Month Follow-up|Death|8|||
155541721|NCT05467540|561407254|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
155541722|NCT03382041|561407278|FG000|Overall Study|Consent Form Lost|2|||
155541723|NCT03382041|561407279|FG001|Overall Study|Consent Form Lost|1|||
155541724|NCT03382041|561407278|FG000|Overall Study|Withdrawal by Subject|1|||
155541725|NCT03382041|561407279|FG001|Overall Study|Withdrawal by Subject|4|||
155541726|NCT03382041|561407278|FG000|Overall Study|Lost to Follow-up|1|||
155541727|NCT03382041|561407279|FG001|Overall Study|Lost to Follow-up|4|||
155541728|NCT01374451|561407282|FG000|Overall Study|Administrative problems|1|||
155541729|NCT01374451|561407283|FG001|Overall Study|Administrative problems|0|||
155541730|NCT00089973|561407284|FG000|Overall Study|Adverse Event|3|||
155541731|NCT00089973|561407284|FG000|Overall Study|Withdrawal by Subject|1|||
155541732|NCT00089973|561407284|FG000|Overall Study|Disease progression|45|||
155541733|NCT00089973|561407284|FG000|Overall Study|Death|1|||
155541734|NCT03493919|561407288|FG000|Overall Study|Other|2|||
155541735|NCT03493919|561407289|FG001|Overall Study|Other|0|||
155541736|NCT03493919|561407290|FG002|Overall Study|Other|1|||
155541737|NCT03493919|561407291|FG003|Overall Study|Other|0|||
155541738|NCT03493919|561407288|FG000|Overall Study|Withdrawal by Subject|9|||
155541739|NCT03493919|561407289|FG001|Overall Study|Withdrawal by Subject|3|||
155541740|NCT03493919|561407290|FG002|Overall Study|Withdrawal by Subject|1|||
155541741|NCT03493919|561407291|FG003|Overall Study|Withdrawal by Subject|1|||
155541742|NCT03493919|561407288|FG000|Overall Study|Lost to Follow-up|5|||
155541743|NCT03493919|561407289|FG001|Overall Study|Lost to Follow-up|0|||
155541744|NCT03493919|561407290|FG002|Overall Study|Lost to Follow-up|0|||
155541745|NCT03493919|561407291|FG003|Overall Study|Lost to Follow-up|3|||
155541746|NCT03493919|561407288|FG000|Overall Study|Adverse Event|0|||
155541747|NCT03493919|561407289|FG001|Overall Study|Adverse Event|1|||
155541748|NCT03493919|561407290|FG002|Overall Study|Adverse Event|0|||
155541749|NCT03493919|561407291|FG003|Overall Study|Adverse Event|0|||
155541750|NCT01337596|561407292|FG000|Overall Study|Withdrawal by Subject|0|||
155541751|NCT01337596|561407293|FG001|Overall Study|Withdrawal by Subject|0|||
155541752|NCT01337596|561407294|FG002|Overall Study|Withdrawal by Subject|0|||
155541753|NCT01337596|561407295|FG003|Overall Study|Withdrawal by Subject|0|||
155541754|NCT01337596|561407296|FG004|Overall Study|Withdrawal by Subject|2|||
155541755|NCT01337596|561407297|FG005|Overall Study|Withdrawal by Subject|0|||
155541756|NCT01337596|561407298|FG006|Overall Study|Withdrawal by Subject|0|||
155541757|NCT01337596|561407299|FG007|Overall Study|Withdrawal by Subject|0|||
155541758|NCT01337596|561407300|FG008|Overall Study|Withdrawal by Subject|0|||
155541759|NCT04640194|561407301|FG000|Overall Study|Adverse Event|3|||
155541760|NCT04640194|561407302|FG001|Overall Study|Adverse Event|7|||
155541761|NCT04640194|561407303|FG002|Overall Study|Adverse Event|0|||
155541762|NCT04640194|561407304|FG003|Overall Study|Adverse Event|5|||
155541763|NCT04640194|561407305|FG004|Overall Study|Adverse Event|0|||
155541764|NCT04640194|561407306|FG005|Overall Study|Adverse Event|4|||
155541765|NCT04640194|561407307|FG006|Overall Study|Adverse Event|0|||
155541766|NCT04640194|561407301|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
155541767|NCT04640194|561407302|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
155541768|NCT04640194|561407303|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
155541769|NCT04640194|561407304|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
155541770|NCT04640194|561407305|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
155541771|NCT04640194|561407306|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
155541772|NCT04640194|561407307|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
155541773|NCT04640194|561407301|FG000|Overall Study|fibrinogen level too low|0|||
155541774|NCT04640194|561407302|FG001|Overall Study|fibrinogen level too low|0|||
155541775|NCT04640194|561407303|FG002|Overall Study|fibrinogen level too low|0|||
155541776|NCT04640194|561407304|FG003|Overall Study|fibrinogen level too low|1|||
155541777|NCT04640194|561407305|FG004|Overall Study|fibrinogen level too low|0|||
155541778|NCT04640194|561407306|FG005|Overall Study|fibrinogen level too low|0|||
155541779|NCT04640194|561407307|FG006|Overall Study|fibrinogen level too low|0|||
155541780|NCT04640194|561407301|FG000|Overall Study|mild bleeding|0|||
155541781|NCT04640194|561407302|FG001|Overall Study|mild bleeding|0|||
155541782|NCT04640194|561407303|FG002|Overall Study|mild bleeding|0|||
155541783|NCT04640194|561407304|FG003|Overall Study|mild bleeding|1|||
155541784|NCT04640194|561407305|FG004|Overall Study|mild bleeding|0|||
155541785|NCT04640194|561407306|FG005|Overall Study|mild bleeding|0|||
155541786|NCT04640194|561407307|FG006|Overall Study|mild bleeding|0|||
155541787|NCT04640194|561407301|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541788|NCT04640194|561407302|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
155541789|NCT04640194|561407303|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541790|NCT04640194|561407304|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541791|NCT04640194|561407305|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541792|NCT04640194|561407306|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541793|NCT04640194|561407307|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
155541794|NCT04490057|561407313|FG000|Stage 1|Death|1|||
155541795|NCT04490057|561407314|FG001|Stage 1|Death|2|||
155541796|NCT04490057|561407315|FG002|Stage 1|Death|0|||
155541797|NCT04490057|561407316|FG003|Stage 1|Death|0|||
155541798|NCT04490057|561407317|FG004|Stage 1|Death|0|||
155541799|NCT04490057|561407318|FG005|Stage 1|Death|0|||
155541800|NCT04490057|561407319|FG006|Stage 1|Death|0|||
155541801|NCT04490057|561407320|FG007|Stage 1|Death|0|||
155541802|NCT04490057|561407313|FG000|Stage 1|Withdrawal by Subject|2|||
155541803|NCT04490057|561407314|FG001|Stage 1|Withdrawal by Subject|0|||
155541804|NCT04490057|561407315|FG002|Stage 1|Withdrawal by Subject|0|||
155541805|NCT04490057|561407316|FG003|Stage 1|Withdrawal by Subject|0|||
155541806|NCT04490057|561407317|FG004|Stage 1|Withdrawal by Subject|0|||
155541807|NCT04490057|561407318|FG005|Stage 1|Withdrawal by Subject|0|||
155541808|NCT04490057|561407319|FG006|Stage 1|Withdrawal by Subject|0|||
155541809|NCT04490057|561407320|FG007|Stage 1|Withdrawal by Subject|0|||
155541810|NCT04490057|561407313|FG000|Stage 2|Death|0|||
155541811|NCT04490057|561407314|FG001|Stage 2|Death|0|||
155541812|NCT04490057|561407315|FG002|Stage 2|Death|0|||
155541813|NCT04490057|561407316|FG003|Stage 2|Death|0|||
155541814|NCT04490057|561407317|FG004|Stage 2|Death|1|||
155541815|NCT04490057|561407318|FG005|Stage 2|Death|0|||
155541816|NCT04490057|561407319|FG006|Stage 2|Death|0|||
155541817|NCT04490057|561407320|FG007|Stage 2|Death|0|||
155541818|NCT04490057|561407313|FG000|Stage 2|Lost to Follow-up|0|||
155541819|NCT04490057|561407314|FG001|Stage 2|Lost to Follow-up|0|||
155541820|NCT04490057|561407315|FG002|Stage 2|Lost to Follow-up|0|||
155541821|NCT04490057|561407316|FG003|Stage 2|Lost to Follow-up|11|||
155541822|NCT04490057|561407317|FG004|Stage 2|Lost to Follow-up|17|||
155541823|NCT04490057|561407318|FG005|Stage 2|Lost to Follow-up|4|||
155541824|NCT04490057|561407319|FG006|Stage 2|Lost to Follow-up|21|||
155541825|NCT04490057|561407320|FG007|Stage 2|Lost to Follow-up|14|||
155541826|NCT04584983|561407322|FG000|Overall Study|Parental request for withdraw|2|||
155541827|NCT04584983|561407323|FG001|Overall Study|Parental request for withdraw|0|||
155541828|NCT05377489|561407324|FG000|Overall Study|Withdrawal by Subject|122|||
155541829|NCT05377489|561407324|FG000|Overall Study|Lost to Follow-up|21|||
155541830|NCT05377489|561407324|FG000|Overall Study|Lack of Efficacy|10|||
155541831|NCT05377489|561407324|FG000|Overall Study|Adverse Event|5|||
155541832|NCT05377489|561407324|FG000|Overall Study|Death|4|||
155541833|NCT05377489|561407324|FG000|Overall Study|Physician Decision|3|||
155541834|NCT05377489|561407324|FG000|Overall Study|Protocol Violation|1|||
155541835|NCT05377489|561407324|FG000|Overall Study|Other|9|||
155541836|NCT00724958|561407325|FG000|Overall Study|Adverse Event|28|||
155541837|NCT00724958|561407325|FG000|Overall Study|Loss of Response|40|||
155541838|NCT00724958|561407325|FG000|Overall Study|No Response|18|||
155541839|NCT00724958|561407325|FG000|Overall Study|Remission|7|||
155541840|NCT00724958|561407325|FG000|Overall Study|Other Reason|76|||
155541841|NCT00724958|561407325|FG000|Overall Study|No documentation for end of therapy|13|||
155541842|NCT05480800|561408669|FG000|Overall Study|Withdrawal by Subject|0|||
155541843|NCT05480800|561408670|FG001|Overall Study|Withdrawal by Subject|0|||
155541844|NCT05480800|561408671|FG002|Overall Study|Withdrawal by Subject|2|||
155541845|NCT05480800|561408672|FG003|Overall Study|Withdrawal by Subject|1|||
155541846|NCT05480800|561408673|FG004|Overall Study|Withdrawal by Subject|0|||
155541847|NCT05480800|561408674|FG005|Overall Study|Withdrawal by Subject|0|||
155541848|NCT05480800|561408675|FG006|Overall Study|Withdrawal by Subject|1|||
155541849|NCT05480800|561408676|FG007|Overall Study|Withdrawal by Subject|0|||
155541850|NCT05480800|561408669|FG000|Overall Study|Other|0|||
155541851|NCT05480800|561408670|FG001|Overall Study|Other|0|||
155541852|NCT05480800|561408671|FG002|Overall Study|Other|0|||
155541853|NCT05480800|561408672|FG003|Overall Study|Other|0|||
155541854|NCT05480800|561408673|FG004|Overall Study|Other|0|||
155541855|NCT05480800|561408674|FG005|Overall Study|Other|0|||
155541856|NCT05480800|561408675|FG006|Overall Study|Other|1|||
155541857|NCT05480800|561408676|FG007|Overall Study|Other|0|||
155541858|NCT00676650|561408681|FG000|Overall Study|Death|45|||
155541859|NCT00676650|561408682|FG001|Overall Study|Death|14|||
155541860|NCT00676650|561408681|FG000|Overall Study|Adverse Event|159|||
155541861|NCT00676650|561408682|FG001|Overall Study|Adverse Event|21|||
155541862|NCT00676650|561408681|FG000|Overall Study|Global deterioration of health status|66|||
155541863|NCT00676650|561408682|FG001|Overall Study|Global deterioration of health status|31|||
155541864|NCT00676650|561408681|FG000|Overall Study|Lost to Follow-up|0|||
155541865|NCT00676650|561408682|FG001|Overall Study|Lost to Follow-up|1|||
155541866|NCT00676650|561408681|FG000|Overall Study|Objective progression or relapse|189|||
155541867|NCT00676650|561408682|FG001|Overall Study|Objective progression or relapse|140|||
155541868|NCT00676650|561408681|FG000|Overall Study|Other|14|||
155541869|NCT00676650|561408682|FG001|Overall Study|Other|10|||
155541870|NCT00676650|561408681|FG000|Overall Study|Protocol Violation|3|||
155541871|NCT00676650|561408682|FG001|Overall Study|Protocol Violation|1|||
155541872|NCT00676650|561408681|FG000|Overall Study|Study terminated by sponsor|57|||
155541873|NCT00676650|561408682|FG001|Overall Study|Study terminated by sponsor|43|||
155541874|NCT00676650|561408681|FG000|Overall Study|Withdrawal by Subject|48|||
155541875|NCT00676650|561408682|FG001|Overall Study|Withdrawal by Subject|24|||
155541876|NCT00676650|561408681|FG000|Overall Study|Randomized but not treated|3|||
155541877|NCT00676650|561408682|FG001|Overall Study|Randomized but not treated|4|||
155541878|NCT02297841|561408686|FG000|Overall Study|Withdrawal by Subject|1|||
155541879|NCT02297841|561408686|FG000|Overall Study|Protocol Violation|7|||
155541880|NCT05061992|561408687|FG000|Overall Study|Excess bowel movements|1|||
155541881|NCT05061992|561408688|FG001|Overall Study|Excess bowel movements|0|||
155541882|NCT05061992|561408687|FG000|Overall Study|Complications of Medical Care|1|||
155541883|NCT05061992|561408688|FG001|Overall Study|Complications of Medical Care|0|||
155541884|NCT05061992|561408687|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
155541885|NCT05061992|561408688|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
155541886|NCT05061992|561408687|FG000|Overall Study|Withdrawal by Subject|0|||
155541887|NCT05061992|561408688|FG001|Overall Study|Withdrawal by Subject|1|||
155541888|NCT05212948|561408701|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
155541889|NCT05212948|561408702|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
155541890|NCT05212948|561408701|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
155541891|NCT05212948|561408702|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
155541892|NCT05212948|561408701|FG000|Initial Vaccination Period|Pregnancy|20|||
155541893|NCT05212948|561408702|FG001|Initial Vaccination Period|Pregnancy|14|||
155541894|NCT05212948|561408701|FG000|Initial Vaccination Period|Physician Decision|686|||
155541895|NCT05212948|561408702|FG001|Initial Vaccination Period|Physician Decision|401|||
155541896|NCT05212948|561408701|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
155541897|NCT05212948|561408702|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
155541898|NCT05212948|561408701|FG000|Initial Vaccination Period|Death|23|||
155541899|NCT05212948|561408702|FG001|Initial Vaccination Period|Death|18|||
155541900|NCT05212948|561408701|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
155541901|NCT05212948|561408702|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
155541902|NCT05212948|561408701|FG000|Initial Vaccination Period|Adverse Event|36|||
155541903|NCT05212948|561408702|FG001|Initial Vaccination Period|Adverse Event|23|||
155541904|NCT05212948|561408701|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
155541905|NCT05212948|561408702|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
155541906|NCT05212948|561408701|FG000|Crossover Vaccination Period|Pregnancy|6|||
155541907|NCT05212948|561408702|FG001|Crossover Vaccination Period|Pregnancy|1|||
155541908|NCT05212948|561408701|FG000|Crossover Vaccination Period|Physician Decision|49|||
155541909|NCT05212948|561408702|FG001|Crossover Vaccination Period|Physician Decision|24|||
155541910|NCT05212948|561408701|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
155541911|NCT05212948|561408702|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
155541912|NCT05212948|561408701|FG000|Crossover Vaccination Period|Death|10|||
155541913|NCT05212948|561408702|FG001|Crossover Vaccination Period|Death|5|||
155541914|NCT05212948|561408701|FG000|Crossover Vaccination Period|Adverse Event|9|||
155541915|NCT05212948|561408702|FG001|Crossover Vaccination Period|Adverse Event|4|||
155541916|NCT05347693|561408703|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
155541917|NCT05347693|561408704|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
155541918|NCT05347693|561408705|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
155541919|NCT05347693|561408703|FG000|Inpatient Period|Withdrawal of consent|10|||
155541920|NCT05347693|561408704|FG001|Inpatient Period|Withdrawal of consent|0|||
155541921|NCT05347693|561408705|FG002|Inpatient Period|Withdrawal of consent|0|||
155541922|NCT05347693|561408703|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
155541923|NCT05347693|561408704|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
155541924|NCT05347693|561408705|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
155541925|NCT05347693|561408703|FG000|Inpatient Period|Screening Failure|8|||
155541926|NCT05347693|561408704|FG001|Inpatient Period|Screening Failure|0|||
155541927|NCT05347693|561408705|FG002|Inpatient Period|Screening Failure|0|||
155541928|NCT05347693|561408703|FG000|Inpatient Period|Death|2|||
155541929|NCT05347693|561408704|FG001|Inpatient Period|Death|0|||
155541930|NCT05347693|561408705|FG002|Inpatient Period|Death|0|||
155541931|NCT05347693|561408703|FG000|Inpatient Period|Physician Decision|5|||
155541932|NCT05347693|561408704|FG001|Inpatient Period|Physician Decision|0|||
155541933|NCT05347693|561408705|FG002|Inpatient Period|Physician Decision|0|||
155541934|NCT05347693|561408703|FG000|Inpatient Period|Adverse Event|3|||
155541935|NCT05347693|561408704|FG001|Inpatient Period|Adverse Event|0|||
155541936|NCT05347693|561408705|FG002|Inpatient Period|Adverse Event|0|||
155541937|NCT05347693|561408703|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
155541938|NCT05347693|561408704|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
155541939|NCT05347693|561408705|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
155541940|NCT05347693|561408703|FG000|Outpatient Period|Adverse Event|0|||
155541941|NCT05347693|561408704|FG001|Outpatient Period|Adverse Event|9|||
155541942|NCT05347693|561408705|FG002|Outpatient Period|Adverse Event|0|||
155541943|NCT05347693|561408703|FG000|Outpatient Period|Death|0|||
155541944|NCT05347693|561408704|FG001|Outpatient Period|Death|6|||
155541945|NCT05347693|561408705|FG002|Outpatient Period|Death|2|||
155541946|NCT05347693|561408703|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
155541947|NCT05347693|561408704|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
155541948|NCT05347693|561408705|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
155541949|NCT05347693|561408703|FG000|Outpatient Period|Lost to Follow-up|0|||
155541950|NCT05347693|561408704|FG001|Outpatient Period|Lost to Follow-up|0|||
155541951|NCT05347693|561408705|FG002|Outpatient Period|Lost to Follow-up|1|||
155541952|NCT05347693|561408703|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
155541953|NCT05347693|561408704|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
155541954|NCT05347693|561408705|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
155541955|NCT05347693|561408703|FG000|Outpatient Period|Scheduled hemodialysis|0|||
155541956|NCT05347693|561408704|FG001|Outpatient Period|Scheduled hemodialysis|1|||
155541957|NCT05347693|561408705|FG002|Outpatient Period|Scheduled hemodialysis|0|||
155541958|NCT05347693|561408703|FG000|Outpatient Period|Severe HK|0|||
155541959|NCT05347693|561408704|FG001|Outpatient Period|Severe HK|0|||
155541960|NCT05347693|561408705|FG002|Outpatient Period|Severe HK|1|||
155541961|NCT05347693|561408703|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
155541962|NCT05347693|561408704|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
155541963|NCT05347693|561408705|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
155541964|NCT05347693|561408703|FG000|Outpatient Period|Start of dialysis|0|||
155541965|NCT05347693|561408704|FG001|Outpatient Period|Start of dialysis|0|||
155541966|NCT05347693|561408705|FG002|Outpatient Period|Start of dialysis|1|||
155541967|NCT05347693|561408703|FG000|Outpatient Period|The participant entered hemodialysis|0|||
155541968|NCT05347693|561408704|FG001|Outpatient Period|The participant entered hemodialysis|0|||
155541969|NCT05347693|561408705|FG002|Outpatient Period|The participant entered hemodialysis|1|||
155541970|NCT05347693|561408703|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
155541971|NCT05347693|561408704|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
155541972|NCT05347693|561408705|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
155541973|NCT05347693|561408703|FG000|Outpatient Period|Withdrawal by Subject|0|||
155541974|NCT05347693|561408704|FG001|Outpatient Period|Withdrawal by Subject|8|||
155541975|NCT05347693|561408705|FG002|Outpatient Period|Withdrawal by Subject|5|||
155541976|NCT00695110|561408708|FG000|Treatment Period 1|Adverse Event|1|||
155541977|NCT00695110|561408708|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155541978|NCT00695110|561408708|FG000|Treatment Period 3|Withdrawal by Subject|1|||
155541979|NCT00695110|561408708|FG000|Treatment Period 4|Adverse Event|1|||
155541980|NCT04675775|561408712|FG000|Overall Study|Withdrawal by Subject|7|||
155541981|NCT04941768|561408716|FG000|Overall Study|Lost to Follow-up|10|||
155541982|NCT04941768|561408716|FG000|Overall Study|Death|24|||
155541983|NCT04941768|561408716|FG000|Overall Study|Progressive Disease|4|||
155541984|NCT04941768|561408716|FG000|Overall Study|Withdrawal by Subject|4|||
155541985|NCT04941768|561408716|FG000|Overall Study|Other|3|||
155541986|NCT04941768|561408716|FG000|Overall Study|Treatment ongoing|21|||
155541987|NCT04941768|561408716|FG000|Overall Study|Off treatment and in follow-up|21|||
155541988|NCT03302078|561408717|FG000|Washout Period|Adverse Event|0|||
155541989|NCT03302078|561408718|FG001|Washout Period|Adverse Event|1|||
155541990|NCT05148299|561408719|FG000|Treatment Period|Adverse Event|1|||
155541991|NCT05148299|561408719|FG000|Treatment Period|Physician Decision|1|||
155541992|NCT05148299|561408719|FG000|Treatment Period|Death|1|||
155541993|NCT05148299|561408719|FG000|Follow-up Period|Death|3|||
155541994|NCT02161549|561408720|FG000|Overall Study|Physician Decision|6|||
155541995|NCT02161549|561408721|FG001|Overall Study|Physician Decision|2|||
155541996|NCT02340780|561408722|FG000|Overall Study|Ineligible|1|||
155541997|NCT01957150|561408723|FG000|Overall Study|Adverse Event|23|||
155541998|NCT01957150|561408724|FG001|Overall Study|Adverse Event|20|||
155541999|NCT01957150|561408723|FG000|Overall Study|Withdrawal by Subject|13|||
155542000|NCT01957150|561408724|FG001|Overall Study|Withdrawal by Subject|17|||
155542001|NCT01957150|561408723|FG000|Overall Study|Physician Decision|3|||
155542002|NCT01957150|561408724|FG001|Overall Study|Physician Decision|6|||
155542003|NCT01957150|561408723|FG000|Overall Study|Lost to Follow-up|4|||
155542004|NCT01957150|561408724|FG001|Overall Study|Lost to Follow-up|4|||
155542005|NCT01957150|561408723|FG000|Overall Study|Protocol Violation|1|||
155542006|NCT01957150|561408724|FG001|Overall Study|Protocol Violation|0|||
155542007|NCT01957150|561408723|FG000|Overall Study|Lack of Efficacy|11|||
155542008|NCT01957150|561408724|FG001|Overall Study|Lack of Efficacy|11|||
155656162|NCT03895372|561835154|FG006|Investigational Treatment Period|Other|0|||
155656163|NCT03895372|561835155|FG007|Investigational Treatment Period|Other|2|||
155542009|NCT01856192|561408725|FG000|Overall Study|Adverse Event|12|||
155542010|NCT01856192|561408726|FG001|Overall Study|Adverse Event|4|||
155542011|NCT01856192|561408725|FG000|Overall Study|Alternative therapy|0|||
155542012|NCT01856192|561408726|FG001|Overall Study|Alternative therapy|3|||
155542013|NCT01856192|561408725|FG000|Overall Study|Death|3|||
155542014|NCT01856192|561408726|FG001|Overall Study|Death|5|||
155542015|NCT01856192|561408725|FG000|Overall Study|Lack of Efficacy|0|||
155542016|NCT01856192|561408726|FG001|Overall Study|Lack of Efficacy|5|||
155542017|NCT01856192|561408725|FG000|Overall Study|Withdrawal by Subject|1|||
155542018|NCT01856192|561408726|FG001|Overall Study|Withdrawal by Subject|1|||
155542019|NCT01856192|561408725|FG000|Overall Study|Other diseases|1|||
155542020|NCT01856192|561408726|FG001|Overall Study|Other diseases|0|||
155542021|NCT01856192|561408725|FG000|Overall Study|Never started treatment|7|||
155542022|NCT01856192|561408726|FG001|Overall Study|Never started treatment|5|||
155542023|NCT01856192|561408725|FG000|Overall Study|Path ineligible|20|||
155542024|NCT01856192|561408726|FG001|Overall Study|Path ineligible|34|||
155542025|NCT01856192|561408725|FG000|Overall Study|Non-path ineligible|2|||
155542026|NCT01856192|561408726|FG001|Overall Study|Non-path ineligible|2|||
155542027|NCT01856192|561408725|FG000|Overall Study|Physician Decision|1|||
155542028|NCT01856192|561408726|FG001|Overall Study|Physician Decision|1|||
155542029|NCT01856192|561408725|FG000|Overall Study|Suspicion of progressive disease|1|||
155542030|NCT01856192|561408726|FG001|Overall Study|Suspicion of progressive disease|0|||
155542031|NCT01856192|561408725|FG000|Overall Study|Non-compliance|1|||
155542032|NCT01856192|561408726|FG001|Overall Study|Non-compliance|0|||
155542033|NCT00640926|561408730|FG000|Overall Study|Adverse Event|2|||
155542034|NCT00640926|561408731|FG001|Overall Study|Adverse Event|3|||
155542035|NCT00640926|561408732|FG002|Overall Study|Adverse Event|2|||
155542036|NCT00640926|561408730|FG000|Overall Study|Lack of Efficacy|0|||
155542037|NCT00640926|561408731|FG001|Overall Study|Lack of Efficacy|2|||
155542038|NCT00640926|561408732|FG002|Overall Study|Lack of Efficacy|1|||
155542039|NCT00640926|561408730|FG000|Overall Study|Protocol Violation|2|||
155542040|NCT00640926|561408731|FG001|Overall Study|Protocol Violation|0|||
155542041|NCT00640926|561408732|FG002|Overall Study|Protocol Violation|2|||
155542042|NCT00640926|561408730|FG000|Overall Study|Lost to Follow-up|3|||
155542043|NCT00640926|561408731|FG001|Overall Study|Lost to Follow-up|1|||
155542044|NCT00640926|561408732|FG002|Overall Study|Lost to Follow-up|2|||
155542045|NCT00640926|561408730|FG000|Overall Study|Withdrawal by Subject|1|||
155542046|NCT00640926|561408731|FG001|Overall Study|Withdrawal by Subject|0|||
155542047|NCT00640926|561408732|FG002|Overall Study|Withdrawal by Subject|1|||
155542048|NCT01841073|561408733|FG000|Overall Study|Adverse Event|1|||
155542049|NCT01841073|561408734|FG001|Overall Study|Adverse Event|1|||
155542050|NCT01841073|561408733|FG000|Overall Study|Physician Decision|1|||
155542051|NCT01841073|561408734|FG001|Overall Study|Physician Decision|0|||
155542052|NCT01841073|561408733|FG000|Overall Study|Lost to Follow-up|0|||
155542053|NCT01841073|561408734|FG001|Overall Study|Lost to Follow-up|2|||
155542054|NCT02858037|561408737|FG000|Overall Study|Death|1|||
155542055|NCT02858037|561408737|FG000|Overall Study|Withdrawal by Subject|18|||
155542056|NCT02858037|561408737|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
155542057|NCT02858037|561408737|FG000|Overall Study|Lost to Follow-up|3|||
155542058|NCT02858037|561408737|FG000|Overall Study|Other|4|||
155542059|NCT00283842|561408738|FG000|Overall Study|Adverse Event|8|||
155542060|NCT00283842|561408739|FG001|Overall Study|Adverse Event|7|||
155542061|NCT00283842|561408740|FG002|Overall Study|Adverse Event|21|||
155542062|NCT00283842|561408741|FG003|Overall Study|Adverse Event|21|||
155542063|NCT00283842|561408742|FG004|Overall Study|Adverse Event|5|||
155542064|NCT00283842|561408738|FG000|Overall Study|Protocol Violation|1|||
155542065|NCT00283842|561408739|FG001|Overall Study|Protocol Violation|5|||
155542066|NCT00283842|561408740|FG002|Overall Study|Protocol Violation|4|||
155542067|NCT00283842|561408741|FG003|Overall Study|Protocol Violation|0|||
155542068|NCT00283842|561408742|FG004|Overall Study|Protocol Violation|0|||
155542069|NCT00283842|561408738|FG000|Overall Study|Protocol deviation|0|||
155542070|NCT00283842|561408739|FG001|Overall Study|Protocol deviation|0|||
155542071|NCT00283842|561408740|FG002|Overall Study|Protocol deviation|0|||
155656164|NCT03895372|561835148|FG000|Investigational Treatment Period|Protocol Violation|0|||
155542072|NCT00283842|561408741|FG003|Overall Study|Protocol deviation|0|||
155542073|NCT00283842|561408742|FG004|Overall Study|Protocol deviation|2|||
155656165|NCT03895372|561835149|FG001|Investigational Treatment Period|Protocol Violation|0|||
155656166|NCT03895372|561835150|FG002|Investigational Treatment Period|Protocol Violation|0|||
155542074|NCT00283842|561408738|FG000|Overall Study|Withdrawal by Subject|2|||
155542075|NCT00283842|561408739|FG001|Overall Study|Withdrawal by Subject|1|||
155656167|NCT03895372|561835151|FG003|Investigational Treatment Period|Protocol Violation|1|||
155542076|NCT00283842|561408740|FG002|Overall Study|Withdrawal by Subject|1|||
155656168|NCT03895372|561835152|FG004|Investigational Treatment Period|Protocol Violation|0|||
155542077|NCT00283842|561408741|FG003|Overall Study|Withdrawal by Subject|5|||
155542078|NCT00283842|561408742|FG004|Overall Study|Withdrawal by Subject|4|||
155542079|NCT00283842|561408738|FG000|Overall Study|Lack of Efficacy|1|||
155542080|NCT00283842|561408739|FG001|Overall Study|Lack of Efficacy|3|||
155542081|NCT00283842|561408740|FG002|Overall Study|Lack of Efficacy|1|||
155542082|NCT00283842|561408741|FG003|Overall Study|Lack of Efficacy|0|||
155542083|NCT00283842|561408742|FG004|Overall Study|Lack of Efficacy|3|||
155542084|NCT00283842|561408738|FG000|Overall Study|Lost to Follow-up|0|||
155542085|NCT00283842|561408739|FG001|Overall Study|Lost to Follow-up|2|||
155542086|NCT00283842|561408740|FG002|Overall Study|Lost to Follow-up|4|||
155542087|NCT00283842|561408741|FG003|Overall Study|Lost to Follow-up|1|||
155542088|NCT00283842|561408742|FG004|Overall Study|Lost to Follow-up|1|||
155542089|NCT00550147|561408743|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
155542090|NCT00550147|561408743|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
155542091|NCT00550147|561408743|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
155542092|NCT00550147|561408743|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
155542093|NCT00550147|561408743|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
155542094|NCT04320745|561408744|FG000|Overall Study|Adverse Event|26|||
155542095|NCT04320745|561408744|FG000|Overall Study|Withdrawal by Subject|4|||
155542096|NCT04320745|561408744|FG000|Overall Study|Lost to Follow-up|12|||
155542097|NCT04320745|561408744|FG000|Overall Study|Protocol Deviation|2|||
155542098|NCT04320745|561408744|FG000|Overall Study|Non-compliance With Study Drug|2|||
155542099|NCT04320745|561408744|FG000|Overall Study|Reason Not Specified|1|||
155542100|NCT01685008|561408745|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
155542101|NCT01685008|561408746|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
155542102|NCT01685008|561408747|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
155542103|NCT01685008|561408748|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
155542104|NCT01685008|561408745|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
155542105|NCT01685008|561408746|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
155542106|NCT01685008|561408747|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
155542107|NCT01685008|561408748|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
155542108|NCT01685008|561408745|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
155542109|NCT01685008|561408746|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
155542110|NCT01685008|561408747|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
155542111|NCT01685008|561408748|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
155542112|NCT01685008|561408745|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
155542113|NCT01685008|561408746|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
155542114|NCT01685008|561408747|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
155542115|NCT01685008|561408748|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
155542116|NCT01685008|561408745|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
155542117|NCT01685008|561408746|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
155542118|NCT01685008|561408747|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
155542119|NCT01685008|561408748|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
155542120|NCT04994431|561408750|FG000|Overall Study|Adverse Event|1|||
155542121|NCT04994431|561408751|FG001|Overall Study|Adverse Event|0|||
155542122|NCT02151149|561408755|FG000|Treatment Period|Death|2|||
155542123|NCT02151149|561408756|FG001|Treatment Period|Death|3|||
155542124|NCT02151149|561408755|FG000|Treatment Period|Adverse Event|17|||
155542125|NCT02151149|561408756|FG001|Treatment Period|Adverse Event|14|||
155542126|NCT02151149|561408755|FG000|Treatment Period|Progressive Disease|25|||
155542127|NCT02151149|561408756|FG001|Treatment Period|Progressive Disease|24|||
155542128|NCT02151149|561408755|FG000|Treatment Period|Symptomatic Deterioration|2|||
155542129|NCT02151149|561408756|FG001|Treatment Period|Symptomatic Deterioration|10|||
155542130|NCT02151149|561408755|FG000|Treatment Period|Withdrawal by Subject|13|||
155542131|NCT02151149|561408756|FG001|Treatment Period|Withdrawal by Subject|11|||
155542132|NCT02151149|561408755|FG000|Treatment Period|Miscellaneous|8|||
155542133|NCT02151149|561408756|FG001|Treatment Period|Miscellaneous|7|||
155542134|NCT02151149|561408755|FG000|Treatment Period|Participants randomized but not treated|3|||
155542135|NCT02151149|561408756|FG001|Treatment Period|Participants randomized but not treated|2|||
155542136|NCT02151149|561408755|FG000|Follow-Up Period|Lost to Follow-up|2|||
155542137|NCT02151149|561408756|FG001|Follow-Up Period|Lost to Follow-up|3|||
155542138|NCT02151149|561408755|FG000|Follow-Up Period|Death|37|||
155542139|NCT02151149|561408756|FG001|Follow-Up Period|Death|34|||
155542140|NCT03419962|561408759|FG000|Overall Study|Change to other medication|1|||
155542141|NCT03419962|561408759|FG000|Overall Study|Refusal of continuing with trial drug|1|||
155542142|NCT03419962|561408759|FG000|Overall Study|Lost to Follow-up|3|||
155542143|NCT03419962|561408759|FG000|Overall Study|Difficulty in inhaling the doses|1|||
155542144|NCT03419962|561408759|FG000|Overall Study|Missing completion data|31|||
155542145|NCT04142658|561408760|FG000|Overall Study|Death|2|||
155542146|NCT04142658|561408761|FG001|Overall Study|Death|1|||
155542147|NCT04142658|561408760|FG000|Overall Study|Lost to Follow-up|4|||
155542148|NCT04142658|561408761|FG001|Overall Study|Lost to Follow-up|13|||
155542149|NCT04142658|561408760|FG000|Overall Study|Withdrawal by Subject|9|||
155542150|NCT04142658|561408761|FG001|Overall Study|Withdrawal by Subject|16|||
155542151|NCT01781234|561408762|FG000|Overall Study|Adverse Event|2|||
155542152|NCT01781234|561408763|FG001|Overall Study|Adverse Event|0|||
155542153|NCT01781234|561408762|FG000|Overall Study|Protocol Violation|3|||
155542154|NCT01781234|561408763|FG001|Overall Study|Protocol Violation|0|||
155542155|NCT01781234|561408762|FG000|Overall Study|Withdrawal by Subject|4|||
155542156|NCT01781234|561408763|FG001|Overall Study|Withdrawal by Subject|3|||
155542157|NCT03439085|561408764|FG000|Overall Study|Death|2|||
155542158|NCT03439085|561408764|FG000|Overall Study|Screen Failure|20|||
155542159|NCT01499160|561408768|FG000|Overall Study|Adverse Event|1|||
155542160|NCT01499160|561408768|FG000|Overall Study|Withdrawal by Subject|1|||
155542161|NCT01438476|561408772|FG000|Overall Study|Protocol Violation|1|||
155542162|NCT01438476|561408773|FG001|Overall Study|Protocol Violation|0|||
155542163|NCT01438476|561408772|FG000|Overall Study|Withdrawal by Subject|1|||
155542164|NCT01438476|561408773|FG001|Overall Study|Withdrawal by Subject|0|||
155542165|NCT01438476|561408772|FG000|Overall Study|No Surgery- Disease|8|||
155542166|NCT01438476|561408773|FG001|Overall Study|No Surgery- Disease|10|||
155542167|NCT01438476|561408772|FG000|Overall Study|Communication barrier|0|||
155542168|NCT01438476|561408773|FG001|Overall Study|Communication barrier|1|||
155542169|NCT03566238|561408775|FG000|Overall Study|Adverse Event|0|||
155542170|NCT03566238|561408776|FG001|Overall Study|Adverse Event|0|||
155542171|NCT03566238|561408777|FG002|Overall Study|Adverse Event|1|||
155542172|NCT03566238|561408775|FG000|Overall Study|Lack of Efficacy|5|||
155542173|NCT03566238|561408776|FG001|Overall Study|Lack of Efficacy|4|||
155542174|NCT03566238|561408777|FG002|Overall Study|Lack of Efficacy|2|||
155542175|NCT03566238|561408775|FG000|Overall Study|Other|0|||
155542176|NCT03566238|561408776|FG001|Overall Study|Other|1|||
155542177|NCT03566238|561408777|FG002|Overall Study|Other|0|||
155542178|NCT03370510|561408782|FG000|Overall Study|COVID-19|2|||
155542179|NCT03370510|561408783|FG001|Overall Study|COVID-19|0|||
155542180|NCT00688844|561408784|FG000|Overall Study|Lost to Follow-up|10|||
155542181|NCT01475487|561408785|FG000|Overall Study|had to leave early for personal reasons|2|||
155542182|NCT01475487|561408786|FG001|Overall Study|had to leave early for personal reasons|1|||
155542183|NCT00857818|561408789|FG000|Overall Study|Lack of Efficacy|1|||
155542184|NCT00857818|561408790|FG001|Overall Study|Lack of Efficacy|0|||
155542185|NCT00857818|561408789|FG000|Overall Study|Adverse Event|3|||
155542186|NCT00857818|561408790|FG001|Overall Study|Adverse Event|0|||
155542187|NCT00857818|561408789|FG000|Overall Study|Withdrawal by Subject|0|||
155542188|NCT00857818|561408790|FG001|Overall Study|Withdrawal by Subject|4|||
155542189|NCT00857818|561408789|FG000|Overall Study|Sponsor terminated study|6|||
155542190|NCT00857818|561408790|FG001|Overall Study|Sponsor terminated study|4|||
155542191|NCT00857818|561408789|FG000|Overall Study|Investigator decision|1|||
155542192|NCT00857818|561408790|FG001|Overall Study|Investigator decision|0|||
155542193|NCT01049581|561408791|FG000|Overall Study|Lost to Follow-up|2|||
155542194|NCT01049581|561408792|FG001|Overall Study|Lost to Follow-up|1|||
155542195|NCT02129062|561410381|FG000|Overall Study|Death|1|||
155542196|NCT02129062|561410381|FG000|Overall Study|Disease Progression|2|||
155542197|NCT02031237|561410382|FG000|Overall Study|Death|1|||
155542198|NCT02031237|561410383|FG001|Overall Study|Death|5|||
155542199|NCT02031237|561410384|FG002|Overall Study|Death|0|||
155542200|NCT02031237|561410382|FG000|Overall Study|Physician Decision|0|||
155542201|NCT02031237|561410383|FG001|Overall Study|Physician Decision|1|||
155542202|NCT02031237|561410384|FG002|Overall Study|Physician Decision|0|||
155542203|NCT02031237|561410382|FG000|Overall Study|Withdrawal by Subject|2|||
155542204|NCT02031237|561410383|FG001|Overall Study|Withdrawal by Subject|2|||
155542205|NCT02031237|561410384|FG002|Overall Study|Withdrawal by Subject|0|||
155542206|NCT02031237|561410382|FG000|Overall Study|Protocol Violation|2|||
155542207|NCT02031237|561410383|FG001|Overall Study|Protocol Violation|6|||
155656169|NCT03895372|561835153|FG005|Investigational Treatment Period|Protocol Violation|0|||
155542208|NCT02031237|561410384|FG002|Overall Study|Protocol Violation|0|||
155542209|NCT02031237|561410382|FG000|Overall Study|Alternate Treatment Given|0|||
155542210|NCT02031237|561410383|FG001|Overall Study|Alternate Treatment Given|0|||
155542211|NCT02031237|561410384|FG002|Overall Study|Alternate Treatment Given|3|||
155542212|NCT00377156|561410390|FG000|Overall Study|Death|23|||
155542213|NCT00377156|561410391|FG001|Overall Study|Death|19|||
155542214|NCT00377156|561410390|FG000|Overall Study|Withdrawal by Subject|16|||
155542215|NCT00377156|561410391|FG001|Overall Study|Withdrawal by Subject|24|||
155542216|NCT00377156|561410390|FG000|Overall Study|Had follow-up <90 d|3|||
155542217|NCT00377156|561410391|FG001|Overall Study|Had follow-up <90 d|6|||
155542218|NCT00377156|561410390|FG000|Overall Study|Cancellation|1|||
155542219|NCT00377156|561410391|FG001|Overall Study|Cancellation|0|||
155542220|NCT00377156|561410390|FG000|Overall Study|Refused testing|0|||
155542221|NCT00377156|561410391|FG001|Overall Study|Refused testing|1|||
155542222|NCT00377156|561410390|FG000|Overall Study|Ineligible|0|||
155542223|NCT00377156|561410391|FG001|Overall Study|Ineligible|1|||
155542224|NCT00377156|561410390|FG000|Overall Study|Disability or language problem|0|||
155542225|NCT00377156|561410391|FG001|Overall Study|Disability or language problem|1|||
155542226|NCT00377156|561410390|FG000|Overall Study|Other|5|||
155542227|NCT00377156|561410391|FG001|Overall Study|Other|2|||
155542228|NCT01802216|561410392|FG000|4 Month Visit|Participant did not show to visit|3|||
155542229|NCT01802216|561410393|FG001|4 Month Visit|Participant did not show to visit|4|||
155542230|NCT01802216|561410392|FG000|8 Month Visit|Participant did not show to visit|3|||
155542231|NCT01802216|561410393|FG001|8 Month Visit|Participant did not show to visit|5|||
155542232|NCT01802216|561410392|FG000|12 Month Visit|Participant did not show to visit|3|||
155542233|NCT01802216|561410393|FG001|12 Month Visit|Participant did not show to visit|4|||
155542234|NCT02459418|561410394|FG000|Overall Study|Exclusion Criteria|4|||
155542235|NCT02459418|561410395|FG001|Overall Study|Exclusion Criteria|0|||
155542236|NCT02459418|561410394|FG000|Overall Study|Protocol Violation|0|||
155542237|NCT02459418|561410395|FG001|Overall Study|Protocol Violation|2|||
155542238|NCT02459418|561410394|FG000|Overall Study|Physician Decision|0|||
155542239|NCT02459418|561410395|FG001|Overall Study|Physician Decision|2|||
155542240|NCT02459418|561410394|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
155542241|NCT02459418|561410395|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
155542242|NCT02459418|561410394|FG000|Overall Study|Adverse Event|0|||
155542243|NCT02459418|561410395|FG001|Overall Study|Adverse Event|1|||
155542244|NCT02459418|561410394|FG000|Overall Study|Withdrawal by Subject|1|||
155542245|NCT02459418|561410395|FG001|Overall Study|Withdrawal by Subject|1|||
155542246|NCT02459418|561410394|FG000|Overall Study|Elevated Creatine Kinase|1|||
155542247|NCT02459418|561410395|FG001|Overall Study|Elevated Creatine Kinase|0|||
155542248|NCT02459418|561410394|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
155542249|NCT02459418|561410395|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
155542250|NCT00653159|561410396|FG000|Overall Study|Adverse Event|4|||
155542251|NCT00653159|561410397|FG001|Overall Study|Adverse Event|1|||
155542252|NCT00653159|561410396|FG000|Overall Study|Lost to Follow-up|1|||
155542253|NCT00653159|561410397|FG001|Overall Study|Lost to Follow-up|2|||
155542254|NCT01872715|561410398|FG000|Overall Study|Adverse Event|1|||
155542255|NCT01872715|561410398|FG000|Overall Study|Protocol Violation|1|||
155542256|NCT01872715|561410398|FG000|Overall Study|Withdrawal by Subject|2|||
155542257|NCT00683592|561410399|FG000|Overall Study|Adverse Event|12|||
155542258|NCT00683592|561410400|FG001|Overall Study|Adverse Event|4|||
155542259|NCT00683592|561410399|FG000|Overall Study|Withdrawal by Subject|11|||
155542260|NCT00683592|561410400|FG001|Overall Study|Withdrawal by Subject|11|||
155542261|NCT00683592|561410399|FG000|Overall Study|Lost to Follow-up|17|||
155542262|NCT00683592|561410400|FG001|Overall Study|Lost to Follow-up|17|||
155542263|NCT00683592|561410399|FG000|Overall Study|Lack of Efficacy|3|||
155542264|NCT00683592|561410400|FG001|Overall Study|Lack of Efficacy|7|||
155542265|NCT00683592|561410399|FG000|Overall Study|Physician Decision|0|||
155542266|NCT00683592|561410400|FG001|Overall Study|Physician Decision|1|||
155542267|NCT00683592|561410399|FG000|Overall Study|Non-compliance|3|||
155542268|NCT00683592|561410400|FG001|Overall Study|Non-compliance|5|||
155542269|NCT00683592|561410399|FG000|Overall Study|Other|1|||
155542270|NCT00683592|561410400|FG001|Overall Study|Other|1|||
155542271|NCT00381849|561410408|FG000|Wash Out|Withdrawal by Subject|0|||
155542272|NCT00381849|561410409|FG001|Wash Out|Withdrawal by Subject|1|||
155542273|NCT02426541|561410412|FG000|Overall Study|Protocol Violation|1|||
155542274|NCT02426541|561410413|FG001|Overall Study|Protocol Violation|0|||
155542275|NCT02674633|561410418|FG000|Overall Study|Lost to Follow-up|3|||
155542276|NCT02674633|561410419|FG001|Overall Study|Lost to Follow-up|2|||
155542277|NCT02674633|561410418|FG000|Overall Study|Physician Decision|1|||
155542278|NCT02674633|561410419|FG001|Overall Study|Physician Decision|0|||
155542279|NCT02674633|561410418|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155542280|NCT02674633|561410419|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155542281|NCT04167618|561410420|FG000|Overall Study|Trial terminated by sponsor|1|||
155542282|NCT04167618|561410421|FG001|Overall Study|Trial terminated by sponsor|1|||
155542283|NCT02994394|561410422|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
155542284|NCT02994394|561410423|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
155542285|NCT02994394|561410424|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
155542286|NCT02994394|561410425|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
155542287|NCT02994394|561410426|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
155542288|NCT02994394|561410427|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
155542289|NCT02994394|561410422|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
155542290|NCT02994394|561410423|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
155542291|NCT02994394|561410424|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
155542292|NCT02994394|561410425|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
155542293|NCT02994394|561410426|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
155542294|NCT02994394|561410427|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
155542295|NCT05693805|561410428|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
155542296|NCT05693805|561410429|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
155542297|NCT04982445|561410433|FG000|Overall Study|Protocol Violation|1|||
155542298|NCT04982445|561410433|FG000|Overall Study|Withdrawal by Subject|4|||
155542299|NCT04982445|561410433|FG000|Overall Study|Lost to Follow-up|1|||
155542300|NCT02152982|561410434|FG000|Overall Study|Withdrawal by Subject|17|||
155542301|NCT02152982|561410435|FG001|Overall Study|Withdrawal by Subject|16|||
155542302|NCT02152982|561410434|FG000|Overall Study|Did not start treatment|11|||
155542303|NCT02152982|561410435|FG001|Overall Study|Did not start treatment|5|||
155542304|NCT02152982|561410434|FG000|Overall Study|Disease progression|41|||
155542305|NCT02152982|561410435|FG001|Overall Study|Disease progression|52|||
155542306|NCT02152982|561410434|FG000|Overall Study|Adverse Event|7|||
155542307|NCT02152982|561410435|FG001|Overall Study|Adverse Event|12|||
155542308|NCT02152982|561410434|FG000|Overall Study|Complicating disease|1|||
155542309|NCT02152982|561410435|FG001|Overall Study|Complicating disease|1|||
155542310|NCT02152982|561410434|FG000|Overall Study|Death|0|||
155542311|NCT02152982|561410435|FG001|Overall Study|Death|3|||
155542312|NCT02152982|561410434|FG000|Overall Study|Physician Decision|3|||
155542313|NCT02152982|561410435|FG001|Overall Study|Physician Decision|0|||
155542314|NCT03230487|561410438|FG000|Overall Study|Adverse Event|0|||
155542315|NCT03230487|561410439|FG001|Overall Study|Adverse Event|0|||
155542316|NCT03230487|561410440|FG002|Overall Study|Adverse Event|0|||
155542317|NCT03230487|561410441|FG003|Overall Study|Adverse Event|1|||
155542318|NCT03230487|561410442|FG004|Overall Study|Adverse Event|0|||
155542319|NCT03230487|561410443|FG005|Overall Study|Adverse Event|0|||
155542320|NCT01755975|561410448|FG000|Overall Study|Adverse Event|0|||
155542321|NCT01755975|561410449|FG001|Overall Study|Adverse Event|0|||
155542322|NCT01755975|561410450|FG002|Overall Study|Adverse Event|1|||
155542323|NCT01755975|561410451|FG003|Overall Study|Adverse Event|0|||
155542324|NCT01755975|561410452|FG004|Overall Study|Adverse Event|2|||
155542325|NCT03653026|561410453|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
155542326|NCT03653026|561410454|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
155542327|NCT03653026|561410455|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
155542328|NCT03653026|561410456|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
155542329|NCT03653026|561410453|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
155542330|NCT03653026|561410454|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
155542331|NCT03653026|561410455|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155542332|NCT03653026|561410456|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155542333|NCT03653026|561410453|FG000|Part 1: Placebo-controlled Period|Other|0|||
155542334|NCT03653026|561410454|FG001|Part 1: Placebo-controlled Period|Other|3|||
155542335|NCT03653026|561410455|FG002|Part 1: Placebo-controlled Period|Other|0|||
155542336|NCT03653026|561410456|FG003|Part 1: Placebo-controlled Period|Other|0|||
155542337|NCT03653026|561410453|FG000|Part 2: Open-label Extension|Adverse Event|0|||
155542338|NCT03653026|561410454|FG001|Part 2: Open-label Extension|Adverse Event|0|||
155542339|NCT03653026|561410455|FG002|Part 2: Open-label Extension|Adverse Event|1|||
155542340|NCT03653026|561410456|FG003|Part 2: Open-label Extension|Adverse Event|1|||
155542341|NCT03653026|561410453|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155542342|NCT03653026|561410454|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155542343|NCT03653026|561410455|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
155542344|NCT03653026|561410456|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
155542345|NCT03653026|561410453|FG000|Part 2: Open-label Extension|Other|0|||
155542346|NCT03653026|561410454|FG001|Part 2: Open-label Extension|Other|0|||
155542347|NCT03653026|561410455|FG002|Part 2: Open-label Extension|Other|1|||
155542348|NCT03653026|561410456|FG003|Part 2: Open-label Extension|Other|2|||
155542349|NCT01933919|561410459|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
155542350|NCT01933919|561410460|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
155542351|NCT01933919|561410459|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
155542352|NCT01933919|561410460|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
155542353|NCT01933919|561410459|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
155542354|NCT01933919|561410460|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
155542355|NCT01933919|561410459|FG000|Open-label Long-term Phase|Adverse Event|2|||
155542356|NCT01933919|561410460|FG001|Open-label Long-term Phase|Adverse Event|0|||
155542357|NCT01933919|561410459|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
155542358|NCT01933919|561410460|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
155542359|NCT01933919|561410459|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
155542360|NCT01933919|561410460|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
155542361|NCT01933919|561410459|FG000|Open-label Long-term Phase|Other|1|||
155542362|NCT01933919|561410460|FG001|Open-label Long-term Phase|Other|2|||
155542363|NCT00852917|561410461|FG000|Overall Study|Adverse Event|13|||
155542364|NCT00852917|561410462|FG001|Overall Study|Adverse Event|20|||
155542365|NCT00852917|561410463|FG002|Overall Study|Adverse Event|35|||
155542366|NCT00852917|561410464|FG003|Overall Study|Adverse Event|17|||
155542367|NCT00852917|561410461|FG000|Overall Study|Lack of Efficacy|21|||
155542368|NCT00852917|561410462|FG001|Overall Study|Lack of Efficacy|11|||
155542369|NCT00852917|561410463|FG002|Overall Study|Lack of Efficacy|11|||
155542370|NCT00852917|561410464|FG003|Overall Study|Lack of Efficacy|47|||
155542371|NCT00852917|561410461|FG000|Overall Study|Withdrawal by Subject|4|||
155542372|NCT00852917|561410462|FG001|Overall Study|Withdrawal by Subject|8|||
155542373|NCT00852917|561410463|FG002|Overall Study|Withdrawal by Subject|10|||
155542374|NCT00852917|561410464|FG003|Overall Study|Withdrawal by Subject|9|||
155542375|NCT00852917|561410461|FG000|Overall Study|Physician Decision|6|||
155542376|NCT00852917|561410462|FG001|Overall Study|Physician Decision|7|||
155542377|NCT00852917|561410463|FG002|Overall Study|Physician Decision|2|||
155542378|NCT00852917|561410464|FG003|Overall Study|Physician Decision|19|||
155542379|NCT00852917|561410461|FG000|Overall Study|Death|0|||
155542380|NCT00852917|561410462|FG001|Overall Study|Death|0|||
155542381|NCT00852917|561410463|FG002|Overall Study|Death|0|||
155542382|NCT00852917|561410464|FG003|Overall Study|Death|1|||
155542383|NCT02575339|561410465|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
155542384|NCT02575339|561410466|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155542385|NCT02575339|561410467|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155542386|NCT02575339|561410465|FG000|Study Treatment|Disease Progression|5|||
155542387|NCT02575339|561410466|FG001|Study Treatment|Disease Progression|2|||
155542388|NCT02575339|561410467|FG002|Study Treatment|Disease Progression|0|||
155542389|NCT02575339|561410465|FG000|Study Treatment|Adverse Event|1|||
155542390|NCT02575339|561410466|FG001|Study Treatment|Adverse Event|2|||
155542391|NCT02575339|561410467|FG002|Study Treatment|Adverse Event|0|||
155542392|NCT02575339|561410465|FG000|Follow up|Death|6|||
155542393|NCT02575339|561410466|FG001|Follow up|Death|2|||
155542394|NCT02575339|561410467|FG002|Follow up|Death|0|||
155542395|NCT02575339|561410465|FG000|Follow up|Study Terminated|0|||
155542396|NCT02575339|561410466|FG001|Follow up|Study Terminated|2|||
155542397|NCT02575339|561410467|FG002|Follow up|Study Terminated|0|||
155542398|NCT02575339|561410465|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
155542399|NCT02575339|561410466|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
155542400|NCT02575339|561410467|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
155542401|NCT01358877|561410468|FG000|Overall Study|Withdrawal by Subject|475|||
155542402|NCT01358877|561410469|FG001|Overall Study|Withdrawal by Subject|466|||
155542403|NCT01358877|561410468|FG000|Overall Study|Recurrence of disease|181|||
155542404|NCT01358877|561410469|FG001|Overall Study|Recurrence of disease|269|||
155542405|NCT01358877|561410468|FG000|Overall Study|Lost to Follow-up|181|||
155542406|NCT01358877|561410469|FG001|Overall Study|Lost to Follow-up|176|||
155542407|NCT01358877|561410468|FG000|Overall Study|Death|41|||
155542408|NCT01358877|561410469|FG001|Overall Study|Death|46|||
155542409|NCT01358877|561410468|FG000|Overall Study|Adverse Event|39|||
155542410|NCT01358877|561410469|FG001|Overall Study|Adverse Event|42|||
155542411|NCT01358877|561410468|FG000|Overall Study|Physician Decision|43|||
155542412|NCT01358877|561410469|FG001|Overall Study|Physician Decision|32|||
155542413|NCT01358877|561410468|FG000|Overall Study|Contralateral breast cancer|42|||
155542414|NCT01358877|561410469|FG001|Overall Study|Contralateral breast cancer|28|||
155542415|NCT01358877|561410468|FG000|Overall Study|Reason not specified|37|||
155542416|NCT01358877|561410469|FG001|Overall Study|Reason not specified|29|||
155542417|NCT02510261|561410470|FG000|Overall Study|Adverse Event|5|||
155542418|NCT02510261|561410471|FG001|Overall Study|Adverse Event|8|||
155542419|NCT02510261|561410472|FG002|Overall Study|Adverse Event|0|||
155542420|NCT02510261|561410470|FG000|Overall Study|Physician Decision|1|||
155542421|NCT02510261|561410471|FG001|Overall Study|Physician Decision|5|||
155542422|NCT02510261|561410472|FG002|Overall Study|Physician Decision|0|||
155542423|NCT02510261|561410470|FG000|Overall Study|Death|19|||
155542424|NCT02510261|561410471|FG001|Overall Study|Death|19|||
155542425|NCT02510261|561410472|FG002|Overall Study|Death|0|||
155542426|NCT02510261|561410470|FG000|Overall Study|Withdrawal by Subject|3|||
155542427|NCT02510261|561410471|FG001|Overall Study|Withdrawal by Subject|10|||
155542428|NCT02510261|561410472|FG002|Overall Study|Withdrawal by Subject|3|||
155542429|NCT02003222|561410476|FG000|Induction|Never started treatment|0|||
155542430|NCT02003222|561410477|FG001|Induction|Never started treatment|0|||
155542431|NCT02003222|561410478|FG002|Induction|Never started treatment|0|||
155542432|NCT02003222|561410479|FG003|Induction|Never started treatment|0|||
155542433|NCT02003222|561410480|FG004|Induction|Never started treatment|8|||
155542434|NCT02003222|561410476|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
155542435|NCT02003222|561410477|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
155542436|NCT02003222|561410478|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
155542437|NCT02003222|561410479|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
155542438|NCT02003222|561410480|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
155542439|NCT02003222|561410476|FG000|Induction|Adverse Event|0|||
155542440|NCT02003222|561410477|FG001|Induction|Adverse Event|0|||
155542441|NCT02003222|561410478|FG002|Induction|Adverse Event|0|||
155542442|NCT02003222|561410479|FG003|Induction|Adverse Event|0|||
155542443|NCT02003222|561410480|FG004|Induction|Adverse Event|13|||
155542444|NCT02003222|561410476|FG000|Induction|Alternative therapy|0|||
155542445|NCT02003222|561410477|FG001|Induction|Alternative therapy|0|||
155542446|NCT02003222|561410478|FG002|Induction|Alternative therapy|0|||
155542447|NCT02003222|561410479|FG003|Induction|Alternative therapy|0|||
155542448|NCT02003222|561410480|FG004|Induction|Alternative therapy|12|||
155542449|NCT02003222|561410476|FG000|Induction|Disease progression|0|||
155542450|NCT02003222|561410477|FG001|Induction|Disease progression|0|||
155542451|NCT02003222|561410478|FG002|Induction|Disease progression|0|||
155542452|NCT02003222|561410479|FG003|Induction|Disease progression|0|||
155542453|NCT02003222|561410480|FG004|Induction|Disease progression|22|||
155542454|NCT02003222|561410476|FG000|Induction|Death|0|||
155542455|NCT02003222|561410477|FG001|Induction|Death|0|||
155542456|NCT02003222|561410478|FG002|Induction|Death|0|||
155542457|NCT02003222|561410479|FG003|Induction|Death|0|||
155542458|NCT02003222|561410480|FG004|Induction|Death|3|||
155542459|NCT02003222|561410476|FG000|Induction|Withdrawal by Subject|0|||
155542460|NCT02003222|561410477|FG001|Induction|Withdrawal by Subject|0|||
155542461|NCT02003222|561410478|FG002|Induction|Withdrawal by Subject|0|||
155542462|NCT02003222|561410479|FG003|Induction|Withdrawal by Subject|0|||
155542463|NCT02003222|561410480|FG004|Induction|Withdrawal by Subject|8|||
155542464|NCT02003222|561410476|FG000|Induction|Other reasons|0|||
155542465|NCT02003222|561410477|FG001|Induction|Other reasons|0|||
155542466|NCT02003222|561410478|FG002|Induction|Other reasons|0|||
155542467|NCT02003222|561410479|FG003|Induction|Other reasons|0|||
155542468|NCT02003222|561410480|FG004|Induction|Other reasons|22|||
155542469|NCT02003222|561410476|FG000|Intensification|Never started treatment|0|||
155542470|NCT02003222|561410477|FG001|Intensification|Never started treatment|0|||
155542471|NCT02003222|561410478|FG002|Intensification|Never started treatment|0|||
155542472|NCT02003222|561410479|FG003|Intensification|Never started treatment|0|||
155542473|NCT02003222|561410480|FG004|Intensification|Never started treatment|2|||
155542474|NCT02003222|561410476|FG000|Intensification|Adverse Event|0|||
155542475|NCT02003222|561410477|FG001|Intensification|Adverse Event|0|||
155542476|NCT02003222|561410478|FG002|Intensification|Adverse Event|0|||
155542477|NCT02003222|561410479|FG003|Intensification|Adverse Event|0|||
155542478|NCT02003222|561410480|FG004|Intensification|Adverse Event|6|||
155542479|NCT02003222|561410476|FG000|Intensification|Alternative therapy|0|||
155542480|NCT02003222|561410477|FG001|Intensification|Alternative therapy|0|||
155542481|NCT02003222|561410478|FG002|Intensification|Alternative therapy|0|||
155542482|NCT02003222|561410479|FG003|Intensification|Alternative therapy|0|||
155542483|NCT02003222|561410480|FG004|Intensification|Alternative therapy|8|||
155542484|NCT02003222|561410476|FG000|Intensification|Disease progression|0|||
155542485|NCT02003222|561410477|FG001|Intensification|Disease progression|0|||
155542486|NCT02003222|561410478|FG002|Intensification|Disease progression|0|||
155542487|NCT02003222|561410479|FG003|Intensification|Disease progression|0|||
155542488|NCT02003222|561410480|FG004|Intensification|Disease progression|18|||
155542489|NCT02003222|561410476|FG000|Intensification|Withdrawal by Subject|0|||
155542490|NCT02003222|561410477|FG001|Intensification|Withdrawal by Subject|0|||
155542491|NCT02003222|561410478|FG002|Intensification|Withdrawal by Subject|0|||
155542492|NCT02003222|561410479|FG003|Intensification|Withdrawal by Subject|0|||
155542493|NCT02003222|561410480|FG004|Intensification|Withdrawal by Subject|5|||
155542494|NCT02003222|561410476|FG000|Intensification|Other reasons|0|||
155542495|NCT02003222|561410477|FG001|Intensification|Other reasons|0|||
155542496|NCT02003222|561410478|FG002|Intensification|Other reasons|0|||
155542497|NCT02003222|561410479|FG003|Intensification|Other reasons|0|||
155542498|NCT02003222|561410480|FG004|Intensification|Other reasons|8|||
155542499|NCT01886872|561410486|FG000|Overall Study|Ineligible|7|||
155542500|NCT01886872|561410487|FG001|Overall Study|Ineligible|4|||
155542501|NCT01886872|561410488|FG002|Overall Study|Ineligible|12|||
155542502|NCT02167594|561410489|FG000|Overall Study|Withdrawal by Subject|2|||
155542503|NCT02167594|561410490|FG001|Overall Study|Withdrawal by Subject|0|||
155542504|NCT02167594|561410491|FG002|Overall Study|Withdrawal by Subject|0|||
155542505|NCT02167594|561410489|FG000|Overall Study|Death|0|||
155542506|NCT02167594|561410490|FG001|Overall Study|Death|1|||
155542507|NCT02167594|561410491|FG002|Overall Study|Death|0|||
155542508|NCT03294317|561410493|FG000|Overall Study|Physician Decision|1|||
155542509|NCT03294317|561410493|FG000|Overall Study|Withdrawal by Subject|6|||
155542510|NCT03294317|561410493|FG000|Overall Study|Lost to Follow-up|1|||
155542511|NCT03294317|561410493|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
155542512|NCT03294317|561410493|FG000|Overall Study|Failed HB lead implant|8|||
155542513|NCT03294317|561410493|FG000|Overall Study|Received CRT instead|1|||
155542514|NCT03294317|561410493|FG000|Overall Study|Exited after lead revision|2|||
155542515|NCT02911935|561410494|FG000|Overall Study|Lost to Follow-up|5|||
155542516|NCT02911935|561410495|FG001|Overall Study|Lost to Follow-up|7|||
155542517|NCT00603512|561410496|FG000|Overall Study|Adverse Event|0|||
155542518|NCT00603512|561410497|FG001|Overall Study|Adverse Event|2|||
155542519|NCT00603512|561410498|FG002|Overall Study|Adverse Event|4|||
155542520|NCT00603512|561410499|FG003|Overall Study|Adverse Event|4|||
155542521|NCT00603512|561410500|FG004|Overall Study|Adverse Event|2|||
155542522|NCT00603512|561410496|FG000|Overall Study|Lack of Efficacy|0|||
155542523|NCT00603512|561410497|FG001|Overall Study|Lack of Efficacy|1|||
155542524|NCT00603512|561410498|FG002|Overall Study|Lack of Efficacy|0|||
155542525|NCT00603512|561410499|FG003|Overall Study|Lack of Efficacy|0|||
155542526|NCT00603512|561410500|FG004|Overall Study|Lack of Efficacy|1|||
155542527|NCT00603512|561410496|FG000|Overall Study|Other|2|||
155542528|NCT00603512|561410497|FG001|Overall Study|Other|1|||
155542529|NCT00603512|561410498|FG002|Overall Study|Other|0|||
155542530|NCT00603512|561410499|FG003|Overall Study|Other|1|||
155542531|NCT00603512|561410500|FG004|Overall Study|Other|1|||
155542532|NCT00603512|561410496|FG000|Overall Study|Withdrawal by Subject|0|||
155542533|NCT00603512|561410497|FG001|Overall Study|Withdrawal by Subject|0|||
155542534|NCT00603512|561410498|FG002|Overall Study|Withdrawal by Subject|0|||
155542535|NCT00603512|561410499|FG003|Overall Study|Withdrawal by Subject|0|||
155542536|NCT00603512|561410500|FG004|Overall Study|Withdrawal by Subject|1|||
155542537|NCT00603512|561410496|FG000|Overall Study|Randomized but not treated|0|||
155656170|NCT03895372|561835154|FG006|Investigational Treatment Period|Protocol Violation|0|||
155656171|NCT03895372|561835155|FG007|Investigational Treatment Period|Protocol Violation|0|||
155656172|NCT03895372|561835148|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
155656173|NCT03895372|561835149|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
155656174|NCT03895372|561835150|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
155656175|NCT03895372|561835151|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
155656176|NCT03895372|561835152|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
155656177|NCT03895372|561835153|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
155656178|NCT03895372|561835154|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
155656179|NCT03895372|561835155|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
155656180|NCT03895372|561835148|FG000|Extension Treatment Period|Adverse Event|0|||
155656181|NCT03895372|561835149|FG001|Extension Treatment Period|Adverse Event|1|||
155656182|NCT03895372|561835150|FG002|Extension Treatment Period|Adverse Event|0|||
155656183|NCT03895372|561835151|FG003|Extension Treatment Period|Adverse Event|1|||
155656184|NCT03895372|561835152|FG004|Extension Treatment Period|Adverse Event|0|||
155656185|NCT03895372|561835153|FG005|Extension Treatment Period|Adverse Event|0|||
155656186|NCT03895372|561835154|FG006|Extension Treatment Period|Adverse Event|3|||
155656187|NCT03895372|561835155|FG007|Extension Treatment Period|Adverse Event|3|||
155656188|NCT03895372|561835148|FG000|Extension Treatment Period|Other|1|||
155656189|NCT03895372|561835149|FG001|Extension Treatment Period|Other|3|||
155656190|NCT03895372|561835150|FG002|Extension Treatment Period|Other|0|||
155656191|NCT03895372|561835151|FG003|Extension Treatment Period|Other|0|||
155656192|NCT03895372|561835152|FG004|Extension Treatment Period|Other|1|||
155656193|NCT03895372|561835153|FG005|Extension Treatment Period|Other|0|||
155656194|NCT03895372|561835154|FG006|Extension Treatment Period|Other|0|||
155656195|NCT03895372|561835155|FG007|Extension Treatment Period|Other|2|||
155656196|NCT03895372|561835148|FG000|Extension Treatment Period|Pregnancy|0|||
155656197|NCT03895372|561835149|FG001|Extension Treatment Period|Pregnancy|0|||
155656198|NCT03895372|561835150|FG002|Extension Treatment Period|Pregnancy|0|||
155656199|NCT03895372|561835151|FG003|Extension Treatment Period|Pregnancy|0|||
155656200|NCT03895372|561835152|FG004|Extension Treatment Period|Pregnancy|1|||
155656201|NCT03895372|561835153|FG005|Extension Treatment Period|Pregnancy|0|||
155656202|NCT03895372|561835154|FG006|Extension Treatment Period|Pregnancy|0|||
155656203|NCT03895372|561835155|FG007|Extension Treatment Period|Pregnancy|0|||
155656204|NCT03895372|561835148|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
155656205|NCT03895372|561835149|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
155656206|NCT03895372|561835150|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155656207|NCT03895372|561835151|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
155656208|NCT03895372|561835152|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
155656209|NCT03895372|561835153|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
155656210|NCT03895372|561835154|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
155656211|NCT03895372|561835155|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
155656212|NCT03685149|561835156|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
155656213|NCT03685149|561835157|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
155656214|NCT03685149|561835156|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155656215|NCT03685149|561835157|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155656216|NCT03685149|561835156|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
155656217|NCT03685149|561835157|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
155656218|NCT02655601|561835161|FG000|Overall Study|Adverse Event|0|||
155656219|NCT02655601|561835162|FG001|Overall Study|Adverse Event|0|||
155656220|NCT02655601|561835163|FG002|Overall Study|Adverse Event|0|||
155656221|NCT02655601|561835164|FG003|Overall Study|Adverse Event|1|||
155656222|NCT02655601|561835165|FG004|Overall Study|Adverse Event|1|||
155656223|NCT02655601|561835166|FG005|Overall Study|Adverse Event|0|||
155542538|NCT00603512|561410497|FG001|Overall Study|Randomized but not treated|1|||
155542539|NCT00603512|561410498|FG002|Overall Study|Randomized but not treated|1|||
155542540|NCT00603512|561410499|FG003|Overall Study|Randomized but not treated|2|||
155656224|NCT02655601|561835161|FG000|Overall Study|Physician Decision|0|||
155656225|NCT02655601|561835162|FG001|Overall Study|Physician Decision|0|||
155656226|NCT02655601|561835163|FG002|Overall Study|Physician Decision|0|||
155542541|NCT00603512|561410500|FG004|Overall Study|Randomized but not treated|0|||
155542542|NCT04979858|561410501|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
155542543|NCT04979858|561410502|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
155542544|NCT04253236|561410503|FG000|Overall Study|Adverse Event|1|||
155542545|NCT04253236|561410504|FG001|Overall Study|Adverse Event|0|||
155542546|NCT04253236|561410503|FG000|Overall Study|Safety Concerns|1|||
155542547|NCT04253236|561410504|FG001|Overall Study|Safety Concerns|0|||
155542548|NCT04253236|561410503|FG000|Overall Study|Study Terminated by Sponsor|1|||
155542549|NCT04253236|561410504|FG001|Overall Study|Study Terminated by Sponsor|0|||
155542550|NCT02169336|561410509|FG000|Overall Study|Lack of Efficacy|1|||
155542551|NCT02169336|561410510|FG001|Overall Study|Lack of Efficacy|1|||
155542552|NCT02169336|561410511|FG002|Overall Study|Lack of Efficacy|0|||
155542553|NCT02169336|561410509|FG000|Overall Study|Adverse Event|2|||
155542554|NCT02169336|561410510|FG001|Overall Study|Adverse Event|3|||
155542555|NCT02169336|561410511|FG002|Overall Study|Adverse Event|1|||
155542556|NCT02169336|561410509|FG000|Overall Study|Withdrawal by Subject|1|||
155542557|NCT02169336|561410510|FG001|Overall Study|Withdrawal by Subject|0|||
155542558|NCT02169336|561410511|FG002|Overall Study|Withdrawal by Subject|0|||
155542559|NCT02169336|561410509|FG000|Overall Study|Physician Decision|0|||
155542560|NCT02169336|561410510|FG001|Overall Study|Physician Decision|0|||
155542561|NCT02169336|561410511|FG002|Overall Study|Physician Decision|1|||
155542562|NCT02169336|561410509|FG000|Overall Study|Subject declined to continue dosing|0|||
155542563|NCT02169336|561410510|FG001|Overall Study|Subject declined to continue dosing|0|||
155542564|NCT02169336|561410511|FG002|Overall Study|Subject declined to continue dosing|1|||
155542565|NCT04718129|561410512|FG000|Overall Study|Lost to Follow-up|6|||
155542566|NCT04718129|561410513|FG001|Overall Study|Lost to Follow-up|7|||
155542567|NCT01598896|561410514|FG000|Overall Study|Withdrawal by Subject|0|||
155542568|NCT01598896|561410515|FG001|Overall Study|Withdrawal by Subject|1|||
155542569|NCT01598896|561410514|FG000|Overall Study|Lack of Efficacy|0|||
155542570|NCT01598896|561410515|FG001|Overall Study|Lack of Efficacy|1|||
155542571|NCT00420095|561410516|FG000|Overall Study|Adverse Event|1|||
155542572|NCT00420095|561410517|FG001|Overall Study|Adverse Event|0|||
155542573|NCT00420095|561410516|FG000|Overall Study|Protocol Violation|1|||
155542574|NCT00420095|561410517|FG001|Overall Study|Protocol Violation|1|||
155542575|NCT00420095|561410516|FG000|Overall Study|Lost to Follow-up|1|||
155542576|NCT00420095|561410517|FG001|Overall Study|Lost to Follow-up|0|||
155542577|NCT00393705|561410518|FG000|Overall Study|Adverse Event|0|||
155542578|NCT00393705|561410519|FG001|Overall Study|Adverse Event|2|||
155542579|NCT00393705|561410518|FG000|Overall Study|Death|0|||
155542580|NCT00393705|561410519|FG001|Overall Study|Death|1|||
155542581|NCT00393705|561410518|FG000|Overall Study|Lost to Follow-up|2|||
155542582|NCT00393705|561410519|FG001|Overall Study|Lost to Follow-up|2|||
155542583|NCT00393705|561410518|FG000|Overall Study|Entry Criteria Not Met|10|||
155542584|NCT00393705|561410519|FG001|Overall Study|Entry Criteria Not Met|10|||
155542585|NCT00393705|561410518|FG000|Overall Study|Protocol Violation|4|||
155542586|NCT00393705|561410519|FG001|Overall Study|Protocol Violation|3|||
155542587|NCT00393705|561410518|FG000|Overall Study|Withdrawal by Subject|5|||
155542588|NCT00393705|561410519|FG001|Overall Study|Withdrawal by Subject|3|||
155542589|NCT00393705|561410518|FG000|Overall Study|Physician Decision|2|||
155542590|NCT00393705|561410519|FG001|Overall Study|Physician Decision|2|||
155542591|NCT01120691|561410522|FG000|Overall Study|Adverse Event|59|||
155542592|NCT01120691|561410523|FG001|Overall Study|Adverse Event|67|||
155542593|NCT01120691|561410524|FG002|Overall Study|Adverse Event|47|||
155542594|NCT01120691|561410522|FG000|Overall Study|Subject withdrew consent|33|||
155542595|NCT01120691|561410523|FG001|Overall Study|Subject withdrew consent|50|||
155542596|NCT01120691|561410524|FG002|Overall Study|Subject withdrew consent|44|||
155542597|NCT01120691|561410522|FG000|Overall Study|Death|21|||
155542598|NCT01120691|561410523|FG001|Overall Study|Death|22|||
155542599|NCT01120691|561410524|FG002|Overall Study|Death|24|||
155542600|NCT01120691|561410522|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
155542601|NCT01120691|561410523|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
155542602|NCT01120691|561410524|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
155542603|NCT01120691|561410522|FG000|Overall Study|Administrative problems|15|||
155542604|NCT01120691|561410523|FG001|Overall Study|Administrative problems|8|||
155542605|NCT01120691|561410524|FG002|Overall Study|Administrative problems|9|||
155542606|NCT01120691|561410522|FG000|Overall Study|Protocol deviation|13|||
155542607|NCT01120691|561410523|FG001|Overall Study|Protocol deviation|12|||
155542608|NCT01120691|561410524|FG002|Overall Study|Protocol deviation|12|||
155542609|NCT01120691|561410522|FG000|Overall Study|Lost to Follow-up|5|||
155542610|NCT01120691|561410523|FG001|Overall Study|Lost to Follow-up|6|||
155542611|NCT01120691|561410524|FG002|Overall Study|Lost to Follow-up|4|||
155542612|NCT01120691|561410522|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155542613|NCT01120691|561410523|FG001|Overall Study|Abnormal test procedure result(s)|2|||
155542614|NCT01120691|561410524|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155542615|NCT01120691|561410522|FG000|Overall Study|Patient's inability to use the device|3|||
155542616|NCT01120691|561410523|FG001|Overall Study|Patient's inability to use the device|1|||
155542617|NCT01120691|561410524|FG002|Overall Study|Patient's inability to use the device|0|||
155542618|NCT01120691|561410522|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155542619|NCT01120691|561410523|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155542620|NCT01120691|561410524|FG002|Overall Study|Abnormal laboratory value(s)|4|||
155542621|NCT01223027|561410529|FG000|Overall Study|Adverse Event|20|||
155542622|NCT01223027|561410530|FG001|Overall Study|Adverse Event|10|||
155542623|NCT01223027|561410529|FG000|Overall Study|Death|42|||
155542624|NCT01223027|561410530|FG001|Overall Study|Death|42|||
155542625|NCT01223027|561410529|FG000|Overall Study|Lost to Follow-up|2|||
155542626|NCT01223027|561410530|FG001|Overall Study|Lost to Follow-up|1|||
155542627|NCT01223027|561410529|FG000|Overall Study|Physician Decision|4|||
155542628|NCT01223027|561410530|FG001|Overall Study|Physician Decision|8|||
155542629|NCT01223027|561410529|FG000|Overall Study|Progressive Disease|167|||
155542630|NCT01223027|561410530|FG001|Overall Study|Progressive Disease|183|||
155542631|NCT01223027|561410529|FG000|Overall Study|Protocol Violation|2|||
155542632|NCT01223027|561410530|FG001|Overall Study|Protocol Violation|1|||
155542633|NCT01223027|561410529|FG000|Overall Study|Subject/guardian decicion|18|||
155542634|NCT01223027|561410530|FG001|Overall Study|Subject/guardian decicion|16|||
155542635|NCT01223027|561410529|FG000|Overall Study|New therapy for study indication|17|||
155542636|NCT01223027|561410530|FG001|Overall Study|New therapy for study indication|8|||
155542637|NCT01223027|561410529|FG000|Overall Study|Study terminated by sponsor|2|||
155542638|NCT01223027|561410530|FG001|Overall Study|Study terminated by sponsor|8|||
155542639|NCT04428645|561410531|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
155542640|NCT01321697|561410532|FG000|Overall Study|Study Terminated|7|||
155542641|NCT02061280|561410533|FG000|Overall Study|Protocol Violation|12|||
155542642|NCT02061280|561410534|FG001|Overall Study|Protocol Violation|8|||
155542643|NCT02061280|561410533|FG000|Overall Study|moved out of state|0|||
155542644|NCT02061280|561410534|FG001|Overall Study|moved out of state|1|||
155542645|NCT02061280|561410533|FG000|Overall Study|Withdrawal by Subject|1|||
155542646|NCT02061280|561410534|FG001|Overall Study|Withdrawal by Subject|2|||
155542647|NCT02061280|561410533|FG000|Overall Study|Lost to Follow-up|5|||
155542648|NCT02061280|561410534|FG001|Overall Study|Lost to Follow-up|1|||
155542649|NCT01977456|561410535|FG000|Overall Study|Death|5|||
155542650|NCT03303417|561412342|FG000|Overall Study|Withdrawal by Subject|1|||
155542651|NCT03303417|561412343|FG001|Overall Study|Withdrawal by Subject|1|||
155542652|NCT02697617|561412344|FG000|Overall Study|Withdrawal by Subject|0|||
155542653|NCT02697617|561412345|FG001|Overall Study|Withdrawal by Subject|2|||
155542654|NCT02697617|561412344|FG000|Overall Study|Pregnancy|1|||
155542655|NCT02697617|561412345|FG001|Overall Study|Pregnancy|0|||
155656227|NCT02655601|561835164|FG003|Overall Study|Physician Decision|0|||
155542656|NCT01765270|561412349|FG000|Overall Study|Physician Decision|1|||
155542657|NCT01765270|561412350|FG001|Overall Study|Physician Decision|0|||
155542658|NCT01765270|561412349|FG000|Overall Study|Withdrawal by Subject|0|||
155542659|NCT01765270|561412350|FG001|Overall Study|Withdrawal by Subject|1|||
155542660|NCT00329160|561412351|FG000|Overall Study|Adverse Event|27|||
155542661|NCT00329160|561412351|FG000|Overall Study|Withdrawal by Subject|13|||
155542662|NCT00329160|561412351|FG000|Overall Study|Protocol Violation|2|||
155542663|NCT00329160|561412351|FG000|Overall Study|Did not Receive Study Drug|1|||
155542664|NCT00329160|561412351|FG000|Overall Study|Incomplete IVUS|45|||
155542665|NCT02419573|561412352|FG000|Overall Study|Lost to Follow-up|3|||
155542666|NCT02419573|561412353|FG001|Overall Study|Lost to Follow-up|0|||
155542667|NCT02419573|561412352|FG000|Overall Study|Withdrawal by Subject|1|||
155542668|NCT02419573|561412353|FG001|Overall Study|Withdrawal by Subject|0|||
155542669|NCT00493792|561412354|FG000|Overall Study|Death|55|||
155542670|NCT00493792|561412355|FG001|Overall Study|Death|50|||
155542671|NCT00493792|561412354|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
155542672|NCT00493792|561412355|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
155542673|NCT00894933|561412359|FG000|Overall Study|Lost to Follow-up|2|||
155542674|NCT00894933|561412359|FG000|Overall Study|Cancelled Procedure|1|||
155542675|NCT00894933|561412359|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
155542676|NCT04968925|561412363|FG000|Phase I- Period 1|COVID-19 related|0|||
155542677|NCT04968925|561412364|FG001|Phase I- Period 1|COVID-19 related|1|||
155542678|NCT04968925|561412365|FG002|Phase I- Period 1|COVID-19 related|0|||
155542679|NCT04968925|561412366|FG003|Phase I- Period 1|COVID-19 related|0|||
155542680|NCT04968925|561412363|FG000|Phase I- Period 1|Subject enrolled in error|1|||
155542681|NCT04968925|561412364|FG001|Phase I- Period 1|Subject enrolled in error|1|||
155542682|NCT04968925|561412365|FG002|Phase I- Period 1|Subject enrolled in error|0|||
155542683|NCT04968925|561412366|FG003|Phase I- Period 1|Subject enrolled in error|0|||
155542684|NCT04968925|561412363|FG000|Phase II- Period 1|COVID-19 Related|0|||
155542685|NCT04968925|561412364|FG001|Phase II- Period 1|COVID-19 Related|0|||
155542686|NCT04968925|561412365|FG002|Phase II- Period 1|COVID-19 Related|6|||
155542687|NCT04968925|561412366|FG003|Phase II- Period 1|COVID-19 Related|6|||
155542688|NCT04968925|561412363|FG000|Phase II- Period 1|Subject enrolled in error|0|||
155542689|NCT04968925|561412364|FG001|Phase II- Period 1|Subject enrolled in error|0|||
155542690|NCT04968925|561412365|FG002|Phase II- Period 1|Subject enrolled in error|1|||
155542691|NCT04968925|561412366|FG003|Phase II- Period 1|Subject enrolled in error|0|||
155542692|NCT04968925|561412363|FG000|Phase II -Period 2|COVID-19 related|0|||
155542693|NCT04968925|561412364|FG001|Phase II -Period 2|COVID-19 related|0|||
155542694|NCT04968925|561412365|FG002|Phase II -Period 2|COVID-19 related|4|||
155542695|NCT04968925|561412366|FG003|Phase II -Period 2|COVID-19 related|3|||
155542696|NCT04968925|561412363|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
155542697|NCT04968925|561412364|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
155542698|NCT04968925|561412365|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
155542699|NCT04968925|561412366|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
155542700|NCT00996437|561412370|FG000|Overall Study|Death|1|||
155542701|NCT00996437|561412371|FG001|Overall Study|Death|0|||
155542702|NCT00996437|561412370|FG000|Overall Study|Dropped|2|||
155542703|NCT00996437|561412371|FG001|Overall Study|Dropped|2|||
155542704|NCT00996437|561412370|FG000|Overall Study|Missed|2|||
155542705|NCT00996437|561412371|FG001|Overall Study|Missed|5|||
155542706|NCT01091103|561412372|FG000|Overall Study|Adverse Event|1|||
155542707|NCT01091103|561412372|FG000|Overall Study|Progressive Disease|3|||
155542708|NCT01270620|561412373|FG000|Overall Study|Withdrawal by Subject|1|||
155542709|NCT01270620|561412374|FG001|Overall Study|Withdrawal by Subject|3|||
155542710|NCT01597479|561412376|FG000|Overall Study|Protocol Violation|1|||
155542711|NCT01597479|561412377|FG001|Overall Study|Protocol Violation|0|||
155542712|NCT01597479|561412376|FG000|Overall Study|Lost to Follow-up|1|||
155542713|NCT01597479|561412377|FG001|Overall Study|Lost to Follow-up|0|||
155542714|NCT01045707|561412378|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
155542715|NCT01045707|561412379|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
155542716|NCT01045707|561412378|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
155542717|NCT01045707|561412379|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
155542718|NCT01045707|561412378|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
155542719|NCT01045707|561412379|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
155542720|NCT01045707|561412378|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
155542721|NCT01045707|561412379|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
155542722|NCT01045707|561412378|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
155542723|NCT01045707|561412379|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
155542724|NCT01045707|561412378|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
155542725|NCT01045707|561412379|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
155542726|NCT01045707|561412378|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
155542727|NCT01045707|561412379|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
155542728|NCT01045707|561412378|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
155542729|NCT01045707|561412379|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
155542730|NCT01045707|561412378|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
155542731|NCT01045707|561412379|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
155542732|NCT00348816|561412380|FG000|Overall Study|Noncompliance with radiation treatment|1|||
155542733|NCT05552261|561412381|FG000|Overall Study|Withdrawal by Subject|1|||
155542734|NCT05552261|561412381|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
155542735|NCT00979212|561412385|FG000|Overall Study|Protocol Violation|1|||
155542736|NCT00979212|561412386|FG001|Overall Study|Protocol Violation|8|||
155542737|NCT00979212|561412385|FG000|Overall Study|No protocol therapy received|1|||
155542738|NCT00979212|561412386|FG001|Overall Study|No protocol therapy received|0|||
155542739|NCT00177164|561412396|FG000|Overall Study|Protocol Violation|0|||
155542740|NCT00177164|561412397|FG001|Overall Study|Protocol Violation|7|||
155542741|NCT00177164|561412396|FG000|Overall Study|Lost to Follow-up|4|||
155542742|NCT00177164|561412397|FG001|Overall Study|Lost to Follow-up|5|||
155542743|NCT00177164|561412396|FG000|Overall Study|increase in alcohol and drug use|1|||
155542744|NCT00177164|561412397|FG001|Overall Study|increase in alcohol and drug use|2|||
155542745|NCT00177164|561412396|FG000|Overall Study|Adverse Event|1|||
155542746|NCT00177164|561412397|FG001|Overall Study|Adverse Event|0|||
155542747|NCT00177164|561412396|FG000|Overall Study|discharge from hospital|1|||
155542748|NCT00177164|561412397|FG001|Overall Study|discharge from hospital|0|||
155542749|NCT00177164|561412396|FG000|Overall Study|Lack of Efficacy|2|||
155542750|NCT00177164|561412397|FG001|Overall Study|Lack of Efficacy|1|||
155542751|NCT00177164|561412396|FG000|Overall Study|Pregnancy|0|||
155542752|NCT00177164|561412397|FG001|Overall Study|Pregnancy|1|||
155542753|NCT00965757|561412400|FG000|Double-blind Phase|Progression of concomitant disease|1|||
155542754|NCT00965757|561412401|FG001|Double-blind Phase|Progression of concomitant disease|2|||
155542755|NCT00965757|561412402|FG002|Double-blind Phase|Progression of concomitant disease|0|||
155542756|NCT00965757|561412403|FG003|Double-blind Phase|Progression of concomitant disease|0|||
155542757|NCT00965757|561412400|FG000|Double-blind Phase|Adverse drug reaction|2|||
155542758|NCT00965757|561412401|FG001|Double-blind Phase|Adverse drug reaction|1|||
155542759|NCT00965757|561412402|FG002|Double-blind Phase|Adverse drug reaction|0|||
155542760|NCT00965757|561412403|FG003|Double-blind Phase|Adverse drug reaction|0|||
155542761|NCT00965757|561412400|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
155542762|NCT00965757|561412401|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
155542763|NCT00965757|561412402|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
155542764|NCT00965757|561412403|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
155542765|NCT00965757|561412400|FG000|Double-blind Phase|Lack of Efficacy|7|||
155542766|NCT00965757|561412401|FG001|Double-blind Phase|Lack of Efficacy|11|||
155542767|NCT00965757|561412402|FG002|Double-blind Phase|Lack of Efficacy|0|||
155542768|NCT00965757|561412403|FG003|Double-blind Phase|Lack of Efficacy|0|||
155542769|NCT00965757|561412400|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
155542770|NCT00965757|561412401|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
155542771|NCT00965757|561412402|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
155542772|NCT00965757|561412403|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
155542773|NCT00965757|561412400|FG000|Double-blind Phase|Lost to Follow-up|0|||
155542774|NCT00965757|561412401|FG001|Double-blind Phase|Lost to Follow-up|1|||
155542775|NCT00965757|561412402|FG002|Double-blind Phase|Lost to Follow-up|0|||
155542776|NCT00965757|561412403|FG003|Double-blind Phase|Lost to Follow-up|0|||
155542777|NCT00965757|561412400|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
155542778|NCT00965757|561412401|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
155542779|NCT00965757|561412402|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
155542780|NCT00965757|561412403|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
155542781|NCT00965757|561412400|FG000|Double-blind Phase|Other|1|||
155542782|NCT00965757|561412401|FG001|Double-blind Phase|Other|0|||
155542783|NCT00965757|561412402|FG002|Double-blind Phase|Other|0|||
155542784|NCT00965757|561412403|FG003|Double-blind Phase|Other|0|||
155542785|NCT00965757|561412400|FG000|Extension Phase|Progression of concomitant disease|0|||
155542786|NCT00965757|561412401|FG001|Extension Phase|Progression of concomitant disease|0|||
155542787|NCT00965757|561412402|FG002|Extension Phase|Progression of concomitant disease|4|||
155542788|NCT00965757|561412403|FG003|Extension Phase|Progression of concomitant disease|2|||
155542789|NCT00965757|561412400|FG000|Extension Phase|Adverse drug reaction|0|||
155542790|NCT00965757|561412401|FG001|Extension Phase|Adverse drug reaction|0|||
155542791|NCT00965757|561412402|FG002|Extension Phase|Adverse drug reaction|6|||
155542792|NCT00965757|561412403|FG003|Extension Phase|Adverse drug reaction|3|||
155542793|NCT00965757|561412400|FG000|Extension Phase|Abnormal Laboratory Value|0|||
155542794|NCT00965757|561412401|FG001|Extension Phase|Abnormal Laboratory Value|0|||
155542795|NCT00965757|561412402|FG002|Extension Phase|Abnormal Laboratory Value|6|||
155542796|NCT00965757|561412403|FG003|Extension Phase|Abnormal Laboratory Value|1|||
155542797|NCT00965757|561412400|FG000|Extension Phase|Lack of Efficacy|0|||
155542798|NCT00965757|561412401|FG001|Extension Phase|Lack of Efficacy|0|||
155542799|NCT00965757|561412402|FG002|Extension Phase|Lack of Efficacy|8|||
155542800|NCT00965757|561412403|FG003|Extension Phase|Lack of Efficacy|12|||
155542801|NCT00965757|561412400|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
155542802|NCT00965757|561412401|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
155542803|NCT00965757|561412402|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
155542804|NCT00965757|561412403|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
155656228|NCT02655601|561835165|FG004|Overall Study|Physician Decision|1|||
155542805|NCT00965757|561412400|FG000|Extension Phase|Lost to Follow-up|0|||
155542806|NCT00965757|561412401|FG001|Extension Phase|Lost to Follow-up|0|||
155542807|NCT00965757|561412402|FG002|Extension Phase|Lost to Follow-up|0|||
155542808|NCT00965757|561412403|FG003|Extension Phase|Lost to Follow-up|1|||
155542809|NCT00965757|561412400|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
155542810|NCT00965757|561412401|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
155542811|NCT00965757|561412402|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
155542812|NCT00965757|561412403|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
155542813|NCT00965757|561412400|FG000|Extension Phase|Protocol Violation|0|||
155542814|NCT00965757|561412401|FG001|Extension Phase|Protocol Violation|0|||
155542815|NCT00965757|561412402|FG002|Extension Phase|Protocol Violation|0|||
155542816|NCT00965757|561412403|FG003|Extension Phase|Protocol Violation|1|||
155542817|NCT00965757|561412400|FG000|Extension Phase|Other|0|||
155542818|NCT00965757|561412401|FG001|Extension Phase|Other|0|||
155542819|NCT00965757|561412402|FG002|Extension Phase|Other|2|||
155542820|NCT00965757|561412403|FG003|Extension Phase|Other|1|||
155542821|NCT03807440|561412404|FG000|Overall Study|No documentation of index date 2|320|||
155542822|NCT03807440|561412404|FG000|Overall Study|No informed consent for index date 2|117|||
155542823|NCT02451358|561412405|FG000|Overall Study|Withdrawal by Subject|1|||
155542824|NCT02451358|561412406|FG001|Overall Study|Withdrawal by Subject|1|||
155542825|NCT02451358|561412407|FG002|Overall Study|Withdrawal by Subject|0|||
155542826|NCT02451358|561412408|FG003|Overall Study|Withdrawal by Subject|0|||
155542827|NCT02451358|561412405|FG000|Overall Study|Protocol Violation|0|||
155542828|NCT02451358|561412406|FG001|Overall Study|Protocol Violation|1|||
155542829|NCT02451358|561412407|FG002|Overall Study|Protocol Violation|1|||
155542830|NCT02451358|561412408|FG003|Overall Study|Protocol Violation|0|||
155542831|NCT05070754|561412409|FG000|Overall Study|Withdrawal by Subject|0|||
155542832|NCT05070754|561412410|FG001|Overall Study|Withdrawal by Subject|0|||
155542833|NCT05070754|561412411|FG002|Overall Study|Withdrawal by Subject|0|||
155542834|NCT05070754|561412412|FG003|Overall Study|Withdrawal by Subject|1|||
155542835|NCT05070754|561412409|FG000|Overall Study|Protocol Violation|0|||
155542836|NCT05070754|561412410|FG001|Overall Study|Protocol Violation|0|||
155542837|NCT05070754|561412411|FG002|Overall Study|Protocol Violation|0|||
155542838|NCT05070754|561412412|FG003|Overall Study|Protocol Violation|1|||
155542839|NCT01398787|561412413|FG000|Overall Study|Adverse Event|1|||
155542840|NCT03414034|561412414|FG000|Overall Study|Adverse Event|6|||
155542841|NCT03414034|561412415|FG001|Overall Study|Adverse Event|1|||
155542842|NCT03414034|561412416|FG002|Overall Study|Adverse Event|1|||
155542843|NCT03414034|561412414|FG000|Overall Study|Death|0|||
155542844|NCT03414034|561412415|FG001|Overall Study|Death|0|||
155542845|NCT03414034|561412416|FG002|Overall Study|Death|1|||
155542846|NCT03414034|561412414|FG000|Overall Study|Non-compliance With Study Drug|0|||
155542847|NCT03414034|561412415|FG001|Overall Study|Non-compliance With Study Drug|0|||
155542848|NCT03414034|561412416|FG002|Overall Study|Non-compliance With Study Drug|1|||
155542849|NCT03414034|561412414|FG000|Overall Study|Physician Decision|1|||
155542850|NCT03414034|561412415|FG001|Overall Study|Physician Decision|3|||
155542851|NCT03414034|561412416|FG002|Overall Study|Physician Decision|2|||
155542852|NCT03414034|561412414|FG000|Overall Study|Withdrawal of Informed Consent|2|||
155542853|NCT03414034|561412415|FG001|Overall Study|Withdrawal of Informed Consent|1|||
155542854|NCT03414034|561412416|FG002|Overall Study|Withdrawal of Informed Consent|4|||
155542855|NCT03414034|561412414|FG000|Overall Study|Progressive Disease|15|||
155542856|NCT03414034|561412415|FG001|Overall Study|Progressive Disease|15|||
155542857|NCT03414034|561412416|FG002|Overall Study|Progressive Disease|17|||
155542858|NCT03414034|561412414|FG000|Overall Study|Miscellaneous|0|||
155542859|NCT03414034|561412415|FG001|Overall Study|Miscellaneous|0|||
155656229|NCT02655601|561835166|FG005|Overall Study|Physician Decision|1|||
155542860|NCT03414034|561412416|FG002|Overall Study|Miscellaneous|2|||
155542861|NCT04010227|561412417|FG000|Overall Study|Death|1|||
155542862|NCT04010227|561412418|FG001|Overall Study|Death|2|||
155542863|NCT04010227|561412417|FG000|Overall Study|Medical Reasons|4|||
155542864|NCT04010227|561412418|FG001|Overall Study|Medical Reasons|3|||
155542865|NCT04010227|561412417|FG000|Overall Study|Withdrawal by Subject|2|||
155542866|NCT04010227|561412418|FG001|Overall Study|Withdrawal by Subject|0|||
155542867|NCT04010227|561412417|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
155542868|NCT04010227|561412418|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
155542869|NCT00702507|561412419|FG000|Initial Treatment Phase|Adverse Event|2|||
155542870|NCT00702507|561412419|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
155542871|NCT00702507|561412419|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
155542872|NCT00702507|561412419|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
155542873|NCT00702507|561412419|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
155542874|NCT00702507|561412419|FG000|Follow-up Phase|Protocol Violation|2|||
155542875|NCT00702507|561412419|FG000|Follow-up Phase|Lost to Follow-up|23|||
155542876|NCT00702507|561412419|FG000|Follow-up Phase|Late Enrollment|1|||
155656230|NCT02655601|561835161|FG000|Overall Study|Withdrawal by Subject|0|||
155542877|NCT02308696|561412420|FG000|Overall Study|Lost to Follow-up|28|||
155542878|NCT02308696|561412421|FG001|Overall Study|Lost to Follow-up|21|||
155542879|NCT02308696|561412420|FG000|Overall Study|Death|8|||
155542880|NCT02308696|561412421|FG001|Overall Study|Death|4|||
155542881|NCT02308696|561412420|FG000|Overall Study|Moved to a Higher Level of Care|17|||
155542882|NCT02308696|561412421|FG001|Overall Study|Moved to a Higher Level of Care|6|||
155542883|NCT00113919|561412423|FG000|Overall Study|Physician Decision|8|||
155542884|NCT00113919|561412423|FG000|Overall Study|Death|6|||
155542885|NCT02340962|561412427|FG000|Overall Study|Lost to Follow-up|1|||
155542886|NCT02340962|561412428|FG001|Overall Study|Lost to Follow-up|0|||
155542887|NCT04194008|561412433|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
155542888|NCT04194008|561412433|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
155542889|NCT04194008|561412433|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
155542890|NCT04194008|561412433|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
155542891|NCT04194008|561412433|FG000|Treatment Phase With Nerivio|Missing data|4|||
155542892|NCT04194008|561412433|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
155542893|NCT01785615|561412434|FG000|Dietary Phase|Lost to Follow-up|0|||
155542894|NCT01785615|561412435|FG001|Dietary Phase|Lost to Follow-up|0|||
155542895|NCT01785615|561412436|FG002|Dietary Phase|Lost to Follow-up|0|||
155542896|NCT01785615|561412437|FG003|Dietary Phase|Lost to Follow-up|24|||
155542897|NCT01881737|561412438|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
155542898|NCT01881737|561412438|FG000|Overall Study|Withdrawal by Subject|1|||
155542899|NCT01881737|561412438|FG000|Overall Study|Worsening of baseline behavior|1|||
155542900|NCT00926367|561412442|FG000|Overall Study|Withdrawal by Subject|0|||
155542901|NCT00926367|561412443|FG001|Overall Study|Withdrawal by Subject|1|||
155542902|NCT00926367|561412442|FG000|Overall Study|Lost to Follow-up|1|||
155542903|NCT00926367|561412443|FG001|Overall Study|Lost to Follow-up|0|||
155542904|NCT00926367|561412442|FG000|Overall Study|Skin Irritation|1|||
155542905|NCT00926367|561412443|FG001|Overall Study|Skin Irritation|2|||
155542906|NCT01517867|561412444|FG000|Overall Study|never started treatment|29|||
155542907|NCT01517867|561412445|FG001|Overall Study|never started treatment|32|||
155542908|NCT01517867|561412444|FG000|Overall Study|Withdrawal by Subject|34|||
155542909|NCT01517867|561412445|FG001|Overall Study|Withdrawal by Subject|30|||
155542910|NCT01517867|561412444|FG000|Overall Study|Still in treatment at study end|0|||
155542911|NCT01517867|561412445|FG001|Overall Study|Still in treatment at study end|3|||
155542912|NCT03847974|561412446|FG000|Overall Study|relocated out of region|3|||
155542913|NCT03847974|561412446|FG000|Overall Study|Withdrawal by Subject|2|||
155542914|NCT03847974|561412446|FG000|Overall Study|Adverse Event|1|||
155542915|NCT01685216|561412449|FG000|Overall Study|Did not receive study drug|1|||
155542916|NCT01294449|561412450|FG000|Overall Study|Death|11|||
155542917|NCT01294449|561412451|FG001|Overall Study|Death|12|||
155542918|NCT01294449|561412450|FG000|Overall Study|Withdrawal by Subject|1|||
155542919|NCT01294449|561412451|FG001|Overall Study|Withdrawal by Subject|3|||
155542920|NCT02654015|561412452|FG000|Overall Study|Death|12|||
155542921|NCT02654015|561412452|FG000|Overall Study|Lost to Follow-up|3|||
155542922|NCT02466386|561412455|FG000|Overall Study|Adverse Event|5|||
155542923|NCT02466386|561412455|FG000|Overall Study|Protocol Violation|2|||
155542924|NCT02466386|561412455|FG000|Overall Study|Withdrawal by Subject|14|||
155542925|NCT02466386|561412455|FG000|Overall Study|Lost to Follow-up|5|||
155542926|NCT02466386|561412455|FG000|Overall Study|Lack of Efficacy|8|||
155542927|NCT02466386|561412455|FG000|Overall Study|Other|10|||
155542928|NCT05317195|561412456|FG000|Randomization|Withdrawal by Subject|1|||
155542929|NCT05317195|561412456|FG000|Randomization|Discontinued|6|||
155542930|NCT05317195|561412456|FG000|Admission|Withdrawal by Subject|2|||
155542931|NCT03259789|561412457|FG000|Overall Study|Adverse Event|3|||
155542932|NCT03259789|561412458|FG001|Overall Study|Adverse Event|2|||
155542933|NCT03259789|561412459|FG002|Overall Study|Adverse Event|1|||
155542934|NCT03259789|561412457|FG000|Overall Study|Withdrawal by Subject|9|||
155542935|NCT03259789|561412458|FG001|Overall Study|Withdrawal by Subject|5|||
155542936|NCT03259789|561412459|FG002|Overall Study|Withdrawal by Subject|1|||
155542937|NCT03259789|561412457|FG000|Overall Study|Lost to Follow-up|5|||
155542938|NCT03259789|561412458|FG001|Overall Study|Lost to Follow-up|9|||
155542939|NCT03259789|561412459|FG002|Overall Study|Lost to Follow-up|4|||
155542940|NCT03259789|561412457|FG000|Overall Study|Physician Decision|0|||
155542941|NCT03259789|561412458|FG001|Overall Study|Physician Decision|1|||
155542942|NCT03259789|561412459|FG002|Overall Study|Physician Decision|0|||
155542943|NCT02063217|561412460|FG000|Overall Study|Withdrawal by Subject|1|||
155542944|NCT02063217|561412461|FG001|Overall Study|Withdrawal by Subject|0|||
155542945|NCT02063217|561412462|FG002|Overall Study|Withdrawal by Subject|0|||
155542946|NCT00889252|561412463|FG000|Overall Study|Adverse Event|2|||
155542947|NCT00889252|561412464|FG001|Overall Study|Adverse Event|4|||
155542948|NCT00889252|561412463|FG000|Overall Study|Withdrawal by Subject|3|||
155542949|NCT00889252|561412464|FG001|Overall Study|Withdrawal by Subject|0|||
155542950|NCT00889252|561412463|FG000|Overall Study|Protocol Violation|2|||
155542951|NCT00889252|561412464|FG001|Overall Study|Protocol Violation|0|||
155542952|NCT04291508|561412465|FG000|Overall Study|Withdrawal by Subject|1|||
155542953|NCT04291508|561412466|FG001|Overall Study|Withdrawal by Subject|0|||
155542954|NCT04291508|561412467|FG002|Overall Study|Withdrawal by Subject|1|||
155542955|NCT04291508|561412468|FG003|Overall Study|Withdrawal by Subject|0|||
155542956|NCT04291508|561412465|FG000|Overall Study|lost to follow up|4|||
155542957|NCT04291508|561412466|FG001|Overall Study|lost to follow up|0|||
155542958|NCT04291508|561412467|FG002|Overall Study|lost to follow up|1|||
155542959|NCT04291508|561412468|FG003|Overall Study|lost to follow up|0|||
155542960|NCT01833169|561412475|FG000|Overall Study|Disease Progression|99|||
155542961|NCT01833169|561412475|FG000|Overall Study|Adverse Event|33|||
155542962|NCT01833169|561412475|FG000|Overall Study|Withdrawal by Subject|9|||
155542963|NCT01833169|561412475|FG000|Overall Study|Death|3|||
155542964|NCT01833169|561412475|FG000|Overall Study|Physician Decision|2|||
155542965|NCT01183884|561412479|FG000|Overall Study|Progressive Disease|26|||
155542966|NCT01183884|561412479|FG000|Overall Study|Adverse Event|3|||
155542967|NCT01183884|561412479|FG000|Overall Study|Withdrawal by Subject|1|||
155542968|NCT01183884|561412479|FG000|Overall Study|Other Complicating Disease|3|||
155542969|NCT01183884|561412479|FG000|Overall Study|Not Treated|1|||
155542970|NCT01183884|561412479|FG000|Overall Study|Other|4|||
155542971|NCT00772148|561412480|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
155542972|NCT00772148|561412481|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
155542973|NCT00772148|561412480|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
155542974|NCT00772148|561412481|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
155542975|NCT00772148|561412480|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
155542976|NCT00772148|561412481|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
155542977|NCT00772148|561412480|FG000|Maintenance Phase (Week 52)|Death|2|||
155542978|NCT00772148|561412481|FG001|Maintenance Phase (Week 52)|Death|2|||
155542979|NCT00772148|561412480|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
155542980|NCT00772148|561412481|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
155542981|NCT00772148|561412480|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
155542982|NCT00772148|561412481|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
155542983|NCT00772148|561412480|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
155542984|NCT00772148|561412481|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
155542985|NCT01214239|561412482|FG000|Overall Study|Adverse Event|3|||
155542986|NCT01214239|561412483|FG001|Overall Study|Adverse Event|4|||
155542987|NCT01214239|561412482|FG000|Overall Study|Protocol Violation|2|||
155542988|NCT01214239|561412483|FG001|Overall Study|Protocol Violation|1|||
155542989|NCT01214239|561412482|FG000|Overall Study|Lost to Follow-up|1|||
155542990|NCT01214239|561412483|FG001|Overall Study|Lost to Follow-up|1|||
155542991|NCT01214239|561412482|FG000|Overall Study|Withdrawal by Subject|4|||
155542992|NCT01214239|561412483|FG001|Overall Study|Withdrawal by Subject|9|||
155542993|NCT01214239|561412482|FG000|Overall Study|Lack of Efficacy|1|||
155542994|NCT01214239|561412483|FG001|Overall Study|Lack of Efficacy|2|||
155542995|NCT01214239|561412482|FG000|Overall Study|patient's private reason|1|||
155542996|NCT01214239|561412483|FG001|Overall Study|patient's private reason|1|||
155542997|NCT00559637|561414592|FG000|Overall Study|Adverse Event|22|||
155542998|NCT00559637|561414592|FG000|Overall Study|Withdrawal by Subject|4|||
155542999|NCT00559637|561414592|FG000|Overall Study|Protocol Violation|6|||
155543000|NCT00559637|561414592|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
155543001|NCT00559637|561414592|FG000|Overall Study|Failure to return|6|||
155543002|NCT00559637|561414592|FG000|Overall Study|Insufficient response|3|||
155543003|NCT00559637|561414592|FG000|Overall Study|Started requiring dialysis after month 7|2|||
155543004|NCT00559637|561414592|FG000|Overall Study|Suspected lung cancer|1|||
155543005|NCT00559637|561414592|FG000|Overall Study|Participation in another study|1|||
155543006|NCT00559637|561414592|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
155543007|NCT00559637|561414592|FG000|Overall Study|Change of center|1|||
155543008|NCT00559637|561414592|FG000|Overall Study|Change of home|1|||
155543009|NCT00559637|561414592|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
155543010|NCT04501094|561414595|FG000|Overall Study|Death (unrelated to research)|1|||
155543011|NCT04501094|561414596|FG001|Overall Study|Death (unrelated to research)|0|||
155543012|NCT00685035|561414597|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
155543013|NCT00685035|561414598|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
155543014|NCT00784979|561414601|FG000|Overall Study|incomplete data|6|||
155543015|NCT04241133|561414605|FG000|Overall Study|COVID19 Precautions|14|||
155543016|NCT04241133|561414606|FG001|Overall Study|COVID19 Precautions|34|||
155543017|NCT00631007|561414608|FG000|Overall Study|Adverse Event|0|||
155543018|NCT00631007|561414609|FG001|Overall Study|Adverse Event|2|||
155543019|NCT00631007|561414610|FG002|Overall Study|Adverse Event|0|||
155543020|NCT00631007|561414611|FG003|Overall Study|Adverse Event|2|||
155543021|NCT00631007|561414612|FG004|Overall Study|Adverse Event|3|||
155543022|NCT00631007|561414613|FG005|Overall Study|Adverse Event|2|||
155543023|NCT00631007|561414608|FG000|Overall Study|Lost to Follow-up|2|||
155543024|NCT00631007|561414609|FG001|Overall Study|Lost to Follow-up|1|||
155543025|NCT00631007|561414610|FG002|Overall Study|Lost to Follow-up|2|||
155543026|NCT00631007|561414611|FG003|Overall Study|Lost to Follow-up|4|||
155543027|NCT00631007|561414612|FG004|Overall Study|Lost to Follow-up|5|||
155543028|NCT00631007|561414613|FG005|Overall Study|Lost to Follow-up|3|||
155543029|NCT00631007|561414608|FG000|Overall Study|Physician Decision|1|||
155543030|NCT00631007|561414609|FG001|Overall Study|Physician Decision|0|||
155543031|NCT00631007|561414610|FG002|Overall Study|Physician Decision|1|||
155543032|NCT00631007|561414611|FG003|Overall Study|Physician Decision|0|||
155543033|NCT00631007|561414612|FG004|Overall Study|Physician Decision|0|||
155543034|NCT00631007|561414613|FG005|Overall Study|Physician Decision|2|||
155543035|NCT00631007|561414608|FG000|Overall Study|Persistent Hyperglycemia|2|||
155543036|NCT00631007|561414609|FG001|Overall Study|Persistent Hyperglycemia|2|||
155543037|NCT00631007|561414610|FG002|Overall Study|Persistent Hyperglycemia|5|||
155543038|NCT00631007|561414611|FG003|Overall Study|Persistent Hyperglycemia|1|||
155543039|NCT00631007|561414612|FG004|Overall Study|Persistent Hyperglycemia|2|||
155543040|NCT00631007|561414613|FG005|Overall Study|Persistent Hyperglycemia|5|||
155543041|NCT00631007|561414608|FG000|Overall Study|Withdrawal by Subject|4|||
155543042|NCT00631007|561414609|FG001|Overall Study|Withdrawal by Subject|5|||
155543043|NCT00631007|561414610|FG002|Overall Study|Withdrawal by Subject|2|||
155543044|NCT00631007|561414611|FG003|Overall Study|Withdrawal by Subject|2|||
155543045|NCT00631007|561414612|FG004|Overall Study|Withdrawal by Subject|1|||
155543046|NCT00631007|561414613|FG005|Overall Study|Withdrawal by Subject|3|||
155543047|NCT00631007|561414608|FG000|Overall Study|Other|2|||
155543048|NCT00631007|561414609|FG001|Overall Study|Other|1|||
155543049|NCT00631007|561414610|FG002|Overall Study|Other|0|||
155543050|NCT00631007|561414611|FG003|Overall Study|Other|0|||
155543051|NCT00631007|561414612|FG004|Overall Study|Other|1|||
155543052|NCT00631007|561414613|FG005|Overall Study|Other|0|||
155543053|NCT00683787|561414614|FG000|Overall Study|Progression|3|||
155543054|NCT00683787|561414615|FG001|Overall Study|Progression|3|||
155543055|NCT00683787|561414616|FG002|Overall Study|Progression|0|||
155543056|NCT00683787|561414614|FG000|Overall Study|Adverse Event|0|||
155543057|NCT00683787|561414615|FG001|Overall Study|Adverse Event|0|||
155543058|NCT00683787|561414616|FG002|Overall Study|Adverse Event|2|||
155543059|NCT00460109|561414617|FG000|Overall Study|Death|1|||
155543060|NCT01235715|561414618|FG000|Overall Study|Physician Decision|0|||
155543061|NCT01235715|561414619|FG001|Overall Study|Physician Decision|2|||
155543062|NCT03619876|561414620|FG000|Overall Study|Withdrawal by Subject|1|||
155543063|NCT03619876|561414621|FG001|Overall Study|Withdrawal by Subject|2|||
155543064|NCT03619876|561414620|FG000|Overall Study|Withdrawal due to incidental finding|0|||
155543065|NCT03619876|561414621|FG001|Overall Study|Withdrawal due to incidental finding|2|||
155543066|NCT02344745|561414622|FG000|Overall Study|Data collection sheets were lost|2|||
155543067|NCT02344745|561414623|FG001|Overall Study|Data collection sheets were lost|0|||
155543068|NCT02788513|561414624|FG000|Overall Study|Withdrawal by Subject|3|||
155543069|NCT02788513|561414625|FG001|Overall Study|Withdrawal by Subject|0|||
155543070|NCT02788513|561414626|FG002|Overall Study|Withdrawal by Subject|2|||
155543071|NCT02788513|561414627|FG003|Overall Study|Withdrawal by Subject|3|||
155543072|NCT02788513|561414628|FG004|Overall Study|Withdrawal by Subject|1|||
155543073|NCT02788513|561414624|FG000|Overall Study|Lost to Follow-up|1|||
155543074|NCT02788513|561414625|FG001|Overall Study|Lost to Follow-up|0|||
155543075|NCT02788513|561414626|FG002|Overall Study|Lost to Follow-up|0|||
155543076|NCT02788513|561414627|FG003|Overall Study|Lost to Follow-up|0|||
155543077|NCT02788513|561414628|FG004|Overall Study|Lost to Follow-up|1|||
155543078|NCT02788513|561414624|FG000|Overall Study|Adverse Event|5|||
155543079|NCT02788513|561414625|FG001|Overall Study|Adverse Event|8|||
155543080|NCT02788513|561414626|FG002|Overall Study|Adverse Event|4|||
155543081|NCT02788513|561414627|FG003|Overall Study|Adverse Event|2|||
155543082|NCT02788513|561414628|FG004|Overall Study|Adverse Event|2|||
155543083|NCT02788513|561414624|FG000|Overall Study|Protocol Violation|0|||
155543084|NCT02788513|561414625|FG001|Overall Study|Protocol Violation|0|||
155543085|NCT02788513|561414626|FG002|Overall Study|Protocol Violation|1|||
155543086|NCT02788513|561414627|FG003|Overall Study|Protocol Violation|1|||
155543087|NCT02788513|561414628|FG004|Overall Study|Protocol Violation|0|||
155543088|NCT02788513|561414624|FG000|Overall Study|Subject decided to stop taking treatment|0|||
155543089|NCT02788513|561414625|FG001|Overall Study|Subject decided to stop taking treatment|0|||
155543090|NCT02788513|561414626|FG002|Overall Study|Subject decided to stop taking treatment|1|||
155543091|NCT02788513|561414627|FG003|Overall Study|Subject decided to stop taking treatment|0|||
155543092|NCT02788513|561414628|FG004|Overall Study|Subject decided to stop taking treatment|0|||
155543093|NCT02788513|561414624|FG000|Overall Study|Decision by the study team|0|||
155543094|NCT02788513|561414625|FG001|Overall Study|Decision by the study team|0|||
155543095|NCT02788513|561414626|FG002|Overall Study|Decision by the study team|0|||
155543096|NCT02788513|561414627|FG003|Overall Study|Decision by the study team|0|||
155543097|NCT02788513|561414628|FG004|Overall Study|Decision by the study team|1|||
155543098|NCT02943993|561414629|FG000|Overall Study|Withdrawal by Subject|52|||
155543099|NCT02943993|561414629|FG000|Overall Study|Transfer to another institution|6|||
155543100|NCT02943993|561414629|FG000|Overall Study|Lost to Follow-up|135|||
155543101|NCT02943993|561414629|FG000|Overall Study|Death|98|||
155543102|NCT02943993|561414629|FG000|Overall Study|Other reason for premature termination|32|||
155543103|NCT02943993|561414629|FG000|Overall Study|Missing reason for termination|7|||
155543104|NCT00835796|561414635|FG000|First Intervention|Withdrawal by Subject|0|||
155543105|NCT00835796|561414636|FG001|First Intervention|Withdrawal by Subject|1|||
155543106|NCT00396630|561414637|FG000|Overall Study|Lost to Follow-up|1|||
155543107|NCT00396630|561414638|FG001|Overall Study|Lost to Follow-up|1|||
155543108|NCT00396630|561414637|FG000|Overall Study|Withdrawal by Subject|1|||
155543109|NCT00396630|561414638|FG001|Overall Study|Withdrawal by Subject|1|||
155543110|NCT00396630|561414637|FG000|Overall Study|Not vaccinated at Visit 3|3|||
155543111|NCT00396630|561414638|FG001|Overall Study|Not vaccinated at Visit 3|3|||
155543112|NCT00876265|561414639|FG000|Overall Study|Miscellaneous reasons|4|||
155543113|NCT00876265|561414639|FG000|Overall Study|Lost to Follow-up|6|||
155543114|NCT00876265|561414639|FG000|Overall Study|Withdrawal by Subject|2|||
155543115|NCT02327325|561414640|FG000|Overall Study|Withdrawal by Subject|1|||
155543116|NCT02327325|561414641|FG001|Overall Study|Withdrawal by Subject|4|||
155543117|NCT02327325|561414642|FG002|Overall Study|Withdrawal by Subject|4|||
155543118|NCT02327325|561414640|FG000|Overall Study|Excluded by Study Team|0|||
155543119|NCT02327325|561414641|FG001|Overall Study|Excluded by Study Team|0|||
155543120|NCT02327325|561414642|FG002|Overall Study|Excluded by Study Team|1|||
155543121|NCT00651183|561414645|FG000|Overall Study|Lack of Efficacy|1|||
155543122|NCT00651183|561414646|FG001|Overall Study|Lack of Efficacy|0|||
155543123|NCT00651183|561414645|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
155543124|NCT00651183|561414646|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
155543125|NCT00651183|561414645|FG000|Overall Study|Tolerability insufficient|5|||
155543126|NCT00651183|561414646|FG001|Overall Study|Tolerability insufficient|2|||
155543127|NCT00651183|561414645|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
155543128|NCT00651183|561414646|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
155543129|NCT00651183|561414645|FG000|Overall Study|Withdrawal by Subject|6|||
155543130|NCT00651183|561414646|FG001|Overall Study|Withdrawal by Subject|3|||
155543131|NCT00651183|561414645|FG000|Overall Study|Lost to Follow-up|3|||
155543132|NCT00651183|561414646|FG001|Overall Study|Lost to Follow-up|1|||
155543133|NCT00651183|561414645|FG000|Overall Study|Other reasons|4|||
155543134|NCT00651183|561414646|FG001|Overall Study|Other reasons|2|||
155543135|NCT00651183|561414645|FG000|Overall Study|missing|1|||
155543136|NCT00651183|561414646|FG001|Overall Study|missing|0|||
155543137|NCT02014441|561414650|FG000|Overall Study|Withdrawal by Subject|12|||
155543138|NCT02576717|561414652|FG000|Overall Study|Other Reasons|16|||
155543139|NCT02576717|561414653|FG001|Overall Study|Other Reasons|18|||
155543140|NCT02576717|561414654|FG002|Overall Study|Other Reasons|15|||
155543141|NCT02576717|561414652|FG000|Overall Study|Covid-19 Pandemic|0|||
155543142|NCT02576717|561414653|FG001|Overall Study|Covid-19 Pandemic|1|||
155543143|NCT02576717|561414654|FG002|Overall Study|Covid-19 Pandemic|1|||
155543144|NCT02576717|561414652|FG000|Overall Study|Sponsor Decision|0|||
155543145|NCT02576717|561414653|FG001|Overall Study|Sponsor Decision|0|||
155543146|NCT02576717|561414654|FG002|Overall Study|Sponsor Decision|1|||
155543147|NCT02576717|561414652|FG000|Overall Study|Physician Decision|3|||
155543148|NCT02576717|561414653|FG001|Overall Study|Physician Decision|8|||
155543149|NCT02576717|561414654|FG002|Overall Study|Physician Decision|9|||
155543150|NCT02576717|561414652|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
155543151|NCT02576717|561414653|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
155543152|NCT02576717|561414654|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
155543153|NCT02576717|561414652|FG000|Overall Study|Death|3|||
155543154|NCT02576717|561414653|FG001|Overall Study|Death|5|||
155543155|NCT02576717|561414654|FG002|Overall Study|Death|3|||
155543156|NCT02576717|561414652|FG000|Overall Study|Lost to Follow-up|9|||
155543157|NCT02576717|561414653|FG001|Overall Study|Lost to Follow-up|10|||
155543158|NCT02576717|561414654|FG002|Overall Study|Lost to Follow-up|19|||
155543159|NCT02576717|561414652|FG000|Overall Study|Protocol Violation|4|||
155543160|NCT02576717|561414653|FG001|Overall Study|Protocol Violation|0|||
155543161|NCT02576717|561414654|FG002|Overall Study|Protocol Violation|5|||
155543162|NCT02576717|561414652|FG000|Overall Study|Lack of Efficacy|24|||
155543163|NCT02576717|561414653|FG001|Overall Study|Lack of Efficacy|28|||
155543164|NCT02576717|561414654|FG002|Overall Study|Lack of Efficacy|20|||
155543165|NCT02576717|561414652|FG000|Overall Study|Adverse Event|26|||
155543166|NCT02576717|561414653|FG001|Overall Study|Adverse Event|32|||
155543167|NCT02576717|561414654|FG002|Overall Study|Adverse Event|26|||
155543168|NCT01363011|561414655|FG000|Main Study|Adverse Event|2|||
155543169|NCT01363011|561414656|FG001|Main Study|Adverse Event|3|||
155543170|NCT01363011|561414655|FG000|Main Study|Investigator's Discretion|1|||
155543171|NCT01363011|561414656|FG001|Main Study|Investigator's Discretion|1|||
155543172|NCT01363011|561414655|FG000|Main Study|Withdrew Consent|1|||
155543173|NCT01363011|561414656|FG001|Main Study|Withdrew Consent|4|||
155543174|NCT01363011|561414655|FG000|Main Study|Protocol Violation|0|||
155543175|NCT01363011|561414656|FG001|Main Study|Protocol Violation|1|||
155543176|NCT01363011|561414655|FG000|Extension Phase|Adverse Event|1|||
155543177|NCT01363011|561414656|FG001|Extension Phase|Adverse Event|1|||
155543178|NCT01363011|561414655|FG000|Extension Phase|Lack of Efficacy|0|||
155543179|NCT01363011|561414656|FG001|Extension Phase|Lack of Efficacy|1|||
155543180|NCT01363011|561414655|FG000|Extension Phase|Investigator's Discretion|2|||
155543181|NCT01363011|561414656|FG001|Extension Phase|Investigator's Discretion|2|||
155543182|NCT01363011|561414655|FG000|Extension Phase|Withdrew Consent|0|||
155543183|NCT01363011|561414656|FG001|Extension Phase|Withdrew Consent|1|||
155543184|NCT01363011|561414655|FG000|Extension Phase|Lost to Follow-up|0|||
155543185|NCT01363011|561414656|FG001|Extension Phase|Lost to Follow-up|2|||
155543186|NCT01363011|561414655|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
155543187|NCT01363011|561414656|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
155543188|NCT02457819|561414657|FG000|Overall Study|reason not given|8|||
155543189|NCT02457819|561414657|FG000|Overall Study|Withdrawal by Subject|24|||
155543190|NCT02457819|561414657|FG000|Overall Study|Protocol Violation|1|||
155543191|NCT02457819|561414657|FG000|Overall Study|non compliance with study drug|4|||
155543192|NCT02457819|561414657|FG000|Overall Study|Lost to Follow-up|10|||
155543193|NCT02457819|561414657|FG000|Overall Study|Lack of Efficacy|19|||
155543194|NCT02457819|561414657|FG000|Overall Study|Adverse Event|33|||
155543195|NCT03330236|561414658|FG000|Overall Study|Death|2|||
155543196|NCT03330236|561414659|FG001|Overall Study|Death|1|||
155543197|NCT03330236|561414658|FG000|Overall Study|Withdrawal by Subject|2|||
155543198|NCT03330236|561414659|FG001|Overall Study|Withdrawal by Subject|4|||
155543199|NCT03330236|561414658|FG000|Overall Study|Lost to Follow-up|0|||
155543200|NCT03330236|561414659|FG001|Overall Study|Lost to Follow-up|2|||
155543201|NCT03330236|561414658|FG000|Overall Study|Physician Decision|2|||
155543202|NCT03330236|561414659|FG001|Overall Study|Physician Decision|0|||
155543203|NCT03330236|561414658|FG000|Overall Study|Protocol Violation|4|||
155543204|NCT03330236|561414659|FG001|Overall Study|Protocol Violation|3|||
155543205|NCT03330236|561414658|FG000|Overall Study|SedLine malfunction/blinding|19|||
155543206|NCT03330236|561414659|FG001|Overall Study|SedLine malfunction/blinding|14|||
155543207|NCT03330236|561414658|FG000|Overall Study|Volatile anesthetics used|11|||
155543208|NCT03330236|561414659|FG001|Overall Study|Volatile anesthetics used|8|||
155543209|NCT03330236|561414658|FG000|Overall Study|Surgery aborted/converted to open|60|||
155543210|NCT03330236|561414659|FG001|Overall Study|Surgery aborted/converted to open|52|||
155543211|NCT00763555|561414660|FG000|Overall Study|Adverse Event|2|||
155543212|NCT00763555|561414661|FG001|Overall Study|Adverse Event|1|||
155543213|NCT00763555|561414660|FG000|Overall Study|Withdrawal by Subject|2|||
155543214|NCT00763555|561414661|FG001|Overall Study|Withdrawal by Subject|6|||
155543215|NCT00763555|561414660|FG000|Overall Study|Lost to Follow-up|0|||
155543216|NCT00763555|561414661|FG001|Overall Study|Lost to Follow-up|3|||
155543217|NCT00407745|561414662|FG000|Overall Study|Lack of Efficacy|1|||
155543218|NCT00407745|561414663|FG001|Overall Study|Lack of Efficacy|2|||
155543219|NCT00407745|561414662|FG000|Overall Study|Withdrawal by Subject|3|||
155543220|NCT00407745|561414663|FG001|Overall Study|Withdrawal by Subject|3|||
155543221|NCT00407745|561414662|FG000|Overall Study|Protocol Violation|5|||
155543222|NCT00407745|561414663|FG001|Overall Study|Protocol Violation|3|||
155543223|NCT00407745|561414662|FG000|Overall Study|Adverse Event|8|||
155543224|NCT00407745|561414663|FG001|Overall Study|Adverse Event|8|||
155543225|NCT00407745|561414662|FG000|Overall Study|Other|2|||
155543226|NCT00407745|561414663|FG001|Overall Study|Other|0|||
155543227|NCT00407745|561414662|FG000|Overall Study|Randomized, unknown if treated|0|||
155543228|NCT00407745|561414663|FG001|Overall Study|Randomized, unknown if treated|1|||
155543229|NCT00298740|561414664|FG000|Overall Study|Lack of Efficacy|6|||
155543230|NCT00298740|561414664|FG000|Overall Study|Withdrawal by Subject|3|||
155543231|NCT03449199|561414669|FG000|Overall Study|Lost to Follow-up|1|||
155543232|NCT03449199|561414670|FG001|Overall Study|Lost to Follow-up|1|||
155543233|NCT03449199|561414671|FG002|Overall Study|Lost to Follow-up|0|||
155543234|NCT03449199|561414669|FG000|Overall Study|Protocol Deviation|0|||
155543235|NCT03449199|561414670|FG001|Overall Study|Protocol Deviation|0|||
155543236|NCT03449199|561414671|FG002|Overall Study|Protocol Deviation|1|||
155543237|NCT03449199|561414669|FG000|Overall Study|Withdrawal by Subject|0|||
155543238|NCT03449199|561414670|FG001|Overall Study|Withdrawal by Subject|0|||
155543239|NCT03449199|561414671|FG002|Overall Study|Withdrawal by Subject|1|||
155543240|NCT00684567|561414672|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
155543241|NCT00684567|561414672|FG000|Monotherapy Period|Adverse Event|2|||
155543242|NCT00684567|561414672|FG000|Monotherapy Period|Death|1|||
155543243|NCT00684567|561414672|FG000|Monotherapy Period|Progression of primary disease|11|||
155543244|NCT00848042|561414673|FG000|Overall Study|Death|1|||
155543245|NCT00848042|561414674|FG001|Overall Study|Death|2|||
155543246|NCT00848042|561414675|FG002|Overall Study|Death|0|||
155543247|NCT00848042|561414673|FG000|Overall Study|Other Therapy|3|||
155543248|NCT00848042|561414674|FG001|Overall Study|Other Therapy|0|||
155543249|NCT00848042|561414675|FG002|Overall Study|Other Therapy|0|||
155543250|NCT02744755|561414676|FG000|Study Period 1|Protocol Violation|2|||
155543251|NCT02744755|561414677|FG001|Study Period 1|Protocol Violation|1|||
155543252|NCT02744755|561414676|FG000|Study Period 1|not defined|0|||
155543253|NCT02744755|561414677|FG001|Study Period 1|not defined|1|||
155543254|NCT02744755|561414676|FG000|Study Period 1|Pregnancy|1|||
155543255|NCT02744755|561414677|FG001|Study Period 1|Pregnancy|0|||
155543256|NCT02744755|561414676|FG000|Study Period 1|Adverse Event|1|||
155543257|NCT02744755|561414677|FG001|Study Period 1|Adverse Event|1|||
155543258|NCT02744755|561414676|FG000|Study Period 1|Lost to Follow-up|1|||
155543259|NCT02744755|561414677|FG001|Study Period 1|Lost to Follow-up|1|||
155543260|NCT02744755|561414676|FG000|Study Period 1|Lack of Efficacy|1|||
155543261|NCT02744755|561414677|FG001|Study Period 1|Lack of Efficacy|0|||
155543262|NCT02744755|561414676|FG000|Study Period 1|Withdrawal by Subject|8|||
155543263|NCT02744755|561414677|FG001|Study Period 1|Withdrawal by Subject|4|||
155543264|NCT02744755|561414676|FG000|Study Period 2|Adverse Event|5|||
155543265|NCT02744755|561414677|FG001|Study Period 2|Adverse Event|0|||
155543266|NCT02744755|561414676|FG000|Study Period 2|Protocol Violation|1|||
155543267|NCT02744755|561414677|FG001|Study Period 2|Protocol Violation|0|||
155543268|NCT02744755|561414676|FG000|Study Period 2|not defined|3|||
155543269|NCT02744755|561414677|FG001|Study Period 2|not defined|2|||
155543270|NCT02744755|561414676|FG000|Study Period 2|Lost to Follow-up|0|||
155543271|NCT02744755|561414677|FG001|Study Period 2|Lost to Follow-up|2|||
155543272|NCT02744755|561414676|FG000|Study Period 2|Withdrawal by Subject|2|||
155543273|NCT02744755|561414677|FG001|Study Period 2|Withdrawal by Subject|2|||
155543274|NCT02744755|561414676|FG000|Study Period 2|Lack of Efficacy|3|||
155543275|NCT02744755|561414677|FG001|Study Period 2|Lack of Efficacy|2|||
155543276|NCT00809965|561414678|FG000|Overall Study|Death|194|||
155543277|NCT00809965|561414679|FG001|Overall Study|Death|147|||
155543278|NCT00809965|561414680|FG002|Overall Study|Death|196|||
155543279|NCT00809965|561414678|FG000|Overall Study|Lost to Follow-up|17|||
155543280|NCT00809965|561414679|FG001|Overall Study|Lost to Follow-up|10|||
155543281|NCT00809965|561414680|FG002|Overall Study|Lost to Follow-up|18|||
155656231|NCT02655601|561835162|FG001|Overall Study|Withdrawal by Subject|0|||
155656232|NCT02655601|561835163|FG002|Overall Study|Withdrawal by Subject|0|||
155656233|NCT02655601|561835164|FG003|Overall Study|Withdrawal by Subject|0|||
155656234|NCT02655601|561835165|FG004|Overall Study|Withdrawal by Subject|4|||
155543282|NCT00809965|561414678|FG000|Overall Study|Withdrawal by Subject|405|||
155543283|NCT00809965|561414679|FG001|Overall Study|Withdrawal by Subject|448|||
155543284|NCT00809965|561414680|FG002|Overall Study|Withdrawal by Subject|441|||
155543285|NCT00809965|561414678|FG000|Overall Study|Other Reason|167|||
155543286|NCT00809965|561414679|FG001|Overall Study|Other Reason|170|||
155543287|NCT00809965|561414680|FG002|Overall Study|Other Reason|189|||
155656235|NCT02655601|561835166|FG005|Overall Study|Withdrawal by Subject|8|||
155656236|NCT02655601|561835161|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
155543288|NCT01628549|561414683|FG000|Overall Study|Adverse Event|1|||
155543289|NCT01628549|561414684|FG001|Overall Study|Adverse Event|1|||
155656237|NCT02655601|561835162|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155656238|NCT02655601|561835163|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155543290|NCT01628549|561414685|FG002|Overall Study|Adverse Event|0|||
155543291|NCT01628549|561414686|FG003|Overall Study|Adverse Event|4|||
155543292|NCT01628549|561414683|FG000|Overall Study|Lost to Follow-up|3|||
155543293|NCT01628549|561414684|FG001|Overall Study|Lost to Follow-up|4|||
155543294|NCT01628549|561414685|FG002|Overall Study|Lost to Follow-up|3|||
155543295|NCT01628549|561414686|FG003|Overall Study|Lost to Follow-up|3|||
155543296|NCT01628549|561414683|FG000|Overall Study|Withdrawal by Subject|3|||
155543297|NCT01628549|561414684|FG001|Overall Study|Withdrawal by Subject|4|||
155543298|NCT01628549|561414685|FG002|Overall Study|Withdrawal by Subject|4|||
155543299|NCT01628549|561414686|FG003|Overall Study|Withdrawal by Subject|1|||
155543300|NCT01628549|561414683|FG000|Overall Study|Protocol Violation|2|||
155543301|NCT01628549|561414684|FG001|Overall Study|Protocol Violation|1|||
155543302|NCT01628549|561414685|FG002|Overall Study|Protocol Violation|1|||
155543303|NCT01628549|561414686|FG003|Overall Study|Protocol Violation|0|||
155543304|NCT01628549|561414683|FG000|Overall Study|withdrawn for noncompliance|0|||
155543305|NCT01628549|561414684|FG001|Overall Study|withdrawn for noncompliance|2|||
155543306|NCT01628549|561414685|FG002|Overall Study|withdrawn for noncompliance|1|||
155543307|NCT01628549|561414686|FG003|Overall Study|withdrawn for noncompliance|0|||
155543308|NCT01628549|561414683|FG000|Overall Study|abnormal laboratory test results|0|||
155543309|NCT01628549|561414684|FG001|Overall Study|abnormal laboratory test results|0|||
155543310|NCT01628549|561414685|FG002|Overall Study|abnormal laboratory test results|1|||
155543311|NCT01628549|561414686|FG003|Overall Study|abnormal laboratory test results|0|||
155543312|NCT01628549|561414683|FG000|Overall Study|positive pregnancy test|0|||
155543313|NCT01628549|561414684|FG001|Overall Study|positive pregnancy test|0|||
155543314|NCT01628549|561414685|FG002|Overall Study|positive pregnancy test|0|||
155543315|NCT01628549|561414686|FG003|Overall Study|positive pregnancy test|1|||
155543316|NCT06128525|561414687|FG000|Overall Study|Patient withdrew consent|1|||
155543317|NCT01344018|561414695|FG000|Overall Study|Death|22|||
155543318|NCT01344018|561414696|FG001|Overall Study|Death|25|||
155543319|NCT01344018|561414695|FG000|Overall Study|Lost to Follow-up|4|||
155543320|NCT01344018|561414696|FG001|Overall Study|Lost to Follow-up|7|||
155543321|NCT01332968|561414698|FG000|Induction Period|Adverse Event|23|||
155543322|NCT01332968|561414699|FG001|Induction Period|Adverse Event|26|||
155543323|NCT01332968|561414700|FG002|Induction Period|Adverse Event|0|||
155543324|NCT01332968|561414701|FG003|Induction Period|Adverse Event|0|||
155543325|NCT01332968|561414702|FG004|Induction Period|Adverse Event|0|||
155543326|NCT01332968|561414703|FG005|Induction Period|Adverse Event|0|||
155543327|NCT01332968|561414704|FG006|Induction Period|Adverse Event|0|||
155543328|NCT01332968|561414705|FG007|Induction Period|Adverse Event|0|||
155543329|NCT01332968|561414698|FG000|Induction Period|Death|1|||
155543330|NCT01332968|561414699|FG001|Induction Period|Death|4|||
155543331|NCT01332968|561414700|FG002|Induction Period|Death|0|||
155543332|NCT01332968|561414701|FG003|Induction Period|Death|0|||
155543333|NCT01332968|561414702|FG004|Induction Period|Death|0|||
155543334|NCT01332968|561414703|FG005|Induction Period|Death|0|||
155543335|NCT01332968|561414704|FG006|Induction Period|Death|0|||
155543336|NCT01332968|561414705|FG007|Induction Period|Death|0|||
155543337|NCT01332968|561414698|FG000|Induction Period|Non-compliance|1|||
155543338|NCT01332968|561414699|FG001|Induction Period|Non-compliance|0|||
155543339|NCT01332968|561414700|FG002|Induction Period|Non-compliance|0|||
155543340|NCT01332968|561414701|FG003|Induction Period|Non-compliance|0|||
155543341|NCT01332968|561414702|FG004|Induction Period|Non-compliance|0|||
155543342|NCT01332968|561414703|FG005|Induction Period|Non-compliance|0|||
155543343|NCT01332968|561414704|FG006|Induction Period|Non-compliance|0|||
155543344|NCT01332968|561414705|FG007|Induction Period|Non-compliance|0|||
155543345|NCT01332968|561414698|FG000|Induction Period|Other|2|||
155543346|NCT01332968|561414699|FG001|Induction Period|Other|2|||
155543347|NCT01332968|561414700|FG002|Induction Period|Other|0|||
155543348|NCT01332968|561414701|FG003|Induction Period|Other|0|||
155543349|NCT01332968|561414702|FG004|Induction Period|Other|0|||
155543350|NCT01332968|561414703|FG005|Induction Period|Other|0|||
155543351|NCT01332968|561414704|FG006|Induction Period|Other|0|||
155543352|NCT01332968|561414705|FG007|Induction Period|Other|0|||
155543353|NCT01332968|561414698|FG000|Induction Period|Physician Decision|6|||
155543354|NCT01332968|561414699|FG001|Induction Period|Physician Decision|1|||
155543355|NCT01332968|561414700|FG002|Induction Period|Physician Decision|0|||
155543356|NCT01332968|561414701|FG003|Induction Period|Physician Decision|0|||
155543357|NCT01332968|561414702|FG004|Induction Period|Physician Decision|0|||
155543358|NCT01332968|561414703|FG005|Induction Period|Physician Decision|0|||
155543359|NCT01332968|561414704|FG006|Induction Period|Physician Decision|0|||
155543360|NCT01332968|561414705|FG007|Induction Period|Physician Decision|0|||
155543361|NCT01332968|561414698|FG000|Induction Period|Progressive Disease|15|||
155543362|NCT01332968|561414699|FG001|Induction Period|Progressive Disease|7|||
155543363|NCT01332968|561414700|FG002|Induction Period|Progressive Disease|0|||
155543364|NCT01332968|561414701|FG003|Induction Period|Progressive Disease|0|||
155543365|NCT01332968|561414702|FG004|Induction Period|Progressive Disease|0|||
155543366|NCT01332968|561414703|FG005|Induction Period|Progressive Disease|0|||
155543367|NCT01332968|561414704|FG006|Induction Period|Progressive Disease|0|||
155543368|NCT01332968|561414705|FG007|Induction Period|Progressive Disease|0|||
155543369|NCT01332968|561414698|FG000|Induction Period|Protocol Violation|3|||
155543370|NCT01332968|561414699|FG001|Induction Period|Protocol Violation|4|||
155543371|NCT01332968|561414700|FG002|Induction Period|Protocol Violation|0|||
155543372|NCT01332968|561414701|FG003|Induction Period|Protocol Violation|0|||
155543373|NCT01332968|561414702|FG004|Induction Period|Protocol Violation|0|||
155543374|NCT01332968|561414703|FG005|Induction Period|Protocol Violation|0|||
155543375|NCT01332968|561414704|FG006|Induction Period|Protocol Violation|0|||
155543376|NCT01332968|561414705|FG007|Induction Period|Protocol Violation|0|||
155543377|NCT01332968|561414698|FG000|Induction Period|Withdrawal by Subject|3|||
155543378|NCT01332968|561414699|FG001|Induction Period|Withdrawal by Subject|5|||
155543379|NCT01332968|561414700|FG002|Induction Period|Withdrawal by Subject|0|||
155543380|NCT01332968|561414701|FG003|Induction Period|Withdrawal by Subject|0|||
155543381|NCT01332968|561414702|FG004|Induction Period|Withdrawal by Subject|0|||
155543382|NCT01332968|561414703|FG005|Induction Period|Withdrawal by Subject|0|||
155543383|NCT01332968|561414704|FG006|Induction Period|Withdrawal by Subject|0|||
155543384|NCT01332968|561414705|FG007|Induction Period|Withdrawal by Subject|0|||
155543385|NCT01332968|561414698|FG000|Induction Period|Randomised but not treated|4|||
155543386|NCT01332968|561414699|FG001|Induction Period|Randomised but not treated|7|||
155543387|NCT01332968|561414700|FG002|Induction Period|Randomised but not treated|0|||
155543388|NCT01332968|561414701|FG003|Induction Period|Randomised but not treated|0|||
155543389|NCT01332968|561414702|FG004|Induction Period|Randomised but not treated|0|||
155543390|NCT01332968|561414703|FG005|Induction Period|Randomised but not treated|0|||
155543391|NCT01332968|561414704|FG006|Induction Period|Randomised but not treated|0|||
155543392|NCT01332968|561414705|FG007|Induction Period|Randomised but not treated|0|||
155543393|NCT01332968|561414698|FG000|Maintenance/Observation Period|Adverse Event|0|||
155543394|NCT01332968|561414699|FG001|Maintenance/Observation Period|Adverse Event|0|||
155543395|NCT01332968|561414700|FG002|Maintenance/Observation Period|Adverse Event|53|||
155543396|NCT01332968|561414701|FG003|Maintenance/Observation Period|Adverse Event|66|||
155543397|NCT01332968|561414702|FG004|Maintenance/Observation Period|Adverse Event|0|||
155543398|NCT01332968|561414703|FG005|Maintenance/Observation Period|Adverse Event|0|||
155543399|NCT01332968|561414704|FG006|Maintenance/Observation Period|Adverse Event|0|||
155543400|NCT01332968|561414705|FG007|Maintenance/Observation Period|Adverse Event|0|||
155543401|NCT01332968|561414698|FG000|Maintenance/Observation Period|Death|0|||
155543402|NCT01332968|561414699|FG001|Maintenance/Observation Period|Death|0|||
155543403|NCT01332968|561414700|FG002|Maintenance/Observation Period|Death|5|||
155543404|NCT01332968|561414701|FG003|Maintenance/Observation Period|Death|6|||
155543405|NCT01332968|561414702|FG004|Maintenance/Observation Period|Death|0|||
155543406|NCT01332968|561414703|FG005|Maintenance/Observation Period|Death|0|||
155543407|NCT01332968|561414704|FG006|Maintenance/Observation Period|Death|0|||
155543408|NCT01332968|561414705|FG007|Maintenance/Observation Period|Death|0|||
155543409|NCT01332968|561414698|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
155543410|NCT01332968|561414699|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
155543411|NCT01332968|561414700|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
155543412|NCT01332968|561414701|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
155543413|NCT01332968|561414702|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
155543414|NCT01332968|561414703|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
155543415|NCT01332968|561414704|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
155543416|NCT01332968|561414705|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
155543417|NCT01332968|561414698|FG000|Maintenance/Observation Period|Non-compliance|0|||
155543418|NCT01332968|561414699|FG001|Maintenance/Observation Period|Non-compliance|0|||
155543419|NCT01332968|561414700|FG002|Maintenance/Observation Period|Non-compliance|4|||
155543420|NCT01332968|561414701|FG003|Maintenance/Observation Period|Non-compliance|3|||
155543421|NCT01332968|561414702|FG004|Maintenance/Observation Period|Non-compliance|0|||
155543422|NCT01332968|561414703|FG005|Maintenance/Observation Period|Non-compliance|0|||
155543423|NCT01332968|561414704|FG006|Maintenance/Observation Period|Non-compliance|0|||
155543424|NCT01332968|561414705|FG007|Maintenance/Observation Period|Non-compliance|0|||
155543425|NCT01332968|561414698|FG000|Maintenance/Observation Period|Other|0|||
155543426|NCT01332968|561414699|FG001|Maintenance/Observation Period|Other|0|||
155543427|NCT01332968|561414700|FG002|Maintenance/Observation Period|Other|4|||
155543428|NCT01332968|561414701|FG003|Maintenance/Observation Period|Other|7|||
155543429|NCT01332968|561414702|FG004|Maintenance/Observation Period|Other|0|||
155543430|NCT01332968|561414703|FG005|Maintenance/Observation Period|Other|0|||
155543431|NCT01332968|561414704|FG006|Maintenance/Observation Period|Other|0|||
155543432|NCT01332968|561414705|FG007|Maintenance/Observation Period|Other|0|||
155543433|NCT01332968|561414698|FG000|Maintenance/Observation Period|Physician Decision|0|||
155543434|NCT01332968|561414699|FG001|Maintenance/Observation Period|Physician Decision|0|||
155543435|NCT01332968|561414700|FG002|Maintenance/Observation Period|Physician Decision|14|||
155543436|NCT01332968|561414701|FG003|Maintenance/Observation Period|Physician Decision|19|||
155543437|NCT01332968|561414702|FG004|Maintenance/Observation Period|Physician Decision|0|||
155543438|NCT01332968|561414703|FG005|Maintenance/Observation Period|Physician Decision|1|||
155543439|NCT01332968|561414704|FG006|Maintenance/Observation Period|Physician Decision|0|||
155543440|NCT01332968|561414705|FG007|Maintenance/Observation Period|Physician Decision|0|||
155543441|NCT01332968|561414698|FG000|Maintenance/Observation Period|Progressive Disease|0|||
155543442|NCT01332968|561414699|FG001|Maintenance/Observation Period|Progressive Disease|0|||
155543443|NCT01332968|561414700|FG002|Maintenance/Observation Period|Progressive Disease|72|||
155543444|NCT01332968|561414701|FG003|Maintenance/Observation Period|Progressive Disease|40|||
155543445|NCT01332968|561414702|FG004|Maintenance/Observation Period|Progressive Disease|0|||
155543446|NCT01332968|561414703|FG005|Maintenance/Observation Period|Progressive Disease|0|||
155543447|NCT01332968|561414704|FG006|Maintenance/Observation Period|Progressive Disease|0|||
155543448|NCT01332968|561414705|FG007|Maintenance/Observation Period|Progressive Disease|0|||
155543449|NCT01332968|561414698|FG000|Maintenance/Observation Period|Protocol Violation|0|||
155543450|NCT01332968|561414699|FG001|Maintenance/Observation Period|Protocol Violation|0|||
155543451|NCT01332968|561414700|FG002|Maintenance/Observation Period|Protocol Violation|1|||
155543452|NCT01332968|561414701|FG003|Maintenance/Observation Period|Protocol Violation|1|||
155543453|NCT01332968|561414702|FG004|Maintenance/Observation Period|Protocol Violation|0|||
155543454|NCT01332968|561414703|FG005|Maintenance/Observation Period|Protocol Violation|0|||
155543455|NCT01332968|561414704|FG006|Maintenance/Observation Period|Protocol Violation|0|||
155543456|NCT01332968|561414705|FG007|Maintenance/Observation Period|Protocol Violation|0|||
155543457|NCT01332968|561414698|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
155543458|NCT01332968|561414699|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
155543459|NCT01332968|561414700|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
155543460|NCT01332968|561414701|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
155543461|NCT01332968|561414702|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
155543462|NCT01332968|561414703|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
155656239|NCT02655601|561835164|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155656240|NCT02655601|561835165|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155656241|NCT02655601|561835166|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155656242|NCT04642079|561835169|FG000|Overall Study|Lost to Follow-up|2|||
155543463|NCT01332968|561414704|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
155656243|NCT04642079|561835170|FG001|Overall Study|Lost to Follow-up|5|||
155543464|NCT01332968|561414705|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
155543465|NCT01332968|561414698|FG000|Follow-Up Period|Adverse Event|0|||
155543466|NCT01332968|561414699|FG001|Follow-Up Period|Adverse Event|0|||
155543467|NCT01332968|561414700|FG002|Follow-Up Period|Adverse Event|0|||
155543468|NCT01332968|561414701|FG003|Follow-Up Period|Adverse Event|0|||
155543469|NCT01332968|561414702|FG004|Follow-Up Period|Adverse Event|0|||
155543470|NCT01332968|561414703|FG005|Follow-Up Period|Adverse Event|0|||
155543471|NCT01332968|561414704|FG006|Follow-Up Period|Adverse Event|0|||
155543472|NCT01332968|561414705|FG007|Follow-Up Period|Adverse Event|4|||
155543473|NCT01332968|561414698|FG000|Follow-Up Period|Death|0|||
155543474|NCT01332968|561414699|FG001|Follow-Up Period|Death|0|||
155543475|NCT01332968|561414700|FG002|Follow-Up Period|Death|0|||
155543476|NCT01332968|561414701|FG003|Follow-Up Period|Death|0|||
155543477|NCT01332968|561414702|FG004|Follow-Up Period|Death|0|||
155543478|NCT01332968|561414703|FG005|Follow-Up Period|Death|0|||
155543479|NCT01332968|561414704|FG006|Follow-Up Period|Death|27|||
155543480|NCT01332968|561414705|FG007|Follow-Up Period|Death|30|||
155543481|NCT01332968|561414698|FG000|Follow-Up Period|Lost to Follow-up|0|||
155543482|NCT01332968|561414699|FG001|Follow-Up Period|Lost to Follow-up|0|||
155543483|NCT01332968|561414700|FG002|Follow-Up Period|Lost to Follow-up|0|||
155543484|NCT01332968|561414701|FG003|Follow-Up Period|Lost to Follow-up|0|||
155543485|NCT01332968|561414702|FG004|Follow-Up Period|Lost to Follow-up|0|||
155543486|NCT01332968|561414703|FG005|Follow-Up Period|Lost to Follow-up|0|||
155543487|NCT01332968|561414704|FG006|Follow-Up Period|Lost to Follow-up|11|||
155543488|NCT01332968|561414705|FG007|Follow-Up Period|Lost to Follow-up|15|||
155543489|NCT01332968|561414698|FG000|Follow-Up Period|Non-compliance|0|||
155543490|NCT01332968|561414699|FG001|Follow-Up Period|Non-compliance|0|||
155543491|NCT01332968|561414700|FG002|Follow-Up Period|Non-compliance|0|||
155543492|NCT01332968|561414701|FG003|Follow-Up Period|Non-compliance|0|||
155543493|NCT01332968|561414702|FG004|Follow-Up Period|Non-compliance|0|||
155656244|NCT04642079|561835171|FG002|Overall Study|Lost to Follow-up|2|||
155656245|NCT04642079|561835172|FG003|Overall Study|Lost to Follow-up|0|||
155543494|NCT01332968|561414703|FG005|Follow-Up Period|Non-compliance|0|||
155543495|NCT01332968|561414704|FG006|Follow-Up Period|Non-compliance|4|||
155543496|NCT01332968|561414705|FG007|Follow-Up Period|Non-compliance|9|||
155543497|NCT01332968|561414698|FG000|Follow-Up Period|Other|0|||
155543498|NCT01332968|561414699|FG001|Follow-Up Period|Other|0|||
155543499|NCT01332968|561414700|FG002|Follow-Up Period|Other|0|||
155543500|NCT01332968|561414701|FG003|Follow-Up Period|Other|0|||
155543501|NCT01332968|561414702|FG004|Follow-Up Period|Other|0|||
155543502|NCT01332968|561414703|FG005|Follow-Up Period|Other|0|||
155543503|NCT01332968|561414704|FG006|Follow-Up Period|Other|18|||
155543504|NCT01332968|561414705|FG007|Follow-Up Period|Other|21|||
155543505|NCT01332968|561414698|FG000|Follow-Up Period|Physician Decision|0|||
155543506|NCT01332968|561414699|FG001|Follow-Up Period|Physician Decision|0|||
155543507|NCT01332968|561414700|FG002|Follow-Up Period|Physician Decision|0|||
155543508|NCT01332968|561414701|FG003|Follow-Up Period|Physician Decision|0|||
155543509|NCT01332968|561414702|FG004|Follow-Up Period|Physician Decision|0|||
155543510|NCT01332968|561414703|FG005|Follow-Up Period|Physician Decision|0|||
155656246|NCT04642079|561835169|FG000|Overall Study|Withdrawal by Subject|0|||
155656247|NCT04642079|561835170|FG001|Overall Study|Withdrawal by Subject|4|||
155656248|NCT04642079|561835171|FG002|Overall Study|Withdrawal by Subject|1|||
155543511|NCT01332968|561414704|FG006|Follow-Up Period|Physician Decision|12|||
155543512|NCT01332968|561414705|FG007|Follow-Up Period|Physician Decision|15|||
155543513|NCT01332968|561414698|FG000|Follow-Up Period|Progressive Disease|0|||
155656249|NCT04642079|561835172|FG003|Overall Study|Withdrawal by Subject|2|||
155656250|NCT04642079|561835169|FG000|Overall Study|Other|0|||
155543514|NCT01332968|561414699|FG001|Follow-Up Period|Progressive Disease|0|||
155656251|NCT04642079|561835170|FG001|Overall Study|Other|0|||
155543515|NCT01332968|561414700|FG002|Follow-Up Period|Progressive Disease|0|||
155543516|NCT01332968|561414701|FG003|Follow-Up Period|Progressive Disease|0|||
155543517|NCT01332968|561414702|FG004|Follow-Up Period|Progressive Disease|0|||
155543518|NCT01332968|561414703|FG005|Follow-Up Period|Progressive Disease|0|||
155543519|NCT01332968|561414704|FG006|Follow-Up Period|Progressive Disease|126|||
155543520|NCT01332968|561414705|FG007|Follow-Up Period|Progressive Disease|106|||
155543521|NCT01332968|561414698|FG000|Follow-Up Period|Protocol Violation|0|||
155543522|NCT01332968|561414699|FG001|Follow-Up Period|Protocol Violation|0|||
155543523|NCT01332968|561414700|FG002|Follow-Up Period|Protocol Violation|0|||
155656252|NCT04642079|561835171|FG002|Overall Study|Other|0|||
155543524|NCT01332968|561414701|FG003|Follow-Up Period|Protocol Violation|0|||
155543525|NCT01332968|561414702|FG004|Follow-Up Period|Protocol Violation|0|||
155543526|NCT01332968|561414703|FG005|Follow-Up Period|Protocol Violation|0|||
155543527|NCT01332968|561414704|FG006|Follow-Up Period|Protocol Violation|1|||
155543528|NCT01332968|561414705|FG007|Follow-Up Period|Protocol Violation|0|||
155543529|NCT01332968|561414698|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155543530|NCT01332968|561414699|FG001|Follow-Up Period|Withdrawal by Subject|0|||
155543531|NCT01332968|561414700|FG002|Follow-Up Period|Withdrawal by Subject|0|||
155543532|NCT01332968|561414701|FG003|Follow-Up Period|Withdrawal by Subject|0|||
155543533|NCT01332968|561414702|FG004|Follow-Up Period|Withdrawal by Subject|0|||
155543534|NCT01332968|561414703|FG005|Follow-Up Period|Withdrawal by Subject|0|||
155543535|NCT01332968|561414704|FG006|Follow-Up Period|Withdrawal by Subject|29|||
155543536|NCT01332968|561414705|FG007|Follow-Up Period|Withdrawal by Subject|32|||
155543537|NCT01332968|561414698|FG000|Follow-Up Period|No reason provided|0|||
155543538|NCT01332968|561414699|FG001|Follow-Up Period|No reason provided|0|||
155543539|NCT01332968|561414700|FG002|Follow-Up Period|No reason provided|0|||
155543540|NCT01332968|561414701|FG003|Follow-Up Period|No reason provided|0|||
155543541|NCT01332968|561414702|FG004|Follow-Up Period|No reason provided|0|||
155543542|NCT01332968|561414703|FG005|Follow-Up Period|No reason provided|0|||
155543543|NCT01332968|561414704|FG006|Follow-Up Period|No reason provided|2|||
155543544|NCT01332968|561414705|FG007|Follow-Up Period|No reason provided|3|||
155543545|NCT02351167|561414706|FG000|Overall Study|Withdrawal by Subject|19|||
155543546|NCT02351167|561414707|FG001|Overall Study|Withdrawal by Subject|18|||
155543547|NCT02351167|561414708|FG002|Overall Study|Withdrawal by Subject|21|||
155543548|NCT00194792|561414709|FG000|Overall Study|Withdrawal by Subject|1|||
155543549|NCT02448563|561414710|FG000|Overall Study|Lost to Follow-up|16|||
155543550|NCT02448563|561414711|FG001|Overall Study|Lost to Follow-up|10|||
155543551|NCT02448563|561414710|FG000|Overall Study|Withdrawal by Subject|0|||
155543552|NCT02448563|561414711|FG001|Overall Study|Withdrawal by Subject|1|||
155543553|NCT01292837|561414718|FG000|Overall Study|Adverse Event|1|||
155543554|NCT01292837|561414718|FG000|Overall Study|Further treatment determined|1|||
155543555|NCT02174276|561414721|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
155543556|NCT02174276|561414722|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
155543557|NCT02174276|561414723|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
155543558|NCT02174276|561414724|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
155543559|NCT02174276|561414721|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
155543560|NCT02174276|561414722|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
155543561|NCT02174276|561414723|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
155543562|NCT02174276|561414724|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
155543563|NCT02174276|561414721|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
155543564|NCT02174276|561414722|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
155543565|NCT02174276|561414723|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
155543566|NCT02174276|561414724|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
155543567|NCT02174276|561414721|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
155543568|NCT02174276|561414722|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
155543569|NCT02174276|561414723|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
155543570|NCT02174276|561414724|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
155543571|NCT02174276|561414721|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
155543572|NCT02174276|561414722|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
155543573|NCT02174276|561414723|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
155543574|NCT02174276|561414724|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
155543575|NCT02174276|561414721|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
155543576|NCT02174276|561414722|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
155543577|NCT02174276|561414723|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
155543578|NCT02174276|561414724|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
155543579|NCT02522780|561414725|FG000|Overall Study|Consent withdrawn by subject|5|||
155543580|NCT02522780|561414726|FG001|Overall Study|Consent withdrawn by subject|7|||
155543581|NCT02522780|561414725|FG000|Overall Study|Protocol deviation|1|||
155543582|NCT02522780|561414726|FG001|Overall Study|Protocol deviation|3|||
155543583|NCT02522780|561414725|FG000|Overall Study|Subject refused endoscopic procedure|0|||
155543584|NCT02522780|561414726|FG001|Overall Study|Subject refused endoscopic procedure|1|||
155543585|NCT02522780|561414725|FG000|Overall Study|Adverse event, non-fatal|11|||
155543586|NCT02522780|561414726|FG001|Overall Study|Adverse event, non-fatal|16|||
155543587|NCT04106817|561414727|FG000|Overall Study|Lost to Follow-up|1|||
155543588|NCT04106817|561414728|FG001|Overall Study|Lost to Follow-up|0|||
155543589|NCT04106817|561414729|FG002|Overall Study|Lost to Follow-up|0|||
155543590|NCT02260635|561414730|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
155543591|NCT02260635|561414731|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
155543592|NCT02260635|561414730|FG000|Open-Label Extension|Study Termination|25|||
155543593|NCT02260635|561414731|FG001|Open-Label Extension|Study Termination|25|||
155543594|NCT02260635|561414730|FG000|Open-Label Extension|Withdrawal by Subject|1|||
155543595|NCT02260635|561414731|FG001|Open-Label Extension|Withdrawal by Subject|0|||
155543596|NCT03310619|561414732|FG000|Pre-Treatment Period|Death|1|||
155543597|NCT03310619|561414733|FG001|Pre-Treatment Period|Death|0|||
155543598|NCT03310619|561414734|FG002|Pre-Treatment Period|Death|0|||
155543599|NCT03310619|561414735|FG003|Pre-Treatment Period|Death|0|||
155543600|NCT03310619|561414736|FG004|Pre-Treatment Period|Death|1|||
155543601|NCT03310619|561414737|FG005|Pre-Treatment Period|Death|0|||
155543602|NCT03310619|561414738|FG006|Pre-Treatment Period|Death|0|||
155543603|NCT03310619|561414739|FG007|Pre-Treatment Period|Death|0|||
155543604|NCT03310619|561414732|FG000|Pre-Treatment Period|Other reasons|2|||
155543605|NCT03310619|561414733|FG001|Pre-Treatment Period|Other reasons|1|||
155543606|NCT03310619|561414734|FG002|Pre-Treatment Period|Other reasons|2|||
155543607|NCT03310619|561414735|FG003|Pre-Treatment Period|Other reasons|0|||
155543608|NCT03310619|561414736|FG004|Pre-Treatment Period|Other reasons|0|||
155543609|NCT03310619|561414737|FG005|Pre-Treatment Period|Other reasons|0|||
155543610|NCT03310619|561414738|FG006|Pre-Treatment Period|Other reasons|2|||
155543611|NCT03310619|561414739|FG007|Pre-Treatment Period|Other reasons|0|||
155543612|NCT03310619|561414732|FG000|Treatment Period|Death|1|||
155543613|NCT03310619|561414733|FG001|Treatment Period|Death|2|||
155543614|NCT03310619|561414734|FG002|Treatment Period|Death|0|||
155543615|NCT03310619|561414735|FG003|Treatment Period|Death|0|||
155543616|NCT03310619|561414736|FG004|Treatment Period|Death|1|||
155543617|NCT03310619|561414737|FG005|Treatment Period|Death|0|||
155543618|NCT03310619|561414738|FG006|Treatment Period|Death|2|||
155543619|NCT03310619|561414739|FG007|Treatment Period|Death|0|||
155543620|NCT03310619|561414732|FG000|Treatment Period|Adverse Event|0|||
155543621|NCT03310619|561414733|FG001|Treatment Period|Adverse Event|1|||
155543622|NCT03310619|561414734|FG002|Treatment Period|Adverse Event|4|||
155543623|NCT03310619|561414735|FG003|Treatment Period|Adverse Event|1|||
155543624|NCT03310619|561414736|FG004|Treatment Period|Adverse Event|0|||
155543625|NCT03310619|561414737|FG005|Treatment Period|Adverse Event|0|||
155543626|NCT03310619|561414738|FG006|Treatment Period|Adverse Event|0|||
155543627|NCT03310619|561414739|FG007|Treatment Period|Adverse Event|0|||
155543628|NCT03310619|561414732|FG000|Treatment Period|Withdrawal by participant|0|||
155543629|NCT03310619|561414733|FG001|Treatment Period|Withdrawal by participant|0|||
155543630|NCT03310619|561414734|FG002|Treatment Period|Withdrawal by participant|1|||
155543631|NCT03310619|561414735|FG003|Treatment Period|Withdrawal by participant|0|||
155543632|NCT03310619|561414736|FG004|Treatment Period|Withdrawal by participant|0|||
155543633|NCT03310619|561414737|FG005|Treatment Period|Withdrawal by participant|0|||
155543634|NCT03310619|561414738|FG006|Treatment Period|Withdrawal by participant|0|||
155543635|NCT03310619|561414739|FG007|Treatment Period|Withdrawal by participant|0|||
155543636|NCT03310619|561414732|FG000|Treatment Period|Lost to Follow-up|0|||
155543637|NCT03310619|561414733|FG001|Treatment Period|Lost to Follow-up|0|||
155543638|NCT03310619|561414734|FG002|Treatment Period|Lost to Follow-up|0|||
155543639|NCT03310619|561414735|FG003|Treatment Period|Lost to Follow-up|0|||
155543640|NCT03310619|561414736|FG004|Treatment Period|Lost to Follow-up|0|||
155543641|NCT03310619|561414737|FG005|Treatment Period|Lost to Follow-up|0|||
155543642|NCT03310619|561414738|FG006|Treatment Period|Lost to Follow-up|0|||
155543643|NCT03310619|561414739|FG007|Treatment Period|Lost to Follow-up|1|||
155543644|NCT03310619|561414732|FG000|Treatment Period|Study terminated by sponsor|0|||
155543645|NCT03310619|561414733|FG001|Treatment Period|Study terminated by sponsor|0|||
155543646|NCT03310619|561414734|FG002|Treatment Period|Study terminated by sponsor|0|||
155543647|NCT03310619|561414735|FG003|Treatment Period|Study terminated by sponsor|0|||
155543648|NCT03310619|561414736|FG004|Treatment Period|Study terminated by sponsor|0|||
155543649|NCT03310619|561414737|FG005|Treatment Period|Study terminated by sponsor|0|||
155543650|NCT03310619|561414738|FG006|Treatment Period|Study terminated by sponsor|0|||
155543651|NCT03310619|561414739|FG007|Treatment Period|Study terminated by sponsor|1|||
155543652|NCT03310619|561414732|FG000|Treatment Period|Physician Decision|0|||
155543653|NCT03310619|561414733|FG001|Treatment Period|Physician Decision|0|||
155543654|NCT03310619|561414734|FG002|Treatment Period|Physician Decision|0|||
155543655|NCT03310619|561414735|FG003|Treatment Period|Physician Decision|0|||
155543656|NCT03310619|561414736|FG004|Treatment Period|Physician Decision|3|||
155543657|NCT03310619|561414737|FG005|Treatment Period|Physician Decision|0|||
155543658|NCT03310619|561414738|FG006|Treatment Period|Physician Decision|0|||
155543659|NCT03310619|561414739|FG007|Treatment Period|Physician Decision|0|||
155543660|NCT03310619|561414732|FG000|Treatment Period|Other reasons|1|||
155543661|NCT03310619|561414733|FG001|Treatment Period|Other reasons|0|||
155543662|NCT03310619|561414734|FG002|Treatment Period|Other reasons|2|||
155543663|NCT03310619|561414735|FG003|Treatment Period|Other reasons|0|||
155543664|NCT03310619|561414736|FG004|Treatment Period|Other reasons|0|||
155543665|NCT03310619|561414737|FG005|Treatment Period|Other reasons|0|||
155543666|NCT03310619|561414738|FG006|Treatment Period|Other reasons|0|||
155543667|NCT03310619|561414739|FG007|Treatment Period|Other reasons|0|||
155543668|NCT04307849|561414742|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
155543669|NCT04307849|561414743|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
155543670|NCT04307849|561414744|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
155543671|NCT04307849|561414745|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
155543672|NCT04307849|561414746|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
155543673|NCT04307849|561414747|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
155543674|NCT04307849|561414742|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
155543675|NCT04307849|561414743|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
155543676|NCT04307849|561414744|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
155543677|NCT04307849|561414745|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
155543678|NCT04307849|561414746|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
155543679|NCT04307849|561414747|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
155543680|NCT04307849|561414742|FG000|Overall Study|Family member did not want them to continue|0|||
155543681|NCT04307849|561414743|FG001|Overall Study|Family member did not want them to continue|0|||
155543682|NCT04307849|561414744|FG002|Overall Study|Family member did not want them to continue|1|||
155543683|NCT04307849|561414745|FG003|Overall Study|Family member did not want them to continue|0|||
155543684|NCT04307849|561414746|FG004|Overall Study|Family member did not want them to continue|0|||
155543685|NCT04307849|561414747|FG005|Overall Study|Family member did not want them to continue|0|||
155543686|NCT04307849|561414742|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
155543687|NCT04307849|561414743|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
155543688|NCT04307849|561414744|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
155543689|NCT04307849|561414745|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
155543690|NCT04307849|561414746|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
155543691|NCT04307849|561414747|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
155543692|NCT02418754|561414750|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
155543693|NCT02418754|561414751|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
155543694|NCT02418754|561414752|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
155543695|NCT02418754|561414753|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
155543696|NCT02418754|561414754|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
155543697|NCT02418754|561414750|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
155543698|NCT02418754|561414751|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
155543699|NCT02418754|561414752|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
155543700|NCT02418754|561414753|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
155543701|NCT02418754|561414754|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
155543702|NCT02418754|561414750|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
155543703|NCT02418754|561414751|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
155543704|NCT02418754|561414752|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
155543705|NCT02418754|561414753|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
155543706|NCT02418754|561414754|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
155543707|NCT02418754|561414750|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
155543708|NCT02418754|561414751|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
155543709|NCT02418754|561414752|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
155543710|NCT02418754|561414753|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
155543711|NCT02418754|561414754|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
155543712|NCT02418754|561414750|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
155543713|NCT02418754|561414751|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
155543714|NCT02418754|561414752|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
155543715|NCT02418754|561414753|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
155543716|NCT02418754|561414754|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
155543717|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
155543718|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
155543719|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
155543720|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
155543721|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
155543722|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
155543723|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
155543724|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
155543725|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
155543726|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
155543727|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
155543728|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
155543729|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
155543730|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
155543731|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
155543732|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
155543733|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
155543734|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
155543735|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
155543736|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
155656253|NCT04642079|561835172|FG003|Overall Study|Other|1|||
155543737|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
155543738|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
155543739|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
155543740|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
155543741|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
155543742|NCT02418754|561414750|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
155543743|NCT02418754|561414751|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
155543744|NCT02418754|561414752|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
155543745|NCT02418754|561414753|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
155543746|NCT02418754|561414754|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
155543747|NCT01896505|561414755|FG000|Overall Study|Adverse Event|1|||
155543748|NCT01896505|561414756|FG001|Overall Study|Adverse Event|0|||
155543749|NCT01896505|561414757|FG002|Overall Study|Adverse Event|2|||
155543750|NCT01896505|561414758|FG003|Overall Study|Adverse Event|1|||
155543751|NCT01896505|561414759|FG004|Overall Study|Adverse Event|1|||
155543752|NCT01896505|561414760|FG005|Overall Study|Adverse Event|0|||
155543753|NCT01896505|561414755|FG000|Overall Study|Physician Decision|1|||
155543754|NCT01896505|561414756|FG001|Overall Study|Physician Decision|3|||
155543755|NCT01896505|561414757|FG002|Overall Study|Physician Decision|2|||
155543756|NCT01896505|561414758|FG003|Overall Study|Physician Decision|0|||
155543757|NCT01896505|561414759|FG004|Overall Study|Physician Decision|0|||
155543758|NCT01896505|561414760|FG005|Overall Study|Physician Decision|1|||
155543759|NCT01896505|561414755|FG000|Overall Study|Withdrawal by Subject|1|||
155543760|NCT01896505|561414756|FG001|Overall Study|Withdrawal by Subject|0|||
155543761|NCT01896505|561414757|FG002|Overall Study|Withdrawal by Subject|3|||
155543762|NCT01896505|561414758|FG003|Overall Study|Withdrawal by Subject|1|||
155543763|NCT01896505|561414759|FG004|Overall Study|Withdrawal by Subject|0|||
155543764|NCT01896505|561414760|FG005|Overall Study|Withdrawal by Subject|0|||
155543765|NCT01896505|561414755|FG000|Overall Study|Disease Progression|7|||
155543766|NCT01896505|561414756|FG001|Overall Study|Disease Progression|5|||
155543767|NCT01896505|561414757|FG002|Overall Study|Disease Progression|8|||
155543768|NCT01896505|561414758|FG003|Overall Study|Disease Progression|4|||
155543769|NCT01896505|561414759|FG004|Overall Study|Disease Progression|4|||
155543770|NCT01896505|561414760|FG005|Overall Study|Disease Progression|4|||
155543771|NCT01896505|561414755|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
155543772|NCT01896505|561414756|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
155543773|NCT01896505|561414757|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
155543774|NCT01896505|561414758|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
155543775|NCT01896505|561414759|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
155543776|NCT01896505|561414760|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
155543777|NCT01896505|561414755|FG000|Overall Study|Intercurrent illness|0|||
155543778|NCT01896505|561414756|FG001|Overall Study|Intercurrent illness|1|||
155543779|NCT01896505|561414757|FG002|Overall Study|Intercurrent illness|0|||
155543780|NCT01896505|561414758|FG003|Overall Study|Intercurrent illness|0|||
155543781|NCT01896505|561414759|FG004|Overall Study|Intercurrent illness|0|||
155543782|NCT01896505|561414760|FG005|Overall Study|Intercurrent illness|0|||
155543783|NCT01896505|561414755|FG000|Overall Study|Death|0|||
155543784|NCT01896505|561414756|FG001|Overall Study|Death|0|||
155543785|NCT01896505|561414757|FG002|Overall Study|Death|1|||
155543786|NCT01896505|561414758|FG003|Overall Study|Death|1|||
155543787|NCT01896505|561414759|FG004|Overall Study|Death|0|||
155543788|NCT01896505|561414760|FG005|Overall Study|Death|1|||
155543789|NCT02387762|561414761|FG000|Overall Study|Withdrawal by Subject|1|||
155543790|NCT02387762|561414762|FG001|Overall Study|Withdrawal by Subject|0|||
155543791|NCT04203667|561414763|FG000|Overall Study|Withdrawal by Subject|1|||
155543792|NCT04203667|561414763|FG000|Overall Study|Lost to Follow-up|1|||
155543793|NCT04203667|561414763|FG000|Overall Study|Death|1|||
155543794|NCT04203667|561414763|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
155543795|NCT00593827|561414764|FG000|Overall Study|On Active Treatment/Pending|0|||
155543796|NCT00593827|561414765|FG001|Overall Study|On Active Treatment/Pending|2|||
155543797|NCT01160640|561414766|FG000|Overall Study|Physician Decision|3|||
155543798|NCT01160640|561414767|FG001|Overall Study|Physician Decision|3|||
155543799|NCT01160640|561414766|FG000|Overall Study|Incarceration|1|||
155543800|NCT01160640|561414767|FG001|Overall Study|Incarceration|0|||
155543801|NCT01160640|561414766|FG000|Overall Study|Withdrawal by Subject|0|||
155543802|NCT01160640|561414767|FG001|Overall Study|Withdrawal by Subject|3|||
155543803|NCT02212457|561414768|FG000|Overall Study|Adverse Event|1|||
155543804|NCT02212457|561414769|FG001|Overall Study|Adverse Event|2|||
155543805|NCT02212457|561414770|FG002|Overall Study|Adverse Event|2|||
155543806|NCT02212457|561414771|FG003|Overall Study|Adverse Event|2|||
155543807|NCT02212457|561414772|FG004|Overall Study|Adverse Event|0|||
155543808|NCT02212457|561414773|FG005|Overall Study|Adverse Event|1|||
155543809|NCT02212457|561414768|FG000|Overall Study|Withdrawal by Subject|8|||
155543810|NCT02212457|561414769|FG001|Overall Study|Withdrawal by Subject|10|||
155543811|NCT02212457|561414770|FG002|Overall Study|Withdrawal by Subject|8|||
155543812|NCT02212457|561414771|FG003|Overall Study|Withdrawal by Subject|6|||
155543813|NCT02212457|561414772|FG004|Overall Study|Withdrawal by Subject|5|||
155543814|NCT02212457|561414773|FG005|Overall Study|Withdrawal by Subject|4|||
155543815|NCT02212457|561414768|FG000|Overall Study|Lost to Follow-up|6|||
155543816|NCT02212457|561414769|FG001|Overall Study|Lost to Follow-up|7|||
155543817|NCT02212457|561414770|FG002|Overall Study|Lost to Follow-up|4|||
155543818|NCT02212457|561414771|FG003|Overall Study|Lost to Follow-up|1|||
155543819|NCT02212457|561414772|FG004|Overall Study|Lost to Follow-up|8|||
155543820|NCT02212457|561414773|FG005|Overall Study|Lost to Follow-up|4|||
155543821|NCT02212457|561414768|FG000|Overall Study|Protocol Violation|2|||
155543822|NCT02212457|561414769|FG001|Overall Study|Protocol Violation|1|||
155543823|NCT02212457|561414770|FG002|Overall Study|Protocol Violation|0|||
155543824|NCT02212457|561414771|FG003|Overall Study|Protocol Violation|1|||
155543825|NCT02212457|561414772|FG004|Overall Study|Protocol Violation|2|||
155543826|NCT02212457|561414773|FG005|Overall Study|Protocol Violation|3|||
155543827|NCT02212457|561414768|FG000|Overall Study|Other|2|||
155543828|NCT02212457|561414769|FG001|Overall Study|Other|1|||
155543829|NCT02212457|561414770|FG002|Overall Study|Other|2|||
155543830|NCT02212457|561414771|FG003|Overall Study|Other|1|||
155543831|NCT02212457|561414772|FG004|Overall Study|Other|0|||
155543832|NCT02212457|561414773|FG005|Overall Study|Other|1|||
155543833|NCT00642811|561414775|FG000|Overall Study|Adverse Event|2|||
155543834|NCT00642811|561414776|FG001|Overall Study|Adverse Event|3|||
155543835|NCT00642811|561414777|FG002|Overall Study|Adverse Event|0|||
155543836|NCT00642811|561414778|FG003|Overall Study|Adverse Event|0|||
155543837|NCT00642811|561414779|FG004|Overall Study|Adverse Event|0|||
155543838|NCT00642811|561414780|FG005|Overall Study|Adverse Event|1|||
155543839|NCT00642811|561414775|FG000|Overall Study|Developement of discontinuation criteria|0|||
155543840|NCT00642811|561414776|FG001|Overall Study|Developement of discontinuation criteria|0|||
155543841|NCT00642811|561414777|FG002|Overall Study|Developement of discontinuation criteria|0|||
155543842|NCT00642811|561414778|FG003|Overall Study|Developement of discontinuation criteria|0|||
155543843|NCT00642811|561414779|FG004|Overall Study|Developement of discontinuation criteria|1|||
155543844|NCT00642811|561414780|FG005|Overall Study|Developement of discontinuation criteria|0|||
155543845|NCT00642811|561414775|FG000|Overall Study|Severe Non-compliance to protocol|1|||
155543846|NCT00642811|561414776|FG001|Overall Study|Severe Non-compliance to protocol|0|||
155543847|NCT00642811|561414777|FG002|Overall Study|Severe Non-compliance to protocol|0|||
155543848|NCT00642811|561414778|FG003|Overall Study|Severe Non-compliance to protocol|0|||
155543849|NCT00642811|561414779|FG004|Overall Study|Severe Non-compliance to protocol|0|||
155543850|NCT00642811|561414780|FG005|Overall Study|Severe Non-compliance to protocol|0|||
155543851|NCT00642811|561414775|FG000|Overall Study|Other|0|||
155543852|NCT00642811|561414776|FG001|Overall Study|Other|1|||
155543853|NCT00642811|561414777|FG002|Overall Study|Other|0|||
155543854|NCT00642811|561414778|FG003|Overall Study|Other|1|||
155543855|NCT00642811|561414779|FG004|Overall Study|Other|0|||
155543856|NCT00642811|561414780|FG005|Overall Study|Other|0|||
155543857|NCT04553406|561414781|FG000|Overall Study|Study Discontinuation|0|||
155543858|NCT04553406|561414782|FG001|Overall Study|Study Discontinuation|1|||
155543859|NCT03168906|561414783|FG000|Overall Study|Lack of Efficacy|6|||
155543860|NCT03168906|561414784|FG001|Overall Study|Lack of Efficacy|6|||
155543861|NCT01841060|561417322|FG000|Overall Study|Protocol Violation|10|||
155543862|NCT01848210|561417323|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
155543863|NCT01848210|561417324|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
155543864|NCT01848210|561417323|FG000|Overall Study|Lost to Follow-up|24|||
155487960|NCT03410693|561209774|FG000|Overall Study|Disc trt: Lost to follow up|0|||
155487961|NCT03410693|561209775|FG001|Overall Study|Disc trt: Lost to follow up|1|||
155487962|NCT03410693|561209774|FG000|Overall Study|Disc trt: radiological progression|58|||
155487963|NCT03410693|561209775|FG001|Overall Study|Disc trt: radiological progression|50|||
155487964|NCT03410693|561209774|FG000|Overall Study|Disc trt: Other|1|||
155487965|NCT03410693|561209775|FG001|Overall Study|Disc trt: Other|0|||
155487966|NCT03410693|561209774|FG000|Overall Study|Study drug never administered|1|||
155487967|NCT03410693|561209775|FG001|Overall Study|Study drug never administered|6|||
155487968|NCT03410693|561209774|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
155487969|NCT03410693|561209775|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
155487970|NCT03410693|561209774|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
155487971|NCT03410693|561209775|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
155487972|NCT03410693|561209774|FG000|Overall Study|Disc trt: Physician decision|0|||
155487973|NCT03410693|561209775|FG001|Overall Study|Disc trt: Physician decision|5|||
155487974|NCT03410693|561209774|FG000|Overall Study|Disc trt: clinical progression|1|||
155487975|NCT03410693|561209775|FG001|Overall Study|Disc trt: clinical progression|5|||
155487976|NCT03410693|561209774|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
155487977|NCT03410693|561209775|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
155487978|NCT01789476|561209776|FG000|Overall Study|Lack of Efficacy|6|||
155487979|NCT01789476|561209777|FG001|Overall Study|Lack of Efficacy|2|||
155487980|NCT01789476|561209776|FG000|Overall Study|Adverse Event|1|||
155487981|NCT01789476|561209777|FG001|Overall Study|Adverse Event|0|||
155487982|NCT01789476|561209776|FG000|Overall Study|Unable to get IV access|1|||
155487983|NCT01789476|561209777|FG001|Overall Study|Unable to get IV access|0|||
155487984|NCT00953576|561209778|FG000|Overall Study|Adverse Event|0|||
155487985|NCT00953576|561209779|FG001|Overall Study|Adverse Event|1|||
155487986|NCT00953576|561209778|FG000|Overall Study|Ineligible after Consent|2|||
155487987|NCT00953576|561209779|FG001|Overall Study|Ineligible after Consent|0|||
155487988|NCT03778021|561209780|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
155487989|NCT03778021|561209781|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
155487990|NCT00679042|561209782|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
155487991|NCT00679042|561209782|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
155487992|NCT00679042|561209782|FG000|5-Year Follow Up|Death|1|||
155487993|NCT00679042|561209782|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
155487994|NCT00679042|561209782|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
155487995|NCT03053102|561209783|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
155487996|NCT03053102|561209783|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
155487997|NCT01798056|561209784|FG000|Overall Study|Serious Adverse Event|13|||
155487998|NCT01798056|561209785|FG001|Overall Study|Serious Adverse Event|12|||
155487999|NCT01798056|561209784|FG000|Overall Study|Withdrawal by Subject|12|||
155488000|NCT01798056|561209785|FG001|Overall Study|Withdrawal by Subject|9|||
155488001|NCT01798056|561209784|FG000|Overall Study|Migrated/moved from study area|1|||
155488002|NCT01798056|561209785|FG001|Overall Study|Migrated/moved from study area|1|||
155488003|NCT01798056|561209784|FG000|Overall Study|Lost to Follow-up|1|||
155488004|NCT01798056|561209785|FG001|Overall Study|Lost to Follow-up|1|||
155488005|NCT01798056|561209784|FG000|Overall Study|Other|0|||
155488006|NCT01798056|561209785|FG001|Overall Study|Other|2|||
155488007|NCT01269346|561209786|FG000|Treatment Phase|Disease progression|3|||
155488008|NCT01269346|561209786|FG000|Treatment Phase|Adverse Event|3|||
155488009|NCT01269346|561209786|FG000|Treatment Phase|Withdrawal by Subject|1|||
155488010|NCT01269346|561209786|FG000|Treatment Phase|Other|2|||
155488011|NCT01269346|561209786|FG000|Extension Phase|Adverse Event|6|||
155488012|NCT01269346|561209786|FG000|Extension Phase|Withdrawal by Subject|4|||
155488013|NCT01269346|561209786|FG000|Extension Phase|Disease progression|22|||
155488014|NCT01269346|561209786|FG000|Extension Phase|Physician decision or participant choice|9|||
155488015|NCT01269346|561209786|FG000|Extension Phase|Clinical progression|1|||
155488016|NCT01269346|561209786|FG000|Extension Phase|Started a prohibited con med|1|||
155488017|NCT04963231|561209794|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
155488018|NCT04963231|561209795|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
155488019|NCT04963231|561209796|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
155488020|NCT04963231|561209794|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
155488021|NCT04963231|561209795|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
155488022|NCT04963231|561209796|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
155543865|NCT01848210|561417324|FG001|Overall Study|Lost to Follow-up|12|||
155488023|NCT04963231|561209794|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
155488024|NCT04963231|561209795|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
155543866|NCT01848210|561417323|FG000|Overall Study|Protocol Violation|3|||
155488025|NCT04963231|561209796|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
155488026|NCT04963231|561209794|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
155488027|NCT04963231|561209795|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
155488028|NCT04963231|561209796|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
155488029|NCT04963231|561209794|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
155488030|NCT04963231|561209795|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
155488031|NCT04963231|561209796|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
155488032|NCT04963231|561209794|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
155488033|NCT04963231|561209795|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
155488034|NCT04963231|561209796|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
155488035|NCT04963231|561209794|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
155488036|NCT04963231|561209795|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
155488037|NCT04963231|561209796|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
155488038|NCT01059175|561209799|FG000|Overall Study|Death|17|||
155488039|NCT01059175|561209800|FG001|Overall Study|Death|17|||
155488040|NCT01059175|561209799|FG000|Overall Study|Adverse Event|4|||
155488041|NCT01059175|561209800|FG001|Overall Study|Adverse Event|2|||
155488042|NCT01059175|561209799|FG000|Overall Study|Lost to Follow-up|0|||
155488043|NCT01059175|561209800|FG001|Overall Study|Lost to Follow-up|1|||
155488044|NCT02957149|561209801|FG000|Overall Study|Withdrawal by Subject|5|||
155488045|NCT06045026|561209802|FG000|Overall Study|Lost to Follow-up|60|||
155488046|NCT06045026|561209802|FG000|Overall Study|Adverse Event|12|||
155488047|NCT06045026|561209802|FG000|Overall Study|Withdrawal by Subject|3|||
155488048|NCT06045026|561209802|FG000|Overall Study|Enrollment closed|1|||
155488049|NCT00148109|561209803|FG000|Overall Study|Lack of Efficacy|10|||
155488050|NCT00148109|561209804|FG001|Overall Study|Lack of Efficacy|18|||
155488051|NCT00148109|561209803|FG000|Overall Study|Adverse Event|0|||
155488052|NCT00148109|561209804|FG001|Overall Study|Adverse Event|2|||
155488053|NCT00148109|561209803|FG000|Overall Study|Withdrawal by Subject|2|||
155488054|NCT00148109|561209804|FG001|Overall Study|Withdrawal by Subject|0|||
155543867|NCT01848210|561417324|FG001|Overall Study|Protocol Violation|5|||
155543868|NCT01848210|561417323|FG000|Overall Study|Use of Forbidden Drugs|9|||
155543869|NCT01848210|561417324|FG001|Overall Study|Use of Forbidden Drugs|10|||
155543870|NCT01848210|561417323|FG000|Overall Study|Impedition Condition|5|||
155543871|NCT01848210|561417324|FG001|Overall Study|Impedition Condition|9|||
155543872|NCT01848210|561417323|FG000|Overall Study|Adverse Event|7|||
155543873|NCT01848210|561417324|FG001|Overall Study|Adverse Event|9|||
155543874|NCT01848210|561417323|FG000|Overall Study|Discontinuation Criterion|5|||
155543875|NCT01848210|561417324|FG001|Overall Study|Discontinuation Criterion|7|||
155543876|NCT01848210|561417323|FG000|Overall Study|Hypesensitivity|1|||
155543877|NCT01848210|561417324|FG001|Overall Study|Hypesensitivity|0|||
155543878|NCT01848210|561417323|FG000|Overall Study|Hepatic Function Alteration|4|||
155543879|NCT01848210|561417324|FG001|Overall Study|Hepatic Function Alteration|0|||
155543880|NCT01848210|561417323|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
155543881|NCT01848210|561417324|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
155543882|NCT01848210|561417323|FG000|Overall Study|Administrative|1|||
155543883|NCT01848210|561417324|FG001|Overall Study|Administrative|0|||
155543884|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
155543885|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
155543886|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
155543887|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
155488055|NCT02557308|561209807|FG000|Overall Study|Withdrawal by Subject|11|||
155488056|NCT02557308|561209808|FG001|Overall Study|Withdrawal by Subject|3|||
155488057|NCT02557308|561209809|FG002|Overall Study|Withdrawal by Subject|2|||
155488058|NCT02557308|561209810|FG003|Overall Study|Withdrawal by Subject|0|||
155488059|NCT02557308|561209811|FG004|Overall Study|Withdrawal by Subject|1|||
155488060|NCT02557308|561209812|FG005|Overall Study|Withdrawal by Subject|0|||
155488061|NCT02557308|561209813|FG006|Overall Study|Withdrawal by Subject|10|||
155488062|NCT02557308|561209814|FG007|Overall Study|Withdrawal by Subject|1|||
155488063|NCT02557308|561209807|FG000|Overall Study|Disease Progression|0|||
155488064|NCT02557308|561209808|FG001|Overall Study|Disease Progression|1|||
155488065|NCT02557308|561209809|FG002|Overall Study|Disease Progression|0|||
155488066|NCT02557308|561209810|FG003|Overall Study|Disease Progression|0|||
155488067|NCT02557308|561209811|FG004|Overall Study|Disease Progression|0|||
155488068|NCT02557308|561209812|FG005|Overall Study|Disease Progression|0|||
155488069|NCT02557308|561209813|FG006|Overall Study|Disease Progression|0|||
155488070|NCT02557308|561209814|FG007|Overall Study|Disease Progression|0|||
155656254|NCT04642079|561835169|FG000|Overall Study|No longer met eligibility criteria|1|||
155656255|NCT04642079|561835170|FG001|Overall Study|No longer met eligibility criteria|0|||
155488071|NCT02557308|561209807|FG000|Overall Study|Lack of Efficacy|3|||
155488072|NCT02557308|561209808|FG001|Overall Study|Lack of Efficacy|0|||
155488073|NCT02557308|561209809|FG002|Overall Study|Lack of Efficacy|0|||
155488074|NCT02557308|561209810|FG003|Overall Study|Lack of Efficacy|0|||
155543888|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
155488075|NCT02557308|561209811|FG004|Overall Study|Lack of Efficacy|0|||
155488076|NCT02557308|561209812|FG005|Overall Study|Lack of Efficacy|0|||
155488077|NCT02557308|561209813|FG006|Overall Study|Lack of Efficacy|1|||
155488078|NCT02557308|561209814|FG007|Overall Study|Lack of Efficacy|0|||
155488079|NCT02557308|561209807|FG000|Overall Study|Adverse Event|4|||
155488080|NCT02557308|561209808|FG001|Overall Study|Adverse Event|1|||
155488081|NCT02557308|561209809|FG002|Overall Study|Adverse Event|2|||
155488082|NCT02557308|561209810|FG003|Overall Study|Adverse Event|0|||
155488083|NCT02557308|561209811|FG004|Overall Study|Adverse Event|0|||
155488084|NCT02557308|561209812|FG005|Overall Study|Adverse Event|0|||
155488085|NCT02557308|561209813|FG006|Overall Study|Adverse Event|4|||
155488086|NCT02557308|561209814|FG007|Overall Study|Adverse Event|1|||
155488087|NCT02557308|561209807|FG000|Overall Study|Lost to Follow-up|2|||
155488088|NCT02557308|561209808|FG001|Overall Study|Lost to Follow-up|0|||
155488089|NCT02557308|561209809|FG002|Overall Study|Lost to Follow-up|1|||
155488090|NCT02557308|561209810|FG003|Overall Study|Lost to Follow-up|0|||
155488091|NCT02557308|561209811|FG004|Overall Study|Lost to Follow-up|0|||
155488092|NCT02557308|561209812|FG005|Overall Study|Lost to Follow-up|0|||
155488093|NCT02557308|561209813|FG006|Overall Study|Lost to Follow-up|2|||
155488094|NCT02557308|561209814|FG007|Overall Study|Lost to Follow-up|0|||
155488095|NCT02557308|561209807|FG000|Overall Study|Death|1|||
155488096|NCT02557308|561209808|FG001|Overall Study|Death|0|||
155488097|NCT02557308|561209809|FG002|Overall Study|Death|0|||
155488098|NCT02557308|561209810|FG003|Overall Study|Death|0|||
155488099|NCT02557308|561209811|FG004|Overall Study|Death|0|||
155488100|NCT02557308|561209812|FG005|Overall Study|Death|0|||
155488101|NCT02557308|561209813|FG006|Overall Study|Death|0|||
155488102|NCT02557308|561209814|FG007|Overall Study|Death|0|||
155488103|NCT02557308|561209807|FG000|Overall Study|Study Close|98|||
155488104|NCT02557308|561209808|FG001|Overall Study|Study Close|18|||
155488105|NCT02557308|561209809|FG002|Overall Study|Study Close|5|||
155488106|NCT02557308|561209810|FG003|Overall Study|Study Close|3|||
155488107|NCT02557308|561209811|FG004|Overall Study|Study Close|1|||
155488108|NCT02557308|561209812|FG005|Overall Study|Study Close|0|||
155488109|NCT02557308|561209813|FG006|Overall Study|Study Close|123|||
155488110|NCT02557308|561209814|FG007|Overall Study|Study Close|5|||
155488111|NCT02557308|561209807|FG000|Overall Study|Except for study close|5|||
155488112|NCT02557308|561209808|FG001|Overall Study|Except for study close|0|||
155488113|NCT02557308|561209809|FG002|Overall Study|Except for study close|0|||
155488114|NCT02557308|561209810|FG003|Overall Study|Except for study close|0|||
155488115|NCT02557308|561209811|FG004|Overall Study|Except for study close|3|||
155488116|NCT02557308|561209812|FG005|Overall Study|Except for study close|0|||
155488117|NCT02557308|561209813|FG006|Overall Study|Except for study close|6|||
155488118|NCT02557308|561209814|FG007|Overall Study|Except for study close|10|||
155488119|NCT03911401|561209815|FG000|Overall Study|Adverse Event|1|||
155488120|NCT03911401|561209816|FG001|Overall Study|Adverse Event|2|||
155488121|NCT03911401|561209817|FG002|Overall Study|Adverse Event|5|||
155488122|NCT03911401|561209815|FG000|Overall Study|Lack of Efficacy|1|||
155656256|NCT04642079|561835171|FG002|Overall Study|No longer met eligibility criteria|1|||
155656257|NCT04642079|561835172|FG003|Overall Study|No longer met eligibility criteria|1|||
155488123|NCT03911401|561209816|FG001|Overall Study|Lack of Efficacy|1|||
155488124|NCT03911401|561209817|FG002|Overall Study|Lack of Efficacy|8|||
155488125|NCT03911401|561209815|FG000|Overall Study|Physician Decision|0|||
155488126|NCT03911401|561209816|FG001|Overall Study|Physician Decision|0|||
155488127|NCT03911401|561209817|FG002|Overall Study|Physician Decision|1|||
155488128|NCT03911401|561209815|FG000|Overall Study|Withdrawal by Subject|1|||
155488129|NCT03911401|561209816|FG001|Overall Study|Withdrawal by Subject|2|||
155488130|NCT03911401|561209817|FG002|Overall Study|Withdrawal by Subject|0|||
155488131|NCT03911401|561209815|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155488132|NCT03911401|561209816|FG001|Overall Study|Withdrawal by parent/guardian|4|||
155488133|NCT03911401|561209817|FG002|Overall Study|Withdrawal by parent/guardian|11|||
155488134|NCT00351611|561209823|FG000|Overall Study|Adverse Event|11|||
155488135|NCT00351611|561209824|FG001|Overall Study|Adverse Event|3|||
155488136|NCT00351611|561209823|FG000|Overall Study|Death|1|||
155488137|NCT00351611|561209824|FG001|Overall Study|Death|0|||
155488138|NCT00351611|561209823|FG000|Overall Study|Lost to Follow-up|1|||
155488139|NCT00351611|561209824|FG001|Overall Study|Lost to Follow-up|0|||
155488140|NCT00351611|561209823|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
155488141|NCT00351611|561209824|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
155488142|NCT00351611|561209823|FG000|Overall Study|Other|1|||
155488143|NCT00351611|561209824|FG001|Overall Study|Other|0|||
155488144|NCT00351611|561209823|FG000|Overall Study|Protocol Violation|0|||
155488145|NCT00351611|561209824|FG001|Overall Study|Protocol Violation|2|||
155488146|NCT03417245|561209825|FG000|Overall Study|Adverse Event|1|||
155488147|NCT03417245|561209826|FG001|Overall Study|Adverse Event|0|||
155488148|NCT03417245|561209825|FG000|Overall Study|Protocol Violation|1|||
155488149|NCT03417245|561209826|FG001|Overall Study|Protocol Violation|0|||
155488150|NCT03417245|561209825|FG000|Overall Study|Withdrawal by Subject|1|||
155488151|NCT03417245|561209826|FG001|Overall Study|Withdrawal by Subject|1|||
155488152|NCT01589185|561209827|FG000|Overall Study|Death|1|||
155488153|NCT01589185|561209828|FG001|Overall Study|Death|2|||
155488154|NCT01589185|561209829|FG002|Overall Study|Death|2|||
155488155|NCT01589185|561209830|FG003|Overall Study|Death|0|||
155488156|NCT01589185|561209831|FG004|Overall Study|Death|1|||
155488157|NCT01589185|561209827|FG000|Overall Study|Lost to Follow-up|1|||
155488158|NCT01589185|561209828|FG001|Overall Study|Lost to Follow-up|0|||
155488159|NCT01589185|561209829|FG002|Overall Study|Lost to Follow-up|2|||
155488160|NCT01589185|561209830|FG003|Overall Study|Lost to Follow-up|3|||
155488161|NCT01589185|561209831|FG004|Overall Study|Lost to Follow-up|0|||
155488162|NCT02046993|561209832|FG000|Overall Study|Withdrawal by Subject|2|||
155488163|NCT02046993|561209833|FG001|Overall Study|Withdrawal by Subject|10|||
155488164|NCT02046993|561209832|FG000|Overall Study|Lost to Follow-up|1|||
155488165|NCT02046993|561209833|FG001|Overall Study|Lost to Follow-up|1|||
155488166|NCT02708524|561209840|FG000|Overall Study|Adverse Event|0|||
155488167|NCT02708524|561209841|FG001|Overall Study|Adverse Event|1|||
155488168|NCT02708524|561209842|FG002|Overall Study|Adverse Event|0|||
155488169|NCT02708524|561209843|FG003|Overall Study|Adverse Event|0|||
155488170|NCT02708524|561209840|FG000|Overall Study|Lens Discomfort|1|||
155488171|NCT02708524|561209841|FG001|Overall Study|Lens Discomfort|0|||
155488172|NCT02708524|561209842|FG002|Overall Study|Lens Discomfort|1|||
155488173|NCT02708524|561209843|FG003|Overall Study|Lens Discomfort|0|||
155488174|NCT02708524|561209840|FG000|Overall Study|Lost to Follow-up|1|||
155488175|NCT02708524|561209841|FG001|Overall Study|Lost to Follow-up|1|||
155488176|NCT02708524|561209842|FG002|Overall Study|Lost to Follow-up|1|||
155488177|NCT02708524|561209843|FG003|Overall Study|Lost to Follow-up|0|||
155488178|NCT02708524|561209840|FG000|Overall Study|Protocol Violation|0|||
155488179|NCT02708524|561209841|FG001|Overall Study|Protocol Violation|1|||
155488180|NCT02708524|561209842|FG002|Overall Study|Protocol Violation|0|||
155488181|NCT02708524|561209843|FG003|Overall Study|Protocol Violation|0|||
155488182|NCT02708524|561209840|FG000|Overall Study|Withdrawal by Subject|1|||
155488183|NCT02708524|561209841|FG001|Overall Study|Withdrawal by Subject|1|||
155488184|NCT02708524|561209842|FG002|Overall Study|Withdrawal by Subject|0|||
155488185|NCT02708524|561209843|FG003|Overall Study|Withdrawal by Subject|0|||
155488186|NCT02708524|561209840|FG000|Overall Study|Dispensed incorrect study lens|0|||
155656258|NCT02226653|561835173|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
155488187|NCT02708524|561209841|FG001|Overall Study|Dispensed incorrect study lens|1|||
155488188|NCT02708524|561209842|FG002|Overall Study|Dispensed incorrect study lens|1|||
155488189|NCT02708524|561209843|FG003|Overall Study|Dispensed incorrect study lens|0|||
155488190|NCT02708524|561209840|FG000|Overall Study|Did not wear lens at final visit|0|||
155488191|NCT02708524|561209841|FG001|Overall Study|Did not wear lens at final visit|1|||
155488192|NCT02708524|561209842|FG002|Overall Study|Did not wear lens at final visit|0|||
155488193|NCT02708524|561209843|FG003|Overall Study|Did not wear lens at final visit|0|||
155488194|NCT02708524|561209840|FG000|Overall Study|Subject lost study lens|1|||
155488195|NCT02708524|561209841|FG001|Overall Study|Subject lost study lens|0|||
155488196|NCT02708524|561209842|FG002|Overall Study|Subject lost study lens|0|||
155488197|NCT02708524|561209843|FG003|Overall Study|Subject lost study lens|0|||
155488198|NCT03781167|561209847|FG000|Overall Study|Adverse Event|23|||
155488199|NCT03781167|561209848|FG001|Overall Study|Adverse Event|25|||
155488200|NCT03781167|561209847|FG000|Overall Study|Withdrew consent|16|||
155488201|NCT03781167|561209848|FG001|Overall Study|Withdrew consent|12|||
155488202|NCT03781167|561209847|FG000|Overall Study|Lost to Follow-up|0|||
155488203|NCT03781167|561209848|FG001|Overall Study|Lost to Follow-up|1|||
155488204|NCT03781167|561209847|FG000|Overall Study|Lack of Efficacy|4|||
155488205|NCT03781167|561209848|FG001|Overall Study|Lack of Efficacy|5|||
155488206|NCT03781167|561209847|FG000|Overall Study|Difficulty with drug delivery system|2|||
155488207|NCT03781167|561209848|FG001|Overall Study|Difficulty with drug delivery system|3|||
155488208|NCT03781167|561209847|FG000|Overall Study|Other, not specified|2|||
155488209|NCT03781167|561209848|FG001|Overall Study|Other, not specified|2|||
155488210|NCT00679354|561209854|FG000|Overall Study|Death|3|||
155488211|NCT00679354|561209854|FG000|Overall Study|Lack of Efficacy|22|||
155488212|NCT00679354|561209854|FG000|Overall Study|Physician Decision|4|||
155488213|NCT00679354|561209854|FG000|Overall Study|Ineligible|1|||
155488214|NCT00267202|561209855|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
155488215|NCT00267202|561209856|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155488216|NCT00267202|561209855|FG000|Overall Study|Withdrawal by Subject|12|||
155488217|NCT00267202|561209856|FG001|Overall Study|Withdrawal by Subject|15|||
155488218|NCT00267202|561209855|FG000|Overall Study|Adverse Event|13|||
155488219|NCT00267202|561209856|FG001|Overall Study|Adverse Event|7|||
155488220|NCT00267202|561209855|FG000|Overall Study|Protocol Violation|2|||
155488221|NCT00267202|561209856|FG001|Overall Study|Protocol Violation|3|||
155488222|NCT00267202|561209855|FG000|Overall Study|Administrative problems|2|||
155488223|NCT00267202|561209856|FG001|Overall Study|Administrative problems|1|||
155488224|NCT00267202|561209855|FG000|Overall Study|Lost to Follow-up|3|||
155488225|NCT00267202|561209856|FG001|Overall Study|Lost to Follow-up|0|||
155488226|NCT03831282|561209857|FG000|Overall Study|Could not place sensor|1|||
155488227|NCT00334893|561209858|FG000|Overall Study|Not Treated|1|||
155488228|NCT00334893|561209859|FG001|Overall Study|Not Treated|0|||
155488229|NCT00920582|561209860|FG000|Overall Study|Lost to Follow-up|5|||
155488230|NCT00920582|561209861|FG001|Overall Study|Lost to Follow-up|1|||
155488231|NCT00920582|561209862|FG002|Overall Study|Lost to Follow-up|2|||
155488232|NCT00920582|561209863|FG003|Overall Study|Lost to Follow-up|0|||
155488233|NCT00920582|561209860|FG000|Overall Study|Withdrawal by Subject|5|||
155488234|NCT00920582|561209861|FG001|Overall Study|Withdrawal by Subject|4|||
155488235|NCT00920582|561209862|FG002|Overall Study|Withdrawal by Subject|6|||
155488236|NCT00920582|561209863|FG003|Overall Study|Withdrawal by Subject|3|||
155488237|NCT00920582|561209860|FG000|Overall Study|Protocol Violation|1|||
155488238|NCT00920582|561209861|FG001|Overall Study|Protocol Violation|0|||
155488239|NCT00920582|561209862|FG002|Overall Study|Protocol Violation|0|||
155488240|NCT00920582|561209863|FG003|Overall Study|Protocol Violation|0|||
155488241|NCT00920582|561209860|FG000|Overall Study|Other|2|||
155488242|NCT00920582|561209861|FG001|Overall Study|Other|1|||
155488243|NCT00920582|561209862|FG002|Overall Study|Other|3|||
155488244|NCT00920582|561209863|FG003|Overall Study|Other|2|||
155488245|NCT01552408|561209868|FG000|Overall Study|Lost to Follow-up|2|||
155488246|NCT01552408|561209869|FG001|Overall Study|Lost to Follow-up|0|||
155488247|NCT01552408|561209868|FG000|Overall Study|Relocation|0|||
155488248|NCT01552408|561209869|FG001|Overall Study|Relocation|1|||
155488249|NCT01552408|561209868|FG000|Overall Study|Withdrawal by Subject|2|||
155488250|NCT01552408|561209869|FG001|Overall Study|Withdrawal by Subject|1|||
155488251|NCT01365468|561209873|FG000|Overall Study|Physician Decision|1|||
155488252|NCT01365468|561209874|FG001|Overall Study|Physician Decision|0|||
155488253|NCT01365468|561209873|FG000|Overall Study|Disease progression|1|||
155488254|NCT01365468|561209874|FG001|Overall Study|Disease progression|0|||
155488255|NCT01365468|561209873|FG000|Overall Study|Lost to Follow-up|2|||
155488256|NCT01365468|561209874|FG001|Overall Study|Lost to Follow-up|0|||
155488257|NCT01018680|561211631|FG000|Overall Study|Adverse Event|23|||
155488258|NCT01018680|561211632|FG001|Overall Study|Adverse Event|40|||
155488259|NCT01018680|561211631|FG000|Overall Study|Withdrawal by Subject|10|||
155488260|NCT01018680|561211632|FG001|Overall Study|Withdrawal by Subject|10|||
155488261|NCT01018680|561211631|FG000|Overall Study|Protocol Violation|5|||
155488262|NCT01018680|561211632|FG001|Overall Study|Protocol Violation|8|||
155488263|NCT01018680|561211631|FG000|Overall Study|Sponsor Decision|6|||
155488264|NCT01018680|561211632|FG001|Overall Study|Sponsor Decision|7|||
155488265|NCT01018680|561211631|FG000|Overall Study|Lack of Efficacy|8|||
155488266|NCT01018680|561211632|FG001|Overall Study|Lack of Efficacy|2|||
155488267|NCT01018680|561211631|FG000|Overall Study|Lost to Follow-up|5|||
155488268|NCT01018680|561211632|FG001|Overall Study|Lost to Follow-up|3|||
155488269|NCT01018680|561211631|FG000|Overall Study|Entry Criteria Not Met|1|||
155488270|NCT01018680|561211632|FG001|Overall Study|Entry Criteria Not Met|4|||
155488271|NCT01018680|561211631|FG000|Overall Study|Physician Decision|3|||
155488272|NCT01018680|561211632|FG001|Overall Study|Physician Decision|1|||
155488273|NCT05056311|561211633|FG000|Overall Study|Lost to Follow-up|14|||
155488274|NCT05056311|561211633|FG000|Overall Study|Withdrawal by Subject|1|||
155488275|NCT05056311|561211633|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
155488276|NCT00960869|561211634|FG000|Overall Study|Adverse Event|17|||
155488277|NCT00960869|561211635|FG001|Overall Study|Adverse Event|26|||
155488278|NCT00960869|561211634|FG000|Overall Study|Withdrawal by Subject|16|||
155488279|NCT00960869|561211635|FG001|Overall Study|Withdrawal by Subject|14|||
155488280|NCT00960869|561211634|FG000|Overall Study|Lost to Follow-up|1|||
155488281|NCT00960869|561211635|FG001|Overall Study|Lost to Follow-up|4|||
155488282|NCT00960869|561211634|FG000|Overall Study|Misc|19|||
155488283|NCT00960869|561211635|FG001|Overall Study|Misc|18|||
155488284|NCT01153971|561211641|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
155488285|NCT01153971|561211641|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
155488286|NCT01153971|561211641|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
155488287|NCT01153971|561211641|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
155488288|NCT01153971|561211641|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
155488289|NCT01153971|561211641|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
155488290|NCT01153971|561211641|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
155488291|NCT03472586|561211649|FG000|Overall Study|Physician Decision|6|||
155488292|NCT03472586|561211649|FG000|Overall Study|Death|6|||
155488293|NCT03472586|561211649|FG000|Overall Study|Adverse Event|1|||
155488294|NCT01342445|561211650|FG000|Overall Study|Experienced side effects|0|||
155488295|NCT01342445|561211651|FG001|Overall Study|Experienced side effects|2|||
155488296|NCT02652793|561211652|FG000|Overall Study|Adverse Event|1|||
155488297|NCT02652793|561211652|FG000|Overall Study|Lost to Follow-up|2|||
155488298|NCT02652793|561211652|FG000|Overall Study|Withdrawal by Subject|1|||
155488299|NCT04511533|561211653|FG000|Treatment|Other|2|||
155488300|NCT04511533|561211653|FG000|Treatment|Withdrawal by Subject|11|||
155488301|NCT04511533|561211653|FG000|Treatment|Death|5|||
155488302|NCT04511533|561211653|FG000|Treatment|Physician Decision|1|||
155488303|NCT04511533|561211653|FG000|Treatment|Progressive Disease|61|||
155488304|NCT04511533|561211653|FG000|Follow-Up|Other|7|||
155488305|NCT04511533|561211653|FG000|Follow-Up|Withdrawal by Subject|5|||
155488306|NCT04511533|561211653|FG000|Follow-Up|Lost to Follow-up|2|||
155488307|NCT04511533|561211653|FG000|Follow-Up|Death|4|||
155488308|NCT01928758|561211654|FG000|Overall Study|Lost to Follow-up|14|||
155488309|NCT01928758|561211655|FG001|Overall Study|Lost to Follow-up|9|||
155488310|NCT01928758|561211654|FG000|Overall Study|Withdrawal by Subject|5|||
155488311|NCT01928758|561211655|FG001|Overall Study|Withdrawal by Subject|2|||
155488312|NCT01928758|561211654|FG000|Overall Study|Adverse Event|3|||
155488313|NCT01928758|561211655|FG001|Overall Study|Adverse Event|5|||
155488314|NCT01928758|561211654|FG000|Overall Study|Protocol Violation|3|||
155488315|NCT01928758|561211655|FG001|Overall Study|Protocol Violation|4|||
155488316|NCT02718131|561211656|FG000|Overall Study|Withdrawal by Subject|1|||
155488317|NCT02718131|561211657|FG001|Overall Study|Withdrawal by Subject|0|||
155488318|NCT02718131|561211656|FG000|Overall Study|Adverse Event|1|||
155488319|NCT02718131|561211657|FG001|Overall Study|Adverse Event|0|||
155488320|NCT02718131|561211656|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
155488321|NCT02718131|561211657|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
155488322|NCT03198559|561211658|FG000|Overall Study|Adverse Event|2|||
155488323|NCT01474291|561211662|FG000|Overall Study|Not Evaluable for Efficacy|26|||
155488324|NCT01474291|561211662|FG000|Overall Study|Lack of Treatment Efficacy|88|||
155488325|NCT01474291|561211662|FG000|Overall Study|Adverse Event|53|||
155488326|NCT01474291|561211662|FG000|Overall Study|Lost to Follow-up|29|||
155488327|NCT01474291|561211662|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
155488328|NCT01474291|561211662|FG000|Overall Study|No Reason Reported|10|||
155488329|NCT01474291|561211662|FG000|Overall Study|Death|2|||
155488330|NCT03471507|561211663|FG000|Overall Study|Lost to Follow-up|1|||
155488331|NCT03471507|561211664|FG001|Overall Study|Lost to Follow-up|3|||
155488332|NCT03471507|561211663|FG000|Overall Study|Physician Decision|0|||
155488333|NCT03471507|561211664|FG001|Overall Study|Physician Decision|1|||
155488334|NCT03471507|561211663|FG000|Overall Study|Withdrawal by Subject|2|||
155543889|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
155488335|NCT03471507|561211664|FG001|Overall Study|Withdrawal by Subject|1|||
155488336|NCT00598442|561211668|FG000|Overall Study|Adverse Event|3|||
155488337|NCT00598442|561211669|FG001|Overall Study|Adverse Event|0|||
155488338|NCT00598442|561211670|FG002|Overall Study|Adverse Event|0|||
155488339|NCT00598442|561211668|FG000|Overall Study|Death|19|||
155488340|NCT00598442|561211669|FG001|Overall Study|Death|11|||
155488341|NCT00598442|561211670|FG002|Overall Study|Death|11|||
155488342|NCT00598442|561211668|FG000|Overall Study|Lost to Follow-up|4|||
155488343|NCT00598442|561211669|FG001|Overall Study|Lost to Follow-up|3|||
155488344|NCT00598442|561211670|FG002|Overall Study|Lost to Follow-up|3|||
155488345|NCT00598442|561211668|FG000|Overall Study|Physician Decision|2|||
155488346|NCT00598442|561211669|FG001|Overall Study|Physician Decision|1|||
155488347|NCT00598442|561211670|FG002|Overall Study|Physician Decision|1|||
155488348|NCT00598442|561211668|FG000|Overall Study|Withdrawal by Subject|8|||
155488349|NCT00598442|561211669|FG001|Overall Study|Withdrawal by Subject|16|||
155488350|NCT00598442|561211670|FG002|Overall Study|Withdrawal by Subject|6|||
155488351|NCT00598442|561211668|FG000|Overall Study|Noncompliance|0|||
155488352|NCT00598442|561211669|FG001|Overall Study|Noncompliance|2|||
155488353|NCT00598442|561211670|FG002|Overall Study|Noncompliance|1|||
155488354|NCT00598442|561211668|FG000|Overall Study|Relocation|1|||
155488355|NCT00598442|561211669|FG001|Overall Study|Relocation|4|||
155488356|NCT00598442|561211670|FG002|Overall Study|Relocation|0|||
155488357|NCT00598442|561211668|FG000|Overall Study|Renal transplant|0|||
155488358|NCT00598442|561211669|FG001|Overall Study|Renal transplant|0|||
155488359|NCT00598442|561211670|FG002|Overall Study|Renal transplant|1|||
155488360|NCT00598442|561211668|FG000|Overall Study|Site closed by sponsor|5|||
155488361|NCT00598442|561211669|FG001|Overall Study|Site closed by sponsor|2|||
155488362|NCT00598442|561211670|FG002|Overall Study|Site closed by sponsor|1|||
155488363|NCT00598442|561211668|FG000|Overall Study|Started dialysis|1|||
155488364|NCT00598442|561211669|FG001|Overall Study|Started dialysis|0|||
155488365|NCT00598442|561211670|FG002|Overall Study|Started dialysis|0|||
155488366|NCT01590628|561211680|FG000|Overall Study|Death|2|||
155488367|NCT01590628|561211681|FG001|Overall Study|Death|0|||
155488368|NCT00475657|561211682|FG000|Overall Study|Death|1|||
155488369|NCT00475657|561211682|FG000|Overall Study|Sponsor's Decision|3|||
155488370|NCT04629534|561211697|FG000|Overall Study|Physician Decision|1|||
155488371|NCT04629534|561211698|FG001|Overall Study|Physician Decision|0|||
155488372|NCT04629534|561211697|FG000|Overall Study|Protocol Violation|0|||
155488373|NCT04629534|561211698|FG001|Overall Study|Protocol Violation|2|||
155488374|NCT00808665|561211699|FG000|Overall Study|Withdrawal by Subject|1|||
155488375|NCT00808665|561211700|FG001|Overall Study|Withdrawal by Subject|0|||
155488376|NCT00808665|561211699|FG000|Overall Study|only required minimally invasive surgery|1|||
155488377|NCT00808665|561211700|FG001|Overall Study|only required minimally invasive surgery|0|||
155488378|NCT00808665|561211699|FG000|Overall Study|surgery cancelled|1|||
155488379|NCT00808665|561211700|FG001|Overall Study|surgery cancelled|0|||
155488380|NCT00808665|561211699|FG000|Overall Study|required an additional procedure|0|||
155488381|NCT00808665|561211700|FG001|Overall Study|required an additional procedure|1|||
155488382|NCT00808665|561211699|FG000|Overall Study|Physician Decision|3|||
155488383|NCT00808665|561211700|FG001|Overall Study|Physician Decision|1|||
155488384|NCT00808665|561211699|FG000|Overall Study|Medication stopped by resident|0|||
155488385|NCT00808665|561211700|FG001|Overall Study|Medication stopped by resident|1|||
155488386|NCT01258803|561211701|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
155488387|NCT01258803|561211702|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
155488388|NCT01258803|561211703|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
155488389|NCT01258803|561211704|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
155488390|NCT01258803|561211705|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
155488391|NCT01258803|561211706|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
155488392|NCT01258803|561211701|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
155488393|NCT01258803|561211702|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
155488394|NCT01258803|561211703|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
155488395|NCT01258803|561211704|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
155488396|NCT01258803|561211705|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
155488397|NCT01258803|561211706|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
155488398|NCT01258803|561211701|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
155488399|NCT01258803|561211702|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
155488400|NCT01258803|561211703|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
155488401|NCT01258803|561211704|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
155488402|NCT01258803|561211705|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
155488403|NCT01258803|561211706|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
155488404|NCT00678652|561211707|FG000|Overall Study|Protocol Violation|2|||
155488405|NCT00678652|561211708|FG001|Overall Study|Protocol Violation|0|||
155488406|NCT00678652|561211709|FG002|Overall Study|Protocol Violation|0|||
155488407|NCT00678652|561211710|FG003|Overall Study|Protocol Violation|0|||
155488408|NCT00678652|561211707|FG000|Overall Study|Pregnancy|0|||
155488409|NCT00678652|561211708|FG001|Overall Study|Pregnancy|0|||
155488410|NCT00678652|561211709|FG002|Overall Study|Pregnancy|1|||
155488411|NCT00678652|561211710|FG003|Overall Study|Pregnancy|0|||
155488412|NCT00678652|561211707|FG000|Overall Study|Relocation|1|||
155488413|NCT00678652|561211708|FG001|Overall Study|Relocation|0|||
155488414|NCT00678652|561211709|FG002|Overall Study|Relocation|0|||
155488415|NCT00678652|561211710|FG003|Overall Study|Relocation|0|||
155488416|NCT05146999|561211711|FG000|Overall Study|Withdrew consent|6|||
155488417|NCT05146999|561211712|FG001|Overall Study|Withdrew consent|1|||
155488418|NCT05146999|561211711|FG000|Overall Study|Lost to Follow-up|3|||
155488419|NCT05146999|561211712|FG001|Overall Study|Lost to Follow-up|2|||
155488420|NCT05146999|561211711|FG000|Overall Study|Other|1|||
155488421|NCT05146999|561211712|FG001|Overall Study|Other|3|||
155488422|NCT03319160|561211713|FG000|Overall Study|Data not available.|7|||
155488423|NCT04533204|561211716|FG000|Overall Study|Unable to understand training instructions|1|||
155488424|NCT04533204|561211717|FG001|Overall Study|Unable to understand training instructions|1|||
155488425|NCT00383292|561211718|FG000|Overall Study|Adverse Event|4|||
155488426|NCT00383292|561211719|FG001|Overall Study|Adverse Event|1|||
155488427|NCT00383292|561211720|FG002|Overall Study|Adverse Event|2|||
155488428|NCT00383292|561211718|FG000|Overall Study|Death|3|||
155488429|NCT00383292|561211719|FG001|Overall Study|Death|3|||
155488430|NCT00383292|561211720|FG002|Overall Study|Death|3|||
155488431|NCT00383292|561211718|FG000|Overall Study|Physician Decision|4|||
155488432|NCT00383292|561211719|FG001|Overall Study|Physician Decision|0|||
155488433|NCT00383292|561211720|FG002|Overall Study|Physician Decision|1|||
155488434|NCT00383292|561211718|FG000|Overall Study|Withdrawal by Subject|3|||
155488435|NCT00383292|561211719|FG001|Overall Study|Withdrawal by Subject|2|||
155488436|NCT00383292|561211720|FG002|Overall Study|Withdrawal by Subject|2|||
155488437|NCT00383292|561211718|FG000|Overall Study|Other|1|||
155488438|NCT00383292|561211719|FG001|Overall Study|Other|0|||
155488439|NCT00383292|561211720|FG002|Overall Study|Other|0|||
155488440|NCT00697255|561211721|FG000|Stage 1a|Insufficient ovarian response|1|||
155488441|NCT00697255|561211722|FG001|Stage 1a|Insufficient ovarian response|0|||
155488442|NCT00697255|561211721|FG000|Stage 1a|Multifollicular growth|1|||
155488443|NCT00697255|561211722|FG001|Stage 1a|Multifollicular growth|0|||
155488444|NCT00697255|561211721|FG000|Stage 1a|Not growing of dominant follicle|1|||
155488445|NCT00697255|561211722|FG001|Stage 1a|Not growing of dominant follicle|0|||
155488446|NCT00697255|561211721|FG000|Stage 1b|Not growing of dominant follicle|0|||
155488447|NCT00697255|561211722|FG001|Stage 1b|Not growing of dominant follicle|1|||
155488448|NCT00697255|561211721|FG000|Stage 1b|Insufficient ovarian response|0|||
155488449|NCT00697255|561211722|FG001|Stage 1b|Insufficient ovarian response|1|||
155488450|NCT04034225|561211726|FG000|Overall Study|Death|3|||
155488451|NCT04034225|561211726|FG000|Overall Study|Withdrawal by Subject|2|||
155488452|NCT04034225|561211726|FG000|Overall Study|Study termination by Sponsor|18|||
155488453|NCT04034225|561211726|FG000|Overall Study|Physician Decision|1|||
155488454|NCT04034225|561211726|FG000|Overall Study|Lack of Efficacy|1|||
155488455|NCT02260791|561211731|FG000|Overall Study|Lost to Follow-up|4|||
155488456|NCT02260791|561211732|FG001|Overall Study|Lost to Follow-up|4|||
155488457|NCT02260791|561211731|FG000|Overall Study|Lack of Efficacy|2|||
155488458|NCT02260791|561211732|FG001|Overall Study|Lack of Efficacy|1|||
155488459|NCT02260791|561211731|FG000|Overall Study|Adverse Event|13|||
155488460|NCT02260791|561211732|FG001|Overall Study|Adverse Event|9|||
155488461|NCT02260791|561211731|FG000|Overall Study|Death|1|||
155488462|NCT02260791|561211732|FG001|Overall Study|Death|0|||
155488463|NCT02260791|561211731|FG000|Overall Study|Withdrawal by Subject|11|||
155488464|NCT02260791|561211732|FG001|Overall Study|Withdrawal by Subject|16|||
155488465|NCT02260791|561211731|FG000|Overall Study|Screen failure|0|||
155488466|NCT02260791|561211732|FG001|Overall Study|Screen failure|1|||
155488467|NCT02260791|561211731|FG000|Overall Study|Protocol deviation|2|||
155488468|NCT02260791|561211732|FG001|Overall Study|Protocol deviation|3|||
155488469|NCT04246996|561211735|FG000|Overall Study|Physician Decision|1|||
155488470|NCT04246996|561211736|FG001|Overall Study|Physician Decision|1|||
155488471|NCT04246996|561211735|FG000|Overall Study|Did not meet eligibility criteria|1|||
155488472|NCT04246996|561211736|FG001|Overall Study|Did not meet eligibility criteria|4|||
155488473|NCT00736840|561211740|FG000|Overall Study|Lost to Follow-up|13|||
155488474|NCT02815670|561211741|FG000|Overall Study|Prematurely discontinued of the trial|1|||
155488475|NCT01411917|561211742|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
155488476|NCT01411917|561211743|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
155488477|NCT01815099|561211746|FG000|Overall Study|Lack of Efficacy|1|||
155543890|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
155488478|NCT01815099|561211746|FG000|Overall Study|unable to attend study visits|1|||
155488479|NCT01475214|561211747|FG000|Overall Study|Lost to Follow-up|1|||
155488480|NCT01475214|561211748|FG001|Overall Study|Lost to Follow-up|0|||
155488481|NCT01475214|561211749|FG002|Overall Study|Lost to Follow-up|1|||
155488482|NCT01475214|561211747|FG000|Overall Study|Physician Decision|2|||
155488483|NCT01475214|561211748|FG001|Overall Study|Physician Decision|0|||
155488484|NCT01475214|561211749|FG002|Overall Study|Physician Decision|0|||
155488485|NCT01475214|561211747|FG000|Overall Study|Withdrawal by Subject|2|||
155488486|NCT01475214|561211748|FG001|Overall Study|Withdrawal by Subject|4|||
155488487|NCT01475214|561211749|FG002|Overall Study|Withdrawal by Subject|1|||
155488488|NCT03289676|561211750|FG000|Overall Study|Withdrawal by Subject|2|||
155488489|NCT03289676|561211751|FG001|Overall Study|Withdrawal by Subject|0|||
155488490|NCT03289676|561211750|FG000|Overall Study|Protocol Violation|2|||
155488491|NCT03289676|561211751|FG001|Overall Study|Protocol Violation|0|||
155488492|NCT03289676|561211750|FG000|Overall Study|Lost to Follow-up|0|||
155488493|NCT03289676|561211751|FG001|Overall Study|Lost to Follow-up|1|||
155488494|NCT02354599|561211752|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155488495|NCT02354599|561211753|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155488496|NCT02354599|561211754|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155488497|NCT02354599|561211755|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
155488498|NCT02354599|561211756|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155488499|NCT02354599|561211757|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
155488500|NCT02354599|561211752|FG000|Overall Study|Withdrawal by Subject|1|||
155488501|NCT02354599|561211753|FG001|Overall Study|Withdrawal by Subject|1|||
155488502|NCT02354599|561211754|FG002|Overall Study|Withdrawal by Subject|0|||
155488503|NCT02354599|561211755|FG003|Overall Study|Withdrawal by Subject|0|||
155488504|NCT02354599|561211756|FG004|Overall Study|Withdrawal by Subject|0|||
155488505|NCT02354599|561211757|FG005|Overall Study|Withdrawal by Subject|0|||
155488506|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Death|2|||
155488507|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Death|0|||
155488508|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Adverse Event|33|||
155488509|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Adverse Event|31|||
155488510|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
155488511|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
155488512|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
155488513|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
155488514|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
155488515|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
155488516|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Other|7|||
155488517|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Other|8|||
155488518|NCT00280059|561211758|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
155488519|NCT00280059|561211759|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
155488520|NCT00495794|561211762|FG000|Overall Study|Pharmacist did not activate patient|522|||
155488521|NCT00495794|561211763|FG001|Overall Study|Pharmacist did not activate patient|0|||
155488522|NCT02127931|561211764|FG000|Overall Study|Glitch in Game|1|||
155488523|NCT01636076|561211765|FG000|Overall Study|Terminated by sponsor|1|||
155488524|NCT01636076|561211766|FG001|Overall Study|Terminated by sponsor|1|||
155488525|NCT01636076|561211765|FG000|Overall Study|Lack of Efficacy|0|||
155488526|NCT01636076|561211766|FG001|Overall Study|Lack of Efficacy|1|||
155488527|NCT01636076|561211765|FG000|Overall Study|Lost to Follow-up|1|||
155488528|NCT01636076|561211766|FG001|Overall Study|Lost to Follow-up|0|||
155488529|NCT01636076|561211765|FG000|Overall Study|Physician Decision|1|||
155488530|NCT01636076|561211766|FG001|Overall Study|Physician Decision|1|||
155488531|NCT01636076|561211765|FG000|Overall Study|Non-compliance with study treatment|1|||
155488532|NCT01636076|561211766|FG001|Overall Study|Non-compliance with study treatment|1|||
155488533|NCT01636076|561211765|FG000|Overall Study|Adverse Event|6|||
155488534|NCT01636076|561211766|FG001|Overall Study|Adverse Event|11|||
155488535|NCT01636076|561211765|FG000|Overall Study|Withdrawal by Subject|7|||
155656259|NCT02226653|561835174|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
155656260|NCT02226653|561835173|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
155656261|NCT02226653|561835174|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
155656262|NCT00759395|561835176|FG000|Overall Study|Adverse Event|1|||
155656263|NCT00759395|561835177|FG001|Overall Study|Adverse Event|0|||
155656264|NCT00759395|561835176|FG000|Overall Study|Withdrawal by Subject|1|||
155656265|NCT00759395|561835177|FG001|Overall Study|Withdrawal by Subject|0|||
155656266|NCT00759395|561835176|FG000|Overall Study|Lack of Efficacy|0|||
155656267|NCT00759395|561835177|FG001|Overall Study|Lack of Efficacy|2|||
155656268|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
155656269|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
155656270|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
155656271|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
155656272|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
155656273|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
155656274|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
155656275|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
155656276|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
155656277|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
155656278|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
155656279|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
155656280|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
155656281|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
155488536|NCT01636076|561211766|FG001|Overall Study|Withdrawal by Subject|10|||
155488537|NCT01159665|561211767|FG000|Overall Study|Withdrawal by Subject|0|||
155488538|NCT01159665|561211768|FG001|Overall Study|Withdrawal by Subject|1|||
155488539|NCT01159665|561211769|FG002|Overall Study|Withdrawal by Subject|0|||
155488540|NCT01159665|561211770|FG003|Overall Study|Withdrawal by Subject|0|||
155488541|NCT01159665|561211771|FG004|Overall Study|Withdrawal by Subject|0|||
155488542|NCT01159665|561211772|FG005|Overall Study|Withdrawal by Subject|0|||
155488543|NCT01130831|561211773|FG000|Overall Study|Withdrawal by Subject|7|||
155488544|NCT01130831|561211773|FG000|Overall Study|Death|4|||
155488545|NCT01130831|561211773|FG000|Overall Study|Information was missing|3|||
155488546|NCT00951912|561211774|FG000|Overall Study|Lack of Efficacy|1|||
155488547|NCT00951912|561211775|FG001|Overall Study|Lack of Efficacy|0|||
155488548|NCT00951912|561211776|FG002|Overall Study|Lack of Efficacy|0|||
155488549|NCT00951912|561211774|FG000|Overall Study|Adverse Event|0|||
155488550|NCT00951912|561211775|FG001|Overall Study|Adverse Event|1|||
155488551|NCT00951912|561211776|FG002|Overall Study|Adverse Event|1|||
155488552|NCT00951912|561211774|FG000|Overall Study|Lost to Follow-up|2|||
155488553|NCT00951912|561211775|FG001|Overall Study|Lost to Follow-up|2|||
155488554|NCT00951912|561211776|FG002|Overall Study|Lost to Follow-up|0|||
155488555|NCT00951912|561211774|FG000|Overall Study|Physician Decision|1|||
155488556|NCT00951912|561211775|FG001|Overall Study|Physician Decision|0|||
155488557|NCT00951912|561211776|FG002|Overall Study|Physician Decision|1|||
155488558|NCT00951912|561211774|FG000|Overall Study|Withdrawal by Subject|1|||
155488559|NCT00951912|561211775|FG001|Overall Study|Withdrawal by Subject|1|||
155488560|NCT00951912|561211776|FG002|Overall Study|Withdrawal by Subject|0|||
155488561|NCT00951912|561211774|FG000|Overall Study|Other:Depression|1|||
155488562|NCT00951912|561211775|FG001|Overall Study|Other:Depression|0|||
155488563|NCT00951912|561211776|FG002|Overall Study|Other:Depression|0|||
155488564|NCT00951912|561211774|FG000|Overall Study|Other: Colon cancer|1|||
155488565|NCT00951912|561211775|FG001|Overall Study|Other: Colon cancer|0|||
155488566|NCT00951912|561211776|FG002|Overall Study|Other: Colon cancer|0|||
155488567|NCT00951912|561211774|FG000|Overall Study|Other: Stroke|0|||
155488568|NCT00951912|561211775|FG001|Overall Study|Other: Stroke|1|||
155488569|NCT00951912|561211776|FG002|Overall Study|Other: Stroke|0|||
155488570|NCT02173158|561211778|FG000|Efficacy Phase|Adverse Event|1|||
155488571|NCT01377194|561211779|FG000|Overall Study|Adverse Event|3|||
155488572|NCT01377194|561211780|FG001|Overall Study|Adverse Event|12|||
155488573|NCT01377194|561211781|FG002|Overall Study|Adverse Event|19|||
155488574|NCT01377194|561211779|FG000|Overall Study|Lack of Efficacy|3|||
155488575|NCT01377194|561211780|FG001|Overall Study|Lack of Efficacy|3|||
155488576|NCT01377194|561211781|FG002|Overall Study|Lack of Efficacy|3|||
155488577|NCT01377194|561211779|FG000|Overall Study|Protocol Violation|4|||
155488578|NCT01377194|561211780|FG001|Overall Study|Protocol Violation|10|||
155488579|NCT01377194|561211781|FG002|Overall Study|Protocol Violation|6|||
155488580|NCT01377194|561211779|FG000|Overall Study|Withdrawal by Subject|8|||
155488581|NCT01377194|561211780|FG001|Overall Study|Withdrawal by Subject|10|||
155488582|NCT01377194|561211781|FG002|Overall Study|Withdrawal by Subject|7|||
155488583|NCT01377194|561211779|FG000|Overall Study|Lost to Follow-up|14|||
155488584|NCT01377194|561211780|FG001|Overall Study|Lost to Follow-up|8|||
155488585|NCT01377194|561211781|FG002|Overall Study|Lost to Follow-up|11|||
155488586|NCT00323479|561211782|FG000|Overall Study|Adverse Event|2|||
155488587|NCT00323479|561211782|FG000|Overall Study|Withdrawal by Subject|2|||
155488588|NCT00323479|561211782|FG000|Overall Study|Protocol Violation|3|||
155488589|NCT00323479|561211782|FG000|Overall Study|house moving|1|||
155488590|NCT00967343|561211786|FG000|Overall Study|Study termination by sponsor|12|||
155488591|NCT00967343|561211786|FG000|Overall Study|Death|24|||
155488592|NCT00967343|561211786|FG000|Overall Study|Relapse|1|||
155488593|NCT00967343|561211786|FG000|Overall Study|Lost to Follow-up|1|||
155488594|NCT02777554|561213216|FG000|Overall Study|Adverse Event|4|||
155488595|NCT02777554|561213217|FG001|Overall Study|Adverse Event|4|||
155488596|NCT02777554|561213218|FG002|Overall Study|Adverse Event|0|||
155488597|NCT02777554|561213219|FG003|Overall Study|Adverse Event|1|||
155488598|NCT02777554|561213220|FG004|Overall Study|Adverse Event|0|||
155488599|NCT02777554|561213221|FG005|Overall Study|Adverse Event|0|||
155488600|NCT02777554|561213216|FG000|Overall Study|Withdrawal by Subject|3|||
155488601|NCT02777554|561213217|FG001|Overall Study|Withdrawal by Subject|1|||
155488602|NCT02777554|561213218|FG002|Overall Study|Withdrawal by Subject|1|||
155488603|NCT02777554|561213219|FG003|Overall Study|Withdrawal by Subject|0|||
155488604|NCT02777554|561213220|FG004|Overall Study|Withdrawal by Subject|0|||
155488605|NCT02777554|561213221|FG005|Overall Study|Withdrawal by Subject|0|||
155488606|NCT02777554|561213216|FG000|Overall Study|Discharged early due to hurricane|22|||
155488607|NCT02777554|561213217|FG001|Overall Study|Discharged early due to hurricane|20|||
155488608|NCT02777554|561213218|FG002|Overall Study|Discharged early due to hurricane|0|||
155488609|NCT02777554|561213219|FG003|Overall Study|Discharged early due to hurricane|0|||
155488610|NCT02777554|561213220|FG004|Overall Study|Discharged early due to hurricane|0|||
155488611|NCT02777554|561213221|FG005|Overall Study|Discharged early due to hurricane|0|||
155488612|NCT02777554|561213216|FG000|Overall Study|Other - Miscellaneous|1|||
155488613|NCT02777554|561213217|FG001|Overall Study|Other - Miscellaneous|0|||
155488614|NCT02777554|561213218|FG002|Overall Study|Other - Miscellaneous|0|||
155488615|NCT02777554|561213219|FG003|Overall Study|Other - Miscellaneous|0|||
155488616|NCT02777554|561213220|FG004|Overall Study|Other - Miscellaneous|0|||
155488617|NCT02777554|561213221|FG005|Overall Study|Other - Miscellaneous|0|||
155488618|NCT01541644|561213222|FG000|Overall Study|Withdrawal by Subject|3|||
155488619|NCT01458535|561213223|FG000|Overall Study|Other|0|||
155488620|NCT01458535|561213224|FG001|Overall Study|Other|0|||
155488621|NCT01458535|561213225|FG002|Overall Study|Other|0|||
155488622|NCT01458535|561213226|FG003|Overall Study|Other|0|||
155488623|NCT01458535|561213227|FG004|Overall Study|Other|1|||
155488624|NCT01458535|561213228|FG005|Overall Study|Other|1|||
155488625|NCT01458535|561213223|FG000|Overall Study|Withdrawal by Subject|0|||
155488626|NCT01458535|561213224|FG001|Overall Study|Withdrawal by Subject|0|||
155488627|NCT01458535|561213225|FG002|Overall Study|Withdrawal by Subject|2|||
155488628|NCT01458535|561213226|FG003|Overall Study|Withdrawal by Subject|0|||
155488629|NCT01458535|561213227|FG004|Overall Study|Withdrawal by Subject|1|||
155488630|NCT01458535|561213228|FG005|Overall Study|Withdrawal by Subject|1|||
155488631|NCT01458535|561213223|FG000|Overall Study|Lost to Follow-up|0|||
155488632|NCT01458535|561213224|FG001|Overall Study|Lost to Follow-up|2|||
155488633|NCT01458535|561213225|FG002|Overall Study|Lost to Follow-up|0|||
155488634|NCT01458535|561213226|FG003|Overall Study|Lost to Follow-up|3|||
155488635|NCT01458535|561213227|FG004|Overall Study|Lost to Follow-up|2|||
155488636|NCT01458535|561213228|FG005|Overall Study|Lost to Follow-up|2|||
155488637|NCT01458535|561213223|FG000|Overall Study|Adverse Event|0|||
155488638|NCT01458535|561213224|FG001|Overall Study|Adverse Event|0|||
155488639|NCT01458535|561213225|FG002|Overall Study|Adverse Event|0|||
155488640|NCT01458535|561213226|FG003|Overall Study|Adverse Event|1|||
155488641|NCT01458535|561213227|FG004|Overall Study|Adverse Event|0|||
155488642|NCT01458535|561213228|FG005|Overall Study|Adverse Event|0|||
155488643|NCT02706327|561213237|FG000|Overall Study|Lost to Follow-up|1|||
155488644|NCT02706327|561213238|FG001|Overall Study|Lost to Follow-up|1|||
155488645|NCT02706327|561213239|FG002|Overall Study|Lost to Follow-up|2|||
155488646|NCT05450198|561213240|FG000|Overall Study|Withdrawal by Subject|1|||
155488647|NCT05450198|561213241|FG001|Overall Study|Withdrawal by Subject|1|||
155488648|NCT05450198|561213242|FG002|Overall Study|Withdrawal by Subject|2|||
155488649|NCT05450198|561213243|FG003|Overall Study|Withdrawal by Subject|0|||
155488650|NCT05450198|561213240|FG000|Overall Study|Lost to Follow-up|1|||
155488651|NCT05450198|561213241|FG001|Overall Study|Lost to Follow-up|0|||
155488652|NCT05450198|561213242|FG002|Overall Study|Lost to Follow-up|2|||
155488653|NCT05450198|561213243|FG003|Overall Study|Lost to Follow-up|1|||
155488654|NCT01224171|561213249|FG000|Overall Study|Adverse Event|8|||
155488655|NCT01224171|561213250|FG001|Overall Study|Adverse Event|4|||
155488656|NCT01224171|561213249|FG000|Overall Study|Protocol Violation|0|||
155488657|NCT01224171|561213250|FG001|Overall Study|Protocol Violation|1|||
155488658|NCT01224171|561213249|FG000|Overall Study|Lack of Efficacy|5|||
155488659|NCT01224171|561213250|FG001|Overall Study|Lack of Efficacy|1|||
155488660|NCT01224171|561213249|FG000|Overall Study|Withdrawal of Consent|2|||
155488661|NCT01224171|561213250|FG001|Overall Study|Withdrawal of Consent|4|||
155488662|NCT01224171|561213249|FG000|Overall Study|Lost to Follow-up|0|||
155488663|NCT01224171|561213250|FG001|Overall Study|Lost to Follow-up|3|||
155488664|NCT01097057|561213251|FG000|Overall Study|Physician Decision|3|||
155488665|NCT01270139|561213252|FG000|Overall Study|Adverse Event|8|||
155488666|NCT01270139|561213253|FG001|Overall Study|Adverse Event|17|||
155488667|NCT01270139|561213254|FG002|Overall Study|Adverse Event|18|||
155488668|NCT01270139|561213252|FG000|Overall Study|Lost to Follow-up|10|||
155488669|NCT01270139|561213253|FG001|Overall Study|Lost to Follow-up|9|||
155488670|NCT01270139|561213254|FG002|Overall Study|Lost to Follow-up|2|||
155488671|NCT01161173|561213263|FG000|Overall Study|Protocol Violation|13|||
155488672|NCT01161173|561213263|FG000|Overall Study|Lost to Follow-up|7|||
155488673|NCT01161173|561213263|FG000|Overall Study|Progressive Disease|82|||
155488674|NCT01161173|561213263|FG000|Overall Study|Withdrawal of Consent|5|||
155488675|NCT01161173|561213263|FG000|Overall Study|Unacceptable Toxicity|21|||
155488676|NCT01161173|561213263|FG000|Overall Study|Death|194|||
155488677|NCT01161173|561213263|FG000|Overall Study|End of Study|2|||
155488678|NCT01161173|561213263|FG000|Overall Study|Reasons Not Specified|23|||
155488679|NCT01911546|561213264|FG000|Overall Study|Lost to Follow-up|1|||
155488680|NCT01911546|561213264|FG000|Overall Study|Everolimus was discontinued|5|||
155488681|NCT02213666|561213266|FG000|Overall Study|Withdrawal by Subject|1|||
155488682|NCT01319422|561213267|FG000|Overall Study|Withdrawal by Subject|1|||
155488683|NCT01319422|561213268|FG001|Overall Study|Withdrawal by Subject|0|||
155488684|NCT01399619|561213269|FG000|Overall Study|Adverse Event|10|||
155488685|NCT01399619|561213270|FG001|Overall Study|Adverse Event|0|||
155488686|NCT01399619|561213271|FG002|Overall Study|Adverse Event|4|||
155488687|NCT01399619|561213272|FG003|Overall Study|Adverse Event|10|||
155488688|NCT01399619|561213269|FG000|Overall Study|Lack of Efficacy|9|||
155488689|NCT01399619|561213270|FG001|Overall Study|Lack of Efficacy|0|||
155488690|NCT01399619|561213271|FG002|Overall Study|Lack of Efficacy|5|||
155488691|NCT01399619|561213272|FG003|Overall Study|Lack of Efficacy|0|||
155488692|NCT01399619|561213269|FG000|Overall Study|Withdrawal by Subject|6|||
155488693|NCT01399619|561213270|FG001|Overall Study|Withdrawal by Subject|0|||
155488694|NCT01399619|561213271|FG002|Overall Study|Withdrawal by Subject|3|||
155488695|NCT01399619|561213272|FG003|Overall Study|Withdrawal by Subject|4|||
155488696|NCT01399619|561213269|FG000|Overall Study|Protocol Violation|0|||
155488697|NCT01399619|561213270|FG001|Overall Study|Protocol Violation|0|||
155488698|NCT01399619|561213271|FG002|Overall Study|Protocol Violation|0|||
155488699|NCT01399619|561213272|FG003|Overall Study|Protocol Violation|1|||
155488700|NCT01399619|561213269|FG000|Overall Study|Not treated|0|||
155488701|NCT01399619|561213270|FG001|Overall Study|Not treated|0|||
155488702|NCT01399619|561213271|FG002|Overall Study|Not treated|0|||
155488703|NCT01399619|561213272|FG003|Overall Study|Not treated|2|||
155488704|NCT02918968|561213273|FG000|1st Line AAT|Progressive disease|9|||
155488705|NCT02918968|561213274|FG001|1st Line AAT|Progressive disease|4|||
155488706|NCT02918968|561213273|FG000|1st Line AAT|Adverse Event|12|||
155488707|NCT02918968|561213274|FG001|1st Line AAT|Adverse Event|3|||
155488708|NCT02918968|561213273|FG000|1st Line AAT|Physician Decision|4|||
155488709|NCT02918968|561213274|FG001|1st Line AAT|Physician Decision|2|||
155488710|NCT02918968|561213273|FG000|1st Line AAT|Withdrawal by Subject|2|||
155488711|NCT02918968|561213274|FG001|1st Line AAT|Withdrawal by Subject|1|||
155488712|NCT02918968|561213273|FG000|1st Line AAT|Lost to Follow-up|0|||
155488713|NCT02918968|561213274|FG001|1st Line AAT|Lost to Follow-up|1|||
155488714|NCT02918968|561213273|FG000|1st Line AAT|Death|1|||
155488715|NCT02918968|561213274|FG001|1st Line AAT|Death|0|||
155488716|NCT02918968|561213273|FG000|1st Line AAT|Miscellaneous|1|||
155488717|NCT02918968|561213274|FG001|1st Line AAT|Miscellaneous|0|||
155488718|NCT02918968|561213273|FG000|2nd Line AAT|Progressive disease|21|||
155488719|NCT02918968|561213274|FG001|2nd Line AAT|Progressive disease|3|||
155488720|NCT02918968|561213273|FG000|2nd Line AAT|Adverse Event|2|||
155488721|NCT02918968|561213274|FG001|2nd Line AAT|Adverse Event|5|||
155488722|NCT02918968|561213273|FG000|2nd Line AAT|Physician Decision|0|||
155488723|NCT02918968|561213274|FG001|2nd Line AAT|Physician Decision|1|||
155488724|NCT02918968|561213273|FG000|2nd Line AAT|Withdrawal by Subject|2|||
155488725|NCT02918968|561213274|FG001|2nd Line AAT|Withdrawal by Subject|2|||
155488726|NCT02918968|561213273|FG000|2nd Line AAT|Death|0|||
155488727|NCT02918968|561213274|FG001|2nd Line AAT|Death|1|||
155488728|NCT05602818|561213275|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
155488729|NCT05602818|561213276|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
155488730|NCT05602818|561213277|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
155488731|NCT05602818|561213278|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
155488732|NCT05602818|561213279|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
155488733|NCT05602818|561213280|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
155488734|NCT05602818|561213281|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
155488735|NCT05602818|561213282|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
155488736|NCT05602818|561213283|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
155488737|NCT05602818|561213284|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
155488738|NCT05602818|561213285|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
155543891|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
155543892|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
155543893|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
155543894|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
155543895|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
155543896|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
155543897|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
155543898|NCT04592419|561417325|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
155488739|NCT05602818|561213286|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
155488740|NCT05602818|561213275|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
155543899|NCT04592419|561417326|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
155543900|NCT04592419|561417325|FG000|Open-Label Extension Period|Adverse Event|1|||
155543901|NCT04592419|561417326|FG001|Open-Label Extension Period|Adverse Event|2|||
155543902|NCT04592419|561417325|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
155543903|NCT04592419|561417326|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
155543904|NCT04592419|561417325|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
155543905|NCT04592419|561417326|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
155543906|NCT04592419|561417325|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
155543907|NCT04592419|561417326|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
155543908|NCT04592419|561417325|FG000|Open-Label Extension Period|Sponsor Request|73|||
155543909|NCT04592419|561417326|FG001|Open-Label Extension Period|Sponsor Request|84|||
155543910|NCT01901848|561417336|FG000|Randomized and Treated|Lost to Follow-up|3|||
155488741|NCT05602818|561213276|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
155488742|NCT05602818|561213277|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488743|NCT05602818|561213278|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488744|NCT05602818|561213279|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488745|NCT05602818|561213280|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488746|NCT05602818|561213281|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488747|NCT05602818|561213282|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488748|NCT05602818|561213283|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488749|NCT05602818|561213284|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488750|NCT05602818|561213285|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488751|NCT05602818|561213286|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
155488752|NCT05602818|561213275|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
155488753|NCT05602818|561213276|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488754|NCT05602818|561213277|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488755|NCT05602818|561213278|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488756|NCT05602818|561213279|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488757|NCT05602818|561213280|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488758|NCT05602818|561213281|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488759|NCT05602818|561213282|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488760|NCT05602818|561213283|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488761|NCT05602818|561213284|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488762|NCT05602818|561213285|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488763|NCT05602818|561213286|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
155488764|NCT05602818|561213275|FG000|Qualification Phase (3 Days)|Other|1|||
155488765|NCT05602818|561213276|FG001|Qualification Phase (3 Days)|Other|0|||
155488766|NCT05602818|561213277|FG002|Qualification Phase (3 Days)|Other|0|||
155488767|NCT05602818|561213278|FG003|Qualification Phase (3 Days)|Other|0|||
155488768|NCT05602818|561213279|FG004|Qualification Phase (3 Days)|Other|0|||
155488769|NCT05602818|561213280|FG005|Qualification Phase (3 Days)|Other|0|||
155488770|NCT05602818|561213281|FG006|Qualification Phase (3 Days)|Other|0|||
155488771|NCT05602818|561213282|FG007|Qualification Phase (3 Days)|Other|0|||
155488772|NCT05602818|561213283|FG008|Qualification Phase (3 Days)|Other|0|||
155543911|NCT01901848|561417337|FG001|Randomized and Treated|Lost to Follow-up|6|||
155543912|NCT01901848|561417336|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
155543913|NCT01901848|561417337|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
155543914|NCT01729026|561417338|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
155543915|NCT01729026|561417339|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
155543916|NCT01729026|561417338|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
155543917|NCT01729026|561417339|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
155543918|NCT00108082|561417341|FG000|Overall Study|Adverse Event|14|||
155543919|NCT00108082|561417342|FG001|Overall Study|Adverse Event|12|||
155543920|NCT00108082|561417343|FG002|Overall Study|Adverse Event|17|||
155543921|NCT00108082|561417341|FG000|Overall Study|Lost to Follow-up|6|||
155543922|NCT00108082|561417342|FG001|Overall Study|Lost to Follow-up|3|||
155543923|NCT00108082|561417343|FG002|Overall Study|Lost to Follow-up|7|||
155543924|NCT00108082|561417341|FG000|Overall Study|Consent Withdrawn|3|||
155543925|NCT00108082|561417342|FG001|Overall Study|Consent Withdrawn|3|||
155543926|NCT00108082|561417343|FG002|Overall Study|Consent Withdrawn|5|||
155543927|NCT00108082|561417341|FG000|Overall Study|Protocol Violation|1|||
155543928|NCT00108082|561417342|FG001|Overall Study|Protocol Violation|2|||
155543929|NCT00108082|561417343|FG002|Overall Study|Protocol Violation|0|||
155543930|NCT00108082|561417341|FG000|Overall Study|Lack of Efficacy|3|||
155543931|NCT00108082|561417342|FG001|Overall Study|Lack of Efficacy|1|||
155543932|NCT00108082|561417343|FG002|Overall Study|Lack of Efficacy|2|||
155543933|NCT00108082|561417341|FG000|Overall Study|Amendment 4: > Month 12|5|||
155543934|NCT00108082|561417342|FG001|Overall Study|Amendment 4: > Month 12|7|||
155543935|NCT00108082|561417343|FG002|Overall Study|Amendment 4: > Month 12|5|||
155543936|NCT00108082|561417341|FG000|Overall Study|Woman of Child-bearing Potential|2|||
155543937|NCT00108082|561417342|FG001|Overall Study|Woman of Child-bearing Potential|0|||
155543938|NCT00108082|561417343|FG002|Overall Study|Woman of Child-bearing Potential|2|||
155543939|NCT00108082|561417341|FG000|Overall Study|Incorrectly Randomized|0|||
155543940|NCT00108082|561417342|FG001|Overall Study|Incorrectly Randomized|0|||
155543941|NCT00108082|561417343|FG002|Overall Study|Incorrectly Randomized|2|||
155543942|NCT00108082|561417341|FG000|Overall Study|Non-compliance|1|||
155543943|NCT00108082|561417342|FG001|Overall Study|Non-compliance|0|||
155543944|NCT00108082|561417343|FG002|Overall Study|Non-compliance|2|||
155543945|NCT00108082|561417341|FG000|Overall Study|Stopped Study Medication|0|||
155543946|NCT00108082|561417342|FG001|Overall Study|Stopped Study Medication|0|||
155488773|NCT05602818|561213284|FG009|Qualification Phase (3 Days)|Other|0|||
155488774|NCT05602818|561213285|FG010|Qualification Phase (3 Days)|Other|0|||
155488775|NCT05602818|561213286|FG011|Qualification Phase (3 Days)|Other|0|||
155488776|NCT05602818|561213275|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488777|NCT05602818|561213276|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
155488778|NCT05602818|561213277|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488779|NCT05602818|561213278|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488780|NCT05602818|561213279|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488781|NCT05602818|561213280|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488782|NCT05602818|561213281|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488783|NCT05602818|561213282|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488784|NCT05602818|561213283|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488785|NCT05602818|561213284|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488786|NCT05602818|561213285|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488787|NCT05602818|561213286|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
155488788|NCT05602818|561213275|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
155488789|NCT05602818|561213276|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
155488790|NCT05602818|561213277|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
155488791|NCT05602818|561213278|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
155488792|NCT05602818|561213279|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
155488793|NCT05602818|561213280|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
155488794|NCT05602818|561213281|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
155488795|NCT05602818|561213282|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
155488796|NCT05602818|561213283|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
155488797|NCT05602818|561213284|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
155488798|NCT05602818|561213285|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
155488799|NCT05602818|561213286|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
155488800|NCT05602818|561213275|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155543947|NCT00108082|561417343|FG002|Overall Study|Stopped Study Medication|1|||
155543948|NCT00108082|561417341|FG000|Overall Study|Site Closed Study|0|||
155543949|NCT00108082|561417342|FG001|Overall Study|Site Closed Study|2|||
155488801|NCT05602818|561213276|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488802|NCT05602818|561213277|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488803|NCT05602818|561213278|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488804|NCT05602818|561213279|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488805|NCT05602818|561213280|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488806|NCT05602818|561213281|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488807|NCT05602818|561213282|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488808|NCT05602818|561213283|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488809|NCT05602818|561213284|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
155488810|NCT05602818|561213285|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
155488811|NCT05602818|561213286|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
155488812|NCT05602818|561213275|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
155488813|NCT05602818|561213276|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
155488814|NCT05602818|561213277|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
155488815|NCT05602818|561213278|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
155488816|NCT05602818|561213279|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
155488817|NCT05602818|561213280|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
155488818|NCT05602818|561213281|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
155488819|NCT05602818|561213282|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
155488820|NCT05602818|561213283|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
155488821|NCT05602818|561213284|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
155488822|NCT05602818|561213285|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
155488823|NCT05602818|561213286|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
155488824|NCT00750061|561213287|FG000|Overall Study|Adverse Event|2|||
155488825|NCT00750061|561213288|FG001|Overall Study|Adverse Event|0|||
155488826|NCT00750061|561213287|FG000|Overall Study|Withdrawal by Subject|0|||
155488827|NCT00750061|561213288|FG001|Overall Study|Withdrawal by Subject|1|||
155488828|NCT00750061|561213287|FG000|Overall Study|Physician Decision|0|||
155488829|NCT00750061|561213288|FG001|Overall Study|Physician Decision|1|||
155488830|NCT00229931|561213294|FG000|Overall Study|Death|1|||
155488831|NCT00229931|561213295|FG001|Overall Study|Death|0|||
155488832|NCT00229931|561213294|FG000|Overall Study|Lost to Follow-up|3|||
155488833|NCT00229931|561213295|FG001|Overall Study|Lost to Follow-up|2|||
155488834|NCT02992743|561213296|FG000|Overall Study|Withdrawal by Subject|1|||
155488835|NCT02992743|561213297|FG001|Overall Study|Withdrawal by Subject|1|||
155488836|NCT02992743|561213296|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
155488837|NCT02992743|561213297|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
155488838|NCT02992743|561213296|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
155488839|NCT02992743|561213297|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
155488840|NCT02992743|561213296|FG000|Overall Study|No measurable disease|1|||
155488841|NCT02992743|561213297|FG001|Overall Study|No measurable disease|0|||
155488842|NCT02992743|561213296|FG000|Overall Study|Lost to Follow-up|0|||
155488843|NCT02992743|561213297|FG001|Overall Study|Lost to Follow-up|1|||
155488844|NCT00761735|561213298|FG000|Overall Study|Lost to Follow-up|6|||
155488845|NCT00761735|561213298|FG000|Overall Study|Withdrawal by Subject|6|||
155488846|NCT00761735|561213298|FG000|Overall Study|Non-compliance with protocol|1|||
155488847|NCT00761735|561213298|FG000|Overall Study|Administrative|1|||
155488848|NCT00381680|561213299|FG000|Overall Study|Adverse Event|9|||
155488849|NCT00381680|561213300|FG001|Overall Study|Adverse Event|3|||
155488850|NCT00381680|561213299|FG000|Overall Study|Death|10|||
155488851|NCT00381680|561213300|FG001|Overall Study|Death|7|||
155488852|NCT00381680|561213299|FG000|Overall Study|Lost to Follow-up|3|||
155488853|NCT00381680|561213300|FG001|Overall Study|Lost to Follow-up|2|||
155488854|NCT00381680|561213299|FG000|Overall Study|Physician Decision|25|||
155488855|NCT00381680|561213300|FG001|Overall Study|Physician Decision|6|||
155488856|NCT00381680|561213299|FG000|Overall Study|Withdrawal by Subject|3|||
155488857|NCT00381680|561213300|FG001|Overall Study|Withdrawal by Subject|1|||
155488858|NCT00381680|561213299|FG000|Overall Study|Entry onto another COG Trial|1|||
155488859|NCT00381680|561213300|FG001|Overall Study|Entry onto another COG Trial|2|||
155488860|NCT00381680|561213299|FG000|Overall Study|Alternative Therapy|11|||
155488861|NCT00381680|561213300|FG001|Overall Study|Alternative Therapy|5|||
155488862|NCT00381680|561213299|FG000|Overall Study|Secondary Malignancy|3|||
155488863|NCT00381680|561213300|FG001|Overall Study|Secondary Malignancy|0|||
155488864|NCT00381680|561213299|FG000|Overall Study|Delay initiation|1|||
155488865|NCT00381680|561213300|FG001|Overall Study|Delay initiation|0|||
155488866|NCT00381680|561213299|FG000|Overall Study|Stem Cell Transplant|26|||
155488867|NCT00381680|561213300|FG001|Overall Study|Stem Cell Transplant|10|||
155488868|NCT00381680|561213299|FG000|Overall Study|Relapse|18|||
155488869|NCT00381680|561213300|FG001|Overall Study|Relapse|9|||
155488870|NCT00381680|561213299|FG000|Overall Study|Induction Failure|4|||
155488871|NCT00381680|561213300|FG001|Overall Study|Induction Failure|1|||
155488872|NCT00381680|561213299|FG000|Overall Study|Progression|1|||
155488873|NCT00381680|561213300|FG001|Overall Study|Progression|1|||
155543950|NCT00108082|561417343|FG002|Overall Study|Site Closed Study|0|||
155488874|NCT00381680|561213299|FG000|Overall Study|Other not otherwise specified|7|||
155488875|NCT00381680|561213300|FG001|Overall Study|Other not otherwise specified|2|||
155488876|NCT00381680|561213299|FG000|Overall Study|Ineligible|3|||
155488877|NCT00381680|561213300|FG001|Overall Study|Ineligible|1|||
155488878|NCT00998166|561213303|FG000|Overall Study|Early Study Termination|8|||
155488879|NCT00450814|561213306|FG000|Overall Study|Failed to complete the initial therapy|0|||
155488880|NCT00450814|561213307|FG001|Overall Study|Failed to complete the initial therapy|0|||
155488881|NCT00450814|561213308|FG002|Overall Study|Failed to complete the initial therapy|0|||
155488882|NCT00450814|561213309|FG003|Overall Study|Failed to complete the initial therapy|1|||
155488883|NCT00450814|561213310|FG004|Overall Study|Failed to complete the initial therapy|1|||
155488884|NCT00450814|561213311|FG005|Overall Study|Failed to complete the initial therapy|1|||
155488885|NCT00450814|561213312|FG006|Overall Study|Failed to complete the initial therapy|0|||
155488886|NCT00450814|561213313|FG007|Overall Study|Failed to complete the initial therapy|0|||
155488887|NCT00450814|561213314|FG008|Overall Study|Failed to complete the initial therapy|0|||
155488888|NCT00450814|561213315|FG009|Overall Study|Failed to complete the initial therapy|0|||
155488889|NCT00450814|561213316|FG010|Overall Study|Failed to complete the initial therapy|0|||
155488890|NCT00450814|561213306|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
155488891|NCT00450814|561213307|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
155488892|NCT00450814|561213308|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
155488893|NCT00450814|561213309|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
155488894|NCT00450814|561213310|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
155488895|NCT00450814|561213311|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
155488896|NCT00450814|561213312|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
155488897|NCT00450814|561213313|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
155488898|NCT00450814|561213314|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
155488899|NCT00450814|561213315|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
155488900|NCT00450814|561213316|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
155488901|NCT03602976|561213319|FG000|Overall Study|Withdrawal by Subject|1|||
155488902|NCT04837807|561213320|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
155488903|NCT04837807|561213321|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
155488904|NCT03732534|561213322|FG000|Overall Study|Study terminated by Sponsor|6|||
155488905|NCT03735849|561213323|FG000|Overall Study|Lost to Follow-up|1|||
155488906|NCT03735849|561213324|FG001|Overall Study|Lost to Follow-up|0|||
155488907|NCT03735849|561213325|FG002|Overall Study|Lost to Follow-up|0|||
155488908|NCT03735849|561213323|FG000|Overall Study|Participant unable to adhere to visit|1|||
155488909|NCT03735849|561213324|FG001|Overall Study|Participant unable to adhere to visit|0|||
155488910|NCT03735849|561213325|FG002|Overall Study|Participant unable to adhere to visit|0|||
155488911|NCT03735849|561213323|FG000|Overall Study|Not Randomized|0|||
155488912|NCT03735849|561213324|FG001|Overall Study|Not Randomized|0|||
155488913|NCT03735849|561213325|FG002|Overall Study|Not Randomized|4|||
155488914|NCT03125382|561213328|FG000|Randomization|screening failure|1|||
155488915|NCT03125382|561213329|FG001|Randomization|screening failure|4|||
155488916|NCT03125382|561213330|FG002|Randomization|screening failure|2|||
155488917|NCT03125382|561213331|FG003|Randomization|screening failure|0|||
155488918|NCT03125382|561213328|FG000|Follow-up|Death|1|||
155488919|NCT03125382|561213329|FG001|Follow-up|Death|2|||
155488920|NCT03125382|561213330|FG002|Follow-up|Death|1|||
155488921|NCT03125382|561213331|FG003|Follow-up|Death|2|||
155488922|NCT03125382|561213328|FG000|Follow-up|Lost to Follow-up|1|||
155488923|NCT03125382|561213329|FG001|Follow-up|Lost to Follow-up|4|||
155488924|NCT03125382|561213330|FG002|Follow-up|Lost to Follow-up|3|||
155488925|NCT03125382|561213331|FG003|Follow-up|Lost to Follow-up|1|||
155488926|NCT00612456|561213332|FG000|Overall Study|Adverse Event|1|||
155488927|NCT00612456|561213333|FG001|Overall Study|Adverse Event|0|||
155488928|NCT00612456|561213334|FG002|Overall Study|Adverse Event|0|||
155488929|NCT00612456|561213332|FG000|Overall Study|Lack of Efficacy|1|||
155488930|NCT00612456|561213333|FG001|Overall Study|Lack of Efficacy|1|||
155488931|NCT00612456|561213334|FG002|Overall Study|Lack of Efficacy|0|||
155488932|NCT00612456|561213332|FG000|Overall Study|Withdrawal by Subject|0|||
155488933|NCT00612456|561213333|FG001|Overall Study|Withdrawal by Subject|1|||
155488934|NCT00612456|561213334|FG002|Overall Study|Withdrawal by Subject|0|||
155488935|NCT03907072|561213335|FG000|Overall Study|Study Terminated by Sponsor|2|||
155488936|NCT03907072|561213336|FG001|Overall Study|Study Terminated by Sponsor|2|||
155488937|NCT03907072|561213337|FG002|Overall Study|Study Terminated by Sponsor|2|||
155488938|NCT02463097|561213338|FG000|Overall Study|Withdrawal by Subject|1|||
155488939|NCT03326323|561213339|FG000|Overall Study|Unable to receive ANH protocol|3|||
155488940|NCT03556202|561213346|FG000|Extension Treatment Period|Adverse Event|18|||
155488941|NCT03556202|561213347|FG001|Extension Treatment Period|Adverse Event|14|||
155488942|NCT03556202|561213348|FG002|Extension Treatment Period|Adverse Event|9|||
155488943|NCT03556202|561213346|FG000|Extension Treatment Period|Death|2|||
155488944|NCT03556202|561213347|FG001|Extension Treatment Period|Death|6|||
155488945|NCT03556202|561213348|FG002|Extension Treatment Period|Death|0|||
155488946|NCT03556202|561213346|FG000|Extension Treatment Period|Lack of Efficacy|5|||
155488947|NCT03556202|561213347|FG001|Extension Treatment Period|Lack of Efficacy|12|||
155488948|NCT03556202|561213348|FG002|Extension Treatment Period|Lack of Efficacy|18|||
155488949|NCT03556202|561213346|FG000|Extension Treatment Period|Lost to Follow-up|9|||
155488950|NCT03556202|561213347|FG001|Extension Treatment Period|Lost to Follow-up|20|||
155488951|NCT03556202|561213348|FG002|Extension Treatment Period|Lost to Follow-up|2|||
155488952|NCT03556202|561213346|FG000|Extension Treatment Period|Pregnancy|2|||
155488953|NCT03556202|561213347|FG001|Extension Treatment Period|Pregnancy|4|||
155488954|NCT03556202|561213348|FG002|Extension Treatment Period|Pregnancy|3|||
155488955|NCT03556202|561213346|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
155488956|NCT03556202|561213347|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
155488957|NCT03556202|561213348|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
155488958|NCT03556202|561213346|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
155488959|NCT03556202|561213347|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
155488960|NCT03556202|561213348|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
155488961|NCT03556202|561213346|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
155488962|NCT03556202|561213347|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
155488963|NCT03556202|561213348|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
155488964|NCT03556202|561213346|FG000|Extension Treatment Period|Physician Decision|0|||
155543951|NCT00108082|561417341|FG000|Overall Study|Protocol Amendment|0|||
155543952|NCT00108082|561417342|FG001|Overall Study|Protocol Amendment|1|||
155488965|NCT03556202|561213347|FG001|Extension Treatment Period|Physician Decision|8|||
155488966|NCT03556202|561213348|FG002|Extension Treatment Period|Physician Decision|2|||
155488967|NCT03556202|561213346|FG000|Extension Treatment Period|Protocol Violation|0|||
155488968|NCT03556202|561213347|FG001|Extension Treatment Period|Protocol Violation|1|||
155488969|NCT03556202|561213348|FG002|Extension Treatment Period|Protocol Violation|1|||
155488970|NCT03556202|561213346|FG000|Extension Treatment Period|Sponsor Decision|0|||
155488971|NCT03556202|561213347|FG001|Extension Treatment Period|Sponsor Decision|1|||
155488972|NCT03556202|561213348|FG002|Extension Treatment Period|Sponsor Decision|0|||
155488973|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
155488974|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
155488975|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
155488976|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Death|1|||
155488977|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Death|0|||
155488978|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Death|0|||
155488979|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
155488980|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
155488981|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
155488982|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
155488983|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
155488984|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
155488985|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
155488986|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
155543953|NCT00108082|561417343|FG002|Overall Study|Protocol Amendment|0|||
155543954|NCT00108082|561417341|FG000|Overall Study|Study Medication Not Tapered|0|||
155543955|NCT00108082|561417342|FG001|Overall Study|Study Medication Not Tapered|1|||
155543956|NCT00108082|561417343|FG002|Overall Study|Study Medication Not Tapered|0|||
155488987|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
155488988|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
155543957|NCT00108082|561417341|FG000|Overall Study|Subject Left Site Location|1|||
155543958|NCT00108082|561417342|FG001|Overall Study|Subject Left Site Location|0|||
155488989|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
155488990|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
155488991|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
155488992|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
155488993|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
155488994|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
155488995|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
155488996|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
155488997|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
155488998|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
155488999|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
155489000|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
155489001|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
155489002|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
155489003|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
155489004|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
155489005|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
155489006|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
155489007|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
155489008|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
155489009|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
155489010|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
155489011|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
155489012|NCT03556202|561213346|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
155489013|NCT03556202|561213347|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
155489014|NCT03556202|561213348|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
155489015|NCT00665002|561213349|FG000|Overall Study|Progression/relapse during treatment|11|||
155489016|NCT00665002|561213349|FG000|Overall Study|Cytogenetic resistance|1|||
155489017|NCT00643851|561213358|FG000|Overall Study|Death|0|||
155489018|NCT00643851|561213359|FG001|Overall Study|Death|1|||
155489019|NCT00643851|561213360|FG002|Overall Study|Death|0|||
155489020|NCT00643851|561213358|FG000|Overall Study|Lack of Efficacy|0|||
155489021|NCT00643851|561213359|FG001|Overall Study|Lack of Efficacy|1|||
155489022|NCT00643851|561213360|FG002|Overall Study|Lack of Efficacy|0|||
155489023|NCT00643851|561213358|FG000|Overall Study|Adverse Event|2|||
155489024|NCT00643851|561213359|FG001|Overall Study|Adverse Event|6|||
155489025|NCT00643851|561213360|FG002|Overall Study|Adverse Event|6|||
155489026|NCT00643851|561213358|FG000|Overall Study|Lost to Follow-up|4|||
155489027|NCT00643851|561213359|FG001|Overall Study|Lost to Follow-up|6|||
155489028|NCT00643851|561213360|FG002|Overall Study|Lost to Follow-up|9|||
155489029|NCT00643851|561213358|FG000|Overall Study|Withdrawal by Subject|8|||
155489030|NCT00643851|561213359|FG001|Overall Study|Withdrawal by Subject|15|||
155489031|NCT00643851|561213360|FG002|Overall Study|Withdrawal by Subject|9|||
155489032|NCT00643851|561213358|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
155489033|NCT00643851|561213359|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
155489034|NCT00643851|561213360|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
155489035|NCT04806334|561213363|FG000|Overall Study|Withdrawal by Subject|1|||
155489036|NCT00660829|561213364|FG000|Overall Study|Adverse Event|3|||
155489037|NCT00660829|561213365|FG001|Overall Study|Adverse Event|4|||
155489038|NCT00660829|561213364|FG000|Overall Study|Lack of Efficacy|2|||
155489039|NCT00660829|561213365|FG001|Overall Study|Lack of Efficacy|3|||
155489040|NCT00660829|561213364|FG000|Overall Study|Non-Compliance|0|||
155489041|NCT00660829|561213365|FG001|Overall Study|Non-Compliance|4|||
155489042|NCT00660829|561213364|FG000|Overall Study|Withdrawal by Subject|1|||
155489043|NCT00660829|561213365|FG001|Overall Study|Withdrawal by Subject|2|||
155489044|NCT00660829|561213364|FG000|Overall Study|Lost to Follow-up|3|||
155489045|NCT00660829|561213365|FG001|Overall Study|Lost to Follow-up|2|||
155489046|NCT00660829|561213364|FG000|Overall Study|Other|9|||
155489047|NCT00660829|561213365|FG001|Overall Study|Other|4|||
155489048|NCT01977573|561213368|FG000|Overall Study|Adverse Event|7|||
155489049|NCT01977573|561213369|FG001|Overall Study|Adverse Event|0|||
155489050|NCT01977573|561213370|FG002|Overall Study|Adverse Event|2|||
155489051|NCT01977573|561213371|FG003|Overall Study|Adverse Event|1|||
155489052|NCT01977573|561213368|FG000|Overall Study|Lost to Follow-up|1|||
155489053|NCT01977573|561213369|FG001|Overall Study|Lost to Follow-up|0|||
155489054|NCT01977573|561213370|FG002|Overall Study|Lost to Follow-up|0|||
155489055|NCT01977573|561213371|FG003|Overall Study|Lost to Follow-up|1|||
155489056|NCT01977573|561213368|FG000|Overall Study|Physician Decision|1|||
155489057|NCT01977573|561213369|FG001|Overall Study|Physician Decision|0|||
155489058|NCT01977573|561213370|FG002|Overall Study|Physician Decision|0|||
155489059|NCT01977573|561213371|FG003|Overall Study|Physician Decision|0|||
155489060|NCT01977573|561213368|FG000|Overall Study|Protocol Violation|3|||
155489061|NCT01977573|561213369|FG001|Overall Study|Protocol Violation|1|||
155489062|NCT01977573|561213370|FG002|Overall Study|Protocol Violation|0|||
155489063|NCT01977573|561213371|FG003|Overall Study|Protocol Violation|0|||
155489064|NCT01977573|561213368|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
155489065|NCT01977573|561213369|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
155489066|NCT01977573|561213370|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
155489067|NCT01977573|561213371|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
155489068|NCT01977573|561213368|FG000|Overall Study|Withdrawal by Subject|6|||
155489069|NCT01977573|561213369|FG001|Overall Study|Withdrawal by Subject|1|||
155489070|NCT01977573|561213370|FG002|Overall Study|Withdrawal by Subject|1|||
155489071|NCT01977573|561213371|FG003|Overall Study|Withdrawal by Subject|1|||
155489072|NCT03044730|561213372|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
155489073|NCT03044730|561213372|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
155489074|NCT03044730|561213372|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
155489075|NCT03044730|561213372|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
155489076|NCT03044730|561213372|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
155489077|NCT03044730|561213372|FG000|Cycles 4 and Beyond|Adverse Event|1|||
155489078|NCT03044730|561213372|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
155489079|NCT03044730|561213372|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
155489080|NCT03044730|561213372|FG000|On Follow-up for 2 Years|Death|17|||
155489081|NCT00934661|561214872|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
155489082|NCT00934661|561214873|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
155489083|NCT01846442|561214875|FG000|Overall Study|Adverse Event|2|||
155489084|NCT01846442|561214876|FG001|Overall Study|Adverse Event|4|||
155489085|NCT01846442|561214877|FG002|Overall Study|Adverse Event|2|||
155489086|NCT01846442|561214878|FG003|Overall Study|Adverse Event|1|||
155489087|NCT01846442|561214875|FG000|Overall Study|Lost to Follow-up|0|||
155489088|NCT01846442|561214876|FG001|Overall Study|Lost to Follow-up|0|||
155489089|NCT01846442|561214877|FG002|Overall Study|Lost to Follow-up|1|||
155489090|NCT01846442|561214878|FG003|Overall Study|Lost to Follow-up|0|||
155489091|NCT01846442|561214875|FG000|Overall Study|Withdrawal by Subject|3|||
155489092|NCT01846442|561214876|FG001|Overall Study|Withdrawal by Subject|2|||
155489093|NCT01846442|561214877|FG002|Overall Study|Withdrawal by Subject|0|||
155489094|NCT01846442|561214878|FG003|Overall Study|Withdrawal by Subject|1|||
155489095|NCT01846442|561214875|FG000|Overall Study|Left the city/Lost medication|1|||
155489096|NCT01846442|561214876|FG001|Overall Study|Left the city/Lost medication|0|||
155489097|NCT01846442|561214877|FG002|Overall Study|Left the city/Lost medication|1|||
155489098|NCT01846442|561214878|FG003|Overall Study|Left the city/Lost medication|1|||
155489099|NCT01013207|561214885|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
155489100|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
155489101|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
155489102|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489103|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489104|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489105|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489106|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155656282|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
155656283|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
155489107|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489108|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489109|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489110|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489111|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155489112|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
155489113|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489114|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489115|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489116|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489117|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489118|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
155489119|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489120|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489121|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489122|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
155489123|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
155489124|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489125|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
155489126|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489127|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489128|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489129|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489130|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489131|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489132|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489133|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489134|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489135|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
155489136|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
155489137|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
155489138|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
155489139|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
155489140|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
155489141|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
155489142|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
155489143|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
155489144|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
155489145|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
155489146|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
155489147|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
155489148|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489149|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489150|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489151|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489152|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489153|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
155489154|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489155|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489156|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489157|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489158|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489159|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
155489160|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489161|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489162|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489163|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489164|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489165|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
155489166|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489167|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489168|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489169|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489170|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155489171|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
155543959|NCT00108082|561417343|FG002|Overall Study|Subject Left Site Location|0|||
155543960|NCT00108082|561417341|FG000|Overall Study|Investigator Not at Site|1|||
155543961|NCT00108082|561417342|FG001|Overall Study|Investigator Not at Site|0|||
155489172|NCT00151775|561214886|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489173|NCT00151775|561214887|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489174|NCT00151775|561214888|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489175|NCT00151775|561214889|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489176|NCT00151775|561214890|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489177|NCT00151775|561214891|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489178|NCT00151775|561214892|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
155489179|NCT00151775|561214893|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489180|NCT00151775|561214894|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489181|NCT00151775|561214895|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489182|NCT00151775|561214896|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489183|NCT00151775|561214897|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
155489184|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489185|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489186|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489187|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489188|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489189|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
155489190|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489191|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489192|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489193|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489194|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489195|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155489196|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
155489197|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
155489198|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
155489199|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
155489200|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
155489201|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
155489202|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
155489203|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
155489204|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
155489205|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
155489206|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
155489207|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
155489208|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489209|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489210|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489211|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489212|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489213|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489214|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
155489215|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489216|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489217|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489218|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489219|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
155489220|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489221|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489222|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
155489223|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489224|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489225|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489226|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489227|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489228|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489229|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489230|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489231|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
155489232|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489233|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489234|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
155489235|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489236|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489237|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489238|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489239|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489240|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489241|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489242|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489243|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
155489244|NCT00151775|561214886|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489245|NCT00151775|561214887|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489246|NCT00151775|561214888|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489247|NCT00151775|561214889|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489248|NCT00151775|561214890|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489249|NCT00151775|561214891|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489250|NCT00151775|561214892|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489251|NCT00151775|561214893|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489252|NCT00151775|561214894|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489253|NCT00151775|561214895|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489254|NCT00151775|561214896|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
155489255|NCT00151775|561214897|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
155489256|NCT00151775|561214886|FG000|Period 4: Open Label|Increased blood pressure|0|||
155489257|NCT00151775|561214887|FG001|Period 4: Open Label|Increased blood pressure|0|||
155489258|NCT00151775|561214888|FG002|Period 4: Open Label|Increased blood pressure|0|||
155489259|NCT00151775|561214889|FG003|Period 4: Open Label|Increased blood pressure|0|||
155489260|NCT00151775|561214890|FG004|Period 4: Open Label|Increased blood pressure|1|||
155489261|NCT00151775|561214891|FG005|Period 4: Open Label|Increased blood pressure|0|||
155489262|NCT00151775|561214892|FG006|Period 4: Open Label|Increased blood pressure|0|||
155489263|NCT00151775|561214893|FG007|Period 4: Open Label|Increased blood pressure|0|||
155489264|NCT00151775|561214894|FG008|Period 4: Open Label|Increased blood pressure|0|||
155489265|NCT00151775|561214895|FG009|Period 4: Open Label|Increased blood pressure|1|||
155489266|NCT00151775|561214896|FG010|Period 4: Open Label|Increased blood pressure|0|||
155489267|NCT00151775|561214897|FG011|Period 4: Open Label|Increased blood pressure|0|||
155489268|NCT00151775|561214886|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
155489269|NCT00151775|561214887|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
155489270|NCT00151775|561214888|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
155489271|NCT00151775|561214889|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
155489272|NCT00151775|561214890|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
155489273|NCT00151775|561214891|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
155489274|NCT00151775|561214892|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
155489275|NCT00151775|561214893|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
155489276|NCT00151775|561214894|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
155489277|NCT00151775|561214895|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
155489278|NCT00151775|561214896|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
155489279|NCT00151775|561214897|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
155489280|NCT00151775|561214886|FG000|Period 4: Open Label|Adverse Event|0|||
155489281|NCT00151775|561214887|FG001|Period 4: Open Label|Adverse Event|0|||
155489282|NCT00151775|561214888|FG002|Period 4: Open Label|Adverse Event|0|||
155489283|NCT00151775|561214889|FG003|Period 4: Open Label|Adverse Event|0|||
155489284|NCT00151775|561214890|FG004|Period 4: Open Label|Adverse Event|1|||
155489285|NCT00151775|561214891|FG005|Period 4: Open Label|Adverse Event|0|||
155489286|NCT00151775|561214892|FG006|Period 4: Open Label|Adverse Event|0|||
155489287|NCT00151775|561214893|FG007|Period 4: Open Label|Adverse Event|0|||
155489288|NCT00151775|561214894|FG008|Period 4: Open Label|Adverse Event|0|||
155489289|NCT00151775|561214895|FG009|Period 4: Open Label|Adverse Event|2|||
155489290|NCT00151775|561214896|FG010|Period 4: Open Label|Adverse Event|0|||
155543962|NCT00108082|561417343|FG002|Overall Study|Investigator Not at Site|0|||
155543963|NCT00108082|561417341|FG000|Overall Study|Blood Pressure Not Controlled|1|||
155543964|NCT00108082|561417342|FG001|Overall Study|Blood Pressure Not Controlled|0|||
155543965|NCT00108082|561417343|FG002|Overall Study|Blood Pressure Not Controlled|0|||
155543966|NCT02940730|561417347|FG000|Intervention 2|Physician Decision|7|||
155543967|NCT02940730|561417348|FG001|Intervention 2|Physician Decision|0|||
155543968|NCT01064531|561417349|FG000|Overall Study|Lost to Follow-up|0|||
155489291|NCT00151775|561214897|FG011|Period 4: Open Label|Adverse Event|0|||
155489292|NCT00151775|561214886|FG000|Period 4: Open Label|Lost to Follow-up|0|||
155489293|NCT00151775|561214887|FG001|Period 4: Open Label|Lost to Follow-up|0|||
155489294|NCT00151775|561214888|FG002|Period 4: Open Label|Lost to Follow-up|0|||
155489295|NCT00151775|561214889|FG003|Period 4: Open Label|Lost to Follow-up|0|||
155489296|NCT00151775|561214890|FG004|Period 4: Open Label|Lost to Follow-up|17|||
155489297|NCT00151775|561214891|FG005|Period 4: Open Label|Lost to Follow-up|0|||
155489298|NCT00151775|561214892|FG006|Period 4: Open Label|Lost to Follow-up|0|||
155489299|NCT00151775|561214893|FG007|Period 4: Open Label|Lost to Follow-up|0|||
155489300|NCT00151775|561214894|FG008|Period 4: Open Label|Lost to Follow-up|0|||
155489301|NCT00151775|561214895|FG009|Period 4: Open Label|Lost to Follow-up|7|||
155489302|NCT00151775|561214896|FG010|Period 4: Open Label|Lost to Follow-up|0|||
155489303|NCT00151775|561214897|FG011|Period 4: Open Label|Lost to Follow-up|0|||
155489304|NCT00151775|561214886|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
155489305|NCT00151775|561214887|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
155489306|NCT00151775|561214888|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
155489307|NCT00151775|561214889|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
155489308|NCT00151775|561214890|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
155489309|NCT00151775|561214891|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
155489310|NCT00151775|561214892|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
155489311|NCT00151775|561214893|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
155489312|NCT00151775|561214894|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
155489313|NCT00151775|561214895|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
155489314|NCT00151775|561214896|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
155489315|NCT00151775|561214897|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
155489316|NCT00151775|561214886|FG000|Period 4: Open Label|Other|0|||
155489317|NCT00151775|561214887|FG001|Period 4: Open Label|Other|0|||
155489318|NCT00151775|561214888|FG002|Period 4: Open Label|Other|0|||
155489319|NCT00151775|561214889|FG003|Period 4: Open Label|Other|0|||
155489320|NCT00151775|561214890|FG004|Period 4: Open Label|Other|1|||
155489321|NCT00151775|561214891|FG005|Period 4: Open Label|Other|0|||
155489322|NCT00151775|561214892|FG006|Period 4: Open Label|Other|0|||
155489323|NCT00151775|561214893|FG007|Period 4: Open Label|Other|0|||
155489324|NCT00151775|561214894|FG008|Period 4: Open Label|Other|0|||
155543969|NCT01064531|561417350|FG001|Overall Study|Lost to Follow-up|2|||
155543970|NCT01064531|561417349|FG000|Overall Study|Physician Decision|0|||
155543971|NCT01064531|561417350|FG001|Overall Study|Physician Decision|1|||
155543972|NCT01064531|561417349|FG000|Overall Study|Withdrawal by Subject|2|||
155543973|NCT01064531|561417350|FG001|Overall Study|Withdrawal by Subject|2|||
155543974|NCT01064531|561417349|FG000|Overall Study|Revision due to femoral stem loosening|1|||
155543975|NCT01064531|561417350|FG001|Overall Study|Revision due to femoral stem loosening|0|||
155543976|NCT01064531|561417349|FG000|Overall Study|Revision due to dislocation|0|||
155543977|NCT01064531|561417350|FG001|Overall Study|Revision due to dislocation|1|||
155543978|NCT01064531|561417349|FG000|Overall Study|Death|0|||
155543979|NCT01064531|561417350|FG001|Overall Study|Death|1|||
155543980|NCT01201759|561417351|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
155543981|NCT01201759|561417352|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
155656284|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
155489325|NCT00151775|561214895|FG009|Period 4: Open Label|Other|3|||
155489326|NCT00151775|561214896|FG010|Period 4: Open Label|Other|0|||
155489327|NCT00151775|561214897|FG011|Period 4: Open Label|Other|0|||
155489328|NCT00151775|561214886|FG000|Period 4: Open Label|Physician Decision|0|||
155489329|NCT00151775|561214887|FG001|Period 4: Open Label|Physician Decision|0|||
155489330|NCT00151775|561214888|FG002|Period 4: Open Label|Physician Decision|0|||
155489331|NCT00151775|561214889|FG003|Period 4: Open Label|Physician Decision|0|||
155489332|NCT00151775|561214890|FG004|Period 4: Open Label|Physician Decision|0|||
155489333|NCT00151775|561214891|FG005|Period 4: Open Label|Physician Decision|0|||
155489334|NCT00151775|561214892|FG006|Period 4: Open Label|Physician Decision|0|||
155489335|NCT00151775|561214893|FG007|Period 4: Open Label|Physician Decision|0|||
155489336|NCT00151775|561214894|FG008|Period 4: Open Label|Physician Decision|0|||
155489337|NCT00151775|561214895|FG009|Period 4: Open Label|Physician Decision|2|||
155489338|NCT00151775|561214896|FG010|Period 4: Open Label|Physician Decision|0|||
155489339|NCT00151775|561214897|FG011|Period 4: Open Label|Physician Decision|0|||
155489340|NCT00151775|561214886|FG000|Period 4: Open Label|Protocol Violation|0|||
155489341|NCT00151775|561214887|FG001|Period 4: Open Label|Protocol Violation|0|||
155489342|NCT00151775|561214888|FG002|Period 4: Open Label|Protocol Violation|0|||
155489343|NCT00151775|561214889|FG003|Period 4: Open Label|Protocol Violation|0|||
155489344|NCT00151775|561214890|FG004|Period 4: Open Label|Protocol Violation|1|||
155489345|NCT00151775|561214891|FG005|Period 4: Open Label|Protocol Violation|0|||
155489346|NCT00151775|561214892|FG006|Period 4: Open Label|Protocol Violation|0|||
155489347|NCT00151775|561214893|FG007|Period 4: Open Label|Protocol Violation|0|||
155489348|NCT00151775|561214894|FG008|Period 4: Open Label|Protocol Violation|0|||
155489349|NCT00151775|561214895|FG009|Period 4: Open Label|Protocol Violation|0|||
155489350|NCT00151775|561214896|FG010|Period 4: Open Label|Protocol Violation|0|||
155489351|NCT00151775|561214897|FG011|Period 4: Open Label|Protocol Violation|0|||
155489352|NCT00247416|561214898|FG000|Overall Study|3 patients were found to be ineligible|1|||
155489353|NCT00247416|561214899|FG001|Overall Study|3 patients were found to be ineligible|2|||
155489354|NCT02660489|561214900|FG000|Overall Study|Lost to Follow-up|1|||
155489355|NCT02660489|561214901|FG001|Overall Study|Lost to Follow-up|1|||
155489356|NCT02660489|561214900|FG000|Overall Study|Adverse Event|1|||
155489357|NCT02660489|561214901|FG001|Overall Study|Adverse Event|3|||
155489358|NCT02660489|561214900|FG000|Overall Study|no rhinovirus infection|4|||
155489359|NCT02660489|561214901|FG001|Overall Study|no rhinovirus infection|4|||
155489360|NCT00474994|561214902|FG000|Overall Study|Patient Not treated|1|||
155489361|NCT00474994|561214902|FG000|Overall Study|Patient evaluable for toxicity only|3|||
155489362|NCT00474994|561214902|FG000|Overall Study|Patient found to be ineligible|1|||
155489363|NCT00278473|561214903|FG000|Overall Study|drop out|4|||
155489364|NCT00278473|561214904|FG001|Overall Study|drop out|3|||
155489365|NCT02322866|561214905|FG000|Overall Study|Adverse Event|6|||
155489366|NCT02322866|561214906|FG001|Overall Study|Adverse Event|11|||
155489367|NCT02322866|561214905|FG000|Overall Study|Withdrawal of Consent|16|||
155489368|NCT02322866|561214906|FG001|Overall Study|Withdrawal of Consent|25|||
155489369|NCT02322866|561214905|FG000|Overall Study|Lost to Follow-up|36|||
155489370|NCT02322866|561214906|FG001|Overall Study|Lost to Follow-up|39|||
155489371|NCT02322866|561214905|FG000|Overall Study|Protocol Violation|1|||
155489372|NCT02322866|561214906|FG001|Overall Study|Protocol Violation|0|||
155489373|NCT02322866|561214905|FG000|Overall Study|Noncompliance with Treatment|3|||
155489374|NCT02322866|561214906|FG001|Overall Study|Noncompliance with Treatment|4|||
155489375|NCT02322866|561214905|FG000|Overall Study|Lack of Efficacy|3|||
155489376|NCT02322866|561214906|FG001|Overall Study|Lack of Efficacy|1|||
155489377|NCT02322866|561214905|FG000|Overall Study|Other Miscellaneous Reasons|6|||
155489378|NCT02322866|561214906|FG001|Overall Study|Other Miscellaneous Reasons|6|||
155489379|NCT03735680|561214907|FG000|Overall Study|Withdrawal by Subject|0|||
155489380|NCT03735680|561214908|FG001|Overall Study|Withdrawal by Subject|1|||
155489381|NCT03735680|561214909|FG002|Overall Study|Withdrawal by Subject|0|||
155489382|NCT03735680|561214910|FG003|Overall Study|Withdrawal by Subject|0|||
155489383|NCT03735680|561214911|FG004|Overall Study|Withdrawal by Subject|0|||
155489384|NCT03735680|561214912|FG005|Overall Study|Withdrawal by Subject|1|||
155489385|NCT03735680|561214907|FG000|Overall Study|Patient unable or unwilling to continue|0|||
155489386|NCT03735680|561214908|FG001|Overall Study|Patient unable or unwilling to continue|0|||
155489387|NCT03735680|561214909|FG002|Overall Study|Patient unable or unwilling to continue|1|||
155489388|NCT03735680|561214910|FG003|Overall Study|Patient unable or unwilling to continue|0|||
155489389|NCT03735680|561214911|FG004|Overall Study|Patient unable or unwilling to continue|0|||
155489390|NCT03735680|561214912|FG005|Overall Study|Patient unable or unwilling to continue|0|||
155489391|NCT00761761|561214920|FG000|Overall Study|Lost to Follow-up|3|||
155489392|NCT00761761|561214921|FG001|Overall Study|Lost to Follow-up|1|||
155489393|NCT00761761|561214920|FG000|Overall Study|Withdrawal by Subject|3|||
155489394|NCT00761761|561214921|FG001|Overall Study|Withdrawal by Subject|0|||
155489395|NCT05064436|561214926|FG000|Overall Study|Other Reasons|1|||
155489396|NCT05064436|561214927|FG001|Overall Study|Other Reasons|0|||
155489397|NCT01711736|561214928|FG000|Overall Study|Lost to Follow-up|4|||
155489398|NCT01711736|561214929|FG001|Overall Study|Lost to Follow-up|1|||
155489399|NCT01711736|561214928|FG000|Overall Study|Withdrawal by Subject|6|||
155489400|NCT01711736|561214929|FG001|Overall Study|Withdrawal by Subject|6|||
155489401|NCT01711736|561214928|FG000|Overall Study|Migrated/moved from study area|2|||
155489402|NCT01711736|561214929|FG001|Overall Study|Migrated/moved from study area|1|||
155489403|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Adverse Event|4|||
155489404|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Adverse Event|3|||
155489405|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Adverse Event|0|||
155489406|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Adverse Event|0|||
155489407|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Death|24|||
155489408|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Death|9|||
155489409|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Death|0|||
155489410|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Death|0|||
155489411|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
155489412|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
155489413|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
155489414|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
155489415|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Physician Decision|4|||
155489416|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Physician Decision|1|||
155489417|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Physician Decision|0|||
155489418|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Physician Decision|0|||
155489419|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Progressive disease|1|||
155489420|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Progressive disease|0|||
155489421|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Progressive disease|0|||
155489422|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Progressive disease|0|||
155489423|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
155489424|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
155489425|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
155489426|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
155489427|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
155489428|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
155489429|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
155489430|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
155489431|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
155489432|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
155489433|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
155489434|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
155489435|NCT04579666|561214930|FG000|RTP (Up to Week 52)|Other|2|||
155489436|NCT04579666|561214931|FG001|RTP (Up to Week 52)|Other|0|||
155489437|NCT04579666|561214932|FG002|RTP (Up to Week 52)|Other|0|||
155489438|NCT04579666|561214933|FG003|RTP (Up to Week 52)|Other|0|||
155489439|NCT04579666|561214930|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
155489440|NCT04579666|561214931|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
155489441|NCT04579666|561214932|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
155489442|NCT04579666|561214933|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
155489443|NCT04579666|561214930|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
155489444|NCT04579666|561214931|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
155489445|NCT04579666|561214932|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
155489446|NCT04579666|561214933|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
155489447|NCT04579666|561214930|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
155489448|NCT04579666|561214931|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
155489449|NCT04579666|561214932|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
155489450|NCT04579666|561214933|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
155489451|NCT04579666|561214930|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
155489452|NCT04579666|561214931|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
155489453|NCT04579666|561214932|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
155489454|NCT04579666|561214933|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
155489455|NCT04579666|561214930|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
155489456|NCT04579666|561214931|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
155489457|NCT04579666|561214932|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
155489458|NCT04579666|561214933|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
155489459|NCT03290131|561214934|FG000|Overall Study|Adverse Event|22|||
155489460|NCT03290131|561214935|FG001|Overall Study|Adverse Event|57|||
155489461|NCT03290131|561214936|FG002|Overall Study|Adverse Event|11|||
155489462|NCT03290131|561214934|FG000|Overall Study|Withdrawal by Subject|18|||
155489463|NCT03290131|561214935|FG001|Overall Study|Withdrawal by Subject|13|||
155489464|NCT03290131|561214936|FG002|Overall Study|Withdrawal by Subject|8|||
155489465|NCT03290131|561214934|FG000|Overall Study|MS Relapse|2|||
155489466|NCT03290131|561214935|FG001|Overall Study|MS Relapse|1|||
155489467|NCT03290131|561214936|FG002|Overall Study|MS Relapse|0|||
155489468|NCT03290131|561214934|FG000|Overall Study|Unknown reason|0|||
155489469|NCT03290131|561214935|FG001|Overall Study|Unknown reason|1|||
155489470|NCT03290131|561214936|FG002|Overall Study|Unknown reason|0|||
155489471|NCT03099096|561214937|FG000|Overall Study|Adverse Event|1|||
155489472|NCT03099096|561214937|FG000|Overall Study|Physician Decision|1|||
155489473|NCT00361504|561214938|FG000|Overall Study|Withdrawal by Subject|94|||
155489474|NCT00361504|561214939|FG001|Overall Study|Withdrawal by Subject|31|||
155489475|NCT00361504|561214938|FG000|Overall Study|Lost to Follow-up|40|||
155489476|NCT00361504|561214939|FG001|Overall Study|Lost to Follow-up|7|||
155489477|NCT00361504|561214938|FG000|Overall Study|Adverse Event|203|||
155489478|NCT00361504|561214939|FG001|Overall Study|Adverse Event|82|||
155489479|NCT00361504|561214938|FG000|Overall Study|Lack of Efficacy|72|||
155489480|NCT00361504|561214939|FG001|Overall Study|Lack of Efficacy|7|||
155489481|NCT00361504|561214938|FG000|Overall Study|Resolution of Pain|2|||
155489482|NCT00361504|561214939|FG001|Overall Study|Resolution of Pain|0|||
155489483|NCT00361504|561214938|FG000|Overall Study|Study medication non compliant|42|||
155489484|NCT00361504|561214939|FG001|Overall Study|Study medication non compliant|15|||
155489485|NCT00361504|561214938|FG000|Overall Study|All other|28|||
155489486|NCT00361504|561214939|FG001|Overall Study|All other|3|||
155489487|NCT01374516|561214940|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
155489488|NCT01374516|561214941|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
155489489|NCT01374516|561214940|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
155489490|NCT01374516|561214941|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
155489491|NCT01374516|561214940|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
155489492|NCT01374516|561214941|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
155489493|NCT01374516|561214940|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
155489494|NCT01374516|561214941|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
155489495|NCT01374516|561214940|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
155489496|NCT01374516|561214941|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
155489497|NCT01374516|561214940|FG000|Surveillance Expansion Period|Protocol Violation|386|||
155489498|NCT01374516|561214941|FG001|Surveillance Expansion Period|Protocol Violation|217|||
155489499|NCT01374516|561214940|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
155489500|NCT01374516|561214941|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
155489501|NCT01374516|561214940|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
155489502|NCT01374516|561214941|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
155489503|NCT01374516|561214940|FG000|Surveillance Expansion Period|Serious adverse event|20|||
155489504|NCT01374516|561214941|FG001|Surveillance Expansion Period|Serious adverse event|5|||
155489505|NCT02190604|561214948|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489506|NCT02190604|561214949|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489507|NCT02190604|561214950|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489508|NCT02190604|561214951|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489509|NCT02190604|561214952|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489510|NCT02190604|561214953|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489511|NCT02190604|561214954|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489512|NCT02190604|561214955|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489513|NCT02190604|561214956|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489514|NCT02190604|561214957|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489515|NCT02190604|561214958|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489516|NCT02190604|561214959|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489517|NCT02190604|561214960|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489518|NCT02190604|561214961|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489519|NCT02190604|561214962|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
155489520|NCT02190604|561214963|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489521|NCT02190604|561214964|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489522|NCT02190604|561214965|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489523|NCT02190604|561214966|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
155489524|NCT02190604|561214948|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489525|NCT02190604|561214949|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489526|NCT02190604|561214950|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489527|NCT02190604|561214951|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489528|NCT02190604|561214952|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489529|NCT02190604|561214953|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489530|NCT02190604|561214954|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489531|NCT02190604|561214955|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489532|NCT02190604|561214956|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489533|NCT02190604|561214957|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489534|NCT02190604|561214958|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489535|NCT02190604|561214959|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489536|NCT02190604|561214960|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489537|NCT02190604|561214961|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
155489538|NCT02190604|561214962|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489539|NCT02190604|561214963|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489540|NCT02190604|561214964|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489541|NCT02190604|561214965|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489542|NCT02190604|561214966|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
155489543|NCT02797951|561214967|FG000|Overall Study|Adverse Event|4|||
155489544|NCT02797951|561214967|FG000|Overall Study|Death|1|||
155489545|NCT02797951|561214967|FG000|Overall Study|Lack of Efficacy|19|||
155489546|NCT02797951|561214967|FG000|Overall Study|Lost to Follow-up|4|||
155489547|NCT02797951|561214967|FG000|Overall Study|Physician Decision|6|||
155489548|NCT02797951|561214967|FG000|Overall Study|Withdrawal by Subject|15|||
155489549|NCT00814502|561214968|FG000|Overall Study|Adverse Event|1|||
155489550|NCT00814502|561214969|FG001|Overall Study|Adverse Event|0|||
155489551|NCT00814502|561214968|FG000|Overall Study|Withdrawal by Subject|0|||
155489552|NCT00814502|561214969|FG001|Overall Study|Withdrawal by Subject|2|||
155543982|NCT01201759|561417351|FG000|Visit 3 - Washout|Adverse Event|0|||
155543983|NCT01201759|561417352|FG001|Visit 3 - Washout|Adverse Event|3|||
155543984|NCT01201759|561417351|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
155543985|NCT01201759|561417352|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
155543986|NCT01201759|561417351|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
155543987|NCT01201759|561417352|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
155543988|NCT00906373|561417353|FG000|Overall Study|Withdrawal by Subject|0|||
155543989|NCT00906373|561417354|FG001|Overall Study|Withdrawal by Subject|5|||
155543990|NCT00906373|561417353|FG000|Overall Study|Other|0|||
155543991|NCT00906373|561417354|FG001|Overall Study|Other|1|||
155543992|NCT00906373|561417353|FG000|Overall Study|Still on treatment at cutoff date|0|||
155543993|NCT00906373|561417354|FG001|Overall Study|Still on treatment at cutoff date|2|||
155543994|NCT02780167|561417355|FG000|Overall Study|Adverse Event|9|||
155543995|NCT02780167|561417356|FG001|Overall Study|Adverse Event|8|||
155543996|NCT02780167|561417357|FG002|Overall Study|Adverse Event|8|||
155543997|NCT02780167|561417358|FG003|Overall Study|Adverse Event|12|||
155543998|NCT02780167|561417359|FG004|Overall Study|Adverse Event|8|||
155543999|NCT02780167|561417355|FG000|Overall Study|Lack of Efficacy|6|||
155544000|NCT02780167|561417356|FG001|Overall Study|Lack of Efficacy|5|||
155544001|NCT02780167|561417357|FG002|Overall Study|Lack of Efficacy|6|||
155489553|NCT01901393|561214970|FG000|Overall Study|Adverse Event|1|||
155489554|NCT01901393|561214971|FG001|Overall Study|Adverse Event|0|||
155489555|NCT00265109|561214978|FG000|Overall Study|Withdrawal by Subject|5|||
155489556|NCT00265109|561214978|FG000|Overall Study|Adverse Event|1|||
155489557|NCT01757821|561214979|FG000|Overall Study|Adverse Event|1|||
155489558|NCT00499694|561214982|FG000|Overall Study|Patient never received treatment.|1|||
155489559|NCT03604159|561214987|FG000|Overall Study|Lost to Follow-up|6|||
155489560|NCT03604159|561214988|FG001|Overall Study|Lost to Follow-up|7|||
155489561|NCT02243306|561214995|FG000|Overall Study|Adverse Event|0|||
155489562|NCT02243306|561214996|FG001|Overall Study|Adverse Event|1|||
155489563|NCT02243306|561214995|FG000|Overall Study|Other: Reached stopping criteria|0|||
155489564|NCT02243306|561214996|FG001|Overall Study|Other: Reached stopping criteria|1|||
155489565|NCT02243306|561214995|FG000|Overall Study|Physician Decision|0|||
155489566|NCT02243306|561214996|FG001|Overall Study|Physician Decision|1|||
155489567|NCT04768881|561215001|FG000|Overall Study|Completed Study Follow-up|0|||
155489568|NCT04768881|561215002|FG001|Overall Study|Completed Study Follow-up|2|||
155489569|NCT04768881|561215001|FG000|Overall Study|Death|3|||
155489570|NCT04768881|561215002|FG001|Overall Study|Death|2|||
155489571|NCT04768881|561215001|FG000|Overall Study|Study Terminated by Sponsor|2|||
155489572|NCT04768881|561215002|FG001|Overall Study|Study Terminated by Sponsor|2|||
155489573|NCT04768881|561215001|FG000|Overall Study|Withdrawal by Subject|2|||
155489574|NCT04768881|561215002|FG001|Overall Study|Withdrawal by Subject|0|||
155489575|NCT04768881|561215001|FG000|Overall Study|Other|2|||
155489576|NCT04768881|561215002|FG001|Overall Study|Other|0|||
155489577|NCT04236986|561215005|FG000|Overall Study|Withdrawal by Subject|3|||
155489578|NCT04236986|561215006|FG001|Overall Study|Withdrawal by Subject|1|||
155489579|NCT00307736|561215009|FG000|Overall Study|Adverse Event|0|||
155489580|NCT00307736|561215010|FG001|Overall Study|Adverse Event|0|||
155489581|NCT00307736|561215011|FG002|Overall Study|Adverse Event|1|||
155489582|NCT00307736|561215012|FG003|Overall Study|Adverse Event|3|||
155489583|NCT00307736|561215009|FG000|Overall Study|Withdrawal by Subject|0|||
155489584|NCT00307736|561215010|FG001|Overall Study|Withdrawal by Subject|0|||
155489585|NCT00307736|561215011|FG002|Overall Study|Withdrawal by Subject|2|||
155489586|NCT00307736|561215012|FG003|Overall Study|Withdrawal by Subject|0|||
155489587|NCT01365182|561215015|FG000|Overall Study|Withdrawal by Subject|10|||
155489588|NCT01365182|561215016|FG001|Overall Study|Withdrawal by Subject|13|||
155489589|NCT01365182|561215017|FG002|Overall Study|Withdrawal by Subject|12|||
155489590|NCT01990339|561215022|FG000|Overall Study|Data Not Available|49|||
155489591|NCT01990339|561215022|FG000|Overall Study|Voluntary Withdrawal|1402|||
155489592|NCT01990339|561215022|FG000|Overall Study|Lost to Follow-up|861|||
155489593|NCT01728194|561215023|FG000|Overall Study|Lost to Follow-up|4|||
155489594|NCT01728194|561215024|FG001|Overall Study|Lost to Follow-up|3|||
155489595|NCT01728194|561215023|FG000|Overall Study|Physician Decision|4|||
155489596|NCT01728194|561215024|FG001|Overall Study|Physician Decision|0|||
155489597|NCT01728194|561215023|FG000|Overall Study|Withdrawal by Subject|7|||
155489598|NCT01728194|561215024|FG001|Overall Study|Withdrawal by Subject|3|||
155489599|NCT01728194|561215023|FG000|Overall Study|Perceived Medication Side Effects|4|||
155489600|NCT01728194|561215024|FG001|Overall Study|Perceived Medication Side Effects|0|||
155489601|NCT01728194|561215023|FG000|Overall Study|Family Member Request|1|||
155489602|NCT01728194|561215024|FG001|Overall Study|Family Member Request|0|||
155489603|NCT02309372|561215027|FG000|Overall Study|Lost to Follow-up|3|||
155489604|NCT02309372|561215028|FG001|Overall Study|Lost to Follow-up|2|||
155489605|NCT00242658|561215029|FG000|Overall Study|Lost to Follow-up|22|||
155489606|NCT00242658|561215030|FG001|Overall Study|Lost to Follow-up|19|||
155489607|NCT02576652|561215035|FG000|Overall Study|Withdrawal by Subject|2|||
155489608|NCT00553319|561215039|FG000|Overall Study|Lost to Follow-up|10|||
155489609|NCT00553319|561215040|FG001|Overall Study|Lost to Follow-up|9|||
155489610|NCT00553319|561215041|FG002|Overall Study|Lost to Follow-up|5|||
155489611|NCT00553319|561215039|FG000|Overall Study|wanted treatment elsewhere|2|||
155489612|NCT00553319|561215040|FG001|Overall Study|wanted treatment elsewhere|1|||
155489613|NCT00553319|561215041|FG002|Overall Study|wanted treatment elsewhere|1|||
155489614|NCT00553319|561215039|FG000|Overall Study|non-compliance|0|||
155489615|NCT00553319|561215040|FG001|Overall Study|non-compliance|0|||
155489616|NCT00553319|561215041|FG002|Overall Study|non-compliance|2|||
155544002|NCT02780167|561417358|FG003|Overall Study|Lack of Efficacy|1|||
155489617|NCT00553319|561215039|FG000|Overall Study|incarceration|1|||
155489618|NCT00553319|561215040|FG001|Overall Study|incarceration|0|||
155489619|NCT00553319|561215041|FG002|Overall Study|incarceration|0|||
155489620|NCT00553319|561215039|FG000|Overall Study|moved|1|||
155489621|NCT00553319|561215040|FG001|Overall Study|moved|0|||
155489622|NCT00553319|561215041|FG002|Overall Study|moved|1|||
155489623|NCT04369742|561215042|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
155489624|NCT04369742|561215043|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
155489625|NCT04369742|561215042|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
155489626|NCT04369742|561215043|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
155489627|NCT03575975|561215044|FG000|Overall Study|Lost to Follow-up|1|||
155489628|NCT03575975|561215045|FG001|Overall Study|Lost to Follow-up|0|||
155489629|NCT03575975|561215046|FG002|Overall Study|Lost to Follow-up|0|||
155489630|NCT00465894|561215047|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
155489631|NCT00465894|561215048|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
155489632|NCT00465894|561215047|FG000|Treatment For 12 Weeks|Family Issues|1|||
155489633|NCT00465894|561215048|FG001|Treatment For 12 Weeks|Family Issues|1|||
155489634|NCT00465894|561215047|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
155489635|NCT00465894|561215048|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
155489636|NCT01349816|561215049|FG000|Overall Study|Withdrawal by Subject|4|||
155489637|NCT01349816|561215049|FG000|Overall Study|Physician Decision|1|||
155489638|NCT01349816|561215049|FG000|Overall Study|Adverse Event|14|||
155489639|NCT01349816|561215049|FG000|Overall Study|Lost to Follow-up|2|||
155489640|NCT01349816|561215049|FG000|Overall Study|Protocol Violation|1|||
155489641|NCT01349816|561215049|FG000|Overall Study|Protocol-specified criteria|8|||
155489642|NCT01207427|561215050|FG000|Double-blind Treatment Period|Adverse Event|0|||
155489643|NCT01207427|561215051|FG001|Double-blind Treatment Period|Adverse Event|1|||
155489644|NCT01207427|561215052|FG002|Double-blind Treatment Period|Adverse Event|0|||
155489645|NCT01207427|561215050|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155489646|NCT01207427|561215051|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155489647|NCT01207427|561215052|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155489648|NCT01207427|561215050|FG000|Double-blind Treatment Period|Protocol Violation|2|||
155489649|NCT01207427|561215051|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155489650|NCT01207427|561215052|FG002|Double-blind Treatment Period|Protocol Violation|1|||
155489651|NCT01207427|561215050|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155489652|NCT01207427|561215051|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155489653|NCT01207427|561215052|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155489654|NCT01230489|561215053|FG000|Overall Study|Death|2|||
155489655|NCT01230489|561215053|FG000|Overall Study|Adverse Event|2|||
155489656|NCT01230489|561215053|FG000|Overall Study|Treatment modality changed|1|||
155489657|NCT02451137|561215054|FG000|Overall Study|Randomized but not treated|19|||
155489658|NCT02451137|561215055|FG001|Overall Study|Randomized but not treated|27|||
155489659|NCT02451137|561215054|FG000|Overall Study|Adverse Event|43|||
155489660|NCT02451137|561215055|FG001|Overall Study|Adverse Event|42|||
155489661|NCT02451137|561215054|FG000|Overall Study|Lack of Efficacy|4|||
155489662|NCT02451137|561215055|FG001|Overall Study|Lack of Efficacy|9|||
155489663|NCT02451137|561215054|FG000|Overall Study|Participant decision:discontinue insulin|41|||
155489664|NCT02451137|561215055|FG001|Overall Study|Participant decision:discontinue insulin|43|||
155489665|NCT02451137|561215054|FG000|Overall Study|Hypoglycemia|2|||
155489666|NCT02451137|561215055|FG001|Overall Study|Hypoglycemia|1|||
155489667|NCT02451137|561215054|FG000|Overall Study|Investigator's decision|23|||
155489668|NCT02451137|561215055|FG001|Overall Study|Investigator's decision|19|||
155489669|NCT02451137|561215054|FG000|Overall Study|Lost to Follow-up|53|||
155489670|NCT02451137|561215055|FG001|Overall Study|Lost to Follow-up|61|||
155489671|NCT02451137|561215054|FG000|Overall Study|Physician Decision|6|||
155489672|NCT02451137|561215055|FG001|Overall Study|Physician Decision|5|||
155489673|NCT02451137|561215054|FG000|Overall Study|Sponsor decision|13|||
155489674|NCT02451137|561215055|FG001|Overall Study|Sponsor decision|25|||
155489675|NCT02451137|561215054|FG000|Overall Study|Withdrawal by Subject|40|||
155489676|NCT02451137|561215055|FG001|Overall Study|Withdrawal by Subject|63|||
155489677|NCT02451137|561215054|FG000|Overall Study|Other than specified above|2|||
155489678|NCT02451137|561215055|FG001|Overall Study|Other than specified above|3|||
155489679|NCT01302366|561216968|FG000|Overall Study|patient choice or noncompliance|5|||
155489680|NCT00198107|561216971|FG000|Double-Blind Period|Adverse Event|1|||
155489681|NCT00198107|561216972|FG001|Double-Blind Period|Adverse Event|1|||
155489682|NCT00198107|561216973|FG002|Double-Blind Period|Adverse Event|0|||
155489683|NCT00198107|561216971|FG000|Double-Blind Period|Lack of Efficacy|2|||
155489684|NCT00198107|561216972|FG001|Double-Blind Period|Lack of Efficacy|0|||
155489685|NCT00198107|561216973|FG002|Double-Blind Period|Lack of Efficacy|0|||
155489686|NCT00198107|561216971|FG000|Double-Blind Period|Lost to Follow-up|2|||
155489687|NCT00198107|561216972|FG001|Double-Blind Period|Lost to Follow-up|1|||
155489688|NCT00198107|561216973|FG002|Double-Blind Period|Lost to Follow-up|0|||
155489689|NCT00198107|561216971|FG000|Double-Blind Period|Physician Decision|1|||
155489690|NCT00198107|561216972|FG001|Double-Blind Period|Physician Decision|0|||
155489691|NCT00198107|561216973|FG002|Double-Blind Period|Physician Decision|0|||
155489692|NCT00198107|561216971|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155489693|NCT00198107|561216972|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155489694|NCT00198107|561216973|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155489695|NCT00198107|561216971|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
155489696|NCT00198107|561216972|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
155489697|NCT00198107|561216973|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
155489698|NCT02513732|561216974|FG000|Overall Study|Lost to Follow-up|11|||
155489699|NCT02513732|561216974|FG000|Overall Study|Death|9|||
155489700|NCT02513732|561216974|FG000|Overall Study|Changing hospital|2|||
155489701|NCT00467051|561216975|FG000|Overall Study|Adverse Event|2|||
155489702|NCT02147132|561216978|FG000|Overall Study|Lost to Follow-up|1|||
155489703|NCT02147132|561216979|FG001|Overall Study|Lost to Follow-up|0|||
155489704|NCT02147132|561216980|FG002|Overall Study|Lost to Follow-up|0|||
155489705|NCT02147132|561216981|FG003|Overall Study|Lost to Follow-up|0|||
155489706|NCT02842736|561216988|FG000|Overall Study|Lost to Follow-up|13|||
155489707|NCT02842736|561216988|FG000|Overall Study|Intervention for menstrual bleeding|17|||
155489708|NCT02842736|561216988|FG000|Overall Study|Withdrawal by Subject|4|||
155489709|NCT02842736|561216988|FG000|Overall Study|Pregnancy|3|||
155489710|NCT02842736|561216988|FG000|Overall Study|Hysterectomy for fibroids|2|||
155489711|NCT02842736|561216988|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
155489712|NCT02842736|561216988|FG000|Overall Study|IUD: Mirena|1|||
155489713|NCT03323034|561216992|FG000|Overall Study|Lack of Efficacy|5|||
155489714|NCT03323034|561216993|FG001|Overall Study|Lack of Efficacy|5|||
155489715|NCT03323034|561216994|FG002|Overall Study|Lack of Efficacy|6|||
155489716|NCT03323034|561216995|FG003|Overall Study|Lack of Efficacy|5|||
155489717|NCT03323034|561216996|FG004|Overall Study|Lack of Efficacy|5|||
155489718|NCT03323034|561216992|FG000|Overall Study|Physician Decision|0|||
155489719|NCT03323034|561216993|FG001|Overall Study|Physician Decision|0|||
155489720|NCT03323034|561216994|FG002|Overall Study|Physician Decision|0|||
155489721|NCT03323034|561216995|FG003|Overall Study|Physician Decision|0|||
155489722|NCT03323034|561216996|FG004|Overall Study|Physician Decision|1|||
155489723|NCT03323034|561216992|FG000|Overall Study|Withdrawal by Subject|1|||
155489724|NCT03323034|561216993|FG001|Overall Study|Withdrawal by Subject|1|||
155489725|NCT03323034|561216994|FG002|Overall Study|Withdrawal by Subject|0|||
155489726|NCT03323034|561216995|FG003|Overall Study|Withdrawal by Subject|1|||
155489727|NCT03323034|561216996|FG004|Overall Study|Withdrawal by Subject|0|||
155489728|NCT02646566|561216998|FG000|Overall Study|Lost to Follow-up|5|||
155489729|NCT02646566|561216999|FG001|Overall Study|Lost to Follow-up|4|||
155489730|NCT02646566|561217000|FG002|Overall Study|Lost to Follow-up|5|||
155489731|NCT02646566|561216998|FG000|Overall Study|Treatment failure|1|||
155489732|NCT02646566|561216999|FG001|Overall Study|Treatment failure|0|||
155489733|NCT02646566|561217000|FG002|Overall Study|Treatment failure|0|||
155489734|NCT04887922|561217010|FG000|1st Randomization|Decided not to have surgery|0|||
155489735|NCT04887922|561217011|FG001|1st Randomization|Decided not to have surgery|1|||
155489736|NCT04887922|561217012|FG002|1st Randomization|Decided not to have surgery|0|||
155489737|NCT04887922|561217013|FG003|1st Randomization|Decided not to have surgery|0|||
155489738|NCT04887922|561217014|FG004|1st Randomization|Decided not to have surgery|0|||
155489739|NCT00953017|561217015|FG000|Overall Study|DId not show up for colonoscopy|4|||
155489740|NCT00953017|561217016|FG001|Overall Study|DId not show up for colonoscopy|4|||
155489741|NCT00953017|561217017|FG002|Overall Study|DId not show up for colonoscopy|5|||
155489742|NCT00953017|561217018|FG003|Overall Study|DId not show up for colonoscopy|4|||
155489743|NCT00953017|561217015|FG000|Overall Study|Incomplete data|1|||
155489744|NCT00953017|561217016|FG001|Overall Study|Incomplete data|1|||
155489745|NCT00953017|561217017|FG002|Overall Study|Incomplete data|0|||
155489746|NCT00953017|561217018|FG003|Overall Study|Incomplete data|0|||
155489747|NCT00953017|561217015|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
155489748|NCT00953017|561217016|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
155544003|NCT02780167|561417359|FG004|Overall Study|Lack of Efficacy|0|||
155544004|NCT02780167|561417355|FG000|Overall Study|Lost to Follow-up|2|||
155544005|NCT02780167|561417356|FG001|Overall Study|Lost to Follow-up|0|||
155544006|NCT02780167|561417357|FG002|Overall Study|Lost to Follow-up|1|||
155544007|NCT02780167|561417358|FG003|Overall Study|Lost to Follow-up|0|||
155544008|NCT02780167|561417359|FG004|Overall Study|Lost to Follow-up|0|||
155544009|NCT02780167|561417355|FG000|Overall Study|Does not meet entrance criteria|0|||
155544010|NCT02780167|561417356|FG001|Overall Study|Does not meet entrance criteria|0|||
155544011|NCT02780167|561417357|FG002|Overall Study|Does not meet entrance criteria|1|||
155544012|NCT02780167|561417358|FG003|Overall Study|Does not meet entrance criteria|0|||
155544013|NCT02780167|561417359|FG004|Overall Study|Does not meet entrance criteria|0|||
155544014|NCT02780167|561417355|FG000|Overall Study|No longer meets eligibility criteria|0|||
155544015|NCT02780167|561417356|FG001|Overall Study|No longer meets eligibility criteria|0|||
155544016|NCT02780167|561417357|FG002|Overall Study|No longer meets eligibility criteria|0|||
155544017|NCT02780167|561417358|FG003|Overall Study|No longer meets eligibility criteria|1|||
155544018|NCT02780167|561417359|FG004|Overall Study|No longer meets eligibility criteria|1|||
155544019|NCT02780167|561417355|FG000|Overall Study|Protocol Violation|5|||
155489749|NCT00953017|561217017|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
155489750|NCT00953017|561217018|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
155489751|NCT00953017|561217015|FG000|Overall Study|Brown stool prior to procedure|0|||
155489752|NCT00953017|561217016|FG001|Overall Study|Brown stool prior to procedure|0|||
155489753|NCT00953017|561217017|FG002|Overall Study|Brown stool prior to procedure|1|||
155544020|NCT02780167|561417356|FG001|Overall Study|Protocol Violation|5|||
155489754|NCT00953017|561217018|FG003|Overall Study|Brown stool prior to procedure|0|||
155489755|NCT01300741|561217020|FG000|Overall Study|Lens deposits|1|||
155489756|NCT01300741|561217020|FG000|Overall Study|Lost to Follow-up|1|||
155489757|NCT01300741|561217020|FG000|Overall Study|Discomfort|1|||
155489758|NCT04854421|561217021|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
155489759|NCT04854421|561217022|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
155489760|NCT00718809|561217024|FG000|Overall Study|Disease progression|9|||
155489761|NCT00718809|561217025|FG001|Overall Study|Disease progression|7|||
155489762|NCT00718809|561217024|FG000|Overall Study|Adverse Event|1|||
155489763|NCT00718809|561217025|FG001|Overall Study|Adverse Event|1|||
155489764|NCT00718809|561217024|FG000|Overall Study|Withdrawal by Subject|0|||
155489765|NCT00718809|561217025|FG001|Overall Study|Withdrawal by Subject|1|||
155489766|NCT00718809|561217024|FG000|Overall Study|Lost to Follow-up|1|||
155489767|NCT00718809|561217025|FG001|Overall Study|Lost to Follow-up|0|||
155489768|NCT00718809|561217024|FG000|Overall Study|Noncompliance|1|||
155489769|NCT00718809|561217025|FG001|Overall Study|Noncompliance|0|||
155489770|NCT00463385|561217026|FG000|Overall Study|Other|4|||
155489771|NCT00463385|561217027|FG001|Overall Study|Other|3|||
155489772|NCT00463385|561217028|FG002|Overall Study|Other|6|||
155489773|NCT00463385|561217029|FG003|Overall Study|Other|4|||
155489774|NCT00463385|561217026|FG000|Overall Study|Adverse Event|5|||
155489775|NCT00463385|561217027|FG001|Overall Study|Adverse Event|8|||
155489776|NCT00463385|561217028|FG002|Overall Study|Adverse Event|4|||
155489777|NCT00463385|561217029|FG003|Overall Study|Adverse Event|2|||
155489778|NCT00463385|561217026|FG000|Overall Study|Lack of Efficacy|6|||
155489779|NCT00463385|561217027|FG001|Overall Study|Lack of Efficacy|6|||
155489780|NCT00463385|561217028|FG002|Overall Study|Lack of Efficacy|7|||
155489781|NCT00463385|561217029|FG003|Overall Study|Lack of Efficacy|9|||
155489782|NCT00463385|561217026|FG000|Overall Study|Withdrawal by Subject|3|||
155489783|NCT00463385|561217027|FG001|Overall Study|Withdrawal by Subject|3|||
155489784|NCT00463385|561217028|FG002|Overall Study|Withdrawal by Subject|3|||
155489785|NCT00463385|561217029|FG003|Overall Study|Withdrawal by Subject|4|||
155489786|NCT00463385|561217026|FG000|Overall Study|Lost to Follow-up|0|||
155489787|NCT00463385|561217027|FG001|Overall Study|Lost to Follow-up|0|||
155489788|NCT00463385|561217028|FG002|Overall Study|Lost to Follow-up|0|||
155489789|NCT00463385|561217029|FG003|Overall Study|Lost to Follow-up|1|||
155489790|NCT00463385|561217026|FG000|Overall Study|Death|2|||
155489791|NCT00463385|561217027|FG001|Overall Study|Death|1|||
155489792|NCT00463385|561217028|FG002|Overall Study|Death|2|||
155489793|NCT00463385|561217029|FG003|Overall Study|Death|0|||
155489794|NCT00463385|561217026|FG000|Overall Study|Missing|2|||
155489795|NCT00463385|561217027|FG001|Overall Study|Missing|0|||
155489796|NCT00463385|561217028|FG002|Overall Study|Missing|0|||
155489797|NCT00463385|561217029|FG003|Overall Study|Missing|2|||
155489798|NCT00463385|561217026|FG000|Overall Study|1 participant received commercial drug|0|||
155489799|NCT00463385|561217027|FG001|Overall Study|1 participant received commercial drug|1|||
155489800|NCT00463385|561217028|FG002|Overall Study|1 participant received commercial drug|0|||
155489801|NCT00463385|561217029|FG003|Overall Study|1 participant received commercial drug|0|||
155489802|NCT00798161|561217030|FG000|Overall Study|Adverse Event|3|||
155489803|NCT00798161|561217031|FG001|Overall Study|Adverse Event|4|||
155489804|NCT00798161|561217032|FG002|Overall Study|Adverse Event|6|||
155489805|NCT00798161|561217033|FG003|Overall Study|Adverse Event|6|||
155489806|NCT00798161|561217034|FG004|Overall Study|Adverse Event|5|||
155489807|NCT00798161|561217035|FG005|Overall Study|Adverse Event|2|||
155489808|NCT00798161|561217036|FG006|Overall Study|Adverse Event|4|||
155489809|NCT00798161|561217030|FG000|Overall Study|Protocol Violation|2|||
155489810|NCT00798161|561217031|FG001|Overall Study|Protocol Violation|1|||
155489811|NCT00798161|561217032|FG002|Overall Study|Protocol Violation|3|||
155489812|NCT00798161|561217033|FG003|Overall Study|Protocol Violation|3|||
155489813|NCT00798161|561217034|FG004|Overall Study|Protocol Violation|3|||
155489814|NCT00798161|561217035|FG005|Overall Study|Protocol Violation|2|||
155489815|NCT00798161|561217036|FG006|Overall Study|Protocol Violation|0|||
155544021|NCT02780167|561417357|FG002|Overall Study|Protocol Violation|1|||
155544022|NCT02780167|561417358|FG003|Overall Study|Protocol Violation|1|||
155489816|NCT00798161|561217030|FG000|Overall Study|Lost to Follow-up|1|||
155489817|NCT00798161|561217031|FG001|Overall Study|Lost to Follow-up|3|||
155489818|NCT00798161|561217032|FG002|Overall Study|Lost to Follow-up|4|||
155489819|NCT00798161|561217033|FG003|Overall Study|Lost to Follow-up|3|||
155489820|NCT00798161|561217034|FG004|Overall Study|Lost to Follow-up|4|||
155489821|NCT00798161|561217035|FG005|Overall Study|Lost to Follow-up|0|||
155489822|NCT00798161|561217036|FG006|Overall Study|Lost to Follow-up|0|||
155489823|NCT00798161|561217030|FG000|Overall Study|Withdrawal by Subject|5|||
155489824|NCT00798161|561217031|FG001|Overall Study|Withdrawal by Subject|4|||
155489825|NCT00798161|561217032|FG002|Overall Study|Withdrawal by Subject|5|||
155489826|NCT00798161|561217033|FG003|Overall Study|Withdrawal by Subject|4|||
155489827|NCT00798161|561217034|FG004|Overall Study|Withdrawal by Subject|2|||
155544023|NCT02780167|561417359|FG004|Overall Study|Protocol Violation|2|||
155489828|NCT00798161|561217035|FG005|Overall Study|Withdrawal by Subject|3|||
155489829|NCT00798161|561217036|FG006|Overall Study|Withdrawal by Subject|1|||
155489830|NCT00798161|561217030|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
155489831|NCT00798161|561217031|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
155489832|NCT00798161|561217032|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
155489833|NCT00798161|561217033|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
155489834|NCT00798161|561217034|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
155489835|NCT00798161|561217035|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
155489836|NCT00798161|561217036|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
155489837|NCT00344968|561217037|FG000|Overall Study|Adverse Event|5|||
155489838|NCT00344968|561217038|FG001|Overall Study|Adverse Event|4|||
155489839|NCT00344968|561217039|FG002|Overall Study|Adverse Event|15|||
155489840|NCT00344968|561217037|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155489841|NCT00344968|561217038|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155489842|NCT00344968|561217039|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155489843|NCT00344968|561217037|FG000|Overall Study|Protocol Violation|2|||
155489844|NCT00344968|561217038|FG001|Overall Study|Protocol Violation|2|||
155489845|NCT00344968|561217039|FG002|Overall Study|Protocol Violation|5|||
155489846|NCT00344968|561217037|FG000|Overall Study|Withdrawal by Subject|14|||
155489847|NCT00344968|561217038|FG001|Overall Study|Withdrawal by Subject|31|||
155489848|NCT00344968|561217039|FG002|Overall Study|Withdrawal by Subject|27|||
155489849|NCT00344968|561217037|FG000|Overall Study|Lost to Follow-up|24|||
155489850|NCT00344968|561217038|FG001|Overall Study|Lost to Follow-up|37|||
155489851|NCT00344968|561217039|FG002|Overall Study|Lost to Follow-up|37|||
155489852|NCT00344968|561217037|FG000|Overall Study|Death|11|||
155489853|NCT00344968|561217038|FG001|Overall Study|Death|27|||
155489854|NCT00344968|561217039|FG002|Overall Study|Death|31|||
155489855|NCT00344968|561217037|FG000|Overall Study|Other|0|||
155489856|NCT00344968|561217038|FG001|Overall Study|Other|1|||
155489857|NCT00344968|561217039|FG002|Overall Study|Other|0|||
155489858|NCT04001790|561217043|FG000|Overall Study|Withdrawal by Subject|1|||
155489859|NCT04001790|561217044|FG001|Overall Study|Withdrawal by Subject|2|||
155489860|NCT00465101|561217045|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
155489861|NCT00465101|561217045|FG000|Overall Study|Change in health precluded follow up|4|||
155489862|NCT00465101|561217045|FG000|Overall Study|Did not meet study criteria|4|||
155489863|NCT00465101|561217045|FG000|Overall Study|Lost to Follow-up|5|||
155489864|NCT00465101|561217045|FG000|Overall Study|Other|6|||
155489865|NCT00465101|561217045|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
155489866|NCT00465101|561217045|FG000|Overall Study|Patient postponed procedure|1|||
155489867|NCT00465101|561217045|FG000|Overall Study|Site closed due to IRB expiration|1|||
155489868|NCT00465101|561217045|FG000|Overall Study|Unable to obtain IRB approval|1|||
155489869|NCT00465101|561217045|FG000|Overall Study|Death|3|||
155489870|NCT00465101|561217045|FG000|Overall Study|Withdrawal by Subject|25|||
155489871|NCT00465101|561217045|FG000|Overall Study|Physician Decision|1|||
155489872|NCT00465101|561217045|FG000|Overall Study|Withdrew consent prior to procedure|3|||
155489873|NCT04585906|561217051|FG000|Overall Study|Lost to Follow-up|8|||
155489874|NCT04585906|561217052|FG001|Overall Study|Lost to Follow-up|5|||
155489875|NCT04626947|561217053|FG000|Overall Study|Study terminated|14|||
155489876|NCT04246593|561217061|FG000|Overall Study|Withdrawal by Subject|14|||
155489877|NCT04246593|561217062|FG001|Overall Study|Withdrawal by Subject|13|||
155489878|NCT04246593|561217061|FG000|Overall Study|Lost to Follow-up|124|||
155489879|NCT04246593|561217062|FG001|Overall Study|Lost to Follow-up|71|||
155489880|NCT04246593|561217061|FG000|Overall Study|Moved out of area/became ineligible|3|||
155489881|NCT04246593|561217062|FG001|Overall Study|Moved out of area/became ineligible|1|||
155489882|NCT04246593|561217061|FG000|Overall Study|Reason unknown|4|||
155489883|NCT04246593|561217062|FG001|Overall Study|Reason unknown|2|||
155489884|NCT01012765|561217065|FG000|Treatment Period 1|Adverse Event|1|||
155489885|NCT01012765|561217066|FG001|Treatment Period 1|Adverse Event|0|||
155489886|NCT01012765|561217067|FG002|Treatment Period 1|Adverse Event|1|||
155544024|NCT02780167|561417355|FG000|Overall Study|Withdrawal by Subject|6|||
155544025|NCT02780167|561417356|FG001|Overall Study|Withdrawal by Subject|4|||
155544026|NCT02780167|561417357|FG002|Overall Study|Withdrawal by Subject|4|||
155544027|NCT02780167|561417358|FG003|Overall Study|Withdrawal by Subject|3|||
155544028|NCT02780167|561417359|FG004|Overall Study|Withdrawal by Subject|4|||
155544029|NCT02780167|561417355|FG000|Overall Study|Other|0|||
155544030|NCT02780167|561417356|FG001|Overall Study|Other|0|||
155544031|NCT02780167|561417357|FG002|Overall Study|Other|3|||
155544032|NCT02780167|561417358|FG003|Overall Study|Other|1|||
155544033|NCT02780167|561417359|FG004|Overall Study|Other|2|||
155544034|NCT02315066|561417361|FG000|Overall Study|Lost to Follow-up|0|||
155544035|NCT02315066|561417362|FG001|Overall Study|Lost to Follow-up|1|||
155544036|NCT02315066|561417363|FG002|Overall Study|Lost to Follow-up|1|||
155544037|NCT02315066|561417364|FG003|Overall Study|Lost to Follow-up|0|||
155544038|NCT02315066|561417365|FG004|Overall Study|Lost to Follow-up|1|||
155544039|NCT02315066|561417366|FG005|Overall Study|Lost to Follow-up|0|||
155544040|NCT02315066|561417367|FG006|Overall Study|Lost to Follow-up|2|||
155544041|NCT02315066|561417368|FG007|Overall Study|Lost to Follow-up|1|||
155544042|NCT02315066|561417369|FG008|Overall Study|Lost to Follow-up|0|||
155489887|NCT01012765|561217068|FG003|Treatment Period 1|Adverse Event|0|||
155489888|NCT01012765|561217069|FG004|Treatment Period 1|Adverse Event|0|||
155489889|NCT01012765|561217070|FG005|Treatment Period 1|Adverse Event|0|||
155489890|NCT01012765|561217065|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155489891|NCT01012765|561217066|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155489892|NCT01012765|561217067|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155544043|NCT02315066|561417370|FG009|Overall Study|Lost to Follow-up|0|||
155489893|NCT01012765|561217068|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155489894|NCT01012765|561217069|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155489895|NCT01012765|561217070|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155489896|NCT01012765|561217065|FG000|Treatment Period 1|Administrative problems|0|||
155489897|NCT01012765|561217066|FG001|Treatment Period 1|Administrative problems|0|||
155544044|NCT02315066|561417371|FG010|Overall Study|Lost to Follow-up|1|||
155544045|NCT02315066|561417372|FG011|Overall Study|Lost to Follow-up|2|||
155489898|NCT01012765|561217067|FG002|Treatment Period 1|Administrative problems|1|||
155489899|NCT01012765|561217068|FG003|Treatment Period 1|Administrative problems|1|||
155489900|NCT01012765|561217069|FG004|Treatment Period 1|Administrative problems|1|||
155544046|NCT02315066|561417373|FG012|Overall Study|Lost to Follow-up|0|||
155544047|NCT02315066|561417374|FG013|Overall Study|Lost to Follow-up|4|||
155544048|NCT02315066|561417361|FG000|Overall Study|Death|2|||
155544049|NCT02315066|561417362|FG001|Overall Study|Death|7|||
155489901|NCT01012765|561217070|FG005|Treatment Period 1|Administrative problems|0|||
155489902|NCT01012765|561217065|FG000|Treatment Period 1|Protocol Violation|0|||
155489903|NCT01012765|561217066|FG001|Treatment Period 1|Protocol Violation|0|||
155489904|NCT01012765|561217067|FG002|Treatment Period 1|Protocol Violation|0|||
155489905|NCT01012765|561217068|FG003|Treatment Period 1|Protocol Violation|2|||
155489906|NCT01012765|561217069|FG004|Treatment Period 1|Protocol Violation|1|||
155489907|NCT01012765|561217070|FG005|Treatment Period 1|Protocol Violation|0|||
155489908|NCT01012765|561217065|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
155489909|NCT01012765|561217066|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
155489910|NCT01012765|561217067|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
155489911|NCT01012765|561217068|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
155489912|NCT01012765|561217069|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
155489913|NCT01012765|561217070|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
155489914|NCT01012765|561217065|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155489915|NCT01012765|561217066|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155489916|NCT01012765|561217067|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155489917|NCT01012765|561217068|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155489918|NCT01012765|561217069|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155489919|NCT01012765|561217070|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155489920|NCT01012765|561217065|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
155489921|NCT01012765|561217066|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
155489922|NCT01012765|561217067|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
155544050|NCT02315066|561417363|FG002|Overall Study|Death|6|||
155544051|NCT02315066|561417364|FG003|Overall Study|Death|11|||
155544052|NCT02315066|561417365|FG004|Overall Study|Death|10|||
155544053|NCT02315066|561417366|FG005|Overall Study|Death|3|||
155544054|NCT02315066|561417367|FG006|Overall Study|Death|9|||
155544055|NCT02315066|561417368|FG007|Overall Study|Death|9|||
155544056|NCT02315066|561417369|FG008|Overall Study|Death|10|||
155489923|NCT01012765|561217068|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
155544057|NCT02315066|561417370|FG009|Overall Study|Death|8|||
155544058|NCT02315066|561417371|FG010|Overall Study|Death|10|||
155544059|NCT02315066|561417372|FG011|Overall Study|Death|7|||
155544060|NCT02315066|561417373|FG012|Overall Study|Death|8|||
155544061|NCT02315066|561417374|FG013|Overall Study|Death|21|||
155544062|NCT02315066|561417361|FG000|Overall Study|Other|0|||
155544063|NCT02315066|561417362|FG001|Overall Study|Other|0|||
155544064|NCT02315066|561417363|FG002|Overall Study|Other|0|||
155544065|NCT02315066|561417364|FG003|Overall Study|Other|0|||
155544066|NCT02315066|561417365|FG004|Overall Study|Other|0|||
155544067|NCT02315066|561417366|FG005|Overall Study|Other|0|||
155544068|NCT02315066|561417367|FG006|Overall Study|Other|0|||
155544069|NCT02315066|561417368|FG007|Overall Study|Other|1|||
155489924|NCT01012765|561217069|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
155489925|NCT01012765|561217070|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
155489926|NCT01012765|561217065|FG000|Treatment Period 2|Adverse Event|0|||
155489927|NCT01012765|561217066|FG001|Treatment Period 2|Adverse Event|1|||
155489928|NCT01012765|561217067|FG002|Treatment Period 2|Adverse Event|1|||
155489929|NCT01012765|561217068|FG003|Treatment Period 2|Adverse Event|0|||
155489930|NCT01012765|561217069|FG004|Treatment Period 2|Adverse Event|0|||
155489931|NCT01012765|561217070|FG005|Treatment Period 2|Adverse Event|0|||
155489932|NCT01012765|561217065|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
155489933|NCT01012765|561217066|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
155489934|NCT01012765|561217067|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
155489935|NCT01012765|561217068|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
155489936|NCT01012765|561217069|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
155489937|NCT01012765|561217070|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
155489938|NCT01326312|561217071|FG000|Overall Study|Adverse Event|11|||
155489939|NCT01326312|561217072|FG001|Overall Study|Adverse Event|11|||
155489940|NCT01326312|561217073|FG002|Overall Study|Adverse Event|1|||
155489941|NCT01326312|561217071|FG000|Overall Study|Withdrawal by Subject|1|||
155489942|NCT01326312|561217072|FG001|Overall Study|Withdrawal by Subject|2|||
155489943|NCT01326312|561217073|FG002|Overall Study|Withdrawal by Subject|1|||
155489944|NCT01326312|561217071|FG000|Overall Study|Protocol Violation|0|||
155489945|NCT01326312|561217072|FG001|Overall Study|Protocol Violation|1|||
155489946|NCT01326312|561217073|FG002|Overall Study|Protocol Violation|0|||
155489947|NCT01326312|561217071|FG000|Overall Study|Lack of Efficacy|13|||
155489948|NCT01326312|561217072|FG001|Overall Study|Lack of Efficacy|7|||
155489949|NCT01326312|561217073|FG002|Overall Study|Lack of Efficacy|1|||
155489950|NCT01326312|561217071|FG000|Overall Study|Death|1|||
155489951|NCT01326312|561217072|FG001|Overall Study|Death|0|||
155489952|NCT01326312|561217073|FG002|Overall Study|Death|1|||
155489953|NCT01326312|561217071|FG000|Overall Study|progressive disease|0|||
155489954|NCT01326312|561217072|FG001|Overall Study|progressive disease|1|||
155489955|NCT01326312|561217073|FG002|Overall Study|progressive disease|1|||
155489956|NCT01326312|561217071|FG000|Overall Study|Study terminated by Sponsor|8|||
155489957|NCT01326312|561217072|FG001|Overall Study|Study terminated by Sponsor|32|||
155489958|NCT01326312|561217073|FG002|Overall Study|Study terminated by Sponsor|46|||
155489959|NCT01326312|561217071|FG000|Overall Study|Treatment arm terminated|19|||
155489960|NCT01326312|561217072|FG001|Overall Study|Treatment arm terminated|0|||
155489961|NCT01326312|561217073|FG002|Overall Study|Treatment arm terminated|0|||
155489962|NCT01326312|561217071|FG000|Overall Study|QTc > 500|0|||
155489963|NCT01326312|561217072|FG001|Overall Study|QTc > 500|1|||
155489964|NCT01326312|561217073|FG002|Overall Study|QTc > 500|0|||
155489965|NCT00903357|561217074|FG000|First Intervention|Withdrawal by Subject|5|||
155489966|NCT00903357|561217075|FG001|First Intervention|Withdrawal by Subject|3|||
155489967|NCT00903357|561217074|FG000|First Intervention|Flu|0|||
155489968|NCT00903357|561217075|FG001|First Intervention|Flu|1|||
155489969|NCT00903357|561217074|FG000|Wash Out Period of 2 Weeks|Flu|0|||
155489970|NCT00903357|561217075|FG001|Wash Out Period of 2 Weeks|Flu|1|||
155489971|NCT00903357|561217074|FG000|Second Intervention|Lost to Follow-up|1|||
155489972|NCT00903357|561217075|FG001|Second Intervention|Lost to Follow-up|0|||
155489973|NCT01463631|561217079|FG000|Overall Study|Withdrawal by Subject|0|||
155489974|NCT01463631|561217080|FG001|Overall Study|Withdrawal by Subject|0|||
155489975|NCT01463631|561217081|FG002|Overall Study|Withdrawal by Subject|0|||
155489976|NCT01463631|561217082|FG003|Overall Study|Withdrawal by Subject|1|||
155489977|NCT01463631|561217079|FG000|Overall Study|Death|0|||
155489978|NCT01463631|561217080|FG001|Overall Study|Death|0|||
155489979|NCT01463631|561217081|FG002|Overall Study|Death|1|||
155489980|NCT01463631|561217082|FG003|Overall Study|Death|0|||
155489981|NCT01463631|561217079|FG000|Overall Study|Progressive Disease|0|||
155489982|NCT01463631|561217080|FG001|Overall Study|Progressive Disease|0|||
155489983|NCT01463631|561217081|FG002|Overall Study|Progressive Disease|0|||
155489984|NCT01463631|561217082|FG003|Overall Study|Progressive Disease|5|||
155489985|NCT05664672|561217086|FG000|Overall Study|Adverse Event|0|||
155489986|NCT05664672|561217087|FG001|Overall Study|Adverse Event|0|||
155544070|NCT02315066|561417369|FG008|Overall Study|Other|1|||
155544071|NCT02315066|561417370|FG009|Overall Study|Other|2|||
155544072|NCT02315066|561417371|FG010|Overall Study|Other|0|||
155544073|NCT02315066|561417372|FG011|Overall Study|Other|0|||
155489987|NCT05664672|561217088|FG002|Overall Study|Adverse Event|0|||
155544074|NCT02315066|561417373|FG012|Overall Study|Other|0|||
155656285|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
155656286|NCT00086515|561835178|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
155656287|NCT00086515|561835179|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
155656288|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
155656289|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
155656290|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
155656291|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
155656292|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
155656293|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
155656294|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
155656295|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
155656296|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
155489988|NCT05664672|561217089|FG003|Overall Study|Adverse Event|0|||
155489989|NCT05664672|561217090|FG004|Overall Study|Adverse Event|0|||
155489990|NCT05664672|561217091|FG005|Overall Study|Adverse Event|1|||
155489991|NCT05664672|561217086|FG000|Overall Study|Withdrawal by Subject|0|||
155489992|NCT05664672|561217087|FG001|Overall Study|Withdrawal by Subject|1|||
155489993|NCT05664672|561217088|FG002|Overall Study|Withdrawal by Subject|3|||
155489994|NCT05664672|561217089|FG003|Overall Study|Withdrawal by Subject|0|||
155489995|NCT05664672|561217090|FG004|Overall Study|Withdrawal by Subject|5|||
155489996|NCT05664672|561217091|FG005|Overall Study|Withdrawal by Subject|6|||
155489997|NCT05664672|561217086|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
155489998|NCT05664672|561217087|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155489999|NCT05664672|561217088|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155490000|NCT05664672|561217089|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
155490001|NCT05664672|561217090|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
155490002|NCT05664672|561217091|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
155490003|NCT05664672|561217086|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
155490004|NCT05664672|561217087|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
155490005|NCT05664672|561217088|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
155490006|NCT05664672|561217089|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
155490007|NCT05664672|561217090|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
155490008|NCT05664672|561217091|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
155490009|NCT02370173|561217100|FG000|Overall Study|Protocol Violation|1|||
155490010|NCT02370173|561217101|FG001|Overall Study|Protocol Violation|1|||
155490011|NCT02370173|561217100|FG000|Overall Study|Withdrawal by Subject|2|||
155490012|NCT02370173|561217101|FG001|Overall Study|Withdrawal by Subject|2|||
155490013|NCT01326481|561217102|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
155490014|NCT01038609|561217105|FG000|Overall Study|Adverse Event|0|||
155490015|NCT01038609|561217106|FG001|Overall Study|Adverse Event|0|||
155490016|NCT01038609|561217107|FG002|Overall Study|Adverse Event|1|||
155490017|NCT01038609|561217108|FG003|Overall Study|Adverse Event|0|||
155490018|NCT01038609|561217109|FG004|Overall Study|Adverse Event|0|||
155490019|NCT01038609|561217105|FG000|Overall Study|Dosing Error|0|||
155490020|NCT01038609|561217106|FG001|Overall Study|Dosing Error|0|||
155490021|NCT01038609|561217107|FG002|Overall Study|Dosing Error|0|||
155490022|NCT01038609|561217108|FG003|Overall Study|Dosing Error|1|||
155490023|NCT01038609|561217109|FG004|Overall Study|Dosing Error|1|||
155490024|NCT01038609|561217105|FG000|Overall Study|Death in the Family|1|||
155490025|NCT01038609|561217106|FG001|Overall Study|Death in the Family|0|||
155490026|NCT01038609|561217107|FG002|Overall Study|Death in the Family|0|||
155490027|NCT01038609|561217108|FG003|Overall Study|Death in the Family|0|||
155490028|NCT01038609|561217109|FG004|Overall Study|Death in the Family|0|||
155490029|NCT01038609|561217105|FG000|Overall Study|Refusal of Blood Draws|0|||
155490030|NCT01038609|561217106|FG001|Overall Study|Refusal of Blood Draws|1|||
155490031|NCT01038609|561217107|FG002|Overall Study|Refusal of Blood Draws|0|||
155490032|NCT01038609|561217108|FG003|Overall Study|Refusal of Blood Draws|0|||
155721124|NCT00286468|562077743|FG002|Overall Study|Withdrawal by Subject|11|||
155721125|NCT00286468|562077741|FG000|Overall Study|Physician Decision|3|||
155490033|NCT01038609|561217109|FG004|Overall Study|Refusal of Blood Draws|0|||
155490034|NCT04604015|561217110|FG000|Overall Study|Incomplete Data Collection|33|||
155490035|NCT02811640|561217111|FG000|Overall Study|Technology malfunction|2|||
155490036|NCT01087944|561217127|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
155490037|NCT01087944|561217128|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
155721126|NCT00286468|562077742|FG001|Overall Study|Physician Decision|2|||
155721127|NCT00286468|562077743|FG002|Overall Study|Physician Decision|1|||
155721128|NCT02953652|562077744|FG000|Overall Study|Adverse Event|18|||
155721129|NCT02953652|562077744|FG000|Overall Study|Withdrawal by Subject|6|||
155721130|NCT02953652|562077744|FG000|Overall Study|Protocol Violation|1|||
155721131|NCT02953652|562077744|FG000|Overall Study|Disease Progression|27|||
155721132|NCT00671658|562077748|FG000|Overall Study|Physician Decision|5|||
155721133|NCT03617172|562077757|FG000|Overall Study|Lost to Follow-up|1|||
155721134|NCT03617172|562077758|FG001|Overall Study|Lost to Follow-up|0|||
155490038|NCT01087944|561217127|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
155490039|NCT01087944|561217128|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
155490040|NCT03590613|561217129|FG000|Period 2, 4 Days|Physician Decision|0|||
155490041|NCT03590613|561217130|FG001|Period 2, 4 Days|Physician Decision|0|||
155490042|NCT03590613|561217131|FG002|Period 2, 4 Days|Physician Decision|0|||
155490043|NCT03590613|561217132|FG003|Period 2, 4 Days|Physician Decision|1|||
155490044|NCT01731600|561217138|FG000|Overall Study|Adverse Event|2|||
155490045|NCT01731600|561217139|FG001|Overall Study|Adverse Event|0|||
155490046|NCT01731600|561217138|FG000|Overall Study|Withdrawal criteria|1|||
155490047|NCT01731600|561217139|FG001|Overall Study|Withdrawal criteria|0|||
155490048|NCT01731600|561217138|FG000|Overall Study|Other reasons|3|||
155490049|NCT01731600|561217139|FG001|Overall Study|Other reasons|0|||
155490050|NCT00129220|561217141|FG000|Study Period II|Adverse Event|9|||
155490051|NCT00129220|561217142|FG001|Study Period II|Adverse Event|5|||
155490052|NCT00129220|561217143|FG002|Study Period II|Adverse Event|7|||
155490053|NCT00129220|561217141|FG000|Study Period II|Lack of Efficacy|15|||
155490054|NCT00129220|561217142|FG001|Study Period II|Lack of Efficacy|1|||
155490055|NCT00129220|561217143|FG002|Study Period II|Lack of Efficacy|28|||
155490056|NCT00129220|561217141|FG000|Study Period II|Entry Criteria Not Met|2|||
155490057|NCT00129220|561217142|FG001|Study Period II|Entry Criteria Not Met|0|||
155490058|NCT00129220|561217143|FG002|Study Period II|Entry Criteria Not Met|2|||
155490059|NCT00129220|561217141|FG000|Study Period II|Protocol Violation|4|||
155544075|NCT02315066|561417374|FG013|Overall Study|Other|0|||
155544076|NCT02315066|561417361|FG000|Overall Study|Subject refused further follow-up|0|||
155544077|NCT02315066|561417362|FG001|Overall Study|Subject refused further follow-up|2|||
155544078|NCT02315066|561417363|FG002|Overall Study|Subject refused further follow-up|2|||
155544079|NCT02315066|561417364|FG003|Overall Study|Subject refused further follow-up|0|||
155544080|NCT02315066|561417365|FG004|Overall Study|Subject refused further follow-up|0|||
155544081|NCT02315066|561417366|FG005|Overall Study|Subject refused further follow-up|0|||
155490060|NCT00129220|561217142|FG001|Study Period II|Protocol Violation|2|||
155490061|NCT00129220|561217143|FG002|Study Period II|Protocol Violation|1|||
155490062|NCT00129220|561217141|FG000|Study Period II|Physician Decision|0|||
155490063|NCT00129220|561217142|FG001|Study Period II|Physician Decision|1|||
155490064|NCT00129220|561217143|FG002|Study Period II|Physician Decision|0|||
155490065|NCT00129220|561217141|FG000|Study Period II|Withdrawal by Subject|1|||
155490066|NCT00129220|561217142|FG001|Study Period II|Withdrawal by Subject|3|||
155490067|NCT00129220|561217143|FG002|Study Period II|Withdrawal by Subject|4|||
155490068|NCT00129220|561217141|FG000|Study Period II|Reason Not Specified|2|||
155490069|NCT00129220|561217142|FG001|Study Period II|Reason Not Specified|0|||
155490070|NCT00129220|561217143|FG002|Study Period II|Reason Not Specified|5|||
155490071|NCT00129220|561217141|FG000|Study Period III|Adverse Event|1|||
155490072|NCT00129220|561217142|FG001|Study Period III|Adverse Event|0|||
155490073|NCT00129220|561217143|FG002|Study Period III|Adverse Event|3|||
155490074|NCT00129220|561217141|FG000|Study Period III|Protocol Violation|1|||
155490075|NCT00129220|561217142|FG001|Study Period III|Protocol Violation|1|||
155490076|NCT00129220|561217143|FG002|Study Period III|Protocol Violation|2|||
155490077|NCT00129220|561217141|FG000|Study Period III|Withdrawal by Subject|1|||
155490078|NCT00129220|561217142|FG001|Study Period III|Withdrawal by Subject|0|||
155490079|NCT00129220|561217143|FG002|Study Period III|Withdrawal by Subject|3|||
155490080|NCT00129220|561217141|FG000|Study Period III|Sponsor Decision|1|||
155490081|NCT00129220|561217142|FG001|Study Period III|Sponsor Decision|0|||
155490082|NCT00129220|561217143|FG002|Study Period III|Sponsor Decision|0|||
155490083|NCT00129220|561217141|FG000|Study Period III|Reason Not Specified|9|||
155490084|NCT00129220|561217142|FG001|Study Period III|Reason Not Specified|0|||
155490085|NCT00129220|561217143|FG002|Study Period III|Reason Not Specified|2|||
155490086|NCT00540228|561217144|FG000|Overall Study|Adverse Event|2|||
155490087|NCT00540228|561217145|FG001|Overall Study|Adverse Event|0|||
155490088|NCT00540228|561217146|FG002|Overall Study|Adverse Event|0|||
155490089|NCT00540228|561217147|FG003|Overall Study|Adverse Event|0|||
155490090|NCT00540228|561217148|FG004|Overall Study|Adverse Event|0|||
155490091|NCT00540228|561217144|FG000|Overall Study|Lost to Follow-up|1|||
155490092|NCT00540228|561217145|FG001|Overall Study|Lost to Follow-up|1|||
155490093|NCT00540228|561217146|FG002|Overall Study|Lost to Follow-up|0|||
155490094|NCT00540228|561217147|FG003|Overall Study|Lost to Follow-up|0|||
155490095|NCT00540228|561217148|FG004|Overall Study|Lost to Follow-up|0|||
155490096|NCT01883362|561217149|FG000|Treatment|Adverse Event|1|||
155490097|NCT01883362|561217150|FG001|Treatment|Adverse Event|8|||
155490098|NCT01883362|561217149|FG000|Treatment|Withdrawal by Subject|6|||
155490099|NCT01883362|561217150|FG001|Treatment|Withdrawal by Subject|2|||
155490100|NCT01883362|561217149|FG000|Treatment|Administrative problems|4|||
155490101|NCT01883362|561217150|FG001|Treatment|Administrative problems|1|||
155490102|NCT01883362|561217149|FG000|Treatment|Relapse|4|||
155490103|NCT01883362|561217150|FG001|Treatment|Relapse|2|||
155490104|NCT01883362|561217149|FG000|Treatment|Randomized, not treated|1|||
155490105|NCT01883362|561217150|FG001|Treatment|Randomized, not treated|1|||
155490106|NCT01883362|561217149|FG000|Post Treatment Follow-up|Protocol Violation|0|||
155490107|NCT01883362|561217150|FG001|Post Treatment Follow-up|Protocol Violation|1|||
155490108|NCT01883362|561217149|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
155490109|NCT01883362|561217150|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
155490110|NCT01883362|561217149|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
155490111|NCT01883362|561217150|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
155490112|NCT01883362|561217149|FG000|Post Treatment Follow-up|Administrative problems|2|||
155490113|NCT01883362|561217150|FG001|Post Treatment Follow-up|Administrative problems|0|||
155490114|NCT01883362|561217149|FG000|Post Treatment Follow-up|Death|8|||
155490115|NCT01883362|561217150|FG001|Post Treatment Follow-up|Death|4|||
155490116|NCT01883362|561217149|FG000|Post Treatment Follow-up|Relapse|1|||
155490117|NCT01883362|561217150|FG001|Post Treatment Follow-up|Relapse|2|||
155490118|NCT01383317|561217151|FG000|Overall Study|Lost to Follow-up|2|||
155490119|NCT01383317|561217152|FG001|Overall Study|Lost to Follow-up|1|||
155490120|NCT01383317|561217151|FG000|Overall Study|Death|1|||
155490121|NCT01383317|561217152|FG001|Overall Study|Death|0|||
155490122|NCT01383317|561217151|FG000|Overall Study|Adverse Event|0|||
155490123|NCT01383317|561217152|FG001|Overall Study|Adverse Event|1|||
155490124|NCT02569996|561217155|FG000|Overall Study|Adverse Event|6|||
155490125|NCT02569996|561217155|FG000|Overall Study|Physician Decision|3|||
155490126|NCT02569996|561217155|FG000|Overall Study|Progression of the disease|18|||
155490127|NCT02569996|561217155|FG000|Overall Study|New anti-lymphoma treatment|1|||
155490128|NCT02569996|561217155|FG000|Overall Study|Non-compliance|9|||
155490129|NCT02569996|561217155|FG000|Overall Study|Withdrawal by Subject|5|||
155490130|NCT02569996|561217155|FG000|Overall Study|Lost to Follow-up|5|||
155490131|NCT02569996|561217155|FG000|Overall Study|Complete remission|7|||
155490132|NCT02569996|561217155|FG000|Overall Study|Unknown reason|1|||
155490133|NCT03996694|561219613|FG000|First Washout (7 Days)|positive urine drug screen|0|||
155490134|NCT03996694|561219614|FG001|First Washout (7 Days)|positive urine drug screen|0|||
155490135|NCT03996694|561219615|FG002|First Washout (7 Days)|positive urine drug screen|1|||
155490136|NCT03996694|561219616|FG003|First Washout (7 Days)|positive urine drug screen|0|||
155490137|NCT03996694|561219617|FG004|First Washout (7 Days)|positive urine drug screen|0|||
155490138|NCT03996694|561219618|FG005|First Washout (7 Days)|positive urine drug screen|0|||
155490139|NCT03996694|561219613|FG000|First Washout (7 Days)|Adverse Event|0|||
155490140|NCT03996694|561219614|FG001|First Washout (7 Days)|Adverse Event|1|||
155490141|NCT03996694|561219615|FG002|First Washout (7 Days)|Adverse Event|0|||
155490142|NCT03996694|561219616|FG003|First Washout (7 Days)|Adverse Event|0|||
155490143|NCT03996694|561219617|FG004|First Washout (7 Days)|Adverse Event|0|||
155490144|NCT03996694|561219618|FG005|First Washout (7 Days)|Adverse Event|0|||
155490145|NCT03996694|561219613|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
155490146|NCT03996694|561219614|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
155490147|NCT03996694|561219615|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
155490148|NCT03996694|561219616|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
155490149|NCT03996694|561219617|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
155490150|NCT03996694|561219618|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
155490151|NCT03996694|561219613|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
155490152|NCT03996694|561219614|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
155490153|NCT03996694|561219615|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
155490154|NCT03996694|561219616|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
155490155|NCT03996694|561219617|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
155490156|NCT03996694|561219618|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
155490157|NCT02526017|561219624|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490158|NCT02526017|561219625|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490159|NCT02526017|561219626|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490160|NCT02526017|561219627|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490161|NCT02526017|561219628|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
155490162|NCT02526017|561219629|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490163|NCT02526017|561219630|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490164|NCT02526017|561219631|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490165|NCT02526017|561219632|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
155490166|NCT01548573|561219636|FG000|Overall Study|Death|3|||
155490167|NCT01548573|561219636|FG000|Overall Study|Withdrawal by Subject|2|||
155490168|NCT00447265|561219642|FG000|Overall Study|Physician Decision|1|||
155490169|NCT00447265|561219643|FG001|Overall Study|Physician Decision|0|||
155490170|NCT00503035|561219644|FG000|Overall Study|Lost to Follow-up|2|||
155490171|NCT00503035|561219644|FG000|Overall Study|Physician Decision|3|||
155490172|NCT00503035|561219644|FG000|Overall Study|Ineligible|15|||
155490173|NCT05028816|561219648|FG000|Overall Study|Lost to Follow-up|5|||
155490174|NCT05028816|561219649|FG001|Overall Study|Lost to Follow-up|3|||
155490175|NCT05028816|561219648|FG000|Overall Study|Withdrawal by Subject|4|||
155490176|NCT05028816|561219649|FG001|Overall Study|Withdrawal by Subject|1|||
155490177|NCT05028816|561219648|FG000|Overall Study|Physician Decision|1|||
155490178|NCT05028816|561219649|FG001|Overall Study|Physician Decision|0|||
155490179|NCT04576702|561219655|FG000|Overall Study|Death|1|||
155490180|NCT04576702|561219656|FG001|Overall Study|Death|0|||
155490181|NCT04576702|561219657|FG002|Overall Study|Death|0|||
155490182|NCT04576702|561219658|FG003|Overall Study|Death|0|||
155490183|NCT04576702|561219655|FG000|Overall Study|Withdrawal by Subject|0|||
155490184|NCT04576702|561219656|FG001|Overall Study|Withdrawal by Subject|2|||
155490185|NCT04576702|561219657|FG002|Overall Study|Withdrawal by Subject|1|||
155490186|NCT04576702|561219658|FG003|Overall Study|Withdrawal by Subject|0|||
155490187|NCT04576702|561219655|FG000|Overall Study|Lost to Follow-up|3|||
155490188|NCT04576702|561219656|FG001|Overall Study|Lost to Follow-up|3|||
155490189|NCT04576702|561219657|FG002|Overall Study|Lost to Follow-up|3|||
155490190|NCT04576702|561219658|FG003|Overall Study|Lost to Follow-up|4|||
155490191|NCT02985996|561219661|FG000|Overall Study|Withdrawal by Subject|0|||
155490192|NCT02985996|561219662|FG001|Overall Study|Withdrawal by Subject|0|||
155490193|NCT02985996|561219663|FG002|Overall Study|Withdrawal by Subject|1|||
155490194|NCT02985996|561219664|FG003|Overall Study|Withdrawal by Subject|0|||
155490195|NCT02985996|561219665|FG004|Overall Study|Withdrawal by Subject|0|||
155490196|NCT02985996|561219661|FG000|Overall Study|Protocol Violation|0|||
155490197|NCT02985996|561219662|FG001|Overall Study|Protocol Violation|1|||
155490198|NCT02985996|561219663|FG002|Overall Study|Protocol Violation|0|||
155490199|NCT02985996|561219664|FG003|Overall Study|Protocol Violation|0|||
155490200|NCT02985996|561219665|FG004|Overall Study|Protocol Violation|0|||
155490201|NCT00401726|561219666|FG000|Overall Study|Adverse Event|34|||
155490202|NCT00401726|561219667|FG001|Overall Study|Adverse Event|45|||
155490203|NCT00401726|561219666|FG000|Overall Study|Death|0|||
155490204|NCT00401726|561219667|FG001|Overall Study|Death|3|||
155490205|NCT00401726|561219666|FG000|Overall Study|Sponsor Request|0|||
155490206|NCT00401726|561219667|FG001|Overall Study|Sponsor Request|1|||
155490207|NCT00401726|561219666|FG000|Overall Study|Physician Decision|3|||
155490208|NCT00401726|561219667|FG001|Overall Study|Physician Decision|6|||
155490209|NCT00401726|561219666|FG000|Overall Study|Lost to Follow-up|23|||
155490210|NCT00401726|561219667|FG001|Overall Study|Lost to Follow-up|20|||
155490211|NCT00401726|561219666|FG000|Overall Study|Protocol Violation|6|||
155490212|NCT00401726|561219667|FG001|Overall Study|Protocol Violation|3|||
155490213|NCT00401726|561219666|FG000|Overall Study|Withdrawal by Subject|18|||
155490214|NCT00401726|561219667|FG001|Overall Study|Withdrawal by Subject|24|||
155490215|NCT00401726|561219666|FG000|Overall Study|Lack of Efficacy|4|||
155490216|NCT00401726|561219667|FG001|Overall Study|Lack of Efficacy|6|||
155490217|NCT00401726|561219666|FG000|Overall Study|Protocol Deviation|9|||
155490218|NCT00401726|561219667|FG001|Overall Study|Protocol Deviation|4|||
155490219|NCT02067728|561219668|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
155490220|NCT02067728|561219669|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
155490221|NCT02067728|561219668|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
155490222|NCT02067728|561219669|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
155490223|NCT02067728|561219668|FG000|6 Month Measurements|Unable to attend|114|||
155490224|NCT02067728|561219669|FG001|6 Month Measurements|Unable to attend|97|||
155490225|NCT00933543|561219671|FG000|Overall Study|Adverse Event|2|||
155490226|NCT00933543|561219672|FG001|Overall Study|Adverse Event|1|||
155490227|NCT00933543|561219671|FG000|Overall Study|Lost to Follow-up|0|||
155490228|NCT00933543|561219672|FG001|Overall Study|Lost to Follow-up|1|||
155490229|NCT00933543|561219671|FG000|Overall Study|Withdrawal by Subject|0|||
155490230|NCT00933543|561219672|FG001|Overall Study|Withdrawal by Subject|1|||
155490231|NCT00933543|561219671|FG000|Overall Study|Lack of Efficacy|0|||
155490232|NCT00933543|561219672|FG001|Overall Study|Lack of Efficacy|3|||
155490233|NCT00933543|561219671|FG000|Overall Study|Other|1|||
155490234|NCT00933543|561219672|FG001|Overall Study|Other|1|||
155490235|NCT04988035|561219674|FG000|Overall Study|Death|19|||
155490236|NCT04988035|561219675|FG001|Overall Study|Death|13|||
155490237|NCT04988035|561219674|FG000|Overall Study|Lost to Follow-up|12|||
155490238|NCT04988035|561219675|FG001|Overall Study|Lost to Follow-up|6|||
155490239|NCT04988035|561219674|FG000|Overall Study|Protocol Violation|0|||
155490240|NCT04988035|561219675|FG001|Overall Study|Protocol Violation|1|||
155490241|NCT04988035|561219674|FG000|Overall Study|Withdrawal by Subject|2|||
155490242|NCT04988035|561219675|FG001|Overall Study|Withdrawal by Subject|4|||
155490243|NCT04988035|561219674|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
155490244|NCT04988035|561219675|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
155490245|NCT03532048|561219676|FG000|Overall Study|Lost to Follow-up|12|||
155490246|NCT03532048|561219677|FG001|Overall Study|Lost to Follow-up|17|||
155656297|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
155490247|NCT03532048|561219676|FG000|Overall Study|Withdrawal by Subject|7|||
155490248|NCT03532048|561219677|FG001|Overall Study|Withdrawal by Subject|0|||
155490249|NCT03557775|561219678|FG000|Overall Study|Withdrawal by Subject|1|||
155490250|NCT03557775|561219679|FG001|Overall Study|Withdrawal by Subject|2|||
155490251|NCT03557775|561219680|FG002|Overall Study|Withdrawal by Subject|4|||
155490252|NCT03557775|561219678|FG000|Overall Study|Physician Decision|0|||
155490253|NCT03557775|561219679|FG001|Overall Study|Physician Decision|1|||
155490254|NCT03557775|561219680|FG002|Overall Study|Physician Decision|0|||
155490255|NCT00308555|561219685|FG000|Overall Study|Withdrawal by Subject|1|||
155490256|NCT00308555|561219686|FG001|Overall Study|Withdrawal by Subject|0|||
155490257|NCT00308555|561219685|FG000|Overall Study|Physician Decision|2|||
155490258|NCT00308555|561219686|FG001|Overall Study|Physician Decision|0|||
155490259|NCT04113746|561219690|FG000|Overall Study|Lost to Follow-up|4|||
155490260|NCT04113746|561219691|FG001|Overall Study|Lost to Follow-up|4|||
155490261|NCT01050998|561219693|FG000|Overall Study|Adverse Event|1|||
155490262|NCT01050998|561219694|FG001|Overall Study|Adverse Event|0|||
155490263|NCT01050998|561219695|FG002|Overall Study|Adverse Event|1|||
155490264|NCT01050998|561219696|FG003|Overall Study|Adverse Event|0|||
155490265|NCT01050998|561219697|FG004|Overall Study|Adverse Event|2|||
155490266|NCT01050998|561219693|FG000|Overall Study|Withdrawal by Subject|0|||
155490267|NCT01050998|561219694|FG001|Overall Study|Withdrawal by Subject|0|||
155490268|NCT01050998|561219695|FG002|Overall Study|Withdrawal by Subject|0|||
155490269|NCT01050998|561219696|FG003|Overall Study|Withdrawal by Subject|1|||
155490270|NCT01050998|561219697|FG004|Overall Study|Withdrawal by Subject|3|||
155490271|NCT01050998|561219693|FG000|Overall Study|Other|3|||
155490272|NCT01050998|561219694|FG001|Overall Study|Other|2|||
155490273|NCT01050998|561219695|FG002|Overall Study|Other|1|||
155490274|NCT01050998|561219696|FG003|Overall Study|Other|1|||
155490275|NCT01050998|561219697|FG004|Overall Study|Other|5|||
155490276|NCT01050998|561219693|FG000|Overall Study|Data integrity issues|0|||
155490277|NCT01050998|561219694|FG001|Overall Study|Data integrity issues|0|||
155490278|NCT01050998|561219695|FG002|Overall Study|Data integrity issues|1|||
155490279|NCT01050998|561219696|FG003|Overall Study|Data integrity issues|1|||
155490280|NCT01050998|561219697|FG004|Overall Study|Data integrity issues|4|||
155490281|NCT01428882|561219700|FG000|Overall Study|Lack of Efficacy|2|||
155490282|NCT01428882|561219701|FG001|Overall Study|Lack of Efficacy|7|||
155490283|NCT01428882|561219700|FG000|Overall Study|Protocol Violation|4|||
155490284|NCT01428882|561219701|FG001|Overall Study|Protocol Violation|3|||
155490285|NCT00429026|561219708|FG000|Overall Study|Inevaluable for response.|40|||
155490286|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
155490287|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
155490288|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
155490289|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
155490290|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
155490291|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
155490292|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
155490293|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
155490294|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
155490295|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
155490296|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
155490297|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
155490298|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
155656298|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
155490299|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
155490300|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
155490301|NCT01694849|561219709|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
155490302|NCT01694849|561219710|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
155490303|NCT01694849|561219711|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
155490304|NCT01694849|561219709|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
155490305|NCT01694849|561219710|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
155490306|NCT01694849|561219711|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
155490307|NCT01694849|561219709|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
155490308|NCT01694849|561219710|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
155490309|NCT01694849|561219711|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
155490310|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
155490311|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
155490312|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
155490313|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
155490314|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
155490315|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
155490316|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
155490317|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
155490318|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
155490319|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
155490320|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
155490321|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
155490322|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
155490323|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
155490324|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
155490325|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
155490326|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
155490327|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
155490328|NCT00570492|561219716|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
155490329|NCT00570492|561219717|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
155490330|NCT00570492|561219718|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
155490331|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155490332|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
155490333|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
155490334|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
155490335|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
155490336|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
155490337|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
155490338|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
155490339|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
155490340|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
155490341|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
155490342|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
155490343|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
155490344|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
155490345|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
155490346|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
155490347|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
155490348|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
155490349|NCT00570492|561219716|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
155656299|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
155656300|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
155656301|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
155656302|NCT00086515|561835178|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
155656303|NCT00086515|561835179|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
155656304|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
155656305|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
155656306|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
155656307|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
155656308|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
155656309|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
155656310|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
155656311|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
155656312|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
155656313|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
155721135|NCT02587221|562077762|FG000|Overall Study|Adverse Event|3|||
155721136|NCT02587221|562077763|FG001|Overall Study|Adverse Event|3|||
155721137|NCT02587221|562077762|FG000|Overall Study|Death|33|||
155721138|NCT02587221|562077763|FG001|Overall Study|Death|34|||
155721139|NCT02587221|562077762|FG000|Overall Study|Withdrawal by Subject|66|||
155490350|NCT00570492|561219717|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
155490351|NCT00570492|561219718|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
155490352|NCT00976989|561219719|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155490353|NCT00976989|561219720|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155490354|NCT00976989|561219721|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
155490355|NCT00976989|561219719|FG000|Overall Study|Death|5|||
155490356|NCT00976989|561219720|FG001|Overall Study|Death|7|||
155490357|NCT00976989|561219721|FG002|Overall Study|Death|10|||
155490358|NCT00976989|561219719|FG000|Overall Study|Refused Treatment|4|||
155490359|NCT00976989|561219720|FG001|Overall Study|Refused Treatment|3|||
155490360|NCT00976989|561219721|FG002|Overall Study|Refused Treatment|5|||
155490361|NCT00976989|561219719|FG000|Overall Study|Failure to Return|2|||
155490362|NCT00976989|561219720|FG001|Overall Study|Failure to Return|1|||
155490363|NCT00976989|561219721|FG002|Overall Study|Failure to Return|0|||
155490364|NCT00976989|561219719|FG000|Overall Study|Recurrence of Disease|0|||
155490365|NCT00976989|561219720|FG001|Overall Study|Recurrence of Disease|1|||
155490366|NCT00976989|561219721|FG002|Overall Study|Recurrence of Disease|0|||
155490367|NCT00976989|561219719|FG000|Overall Study|Other|1|||
155490368|NCT00976989|561219720|FG001|Overall Study|Other|0|||
155490369|NCT00976989|561219721|FG002|Overall Study|Other|1|||
155490370|NCT00752206|561219724|FG000|Overall Study|Disease progression|8|||
155490371|NCT00752206|561219725|FG001|Overall Study|Disease progression|11|||
155490372|NCT00752206|561219724|FG000|Overall Study|Pregnancy|1|||
155656314|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
155656315|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
155490373|NCT00752206|561219725|FG001|Overall Study|Pregnancy|0|||
155490374|NCT01484691|561219726|FG000|Overall Study|Withdrawal by Subject|1|||
155490375|NCT01484691|561219727|FG001|Overall Study|Withdrawal by Subject|1|||
155490376|NCT01484691|561219728|FG002|Overall Study|Withdrawal by Subject|1|||
155490377|NCT01484691|561219726|FG000|Overall Study|Physician Decision|0|||
155490378|NCT01484691|561219727|FG001|Overall Study|Physician Decision|2|||
155490379|NCT01484691|561219728|FG002|Overall Study|Physician Decision|1|||
155490380|NCT04668157|561219733|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
155490381|NCT04668157|561219734|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
155656316|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
155490382|NCT04668157|561219733|FG000|Treatment Period (52 Weeks)|Other|0|||
155490383|NCT04668157|561219734|FG001|Treatment Period (52 Weeks)|Other|2|||
155490384|NCT03958045|561219735|FG000|Overall Study|Withdrawal by Subject|1|||
155490385|NCT05437211|561219740|FG000|Overall Study|Patient's decision|1|||
155656317|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
155656318|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
155656319|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
155656320|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
155656321|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
155656322|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
155656323|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
155490386|NCT05437211|561219741|FG001|Overall Study|Patient's decision|1|||
155490387|NCT00674440|561219742|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
155490388|NCT00674440|561219742|FG000|Overall Study|did not have surgery, so unevaluable|7|||
155490389|NCT00674440|561219742|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
155490390|NCT02221882|561219743|FG000|Overall Study|Withdrawal by Subject|0|||
155490391|NCT02221882|561219744|FG001|Overall Study|Withdrawal by Subject|0|||
155490392|NCT02221882|561219745|FG002|Overall Study|Withdrawal by Subject|4|||
155490393|NCT02221882|561219746|FG003|Overall Study|Withdrawal by Subject|2|||
155490394|NCT02221882|561219747|FG004|Overall Study|Withdrawal by Subject|2|||
155490395|NCT02221882|561219748|FG005|Overall Study|Withdrawal by Subject|2|||
155490396|NCT02221882|561219743|FG000|Overall Study|Death|0|||
155490397|NCT02221882|561219744|FG001|Overall Study|Death|1|||
155490398|NCT02221882|561219745|FG002|Overall Study|Death|0|||
155490399|NCT02221882|561219746|FG003|Overall Study|Death|0|||
155490400|NCT02221882|561219747|FG004|Overall Study|Death|0|||
155490401|NCT02221882|561219748|FG005|Overall Study|Death|0|||
155490402|NCT00796367|561219749|FG000|Overall Study|Adverse Event|6|||
155490403|NCT00796367|561219750|FG001|Overall Study|Adverse Event|4|||
155490404|NCT00796367|561219751|FG002|Overall Study|Adverse Event|7|||
155490405|NCT00796367|561219749|FG000|Overall Study|Lost to Follow-up|5|||
155490406|NCT00796367|561219750|FG001|Overall Study|Lost to Follow-up|4|||
155490407|NCT00796367|561219751|FG002|Overall Study|Lost to Follow-up|21|||
155490408|NCT00796367|561219749|FG000|Overall Study|Withdrawal by Subject|9|||
155490409|NCT00796367|561219750|FG001|Overall Study|Withdrawal by Subject|11|||
155490410|NCT00796367|561219751|FG002|Overall Study|Withdrawal by Subject|12|||
155490411|NCT00796367|561219749|FG000|Overall Study|Lack of Efficacy|2|||
155490412|NCT00796367|561219750|FG001|Overall Study|Lack of Efficacy|1|||
155490413|NCT00796367|561219751|FG002|Overall Study|Lack of Efficacy|0|||
155490414|NCT00796367|561219749|FG000|Overall Study|non compliance|3|||
155490415|NCT00796367|561219750|FG001|Overall Study|non compliance|1|||
155490416|NCT00796367|561219751|FG002|Overall Study|non compliance|1|||
155490417|NCT00796367|561219749|FG000|Overall Study|Pregnancy|1|||
155490418|NCT00796367|561219750|FG001|Overall Study|Pregnancy|0|||
155490419|NCT00796367|561219751|FG002|Overall Study|Pregnancy|1|||
155490420|NCT00796367|561219749|FG000|Overall Study|Requirement for restricted medication|2|||
155490421|NCT00796367|561219750|FG001|Overall Study|Requirement for restricted medication|0|||
155490422|NCT00796367|561219751|FG002|Overall Study|Requirement for restricted medication|2|||
155490423|NCT00796367|561219749|FG000|Overall Study|other|2|||
155490424|NCT00796367|561219750|FG001|Overall Study|other|4|||
155490425|NCT00796367|561219751|FG002|Overall Study|other|3|||
155490426|NCT04095039|561219757|FG000|Overall Study|Withdrawal by Subject|2|||
155490427|NCT04095039|561219758|FG001|Overall Study|Withdrawal by Subject|16|||
155490428|NCT04095039|561219757|FG000|Overall Study|Transplanted|21|||
155490429|NCT04095039|561219758|FG001|Overall Study|Transplanted|24|||
155490430|NCT04095039|561219757|FG000|Overall Study|Transferred to Non-study Facility|47|||
155490431|NCT04095039|561219758|FG001|Overall Study|Transferred to Non-study Facility|44|||
155490432|NCT04095039|561219757|FG000|Overall Study|Withdrawal from internvention target|0|||
155490433|NCT04095039|561219758|FG001|Overall Study|Withdrawal from internvention target|2|||
155490434|NCT04095039|561219757|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
155656324|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
155656325|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
155656326|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
155656327|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
155656328|NCT00086515|561835178|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
155656329|NCT00086515|561835179|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
155490435|NCT04095039|561219758|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
155490436|NCT04095039|561219757|FG000|Overall Study|Cacliphylaxis|0|||
155490437|NCT04095039|561219758|FG001|Overall Study|Cacliphylaxis|1|||
155490438|NCT04095039|561219757|FG000|Overall Study|Pregnancy|1|||
155490439|NCT04095039|561219758|FG001|Overall Study|Pregnancy|0|||
155490440|NCT04794491|561219759|FG000|Overall Study|Adverse Event|1|||
155490441|NCT04794491|561219759|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
155490442|NCT04794491|561219759|FG000|Overall Study|Noncompliance With Study Intervention|1|||
155490443|NCT04794491|561219759|FG000|Overall Study|Withdrawal by Subject|2|||
155490444|NCT01314261|561219762|FG000|Overall Study|Adverse Event|1|||
155490445|NCT01314261|561219763|FG001|Overall Study|Adverse Event|0|||
155490446|NCT01314261|561219764|FG002|Overall Study|Adverse Event|0|||
155490447|NCT01314261|561219765|FG003|Overall Study|Adverse Event|0|||
155490448|NCT01314261|561219762|FG000|Overall Study|Withdrawal by Subject|0|||
155490449|NCT01314261|561219763|FG001|Overall Study|Withdrawal by Subject|3|||
155490450|NCT01314261|561219764|FG002|Overall Study|Withdrawal by Subject|1|||
155490451|NCT01314261|561219765|FG003|Overall Study|Withdrawal by Subject|0|||
155490452|NCT01314261|561219762|FG000|Overall Study|Lost to Follow-up|1|||
155490453|NCT01314261|561219763|FG001|Overall Study|Lost to Follow-up|0|||
155490454|NCT01314261|561219764|FG002|Overall Study|Lost to Follow-up|2|||
155490455|NCT01314261|561219765|FG003|Overall Study|Lost to Follow-up|2|||
155490456|NCT01314261|561219762|FG000|Overall Study|Virologic Failure|0|||
155490457|NCT01314261|561219763|FG001|Overall Study|Virologic Failure|1|||
155490458|NCT01314261|561219764|FG002|Overall Study|Virologic Failure|0|||
155490459|NCT01314261|561219765|FG003|Overall Study|Virologic Failure|1|||
155490460|NCT02129192|561219766|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
155490461|NCT02129192|561219767|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
155490462|NCT01231620|561219768|FG000|Overall Study|Physician Decision|3|||
155490463|NCT01231620|561219769|FG001|Overall Study|Physician Decision|5|||
155490464|NCT01231620|561219770|FG002|Overall Study|Physician Decision|10|||
155544082|NCT02315066|561417367|FG006|Overall Study|Subject refused further follow-up|2|||
155544083|NCT02315066|561417368|FG007|Overall Study|Subject refused further follow-up|3|||
155490465|NCT01231620|561219768|FG000|Overall Study|Death|12|||
155490466|NCT01231620|561219769|FG001|Overall Study|Death|14|||
155544084|NCT02315066|561417369|FG008|Overall Study|Subject refused further follow-up|0|||
155544085|NCT02315066|561417370|FG009|Overall Study|Subject refused further follow-up|1|||
155490467|NCT01231620|561219770|FG002|Overall Study|Death|11|||
155656330|NCT01435356|561835180|FG000|Overall Study|Adverse Event|2|||
155490468|NCT01231620|561219768|FG000|Overall Study|Adverse Event|2|||
155490469|NCT01231620|561219769|FG001|Overall Study|Adverse Event|2|||
155490470|NCT01231620|561219770|FG002|Overall Study|Adverse Event|1|||
155490471|NCT01231620|561219768|FG000|Overall Study|Withdrawal by Subject|6|||
155490472|NCT01231620|561219769|FG001|Overall Study|Withdrawal by Subject|6|||
155490473|NCT01231620|561219770|FG002|Overall Study|Withdrawal by Subject|8|||
155490474|NCT01231620|561219768|FG000|Overall Study|Lost to Follow-up|3|||
155490475|NCT01231620|561219769|FG001|Overall Study|Lost to Follow-up|4|||
155490476|NCT01231620|561219770|FG002|Overall Study|Lost to Follow-up|9|||
155490477|NCT04557189|561219780|FG000|Overall Study|Adverse Event|0|||
155490478|NCT04557189|561219781|FG001|Overall Study|Adverse Event|1|||
155490479|NCT04557189|561219780|FG000|Overall Study|Lost to Follow-up|1|||
155490480|NCT04557189|561219781|FG001|Overall Study|Lost to Follow-up|1|||
155490481|NCT04557189|561219780|FG000|Overall Study|Withdrawal by Subject|2|||
155490482|NCT04557189|561219781|FG001|Overall Study|Withdrawal by Subject|1|||
155490483|NCT04557189|561219780|FG000|Overall Study|Reason not Specified|3|||
155490484|NCT04557189|561219781|FG001|Overall Study|Reason not Specified|6|||
155490485|NCT01479777|561221346|FG000|Overall Study|Physician Decision|2|||
155490486|NCT00869362|561221352|FG000|Overall Study|Death|0|||
155490487|NCT00869362|561221353|FG001|Overall Study|Death|2|||
155490488|NCT00869362|561221352|FG000|Overall Study|Lost to Follow-up|1|||
155490489|NCT00869362|561221353|FG001|Overall Study|Lost to Follow-up|3|||
155490490|NCT01241591|561221354|FG000|Overall Study|Lack of Efficacy|5|||
155490491|NCT01241591|561221355|FG001|Overall Study|Lack of Efficacy|2|||
155490492|NCT01241591|561221356|FG002|Overall Study|Lack of Efficacy|2|||
155490493|NCT01241591|561221357|FG003|Overall Study|Lack of Efficacy|3|||
155490494|NCT01241591|561221354|FG000|Overall Study|Protocol Violation|5|||
155490495|NCT01241591|561221355|FG001|Overall Study|Protocol Violation|2|||
155490496|NCT01241591|561221356|FG002|Overall Study|Protocol Violation|3|||
155490497|NCT01241591|561221357|FG003|Overall Study|Protocol Violation|0|||
155490498|NCT01241591|561221354|FG000|Overall Study|Lost to Follow-up|1|||
155490499|NCT01241591|561221355|FG001|Overall Study|Lost to Follow-up|2|||
155490500|NCT01241591|561221356|FG002|Overall Study|Lost to Follow-up|2|||
155490501|NCT01241591|561221357|FG003|Overall Study|Lost to Follow-up|2|||
155490502|NCT01241591|561221354|FG000|Overall Study|Screen Failure|3|||
155490503|NCT01241591|561221355|FG001|Overall Study|Screen Failure|2|||
155490504|NCT01241591|561221356|FG002|Overall Study|Screen Failure|1|||
155490505|NCT01241591|561221357|FG003|Overall Study|Screen Failure|0|||
155490506|NCT01241591|561221354|FG000|Overall Study|Withdrawal by Subject|6|||
155490507|NCT01241591|561221355|FG001|Overall Study|Withdrawal by Subject|4|||
155490508|NCT01241591|561221356|FG002|Overall Study|Withdrawal by Subject|2|||
155490509|NCT01241591|561221357|FG003|Overall Study|Withdrawal by Subject|2|||
155490510|NCT01241591|561221354|FG000|Overall Study|Other|0|||
155490511|NCT01241591|561221355|FG001|Overall Study|Other|1|||
155490512|NCT01241591|561221356|FG002|Overall Study|Other|0|||
155490513|NCT01241591|561221357|FG003|Overall Study|Other|1|||
155490514|NCT01241591|561221354|FG000|Overall Study|Adverse Event|3|||
155490515|NCT01241591|561221355|FG001|Overall Study|Adverse Event|11|||
155490516|NCT01241591|561221356|FG002|Overall Study|Adverse Event|12|||
155490517|NCT01241591|561221357|FG003|Overall Study|Adverse Event|4|||
155490518|NCT02389621|561221361|FG000|Treatment Period|Withdrawal by Subject|1|||
155490519|NCT02389621|561221362|FG001|Treatment Period|Withdrawal by Subject|1|||
155490520|NCT02389621|561221361|FG000|Posttreatment Period|Adverse Event|3|||
155490521|NCT02389621|561221362|FG001|Posttreatment Period|Adverse Event|1|||
155490522|NCT02389621|561221361|FG000|Posttreatment Period|Withdrawal by Subject|3|||
155490523|NCT02389621|561221362|FG001|Posttreatment Period|Withdrawal by Subject|2|||
155490524|NCT02389621|561221361|FG000|Posttreatment Period|Lost to Follow-up|1|||
155490525|NCT02389621|561221362|FG001|Posttreatment Period|Lost to Follow-up|1|||
155490526|NCT02389621|561221361|FG000|Posttreatment Period|Other - Miscellaneous|2|||
155490527|NCT02389621|561221362|FG001|Posttreatment Period|Other - Miscellaneous|0|||
155490528|NCT02815540|561221365|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
155490529|NCT00726882|561221366|FG000|Overall Study|Withdrawal by Subject|5|||
155490530|NCT00726882|561221366|FG000|Overall Study|Lost to Follow-up|7|||
155490531|NCT00726882|561221366|FG000|Overall Study|Other|10|||
155490532|NCT00594568|561221367|FG000|Initial Treatment|Adverse Event|51|||
155490533|NCT00594568|561221368|FG001|Initial Treatment|Adverse Event|121|||
155490534|NCT00594568|561221369|FG002|Initial Treatment|Adverse Event|144|||
155490535|NCT00594568|561221367|FG000|Initial Treatment|Death|6|||
155490536|NCT00594568|561221368|FG001|Initial Treatment|Death|11|||
155490537|NCT00594568|561221369|FG002|Initial Treatment|Death|15|||
155490538|NCT00594568|561221367|FG000|Initial Treatment|Lost to Follow-up|4|||
155490539|NCT00594568|561221368|FG001|Initial Treatment|Lost to Follow-up|1|||
155490540|NCT00594568|561221369|FG002|Initial Treatment|Lost to Follow-up|4|||
155490541|NCT00594568|561221367|FG000|Initial Treatment|Physician Decision|3|||
155490542|NCT00594568|561221368|FG001|Initial Treatment|Physician Decision|2|||
155490543|NCT00594568|561221369|FG002|Initial Treatment|Physician Decision|4|||
155490544|NCT00594568|561221367|FG000|Initial Treatment|Protocol Violation|2|||
155490545|NCT00594568|561221368|FG001|Initial Treatment|Protocol Violation|2|||
155490546|NCT00594568|561221369|FG002|Initial Treatment|Protocol Violation|5|||
155490547|NCT00594568|561221367|FG000|Initial Treatment|Withdrawal by Subject|25|||
155490548|NCT00594568|561221368|FG001|Initial Treatment|Withdrawal by Subject|31|||
155490549|NCT00594568|561221369|FG002|Initial Treatment|Withdrawal by Subject|46|||
155490550|NCT00594568|561221367|FG000|Initial Treatment|Sponsor decision|193|||
155490551|NCT00594568|561221368|FG001|Initial Treatment|Sponsor decision|142|||
155490552|NCT00594568|561221369|FG002|Initial Treatment|Sponsor decision|147|||
155490553|NCT00594568|561221367|FG000|Initial Treatment|Caregiver decision|21|||
155490554|NCT00594568|561221368|FG001|Initial Treatment|Caregiver decision|36|||
155490555|NCT00594568|561221369|FG002|Initial Treatment|Caregiver decision|36|||
155490556|NCT00594568|561221367|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
155490557|NCT00594568|561221368|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
155490558|NCT00594568|561221369|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
155490559|NCT00594568|561221367|FG000|Initial Treatment|Entry criteria exclusion|0|||
155544086|NCT02315066|561417371|FG010|Overall Study|Subject refused further follow-up|1|||
155544087|NCT02315066|561417372|FG011|Overall Study|Subject refused further follow-up|2|||
155544088|NCT02315066|561417373|FG012|Overall Study|Subject refused further follow-up|2|||
155544089|NCT02315066|561417374|FG013|Overall Study|Subject refused further follow-up|4|||
155544090|NCT02315066|561417361|FG000|Overall Study|Study ongoing at date of cut-off|0|||
155544091|NCT02315066|561417362|FG001|Overall Study|Study ongoing at date of cut-off|0|||
155544092|NCT02315066|561417363|FG002|Overall Study|Study ongoing at date of cut-off|0|||
155544093|NCT02315066|561417364|FG003|Overall Study|Study ongoing at date of cut-off|0|||
155544094|NCT02315066|561417365|FG004|Overall Study|Study ongoing at date of cut-off|0|||
155544095|NCT02315066|561417366|FG005|Overall Study|Study ongoing at date of cut-off|0|||
155544096|NCT02315066|561417367|FG006|Overall Study|Study ongoing at date of cut-off|0|||
155544097|NCT02315066|561417368|FG007|Overall Study|Study ongoing at date of cut-off|0|||
155544098|NCT02315066|561417369|FG008|Overall Study|Study ongoing at date of cut-off|0|||
155544099|NCT02315066|561417370|FG009|Overall Study|Study ongoing at date of cut-off|0|||
155544100|NCT02315066|561417371|FG010|Overall Study|Study ongoing at date of cut-off|0|||
155544101|NCT02315066|561417372|FG011|Overall Study|Study ongoing at date of cut-off|0|||
155544102|NCT02315066|561417373|FG012|Overall Study|Study ongoing at date of cut-off|0|||
155544103|NCT02315066|561417374|FG013|Overall Study|Study ongoing at date of cut-off|1|||
155544104|NCT02916693|561417375|FG000|Overall Study|Lost to Follow-up|7|||
155544105|NCT01190930|561417376|FG000|Induction|Adverse Event|17|||
155544106|NCT01190930|561417377|FG001|Induction|Adverse Event|0|||
155544107|NCT01190930|561417378|FG002|Induction|Adverse Event|0|||
155544108|NCT01190930|561417379|FG003|Induction|Adverse Event|0|||
155544109|NCT01190930|561417380|FG004|Induction|Adverse Event|0|||
155544110|NCT01190930|561417381|FG005|Induction|Adverse Event|0|||
155544111|NCT01190930|561417382|FG006|Induction|Adverse Event|0|||
155544112|NCT01190930|561417383|FG007|Induction|Adverse Event|0|||
155544113|NCT01190930|561417384|FG008|Induction|Adverse Event|0|||
155544114|NCT01190930|561417385|FG009|Induction|Adverse Event|0|||
155544115|NCT01190930|561417376|FG000|Induction|Death|34|||
155544116|NCT01190930|561417377|FG001|Induction|Death|0|||
155544117|NCT01190930|561417378|FG002|Induction|Death|0|||
155544118|NCT01190930|561417379|FG003|Induction|Death|0|||
155544119|NCT01190930|561417380|FG004|Induction|Death|0|||
155544120|NCT01190930|561417381|FG005|Induction|Death|0|||
155544121|NCT01190930|561417382|FG006|Induction|Death|0|||
155544122|NCT01190930|561417383|FG007|Induction|Death|0|||
155544123|NCT01190930|561417384|FG008|Induction|Death|0|||
155544124|NCT01190930|561417385|FG009|Induction|Death|0|||
155544125|NCT01190930|561417376|FG000|Induction|Lost to Follow-up|1|||
155544126|NCT01190930|561417377|FG001|Induction|Lost to Follow-up|0|||
155544127|NCT01190930|561417378|FG002|Induction|Lost to Follow-up|0|||
155544128|NCT01190930|561417379|FG003|Induction|Lost to Follow-up|0|||
155544129|NCT01190930|561417380|FG004|Induction|Lost to Follow-up|0|||
155544130|NCT01190930|561417381|FG005|Induction|Lost to Follow-up|0|||
155544131|NCT01190930|561417382|FG006|Induction|Lost to Follow-up|0|||
155544132|NCT01190930|561417383|FG007|Induction|Lost to Follow-up|0|||
155544133|NCT01190930|561417384|FG008|Induction|Lost to Follow-up|0|||
155544134|NCT01190930|561417385|FG009|Induction|Lost to Follow-up|0|||
155544135|NCT01190930|561417376|FG000|Induction|Physician Decision|125|||
155544136|NCT01190930|561417377|FG001|Induction|Physician Decision|3|||
155544137|NCT01190930|561417378|FG002|Induction|Physician Decision|0|||
155544138|NCT01190930|561417379|FG003|Induction|Physician Decision|0|||
155544139|NCT01190930|561417380|FG004|Induction|Physician Decision|0|||
155544140|NCT01190930|561417381|FG005|Induction|Physician Decision|0|||
155544141|NCT01190930|561417382|FG006|Induction|Physician Decision|0|||
155544142|NCT01190930|561417383|FG007|Induction|Physician Decision|0|||
155544143|NCT01190930|561417384|FG008|Induction|Physician Decision|0|||
155544144|NCT01190930|561417385|FG009|Induction|Physician Decision|0|||
155544145|NCT01190930|561417376|FG000|Induction|Withdrawal by Subject|9|||
155544146|NCT01190930|561417377|FG001|Induction|Withdrawal by Subject|0|||
155544147|NCT01190930|561417378|FG002|Induction|Withdrawal by Subject|0|||
155544148|NCT01190930|561417379|FG003|Induction|Withdrawal by Subject|0|||
155544149|NCT01190930|561417380|FG004|Induction|Withdrawal by Subject|0|||
155544150|NCT01190930|561417381|FG005|Induction|Withdrawal by Subject|0|||
155544151|NCT01190930|561417382|FG006|Induction|Withdrawal by Subject|0|||
155544152|NCT01190930|561417383|FG007|Induction|Withdrawal by Subject|0|||
155544153|NCT01190930|561417384|FG008|Induction|Withdrawal by Subject|0|||
155544154|NCT01190930|561417385|FG009|Induction|Withdrawal by Subject|0|||
155544155|NCT01190930|561417376|FG000|Induction|Refusal|235|||
155544156|NCT01190930|561417377|FG001|Induction|Refusal|0|||
155544157|NCT01190930|561417378|FG002|Induction|Refusal|0|||
155544158|NCT01190930|561417379|FG003|Induction|Refusal|0|||
155544159|NCT01190930|561417380|FG004|Induction|Refusal|0|||
155544160|NCT01190930|561417381|FG005|Induction|Refusal|0|||
155544161|NCT01190930|561417382|FG006|Induction|Refusal|0|||
155544162|NCT01190930|561417383|FG007|Induction|Refusal|0|||
155544163|NCT01190930|561417384|FG008|Induction|Refusal|0|||
155544164|NCT01190930|561417385|FG009|Induction|Refusal|0|||
155544165|NCT01190930|561417376|FG000|Induction|Inevaluable|23|||
155544166|NCT01190930|561417377|FG001|Induction|Inevaluable|1|||
155544167|NCT01190930|561417378|FG002|Induction|Inevaluable|0|||
155544168|NCT01190930|561417379|FG003|Induction|Inevaluable|0|||
155544169|NCT01190930|561417380|FG004|Induction|Inevaluable|0|||
155544170|NCT01190930|561417381|FG005|Induction|Inevaluable|0|||
155544171|NCT01190930|561417382|FG006|Induction|Inevaluable|0|||
155544172|NCT01190930|561417383|FG007|Induction|Inevaluable|0|||
155544173|NCT01190930|561417384|FG008|Induction|Inevaluable|0|||
155656331|NCT01435356|561835181|FG001|Overall Study|Adverse Event|0|||
155656332|NCT01435356|561835180|FG000|Overall Study|Disease progression/recurrence|17|||
155656333|NCT01435356|561835181|FG001|Overall Study|Disease progression/recurrence|10|||
155656334|NCT01435356|561835180|FG000|Overall Study|Protocol Violation|0|||
155656335|NCT01435356|561835181|FG001|Overall Study|Protocol Violation|1|||
155656336|NCT01435356|561835180|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
155656337|NCT01435356|561835181|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
155656338|NCT01435356|561835180|FG000|Overall Study|Withdrawal by Subject|1|||
155656339|NCT01435356|561835181|FG001|Overall Study|Withdrawal by Subject|1|||
155656340|NCT01435356|561835180|FG000|Overall Study|Facial palsy|1|||
155656341|NCT01435356|561835181|FG001|Overall Study|Facial palsy|0|||
155656342|NCT01435356|561835180|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
155656343|NCT01435356|561835181|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
155656344|NCT01435356|561835180|FG000|Overall Study|Physician Decision|1|||
155656345|NCT01435356|561835181|FG001|Overall Study|Physician Decision|0|||
155656346|NCT01435356|561835180|FG000|Overall Study|Patient decision|3|||
155656347|NCT01435356|561835181|FG001|Overall Study|Patient decision|0|||
155656348|NCT01435356|561835180|FG000|Overall Study|Patient moved to another city|1|||
155656349|NCT01435356|561835181|FG001|Overall Study|Patient moved to another city|1|||
155656350|NCT02796651|561835182|FG000|Overall Study|Adverse Event|6|||
155656351|NCT02796651|561835182|FG000|Overall Study|Lost to Follow-up|1|||
155656352|NCT02796651|561835182|FG000|Overall Study|Withdrawal by Subject|4|||
155656353|NCT02796651|561835182|FG000|Overall Study|Protocol Violation|4|||
155656354|NCT02796651|561835182|FG000|Overall Study|Lack of Efficacy|1|||
155656355|NCT02796651|561835182|FG000|Overall Study|Other|10|||
155656356|NCT02251041|561835186|FG000|Overall Study|Did not receive intervention|15|||
155656357|NCT02251041|561835187|FG001|Overall Study|Did not receive intervention|4|||
155656358|NCT02971163|561835190|FG000|Overall Study|Lost to Follow-up|4|||
155656359|NCT02971163|561835191|FG001|Overall Study|Lost to Follow-up|2|||
155656360|NCT00526799|561835192|FG000|Overall Study|Withdrawal by Subject|1|||
155656361|NCT00526799|561835193|FG001|Overall Study|Withdrawal by Subject|0|||
155656362|NCT00526799|561835192|FG000|Overall Study|Intercurrent Complicating Disease|0|||
155656363|NCT00526799|561835193|FG001|Overall Study|Intercurrent Complicating Disease|1|||
155656364|NCT02871219|561835195|FG000|Overall Study|Adverse Event|15|||
155544174|NCT01190930|561417385|FG009|Induction|Inevaluable|0|||
155544175|NCT01190930|561417376|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
155544176|NCT01190930|561417377|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544177|NCT01190930|561417378|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544178|NCT01190930|561417379|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544179|NCT01190930|561417380|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544180|NCT01190930|561417381|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544181|NCT01190930|561417382|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544182|NCT01190930|561417383|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544183|NCT01190930|561417384|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544184|NCT01190930|561417385|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
155544185|NCT01190930|561417376|FG000|Induction|High Risk Downs|80|||
155544186|NCT01190930|561417377|FG001|Induction|High Risk Downs|0|||
155544187|NCT01190930|561417378|FG002|Induction|High Risk Downs|0|||
155544188|NCT01190930|561417379|FG003|Induction|High Risk Downs|0|||
155544189|NCT01190930|561417380|FG004|Induction|High Risk Downs|0|||
155656365|NCT02871219|561835195|FG000|Overall Study|Death|3|||
155656366|NCT02871219|561835195|FG000|Overall Study|Progression|3|||
155656367|NCT02871219|561835195|FG000|Overall Study|Infections|7|||
155656368|NCT02871219|561835195|FG000|Overall Study|Infusion Related|4|||
155656369|NCT03034044|561835197|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
155656370|NCT04134936|561835198|FG000|Overall Study|Adverse Event|3|||
155656371|NCT04134936|561835199|FG001|Overall Study|Adverse Event|2|||
155544190|NCT01190930|561417381|FG005|Induction|High Risk Downs|0|||
155544191|NCT01190930|561417382|FG006|Induction|High Risk Downs|0|||
155544192|NCT01190930|561417383|FG007|Induction|High Risk Downs|0|||
155544193|NCT01190930|561417384|FG008|Induction|High Risk Downs|0|||
155544194|NCT01190930|561417385|FG009|Induction|High Risk Downs|0|||
155544195|NCT01190930|561417376|FG000|Induction|Enrollment onto another COG Protocol|1|||
155544196|NCT01190930|561417377|FG001|Induction|Enrollment onto another COG Protocol|0|||
155544197|NCT01190930|561417378|FG002|Induction|Enrollment onto another COG Protocol|0|||
155544198|NCT01190930|561417379|FG003|Induction|Enrollment onto another COG Protocol|0|||
155544199|NCT01190930|561417380|FG004|Induction|Enrollment onto another COG Protocol|0|||
155544200|NCT01190930|561417381|FG005|Induction|Enrollment onto another COG Protocol|0|||
155544201|NCT01190930|561417382|FG006|Induction|Enrollment onto another COG Protocol|0|||
155544202|NCT01190930|561417383|FG007|Induction|Enrollment onto another COG Protocol|0|||
155544203|NCT01190930|561417384|FG008|Induction|Enrollment onto another COG Protocol|0|||
155544204|NCT01190930|561417385|FG009|Induction|Enrollment onto another COG Protocol|0|||
155544205|NCT01190930|561417376|FG000|Induction|Average Risk|1847|||
155544206|NCT01190930|561417377|FG001|Induction|Average Risk|0|||
155544207|NCT01190930|561417378|FG002|Induction|Average Risk|0|||
155544208|NCT01190930|561417379|FG003|Induction|Average Risk|0|||
155544209|NCT01190930|561417380|FG004|Induction|Average Risk|0|||
155544210|NCT01190930|561417381|FG005|Induction|Average Risk|0|||
155656372|NCT04134936|561835198|FG000|Overall Study|Withdrawal by Subject|2|||
155544211|NCT01190930|561417382|FG006|Induction|Average Risk|0|||
155544212|NCT01190930|561417383|FG007|Induction|Average Risk|0|||
155544213|NCT01190930|561417384|FG008|Induction|Average Risk|0|||
155544214|NCT01190930|561417385|FG009|Induction|Average Risk|0|||
155544215|NCT01190930|561417376|FG000|Induction|High Risk|1227|||
155544216|NCT01190930|561417377|FG001|Induction|High Risk|0|||
155544217|NCT01190930|561417378|FG002|Induction|High Risk|0|||
155544218|NCT01190930|561417379|FG003|Induction|High Risk|0|||
155544219|NCT01190930|561417380|FG004|Induction|High Risk|0|||
155544220|NCT01190930|561417381|FG005|Induction|High Risk|0|||
155544221|NCT01190930|561417382|FG006|Induction|High Risk|0|||
155544222|NCT01190930|561417383|FG007|Induction|High Risk|0|||
155544223|NCT01190930|561417384|FG008|Induction|High Risk|0|||
155656373|NCT04134936|561835199|FG001|Overall Study|Withdrawal by Subject|3|||
155656374|NCT04134936|561835198|FG000|Overall Study|Physician Decision|0|||
155656375|NCT04134936|561835199|FG001|Overall Study|Physician Decision|1|||
155656376|NCT04134936|561835198|FG000|Overall Study|Progressive disease, joined another trial|1|||
155656377|NCT04134936|561835199|FG001|Overall Study|Progressive disease, joined another trial|0|||
155656378|NCT04134936|561835198|FG000|Overall Study|Progressive disease|1|||
155656379|NCT04134936|561835199|FG001|Overall Study|Progressive disease|0|||
155656380|NCT04629196|561835200|FG000|Overall Study|Subject discontinued study drug|1|||
155656381|NCT04629196|561835201|FG001|Overall Study|Subject discontinued study drug|0|||
155656382|NCT04629196|561835200|FG000|Overall Study|Subject study drug dosing increased|1|||
155656383|NCT04629196|561835201|FG001|Overall Study|Subject study drug dosing increased|1|||
155656384|NCT04629196|561835200|FG000|Overall Study|Withdrawal by Subject|1|||
155656385|NCT04629196|561835201|FG001|Overall Study|Withdrawal by Subject|2|||
155656386|NCT00323622|561835205|FG000|Overall Study|Other|30|||
155656387|NCT00323622|561835206|FG001|Overall Study|Other|91|||
155656388|NCT00323622|561835207|FG002|Overall Study|Other|4|||
155656389|NCT00323622|561835208|FG003|Overall Study|Other|12|||
155656390|NCT00323622|561835209|FG004|Overall Study|Other|32|||
155656391|NCT00323622|561835210|FG005|Overall Study|Other|74|||
155656392|NCT00323622|561835211|FG006|Overall Study|Other|5|||
155656393|NCT00323622|561835212|FG007|Overall Study|Other|13|||
155656394|NCT00323622|561835205|FG000|Overall Study|Death|1|||
155656395|NCT00323622|561835206|FG001|Overall Study|Death|1|||
155656396|NCT00323622|561835207|FG002|Overall Study|Death|0|||
155656397|NCT00323622|561835208|FG003|Overall Study|Death|0|||
155656398|NCT00323622|561835209|FG004|Overall Study|Death|7|||
155656399|NCT00323622|561835210|FG005|Overall Study|Death|0|||
155656400|NCT00323622|561835211|FG006|Overall Study|Death|0|||
155656401|NCT00323622|561835212|FG007|Overall Study|Death|2|||
155656402|NCT02061085|561835215|FG000|Overall Study|Adverse Event|8|||
155656403|NCT03709472|561835220|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
155656404|NCT03709472|561835221|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
155656405|NCT03709472|561835220|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
155656406|NCT03709472|561835221|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
155656407|NCT02038036|561835225|FG000|Core Study|Adverse Event|7|||
155656408|NCT02038036|561835226|FG001|Core Study|Adverse Event|7|||
155656409|NCT02038036|561835225|FG000|Core Study|Death|1|||
155656410|NCT02038036|561835226|FG001|Core Study|Death|1|||
155656411|NCT02038036|561835225|FG000|Core Study|Disease progression|2|||
155656412|NCT02038036|561835226|FG001|Core Study|Disease progression|2|||
155656413|NCT02038036|561835225|FG000|Core Study|Lost to Follow-up|0|||
155656414|NCT02038036|561835226|FG001|Core Study|Lost to Follow-up|1|||
155656415|NCT02038036|561835225|FG000|Core Study|Physician Decision|2|||
155656416|NCT02038036|561835226|FG001|Core Study|Physician Decision|1|||
155656417|NCT02038036|561835225|FG000|Core Study|Subject/guardian decision|0|||
155656418|NCT02038036|561835226|FG001|Core Study|Subject/guardian decision|1|||
155656419|NCT02038036|561835225|FG000|Core Study|Withdrawal by Subject|3|||
155544224|NCT01190930|561417385|FG009|Induction|High Risk|0|||
155544225|NCT01190930|561417376|FG000|Induction|Low Risk|443|||
155544226|NCT01190930|561417377|FG001|Induction|Low Risk|0|||
155544227|NCT01190930|561417378|FG002|Induction|Low Risk|0|||
155544228|NCT01190930|561417379|FG003|Induction|Low Risk|0|||
155544229|NCT01190930|561417380|FG004|Induction|Low Risk|0|||
155544230|NCT01190930|561417381|FG005|Induction|Low Risk|0|||
155544231|NCT01190930|561417382|FG006|Induction|Low Risk|0|||
155544232|NCT01190930|561417383|FG007|Induction|Low Risk|0|||
155544233|NCT01190930|561417384|FG008|Induction|Low Risk|0|||
155544234|NCT01190930|561417385|FG009|Induction|Low Risk|0|||
155544235|NCT01190930|561417376|FG000|Induction|Very High Risk|1012|||
155544236|NCT01190930|561417377|FG001|Induction|Very High Risk|0|||
155544237|NCT01190930|561417378|FG002|Induction|Very High Risk|0|||
155544238|NCT01190930|561417379|FG003|Induction|Very High Risk|0|||
155544239|NCT01190930|561417380|FG004|Induction|Very High Risk|0|||
155544240|NCT01190930|561417381|FG005|Induction|Very High Risk|0|||
155544241|NCT01190930|561417382|FG006|Induction|Very High Risk|0|||
155544242|NCT01190930|561417383|FG007|Induction|Very High Risk|0|||
155544243|NCT01190930|561417384|FG008|Induction|Very High Risk|0|||
155544244|NCT01190930|561417385|FG009|Induction|Very High Risk|0|||
155544245|NCT01190930|561417376|FG000|Induction|Philadelphia chromosome-positive|99|||
155544246|NCT01190930|561417377|FG001|Induction|Philadelphia chromosome-positive|0|||
155656420|NCT02038036|561835226|FG001|Core Study|Withdrawal by Subject|1|||
155656421|NCT02038036|561835225|FG000|Crossover Period|Withdrawal by Subject|0|||
155656422|NCT02038036|561835226|FG001|Crossover Period|Withdrawal by Subject|3|||
155656423|NCT02038036|561835225|FG000|Crossover Period|Adverse Event|0|||
155656424|NCT02038036|561835226|FG001|Crossover Period|Adverse Event|9|||
155656425|NCT02038036|561835225|FG000|Crossover Period|Death|0|||
155544247|NCT01190930|561417378|FG002|Induction|Philadelphia chromosome-positive|0|||
155544248|NCT01190930|561417379|FG003|Induction|Philadelphia chromosome-positive|0|||
155544249|NCT01190930|561417380|FG004|Induction|Philadelphia chromosome-positive|0|||
155656426|NCT02038036|561835226|FG001|Crossover Period|Death|2|||
155656427|NCT02038036|561835225|FG000|Crossover Period|Disease progression|0|||
155490560|NCT00594568|561221368|FG001|Initial Treatment|Entry criteria exclusion|1|||
155490561|NCT00594568|561221369|FG002|Initial Treatment|Entry criteria exclusion|1|||
155490562|NCT00594568|561221367|FG000|Delayed Start|Death|0|||
155490563|NCT00594568|561221368|FG001|Delayed Start|Death|0|||
155490564|NCT00594568|561221369|FG002|Delayed Start|Death|1|||
155490565|NCT00594568|561221367|FG000|Delayed Start|Adverse Event|12|||
155490566|NCT00594568|561221368|FG001|Delayed Start|Adverse Event|2|||
155490567|NCT00594568|561221369|FG002|Delayed Start|Adverse Event|2|||
155490568|NCT00594568|561221367|FG000|Delayed Start|Withdrawal by Subject|4|||
155490569|NCT00594568|561221368|FG001|Delayed Start|Withdrawal by Subject|3|||
155490570|NCT00594568|561221369|FG002|Delayed Start|Withdrawal by Subject|0|||
155490571|NCT00594568|561221367|FG000|Delayed Start|Physician Decision|0|||
155490572|NCT00594568|561221368|FG001|Delayed Start|Physician Decision|0|||
155490573|NCT00594568|561221369|FG002|Delayed Start|Physician Decision|1|||
155490574|NCT00594568|561221367|FG000|Delayed Start|Lost to Follow-up|0|||
155490575|NCT00594568|561221368|FG001|Delayed Start|Lost to Follow-up|0|||
155490576|NCT00594568|561221369|FG002|Delayed Start|Lost to Follow-up|1|||
155490577|NCT00594568|561221367|FG000|Delayed Start|Caregiver Decision|5|||
155490578|NCT00594568|561221368|FG001|Delayed Start|Caregiver Decision|6|||
155490579|NCT00594568|561221369|FG002|Delayed Start|Caregiver Decision|2|||
155490580|NCT00594568|561221367|FG000|Delayed Start|Sponsor Decision|77|||
155490581|NCT00594568|561221368|FG001|Delayed Start|Sponsor Decision|66|||
155490582|NCT00594568|561221369|FG002|Delayed Start|Sponsor Decision|59|||
155490583|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
155490584|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
155490585|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
155490586|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
155490587|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
155490588|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
155490589|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
155490590|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
155544250|NCT01190930|561417381|FG005|Induction|Philadelphia chromosome-positive|0|||
155544251|NCT01190930|561417382|FG006|Induction|Philadelphia chromosome-positive|0|||
155544252|NCT01190930|561417383|FG007|Induction|Philadelphia chromosome-positive|0|||
155544253|NCT01190930|561417384|FG008|Induction|Philadelphia chromosome-positive|0|||
155544254|NCT01190930|561417385|FG009|Induction|Philadelphia chromosome-positive|0|||
155544255|NCT01190930|561417376|FG000|Induction|Incomplete Induction data|63|||
155544256|NCT01190930|561417377|FG001|Induction|Incomplete Induction data|0|||
155544257|NCT01190930|561417378|FG002|Induction|Incomplete Induction data|0|||
155544258|NCT01190930|561417379|FG003|Induction|Incomplete Induction data|0|||
155544259|NCT01190930|561417380|FG004|Induction|Incomplete Induction data|0|||
155544260|NCT01190930|561417381|FG005|Induction|Incomplete Induction data|0|||
155544261|NCT01190930|561417382|FG006|Induction|Incomplete Induction data|0|||
155544262|NCT01190930|561417383|FG007|Induction|Incomplete Induction data|0|||
155544263|NCT01190930|561417384|FG008|Induction|Incomplete Induction data|0|||
155544264|NCT01190930|561417385|FG009|Induction|Incomplete Induction data|0|||
155544265|NCT01190930|561417376|FG000|Induction|Progressive disease|0|||
155544266|NCT01190930|561417377|FG001|Induction|Progressive disease|1|||
155544267|NCT01190930|561417378|FG002|Induction|Progressive disease|0|||
155544268|NCT01190930|561417379|FG003|Induction|Progressive disease|0|||
155544269|NCT01190930|561417380|FG004|Induction|Progressive disease|0|||
155544270|NCT01190930|561417381|FG005|Induction|Progressive disease|0|||
155544271|NCT01190930|561417382|FG006|Induction|Progressive disease|0|||
155544272|NCT01190930|561417383|FG007|Induction|Progressive disease|0|||
155544273|NCT01190930|561417384|FG008|Induction|Progressive disease|0|||
155544274|NCT01190930|561417385|FG009|Induction|Progressive disease|0|||
155544275|NCT01190930|561417376|FG000|Induction|No treatment|3|||
155544276|NCT01190930|561417377|FG001|Induction|No treatment|0|||
155656428|NCT02038036|561835226|FG001|Crossover Period|Disease progression|3|||
155490591|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
155490592|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
155490593|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
155490594|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
155490595|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
155490596|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
155490597|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
155490598|NCT00594568|561221367|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
155490599|NCT00594568|561221368|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
155490600|NCT00594568|561221369|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
155490601|NCT00290511|561221372|FG000|Overall Study|Adverse Event|1|||
155490602|NCT00290511|561221372|FG000|Overall Study|Death|1|||
155490603|NCT00290511|561221372|FG000|Overall Study|Physician Decision|1|||
155490604|NCT00290511|561221372|FG000|Overall Study|Withdrawal by Subject|1|||
155490605|NCT02204449|561221373|FG000|Overall Study|Lost to Follow-up|7|||
155490606|NCT02204449|561221374|FG001|Overall Study|Lost to Follow-up|9|||
155490607|NCT02204449|561221373|FG000|Overall Study|Death|0|||
155490608|NCT02204449|561221374|FG001|Overall Study|Death|1|||
155490609|NCT02204449|561221373|FG000|Overall Study|Withdrawal by Subject|0|||
155490610|NCT02204449|561221374|FG001|Overall Study|Withdrawal by Subject|1|||
155490611|NCT01976663|561221377|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
155490612|NCT01976663|561221377|FG000|Overall Study|Personal Reasons|6|||
155490613|NCT01976663|561221377|FG000|Overall Study|Withdrawal by Subject|4|||
155490614|NCT01976663|561221377|FG000|Overall Study|Screen Failure|3|||
155490615|NCT01976663|561221377|FG000|Overall Study|Adverse Event|2|||
155490616|NCT01976663|561221377|FG000|Overall Study|Lost to Follow-up|3|||
155490617|NCT04780776|561221378|FG000|Titration Week 1-5|Lost to Follow-up|2|||
155490618|NCT04780776|561221379|FG001|Titration Week 1-5|Lost to Follow-up|8|||
155490619|NCT04780776|561221378|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
155490620|NCT04780776|561221379|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
155490621|NCT04780776|561221378|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
155490622|NCT04780776|561221379|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
155490623|NCT03113760|561221381|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
155490624|NCT03113760|561221382|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
155490625|NCT03113760|561221383|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
155490626|NCT03113760|561221384|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
155490627|NCT03113760|561221381|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
155544277|NCT01190930|561417378|FG002|Induction|No treatment|0|||
155544278|NCT01190930|561417379|FG003|Induction|No treatment|0|||
155544279|NCT01190930|561417380|FG004|Induction|No treatment|0|||
155544280|NCT01190930|561417381|FG005|Induction|No treatment|0|||
155656429|NCT02038036|561835225|FG000|Crossover Period|Lost to Follow-up|0|||
155656430|NCT02038036|561835226|FG001|Crossover Period|Lost to Follow-up|1|||
155544281|NCT01190930|561417382|FG006|Induction|No treatment|0|||
155656431|NCT02038036|561835225|FG000|Crossover Period|Physician Decision|0|||
155544282|NCT01190930|561417383|FG007|Induction|No treatment|0|||
155490628|NCT03113760|561221382|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
155490629|NCT03113760|561221383|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
155490630|NCT03113760|561221384|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
155490631|NCT03113760|561221381|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
155490632|NCT03113760|561221382|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
155490633|NCT03113760|561221383|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
155490634|NCT03113760|561221384|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
155490635|NCT01982942|561221385|FG000|Overall Study|Adverse Event|10|||
155490636|NCT01982942|561221386|FG001|Overall Study|Adverse Event|5|||
155490637|NCT01982942|561221385|FG000|Overall Study|Lost to Follow-up|4|||
155490638|NCT01982942|561221386|FG001|Overall Study|Lost to Follow-up|3|||
155490639|NCT01982942|561221385|FG000|Overall Study|Multiple sclerosis progression|3|||
155490640|NCT01982942|561221386|FG001|Overall Study|Multiple sclerosis progression|2|||
155490641|NCT01982942|561221385|FG000|Overall Study|Wanted to try therapy not permitted|1|||
155490642|NCT01982942|561221386|FG001|Overall Study|Wanted to try therapy not permitted|0|||
155490643|NCT01982942|561221385|FG000|Overall Study|Subject declined future visits|0|||
155490644|NCT01982942|561221386|FG001|Overall Study|Subject declined future visits|1|||
155490645|NCT01982942|561221385|FG000|Overall Study|Left geographical area|2|||
155490646|NCT01982942|561221386|FG001|Overall Study|Left geographical area|0|||
155490647|NCT01982942|561221385|FG000|Overall Study|Too many pills|1|||
155490648|NCT01982942|561221386|FG001|Overall Study|Too many pills|0|||
155490649|NCT01982942|561221385|FG000|Overall Study|MS Relapse|0|||
155490650|NCT01982942|561221386|FG001|Overall Study|MS Relapse|1|||
155490651|NCT01982942|561221385|FG000|Overall Study|Chose to join a stem cell trial|0|||
155490652|NCT01982942|561221386|FG001|Overall Study|Chose to join a stem cell trial|1|||
155490653|NCT01982942|561221385|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
155490654|NCT01982942|561221386|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
155490655|NCT01151085|561221389|FG000|Overall Study|Lost to Follow-up|31|||
155490656|NCT01151085|561221389|FG000|Overall Study|Protocol Violation|25|||
155490657|NCT03246152|561221390|FG000|Overall Study|Lost to Follow-up|2|||
155490658|NCT03246152|561221390|FG000|Overall Study|Protocol Violation|1|||
155490659|NCT01243762|561221391|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
155490660|NCT01243762|561221392|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
155490661|NCT01243762|561221393|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
155490662|NCT01243762|561221394|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
155490663|NCT01243762|561221395|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
155490664|NCT01243762|561221396|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
155490665|NCT01243762|561221397|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
155490666|NCT01243762|561221391|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155490667|NCT01243762|561221392|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
155490668|NCT01243762|561221393|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155490669|NCT01243762|561221394|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
155490670|NCT01243762|561221395|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155490671|NCT01243762|561221396|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155490672|NCT01243762|561221397|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155490673|NCT01243762|561221391|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
155490674|NCT01243762|561221392|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
155490675|NCT01243762|561221393|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
155490676|NCT01243762|561221394|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
155490677|NCT01243762|561221395|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
155490678|NCT01243762|561221396|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
155490679|NCT01243762|561221397|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
155490680|NCT01243762|561221391|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490681|NCT01243762|561221392|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
155490682|NCT01243762|561221393|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490683|NCT01243762|561221394|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490684|NCT01243762|561221395|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490685|NCT01243762|561221396|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490686|NCT01243762|561221397|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
155490687|NCT01243762|561221391|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
155490688|NCT01243762|561221392|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
155490689|NCT01243762|561221393|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
155656432|NCT02038036|561835226|FG001|Crossover Period|Physician Decision|2|||
155490690|NCT01243762|561221394|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
155490691|NCT01243762|561221395|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
155490692|NCT01243762|561221396|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
155490693|NCT01243762|561221397|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
155490694|NCT01243762|561221391|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
155490695|NCT01243762|561221392|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
155490696|NCT01243762|561221393|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
155490697|NCT01243762|561221394|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
155490698|NCT01243762|561221395|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
155490699|NCT01243762|561221396|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
155490700|NCT01243762|561221397|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
155490701|NCT01243762|561221391|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
155490702|NCT01243762|561221392|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
155490703|NCT01243762|561221393|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
155490704|NCT01243762|561221394|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
155490705|NCT01243762|561221395|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
155490706|NCT01243762|561221396|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
155490707|NCT01243762|561221397|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
155490708|NCT01243762|561221391|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
155490709|NCT01243762|561221392|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
155490710|NCT01243762|561221393|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
155490711|NCT01243762|561221394|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
155490712|NCT01243762|561221395|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
155490713|NCT01243762|561221396|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
155490714|NCT01243762|561221397|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
155490715|NCT00003526|561221398|FG000|Overall Study|Not evaluable|6|||
155490716|NCT02059265|561221399|FG000|Overall Study|Ineligible|4|||
155490717|NCT03358407|561221404|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490718|NCT03358407|561221405|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490719|NCT03358407|561221406|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
155490720|NCT03358407|561221407|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490721|NCT03358407|561221408|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490722|NCT03358407|561221409|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490723|NCT03358407|561221410|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490724|NCT03358407|561221411|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490725|NCT03358407|561221412|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490726|NCT03358407|561221413|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
155490727|NCT03358407|561221404|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490728|NCT03358407|561221405|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490729|NCT03358407|561221406|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490730|NCT03358407|561221407|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490731|NCT03358407|561221408|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
155490732|NCT03358407|561221409|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490733|NCT03358407|561221410|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490734|NCT03358407|561221411|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490735|NCT03358407|561221412|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490736|NCT03358407|561221413|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490737|NCT03358407|561221404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490738|NCT03358407|561221405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490739|NCT03358407|561221406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490740|NCT03358407|561221407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490741|NCT03358407|561221408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490742|NCT03358407|561221409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
155490743|NCT03358407|561221410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490744|NCT03358407|561221411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
155490745|NCT03358407|561221412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490746|NCT03358407|561221413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155490747|NCT03358407|561221404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490748|NCT03358407|561221405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490749|NCT03358407|561221406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490750|NCT03358407|561221407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490751|NCT03358407|561221408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490752|NCT03358407|561221409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
155490753|NCT03358407|561221410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490754|NCT03358407|561221411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
155490755|NCT03358407|561221412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490756|NCT03358407|561221413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
155490757|NCT03358407|561221404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490758|NCT03358407|561221405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490759|NCT03358407|561221406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155656433|NCT02613507|561835231|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
155490760|NCT03358407|561221407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490761|NCT03358407|561221408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490762|NCT03358407|561221409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
155490763|NCT03358407|561221410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
155490764|NCT03358407|561221411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490765|NCT03358407|561221412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490766|NCT03358407|561221413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155490767|NCT03358407|561221404|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490768|NCT03358407|561221405|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490769|NCT03358407|561221406|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490770|NCT03358407|561221407|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490771|NCT03358407|561221408|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490772|NCT03358407|561221409|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
155490773|NCT03358407|561221410|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
155490774|NCT03358407|561221411|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
155490775|NCT03358407|561221412|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155656434|NCT02613507|561835232|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
155656435|NCT02613507|561835231|FG000|Pre-Treamtent|Participant withdrew consent|0|||
155656436|NCT02613507|561835232|FG001|Pre-Treamtent|Participant withdrew consent|4|||
155490776|NCT03358407|561221413|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
155490777|NCT00483574|561221414|FG000|Overall Study|Adverse Event|6|||
155490778|NCT00483574|561221415|FG001|Overall Study|Adverse Event|0|||
155490779|NCT00483574|561221414|FG000|Overall Study|Protocol Violation|28|||
155490780|NCT00483574|561221415|FG001|Overall Study|Protocol Violation|9|||
155490781|NCT00483574|561221414|FG000|Overall Study|Lost to Follow-up|16|||
155490782|NCT00483574|561221415|FG001|Overall Study|Lost to Follow-up|4|||
155490783|NCT00483574|561221414|FG000|Overall Study|Withdrawal by Subject|52|||
155490784|NCT00483574|561221415|FG001|Overall Study|Withdrawal by Subject|0|||
155490785|NCT03605758|561221416|FG000|Overall Study|Lost to Follow-up|2|||
155490786|NCT03605758|561221417|FG001|Overall Study|Lost to Follow-up|1|||
155490787|NCT03605758|561221416|FG000|Overall Study|Illness|0|||
155490788|NCT03605758|561221417|FG001|Overall Study|Illness|1|||
155490789|NCT03605758|561221416|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
155490790|NCT03605758|561221417|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
155490791|NCT00489411|561221420|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
155490792|NCT00489411|561221421|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
155490793|NCT00489411|561221420|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
155490794|NCT00489411|561221421|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
155490795|NCT00489411|561221420|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
155490796|NCT00489411|561221421|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
155490797|NCT00489411|561221420|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
155490798|NCT00489411|561221421|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
155490799|NCT00489411|561221420|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
155490800|NCT00489411|561221421|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
155490801|NCT01748162|561221424|FG000|Overall Study|no additional croup episodes to evaluate|2|||
155490802|NCT01748162|561221425|FG001|Overall Study|no additional croup episodes to evaluate|2|||
155490803|NCT01748162|561221424|FG000|Overall Study|participant consented but did not begin|0|||
155490804|NCT01748162|561221425|FG001|Overall Study|participant consented but did not begin|1|||
155490805|NCT01748162|561221424|FG000|Overall Study|reasons not available|3|||
155490806|NCT01748162|561221425|FG001|Overall Study|reasons not available|2|||
155490807|NCT03219372|561221426|FG000|Overall Study|Withdrawal by Subject|1|||
155490808|NCT03219372|561221427|FG001|Overall Study|Withdrawal by Subject|0|||
155490809|NCT03841331|561221428|FG000|Overall Study|Withdrawal by Subject|4|||
155490810|NCT03841331|561221429|FG001|Overall Study|Withdrawal by Subject|9|||
155490811|NCT03841331|561221428|FG000|Overall Study|Lost to Follow-up|5|||
155490812|NCT03841331|561221429|FG001|Overall Study|Lost to Follow-up|1|||
155490813|NCT04145531|561221430|FG000|Part A|Adverse Event|2|||
155490814|NCT04145531|561221431|FG001|Part A|Adverse Event|12|||
155490815|NCT04145531|561221432|FG002|Part A|Adverse Event|6|||
155490816|NCT04145531|561221433|FG003|Part A|Adverse Event|0|||
155490817|NCT04145531|561221430|FG000|Part A|Death|1|||
155490818|NCT04145531|561221431|FG001|Part A|Death|2|||
155490819|NCT04145531|561221432|FG002|Part A|Death|0|||
155490820|NCT04145531|561221433|FG003|Part A|Death|0|||
155490821|NCT04145531|561221430|FG000|Part A|Physician Decision|2|||
155490822|NCT04145531|561221431|FG001|Part A|Physician Decision|5|||
155490823|NCT04145531|561221432|FG002|Part A|Physician Decision|2|||
155490824|NCT04145531|561221433|FG003|Part A|Physician Decision|0|||
155490825|NCT04145531|561221430|FG000|Part A|Progressive disease|0|||
155490826|NCT04145531|561221431|FG001|Part A|Progressive disease|2|||
155490827|NCT04145531|561221432|FG002|Part A|Progressive disease|1|||
155490828|NCT04145531|561221433|FG003|Part A|Progressive disease|0|||
155490829|NCT04145531|561221430|FG000|Part A|Protocol deviation|0|||
155490830|NCT04145531|561221431|FG001|Part A|Protocol deviation|0|||
155490831|NCT04145531|561221432|FG002|Part A|Protocol deviation|1|||
155490832|NCT04145531|561221433|FG003|Part A|Protocol deviation|0|||
155490833|NCT04145531|561221430|FG000|Part A|Withdrawal by parent or guardian|1|||
155490834|NCT04145531|561221431|FG001|Part A|Withdrawal by parent or guardian|0|||
155490835|NCT04145531|561221432|FG002|Part A|Withdrawal by parent or guardian|0|||
155490836|NCT04145531|561221433|FG003|Part A|Withdrawal by parent or guardian|0|||
155490837|NCT04145531|561221430|FG000|Part A|Withdrawal by participant|0|||
155490838|NCT04145531|561221431|FG001|Part A|Withdrawal by participant|0|||
155490839|NCT04145531|561221432|FG002|Part A|Withdrawal by participant|1|||
155490840|NCT04145531|561221433|FG003|Part A|Withdrawal by participant|0|||
155490841|NCT04145531|561221430|FG000|Part A|Other|0|||
155490842|NCT04145531|561221431|FG001|Part A|Other|0|||
155490843|NCT04145531|561221432|FG002|Part A|Other|1|||
155490844|NCT04145531|561221433|FG003|Part A|Other|0|||
155490845|NCT04145531|561221430|FG000|Part B|Adverse Event|0|||
155490846|NCT04145531|561221431|FG001|Part B|Adverse Event|0|||
155490847|NCT04145531|561221432|FG002|Part B|Adverse Event|0|||
155490848|NCT04145531|561221433|FG003|Part B|Adverse Event|21|||
155490849|NCT04145531|561221430|FG000|Part B|Physician Decision|0|||
155490850|NCT04145531|561221431|FG001|Part B|Physician Decision|0|||
155490851|NCT04145531|561221432|FG002|Part B|Physician Decision|0|||
155490852|NCT04145531|561221433|FG003|Part B|Physician Decision|7|||
155490853|NCT04145531|561221430|FG000|Part B|Progressive disease|0|||
155490854|NCT04145531|561221431|FG001|Part B|Progressive disease|0|||
155490855|NCT04145531|561221432|FG002|Part B|Progressive disease|0|||
155490856|NCT04145531|561221433|FG003|Part B|Progressive disease|1|||
155490857|NCT04145531|561221430|FG000|Part B|Recurrent disease|0|||
155490858|NCT04145531|561221431|FG001|Part B|Recurrent disease|0|||
155490859|NCT04145531|561221432|FG002|Part B|Recurrent disease|0|||
155490860|NCT04145531|561221433|FG003|Part B|Recurrent disease|1|||
155490861|NCT04145531|561221430|FG000|Part B|Withdrawal by parent or guardian|0|||
155490862|NCT04145531|561221431|FG001|Part B|Withdrawal by parent or guardian|0|||
155490863|NCT04145531|561221432|FG002|Part B|Withdrawal by parent or guardian|0|||
155490864|NCT04145531|561221433|FG003|Part B|Withdrawal by parent or guardian|3|||
155490865|NCT04145531|561221430|FG000|Part B|Withdrawal by participant|0|||
155490866|NCT04145531|561221431|FG001|Part B|Withdrawal by participant|0|||
155490867|NCT04145531|561221432|FG002|Part B|Withdrawal by participant|0|||
155490868|NCT04145531|561221433|FG003|Part B|Withdrawal by participant|1|||
155490869|NCT04145531|561221430|FG000|Part B|Other|0|||
155490870|NCT04145531|561221431|FG001|Part B|Other|0|||
155490871|NCT04145531|561221432|FG002|Part B|Other|0|||
155490872|NCT04145531|561221433|FG003|Part B|Other|1|||
155490873|NCT04640168|561221434|FG000|Overall Study|Withdrawal by Subject|8|||
155490874|NCT04640168|561221435|FG001|Overall Study|Withdrawal by Subject|7|||
155490875|NCT04640168|561221434|FG000|Overall Study|Lost to Follow-up|1|||
155490876|NCT04640168|561221435|FG001|Overall Study|Lost to Follow-up|0|||
155490877|NCT04640168|561221434|FG000|Overall Study|Enrolled but not treated|12|||
155490878|NCT04640168|561221435|FG001|Overall Study|Enrolled but not treated|12|||
155490879|NCT00779857|561221436|FG000|Overall Study|Death|1|||
155490880|NCT00779857|561221436|FG000|Overall Study|Withdrawal by Subject|3|||
155490881|NCT00779857|561221436|FG000|Overall Study|Missed Visit|2|||
155656437|NCT02613507|561835231|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
155490882|NCT04338685|561221439|FG000|Overall Study|Death|3|||
155490883|NCT04338685|561221440|FG001|Overall Study|Death|4|||
155490884|NCT04338685|561221441|FG002|Overall Study|Death|2|||
155490885|NCT04338685|561221442|FG003|Overall Study|Death|4|||
155490886|NCT04338685|561221443|FG004|Overall Study|Death|4|||
155490887|NCT04338685|561221444|FG005|Overall Study|Death|8|||
155490888|NCT04338685|561221445|FG006|Overall Study|Death|1|||
155490889|NCT04338685|561221446|FG007|Overall Study|Death|0|||
155490890|NCT04338685|561221447|FG008|Overall Study|Death|0|||
155490891|NCT04338685|561221439|FG000|Overall Study|Study terminated by Sponsor|0|||
155490892|NCT04338685|561221440|FG001|Overall Study|Study terminated by Sponsor|0|||
155490893|NCT04338685|561221441|FG002|Overall Study|Study terminated by Sponsor|1|||
155490894|NCT04338685|561221442|FG003|Overall Study|Study terminated by Sponsor|4|||
155490895|NCT04338685|561221443|FG004|Overall Study|Study terminated by Sponsor|0|||
155490896|NCT04338685|561221444|FG005|Overall Study|Study terminated by Sponsor|5|||
155490897|NCT04338685|561221445|FG006|Overall Study|Study terminated by Sponsor|2|||
155490898|NCT04338685|561221446|FG007|Overall Study|Study terminated by Sponsor|4|||
155490899|NCT04338685|561221447|FG008|Overall Study|Study terminated by Sponsor|1|||
155490900|NCT04338685|561221439|FG000|Overall Study|Withdrawal by Subject|1|||
155490901|NCT04338685|561221440|FG001|Overall Study|Withdrawal by Subject|2|||
155490902|NCT04338685|561221441|FG002|Overall Study|Withdrawal by Subject|0|||
155490903|NCT04338685|561221442|FG003|Overall Study|Withdrawal by Subject|2|||
155490904|NCT04338685|561221443|FG004|Overall Study|Withdrawal by Subject|0|||
155490905|NCT04338685|561221444|FG005|Overall Study|Withdrawal by Subject|5|||
155490906|NCT04338685|561221445|FG006|Overall Study|Withdrawal by Subject|1|||
155490907|NCT04338685|561221446|FG007|Overall Study|Withdrawal by Subject|1|||
155490908|NCT04338685|561221447|FG008|Overall Study|Withdrawal by Subject|0|||
155490909|NCT00234533|561221448|FG000|Overall Study|Withdrawal by Subject|6|||
155490910|NCT00234533|561221448|FG000|Overall Study|Adverse Event|2|||
155490911|NCT00234533|561221448|FG000|Overall Study|Enrolled but not treated|3|||
155490912|NCT02967055|561221449|FG000|Overall Study|Excluded|40|||
155490913|NCT02967055|561221449|FG000|Overall Study|Screen fail|3|||
155490914|NCT02967055|561221449|FG000|Overall Study|Lost to Follow-up|2|||
155490915|NCT02967055|561221449|FG000|Overall Study|Stopped due to side effects|3|||
155490916|NCT02967055|561221449|FG000|Overall Study|Stopped due to drug cost|1|||
155656438|NCT02613507|561835232|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
155656439|NCT02613507|561835231|FG000|Treatment|Not reported|3|||
155656440|NCT02613507|561835232|FG001|Treatment|Not reported|0|||
155656441|NCT02613507|561835231|FG000|Treatment|Other reasons|8|||
155656442|NCT02613507|561835232|FG001|Treatment|Other reasons|0|||
155656443|NCT02613507|561835231|FG000|Treatment|Participant no longer meets criteria|3|||
155656444|NCT02613507|561835232|FG001|Treatment|Participant no longer meets criteria|0|||
155656445|NCT02613507|561835231|FG000|Treatment|Maximum clinical benefit|5|||
155656446|NCT02613507|561835232|FG001|Treatment|Maximum clinical benefit|10|||
155656447|NCT02613507|561835231|FG000|Treatment|Lost to Follow-up|1|||
155656448|NCT02613507|561835232|FG001|Treatment|Lost to Follow-up|0|||
155656449|NCT02613507|561835231|FG000|Treatment|Participant withdrew consent|0|||
155656450|NCT02613507|561835232|FG001|Treatment|Participant withdrew consent|2|||
155656451|NCT02613507|561835231|FG000|Treatment|Participant request to discontinue study treatment|13|||
155656452|NCT02613507|561835232|FG001|Treatment|Participant request to discontinue study treatment|17|||
155656453|NCT02613507|561835231|FG000|Treatment|Adverse event unrelated to study drug|20|||
155656454|NCT02613507|561835232|FG001|Treatment|Adverse event unrelated to study drug|3|||
155656455|NCT02613507|561835231|FG000|Treatment|Death|2|||
155656456|NCT02613507|561835232|FG001|Treatment|Death|0|||
155656457|NCT02613507|561835231|FG000|Treatment|Study drug toxicity|19|||
155656458|NCT02613507|561835232|FG001|Treatment|Study drug toxicity|14|||
155656459|NCT02613507|561835231|FG000|Treatment|Disease progression|263|||
155656460|NCT02613507|561835232|FG001|Treatment|Disease progression|110|||
155656461|NCT03514134|561837348|FG000|Overall Study|Lost to Follow-up|0|||
155656462|NCT03514134|561837349|FG001|Overall Study|Lost to Follow-up|1|||
155656463|NCT02471144|561837350|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
155656464|NCT02471144|561837351|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
155656465|NCT02471144|561837352|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
155656466|NCT02471144|561837353|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
155656467|NCT02471144|561837354|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
155490917|NCT00908375|561221450|FG000|Overall Study|Withdrawal by Subject|2|||
155490918|NCT00908375|561221451|FG001|Overall Study|Withdrawal by Subject|4|||
155490919|NCT00908375|561221450|FG000|Overall Study|Lost to Follow-up|8|||
155490920|NCT00908375|561221451|FG001|Overall Study|Lost to Follow-up|6|||
155490921|NCT02279888|561221452|FG000|Overall Study|Death|326|||
155490922|NCT02279888|561221452|FG000|Overall Study|Withdrawal by Subject|38|||
155490923|NCT02279888|561221452|FG000|Overall Study|Lost to Follow-up|21|||
155656468|NCT02471144|561837355|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
155656469|NCT02471144|561837356|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
155656470|NCT02471144|561837357|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
155656471|NCT02471144|561837358|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
155656472|NCT02471144|561837359|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
155656473|NCT02471144|561837360|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
155656474|NCT02471144|561837350|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155490924|NCT02279888|561221452|FG000|Overall Study|Physician Decision|62|||
155490925|NCT02279888|561221452|FG000|Overall Study|Subject Non-compliance|43|||
155490926|NCT02279888|561221452|FG000|Overall Study|Not implanted|14|||
155490927|NCT02279888|561221452|FG000|Overall Study|Visit not performed|26|||
155490928|NCT02283411|561221455|FG000|Overall Study|Withdrawal by Subject|3|||
155490929|NCT02283411|561221455|FG000|Overall Study|Screen Failed|28|||
155490930|NCT01683565|561221456|FG000|Overall Study|Lost to Follow-up|2|||
155490931|NCT01683565|561221457|FG001|Overall Study|Lost to Follow-up|0|||
155490932|NCT01683565|561221456|FG000|Overall Study|Discontinued Intervention|1|||
155490933|NCT01683565|561221457|FG001|Overall Study|Discontinued Intervention|1|||
155656475|NCT02471144|561837351|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656476|NCT02471144|561837352|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656477|NCT02471144|561837353|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
155656478|NCT02471144|561837354|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656479|NCT02471144|561837355|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656480|NCT02471144|561837356|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656481|NCT02471144|561837357|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656482|NCT02471144|561837358|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656483|NCT02471144|561837359|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656484|NCT02471144|561837360|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155656485|NCT02471144|561837350|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656486|NCT02471144|561837351|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656487|NCT02471144|561837352|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
155656488|NCT02471144|561837353|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656489|NCT02471144|561837354|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656490|NCT02471144|561837355|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656491|NCT02471144|561837356|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656492|NCT02471144|561837357|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656493|NCT02471144|561837358|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656494|NCT02471144|561837359|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656495|NCT02471144|561837360|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155656496|NCT02471144|561837350|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
155656497|NCT02471144|561837351|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
155656498|NCT02471144|561837352|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656499|NCT02471144|561837353|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656500|NCT02471144|561837354|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656501|NCT02471144|561837355|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656502|NCT02471144|561837356|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656503|NCT02471144|561837357|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656504|NCT02471144|561837358|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656505|NCT02471144|561837359|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656506|NCT02471144|561837360|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155656507|NCT02471144|561837350|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656508|NCT02471144|561837351|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656509|NCT02471144|561837352|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656510|NCT02471144|561837353|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656511|NCT02471144|561837354|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155656512|NCT02471144|561837355|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656513|NCT02471144|561837356|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155656514|NCT02471144|561837357|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656515|NCT02471144|561837358|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155490934|NCT00945815|561221459|FG000|Overall Study|Death|3|||
155490935|NCT00945815|561221459|FG000|Overall Study|Not protocol specified|1|||
155490936|NCT00945815|561221459|FG000|Overall Study|Ineligible|3|||
155490937|NCT00945815|561221459|FG000|Overall Study|Did not begin protocol therapy|1|||
155490938|NCT02400281|561221460|FG000|Overall Study|Adverse Event|0|||
155490939|NCT02400281|561221461|FG001|Overall Study|Adverse Event|0|||
155490940|NCT02400281|561221462|FG002|Overall Study|Adverse Event|1|||
155490941|NCT02400281|561221463|FG003|Overall Study|Adverse Event|0|||
155490942|NCT02400281|561221464|FG004|Overall Study|Adverse Event|1|||
155490943|NCT02400281|561221465|FG005|Overall Study|Adverse Event|0|||
155490944|NCT02400281|561221460|FG000|Overall Study|Physician Decision|0|||
155490945|NCT02400281|561221461|FG001|Overall Study|Physician Decision|0|||
155490946|NCT02400281|561221462|FG002|Overall Study|Physician Decision|1|||
155490947|NCT02400281|561221463|FG003|Overall Study|Physician Decision|0|||
155490948|NCT02400281|561221464|FG004|Overall Study|Physician Decision|0|||
155490949|NCT02400281|561221465|FG005|Overall Study|Physician Decision|0|||
155490950|NCT04524507|561221466|FG000|Overall Study|Lost to Follow-up|2|||
155490951|NCT04524507|561221467|FG001|Overall Study|Lost to Follow-up|4|||
155490952|NCT04524507|561221466|FG000|Overall Study|Withdrawal by Subject|2|||
155490953|NCT04524507|561221467|FG001|Overall Study|Withdrawal by Subject|9|||
155490954|NCT04524507|561221466|FG000|Overall Study|Death|2|||
155490955|NCT04524507|561221467|FG001|Overall Study|Death|10|||
155490956|NCT02441517|561221474|FG000|Overall Study|Lost to Follow-up|1|||
155490957|NCT02441517|561221474|FG000|Overall Study|Withdrawal by Subject|2|||
155490958|NCT02441517|561221474|FG000|Overall Study|Study Terminated by Sponsor|1|||
155490959|NCT03039699|561221475|FG000|Overall Study|Incorrect inclusion|5|||
155490960|NCT03039699|561221476|FG001|Overall Study|Incorrect inclusion|4|||
155490961|NCT03039699|561221475|FG000|Overall Study|Lack of data to assess study endpoint|5|||
155490962|NCT03039699|561221476|FG001|Overall Study|Lack of data to assess study endpoint|3|||
155490963|NCT03039699|561221475|FG000|Overall Study|Bacterial infection|12|||
155490964|NCT03039699|561221476|FG001|Overall Study|Bacterial infection|28|||
155490965|NCT02911285|561221477|FG000|Overall Study|Lost to Follow-up|8|||
155490966|NCT02911285|561221478|FG001|Overall Study|Lost to Follow-up|5|||
155490967|NCT02911285|561221477|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
155490968|NCT02911285|561221478|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
155490969|NCT00422227|561221479|FG000|Overall Study|Adverse Event|3|||
155490970|NCT00422227|561221480|FG001|Overall Study|Adverse Event|8|||
155490971|NCT00422227|561221479|FG000|Overall Study|Lost to Follow-up|1|||
155490972|NCT00422227|561221480|FG001|Overall Study|Lost to Follow-up|3|||
155490973|NCT00422227|561221479|FG000|Overall Study|Withdrawal by Subject|0|||
155490974|NCT00422227|561221480|FG001|Overall Study|Withdrawal by Subject|4|||
155490975|NCT00686894|561221482|FG000|Overall Study|Relapse|2|||
155490976|NCT00686894|561221482|FG000|Overall Study|Protocol Violation|4|||
155490977|NCT01790633|561221487|FG000|Overall Study|Protocol Violation|1|||
155490978|NCT01790633|561221488|FG001|Overall Study|Protocol Violation|2|||
155490979|NCT01790633|561221487|FG000|Overall Study|Did not have serology performed|47|||
155490980|NCT01790633|561221488|FG001|Overall Study|Did not have serology performed|0|||
155490981|NCT01790633|561221487|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
155490982|NCT01790633|561221488|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
155490983|NCT00761462|561223382|FG000|Treatment|Subjects never received study medication|23|||
155490984|NCT00761462|561223383|FG001|Treatment|Subjects never received study medication|12|||
155490985|NCT00761462|561223382|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
155490986|NCT00761462|561223383|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
155490987|NCT00761462|561223382|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
155490988|NCT00761462|561223383|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
155490989|NCT00761462|561223382|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
155490990|NCT00761462|561223383|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
155490991|NCT02985541|561223387|FG000|Overall Study|Withdrawal by Subject|33|||
155490992|NCT02985541|561223387|FG000|Overall Study|Lost to Follow-up|26|||
155490993|NCT02985541|561223387|FG000|Overall Study|Adverse Event|27|||
155490994|NCT02985541|561223387|FG000|Overall Study|Physician Decision|2|||
155490995|NCT02985541|561223387|FG000|Overall Study|Pregnancy|2|||
155490996|NCT02985541|561223387|FG000|Overall Study|Wish for pregnancy|44|||
155490997|NCT02985541|561223387|FG000|Overall Study|Other reason|5|||
155490998|NCT02985541|561223387|FG000|Overall Study|Not valid for analysis|2|||
155490999|NCT02163759|561223391|FG000|Overall Study|Withdrawal by Subject|1|||
155491000|NCT02163759|561223392|FG001|Overall Study|Withdrawal by Subject|5|||
155491001|NCT02163759|561223393|FG002|Overall Study|Withdrawal by Subject|1|||
155491002|NCT02163759|561223391|FG000|Overall Study|Adverse Event|0|||
155544283|NCT01190930|561417384|FG008|Induction|No treatment|0|||
155544284|NCT01190930|561417385|FG009|Induction|No treatment|0|||
155544285|NCT01190930|561417376|FG000|Induction|Ineligible|69|||
155544286|NCT01190930|561417377|FG001|Induction|Ineligible|4|||
155544287|NCT01190930|561417378|FG002|Induction|Ineligible|0|||
155544288|NCT01190930|561417379|FG003|Induction|Ineligible|0|||
155544289|NCT01190930|561417380|FG004|Induction|Ineligible|0|||
155544290|NCT01190930|561417381|FG005|Induction|Ineligible|0|||
155544291|NCT01190930|561417382|FG006|Induction|Ineligible|0|||
155491003|NCT02163759|561223392|FG001|Overall Study|Adverse Event|0|||
155491004|NCT02163759|561223393|FG002|Overall Study|Adverse Event|1|||
155491005|NCT02163759|561223391|FG000|Overall Study|Death|0|||
155491006|NCT02163759|561223392|FG001|Overall Study|Death|0|||
155491007|NCT02163759|561223393|FG002|Overall Study|Death|1|||
155491008|NCT00451191|561223404|FG000|Overall Study|withdrawal or received alternate tx|15|||
155491009|NCT00451191|561223405|FG001|Overall Study|withdrawal or received alternate tx|11|||
155491010|NCT00656669|561223413|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
155491011|NCT00656669|561223413|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
155491012|NCT00656669|561223413|FG000|AC (Cycles 6-9)|Adverse Event|1|||
155491013|NCT00656669|561223413|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
155491014|NCT03575806|561223414|FG000|Overall Study|Withdrawal by Subject|0|||
155491015|NCT03575806|561223415|FG001|Overall Study|Withdrawal by Subject|2|||
155491016|NCT03575806|561223414|FG000|Overall Study|Protocol Violation|0|||
155491017|NCT03575806|561223415|FG001|Overall Study|Protocol Violation|2|||
155491018|NCT00219349|561223416|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
155491019|NCT00219349|561223416|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
155491020|NCT00219349|561223416|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
155491021|NCT00219349|561223416|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
155491022|NCT01945034|561223420|FG000|Overall Study|Medication Error|0|||
155491023|NCT01945034|561223421|FG001|Overall Study|Medication Error|1|||
155491024|NCT01945034|561223422|FG002|Overall Study|Medication Error|0|||
155491025|NCT01945034|561223420|FG000|Overall Study|Withdrawal by Subject|0|||
155491026|NCT01945034|561223421|FG001|Overall Study|Withdrawal by Subject|3|||
155491027|NCT01945034|561223422|FG002|Overall Study|Withdrawal by Subject|1|||
155491028|NCT01945034|561223420|FG000|Overall Study|Other|0|||
155491029|NCT01945034|561223421|FG001|Overall Study|Other|1|||
155491030|NCT01945034|561223422|FG002|Overall Study|Other|3|||
155491031|NCT01945034|561223420|FG000|Overall Study|Lost to Follow-up|0|||
155491032|NCT01945034|561223421|FG001|Overall Study|Lost to Follow-up|0|||
155491033|NCT01945034|561223422|FG002|Overall Study|Lost to Follow-up|2|||
155491034|NCT01945034|561223420|FG000|Overall Study|Protocol Violation|1|||
155491035|NCT01945034|561223421|FG001|Overall Study|Protocol Violation|0|||
155491036|NCT01945034|561223422|FG002|Overall Study|Protocol Violation|1|||
155491037|NCT02222246|561223426|FG000|Overall Study|No Emergency Department Visits|27|||
155491038|NCT02222246|561223427|FG001|Overall Study|No Emergency Department Visits|26|||
155491039|NCT02222246|561223426|FG000|Overall Study|Physician Decision|0|||
155491040|NCT02222246|561223427|FG001|Overall Study|Physician Decision|1|||
155491041|NCT00560573|561223429|FG000|Overall Study|Death|4|||
155491042|NCT00560573|561223430|FG001|Overall Study|Death|1|||
155491043|NCT00560573|561223431|FG002|Overall Study|Death|4|||
155491044|NCT00560573|561223432|FG003|Overall Study|Death|5|||
155491045|NCT00560573|561223433|FG004|Overall Study|Death|1|||
155491046|NCT00560573|561223434|FG005|Overall Study|Death|10|||
155491047|NCT00560573|561223429|FG000|Overall Study|Lost to Follow-up|0|||
155491048|NCT00560573|561223430|FG001|Overall Study|Lost to Follow-up|0|||
155491049|NCT00560573|561223431|FG002|Overall Study|Lost to Follow-up|0|||
155491050|NCT00560573|561223432|FG003|Overall Study|Lost to Follow-up|1|||
155491051|NCT00560573|561223433|FG004|Overall Study|Lost to Follow-up|1|||
155491052|NCT00560573|561223434|FG005|Overall Study|Lost to Follow-up|0|||
155491053|NCT00560573|561223429|FG000|Overall Study|Withdrawal by Subject|0|||
155491054|NCT00560573|561223430|FG001|Overall Study|Withdrawal by Subject|0|||
155491055|NCT00560573|561223431|FG002|Overall Study|Withdrawal by Subject|0|||
155491056|NCT00560573|561223432|FG003|Overall Study|Withdrawal by Subject|1|||
155491057|NCT00560573|561223433|FG004|Overall Study|Withdrawal by Subject|1|||
155491058|NCT00560573|561223434|FG005|Overall Study|Withdrawal by Subject|0|||
155491059|NCT00560573|561223429|FG000|Overall Study|Other|2|||
155491060|NCT00560573|561223430|FG001|Overall Study|Other|2|||
155491061|NCT00560573|561223431|FG002|Overall Study|Other|2|||
155491062|NCT00560573|561223432|FG003|Overall Study|Other|3|||
155491063|NCT00560573|561223433|FG004|Overall Study|Other|3|||
155491064|NCT00560573|561223434|FG005|Overall Study|Other|3|||
155491065|NCT00560573|561223429|FG000|Overall Study|Enrolled, not treated|0|||
155491066|NCT00560573|561223430|FG001|Overall Study|Enrolled, not treated|0|||
155491067|NCT00560573|561223431|FG002|Overall Study|Enrolled, not treated|0|||
155491068|NCT00560573|561223432|FG003|Overall Study|Enrolled, not treated|0|||
155491069|NCT00560573|561223433|FG004|Overall Study|Enrolled, not treated|1|||
155491070|NCT00560573|561223434|FG005|Overall Study|Enrolled, not treated|0|||
155491071|NCT01339273|561223435|FG000|Overall Study|Lost to Follow-up|8|||
155491072|NCT01339273|561223436|FG001|Overall Study|Lost to Follow-up|8|||
155491073|NCT00423137|561223444|FG000|Overall Study|Lost to Follow-up|0|||
155491074|NCT00423137|561223445|FG001|Overall Study|Lost to Follow-up|0|||
155491075|NCT00423137|561223446|FG002|Overall Study|Lost to Follow-up|1|||
155491076|NCT00423137|561223447|FG003|Overall Study|Lost to Follow-up|0|||
155491077|NCT00423137|561223444|FG000|Overall Study|Protocol Violation|0|||
155491078|NCT00423137|561223445|FG001|Overall Study|Protocol Violation|0|||
155491079|NCT00423137|561223446|FG002|Overall Study|Protocol Violation|0|||
155491080|NCT00423137|561223447|FG003|Overall Study|Protocol Violation|1|||
155491081|NCT00423137|561223444|FG000|Overall Study|Adverse Event Study disease worse|1|||
155491082|NCT00423137|561223445|FG001|Overall Study|Adverse Event Study disease worse|0|||
155544292|NCT01190930|561417383|FG007|Induction|Ineligible|0|||
155544293|NCT01190930|561417384|FG008|Induction|Ineligible|0|||
155544294|NCT01190930|561417385|FG009|Induction|Ineligible|0|||
155544295|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
155544296|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
155544297|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
155544298|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
155544299|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
155544300|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
155544301|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
155544302|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
155544303|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
155544304|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
155544305|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Death|0|||
155544306|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Death|0|||
155544307|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Death|8|||
155544308|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Death|4|||
155544309|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Death|0|||
155544310|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Death|0|||
155544311|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Death|0|||
155544312|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Death|0|||
155544313|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Death|0|||
155544314|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Death|0|||
155544315|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
155544316|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
155544317|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
155544318|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
155544319|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
155544320|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
155544321|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
155544322|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
155544323|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
155544324|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
155544325|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544326|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
155544327|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
155544328|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
155544329|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544330|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544331|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544332|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155656516|NCT02471144|561837359|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656517|NCT02471144|561837360|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155656518|NCT02471144|561837350|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155544333|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544334|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
155544335|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Refusal|0|||
155544336|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Refusal|2|||
155544337|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Refusal|694|||
155544338|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Refusal|4|||
155544339|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Refusal|0|||
155544340|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Refusal|3|||
155544341|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Refusal|0|||
155544342|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Refusal|0|||
155544343|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Refusal|0|||
155544344|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Refusal|0|||
155544345|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
155544346|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
155544347|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
155544348|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
155544349|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
155544350|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
155544351|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
155544352|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
155544353|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
155544354|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
155544355|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544356|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
155544357|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544358|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544359|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544360|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544361|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544362|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544363|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544364|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155544365|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
155544366|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
155544367|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
155544368|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
155544369|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
155544370|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
155544371|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
155544372|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
155544373|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
155544374|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
155544375|NCT01190930|561417376|FG000|Post Induction Pre-Maintenance|Relapse|0|||
155544376|NCT01190930|561417377|FG001|Post Induction Pre-Maintenance|Relapse|0|||
155544377|NCT01190930|561417378|FG002|Post Induction Pre-Maintenance|Relapse|1|||
155544378|NCT01190930|561417379|FG003|Post Induction Pre-Maintenance|Relapse|0|||
155544379|NCT01190930|561417380|FG004|Post Induction Pre-Maintenance|Relapse|0|||
155544380|NCT01190930|561417381|FG005|Post Induction Pre-Maintenance|Relapse|0|||
155544381|NCT01190930|561417382|FG006|Post Induction Pre-Maintenance|Relapse|0|||
155544382|NCT01190930|561417383|FG007|Post Induction Pre-Maintenance|Relapse|0|||
155544383|NCT01190930|561417384|FG008|Post Induction Pre-Maintenance|Relapse|0|||
155544384|NCT01190930|561417385|FG009|Post Induction Pre-Maintenance|Relapse|0|||
155544385|NCT01190930|561417376|FG000|Maintenance|Adverse Event|0|||
155544386|NCT01190930|561417377|FG001|Maintenance|Adverse Event|0|||
155544387|NCT01190930|561417378|FG002|Maintenance|Adverse Event|0|||
155544388|NCT01190930|561417379|FG003|Maintenance|Adverse Event|0|||
155544389|NCT01190930|561417380|FG004|Maintenance|Adverse Event|0|||
155544390|NCT01190930|561417381|FG005|Maintenance|Adverse Event|1|||
155544391|NCT01190930|561417382|FG006|Maintenance|Adverse Event|1|||
155544392|NCT01190930|561417383|FG007|Maintenance|Adverse Event|3|||
155544393|NCT01190930|561417384|FG008|Maintenance|Adverse Event|3|||
155544394|NCT01190930|561417385|FG009|Maintenance|Adverse Event|0|||
155544395|NCT01190930|561417376|FG000|Maintenance|Death|0|||
155544396|NCT01190930|561417377|FG001|Maintenance|Death|0|||
155544397|NCT01190930|561417378|FG002|Maintenance|Death|0|||
155544398|NCT01190930|561417379|FG003|Maintenance|Death|1|||
155544399|NCT01190930|561417380|FG004|Maintenance|Death|0|||
155544400|NCT01190930|561417381|FG005|Maintenance|Death|0|||
155544401|NCT01190930|561417382|FG006|Maintenance|Death|2|||
155544402|NCT01190930|561417383|FG007|Maintenance|Death|2|||
155544403|NCT01190930|561417384|FG008|Maintenance|Death|2|||
155544404|NCT01190930|561417385|FG009|Maintenance|Death|2|||
155544405|NCT01190930|561417376|FG000|Maintenance|Lost to Follow-up|0|||
155544406|NCT01190930|561417377|FG001|Maintenance|Lost to Follow-up|0|||
155544407|NCT01190930|561417378|FG002|Maintenance|Lost to Follow-up|0|||
155544408|NCT01190930|561417379|FG003|Maintenance|Lost to Follow-up|0|||
155544409|NCT01190930|561417380|FG004|Maintenance|Lost to Follow-up|0|||
155544410|NCT01190930|561417381|FG005|Maintenance|Lost to Follow-up|0|||
155544411|NCT01190930|561417382|FG006|Maintenance|Lost to Follow-up|1|||
155544412|NCT01190930|561417383|FG007|Maintenance|Lost to Follow-up|1|||
155544413|NCT01190930|561417384|FG008|Maintenance|Lost to Follow-up|1|||
155544414|NCT01190930|561417385|FG009|Maintenance|Lost to Follow-up|0|||
155544415|NCT01190930|561417376|FG000|Maintenance|Physician Decision|0|||
155544416|NCT01190930|561417377|FG001|Maintenance|Physician Decision|1|||
155544417|NCT01190930|561417378|FG002|Maintenance|Physician Decision|0|||
155491083|NCT00423137|561223446|FG002|Overall Study|Adverse Event Study disease worse|3|||
155491084|NCT00423137|561223447|FG003|Overall Study|Adverse Event Study disease worse|1|||
155491085|NCT00423137|561223444|FG000|Overall Study|Adverse Event Other|0|||
155491086|NCT00423137|561223445|FG001|Overall Study|Adverse Event Other|0|||
155491087|NCT00423137|561223446|FG002|Overall Study|Adverse Event Other|2|||
155491088|NCT00423137|561223447|FG003|Overall Study|Adverse Event Other|0|||
155491089|NCT04196023|561223449|FG000|Overall Study|Withdrawal by Subject|0|||
155491090|NCT04196023|561223450|FG001|Overall Study|Withdrawal by Subject|1|||
155491091|NCT04196023|561223449|FG000|Overall Study|Adverse Event|3|||
155491092|NCT04196023|561223450|FG001|Overall Study|Adverse Event|1|||
155491093|NCT04196023|561223449|FG000|Overall Study|Lost to Follow-up|0|||
155491094|NCT04196023|561223450|FG001|Overall Study|Lost to Follow-up|1|||
155544418|NCT01190930|561417379|FG003|Maintenance|Physician Decision|5|||
155544419|NCT01190930|561417380|FG004|Maintenance|Physician Decision|9|||
155544420|NCT01190930|561417381|FG005|Maintenance|Physician Decision|4|||
155544421|NCT01190930|561417382|FG006|Maintenance|Physician Decision|8|||
155544422|NCT01190930|561417383|FG007|Maintenance|Physician Decision|8|||
155544423|NCT01190930|561417384|FG008|Maintenance|Physician Decision|10|||
155544424|NCT01190930|561417385|FG009|Maintenance|Physician Decision|17|||
155544425|NCT01190930|561417376|FG000|Maintenance|Withdrawal by Subject|0|||
155544426|NCT01190930|561417377|FG001|Maintenance|Withdrawal by Subject|0|||
155544427|NCT01190930|561417378|FG002|Maintenance|Withdrawal by Subject|0|||
155544428|NCT01190930|561417379|FG003|Maintenance|Withdrawal by Subject|0|||
155544429|NCT01190930|561417380|FG004|Maintenance|Withdrawal by Subject|0|||
155544430|NCT01190930|561417381|FG005|Maintenance|Withdrawal by Subject|0|||
155544431|NCT01190930|561417382|FG006|Maintenance|Withdrawal by Subject|2|||
155544432|NCT01190930|561417383|FG007|Maintenance|Withdrawal by Subject|1|||
155544433|NCT01190930|561417384|FG008|Maintenance|Withdrawal by Subject|4|||
155544434|NCT01190930|561417385|FG009|Maintenance|Withdrawal by Subject|1|||
155544435|NCT01190930|561417376|FG000|Maintenance|Refusal|0|||
155544436|NCT01190930|561417377|FG001|Maintenance|Refusal|1|||
155544437|NCT01190930|561417378|FG002|Maintenance|Refusal|0|||
155544438|NCT01190930|561417379|FG003|Maintenance|Refusal|2|||
155544439|NCT01190930|561417380|FG004|Maintenance|Refusal|0|||
155544440|NCT01190930|561417381|FG005|Maintenance|Refusal|4|||
155544441|NCT01190930|561417382|FG006|Maintenance|Refusal|5|||
155544442|NCT01190930|561417383|FG007|Maintenance|Refusal|17|||
155544443|NCT01190930|561417384|FG008|Maintenance|Refusal|13|||
155544444|NCT01190930|561417385|FG009|Maintenance|Refusal|6|||
155544445|NCT01190930|561417376|FG000|Maintenance|second malignant neoplasm|0|||
155544446|NCT01190930|561417377|FG001|Maintenance|second malignant neoplasm|0|||
155544447|NCT01190930|561417378|FG002|Maintenance|second malignant neoplasm|0|||
155544448|NCT01190930|561417379|FG003|Maintenance|second malignant neoplasm|1|||
155544449|NCT01190930|561417380|FG004|Maintenance|second malignant neoplasm|0|||
155544450|NCT01190930|561417381|FG005|Maintenance|second malignant neoplasm|1|||
155544451|NCT01190930|561417382|FG006|Maintenance|second malignant neoplasm|0|||
155544452|NCT01190930|561417383|FG007|Maintenance|second malignant neoplasm|0|||
155544453|NCT01190930|561417384|FG008|Maintenance|second malignant neoplasm|1|||
155544454|NCT01190930|561417385|FG009|Maintenance|second malignant neoplasm|0|||
155544455|NCT01190930|561417376|FG000|Maintenance|Inevaluable|0|||
155544456|NCT01190930|561417377|FG001|Maintenance|Inevaluable|0|||
155544457|NCT01190930|561417378|FG002|Maintenance|Inevaluable|0|||
155544458|NCT01190930|561417379|FG003|Maintenance|Inevaluable|0|||
155544459|NCT01190930|561417380|FG004|Maintenance|Inevaluable|0|||
155544460|NCT01190930|561417381|FG005|Maintenance|Inevaluable|1|||
155544461|NCT01190930|561417382|FG006|Maintenance|Inevaluable|1|||
155656519|NCT02471144|561837351|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656520|NCT02471144|561837352|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656521|NCT02471144|561837353|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155491095|NCT04359758|561223453|FG000|Overall Study|Protocol Violation|3|||
155544462|NCT01190930|561417383|FG007|Maintenance|Inevaluable|1|||
155544463|NCT01190930|561417384|FG008|Maintenance|Inevaluable|0|||
155544464|NCT01190930|561417385|FG009|Maintenance|Inevaluable|0|||
155544465|NCT01190930|561417376|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
155544466|NCT01190930|561417377|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
155544467|NCT01190930|561417378|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
155544468|NCT01190930|561417379|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
155544469|NCT01190930|561417380|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
155544470|NCT01190930|561417381|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
155544471|NCT01190930|561417382|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
155544472|NCT01190930|561417383|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
155544473|NCT01190930|561417384|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
155544474|NCT01190930|561417385|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
155544475|NCT01190930|561417376|FG000|Maintenance|Relapse|0|||
155544476|NCT01190930|561417377|FG001|Maintenance|Relapse|0|||
155544477|NCT01190930|561417378|FG002|Maintenance|Relapse|0|||
155544478|NCT01190930|561417379|FG003|Maintenance|Relapse|2|||
155544479|NCT01190930|561417380|FG004|Maintenance|Relapse|0|||
155544480|NCT01190930|561417381|FG005|Maintenance|Relapse|1|||
155544481|NCT01190930|561417382|FG006|Maintenance|Relapse|6|||
155544482|NCT01190930|561417383|FG007|Maintenance|Relapse|13|||
155544483|NCT01190930|561417384|FG008|Maintenance|Relapse|11|||
155544484|NCT01190930|561417385|FG009|Maintenance|Relapse|11|||
155544485|NCT01190930|561417376|FG000|Maintenance|Still on therapy|0|||
155544486|NCT01190930|561417377|FG001|Maintenance|Still on therapy|8|||
155544487|NCT01190930|561417378|FG002|Maintenance|Still on therapy|0|||
155544488|NCT01190930|561417379|FG003|Maintenance|Still on therapy|29|||
155544489|NCT01190930|561417380|FG004|Maintenance|Still on therapy|0|||
155544490|NCT01190930|561417381|FG005|Maintenance|Still on therapy|0|||
155544491|NCT01190930|561417382|FG006|Maintenance|Still on therapy|0|||
155544492|NCT01190930|561417383|FG007|Maintenance|Still on therapy|0|||
155544493|NCT01190930|561417384|FG008|Maintenance|Still on therapy|0|||
155544494|NCT01190930|561417385|FG009|Maintenance|Still on therapy|0|||
155544495|NCT00035555|561417386|FG000|Overall Study|Adverse Event|5|||
155544496|NCT00035555|561417387|FG001|Overall Study|Adverse Event|8|||
155544497|NCT00035555|561417388|FG002|Overall Study|Adverse Event|9|||
155544498|NCT00035555|561417386|FG000|Overall Study|Allograft loss|1|||
155544499|NCT00035555|561417387|FG001|Overall Study|Allograft loss|1|||
155544500|NCT00035555|561417388|FG002|Overall Study|Allograft loss|2|||
155544501|NCT00035555|561417386|FG000|Overall Study|Death|0|||
155544502|NCT00035555|561417387|FG001|Overall Study|Death|0|||
155544503|NCT00035555|561417388|FG002|Overall Study|Death|2|||
155544504|NCT00035555|561417386|FG000|Overall Study|Lost to Follow-up|0|||
155544505|NCT00035555|561417387|FG001|Overall Study|Lost to Follow-up|0|||
155656522|NCT02471144|561837354|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155491096|NCT04359758|561223454|FG001|Overall Study|Protocol Violation|2|||
155491097|NCT04753606|561223458|FG000|Overall Study|Adverse Event|1|||
155491098|NCT04753606|561223459|FG001|Overall Study|Adverse Event|0|||
155491099|NCT04753606|561223460|FG002|Overall Study|Adverse Event|0|||
155491100|NCT00442572|561223464|FG000|Overall Study|Relapse|8|||
155491101|NCT00442572|561223465|FG001|Overall Study|Relapse|1|||
155544506|NCT00035555|561417388|FG002|Overall Study|Lost to Follow-up|1|||
155544507|NCT00035555|561417386|FG000|Overall Study|Noncompliance|0|||
155491102|NCT00442572|561223464|FG000|Overall Study|Lost to Follow-up|0|||
155544508|NCT00035555|561417387|FG001|Overall Study|Noncompliance|1|||
155544509|NCT00035555|561417388|FG002|Overall Study|Noncompliance|1|||
155544510|NCT00035555|561417386|FG000|Overall Study|Prohibited medication|1|||
155544511|NCT00035555|561417387|FG001|Overall Study|Prohibited medication|1|||
155544512|NCT00035555|561417388|FG002|Overall Study|Prohibited medication|0|||
155544513|NCT00035555|561417386|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
155544514|NCT00035555|561417387|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
155544515|NCT00035555|561417388|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
155544516|NCT00035555|561417386|FG000|Overall Study|Withdrawal by Subject|2|||
155544517|NCT00035555|561417387|FG001|Overall Study|Withdrawal by Subject|0|||
155544518|NCT00035555|561417388|FG002|Overall Study|Withdrawal by Subject|2|||
155544519|NCT00035555|561417386|FG000|Overall Study|Investigator deemed not a good candidate|0|||
155544520|NCT00035555|561417387|FG001|Overall Study|Investigator deemed not a good candidate|0|||
155544521|NCT00035555|561417388|FG002|Overall Study|Investigator deemed not a good candidate|1|||
155544522|NCT00035555|561417386|FG000|Overall Study|Received cyclosporin in error|0|||
155544523|NCT00035555|561417387|FG001|Overall Study|Received cyclosporin in error|0|||
155544524|NCT00035555|561417388|FG002|Overall Study|Received cyclosporin in error|1|||
155544525|NCT00337428|561417389|FG000|Overall Study|Withdrawal by Subject|1|||
155544526|NCT00337428|561417390|FG001|Overall Study|Withdrawal by Subject|2|||
155544527|NCT00337428|561417389|FG000|Overall Study|Lack of Time|1|||
155544528|NCT00337428|561417390|FG001|Overall Study|Lack of Time|1|||
155544529|NCT00337428|561417389|FG000|Overall Study|Unwilling to Continue|1|||
155544530|NCT00337428|561417390|FG001|Overall Study|Unwilling to Continue|0|||
155544531|NCT00337428|561417389|FG000|Overall Study|Anorexia|1|||
155544532|NCT00337428|561417390|FG001|Overall Study|Anorexia|0|||
155544533|NCT02618382|561417391|FG000|Overall Study|Physician Decision|1|||
155544534|NCT02618382|561417391|FG000|Overall Study|Withdrawal by Subject|1|||
155544535|NCT02618382|561417391|FG000|Overall Study|Protocol Violation|1|||
155544536|NCT04886063|561417394|FG000|Overall Study|Adverse Event|50|||
155544537|NCT04886063|561417394|FG000|Overall Study|Lack of Efficacy|31|||
155544538|NCT04886063|561417394|FG000|Overall Study|Withdrawal by Subject|45|||
155544539|NCT04886063|561417394|FG000|Overall Study|Physician Decision|3|||
155544540|NCT04886063|561417394|FG000|Overall Study|Protocol Violation|3|||
155544541|NCT04886063|561417394|FG000|Overall Study|Site closure|4|||
155544542|NCT04886063|561417394|FG000|Overall Study|Nursing home replacement|3|||
155544543|NCT04886063|561417394|FG000|Overall Study|Lost to Follow-up|5|||
155544544|NCT04886063|561417394|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
155544545|NCT04886063|561417394|FG000|Overall Study|>1 reason|20|||
155544546|NCT02914457|561417395|FG000|Overall Study|Withdrawal by Subject|1|||
155544547|NCT02914457|561417395|FG000|Overall Study|Physician Decision|1|||
155544548|NCT02914457|561417395|FG000|Overall Study|No veins available for lead placement|1|||
155544549|NCT02914457|561417395|FG000|Overall Study|Electrical instability of patient|1|||
155544550|NCT02914457|561417395|FG000|Overall Study|ECG acquisition error due to sweating|1|||
155544551|NCT02914457|561417395|FG000|Overall Study|Protocol Violation|1|||
155544552|NCT00721955|561417398|FG000|Overall Study|Adverse Event|0|||
155544553|NCT00721955|561417399|FG001|Overall Study|Adverse Event|0|||
155544554|NCT00721955|561417400|FG002|Overall Study|Adverse Event|2|||
155544555|NCT01206439|561417401|FG000|Overall Study|subject did not meet inclusion criteria|1|||
155544556|NCT01055886|561417403|FG000|Overall Study|Withdrawal by Subject|4|||
155544557|NCT01055886|561417404|FG001|Overall Study|Withdrawal by Subject|9|||
155544558|NCT01055886|561417403|FG000|Overall Study|Lost to Follow-up|1|||
155544559|NCT01055886|561417404|FG001|Overall Study|Lost to Follow-up|1|||
155544560|NCT01055886|561417403|FG000|Overall Study|Withdrawal by PI|0|||
155544561|NCT01055886|561417404|FG001|Overall Study|Withdrawal by PI|1|||
155544562|NCT04254809|561417407|FG000|Overall Study|Lost to Follow-up|5|||
155544563|NCT04254809|561417408|FG001|Overall Study|Lost to Follow-up|10|||
155544564|NCT01928615|561417409|FG000|Overall Study|Study Terminated by Sponsor|2|||
155544565|NCT00434837|561417414|FG000|Overall Study|Lost to Follow-up|20|||
155544566|NCT00434837|561417415|FG001|Overall Study|Lost to Follow-up|23|||
155544567|NCT00434837|561417416|FG002|Overall Study|Lost to Follow-up|30|||
155544568|NCT01077258|561417417|FG000|Overall Study|Lost to Follow-up|1390|||
155544569|NCT01077258|561417417|FG000|Overall Study|Adverse drug reaction|218|||
155544570|NCT01077258|561417417|FG000|Overall Study|Lack of Efficacy|663|||
155544571|NCT01077258|561417417|FG000|Overall Study|Clinical remission|37|||
155544572|NCT01077258|561417417|FG000|Overall Study|Other reasons|260|||
155544573|NCT00726895|561417418|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155544574|NCT00726895|561417419|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155544575|NCT02608476|561417430|FG000|Overall Study|Withdrawal by Subject|30|||
155544576|NCT02608476|561417431|FG001|Overall Study|Withdrawal by Subject|37|||
155544577|NCT02608476|561417430|FG000|Overall Study|Lost to Follow-up|24|||
155544578|NCT02608476|561417431|FG001|Overall Study|Lost to Follow-up|24|||
155544579|NCT02608476|561417430|FG000|Overall Study|Adverse Event|2|||
155544580|NCT02608476|561417431|FG001|Overall Study|Adverse Event|8|||
155544581|NCT02608476|561417430|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
155544582|NCT02608476|561417431|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
155544583|NCT02608476|561417430|FG000|Overall Study|Noncompliance with treatment|1|||
155544584|NCT02608476|561417431|FG001|Overall Study|Noncompliance with treatment|5|||
155544585|NCT02608476|561417430|FG000|Overall Study|Lack of Efficacy|3|||
155544586|NCT02608476|561417431|FG001|Overall Study|Lack of Efficacy|1|||
155544587|NCT02608476|561417430|FG000|Overall Study|Other|0|||
155544588|NCT02608476|561417431|FG001|Overall Study|Other|1|||
155544589|NCT02608476|561417430|FG000|Overall Study|Physician Decision|1|||
155544590|NCT02608476|561417431|FG001|Overall Study|Physician Decision|0|||
155544591|NCT02608476|561417430|FG000|Overall Study|Pregnancy|0|||
155544592|NCT02608476|561417431|FG001|Overall Study|Pregnancy|1|||
155544593|NCT02608476|561417430|FG000|Overall Study|Progressive disease|1|||
155544594|NCT02608476|561417431|FG001|Overall Study|Progressive disease|0|||
155544595|NCT04660032|561417437|FG000|Overall Study|Protocol Violation|1|||
155544596|NCT04660032|561417438|FG001|Overall Study|Protocol Violation|1|||
155544597|NCT01266603|561417441|FG000|Overall Study|Adverse Event|1|||
155544598|NCT01266603|561417441|FG000|Overall Study|Lack of Efficacy|14|||
155544599|NCT01266603|561417441|FG000|Overall Study|Withdrawal by Subject|1|||
155544600|NCT01266603|561417441|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
155544601|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
155544602|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
155544603|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
155544604|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
155544605|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
155544606|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
155544607|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
155544608|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
155544609|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
155544610|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Other|1|||
155544611|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Other|4|||
155544612|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Other|5|||
155544613|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
155544614|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
155544615|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
155544616|NCT02725411|561417442|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
155544617|NCT02725411|561417443|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
155544618|NCT02725411|561417444|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
155544619|NCT02725411|561417442|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
155544620|NCT02725411|561417443|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
155544621|NCT02725411|561417444|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
155544622|NCT02725411|561417442|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
155544623|NCT02725411|561417443|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
155544624|NCT02725411|561417444|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
155544625|NCT02725411|561417442|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
155544626|NCT02725411|561417443|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
155544627|NCT02725411|561417444|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
155544628|NCT02725411|561417442|FG000|Follow-up Period (24 Weeks)|Other|1|||
155544629|NCT02725411|561417443|FG001|Follow-up Period (24 Weeks)|Other|4|||
155544630|NCT02725411|561417444|FG002|Follow-up Period (24 Weeks)|Other|2|||
155544631|NCT02725411|561417442|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
155544632|NCT02725411|561417443|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
155544633|NCT02725411|561417444|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
155544634|NCT00819767|561417445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155544635|NCT00819767|561417446|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155544636|NCT00756717|561417447|FG000|Overall Study|Withdrawal by Subject|2|||
155544637|NCT02762994|561417448|FG000|Overall Study|Withdrawal by Subject|0|||
155544638|NCT02762994|561417449|FG001|Overall Study|Withdrawal by Subject|1|||
155544639|NCT02762994|561417450|FG002|Overall Study|Withdrawal by Subject|2|||
155544640|NCT02762994|561417451|FG003|Overall Study|Withdrawal by Subject|0|||
155544641|NCT02762994|561417448|FG000|Overall Study|Protocol Violation|1|||
155544642|NCT02762994|561417449|FG001|Overall Study|Protocol Violation|0|||
155544643|NCT02762994|561417450|FG002|Overall Study|Protocol Violation|0|||
155544644|NCT02762994|561417451|FG003|Overall Study|Protocol Violation|2|||
155544645|NCT02539368|561417464|FG000|Overall Study|Death|4|||
155544646|NCT02539368|561417465|FG001|Overall Study|Death|2|||
155544647|NCT02539368|561417466|FG002|Overall Study|Death|1|||
155491103|NCT00442572|561223465|FG001|Overall Study|Lost to Follow-up|1|||
155491104|NCT00442572|561223464|FG000|Overall Study|Withdrawal by Subject|0|||
155491105|NCT00442572|561223465|FG001|Overall Study|Withdrawal by Subject|1|||
155491106|NCT04366258|561223466|FG000|Baseline Assessments|Screen Failure|21|||
155491107|NCT04366258|561223466|FG000|Baseline Assessments|Early Termination|3|||
155544648|NCT02539368|561417467|FG003|Overall Study|Death|0|||
155544649|NCT02539368|561417468|FG004|Overall Study|Death|0|||
155544650|NCT02539368|561417464|FG000|Overall Study|Withdrawal by Subject|44|||
155544651|NCT02539368|561417465|FG001|Overall Study|Withdrawal by Subject|35|||
155544652|NCT02539368|561417466|FG002|Overall Study|Withdrawal by Subject|9|||
155656523|NCT02471144|561837355|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
155656524|NCT02471144|561837356|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656525|NCT02471144|561837357|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656526|NCT02471144|561837358|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
155656527|NCT02471144|561837359|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656528|NCT02471144|561837360|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155656529|NCT02471144|561837350|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656530|NCT02471144|561837351|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656531|NCT02471144|561837352|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656532|NCT02471144|561837353|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656533|NCT02471144|561837354|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656534|NCT02471144|561837355|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656535|NCT02471144|561837356|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656536|NCT02471144|561837357|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656537|NCT02471144|561837358|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
155656538|NCT02471144|561837359|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656539|NCT02471144|561837360|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155656540|NCT02471144|561837350|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656541|NCT02471144|561837351|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656542|NCT02471144|561837352|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656543|NCT02471144|561837353|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656544|NCT02471144|561837354|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656545|NCT02471144|561837355|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656546|NCT02471144|561837356|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656547|NCT02471144|561837357|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
155656548|NCT02471144|561837358|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
155656549|NCT02471144|561837359|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656550|NCT02471144|561837360|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155656551|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656552|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656553|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656554|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656555|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656556|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656557|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656558|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656559|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155656560|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
155656561|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
155656562|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656563|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656564|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656565|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656566|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656567|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656568|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656569|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656570|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656571|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
155656572|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155656573|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656574|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656575|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656576|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656577|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656578|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656579|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656580|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656581|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656582|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155656583|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
155656584|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656585|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656586|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155544653|NCT02539368|561417467|FG003|Overall Study|Withdrawal by Subject|1|||
155544654|NCT02539368|561417468|FG004|Overall Study|Withdrawal by Subject|3|||
155544655|NCT02539368|561417464|FG000|Overall Study|Physician Decision|49|||
155544656|NCT02539368|561417465|FG001|Overall Study|Physician Decision|15|||
155544657|NCT02539368|561417466|FG002|Overall Study|Physician Decision|7|||
155544658|NCT02539368|561417467|FG003|Overall Study|Physician Decision|0|||
155544659|NCT02539368|561417468|FG004|Overall Study|Physician Decision|2|||
155544660|NCT02539368|561417464|FG000|Overall Study|Lost to Follow-up|96|||
155544661|NCT02539368|561417465|FG001|Overall Study|Lost to Follow-up|21|||
155544662|NCT02539368|561417466|FG002|Overall Study|Lost to Follow-up|16|||
155544663|NCT02539368|561417467|FG003|Overall Study|Lost to Follow-up|4|||
155544664|NCT02539368|561417468|FG004|Overall Study|Lost to Follow-up|3|||
155544665|NCT02539368|561417464|FG000|Overall Study|Adverse Event|44|||
155544666|NCT02539368|561417465|FG001|Overall Study|Adverse Event|5|||
155544667|NCT02539368|561417466|FG002|Overall Study|Adverse Event|9|||
155544668|NCT02539368|561417467|FG003|Overall Study|Adverse Event|0|||
155544669|NCT02539368|561417468|FG004|Overall Study|Adverse Event|3|||
155544670|NCT02539368|561417464|FG000|Overall Study|Participant Non-compliant|13|||
155544671|NCT02539368|561417465|FG001|Overall Study|Participant Non-compliant|2|||
155544672|NCT02539368|561417466|FG002|Overall Study|Participant Non-compliant|1|||
155544673|NCT02539368|561417467|FG003|Overall Study|Participant Non-compliant|1|||
155544674|NCT02539368|561417468|FG004|Overall Study|Participant Non-compliant|0|||
155544675|NCT02539368|561417464|FG000|Overall Study|Other|145|||
155544676|NCT02539368|561417465|FG001|Overall Study|Other|18|||
155544677|NCT02539368|561417466|FG002|Overall Study|Other|24|||
155544678|NCT02539368|561417467|FG003|Overall Study|Other|1|||
155544679|NCT02539368|561417468|FG004|Overall Study|Other|3|||
155544680|NCT02539368|561417464|FG000|Overall Study|Missing|10|||
155544681|NCT02539368|561417465|FG001|Overall Study|Missing|3|||
155544682|NCT02539368|561417466|FG002|Overall Study|Missing|0|||
155544683|NCT02539368|561417467|FG003|Overall Study|Missing|0|||
155544684|NCT02539368|561417468|FG004|Overall Study|Missing|0|||
155544685|NCT00398073|561417469|FG000|Overall Study|Withdrawal by Subject|1|||
155544686|NCT00398073|561417470|FG001|Overall Study|Withdrawal by Subject|0|||
155544687|NCT01263561|561417471|FG000|Overall Study|Death|1|||
155544688|NCT01263561|561417472|FG001|Overall Study|Death|2|||
155544689|NCT00879684|561417473|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
155544690|NCT00879684|561417474|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
155544691|NCT00879684|561417475|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
155544692|NCT00879684|561417476|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
155544693|NCT00879684|561417477|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
155544694|NCT00879684|561417478|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
155544695|NCT00879684|561417479|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
155544696|NCT00879684|561417473|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
155544697|NCT00879684|561417474|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
155544698|NCT00879684|561417475|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
155544699|NCT00879684|561417476|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
155544700|NCT00879684|561417477|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
155544701|NCT00879684|561417478|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
155544702|NCT00879684|561417479|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
155544703|NCT00879684|561417473|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
155544704|NCT00879684|561417474|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
155544705|NCT00879684|561417475|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
155544706|NCT00879684|561417476|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
155544707|NCT00879684|561417477|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
155544708|NCT00879684|561417478|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
155544709|NCT00879684|561417479|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
155544710|NCT00879684|561417473|FG000|Stage 1: Dose Escalation|Death|0|||
155544711|NCT00879684|561417474|FG001|Stage 1: Dose Escalation|Death|0|||
155544712|NCT00879684|561417475|FG002|Stage 1: Dose Escalation|Death|1|||
155544713|NCT00879684|561417476|FG003|Stage 1: Dose Escalation|Death|0|||
155544714|NCT00879684|561417477|FG004|Stage 1: Dose Escalation|Death|0|||
155544715|NCT00879684|561417478|FG005|Stage 1: Dose Escalation|Death|0|||
155544716|NCT00879684|561417479|FG006|Stage 1: Dose Escalation|Death|0|||
155544717|NCT00879684|561417473|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544718|NCT00879684|561417474|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544719|NCT00879684|561417475|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544720|NCT00879684|561417476|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544721|NCT00879684|561417477|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544722|NCT00879684|561417478|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
155544723|NCT00879684|561417479|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
155544724|NCT00879684|561417473|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544725|NCT00879684|561417474|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544726|NCT00879684|561417475|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544727|NCT00879684|561417476|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544728|NCT00879684|561417477|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544729|NCT00879684|561417478|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
155544730|NCT00879684|561417479|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
155544731|NCT00879684|561417473|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544732|NCT00879684|561417474|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544733|NCT00879684|561417475|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544734|NCT00879684|561417476|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544735|NCT00879684|561417477|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544736|NCT00879684|561417478|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
155544737|NCT00879684|561417479|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
155544738|NCT03185741|561417484|FG000|Baseline|Withdrawal by Subject|1|||
155544739|NCT03185741|561417485|FG001|Baseline|Withdrawal by Subject|3|||
155544740|NCT03185741|561417486|FG002|Baseline|Withdrawal by Subject|2|||
155544741|NCT03185741|561417484|FG000|Baseline|Lost to Follow-up|1|||
155544742|NCT03185741|561417485|FG001|Baseline|Lost to Follow-up|2|||
155544743|NCT03185741|561417486|FG002|Baseline|Lost to Follow-up|3|||
155544744|NCT03185741|561417484|FG000|3Month|Death|1|||
155544745|NCT03185741|561417485|FG001|3Month|Death|1|||
155544746|NCT03185741|561417486|FG002|3Month|Death|2|||
155544747|NCT03185741|561417484|FG000|3Month|Withdrawal by Subject|1|||
155544748|NCT03185741|561417485|FG001|3Month|Withdrawal by Subject|5|||
155544749|NCT03185741|561417486|FG002|3Month|Withdrawal by Subject|1|||
155544750|NCT03185741|561417484|FG000|3Month|Lost to Follow-up|7|||
155544751|NCT03185741|561417485|FG001|3Month|Lost to Follow-up|9|||
155544752|NCT03185741|561417486|FG002|3Month|Lost to Follow-up|8|||
155656587|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155544753|NCT03185741|561417484|FG000|3Month|Unavailable for 3Month|11|||
155544754|NCT03185741|561417485|FG001|3Month|Unavailable for 3Month|10|||
155544755|NCT03185741|561417486|FG002|3Month|Unavailable for 3Month|11|||
155544756|NCT03185741|561417484|FG000|3Month|Protocol Violation|0|||
155544757|NCT03185741|561417485|FG001|3Month|Protocol Violation|0|||
155544758|NCT03185741|561417486|FG002|3Month|Protocol Violation|3|||
155544759|NCT03185741|561417484|FG000|6Month|Death|1|||
155544760|NCT03185741|561417485|FG001|6Month|Death|1|||
155544761|NCT03185741|561417486|FG002|6Month|Death|2|||
155544762|NCT03185741|561417484|FG000|6Month|Withdrawal by Subject|2|||
155544763|NCT03185741|561417485|FG001|6Month|Withdrawal by Subject|3|||
155544764|NCT03185741|561417486|FG002|6Month|Withdrawal by Subject|1|||
155544765|NCT03185741|561417484|FG000|6Month|Lost to Follow-up|16|||
155544766|NCT03185741|561417485|FG001|6Month|Lost to Follow-up|15|||
155544767|NCT03185741|561417486|FG002|6Month|Lost to Follow-up|16|||
155544768|NCT01525628|561417489|FG000|Overall Study|Adverse Event|1|||
155544769|NCT01525628|561417490|FG001|Overall Study|Adverse Event|1|||
155544770|NCT01525628|561417491|FG002|Overall Study|Adverse Event|2|||
155544771|NCT01525628|561417492|FG003|Overall Study|Adverse Event|0|||
155544772|NCT01525628|561417493|FG004|Overall Study|Adverse Event|1|||
155544773|NCT01525628|561417489|FG000|Overall Study|Lack of Efficacy|0|||
155544774|NCT01525628|561417490|FG001|Overall Study|Lack of Efficacy|2|||
155544775|NCT01525628|561417491|FG002|Overall Study|Lack of Efficacy|2|||
155544776|NCT01525628|561417492|FG003|Overall Study|Lack of Efficacy|1|||
155544777|NCT01525628|561417493|FG004|Overall Study|Lack of Efficacy|2|||
155544778|NCT01525628|561417489|FG000|Overall Study|Protocol Violation|0|||
155544779|NCT01525628|561417490|FG001|Overall Study|Protocol Violation|0|||
155544780|NCT01525628|561417491|FG002|Overall Study|Protocol Violation|1|||
155544781|NCT01525628|561417492|FG003|Overall Study|Protocol Violation|0|||
155544782|NCT01525628|561417493|FG004|Overall Study|Protocol Violation|0|||
155544783|NCT01525628|561417489|FG000|Overall Study|Lost to Follow-up|1|||
155544784|NCT01525628|561417490|FG001|Overall Study|Lost to Follow-up|1|||
155544785|NCT01525628|561417491|FG002|Overall Study|Lost to Follow-up|0|||
155544786|NCT01525628|561417492|FG003|Overall Study|Lost to Follow-up|0|||
155544787|NCT01525628|561417493|FG004|Overall Study|Lost to Follow-up|0|||
155544788|NCT01525628|561417489|FG000|Overall Study|Withdrawal by Subject|0|||
155544789|NCT01525628|561417490|FG001|Overall Study|Withdrawal by Subject|1|||
155544790|NCT01525628|561417491|FG002|Overall Study|Withdrawal by Subject|0|||
155544791|NCT01525628|561417492|FG003|Overall Study|Withdrawal by Subject|0|||
155544792|NCT01525628|561417493|FG004|Overall Study|Withdrawal by Subject|0|||
155544793|NCT01525628|561417489|FG000|Overall Study|Other reason not defined above|0|||
155544794|NCT01525628|561417490|FG001|Overall Study|Other reason not defined above|0|||
155544795|NCT01525628|561417491|FG002|Overall Study|Other reason not defined above|0|||
155544796|NCT01525628|561417492|FG003|Overall Study|Other reason not defined above|3|||
155544797|NCT01525628|561417493|FG004|Overall Study|Other reason not defined above|0|||
155544798|NCT03573336|561417494|FG000|Overall Study|Study terminated|2|||
155544799|NCT03573336|561417495|FG001|Overall Study|Study terminated|4|||
155544800|NCT03573336|561417496|FG002|Overall Study|Study terminated|2|||
155544801|NCT00239005|561417497|FG000|Overall Study|Adverse Event|6|||
155544802|NCT00239005|561417498|FG001|Overall Study|Adverse Event|6|||
155544803|NCT00239005|561417497|FG000|Overall Study|Withdrawal by Subject|3|||
155544804|NCT00239005|561417498|FG001|Overall Study|Withdrawal by Subject|4|||
155544805|NCT00239005|561417497|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
155544806|NCT00239005|561417498|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
155544807|NCT00239005|561417497|FG000|Overall Study|Protocol Violation|1|||
155544808|NCT00239005|561417498|FG001|Overall Study|Protocol Violation|0|||
155544809|NCT00239005|561417497|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
155544810|NCT00239005|561417498|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
155544811|NCT00239005|561417497|FG000|Overall Study|Lost to Follow-up|0|||
155544812|NCT00239005|561417498|FG001|Overall Study|Lost to Follow-up|1|||
155544813|NCT02614898|561417499|FG000|Overall Study|Participated until study termination|10|||
155544814|NCT02614898|561417500|FG001|Overall Study|Participated until study termination|26|||
155544815|NCT02614898|561417499|FG000|Overall Study|Lost to Follow-up|0|||
155544816|NCT02614898|561417500|FG001|Overall Study|Lost to Follow-up|2|||
155544817|NCT02614898|561417499|FG000|Overall Study|Physician Decision|1|||
155544818|NCT02614898|561417500|FG001|Overall Study|Physician Decision|8|||
155544819|NCT02614898|561417499|FG000|Overall Study|Study Terminated by Sponsor|3|||
155544820|NCT02614898|561417500|FG001|Overall Study|Study Terminated by Sponsor|0|||
155544821|NCT02614898|561417499|FG000|Overall Study|Withdrawal by Subject|0|||
155544822|NCT02614898|561417500|FG001|Overall Study|Withdrawal by Subject|2|||
155544823|NCT02614898|561417499|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155544824|NCT02614898|561417500|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155544825|NCT02614898|561417499|FG000|Overall Study|Other-Additional Information Unavailable|0|||
155544826|NCT02614898|561417500|FG001|Overall Study|Other-Additional Information Unavailable|11|||
155544827|NCT02614898|561417499|FG000|Overall Study|Missing|0|||
155544828|NCT02614898|561417500|FG001|Overall Study|Missing|1|||
155544829|NCT00787605|561417501|FG000|Overall Study|Administrative Problems|3|||
155544830|NCT00787605|561417502|FG001|Overall Study|Administrative Problems|0|||
155544831|NCT00787605|561417501|FG000|Overall Study|Adverse Event|14|||
155544832|NCT00787605|561417502|FG001|Overall Study|Adverse Event|25|||
155544833|NCT00787605|561417501|FG000|Overall Study|Lost to Follow-up|3|||
155544834|NCT00787605|561417502|FG001|Overall Study|Lost to Follow-up|6|||
155544835|NCT00787605|561417501|FG000|Overall Study|Protocol Violation|7|||
155544836|NCT00787605|561417502|FG001|Overall Study|Protocol Violation|3|||
155544837|NCT00787605|561417501|FG000|Overall Study|Withdrawal by Subject|6|||
155544838|NCT00787605|561417502|FG001|Overall Study|Withdrawal by Subject|13|||
155544839|NCT00787605|561417501|FG000|Overall Study|Lack of Efficacy|13|||
155544840|NCT00787605|561417502|FG001|Overall Study|Lack of Efficacy|9|||
155544841|NCT03108820|561417503|FG000|Overall Study|Lost to Follow-up|30|||
155544842|NCT03108820|561417504|FG001|Overall Study|Lost to Follow-up|28|||
155544843|NCT03108820|561417503|FG000|Overall Study|Withdrawal by Subject|32|||
155544844|NCT03108820|561417504|FG001|Overall Study|Withdrawal by Subject|24|||
155544845|NCT03108820|561417503|FG000|Overall Study|Death|6|||
155544846|NCT03108820|561417504|FG001|Overall Study|Death|11|||
155544847|NCT01488448|561417510|FG000|Overall Study|Withdrawal by Subject|3|||
155544848|NCT01488448|561417511|FG001|Overall Study|Withdrawal by Subject|1|||
155544849|NCT01488448|561417510|FG000|Overall Study|Adverse Event|9|||
155544850|NCT01488448|561417511|FG001|Overall Study|Adverse Event|4|||
155544851|NCT01488448|561417510|FG000|Overall Study|Physician Decision|4|||
155544852|NCT01488448|561417511|FG001|Overall Study|Physician Decision|9|||
155544853|NCT01488448|561417510|FG000|Overall Study|Protocol Violation|4|||
155544854|NCT01488448|561417511|FG001|Overall Study|Protocol Violation|3|||
155544855|NCT00654641|561417512|FG000|Overall Study|Lost to Follow-up|2|||
155544856|NCT00654641|561417513|FG001|Overall Study|Lost to Follow-up|3|||
155544857|NCT01992094|561417514|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
155544858|NCT01992094|561417515|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
155544859|NCT01992094|561417516|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
155544860|NCT01992094|561417514|FG000|Overall Study|Adverse Event|1|||
155544861|NCT01992094|561417515|FG001|Overall Study|Adverse Event|0|||
155544862|NCT01992094|561417516|FG002|Overall Study|Adverse Event|0|||
155544863|NCT01992094|561417514|FG000|Overall Study|Death|5|||
155544864|NCT01992094|561417515|FG001|Overall Study|Death|5|||
155544865|NCT01992094|561417516|FG002|Overall Study|Death|2|||
155544866|NCT01992094|561417514|FG000|Overall Study|Lost to Follow-up|26|||
155544867|NCT01992094|561417515|FG001|Overall Study|Lost to Follow-up|9|||
155544868|NCT01992094|561417516|FG002|Overall Study|Lost to Follow-up|13|||
155544869|NCT01992094|561417514|FG000|Overall Study|OTHER|4|||
155544870|NCT01992094|561417515|FG001|Overall Study|OTHER|0|||
155544871|NCT01992094|561417516|FG002|Overall Study|OTHER|0|||
155544872|NCT01992094|561417514|FG000|Overall Study|Protocol Violation|1|||
155656588|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155544873|NCT01992094|561417515|FG001|Overall Study|Protocol Violation|0|||
155544874|NCT01992094|561417516|FG002|Overall Study|Protocol Violation|1|||
155544875|NCT01992094|561417514|FG000|Overall Study|Withdrawal by Subject|7|||
155544876|NCT01992094|561417515|FG001|Overall Study|Withdrawal by Subject|3|||
155491108|NCT00276458|561223467|FG000|Overall Study|Adverse Event|0|||
155491109|NCT00276458|561223468|FG001|Overall Study|Adverse Event|2|||
155491110|NCT00276458|561223467|FG000|Overall Study|Lost to Follow-up|2|||
155491111|NCT00276458|561223468|FG001|Overall Study|Lost to Follow-up|2|||
155491112|NCT00276458|561223467|FG000|Overall Study|Protocol Violation|4|||
155491113|NCT00276458|561223468|FG001|Overall Study|Protocol Violation|3|||
155491114|NCT03205046|561223472|FG000|Overall Study|Death|10|||
155491115|NCT03205046|561223473|FG001|Overall Study|Death|6|||
155491116|NCT03205046|561223472|FG000|Overall Study|Withdrawal by Subject|1|||
155491117|NCT03205046|561223473|FG001|Overall Study|Withdrawal by Subject|2|||
155491118|NCT03205046|561223472|FG000|Overall Study|Lost to Follow-up|0|||
155491119|NCT03205046|561223473|FG001|Overall Study|Lost to Follow-up|1|||
155491120|NCT03205046|561223472|FG000|Overall Study|Study terminated by sponsor|2|||
155544877|NCT01992094|561417516|FG002|Overall Study|Withdrawal by Subject|4|||
155544878|NCT00434590|561417519|FG000|Overall Study|Administrative problems|5|||
155544879|NCT00434590|561417520|FG001|Overall Study|Administrative problems|5|||
155544880|NCT00965731|561417523|FG000|Overall Study|Death|0|||
155544881|NCT00965731|561417524|FG001|Overall Study|Death|4|||
155544882|NCT00965731|561417523|FG000|Overall Study|Withdrawal by Subject|0|||
155544883|NCT00965731|561417524|FG001|Overall Study|Withdrawal by Subject|1|||
155544884|NCT00965731|561417523|FG000|Overall Study|Other|7|||
155544885|NCT00965731|561417524|FG001|Overall Study|Other|15|||
155544886|NCT03429049|561419042|FG000|Overall Study|Adverse Event|2|||
155544887|NCT03429049|561419043|FG001|Overall Study|Adverse Event|3|||
155544888|NCT03429049|561419042|FG000|Overall Study|Death|0|||
155544889|NCT03429049|561419043|FG001|Overall Study|Death|1|||
155544890|NCT03429049|561419042|FG000|Overall Study|Lack of Efficacy|4|||
155544891|NCT03429049|561419043|FG001|Overall Study|Lack of Efficacy|2|||
155544892|NCT03429049|561419042|FG000|Overall Study|Lost to Follow-up|9|||
155544893|NCT03429049|561419043|FG001|Overall Study|Lost to Follow-up|8|||
155544894|NCT03429049|561419042|FG000|Overall Study|Physician Decision|1|||
155544895|NCT03429049|561419043|FG001|Overall Study|Physician Decision|0|||
155544896|NCT03429049|561419042|FG000|Overall Study|Protocol Violation|3|||
155544897|NCT03429049|561419043|FG001|Overall Study|Protocol Violation|0|||
155544898|NCT03429049|561419042|FG000|Overall Study|Sponsor Decision|2|||
155544899|NCT03429049|561419043|FG001|Overall Study|Sponsor Decision|0|||
155544900|NCT03429049|561419042|FG000|Overall Study|Withdrawal by Subject|4|||
155544901|NCT03429049|561419043|FG001|Overall Study|Withdrawal by Subject|20|||
155544902|NCT03429049|561419042|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
155544903|NCT03429049|561419043|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
155544904|NCT04703855|561419044|FG000|Overall Study|Heart Transplant|1|||
155544905|NCT05258630|561419046|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
155544906|NCT05258630|561419047|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
155544907|NCT05258630|561419046|FG000|Overall Study|Lost to Follow-up|0|||
155544908|NCT05258630|561419047|FG001|Overall Study|Lost to Follow-up|2|||
155544909|NCT03431337|561419048|FG000|Overall Study|Lost to Follow-up|21|||
155544910|NCT03431337|561419049|FG001|Overall Study|Lost to Follow-up|19|||
155544911|NCT03431337|561419048|FG000|Overall Study|Withdrawal by Subject|8|||
155544912|NCT03431337|561419049|FG001|Overall Study|Withdrawal by Subject|3|||
155544913|NCT00401245|561419050|FG000|Double Blind Titration Phase|Adverse Event|3|||
155544914|NCT00401245|561419051|FG001|Double Blind Titration Phase|Adverse Event|2|||
155544915|NCT00401245|561419052|FG002|Double Blind Titration Phase|Adverse Event|5|||
155544916|NCT00401245|561419053|FG003|Double Blind Titration Phase|Adverse Event|12|||
155544917|NCT00401245|561419054|FG004|Double Blind Titration Phase|Adverse Event|0|||
155544918|NCT00401245|561419055|FG005|Double Blind Titration Phase|Adverse Event|0|||
155544919|NCT00401245|561419056|FG006|Double Blind Titration Phase|Adverse Event|0|||
155544920|NCT00401245|561419057|FG007|Double Blind Titration Phase|Adverse Event|0|||
155544921|NCT00401245|561419050|FG000|Double Blind Titration Phase|Other|0|||
155544922|NCT00401245|561419051|FG001|Double Blind Titration Phase|Other|0|||
155544923|NCT00401245|561419052|FG002|Double Blind Titration Phase|Other|1|||
155544924|NCT00401245|561419053|FG003|Double Blind Titration Phase|Other|0|||
155544925|NCT00401245|561419054|FG004|Double Blind Titration Phase|Other|0|||
155544926|NCT00401245|561419055|FG005|Double Blind Titration Phase|Other|0|||
155544927|NCT00401245|561419056|FG006|Double Blind Titration Phase|Other|0|||
155544928|NCT00401245|561419057|FG007|Double Blind Titration Phase|Other|0|||
155544929|NCT00401245|561419050|FG000|Double Blind Titration Phase|Protocol Violation|0|||
155544930|NCT00401245|561419051|FG001|Double Blind Titration Phase|Protocol Violation|0|||
155544931|NCT00401245|561419052|FG002|Double Blind Titration Phase|Protocol Violation|0|||
155544932|NCT00401245|561419053|FG003|Double Blind Titration Phase|Protocol Violation|1|||
155544933|NCT00401245|561419054|FG004|Double Blind Titration Phase|Protocol Violation|0|||
155544934|NCT00401245|561419055|FG005|Double Blind Titration Phase|Protocol Violation|0|||
155544935|NCT00401245|561419056|FG006|Double Blind Titration Phase|Protocol Violation|0|||
155544936|NCT00401245|561419057|FG007|Double Blind Titration Phase|Protocol Violation|0|||
155544937|NCT00401245|561419050|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
155544938|NCT00401245|561419051|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
155544939|NCT00401245|561419052|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
155544940|NCT00401245|561419053|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
155656589|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656590|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656591|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656592|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155656593|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
155656594|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
155656595|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656596|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656597|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656598|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656599|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656600|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656601|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656602|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656603|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656604|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
155656605|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155656606|NCT02471144|561837350|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656607|NCT02471144|561837351|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656608|NCT02471144|561837352|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656609|NCT02471144|561837353|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656610|NCT02471144|561837354|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656611|NCT02471144|561837355|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656612|NCT02471144|561837356|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656613|NCT02471144|561837357|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656614|NCT02471144|561837358|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155656615|NCT02471144|561837359|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
155656616|NCT02471144|561837360|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
155656617|NCT00791648|561837364|FG000|Overall Study|Physician Decision|0|||
155656618|NCT00791648|561837365|FG001|Overall Study|Physician Decision|1|||
155656619|NCT00791648|561837364|FG000|Overall Study|Withdrawal by Subject|0|||
155656620|NCT00791648|561837365|FG001|Overall Study|Withdrawal by Subject|1|||
155656621|NCT00462826|561837366|FG000|Overall Study|Ineligible - second primary|1|||
155656622|NCT00462826|561837366|FG000|Overall Study|Ineligible - wrong cell type|1|||
155656623|NCT00462826|561837366|FG000|Overall Study|Ineligible - wrong primary|2|||
155656624|NCT00462826|561837366|FG000|Overall Study|Never treated|1|||
155656625|NCT03977155|561837367|FG000|Overall Study|Adverse Event|3|||
155656626|NCT03977155|561837368|FG001|Overall Study|Adverse Event|0|||
155656627|NCT03977155|561837369|FG002|Overall Study|Adverse Event|0|||
155656628|NCT03977155|561837367|FG000|Overall Study|Lost to Follow-up|0|||
155656629|NCT03977155|561837368|FG001|Overall Study|Lost to Follow-up|1|||
155656630|NCT03977155|561837369|FG002|Overall Study|Lost to Follow-up|0|||
155656631|NCT03977155|561837367|FG000|Overall Study|Withdrawal by Subject|1|||
155656632|NCT03977155|561837368|FG001|Overall Study|Withdrawal by Subject|1|||
155656633|NCT03977155|561837369|FG002|Overall Study|Withdrawal by Subject|2|||
155656634|NCT03977155|561837367|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
155656635|NCT03977155|561837368|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
155656636|NCT03977155|561837369|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
155656637|NCT00936936|561837370|FG000|Overall Study|Adverse Event|7|||
155656638|NCT00936936|561837371|FG001|Overall Study|Adverse Event|1|||
155656639|NCT00936936|561837370|FG000|Overall Study|Disease Progression|2|||
155656640|NCT00936936|561837371|FG001|Overall Study|Disease Progression|2|||
155656641|NCT00936936|561837370|FG000|Overall Study|Unrelated|3|||
155656642|NCT00936936|561837371|FG001|Overall Study|Unrelated|1|||
155656643|NCT02278003|561837373|FG000|Overall Study|Withdrawal by Subject|11|||
155656644|NCT02278003|561837374|FG001|Overall Study|Withdrawal by Subject|0|||
155656645|NCT02278003|561837373|FG000|Overall Study|Not Treated|1|||
155544941|NCT00401245|561419054|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
155544942|NCT00401245|561419055|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
155544943|NCT00401245|561419056|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
155544944|NCT00401245|561419057|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
155544945|NCT00401245|561419050|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544946|NCT00401245|561419051|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
155544947|NCT00401245|561419052|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544948|NCT00401245|561419053|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
155544949|NCT00401245|561419054|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544950|NCT00401245|561419055|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544951|NCT00401245|561419056|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544952|NCT00401245|561419057|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
155544953|NCT00401245|561419050|FG000|Open Label Phase|Adverse Event|5|||
155544954|NCT00401245|561419051|FG001|Open Label Phase|Adverse Event|14|||
155544955|NCT00401245|561419052|FG002|Open Label Phase|Adverse Event|6|||
155544956|NCT00401245|561419053|FG003|Open Label Phase|Adverse Event|7|||
155544957|NCT00401245|561419054|FG004|Open Label Phase|Adverse Event|0|||
155544958|NCT00401245|561419055|FG005|Open Label Phase|Adverse Event|0|||
155544959|NCT00401245|561419056|FG006|Open Label Phase|Adverse Event|0|||
155544960|NCT00401245|561419057|FG007|Open Label Phase|Adverse Event|0|||
155544961|NCT00401245|561419050|FG000|Open Label Phase|Lost to Follow-up|5|||
155544962|NCT00401245|561419051|FG001|Open Label Phase|Lost to Follow-up|7|||
155544963|NCT00401245|561419052|FG002|Open Label Phase|Lost to Follow-up|5|||
155544964|NCT00401245|561419053|FG003|Open Label Phase|Lost to Follow-up|4|||
155544965|NCT00401245|561419054|FG004|Open Label Phase|Lost to Follow-up|0|||
155544966|NCT00401245|561419055|FG005|Open Label Phase|Lost to Follow-up|0|||
155544967|NCT00401245|561419056|FG006|Open Label Phase|Lost to Follow-up|0|||
155544968|NCT00401245|561419057|FG007|Open Label Phase|Lost to Follow-up|0|||
155544969|NCT00401245|561419050|FG000|Open Label Phase|Other|4|||
155544970|NCT00401245|561419051|FG001|Open Label Phase|Other|8|||
155544971|NCT00401245|561419052|FG002|Open Label Phase|Other|7|||
155544972|NCT00401245|561419053|FG003|Open Label Phase|Other|8|||
155544973|NCT00401245|561419054|FG004|Open Label Phase|Other|0|||
155544974|NCT00401245|561419055|FG005|Open Label Phase|Other|0|||
155544975|NCT00401245|561419056|FG006|Open Label Phase|Other|0|||
155544976|NCT00401245|561419057|FG007|Open Label Phase|Other|0|||
155544977|NCT00401245|561419050|FG000|Open Label Phase|Protocol Violation|0|||
155544978|NCT00401245|561419051|FG001|Open Label Phase|Protocol Violation|1|||
155544979|NCT00401245|561419052|FG002|Open Label Phase|Protocol Violation|0|||
155544980|NCT00401245|561419053|FG003|Open Label Phase|Protocol Violation|1|||
155544981|NCT00401245|561419054|FG004|Open Label Phase|Protocol Violation|0|||
155544982|NCT00401245|561419055|FG005|Open Label Phase|Protocol Violation|0|||
155544983|NCT00401245|561419056|FG006|Open Label Phase|Protocol Violation|0|||
155544984|NCT00401245|561419057|FG007|Open Label Phase|Protocol Violation|0|||
155544985|NCT00401245|561419050|FG000|Open Label Phase|Withdrawal by Subject|3|||
155544986|NCT00401245|561419051|FG001|Open Label Phase|Withdrawal by Subject|3|||
155544987|NCT00401245|561419052|FG002|Open Label Phase|Withdrawal by Subject|2|||
155544988|NCT00401245|561419053|FG003|Open Label Phase|Withdrawal by Subject|1|||
155544989|NCT00401245|561419054|FG004|Open Label Phase|Withdrawal by Subject|0|||
155544990|NCT00401245|561419055|FG005|Open Label Phase|Withdrawal by Subject|0|||
155544991|NCT00401245|561419056|FG006|Open Label Phase|Withdrawal by Subject|0|||
155544992|NCT00401245|561419057|FG007|Open Label Phase|Withdrawal by Subject|0|||
155544993|NCT00401245|561419050|FG000|Open Label Phase|Lack of Efficacy|4|||
155544994|NCT00401245|561419051|FG001|Open Label Phase|Lack of Efficacy|2|||
155544995|NCT00401245|561419052|FG002|Open Label Phase|Lack of Efficacy|3|||
155544996|NCT00401245|561419053|FG003|Open Label Phase|Lack of Efficacy|0|||
155544997|NCT00401245|561419054|FG004|Open Label Phase|Lack of Efficacy|0|||
155544998|NCT00401245|561419055|FG005|Open Label Phase|Lack of Efficacy|0|||
155544999|NCT00401245|561419056|FG006|Open Label Phase|Lack of Efficacy|0|||
155545000|NCT00401245|561419057|FG007|Open Label Phase|Lack of Efficacy|0|||
155545001|NCT00401245|561419050|FG000|Double Blind Tapering Phase|Adverse Event|0|||
155545002|NCT00401245|561419051|FG001|Double Blind Tapering Phase|Adverse Event|0|||
155545003|NCT00401245|561419052|FG002|Double Blind Tapering Phase|Adverse Event|0|||
155545004|NCT00401245|561419053|FG003|Double Blind Tapering Phase|Adverse Event|0|||
155545005|NCT00401245|561419054|FG004|Double Blind Tapering Phase|Adverse Event|1|||
155545006|NCT00401245|561419055|FG005|Double Blind Tapering Phase|Adverse Event|1|||
155545007|NCT00401245|561419056|FG006|Double Blind Tapering Phase|Adverse Event|2|||
155545008|NCT00401245|561419057|FG007|Double Blind Tapering Phase|Adverse Event|4|||
155545009|NCT00401245|561419050|FG000|Double Blind Tapering Phase|Investigator request|0|||
155545010|NCT00401245|561419051|FG001|Double Blind Tapering Phase|Investigator request|0|||
155545011|NCT00401245|561419052|FG002|Double Blind Tapering Phase|Investigator request|0|||
155545012|NCT00401245|561419053|FG003|Double Blind Tapering Phase|Investigator request|0|||
155545013|NCT00401245|561419054|FG004|Double Blind Tapering Phase|Investigator request|0|||
155545014|NCT00401245|561419055|FG005|Double Blind Tapering Phase|Investigator request|0|||
155545015|NCT00401245|561419056|FG006|Double Blind Tapering Phase|Investigator request|0|||
155545016|NCT00401245|561419057|FG007|Double Blind Tapering Phase|Investigator request|1|||
155545017|NCT00401245|561419050|FG000|Double Blind Tapering Phase|Other|0|||
155545018|NCT00401245|561419051|FG001|Double Blind Tapering Phase|Other|0|||
155545019|NCT00401245|561419052|FG002|Double Blind Tapering Phase|Other|0|||
155545020|NCT00401245|561419053|FG003|Double Blind Tapering Phase|Other|0|||
155545021|NCT00401245|561419054|FG004|Double Blind Tapering Phase|Other|1|||
155545022|NCT00401245|561419055|FG005|Double Blind Tapering Phase|Other|0|||
155545023|NCT00401245|561419056|FG006|Double Blind Tapering Phase|Other|2|||
155545024|NCT00401245|561419057|FG007|Double Blind Tapering Phase|Other|2|||
155545025|NCT00401245|561419050|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
155545026|NCT00401245|561419051|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
155545027|NCT00401245|561419052|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
155545028|NCT00401245|561419053|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
155545029|NCT00401245|561419054|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
155545030|NCT00401245|561419055|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
155545031|NCT00401245|561419056|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
155545032|NCT00401245|561419057|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
155545033|NCT00401245|561419050|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545034|NCT00401245|561419051|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545035|NCT00401245|561419052|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545036|NCT00401245|561419053|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545037|NCT00401245|561419054|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545038|NCT00401245|561419055|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
155545039|NCT00401245|561419056|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545040|NCT00401245|561419057|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
155545041|NCT01560819|561419058|FG000|Overall Study|Physician Decision|1|||
155545042|NCT01560819|561419059|FG001|Overall Study|Physician Decision|0|||
155545043|NCT00399893|561419064|FG000|Overall Study|Withdrawal by Subject|1|||
155545044|NCT00399893|561419065|FG001|Overall Study|Withdrawal by Subject|0|||
155545045|NCT04412057|561419066|FG000|Overall Study|Death|3|||
155545046|NCT04412057|561419067|FG001|Overall Study|Death|7|||
155545047|NCT04412057|561419066|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
155545048|NCT04412057|561419067|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
155545049|NCT00114231|561419068|FG000|Overall Study|No consent|2|||
155545050|NCT00114231|561419069|FG001|Overall Study|No consent|0|||
155545051|NCT00114231|561419068|FG000|Overall Study|QARC requirement not met|1|||
155545052|NCT00114231|561419069|FG001|Overall Study|QARC requirement not met|0|||
155545053|NCT00114231|561419068|FG000|Overall Study|Suspected metastatic disease|1|||
155545054|NCT00114231|561419069|FG001|Overall Study|Suspected metastatic disease|0|||
155545055|NCT00114231|561419068|FG000|Overall Study|No adenocarcinoma|1|||
155545056|NCT00114231|561419069|FG001|Overall Study|No adenocarcinoma|0|||
155545057|NCT00114231|561419068|FG000|Overall Study|Low creatinine clearance|0|||
155545058|NCT00114231|561419069|FG001|Overall Study|Low creatinine clearance|1|||
155545059|NCT00114231|561419068|FG000|Overall Study|Tumor size > 4cm|1|||
155545060|NCT00114231|561419069|FG001|Overall Study|Tumor size > 4cm|0|||
155545061|NCT00114231|561419068|FG000|Overall Study|Tumor fixed on digital exam|0|||
155545062|NCT00114231|561419069|FG001|Overall Study|Tumor fixed on digital exam|1|||
155545063|NCT00114231|561419068|FG000|Overall Study|No Absolute Neutrophil Count|2|||
155656646|NCT02278003|561837374|FG001|Overall Study|Not Treated|0|||
155656647|NCT02278003|561837373|FG000|Overall Study|Recognition task improperly completed|7|||
155656648|NCT02278003|561837374|FG001|Overall Study|Recognition task improperly completed|0|||
155656649|NCT04123704|561837387|FG000|Overall Study|Disease progression|2|||
155656650|NCT03440385|561837388|FG000|Overall Study|Other Reason|4|||
155656651|NCT03440385|561837389|FG001|Overall Study|Other Reason|1|||
155656652|NCT03440385|561837388|FG000|Overall Study|Site Closed|1|||
155656653|NCT03440385|561837389|FG001|Overall Study|Site Closed|0|||
155656654|NCT03440385|561837388|FG000|Overall Study|Lost to Follow-up|2|||
155656655|NCT03440385|561837389|FG001|Overall Study|Lost to Follow-up|0|||
155656656|NCT03440385|561837388|FG000|Overall Study|Withdrawal by Subject|12|||
155656657|NCT03440385|561837389|FG001|Overall Study|Withdrawal by Subject|6|||
155656658|NCT03440385|561837388|FG000|Overall Study|Lack of Efficacy|9|||
155656659|NCT03440385|561837389|FG001|Overall Study|Lack of Efficacy|2|||
155656660|NCT03440385|561837388|FG000|Overall Study|Adverse Event|15|||
155656661|NCT03440385|561837389|FG001|Overall Study|Adverse Event|11|||
155656662|NCT00488293|561837390|FG000|Overall Study|Lost to Follow-up|28|||
155656663|NCT00488293|561837391|FG001|Overall Study|Lost to Follow-up|25|||
155656664|NCT00488293|561837390|FG000|Overall Study|Withdrawal by Subject|5|||
155656665|NCT00488293|561837391|FG001|Overall Study|Withdrawal by Subject|3|||
155656666|NCT00488293|561837390|FG000|Overall Study|Death|2|||
155656667|NCT00488293|561837391|FG001|Overall Study|Death|1|||
155656668|NCT00488293|561837390|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
155656669|NCT00488293|561837391|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
155656670|NCT00939185|561837392|FG000|Overall Study|Adverse Event|3|||
155656671|NCT00939185|561837392|FG000|Overall Study|Lack of Efficacy|1|||
155656672|NCT00939185|561837392|FG000|Overall Study|Lost to Follow-up|6|||
155656673|NCT00939185|561837392|FG000|Overall Study|Other|3|||
155656674|NCT00939185|561837392|FG000|Overall Study|Withdrawal by Subject|2|||
155656675|NCT00939185|561837392|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
155656676|NCT02374255|561837393|FG000|Overall Study|Withdrawal by Subject|2|||
155656677|NCT02374255|561837394|FG001|Overall Study|Withdrawal by Subject|0|||
155656678|NCT02374255|561837395|FG002|Overall Study|Withdrawal by Subject|0|||
155656679|NCT02374255|561837396|FG003|Overall Study|Withdrawal by Subject|0|||
155656680|NCT03360344|561837399|FG000|Overall Study|Withdrawal by Subject|0|||
155656681|NCT03360344|561837400|FG001|Overall Study|Withdrawal by Subject|1|||
155656682|NCT03360344|561837401|FG002|Overall Study|Withdrawal by Subject|1|||
155656683|NCT00133705|561837402|FG000|Overall Study|Withdrawal by Subject|2|||
155656684|NCT00133705|561837403|FG001|Overall Study|Withdrawal by Subject|3|||
155656685|NCT00959049|561837404|FG000|Overall Study|Adverse Event|1|||
155656686|NCT00959049|561837405|FG001|Overall Study|Adverse Event|0|||
155656687|NCT00959049|561837406|FG002|Overall Study|Adverse Event|0|||
155656688|NCT00959049|561837407|FG003|Overall Study|Adverse Event|0|||
155656689|NCT00959049|561837408|FG004|Overall Study|Adverse Event|0|||
155656690|NCT00959049|561837409|FG005|Overall Study|Adverse Event|0|||
155656691|NCT00959049|561837404|FG000|Overall Study|Lost to Follow-up|17|||
155656692|NCT00959049|561837405|FG001|Overall Study|Lost to Follow-up|5|||
155656693|NCT00959049|561837406|FG002|Overall Study|Lost to Follow-up|1|||
155656694|NCT00959049|561837407|FG003|Overall Study|Lost to Follow-up|10|||
155656695|NCT00959049|561837408|FG004|Overall Study|Lost to Follow-up|9|||
155656696|NCT00959049|561837409|FG005|Overall Study|Lost to Follow-up|1|||
155656697|NCT00959049|561837404|FG000|Overall Study|Contraindicated medication|0|||
155656698|NCT00959049|561837405|FG001|Overall Study|Contraindicated medication|0|||
155656699|NCT00959049|561837406|FG002|Overall Study|Contraindicated medication|0|||
155656700|NCT00959049|561837407|FG003|Overall Study|Contraindicated medication|1|||
155656701|NCT00959049|561837408|FG004|Overall Study|Contraindicated medication|0|||
155656702|NCT00959049|561837409|FG005|Overall Study|Contraindicated medication|0|||
155656703|NCT00959049|561837404|FG000|Overall Study|Withdrawal by Subject|0|||
155656704|NCT00959049|561837405|FG001|Overall Study|Withdrawal by Subject|2|||
155656705|NCT00959049|561837406|FG002|Overall Study|Withdrawal by Subject|0|||
155656706|NCT00959049|561837407|FG003|Overall Study|Withdrawal by Subject|0|||
155656707|NCT00959049|561837408|FG004|Overall Study|Withdrawal by Subject|0|||
155656708|NCT00959049|561837409|FG005|Overall Study|Withdrawal by Subject|0|||
155656709|NCT00836706|561837418|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
155656710|NCT00836706|561837419|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
155656711|NCT01992757|561837420|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
155656712|NCT02332928|561837424|FG000|Overall Study|Withdrawal by Subject|0|||
155656713|NCT02332928|561837425|FG001|Overall Study|Withdrawal by Subject|2|||
155656714|NCT02332928|561837424|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
155656715|NCT02332928|561837425|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
155656716|NCT01497197|561837426|FG000|Overall Study|Lost to Follow-up|1|||
155656717|NCT01497197|561837427|FG001|Overall Study|Lost to Follow-up|0|||
155656718|NCT01497197|561837426|FG000|Overall Study|Protocol Violation|0|||
155656719|NCT01497197|561837427|FG001|Overall Study|Protocol Violation|2|||
155656720|NCT01497197|561837426|FG000|Overall Study|Withdrawal by Subject|2|||
155656721|NCT01497197|561837427|FG001|Overall Study|Withdrawal by Subject|1|||
155656722|NCT01497197|561837426|FG000|Overall Study|Excessive/lack of response to treatment|1|||
155545064|NCT00114231|561419069|FG001|Overall Study|No Absolute Neutrophil Count|0|||
155545065|NCT00114231|561419068|FG000|Overall Study|Biopsy done after registration|1|||
155545066|NCT00114231|561419069|FG001|Overall Study|Biopsy done after registration|0|||
155545067|NCT01961882|561419074|FG000|Overall Study|Adverse Event|3|||
155545068|NCT01961882|561419075|FG001|Overall Study|Adverse Event|2|||
155545069|NCT01961882|561419074|FG000|Overall Study|Physician Decision|1|||
155545070|NCT01961882|561419075|FG001|Overall Study|Physician Decision|0|||
155545071|NCT01961882|561419074|FG000|Overall Study|Withdrawal by Subject|4|||
155545072|NCT01961882|561419075|FG001|Overall Study|Withdrawal by Subject|1|||
155545073|NCT01961882|561419074|FG000|Overall Study|Relapse of AML|39|||
155545074|NCT01961882|561419075|FG001|Overall Study|Relapse of AML|37|||
155545075|NCT01961882|561419074|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
155545076|NCT01961882|561419075|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
155545077|NCT01961882|561419074|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
155545078|NCT01961882|561419075|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
155545079|NCT02668822|561419086|FG000|Overall Study|Protocol Violation|2|||
155545080|NCT02668822|561419087|FG001|Overall Study|Protocol Violation|0|||
155545081|NCT02668822|561419086|FG000|Overall Study|Study Terminated by Sponsor|7|||
155545082|NCT02668822|561419087|FG001|Overall Study|Study Terminated by Sponsor|9|||
155545083|NCT01522950|561419088|FG000|Overall Study|Withdrawal by Subject|3|||
155545084|NCT01522950|561419089|FG001|Overall Study|Withdrawal by Subject|2|||
155545085|NCT01522950|561419090|FG002|Overall Study|Withdrawal by Subject|1|||
155545086|NCT01522950|561419088|FG000|Overall Study|Adverse Event|3|||
155545087|NCT01522950|561419089|FG001|Overall Study|Adverse Event|1|||
155545088|NCT01522950|561419090|FG002|Overall Study|Adverse Event|1|||
155545089|NCT01522950|561419088|FG000|Overall Study|Protocol Violation|0|||
155545090|NCT01522950|561419089|FG001|Overall Study|Protocol Violation|0|||
155545091|NCT01522950|561419090|FG002|Overall Study|Protocol Violation|2|||
155545092|NCT01522950|561419088|FG000|Overall Study|Death|0|||
155545093|NCT01522950|561419089|FG001|Overall Study|Death|1|||
155545094|NCT01522950|561419090|FG002|Overall Study|Death|1|||
155545095|NCT01522950|561419088|FG000|Overall Study|Study Medication Sensitivity|0|||
155545096|NCT01522950|561419089|FG001|Overall Study|Study Medication Sensitivity|1|||
155545097|NCT01522950|561419090|FG002|Overall Study|Study Medication Sensitivity|0|||
155545098|NCT03036839|561419093|FG000|Overall Study|Adverse Event|0|||
155545099|NCT03036839|561419094|FG001|Overall Study|Adverse Event|0|||
155545100|NCT03036839|561419095|FG002|Overall Study|Adverse Event|1|||
155545101|NCT03036839|561419093|FG000|Overall Study|Death|3|||
155545102|NCT03036839|561419094|FG001|Overall Study|Death|0|||
155545103|NCT03036839|561419095|FG002|Overall Study|Death|3|||
155545104|NCT03036839|561419093|FG000|Overall Study|Withdrew Consent|0|||
155656723|NCT01497197|561837427|FG001|Overall Study|Excessive/lack of response to treatment|0|||
155656724|NCT01497197|561837426|FG000|Overall Study|Risk of OHSS|1|||
155656725|NCT01497197|561837427|FG001|Overall Study|Risk of OHSS|0|||
155656726|NCT01497197|561837426|FG000|Overall Study|No oocytes retrieved|3|||
155656727|NCT01497197|561837427|FG001|Overall Study|No oocytes retrieved|2|||
155656728|NCT01497197|561837426|FG000|Overall Study|No fertilisation|6|||
155656729|NCT01497197|561837427|FG001|Overall Study|No fertilisation|5|||
155656730|NCT01497197|561837426|FG000|Overall Study|Intention to freeze all embryos|0|||
155656731|NCT01497197|561837427|FG001|Overall Study|Intention to freeze all embryos|1|||
155656732|NCT01497197|561837426|FG000|Overall Study|All embryos discarded|0|||
155656733|NCT01497197|561837427|FG001|Overall Study|All embryos discarded|3|||
155656734|NCT01497197|561837426|FG000|Overall Study|Other|3|||
155656735|NCT01497197|561837427|FG001|Overall Study|Other|1|||
155656736|NCT04484857|561837428|FG000|Overall Study|Adverse Event|2|||
155656737|NCT04484857|561837428|FG000|Overall Study|Death|10|||
155656738|NCT04484857|561837428|FG000|Overall Study|Withdrawal by Subject|3|||
155656739|NCT04484857|561837428|FG000|Overall Study|Transferred/Relocation|5|||
155656740|NCT04484857|561837428|FG000|Overall Study|Kidney Transplant|7|||
155656741|NCT04484857|561837428|FG000|Overall Study|Other than specified|4|||
155656742|NCT04484857|561837428|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
155656743|NCT01425814|561837429|FG000|Period 1|Stability criteria not fulfilled|0|||
155656744|NCT01425814|561837430|FG001|Period 1|Stability criteria not fulfilled|1|||
155656745|NCT01425814|561837431|FG002|Period 1|Stability criteria not fulfilled|0|||
155656746|NCT01425814|561837432|FG003|Period 1|Stability criteria not fulfilled|0|||
155656747|NCT01425814|561837433|FG004|Period 1|Stability criteria not fulfilled|0|||
155656748|NCT01425814|561837434|FG005|Period 1|Stability criteria not fulfilled|0|||
155656749|NCT01425814|561837429|FG000|Period 2|Stability criteria not fulfilled|0|||
155656750|NCT01425814|561837430|FG001|Period 2|Stability criteria not fulfilled|1|||
155656751|NCT01425814|561837431|FG002|Period 2|Stability criteria not fulfilled|0|||
155656752|NCT01425814|561837432|FG003|Period 2|Stability criteria not fulfilled|0|||
155656753|NCT01425814|561837433|FG004|Period 2|Stability criteria not fulfilled|0|||
155656754|NCT01425814|561837434|FG005|Period 2|Stability criteria not fulfilled|0|||
155656755|NCT01425814|561837429|FG000|Period 3|Adverse Event|0|||
155656756|NCT01425814|561837430|FG001|Period 3|Adverse Event|0|||
155656757|NCT01425814|561837431|FG002|Period 3|Adverse Event|0|||
155656758|NCT01425814|561837432|FG003|Period 3|Adverse Event|0|||
155656759|NCT01425814|561837433|FG004|Period 3|Adverse Event|0|||
155656760|NCT01425814|561837434|FG005|Period 3|Adverse Event|1|||
155656761|NCT01425814|561837429|FG000|Period 4|Adverse Event|1|||
155656762|NCT01425814|561837430|FG001|Period 4|Adverse Event|0|||
155656763|NCT01425814|561837431|FG002|Period 4|Adverse Event|1|||
155656764|NCT01425814|561837432|FG003|Period 4|Adverse Event|0|||
155656765|NCT01425814|561837433|FG004|Period 4|Adverse Event|0|||
155656766|NCT01425814|561837434|FG005|Period 4|Adverse Event|0|||
155656767|NCT01425814|561837429|FG000|Period 5|Stability criteria not fulfilled|0|||
155656768|NCT01425814|561837430|FG001|Period 5|Stability criteria not fulfilled|0|||
155656769|NCT01425814|561837431|FG002|Period 5|Stability criteria not fulfilled|1|||
155656770|NCT01425814|561837432|FG003|Period 5|Stability criteria not fulfilled|0|||
155656771|NCT01425814|561837433|FG004|Period 5|Stability criteria not fulfilled|0|||
155656772|NCT01425814|561837434|FG005|Period 5|Stability criteria not fulfilled|1|||
155656773|NCT00565747|561837435|FG000|Overall Study|No embryo transfer|67|||
155656774|NCT00565747|561837436|FG001|Overall Study|No embryo transfer|73|||
155656775|NCT02684461|561837437|FG000|Overall Study|Adverse Event|1|||
155656776|NCT02684461|561837438|FG001|Overall Study|Adverse Event|0|||
155656777|NCT02684461|561837439|FG002|Overall Study|Adverse Event|0|||
155656778|NCT02684461|561837437|FG000|Overall Study|Lack of Efficacy|1|||
155656779|NCT02684461|561837438|FG001|Overall Study|Lack of Efficacy|2|||
155656780|NCT02684461|561837439|FG002|Overall Study|Lack of Efficacy|0|||
155656781|NCT04507204|561837440|FG000|Overall Study|Adverse Event|8|||
155656782|NCT04507204|561837441|FG001|Overall Study|Adverse Event|13|||
155656783|NCT04507204|561837440|FG000|Overall Study|Death|0|||
155656784|NCT04507204|561837441|FG001|Overall Study|Death|1|||
155656785|NCT04507204|561837440|FG000|Overall Study|Lost to Follow-up|15|||
155656786|NCT04507204|561837441|FG001|Overall Study|Lost to Follow-up|14|||
155656787|NCT04507204|561837440|FG000|Overall Study|Poor Compliance with Protocol|2|||
155656788|NCT04507204|561837441|FG001|Overall Study|Poor Compliance with Protocol|4|||
155656789|NCT04507204|561837440|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
155545105|NCT03036839|561419094|FG001|Overall Study|Withdrew Consent|0|||
155545106|NCT03036839|561419095|FG002|Overall Study|Withdrew Consent|1|||
155545107|NCT03136406|561419098|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
155545108|NCT04317599|561419103|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
155545109|NCT04317599|561419103|FG000|Overall Study|treatment outside standard of care|4|||
155545110|NCT04364737|561419104|FG000|Overall Study|Withdrawal by Subject|4|||
155545111|NCT04364737|561419105|FG001|Overall Study|Withdrawal by Subject|9|||
155545112|NCT04364737|561419104|FG000|Overall Study|Lost to Follow-up|1|||
155545113|NCT04364737|561419105|FG001|Overall Study|Lost to Follow-up|1|||
155545114|NCT00112294|561419106|FG000|Overall Study|Still on study|5|||
155545115|NCT00112294|561419107|FG001|Overall Study|Still on study|0|||
155545116|NCT03843125|561419111|FG000|Overall Study|Adverse Event|17|||
155545117|NCT03843125|561419112|FG001|Overall Study|Adverse Event|13|||
155545118|NCT03843125|561419113|FG002|Overall Study|Adverse Event|5|||
155545119|NCT03843125|561419114|FG003|Overall Study|Adverse Event|9|||
155545120|NCT03843125|561419111|FG000|Overall Study|Death|0|||
155545121|NCT03843125|561419112|FG001|Overall Study|Death|6|||
155545122|NCT03843125|561419113|FG002|Overall Study|Death|2|||
155545123|NCT03843125|561419114|FG003|Overall Study|Death|0|||
155545124|NCT03843125|561419111|FG000|Overall Study|Lack of Efficacy|14|||
155545125|NCT03843125|561419112|FG001|Overall Study|Lack of Efficacy|11|||
155545126|NCT03843125|561419113|FG002|Overall Study|Lack of Efficacy|9|||
155545127|NCT03843125|561419114|FG003|Overall Study|Lack of Efficacy|4|||
155545128|NCT03843125|561419111|FG000|Overall Study|Lost to Follow-up|3|||
155545129|NCT03843125|561419112|FG001|Overall Study|Lost to Follow-up|4|||
155545130|NCT03843125|561419113|FG002|Overall Study|Lost to Follow-up|0|||
155545131|NCT03843125|561419114|FG003|Overall Study|Lost to Follow-up|2|||
155545132|NCT03843125|561419111|FG000|Overall Study|Other|12|||
155545133|NCT03843125|561419112|FG001|Overall Study|Other|14|||
155545134|NCT03843125|561419113|FG002|Overall Study|Other|3|||
155545135|NCT03843125|561419114|FG003|Overall Study|Other|4|||
155545136|NCT03843125|561419111|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
155545137|NCT03843125|561419112|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
155545138|NCT03843125|561419113|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
155545139|NCT03843125|561419114|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
155545140|NCT03843125|561419111|FG000|Overall Study|Study Terminated by Sponsor|318|||
155545141|NCT03843125|561419112|FG001|Overall Study|Study Terminated by Sponsor|318|||
155545142|NCT03843125|561419113|FG002|Overall Study|Study Terminated by Sponsor|163|||
155545143|NCT03843125|561419114|FG003|Overall Study|Study Terminated by Sponsor|163|||
155545144|NCT03843125|561419111|FG000|Overall Study|Withdrawal by Subject|23|||
155545145|NCT03843125|561419112|FG001|Overall Study|Withdrawal by Subject|12|||
155545146|NCT03843125|561419113|FG002|Overall Study|Withdrawal by Subject|6|||
155545147|NCT03843125|561419114|FG003|Overall Study|Withdrawal by Subject|9|||
155545148|NCT03843125|561419111|FG000|Overall Study|Missing data|0|||
155545149|NCT03843125|561419112|FG001|Overall Study|Missing data|1|||
155545150|NCT03843125|561419113|FG002|Overall Study|Missing data|1|||
155545151|NCT03843125|561419114|FG003|Overall Study|Missing data|0|||
155545152|NCT05889039|561419115|FG000|Overall Study|error in completing survey|0|||
155545153|NCT05889039|561419116|FG001|Overall Study|error in completing survey|2|||
155545154|NCT05889039|561419117|FG002|Overall Study|error in completing survey|0|||
155545155|NCT05889039|561419118|FG003|Overall Study|error in completing survey|0|||
155545156|NCT05889039|561419115|FG000|Overall Study|Lost to Follow-up|4|||
155545157|NCT05889039|561419116|FG001|Overall Study|Lost to Follow-up|0|||
155545158|NCT05889039|561419117|FG002|Overall Study|Lost to Follow-up|0|||
155545159|NCT05889039|561419118|FG003|Overall Study|Lost to Follow-up|0|||
155545160|NCT02661022|561419119|FG000|Overall Study|Withdrawal by Subject|3|||
155545161|NCT02661022|561419120|FG001|Overall Study|Withdrawal by Subject|0|||
155545162|NCT02661022|561419119|FG000|Overall Study|Adverse Event|1|||
155545163|NCT02661022|561419120|FG001|Overall Study|Adverse Event|1|||
155545164|NCT02661022|561419119|FG000|Overall Study|Physician Decision|1|||
155545165|NCT02661022|561419120|FG001|Overall Study|Physician Decision|0|||
155545166|NCT02661022|561419119|FG000|Overall Study|Progressive Disease|2|||
155545167|NCT02661022|561419120|FG001|Overall Study|Progressive Disease|1|||
155545168|NCT02972515|561419121|FG000|Overall Study|Lost to Follow-up|78|||
155545169|NCT00609154|561419122|FG000|Overall Study|Protocol Violation|1|||
155545170|NCT00609154|561419123|FG001|Overall Study|Protocol Violation|2|||
155545171|NCT00609154|561419122|FG000|Overall Study|Unable to establish IV access|0|||
155545172|NCT00609154|561419123|FG001|Overall Study|Unable to establish IV access|4|||
155545173|NCT00609154|561419122|FG000|Overall Study|Adverse Event|0|||
155545174|NCT00609154|561419123|FG001|Overall Study|Adverse Event|2|||
155545175|NCT04531527|561419124|FG000|Overall Study|Found to be Ineligible|3|||
155545176|NCT01450800|561419132|FG000|Overall Study|Protocol Violation|1|||
155545177|NCT01450800|561419133|FG001|Overall Study|Protocol Violation|3|||
155545178|NCT03496298|561419134|FG000|Overall Study|Adverse Event|49|||
155545179|NCT03496298|561419135|FG001|Overall Study|Adverse Event|68|||
155545180|NCT03496298|561419136|FG002|Overall Study|Adverse Event|79|||
155545181|NCT03496298|561419134|FG000|Overall Study|Study terminated by Sponsor|1050|||
155545182|NCT03496298|561419135|FG001|Overall Study|Study terminated by Sponsor|1063|||
155545183|NCT03496298|561419136|FG002|Overall Study|Study terminated by Sponsor|1071|||
155545184|NCT03496298|561419134|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
155545185|NCT03496298|561419135|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
155545186|NCT03496298|561419136|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
155545187|NCT03496298|561419134|FG000|Overall Study|Withdrawal by Subject|176|||
155545188|NCT03496298|561419135|FG001|Overall Study|Withdrawal by Subject|154|||
155545189|NCT03496298|561419136|FG002|Overall Study|Withdrawal by Subject|151|||
155545190|NCT03496298|561419134|FG000|Overall Study|Other|29|||
155545191|NCT03496298|561419135|FG001|Overall Study|Other|20|||
155545192|NCT03496298|561419136|FG002|Overall Study|Other|23|||
155545193|NCT03496298|561419134|FG000|Overall Study|Randomized and not treated|1|||
155545194|NCT03496298|561419135|FG001|Overall Study|Randomized and not treated|1|||
155545195|NCT03496298|561419136|FG002|Overall Study|Randomized and not treated|1|||
155545196|NCT00761176|561419149|FG000|Overall Study|Death|1|||
155545197|NCT00761176|561419150|FG001|Overall Study|Death|0|||
155545198|NCT00761176|561419149|FG000|Overall Study|Withdrawal by Subject|1|||
155545199|NCT00761176|561419150|FG001|Overall Study|Withdrawal by Subject|1|||
155545200|NCT02020967|561419151|FG000|Overall Study|Withdrawal by Subject|51|||
155545201|NCT03507686|561419152|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
155545202|NCT03507686|561419153|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
155545203|NCT03507686|561419152|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
155545204|NCT03507686|561419153|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
155545205|NCT03507686|561419152|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
155545206|NCT03507686|561419153|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
155545207|NCT03507686|561419152|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
155545208|NCT03507686|561419153|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
155545209|NCT03507686|561419152|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
155545210|NCT03507686|561419153|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
155545211|NCT03507686|561419152|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
155545212|NCT03507686|561419153|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
155545213|NCT00585312|561419154|FG000|Overall Study|Adverse Event|3|||
155545214|NCT00585312|561419155|FG001|Overall Study|Adverse Event|0|||
155545215|NCT00585312|561419154|FG000|Overall Study|Lack of Efficacy|6|||
155545216|NCT00585312|561419155|FG001|Overall Study|Lack of Efficacy|11|||
155545217|NCT00585312|561419154|FG000|Overall Study|Lost to Follow-up|1|||
155545218|NCT00585312|561419155|FG001|Overall Study|Lost to Follow-up|1|||
155545219|NCT00585312|561419154|FG000|Overall Study|Reason not specified|2|||
155545220|NCT00585312|561419155|FG001|Overall Study|Reason not specified|0|||
155545221|NCT00585312|561419154|FG000|Overall Study|Withdrawal by Subject|5|||
155545222|NCT00585312|561419155|FG001|Overall Study|Withdrawal by Subject|1|||
155545223|NCT00585312|561419154|FG000|Overall Study|Study terminated by the sponsor|34|||
155545224|NCT00585312|561419155|FG001|Overall Study|Study terminated by the sponsor|31|||
155545225|NCT00129116|561419156|FG000|Primary Phase|Lost to Follow-up|1|||
155545226|NCT00129116|561419157|FG001|Primary Phase|Lost to Follow-up|1|||
155545227|NCT00129116|561419158|FG002|Primary Phase|Lost to Follow-up|0|||
155545228|NCT00129116|561419159|FG003|Primary Phase|Lost to Follow-up|1|||
155545229|NCT00129116|561419160|FG004|Primary Phase|Lost to Follow-up|1|||
155545230|NCT00129116|561419156|FG000|Primary Phase|Protocol Violation|0|||
155545231|NCT00129116|561419157|FG001|Primary Phase|Protocol Violation|1|||
155545232|NCT00129116|561419158|FG002|Primary Phase|Protocol Violation|0|||
155545233|NCT00129116|561419159|FG003|Primary Phase|Protocol Violation|0|||
155545234|NCT00129116|561419160|FG004|Primary Phase|Protocol Violation|0|||
155545235|NCT00129116|561419156|FG000|Primary Phase|Adverse Event|1|||
155545236|NCT00129116|561419157|FG001|Primary Phase|Adverse Event|1|||
155545237|NCT00129116|561419158|FG002|Primary Phase|Adverse Event|0|||
155545238|NCT00129116|561419159|FG003|Primary Phase|Adverse Event|0|||
155545239|NCT00129116|561419160|FG004|Primary Phase|Adverse Event|0|||
155545240|NCT00129116|561419156|FG000|Primary Phase|Withdrawal by Subject|0|||
155545241|NCT00129116|561419157|FG001|Primary Phase|Withdrawal by Subject|1|||
155545242|NCT00129116|561419158|FG002|Primary Phase|Withdrawal by Subject|0|||
155545243|NCT00129116|561419159|FG003|Primary Phase|Withdrawal by Subject|0|||
155545244|NCT00129116|561419160|FG004|Primary Phase|Withdrawal by Subject|0|||
155545245|NCT00129116|561419156|FG000|Primary Phase|Other|0|||
155545246|NCT00129116|561419157|FG001|Primary Phase|Other|0|||
155545247|NCT00129116|561419158|FG002|Primary Phase|Other|1|||
155545248|NCT00129116|561419159|FG003|Primary Phase|Other|0|||
155545249|NCT00129116|561419160|FG004|Primary Phase|Other|0|||
155545250|NCT00129116|561419156|FG000|Booster Phase|Lost to Follow-up|2|||
155545251|NCT00129116|561419157|FG001|Booster Phase|Lost to Follow-up|0|||
155545252|NCT00129116|561419158|FG002|Booster Phase|Lost to Follow-up|0|||
155545253|NCT00129116|561419159|FG003|Booster Phase|Lost to Follow-up|0|||
155545254|NCT00129116|561419160|FG004|Booster Phase|Lost to Follow-up|1|||
155545255|NCT00708682|561419162|FG000|Infant Series|Adverse Event|1|||
155545256|NCT00708682|561419162|FG000|Infant Series|Lost to Follow-up|4|||
155545257|NCT00708682|561419162|FG000|Infant Series|Protocol Violation|1|||
155545258|NCT00708682|561419162|FG000|Infant Series|Parent/legal guardian request|6|||
155545259|NCT00708682|561419162|FG000|Infant Series|Failed to return|2|||
155545260|NCT00708682|561419162|FG000|Infant Series|Other|19|||
155545261|NCT00708682|561419162|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
155545262|NCT00708682|561419162|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
155545263|NCT00708682|561419162|FG000|Toddler Dose|Lost to Follow-up|3|||
155545264|NCT00708682|561419162|FG000|Toddler Dose|Failed to Return|4|||
155545265|NCT00810602|561419165|FG000|Overall Study|Withdrawal by Subject|8|||
155545266|NCT00810602|561419166|FG001|Overall Study|Withdrawal by Subject|3|||
155545267|NCT03840382|561419167|FG000|Overall Study|Lost to Follow-up|11|||
155545268|NCT02625974|561419168|FG000|Part 1|Lost to Follow-up|9|||
155545269|NCT02625974|561419169|FG001|Part 1|Lost to Follow-up|3|||
155545270|NCT02625974|561419168|FG000|Part 2|Lost to Follow-up|4|||
155545271|NCT02625974|561419169|FG001|Part 2|Lost to Follow-up|6|||
155545272|NCT02625974|561419168|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
155545273|NCT02625974|561419169|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
155545274|NCT01142661|561419170|FG000|Overall Study|Adverse Event|2|||
155545275|NCT01142661|561419170|FG000|Overall Study|Withdrawal by Subject|1|||
155545276|NCT01142661|561419170|FG000|Overall Study|Physician Decision|1|||
155545277|NCT04773600|561419171|FG000|Overall Study|Withdrawal by Subject|15|||
155545278|NCT04773600|561419172|FG001|Overall Study|Withdrawal by Subject|9|||
155545279|NCT04773600|561419171|FG000|Overall Study|Lost to Follow-up|10|||
155545280|NCT04773600|561419172|FG001|Overall Study|Lost to Follow-up|6|||
155545281|NCT04773600|561419171|FG000|Overall Study|Adverse Event|8|||
155545282|NCT04773600|561419172|FG001|Overall Study|Adverse Event|2|||
155545283|NCT04773600|561419171|FG000|Overall Study|Lack of Efficacy|2|||
155545284|NCT04773600|561419172|FG001|Overall Study|Lack of Efficacy|3|||
155545285|NCT04773600|561419171|FG000|Overall Study|Noncompliance|2|||
155545286|NCT04773600|561419172|FG001|Overall Study|Noncompliance|0|||
155545287|NCT04773600|561419171|FG000|Overall Study|Protocol Violation|2|||
155545288|NCT04773600|561419172|FG001|Overall Study|Protocol Violation|0|||
155545289|NCT04773600|561419171|FG000|Overall Study|Physician Decision|0|||
155545290|NCT04773600|561419172|FG001|Overall Study|Physician Decision|1|||
155545291|NCT04773600|561419171|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
155545292|NCT04773600|561419172|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
155545293|NCT04773600|561419171|FG000|Overall Study|Emergency Travel Out of Country|1|||
155545294|NCT04773600|561419172|FG001|Overall Study|Emergency Travel Out of Country|0|||
155545295|NCT01923311|561420204|FG000|Overall Study|Pregnancy|1|||
155545296|NCT01923311|561420205|FG001|Overall Study|Pregnancy|0|||
155545297|NCT01923311|561420204|FG000|Overall Study|Investigator's Discretion|1|||
155545298|NCT01923311|561420205|FG001|Overall Study|Investigator's Discretion|0|||
155545299|NCT01923311|561420204|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155545300|NCT01923311|561420205|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155545301|NCT01923311|561420204|FG000|Overall Study|Withdrew Consent|1|||
155545302|NCT01923311|561420205|FG001|Overall Study|Withdrew Consent|0|||
155545303|NCT01923311|561420204|FG000|Overall Study|Study Terminated by Sponsor|12|||
155545304|NCT01923311|561420205|FG001|Overall Study|Study Terminated by Sponsor|0|||
155545305|NCT03180528|561420209|FG000|Overall Study|Adverse Event|1|||
155545306|NCT03180528|561420209|FG000|Overall Study|Withdrawal by Subject|1|||
155545307|NCT03180528|561420209|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
155545308|NCT02839798|561420210|FG000|Overall Study|Withdrawal by Subject|2|||
155545309|NCT04129944|561420211|FG000|Overall Study|Death|0|||
155545310|NCT04129944|561420212|FG001|Overall Study|Death|0|||
155545311|NCT04129944|561420213|FG002|Overall Study|Death|0|||
155545312|NCT04129944|561420214|FG003|Overall Study|Death|1|||
155545313|NCT04129944|561420211|FG000|Overall Study|Lost to Follow-up|1|||
155545314|NCT04129944|561420212|FG001|Overall Study|Lost to Follow-up|0|||
155545315|NCT04129944|561420213|FG002|Overall Study|Lost to Follow-up|0|||
155545316|NCT04129944|561420214|FG003|Overall Study|Lost to Follow-up|0|||
155545317|NCT04129944|561420211|FG000|Overall Study|Withdrawal by Subject|1|||
155545318|NCT04129944|561420212|FG001|Overall Study|Withdrawal by Subject|0|||
155545319|NCT04129944|561420213|FG002|Overall Study|Withdrawal by Subject|1|||
155545320|NCT04129944|561420214|FG003|Overall Study|Withdrawal by Subject|2|||
155545321|NCT03710590|561420215|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
155545322|NCT03710590|561420216|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
155545323|NCT02488824|561420217|FG000|Overall Study|Adverse Event|1|||
155545324|NCT02488824|561420218|FG001|Overall Study|Adverse Event|1|||
155545325|NCT00412737|561420220|FG000|Overall Study|Death|1|||
155545326|NCT00412737|561420221|FG001|Overall Study|Death|0|||
155545327|NCT00412737|561420220|FG000|Overall Study|Adverse Event|3|||
155545328|NCT00412737|561420221|FG001|Overall Study|Adverse Event|2|||
155545329|NCT00412737|561420220|FG000|Overall Study|Refused Treatment|6|||
155545330|NCT00412737|561420221|FG001|Overall Study|Refused Treatment|2|||
155545331|NCT00412737|561420220|FG000|Overall Study|Failure to Return|6|||
155545332|NCT00412737|561420221|FG001|Overall Study|Failure to Return|2|||
155545333|NCT02695719|561420223|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
155545334|NCT02695719|561420224|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
155545335|NCT02695719|561420223|FG000|Overall Study|Significant Protocol Deviation|0|||
155545336|NCT02695719|561420224|FG001|Overall Study|Significant Protocol Deviation|1|||
155545337|NCT02695719|561420223|FG000|Overall Study|Voluntary Withdrawal|1|||
155545338|NCT02695719|561420224|FG001|Overall Study|Voluntary Withdrawal|0|||
155545339|NCT00483548|561420225|FG000|Overall Study|Randomized; not treated with study drug|1|||
155545340|NCT00483548|561420226|FG001|Overall Study|Randomized; not treated with study drug|3|||
155545341|NCT00483548|561420225|FG000|Overall Study|Adverse Event|25|||
155545342|NCT00483548|561420226|FG001|Overall Study|Adverse Event|14|||
155545343|NCT00483548|561420225|FG000|Overall Study|Laboratory abnormality|1|||
155545344|NCT00483548|561420226|FG001|Overall Study|Laboratory abnormality|2|||
155545345|NCT00483548|561420225|FG000|Overall Study|Lack of Efficacy|4|||
155545346|NCT00483548|561420226|FG001|Overall Study|Lack of Efficacy|8|||
155545347|NCT00483548|561420225|FG000|Overall Study|Protocol Violation|11|||
155545348|NCT00483548|561420226|FG001|Overall Study|Protocol Violation|7|||
155545349|NCT00483548|561420225|FG000|Overall Study|Pregnancy|1|||
155545350|NCT00483548|561420226|FG001|Overall Study|Pregnancy|0|||
155545351|NCT00483548|561420225|FG000|Overall Study|Protocol required discontinuation|6|||
155545352|NCT00483548|561420226|FG001|Overall Study|Protocol required discontinuation|6|||
155545353|NCT00483548|561420225|FG000|Overall Study|Unable to comply with protocol schedule|1|||
155545354|NCT00483548|561420226|FG001|Overall Study|Unable to comply with protocol schedule|0|||
155545355|NCT00483548|561420225|FG000|Overall Study|Non-compliance with medication|2|||
155545356|NCT00483548|561420226|FG001|Overall Study|Non-compliance with medication|0|||
155545357|NCT00483548|561420225|FG000|Overall Study|Lost to Follow-up|3|||
155545358|NCT00483548|561420226|FG001|Overall Study|Lost to Follow-up|4|||
155545359|NCT00483548|561420225|FG000|Overall Study|Withdrawal by Subject|5|||
155545360|NCT00483548|561420226|FG001|Overall Study|Withdrawal by Subject|2|||
155545361|NCT01220609|561420228|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
155545362|NCT01220609|561420228|FG000|Overall Study|Ineligible- Wrong cell type|1|||
155545363|NCT01220609|561420228|FG000|Overall Study|Ineligible-Never treated|1|||
155545364|NCT00868296|561420230|FG000|Overall Study|Adverse Event|0|||
155545365|NCT00868296|561420231|FG001|Overall Study|Adverse Event|2|||
155545366|NCT00868296|561420230|FG000|Overall Study|Withdrawal by Subject|0|||
155545367|NCT00868296|561420231|FG001|Overall Study|Withdrawal by Subject|1|||
155545368|NCT04205162|561420245|FG000|Overall Study|Lost to Follow-up|1|||
155545369|NCT04205162|561420246|FG001|Overall Study|Lost to Follow-up|0|||
155545370|NCT04205162|561420245|FG000|Overall Study|Withdrawal by Subject|2|||
155545371|NCT04205162|561420246|FG001|Overall Study|Withdrawal by Subject|0|||
155545372|NCT04205162|561420245|FG000|Overall Study|University closure due to COVID-19|1|||
155545373|NCT04205162|561420246|FG001|Overall Study|University closure due to COVID-19|0|||
155545374|NCT01999894|561420247|FG000|Overall Study|Adverse Event|9|||
155545375|NCT01999894|561420247|FG000|Overall Study|Lack of Efficacy|5|||
155545376|NCT01999894|561420247|FG000|Overall Study|Protocol Violation|1|||
155545377|NCT01999894|561420247|FG000|Overall Study|Withdrawal by Subject|7|||
155545378|NCT01999894|561420247|FG000|Overall Study|Lost to Follow-up|10|||
155545379|NCT01999894|561420247|FG000|Overall Study|Other Reason|3|||
155545380|NCT01999894|561420247|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
155545381|NCT00372996|561420249|FG000|Overall Study|Death|11|||
155545382|NCT00372996|561420250|FG001|Overall Study|Death|4|||
155545383|NCT00372996|561420251|FG002|Overall Study|Death|8|||
155545384|NCT00372996|561420252|FG003|Overall Study|Death|7|||
155545385|NCT00372996|561420249|FG000|Overall Study|Lost to Follow-up|0|||
155545386|NCT00372996|561420250|FG001|Overall Study|Lost to Follow-up|2|||
155545387|NCT00372996|561420251|FG002|Overall Study|Lost to Follow-up|0|||
155545388|NCT00372996|561420252|FG003|Overall Study|Lost to Follow-up|1|||
155545389|NCT00372996|561420249|FG000|Overall Study|Withdrawal by Subject|12|||
155545390|NCT00372996|561420250|FG001|Overall Study|Withdrawal by Subject|6|||
155545391|NCT00372996|561420251|FG002|Overall Study|Withdrawal by Subject|9|||
155545392|NCT00372996|561420252|FG003|Overall Study|Withdrawal by Subject|5|||
155545393|NCT00372996|561420249|FG000|Overall Study|Study Terminated by Sponsor|4|||
155545394|NCT00372996|561420250|FG001|Overall Study|Study Terminated by Sponsor|0|||
155545395|NCT00372996|561420251|FG002|Overall Study|Study Terminated by Sponsor|4|||
155545396|NCT00372996|561420252|FG003|Overall Study|Study Terminated by Sponsor|0|||
155545397|NCT00372996|561420249|FG000|Overall Study|Other|10|||
155545398|NCT00372996|561420250|FG001|Overall Study|Other|2|||
155545399|NCT00372996|561420251|FG002|Overall Study|Other|7|||
155545400|NCT00372996|561420252|FG003|Overall Study|Other|7|||
155545401|NCT01186016|561420253|FG000|Overall Study|Withdrawal by Subject|46|||
155545402|NCT01186016|561420254|FG001|Overall Study|Withdrawal by Subject|29|||
155545403|NCT03750695|561420256|FG000|Overall Study|Lost to Follow-up|0|||
155545404|NCT03750695|561420257|FG001|Overall Study|Lost to Follow-up|1|||
155545405|NCT01386125|561420258|FG000|Overall Study|Lost to Follow-up|3|||
155545406|NCT01386125|561420259|FG001|Overall Study|Lost to Follow-up|9|||
155545407|NCT01386125|561420258|FG000|Overall Study|Physician Decision|0|||
155545408|NCT01386125|561420259|FG001|Overall Study|Physician Decision|1|||
155545409|NCT01386125|561420258|FG000|Overall Study|Protocol Violation|5|||
155545410|NCT01386125|561420259|FG001|Overall Study|Protocol Violation|7|||
155545411|NCT01386125|561420258|FG000|Overall Study|Disease Progress|1|||
155545412|NCT01386125|561420259|FG001|Overall Study|Disease Progress|2|||
155545413|NCT01386125|561420258|FG000|Overall Study|Withdrawal by Subject|13|||
155545414|NCT01386125|561420259|FG001|Overall Study|Withdrawal by Subject|12|||
155545415|NCT01386125|561420258|FG000|Overall Study|Adverse Event|2|||
155545416|NCT01386125|561420259|FG001|Overall Study|Adverse Event|5|||
155545417|NCT01386125|561420258|FG000|Overall Study|Lack of Efficacy|0|||
155545418|NCT01386125|561420259|FG001|Overall Study|Lack of Efficacy|1|||
155545419|NCT01386125|561420258|FG000|Overall Study|Participant Leaving Country|1|||
155545420|NCT01386125|561420259|FG001|Overall Study|Participant Leaving Country|0|||
155545421|NCT01098539|561420260|FG000|Overall Study|Adverse Event|26|||
155545422|NCT01098539|561420261|FG001|Overall Study|Adverse Event|26|||
155545423|NCT01098539|561420260|FG000|Overall Study|Protocol Violation|1|||
155545424|NCT01098539|561420261|FG001|Overall Study|Protocol Violation|4|||
155545425|NCT01098539|561420260|FG000|Overall Study|Noncompliance|3|||
155545426|NCT01098539|561420261|FG001|Overall Study|Noncompliance|5|||
155545427|NCT01098539|561420260|FG000|Overall Study|Lost to Follow-up|4|||
155545428|NCT01098539|561420261|FG001|Overall Study|Lost to Follow-up|4|||
155545429|NCT01098539|561420260|FG000|Overall Study|Withdrawal by Subject|12|||
155545430|NCT01098539|561420261|FG001|Overall Study|Withdrawal by Subject|26|||
155545431|NCT01098539|561420260|FG000|Overall Study|Physician Decision|5|||
155545432|NCT01098539|561420261|FG001|Overall Study|Physician Decision|3|||
155545433|NCT03173560|561420262|FG000|Overall Study|Death|70|||
155545434|NCT03173560|561420263|FG001|Overall Study|Death|60|||
155545435|NCT03173560|561420262|FG000|Overall Study|Lost to Follow-up|1|||
155545436|NCT03173560|561420263|FG001|Overall Study|Lost to Follow-up|4|||
155545437|NCT03173560|561420262|FG000|Overall Study|Withdrawal by Subject|10|||
155545438|NCT03173560|561420263|FG001|Overall Study|Withdrawal by Subject|5|||
155545439|NCT03173560|561420262|FG000|Overall Study|Other|0|||
155545440|NCT03173560|561420263|FG001|Overall Study|Other|1|||
155545441|NCT02359864|561420264|FG000|Overall Study|Withdrawal by Subject|1|||
155545442|NCT02359864|561420265|FG001|Overall Study|Withdrawal by Subject|0|||
155545443|NCT00725764|561420266|FG000|Overall Study|Withdrawal by Subject|2|||
155545444|NCT00725764|561420266|FG000|Overall Study|Physician Decision|1|||
155545445|NCT00725764|561420266|FG000|Overall Study|Progressive Disease|7|||
155545446|NCT00725764|561420266|FG000|Overall Study|Lost to Follow-up|1|||
155545447|NCT00725764|561420266|FG000|Overall Study|Death|1|||
155545448|NCT00725764|561420266|FG000|Overall Study|Participant non compliant with protocol|1|||
155545449|NCT00725764|561420266|FG000|Overall Study|Decline in performance status|1|||
155545450|NCT04480307|561420267|FG000|Overall Study|Withdrawal by Subject|0|||
155545451|NCT04480307|561420268|FG001|Overall Study|Withdrawal by Subject|1|||
155545452|NCT04480307|561420269|FG002|Overall Study|Withdrawal by Subject|0|||
155545453|NCT04480307|561420270|FG003|Overall Study|Withdrawal by Subject|0|||
155545454|NCT04480307|561420267|FG000|Overall Study|Adverse Event|0|||
155545455|NCT04480307|561420268|FG001|Overall Study|Adverse Event|0|||
155545456|NCT04480307|561420269|FG002|Overall Study|Adverse Event|0|||
155545457|NCT04480307|561420270|FG003|Overall Study|Adverse Event|1|||
155545458|NCT00515216|561420275|FG000|Overall Study|Withdrawal by Subject|1|||
155545459|NCT03023137|561420276|FG000|Overall Study|Multiple pregnancy|2|||
155545460|NCT03023137|561420277|FG001|Overall Study|Multiple pregnancy|4|||
155545461|NCT03023137|561420276|FG000|Overall Study|Lost to Follow-up|1|||
155545462|NCT03023137|561420277|FG001|Overall Study|Lost to Follow-up|1|||
155545463|NCT03023137|561420276|FG000|Overall Study|Protocol Violation|0|||
155545464|NCT03023137|561420277|FG001|Overall Study|Protocol Violation|4|||
155545465|NCT03023137|561420276|FG000|Overall Study|Lost the baby in a car accident|1|||
155545466|NCT03023137|561420277|FG001|Overall Study|Lost the baby in a car accident|0|||
155545467|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
155545468|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
155545469|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
155545470|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
155545471|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
155545472|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
155545473|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
155545474|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
155545475|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
155545476|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
155545477|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
155545478|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
155545479|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
155545480|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
155545481|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
155545482|NCT02250651|561420278|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
155545483|NCT02250651|561420279|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
155545484|NCT02250651|561420280|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
155545485|NCT02250651|561420278|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
155545486|NCT02250651|561420279|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
155545487|NCT02250651|561420280|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
155545488|NCT02250651|561420278|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
155545489|NCT02250651|561420279|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
155545490|NCT02250651|561420280|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
155545491|NCT02250651|561420278|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
155545492|NCT02250651|561420279|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
155545493|NCT02250651|561420280|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
155545494|NCT02250651|561420278|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
155545495|NCT02250651|561420279|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
155545496|NCT02250651|561420280|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
155545497|NCT02250651|561420278|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
155545498|NCT02250651|561420279|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
155545499|NCT02250651|561420280|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
155545500|NCT02250651|561420278|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
155545501|NCT02250651|561420279|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
155545502|NCT02250651|561420280|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
155545503|NCT02250651|561420278|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
155545504|NCT02250651|561420279|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
155545505|NCT02250651|561420280|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
155545506|NCT02250651|561420278|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
155545507|NCT02250651|561420279|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
155545508|NCT02250651|561420280|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
155545509|NCT02250651|561420278|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
155545510|NCT02250651|561420279|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
155656790|NCT04507204|561837441|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
155545511|NCT02250651|561420280|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
155545512|NCT00732160|561420284|FG000|Overall Study|Adverse Event|1|||
155545513|NCT00732160|561420285|FG001|Overall Study|Adverse Event|0|||
155545514|NCT00732160|561420286|FG002|Overall Study|Adverse Event|1|||
155545515|NCT00732160|561420287|FG003|Overall Study|Adverse Event|1|||
155545516|NCT00732160|561420284|FG000|Overall Study|scheduling|4|||
155545517|NCT00732160|561420285|FG001|Overall Study|scheduling|4|||
155545518|NCT00732160|561420286|FG002|Overall Study|scheduling|2|||
155545519|NCT00732160|561420287|FG003|Overall Study|scheduling|1|||
155545520|NCT00676494|561420288|FG000|Overall Study|Missed Visit|8|||
155545521|NCT00676494|561420288|FG000|Overall Study|Withdrawal by Subject|6|||
155545522|NCT02795676|561420289|FG000|Overall Study|Adverse Event|2|||
155545523|NCT02795676|561420290|FG001|Overall Study|Adverse Event|0|||
155545524|NCT02795676|561420289|FG000|Overall Study|Withdrawal by Subject|3|||
155545525|NCT02795676|561420290|FG001|Overall Study|Withdrawal by Subject|1|||
155545526|NCT02058160|561420291|FG000|Overall Study|Randomized but not treated|2|||
155545527|NCT02058160|561420292|FG001|Overall Study|Randomized but not treated|4|||
155545528|NCT02058160|561420291|FG000|Overall Study|Poor compliance to protocol|4|||
155545529|NCT02058160|561420292|FG001|Overall Study|Poor compliance to protocol|1|||
155545530|NCT02058160|561420291|FG000|Overall Study|Adverse Event|12|||
155545531|NCT02058160|561420292|FG001|Overall Study|Adverse Event|3|||
155545532|NCT02058160|561420291|FG000|Overall Study|Lost to Follow-up|1|||
155545533|NCT02058160|561420292|FG001|Overall Study|Lost to Follow-up|0|||
155545534|NCT02058160|561420291|FG000|Overall Study|Other than specified above|12|||
155545535|NCT02058160|561420292|FG001|Overall Study|Other than specified above|6|||
155545536|NCT01203917|561420293|FG000|Overall Study|Death|29|||
155545537|NCT01203917|561420293|FG000|Overall Study|Lost to Follow-up|2|||
155545538|NCT01203917|561420293|FG000|Overall Study|Withdrawal by Subject|3|||
155545539|NCT01203917|561420293|FG000|Overall Study|Due to objective disease progression|1|||
155545540|NCT01203917|561420293|FG000|Overall Study|Due to EGFR M+I patient|1|||
155545541|NCT00152516|561420294|FG000|Overall Study|Adverse Event|18|||
155545542|NCT00152516|561420294|FG000|Overall Study|Lack and Loss of Efficacy|30|||
155545543|NCT00152516|561420294|FG000|Overall Study|Lost to Follow-up|5|||
155545544|NCT00152516|561420294|FG000|Overall Study|Withdrawal by Subject|8|||
155545545|NCT00152516|561420294|FG000|Overall Study|Protocol Violation|3|||
155545546|NCT00152516|561420294|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
155545547|NCT00152516|561420294|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
155545548|NCT00152516|561420294|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
155545549|NCT00152516|561420294|FG000|Overall Study|Other: Non-Compliance|2|||
155545550|NCT00152516|561420294|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
155545551|NCT00152516|561420294|FG000|Overall Study|Other: Moved Out Of State|1|||
155545552|NCT00152516|561420294|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
155545553|NCT00152516|561420294|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
155545554|NCT00090753|561420297|FG000|First Treatment Period|Adverse Event|20|||
155545555|NCT00090753|561420298|FG001|First Treatment Period|Adverse Event|8|||
155545556|NCT00090753|561420297|FG000|First Treatment Period|Death|88|||
155545557|NCT00090753|561420298|FG001|First Treatment Period|Death|62|||
155545558|NCT00090753|561420297|FG000|First Treatment Period|Lack of Efficacy|2|||
155545559|NCT00090753|561420298|FG001|First Treatment Period|Lack of Efficacy|1|||
155545560|NCT00090753|561420297|FG000|First Treatment Period|Refused Treatment|32|||
155545561|NCT00090753|561420298|FG001|First Treatment Period|Refused Treatment|25|||
155545562|NCT00090753|561420297|FG000|First Treatment Period|Lost to Follow-up|4|||
155545563|NCT00090753|561420298|FG001|First Treatment Period|Lost to Follow-up|4|||
155545564|NCT00090753|561420297|FG000|First Treatment Period|Renal Transplant|70|||
155545565|NCT00090753|561420298|FG001|First Treatment Period|Renal Transplant|50|||
155545566|NCT00090753|561420297|FG000|First Treatment Period|Mircera Commercialization|1|||
155545567|NCT00090753|561420298|FG001|First Treatment Period|Mircera Commercialization|0|||
155545568|NCT00090753|561420297|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
155545569|NCT00090753|561420298|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
155545570|NCT00090753|561420297|FG000|Extended Treatment Period|Adverse Event|11|||
155545571|NCT00090753|561420298|FG001|Extended Treatment Period|Adverse Event|0|||
155545572|NCT00090753|561420297|FG000|Extended Treatment Period|Death|58|||
155545573|NCT00090753|561420298|FG001|Extended Treatment Period|Death|30|||
155545574|NCT00090753|561420297|FG000|Extended Treatment Period|Lack of Efficacy|1|||
155545575|NCT00090753|561420298|FG001|Extended Treatment Period|Lack of Efficacy|0|||
155545576|NCT00090753|561420297|FG000|Extended Treatment Period|Refused Treatment|18|||
155545577|NCT00090753|561420298|FG001|Extended Treatment Period|Refused Treatment|12|||
155545578|NCT00090753|561420297|FG000|Extended Treatment Period|Lost to Follow-up|3|||
155545579|NCT00090753|561420298|FG001|Extended Treatment Period|Lost to Follow-up|1|||
155545580|NCT00090753|561420297|FG000|Extended Treatment Period|Renal Transplant|15|||
155545581|NCT00090753|561420298|FG001|Extended Treatment Period|Renal Transplant|12|||
155545582|NCT00090753|561420297|FG000|Extended Treatment Period|Mircera Commercialization|188|||
155545583|NCT00090753|561420298|FG001|Extended Treatment Period|Mircera Commercialization|93|||
155545584|NCT00090753|561420297|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
155545585|NCT00090753|561420298|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
155545586|NCT01086969|561420301|FG000|Overall Study|Withdrawal by Subject|1|||
155545587|NCT01086969|561420302|FG001|Overall Study|Withdrawal by Subject|2|||
155545588|NCT01086969|561420303|FG002|Overall Study|Withdrawal by Subject|0|||
155545589|NCT01466036|561420306|FG000|Overall Study|Death|1|||
155545590|NCT01466036|561420307|FG001|Overall Study|Death|1|||
155545591|NCT01466036|561420306|FG000|Overall Study|Physician Decision|0|||
155545592|NCT01466036|561420307|FG001|Overall Study|Physician Decision|4|||
155545593|NCT01466036|561420306|FG000|Overall Study|Adverse Event|2|||
155545594|NCT01466036|561420307|FG001|Overall Study|Adverse Event|6|||
155545595|NCT01466036|561420306|FG000|Overall Study|Withdrawal by Subject|2|||
155545596|NCT01466036|561420307|FG001|Overall Study|Withdrawal by Subject|8|||
155545597|NCT01466036|561420306|FG000|Overall Study|progression/relapse|14|||
155545598|NCT01466036|561420307|FG001|Overall Study|progression/relapse|21|||
155545599|NCT01466036|561420306|FG000|Overall Study|prolonged treatment delay|1|||
155545600|NCT01466036|561420307|FG001|Overall Study|prolonged treatment delay|1|||
155545601|NCT01609582|561420310|FG000|Overall Study|Adverse Event|20|||
155545602|NCT01609582|561420311|FG001|Overall Study|Adverse Event|18|||
155545603|NCT01609582|561420310|FG000|Overall Study|Lost to Follow-up|10|||
155545604|NCT01609582|561420311|FG001|Overall Study|Lost to Follow-up|10|||
155545605|NCT01609582|561420310|FG000|Overall Study|Withdrawal by Subject|21|||
155545606|NCT01609582|561420311|FG001|Overall Study|Withdrawal by Subject|15|||
155545607|NCT01609582|561420310|FG000|Overall Study|Study Terminated by Sponsor|1543|||
155545608|NCT01609582|561420311|FG001|Overall Study|Study Terminated by Sponsor|1548|||
155545609|NCT01609582|561420310|FG000|Overall Study|Other|9|||
155545610|NCT01609582|561420311|FG001|Overall Study|Other|10|||
155545611|NCT01609582|561420310|FG000|Overall Study|Randomized, but not treated|0|||
155545612|NCT01609582|561420311|FG001|Overall Study|Randomized, but not treated|3|||
155545613|NCT00250705|561420314|FG000|Overall Study|Lack of Efficacy|2|||
155545614|NCT05103657|561420317|FG000|Overall Study|Other reasons than listed|9|||
155545615|NCT05103657|561420318|FG001|Overall Study|Other reasons than listed|8|||
155545616|NCT05103657|561420317|FG000|Overall Study|Protocol deviation|2|||
155545617|NCT05103657|561420318|FG001|Overall Study|Protocol deviation|2|||
155545618|NCT05103657|561420317|FG000|Overall Study|No reason available|5|||
155545619|NCT05103657|561420318|FG001|Overall Study|No reason available|4|||
155545620|NCT05103657|561420317|FG000|Overall Study|Burden of study procedures|3|||
155545621|NCT05103657|561420318|FG001|Overall Study|Burden of study procedures|1|||
155545622|NCT05103657|561420317|FG000|Overall Study|Perceived lack of efficacy|1|||
155545623|NCT05103657|561420318|FG001|Overall Study|Perceived lack of efficacy|1|||
155545624|NCT05103657|561420317|FG000|Overall Study|Adverse Event|6|||
155545625|NCT05103657|561420318|FG001|Overall Study|Adverse Event|14|||
155545626|NCT05103657|561420317|FG000|Overall Study|Not Treated|1|||
155545627|NCT05103657|561420318|FG001|Overall Study|Not Treated|1|||
155545628|NCT04100096|561422098|FG000|Overall Study|Adverse Event|19|||
155545629|NCT04100096|561422099|FG001|Overall Study|Adverse Event|7|||
155545630|NCT04100096|561422098|FG000|Overall Study|Lack of Efficacy|0|||
155656791|NCT04507204|561837440|FG000|Overall Study|Withdrawal of Patient Consent|21|||
155656792|NCT04507204|561837441|FG001|Overall Study|Withdrawal of Patient Consent|13|||
155656793|NCT03580044|561837442|FG000|Overall Study|Death|2|||
155545631|NCT04100096|561422099|FG001|Overall Study|Lack of Efficacy|1|||
155545632|NCT04100096|561422098|FG000|Overall Study|Lost to Follow-up|13|||
155545633|NCT04100096|561422099|FG001|Overall Study|Lost to Follow-up|11|||
155545634|NCT04100096|561422098|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155545635|NCT04100096|561422099|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155545636|NCT04100096|561422098|FG000|Overall Study|Protocol Deviation|1|||
155545637|NCT04100096|561422099|FG001|Overall Study|Protocol Deviation|1|||
155545638|NCT04100096|561422098|FG000|Overall Study|Withdrawal by Participant|13|||
155545639|NCT04100096|561422099|FG001|Overall Study|Withdrawal by Participant|15|||
155545640|NCT00991510|561422102|FG000|Period I (Days 1-14)|Adverse Event|1|||
155545641|NCT00991510|561422103|FG001|Period I (Days 1-14)|Adverse Event|0|||
155545642|NCT00991510|561422102|FG000|Period III (Days 29-112)|Adverse Event|1|||
155545643|NCT00991510|561422103|FG001|Period III (Days 29-112)|Adverse Event|1|||
155656794|NCT03580044|561837443|FG001|Overall Study|Death|1|||
155545644|NCT01976728|561422104|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
155545645|NCT01976728|561422105|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
155545646|NCT01976728|561422106|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
155545647|NCT01976728|561422107|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
155545648|NCT02356211|561422108|FG000|Overall Study|Withdrawal by Subject|2|||
155545649|NCT02356211|561422109|FG001|Overall Study|Withdrawal by Subject|2|||
155545650|NCT02356211|561422108|FG000|Overall Study|ineligible|1|||
155545651|NCT02356211|561422109|FG001|Overall Study|ineligible|8|||
155545652|NCT01563237|561422110|FG000|Overall Study|Lost to Follow-up|6|||
155545653|NCT01563237|561422111|FG001|Overall Study|Lost to Follow-up|0|||
155545654|NCT01563237|561422110|FG000|Overall Study|Withdrawal by Subject|1|||
155545655|NCT01563237|561422111|FG001|Overall Study|Withdrawal by Subject|0|||
155545656|NCT01563237|561422110|FG000|Overall Study|Adverse Event|1|||
155545657|NCT01563237|561422111|FG001|Overall Study|Adverse Event|0|||
155545658|NCT01563237|561422110|FG000|Overall Study|Medical Reasons|1|||
155545659|NCT01563237|561422111|FG001|Overall Study|Medical Reasons|0|||
155545660|NCT01563237|561422110|FG000|Overall Study|Death|1|||
155545661|NCT01563237|561422111|FG001|Overall Study|Death|0|||
155545662|NCT01124695|561422115|FG000|Overall Study|Disease progression|77|||
155545663|NCT01124695|561422115|FG000|Overall Study|Adverse Event|11|||
155545664|NCT01124695|561422115|FG000|Overall Study|Death|1|||
155545665|NCT01124695|561422115|FG000|Overall Study|Withdrawal by Subject|7|||
155545666|NCT01124695|561422115|FG000|Overall Study|Physician Decision|3|||
155545667|NCT01124695|561422115|FG000|Overall Study|Alternative therapy|9|||
155545668|NCT01124695|561422115|FG000|Overall Study|No documentation that patient went off treatment|4|||
155545669|NCT01124695|561422115|FG000|Overall Study|Ineligible|9|||
155545670|NCT01124695|561422115|FG000|Overall Study|Ineligible and never start treatment|2|||
155545671|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
155545672|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
155545673|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
155545674|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
155545675|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
155545676|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
155545677|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
155545678|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
155545679|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
155545680|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
155545681|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
155545682|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
155545683|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
155545684|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
155545685|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
155545686|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
155545687|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
155545688|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
155545689|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
155545690|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
155545691|NCT02960438|561422116|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
155545692|NCT02960438|561422117|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
155545693|NCT02960438|561422118|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
155545694|NCT02960438|561422119|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
155545695|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
155545696|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
155545697|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
155656795|NCT03580044|561837442|FG000|Overall Study|Withdrawal by Subject|1|||
155545698|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
155545699|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
155545700|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
155545701|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
155545702|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
155545703|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
155545704|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
155545705|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
155545706|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
155545707|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
155656796|NCT03580044|561837443|FG001|Overall Study|Withdrawal by Subject|1|||
155545708|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
155656797|NCT00863304|561837446|FG000|Overall Study|Adverse Event|10|||
155656798|NCT00863304|561837447|FG001|Overall Study|Adverse Event|4|||
155656799|NCT00863304|561837448|FG002|Overall Study|Adverse Event|14|||
155656800|NCT00863304|561837449|FG003|Overall Study|Adverse Event|16|||
155656801|NCT00863304|561837446|FG000|Overall Study|Lost to Follow-up|1|||
155656802|NCT00863304|561837447|FG001|Overall Study|Lost to Follow-up|5|||
155656803|NCT00863304|561837448|FG002|Overall Study|Lost to Follow-up|4|||
155656804|NCT00863304|561837449|FG003|Overall Study|Lost to Follow-up|2|||
155656805|NCT00863304|561837446|FG000|Overall Study|Lack of Efficacy|57|||
155656806|NCT00863304|561837447|FG001|Overall Study|Lack of Efficacy|26|||
155656807|NCT00863304|561837448|FG002|Overall Study|Lack of Efficacy|30|||
155656808|NCT00863304|561837449|FG003|Overall Study|Lack of Efficacy|28|||
155656809|NCT00863304|561837446|FG000|Overall Study|Withdrawal by Subject|19|||
155656810|NCT00863304|561837447|FG001|Overall Study|Withdrawal by Subject|14|||
155656811|NCT00863304|561837448|FG002|Overall Study|Withdrawal by Subject|20|||
155656812|NCT00863304|561837449|FG003|Overall Study|Withdrawal by Subject|18|||
155656813|NCT00863304|561837446|FG000|Overall Study|Other|1|||
155656814|NCT00863304|561837447|FG001|Overall Study|Other|0|||
155656815|NCT00863304|561837448|FG002|Overall Study|Other|0|||
155656816|NCT00863304|561837449|FG003|Overall Study|Other|1|||
155656817|NCT00863304|561837446|FG000|Overall Study|Protocol Violation|2|||
155656818|NCT00863304|561837447|FG001|Overall Study|Protocol Violation|6|||
155656819|NCT00863304|561837448|FG002|Overall Study|Protocol Violation|2|||
155656820|NCT00863304|561837449|FG003|Overall Study|Protocol Violation|0|||
155656821|NCT00863304|561837446|FG000|Overall Study|Randomized, but not Treated|3|||
155656822|NCT00863304|561837447|FG001|Overall Study|Randomized, but not Treated|1|||
155656823|NCT00863304|561837448|FG002|Overall Study|Randomized, but not Treated|4|||
155656824|NCT00863304|561837449|FG003|Overall Study|Randomized, but not Treated|1|||
155656825|NCT00863304|561837446|FG000|Overall Study|Entered extension study|101|||
155656826|NCT00863304|561837447|FG001|Overall Study|Entered extension study|129|||
155656827|NCT00863304|561837448|FG002|Overall Study|Entered extension study|113|||
155656828|NCT00863304|561837449|FG003|Overall Study|Entered extension study|125|||
155656829|NCT00478257|561837450|FG000|Overall Study|Withdrawal by Subject|8|||
155656830|NCT00478257|561837451|FG001|Overall Study|Withdrawal by Subject|3|||
155656831|NCT01182350|561837452|FG000|Overall Study|Adverse Event|5|||
155656832|NCT01182350|561837453|FG001|Overall Study|Adverse Event|0|||
155656833|NCT01182350|561837454|FG002|Overall Study|Adverse Event|0|||
155656834|NCT01182350|561837455|FG003|Overall Study|Adverse Event|0|||
155656835|NCT01182350|561837456|FG004|Overall Study|Adverse Event|0|||
155656836|NCT01182350|561837452|FG000|Overall Study|Disease Progression|15|||
155656837|NCT01182350|561837453|FG001|Overall Study|Disease Progression|12|||
155656838|NCT01182350|561837454|FG002|Overall Study|Disease Progression|0|||
155656839|NCT01182350|561837455|FG003|Overall Study|Disease Progression|1|||
155656840|NCT01182350|561837456|FG004|Overall Study|Disease Progression|0|||
155656841|NCT01182350|561837452|FG000|Overall Study|Death|0|||
155656842|NCT01182350|561837453|FG001|Overall Study|Death|1|||
155656843|NCT01182350|561837454|FG002|Overall Study|Death|1|||
155656844|NCT01182350|561837455|FG003|Overall Study|Death|0|||
155656845|NCT01182350|561837456|FG004|Overall Study|Death|0|||
155656846|NCT01182350|561837452|FG000|Overall Study|Withdrawal by Subject|3|||
155656847|NCT01182350|561837453|FG001|Overall Study|Withdrawal by Subject|1|||
155656848|NCT01182350|561837454|FG002|Overall Study|Withdrawal by Subject|0|||
155656849|NCT01182350|561837455|FG003|Overall Study|Withdrawal by Subject|1|||
155656850|NCT01182350|561837456|FG004|Overall Study|Withdrawal by Subject|0|||
155656851|NCT01182350|561837452|FG000|Overall Study|Alternative Therapy|2|||
155656852|NCT01182350|561837453|FG001|Overall Study|Alternative Therapy|0|||
155656853|NCT01182350|561837454|FG002|Overall Study|Alternative Therapy|1|||
155545709|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
155545710|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
155545711|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
155656854|NCT01182350|561837455|FG003|Overall Study|Alternative Therapy|0|||
155656855|NCT01182350|561837456|FG004|Overall Study|Alternative Therapy|0|||
155656856|NCT01182350|561837452|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
155545712|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
155545713|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
155545714|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
155545715|NCT02960438|561422116|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
155545716|NCT02960438|561422117|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
155545717|NCT02960438|561422118|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
155545718|NCT02960438|561422119|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
155545719|NCT01652729|561422131|FG000|Overall Study|Withdrawal by Subject|14|||
155545720|NCT01652729|561422132|FG001|Overall Study|Withdrawal by Subject|7|||
155545721|NCT01652729|561422133|FG002|Overall Study|Withdrawal by Subject|7|||
155545722|NCT01652729|561422131|FG000|Overall Study|Adverse Event|4|||
155545723|NCT01652729|561422132|FG001|Overall Study|Adverse Event|0|||
155545724|NCT01652729|561422133|FG002|Overall Study|Adverse Event|3|||
155545725|NCT01652729|561422131|FG000|Overall Study|Physician Decision|1|||
155545726|NCT01652729|561422132|FG001|Overall Study|Physician Decision|0|||
155545727|NCT01652729|561422133|FG002|Overall Study|Physician Decision|1|||
155545728|NCT01652729|561422131|FG000|Overall Study|Protocol Violation|1|||
155545729|NCT01652729|561422132|FG001|Overall Study|Protocol Violation|0|||
155545730|NCT01652729|561422133|FG002|Overall Study|Protocol Violation|0|||
155545731|NCT01652729|561422131|FG000|Overall Study|Lost to Follow-up|6|||
155545732|NCT01652729|561422132|FG001|Overall Study|Lost to Follow-up|6|||
155545733|NCT01652729|561422133|FG002|Overall Study|Lost to Follow-up|3|||
155545734|NCT01652729|561422131|FG000|Overall Study|Administrative|1|||
155545735|NCT01652729|561422132|FG001|Overall Study|Administrative|0|||
155545736|NCT01652729|561422133|FG002|Overall Study|Administrative|0|||
155545737|NCT03180801|561422136|FG000|Overall Study|Physician Decision|3|||
155545738|NCT03180801|561422137|FG001|Overall Study|Physician Decision|3|||
155545739|NCT03180801|561422138|FG002|Overall Study|Physician Decision|1|||
155545740|NCT03180801|561422136|FG000|Overall Study|Non-compliance|1|||
155545741|NCT03180801|561422137|FG001|Overall Study|Non-compliance|4|||
155545742|NCT03180801|561422138|FG002|Overall Study|Non-compliance|0|||
155545743|NCT03180801|561422136|FG000|Overall Study|Inoculation Target Reached|1|||
155545744|NCT03180801|561422137|FG001|Overall Study|Inoculation Target Reached|1|||
155545745|NCT03180801|561422138|FG002|Overall Study|Inoculation Target Reached|3|||
155545746|NCT03180801|561422136|FG000|Overall Study|Adverse Event|1|||
155545747|NCT03180801|561422137|FG001|Overall Study|Adverse Event|0|||
155545748|NCT03180801|561422138|FG002|Overall Study|Adverse Event|2|||
155545749|NCT03180801|561422136|FG000|Overall Study|Withdrawal by Subject|2|||
155545750|NCT03180801|561422137|FG001|Overall Study|Withdrawal by Subject|2|||
155545751|NCT03180801|561422138|FG002|Overall Study|Withdrawal by Subject|1|||
155545752|NCT03180801|561422136|FG000|Overall Study|Lost to Follow-up|0|||
155545753|NCT03180801|561422137|FG001|Overall Study|Lost to Follow-up|2|||
155545754|NCT03180801|561422138|FG002|Overall Study|Lost to Follow-up|3|||
155545755|NCT01142908|561422140|FG000|Overall Study|Lost to Follow-up|19|||
155545756|NCT01142908|561422141|FG001|Overall Study|Lost to Follow-up|13|||
155545757|NCT01142908|561422140|FG000|Overall Study|Death|1|||
155545758|NCT01142908|561422141|FG001|Overall Study|Death|4|||
155545759|NCT01142908|561422140|FG000|Overall Study|Excluded - did not meet criteria|9|||
155545760|NCT01142908|561422141|FG001|Overall Study|Excluded - did not meet criteria|5|||
155545761|NCT01142908|561422140|FG000|Overall Study|Withdrawal by Subject|3|||
155545762|NCT01142908|561422141|FG001|Overall Study|Withdrawal by Subject|0|||
155545763|NCT00529217|561422157|FG000|Overall Study|Lack of Efficacy|2|||
155545764|NCT00529217|561422157|FG000|Overall Study|Unable to adhere to study schedule|2|||
155545765|NCT01546519|561422158|FG000|Overall Study|Adverse Event|0|||
155545766|NCT01546519|561422159|FG001|Overall Study|Adverse Event|0|||
155545767|NCT01546519|561422160|FG002|Overall Study|Adverse Event|1|||
155545768|NCT01546519|561422161|FG003|Overall Study|Adverse Event|1|||
155545769|NCT01546519|561422158|FG000|Overall Study|Death|0|||
155545770|NCT01546519|561422159|FG001|Overall Study|Death|1|||
155545771|NCT01546519|561422160|FG002|Overall Study|Death|3|||
155545772|NCT01546519|561422161|FG003|Overall Study|Death|1|||
155545773|NCT01546519|561422158|FG000|Overall Study|related to disease progression|2|||
155545774|NCT01546519|561422159|FG001|Overall Study|related to disease progression|2|||
155545775|NCT01546519|561422160|FG002|Overall Study|related to disease progression|2|||
155545776|NCT01546519|561422161|FG003|Overall Study|related to disease progression|1|||
155545777|NCT01546519|561422158|FG000|Overall Study|Physician Decision|6|||
155545778|NCT01546519|561422159|FG001|Overall Study|Physician Decision|5|||
155545779|NCT01546519|561422160|FG002|Overall Study|Physician Decision|2|||
155545780|NCT01546519|561422161|FG003|Overall Study|Physician Decision|3|||
155545781|NCT01546519|561422158|FG000|Overall Study|Withdrawal by Subject|1|||
155545782|NCT01546519|561422159|FG001|Overall Study|Withdrawal by Subject|0|||
155545783|NCT01546519|561422160|FG002|Overall Study|Withdrawal by Subject|0|||
155545784|NCT01546519|561422161|FG003|Overall Study|Withdrawal by Subject|0|||
155545785|NCT01519947|561422162|FG000|Overall Study|Death|0|||
155545786|NCT01519947|561422163|FG001|Overall Study|Death|0|||
155545787|NCT01519947|561422164|FG002|Overall Study|Death|0|||
155545788|NCT01519947|561422165|FG003|Overall Study|Death|1|||
155545789|NCT01519947|561422162|FG000|Overall Study|Protocol Violation|0|||
155545790|NCT01519947|561422163|FG001|Overall Study|Protocol Violation|0|||
155545791|NCT01519947|561422164|FG002|Overall Study|Protocol Violation|2|||
155545792|NCT01519947|561422165|FG003|Overall Study|Protocol Violation|1|||
155545793|NCT01519947|561422162|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
155545794|NCT01519947|561422163|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
155545795|NCT01519947|561422164|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
155545796|NCT01519947|561422165|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
155545797|NCT01519947|561422162|FG000|Overall Study|Development of Anemia|0|||
155545798|NCT01519947|561422163|FG001|Overall Study|Development of Anemia|1|||
155545799|NCT01519947|561422164|FG002|Overall Study|Development of Anemia|0|||
155545800|NCT01519947|561422165|FG003|Overall Study|Development of Anemia|1|||
155545801|NCT01519947|561422162|FG000|Overall Study|Blood Transfusion|0|||
155545802|NCT01519947|561422163|FG001|Overall Study|Blood Transfusion|1|||
155545803|NCT01519947|561422164|FG002|Overall Study|Blood Transfusion|1|||
155545804|NCT01519947|561422165|FG003|Overall Study|Blood Transfusion|0|||
155545805|NCT01519947|561422162|FG000|Overall Study|Withdrawal by Subject|0|||
155545806|NCT01519947|561422163|FG001|Overall Study|Withdrawal by Subject|1|||
155545807|NCT01519947|561422164|FG002|Overall Study|Withdrawal by Subject|0|||
155545808|NCT01519947|561422165|FG003|Overall Study|Withdrawal by Subject|1|||
155545809|NCT01519947|561422162|FG000|Overall Study|Lost to Follow-up|0|||
155545810|NCT01519947|561422163|FG001|Overall Study|Lost to Follow-up|0|||
155545811|NCT01519947|561422164|FG002|Overall Study|Lost to Follow-up|3|||
155545812|NCT01519947|561422165|FG003|Overall Study|Lost to Follow-up|2|||
155545813|NCT01519947|561422162|FG000|Overall Study|Poor Response|1|||
155545814|NCT01519947|561422163|FG001|Overall Study|Poor Response|0|||
155545815|NCT01519947|561422164|FG002|Overall Study|Poor Response|0|||
155545816|NCT01519947|561422165|FG003|Overall Study|Poor Response|1|||
155545817|NCT01519947|561422162|FG000|Overall Study|Adverse Event|1|||
155545818|NCT01519947|561422163|FG001|Overall Study|Adverse Event|0|||
155545819|NCT01519947|561422164|FG002|Overall Study|Adverse Event|1|||
155545820|NCT01519947|561422165|FG003|Overall Study|Adverse Event|1|||
155545821|NCT01264835|561422170|FG000|Overall Study|Lost to Follow-up|1|||
155545822|NCT01115933|561422174|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
155545823|NCT02427399|561422175|FG000|Overall Study|Protocol Violation|14|||
155545824|NCT02427399|561422176|FG001|Overall Study|Protocol Violation|16|||
155545825|NCT02427399|561422177|FG002|Overall Study|Protocol Violation|12|||
155545826|NCT02427399|561422178|FG003|Overall Study|Protocol Violation|18|||
155545827|NCT02427399|561422179|FG004|Overall Study|Protocol Violation|15|||
155545828|NCT00605176|561422180|FG000|Overall Study|Adverse Event|2|||
155545829|NCT00605176|561422181|FG001|Overall Study|Adverse Event|1|||
155545830|NCT00605176|561422182|FG002|Overall Study|Adverse Event|3|||
155545831|NCT00605176|561422180|FG000|Overall Study|Withdrawal by Subject|4|||
155545832|NCT00605176|561422181|FG001|Overall Study|Withdrawal by Subject|2|||
155545833|NCT00605176|561422182|FG002|Overall Study|Withdrawal by Subject|4|||
155545834|NCT00605176|561422180|FG000|Overall Study|Lost to Follow-up|2|||
155545835|NCT00605176|561422181|FG001|Overall Study|Lost to Follow-up|2|||
155545836|NCT00605176|561422182|FG002|Overall Study|Lost to Follow-up|1|||
155545837|NCT00605176|561422180|FG000|Overall Study|Non-complicance with study procedures|1|||
155545838|NCT00605176|561422181|FG001|Overall Study|Non-complicance with study procedures|0|||
155545839|NCT00605176|561422182|FG002|Overall Study|Non-complicance with study procedures|0|||
155545840|NCT00605176|561422180|FG000|Overall Study|Use of concomitant therapy|1|||
155545841|NCT00605176|561422181|FG001|Overall Study|Use of concomitant therapy|0|||
155545842|NCT00605176|561422182|FG002|Overall Study|Use of concomitant therapy|1|||
155545843|NCT00605176|561422180|FG000|Overall Study|Other (not due to AE)|1|||
155545844|NCT00605176|561422181|FG001|Overall Study|Other (not due to AE)|1|||
155545845|NCT00605176|561422182|FG002|Overall Study|Other (not due to AE)|0|||
155545846|NCT00685750|561422183|FG000|Overall Study|Tumor sampling failure|0|||
155545847|NCT00685750|561422184|FG001|Overall Study|Tumor sampling failure|0|||
155545848|NCT00685750|561422185|FG002|Overall Study|Tumor sampling failure|1|||
155545849|NCT00685750|561422186|FG003|Overall Study|Tumor sampling failure|0|||
155545850|NCT00685750|561422187|FG004|Overall Study|Tumor sampling failure|0|||
155545851|NCT00685750|561422188|FG005|Overall Study|Tumor sampling failure|0|||
155545852|NCT00685750|561422189|FG006|Overall Study|Tumor sampling failure|0|||
155545853|NCT00685750|561422183|FG000|Overall Study|Patient didn't receive the treatment|0|||
155545854|NCT00685750|561422184|FG001|Overall Study|Patient didn't receive the treatment|0|||
155545855|NCT00685750|561422185|FG002|Overall Study|Patient didn't receive the treatment|0|||
155545856|NCT00685750|561422186|FG003|Overall Study|Patient didn't receive the treatment|0|||
155545857|NCT00685750|561422187|FG004|Overall Study|Patient didn't receive the treatment|0|||
155545858|NCT00685750|561422188|FG005|Overall Study|Patient didn't receive the treatment|0|||
155545859|NCT00685750|561422189|FG006|Overall Study|Patient didn't receive the treatment|1|||
155545860|NCT00685750|561422183|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155545861|NCT00685750|561422184|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155545862|NCT00685750|561422185|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155545863|NCT00685750|561422186|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
155545864|NCT00685750|561422187|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155545865|NCT00685750|561422188|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
155545866|NCT00685750|561422189|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
155545867|NCT04974580|561422190|FG000|Overall Study|Lost to Follow-up|33|||
155545868|NCT04974580|561422191|FG001|Overall Study|Lost to Follow-up|39|||
155545869|NCT04974580|561422192|FG002|Overall Study|Lost to Follow-up|30|||
155545870|NCT04974580|561422193|FG003|Overall Study|Lost to Follow-up|29|||
155545871|NCT00587431|561422194|FG000|Overall Study|Adverse Event|1|||
155545872|NCT00587431|561422195|FG001|Overall Study|Adverse Event|0|||
155545873|NCT00587431|561422194|FG000|Overall Study|Withdrawal by Subject|0|||
155545874|NCT00587431|561422195|FG001|Overall Study|Withdrawal by Subject|1|||
155545875|NCT05467982|561422196|FG000|Overall Study|Death|0|||
155545876|NCT05467982|561422197|FG001|Overall Study|Death|1|||
155545877|NCT05467982|561422196|FG000|Overall Study|Lost to Follow-up|3|||
155545878|NCT05467982|561422197|FG001|Overall Study|Lost to Follow-up|1|||
155545879|NCT00220727|561422222|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
155545880|NCT00220727|561422223|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
155545881|NCT02508116|561422226|FG000|Overall Study|Lost to Follow-up|2|||
155545882|NCT02508116|561422227|FG001|Overall Study|Lost to Follow-up|3|||
155545883|NCT02508116|561422226|FG000|Overall Study|Withdrawal by Subject|3|||
155545884|NCT02508116|561422227|FG001|Overall Study|Withdrawal by Subject|2|||
155545885|NCT02508116|561422226|FG000|Overall Study|Protocol Violation|1|||
155545886|NCT02508116|561422227|FG001|Overall Study|Protocol Violation|2|||
155545887|NCT02508116|561422226|FG000|Overall Study|Physician Decision|2|||
155545888|NCT02508116|561422227|FG001|Overall Study|Physician Decision|0|||
155545889|NCT00109850|561422228|FG000|Overall Study|Adverse Event|1|||
155545890|NCT00109850|561422228|FG000|Overall Study|Death|2|||
155656857|NCT01182350|561837453|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
155656858|NCT01182350|561837454|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
155656859|NCT01182350|561837455|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
155656860|NCT01182350|561837456|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
155656861|NCT01182350|561837452|FG000|Overall Study|Unevaluable for Biopsy|0|||
155656862|NCT01182350|561837453|FG001|Overall Study|Unevaluable for Biopsy|0|||
155656863|NCT01182350|561837454|FG002|Overall Study|Unevaluable for Biopsy|0|||
155656864|NCT01182350|561837455|FG003|Overall Study|Unevaluable for Biopsy|0|||
155656865|NCT01182350|561837456|FG004|Overall Study|Unevaluable for Biopsy|3|||
155656866|NCT02592863|561837461|FG000|Overall Study|Withdrawal by Subject|2|||
155656867|NCT02592863|561837462|FG001|Overall Study|Withdrawal by Subject|2|||
155656868|NCT02592863|561837461|FG000|Overall Study|Lost to Follow-up|1|||
155656869|NCT02592863|561837462|FG001|Overall Study|Lost to Follow-up|1|||
155656870|NCT02743221|561837463|FG000|Overall Study|Progressive disease|29|||
155656871|NCT02743221|561837464|FG001|Overall Study|Progressive disease|38|||
155656872|NCT02743221|561837463|FG000|Overall Study|Adverse Event|17|||
155656873|NCT02743221|561837464|FG001|Overall Study|Adverse Event|14|||
155656874|NCT02743221|561837463|FG000|Overall Study|non medical reason|8|||
155656875|NCT02743221|561837464|FG001|Overall Study|non medical reason|2|||
155656876|NCT02743221|561837463|FG000|Overall Study|Physician Decision|2|||
155656877|NCT02743221|561837464|FG001|Overall Study|Physician Decision|5|||
155656878|NCT02743221|561837463|FG000|Overall Study|Patient not eligible, not treated|0|||
155656879|NCT02743221|561837464|FG001|Overall Study|Patient not eligible, not treated|1|||
155545891|NCT00109850|561422228|FG000|Overall Study|Ineligible|1|||
155545892|NCT04234464|561422229|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
155545893|NCT04234464|561422230|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
155545894|NCT00983528|561422231|FG000|Overall Study|Death|4|||
155545895|NCT00983528|561422231|FG000|Overall Study|Lost to Follow-up|1|||
155545896|NCT00983528|561422231|FG000|Overall Study|Study Terminated|1|||
155545897|NCT00476593|561422232|FG000|Overall Study|Lost to Follow-up|10|||
155545898|NCT00476593|561422233|FG001|Overall Study|Lost to Follow-up|2|||
155545899|NCT00476593|561422234|FG002|Overall Study|Lost to Follow-up|8|||
155545900|NCT00476593|561422235|FG003|Overall Study|Lost to Follow-up|22|||
155545901|NCT03430011|561422237|FG000|Pre-Treatment|Death|1|||
155545902|NCT03430011|561422238|FG001|Pre-Treatment|Death|0|||
155545903|NCT03430011|561422239|FG002|Pre-Treatment|Death|0|||
155545904|NCT03430011|561422240|FG003|Pre-Treatment|Death|0|||
155545905|NCT03430011|561422241|FG004|Pre-Treatment|Death|1|||
155545906|NCT03430011|561422242|FG005|Pre-Treatment|Death|0|||
155545907|NCT03430011|561422243|FG006|Pre-Treatment|Death|1|||
155545908|NCT03430011|561422244|FG007|Pre-Treatment|Death|0|||
155545909|NCT03430011|561422237|FG000|Pre-Treatment|Screen Fail|0|||
155545910|NCT03430011|561422238|FG001|Pre-Treatment|Screen Fail|0|||
155545911|NCT03430011|561422239|FG002|Pre-Treatment|Screen Fail|0|||
155545912|NCT03430011|561422240|FG003|Pre-Treatment|Screen Fail|0|||
155545913|NCT03430011|561422241|FG004|Pre-Treatment|Screen Fail|1|||
155545914|NCT03430011|561422242|FG005|Pre-Treatment|Screen Fail|0|||
155545915|NCT03430011|561422243|FG006|Pre-Treatment|Screen Fail|0|||
155545916|NCT03430011|561422244|FG007|Pre-Treatment|Screen Fail|0|||
155545917|NCT03430011|561422237|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545918|NCT03430011|561422238|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545919|NCT03430011|561422239|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
155545920|NCT03430011|561422240|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545921|NCT03430011|561422241|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545922|NCT03430011|561422242|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545923|NCT03430011|561422243|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545924|NCT03430011|561422244|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
155545925|NCT03430011|561422237|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
155545926|NCT03430011|561422238|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
155656880|NCT03411044|561837467|FG000|Overall Study|Death|30|||
155656881|NCT03411044|561837467|FG000|Overall Study|Withdrawal by Subject|48|||
155656882|NCT03411044|561837467|FG000|Overall Study|Lost to Follow-up|78|||
155656883|NCT03411044|561837467|FG000|Overall Study|Adverse Event|30|||
155656884|NCT03411044|561837467|FG000|Overall Study|Missing status|4|||
155545927|NCT03430011|561422239|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
155545928|NCT03430011|561422240|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
155545929|NCT03430011|561422241|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
155545930|NCT03430011|561422242|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
155545931|NCT03430011|561422243|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
155545932|NCT03430011|561422244|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
155545933|NCT03430011|561422237|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
155545934|NCT03430011|561422238|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
155545935|NCT03430011|561422239|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
155545936|NCT03430011|561422240|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
155545937|NCT03430011|561422241|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
155545938|NCT03430011|561422242|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
155545939|NCT03430011|561422243|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
155545940|NCT03430011|561422244|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
155545941|NCT03430011|561422237|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
155545942|NCT03430011|561422238|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
155545943|NCT03430011|561422239|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
155545944|NCT03430011|561422240|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
155545945|NCT03430011|561422241|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
155545946|NCT03430011|561422242|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
155545947|NCT03430011|561422243|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
155545948|NCT03430011|561422244|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
155545949|NCT03430011|561422237|FG000|JCARH125 Treatment|Death|4|||
155545950|NCT03430011|561422238|FG001|JCARH125 Treatment|Death|19|||
155545951|NCT03430011|561422239|FG002|JCARH125 Treatment|Death|10|||
155545952|NCT03430011|561422240|FG003|JCARH125 Treatment|Death|8|||
155545953|NCT03430011|561422241|FG004|JCARH125 Treatment|Death|5|||
155545954|NCT03430011|561422242|FG005|JCARH125 Treatment|Death|3|||
155545955|NCT03430011|561422243|FG006|JCARH125 Treatment|Death|4|||
155545956|NCT03430011|561422244|FG007|JCARH125 Treatment|Death|2|||
155545957|NCT03430011|561422237|FG000|JCARH125 Treatment|Other reasons|1|||
155545958|NCT03430011|561422238|FG001|JCARH125 Treatment|Other reasons|0|||
155545959|NCT03430011|561422239|FG002|JCARH125 Treatment|Other reasons|4|||
155545960|NCT03430011|561422240|FG003|JCARH125 Treatment|Other reasons|2|||
155545961|NCT03430011|561422241|FG004|JCARH125 Treatment|Other reasons|2|||
155545962|NCT03430011|561422242|FG005|JCARH125 Treatment|Other reasons|1|||
155545963|NCT03430011|561422243|FG006|JCARH125 Treatment|Other reasons|3|||
155545964|NCT03430011|561422244|FG007|JCARH125 Treatment|Other reasons|2|||
155545965|NCT00330460|561422249|FG000|Overall Study|Physician Decision|1|||
155545966|NCT00330460|561422250|FG001|Overall Study|Physician Decision|0|||
155545967|NCT00330460|561422249|FG000|Overall Study|Adverse Event|10|||
155545968|NCT00330460|561422250|FG001|Overall Study|Adverse Event|8|||
155545969|NCT00330460|561422249|FG000|Overall Study|Withdrawal by Subject|18|||
155545970|NCT00330460|561422250|FG001|Overall Study|Withdrawal by Subject|17|||
155545971|NCT00330460|561422249|FG000|Overall Study|Death|1|||
155545972|NCT00330460|561422250|FG001|Overall Study|Death|1|||
155545973|NCT00330460|561422249|FG000|Overall Study|Ineligibility determined|1|||
155545974|NCT00330460|561422250|FG001|Overall Study|Ineligibility determined|3|||
155545975|NCT00330460|561422249|FG000|Overall Study|Lost to Follow-up|8|||
155545976|NCT00330460|561422250|FG001|Overall Study|Lost to Follow-up|3|||
155545977|NCT00330460|561422249|FG000|Overall Study|Noncompliance|2|||
155545978|NCT00330460|561422250|FG001|Overall Study|Noncompliance|1|||
155545979|NCT00330460|561422249|FG000|Overall Study|Other|1|||
155545980|NCT00330460|561422250|FG001|Overall Study|Other|0|||
155545981|NCT03712124|561422251|FG000|Overall Study|Protocol Violation|1|||
155545982|NCT03712124|561422252|FG001|Overall Study|Protocol Violation|0|||
155545983|NCT00388037|561422254|FG000|Overall Study|Protocol Violation|1|||
155545984|NCT00602537|561422255|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
155545985|NCT00602537|561422256|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
155545986|NCT00602537|561422255|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
155656885|NCT00815633|561837472|FG000|Overall Study|study terminated|1|||
155545987|NCT00602537|561422256|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
155545988|NCT00602537|561422255|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
155545989|NCT00602537|561422256|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
155545990|NCT00602537|561422255|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
155545991|NCT00602537|561422256|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
155545992|NCT00602537|561422255|FG000|Follow Up Study Comparison|Adverse Event|1|||
155545993|NCT00602537|561422256|FG001|Follow Up Study Comparison|Adverse Event|0|||
155545994|NCT00602537|561422255|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
155545995|NCT00602537|561422256|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
155545996|NCT00602537|561422255|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
155545997|NCT00602537|561422256|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
155545998|NCT02941523|561422259|FG000|Monotherapy|Withdrawal by Subject|0|||
155545999|NCT02941523|561422260|FG001|Monotherapy|Withdrawal by Subject|1|||
155546000|NCT02941523|561422259|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
155546001|NCT02941523|561422260|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
155546002|NCT02941523|561422259|FG000|Carboplatin Combination Therapy|Death|1|||
155546003|NCT02941523|561422260|FG001|Carboplatin Combination Therapy|Death|2|||
155546004|NCT02941523|561422259|FG000|Carboplatin Combination Therapy|Disease progression|2|||
155546005|NCT02941523|561422260|FG001|Carboplatin Combination Therapy|Disease progression|0|||
155546006|NCT02941523|561422259|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
155546007|NCT02941523|561422260|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
155546008|NCT04330157|561422261|FG000|Overall Study|Protocol Violation|4|||
155546009|NCT04330157|561422261|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
155546010|NCT00869440|561422263|FG000|Overall Study|Withdrawal by Subject|1|||
155546011|NCT00869440|561422264|FG001|Overall Study|Withdrawal by Subject|0|||
155546012|NCT00869440|561422265|FG002|Overall Study|Withdrawal by Subject|0|||
155546013|NCT00869440|561422266|FG003|Overall Study|Withdrawal by Subject|0|||
155546014|NCT00869440|561422263|FG000|Overall Study|Physician Decision|1|||
155546015|NCT00869440|561422264|FG001|Overall Study|Physician Decision|1|||
155546016|NCT00869440|561422265|FG002|Overall Study|Physician Decision|0|||
155546017|NCT00869440|561422266|FG003|Overall Study|Physician Decision|0|||
155546018|NCT04314843|561422267|FG000|Overall Study|Death|2|||
155546019|NCT04314843|561422268|FG001|Overall Study|Death|2|||
155546020|NCT04314843|561422267|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
155546021|NCT04314843|561422268|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
155546022|NCT01899326|561422269|FG000|Overall Study|Withdrawal by Subject|1|||
155546023|NCT01899326|561422269|FG000|Overall Study|Adverse Event|2|||
155546024|NCT01899326|561422269|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
155546025|NCT03558139|561422270|FG000|Overall Study|Consent Withdrawn|1|||
155546026|NCT03558139|561422271|FG001|Overall Study|Consent Withdrawn|1|||
155546027|NCT03558139|561422272|FG002|Overall Study|Consent Withdrawn|4|||
155546028|NCT03558139|561422270|FG000|Overall Study|Death|5|||
155546029|NCT03558139|561422271|FG001|Overall Study|Death|3|||
155546030|NCT03558139|561422272|FG002|Overall Study|Death|8|||
155546031|NCT03558139|561422270|FG000|Overall Study|Lost to Follow-up|0|||
155546032|NCT03558139|561422271|FG001|Overall Study|Lost to Follow-up|0|||
155546033|NCT03558139|561422272|FG002|Overall Study|Lost to Follow-up|3|||
155546034|NCT03558139|561422270|FG000|Overall Study|Study Ended Per Protocol|0|||
155546035|NCT03558139|561422271|FG001|Overall Study|Study Ended Per Protocol|3|||
155546036|NCT03558139|561422272|FG002|Overall Study|Study Ended Per Protocol|6|||
155546037|NCT00373425|561422273|FG000|Overall Study|Relapse of NSCLC|116|||
155546038|NCT00373425|561422274|FG001|Overall Study|Relapse of NSCLC|104|||
155546039|NCT00373425|561422275|FG002|Overall Study|Relapse of NSCLC|19|||
155546040|NCT00373425|561422276|FG003|Overall Study|Relapse of NSCLC|2|||
155546041|NCT00373425|561422277|FG004|Overall Study|Relapse of NSCLC|26|||
155546042|NCT00373425|561422273|FG000|Overall Study|Adverse Event|191|||
155546043|NCT00373425|561422274|FG001|Overall Study|Adverse Event|22|||
155546044|NCT00373425|561422275|FG002|Overall Study|Adverse Event|59|||
155546045|NCT00373425|561422276|FG003|Overall Study|Adverse Event|0|||
155546046|NCT00373425|561422277|FG004|Overall Study|Adverse Event|34|||
155546047|NCT00373425|561422273|FG000|Overall Study|Patient request|35|||
155546048|NCT00373425|561422274|FG001|Overall Study|Patient request|18|||
155546049|NCT00373425|561422275|FG002|Overall Study|Patient request|43|||
155546050|NCT00373425|561422276|FG003|Overall Study|Patient request|6|||
155546051|NCT00373425|561422277|FG004|Overall Study|Patient request|7|||
155546052|NCT00373425|561422273|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
155546053|NCT00373425|561422274|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
155546054|NCT00373425|561422275|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
155546055|NCT00373425|561422276|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
155546056|NCT00373425|561422277|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
155546057|NCT00373425|561422273|FG000|Overall Study|Death|7|||
155546058|NCT00373425|561422274|FG001|Overall Study|Death|0|||
155546059|NCT00373425|561422275|FG002|Overall Study|Death|3|||
155546060|NCT00373425|561422276|FG003|Overall Study|Death|1|||
155546061|NCT00373425|561422277|FG004|Overall Study|Death|0|||
155546062|NCT02808819|561422278|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
155546063|NCT02808819|561422279|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
155546064|NCT02808819|561422278|FG000|Overall Study|Withdrawal by Subject|10|||
155546065|NCT02808819|561422279|FG001|Overall Study|Withdrawal by Subject|13|||
155546066|NCT02808819|561422278|FG000|Overall Study|Site terminated by sponsor|2|||
155546067|NCT02808819|561422279|FG001|Overall Study|Site terminated by sponsor|0|||
155656886|NCT03485157|561837474|FG000|Double Blind Phase|Lost to Follow-up|4|||
155546068|NCT02808819|561422278|FG000|Overall Study|Pregnancy|1|||
155546069|NCT02808819|561422279|FG001|Overall Study|Pregnancy|0|||
155546070|NCT02808819|561422278|FG000|Overall Study|Lost to Follow-up|1|||
155546071|NCT02808819|561422279|FG001|Overall Study|Lost to Follow-up|6|||
155546072|NCT02808819|561422278|FG000|Overall Study|Protocol Violation|0|||
155546073|NCT02808819|561422279|FG001|Overall Study|Protocol Violation|1|||
155546074|NCT02808819|561422278|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
155546075|NCT02808819|561422279|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
155546076|NCT02808819|561422278|FG000|Overall Study|Death|1|||
155546077|NCT02808819|561422279|FG001|Overall Study|Death|0|||
155546078|NCT02808819|561422278|FG000|Overall Study|Adverse Event|3|||
155546079|NCT02808819|561422279|FG001|Overall Study|Adverse Event|4|||
155546080|NCT02752802|561422280|FG000|Overall Study|Contrast Volume Not Collected|1|||
155546081|NCT02752802|561422281|FG001|Overall Study|Contrast Volume Not Collected|0|||
155546082|NCT00251316|561422282|FG000|Overall Study|Physician Decision|2|||
155546083|NCT00251316|561422283|FG001|Overall Study|Physician Decision|3|||
155546084|NCT00569777|561422286|FG000|Overall Study|Withdrawal by Subject|4|||
155546085|NCT00569777|561422287|FG001|Overall Study|Withdrawal by Subject|0|||
155546086|NCT00569777|561422286|FG000|Overall Study|Adverse Event|3|||
155546087|NCT00569777|561422287|FG001|Overall Study|Adverse Event|0|||
155546088|NCT00569777|561422286|FG000|Overall Study|Lost to Follow-up|1|||
155546089|NCT00569777|561422287|FG001|Overall Study|Lost to Follow-up|0|||
155546090|NCT00569777|561422286|FG000|Overall Study|scheduled eye surgery|0|||
155546091|NCT00569777|561422287|FG001|Overall Study|scheduled eye surgery|1|||
155546092|NCT00569777|561422286|FG000|Overall Study|did not meet exclusion criteria|1|||
155546093|NCT00569777|561422287|FG001|Overall Study|did not meet exclusion criteria|2|||
155546094|NCT00569777|561422286|FG000|Overall Study|pregnant|1|||
155546095|NCT00569777|561422287|FG001|Overall Study|pregnant|0|||
155546096|NCT02030535|561422289|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
155546097|NCT00576303|561422294|FG000|Dose Titration Period|Early withdrawal|17|||
155546098|NCT00576303|561422294|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
155546099|NCT00576303|561422294|FG000|Long Term Safety Period|Early withdrawal|16|||
155546100|NCT02447887|561424238|FG000|Overall Study|Study was terminated|3|||
155546101|NCT03941834|561424239|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
155546102|NCT03941834|561424240|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
155546103|NCT03941834|561424241|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
155546104|NCT03941834|561424239|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
155546105|NCT03941834|561424240|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
155546106|NCT03941834|561424241|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
155546107|NCT03941834|561424239|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
155546108|NCT03941834|561424240|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
155546109|NCT03941834|561424241|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
155546110|NCT03941834|561424239|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
155546111|NCT03941834|561424240|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
155546112|NCT03941834|561424241|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
155546113|NCT03941834|561424239|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
155546114|NCT03941834|561424240|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
155546115|NCT03941834|561424241|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
155546116|NCT03941834|561424239|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
155546117|NCT03941834|561424240|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
155546118|NCT03941834|561424241|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
155546119|NCT02688387|561424242|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546120|NCT02688387|561424243|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546121|NCT02688387|561424244|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
155546122|NCT02688387|561424245|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546123|NCT02688387|561424246|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546124|NCT02688387|561424247|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546125|NCT02688387|561424248|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546126|NCT02688387|561424249|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546127|NCT02688387|561424250|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546128|NCT02688387|561424251|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546129|NCT02688387|561424252|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546130|NCT02688387|561424253|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546131|NCT02688387|561424254|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546132|NCT02688387|561424255|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546133|NCT02688387|561424256|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546134|NCT02688387|561424257|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546135|NCT02688387|561424258|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546136|NCT02688387|561424259|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546137|NCT02688387|561424260|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546138|NCT02688387|561424261|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546139|NCT02688387|561424262|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155656887|NCT03485157|561837475|FG001|Double Blind Phase|Lost to Follow-up|4|||
155546140|NCT02688387|561424263|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
155546141|NCT02688387|561424242|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546142|NCT02688387|561424243|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546143|NCT02688387|561424244|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546144|NCT02688387|561424245|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
155546145|NCT02688387|561424246|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546146|NCT02688387|561424247|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546147|NCT02688387|561424248|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546148|NCT02688387|561424249|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546149|NCT02688387|561424250|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546150|NCT02688387|561424251|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546151|NCT02688387|561424252|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546152|NCT02688387|561424253|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546153|NCT02688387|561424254|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546154|NCT02688387|561424255|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546155|NCT02688387|561424256|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546156|NCT02688387|561424257|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546157|NCT02688387|561424258|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546158|NCT02688387|561424259|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546159|NCT02688387|561424260|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546160|NCT02688387|561424261|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546161|NCT02688387|561424262|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546162|NCT02688387|561424263|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546163|NCT02688387|561424242|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546164|NCT02688387|561424243|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
155546165|NCT02688387|561424244|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546166|NCT02688387|561424245|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546167|NCT02688387|561424246|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546168|NCT02688387|561424247|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546169|NCT02688387|561424248|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546170|NCT02688387|561424249|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546171|NCT02688387|561424250|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546172|NCT02688387|561424251|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546173|NCT02688387|561424252|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546174|NCT02688387|561424253|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546175|NCT02688387|561424254|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546176|NCT02688387|561424255|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546177|NCT02688387|561424256|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546178|NCT02688387|561424257|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155606850|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155656888|NCT03485157|561837474|FG000|Double Blind Phase|Adverse Event|2|||
155546179|NCT02688387|561424258|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546180|NCT02688387|561424259|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546181|NCT02688387|561424260|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546182|NCT02688387|561424261|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546183|NCT02688387|561424262|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546184|NCT02688387|561424263|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
155546185|NCT02688387|561424242|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546186|NCT02688387|561424243|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546187|NCT02688387|561424244|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
155546188|NCT02688387|561424245|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546189|NCT02688387|561424246|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
155546190|NCT02688387|561424247|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546191|NCT02688387|561424248|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546192|NCT02688387|561424249|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546193|NCT02688387|561424250|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546194|NCT02688387|561424251|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546195|NCT02688387|561424252|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546196|NCT02688387|561424253|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546197|NCT02688387|561424254|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546198|NCT02688387|561424255|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546199|NCT02688387|561424256|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546200|NCT02688387|561424257|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546201|NCT02688387|561424258|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546202|NCT02688387|561424259|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546203|NCT02688387|561424260|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546204|NCT02688387|561424261|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546205|NCT02688387|561424262|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546206|NCT02688387|561424263|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
155546207|NCT02688387|561424242|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
155546208|NCT02688387|561424243|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546209|NCT02688387|561424244|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546210|NCT02688387|561424245|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546211|NCT02688387|561424246|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546212|NCT02688387|561424247|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546213|NCT02688387|561424248|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546214|NCT02688387|561424249|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546215|NCT02688387|561424250|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546216|NCT02688387|561424251|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546217|NCT02688387|561424252|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546218|NCT02688387|561424253|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546219|NCT02688387|561424254|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546220|NCT02688387|561424255|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546221|NCT02688387|561424256|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546222|NCT02688387|561424257|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546223|NCT02688387|561424258|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546224|NCT02688387|561424259|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546225|NCT02688387|561424260|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546226|NCT02688387|561424261|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546227|NCT02688387|561424262|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546228|NCT02688387|561424263|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155546229|NCT02688387|561424242|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546230|NCT02688387|561424243|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546231|NCT02688387|561424244|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546232|NCT02688387|561424245|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546233|NCT02688387|561424246|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546234|NCT02688387|561424247|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546235|NCT02688387|561424248|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546236|NCT02688387|561424249|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546237|NCT02688387|561424250|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546238|NCT02688387|561424251|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546239|NCT02688387|561424252|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
155546240|NCT02688387|561424253|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546241|NCT02688387|561424254|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546242|NCT02688387|561424255|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546243|NCT02688387|561424256|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546244|NCT02688387|561424257|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546245|NCT02688387|561424258|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546246|NCT02688387|561424259|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546247|NCT02688387|561424260|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546248|NCT02688387|561424261|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546249|NCT02688387|561424262|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546250|NCT02688387|561424263|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
155546251|NCT02688387|561424242|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546252|NCT02688387|561424243|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546253|NCT02688387|561424244|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546254|NCT02688387|561424245|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546255|NCT02688387|561424246|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546256|NCT02688387|561424247|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546257|NCT02688387|561424248|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546258|NCT02688387|561424249|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546259|NCT02688387|561424250|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546260|NCT02688387|561424251|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546261|NCT02688387|561424252|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546262|NCT02688387|561424253|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546263|NCT02688387|561424254|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546264|NCT02688387|561424255|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546265|NCT02688387|561424256|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
155546266|NCT02688387|561424257|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546267|NCT02688387|561424258|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546268|NCT02688387|561424259|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546269|NCT02688387|561424260|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546270|NCT02688387|561424261|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546271|NCT02688387|561424262|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546272|NCT02688387|561424263|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155546273|NCT02688387|561424242|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546274|NCT02688387|561424243|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546275|NCT02688387|561424244|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546276|NCT02688387|561424245|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546277|NCT02688387|561424246|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546278|NCT02688387|561424247|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546279|NCT02688387|561424248|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546280|NCT02688387|561424249|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546281|NCT02688387|561424250|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546282|NCT02688387|561424251|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546283|NCT02688387|561424252|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546284|NCT02688387|561424253|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546285|NCT02688387|561424254|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546286|NCT02688387|561424255|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546287|NCT02688387|561424256|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546288|NCT02688387|561424257|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546289|NCT02688387|561424258|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546290|NCT02688387|561424259|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546291|NCT02688387|561424260|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546292|NCT02688387|561424261|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546293|NCT02688387|561424262|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
155546294|NCT02688387|561424263|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
155546295|NCT02688387|561424242|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546296|NCT02688387|561424243|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546297|NCT02688387|561424244|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546298|NCT02688387|561424245|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546299|NCT02688387|561424246|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546300|NCT02688387|561424247|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546301|NCT02688387|561424248|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546302|NCT02688387|561424249|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546303|NCT02688387|561424250|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546304|NCT02688387|561424251|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546305|NCT02688387|561424252|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546306|NCT02688387|561424253|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546307|NCT02688387|561424254|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546308|NCT02688387|561424255|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546309|NCT02688387|561424256|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546310|NCT02688387|561424257|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546311|NCT02688387|561424258|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546312|NCT02688387|561424259|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546313|NCT02688387|561424260|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
155546314|NCT02688387|561424261|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546315|NCT02688387|561424262|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
155546316|NCT02688387|561424263|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
155546317|NCT02688387|561424242|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546318|NCT02688387|561424243|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546319|NCT02688387|561424244|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546320|NCT02688387|561424245|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546321|NCT02688387|561424246|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546322|NCT02688387|561424247|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546323|NCT02688387|561424248|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546324|NCT02688387|561424249|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546325|NCT02688387|561424250|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546326|NCT02688387|561424251|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546327|NCT02688387|561424252|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546328|NCT02688387|561424253|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546329|NCT02688387|561424254|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546330|NCT02688387|561424255|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546331|NCT02688387|561424256|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546332|NCT02688387|561424257|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546333|NCT02688387|561424258|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546334|NCT02688387|561424259|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546335|NCT02688387|561424260|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546336|NCT02688387|561424261|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
155546337|NCT02688387|561424262|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546338|NCT02688387|561424263|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155546339|NCT00418522|561424264|FG000|Overall Study|Adverse Event|7|||
155546340|NCT00418522|561424265|FG001|Overall Study|Adverse Event|1|||
155546341|NCT00418522|561424264|FG000|Overall Study|Lack of Efficacy|1|||
155546342|NCT00418522|561424265|FG001|Overall Study|Lack of Efficacy|3|||
155546343|NCT00418522|561424264|FG000|Overall Study|Lost to Follow-up|10|||
155546344|NCT00418522|561424265|FG001|Overall Study|Lost to Follow-up|4|||
155546345|NCT00418522|561424264|FG000|Overall Study|Withdrawal by Subject|31|||
155546346|NCT00418522|561424265|FG001|Overall Study|Withdrawal by Subject|7|||
155546347|NCT00418522|561424264|FG000|Overall Study|Other|27|||
155546348|NCT00418522|561424265|FG001|Overall Study|Other|23|||
155546349|NCT00418522|561424264|FG000|Overall Study|Randomized but did not receive treatment|7|||
155546350|NCT00418522|561424265|FG001|Overall Study|Randomized but did not receive treatment|4|||
155546351|NCT01049412|561424268|FG000|Period I|Withdrawal by Subject|4|||
155546352|NCT01049412|561424269|FG001|Period I|Withdrawal by Subject|6|||
155546353|NCT01049412|561424268|FG000|Period I|Lost to Follow-up|2|||
155546354|NCT01049412|561424269|FG001|Period I|Lost to Follow-up|2|||
155546355|NCT01049412|561424268|FG000|Period I|Physician Decision|0|||
155546356|NCT01049412|561424269|FG001|Period I|Physician Decision|3|||
155546357|NCT01049412|561424268|FG000|Period I|Protocol Violation|1|||
155546358|NCT01049412|561424269|FG001|Period I|Protocol Violation|2|||
155546359|NCT01049412|561424268|FG000|Period I|Adverse Event|1|||
155546360|NCT01049412|561424269|FG001|Period I|Adverse Event|0|||
155546361|NCT01049412|561424268|FG000|Period II|Withdrawal by Subject|2|||
155546362|NCT01049412|561424269|FG001|Period II|Withdrawal by Subject|3|||
155546363|NCT01049412|561424268|FG000|Period II|Adverse Event|1|||
155546364|NCT01049412|561424269|FG001|Period II|Adverse Event|0|||
155546365|NCT01049412|561424268|FG000|Period II|Lost to Follow-up|1|||
155546366|NCT01049412|561424269|FG001|Period II|Lost to Follow-up|0|||
155546367|NCT05966090|561424270|FG000|Overall Study|Lost to Follow-up|6|||
155546368|NCT05966090|561424271|FG001|Overall Study|Lost to Follow-up|6|||
155546369|NCT05966090|561424270|FG000|Overall Study|Adverse Event|1|||
155546370|NCT05966090|561424271|FG001|Overall Study|Adverse Event|1|||
155546371|NCT05966090|561424270|FG000|Overall Study|Withdrawal by Subject|1|||
155546372|NCT05966090|561424271|FG001|Overall Study|Withdrawal by Subject|1|||
155546373|NCT05966090|561424270|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155546374|NCT05966090|561424271|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155546375|NCT05966090|561424270|FG000|Overall Study|Other|1|||
155546376|NCT05966090|561424271|FG001|Overall Study|Other|1|||
155546377|NCT00804141|561424272|FG000|Overall Study|Adverse Event|157|||
155546378|NCT00804141|561424272|FG000|Overall Study|Death|4|||
155546379|NCT00804141|561424272|FG000|Overall Study|Failed to return|96|||
155546380|NCT00804141|561424272|FG000|Overall Study|Investigator request|8|||
155546381|NCT00804141|561424272|FG000|Overall Study|Protocol Violation|85|||
155546382|NCT00804141|561424272|FG000|Overall Study|Withdrawal by Subject|131|||
155546383|NCT00804141|561424272|FG000|Overall Study|Lack of Efficacy|46|||
155546384|NCT00804141|561424272|FG000|Overall Study|Other than specified|30|||
155546385|NCT00804141|561424272|FG000|Overall Study|Enrolled but not treated|6|||
155546386|NCT02418455|561424274|FG000|48-Week Treatment Period|Other- Not Specified|1|||
155546387|NCT02418455|561424274|FG000|Continuation Period|Sponsor Decision|7|||
155546388|NCT03235479|561424277|FG000|Overall Study|Lost to Follow-up|8|||
155546389|NCT03235479|561424278|FG001|Overall Study|Lost to Follow-up|11|||
155546390|NCT03235479|561424277|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
155546391|NCT03235479|561424278|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
155546392|NCT03235479|561424277|FG000|Overall Study|Pregnancy|1|||
155546393|NCT03235479|561424278|FG001|Overall Study|Pregnancy|0|||
155546394|NCT03235479|561424277|FG000|Overall Study|Protocol Deviation|1|||
155546395|NCT03235479|561424278|FG001|Overall Study|Protocol Deviation|3|||
155546396|NCT03235479|561424277|FG000|Overall Study|Technical Problems|3|||
155546397|NCT03235479|561424278|FG001|Overall Study|Technical Problems|2|||
155546398|NCT03235479|561424277|FG000|Overall Study|Withdrawal by Subject|2|||
155546399|NCT03235479|561424278|FG001|Overall Study|Withdrawal by Subject|2|||
155546400|NCT03235479|561424277|FG000|Overall Study|Other Reasons|3|||
155546401|NCT03235479|561424278|FG001|Overall Study|Other Reasons|5|||
155546402|NCT02001051|561424279|FG000|Overall Study|Deemed not eligible following enrollment|0|||
155546403|NCT02001051|561424280|FG001|Overall Study|Deemed not eligible following enrollment|1|||
155546404|NCT00779402|561424281|FG000|Treatment Phase 1|Disease Progression|1|||
155546405|NCT00779402|561424282|FG001|Treatment Phase 1|Disease Progression|0|||
155546406|NCT00779402|561424281|FG000|Treatment Phase 1|Adverse Event|2|||
155546407|NCT00779402|561424282|FG001|Treatment Phase 1|Adverse Event|0|||
155546408|NCT00779402|561424281|FG000|Treatment Phase 1|Protocol Violation|1|||
155546409|NCT00779402|561424282|FG001|Treatment Phase 1|Protocol Violation|0|||
155546410|NCT00779402|561424281|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
155546411|NCT00779402|561424282|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
155546412|NCT00779402|561424281|FG000|Treatment Phase 1|Lost to Follow-up|0|||
155546413|NCT00779402|561424282|FG001|Treatment Phase 1|Lost to Follow-up|1|||
155546414|NCT00779402|561424281|FG000|Treatment Phase 1|Death|0|||
155546415|NCT00779402|561424282|FG001|Treatment Phase 1|Death|1|||
155546416|NCT00779402|561424281|FG000|Treatment Phase 1|Intercurrent Illness|1|||
155546417|NCT00779402|561424282|FG001|Treatment Phase 1|Intercurrent Illness|1|||
155546418|NCT00779402|561424281|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
155546419|NCT00779402|561424282|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
155546420|NCT00779402|561424281|FG000|Treatment Phase 1|Other|4|||
155546421|NCT00779402|561424282|FG001|Treatment Phase 1|Other|2|||
155546422|NCT00779402|561424281|FG000|Treatment Phase 1|Closure of Study|3|||
155546423|NCT00779402|561424282|FG001|Treatment Phase 1|Closure of Study|2|||
155546424|NCT00779402|561424281|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
155546425|NCT00779402|561424282|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
155546426|NCT00779402|561424281|FG000|Surveillance Phase|Protocol Violation|0|||
155546427|NCT00779402|561424282|FG001|Surveillance Phase|Protocol Violation|1|||
155546428|NCT00779402|561424281|FG000|Surveillance Phase|Patient refused to continue|22|||
155546429|NCT00779402|561424282|FG001|Surveillance Phase|Patient refused to continue|14|||
155546430|NCT00779402|561424281|FG000|Surveillance Phase|Lost to Follow-up|2|||
155546431|NCT00779402|561424282|FG001|Surveillance Phase|Lost to Follow-up|1|||
155546432|NCT00779402|561424281|FG000|Surveillance Phase|Death|0|||
155546433|NCT00779402|561424282|FG001|Surveillance Phase|Death|1|||
155546434|NCT00779402|561424281|FG000|Surveillance Phase|Intercurrent Illness|2|||
155546435|NCT00779402|561424282|FG001|Surveillance Phase|Intercurrent Illness|0|||
155546436|NCT00779402|561424281|FG000|Surveillance Phase|Other|5|||
155546437|NCT00779402|561424282|FG001|Surveillance Phase|Other|5|||
155546438|NCT00779402|561424281|FG000|Surveillance Phase|Withdrawal by Subject|4|||
155546439|NCT00779402|561424282|FG001|Surveillance Phase|Withdrawal by Subject|1|||
155546440|NCT00779402|561424281|FG000|Surveillance Phase|Closure of study|5|||
155546441|NCT00779402|561424282|FG001|Surveillance Phase|Closure of study|6|||
155546442|NCT00779402|561424281|FG000|Surveillance Phase|Completed Protocol Visits|3|||
155546443|NCT00779402|561424282|FG001|Surveillance Phase|Completed Protocol Visits|2|||
155546444|NCT00779402|561424281|FG000|Long-term Follow-up|Patient refused to continue|2|||
155546445|NCT00779402|561424282|FG001|Long-term Follow-up|Patient refused to continue|0|||
155546446|NCT00779402|561424281|FG000|Long-term Follow-up|Other|5|||
155546447|NCT00779402|561424282|FG001|Long-term Follow-up|Other|0|||
155546448|NCT00779402|561424281|FG000|Long-term Follow-up|Closure of Study|8|||
155546449|NCT00779402|561424282|FG001|Long-term Follow-up|Closure of Study|4|||
155546450|NCT00779402|561424281|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
155546451|NCT00779402|561424282|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
155546452|NCT00693225|561424287|FG000|Overall Study|Lost to Follow-up|1|||
155546453|NCT00693225|561424288|FG001|Overall Study|Lost to Follow-up|2|||
155546454|NCT00693225|561424287|FG000|Overall Study|Adverse Event|1|||
155546455|NCT00693225|561424288|FG001|Overall Study|Adverse Event|3|||
155546456|NCT01315028|561424289|FG000|Overall Study|Lost to Follow-up|1|||
155546457|NCT01315028|561424290|FG001|Overall Study|Lost to Follow-up|0|||
155546458|NCT01315028|561424289|FG000|Overall Study|Death|0|||
155546459|NCT01315028|561424290|FG001|Overall Study|Death|1|||
155546460|NCT03585959|561424295|FG000|Overall Study|Physician Decision|1|||
155546461|NCT03585959|561424295|FG000|Overall Study|Unsuccessful Procedure|2|||
155546462|NCT02531594|561424296|FG000|Overall Study|Withdrawal by Subject|7|||
155546463|NCT02531594|561424297|FG001|Overall Study|Withdrawal by Subject|8|||
155546464|NCT01557920|561424305|FG000|Overall Study|Withdrawal by Subject|2|||
155546465|NCT01557920|561424306|FG001|Overall Study|Withdrawal by Subject|3|||
155546466|NCT01557920|561424305|FG000|Overall Study|Lack of Efficacy|1|||
155546467|NCT01557920|561424306|FG001|Overall Study|Lack of Efficacy|0|||
155546468|NCT01808248|561424313|FG000|Overall Study|Lack of Efficacy|3|||
155546469|NCT01808248|561424313|FG000|Overall Study|Withdrawal by Subject|1|||
155546470|NCT01808248|561424313|FG000|Overall Study|Lost to Follow-up|1|||
155546471|NCT00559364|561424324|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
155546472|NCT00559364|561424325|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
155546473|NCT04126343|561424326|FG000|Overall Study|Adverse Event|0|||
155546474|NCT04126343|561424327|FG001|Overall Study|Adverse Event|0|||
155546475|NCT04126343|561424328|FG002|Overall Study|Adverse Event|0|||
155546476|NCT04126343|561424329|FG003|Overall Study|Adverse Event|0|||
155546477|NCT04126343|561424330|FG004|Overall Study|Adverse Event|0|||
155546478|NCT04126343|561424331|FG005|Overall Study|Adverse Event|1|||
155546479|NCT04126343|561424326|FG000|Overall Study|Withdrawal by Subject|0|||
155546480|NCT04126343|561424327|FG001|Overall Study|Withdrawal by Subject|0|||
155546481|NCT04126343|561424328|FG002|Overall Study|Withdrawal by Subject|0|||
155546482|NCT04126343|561424329|FG003|Overall Study|Withdrawal by Subject|1|||
155546483|NCT04126343|561424330|FG004|Overall Study|Withdrawal by Subject|0|||
155546484|NCT04126343|561424331|FG005|Overall Study|Withdrawal by Subject|0|||
155546485|NCT04126343|561424326|FG000|Overall Study|Related to COVID-19 pandemic|3|||
155546486|NCT04126343|561424327|FG001|Overall Study|Related to COVID-19 pandemic|4|||
155546487|NCT04126343|561424328|FG002|Overall Study|Related to COVID-19 pandemic|3|||
155546488|NCT04126343|561424329|FG003|Overall Study|Related to COVID-19 pandemic|3|||
155546489|NCT04126343|561424330|FG004|Overall Study|Related to COVID-19 pandemic|3|||
155546490|NCT04126343|561424331|FG005|Overall Study|Related to COVID-19 pandemic|3|||
155546491|NCT01857973|561424336|FG000|Overall Study|Subject did not meet required BG range|3|||
155546492|NCT01857973|561424336|FG000|Overall Study|drop out after 3 failed attempts|1|||
155546493|NCT01857973|561424336|FG000|Overall Study|Physician Decision|1|||
155546494|NCT01701973|561424339|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546495|NCT01701973|561424340|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
155546496|NCT01701973|561424341|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546497|NCT01701973|561424342|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546498|NCT01701973|561424343|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546499|NCT01701973|561424344|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546500|NCT01701973|561424345|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546501|NCT01701973|561424346|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
155546502|NCT02412722|561424351|FG000|Overall Study|Adverse Event|0|||
155546503|NCT02412722|561424352|FG001|Overall Study|Adverse Event|2|||
155546504|NCT02412722|561424353|FG002|Overall Study|Adverse Event|0|||
155546505|NCT02412722|561424354|FG003|Overall Study|Adverse Event|3|||
155546506|NCT02412722|561424355|FG004|Overall Study|Adverse Event|0|||
155546507|NCT02412722|561424356|FG005|Overall Study|Adverse Event|3|||
155546508|NCT02412722|561424351|FG000|Overall Study|Progressive Disease|6|||
155546509|NCT02412722|561424352|FG001|Overall Study|Progressive Disease|4|||
155546510|NCT02412722|561424353|FG002|Overall Study|Progressive Disease|4|||
155546511|NCT02412722|561424354|FG003|Overall Study|Progressive Disease|9|||
155546512|NCT02412722|561424355|FG004|Overall Study|Progressive Disease|3|||
155546513|NCT02412722|561424356|FG005|Overall Study|Progressive Disease|3|||
155546514|NCT02412722|561424351|FG000|Overall Study|Withdrawal by Subject|2|||
155546515|NCT02412722|561424352|FG001|Overall Study|Withdrawal by Subject|0|||
155546516|NCT02412722|561424353|FG002|Overall Study|Withdrawal by Subject|1|||
155546517|NCT02412722|561424354|FG003|Overall Study|Withdrawal by Subject|2|||
155546518|NCT02412722|561424355|FG004|Overall Study|Withdrawal by Subject|1|||
155546519|NCT02412722|561424356|FG005|Overall Study|Withdrawal by Subject|1|||
155546520|NCT02412722|561424351|FG000|Overall Study|Lost to Follow-up|0|||
155546521|NCT02412722|561424352|FG001|Overall Study|Lost to Follow-up|0|||
155546522|NCT02412722|561424353|FG002|Overall Study|Lost to Follow-up|0|||
155546523|NCT02412722|561424354|FG003|Overall Study|Lost to Follow-up|0|||
155546524|NCT02412722|561424355|FG004|Overall Study|Lost to Follow-up|1|||
155546525|NCT02412722|561424356|FG005|Overall Study|Lost to Follow-up|0|||
155546526|NCT02412722|561424351|FG000|Overall Study|Received drug in run-in and discontinued|0|||
155546527|NCT02412722|561424352|FG001|Overall Study|Received drug in run-in and discontinued|2|||
155546528|NCT02412722|561424353|FG002|Overall Study|Received drug in run-in and discontinued|0|||
155546529|NCT02412722|561424354|FG003|Overall Study|Received drug in run-in and discontinued|0|||
155546530|NCT02412722|561424355|FG004|Overall Study|Received drug in run-in and discontinued|0|||
155546531|NCT02412722|561424356|FG005|Overall Study|Received drug in run-in and discontinued|0|||
155546532|NCT02412722|561424351|FG000|Overall Study|Reason not Specified|3|||
155546533|NCT02412722|561424352|FG001|Overall Study|Reason not Specified|0|||
155546534|NCT02412722|561424353|FG002|Overall Study|Reason not Specified|2|||
155546535|NCT02412722|561424354|FG003|Overall Study|Reason not Specified|1|||
155546536|NCT02412722|561424355|FG004|Overall Study|Reason not Specified|2|||
155546537|NCT02412722|561424356|FG005|Overall Study|Reason not Specified|6|||
155546538|NCT00551616|561424359|FG000|Overall Study|Lost to Follow-up|48|||
155546539|NCT00551616|561424360|FG001|Overall Study|Lost to Follow-up|40|||
155546540|NCT02692482|561424361|FG000|Overall Study|Death|2|||
155546541|NCT02692482|561424362|FG001|Overall Study|Death|2|||
155546542|NCT02692482|561424361|FG000|Overall Study|Withdrawal by Subject|1|||
155546543|NCT02692482|561424362|FG001|Overall Study|Withdrawal by Subject|2|||
155546544|NCT00105157|561424363|FG000|Double-Blind (DB)|Never Treated|1|||
155546545|NCT00105157|561424364|FG001|Double-Blind (DB)|Never Treated|0|||
155546546|NCT00105157|561424365|FG002|Double-Blind (DB)|Never Treated|0|||
155546547|NCT00105157|561424366|FG003|Double-Blind (DB)|Never Treated|0|||
155546548|NCT00105157|561424363|FG000|Double-Blind (DB)|Adverse Event|2|||
155546549|NCT00105157|561424364|FG001|Double-Blind (DB)|Adverse Event|0|||
155546550|NCT00105157|561424365|FG002|Double-Blind (DB)|Adverse Event|1|||
155546551|NCT00105157|561424366|FG003|Double-Blind (DB)|Adverse Event|1|||
155546552|NCT00105157|561424363|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
155546553|NCT00105157|561424364|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
155546554|NCT00105157|561424365|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
155546555|NCT00105157|561424366|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
155546556|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Adverse Event|3|||
155546557|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Adverse Event|1|||
155546558|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Adverse Event|0|||
155546559|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Adverse Event|0|||
155656889|NCT03485157|561837475|FG001|Double Blind Phase|Adverse Event|1|||
155546560|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
155546561|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
155546562|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
155656890|NCT03485157|561837474|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155656891|NCT03485157|561837475|FG001|Double Blind Phase|Withdrawal by Subject|9|||
155656892|NCT03485157|561837474|FG000|Double Blind Phase|Removal by PI|3|||
155546563|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
155546564|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
155546565|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
155546566|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
155546567|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
155546568|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
155546569|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
155656893|NCT03485157|561837475|FG001|Double Blind Phase|Removal by PI|7|||
155546570|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
155546571|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
155546572|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
155546573|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
155546574|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
155546575|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
155546576|NCT00105157|561424363|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
155546577|NCT00105157|561424364|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
155546578|NCT00105157|561424365|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
155546579|NCT00105157|561424366|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
155546580|NCT00105157|561424363|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
155546581|NCT00105157|561424364|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
155546582|NCT00105157|561424365|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
155546583|NCT00105157|561424366|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
155546584|NCT00105157|561424363|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
155546585|NCT00105157|561424364|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
155546586|NCT00105157|561424365|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
155546587|NCT00105157|561424366|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
155546588|NCT00105157|561424363|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
155546589|NCT00105157|561424364|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
155546590|NCT00105157|561424365|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
155546591|NCT00105157|561424366|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
155546592|NCT00105157|561424363|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
155546593|NCT00105157|561424364|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
155546594|NCT00105157|561424365|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
155546595|NCT00105157|561424366|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
155546596|NCT00105157|561424363|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
155546597|NCT00105157|561424364|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
155546598|NCT00105157|561424365|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
155546599|NCT00105157|561424366|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
155546600|NCT03689894|561424367|FG000|Overall Study|Adverse Event|1|||
155546601|NCT01610063|561424372|FG000|Overall Study|Lost to Follow-up|42|||
155546602|NCT01610063|561424373|FG001|Overall Study|Lost to Follow-up|20|||
155546603|NCT04405739|561424378|FG000|Overall Study|Adverse Event|0|||
155546604|NCT04405739|561424379|FG001|Overall Study|Adverse Event|1|||
155546605|NCT04405739|561424380|FG002|Overall Study|Adverse Event|0|||
155546606|NCT04405739|561424381|FG003|Overall Study|Adverse Event|0|||
155546607|NCT04405739|561424378|FG000|Overall Study|Lost to Follow-up|0|||
155546608|NCT04405739|561424379|FG001|Overall Study|Lost to Follow-up|2|||
155546609|NCT04405739|561424380|FG002|Overall Study|Lost to Follow-up|1|||
155546610|NCT04405739|561424381|FG003|Overall Study|Lost to Follow-up|3|||
155546611|NCT04405739|561424378|FG000|Overall Study|Withdrawal by Subject|0|||
155546612|NCT04405739|561424379|FG001|Overall Study|Withdrawal by Subject|2|||
155546613|NCT04405739|561424380|FG002|Overall Study|Withdrawal by Subject|1|||
155546614|NCT04405739|561424381|FG003|Overall Study|Withdrawal by Subject|1|||
155546615|NCT04405739|561424378|FG000|Overall Study|Death|0|||
155546616|NCT04405739|561424379|FG001|Overall Study|Death|0|||
155546617|NCT04405739|561424380|FG002|Overall Study|Death|1|||
155546618|NCT04405739|561424381|FG003|Overall Study|Death|0|||
155546619|NCT04405739|561424378|FG000|Overall Study|Transferred to rehab|0|||
155546620|NCT04405739|561424379|FG001|Overall Study|Transferred to rehab|0|||
155546621|NCT04405739|561424380|FG002|Overall Study|Transferred to rehab|0|||
155546622|NCT04405739|561424381|FG003|Overall Study|Transferred to rehab|1|||
155546623|NCT04405739|561424378|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
155546624|NCT04405739|561424379|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
155546625|NCT04405739|561424380|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
155546626|NCT04405739|561424381|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
155546627|NCT01378962|561424382|FG000|Overall Study|Death|14|||
155546628|NCT01378962|561424382|FG000|Overall Study|Lost to Follow-up|1|||
155546629|NCT01378962|561424382|FG000|Overall Study|Other|2|||
155546630|NCT02056652|561424383|FG000|Overall Study|Withdrawal by Subject|1|||
155546631|NCT02056652|561424384|FG001|Overall Study|Withdrawal by Subject|0|||
155546632|NCT02056652|561424383|FG000|Overall Study|Lost to Follow-up|0|||
155546633|NCT02056652|561424384|FG001|Overall Study|Lost to Follow-up|3|||
155546634|NCT01835548|561424387|FG000|Dose Optimization Period|Adverse Event|0|||
155546635|NCT01835548|561424388|FG001|Dose Optimization Period|Adverse Event|0|||
155546636|NCT01835548|561424389|FG002|Dose Optimization Period|Adverse Event|1|||
155546637|NCT01835548|561424387|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
155546638|NCT01835548|561424388|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
155656894|NCT03485157|561837474|FG000|Open Label Phase|Lost to Follow-up|1|||
155546639|NCT01835548|561424389|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
155546640|NCT01835548|561424387|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155546641|NCT01835548|561424388|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155546642|NCT01835548|561424389|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155546643|NCT01835548|561424387|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155546644|NCT01835548|561424388|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155546645|NCT01835548|561424389|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155546646|NCT01634854|561424390|FG000|Overall Study|Cesarean delivery|2|||
155546647|NCT01634854|561424391|FG001|Overall Study|Cesarean delivery|7|||
155546648|NCT00987831|561424392|FG000|Overall Study|Never flared in 12 months|1|||
155546649|NCT00987831|561424393|FG001|Overall Study|Never flared in 12 months|0|||
155546650|NCT00987831|561424394|FG002|Overall Study|Never flared in 12 months|0|||
155546651|NCT00987831|561424392|FG000|Overall Study|Lost to Follow-up|0|||
155546652|NCT00987831|561424393|FG001|Overall Study|Lost to Follow-up|3|||
155546653|NCT00987831|561424394|FG002|Overall Study|Lost to Follow-up|0|||
155546654|NCT03253094|561424395|FG000|Overall Study|Adverse Event|2|||
155546655|NCT03253094|561424396|FG001|Overall Study|Adverse Event|0|||
155546656|NCT03253094|561424397|FG002|Overall Study|Adverse Event|0|||
155546657|NCT03253094|561424398|FG003|Overall Study|Adverse Event|0|||
155546658|NCT03253094|561424399|FG004|Overall Study|Adverse Event|0|||
155546659|NCT03253094|561424400|FG005|Overall Study|Adverse Event|0|||
155546660|NCT03253094|561424395|FG000|Overall Study|Lack of Efficacy|0|||
155546661|NCT03253094|561424396|FG001|Overall Study|Lack of Efficacy|0|||
155546662|NCT03253094|561424397|FG002|Overall Study|Lack of Efficacy|2|||
155546663|NCT03253094|561424398|FG003|Overall Study|Lack of Efficacy|1|||
155546664|NCT03253094|561424399|FG004|Overall Study|Lack of Efficacy|2|||
155546665|NCT03253094|561424400|FG005|Overall Study|Lack of Efficacy|1|||
155546666|NCT03253094|561424395|FG000|Overall Study|Lost to Follow-up|0|||
155546667|NCT03253094|561424396|FG001|Overall Study|Lost to Follow-up|0|||
155546668|NCT03253094|561424397|FG002|Overall Study|Lost to Follow-up|1|||
155546669|NCT03253094|561424398|FG003|Overall Study|Lost to Follow-up|1|||
155546670|NCT03253094|561424399|FG004|Overall Study|Lost to Follow-up|0|||
155546671|NCT03253094|561424400|FG005|Overall Study|Lost to Follow-up|1|||
155546672|NCT03253094|561424395|FG000|Overall Study|Physician Decision|1|||
155546673|NCT03253094|561424396|FG001|Overall Study|Physician Decision|0|||
155546674|NCT03253094|561424397|FG002|Overall Study|Physician Decision|0|||
155546675|NCT03253094|561424398|FG003|Overall Study|Physician Decision|1|||
155546676|NCT03253094|561424399|FG004|Overall Study|Physician Decision|0|||
155546677|NCT03253094|561424400|FG005|Overall Study|Physician Decision|2|||
155546678|NCT03253094|561424395|FG000|Overall Study|Withdrawal by Subject|1|||
155546679|NCT03253094|561424396|FG001|Overall Study|Withdrawal by Subject|2|||
155546680|NCT03253094|561424397|FG002|Overall Study|Withdrawal by Subject|1|||
155546681|NCT03253094|561424398|FG003|Overall Study|Withdrawal by Subject|0|||
155546682|NCT03253094|561424399|FG004|Overall Study|Withdrawal by Subject|3|||
155546683|NCT03253094|561424400|FG005|Overall Study|Withdrawal by Subject|0|||
155546684|NCT03253094|561424395|FG000|Overall Study|Other|0|||
155546685|NCT03253094|561424396|FG001|Overall Study|Other|1|||
155546686|NCT03253094|561424397|FG002|Overall Study|Other|2|||
155546687|NCT03253094|561424398|FG003|Overall Study|Other|1|||
155546688|NCT03253094|561424399|FG004|Overall Study|Other|0|||
155546689|NCT03253094|561424400|FG005|Overall Study|Other|0|||
155546690|NCT02219308|561424401|FG000|Overall Study|Withdrawal by Subject|1|||
155546691|NCT02219308|561424402|FG001|Overall Study|Withdrawal by Subject|2|||
155546692|NCT00824369|561424403|FG000|Overall Study|Nolonger willing to participate in study|1|||
155546693|NCT00824369|561424404|FG001|Overall Study|Nolonger willing to participate in study|0|||
155546694|NCT00824369|561424405|FG002|Overall Study|Nolonger willing to participate in study|1|||
155546695|NCT00824369|561424406|FG003|Overall Study|Nolonger willing to participate in study|2|||
155546696|NCT00824369|561424407|FG004|Overall Study|Nolonger willing to participate in study|0|||
155546697|NCT00824369|561424408|FG005|Overall Study|Nolonger willing to participate in study|1|||
155546698|NCT00824369|561424403|FG000|Overall Study|Lost to Follow-up|0|||
155546699|NCT00824369|561424404|FG001|Overall Study|Lost to Follow-up|0|||
155546700|NCT00824369|561424405|FG002|Overall Study|Lost to Follow-up|0|||
155546701|NCT00824369|561424406|FG003|Overall Study|Lost to Follow-up|0|||
155546702|NCT00824369|561424407|FG004|Overall Study|Lost to Follow-up|1|||
155546703|NCT00824369|561424408|FG005|Overall Study|Lost to Follow-up|0|||
155546704|NCT00442546|561424409|FG000|Overall Study|Adverse Event|11|||
155546705|NCT00442546|561424410|FG001|Overall Study|Adverse Event|17|||
155546706|NCT00442546|561424411|FG002|Overall Study|Adverse Event|13|||
155546707|NCT00442546|561424409|FG000|Overall Study|Lost to Follow-up|1|||
155546708|NCT00442546|561424410|FG001|Overall Study|Lost to Follow-up|2|||
155546709|NCT00442546|561424411|FG002|Overall Study|Lost to Follow-up|1|||
155546710|NCT00442546|561424409|FG000|Overall Study|Other|4|||
155546711|NCT00442546|561424410|FG001|Overall Study|Other|9|||
155546712|NCT00442546|561424411|FG002|Overall Study|Other|6|||
155546713|NCT00442546|561424409|FG000|Overall Study|Withdrawal by Subject|5|||
155546714|NCT00442546|561424410|FG001|Overall Study|Withdrawal by Subject|5|||
155546715|NCT00442546|561424411|FG002|Overall Study|Withdrawal by Subject|7|||
155546716|NCT00442546|561424409|FG000|Overall Study|Randomized But Not Treated|5|||
155546717|NCT00442546|561424410|FG001|Overall Study|Randomized But Not Treated|4|||
155546718|NCT00442546|561424411|FG002|Overall Study|Randomized But Not Treated|6|||
155546719|NCT01557582|561424414|FG000|Overall Study|Protocol Violation|4|||
155546720|NCT01557582|561424414|FG000|Overall Study|Operator error|2|||
155546721|NCT02843659|561424415|FG000|Overall Study|Subject Withdrew Consent|0|||
155546722|NCT02843659|561424416|FG001|Overall Study|Subject Withdrew Consent|0|||
155546723|NCT02843659|561424417|FG002|Overall Study|Subject Withdrew Consent|1|||
155546724|NCT02843659|561424415|FG000|Overall Study|Administrative Reason by Sponsor|4|||
155546725|NCT02843659|561424416|FG001|Overall Study|Administrative Reason by Sponsor|5|||
155546726|NCT02843659|561424417|FG002|Overall Study|Administrative Reason by Sponsor|4|||
155546727|NCT02843659|561424415|FG000|Overall Study|Adverse Event|0|||
155546728|NCT02843659|561424416|FG001|Overall Study|Adverse Event|1|||
155546729|NCT02843659|561424417|FG002|Overall Study|Adverse Event|0|||
155546730|NCT03203642|561424418|FG000|Overall Study|Adverse Event|3|||
155546731|NCT03203642|561424419|FG001|Overall Study|Adverse Event|1|||
155546732|NCT03203642|561424418|FG000|Overall Study|Withdrawal by Subject|6|||
155546733|NCT03203642|561424419|FG001|Overall Study|Withdrawal by Subject|6|||
155546734|NCT03203642|561424418|FG000|Overall Study|Lost to Follow-up|2|||
155546735|NCT03203642|561424419|FG001|Overall Study|Lost to Follow-up|1|||
155546736|NCT03203642|561424418|FG000|Overall Study|Termination of the study by sponsor|1|||
155546737|NCT03203642|561424419|FG001|Overall Study|Termination of the study by sponsor|1|||
155546738|NCT03203642|561424418|FG000|Overall Study|Participant moved|0|||
155546739|NCT03203642|561424419|FG001|Overall Study|Participant moved|1|||
155546740|NCT03203642|561424418|FG000|Overall Study|Investigator's decision|3|||
155546741|NCT03203642|561424419|FG001|Overall Study|Investigator's decision|0|||
155546742|NCT03203642|561424418|FG000|Overall Study|Other than above specified|0|||
155546743|NCT03203642|561424419|FG001|Overall Study|Other than above specified|1|||
155546744|NCT02413294|561424420|FG000|Overall Study|Withdrawal by Subject|1|||
155546745|NCT04149535|561424424|FG000|Overall Study|Death|11|||
155546746|NCT04149535|561424425|FG001|Overall Study|Death|7|||
155546747|NCT04149535|561424424|FG000|Overall Study|Physician Decision|10|||
155546748|NCT04149535|561424425|FG001|Overall Study|Physician Decision|4|||
155546749|NCT04149535|561424424|FG000|Overall Study|Withdrawal by Subject|6|||
155546750|NCT04149535|561424425|FG001|Overall Study|Withdrawal by Subject|7|||
155546751|NCT04149535|561424424|FG000|Overall Study|Not described|2|||
155546752|NCT04149535|561424425|FG001|Overall Study|Not described|0|||
155546753|NCT02175368|561424426|FG000|Overall Study|Lost to Follow-up|1|||
155546754|NCT02875028|561424427|FG000|Washout Period|Withdrawal by Subject|0|||
155546755|NCT02875028|561424428|FG001|Washout Period|Withdrawal by Subject|1|||
155546756|NCT05068284|561424429|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
155546757|NCT05068284|561424430|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
155546758|NCT05068284|561424431|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546759|NCT05068284|561424432|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546760|NCT05068284|561424433|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546761|NCT05068284|561424434|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546762|NCT05068284|561424435|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546763|NCT05068284|561424436|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
155546764|NCT05068284|561424429|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546765|NCT05068284|561424430|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546766|NCT05068284|561424431|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
155546767|NCT05068284|561424432|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546768|NCT05068284|561424433|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546769|NCT05068284|561424434|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546770|NCT05068284|561424435|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546771|NCT05068284|561424436|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
155546772|NCT05068284|561424429|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
155546773|NCT05068284|561424430|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
155546774|NCT05068284|561424431|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
155546775|NCT05068284|561424432|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
155546776|NCT05068284|561424433|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
155546777|NCT05068284|561424434|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
155546778|NCT05068284|561424435|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
155546779|NCT05068284|561424436|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
155546780|NCT05068284|561424429|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546781|NCT05068284|561424430|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546782|NCT05068284|561424431|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
155546783|NCT05068284|561424432|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546784|NCT05068284|561424433|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
155546785|NCT05068284|561424434|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546786|NCT05068284|561424435|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546787|NCT05068284|561424436|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
155546788|NCT05068284|561424429|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546789|NCT05068284|561424430|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546790|NCT05068284|561424431|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546791|NCT05068284|561424432|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
155546792|NCT05068284|561424433|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546793|NCT05068284|561424434|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546794|NCT05068284|561424435|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546795|NCT05068284|561424436|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
155546796|NCT05068284|561424429|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546797|NCT05068284|561424430|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546798|NCT05068284|561424431|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
155546799|NCT05068284|561424432|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
155546800|NCT05068284|561424433|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546801|NCT05068284|561424434|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546802|NCT05068284|561424435|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546803|NCT05068284|561424436|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
155546804|NCT05068284|561424429|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546805|NCT05068284|561424430|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546806|NCT05068284|561424431|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
155546807|NCT05068284|561424432|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546808|NCT05068284|561424433|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546809|NCT05068284|561424434|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546810|NCT05068284|561424435|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546811|NCT05068284|561424436|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
155546812|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
155546813|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546814|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546815|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546816|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546817|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546818|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546819|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
155546820|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
155546821|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
155546822|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
155546823|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
155546824|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
155546825|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
155546826|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
155546827|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
155546828|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
155546829|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546830|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546831|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546832|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546833|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546834|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
155546835|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155546836|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
155546837|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546838|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546839|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155656895|NCT03485157|561837475|FG001|Open Label Phase|Lost to Follow-up|2|||
155546840|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546841|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546842|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546843|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
155546844|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
155546845|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546846|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546847|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155656896|NCT03485157|561837474|FG000|Open Label Phase|Adverse Event|0|||
155656897|NCT03485157|561837475|FG001|Open Label Phase|Adverse Event|1|||
155656898|NCT03485157|561837474|FG000|Open Label Phase|Withdrawal by Subject|1|||
155656899|NCT03485157|561837475|FG001|Open Label Phase|Withdrawal by Subject|2|||
155656900|NCT03485157|561837474|FG000|Open Label Phase|Removal by PI|2|||
155656901|NCT03485157|561837475|FG001|Open Label Phase|Removal by PI|0|||
155656902|NCT01849276|561837476|FG000|Followed for Survival for 5 Years|Death|1|||
155656903|NCT01849276|561837476|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
155656904|NCT05081843|561837485|FG000|Overall Study|Lost to Follow-up|135|||
155656905|NCT05081843|561837486|FG001|Overall Study|Lost to Follow-up|145|||
155656906|NCT00050011|561837488|FG000|Overall Study|Adverse Event|41|||
155656907|NCT00050011|561837489|FG001|Overall Study|Adverse Event|46|||
155656908|NCT00050011|561837488|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155656909|NCT00050011|561837489|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155656910|NCT00050011|561837488|FG000|Overall Study|Abnormal test procedure results|0|||
155656911|NCT00050011|561837489|FG001|Overall Study|Abnormal test procedure results|1|||
155656912|NCT00050011|561837488|FG000|Overall Study|Lack of Efficacy|16|||
155656913|NCT00050011|561837489|FG001|Overall Study|Lack of Efficacy|21|||
155656914|NCT00050011|561837488|FG000|Overall Study|Participant condition no longer required|1|||
155656915|NCT00050011|561837489|FG001|Overall Study|Participant condition no longer required|0|||
155656916|NCT00050011|561837488|FG000|Overall Study|Protocol Violation|4|||
155656917|NCT00050011|561837489|FG001|Overall Study|Protocol Violation|10|||
155656918|NCT00050011|561837488|FG000|Overall Study|Withdrawal by Subject|34|||
155656919|NCT00050011|561837489|FG001|Overall Study|Withdrawal by Subject|26|||
155656920|NCT00050011|561837488|FG000|Overall Study|Lost to Follow-up|7|||
155656921|NCT00050011|561837489|FG001|Overall Study|Lost to Follow-up|9|||
155656922|NCT00050011|561837488|FG000|Overall Study|Administrative problems|10|||
155656923|NCT00050011|561837489|FG001|Overall Study|Administrative problems|6|||
155656924|NCT00050011|561837488|FG000|Overall Study|Death|7|||
155656925|NCT00050011|561837489|FG001|Overall Study|Death|4|||
155656926|NCT00050011|561837488|FG000|Overall Study|Unknown - Reason is missing|0|||
155656927|NCT00050011|561837489|FG001|Overall Study|Unknown - Reason is missing|2|||
155656928|NCT00835354|561837490|FG000|First Intervention|Adverse Event|0|||
155656929|NCT00835354|561837491|FG001|First Intervention|Adverse Event|1|||
155656930|NCT03648372|561837503|FG000|Overall Study|Withdrawal by Subject|2|||
155656931|NCT03648372|561837504|FG001|Overall Study|Withdrawal by Subject|0|||
155656932|NCT03648372|561837505|FG002|Overall Study|Withdrawal by Subject|0|||
155656933|NCT03648372|561837506|FG003|Overall Study|Withdrawal by Subject|0|||
155656934|NCT03648372|561837507|FG004|Overall Study|Withdrawal by Subject|0|||
155656935|NCT03648372|561837508|FG005|Overall Study|Withdrawal by Subject|1|||
155546848|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546849|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546850|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546851|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
155546852|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
155546853|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
155546854|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
155546855|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
155546856|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
155546857|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
155546858|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
155546859|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
155546860|NCT05068284|561424429|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
155546861|NCT05068284|561424430|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
155546862|NCT05068284|561424431|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
155546863|NCT05068284|561424432|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
155656936|NCT03648372|561837509|FG006|Overall Study|Withdrawal by Subject|2|||
155656937|NCT03648372|561837510|FG007|Overall Study|Withdrawal by Subject|0|||
155546864|NCT05068284|561424433|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
155546865|NCT05068284|561424434|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
155656938|NCT03648372|561837511|FG008|Overall Study|Withdrawal by Subject|0|||
155656939|NCT03648372|561837512|FG009|Overall Study|Withdrawal by Subject|0|||
155656940|NCT03648372|561837513|FG010|Overall Study|Withdrawal by Subject|2|||
155656941|NCT03648372|561837514|FG011|Overall Study|Withdrawal by Subject|0|||
155656942|NCT03648372|561837515|FG012|Overall Study|Withdrawal by Subject|2|||
155656943|NCT03648372|561837516|FG013|Overall Study|Withdrawal by Subject|0|||
155656944|NCT03648372|561837517|FG014|Overall Study|Withdrawal by Subject|0|||
155656945|NCT03648372|561837518|FG015|Overall Study|Withdrawal by Subject|0|||
155656946|NCT03648372|561837519|FG016|Overall Study|Withdrawal by Subject|1|||
155656947|NCT03648372|561837520|FG017|Overall Study|Withdrawal by Subject|0|||
155546866|NCT05068284|561424435|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
155546867|NCT05068284|561424436|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
155546868|NCT00109837|561426110|FG000|Overall Study|Adverse Event|2|||
155546869|NCT00109837|561426110|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
155546870|NCT00109837|561426110|FG000|Overall Study|Death|1|||
155546871|NCT00109837|561426110|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
155546872|NCT00109837|561426110|FG000|Overall Study|Not treated|1|||
155546873|NCT00109837|561426110|FG000|Overall Study|Ineligible|1|||
155546874|NCT02012452|561426113|FG000|Overall Study|Lost to Follow-up|2|||
155546875|NCT02012452|561426114|FG001|Overall Study|Lost to Follow-up|1|||
155546876|NCT02012452|561426113|FG000|Overall Study|Withdrawal by Subject|4|||
155546877|NCT02012452|561426114|FG001|Overall Study|Withdrawal by Subject|0|||
155546878|NCT02190279|561426115|FG000|Overall Study|Withdrawal consent|1|||
155546879|NCT02190279|561426116|FG001|Overall Study|Withdrawal consent|0|||
155546880|NCT02190279|561426117|FG002|Overall Study|Withdrawal consent|1|||
155546881|NCT02190279|561426115|FG000|Overall Study|Lost to Follow-up|2|||
155546882|NCT02190279|561426116|FG001|Overall Study|Lost to Follow-up|0|||
155546883|NCT02190279|561426117|FG002|Overall Study|Lost to Follow-up|0|||
155546884|NCT02190279|561426115|FG000|Overall Study|Refused further treatment|0|||
155546885|NCT02190279|561426116|FG001|Overall Study|Refused further treatment|0|||
155546886|NCT02190279|561426117|FG002|Overall Study|Refused further treatment|1|||
155546887|NCT02190279|561426115|FG000|Overall Study|Screening failure|0|||
155546888|NCT02190279|561426116|FG001|Overall Study|Screening failure|0|||
155546889|NCT02190279|561426117|FG002|Overall Study|Screening failure|1|||
155546890|NCT04403399|561426118|FG000|Period 2|Physician Decision|0|||
155546891|NCT04403399|561426119|FG001|Period 2|Physician Decision|1|||
155546892|NCT00802178|561426120|FG000|Overall Study|Lack of Efficacy|36|||
155546893|NCT00802178|561426120|FG000|Overall Study|Insufficient tolerability (IT)|17|||
155546894|NCT00802178|561426120|FG000|Overall Study|Withdrawal by Subject|18|||
155546895|NCT00802178|561426120|FG000|Overall Study|Other|32|||
155546896|NCT00802178|561426120|FG000|Overall Study|Lack of efficacy and patient wish|1|||
155546897|NCT00802178|561426120|FG000|Overall Study|IT and patient wish|8|||
155546898|NCT00802178|561426120|FG000|Overall Study|Patients wish and other reason|1|||
155546899|NCT01606228|561426121|FG000|Overall Study|Lost to Follow-up|20|||
155546900|NCT01606228|561426121|FG000|Overall Study|Withdrawal by Subject|3|||
155546901|NCT01606228|561426121|FG000|Overall Study|Non-compliant|3|||
155546902|NCT01606228|561426121|FG000|Overall Study|Lack of Efficacy|2|||
155546903|NCT01606228|561426121|FG000|Overall Study|Adverse Event|1|||
155546904|NCT00831233|561426122|FG000|Overall Study|Adverse Event|0|||
155546905|NCT00831233|561426123|FG001|Overall Study|Adverse Event|1|||
155546906|NCT00831233|561426122|FG000|Overall Study|Protocol Violation|1|||
155546907|NCT00831233|561426123|FG001|Overall Study|Protocol Violation|0|||
155546908|NCT00831233|561426122|FG000|Overall Study|Selection Criteria Not Met|2|||
155546909|NCT00831233|561426123|FG001|Overall Study|Selection Criteria Not Met|0|||
155546910|NCT00784134|561426124|FG000|Overall Study|Lost to Follow-up|3|||
155546911|NCT00784134|561426125|FG001|Overall Study|Lost to Follow-up|6|||
155546912|NCT03785145|561426126|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
155546913|NCT03785145|561426127|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
155546914|NCT03785145|561426126|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
155546915|NCT03785145|561426127|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
155546916|NCT03785145|561426126|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
155546917|NCT03785145|561426127|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
155546918|NCT03785145|561426126|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
155546919|NCT03785145|561426127|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
155546920|NCT03785145|561426126|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
155546921|NCT03785145|561426127|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
155546922|NCT03785145|561426126|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
155546923|NCT03785145|561426127|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
155546924|NCT03785145|561426126|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
155546925|NCT03785145|561426127|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
155546926|NCT03785145|561426126|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
155546927|NCT03785145|561426127|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
155546928|NCT03785145|561426126|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
155546929|NCT03785145|561426127|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
155546930|NCT03785145|561426126|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
155546931|NCT03785145|561426127|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
155546932|NCT03785145|561426126|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
155546933|NCT03785145|561426127|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
155546934|NCT02211014|561426128|FG000|Overall Study|Adverse Event|0|||
155546935|NCT02211014|561426129|FG001|Overall Study|Adverse Event|2|||
155546936|NCT02211014|561426128|FG000|Overall Study|Physician Decision|1|||
155546937|NCT02211014|561426129|FG001|Overall Study|Physician Decision|2|||
155546938|NCT02211014|561426128|FG000|Overall Study|Started another cancer therapy|1|||
155546939|NCT02211014|561426129|FG001|Overall Study|Started another cancer therapy|0|||
155546940|NCT02211014|561426128|FG000|Overall Study|Withdrawal by Subject|0|||
155546941|NCT02211014|561426129|FG001|Overall Study|Withdrawal by Subject|1|||
155546942|NCT02211014|561426128|FG000|Overall Study|In agreement with patient, no benefit|0|||
155546943|NCT02211014|561426129|FG001|Overall Study|In agreement with patient, no benefit|1|||
155546944|NCT00097786|561426130|FG000|Overall Study|lost to follow-up for all-cause death|296|||
155546945|NCT00097786|561426131|FG001|Overall Study|lost to follow-up for all-cause death|292|||
155546946|NCT00097786|561426132|FG002|Overall Study|lost to follow-up for all-cause death|313|||
155546947|NCT00097786|561426133|FG003|Overall Study|lost to follow-up for all-cause death|310|||
155546948|NCT02443324|561426135|FG000|Overall Study|Death|4|||
155546949|NCT02443324|561426136|FG001|Overall Study|Death|1|||
155546950|NCT02443324|561426137|FG002|Overall Study|Death|0|||
155546951|NCT02443324|561426138|FG003|Overall Study|Death|3|||
155546952|NCT02443324|561426139|FG004|Overall Study|Death|1|||
155546953|NCT02443324|561426140|FG005|Overall Study|Death|3|||
155546954|NCT02443324|561426141|FG006|Overall Study|Death|2|||
155546955|NCT02443324|561426135|FG000|Overall Study|Lost to Follow-up|0|||
155546956|NCT02443324|561426136|FG001|Overall Study|Lost to Follow-up|0|||
155546957|NCT02443324|561426137|FG002|Overall Study|Lost to Follow-up|0|||
155546958|NCT02443324|561426138|FG003|Overall Study|Lost to Follow-up|1|||
155546959|NCT02443324|561426139|FG004|Overall Study|Lost to Follow-up|0|||
155546960|NCT02443324|561426140|FG005|Overall Study|Lost to Follow-up|1|||
155546961|NCT02443324|561426141|FG006|Overall Study|Lost to Follow-up|0|||
155546962|NCT02443324|561426135|FG000|Overall Study|Physician Decision|0|||
155546963|NCT02443324|561426136|FG001|Overall Study|Physician Decision|3|||
155546964|NCT02443324|561426137|FG002|Overall Study|Physician Decision|5|||
155546965|NCT02443324|561426138|FG003|Overall Study|Physician Decision|1|||
155546966|NCT02443324|561426139|FG004|Overall Study|Physician Decision|1|||
155546967|NCT02443324|561426140|FG005|Overall Study|Physician Decision|0|||
155546968|NCT02443324|561426141|FG006|Overall Study|Physician Decision|2|||
155546969|NCT02443324|561426135|FG000|Overall Study|Progressive Disease|20|||
155546970|NCT02443324|561426136|FG001|Overall Study|Progressive Disease|20|||
155546971|NCT02443324|561426137|FG002|Overall Study|Progressive Disease|13|||
155546972|NCT02443324|561426138|FG003|Overall Study|Progressive Disease|10|||
155546973|NCT02443324|561426139|FG004|Overall Study|Progressive Disease|13|||
155546974|NCT02443324|561426140|FG005|Overall Study|Progressive Disease|17|||
155546975|NCT02443324|561426141|FG006|Overall Study|Progressive Disease|10|||
155546976|NCT02443324|561426135|FG000|Overall Study|Withdrawal by Subject|0|||
155546977|NCT02443324|561426136|FG001|Overall Study|Withdrawal by Subject|0|||
155546978|NCT02443324|561426137|FG002|Overall Study|Withdrawal by Subject|3|||
155546979|NCT02443324|561426138|FG003|Overall Study|Withdrawal by Subject|1|||
155546980|NCT02443324|561426139|FG004|Overall Study|Withdrawal by Subject|1|||
155546981|NCT02443324|561426140|FG005|Overall Study|Withdrawal by Subject|0|||
155546982|NCT02443324|561426141|FG006|Overall Study|Withdrawal by Subject|1|||
155546983|NCT02443324|561426135|FG000|Overall Study|Adverse Event|0|||
155546984|NCT02443324|561426136|FG001|Overall Study|Adverse Event|1|||
155546985|NCT02443324|561426137|FG002|Overall Study|Adverse Event|3|||
155546986|NCT02443324|561426138|FG003|Overall Study|Adverse Event|0|||
155546987|NCT02443324|561426139|FG004|Overall Study|Adverse Event|4|||
155546988|NCT02443324|561426140|FG005|Overall Study|Adverse Event|3|||
155546989|NCT02443324|561426141|FG006|Overall Study|Adverse Event|3|||
155546990|NCT02443324|561426135|FG000|Overall Study|Enrolled but Never Treated|0|||
155546991|NCT02443324|561426136|FG001|Overall Study|Enrolled but Never Treated|0|||
155546992|NCT02443324|561426137|FG002|Overall Study|Enrolled but Never Treated|1|||
155546993|NCT02443324|561426138|FG003|Overall Study|Enrolled but Never Treated|0|||
155546994|NCT02443324|561426139|FG004|Overall Study|Enrolled but Never Treated|1|||
155546995|NCT02443324|561426140|FG005|Overall Study|Enrolled but Never Treated|0|||
155546996|NCT02443324|561426141|FG006|Overall Study|Enrolled but Never Treated|1|||
155546997|NCT01647711|561426142|FG000|Overall Study|Progressive disease|6|||
155546998|NCT01647711|561426143|FG001|Overall Study|Progressive disease|2|||
155546999|NCT01647711|561426144|FG002|Overall Study|Progressive disease|6|||
155547000|NCT01647711|561426145|FG003|Overall Study|Progressive disease|8|||
155547001|NCT01647711|561426146|FG004|Overall Study|Progressive disease|2|||
155547002|NCT01647711|561426142|FG000|Overall Study|Other adverse event|0|||
155547003|NCT01647711|561426143|FG001|Overall Study|Other adverse event|0|||
155547004|NCT01647711|561426144|FG002|Overall Study|Other adverse event|2|||
155547005|NCT01647711|561426145|FG003|Overall Study|Other adverse event|0|||
155547006|NCT01647711|561426146|FG004|Overall Study|Other adverse event|2|||
155547007|NCT01647711|561426142|FG000|Overall Study|Protocol Violation|0|||
155547008|NCT01647711|561426143|FG001|Overall Study|Protocol Violation|0|||
155547009|NCT01647711|561426144|FG002|Overall Study|Protocol Violation|0|||
155547010|NCT01647711|561426145|FG003|Overall Study|Protocol Violation|0|||
155547011|NCT01647711|561426146|FG004|Overall Study|Protocol Violation|1|||
155547012|NCT01647711|561426142|FG000|Overall Study|Refused to continue taking medication|0|||
155547013|NCT01647711|561426143|FG001|Overall Study|Refused to continue taking medication|0|||
155547014|NCT01647711|561426144|FG002|Overall Study|Refused to continue taking medication|0|||
155547015|NCT01647711|561426145|FG003|Overall Study|Refused to continue taking medication|2|||
155547016|NCT01647711|561426146|FG004|Overall Study|Refused to continue taking medication|1|||
155547017|NCT01647711|561426142|FG000|Overall Study|Other reason not defined|0|||
155547018|NCT01647711|561426143|FG001|Overall Study|Other reason not defined|1|||
155547019|NCT01647711|561426144|FG002|Overall Study|Other reason not defined|1|||
155547020|NCT01647711|561426145|FG003|Overall Study|Other reason not defined|1|||
155547021|NCT01647711|561426146|FG004|Overall Study|Other reason not defined|0|||
155547022|NCT01316419|561426147|FG000|Overall Study|Not treated|103|||
155547023|NCT01316419|561426147|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
155547024|NCT01316419|561426147|FG000|Overall Study|Lost to Follow-up|19|||
155547025|NCT00988208|561426160|FG000|Overall Study|Adverse Event|71|||
155547026|NCT00988208|561426161|FG001|Overall Study|Adverse Event|122|||
155547027|NCT00988208|561426160|FG000|Overall Study|Disease Progression|103|||
155547028|NCT00988208|561426161|FG001|Overall Study|Disease Progression|89|||
155547029|NCT00988208|561426160|FG000|Overall Study|Withdrawal by Subject|50|||
155547030|NCT00988208|561426161|FG001|Overall Study|Withdrawal by Subject|57|||
155547031|NCT00988208|561426160|FG000|Overall Study|Death|9|||
155547032|NCT00988208|561426161|FG001|Overall Study|Death|15|||
155547033|NCT00988208|561426160|FG000|Overall Study|Lost to Follow-up|2|||
155547034|NCT00988208|561426161|FG001|Overall Study|Lost to Follow-up|3|||
155547035|NCT00988208|561426160|FG000|Overall Study|Protocol Violation|9|||
155547036|NCT00988208|561426161|FG001|Overall Study|Protocol Violation|2|||
155547037|NCT00988208|561426160|FG000|Overall Study|Sponsor Decision|102|||
155547038|NCT00988208|561426161|FG001|Overall Study|Sponsor Decision|78|||
155547039|NCT00988208|561426160|FG000|Overall Study|Clinical Progression|17|||
155547040|NCT00988208|561426161|FG001|Overall Study|Clinical Progression|16|||
155547041|NCT00988208|561426160|FG000|Overall Study|Biochemical Progression|21|||
155547042|NCT00988208|561426161|FG001|Overall Study|Biochemical Progression|7|||
155547043|NCT00988208|561426160|FG000|Overall Study|Clinical Deterioration|7|||
155547044|NCT00988208|561426161|FG001|Overall Study|Clinical Deterioration|14|||
155547045|NCT00988208|561426160|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
155547046|NCT00988208|561426161|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
155547047|NCT00988208|561426160|FG000|Overall Study|Other|8|||
155547048|NCT00988208|561426161|FG001|Overall Study|Other|3|||
155547049|NCT01796964|561426162|FG000|Overall Study|Adverse Event|1|||
155547050|NCT01796964|561426163|FG001|Overall Study|Adverse Event|1|||
155547051|NCT01796964|561426162|FG000|Overall Study|Death|1|||
155547052|NCT01796964|561426163|FG001|Overall Study|Death|0|||
155547053|NCT01796964|561426162|FG000|Overall Study|Protocol Violation|0|||
155547054|NCT01796964|561426163|FG001|Overall Study|Protocol Violation|1|||
155547055|NCT01796964|561426162|FG000|Overall Study|Withdrawal by Subject|1|||
155547056|NCT01796964|561426163|FG001|Overall Study|Withdrawal by Subject|1|||
155547057|NCT04025684|561426164|FG000|Overall Study|Withdrawal by Subject|1|||
155547058|NCT04025684|561426165|FG001|Overall Study|Withdrawal by Subject|1|||
155547059|NCT04025684|561426166|FG002|Overall Study|Withdrawal by Subject|0|||
155547060|NCT04025684|561426167|FG003|Overall Study|Withdrawal by Subject|0|||
155547061|NCT04025684|561426164|FG000|Overall Study|Multiple reasons|1|||
155547062|NCT04025684|561426165|FG001|Overall Study|Multiple reasons|3|||
155547063|NCT04025684|561426166|FG002|Overall Study|Multiple reasons|0|||
155547064|NCT04025684|561426167|FG003|Overall Study|Multiple reasons|1|||
155547065|NCT01613378|561426172|FG000|Overall Study|Lack of Efficacy|13|||
155547066|NCT01613378|561426172|FG000|Overall Study|Adverse Event|11|||
155547067|NCT01613378|561426172|FG000|Overall Study|Withdrawal by Subject|8|||
155547068|NCT01613378|561426172|FG000|Overall Study|Death|2|||
155547069|NCT01613378|561426172|FG000|Overall Study|Lost to Follow-up|1|||
155547070|NCT01613378|561426172|FG000|Overall Study|Other Reason|4|||
155547071|NCT02000531|561426173|FG000|Overall Study|Lost to Follow-up|1|||
155547072|NCT02000531|561426174|FG001|Overall Study|Lost to Follow-up|0|||
155547073|NCT02000531|561426173|FG000|Overall Study|Discontinued due to data cut-off|3|||
155547074|NCT02000531|561426174|FG001|Overall Study|Discontinued due to data cut-off|8|||
155547075|NCT00794417|561426175|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
155547076|NCT00794417|561426176|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
155547077|NCT00794417|561426177|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
155547078|NCT00794417|561426178|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
155547079|NCT00794417|561426175|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
155547080|NCT00794417|561426176|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
155547081|NCT00794417|561426177|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
155547082|NCT00794417|561426178|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
155547083|NCT00794417|561426175|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
155547084|NCT00794417|561426176|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
155547085|NCT00794417|561426177|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
155547086|NCT00794417|561426178|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
155547087|NCT00794417|561426175|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
155547088|NCT00794417|561426176|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
155547089|NCT00794417|561426177|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
155547090|NCT00794417|561426178|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
155547091|NCT00794417|561426175|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
155547092|NCT00794417|561426176|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
155547093|NCT00794417|561426177|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
155547094|NCT00794417|561426178|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
155547095|NCT00794417|561426175|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
155547096|NCT00794417|561426176|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
155547097|NCT00794417|561426177|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
155547098|NCT00794417|561426178|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
155547099|NCT00317642|561426179|FG000|Overall Study|Not Received Either Study Drug|1|||
155547100|NCT00317642|561426180|FG001|Overall Study|Not Received Either Study Drug|3|||
155547101|NCT00317642|561426179|FG000|Overall Study|Physician Decision|15|||
155547102|NCT00317642|561426180|FG001|Overall Study|Physician Decision|7|||
155547103|NCT00317642|561426179|FG000|Overall Study|Participant declined treatment|14|||
155547104|NCT00317642|561426180|FG001|Overall Study|Participant declined treatment|3|||
155547105|NCT00317642|561426179|FG000|Overall Study|Adverse Event|17|||
155547106|NCT00317642|561426180|FG001|Overall Study|Adverse Event|5|||
155547107|NCT00317642|561426179|FG000|Overall Study|Treatment Failure|56|||
155547108|NCT00317642|561426180|FG001|Overall Study|Treatment Failure|102|||
155547109|NCT00317642|561426179|FG000|Overall Study|Disease Recurrence|1|||
155547110|NCT00317642|561426180|FG001|Overall Study|Disease Recurrence|2|||
155547111|NCT00317642|561426179|FG000|Overall Study|Death|14|||
155547112|NCT00317642|561426180|FG001|Overall Study|Death|7|||
155547113|NCT00317642|561426179|FG000|Overall Study|Not Continue to Consolidation|2|||
155547114|NCT00317642|561426180|FG001|Overall Study|Not Continue to Consolidation|0|||
155547115|NCT00317642|561426179|FG000|Overall Study|Withdrawal by Subject|0|||
155547116|NCT00317642|561426180|FG001|Overall Study|Withdrawal by Subject|1|||
155547117|NCT00317642|561426179|FG000|Overall Study|Referred For Transplantation|1|||
155547118|NCT00317642|561426180|FG001|Overall Study|Referred For Transplantation|0|||
155547119|NCT00317642|561426179|FG000|Overall Study|AML Not Centrally Confirmed|1|||
155547120|NCT00317642|561426180|FG001|Overall Study|AML Not Centrally Confirmed|5|||
155547121|NCT00255151|561426181|FG000|Overall Study|Adverse Event|10|||
155547122|NCT00255151|561426182|FG001|Overall Study|Adverse Event|6|||
155547123|NCT00255151|561426183|FG002|Overall Study|Adverse Event|9|||
155547124|NCT00255151|561426181|FG000|Overall Study|Lost to Follow-up|4|||
155547125|NCT00255151|561426182|FG001|Overall Study|Lost to Follow-up|3|||
155547126|NCT00255151|561426183|FG002|Overall Study|Lost to Follow-up|4|||
155547127|NCT00255151|561426181|FG000|Overall Study|Withdrawal by Subject|18|||
155547128|NCT00255151|561426182|FG001|Overall Study|Withdrawal by Subject|17|||
155547129|NCT00255151|561426183|FG002|Overall Study|Withdrawal by Subject|8|||
155547130|NCT00255151|561426181|FG000|Overall Study|Noncompliance|0|||
155547131|NCT00255151|561426182|FG001|Overall Study|Noncompliance|1|||
155547132|NCT00255151|561426183|FG002|Overall Study|Noncompliance|2|||
155547133|NCT00255151|561426181|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
155547134|NCT00255151|561426182|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
155547135|NCT00255151|561426183|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
155547136|NCT00255151|561426181|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
155547137|NCT00255151|561426182|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
155547138|NCT00255151|561426183|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
155547139|NCT00255151|561426181|FG000|Overall Study|Possible Barrett's Esophagus|1|||
155547140|NCT00255151|561426182|FG001|Overall Study|Possible Barrett's Esophagus|3|||
155547141|NCT00255151|561426183|FG002|Overall Study|Possible Barrett's Esophagus|8|||
155547142|NCT00255151|561426181|FG000|Overall Study|Esophageal Stricture|0|||
155547143|NCT00255151|561426182|FG001|Overall Study|Esophageal Stricture|0|||
155547144|NCT00255151|561426183|FG002|Overall Study|Esophageal Stricture|1|||
155547145|NCT00255151|561426181|FG000|Overall Study|Therapeutic Failure|11|||
155547146|NCT00255151|561426182|FG001|Overall Study|Therapeutic Failure|2|||
155547147|NCT00255151|561426183|FG002|Overall Study|Therapeutic Failure|3|||
155547148|NCT03170869|561426197|FG000|Overall Study|Protocol Violation|5|||
155547149|NCT03170869|561426197|FG000|Overall Study|Early study termination|3|||
155547150|NCT01175473|561426202|FG000|Overall Study|Adverse Event|2|||
155547151|NCT01175473|561426203|FG001|Overall Study|Adverse Event|2|||
155547152|NCT03635983|561426206|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
155547153|NCT03635983|561426207|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
155547154|NCT03635983|561426206|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155547155|NCT03635983|561426207|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155547156|NCT03635983|561426206|FG000|Pre-Treatment Period|Other reasons|0|||
155547157|NCT03635983|561426207|FG001|Pre-Treatment Period|Other reasons|1|||
155547158|NCT03635983|561426206|FG000|Pre-Treatment Period|Disease Progression|0|||
155547159|NCT03635983|561426207|FG001|Pre-Treatment Period|Disease Progression|1|||
155547160|NCT03635983|561426206|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
155547161|NCT03635983|561426207|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
155547162|NCT03635983|561426206|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
155547163|NCT03635983|561426207|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
155547164|NCT03635983|561426206|FG000|Treatment Period|Withdrawal by Subject|3|||
155547165|NCT03635983|561426207|FG001|Treatment Period|Withdrawal by Subject|5|||
155547166|NCT03635983|561426206|FG000|Treatment Period|Death|3|||
155547167|NCT03635983|561426207|FG001|Treatment Period|Death|5|||
155547168|NCT03635983|561426206|FG000|Treatment Period|Poor/Non-compliance|2|||
155547169|NCT03635983|561426207|FG001|Treatment Period|Poor/Non-compliance|1|||
155547170|NCT03635983|561426206|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
155547171|NCT03635983|561426207|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
155547172|NCT03635983|561426206|FG000|Treatment Period|Other reasons|7|||
155547173|NCT03635983|561426207|FG001|Treatment Period|Other reasons|4|||
155547174|NCT03635983|561426206|FG000|Treatment Period|Disease progression|230|||
155547175|NCT03635983|561426207|FG001|Treatment Period|Disease progression|201|||
155547176|NCT03635983|561426206|FG000|Treatment Period|Study drug toxicity|35|||
155547177|NCT03635983|561426207|FG001|Treatment Period|Study drug toxicity|36|||
155547178|NCT03635983|561426206|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
155547179|NCT03635983|561426207|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
155547180|NCT03635983|561426206|FG000|Treatment Period|Maximum clinical benefit|3|||
155547181|NCT03635983|561426207|FG001|Treatment Period|Maximum clinical benefit|5|||
155547182|NCT03635983|561426206|FG000|Treatment Period|Administrative reason by the sponsor|1|||
155547183|NCT03635983|561426207|FG001|Treatment Period|Administrative reason by the sponsor|2|||
155547184|NCT03635983|561426206|FG000|Treatment Period|Lost to Follow-up|0|||
155547185|NCT03635983|561426207|FG001|Treatment Period|Lost to Follow-up|1|||
155547186|NCT01235442|561426208|FG000|Overall Study|Lost to Follow-up|12|||
155547187|NCT01235442|561426209|FG001|Overall Study|Lost to Follow-up|10|||
155547188|NCT01235442|561426208|FG000|Overall Study|Death|0|||
155547189|NCT01235442|561426209|FG001|Overall Study|Death|2|||
155547190|NCT01235442|561426208|FG000|Overall Study|Pregnancy|1|||
155547191|NCT01235442|561426209|FG001|Overall Study|Pregnancy|1|||
155547192|NCT01235442|561426208|FG000|Overall Study|Ineligibility determined|5|||
155547193|NCT01235442|561426209|FG001|Overall Study|Ineligibility determined|4|||
155547194|NCT01235442|561426208|FG000|Overall Study|Protocol Violation|3|||
155547195|NCT01235442|561426209|FG001|Overall Study|Protocol Violation|3|||
155547196|NCT01235442|561426208|FG000|Overall Study|Adverse Event|4|||
155547197|NCT01235442|561426209|FG001|Overall Study|Adverse Event|6|||
155547198|NCT01235442|561426208|FG000|Overall Study|Withdrawal by Subject|15|||
155547199|NCT01235442|561426209|FG001|Overall Study|Withdrawal by Subject|9|||
155547200|NCT01235442|561426208|FG000|Overall Study|Lack of Efficacy|1|||
155547201|NCT01235442|561426209|FG001|Overall Study|Lack of Efficacy|3|||
155547202|NCT01235442|561426208|FG000|Overall Study|Noncompliance|1|||
155547203|NCT01235442|561426209|FG001|Overall Study|Noncompliance|2|||
155547204|NCT01235442|561426208|FG000|Overall Study|Administrative decision|1|||
155547205|NCT01235442|561426209|FG001|Overall Study|Administrative decision|2|||
155547206|NCT01235442|561426208|FG000|Overall Study|Other unspecified|1|||
155547207|NCT01235442|561426209|FG001|Overall Study|Other unspecified|2|||
155547208|NCT02663882|561426210|FG000|Overall Study|Lost to Follow-up|4|||
155547209|NCT02663882|561426211|FG001|Overall Study|Lost to Follow-up|2|||
155547210|NCT04449341|561426214|FG000|Overall Study|Protocol Violation|1|||
155547211|NCT04449341|561426215|FG001|Overall Study|Protocol Violation|0|||
155547212|NCT01020526|561426217|FG000|Overall Study|Withdrawal by Subject|5|||
155547213|NCT01020526|561426217|FG000|Overall Study|Other reasons|3|||
155547214|NCT01020526|561426217|FG000|Overall Study|Insufficient clinical response|3|||
155547215|NCT01020526|561426217|FG000|Overall Study|Lost to Follow-up|1|||
155547216|NCT01020526|561426217|FG000|Overall Study|Adverse Event|2|||
155547217|NCT03546647|561426218|FG000|Overall Study|Adverse Event|1|||
155547218|NCT03546647|561426219|FG001|Overall Study|Adverse Event|0|||
155547219|NCT00124462|561426220|FG000|Overall Study|Lost to Follow-up|3|||
155547220|NCT00124462|561426221|FG001|Overall Study|Lost to Follow-up|3|||
155547221|NCT00124462|561426220|FG000|Overall Study|Physician Decision|3|||
155547222|NCT00124462|561426221|FG001|Overall Study|Physician Decision|4|||
155547223|NCT00124462|561426220|FG000|Overall Study|Withdrawal by Subject|4|||
155547224|NCT00124462|561426221|FG001|Overall Study|Withdrawal by Subject|5|||
155547225|NCT00124462|561426220|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
155547226|NCT00124462|561426221|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
155547227|NCT03297294|561426222|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
155547228|NCT03297294|561426223|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
155547229|NCT03297294|561426224|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155547230|NCT03297294|561426225|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155547231|NCT03297294|561426226|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
155547232|NCT03297294|561426222|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
155547233|NCT03297294|561426223|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
155547234|NCT03297294|561426224|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155547235|NCT03297294|561426225|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155547236|NCT03297294|561426226|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
155547237|NCT03297294|561426222|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
155547238|NCT03297294|561426223|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
155547239|NCT03297294|561426224|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155547240|NCT03297294|561426225|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155547241|NCT03297294|561426226|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
155547242|NCT03297294|561426222|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
155547243|NCT03297294|561426223|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
155547244|NCT03297294|561426224|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155547245|NCT03297294|561426225|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155547246|NCT03297294|561426226|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
155547247|NCT03297294|561426222|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
155547248|NCT03297294|561426223|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
155547249|NCT03297294|561426224|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
155547250|NCT03297294|561426225|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
155547251|NCT03297294|561426226|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
155547252|NCT01396421|561426227|FG000|Overall Study|Lost to Follow-up|0|||
155547253|NCT01396421|561426228|FG001|Overall Study|Lost to Follow-up|0|||
155547254|NCT01396421|561426229|FG002|Overall Study|Lost to Follow-up|0|||
155547255|NCT01396421|561426230|FG003|Overall Study|Lost to Follow-up|1|||
155547256|NCT01396421|561426227|FG000|Overall Study|Adverse Event|17|||
155547257|NCT01396421|561426228|FG001|Overall Study|Adverse Event|15|||
155547258|NCT01396421|561426229|FG002|Overall Study|Adverse Event|12|||
155547259|NCT01396421|561426230|FG003|Overall Study|Adverse Event|32|||
155547260|NCT01396421|561426227|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155547261|NCT01396421|561426228|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
155547262|NCT01396421|561426229|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
155547263|NCT01396421|561426230|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
155547264|NCT01396421|561426227|FG000|Overall Study|Physician Decision|1|||
155547265|NCT01396421|561426228|FG001|Overall Study|Physician Decision|1|||
155547266|NCT01396421|561426229|FG002|Overall Study|Physician Decision|0|||
155547267|NCT01396421|561426230|FG003|Overall Study|Physician Decision|3|||
155547268|NCT01396421|561426227|FG000|Overall Study|Withdrawal by Subject|31|||
155547269|NCT01396421|561426228|FG001|Overall Study|Withdrawal by Subject|24|||
155547270|NCT01396421|561426229|FG002|Overall Study|Withdrawal by Subject|13|||
155547271|NCT01396421|561426230|FG003|Overall Study|Withdrawal by Subject|21|||
155547272|NCT01396421|561426227|FG000|Overall Study|Protocol Deviation|2|||
155547273|NCT01396421|561426228|FG001|Overall Study|Protocol Deviation|1|||
155547274|NCT01396421|561426229|FG002|Overall Study|Protocol Deviation|1|||
155547275|NCT01396421|561426230|FG003|Overall Study|Protocol Deviation|0|||
155547276|NCT01396421|561426227|FG000|Overall Study|Lack of Efficacy|7|||
155547277|NCT01396421|561426228|FG001|Overall Study|Lack of Efficacy|17|||
155547278|NCT01396421|561426229|FG002|Overall Study|Lack of Efficacy|7|||
155547279|NCT01396421|561426230|FG003|Overall Study|Lack of Efficacy|18|||
155547280|NCT03314662|561426231|FG000|Overall Study|Withdrawal by Subject|1|||
155547281|NCT03314662|561426232|FG001|Overall Study|Withdrawal by Subject|1|||
155547282|NCT03314662|561426233|FG002|Overall Study|Withdrawal by Subject|1|||
155547283|NCT03314662|561426231|FG000|Overall Study|Lost to Follow-up|5|||
155547284|NCT03314662|561426232|FG001|Overall Study|Lost to Follow-up|4|||
155547285|NCT03314662|561426233|FG002|Overall Study|Lost to Follow-up|4|||
155547286|NCT03314662|561426231|FG000|Overall Study|Death|2|||
155547287|NCT03314662|561426232|FG001|Overall Study|Death|0|||
155547288|NCT03314662|561426233|FG002|Overall Study|Death|0|||
155547289|NCT00925301|561426234|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
155547290|NCT00925301|561426235|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
155547291|NCT00925301|561426236|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
155547292|NCT00925301|561426237|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
155547293|NCT00925301|561426234|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
155547294|NCT00925301|561426235|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
155547295|NCT00925301|561426236|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
155547296|NCT00925301|561426237|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
155547297|NCT00925301|561426234|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
155547298|NCT00925301|561426235|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
155547299|NCT00925301|561426236|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
155547300|NCT00925301|561426237|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
155547301|NCT00925301|561426234|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
155547302|NCT00925301|561426235|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
155547303|NCT00925301|561426236|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
155547304|NCT00925301|561426237|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
155547305|NCT00925301|561426234|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
155547306|NCT00925301|561426235|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
155547307|NCT00925301|561426236|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
155547308|NCT00925301|561426237|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
155547309|NCT00925301|561426234|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
155547310|NCT00925301|561426235|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
155547311|NCT00925301|561426236|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
155547312|NCT00925301|561426237|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
155547313|NCT00925301|561426234|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
155547314|NCT00925301|561426235|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
155547315|NCT00925301|561426236|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
155547316|NCT00925301|561426237|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
155547317|NCT05766787|561426238|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
155547318|NCT05766787|561426239|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
155547319|NCT05766787|561426238|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
155547320|NCT05766787|561426239|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
155547321|NCT05766787|561426238|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
155547322|NCT05766787|561426239|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
155547323|NCT00438659|561426240|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
155547324|NCT00438659|561426241|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
155547325|NCT00438659|561426240|FG000|Overall Study|Cancel|5|||
155547326|NCT00438659|561426241|FG001|Overall Study|Cancel|2|||
155547327|NCT01867606|561426242|FG000|Overall Study|Withdrawal by Subject|10|||
155547328|NCT01867606|561426243|FG001|Overall Study|Withdrawal by Subject|14|||
155547329|NCT01867606|561426242|FG000|Overall Study|Protocol Violation|0|||
155547330|NCT01867606|561426243|FG001|Overall Study|Protocol Violation|1|||
155547331|NCT01588548|561426244|FG000|Overall Study|Withdrawal by Subject|0|||
155547332|NCT01588548|561426245|FG001|Overall Study|Withdrawal by Subject|1|||
155547333|NCT01588548|561426246|FG002|Overall Study|Withdrawal by Subject|1|||
155547334|NCT01588548|561426247|FG003|Overall Study|Withdrawal by Subject|1|||
155547335|NCT01588548|561426248|FG004|Overall Study|Withdrawal by Subject|2|||
155547336|NCT01588548|561426249|FG005|Overall Study|Withdrawal by Subject|3|||
155547337|NCT01588548|561426244|FG000|Overall Study|Adverse Event|0|||
155547338|NCT01588548|561426245|FG001|Overall Study|Adverse Event|0|||
155547339|NCT01588548|561426246|FG002|Overall Study|Adverse Event|1|||
155547340|NCT01588548|561426247|FG003|Overall Study|Adverse Event|2|||
155547341|NCT01588548|561426248|FG004|Overall Study|Adverse Event|1|||
155547342|NCT01588548|561426249|FG005|Overall Study|Adverse Event|0|||
155547343|NCT01588548|561426244|FG000|Overall Study|Condition Under Investigation Worsened|3|||
155547344|NCT01588548|561426245|FG001|Overall Study|Condition Under Investigation Worsened|6|||
155547345|NCT01588548|561426246|FG002|Overall Study|Condition Under Investigation Worsened|4|||
155547346|NCT01588548|561426247|FG003|Overall Study|Condition Under Investigation Worsened|4|||
155547347|NCT01588548|561426248|FG004|Overall Study|Condition Under Investigation Worsened|3|||
155547348|NCT01588548|561426249|FG005|Overall Study|Condition Under Investigation Worsened|3|||
155547349|NCT01169038|561426250|FG000|Overall Study|Death|1|||
155547350|NCT01169038|561426250|FG000|Overall Study|Adverse Event|5|||
155547351|NCT01169038|561426250|FG000|Overall Study|Required antibiotic administration|1|||
155547352|NCT02490800|561426251|FG000|Overall Study|Adverse Event|0|||
155547353|NCT02490800|561426252|FG001|Overall Study|Adverse Event|0|||
155547354|NCT02490800|561426253|FG002|Overall Study|Adverse Event|0|||
155547355|NCT02490800|561426254|FG003|Overall Study|Adverse Event|2|||
155547356|NCT02490800|561426255|FG004|Overall Study|Adverse Event|3|||
155547357|NCT02490800|561426256|FG005|Overall Study|Adverse Event|2|||
155547358|NCT02490800|561426257|FG006|Overall Study|Adverse Event|0|||
155547359|NCT02490800|561426258|FG007|Overall Study|Adverse Event|0|||
155547360|NCT02490800|561426259|FG008|Overall Study|Adverse Event|0|||
155547361|NCT02490800|561426260|FG009|Overall Study|Adverse Event|0|||
155547362|NCT02490800|561426261|FG010|Overall Study|Adverse Event|0|||
155547363|NCT02490800|561426262|FG011|Overall Study|Adverse Event|2|||
155547364|NCT02490800|561426263|FG012|Overall Study|Adverse Event|2|||
155547365|NCT02490800|561426251|FG000|Overall Study|Withdrawal by Subject|0|||
155547366|NCT02490800|561426252|FG001|Overall Study|Withdrawal by Subject|0|||
155547367|NCT02490800|561426253|FG002|Overall Study|Withdrawal by Subject|0|||
155547368|NCT02490800|561426254|FG003|Overall Study|Withdrawal by Subject|1|||
155547369|NCT02490800|561426255|FG004|Overall Study|Withdrawal by Subject|0|||
155547370|NCT02490800|561426256|FG005|Overall Study|Withdrawal by Subject|0|||
155547371|NCT02490800|561426257|FG006|Overall Study|Withdrawal by Subject|0|||
155547372|NCT02490800|561426258|FG007|Overall Study|Withdrawal by Subject|0|||
155547373|NCT02490800|561426259|FG008|Overall Study|Withdrawal by Subject|1|||
155547374|NCT02490800|561426260|FG009|Overall Study|Withdrawal by Subject|0|||
155547375|NCT02490800|561426261|FG010|Overall Study|Withdrawal by Subject|0|||
155547376|NCT02490800|561426262|FG011|Overall Study|Withdrawal by Subject|0|||
155547377|NCT02490800|561426263|FG012|Overall Study|Withdrawal by Subject|0|||
155547378|NCT02490800|561426251|FG000|Overall Study|Progressive disease|3|||
155547379|NCT02490800|561426252|FG001|Overall Study|Progressive disease|3|||
155547380|NCT02490800|561426253|FG002|Overall Study|Progressive disease|3|||
155547381|NCT02490800|561426254|FG003|Overall Study|Progressive disease|4|||
155547382|NCT02490800|561426255|FG004|Overall Study|Progressive disease|4|||
155547383|NCT02490800|561426256|FG005|Overall Study|Progressive disease|1|||
155547384|NCT02490800|561426257|FG006|Overall Study|Progressive disease|4|||
155547385|NCT02490800|561426258|FG007|Overall Study|Progressive disease|3|||
155547386|NCT02490800|561426259|FG008|Overall Study|Progressive disease|6|||
155547387|NCT02490800|561426260|FG009|Overall Study|Progressive disease|2|||
155547388|NCT02490800|561426261|FG010|Overall Study|Progressive disease|7|||
155547389|NCT02490800|561426262|FG011|Overall Study|Progressive disease|1|||
155547390|NCT02490800|561426263|FG012|Overall Study|Progressive disease|10|||
155547391|NCT02490800|561426251|FG000|Overall Study|Patient enrolled in post-trial access|0|||
155547392|NCT02490800|561426252|FG001|Overall Study|Patient enrolled in post-trial access|0|||
155547393|NCT02490800|561426253|FG002|Overall Study|Patient enrolled in post-trial access|0|||
155547394|NCT02490800|561426254|FG003|Overall Study|Patient enrolled in post-trial access|0|||
155547395|NCT02490800|561426255|FG004|Overall Study|Patient enrolled in post-trial access|0|||
155547396|NCT02490800|561426256|FG005|Overall Study|Patient enrolled in post-trial access|0|||
155547397|NCT02490800|561426257|FG006|Overall Study|Patient enrolled in post-trial access|0|||
155547398|NCT02490800|561426258|FG007|Overall Study|Patient enrolled in post-trial access|0|||
155547399|NCT02490800|561426259|FG008|Overall Study|Patient enrolled in post-trial access|0|||
155547400|NCT02490800|561426260|FG009|Overall Study|Patient enrolled in post-trial access|1|||
155547401|NCT02490800|561426261|FG010|Overall Study|Patient enrolled in post-trial access|1|||
155547402|NCT02490800|561426262|FG011|Overall Study|Patient enrolled in post-trial access|0|||
155547403|NCT02490800|561426263|FG012|Overall Study|Patient enrolled in post-trial access|6|||
155547404|NCT03257254|561426264|FG000|Overall Study|Withdrawal by Subject|7|||
155547405|NCT03257254|561426264|FG000|Overall Study|Lost to Follow-up|9|||
155547406|NCT03257254|561426264|FG000|Overall Study|Study discontinued by sponsor|5|||
155547407|NCT03365791|561426265|FG000|Overall Study|Adverse Event|5|||
155547408|NCT03365791|561426265|FG000|Overall Study|Death|1|||
155547409|NCT03365791|561426265|FG000|Overall Study|Lost to Follow-up|1|||
155547410|NCT03365791|561426265|FG000|Overall Study|Physician Decision|9|||
155547411|NCT03365791|561426265|FG000|Overall Study|Progressive disease|51|||
155547412|NCT03365791|561426265|FG000|Overall Study|Subject/guardian decision|5|||
155547413|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
155547414|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547415|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547416|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547417|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547418|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547419|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547420|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547421|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155547422|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
155547423|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547424|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547425|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547426|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547427|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547428|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547429|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547430|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
155547431|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
155547432|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547433|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547434|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547435|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547436|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547437|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547438|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547439|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
155547440|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
155547441|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547442|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547443|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547444|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547445|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547446|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547447|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547448|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
155547449|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
155547450|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547451|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547452|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547453|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547454|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547455|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547456|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547457|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
155547458|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
155547459|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547460|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547461|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547462|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547463|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547464|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547465|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547466|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155547467|NCT00739973|561426266|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
155547468|NCT00739973|561426267|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547469|NCT00739973|561426268|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547470|NCT00739973|561426269|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547471|NCT00739973|561426270|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547472|NCT00739973|561426271|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547473|NCT00739973|561426272|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547474|NCT00739973|561426273|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547475|NCT00739973|561426274|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
155547476|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
155547477|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
155547478|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
155547479|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
155547480|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
155547481|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
155547482|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
155547483|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
155547484|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
155547485|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547486|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547487|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547488|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547489|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
155547490|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547491|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547492|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
155547493|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
155547494|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
155547495|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
155547496|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547497|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547498|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547499|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547500|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547501|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547502|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
155547503|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
155547504|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
155547505|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
155547506|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
155547507|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
155547508|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
155547509|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
155547510|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
155547511|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
155547512|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547513|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547514|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
155547515|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547516|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547517|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547518|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547519|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547520|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
155547521|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
155547522|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
155547523|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
155547524|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
155547525|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
155547526|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
155547527|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
155547528|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
155547529|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
155547530|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
155547531|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
155547532|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
155547533|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
155547534|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
155547535|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
155547536|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
155547537|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
155547538|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
155547539|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547540|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547541|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547542|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547543|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547544|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547545|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
155547546|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547547|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155547548|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
155547549|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
155547550|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
155547551|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
155547552|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
155547553|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
155547554|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
155547555|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
155547556|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
155547557|NCT00739973|561426266|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547558|NCT00739973|561426267|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
155547559|NCT00739973|561426268|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547560|NCT00739973|561426269|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155656948|NCT03648372|561837521|FG018|Overall Study|Withdrawal by Subject|0|||
155656949|NCT03648372|561837522|FG019|Overall Study|Withdrawal by Subject|0|||
155656950|NCT03648372|561837523|FG020|Overall Study|Withdrawal by Subject|0|||
155656951|NCT03648372|561837503|FG000|Overall Study|Progressive Disease|2|||
155547561|NCT00739973|561426270|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547562|NCT00739973|561426271|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547563|NCT00739973|561426272|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
155547564|NCT00739973|561426273|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547565|NCT00739973|561426274|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
155547566|NCT01989676|561429194|FG000|Overall Study|Death|52|||
155547567|NCT01989676|561429195|FG001|Overall Study|Death|60|||
155547568|NCT01989676|561429194|FG000|Overall Study|Protocol Violation|2|||
155547569|NCT01989676|561429195|FG001|Overall Study|Protocol Violation|1|||
155547570|NCT01989676|561429194|FG000|Overall Study|Lost to Follow-up|8|||
155547571|NCT01989676|561429195|FG001|Overall Study|Lost to Follow-up|18|||
155547572|NCT01989676|561429194|FG000|Overall Study|No longer willing to participate in study|26|||
155547573|NCT01989676|561429195|FG001|Overall Study|No longer willing to participate in study|26|||
155547574|NCT01989676|561429194|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
155547575|NCT01989676|561429195|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
155547576|NCT01989676|561429194|FG000|Overall Study|Other|4|||
155547577|NCT01989676|561429195|FG001|Overall Study|Other|3|||
155547578|NCT02938442|561429196|FG000|Overall Study|Death|0|||
155547579|NCT02938442|561429197|FG001|Overall Study|Death|1|||
155547580|NCT02938442|561429196|FG000|Overall Study|Lost to Follow-up|0|||
155547581|NCT02938442|561429197|FG001|Overall Study|Lost to Follow-up|1|||
155547582|NCT02938442|561429196|FG000|Overall Study|Physician Decision|0|||
155547583|NCT02938442|561429197|FG001|Overall Study|Physician Decision|1|||
155547584|NCT02938442|561429196|FG000|Overall Study|Withdrawal by Subject|2|||
155547585|NCT02938442|561429197|FG001|Overall Study|Withdrawal by Subject|0|||
155547586|NCT01115855|561429198|FG000|Overall Study|Adverse Event|16|||
155547587|NCT01115855|561429199|FG001|Overall Study|Adverse Event|18|||
155547588|NCT01115855|561429198|FG000|Overall Study|Death|6|||
155547589|NCT01115855|561429199|FG001|Overall Study|Death|5|||
155547590|NCT01115855|561429198|FG000|Overall Study|Lab Abnormality|1|||
155547591|NCT01115855|561429199|FG001|Overall Study|Lab Abnormality|1|||
155547592|NCT01115855|561429198|FG000|Overall Study|Protocol Violation|0|||
155547593|NCT01115855|561429199|FG001|Overall Study|Protocol Violation|1|||
155547594|NCT01115855|561429198|FG000|Overall Study|Withdrawal by Subject|5|||
155547595|NCT01115855|561429199|FG001|Overall Study|Withdrawal by Subject|5|||
155547596|NCT01115855|561429198|FG000|Overall Study|Other|8|||
155547597|NCT01115855|561429199|FG001|Overall Study|Other|6|||
155547598|NCT00480324|561429200|FG000|Overall Study|Adverse Event|1|||
155547599|NCT00480324|561429201|FG001|Overall Study|Adverse Event|1|||
155547600|NCT00480324|561429200|FG000|Overall Study|Protocol Violation|0|||
155547601|NCT00480324|561429201|FG001|Overall Study|Protocol Violation|1|||
155547602|NCT00480324|561429200|FG000|Overall Study|Withdrawal by Subject|14|||
155547603|NCT00480324|561429201|FG001|Overall Study|Withdrawal by Subject|5|||
155547604|NCT00480324|561429200|FG000|Overall Study|Lost to Follow-up|17|||
155547605|NCT00480324|561429201|FG001|Overall Study|Lost to Follow-up|8|||
155547606|NCT00480324|561429200|FG000|Overall Study|Subject's mother pregnant|0|||
155547607|NCT00480324|561429201|FG001|Overall Study|Subject's mother pregnant|1|||
155547608|NCT00966381|561429202|FG000|Overall Study|Withdrawal by Subject|2|||
155547609|NCT00966381|561429203|FG001|Overall Study|Withdrawal by Subject|2|||
155547610|NCT01915940|561429204|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
155547611|NCT01915940|561429205|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
155547612|NCT01915940|561429206|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
155547613|NCT01915940|561429204|FG000|Treatment Period|Decision of Participant|0|||
155547614|NCT01915940|561429205|FG001|Treatment Period|Decision of Participant|1|||
155547615|NCT01915940|561429206|FG002|Treatment Period|Decision of Participant|3|||
155547616|NCT01915940|561429204|FG000|Treatment Period|Adverse Event|0|||
155547617|NCT01915940|561429205|FG001|Treatment Period|Adverse Event|9|||
155547618|NCT01915940|561429206|FG002|Treatment Period|Adverse Event|1|||
155547619|NCT01915940|561429204|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
155547620|NCT01915940|561429205|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
155547621|NCT01915940|561429206|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
155547622|NCT03686150|561429207|FG000|Overall Study|Withdrawal by Subject|1|||
155547623|NCT03686150|561429208|FG001|Overall Study|Withdrawal by Subject|1|||
155547624|NCT03686150|561429209|FG002|Overall Study|Withdrawal by Subject|1|||
155547625|NCT03686150|561429210|FG003|Overall Study|Withdrawal by Subject|0|||
155547626|NCT03686150|561429211|FG004|Overall Study|Withdrawal by Subject|1|||
155547627|NCT03686150|561429212|FG005|Overall Study|Withdrawal by Subject|2|||
155547628|NCT03686150|561429207|FG000|Overall Study|Physician Decision|1|||
155547629|NCT03686150|561429208|FG001|Overall Study|Physician Decision|0|||
155547630|NCT03686150|561429209|FG002|Overall Study|Physician Decision|0|||
155547631|NCT03686150|561429210|FG003|Overall Study|Physician Decision|0|||
155547632|NCT03686150|561429211|FG004|Overall Study|Physician Decision|0|||
155547633|NCT03686150|561429212|FG005|Overall Study|Physician Decision|1|||
155547634|NCT03686150|561429207|FG000|Overall Study|Lost to Follow-up|0|||
155547635|NCT03686150|561429208|FG001|Overall Study|Lost to Follow-up|1|||
155547636|NCT03686150|561429209|FG002|Overall Study|Lost to Follow-up|0|||
155547637|NCT03686150|561429210|FG003|Overall Study|Lost to Follow-up|0|||
155547638|NCT03686150|561429211|FG004|Overall Study|Lost to Follow-up|0|||
155547639|NCT03686150|561429212|FG005|Overall Study|Lost to Follow-up|0|||
155547640|NCT01844531|561429215|FG000|Overall Study|Withdrawal by Subject|0|||
155547641|NCT01844531|561429216|FG001|Overall Study|Withdrawal by Subject|1|||
155547642|NCT01844531|561429217|FG002|Overall Study|Withdrawal by Subject|0|||
155547643|NCT01844531|561429218|FG003|Overall Study|Withdrawal by Subject|0|||
155547644|NCT01345318|561429235|FG000|Overall Study|Adverse Event|16|||
155547645|NCT01345318|561429235|FG000|Overall Study|Lack of Efficacy|17|||
155547646|NCT01345318|561429235|FG000|Overall Study|Lost to Follow-up|2|||
155547647|NCT01345318|561429235|FG000|Overall Study|Protocol Violation|1|||
155547648|NCT01345318|561429235|FG000|Overall Study|Withdrawal by Subject|41|||
155547649|NCT01345318|561429235|FG000|Overall Study|Other|3|||
155547650|NCT00792623|561429237|FG000|Overall Study|Adverse Event|2|||
155547651|NCT00792623|561429237|FG000|Overall Study|Withdrawal by Subject|5|||
155547652|NCT01685073|561429238|FG000|Overall Study|Lost to Follow-up|6|||
155547653|NCT01685073|561429239|FG001|Overall Study|Lost to Follow-up|8|||
155547654|NCT01685073|561429238|FG000|Overall Study|Withdrawal by Subject|24|||
155547655|NCT01685073|561429239|FG001|Overall Study|Withdrawal by Subject|24|||
155547656|NCT00880087|561429242|FG000|Overall Study|Lost to Follow-up|0|||
155547657|NCT00880087|561429243|FG001|Overall Study|Lost to Follow-up|2|||
155656952|NCT03648372|561837504|FG001|Overall Study|Progressive Disease|3|||
155547658|NCT00743509|561429244|FG000|Overall Study|Withdrawal by Subject|2|||
155547659|NCT01239472|561429245|FG000|Overall Study|Withdrawal by Subject|5|||
155547660|NCT01239472|561429246|FG001|Overall Study|Withdrawal by Subject|1|||
155656953|NCT03648372|561837505|FG002|Overall Study|Progressive Disease|4|||
155547661|NCT01239472|561429245|FG000|Overall Study|Adverse Event|0|||
155547662|NCT01239472|561429246|FG001|Overall Study|Adverse Event|1|||
155547663|NCT01239472|561429245|FG000|Overall Study|Lack of Efficacy|0|||
155547664|NCT01239472|561429246|FG001|Overall Study|Lack of Efficacy|1|||
155547665|NCT01005329|561429250|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
155547666|NCT01280617|561429253|FG000|Overall Study|Adverse Event|0|||
155547667|NCT01280617|561429254|FG001|Overall Study|Adverse Event|1|||
155547668|NCT00573170|561429255|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
155547669|NCT00573170|561429256|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
155547670|NCT00573170|561429257|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
155547671|NCT00573170|561429258|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
155547672|NCT00573170|561429259|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
155547673|NCT00573170|561429260|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
155547674|NCT00573170|561429255|FG000|First Washout Period|Adverse Event|1|||
155547675|NCT00573170|561429256|FG001|First Washout Period|Adverse Event|1|||
155547676|NCT00573170|561429257|FG002|First Washout Period|Adverse Event|0|||
155547677|NCT00573170|561429258|FG003|First Washout Period|Adverse Event|0|||
155656954|NCT03648372|561837506|FG003|Overall Study|Progressive Disease|3|||
155656955|NCT03648372|561837507|FG004|Overall Study|Progressive Disease|2|||
155656956|NCT03648372|561837508|FG005|Overall Study|Progressive Disease|2|||
155656957|NCT03648372|561837509|FG006|Overall Study|Progressive Disease|3|||
155656958|NCT03648372|561837510|FG007|Overall Study|Progressive Disease|3|||
155656959|NCT03648372|561837511|FG008|Overall Study|Progressive Disease|5|||
155656960|NCT03648372|561837512|FG009|Overall Study|Progressive Disease|5|||
155656961|NCT03648372|561837513|FG010|Overall Study|Progressive Disease|2|||
155656962|NCT03648372|561837514|FG011|Overall Study|Progressive Disease|3|||
155656963|NCT03648372|561837515|FG012|Overall Study|Progressive Disease|3|||
155547678|NCT00573170|561429259|FG004|First Washout Period|Adverse Event|0|||
155547679|NCT00573170|561429260|FG005|First Washout Period|Adverse Event|1|||
155547680|NCT00573170|561429255|FG000|First Washout Period|Lack of Efficacy|0|||
155547681|NCT00573170|561429256|FG001|First Washout Period|Lack of Efficacy|0|||
155656964|NCT03648372|561837516|FG013|Overall Study|Progressive Disease|3|||
155656965|NCT03648372|561837517|FG014|Overall Study|Progressive Disease|6|||
155547682|NCT00573170|561429257|FG002|First Washout Period|Lack of Efficacy|0|||
155547683|NCT00573170|561429258|FG003|First Washout Period|Lack of Efficacy|0|||
155547684|NCT00573170|561429259|FG004|First Washout Period|Lack of Efficacy|0|||
155547685|NCT00573170|561429260|FG005|First Washout Period|Lack of Efficacy|1|||
155547686|NCT00573170|561429255|FG000|First Washout Period|Lost to Follow-up|1|||
155547687|NCT00573170|561429256|FG001|First Washout Period|Lost to Follow-up|1|||
155547688|NCT00573170|561429257|FG002|First Washout Period|Lost to Follow-up|0|||
155547689|NCT00573170|561429258|FG003|First Washout Period|Lost to Follow-up|2|||
155547690|NCT00573170|561429259|FG004|First Washout Period|Lost to Follow-up|0|||
155547691|NCT00573170|561429260|FG005|First Washout Period|Lost to Follow-up|2|||
155547692|NCT00573170|561429255|FG000|First Washout Period|Withdrawal by Subject|2|||
155547693|NCT00573170|561429256|FG001|First Washout Period|Withdrawal by Subject|0|||
155547694|NCT00573170|561429257|FG002|First Washout Period|Withdrawal by Subject|0|||
155547695|NCT00573170|561429258|FG003|First Washout Period|Withdrawal by Subject|2|||
155547696|NCT00573170|561429259|FG004|First Washout Period|Withdrawal by Subject|3|||
155547697|NCT00573170|561429260|FG005|First Washout Period|Withdrawal by Subject|3|||
155547698|NCT00573170|561429255|FG000|First Washout Period|Other|4|||
155547699|NCT00573170|561429256|FG001|First Washout Period|Other|0|||
155547700|NCT00573170|561429257|FG002|First Washout Period|Other|1|||
155547701|NCT00573170|561429258|FG003|First Washout Period|Other|1|||
155656966|NCT03648372|561837518|FG015|Overall Study|Progressive Disease|0|||
155656967|NCT03648372|561837519|FG016|Overall Study|Progressive Disease|0|||
155656968|NCT03648372|561837520|FG017|Overall Study|Progressive Disease|0|||
155656969|NCT03648372|561837521|FG018|Overall Study|Progressive Disease|0|||
155656970|NCT03648372|561837522|FG019|Overall Study|Progressive Disease|0|||
155656971|NCT03648372|561837523|FG020|Overall Study|Progressive Disease|0|||
155656972|NCT03648372|561837503|FG000|Overall Study|Other|0|||
155656973|NCT03648372|561837504|FG001|Overall Study|Other|0|||
155656974|NCT03648372|561837505|FG002|Overall Study|Other|0|||
155547702|NCT00573170|561429259|FG004|First Washout Period|Other|0|||
155547703|NCT00573170|561429260|FG005|First Washout Period|Other|0|||
155656975|NCT03648372|561837506|FG003|Overall Study|Other|0|||
155656976|NCT03648372|561837507|FG004|Overall Study|Other|1|||
155656977|NCT03648372|561837508|FG005|Overall Study|Other|0|||
155656978|NCT03648372|561837509|FG006|Overall Study|Other|0|||
155656979|NCT03648372|561837510|FG007|Overall Study|Other|0|||
155547704|NCT00573170|561429255|FG000|Second Washout Period|Adverse Event|1|||
155547705|NCT00573170|561429256|FG001|Second Washout Period|Adverse Event|0|||
155547706|NCT00573170|561429257|FG002|Second Washout Period|Adverse Event|0|||
155547707|NCT00573170|561429258|FG003|Second Washout Period|Adverse Event|0|||
155656980|NCT03648372|561837511|FG008|Overall Study|Other|0|||
155656981|NCT03648372|561837512|FG009|Overall Study|Other|0|||
155656982|NCT03648372|561837513|FG010|Overall Study|Other|1|||
155656983|NCT03648372|561837514|FG011|Overall Study|Other|2|||
155656984|NCT03648372|561837515|FG012|Overall Study|Other|1|||
155547708|NCT00573170|561429259|FG004|Second Washout Period|Adverse Event|1|||
155547709|NCT00573170|561429260|FG005|Second Washout Period|Adverse Event|0|||
155547710|NCT00573170|561429255|FG000|Second Washout Period|Protocol Violation|2|||
155547711|NCT00573170|561429256|FG001|Second Washout Period|Protocol Violation|1|||
155547712|NCT00573170|561429257|FG002|Second Washout Period|Protocol Violation|1|||
155547713|NCT00573170|561429258|FG003|Second Washout Period|Protocol Violation|0|||
155547714|NCT00573170|561429259|FG004|Second Washout Period|Protocol Violation|0|||
155547715|NCT00573170|561429260|FG005|Second Washout Period|Protocol Violation|0|||
155547716|NCT00573170|561429255|FG000|Second Washout Period|Withdrawal by Subject|1|||
155547717|NCT00573170|561429256|FG001|Second Washout Period|Withdrawal by Subject|1|||
155547718|NCT00573170|561429257|FG002|Second Washout Period|Withdrawal by Subject|2|||
155547719|NCT00573170|561429258|FG003|Second Washout Period|Withdrawal by Subject|0|||
155547720|NCT00573170|561429259|FG004|Second Washout Period|Withdrawal by Subject|1|||
155547721|NCT00573170|561429260|FG005|Second Washout Period|Withdrawal by Subject|0|||
155547722|NCT00573170|561429255|FG000|Second Washout Period|Lost to Follow-up|0|||
155547723|NCT00573170|561429256|FG001|Second Washout Period|Lost to Follow-up|0|||
155547724|NCT00573170|561429257|FG002|Second Washout Period|Lost to Follow-up|0|||
155547725|NCT00573170|561429258|FG003|Second Washout Period|Lost to Follow-up|1|||
155547726|NCT00573170|561429259|FG004|Second Washout Period|Lost to Follow-up|0|||
155547727|NCT00573170|561429260|FG005|Second Washout Period|Lost to Follow-up|0|||
155547728|NCT00573170|561429255|FG000|Second Washout Period|Other|1|||
155547729|NCT00573170|561429256|FG001|Second Washout Period|Other|2|||
155547730|NCT00573170|561429257|FG002|Second Washout Period|Other|1|||
155547731|NCT00573170|561429258|FG003|Second Washout Period|Other|4|||
155547732|NCT00573170|561429259|FG004|Second Washout Period|Other|6|||
155547733|NCT00573170|561429260|FG005|Second Washout Period|Other|2|||
155547734|NCT00573170|561429255|FG000|Third Treatment Period|Withdrawal by Subject|1|||
155547735|NCT00573170|561429256|FG001|Third Treatment Period|Withdrawal by Subject|0|||
155547736|NCT00573170|561429257|FG002|Third Treatment Period|Withdrawal by Subject|0|||
155547737|NCT00573170|561429258|FG003|Third Treatment Period|Withdrawal by Subject|0|||
155547738|NCT00573170|561429259|FG004|Third Treatment Period|Withdrawal by Subject|0|||
155547739|NCT00573170|561429260|FG005|Third Treatment Period|Withdrawal by Subject|0|||
155547740|NCT00573170|561429255|FG000|Third Treatment Period|Lost to Follow-up|0|||
155547741|NCT00573170|561429256|FG001|Third Treatment Period|Lost to Follow-up|0|||
155547742|NCT00573170|561429257|FG002|Third Treatment Period|Lost to Follow-up|0|||
155547743|NCT00573170|561429258|FG003|Third Treatment Period|Lost to Follow-up|0|||
155547744|NCT00573170|561429259|FG004|Third Treatment Period|Lost to Follow-up|0|||
155547745|NCT00573170|561429260|FG005|Third Treatment Period|Lost to Follow-up|2|||
155547746|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
155547747|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
155547748|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
155547749|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
155547750|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
155547751|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
155547752|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155547753|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155547754|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
155547755|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155547756|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155547757|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155547758|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
155547759|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
155656985|NCT03648372|561837516|FG013|Overall Study|Other|3|||
155656986|NCT03648372|561837517|FG014|Overall Study|Other|0|||
155656987|NCT03648372|561837518|FG015|Overall Study|Other|5|||
155656988|NCT03648372|561837519|FG016|Overall Study|Other|1|||
155656989|NCT03648372|561837520|FG017|Overall Study|Other|5|||
155656990|NCT03648372|561837521|FG018|Overall Study|Other|0|||
155656991|NCT03648372|561837522|FG019|Overall Study|Other|1|||
155656992|NCT03648372|561837523|FG020|Overall Study|Other|0|||
155656993|NCT03648372|561837503|FG000|Overall Study|Lost to Follow-up|0|||
155656994|NCT03648372|561837504|FG001|Overall Study|Lost to Follow-up|0|||
155656995|NCT03648372|561837505|FG002|Overall Study|Lost to Follow-up|0|||
155656996|NCT03648372|561837506|FG003|Overall Study|Lost to Follow-up|0|||
155656997|NCT03648372|561837507|FG004|Overall Study|Lost to Follow-up|0|||
155656998|NCT03648372|561837508|FG005|Overall Study|Lost to Follow-up|0|||
155656999|NCT03648372|561837509|FG006|Overall Study|Lost to Follow-up|0|||
155657000|NCT03648372|561837510|FG007|Overall Study|Lost to Follow-up|0|||
155657001|NCT03648372|561837511|FG008|Overall Study|Lost to Follow-up|0|||
155657002|NCT03648372|561837512|FG009|Overall Study|Lost to Follow-up|0|||
155657003|NCT03648372|561837513|FG010|Overall Study|Lost to Follow-up|0|||
155657004|NCT03648372|561837514|FG011|Overall Study|Lost to Follow-up|0|||
155657005|NCT03648372|561837515|FG012|Overall Study|Lost to Follow-up|0|||
155657006|NCT03648372|561837516|FG013|Overall Study|Lost to Follow-up|1|||
155657007|NCT03648372|561837517|FG014|Overall Study|Lost to Follow-up|0|||
155657008|NCT03648372|561837518|FG015|Overall Study|Lost to Follow-up|1|||
155657009|NCT03648372|561837519|FG016|Overall Study|Lost to Follow-up|0|||
155657010|NCT03648372|561837520|FG017|Overall Study|Lost to Follow-up|1|||
155657011|NCT03648372|561837521|FG018|Overall Study|Lost to Follow-up|0|||
155657012|NCT03648372|561837522|FG019|Overall Study|Lost to Follow-up|0|||
155657013|NCT03648372|561837523|FG020|Overall Study|Lost to Follow-up|0|||
155657014|NCT03648372|561837503|FG000|Overall Study|Start of a New Systemic Treatment|0|||
155547760|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155547761|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155547762|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Death|2|||
155547763|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Death|1|||
155547764|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Death|0|||
155657015|NCT03648372|561837504|FG001|Overall Study|Start of a New Systemic Treatment|0|||
155657016|NCT03648372|561837505|FG002|Overall Study|Start of a New Systemic Treatment|0|||
155657017|NCT03648372|561837506|FG003|Overall Study|Start of a New Systemic Treatment|0|||
155547765|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Death|0|||
155547766|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
155547767|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
155547768|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
155547769|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
155547770|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
155547771|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155547772|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155547773|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
155547774|NCT03110380|561429262|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
155547775|NCT03110380|561429263|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
155547776|NCT03110380|561429264|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
155547777|NCT03110380|561429265|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
155547778|NCT03110380|561429262|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155547779|NCT03110380|561429263|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155547780|NCT03110380|561429264|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
155547781|NCT03110380|561429265|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
155547782|NCT03110380|561429262|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
155547783|NCT03110380|561429263|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
155547784|NCT03110380|561429264|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
155547785|NCT03110380|561429265|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
155547786|NCT03110380|561429262|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
155547787|NCT03110380|561429263|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
155547788|NCT03110380|561429264|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
155547789|NCT03110380|561429265|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
155547790|NCT02147587|561429266|FG000|Overall Study|Adverse Event|9|||
155547791|NCT02147587|561429267|FG001|Overall Study|Adverse Event|4|||
155547792|NCT02147587|561429266|FG000|Overall Study|Lack of Efficacy|2|||
155547793|NCT02147587|561429267|FG001|Overall Study|Lack of Efficacy|1|||
155547794|NCT01714739|561429268|FG000|Overall Study|Disease progression|3|||
155547795|NCT01714739|561429269|FG001|Overall Study|Disease progression|5|||
155547796|NCT01714739|561429270|FG002|Overall Study|Disease progression|5|||
155547797|NCT01714739|561429271|FG003|Overall Study|Disease progression|204|||
155547798|NCT01714739|561429272|FG004|Overall Study|Disease progression|1|||
155547799|NCT01714739|561429273|FG005|Overall Study|Disease progression|3|||
155547800|NCT01714739|561429274|FG006|Overall Study|Disease progression|5|||
155547801|NCT01714739|561429268|FG000|Overall Study|Study drug toxicity|1|||
155547802|NCT01714739|561429269|FG001|Overall Study|Study drug toxicity|1|||
155547803|NCT01714739|561429270|FG002|Overall Study|Study drug toxicity|1|||
155547804|NCT01714739|561429271|FG003|Overall Study|Study drug toxicity|15|||
155547805|NCT01714739|561429272|FG004|Overall Study|Study drug toxicity|0|||
155547806|NCT01714739|561429273|FG005|Overall Study|Study drug toxicity|0|||
155547807|NCT01714739|561429274|FG006|Overall Study|Study drug toxicity|5|||
155547808|NCT01714739|561429268|FG000|Overall Study|Death|0|||
155547809|NCT01714739|561429269|FG001|Overall Study|Death|0|||
155547810|NCT01714739|561429270|FG002|Overall Study|Death|0|||
155547811|NCT01714739|561429271|FG003|Overall Study|Death|1|||
155547812|NCT01714739|561429272|FG004|Overall Study|Death|0|||
155547813|NCT01714739|561429273|FG005|Overall Study|Death|0|||
155547814|NCT01714739|561429274|FG006|Overall Study|Death|0|||
155547815|NCT01714739|561429268|FG000|Overall Study|Adverse Event unrelated to drug|0|||
155547816|NCT01714739|561429269|FG001|Overall Study|Adverse Event unrelated to drug|0|||
155547817|NCT01714739|561429270|FG002|Overall Study|Adverse Event unrelated to drug|3|||
155547818|NCT01714739|561429271|FG003|Overall Study|Adverse Event unrelated to drug|21|||
155547819|NCT01714739|561429272|FG004|Overall Study|Adverse Event unrelated to drug|0|||
155547820|NCT01714739|561429273|FG005|Overall Study|Adverse Event unrelated to drug|0|||
155547821|NCT01714739|561429274|FG006|Overall Study|Adverse Event unrelated to drug|0|||
155547822|NCT01714739|561429268|FG000|Overall Study|Participant request to stop therapy|0|||
155547823|NCT01714739|561429269|FG001|Overall Study|Participant request to stop therapy|1|||
155547824|NCT01714739|561429270|FG002|Overall Study|Participant request to stop therapy|0|||
155547825|NCT01714739|561429271|FG003|Overall Study|Participant request to stop therapy|6|||
155547826|NCT01714739|561429272|FG004|Overall Study|Participant request to stop therapy|0|||
155547827|NCT01714739|561429273|FG005|Overall Study|Participant request to stop therapy|0|||
155657018|NCT03648372|561837507|FG004|Overall Study|Start of a New Systemic Treatment|0|||
155547828|NCT01714739|561429274|FG006|Overall Study|Participant request to stop therapy|0|||
155547829|NCT01714739|561429268|FG000|Overall Study|Participant withdrew consent|0|||
155547830|NCT01714739|561429269|FG001|Overall Study|Participant withdrew consent|1|||
155547831|NCT01714739|561429270|FG002|Overall Study|Participant withdrew consent|0|||
155547832|NCT01714739|561429271|FG003|Overall Study|Participant withdrew consent|8|||
155547833|NCT01714739|561429272|FG004|Overall Study|Participant withdrew consent|0|||
155547834|NCT01714739|561429273|FG005|Overall Study|Participant withdrew consent|0|||
155547835|NCT01714739|561429274|FG006|Overall Study|Participant withdrew consent|0|||
155547836|NCT01714739|561429268|FG000|Overall Study|Lost to Follow-up|0|||
155547837|NCT01714739|561429269|FG001|Overall Study|Lost to Follow-up|0|||
155547838|NCT01714739|561429270|FG002|Overall Study|Lost to Follow-up|0|||
155547839|NCT01714739|561429271|FG003|Overall Study|Lost to Follow-up|1|||
155547840|NCT01714739|561429272|FG004|Overall Study|Lost to Follow-up|0|||
155547841|NCT01714739|561429273|FG005|Overall Study|Lost to Follow-up|0|||
155547842|NCT01714739|561429274|FG006|Overall Study|Lost to Follow-up|0|||
155547843|NCT01714739|561429268|FG000|Overall Study|Maximum clinical benefit|0|||
155547844|NCT01714739|561429269|FG001|Overall Study|Maximum clinical benefit|1|||
155547845|NCT01714739|561429270|FG002|Overall Study|Maximum clinical benefit|1|||
155547846|NCT01714739|561429271|FG003|Overall Study|Maximum clinical benefit|3|||
155547847|NCT01714739|561429272|FG004|Overall Study|Maximum clinical benefit|0|||
155547848|NCT01714739|561429273|FG005|Overall Study|Maximum clinical benefit|0|||
155547849|NCT01714739|561429274|FG006|Overall Study|Maximum clinical benefit|0|||
155547850|NCT01714739|561429268|FG000|Overall Study|Poor/non-comliance|0|||
155547851|NCT01714739|561429269|FG001|Overall Study|Poor/non-comliance|1|||
155547852|NCT01714739|561429270|FG002|Overall Study|Poor/non-comliance|0|||
155547853|NCT01714739|561429271|FG003|Overall Study|Poor/non-comliance|1|||
155547854|NCT01714739|561429272|FG004|Overall Study|Poor/non-comliance|0|||
155547855|NCT01714739|561429273|FG005|Overall Study|Poor/non-comliance|0|||
155547856|NCT01714739|561429274|FG006|Overall Study|Poor/non-comliance|0|||
155547857|NCT01714739|561429268|FG000|Overall Study|No longer meets study criteria|0|||
155547858|NCT01714739|561429269|FG001|Overall Study|No longer meets study criteria|0|||
155547859|NCT01714739|561429270|FG002|Overall Study|No longer meets study criteria|0|||
155547860|NCT01714739|561429271|FG003|Overall Study|No longer meets study criteria|1|||
155547861|NCT01714739|561429272|FG004|Overall Study|No longer meets study criteria|0|||
155547862|NCT01714739|561429273|FG005|Overall Study|No longer meets study criteria|0|||
155547863|NCT01714739|561429274|FG006|Overall Study|No longer meets study criteria|0|||
155547864|NCT01714739|561429268|FG000|Overall Study|Other reason|0|||
155547865|NCT01714739|561429269|FG001|Overall Study|Other reason|0|||
155547866|NCT01714739|561429270|FG002|Overall Study|Other reason|0|||
155547867|NCT01714739|561429271|FG003|Overall Study|Other reason|3|||
155547868|NCT01714739|561429272|FG004|Overall Study|Other reason|1|||
155547869|NCT01714739|561429273|FG005|Overall Study|Other reason|0|||
155547870|NCT01714739|561429274|FG006|Overall Study|Other reason|0|||
155547871|NCT00707434|561429277|FG000|Overall Study|Adverse Event|1|||
155547872|NCT01011556|561429278|FG000|Overall Study|Adverse Event|1|||
155547873|NCT01011556|561429279|FG001|Overall Study|Adverse Event|3|||
155547874|NCT01011556|561429280|FG002|Overall Study|Adverse Event|2|||
155547875|NCT01011556|561429281|FG003|Overall Study|Adverse Event|1|||
155547876|NCT01011556|561429278|FG000|Overall Study|Lost to Follow-up|1|||
155547877|NCT01011556|561429279|FG001|Overall Study|Lost to Follow-up|0|||
155547878|NCT01011556|561429280|FG002|Overall Study|Lost to Follow-up|0|||
155547879|NCT01011556|561429281|FG003|Overall Study|Lost to Follow-up|0|||
155547880|NCT01011556|561429278|FG000|Overall Study|Physician Decision|1|||
155547881|NCT01011556|561429279|FG001|Overall Study|Physician Decision|0|||
155547882|NCT01011556|561429280|FG002|Overall Study|Physician Decision|0|||
155547883|NCT01011556|561429281|FG003|Overall Study|Physician Decision|1|||
155547884|NCT01011556|561429278|FG000|Overall Study|Protocol Violation|0|||
155547885|NCT01011556|561429279|FG001|Overall Study|Protocol Violation|1|||
155547886|NCT01011556|561429280|FG002|Overall Study|Protocol Violation|0|||
155547887|NCT01011556|561429281|FG003|Overall Study|Protocol Violation|0|||
155547888|NCT01011556|561429278|FG000|Overall Study|Withdrawal by Subject|1|||
155547889|NCT01011556|561429279|FG001|Overall Study|Withdrawal by Subject|2|||
155547890|NCT01011556|561429280|FG002|Overall Study|Withdrawal by Subject|4|||
155547891|NCT01011556|561429281|FG003|Overall Study|Withdrawal by Subject|4|||
155547892|NCT01011556|561429278|FG000|Overall Study|Sponsor decision|0|||
155547893|NCT01011556|561429279|FG001|Overall Study|Sponsor decision|1|||
155547894|NCT01011556|561429280|FG002|Overall Study|Sponsor decision|1|||
155547895|NCT01011556|561429281|FG003|Overall Study|Sponsor decision|2|||
155547896|NCT01011556|561429278|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
155547897|NCT01011556|561429279|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
155547898|NCT01011556|561429280|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
155547899|NCT01011556|561429281|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
155547900|NCT00614822|561429282|FG000|Overall Study|Adverse Event|3|||
155547901|NCT03649412|561429283|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
155547902|NCT03649412|561429284|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
155547903|NCT03649412|561429283|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
155547904|NCT03649412|561429284|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
155547905|NCT03649412|561429283|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
155547906|NCT03649412|561429284|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155547907|NCT03649412|561429283|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
155547908|NCT03649412|561429284|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
155547909|NCT03649412|561429283|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
155547910|NCT03649412|561429284|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
155547911|NCT03649412|561429283|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
155547912|NCT03649412|561429284|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
155547913|NCT00530348|561429285|FG000|Overall Study|Adverse Event|5|||
155547914|NCT00530348|561429286|FG001|Overall Study|Adverse Event|1|||
155547915|NCT00530348|561429285|FG000|Overall Study|Death|0|||
155547916|NCT00530348|561429286|FG001|Overall Study|Death|1|||
155547917|NCT00530348|561429285|FG000|Overall Study|Lack of Efficacy|2|||
155547918|NCT00530348|561429286|FG001|Overall Study|Lack of Efficacy|0|||
155547919|NCT00530348|561429285|FG000|Overall Study|Lost to Follow-up|0|||
155547920|NCT00530348|561429286|FG001|Overall Study|Lost to Follow-up|2|||
155547921|NCT00530348|561429285|FG000|Overall Study|Physician Decision|1|||
155547922|NCT00530348|561429286|FG001|Overall Study|Physician Decision|2|||
155547923|NCT00530348|561429285|FG000|Overall Study|Pregnancy|1|||
155547924|NCT00530348|561429286|FG001|Overall Study|Pregnancy|0|||
155547925|NCT00530348|561429285|FG000|Overall Study|Withdrawal by Subject|12|||
155547926|NCT00530348|561429286|FG001|Overall Study|Withdrawal by Subject|12|||
155547927|NCT00530348|561429285|FG000|Overall Study|Randomised in error|1|||
155547928|NCT00530348|561429286|FG001|Overall Study|Randomised in error|0|||
155547929|NCT00530348|561429285|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
155547930|NCT00530348|561429286|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
155547931|NCT04364763|561429287|FG000|Overall Study|Death|1|||
155547932|NCT04364763|561429288|FG001|Overall Study|Death|2|||
155547933|NCT04364763|561429287|FG000|Overall Study|Lost to Follow-up|1|||
155547934|NCT04364763|561429288|FG001|Overall Study|Lost to Follow-up|0|||
155547935|NCT01256060|561429290|FG000|Overall Study|Lost to Follow-up|0|||
155547936|NCT01256060|561429291|FG001|Overall Study|Lost to Follow-up|1|||
155547937|NCT01256060|561429292|FG002|Overall Study|Lost to Follow-up|0|||
155547938|NCT01256060|561429293|FG003|Overall Study|Lost to Follow-up|0|||
155547939|NCT00089076|561429298|FG000|Overall Study|Alternate Therapy|1|||
155547940|NCT00089076|561429298|FG000|Overall Study|Withdrawal by Subject|2|||
155547941|NCT00089076|561429298|FG000|Overall Study|Progression|7|||
155547942|NCT00808509|561429299|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
155547943|NCT00808509|561429300|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
155547944|NCT00808509|561429299|FG000|Randomized Phase|Reduced methotrexate dose|1|||
155547945|NCT00808509|561429300|FG001|Randomized Phase|Reduced methotrexate dose|2|||
155547946|NCT00808509|561429299|FG000|Randomized Phase|Patient refused rescue therapy|0|||
155547947|NCT00808509|561429300|FG001|Randomized Phase|Patient refused rescue therapy|3|||
155547948|NCT00931463|561429301|FG000|Overall Study|Death|8|||
155547949|NCT00931463|561429302|FG001|Overall Study|Death|4|||
155547950|NCT00931463|561429301|FG000|Overall Study|Withdrawal by Subject|5|||
155547951|NCT00931463|561429302|FG001|Overall Study|Withdrawal by Subject|0|||
155547952|NCT00931463|561429301|FG000|Overall Study|Lost to Follow-up|4|||
155547953|NCT00931463|561429302|FG001|Overall Study|Lost to Follow-up|1|||
155547954|NCT00084799|561429306|FG000|Overall Study|Disease Progression|1|||
155547955|NCT00084799|561429307|FG001|Overall Study|Disease Progression|0|||
155547956|NCT04499482|561429308|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
155547957|NCT02487082|561429309|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
155547958|NCT02487082|561429310|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
155547959|NCT02487082|561429309|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
155547960|NCT02487082|561429310|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
155547961|NCT04569786|561429319|FG000|Overall Study|Lost to Follow-up|1|||
155547962|NCT04569786|561429320|FG001|Overall Study|Lost to Follow-up|0|||
155547963|NCT04569786|561429321|FG002|Overall Study|Lost to Follow-up|4|||
155547964|NCT04569786|561429322|FG003|Overall Study|Lost to Follow-up|1|||
155547965|NCT04569786|561429323|FG004|Overall Study|Lost to Follow-up|0|||
155547966|NCT04569786|561429319|FG000|Overall Study|Withdrawal by Subject|0|||
155547967|NCT04569786|561429320|FG001|Overall Study|Withdrawal by Subject|0|||
155547968|NCT04569786|561429321|FG002|Overall Study|Withdrawal by Subject|0|||
155547969|NCT04569786|561429322|FG003|Overall Study|Withdrawal by Subject|5|||
155547970|NCT04569786|561429323|FG004|Overall Study|Withdrawal by Subject|1|||
155547971|NCT04569786|561429319|FG000|Overall Study|Physician Decision|0|||
155547972|NCT04569786|561429320|FG001|Overall Study|Physician Decision|0|||
155547973|NCT04569786|561429321|FG002|Overall Study|Physician Decision|0|||
155547974|NCT04569786|561429322|FG003|Overall Study|Physician Decision|1|||
155547975|NCT04569786|561429323|FG004|Overall Study|Physician Decision|0|||
155547976|NCT01684878|561429324|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
155547977|NCT01684878|561429325|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
155547978|NCT01684878|561429326|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
155547979|NCT01684878|561429327|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
155547980|NCT01684878|561429324|FG000|Part 1: Safety Run in Phase|Death|15|||
155547981|NCT01684878|561429325|FG001|Part 1: Safety Run in Phase|Death|20|||
155547982|NCT01684878|561429326|FG002|Part 1: Safety Run in Phase|Death|0|||
155547983|NCT01684878|561429327|FG003|Part 1: Safety Run in Phase|Death|0|||
155547984|NCT01684878|561429324|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
155547985|NCT01684878|561429325|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
155547986|NCT01684878|561429326|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
155547987|NCT01684878|561429327|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
155547988|NCT01684878|561429324|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
155547989|NCT01684878|561429325|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
155547990|NCT01684878|561429326|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
155547991|NCT01684878|561429327|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
155547992|NCT01684878|561429324|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
155547993|NCT01684878|561429325|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
155547994|NCT01684878|561429326|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
155547995|NCT01684878|561429327|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
155547996|NCT01684878|561429324|FG000|Part 2: Randomized Phase|Death|0|||
155547997|NCT01684878|561429325|FG001|Part 2: Randomized Phase|Death|0|||
155547998|NCT01684878|561429326|FG002|Part 2: Randomized Phase|Death|62|||
155547999|NCT01684878|561429327|FG003|Part 2: Randomized Phase|Death|68|||
155548000|NCT01684878|561429324|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
155548001|NCT01684878|561429325|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
155548002|NCT01684878|561429326|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
155548003|NCT01684878|561429327|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
155548004|NCT01684878|561429324|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
155548005|NCT01684878|561429325|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
155548006|NCT01684878|561429326|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
155548007|NCT01684878|561429327|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
155548008|NCT01435031|561429331|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
155548009|NCT01435031|561429331|FG000|ITT at 1 Month|Death|1|||
155548010|NCT01435031|561429331|FG000|ITT at 1 Month|Lost to Follow-up|4|||
155548011|NCT01435031|561429331|FG000|ITT at 6 Months|Death|2|||
155548012|NCT01435031|561429331|FG000|ITT at 6 Months|Lost to Follow-up|3|||
155548013|NCT01435031|561429331|FG000|ITT at 1 Year|Death|1|||
155548014|NCT01435031|561429331|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
155548015|NCT01435031|561429331|FG000|ITT at 1 Year|Lost to Follow-up|6|||
155548016|NCT01435031|561429331|FG000|ITT at 2 Years|Death|7|||
155548017|NCT01435031|561429331|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
155548018|NCT01435031|561429331|FG000|ITT at 2 Years|Lost to Follow-up|4|||
155548019|NCT01435031|561429331|FG000|ITT at 3 Years|Death|5|||
155548020|NCT01435031|561429331|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
155548021|NCT01435031|561429331|FG000|ITT at 3 Years|Lost to Follow-up|4|||
155548022|NCT01435031|561429331|FG000|ITT at 4 Years|Death|4|||
155548023|NCT01435031|561429331|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
155548024|NCT01435031|561429331|FG000|ITT at 4 Years|Lost to Follow-up|1|||
155548025|NCT03942211|561429334|FG000|Overall Study|Death|1|||
155548026|NCT03942211|561429335|FG001|Overall Study|Death|0|||
155548027|NCT03942211|561429334|FG000|Overall Study|Study terminated by sponsor|5|||
155548028|NCT03942211|561429335|FG001|Overall Study|Study terminated by sponsor|3|||
155548029|NCT03942211|561429334|FG000|Overall Study|Adverse Event|0|||
155548030|NCT03942211|561429335|FG001|Overall Study|Adverse Event|1|||
155548031|NCT00127166|561429336|FG000|Period I|Protocol Violation|0|||
155548032|NCT00127166|561429337|FG001|Period I|Protocol Violation|2|||
155548033|NCT00127166|561429336|FG000|Period I|Withdrawal by Subject|2|||
155548034|NCT00127166|561429337|FG001|Period I|Withdrawal by Subject|0|||
155548035|NCT00127166|561429336|FG000|Period I|Patient did not meet inclusion criteria|1|||
155548036|NCT00127166|561429337|FG001|Period I|Patient did not meet inclusion criteria|0|||
155548037|NCT00127166|561429336|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
155548038|NCT00127166|561429337|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
155548039|NCT00127166|561429336|FG000|Period II|Withdrawal by Subject|2|||
155548040|NCT00127166|561429337|FG001|Period II|Withdrawal by Subject|0|||
155548041|NCT00127166|561429336|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
155548042|NCT00127166|561429337|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
155548043|NCT01148225|561429340|FG000|Overall Study|Other|185|||
155548044|NCT00104247|561429343|FG000|Overall Study|Withdrawal by Subject|1|||
155548045|NCT00104247|561429344|FG001|Overall Study|Withdrawal by Subject|0|||
155548046|NCT00104247|561429343|FG000|Overall Study|Noncompliant with dosing|0|||
155548047|NCT00104247|561429344|FG001|Overall Study|Noncompliant with dosing|1|||
155548048|NCT00605917|561429348|FG000|Overall Study|Protocol Violation|79|||
155548049|NCT01506908|561429349|FG000|Overall Study|Adverse Event|1|||
155548050|NCT01506908|561429350|FG001|Overall Study|Adverse Event|0|||
155548051|NCT03043560|561429359|FG000|Overall Study|Discontinued Intervention|1|||
155548052|NCT03043560|561429360|FG001|Overall Study|Discontinued Intervention|2|||
155548053|NCT03043560|561429359|FG000|Overall Study|Lost to Follow-up|0|||
155548054|NCT03043560|561429360|FG001|Overall Study|Lost to Follow-up|1|||
155548055|NCT01117766|561429361|FG000|First Intervention|Adverse Event|0|||
155548056|NCT01117766|561429362|FG001|First Intervention|Adverse Event|1|||
155548057|NCT01117766|561429361|FG000|First Intervention|Protocol Violation|1|||
155548058|NCT01117766|561429362|FG001|First Intervention|Protocol Violation|0|||
155548059|NCT01117766|561429361|FG000|Washout Period|Protocol Violation|0|||
155548060|NCT01117766|561429362|FG001|Washout Period|Protocol Violation|2|||
155548061|NCT01117766|561429361|FG000|Second Intervention|Lost to Follow-up|1|||
155548062|NCT01117766|561429362|FG001|Second Intervention|Lost to Follow-up|0|||
155548063|NCT01117766|561429361|FG000|Second Intervention|Other|1|||
155548064|NCT01117766|561429362|FG001|Second Intervention|Other|2|||
155548065|NCT01117766|561429361|FG000|Second Intervention|Adverse Event|0|||
155548066|NCT01117766|561429362|FG001|Second Intervention|Adverse Event|2|||
155548067|NCT01117766|561429361|FG000|Second Intervention|Withdrawal by Subject|0|||
155548068|NCT01117766|561429362|FG001|Second Intervention|Withdrawal by Subject|1|||
155548069|NCT03718117|561429363|FG000|Overall Study|Death|12|||
155548070|NCT03718117|561429364|FG001|Overall Study|Death|11|||
155548071|NCT03718117|561429365|FG002|Overall Study|Death|0|||
155548072|NCT03718117|561429363|FG000|Overall Study|Other|0|||
155548073|NCT03718117|561429364|FG001|Overall Study|Other|1|||
155548074|NCT03718117|561429365|FG002|Overall Study|Other|0|||
155548075|NCT03718117|561429363|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
155548076|NCT03718117|561429364|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
155548077|NCT03718117|561429365|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
155548078|NCT03718117|561429363|FG000|Overall Study|Participant not met eligibility criteria|0|||
155548079|NCT03718117|561429364|FG001|Overall Study|Participant not met eligibility criteria|0|||
155548080|NCT03718117|561429365|FG002|Overall Study|Participant not met eligibility criteria|2|||
155548081|NCT00206102|561429366|FG000|Overall Study|Adverse Event|119|||
155548082|NCT00206102|561429367|FG001|Overall Study|Adverse Event|82|||
155548083|NCT00206102|561429366|FG000|Overall Study|Protocol Violation|0|||
155548084|NCT00206102|561429367|FG001|Overall Study|Protocol Violation|2|||
155548085|NCT00206102|561429366|FG000|Overall Study|Lack of therapeutic response|16|||
155548086|NCT00206102|561429367|FG001|Overall Study|Lack of therapeutic response|11|||
155548087|NCT00206102|561429366|FG000|Overall Study|Lost to Follow-up|95|||
155548088|NCT00206102|561429367|FG001|Overall Study|Lost to Follow-up|66|||
155548089|NCT00206102|561429366|FG000|Overall Study|Withdrawal by Subject|118|||
155548090|NCT00206102|561429367|FG001|Overall Study|Withdrawal by Subject|101|||
155548091|NCT00206102|561429366|FG000|Overall Study|Study-specific discontinuation criteria|18|||
155548092|NCT00206102|561429367|FG001|Overall Study|Study-specific discontinuation criteria|17|||
155548093|NCT00206102|561429366|FG000|Overall Study|None of those categories|42|||
155548094|NCT00206102|561429367|FG001|Overall Study|None of those categories|36|||
155548095|NCT01917968|561429368|FG000|Overall Study|Death|3|||
155548096|NCT01917968|561429369|FG001|Overall Study|Death|2|||
155548097|NCT01917968|561429368|FG000|Overall Study|Lost to Follow-up|21|||
155548098|NCT01917968|561429369|FG001|Overall Study|Lost to Follow-up|39|||
155548099|NCT01917968|561429368|FG000|Overall Study|Physician Decision|1|||
155548100|NCT01917968|561429369|FG001|Overall Study|Physician Decision|2|||
155548101|NCT01917968|561429368|FG000|Overall Study|Withdrawal by Subject|20|||
155548102|NCT01917968|561429369|FG001|Overall Study|Withdrawal by Subject|35|||
155548103|NCT01917968|561429368|FG000|Overall Study|Subject Relocation|5|||
155548104|NCT01917968|561429369|FG001|Overall Study|Subject Relocation|1|||
155548105|NCT01917968|561429368|FG000|Overall Study|36M Missed Visit|3|||
155548106|NCT01917968|561429369|FG001|Overall Study|36M Missed Visit|2|||
155548107|NCT01917968|561429368|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
155548108|NCT01917968|561429369|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
155548109|NCT01917968|561429368|FG000|Overall Study|Change in Family Circumstances|0|||
155548110|NCT01917968|561429369|FG001|Overall Study|Change in Family Circumstances|1|||
155548111|NCT01917968|561429368|FG000|Overall Study|No Data Available|0|||
155548112|NCT01917968|561429369|FG001|Overall Study|No Data Available|2|||
155548113|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
155548114|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
155548115|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
155548116|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
155548117|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
155548118|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
155548119|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
155548120|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
155548121|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
155548122|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
155548123|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
155548124|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
155548125|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
155548126|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
155548127|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
155548128|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
155548129|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
155548130|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
155548131|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
155548132|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
155548133|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
155548134|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
155548135|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
155548136|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
155548137|NCT01435928|561429371|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
155548138|NCT01435928|561429372|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
155548139|NCT01435928|561429373|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
155548140|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
155548141|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
155548142|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
155548143|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
155548144|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
155548145|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
155548146|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
155548147|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
155548148|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
155548149|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
155548150|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
155548151|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
155548152|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
155548153|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
155548154|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
155548155|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
155548156|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
155548157|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
155548158|NCT01435928|561429371|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
155548159|NCT01435928|561429372|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
155548160|NCT01435928|561429373|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
155548161|NCT00292227|561429377|FG000|Patch Period|Adverse Event|1|||
155548162|NCT00292227|561429378|FG001|Patch Period|Adverse Event|0|||
155548163|NCT00292227|561429379|FG002|Patch Period|Adverse Event|2|||
155548164|NCT00292227|561429377|FG000|Patch Period|Withdrawal by Subject|0|||
155548165|NCT00292227|561429378|FG001|Patch Period|Withdrawal by Subject|0|||
155548166|NCT00292227|561429379|FG002|Patch Period|Withdrawal by Subject|1|||
155548167|NCT00537017|561429382|FG000|Treatment Phase|Adverse Event|19|||
155548168|NCT00537017|561429382|FG000|Treatment Phase|Withdrawal by Subject|13|||
155548169|NCT00537017|561429382|FG000|Treatment Phase|Protocol Violation|2|||
155548170|NCT00537017|561429382|FG000|Follow-up Phase|Withdrawal by Subject|9|||
155548171|NCT02329431|561429384|FG000|Overall Study|Lost to Follow-up|20|||
155548172|NCT02329431|561429385|FG001|Overall Study|Lost to Follow-up|13|||
155548173|NCT03581188|561431093|FG000|Overall Study|Inclusion criteria not met|3|||
155548174|NCT03581188|561431094|FG001|Overall Study|Inclusion criteria not met|2|||
155548175|NCT03581188|561431093|FG000|Overall Study|Lost to Follow-up|5|||
155548176|NCT03581188|561431094|FG001|Overall Study|Lost to Follow-up|5|||
155548177|NCT03581188|561431093|FG000|Overall Study|Discontinued intervention|11|||
155548178|NCT03581188|561431094|FG001|Overall Study|Discontinued intervention|8|||
155548179|NCT01619579|561431097|FG000|Overall Study|Withdrawal by Subject|0|||
155548180|NCT01619579|561431098|FG001|Overall Study|Withdrawal by Subject|3|||
155548181|NCT01684215|561431100|FG000|Phase 1, Part 1|Adverse Event|1|||
155548182|NCT01684215|561431101|FG001|Phase 1, Part 1|Adverse Event|0|||
155548183|NCT01684215|561431102|FG002|Phase 1, Part 1|Adverse Event|0|||
155548184|NCT01684215|561431103|FG003|Phase 1, Part 1|Adverse Event|0|||
155548185|NCT01684215|561431100|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
155548186|NCT01684215|561431101|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
155548187|NCT01684215|561431102|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
155548188|NCT01684215|561431103|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
155548189|NCT01684215|561431100|FG000|Phase 1, Part 2|Adverse Event|0|||
155548190|NCT01684215|561431101|FG001|Phase 1, Part 2|Adverse Event|0|||
155548191|NCT01684215|561431102|FG002|Phase 1, Part 2|Adverse Event|1|||
155548192|NCT01684215|561431103|FG003|Phase 1, Part 2|Adverse Event|0|||
155548193|NCT01684215|561431100|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
155548194|NCT01684215|561431101|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
155548195|NCT01684215|561431102|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
155548196|NCT01684215|561431103|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
155548197|NCT01684215|561431100|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
155548198|NCT01684215|561431101|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
155548199|NCT01684215|561431102|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
155548200|NCT01684215|561431103|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
155548201|NCT01684215|561431100|FG000|Phase 2|Death|0|||
155657019|NCT03648372|561837508|FG005|Overall Study|Start of a New Systemic Treatment|0|||
155548202|NCT01684215|561431101|FG001|Phase 2|Death|0|||
155548203|NCT01684215|561431102|FG002|Phase 2|Death|0|||
155548204|NCT01684215|561431103|FG003|Phase 2|Death|8|||
155548205|NCT01684215|561431100|FG000|Phase 2|Study terminated by sponsor|0|||
155548206|NCT01684215|561431101|FG001|Phase 2|Study terminated by sponsor|0|||
155548207|NCT01684215|561431102|FG002|Phase 2|Study terminated by sponsor|0|||
155548208|NCT01684215|561431103|FG003|Phase 2|Study terminated by sponsor|30|||
155548209|NCT01684215|561431100|FG000|Phase 2|Enrolled but not treated|0|||
155548210|NCT01684215|561431101|FG001|Phase 2|Enrolled but not treated|0|||
155548211|NCT01684215|561431102|FG002|Phase 2|Enrolled but not treated|0|||
155548212|NCT01684215|561431103|FG003|Phase 2|Enrolled but not treated|1|||
155548213|NCT01684215|561431100|FG000|Phase 2|Lost to Follow-up|0|||
155548214|NCT01684215|561431101|FG001|Phase 2|Lost to Follow-up|0|||
155548215|NCT01684215|561431102|FG002|Phase 2|Lost to Follow-up|0|||
155548216|NCT01684215|561431103|FG003|Phase 2|Lost to Follow-up|4|||
155548217|NCT04039919|561431107|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155548218|NCT04039919|561431108|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155548219|NCT04039919|561431109|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155548220|NCT04039919|561431110|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155548221|NCT04039919|561431111|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155548222|NCT04039919|561431107|FG000|Treatment Period 1|Sponsor's decision|0|||
155548223|NCT04039919|561431108|FG001|Treatment Period 1|Sponsor's decision|0|||
155548224|NCT04039919|561431109|FG002|Treatment Period 1|Sponsor's decision|0|||
155548225|NCT04039919|561431110|FG003|Treatment Period 1|Sponsor's decision|0|||
155548226|NCT04039919|561431111|FG004|Treatment Period 1|Sponsor's decision|16|||
155548227|NCT04039919|561431107|FG000|Treatment Period 5|Withdrawal by Subject|1|||
155548228|NCT04039919|561431108|FG001|Treatment Period 5|Withdrawal by Subject|0|||
155548229|NCT04039919|561431109|FG002|Treatment Period 5|Withdrawal by Subject|0|||
155548230|NCT04039919|561431110|FG003|Treatment Period 5|Withdrawal by Subject|0|||
155548231|NCT04039919|561431111|FG004|Treatment Period 5|Withdrawal by Subject|0|||
155548232|NCT00983918|561431116|FG000|Overall Study|conversion to open cholecystectomy|0|||
155548233|NCT00983918|561431117|FG001|Overall Study|conversion to open cholecystectomy|2|||
155548234|NCT00983918|561431118|FG002|Overall Study|conversion to open cholecystectomy|2|||
155548235|NCT00983918|561431119|FG003|Overall Study|conversion to open cholecystectomy|2|||
155548236|NCT03250299|561431123|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
155548237|NCT03250299|561431124|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
155548238|NCT03250299|561431125|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
155548239|NCT03250299|561431126|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
155548240|NCT03250299|561431127|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
155548241|NCT03250299|561431123|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
155548242|NCT03250299|561431124|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
155548243|NCT03250299|561431125|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
155548244|NCT03250299|561431126|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
155548245|NCT03250299|561431127|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
155548246|NCT03250299|561431123|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
155548247|NCT03250299|561431124|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
155548248|NCT03250299|561431125|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
155548249|NCT03250299|561431126|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
155548250|NCT03250299|561431127|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
155548251|NCT03250299|561431123|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
155548252|NCT03250299|561431124|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
155548253|NCT03250299|561431125|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
155548254|NCT03250299|561431126|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
155548255|NCT03250299|561431127|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
155548256|NCT01546922|561431128|FG000|First Period of 10 Weeks|Protocol Violation|3|||
155548257|NCT01546922|561431129|FG001|First Period of 10 Weeks|Protocol Violation|1|||
155548258|NCT01546922|561431128|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
155548259|NCT01546922|561431129|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
155548260|NCT01546922|561431128|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
155548261|NCT01546922|561431129|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
155548262|NCT01546922|561431128|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
155548263|NCT01546922|561431129|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
155548264|NCT01546922|561431128|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
155548265|NCT01546922|561431129|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
155548266|NCT04086641|561431132|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
155548267|NCT04086641|561431133|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
155548268|NCT00126126|561431136|FG000|Overall Study|Lost to Follow-up|0|||
155548269|NCT00126126|561431137|FG001|Overall Study|Lost to Follow-up|2|||
155548270|NCT01534078|561431138|FG000|Overall Study|Death|1|||
155548271|NCT01534078|561431138|FG000|Overall Study|Withdrawal by Subject|1|||
155548272|NCT00986570|561431142|FG000|Overall Study|Lost to Follow-up|6|||
155548273|NCT00986570|561431142|FG000|Overall Study|Potential bias for objective assessment|1|||
155548274|NCT02225665|561431143|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
155548275|NCT02225665|561431144|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
155548276|NCT02225665|561431143|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
155548277|NCT02225665|561431144|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
155548278|NCT01311557|561431145|FG000|Overall Study|Serious adverse event|0|||
155548279|NCT01311557|561431146|FG001|Overall Study|Serious adverse event|1|||
155548280|NCT01311557|561431145|FG000|Overall Study|Protocol Violation|4|||
155548281|NCT01311557|561431146|FG001|Overall Study|Protocol Violation|2|||
155548282|NCT01311557|561431145|FG000|Overall Study|Lost to Follow-up|0|||
155548283|NCT01311557|561431146|FG001|Overall Study|Lost to Follow-up|1|||
155548284|NCT01311557|561431145|FG000|Overall Study|Withdrawal by Subject|1|||
155548285|NCT01311557|561431146|FG001|Overall Study|Withdrawal by Subject|2|||
155548286|NCT00608517|561431147|FG000|Overall Study|Death|1|||
155548287|NCT00608517|561431148|FG001|Overall Study|Death|0|||
155548288|NCT00608517|561431149|FG002|Overall Study|Death|0|||
155548289|NCT00572039|561431150|FG000|Overall Study|Withdrawal by Subject|9|||
155548290|NCT00572039|561431151|FG001|Overall Study|Withdrawal by Subject|6|||
155548291|NCT00572039|561431150|FG000|Overall Study|Death|2|||
155548292|NCT00572039|561431151|FG001|Overall Study|Death|3|||
155548293|NCT00572039|561431150|FG000|Overall Study|Ill|5|||
155548294|NCT00572039|561431151|FG001|Overall Study|Ill|1|||
155548295|NCT01470417|561431154|FG000|Overall Study|Disease progression|0|||
155548296|NCT01470417|561431155|FG001|Overall Study|Disease progression|2|||
155548297|NCT02973321|561431158|FG000|Overall Study|Other than specified|0|||
155548298|NCT02973321|561431159|FG001|Overall Study|Other than specified|5|||
155548299|NCT02973321|561431160|FG002|Overall Study|Other than specified|3|||
155548300|NCT02973321|561431161|FG003|Overall Study|Other than specified|3|||
155548301|NCT02973321|561431162|FG004|Overall Study|Other than specified|1|||
155548302|NCT02973321|561431158|FG000|Overall Study|Lack of Efficacy|0|||
155548303|NCT02973321|561431159|FG001|Overall Study|Lack of Efficacy|0|||
155548304|NCT02973321|561431160|FG002|Overall Study|Lack of Efficacy|0|||
155548305|NCT02973321|561431161|FG003|Overall Study|Lack of Efficacy|0|||
155548306|NCT02973321|561431162|FG004|Overall Study|Lack of Efficacy|1|||
155548307|NCT02973321|561431158|FG000|Overall Study|Adverse Event|1|||
155548308|NCT02973321|561431159|FG001|Overall Study|Adverse Event|10|||
155548309|NCT02973321|561431160|FG002|Overall Study|Adverse Event|11|||
155548310|NCT02973321|561431161|FG003|Overall Study|Adverse Event|13|||
155548311|NCT02973321|561431162|FG004|Overall Study|Adverse Event|3|||
155548312|NCT01098110|561431167|FG000|Overall Study|Withdrawal by Subject|14|||
155548313|NCT01098110|561431168|FG001|Overall Study|Withdrawal by Subject|24|||
155548314|NCT01098110|561431169|FG002|Overall Study|Withdrawal by Subject|19|||
155548315|NCT01098110|561431167|FG000|Overall Study|Adverse Event|30|||
155548316|NCT01098110|561431168|FG001|Overall Study|Adverse Event|32|||
155548317|NCT01098110|561431169|FG002|Overall Study|Adverse Event|43|||
155548318|NCT01098110|561431167|FG000|Overall Study|Lack of Efficacy|13|||
155548319|NCT01098110|561431168|FG001|Overall Study|Lack of Efficacy|9|||
155548320|NCT01098110|561431169|FG002|Overall Study|Lack of Efficacy|27|||
155548321|NCT01098110|561431167|FG000|Overall Study|Other|4|||
155548322|NCT01098110|561431168|FG001|Overall Study|Other|7|||
155548323|NCT01098110|561431169|FG002|Overall Study|Other|5|||
155548324|NCT01098110|561431167|FG000|Overall Study|Untreated|1|||
155548325|NCT01098110|561431168|FG001|Overall Study|Untreated|1|||
155548326|NCT01098110|561431169|FG002|Overall Study|Untreated|0|||
155548327|NCT01355302|561431170|FG000|Phase 1b|Death|4|||
155548328|NCT01355302|561431171|FG001|Phase 1b|Death|0|||
155548329|NCT01355302|561431172|FG002|Phase 1b|Death|0|||
155548330|NCT01355302|561431170|FG000|Phase 1b|Study terminated by sponsor|2|||
155548331|NCT01355302|561431171|FG001|Phase 1b|Study terminated by sponsor|0|||
155548332|NCT01355302|561431172|FG002|Phase 1b|Study terminated by sponsor|0|||
155548333|NCT00263887|561431173|FG000|Overall Study|Withdrawal by Subject|1|||
155548334|NCT00263887|561431174|FG001|Overall Study|Withdrawal by Subject|1|||
155548335|NCT00263887|561431173|FG000|Overall Study|Lung transplantation|1|||
155548336|NCT00263887|561431174|FG001|Overall Study|Lung transplantation|2|||
155548337|NCT00263887|561431173|FG000|Overall Study|Too ill to attend visit|1|||
155548338|NCT00263887|561431174|FG001|Overall Study|Too ill to attend visit|0|||
155548339|NCT00263887|561431173|FG000|Overall Study|Adverse Event|0|||
155548340|NCT00263887|561431174|FG001|Overall Study|Adverse Event|2|||
155548341|NCT00263887|561431173|FG000|Overall Study|Disease progression|0|||
155548342|NCT00263887|561431174|FG001|Overall Study|Disease progression|1|||
155548343|NCT00263887|561431173|FG000|Overall Study|Lack of Efficacy|0|||
155548344|NCT00263887|561431174|FG001|Overall Study|Lack of Efficacy|1|||
155548345|NCT02274948|561431175|FG000|Overall Study|Lost to Follow-up|28|||
155548346|NCT02274948|561431176|FG001|Overall Study|Lost to Follow-up|25|||
155548347|NCT02274948|561431175|FG000|Overall Study|Withdrawal by Subject|64|||
155548348|NCT02274948|561431176|FG001|Overall Study|Withdrawal by Subject|58|||
155548349|NCT02274948|561431175|FG000|Overall Study|Stopped on family Practitioner advice|2|||
155548350|NCT02274948|561431176|FG001|Overall Study|Stopped on family Practitioner advice|5|||
155548351|NCT02274948|561431175|FG000|Overall Study|Left the area|4|||
155548352|NCT02274948|561431176|FG001|Overall Study|Left the area|3|||
155548353|NCT00865514|561431180|FG000|Overall Study|Infusion cost exceeded funding|2|||
155548354|NCT02865395|561431181|FG000|Overall Study|Physician Decision|6|||
155548355|NCT02865395|561431182|FG001|Overall Study|Physician Decision|10|||
155548356|NCT02865395|561431183|FG002|Overall Study|Physician Decision|7|||
155548357|NCT03920280|561431184|FG000|Overall Study|Adverse Event|2|||
155548358|NCT03920280|561431185|FG001|Overall Study|Adverse Event|3|||
155548359|NCT03920280|561431184|FG000|Overall Study|Lost to Follow-up|0|||
155548360|NCT03920280|561431185|FG001|Overall Study|Lost to Follow-up|1|||
155548361|NCT03920280|561431184|FG000|Overall Study|Withdrawal by Subject|1|||
155548362|NCT03920280|561431185|FG001|Overall Study|Withdrawal by Subject|1|||
155548363|NCT03920280|561431184|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
155548364|NCT03920280|561431185|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
155548365|NCT00985231|561431188|FG000|Overall Study|ineligible|1|||
155548366|NCT00985231|561431189|FG001|Overall Study|ineligible|0|||
155548367|NCT00985231|561431188|FG000|Overall Study|Protocol Violation|1|||
155548368|NCT00985231|561431189|FG001|Overall Study|Protocol Violation|0|||
155548369|NCT00985231|561431188|FG000|Overall Study|Withdrawal by Subject|1|||
155548370|NCT00985231|561431189|FG001|Overall Study|Withdrawal by Subject|0|||
155548371|NCT00985231|561431188|FG000|Overall Study|Lost to Follow-up|0|||
155548372|NCT00985231|561431189|FG001|Overall Study|Lost to Follow-up|1|||
155548373|NCT00985231|561431188|FG000|Overall Study|Study related symptoms & complaints|0|||
155548374|NCT00985231|561431189|FG001|Overall Study|Study related symptoms & complaints|2|||
155548375|NCT00983476|561431193|FG000|Overall Study|Did not receive intervention|17|||
155548376|NCT00983476|561431194|FG001|Overall Study|Did not receive intervention|22|||
155548377|NCT00983476|561431195|FG002|Overall Study|Did not receive intervention|0|||
155548378|NCT00575380|561431201|FG000|Overall Study|Withdrawal by Subject|1|||
155548379|NCT00575380|561431202|FG001|Overall Study|Withdrawal by Subject|0|||
155548380|NCT00575380|561431201|FG000|Overall Study|Adverse Event|0|||
155548381|NCT00575380|561431202|FG001|Overall Study|Adverse Event|1|||
155548382|NCT00575380|561431201|FG000|Overall Study|Various|0|||
155548383|NCT00575380|561431202|FG001|Overall Study|Various|2|||
155548384|NCT04019054|561431203|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
155548385|NCT04019054|561431204|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
155548386|NCT04019054|561431203|FG000|Overall Study|Withdrawal by Subject|3|||
155548387|NCT04019054|561431204|FG001|Overall Study|Withdrawal by Subject|1|||
155548388|NCT01040793|561431205|FG000|Overall Study|Adverse Event|5|||
155548389|NCT01040793|561431206|FG001|Overall Study|Adverse Event|3|||
155548390|NCT01040793|561431207|FG002|Overall Study|Adverse Event|0|||
155548391|NCT01040793|561431208|FG003|Overall Study|Adverse Event|2|||
155548392|NCT01040793|561431209|FG004|Overall Study|Adverse Event|2|||
155548393|NCT01040793|561431210|FG005|Overall Study|Adverse Event|1|||
155548394|NCT01040793|561431205|FG000|Overall Study|Protocol Violation|1|||
155548395|NCT01040793|561431206|FG001|Overall Study|Protocol Violation|1|||
155548396|NCT01040793|561431207|FG002|Overall Study|Protocol Violation|1|||
155548397|NCT01040793|561431208|FG003|Overall Study|Protocol Violation|0|||
155548398|NCT01040793|561431209|FG004|Overall Study|Protocol Violation|1|||
155548399|NCT01040793|561431210|FG005|Overall Study|Protocol Violation|0|||
155548400|NCT01040793|561431205|FG000|Overall Study|Lost to Follow-up|0|||
155548401|NCT01040793|561431206|FG001|Overall Study|Lost to Follow-up|1|||
155548402|NCT01040793|561431207|FG002|Overall Study|Lost to Follow-up|1|||
155548403|NCT01040793|561431208|FG003|Overall Study|Lost to Follow-up|0|||
155548404|NCT01040793|561431209|FG004|Overall Study|Lost to Follow-up|0|||
155548405|NCT01040793|561431210|FG005|Overall Study|Lost to Follow-up|0|||
155548406|NCT01040793|561431205|FG000|Overall Study|Withdrawal by Subject|0|||
155548407|NCT01040793|561431206|FG001|Overall Study|Withdrawal by Subject|0|||
155548408|NCT01040793|561431207|FG002|Overall Study|Withdrawal by Subject|0|||
155548409|NCT01040793|561431208|FG003|Overall Study|Withdrawal by Subject|2|||
155548410|NCT01040793|561431209|FG004|Overall Study|Withdrawal by Subject|0|||
155548411|NCT01040793|561431210|FG005|Overall Study|Withdrawal by Subject|0|||
155548412|NCT01040793|561431205|FG000|Overall Study|Other reasons not listed above|0|||
155548413|NCT01040793|561431206|FG001|Overall Study|Other reasons not listed above|0|||
155548414|NCT01040793|561431207|FG002|Overall Study|Other reasons not listed above|1|||
155548415|NCT01040793|561431208|FG003|Overall Study|Other reasons not listed above|0|||
155548416|NCT01040793|561431209|FG004|Overall Study|Other reasons not listed above|1|||
155548417|NCT01040793|561431210|FG005|Overall Study|Other reasons not listed above|0|||
155548418|NCT00003531|561431211|FG000|Overall Study|Not evaluable|10|||
155548419|NCT00346164|561431212|FG000|Overall Study|Adverse Event|0|||
155548420|NCT00346164|561431213|FG001|Overall Study|Adverse Event|0|||
155548421|NCT00346164|561431214|FG002|Overall Study|Adverse Event|0|||
155548422|NCT00346164|561431215|FG003|Overall Study|Adverse Event|1|||
155548423|NCT00346164|561431212|FG000|Overall Study|Lack of Efficacy|0|||
155548424|NCT00346164|561431213|FG001|Overall Study|Lack of Efficacy|1|||
155548425|NCT00346164|561431214|FG002|Overall Study|Lack of Efficacy|7|||
155548426|NCT00346164|561431215|FG003|Overall Study|Lack of Efficacy|25|||
155548427|NCT00346164|561431212|FG000|Overall Study|Physician Decision|0|||
155548428|NCT00346164|561431213|FG001|Overall Study|Physician Decision|1|||
155548429|NCT00346164|561431214|FG002|Overall Study|Physician Decision|2|||
155548430|NCT00346164|561431215|FG003|Overall Study|Physician Decision|27|||
155548431|NCT00346164|561431212|FG000|Overall Study|Protocol Violation|6|||
155548432|NCT00346164|561431213|FG001|Overall Study|Protocol Violation|2|||
155548433|NCT00346164|561431214|FG002|Overall Study|Protocol Violation|10|||
155548434|NCT00346164|561431215|FG003|Overall Study|Protocol Violation|4|||
155657020|NCT03648372|561837509|FG006|Overall Study|Start of a New Systemic Treatment|0|||
155548435|NCT00346164|561431212|FG000|Overall Study|Withdrawal by Subject|0|||
155548436|NCT00346164|561431213|FG001|Overall Study|Withdrawal by Subject|0|||
155548437|NCT00346164|561431214|FG002|Overall Study|Withdrawal by Subject|2|||
155548438|NCT00346164|561431215|FG003|Overall Study|Withdrawal by Subject|0|||
155548439|NCT00346164|561431212|FG000|Overall Study|Ineligible|11|||
155548440|NCT00346164|561431213|FG001|Overall Study|Ineligible|2|||
155548441|NCT00346164|561431214|FG002|Overall Study|Ineligible|2|||
155548442|NCT00346164|561431215|FG003|Overall Study|Ineligible|23|||
155548443|NCT00346164|561431212|FG000|Overall Study|Refusal of further protocol therapy|0|||
155548444|NCT00346164|561431213|FG001|Overall Study|Refusal of further protocol therapy|1|||
155548445|NCT00346164|561431214|FG002|Overall Study|Refusal of further protocol therapy|3|||
155548446|NCT00346164|561431215|FG003|Overall Study|Refusal of further protocol therapy|15|||
155548447|NCT00346164|561431212|FG000|Overall Study|Inability to start week 16 tx on time|0|||
155548448|NCT00346164|561431213|FG001|Overall Study|Inability to start week 16 tx on time|0|||
155548449|NCT00346164|561431214|FG002|Overall Study|Inability to start week 16 tx on time|0|||
155548450|NCT00346164|561431215|FG003|Overall Study|Inability to start week 16 tx on time|11|||
155548451|NCT03139240|561431216|FG000|Overall Study|Lost to Follow-up|0|||
155548452|NCT03139240|561431217|FG001|Overall Study|Lost to Follow-up|1|||
155548453|NCT03139240|561431218|FG002|Overall Study|Lost to Follow-up|1|||
155548454|NCT03139240|561431219|FG003|Overall Study|Lost to Follow-up|0|||
155548455|NCT01955044|561431220|FG000|Overall Study|Death|1|||
155548456|NCT01955044|561431221|FG001|Overall Study|Death|1|||
155548457|NCT01955044|561431222|FG002|Overall Study|Death|0|||
155548458|NCT02260258|561431226|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
155548459|NCT02260258|561431227|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
155548460|NCT04232540|561431229|FG000|Overall Study|Lost to Follow-up|1|||
155548461|NCT04232540|561431230|FG001|Overall Study|Lost to Follow-up|0|||
155548462|NCT02105701|561431231|FG000|Overall Study|Lost to Follow-up|1|||
155548463|NCT02105701|561431232|FG001|Overall Study|Lost to Follow-up|0|||
155548464|NCT02105701|561431233|FG002|Overall Study|Lost to Follow-up|2|||
155548465|NCT02105701|561431234|FG003|Overall Study|Lost to Follow-up|1|||
155548466|NCT02105701|561431231|FG000|Overall Study|Protocol Violation|0|||
155548467|NCT02105701|561431232|FG001|Overall Study|Protocol Violation|0|||
155548468|NCT02105701|561431233|FG002|Overall Study|Protocol Violation|1|||
155548469|NCT02105701|561431234|FG003|Overall Study|Protocol Violation|0|||
155548470|NCT02105701|561431231|FG000|Overall Study|Withdrawal by Subject|2|||
155548471|NCT02105701|561431232|FG001|Overall Study|Withdrawal by Subject|1|||
155548472|NCT02105701|561431233|FG002|Overall Study|Withdrawal by Subject|0|||
155548473|NCT02105701|561431234|FG003|Overall Study|Withdrawal by Subject|1|||
155548474|NCT02105701|561431231|FG000|Overall Study|Death|1|||
155548475|NCT02105701|561431232|FG001|Overall Study|Death|0|||
155548476|NCT02105701|561431233|FG002|Overall Study|Death|0|||
155548477|NCT02105701|561431234|FG003|Overall Study|Death|0|||
155548478|NCT03234608|561431235|FG000|Overall Study|Lost to Follow-up|23|||
155548479|NCT03234608|561431236|FG001|Overall Study|Lost to Follow-up|21|||
155548480|NCT01362296|561431237|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
155548481|NCT01362296|561431238|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
155548482|NCT01362296|561431239|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
155548483|NCT01362296|561431240|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
155548484|NCT01362296|561431237|FG000|Randomized Phase (RP)|Physician Decision|1|||
155548485|NCT01362296|561431238|FG001|Randomized Phase (RP)|Physician Decision|9|||
155548486|NCT01362296|561431239|FG002|Randomized Phase (RP)|Physician Decision|0|||
155548487|NCT01362296|561431240|FG003|Randomized Phase (RP)|Physician Decision|0|||
155548488|NCT01362296|561431237|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
155548489|NCT01362296|561431238|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
155548490|NCT01362296|561431239|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
155548491|NCT01362296|561431240|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
155548492|NCT01362296|561431237|FG000|Randomized Phase (RP)|Adverse Event|20|||
155548493|NCT01362296|561431238|FG001|Randomized Phase (RP)|Adverse Event|4|||
155657021|NCT03648372|561837510|FG007|Overall Study|Start of a New Systemic Treatment|2|||
155657022|NCT03648372|561837511|FG008|Overall Study|Start of a New Systemic Treatment|0|||
155548494|NCT01362296|561431239|FG002|Randomized Phase (RP)|Adverse Event|0|||
155548495|NCT01362296|561431240|FG003|Randomized Phase (RP)|Adverse Event|0|||
155548496|NCT01362296|561431237|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
155548497|NCT01362296|561431238|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
155548498|NCT01362296|561431239|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
155548499|NCT01362296|561431240|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
155657023|NCT03648372|561837512|FG009|Overall Study|Start of a New Systemic Treatment|0|||
155657024|NCT03648372|561837513|FG010|Overall Study|Start of a New Systemic Treatment|1|||
155548500|NCT01362296|561431237|FG000|Crossover Phase|PD including Death due to PD|0|||
155548501|NCT01362296|561431238|FG001|Crossover Phase|PD including Death due to PD|0|||
155548502|NCT01362296|561431239|FG002|Crossover Phase|PD including Death due to PD|16|||
155657025|NCT03648372|561837514|FG011|Overall Study|Start of a New Systemic Treatment|0|||
155548503|NCT01362296|561431240|FG003|Crossover Phase|PD including Death due to PD|1|||
155548504|NCT01362296|561431237|FG000|Crossover Phase|Withdrawal by Subject|0|||
155548505|NCT01362296|561431238|FG001|Crossover Phase|Withdrawal by Subject|0|||
155548506|NCT01362296|561431239|FG002|Crossover Phase|Withdrawal by Subject|2|||
155548507|NCT01362296|561431240|FG003|Crossover Phase|Withdrawal by Subject|1|||
155548508|NCT01362296|561431237|FG000|Crossover Phase|Adverse Event|0|||
155548509|NCT01362296|561431238|FG001|Crossover Phase|Adverse Event|0|||
155548510|NCT01362296|561431239|FG002|Crossover Phase|Adverse Event|4|||
155548511|NCT01362296|561431240|FG003|Crossover Phase|Adverse Event|0|||
155548512|NCT01362296|561431237|FG000|Crossover Phase|Study Closed/Terminated|0|||
155548513|NCT01362296|561431238|FG001|Crossover Phase|Study Closed/Terminated|0|||
155548514|NCT01362296|561431239|FG002|Crossover Phase|Study Closed/Terminated|1|||
155548515|NCT01362296|561431240|FG003|Crossover Phase|Study Closed/Terminated|0|||
155548516|NCT03693950|561431241|FG000|Overall Study|Withdrawal by Subject|1|||
155548517|NCT03693950|561431242|FG001|Overall Study|Withdrawal by Subject|0|||
155548518|NCT04230876|561431243|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
155548519|NCT04230876|561431244|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
155548520|NCT01662362|561431246|FG000|Overall Study|Lost to Follow-up|38|||
155548521|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
155548522|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
155548523|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
155548524|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
155548525|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
155548526|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
155548527|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
155548528|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
155548529|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
155548530|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
155548531|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
155548532|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
155548533|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Death|0|||
155548534|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Death|1|||
155548535|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Death|0|||
155548536|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Death|0|||
155548537|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
155548538|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
155548539|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
155548540|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
155548541|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
155548542|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
155548543|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
155548544|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
155548545|NCT00545688|561431248|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
155548546|NCT00545688|561431249|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
155548547|NCT00545688|561431250|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
155548548|NCT00545688|561431251|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
155548549|NCT00545688|561431248|FG000|Adjuvant Treatment Period|Disease Progression|3|||
155548550|NCT00545688|561431249|FG001|Adjuvant Treatment Period|Disease Progression|3|||
155548551|NCT00545688|561431250|FG002|Adjuvant Treatment Period|Disease Progression|0|||
155548552|NCT00545688|561431251|FG003|Adjuvant Treatment Period|Disease Progression|7|||
155548553|NCT00545688|561431248|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
155548554|NCT00545688|561431249|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
155548555|NCT00545688|561431250|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
155548556|NCT00545688|561431251|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
155548557|NCT00545688|561431248|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
155548558|NCT00545688|561431249|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
155548559|NCT00545688|561431250|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
155548560|NCT00545688|561431251|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
155548561|NCT00545688|561431248|FG000|Adjuvant Treatment Period|Adverse Event|0|||
155548562|NCT00545688|561431249|FG001|Adjuvant Treatment Period|Adverse Event|3|||
155548563|NCT00545688|561431250|FG002|Adjuvant Treatment Period|Adverse Event|2|||
155548564|NCT00545688|561431251|FG003|Adjuvant Treatment Period|Adverse Event|2|||
155548565|NCT00545688|561431248|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
155548566|NCT00545688|561431249|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
155548567|NCT00545688|561431250|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
155548568|NCT00545688|561431251|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
155548569|NCT00545688|561431248|FG000|Follow-Up Period|Death|4|||
155548570|NCT00545688|561431249|FG001|Follow-Up Period|Death|2|||
155548571|NCT00545688|561431250|FG002|Follow-Up Period|Death|2|||
155548572|NCT00545688|561431251|FG003|Follow-Up Period|Death|6|||
155548573|NCT00545688|561431248|FG000|Follow-Up Period|Disease Progression|6|||
155548574|NCT00545688|561431249|FG001|Follow-Up Period|Disease Progression|5|||
155548575|NCT00545688|561431250|FG002|Follow-Up Period|Disease Progression|9|||
155548576|NCT00545688|561431251|FG003|Follow-Up Period|Disease Progression|9|||
155548577|NCT00545688|561431248|FG000|Follow-Up Period|Refused Treatment|6|||
155548578|NCT00545688|561431249|FG001|Follow-Up Period|Refused Treatment|2|||
155548579|NCT00545688|561431250|FG002|Follow-Up Period|Refused Treatment|0|||
155548580|NCT00545688|561431251|FG003|Follow-Up Period|Refused Treatment|2|||
155548581|NCT00545688|561431248|FG000|Follow-Up Period|Lost to Follow-up|3|||
155548582|NCT00545688|561431249|FG001|Follow-Up Period|Lost to Follow-up|3|||
155548583|NCT00545688|561431250|FG002|Follow-Up Period|Lost to Follow-up|3|||
155548584|NCT00545688|561431251|FG003|Follow-Up Period|Lost to Follow-up|1|||
155548585|NCT00545688|561431248|FG000|Follow-Up Period|Unspecified Reason|2|||
155548586|NCT00545688|561431249|FG001|Follow-Up Period|Unspecified Reason|5|||
155548587|NCT00545688|561431250|FG002|Follow-Up Period|Unspecified Reason|6|||
155548588|NCT00545688|561431251|FG003|Follow-Up Period|Unspecified Reason|8|||
155548589|NCT00545688|561431248|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
155548590|NCT00545688|561431249|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
155548591|NCT00545688|561431250|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
155548592|NCT00545688|561431251|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
155548593|NCT02339090|561431252|FG000|Overall Study|Adverse Event|1|||
155548594|NCT02339090|561431253|FG001|Overall Study|Adverse Event|0|||
155548595|NCT02339090|561431252|FG000|Overall Study|Lost to Follow-up|0|||
155548596|NCT02339090|561431253|FG001|Overall Study|Lost to Follow-up|1|||
155548597|NCT02339090|561431252|FG000|Overall Study|Non-compliance With Study Drug|0|||
155548598|NCT02339090|561431253|FG001|Overall Study|Non-compliance With Study Drug|1|||
155548599|NCT02339090|561431252|FG000|Overall Study|Withdrawal by Subject|2|||
155548600|NCT02339090|561431253|FG001|Overall Study|Withdrawal by Subject|1|||
155548601|NCT02339090|561431252|FG000|Overall Study|Poor Growth|3|||
155548602|NCT02339090|561431253|FG001|Overall Study|Poor Growth|0|||
155548603|NCT02339090|561431252|FG000|Overall Study|Randomized but not treated|0|||
155548604|NCT02339090|561431253|FG001|Overall Study|Randomized but not treated|2|||
155548605|NCT00248170|561431257|FG000|Overall Study|Withdrawal by Subject|71|||
155548606|NCT00248170|561431258|FG001|Overall Study|Withdrawal by Subject|79|||
155548607|NCT00248170|561431257|FG000|Overall Study|Protocol Violation|35|||
155548608|NCT00248170|561431258|FG001|Overall Study|Protocol Violation|30|||
155548609|NCT00248170|561431257|FG000|Overall Study|Lost to Follow-up|28|||
155548610|NCT00248170|561431258|FG001|Overall Study|Lost to Follow-up|35|||
155548611|NCT00248170|561431257|FG000|Overall Study|Disease progression|196|||
155548612|NCT00248170|561431258|FG001|Overall Study|Disease progression|216|||
155548613|NCT00248170|561431257|FG000|Overall Study|Death|28|||
155548614|NCT00248170|561431258|FG001|Overall Study|Death|47|||
155548615|NCT00248170|561431257|FG000|Overall Study|Adverse Event|311|||
155548616|NCT00248170|561431258|FG001|Overall Study|Adverse Event|296|||
155548617|NCT00248170|561431257|FG000|Overall Study|Administrative problems|22|||
155548618|NCT00248170|561431258|FG001|Overall Study|Administrative problems|25|||
155548619|NCT00248170|561431257|FG000|Overall Study|Abnormal test procedure(s) result|49|||
155548620|NCT00248170|561431258|FG001|Overall Study|Abnormal test procedure(s) result|61|||
155548621|NCT00248170|561431257|FG000|Overall Study|Abnormal laboratory values|4|||
155548622|NCT00248170|561431258|FG001|Overall Study|Abnormal laboratory values|0|||
155548623|NCT00248170|561431257|FG000|Overall Study|Protocol deviation|17|||
155548624|NCT00248170|561431258|FG001|Overall Study|Protocol deviation|19|||
155548625|NCT03346070|561432675|FG000|Overall Study|Death|0|||
155548626|NCT03346070|561432676|FG001|Overall Study|Death|0|||
155548627|NCT03346070|561432677|FG002|Overall Study|Death|0|||
155548628|NCT03346070|561432678|FG003|Overall Study|Death|0|||
155548629|NCT03346070|561432679|FG004|Overall Study|Death|1|||
155548630|NCT03346070|561432675|FG000|Overall Study|Lost to Follow-up|0|||
155548631|NCT03346070|561432676|FG001|Overall Study|Lost to Follow-up|1|||
155548632|NCT03346070|561432677|FG002|Overall Study|Lost to Follow-up|2|||
155548633|NCT03346070|561432678|FG003|Overall Study|Lost to Follow-up|0|||
155548634|NCT03346070|561432679|FG004|Overall Study|Lost to Follow-up|0|||
155548635|NCT03346070|561432675|FG000|Overall Study|Physician Decision|0|||
155548636|NCT03346070|561432676|FG001|Overall Study|Physician Decision|0|||
155548637|NCT03346070|561432677|FG002|Overall Study|Physician Decision|0|||
155548638|NCT03346070|561432678|FG003|Overall Study|Physician Decision|1|||
155548639|NCT03346070|561432679|FG004|Overall Study|Physician Decision|1|||
155548640|NCT03346070|561432675|FG000|Overall Study|Withdrawal by Subject|1|||
155548641|NCT03346070|561432676|FG001|Overall Study|Withdrawal by Subject|0|||
155548642|NCT03346070|561432677|FG002|Overall Study|Withdrawal by Subject|0|||
155548643|NCT03346070|561432678|FG003|Overall Study|Withdrawal by Subject|1|||
155548644|NCT03346070|561432679|FG004|Overall Study|Withdrawal by Subject|0|||
155548645|NCT03346070|561432675|FG000|Overall Study|Study medication not received as planned|2|||
155548646|NCT03346070|561432676|FG001|Overall Study|Study medication not received as planned|3|||
155548647|NCT03346070|561432677|FG002|Overall Study|Study medication not received as planned|2|||
155548648|NCT03346070|561432678|FG003|Overall Study|Study medication not received as planned|3|||
155548649|NCT03346070|561432679|FG004|Overall Study|Study medication not received as planned|2|||
155548650|NCT03346070|561432675|FG000|Overall Study|Screen Failure|0|||
155548651|NCT03346070|561432676|FG001|Overall Study|Screen Failure|0|||
155548652|NCT03346070|561432677|FG002|Overall Study|Screen Failure|0|||
155548653|NCT03346070|561432678|FG003|Overall Study|Screen Failure|1|||
155548654|NCT03346070|561432679|FG004|Overall Study|Screen Failure|1|||
155548655|NCT00977548|561432680|FG000|Overall Study|Ineligible|4|||
155548656|NCT00977548|561432680|FG000|Overall Study|Adverse Event|8|||
155548657|NCT00977548|561432680|FG000|Overall Study|Withdrawal by Subject|1|||
155548658|NCT02070757|561432683|FG000|Overall Study|Adverse Event|107|||
155548659|NCT02070757|561432684|FG001|Overall Study|Adverse Event|99|||
155548660|NCT02070757|561432683|FG000|Overall Study|Lost to Follow-up|7|||
155548661|NCT02070757|561432684|FG001|Overall Study|Lost to Follow-up|4|||
155548662|NCT02070757|561432683|FG000|Overall Study|Protocol Violation|0|||
155548663|NCT02070757|561432684|FG001|Overall Study|Protocol Violation|4|||
155548664|NCT02070757|561432683|FG000|Overall Study|Withdrawal by Subject|1|||
155548665|NCT02070757|561432684|FG001|Overall Study|Withdrawal by Subject|3|||
155548666|NCT02070757|561432683|FG000|Overall Study|Investigator Decision|0|||
155548667|NCT02070757|561432684|FG001|Overall Study|Investigator Decision|2|||
155548668|NCT02070757|561432683|FG000|Overall Study|Discharged from Study Hospital|2|||
155548669|NCT02070757|561432684|FG001|Overall Study|Discharged from Study Hospital|2|||
155548670|NCT01546142|561432685|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
155548671|NCT01546142|561432686|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
155548672|NCT01546142|561432685|FG000|Overall Study|Subject Noncompliance|1|||
155548673|NCT01546142|561432686|FG001|Overall Study|Subject Noncompliance|1|||
155548674|NCT01546142|561432685|FG000|Overall Study|Adverse Event|6|||
155548675|NCT01546142|561432686|FG001|Overall Study|Adverse Event|3|||
155548676|NCT01546142|561432685|FG000|Overall Study|Lost to Follow-up|20|||
155548677|NCT01546142|561432686|FG001|Overall Study|Lost to Follow-up|15|||
155548678|NCT01546142|561432685|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
155548679|NCT01546142|561432686|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
155548680|NCT01546142|561432685|FG000|Overall Study|Subject Randomized but Not Treated|1|||
155548681|NCT01546142|561432686|FG001|Overall Study|Subject Randomized but Not Treated|0|||
155548682|NCT01213836|561432687|FG000|Period 1, First Intervention|Adverse Event|2|||
155548683|NCT01213836|561432688|FG001|Period 1, First Intervention|Adverse Event|1|||
155548684|NCT01213836|561432687|FG000|Period 1, First Intervention|Protocol Violation|0|||
155548685|NCT01213836|561432688|FG001|Period 1, First Intervention|Protocol Violation|1|||
155548686|NCT01213836|561432687|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
155548687|NCT01213836|561432688|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
155548688|NCT00706095|561432694|FG000|Overall Study|Progressive Disease|4|||
155548689|NCT00706095|561432695|FG001|Overall Study|Progressive Disease|5|||
155548690|NCT00706095|561432696|FG002|Overall Study|Progressive Disease|3|||
155548691|NCT00706095|561432694|FG000|Overall Study|Clinical Progression|1|||
155548692|NCT00706095|561432695|FG001|Overall Study|Clinical Progression|2|||
155548693|NCT00706095|561432696|FG002|Overall Study|Clinical Progression|2|||
155548694|NCT00706095|561432694|FG000|Overall Study|Withdrawal by Subject|1|||
155548695|NCT00706095|561432695|FG001|Overall Study|Withdrawal by Subject|0|||
155548696|NCT00706095|561432696|FG002|Overall Study|Withdrawal by Subject|0|||
155548697|NCT00892281|561432704|FG000|Overall Study|Adverse Event|65|||
155548698|NCT00892281|561432705|FG001|Overall Study|Adverse Event|8|||
155548699|NCT00892281|561432704|FG000|Overall Study|Lost to Follow-up|81|||
155548700|NCT00892281|561432705|FG001|Overall Study|Lost to Follow-up|8|||
155548701|NCT00892281|561432704|FG000|Overall Study|Pregnancy|1|||
155548702|NCT00892281|561432705|FG001|Overall Study|Pregnancy|0|||
155548703|NCT00892281|561432704|FG000|Overall Study|Protocol Violation|7|||
155548704|NCT00892281|561432705|FG001|Overall Study|Protocol Violation|2|||
155548705|NCT00892281|561432704|FG000|Overall Study|Withdrawal by Subject|86|||
155548706|NCT00892281|561432705|FG001|Overall Study|Withdrawal by Subject|14|||
155548707|NCT00892281|561432704|FG000|Overall Study|Subject failed to return for final visit|2|||
155548708|NCT00892281|561432705|FG001|Overall Study|Subject failed to return for final visit|0|||
155548709|NCT00892281|561432704|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
155548710|NCT00892281|561432705|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
155548711|NCT00892281|561432704|FG000|Overall Study|Final visit completed 4 weeks late|0|||
155548712|NCT00892281|561432705|FG001|Overall Study|Final visit completed 4 weeks late|1|||
155548713|NCT00892281|561432704|FG000|Overall Study|Subject completed day after study closed|1|||
155548714|NCT00892281|561432705|FG001|Overall Study|Subject completed day after study closed|0|||
155548715|NCT00892281|561432704|FG000|Overall Study|Family emergency|1|||
155548716|NCT00892281|561432705|FG001|Overall Study|Family emergency|0|||
155548717|NCT00892281|561432704|FG000|Overall Study|Last visit not done - death in family|1|||
155548718|NCT00892281|561432705|FG001|Overall Study|Last visit not done - death in family|0|||
155548719|NCT00892281|561432704|FG000|Overall Study|Did not meet incl/excl criteria|1|||
155548720|NCT00892281|561432705|FG001|Overall Study|Did not meet incl/excl criteria|0|||
155548721|NCT00892281|561432704|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
155548722|NCT00892281|561432705|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
155548723|NCT00892281|561432704|FG000|Overall Study|Unable to redeem the drug voucher|1|||
155548724|NCT00892281|561432705|FG001|Overall Study|Unable to redeem the drug voucher|0|||
155548725|NCT00892281|561432704|FG000|Overall Study|Subject not good candidate for study|1|||
155548726|NCT00892281|561432705|FG001|Overall Study|Subject not good candidate for study|0|||
155548727|NCT00892281|561432704|FG000|Overall Study|Subject did not return for any visits|1|||
155548728|NCT00892281|561432705|FG001|Overall Study|Subject did not return for any visits|0|||
155548729|NCT00892281|561432704|FG000|Overall Study|Subject missed several visits/lost meds|1|||
155548730|NCT00892281|561432705|FG001|Overall Study|Subject missed several visits/lost meds|0|||
155548731|NCT00892281|561432704|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
155548732|NCT00892281|561432705|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
155548733|NCT00892281|561432704|FG000|Overall Study|Scheduled for knee replacement|0|||
155548734|NCT00892281|561432705|FG001|Overall Study|Scheduled for knee replacement|1|||
155548735|NCT00892281|561432704|FG000|Overall Study|PI complained of inadequate compensation|3|||
155548736|NCT00892281|561432705|FG001|Overall Study|PI complained of inadequate compensation|0|||
155548737|NCT00892281|561432704|FG000|Overall Study|Subject lost interest in program|0|||
155548738|NCT00892281|561432705|FG001|Overall Study|Subject lost interest in program|1|||
155548739|NCT00892281|561432704|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
155548740|NCT00892281|561432705|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
155548741|NCT00892281|561432704|FG000|Overall Study|Death in family|1|||
155548742|NCT00892281|561432705|FG001|Overall Study|Death in family|0|||
155548743|NCT00892281|561432704|FG000|Overall Study|Lack of efficacy of study product|2|||
155657026|NCT03648372|561837515|FG012|Overall Study|Start of a New Systemic Treatment|0|||
155657027|NCT03648372|561837516|FG013|Overall Study|Start of a New Systemic Treatment|0|||
155657028|NCT03648372|561837517|FG014|Overall Study|Start of a New Systemic Treatment|0|||
155657029|NCT03648372|561837518|FG015|Overall Study|Start of a New Systemic Treatment|0|||
155657030|NCT03648372|561837519|FG016|Overall Study|Start of a New Systemic Treatment|0|||
155657031|NCT03648372|561837520|FG017|Overall Study|Start of a New Systemic Treatment|0|||
155657032|NCT03648372|561837521|FG018|Overall Study|Start of a New Systemic Treatment|0|||
155657033|NCT03648372|561837522|FG019|Overall Study|Start of a New Systemic Treatment|0|||
155657034|NCT03648372|561837523|FG020|Overall Study|Start of a New Systemic Treatment|0|||
155657035|NCT04976777|561838882|FG000|Overall Study|COVID-19 Infection|1|||
155657036|NCT04976777|561838883|FG001|Overall Study|COVID-19 Infection|0|||
155657037|NCT00363298|561838884|FG000|First Study Week|Lack of Efficacy|6|||
155657038|NCT00363298|561838885|FG001|First Study Week|Lack of Efficacy|5|||
155657039|NCT00363298|561838884|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
155657040|NCT00363298|561838885|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
155657041|NCT03332056|561838892|FG000|Overall Study|Incomplete questionnaires|8|||
155657042|NCT03332056|561838893|FG001|Overall Study|Incomplete questionnaires|9|||
155657043|NCT03332056|561838892|FG000|Overall Study|Passed stone prior to surgery date|1|||
155657044|NCT03332056|561838893|FG001|Overall Study|Passed stone prior to surgery date|0|||
155657045|NCT03332056|561838892|FG000|Overall Study|Did not require a ureteral stent|0|||
155657046|NCT03332056|561838893|FG001|Overall Study|Did not require a ureteral stent|1|||
155657047|NCT00730327|561838894|FG000|Overall Study|Lost to Follow-up|14|||
155657048|NCT00730327|561838895|FG001|Overall Study|Lost to Follow-up|16|||
155657049|NCT00730327|561838894|FG000|Overall Study|Adverse Event|8|||
155657050|NCT00730327|561838895|FG001|Overall Study|Adverse Event|1|||
155657051|NCT00730327|561838894|FG000|Overall Study|Withdrawal by Subject|3|||
155657052|NCT00730327|561838895|FG001|Overall Study|Withdrawal by Subject|13|||
155657053|NCT00730327|561838894|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
155657054|NCT00730327|561838895|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
155657055|NCT02989857|561838901|FG000|Randomization Phase|Not Treated|3|||
155657056|NCT02989857|561838902|FG001|Randomization Phase|Not Treated|2|||
155657057|NCT02989857|561838903|FG002|Randomization Phase|Not Treated|0|||
155657058|NCT00688740|561838904|FG000|Overall Study|Adverse Event|45|||
155657059|NCT00688740|561838905|FG001|Overall Study|Adverse Event|8|||
155657060|NCT00688740|561838904|FG000|Overall Study|Death|2|||
155657061|NCT00688740|561838905|FG001|Overall Study|Death|2|||
155657062|NCT00688740|561838904|FG000|Overall Study|Lost to Follow-up|0|||
155657063|NCT00688740|561838905|FG001|Overall Study|Lost to Follow-up|1|||
155657064|NCT00688740|561838904|FG000|Overall Study|Consent Withdrawn|17|||
155657065|NCT00688740|561838905|FG001|Overall Study|Consent Withdrawn|17|||
155657066|NCT00688740|561838904|FG000|Overall Study|Breast Cancer Relapse|1|||
155657067|NCT00688740|561838905|FG001|Overall Study|Breast Cancer Relapse|4|||
155657068|NCT00688740|561838904|FG000|Overall Study|Violation of Inclusion Criteria|1|||
155657069|NCT00688740|561838905|FG001|Overall Study|Violation of Inclusion Criteria|3|||
155657070|NCT01905540|561838908|FG000|Period 3|Other|1|||
155657071|NCT01905540|561838909|FG001|Period 3|Other|0|||
155657072|NCT01905540|561838910|FG002|Period 3|Other|1|||
155657073|NCT01905540|561838911|FG003|Period 3|Other|1|||
155657074|NCT02743962|561838912|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
155657075|NCT02743962|561838913|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
155657076|NCT00725985|561838914|FG000|ITP- Treatment Disposition|Adverse Event|20|||
155657077|NCT00725985|561838915|FG001|ITP- Treatment Disposition|Adverse Event|10|||
155548744|NCT00892281|561432705|FG001|Overall Study|Lack of efficacy of study product|0|||
155548745|NCT00892281|561432704|FG000|Overall Study|Subject not seen by PI at final visit|1|||
155548746|NCT00892281|561432705|FG001|Overall Study|Subject not seen by PI at final visit|0|||
155548747|NCT00892281|561432704|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
155657078|NCT00725985|561838916|FG002|ITP- Treatment Disposition|Adverse Event|5|||
155657079|NCT00725985|561838917|FG003|ITP- Treatment Disposition|Adverse Event|0|||
155657080|NCT00725985|561838918|FG004|ITP- Treatment Disposition|Adverse Event|0|||
155657081|NCT00725985|561838919|FG005|ITP- Treatment Disposition|Adverse Event|0|||
155657082|NCT00725985|561838920|FG006|ITP- Treatment Disposition|Adverse Event|0|||
155657083|NCT00725985|561838921|FG007|ITP- Treatment Disposition|Adverse Event|0|||
155548748|NCT00892281|561432705|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
155657084|NCT00725985|561838922|FG008|ITP- Treatment Disposition|Adverse Event|0|||
155657085|NCT00725985|561838923|FG009|ITP- Treatment Disposition|Adverse Event|0|||
155657086|NCT00725985|561838924|FG010|ITP- Treatment Disposition|Adverse Event|0|||
155657087|NCT00725985|561838925|FG011|ITP- Treatment Disposition|Adverse Event|0|||
155548749|NCT00892281|561432704|FG000|Overall Study|Missed multiple visits|1|||
155548750|NCT00892281|561432705|FG001|Overall Study|Missed multiple visits|0|||
155548751|NCT00892281|561432704|FG000|Overall Study|Missed visits rescheduled out of window|1|||
155548752|NCT00892281|561432705|FG001|Overall Study|Missed visits rescheduled out of window|0|||
155548753|NCT00892281|561432704|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
155548754|NCT00892281|561432705|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
155548755|NCT00892281|561432704|FG000|Overall Study|Subject had history of drug abuse|1|||
155548756|NCT00892281|561432705|FG001|Overall Study|Subject had history of drug abuse|0|||
155548757|NCT00892281|561432704|FG000|Overall Study|Rash on hand|1|||
155548758|NCT00892281|561432705|FG001|Overall Study|Rash on hand|0|||
155548759|NCT00892281|561432704|FG000|Overall Study|Visit 4 date out of window|1|||
155548760|NCT00892281|561432705|FG001|Overall Study|Visit 4 date out of window|0|||
155548761|NCT04220775|561432708|FG000|Overall Study|Adverse Event|1|||
155548762|NCT04220775|561432709|FG001|Overall Study|Adverse Event|0|||
155548763|NCT04220775|561432708|FG000|Overall Study|Disease Progression|1|||
155548764|NCT04220775|561432709|FG001|Overall Study|Disease Progression|0|||
155548765|NCT00436917|561432710|FG000|Overall Study|Withdrawal by Subject|13|||
155548766|NCT00436917|561432710|FG000|Overall Study|Adverse Event|2|||
155548767|NCT00436917|561432710|FG000|Overall Study|Physician Decision|1|||
155548768|NCT00436917|561432710|FG000|Overall Study|Death|1|||
155548769|NCT00436917|561432710|FG000|Overall Study|Lost to Follow-up|1|||
155548770|NCT00436917|561432710|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
155548771|NCT00436917|561432710|FG000|Overall Study|Increased creatinine|1|||
155548772|NCT00436917|561432710|FG000|Overall Study|Personal conflicts of patient|1|||
155548773|NCT02169791|561432711|FG000|Overall Study|Death|6|||
155548774|NCT02169791|561432711|FG000|Overall Study|patient withdrew consent|1|||
155548775|NCT01009515|561432713|FG000|Overall Study|Withdrawal by Subject|3|||
155548776|NCT01501110|561432715|FG000|Overall Study|Death|0|||
155548777|NCT01501110|561432716|FG001|Overall Study|Death|1|||
155548778|NCT02075606|561432717|FG000|Overall Study|Adverse Event|5|||
155548779|NCT02075606|561432717|FG000|Overall Study|Withdrawal by Subject|1|||
155548780|NCT02075606|561432717|FG000|Overall Study|Death|1|||
155548781|NCT02075606|561432717|FG000|Overall Study|Investigator's decision|1|||
155548782|NCT02075606|561432717|FG000|Overall Study|Symptom management|1|||
155548783|NCT02075606|561432717|FG000|Overall Study|Increasing Symptoms|1|||
155548784|NCT01439724|561432719|FG000|Overall Study|missing consultation|9|||
155548785|NCT01439724|561432720|FG001|Overall Study|missing consultation|8|||
155548786|NCT01857206|561432721|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
155548787|NCT01857206|561432722|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
155548788|NCT01857206|561432721|FG000|Overall Study|Lost to Follow-up|9|||
155548789|NCT01857206|561432722|FG001|Overall Study|Lost to Follow-up|6|||
155548790|NCT01857206|561432721|FG000|Overall Study|Unclassified|3|||
155548791|NCT01857206|561432722|FG001|Overall Study|Unclassified|3|||
155548792|NCT01857206|561432721|FG000|Overall Study|Withdrawal by Subject|1|||
155548793|NCT01857206|561432722|FG001|Overall Study|Withdrawal by Subject|0|||
155548794|NCT01483625|561432725|FG000|Overall Study|Adverse Event|1|||
155548795|NCT01483625|561432726|FG001|Overall Study|Adverse Event|1|||
155548796|NCT01483625|561432725|FG000|Overall Study|Refused to continue medication|2|||
155548797|NCT01483625|561432726|FG001|Overall Study|Refused to continue medication|1|||
155657088|NCT00725985|561838914|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
155548798|NCT01483625|561432725|FG000|Overall Study|Due to other reason|1|||
155548799|NCT01483625|561432726|FG001|Overall Study|Due to other reason|0|||
155548800|NCT01261624|561432731|FG000|Week 0 to Week 12|Disease Progression|1|||
155548801|NCT01261624|561432732|FG001|Week 0 to Week 12|Disease Progression|1|||
155548802|NCT01261624|561432731|FG000|Week 0 to Week 12|Insufficient Response|0|||
155548803|NCT01261624|561432732|FG001|Week 0 to Week 12|Insufficient Response|2|||
155548804|NCT01261624|561432731|FG000|Week 13 to Week 24|Insufficient Response|0|||
155548805|NCT01261624|561432732|FG001|Week 13 to Week 24|Insufficient Response|1|||
155548806|NCT00271024|561432733|FG000|Overall Study|Lost Interest|3|||
155548807|NCT00271024|561432734|FG001|Overall Study|Lost Interest|4|||
155548808|NCT00271024|561432735|FG002|Overall Study|Lost Interest|2|||
155548809|NCT00271024|561432736|FG003|Overall Study|Lost Interest|3|||
155548810|NCT00271024|561432733|FG000|Overall Study|Unknown/Unspecified|11|||
155548811|NCT00271024|561432734|FG001|Overall Study|Unknown/Unspecified|11|||
155548812|NCT00271024|561432735|FG002|Overall Study|Unknown/Unspecified|8|||
155548813|NCT00271024|561432736|FG003|Overall Study|Unknown/Unspecified|4|||
155548814|NCT00271024|561432733|FG000|Overall Study|Protocol Violation|1|||
155548815|NCT00271024|561432734|FG001|Overall Study|Protocol Violation|6|||
155548816|NCT00271024|561432735|FG002|Overall Study|Protocol Violation|5|||
155548817|NCT00271024|561432736|FG003|Overall Study|Protocol Violation|11|||
155548818|NCT00271024|561432733|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
155548819|NCT00271024|561432734|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
155548820|NCT00271024|561432735|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
155548821|NCT00271024|561432736|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
155548822|NCT00271024|561432733|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
155548823|NCT00271024|561432734|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
155548824|NCT00271024|561432735|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
155548825|NCT00271024|561432736|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
155548826|NCT02094261|561432740|FG000|Overall Study|Death|24|||
155548827|NCT02094261|561432740|FG000|Overall Study|Lost to Follow-up|1|||
155548828|NCT02094261|561432740|FG000|Overall Study|Withdrawal by Subject|4|||
155548829|NCT02094261|561432740|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
155548830|NCT01083680|561432750|FG000|Overall Study|Lost to Follow-up|2758|||
155548831|NCT01083680|561432750|FG000|Overall Study|Withdrawal by Subject|1086|||
155548832|NCT03877926|561432751|FG000|Overall Study|Adverse Event|1|||
155548833|NCT03877926|561432752|FG001|Overall Study|Adverse Event|0|||
155548834|NCT03877926|561432753|FG002|Overall Study|Adverse Event|0|||
155548835|NCT03877926|561432754|FG003|Overall Study|Adverse Event|0|||
155548836|NCT03877926|561432751|FG000|Overall Study|Death|2|||
155548837|NCT03877926|561432752|FG001|Overall Study|Death|2|||
155548838|NCT03877926|561432753|FG002|Overall Study|Death|2|||
155548839|NCT03877926|561432754|FG003|Overall Study|Death|0|||
155548840|NCT03877926|561432751|FG000|Overall Study|Lost to Follow-up|41|||
155548841|NCT03877926|561432752|FG001|Overall Study|Lost to Follow-up|52|||
155548842|NCT03877926|561432753|FG002|Overall Study|Lost to Follow-up|45|||
155548843|NCT03877926|561432754|FG003|Overall Study|Lost to Follow-up|17|||
155548844|NCT03877926|561432751|FG000|Overall Study|Physician Decision|2|||
155548845|NCT03877926|561432752|FG001|Overall Study|Physician Decision|0|||
155548846|NCT03877926|561432753|FG002|Overall Study|Physician Decision|2|||
155548847|NCT03877926|561432754|FG003|Overall Study|Physician Decision|0|||
155548848|NCT03877926|561432751|FG000|Overall Study|Withdrawal by Subject|18|||
155548849|NCT03877926|561432752|FG001|Overall Study|Withdrawal by Subject|21|||
155548850|NCT03877926|561432753|FG002|Overall Study|Withdrawal by Subject|12|||
155548851|NCT03877926|561432754|FG003|Overall Study|Withdrawal by Subject|4|||
155548852|NCT03877926|561432751|FG000|Overall Study|Other - Various|4|||
155548853|NCT03877926|561432752|FG001|Overall Study|Other - Various|1|||
155548854|NCT03877926|561432753|FG002|Overall Study|Other - Various|1|||
155548855|NCT03877926|561432754|FG003|Overall Study|Other - Various|0|||
155548856|NCT03877926|561432751|FG000|Overall Study|Not Treated|3|||
155548857|NCT03877926|561432752|FG001|Overall Study|Not Treated|1|||
155548858|NCT03877926|561432753|FG002|Overall Study|Not Treated|1|||
155548859|NCT03877926|561432754|FG003|Overall Study|Not Treated|0|||
155548860|NCT02400476|561432755|FG000|Overall Study|Adverse Event|57|||
155548861|NCT02400476|561432756|FG001|Overall Study|Adverse Event|10|||
155548862|NCT02400476|561432757|FG002|Overall Study|Adverse Event|22|||
155548863|NCT02400476|561432758|FG003|Overall Study|Adverse Event|19|||
155548864|NCT02400476|561432759|FG004|Overall Study|Adverse Event|5|||
155548865|NCT02400476|561432760|FG005|Overall Study|Adverse Event|8|||
155548866|NCT02400476|561432755|FG000|Overall Study|Withdrawal by Subject|4|||
155548867|NCT02400476|561432756|FG001|Overall Study|Withdrawal by Subject|1|||
155548868|NCT02400476|561432757|FG002|Overall Study|Withdrawal by Subject|12|||
155548869|NCT02400476|561432758|FG003|Overall Study|Withdrawal by Subject|7|||
155548870|NCT02400476|561432759|FG004|Overall Study|Withdrawal by Subject|5|||
155548871|NCT02400476|561432760|FG005|Overall Study|Withdrawal by Subject|5|||
155548872|NCT02400476|561432755|FG000|Overall Study|Lost to Follow-up|0|||
155548873|NCT02400476|561432756|FG001|Overall Study|Lost to Follow-up|0|||
155548874|NCT02400476|561432757|FG002|Overall Study|Lost to Follow-up|0|||
155548875|NCT02400476|561432758|FG003|Overall Study|Lost to Follow-up|1|||
155548876|NCT02400476|561432759|FG004|Overall Study|Lost to Follow-up|3|||
155548877|NCT02400476|561432760|FG005|Overall Study|Lost to Follow-up|1|||
155548878|NCT02400476|561432755|FG000|Overall Study|Physician Decision|0|||
155548879|NCT02400476|561432756|FG001|Overall Study|Physician Decision|0|||
155548880|NCT02400476|561432757|FG002|Overall Study|Physician Decision|1|||
155548881|NCT02400476|561432758|FG003|Overall Study|Physician Decision|1|||
155548882|NCT02400476|561432759|FG004|Overall Study|Physician Decision|0|||
155548883|NCT02400476|561432760|FG005|Overall Study|Physician Decision|1|||
155548884|NCT02400476|561432755|FG000|Overall Study|Other, Disease Progression|0|||
155548885|NCT02400476|561432756|FG001|Overall Study|Other, Disease Progression|1|||
155548886|NCT02400476|561432757|FG002|Overall Study|Other, Disease Progression|2|||
155548887|NCT02400476|561432758|FG003|Overall Study|Other, Disease Progression|1|||
155548888|NCT02400476|561432759|FG004|Overall Study|Other, Disease Progression|2|||
155548889|NCT02400476|561432760|FG005|Overall Study|Other, Disease Progression|1|||
155548890|NCT02400476|561432755|FG000|Overall Study|Other, Decreased Quality of Life|0|||
155548891|NCT02400476|561432756|FG001|Overall Study|Other, Decreased Quality of Life|0|||
155548892|NCT02400476|561432757|FG002|Overall Study|Other, Decreased Quality of Life|2|||
155548893|NCT02400476|561432758|FG003|Overall Study|Other, Decreased Quality of Life|0|||
155548894|NCT02400476|561432759|FG004|Overall Study|Other, Decreased Quality of Life|0|||
155548895|NCT02400476|561432760|FG005|Overall Study|Other, Decreased Quality of Life|0|||
155548896|NCT02400476|561432755|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
155548897|NCT02400476|561432756|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
155548898|NCT02400476|561432757|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
155548899|NCT02400476|561432758|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
155548900|NCT02400476|561432759|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
155548901|NCT02400476|561432760|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
155548902|NCT00588731|561432761|FG000|Overall Study|Withdrawal by Subject|3|||
155548903|NCT00588731|561432762|FG001|Overall Study|Withdrawal by Subject|2|||
155548904|NCT00467831|561432764|FG000|Overall Study|Death|2|||
155548905|NCT00467831|561432764|FG000|Overall Study|Withdrawal by Subject|1|||
155548906|NCT01832402|561432765|FG000|Overall Study|Lost to Follow-up|2|||
155548907|NCT01832402|561432766|FG001|Overall Study|Lost to Follow-up|0|||
155548908|NCT01832402|561432765|FG000|Overall Study|Withdrawal by Subject|3|||
155548909|NCT01832402|561432766|FG001|Overall Study|Withdrawal by Subject|3|||
155548910|NCT01832402|561432765|FG000|Overall Study|Declining Performance status|2|||
155548911|NCT01832402|561432766|FG001|Overall Study|Declining Performance status|1|||
155548912|NCT01198873|561432767|FG000|Overall Study|Adverse Event|4|||
155548913|NCT01198873|561432768|FG001|Overall Study|Adverse Event|7|||
155548914|NCT01198873|561432767|FG000|Overall Study|Study closure|29|||
155548915|NCT01198873|561432768|FG001|Overall Study|Study closure|23|||
155548916|NCT01198873|561432767|FG000|Overall Study|Other than above|4|||
155548917|NCT01198873|561432768|FG001|Overall Study|Other than above|2|||
155548918|NCT00860743|561432769|FG000|Overall Study|Withdrawal by Subject|3|||
155548919|NCT00860743|561432770|FG001|Overall Study|Withdrawal by Subject|0|||
155548920|NCT02776553|561432771|FG000|Overall Study|Lost to Follow-up|1|||
155548921|NCT02776553|561432772|FG001|Overall Study|Lost to Follow-up|0|||
155548922|NCT02776553|561432771|FG000|Overall Study|got liver transplant|1|||
155548923|NCT02776553|561432772|FG001|Overall Study|got liver transplant|2|||
155548924|NCT02776553|561432771|FG000|Overall Study|had other surgery|1|||
155548925|NCT02776553|561432772|FG001|Overall Study|had other surgery|0|||
155548926|NCT02776553|561432771|FG000|Overall Study|Protocol Violation|0|||
155548927|NCT02776553|561432772|FG001|Overall Study|Protocol Violation|1|||
155548928|NCT02927834|561432773|FG000|Overall Study|Lost to Follow-up|1|||
155548929|NCT02927834|561432774|FG001|Overall Study|Lost to Follow-up|2|||
155548930|NCT02927834|561432775|FG002|Overall Study|Lost to Follow-up|2|||
155548931|NCT00479388|561432776|FG000|Overall Study|Adverse Event|90|||
155548932|NCT00479388|561432777|FG001|Overall Study|Adverse Event|45|||
155548933|NCT00479388|561432776|FG000|Overall Study|Lost to Follow-up|0|||
155548934|NCT00479388|561432777|FG001|Overall Study|Lost to Follow-up|2|||
155548935|NCT00479388|561432776|FG000|Overall Study|Protocol Violation|10|||
155548936|NCT00479388|561432777|FG001|Overall Study|Protocol Violation|9|||
155548937|NCT00479388|561432776|FG000|Overall Study|Withdrawal by Subject|32|||
155548938|NCT00479388|561432777|FG001|Overall Study|Withdrawal by Subject|17|||
155548939|NCT01644149|561432778|FG000|Overall Study|Withdrawal by Subject|1|||
155548940|NCT01644149|561432779|FG001|Overall Study|Withdrawal by Subject|0|||
155548941|NCT01644149|561432778|FG000|Overall Study|Lost to Follow-up|3|||
155548942|NCT01644149|561432779|FG001|Overall Study|Lost to Follow-up|1|||
155548943|NCT04798482|561432782|FG000|Overall Study|Physician Decision|1|||
155548944|NCT04798482|561432782|FG000|Overall Study|Lost eligibility|1|||
155548945|NCT00690482|561432783|FG000|Overall Study|Adverse Event|2|||
155548946|NCT00690482|561432784|FG001|Overall Study|Adverse Event|1|||
155548947|NCT00690482|561432783|FG000|Overall Study|Incorrect enrolment|0|||
155548948|NCT00690482|561432784|FG001|Overall Study|Incorrect enrolment|1|||
155548949|NCT00690482|561432783|FG000|Overall Study|Study-specific discontinuation criteria|1|||
155548950|NCT00690482|561432784|FG001|Overall Study|Study-specific discontinuation criteria|0|||
155548951|NCT00690482|561432783|FG000|Overall Study|Intake of prohibited medicine|1|||
155548952|NCT00690482|561432784|FG001|Overall Study|Intake of prohibited medicine|0|||
155548953|NCT00690482|561432783|FG000|Overall Study|withdrew consent at rand.day|0|||
155548954|NCT00690482|561432784|FG001|Overall Study|withdrew consent at rand.day|1|||
155548955|NCT00890552|561432785|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
155548956|NCT00890552|561432785|FG000|On-treatment|Early prog disease/ death|10|||
155548957|NCT02244424|561432789|FG000|Overall Study|Lost to Follow-up|20|||
155548958|NCT02244424|561432790|FG001|Overall Study|Lost to Follow-up|10|||
155548959|NCT04117945|561432791|FG000|Overall Study|Death|1|||
155548960|NCT04117945|561432792|FG001|Overall Study|Death|0|||
155548961|NCT04117945|561432791|FG000|Overall Study|Withdrawal by Subject|3|||
155548962|NCT04117945|561432792|FG001|Overall Study|Withdrawal by Subject|1|||
155548963|NCT04117945|561432791|FG000|Overall Study|Disease Progression|0|||
155548964|NCT04117945|561432792|FG001|Overall Study|Disease Progression|2|||
155548965|NCT04117945|561432791|FG000|Overall Study|Ineligible|8|||
155548966|NCT04117945|561432792|FG001|Overall Study|Ineligible|7|||
155548967|NCT00562120|561432796|FG000|First Intervention Period|Adverse Event|1|||
155548968|NCT00562120|561432797|FG001|First Intervention Period|Adverse Event|0|||
155548969|NCT00562120|561432798|FG002|First Intervention Period|Adverse Event|0|||
155548970|NCT00562120|561432799|FG003|First Intervention Period|Adverse Event|0|||
155548971|NCT00562120|561432796|FG000|First Intervention Period|Randomized but not Treated|1|||
155548972|NCT00562120|561432797|FG001|First Intervention Period|Randomized but not Treated|0|||
155548973|NCT00562120|561432798|FG002|First Intervention Period|Randomized but not Treated|0|||
155548974|NCT00562120|561432799|FG003|First Intervention Period|Randomized but not Treated|0|||
155548975|NCT02148445|561432800|FG000|Overall Study|Death|1|||
155548976|NCT02148445|561432801|FG001|Overall Study|Death|3|||
155548977|NCT02093923|561432802|FG000|Overall Study|Lost to Follow-up|0|||
155548978|NCT02093923|561432803|FG001|Overall Study|Lost to Follow-up|0|||
155548979|NCT02093923|561432804|FG002|Overall Study|Lost to Follow-up|0|||
155548980|NCT02093923|561432805|FG003|Overall Study|Lost to Follow-up|1|||
155548981|NCT02093923|561432806|FG004|Overall Study|Lost to Follow-up|0|||
155548982|NCT02093923|561432802|FG000|Overall Study|Screen failure after randomization|0|||
155548983|NCT02093923|561432803|FG001|Overall Study|Screen failure after randomization|0|||
155548984|NCT02093923|561432804|FG002|Overall Study|Screen failure after randomization|0|||
155548985|NCT02093923|561432805|FG003|Overall Study|Screen failure after randomization|1|||
155548986|NCT02093923|561432806|FG004|Overall Study|Screen failure after randomization|0|||
155548987|NCT03438006|561432807|FG000|Overall Study|Adverse Event|1|||
155548988|NCT03438006|561432807|FG000|Overall Study|Lost to Follow-up|67|||
155548989|NCT03438006|561432807|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
155548990|NCT03438006|561432807|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
155548991|NCT02737592|561432808|FG000|Overall Study|Withdrawal by Subject|1|||
155548992|NCT02792218|561432809|FG000|Overall Study|Patient/guardian decision|15|||
155548993|NCT02792218|561432810|FG001|Overall Study|Patient/guardian decision|42|||
155548994|NCT02792218|561432809|FG000|Overall Study|Adverse Event|15|||
155548995|NCT02792218|561432810|FG001|Overall Study|Adverse Event|14|||
155548996|NCT02792218|561432809|FG000|Overall Study|Lost to Follow-up|10|||
155548997|NCT02792218|561432810|FG001|Overall Study|Lost to Follow-up|5|||
155548998|NCT02792218|561432809|FG000|Overall Study|Lack of Efficacy|1|||
155548999|NCT02792218|561432810|FG001|Overall Study|Lack of Efficacy|12|||
155549000|NCT02792218|561432809|FG000|Overall Study|Physician Decision|4|||
155549001|NCT02792218|561432810|FG001|Overall Study|Physician Decision|4|||
155549002|NCT02792218|561432809|FG000|Overall Study|Protocol deviation|3|||
155549003|NCT02792218|561432810|FG001|Overall Study|Protocol deviation|2|||
155549004|NCT02792218|561432809|FG000|Overall Study|New therapy for study indication|0|||
155549005|NCT02792218|561432810|FG001|Overall Study|New therapy for study indication|1|||
155549006|NCT02792218|561432809|FG000|Overall Study|Non-compliance with study treatment|0|||
155549007|NCT02792218|561432810|FG001|Overall Study|Non-compliance with study treatment|1|||
155549008|NCT02792218|561432809|FG000|Overall Study|Pregnancy|1|||
155549009|NCT02792218|561432810|FG001|Overall Study|Pregnancy|0|||
155549010|NCT03123783|561432811|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549011|NCT03123783|561432812|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
155657089|NCT00725985|561838915|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657090|NCT00725985|561838916|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
155549012|NCT03123783|561432813|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549013|NCT03123783|561432814|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549014|NCT03123783|561432815|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549015|NCT03123783|561432816|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549016|NCT03123783|561432817|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
155549017|NCT03123783|561432811|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
155549018|NCT03123783|561432812|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
155549019|NCT03123783|561432813|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
155549020|NCT03123783|561432814|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
155549021|NCT03123783|561432815|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
155549022|NCT03123783|561432816|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
155549023|NCT03123783|561432817|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
155549024|NCT03123783|561432811|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
155549025|NCT03123783|561432812|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
155549026|NCT03123783|561432813|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
155549027|NCT03123783|561432814|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
155549028|NCT03123783|561432815|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
155549029|NCT03123783|561432816|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
155549030|NCT03123783|561432817|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
155549031|NCT03123783|561432811|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155549032|NCT03123783|561432812|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155549033|NCT03123783|561432813|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155549034|NCT03123783|561432814|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155657091|NCT00725985|561838917|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
155549035|NCT03123783|561432815|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
155549036|NCT03123783|561432816|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155549037|NCT03123783|561432817|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155549038|NCT00955721|561432819|FG000|Overall Study|Physician Decision|1|||
155549039|NCT00955721|561432820|FG001|Overall Study|Physician Decision|0|||
155549040|NCT00955721|561432819|FG000|Overall Study|Death|1|||
155549041|NCT00955721|561432820|FG001|Overall Study|Death|0|||
155549042|NCT00955721|561432819|FG000|Overall Study|Withdrawal by Subject|1|||
155549043|NCT00955721|561432820|FG001|Overall Study|Withdrawal by Subject|0|||
155549044|NCT01253317|561432829|FG000|Overall Study|Adverse Event|2|||
155549045|NCT00749411|561432834|FG000|Overall Study|Adverse Event|0|||
155549046|NCT00749411|561432835|FG001|Overall Study|Adverse Event|2|||
155549047|NCT00749411|561432834|FG000|Overall Study|Lack of Efficacy|0|||
155549048|NCT00749411|561432835|FG001|Overall Study|Lack of Efficacy|1|||
155549049|NCT00749411|561432834|FG000|Overall Study|Protocol Violation|1|||
155549050|NCT00749411|561432835|FG001|Overall Study|Protocol Violation|1|||
155549051|NCT00749411|561432834|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155549052|NCT00749411|561432835|FG001|Overall Study|Protocol-defined stopping criteria|1|||
155549053|NCT01507090|561432839|FG000|Overall Study|incomplete dataset|18|||
155549054|NCT02284347|561434182|FG000|Overall Study|Lost to Follow-up|2|||
155549055|NCT02284347|561434182|FG000|Overall Study|Withdrawn prior to treatment|1|||
155549056|NCT01301482|561434183|FG000|Overall Study|Withdrawal by Subject|1|||
155549057|NCT02999984|561434191|FG000|Overall Study|Treatment Failure|1|||
155549058|NCT00754013|561434194|FG000|Overall Study|Lost to Follow-up|1|||
155549059|NCT00754013|561434195|FG001|Overall Study|Lost to Follow-up|1|||
155549060|NCT00754013|561434194|FG000|Overall Study|didn't return after study termed|3|||
155549061|NCT00754013|561434195|FG001|Overall Study|didn't return after study termed|4|||
155549062|NCT03756883|561434198|FG000|Overall Study|Adverse Event|2|||
155549063|NCT03756883|561434199|FG001|Overall Study|Adverse Event|2|||
155549064|NCT03756883|561434200|FG002|Overall Study|Adverse Event|2|||
155549065|NCT03756883|561434198|FG000|Overall Study|Lack of Efficacy|0|||
155549066|NCT03756883|561434199|FG001|Overall Study|Lack of Efficacy|1|||
155549067|NCT03756883|561434200|FG002|Overall Study|Lack of Efficacy|2|||
155549068|NCT03756883|561434198|FG000|Overall Study|Lost to Follow-up|3|||
155549069|NCT03756883|561434199|FG001|Overall Study|Lost to Follow-up|3|||
155549070|NCT03756883|561434200|FG002|Overall Study|Lost to Follow-up|0|||
155549071|NCT03756883|561434198|FG000|Overall Study|Protocol Violation|2|||
155549072|NCT03756883|561434199|FG001|Overall Study|Protocol Violation|0|||
155549073|NCT03756883|561434200|FG002|Overall Study|Protocol Violation|1|||
155549074|NCT03756883|561434198|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
155549075|NCT03756883|561434199|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
155549076|NCT03756883|561434200|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
155549077|NCT03756883|561434198|FG000|Overall Study|Withdrawal by Subject|4|||
155549078|NCT03756883|561434199|FG001|Overall Study|Withdrawal by Subject|1|||
155549079|NCT03756883|561434200|FG002|Overall Study|Withdrawal by Subject|0|||
155549080|NCT03756883|561434198|FG000|Overall Study|Other Reasons|2|||
155549081|NCT03756883|561434199|FG001|Overall Study|Other Reasons|4|||
155549082|NCT03756883|561434200|FG002|Overall Study|Other Reasons|0|||
155549083|NCT00619359|561434201|FG000|Overall Study|Adverse Event|32|||
155549084|NCT00619359|561434202|FG001|Overall Study|Adverse Event|36|||
155549085|NCT00619359|561434201|FG000|Overall Study|Lost to Follow-up|12|||
155549086|NCT00619359|561434202|FG001|Overall Study|Lost to Follow-up|16|||
155549087|NCT00619359|561434201|FG000|Overall Study|Physician Decision|0|||
155549088|NCT00619359|561434202|FG001|Overall Study|Physician Decision|7|||
155549089|NCT00619359|561434201|FG000|Overall Study|Protocol Violation|1|||
155549090|NCT00619359|561434202|FG001|Overall Study|Protocol Violation|1|||
155549091|NCT00619359|561434201|FG000|Overall Study|Withdrawal by Subject|19|||
155549092|NCT00619359|561434202|FG001|Overall Study|Withdrawal by Subject|20|||
155549093|NCT00619359|561434201|FG000|Overall Study|Progressive Disease|3|||
155549094|NCT00619359|561434202|FG001|Overall Study|Progressive Disease|1|||
155549095|NCT05212883|561434206|FG000|Overall Study|Invalid test result|125|||
155549096|NCT02502734|561434207|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
155549097|NCT02502734|561434208|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
155549098|NCT02502734|561434207|FG000|Washout Period|Adverse Event|1|||
155549099|NCT02502734|561434208|FG001|Washout Period|Adverse Event|0|||
155549100|NCT03095118|561434214|FG000|Overall Study|Adverse Event|1|||
155549101|NCT03095118|561434214|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
155549102|NCT02363439|561434217|FG000|Overall Study|Lack of Efficacy|4|||
155549103|NCT03573817|561434222|FG000|Overall Study|Adverse Event|0|||
155549104|NCT03573817|561434223|FG001|Overall Study|Adverse Event|2|||
155549105|NCT03573817|561434222|FG000|Overall Study|Protocol Violation|0|||
155549106|NCT03573817|561434223|FG001|Overall Study|Protocol Violation|1|||
155549107|NCT03573817|561434222|FG000|Overall Study|Withdrawal by Subject|1|||
155549108|NCT03573817|561434223|FG001|Overall Study|Withdrawal by Subject|1|||
155549109|NCT01719562|561434226|FG000|Overall Study|Lost to Follow-up|1|||
155549110|NCT01719562|561434227|FG001|Overall Study|Lost to Follow-up|0|||
155549111|NCT01719562|561434226|FG000|Overall Study|Death|1|||
155549112|NCT01719562|561434227|FG001|Overall Study|Death|0|||
155549113|NCT01719562|561434226|FG000|Overall Study|New cancer diagnosis|1|||
155549114|NCT01719562|561434227|FG001|Overall Study|New cancer diagnosis|0|||
155549115|NCT00508027|561434228|FG000|Dose Level 1|Lost to Follow-up|4|||
155549116|NCT00508027|561434228|FG000|Dose Level 1|Withdrawal by Subject|2|||
155549117|NCT00508027|561434228|FG000|Dose Level 1|Physician Decision|2|||
155549118|NCT00508027|561434228|FG000|Dose Level 2|Lost to Follow-up|2|||
155549119|NCT00508027|561434228|FG000|Dose Level 2|Withdrawal by Subject|2|||
155549120|NCT02013531|561434231|FG000|Overall Study|Lost to Follow-up|3|||
155549121|NCT02013531|561434231|FG000|Overall Study|Met Withdrawal Criteria|1|||
155549122|NCT02013531|561434231|FG000|Overall Study|Withdrawal by Subject|1|||
155549123|NCT03554317|561434233|FG000|Overall Study|Withdrawal by Subject|1|||
155549124|NCT03554317|561434233|FG000|Overall Study|PSA Progression|3|||
155549125|NCT03554317|561434233|FG000|Overall Study|Radiographic Progression|4|||
155549126|NCT00939627|561434238|FG000|Overall Study|Disease Progression|16|||
155549127|NCT00939627|561434239|FG001|Overall Study|Disease Progression|12|||
155549128|NCT00939627|561434240|FG002|Overall Study|Disease Progression|0|||
155549129|NCT00939627|561434238|FG000|Overall Study|Adverse Event|6|||
155549130|NCT00939627|561434239|FG001|Overall Study|Adverse Event|7|||
155549131|NCT00939627|561434240|FG002|Overall Study|Adverse Event|0|||
155549132|NCT00939627|561434238|FG000|Overall Study|Death|0|||
155549133|NCT00939627|561434239|FG001|Overall Study|Death|2|||
155549134|NCT00939627|561434240|FG002|Overall Study|Death|0|||
155549135|NCT00939627|561434238|FG000|Overall Study|Withdrawal by Subject|2|||
155549136|NCT00939627|561434239|FG001|Overall Study|Withdrawal by Subject|4|||
155549137|NCT00939627|561434240|FG002|Overall Study|Withdrawal by Subject|0|||
155549138|NCT00939627|561434238|FG000|Overall Study|Other complicating disease|1|||
155549139|NCT00939627|561434239|FG001|Overall Study|Other complicating disease|1|||
155549140|NCT00939627|561434240|FG002|Overall Study|Other complicating disease|0|||
155549141|NCT00939627|561434238|FG000|Overall Study|Not compliant|2|||
155549142|NCT00939627|561434239|FG001|Overall Study|Not compliant|0|||
155549143|NCT00939627|561434240|FG002|Overall Study|Not compliant|0|||
155549144|NCT00939627|561434238|FG000|Overall Study|No off-tx reason given|0|||
155549145|NCT00939627|561434239|FG001|Overall Study|No off-tx reason given|2|||
155549146|NCT00939627|561434240|FG002|Overall Study|No off-tx reason given|0|||
155549147|NCT00537199|561434245|FG000|Overall Study|Study Terminated|1|||
155549148|NCT00612677|561434250|FG000|Overall Study|study closed before treatment started|1|||
155549149|NCT03417830|561434252|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
155549150|NCT03417830|561434253|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
155549151|NCT00823199|561434254|FG000|Overall Study|Withdrawal by Subject|2|||
155549152|NCT00941720|561434258|FG000|Overall Study|Withdrawal by Subject|1|||
155549153|NCT00941720|561434258|FG000|Overall Study|Insurance denied participation|11|||
155549154|NCT00941720|561434258|FG000|Overall Study|ineligible|2|||
155549155|NCT01998243|561434261|FG000|Overall Study|Pregnancy|0|||
155549156|NCT01998243|561434262|FG001|Overall Study|Pregnancy|1|||
155549157|NCT01998243|561434261|FG000|Overall Study|Protocol Violation|5|||
155549158|NCT01998243|561434262|FG001|Overall Study|Protocol Violation|2|||
155549159|NCT01998243|561434261|FG000|Overall Study|Withdrawal by Subject|3|||
155549160|NCT01998243|561434262|FG001|Overall Study|Withdrawal by Subject|4|||
155549161|NCT00268892|561434266|FG000|Overall Study|Adverse Event|14|||
155549162|NCT00268892|561434267|FG001|Overall Study|Adverse Event|17|||
155549163|NCT00268892|561434268|FG002|Overall Study|Adverse Event|20|||
155549164|NCT00268892|561434266|FG000|Overall Study|Lack of Efficacy|1|||
155549165|NCT00268892|561434267|FG001|Overall Study|Lack of Efficacy|3|||
155549166|NCT00268892|561434268|FG002|Overall Study|Lack of Efficacy|0|||
155549167|NCT00268892|561434266|FG000|Overall Study|Withdrawal by Subject|14|||
155549168|NCT00268892|561434267|FG001|Overall Study|Withdrawal by Subject|15|||
155549169|NCT00268892|561434268|FG002|Overall Study|Withdrawal by Subject|13|||
155549170|NCT00268892|561434266|FG000|Overall Study|Physician Decision|0|||
155549171|NCT00268892|561434267|FG001|Overall Study|Physician Decision|1|||
155549172|NCT00268892|561434268|FG002|Overall Study|Physician Decision|0|||
155549173|NCT00268892|561434266|FG000|Overall Study|Lost to Follow-up|5|||
155549174|NCT00268892|561434267|FG001|Overall Study|Lost to Follow-up|2|||
155549175|NCT00268892|561434268|FG002|Overall Study|Lost to Follow-up|4|||
155549176|NCT00268892|561434266|FG000|Overall Study|Protocol Violation|0|||
155549177|NCT00268892|561434267|FG001|Overall Study|Protocol Violation|1|||
155549178|NCT00268892|561434268|FG002|Overall Study|Protocol Violation|0|||
155549179|NCT00268892|561434266|FG000|Overall Study|Disease Progression|1|||
155549180|NCT00268892|561434267|FG001|Overall Study|Disease Progression|1|||
155549181|NCT00268892|561434268|FG002|Overall Study|Disease Progression|0|||
155549182|NCT00268892|561434266|FG000|Overall Study|Trial Site Closed|4|||
155549183|NCT00268892|561434267|FG001|Overall Study|Trial Site Closed|2|||
155549184|NCT00268892|561434268|FG002|Overall Study|Trial Site Closed|2|||
155549185|NCT01640184|561434269|FG000|Overall Study|Death|1|||
155549186|NCT01640184|561434270|FG001|Overall Study|Death|0|||
155549187|NCT01640184|561434271|FG002|Overall Study|Death|0|||
155549188|NCT01640184|561434269|FG000|Overall Study|Lost to Follow-up|4|||
155549189|NCT01640184|561434270|FG001|Overall Study|Lost to Follow-up|1|||
155549190|NCT01640184|561434271|FG002|Overall Study|Lost to Follow-up|0|||
155549191|NCT01640184|561434269|FG000|Overall Study|Physician Decision|3|||
155549192|NCT01640184|561434270|FG001|Overall Study|Physician Decision|0|||
155549193|NCT01640184|561434271|FG002|Overall Study|Physician Decision|0|||
155549194|NCT01640184|561434269|FG000|Overall Study|Withdrawal by Subject|0|||
155549195|NCT01640184|561434270|FG001|Overall Study|Withdrawal by Subject|1|||
155549196|NCT01640184|561434271|FG002|Overall Study|Withdrawal by Subject|1|||
155549197|NCT01640184|561434269|FG000|Overall Study|Protocol Violation|0|||
155549198|NCT01640184|561434270|FG001|Overall Study|Protocol Violation|0|||
155549199|NCT01640184|561434271|FG002|Overall Study|Protocol Violation|1|||
155549200|NCT02087176|561434272|FG000|Overall Study|Withdrawal by Subject|1|||
155549201|NCT02087176|561434272|FG000|Overall Study|Death|10|||
155549202|NCT02087176|561434272|FG000|Overall Study|Censored|19|||
155549203|NCT02087176|561434272|FG000|Overall Study|Study Terminated by Sponsor|2|||
155549204|NCT02492841|561434273|FG000|Overall Study|Lost to Follow-up|34|||
155549205|NCT02492841|561434274|FG001|Overall Study|Lost to Follow-up|31|||
155549206|NCT02492841|561434275|FG002|Overall Study|Lost to Follow-up|35|||
155549207|NCT03812991|561434277|FG000|Overall Study|Lost to Follow-up|3|||
155549208|NCT03812991|561434278|FG001|Overall Study|Lost to Follow-up|1|||
155549209|NCT01876368|561434279|FG000|Overall Study|Adverse Event|2|||
155549210|NCT01876368|561434280|FG001|Overall Study|Adverse Event|5|||
155549211|NCT01876368|561434279|FG000|Overall Study|Lack of Efficacy|1|||
155549212|NCT01876368|561434280|FG001|Overall Study|Lack of Efficacy|0|||
155549213|NCT01876368|561434279|FG000|Overall Study|Lost to Follow-up|0|||
155549214|NCT01876368|561434280|FG001|Overall Study|Lost to Follow-up|1|||
155549215|NCT01876368|561434279|FG000|Overall Study|Non-compliance with study treatment|0|||
155549216|NCT01876368|561434280|FG001|Overall Study|Non-compliance with study treatment|1|||
155549217|NCT01876368|561434279|FG000|Overall Study|Physician Decision|0|||
155549218|NCT01876368|561434280|FG001|Overall Study|Physician Decision|2|||
155549219|NCT01876368|561434279|FG000|Overall Study|Protocol deviation|3|||
155549220|NCT01876368|561434280|FG001|Overall Study|Protocol deviation|3|||
155549221|NCT01876368|561434279|FG000|Overall Study|Subject/guardian decision|3|||
155549222|NCT01876368|561434280|FG001|Overall Study|Subject/guardian decision|1|||
155549223|NCT02563769|561434281|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
155549224|NCT02563769|561434282|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
155549225|NCT02563769|561434283|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
155549226|NCT01192399|561434287|FG000|Overall Study|Lack of Efficacy|2|||
155549227|NCT01930175|561434288|FG000|Core Study|Lost to Follow-up|0|||
155549228|NCT01930175|561434289|FG001|Core Study|Lost to Follow-up|1|||
155549229|NCT01930175|561434290|FG002|Core Study|Lost to Follow-up|0|||
155549230|NCT01930175|561434288|FG000|Core Study|Adverse Event|0|||
155549231|NCT01930175|561434289|FG001|Core Study|Adverse Event|0|||
155549232|NCT01930175|561434290|FG002|Core Study|Adverse Event|1|||
155549233|NCT02820740|561434291|FG000|Overall Study|Did not have procedure|2|||
155549234|NCT03903159|561434294|FG000|Overall Study|Discharged with Staff Approval|2|||
155549235|NCT03903159|561434294|FG000|Overall Study|Discharged at Staff Request|2|||
155549236|NCT03903159|561434294|FG000|Overall Study|Discharged Against Staff Advice|1|||
155549237|NCT00724373|561434295|FG000|Overall Study|Adverse Event|41|||
155549238|NCT00724373|561434295|FG000|Overall Study|Lack of Efficacy|82|||
155549239|NCT00724373|561434295|FG000|Overall Study|Lost to Follow-up|7|||
155549240|NCT00724373|561434295|FG000|Overall Study|Non-compliance|2|||
155549241|NCT00724373|561434295|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
155549242|NCT00724373|561434295|FG000|Overall Study|Participant moved away|1|||
155549243|NCT00724373|561434295|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
155549244|NCT00724373|561434295|FG000|Overall Study|Only to have 24 week regimen|1|||
155549245|NCT00724373|561434295|FG000|Overall Study|Viral Relapse|1|||
155549246|NCT00724373|561434295|FG000|Overall Study|Acute HCV infection|1|||
155549247|NCT00724373|561434295|FG000|Overall Study|Drug Relapse|1|||
155549248|NCT00724373|561434295|FG000|Overall Study|Tolerability|23|||
155549249|NCT03450629|561434297|FG000|Overall Study|Adverse Event|15|||
155549250|NCT03450629|561434298|FG001|Overall Study|Adverse Event|14|||
155549251|NCT03450629|561434297|FG000|Overall Study|Physician Decision|2|||
155549252|NCT03450629|561434298|FG001|Overall Study|Physician Decision|2|||
155549253|NCT03450629|561434297|FG000|Overall Study|Lack of Efficacy|2|||
155549254|NCT03450629|561434298|FG001|Overall Study|Lack of Efficacy|0|||
155549255|NCT03450629|561434297|FG000|Overall Study|Lost to Follow-up|4|||
155549256|NCT03450629|561434298|FG001|Overall Study|Lost to Follow-up|2|||
155549257|NCT03450629|561434297|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155549258|NCT03450629|561434298|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
155549259|NCT03450629|561434297|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155549260|NCT03450629|561434298|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155549261|NCT03450629|561434297|FG000|Overall Study|Protocol Violation|11|||
155549262|NCT03450629|561434298|FG001|Overall Study|Protocol Violation|8|||
155549263|NCT03450629|561434297|FG000|Overall Study|Withdrawal by Subject|12|||
155549264|NCT03450629|561434298|FG001|Overall Study|Withdrawal by Subject|6|||
155549265|NCT03366194|561434299|FG000|Overall Study|Lost to Follow-up|2|||
155549266|NCT01181531|561434300|FG000|Overall Study|Other|17|||
155549267|NCT01181531|561434301|FG001|Overall Study|Other|12|||
155549268|NCT01181531|561434300|FG000|Overall Study|Partial consent by subject withdrawn|0|||
155549269|NCT01181531|561434301|FG001|Overall Study|Partial consent by subject withdrawn|1|||
155549270|NCT01181531|561434300|FG000|Overall Study|Physician Decision|3|||
155549271|NCT01181531|561434301|FG001|Overall Study|Physician Decision|1|||
155549272|NCT01181531|561434300|FG000|Overall Study|Noncompliance|2|||
155549273|NCT01181531|561434301|FG001|Overall Study|Noncompliance|2|||
155549274|NCT01181531|561434300|FG000|Overall Study|Ineligibility determined|1|||
155549275|NCT01181531|561434301|FG001|Overall Study|Ineligibility determined|2|||
155549276|NCT01181531|561434300|FG000|Overall Study|Protocol Specified Criteria|15|||
155549277|NCT01181531|561434301|FG001|Overall Study|Protocol Specified Criteria|8|||
155549278|NCT01181531|561434300|FG000|Overall Study|Pregnancy|0|||
155549279|NCT01181531|561434301|FG001|Overall Study|Pregnancy|1|||
155549280|NCT01181531|561434300|FG000|Overall Study|Withdrawal by Subject|8|||
155549281|NCT01181531|561434301|FG001|Overall Study|Withdrawal by Subject|7|||
155549282|NCT01181531|561434300|FG000|Overall Study|Protocol Violation|6|||
155549283|NCT01181531|561434301|FG001|Overall Study|Protocol Violation|6|||
155549284|NCT01181531|561434300|FG000|Overall Study|Death|9|||
155549285|NCT01181531|561434301|FG001|Overall Study|Death|12|||
155549286|NCT01181531|561434300|FG000|Overall Study|Adverse Event|0|||
155549287|NCT01181531|561434301|FG001|Overall Study|Adverse Event|1|||
155549288|NCT02953678|561434305|FG000|Overall Study|Adverse Event|20|||
155549289|NCT02953678|561434305|FG000|Overall Study|Death|7|||
155549290|NCT02953678|561434305|FG000|Overall Study|Physician Decision|23|||
155549291|NCT02953678|561434305|FG000|Overall Study|Progressive Disease of GVHD|7|||
155549292|NCT02953678|561434305|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
155549293|NCT02953678|561434305|FG000|Overall Study|Withdrawal by participant|3|||
155549294|NCT02953678|561434305|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
155549295|NCT02953678|561434305|FG000|Overall Study|Participants were transferred to commercial product.|3|||
155549296|NCT04678817|561435687|FG000|Overall Study|Lost to Follow-up|28|||
155549297|NCT04678817|561435688|FG001|Overall Study|Lost to Follow-up|0|||
155549298|NCT04678817|561435689|FG002|Overall Study|Lost to Follow-up|0|||
155549299|NCT02124902|561435693|FG000|Overall Study|Adverse Event|7|||
155549300|NCT02124902|561435694|FG001|Overall Study|Adverse Event|2|||
155549301|NCT02124902|561435693|FG000|Overall Study|Went to alternative treatment|4|||
155549302|NCT02124902|561435694|FG001|Overall Study|Went to alternative treatment|0|||
155549303|NCT02124902|561435693|FG000|Overall Study|Withdrawal by Subject|2|||
155549304|NCT02124902|561435694|FG001|Overall Study|Withdrawal by Subject|1|||
155549305|NCT02124902|561435693|FG000|Overall Study|Physician Decision|2|||
155549306|NCT02124902|561435694|FG001|Overall Study|Physician Decision|0|||
155549307|NCT02124902|561435693|FG000|Overall Study|Not eligible|1|||
155549308|NCT02124902|561435694|FG001|Overall Study|Not eligible|0|||
155549309|NCT02124902|561435693|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
155549310|NCT02124902|561435694|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
155549311|NCT00546910|561435695|FG000|Overall Study|Adverse Event|2|||
155549312|NCT00546910|561435696|FG001|Overall Study|Adverse Event|3|||
155549313|NCT00546910|561435695|FG000|Overall Study|Lack of Efficacy|5|||
155549314|NCT00546910|561435696|FG001|Overall Study|Lack of Efficacy|7|||
155549315|NCT00546910|561435695|FG000|Overall Study|Physician Decision|0|||
155549316|NCT00546910|561435696|FG001|Overall Study|Physician Decision|1|||
155549317|NCT00546910|561435695|FG000|Overall Study|Withdrawal by Subject|2|||
155549318|NCT00546910|561435696|FG001|Overall Study|Withdrawal by Subject|0|||
155549319|NCT01730040|561435698|FG000|Overall Study|Randomized but not treated|0|||
155549320|NCT01730040|561435699|FG001|Overall Study|Randomized but not treated|0|||
155549321|NCT01730040|561435700|FG002|Overall Study|Randomized but not treated|0|||
155549322|NCT01730040|561435701|FG003|Overall Study|Randomized but not treated|0|||
155549323|NCT01730040|561435702|FG004|Overall Study|Randomized but not treated|0|||
155549324|NCT01730040|561435703|FG005|Overall Study|Randomized but not treated|1|||
155549325|NCT01730040|561435704|FG006|Overall Study|Randomized but not treated|0|||
155549326|NCT01730040|561435698|FG000|Overall Study|Subject moved|0|||
155549327|NCT01730040|561435699|FG001|Overall Study|Subject moved|0|||
155549328|NCT01730040|561435700|FG002|Overall Study|Subject moved|1|||
155549329|NCT01730040|561435701|FG003|Overall Study|Subject moved|0|||
155549330|NCT01730040|561435702|FG004|Overall Study|Subject moved|0|||
155549331|NCT01730040|561435703|FG005|Overall Study|Subject moved|0|||
155549332|NCT01730040|561435704|FG006|Overall Study|Subject moved|1|||
155549333|NCT01730040|561435698|FG000|Overall Study|Physician Decision|0|||
155549334|NCT01730040|561435699|FG001|Overall Study|Physician Decision|0|||
155549335|NCT01730040|561435700|FG002|Overall Study|Physician Decision|0|||
155549336|NCT01730040|561435701|FG003|Overall Study|Physician Decision|0|||
155549337|NCT01730040|561435702|FG004|Overall Study|Physician Decision|0|||
155549338|NCT01730040|561435703|FG005|Overall Study|Physician Decision|1|||
155549339|NCT01730040|561435704|FG006|Overall Study|Physician Decision|1|||
155549340|NCT01730040|561435698|FG000|Overall Study|Other than specified|7|||
155549341|NCT01730040|561435699|FG001|Overall Study|Other than specified|8|||
155549342|NCT01730040|561435700|FG002|Overall Study|Other than specified|5|||
155549343|NCT01730040|561435701|FG003|Overall Study|Other than specified|5|||
155549344|NCT01730040|561435702|FG004|Overall Study|Other than specified|5|||
155549345|NCT01730040|561435703|FG005|Overall Study|Other than specified|4|||
155549346|NCT01730040|561435704|FG006|Overall Study|Other than specified|4|||
155549347|NCT01730040|561435698|FG000|Overall Study|Adverse Event|4|||
155549348|NCT01730040|561435699|FG001|Overall Study|Adverse Event|3|||
155549349|NCT01730040|561435700|FG002|Overall Study|Adverse Event|5|||
155549350|NCT01730040|561435701|FG003|Overall Study|Adverse Event|3|||
155549351|NCT01730040|561435702|FG004|Overall Study|Adverse Event|1|||
155549352|NCT01730040|561435703|FG005|Overall Study|Adverse Event|1|||
155549353|NCT01730040|561435704|FG006|Overall Study|Adverse Event|2|||
155549354|NCT01730040|561435698|FG000|Overall Study|Poor compliance to protocol|2|||
155549355|NCT01730040|561435699|FG001|Overall Study|Poor compliance to protocol|4|||
155549356|NCT01730040|561435700|FG002|Overall Study|Poor compliance to protocol|0|||
155549357|NCT01730040|561435701|FG003|Overall Study|Poor compliance to protocol|0|||
155549358|NCT01730040|561435702|FG004|Overall Study|Poor compliance to protocol|0|||
155549359|NCT01730040|561435703|FG005|Overall Study|Poor compliance to protocol|0|||
155549360|NCT01730040|561435704|FG006|Overall Study|Poor compliance to protocol|1|||
155549361|NCT00544817|561435707|FG000|Combined Modality|Lack of Efficacy|2|||
155549362|NCT00544817|561435707|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
155549363|NCT00544817|561435707|FG000|Combined Modality|Adverse Event|2|||
155549364|NCT00544817|561435707|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
155549365|NCT00544817|561435707|FG000|No Treatment Interval|Lack of Efficacy|8|||
155549366|NCT00544817|561435707|FG000|No Treatment Interval|Physician Decision|3|||
155549367|NCT00544817|561435707|FG000|No Treatment Interval|Adverse Event|1|||
155549368|NCT00544817|561435707|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
155549369|NCT00544817|561435707|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
155549370|NCT00544817|561435707|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
155549371|NCT01552369|561435708|FG000|Overall Study|Did not consent to extended follow up|8|||
155549372|NCT01552369|561435709|FG001|Overall Study|Did not consent to extended follow up|9|||
155549373|NCT00614926|561435710|FG000|Overall Study|Burden of travel|1|||
155549374|NCT00614926|561435711|FG001|Overall Study|Burden of travel|0|||
155549375|NCT00614926|561435710|FG000|Overall Study|Adverse Event|3|||
155549376|NCT00614926|561435711|FG001|Overall Study|Adverse Event|0|||
155549377|NCT02310789|561435716|FG000|Overall Study|Adverse Event|1|||
155549378|NCT01197417|561435717|FG000|Overall Study|Physician Decision|3|||
155549379|NCT01197417|561435718|FG001|Overall Study|Physician Decision|2|||
155549380|NCT01197417|561435717|FG000|Overall Study|Withdrawal by Subject|2|||
155549381|NCT01197417|561435718|FG001|Overall Study|Withdrawal by Subject|4|||
155549382|NCT01197417|561435717|FG000|Overall Study|Site miscommunication|0|||
155549383|NCT01197417|561435718|FG001|Overall Study|Site miscommunication|1|||
155549384|NCT01197417|561435717|FG000|Overall Study|Subject transferred to intensive care|0|||
155549385|NCT01197417|561435718|FG001|Overall Study|Subject transferred to intensive care|1|||
155549386|NCT01197417|561435717|FG000|Overall Study|Not consented in time to receive drug|0|||
155549387|NCT01197417|561435718|FG001|Overall Study|Not consented in time to receive drug|1|||
155549388|NCT01197417|561435717|FG000|Overall Study|Hypotension|1|||
155549389|NCT01197417|561435718|FG001|Overall Study|Hypotension|2|||
155549390|NCT01197417|561435717|FG000|Overall Study|Found to be ineligible|2|||
155549391|NCT01197417|561435718|FG001|Overall Study|Found to be ineligible|5|||
155549392|NCT01197417|561435717|FG000|Overall Study|No 25-hour magnesium level|0|||
155549393|NCT01197417|561435718|FG001|Overall Study|No 25-hour magnesium level|2|||
155549394|NCT02813421|561435723|FG000|Overall Study|Withdrawal by Subject|1|||
155549395|NCT02813421|561435724|FG001|Overall Study|Withdrawal by Subject|2|||
155549396|NCT02813421|561435723|FG000|Overall Study|Lost to Follow-up|1|||
155549397|NCT02813421|561435724|FG001|Overall Study|Lost to Follow-up|1|||
155549398|NCT04213209|561435732|FG000|Overall Study|Protocol Violation|1|||
155549399|NCT04213209|561435733|FG001|Overall Study|Protocol Violation|0|||
155549400|NCT04213209|561435734|FG002|Overall Study|Protocol Violation|0|||
155549401|NCT04213209|561435735|FG003|Overall Study|Protocol Violation|0|||
155549402|NCT04213209|561435736|FG004|Overall Study|Protocol Violation|0|||
155549403|NCT04213209|561435737|FG005|Overall Study|Protocol Violation|0|||
155549404|NCT02129647|561435747|FG000|Overall Study|Adverse Event|2|||
155657092|NCT00725985|561838918|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
155549405|NCT02129647|561435747|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
155549406|NCT01570283|561435749|FG000|Cohort 1: Dose Level 1|Death|0|||
155549407|NCT01570283|561435750|FG001|Cohort 1: Dose Level 1|Death|1|||
155549408|NCT01570283|561435751|FG002|Cohort 1: Dose Level 1|Death|0|||
155549409|NCT01570283|561435752|FG003|Cohort 1: Dose Level 1|Death|0|||
155549410|NCT01570283|561435753|FG004|Cohort 1: Dose Level 1|Death|0|||
155549411|NCT01570283|561435754|FG005|Cohort 1: Dose Level 1|Death|0|||
155549412|NCT01570283|561435749|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
155549413|NCT01570283|561435750|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
155549414|NCT01570283|561435751|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
155549415|NCT01570283|561435752|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
155549416|NCT01570283|561435753|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
155549417|NCT01570283|561435754|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
155549418|NCT01570283|561435749|FG000|Cohort 2: Dose Level 2|Death|0|||
155549419|NCT01570283|561435750|FG001|Cohort 2: Dose Level 2|Death|0|||
155549420|NCT01570283|561435751|FG002|Cohort 2: Dose Level 2|Death|1|||
155549421|NCT01570283|561435752|FG003|Cohort 2: Dose Level 2|Death|0|||
155549422|NCT01570283|561435753|FG004|Cohort 2: Dose Level 2|Death|0|||
155549423|NCT01570283|561435754|FG005|Cohort 2: Dose Level 2|Death|0|||
155549424|NCT01570283|561435749|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
155549425|NCT01570283|561435750|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
155549426|NCT01570283|561435751|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
155549427|NCT01570283|561435752|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
155549428|NCT01570283|561435753|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
155549429|NCT01570283|561435754|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
155549430|NCT01570283|561435749|FG000|Cohort 3: Dose Level 3|Death|0|||
155549431|NCT01570283|561435750|FG001|Cohort 3: Dose Level 3|Death|0|||
155549432|NCT01570283|561435751|FG002|Cohort 3: Dose Level 3|Death|0|||
155549433|NCT01570283|561435752|FG003|Cohort 3: Dose Level 3|Death|0|||
155549434|NCT01570283|561435753|FG004|Cohort 3: Dose Level 3|Death|0|||
155549435|NCT01570283|561435754|FG005|Cohort 3: Dose Level 3|Death|1|||
155549436|NCT01570283|561435749|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155549437|NCT01570283|561435750|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155549438|NCT01570283|561435751|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155549439|NCT01570283|561435752|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155549440|NCT01570283|561435753|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155549441|NCT01570283|561435754|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
155549442|NCT00685802|561435757|FG000|Washout Period of 7 Days|Protocol Violation|2|||
155549443|NCT00685802|561435758|FG001|Washout Period of 7 Days|Protocol Violation|0|||
155549444|NCT00685802|561435757|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155549445|NCT00685802|561435758|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155549446|NCT01333072|561435759|FG000|Overall Study|Lost to Follow-up|3|||
155549447|NCT01333072|561435760|FG001|Overall Study|Lost to Follow-up|0|||
155549448|NCT01333072|561435759|FG000|Overall Study|Adverse Event|2|||
155549449|NCT01333072|561435760|FG001|Overall Study|Adverse Event|4|||
155549450|NCT01333072|561435759|FG000|Overall Study|Physician Decision|1|||
155549451|NCT01333072|561435760|FG001|Overall Study|Physician Decision|0|||
155549452|NCT00103038|561435763|FG000|Overall Study|Withdrawal by Subject|8|||
155549453|NCT00103038|561435763|FG000|Overall Study|Screen failure|3|||
155549454|NCT00103038|561435763|FG000|Overall Study|Death|1|||
155549455|NCT00103038|561435763|FG000|Overall Study|Physician Decision|1|||
155549456|NCT01463982|561435764|FG000|Overall Study|Withdrawal by Subject|0|||
155549457|NCT01463982|561435765|FG001|Overall Study|Withdrawal by Subject|1|||
155549458|NCT01463982|561435766|FG002|Overall Study|Withdrawal by Subject|1|||
155549459|NCT01463982|561435767|FG003|Overall Study|Withdrawal by Subject|0|||
155549460|NCT01463982|561435764|FG000|Overall Study|Treatment delay over 5 week|0|||
155549461|NCT01463982|561435765|FG001|Overall Study|Treatment delay over 5 week|0|||
155549462|NCT01463982|561435766|FG002|Overall Study|Treatment delay over 5 week|1|||
155549463|NCT01463982|561435767|FG003|Overall Study|Treatment delay over 5 week|0|||
155549464|NCT02462486|561435770|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155549465|NCT02462486|561435771|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155549466|NCT02462486|561435772|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
155549467|NCT02462486|561435770|FG000|Overall Study|Adverse Event|53|||
155549468|NCT02462486|561435771|FG001|Overall Study|Adverse Event|48|||
155549469|NCT02462486|561435772|FG002|Overall Study|Adverse Event|21|||
155549470|NCT02462486|561435770|FG000|Overall Study|Lack of Efficacy|6|||
155549471|NCT02462486|561435771|FG001|Overall Study|Lack of Efficacy|12|||
155549472|NCT02462486|561435772|FG002|Overall Study|Lack of Efficacy|3|||
155549473|NCT02462486|561435770|FG000|Overall Study|Lost to Follow-up|3|||
155549474|NCT02462486|561435771|FG001|Overall Study|Lost to Follow-up|4|||
155549475|NCT02462486|561435772|FG002|Overall Study|Lost to Follow-up|2|||
155549476|NCT02462486|561435770|FG000|Overall Study|Withdrawal by Subject|25|||
155549477|NCT02462486|561435771|FG001|Overall Study|Withdrawal by Subject|22|||
155549478|NCT02462486|561435772|FG002|Overall Study|Withdrawal by Subject|19|||
155549479|NCT02462486|561435770|FG000|Overall Study|Protocol Violation|3|||
155549480|NCT02462486|561435771|FG001|Overall Study|Protocol Violation|1|||
155549481|NCT02462486|561435772|FG002|Overall Study|Protocol Violation|1|||
155549482|NCT02462486|561435770|FG000|Overall Study|Reason not Specified|3|||
155549483|NCT02462486|561435771|FG001|Overall Study|Reason not Specified|4|||
155549484|NCT02462486|561435772|FG002|Overall Study|Reason not Specified|3|||
155549485|NCT01731886|561435774|FG000|Overall Study|Death|1|||
155549486|NCT01731886|561435775|FG001|Overall Study|Death|0|||
155549487|NCT01731886|561435774|FG000|Overall Study|Never started treatment|0|||
155549488|NCT01731886|561435775|FG001|Overall Study|Never started treatment|1|||
155549489|NCT01731886|561435774|FG000|Overall Study|Non-compliant|1|||
155549490|NCT01731886|561435775|FG001|Overall Study|Non-compliant|0|||
155549491|NCT02280187|561435776|FG000|Overall Study|Lost to Follow-up|218|||
155549492|NCT04668274|561435777|FG000|Part 1 Study Period 1|Adverse Event|3|||
155549493|NCT04668274|561435778|FG001|Part 1 Study Period 1|Adverse Event|0|||
155549494|NCT04668274|561435779|FG002|Part 1 Study Period 1|Adverse Event|0|||
155549495|NCT04668274|561435780|FG003|Part 1 Study Period 1|Adverse Event|0|||
155549496|NCT04668274|561435777|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
155549497|NCT04668274|561435778|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
155549498|NCT04668274|561435779|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
155549499|NCT04668274|561435780|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
155549500|NCT04668274|561435777|FG000|Part 1 Study Period 2|Other|0|||
155549501|NCT04668274|561435778|FG001|Part 1 Study Period 2|Other|1|||
155549502|NCT04668274|561435779|FG002|Part 1 Study Period 2|Other|0|||
155549503|NCT04668274|561435780|FG003|Part 1 Study Period 2|Other|0|||
155549504|NCT04668274|561435777|FG000|Part 1 Study Period 3|Adverse Event|0|||
155549505|NCT04668274|561435778|FG001|Part 1 Study Period 3|Adverse Event|0|||
155549506|NCT04668274|561435779|FG002|Part 1 Study Period 3|Adverse Event|1|||
155549507|NCT04668274|561435780|FG003|Part 1 Study Period 3|Adverse Event|0|||
155549508|NCT04668274|561435777|FG000|Part 1 Study Period 3|Other|0|||
155549509|NCT04668274|561435778|FG001|Part 1 Study Period 3|Other|0|||
155549510|NCT04668274|561435779|FG002|Part 1 Study Period 3|Other|2|||
155549511|NCT04668274|561435780|FG003|Part 1 Study Period 3|Other|0|||
155549512|NCT04668274|561435777|FG000|Part 2 Study Period 4|Other|0|||
155549513|NCT04668274|561435778|FG001|Part 2 Study Period 4|Other|0|||
155549514|NCT04668274|561435779|FG002|Part 2 Study Period 4|Other|0|||
155549515|NCT04668274|561435780|FG003|Part 2 Study Period 4|Other|1|||
155549516|NCT02039063|561435782|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
155657093|NCT00725985|561838919|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657094|NCT00725985|561838920|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657095|NCT00725985|561838921|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657096|NCT00725985|561838922|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657097|NCT00725985|561838923|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657098|NCT00725985|561838924|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657099|NCT00725985|561838925|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
155657100|NCT00725985|561838914|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
155549517|NCT02039063|561435783|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
155549518|NCT02039063|561435784|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
155549519|NCT02039063|561435785|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
155549520|NCT02039063|561435782|FG000|Treatment Phase|Progression of disease|0|||
155549521|NCT02039063|561435783|FG001|Treatment Phase|Progression of disease|0|||
155549522|NCT02039063|561435784|FG002|Treatment Phase|Progression of disease|1|||
155549523|NCT02039063|561435785|FG003|Treatment Phase|Progression of disease|1|||
155549524|NCT02039063|561435782|FG000|Extension Phase|Inadequate therapeutic effect|0|||
155549525|NCT02039063|561435783|FG001|Extension Phase|Inadequate therapeutic effect|1|||
155549526|NCT02039063|561435784|FG002|Extension Phase|Inadequate therapeutic effect|2|||
155549527|NCT02039063|561435785|FG003|Extension Phase|Inadequate therapeutic effect|0|||
155549528|NCT02039063|561435782|FG000|Extension Phase|Progression of disease|0|||
155549529|NCT02039063|561435783|FG001|Extension Phase|Progression of disease|0|||
155549530|NCT02039063|561435784|FG002|Extension Phase|Progression of disease|0|||
155657101|NCT00725985|561838915|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
155657102|NCT00725985|561838916|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
155549531|NCT02039063|561435785|FG003|Extension Phase|Progression of disease|1|||
155549532|NCT02039063|561435782|FG000|Extension Phase|Adverse Event|0|||
155549533|NCT02039063|561435783|FG001|Extension Phase|Adverse Event|0|||
155549534|NCT02039063|561435784|FG002|Extension Phase|Adverse Event|1|||
155549535|NCT02039063|561435785|FG003|Extension Phase|Adverse Event|0|||
155549536|NCT00171340|561435786|FG000|Overall Study|Adverse Event|46|||
155549537|NCT00171340|561435787|FG001|Overall Study|Adverse Event|42|||
155549538|NCT00171340|561435786|FG000|Overall Study|Lack of Efficacy|29|||
155549539|NCT00171340|561435787|FG001|Overall Study|Lack of Efficacy|41|||
155549540|NCT00171340|561435786|FG000|Overall Study|Protocol Violation|7|||
155549541|NCT00171340|561435787|FG001|Overall Study|Protocol Violation|8|||
155549542|NCT00171340|561435786|FG000|Overall Study|Withdrawal by Subject|22|||
155549543|NCT00171340|561435787|FG001|Overall Study|Withdrawal by Subject|19|||
155549544|NCT00171340|561435786|FG000|Overall Study|Lost to Follow-up|0|||
155549545|NCT00171340|561435787|FG001|Overall Study|Lost to Follow-up|5|||
155549546|NCT00171340|561435786|FG000|Overall Study|Abnormal Laboratory Results|2|||
155549547|NCT00171340|561435787|FG001|Overall Study|Abnormal Laboratory Results|0|||
155549548|NCT00171340|561435786|FG000|Overall Study|Abnormal Test Procedure Results|6|||
155549549|NCT00171340|561435787|FG001|Overall Study|Abnormal Test Procedure Results|11|||
155549550|NCT00171340|561435786|FG000|Overall Study|No Longer Required Study Drug|1|||
155549551|NCT00171340|561435787|FG001|Overall Study|No Longer Required Study Drug|1|||
155549552|NCT00171340|561435786|FG000|Overall Study|Administrative Problems|5|||
155549553|NCT00171340|561435787|FG001|Overall Study|Administrative Problems|2|||
155549554|NCT00171340|561435786|FG000|Overall Study|Death|6|||
155549555|NCT00171340|561435787|FG001|Overall Study|Death|6|||
155549556|NCT03827018|561435788|FG000|Overall Study|Adverse Event|1|||
155549557|NCT03827018|561435789|FG001|Overall Study|Adverse Event|0|||
155549558|NCT03827018|561435788|FG000|Overall Study|Withdrawal by Subject|2|||
155549559|NCT03827018|561435789|FG001|Overall Study|Withdrawal by Subject|2|||
155549560|NCT03827018|561435788|FG000|Overall Study|Lack of Efficacy|0|||
155549561|NCT03827018|561435789|FG001|Overall Study|Lack of Efficacy|1|||
155549562|NCT00680186|561435795|FG000|Overall Study|Adverse Event|47|||
155549563|NCT00680186|561435796|FG001|Overall Study|Adverse Event|44|||
155549564|NCT00680186|561435795|FG000|Overall Study|Protocol Violation|31|||
155549565|NCT00680186|561435796|FG001|Overall Study|Protocol Violation|26|||
155549566|NCT00680186|561435795|FG000|Overall Study|Lost to Follow-up|11|||
155549567|NCT00680186|561435796|FG001|Overall Study|Lost to Follow-up|6|||
155549568|NCT00680186|561435795|FG000|Overall Study|Withdrawal by Subject|32|||
155549569|NCT00680186|561435796|FG001|Overall Study|Withdrawal by Subject|39|||
155549570|NCT00680186|561435795|FG000|Overall Study|Other|4|||
155549571|NCT00680186|561435796|FG001|Overall Study|Other|1|||
155549572|NCT01351350|561435797|FG000|Overall Study|Disease Progression|5|||
155549573|NCT01351350|561435798|FG001|Overall Study|Disease Progression|13|||
155549574|NCT01351350|561435799|FG002|Overall Study|Disease Progression|6|||
155549575|NCT01351350|561435800|FG003|Overall Study|Disease Progression|8|||
155549576|NCT01351350|561435801|FG004|Overall Study|Disease Progression|5|||
155549577|NCT01351350|561435797|FG000|Overall Study|Adverse Event|1|||
155549578|NCT01351350|561435798|FG001|Overall Study|Adverse Event|10|||
155549579|NCT01351350|561435799|FG002|Overall Study|Adverse Event|1|||
155549580|NCT01351350|561435800|FG003|Overall Study|Adverse Event|2|||
155549581|NCT01351350|561435801|FG004|Overall Study|Adverse Event|0|||
155549582|NCT01351350|561435797|FG000|Overall Study|Participant Decision|2|||
155549583|NCT01351350|561435798|FG001|Overall Study|Participant Decision|6|||
155657103|NCT00725985|561838917|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
155657104|NCT00725985|561838918|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
155657105|NCT00725985|561838919|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
155657106|NCT00725985|561838920|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
155549584|NCT01351350|561435799|FG002|Overall Study|Participant Decision|3|||
155549585|NCT01351350|561435800|FG003|Overall Study|Participant Decision|3|||
155549586|NCT01351350|561435801|FG004|Overall Study|Participant Decision|2|||
155549587|NCT01351350|561435797|FG000|Overall Study|Enrolled but not Treated|0|||
155549588|NCT01351350|561435798|FG001|Overall Study|Enrolled but not Treated|0|||
155549589|NCT01351350|561435799|FG002|Overall Study|Enrolled but not Treated|1|||
155549590|NCT01351350|561435800|FG003|Overall Study|Enrolled but not Treated|0|||
155549591|NCT01351350|561435801|FG004|Overall Study|Enrolled but not Treated|0|||
155549592|NCT04647383|561435802|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
155549593|NCT04647383|561435803|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
155549594|NCT04647383|561435804|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
155549595|NCT04647383|561435805|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
155549596|NCT00613730|561435810|FG000|Overall Study|Disease progression|2|||
155549597|NCT00613730|561435810|FG000|Overall Study|Administrative decision|1|||
155549598|NCT04965389|561435818|FG000|Overall Study|Other reasons|1|||
155549599|NCT04965389|561435819|FG001|Overall Study|Other reasons|0|||
155549600|NCT04965389|561435820|FG002|Overall Study|Other reasons|0|||
155549601|NCT04965389|561435821|FG003|Overall Study|Other reasons|0|||
155549602|NCT04965389|561435818|FG000|Overall Study|Participant withdrew consent|0|||
155549603|NCT04965389|561435819|FG001|Overall Study|Participant withdrew consent|1|||
155549604|NCT04965389|561435820|FG002|Overall Study|Participant withdrew consent|0|||
155549605|NCT04965389|561435821|FG003|Overall Study|Participant withdrew consent|0|||
155549606|NCT04965389|561435818|FG000|Overall Study|Poor/Non-compliance|0|||
155549607|NCT04965389|561435819|FG001|Overall Study|Poor/Non-compliance|1|||
155549608|NCT04965389|561435820|FG002|Overall Study|Poor/Non-compliance|0|||
155549609|NCT04965389|561435821|FG003|Overall Study|Poor/Non-compliance|0|||
155549610|NCT01436643|561435822|FG000|2-week Pre-treatment|Abnormal test result|0|||
155549611|NCT01436643|561435823|FG001|2-week Pre-treatment|Abnormal test result|0|||
155549612|NCT01436643|561435824|FG002|2-week Pre-treatment|Abnormal test result|0|||
155549613|NCT01436643|561435825|FG003|2-week Pre-treatment|Abnormal test result|1|||
155549614|NCT01436643|561435822|FG000|2-week Pre-treatment|Adverse Event|0|||
155549615|NCT01436643|561435823|FG001|2-week Pre-treatment|Adverse Event|0|||
155549616|NCT01436643|561435824|FG002|2-week Pre-treatment|Adverse Event|0|||
155549617|NCT01436643|561435825|FG003|2-week Pre-treatment|Adverse Event|5|||
155549618|NCT01436643|561435822|FG000|2-week Pre-treatment|Protocol Violation|0|||
155549619|NCT01436643|561435823|FG001|2-week Pre-treatment|Protocol Violation|0|||
155549620|NCT01436643|561435824|FG002|2-week Pre-treatment|Protocol Violation|0|||
155549621|NCT01436643|561435825|FG003|2-week Pre-treatment|Protocol Violation|4|||
155549622|NCT01436643|561435822|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
155549623|NCT01436643|561435823|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
155549624|NCT01436643|561435824|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
155549625|NCT01436643|561435825|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
155549626|NCT01436643|561435822|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
155549627|NCT01436643|561435823|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
155549628|NCT01436643|561435824|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
155549629|NCT01436643|561435825|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
155549630|NCT01436643|561435822|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
155549631|NCT01436643|561435823|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
155549632|NCT01436643|561435824|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
155549633|NCT01436643|561435825|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
155549634|NCT00842530|561435826|FG000|Overall Study|Serious adverse event|0|||
155549635|NCT00842530|561435827|FG001|Overall Study|Serious adverse event|6|||
155549636|NCT00842530|561435826|FG000|Overall Study|Other adverse event|6|||
155549637|NCT00842530|561435827|FG001|Overall Study|Other adverse event|1|||
155549638|NCT00842530|561435826|FG000|Overall Study|Protocol Violation|32|||
155549639|NCT00842530|561435827|FG001|Overall Study|Protocol Violation|14|||
155549640|NCT00842530|561435826|FG000|Overall Study|Lost to Follow-up|6|||
155549641|NCT00842530|561435827|FG001|Overall Study|Lost to Follow-up|8|||
155549642|NCT00842530|561435826|FG000|Overall Study|Withdrawal by Subject|73|||
155549643|NCT00842530|561435827|FG001|Overall Study|Withdrawal by Subject|28|||
155549644|NCT01382251|561435828|FG000|Overall Study|Surgeries cancelled or delayed|16|||
155549645|NCT01382251|561435829|FG001|Overall Study|Surgeries cancelled or delayed|16|||
155549646|NCT01382251|561435828|FG000|Overall Study|Lost to Follow-up|4|||
155549647|NCT01382251|561435829|FG001|Overall Study|Lost to Follow-up|4|||
155549648|NCT01382251|561435828|FG000|Overall Study|Contacted after study closed|1|||
155549649|NCT01382251|561435829|FG001|Overall Study|Contacted after study closed|1|||
155549650|NCT01117987|561435830|FG000|Overall Study|Protocol deviation|0|||
155549651|NCT01117987|561435831|FG001|Overall Study|Protocol deviation|1|||
155549652|NCT01117987|561435830|FG000|Overall Study|Subject no longer requires study drug|1|||
155549653|NCT01117987|561435831|FG001|Overall Study|Subject no longer requires study drug|0|||
155549654|NCT01117987|561435830|FG000|Overall Study|Lost to Follow-up|1|||
155549655|NCT01117987|561435831|FG001|Overall Study|Lost to Follow-up|1|||
155549656|NCT01117987|561435830|FG000|Overall Study|Abnormal test procedure result|2|||
155549657|NCT01117987|561435831|FG001|Overall Study|Abnormal test procedure result|0|||
155549658|NCT01117987|561435830|FG000|Overall Study|Lack of Efficacy|3|||
155549659|NCT01117987|561435831|FG001|Overall Study|Lack of Efficacy|4|||
155549660|NCT01117987|561435830|FG000|Overall Study|Death|5|||
155549661|NCT01117987|561435831|FG001|Overall Study|Death|10|||
155549662|NCT01117987|561435830|FG000|Overall Study|Withdrawal by Subject|5|||
155549663|NCT01117987|561435831|FG001|Overall Study|Withdrawal by Subject|10|||
155549664|NCT01117987|561435830|FG000|Overall Study|Adverse Event|19|||
155549665|NCT01117987|561435831|FG001|Overall Study|Adverse Event|26|||
155549666|NCT01117987|561435830|FG000|Overall Study|Administrative problems|25|||
155549667|NCT01117987|561435831|FG001|Overall Study|Administrative problems|22|||
155549668|NCT02377063|561435832|FG000|Overall Study|Non-compliance|5|||
155549669|NCT01524913|561435833|FG000|Overall Study|Lost to Follow-up|4|||
155549670|NCT01524913|561435834|FG001|Overall Study|Lost to Follow-up|0|||
155549671|NCT01524913|561435835|FG002|Overall Study|Lost to Follow-up|0|||
155549672|NCT00702208|561435836|FG000|Overall Study|Lost to Follow-up|28|||
155549673|NCT00702208|561435836|FG000|Overall Study|Did not self-lavage|1|||
155549674|NCT00702208|561435836|FG000|Overall Study|Unsatisfactory colposcopy|2|||
155549675|NCT03183141|561435840|FG000|Overall Study|Withdrawal by Subject|2|||
155549676|NCT03183141|561435841|FG001|Overall Study|Withdrawal by Subject|4|||
155549677|NCT03183141|561435840|FG000|Overall Study|Death|0|||
155549678|NCT03183141|561435841|FG001|Overall Study|Death|8|||
155549679|NCT04034355|561435842|FG000|Overall Study|Study terminated by Sponsor|10|||
155549680|NCT04034355|561435843|FG001|Overall Study|Study terminated by Sponsor|17|||
155549681|NCT04034355|561435842|FG000|Overall Study|Withdrawal by Subject|12|||
155549682|NCT04034355|561435843|FG001|Overall Study|Withdrawal by Subject|11|||
155549683|NCT04034355|561435842|FG000|Overall Study|Site terminated by Sponsor|4|||
155549684|NCT04034355|561435843|FG001|Overall Study|Site terminated by Sponsor|5|||
155549685|NCT04034355|561435842|FG000|Overall Study|Adverse Event|2|||
155549686|NCT04034355|561435843|FG001|Overall Study|Adverse Event|0|||
155549687|NCT04034355|561435842|FG000|Overall Study|Death|1|||
155549688|NCT04034355|561435843|FG001|Overall Study|Death|1|||
155549689|NCT04034355|561435842|FG000|Overall Study|Not reported|2|||
155549690|NCT04034355|561435843|FG001|Overall Study|Not reported|0|||
155549691|NCT04034355|561435842|FG000|Overall Study|Lost to Follow-up|1|||
155549692|NCT04034355|561435843|FG001|Overall Study|Lost to Follow-up|0|||
155549693|NCT04034355|561435842|FG000|Overall Study|Physician Decision|1|||
155549694|NCT04034355|561435843|FG001|Overall Study|Physician Decision|0|||
155549695|NCT04034355|561435842|FG000|Overall Study|Protocol Violation|0|||
155549696|NCT04034355|561435843|FG001|Overall Study|Protocol Violation|1|||
155549697|NCT04034355|561435842|FG000|Overall Study|Progressive disease|1|||
155549698|NCT04034355|561435843|FG001|Overall Study|Progressive disease|0|||
155549699|NCT01937351|561437517|FG000|Overall Study|Withdrawal by Subject|4|||
155549700|NCT01937351|561437518|FG001|Overall Study|Withdrawal by Subject|2|||
155549701|NCT01937351|561437517|FG000|Overall Study|Death|1|||
155549702|NCT01937351|561437518|FG001|Overall Study|Death|0|||
155549703|NCT01937351|561437517|FG000|Overall Study|Not treated w device, per protocol fail|4|||
155549704|NCT01937351|561437518|FG001|Overall Study|Not treated w device, per protocol fail|0|||
155549705|NCT01961687|561437519|FG000|Overall Study|Lost to Follow-up|19|||
155549706|NCT01961687|561437519|FG000|Overall Study|Re-operation|17|||
155549707|NCT01961687|561437519|FG000|Overall Study|Death|7|||
155549708|NCT01961687|561437519|FG000|Overall Study|Withdrawal by Subject|6|||
155549709|NCT01961687|561437519|FG000|Overall Study|Adverse Event|6|||
155549710|NCT01961687|561437519|FG000|Overall Study|Moved to area without study site|2|||
155549711|NCT01961687|561437519|FG000|Overall Study|Sponsor decision|2|||
155549712|NCT01961687|561437519|FG000|Overall Study|Physician Decision|1|||
155549713|NCT01961687|561437519|FG000|Overall Study|Unable to meet follow-up requirements|1|||
155549714|NCT01467479|561437522|FG000|Overall Study|No Study Medication|1|||
155549715|NCT01467479|561437523|FG001|Overall Study|No Study Medication|0|||
155549716|NCT01467479|561437524|FG002|Overall Study|No Study Medication|2|||
155549717|NCT01467479|561437522|FG000|Overall Study|Adverse Event|1|||
155549718|NCT01467479|561437523|FG001|Overall Study|Adverse Event|2|||
155549719|NCT01467479|561437524|FG002|Overall Study|Adverse Event|0|||
155549720|NCT01467479|561437522|FG000|Overall Study|Death|0|||
155549721|NCT01467479|561437523|FG001|Overall Study|Death|0|||
155549722|NCT01467479|561437524|FG002|Overall Study|Death|1|||
155549723|NCT01467479|561437522|FG000|Overall Study|Lost to Follow-up|2|||
155549724|NCT01467479|561437523|FG001|Overall Study|Lost to Follow-up|5|||
155549725|NCT01467479|561437524|FG002|Overall Study|Lost to Follow-up|3|||
155549726|NCT01467479|561437522|FG000|Overall Study|Withdrawal of Consent|3|||
155549727|NCT01467479|561437523|FG001|Overall Study|Withdrawal of Consent|7|||
155549728|NCT01467479|561437524|FG002|Overall Study|Withdrawal of Consent|7|||
155549729|NCT01467479|561437522|FG000|Overall Study|Study Terminated by Sponsor|1|||
155549730|NCT01467479|561437523|FG001|Overall Study|Study Terminated by Sponsor|3|||
155549731|NCT01467479|561437524|FG002|Overall Study|Study Terminated by Sponsor|3|||
155549732|NCT01467479|561437522|FG000|Overall Study|Other|1|||
155549733|NCT01467479|561437523|FG001|Overall Study|Other|0|||
155549734|NCT01467479|561437524|FG002|Overall Study|Other|0|||
155549735|NCT02065713|561437534|FG000|Overall Study|Adverse Event|0|||
155549736|NCT02065713|561437535|FG001|Overall Study|Adverse Event|1|||
155549737|NCT02065713|561437534|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155549738|NCT02065713|561437535|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155549739|NCT00655850|561437536|FG000|Overall Study|Death|2|||
155549740|NCT00655850|561437536|FG000|Overall Study|Withdrawal by Subject|1|||
155549741|NCT02459665|561437537|FG000|Overall Study|Withdrawal by Subject|0|||
155549742|NCT02459665|561437538|FG001|Overall Study|Withdrawal by Subject|1|||
155549743|NCT02459665|561437539|FG002|Overall Study|Withdrawal by Subject|1|||
155549744|NCT02459665|561437540|FG003|Overall Study|Withdrawal by Subject|2|||
155549745|NCT01117337|561437541|FG000|Overall Study|Lost to Follow-up|4|||
155549746|NCT01117337|561437542|FG001|Overall Study|Lost to Follow-up|0|||
155549747|NCT01045993|561437543|FG000|Overall Study|Treated-later found eligibility not met|0|||
155549748|NCT01045993|561437544|FG001|Overall Study|Treated-later found eligibility not met|1|||
155549749|NCT01045993|561437545|FG002|Overall Study|Treated-later found eligibility not met|0|||
155549750|NCT01045993|561437546|FG003|Overall Study|Treated-later found eligibility not met|0|||
155549751|NCT01833533|561437551|FG000|Overall Study|Adverse Event|0|||
155549752|NCT01833533|561437552|FG001|Overall Study|Adverse Event|1|||
155549753|NCT01833533|561437551|FG000|Overall Study|Lost to Follow-up|4|||
155549754|NCT01833533|561437552|FG001|Overall Study|Lost to Follow-up|9|||
155549755|NCT01833533|561437551|FG000|Overall Study|To Enter an Extension Study|0|||
155549756|NCT01833533|561437552|FG001|Overall Study|To Enter an Extension Study|4|||
155549757|NCT01833533|561437551|FG000|Overall Study|Other|2|||
155549758|NCT01833533|561437552|FG001|Overall Study|Other|7|||
155549759|NCT02017860|561437553|FG000|Overall Study|Adverse Event|1|||
155549760|NCT02017860|561437553|FG000|Overall Study|Withdrawal by Subject|1|||
155549761|NCT02772562|561437555|FG000|Overall Study|Withdrawal by Subject|1|||
155549762|NCT02772562|561437555|FG000|Overall Study|Protocol Violation|1|||
155549763|NCT01048502|561437560|FG000|Overall Study|Lost to Follow-up|2|||
155549764|NCT01048502|561437561|FG001|Overall Study|Lost to Follow-up|0|||
155549765|NCT01048502|561437562|FG002|Overall Study|Lost to Follow-up|0|||
155549766|NCT01048502|561437563|FG003|Overall Study|Lost to Follow-up|0|||
155549767|NCT01048502|561437560|FG000|Overall Study|Adverse Event|1|||
155549768|NCT01048502|561437561|FG001|Overall Study|Adverse Event|0|||
155549769|NCT01048502|561437562|FG002|Overall Study|Adverse Event|0|||
155549770|NCT01048502|561437563|FG003|Overall Study|Adverse Event|0|||
155549771|NCT01048502|561437560|FG000|Overall Study|Withdrawal by Subject|1|||
155549772|NCT01048502|561437561|FG001|Overall Study|Withdrawal by Subject|4|||
155549773|NCT01048502|561437562|FG002|Overall Study|Withdrawal by Subject|5|||
155549774|NCT01048502|561437563|FG003|Overall Study|Withdrawal by Subject|3|||
155657107|NCT00725985|561838921|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
155657108|NCT00725985|561838922|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
155657109|NCT00725985|561838923|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
155657110|NCT00725985|561838924|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
155657111|NCT00725985|561838925|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
155657112|NCT00725985|561838914|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
155657113|NCT00725985|561838915|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
155657114|NCT00725985|561838916|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
155657115|NCT00725985|561838917|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
155657116|NCT00725985|561838918|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
155657117|NCT00725985|561838919|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
155657118|NCT00725985|561838920|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
155657119|NCT00725985|561838921|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
155657120|NCT00725985|561838922|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
155657121|NCT00725985|561838923|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
155657122|NCT00725985|561838924|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
155657123|NCT00725985|561838925|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
155657124|NCT00725985|561838914|FG000|ITP- Treatment Disposition|Other|50|||
155657125|NCT00725985|561838915|FG001|ITP- Treatment Disposition|Other|38|||
155657126|NCT00725985|561838916|FG002|ITP- Treatment Disposition|Other|24|||
155549775|NCT01048502|561437560|FG000|Overall Study|Physician Decision|0|||
155549776|NCT01048502|561437561|FG001|Overall Study|Physician Decision|3|||
155549777|NCT01048502|561437562|FG002|Overall Study|Physician Decision|0|||
155549778|NCT01048502|561437563|FG003|Overall Study|Physician Decision|1|||
155549779|NCT03336242|561437564|FG000|Overall Study|Adverse Event|0|||
155549780|NCT03336242|561437565|FG001|Overall Study|Adverse Event|1|||
155549781|NCT02457611|561437567|FG000|Overall Study|Lost to Follow-up|3|||
155549782|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
155549783|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
155549784|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
155549785|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
155549786|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
155549787|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
155549788|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
155549789|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
155549790|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
155549791|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
155549792|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
155549793|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
155549794|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
155657127|NCT00725985|561838917|FG003|ITP- Treatment Disposition|Other|0|||
155657128|NCT00725985|561838918|FG004|ITP- Treatment Disposition|Other|0|||
155657129|NCT00725985|561838919|FG005|ITP- Treatment Disposition|Other|0|||
155657130|NCT00725985|561838920|FG006|ITP- Treatment Disposition|Other|0|||
155657131|NCT00725985|561838921|FG007|ITP- Treatment Disposition|Other|0|||
155657132|NCT00725985|561838922|FG008|ITP- Treatment Disposition|Other|0|||
155657133|NCT00725985|561838923|FG009|ITP- Treatment Disposition|Other|0|||
155657134|NCT00725985|561838924|FG010|ITP- Treatment Disposition|Other|0|||
155657135|NCT00725985|561838925|FG011|ITP- Treatment Disposition|Other|0|||
155657136|NCT00725985|561838914|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657137|NCT00725985|561838915|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657138|NCT00725985|561838916|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657139|NCT00725985|561838917|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
155549795|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
155549796|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
155549797|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
155549798|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
155549799|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
155549800|NCT00384293|561437568|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
155549801|NCT00384293|561437569|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
155549802|NCT00384293|561437570|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
155549803|NCT00384293|561437568|FG000|Post-randomization Period|Adverse Event|0|||
155549804|NCT00384293|561437569|FG001|Post-randomization Period|Adverse Event|23|||
155549805|NCT00384293|561437570|FG002|Post-randomization Period|Adverse Event|7|||
155549806|NCT00384293|561437568|FG000|Post-randomization Period|Lost to Follow-up|0|||
155549807|NCT00384293|561437569|FG001|Post-randomization Period|Lost to Follow-up|2|||
155549808|NCT00384293|561437570|FG002|Post-randomization Period|Lost to Follow-up|1|||
155549809|NCT00384293|561437568|FG000|Post-randomization Period|Protocol Violation|0|||
155549810|NCT00384293|561437569|FG001|Post-randomization Period|Protocol Violation|1|||
155549811|NCT00384293|561437570|FG002|Post-randomization Period|Protocol Violation|0|||
155549812|NCT00384293|561437568|FG000|Post-randomization Period|Withdrawal by Subject|0|||
155549813|NCT00384293|561437569|FG001|Post-randomization Period|Withdrawal by Subject|8|||
155549814|NCT00384293|561437570|FG002|Post-randomization Period|Withdrawal by Subject|6|||
155549815|NCT00384293|561437568|FG000|Post-randomization Period|Trial Termination|0|||
155549816|NCT00384293|561437569|FG001|Post-randomization Period|Trial Termination|180|||
155549817|NCT00384293|561437570|FG002|Post-randomization Period|Trial Termination|204|||
155549818|NCT00384293|561437568|FG000|Post-randomization Period|Patient Randomized in Error|0|||
155549819|NCT00384293|561437569|FG001|Post-randomization Period|Patient Randomized in Error|0|||
155549820|NCT00384293|561437570|FG002|Post-randomization Period|Patient Randomized in Error|1|||
155549821|NCT03005067|561437571|FG000|Overall Study|Withdrawal by Subject|3|||
155549822|NCT03005067|561437572|FG001|Overall Study|Withdrawal by Subject|2|||
155549823|NCT03005067|561437571|FG000|Overall Study|Adverse Event|4|||
155549824|NCT03005067|561437572|FG001|Overall Study|Adverse Event|3|||
155549825|NCT03005067|561437571|FG000|Overall Study|Other (reason not specified)|3|||
155549826|NCT03005067|561437572|FG001|Overall Study|Other (reason not specified)|1|||
155549827|NCT03005067|561437571|FG000|Overall Study|Protocol Violation|0|||
155549828|NCT03005067|561437572|FG001|Overall Study|Protocol Violation|1|||
155549829|NCT00296491|561437573|FG000|Overall Study|Low Pollen Counts|18|||
155549830|NCT00296491|561437574|FG001|Overall Study|Low Pollen Counts|26|||
155549831|NCT00296491|561437575|FG002|Overall Study|Low Pollen Counts|25|||
155549832|NCT00296491|561437576|FG003|Overall Study|Low Pollen Counts|16|||
155549833|NCT00296491|561437573|FG000|Overall Study|Protocol Violation|4|||
155549834|NCT00296491|561437574|FG001|Overall Study|Protocol Violation|6|||
155549835|NCT00296491|561437575|FG002|Overall Study|Protocol Violation|2|||
155549836|NCT00296491|561437576|FG003|Overall Study|Protocol Violation|3|||
155549837|NCT00296491|561437573|FG000|Overall Study|Adverse Event|1|||
155549838|NCT00296491|561437574|FG001|Overall Study|Adverse Event|3|||
155549839|NCT00296491|561437575|FG002|Overall Study|Adverse Event|1|||
155549840|NCT00296491|561437576|FG003|Overall Study|Adverse Event|4|||
155549841|NCT00296491|561437573|FG000|Overall Study|Withdrawn due to Asthma|0|||
155549842|NCT00296491|561437574|FG001|Overall Study|Withdrawn due to Asthma|0|||
155549843|NCT00296491|561437575|FG002|Overall Study|Withdrawn due to Asthma|0|||
155549844|NCT00296491|561437576|FG003|Overall Study|Withdrawn due to Asthma|4|||
155549845|NCT00296491|561437573|FG000|Overall Study|Withdrawal by Subject|7|||
155549846|NCT00296491|561437574|FG001|Overall Study|Withdrawal by Subject|3|||
155549847|NCT00296491|561437575|FG002|Overall Study|Withdrawal by Subject|3|||
155549848|NCT00296491|561437576|FG003|Overall Study|Withdrawal by Subject|2|||
155549849|NCT00296491|561437573|FG000|Overall Study|Non-Compliance|12|||
155549850|NCT00296491|561437574|FG001|Overall Study|Non-Compliance|13|||
155549851|NCT00296491|561437575|FG002|Overall Study|Non-Compliance|10|||
155549852|NCT00296491|561437576|FG003|Overall Study|Non-Compliance|14|||
155549853|NCT00296491|561437573|FG000|Overall Study|Lost to Follow-up|0|||
155549854|NCT00296491|561437574|FG001|Overall Study|Lost to Follow-up|2|||
155549855|NCT00296491|561437575|FG002|Overall Study|Lost to Follow-up|2|||
155549856|NCT00296491|561437576|FG003|Overall Study|Lost to Follow-up|0|||
155549857|NCT05575063|561437583|FG000|Overall Study|Withdrawal by Subject|1|||
155549858|NCT00493454|561437584|FG000|Overall Study|Withdrawal by Subject|1|||
155549859|NCT01740791|561437587|FG000|Overall Study|Randomized but never treated|5|||
155549860|NCT01740791|561437588|FG001|Overall Study|Randomized but never treated|3|||
155549861|NCT01740791|561437589|FG002|Overall Study|Randomized but never treated|2|||
155549862|NCT01740791|561437590|FG003|Overall Study|Randomized but never treated|2|||
155549863|NCT01740791|561437591|FG004|Overall Study|Randomized but never treated|1|||
155549864|NCT01740791|561437592|FG005|Overall Study|Randomized but never treated|3|||
155549865|NCT01740791|561437587|FG000|Overall Study|Lost to Follow-up|2|||
155549866|NCT01740791|561437588|FG001|Overall Study|Lost to Follow-up|0|||
155549867|NCT01740791|561437589|FG002|Overall Study|Lost to Follow-up|2|||
155549868|NCT01740791|561437590|FG003|Overall Study|Lost to Follow-up|3|||
155549869|NCT01740791|561437591|FG004|Overall Study|Lost to Follow-up|2|||
155549870|NCT01740791|561437592|FG005|Overall Study|Lost to Follow-up|3|||
155549871|NCT01740791|561437587|FG000|Overall Study|Withdrew Consent|4|||
155549872|NCT01740791|561437588|FG001|Overall Study|Withdrew Consent|0|||
155549873|NCT01740791|561437589|FG002|Overall Study|Withdrew Consent|1|||
155549874|NCT01740791|561437590|FG003|Overall Study|Withdrew Consent|2|||
155549875|NCT01740791|561437591|FG004|Overall Study|Withdrew Consent|0|||
155549876|NCT01740791|561437592|FG005|Overall Study|Withdrew Consent|3|||
155549877|NCT01740791|561437587|FG000|Overall Study|Investigator's discretion|1|||
155549878|NCT01740791|561437588|FG001|Overall Study|Investigator's discretion|0|||
155549879|NCT01740791|561437589|FG002|Overall Study|Investigator's discretion|1|||
155549880|NCT01740791|561437590|FG003|Overall Study|Investigator's discretion|0|||
155549881|NCT01740791|561437591|FG004|Overall Study|Investigator's discretion|0|||
155549882|NCT01740791|561437592|FG005|Overall Study|Investigator's discretion|1|||
155549883|NCT01740791|561437587|FG000|Overall Study|Adverse Event|0|||
155549884|NCT01740791|561437588|FG001|Overall Study|Adverse Event|0|||
155549885|NCT01740791|561437589|FG002|Overall Study|Adverse Event|0|||
155549886|NCT01740791|561437590|FG003|Overall Study|Adverse Event|0|||
155549887|NCT01740791|561437591|FG004|Overall Study|Adverse Event|0|||
155549888|NCT01740791|561437592|FG005|Overall Study|Adverse Event|1|||
155549889|NCT02310763|561437597|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
155549890|NCT02310763|561437598|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
155549891|NCT02310763|561437599|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
155549892|NCT02310763|561437597|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
155549893|NCT02310763|561437598|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
155549894|NCT02310763|561437599|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
155549895|NCT02310763|561437597|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
155549896|NCT02310763|561437598|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
155549897|NCT02310763|561437599|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
155549898|NCT02310763|561437597|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
155549899|NCT02310763|561437598|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
155549900|NCT02310763|561437599|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
155549901|NCT02310763|561437597|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
155549902|NCT02310763|561437598|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
155549903|NCT02310763|561437599|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
155549904|NCT02010255|561437600|FG000|Overall Study|Death|0|||
155549905|NCT02010255|561437601|FG001|Overall Study|Death|1|||
155549906|NCT02010255|561437602|FG002|Overall Study|Death|4|||
155549907|NCT02010255|561437603|FG003|Overall Study|Death|4|||
155549908|NCT02010255|561437604|FG004|Overall Study|Death|2|||
155549909|NCT02010255|561437605|FG005|Overall Study|Death|0|||
155549910|NCT02010255|561437606|FG006|Overall Study|Death|1|||
155549911|NCT02010255|561437607|FG007|Overall Study|Death|1|||
155549912|NCT02010255|561437608|FG008|Overall Study|Death|1|||
155549913|NCT02010255|561437609|FG009|Overall Study|Death|0|||
155549914|NCT02010255|561437610|FG010|Overall Study|Death|1|||
155549915|NCT02010255|561437611|FG011|Overall Study|Death|1|||
155549916|NCT02010255|561437612|FG012|Overall Study|Death|0|||
155549917|NCT02010255|561437613|FG013|Overall Study|Death|0|||
155549918|NCT02010255|561437600|FG000|Overall Study|Lack of Efficacy|4|||
155549919|NCT02010255|561437601|FG001|Overall Study|Lack of Efficacy|1|||
155549920|NCT02010255|561437602|FG002|Overall Study|Lack of Efficacy|2|||
155549921|NCT02010255|561437603|FG003|Overall Study|Lack of Efficacy|1|||
155549922|NCT02010255|561437604|FG004|Overall Study|Lack of Efficacy|1|||
155549923|NCT02010255|561437605|FG005|Overall Study|Lack of Efficacy|0|||
155549924|NCT02010255|561437606|FG006|Overall Study|Lack of Efficacy|0|||
155549925|NCT02010255|561437607|FG007|Overall Study|Lack of Efficacy|0|||
155549926|NCT02010255|561437608|FG008|Overall Study|Lack of Efficacy|0|||
155549927|NCT02010255|561437609|FG009|Overall Study|Lack of Efficacy|0|||
155549928|NCT02010255|561437610|FG010|Overall Study|Lack of Efficacy|1|||
155549929|NCT02010255|561437611|FG011|Overall Study|Lack of Efficacy|0|||
155549930|NCT02010255|561437612|FG012|Overall Study|Lack of Efficacy|0|||
155549931|NCT02010255|561437613|FG013|Overall Study|Lack of Efficacy|0|||
155549932|NCT02010255|561437600|FG000|Overall Study|Withdrew Consent|1|||
155549933|NCT02010255|561437601|FG001|Overall Study|Withdrew Consent|0|||
155549934|NCT02010255|561437602|FG002|Overall Study|Withdrew Consent|0|||
155549935|NCT02010255|561437603|FG003|Overall Study|Withdrew Consent|1|||
155549936|NCT02010255|561437604|FG004|Overall Study|Withdrew Consent|0|||
155549937|NCT02010255|561437605|FG005|Overall Study|Withdrew Consent|0|||
155549938|NCT02010255|561437606|FG006|Overall Study|Withdrew Consent|0|||
155549939|NCT02010255|561437607|FG007|Overall Study|Withdrew Consent|0|||
155549940|NCT02010255|561437608|FG008|Overall Study|Withdrew Consent|0|||
155549941|NCT02010255|561437609|FG009|Overall Study|Withdrew Consent|0|||
155549942|NCT02010255|561437610|FG010|Overall Study|Withdrew Consent|0|||
155549943|NCT02010255|561437611|FG011|Overall Study|Withdrew Consent|0|||
155549944|NCT02010255|561437612|FG012|Overall Study|Withdrew Consent|0|||
155549945|NCT02010255|561437613|FG013|Overall Study|Withdrew Consent|0|||
155549946|NCT02010255|561437600|FG000|Overall Study|Adverse Event|1|||
155549947|NCT02010255|561437601|FG001|Overall Study|Adverse Event|0|||
155549948|NCT02010255|561437602|FG002|Overall Study|Adverse Event|0|||
155549949|NCT02010255|561437603|FG003|Overall Study|Adverse Event|0|||
155549950|NCT02010255|561437604|FG004|Overall Study|Adverse Event|0|||
155549951|NCT02010255|561437605|FG005|Overall Study|Adverse Event|0|||
155549952|NCT02010255|561437606|FG006|Overall Study|Adverse Event|0|||
155549953|NCT02010255|561437607|FG007|Overall Study|Adverse Event|0|||
155549954|NCT02010255|561437608|FG008|Overall Study|Adverse Event|0|||
155549955|NCT02010255|561437609|FG009|Overall Study|Adverse Event|0|||
155549956|NCT02010255|561437610|FG010|Overall Study|Adverse Event|0|||
155549957|NCT02010255|561437611|FG011|Overall Study|Adverse Event|0|||
155549958|NCT02010255|561437612|FG012|Overall Study|Adverse Event|0|||
155549959|NCT02010255|561437613|FG013|Overall Study|Adverse Event|0|||
155549960|NCT02010255|561437600|FG000|Overall Study|Lost to Follow-up|0|||
155549961|NCT02010255|561437601|FG001|Overall Study|Lost to Follow-up|0|||
155549962|NCT02010255|561437602|FG002|Overall Study|Lost to Follow-up|1|||
155549963|NCT02010255|561437603|FG003|Overall Study|Lost to Follow-up|0|||
155549964|NCT02010255|561437604|FG004|Overall Study|Lost to Follow-up|1|||
155549965|NCT02010255|561437605|FG005|Overall Study|Lost to Follow-up|0|||
155549966|NCT02010255|561437606|FG006|Overall Study|Lost to Follow-up|0|||
155549967|NCT02010255|561437607|FG007|Overall Study|Lost to Follow-up|0|||
155549968|NCT02010255|561437608|FG008|Overall Study|Lost to Follow-up|0|||
155549969|NCT02010255|561437609|FG009|Overall Study|Lost to Follow-up|0|||
155549970|NCT02010255|561437610|FG010|Overall Study|Lost to Follow-up|0|||
155549971|NCT02010255|561437611|FG011|Overall Study|Lost to Follow-up|0|||
155549972|NCT02010255|561437612|FG012|Overall Study|Lost to Follow-up|0|||
155549973|NCT02010255|561437613|FG013|Overall Study|Lost to Follow-up|0|||
155549974|NCT02010255|561437600|FG000|Overall Study|Randomized but Not Treated|0|||
155549975|NCT02010255|561437601|FG001|Overall Study|Randomized but Not Treated|0|||
155549976|NCT02010255|561437602|FG002|Overall Study|Randomized but Not Treated|0|||
155549977|NCT02010255|561437603|FG003|Overall Study|Randomized but Not Treated|0|||
155549978|NCT02010255|561437604|FG004|Overall Study|Randomized but Not Treated|0|||
155549979|NCT02010255|561437605|FG005|Overall Study|Randomized but Not Treated|0|||
155549980|NCT02010255|561437606|FG006|Overall Study|Randomized but Not Treated|0|||
155549981|NCT02010255|561437607|FG007|Overall Study|Randomized but Not Treated|0|||
155549982|NCT02010255|561437608|FG008|Overall Study|Randomized but Not Treated|0|||
155549983|NCT02010255|561437609|FG009|Overall Study|Randomized but Not Treated|0|||
155549984|NCT02010255|561437610|FG010|Overall Study|Randomized but Not Treated|0|||
155549985|NCT02010255|561437611|FG011|Overall Study|Randomized but Not Treated|0|||
155549986|NCT02010255|561437612|FG012|Overall Study|Randomized but Not Treated|0|||
155549987|NCT02010255|561437613|FG013|Overall Study|Randomized but Not Treated|1|||
155549988|NCT00396331|561437616|FG000|Overall Study|Failed to mobilize - no transplant|8|||
155549989|NCT00396331|561437616|FG000|Overall Study|Did not go on to transplant|5|||
155549990|NCT00396331|561437616|FG000|Overall Study|Lost to Follow-up|3|||
155549991|NCT00396331|561437616|FG000|Overall Study|Death|16|||
155549992|NCT02470091|561437627|FG000|Overall Study|Withdrawal by Subject|1|||
155549993|NCT02470091|561437628|FG001|Overall Study|Withdrawal by Subject|0|||
155549994|NCT02470091|561437627|FG000|Overall Study|Ineligible|0|||
155549995|NCT02470091|561437628|FG001|Overall Study|Ineligible|2|||
155657140|NCT00725985|561838918|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
155657141|NCT00725985|561838919|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
155657142|NCT00725985|561838920|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155549996|NCT01298778|561437631|FG000|Overall Study|Lost to Follow-up|2|||
155549997|NCT01298778|561437632|FG001|Overall Study|Lost to Follow-up|3|||
155549998|NCT01298778|561437631|FG000|Overall Study|Incorrect use of VAS|1|||
155549999|NCT01298778|561437632|FG001|Overall Study|Incorrect use of VAS|0|||
155550000|NCT01298778|561437631|FG000|Overall Study|Withdrawal by Subject|0|||
155657143|NCT00725985|561838921|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657144|NCT00725985|561838922|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657145|NCT00725985|561838923|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657146|NCT00725985|561838924|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657147|NCT00725985|561838925|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155657148|NCT00725985|561838914|FG000|OLMP (Up to 96 Weeks)|Death|0|||
155657149|NCT00725985|561838915|FG001|OLMP (Up to 96 Weeks)|Death|0|||
155657150|NCT00725985|561838916|FG002|OLMP (Up to 96 Weeks)|Death|0|||
155657151|NCT00725985|561838917|FG003|OLMP (Up to 96 Weeks)|Death|0|||
155657152|NCT00725985|561838918|FG004|OLMP (Up to 96 Weeks)|Death|1|||
155657153|NCT00725985|561838919|FG005|OLMP (Up to 96 Weeks)|Death|0|||
155657154|NCT00725985|561838920|FG006|OLMP (Up to 96 Weeks)|Death|0|||
155657155|NCT00725985|561838921|FG007|OLMP (Up to 96 Weeks)|Death|0|||
155657156|NCT00725985|561838922|FG008|OLMP (Up to 96 Weeks)|Death|0|||
155657157|NCT00725985|561838923|FG009|OLMP (Up to 96 Weeks)|Death|0|||
155657158|NCT00725985|561838924|FG010|OLMP (Up to 96 Weeks)|Death|0|||
155657159|NCT00725985|561838925|FG011|OLMP (Up to 96 Weeks)|Death|0|||
155657160|NCT00725985|561838914|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657161|NCT00725985|561838915|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657162|NCT00725985|561838916|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657163|NCT00725985|561838917|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
155657164|NCT00725985|561838918|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657165|NCT00725985|561838919|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657166|NCT00725985|561838920|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657167|NCT00725985|561838921|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657168|NCT00725985|561838922|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657169|NCT00725985|561838923|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657170|NCT00725985|561838924|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657171|NCT00725985|561838925|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155657172|NCT00725985|561838914|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657173|NCT00725985|561838915|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657174|NCT00725985|561838916|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657175|NCT00725985|561838917|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657176|NCT00725985|561838918|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657177|NCT00725985|561838919|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
155657178|NCT00725985|561838920|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657179|NCT00725985|561838921|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657180|NCT00725985|561838922|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657181|NCT00725985|561838923|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657182|NCT00725985|561838924|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657183|NCT00725985|561838925|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
155657184|NCT00725985|561838914|FG000|OLMP (Up to 96 Weeks)|Other|0|||
155657185|NCT00725985|561838915|FG001|OLMP (Up to 96 Weeks)|Other|0|||
155657186|NCT00725985|561838916|FG002|OLMP (Up to 96 Weeks)|Other|0|||
155657187|NCT00725985|561838917|FG003|OLMP (Up to 96 Weeks)|Other|15|||
155657188|NCT00725985|561838918|FG004|OLMP (Up to 96 Weeks)|Other|20|||
155657189|NCT00725985|561838919|FG005|OLMP (Up to 96 Weeks)|Other|44|||
155657190|NCT00725985|561838920|FG006|OLMP (Up to 96 Weeks)|Other|0|||
155657191|NCT00725985|561838921|FG007|OLMP (Up to 96 Weeks)|Other|0|||
155657192|NCT00725985|561838922|FG008|OLMP (Up to 96 Weeks)|Other|0|||
155657193|NCT00725985|561838923|FG009|OLMP (Up to 96 Weeks)|Other|0|||
155657194|NCT00725985|561838924|FG010|OLMP (Up to 96 Weeks)|Other|0|||
155657195|NCT00725985|561838925|FG011|OLMP (Up to 96 Weeks)|Other|0|||
155657196|NCT00725985|561838914|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657197|NCT00725985|561838915|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657198|NCT00725985|561838916|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657199|NCT00725985|561838917|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657200|NCT00725985|561838918|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657201|NCT00725985|561838919|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657202|NCT00725985|561838920|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657203|NCT00725985|561838921|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
155657204|NCT00725985|561838922|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657205|NCT00725985|561838923|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155550001|NCT01298778|561437632|FG001|Overall Study|Withdrawal by Subject|1|||
155550002|NCT01298778|561437631|FG000|Overall Study|Protocol Violation|0|||
155550003|NCT01298778|561437632|FG001|Overall Study|Protocol Violation|1|||
155550004|NCT01298778|561437631|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
155550005|NCT01298778|561437632|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
155550006|NCT00536484|561437636|FG000|Overall Study|Adverse Event|21|||
155550007|NCT00536484|561437637|FG001|Overall Study|Adverse Event|34|||
155550008|NCT00536484|561437636|FG000|Overall Study|Withdrawal by Subject|11|||
155550009|NCT00536484|561437637|FG001|Overall Study|Withdrawal by Subject|11|||
155550010|NCT00536484|561437636|FG000|Overall Study|Lost to Follow-up|8|||
155550011|NCT00536484|561437637|FG001|Overall Study|Lost to Follow-up|6|||
155550012|NCT00536484|561437636|FG000|Overall Study|Lack of Efficacy|16|||
155550013|NCT00536484|561437637|FG001|Overall Study|Lack of Efficacy|5|||
155550014|NCT00536484|561437636|FG000|Overall Study|Other|4|||
155550015|NCT00536484|561437637|FG001|Overall Study|Other|0|||
155550016|NCT02549573|561437640|FG000|Overall Study|Withdrawal by Subject|0|||
155550017|NCT02549573|561437641|FG001|Overall Study|Withdrawal by Subject|2|||
155550018|NCT02549573|561437640|FG000|Overall Study|Protocol Violation|0|||
155550019|NCT02549573|561437641|FG001|Overall Study|Protocol Violation|1|||
155550020|NCT02083926|561437642|FG000|Overall Study|Withdrawal by Subject|1|||
155550021|NCT02083926|561437643|FG001|Overall Study|Withdrawal by Subject|0|||
155550022|NCT02939950|561437646|FG000|Overall Study|Lost to Follow-up|13|||
155550023|NCT02939950|561437647|FG001|Overall Study|Lost to Follow-up|16|||
155550024|NCT02939950|561437646|FG000|Overall Study|Positive slit lamp findings|0|||
155550025|NCT02939950|561437647|FG001|Overall Study|Positive slit lamp findings|1|||
155550026|NCT02939950|561437646|FG000|Overall Study|Chalazion upper lid|0|||
155550027|NCT02939950|561437647|FG001|Overall Study|Chalazion upper lid|1|||
155550028|NCT02939950|561437646|FG000|Overall Study|Lack of motivation|0|||
155550029|NCT02939950|561437647|FG001|Overall Study|Lack of motivation|2|||
155550030|NCT02939950|561437646|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
155550031|NCT02939950|561437647|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
155550032|NCT02939950|561437646|FG000|Overall Study|Military orders|1|||
155550033|NCT02939950|561437647|FG001|Overall Study|Military orders|0|||
155550034|NCT02939950|561437646|FG000|Overall Study|Participant Relocated|5|||
155550035|NCT02939950|561437647|FG001|Overall Study|Participant Relocated|3|||
155550036|NCT02939950|561437646|FG000|Overall Study|Study related symptoms|8|||
155550037|NCT02939950|561437647|FG001|Overall Study|Study related symptoms|8|||
155550038|NCT02939950|561437646|FG000|Overall Study|Unacceptable lens movement|2|||
155550039|NCT02939950|561437647|FG001|Overall Study|Unacceptable lens movement|0|||
155550040|NCT02939950|561437646|FG000|Overall Study|Protocol Violation|6|||
155550041|NCT02939950|561437647|FG001|Overall Study|Protocol Violation|3|||
155550042|NCT02939950|561437646|FG000|Overall Study|Physician Decision|2|||
155550043|NCT02939950|561437647|FG001|Overall Study|Physician Decision|0|||
155550044|NCT02939950|561437646|FG000|Overall Study|Pregnancy|6|||
155550045|NCT02939950|561437647|FG001|Overall Study|Pregnancy|7|||
155550046|NCT02939950|561437646|FG000|Overall Study|Withdrawal by Subject|12|||
155550047|NCT02939950|561437647|FG001|Overall Study|Withdrawal by Subject|28|||
155550048|NCT02939950|561437646|FG000|Overall Study|Adverse Event|7|||
155550049|NCT02939950|561437647|FG001|Overall Study|Adverse Event|3|||
155550050|NCT02939950|561437646|FG000|Overall Study|Randomized, not dispensed|1|||
155550051|NCT02939950|561437647|FG001|Overall Study|Randomized, not dispensed|0|||
155550052|NCT02939950|561437646|FG000|Overall Study|Ineligible at Baseline|2|||
155550053|NCT02939950|561437647|FG001|Overall Study|Ineligible at Baseline|8|||
155550054|NCT00865098|561438422|FG000|Overall Study|Progressive disease|1|||
155550055|NCT01014624|561438423|FG000|Overall Study|Adverse Event|0|||
155550056|NCT01014624|561438424|FG001|Overall Study|Adverse Event|1|||
155550057|NCT01014624|561438423|FG000|Overall Study|Protocol Violation|1|||
155550058|NCT01014624|561438424|FG001|Overall Study|Protocol Violation|0|||
155550059|NCT01014624|561438423|FG000|Overall Study|Withdrawal by Subject|1|||
155550060|NCT01014624|561438424|FG001|Overall Study|Withdrawal by Subject|0|||
155550061|NCT01715896|561438425|FG000|Overall Study|Lost to Follow-up|0|||
155550062|NCT01715896|561438426|FG001|Overall Study|Lost to Follow-up|2|||
155550063|NCT01715896|561438425|FG000|Overall Study|Withdrawal by Subject|1|||
155550064|NCT01715896|561438426|FG001|Overall Study|Withdrawal by Subject|4|||
155550065|NCT01715896|561438425|FG000|Overall Study|Other|2|||
155550066|NCT01715896|561438426|FG001|Overall Study|Other|5|||
155550067|NCT01659736|561438428|FG000|Treatment Period|Adverse Event|1|||
155550068|NCT01659736|561438429|FG001|Treatment Period|Adverse Event|1|||
155550069|NCT01659736|561438428|FG000|Treatment Period|Protocol Violation|3|||
155550070|NCT01659736|561438429|FG001|Treatment Period|Protocol Violation|1|||
155550071|NCT01659736|561438428|FG000|Treatment Period|Withdrawal by Subject|1|||
155550072|NCT01659736|561438429|FG001|Treatment Period|Withdrawal by Subject|0|||
155550073|NCT01659736|561438428|FG000|3-month Follow-up|Lost to Follow-up|0|||
155550074|NCT01659736|561438429|FG001|3-month Follow-up|Lost to Follow-up|1|||
155550075|NCT05444556|561438430|FG000|Overall Study|Withdrawal by Subject|0|||
155550076|NCT05444556|561438431|FG001|Overall Study|Withdrawal by Subject|0|||
155550077|NCT05444556|561438432|FG002|Overall Study|Withdrawal by Subject|2|||
155550078|NCT05444556|561438433|FG003|Overall Study|Withdrawal by Subject|1|||
155550079|NCT02791893|561438435|FG000|Blinded Phase|Lost to Follow-up|2|||
155550080|NCT02791893|561438436|FG001|Blinded Phase|Lost to Follow-up|2|||
155550081|NCT02791893|561438435|FG000|Blinded Phase|Withdrawal by Subject|1|||
155550082|NCT02791893|561438436|FG001|Blinded Phase|Withdrawal by Subject|2|||
155550083|NCT02791893|561438435|FG000|Open Label Phase|Lost to Follow-up|3|||
155550084|NCT02791893|561438436|FG001|Open Label Phase|Lost to Follow-up|0|||
155550085|NCT02791893|561438435|FG000|Open Label Phase|Withdrawal by Subject|0|||
155550086|NCT02791893|561438436|FG001|Open Label Phase|Withdrawal by Subject|2|||
155550087|NCT00775528|561438446|FG000|Overall Study|Protocol Violation|1|||
155550088|NCT00873119|561438453|FG000|Overall Study|Patient request|4|||
155550089|NCT00873119|561438454|FG001|Overall Study|Patient request|2|||
155550090|NCT00873119|561438453|FG000|Overall Study|Adverse Event|8|||
155550091|NCT00873119|561438454|FG001|Overall Study|Adverse Event|0|||
155550092|NCT00873119|561438453|FG000|Overall Study|Progressive disease|26|||
155550093|NCT00873119|561438454|FG001|Overall Study|Progressive disease|18|||
155550094|NCT00873119|561438453|FG000|Overall Study|Death|2|||
155550095|NCT00873119|561438454|FG001|Overall Study|Death|1|||
155550096|NCT00873119|561438453|FG000|Overall Study|Other|2|||
155550097|NCT00873119|561438454|FG001|Overall Study|Other|5|||
155550098|NCT00873119|561438453|FG000|Overall Study|Not treated|2|||
155550099|NCT00873119|561438454|FG001|Overall Study|Not treated|0|||
155550100|NCT03648879|561438455|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
155550101|NCT01884688|561438458|FG000|Overall Study|Screen Failure|2|||
155550102|NCT04099641|561438462|FG000|Overall Study|Death|46|||
155550103|NCT04099641|561438463|FG001|Overall Study|Death|12|||
155550104|NCT04099641|561438462|FG000|Overall Study|Lost to Follow-up|1|||
155657206|NCT00725985|561838924|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657207|NCT00725985|561838925|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155657208|NCT00725985|561838914|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657209|NCT00725985|561838915|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657210|NCT00725985|561838916|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657211|NCT00725985|561838917|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657212|NCT00725985|561838918|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657213|NCT00725985|561838919|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657214|NCT00725985|561838920|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657215|NCT00725985|561838921|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657216|NCT00725985|561838922|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
155657217|NCT00725985|561838923|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657218|NCT00725985|561838924|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657219|NCT00725985|561838925|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155657220|NCT00725985|561838914|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657221|NCT00725985|561838915|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657222|NCT00725985|561838916|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657223|NCT00725985|561838917|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657224|NCT00725985|561838918|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657225|NCT00725985|561838919|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657226|NCT00725985|561838920|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
155657227|NCT00725985|561838921|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
155657228|NCT00725985|561838922|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
155657229|NCT00725985|561838923|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657230|NCT00725985|561838924|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657231|NCT00725985|561838925|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155657232|NCT00725985|561838914|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657233|NCT00725985|561838915|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657234|NCT00725985|561838916|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657235|NCT00725985|561838917|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657236|NCT00725985|561838918|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657237|NCT00725985|561838919|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657238|NCT00725985|561838920|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657239|NCT00725985|561838921|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657240|NCT00725985|561838922|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155657241|NCT00725985|561838923|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
155657242|NCT00725985|561838924|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
155657243|NCT00725985|561838925|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
155657244|NCT01381679|561838926|FG000|Overall Study|Adverse Event|3|||
155657245|NCT01381679|561838926|FG000|Overall Study|Lost to Follow-up|885|||
155657246|NCT05473715|561838927|FG000|Overall Study|Trial terminate|2|||
155657247|NCT05473715|561838928|FG001|Overall Study|Trial terminate|1|||
155657248|NCT03528902|561838929|FG000|Overall Study|Adverse Event|1|||
155657249|NCT03528902|561838930|FG001|Overall Study|Adverse Event|0|||
155657250|NCT04770285|561838931|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
155657251|NCT04770285|561838932|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
155657252|NCT04770285|561838931|FG000|Overall Study|Lack of Efficacy|0|||
155657253|NCT04770285|561838932|FG001|Overall Study|Lack of Efficacy|1|||
155657254|NCT04770285|561838931|FG000|Overall Study|Lost to Follow-up|11|||
155657255|NCT04770285|561838932|FG001|Overall Study|Lost to Follow-up|8|||
155657256|NCT04770285|561838931|FG000|Overall Study|Protocol Deviation|6|||
155657257|NCT04770285|561838932|FG001|Overall Study|Protocol Deviation|6|||
155657258|NCT04770285|561838931|FG000|Overall Study|Technical Problem|0|||
155657259|NCT04770285|561838932|FG001|Overall Study|Technical Problem|1|||
155657260|NCT04770285|561838931|FG000|Overall Study|Withdrawal by Subject|9|||
155657261|NCT04770285|561838932|FG001|Overall Study|Withdrawal by Subject|8|||
155657262|NCT04770285|561838931|FG000|Overall Study|Reason Not Specified|0|||
155657263|NCT04770285|561838932|FG001|Overall Study|Reason Not Specified|1|||
155657264|NCT04620668|561838933|FG000|Overall Study|Withdrawal by Subject|2|||
155657265|NCT04620668|561838934|FG001|Overall Study|Withdrawal by Subject|0|||
155657266|NCT04620668|561838933|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
155657267|NCT04620668|561838934|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
155657268|NCT04620668|561838933|FG000|Overall Study|Removed before analysis: missing data|2|||
155657269|NCT04620668|561838934|FG001|Overall Study|Removed before analysis: missing data|0|||
155657270|NCT04620668|561838933|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
155657271|NCT04620668|561838934|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
155657272|NCT04620668|561838933|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
155657273|NCT04620668|561838934|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
155657274|NCT03559530|561838935|FG000|Overall Study|non-location of medical records|44|||
155657275|NCT03559530|561838936|FG001|Overall Study|non-location of medical records|0|||
155657276|NCT03559530|561838935|FG000|Overall Study|culture results not considered for treat|29|||
155657277|NCT03559530|561838936|FG001|Overall Study|culture results not considered for treat|0|||
155657278|NCT03559530|561838935|FG000|Overall Study|duplicate cases|8|||
155657279|NCT03559530|561838936|FG001|Overall Study|duplicate cases|0|||
155657280|NCT03559530|561838935|FG000|Overall Study|other species of Acinetobacte|7|||
155657281|NCT03559530|561838936|FG001|Overall Study|other species of Acinetobacte|0|||
155657282|NCT03559530|561838935|FG000|Overall Study|contamination / colonization|3|||
155657283|NCT03559530|561838936|FG001|Overall Study|contamination / colonization|0|||
155657284|NCT01472185|561838939|FG000|Overall Study|Randomized but Not Treated|0|||
155657285|NCT01472185|561838940|FG001|Overall Study|Randomized but Not Treated|1|||
155657286|NCT01472185|561838939|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
155657287|NCT01472185|561838940|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
155657288|NCT01472185|561838939|FG000|Overall Study|Hyperglycemia|5|||
155657289|NCT01472185|561838940|FG001|Overall Study|Hyperglycemia|2|||
155657290|NCT01472185|561838939|FG000|Overall Study|Investigator's Discretion|3|||
155657291|NCT01472185|561838940|FG001|Overall Study|Investigator's Discretion|1|||
155657292|NCT01472185|561838939|FG000|Overall Study|Lost to Follow-up|4|||
155657293|NCT01472185|561838940|FG001|Overall Study|Lost to Follow-up|1|||
155657294|NCT01472185|561838939|FG000|Overall Study|Protocol Violation|5|||
155657295|NCT01472185|561838940|FG001|Overall Study|Protocol Violation|1|||
155657296|NCT01472185|561838939|FG000|Overall Study|Subject Noncompliance|8|||
155657297|NCT01472185|561838940|FG001|Overall Study|Subject Noncompliance|15|||
155657298|NCT01472185|561838939|FG000|Overall Study|Subject Withdrew Consent|6|||
155657299|NCT01472185|561838940|FG001|Overall Study|Subject Withdrew Consent|3|||
155657300|NCT03232567|561838943|FG000|Overall Study|Withdrawal by Subject|0|||
155657301|NCT03232567|561838944|FG001|Overall Study|Withdrawal by Subject|1|||
155657302|NCT03232567|561838945|FG002|Overall Study|Withdrawal by Subject|0|||
155657303|NCT03232567|561838946|FG003|Overall Study|Withdrawal by Subject|0|||
155657304|NCT05837481|561838947|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
155657305|NCT05837481|561838948|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
155657306|NCT00427700|561838949|FG000|Overall Study|Lost to Follow-up|2|||
155550105|NCT04099641|561438463|FG001|Overall Study|Lost to Follow-up|0|||
155550106|NCT04099641|561438462|FG000|Overall Study|Withdrawal by Subject|2|||
155550107|NCT04099641|561438463|FG001|Overall Study|Withdrawal by Subject|0|||
155550108|NCT00895037|561438464|FG000|Overall Study|Death|0|||
155550109|NCT00895037|561438465|FG001|Overall Study|Death|2|||
155550110|NCT00895037|561438466|FG002|Overall Study|Death|1|||
155550111|NCT01103479|561438468|FG000|Overall Study|Up to date with CRC screening|1|||
155550112|NCT01103479|561438469|FG001|Overall Study|Up to date with CRC screening|9|||
155550113|NCT01103479|561438470|FG002|Overall Study|Up to date with CRC screening|12|||
155550114|NCT01103479|561438468|FG000|Overall Study|Family history of CRC|1|||
155550115|NCT01103479|561438469|FG001|Overall Study|Family history of CRC|0|||
155550116|NCT01103479|561438470|FG002|Overall Study|Family history of CRC|2|||
155550117|NCT01103479|561438468|FG000|Overall Study|Active cancer|1|||
155550118|NCT01103479|561438469|FG001|Overall Study|Active cancer|0|||
155550119|NCT01103479|561438470|FG002|Overall Study|Active cancer|0|||
155550120|NCT01103479|561438468|FG000|Overall Study|Saw non-study physician|2|||
155550121|NCT01103479|561438469|FG001|Overall Study|Saw non-study physician|0|||
155550122|NCT01103479|561438470|FG002|Overall Study|Saw non-study physician|0|||
155550123|NCT00834899|561438471|FG000|Overall Study|Withdrawal by Subject|1|||
155550124|NCT00834899|561438472|FG001|Overall Study|Withdrawal by Subject|1|||
155550125|NCT02610816|561438475|FG000|Phase 1|Withdrawal by Subject|2|||
155550126|NCT02610816|561438476|FG001|Phase 1|Withdrawal by Subject|6|||
155550127|NCT02610816|561438477|FG002|Phase 1|Withdrawal by Subject|0|||
155550128|NCT02610816|561438478|FG003|Phase 1|Withdrawal by Subject|0|||
155550129|NCT02610816|561438475|FG000|Phase 1|Lost to Follow-up|2|||
155550130|NCT02610816|561438476|FG001|Phase 1|Lost to Follow-up|1|||
155550131|NCT02610816|561438477|FG002|Phase 1|Lost to Follow-up|0|||
155550132|NCT02610816|561438478|FG003|Phase 1|Lost to Follow-up|0|||
155550133|NCT02610816|561438475|FG000|Phase 1|Physician Decision|0|||
155550134|NCT02610816|561438476|FG001|Phase 1|Physician Decision|1|||
155550135|NCT02610816|561438477|FG002|Phase 1|Physician Decision|0|||
155550136|NCT02610816|561438478|FG003|Phase 1|Physician Decision|0|||
155550137|NCT02610816|561438475|FG000|Phase 2|Withdrawal by Subject|0|||
155550138|NCT02610816|561438476|FG001|Phase 2|Withdrawal by Subject|0|||
155550139|NCT02610816|561438477|FG002|Phase 2|Withdrawal by Subject|9|||
155550140|NCT02610816|561438478|FG003|Phase 2|Withdrawal by Subject|3|||
155550141|NCT02610816|561438475|FG000|Phase 2|Lost to Follow-up|0|||
155550142|NCT02610816|561438476|FG001|Phase 2|Lost to Follow-up|0|||
155550143|NCT02610816|561438477|FG002|Phase 2|Lost to Follow-up|2|||
155550144|NCT02610816|561438478|FG003|Phase 2|Lost to Follow-up|0|||
155550145|NCT02610816|561438475|FG000|Phase 2|Physician Decision|0|||
155550146|NCT02610816|561438476|FG001|Phase 2|Physician Decision|0|||
155657307|NCT00427700|561838950|FG001|Overall Study|Lost to Follow-up|5|||
155657308|NCT00427700|561838949|FG000|Overall Study|no induction of menses|1|||
155657309|NCT00427700|561838950|FG001|Overall Study|no induction of menses|4|||
155657310|NCT00427700|561838949|FG000|Overall Study|Pregnancy|0|||
155550147|NCT02610816|561438477|FG002|Phase 2|Physician Decision|0|||
155550148|NCT02610816|561438478|FG003|Phase 2|Physician Decision|2|||
155550149|NCT02610816|561438475|FG000|Phase 2|Pregnancy|0|||
155550150|NCT02610816|561438476|FG001|Phase 2|Pregnancy|0|||
155550151|NCT02610816|561438477|FG002|Phase 2|Pregnancy|0|||
155550152|NCT02610816|561438478|FG003|Phase 2|Pregnancy|1|||
155550153|NCT00384176|561438479|FG000|Overall Study|Death|239|||
155550154|NCT00384176|561438480|FG001|Overall Study|Death|247|||
155550155|NCT00384176|561438481|FG002|Overall Study|Death|105|||
155550156|NCT00384176|561438479|FG000|Overall Study|Withdrawal by Subject|52|||
155550157|NCT00384176|561438480|FG001|Overall Study|Withdrawal by Subject|48|||
155550158|NCT00384176|561438481|FG002|Overall Study|Withdrawal by Subject|22|||
155550159|NCT00384176|561438479|FG000|Overall Study|Lost to Follow-up|16|||
155550160|NCT00384176|561438480|FG001|Overall Study|Lost to Follow-up|18|||
155550161|NCT00384176|561438481|FG002|Overall Study|Lost to Follow-up|4|||
155550162|NCT00384176|561438479|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
155550163|NCT00384176|561438480|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
155550164|NCT00384176|561438481|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
155550165|NCT00384176|561438479|FG000|Overall Study|Longer QTC as Visit 1|1|||
155550166|NCT00384176|561438480|FG001|Overall Study|Longer QTC as Visit 1|0|||
155550167|NCT00384176|561438481|FG002|Overall Study|Longer QTC as Visit 1|0|||
155550168|NCT00384176|561438479|FG000|Overall Study|Toxicity of treatment|1|||
155550169|NCT00384176|561438480|FG001|Overall Study|Toxicity of treatment|0|||
155550170|NCT00384176|561438481|FG002|Overall Study|Toxicity of treatment|0|||
155550171|NCT00384176|561438479|FG000|Overall Study|Did not receive study treatment|0|||
155550172|NCT00384176|561438480|FG001|Overall Study|Did not receive study treatment|1|||
155550173|NCT00384176|561438481|FG002|Overall Study|Did not receive study treatment|1|||
155550174|NCT00384176|561438479|FG000|Overall Study|Physician Decision|0|||
155550175|NCT00384176|561438480|FG001|Overall Study|Physician Decision|2|||
155550176|NCT00384176|561438481|FG002|Overall Study|Physician Decision|0|||
155550177|NCT00384176|561438479|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
155550178|NCT00384176|561438480|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
155550179|NCT00384176|561438481|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
155550180|NCT00402025|561438482|FG000|Overall Study|Adverse Event|0|||
155550181|NCT00402025|561438483|FG001|Overall Study|Adverse Event|0|||
155550182|NCT00402025|561438484|FG002|Overall Study|Adverse Event|2|||
155550183|NCT00402025|561438482|FG000|Overall Study|Death|0|||
155550184|NCT00402025|561438483|FG001|Overall Study|Death|1|||
155550185|NCT00402025|561438484|FG002|Overall Study|Death|5|||
155550186|NCT00402025|561438482|FG000|Overall Study|Disease Progression|1|||
155550187|NCT00402025|561438483|FG001|Overall Study|Disease Progression|1|||
155550188|NCT00402025|561438484|FG002|Overall Study|Disease Progression|2|||
155550189|NCT00402025|561438482|FG000|Overall Study|Physician Decision|1|||
155550190|NCT00402025|561438483|FG001|Overall Study|Physician Decision|1|||
155550191|NCT00402025|561438484|FG002|Overall Study|Physician Decision|0|||
155657311|NCT00427700|561838950|FG001|Overall Study|Pregnancy|2|||
155657312|NCT04581395|561838951|FG000|Overall Study|Protocol Violation|4|||
155657313|NCT04581395|561838952|FG001|Overall Study|Protocol Violation|3|||
155657314|NCT04581395|561838953|FG002|Overall Study|Protocol Violation|2|||
155657315|NCT04581395|561838951|FG000|Overall Study|Physician Decision|0|||
155657316|NCT04581395|561838952|FG001|Overall Study|Physician Decision|1|||
155657317|NCT04581395|561838953|FG002|Overall Study|Physician Decision|0|||
155657318|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
155657319|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657320|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657321|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657322|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657323|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657324|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155657325|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
155657326|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
155657327|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
155657328|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
155657329|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
155657330|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
155657331|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
155657332|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
155657333|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
155657334|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
155657335|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
155657336|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
155657337|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
155657338|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
155657339|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
155657340|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
155657341|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
155657342|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
155657343|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
155550192|NCT00402025|561438482|FG000|Overall Study|Participant Decision|0|||
155550193|NCT00402025|561438483|FG001|Overall Study|Participant Decision|0|||
155550194|NCT00402025|561438484|FG002|Overall Study|Participant Decision|1|||
155550195|NCT03078478|561438492|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
155550196|NCT03078478|561438493|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
155550197|NCT03078478|561438492|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
155550198|NCT03078478|561438493|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
155550199|NCT03078478|561438492|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
155550200|NCT03078478|561438493|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
155550201|NCT03078478|561438492|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
155550202|NCT03078478|561438493|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
155550203|NCT03078478|561438492|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
155550204|NCT03078478|561438493|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
155550205|NCT03078478|561438492|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
155550206|NCT03078478|561438493|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
155550207|NCT03078478|561438492|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
155550208|NCT03078478|561438493|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
155550209|NCT03078478|561438492|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
155550210|NCT03078478|561438493|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
155550211|NCT02756637|561438498|FG000|Overall Study|Not eligible for initial SWOG study|10|||
155550212|NCT02756637|561438499|FG001|Overall Study|Not eligible for initial SWOG study|10|||
155550213|NCT02756637|561438498|FG000|Overall Study|No available NLR value|44|||
155550214|NCT02756637|561438499|FG001|Overall Study|No available NLR value|44|||
155550215|NCT02756637|561438498|FG000|Overall Study|Did not complete curative therapy|33|||
155550216|NCT02756637|561438499|FG001|Overall Study|Did not complete curative therapy|0|||
155550217|NCT03064438|561440474|FG000|Overall Study|Lost to Follow-up|1|||
155550218|NCT03064438|561440475|FG001|Overall Study|Lost to Follow-up|0|||
155550219|NCT03064438|561440474|FG000|Overall Study|Withdrawal by Subject|0|||
155550220|NCT03064438|561440475|FG001|Overall Study|Withdrawal by Subject|1|||
155550221|NCT01314118|561440476|FG000|Overall Study|Adverse Event|10|||
155550222|NCT01314118|561440476|FG000|Overall Study|Progressive disease|3|||
155550223|NCT01314118|561440476|FG000|Overall Study|Death|8|||
155550224|NCT01314118|561440476|FG000|Overall Study|Physician Decision|13|||
155550225|NCT01314118|561440476|FG000|Overall Study|Sponsor Decision|1|||
155550226|NCT01314118|561440476|FG000|Overall Study|Protocol Violation|2|||
155550227|NCT01314118|561440476|FG000|Overall Study|Withdrawal by Subject|26|||
155550228|NCT01314118|561440476|FG000|Overall Study|Other|21|||
155550229|NCT04266301|561440477|FG000|Overall Study|Progressive Disease|111|||
155550230|NCT04266301|561440478|FG001|Overall Study|Progressive Disease|92|||
155550231|NCT04266301|561440477|FG000|Overall Study|Adverse Event|41|||
155550232|NCT04266301|561440478|FG001|Overall Study|Adverse Event|43|||
155550233|NCT04266301|561440477|FG000|Overall Study|Death|26|||
155550234|NCT04266301|561440478|FG001|Overall Study|Death|35|||
155550235|NCT04266301|561440477|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
155550236|NCT04266301|561440478|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
155550237|NCT04266301|561440477|FG000|Overall Study|Study Terminated by Sponsor|22|||
155550238|NCT04266301|561440478|FG001|Overall Study|Study Terminated by Sponsor|27|||
155550239|NCT04266301|561440477|FG000|Overall Study|Participant Decision|22|||
155550240|NCT04266301|561440478|FG001|Overall Study|Participant Decision|28|||
155550241|NCT04266301|561440477|FG000|Overall Study|Physician Decision|14|||
155550242|NCT04266301|561440478|FG001|Overall Study|Physician Decision|9|||
155550243|NCT04266301|561440477|FG000|Overall Study|New Therapy for Study Indication|2|||
155550244|NCT04266301|561440478|FG001|Overall Study|New Therapy for Study Indication|4|||
155550245|NCT04266301|561440477|FG000|Overall Study|Protocol Deviation|2|||
155550246|NCT04266301|561440478|FG001|Overall Study|Protocol Deviation|4|||
155550247|NCT04266301|561440477|FG000|Overall Study|Guardian Decision|1|||
155550248|NCT04266301|561440478|FG001|Overall Study|Guardian Decision|0|||
155550249|NCT04266301|561440477|FG000|Overall Study|Lost to Follow-up|1|||
155550250|NCT04266301|561440478|FG001|Overall Study|Lost to Follow-up|0|||
155550251|NCT04266301|561440477|FG000|Overall Study|Participants Not Treated|1|||
155657344|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
155657345|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
155657346|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
155550252|NCT04266301|561440478|FG001|Overall Study|Participants Not Treated|1|||
155550253|NCT04079712|561440479|FG000|Overall Study|Disease progression before starting treatment|1|||
155550254|NCT01432574|561440480|FG000|Overall Study|Moved|2|||
155550255|NCT01432574|561440480|FG000|Overall Study|Not interested|1|||
155550256|NCT04373551|561440481|FG000|Overall Study|Lost to Follow-up|15|||
155550257|NCT04373551|561440481|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
155550258|NCT01042535|561440482|FG000|Overall Study|disease progression prior to treatment|3|||
155550259|NCT01042535|561440482|FG000|Overall Study|disease progression during treatment|3|||
155550260|NCT01042535|561440482|FG000|Overall Study|complications from other disease|2|||
155550261|NCT00107042|561440485|FG000|Overall Study|Lost to Follow-up|9|||
155550262|NCT00107042|561440486|FG001|Overall Study|Lost to Follow-up|7|||
155550263|NCT00107042|561440485|FG000|Overall Study|Withdrawal by Subject|6|||
155550264|NCT00107042|561440486|FG001|Overall Study|Withdrawal by Subject|1|||
155550265|NCT00107042|561440485|FG000|Overall Study|Moved out of area|5|||
155550266|NCT00107042|561440486|FG001|Overall Study|Moved out of area|3|||
155550267|NCT00107042|561440485|FG000|Overall Study|Pregnancy|1|||
155550268|NCT00107042|561440486|FG001|Overall Study|Pregnancy|1|||
155550269|NCT00107042|561440485|FG000|Overall Study|Inadvertent enrollment|0|||
155550270|NCT00107042|561440486|FG001|Overall Study|Inadvertent enrollment|1|||
155550271|NCT00107042|561440485|FG000|Overall Study|vaccinated outside window|1|||
155550272|NCT00107042|561440486|FG001|Overall Study|vaccinated outside window|1|||
155550273|NCT00107042|561440485|FG000|Overall Study|Disallowed medications|0|||
155550274|NCT00107042|561440486|FG001|Overall Study|Disallowed medications|2|||
155550275|NCT03919448|561440487|FG000|Overall Study|Withdrawal by Subject|1|||
155550276|NCT03919448|561440488|FG001|Overall Study|Withdrawal by Subject|0|||
155550277|NCT03919448|561440489|FG002|Overall Study|Withdrawal by Subject|0|||
155550278|NCT01221090|561440491|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
155550279|NCT01221090|561440492|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
155550280|NCT01221090|561440493|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
155550281|NCT01221090|561440494|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
155550282|NCT01221090|561440491|FG000|Overall Study|Withdrawal by Subject|0|||
155550283|NCT01221090|561440492|FG001|Overall Study|Withdrawal by Subject|22|||
155550284|NCT01221090|561440493|FG002|Overall Study|Withdrawal by Subject|27|||
155550285|NCT01221090|561440494|FG003|Overall Study|Withdrawal by Subject|2|||
155550286|NCT03438539|561440495|FG000|Overall Study|Lost to Follow-up|8|||
155550287|NCT03438539|561440496|FG001|Overall Study|Lost to Follow-up|4|||
155550288|NCT03438539|561440497|FG002|Overall Study|Lost to Follow-up|10|||
155550289|NCT03438539|561440498|FG003|Overall Study|Lost to Follow-up|9|||
155550290|NCT03438539|561440499|FG004|Overall Study|Lost to Follow-up|3|||
155550291|NCT03438539|561440500|FG005|Overall Study|Lost to Follow-up|8|||
155550292|NCT04507126|561440501|FG000|Overall Study|Withdrawal by Subject|3|||
155550293|NCT04507126|561440501|FG000|Overall Study|Protocol Violation|4|||
155550294|NCT00440466|561440503|FG000|Overall Study|Death|3|||
155550295|NCT00440466|561440504|FG001|Overall Study|Death|2|||
155550296|NCT00440466|561440505|FG002|Overall Study|Death|9|||
155550297|NCT00440466|561440503|FG000|Overall Study|Adverse Event|3|||
155550298|NCT00440466|561440504|FG001|Overall Study|Adverse Event|4|||
155550299|NCT00440466|561440505|FG002|Overall Study|Adverse Event|11|||
155550300|NCT00440466|561440503|FG000|Overall Study|Lost to Follow-up|1|||
155550301|NCT00440466|561440504|FG001|Overall Study|Lost to Follow-up|0|||
155550302|NCT00440466|561440505|FG002|Overall Study|Lost to Follow-up|2|||
155550303|NCT00440466|561440503|FG000|Overall Study|Physician Decision|2|||
155550304|NCT00440466|561440504|FG001|Overall Study|Physician Decision|0|||
155550305|NCT00440466|561440505|FG002|Overall Study|Physician Decision|1|||
155550306|NCT00440466|561440503|FG000|Overall Study|Protocol Violation|2|||
155550307|NCT00440466|561440504|FG001|Overall Study|Protocol Violation|0|||
155550308|NCT00440466|561440505|FG002|Overall Study|Protocol Violation|4|||
155550309|NCT00440466|561440503|FG000|Overall Study|Withdrawal by Subject|2|||
155550310|NCT00440466|561440504|FG001|Overall Study|Withdrawal by Subject|5|||
155550311|NCT00440466|561440505|FG002|Overall Study|Withdrawal by Subject|9|||
155550312|NCT00440466|561440503|FG000|Overall Study|Began Dialysis|0|||
155550313|NCT00440466|561440504|FG001|Overall Study|Began Dialysis|0|||
155550314|NCT00440466|561440505|FG002|Overall Study|Began Dialysis|1|||
155550315|NCT00440466|561440503|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
155550316|NCT00440466|561440504|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
155550317|NCT00440466|561440505|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
155550318|NCT00140413|561440508|FG000|Overall Study|Lost to Follow-up|1|||
155550319|NCT00140413|561440509|FG001|Overall Study|Lost to Follow-up|0|||
155550320|NCT00140413|561440508|FG000|Overall Study|Withdrawal by Subject|2|||
155550321|NCT00140413|561440509|FG001|Overall Study|Withdrawal by Subject|0|||
155550322|NCT01223235|561440512|FG000|Overall Study|Withdrawal by Subject|1|||
155550323|NCT04976621|561440524|FG000|Overall Study|Lost to Follow-up|2|||
155550324|NCT04976621|561440525|FG001|Overall Study|Lost to Follow-up|2|||
155550325|NCT04976621|561440524|FG000|Overall Study|Withdrawal by Subject|1|||
155550326|NCT04976621|561440525|FG001|Overall Study|Withdrawal by Subject|1|||
155550327|NCT05560763|561440532|FG000|Overall Study|Withdrawal by Subject|4|||
155550328|NCT00949988|561440536|FG000|Overall Study|Withdrawal by Subject|3|||
155550329|NCT01929395|561440537|FG000|Overall Study|Did not complete - non-related toxicity|1|||
155550330|NCT01929395|561440538|FG001|Overall Study|Did not complete - non-related toxicity|0|||
155550331|NCT01929395|561440539|FG002|Overall Study|Did not complete - non-related toxicity|0|||
155550332|NCT01929395|561440537|FG000|Overall Study|Withdrawal by Subject|0|||
155550333|NCT01929395|561440538|FG001|Overall Study|Withdrawal by Subject|1|||
155550334|NCT01929395|561440539|FG002|Overall Study|Withdrawal by Subject|0|||
155550335|NCT01929395|561440537|FG000|Overall Study|Screen Fail|0|||
155550336|NCT01929395|561440538|FG001|Overall Study|Screen Fail|0|||
155550337|NCT01929395|561440539|FG002|Overall Study|Screen Fail|1|||
155550338|NCT03604341|561440541|FG000|Overall Study|Withdrawal by Subject|1|||
155550339|NCT03604341|561440542|FG001|Overall Study|Withdrawal by Subject|1|||
155550340|NCT03604341|561440541|FG000|Overall Study|Adverse Event|1|||
155550341|NCT03604341|561440542|FG001|Overall Study|Adverse Event|0|||
155550342|NCT03604341|561440541|FG000|Overall Study|Protocol Violation|0|||
155550343|NCT03604341|561440542|FG001|Overall Study|Protocol Violation|1|||
155550344|NCT00484419|561440543|FG000|Overall Study|Adverse Event|3|||
155550345|NCT00484419|561440544|FG001|Overall Study|Adverse Event|0|||
155550346|NCT00484419|561440545|FG002|Overall Study|Adverse Event|0|||
155550347|NCT00484419|561440543|FG000|Overall Study|Lost to Follow-up|1|||
155550348|NCT00484419|561440544|FG001|Overall Study|Lost to Follow-up|0|||
155550349|NCT00484419|561440545|FG002|Overall Study|Lost to Follow-up|2|||
155550350|NCT00484419|561440543|FG000|Overall Study|Withdrawal by Subject|3|||
155550351|NCT00484419|561440544|FG001|Overall Study|Withdrawal by Subject|1|||
155550352|NCT00484419|561440545|FG002|Overall Study|Withdrawal by Subject|1|||
155550353|NCT00484419|561440543|FG000|Overall Study|subject met discontinuation criteria|2|||
155550354|NCT00484419|561440544|FG001|Overall Study|subject met discontinuation criteria|2|||
155550355|NCT00484419|561440545|FG002|Overall Study|subject met discontinuation criteria|4|||
155550356|NCT00484419|561440543|FG000|Overall Study|required restricted medication|1|||
155550357|NCT00484419|561440544|FG001|Overall Study|required restricted medication|0|||
155550358|NCT00484419|561440545|FG002|Overall Study|required restricted medication|1|||
155550359|NCT00484419|561440543|FG000|Overall Study|Physician Decision|1|||
155550360|NCT00484419|561440544|FG001|Overall Study|Physician Decision|1|||
155550361|NCT00484419|561440545|FG002|Overall Study|Physician Decision|1|||
155550362|NCT00484419|561440543|FG000|Overall Study|subject unable to receive medication|1|||
155550363|NCT00484419|561440544|FG001|Overall Study|subject unable to receive medication|0|||
155550364|NCT00484419|561440545|FG002|Overall Study|subject unable to receive medication|0|||
155550365|NCT00484419|561440543|FG000|Overall Study|subject relocated|0|||
155550366|NCT00484419|561440544|FG001|Overall Study|subject relocated|1|||
155550367|NCT00484419|561440545|FG002|Overall Study|subject relocated|0|||
155550368|NCT00484419|561440543|FG000|Overall Study|sponsor decision, randomized in error|0|||
155550369|NCT00484419|561440544|FG001|Overall Study|sponsor decision, randomized in error|0|||
155550370|NCT00484419|561440545|FG002|Overall Study|sponsor decision, randomized in error|2|||
155550371|NCT01829113|561440546|FG000|Overall Study|Disease Progression|37|||
155550372|NCT01829113|561440547|FG001|Overall Study|Disease Progression|48|||
155550373|NCT01829113|561440546|FG000|Overall Study|Adverse Event|14|||
155550374|NCT01829113|561440547|FG001|Overall Study|Adverse Event|10|||
155550375|NCT01829113|561440546|FG000|Overall Study|Withdrawal by Subject|17|||
155550376|NCT01829113|561440547|FG001|Overall Study|Withdrawal by Subject|10|||
155550377|NCT01829113|561440546|FG000|Overall Study|Death|4|||
155550378|NCT01829113|561440547|FG001|Overall Study|Death|6|||
155550379|NCT01829113|561440546|FG000|Overall Study|Sponsor Decision|1|||
155550380|NCT01829113|561440547|FG001|Overall Study|Sponsor Decision|1|||
155550381|NCT01829113|561440546|FG000|Overall Study|No Study Treatment Received|3|||
155550382|NCT01829113|561440547|FG001|Overall Study|No Study Treatment Received|2|||
155550383|NCT01829113|561440546|FG000|Overall Study|Physician Decision|1|||
155550384|NCT01829113|561440547|FG001|Overall Study|Physician Decision|1|||
155550385|NCT00355472|561440550|FG000|Overall Study|Physician Decision|1|||
155550386|NCT05445843|561440551|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
155550387|NCT05445843|561440552|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
155550388|NCT05445843|561440551|FG000|Overall Study|Progressive disease|17|||
155550389|NCT05445843|561440552|FG001|Overall Study|Progressive disease|9|||
155550390|NCT05445843|561440551|FG000|Overall Study|Physician Decision|16|||
155550391|NCT05445843|561440552|FG001|Overall Study|Physician Decision|4|||
155550392|NCT05445843|561440551|FG000|Overall Study|Death|6|||
155550393|NCT05445843|561440552|FG001|Overall Study|Death|3|||
155550394|NCT05445843|561440551|FG000|Overall Study|Subject decision|6|||
155550395|NCT05445843|561440552|FG001|Overall Study|Subject decision|2|||
155550396|NCT05445843|561440551|FG000|Overall Study|Adverse Event|2|||
155550397|NCT05445843|561440552|FG001|Overall Study|Adverse Event|0|||
155550398|NCT05307679|561440557|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
155550399|NCT05307679|561440558|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
155550400|NCT06279871|561440561|FG000|Overall Study|Death|0|||
155550401|NCT06279871|561440562|FG001|Overall Study|Death|0|||
155550402|NCT06279871|561440563|FG002|Overall Study|Death|0|||
155550403|NCT06279871|561440564|FG003|Overall Study|Death|0|||
155550404|NCT06279871|561440565|FG004|Overall Study|Death|0|||
155550405|NCT06279871|561440566|FG005|Overall Study|Death|1|||
155550406|NCT06279871|561440567|FG006|Overall Study|Death|0|||
155550407|NCT06279871|561440561|FG000|Overall Study|Other than Specified|1|||
155550408|NCT06279871|561440562|FG001|Overall Study|Other than Specified|0|||
155550409|NCT06279871|561440563|FG002|Overall Study|Other than Specified|4|||
155550410|NCT06279871|561440564|FG003|Overall Study|Other than Specified|0|||
155550411|NCT06279871|561440565|FG004|Overall Study|Other than Specified|0|||
155550412|NCT06279871|561440566|FG005|Overall Study|Other than Specified|0|||
155550413|NCT06279871|561440567|FG006|Overall Study|Other than Specified|0|||
155550414|NCT06279871|561440561|FG000|Overall Study|Withdrawal by Subject|4|||
155550415|NCT06279871|561440562|FG001|Overall Study|Withdrawal by Subject|8|||
155550416|NCT06279871|561440563|FG002|Overall Study|Withdrawal by Subject|4|||
155550417|NCT06279871|561440564|FG003|Overall Study|Withdrawal by Subject|2|||
155550418|NCT06279871|561440565|FG004|Overall Study|Withdrawal by Subject|0|||
155550419|NCT06279871|561440566|FG005|Overall Study|Withdrawal by Subject|0|||
155550420|NCT06279871|561440567|FG006|Overall Study|Withdrawal by Subject|0|||
155550421|NCT06279871|561440561|FG000|Overall Study|Lost to Follow-up|11|||
155550422|NCT06279871|561440562|FG001|Overall Study|Lost to Follow-up|10|||
155550423|NCT06279871|561440563|FG002|Overall Study|Lost to Follow-up|8|||
155550424|NCT06279871|561440564|FG003|Overall Study|Lost to Follow-up|0|||
155550425|NCT06279871|561440565|FG004|Overall Study|Lost to Follow-up|0|||
155550426|NCT06279871|561440566|FG005|Overall Study|Lost to Follow-up|0|||
155550427|NCT06279871|561440567|FG006|Overall Study|Lost to Follow-up|0|||
155550428|NCT06279871|561440561|FG000|Overall Study|Adverse Event|0|||
155550429|NCT06279871|561440562|FG001|Overall Study|Adverse Event|1|||
155550430|NCT06279871|561440563|FG002|Overall Study|Adverse Event|0|||
155550431|NCT06279871|561440564|FG003|Overall Study|Adverse Event|0|||
155550432|NCT06279871|561440565|FG004|Overall Study|Adverse Event|0|||
155550433|NCT06279871|561440566|FG005|Overall Study|Adverse Event|0|||
155550434|NCT06279871|561440567|FG006|Overall Study|Adverse Event|0|||
155550435|NCT02674386|561440568|FG000|Overall Study|Lost to Follow-up|0|||
155550436|NCT02674386|561440569|FG001|Overall Study|Lost to Follow-up|1|||
155550437|NCT02674386|561440570|FG002|Overall Study|Lost to Follow-up|1|||
155550438|NCT02674386|561440568|FG000|Overall Study|Withdrawal by Subject|0|||
155550439|NCT02674386|561440569|FG001|Overall Study|Withdrawal by Subject|4|||
155550440|NCT02674386|561440570|FG002|Overall Study|Withdrawal by Subject|0|||
155550441|NCT02674386|561440568|FG000|Overall Study|Other|0|||
155550442|NCT02674386|561440569|FG001|Overall Study|Other|1|||
155550443|NCT02674386|561440570|FG002|Overall Study|Other|0|||
155550444|NCT02674386|561440568|FG000|Overall Study|Enrolled but not evaluated|0|||
155550445|NCT02674386|561440569|FG001|Overall Study|Enrolled but not evaluated|4|||
155550446|NCT02674386|561440570|FG002|Overall Study|Enrolled but not evaluated|0|||
155550447|NCT04706507|561440571|FG000|Overall Study|Death|45|||
155550448|NCT04706507|561440572|FG001|Overall Study|Death|22|||
155550449|NCT04706507|561440571|FG000|Overall Study|Unable to adhere|0|||
155550450|NCT04706507|561440572|FG001|Overall Study|Unable to adhere|2|||
155550451|NCT04706507|561440571|FG000|Overall Study|Lost to Follow-up|13|||
155550452|NCT04706507|561440572|FG001|Overall Study|Lost to Follow-up|12|||
155550453|NCT04706507|561440571|FG000|Overall Study|Withdrawal of consent|1|||
155550454|NCT04706507|561440572|FG001|Overall Study|Withdrawal of consent|1|||
155550455|NCT04706507|561440571|FG000|Overall Study|Patient or LAR refuses further participation|0|||
155550456|NCT04706507|561440572|FG001|Overall Study|Patient or LAR refuses further participation|3|||
155550457|NCT00285584|561440577|FG000|Month 3|Lost to Follow-up|3|||
155550458|NCT00285584|561440578|FG001|Month 3|Lost to Follow-up|3|||
155550459|NCT00285584|561440577|FG000|Month 3|Withdrawal by Subject|1|||
155550460|NCT00285584|561440578|FG001|Month 3|Withdrawal by Subject|0|||
155550461|NCT00285584|561440577|FG000|Month 6|Lost to Follow-up|0|||
155550462|NCT00285584|561440578|FG001|Month 6|Lost to Follow-up|1|||
155550463|NCT00303667|561440585|FG000|Overall Study|Death|0|||
155550464|NCT00303667|561440586|FG001|Overall Study|Death|4|||
155550465|NCT01029392|561440587|FG000|Overall Study|Withdrawal by Subject|18|||
155550466|NCT01029392|561440588|FG001|Overall Study|Withdrawal by Subject|11|||
155550467|NCT01029392|561440587|FG000|Overall Study|Physician Decision|2|||
155550468|NCT01029392|561440588|FG001|Overall Study|Physician Decision|0|||
155550469|NCT01534637|561440589|FG000|Overall Study|Physician Decision|3|||
155550470|NCT01534637|561440589|FG000|Overall Study|Lack of Efficacy|3|||
155550471|NCT01534637|561440589|FG000|Overall Study|Withdrawal by Subject|1|||
155550472|NCT01534637|561440589|FG000|Overall Study|Adverse Event|1|||
155550473|NCT01534637|561440589|FG000|Overall Study|Liver Mets before treatment|1|||
155550474|NCT01523587|561440590|FG000|Overall Study|Other than listed|5|||
155550475|NCT01523587|561440591|FG001|Overall Study|Other than listed|5|||
155550476|NCT01523587|561440590|FG000|Overall Study|Worsening of underlying cancer disease|19|||
155550477|NCT01523587|561440591|FG001|Overall Study|Worsening of underlying cancer disease|34|||
155550478|NCT01523587|561440590|FG000|Overall Study|Adverse Event|68|||
155550479|NCT01523587|561440591|FG001|Overall Study|Adverse Event|52|||
155550480|NCT01523587|561440590|FG000|Overall Study|Protocol Violation|5|||
155550481|NCT01523587|561440591|FG001|Overall Study|Protocol Violation|3|||
155550482|NCT01523587|561440590|FG000|Overall Study|Lost to Follow-up|2|||
155550483|NCT01523587|561440591|FG001|Overall Study|Lost to Follow-up|2|||
155550484|NCT01523587|561440590|FG000|Overall Study|Withdrawal by Subject|28|||
155550485|NCT01523587|561440591|FG001|Overall Study|Withdrawal by Subject|20|||
155550486|NCT01523587|561440590|FG000|Overall Study|Withdrew due to Progressive disease|265|||
155550487|NCT01523587|561440591|FG001|Overall Study|Withdrew due to Progressive disease|279|||
155550488|NCT01523587|561440590|FG000|Overall Study|Randomised but bot treated|6|||
155550489|NCT01523587|561440591|FG001|Overall Study|Randomised but bot treated|2|||
155550490|NCT02709486|561440592|FG000|Overall Study|Adverse Event|2|||
155550491|NCT02709486|561440593|FG001|Overall Study|Adverse Event|5|||
155550492|NCT02709486|561440594|FG002|Overall Study|Adverse Event|3|||
155550493|NCT02709486|561440592|FG000|Overall Study|Death|0|||
155550494|NCT02709486|561440593|FG001|Overall Study|Death|0|||
155550495|NCT02709486|561440594|FG002|Overall Study|Death|2|||
155550496|NCT02709486|561440592|FG000|Overall Study|Insufficient clinical response|7|||
155550497|NCT02709486|561440593|FG001|Overall Study|Insufficient clinical response|3|||
155550498|NCT02709486|561440594|FG002|Overall Study|Insufficient clinical response|3|||
155550499|NCT02709486|561440592|FG000|Overall Study|Lost to Follow-up|3|||
155550500|NCT02709486|561440593|FG001|Overall Study|Lost to Follow-up|2|||
155550501|NCT02709486|561440594|FG002|Overall Study|Lost to Follow-up|2|||
155550502|NCT02709486|561440592|FG000|Overall Study|Other|0|||
155550503|NCT02709486|561440593|FG001|Overall Study|Other|2|||
155550504|NCT02709486|561440594|FG002|Overall Study|Other|3|||
155550505|NCT02709486|561440592|FG000|Overall Study|Withdrawal by Subject|32|||
155550506|NCT02709486|561440593|FG001|Overall Study|Withdrawal by Subject|22|||
155550507|NCT02709486|561440594|FG002|Overall Study|Withdrawal by Subject|32|||
155550508|NCT00706355|561440599|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
155550509|NCT00706355|561440600|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
155550510|NCT00706355|561440601|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
155550511|NCT00706355|561440602|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
155550512|NCT00706355|561440599|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
155550513|NCT00706355|561440600|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
155550514|NCT00706355|561440601|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
155550515|NCT00706355|561440602|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
155550516|NCT00706355|561440599|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
155550517|NCT00706355|561440600|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
155550518|NCT00706355|561440601|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
155550519|NCT00706355|561440602|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
155550520|NCT00706355|561440599|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
155550521|NCT00706355|561440600|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
155550522|NCT00706355|561440601|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
155550523|NCT00706355|561440602|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
155550524|NCT00706355|561440599|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
155550525|NCT00706355|561440600|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
155550526|NCT00706355|561440601|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
155550527|NCT00706355|561440602|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
155550528|NCT00706355|561440599|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
155550529|NCT00706355|561440600|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
155550530|NCT00706355|561440601|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
155550531|NCT00706355|561440602|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
155550532|NCT00706355|561440599|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
155550533|NCT00706355|561440600|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
155550534|NCT00706355|561440601|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
155550535|NCT00706355|561440602|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
155550536|NCT00706355|561440599|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
155550537|NCT00706355|561440600|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
155550538|NCT00706355|561440601|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
155550539|NCT00706355|561440602|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
155550540|NCT00706355|561440599|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
155550541|NCT00706355|561440600|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
155550542|NCT00706355|561440601|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
155550543|NCT00706355|561440602|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
155550544|NCT02691741|561440605|FG000|Overall Study|Adverse Event|0|||
155550545|NCT02691741|561440606|FG001|Overall Study|Adverse Event|2|||
155550546|NCT02691741|561440605|FG000|Overall Study|Lost to Follow-up|1|||
155550547|NCT02691741|561440606|FG001|Overall Study|Lost to Follow-up|0|||
155550548|NCT02691741|561440605|FG000|Overall Study|Physician Decision|0|||
155550549|NCT02691741|561440606|FG001|Overall Study|Physician Decision|1|||
155550550|NCT02691741|561440605|FG000|Overall Study|Withdrawal by Subject|0|||
155550551|NCT02691741|561440606|FG001|Overall Study|Withdrawal by Subject|4|||
155550552|NCT02139124|561440607|FG000|Overall Study|Adverse Event|2|||
155550553|NCT02139124|561440608|FG001|Overall Study|Adverse Event|0|||
155550554|NCT02139124|561440609|FG002|Overall Study|Adverse Event|1|||
155550555|NCT02139124|561440610|FG003|Overall Study|Adverse Event|2|||
155550556|NCT02139124|561440611|FG004|Overall Study|Adverse Event|5|||
155550557|NCT02139124|561440607|FG000|Overall Study|Withdrawal by Subject|2|||
155550558|NCT02139124|561440608|FG001|Overall Study|Withdrawal by Subject|2|||
155550559|NCT02139124|561440609|FG002|Overall Study|Withdrawal by Subject|2|||
155550560|NCT02139124|561440610|FG003|Overall Study|Withdrawal by Subject|2|||
155550561|NCT02139124|561440611|FG004|Overall Study|Withdrawal by Subject|3|||
155550562|NCT02139124|561440607|FG000|Overall Study|Protocol Violation|0|||
155550563|NCT02139124|561440608|FG001|Overall Study|Protocol Violation|0|||
155550564|NCT02139124|561440609|FG002|Overall Study|Protocol Violation|0|||
155550565|NCT02139124|561440610|FG003|Overall Study|Protocol Violation|1|||
155550566|NCT02139124|561440611|FG004|Overall Study|Protocol Violation|1|||
155550567|NCT02139124|561440607|FG000|Overall Study|non-compliant|1|||
155550568|NCT02139124|561440608|FG001|Overall Study|non-compliant|0|||
155550569|NCT02139124|561440609|FG002|Overall Study|non-compliant|0|||
155550570|NCT02139124|561440610|FG003|Overall Study|non-compliant|2|||
155550571|NCT02139124|561440611|FG004|Overall Study|non-compliant|0|||
155550572|NCT02139124|561440607|FG000|Overall Study|incarceration|0|||
155550573|NCT02139124|561440608|FG001|Overall Study|incarceration|0|||
155550574|NCT02139124|561440609|FG002|Overall Study|incarceration|1|||
155550575|NCT02139124|561440610|FG003|Overall Study|incarceration|0|||
155550576|NCT02139124|561440611|FG004|Overall Study|incarceration|0|||
155550577|NCT02139124|561440607|FG000|Overall Study|subject moved|1|||
155550578|NCT02139124|561440608|FG001|Overall Study|subject moved|0|||
155550579|NCT02139124|561440609|FG002|Overall Study|subject moved|0|||
155550580|NCT02139124|561440610|FG003|Overall Study|subject moved|0|||
155550581|NCT02139124|561440611|FG004|Overall Study|subject moved|0|||
155550582|NCT02139124|561440607|FG000|Overall Study|Lost to Follow-up|3|||
155550583|NCT02139124|561440608|FG001|Overall Study|Lost to Follow-up|2|||
155550584|NCT02139124|561440609|FG002|Overall Study|Lost to Follow-up|0|||
155550585|NCT02139124|561440610|FG003|Overall Study|Lost to Follow-up|5|||
155550586|NCT02139124|561440611|FG004|Overall Study|Lost to Follow-up|4|||
155550587|NCT02697773|561440612|FG000|Overall Study|Adverse Event|2|||
155657347|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
155657348|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
155657349|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
155657350|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
155657351|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
155657352|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
155657353|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
155657354|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
155657355|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
155550588|NCT02697773|561440613|FG001|Overall Study|Adverse Event|1|||
155550589|NCT02697773|561440614|FG002|Overall Study|Adverse Event|2|||
155550590|NCT02697773|561440612|FG000|Overall Study|Death|0|||
155550591|NCT02697773|561440613|FG001|Overall Study|Death|0|||
155550592|NCT02697773|561440614|FG002|Overall Study|Death|2|||
155550593|NCT02697773|561440612|FG000|Overall Study|Lack of Efficacy|4|||
155550594|NCT02697773|561440613|FG001|Overall Study|Lack of Efficacy|6|||
155550595|NCT02697773|561440614|FG002|Overall Study|Lack of Efficacy|6|||
155550596|NCT02697773|561440612|FG000|Overall Study|Lost to Follow-up|5|||
155550597|NCT02697773|561440613|FG001|Overall Study|Lost to Follow-up|5|||
155550598|NCT02697773|561440614|FG002|Overall Study|Lost to Follow-up|7|||
155550599|NCT02697773|561440612|FG000|Overall Study|Other|15|||
155550600|NCT02697773|561440613|FG001|Overall Study|Other|11|||
155550601|NCT02697773|561440614|FG002|Overall Study|Other|10|||
155550602|NCT02697773|561440612|FG000|Overall Study|Protocol Violation|1|||
155550603|NCT02697773|561440613|FG001|Overall Study|Protocol Violation|1|||
155550604|NCT02697773|561440614|FG002|Overall Study|Protocol Violation|0|||
155550605|NCT02697773|561440612|FG000|Overall Study|Withdrawal by Subject|10|||
155550606|NCT02697773|561440613|FG001|Overall Study|Withdrawal by Subject|13|||
155550607|NCT02697773|561440614|FG002|Overall Study|Withdrawal by Subject|13|||
155550608|NCT02697773|561440612|FG000|Overall Study|Randomized but not treated|1|||
155550609|NCT02697773|561440613|FG001|Overall Study|Randomized but not treated|1|||
155550610|NCT02697773|561440614|FG002|Overall Study|Randomized but not treated|0|||
155550611|NCT02243293|561440615|FG000|Overall Study|Adverse Event|1|||
155550612|NCT02243293|561440616|FG001|Overall Study|Adverse Event|0|||
155550613|NCT02243293|561440617|FG002|Overall Study|Adverse Event|0|||
155550614|NCT02243293|561440618|FG003|Overall Study|Adverse Event|0|||
155550615|NCT02243293|561440619|FG004|Overall Study|Adverse Event|0|||
155550616|NCT02243293|561440620|FG005|Overall Study|Adverse Event|0|||
155550617|NCT02243293|561440621|FG006|Overall Study|Adverse Event|0|||
155550618|NCT02243293|561440622|FG007|Overall Study|Adverse Event|0|||
155550619|NCT02243293|561440623|FG008|Overall Study|Adverse Event|0|||
155550620|NCT02243293|561440624|FG009|Overall Study|Adverse Event|0|||
155550621|NCT02243293|561440625|FG010|Overall Study|Adverse Event|0|||
155550622|NCT02243293|561440626|FG011|Overall Study|Adverse Event|0|||
155550623|NCT02243293|561440627|FG012|Overall Study|Adverse Event|0|||
155550624|NCT02243293|561440628|FG013|Overall Study|Adverse Event|0|||
155550625|NCT02243293|561440629|FG014|Overall Study|Adverse Event|0|||
155550626|NCT02243293|561440630|FG015|Overall Study|Adverse Event|1|||
155550627|NCT02243293|561440631|FG016|Overall Study|Adverse Event|0|||
155550628|NCT02243293|561440632|FG017|Overall Study|Adverse Event|0|||
155550629|NCT02243293|561440633|FG018|Overall Study|Adverse Event|0|||
155550630|NCT02243293|561440634|FG019|Overall Study|Adverse Event|0|||
155550631|NCT02243293|561440635|FG020|Overall Study|Adverse Event|1|||
155550632|NCT02243293|561440636|FG021|Overall Study|Adverse Event|0|||
155550633|NCT02243293|561440615|FG000|Overall Study|Withdrawal by Subject|1|||
155550634|NCT02243293|561440616|FG001|Overall Study|Withdrawal by Subject|0|||
155550635|NCT02243293|561440617|FG002|Overall Study|Withdrawal by Subject|0|||
155550636|NCT02243293|561440618|FG003|Overall Study|Withdrawal by Subject|0|||
155550637|NCT02243293|561440619|FG004|Overall Study|Withdrawal by Subject|0|||
155550638|NCT02243293|561440620|FG005|Overall Study|Withdrawal by Subject|0|||
155550639|NCT02243293|561440621|FG006|Overall Study|Withdrawal by Subject|0|||
155550640|NCT02243293|561440622|FG007|Overall Study|Withdrawal by Subject|0|||
155550641|NCT02243293|561440623|FG008|Overall Study|Withdrawal by Subject|0|||
155550642|NCT02243293|561440624|FG009|Overall Study|Withdrawal by Subject|1|||
155550643|NCT02243293|561440625|FG010|Overall Study|Withdrawal by Subject|0|||
155550644|NCT02243293|561440626|FG011|Overall Study|Withdrawal by Subject|1|||
155550645|NCT02243293|561440627|FG012|Overall Study|Withdrawal by Subject|0|||
155550646|NCT02243293|561440628|FG013|Overall Study|Withdrawal by Subject|0|||
155550647|NCT02243293|561440629|FG014|Overall Study|Withdrawal by Subject|0|||
155550648|NCT02243293|561440630|FG015|Overall Study|Withdrawal by Subject|0|||
155550649|NCT02243293|561440631|FG016|Overall Study|Withdrawal by Subject|0|||
155550650|NCT02243293|561440632|FG017|Overall Study|Withdrawal by Subject|0|||
155550651|NCT02243293|561440633|FG018|Overall Study|Withdrawal by Subject|0|||
155550652|NCT02243293|561440634|FG019|Overall Study|Withdrawal by Subject|0|||
155550653|NCT02243293|561440635|FG020|Overall Study|Withdrawal by Subject|0|||
155550654|NCT02243293|561440636|FG021|Overall Study|Withdrawal by Subject|1|||
155550655|NCT02243293|561440615|FG000|Overall Study|Lost to Follow-up|0|||
155550656|NCT02243293|561440616|FG001|Overall Study|Lost to Follow-up|1|||
155550657|NCT02243293|561440617|FG002|Overall Study|Lost to Follow-up|1|||
155550658|NCT02243293|561440618|FG003|Overall Study|Lost to Follow-up|1|||
155550659|NCT02243293|561440619|FG004|Overall Study|Lost to Follow-up|0|||
155550660|NCT02243293|561440620|FG005|Overall Study|Lost to Follow-up|0|||
155550661|NCT02243293|561440621|FG006|Overall Study|Lost to Follow-up|3|||
155550662|NCT02243293|561440622|FG007|Overall Study|Lost to Follow-up|0|||
155550663|NCT02243293|561440623|FG008|Overall Study|Lost to Follow-up|0|||
155550664|NCT02243293|561440624|FG009|Overall Study|Lost to Follow-up|0|||
155550665|NCT02243293|561440625|FG010|Overall Study|Lost to Follow-up|0|||
155550666|NCT02243293|561440626|FG011|Overall Study|Lost to Follow-up|2|||
155550667|NCT02243293|561440627|FG012|Overall Study|Lost to Follow-up|0|||
155550668|NCT02243293|561440628|FG013|Overall Study|Lost to Follow-up|0|||
155550669|NCT02243293|561440629|FG014|Overall Study|Lost to Follow-up|0|||
155550670|NCT02243293|561440630|FG015|Overall Study|Lost to Follow-up|0|||
155550671|NCT02243293|561440631|FG016|Overall Study|Lost to Follow-up|3|||
155550672|NCT02243293|561440632|FG017|Overall Study|Lost to Follow-up|1|||
155550673|NCT02243293|561440633|FG018|Overall Study|Lost to Follow-up|0|||
155550674|NCT02243293|561440634|FG019|Overall Study|Lost to Follow-up|0|||
155550675|NCT02243293|561440635|FG020|Overall Study|Lost to Follow-up|1|||
155550676|NCT02243293|561440636|FG021|Overall Study|Lost to Follow-up|2|||
155550677|NCT02243293|561440615|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
155550678|NCT02243293|561440616|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
155550679|NCT02243293|561440617|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
155550680|NCT02243293|561440618|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
155550681|NCT02243293|561440619|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
155550682|NCT02243293|561440620|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
155550683|NCT02243293|561440621|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
155550684|NCT02243293|561440622|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
155550685|NCT02243293|561440623|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
155550686|NCT02243293|561440624|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
155550687|NCT02243293|561440625|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
155550688|NCT02243293|561440626|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
155550689|NCT02243293|561440627|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
155550690|NCT02243293|561440628|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
155550691|NCT02243293|561440629|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
155550692|NCT02243293|561440630|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
155550693|NCT02243293|561440631|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
155550694|NCT02243293|561440632|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
155550695|NCT02243293|561440633|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
155550696|NCT02243293|561440634|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
155550697|NCT02243293|561440635|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
155550698|NCT02243293|561440636|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
155550699|NCT02243293|561440615|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
155550700|NCT02243293|561440616|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
155550701|NCT02243293|561440617|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
155550702|NCT02243293|561440618|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
155550703|NCT02243293|561440619|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
155550704|NCT02243293|561440620|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
155550705|NCT02243293|561440621|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
155550706|NCT02243293|561440622|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
155550707|NCT02243293|561440623|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
155550708|NCT02243293|561440624|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
155550709|NCT02243293|561440625|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
155550710|NCT02243293|561440626|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
155550711|NCT02243293|561440627|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
155550712|NCT02243293|561440628|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
155550713|NCT02243293|561440629|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
155550714|NCT02243293|561440630|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
155550715|NCT02243293|561440631|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
155550716|NCT02243293|561440632|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
155550717|NCT02243293|561440633|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
155550718|NCT02243293|561440634|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
155550719|NCT02243293|561440635|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
155550720|NCT02243293|561440636|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
155550721|NCT03069417|561440637|FG000|Overall Study|Lost to Follow-up|2|||
155550722|NCT03069417|561440638|FG001|Overall Study|Lost to Follow-up|0|||
155550723|NCT03069417|561440637|FG000|Overall Study|Reason Unknown|4|||
155550724|NCT03069417|561440638|FG001|Overall Study|Reason Unknown|7|||
155550725|NCT00440115|561440639|FG000|Overall Study|Death|7|||
155550726|NCT00440115|561440640|FG001|Overall Study|Death|9|||
155550727|NCT00440115|561440641|FG002|Overall Study|Death|5|||
155550728|NCT00440115|561440639|FG000|Overall Study|Incarceration|0|||
155550729|NCT00440115|561440640|FG001|Overall Study|Incarceration|2|||
155550730|NCT00440115|561440641|FG002|Overall Study|Incarceration|1|||
155550731|NCT01172821|561440645|FG000|Overall Study|Adverse Event|5|||
155550732|NCT01172821|561440646|FG001|Overall Study|Adverse Event|2|||
155550733|NCT01172821|561440647|FG002|Overall Study|Adverse Event|2|||
155550734|NCT01172821|561440648|FG003|Overall Study|Adverse Event|7|||
155550735|NCT01172821|561440645|FG000|Overall Study|Protocol Violation|0|||
155550736|NCT01172821|561440646|FG001|Overall Study|Protocol Violation|2|||
155550737|NCT01172821|561440647|FG002|Overall Study|Protocol Violation|1|||
155550738|NCT01172821|561440648|FG003|Overall Study|Protocol Violation|2|||
155550739|NCT01172821|561440645|FG000|Overall Study|Lost to Follow-up|4|||
155550740|NCT01172821|561440646|FG001|Overall Study|Lost to Follow-up|1|||
155550741|NCT01172821|561440647|FG002|Overall Study|Lost to Follow-up|2|||
155550742|NCT01172821|561440648|FG003|Overall Study|Lost to Follow-up|2|||
155550743|NCT01172821|561440645|FG000|Overall Study|Withdrawal by Subject|2|||
155550744|NCT01172821|561440646|FG001|Overall Study|Withdrawal by Subject|3|||
155550745|NCT01172821|561440647|FG002|Overall Study|Withdrawal by Subject|3|||
155550746|NCT01172821|561440648|FG003|Overall Study|Withdrawal by Subject|3|||
155550747|NCT01172821|561440645|FG000|Overall Study|Other|3|||
155550748|NCT01172821|561440646|FG001|Overall Study|Other|4|||
155550749|NCT01172821|561440647|FG002|Overall Study|Other|5|||
155550750|NCT01172821|561440648|FG003|Overall Study|Other|3|||
155550751|NCT02985879|561440649|FG000|Overall Study|Adverse Event|7|||
155550752|NCT02985879|561440650|FG001|Overall Study|Adverse Event|9|||
155550753|NCT02985879|561440651|FG002|Overall Study|Adverse Event|7|||
155550754|NCT02985879|561440649|FG000|Overall Study|Withdrew consent|6|||
155550755|NCT02985879|561440650|FG001|Overall Study|Withdrew consent|8|||
155550756|NCT02985879|561440651|FG002|Overall Study|Withdrew consent|10|||
155550757|NCT02985879|561440649|FG000|Overall Study|Lost to Follow-up|1|||
155550758|NCT02985879|561440650|FG001|Overall Study|Lost to Follow-up|0|||
155550759|NCT02985879|561440651|FG002|Overall Study|Lost to Follow-up|2|||
155550760|NCT02985879|561440649|FG000|Overall Study|Other, not specified|62|||
155550761|NCT02985879|561440650|FG001|Overall Study|Other, not specified|58|||
155550762|NCT02985879|561440651|FG002|Overall Study|Other, not specified|58|||
155550763|NCT02723773|561442560|FG000|Overall Study|Adverse Event|934|||
155550764|NCT02723773|561442561|FG001|Overall Study|Adverse Event|3|||
155550765|NCT02723773|561442562|FG002|Overall Study|Adverse Event|1|||
155550766|NCT02723773|561442563|FG003|Overall Study|Adverse Event|9|||
155550767|NCT02723773|561442560|FG000|Overall Study|Protocol Violation|1|||
155550768|NCT02723773|561442561|FG001|Overall Study|Protocol Violation|0|||
155550769|NCT02723773|561442562|FG002|Overall Study|Protocol Violation|0|||
155550770|NCT02723773|561442563|FG003|Overall Study|Protocol Violation|0|||
155550771|NCT02723773|561442560|FG000|Overall Study|Withdrawal by Subject|360|||
155550772|NCT02723773|561442561|FG001|Overall Study|Withdrawal by Subject|5|||
155550773|NCT02723773|561442562|FG002|Overall Study|Withdrawal by Subject|6|||
155550774|NCT02723773|561442563|FG003|Overall Study|Withdrawal by Subject|10|||
155550775|NCT02723773|561442560|FG000|Overall Study|Migrated/moved from study area|37|||
155550776|NCT02723773|561442561|FG001|Overall Study|Migrated/moved from study area|0|||
155550777|NCT02723773|561442562|FG002|Overall Study|Migrated/moved from study area|0|||
155550778|NCT02723773|561442563|FG003|Overall Study|Migrated/moved from study area|1|||
155550779|NCT02723773|561442560|FG000|Overall Study|Lost to Follow-up|198|||
155550780|NCT02723773|561442561|FG001|Overall Study|Lost to Follow-up|0|||
155550781|NCT02723773|561442562|FG002|Overall Study|Lost to Follow-up|0|||
155550782|NCT02723773|561442563|FG003|Overall Study|Lost to Follow-up|0|||
155550783|NCT02723773|561442560|FG000|Overall Study|Other|189|||
155550784|NCT02723773|561442561|FG001|Overall Study|Other|1|||
155550785|NCT02723773|561442562|FG002|Overall Study|Other|2|||
155550786|NCT02723773|561442563|FG003|Overall Study|Other|2|||
155550787|NCT05168774|561442564|FG000|Overall Study|Lack of Efficacy|1|||
155550788|NCT05168774|561442565|FG001|Overall Study|Lack of Efficacy|2|||
155550789|NCT05168774|561442564|FG000|Overall Study|Withdrawal by Subject|1|||
155550790|NCT05168774|561442565|FG001|Overall Study|Withdrawal by Subject|2|||
155550791|NCT05168774|561442564|FG000|Overall Study|Adverse Event|2|||
155550792|NCT05168774|561442565|FG001|Overall Study|Adverse Event|0|||
155550793|NCT03940703|561442566|FG000|Overall Study|Still under treatment|31|||
155550794|NCT03940703|561442567|FG001|Overall Study|Still under treatment|0|||
155550795|NCT03310957|561442568|FG000|Overall Study|Withdrawal by Subject|1|||
155550796|NCT03310957|561442569|FG001|Overall Study|Withdrawal by Subject|1|||
155550797|NCT03310957|561442570|FG002|Overall Study|Withdrawal by Subject|1|||
155550798|NCT03310957|561442571|FG003|Overall Study|Withdrawal by Subject|5|||
155550799|NCT03310957|561442572|FG004|Overall Study|Withdrawal by Subject|0|||
155550800|NCT03310957|561442573|FG005|Overall Study|Withdrawal by Subject|4|||
155550801|NCT03310957|561442574|FG006|Overall Study|Withdrawal by Subject|3|||
155550802|NCT03310957|561442568|FG000|Overall Study|Site Terminated|0|||
155550803|NCT03310957|561442569|FG001|Overall Study|Site Terminated|1|||
155550804|NCT03310957|561442570|FG002|Overall Study|Site Terminated|1|||
155550805|NCT03310957|561442571|FG003|Overall Study|Site Terminated|1|||
155550806|NCT03310957|561442572|FG004|Overall Study|Site Terminated|0|||
155550807|NCT03310957|561442573|FG005|Overall Study|Site Terminated|2|||
155550808|NCT03310957|561442574|FG006|Overall Study|Site Terminated|8|||
155550809|NCT03310957|561442568|FG000|Overall Study|Lost to Follow-up|1|||
155550810|NCT03310957|561442569|FG001|Overall Study|Lost to Follow-up|1|||
155550811|NCT03310957|561442570|FG002|Overall Study|Lost to Follow-up|1|||
155550812|NCT03310957|561442571|FG003|Overall Study|Lost to Follow-up|4|||
155550813|NCT03310957|561442572|FG004|Overall Study|Lost to Follow-up|0|||
155550814|NCT03310957|561442573|FG005|Overall Study|Lost to Follow-up|4|||
155550815|NCT03310957|561442574|FG006|Overall Study|Lost to Follow-up|2|||
155550816|NCT03310957|561442568|FG000|Overall Study|Death|5|||
155550817|NCT03310957|561442569|FG001|Overall Study|Death|8|||
155550818|NCT03310957|561442570|FG002|Overall Study|Death|18|||
155550819|NCT03310957|561442571|FG003|Overall Study|Death|31|||
155550820|NCT03310957|561442572|FG004|Overall Study|Death|1|||
155550821|NCT03310957|561442573|FG005|Overall Study|Death|29|||
155550822|NCT03310957|561442574|FG006|Overall Study|Death|7|||
155550823|NCT03310957|561442568|FG000|Overall Study|Discontinuation per sponsor|0|||
155550824|NCT03310957|561442569|FG001|Overall Study|Discontinuation per sponsor|1|||
155550825|NCT03310957|561442570|FG002|Overall Study|Discontinuation per sponsor|2|||
155550826|NCT03310957|561442571|FG003|Overall Study|Discontinuation per sponsor|4|||
155550827|NCT03310957|561442572|FG004|Overall Study|Discontinuation per sponsor|1|||
155550828|NCT03310957|561442573|FG005|Overall Study|Discontinuation per sponsor|9|||
155550829|NCT03310957|561442574|FG006|Overall Study|Discontinuation per sponsor|12|||
155550830|NCT03310957|561442568|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
155550831|NCT03310957|561442569|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
155550832|NCT03310957|561442570|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
155550833|NCT03310957|561442571|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
155657356|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
155550834|NCT03310957|561442572|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
155550835|NCT03310957|561442573|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
155550836|NCT03310957|561442574|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
155550837|NCT03310957|561442568|FG000|Overall Study|Treatment landscape|0|||
155550838|NCT03310957|561442569|FG001|Overall Study|Treatment landscape|0|||
155550839|NCT03310957|561442570|FG002|Overall Study|Treatment landscape|1|||
155550840|NCT03310957|561442571|FG003|Overall Study|Treatment landscape|1|||
155550841|NCT03310957|561442572|FG004|Overall Study|Treatment landscape|0|||
155550842|NCT03310957|561442573|FG005|Overall Study|Treatment landscape|1|||
155550843|NCT03310957|561442574|FG006|Overall Study|Treatment landscape|0|||
155550844|NCT03310957|561442568|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550845|NCT03310957|561442569|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550846|NCT03310957|561442570|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550847|NCT03310957|561442571|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550848|NCT03310957|561442572|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
155550849|NCT03310957|561442573|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550850|NCT03310957|561442574|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
155550851|NCT03310957|561442568|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550852|NCT03310957|561442569|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550853|NCT03310957|561442570|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
155550854|NCT03310957|561442571|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550855|NCT03310957|561442572|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550856|NCT03310957|561442573|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550857|NCT03310957|561442574|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
155550858|NCT03310957|561442568|FG000|Overall Study|Hospice|0|||
155550859|NCT03310957|561442569|FG001|Overall Study|Hospice|0|||
155550860|NCT03310957|561442570|FG002|Overall Study|Hospice|0|||
155550861|NCT03310957|561442571|FG003|Overall Study|Hospice|0|||
155550862|NCT03310957|561442572|FG004|Overall Study|Hospice|0|||
155550863|NCT03310957|561442573|FG005|Overall Study|Hospice|1|||
155550864|NCT03310957|561442574|FG006|Overall Study|Hospice|0|||
155550865|NCT03310957|561442568|FG000|Overall Study|Progressive|0|||
155550866|NCT03310957|561442569|FG001|Overall Study|Progressive|0|||
155550867|NCT03310957|561442570|FG002|Overall Study|Progressive|1|||
155550868|NCT03310957|561442571|FG003|Overall Study|Progressive|0|||
155550869|NCT03310957|561442572|FG004|Overall Study|Progressive|0|||
155550870|NCT03310957|561442573|FG005|Overall Study|Progressive|0|||
155550871|NCT03310957|561442574|FG006|Overall Study|Progressive|0|||
155550872|NCT02658487|561442580|FG000|Overall Study|Death|2|||
155550873|NCT02658487|561442580|FG000|Overall Study|Disease progression|10|||
155550874|NCT02658487|561442580|FG000|Overall Study|Alternative therapy|1|||
155550875|NCT02658487|561442580|FG000|Overall Study|Adverse Event|1|||
155550876|NCT02658487|561442580|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
155550877|NCT02658487|561442580|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
155550878|NCT03768726|561442596|FG000|Treatment Phase|Adverse Event|2|||
155550879|NCT03768726|561442597|FG001|Treatment Phase|Adverse Event|2|||
155550880|NCT03768726|561442596|FG000|Treatment Phase|Lost to Follow-up|1|||
155550881|NCT03768726|561442597|FG001|Treatment Phase|Lost to Follow-up|0|||
155550882|NCT03768726|561442596|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
155550883|NCT03768726|561442597|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
155550884|NCT03768726|561442596|FG000|Treatment Phase|Withdrawal by Subject|3|||
155550885|NCT03768726|561442597|FG001|Treatment Phase|Withdrawal by Subject|1|||
155550886|NCT03768726|561442596|FG000|Follow-Up|Adverse Event|2|||
155550887|NCT03768726|561442597|FG001|Follow-Up|Adverse Event|2|||
155550888|NCT03768726|561442596|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
155550889|NCT03768726|561442597|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
155550890|NCT03768726|561442596|FG000|Follow-Up|Withdrawal by Subject|2|||
155550891|NCT03768726|561442597|FG001|Follow-Up|Withdrawal by Subject|0|||
155550892|NCT03768726|561442596|FG000|Follow-Up|Other|1|||
155550893|NCT03768726|561442597|FG001|Follow-Up|Other|0|||
155550894|NCT01286558|561442598|FG000|Overall Study|Adverse Event|1|||
155550895|NCT01286558|561442599|FG001|Overall Study|Adverse Event|1|||
155550896|NCT01286558|561442598|FG000|Overall Study|Withdrawal by Subject|0|||
155550897|NCT01286558|561442599|FG001|Overall Study|Withdrawal by Subject|1|||
155550898|NCT01787279|561442601|FG000|Overall Study|Lost to Follow-up|2|||
155550899|NCT01787279|561442601|FG000|Overall Study|Lack of Efficacy|1|||
155550900|NCT01567826|561442603|FG000|Overall Study|Lost to Follow-up|3|||
155550901|NCT01567826|561442604|FG001|Overall Study|Lost to Follow-up|2|||
155550902|NCT01360866|561442607|FG000|Overall Study|Lost to Follow-up|11|||
155550903|NCT01360866|561442608|FG001|Overall Study|Lost to Follow-up|28|||
155550904|NCT01360866|561442609|FG002|Overall Study|Lost to Follow-up|41|||
155550905|NCT01360866|561442610|FG003|Overall Study|Lost to Follow-up|0|||
155550906|NCT01360866|561442607|FG000|Overall Study|Adverse Event|56|||
155550907|NCT01360866|561442608|FG001|Overall Study|Adverse Event|61|||
155550908|NCT01360866|561442609|FG002|Overall Study|Adverse Event|134|||
155550909|NCT01360866|561442610|FG003|Overall Study|Adverse Event|6|||
155550910|NCT01360866|561442607|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
155550911|NCT01360866|561442608|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
155550912|NCT01360866|561442609|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
155550913|NCT01360866|561442610|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
155550914|NCT01360866|561442607|FG000|Overall Study|Withdrawn by Investigator|9|||
155550915|NCT01360866|561442608|FG001|Overall Study|Withdrawn by Investigator|8|||
155550916|NCT01360866|561442609|FG002|Overall Study|Withdrawn by Investigator|31|||
155550917|NCT01360866|561442610|FG003|Overall Study|Withdrawn by Investigator|2|||
155550918|NCT01360866|561442607|FG000|Overall Study|Withdrawal by participant|79|||
155550919|NCT01360866|561442608|FG001|Overall Study|Withdrawal by participant|89|||
155550920|NCT01360866|561442609|FG002|Overall Study|Withdrawal by participant|168|||
155550921|NCT01360866|561442610|FG003|Overall Study|Withdrawal by participant|8|||
155550922|NCT01360866|561442607|FG000|Overall Study|Protocol Deviation|25|||
155550923|NCT01360866|561442608|FG001|Overall Study|Protocol Deviation|33|||
155550924|NCT01360866|561442609|FG002|Overall Study|Protocol Deviation|61|||
155550925|NCT01360866|561442610|FG003|Overall Study|Protocol Deviation|2|||
155550926|NCT01360866|561442607|FG000|Overall Study|Lack of Efficacy|30|||
155550927|NCT01360866|561442608|FG001|Overall Study|Lack of Efficacy|40|||
155550928|NCT01360866|561442609|FG002|Overall Study|Lack of Efficacy|30|||
155550929|NCT01360866|561442610|FG003|Overall Study|Lack of Efficacy|4|||
155550930|NCT00918463|561442612|FG000|Overall Study|Death|1|||
155550931|NCT00918463|561442612|FG000|Overall Study|Lack of Efficacy|1|||
155550932|NCT04319159|561442622|FG000|Overall Study|Screening failure|13|||
155550933|NCT04319159|561442622|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
155550934|NCT04319159|561442622|FG000|Overall Study|Withdrawal by Subject|1|||
155550935|NCT00754442|561442625|FG000|Overall Study|Withdrawal by Subject|5|||
155550936|NCT00754442|561442626|FG001|Overall Study|Withdrawal by Subject|3|||
155550937|NCT01557842|561442627|FG000|Overall Study|Lost to Follow-up|0|||
155550938|NCT01557842|561442628|FG001|Overall Study|Lost to Follow-up|1|||
155550939|NCT01557842|561442627|FG000|Overall Study|Death|1|||
155550940|NCT01557842|561442628|FG001|Overall Study|Death|0|||
155550941|NCT01557842|561442627|FG000|Overall Study|Lack of Efficacy|0|||
155550942|NCT01557842|561442628|FG001|Overall Study|Lack of Efficacy|1|||
155550943|NCT01557842|561442627|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
155550944|NCT01557842|561442628|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
155550945|NCT01557842|561442627|FG000|Overall Study|Study Terminated by Sponsor|3|||
155550946|NCT01557842|561442628|FG001|Overall Study|Study Terminated by Sponsor|4|||
155550947|NCT01557842|561442627|FG000|Overall Study|Not Ablated|2|||
155550948|NCT01557842|561442628|FG001|Overall Study|Not Ablated|0|||
155550949|NCT06972251|561442629|FG000|Overall Study|Withdrawal by Subject|1|||
155550950|NCT06972251|561442630|FG001|Overall Study|Withdrawal by Subject|0|||
155550951|NCT06972251|561442629|FG000|Overall Study|Lost to Follow-up|10|||
155550952|NCT06972251|561442630|FG001|Overall Study|Lost to Follow-up|2|||
155550953|NCT05224544|561442632|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
155550954|NCT05224544|561442633|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
155550955|NCT00351351|561442639|FG000|Overall Study|surgical access pbs; device issues|9|||
155550956|NCT00351351|561442640|FG001|Overall Study|surgical access pbs; device issues|4|||
155550957|NCT01341587|561442641|FG000|Overall Study|Lost to Follow-up|2|||
155550958|NCT01341587|561442642|FG001|Overall Study|Lost to Follow-up|0|||
155550959|NCT01341587|561442641|FG000|Overall Study|stopped using the meters|2|||
155550960|NCT01341587|561442642|FG001|Overall Study|stopped using the meters|10|||
155550961|NCT03891329|561442644|FG000|Overall Study|Death|5|||
155550962|NCT03891329|561442644|FG000|Overall Study|Lost to Follow-up|4|||
155550963|NCT03891329|561442644|FG000|Overall Study|Physician Decision|4|||
155550964|NCT03891329|561442644|FG000|Overall Study|Device explanted|3|||
155550965|NCT03891329|561442644|FG000|Overall Study|No study device implanted|3|||
155550966|NCT03176784|561442645|FG000|Overall Study|Lost to Follow-up|77|||
155550967|NCT03176784|561442646|FG001|Overall Study|Lost to Follow-up|79|||
155550968|NCT03176784|561442647|FG002|Overall Study|Lost to Follow-up|79|||
155550969|NCT03176784|561442648|FG003|Overall Study|Lost to Follow-up|49|||
155550970|NCT03176784|561442645|FG000|Overall Study|Withdrawal by Subject|28|||
155550971|NCT03176784|561442646|FG001|Overall Study|Withdrawal by Subject|34|||
155550972|NCT03176784|561442647|FG002|Overall Study|Withdrawal by Subject|34|||
155550973|NCT03176784|561442648|FG003|Overall Study|Withdrawal by Subject|21|||
155550974|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
155550975|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
155550976|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
155550977|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
155550978|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
155550979|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
155550980|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
155550981|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
155550982|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
155550983|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
155550984|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
155550985|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
155550986|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155550987|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155550988|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
155550989|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
155550990|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
155550991|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
155550992|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
155550993|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
155550994|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
155550995|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
155550996|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
155550997|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
155550998|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
155550999|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
155551000|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
155551001|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
155551002|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Death|0|||
155551003|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Death|1|||
155551004|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Death|0|||
155551005|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Death|0|||
155551006|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
155551007|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
155551008|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
155551009|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
155551010|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
155551011|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
155551012|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
155551013|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
155551014|NCT02990806|561442649|FG000|Stage 1 (22 Weeks)|Other|1|||
155551015|NCT02990806|561442650|FG001|Stage 1 (22 Weeks)|Other|3|||
155551016|NCT02990806|561442651|FG002|Stage 1 (22 Weeks)|Other|0|||
155551017|NCT02990806|561442652|FG003|Stage 1 (22 Weeks)|Other|0|||
155551018|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
155551019|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
155551020|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
155551021|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
155551022|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Death|1|||
155551023|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Death|0|||
155551024|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Death|0|||
155551025|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Death|0|||
155551026|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
155551027|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
155551028|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
155551029|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
155551030|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
155551031|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
155551032|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
155551033|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
155551034|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
155551035|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
155551036|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
155551037|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
155551038|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
155551039|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
155551040|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
155551041|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
155551042|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155551043|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
155551044|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
155551045|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
155551046|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
155551047|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
155551048|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
155551049|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
155551050|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
155551051|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
155551052|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
155551053|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
155551054|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
155551055|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
155551056|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
155551057|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
155551058|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
155551059|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
155551060|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
155551061|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
155551062|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Other|3|||
155551063|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Other|0|||
155551064|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Other|4|||
155551065|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Other|1|||
155551066|NCT02990806|561442649|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
155551067|NCT02990806|561442650|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
155551068|NCT02990806|561442651|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
155551069|NCT02990806|561442652|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
155551070|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
155551071|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
155551072|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
155551073|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
155551074|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
155551075|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
155551076|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
155551077|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
155551078|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155551079|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
155551080|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155551081|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
155551082|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
155551083|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
155551084|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
155551085|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
155551086|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
155551087|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
155551088|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
155551089|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
155551090|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
155551091|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
155551092|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
155551093|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
155551094|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
155551095|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
155551096|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
155551097|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
155551098|NCT02990806|561442649|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
155551099|NCT02990806|561442650|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
155551100|NCT02990806|561442651|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
155551101|NCT02990806|561442652|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
155551102|NCT02654587|561442653|FG000|Overall Study|patient alive at end of study|22|||
155551103|NCT02654587|561442654|FG001|Overall Study|patient alive at end of study|8|||
155551104|NCT02654587|561442653|FG000|Overall Study|Withdrawal by Subject|1|||
155551105|NCT02654587|561442654|FG001|Overall Study|Withdrawal by Subject|7|||
155551106|NCT01825837|561442655|FG000|PART I|Withdrawal by Subject|0|||
155551107|NCT01825837|561442656|FG001|PART I|Withdrawal by Subject|0|||
155551108|NCT01825837|561442657|FG002|PART I|Withdrawal by Subject|0|||
155551109|NCT01825837|561442658|FG003|PART I|Withdrawal by Subject|6|||
155551110|NCT01825837|561442655|FG000|PART I|Patient non-compliance|0|||
155551111|NCT01825837|561442656|FG001|PART I|Patient non-compliance|0|||
155551112|NCT01825837|561442657|FG002|PART I|Patient non-compliance|0|||
155551113|NCT01825837|561442658|FG003|PART I|Patient non-compliance|1|||
155551114|NCT01825837|561442655|FG000|PART I|Treatment failure|0|||
155551115|NCT01825837|561442656|FG001|PART I|Treatment failure|0|||
155551116|NCT01825837|561442657|FG002|PART I|Treatment failure|0|||
155551117|NCT01825837|561442658|FG003|PART I|Treatment failure|7|||
155551118|NCT01825837|561442655|FG000|PART I|reason unspecified|0|||
155551119|NCT01825837|561442656|FG001|PART I|reason unspecified|0|||
155551120|NCT01825837|561442657|FG002|PART I|reason unspecified|0|||
155551121|NCT01825837|561442658|FG003|PART I|reason unspecified|3|||
155551122|NCT01825837|561442655|FG000|PART II|Withdrawal by Subject|3|||
155551123|NCT01825837|561442656|FG001|PART II|Withdrawal by Subject|3|||
155551124|NCT01825837|561442657|FG002|PART II|Withdrawal by Subject|7|||
155551125|NCT01825837|561442658|FG003|PART II|Withdrawal by Subject|0|||
155551126|NCT01825837|561442655|FG000|PART II|Patient non-compliance|5|||
155551127|NCT01825837|561442656|FG001|PART II|Patient non-compliance|2|||
155551128|NCT01825837|561442657|FG002|PART II|Patient non-compliance|4|||
155551129|NCT01825837|561442658|FG003|PART II|Patient non-compliance|0|||
155551130|NCT01825837|561442655|FG000|PART II|Adverse Event|3|||
155551131|NCT01825837|561442656|FG001|PART II|Adverse Event|3|||
155551132|NCT01825837|561442657|FG002|PART II|Adverse Event|1|||
155551133|NCT01825837|561442658|FG003|PART II|Adverse Event|0|||
155551134|NCT01825837|561442655|FG000|PART II|Treatment failure|6|||
155551135|NCT01825837|561442656|FG001|PART II|Treatment failure|4|||
155551136|NCT01825837|561442657|FG002|PART II|Treatment failure|5|||
155551137|NCT01825837|561442658|FG003|PART II|Treatment failure|0|||
155551138|NCT01825837|561442655|FG000|PART II|reason unspecified|2|||
155551139|NCT01825837|561442656|FG001|PART II|reason unspecified|2|||
155551140|NCT01825837|561442657|FG002|PART II|reason unspecified|2|||
155551141|NCT01825837|561442658|FG003|PART II|reason unspecified|0|||
155551142|NCT00904748|561442661|FG000|Overall Study|Withdrawal by Subject|1|||
155551143|NCT00904748|561442662|FG001|Overall Study|Withdrawal by Subject|1|||
155551144|NCT00904748|561442663|FG002|Overall Study|Withdrawal by Subject|1|||
155551145|NCT00904748|561442664|FG003|Overall Study|Withdrawal by Subject|2|||
155551146|NCT00904748|561442665|FG004|Overall Study|Withdrawal by Subject|0|||
155551147|NCT00904748|561442666|FG005|Overall Study|Withdrawal by Subject|0|||
155551148|NCT00904748|561442661|FG000|Overall Study|Adverse Event|0|||
155551149|NCT00904748|561442662|FG001|Overall Study|Adverse Event|0|||
155551150|NCT00904748|561442663|FG002|Overall Study|Adverse Event|0|||
155551151|NCT00904748|561442664|FG003|Overall Study|Adverse Event|0|||
155551152|NCT00904748|561442665|FG004|Overall Study|Adverse Event|1|||
155551153|NCT00904748|561442666|FG005|Overall Study|Adverse Event|0|||
155551154|NCT01682148|561442667|FG000|Overall Study|Withdrawal by Subject|2|||
155551155|NCT01682148|561442668|FG001|Overall Study|Withdrawal by Subject|0|||
155551156|NCT01682148|561442667|FG000|Overall Study|Lost to Follow-up|1|||
155551157|NCT01682148|561442668|FG001|Overall Study|Lost to Follow-up|2|||
155551158|NCT01682148|561442667|FG000|Overall Study|Protocol Violation|1|||
155551159|NCT01682148|561442668|FG001|Overall Study|Protocol Violation|1|||
155551160|NCT01056640|561442669|FG000|Overall Study|Withdrawal by Subject|11|||
155551161|NCT01056640|561442670|FG001|Overall Study|Withdrawal by Subject|8|||
155551162|NCT01056640|561442669|FG000|Overall Study|Death|15|||
155551163|NCT01056640|561442670|FG001|Overall Study|Death|4|||
155551164|NCT01803269|561442671|FG000|Overall Study|Withdrawal by Subject|3|||
155551165|NCT01803269|561442672|FG001|Overall Study|Withdrawal by Subject|0|||
155551166|NCT01803269|561442673|FG002|Overall Study|Withdrawal by Subject|0|||
155551167|NCT01202877|561442674|FG000|Overall Study|Disease Progression|0|||
155551168|NCT01202877|561442675|FG001|Overall Study|Disease Progression|1|||
155551169|NCT01202877|561442676|FG002|Overall Study|Disease Progression|2|||
155551170|NCT01202877|561442674|FG000|Overall Study|Adverse Event|0|||
155551171|NCT01202877|561442675|FG001|Overall Study|Adverse Event|0|||
155551172|NCT01202877|561442676|FG002|Overall Study|Adverse Event|2|||
155551173|NCT01202877|561442674|FG000|Overall Study|Withdrawal by Subject|0|||
155551174|NCT01202877|561442675|FG001|Overall Study|Withdrawal by Subject|0|||
155551175|NCT01202877|561442676|FG002|Overall Study|Withdrawal by Subject|1|||
155551176|NCT01202877|561442674|FG000|Overall Study|Death|0|||
155551177|NCT01202877|561442675|FG001|Overall Study|Death|0|||
155551178|NCT01202877|561442676|FG002|Overall Study|Death|1|||
155551179|NCT04403763|561442677|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
155551180|NCT04403763|561442678|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
155551181|NCT04403763|561442679|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
155551182|NCT04403763|561442680|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
155551183|NCT04403763|561442681|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
155551184|NCT04403763|561442682|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
155551185|NCT04403763|561442683|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
155551186|NCT04403763|561442677|FG000|Stage 1|Early termination due to PK tube failure|0|||
155551187|NCT04403763|561442678|FG001|Stage 1|Early termination due to PK tube failure|0|||
155551188|NCT04403763|561442679|FG002|Stage 1|Early termination due to PK tube failure|1|||
155551189|NCT04403763|561442680|FG003|Stage 1|Early termination due to PK tube failure|0|||
155551190|NCT04403763|561442681|FG004|Stage 1|Early termination due to PK tube failure|0|||
155551191|NCT04403763|561442682|FG005|Stage 1|Early termination due to PK tube failure|0|||
155551192|NCT04403763|561442683|FG006|Stage 1|Early termination due to PK tube failure|0|||
155551193|NCT04403763|561442677|FG000|Stage 2A|Adverse Event|0|||
155551194|NCT04403763|561442678|FG001|Stage 2A|Adverse Event|0|||
155551195|NCT04403763|561442679|FG002|Stage 2A|Adverse Event|0|||
155551196|NCT04403763|561442680|FG003|Stage 2A|Adverse Event|0|||
155551197|NCT04403763|561442681|FG004|Stage 2A|Adverse Event|0|||
155551198|NCT04403763|561442682|FG005|Stage 2A|Adverse Event|0|||
155551199|NCT04403763|561442683|FG006|Stage 2A|Adverse Event|1|||
155551200|NCT01376310|561442684|FG000|Overall Study|Study closed/terminated|1|||
155551201|NCT01376310|561442685|FG001|Overall Study|Study closed/terminated|2|||
155551202|NCT01376310|561442684|FG000|Overall Study|Withdrawal by Subject|8|||
155551203|NCT01376310|561442685|FG001|Overall Study|Withdrawal by Subject|2|||
155551204|NCT01376310|561442684|FG000|Overall Study|Physician Decision|26|||
155551205|NCT01376310|561442685|FG001|Overall Study|Physician Decision|7|||
155551206|NCT01376310|561442684|FG000|Overall Study|Lost to Follow-up|1|||
155551207|NCT01376310|561442685|FG001|Overall Study|Lost to Follow-up|0|||
155551208|NCT02339740|561442688|FG000|Overall Study|Death|1|||
155551209|NCT02339740|561442689|FG001|Overall Study|Death|0|||
155551210|NCT02339740|561442688|FG000|Overall Study|Physician Decision|0|||
155551211|NCT02339740|561442689|FG001|Overall Study|Physician Decision|2|||
155551212|NCT02339740|561442688|FG000|Overall Study|Withdrawal by Subject|5|||
155551213|NCT02339740|561442689|FG001|Overall Study|Withdrawal by Subject|1|||
155551214|NCT02339740|561442688|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
155551215|NCT02339740|561442689|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
155551216|NCT01807117|561442690|FG000|Overall Study|Physician Decision|2|||
155551217|NCT01807117|561442690|FG000|Overall Study|Disease diagnosis not a study disease|1|||
155551218|NCT00606502|561442693|FG000|Randomization|Randomized but not treated|3|||
155551219|NCT00606502|561442694|FG001|Randomization|Randomized but not treated|0|||
155551220|NCT00606502|561442693|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
155551221|NCT00606502|561442694|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
155551222|NCT02443545|561442697|FG000|Overall Study|Adverse Event|1|||
155551223|NCT02443545|561442698|FG001|Overall Study|Adverse Event|1|||
155551224|NCT02443545|561442697|FG000|Overall Study|Lost to Follow-up|0|||
155551225|NCT02443545|561442698|FG001|Overall Study|Lost to Follow-up|2|||
155551226|NCT02443545|561442697|FG000|Overall Study|Physician Decision|3|||
155551227|NCT02443545|561442698|FG001|Overall Study|Physician Decision|0|||
155551228|NCT02443545|561442697|FG000|Overall Study|Protocol Violation|8|||
155551229|NCT02443545|561442698|FG001|Overall Study|Protocol Violation|1|||
155551230|NCT02443545|561442697|FG000|Overall Study|Pregnancy|1|||
155551231|NCT02443545|561442698|FG001|Overall Study|Pregnancy|1|||
155551232|NCT02443545|561442697|FG000|Overall Study|Withdrawal by Subject|6|||
155551233|NCT02443545|561442698|FG001|Overall Study|Withdrawal by Subject|3|||
155551234|NCT02443545|561442697|FG000|Overall Study|Termination of study|20|||
155551235|NCT02443545|561442698|FG001|Overall Study|Termination of study|11|||
155551236|NCT04179019|561442699|FG000|Overall Study|Lost to Follow-up|2|||
155551237|NCT04179019|561442699|FG000|Overall Study|Physician Decision|2|||
155551238|NCT04179019|561442699|FG000|Overall Study|Withdrawal by Subject|5|||
155551239|NCT04179019|561442699|FG000|Overall Study|Adverse Event|4|||
155551240|NCT01855048|561442700|FG000|Overall Study|Withdrawal by Subject|0|||
155551241|NCT01855048|561442701|FG001|Overall Study|Withdrawal by Subject|1|||
155551242|NCT01855048|561442702|FG002|Overall Study|Withdrawal by Subject|0|||
155551243|NCT01855048|561442703|FG003|Overall Study|Withdrawal by Subject|0|||
155551244|NCT01855048|561442704|FG004|Overall Study|Withdrawal by Subject|1|||
155551245|NCT01855048|561442705|FG005|Overall Study|Withdrawal by Subject|0|||
155551246|NCT03465436|561442706|FG000|Period 1|Protocol Violation|0|||
155551247|NCT03465436|561442707|FG001|Period 1|Protocol Violation|0|||
155551248|NCT03465436|561442708|FG002|Period 1|Protocol Violation|1|||
155551249|NCT03465436|561442709|FG003|Period 1|Protocol Violation|0|||
155551250|NCT03465436|561442706|FG000|Period 2|Protocol Violation|0|||
155551251|NCT03465436|561442707|FG001|Period 2|Protocol Violation|1|||
155551252|NCT03465436|561442708|FG002|Period 2|Protocol Violation|0|||
155551253|NCT03465436|561442709|FG003|Period 2|Protocol Violation|0|||
155551254|NCT03465436|561442706|FG000|Period 3|Protocol Violation|1|||
155551255|NCT03465436|561442707|FG001|Period 3|Protocol Violation|1|||
155657357|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
155657358|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
155657359|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
155551256|NCT03465436|561442708|FG002|Period 3|Protocol Violation|0|||
155551257|NCT03465436|561442709|FG003|Period 3|Protocol Violation|0|||
155551258|NCT03465436|561442706|FG000|Period 4|Protocol Violation|0|||
155551259|NCT03465436|561442707|FG001|Period 4|Protocol Violation|0|||
155551260|NCT03465436|561442708|FG002|Period 4|Protocol Violation|1|||
155551261|NCT03465436|561442709|FG003|Period 4|Protocol Violation|0|||
155657360|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
155551262|NCT01813071|561442710|FG000|Overall Study|Protocol Violation|0|||
155551263|NCT01813071|561442711|FG001|Overall Study|Protocol Violation|0|||
155551264|NCT01813071|561442712|FG002|Overall Study|Protocol Violation|0|||
155551265|NCT01813071|561442713|FG003|Overall Study|Protocol Violation|0|||
155551266|NCT01813071|561442714|FG004|Overall Study|Protocol Violation|1|||
155551267|NCT01813071|561442715|FG005|Overall Study|Protocol Violation|4|||
155551268|NCT01813071|561442716|FG006|Overall Study|Protocol Violation|2|||
155551269|NCT01813071|561442717|FG007|Overall Study|Protocol Violation|4|||
155551270|NCT01813071|561442718|FG008|Overall Study|Protocol Violation|2|||
155551271|NCT01813071|561442710|FG000|Overall Study|Withdrawal by Subject|0|||
155551272|NCT01813071|561442711|FG001|Overall Study|Withdrawal by Subject|0|||
155551273|NCT01813071|561442712|FG002|Overall Study|Withdrawal by Subject|0|||
155551274|NCT01813071|561442713|FG003|Overall Study|Withdrawal by Subject|0|||
155551275|NCT01813071|561442714|FG004|Overall Study|Withdrawal by Subject|0|||
155551276|NCT01813071|561442715|FG005|Overall Study|Withdrawal by Subject|1|||
155551277|NCT01813071|561442716|FG006|Overall Study|Withdrawal by Subject|0|||
155551278|NCT01813071|561442717|FG007|Overall Study|Withdrawal by Subject|0|||
155551279|NCT01813071|561442718|FG008|Overall Study|Withdrawal by Subject|0|||
155551280|NCT01813071|561442710|FG000|Overall Study|Adverse Event|0|||
155551281|NCT01813071|561442711|FG001|Overall Study|Adverse Event|0|||
155551282|NCT01813071|561442712|FG002|Overall Study|Adverse Event|0|||
155551283|NCT01813071|561442713|FG003|Overall Study|Adverse Event|0|||
155551284|NCT01813071|561442714|FG004|Overall Study|Adverse Event|0|||
155551285|NCT01813071|561442715|FG005|Overall Study|Adverse Event|1|||
155551286|NCT01813071|561442716|FG006|Overall Study|Adverse Event|0|||
155551287|NCT01813071|561442717|FG007|Overall Study|Adverse Event|0|||
155551288|NCT01813071|561442718|FG008|Overall Study|Adverse Event|0|||
155551289|NCT01813071|561442710|FG000|Overall Study|Physician Decision|0|||
155551290|NCT01813071|561442711|FG001|Overall Study|Physician Decision|0|||
155551291|NCT01813071|561442712|FG002|Overall Study|Physician Decision|0|||
155551292|NCT01813071|561442713|FG003|Overall Study|Physician Decision|0|||
155551293|NCT01813071|561442714|FG004|Overall Study|Physician Decision|0|||
155551294|NCT01813071|561442715|FG005|Overall Study|Physician Decision|0|||
155551295|NCT01813071|561442716|FG006|Overall Study|Physician Decision|1|||
155551296|NCT01813071|561442717|FG007|Overall Study|Physician Decision|0|||
155551297|NCT01813071|561442718|FG008|Overall Study|Physician Decision|0|||
155551298|NCT01813071|561442710|FG000|Overall Study|Met inc/exc criteria|0|||
155551299|NCT01813071|561442711|FG001|Overall Study|Met inc/exc criteria|0|||
155551300|NCT01813071|561442712|FG002|Overall Study|Met inc/exc criteria|0|||
155551301|NCT01813071|561442713|FG003|Overall Study|Met inc/exc criteria|0|||
155551302|NCT01813071|561442714|FG004|Overall Study|Met inc/exc criteria|0|||
155551303|NCT01813071|561442715|FG005|Overall Study|Met inc/exc criteria|1|||
155551304|NCT01813071|561442716|FG006|Overall Study|Met inc/exc criteria|0|||
155551305|NCT01813071|561442717|FG007|Overall Study|Met inc/exc criteria|1|||
155551306|NCT01813071|561442718|FG008|Overall Study|Met inc/exc criteria|1|||
155551307|NCT05486065|561442719|FG000|Overall Study|Withdrawal by Subject|1|||
155551308|NCT05486065|561442720|FG001|Overall Study|Withdrawal by Subject|5|||
155551309|NCT05486065|561442721|FG002|Overall Study|Withdrawal by Subject|4|||
155551310|NCT05486065|561442722|FG003|Overall Study|Withdrawal by Subject|3|||
155551311|NCT05486065|561442719|FG000|Overall Study|Lost to Follow-up|4|||
155551312|NCT05486065|561442720|FG001|Overall Study|Lost to Follow-up|2|||
155551313|NCT05486065|561442721|FG002|Overall Study|Lost to Follow-up|2|||
155551314|NCT05486065|561442722|FG003|Overall Study|Lost to Follow-up|2|||
155551315|NCT05486065|561442719|FG000|Overall Study|Physician Decision|0|||
155551316|NCT05486065|561442720|FG001|Overall Study|Physician Decision|1|||
155551317|NCT05486065|561442721|FG002|Overall Study|Physician Decision|1|||
155551318|NCT05486065|561442722|FG003|Overall Study|Physician Decision|0|||
155551319|NCT05486065|561442719|FG000|Overall Study|Failure to meet randomization criteria|0|||
155551320|NCT05486065|561442720|FG001|Overall Study|Failure to meet randomization criteria|0|||
155551321|NCT05486065|561442721|FG002|Overall Study|Failure to meet randomization criteria|0|||
155551322|NCT05486065|561442722|FG003|Overall Study|Failure to meet randomization criteria|1|||
155551323|NCT01425528|561442723|FG000|Overall Study|Withdrawal by Subject|1|||
155551324|NCT01425528|561442724|FG001|Overall Study|Withdrawal by Subject|1|||
155551325|NCT00307931|561442725|FG000|Overall Study|Adverse Event|1|||
155551326|NCT00613834|561442728|FG000|Overall Study|Withdrawal by Subject|0|||
155551327|NCT00613834|561442729|FG001|Overall Study|Withdrawal by Subject|3|||
155551328|NCT02516410|561443984|FG000|Overall Study|Adverse Event|0|||
155551329|NCT02516410|561443985|FG001|Overall Study|Adverse Event|1|||
155551330|NCT02516410|561443984|FG000|Overall Study|Withdrawal by Subject|0|||
155551331|NCT02516410|561443985|FG001|Overall Study|Withdrawal by Subject|1|||
155551332|NCT01475253|561443990|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
155551333|NCT01475253|561443991|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
155551334|NCT01475253|561443992|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
155551335|NCT01475253|561443993|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
155657361|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155551336|NCT01475253|561443990|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
155551337|NCT01475253|561443991|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
155551338|NCT01475253|561443992|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
155551339|NCT01475253|561443993|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
155551340|NCT03135899|561443994|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551341|NCT03135899|561443995|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
155657362|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155198469|NCT00745823|560164973|FG001|Overall Study|Withdrawal by Subject|8|||
155551342|NCT03135899|561443996|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551343|NCT03135899|561443997|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551344|NCT03135899|561443998|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551345|NCT03135899|561443999|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551346|NCT03135899|561444000|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
155551347|NCT03135899|561444001|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
155551348|NCT03135899|561443994|FG000|Overall Study|Withdrawal by Subject|0|||
155551349|NCT03135899|561443995|FG001|Overall Study|Withdrawal by Subject|0|||
155551350|NCT03135899|561443996|FG002|Overall Study|Withdrawal by Subject|0|||
155551351|NCT03135899|561443997|FG003|Overall Study|Withdrawal by Subject|0|||
155551352|NCT03135899|561443998|FG004|Overall Study|Withdrawal by Subject|0|||
155551353|NCT03135899|561443999|FG005|Overall Study|Withdrawal by Subject|2|||
155551354|NCT03135899|561444000|FG006|Overall Study|Withdrawal by Subject|0|||
155551355|NCT03135899|561444001|FG007|Overall Study|Withdrawal by Subject|0|||
155551356|NCT04146363|561444002|FG000|Induction Period|Adverse Event|1|||
155551357|NCT04146363|561444003|FG001|Induction Period|Adverse Event|2|||
155551358|NCT04146363|561444004|FG002|Induction Period|Adverse Event|0|||
155551359|NCT04146363|561444005|FG003|Induction Period|Adverse Event|0|||
155551360|NCT04146363|561444006|FG004|Induction Period|Adverse Event|0|||
155551361|NCT04146363|561444007|FG005|Induction Period|Adverse Event|0|||
155551362|NCT04146363|561444008|FG006|Induction Period|Adverse Event|0|||
155551363|NCT04146363|561444009|FG007|Induction Period|Adverse Event|0|||
155551364|NCT04146363|561444010|FG008|Induction Period|Adverse Event|0|||
155551365|NCT04146363|561444011|FG009|Induction Period|Adverse Event|0|||
155551366|NCT04146363|561444012|FG010|Induction Period|Adverse Event|0|||
155551367|NCT04146363|561444002|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
155551368|NCT04146363|561444003|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
155551369|NCT04146363|561444004|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
155551370|NCT04146363|561444005|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
155551371|NCT04146363|561444006|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
155551372|NCT04146363|561444007|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
155551373|NCT04146363|561444008|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
155551374|NCT04146363|561444009|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
155551375|NCT04146363|561444010|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
155551376|NCT04146363|561444011|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
155551377|NCT04146363|561444012|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
155551378|NCT04146363|561444002|FG000|Induction Period|Lack of Efficacy|7|||
155551379|NCT04146363|561444003|FG001|Induction Period|Lack of Efficacy|2|||
155551380|NCT04146363|561444004|FG002|Induction Period|Lack of Efficacy|0|||
155551381|NCT04146363|561444005|FG003|Induction Period|Lack of Efficacy|0|||
155551382|NCT04146363|561444006|FG004|Induction Period|Lack of Efficacy|0|||
155551383|NCT04146363|561444007|FG005|Induction Period|Lack of Efficacy|0|||
155551384|NCT04146363|561444008|FG006|Induction Period|Lack of Efficacy|0|||
155551385|NCT04146363|561444009|FG007|Induction Period|Lack of Efficacy|0|||
155551386|NCT04146363|561444010|FG008|Induction Period|Lack of Efficacy|0|||
155551387|NCT04146363|561444011|FG009|Induction Period|Lack of Efficacy|0|||
155551388|NCT04146363|561444012|FG010|Induction Period|Lack of Efficacy|0|||
155551389|NCT04146363|561444002|FG000|Induction Period|Lost to Follow-up|1|||
155551390|NCT04146363|561444003|FG001|Induction Period|Lost to Follow-up|4|||
155551391|NCT04146363|561444004|FG002|Induction Period|Lost to Follow-up|0|||
155551392|NCT04146363|561444005|FG003|Induction Period|Lost to Follow-up|0|||
155551393|NCT04146363|561444006|FG004|Induction Period|Lost to Follow-up|0|||
155551394|NCT04146363|561444007|FG005|Induction Period|Lost to Follow-up|0|||
155551395|NCT04146363|561444008|FG006|Induction Period|Lost to Follow-up|0|||
155551396|NCT04146363|561444009|FG007|Induction Period|Lost to Follow-up|0|||
155551397|NCT04146363|561444010|FG008|Induction Period|Lost to Follow-up|0|||
155551398|NCT04146363|561444011|FG009|Induction Period|Lost to Follow-up|0|||
155551399|NCT04146363|561444012|FG010|Induction Period|Lost to Follow-up|0|||
155551400|NCT04146363|561444002|FG000|Induction Period|Positive quantiferon test|0|||
155551401|NCT04146363|561444003|FG001|Induction Period|Positive quantiferon test|1|||
155551402|NCT04146363|561444004|FG002|Induction Period|Positive quantiferon test|0|||
155551403|NCT04146363|561444005|FG003|Induction Period|Positive quantiferon test|0|||
155551404|NCT04146363|561444006|FG004|Induction Period|Positive quantiferon test|0|||
155551405|NCT04146363|561444007|FG005|Induction Period|Positive quantiferon test|0|||
155551406|NCT04146363|561444008|FG006|Induction Period|Positive quantiferon test|0|||
155551407|NCT04146363|561444009|FG007|Induction Period|Positive quantiferon test|0|||
155551408|NCT04146363|561444010|FG008|Induction Period|Positive quantiferon test|0|||
155551409|NCT04146363|561444011|FG009|Induction Period|Positive quantiferon test|0|||
155551410|NCT04146363|561444012|FG010|Induction Period|Positive quantiferon test|0|||
155551411|NCT04146363|561444002|FG000|Induction Period|Protocol Deviation|5|||
155551412|NCT04146363|561444003|FG001|Induction Period|Protocol Deviation|6|||
155551413|NCT04146363|561444004|FG002|Induction Period|Protocol Deviation|0|||
155551414|NCT04146363|561444005|FG003|Induction Period|Protocol Deviation|0|||
155551415|NCT04146363|561444006|FG004|Induction Period|Protocol Deviation|0|||
155551416|NCT04146363|561444007|FG005|Induction Period|Protocol Deviation|0|||
155551417|NCT04146363|561444008|FG006|Induction Period|Protocol Deviation|0|||
155551418|NCT04146363|561444009|FG007|Induction Period|Protocol Deviation|0|||
155551419|NCT04146363|561444010|FG008|Induction Period|Protocol Deviation|0|||
155551420|NCT04146363|561444011|FG009|Induction Period|Protocol Deviation|0|||
155551421|NCT04146363|561444012|FG010|Induction Period|Protocol Deviation|0|||
155551422|NCT04146363|561444002|FG000|Induction Period|Withdrawal by Subject|6|||
155551423|NCT04146363|561444003|FG001|Induction Period|Withdrawal by Subject|3|||
155551424|NCT04146363|561444004|FG002|Induction Period|Withdrawal by Subject|0|||
155551425|NCT04146363|561444005|FG003|Induction Period|Withdrawal by Subject|0|||
155551426|NCT04146363|561444006|FG004|Induction Period|Withdrawal by Subject|0|||
155551427|NCT04146363|561444007|FG005|Induction Period|Withdrawal by Subject|0|||
155551428|NCT04146363|561444008|FG006|Induction Period|Withdrawal by Subject|0|||
155551429|NCT04146363|561444009|FG007|Induction Period|Withdrawal by Subject|0|||
155551430|NCT04146363|561444010|FG008|Induction Period|Withdrawal by Subject|0|||
155551431|NCT04146363|561444011|FG009|Induction Period|Withdrawal by Subject|0|||
155551432|NCT04146363|561444012|FG010|Induction Period|Withdrawal by Subject|0|||
155551433|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551434|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551435|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551436|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551437|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551438|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551439|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
155551440|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
155551441|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551442|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551443|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
155551444|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551445|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551446|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551447|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551448|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551449|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551450|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551451|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
155551452|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551453|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551454|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155551455|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551456|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155657363|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155551457|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551458|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155657364|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155657365|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155551459|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551460|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551461|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
155551462|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
155551463|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551464|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551465|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155551466|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551467|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551468|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
155551469|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551470|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551471|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
155551472|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551473|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551474|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551475|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551476|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
155551477|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551478|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551479|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551480|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551481|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
155551482|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
155551483|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
155551484|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
155551485|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551486|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551487|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155551488|NCT04146363|561444002|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551489|NCT04146363|561444003|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551490|NCT04146363|561444004|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
155551491|NCT04146363|561444005|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551492|NCT04146363|561444006|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551493|NCT04146363|561444007|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
155551494|NCT04146363|561444008|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
155551495|NCT04146363|561444009|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
155551496|NCT04146363|561444010|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551497|NCT04146363|561444011|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551498|NCT04146363|561444012|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155551499|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551500|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551501|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551502|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551503|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551504|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551505|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551506|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551507|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
155551508|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
155551509|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
155551510|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551511|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551512|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551513|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551514|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551515|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551516|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551517|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155551518|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
155551519|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
155551520|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
155551521|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551522|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551523|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551524|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551525|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551526|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551527|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551528|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551529|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
155551530|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
155551531|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155551532|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551533|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551534|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551535|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551536|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551537|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551538|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551539|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551540|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
155551541|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
155551542|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
155551543|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551544|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551545|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551546|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551547|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551548|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551549|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551550|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155551551|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
155551552|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
155551553|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
155551554|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551555|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551556|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551557|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551558|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551559|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551560|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551561|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551562|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551563|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
155551564|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
155551565|NCT04146363|561444002|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551566|NCT04146363|561444003|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551567|NCT04146363|561444004|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551568|NCT04146363|561444005|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551569|NCT04146363|561444006|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551570|NCT04146363|561444007|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551571|NCT04146363|561444008|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551572|NCT04146363|561444009|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551573|NCT04146363|561444010|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551574|NCT04146363|561444011|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
155551575|NCT04146363|561444012|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155551576|NCT02914236|561444017|FG000|Overall Study|Lost to Follow-up|1|||
155551577|NCT00380692|561444018|FG000|Study Period II - Double Blind|Adverse Event|1|||
155551578|NCT00380692|561444019|FG001|Study Period II - Double Blind|Adverse Event|0|||
155551579|NCT00380692|561444018|FG000|Study Period II - Double Blind|Protocol Violation|2|||
155551580|NCT00380692|561444019|FG001|Study Period II - Double Blind|Protocol Violation|2|||
155551581|NCT00380692|561444018|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
155551582|NCT00380692|561444019|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
155551583|NCT00380692|561444018|FG000|Study Period II - Double Blind|Physician Decision|0|||
155551584|NCT00380692|561444019|FG001|Study Period II - Double Blind|Physician Decision|1|||
155551585|NCT00380692|561444018|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
155551586|NCT00380692|561444019|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
155551587|NCT00380692|561444018|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
155551588|NCT00380692|561444019|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
155551589|NCT00380692|561444018|FG000|Study Period III - Open Label|Adverse Event|5|||
155551590|NCT00380692|561444019|FG001|Study Period III - Open Label|Adverse Event|3|||
155551591|NCT00380692|561444018|FG000|Study Period III - Open Label|Protocol Violation|0|||
155551592|NCT00380692|561444019|FG001|Study Period III - Open Label|Protocol Violation|0|||
155551593|NCT00380692|561444018|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
155551594|NCT00380692|561444019|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
155551595|NCT00380692|561444018|FG000|Study Period III - Open Label|Physician Decision|0|||
155551596|NCT00380692|561444019|FG001|Study Period III - Open Label|Physician Decision|3|||
155551597|NCT00380692|561444018|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
155551598|NCT00380692|561444019|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
155551599|NCT00380692|561444018|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
155551600|NCT00380692|561444019|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
155551601|NCT02676284|561444020|FG000|Overall Study|Withdrawal by Subject|1|||
155551602|NCT00708708|561444022|FG000|Overall Study|Another therapy instead of Enbrel|141|||
155551603|NCT00708708|561444022|FG000|Overall Study|Lost to Follow-up|52|||
155551604|NCT00708708|561444022|FG000|Overall Study|Withdrawal by Subject|51|||
155551605|NCT00708708|561444022|FG000|Overall Study|Intolerance|42|||
155551606|NCT00708708|561444022|FG000|Overall Study|Another therapy along with Enbrel|15|||
155551607|NCT00708708|561444022|FG000|Overall Study|Other unspecified|11|||
155551608|NCT00708708|561444022|FG000|Overall Study|Good effectiveness|9|||
155551609|NCT00708708|561444022|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
155551610|NCT00708708|561444022|FG000|Overall Study|Administrative reasons|7|||
155551611|NCT00708708|561444022|FG000|Overall Study|Lack of effectiveness|4|||
155551612|NCT00708708|561444022|FG000|Overall Study|Lack of compliance|3|||
155551613|NCT00708708|561444022|FG000|Overall Study|Pregnancy|3|||
155551614|NCT00708708|561444022|FG000|Overall Study|Adverse Event|3|||
155551615|NCT00708708|561444022|FG000|Overall Study|Missing values|392|||
155551616|NCT04776746|561444023|FG000|Overall Study|Study terminated by sponsor|61|||
155551617|NCT04776746|561444023|FG000|Overall Study|Adverse Event|5|||
155551618|NCT04776746|561444023|FG000|Overall Study|Death|4|||
155551619|NCT04776746|561444023|FG000|Overall Study|Lack of Efficacy|3|||
155551620|NCT04776746|561444023|FG000|Overall Study|Noncompliance with study drug|2|||
155551621|NCT04776746|561444023|FG000|Overall Study|Not related to COVID-19|2|||
155551622|NCT00856830|561444026|FG000|Irinotecan & Bendamustine|Death|0|||
155551623|NCT00856830|561444027|FG001|Irinotecan & Bendamustine|Death|0|||
155551624|NCT00856830|561444028|FG002|Irinotecan & Bendamustine|Death|0|||
155551625|NCT00856830|561444029|FG003|Irinotecan & Bendamustine|Death|2|||
155551626|NCT00856830|561444026|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
155551627|NCT00856830|561444027|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
155551628|NCT00856830|561444028|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
155551629|NCT00856830|561444029|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
155551630|NCT02148913|561444030|FG000|Overall Study|Death|0|||
155551631|NCT02148913|561444031|FG001|Overall Study|Death|1|||
155551632|NCT02148913|561444032|FG002|Overall Study|Death|0|||
155551633|NCT02148913|561444033|FG003|Overall Study|Death|0|||
155551634|NCT01287039|561444035|FG000|Overall Study|Noncompliance with study procedures|0|||
155551635|NCT01287039|561444036|FG001|Overall Study|Noncompliance with study procedures|1|||
155551636|NCT01287039|561444035|FG000|Overall Study|Change of location/residence|0|||
155551637|NCT01287039|561444036|FG001|Overall Study|Change of location/residence|3|||
155551638|NCT01287039|561444035|FG000|Overall Study|Elective surgery|0|||
155551639|NCT01287039|561444036|FG001|Overall Study|Elective surgery|1|||
155551640|NCT01287039|561444035|FG000|Overall Study|Protocol Violation|2|||
155551641|NCT01287039|561444036|FG001|Overall Study|Protocol Violation|3|||
155551642|NCT01287039|561444035|FG000|Overall Study|Excluded medication taken|1|||
155551643|NCT01287039|561444036|FG001|Overall Study|Excluded medication taken|0|||
155551644|NCT01287039|561444035|FG000|Overall Study|Noncompliance with study medication|0|||
155551645|NCT01287039|561444036|FG001|Overall Study|Noncompliance with study medication|1|||
155551646|NCT01287039|561444035|FG000|Overall Study|Problem with travel|0|||
155551647|NCT01287039|561444036|FG001|Overall Study|Problem with travel|1|||
155551648|NCT01287039|561444035|FG000|Overall Study|Death|1|||
155551649|NCT01287039|561444036|FG001|Overall Study|Death|0|||
155551650|NCT01287039|561444035|FG000|Overall Study|Change of residence|1|||
155551651|NCT01287039|561444036|FG001|Overall Study|Change of residence|0|||
155551652|NCT01287039|561444035|FG000|Overall Study|Adverse Event|7|||
155551653|NCT01287039|561444036|FG001|Overall Study|Adverse Event|4|||
155551654|NCT01287039|561444035|FG000|Overall Study|Withdrawal by Subject|14|||
155551655|NCT01287039|561444036|FG001|Overall Study|Withdrawal by Subject|11|||
155551656|NCT01287039|561444035|FG000|Overall Study|Lost to Follow-up|3|||
155551657|NCT01287039|561444036|FG001|Overall Study|Lost to Follow-up|2|||
155551658|NCT02694549|561444037|FG000|Overall Study|screen failures|2|||
155551659|NCT03265288|561444042|FG000|Overall Study|Adverse Event|0|||
155551660|NCT03265288|561444043|FG001|Overall Study|Adverse Event|1|||
155551661|NCT03265288|561444042|FG000|Overall Study|Withdrawal by Subject|13|||
155551662|NCT03265288|561444043|FG001|Overall Study|Withdrawal by Subject|5|||
155551663|NCT03265288|561444042|FG000|Overall Study|Drug Withdrawn|3|||
155551664|NCT03265288|561444043|FG001|Overall Study|Drug Withdrawn|3|||
155551665|NCT03265288|561444042|FG000|Overall Study|Any Other Reason|7|||
155551666|NCT03265288|561444043|FG001|Overall Study|Any Other Reason|3|||
155551667|NCT00099268|561444047|FG000|Overall Study|Withdrawal by Subject|46|||
155551668|NCT00099268|561444048|FG001|Overall Study|Withdrawal by Subject|28|||
155551669|NCT00099268|561444047|FG000|Overall Study|Adverse Event|19|||
155551670|NCT00099268|561444048|FG001|Overall Study|Adverse Event|19|||
155551671|NCT00099268|561444047|FG000|Overall Study|Protocol Violation|9|||
155551672|NCT00099268|561444048|FG001|Overall Study|Protocol Violation|8|||
155551673|NCT00099268|561444047|FG000|Overall Study|Lost to Follow-up|6|||
155551674|NCT00099268|561444048|FG001|Overall Study|Lost to Follow-up|4|||
155551675|NCT00099268|561444047|FG000|Overall Study|Lack of Efficacy|5|||
155551676|NCT00099268|561444048|FG001|Overall Study|Lack of Efficacy|18|||
155657366|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155551677|NCT00099268|561444047|FG000|Overall Study|Administrative problems|4|||
155657367|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155657368|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
155198470|NCT00745823|560164972|FG000|Overall Study|Study Terminated by Sponsor|326|||
155551678|NCT00099268|561444048|FG001|Overall Study|Administrative problems|4|||
155551679|NCT00099268|561444047|FG000|Overall Study|Death|3|||
155551680|NCT00099268|561444048|FG001|Overall Study|Death|1|||
155551681|NCT03702049|561444049|FG000|Overall Study|Lost to Follow-up|4|||
155551682|NCT03702049|561444049|FG000|Overall Study|Physician Decision|1|||
155551683|NCT05016622|561444050|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
155551684|NCT05016622|561444050|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
155551685|NCT00171301|561444058|FG000|Overall Study|Death|1|||
155551686|NCT00171301|561444059|FG001|Overall Study|Death|2|||
155551687|NCT00171301|561444058|FG000|Overall Study|Adverse Event|1|||
155551688|NCT00171301|561444059|FG001|Overall Study|Adverse Event|2|||
155551689|NCT00171301|561444058|FG000|Overall Study|Lost to Follow-up|6|||
155551690|NCT00171301|561444059|FG001|Overall Study|Lost to Follow-up|2|||
155551691|NCT00171301|561444058|FG000|Overall Study|Protocol Violation|0|||
155551692|NCT00171301|561444059|FG001|Overall Study|Protocol Violation|2|||
155551693|NCT00171301|561444058|FG000|Overall Study|Withdrawal by Subject|0|||
155551694|NCT00171301|561444059|FG001|Overall Study|Withdrawal by Subject|1|||
155551695|NCT02370914|561444062|FG000|Overall Study|Protocol Violation|2|||
155551696|NCT00252174|561444064|FG000|Overall Study|Withdrawal by Subject|0|||
155551697|NCT00252174|561444065|FG001|Overall Study|Withdrawal by Subject|1|||
155551698|NCT00252174|561444066|FG002|Overall Study|Withdrawal by Subject|0|||
155551699|NCT04440449|561444068|FG000|Overall Study|Lost to Follow-up|2|||
155551700|NCT04440449|561444069|FG001|Overall Study|Lost to Follow-up|0|||
155551701|NCT01134627|561444070|FG000|Overall Study|Adverse Event|47|||
155551702|NCT01134627|561444071|FG001|Overall Study|Adverse Event|31|||
155551703|NCT01134627|561444070|FG000|Overall Study|Lost to Follow-up|1|||
155551704|NCT01134627|561444071|FG001|Overall Study|Lost to Follow-up|2|||
155551705|NCT01134627|561444070|FG000|Overall Study|Protocol Violation|3|||
155551706|NCT01134627|561444071|FG001|Overall Study|Protocol Violation|5|||
155551707|NCT01134627|561444070|FG000|Overall Study|Lack of Efficacy|2|||
155551708|NCT01134627|561444071|FG001|Overall Study|Lack of Efficacy|12|||
155551709|NCT01134627|561444070|FG000|Overall Study|Withdrawal by Subject|4|||
155551710|NCT01134627|561444071|FG001|Overall Study|Withdrawal by Subject|3|||
155551711|NCT01134627|561444070|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
155551712|NCT01134627|561444071|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
155551713|NCT01134627|561444070|FG000|Overall Study|Other|11|||
155551714|NCT01134627|561444071|FG001|Overall Study|Other|14|||
155551715|NCT00466726|561444074|FG000|Overall Study|Not evaluable for response|14|||
155551716|NCT00350402|561444075|FG000|Overall Study|Lost to Follow-up|1|||
155551717|NCT00350402|561444076|FG001|Overall Study|Lost to Follow-up|1|||
155551718|NCT00645944|561444077|FG000|Randomized|Withdrawal by Subject|1|||
155551719|NCT00645944|561444078|FG001|Randomized|Withdrawal by Subject|2|||
155551720|NCT00645944|561444077|FG000|Received Medication|Adverse Event|2|||
155551721|NCT00645944|561444078|FG001|Received Medication|Adverse Event|1|||
155551722|NCT00645944|561444077|FG000|Received Medication|Withdrawal by Subject|1|||
155551723|NCT00645944|561444078|FG001|Received Medication|Withdrawal by Subject|1|||
155551724|NCT00645944|561444077|FG000|Received Medication|Lost to Follow-up|1|||
155551725|NCT00645944|561444078|FG001|Received Medication|Lost to Follow-up|0|||
155551726|NCT00645944|561444077|FG000|Received Medication|Protocol Violation|2|||
155551727|NCT00645944|561444078|FG001|Received Medication|Protocol Violation|1|||
155551728|NCT02377921|561444085|FG000|Overall Study|Subject non-compliance|1|||
155551729|NCT02377921|561444086|FG001|Overall Study|Subject non-compliance|1|||
155551730|NCT00560937|561444093|FG000|Overall Study|Withdrawal by Subject|0|||
155551731|NCT00560937|561444094|FG001|Overall Study|Withdrawal by Subject|1|||
155551732|NCT00560937|561444093|FG000|Overall Study|Physician Decision|1|||
155551733|NCT00560937|561444094|FG001|Overall Study|Physician Decision|1|||
155551734|NCT03919162|561444095|FG000|Overall Study|Adverse Event|3|||
155551735|NCT03919162|561444096|FG001|Overall Study|Adverse Event|2|||
155551736|NCT03919162|561444095|FG000|Overall Study|Death|2|||
155551737|NCT03919162|561444096|FG001|Overall Study|Death|0|||
155551738|NCT03919162|561444095|FG000|Overall Study|Lost to Follow-up|1|||
155551739|NCT03919162|561444096|FG001|Overall Study|Lost to Follow-up|0|||
155551740|NCT03919162|561444095|FG000|Overall Study|Withdrawal by Subject|12|||
155551741|NCT03919162|561444096|FG001|Overall Study|Withdrawal by Subject|12|||
155551742|NCT03919162|561444095|FG000|Overall Study|Study terminated by Sponsor|20|||
155551743|NCT03919162|561444096|FG001|Overall Study|Study terminated by Sponsor|24|||
155657369|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155551744|NCT03919162|561444095|FG000|Overall Study|Screen failure|1|||
155657370|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155551745|NCT03919162|561444096|FG001|Overall Study|Screen failure|0|||
155551746|NCT03919162|561444095|FG000|Overall Study|Missing|1|||
155551747|NCT03919162|561444096|FG001|Overall Study|Missing|1|||
155551748|NCT01688726|561444098|FG000|Overall Study|Adverse Event|1|||
155551749|NCT01688726|561444099|FG001|Overall Study|Adverse Event|0|||
155551750|NCT01688726|561444098|FG000|Overall Study|Relocated abroad|0|||
155551751|NCT01688726|561444099|FG001|Overall Study|Relocated abroad|1|||
155551752|NCT04553913|561444100|FG000|Overall Study|patient's block resolved prior to PACU|1|||
155551753|NCT04553913|561444100|FG000|Overall Study|did not use the device properly|5|||
155551754|NCT01481324|561444101|FG000|Overall Study|Missing Data|0|||
155551755|NCT01481324|561444102|FG001|Overall Study|Missing Data|2|||
155551756|NCT01481324|561444103|FG002|Overall Study|Missing Data|2|||
155551757|NCT01885182|561445447|FG000|Overall Study|Adverse Event|11|||
155551758|NCT01885182|561445448|FG001|Overall Study|Adverse Event|13|||
155551759|NCT01885182|561445447|FG000|Overall Study|Withdrawal by Subject|13|||
155551760|NCT01885182|561445448|FG001|Overall Study|Withdrawal by Subject|6|||
155551761|NCT01885182|561445447|FG000|Overall Study|Lost to Follow-up|2|||
155551762|NCT01885182|561445448|FG001|Overall Study|Lost to Follow-up|2|||
155551763|NCT01885182|561445447|FG000|Overall Study|Lack of Efficacy|8|||
155551764|NCT01885182|561445448|FG001|Overall Study|Lack of Efficacy|1|||
155551765|NCT03575871|561445453|FG000|Overall Study|Adverse Event|5|||
155551766|NCT03575871|561445454|FG001|Overall Study|Adverse Event|5|||
155551767|NCT03575871|561445455|FG002|Overall Study|Adverse Event|8|||
155551768|NCT03575871|561445453|FG000|Overall Study|Death|1|||
155551769|NCT03575871|561445454|FG001|Overall Study|Death|0|||
155551770|NCT03575871|561445455|FG002|Overall Study|Death|0|||
155551771|NCT03575871|561445453|FG000|Overall Study|Lack of Efficacy|5|||
155551772|NCT03575871|561445454|FG001|Overall Study|Lack of Efficacy|4|||
155551773|NCT03575871|561445455|FG002|Overall Study|Lack of Efficacy|7|||
155551774|NCT03575871|561445453|FG000|Overall Study|Lost to Follow-up|1|||
155551775|NCT03575871|561445454|FG001|Overall Study|Lost to Follow-up|1|||
155551776|NCT03575871|561445455|FG002|Overall Study|Lost to Follow-up|1|||
155551777|NCT03575871|561445453|FG000|Overall Study|Protocol Deviation|1|||
155551778|NCT03575871|561445454|FG001|Overall Study|Protocol Deviation|1|||
155551779|NCT03575871|561445455|FG002|Overall Study|Protocol Deviation|1|||
155551780|NCT03575871|561445453|FG000|Overall Study|Withdrawal by Subject|6|||
155551781|NCT03575871|561445454|FG001|Overall Study|Withdrawal by Subject|1|||
155551782|NCT03575871|561445455|FG002|Overall Study|Withdrawal by Subject|9|||
155551783|NCT03575871|561445453|FG000|Overall Study|Other than specified|2|||
155551784|NCT03575871|561445454|FG001|Overall Study|Other than specified|2|||
155551785|NCT03575871|561445455|FG002|Overall Study|Other than specified|0|||
155551786|NCT05506358|561445456|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
155551787|NCT05506358|561445457|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
155551788|NCT05506358|561445458|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
155551789|NCT05506358|561445459|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
155551790|NCT05506358|561445460|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
155551791|NCT05506358|561445456|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
155551792|NCT05506358|561445457|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
155551793|NCT05506358|561445458|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
155551794|NCT05506358|561445459|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
155551795|NCT05506358|561445460|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
155551796|NCT05506358|561445456|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
155551797|NCT05506358|561445457|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
155551798|NCT05506358|561445458|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
155551799|NCT05506358|561445459|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
155551800|NCT05506358|561445460|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
155551801|NCT05506358|561445456|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
155551802|NCT05506358|561445457|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
155551803|NCT05506358|561445458|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
155551804|NCT05506358|561445459|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
155551805|NCT05506358|561445460|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
155551806|NCT05506358|561445456|FG000|Overall Study|HbE trait|0|||
155551807|NCT05506358|561445457|FG001|Overall Study|HbE trait|0|||
155551808|NCT05506358|561445458|FG002|Overall Study|HbE trait|0|||
155551809|NCT05506358|561445459|FG003|Overall Study|HbE trait|1|||
155551810|NCT05506358|561445460|FG004|Overall Study|HbE trait|0|||
155551811|NCT03438396|561445463|FG000|Overall Study|Reason Not Specified|9|||
155551812|NCT03438396|561445463|FG000|Overall Study|Withdrawal by Subject|5|||
155551813|NCT03438396|561445463|FG000|Overall Study|Lost to Follow-up|2|||
155551814|NCT03438396|561445463|FG000|Overall Study|Death|85|||
155551815|NCT03438396|561445463|FG000|Overall Study|Not treated|1|||
155551816|NCT00262041|561445464|FG000|Overall Study|Withdrawal by Subject|0|||
155551817|NCT00262041|561445465|FG001|Overall Study|Withdrawal by Subject|3|||
155657371|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155657372|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155551818|NCT00262041|561445466|FG002|Overall Study|Withdrawal by Subject|1|||
155551819|NCT00262041|561445464|FG000|Overall Study|Lost to Follow-up|1|||
155551820|NCT00262041|561445465|FG001|Overall Study|Lost to Follow-up|1|||
155551821|NCT00262041|561445466|FG002|Overall Study|Lost to Follow-up|5|||
155551822|NCT00262041|561445464|FG000|Overall Study|Unable to classify|1|||
155551823|NCT00262041|561445465|FG001|Overall Study|Unable to classify|0|||
155551824|NCT00262041|561445466|FG002|Overall Study|Unable to classify|0|||
155551825|NCT03578237|561445469|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
155551826|NCT03578237|561445470|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
155551827|NCT01173471|561445471|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155551828|NCT01173471|561445472|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155551829|NCT01173471|561445473|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155551830|NCT01173471|561445474|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155551831|NCT01173471|561445471|FG000|Overall Study|Condition under investigation worsened|2|||
155551832|NCT01173471|561445472|FG001|Overall Study|Condition under investigation worsened|0|||
155551833|NCT01173471|561445473|FG002|Overall Study|Condition under investigation worsened|0|||
155551834|NCT01173471|561445474|FG003|Overall Study|Condition under investigation worsened|0|||
155551835|NCT01173471|561445471|FG000|Overall Study|Lost to Follow-up|0|||
155551836|NCT01173471|561445472|FG001|Overall Study|Lost to Follow-up|0|||
155551837|NCT01173471|561445473|FG002|Overall Study|Lost to Follow-up|1|||
155551838|NCT01173471|561445474|FG003|Overall Study|Lost to Follow-up|0|||
155551839|NCT01173471|561445471|FG000|Overall Study|Reason given as Other|0|||
155551840|NCT01173471|561445472|FG001|Overall Study|Reason given as Other|0|||
155551841|NCT01173471|561445473|FG002|Overall Study|Reason given as Other|1|||
155551842|NCT01173471|561445474|FG003|Overall Study|Reason given as Other|0|||
155551843|NCT04132336|561445475|FG000|Overall Study|Investigator Decision|0|||
155551844|NCT04132336|561445476|FG001|Overall Study|Investigator Decision|1|||
155551845|NCT04132336|561445477|FG002|Overall Study|Investigator Decision|0|||
155551846|NCT04132336|561445478|FG003|Overall Study|Investigator Decision|0|||
155551847|NCT04132336|561445479|FG004|Overall Study|Investigator Decision|0|||
155551848|NCT04132336|561445480|FG005|Overall Study|Investigator Decision|0|||
155551849|NCT04132336|561445481|FG006|Overall Study|Investigator Decision|0|||
155551850|NCT02488330|561445482|FG000|Overall Study|Adverse Event|1|||
155551851|NCT02488330|561445482|FG000|Overall Study|Physician Decision|2|||
155551852|NCT02488330|561445482|FG000|Overall Study|Death|2|||
155551853|NCT02488330|561445482|FG000|Overall Study|Disease Progression|3|||
155551854|NCT02488330|561445482|FG000|Overall Study|Study Termination by Sponsor|4|||
155551855|NCT00584844|561445483|FG000|Overall Study|Withdrawal by Subject|59|||
155551856|NCT00584844|561445483|FG000|Overall Study|Screen Failure|20|||
155551857|NCT02384941|561445488|FG000|Overall Study|Adverse Event|11|||
155551858|NCT02384941|561445489|FG001|Overall Study|Adverse Event|13|||
155551859|NCT02384941|561445490|FG002|Overall Study|Adverse Event|17|||
155551860|NCT02384941|561445488|FG000|Overall Study|Lost to Follow-up|3|||
155551861|NCT02384941|561445489|FG001|Overall Study|Lost to Follow-up|2|||
155551862|NCT02384941|561445490|FG002|Overall Study|Lost to Follow-up|1|||
155551863|NCT02384941|561445488|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155551864|NCT02384941|561445489|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155551865|NCT02384941|561445490|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155551866|NCT02384941|561445488|FG000|Overall Study|Physician Decision|1|||
155551867|NCT02384941|561445489|FG001|Overall Study|Physician Decision|1|||
155551868|NCT02384941|561445490|FG002|Overall Study|Physician Decision|0|||
155551869|NCT02384941|561445488|FG000|Overall Study|Protocol Violation|3|||
155551870|NCT02384941|561445489|FG001|Overall Study|Protocol Violation|0|||
155551871|NCT02384941|561445490|FG002|Overall Study|Protocol Violation|0|||
155551872|NCT02384941|561445488|FG000|Overall Study|Withdrawal by Subject|26|||
155551873|NCT02384941|561445489|FG001|Overall Study|Withdrawal by Subject|19|||
155551874|NCT02384941|561445490|FG002|Overall Study|Withdrawal by Subject|20|||
155551875|NCT02384941|561445488|FG000|Overall Study|Pregnancy|0|||
155551876|NCT02384941|561445489|FG001|Overall Study|Pregnancy|0|||
155551877|NCT02384941|561445490|FG002|Overall Study|Pregnancy|1|||
155551878|NCT02384941|561445488|FG000|Overall Study|Other than specified above|4|||
155551879|NCT02384941|561445489|FG001|Overall Study|Other than specified above|0|||
155551880|NCT02384941|561445490|FG002|Overall Study|Other than specified above|1|||
155551881|NCT02493777|561445491|FG000|Overall Study|Lost to Follow-up|0|||
155551882|NCT02493777|561445492|FG001|Overall Study|Lost to Follow-up|1|||
155551883|NCT00468728|561445493|FG000|Treatment|criteria for mITT population|4|||
155551884|NCT00468728|561445494|FG001|Treatment|criteria for mITT population|11|||
155551885|NCT00468728|561445493|FG000|Follow-up|mITT failure|34|||
155551886|NCT00468728|561445494|FG001|Follow-up|mITT failure|31|||
155551887|NCT01705236|561445495|FG000|Overall Study|Lost to Follow-up|1|||
155551888|NCT01705236|561445495|FG000|Overall Study|Administrative problems|2|||
155551889|NCT01705236|561445495|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155551890|NCT01705236|561445495|FG000|Overall Study|Protocol Violation|3|||
155551891|NCT01705236|561445495|FG000|Overall Study|Abnormal test procedure result(s)|4|||
155551892|NCT01705236|561445495|FG000|Overall Study|Abnormal laboratory value(s)|4|||
155551893|NCT01705236|561445495|FG000|Overall Study|Withdrawal by Subject|5|||
155551894|NCT01705236|561445495|FG000|Overall Study|Adverse Event|5|||
155551895|NCT06005597|561445496|FG000|Overall Study|Lost to Follow-up|1|||
155551896|NCT06005597|561445497|FG001|Overall Study|Lost to Follow-up|2|||
155551897|NCT06005597|561445498|FG002|Overall Study|Lost to Follow-up|1|||
155551898|NCT06005597|561445499|FG003|Overall Study|Lost to Follow-up|2|||
155551899|NCT06005597|561445496|FG000|Overall Study|Death|1|||
155551900|NCT06005597|561445497|FG001|Overall Study|Death|1|||
155551901|NCT06005597|561445498|FG002|Overall Study|Death|1|||
155551902|NCT06005597|561445499|FG003|Overall Study|Death|0|||
155551903|NCT02100319|561445500|FG000|Overall Study|Case Report Forms Uncollected|11|||
155551904|NCT02100319|561445500|FG000|Overall Study|Protocol Deviation|5|||
155551905|NCT02224573|561445501|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
155551906|NCT02224573|561445502|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
155551907|NCT02224573|561445501|FG000|Treatment Phase|Started on Other IMP|1|||
155551908|NCT02224573|561445502|FG001|Treatment Phase|Started on Other IMP|0|||
155551909|NCT02224573|561445501|FG000|Treatment Phase|Participant Discontinued IMP|0|||
155551910|NCT02224573|561445502|FG001|Treatment Phase|Participant Discontinued IMP|1|||
155551911|NCT02224573|561445501|FG000|Treatment Phase|Lack of Efficacy|15|||
155551912|NCT02224573|561445502|FG001|Treatment Phase|Lack of Efficacy|8|||
155551913|NCT02224573|561445501|FG000|Treatment Phase|Began Commercial Product|1|||
155551914|NCT02224573|561445502|FG001|Treatment Phase|Began Commercial Product|0|||
155551915|NCT02224573|561445501|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
155551916|NCT02224573|561445502|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
155551917|NCT02224573|561445501|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
155551918|NCT02224573|561445502|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
155551919|NCT02224573|561445501|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
155551920|NCT02224573|561445502|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
155551921|NCT02224573|561445501|FG000|Treatment Phase|Continued Compassionate Use|1|||
155551922|NCT02224573|561445502|FG001|Treatment Phase|Continued Compassionate Use|0|||
155551923|NCT02224573|561445501|FG000|Treatment Phase|Lack of Efficiency|2|||
155551924|NCT02224573|561445502|FG001|Treatment Phase|Lack of Efficiency|1|||
155551925|NCT02224573|561445501|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
155551926|NCT02224573|561445502|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
155551927|NCT02224573|561445501|FG000|Treatment Phase|Participant Moved|2|||
155551928|NCT02224573|561445502|FG001|Treatment Phase|Participant Moved|0|||
155551929|NCT02224573|561445501|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
155551930|NCT02224573|561445502|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
155551931|NCT02224573|561445501|FG000|Treatment Phase|Refused Medication|1|||
155551932|NCT02224573|561445502|FG001|Treatment Phase|Refused Medication|1|||
155551933|NCT02224573|561445501|FG000|Treatment Phase|Adverse Event|26|||
155551934|NCT02224573|561445502|FG001|Treatment Phase|Adverse Event|38|||
155551935|NCT02224573|561445501|FG000|Treatment Phase|Placed in Group Home|0|||
155551936|NCT02224573|561445502|FG001|Treatment Phase|Placed in Group Home|1|||
155551937|NCT02224573|561445501|FG000|Treatment Phase|Pursued Other Trials|1|||
155551938|NCT02224573|561445502|FG001|Treatment Phase|Pursued Other Trials|0|||
155551939|NCT02224573|561445501|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
155551940|NCT02224573|561445502|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
155551941|NCT02224573|561445501|FG000|Treatment Phase|Lost to Follow-up|2|||
155551942|NCT02224573|561445502|FG001|Treatment Phase|Lost to Follow-up|1|||
155551943|NCT02224573|561445501|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
155551944|NCT02224573|561445502|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
155551945|NCT02224573|561445501|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
155551946|NCT02224573|561445502|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
155551947|NCT02224573|561445501|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
155551948|NCT02224573|561445502|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
155551949|NCT02224573|561445501|FG000|Taper Phase|Adverse Event|1|||
155551950|NCT02224573|561445502|FG001|Taper Phase|Adverse Event|1|||
155551951|NCT02546362|561445503|FG000|4-week Treatment Period|Lost to Follow-up|1|||
155551952|NCT02546362|561445503|FG000|4-week Treatment Period|Change in medication|2|||
155551953|NCT02546362|561445503|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
155551954|NCT02546362|561445503|FG000|12-week Treatment Period|Lost to Follow-up|2|||
155551955|NCT02546362|561445503|FG000|12-week Treatment Period|Change in medication|1|||
155551956|NCT01138826|561445504|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
155551957|NCT01138826|561445505|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
155551958|NCT01138826|561445506|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
155551959|NCT01138826|561445507|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
155551960|NCT01138826|561445508|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
155551961|NCT01138826|561445509|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
155551962|NCT02566993|561445510|FG000|Overall Study|Randomized but not treated|5|||
155551963|NCT02566993|561445511|FG001|Overall Study|Randomized but not treated|16|||
155551964|NCT02566993|561445510|FG000|Overall Study|Progressive disease|213|||
155551965|NCT02566993|561445511|FG001|Overall Study|Progressive disease|152|||
155551966|NCT02566993|561445510|FG000|Overall Study|Withdrawal by Subject|12|||
155551967|NCT02566993|561445511|FG001|Overall Study|Withdrawal by Subject|28|||
155551968|NCT02566993|561445510|FG000|Overall Study|Death|17|||
155551969|NCT02566993|561445511|FG001|Overall Study|Death|23|||
155551970|NCT02566993|561445510|FG000|Overall Study|Physician Decision|10|||
155551971|NCT02566993|561445511|FG001|Overall Study|Physician Decision|17|||
155551972|NCT02566993|561445510|FG000|Overall Study|Study drug-related adverse event|20|||
155551973|NCT02566993|561445511|FG001|Overall Study|Study drug-related adverse event|41|||
155551974|NCT02566993|561445510|FG000|Overall Study|Non study drug-related adverse event|9|||
155551975|NCT02566993|561445511|FG001|Overall Study|Non study drug-related adverse event|9|||
155551976|NCT02566993|561445510|FG000|Overall Study|Symptomatic deterioration|9|||
155551977|NCT02566993|561445511|FG001|Overall Study|Symptomatic deterioration|16|||
155551978|NCT02566993|561445510|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
155551979|NCT02566993|561445511|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
155551980|NCT02566993|561445510|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
155551981|NCT02566993|561445511|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
155551982|NCT02566993|561445510|FG000|Overall Study|Screening failure|2|||
155551983|NCT02566993|561445511|FG001|Overall Study|Screening failure|0|||
155551984|NCT02566993|561445510|FG000|Overall Study|Lost to Follow-up|0|||
155551985|NCT02566993|561445511|FG001|Overall Study|Lost to Follow-up|1|||
155551986|NCT02566993|561445510|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
155551987|NCT02566993|561445511|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
155551988|NCT05206448|561445512|FG000|Overall Study|Lost to Follow-up|2|||
155551989|NCT05206448|561445513|FG001|Overall Study|Lost to Follow-up|2|||
155551990|NCT05206448|561445512|FG000|Overall Study|Withdrawal by Subject|2|||
155551991|NCT05206448|561445513|FG001|Overall Study|Withdrawal by Subject|0|||
155551992|NCT05206448|561445512|FG000|Overall Study|found ineligible after randomization|1|||
155551993|NCT05206448|561445513|FG001|Overall Study|found ineligible after randomization|1|||
155551994|NCT05206448|561445512|FG000|Overall Study|unable to complete study due to personal constraints|1|||
155551995|NCT05206448|561445513|FG001|Overall Study|unable to complete study due to personal constraints|0|||
155551996|NCT05206448|561445512|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
155551997|NCT05206448|561445513|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
155551998|NCT02589522|561445517|FG000|Overall Study|Physician Decision|1|||
155551999|NCT02589522|561445518|FG001|Overall Study|Physician Decision|2|||
155552000|NCT02589522|561445519|FG002|Overall Study|Physician Decision|0|||
155552001|NCT02589522|561445517|FG000|Overall Study|Did not start treatment|1|||
155552002|NCT02589522|561445518|FG001|Overall Study|Did not start treatment|0|||
155552003|NCT02589522|561445519|FG002|Overall Study|Did not start treatment|0|||
155552004|NCT01478828|561445520|FG000|Overall Study|Adverse Event|1|||
155552005|NCT05611996|561445521|FG000|Overall Study|Ineligible|1|||
155552006|NCT05611996|561445521|FG000|Overall Study|Withdrawal by Subject|9|||
155552007|NCT04479475|561445525|FG000|Overall Study|Withdrawal by Subject|7|||
155552008|NCT02025010|561445526|FG000|Overall Study|Symptomatic or radiographic progression|36|||
155552009|NCT02025010|561445526|FG000|Overall Study|Adverse Event|6|||
155552010|NCT02025010|561445526|FG000|Overall Study|Physician Decision|7|||
155552011|NCT02025010|561445526|FG000|Overall Study|Withdrawal by Subject|3|||
155552012|NCT02025010|561445526|FG000|Overall Study|Intercurrent illness|3|||
155552013|NCT02025010|561445526|FG000|Overall Study|Patients still on treatment|3|||
155552014|NCT02025010|561445526|FG000|Overall Study|Never initiate the treatment|2|||
155552015|NCT04572243|561445528|FG000|Core Study: 14 Weeks|Adverse Event|1|||
155552016|NCT04572243|561445529|FG001|Core Study: 14 Weeks|Adverse Event|2|||
155552017|NCT04572243|561445530|FG002|Core Study: 14 Weeks|Adverse Event|0|||
155552018|NCT04572243|561445531|FG003|Core Study: 14 Weeks|Adverse Event|0|||
155552019|NCT04572243|561445528|FG000|Core Study: 14 Weeks|Subject choice|0|||
155552020|NCT04572243|561445529|FG001|Core Study: 14 Weeks|Subject choice|2|||
155552021|NCT04572243|561445530|FG002|Core Study: 14 Weeks|Subject choice|0|||
155552022|NCT04572243|561445531|FG003|Core Study: 14 Weeks|Subject choice|0|||
155552023|NCT04572243|561445528|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
155552024|NCT04572243|561445529|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
155552025|NCT04572243|561445530|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
155552026|NCT04572243|561445531|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
155552027|NCT04572243|561445528|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
155552028|NCT04572243|561445529|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
155552029|NCT04572243|561445530|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
155552030|NCT04572243|561445531|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
155552031|NCT01661881|561445532|FG000|Overall Study|Disease Progression|1|||
155552032|NCT03451006|561445533|FG000|Overall Study|Withdrawal by Subject|2|||
155552033|NCT03451006|561445534|FG001|Overall Study|Withdrawal by Subject|2|||
155552034|NCT02278718|561445539|FG000|Overall Study|Adverse Event|1|||
155552035|NCT02278718|561445540|FG001|Overall Study|Adverse Event|0|||
155552036|NCT02278718|561445539|FG000|Overall Study|Lost to Follow-up|2|||
155552037|NCT02278718|561445540|FG001|Overall Study|Lost to Follow-up|4|||
155552038|NCT02278718|561445539|FG000|Overall Study|Withdrawal by Subject|1|||
155552039|NCT02278718|561445540|FG001|Overall Study|Withdrawal by Subject|4|||
155552040|NCT02278718|561445539|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
155552041|NCT02278718|561445540|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
155552042|NCT02278718|561445539|FG000|Overall Study|Missing|0|||
155552043|NCT02278718|561445540|FG001|Overall Study|Missing|1|||
155552044|NCT02547766|561445541|FG000|Overall Study|Withdrawal by Subject|1|||
155552045|NCT03253744|561445548|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
155552046|NCT03253744|561445549|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
155552047|NCT03253744|561445550|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
155552048|NCT03253744|561445551|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
155552049|NCT03847194|561445552|FG000|Overall Study|Lost to Follow-up|2|||
155552050|NCT03847194|561445553|FG001|Overall Study|Lost to Follow-up|5|||
155552051|NCT03847194|561445552|FG000|Overall Study|Withdrawal by Subject|1|||
155552052|NCT03847194|561445553|FG001|Overall Study|Withdrawal by Subject|2|||
155552053|NCT03847194|561445552|FG000|Overall Study|Death|0|||
155552054|NCT03847194|561445553|FG001|Overall Study|Death|1|||
155552055|NCT01010750|561445554|FG000|Second Intervention|Adverse Event|0|||
155552056|NCT01010750|561445555|FG001|Second Intervention|Adverse Event|1|||
155552057|NCT01010750|561445556|FG002|Second Intervention|Adverse Event|0|||
155552058|NCT01010750|561445557|FG003|Second Intervention|Adverse Event|0|||
155552059|NCT01010750|561445558|FG004|Second Intervention|Adverse Event|0|||
155552060|NCT01010750|561445559|FG005|Second Intervention|Adverse Event|0|||
155552061|NCT02442271|561445561|FG000|Overall Study|Adverse Event|1|||
155552062|NCT02442271|561445561|FG000|Overall Study|Withdrew Consent|1|||
155552063|NCT02442271|561445561|FG000|Overall Study|Lost to Follow-up|1|||
155552064|NCT02442271|561445561|FG000|Overall Study|Other|1|||
155552065|NCT01560507|561445562|FG000|Overall Study|Lost to Follow-up|3|||
155552066|NCT01560507|561445563|FG001|Overall Study|Lost to Follow-up|1|||
155552067|NCT01560507|561445564|FG002|Overall Study|Lost to Follow-up|2|||
155552068|NCT01560507|561445562|FG000|Overall Study|Withdrawal by Subject|1|||
155552069|NCT01560507|561445563|FG001|Overall Study|Withdrawal by Subject|1|||
155552070|NCT01560507|561445564|FG002|Overall Study|Withdrawal by Subject|0|||
155552071|NCT03545191|561445565|FG000|Overall Study|Death|1|||
155552072|NCT03545191|561445566|FG001|Overall Study|Death|0|||
155552073|NCT03545191|561445567|FG002|Overall Study|Death|0|||
155552074|NCT03545191|561445565|FG000|Overall Study|Adverse Event|4|||
155552075|NCT03545191|561445566|FG001|Overall Study|Adverse Event|2|||
155552076|NCT03545191|561445567|FG002|Overall Study|Adverse Event|7|||
155552077|NCT03545191|561445565|FG000|Overall Study|Other reasons|3|||
155552078|NCT03545191|561445566|FG001|Overall Study|Other reasons|11|||
155552079|NCT03545191|561445567|FG002|Overall Study|Other reasons|8|||
155552080|NCT03545191|561445565|FG000|Overall Study|Withdrawal by Subject|13|||
155552081|NCT03545191|561445566|FG001|Overall Study|Withdrawal by Subject|10|||
155552082|NCT03545191|561445567|FG002|Overall Study|Withdrawal by Subject|12|||
155552083|NCT03545191|561445565|FG000|Overall Study|Lost to Follow-up|1|||
155552084|NCT03545191|561445566|FG001|Overall Study|Lost to Follow-up|2|||
155552085|NCT03545191|561445567|FG002|Overall Study|Lost to Follow-up|3|||
155552086|NCT02746627|561445572|FG000|Overall Study|Withdrawal by Subject|1|||
155552087|NCT02746627|561445573|FG001|Overall Study|Withdrawal by Subject|1|||
155552088|NCT02746627|561445574|FG002|Overall Study|Withdrawal by Subject|1|||
155552089|NCT02858726|561445575|FG000|Overall Study|Adverse Event|4|||
155552090|NCT02858726|561445576|FG001|Overall Study|Adverse Event|4|||
155552091|NCT02858726|561445577|FG002|Overall Study|Adverse Event|9|||
155552092|NCT02858726|561445578|FG003|Overall Study|Adverse Event|1|||
155552093|NCT02858726|561445575|FG000|Overall Study|Physician Decision|0|||
155552094|NCT02858726|561445576|FG001|Overall Study|Physician Decision|0|||
155552095|NCT02858726|561445577|FG002|Overall Study|Physician Decision|1|||
155552096|NCT02858726|561445578|FG003|Overall Study|Physician Decision|0|||
155552097|NCT02858726|561445575|FG000|Overall Study|Protocol Violation|0|||
155552098|NCT02858726|561445576|FG001|Overall Study|Protocol Violation|0|||
155552099|NCT02858726|561445577|FG002|Overall Study|Protocol Violation|0|||
155552100|NCT02858726|561445578|FG003|Overall Study|Protocol Violation|1|||
155552101|NCT02858726|561445575|FG000|Overall Study|Study Terminated by Sponsor|0|||
155552102|NCT02858726|561445576|FG001|Overall Study|Study Terminated by Sponsor|0|||
155552103|NCT02858726|561445577|FG002|Overall Study|Study Terminated by Sponsor|0|||
155552104|NCT02858726|561445578|FG003|Overall Study|Study Terminated by Sponsor|1|||
155552105|NCT02858726|561445575|FG000|Overall Study|Withdrawal by Subject|1|||
155552106|NCT02858726|561445576|FG001|Overall Study|Withdrawal by Subject|2|||
155552107|NCT02858726|561445577|FG002|Overall Study|Withdrawal by Subject|1|||
155552108|NCT02858726|561445578|FG003|Overall Study|Withdrawal by Subject|0|||
155552109|NCT02858726|561445575|FG000|Overall Study|Noncompliance|0|||
155552110|NCT02858726|561445576|FG001|Overall Study|Noncompliance|1|||
155552111|NCT02858726|561445577|FG002|Overall Study|Noncompliance|0|||
155552112|NCT02858726|561445578|FG003|Overall Study|Noncompliance|0|||
155552113|NCT00233987|561445583|FG000|Overall Study|Withdrawal by Subject|1|||
155552114|NCT00233987|561445583|FG000|Overall Study|Lack of Efficacy|2|||
155552115|NCT00233987|561445583|FG000|Overall Study|Reason Under Review|1|||
155552116|NCT00233987|561445583|FG000|Overall Study|Other - Not Protocol Specified|5|||
155552117|NCT00233987|561445583|FG000|Overall Study|Eligible but No Treatment Received|2|||
155552118|NCT00233987|561445583|FG000|Overall Study|Ineligible|4|||
155552119|NCT00710749|561445587|FG000|First Intervention|Withdrawal by Subject|1|||
155552120|NCT00710749|561445588|FG001|First Intervention|Withdrawal by Subject|0|||
155552121|NCT05478252|561445590|FG000|Overall Study|Withdrawal by Subject|2|||
155552122|NCT05478252|561445591|FG001|Overall Study|Withdrawal by Subject|3|||
155552123|NCT05478252|561445590|FG000|Overall Study|Lost to Follow-up|4|||
155552124|NCT05478252|561445591|FG001|Overall Study|Lost to Follow-up|2|||
155552125|NCT05478252|561445590|FG000|Overall Study|Physician Decision|1|||
155552126|NCT05478252|561445591|FG001|Overall Study|Physician Decision|1|||
155552127|NCT05478252|561445590|FG000|Overall Study|Death|1|||
155552128|NCT05478252|561445591|FG001|Overall Study|Death|0|||
155552129|NCT04846881|561445592|FG000|Overall Study|Adverse Event|14|||
155552130|NCT04846881|561445593|FG001|Overall Study|Adverse Event|15|||
155552131|NCT04846881|561445592|FG000|Overall Study|Burden of study procedures|7|||
155552132|NCT04846881|561445593|FG001|Overall Study|Burden of study procedures|3|||
155552133|NCT04846881|561445592|FG000|Overall Study|Protocol deviation|6|||
155552134|NCT04846881|561445593|FG001|Overall Study|Protocol deviation|4|||
155552135|NCT04846881|561445592|FG000|Overall Study|Perceived lack of efficacy|5|||
155552136|NCT04846881|561445593|FG001|Overall Study|Perceived lack of efficacy|2|||
155552137|NCT04846881|561445592|FG000|Overall Study|Change of residence|2|||
155552138|NCT04846881|561445593|FG001|Overall Study|Change of residence|0|||
155552139|NCT04846881|561445592|FG000|Overall Study|Technical problems|0|||
155552140|NCT04846881|561445593|FG001|Overall Study|Technical problems|1|||
155552141|NCT04846881|561445592|FG000|Overall Study|Other than listed|3|||
155552142|NCT04846881|561445593|FG001|Overall Study|Other than listed|10|||
155552143|NCT04846881|561445592|FG000|Overall Study|No reason available|1|||
155552144|NCT04846881|561445593|FG001|Overall Study|No reason available|3|||
155552145|NCT04846881|561445592|FG000|Overall Study|Patient randomised in error|1|||
155552146|NCT04846881|561445593|FG001|Overall Study|Patient randomised in error|0|||
155552147|NCT04560998|561445594|FG000|Overall Study|Withdrawal by Subject|18|||
155552148|NCT04560998|561445595|FG001|Overall Study|Withdrawal by Subject|12|||
155552149|NCT04560998|561445594|FG000|Overall Study|Lost to Follow-up|8|||
155552150|NCT04560998|561445595|FG001|Overall Study|Lost to Follow-up|5|||
155552151|NCT04560998|561445594|FG000|Overall Study|Physician Decision|4|||
155552152|NCT04560998|561445595|FG001|Overall Study|Physician Decision|0|||
155552153|NCT03821272|561448027|FG000|Overall Study|Death|1|||
155552154|NCT03821272|561448028|FG001|Overall Study|Death|0|||
155552155|NCT03821272|561448027|FG000|Overall Study|Physician Decision|1|||
155552156|NCT03821272|561448028|FG001|Overall Study|Physician Decision|0|||
155552157|NCT03821272|561448027|FG000|Overall Study|Withdrawal by Subject|1|||
155552158|NCT03821272|561448028|FG001|Overall Study|Withdrawal by Subject|0|||
155552159|NCT05904769|561448029|FG000|Overall Study|Physician Decision|0|||
155552160|NCT05904769|561448030|FG001|Overall Study|Physician Decision|6|||
155552161|NCT05626803|561448033|FG000|Overall Study|Lost to Follow-up|0|||
155552162|NCT05626803|561448034|FG001|Overall Study|Lost to Follow-up|1|||
155552163|NCT05626803|561448035|FG002|Overall Study|Lost to Follow-up|0|||
155552164|NCT05626803|561448036|FG003|Overall Study|Lost to Follow-up|0|||
155552165|NCT04974619|561448040|FG000|Overall Study|Lost to Follow-up|0|||
155552166|NCT04974619|561448041|FG001|Overall Study|Lost to Follow-up|0|||
155552167|NCT04974619|561448042|FG002|Overall Study|Lost to Follow-up|1|||
155552168|NCT04974619|561448040|FG000|Overall Study|Withdrawal by Subject|0|||
155552169|NCT04974619|561448041|FG001|Overall Study|Withdrawal by Subject|0|||
155552170|NCT04974619|561448042|FG002|Overall Study|Withdrawal by Subject|1|||
155552171|NCT04974619|561448040|FG000|Overall Study|Protocol Violation|0|||
155552172|NCT04974619|561448041|FG001|Overall Study|Protocol Violation|1|||
155552173|NCT04974619|561448042|FG002|Overall Study|Protocol Violation|0|||
155552174|NCT03959527|561448050|FG000|Overall Study|Withdrawal by Subject|8|||
155552175|NCT03959527|561448051|FG001|Overall Study|Withdrawal by Subject|3|||
155552176|NCT03959527|561448050|FG000|Overall Study|Lost to Follow-up|31|||
155552177|NCT03959527|561448051|FG001|Overall Study|Lost to Follow-up|15|||
155552178|NCT03959527|561448050|FG000|Overall Study|Did not meet eligibility criteria|1|||
155552179|NCT03959527|561448051|FG001|Overall Study|Did not meet eligibility criteria|1|||
155552180|NCT03959527|561448050|FG000|Overall Study|Protocol Violation|10|||
155552181|NCT03959527|561448051|FG001|Overall Study|Protocol Violation|5|||
155552182|NCT01688466|561448052|FG000|Overall Study|Withdrawal by Subject|2|||
155552183|NCT01688466|561448053|FG001|Overall Study|Withdrawal by Subject|1|||
155552184|NCT01688466|561448052|FG000|Overall Study|Death|0|||
155552185|NCT01688466|561448053|FG001|Overall Study|Death|1|||
155552186|NCT01688466|561448052|FG000|Overall Study|Adverse Event|0|||
155552187|NCT01688466|561448053|FG001|Overall Study|Adverse Event|4|||
155552188|NCT01688466|561448052|FG000|Overall Study|Not evaluable|0|||
155552189|NCT01688466|561448053|FG001|Overall Study|Not evaluable|1|||
155552190|NCT01000610|561448058|FG000|Overall Study|Adverse Event|1|||
155552191|NCT01000610|561448058|FG000|Overall Study|Lost to Follow-up|4|||
155552192|NCT01000610|561448058|FG000|Overall Study|Treatment failure|1|||
155552193|NCT01010126|561448059|FG000|Overall Study|Withdrawal by Subject|1|||
155552194|NCT01010126|561448060|FG001|Overall Study|Withdrawal by Subject|0|||
155552195|NCT01010126|561448061|FG002|Overall Study|Withdrawal by Subject|1|||
155552196|NCT01010126|561448062|FG003|Overall Study|Withdrawal by Subject|0|||
155552197|NCT01010126|561448063|FG004|Overall Study|Withdrawal by Subject|3|||
155552198|NCT01010126|561448064|FG005|Overall Study|Withdrawal by Subject|0|||
155552199|NCT00493246|561448067|FG000|Overall Study|Withdrawal by Subject|0|||
155552200|NCT00493246|561448068|FG001|Overall Study|Withdrawal by Subject|0|||
155552201|NCT00493246|561448069|FG002|Overall Study|Withdrawal by Subject|0|||
155552202|NCT00493246|561448070|FG003|Overall Study|Withdrawal by Subject|0|||
155552203|NCT00493246|561448071|FG004|Overall Study|Withdrawal by Subject|1|||
155552204|NCT00493246|561448072|FG005|Overall Study|Withdrawal by Subject|0|||
155552205|NCT00493246|561448073|FG006|Overall Study|Withdrawal by Subject|0|||
155552206|NCT00493246|561448074|FG007|Overall Study|Withdrawal by Subject|0|||
155552207|NCT00493246|561448067|FG000|Overall Study|No access to draw blood|0|||
155552208|NCT00493246|561448068|FG001|Overall Study|No access to draw blood|0|||
155552209|NCT00493246|561448069|FG002|Overall Study|No access to draw blood|0|||
155552210|NCT00493246|561448070|FG003|Overall Study|No access to draw blood|0|||
155552211|NCT00493246|561448071|FG004|Overall Study|No access to draw blood|0|||
155552212|NCT00493246|561448072|FG005|Overall Study|No access to draw blood|1|||
155552213|NCT00493246|561448073|FG006|Overall Study|No access to draw blood|0|||
155552214|NCT00493246|561448074|FG007|Overall Study|No access to draw blood|0|||
155552215|NCT00493246|561448067|FG000|Overall Study|Lost to Follow-up|0|||
155552216|NCT00493246|561448068|FG001|Overall Study|Lost to Follow-up|0|||
155552217|NCT00493246|561448069|FG002|Overall Study|Lost to Follow-up|0|||
155552218|NCT00493246|561448070|FG003|Overall Study|Lost to Follow-up|0|||
155552219|NCT00493246|561448071|FG004|Overall Study|Lost to Follow-up|0|||
155552220|NCT00493246|561448072|FG005|Overall Study|Lost to Follow-up|0|||
155552221|NCT00493246|561448073|FG006|Overall Study|Lost to Follow-up|1|||
155552222|NCT00493246|561448074|FG007|Overall Study|Lost to Follow-up|0|||
155552223|NCT00595335|561448079|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
155552224|NCT00595335|561448080|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
155552225|NCT00595335|561448079|FG000|Baseline to Six Months|Disease Progression|1|||
155552226|NCT00595335|561448080|FG001|Baseline to Six Months|Disease Progression|1|||
155552227|NCT00595335|561448079|FG000|Baseline to Six Months|Adverse Event|1|||
155552228|NCT00595335|561448080|FG001|Baseline to Six Months|Adverse Event|0|||
155552229|NCT00595335|561448079|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
155552230|NCT00595335|561448080|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
155552231|NCT00595335|561448079|FG000|Six Months to Twelve Months|Disease Progression|1|||
155552232|NCT00595335|561448080|FG001|Six Months to Twelve Months|Disease Progression|0|||
155552233|NCT00493779|561448092|FG000|Overall Study|Logistical issue at site|1|||
155552234|NCT01647958|561448093|FG000|Initial Study|Lost to Follow-up|2|||
155552235|NCT01647958|561448094|FG001|Initial Study|Lost to Follow-up|3|||
155552236|NCT01647958|561448093|FG000|Continuation Phase|treatment received during Overall Study|39|||
155552237|NCT01647958|561448094|FG001|Continuation Phase|treatment received during Overall Study|0|||
155552238|NCT01647958|561448093|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
155552239|NCT01647958|561448094|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
155552240|NCT01131299|561448095|FG000|Overall Study|Withdrawal by Subject|4|||
155552241|NCT01131299|561448096|FG001|Overall Study|Withdrawal by Subject|7|||
155552242|NCT01207440|561448104|FG000|Overall Study|Adverse Event|46|||
155552243|NCT01207440|561448105|FG001|Overall Study|Adverse Event|11|||
155552244|NCT01207440|561448106|FG002|Overall Study|Adverse Event|7|||
155552245|NCT01207440|561448107|FG003|Overall Study|Adverse Event|2|||
155552246|NCT01207440|561448108|FG004|Overall Study|Adverse Event|6|||
155552247|NCT01207440|561448109|FG005|Overall Study|Adverse Event|6|||
155552248|NCT01207440|561448110|FG006|Overall Study|Adverse Event|2|||
155552249|NCT01207440|561448104|FG000|Overall Study|Death|6|||
155552250|NCT01207440|561448105|FG001|Overall Study|Death|3|||
155552251|NCT01207440|561448106|FG002|Overall Study|Death|2|||
155552252|NCT01207440|561448107|FG003|Overall Study|Death|2|||
155552253|NCT01207440|561448108|FG004|Overall Study|Death|7|||
155552254|NCT01207440|561448109|FG005|Overall Study|Death|5|||
155552255|NCT01207440|561448110|FG006|Overall Study|Death|1|||
155552256|NCT01207440|561448104|FG000|Overall Study|Lack of Efficacy|13|||
155552257|NCT01207440|561448105|FG001|Overall Study|Lack of Efficacy|2|||
155552258|NCT01207440|561448106|FG002|Overall Study|Lack of Efficacy|5|||
155552259|NCT01207440|561448107|FG003|Overall Study|Lack of Efficacy|1|||
155552260|NCT01207440|561448108|FG004|Overall Study|Lack of Efficacy|2|||
155552261|NCT01207440|561448109|FG005|Overall Study|Lack of Efficacy|3|||
155552262|NCT01207440|561448110|FG006|Overall Study|Lack of Efficacy|0|||
155552263|NCT01207440|561448104|FG000|Overall Study|Lost to Follow-up|0|||
155552264|NCT01207440|561448105|FG001|Overall Study|Lost to Follow-up|0|||
155552265|NCT01207440|561448106|FG002|Overall Study|Lost to Follow-up|2|||
155552266|NCT01207440|561448107|FG003|Overall Study|Lost to Follow-up|1|||
155552267|NCT01207440|561448108|FG004|Overall Study|Lost to Follow-up|0|||
155552268|NCT01207440|561448109|FG005|Overall Study|Lost to Follow-up|0|||
155552269|NCT01207440|561448110|FG006|Overall Study|Lost to Follow-up|0|||
155552270|NCT01207440|561448104|FG000|Overall Study|Non-compliance with Study Drug|3|||
155552271|NCT01207440|561448105|FG001|Overall Study|Non-compliance with Study Drug|0|||
155552272|NCT01207440|561448106|FG002|Overall Study|Non-compliance with Study Drug|1|||
155552273|NCT01207440|561448107|FG003|Overall Study|Non-compliance with Study Drug|0|||
155552274|NCT01207440|561448108|FG004|Overall Study|Non-compliance with Study Drug|0|||
155552275|NCT01207440|561448109|FG005|Overall Study|Non-compliance with Study Drug|0|||
155552276|NCT01207440|561448110|FG006|Overall Study|Non-compliance with Study Drug|0|||
155552277|NCT01207440|561448104|FG000|Overall Study|Physician Decision|6|||
155552278|NCT01207440|561448105|FG001|Overall Study|Physician Decision|5|||
155552279|NCT01207440|561448106|FG002|Overall Study|Physician Decision|5|||
155552280|NCT01207440|561448107|FG003|Overall Study|Physician Decision|0|||
155552281|NCT01207440|561448108|FG004|Overall Study|Physician Decision|1|||
155552282|NCT01207440|561448109|FG005|Overall Study|Physician Decision|0|||
155552283|NCT01207440|561448110|FG006|Overall Study|Physician Decision|0|||
155552284|NCT01207440|561448104|FG000|Overall Study|Progressive Disease|19|||
155552285|NCT01207440|561448105|FG001|Overall Study|Progressive Disease|10|||
155552286|NCT01207440|561448106|FG002|Overall Study|Progressive Disease|19|||
155552287|NCT01207440|561448107|FG003|Overall Study|Progressive Disease|7|||
155552288|NCT01207440|561448108|FG004|Overall Study|Progressive Disease|23|||
155552289|NCT01207440|561448109|FG005|Overall Study|Progressive Disease|27|||
155552290|NCT01207440|561448110|FG006|Overall Study|Progressive Disease|0|||
155552291|NCT01207440|561448104|FG000|Overall Study|Protocol Violation|2|||
155552292|NCT01207440|561448105|FG001|Overall Study|Protocol Violation|0|||
155552293|NCT01207440|561448106|FG002|Overall Study|Protocol Violation|0|||
155552294|NCT01207440|561448107|FG003|Overall Study|Protocol Violation|0|||
155552295|NCT01207440|561448108|FG004|Overall Study|Protocol Violation|0|||
155552296|NCT01207440|561448109|FG005|Overall Study|Protocol Violation|0|||
155552297|NCT01207440|561448110|FG006|Overall Study|Protocol Violation|0|||
155552298|NCT01207440|561448104|FG000|Overall Study|Site Terminated by Sponsor|69|||
155552299|NCT01207440|561448105|FG001|Overall Study|Site Terminated by Sponsor|19|||
155552300|NCT01207440|561448106|FG002|Overall Study|Site Terminated by Sponsor|12|||
155552301|NCT01207440|561448107|FG003|Overall Study|Site Terminated by Sponsor|2|||
155552302|NCT01207440|561448108|FG004|Overall Study|Site Terminated by Sponsor|3|||
155552303|NCT01207440|561448109|FG005|Overall Study|Site Terminated by Sponsor|0|||
155552304|NCT01207440|561448110|FG006|Overall Study|Site Terminated by Sponsor|2|||
155552305|NCT01207440|561448104|FG000|Overall Study|Withdrawal by Subject|29|||
155552306|NCT01207440|561448105|FG001|Overall Study|Withdrawal by Subject|4|||
155552307|NCT01207440|561448106|FG002|Overall Study|Withdrawal by Subject|5|||
155552308|NCT01207440|561448107|FG003|Overall Study|Withdrawal by Subject|3|||
155552309|NCT01207440|561448108|FG004|Overall Study|Withdrawal by Subject|2|||
155552310|NCT01207440|561448109|FG005|Overall Study|Withdrawal by Subject|2|||
155552311|NCT01207440|561448110|FG006|Overall Study|Withdrawal by Subject|0|||
155552312|NCT01207440|561448104|FG000|Overall Study|Reason Not Specified|10|||
155552313|NCT01207440|561448105|FG001|Overall Study|Reason Not Specified|10|||
155552314|NCT01207440|561448106|FG002|Overall Study|Reason Not Specified|7|||
155552315|NCT01207440|561448107|FG003|Overall Study|Reason Not Specified|0|||
155552316|NCT01207440|561448108|FG004|Overall Study|Reason Not Specified|4|||
155552317|NCT01207440|561448109|FG005|Overall Study|Reason Not Specified|3|||
155552318|NCT01207440|561448110|FG006|Overall Study|Reason Not Specified|0|||
155552319|NCT03341000|561448111|FG000|Overall Study|Adverse Event|1|||
155552320|NCT01592721|561448112|FG000|Long-term Follow-up|Death|1|||
155552321|NCT00821873|561448113|FG000|Overall Study|Lost to Follow-up|4|||
155552322|NCT02698865|561448114|FG000|Overall Study|Other|11|||
155552323|NCT02698865|561448115|FG001|Overall Study|Other|11|||
155552324|NCT02698865|561448114|FG000|Overall Study|Withdrawal by Subject|20|||
155552325|NCT02698865|561448115|FG001|Overall Study|Withdrawal by Subject|16|||
155552326|NCT02698865|561448114|FG000|Overall Study|Physician Decision|0|||
155552327|NCT02698865|561448115|FG001|Overall Study|Physician Decision|4|||
155552328|NCT02698865|561448114|FG000|Overall Study|Lost to Follow-up|4|||
155552329|NCT02698865|561448115|FG001|Overall Study|Lost to Follow-up|2|||
155552330|NCT03861481|561448116|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
155552331|NCT03861481|561448117|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
155552332|NCT03861481|561448116|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
155552333|NCT03861481|561448117|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
155552334|NCT03861481|561448116|FG000|Overall Study|Relapse|1|||
155552335|NCT03861481|561448117|FG001|Overall Study|Relapse|0|||
155552336|NCT03861481|561448116|FG000|Overall Study|Withdrawal by Subject|0|||
155552337|NCT03861481|561448117|FG001|Overall Study|Withdrawal by Subject|1|||
155552338|NCT03861481|561448116|FG000|Overall Study|Lack of Efficacy|4|||
155552339|NCT03861481|561448117|FG001|Overall Study|Lack of Efficacy|5|||
155552340|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
155552341|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
155657373|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155552342|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
155552343|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
155552344|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
155552345|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
155657374|NCT01362790|561838956|FG000|Pilot Phase & Phase 2|Death on study|0|||
155552346|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
155552347|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
155552348|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
155552349|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
155552350|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
155552351|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
155552352|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
155552353|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
155552354|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
155552355|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
155552356|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155552357|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155552358|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
155552359|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
155552360|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
155552361|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
155552362|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
155552363|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
155552364|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
155552365|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
155552366|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
155552367|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
155552368|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
155552369|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
155552370|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
155552371|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
155552372|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
155552373|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
155552374|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
155552375|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
155552376|NCT00773734|561448118|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
155552377|NCT00773734|561448119|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
155552378|NCT00773734|561448120|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
155552379|NCT00773734|561448121|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
155552380|NCT00773734|561448122|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
155552381|NCT00773734|561448123|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
155552382|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
155552383|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
155552384|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
155552385|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
155552386|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
155552387|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
155552388|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
155552389|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
155552390|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
155552391|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
155552392|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
155552393|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
155552394|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
155552395|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
155552396|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
155552397|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
155552398|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
155552399|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
155552400|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
155552401|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
155552402|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
155552403|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
155552404|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
155552405|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
155552406|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
155552407|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
155552408|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
155552409|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
155552410|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
155552411|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
155552412|NCT00773734|561448118|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
155552413|NCT00773734|561448119|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
155552414|NCT00773734|561448120|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
155552415|NCT00773734|561448121|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
155552416|NCT00773734|561448122|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
155552417|NCT00773734|561448123|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
155552418|NCT00773734|561448118|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
155552419|NCT00773734|561448119|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
155552420|NCT00773734|561448120|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
155552421|NCT00773734|561448121|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
155552422|NCT00773734|561448122|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
155552423|NCT00773734|561448123|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
155552424|NCT00773734|561448118|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
155552425|NCT00773734|561448119|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
155552426|NCT00773734|561448120|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
155552427|NCT00773734|561448121|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
155552428|NCT00773734|561448122|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
155552429|NCT00773734|561448123|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
155552430|NCT00773734|561448118|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
155552431|NCT00773734|561448119|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
155552432|NCT00773734|561448120|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
155552433|NCT00773734|561448121|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
155552434|NCT00773734|561448122|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
155657375|NCT01362790|561838957|FG001|Pilot Phase & Phase 2|Death on study|0|||
155552435|NCT00773734|561448123|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
155552436|NCT00773734|561448118|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
155552437|NCT00773734|561448119|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
155552438|NCT00773734|561448120|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
155552439|NCT00773734|561448121|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
155552440|NCT00773734|561448122|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
155552441|NCT00773734|561448123|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
155552442|NCT00773734|561448118|FG000|Extension: Active Treatment Week 24-52|Other|0|||
155552443|NCT00773734|561448119|FG001|Extension: Active Treatment Week 24-52|Other|0|||
155552444|NCT00773734|561448120|FG002|Extension: Active Treatment Week 24-52|Other|1|||
155552445|NCT00773734|561448121|FG003|Extension: Active Treatment Week 24-52|Other|2|||
155552446|NCT00773734|561448122|FG004|Extension: Active Treatment Week 24-52|Other|0|||
155552447|NCT00773734|561448123|FG005|Extension: Active Treatment Week 24-52|Other|1|||
155552448|NCT00773734|561448118|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155552449|NCT00773734|561448119|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155552450|NCT00773734|561448120|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155552451|NCT00773734|561448121|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
155552452|NCT00773734|561448122|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155552453|NCT00773734|561448123|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155552454|NCT00773734|561448118|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
155552455|NCT00773734|561448119|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
155552456|NCT00773734|561448120|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
155552457|NCT00773734|561448121|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
155552458|NCT00773734|561448122|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
155552459|NCT00773734|561448123|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
155552460|NCT00773734|561448118|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
155552461|NCT00773734|561448119|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
155552462|NCT00773734|561448120|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
155552463|NCT00773734|561448121|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
155552464|NCT00773734|561448122|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
155552465|NCT00773734|561448123|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
155552466|NCT00773734|561448118|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
155552467|NCT00773734|561448119|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
155552468|NCT00773734|561448120|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
155552469|NCT00773734|561448121|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
155552470|NCT00773734|561448122|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
155552471|NCT00773734|561448123|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
155552472|NCT01220297|561448130|FG000|Overall Study|Death|2|||
155552473|NCT01220297|561448130|FG000|Overall Study|Lost to Follow-up|1|||
155552474|NCT02119286|561448132|FG000|Overall Study|Adverse Event|9|||
155552475|NCT02119286|561448133|FG001|Overall Study|Adverse Event|7|||
155552476|NCT02119286|561448134|FG002|Overall Study|Adverse Event|2|||
155552477|NCT02119286|561448132|FG000|Overall Study|Lack of Efficacy|11|||
155552478|NCT02119286|561448133|FG001|Overall Study|Lack of Efficacy|3|||
155552479|NCT02119286|561448134|FG002|Overall Study|Lack of Efficacy|4|||
155552480|NCT02119286|561448132|FG000|Overall Study|Lost to Follow-up|2|||
155552481|NCT02119286|561448133|FG001|Overall Study|Lost to Follow-up|0|||
155552482|NCT02119286|561448134|FG002|Overall Study|Lost to Follow-up|1|||
155552483|NCT02119286|561448132|FG000|Overall Study|Withdrawal by Subject|4|||
155552484|NCT02119286|561448133|FG001|Overall Study|Withdrawal by Subject|1|||
155552485|NCT02119286|561448134|FG002|Overall Study|Withdrawal by Subject|0|||
155552486|NCT04109313|561448135|FG000|Overall Study|Pregnancy|1|||
155552487|NCT04109313|561448135|FG000|Overall Study|Adverse Event|11|||
155552488|NCT04109313|561448135|FG000|Overall Study|Lack of Efficacy|11|||
155552489|NCT04109313|561448135|FG000|Overall Study|Lost to Follow-up|1|||
155552490|NCT04109313|561448135|FG000|Overall Study|Physician Decision|2|||
155552491|NCT04109313|561448135|FG000|Overall Study|Subject Decision|13|||
155552492|NCT04109313|561448135|FG000|Overall Study|Covid-19 situation|2|||
155552493|NCT01272921|561448136|FG000|Overall Study|Protocol Violation|2|||
155552494|NCT01272921|561448137|FG001|Overall Study|Protocol Violation|1|||
155552495|NCT01132664|561448138|FG000|Phase lb|Adverse Event|0|||
155552496|NCT01132664|561448139|FG001|Phase lb|Adverse Event|1|||
155552497|NCT01132664|561448140|FG002|Phase lb|Adverse Event|0|||
155552498|NCT01132664|561448141|FG003|Phase lb|Adverse Event|0|||
155552499|NCT01132664|561448142|FG004|Phase lb|Adverse Event|0|||
155552500|NCT01132664|561448138|FG000|Phase lb|Withdrawal by Subject|1|||
155552501|NCT01132664|561448139|FG001|Phase lb|Withdrawal by Subject|2|||
155552502|NCT01132664|561448140|FG002|Phase lb|Withdrawal by Subject|0|||
155552503|NCT01132664|561448141|FG003|Phase lb|Withdrawal by Subject|0|||
155552504|NCT01132664|561448142|FG004|Phase lb|Withdrawal by Subject|0|||
155552505|NCT01132664|561448138|FG000|Phase lb|Disease Progression|4|||
155552506|NCT01132664|561448139|FG001|Phase lb|Disease Progression|9|||
155552507|NCT01132664|561448140|FG002|Phase lb|Disease Progression|0|||
155552508|NCT01132664|561448141|FG003|Phase lb|Disease Progression|0|||
155552509|NCT01132664|561448142|FG004|Phase lb|Disease Progression|0|||
155552510|NCT01132664|561448138|FG000|Phase ll|Death|0|||
155552511|NCT01132664|561448139|FG001|Phase ll|Death|0|||
155552512|NCT01132664|561448140|FG002|Phase ll|Death|2|||
155552513|NCT01132664|561448141|FG003|Phase ll|Death|0|||
155552514|NCT01132664|561448142|FG004|Phase ll|Death|0|||
155552515|NCT01132664|561448138|FG000|Phase ll|Adverse Event|0|||
155552516|NCT01132664|561448139|FG001|Phase ll|Adverse Event|0|||
155552517|NCT01132664|561448140|FG002|Phase ll|Adverse Event|10|||
155552518|NCT01132664|561448141|FG003|Phase ll|Adverse Event|0|||
155552519|NCT01132664|561448142|FG004|Phase ll|Adverse Event|0|||
155552520|NCT01132664|561448138|FG000|Phase ll|Withdrawal by Subject|0|||
155552521|NCT01132664|561448139|FG001|Phase ll|Withdrawal by Subject|0|||
155552522|NCT01132664|561448140|FG002|Phase ll|Withdrawal by Subject|3|||
155552523|NCT01132664|561448141|FG003|Phase ll|Withdrawal by Subject|0|||
155552524|NCT01132664|561448142|FG004|Phase ll|Withdrawal by Subject|0|||
155552525|NCT01132664|561448138|FG000|Phase ll|Disease progression|0|||
155552526|NCT01132664|561448139|FG001|Phase ll|Disease progression|0|||
155552527|NCT01132664|561448140|FG002|Phase ll|Disease progression|35|||
155552528|NCT01132664|561448141|FG003|Phase ll|Disease progression|0|||
155552529|NCT01132664|561448142|FG004|Phase ll|Disease progression|0|||
155552530|NCT01132664|561448138|FG000|BM Cohort|Disease progression|0|||
155552531|NCT01132664|561448139|FG001|BM Cohort|Disease progression|0|||
155552532|NCT01132664|561448140|FG002|BM Cohort|Disease progression|0|||
155552533|NCT01132664|561448141|FG003|BM Cohort|Disease progression|3|||
155552534|NCT01132664|561448142|FG004|BM Cohort|Disease progression|4|||
155552535|NCT01132664|561448138|FG000|BM Cohort|Adverse Event|0|||
155552536|NCT01132664|561448139|FG001|BM Cohort|Adverse Event|0|||
155552537|NCT01132664|561448140|FG002|BM Cohort|Adverse Event|0|||
155552538|NCT01132664|561448141|FG003|BM Cohort|Adverse Event|0|||
155552539|NCT01132664|561448142|FG004|BM Cohort|Adverse Event|1|||
155552540|NCT01132664|561448138|FG000|BM Cohort|Withdrawal by Subject|0|||
155552541|NCT01132664|561448139|FG001|BM Cohort|Withdrawal by Subject|0|||
155552542|NCT01132664|561448140|FG002|BM Cohort|Withdrawal by Subject|0|||
155552543|NCT01132664|561448141|FG003|BM Cohort|Withdrawal by Subject|0|||
155552544|NCT01132664|561448142|FG004|BM Cohort|Withdrawal by Subject|1|||
155552545|NCT01996332|561448144|FG000|Overall Study|Adverse Event|117|||
155552546|NCT01996332|561448144|FG000|Overall Study|Lack of Efficacy|1245|||
155552547|NCT01996332|561448144|FG000|Overall Study|Death|264|||
155552548|NCT01996332|561448144|FG000|Overall Study|Protocol Violation|9|||
155552549|NCT01996332|561448144|FG000|Overall Study|Withdrawal by Subject|71|||
155552550|NCT01996332|561448144|FG000|Overall Study|Other|20|||
155552551|NCT01996332|561448144|FG000|Overall Study|Clinical Deterioration|28|||
155552552|NCT01996332|561448144|FG000|Overall Study|Physician Decision|17|||
155552553|NCT01996332|561448144|FG000|Overall Study|Lost to Follow-up|34|||
155552554|NCT02113189|561448145|FG000|Overall Study|Lost to follow up|2|||
155552555|NCT02113189|561448146|FG001|Overall Study|Lost to follow up|1|||
155552556|NCT02113189|561448147|FG002|Overall Study|Lost to follow up|3|||
155552557|NCT02954159|561448148|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
155552558|NCT02954159|561448149|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
155552559|NCT02954159|561448148|FG000|Overall Study|Withdrawal by Subject|0|||
155552560|NCT02954159|561448149|FG001|Overall Study|Withdrawal by Subject|1|||
155552561|NCT01744093|561448150|FG000|Overall Study|Withdrawal by Subject|6|||
155552562|NCT01744093|561448151|FG001|Overall Study|Withdrawal by Subject|1|||
155552563|NCT02006628|561448152|FG000|Overall Study|Adverse Event|1|||
155552564|NCT02006628|561448153|FG001|Overall Study|Adverse Event|1|||
155552565|NCT02006628|561448152|FG000|Overall Study|Withdrawal by Subject|2|||
155552566|NCT02006628|561448153|FG001|Overall Study|Withdrawal by Subject|1|||
155552567|NCT01642914|561448154|FG000|Overall Study|Adverse Event|11|||
155552568|NCT01642914|561448155|FG001|Overall Study|Adverse Event|7|||
155552569|NCT01642914|561448156|FG002|Overall Study|Adverse Event|15|||
155552570|NCT01642914|561448154|FG000|Overall Study|Lack of Efficacy|9|||
155552571|NCT01642914|561448155|FG001|Overall Study|Lack of Efficacy|4|||
155552572|NCT01642914|561448156|FG002|Overall Study|Lack of Efficacy|2|||
155552573|NCT01642914|561448154|FG000|Overall Study|Protocol Violation|15|||
155552574|NCT01642914|561448155|FG001|Overall Study|Protocol Violation|13|||
155552575|NCT01642914|561448156|FG002|Overall Study|Protocol Violation|6|||
155657376|NCT01362790|561838958|FG002|Pilot Phase & Phase 2|Death on study|0|||
155552576|NCT01642914|561448154|FG000|Overall Study|Withdrawal by Subject|5|||
155552577|NCT01642914|561448155|FG001|Overall Study|Withdrawal by Subject|5|||
155552578|NCT01642914|561448156|FG002|Overall Study|Withdrawal by Subject|10|||
155552579|NCT01642914|561448154|FG000|Overall Study|Lost to Follow-up|5|||
155552580|NCT01642914|561448155|FG001|Overall Study|Lost to Follow-up|3|||
155552581|NCT01642914|561448156|FG002|Overall Study|Lost to Follow-up|7|||
155552582|NCT01642914|561448154|FG000|Overall Study|Other Reason|1|||
155552583|NCT01642914|561448155|FG001|Overall Study|Other Reason|0|||
155552584|NCT01642914|561448156|FG002|Overall Study|Other Reason|0|||
155552585|NCT03028740|561448157|FG000|Overall Study|Did not Receive Study Drug|4|||
155552586|NCT03028740|561448158|FG001|Overall Study|Did not Receive Study Drug|5|||
155552587|NCT03028740|561448157|FG000|Overall Study|Adverse Event|8|||
155552588|NCT03028740|561448158|FG001|Overall Study|Adverse Event|26|||
155552589|NCT03028740|561448157|FG000|Overall Study|Lack of Efficacy|0|||
155552590|NCT03028740|561448158|FG001|Overall Study|Lack of Efficacy|1|||
155552591|NCT03028740|561448157|FG000|Overall Study|Withdrawal by Subject|48|||
155552592|NCT03028740|561448158|FG001|Overall Study|Withdrawal by Subject|101|||
155552593|NCT03028740|561448157|FG000|Overall Study|Lost to Follow-up|30|||
155552594|NCT03028740|561448158|FG001|Overall Study|Lost to Follow-up|54|||
155552595|NCT03028740|561448157|FG000|Overall Study|Physician Decision|4|||
155552596|NCT03028740|561448158|FG001|Overall Study|Physician Decision|11|||
155552597|NCT03028740|561448157|FG000|Overall Study|Protocol Violation|4|||
155552598|NCT03028740|561448158|FG001|Overall Study|Protocol Violation|8|||
155552599|NCT03028740|561448157|FG000|Overall Study|Non-compliance with Study Drug|0|||
155552600|NCT03028740|561448158|FG001|Overall Study|Non-compliance with Study Drug|2|||
155552601|NCT03028740|561448157|FG000|Overall Study|Study Terminated by Sponsor|467|||
155552602|NCT03028740|561448158|FG001|Overall Study|Study Terminated by Sponsor|917|||
155552603|NCT03028740|561448157|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
155552604|NCT03028740|561448158|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
155552605|NCT03028740|561448157|FG000|Overall Study|Reason not Specified|1|||
155552606|NCT03028740|561448158|FG001|Overall Study|Reason not Specified|5|||
155552607|NCT01231373|561448159|FG000|Overall Study|Withdrew consent prior to randomization|2|||
155552608|NCT01231373|561448160|FG001|Overall Study|Withdrew consent prior to randomization|1|||
155552609|NCT01231373|561448161|FG002|Overall Study|Withdrew consent prior to randomization|0|||
155552610|NCT01231373|561448162|FG003|Overall Study|Withdrew consent prior to randomization|0|||
155552611|NCT01231373|561448159|FG000|Overall Study|Lost to Follow-up|0|||
155552612|NCT01231373|561448160|FG001|Overall Study|Lost to Follow-up|0|||
155552613|NCT01231373|561448161|FG002|Overall Study|Lost to Follow-up|0|||
155552614|NCT01231373|561448162|FG003|Overall Study|Lost to Follow-up|1|||
155552615|NCT01231373|561448159|FG000|Overall Study|Withdrew Consent|1|||
155552616|NCT01231373|561448160|FG001|Overall Study|Withdrew Consent|0|||
155552617|NCT01231373|561448161|FG002|Overall Study|Withdrew Consent|0|||
155657377|NCT01362790|561838959|FG003|Pilot Phase & Phase 2|Death on study|1|||
155657378|NCT01362790|561838960|FG004|Pilot Phase & Phase 2|Death on study|0|||
155552618|NCT01231373|561448162|FG003|Overall Study|Withdrew Consent|0|||
155552619|NCT01790113|561448163|FG000|Overall Study|Adverse Event|2|||
155552620|NCT01790113|561448164|FG001|Overall Study|Adverse Event|7|||
155552621|NCT01790113|561448163|FG000|Overall Study|Study ended due to FDA clearance|1|||
155552622|NCT01790113|561448164|FG001|Overall Study|Study ended due to FDA clearance|68|||
155552623|NCT00775606|561448165|FG000|Overall Study|Study sponsor terminated funding|3|||
155657379|NCT01362790|561838961|FG005|Pilot Phase & Phase 2|Death on study|0|||
155552624|NCT00775606|561448166|FG001|Overall Study|Study sponsor terminated funding|0|||
155552625|NCT01144403|561448168|FG000|Overall Study|Lost to Follow-up|3|||
155552626|NCT01144403|561448168|FG000|Overall Study|Death|1|||
155552627|NCT01144403|561448168|FG000|Overall Study|Adverse Event|1|||
155552628|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
155552629|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
155552630|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
155552631|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
155552632|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
155552633|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
155552634|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
155552635|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
155552636|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
155552637|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
155552638|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
155552639|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
155552640|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
155552641|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
155552642|NCT04740931|561448170|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
155552643|NCT04740931|561448171|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
155552644|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
155552645|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
155552646|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
155552647|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
155552648|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
155552649|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
155552650|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
155552651|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
155552652|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
155552653|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
155552654|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
155552655|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
155552656|NCT04740931|561448170|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
155552657|NCT04740931|561448171|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
155552658|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
155552659|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
155552660|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
155552661|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
155552662|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
155552663|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
155552664|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
155552665|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
155552666|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
155552667|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
155552668|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
155552669|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
155552670|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
155552671|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
155552672|NCT02510014|561448175|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
155552673|NCT02510014|561448176|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
155552674|NCT02510014|561448175|FG000|Treatment Period|Adverse Event|11|||
155552675|NCT02510014|561448176|FG001|Treatment Period|Adverse Event|4|||
155552676|NCT02510014|561448175|FG000|Treatment Period|Withdrawal symptoms|3|||
155552677|NCT02510014|561448176|FG001|Treatment Period|Withdrawal symptoms|0|||
155552678|NCT02510014|561448175|FG000|Treatment Period|Lost to Follow-up|80|||
155552679|NCT02510014|561448176|FG001|Treatment Period|Lost to Follow-up|19|||
155552680|NCT02510014|561448175|FG000|Treatment Period|Physician Decision|5|||
155552681|NCT02510014|561448176|FG001|Treatment Period|Physician Decision|0|||
155552682|NCT02510014|561448175|FG000|Treatment Period|Withdrawal by Subject|67|||
155552683|NCT02510014|561448176|FG001|Treatment Period|Withdrawal by Subject|24|||
155552684|NCT02510014|561448175|FG000|Treatment Period|Withdrawn by the investigator|7|||
155552685|NCT02510014|561448176|FG001|Treatment Period|Withdrawn by the investigator|1|||
155552686|NCT02510014|561448175|FG000|Treatment Period|Protocol Violation|4|||
155552687|NCT02510014|561448176|FG001|Treatment Period|Protocol Violation|4|||
155552688|NCT02510014|561448175|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
155552689|NCT02510014|561448176|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
155552690|NCT01020799|561448180|FG000|Overall Study|Adverse Event|4|||
155552691|NCT01020799|561448181|FG001|Overall Study|Adverse Event|3|||
155552692|NCT01020799|561448182|FG002|Overall Study|Adverse Event|2|||
155552693|NCT01020799|561448180|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
155552694|NCT01020799|561448181|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
155552695|NCT01020799|561448182|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
155552696|NCT01020799|561448180|FG000|Overall Study|Protocol Violation|3|||
155552697|NCT01020799|561448181|FG001|Overall Study|Protocol Violation|2|||
155552698|NCT01020799|561448182|FG002|Overall Study|Protocol Violation|0|||
155552699|NCT01020799|561448180|FG000|Overall Study|Withdrawal by Subject|2|||
155552700|NCT01020799|561448181|FG001|Overall Study|Withdrawal by Subject|2|||
155552701|NCT01020799|561448182|FG002|Overall Study|Withdrawal by Subject|3|||
155552702|NCT01020799|561448180|FG000|Overall Study|Lost to Follow-up|6|||
155552703|NCT01020799|561448181|FG001|Overall Study|Lost to Follow-up|4|||
155552704|NCT01020799|561448182|FG002|Overall Study|Lost to Follow-up|2|||
155552705|NCT01949116|561448184|FG000|Overall Study|Death|2|||
155552706|NCT01949116|561448185|FG001|Overall Study|Death|0|||
155552707|NCT01949116|561448184|FG000|Overall Study|Lost to Follow-up|1|||
155552708|NCT01949116|561448185|FG001|Overall Study|Lost to Follow-up|3|||
155552709|NCT01949116|561448184|FG000|Overall Study|Withdrawal by Subject|5|||
155552710|NCT01949116|561448185|FG001|Overall Study|Withdrawal by Subject|3|||
155552711|NCT02972502|561448186|FG000|Overall Study|Lost to Follow-up|3|||
155552712|NCT02972502|561448187|FG001|Overall Study|Lost to Follow-up|1|||
155552713|NCT02972502|561448186|FG000|Overall Study|Withdrawal by Subject|1|||
155552714|NCT02972502|561448187|FG001|Overall Study|Withdrawal by Subject|1|||
155552715|NCT03832738|561448188|FG000|Overall Study|Withdrawal by Subject|6|||
155552716|NCT03832738|561448189|FG001|Overall Study|Withdrawal by Subject|7|||
155552717|NCT03832738|561448190|FG002|Overall Study|Withdrawal by Subject|16|||
155552718|NCT03832738|561448188|FG000|Overall Study|Physician Decision|0|||
155552719|NCT03832738|561448189|FG001|Overall Study|Physician Decision|1|||
155552720|NCT03832738|561448190|FG002|Overall Study|Physician Decision|2|||
155552721|NCT03832738|561448188|FG000|Overall Study|Adverse Event|2|||
155552722|NCT03832738|561448189|FG001|Overall Study|Adverse Event|3|||
155552723|NCT03832738|561448190|FG002|Overall Study|Adverse Event|1|||
155552724|NCT03832738|561448188|FG000|Overall Study|Pregnancy|0|||
155552725|NCT03832738|561448189|FG001|Overall Study|Pregnancy|1|||
155552726|NCT03832738|561448190|FG002|Overall Study|Pregnancy|0|||
155552727|NCT03852459|561448191|FG000|Overall Study|Adverse Event|2|||
155552728|NCT03852459|561448192|FG001|Overall Study|Adverse Event|2|||
155552729|NCT03852459|561448191|FG000|Overall Study|Withdrawal by Subject|1|||
155552730|NCT03852459|561448192|FG001|Overall Study|Withdrawal by Subject|1|||
155552731|NCT00049842|561448193|FG000|Treatment Phase|Adverse Event|47|||
155552732|NCT00049842|561448194|FG001|Treatment Phase|Adverse Event|12|||
155552733|NCT00049842|561448193|FG000|Treatment Phase|Withdrawal by Subject|35|||
155552734|NCT00049842|561448194|FG001|Treatment Phase|Withdrawal by Subject|46|||
155552735|NCT00049842|561448193|FG000|Treatment Phase|Non-compliance with protocol|7|||
155552736|NCT00049842|561448194|FG001|Treatment Phase|Non-compliance with protocol|8|||
155552737|NCT00049842|561448193|FG000|Treatment Phase|Lost to Follow-up|4|||
155552738|NCT00049842|561448194|FG001|Treatment Phase|Lost to Follow-up|8|||
155552739|NCT00049842|561448193|FG000|Treatment Phase|Administrative|0|||
155552740|NCT00049842|561448194|FG001|Treatment Phase|Administrative|3|||
155552741|NCT00049842|561448193|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
155552742|NCT00049842|561448194|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
155552743|NCT00049842|561448193|FG000|Follow-up Phase|Adverse Event|6|||
155552744|NCT00049842|561448194|FG001|Follow-up Phase|Adverse Event|1|||
155552745|NCT00049842|561448193|FG000|Follow-up Phase|Other|1|||
155552746|NCT00049842|561448194|FG001|Follow-up Phase|Other|4|||
155552747|NCT00831623|561448195|FG000|Overall Study|Withdrawal by Subject|9|||
155552748|NCT00831623|561448195|FG000|Overall Study|Lost to Follow-up|1|||
155552749|NCT00831623|561448195|FG000|Overall Study|Not 2 years post-treatment|12|||
155552750|NCT02080832|561448201|FG000|Overall Study|Excluded from analysis by MRI|9|||
155552751|NCT02080832|561448202|FG001|Overall Study|Excluded from analysis by MRI|10|||
155552752|NCT02080832|561448203|FG002|Overall Study|Excluded from analysis by MRI|14|||
155552753|NCT02080832|561448201|FG000|Overall Study|Lost to Follow-up|0|||
155552754|NCT02080832|561448202|FG001|Overall Study|Lost to Follow-up|2|||
155552755|NCT02080832|561448203|FG002|Overall Study|Lost to Follow-up|2|||
155552756|NCT01138111|561448207|FG000|Overall Study|Withdrawal by Subject|5|||
155552757|NCT01138111|561448207|FG000|Overall Study|Adverse Event|1|||
155552758|NCT01138111|561448207|FG000|Overall Study|Death|1|||
155552759|NCT01138111|561448207|FG000|Overall Study|Lost to Follow-up|2|||
155552760|NCT01118117|561448208|FG000|Overall Study|Death|8|||
155552761|NCT01118117|561448209|FG001|Overall Study|Death|0|||
155552762|NCT01118117|561448208|FG000|Overall Study|Lost to Follow-up|6|||
155552763|NCT01118117|561448209|FG001|Overall Study|Lost to Follow-up|0|||
155552764|NCT01118117|561448208|FG000|Overall Study|Missed 12 Month Visit|7|||
155552765|NCT01118117|561448209|FG001|Overall Study|Missed 12 Month Visit|0|||
155552766|NCT01660022|561448210|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
155552767|NCT01660022|561448211|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
155552768|NCT01660022|561448212|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
155552769|NCT01660022|561448213|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
155552770|NCT01660022|561448214|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
155552771|NCT01660022|561448215|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
155552772|NCT01660022|561448210|FG000|First Sequence (7 Days)|Adverse Event|0|||
155552773|NCT01660022|561448211|FG001|First Sequence (7 Days)|Adverse Event|0|||
155552774|NCT01660022|561448212|FG002|First Sequence (7 Days)|Adverse Event|0|||
155552775|NCT01660022|561448213|FG003|First Sequence (7 Days)|Adverse Event|0|||
155552776|NCT01660022|561448214|FG004|First Sequence (7 Days)|Adverse Event|1|||
155552777|NCT01660022|561448215|FG005|First Sequence (7 Days)|Adverse Event|3|||
155552778|NCT01660022|561448210|FG000|First Sequence (7 Days)|Protocol Violation|0|||
155552779|NCT01660022|561448211|FG001|First Sequence (7 Days)|Protocol Violation|0|||
155552780|NCT01660022|561448212|FG002|First Sequence (7 Days)|Protocol Violation|0|||
155552781|NCT01660022|561448213|FG003|First Sequence (7 Days)|Protocol Violation|0|||
155552782|NCT01660022|561448214|FG004|First Sequence (7 Days)|Protocol Violation|0|||
155552783|NCT01660022|561448215|FG005|First Sequence (7 Days)|Protocol Violation|1|||
155552784|NCT01277718|561448219|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
155552785|NCT01277718|561448220|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
155552786|NCT01277718|561448219|FG000|Period 2 - Second Intervention|Physician Decision|0|||
155552787|NCT01277718|561448220|FG001|Period 2 - Second Intervention|Physician Decision|2|||
155552788|NCT00653991|561448221|FG000|3 Month Follow-up|Participant would not respond|150|||
155552789|NCT00653991|561448222|FG001|3 Month Follow-up|Participant would not respond|157|||
155552790|NCT00653991|561448221|FG000|6 Month Follow-up|Participant would not respond|133|||
155552791|NCT00653991|561448222|FG001|6 Month Follow-up|Participant would not respond|141|||
155552792|NCT02149121|561448223|FG000|Main Study Period|Lack of Efficacy|2|||
155552793|NCT02149121|561448224|FG001|Main Study Period|Lack of Efficacy|2|||
155552794|NCT02149121|561448225|FG002|Main Study Period|Lack of Efficacy|1|||
155552795|NCT02149121|561448226|FG003|Main Study Period|Lack of Efficacy|0|||
155552796|NCT02149121|561448227|FG004|Main Study Period|Lack of Efficacy|0|||
155552797|NCT02149121|561448228|FG005|Main Study Period|Lack of Efficacy|0|||
155552798|NCT02149121|561448229|FG006|Main Study Period|Lack of Efficacy|0|||
155552799|NCT02149121|561448223|FG000|Main Study Period|Withdrawal by Subject|9|||
155552800|NCT02149121|561448224|FG001|Main Study Period|Withdrawal by Subject|5|||
155552801|NCT02149121|561448225|FG002|Main Study Period|Withdrawal by Subject|1|||
155552802|NCT02149121|561448226|FG003|Main Study Period|Withdrawal by Subject|0|||
155552803|NCT02149121|561448227|FG004|Main Study Period|Withdrawal by Subject|0|||
155552804|NCT02149121|561448228|FG005|Main Study Period|Withdrawal by Subject|0|||
155552805|NCT02149121|561448229|FG006|Main Study Period|Withdrawal by Subject|0|||
155552806|NCT02149121|561448223|FG000|Main Study Period|Adverse Event|2|||
155552807|NCT02149121|561448224|FG001|Main Study Period|Adverse Event|5|||
155552808|NCT02149121|561448225|FG002|Main Study Period|Adverse Event|1|||
155552809|NCT02149121|561448226|FG003|Main Study Period|Adverse Event|0|||
155552810|NCT02149121|561448227|FG004|Main Study Period|Adverse Event|0|||
155552811|NCT02149121|561448228|FG005|Main Study Period|Adverse Event|0|||
155552812|NCT02149121|561448229|FG006|Main Study Period|Adverse Event|0|||
155552813|NCT02149121|561448223|FG000|Main Study Period|Protocol Violation|2|||
155552814|NCT02149121|561448224|FG001|Main Study Period|Protocol Violation|0|||
155552815|NCT02149121|561448225|FG002|Main Study Period|Protocol Violation|0|||
155552816|NCT02149121|561448226|FG003|Main Study Period|Protocol Violation|0|||
155552817|NCT02149121|561448227|FG004|Main Study Period|Protocol Violation|0|||
155552818|NCT02149121|561448228|FG005|Main Study Period|Protocol Violation|0|||
155552819|NCT02149121|561448229|FG006|Main Study Period|Protocol Violation|0|||
155552820|NCT02149121|561448223|FG000|Main Study Period|Lost to Follow-up|2|||
155552821|NCT02149121|561448224|FG001|Main Study Period|Lost to Follow-up|1|||
155552822|NCT02149121|561448225|FG002|Main Study Period|Lost to Follow-up|0|||
155552823|NCT02149121|561448226|FG003|Main Study Period|Lost to Follow-up|0|||
155552824|NCT02149121|561448227|FG004|Main Study Period|Lost to Follow-up|0|||
155552825|NCT02149121|561448228|FG005|Main Study Period|Lost to Follow-up|0|||
155552826|NCT02149121|561448229|FG006|Main Study Period|Lost to Follow-up|0|||
155552827|NCT02149121|561448223|FG000|Main Study Period|Death|1|||
155552828|NCT02149121|561448224|FG001|Main Study Period|Death|0|||
155552829|NCT02149121|561448225|FG002|Main Study Period|Death|0|||
155552830|NCT02149121|561448226|FG003|Main Study Period|Death|0|||
155552831|NCT02149121|561448227|FG004|Main Study Period|Death|0|||
155552832|NCT02149121|561448228|FG005|Main Study Period|Death|0|||
155552833|NCT02149121|561448229|FG006|Main Study Period|Death|0|||
155552834|NCT02149121|561448223|FG000|Main Study Period|Physician Decision|1|||
155552835|NCT02149121|561448224|FG001|Main Study Period|Physician Decision|0|||
155552836|NCT02149121|561448225|FG002|Main Study Period|Physician Decision|0|||
155552837|NCT02149121|561448226|FG003|Main Study Period|Physician Decision|0|||
155552838|NCT02149121|561448227|FG004|Main Study Period|Physician Decision|0|||
155552839|NCT02149121|561448228|FG005|Main Study Period|Physician Decision|0|||
155552840|NCT02149121|561448229|FG006|Main Study Period|Physician Decision|0|||
155552841|NCT02149121|561448223|FG000|Main Study Period|Developed any malignancy|0|||
155552842|NCT02149121|561448224|FG001|Main Study Period|Developed any malignancy|1|||
155552843|NCT02149121|561448225|FG002|Main Study Period|Developed any malignancy|1|||
155552844|NCT02149121|561448226|FG003|Main Study Period|Developed any malignancy|0|||
155552845|NCT02149121|561448227|FG004|Main Study Period|Developed any malignancy|0|||
155552846|NCT02149121|561448228|FG005|Main Study Period|Developed any malignancy|0|||
155552847|NCT02149121|561448229|FG006|Main Study Period|Developed any malignancy|0|||
155552848|NCT02149121|561448223|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
155552849|NCT02149121|561448224|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
155552850|NCT02149121|561448225|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
155552851|NCT02149121|561448226|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
155552852|NCT02149121|561448227|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
155552853|NCT02149121|561448228|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
155552854|NCT02149121|561448229|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
155552855|NCT02149121|561448223|FG000|Main Study Period|Disease progression|0|||
155552856|NCT02149121|561448224|FG001|Main Study Period|Disease progression|1|||
155552857|NCT02149121|561448225|FG002|Main Study Period|Disease progression|0|||
155552858|NCT02149121|561448226|FG003|Main Study Period|Disease progression|0|||
155552859|NCT02149121|561448227|FG004|Main Study Period|Disease progression|0|||
155552860|NCT02149121|561448228|FG005|Main Study Period|Disease progression|0|||
155552861|NCT02149121|561448229|FG006|Main Study Period|Disease progression|0|||
155552862|NCT02149121|561448223|FG000|Extension Study Period|Withdrawal by Subject|0|||
155552863|NCT02149121|561448224|FG001|Extension Study Period|Withdrawal by Subject|0|||
155552864|NCT02149121|561448225|FG002|Extension Study Period|Withdrawal by Subject|0|||
155552865|NCT02149121|561448226|FG003|Extension Study Period|Withdrawal by Subject|1|||
155552866|NCT02149121|561448227|FG004|Extension Study Period|Withdrawal by Subject|0|||
155552867|NCT02149121|561448228|FG005|Extension Study Period|Withdrawal by Subject|2|||
155552868|NCT02149121|561448229|FG006|Extension Study Period|Withdrawal by Subject|0|||
155552869|NCT00515034|561448230|FG000|Overall Study|Adverse Event|2|||
155552870|NCT00515034|561448231|FG001|Overall Study|Adverse Event|0|||
155552871|NCT00515034|561448232|FG002|Overall Study|Adverse Event|1|||
155552872|NCT00515034|561448233|FG003|Overall Study|Adverse Event|0|||
155552873|NCT00515034|561448230|FG000|Overall Study|Death|4|||
155552874|NCT00515034|561448231|FG001|Overall Study|Death|2|||
155552875|NCT00515034|561448232|FG002|Overall Study|Death|1|||
155552876|NCT00515034|561448233|FG003|Overall Study|Death|3|||
155552877|NCT00515034|561448230|FG000|Overall Study|Withdrawal by Subject|1|||
155552878|NCT00515034|561448231|FG001|Overall Study|Withdrawal by Subject|0|||
155552879|NCT00515034|561448232|FG002|Overall Study|Withdrawal by Subject|3|||
155552880|NCT00515034|561448233|FG003|Overall Study|Withdrawal by Subject|0|||
155552881|NCT00515034|561448230|FG000|Overall Study|Physician Decision|0|||
155552882|NCT00515034|561448231|FG001|Overall Study|Physician Decision|0|||
155552883|NCT00515034|561448232|FG002|Overall Study|Physician Decision|1|||
155552884|NCT00515034|561448233|FG003|Overall Study|Physician Decision|1|||
155552885|NCT00515034|561448230|FG000|Overall Study|Other|1|||
155552886|NCT00515034|561448231|FG001|Overall Study|Other|0|||
155552887|NCT00515034|561448232|FG002|Overall Study|Other|2|||
155552888|NCT00515034|561448233|FG003|Overall Study|Other|1|||
155552889|NCT02655016|561448234|FG000|Overall Study|Disease progression|6|||
155552890|NCT02655016|561448235|FG001|Overall Study|Disease progression|4|||
155552891|NCT02655016|561448234|FG000|Overall Study|Site closed|0|||
155552892|NCT02655016|561448235|FG001|Overall Study|Site closed|1|||
155552893|NCT02655016|561448234|FG000|Overall Study|Death|30|||
155552894|NCT02655016|561448235|FG001|Overall Study|Death|48|||
155552895|NCT02655016|561448234|FG000|Overall Study|Lost to Follow-up|1|||
155552896|NCT02655016|561448235|FG001|Overall Study|Lost to Follow-up|1|||
155552897|NCT02655016|561448234|FG000|Overall Study|Withdrawal by Subject|18|||
155552898|NCT02655016|561448235|FG001|Overall Study|Withdrawal by Subject|36|||
155552899|NCT06029959|561449906|FG000|Overall Study|Physician Decision|6|||
155552900|NCT04495283|561449907|FG000|Overall Study|Physician Decision|0|||
155552901|NCT04495283|561449908|FG001|Overall Study|Physician Decision|0|||
155552902|NCT04495283|561449909|FG002|Overall Study|Physician Decision|1|||
155552903|NCT04495283|561449907|FG000|Overall Study|Withdrawal by Subject|0|||
155552904|NCT04495283|561449908|FG001|Overall Study|Withdrawal by Subject|1|||
155552905|NCT04495283|561449909|FG002|Overall Study|Withdrawal by Subject|1|||
155552906|NCT04495283|561449907|FG000|Overall Study|Other|1|||
155552907|NCT04495283|561449908|FG001|Overall Study|Other|0|||
155552908|NCT04495283|561449909|FG002|Overall Study|Other|1|||
155552909|NCT04718194|561449914|FG000|Overall Study|Withdrawal by Subject|3|||
155552910|NCT04718194|561449915|FG001|Overall Study|Withdrawal by Subject|0|||
155552911|NCT04718194|561449914|FG000|Overall Study|Lost to Follow-up|3|||
155552912|NCT04718194|561449915|FG001|Overall Study|Lost to Follow-up|0|||
155552913|NCT01215513|561449916|FG000|Overall Study|Not completed CS42|9|||
155552914|NCT01215513|561449916|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
155552915|NCT01215513|561449916|FG000|Overall Study|Adverse event (CS42A)|2|||
155552916|NCT01215513|561449916|FG000|Overall Study|Physician decision (CS42A)|6|||
155552917|NCT01215513|561449916|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
155552918|NCT01215513|561449916|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
155552919|NCT01304693|561449922|FG000|Overall Study|Adverse Event|0|||
155552920|NCT01304693|561449923|FG001|Overall Study|Adverse Event|0|||
155552921|NCT01304693|561449924|FG002|Overall Study|Adverse Event|0|||
155552922|NCT01304693|561449925|FG003|Overall Study|Adverse Event|0|||
155552923|NCT01304693|561449926|FG004|Overall Study|Adverse Event|1|||
155552924|NCT01304693|561449922|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
155552925|NCT01304693|561449923|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
155552926|NCT01304693|561449924|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
155552927|NCT01304693|561449925|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
155552928|NCT01304693|561449926|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
155552929|NCT02581163|561449928|FG000|Overall Study|Failure to return|15|||
155552930|NCT02581163|561449928|FG000|Overall Study|Insufficient virological response|3|||
155552931|NCT02581163|561449928|FG000|Overall Study|Withdrew consent|1|||
155552932|NCT02581163|561449928|FG000|Overall Study|Death|1|||
155552933|NCT02581163|561449928|FG000|Overall Study|Other, not specified|9|||
155552934|NCT00158756|561449934|FG000|Overall Study|Withdrawal by Subject|5|||
155552935|NCT00158756|561449935|FG001|Overall Study|Withdrawal by Subject|0|||
155552936|NCT00158756|561449936|FG002|Overall Study|Withdrawal by Subject|6|||
155552937|NCT00158756|561449937|FG003|Overall Study|Withdrawal by Subject|1|||
155552938|NCT00158756|561449938|FG004|Overall Study|Withdrawal by Subject|3|||
155552939|NCT00158756|561449934|FG000|Overall Study|Adverse Event|0|||
155552940|NCT00158756|561449935|FG001|Overall Study|Adverse Event|0|||
155552941|NCT00158756|561449936|FG002|Overall Study|Adverse Event|1|||
155552942|NCT00158756|561449937|FG003|Overall Study|Adverse Event|0|||
155552943|NCT00158756|561449938|FG004|Overall Study|Adverse Event|0|||
155552944|NCT00158756|561449934|FG000|Overall Study|Serious adverse event|0|||
155552945|NCT00158756|561449935|FG001|Overall Study|Serious adverse event|0|||
155552946|NCT00158756|561449936|FG002|Overall Study|Serious adverse event|1|||
155552947|NCT00158756|561449937|FG003|Overall Study|Serious adverse event|0|||
155552948|NCT00158756|561449938|FG004|Overall Study|Serious adverse event|0|||
155552949|NCT01206816|561449939|FG000|Overall Study|Protocol Violation|0|||
155552950|NCT01206816|561449940|FG001|Overall Study|Protocol Violation|0|||
155552951|NCT01206816|561449941|FG002|Overall Study|Protocol Violation|1|||
155552952|NCT01206816|561449942|FG003|Overall Study|Protocol Violation|0|||
155552953|NCT01206816|561449943|FG004|Overall Study|Protocol Violation|0|||
155552954|NCT01206816|561449944|FG005|Overall Study|Protocol Violation|0|||
155552955|NCT01206816|561449945|FG006|Overall Study|Protocol Violation|0|||
155552956|NCT01206816|561449939|FG000|Overall Study|Withdrawal by Subject|0|||
155552957|NCT01206816|561449940|FG001|Overall Study|Withdrawal by Subject|0|||
155552958|NCT01206816|561449941|FG002|Overall Study|Withdrawal by Subject|1|||
155552959|NCT01206816|561449942|FG003|Overall Study|Withdrawal by Subject|0|||
155552960|NCT01206816|561449943|FG004|Overall Study|Withdrawal by Subject|0|||
155552961|NCT01206816|561449944|FG005|Overall Study|Withdrawal by Subject|0|||
155552962|NCT01206816|561449945|FG006|Overall Study|Withdrawal by Subject|0|||
155657380|NCT01362790|561838962|FG006|Pilot Phase & Phase 2|Death on study|0|||
155657381|NCT01362790|561838956|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
155657382|NCT01362790|561838957|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
155657383|NCT01362790|561838958|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
155657384|NCT01362790|561838959|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
155657385|NCT01362790|561838960|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
155657386|NCT01362790|561838961|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
155552963|NCT01206816|561449939|FG000|Overall Study|Progressive disease|3|||
155552964|NCT01206816|561449940|FG001|Overall Study|Progressive disease|3|||
155552965|NCT01206816|561449941|FG002|Overall Study|Progressive disease|13|||
155552966|NCT01206816|561449942|FG003|Overall Study|Progressive disease|3|||
155552967|NCT01206816|561449943|FG004|Overall Study|Progressive disease|3|||
155552968|NCT01206816|561449944|FG005|Overall Study|Progressive disease|16|||
155552969|NCT01206816|561449945|FG006|Overall Study|Progressive disease|3|||
155552970|NCT01206816|561449939|FG000|Overall Study|Other AE|0|||
155552971|NCT01206816|561449940|FG001|Overall Study|Other AE|0|||
155552972|NCT01206816|561449941|FG002|Overall Study|Other AE|4|||
155552973|NCT01206816|561449942|FG003|Overall Study|Other AE|0|||
155552974|NCT01206816|561449943|FG004|Overall Study|Other AE|0|||
155552975|NCT01206816|561449944|FG005|Overall Study|Other AE|3|||
155552976|NCT01206816|561449945|FG006|Overall Study|Other AE|2|||
155552977|NCT01206816|561449939|FG000|Overall Study|other than stated above|0|||
155552978|NCT01206816|561449940|FG001|Overall Study|other than stated above|0|||
155552979|NCT01206816|561449941|FG002|Overall Study|other than stated above|1|||
155552980|NCT01206816|561449942|FG003|Overall Study|other than stated above|0|||
155552981|NCT01206816|561449943|FG004|Overall Study|other than stated above|0|||
155552982|NCT01206816|561449944|FG005|Overall Study|other than stated above|0|||
155552983|NCT01206816|561449945|FG006|Overall Study|other than stated above|1|||
155552984|NCT01939496|561449946|FG000|Overall Study|Adverse Event|2|||
155552985|NCT01939496|561449947|FG001|Overall Study|Adverse Event|0|||
155552986|NCT01939496|561449948|FG002|Overall Study|Adverse Event|0|||
155552987|NCT01939496|561449946|FG000|Overall Study|Lost to Follow-up|1|||
155552988|NCT01939496|561449947|FG001|Overall Study|Lost to Follow-up|1|||
155552989|NCT01939496|561449948|FG002|Overall Study|Lost to Follow-up|0|||
155552990|NCT01939496|561449946|FG000|Overall Study|Physician Decision|1|||
155552991|NCT01939496|561449947|FG001|Overall Study|Physician Decision|0|||
155552992|NCT01939496|561449948|FG002|Overall Study|Physician Decision|0|||
155552993|NCT01939496|561449946|FG000|Overall Study|Protocol Violation|3|||
155552994|NCT01939496|561449947|FG001|Overall Study|Protocol Violation|0|||
155552995|NCT01939496|561449948|FG002|Overall Study|Protocol Violation|0|||
155552996|NCT01939496|561449946|FG000|Overall Study|Withdrawal by Subject|0|||
155552997|NCT01939496|561449947|FG001|Overall Study|Withdrawal by Subject|1|||
155552998|NCT01939496|561449948|FG002|Overall Study|Withdrawal by Subject|1|||
155552999|NCT01939496|561449946|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
155553000|NCT01939496|561449947|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
155553001|NCT01939496|561449948|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
155553002|NCT01939496|561449946|FG000|Overall Study|Other|2|||
155553003|NCT01939496|561449947|FG001|Overall Study|Other|0|||
155553004|NCT01939496|561449948|FG002|Overall Study|Other|1|||
155553005|NCT01300052|561449950|FG000|Overall Study|Adverse Event|3|||
155553006|NCT01300052|561449951|FG001|Overall Study|Adverse Event|0|||
155553007|NCT01300052|561449950|FG000|Overall Study|Withdrawal by Subject|2|||
155553008|NCT01300052|561449951|FG001|Overall Study|Withdrawal by Subject|2|||
155553009|NCT01300052|561449950|FG000|Overall Study|Protocol Violation|1|||
155553010|NCT01300052|561449951|FG001|Overall Study|Protocol Violation|1|||
155606851|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
155606852|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155606853|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155606854|NCT01179737|561649576|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
155606855|NCT01179737|561649577|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
155606856|NCT01179737|561649578|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
155606857|NCT01179737|561649579|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
155606858|NCT01179737|561649576|FG000|Extension|The study was terminated|3|||
155606859|NCT01179737|561649577|FG001|Extension|The study was terminated|0|||
155606860|NCT01179737|561649578|FG002|Extension|The study was terminated|0|||
155606861|NCT01179737|561649579|FG003|Extension|The study was terminated|0|||
155606862|NCT03597022|561649581|FG000|Overall Study|Premature termination of the study|7|||
155606863|NCT03597022|561649582|FG001|Overall Study|Premature termination of the study|7|||
155606864|NCT03597022|561649583|FG002|Overall Study|Premature termination of the study|8|||
155606865|NCT03597022|561649581|FG000|Overall Study|Serious adverse event|1|||
155606866|NCT03597022|561649582|FG001|Overall Study|Serious adverse event|1|||
155606867|NCT03597022|561649583|FG002|Overall Study|Serious adverse event|0|||
155606868|NCT00312572|561649584|FG000|Overall Study|Adverse Event|10|||
155606869|NCT00312572|561649585|FG001|Overall Study|Adverse Event|16|||
155657387|NCT01362790|561838962|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
155657388|NCT01362790|561838956|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657389|NCT01362790|561838957|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657390|NCT01362790|561838958|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657391|NCT01362790|561838959|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657392|NCT01362790|561838960|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
155657393|NCT01362790|561838961|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657394|NCT01362790|561838962|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155657395|NCT01362790|561838956|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
155657396|NCT01362790|561838957|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
155657397|NCT01362790|561838958|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
155657398|NCT01362790|561838959|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
155657399|NCT01362790|561838960|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
155657400|NCT01362790|561838961|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
155657401|NCT01362790|561838962|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
155657402|NCT02457065|561838963|FG000|Overall Study|Lost to Follow-up|9|||
155657403|NCT02457065|561838964|FG001|Overall Study|Lost to Follow-up|11|||
155657404|NCT03038087|561838965|FG000|Overall Study|lost data|1|||
155657405|NCT00654355|561838966|FG000|Overall Study|Lost to Follow-up|2|||
155657406|NCT00654355|561838967|FG001|Overall Study|Lost to Follow-up|2|||
155657407|NCT00635050|561838968|FG000|Overall Study|Withdrawal by Subject|1|||
155657408|NCT02011542|561838970|FG000|Overall Study|Physician Decision|1|||
155657409|NCT00663260|561838971|FG000|Overall Study|Lack of Efficacy|2|||
155657410|NCT00663260|561838972|FG001|Overall Study|Lack of Efficacy|0|||
155657411|NCT00663260|561838973|FG002|Overall Study|Lack of Efficacy|0|||
155657412|NCT00663260|561838971|FG000|Overall Study|Adverse Event|12|||
155657413|NCT00663260|561838972|FG001|Overall Study|Adverse Event|7|||
155657414|NCT00663260|561838973|FG002|Overall Study|Adverse Event|6|||
155657415|NCT00663260|561838971|FG000|Overall Study|Withdrawal by Subject|3|||
155657416|NCT00663260|561838972|FG001|Overall Study|Withdrawal by Subject|1|||
155657417|NCT00663260|561838973|FG002|Overall Study|Withdrawal by Subject|6|||
155657418|NCT00663260|561838971|FG000|Overall Study|Death|1|||
155657419|NCT00663260|561838972|FG001|Overall Study|Death|0|||
155657420|NCT00663260|561838973|FG002|Overall Study|Death|1|||
155657421|NCT00663260|561838971|FG000|Overall Study|Lost to Follow-up|0|||
155657422|NCT00663260|561838972|FG001|Overall Study|Lost to Follow-up|1|||
155657423|NCT00663260|561838973|FG002|Overall Study|Lost to Follow-up|0|||
155657424|NCT00663260|561838971|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
155553011|NCT03212794|561449952|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
155553012|NCT03212794|561449953|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
155553013|NCT03212794|561449952|FG000|Overall Study|Lost to Follow-up|5|||
155553014|NCT03212794|561449953|FG001|Overall Study|Lost to Follow-up|6|||
155553015|NCT03212794|561449952|FG000|Overall Study|Incarcerated; unable to participate|2|||
155553016|NCT03212794|561449953|FG001|Overall Study|Incarcerated; unable to participate|0|||
155553017|NCT03212794|561449952|FG000|Overall Study|Withdrawal by Subject|1|||
155553018|NCT03212794|561449953|FG001|Overall Study|Withdrawal by Subject|0|||
155553019|NCT03212794|561449952|FG000|Overall Study|Death|0|||
155553020|NCT03212794|561449953|FG001|Overall Study|Death|1|||
155553021|NCT03212794|561449952|FG000|Overall Study|Found to be ineligible after allocation|0|||
155553022|NCT03212794|561449953|FG001|Overall Study|Found to be ineligible after allocation|1|||
155553023|NCT03212794|561449952|FG000|Overall Study|Relocated out of area|2|||
155553024|NCT03212794|561449953|FG001|Overall Study|Relocated out of area|0|||
155553025|NCT00897949|561449957|FG000|Overall Study|Adverse Event|1|||
155553026|NCT00897949|561449958|FG001|Overall Study|Adverse Event|1|||
155553027|NCT00897949|561449959|FG002|Overall Study|Adverse Event|0|||
155553028|NCT00897949|561449957|FG000|Overall Study|Lost to Follow-up|0|||
155553029|NCT00897949|561449958|FG001|Overall Study|Lost to Follow-up|2|||
155553030|NCT00897949|561449959|FG002|Overall Study|Lost to Follow-up|1|||
155553031|NCT00897949|561449957|FG000|Overall Study|Protocol Violation|6|||
155553032|NCT00897949|561449958|FG001|Overall Study|Protocol Violation|3|||
155553033|NCT00897949|561449959|FG002|Overall Study|Protocol Violation|1|||
155553034|NCT00897949|561449957|FG000|Overall Study|Withdrawal by Subject|1|||
155553035|NCT00897949|561449958|FG001|Overall Study|Withdrawal by Subject|2|||
155657425|NCT00663260|561838972|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
155657426|NCT00663260|561838973|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
155657427|NCT01813357|561838974|FG000|Overall Study|Lost to Follow-up|5|||
155657428|NCT01813357|561838975|FG001|Overall Study|Lost to Follow-up|6|||
155657429|NCT01979185|561838979|FG000|Period 2|Other|0|||
155553036|NCT00897949|561449959|FG002|Overall Study|Withdrawal by Subject|0|||
155553037|NCT00897949|561449957|FG000|Overall Study|Patient Uncoorperative|0|||
155657430|NCT01979185|561838980|FG001|Period 2|Other|1|||
155657431|NCT00980798|561838981|FG000|Overall Study|Adverse Event|7|||
155657432|NCT00980798|561838982|FG001|Overall Study|Adverse Event|36|||
155657433|NCT00980798|561838981|FG000|Overall Study|Lack of Efficacy|16|||
155553038|NCT00897949|561449958|FG001|Overall Study|Patient Uncoorperative|2|||
155553039|NCT00897949|561449959|FG002|Overall Study|Patient Uncoorperative|1|||
155553040|NCT00897949|561449957|FG000|Overall Study|Lost to Follow-up|30|||
155553041|NCT00897949|561449958|FG001|Overall Study|Lost to Follow-up|23|||
155553042|NCT00897949|561449959|FG002|Overall Study|Lost to Follow-up|17|||
155553043|NCT00897949|561449957|FG000|Overall Study|Withdrawal by Subject|24|||
155553044|NCT00897949|561449958|FG001|Overall Study|Withdrawal by Subject|31|||
155553045|NCT00897949|561449959|FG002|Overall Study|Withdrawal by Subject|17|||
155553046|NCT00897949|561449957|FG000|Overall Study|Abnormal Prestudy Labs|2|||
155553047|NCT00897949|561449958|FG001|Overall Study|Abnormal Prestudy Labs|3|||
155553048|NCT00897949|561449959|FG002|Overall Study|Abnormal Prestudy Labs|4|||
155553049|NCT00897949|561449957|FG000|Overall Study|Abnormal Baseline ECG|2|||
155553050|NCT00897949|561449958|FG001|Overall Study|Abnormal Baseline ECG|2|||
155553051|NCT00897949|561449959|FG002|Overall Study|Abnormal Baseline ECG|4|||
155553052|NCT00897949|561449957|FG000|Overall Study|Need for Concom. Med.|0|||
155553053|NCT00897949|561449958|FG001|Overall Study|Need for Concom. Med.|1|||
155553054|NCT00897949|561449959|FG002|Overall Study|Need for Concom. Med.|1|||
155553055|NCT00897949|561449957|FG000|Overall Study|Lack of Migraine Attack|29|||
155553056|NCT00897949|561449958|FG001|Overall Study|Lack of Migraine Attack|30|||
155553057|NCT00897949|561449959|FG002|Overall Study|Lack of Migraine Attack|19|||
155553058|NCT00897949|561449957|FG000|Overall Study|Did not take study drug|9|||
155553059|NCT00897949|561449958|FG001|Overall Study|Did not take study drug|3|||
155553060|NCT00897949|561449959|FG002|Overall Study|Did not take study drug|4|||
155553061|NCT01763918|561449960|FG000|Overall Study|Withdrawal by Subject|2|||
155553062|NCT01763918|561449961|FG001|Overall Study|Withdrawal by Subject|1|||
155553063|NCT01763918|561449962|FG002|Overall Study|Withdrawal by Subject|1|||
155553064|NCT01763918|561449963|FG003|Overall Study|Withdrawal by Subject|2|||
155553065|NCT01763918|561449960|FG000|Overall Study|Sponsor Decision|4|||
155553066|NCT01763918|561449961|FG001|Overall Study|Sponsor Decision|0|||
155553067|NCT01763918|561449962|FG002|Overall Study|Sponsor Decision|9|||
155553068|NCT01763918|561449963|FG003|Overall Study|Sponsor Decision|0|||
155553069|NCT01553747|561449964|FG000|Overall Study|Protocol Violation|0|||
155553070|NCT01553747|561449965|FG001|Overall Study|Protocol Violation|2|||
155553071|NCT01553747|561449966|FG002|Overall Study|Protocol Violation|0|||
155553072|NCT01553747|561449964|FG000|Overall Study|Voluntarily withdrew|70|||
155553073|NCT01553747|561449965|FG001|Overall Study|Voluntarily withdrew|66|||
155553074|NCT01553747|561449966|FG002|Overall Study|Voluntarily withdrew|74|||
155553075|NCT01553747|561449964|FG000|Overall Study|Adverse event or SAE|32|||
155553076|NCT01553747|561449965|FG001|Overall Study|Adverse event or SAE|28|||
155553077|NCT01553747|561449966|FG002|Overall Study|Adverse event or SAE|19|||
155553078|NCT01553747|561449964|FG000|Overall Study|Physician decision: other|10|||
155553079|NCT01553747|561449965|FG001|Overall Study|Physician decision: other|8|||
155553080|NCT01553747|561449966|FG002|Overall Study|Physician decision: other|7|||
155553081|NCT01553747|561449964|FG000|Overall Study|Lost to Follow-up|11|||
155553082|NCT01553747|561449965|FG001|Overall Study|Lost to Follow-up|5|||
155553083|NCT01553747|561449966|FG002|Overall Study|Lost to Follow-up|6|||
155553084|NCT01553747|561449964|FG000|Overall Study|Sponsor decision, specify|7|||
155553085|NCT01553747|561449965|FG001|Overall Study|Sponsor decision, specify|5|||
155553086|NCT01553747|561449966|FG002|Overall Study|Sponsor decision, specify|0|||
155553087|NCT01553747|561449964|FG000|Overall Study|Physician decision: lack of efficacy|1|||
155553088|NCT01553747|561449965|FG001|Overall Study|Physician decision: lack of efficacy|5|||
155553089|NCT01553747|561449966|FG002|Overall Study|Physician decision: lack of efficacy|3|||
155553090|NCT00102687|561449967|FG000|Initial Period|Withdrawal by Subject|6|||
155553091|NCT00102687|561449968|FG001|Initial Period|Withdrawal by Subject|3|||
155553092|NCT00102687|561449969|FG002|Initial Period|Withdrawal by Subject|5|||
155553093|NCT00102687|561449970|FG003|Initial Period|Withdrawal by Subject|0|||
155553094|NCT00102687|561449971|FG004|Initial Period|Withdrawal by Subject|0|||
155553095|NCT00102687|561449967|FG000|Initial Period|Adverse Event|4|||
155553096|NCT00102687|561449968|FG001|Initial Period|Adverse Event|7|||
155553097|NCT00102687|561449969|FG002|Initial Period|Adverse Event|9|||
155553098|NCT00102687|561449970|FG003|Initial Period|Adverse Event|0|||
155553099|NCT00102687|561449971|FG004|Initial Period|Adverse Event|0|||
155553100|NCT00102687|561449967|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
155553101|NCT00102687|561449968|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
155553102|NCT00102687|561449969|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
155553103|NCT00102687|561449970|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
155553104|NCT00102687|561449971|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
155553105|NCT00102687|561449967|FG000|Initial Period|Protocol Violation|0|||
155553106|NCT00102687|561449968|FG001|Initial Period|Protocol Violation|0|||
155553107|NCT00102687|561449969|FG002|Initial Period|Protocol Violation|2|||
155553108|NCT00102687|561449970|FG003|Initial Period|Protocol Violation|0|||
155553109|NCT00102687|561449971|FG004|Initial Period|Protocol Violation|0|||
155553110|NCT00102687|561449967|FG000|Initial Period|Physician Decision|2|||
155553111|NCT00102687|561449968|FG001|Initial Period|Physician Decision|9|||
155553112|NCT00102687|561449969|FG002|Initial Period|Physician Decision|6|||
155553113|NCT00102687|561449970|FG003|Initial Period|Physician Decision|0|||
155553114|NCT00102687|561449971|FG004|Initial Period|Physician Decision|0|||
155553115|NCT00102687|561449967|FG000|Initial Period|Sponsor's decision|0|||
155553116|NCT00102687|561449968|FG001|Initial Period|Sponsor's decision|1|||
155553117|NCT00102687|561449969|FG002|Initial Period|Sponsor's decision|1|||
155553118|NCT00102687|561449970|FG003|Initial Period|Sponsor's decision|0|||
155553119|NCT00102687|561449971|FG004|Initial Period|Sponsor's decision|0|||
155553120|NCT00102687|561449967|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
155553121|NCT00102687|561449968|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
155553122|NCT00102687|561449969|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
155553123|NCT00102687|561449970|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
155553124|NCT00102687|561449971|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
155553125|NCT00102687|561449967|FG000|Initial Period|Death|1|||
155553126|NCT00102687|561449968|FG001|Initial Period|Death|1|||
155553127|NCT00102687|561449969|FG002|Initial Period|Death|1|||
155553128|NCT00102687|561449970|FG003|Initial Period|Death|0|||
155553129|NCT00102687|561449971|FG004|Initial Period|Death|0|||
155553130|NCT00102687|561449967|FG000|Maintenance Period|Withdrawal by Subject|4|||
155553131|NCT00102687|561449968|FG001|Maintenance Period|Withdrawal by Subject|0|||
155553132|NCT00102687|561449969|FG002|Maintenance Period|Withdrawal by Subject|2|||
155553133|NCT00102687|561449970|FG003|Maintenance Period|Withdrawal by Subject|3|||
155553134|NCT00102687|561449971|FG004|Maintenance Period|Withdrawal by Subject|1|||
155553135|NCT00102687|561449967|FG000|Maintenance Period|Adverse Event|1|||
155553136|NCT00102687|561449968|FG001|Maintenance Period|Adverse Event|0|||
155553137|NCT00102687|561449969|FG002|Maintenance Period|Adverse Event|0|||
155553138|NCT00102687|561449970|FG003|Maintenance Period|Adverse Event|1|||
155553139|NCT00102687|561449971|FG004|Maintenance Period|Adverse Event|3|||
155553140|NCT00102687|561449967|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
155553141|NCT00102687|561449968|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
155553142|NCT00102687|561449969|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
155553143|NCT00102687|561449970|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
155553144|NCT00102687|561449971|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
155553145|NCT00102687|561449967|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
155553146|NCT00102687|561449968|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
155553147|NCT00102687|561449969|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
155553148|NCT00102687|561449970|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
155553149|NCT00102687|561449971|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
155553150|NCT00102687|561449967|FG000|Maintenance Period|Death|0|||
155553151|NCT00102687|561449968|FG001|Maintenance Period|Death|0|||
155553152|NCT00102687|561449969|FG002|Maintenance Period|Death|0|||
155553153|NCT00102687|561449970|FG003|Maintenance Period|Death|1|||
155553154|NCT00102687|561449971|FG004|Maintenance Period|Death|1|||
155553155|NCT00102687|561449967|FG000|Maintenance Period|Physician Decision|1|||
155553156|NCT00102687|561449968|FG001|Maintenance Period|Physician Decision|2|||
155553157|NCT00102687|561449969|FG002|Maintenance Period|Physician Decision|3|||
155553158|NCT00102687|561449970|FG003|Maintenance Period|Physician Decision|0|||
155553159|NCT00102687|561449971|FG004|Maintenance Period|Physician Decision|4|||
155553160|NCT05444543|561449973|FG000|Overall Study|Withdrawal by Subject|1|||
155553161|NCT05444543|561449974|FG001|Overall Study|Withdrawal by Subject|0|||
155553162|NCT05444543|561449973|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
155553163|NCT05444543|561449974|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
155553164|NCT05444543|561449973|FG000|Overall Study|Adverse Event|0|||
155553165|NCT05444543|561449974|FG001|Overall Study|Adverse Event|1|||
155553166|NCT05444543|561449973|FG000|Overall Study|Family relocating at a distance from study site|0|||
155553167|NCT05444543|561449974|FG001|Overall Study|Family relocating at a distance from study site|1|||
155553168|NCT02408120|561449975|FG000|Overall Study|Withdrawal by Subject|0|||
155553169|NCT02408120|561449976|FG001|Overall Study|Withdrawal by Subject|1|||
155553170|NCT02408120|561449975|FG000|Overall Study|Treatment Refusal|1|||
155553171|NCT02408120|561449976|FG001|Overall Study|Treatment Refusal|0|||
155553172|NCT02408120|561449975|FG000|Overall Study|Received Steroids|1|||
155553173|NCT02408120|561449976|FG001|Overall Study|Received Steroids|1|||
155553174|NCT02408120|561449975|FG000|Overall Study|Discharged same day|1|||
155553175|NCT02408120|561449976|FG001|Overall Study|Discharged same day|1|||
155553176|NCT02408120|561449975|FG000|Overall Study|Did not receive insulin|1|||
155553177|NCT02408120|561449976|FG001|Overall Study|Did not receive insulin|2|||
155553178|NCT00977431|561449980|FG000|Overall Study|Other than listed|1|||
155553179|NCT00977431|561449981|FG001|Overall Study|Other than listed|0|||
155553180|NCT00977431|561449982|FG002|Overall Study|Other than listed|0|||
155553181|NCT00977431|561449983|FG003|Overall Study|Other than listed|0|||
155553182|NCT00977431|561449984|FG004|Overall Study|Other than listed|2|||
155553183|NCT00977431|561449980|FG000|Overall Study|Protocol Violation|0|||
155553184|NCT00977431|561449981|FG001|Overall Study|Protocol Violation|0|||
155553185|NCT00977431|561449982|FG002|Overall Study|Protocol Violation|1|||
155553186|NCT00977431|561449983|FG003|Overall Study|Protocol Violation|0|||
155553187|NCT00977431|561449984|FG004|Overall Study|Protocol Violation|0|||
155553188|NCT00977431|561449980|FG000|Overall Study|Adverse Event|3|||
155553189|NCT00977431|561449981|FG001|Overall Study|Adverse Event|0|||
155553190|NCT00977431|561449982|FG002|Overall Study|Adverse Event|4|||
155553191|NCT00977431|561449983|FG003|Overall Study|Adverse Event|0|||
155553192|NCT00977431|561449984|FG004|Overall Study|Adverse Event|6|||
155553193|NCT00977431|561449980|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
155553194|NCT00977431|561449981|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
155553195|NCT00977431|561449982|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
155553196|NCT00977431|561449983|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
155553197|NCT00977431|561449984|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
155553198|NCT00977431|561449980|FG000|Overall Study|Progressive disease|2|||
155553199|NCT00977431|561449981|FG001|Overall Study|Progressive disease|6|||
155553200|NCT00977431|561449982|FG002|Overall Study|Progressive disease|1|||
155553201|NCT00977431|561449983|FG003|Overall Study|Progressive disease|3|||
155553202|NCT00977431|561449984|FG004|Overall Study|Progressive disease|5|||
155553203|NCT03739138|561449991|FG000|Overall Study|Death|0|||
155553204|NCT03739138|561449992|FG001|Overall Study|Death|7|||
155553205|NCT03739138|561449993|FG002|Overall Study|Death|4|||
155553206|NCT03739138|561449994|FG003|Overall Study|Death|13|||
155553207|NCT03739138|561449995|FG004|Overall Study|Death|0|||
155553208|NCT03739138|561449991|FG000|Overall Study|Lost to Follow-up|0|||
155553209|NCT03739138|561449992|FG001|Overall Study|Lost to Follow-up|0|||
155553210|NCT03739138|561449993|FG002|Overall Study|Lost to Follow-up|1|||
155553211|NCT03739138|561449994|FG003|Overall Study|Lost to Follow-up|0|||
155553212|NCT03739138|561449995|FG004|Overall Study|Lost to Follow-up|0|||
155553213|NCT03739138|561449991|FG000|Overall Study|Study Terminated By Sponsor|0|||
155553214|NCT03739138|561449992|FG001|Overall Study|Study Terminated By Sponsor|0|||
155553215|NCT03739138|561449993|FG002|Overall Study|Study Terminated By Sponsor|0|||
155553216|NCT03739138|561449994|FG003|Overall Study|Study Terminated By Sponsor|4|||
155553217|NCT03739138|561449995|FG004|Overall Study|Study Terminated By Sponsor|0|||
155553218|NCT03739138|561449991|FG000|Overall Study|Withdrawal by Subject|0|||
155553219|NCT03739138|561449992|FG001|Overall Study|Withdrawal by Subject|0|||
155553220|NCT03739138|561449993|FG002|Overall Study|Withdrawal by Subject|0|||
155553221|NCT03739138|561449994|FG003|Overall Study|Withdrawal by Subject|1|||
155553222|NCT03739138|561449995|FG004|Overall Study|Withdrawal by Subject|0|||
155553223|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
155553224|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
155553225|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
155553226|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
155553227|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
155553228|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
155553229|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
155553230|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
155553231|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
155553232|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
155553233|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Subject decision|1|||
155553234|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Subject decision|1|||
155553235|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
155553236|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
155553237|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
155553238|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
155553239|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
155553240|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
155553241|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
155553242|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
155553243|NCT00518882|561449998|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
155553244|NCT00518882|561449999|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
155553245|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
155553246|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
155553247|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
155553248|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
155553249|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
155553250|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
155553251|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
155553252|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
155553253|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
155553254|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
155553255|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
155553256|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
155553257|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
155553258|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
155553259|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
155553260|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
155553261|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
155553262|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
155553263|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
155606870|NCT00312572|561649584|FG000|Overall Study|Lost to Follow-up|1|||
155606871|NCT00312572|561649585|FG001|Overall Study|Lost to Follow-up|1|||
155606872|NCT00312572|561649584|FG000|Overall Study|Administrative|4|||
155606873|NCT00312572|561649585|FG001|Overall Study|Administrative|2|||
155606874|NCT00312572|561649584|FG000|Overall Study|Lack of Efficacy|1|||
155606875|NCT00312572|561649585|FG001|Overall Study|Lack of Efficacy|2|||
155606876|NCT05385224|561649586|FG000|Overall Study|Unable to swallow capsule|2|||
155606877|NCT05385224|561649586|FG000|Overall Study|Withdrawal by Subject|2|||
155606878|NCT05385224|561649586|FG000|Overall Study|Did not meet study criteria|1|||
155606879|NCT04521114|561649589|FG000|Overall Study|Lost to Follow-up|1|||
155606880|NCT04521114|561649590|FG001|Overall Study|Lost to Follow-up|2|||
155606881|NCT04521114|561649591|FG002|Overall Study|Lost to Follow-up|0|||
155606882|NCT04521114|561649589|FG000|Overall Study|Withdrawal by Subject|1|||
155606883|NCT04521114|561649590|FG001|Overall Study|Withdrawal by Subject|2|||
155606884|NCT04521114|561649591|FG002|Overall Study|Withdrawal by Subject|2|||
155606885|NCT04521114|561649589|FG000|Overall Study|Adverse Event|1|||
155606886|NCT04521114|561649590|FG001|Overall Study|Adverse Event|0|||
155606887|NCT04521114|561649591|FG002|Overall Study|Adverse Event|0|||
155606888|NCT04521114|561649589|FG000|Overall Study|Sponsor Wish|1|||
155606889|NCT04521114|561649590|FG001|Overall Study|Sponsor Wish|0|||
155606890|NCT04521114|561649591|FG002|Overall Study|Sponsor Wish|0|||
155606891|NCT04521114|561649589|FG000|Overall Study|Withdrawal of Consent|2|||
155606892|NCT04521114|561649590|FG001|Overall Study|Withdrawal of Consent|2|||
155606893|NCT04521114|561649591|FG002|Overall Study|Withdrawal of Consent|0|||
155606894|NCT00553358|561649592|FG000|Overall Study|Randomized but did not receive treatment|3|||
155606895|NCT00553358|561649593|FG001|Overall Study|Randomized but did not receive treatment|3|||
155606896|NCT00553358|561649594|FG002|Overall Study|Randomized but did not receive treatment|1|||
155606897|NCT00553358|561649592|FG000|Overall Study|Lost to Follow-up|22|||
155606898|NCT00553358|561649593|FG001|Overall Study|Lost to Follow-up|26|||
155606899|NCT00553358|561649594|FG002|Overall Study|Lost to Follow-up|18|||
155606900|NCT00553358|561649592|FG000|Overall Study|Withdrew completely|23|||
155606901|NCT00553358|561649593|FG001|Overall Study|Withdrew completely|33|||
155606902|NCT00553358|561649594|FG002|Overall Study|Withdrew completely|34|||
155606903|NCT00553358|561649592|FG000|Overall Study|Died during clinical follow-up|25|||
155606904|NCT00553358|561649593|FG001|Overall Study|Died during clinical follow-up|29|||
155606905|NCT00553358|561649594|FG002|Overall Study|Died during clinical follow-up|32|||
155606906|NCT00553358|561649592|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
155606907|NCT00553358|561649593|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
155606908|NCT00553358|561649594|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
155606909|NCT00553358|561649592|FG000|Overall Study|Died after clinical follow-up ended|1|||
155606910|NCT00553358|561649593|FG001|Overall Study|Died after clinical follow-up ended|2|||
155606911|NCT00553358|561649594|FG002|Overall Study|Died after clinical follow-up ended|0|||
155606912|NCT00553358|561649592|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155606913|NCT00553358|561649593|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155606914|NCT00553358|561649594|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155606915|NCT02614131|561649595|FG000|Overall Study|Withdrawal by Subject|1|||
155606916|NCT02614131|561649596|FG001|Overall Study|Withdrawal by Subject|0|||
155606917|NCT02614131|561649597|FG002|Overall Study|Withdrawal by Subject|0|||
155606918|NCT02614131|561649598|FG003|Overall Study|Withdrawal by Subject|0|||
155606919|NCT02614131|561649599|FG004|Overall Study|Withdrawal by Subject|0|||
155606920|NCT02614131|561649600|FG005|Overall Study|Withdrawal by Subject|0|||
155606921|NCT02614131|561649601|FG006|Overall Study|Withdrawal by Subject|0|||
155606922|NCT02614131|561649595|FG000|Overall Study|Adverse Event|0|||
155606923|NCT02614131|561649596|FG001|Overall Study|Adverse Event|0|||
155553264|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
155553265|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
155553266|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
155553267|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
155553268|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
155553269|NCT00518882|561449998|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
155553270|NCT00518882|561449999|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
155553271|NCT02696031|561450000|FG000|Up to Week 24|Adverse Event|2|||
155553272|NCT02696031|561450001|FG001|Up to Week 24|Adverse Event|4|||
155553273|NCT02696031|561450002|FG002|Up to Week 24|Adverse Event|2|||
155553274|NCT02696031|561450003|FG003|Up to Week 24|Adverse Event|0|||
155553275|NCT02696031|561450004|FG004|Up to Week 24|Adverse Event|0|||
155553276|NCT02696031|561450005|FG005|Up to Week 24|Adverse Event|0|||
155553277|NCT02696031|561450000|FG000|Up to Week 24|Lack of Efficacy|2|||
155553278|NCT02696031|561450001|FG001|Up to Week 24|Lack of Efficacy|1|||
155553279|NCT02696031|561450002|FG002|Up to Week 24|Lack of Efficacy|2|||
155553280|NCT02696031|561450003|FG003|Up to Week 24|Lack of Efficacy|0|||
155553281|NCT02696031|561450004|FG004|Up to Week 24|Lack of Efficacy|0|||
155553282|NCT02696031|561450005|FG005|Up to Week 24|Lack of Efficacy|0|||
155553283|NCT02696031|561450000|FG000|Up to Week 24|Lost to Follow-up|0|||
155553284|NCT02696031|561450001|FG001|Up to Week 24|Lost to Follow-up|1|||
155553285|NCT02696031|561450002|FG002|Up to Week 24|Lost to Follow-up|1|||
155553286|NCT02696031|561450003|FG003|Up to Week 24|Lost to Follow-up|0|||
155553287|NCT02696031|561450004|FG004|Up to Week 24|Lost to Follow-up|0|||
155553288|NCT02696031|561450005|FG005|Up to Week 24|Lost to Follow-up|0|||
155553289|NCT02696031|561450000|FG000|Up to Week 24|Physician Decision|1|||
155553290|NCT02696031|561450001|FG001|Up to Week 24|Physician Decision|0|||
155553291|NCT02696031|561450002|FG002|Up to Week 24|Physician Decision|1|||
155553292|NCT02696031|561450003|FG003|Up to Week 24|Physician Decision|0|||
155553293|NCT02696031|561450004|FG004|Up to Week 24|Physician Decision|0|||
155553294|NCT02696031|561450005|FG005|Up to Week 24|Physician Decision|0|||
155553295|NCT02696031|561450000|FG000|Up to Week 24|Protocol Violation|1|||
155553296|NCT02696031|561450001|FG001|Up to Week 24|Protocol Violation|0|||
155553297|NCT02696031|561450002|FG002|Up to Week 24|Protocol Violation|0|||
155553298|NCT02696031|561450003|FG003|Up to Week 24|Protocol Violation|0|||
155553299|NCT02696031|561450004|FG004|Up to Week 24|Protocol Violation|0|||
155553300|NCT02696031|561450005|FG005|Up to Week 24|Protocol Violation|0|||
155553301|NCT02696031|561450000|FG000|Up to Week 24|Withdrawal by Subject|4|||
155553302|NCT02696031|561450001|FG001|Up to Week 24|Withdrawal by Subject|1|||
155553303|NCT02696031|561450002|FG002|Up to Week 24|Withdrawal by Subject|5|||
155553304|NCT02696031|561450003|FG003|Up to Week 24|Withdrawal by Subject|0|||
155553305|NCT02696031|561450004|FG004|Up to Week 24|Withdrawal by Subject|0|||
155553306|NCT02696031|561450005|FG005|Up to Week 24|Withdrawal by Subject|0|||
155553307|NCT02696031|561450000|FG000|Up to Week 52|Adverse Event|4|||
155553308|NCT02696031|561450001|FG001|Up to Week 52|Adverse Event|5|||
155553309|NCT02696031|561450002|FG002|Up to Week 52|Adverse Event|3|||
155553310|NCT02696031|561450003|FG003|Up to Week 52|Adverse Event|0|||
155553311|NCT02696031|561450004|FG004|Up to Week 52|Adverse Event|0|||
155553312|NCT02696031|561450005|FG005|Up to Week 52|Adverse Event|0|||
155553313|NCT02696031|561450000|FG000|Up to Week 52|Lack of Efficacy|10|||
155553314|NCT02696031|561450001|FG001|Up to Week 52|Lack of Efficacy|7|||
155553315|NCT02696031|561450002|FG002|Up to Week 52|Lack of Efficacy|11|||
155553316|NCT02696031|561450003|FG003|Up to Week 52|Lack of Efficacy|0|||
155553317|NCT02696031|561450004|FG004|Up to Week 52|Lack of Efficacy|0|||
155553318|NCT02696031|561450005|FG005|Up to Week 52|Lack of Efficacy|0|||
155553319|NCT02696031|561450000|FG000|Up to Week 52|Lost to Follow-up|1|||
155553320|NCT02696031|561450001|FG001|Up to Week 52|Lost to Follow-up|1|||
155553321|NCT02696031|561450002|FG002|Up to Week 52|Lost to Follow-up|1|||
155553322|NCT02696031|561450003|FG003|Up to Week 52|Lost to Follow-up|0|||
155553323|NCT02696031|561450004|FG004|Up to Week 52|Lost to Follow-up|0|||
155657434|NCT00980798|561838982|FG001|Overall Study|Lack of Efficacy|5|||
155553324|NCT02696031|561450005|FG005|Up to Week 52|Lost to Follow-up|0|||
155553325|NCT02696031|561450000|FG000|Up to Week 52|Physician Decision|1|||
155553326|NCT02696031|561450001|FG001|Up to Week 52|Physician Decision|1|||
155553327|NCT02696031|561450002|FG002|Up to Week 52|Physician Decision|2|||
155553328|NCT02696031|561450003|FG003|Up to Week 52|Physician Decision|0|||
155553329|NCT02696031|561450004|FG004|Up to Week 52|Physician Decision|0|||
155553330|NCT02696031|561450005|FG005|Up to Week 52|Physician Decision|0|||
155553331|NCT02696031|561450000|FG000|Up to Week 52|Pregnancy|0|||
155553332|NCT02696031|561450001|FG001|Up to Week 52|Pregnancy|2|||
155553333|NCT02696031|561450002|FG002|Up to Week 52|Pregnancy|0|||
155553334|NCT02696031|561450003|FG003|Up to Week 52|Pregnancy|0|||
155553335|NCT02696031|561450004|FG004|Up to Week 52|Pregnancy|0|||
155553336|NCT02696031|561450005|FG005|Up to Week 52|Pregnancy|0|||
155553337|NCT02696031|561450000|FG000|Up to Week 52|Protocol Violation|1|||
155553338|NCT02696031|561450001|FG001|Up to Week 52|Protocol Violation|0|||
155553339|NCT02696031|561450002|FG002|Up to Week 52|Protocol Violation|0|||
155553340|NCT02696031|561450003|FG003|Up to Week 52|Protocol Violation|0|||
155553341|NCT02696031|561450004|FG004|Up to Week 52|Protocol Violation|0|||
155553342|NCT02696031|561450005|FG005|Up to Week 52|Protocol Violation|0|||
155553343|NCT02696031|561450000|FG000|Up to Week 52|Withdrawal by Subject|12|||
155553344|NCT02696031|561450001|FG001|Up to Week 52|Withdrawal by Subject|3|||
155553345|NCT02696031|561450002|FG002|Up to Week 52|Withdrawal by Subject|9|||
155553346|NCT02696031|561450003|FG003|Up to Week 52|Withdrawal by Subject|0|||
155553347|NCT02696031|561450004|FG004|Up to Week 52|Withdrawal by Subject|0|||
155553348|NCT02696031|561450005|FG005|Up to Week 52|Withdrawal by Subject|0|||
155553349|NCT02696031|561450000|FG000|Up to Week 104|Pregnancy|0|||
155553350|NCT02696031|561450001|FG001|Up to Week 104|Pregnancy|2|||
155553351|NCT02696031|561450002|FG002|Up to Week 104|Pregnancy|1|||
155553352|NCT02696031|561450003|FG003|Up to Week 104|Pregnancy|0|||
155553353|NCT02696031|561450004|FG004|Up to Week 104|Pregnancy|0|||
155553354|NCT02696031|561450005|FG005|Up to Week 104|Pregnancy|0|||
155553355|NCT02696031|561450000|FG000|Up to Week 104|Withdrawal by Subject|15|||
155553356|NCT02696031|561450001|FG001|Up to Week 104|Withdrawal by Subject|10|||
155553357|NCT02696031|561450002|FG002|Up to Week 104|Withdrawal by Subject|16|||
155553358|NCT02696031|561450003|FG003|Up to Week 104|Withdrawal by Subject|0|||
155553359|NCT02696031|561450004|FG004|Up to Week 104|Withdrawal by Subject|0|||
155553360|NCT02696031|561450005|FG005|Up to Week 104|Withdrawal by Subject|0|||
155657435|NCT00980798|561838981|FG000|Overall Study|Lost to Follow-up|0|||
155657436|NCT00980798|561838982|FG001|Overall Study|Lost to Follow-up|1|||
155657437|NCT00980798|561838981|FG000|Overall Study|Physician Decision|2|||
155657438|NCT00980798|561838982|FG001|Overall Study|Physician Decision|1|||
155657439|NCT00980798|561838981|FG000|Overall Study|Withdrawal by Subject|8|||
155657440|NCT00980798|561838982|FG001|Overall Study|Withdrawal by Subject|11|||
155657441|NCT00980798|561838981|FG000|Overall Study|Other|0|||
155657442|NCT00980798|561838982|FG001|Overall Study|Other|1|||
155657443|NCT00522379|561838983|FG000|Overall Study|Adverse Event|12|||
155553361|NCT02696031|561450000|FG000|Up to Week 104|Protocol Violation|1|||
155553362|NCT02696031|561450001|FG001|Up to Week 104|Protocol Violation|0|||
155553363|NCT02696031|561450002|FG002|Up to Week 104|Protocol Violation|0|||
155553364|NCT02696031|561450003|FG003|Up to Week 104|Protocol Violation|0|||
155553365|NCT02696031|561450004|FG004|Up to Week 104|Protocol Violation|0|||
155553366|NCT02696031|561450005|FG005|Up to Week 104|Protocol Violation|0|||
155553367|NCT02696031|561450000|FG000|Up to Week 104|Physician Decision|1|||
155553368|NCT02696031|561450001|FG001|Up to Week 104|Physician Decision|2|||
155553369|NCT02696031|561450002|FG002|Up to Week 104|Physician Decision|3|||
155553370|NCT02696031|561450003|FG003|Up to Week 104|Physician Decision|0|||
155553371|NCT02696031|561450004|FG004|Up to Week 104|Physician Decision|0|||
155553372|NCT02696031|561450005|FG005|Up to Week 104|Physician Decision|0|||
155553373|NCT02696031|561450000|FG000|Up to Week 104|Lost to Follow-up|2|||
155553374|NCT02696031|561450001|FG001|Up to Week 104|Lost to Follow-up|3|||
155553375|NCT02696031|561450002|FG002|Up to Week 104|Lost to Follow-up|1|||
155553376|NCT02696031|561450003|FG003|Up to Week 104|Lost to Follow-up|0|||
155553377|NCT02696031|561450004|FG004|Up to Week 104|Lost to Follow-up|0|||
155553378|NCT02696031|561450005|FG005|Up to Week 104|Lost to Follow-up|0|||
155553379|NCT02696031|561450000|FG000|Up to Week 104|Lack of Efficacy|13|||
155553380|NCT02696031|561450001|FG001|Up to Week 104|Lack of Efficacy|12|||
155553381|NCT02696031|561450002|FG002|Up to Week 104|Lack of Efficacy|11|||
155553382|NCT02696031|561450003|FG003|Up to Week 104|Lack of Efficacy|0|||
155553383|NCT02696031|561450004|FG004|Up to Week 104|Lack of Efficacy|0|||
155553384|NCT02696031|561450005|FG005|Up to Week 104|Lack of Efficacy|0|||
155553385|NCT02696031|561450000|FG000|Up to Week 104|Adverse Event|7|||
155553386|NCT02696031|561450001|FG001|Up to Week 104|Adverse Event|11|||
155553387|NCT02696031|561450002|FG002|Up to Week 104|Adverse Event|5|||
155657444|NCT00522379|561838984|FG001|Overall Study|Adverse Event|15|||
155657445|NCT00522379|561838985|FG002|Overall Study|Adverse Event|12|||
155657446|NCT00522379|561838986|FG003|Overall Study|Adverse Event|5|||
155553388|NCT02696031|561450003|FG003|Up to Week 104|Adverse Event|0|||
155553389|NCT02696031|561450004|FG004|Up to Week 104|Adverse Event|0|||
155657447|NCT00522379|561838987|FG004|Overall Study|Adverse Event|17|||
155553390|NCT02696031|561450005|FG005|Up to Week 104|Adverse Event|0|||
155553391|NCT02696031|561450000|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
155553392|NCT02696031|561450001|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
155553393|NCT02696031|561450002|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
155553394|NCT02696031|561450003|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
155657448|NCT00522379|561838983|FG000|Overall Study|Lack of Efficacy|3|||
155553395|NCT02696031|561450004|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
155553396|NCT02696031|561450005|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
155553397|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
155553398|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
155553399|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
155553400|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
155553401|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
155553402|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
155553403|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
155553404|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
155553405|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
155553406|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
155553407|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
155553408|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
155553409|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155553410|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155553411|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155553412|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
155553413|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155553414|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155553415|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
155553416|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
155553417|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
155553418|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
155553419|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
155553420|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
155553421|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
155553422|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
155553423|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
155553424|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
155553425|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
155553426|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
155553427|NCT02696031|561450000|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
155553428|NCT02696031|561450001|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
155553429|NCT02696031|561450002|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
155553430|NCT02696031|561450003|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
155553431|NCT02696031|561450004|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
155553432|NCT02696031|561450005|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
155553433|NCT00597116|561450006|FG000|Overall Study|Adverse Event|2|||
155553434|NCT00597116|561450007|FG001|Overall Study|Adverse Event|1|||
155553435|NCT00597116|561450006|FG000|Overall Study|Withdrawal by Subject|0|||
155553436|NCT00597116|561450007|FG001|Overall Study|Withdrawal by Subject|2|||
155553437|NCT00597116|561450006|FG000|Overall Study|Physician Decision|0|||
155553438|NCT00597116|561450007|FG001|Overall Study|Physician Decision|1|||
155553439|NCT00597116|561450006|FG000|Overall Study|Death|0|||
155553440|NCT00597116|561450007|FG001|Overall Study|Death|1|||
155553441|NCT00597116|561450006|FG000|Overall Study|Lost to Follow-up|1|||
155553442|NCT00597116|561450007|FG001|Overall Study|Lost to Follow-up|0|||
155553443|NCT00597116|561450006|FG000|Overall Study|Progressive disease|11|||
155553444|NCT00597116|561450007|FG001|Overall Study|Progressive disease|6|||
155657449|NCT00522379|561838984|FG001|Overall Study|Lack of Efficacy|0|||
155553445|NCT02096588|561450008|FG000|Overall Study|Lack of Efficacy|2|||
155553446|NCT02096588|561450009|FG001|Overall Study|Lack of Efficacy|0|||
155553447|NCT02096588|561450008|FG000|Overall Study|Withdrawal by Subject|0|||
155553448|NCT02096588|561450009|FG001|Overall Study|Withdrawal by Subject|1|||
155553449|NCT01258101|561450010|FG000|Overall Study|Adverse Event|5|||
155553450|NCT01258101|561450011|FG001|Overall Study|Adverse Event|6|||
155553451|NCT01258101|561450012|FG002|Overall Study|Adverse Event|0|||
155553452|NCT01258101|561450013|FG003|Overall Study|Adverse Event|0|||
155553453|NCT01258101|561450010|FG000|Overall Study|Extra exclusion criterion amended|2|||
155553454|NCT01258101|561450011|FG001|Overall Study|Extra exclusion criterion amended|1|||
155553455|NCT01258101|561450012|FG002|Overall Study|Extra exclusion criterion amended|1|||
155553456|NCT01258101|561450013|FG003|Overall Study|Extra exclusion criterion amended|1|||
155553457|NCT01258101|561450010|FG000|Overall Study|Informed consent has been withdrawn|2|||
155553458|NCT01258101|561450011|FG001|Overall Study|Informed consent has been withdrawn|2|||
155553459|NCT01258101|561450012|FG002|Overall Study|Informed consent has been withdrawn|1|||
155553460|NCT01258101|561450013|FG003|Overall Study|Informed consent has been withdrawn|1|||
155553461|NCT01258101|561450010|FG000|Overall Study|Patient is not able to attend visits|8|||
155553462|NCT01258101|561450011|FG001|Overall Study|Patient is not able to attend visits|9|||
155553463|NCT01258101|561450012|FG002|Overall Study|Patient is not able to attend visits|7|||
155553464|NCT01258101|561450013|FG003|Overall Study|Patient is not able to attend visits|6|||
155553465|NCT01258101|561450010|FG000|Overall Study|Patient´s compliance|4|||
155553466|NCT01258101|561450011|FG001|Overall Study|Patient´s compliance|3|||
155553467|NCT01258101|561450012|FG002|Overall Study|Patient´s compliance|1|||
155553468|NCT01258101|561450013|FG003|Overall Study|Patient´s compliance|2|||
155553469|NCT01258101|561450010|FG000|Overall Study|Lost to Follow-up|5|||
155553470|NCT01258101|561450011|FG001|Overall Study|Lost to Follow-up|5|||
155553471|NCT01258101|561450012|FG002|Overall Study|Lost to Follow-up|0|||
155553472|NCT01258101|561450013|FG003|Overall Study|Lost to Follow-up|6|||
155553473|NCT01258101|561450010|FG000|Overall Study|PCR positive at week 24|0|||
155553474|NCT01258101|561450011|FG001|Overall Study|PCR positive at week 24|0|||
155553475|NCT01258101|561450012|FG002|Overall Study|PCR positive at week 24|0|||
155553476|NCT01258101|561450013|FG003|Overall Study|PCR positive at week 24|1|||
155553477|NCT01258101|561450010|FG000|Overall Study|Other reason|7|||
155553478|NCT01258101|561450011|FG001|Overall Study|Other reason|8|||
155553479|NCT01258101|561450012|FG002|Overall Study|Other reason|1|||
155553480|NCT01258101|561450013|FG003|Overall Study|Other reason|8|||
155553481|NCT02903238|561450014|FG000|Overall Study|Lost to Follow-up|4|||
155553482|NCT02556307|561450024|FG000|Overall Study|Premature treatment interruption|11|||
155553483|NCT02556307|561450024|FG000|Overall Study|Lost to Follow-up|36|||
155553484|NCT02556307|561450024|FG000|Overall Study|Change to triple therapy|4|||
155553485|NCT02556307|561450024|FG000|Overall Study|Enrolled but not treated|2|||
155553486|NCT03438227|561450025|FG000|Overall Study|Withdrawal by Subject|10|||
155553487|NCT03438227|561450026|FG001|Overall Study|Withdrawal by Subject|5|||
155553488|NCT00706992|561450037|FG000|Overall Study|Study termination|5|||
155553489|NCT00706992|561450038|FG001|Overall Study|Study termination|5|||
155553490|NCT00706992|561450039|FG002|Overall Study|Study termination|6|||
155553491|NCT00706992|561450040|FG003|Overall Study|Study termination|2|||
155553492|NCT00706992|561450041|FG004|Overall Study|Study termination|3|||
155553493|NCT00706992|561450042|FG005|Overall Study|Study termination|2|||
155553494|NCT00706992|561450043|FG006|Overall Study|Study termination|3|||
155553495|NCT00706992|561450037|FG000|Overall Study|Disease progression before treatment|0|||
155553496|NCT00706992|561450038|FG001|Overall Study|Disease progression before treatment|0|||
155553497|NCT00706992|561450039|FG002|Overall Study|Disease progression before treatment|0|||
155553498|NCT00706992|561450040|FG003|Overall Study|Disease progression before treatment|0|||
155553499|NCT00706992|561450041|FG004|Overall Study|Disease progression before treatment|1|||
155553500|NCT00706992|561450042|FG005|Overall Study|Disease progression before treatment|0|||
155553501|NCT00706992|561450043|FG006|Overall Study|Disease progression before treatment|0|||
155553502|NCT01244061|561450052|FG000|Overall Study|Death|1|||
155553503|NCT01244061|561450053|FG001|Overall Study|Death|0|||
155553504|NCT01244061|561450052|FG000|Overall Study|Did not meet entrance criteria|1|||
155553505|NCT01244061|561450053|FG001|Overall Study|Did not meet entrance criteria|0|||
155553506|NCT01244061|561450052|FG000|Overall Study|Lack of Efficacy|1|||
155553507|NCT01244061|561450053|FG001|Overall Study|Lack of Efficacy|3|||
155553508|NCT01244061|561450052|FG000|Overall Study|Lost to Follow-up|34|||
155553509|NCT01244061|561450053|FG001|Overall Study|Lost to Follow-up|30|||
155553510|NCT01244061|561450052|FG000|Overall Study|Withdrawal by Subject|29|||
155553511|NCT01244061|561450053|FG001|Overall Study|Withdrawal by Subject|46|||
155553512|NCT01244061|561450052|FG000|Overall Study|Other|8|||
155553513|NCT01244061|561450053|FG001|Overall Study|Other|19|||
155553514|NCT01244061|561450052|FG000|Overall Study|Protocol Violation|1|||
155553515|NCT01244061|561450053|FG001|Overall Study|Protocol Violation|1|||
155553516|NCT01244061|561450052|FG000|Overall Study|Adverse Event|5|||
155553517|NCT01244061|561450053|FG001|Overall Study|Adverse Event|2|||
155553518|NCT01244061|561450052|FG000|Overall Study|Randomized but not treated|2|||
155553519|NCT01244061|561450053|FG001|Overall Study|Randomized but not treated|2|||
155553520|NCT03166124|561450054|FG000|Treatment Period 1|Adverse Event|0|||
155553521|NCT03166124|561450055|FG001|Treatment Period 1|Adverse Event|0|||
155553522|NCT03166124|561450056|FG002|Treatment Period 1|Adverse Event|1|||
155553523|NCT03166124|561450057|FG003|Treatment Period 1|Adverse Event|0|||
155553524|NCT03166124|561450054|FG000|Wash-out Period|Withdrawal by Subject|0|||
155553525|NCT03166124|561450055|FG001|Wash-out Period|Withdrawal by Subject|1|||
155553526|NCT03166124|561450056|FG002|Wash-out Period|Withdrawal by Subject|0|||
155553527|NCT03166124|561450057|FG003|Wash-out Period|Withdrawal by Subject|1|||
155553528|NCT03166124|561450054|FG000|Wash-out Period|Adverse Event|0|||
155553529|NCT03166124|561450055|FG001|Wash-out Period|Adverse Event|1|||
155553530|NCT03166124|561450056|FG002|Wash-out Period|Adverse Event|1|||
155553531|NCT03166124|561450057|FG003|Wash-out Period|Adverse Event|0|||
155553532|NCT03487848|561450062|FG000|Overall Study|Lost to Follow-up|1|||
155553533|NCT02246439|561452357|FG000|Overall Study|Adverse Event|3|||
155553534|NCT02246439|561452358|FG001|Overall Study|Adverse Event|0|||
155553535|NCT02246439|561452357|FG000|Overall Study|Lost to Follow-up|7|||
155553536|NCT02246439|561452358|FG001|Overall Study|Lost to Follow-up|5|||
155553537|NCT02246439|561452357|FG000|Overall Study|Protocol Violation|0|||
155553538|NCT02246439|561452358|FG001|Overall Study|Protocol Violation|2|||
155553539|NCT02246439|561452357|FG000|Overall Study|Physician Decision|0|||
155553540|NCT02246439|561452358|FG001|Overall Study|Physician Decision|1|||
155553541|NCT02246439|561452357|FG000|Overall Study|Unkonwn|1|||
155553542|NCT02246439|561452358|FG001|Overall Study|Unkonwn|3|||
155553543|NCT02246439|561452357|FG000|Overall Study|Withdrawal by Subject|1|||
155553544|NCT02246439|561452358|FG001|Overall Study|Withdrawal by Subject|0|||
155553545|NCT03439852|561452361|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
155553546|NCT03439852|561452362|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
155553547|NCT03439852|561452361|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
155553548|NCT03439852|561452362|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
155553549|NCT03439852|561452361|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
155553550|NCT03439852|561452362|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
155553551|NCT04271735|561452363|FG000|Overall Study|Physician Decision|2|||
155553552|NCT04271735|561452364|FG001|Overall Study|Physician Decision|0|||
155553553|NCT00922272|561452365|FG000|Open-label Phase|Adverse Event|5|||
155553554|NCT00922272|561452366|FG001|Open-label Phase|Adverse Event|0|||
155553555|NCT00922272|561452365|FG000|Open-label Phase|Protocol Violation|1|||
155553556|NCT00922272|561452366|FG001|Open-label Phase|Protocol Violation|0|||
155553557|NCT00922272|561452365|FG000|Open-label Phase|Withdrawal by Subject|11|||
155553558|NCT00922272|561452366|FG001|Open-label Phase|Withdrawal by Subject|0|||
155553559|NCT00922272|561452365|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
155553560|NCT00922272|561452366|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
155553561|NCT00922272|561452365|FG000|Open-label Phase|Withdrawal criteria met|5|||
155553562|NCT00922272|561452366|FG001|Open-label Phase|Withdrawal criteria met|0|||
155553563|NCT00922272|561452365|FG000|Double-blind Phase|Adverse Event|1|||
155553564|NCT00922272|561452366|FG001|Double-blind Phase|Adverse Event|1|||
155553565|NCT00922272|561452365|FG000|Double-blind Phase|Withdrawal by Subject|1|||
155553566|NCT00922272|561452366|FG001|Double-blind Phase|Withdrawal by Subject|1|||
155553567|NCT00922272|561452365|FG000|Double-blind Phase|Lost to Follow-up|2|||
155553568|NCT00922272|561452366|FG001|Double-blind Phase|Lost to Follow-up|1|||
155553569|NCT00922272|561452365|FG000|Double-blind Phase|Withdrawal criteria met|1|||
155553570|NCT00922272|561452366|FG001|Double-blind Phase|Withdrawal criteria met|1|||
155553571|NCT00922272|561452365|FG000|Double-blind Phase|Noncompliance|1|||
155553572|NCT00922272|561452366|FG001|Double-blind Phase|Noncompliance|1|||
155553573|NCT00922272|561452365|FG000|Double-blind Phase|Positive urine drug screen|1|||
155553574|NCT00922272|561452366|FG001|Double-blind Phase|Positive urine drug screen|1|||
155553575|NCT03197558|561452367|FG000|Overall Study|Tubes not placed|1|||
155553576|NCT00430495|561452377|FG000|Overall Study|Adverse Event|2|||
155553577|NCT00430495|561452378|FG001|Overall Study|Adverse Event|3|||
155553578|NCT00430495|561452379|FG002|Overall Study|Adverse Event|2|||
155553579|NCT00430495|561452380|FG003|Overall Study|Adverse Event|0|||
155553580|NCT00430495|561452377|FG000|Overall Study|Death|0|||
155553581|NCT00430495|561452378|FG001|Overall Study|Death|0|||
155553582|NCT00430495|561452379|FG002|Overall Study|Death|1|||
155553583|NCT00430495|561452380|FG003|Overall Study|Death|0|||
155553584|NCT00430495|561452377|FG000|Overall Study|Lost to Follow-up|0|||
155553585|NCT00430495|561452378|FG001|Overall Study|Lost to Follow-up|1|||
155553586|NCT00430495|561452379|FG002|Overall Study|Lost to Follow-up|4|||
155553587|NCT00430495|561452380|FG003|Overall Study|Lost to Follow-up|0|||
155553588|NCT00430495|561452377|FG000|Overall Study|Protocol Violation|1|||
155553589|NCT00430495|561452378|FG001|Overall Study|Protocol Violation|0|||
155553590|NCT00430495|561452379|FG002|Overall Study|Protocol Violation|1|||
155553591|NCT00430495|561452380|FG003|Overall Study|Protocol Violation|0|||
155553592|NCT00430495|561452377|FG000|Overall Study|Disease Progression|1|||
155553593|NCT00430495|561452378|FG001|Overall Study|Disease Progression|1|||
155553594|NCT00430495|561452379|FG002|Overall Study|Disease Progression|0|||
155553595|NCT00430495|561452380|FG003|Overall Study|Disease Progression|0|||
155553596|NCT00430495|561452377|FG000|Overall Study|Other|8|||
155553597|NCT00430495|561452378|FG001|Overall Study|Other|2|||
155553598|NCT00430495|561452379|FG002|Overall Study|Other|5|||
155553599|NCT00430495|561452380|FG003|Overall Study|Other|4|||
155553600|NCT00430495|561452377|FG000|Overall Study|Randomized but not Treated|2|||
155553601|NCT00430495|561452378|FG001|Overall Study|Randomized but not Treated|0|||
155553602|NCT00430495|561452379|FG002|Overall Study|Randomized but not Treated|0|||
155553603|NCT00430495|561452380|FG003|Overall Study|Randomized but not Treated|0|||
155553604|NCT03656874|561452381|FG000|Overall Study|Lost to Follow-up|3|||
155553605|NCT03656874|561452382|FG001|Overall Study|Lost to Follow-up|17|||
155553606|NCT00063882|561452387|FG000|Overall Study|Protocol Violation|3|||
155553607|NCT00063882|561452388|FG001|Overall Study|Protocol Violation|3|||
155553608|NCT00063882|561452387|FG000|Overall Study|Withdrawal by Subject|2|||
155553609|NCT00063882|561452388|FG001|Overall Study|Withdrawal by Subject|1|||
155553610|NCT00700817|561452389|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
155553611|NCT00700817|561452390|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
155553612|NCT00700817|561452391|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
155553613|NCT00700817|561452392|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
155553614|NCT00700817|561452393|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
155553615|NCT00700817|561452389|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
155553616|NCT00700817|561452390|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
155553617|NCT00700817|561452391|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
155553618|NCT00700817|561452392|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
155553619|NCT00700817|561452393|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
155657450|NCT00522379|561838985|FG002|Overall Study|Lack of Efficacy|2|||
155657451|NCT00522379|561838986|FG003|Overall Study|Lack of Efficacy|2|||
155657452|NCT00522379|561838987|FG004|Overall Study|Lack of Efficacy|7|||
155657453|NCT00522379|561838983|FG000|Overall Study|Withdrawal by Subject|2|||
155657454|NCT00522379|561838984|FG001|Overall Study|Withdrawal by Subject|3|||
155657455|NCT00522379|561838985|FG002|Overall Study|Withdrawal by Subject|1|||
155657456|NCT00522379|561838986|FG003|Overall Study|Withdrawal by Subject|2|||
155657457|NCT00522379|561838987|FG004|Overall Study|Withdrawal by Subject|0|||
155657458|NCT00522379|561838983|FG000|Overall Study|Protocol Violation|1|||
155657459|NCT00522379|561838984|FG001|Overall Study|Protocol Violation|1|||
155657460|NCT00522379|561838985|FG002|Overall Study|Protocol Violation|2|||
155657461|NCT00522379|561838986|FG003|Overall Study|Protocol Violation|0|||
155657462|NCT00522379|561838987|FG004|Overall Study|Protocol Violation|0|||
155657463|NCT00522379|561838983|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
155657464|NCT00522379|561838984|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
155657465|NCT00522379|561838985|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
155657466|NCT00522379|561838986|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
155657467|NCT00522379|561838987|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
155657468|NCT00522379|561838983|FG000|Overall Study|Lost to Follow-up|1|||
155657469|NCT00522379|561838984|FG001|Overall Study|Lost to Follow-up|0|||
155657470|NCT00522379|561838985|FG002|Overall Study|Lost to Follow-up|4|||
155657471|NCT00522379|561838986|FG003|Overall Study|Lost to Follow-up|2|||
155657472|NCT00522379|561838987|FG004|Overall Study|Lost to Follow-up|2|||
155657473|NCT00522379|561838983|FG000|Overall Study|Randomization error|0|||
155657474|NCT00522379|561838984|FG001|Overall Study|Randomization error|0|||
155657475|NCT00522379|561838985|FG002|Overall Study|Randomization error|0|||
155657476|NCT00522379|561838986|FG003|Overall Study|Randomization error|0|||
155657477|NCT00522379|561838987|FG004|Overall Study|Randomization error|1|||
155657478|NCT00522379|561838983|FG000|Overall Study|Dispensing error|1|||
155657479|NCT00522379|561838984|FG001|Overall Study|Dispensing error|0|||
155657480|NCT00522379|561838985|FG002|Overall Study|Dispensing error|0|||
155657481|NCT00522379|561838986|FG003|Overall Study|Dispensing error|1|||
155657482|NCT00522379|561838987|FG004|Overall Study|Dispensing error|0|||
155657483|NCT00522379|561838983|FG000|Overall Study|Subject Moved|1|||
155657484|NCT00522379|561838984|FG001|Overall Study|Subject Moved|1|||
155657485|NCT00522379|561838985|FG002|Overall Study|Subject Moved|0|||
155657486|NCT00522379|561838986|FG003|Overall Study|Subject Moved|0|||
155657487|NCT00522379|561838987|FG004|Overall Study|Subject Moved|0|||
155657488|NCT00522379|561838983|FG000|Overall Study|Sponsor Request|0|||
155657489|NCT00522379|561838984|FG001|Overall Study|Sponsor Request|1|||
155657490|NCT00522379|561838985|FG002|Overall Study|Sponsor Request|0|||
155657491|NCT00522379|561838986|FG003|Overall Study|Sponsor Request|0|||
155657492|NCT00522379|561838987|FG004|Overall Study|Sponsor Request|0|||
155657493|NCT00522379|561838983|FG000|Overall Study|Family Problem|0|||
155657494|NCT00522379|561838984|FG001|Overall Study|Family Problem|0|||
155657495|NCT00522379|561838985|FG002|Overall Study|Family Problem|1|||
155657496|NCT00522379|561838986|FG003|Overall Study|Family Problem|0|||
155657497|NCT00522379|561838987|FG004|Overall Study|Family Problem|0|||
155657498|NCT00522379|561838983|FG000|Overall Study|Site Closed|0|||
155657499|NCT00522379|561838984|FG001|Overall Study|Site Closed|0|||
155657500|NCT00522379|561838985|FG002|Overall Study|Site Closed|0|||
155657501|NCT00522379|561838986|FG003|Overall Study|Site Closed|1|||
155657502|NCT00522379|561838987|FG004|Overall Study|Site Closed|0|||
155657503|NCT00522379|561838983|FG000|Overall Study|Subject Withdrawal|0|||
155657504|NCT00522379|561838984|FG001|Overall Study|Subject Withdrawal|0|||
155657505|NCT00522379|561838985|FG002|Overall Study|Subject Withdrawal|0|||
155657506|NCT00522379|561838986|FG003|Overall Study|Subject Withdrawal|1|||
155657507|NCT00522379|561838987|FG004|Overall Study|Subject Withdrawal|0|||
155657508|NCT02607722|561838993|FG000|Overall Study|No data reliability|1|||
155657509|NCT02607722|561838993|FG000|Overall Study|no patient visit|18|||
155657510|NCT02607722|561838993|FG000|Overall Study|missing info in CRF|13|||
155657511|NCT02607722|561838993|FG000|Overall Study|Withdrawal by Subject|616|||
155657512|NCT02607722|561838993|FG000|Overall Study|Lost to Follow-up|312|||
155657513|NCT02607722|561838993|FG000|Overall Study|Improved|22|||
155657514|NCT02607722|561838993|FG000|Overall Study|Lack of Efficacy|316|||
155553620|NCT00700817|561452389|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
155553621|NCT00700817|561452390|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
155553622|NCT00700817|561452391|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
155553623|NCT00700817|561452392|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
155553624|NCT00700817|561452393|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
155553625|NCT00700817|561452389|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
155553626|NCT00700817|561452390|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
155553627|NCT00700817|561452391|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
155553628|NCT00700817|561452392|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
155553629|NCT00700817|561452393|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
155553630|NCT00700817|561452389|FG000|Week 0-26 (Main Period)|Unclassified|14|||
155553631|NCT00700817|561452390|FG001|Week 0-26 (Main Period)|Unclassified|4|||
155553632|NCT00700817|561452391|FG002|Week 0-26 (Main Period)|Unclassified|8|||
155553633|NCT00700817|561452392|FG003|Week 0-26 (Main Period)|Unclassified|0|||
155553634|NCT00700817|561452393|FG004|Week 0-26 (Main Period)|Unclassified|0|||
155553635|NCT00700817|561452389|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
155553636|NCT00700817|561452390|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
155553637|NCT00700817|561452391|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
155553638|NCT00700817|561452392|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
155553639|NCT00700817|561452393|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
155553640|NCT00700817|561452389|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
155553641|NCT00700817|561452390|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
155553642|NCT00700817|561452391|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
155657515|NCT02607722|561838993|FG000|Overall Study|Adverse Event|2553|||
155657516|NCT02607722|561838993|FG000|Overall Study|Not treated|1|||
155657517|NCT02607722|561838993|FG000|Overall Study|No CRF collected|138|||
155657518|NCT02607722|561838993|FG000|Overall Study|without CRF|4225|||
155657519|NCT02607722|561838993|FG000|Overall Study|Physician Decision|367|||
155657520|NCT04347538|561838994|FG000|Overall Study|Lost to Follow-up|4|||
155657521|NCT04347538|561838995|FG001|Overall Study|Lost to Follow-up|5|||
155657522|NCT04347538|561838996|FG002|Overall Study|Lost to Follow-up|7|||
155657523|NCT02135133|561838997|FG000|Overall Study|Adverse Event|10|||
155657524|NCT02135133|561838997|FG000|Overall Study|regulatory mandate|5|||
155657525|NCT02259231|561838998|FG000|Overall Study|Adverse Event|1|||
155657526|NCT02259231|561838999|FG001|Overall Study|Adverse Event|1|||
155657527|NCT02259231|561839000|FG002|Overall Study|Adverse Event|2|||
155553643|NCT00700817|561452392|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
155657528|NCT02259231|561839001|FG003|Overall Study|Adverse Event|0|||
155657529|NCT02259231|561839002|FG004|Overall Study|Adverse Event|0|||
155657530|NCT02259231|561839003|FG005|Overall Study|Adverse Event|0|||
155657531|NCT02259231|561839004|FG006|Overall Study|Adverse Event|0|||
155657532|NCT02259231|561838998|FG000|Overall Study|Progressive Disease|4|||
155657533|NCT02259231|561838999|FG001|Overall Study|Progressive Disease|5|||
155657534|NCT02259231|561839000|FG002|Overall Study|Progressive Disease|4|||
155657535|NCT02259231|561839001|FG003|Overall Study|Progressive Disease|5|||
155657536|NCT02259231|561839002|FG004|Overall Study|Progressive Disease|4|||
155657537|NCT02259231|561839003|FG005|Overall Study|Progressive Disease|5|||
155553644|NCT00700817|561452393|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
155553645|NCT00700817|561452389|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
155553646|NCT00700817|561452390|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
155553647|NCT00700817|561452391|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
155553648|NCT00700817|561452392|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
155553649|NCT00700817|561452393|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
155553650|NCT00700817|561452389|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
155553651|NCT00700817|561452390|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
155553652|NCT00700817|561452391|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
155553653|NCT00700817|561452392|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
155553654|NCT00700817|561452393|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
155553655|NCT00700817|561452389|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
155553656|NCT00700817|561452390|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
155553657|NCT00700817|561452391|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
155553658|NCT00700817|561452392|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
155553659|NCT00700817|561452393|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
155553660|NCT00700817|561452389|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
155553661|NCT00700817|561452390|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
155553662|NCT00700817|561452391|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
155553663|NCT00700817|561452392|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
155553664|NCT00700817|561452393|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
155553665|NCT00700817|561452389|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
155553666|NCT00700817|561452390|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
155553667|NCT00700817|561452391|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
155553668|NCT00700817|561452392|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
155553669|NCT00700817|561452393|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
155553670|NCT00700817|561452389|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
155553671|NCT00700817|561452390|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
155553672|NCT00700817|561452391|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
155553673|NCT00700817|561452392|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
155553674|NCT00700817|561452393|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
155553675|NCT00700817|561452389|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
155553676|NCT00700817|561452390|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
155553677|NCT00700817|561452391|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
155553678|NCT00700817|561452392|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
155553679|NCT00700817|561452393|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
155657538|NCT02259231|561839004|FG006|Overall Study|Progressive Disease|4|||
155553680|NCT00700817|561452389|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
155553681|NCT00700817|561452390|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
155657539|NCT02259231|561838998|FG000|Overall Study|Sponsor termination of study|1|||
155657540|NCT02259231|561838999|FG001|Overall Study|Sponsor termination of study|0|||
155657541|NCT02259231|561839000|FG002|Overall Study|Sponsor termination of study|0|||
155657542|NCT02259231|561839001|FG003|Overall Study|Sponsor termination of study|1|||
155657543|NCT02259231|561839002|FG004|Overall Study|Sponsor termination of study|2|||
155657544|NCT02259231|561839003|FG005|Overall Study|Sponsor termination of study|1|||
155657545|NCT02259231|561839004|FG006|Overall Study|Sponsor termination of study|1|||
155657546|NCT03312543|561839007|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
155657547|NCT03312543|561839008|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
155657548|NCT03312543|561839007|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
155657549|NCT03312543|561839008|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
155553682|NCT00700817|561452391|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
155553683|NCT00700817|561452392|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
155553684|NCT00700817|561452393|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
155553685|NCT00767520|561452394|FG000|Overall Study|Participants still on treatment|11|||
155553686|NCT00767520|561452395|FG001|Overall Study|Participants still on treatment|15|||
155553687|NCT00767520|561452394|FG000|Overall Study|Randomized in error and Never treated|0|||
155553688|NCT00767520|561452395|FG001|Overall Study|Randomized in error and Never treated|2|||
155553689|NCT02777918|561452396|FG000|Overall Study|Medical reasons|1|||
155553690|NCT02777918|561452397|FG001|Overall Study|Medical reasons|2|||
155657550|NCT03312543|561839007|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
155657551|NCT03312543|561839008|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
155657552|NCT03312543|561839007|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
155657553|NCT03312543|561839008|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
155657554|NCT03312543|561839007|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
155553691|NCT02777918|561452396|FG000|Overall Study|Too busy / stressed|1|||
155553692|NCT02777918|561452397|FG001|Overall Study|Too busy / stressed|1|||
155553693|NCT02777918|561452396|FG000|Overall Study|Withdrawal by Subject|1|||
155657555|NCT03312543|561839008|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
155657556|NCT03312543|561839007|FG000|Regression (Week 12 to Week 24)|Death|0|||
155553694|NCT02777918|561452397|FG001|Overall Study|Withdrawal by Subject|1|||
155553695|NCT00058214|561452399|FG000|Overall Study|Adverse Event|1|||
155553696|NCT00958126|561452409|FG000|Overall Study|Serious Adverse Event|0|||
155553697|NCT00958126|561452410|FG001|Overall Study|Serious Adverse Event|2|||
155553698|NCT00958126|561452411|FG002|Overall Study|Serious Adverse Event|0|||
155553699|NCT00958126|561452412|FG003|Overall Study|Serious Adverse Event|0|||
155553700|NCT00958126|561452413|FG004|Overall Study|Serious Adverse Event|0|||
155553701|NCT00958126|561452414|FG005|Overall Study|Serious Adverse Event|0|||
155553702|NCT00958126|561452415|FG006|Overall Study|Serious Adverse Event|1|||
155553703|NCT00958126|561452416|FG007|Overall Study|Serious Adverse Event|0|||
155553704|NCT00958126|561452409|FG000|Overall Study|Withdrawal by Subject|0|||
155553705|NCT00958126|561452410|FG001|Overall Study|Withdrawal by Subject|2|||
155553706|NCT00958126|561452411|FG002|Overall Study|Withdrawal by Subject|0|||
155553707|NCT00958126|561452412|FG003|Overall Study|Withdrawal by Subject|0|||
155553708|NCT00958126|561452413|FG004|Overall Study|Withdrawal by Subject|0|||
155553709|NCT00958126|561452414|FG005|Overall Study|Withdrawal by Subject|0|||
155553710|NCT00958126|561452415|FG006|Overall Study|Withdrawal by Subject|0|||
155553711|NCT00958126|561452416|FG007|Overall Study|Withdrawal by Subject|0|||
155553712|NCT00958126|561452409|FG000|Overall Study|Moved away from study area|0|||
155553713|NCT00958126|561452410|FG001|Overall Study|Moved away from study area|0|||
155553714|NCT00958126|561452411|FG002|Overall Study|Moved away from study area|1|||
155553715|NCT00958126|561452412|FG003|Overall Study|Moved away from study area|1|||
155553716|NCT00958126|561452413|FG004|Overall Study|Moved away from study area|0|||
155553717|NCT00958126|561452414|FG005|Overall Study|Moved away from study area|0|||
155553718|NCT00958126|561452415|FG006|Overall Study|Moved away from study area|0|||
155553719|NCT00958126|561452416|FG007|Overall Study|Moved away from study area|0|||
155553720|NCT00958126|561452409|FG000|Overall Study|Lost to Follow-up|1|||
155553721|NCT00958126|561452410|FG001|Overall Study|Lost to Follow-up|5|||
155553722|NCT00958126|561452411|FG002|Overall Study|Lost to Follow-up|9|||
155553723|NCT00958126|561452412|FG003|Overall Study|Lost to Follow-up|8|||
155553724|NCT00958126|561452413|FG004|Overall Study|Lost to Follow-up|0|||
155553725|NCT00958126|561452414|FG005|Overall Study|Lost to Follow-up|0|||
155553726|NCT00958126|561452415|FG006|Overall Study|Lost to Follow-up|0|||
155553727|NCT00958126|561452416|FG007|Overall Study|Lost to Follow-up|0|||
155553728|NCT00958126|561452409|FG000|Overall Study|Sponsor/Investigator decision|0|||
155553729|NCT00958126|561452410|FG001|Overall Study|Sponsor/Investigator decision|0|||
155553730|NCT00958126|561452411|FG002|Overall Study|Sponsor/Investigator decision|0|||
155553731|NCT00958126|561452412|FG003|Overall Study|Sponsor/Investigator decision|1|||
155553732|NCT00958126|561452413|FG004|Overall Study|Sponsor/Investigator decision|0|||
155553733|NCT00958126|561452414|FG005|Overall Study|Sponsor/Investigator decision|0|||
155553734|NCT00958126|561452415|FG006|Overall Study|Sponsor/Investigator decision|0|||
155553735|NCT00958126|561452416|FG007|Overall Study|Sponsor/Investigator decision|0|||
155553736|NCT00958126|561452409|FG000|Overall Study|Other Reason|0|||
155553737|NCT00958126|561452410|FG001|Overall Study|Other Reason|0|||
155553738|NCT00958126|561452411|FG002|Overall Study|Other Reason|0|||
155553739|NCT00958126|561452412|FG003|Overall Study|Other Reason|1|||
155553740|NCT00958126|561452413|FG004|Overall Study|Other Reason|0|||
155553741|NCT00958126|561452414|FG005|Overall Study|Other Reason|1|||
155553742|NCT00958126|561452415|FG006|Overall Study|Other Reason|0|||
155553743|NCT00958126|561452416|FG007|Overall Study|Other Reason|0|||
155553744|NCT00720226|561452417|FG000|Overall Study|Withdrawal by Subject|7|||
155553745|NCT00720226|561452418|FG001|Overall Study|Withdrawal by Subject|4|||
155553746|NCT00733369|561452419|FG000|Overall Study|Lost to Follow-up|2|||
155553747|NCT00733369|561452420|FG001|Overall Study|Lost to Follow-up|1|||
155553748|NCT00733369|561452419|FG000|Overall Study|Adverse Event|4|||
155553749|NCT00733369|561452420|FG001|Overall Study|Adverse Event|4|||
155553750|NCT00733369|561452419|FG000|Overall Study|Protocol Violation|4|||
155553751|NCT00733369|561452420|FG001|Overall Study|Protocol Violation|4|||
155553752|NCT03401073|561452421|FG000|Overall Study|Lost to Follow-up|1|||
155553753|NCT03401073|561452422|FG001|Overall Study|Lost to Follow-up|2|||
155553754|NCT01470612|561452423|FG000|Overall Study|Adverse Event|20|||
155553755|NCT01470612|561452424|FG001|Overall Study|Adverse Event|80|||
155553756|NCT01470612|561452423|FG000|Overall Study|Death|0|||
155553757|NCT01470612|561452424|FG001|Overall Study|Death|1|||
155553758|NCT01470612|561452423|FG000|Overall Study|Lack of Efficacy|20|||
155553759|NCT01470612|561452424|FG001|Overall Study|Lack of Efficacy|326|||
155553760|NCT01470612|561452423|FG000|Overall Study|Lost to Follow-up|2|||
155553761|NCT01470612|561452424|FG001|Overall Study|Lost to Follow-up|5|||
155553762|NCT01470612|561452423|FG000|Overall Study|Did not meet entrance criteria|0|||
155553763|NCT01470612|561452424|FG001|Overall Study|Did not meet entrance criteria|1|||
155553764|NCT01470612|561452423|FG000|Overall Study|Pregnancy|2|||
155553765|NCT01470612|561452424|FG001|Overall Study|Pregnancy|10|||
155553766|NCT01470612|561452423|FG000|Overall Study|Protocol Violation|2|||
155553767|NCT01470612|561452424|FG001|Overall Study|Protocol Violation|7|||
155553768|NCT01470612|561452423|FG000|Overall Study|Withdrawal by Subject|24|||
155553769|NCT01470612|561452424|FG001|Overall Study|Withdrawal by Subject|79|||
155553770|NCT01470612|561452423|FG000|Overall Study|Other|14|||
155553771|NCT01470612|561452424|FG001|Overall Study|Other|156|||
155553772|NCT03078582|561452425|FG000|Overall Study|Adverse Event|0|||
155553773|NCT03078582|561452426|FG001|Overall Study|Adverse Event|8|||
155553774|NCT02039414|561452427|FG000|Overall Study|Delivered|1|||
155553775|NCT02039414|561452428|FG001|Overall Study|Delivered|1|||
155553776|NCT02039414|561452427|FG000|Overall Study|Lost to Follow-up|2|||
155553777|NCT02039414|561452428|FG001|Overall Study|Lost to Follow-up|0|||
155553778|NCT02039414|561452427|FG000|Overall Study|Protocol Violation|3|||
155553779|NCT02039414|561452428|FG001|Overall Study|Protocol Violation|1|||
155553780|NCT01347866|561452429|FG000|Overall Study|Death|0|||
155553781|NCT01347866|561452430|FG001|Overall Study|Death|0|||
155553782|NCT01347866|561452431|FG002|Overall Study|Death|0|||
155553783|NCT01347866|561452432|FG003|Overall Study|Death|1|||
155553784|NCT01347866|561452433|FG004|Overall Study|Death|2|||
155553785|NCT01347866|561452434|FG005|Overall Study|Death|2|||
155553786|NCT01347866|561452435|FG006|Overall Study|Death|1|||
155553787|NCT01347866|561452436|FG007|Overall Study|Death|0|||
155553788|NCT01347866|561452437|FG008|Overall Study|Death|4|||
155553789|NCT01347866|561452438|FG009|Overall Study|Death|1|||
155553790|NCT01347866|561452439|FG010|Overall Study|Death|3|||
155553791|NCT01347866|561452440|FG011|Overall Study|Death|1|||
155553792|NCT01347866|561452441|FG012|Overall Study|Death|2|||
155553793|NCT01347866|561452442|FG013|Overall Study|Death|0|||
155553794|NCT01347866|561452443|FG014|Overall Study|Death|0|||
155553795|NCT01347866|561452444|FG015|Overall Study|Death|1|||
155553796|NCT01347866|561452445|FG016|Overall Study|Death|0|||
155553797|NCT01347866|561452429|FG000|Overall Study|Lost to Follow-up|0|||
155553798|NCT01347866|561452430|FG001|Overall Study|Lost to Follow-up|0|||
155553799|NCT01347866|561452431|FG002|Overall Study|Lost to Follow-up|0|||
155553800|NCT01347866|561452432|FG003|Overall Study|Lost to Follow-up|0|||
155553801|NCT01347866|561452433|FG004|Overall Study|Lost to Follow-up|0|||
155553802|NCT01347866|561452434|FG005|Overall Study|Lost to Follow-up|0|||
155553803|NCT01347866|561452435|FG006|Overall Study|Lost to Follow-up|0|||
155553804|NCT01347866|561452436|FG007|Overall Study|Lost to Follow-up|1|||
155553805|NCT01347866|561452437|FG008|Overall Study|Lost to Follow-up|1|||
155553806|NCT01347866|561452438|FG009|Overall Study|Lost to Follow-up|0|||
155553807|NCT01347866|561452439|FG010|Overall Study|Lost to Follow-up|0|||
155553808|NCT01347866|561452440|FG011|Overall Study|Lost to Follow-up|0|||
155553809|NCT01347866|561452441|FG012|Overall Study|Lost to Follow-up|0|||
155553810|NCT01347866|561452442|FG013|Overall Study|Lost to Follow-up|0|||
155553811|NCT01347866|561452443|FG014|Overall Study|Lost to Follow-up|0|||
155553812|NCT01347866|561452444|FG015|Overall Study|Lost to Follow-up|0|||
155553813|NCT01347866|561452445|FG016|Overall Study|Lost to Follow-up|0|||
155553814|NCT01347866|561452429|FG000|Overall Study|Other|3|||
155553815|NCT01347866|561452430|FG001|Overall Study|Other|1|||
155553816|NCT01347866|561452431|FG002|Overall Study|Other|1|||
155553817|NCT01347866|561452432|FG003|Overall Study|Other|4|||
155553818|NCT01347866|561452433|FG004|Overall Study|Other|5|||
155553819|NCT01347866|561452434|FG005|Overall Study|Other|0|||
155553820|NCT01347866|561452435|FG006|Overall Study|Other|5|||
155553821|NCT01347866|561452436|FG007|Overall Study|Other|3|||
155553822|NCT01347866|561452437|FG008|Overall Study|Other|22|||
155553823|NCT01347866|561452438|FG009|Overall Study|Other|5|||
155553824|NCT01347866|561452439|FG010|Overall Study|Other|0|||
155553825|NCT01347866|561452440|FG011|Overall Study|Other|3|||
155553826|NCT01347866|561452441|FG012|Overall Study|Other|4|||
155553827|NCT01347866|561452442|FG013|Overall Study|Other|4|||
155553828|NCT01347866|561452443|FG014|Overall Study|Other|2|||
155553829|NCT01347866|561452444|FG015|Overall Study|Other|3|||
155553830|NCT01347866|561452445|FG016|Overall Study|Other|0|||
155553831|NCT01347866|561452429|FG000|Overall Study|Subject refused further follow-up|2|||
155553832|NCT01347866|561452430|FG001|Overall Study|Subject refused further follow-up|0|||
155553833|NCT01347866|561452431|FG002|Overall Study|Subject refused further follow-up|0|||
155553834|NCT01347866|561452432|FG003|Overall Study|Subject refused further follow-up|2|||
155553835|NCT01347866|561452433|FG004|Overall Study|Subject refused further follow-up|0|||
155553836|NCT01347866|561452434|FG005|Overall Study|Subject refused further follow-up|1|||
155553837|NCT01347866|561452435|FG006|Overall Study|Subject refused further follow-up|0|||
155553838|NCT01347866|561452436|FG007|Overall Study|Subject refused further follow-up|0|||
155553839|NCT01347866|561452437|FG008|Overall Study|Subject refused further follow-up|4|||
155553840|NCT01347866|561452438|FG009|Overall Study|Subject refused further follow-up|1|||
155553841|NCT01347866|561452439|FG010|Overall Study|Subject refused further follow-up|0|||
155553842|NCT01347866|561452440|FG011|Overall Study|Subject refused further follow-up|0|||
155553843|NCT01347866|561452441|FG012|Overall Study|Subject refused further follow-up|1|||
155553844|NCT01347866|561452442|FG013|Overall Study|Subject refused further follow-up|3|||
155553845|NCT01347866|561452443|FG014|Overall Study|Subject refused further follow-up|1|||
155553846|NCT01347866|561452444|FG015|Overall Study|Subject refused further follow-up|0|||
155553847|NCT01347866|561452445|FG016|Overall Study|Subject refused further follow-up|2|||
155553848|NCT00430950|561452446|FG000|Overall Study|Adverse Event|7|||
155553849|NCT00430950|561452447|FG001|Overall Study|Adverse Event|6|||
155553850|NCT00430950|561452446|FG000|Overall Study|Withdrawal by Subject|1|||
155553851|NCT00430950|561452447|FG001|Overall Study|Withdrawal by Subject|0|||
155553852|NCT00430950|561452446|FG000|Overall Study|concomitant medication,etc.|5|||
155657557|NCT03312543|561839008|FG001|Regression (Week 12 to Week 24)|Death|1|||
155657558|NCT04507269|561839009|FG000|Overall Study|Withdrawal by Subject|1|||
155657559|NCT04507269|561839010|FG001|Overall Study|Withdrawal by Subject|1|||
155657560|NCT04507269|561839011|FG002|Overall Study|Withdrawal by Subject|0|||
155657561|NCT04507269|561839012|FG003|Overall Study|Withdrawal by Subject|0|||
155657562|NCT04507269|561839013|FG004|Overall Study|Withdrawal by Subject|0|||
155657563|NCT04507269|561839014|FG005|Overall Study|Withdrawal by Subject|0|||
155657564|NCT04507269|561839009|FG000|Overall Study|Lost to Follow-up|0|||
155657565|NCT04507269|561839010|FG001|Overall Study|Lost to Follow-up|0|||
155657566|NCT04507269|561839011|FG002|Overall Study|Lost to Follow-up|0|||
155657567|NCT04507269|561839012|FG003|Overall Study|Lost to Follow-up|0|||
155657568|NCT04507269|561839013|FG004|Overall Study|Lost to Follow-up|1|||
155657569|NCT04507269|561839014|FG005|Overall Study|Lost to Follow-up|0|||
155657570|NCT05852340|561839015|FG000|Period 5|Not completing the meal|0|||
155657571|NCT05852340|561839016|FG001|Period 5|Not completing the meal|1|||
155657572|NCT05852340|561839017|FG002|Period 5|Not completing the meal|0|||
155657573|NCT05852340|561839018|FG003|Period 5|Not completing the meal|0|||
155657574|NCT05852340|561839015|FG000|Period 5|Adverse Event|0|||
155657575|NCT05852340|561839016|FG001|Period 5|Adverse Event|0|||
155657576|NCT05852340|561839017|FG002|Period 5|Adverse Event|0|||
155657577|NCT05852340|561839018|FG003|Period 5|Adverse Event|1|||
155657578|NCT02402647|561839019|FG000|Overall Study|Lost to Follow-up|13|||
155657579|NCT02402647|561839020|FG001|Overall Study|Lost to Follow-up|7|||
155657580|NCT02402647|561839019|FG000|Overall Study|Protocol Violation|1|||
155657581|NCT02402647|561839020|FG001|Overall Study|Protocol Violation|1|||
155657582|NCT02402647|561839019|FG000|Overall Study|scheduled and timed out|2|||
155657583|NCT02402647|561839020|FG001|Overall Study|scheduled and timed out|1|||
155657584|NCT02402647|561839019|FG000|Overall Study|medical illness|2|||
155657585|NCT02402647|561839020|FG001|Overall Study|medical illness|4|||
155657586|NCT02402647|561839019|FG000|Overall Study|Moved|2|||
155657587|NCT02402647|561839020|FG001|Overall Study|Moved|0|||
155657588|NCT02402647|561839019|FG000|Overall Study|loved one illness|1|||
155657589|NCT02402647|561839020|FG001|Overall Study|loved one illness|0|||
155657590|NCT02402647|561839019|FG000|Overall Study|deceased preexisting condition|2|||
155657591|NCT02402647|561839020|FG001|Overall Study|deceased preexisting condition|0|||
155657592|NCT02402647|561839019|FG000|Overall Study|Other|2|||
155657593|NCT02402647|561839020|FG001|Overall Study|Other|1|||
155657594|NCT03211416|561839026|FG000|Overall Study|Adverse Event|7|||
155657595|NCT03211416|561839026|FG000|Overall Study|Lack of Efficacy|2|||
155657596|NCT03211416|561839026|FG000|Overall Study|Physician Decision|1|||
155657597|NCT03559556|561839030|FG000|Overall Study|Withdrawal by Subject|1|||
155657598|NCT00095576|561840374|FG000|Overall Study|Adverse Event|5|||
155657599|NCT00095576|561840375|FG001|Overall Study|Adverse Event|3|||
155657600|NCT00095576|561840374|FG000|Overall Study|Lost to Follow-up|233|||
155657601|NCT00095576|561840375|FG001|Overall Study|Lost to Follow-up|229|||
155657602|NCT00095576|561840374|FG000|Overall Study|Protocol Violation|1|||
155657603|NCT00095576|561840375|FG001|Overall Study|Protocol Violation|0|||
155657604|NCT00095576|561840374|FG000|Overall Study|Withdrawal by Subject|34|||
155657605|NCT00095576|561840375|FG001|Overall Study|Withdrawal by Subject|47|||
155657606|NCT00095576|561840374|FG000|Overall Study|Option to switch to a rollover study|1097|||
155657607|NCT00095576|561840375|FG001|Overall Study|Option to switch to a rollover study|1099|||
155657608|NCT00095576|561840374|FG000|Overall Study|Site terminated|75|||
155657609|NCT00095576|561840375|FG001|Overall Study|Site terminated|67|||
155657610|NCT00095576|561840374|FG000|Overall Study|Subject moved|30|||
155657611|NCT00095576|561840375|FG001|Overall Study|Subject moved|36|||
155657612|NCT01344356|561840376|FG000|Overall Study|Physician Decision|0|||
155657613|NCT01344356|561840377|FG001|Overall Study|Physician Decision|3|||
155657614|NCT01344356|561840376|FG000|Overall Study|Lost to Follow-up|0|||
155657615|NCT01344356|561840377|FG001|Overall Study|Lost to Follow-up|6|||
155657616|NCT02390076|561840379|FG000|Overall Study|Lost to Follow-up|2|||
155657617|NCT02390076|561840380|FG001|Overall Study|Lost to Follow-up|1|||
155657618|NCT02390076|561840381|FG002|Overall Study|Lost to Follow-up|4|||
155657619|NCT01206517|561840382|FG000|Overall Study|Withdrawal by Subject|0|||
155657620|NCT01206517|561840383|FG001|Overall Study|Withdrawal by Subject|0|||
155657621|NCT01206517|561840384|FG002|Overall Study|Withdrawal by Subject|2|||
155657622|NCT01206517|561840385|FG003|Overall Study|Withdrawal by Subject|0|||
155657623|NCT01206517|561840386|FG004|Overall Study|Withdrawal by Subject|1|||
155657624|NCT01206517|561840387|FG005|Overall Study|Withdrawal by Subject|0|||
155657625|NCT01822925|561840390|FG000|Overall Study|Adverse Event|1|||
155657626|NCT01822925|561840391|FG001|Overall Study|Adverse Event|1|||
155657627|NCT01822925|561840392|FG002|Overall Study|Adverse Event|1|||
155553853|NCT00430950|561452447|FG001|Overall Study|concomitant medication,etc.|7|||
155553854|NCT02429934|561452450|FG000|Overall Study|Withdrawal by Subject|0|||
155553855|NCT02429934|561452451|FG001|Overall Study|Withdrawal by Subject|2|||
155553856|NCT02429934|561452450|FG000|Overall Study|Adverse Event|2|||
155553857|NCT02429934|561452451|FG001|Overall Study|Adverse Event|0|||
155553858|NCT02429934|561452450|FG000|Overall Study|Lost to Follow-up|1|||
155553859|NCT02429934|561452451|FG001|Overall Study|Lost to Follow-up|1|||
155553860|NCT02429934|561452450|FG000|Overall Study|Physician Decision|1|||
155553861|NCT02429934|561452451|FG001|Overall Study|Physician Decision|0|||
155553862|NCT00869024|561452452|FG000|Overall Study|Death|2|||
155553863|NCT00869024|561452453|FG001|Overall Study|Death|3|||
155553864|NCT00869024|561452452|FG000|Overall Study|Lost to Follow-up|0|||
155553865|NCT00869024|561452453|FG001|Overall Study|Lost to Follow-up|1|||
155553866|NCT00869024|561452452|FG000|Overall Study|Protocol Violation|0|||
155553867|NCT00869024|561452453|FG001|Overall Study|Protocol Violation|1|||
155553868|NCT00293202|561452454|FG000|Overall Study|Withdrawal by Subject|1|||
155553869|NCT00293202|561452455|FG001|Overall Study|Withdrawal by Subject|2|||
155553870|NCT00293202|561452454|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
155553871|NCT00293202|561452455|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
155553872|NCT00293202|561452454|FG000|Overall Study|on-hold due to fistula maturation time|1|||
155553873|NCT00293202|561452455|FG001|Overall Study|on-hold due to fistula maturation time|0|||
155553874|NCT01564459|561452457|FG000|Run-In|Adverse Event|7|||
155553875|NCT01564459|561452458|FG001|Run-In|Adverse Event|0|||
155553876|NCT01564459|561452459|FG002|Run-In|Adverse Event|0|||
155553877|NCT01564459|561452457|FG000|Run-In|Lost to Follow-up|1|||
155553878|NCT01564459|561452458|FG001|Run-In|Lost to Follow-up|0|||
155553879|NCT01564459|561452459|FG002|Run-In|Lost to Follow-up|0|||
155553880|NCT01564459|561452457|FG000|Run-In|Non-compliance with study drug|2|||
155553881|NCT01564459|561452458|FG001|Run-In|Non-compliance with study drug|0|||
155553882|NCT01564459|561452459|FG002|Run-In|Non-compliance with study drug|0|||
155553883|NCT01564459|561452457|FG000|Run-In|Protocol Violation|1|||
155553884|NCT01564459|561452458|FG001|Run-In|Protocol Violation|0|||
155553885|NCT01564459|561452459|FG002|Run-In|Protocol Violation|0|||
155553886|NCT01564459|561452457|FG000|Run-In|Withdrawal by Subject|1|||
155553887|NCT01564459|561452458|FG001|Run-In|Withdrawal by Subject|0|||
155553888|NCT01564459|561452459|FG002|Run-In|Withdrawal by Subject|0|||
155553889|NCT01564459|561452457|FG000|Double-blind Treatment|Adverse Event|0|||
155553890|NCT01564459|561452458|FG001|Double-blind Treatment|Adverse Event|0|||
155553891|NCT01564459|561452459|FG002|Double-blind Treatment|Adverse Event|1|||
155553892|NCT02025751|561452467|FG000|Overall Study|Lost to Follow-up|1|||
155553893|NCT02025751|561452468|FG001|Overall Study|Lost to Follow-up|0|||
155553894|NCT02025751|561452467|FG000|Overall Study|Adverse Event|0|||
155553895|NCT02025751|561452468|FG001|Overall Study|Adverse Event|1|||
155553896|NCT02025751|561452467|FG000|Overall Study|Physician Decision|0|||
155553897|NCT02025751|561452468|FG001|Overall Study|Physician Decision|1|||
155553898|NCT02025751|561452467|FG000|Overall Study|Withdrawal by Subject|0|||
155553899|NCT02025751|561452468|FG001|Overall Study|Withdrawal by Subject|1|||
155553900|NCT02181296|561452469|FG000|Overall Study|Lost to Follow-up|7|||
155553901|NCT02181296|561452470|FG001|Overall Study|Lost to Follow-up|6|||
155553902|NCT03864042|561452471|FG000|DDI Phase|Adverse Event|2|||
155553903|NCT03864042|561452472|FG001|DDI Phase|Adverse Event|0|||
155553904|NCT03864042|561452473|FG002|DDI Phase|Adverse Event|0|||
155553905|NCT03864042|561452471|FG000|DDI Phase|Physician Decision|1|||
155553906|NCT03864042|561452472|FG001|DDI Phase|Physician Decision|0|||
155553907|NCT03864042|561452473|FG002|DDI Phase|Physician Decision|0|||
155553908|NCT03864042|561452471|FG000|DDI Phase|Progressive Disease|1|||
155553909|NCT03864042|561452472|FG001|DDI Phase|Progressive Disease|0|||
155553910|NCT03864042|561452473|FG002|DDI Phase|Progressive Disease|0|||
155553911|NCT03864042|561452471|FG000|Post-DDI Phase|Adverse Event|5|||
155553912|NCT03864042|561452472|FG001|Post-DDI Phase|Adverse Event|3|||
155657628|NCT01822925|561840393|FG003|Overall Study|Adverse Event|1|||
155657629|NCT01822925|561840390|FG000|Overall Study|Lost to Follow-up|0|||
155657630|NCT01822925|561840391|FG001|Overall Study|Lost to Follow-up|1|||
155657631|NCT01822925|561840392|FG002|Overall Study|Lost to Follow-up|0|||
155657632|NCT01822925|561840393|FG003|Overall Study|Lost to Follow-up|0|||
155553913|NCT03864042|561452473|FG002|Post-DDI Phase|Adverse Event|2|||
155553914|NCT03864042|561452471|FG000|Post-DDI Phase|Progressive Disease|11|||
155553915|NCT03864042|561452472|FG001|Post-DDI Phase|Progressive Disease|6|||
155553916|NCT03864042|561452473|FG002|Post-DDI Phase|Progressive Disease|13|||
155553917|NCT03864042|561452471|FG000|Post-DDI Phase|Discretion of investigator|1|||
155553918|NCT03864042|561452472|FG001|Post-DDI Phase|Discretion of investigator|1|||
155553919|NCT03864042|561452473|FG002|Post-DDI Phase|Discretion of investigator|0|||
155553920|NCT03864042|561452471|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
155553921|NCT03864042|561452472|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
155553922|NCT03864042|561452473|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
155553923|NCT03864042|561452471|FG000|Post-DDI Phase|Withdrawal of consent|1|||
155553924|NCT03864042|561452472|FG001|Post-DDI Phase|Withdrawal of consent|2|||
155553925|NCT03864042|561452473|FG002|Post-DDI Phase|Withdrawal of consent|0|||
155553926|NCT00766831|561452476|FG000|Overall Study|Withdrawal by Subject|4|||
155553927|NCT00766831|561452476|FG000|Overall Study|Lost to Follow-up|3|||
155553928|NCT00766831|561452476|FG000|Overall Study|Adverse Event|20|||
155553929|NCT00766831|561452476|FG000|Overall Study|Protocol Violation|15|||
155553930|NCT00766831|561452476|FG000|Overall Study|Physician Decision|5|||
155553931|NCT00766831|561452476|FG000|Overall Study|Withdrawal of consent|26|||
155553932|NCT00766831|561452476|FG000|Overall Study|Non cooperation by participants|14|||
155553933|NCT00766831|561452476|FG000|Overall Study|Other|28|||
155553934|NCT00788593|561452479|FG000|Placebo Run-in Phase|Adverse Event|2|||
155553935|NCT00788593|561452480|FG001|Placebo Run-in Phase|Adverse Event|0|||
155553936|NCT00788593|561452481|FG002|Placebo Run-in Phase|Adverse Event|0|||
155553937|NCT00788593|561452479|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
155553938|NCT00788593|561452480|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
155553939|NCT00788593|561452481|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
155553940|NCT00788593|561452479|FG000|Placebo Run-in Phase|Protocol Violation|2|||
155553941|NCT00788593|561452480|FG001|Placebo Run-in Phase|Protocol Violation|0|||
155553942|NCT00788593|561452481|FG002|Placebo Run-in Phase|Protocol Violation|0|||
155553943|NCT00788593|561452479|FG000|First Intervention Period|Adverse Event|0|||
155553944|NCT00788593|561452480|FG001|First Intervention Period|Adverse Event|1|||
155553945|NCT00788593|561452481|FG002|First Intervention Period|Adverse Event|0|||
155553946|NCT00788593|561452479|FG000|Second Intervention Period|Lost to Follow-up|0|||
155553947|NCT00788593|561452480|FG001|Second Intervention Period|Lost to Follow-up|1|||
155553948|NCT00788593|561452481|FG002|Second Intervention Period|Lost to Follow-up|0|||
155553949|NCT00788593|561452479|FG000|Second Intervention Period|Other|0|||
155553950|NCT00788593|561452480|FG001|Second Intervention Period|Other|0|||
155553951|NCT00788593|561452481|FG002|Second Intervention Period|Other|1|||
155553952|NCT01392326|561452482|FG000|Overall Study|Death|2|||
155553953|NCT01392326|561452483|FG001|Overall Study|Death|0|||
155553954|NCT01392326|561452484|FG002|Overall Study|Death|0|||
155553955|NCT01392326|561452482|FG000|Overall Study|Withdrawal by Subject|12|||
155553956|NCT01392326|561452483|FG001|Overall Study|Withdrawal by Subject|11|||
155553957|NCT01392326|561452484|FG002|Overall Study|Withdrawal by Subject|15|||
155553958|NCT01392326|561452482|FG000|Overall Study|Protocol Violation|2|||
155553959|NCT01392326|561452483|FG001|Overall Study|Protocol Violation|0|||
155553960|NCT01392326|561452484|FG002|Overall Study|Protocol Violation|0|||
155553961|NCT01392326|561452482|FG000|Overall Study|Pregnancy|0|||
155553962|NCT01392326|561452483|FG001|Overall Study|Pregnancy|0|||
155553963|NCT01392326|561452484|FG002|Overall Study|Pregnancy|1|||
155553964|NCT01392326|561452482|FG000|Overall Study|Physician Decision|7|||
155553965|NCT01392326|561452483|FG001|Overall Study|Physician Decision|5|||
155553966|NCT01392326|561452484|FG002|Overall Study|Physician Decision|2|||
155553967|NCT01392326|561452482|FG000|Overall Study|Lost to Follow-up|1|||
155657633|NCT01822925|561840390|FG000|Overall Study|Protocol Violation|1|||
155657634|NCT01822925|561840391|FG001|Overall Study|Protocol Violation|0|||
155657635|NCT01822925|561840392|FG002|Overall Study|Protocol Violation|0|||
155553968|NCT01392326|561452483|FG001|Overall Study|Lost to Follow-up|3|||
155553969|NCT01392326|561452484|FG002|Overall Study|Lost to Follow-up|4|||
155553970|NCT01392326|561452482|FG000|Overall Study|Lack of Efficacy|14|||
155553971|NCT01392326|561452483|FG001|Overall Study|Lack of Efficacy|10|||
155553972|NCT01392326|561452484|FG002|Overall Study|Lack of Efficacy|15|||
155553973|NCT01392326|561452482|FG000|Overall Study|Adverse Event|9|||
155553974|NCT01392326|561452483|FG001|Overall Study|Adverse Event|6|||
155553975|NCT01392326|561452484|FG002|Overall Study|Adverse Event|11|||
155553976|NCT00518622|561452485|FG000|Overall Study|Lost to Follow-up|0|||
155553977|NCT00518622|561452486|FG001|Overall Study|Lost to Follow-up|0|||
155553978|NCT00518622|561452487|FG002|Overall Study|Lost to Follow-up|1|||
155553979|NCT00518622|561452488|FG003|Overall Study|Lost to Follow-up|0|||
155553980|NCT00518622|561452489|FG004|Overall Study|Lost to Follow-up|0|||
155553981|NCT00518622|561452490|FG005|Overall Study|Lost to Follow-up|0|||
155553982|NCT00518622|561452491|FG006|Overall Study|Lost to Follow-up|0|||
155553983|NCT00518622|561452492|FG007|Overall Study|Lost to Follow-up|0|||
155553984|NCT00518622|561452485|FG000|Overall Study|Study medication taken incorrectly|0|||
155553985|NCT00518622|561452486|FG001|Overall Study|Study medication taken incorrectly|1|||
155553986|NCT00518622|561452487|FG002|Overall Study|Study medication taken incorrectly|0|||
155553987|NCT00518622|561452488|FG003|Overall Study|Study medication taken incorrectly|0|||
155553988|NCT00518622|561452489|FG004|Overall Study|Study medication taken incorrectly|0|||
155553989|NCT00518622|561452490|FG005|Overall Study|Study medication taken incorrectly|0|||
155553990|NCT00518622|561452491|FG006|Overall Study|Study medication taken incorrectly|0|||
155553991|NCT00518622|561452492|FG007|Overall Study|Study medication taken incorrectly|0|||
155553992|NCT03499119|561452493|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
155553993|NCT03499119|561452494|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
155553994|NCT03499119|561452495|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
155553995|NCT03499119|561452496|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
155553996|NCT03499119|561452493|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
155553997|NCT03499119|561452494|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
155553998|NCT03499119|561452495|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
155553999|NCT03499119|561452496|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
155554000|NCT03499119|561452493|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
155554001|NCT03499119|561452494|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
155554002|NCT03499119|561452495|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
155554003|NCT03499119|561452496|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
155554004|NCT03499119|561452493|FG000|Optional Extension Phase|Lost to Follow-up|0|||
155554005|NCT03499119|561452494|FG001|Optional Extension Phase|Lost to Follow-up|0|||
155554006|NCT03499119|561452495|FG002|Optional Extension Phase|Lost to Follow-up|0|||
155554007|NCT03499119|561452496|FG003|Optional Extension Phase|Lost to Follow-up|1|||
155554008|NCT03499119|561452493|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
155554009|NCT03499119|561452494|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
155554010|NCT03499119|561452495|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
155554011|NCT03499119|561452496|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
155554012|NCT03499119|561452493|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
155554013|NCT03499119|561452494|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
155554014|NCT03499119|561452495|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
155554015|NCT03499119|561452496|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
155554016|NCT02333487|561452497|FG000|Overall Study|Adverse Event|0|||
155554017|NCT02333487|561452498|FG001|Overall Study|Adverse Event|2|||
155554018|NCT02333487|561452499|FG002|Overall Study|Adverse Event|0|||
155554019|NCT00123955|561452500|FG000|Overall Study|Adverse Event|1|||
155554020|NCT00123955|561452501|FG001|Overall Study|Adverse Event|0|||
155554021|NCT00123955|561452500|FG000|Overall Study|Withdrawal by Subject|4|||
155554022|NCT00123955|561452501|FG001|Overall Study|Withdrawal by Subject|3|||
155554023|NCT00123955|561452500|FG000|Overall Study|Death|0|||
155554024|NCT00123955|561452501|FG001|Overall Study|Death|1|||
155554025|NCT01558297|561452502|FG000|Overall Study|Withdrawal by Subject|2|||
155554026|NCT01558297|561452503|FG001|Overall Study|Withdrawal by Subject|2|||
155554027|NCT01558297|561452504|FG002|Overall Study|Withdrawal by Subject|1|||
155554028|NCT00094094|561452505|FG000|Overall Study|Death|2|||
155554029|NCT00094094|561452505|FG000|Overall Study|Lack of Efficacy|23|||
155554030|NCT00094094|561452505|FG000|Overall Study|Adverse Event|7|||
155554031|NCT04459715|561452510|FG000|Overall Study|Adverse Event|3|||
155554032|NCT04459715|561452511|FG001|Overall Study|Adverse Event|3|||
155554033|NCT04459715|561452510|FG000|Overall Study|Death|111|||
155554034|NCT04459715|561452511|FG001|Overall Study|Death|93|||
155554035|NCT04459715|561452510|FG000|Overall Study|Lost to Follow-up|10|||
155554036|NCT04459715|561452511|FG001|Overall Study|Lost to Follow-up|9|||
155554037|NCT04459715|561452510|FG000|Overall Study|Other Reasons|4|||
155554038|NCT04459715|561452511|FG001|Overall Study|Other Reasons|5|||
155554039|NCT04459715|561452510|FG000|Overall Study|PROTOCOL DEVIATION|0|||
155554040|NCT04459715|561452511|FG001|Overall Study|PROTOCOL DEVIATION|1|||
155554041|NCT04459715|561452510|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
155554042|NCT04459715|561452511|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
155554043|NCT04459715|561452510|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
155554044|NCT04459715|561452511|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
155554045|NCT04459715|561452510|FG000|Overall Study|Withdrawal by Subject|22|||
155554046|NCT04459715|561452511|FG001|Overall Study|Withdrawal by Subject|22|||
155554047|NCT02427984|561452512|FG000|Overall Study|Lost to Follow-up|13|||
155554048|NCT02427984|561452513|FG001|Overall Study|Lost to Follow-up|5|||
155554049|NCT02427984|561452514|FG002|Overall Study|Lost to Follow-up|18|||
155554056|NCT02631876|561453782|FG000|Overall Study|Death|96|||
155554057|NCT02631876|561453783|FG001|Overall Study|Death|50|||
155554058|NCT02631876|561453782|FG000|Overall Study|Investigator's discretion|1|||
155554059|NCT02631876|561453783|FG001|Overall Study|Investigator's discretion|0|||
155554060|NCT02631876|561453782|FG000|Overall Study|Lost to Follow-up|2|||
155554061|NCT02631876|561453783|FG001|Overall Study|Lost to Follow-up|0|||
155554062|NCT02631876|561453782|FG000|Overall Study|Withdrawal by Subject|16|||
155554063|NCT02631876|561453783|FG001|Overall Study|Withdrawal by Subject|9|||
155554064|NCT02631876|561453782|FG000|Overall Study|Other than specified|4|||
155554065|NCT02631876|561453783|FG001|Overall Study|Other than specified|4|||
155554066|NCT01013649|561453786|FG000|First Step|Withdrawal by Subject|36|||
155554067|NCT01013649|561453787|FG001|First Step|Withdrawal by Subject|19|||
155554068|NCT01013649|561453788|FG002|First Step|Withdrawal by Subject|0|||
155554069|NCT01013649|561453789|FG003|First Step|Withdrawal by Subject|0|||
155554070|NCT01013649|561453786|FG000|First Step|Progression|58|||
155554071|NCT01013649|561453787|FG001|First Step|Progression|23|||
155554072|NCT01013649|561453788|FG002|First Step|Progression|0|||
155554073|NCT01013649|561453789|FG003|First Step|Progression|0|||
155554074|NCT01013649|561453786|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
155554075|NCT01013649|561453787|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
155554076|NCT01013649|561453788|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
155554077|NCT01013649|561453789|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
155554078|NCT01013649|561453786|FG000|First Step|Death|3|||
155554079|NCT01013649|561453787|FG001|First Step|Death|4|||
155554080|NCT01013649|561453788|FG002|First Step|Death|0|||
155554081|NCT01013649|561453789|FG003|First Step|Death|0|||
155554082|NCT01013649|561453786|FG000|First Step|Adverse Event|9|||
155554083|NCT01013649|561453787|FG001|First Step|Adverse Event|5|||
155554084|NCT01013649|561453788|FG002|First Step|Adverse Event|0|||
155554085|NCT01013649|561453789|FG003|First Step|Adverse Event|0|||
155554086|NCT01013649|561453786|FG000|First Step|Other|4|||
155554087|NCT01013649|561453787|FG001|First Step|Other|6|||
155554088|NCT01013649|561453788|FG002|First Step|Other|0|||
155554089|NCT01013649|561453789|FG003|First Step|Other|0|||
155554090|NCT04285567|561453790|FG000|Overall Study|Death|3|||
155554091|NCT04285567|561453791|FG001|Overall Study|Death|3|||
155554092|NCT04285567|561453790|FG000|Overall Study|Lost to Follow-up|1|||
155554093|NCT04285567|561453791|FG001|Overall Study|Lost to Follow-up|1|||
155554094|NCT04285567|561453790|FG000|Overall Study|Reason Not Specified|1|||
155554095|NCT04285567|561453791|FG001|Overall Study|Reason Not Specified|1|||
155554096|NCT04285567|561453790|FG000|Overall Study|Physician Decision|2|||
155554097|NCT04285567|561453791|FG001|Overall Study|Physician Decision|1|||
155554098|NCT04285567|561453790|FG000|Overall Study|Withdrawal by Subject|2|||
155554099|NCT04285567|561453791|FG001|Overall Study|Withdrawal by Subject|6|||
155554100|NCT04285567|561453790|FG000|Overall Study|Adverse Event|1|||
155554101|NCT04285567|561453791|FG001|Overall Study|Adverse Event|0|||
155554102|NCT04285567|561453790|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
155554103|NCT04285567|561453791|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
155554104|NCT01408563|561453792|FG000|Overall Study|Ineligible after consent/ registration|2|||
155554105|NCT00931268|561453796|FG000|Overall Study|Lost to Follow-up|6|||
155554106|NCT02072148|561453797|FG000|Overall Study|withdrew prior to surgery|23|||
155554107|NCT02072148|561453798|FG001|Overall Study|withdrew prior to surgery|0|||
155554108|NCT02072148|561453799|FG002|Overall Study|withdrew prior to surgery|0|||
155554109|NCT02072148|561453797|FG000|Overall Study|Death|0|||
155554110|NCT02072148|561453798|FG001|Overall Study|Death|0|||
155554111|NCT02072148|561453799|FG002|Overall Study|Death|1|||
155554112|NCT02072148|561453797|FG000|Overall Study|Withdrawal by Subject|0|||
155554113|NCT02072148|561453798|FG001|Overall Study|Withdrawal by Subject|13|||
155554114|NCT02072148|561453799|FG002|Overall Study|Withdrawal by Subject|12|||
155554115|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
155554116|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
155554117|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
155554118|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
155554119|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
155554120|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
155554121|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
155554122|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
155554123|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
155554124|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
155554125|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
155554126|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
155554127|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
155554128|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
155554129|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
155554130|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
155554131|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
155554132|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
155554133|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
155554134|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
155554135|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
155554136|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
155657636|NCT01822925|561840393|FG003|Overall Study|Protocol Violation|1|||
155657637|NCT01822925|561840390|FG000|Overall Study|Withdrawal by Subject|2|||
155657638|NCT01822925|561840391|FG001|Overall Study|Withdrawal by Subject|0|||
155657639|NCT01822925|561840392|FG002|Overall Study|Withdrawal by Subject|2|||
155657640|NCT01822925|561840393|FG003|Overall Study|Withdrawal by Subject|2|||
155657641|NCT01822925|561840390|FG000|Overall Study|Taking prohibited medication|2|||
155657642|NCT01822925|561840391|FG001|Overall Study|Taking prohibited medication|0|||
155657643|NCT01822925|561840392|FG002|Overall Study|Taking prohibited medication|0|||
155657644|NCT01822925|561840393|FG003|Overall Study|Taking prohibited medication|1|||
155657645|NCT02314923|561840396|FG000|Overall Study|Death|0|||
155657646|NCT02314923|561840397|FG001|Overall Study|Death|0|||
155554137|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
155554138|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
155554139|NCT01421342|561453800|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
155554140|NCT01421342|561453801|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
155554141|NCT01421342|561453802|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
155554142|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
155554143|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
155554144|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
155554145|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
155554146|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
155554147|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
155554148|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
155554149|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
155554150|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
155554151|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
155554152|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
155554153|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
155554154|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
155554155|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
155554156|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
155554157|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
155554158|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
155554159|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
155554160|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
155554161|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
155554162|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
155554163|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
155554164|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
155554165|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
155554166|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
155554167|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
155657647|NCT02314923|561840398|FG002|Overall Study|Death|0|||
155657648|NCT02314923|561840399|FG003|Overall Study|Death|1|||
155554168|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
155657649|NCT02314923|561840400|FG004|Overall Study|Death|0|||
155554169|NCT01421342|561453800|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
155554170|NCT01421342|561453801|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
155554171|NCT01421342|561453802|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
155554172|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
155554173|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
155554174|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
155554175|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
155554176|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
155554177|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
155554178|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
155554179|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
155554180|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
155554181|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
155554182|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
155554183|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
155554184|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
155554185|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
155554186|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
155554187|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
155554188|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
155554189|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
155554190|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
155554191|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
155554192|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
155554193|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
155554194|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
155554195|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
155554196|NCT01421342|561453800|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
155554197|NCT01421342|561453801|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
155554198|NCT01421342|561453802|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
155554199|NCT02528123|561453805|FG000|Overall Study|Lost to Follow-up|1|||
155554200|NCT03463993|561453810|FG000|Overall Study|Lost to Follow-up|7|||
155554201|NCT03463993|561453811|FG001|Overall Study|Lost to Follow-up|8|||
155554202|NCT03463993|561453810|FG000|Overall Study|Withdrawal by Subject|2|||
155554203|NCT03463993|561453811|FG001|Overall Study|Withdrawal by Subject|0|||
155554204|NCT03463993|561453810|FG000|Overall Study|Protocol Violation|4|||
155554205|NCT03463993|561453811|FG001|Overall Study|Protocol Violation|1|||
155554206|NCT03463993|561453810|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
155554207|NCT03463993|561453811|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
155554208|NCT03463993|561453810|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
155554209|NCT03463993|561453811|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
155554210|NCT04355663|561453812|FG000|Overall Study|Physician Decision|2|||
155554211|NCT04355663|561453813|FG001|Overall Study|Physician Decision|7|||
155554212|NCT04355663|561453814|FG002|Overall Study|Physician Decision|0|||
155554213|NCT04355663|561453812|FG000|Overall Study|Adverse Event|0|||
155554214|NCT04355663|561453813|FG001|Overall Study|Adverse Event|0|||
155554215|NCT04355663|561453814|FG002|Overall Study|Adverse Event|1|||
155554216|NCT04355663|561453812|FG000|Overall Study|Withdrawal by Subject|0|||
155554217|NCT04355663|561453813|FG001|Overall Study|Withdrawal by Subject|8|||
155554218|NCT04355663|561453814|FG002|Overall Study|Withdrawal by Subject|3|||
155554219|NCT05420012|561453815|FG000|Overall Study|Lost to Follow-up|0|||
155554220|NCT05420012|561453816|FG001|Overall Study|Lost to Follow-up|1|||
155554221|NCT00942331|561453821|FG000|Overall Study|Did not start treatment|15|||
155554222|NCT00942331|561453822|FG001|Overall Study|Did not start treatment|22|||
155554223|NCT00567476|561453826|FG000|Overall Study|Adverse Event|2|||
155554224|NCT00567476|561453827|FG001|Overall Study|Adverse Event|0|||
155554225|NCT00567476|561453826|FG000|Overall Study|Pregnancy|1|||
155554226|NCT00567476|561453827|FG001|Overall Study|Pregnancy|0|||
155554227|NCT00567476|561453826|FG000|Overall Study|Protocol Violation|4|||
155554228|NCT00567476|561453827|FG001|Overall Study|Protocol Violation|1|||
155554229|NCT00567476|561453826|FG000|Overall Study|Lost to Follow-up|0|||
155554230|NCT00567476|561453827|FG001|Overall Study|Lost to Follow-up|1|||
155554231|NCT00567476|561453826|FG000|Overall Study|Administrative issues|1|||
155554232|NCT00567476|561453827|FG001|Overall Study|Administrative issues|0|||
155554233|NCT00567476|561453826|FG000|Overall Study|Medical Decision|0|||
155554234|NCT00567476|561453827|FG001|Overall Study|Medical Decision|1|||
155554235|NCT00567476|561453826|FG000|Overall Study|Non-adherence to protocol|0|||
155554236|NCT00567476|561453827|FG001|Overall Study|Non-adherence to protocol|1|||
155554237|NCT01338987|561453833|FG000|Overall Study|enrolled on new protocol|0|||
155554238|NCT01338987|561453834|FG001|Overall Study|enrolled on new protocol|0|||
155554239|NCT01338987|561453835|FG002|Overall Study|enrolled on new protocol|1|||
155554240|NCT01338987|561453836|FG003|Overall Study|enrolled on new protocol|0|||
155554241|NCT01338987|561453837|FG004|Overall Study|enrolled on new protocol|0|||
155554242|NCT01338987|561453833|FG000|Overall Study|Disease progression on study|2|||
155554243|NCT01338987|561453834|FG001|Overall Study|Disease progression on study|1|||
155606924|NCT02614131|561649597|FG002|Overall Study|Adverse Event|0|||
155606925|NCT02614131|561649598|FG003|Overall Study|Adverse Event|0|||
155606926|NCT02614131|561649599|FG004|Overall Study|Adverse Event|0|||
155606927|NCT02614131|561649600|FG005|Overall Study|Adverse Event|0|||
155606928|NCT02614131|561649601|FG006|Overall Study|Adverse Event|1|||
155606929|NCT03209518|561649602|FG000|Overall Study|Case Report Forms Uncollected|1|||
155606930|NCT03209518|561649602|FG000|Overall Study|Protocol Deviation|1|||
155606931|NCT01832818|561649603|FG000|Overall Study|Lost to Follow-up|6|||
155606932|NCT00236899|561649604|FG000|Overall Study|Adverse Event (Study Related)|1|||
155606933|NCT00236899|561649605|FG001|Overall Study|Adverse Event (Study Related)|1|||
155606934|NCT00236899|561649606|FG002|Overall Study|Adverse Event (Study Related)|2|||
155606935|NCT00236899|561649607|FG003|Overall Study|Adverse Event (Study Related)|1|||
155606936|NCT00236899|561649604|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
155606937|NCT00236899|561649605|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
155606938|NCT00236899|561649606|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
155606939|NCT00236899|561649607|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
155554244|NCT01338987|561453835|FG002|Overall Study|Disease progression on study|1|||
155554245|NCT01338987|561453836|FG003|Overall Study|Disease progression on study|0|||
155554246|NCT01338987|561453837|FG004|Overall Study|Disease progression on study|0|||
155554247|NCT00757848|561453838|FG000|Overall Study|Voluntary discontinuation|1|||
155554248|NCT00757848|561453839|FG001|Overall Study|Voluntary discontinuation|0|||
155554249|NCT00757848|561453838|FG000|Overall Study|Adverse Event|1|||
155554250|NCT00757848|561453839|FG001|Overall Study|Adverse Event|2|||
155554251|NCT00757848|561453838|FG000|Overall Study|Incorrect enrolment|1|||
155554252|NCT00757848|561453839|FG001|Overall Study|Incorrect enrolment|0|||
155554253|NCT03856593|561453845|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
155554254|NCT03856593|561453846|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
155554255|NCT01901874|561453847|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
155554256|NCT01901874|561453847|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
155554257|NCT01901874|561453847|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
155554258|NCT01901874|561453847|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
155554259|NCT01901874|561453847|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
155554260|NCT01901874|561453847|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
155554261|NCT03977701|561453855|FG000|Overall Study|COVID-19 pandemic|0|||
155554262|NCT03977701|561453856|FG001|Overall Study|COVID-19 pandemic|0|||
155554263|NCT03977701|561453857|FG002|Overall Study|COVID-19 pandemic|0|||
155554264|NCT03977701|561453858|FG003|Overall Study|COVID-19 pandemic|0|||
155554265|NCT03977701|561453859|FG004|Overall Study|COVID-19 pandemic|0|||
155554266|NCT03977701|561453860|FG005|Overall Study|COVID-19 pandemic|1|||
155554267|NCT03977701|561453861|FG006|Overall Study|COVID-19 pandemic|0|||
155554268|NCT03977701|561453862|FG007|Overall Study|COVID-19 pandemic|1|||
155554269|NCT03977701|561453863|FG008|Overall Study|COVID-19 pandemic|0|||
155554270|NCT03977701|561453864|FG009|Overall Study|COVID-19 pandemic|0|||
155554271|NCT02687360|561453873|FG000|Overall Study|Withdrawal by Subject|3|||
155554272|NCT02687360|561453874|FG001|Overall Study|Withdrawal by Subject|0|||
155554273|NCT02939014|561453876|FG000|Overall Study|Lost to Follow-up|1|||
155554274|NCT02939014|561453877|FG001|Overall Study|Lost to Follow-up|0|||
155554275|NCT02939014|561453876|FG000|Overall Study|Death|4|||
155554276|NCT02939014|561453877|FG001|Overall Study|Death|3|||
155554277|NCT01568866|561453878|FG000|Overall Study|Disease Progression|208|||
155554278|NCT01568866|561453879|FG001|Overall Study|Disease Progression|183|||
155554279|NCT01568866|561453878|FG000|Overall Study|Adverse Event|94|||
155554280|NCT01568866|561453879|FG001|Overall Study|Adverse Event|96|||
155554281|NCT01568866|561453878|FG000|Overall Study|Patient Request|55|||
155554282|NCT01568866|561453879|FG001|Overall Study|Patient Request|71|||
155554283|NCT01568866|561453878|FG000|Overall Study|Physician Decision|40|||
155554284|NCT01568866|561453879|FG001|Overall Study|Physician Decision|32|||
155554285|NCT01568866|561453878|FG000|Overall Study|Withdrawal by Subject|19|||
155554286|NCT01568866|561453879|FG001|Overall Study|Withdrawal by Subject|11|||
155554287|NCT01568866|561453878|FG000|Overall Study|Death|10|||
155554288|NCT01568866|561453879|FG001|Overall Study|Death|18|||
155554289|NCT01568866|561453878|FG000|Overall Study|Protocol Non-compliance|2|||
155554290|NCT01568866|561453879|FG001|Overall Study|Protocol Non-compliance|4|||
155554291|NCT01568866|561453878|FG000|Overall Study|Lost to Follow-up|1|||
155554292|NCT01568866|561453879|FG001|Overall Study|Lost to Follow-up|0|||
155554293|NCT01568866|561453878|FG000|Overall Study|Randomized but Not Dosed|9|||
155554294|NCT01568866|561453879|FG001|Overall Study|Randomized but Not Dosed|1|||
155554295|NCT01698775|561453880|FG000|Phase A|Adverse Event|2|||
155554296|NCT01698775|561453881|FG001|Phase A|Adverse Event|1|||
155554297|NCT01698775|561453880|FG000|Phase A|Death|1|||
155554298|NCT01698775|561453881|FG001|Phase A|Death|1|||
155554299|NCT01698775|561453880|FG000|Phase A|Lack of Efficacy|1|||
155554300|NCT01698775|561453881|FG001|Phase A|Lack of Efficacy|0|||
155554301|NCT01698775|561453880|FG000|Phase A|Lost to Follow-up|1|||
155554302|NCT01698775|561453881|FG001|Phase A|Lost to Follow-up|2|||
155554303|NCT01698775|561453880|FG000|Phase A|Protocol Violation|1|||
155554304|NCT01698775|561453881|FG001|Phase A|Protocol Violation|0|||
155554305|NCT01698775|561453880|FG000|Phase A|Withdrawal by Subject|3|||
155554306|NCT01698775|561453881|FG001|Phase A|Withdrawal by Subject|4|||
155554307|NCT01698775|561453880|FG000|Phase A|Kidney [transplant]|0|||
155554308|NCT01698775|561453881|FG001|Phase A|Kidney [transplant]|1|||
155554309|NCT01698775|561453880|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
155554310|NCT01698775|561453881|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
155554311|NCT01698775|561453880|FG000|Phase B|Adverse Event|6|||
155554312|NCT01698775|561453881|FG001|Phase B|Adverse Event|3|||
155554313|NCT01698775|561453880|FG000|Phase B|Death|0|||
155554314|NCT01698775|561453881|FG001|Phase B|Death|1|||
155554315|NCT01698775|561453880|FG000|Phase B|Lack of Efficacy|0|||
155554316|NCT01698775|561453881|FG001|Phase B|Lack of Efficacy|1|||
155554317|NCT01698775|561453880|FG000|Phase B|Lost to Follow-up|0|||
155554318|NCT01698775|561453881|FG001|Phase B|Lost to Follow-up|1|||
155554319|NCT01698775|561453880|FG000|Phase B|Physician Decision|1|||
155554320|NCT01698775|561453881|FG001|Phase B|Physician Decision|1|||
155554321|NCT01698775|561453880|FG000|Phase B|Protocol Violation|1|||
155554322|NCT01698775|561453881|FG001|Phase B|Protocol Violation|1|||
155554323|NCT01698775|561453880|FG000|Phase B|Withdrawal by Subject|6|||
155554324|NCT01698775|561453881|FG001|Phase B|Withdrawal by Subject|2|||
155554325|NCT02143583|561453886|FG000|Overall Study|Withdrawal by Subject|1|||
155554326|NCT02143583|561453887|FG001|Overall Study|Withdrawal by Subject|0|||
155554327|NCT02143583|561453888|FG002|Overall Study|Withdrawal by Subject|1|||
155554328|NCT02143583|561453886|FG000|Overall Study|husband illness|0|||
155554329|NCT02143583|561453887|FG001|Overall Study|husband illness|0|||
155554330|NCT02143583|561453888|FG002|Overall Study|husband illness|1|||
155554331|NCT02340221|561453891|FG000|Overall Study|Death|100|||
155554332|NCT02340221|561453892|FG001|Overall Study|Death|197|||
155554333|NCT02340221|561453891|FG000|Overall Study|Withdrawal by Participant|24|||
155554334|NCT02340221|561453892|FG001|Overall Study|Withdrawal by Participant|37|||
155554335|NCT02340221|561453891|FG000|Overall Study|Lost to Follow-up|4|||
155554336|NCT02340221|561453892|FG001|Overall Study|Lost to Follow-up|15|||
155554337|NCT02340221|561453891|FG000|Overall Study|Reason Not Specified|85|||
155554338|NCT02340221|561453892|FG001|Overall Study|Reason Not Specified|165|||
155554339|NCT02340221|561453891|FG000|Overall Study|Study Terminated by Sponsor|1|||
155554340|NCT02340221|561453892|FG001|Overall Study|Study Terminated by Sponsor|3|||
155554341|NCT01583218|561453893|FG000|Overall Study|Withdrawal by Subject|43|||
155554342|NCT01583218|561453894|FG001|Overall Study|Withdrawal by Subject|29|||
155554343|NCT01583218|561453893|FG000|Overall Study|Death|206|||
155554344|NCT01583218|561453894|FG001|Overall Study|Death|211|||
155554345|NCT01583218|561453893|FG000|Overall Study|Lost to Follow-up|11|||
155554346|NCT01583218|561453894|FG001|Overall Study|Lost to Follow-up|17|||
155554347|NCT01583218|561453893|FG000|Overall Study|Adverse event or serious adverse event|3|||
155554348|NCT01583218|561453894|FG001|Overall Study|Adverse event or serious adverse event|3|||
155554349|NCT01583218|561453893|FG000|Overall Study|Patient /Family decision|3|||
155554350|NCT01583218|561453894|FG001|Overall Study|Patient /Family decision|0|||
155554351|NCT01583218|561453893|FG000|Overall Study|Cannot contact patient directly|1|||
155554352|NCT01583218|561453894|FG001|Overall Study|Cannot contact patient directly|2|||
155554353|NCT01583218|561453893|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
155554354|NCT01583218|561453894|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
155554355|NCT01583218|561453893|FG000|Overall Study|Patient did not wish to attend visits|0|||
155554356|NCT01583218|561453894|FG001|Overall Study|Patient did not wish to attend visits|1|||
155554357|NCT01583218|561453893|FG000|Overall Study|Patient randomized but not dosed|17|||
155554358|NCT01583218|561453894|FG001|Overall Study|Patient randomized but not dosed|16|||
155554359|NCT01583218|561453893|FG000|Overall Study|Patient was assessed via phone in person|1|||
155554360|NCT01583218|561453894|FG001|Overall Study|Patient was assessed via phone in person|0|||
155554361|NCT01583218|561453893|FG000|Overall Study|Patient deemed ineligible after random|2|||
155554362|NCT01583218|561453894|FG001|Overall Study|Patient deemed ineligible after random|0|||
155554363|NCT01583218|561453893|FG000|Overall Study|Patient was early terminated from study|0|||
155554364|NCT01583218|561453894|FG001|Overall Study|Patient was early terminated from study|1|||
155554365|NCT01583218|561453893|FG000|Overall Study|Patient was randomized due to mistake|1|||
155554366|NCT01583218|561453894|FG001|Overall Study|Patient was randomized due to mistake|0|||
155554367|NCT01583218|561453893|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
155554368|NCT01583218|561453894|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
155554369|NCT01583218|561453893|FG000|Overall Study|Withdraw of consent on day of random|1|||
155554370|NCT01583218|561453894|FG001|Overall Study|Withdraw of consent on day of random|0|||
155554371|NCT00952276|561453897|FG000|Overall Study|Withdrawal by Subject|1|||
155554372|NCT00952276|561453898|FG001|Overall Study|Withdrawal by Subject|0|||
155554373|NCT00952276|561453899|FG002|Overall Study|Withdrawal by Subject|0|||
155554374|NCT00952276|561453900|FG003|Overall Study|Withdrawal by Subject|1|||
155554375|NCT00952276|561453901|FG004|Overall Study|Withdrawal by Subject|0|||
155554376|NCT02091141|561455572|FG000|Overall Study|Death|280|||
155554377|NCT02091141|561455573|FG001|Overall Study|Death|118|||
155554378|NCT02091141|561455574|FG002|Overall Study|Death|46|||
155554379|NCT02091141|561455575|FG003|Overall Study|Death|13|||
155554380|NCT02091141|561455576|FG004|Overall Study|Death|31|||
155554381|NCT02091141|561455577|FG005|Overall Study|Death|16|||
155554382|NCT02091141|561455578|FG006|Overall Study|Death|12|||
155554383|NCT02091141|561455572|FG000|Overall Study|Withdrawal by Subject|21|||
155554384|NCT02091141|561455573|FG001|Overall Study|Withdrawal by Subject|13|||
155554385|NCT02091141|561455574|FG002|Overall Study|Withdrawal by Subject|3|||
155554386|NCT02091141|561455575|FG003|Overall Study|Withdrawal by Subject|2|||
155554387|NCT02091141|561455576|FG004|Overall Study|Withdrawal by Subject|2|||
155554388|NCT02091141|561455577|FG005|Overall Study|Withdrawal by Subject|3|||
155554389|NCT02091141|561455578|FG006|Overall Study|Withdrawal by Subject|0|||
155554390|NCT02091141|561455572|FG000|Overall Study|Lost to Follow-up|21|||
155554391|NCT02091141|561455573|FG001|Overall Study|Lost to Follow-up|5|||
155554392|NCT02091141|561455574|FG002|Overall Study|Lost to Follow-up|1|||
155554393|NCT02091141|561455575|FG003|Overall Study|Lost to Follow-up|0|||
155554394|NCT02091141|561455576|FG004|Overall Study|Lost to Follow-up|1|||
155554395|NCT02091141|561455577|FG005|Overall Study|Lost to Follow-up|2|||
155554396|NCT02091141|561455578|FG006|Overall Study|Lost to Follow-up|0|||
155554397|NCT02091141|561455572|FG000|Overall Study|Reason Not Specified|6|||
155554398|NCT02091141|561455573|FG001|Overall Study|Reason Not Specified|5|||
155554399|NCT02091141|561455574|FG002|Overall Study|Reason Not Specified|2|||
155554400|NCT02091141|561455575|FG003|Overall Study|Reason Not Specified|0|||
155554401|NCT02091141|561455576|FG004|Overall Study|Reason Not Specified|0|||
155554402|NCT02091141|561455577|FG005|Overall Study|Reason Not Specified|0|||
155554403|NCT02091141|561455578|FG006|Overall Study|Reason Not Specified|1|||
155554404|NCT02091141|561455572|FG000|Overall Study|Study Ended by Sponsor|1|||
155554405|NCT02091141|561455573|FG001|Overall Study|Study Ended by Sponsor|9|||
155554406|NCT02091141|561455574|FG002|Overall Study|Study Ended by Sponsor|0|||
155554407|NCT02091141|561455575|FG003|Overall Study|Study Ended by Sponsor|0|||
155554408|NCT02091141|561455576|FG004|Overall Study|Study Ended by Sponsor|0|||
155554409|NCT02091141|561455577|FG005|Overall Study|Study Ended by Sponsor|0|||
155554410|NCT02091141|561455578|FG006|Overall Study|Study Ended by Sponsor|0|||
155554411|NCT02091141|561455572|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554412|NCT02091141|561455573|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
155554413|NCT02091141|561455574|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554414|NCT02091141|561455575|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554415|NCT02091141|561455576|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554416|NCT02091141|561455577|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554417|NCT02091141|561455578|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
155554418|NCT04551911|561455579|FG000|Overall Study|Lost to Follow-up|2|||
155554419|NCT04551911|561455580|FG001|Overall Study|Lost to Follow-up|1|||
155554420|NCT04551911|561455579|FG000|Overall Study|Withdrawal by Subject|10|||
155554421|NCT04551911|561455580|FG001|Overall Study|Withdrawal by Subject|10|||
155554422|NCT04551911|561455579|FG000|Overall Study|Did not receive the study drug|3|||
155554423|NCT04551911|561455580|FG001|Overall Study|Did not receive the study drug|4|||
155554424|NCT02177136|561455585|FG000|DB Phase|Withdrawal by Subject|2|||
155554425|NCT02177136|561455586|FG001|DB Phase|Withdrawal by Subject|0|||
155554426|NCT02177136|561455587|FG002|DB Phase|Withdrawal by Subject|0|||
155554427|NCT02177136|561455588|FG003|DB Phase|Withdrawal by Subject|0|||
155554428|NCT02177136|561455585|FG000|DB Phase|Discontinued Due to Pruritus|1|||
155554429|NCT02177136|561455586|FG001|DB Phase|Discontinued Due to Pruritus|3|||
155554430|NCT02177136|561455587|FG002|DB Phase|Discontinued Due to Pruritus|0|||
155554431|NCT02177136|561455588|FG003|DB Phase|Discontinued Due to Pruritus|0|||
155554432|NCT02177136|561455585|FG000|DB Phase|Adverse Event|3|||
155554433|NCT02177136|561455586|FG001|DB Phase|Adverse Event|2|||
155554434|NCT02177136|561455587|FG002|DB Phase|Adverse Event|3|||
155554435|NCT02177136|561455588|FG003|DB Phase|Adverse Event|0|||
155554436|NCT02177136|561455585|FG000|DB Phase|Protocol Violation|0|||
155554437|NCT02177136|561455586|FG001|DB Phase|Protocol Violation|0|||
155554438|NCT02177136|561455587|FG002|DB Phase|Protocol Violation|1|||
155554439|NCT02177136|561455588|FG003|DB Phase|Protocol Violation|0|||
155554440|NCT02177136|561455585|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
155554441|NCT02177136|561455586|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
155554442|NCT02177136|561455587|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
155554443|NCT02177136|561455588|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
155554444|NCT02177136|561455585|FG000|LTSE Phase|Withdrawal by Subject|0|||
155554445|NCT02177136|561455586|FG001|LTSE Phase|Withdrawal by Subject|0|||
155554446|NCT02177136|561455587|FG002|LTSE Phase|Withdrawal by Subject|0|||
155554447|NCT02177136|561455588|FG003|LTSE Phase|Withdrawal by Subject|6|||
155554448|NCT02177136|561455585|FG000|LTSE Phase|Adverse Event|0|||
155554449|NCT02177136|561455586|FG001|LTSE Phase|Adverse Event|0|||
155554450|NCT02177136|561455587|FG002|LTSE Phase|Adverse Event|0|||
155554451|NCT02177136|561455588|FG003|LTSE Phase|Adverse Event|10|||
155554452|NCT02177136|561455585|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
155554453|NCT02177136|561455586|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
155554454|NCT02177136|561455587|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
155554455|NCT02177136|561455588|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
155554456|NCT02177136|561455585|FG000|LTSE Phase|Physician Decision|0|||
155657650|NCT02314923|561840401|FG005|Overall Study|Death|0|||
155554457|NCT02177136|561455586|FG001|LTSE Phase|Physician Decision|0|||
155554458|NCT02177136|561455587|FG002|LTSE Phase|Physician Decision|0|||
155554459|NCT02177136|561455588|FG003|LTSE Phase|Physician Decision|2|||
155554460|NCT02177136|561455585|FG000|LTSE Phase|Lost to Follow-up|0|||
155554461|NCT02177136|561455586|FG001|LTSE Phase|Lost to Follow-up|0|||
155554462|NCT02177136|561455587|FG002|LTSE Phase|Lost to Follow-up|0|||
155554463|NCT02177136|561455588|FG003|LTSE Phase|Lost to Follow-up|1|||
155554464|NCT02177136|561455585|FG000|LTSE Phase|Participant Moved|0|||
155554465|NCT02177136|561455586|FG001|LTSE Phase|Participant Moved|0|||
155554466|NCT02177136|561455587|FG002|LTSE Phase|Participant Moved|0|||
155554467|NCT02177136|561455588|FG003|LTSE Phase|Participant Moved|1|||
155554468|NCT02054130|561455589|FG000|Overall Study|Withdrawal by Subject|4|||
155554469|NCT02054130|561455590|FG001|Overall Study|Withdrawal by Subject|4|||
155554470|NCT02054130|561455591|FG002|Overall Study|Withdrawal by Subject|7|||
155554471|NCT02054130|561455592|FG003|Overall Study|Withdrawal by Subject|10|||
155554472|NCT02054130|561455589|FG000|Overall Study|Death|0|||
155554473|NCT02054130|561455590|FG001|Overall Study|Death|1|||
155554474|NCT02054130|561455591|FG002|Overall Study|Death|0|||
155554475|NCT02054130|561455592|FG003|Overall Study|Death|0|||
155554476|NCT02054130|561455589|FG000|Overall Study|Lost to Follow-up|0|||
155554477|NCT02054130|561455590|FG001|Overall Study|Lost to Follow-up|0|||
155554478|NCT02054130|561455591|FG002|Overall Study|Lost to Follow-up|1|||
155554479|NCT02054130|561455592|FG003|Overall Study|Lost to Follow-up|2|||
155554480|NCT02054130|561455589|FG000|Overall Study|Missed dose|4|||
155554481|NCT02054130|561455590|FG001|Overall Study|Missed dose|6|||
155554482|NCT02054130|561455591|FG002|Overall Study|Missed dose|7|||
155554483|NCT02054130|561455592|FG003|Overall Study|Missed dose|10|||
155554484|NCT01386684|561455593|FG000|Overall Study|Lost to Follow-up|51|||
155554485|NCT01386684|561455593|FG000|Overall Study|Other|51|||
155554486|NCT01386684|561455593|FG000|Overall Study|Death|47|||
155554487|NCT01386684|561455593|FG000|Overall Study|Withdrawal of Consent|44|||
155554488|NCT01386684|561455593|FG000|Overall Study|Alternative Therapy Required|37|||
155554489|NCT01386684|561455593|FG000|Overall Study|Disease Progression|28|||
155554490|NCT01386684|561455593|FG000|Overall Study|Adverse Event|20|||
155554491|NCT01386684|561455593|FG000|Overall Study|Noncompliance|8|||
155554492|NCT01386684|561455593|FG000|Overall Study|Protocol Violation|4|||
155554493|NCT01386684|561455593|FG000|Overall Study|Missing|3|||
155554494|NCT00094458|561455596|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
155554495|NCT00094458|561455597|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
155554496|NCT00094458|561455598|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
155554497|NCT00094458|561455599|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
155554498|NCT00094458|561455600|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
155554499|NCT00094458|561455601|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
155554500|NCT00094458|561455596|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
155554501|NCT00094458|561455597|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
155554502|NCT00094458|561455598|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
155554503|NCT00094458|561455599|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
155554504|NCT00094458|561455600|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
155554505|NCT00094458|561455601|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
155554506|NCT00094458|561455596|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
155554507|NCT00094458|561455597|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
155554508|NCT00094458|561455598|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
155554509|NCT00094458|561455599|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
155554510|NCT00094458|561455600|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
155554511|NCT00094458|561455601|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
155554512|NCT00094458|561455596|FG000|Main Study: Through Week 30|Adverse Event|38|||
155554513|NCT00094458|561455597|FG001|Main Study: Through Week 30|Adverse Event|20|||
155554514|NCT00094458|561455598|FG002|Main Study: Through Week 30|Adverse Event|28|||
155554515|NCT00094458|561455599|FG003|Main Study: Through Week 30|Adverse Event|0|||
155554516|NCT00094458|561455600|FG004|Main Study: Through Week 30|Adverse Event|0|||
155554517|NCT00094458|561455601|FG005|Main Study: Through Week 30|Adverse Event|0|||
155554518|NCT00094458|561455596|FG000|Main Study: Through Week 30|Death|1|||
155554519|NCT00094458|561455597|FG001|Main Study: Through Week 30|Death|0|||
155554520|NCT00094458|561455598|FG002|Main Study: Through Week 30|Death|0|||
155554521|NCT00094458|561455599|FG003|Main Study: Through Week 30|Death|0|||
155554522|NCT00094458|561455600|FG004|Main Study: Through Week 30|Death|0|||
155554523|NCT00094458|561455601|FG005|Main Study: Through Week 30|Death|0|||
155554524|NCT00094458|561455596|FG000|Main Study: Through Week 30|Other|19|||
155554525|NCT00094458|561455597|FG001|Main Study: Through Week 30|Other|16|||
155554526|NCT00094458|561455598|FG002|Main Study: Through Week 30|Other|9|||
155554527|NCT00094458|561455599|FG003|Main Study: Through Week 30|Other|0|||
155554528|NCT00094458|561455600|FG004|Main Study: Through Week 30|Other|0|||
155554529|NCT00094458|561455601|FG005|Main Study: Through Week 30|Other|0|||
155554530|NCT00094458|561455596|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
155554531|NCT00094458|561455597|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
155554532|NCT00094458|561455598|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
155657651|NCT02314923|561840402|FG006|Overall Study|Death|0|||
155657652|NCT02314923|561840403|FG007|Overall Study|Death|0|||
155657653|NCT02314923|561840404|FG008|Overall Study|Death|0|||
155657654|NCT02314923|561840405|FG009|Overall Study|Death|0|||
155657655|NCT02314923|561840396|FG000|Overall Study|Lost to Follow-up|2|||
155657656|NCT02314923|561840397|FG001|Overall Study|Lost to Follow-up|3|||
155657657|NCT02314923|561840398|FG002|Overall Study|Lost to Follow-up|1|||
155657658|NCT02314923|561840399|FG003|Overall Study|Lost to Follow-up|0|||
155657659|NCT02314923|561840400|FG004|Overall Study|Lost to Follow-up|0|||
155657660|NCT02314923|561840401|FG005|Overall Study|Lost to Follow-up|0|||
155657661|NCT02314923|561840402|FG006|Overall Study|Lost to Follow-up|3|||
155554533|NCT00094458|561455599|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
155554534|NCT00094458|561455600|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
155554535|NCT00094458|561455601|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
155554536|NCT00094458|561455596|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
155554537|NCT00094458|561455597|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
155554538|NCT00094458|561455598|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
155657662|NCT02314923|561840403|FG007|Overall Study|Lost to Follow-up|4|||
155657663|NCT02314923|561840404|FG008|Overall Study|Lost to Follow-up|2|||
155657664|NCT02314923|561840405|FG009|Overall Study|Lost to Follow-up|0|||
155657665|NCT02314923|561840396|FG000|Overall Study|Withdrawal by Subject|0|||
155554539|NCT00094458|561455599|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
155554540|NCT00094458|561455600|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
155554541|NCT00094458|561455601|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
155554542|NCT00094458|561455596|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
155554543|NCT00094458|561455597|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
155554544|NCT00094458|561455598|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
155554545|NCT00094458|561455599|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
155554546|NCT00094458|561455600|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
155554547|NCT00094458|561455601|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
155554548|NCT00094458|561455596|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
155554549|NCT00094458|561455597|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
155554550|NCT00094458|561455598|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
155554551|NCT00094458|561455599|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
155554552|NCT00094458|561455600|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
155554553|NCT00094458|561455601|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
155554554|NCT00094458|561455596|FG000|OLE: Open-Label Extension|Adverse Event|0|||
155554555|NCT00094458|561455597|FG001|OLE: Open-Label Extension|Adverse Event|0|||
155554556|NCT00094458|561455598|FG002|OLE: Open-Label Extension|Adverse Event|0|||
155554557|NCT00094458|561455599|FG003|OLE: Open-Label Extension|Adverse Event|0|||
155554558|NCT00094458|561455600|FG004|OLE: Open-Label Extension|Adverse Event|3|||
155554559|NCT00094458|561455601|FG005|OLE: Open-Label Extension|Adverse Event|4|||
155554560|NCT00094458|561455596|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
155554561|NCT00094458|561455597|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
155554562|NCT00094458|561455598|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
155554563|NCT00094458|561455599|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
155554564|NCT00094458|561455600|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
155554565|NCT00094458|561455601|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
155554566|NCT00094458|561455596|FG000|OLE: Open-Label Extension|Patient decision|0|||
155554567|NCT00094458|561455597|FG001|OLE: Open-Label Extension|Patient decision|0|||
155554568|NCT00094458|561455598|FG002|OLE: Open-Label Extension|Patient decision|0|||
155554569|NCT00094458|561455599|FG003|OLE: Open-Label Extension|Patient decision|0|||
155554570|NCT00094458|561455600|FG004|OLE: Open-Label Extension|Patient decision|1|||
155554571|NCT00094458|561455601|FG005|OLE: Open-Label Extension|Patient decision|0|||
155554572|NCT01995266|561455609|FG000|Overall Study|Death|1|||
155554573|NCT01995266|561455609|FG000|Overall Study|Lack of Efficacy|6|||
155554574|NCT01995266|561455609|FG000|Overall Study|Adverse Event|2|||
155554575|NCT03247517|561455610|FG000|Overall Study|Adverse Event|0|||
155554576|NCT03247517|561455611|FG001|Overall Study|Adverse Event|4|||
155554577|NCT03247517|561455612|FG002|Overall Study|Adverse Event|2|||
155554578|NCT03247517|561455610|FG000|Overall Study|Lost to Follow-up|2|||
155554579|NCT03247517|561455611|FG001|Overall Study|Lost to Follow-up|6|||
155554580|NCT03247517|561455612|FG002|Overall Study|Lost to Follow-up|4|||
155554581|NCT03247517|561455610|FG000|Overall Study|Consent withdrawn by caregiver|1|||
155554582|NCT03247517|561455611|FG001|Overall Study|Consent withdrawn by caregiver|4|||
155554583|NCT03247517|561455612|FG002|Overall Study|Consent withdrawn by caregiver|7|||
155554584|NCT03247517|561455610|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
155554585|NCT03247517|561455611|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
155554586|NCT03247517|561455612|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
155554587|NCT03247517|561455610|FG000|Overall Study|Protocol Violation|0|||
155554588|NCT03247517|561455611|FG001|Overall Study|Protocol Violation|2|||
155554589|NCT03247517|561455612|FG002|Overall Study|Protocol Violation|0|||
155554590|NCT03247517|561455610|FG000|Overall Study|Multiple reasons|3|||
155554591|NCT03247517|561455611|FG001|Overall Study|Multiple reasons|1|||
155554592|NCT03247517|561455612|FG002|Overall Study|Multiple reasons|0|||
155554593|NCT00619112|561455613|FG000|Overall Study|Adverse Event|1|||
155554594|NCT00619112|561455614|FG001|Overall Study|Adverse Event|2|||
155554595|NCT00729248|561455615|FG000|Overall Study|Physician Decision|2|||
155554596|NCT03573505|561455618|FG000|Overall Study|Adverse Event|1|||
155554597|NCT03573505|561455619|FG001|Overall Study|Adverse Event|1|||
155554598|NCT03573505|561455618|FG000|Overall Study|Consent withdrawn|0|||
155554599|NCT03573505|561455619|FG001|Overall Study|Consent withdrawn|1|||
155554600|NCT03573505|561455618|FG000|Overall Study|Disease progression|0|||
155554601|NCT03573505|561455619|FG001|Overall Study|Disease progression|1|||
155554602|NCT03573505|561455618|FG000|Overall Study|Site Terminated by Sponsor|1|||
155554603|NCT03573505|561455619|FG001|Overall Study|Site Terminated by Sponsor|1|||
155554604|NCT03573505|561455618|FG000|Overall Study|Study terminated by sponsor|50|||
155554605|NCT03573505|561455619|FG001|Overall Study|Study terminated by sponsor|45|||
155554606|NCT03573505|561455618|FG000|Overall Study|Reason not specified|0|||
155554607|NCT03573505|561455619|FG001|Overall Study|Reason not specified|1|||
155554608|NCT03573505|561455618|FG000|Overall Study|Death|0|||
155554609|NCT03573505|561455619|FG001|Overall Study|Death|4|||
155554610|NCT04268316|561455620|FG000|Overall Study|Withdrawal by Subject|2|||
155554611|NCT04268316|561455621|FG001|Overall Study|Withdrawal by Subject|1|||
155554612|NCT04268316|561455622|FG002|Overall Study|Withdrawal by Subject|0|||
155554613|NCT02040779|561455624|FG000|Overall Study|Adverse Event|1|||
155554614|NCT02040779|561455625|FG001|Overall Study|Adverse Event|0|||
155554615|NCT02040779|561455626|FG002|Overall Study|Adverse Event|0|||
155554616|NCT02040779|561455624|FG000|Overall Study|Withdrawal by Subject|4|||
155554617|NCT02040779|561455625|FG001|Overall Study|Withdrawal by Subject|1|||
155554618|NCT02040779|561455626|FG002|Overall Study|Withdrawal by Subject|3|||
155554619|NCT02040779|561455624|FG000|Overall Study|Non-compliance|0|||
155554620|NCT02040779|561455625|FG001|Overall Study|Non-compliance|1|||
155554621|NCT02040779|561455626|FG002|Overall Study|Non-compliance|0|||
155554622|NCT02040779|561455624|FG000|Overall Study|Protocol Violation|2|||
155554623|NCT02040779|561455625|FG001|Overall Study|Protocol Violation|1|||
155554624|NCT02040779|561455626|FG002|Overall Study|Protocol Violation|0|||
155554625|NCT02040779|561455624|FG000|Overall Study|Lost to Follow-up|1|||
155554626|NCT02040779|561455625|FG001|Overall Study|Lost to Follow-up|2|||
155554627|NCT02040779|561455626|FG002|Overall Study|Lost to Follow-up|1|||
155554628|NCT02040779|561455624|FG000|Overall Study|Lack of Efficacy|4|||
155554629|NCT02040779|561455625|FG001|Overall Study|Lack of Efficacy|2|||
155554630|NCT02040779|561455626|FG002|Overall Study|Lack of Efficacy|0|||
155554631|NCT02132637|561455627|FG000|Study Period 1|Withdrawal by Subject|0|||
155554632|NCT02132637|561455628|FG001|Study Period 1|Withdrawal by Subject|4|||
155554633|NCT02132637|561455627|FG000|Study Period 1|Physician Decision|1|||
155554634|NCT02132637|561455628|FG001|Study Period 1|Physician Decision|0|||
155554635|NCT02132637|561455627|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
155554636|NCT02132637|561455628|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
155554637|NCT02132637|561455627|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
155554638|NCT02132637|561455628|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
155554639|NCT00866658|561455637|FG000|Overall Study|Adverse Event|5|||
155554640|NCT00866658|561455638|FG001|Overall Study|Adverse Event|14|||
155554641|NCT00866658|561455637|FG000|Overall Study|Lack of Efficacy|2|||
155554642|NCT00866658|561455638|FG001|Overall Study|Lack of Efficacy|1|||
155554643|NCT00866658|561455637|FG000|Overall Study|Withdrawal by Subject|1|||
155554644|NCT00866658|561455638|FG001|Overall Study|Withdrawal by Subject|0|||
155554645|NCT00866658|561455637|FG000|Overall Study|Protocol Violation|1|||
155554646|NCT00866658|561455638|FG001|Overall Study|Protocol Violation|1|||
155554647|NCT00866658|561455637|FG000|Overall Study|Familial and Personal Reasons|4|||
155554648|NCT00866658|561455638|FG001|Overall Study|Familial and Personal Reasons|5|||
155554649|NCT00652028|561455641|FG000|Overall Study|Adverse Event|1|||
155554650|NCT00652028|561455642|FG001|Overall Study|Adverse Event|0|||
155554651|NCT00652028|561455643|FG002|Overall Study|Adverse Event|0|||
155554652|NCT00652028|561455644|FG003|Overall Study|Adverse Event|0|||
155554653|NCT00652028|561455641|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
155554654|NCT00652028|561455642|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
155554655|NCT00652028|561455643|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
155554656|NCT00652028|561455644|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
155554657|NCT00652028|561455641|FG000|Overall Study|Physician Decision|0|||
155554658|NCT00652028|561455642|FG001|Overall Study|Physician Decision|0|||
155554659|NCT00652028|561455643|FG002|Overall Study|Physician Decision|1|||
155657666|NCT02314923|561840397|FG001|Overall Study|Withdrawal by Subject|0|||
155657667|NCT02314923|561840398|FG002|Overall Study|Withdrawal by Subject|1|||
155657668|NCT02314923|561840399|FG003|Overall Study|Withdrawal by Subject|0|||
155657669|NCT02314923|561840400|FG004|Overall Study|Withdrawal by Subject|1|||
155657670|NCT02314923|561840401|FG005|Overall Study|Withdrawal by Subject|0|||
155657671|NCT02314923|561840402|FG006|Overall Study|Withdrawal by Subject|1|||
155657672|NCT02314923|561840403|FG007|Overall Study|Withdrawal by Subject|0|||
155657673|NCT02314923|561840404|FG008|Overall Study|Withdrawal by Subject|0|||
155657674|NCT02314923|561840405|FG009|Overall Study|Withdrawal by Subject|0|||
155657675|NCT02314923|561840396|FG000|Overall Study|Physician Decision|0|||
155657676|NCT02314923|561840397|FG001|Overall Study|Physician Decision|1|||
155657677|NCT02314923|561840398|FG002|Overall Study|Physician Decision|0|||
155554660|NCT00652028|561455644|FG003|Overall Study|Physician Decision|0|||
155554661|NCT02751359|561455646|FG000|Overall Study|Lost to Follow-up|1|||
155657678|NCT02314923|561840399|FG003|Overall Study|Physician Decision|0|||
155657679|NCT02314923|561840400|FG004|Overall Study|Physician Decision|0|||
155554662|NCT02400671|561455647|FG000|Overall Study|Death|5|||
155554663|NCT02400671|561455648|FG001|Overall Study|Death|3|||
155554664|NCT02400671|561455649|FG002|Overall Study|Death|4|||
155554665|NCT02400671|561455647|FG000|Overall Study|Lost to Follow-up|20|||
155554666|NCT02400671|561455648|FG001|Overall Study|Lost to Follow-up|27|||
155554667|NCT02400671|561455649|FG002|Overall Study|Lost to Follow-up|24|||
155554668|NCT02400671|561455647|FG000|Overall Study|Withdrawal by Subject|2|||
155657680|NCT02314923|561840401|FG005|Overall Study|Physician Decision|0|||
155657681|NCT02314923|561840402|FG006|Overall Study|Physician Decision|0|||
155657682|NCT02314923|561840403|FG007|Overall Study|Physician Decision|0|||
155554669|NCT02400671|561455648|FG001|Overall Study|Withdrawal by Subject|2|||
155554670|NCT02400671|561455649|FG002|Overall Study|Withdrawal by Subject|0|||
155554671|NCT02145026|561455653|FG000|Overall Study|Adverse Event|2|||
155554672|NCT02145026|561455653|FG000|Overall Study|Death|4|||
155554673|NCT02145026|561455653|FG000|Overall Study|Withdrawal by Subject|2|||
155554674|NCT02145026|561455653|FG000|Overall Study|Physician Decision|4|||
155554675|NCT00127036|561455654|FG000|Overall Study|Insufficient Data for Analysis|6|||
155554676|NCT00127036|561455655|FG001|Overall Study|Insufficient Data for Analysis|11|||
155554677|NCT00127036|561455654|FG000|Overall Study|Screen Failure|2|||
155554678|NCT00127036|561455655|FG001|Overall Study|Screen Failure|0|||
155554679|NCT01797835|561455662|FG000|Overall Study|Lost to Follow-up|31|||
155554680|NCT01797835|561455663|FG001|Overall Study|Lost to Follow-up|27|||
155554681|NCT01403064|561455664|FG000|Overall Study|Death|0|||
155554682|NCT01403064|561455665|FG001|Overall Study|Death|0|||
155554683|NCT01403064|561455666|FG002|Overall Study|Death|1|||
155554684|NCT01403064|561455667|FG003|Overall Study|Death|1|||
155554685|NCT01403064|561455664|FG000|Overall Study|Withdrawal by Subject|0|||
155554686|NCT01403064|561455665|FG001|Overall Study|Withdrawal by Subject|0|||
155554687|NCT01403064|561455666|FG002|Overall Study|Withdrawal by Subject|1|||
155554688|NCT01403064|561455667|FG003|Overall Study|Withdrawal by Subject|1|||
155554689|NCT01403064|561455664|FG000|Overall Study|Other|1|||
155554690|NCT01403064|561455665|FG001|Overall Study|Other|0|||
155554691|NCT01403064|561455666|FG002|Overall Study|Other|2|||
155554692|NCT01403064|561455667|FG003|Overall Study|Other|1|||
155554693|NCT00973765|561455668|FG000|Overall Study|Lost to Follow-up|8|||
155554694|NCT00973765|561455669|FG001|Overall Study|Lost to Follow-up|14|||
155554695|NCT04920916|561455670|FG000|Phase IIa 60 Day Study|Death|2|||
155554696|NCT04920916|561455671|FG001|Phase IIa 60 Day Study|Death|5|||
155554697|NCT04920916|561455670|FG000|1 Year Follow up (Phone Call)|Death|1|||
155554698|NCT04920916|561455671|FG001|1 Year Follow up (Phone Call)|Death|3|||
155554699|NCT04920916|561455670|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
155554700|NCT04920916|561455671|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
155554701|NCT02011113|561455672|FG000|Overall Study|Adverse Event|4|||
155554702|NCT02011113|561455672|FG000|Overall Study|Disease Progression (DP)|16|||
155554703|NCT02011113|561455672|FG000|Overall Study|Death|1|||
155554704|NCT02011113|561455672|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
155554705|NCT02011113|561455672|FG000|Overall Study|Investigator's judgement- DP|3|||
155554706|NCT02011113|561455672|FG000|Overall Study|Study terminated by sponsor|11|||
155554707|NCT02669940|561455675|FG000|Overall Study|Failure to return|0|||
155554708|NCT02669940|561455676|FG001|Overall Study|Failure to return|3|||
155554709|NCT02669940|561455675|FG000|Overall Study|Insufficient follow-up data|1|||
155554710|NCT02669940|561455676|FG001|Overall Study|Insufficient follow-up data|0|||
155554711|NCT01892657|561455677|FG000|Overall Study|Withdrawal by Subject|6|||
155554712|NCT01892657|561455677|FG000|Overall Study|Protocol Violation|12|||
155554713|NCT05065983|561455678|FG000|Overall Study|Lost to Follow-up|2|||
155554714|NCT00986180|561455679|FG000|Overall Study|Adverse Event|21|||
155554715|NCT00986180|561455680|FG001|Overall Study|Adverse Event|23|||
155554716|NCT00986180|561455679|FG000|Overall Study|Lack of Efficacy|4|||
155554717|NCT00986180|561455680|FG001|Overall Study|Lack of Efficacy|3|||
155554718|NCT00986180|561455679|FG000|Overall Study|Lost to Follow-up|5|||
155554719|NCT00986180|561455680|FG001|Overall Study|Lost to Follow-up|7|||
155554720|NCT00986180|561455679|FG000|Overall Study|Physician Decision|1|||
155554721|NCT00986180|561455680|FG001|Overall Study|Physician Decision|3|||
155554722|NCT00986180|561455679|FG000|Overall Study|Protocol Violation|2|||
155554723|NCT00986180|561455680|FG001|Overall Study|Protocol Violation|0|||
155554724|NCT00986180|561455679|FG000|Overall Study|Withdrawal by Subject|1|||
155554725|NCT00986180|561455680|FG001|Overall Study|Withdrawal by Subject|9|||
155554726|NCT00986180|561455679|FG000|Overall Study|Miscellanies|10|||
155554727|NCT00986180|561455680|FG001|Overall Study|Miscellanies|11|||
155554728|NCT03251963|561455683|FG000|Overall Study|inappropriate Xa level timing|6|||
155554729|NCT03251963|561455684|FG001|Overall Study|inappropriate Xa level timing|3|||
155554730|NCT03251963|561455683|FG000|Overall Study|no peak Xa level drawn|2|||
155554731|NCT03251963|561455684|FG001|Overall Study|no peak Xa level drawn|0|||
155554732|NCT03251963|561455683|FG000|Overall Study|bled prior to Xa level|1|||
155554733|NCT03251963|561455684|FG001|Overall Study|bled prior to Xa level|2|||
155554734|NCT04505293|561455685|FG000|Overall Study|Lost to Follow-up|2|||
155554735|NCT04505293|561455685|FG000|Overall Study|Withdrawal by Subject|6|||
155554736|NCT04505293|561455685|FG000|Overall Study|CT scan unreadable|277|||
155554737|NCT00506129|561455686|FG000|Overall Study|Disease Progression/Relapse|15|||
155554738|NCT00506129|561455686|FG000|Overall Study|Death|7|||
155554739|NCT04295135|561455687|FG000|Overall Study|Withdrawal by Subject|2|||
155554740|NCT04295135|561455688|FG001|Overall Study|Withdrawal by Subject|1|||
155554741|NCT04295135|561455687|FG000|Overall Study|Subject left organization|8|||
155554742|NCT04295135|561455688|FG001|Overall Study|Subject left organization|4|||
155554743|NCT02923674|561455689|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
155554744|NCT02923674|561455690|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
155554745|NCT02923674|561455691|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
155554746|NCT02923674|561455689|FG000|Overall Study|Lost to Follow-up|7|||
155554747|NCT02923674|561455690|FG001|Overall Study|Lost to Follow-up|12|||
155554748|NCT02923674|561455691|FG002|Overall Study|Lost to Follow-up|7|||
155657683|NCT02314923|561840404|FG008|Overall Study|Physician Decision|0|||
155554749|NCT02923674|561455689|FG000|Overall Study|Problem with intervention|2|||
155554750|NCT02923674|561455690|FG001|Overall Study|Problem with intervention|2|||
155554751|NCT02923674|561455691|FG002|Overall Study|Problem with intervention|1|||
155554752|NCT02923674|561455689|FG000|Overall Study|Adverse Event|3|||
155554753|NCT02923674|561455690|FG001|Overall Study|Adverse Event|1|||
155554754|NCT02923674|561455691|FG002|Overall Study|Adverse Event|1|||
155554755|NCT02923674|561455689|FG000|Overall Study|Withdrawal by Subject|2|||
155554756|NCT02923674|561455690|FG001|Overall Study|Withdrawal by Subject|2|||
155554757|NCT02923674|561455691|FG002|Overall Study|Withdrawal by Subject|2|||
155554758|NCT02712333|561455692|FG000|First Period|Withdrawal by Subject|3|||
155554759|NCT02712333|561455693|FG001|First Period|Withdrawal by Subject|2|||
155554760|NCT01546649|561455698|FG000|Overall Study|Adverse Event|4|||
155554761|NCT01546649|561455699|FG001|Overall Study|Adverse Event|5|||
155554762|NCT01546649|561455698|FG000|Overall Study|Protocol Violation|1|||
155554763|NCT01546649|561455699|FG001|Overall Study|Protocol Violation|0|||
155554764|NCT01546649|561455698|FG000|Overall Study|Lack of Efficacy|1|||
155554765|NCT01546649|561455699|FG001|Overall Study|Lack of Efficacy|0|||
155554766|NCT01546649|561455698|FG000|Overall Study|Recurrence|1|||
155554767|NCT01546649|561455699|FG001|Overall Study|Recurrence|1|||
155554768|NCT01546649|561455698|FG000|Overall Study|Discovery of secondary cancer|0|||
155554769|NCT01546649|561455699|FG001|Overall Study|Discovery of secondary cancer|1|||
155554770|NCT01546649|561455698|FG000|Overall Study|Withdrawal by Subject|1|||
155554771|NCT01546649|561455699|FG001|Overall Study|Withdrawal by Subject|2|||
155554772|NCT01621191|561455701|FG000|Overall Study|Adverse Event|9|||
155554773|NCT01621191|561455701|FG000|Overall Study|Withdrawal by Subject|8|||
155554774|NCT01621191|561455701|FG000|Overall Study|Lack of Efficacy|6|||
155554775|NCT01621191|561455701|FG000|Overall Study|Lost to Follow-up|1|||
155554776|NCT01621191|561455701|FG000|Overall Study|Site Removed From Study|1|||
155554777|NCT00706381|561455705|FG000|Overall Study|Lost to Follow-up|0|||
155554778|NCT00706381|561455706|FG001|Overall Study|Lost to Follow-up|1|||
155554779|NCT00706381|561455707|FG002|Overall Study|Lost to Follow-up|1|||
155554780|NCT00706381|561455708|FG003|Overall Study|Lost to Follow-up|0|||
155554781|NCT01782482|561455716|FG000|Overall Study|Adverse Event|2|||
155554782|NCT01782482|561455717|FG001|Overall Study|Adverse Event|1|||
155554783|NCT01782482|561455716|FG000|Overall Study|Lost to Follow-up|2|||
155554784|NCT01782482|561455717|FG001|Overall Study|Lost to Follow-up|3|||
155554785|NCT01782482|561455716|FG000|Overall Study|Physician Decision|1|||
155554786|NCT01782482|561455717|FG001|Overall Study|Physician Decision|0|||
155554787|NCT01782482|561455716|FG000|Overall Study|Protocol Violation|1|||
155554788|NCT01782482|561455717|FG001|Overall Study|Protocol Violation|0|||
155554789|NCT01782482|561455716|FG000|Overall Study|Withdrawal by Subject|2|||
155554790|NCT01782482|561455717|FG001|Overall Study|Withdrawal by Subject|3|||
155554791|NCT01782482|561455716|FG000|Overall Study|Randomized in Error|2|||
155554792|NCT01782482|561455717|FG001|Overall Study|Randomized in Error|2|||
155554793|NCT01782482|561455716|FG000|Overall Study|Habitually wearing toric lens OS|0|||
155554794|NCT01782482|561455717|FG001|Overall Study|Habitually wearing toric lens OS|1|||
155554795|NCT03395639|561455719|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
155554796|NCT03395639|561455720|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
155554797|NCT03395639|561455721|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
155554798|NCT03395639|561455719|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
155554799|NCT03395639|561455720|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
155554800|NCT03395639|561455721|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
155554801|NCT03395639|561455719|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
155554802|NCT03395639|561455720|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
155554803|NCT03395639|561455721|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
155554804|NCT03395639|561455719|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
155554805|NCT03395639|561455720|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
155554806|NCT03395639|561455721|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
155554807|NCT03395639|561455719|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
155554808|NCT03395639|561455720|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
155554809|NCT03395639|561455721|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
155554810|NCT01641133|561455736|FG000|Overall Study|Protocol Violation|0|||
155554811|NCT01641133|561455737|FG001|Overall Study|Protocol Violation|1|||
155554812|NCT01641133|561455738|FG002|Overall Study|Protocol Violation|1|||
155554813|NCT01641133|561455736|FG000|Overall Study|Migrated/moved from study area|5|||
155554814|NCT01641133|561455737|FG001|Overall Study|Migrated/moved from study area|3|||
155554815|NCT01641133|561455738|FG002|Overall Study|Migrated/moved from study area|1|||
155554816|NCT01641133|561455736|FG000|Overall Study|Adverse Event|0|||
155554817|NCT01641133|561455737|FG001|Overall Study|Adverse Event|0|||
155554818|NCT01641133|561455738|FG002|Overall Study|Adverse Event|1|||
155554819|NCT01641133|561455736|FG000|Overall Study|Withdrawal by Subject|5|||
155554820|NCT01641133|561455737|FG001|Overall Study|Withdrawal by Subject|3|||
155554821|NCT01641133|561455738|FG002|Overall Study|Withdrawal by Subject|3|||
155554822|NCT01641133|561455736|FG000|Overall Study|Lost to Follow-up|0|||
155554823|NCT01641133|561455737|FG001|Overall Study|Lost to Follow-up|2|||
155554824|NCT01641133|561455738|FG002|Overall Study|Lost to Follow-up|2|||
155554825|NCT02220725|561455739|FG000|Overall Study|Lost to Follow-up|0|||
155554826|NCT02220725|561455740|FG001|Overall Study|Lost to Follow-up|0|||
155554827|NCT02220725|561455741|FG002|Overall Study|Lost to Follow-up|0|||
155554828|NCT02220725|561455742|FG003|Overall Study|Lost to Follow-up|1|||
155554829|NCT02220725|561455739|FG000|Overall Study|Withdrawal by Subject|0|||
155554830|NCT02220725|561455740|FG001|Overall Study|Withdrawal by Subject|0|||
155554831|NCT02220725|561455741|FG002|Overall Study|Withdrawal by Subject|0|||
155554832|NCT02220725|561455742|FG003|Overall Study|Withdrawal by Subject|1|||
155554833|NCT04189445|561457241|FG000|Overall Study|Withdrawal of consent|8|||
155554834|NCT04189445|561457242|FG001|Overall Study|Withdrawal of consent|1|||
155554835|NCT04189445|561457243|FG002|Overall Study|Withdrawal of consent|0|||
155554836|NCT04189445|561457241|FG000|Overall Study|Study Terminated by Sponsor|25|||
155554837|NCT04189445|561457242|FG001|Overall Study|Study Terminated by Sponsor|3|||
155554838|NCT04189445|561457243|FG002|Overall Study|Study Terminated by Sponsor|0|||
155554839|NCT04189445|561457241|FG000|Overall Study|Death|54|||
155554840|NCT04189445|561457242|FG001|Overall Study|Death|24|||
155554841|NCT04189445|561457243|FG002|Overall Study|Death|0|||
155554842|NCT00003138|561457244|FG000|Step 1|Reasons off treatment not documented|60|||
155554843|NCT00003138|561457245|FG001|Step 1|Reasons off treatment not documented|57|||
155554844|NCT00003138|561457244|FG000|Step 1|Never started treatment|1|||
155554845|NCT00003138|561457245|FG001|Step 1|Never started treatment|0|||
155554846|NCT00003138|561457244|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
155554847|NCT00003138|561457245|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
155554848|NCT00003138|561457244|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
155554849|NCT00003138|561457245|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
155554850|NCT00003138|561457244|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
155554851|NCT00003138|561457245|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
155554852|NCT00003138|561457244|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
155554853|NCT00003138|561457245|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
155554854|NCT02960893|561457247|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
155554855|NCT02960893|561457248|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
155554856|NCT02960893|561457249|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
155554857|NCT02960893|561457250|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
155554858|NCT02960893|561457247|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
155554859|NCT02960893|561457248|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
155554860|NCT02960893|561457249|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
155554861|NCT02960893|561457250|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
155554862|NCT02960893|561457247|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
155554863|NCT02960893|561457248|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
155554864|NCT02960893|561457249|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
155554865|NCT02960893|561457250|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
155554866|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
155554867|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
155554868|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
155554869|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
155554870|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
155554871|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
155554872|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
155554873|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
155554874|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
155554875|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
155554876|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
155554877|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
155554878|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
155554879|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
155554880|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
155554881|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
155554882|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
155554883|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
155554884|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
155554885|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
155554886|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
155554887|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
155554888|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
155554889|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
155554890|NCT02960893|561457247|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
155554891|NCT02960893|561457248|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
155554892|NCT02960893|561457249|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
155554893|NCT02960893|561457250|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
155554894|NCT01045421|561457251|FG000|Phase 1|Progressive Disease|0|||
155554895|NCT01045421|561457252|FG001|Phase 1|Progressive Disease|0|||
155554896|NCT01045421|561457253|FG002|Phase 1|Progressive Disease|0|||
155554897|NCT01045421|561457254|FG003|Phase 1|Progressive Disease|0|||
155554898|NCT01045421|561457255|FG004|Phase 1|Progressive Disease|1|||
155554899|NCT01045421|561457256|FG005|Phase 1|Progressive Disease|0|||
155554900|NCT01045421|561457257|FG006|Phase 1|Progressive Disease|0|||
155554901|NCT01045421|561457258|FG007|Phase 1|Progressive Disease|0|||
155554902|NCT01045421|561457259|FG008|Phase 1|Progressive Disease|0|||
155657684|NCT02314923|561840405|FG009|Overall Study|Physician Decision|0|||
155554903|NCT01045421|561457260|FG009|Phase 1|Progressive Disease|0|||
155554904|NCT01045421|561457261|FG010|Phase 1|Progressive Disease|0|||
155554905|NCT01045421|561457251|FG000|Phase 1|Withdrawal by Subject|0|||
155554906|NCT01045421|561457252|FG001|Phase 1|Withdrawal by Subject|0|||
155554907|NCT01045421|561457253|FG002|Phase 1|Withdrawal by Subject|0|||
155554908|NCT01045421|561457254|FG003|Phase 1|Withdrawal by Subject|1|||
155554909|NCT01045421|561457255|FG004|Phase 1|Withdrawal by Subject|0|||
155554910|NCT01045421|561457256|FG005|Phase 1|Withdrawal by Subject|0|||
155554911|NCT01045421|561457257|FG006|Phase 1|Withdrawal by Subject|0|||
155554912|NCT01045421|561457258|FG007|Phase 1|Withdrawal by Subject|0|||
155554913|NCT01045421|561457259|FG008|Phase 1|Withdrawal by Subject|0|||
155554914|NCT01045421|561457260|FG009|Phase 1|Withdrawal by Subject|0|||
155554915|NCT01045421|561457261|FG010|Phase 1|Withdrawal by Subject|0|||
155554916|NCT01045421|561457251|FG000|Phase 2|Progressive Disease|0|||
155554917|NCT01045421|561457252|FG001|Phase 2|Progressive Disease|0|||
155554918|NCT01045421|561457253|FG002|Phase 2|Progressive Disease|0|||
155554919|NCT01045421|561457254|FG003|Phase 2|Progressive Disease|0|||
155554920|NCT01045421|561457255|FG004|Phase 2|Progressive Disease|0|||
155554921|NCT01045421|561457256|FG005|Phase 2|Progressive Disease|0|||
155554922|NCT01045421|561457257|FG006|Phase 2|Progressive Disease|0|||
155554923|NCT01045421|561457258|FG007|Phase 2|Progressive Disease|1|||
155554924|NCT01045421|561457259|FG008|Phase 2|Progressive Disease|1|||
155554925|NCT01045421|561457260|FG009|Phase 2|Progressive Disease|1|||
155554926|NCT01045421|561457261|FG010|Phase 2|Progressive Disease|1|||
155554927|NCT01045421|561457251|FG000|Phase 2|Death|0|||
155554928|NCT01045421|561457252|FG001|Phase 2|Death|0|||
155554929|NCT01045421|561457253|FG002|Phase 2|Death|0|||
155554930|NCT01045421|561457254|FG003|Phase 2|Death|0|||
155554931|NCT01045421|561457255|FG004|Phase 2|Death|0|||
155554932|NCT01045421|561457256|FG005|Phase 2|Death|0|||
155554933|NCT01045421|561457257|FG006|Phase 2|Death|0|||
155554934|NCT01045421|561457258|FG007|Phase 2|Death|1|||
155554935|NCT01045421|561457259|FG008|Phase 2|Death|1|||
155554936|NCT01045421|561457260|FG009|Phase 2|Death|2|||
155554937|NCT01045421|561457261|FG010|Phase 2|Death|0|||
155554938|NCT01045421|561457251|FG000|Phase 2|Other|0|||
155554939|NCT01045421|561457252|FG001|Phase 2|Other|0|||
155554940|NCT01045421|561457253|FG002|Phase 2|Other|0|||
155554941|NCT01045421|561457254|FG003|Phase 2|Other|0|||
155554942|NCT01045421|561457255|FG004|Phase 2|Other|0|||
155554943|NCT01045421|561457256|FG005|Phase 2|Other|0|||
155554944|NCT01045421|561457257|FG006|Phase 2|Other|0|||
155554945|NCT01045421|561457258|FG007|Phase 2|Other|3|||
155554946|NCT01045421|561457259|FG008|Phase 2|Other|0|||
155554947|NCT01045421|561457260|FG009|Phase 2|Other|0|||
155554948|NCT01045421|561457261|FG010|Phase 2|Other|1|||
155554949|NCT00856973|561457262|FG000|Overall Study|Adverse Event|5|||
155554950|NCT00856973|561457263|FG001|Overall Study|Adverse Event|5|||
155554951|NCT00856973|561457264|FG002|Overall Study|Adverse Event|3|||
155554952|NCT00856973|561457262|FG000|Overall Study|Lost to Follow-up|6|||
155554953|NCT00856973|561457263|FG001|Overall Study|Lost to Follow-up|3|||
155554954|NCT00856973|561457264|FG002|Overall Study|Lost to Follow-up|5|||
155554955|NCT00856973|561457262|FG000|Overall Study|Physician Decision|0|||
155554956|NCT00856973|561457263|FG001|Overall Study|Physician Decision|3|||
155554957|NCT00856973|561457264|FG002|Overall Study|Physician Decision|1|||
155554958|NCT00856973|561457262|FG000|Overall Study|Protocol Violation|1|||
155554959|NCT00856973|561457263|FG001|Overall Study|Protocol Violation|2|||
155554960|NCT00856973|561457264|FG002|Overall Study|Protocol Violation|1|||
155554961|NCT00856973|561457262|FG000|Overall Study|Withdrawal by Subject|13|||
155554962|NCT00856973|561457263|FG001|Overall Study|Withdrawal by Subject|16|||
155554963|NCT00856973|561457264|FG002|Overall Study|Withdrawal by Subject|15|||
155554964|NCT00856973|561457262|FG000|Overall Study|Other|11|||
155554965|NCT00856973|561457263|FG001|Overall Study|Other|12|||
155554966|NCT00856973|561457264|FG002|Overall Study|Other|13|||
155554967|NCT04556552|561457265|FG000|Overall Study|Lost to Follow-up|1|||
155554968|NCT04556552|561457266|FG001|Overall Study|Lost to Follow-up|0|||
155554969|NCT04556552|561457265|FG000|Overall Study|Claustrophobia|0|||
155554970|NCT04556552|561457266|FG001|Overall Study|Claustrophobia|1|||
155554971|NCT04556552|561457265|FG000|Overall Study|Inability to continue|0|||
155554972|NCT04556552|561457266|FG001|Overall Study|Inability to continue|1|||
155554973|NCT01553279|561457267|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
155554974|NCT01553279|561457268|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
155554975|NCT01553279|561457267|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
155554976|NCT01553279|561457268|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
155554977|NCT01553279|561457267|FG000|Interim Period|Withdrawal by Subject|2|||
155554978|NCT01553279|561457268|FG001|Interim Period|Withdrawal by Subject|2|||
155554979|NCT01553279|561457267|FG000|Interim Period|Lost to Follow-up|1|||
155554980|NCT01553279|561457268|FG001|Interim Period|Lost to Follow-up|0|||
155554981|NCT01553279|561457267|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
155554982|NCT01553279|561457268|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
155554983|NCT01553279|561457267|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
155554984|NCT01553279|561457268|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
155554985|NCT00605865|561457269|FG000|Overall Study|Protocol Violation|115|||
155554986|NCT03955471|561457270|FG000|Overall Study|Death|22|||
155554987|NCT03955471|561457270|FG000|Overall Study|Lost to Follow-up|1|||
155554988|NCT03955471|561457270|FG000|Overall Study|Withdrawal by Subject|6|||
155554989|NCT03955471|561457270|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
155554990|NCT01030341|561457273|FG000|Overall Study|Withdrawal by Subject|1|||
155554991|NCT01030341|561457273|FG000|Overall Study|Lost to Follow-up|2|||
155554992|NCT01884311|561457274|FG000|Overall Study|Withdrawal by Subject|3|||
155554993|NCT01884311|561457274|FG000|Overall Study|withdrew consent due to AEs|1|||
155554994|NCT01884311|561457274|FG000|Overall Study|Precautionary measure|1|||
155554995|NCT03310411|561457279|FG000|Period 1|Adverse Event|0|||
155554996|NCT03310411|561457280|FG001|Period 1|Adverse Event|0|||
155554997|NCT03310411|561457281|FG002|Period 1|Adverse Event|0|||
155554998|NCT03310411|561457282|FG003|Period 1|Adverse Event|1|||
155554999|NCT03623386|561457285|FG000|Overall Study|Protocol Violation|3|||
155555000|NCT03623386|561457286|FG001|Overall Study|Protocol Violation|2|||
155555001|NCT03623386|561457287|FG002|Overall Study|Protocol Violation|0|||
155555002|NCT03623386|561457285|FG000|Overall Study|Physician Decision|1|||
155555003|NCT03623386|561457286|FG001|Overall Study|Physician Decision|1|||
155555004|NCT03623386|561457287|FG002|Overall Study|Physician Decision|0|||
155555005|NCT03623386|561457285|FG000|Overall Study|Lost to Follow-up|0|||
155555006|NCT03623386|561457286|FG001|Overall Study|Lost to Follow-up|2|||
155555007|NCT03623386|561457287|FG002|Overall Study|Lost to Follow-up|0|||
155555008|NCT03623386|561457285|FG000|Overall Study|COVID-19|0|||
155555009|NCT03623386|561457286|FG001|Overall Study|COVID-19|1|||
155555010|NCT03623386|561457287|FG002|Overall Study|COVID-19|0|||
155555011|NCT03052322|561457288|FG000|Overall Study|Other un-specified|1|||
155555012|NCT03052322|561457289|FG001|Overall Study|Other un-specified|2|||
155555013|NCT03052322|561457288|FG000|Overall Study|Withdrawal by Subject|10|||
155555014|NCT03052322|561457289|FG001|Overall Study|Withdrawal by Subject|9|||
155555015|NCT03052322|561457288|FG000|Overall Study|Death|0|||
155555016|NCT03052322|561457289|FG001|Overall Study|Death|2|||
155555017|NCT03052322|561457288|FG000|Overall Study|Lack of Efficacy|1|||
155555018|NCT03052322|561457289|FG001|Overall Study|Lack of Efficacy|2|||
155555019|NCT03052322|561457288|FG000|Overall Study|Protocol Violation|1|||
155555020|NCT03052322|561457289|FG001|Overall Study|Protocol Violation|0|||
155555021|NCT03052322|561457288|FG000|Overall Study|Lost to Follow-up|2|||
155555022|NCT03052322|561457289|FG001|Overall Study|Lost to Follow-up|4|||
155555023|NCT03052322|561457288|FG000|Overall Study|Adverse Event|6|||
155555024|NCT03052322|561457289|FG001|Overall Study|Adverse Event|13|||
155555025|NCT00003875|561457300|FG000|Overall Study|Screen Failed|1|||
155555026|NCT01070771|561457301|FG000|Overall Study|Adverse Event|2|||
155555027|NCT01070771|561457301|FG000|Overall Study|Protocol Violation|1|||
155555028|NCT03835325|561457304|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
155555029|NCT03835325|561457304|FG000|Overall Study|Selection failure|1|||
155555030|NCT01370213|561457305|FG000|Overall Study|Early Death|1|||
155555031|NCT01370213|561457306|FG001|Overall Study|Early Death|0|||
155555032|NCT01370213|561457307|FG002|Overall Study|Early Death|0|||
155555033|NCT01370213|561457305|FG000|Overall Study|Not evaluable|0|||
155555034|NCT01370213|561457306|FG001|Overall Study|Not evaluable|2|||
155555035|NCT01370213|561457307|FG002|Overall Study|Not evaluable|0|||
155555036|NCT01550744|561457313|FG000|Open-Label|Lost to Follow-up|7|||
155555037|NCT01550744|561457314|FG001|Open-Label|Lost to Follow-up|0|||
155555038|NCT01550744|561457315|FG002|Open-Label|Lost to Follow-up|0|||
155555039|NCT01550744|561457313|FG000|Open-Label|Withdrawal by Subject|13|||
155555040|NCT01550744|561457314|FG001|Open-Label|Withdrawal by Subject|0|||
155657685|NCT02314923|561840396|FG000|Overall Study|Participant unavailable|0|||
155657686|NCT02314923|561840397|FG001|Overall Study|Participant unavailable|0|||
155657687|NCT02314923|561840398|FG002|Overall Study|Participant unavailable|0|||
155555041|NCT01550744|561457315|FG002|Open-Label|Withdrawal by Subject|0|||
155555042|NCT01550744|561457313|FG000|Open-Label|Adverse Event|11|||
155657688|NCT02314923|561840399|FG003|Overall Study|Participant unavailable|0|||
155657689|NCT02314923|561840400|FG004|Overall Study|Participant unavailable|0|||
155555043|NCT01550744|561457314|FG001|Open-Label|Adverse Event|0|||
155555044|NCT01550744|561457315|FG002|Open-Label|Adverse Event|0|||
155555045|NCT01550744|561457313|FG000|Open-Label|Lack of Efficacy|4|||
155555046|NCT01550744|561457314|FG001|Open-Label|Lack of Efficacy|0|||
155657690|NCT02314923|561840401|FG005|Overall Study|Participant unavailable|1|||
155555047|NCT01550744|561457315|FG002|Open-Label|Lack of Efficacy|0|||
155555048|NCT01550744|561457313|FG000|Open-Label|Protocol Violation|4|||
155555049|NCT01550744|561457314|FG001|Open-Label|Protocol Violation|0|||
155555050|NCT01550744|561457315|FG002|Open-Label|Protocol Violation|0|||
155555051|NCT01550744|561457313|FG000|Open-Label|Not all 3 study drug injections received|2|||
155555052|NCT01550744|561457314|FG001|Open-Label|Not all 3 study drug injections received|0|||
155555053|NCT01550744|561457315|FG002|Open-Label|Not all 3 study drug injections received|0|||
155555054|NCT01550744|561457313|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
155555055|NCT01550744|561457314|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
155555056|NCT01550744|561457315|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
155555057|NCT01550744|561457313|FG000|Open-Label|Other|1|||
155555058|NCT01550744|561457314|FG001|Open-Label|Other|0|||
155555059|NCT01550744|561457315|FG002|Open-Label|Other|0|||
155555060|NCT01550744|561457313|FG000|Double-Blind|Lost to Follow-up|0|||
155555061|NCT01550744|561457314|FG001|Double-Blind|Lost to Follow-up|6|||
155555062|NCT01550744|561457315|FG002|Double-Blind|Lost to Follow-up|12|||
155555063|NCT01550744|561457313|FG000|Double-Blind|Withdrawal by Subject|0|||
155555064|NCT01550744|561457314|FG001|Double-Blind|Withdrawal by Subject|2|||
155657691|NCT02314923|561840402|FG006|Overall Study|Participant unavailable|0|||
155555065|NCT01550744|561457315|FG002|Double-Blind|Withdrawal by Subject|15|||
155555066|NCT01550744|561457313|FG000|Double-Blind|Adverse Event|0|||
155657692|NCT02314923|561840403|FG007|Overall Study|Participant unavailable|0|||
155555067|NCT01550744|561457314|FG001|Double-Blind|Adverse Event|4|||
155555068|NCT01550744|561457315|FG002|Double-Blind|Adverse Event|15|||
155555069|NCT01550744|561457313|FG000|Double-Blind|Death|0|||
155555070|NCT01550744|561457314|FG001|Double-Blind|Death|1|||
155555071|NCT01550744|561457315|FG002|Double-Blind|Death|0|||
155555072|NCT01550744|561457313|FG000|Double-Blind|Lack of Efficacy|0|||
155555073|NCT01550744|561457314|FG001|Double-Blind|Lack of Efficacy|2|||
155555074|NCT01550744|561457315|FG002|Double-Blind|Lack of Efficacy|8|||
155555075|NCT01550744|561457313|FG000|Double-Blind|Protocol Violation|0|||
155555076|NCT01550744|561457314|FG001|Double-Blind|Protocol Violation|0|||
155555077|NCT01550744|561457315|FG002|Double-Blind|Protocol Violation|4|||
155555078|NCT01550744|561457313|FG000|Double-Blind|Pregnancy|0|||
155555079|NCT01550744|561457314|FG001|Double-Blind|Pregnancy|0|||
155555080|NCT01550744|561457315|FG002|Double-Blind|Pregnancy|3|||
155555081|NCT01550744|561457313|FG000|Double-Blind|Other|0|||
155555082|NCT01550744|561457314|FG001|Double-Blind|Other|2|||
155555083|NCT01550744|561457315|FG002|Double-Blind|Other|10|||
155555084|NCT02787408|561457317|FG000|Overall Study|Death|16|||
155555085|NCT02787408|561457317|FG000|Overall Study|Withdrawal by Subject|1|||
155555086|NCT02787408|561457317|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
155555087|NCT00995085|561457318|FG000|Overall Study|Withdrawal by Subject|5|||
155555088|NCT01194973|561457319|FG000|Screening Period|Screen Failure|3|||
155555089|NCT01194973|561457319|FG000|26 Week Treatment Period|Adverse Event|1|||
155555090|NCT01194973|561457319|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
155555091|NCT01194973|561457319|FG000|26 Week Treatment Period|Pregnancy|1|||
155555092|NCT02595008|561457322|FG000|Overall Study|Enrolled In Error|1|||
155555093|NCT02595008|561457323|FG001|Overall Study|Enrolled In Error|0|||
155555094|NCT03407118|561457324|FG000|Period 2|Withdrawal by Subject|1|||
155555095|NCT03407118|561457325|FG001|Period 2|Withdrawal by Subject|0|||
155555096|NCT01491035|561457328|FG000|Overall Study|Lost to Follow-up|0|||
155555097|NCT01491035|561457329|FG001|Overall Study|Lost to Follow-up|0|||
155555098|NCT01491035|561457330|FG002|Overall Study|Lost to Follow-up|0|||
155555099|NCT01491035|561457331|FG003|Overall Study|Lost to Follow-up|0|||
155555100|NCT01491035|561457332|FG004|Overall Study|Lost to Follow-up|1|||
155555101|NCT01491035|561457333|FG005|Overall Study|Lost to Follow-up|0|||
155555102|NCT01491035|561457334|FG006|Overall Study|Lost to Follow-up|0|||
155555103|NCT01491035|561457335|FG007|Overall Study|Lost to Follow-up|0|||
155555104|NCT03351231|561457336|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
155555105|NCT03351231|561457336|FG000|Combination Therapy Period|Disease progression|2|||
155555106|NCT03351231|561457336|FG000|Combination Therapy Period|Study drug toxicity|1|||
155555107|NCT03351231|561457336|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
155555108|NCT03351231|561457336|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
155555109|NCT03351231|561457336|FG000|Safety Follow-Up Period|Other reason|2|||
155555110|NCT01673698|561457339|FG000|Overall Study|Lost to Follow-up|51|||
155555111|NCT01673698|561457340|FG001|Overall Study|Lost to Follow-up|13|||
155555112|NCT01297322|561457341|FG000|Overall Study|Lost to Follow-up|1|||
155555113|NCT01297322|561457342|FG001|Overall Study|Lost to Follow-up|0|||
155555114|NCT01297322|561457341|FG000|Overall Study|Withdrawal by Subject|0|||
155555115|NCT01297322|561457342|FG001|Overall Study|Withdrawal by Subject|1|||
155555116|NCT01297322|561457341|FG000|Overall Study|Protocol Violation|0|||
155555117|NCT01297322|561457342|FG001|Overall Study|Protocol Violation|3|||
155555118|NCT01111019|561457343|FG000|Overall Study|Withdrew Prematurely|2|||
155555119|NCT01111019|561457343|FG000|Overall Study|Other|1|||
155555120|NCT02013375|561457344|FG000|Overall Study|Did not engraft|1|||
155555121|NCT02013375|561457344|FG000|Overall Study|Did not engraft|1|||
155555122|NCT00712985|561457345|FG000|Overall Study|1 withdrew prior to start of drug|1|||
155555123|NCT00712985|561457345|FG000|Overall Study|1 patient moved out of state|1|||
155555124|NCT00712985|561457345|FG000|Overall Study|Lack of Efficacy|3|||
155555125|NCT02674061|561457346|FG000|Overall Study|Death|229|||
155555126|NCT02674061|561457347|FG001|Overall Study|Death|77|||
155555127|NCT02674061|561457346|FG000|Overall Study|Lost to Follow-up|3|||
155555128|NCT02674061|561457347|FG001|Overall Study|Lost to Follow-up|3|||
155555129|NCT02674061|561457346|FG000|Overall Study|Withdrawal by Subject|9|||
155555130|NCT02674061|561457347|FG001|Overall Study|Withdrawal by Subject|1|||
155555131|NCT02674061|561457346|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
155555132|NCT02674061|561457347|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
155555133|NCT03334721|561457350|FG000|Overall Study|Withdrawal by Subject|1|||
155555134|NCT03334721|561457351|FG001|Overall Study|Withdrawal by Subject|0|||
155555135|NCT03334721|561457350|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
155555136|NCT03334721|561457351|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
155555137|NCT01663727|561457352|FG000|Overall Study|Death|161|||
155555138|NCT01663727|561457353|FG001|Overall Study|Death|155|||
155555139|NCT01663727|561457352|FG000|Overall Study|Lost to Follow-up|10|||
155555140|NCT01663727|561457353|FG001|Overall Study|Lost to Follow-up|8|||
155555141|NCT01663727|561457352|FG000|Overall Study|Withdrawal by Subject|18|||
155555142|NCT01663727|561457353|FG001|Overall Study|Withdrawal by Subject|25|||
155555143|NCT01663727|561457352|FG000|Overall Study|Study Terminated|51|||
155555144|NCT01663727|561457353|FG001|Overall Study|Study Terminated|50|||
155555145|NCT01663727|561457352|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
155555146|NCT01663727|561457353|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
155657693|NCT02314923|561840404|FG008|Overall Study|Participant unavailable|0|||
155555147|NCT01663727|561457352|FG000|Overall Study|Withdrawal prior to dosing.|1|||
155555148|NCT01663727|561457353|FG001|Overall Study|Withdrawal prior to dosing.|0|||
155555149|NCT01902628|561457354|FG000|Overall Study|Withdrawal of participant's consent|7|||
155555150|NCT01902628|561457354|FG000|Overall Study|Adverse Event|41|||
155555151|NCT01902628|561457354|FG000|Overall Study|Lost to Follow-up|35|||
155555152|NCT01232491|561457355|FG000|Overall Study|Adverse Event|13|||
155555153|NCT01232491|561457356|FG001|Overall Study|Adverse Event|8|||
155555154|NCT01232491|561457355|FG000|Overall Study|Lack of Efficacy|1|||
155555155|NCT01232491|561457356|FG001|Overall Study|Lack of Efficacy|5|||
155555156|NCT01232491|561457355|FG000|Overall Study|Protocol Violation|13|||
155555157|NCT01232491|561457356|FG001|Overall Study|Protocol Violation|11|||
155555158|NCT01232491|561457355|FG000|Overall Study|Withdrawal Criteria|12|||
155555159|NCT01232491|561457356|FG001|Overall Study|Withdrawal Criteria|21|||
155555160|NCT01232491|561457355|FG000|Overall Study|Other|21|||
155555161|NCT01232491|561457356|FG001|Overall Study|Other|18|||
155555162|NCT02932228|561457359|FG000|Overall Study|Death|8|||
155555163|NCT02932228|561457360|FG001|Overall Study|Death|23|||
155555164|NCT02932228|561457359|FG000|Overall Study|not eligible upon chart review|2|||
155555165|NCT02932228|561457360|FG001|Overall Study|not eligible upon chart review|5|||
155555166|NCT03340064|561458918|FG000|First Period|Adverse Event, non-fatal|2|||
155555167|NCT03340064|561458919|FG001|First Period|Adverse Event, non-fatal|0|||
155555168|NCT03340064|561458918|FG000|First Period|Lack of Efficacy|3|||
155555169|NCT03340064|561458919|FG001|First Period|Lack of Efficacy|0|||
155555170|NCT03340064|561458918|FG000|Second Period|Adverse Event, non-fatal|1|||
155555171|NCT03340064|561458919|FG001|Second Period|Adverse Event, non-fatal|1|||
155555172|NCT03340064|561458918|FG000|Second Period|Lack of Efficacy|11|||
155555173|NCT03340064|561458919|FG001|Second Period|Lack of Efficacy|0|||
155555174|NCT03340064|561458918|FG000|Second Period|Physician Decision|3|||
155657694|NCT02314923|561840405|FG009|Overall Study|Participant unavailable|0|||
155657695|NCT02314923|561840396|FG000|Overall Study|Screen failure|0|||
155657696|NCT02314923|561840397|FG001|Overall Study|Screen failure|0|||
155657697|NCT02314923|561840398|FG002|Overall Study|Screen failure|0|||
155657698|NCT02314923|561840399|FG003|Overall Study|Screen failure|0|||
155555175|NCT03340064|561458919|FG001|Second Period|Physician Decision|0|||
155555176|NCT03340064|561458918|FG000|Second Period|Withdrawal by Subject|2|||
155555177|NCT03340064|561458919|FG001|Second Period|Withdrawal by Subject|1|||
155657699|NCT02314923|561840400|FG004|Overall Study|Screen failure|0|||
155555178|NCT03340064|561458918|FG000|Second Period|Approved Drug Available For Indication|1|||
155555179|NCT03340064|561458919|FG001|Second Period|Approved Drug Available For Indication|0|||
155555180|NCT03340064|561458918|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
155555181|NCT03340064|561458919|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
155555182|NCT02522403|561458920|FG000|Overall Study|Lost to Follow-up|2|||
155555183|NCT02522403|561458921|FG001|Overall Study|Lost to Follow-up|2|||
155555184|NCT02522403|561458920|FG000|Overall Study|Withdrawal by Subject|2|||
155555185|NCT02522403|561458921|FG001|Overall Study|Withdrawal by Subject|4|||
155555186|NCT05142566|561458922|FG000|Overall Study|Protocol Violation|1|||
155555187|NCT00515541|561458925|FG000|Overall Study|Physician Decision|0|||
155555188|NCT00515541|561458926|FG001|Overall Study|Physician Decision|2|||
155555189|NCT00515541|561458927|FG002|Overall Study|Physician Decision|0|||
155555190|NCT00515541|561458928|FG003|Overall Study|Physician Decision|1|||
155555191|NCT00515541|561458925|FG000|Overall Study|No show for appointments|0|||
155555192|NCT00515541|561458926|FG001|Overall Study|No show for appointments|1|||
155555193|NCT00515541|561458927|FG002|Overall Study|No show for appointments|0|||
155555194|NCT00515541|561458928|FG003|Overall Study|No show for appointments|2|||
155555195|NCT00515541|561458925|FG000|Overall Study|Withdrawal by Subject|0|||
155555196|NCT00515541|561458926|FG001|Overall Study|Withdrawal by Subject|2|||
155555197|NCT00515541|561458927|FG002|Overall Study|Withdrawal by Subject|0|||
155555198|NCT00515541|561458928|FG003|Overall Study|Withdrawal by Subject|2|||
155555199|NCT02588950|561458929|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
155555200|NCT02588950|561458930|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
155555201|NCT02588950|561458931|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
155555202|NCT02588950|561458932|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
155555203|NCT02588950|561458929|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
155555204|NCT02588950|561458930|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
155555205|NCT02588950|561458931|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
155555206|NCT02588950|561458932|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
155555207|NCT02072824|561458933|FG000|Overall Study|Insufficient clinical response|1|||
155555208|NCT02072824|561458934|FG001|Overall Study|Insufficient clinical response|0|||
155555209|NCT02072824|561458935|FG002|Overall Study|Insufficient clinical response|1|||
155555210|NCT02072824|561458933|FG000|Overall Study|No longer willing to participate|1|||
155555211|NCT02072824|561458934|FG001|Overall Study|No longer willing to participate|0|||
155555212|NCT02072824|561458935|FG002|Overall Study|No longer willing to participate|1|||
155555213|NCT02072824|561458933|FG000|Overall Study|Medication error|0|||
155555214|NCT02072824|561458934|FG001|Overall Study|Medication error|1|||
155555215|NCT02072824|561458935|FG002|Overall Study|Medication error|0|||
155555216|NCT02072824|561458933|FG000|Overall Study|Adverse Event|0|||
155555217|NCT02072824|561458934|FG001|Overall Study|Adverse Event|0|||
155555218|NCT02072824|561458935|FG002|Overall Study|Adverse Event|1|||
155555219|NCT01248013|561458936|FG000|Overall Study|Withdrawal by Subject|14|||
155555220|NCT02667288|561458943|FG000|Overall Study|Protocol Violation|5|||
155555221|NCT02667288|561458943|FG000|Overall Study|Lost to Follow-up|3|||
155555222|NCT02667288|561458943|FG000|Overall Study|Withdrawal by Subject|5|||
155555223|NCT01196078|561458944|FG000|Overall Study|Withdrawal by Subject|3|||
155555224|NCT01196078|561458945|FG001|Overall Study|Withdrawal by Subject|5|||
155555225|NCT01196078|561458944|FG000|Overall Study|Adverse Event|4|||
155555226|NCT01196078|561458945|FG001|Overall Study|Adverse Event|4|||
155555227|NCT01196078|561458944|FG000|Overall Study|Protocol Violation|2|||
155555228|NCT01196078|561458945|FG001|Overall Study|Protocol Violation|1|||
155555229|NCT01196078|561458944|FG000|Overall Study|Lack of Efficacy|17|||
155555230|NCT01196078|561458945|FG001|Overall Study|Lack of Efficacy|23|||
155555231|NCT01196078|561458944|FG000|Overall Study|Lost to Follow-up|1|||
155555232|NCT01196078|561458945|FG001|Overall Study|Lost to Follow-up|0|||
155555233|NCT01196078|561458944|FG000|Overall Study|Death|6|||
155555234|NCT01196078|561458945|FG001|Overall Study|Death|4|||
155555235|NCT03921151|561458946|FG000|Overall Study|Withdrawal by Subject|11|||
155555236|NCT03921151|561458947|FG001|Overall Study|Withdrawal by Subject|16|||
155555237|NCT00857792|561458949|FG000|Overall Study|inadequate image quality for analysis|12|||
155555238|NCT03001219|561458953|FG000|Proof of Concept|Study Termination by Sponsor|0|||
155555239|NCT03001219|561458954|FG001|Proof of Concept|Study Termination by Sponsor|1|||
155555240|NCT03001219|561458953|FG000|Proof of Concept|Withdrawal by Subject|0|||
155555241|NCT03001219|561458954|FG001|Proof of Concept|Withdrawal by Subject|4|||
155555242|NCT03001219|561458953|FG000|Proof of Concept|Protocol Deviation|0|||
155555243|NCT03001219|561458954|FG001|Proof of Concept|Protocol Deviation|1|||
155555244|NCT03001219|561458953|FG000|Proof of Concept|Adverse Event|1|||
155555245|NCT03001219|561458954|FG001|Proof of Concept|Adverse Event|1|||
155555246|NCT03001219|561458953|FG000|Proof of Concept|Physician Decision|1|||
155555247|NCT03001219|561458954|FG001|Proof of Concept|Physician Decision|0|||
155555248|NCT03001219|561458953|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
155555249|NCT03001219|561458954|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
155555250|NCT03001219|561458953|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
155555251|NCT03001219|561458954|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
155555252|NCT03001219|561458953|FG000|Extension Period Analysis|Physician Decision|0|||
155555253|NCT03001219|561458954|FG001|Extension Period Analysis|Physician Decision|1|||
155555254|NCT03001219|561458953|FG000|Extension Period Analysis|Adverse Event|1|||
155555255|NCT03001219|561458954|FG001|Extension Period Analysis|Adverse Event|1|||
155555256|NCT03001219|561458953|FG000|Extension Period Analysis|Protocol Deviation|0|||
155555257|NCT03001219|561458954|FG001|Extension Period Analysis|Protocol Deviation|1|||
155555258|NCT03001219|561458953|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
155555259|NCT03001219|561458954|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
155555260|NCT03760250|561458956|FG000|Overall Study|Withdrawal by Subject|1|||
155555261|NCT03760250|561458956|FG000|Overall Study|Physician Decision|1|||
155555262|NCT03733210|561458957|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
155555263|NCT03733210|561458958|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
155555264|NCT04421586|561458967|FG000|Overall Study|Death|0|||
155555265|NCT04421586|561458968|FG001|Overall Study|Death|1|||
155555266|NCT04421586|561458967|FG000|Overall Study|Lost to Follow-up|2|||
155555267|NCT04421586|561458968|FG001|Overall Study|Lost to Follow-up|2|||
155555268|NCT04421586|561458967|FG000|Overall Study|Withdrawn by PI|1|||
155555269|NCT04421586|561458968|FG001|Overall Study|Withdrawn by PI|0|||
155555270|NCT04421586|561458967|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
155555271|NCT04421586|561458968|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
155555272|NCT02963441|561458969|FG000|Overall Study|Protocol violation or withdrawn|8|||
155555273|NCT02963441|561458969|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
155555274|NCT02963441|561458969|FG000|Overall Study|IDx-DR insufficient quality|33|||
155555275|NCT04688931|561458970|FG000|Overall Study|Adverse Event|4|||
155555276|NCT04688931|561458971|FG001|Overall Study|Adverse Event|1|||
155555277|NCT04688931|561458970|FG000|Overall Study|Withdrawal by Subject|5|||
155555278|NCT04688931|561458971|FG001|Overall Study|Withdrawal by Subject|16|||
155555279|NCT04688931|561458970|FG000|Overall Study|Physician Decision|3|||
155555280|NCT04688931|561458971|FG001|Overall Study|Physician Decision|5|||
155555281|NCT04688931|561458970|FG000|Overall Study|Noncompliance|0|||
155555282|NCT04688931|561458971|FG001|Overall Study|Noncompliance|1|||
155555283|NCT04688931|561458970|FG000|Overall Study|Lost to Follow-up|1|||
155555284|NCT04688931|561458971|FG001|Overall Study|Lost to Follow-up|3|||
155555285|NCT04688931|561458970|FG000|Overall Study|Randomization Error|3|||
155555286|NCT04688931|561458971|FG001|Overall Study|Randomization Error|0|||
155555287|NCT04688931|561458970|FG000|Overall Study|Not Eligible|1|||
155555288|NCT04688931|561458971|FG001|Overall Study|Not Eligible|3|||
155555289|NCT04688931|561458970|FG000|Overall Study|Disease Progression|0|||
155555290|NCT04688931|561458971|FG001|Overall Study|Disease Progression|2|||
155555291|NCT04688931|561458970|FG000|Overall Study|Sponsor Requirement|1|||
155555292|NCT04688931|561458971|FG001|Overall Study|Sponsor Requirement|1|||
155555293|NCT04688931|561458970|FG000|Overall Study|Other Reason|1|||
155555294|NCT04688931|561458971|FG001|Overall Study|Other Reason|2|||
155555295|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Adverse Event|9|||
155555296|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Adverse Event|4|||
155555297|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Adverse Event|5|||
155555298|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Adverse Event|9|||
155555299|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Adverse Event|8|||
155555300|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Adverse Event|0|||
155555301|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Adverse Event|0|||
155555302|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
155555303|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
155555304|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
155555305|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
155555306|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
155555307|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
155555308|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
155555309|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Death|1|||
155555310|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Death|1|||
155555311|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Death|1|||
155555312|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Death|1|||
155555313|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Death|0|||
155555314|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Death|0|||
155555315|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Death|0|||
155555316|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
155555317|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
155555318|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
155555319|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
155555320|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
155555321|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
155555322|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
155555323|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555324|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555325|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
155555326|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555327|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555328|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555329|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
155555330|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
155555331|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
155555332|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
155555333|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
155555334|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
155555335|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
155555336|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
155555337|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Other|2|||
155555338|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Other|9|||
155555339|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Other|9|||
155555340|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Other|3|||
155555341|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Other|2|||
155657700|NCT02314923|561840401|FG005|Overall Study|Screen failure|0|||
155657701|NCT02314923|561840402|FG006|Overall Study|Screen failure|1|||
155657702|NCT02314923|561840403|FG007|Overall Study|Screen failure|0|||
155555342|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Other|0|||
155555343|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Other|0|||
155555344|NCT00361335|561458972|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
155555345|NCT00361335|561458973|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
155555346|NCT00361335|561458974|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
155555347|NCT00361335|561458975|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
155555348|NCT00361335|561458976|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
155555349|NCT00361335|561458977|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
155555350|NCT00361335|561458978|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
155555351|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
155555352|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
155555353|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
155555354|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
155555355|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
155555356|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
155555357|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
155555358|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
155555359|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
155555360|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
155555361|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
155555362|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
155555363|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
155555364|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
155555365|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Death|0|||
155555366|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Death|0|||
155555367|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Death|0|||
155555368|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Death|0|||
155555369|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Death|0|||
155555370|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Death|0|||
155555371|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Death|1|||
155555372|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
155555373|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
155555374|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
155555375|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
155555376|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
155555377|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
155555378|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
155555379|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Other|1|||
155555380|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Other|0|||
155555381|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Other|0|||
155555382|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Other|1|||
155555383|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Other|0|||
155555384|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Other|1|||
155555385|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Other|2|||
155555386|NCT00361335|561458972|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
155555387|NCT00361335|561458973|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
155555388|NCT00361335|561458974|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
155555389|NCT00361335|561458975|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
155555390|NCT00361335|561458976|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
155555391|NCT00361335|561458977|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
155555392|NCT00361335|561458978|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
155555393|NCT01765582|561458979|FG000|Overall Study|Other|3|||
155555394|NCT01765582|561458980|FG001|Overall Study|Other|6|||
155555395|NCT01765582|561458981|FG002|Overall Study|Other|9|||
155555396|NCT01765582|561458979|FG000|Overall Study|Lost to Follow-up|2|||
155555397|NCT01765582|561458980|FG001|Overall Study|Lost to Follow-up|2|||
155555398|NCT01765582|561458981|FG002|Overall Study|Lost to Follow-up|1|||
155555399|NCT01765582|561458979|FG000|Overall Study|Death|31|||
155555400|NCT01765582|561458980|FG001|Overall Study|Death|36|||
155555401|NCT01765582|561458981|FG002|Overall Study|Death|33|||
155555402|NCT01765582|561458979|FG000|Overall Study|Sponsor Decision|46|||
155555403|NCT01765582|561458980|FG001|Overall Study|Sponsor Decision|42|||
155555404|NCT01765582|561458981|FG002|Overall Study|Sponsor Decision|42|||
155555405|NCT01765582|561458979|FG000|Overall Study|Withdrawal of Consent|11|||
155555406|NCT01765582|561458980|FG001|Overall Study|Withdrawal of Consent|6|||
155555407|NCT01765582|561458981|FG002|Overall Study|Withdrawal of Consent|10|||
155555408|NCT00616941|561458984|FG000|Overall Study|Progressive Disease|1|||
155555409|NCT00616941|561458985|FG001|Overall Study|Progressive Disease|2|||
155555410|NCT00616941|561458986|FG002|Overall Study|Progressive Disease|1|||
155555411|NCT00616941|561458984|FG000|Overall Study|Adverse Event|0|||
155555412|NCT00616941|561458985|FG001|Overall Study|Adverse Event|1|||
155555413|NCT00616941|561458986|FG002|Overall Study|Adverse Event|1|||
155555414|NCT00616941|561458984|FG000|Overall Study|Subject Non-compliance|0|||
155555415|NCT00616941|561458985|FG001|Overall Study|Subject Non-compliance|0|||
155555416|NCT00616941|561458986|FG002|Overall Study|Subject Non-compliance|1|||
155555417|NCT00616941|561458984|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
155555418|NCT00616941|561458985|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
155555419|NCT00616941|561458986|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
155555420|NCT00616941|561458984|FG000|Overall Study|Vaccination Suspended|0|||
155555421|NCT00616941|561458985|FG001|Overall Study|Vaccination Suspended|0|||
155555422|NCT00616941|561458986|FG002|Overall Study|Vaccination Suspended|3|||
155555423|NCT00714493|561458994|FG000|Overall Study|Adverse Event|11|||
155555424|NCT00714493|561458994|FG000|Overall Study|Death|3|||
155555425|NCT00714493|561458994|FG000|Overall Study|Lack of Efficacy|10|||
155555426|NCT00714493|561458994|FG000|Overall Study|Lost to Follow-up|3|||
155555427|NCT00714493|561458994|FG000|Overall Study|Protocol Violation|12|||
155555428|NCT00714493|561458994|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
155555429|NCT00714493|561458994|FG000|Overall Study|OTHER|2|||
155555430|NCT00076804|561458995|FG000|Overall Study|Death|9|||
155555431|NCT00076804|561458996|FG001|Overall Study|Death|20|||
155555432|NCT00076804|561458995|FG000|Overall Study|Lost to Follow-up|9|||
155555433|NCT00076804|561458996|FG001|Overall Study|Lost to Follow-up|9|||
155555434|NCT00076804|561458995|FG000|Overall Study|Withdrawal by Subject|10|||
155555435|NCT00076804|561458996|FG001|Overall Study|Withdrawal by Subject|8|||
155555436|NCT00076804|561458995|FG000|Overall Study|Early study Closure|32|||
155555437|NCT00076804|561458996|FG001|Overall Study|Early study Closure|32|||
155555438|NCT00354341|561458997|FG000|Overall Study|Adverse Event|1|||
155555439|NCT00354341|561458998|FG001|Overall Study|Adverse Event|0|||
155555440|NCT00354341|561458997|FG000|Overall Study|Death|0|||
155555441|NCT00354341|561458998|FG001|Overall Study|Death|2|||
155555442|NCT00354341|561458997|FG000|Overall Study|Refused treatment|1|||
155555443|NCT00354341|561458998|FG001|Overall Study|Refused treatment|2|||
155555444|NCT00354341|561458997|FG000|Overall Study|Failure to return|0|||
155555445|NCT00354341|561458998|FG001|Overall Study|Failure to return|1|||
155555446|NCT00354341|561458997|FG000|Overall Study|Other|1|||
155555447|NCT00354341|561458998|FG001|Overall Study|Other|2|||
155555448|NCT00251719|561458999|FG000|Overall Study|Adverse Event|14|||
155555449|NCT00251719|561459000|FG001|Overall Study|Adverse Event|8|||
155555450|NCT00251719|561459001|FG002|Overall Study|Adverse Event|7|||
155555451|NCT00251719|561458999|FG000|Overall Study|Protocol Violation|1|||
155555452|NCT00251719|561459000|FG001|Overall Study|Protocol Violation|1|||
155555453|NCT00251719|561459001|FG002|Overall Study|Protocol Violation|1|||
155555454|NCT00251719|561458999|FG000|Overall Study|Lost to Follow-up|5|||
155555455|NCT00251719|561459000|FG001|Overall Study|Lost to Follow-up|11|||
155555456|NCT00251719|561459001|FG002|Overall Study|Lost to Follow-up|8|||
155555457|NCT00251719|561458999|FG000|Overall Study|Withdrawal by Subject|14|||
155555458|NCT00251719|561459000|FG001|Overall Study|Withdrawal by Subject|12|||
155555459|NCT00251719|561459001|FG002|Overall Study|Withdrawal by Subject|11|||
155555460|NCT00251719|561458999|FG000|Overall Study|Lack of Efficacy|2|||
155555461|NCT00251719|561459000|FG001|Overall Study|Lack of Efficacy|1|||
155555462|NCT00251719|561459001|FG002|Overall Study|Lack of Efficacy|0|||
155555463|NCT00251719|561458999|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
155555464|NCT00251719|561459000|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
155555465|NCT00251719|561459001|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
155555466|NCT00251719|561458999|FG000|Overall Study|Investigator decision|1|||
155555467|NCT00251719|561459000|FG001|Overall Study|Investigator decision|1|||
155555468|NCT00251719|561459001|FG002|Overall Study|Investigator decision|0|||
155555469|NCT00251719|561458999|FG000|Overall Study|Noncompliance|2|||
155555470|NCT00251719|561459000|FG001|Overall Study|Noncompliance|3|||
155555471|NCT00251719|561459001|FG002|Overall Study|Noncompliance|1|||
155555472|NCT00251719|561458999|FG000|Overall Study|Barrett's esophagus|2|||
155555473|NCT00251719|561459000|FG001|Overall Study|Barrett's esophagus|2|||
155555474|NCT00251719|561459001|FG002|Overall Study|Barrett's esophagus|0|||
155555475|NCT01732874|561459003|FG000|Overall Study|Withdrawal by Subject|5|||
155555476|NCT01732874|561459004|FG001|Overall Study|Withdrawal by Subject|1|||
155555477|NCT01732874|561459003|FG000|Overall Study|Death of Infant|3|||
155555478|NCT01732874|561459004|FG001|Overall Study|Death of Infant|2|||
155555479|NCT00688376|561459005|FG000|Double-Blind Phase|Adverse Event|4|||
155555480|NCT00688376|561459006|FG001|Double-Blind Phase|Adverse Event|4|||
155555481|NCT00688376|561459005|FG000|Double-Blind Phase|Protocol Violation|1|||
155555482|NCT00688376|561459006|FG001|Double-Blind Phase|Protocol Violation|2|||
155555483|NCT00688376|561459005|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
155555484|NCT00688376|561459006|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
155555485|NCT00688376|561459005|FG000|Double-Blind Phase|Not treated|0|||
155555486|NCT00688376|561459006|FG001|Double-Blind Phase|Not treated|1|||
155555487|NCT00688376|561459005|FG000|Blinded Extension Phase|Adverse Event|3|||
155555488|NCT00688376|561459006|FG001|Blinded Extension Phase|Adverse Event|4|||
155555489|NCT00688376|561459005|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
155555490|NCT00688376|561459006|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
155555491|NCT00688376|561459005|FG000|Blinded Extension Phase|Physician Decision|1|||
155555492|NCT00688376|561459006|FG001|Blinded Extension Phase|Physician Decision|0|||
155555493|NCT00688376|561459005|FG000|Blinded Extension Phase|Other|1|||
155657703|NCT02314923|561840404|FG008|Overall Study|Screen failure|0|||
155657704|NCT02314923|561840405|FG009|Overall Study|Screen failure|0|||
155657705|NCT02314923|561840396|FG000|Overall Study|Participant relocation|1|||
155657706|NCT02314923|561840397|FG001|Overall Study|Participant relocation|0|||
155657707|NCT02314923|561840398|FG002|Overall Study|Participant relocation|0|||
155657708|NCT02314923|561840399|FG003|Overall Study|Participant relocation|0|||
155657709|NCT02314923|561840400|FG004|Overall Study|Participant relocation|0|||
155555494|NCT00688376|561459006|FG001|Blinded Extension Phase|Other|0|||
155555495|NCT00557076|561459007|FG000|Overall Study|Unblinding|0|||
155555496|NCT00557076|561459008|FG001|Overall Study|Unblinding|1|||
155555497|NCT02792959|561459010|FG000|Overall Study|Protocol Violation|1|||
155555498|NCT03484117|561459014|FG000|Overall Study|Lost to Follow-up|1|||
155555499|NCT03484117|561459015|FG001|Overall Study|Lost to Follow-up|3|||
155555500|NCT03484117|561459014|FG000|Overall Study|Declined participation in exit assess|1|||
155555501|NCT03484117|561459015|FG001|Overall Study|Declined participation in exit assess|1|||
155555502|NCT01780987|561459016|FG000|Overall Study|Adverse Event|0|||
155555503|NCT01780987|561459017|FG001|Overall Study|Adverse Event|4|||
155555504|NCT01780987|561459016|FG000|Overall Study|Withdrawal by Subject|2|||
155555505|NCT01780987|561459017|FG001|Overall Study|Withdrawal by Subject|0|||
155555506|NCT01780987|561459016|FG000|Overall Study|Request of Changing Hospital|0|||
155657710|NCT02314923|561840401|FG005|Overall Study|Participant relocation|0|||
155555507|NCT01780987|561459017|FG001|Overall Study|Request of Changing Hospital|1|||
155555508|NCT01780987|561459016|FG000|Overall Study|Changing Residence|1|||
155555509|NCT01780987|561459017|FG001|Overall Study|Changing Residence|0|||
155555510|NCT01780987|561459016|FG000|Overall Study|Not Receiving any Study Medication|0|||
155555511|NCT01780987|561459017|FG001|Overall Study|Not Receiving any Study Medication|1|||
155555512|NCT02303041|561459018|FG000|Overall Study|Adverse Event|1|||
155555513|NCT02303041|561459019|FG001|Overall Study|Adverse Event|2|||
155555514|NCT00886288|561459020|FG000|Overall Study|no respect of the 12 weeks period|657|||
155555515|NCT00886288|561459021|FG001|Overall Study|no respect of the 12 weeks period|227|||
155555516|NCT00886288|561459020|FG000|Overall Study|Lost to Follow-up|86|||
155555517|NCT00886288|561459021|FG001|Overall Study|Lost to Follow-up|0|||
155555518|NCT02335983|561459022|FG000|Overall Study|Sponsor Decision|0|||
155555519|NCT02335983|561459023|FG001|Overall Study|Sponsor Decision|0|||
155555520|NCT02335983|561459024|FG002|Overall Study|Sponsor Decision|1|||
155555521|NCT02335983|561459025|FG003|Overall Study|Sponsor Decision|1|||
155555522|NCT02335983|561459026|FG004|Overall Study|Sponsor Decision|0|||
155555523|NCT02335983|561459027|FG005|Overall Study|Sponsor Decision|1|||
155555524|NCT02335983|561459022|FG000|Overall Study|Withdrawal by Subject|3|||
155555525|NCT02335983|561459023|FG001|Overall Study|Withdrawal by Subject|2|||
155555526|NCT02335983|561459024|FG002|Overall Study|Withdrawal by Subject|2|||
155555527|NCT02335983|561459025|FG003|Overall Study|Withdrawal by Subject|1|||
155555528|NCT02335983|561459026|FG004|Overall Study|Withdrawal by Subject|3|||
155555529|NCT02335983|561459027|FG005|Overall Study|Withdrawal by Subject|9|||
155555530|NCT02335983|561459022|FG000|Overall Study|Death|0|||
155555531|NCT02335983|561459023|FG001|Overall Study|Death|0|||
155555532|NCT02335983|561459024|FG002|Overall Study|Death|2|||
155555533|NCT02335983|561459025|FG003|Overall Study|Death|0|||
155555534|NCT02335983|561459026|FG004|Overall Study|Death|0|||
155555535|NCT02335983|561459027|FG005|Overall Study|Death|0|||
155555536|NCT02335983|561459022|FG000|Overall Study|Lost to Follow-up|0|||
155555537|NCT02335983|561459023|FG001|Overall Study|Lost to Follow-up|0|||
155555538|NCT02335983|561459024|FG002|Overall Study|Lost to Follow-up|0|||
155555539|NCT02335983|561459025|FG003|Overall Study|Lost to Follow-up|0|||
155555540|NCT02335983|561459026|FG004|Overall Study|Lost to Follow-up|0|||
155555541|NCT02335983|561459027|FG005|Overall Study|Lost to Follow-up|1|||
155555542|NCT02335983|561459022|FG000|Overall Study|Protocol Specified Criteria|5|||
155555543|NCT02335983|561459023|FG001|Overall Study|Protocol Specified Criteria|7|||
155555544|NCT02335983|561459024|FG002|Overall Study|Protocol Specified Criteria|27|||
155555545|NCT02335983|561459025|FG003|Overall Study|Protocol Specified Criteria|7|||
155555546|NCT02335983|561459026|FG004|Overall Study|Protocol Specified Criteria|5|||
155555547|NCT02335983|561459027|FG005|Overall Study|Protocol Specified Criteria|21|||
155555548|NCT00289874|561459028|FG000|Overall Study|Adverse Event|1|||
155555549|NCT00289874|561459029|FG001|Overall Study|Adverse Event|5|||
155555550|NCT00289874|561459028|FG000|Overall Study|Lost to Follow-up|1|||
155555551|NCT00289874|561459029|FG001|Overall Study|Lost to Follow-up|1|||
155555552|NCT00289874|561459028|FG000|Overall Study|Protocol Violation|3|||
155555553|NCT00289874|561459029|FG001|Overall Study|Protocol Violation|2|||
155555554|NCT00289874|561459028|FG000|Overall Study|Did not meet eligibility|1|||
155555555|NCT00289874|561459029|FG001|Overall Study|Did not meet eligibility|0|||
155555556|NCT03127644|561459030|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155555557|NCT03127644|561459031|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155555558|NCT03127644|561459032|FG002|Overall Study|Study-specific withdrawal criteria|2|||
155555559|NCT05070546|561459035|FG000|Overall Study|Death|0|||
155555560|NCT05070546|561459036|FG001|Overall Study|Death|0|||
155555561|NCT05070546|561459037|FG002|Overall Study|Death|0|||
155555562|NCT05070546|561459038|FG003|Overall Study|Death|0|||
155555563|NCT05070546|561459039|FG004|Overall Study|Death|0|||
155555564|NCT05070546|561459040|FG005|Overall Study|Death|1|||
155555565|NCT05070546|561459035|FG000|Overall Study|Lost to Follow-up|8|||
155555566|NCT05070546|561459036|FG001|Overall Study|Lost to Follow-up|2|||
155555567|NCT05070546|561459037|FG002|Overall Study|Lost to Follow-up|7|||
155555568|NCT05070546|561459038|FG003|Overall Study|Lost to Follow-up|1|||
155555569|NCT05070546|561459039|FG004|Overall Study|Lost to Follow-up|2|||
155555570|NCT05070546|561459040|FG005|Overall Study|Lost to Follow-up|0|||
155555571|NCT05070546|561459035|FG000|Overall Study|Withdrawal by Subject|1|||
155555572|NCT05070546|561459036|FG001|Overall Study|Withdrawal by Subject|1|||
155555573|NCT05070546|561459037|FG002|Overall Study|Withdrawal by Subject|3|||
155555574|NCT05070546|561459038|FG003|Overall Study|Withdrawal by Subject|0|||
155555575|NCT05070546|561459039|FG004|Overall Study|Withdrawal by Subject|0|||
155555576|NCT05070546|561459040|FG005|Overall Study|Withdrawal by Subject|0|||
155555577|NCT05070546|561459035|FG000|Overall Study|Other|0|||
155555578|NCT05070546|561459036|FG001|Overall Study|Other|0|||
155555579|NCT05070546|561459037|FG002|Overall Study|Other|0|||
155555580|NCT05070546|561459038|FG003|Overall Study|Other|0|||
155555581|NCT05070546|561459039|FG004|Overall Study|Other|3|||
155555582|NCT05070546|561459040|FG005|Overall Study|Other|0|||
155555583|NCT05070546|561459035|FG000|Overall Study|Randomized but not vaccinated|1|||
155657711|NCT02314923|561840402|FG006|Overall Study|Participant relocation|0|||
155555584|NCT05070546|561459036|FG001|Overall Study|Randomized but not vaccinated|0|||
155555585|NCT05070546|561459037|FG002|Overall Study|Randomized but not vaccinated|1|||
155555586|NCT05070546|561459038|FG003|Overall Study|Randomized but not vaccinated|1|||
155555587|NCT05070546|561459039|FG004|Overall Study|Randomized but not vaccinated|3|||
155555588|NCT05070546|561459040|FG005|Overall Study|Randomized but not vaccinated|0|||
155555589|NCT00136318|561459041|FG000|Overall Study|Adverse Event|5|||
155555590|NCT00136318|561459042|FG001|Overall Study|Adverse Event|5|||
155555591|NCT00136318|561459041|FG000|Overall Study|Withdrawal by Subject|2|||
155555592|NCT00136318|561459042|FG001|Overall Study|Withdrawal by Subject|2|||
155555593|NCT00038649|561459047|FG000|Overall Study|Adverse Event|9|||
155555594|NCT03096847|561459053|FG000|Overall Study|Other|2|||
155555595|NCT03096847|561459054|FG001|Overall Study|Other|1|||
155555596|NCT03096847|561459055|FG002|Overall Study|Other|2|||
155555597|NCT03096847|561459053|FG000|Overall Study|Lost to Follow-up|1|||
155555598|NCT03096847|561459054|FG001|Overall Study|Lost to Follow-up|0|||
155555599|NCT03096847|561459055|FG002|Overall Study|Lost to Follow-up|1|||
155555600|NCT03096847|561459053|FG000|Overall Study|Death|6|||
155555601|NCT03096847|561459054|FG001|Overall Study|Death|0|||
155555602|NCT03096847|561459055|FG002|Overall Study|Death|2|||
155657712|NCT02314923|561840403|FG007|Overall Study|Participant relocation|1|||
155657713|NCT02314923|561840404|FG008|Overall Study|Participant relocation|0|||
155555603|NCT03096847|561459053|FG000|Overall Study|Protocol Violation|3|||
155555604|NCT03096847|561459054|FG001|Overall Study|Protocol Violation|0|||
155555605|NCT03096847|561459055|FG002|Overall Study|Protocol Violation|6|||
155555606|NCT03096847|561459053|FG000|Overall Study|Physician Decision|12|||
155555607|NCT03096847|561459054|FG001|Overall Study|Physician Decision|2|||
155555608|NCT03096847|561459055|FG002|Overall Study|Physician Decision|8|||
155555609|NCT03096847|561459053|FG000|Overall Study|Withdrawal by Subject|24|||
155555610|NCT03096847|561459054|FG001|Overall Study|Withdrawal by Subject|1|||
155555611|NCT03096847|561459055|FG002|Overall Study|Withdrawal by Subject|12|||
155555612|NCT03096847|561459053|FG000|Overall Study|Adverse Event|72|||
155555613|NCT03096847|561459054|FG001|Overall Study|Adverse Event|6|||
155555614|NCT03096847|561459055|FG002|Overall Study|Adverse Event|28|||
155555615|NCT03096847|561459053|FG000|Overall Study|Progressive disease|97|||
155555616|NCT03096847|561459054|FG001|Overall Study|Progressive disease|10|||
155555617|NCT03096847|561459055|FG002|Overall Study|Progressive disease|78|||
155555618|NCT03096847|561459053|FG000|Overall Study|Non-compliance with study medication|1|||
155555619|NCT03096847|561459054|FG001|Overall Study|Non-compliance with study medication|0|||
155555620|NCT03096847|561459055|FG002|Overall Study|Non-compliance with study medication|0|||
155555621|NCT03096847|561459053|FG000|Overall Study|New therapy for study indication|1|||
155555622|NCT03096847|561459054|FG001|Overall Study|New therapy for study indication|0|||
155555623|NCT03096847|561459055|FG002|Overall Study|New therapy for study indication|1|||
155555624|NCT00359632|561459056|FG000|Overall Study|Death|2|||
155555625|NCT00359632|561459057|FG001|Overall Study|Death|0|||
155555626|NCT00359632|561459056|FG000|Overall Study|Adverse Event|1|||
155555627|NCT00359632|561459057|FG001|Overall Study|Adverse Event|0|||
155555628|NCT00359632|561459056|FG000|Overall Study|Non-compliance with visit schedule|1|||
155555629|NCT00359632|561459057|FG001|Overall Study|Non-compliance with visit schedule|0|||
155555630|NCT03978091|561459058|FG000|Overall Study|Lost to Follow-up|0|||
155555631|NCT03978091|561459059|FG001|Overall Study|Lost to Follow-up|0|||
155555632|NCT03978091|561459060|FG002|Overall Study|Lost to Follow-up|1|||
155555633|NCT03978091|561459061|FG003|Overall Study|Lost to Follow-up|0|||
155555634|NCT03978091|561459062|FG004|Overall Study|Lost to Follow-up|0|||
155555635|NCT03978091|561459063|FG005|Overall Study|Lost to Follow-up|0|||
155555636|NCT03978091|561459058|FG000|Overall Study|Withdrawal by Subject|0|||
155555637|NCT03978091|561459059|FG001|Overall Study|Withdrawal by Subject|0|||
155555638|NCT03978091|561459060|FG002|Overall Study|Withdrawal by Subject|0|||
155555639|NCT03978091|561459061|FG003|Overall Study|Withdrawal by Subject|1|||
155555640|NCT03978091|561459062|FG004|Overall Study|Withdrawal by Subject|1|||
155555641|NCT03978091|561459063|FG005|Overall Study|Withdrawal by Subject|0|||
155555642|NCT02999477|561459075|FG000|Overall Study|found ineligible after first dose|0|||
155555643|NCT02999477|561459076|FG001|Overall Study|found ineligible after first dose|1|||
155555644|NCT02999477|561459075|FG000|Overall Study|Withdrawal by Subject|1|||
155555645|NCT02999477|561459076|FG001|Overall Study|Withdrawal by Subject|1|||
155555646|NCT01846273|561459077|FG000|Overall Study|Adverse Event|9|||
155555647|NCT01846273|561459078|FG001|Overall Study|Adverse Event|7|||
155555648|NCT01846273|561459079|FG002|Overall Study|Adverse Event|0|||
155555649|NCT01846273|561459077|FG000|Overall Study|Subject withdrew consent|5|||
155555650|NCT01846273|561459078|FG001|Overall Study|Subject withdrew consent|8|||
155555651|NCT01846273|561459079|FG002|Overall Study|Subject withdrew consent|0|||
155555652|NCT01846273|561459077|FG000|Overall Study|Lost to Follow-up|2|||
155555653|NCT01846273|561459078|FG001|Overall Study|Lost to Follow-up|1|||
155555654|NCT01846273|561459079|FG002|Overall Study|Lost to Follow-up|0|||
155555655|NCT01846273|561459077|FG000|Overall Study|Administrative problems|1|||
155555656|NCT01846273|561459078|FG001|Overall Study|Administrative problems|0|||
155555657|NCT01846273|561459079|FG002|Overall Study|Administrative problems|0|||
155555658|NCT01846273|561459077|FG000|Overall Study|Death|2|||
155555659|NCT01846273|561459078|FG001|Overall Study|Death|1|||
155555660|NCT01846273|561459079|FG002|Overall Study|Death|0|||
155555661|NCT01846273|561459077|FG000|Overall Study|Disease Progression|0|||
155555662|NCT01846273|561459078|FG001|Overall Study|Disease Progression|4|||
155555663|NCT01846273|561459079|FG002|Overall Study|Disease Progression|0|||
155555664|NCT01846273|561459077|FG000|Overall Study|Protocol Deviation|2|||
155555665|NCT01846273|561459078|FG001|Overall Study|Protocol Deviation|3|||
155555666|NCT01846273|561459079|FG002|Overall Study|Protocol Deviation|0|||
155555667|NCT01846273|561459077|FG000|Overall Study|Physician Decision|1|||
155555668|NCT01846273|561459078|FG001|Overall Study|Physician Decision|2|||
155555669|NCT01846273|561459079|FG002|Overall Study|Physician Decision|0|||
155555670|NCT00891839|561459080|FG000|Overall Study|Adverse Event|2|||
155555671|NCT00891839|561459080|FG000|Overall Study|Withdrawal by Subject|2|||
155555672|NCT00891839|561459080|FG000|Overall Study|Disease progression|3|||
155555673|NCT03303625|561460884|FG000|Overall Study|Withdrawal by Subject|2|||
155555674|NCT03303625|561460885|FG001|Overall Study|Withdrawal by Subject|0|||
155555675|NCT03303625|561460886|FG002|Overall Study|Withdrawal by Subject|0|||
155555676|NCT03303625|561460887|FG003|Overall Study|Withdrawal by Subject|0|||
155555677|NCT02221037|561460889|FG000|Overall Study|Physician Decision|0|||
155555678|NCT02221037|561460890|FG001|Overall Study|Physician Decision|0|||
155555679|NCT02221037|561460891|FG002|Overall Study|Physician Decision|1|||
155555680|NCT02221037|561460892|FG003|Overall Study|Physician Decision|0|||
155555681|NCT02307266|561460893|FG000|Overall Study|Adverse Event|3|||
155555682|NCT02307266|561460894|FG001|Overall Study|Adverse Event|1|||
155555683|NCT02307266|561460895|FG002|Overall Study|Adverse Event|5|||
155555684|NCT02307266|561460893|FG000|Overall Study|Withdrawal by Subject|2|||
155555685|NCT02307266|561460894|FG001|Overall Study|Withdrawal by Subject|0|||
155555686|NCT02307266|561460895|FG002|Overall Study|Withdrawal by Subject|1|||
155555687|NCT02307266|561460893|FG000|Overall Study|Lost to Follow-up|3|||
155555688|NCT02307266|561460894|FG001|Overall Study|Lost to Follow-up|0|||
155555689|NCT02307266|561460895|FG002|Overall Study|Lost to Follow-up|0|||
155555690|NCT02856880|561460897|FG000|Overall Study|Withdrawal of consent|1|||
155555691|NCT00793780|561460898|FG000|Overall Study|Withdrawal by Subject|2|||
155555692|NCT00793780|561460899|FG001|Overall Study|Withdrawal by Subject|1|||
155555693|NCT02858492|561460900|FG000|Overall Study|Withdrawal by Subject|0|||
155555694|NCT02858492|561460901|FG001|Overall Study|Withdrawal by Subject|1|||
155555695|NCT02858492|561460902|FG002|Overall Study|Withdrawal by Subject|0|||
155555696|NCT02858492|561460903|FG003|Overall Study|Withdrawal by Subject|1|||
155555697|NCT02858492|561460900|FG000|Overall Study|Adverse Event|0|||
155555698|NCT02858492|561460901|FG001|Overall Study|Adverse Event|0|||
155555699|NCT02858492|561460902|FG002|Overall Study|Adverse Event|0|||
155555700|NCT02858492|561460903|FG003|Overall Study|Adverse Event|3|||
155555701|NCT02858492|561460900|FG000|Overall Study|Lack of Efficacy|0|||
155555702|NCT02858492|561460901|FG001|Overall Study|Lack of Efficacy|0|||
155555703|NCT02858492|561460902|FG002|Overall Study|Lack of Efficacy|0|||
155555704|NCT02858492|561460903|FG003|Overall Study|Lack of Efficacy|1|||
155555705|NCT02858492|561460900|FG000|Overall Study|Protocol defined stopping criteria|0|||
155555706|NCT02858492|561460901|FG001|Overall Study|Protocol defined stopping criteria|0|||
155555707|NCT02858492|561460902|FG002|Overall Study|Protocol defined stopping criteria|0|||
155555708|NCT02858492|561460903|FG003|Overall Study|Protocol defined stopping criteria|1|||
155555709|NCT02944383|561460904|FG000|Overall Study|Lost to Follow-up|0|||
155555710|NCT02944383|561460905|FG001|Overall Study|Lost to Follow-up|0|||
155555711|NCT02944383|561460906|FG002|Overall Study|Lost to Follow-up|1|||
155555712|NCT02944383|561460904|FG000|Overall Study|Withdrawal by Subject|1|||
155555713|NCT02944383|561460905|FG001|Overall Study|Withdrawal by Subject|0|||
155555714|NCT02944383|561460906|FG002|Overall Study|Withdrawal by Subject|0|||
155555715|NCT01032018|561460909|FG000|Overall Study|Lost to Follow-up|6|||
155555716|NCT01032018|561460910|FG001|Overall Study|Lost to Follow-up|5|||
155555717|NCT01032018|561460909|FG000|Overall Study|Death|0|||
155555718|NCT01032018|561460910|FG001|Overall Study|Death|1|||
155555719|NCT00858143|561460914|FG000|Overall Study|Adverse Event|16|||
155555720|NCT00858143|561460914|FG000|Overall Study|Lack of Efficacy|4|||
155555721|NCT00858143|561460914|FG000|Overall Study|Death|7|||
155555722|NCT00858143|561460914|FG000|Overall Study|Other|23|||
155555723|NCT03853148|561460918|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
155555724|NCT03853148|561460919|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
155555725|NCT03853148|561460920|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
155555726|NCT03853148|561460921|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
155555727|NCT00599521|561460926|FG000|Overall Study|Lack of Efficacy|4|||
155657714|NCT02314923|561840405|FG009|Overall Study|Participant relocation|0|||
155555728|NCT00599521|561460927|FG001|Overall Study|Lack of Efficacy|8|||
155657715|NCT04476784|561840406|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
155657716|NCT04476784|561840407|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
155657717|NCT01055028|561840412|FG000|Screening|Screen Failure|1|||
155657718|NCT01055028|561840413|FG001|Screening|Screen Failure|1|||
155555729|NCT00599521|561460926|FG000|Overall Study|Adverse Event|4|||
155555730|NCT00599521|561460927|FG001|Overall Study|Adverse Event|1|||
155555731|NCT00599521|561460926|FG000|Overall Study|Withdrawal by Subject|28|||
155555732|NCT00599521|561460927|FG001|Overall Study|Withdrawal by Subject|34|||
155555733|NCT00599521|561460926|FG000|Overall Study|Protocol Violation|1|||
155555734|NCT00599521|561460927|FG001|Overall Study|Protocol Violation|1|||
155555735|NCT00599521|561460926|FG000|Overall Study|Lost to Follow-up|23|||
155555736|NCT00599521|561460927|FG001|Overall Study|Lost to Follow-up|23|||
155555737|NCT00599521|561460926|FG000|Overall Study|Pregnancy|0|||
155555738|NCT00599521|561460927|FG001|Overall Study|Pregnancy|2|||
155555739|NCT01293539|561460929|FG000|Overall Study|Physician Decision|1|||
155555740|NCT05855616|561460931|FG000|Overall Study|Lost to Follow-up|1|||
155555741|NCT05855616|561460932|FG001|Overall Study|Lost to Follow-up|2|||
155657719|NCT01055028|561840412|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
155555742|NCT00841906|561460935|FG000|Overall Study|Withdrawal by Subject|2|||
155555743|NCT00841906|561460936|FG001|Overall Study|Withdrawal by Subject|0|||
155555744|NCT01449279|561460939|FG000|Overall Study|Lack of Efficacy|5|||
155555745|NCT01449279|561460939|FG000|Overall Study|Toxicity|2|||
155555746|NCT03201250|561460942|FG000|Overall Study|screen failures|3|||
155555747|NCT03201250|561460943|FG001|Overall Study|screen failures|0|||
155555748|NCT03201250|561460944|FG002|Overall Study|screen failures|0|||
155555749|NCT03551496|561460945|FG000|Overall Study|Death|11|||
155555750|NCT03551496|561460946|FG001|Overall Study|Death|7|||
155555751|NCT03551496|561460945|FG000|Overall Study|Withdrawal by Subject|4|||
155555752|NCT03551496|561460946|FG001|Overall Study|Withdrawal by Subject|3|||
155555753|NCT03551496|561460945|FG000|Overall Study|Other Reasons|1|||
155555754|NCT03551496|561460946|FG001|Overall Study|Other Reasons|0|||
155555755|NCT04700280|561460949|FG000|Overall Study|Adverse Event|4|||
155555756|NCT04700280|561460950|FG001|Overall Study|Adverse Event|0|||
155555757|NCT04700280|561460949|FG000|Overall Study|Lack of Efficacy|1|||
155555758|NCT04700280|561460950|FG001|Overall Study|Lack of Efficacy|0|||
155555759|NCT04700280|561460949|FG000|Overall Study|Study terminated by sponsor|5|||
155555760|NCT04700280|561460950|FG001|Overall Study|Study terminated by sponsor|3|||
155555761|NCT04700280|561460949|FG000|Overall Study|Other than specified|1|||
155555762|NCT04700280|561460950|FG001|Overall Study|Other than specified|0|||
155555763|NCT01843348|561460951|FG000|Overall Study|Withdrawal by Subject|4|||
155555764|NCT01843348|561460952|FG001|Overall Study|Withdrawal by Subject|16|||
155555765|NCT01843348|561460953|FG002|Overall Study|Withdrawal by Subject|18|||
155555766|NCT01843348|561460951|FG000|Overall Study|Lost to Follow-up|5|||
155555767|NCT01843348|561460952|FG001|Overall Study|Lost to Follow-up|4|||
155555768|NCT01843348|561460953|FG002|Overall Study|Lost to Follow-up|2|||
155555769|NCT01843348|561460951|FG000|Overall Study|Death|5|||
155555770|NCT01843348|561460952|FG001|Overall Study|Death|3|||
155555771|NCT01843348|561460953|FG002|Overall Study|Death|4|||
155555772|NCT01843348|561460951|FG000|Overall Study|Graft loss/retransplantation|5|||
155555773|NCT01843348|561460952|FG001|Overall Study|Graft loss/retransplantation|8|||
155555774|NCT01843348|561460953|FG002|Overall Study|Graft loss/retransplantation|11|||
155555775|NCT01843348|561460951|FG000|Overall Study|Various reasons|4|||
155555776|NCT01843348|561460952|FG001|Overall Study|Various reasons|9|||
155555777|NCT01843348|561460953|FG002|Overall Study|Various reasons|6|||
155555778|NCT00251641|561460954|FG000|Overall Study|Adverse Event|80|||
155555779|NCT00251641|561460955|FG001|Overall Study|Adverse Event|8|||
155555780|NCT00251641|561460954|FG000|Overall Study|Lack of Efficacy|2|||
155555781|NCT00251641|561460955|FG001|Overall Study|Lack of Efficacy|1|||
155555782|NCT00251641|561460954|FG000|Overall Study|Progression of Disease|0|||
155555783|NCT00251641|561460955|FG001|Overall Study|Progression of Disease|2|||
155555784|NCT00251641|561460954|FG000|Overall Study|Lost to Follow-up|3|||
155555785|NCT00251641|561460955|FG001|Overall Study|Lost to Follow-up|3|||
155555786|NCT00251641|561460954|FG000|Overall Study|Withdrawal by Subject|6|||
155555787|NCT00251641|561460955|FG001|Overall Study|Withdrawal by Subject|8|||
155555788|NCT00251641|561460954|FG000|Overall Study|Protocol Violation|10|||
155555789|NCT00251641|561460955|FG001|Overall Study|Protocol Violation|2|||
155555790|NCT00251641|561460954|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
155555791|NCT00251641|561460955|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
155555792|NCT00251641|561460954|FG000|Overall Study|Switched Treatment|9|||
155555793|NCT00251641|561460955|FG001|Overall Study|Switched Treatment|63|||
155555794|NCT02093221|561460956|FG000|Overall Study|Adverse Event|1|||
155555795|NCT02093221|561460957|FG001|Overall Study|Adverse Event|0|||
155555796|NCT02093221|561460958|FG002|Overall Study|Adverse Event|0|||
155555797|NCT02093221|561460959|FG003|Overall Study|Adverse Event|0|||
155555798|NCT02093221|561460960|FG004|Overall Study|Adverse Event|0|||
155555799|NCT02093221|561460956|FG000|Overall Study|Withdrawal by Subject|1|||
155555800|NCT02093221|561460957|FG001|Overall Study|Withdrawal by Subject|1|||
155555801|NCT02093221|561460958|FG002|Overall Study|Withdrawal by Subject|4|||
155555802|NCT02093221|561460959|FG003|Overall Study|Withdrawal by Subject|1|||
155555803|NCT02093221|561460960|FG004|Overall Study|Withdrawal by Subject|1|||
155555804|NCT02093221|561460956|FG000|Overall Study|Lost to Follow-up|2|||
155555805|NCT02093221|561460957|FG001|Overall Study|Lost to Follow-up|0|||
155555806|NCT02093221|561460958|FG002|Overall Study|Lost to Follow-up|1|||
155555807|NCT02093221|561460959|FG003|Overall Study|Lost to Follow-up|1|||
155555808|NCT02093221|561460960|FG004|Overall Study|Lost to Follow-up|0|||
155555809|NCT02093221|561460956|FG000|Overall Study|Death|0|||
155555810|NCT02093221|561460957|FG001|Overall Study|Death|1|||
155555811|NCT02093221|561460958|FG002|Overall Study|Death|0|||
155555812|NCT02093221|561460959|FG003|Overall Study|Death|0|||
155555813|NCT02093221|561460960|FG004|Overall Study|Death|0|||
155555814|NCT02093221|561460956|FG000|Overall Study|Protocol Violation|0|||
155555815|NCT02093221|561460957|FG001|Overall Study|Protocol Violation|1|||
155555816|NCT02093221|561460958|FG002|Overall Study|Protocol Violation|0|||
155555817|NCT02093221|561460959|FG003|Overall Study|Protocol Violation|0|||
155555818|NCT02093221|561460960|FG004|Overall Study|Protocol Violation|0|||
155555819|NCT02093221|561460956|FG000|Overall Study|Study termination|6|||
155555820|NCT02093221|561460957|FG001|Overall Study|Study termination|5|||
155555821|NCT02093221|561460958|FG002|Overall Study|Study termination|4|||
155555822|NCT02093221|561460959|FG003|Overall Study|Study termination|6|||
155555823|NCT02093221|561460960|FG004|Overall Study|Study termination|7|||
155555824|NCT00725621|561460961|FG000|Overall Study|Adverse Event|25|||
155555825|NCT00725621|561460961|FG000|Overall Study|Lack of Efficacy|46|||
155555826|NCT00725621|561460961|FG000|Overall Study|Withdrawal by Subject|57|||
155555827|NCT00725621|561460961|FG000|Overall Study|Physician Decision|19|||
155555828|NCT00725621|561460961|FG000|Overall Study|Lost to Follow-up|52|||
155555829|NCT00725621|561460961|FG000|Overall Study|Non-compliance|8|||
155555830|NCT00725621|561460961|FG000|Overall Study|Continued treatment by other physician|6|||
155555831|NCT00725621|561460961|FG000|Overall Study|Switched to other study|1|||
155555832|NCT00725621|561460961|FG000|Overall Study|Switched to other drug|1|||
155555833|NCT00725621|561460961|FG000|Overall Study|Prepared for elective surgery|1|||
155555834|NCT00725621|561460961|FG000|Overall Study|Reason not specified|55|||
155555835|NCT01189500|561460962|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
155555836|NCT01189500|561460962|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
155555837|NCT00851643|561460965|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
155555838|NCT00851643|561460966|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
155555839|NCT00851643|561460967|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
155555840|NCT00851643|561460968|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
155555841|NCT00851643|561460969|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
155555842|NCT00851643|561460970|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
155555843|NCT00851643|561460965|FG000|Base Study (Up to 12 Months)|Other|0|||
155555844|NCT00851643|561460966|FG001|Base Study (Up to 12 Months)|Other|0|||
155555845|NCT00851643|561460967|FG002|Base Study (Up to 12 Months)|Other|0|||
155555846|NCT00851643|561460968|FG003|Base Study (Up to 12 Months)|Other|0|||
155555847|NCT00851643|561460969|FG004|Base Study (Up to 12 Months)|Other|0|||
155555848|NCT00851643|561460970|FG005|Base Study (Up to 12 Months)|Other|1|||
155555849|NCT00851643|561460965|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
155555850|NCT00851643|561460966|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
155555851|NCT00851643|561460967|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
155555852|NCT00851643|561460968|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
155555853|NCT00851643|561460969|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
155555854|NCT00851643|561460970|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
155555855|NCT00851643|561460965|FG000|Extension Study (Up to 36 Months)|Moved|0|||
155555856|NCT00851643|561460966|FG001|Extension Study (Up to 36 Months)|Moved|2|||
155555857|NCT00851643|561460967|FG002|Extension Study (Up to 36 Months)|Moved|1|||
155555858|NCT00851643|561460968|FG003|Extension Study (Up to 36 Months)|Moved|1|||
155555859|NCT00851643|561460969|FG004|Extension Study (Up to 36 Months)|Moved|0|||
155555860|NCT00851643|561460970|FG005|Extension Study (Up to 36 Months)|Moved|1|||
155555861|NCT00359788|561460971|FG000|Overall Study|Adverse Event|11|||
155555862|NCT00359788|561460972|FG001|Overall Study|Adverse Event|10|||
155555863|NCT00359788|561460971|FG000|Overall Study|Lack of Efficacy|1|||
155555864|NCT00359788|561460972|FG001|Overall Study|Lack of Efficacy|2|||
155555865|NCT00359788|561460971|FG000|Overall Study|Lost to Follow-up|3|||
155555866|NCT00359788|561460972|FG001|Overall Study|Lost to Follow-up|2|||
155555867|NCT00359788|561460971|FG000|Overall Study|Withdrawal by Subject|4|||
155555868|NCT00359788|561460972|FG001|Overall Study|Withdrawal by Subject|1|||
155555869|NCT00359788|561460971|FG000|Overall Study|Protocol Violation|4|||
155555870|NCT00359788|561460972|FG001|Overall Study|Protocol Violation|2|||
155555871|NCT00673933|561460973|FG000|Overall Study|Withdrawal by Subject|2|||
155555872|NCT00673933|561460973|FG000|Overall Study|Lost to Follow-up|1|||
155555873|NCT04932941|561460974|FG000|Overall Study|Lost to Follow-up|3|||
155555874|NCT04932941|561460975|FG001|Overall Study|Lost to Follow-up|1|||
155555875|NCT04932941|561460974|FG000|Overall Study|Withdrawal by Subject|7|||
155555876|NCT04932941|561460975|FG001|Overall Study|Withdrawal by Subject|4|||
155555877|NCT04932941|561460974|FG000|Overall Study|Other|4|||
155555878|NCT04932941|561460975|FG001|Overall Study|Other|2|||
155555879|NCT05069155|561460976|FG000|Overall Study|Withdrawal by Subject|1|||
155555880|NCT05069155|561460977|FG001|Overall Study|Withdrawal by Subject|3|||
155555881|NCT02206620|561460978|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155555882|NCT02206620|561460979|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155555883|NCT02206620|561460978|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
155555884|NCT02206620|561460979|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
155555885|NCT01929031|561460980|FG000|Overall Study|Adverse Event|3|||
155555886|NCT01929031|561460981|FG001|Overall Study|Adverse Event|1|||
155555887|NCT01929031|561460982|FG002|Overall Study|Adverse Event|1|||
155555888|NCT01929031|561460983|FG003|Overall Study|Adverse Event|0|||
155555889|NCT01929031|561460984|FG004|Overall Study|Adverse Event|0|||
155555890|NCT01929031|561460985|FG005|Overall Study|Adverse Event|0|||
155555891|NCT01929031|561460980|FG000|Overall Study|Protocol Violation|1|||
155555892|NCT01929031|561460981|FG001|Overall Study|Protocol Violation|0|||
155555893|NCT01929031|561460982|FG002|Overall Study|Protocol Violation|0|||
155555894|NCT01929031|561460983|FG003|Overall Study|Protocol Violation|0|||
155555895|NCT01929031|561460984|FG004|Overall Study|Protocol Violation|0|||
155657720|NCT01055028|561840413|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
155657721|NCT01055028|561840412|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
155555896|NCT01929031|561460985|FG005|Overall Study|Protocol Violation|1|||
155555897|NCT01929031|561460980|FG000|Overall Study|Reason other than specified above|0|||
155555898|NCT01929031|561460981|FG001|Overall Study|Reason other than specified above|1|||
155555899|NCT01929031|561460982|FG002|Overall Study|Reason other than specified above|0|||
155555900|NCT01929031|561460983|FG003|Overall Study|Reason other than specified above|0|||
155555901|NCT01929031|561460984|FG004|Overall Study|Reason other than specified above|1|||
155555902|NCT01929031|561460985|FG005|Overall Study|Reason other than specified above|0|||
155555903|NCT05816200|561460986|FG000|Overall Study|Lost to Follow-up|2|||
155555904|NCT05816200|561460987|FG001|Overall Study|Lost to Follow-up|1|||
155555905|NCT01366443|561460988|FG000|Overall Study|Lost to Follow-up|2|||
155555906|NCT01366443|561460988|FG000|Overall Study|Under 18 yo|1|||
155555907|NCT02394730|561460989|FG000|Overall Study|Lost to Follow-up|1|||
155555908|NCT02394730|561460990|FG001|Overall Study|Lost to Follow-up|0|||
155555909|NCT02394730|561460989|FG000|Overall Study|Withdrawal by Subject|0|||
155555910|NCT02394730|561460990|FG001|Overall Study|Withdrawal by Subject|1|||
155555911|NCT00731549|561460991|FG000|Overall Study|Lost to Follow-up|19|||
155555912|NCT00731549|561460991|FG000|Overall Study|Met withdrawal criteria|24|||
155555913|NCT00731549|561460991|FG000|Overall Study|Physician Decision|16|||
155555914|NCT00731549|561460991|FG000|Overall Study|Withdrawal by Subject|89|||
155555915|NCT00731549|561460991|FG000|Overall Study|Protocol deviation|1|||
155555916|NCT00731549|561460991|FG000|Overall Study|Adverse Event|31|||
155555917|NCT00731549|561460991|FG000|Overall Study|Lack of efficacy with AE|37|||
155555918|NCT00731549|561460991|FG000|Overall Study|Lack of efficacy without AE|6|||
155555919|NCT00588640|561460992|FG000|Overall Study|Physician Decision|1|||
155555920|NCT00588640|561460992|FG000|Overall Study|Ineligible Patient|1|||
155555921|NCT00103402|561460993|FG000|Overall Study|Adverse Event|3|||
155555922|NCT00103402|561460994|FG001|Overall Study|Adverse Event|4|||
155555923|NCT00103402|561460993|FG000|Overall Study|Lost to Follow-up|8|||
155555924|NCT00103402|561460994|FG001|Overall Study|Lost to Follow-up|7|||
155555925|NCT00103402|561460993|FG000|Overall Study|Dissatisfied/No longer interested|6|||
155555926|NCT00103402|561460994|FG001|Overall Study|Dissatisfied/No longer interested|6|||
155555927|NCT00103402|561460993|FG000|Overall Study|Personal constraints/Other|5|||
155555928|NCT00103402|561460994|FG001|Overall Study|Personal constraints/Other|0|||
155555929|NCT01393730|561460995|FG000|Overall Study|Withdrawal by Subject|3|||
155555930|NCT01393730|561460995|FG000|Overall Study|Other|2|||
155555931|NCT01393730|561460995|FG000|Overall Study|Adverse Event|1|||
155555932|NCT00507546|561460996|FG000|Overall Study|Withdrawal by Subject|1|||
155555933|NCT00507546|561460997|FG001|Overall Study|Withdrawal by Subject|0|||
155555934|NCT00507546|561460996|FG000|Overall Study|Protocol Violation|1|||
155555935|NCT00507546|561460997|FG001|Overall Study|Protocol Violation|0|||
155555936|NCT00507546|561460996|FG000|Overall Study|Physician Decision|0|||
155555937|NCT00507546|561460997|FG001|Overall Study|Physician Decision|1|||
155555938|NCT02384850|561460998|FG000|Overall Study|Withdrawal by Subject|2|||
155555939|NCT02384850|561460999|FG001|Overall Study|Withdrawal by Subject|2|||
155555940|NCT03510182|561461005|FG000|Overall Study|Withdrawal by Subject|2|||
155555941|NCT00375492|561461007|FG000|Overall Study|Adverse Event|4|||
155555942|NCT00375492|561461008|FG001|Overall Study|Adverse Event|5|||
155555943|NCT00375492|561461007|FG000|Overall Study|Entry Criteria Not Met|0|||
155555944|NCT00375492|561461008|FG001|Overall Study|Entry Criteria Not Met|1|||
155555945|NCT00375492|561461007|FG000|Overall Study|Loss of Glucose Control|0|||
155555946|NCT00375492|561461008|FG001|Overall Study|Loss of Glucose Control|1|||
155555947|NCT00375492|561461007|FG000|Overall Study|Lost to Follow-up|10|||
155555948|NCT00375492|561461008|FG001|Overall Study|Lost to Follow-up|5|||
155555949|NCT00375492|561461007|FG000|Overall Study|Physician Decision|0|||
155555950|NCT00375492|561461008|FG001|Overall Study|Physician Decision|4|||
155555951|NCT00375492|561461007|FG000|Overall Study|Protocol Violation|6|||
155555952|NCT00375492|561461008|FG001|Overall Study|Protocol Violation|3|||
155555953|NCT00375492|561461007|FG000|Overall Study|Sponsor Decision|0|||
155555954|NCT00375492|561461008|FG001|Overall Study|Sponsor Decision|1|||
155555955|NCT00375492|561461007|FG000|Overall Study|Withdrawal by Subject|6|||
155555956|NCT00375492|561461008|FG001|Overall Study|Withdrawal by Subject|6|||
155555957|NCT04062448|561462609|FG000|Overall Study|Lost to Follow-up|1|||
155555958|NCT04062448|561462609|FG000|Overall Study|Withdrawal by Subject|2|||
155555959|NCT04385277|561462610|FG000|Overall Study|Physician Decision|2|||
155555960|NCT04385277|561462610|FG000|Overall Study|Ineligible|1|||
155555961|NCT04385277|561462610|FG000|Overall Study|Patient/Parent Refusal|2|||
155555962|NCT04905290|561462611|FG000|Overall Study|Adverse Event|4|||
155555963|NCT04905290|561462611|FG000|Overall Study|Death|2|||
155555964|NCT04905290|561462611|FG000|Overall Study|Withdrawal by Subject|4|||
155555965|NCT04905290|561462611|FG000|Overall Study|Physician Decision|2|||
155555966|NCT04905290|561462611|FG000|Overall Study|Lost to Follow-up|2|||
155555967|NCT04905290|561462611|FG000|Overall Study|Screen Failure|2|||
155555968|NCT04905290|561462611|FG000|Overall Study|Unsuccessful Procedure|2|||
155555969|NCT03295318|561462612|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
155555970|NCT03295318|561462613|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
155555971|NCT03295318|561462614|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
155555972|NCT03295318|561462612|FG000|Overall Study|Death|1|||
155555973|NCT03295318|561462613|FG001|Overall Study|Death|1|||
155555974|NCT03295318|561462614|FG002|Overall Study|Death|1|||
155555975|NCT03295318|561462612|FG000|Overall Study|Protocol Violation|4|||
155555976|NCT03295318|561462613|FG001|Overall Study|Protocol Violation|3|||
155555977|NCT03295318|561462614|FG002|Overall Study|Protocol Violation|3|||
155555978|NCT03295318|561462612|FG000|Overall Study|Withdrawal by Subject|0|||
155555979|NCT03295318|561462613|FG001|Overall Study|Withdrawal by Subject|0|||
155555980|NCT03295318|561462614|FG002|Overall Study|Withdrawal by Subject|1|||
155555981|NCT03295318|561462612|FG000|Overall Study|Subject discontinued due to travel|0|||
155555982|NCT03295318|561462613|FG001|Overall Study|Subject discontinued due to travel|1|||
155555983|NCT03295318|561462614|FG002|Overall Study|Subject discontinued due to travel|0|||
155555984|NCT03747601|561462615|FG000|Overall Study|COVID halt to visits|4|||
155555985|NCT04319718|561462619|FG000|Overall Study|Adverse Event|0|||
155555986|NCT04319718|561462620|FG001|Overall Study|Adverse Event|2|||
155555987|NCT04319718|561462619|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
155555988|NCT04319718|561462620|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
155555989|NCT00321828|561462621|FG000|Overall Study|Ineligible|3|||
155555990|NCT00321828|561462621|FG000|Overall Study|No follow up data|1|||
155555991|NCT00573157|561462622|FG000|Overall Study|Adverse Event|3|||
155555992|NCT00573157|561462623|FG001|Overall Study|Adverse Event|1|||
155555993|NCT00573157|561462622|FG000|Overall Study|Other|1|||
155555994|NCT00573157|561462623|FG001|Overall Study|Other|1|||
155555995|NCT00090610|561462624|FG000|Overall Study|Withdrawal by Subject|1|||
155555996|NCT00090610|561462625|FG001|Overall Study|Withdrawal by Subject|1|||
155555997|NCT00609518|561462626|FG000|Overall Study|Death from Study Disease|32|||
155555998|NCT00609518|561462627|FG001|Overall Study|Death from Study Disease|32|||
155555999|NCT00609518|561462626|FG000|Overall Study|Withdrawal by Subject|5|||
155556000|NCT00609518|561462627|FG001|Overall Study|Withdrawal by Subject|3|||
155556001|NCT00609518|561462626|FG000|Overall Study|Lost to Follow-up|3|||
155556002|NCT00609518|561462627|FG001|Overall Study|Lost to Follow-up|0|||
155556003|NCT00609518|561462626|FG000|Overall Study|Physician Decision|1|||
155556004|NCT00609518|561462627|FG001|Overall Study|Physician Decision|3|||
155556005|NCT00609518|561462626|FG000|Overall Study|Death from Adverse Event|2|||
155556006|NCT00609518|561462627|FG001|Overall Study|Death from Adverse Event|2|||
155556007|NCT04032158|561462628|FG000|Overall Study|Study Termination|2|||
155556008|NCT04032158|561462629|FG001|Overall Study|Study Termination|1|||
155556009|NCT00059787|561462630|FG000|Overall Study|Adverse Event|13|||
155556010|NCT00059787|561462630|FG000|Overall Study|disease progression|2|||
155556011|NCT00059787|561462630|FG000|Overall Study|ineligible|1|||
155556012|NCT00059787|561462630|FG000|Overall Study|Other|4|||
155556013|NCT01859130|561462631|FG000|Overall Study|Death|4|||
155556014|NCT01859130|561462631|FG000|Overall Study|Lost to Follow-up|16|||
155556015|NCT01859130|561462631|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
155556016|NCT01859130|561462631|FG000|Overall Study|Physician Decision|6|||
155556017|NCT01859130|561462631|FG000|Overall Study|Withdrawal by Subject|17|||
155556018|NCT01859130|561462631|FG000|Overall Study|Adverse Event|11|||
155556019|NCT01388166|561462632|FG000|Overall Study|Adverse Event|16|||
155556020|NCT01388166|561462632|FG000|Overall Study|Lost to Follow-up|30|||
155556021|NCT01388166|561462632|FG000|Overall Study|Others than specified above|13|||
155556022|NCT04325204|561462633|FG000|Overall Study|Death|0|||
155556023|NCT04325204|561462634|FG001|Overall Study|Death|1|||
155556024|NCT04325204|561462633|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
155556025|NCT04325204|561462634|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
155556026|NCT04325204|561462633|FG000|Overall Study|Lost to Follow-up|8|||
155556027|NCT04325204|561462634|FG001|Overall Study|Lost to Follow-up|8|||
155556028|NCT04325204|561462633|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
155556029|NCT04325204|561462634|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
155556030|NCT04710979|561462638|FG000|Overall Study|Lost to Follow-up|2|||
155556031|NCT04710979|561462639|FG001|Overall Study|Lost to Follow-up|4|||
155556032|NCT04710979|561462638|FG000|Overall Study|Withdrawal by Subject|1|||
155556033|NCT04710979|561462639|FG001|Overall Study|Withdrawal by Subject|0|||
155556034|NCT04397445|561462640|FG000|Overall Study|Withdrawal by Subject|1|||
155556035|NCT04397445|561462641|FG001|Overall Study|Withdrawal by Subject|0|||
155556036|NCT04397445|561462642|FG002|Overall Study|Withdrawal by Subject|0|||
155556037|NCT04397445|561462643|FG003|Overall Study|Withdrawal by Subject|0|||
155556038|NCT01429051|561462644|FG000|Titration Phase|Death|1|||
155556039|NCT01429051|561462644|FG000|Titration Phase|Withdrawal by Subject|7|||
155556040|NCT01429051|561462644|FG000|Titration Phase|Physician Decision|1|||
155556041|NCT01429051|561462644|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
155556042|NCT01429051|561462644|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
155556043|NCT01429051|561462644|FG000|Efficacy Phase|Adverse Event|1|||
155556044|NCT01429051|561462644|FG000|Efficacy Phase|Death|1|||
155556045|NCT01429051|561462644|FG000|Tolerability Phase|Death|5|||
155556046|NCT01429051|561462644|FG000|Tolerability Phase|Adverse Event|2|||
155556047|NCT01429051|561462644|FG000|Tolerability Phase|Withdrawal by Subject|5|||
155556048|NCT01429051|561462644|FG000|Tolerability Phase|Physician Decision|1|||
155556049|NCT01429051|561462644|FG000|Tolerability Phase|Other|2|||
155556050|NCT00891371|561462645|FG000|Pre-assignment|Inclusion/exclusion|5|||
155556051|NCT00891371|561462645|FG000|Pre-assignment|Consent withdrawal|1|||
155556052|NCT00891371|561462645|FG000|Treatment|Lack of Efficacy|5|||
155556053|NCT00891371|561462645|FG000|Treatment|Adverse Event|2|||
155556054|NCT00891371|561462645|FG000|Treatment|Death|1|||
155556055|NCT00891371|561462645|FG000|Treatment|Lost to Follow-up|1|||
155556056|NCT00307034|561462646|FG000|Overall Study|Adverse Event|1|||
155556057|NCT00307034|561462647|FG001|Overall Study|Adverse Event|2|||
155556058|NCT00307034|561462646|FG000|Overall Study|Withdrawal by Subject|1|||
155556059|NCT00307034|561462647|FG001|Overall Study|Withdrawal by Subject|2|||
155556060|NCT00307034|561462646|FG000|Overall Study|Lost to Follow-up|0|||
155556061|NCT00307034|561462647|FG001|Overall Study|Lost to Follow-up|3|||
155556062|NCT02034058|561462648|FG000|Overall Study|Death|3|||
155556063|NCT03709823|561462659|FG000|Overall Study|Adverse Event|0|||
155556064|NCT03709823|561462660|FG001|Overall Study|Adverse Event|0|||
155556065|NCT03709823|561462661|FG002|Overall Study|Adverse Event|1|||
155556066|NCT03709823|561462662|FG003|Overall Study|Adverse Event|0|||
155556067|NCT03709823|561462663|FG004|Overall Study|Adverse Event|0|||
155556068|NCT03709823|561462664|FG005|Overall Study|Adverse Event|0|||
155556069|NCT03709823|561462659|FG000|Overall Study|Lost to Follow-up|2|||
155556070|NCT03709823|561462660|FG001|Overall Study|Lost to Follow-up|2|||
155556071|NCT03709823|561462661|FG002|Overall Study|Lost to Follow-up|2|||
155556072|NCT03709823|561462662|FG003|Overall Study|Lost to Follow-up|1|||
155556073|NCT03709823|561462663|FG004|Overall Study|Lost to Follow-up|1|||
155556074|NCT03709823|561462664|FG005|Overall Study|Lost to Follow-up|0|||
155556075|NCT03709823|561462659|FG000|Overall Study|Withdrawal by Subject|1|||
155556076|NCT03709823|561462660|FG001|Overall Study|Withdrawal by Subject|3|||
155556077|NCT03709823|561462661|FG002|Overall Study|Withdrawal by Subject|0|||
155556078|NCT03709823|561462662|FG003|Overall Study|Withdrawal by Subject|0|||
155556079|NCT03709823|561462663|FG004|Overall Study|Withdrawal by Subject|0|||
155556080|NCT03709823|561462664|FG005|Overall Study|Withdrawal by Subject|0|||
155556081|NCT03709823|561462659|FG000|Overall Study|Other, Not Specified|0|||
155556082|NCT03709823|561462660|FG001|Overall Study|Other, Not Specified|0|||
155556083|NCT03709823|561462661|FG002|Overall Study|Other, Not Specified|0|||
155556084|NCT03709823|561462662|FG003|Overall Study|Other, Not Specified|1|||
155556085|NCT03709823|561462663|FG004|Overall Study|Other, Not Specified|0|||
155556086|NCT03709823|561462664|FG005|Overall Study|Other, Not Specified|0|||
155556087|NCT00846521|561462665|FG000|Overall Study|Withdrawal by Subject|5|||
155556088|NCT00846521|561462665|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
155556089|NCT00846521|561462665|FG000|Overall Study|Protocol Violation|1|||
155556090|NCT04392583|561462666|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
155556091|NCT02397408|561462667|FG000|Overall Study|Physician Decision|4|||
155556092|NCT02397408|561462667|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
155556093|NCT00140426|561462670|FG000|Overall Study|Withdrawal by Subject|0|||
155556094|NCT00140426|561462671|FG001|Overall Study|Withdrawal by Subject|3|||
155556095|NCT00950963|561462672|FG000|Overall Study|Lost to Follow-up|29|||
155556096|NCT00950963|561462673|FG001|Overall Study|Lost to Follow-up|24|||
155556097|NCT04168190|561462674|FG000|Overall Study|Lost to Follow-up|0|||
155556098|NCT04168190|561462675|FG001|Overall Study|Lost to Follow-up|1|||
155556099|NCT04168190|561462676|FG002|Overall Study|Lost to Follow-up|0|||
155556100|NCT04168190|561462677|FG003|Overall Study|Lost to Follow-up|7|||
155556101|NCT04168190|561462678|FG004|Overall Study|Lost to Follow-up|5|||
155556102|NCT04168190|561462674|FG000|Overall Study|Withdrawal by Subject|1|||
155556103|NCT04168190|561462675|FG001|Overall Study|Withdrawal by Subject|0|||
155556104|NCT04168190|561462676|FG002|Overall Study|Withdrawal by Subject|0|||
155556105|NCT04168190|561462677|FG003|Overall Study|Withdrawal by Subject|2|||
155556106|NCT04168190|561462678|FG004|Overall Study|Withdrawal by Subject|4|||
155556107|NCT04168190|561462674|FG000|Overall Study|Death|0|||
155556108|NCT04168190|561462675|FG001|Overall Study|Death|0|||
155556109|NCT04168190|561462676|FG002|Overall Study|Death|0|||
155556110|NCT04168190|561462677|FG003|Overall Study|Death|1|||
155556111|NCT04168190|561462678|FG004|Overall Study|Death|0|||
155556112|NCT01675661|561462679|FG000|Overall Study|Lost to Follow-up|22|||
155556113|NCT01675661|561462680|FG001|Overall Study|Lost to Follow-up|23|||
155556114|NCT01675661|561462679|FG000|Overall Study|Practical problems|9|||
155556115|NCT01675661|561462680|FG001|Overall Study|Practical problems|5|||
155556116|NCT01675661|561462679|FG000|Overall Study|Moved away|5|||
155556117|NCT01675661|561462680|FG001|Overall Study|Moved away|6|||
155556118|NCT01675661|561462679|FG000|Overall Study|Withdrawal by Subject|3|||
155556119|NCT01675661|561462680|FG001|Overall Study|Withdrawal by Subject|7|||
155556120|NCT01675661|561462679|FG000|Overall Study|Physician Decision|0|||
155556121|NCT01675661|561462680|FG001|Overall Study|Physician Decision|2|||
155556122|NCT01675661|561462679|FG000|Overall Study|Death|0|||
155556123|NCT01675661|561462680|FG001|Overall Study|Death|1|||
155556124|NCT01675661|561462679|FG000|Overall Study|Other reason|1|||
155556125|NCT01675661|561462680|FG001|Overall Study|Other reason|2|||
155556126|NCT04765384|561462681|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
155556127|NCT04765384|561462682|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
155556128|NCT04765384|561462683|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
155556129|NCT04765384|561462684|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
155556130|NCT04765384|561462685|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
155556131|NCT04765384|561462686|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
155556132|NCT04765384|561462681|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
155556133|NCT04765384|561462682|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
155556134|NCT04765384|561462683|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
155556135|NCT04765384|561462684|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
155556136|NCT04765384|561462685|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
155556137|NCT04765384|561462686|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
155556138|NCT04765384|561462681|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
155556139|NCT04765384|561462682|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
155556140|NCT04765384|561462683|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
155556141|NCT04765384|561462684|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
155556142|NCT04765384|561462685|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
155556143|NCT04765384|561462686|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
155556144|NCT04765384|561462681|FG000|Post-natal: Neonates and Infants|Death|0|||
155556145|NCT04765384|561462682|FG001|Post-natal: Neonates and Infants|Death|0|||
155556146|NCT04765384|561462683|FG002|Post-natal: Neonates and Infants|Death|0|||
155556147|NCT04765384|561462684|FG003|Post-natal: Neonates and Infants|Death|1|||
155556148|NCT04765384|561462685|FG004|Post-natal: Neonates and Infants|Death|0|||
155556149|NCT04765384|561462686|FG005|Post-natal: Neonates and Infants|Death|0|||
155556150|NCT04765384|561462681|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
155556151|NCT04765384|561462682|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
155556152|NCT04765384|561462683|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
155556153|NCT04765384|561462684|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
155556154|NCT04765384|561462685|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
155556155|NCT04765384|561462686|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
155556156|NCT02992418|561462687|FG000|Overall Study|Withdrawal by Subject|11|||
155556157|NCT02992418|561462688|FG001|Overall Study|Withdrawal by Subject|12|||
155556158|NCT02992418|561462687|FG000|Overall Study|Non-compliance with the protocol|308|||
155556159|NCT02992418|561462688|FG001|Overall Study|Non-compliance with the protocol|308|||
155556160|NCT02992418|561462687|FG000|Overall Study|Lost to Follow-up|27|||
155556161|NCT02992418|561462688|FG001|Overall Study|Lost to Follow-up|22|||
155556162|NCT00629265|561462689|FG000|Overall Study|Lost to Follow-up|4|||
155556163|NCT00629265|561462690|FG001|Overall Study|Lost to Follow-up|5|||
155556164|NCT00629265|561462689|FG000|Overall Study|Withdrawal by Subject|11|||
155556165|NCT00629265|561462690|FG001|Overall Study|Withdrawal by Subject|8|||
155556166|NCT00629265|561462689|FG000|Overall Study|Death|1|||
155556167|NCT00629265|561462690|FG001|Overall Study|Death|0|||
155556168|NCT00629265|561462689|FG000|Overall Study|Adverse Event|2|||
155556169|NCT00629265|561462690|FG001|Overall Study|Adverse Event|0|||
155556170|NCT00629265|561462689|FG000|Overall Study|HNC Recurrence|4|||
155556171|NCT00629265|561462690|FG001|Overall Study|HNC Recurrence|0|||
155556172|NCT00629265|561462689|FG000|Overall Study|Other CA Requiring Treatment|1|||
155556173|NCT00629265|561462690|FG001|Overall Study|Other CA Requiring Treatment|3|||
155556174|NCT00629265|561462689|FG000|Overall Study|Needed Esophageal Dilation|4|||
155556175|NCT00629265|561462690|FG001|Overall Study|Needed Esophageal Dilation|1|||
155556176|NCT00629265|561462689|FG000|Overall Study|Unrelated Medical Complications|3|||
155556177|NCT00629265|561462690|FG001|Overall Study|Unrelated Medical Complications|1|||
155556178|NCT00629265|561462689|FG000|Overall Study|Unknown Reason|2|||
155556179|NCT00629265|561462690|FG001|Overall Study|Unknown Reason|2|||
155556180|NCT01006135|561462691|FG000|Overall Study|Adverse Event|22|||
155556181|NCT01006135|561462691|FG000|Overall Study|Protocol Violation|14|||
155556182|NCT01006135|561462691|FG000|Overall Study|Lost to Follow-up|32|||
155556183|NCT01006135|561462691|FG000|Overall Study|Other|72|||
155556184|NCT01732484|561462692|FG000|Overall Study|Death|7|||
155556185|NCT01732484|561462692|FG000|Overall Study|Lost to Follow-up|14|||
155556186|NCT01732484|561462692|FG000|Overall Study|chronical illness|5|||
155556187|NCT01087489|561462693|FG000|Overall Study|enrolled in another VA study|0|||
155556188|NCT01087489|561462694|FG001|Overall Study|enrolled in another VA study|1|||
155556189|NCT01087489|561462693|FG000|Overall Study|Death|0|||
155556190|NCT01087489|561462694|FG001|Overall Study|Death|1|||
155556191|NCT01087489|561462693|FG000|Overall Study|unable to survey by telephone|0|||
155556192|NCT01087489|561462694|FG001|Overall Study|unable to survey by telephone|1|||
155556193|NCT02032706|561462702|FG000|Overall Study|Did not qualify|5|||
155556194|NCT02032706|561462702|FG000|Overall Study|Protocol Violation|1|||
155556195|NCT00893737|561462703|FG000|Overall Study|Adverse Event|4|||
155556196|NCT00893737|561462703|FG000|Overall Study|Withdrawal by Subject|2|||
155556197|NCT00893737|561462703|FG000|Overall Study|Lost to Follow-up|6|||
155556198|NCT00928707|561462704|FG000|Overall Study|Protocol Violation|1|||
155556199|NCT00928707|561462705|FG001|Overall Study|Protocol Violation|0|||
155556200|NCT00132028|561462706|FG000|Overall Study|Adverse Event|7|||
155556201|NCT00132028|561462706|FG000|Overall Study|Death|2|||
155556202|NCT00132028|561462706|FG000|Overall Study|Lack of Efficacy|11|||
155556203|NCT00132028|561462706|FG000|Overall Study|Withdrawal by Subject|2|||
155556204|NCT00132028|561462706|FG000|Overall Study|not eligible|2|||
155556205|NCT00132028|561462706|FG000|Overall Study|Physician Decision|3|||
155556206|NCT02140411|561462707|FG000|Overall Study|Adverse Event|1|||
155556207|NCT03981419|561462710|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
155556208|NCT03981419|561462711|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
155556209|NCT01330459|561462716|FG000|Overall Study|Physician Decision|0|||
155556210|NCT01330459|561462717|FG001|Overall Study|Physician Decision|2|||
155556211|NCT01437943|561462719|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
155556212|NCT01437943|561462720|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
155556213|NCT01437943|561462719|FG000|Overall Study|Subject expressed pregnancy plans|1|||
155556214|NCT01437943|561462720|FG001|Overall Study|Subject expressed pregnancy plans|0|||
155556215|NCT01437943|561462719|FG000|Overall Study|Adverse Event|2|||
155556216|NCT01437943|561462720|FG001|Overall Study|Adverse Event|0|||
155556217|NCT02005887|561462730|FG000|Overall Study|Protocol Violation|0|||
155556218|NCT02005887|561462731|FG001|Overall Study|Protocol Violation|2|||
155556219|NCT01615263|561462732|FG000|Overall Study|Post-randomization exclusion|0|||
155556220|NCT01615263|561462733|FG001|Overall Study|Post-randomization exclusion|2|||
155556221|NCT00160641|561462734|FG000|Overall Study|Adverse Event|102|||
155556222|NCT00160641|561462734|FG000|Overall Study|Withdrawal by Subject|87|||
155556223|NCT00160641|561462734|FG000|Overall Study|Lost to Follow-up|8|||
155556224|NCT00160641|561462734|FG000|Overall Study|Lack of Efficacy|12|||
155556225|NCT00160641|561462734|FG000|Overall Study|Protocol Violation|3|||
155556226|NCT00160641|561462734|FG000|Overall Study|Other|9|||
155556227|NCT01321008|561462735|FG000|Overall Study|Early Study Termination|1|||
155556228|NCT00770692|561462738|FG000|Overall Study|Withdrawal by Subject|7|||
155556229|NCT00770692|561462739|FG001|Overall Study|Withdrawal by Subject|9|||
155556230|NCT00770692|561462740|FG002|Overall Study|Withdrawal by Subject|9|||
155556231|NCT00770692|561462741|FG003|Overall Study|Withdrawal by Subject|6|||
155556232|NCT00770692|561462738|FG000|Overall Study|Adverse Event|3|||
155556233|NCT00770692|561462739|FG001|Overall Study|Adverse Event|0|||
155556234|NCT00770692|561462740|FG002|Overall Study|Adverse Event|4|||
155556235|NCT00770692|561462741|FG003|Overall Study|Adverse Event|4|||
155556236|NCT00770692|561462738|FG000|Overall Study|Investigator judgment|2|||
155556237|NCT00770692|561462739|FG001|Overall Study|Investigator judgment|0|||
155556238|NCT00770692|561462740|FG002|Overall Study|Investigator judgment|1|||
155556239|NCT00770692|561462741|FG003|Overall Study|Investigator judgment|1|||
155556240|NCT01230892|561462742|FG000|Overall Study|Withdrawal by Subject|1|||
155556241|NCT01230892|561462743|FG001|Overall Study|Withdrawal by Subject|1|||
155556242|NCT01230892|561462742|FG000|Overall Study|Lost to Follow-up|2|||
155556243|NCT01230892|561462743|FG001|Overall Study|Lost to Follow-up|0|||
155556244|NCT00679913|561462744|FG000|Overall Study|Protocol Violation|18|||
155556245|NCT00679913|561462745|FG001|Overall Study|Protocol Violation|13|||
155556246|NCT01000493|561462746|FG000|Overall Study|Adverse Event|3|||
155556247|NCT01000493|561462747|FG001|Overall Study|Adverse Event|6|||
155556248|NCT01000493|561462746|FG000|Overall Study|Lack of Efficacy|1|||
155556249|NCT01000493|561462747|FG001|Overall Study|Lack of Efficacy|1|||
155556250|NCT01000493|561462746|FG000|Overall Study|Protocol Violation|1|||
155556251|NCT01000493|561462747|FG001|Overall Study|Protocol Violation|8|||
155556252|NCT01000493|561462746|FG000|Overall Study|Study closed/terminated|25|||
155556253|NCT01000493|561462747|FG001|Overall Study|Study closed/terminated|23|||
155556254|NCT01000493|561462746|FG000|Overall Study|Lost to Follow-up|5|||
155556255|NCT01000493|561462747|FG001|Overall Study|Lost to Follow-up|9|||
155556256|NCT01000493|561462746|FG000|Overall Study|Physician Decision|1|||
155556257|NCT01000493|561462747|FG001|Overall Study|Physician Decision|1|||
155556258|NCT01000493|561462746|FG000|Overall Study|Withdrawal by Subject|3|||
155556259|NCT01000493|561462747|FG001|Overall Study|Withdrawal by Subject|7|||
155556260|NCT00062751|561462748|FG000|Overall Study|Disease progression|24|||
155556261|NCT00062751|561462749|FG001|Overall Study|Disease progression|17|||
155556262|NCT00062751|561462750|FG002|Overall Study|Disease progression|24|||
155556263|NCT00062751|561462751|FG003|Overall Study|Disease progression|2|||
155556264|NCT00062751|561462752|FG004|Overall Study|Disease progression|2|||
155556265|NCT00062751|561462748|FG000|Overall Study|Adverse Event|4|||
155556266|NCT00062751|561462749|FG001|Overall Study|Adverse Event|7|||
155556267|NCT00062751|561462750|FG002|Overall Study|Adverse Event|2|||
155556268|NCT00062751|561462751|FG003|Overall Study|Adverse Event|2|||
155556269|NCT00062751|561462752|FG004|Overall Study|Adverse Event|2|||
155556270|NCT00062751|561462748|FG000|Overall Study|Other|2|||
155556271|NCT00062751|561462749|FG001|Overall Study|Other|3|||
155556272|NCT00062751|561462750|FG002|Overall Study|Other|1|||
155556273|NCT00062751|561462751|FG003|Overall Study|Other|0|||
155556274|NCT00062751|561462752|FG004|Overall Study|Other|1|||
155556275|NCT00062751|561462748|FG000|Overall Study|Withdrawal by Subject|1|||
155556276|NCT00062751|561462749|FG001|Overall Study|Withdrawal by Subject|2|||
155556277|NCT00062751|561462750|FG002|Overall Study|Withdrawal by Subject|2|||
155556278|NCT00062751|561462751|FG003|Overall Study|Withdrawal by Subject|1|||
155556279|NCT00062751|561462752|FG004|Overall Study|Withdrawal by Subject|0|||
155556280|NCT00062751|561462748|FG000|Overall Study|Symptomatic deterioration|1|||
155556281|NCT00062751|561462749|FG001|Overall Study|Symptomatic deterioration|1|||
155556282|NCT00062751|561462750|FG002|Overall Study|Symptomatic deterioration|0|||
155556283|NCT00062751|561462751|FG003|Overall Study|Symptomatic deterioration|0|||
155556284|NCT00062751|561462752|FG004|Overall Study|Symptomatic deterioration|1|||
155556285|NCT00062751|561462748|FG000|Overall Study|Death|1|||
155556286|NCT00062751|561462749|FG001|Overall Study|Death|0|||
155556287|NCT00062751|561462750|FG002|Overall Study|Death|1|||
155556288|NCT00062751|561462751|FG003|Overall Study|Death|0|||
155556289|NCT00062751|561462752|FG004|Overall Study|Death|0|||
155556290|NCT03629028|561462753|FG000|Overall Study|Lost to Follow-up|26|||
155556291|NCT03629028|561462754|FG001|Overall Study|Lost to Follow-up|23|||
155556292|NCT03629028|561462753|FG000|Overall Study|Pregnancy|4|||
155556293|NCT03629028|561462754|FG001|Overall Study|Pregnancy|2|||
155556294|NCT03629028|561462753|FG000|Overall Study|intolerance to examination|2|||
155556295|NCT03629028|561462754|FG001|Overall Study|intolerance to examination|0|||
155556296|NCT03097588|561462758|FG000|Overall Study|Adverse Event|1|||
155556297|NCT01144364|561462759|FG000|Induction Phase|Disease progression|14|||
155556298|NCT01144364|561462760|FG001|Induction Phase|Disease progression|0|||
155556299|NCT01144364|561462761|FG002|Induction Phase|Disease progression|0|||
155556300|NCT01144364|561462759|FG000|Induction Phase|Adverse Event|9|||
155556301|NCT01144364|561462760|FG001|Induction Phase|Adverse Event|0|||
155556302|NCT01144364|561462761|FG002|Induction Phase|Adverse Event|0|||
155556303|NCT01144364|561462759|FG000|Induction Phase|Death|1|||
155556304|NCT01144364|561462760|FG001|Induction Phase|Death|0|||
155556305|NCT01144364|561462761|FG002|Induction Phase|Death|0|||
155556306|NCT01144364|561462759|FG000|Induction Phase|Withdrawal by Subject|1|||
155556307|NCT01144364|561462760|FG001|Induction Phase|Withdrawal by Subject|0|||
155556308|NCT01144364|561462761|FG002|Induction Phase|Withdrawal by Subject|0|||
155556309|NCT01144364|561462759|FG000|Induction Phase|Lost to Follow-up|2|||
155556310|NCT01144364|561462760|FG001|Induction Phase|Lost to Follow-up|0|||
155556311|NCT01144364|561462761|FG002|Induction Phase|Lost to Follow-up|0|||
155556312|NCT01144364|561462759|FG000|Induction Phase|Physician Decision|1|||
155556313|NCT01144364|561462760|FG001|Induction Phase|Physician Decision|0|||
155556314|NCT01144364|561462761|FG002|Induction Phase|Physician Decision|0|||
155556315|NCT01144364|561462759|FG000|Induction Phase|Stable disease|2|||
155556316|NCT01144364|561462760|FG001|Induction Phase|Stable disease|0|||
155556317|NCT01144364|561462761|FG002|Induction Phase|Stable disease|0|||
155556318|NCT01144364|561462759|FG000|Induction Phase|Secondary neoplasia|1|||
155556319|NCT01144364|561462760|FG001|Induction Phase|Secondary neoplasia|0|||
155556320|NCT01144364|561462761|FG002|Induction Phase|Secondary neoplasia|0|||
155556321|NCT01144364|561462759|FG000|Induction Phase|Protocol Violation|1|||
155556322|NCT01144364|561462760|FG001|Induction Phase|Protocol Violation|0|||
155556323|NCT01144364|561462761|FG002|Induction Phase|Protocol Violation|0|||
155556324|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
155556325|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
155556326|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
155556327|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
155556328|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
155657722|NCT01055028|561840413|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
155657723|NCT01055028|561840412|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
155556329|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
155556330|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Death|0|||
155556331|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Death|2|||
155556332|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Death|0|||
155556333|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
155556334|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
155556335|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
155556336|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
155556337|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
155556338|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
155556339|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
155556340|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
155556341|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
155556342|NCT01144364|561462759|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
155556343|NCT01144364|561462760|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
155556344|NCT01144364|561462761|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
155556345|NCT03828448|561462762|FG000|Overall Study|Sponsor's Discretion|34|||
155556346|NCT02037165|561462763|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
155556347|NCT02037165|561462764|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
155556348|NCT02037165|561462765|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
155556349|NCT02037165|561462766|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
155556350|NCT02037165|561462767|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
155556351|NCT02192164|561462771|FG000|Overall Study|Other|8|||
155556352|NCT02192164|561462771|FG000|Overall Study|Withdrawal by Subject|1|||
155556353|NCT02192164|561462771|FG000|Overall Study|Physician Decision|4|||
155556354|NCT02192164|561462771|FG000|Overall Study|Did not meet the exclusion criteria|1|||
155556355|NCT00609466|561462781|FG000|Overall Study|Withdrawal by Subject|0|||
155556356|NCT00609466|561462782|FG001|Overall Study|Withdrawal by Subject|1|||
155556357|NCT00609466|561462783|FG002|Overall Study|Withdrawal by Subject|1|||
155556358|NCT00609466|561462781|FG000|Overall Study|Adverse Event|2|||
155556359|NCT00609466|561462782|FG001|Overall Study|Adverse Event|3|||
155556360|NCT00609466|561462783|FG002|Overall Study|Adverse Event|1|||
155556361|NCT00609466|561462781|FG000|Overall Study|Lack of Efficacy|0|||
155556362|NCT00609466|561462782|FG001|Overall Study|Lack of Efficacy|2|||
155556363|NCT00609466|561462783|FG002|Overall Study|Lack of Efficacy|2|||
155556364|NCT03512262|561462784|FG000|Overall Study|Adverse Event|8|||
155556365|NCT03512262|561462785|FG001|Overall Study|Adverse Event|3|||
155556366|NCT03512262|561462784|FG000|Overall Study|Death (non-treatment emergent)|1|||
155556367|NCT03512262|561462785|FG001|Overall Study|Death (non-treatment emergent)|0|||
155556368|NCT03512262|561462784|FG000|Overall Study|Withdrawal by Subject|17|||
155556369|NCT03512262|561462785|FG001|Overall Study|Withdrawal by Subject|9|||
155556370|NCT03512262|561462784|FG000|Overall Study|Lost to Follow-up|7|||
155556371|NCT03512262|561462785|FG001|Overall Study|Lost to Follow-up|1|||
155556372|NCT03512262|561462784|FG000|Overall Study|Other than Specified|2|||
155556373|NCT03512262|561462785|FG001|Overall Study|Other than Specified|2|||
155556374|NCT01299805|561462786|FG000|Overall Study|Adverse Event|2|||
155556375|NCT01299805|561462787|FG001|Overall Study|Adverse Event|0|||
155556376|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
155556377|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
155556378|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
155556379|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
155556380|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
155556381|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
155556382|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
155556383|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
155556384|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
155556385|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
155556386|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
155556387|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
155556388|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
155556389|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
155556390|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
155556391|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
155556392|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
155657724|NCT01055028|561840413|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
155657725|NCT00645658|561840414|FG000|Overall Study|Withdrawal by Subject|1|||
155657726|NCT00645658|561840415|FG001|Overall Study|Withdrawal by Subject|0|||
155657727|NCT00645658|561840414|FG000|Overall Study|Did not complete all assesments|0|||
155657728|NCT00645658|561840415|FG001|Overall Study|Did not complete all assesments|2|||
155657729|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
155657730|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
155556393|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
155556394|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
155556395|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
155556396|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
155556397|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
155556398|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
155556399|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
155556400|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
155556401|NCT02935686|561464160|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
155556402|NCT02935686|561464161|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
155556403|NCT02935686|561464162|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
155556404|NCT02935686|561464163|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
155556405|NCT02935686|561464164|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
155556406|NCT02935686|561464160|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
155556407|NCT02935686|561464161|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
155657731|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
155657732|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
155657733|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
155657734|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
155657735|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
155657736|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
155657737|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
155657738|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
155657739|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
155657740|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
155657741|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
155657742|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
155657743|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
155657744|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
155657745|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
155657746|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
155657747|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
155657748|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
155556408|NCT02935686|561464162|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
155556409|NCT02935686|561464163|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
155556410|NCT02935686|561464164|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
155556411|NCT02935686|561464160|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
155556412|NCT02935686|561464161|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
155556413|NCT02935686|561464162|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
155556414|NCT02935686|561464163|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
155556415|NCT02935686|561464164|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
155556416|NCT02935686|561464160|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
155556417|NCT02935686|561464161|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
155556418|NCT02935686|561464162|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
155556419|NCT02935686|561464163|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
155556420|NCT02935686|561464164|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
155556421|NCT02935686|561464160|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
155556422|NCT02935686|561464161|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
155556423|NCT02935686|561464162|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
155556424|NCT02935686|561464163|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
155556425|NCT02935686|561464164|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
155556426|NCT02935686|561464160|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
155556427|NCT02935686|561464161|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
155556428|NCT02935686|561464162|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
155556429|NCT02935686|561464163|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
155556430|NCT02935686|561464164|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
155556431|NCT01183221|561464165|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
155556432|NCT01183221|561464166|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
155556433|NCT00103311|561464172|FG000|Overall Study|Lost to Follow-up|1|||
155556434|NCT00103311|561464173|FG001|Overall Study|Lost to Follow-up|0|||
155556435|NCT00103311|561464172|FG000|Overall Study|Withdrawal by Subject|2|||
155556436|NCT00103311|561464173|FG001|Overall Study|Withdrawal by Subject|1|||
155556437|NCT00103311|561464172|FG000|Overall Study|Adverse Event|1|||
155556438|NCT00103311|561464173|FG001|Overall Study|Adverse Event|0|||
155556439|NCT00912093|561464174|FG000|The Controlled Phase|Death|0|||
155556440|NCT00912093|561464175|FG001|The Controlled Phase|Death|1|||
155556441|NCT00912093|561464176|FG002|The Controlled Phase|Death|0|||
155556442|NCT00912093|561464177|FG003|The Controlled Phase|Death|0|||
155556443|NCT00912093|561464178|FG004|The Controlled Phase|Death|0|||
155556444|NCT00912093|561464174|FG000|The Controlled Phase|Medical Condition|0|||
155556445|NCT00912093|561464175|FG001|The Controlled Phase|Medical Condition|1|||
155556446|NCT00912093|561464176|FG002|The Controlled Phase|Medical Condition|0|||
155556447|NCT00912093|561464177|FG003|The Controlled Phase|Medical Condition|0|||
155556448|NCT00912093|561464178|FG004|The Controlled Phase|Medical Condition|0|||
155556449|NCT00912093|561464174|FG000|The Controlled Phase|Lost to Follow-up|0|||
155556450|NCT00912093|561464175|FG001|The Controlled Phase|Lost to Follow-up|0|||
155556451|NCT00912093|561464176|FG002|The Controlled Phase|Lost to Follow-up|0|||
155556452|NCT00912093|561464177|FG003|The Controlled Phase|Lost to Follow-up|0|||
155556453|NCT00912093|561464178|FG004|The Controlled Phase|Lost to Follow-up|1|||
155556454|NCT03827564|561464183|FG000|Overall Study|Discontinued due to Study Termination|1|||
155556455|NCT03827564|561464184|FG001|Overall Study|Discontinued due to Study Termination|0|||
155556456|NCT02621034|561464188|FG000|Overall Study|Lost to Follow-up|3|||
155556457|NCT02621034|561464189|FG001|Overall Study|Lost to Follow-up|2|||
155556458|NCT02621034|561464190|FG002|Overall Study|Lost to Follow-up|5|||
155556459|NCT02372071|561464194|FG000|Overall Study|Protocol Violation|18|||
155556460|NCT01968694|561464195|FG000|Washout (1 Month)|Lost to Follow-up|0|||
155556461|NCT01968694|561464196|FG001|Washout (1 Month)|Lost to Follow-up|1|||
155556462|NCT02836496|561464197|FG000|Overall Study|Adverse Event|2|||
155556463|NCT02836496|561464198|FG001|Overall Study|Adverse Event|1|||
155556464|NCT02836496|561464197|FG000|Overall Study|Withdrawal by Subject|0|||
155556465|NCT02836496|561464198|FG001|Overall Study|Withdrawal by Subject|1|||
155556466|NCT01400919|561464199|FG000|Overall Study|Withdrawal by Subject|4|||
155556467|NCT01400919|561464199|FG000|Overall Study|Lost to Follow-up|2|||
155556468|NCT01400919|561464199|FG000|Overall Study|Missed visit|2|||
155556469|NCT03347422|561464200|FG000|Part A (26 Weeks)|Adverse Event|3|||
155556470|NCT03347422|561464201|FG001|Part A (26 Weeks)|Adverse Event|0|||
155556471|NCT03347422|561464200|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
155556472|NCT03347422|561464201|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
155556473|NCT03347422|561464200|FG000|Part B (149 Weeks)|Adverse Event|0|||
155556474|NCT03347422|561464201|FG001|Part B (149 Weeks)|Adverse Event|1|||
155556475|NCT03347422|561464200|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
155556476|NCT03347422|561464201|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
155556477|NCT03347422|561464200|FG000|Part B (149 Weeks)|Other|1|||
155556478|NCT03347422|561464201|FG001|Part B (149 Weeks)|Other|0|||
155556479|NCT01246011|561464203|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
155556480|NCT01246011|561464204|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
155556481|NCT01246011|561464205|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
155657749|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
155657750|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
155657751|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
155657752|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
155657753|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
155657754|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
155657755|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
155657756|NCT03093415|561840418|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
155657757|NCT03093415|561840419|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
155657758|NCT03093415|561840420|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
155657759|NCT03093415|561840418|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
155657760|NCT03093415|561840419|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
155657761|NCT03093415|561840420|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
155657762|NCT01767987|561840423|FG000|Overall Study|Physician Decision|4|||
155556482|NCT01246011|561464203|FG000|Overall Study|Withdrawal by Subject|0|||
155556483|NCT01246011|561464204|FG001|Overall Study|Withdrawal by Subject|0|||
155556484|NCT01246011|561464205|FG002|Overall Study|Withdrawal by Subject|1|||
155556485|NCT03914950|561464214|FG000|Overall Study|Physician Decision|54|||
155657763|NCT01767987|561840424|FG001|Overall Study|Physician Decision|1|||
155556486|NCT02575911|561464223|FG000|Overall Study|Lost to Follow-up|1|||
155556487|NCT01249365|561464224|FG000|Overall Study|Lost to Follow-up|1|||
155556488|NCT03579966|561464225|FG000|Overall Study|Adverse Event|6|||
155556489|NCT03579966|561464225|FG000|Overall Study|Lost to Follow-up|4|||
155556490|NCT03579966|561464225|FG000|Overall Study|Physician Decision|10|||
155556491|NCT03579966|561464225|FG000|Overall Study|Pregnancy|1|||
155556492|NCT03579966|561464225|FG000|Overall Study|Withdrawal by Subject|16|||
155556493|NCT03579966|561464225|FG000|Overall Study|Study terminated by Sponsor|22|||
155556494|NCT03579966|561464225|FG000|Overall Study|Protocol Violation|1|||
155556495|NCT02408068|561464228|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
155556496|NCT02408068|561464229|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
155556497|NCT02408068|561464230|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
155556498|NCT02408068|561464231|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
155556499|NCT02408068|561464232|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
155556500|NCT02408068|561464233|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
155556501|NCT01340768|561464234|FG000|Overall Study|Lost to Follow-up|10|||
155556502|NCT01340768|561464235|FG001|Overall Study|Lost to Follow-up|4|||
155556503|NCT01340768|561464234|FG000|Overall Study|Withdrawal by Subject|5|||
155556504|NCT01340768|561464235|FG001|Overall Study|Withdrawal by Subject|1|||
155556505|NCT01340768|561464234|FG000|Overall Study|Other|2|||
155556506|NCT01340768|561464235|FG001|Overall Study|Other|0|||
155556507|NCT03052959|561464238|FG000|Overall Study|Lost to Follow-up|4|||
155556508|NCT03052959|561464239|FG001|Overall Study|Lost to Follow-up|5|||
155556509|NCT01524679|561464240|FG000|Overall Study|Lost to Follow-up|1|||
155556510|NCT01524679|561464241|FG001|Overall Study|Lost to Follow-up|4|||
155556511|NCT01524679|561464240|FG000|Overall Study|Withdrawal by Subject|4|||
155556512|NCT01524679|561464241|FG001|Overall Study|Withdrawal by Subject|4|||
155556513|NCT01524679|561464240|FG000|Overall Study|Adverse Event|9|||
155556514|NCT01524679|561464241|FG001|Overall Study|Adverse Event|0|||
155556515|NCT01524679|561464240|FG000|Overall Study|Protocol Violation|1|||
155556516|NCT01524679|561464241|FG001|Overall Study|Protocol Violation|0|||
155556517|NCT01524679|561464240|FG000|Overall Study|Lack of Efficacy|2|||
155556518|NCT01524679|561464241|FG001|Overall Study|Lack of Efficacy|0|||
155556519|NCT01524679|561464240|FG000|Overall Study|e.g.wish for children, relocation|6|||
155556520|NCT01524679|561464241|FG001|Overall Study|e.g.wish for children, relocation|1|||
155556521|NCT03321630|561464244|FG000|Overall Study|Adverse Event|1|||
155556522|NCT03321630|561464244|FG000|Overall Study|Investigator Discretion|2|||
155556523|NCT03321630|561464244|FG000|Overall Study|Withdrawal by Subject|1|||
155556524|NCT02149108|561464245|FG000|Overall Study|Not treated|1|||
155556525|NCT02149108|561464246|FG001|Overall Study|Not treated|2|||
155556526|NCT02149108|561464245|FG000|Overall Study|Progressive Disease (PD)|324|||
155556527|NCT02149108|561464246|FG001|Overall Study|Progressive Disease (PD)|318|||
155556528|NCT02149108|561464245|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
155556529|NCT02149108|561464246|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
155556530|NCT02149108|561464245|FG000|Overall Study|Other Adverse Event (AE)|8|||
155556531|NCT02149108|561464246|FG001|Overall Study|Other Adverse Event (AE)|18|||
155556532|NCT02149108|561464245|FG000|Overall Study|Other not defined above|0|||
155556533|NCT02149108|561464246|FG001|Overall Study|Other not defined above|2|||
155556534|NCT02149108|561464245|FG000|Overall Study|Refusal to continue trial medication|15|||
155556535|NCT02149108|561464246|FG001|Overall Study|Refusal to continue trial medication|11|||
155556536|NCT02149108|561464245|FG000|Overall Study|Lost to Follow-up|1|||
155556537|NCT02149108|561464246|FG001|Overall Study|Lost to Follow-up|0|||
155556538|NCT02325518|561464247|FG000|Overall Study|Adverse Event|4|||
155556539|NCT02325518|561464248|FG001|Overall Study|Adverse Event|1|||
155556540|NCT02325518|561464247|FG000|Overall Study|Physician Decision|0|||
155556541|NCT02325518|561464248|FG001|Overall Study|Physician Decision|1|||
155556542|NCT02325518|561464247|FG000|Overall Study|Withdrawal by Subject|0|||
155556543|NCT02325518|561464248|FG001|Overall Study|Withdrawal by Subject|1|||
155556544|NCT00987389|561464249|FG000|Overall Study|Ineligible|0|||
155556545|NCT00987389|561464250|FG001|Overall Study|Ineligible|3|||
155556546|NCT00987389|561464251|FG002|Overall Study|Ineligible|0|||
155556547|NCT00987389|561464252|FG003|Overall Study|Ineligible|0|||
155556548|NCT00987389|561464249|FG000|Overall Study|Lost to Follow-up|4|||
155556549|NCT00987389|561464250|FG001|Overall Study|Lost to Follow-up|1|||
155556550|NCT00987389|561464251|FG002|Overall Study|Lost to Follow-up|3|||
155556551|NCT00987389|561464252|FG003|Overall Study|Lost to Follow-up|1|||
155556552|NCT00987389|561464249|FG000|Overall Study|Withdrawal by Subject|4|||
155556553|NCT00987389|561464250|FG001|Overall Study|Withdrawal by Subject|3|||
155556554|NCT00987389|561464251|FG002|Overall Study|Withdrawal by Subject|2|||
155556555|NCT00987389|561464252|FG003|Overall Study|Withdrawal by Subject|1|||
155556556|NCT00987389|561464249|FG000|Overall Study|Withdrawn from Treatment|0|||
155556557|NCT00987389|561464250|FG001|Overall Study|Withdrawn from Treatment|1|||
155556558|NCT00987389|561464251|FG002|Overall Study|Withdrawn from Treatment|0|||
155556559|NCT00987389|561464252|FG003|Overall Study|Withdrawn from Treatment|0|||
155556560|NCT00987389|561464249|FG000|Overall Study|Multiple different reasons|1|||
155556561|NCT00987389|561464250|FG001|Overall Study|Multiple different reasons|0|||
155556562|NCT00987389|561464251|FG002|Overall Study|Multiple different reasons|3|||
155556563|NCT00987389|561464252|FG003|Overall Study|Multiple different reasons|1|||
155556564|NCT00289536|561464255|FG000|Period 3|Lost to Follow-up|0|||
155556565|NCT00289536|561464256|FG001|Period 3|Lost to Follow-up|0|||
155556566|NCT00289536|561464257|FG002|Period 3|Lost to Follow-up|1|||
155556567|NCT03246126|561464262|FG000|Overall Study|Withdrawal by Subject|0|||
155556568|NCT03246126|561464263|FG001|Overall Study|Withdrawal by Subject|1|||
155556569|NCT04465630|561464266|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
155556570|NCT04465630|561464266|FG000|Overall Study|Screen failure|8|||
155556571|NCT04465630|561464266|FG000|Overall Study|Baseline failure|16|||
155556572|NCT05297578|561464270|FG000|Overall Study|Lost to Follow-up|1|||
155556573|NCT05297578|561464271|FG001|Overall Study|Lost to Follow-up|1|||
155556574|NCT05297578|561464272|FG002|Overall Study|Lost to Follow-up|2|||
155556575|NCT05297578|561464273|FG003|Overall Study|Lost to Follow-up|1|||
155556576|NCT05297578|561464270|FG000|Overall Study|Death|0|||
155556577|NCT05297578|561464271|FG001|Overall Study|Death|1|||
155556578|NCT05297578|561464272|FG002|Overall Study|Death|0|||
155556579|NCT05297578|561464273|FG003|Overall Study|Death|0|||
155556580|NCT05297578|561464270|FG000|Overall Study|Withdrawal by Subject|0|||
155556581|NCT05297578|561464271|FG001|Overall Study|Withdrawal by Subject|0|||
155556582|NCT05297578|561464272|FG002|Overall Study|Withdrawal by Subject|1|||
155556583|NCT05297578|561464273|FG003|Overall Study|Withdrawal by Subject|0|||
155556584|NCT01169532|561464274|FG000|Overall Study|Withdrawal by Subject|1|||
155556585|NCT01156142|561464278|FG000|Overall Study|Withdrawal by Subject|8|||
155556586|NCT01156142|561464279|FG001|Overall Study|Withdrawal by Subject|6|||
155556587|NCT01156142|561464278|FG000|Overall Study|Ineligible|0|||
155556588|NCT01156142|561464279|FG001|Overall Study|Ineligible|1|||
155556589|NCT02643355|561464280|FG000|Overall Study|Withdrawal by Subject|1|||
155556590|NCT02643355|561464281|FG001|Overall Study|Withdrawal by Subject|3|||
155556591|NCT02643355|561464280|FG000|Overall Study|Protocol Violation|0|||
155556592|NCT02643355|561464281|FG001|Overall Study|Protocol Violation|2|||
155556593|NCT02701413|561464285|FG000|Overall Study|Withdrawal by Subject|7|||
155556594|NCT02701413|561464286|FG001|Overall Study|Withdrawal by Subject|11|||
155556595|NCT00985712|561464287|FG000|Overall Study|Adverse Event|0|||
155556596|NCT00985712|561464288|FG001|Overall Study|Adverse Event|1|||
155556597|NCT00985712|561464287|FG000|Overall Study|Lost to Follow-up|2|||
155556598|NCT00985712|561464288|FG001|Overall Study|Lost to Follow-up|2|||
155556599|NCT00985712|561464287|FG000|Overall Study|Protocol Violation|0|||
155556600|NCT00985712|561464288|FG001|Overall Study|Protocol Violation|1|||
155556601|NCT00985712|561464287|FG000|Overall Study|Withdrawal by Subject|4|||
155556602|NCT00985712|561464288|FG001|Overall Study|Withdrawal by Subject|1|||
155556603|NCT00985712|561464287|FG000|Overall Study|Sponsor decision|0|||
155556604|NCT00985712|561464288|FG001|Overall Study|Sponsor decision|2|||
155556605|NCT01875471|561464289|FG000|Overall Study|Adverse Event|0|||
155556606|NCT01875471|561464290|FG001|Overall Study|Adverse Event|1|||
155556607|NCT01875471|561464289|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
155556608|NCT01875471|561464290|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
155556609|NCT00257920|561464291|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
155556610|NCT00257920|561464292|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
155556611|NCT00257920|561464291|FG000|Period: Second Intervention|Other|2|||
155556612|NCT00257920|561464292|FG001|Period: Second Intervention|Other|1|||
155556613|NCT01346774|561464301|FG000|Overall Study|Did not take a single dose|6|||
155556614|NCT01346774|561464302|FG001|Overall Study|Did not take a single dose|4|||
155556615|NCT01346774|561464301|FG000|Overall Study|Lost to Follow-up|3|||
155556616|NCT01346774|561464302|FG001|Overall Study|Lost to Follow-up|4|||
155556617|NCT01346774|561464301|FG000|Overall Study|Withdrawal by Subject|1|||
155556618|NCT01346774|561464302|FG001|Overall Study|Withdrawal by Subject|4|||
155556619|NCT01346774|561464301|FG000|Overall Study|Protocol Violation|2|||
155556620|NCT01346774|561464302|FG001|Overall Study|Protocol Violation|3|||
155556621|NCT01346774|561464301|FG000|Overall Study|Adverse Event|1|||
155556622|NCT01346774|561464302|FG001|Overall Study|Adverse Event|2|||
155556623|NCT00448136|561464306|FG000|Overall Study|Death|3|||
155556624|NCT00448136|561464307|FG001|Overall Study|Death|8|||
155556625|NCT00448136|561464306|FG000|Overall Study|Investigator's decision (progression)|1|||
155556626|NCT00448136|561464307|FG001|Overall Study|Investigator's decision (progression)|0|||
155556627|NCT03407430|561464310|FG000|Washout|Protocol Violation|1|||
155556628|NCT03407430|561464311|FG001|Washout|Protocol Violation|0|||
155556629|NCT00922987|561464312|FG000|Overall Study|Insufficient clinical response|1|||
155556630|NCT00922987|561464312|FG000|Overall Study|Protocol Violation|2|||
155556631|NCT00922987|561464312|FG000|Overall Study|Adverse Event|1|||
155556632|NCT01334710|561464319|FG000|Overall Study|Trial was terminated|3|||
155556633|NCT00678041|561466387|FG000|Overall Study|Physician Decision|5|||
155556634|NCT00678041|561466388|FG001|Overall Study|Physician Decision|5|||
155556635|NCT02358343|561466389|FG000|Screening Intervention|Death|0|||
155556636|NCT02358343|561466390|FG001|Screening Intervention|Death|2|||
155556637|NCT02358343|561466391|FG002|Screening Intervention|Death|0|||
155556638|NCT02358343|561466392|FG003|Screening Intervention|Death|0|||
155556639|NCT02358343|561466393|FG004|Screening Intervention|Death|0|||
155556640|NCT02358343|561466389|FG000|Screening Intervention|Withdrawal by Subject|1|||
155556641|NCT02358343|561466390|FG001|Screening Intervention|Withdrawal by Subject|0|||
155556642|NCT02358343|561466391|FG002|Screening Intervention|Withdrawal by Subject|0|||
155556643|NCT02358343|561466392|FG003|Screening Intervention|Withdrawal by Subject|0|||
155556644|NCT02358343|561466393|FG004|Screening Intervention|Withdrawal by Subject|0|||
155556645|NCT02358343|561466389|FG000|Screening Intervention|Determined Ineligible|5|||
155556646|NCT02358343|561466390|FG001|Screening Intervention|Determined Ineligible|6|||
155556647|NCT02358343|561466391|FG002|Screening Intervention|Determined Ineligible|0|||
155556648|NCT02358343|561466392|FG003|Screening Intervention|Determined Ineligible|0|||
155556649|NCT02358343|561466393|FG004|Screening Intervention|Determined Ineligible|0|||
155556650|NCT02358343|561466389|FG000|Comparative Efficacy Trial / Observation|Death|0|||
155556651|NCT02358343|561466390|FG001|Comparative Efficacy Trial / Observation|Death|0|||
155556652|NCT02358343|561466391|FG002|Comparative Efficacy Trial / Observation|Death|2|||
155556653|NCT02358343|561466392|FG003|Comparative Efficacy Trial / Observation|Death|0|||
155556654|NCT02358343|561466393|FG004|Comparative Efficacy Trial / Observation|Death|0|||
155556655|NCT02358343|561466389|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
155556656|NCT02358343|561466390|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
155556657|NCT02358343|561466391|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
155556658|NCT02358343|561466392|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
155556659|NCT02358343|561466393|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
155556660|NCT02358343|561466389|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
155657764|NCT01153516|561840425|FG000|Overall Study|Both subjects refused surgery|2|||
155556661|NCT02358343|561466390|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
155556662|NCT02358343|561466391|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
155556663|NCT02358343|561466392|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
155556664|NCT02358343|561466393|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
155556665|NCT00577395|561466394|FG000|Overall Study|Study was terminated early by Sponsor|7|||
155556666|NCT00577395|561466395|FG001|Overall Study|Study was terminated early by Sponsor|6|||
155556667|NCT01700049|561466402|FG000|Overall Study|Withdrawal by Subject|1|||
155556668|NCT03084367|561466405|FG000|Overall Study|Lost to Follow-up|32|||
155556669|NCT03084367|561466405|FG000|Overall Study|Withdrawal by Subject|4|||
155556670|NCT03084367|561466405|FG000|Overall Study|Other|1|||
155556671|NCT01206101|561466406|FG000|Overall Study|Adverse Event|1|||
155556672|NCT01206101|561466407|FG001|Overall Study|Adverse Event|0|||
155556673|NCT01206101|561466406|FG000|Overall Study|Physician Decision|0|||
155556674|NCT01206101|561466407|FG001|Overall Study|Physician Decision|1|||
155556675|NCT01206101|561466406|FG000|Overall Study|Unclassified|1|||
155556676|NCT01206101|561466407|FG001|Overall Study|Unclassified|0|||
155556677|NCT00450619|561466418|FG000|Overall Study|refused treatment after randomization|2|||
155556678|NCT00450619|561466419|FG001|Overall Study|refused treatment after randomization|0|||
155556679|NCT00450619|561466418|FG000|Overall Study|did not progress; refused further trmt|1|||
155556680|NCT00450619|561466419|FG001|Overall Study|did not progress; refused further trmt|1|||
155556681|NCT00450619|561466418|FG000|Overall Study|Adverse Event|1|||
155556682|NCT00450619|561466419|FG001|Overall Study|Adverse Event|0|||
155556683|NCT03254602|561466420|FG000|Overall Study|Lost to Follow-up|4|||
155556684|NCT02963311|561466423|FG000|Overall Study|Withdrawal by Subject|1|||
155556685|NCT02963311|561466423|FG000|Overall Study|Screen Failure|4|||
155556686|NCT01691820|561466424|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
155556687|NCT01691820|561466425|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
155556688|NCT01691820|561466424|FG000|Overall Study|Migrated/moved from study area|7|||
155556689|NCT01691820|561466425|FG001|Overall Study|Migrated/moved from study area|4|||
155556690|NCT01691820|561466424|FG000|Overall Study|Lost to Follow-up|6|||
155556691|NCT01691820|561466425|FG001|Overall Study|Lost to Follow-up|17|||
155657765|NCT01153516|561840426|FG001|Overall Study|Both subjects refused surgery|0|||
155657766|NCT00209131|561840443|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
155657767|NCT00209131|561840444|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
155657768|NCT05360784|561840445|FG000|Overall Study|Discontinued|25|||
155657769|NCT05360784|561840446|FG001|Overall Study|Discontinued|11|||
155657770|NCT00437073|561840447|FG000|Overall Study|Sponsor Terminated Study|1|||
155657771|NCT00437073|561840448|FG001|Overall Study|Sponsor Terminated Study|0|||
155657772|NCT00437073|561840447|FG000|Overall Study|Physician Decision|0|||
155657773|NCT00437073|561840448|FG001|Overall Study|Physician Decision|1|||
155657774|NCT04875533|561840449|FG000|Overall Study|Adverse Event|6|||
155657775|NCT04875533|561840450|FG001|Overall Study|Adverse Event|4|||
155657776|NCT04875533|561840449|FG000|Overall Study|Protocol Violation|4|||
155657777|NCT04875533|561840450|FG001|Overall Study|Protocol Violation|0|||
155657778|NCT04875533|561840449|FG000|Overall Study|Withdrawal by Subject|8|||
155657779|NCT04875533|561840450|FG001|Overall Study|Withdrawal by Subject|5|||
155657780|NCT04875533|561840449|FG000|Overall Study|No longer meets eligibility criteria|1|||
155657781|NCT04875533|561840450|FG001|Overall Study|No longer meets eligibility criteria|0|||
155657782|NCT04875533|561840449|FG000|Overall Study|Other|0|||
155657783|NCT04875533|561840450|FG001|Overall Study|Other|2|||
155657784|NCT04918771|561840451|FG000|Overall Study|Withdrawal by Subject|4|||
155657785|NCT04918771|561840452|FG001|Overall Study|Withdrawal by Subject|5|||
155657786|NCT04918771|561840451|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
155657787|NCT04918771|561840452|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
155657788|NCT00539500|561840453|FG000|Overall Study|Disease Progression|1|||
155657789|NCT00539500|561840453|FG000|Overall Study|Lost to Follow-up|2|||
155657790|NCT02657343|561840456|FG000|Overall Study|Death|0|||
155657791|NCT02657343|561840457|FG001|Overall Study|Death|2|||
155657792|NCT02657343|561840458|FG002|Overall Study|Death|0|||
155657793|NCT02657343|561840459|FG003|Overall Study|Death|0|||
155657794|NCT02657343|561840460|FG004|Overall Study|Death|0|||
155657795|NCT02657343|561840461|FG005|Overall Study|Death|0|||
155657796|NCT02657343|561840456|FG000|Overall Study|Patient went to hospice|1|||
155657797|NCT02657343|561840457|FG001|Overall Study|Patient went to hospice|0|||
155657798|NCT02657343|561840458|FG002|Overall Study|Patient went to hospice|0|||
155657799|NCT02657343|561840459|FG003|Overall Study|Patient went to hospice|0|||
155657800|NCT02657343|561840460|FG004|Overall Study|Patient went to hospice|0|||
155657801|NCT02657343|561840461|FG005|Overall Study|Patient went to hospice|0|||
155657802|NCT02657343|561840456|FG000|Overall Study|Withdrawal by Subject|0|||
155657803|NCT02657343|561840457|FG001|Overall Study|Withdrawal by Subject|0|||
155657804|NCT02657343|561840458|FG002|Overall Study|Withdrawal by Subject|0|||
155556692|NCT01691820|561466424|FG000|Overall Study|Other (unspecified)|4|||
155556693|NCT01691820|561466425|FG001|Overall Study|Other (unspecified)|1|||
155556694|NCT04442490|561466427|FG000|Overall Study|Withdrawal by Subject|18|||
155556695|NCT04442490|561466428|FG001|Overall Study|Withdrawal by Subject|10|||
155556696|NCT04442490|561466427|FG000|Overall Study|Lost to Follow-up|7|||
155556697|NCT04442490|561466428|FG001|Overall Study|Lost to Follow-up|7|||
155657805|NCT02657343|561840459|FG003|Overall Study|Withdrawal by Subject|0|||
155657806|NCT02657343|561840460|FG004|Overall Study|Withdrawal by Subject|1|||
155657807|NCT02657343|561840461|FG005|Overall Study|Withdrawal by Subject|0|||
155657808|NCT01299961|561840464|FG000|Overall Study|Adverse Event|3|||
155657809|NCT01299961|561840464|FG000|Overall Study|Lack of Efficacy|2|||
155657810|NCT01299961|561840464|FG000|Overall Study|Lost to Follow-up|1|||
155657811|NCT02904096|561840465|FG000|Overall Study|Adverse Event|1|||
155657812|NCT02904096|561840466|FG001|Overall Study|Adverse Event|0|||
155657813|NCT02904096|561840465|FG000|Overall Study|Withdrawal by Subject|4|||
155556698|NCT04442490|561466427|FG000|Overall Study|Adverse Event|2|||
155556699|NCT04442490|561466428|FG001|Overall Study|Adverse Event|6|||
155556700|NCT04442490|561466427|FG000|Overall Study|Noncompliance|3|||
155556701|NCT04442490|561466428|FG001|Overall Study|Noncompliance|1|||
155556702|NCT04442490|561466427|FG000|Overall Study|Physician Decision|2|||
155556703|NCT04442490|561466428|FG001|Overall Study|Physician Decision|1|||
155556704|NCT04442490|561466427|FG000|Overall Study|Reason not Specified|2|||
155556705|NCT04442490|561466428|FG001|Overall Study|Reason not Specified|1|||
155556706|NCT04442490|561466427|FG000|Overall Study|Randomized but not Treated|3|||
155556707|NCT04442490|561466428|FG001|Overall Study|Randomized but not Treated|3|||
155556708|NCT02038907|561466434|FG000|Overall Study|Protocol Violation|0|||
155556709|NCT02038907|561466435|FG001|Overall Study|Protocol Violation|0|||
155556710|NCT02038907|561466436|FG002|Overall Study|Protocol Violation|0|||
155556711|NCT02038907|561466437|FG003|Overall Study|Protocol Violation|0|||
155556712|NCT02038907|561466438|FG004|Overall Study|Protocol Violation|0|||
155556713|NCT02038907|561466439|FG005|Overall Study|Protocol Violation|0|||
155556714|NCT02038907|561466440|FG006|Overall Study|Protocol Violation|0|||
155556715|NCT02038907|561466441|FG007|Overall Study|Protocol Violation|0|||
155556716|NCT02038907|561466442|FG008|Overall Study|Protocol Violation|0|||
155556717|NCT02038907|561466443|FG009|Overall Study|Protocol Violation|0|||
155556718|NCT02038907|561466444|FG010|Overall Study|Protocol Violation|1|||
155556719|NCT02038907|561466445|FG011|Overall Study|Protocol Violation|0|||
155556720|NCT02038907|561466446|FG012|Overall Study|Protocol Violation|0|||
155556721|NCT02038907|561466447|FG013|Overall Study|Protocol Violation|0|||
155556722|NCT02038907|561466434|FG000|Overall Study|Withdrawal by Subject|0|||
155556723|NCT02038907|561466435|FG001|Overall Study|Withdrawal by Subject|0|||
155556724|NCT02038907|561466436|FG002|Overall Study|Withdrawal by Subject|0|||
155556725|NCT02038907|561466437|FG003|Overall Study|Withdrawal by Subject|0|||
155556726|NCT02038907|561466438|FG004|Overall Study|Withdrawal by Subject|0|||
155556727|NCT02038907|561466439|FG005|Overall Study|Withdrawal by Subject|0|||
155556728|NCT02038907|561466440|FG006|Overall Study|Withdrawal by Subject|0|||
155556729|NCT02038907|561466441|FG007|Overall Study|Withdrawal by Subject|0|||
155556730|NCT02038907|561466442|FG008|Overall Study|Withdrawal by Subject|0|||
155556731|NCT02038907|561466443|FG009|Overall Study|Withdrawal by Subject|0|||
155657814|NCT02904096|561840466|FG001|Overall Study|Withdrawal by Subject|3|||
155657815|NCT02904096|561840465|FG000|Overall Study|Lost to Follow-up|10|||
155556732|NCT02038907|561466444|FG010|Overall Study|Withdrawal by Subject|1|||
155556733|NCT02038907|561466445|FG011|Overall Study|Withdrawal by Subject|0|||
155556734|NCT02038907|561466446|FG012|Overall Study|Withdrawal by Subject|0|||
155556735|NCT02038907|561466447|FG013|Overall Study|Withdrawal by Subject|0|||
155556736|NCT02618408|561466448|FG000|Overall Study|Withdrawal by Subject|1|||
155556737|NCT02618408|561466449|FG001|Overall Study|Withdrawal by Subject|0|||
155556738|NCT02618408|561466450|FG002|Overall Study|Withdrawal by Subject|4|||
155556739|NCT02618408|561466448|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
155556740|NCT02618408|561466449|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
155556741|NCT02618408|561466450|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
155556742|NCT02618408|561466448|FG000|Overall Study|Lost to Follow-up|4|||
155556743|NCT02618408|561466449|FG001|Overall Study|Lost to Follow-up|2|||
155556744|NCT02618408|561466450|FG002|Overall Study|Lost to Follow-up|6|||
155556745|NCT02618408|561466448|FG000|Overall Study|Adverse Event|4|||
155556746|NCT02618408|561466449|FG001|Overall Study|Adverse Event|0|||
155556747|NCT02618408|561466450|FG002|Overall Study|Adverse Event|10|||
155556748|NCT02618408|561466448|FG000|Overall Study|Physician Decision|1|||
155556749|NCT02618408|561466449|FG001|Overall Study|Physician Decision|1|||
155556750|NCT02618408|561466450|FG002|Overall Study|Physician Decision|2|||
155556751|NCT02618408|561466448|FG000|Overall Study|Protocol Violation|1|||
155556752|NCT02618408|561466449|FG001|Overall Study|Protocol Violation|1|||
155556753|NCT02618408|561466450|FG002|Overall Study|Protocol Violation|2|||
155556754|NCT02618408|561466448|FG000|Overall Study|Other, Multiple Categories|0|||
155556755|NCT02618408|561466449|FG001|Overall Study|Other, Multiple Categories|0|||
155556756|NCT02618408|561466450|FG002|Overall Study|Other, Multiple Categories|4|||
155556757|NCT01155024|561466451|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
155556758|NCT01155024|561466452|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
155556759|NCT01155024|561466451|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
155556760|NCT01155024|561466452|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
155556761|NCT01155024|561466451|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
155556762|NCT01155024|561466452|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
155556763|NCT00415194|561466458|FG000|Overall Study|Adverse Event|37|||
155556764|NCT00415194|561466459|FG001|Overall Study|Adverse Event|32|||
155556765|NCT00415194|561466458|FG000|Overall Study|Entry Criteria Not Met|4|||
155556766|NCT00415194|561466459|FG001|Overall Study|Entry Criteria Not Met|8|||
155556767|NCT00415194|561466458|FG000|Overall Study|Lost to Follow-up|1|||
155556768|NCT00415194|561466459|FG001|Overall Study|Lost to Follow-up|0|||
155556769|NCT00415194|561466458|FG000|Overall Study|Physician Decision|10|||
155556770|NCT00415194|561466459|FG001|Overall Study|Physician Decision|16|||
155556771|NCT00415194|561466458|FG000|Overall Study|Progressive Disease|180|||
155556772|NCT00415194|561466459|FG001|Overall Study|Progressive Disease|217|||
155556773|NCT00415194|561466458|FG000|Overall Study|Protocol Violation|4|||
155556774|NCT00415194|561466459|FG001|Overall Study|Protocol Violation|2|||
155556775|NCT00415194|561466458|FG000|Overall Study|Withdrawal by Subject|28|||
155556776|NCT00415194|561466459|FG001|Overall Study|Withdrawal by Subject|21|||
155556777|NCT00415194|561466458|FG000|Overall Study|Death Due to Study Disease|26|||
155556778|NCT00415194|561466459|FG001|Overall Study|Death Due to Study Disease|29|||
155556779|NCT00415194|561466458|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
155556780|NCT00415194|561466459|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
155556781|NCT00415194|561466458|FG000|Overall Study|Death Due to Procedural Related AE|0|||
155556782|NCT00415194|561466459|FG001|Overall Study|Death Due to Procedural Related AE|1|||
155556783|NCT00415194|561466458|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
155556784|NCT00415194|561466459|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
155556785|NCT01297465|561466460|FG000|Overall Study|Lack of Ovarian Response|1|||
155556786|NCT01297465|561466461|FG001|Overall Study|Lack of Ovarian Response|1|||
155556787|NCT01297465|561466460|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155556788|NCT01297465|561466461|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155556789|NCT01297465|561466460|FG000|Overall Study|No Oocytes Retrieved|1|||
155556790|NCT01297465|561466461|FG001|Overall Study|No Oocytes Retrieved|1|||
155556791|NCT01297465|561466460|FG000|Overall Study|Poor oocyte quality|0|||
155556792|NCT01297465|561466461|FG001|Overall Study|Poor oocyte quality|1|||
155556793|NCT01297465|561466460|FG000|Overall Study|No Fertilization|6|||
155556794|NCT01297465|561466461|FG001|Overall Study|No Fertilization|4|||
155556795|NCT01297465|561466460|FG000|Overall Study|All Embryos Discarded|0|||
155556796|NCT01297465|561466461|FG001|Overall Study|All Embryos Discarded|1|||
155556797|NCT01297465|561466460|FG000|Overall Study|Intention to Freeze all Embryos|0|||
155556798|NCT01297465|561466461|FG001|Overall Study|Intention to Freeze all Embryos|1|||
155556799|NCT00969540|561466462|FG000|Overall Study|Lost to Follow-up|1|||
155556800|NCT00969540|561466463|FG001|Overall Study|Lost to Follow-up|1|||
155556801|NCT01646138|561466464|FG000|Overall Study|Lost to Follow-up|0|||
155556802|NCT01646138|561466465|FG001|Overall Study|Lost to Follow-up|0|||
155556803|NCT01646138|561466466|FG002|Overall Study|Lost to Follow-up|0|||
155556804|NCT01646138|561466467|FG003|Overall Study|Lost to Follow-up|0|||
155556805|NCT01646138|561466468|FG004|Overall Study|Lost to Follow-up|2|||
155556806|NCT01683838|561466469|FG000|Overall Study|Adverse Event|12|||
155556807|NCT01683838|561466470|FG001|Overall Study|Adverse Event|2|||
155556808|NCT01683838|561466469|FG000|Overall Study|Protocol Violation|3|||
155556809|NCT01683838|561466470|FG001|Overall Study|Protocol Violation|1|||
155556810|NCT01683838|561466469|FG000|Overall Study|Withdrawal by Subject|6|||
155556811|NCT01683838|561466470|FG001|Overall Study|Withdrawal by Subject|5|||
155556812|NCT01683838|561466469|FG000|Overall Study|Lost to Follow-up|1|||
155556813|NCT01683838|561466470|FG001|Overall Study|Lost to Follow-up|1|||
155556814|NCT01683838|561466469|FG000|Overall Study|Other|4|||
155556815|NCT01683838|561466470|FG001|Overall Study|Other|3|||
155556816|NCT04049617|561466471|FG000|Overall Study|Adverse Event|0|||
155556817|NCT04049617|561466472|FG001|Overall Study|Adverse Event|0|||
155556818|NCT04049617|561466473|FG002|Overall Study|Adverse Event|0|||
155556819|NCT04049617|561466474|FG003|Overall Study|Adverse Event|1|||
155556820|NCT04049617|561466475|FG004|Overall Study|Adverse Event|0|||
155556821|NCT04049617|561466476|FG005|Overall Study|Adverse Event|0|||
155556822|NCT04049617|561466471|FG000|Overall Study|Death|0|||
155556823|NCT04049617|561466472|FG001|Overall Study|Death|0|||
155556824|NCT04049617|561466473|FG002|Overall Study|Death|0|||
155556825|NCT04049617|561466474|FG003|Overall Study|Death|0|||
155556826|NCT04049617|561466475|FG004|Overall Study|Death|0|||
155556827|NCT04049617|561466476|FG005|Overall Study|Death|1|||
155556828|NCT04049617|561466471|FG000|Overall Study|Lost to Follow-up|0|||
155556829|NCT04049617|561466472|FG001|Overall Study|Lost to Follow-up|0|||
155556830|NCT04049617|561466473|FG002|Overall Study|Lost to Follow-up|0|||
155556831|NCT04049617|561466474|FG003|Overall Study|Lost to Follow-up|1|||
155556832|NCT04049617|561466475|FG004|Overall Study|Lost to Follow-up|0|||
155556833|NCT04049617|561466476|FG005|Overall Study|Lost to Follow-up|0|||
155556834|NCT04049617|561466471|FG000|Overall Study|Withdrew consent|0|||
155556835|NCT04049617|561466472|FG001|Overall Study|Withdrew consent|0|||
155556836|NCT04049617|561466473|FG002|Overall Study|Withdrew consent|1|||
155556837|NCT04049617|561466474|FG003|Overall Study|Withdrew consent|0|||
155556838|NCT04049617|561466475|FG004|Overall Study|Withdrew consent|0|||
155556839|NCT04049617|561466476|FG005|Overall Study|Withdrew consent|0|||
155556840|NCT00801099|561466477|FG000|Overall Study|Lost to Follow-up|101|||
155556841|NCT04078126|561466478|FG000|Washout|Study put on hold due to COVID-19|0|||
155556842|NCT04078126|561466479|FG001|Washout|Study put on hold due to COVID-19|2|||
155556843|NCT04078126|561466478|FG000|Period 2|Study put on hold due to COVID-19|1|||
155556844|NCT04078126|561466479|FG001|Period 2|Study put on hold due to COVID-19|1|||
155556845|NCT02455050|561466480|FG000|Treatment Period 1|Lost to Follow-up|1|||
155556846|NCT02455050|561466481|FG001|Treatment Period 1|Lost to Follow-up|1|||
155556847|NCT02455050|561466482|FG002|Treatment Period 1|Lost to Follow-up|1|||
155556848|NCT02455050|561466483|FG003|Treatment Period 1|Lost to Follow-up|2|||
155556849|NCT02455050|561466480|FG000|Treatment Period 2|Lost to Follow-up|1|||
155556850|NCT02455050|561466481|FG001|Treatment Period 2|Lost to Follow-up|0|||
155556851|NCT02455050|561466482|FG002|Treatment Period 2|Lost to Follow-up|2|||
155556852|NCT02455050|561466483|FG003|Treatment Period 2|Lost to Follow-up|1|||
155556853|NCT03402750|561466484|FG000|Overall Study|Lost to Follow-up|2|||
155556854|NCT03402750|561466485|FG001|Overall Study|Lost to Follow-up|1|||
155556855|NCT02981303|561466486|FG000|Overall Study|Progressive Disease|17|||
155556856|NCT02981303|561466487|FG001|Overall Study|Progressive Disease|37|||
155556857|NCT02981303|561466486|FG000|Overall Study|Adverse Event|1|||
155556858|NCT02981303|561466487|FG001|Overall Study|Adverse Event|4|||
155556859|NCT02981303|561466486|FG000|Overall Study|Withdrawal by Subject|0|||
155556860|NCT02981303|561466487|FG001|Overall Study|Withdrawal by Subject|1|||
155556861|NCT01831765|561466488|FG000|Overall Study|Lack of Efficacy|1|||
155556862|NCT01831765|561466489|FG001|Overall Study|Lack of Efficacy|0|||
155556863|NCT01831765|561466490|FG002|Overall Study|Lack of Efficacy|0|||
155556864|NCT01831765|561466488|FG000|Overall Study|Other, sponsor withdrew subject|0|||
155556865|NCT01831765|561466489|FG001|Overall Study|Other, sponsor withdrew subject|1|||
155556866|NCT01831765|561466490|FG002|Overall Study|Other, sponsor withdrew subject|0|||
155556867|NCT01831765|561466488|FG000|Overall Study|Pregnancy|1|||
155556868|NCT01831765|561466489|FG001|Overall Study|Pregnancy|1|||
155556869|NCT01831765|561466490|FG002|Overall Study|Pregnancy|2|||
155556870|NCT01831765|561466488|FG000|Overall Study|Death|0|||
155556871|NCT01831765|561466489|FG001|Overall Study|Death|1|||
155556872|NCT01831765|561466490|FG002|Overall Study|Death|1|||
155556873|NCT01831765|561466488|FG000|Overall Study|Other, site closed|1|||
155556874|NCT01831765|561466489|FG001|Overall Study|Other, site closed|1|||
155556875|NCT01831765|561466490|FG002|Overall Study|Other, site closed|0|||
155556876|NCT01831765|561466488|FG000|Overall Study|Adverse Event|5|||
155556877|NCT01831765|561466489|FG001|Overall Study|Adverse Event|3|||
155556878|NCT01831765|561466490|FG002|Overall Study|Adverse Event|3|||
155556879|NCT01831765|561466488|FG000|Overall Study|Withdrawal by Subject|22|||
155556880|NCT01831765|561466489|FG001|Overall Study|Withdrawal by Subject|7|||
155556881|NCT01831765|561466490|FG002|Overall Study|Withdrawal by Subject|17|||
155556882|NCT01831765|561466488|FG000|Overall Study|Withdrawal criteria|12|||
155556883|NCT01831765|561466489|FG001|Overall Study|Withdrawal criteria|10|||
155556884|NCT01831765|561466490|FG002|Overall Study|Withdrawal criteria|16|||
155556885|NCT01831765|561466488|FG000|Overall Study|Lost to Follow-up|2|||
155556886|NCT01831765|561466489|FG001|Overall Study|Lost to Follow-up|3|||
155556887|NCT01831765|561466490|FG002|Overall Study|Lost to Follow-up|3|||
155556888|NCT00706511|561466497|FG000|Overall Study|Withdrawal by Subject|1|||
155556889|NCT00706511|561466498|FG001|Overall Study|Withdrawal by Subject|0|||
155556890|NCT00706511|561466499|FG002|Overall Study|Withdrawal by Subject|0|||
155556891|NCT00706511|561466500|FG003|Overall Study|Withdrawal by Subject|0|||
155556892|NCT02116608|561466505|FG000|Overall Study|Lost to Follow-up|0|||
155556893|NCT02116608|561466506|FG001|Overall Study|Lost to Follow-up|0|||
155556894|NCT02116608|561466507|FG002|Overall Study|Lost to Follow-up|1|||
155556895|NCT02116608|561466505|FG000|Overall Study|Physician Decision|0|||
155556896|NCT02116608|561466506|FG001|Overall Study|Physician Decision|1|||
155556897|NCT02116608|561466507|FG002|Overall Study|Physician Decision|0|||
155556898|NCT02116608|561466505|FG000|Overall Study|Death|0|||
155556899|NCT02116608|561466506|FG001|Overall Study|Death|1|||
155556900|NCT02116608|561466507|FG002|Overall Study|Death|0|||
155556901|NCT00988442|561466508|FG000|Overall Study|Death|1|||
155556902|NCT00988442|561466509|FG001|Overall Study|Death|2|||
155556903|NCT00988442|561466508|FG000|Overall Study|Lost to Follow-up|0|||
155556904|NCT00988442|561466509|FG001|Overall Study|Lost to Follow-up|1|||
155556905|NCT00988442|561466508|FG000|Overall Study|Early Study Closure|29|||
155556906|NCT00988442|561466509|FG001|Overall Study|Early Study Closure|25|||
155556907|NCT04620135|561466512|FG000|Study Completion|Adverse Event|2|||
155556908|NCT04620135|561466513|FG001|Study Completion|Adverse Event|3|||
155556909|NCT04620135|561466512|FG000|Study Completion|Withdrawal by Subject|2|||
155556910|NCT04620135|561466513|FG001|Study Completion|Withdrawal by Subject|0|||
155556911|NCT02272634|561466515|FG000|Overall Study|Adverse Event|1|||
155556912|NCT02272634|561466516|FG001|Overall Study|Adverse Event|0|||
155556913|NCT02272634|561466517|FG002|Overall Study|Adverse Event|0|||
155556914|NCT02272634|561466515|FG000|Overall Study|Protocol Violation|0|||
155556915|NCT02272634|561466516|FG001|Overall Study|Protocol Violation|0|||
155556916|NCT02272634|561466517|FG002|Overall Study|Protocol Violation|1|||
155556917|NCT02272634|561466515|FG000|Overall Study|Withdrawal by Subject|0|||
155556918|NCT02272634|561466516|FG001|Overall Study|Withdrawal by Subject|1|||
155556919|NCT02272634|561466517|FG002|Overall Study|Withdrawal by Subject|0|||
155556920|NCT04647721|561466518|FG000|Overall Study|Withdrawal by Subject|0|||
155556921|NCT04647721|561466519|FG001|Overall Study|Withdrawal by Subject|2|||
155556922|NCT04647721|561466518|FG000|Overall Study|Lost to Follow-up|2|||
155556923|NCT04647721|561466519|FG001|Overall Study|Lost to Follow-up|0|||
155556924|NCT01974440|561466522|FG000|Overall Study|Lost to Follow-up|7|||
155556925|NCT01974440|561466523|FG001|Overall Study|Lost to Follow-up|7|||
155556926|NCT01974440|561466522|FG000|Overall Study|Withdrawal by Subject|24|||
155556927|NCT01974440|561466523|FG001|Overall Study|Withdrawal by Subject|20|||
155556928|NCT01974440|561466522|FG000|Overall Study|Sponsor decision|109|||
155556929|NCT01974440|561466523|FG001|Overall Study|Sponsor decision|110|||
155556930|NCT00762437|561466524|FG000|Overall Study|Lost to Follow-up|7|||
155556931|NCT00762437|561466524|FG000|Overall Study|Missed final study visit|11|||
155556932|NCT00762437|561466524|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
155556933|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
155556934|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
155556935|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
155556936|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
155556937|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
155556938|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
155556939|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
155556940|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
155556941|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
155556942|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
155556943|NCT04771403|561466525|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
155556944|NCT04771403|561466526|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
155556945|NCT04771403|561466525|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
155556946|NCT04771403|561466526|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
155556947|NCT04771403|561466525|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
155556948|NCT04771403|561466526|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
155556949|NCT00857259|561466527|FG000|Overall Study|Protocol Violation|1|||
155556950|NCT00857259|561466528|FG001|Overall Study|Protocol Violation|0|||
155556951|NCT00857259|561466529|FG002|Overall Study|Protocol Violation|1|||
155556952|NCT02138136|561466530|FG000|Overall Study|Protocol Violation|4|||
155556953|NCT02138136|561466530|FG000|Overall Study|Physician Decision|7|||
155556954|NCT02138136|561466530|FG000|Overall Study|Lack of Efficacy|35|||
155556955|NCT02138136|561466530|FG000|Overall Study|Pregnancy|2|||
155556956|NCT02138136|561466530|FG000|Overall Study|Adverse Event|18|||
155556957|NCT02138136|561466530|FG000|Overall Study|Withdrawal by Subject|36|||
155556958|NCT02138136|561466530|FG000|Overall Study|Lost to Follow-up|32|||
155556959|NCT02138136|561466530|FG000|Overall Study|Withdrawn by Sponsor|5|||
155556960|NCT01660334|561466535|FG000|Overall Study|Lost to Follow-up|1|||
155556961|NCT00988065|561466536|FG000|Overall Study|Adverse Event|4|||
155556962|NCT00988065|561466537|FG001|Overall Study|Adverse Event|10|||
155556963|NCT00988065|561466538|FG002|Overall Study|Adverse Event|2|||
155556964|NCT00988065|561466536|FG000|Overall Study|Lost to Follow-up|1|||
155556965|NCT00988065|561466537|FG001|Overall Study|Lost to Follow-up|2|||
155556966|NCT00988065|561466538|FG002|Overall Study|Lost to Follow-up|2|||
155556967|NCT00988065|561466536|FG000|Overall Study|Subject withdrew consent|3|||
155556968|NCT00988065|561466537|FG001|Overall Study|Subject withdrew consent|5|||
155556969|NCT00988065|561466538|FG002|Overall Study|Subject withdrew consent|2|||
155556970|NCT00988065|561466536|FG000|Overall Study|Noncompliance with protocol|5|||
155556971|NCT00988065|561466537|FG001|Overall Study|Noncompliance with protocol|6|||
155556972|NCT00988065|561466538|FG002|Overall Study|Noncompliance with protocol|9|||
155556973|NCT01640873|561466541|FG000|Overall Study|Protocol Violation|2|||
155556974|NCT01640873|561466542|FG001|Overall Study|Protocol Violation|1|||
155556975|NCT02749292|561466543|FG000|Overall Study|Physician Decision|1|||
155556976|NCT02749292|561466544|FG001|Overall Study|Physician Decision|0|||
155556977|NCT02749292|561466543|FG000|Overall Study|Withdrawal by Subject|5|||
155556978|NCT02749292|561466544|FG001|Overall Study|Withdrawal by Subject|7|||
155556979|NCT02749292|561466543|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
155556980|NCT02749292|561466544|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
155556981|NCT02749292|561466543|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
155556982|NCT02749292|561466544|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
155556983|NCT02749292|561466543|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
155556984|NCT02749292|561466544|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
155556985|NCT02749292|561466543|FG000|Overall Study|Adverse Event|4|||
155556986|NCT02749292|561466544|FG001|Overall Study|Adverse Event|1|||
155556987|NCT02749292|561466543|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
155556988|NCT02749292|561466544|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
155556989|NCT02749292|561466543|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
155556990|NCT02749292|561466544|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
155556991|NCT02749292|561466543|FG000|Overall Study|Requiring glucocorticoids|0|||
155556992|NCT02749292|561466544|FG001|Overall Study|Requiring glucocorticoids|3|||
155556993|NCT02749292|561466543|FG000|Overall Study|Cancer|1|||
155556994|NCT02749292|561466544|FG001|Overall Study|Cancer|0|||
155556995|NCT02458092|561466545|FG000|Overall Study|Withdrawal by Subject|1|||
155556996|NCT02458092|561466546|FG001|Overall Study|Withdrawal by Subject|0|||
155556997|NCT00876018|561466547|FG000|Overall Study|Lost to Follow-up|0|||
155556998|NCT00876018|561466548|FG001|Overall Study|Lost to Follow-up|1|||
155556999|NCT00876018|561466549|FG002|Overall Study|Lost to Follow-up|1|||
155557000|NCT00876018|561466547|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
155557001|NCT00876018|561466548|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
155557002|NCT00876018|561466549|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
155557003|NCT00456495|561466553|FG000|Overall Study|Physician Decision|2|||
155557004|NCT01301508|561466554|FG000|Overall Study|Withdrawal by Subject|1|||
155557005|NCT01301508|561466555|FG001|Overall Study|Withdrawal by Subject|2|||
155557006|NCT01301508|561466554|FG000|Overall Study|Lost to Follow-up|0|||
155557007|NCT01301508|561466555|FG001|Overall Study|Lost to Follow-up|1|||
155557008|NCT01300923|561466556|FG000|Overall Study|Physician Decision|0|||
155557009|NCT01300923|561466557|FG001|Overall Study|Physician Decision|2|||
155557010|NCT02707861|561466560|FG000|Overall Study|Went onto commercial drug|30|||
155557011|NCT02707861|561466561|FG001|Overall Study|Went onto commercial drug|23|||
155557012|NCT02707861|561466560|FG000|Overall Study|Adverse Event|2|||
155557013|NCT02707861|561466561|FG001|Overall Study|Adverse Event|3|||
155557014|NCT02707861|561466560|FG000|Overall Study|Death|5|||
155557015|NCT02707861|561466561|FG001|Overall Study|Death|2|||
155557016|NCT02707861|561466560|FG000|Overall Study|Lack of Efficacy|0|||
155557017|NCT02707861|561466561|FG001|Overall Study|Lack of Efficacy|2|||
155557018|NCT02707861|561466560|FG000|Overall Study|Physician Decision|1|||
155557019|NCT02707861|561466561|FG001|Overall Study|Physician Decision|4|||
155557020|NCT02707861|561466560|FG000|Overall Study|Withdrawal by Subject|2|||
155557021|NCT02707861|561466561|FG001|Overall Study|Withdrawal by Subject|1|||
155557022|NCT02707861|561466560|FG000|Overall Study|Lost to Follow-up|1|||
155557023|NCT02707861|561466561|FG001|Overall Study|Lost to Follow-up|3|||
155557024|NCT01940497|561466562|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
155557025|NCT01940497|561466563|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
155557026|NCT01940497|561466562|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
155557027|NCT01940497|561466563|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
155557028|NCT01940497|561466562|FG000|Overall Study|Violation of Entry Criteria|1|||
155557029|NCT01940497|561466563|FG001|Overall Study|Violation of Entry Criteria|1|||
155557030|NCT01940497|561466562|FG000|Overall Study|Refused Treatment|1|||
155557031|NCT01940497|561466563|FG001|Overall Study|Refused Treatment|3|||
155557032|NCT01940497|561466562|FG000|Overall Study|Withdrew Consent|6|||
155557033|NCT01940497|561466563|FG001|Overall Study|Withdrew Consent|2|||
155557034|NCT01940497|561466562|FG000|Overall Study|Administrative/Other|1|||
155557035|NCT01940497|561466563|FG001|Overall Study|Administrative/Other|1|||
155557036|NCT03123861|561466564|FG000|Overall Study|Protocol Violation|1|||
155557037|NCT03123861|561466565|FG001|Overall Study|Protocol Violation|1|||
155557038|NCT03123861|561466564|FG000|Overall Study|Withdrawal by Subject|2|||
155557039|NCT03123861|561466565|FG001|Overall Study|Withdrawal by Subject|2|||
155557040|NCT00369382|561466568|FG000|Overall Study|Death|0|||
155557041|NCT00369382|561466569|FG001|Overall Study|Death|2|||
155557042|NCT00369382|561466568|FG000|Overall Study|Physician Decision|2|||
155557043|NCT00369382|561466569|FG001|Overall Study|Physician Decision|1|||
155557044|NCT00369382|561466568|FG000|Overall Study|Withdrawal by Subject|5|||
155557045|NCT00369382|561466569|FG001|Overall Study|Withdrawal by Subject|0|||
155557046|NCT00369382|561466568|FG000|Overall Study|Randomized, not treated|2|||
155557047|NCT00369382|561466569|FG001|Overall Study|Randomized, not treated|0|||
155557048|NCT00369382|561466568|FG000|Overall Study|Other|1|||
155557049|NCT00369382|561466569|FG001|Overall Study|Other|0|||
155557050|NCT04221789|561468739|FG000|Overall Study|deviation from protoco|22|||
155557051|NCT04221789|561468740|FG001|Overall Study|deviation from protoco|8|||
155557052|NCT06218823|561468751|FG000|Overall Study|Death|3|||
155557053|NCT06218823|561468752|FG001|Overall Study|Death|0|||
155557054|NCT06218823|561468751|FG000|Overall Study|Lost to Follow-up|0|||
155557055|NCT06218823|561468752|FG001|Overall Study|Lost to Follow-up|2|||
155557056|NCT06077487|561468753|FG000|Overall Study|Withdrawal by Subject|0|||
155557057|NCT06077487|561468754|FG001|Overall Study|Withdrawal by Subject|1|||
155557058|NCT05101486|561468755|FG000|Overall Study|Death|1|||
155557059|NCT05101486|561468756|FG001|Overall Study|Death|0|||
155557060|NCT05101486|561468757|FG002|Overall Study|Death|1|||
155557061|NCT05101486|561468755|FG000|Overall Study|Lost to Follow-up|12|||
155557062|NCT05101486|561468756|FG001|Overall Study|Lost to Follow-up|8|||
155557063|NCT05101486|561468757|FG002|Overall Study|Lost to Follow-up|17|||
155557064|NCT05101486|561468755|FG000|Overall Study|Physician Decision|1|||
155557065|NCT05101486|561468756|FG001|Overall Study|Physician Decision|0|||
155557066|NCT05101486|561468757|FG002|Overall Study|Physician Decision|0|||
155557067|NCT05101486|561468755|FG000|Overall Study|Protocol Violation|0|||
155557068|NCT05101486|561468756|FG001|Overall Study|Protocol Violation|0|||
155557069|NCT05101486|561468757|FG002|Overall Study|Protocol Violation|1|||
155557070|NCT05101486|561468755|FG000|Overall Study|Withdrawal by Subject|5|||
155557071|NCT05101486|561468756|FG001|Overall Study|Withdrawal by Subject|2|||
155557072|NCT05101486|561468757|FG002|Overall Study|Withdrawal by Subject|4|||
155557073|NCT05101486|561468755|FG000|Overall Study|Randomized but not vaccinated|1|||
155557074|NCT05101486|561468756|FG001|Overall Study|Randomized but not vaccinated|1|||
155557075|NCT05101486|561468757|FG002|Overall Study|Randomized but not vaccinated|1|||
155557076|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
155557077|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
155557078|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
155557079|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
155557080|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
155557081|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
155557082|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
155557083|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
155557084|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
155557085|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
155557086|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
155557087|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
155557088|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
155557089|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
155557090|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
155557091|NCT02788045|561468758|FG000|Main Study (Up to Week 72)|Other|3|||
155557092|NCT02788045|561468759|FG001|Main Study (Up to Week 72)|Other|0|||
155557093|NCT02788045|561468760|FG002|Main Study (Up to Week 72)|Other|0|||
155557094|NCT02788045|561468758|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
155557095|NCT02788045|561468759|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
155557096|NCT02788045|561468760|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
155557097|NCT02788045|561468758|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
155557098|NCT02788045|561468759|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
155557099|NCT02788045|561468760|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
155557100|NCT02788045|561468758|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
155557101|NCT02788045|561468759|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
155557102|NCT02788045|561468760|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
155557103|NCT04394351|561468761|FG000|Part A (16 Weeks)|Adverse Event|1|||
155657816|NCT02904096|561840466|FG001|Overall Study|Lost to Follow-up|17|||
155657817|NCT02904096|561840465|FG000|Overall Study|Non-compliant|3|||
155657818|NCT02904096|561840466|FG001|Overall Study|Non-compliant|1|||
155657819|NCT02904096|561840465|FG000|Overall Study|Sponsor instructed|1|||
155657820|NCT02904096|561840466|FG001|Overall Study|Sponsor instructed|0|||
155657821|NCT03238196|561840468|FG000|Overall Study|Adverse Event|3|||
155657822|NCT03238196|561840469|FG001|Overall Study|Adverse Event|0|||
155657823|NCT03238196|561840470|FG002|Overall Study|Adverse Event|2|||
155657824|NCT03238196|561840471|FG003|Overall Study|Adverse Event|2|||
155657825|NCT03238196|561840468|FG000|Overall Study|Withdrawal by Subject|4|||
155557104|NCT04394351|561468762|FG001|Part A (16 Weeks)|Adverse Event|0|||
155557105|NCT04394351|561468763|FG002|Part A (16 Weeks)|Adverse Event|0|||
155557106|NCT04394351|561468764|FG003|Part A (16 Weeks)|Adverse Event|0|||
155557107|NCT04394351|561468765|FG004|Part A (16 Weeks)|Adverse Event|0|||
155557108|NCT04394351|561468766|FG005|Part A (16 Weeks)|Adverse Event|0|||
155557109|NCT04394351|561468767|FG006|Part A (16 Weeks)|Adverse Event|0|||
155557110|NCT04394351|561468768|FG007|Part A (16 Weeks)|Adverse Event|0|||
155557111|NCT04394351|561468761|FG000|Part A (16 Weeks)|Physician Decision|0|||
155557112|NCT04394351|561468762|FG001|Part A (16 Weeks)|Physician Decision|1|||
155557113|NCT04394351|561468763|FG002|Part A (16 Weeks)|Physician Decision|0|||
155557114|NCT04394351|561468764|FG003|Part A (16 Weeks)|Physician Decision|0|||
155557115|NCT04394351|561468765|FG004|Part A (16 Weeks)|Physician Decision|0|||
155557116|NCT04394351|561468766|FG005|Part A (16 Weeks)|Physician Decision|0|||
155557117|NCT04394351|561468767|FG006|Part A (16 Weeks)|Physician Decision|0|||
155557118|NCT04394351|561468768|FG007|Part A (16 Weeks)|Physician Decision|0|||
155557119|NCT04394351|561468761|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557120|NCT04394351|561468762|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
155557121|NCT04394351|561468763|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557122|NCT04394351|561468764|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557123|NCT04394351|561468765|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557124|NCT04394351|561468766|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557125|NCT04394351|561468767|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557126|NCT04394351|561468768|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
155557127|NCT04394351|561468761|FG000|Part B (36 Weeks)|Adverse Event|0|||
155557128|NCT04394351|561468762|FG001|Part B (36 Weeks)|Adverse Event|0|||
155557129|NCT04394351|561468763|FG002|Part B (36 Weeks)|Adverse Event|0|||
155557130|NCT04394351|561468764|FG003|Part B (36 Weeks)|Adverse Event|0|||
155557131|NCT04394351|561468765|FG004|Part B (36 Weeks)|Adverse Event|0|||
155557132|NCT04394351|561468766|FG005|Part B (36 Weeks)|Adverse Event|0|||
155557133|NCT04394351|561468767|FG006|Part B (36 Weeks)|Adverse Event|1|||
155557134|NCT04394351|561468768|FG007|Part B (36 Weeks)|Adverse Event|0|||
155557135|NCT04394351|561468761|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557136|NCT04394351|561468762|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557137|NCT04394351|561468763|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557138|NCT04394351|561468764|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557139|NCT04394351|561468765|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557140|NCT04394351|561468766|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557141|NCT04394351|561468767|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
155557142|NCT04394351|561468768|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
155557143|NCT04394351|561468761|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557144|NCT04394351|561468762|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557145|NCT04394351|561468763|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557146|NCT04394351|561468764|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557147|NCT04394351|561468765|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557148|NCT04394351|561468766|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557149|NCT04394351|561468767|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
155557150|NCT04394351|561468768|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
155557151|NCT04394351|561468761|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557152|NCT04394351|561468762|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557153|NCT04394351|561468763|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557154|NCT04394351|561468764|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557155|NCT04394351|561468765|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557156|NCT04394351|561468766|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557157|NCT04394351|561468767|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155557158|NCT04394351|561468768|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
155557159|NCT04394351|561468761|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557160|NCT04394351|561468762|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557161|NCT04394351|561468763|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557162|NCT04394351|561468764|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557163|NCT04394351|561468765|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155657826|NCT03238196|561840469|FG001|Overall Study|Withdrawal by Subject|1|||
155657827|NCT03238196|561840470|FG002|Overall Study|Withdrawal by Subject|1|||
155657828|NCT03238196|561840471|FG003|Overall Study|Withdrawal by Subject|0|||
155657829|NCT03238196|561840468|FG000|Overall Study|Disease progression|14|||
155657830|NCT03238196|561840469|FG001|Overall Study|Disease progression|2|||
155657831|NCT03238196|561840470|FG002|Overall Study|Disease progression|3|||
155657832|NCT03238196|561840471|FG003|Overall Study|Disease progression|2|||
155657833|NCT03238196|561840468|FG000|Overall Study|Still on treatment|1|||
155657834|NCT03238196|561840469|FG001|Overall Study|Still on treatment|0|||
155657835|NCT03238196|561840470|FG002|Overall Study|Still on treatment|0|||
155657836|NCT03238196|561840471|FG003|Overall Study|Still on treatment|0|||
155657837|NCT04562090|561840472|FG000|Overall Study|Withdrawal by Subject|3|||
155657838|NCT04562090|561840473|FG001|Overall Study|Withdrawal by Subject|4|||
155657839|NCT04562090|561840472|FG000|Overall Study|Protocol Violation|2|||
155657840|NCT04562090|561840473|FG001|Overall Study|Protocol Violation|0|||
155657841|NCT04562090|561840472|FG000|Overall Study|Lack of Efficacy|0|||
155657842|NCT04562090|561840473|FG001|Overall Study|Lack of Efficacy|1|||
155657843|NCT04562090|561840472|FG000|Overall Study|Adverse Event|1|||
155657844|NCT04562090|561840473|FG001|Overall Study|Adverse Event|4|||
155657845|NCT04562090|561840472|FG000|Overall Study|Miscellaneous|0|||
155657846|NCT04562090|561840473|FG001|Overall Study|Miscellaneous|3|||
155657847|NCT00847730|561840474|FG000|Overall Study|Multiple interruptions in therapy|8|||
155657848|NCT04938427|561840477|FG000|Overall Study|Adverse Event|5|||
155657849|NCT04938427|561840478|FG001|Overall Study|Adverse Event|19|||
155557164|NCT04394351|561468766|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557165|NCT04394351|561468767|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
155557166|NCT04394351|561468768|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
155557167|NCT00144781|561468769|FG000|Overall Study|Adverse Event|0|||
155557168|NCT00144781|561468770|FG001|Overall Study|Adverse Event|1|||
155557169|NCT00144781|561468771|FG002|Overall Study|Adverse Event|0|||
155557170|NCT00144781|561468772|FG003|Overall Study|Adverse Event|0|||
155557171|NCT00144781|561468769|FG000|Overall Study|Non-compliant|0|||
155557172|NCT00144781|561468770|FG001|Overall Study|Non-compliant|1|||
155557173|NCT00144781|561468771|FG002|Overall Study|Non-compliant|0|||
155557174|NCT00144781|561468772|FG003|Overall Study|Non-compliant|0|||
155557175|NCT02068092|561468773|FG000|Overall Study|Physician Decision|2|||
155557176|NCT02068092|561468773|FG000|Overall Study|Adverse Event|2|||
155557177|NCT02068092|561468773|FG000|Overall Study|Lost to Follow-up|4|||
155557178|NCT02068092|561468773|FG000|Overall Study|Withdrawal by Subject|2|||
155557179|NCT03696953|561468774|FG000|Overall Study|Withdrawal by Subject|6|||
155557180|NCT03696953|561468775|FG001|Overall Study|Withdrawal by Subject|1|||
155557181|NCT03696953|561468774|FG000|Overall Study|missed GBS swabs|2|||
155557182|NCT03696953|561468775|FG001|Overall Study|missed GBS swabs|2|||
155557183|NCT03696953|561468774|FG000|Overall Study|lost study bottle containing capsules|2|||
155557184|NCT03696953|561468775|FG001|Overall Study|lost study bottle containing capsules|0|||
155557185|NCT03696953|561468774|FG000|Overall Study|Premature birth|1|||
155557186|NCT03696953|561468775|FG001|Overall Study|Premature birth|4|||
155557187|NCT03696953|561468774|FG000|Overall Study|Gestational hypertension|1|||
155557188|NCT03696953|561468775|FG001|Overall Study|Gestational hypertension|1|||
155557189|NCT03696953|561468774|FG000|Overall Study|Gestational diabetes|2|||
155557190|NCT03696953|561468775|FG001|Overall Study|Gestational diabetes|1|||
155557191|NCT03696953|561468774|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
155557192|NCT03696953|561468775|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
155557193|NCT03696953|561468774|FG000|Overall Study|Changed prenatal provider|1|||
155557194|NCT03696953|561468775|FG001|Overall Study|Changed prenatal provider|1|||
155557195|NCT03502707|561468776|FG000|Overall Study|Adverse Event|0|||
155557196|NCT03502707|561468777|FG001|Overall Study|Adverse Event|0|||
155557197|NCT03502707|561468778|FG002|Overall Study|Adverse Event|0|||
155557198|NCT03502707|561468779|FG003|Overall Study|Adverse Event|0|||
155557199|NCT03502707|561468780|FG004|Overall Study|Adverse Event|0|||
155557200|NCT03502707|561468781|FG005|Overall Study|Adverse Event|0|||
155557201|NCT03502707|561468782|FG006|Overall Study|Adverse Event|0|||
155557202|NCT03502707|561468783|FG007|Overall Study|Adverse Event|0|||
155557203|NCT03502707|561468784|FG008|Overall Study|Adverse Event|0|||
155557204|NCT03502707|561468785|FG009|Overall Study|Adverse Event|0|||
155557205|NCT03502707|561468786|FG010|Overall Study|Adverse Event|0|||
155557206|NCT03502707|561468787|FG011|Overall Study|Adverse Event|0|||
155557207|NCT03502707|561468788|FG012|Overall Study|Adverse Event|0|||
155557208|NCT03502707|561468789|FG013|Overall Study|Adverse Event|0|||
155557209|NCT03502707|561468790|FG014|Overall Study|Adverse Event|0|||
155557210|NCT03502707|561468791|FG015|Overall Study|Adverse Event|1|||
155557211|NCT03502707|561468792|FG016|Overall Study|Adverse Event|5|||
155557212|NCT03502707|561468793|FG017|Overall Study|Adverse Event|0|||
155557213|NCT03502707|561468776|FG000|Overall Study|Death|0|||
155557214|NCT03502707|561468777|FG001|Overall Study|Death|0|||
155557215|NCT03502707|561468778|FG002|Overall Study|Death|0|||
155557216|NCT03502707|561468779|FG003|Overall Study|Death|1|||
155557217|NCT03502707|561468780|FG004|Overall Study|Death|0|||
155557218|NCT03502707|561468781|FG005|Overall Study|Death|0|||
155557219|NCT03502707|561468782|FG006|Overall Study|Death|0|||
155557220|NCT03502707|561468783|FG007|Overall Study|Death|0|||
155557221|NCT03502707|561468784|FG008|Overall Study|Death|1|||
155557222|NCT03502707|561468785|FG009|Overall Study|Death|1|||
155557223|NCT03502707|561468786|FG010|Overall Study|Death|0|||
155557224|NCT03502707|561468787|FG011|Overall Study|Death|0|||
155557225|NCT03502707|561468788|FG012|Overall Study|Death|1|||
155557226|NCT03502707|561468789|FG013|Overall Study|Death|0|||
155557227|NCT03502707|561468790|FG014|Overall Study|Death|0|||
155557228|NCT03502707|561468791|FG015|Overall Study|Death|1|||
155557229|NCT03502707|561468792|FG016|Overall Study|Death|0|||
155557230|NCT03502707|561468793|FG017|Overall Study|Death|0|||
155557231|NCT03502707|561468776|FG000|Overall Study|Lost to Follow-up|0|||
155557232|NCT03502707|561468777|FG001|Overall Study|Lost to Follow-up|0|||
155557233|NCT03502707|561468778|FG002|Overall Study|Lost to Follow-up|0|||
155557234|NCT03502707|561468779|FG003|Overall Study|Lost to Follow-up|0|||
155557235|NCT03502707|561468780|FG004|Overall Study|Lost to Follow-up|0|||
155557236|NCT03502707|561468781|FG005|Overall Study|Lost to Follow-up|0|||
155557237|NCT03502707|561468782|FG006|Overall Study|Lost to Follow-up|0|||
155557238|NCT03502707|561468783|FG007|Overall Study|Lost to Follow-up|5|||
155557239|NCT03502707|561468784|FG008|Overall Study|Lost to Follow-up|0|||
155557240|NCT03502707|561468785|FG009|Overall Study|Lost to Follow-up|2|||
155557241|NCT03502707|561468786|FG010|Overall Study|Lost to Follow-up|1|||
155557242|NCT03502707|561468787|FG011|Overall Study|Lost to Follow-up|2|||
155557243|NCT03502707|561468788|FG012|Overall Study|Lost to Follow-up|1|||
155557244|NCT03502707|561468789|FG013|Overall Study|Lost to Follow-up|1|||
155657850|NCT04938427|561840477|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155657851|NCT04938427|561840478|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155657852|NCT04938427|561840477|FG000|Overall Study|Withdrawal by Subject|1|||
155657853|NCT04938427|561840478|FG001|Overall Study|Withdrawal by Subject|0|||
155657854|NCT04938427|561840477|FG000|Overall Study|Reason Not Specified|2|||
155657855|NCT04938427|561840478|FG001|Overall Study|Reason Not Specified|1|||
155657856|NCT03633058|561840487|FG000|Overall Study|Adverse Event|0|||
155657857|NCT03633058|561840488|FG001|Overall Study|Adverse Event|0|||
155657858|NCT03633058|561840489|FG002|Overall Study|Adverse Event|1|||
155657859|NCT03633058|561840490|FG003|Overall Study|Adverse Event|0|||
155657860|NCT01969058|561840498|FG000|Overall Study|Withdrawal by Subject|2|||
155657861|NCT01969058|561840499|FG001|Overall Study|Withdrawal by Subject|0|||
155657862|NCT01969058|561840498|FG000|Overall Study|Adverse Event|1|||
155657863|NCT01969058|561840499|FG001|Overall Study|Adverse Event|0|||
155657864|NCT04090749|561840502|FG000|Open Label Pilot|Lost to Follow-up|1|||
155657865|NCT04090749|561840503|FG001|Open Label Pilot|Lost to Follow-up|0|||
155657866|NCT04090749|561840504|FG002|Open Label Pilot|Lost to Follow-up|0|||
155657867|NCT04090749|561840502|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
155657868|NCT04090749|561840503|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
155657869|NCT04090749|561840504|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
155657870|NCT04090749|561840502|FG000|Pilot Trial|Lost to Follow-up|0|||
155657871|NCT04090749|561840503|FG001|Pilot Trial|Lost to Follow-up|1|||
155657872|NCT04090749|561840504|FG002|Pilot Trial|Lost to Follow-up|1|||
155557245|NCT03502707|561468790|FG014|Overall Study|Lost to Follow-up|0|||
155557246|NCT03502707|561468791|FG015|Overall Study|Lost to Follow-up|4|||
155557247|NCT03502707|561468792|FG016|Overall Study|Lost to Follow-up|9|||
155557248|NCT03502707|561468793|FG017|Overall Study|Lost to Follow-up|2|||
155557249|NCT03502707|561468776|FG000|Overall Study|Physician Decision|0|||
155557250|NCT03502707|561468777|FG001|Overall Study|Physician Decision|0|||
155557251|NCT03502707|561468778|FG002|Overall Study|Physician Decision|0|||
155557252|NCT03502707|561468779|FG003|Overall Study|Physician Decision|0|||
155557253|NCT03502707|561468780|FG004|Overall Study|Physician Decision|0|||
155557254|NCT03502707|561468781|FG005|Overall Study|Physician Decision|0|||
155557255|NCT03502707|561468782|FG006|Overall Study|Physician Decision|0|||
155557256|NCT03502707|561468783|FG007|Overall Study|Physician Decision|0|||
155557257|NCT03502707|561468784|FG008|Overall Study|Physician Decision|2|||
155557258|NCT03502707|561468785|FG009|Overall Study|Physician Decision|1|||
155557259|NCT03502707|561468786|FG010|Overall Study|Physician Decision|0|||
155557260|NCT03502707|561468787|FG011|Overall Study|Physician Decision|0|||
155557261|NCT03502707|561468788|FG012|Overall Study|Physician Decision|0|||
155557262|NCT03502707|561468789|FG013|Overall Study|Physician Decision|0|||
155557263|NCT03502707|561468790|FG014|Overall Study|Physician Decision|1|||
155557264|NCT03502707|561468791|FG015|Overall Study|Physician Decision|3|||
155557265|NCT03502707|561468792|FG016|Overall Study|Physician Decision|0|||
155557266|NCT03502707|561468793|FG017|Overall Study|Physician Decision|0|||
155557267|NCT03502707|561468776|FG000|Overall Study|Protocol Violation|0|||
155557268|NCT03502707|561468777|FG001|Overall Study|Protocol Violation|0|||
155557269|NCT03502707|561468778|FG002|Overall Study|Protocol Violation|0|||
155557270|NCT03502707|561468779|FG003|Overall Study|Protocol Violation|0|||
155557271|NCT03502707|561468780|FG004|Overall Study|Protocol Violation|0|||
155557272|NCT03502707|561468781|FG005|Overall Study|Protocol Violation|0|||
155557273|NCT03502707|561468782|FG006|Overall Study|Protocol Violation|0|||
155557274|NCT03502707|561468783|FG007|Overall Study|Protocol Violation|0|||
155557275|NCT03502707|561468784|FG008|Overall Study|Protocol Violation|0|||
155557276|NCT03502707|561468785|FG009|Overall Study|Protocol Violation|0|||
155557277|NCT03502707|561468786|FG010|Overall Study|Protocol Violation|0|||
155557278|NCT03502707|561468787|FG011|Overall Study|Protocol Violation|0|||
155557279|NCT03502707|561468788|FG012|Overall Study|Protocol Violation|0|||
155557280|NCT03502707|561468789|FG013|Overall Study|Protocol Violation|0|||
155557281|NCT03502707|561468790|FG014|Overall Study|Protocol Violation|0|||
155557282|NCT03502707|561468791|FG015|Overall Study|Protocol Violation|1|||
155657873|NCT03510715|561840505|FG000|Overall Study|Adverse Event|1|||
155657874|NCT03510715|561840506|FG001|Overall Study|Adverse Event|0|||
155657875|NCT04144517|561840512|FG000|Overall Study|Physician Decision|0|||
155657876|NCT04144517|561840513|FG001|Overall Study|Physician Decision|1|||
155657877|NCT04144517|561840512|FG000|Overall Study|Other|2|||
155557283|NCT03502707|561468792|FG016|Overall Study|Protocol Violation|0|||
155657878|NCT04144517|561840513|FG001|Overall Study|Other|2|||
155557284|NCT03502707|561468793|FG017|Overall Study|Protocol Violation|0|||
155557285|NCT03502707|561468776|FG000|Overall Study|Withdrawal by Subject|1|||
155557286|NCT03502707|561468777|FG001|Overall Study|Withdrawal by Subject|1|||
155557287|NCT03502707|561468778|FG002|Overall Study|Withdrawal by Subject|0|||
155557288|NCT03502707|561468779|FG003|Overall Study|Withdrawal by Subject|0|||
155557289|NCT03502707|561468780|FG004|Overall Study|Withdrawal by Subject|0|||
155557290|NCT03502707|561468781|FG005|Overall Study|Withdrawal by Subject|2|||
155657879|NCT04144517|561840512|FG000|Overall Study|Death|6|||
155657880|NCT04144517|561840513|FG001|Overall Study|Death|3|||
155657881|NCT02457793|561840518|FG000|Overall Study|Reason not specified|0|||
155657882|NCT02457793|561840519|FG001|Overall Study|Reason not specified|0|||
155657883|NCT02457793|561840520|FG002|Overall Study|Reason not specified|0|||
155657884|NCT02457793|561840521|FG003|Overall Study|Reason not specified|1|||
155657885|NCT02457793|561840522|FG004|Overall Study|Reason not specified|1|||
155657886|NCT02457793|561840523|FG005|Overall Study|Reason not specified|1|||
155657887|NCT02457793|561840518|FG000|Overall Study|Withdrawal by Subject|0|||
155657888|NCT02457793|561840519|FG001|Overall Study|Withdrawal by Subject|4|||
155657889|NCT02457793|561840520|FG002|Overall Study|Withdrawal by Subject|2|||
155657890|NCT02457793|561840521|FG003|Overall Study|Withdrawal by Subject|2|||
155657891|NCT02457793|561840522|FG004|Overall Study|Withdrawal by Subject|2|||
155657892|NCT02457793|561840523|FG005|Overall Study|Withdrawal by Subject|2|||
155657893|NCT02457793|561840518|FG000|Overall Study|Adverse Event|0|||
155657894|NCT02457793|561840519|FG001|Overall Study|Adverse Event|0|||
155557291|NCT03502707|561468782|FG006|Overall Study|Withdrawal by Subject|0|||
155557292|NCT03502707|561468783|FG007|Overall Study|Withdrawal by Subject|3|||
155557293|NCT03502707|561468784|FG008|Overall Study|Withdrawal by Subject|1|||
155557294|NCT03502707|561468785|FG009|Overall Study|Withdrawal by Subject|2|||
155557295|NCT03502707|561468786|FG010|Overall Study|Withdrawal by Subject|12|||
155557296|NCT03502707|561468787|FG011|Overall Study|Withdrawal by Subject|23|||
155557297|NCT03502707|561468788|FG012|Overall Study|Withdrawal by Subject|5|||
155557298|NCT03502707|561468789|FG013|Overall Study|Withdrawal by Subject|3|||
155557299|NCT03502707|561468790|FG014|Overall Study|Withdrawal by Subject|3|||
155557300|NCT03502707|561468791|FG015|Overall Study|Withdrawal by Subject|43|||
155557301|NCT03502707|561468792|FG016|Overall Study|Withdrawal by Subject|44|||
155557302|NCT03502707|561468793|FG017|Overall Study|Withdrawal by Subject|18|||
155557303|NCT03502707|561468776|FG000|Overall Study|Sponsor's Decision|1|||
155557304|NCT03502707|561468777|FG001|Overall Study|Sponsor's Decision|0|||
155557305|NCT03502707|561468778|FG002|Overall Study|Sponsor's Decision|0|||
155557306|NCT03502707|561468779|FG003|Overall Study|Sponsor's Decision|0|||
155557307|NCT03502707|561468780|FG004|Overall Study|Sponsor's Decision|0|||
155657895|NCT02457793|561840520|FG002|Overall Study|Adverse Event|0|||
155657896|NCT02457793|561840521|FG003|Overall Study|Adverse Event|1|||
155657897|NCT02457793|561840522|FG004|Overall Study|Adverse Event|0|||
155657898|NCT02457793|561840523|FG005|Overall Study|Adverse Event|0|||
155657899|NCT02457793|561840518|FG000|Overall Study|Physician Decision|1|||
155657900|NCT02457793|561840519|FG001|Overall Study|Physician Decision|0|||
155657901|NCT02457793|561840520|FG002|Overall Study|Physician Decision|1|||
155657902|NCT02457793|561840521|FG003|Overall Study|Physician Decision|1|||
155657903|NCT02457793|561840522|FG004|Overall Study|Physician Decision|1|||
155657904|NCT02457793|561840523|FG005|Overall Study|Physician Decision|3|||
155657905|NCT00835172|561840528|FG000|Washout|Protocol Violation|0|||
155657906|NCT00835172|561840529|FG001|Washout|Protocol Violation|1|||
155657907|NCT03941093|561840530|FG000|Overall Study|Protocol Violation|0|||
155657908|NCT03941093|561840531|FG001|Overall Study|Protocol Violation|1|||
155657909|NCT03941093|561840530|FG000|Overall Study|Withdrawal by Subject|9|||
155657910|NCT03941093|561840531|FG001|Overall Study|Withdrawal by Subject|6|||
155657911|NCT03243084|561842762|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
155657912|NCT03243084|561842763|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
155657913|NCT00553254|561842767|FG000|Overall Study|Death|3|||
155657914|NCT00553254|561842768|FG001|Overall Study|Death|6|||
155657915|NCT00553254|561842769|FG002|Overall Study|Death|25|||
155657916|NCT00553254|561842767|FG000|Overall Study|Lost to Follow-up|0|||
155657917|NCT00553254|561842768|FG001|Overall Study|Lost to Follow-up|0|||
155657918|NCT00553254|561842769|FG002|Overall Study|Lost to Follow-up|2|||
155657919|NCT00553254|561842767|FG000|Overall Study|Withdrawal by Subject|2|||
155657920|NCT00553254|561842768|FG001|Overall Study|Withdrawal by Subject|0|||
155657921|NCT00553254|561842769|FG002|Overall Study|Withdrawal by Subject|2|||
155657922|NCT00553254|561842767|FG000|Overall Study|Study terminated by Sponsor|0|||
155657923|NCT00553254|561842768|FG001|Overall Study|Study terminated by Sponsor|0|||
155657924|NCT00553254|561842769|FG002|Overall Study|Study terminated by Sponsor|1|||
155657925|NCT00553254|561842767|FG000|Overall Study|Other|1|||
155557308|NCT03502707|561468781|FG005|Overall Study|Sponsor's Decision|0|||
155557309|NCT03502707|561468782|FG006|Overall Study|Sponsor's Decision|0|||
155557310|NCT03502707|561468783|FG007|Overall Study|Sponsor's Decision|0|||
155557311|NCT03502707|561468784|FG008|Overall Study|Sponsor's Decision|0|||
155657926|NCT00553254|561842768|FG001|Overall Study|Other|0|||
155657927|NCT00553254|561842769|FG002|Overall Study|Other|13|||
155557312|NCT03502707|561468785|FG009|Overall Study|Sponsor's Decision|1|||
155657928|NCT02546323|561842770|FG000|Overall Study|Withdrawal by Subject|36|||
155657929|NCT02546323|561842771|FG001|Overall Study|Withdrawal by Subject|33|||
155657930|NCT02546323|561842770|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
155657931|NCT02546323|561842771|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
155557313|NCT03502707|561468786|FG010|Overall Study|Sponsor's Decision|0|||
155557314|NCT03502707|561468787|FG011|Overall Study|Sponsor's Decision|0|||
155557315|NCT03502707|561468788|FG012|Overall Study|Sponsor's Decision|0|||
155557316|NCT03502707|561468789|FG013|Overall Study|Sponsor's Decision|0|||
155557317|NCT03502707|561468790|FG014|Overall Study|Sponsor's Decision|0|||
155557318|NCT03502707|561468791|FG015|Overall Study|Sponsor's Decision|2|||
155557319|NCT03502707|561468792|FG016|Overall Study|Sponsor's Decision|1|||
155557320|NCT03502707|561468793|FG017|Overall Study|Sponsor's Decision|0|||
155557321|NCT03502707|561468776|FG000|Overall Study|Initiated Prohibited Medication|0|||
155557322|NCT03502707|561468777|FG001|Overall Study|Initiated Prohibited Medication|0|||
155557323|NCT03502707|561468778|FG002|Overall Study|Initiated Prohibited Medication|0|||
155557324|NCT03502707|561468779|FG003|Overall Study|Initiated Prohibited Medication|0|||
155557325|NCT03502707|561468780|FG004|Overall Study|Initiated Prohibited Medication|0|||
155557326|NCT03502707|561468781|FG005|Overall Study|Initiated Prohibited Medication|0|||
155557327|NCT03502707|561468782|FG006|Overall Study|Initiated Prohibited Medication|0|||
155557328|NCT03502707|561468783|FG007|Overall Study|Initiated Prohibited Medication|0|||
155557329|NCT03502707|561468784|FG008|Overall Study|Initiated Prohibited Medication|0|||
155557330|NCT03502707|561468785|FG009|Overall Study|Initiated Prohibited Medication|0|||
155557331|NCT03502707|561468786|FG010|Overall Study|Initiated Prohibited Medication|0|||
155557332|NCT03502707|561468787|FG011|Overall Study|Initiated Prohibited Medication|0|||
155557333|NCT03502707|561468788|FG012|Overall Study|Initiated Prohibited Medication|0|||
155557334|NCT03502707|561468789|FG013|Overall Study|Initiated Prohibited Medication|0|||
155557335|NCT03502707|561468790|FG014|Overall Study|Initiated Prohibited Medication|0|||
155557336|NCT03502707|561468791|FG015|Overall Study|Initiated Prohibited Medication|0|||
155557337|NCT03502707|561468792|FG016|Overall Study|Initiated Prohibited Medication|1|||
155557338|NCT03502707|561468793|FG017|Overall Study|Initiated Prohibited Medication|0|||
155557339|NCT03502707|561468776|FG000|Overall Study|Other|0|||
155557340|NCT03502707|561468777|FG001|Overall Study|Other|0|||
155557341|NCT03502707|561468778|FG002|Overall Study|Other|0|||
155557342|NCT03502707|561468779|FG003|Overall Study|Other|0|||
155557343|NCT03502707|561468780|FG004|Overall Study|Other|0|||
155557344|NCT03502707|561468781|FG005|Overall Study|Other|0|||
155557345|NCT03502707|561468782|FG006|Overall Study|Other|0|||
155557346|NCT03502707|561468783|FG007|Overall Study|Other|0|||
155557347|NCT03502707|561468784|FG008|Overall Study|Other|1|||
155557348|NCT03502707|561468785|FG009|Overall Study|Other|1|||
155557349|NCT03502707|561468786|FG010|Overall Study|Other|2|||
155557350|NCT03502707|561468787|FG011|Overall Study|Other|0|||
155557351|NCT03502707|561468788|FG012|Overall Study|Other|0|||
155557352|NCT03502707|561468789|FG013|Overall Study|Other|0|||
155557353|NCT03502707|561468790|FG014|Overall Study|Other|0|||
155557354|NCT03502707|561468791|FG015|Overall Study|Other|4|||
155557355|NCT03502707|561468792|FG016|Overall Study|Other|1|||
155557356|NCT03502707|561468793|FG017|Overall Study|Other|0|||
155557357|NCT03502707|561468776|FG000|Overall Study|Randomized but not vaccinated|0|||
155557358|NCT03502707|561468777|FG001|Overall Study|Randomized but not vaccinated|0|||
155557359|NCT03502707|561468778|FG002|Overall Study|Randomized but not vaccinated|0|||
155557360|NCT03502707|561468779|FG003|Overall Study|Randomized but not vaccinated|0|||
155557361|NCT03502707|561468780|FG004|Overall Study|Randomized but not vaccinated|0|||
155557362|NCT03502707|561468781|FG005|Overall Study|Randomized but not vaccinated|0|||
155557363|NCT03502707|561468782|FG006|Overall Study|Randomized but not vaccinated|0|||
155557364|NCT03502707|561468783|FG007|Overall Study|Randomized but not vaccinated|0|||
155557365|NCT03502707|561468784|FG008|Overall Study|Randomized but not vaccinated|0|||
155557366|NCT03502707|561468785|FG009|Overall Study|Randomized but not vaccinated|0|||
155557367|NCT03502707|561468786|FG010|Overall Study|Randomized but not vaccinated|0|||
155557368|NCT03502707|561468787|FG011|Overall Study|Randomized but not vaccinated|1|||
155557369|NCT03502707|561468788|FG012|Overall Study|Randomized but not vaccinated|0|||
155557370|NCT03502707|561468789|FG013|Overall Study|Randomized but not vaccinated|0|||
155557371|NCT03502707|561468790|FG014|Overall Study|Randomized but not vaccinated|0|||
155557372|NCT03502707|561468791|FG015|Overall Study|Randomized but not vaccinated|0|||
155557373|NCT03502707|561468792|FG016|Overall Study|Randomized but not vaccinated|0|||
155557374|NCT03502707|561468793|FG017|Overall Study|Randomized but not vaccinated|1|||
155557375|NCT00461253|561468794|FG000|Overall Study|Death|985|||
155557376|NCT00461253|561468795|FG001|Overall Study|Death|0|||
155557377|NCT00461253|561468794|FG000|Overall Study|Protocol Violation|613|||
155557378|NCT00461253|561468795|FG001|Overall Study|Protocol Violation|236|||
155557379|NCT00461253|561468794|FG000|Overall Study|no response|2609|||
155557380|NCT00461253|561468795|FG001|Overall Study|no response|11789|||
155557381|NCT00461253|561468794|FG000|Overall Study|administrative|773|||
155557382|NCT00461253|561468795|FG001|Overall Study|administrative|7773|||
155557383|NCT01933113|561468796|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
155557384|NCT02297438|561468797|FG000|Overall Study|Death|79|||
155557385|NCT02297438|561468798|FG001|Overall Study|Death|86|||
155557386|NCT02297438|561468797|FG000|Overall Study|Lost to Follow-up|9|||
155557387|NCT02297438|561468798|FG001|Overall Study|Lost to Follow-up|7|||
155557388|NCT02297438|561468797|FG000|Overall Study|Withdrawal by Subject|7|||
155557389|NCT02297438|561468798|FG001|Overall Study|Withdrawal by Subject|0|||
155557390|NCT02297438|561468797|FG000|Overall Study|Other|9|||
155557391|NCT02297438|561468798|FG001|Overall Study|Other|5|||
155557392|NCT02297438|561468797|FG000|Overall Study|Ongoing|65|||
155557393|NCT02297438|561468798|FG001|Overall Study|Ongoing|73|||
155557394|NCT03107026|561468799|FG000|Overall Study|Adverse Event|2|||
155557395|NCT03107026|561468800|FG001|Overall Study|Adverse Event|14|||
155557396|NCT03107026|561468801|FG002|Overall Study|Adverse Event|23|||
155557397|NCT03107026|561468799|FG000|Overall Study|Lost to Follow-up|12|||
155557398|NCT03107026|561468800|FG001|Overall Study|Lost to Follow-up|12|||
155557399|NCT03107026|561468801|FG002|Overall Study|Lost to Follow-up|13|||
155557400|NCT03107026|561468799|FG000|Overall Study|Protocol Violation|1|||
155557401|NCT03107026|561468800|FG001|Overall Study|Protocol Violation|2|||
155557402|NCT03107026|561468801|FG002|Overall Study|Protocol Violation|0|||
155557403|NCT03107026|561468799|FG000|Overall Study|Pregnancy|1|||
155557404|NCT03107026|561468800|FG001|Overall Study|Pregnancy|0|||
155557405|NCT03107026|561468801|FG002|Overall Study|Pregnancy|0|||
155557406|NCT03107026|561468799|FG000|Overall Study|Withdrawal by Subject|13|||
155557407|NCT03107026|561468800|FG001|Overall Study|Withdrawal by Subject|5|||
155557408|NCT03107026|561468801|FG002|Overall Study|Withdrawal by Subject|17|||
155557409|NCT03107026|561468799|FG000|Overall Study|non compliance with study visits|1|||
155557410|NCT03107026|561468800|FG001|Overall Study|non compliance with study visits|2|||
155557411|NCT03107026|561468801|FG002|Overall Study|non compliance with study visits|0|||
155557412|NCT03107026|561468799|FG000|Overall Study|non-compliance with study drug|2|||
155557413|NCT03107026|561468800|FG001|Overall Study|non-compliance with study drug|2|||
155557414|NCT03107026|561468801|FG002|Overall Study|non-compliance with study drug|3|||
155557415|NCT03107026|561468799|FG000|Overall Study|Physician Decision|0|||
155557416|NCT03107026|561468800|FG001|Overall Study|Physician Decision|1|||
155557417|NCT03107026|561468801|FG002|Overall Study|Physician Decision|0|||
155557418|NCT00062010|561468802|FG000|Overall Study|Ineligible|3|||
155557419|NCT00852969|561468803|FG000|Overall Study|Adverse Event|0|||
155557420|NCT00852969|561468804|FG001|Overall Study|Adverse Event|1|||
155557421|NCT00852969|561468803|FG000|Overall Study|Lost to Follow-up|0|||
155557422|NCT00852969|561468804|FG001|Overall Study|Lost to Follow-up|1|||
155657932|NCT02546323|561842770|FG000|Overall Study|Adverse Event|17|||
155557423|NCT00807248|561468805|FG000|Overall Study|Adverse Event|1|||
155557424|NCT00807248|561468806|FG001|Overall Study|Adverse Event|2|||
155557425|NCT00807248|561468807|FG002|Overall Study|Adverse Event|2|||
155557426|NCT00807248|561468808|FG003|Overall Study|Adverse Event|6|||
155557427|NCT00807248|561468805|FG000|Overall Study|Lack of Efficacy|14|||
155557428|NCT00807248|561468806|FG001|Overall Study|Lack of Efficacy|4|||
155557429|NCT00807248|561468807|FG002|Overall Study|Lack of Efficacy|8|||
155557430|NCT00807248|561468808|FG003|Overall Study|Lack of Efficacy|3|||
155557431|NCT00807248|561468805|FG000|Overall Study|Protocol Violation|0|||
155557432|NCT00807248|561468806|FG001|Overall Study|Protocol Violation|1|||
155557433|NCT00807248|561468807|FG002|Overall Study|Protocol Violation|1|||
155557434|NCT00807248|561468808|FG003|Overall Study|Protocol Violation|0|||
155557435|NCT00807248|561468805|FG000|Overall Study|Withdrawal of Consent|5|||
155557436|NCT00807248|561468806|FG001|Overall Study|Withdrawal of Consent|5|||
155557437|NCT00807248|561468807|FG002|Overall Study|Withdrawal of Consent|5|||
155557438|NCT00807248|561468808|FG003|Overall Study|Withdrawal of Consent|5|||
155557439|NCT00807248|561468805|FG000|Overall Study|Lost to Follow-up|1|||
155557440|NCT00807248|561468806|FG001|Overall Study|Lost to Follow-up|0|||
155557441|NCT00807248|561468807|FG002|Overall Study|Lost to Follow-up|0|||
155557442|NCT00807248|561468808|FG003|Overall Study|Lost to Follow-up|0|||
155557443|NCT00807248|561468805|FG000|Overall Study|Other Reason|0|||
155557444|NCT00807248|561468806|FG001|Overall Study|Other Reason|0|||
155557445|NCT00807248|561468807|FG002|Overall Study|Other Reason|2|||
155557446|NCT00807248|561468808|FG003|Overall Study|Other Reason|0|||
155557447|NCT02518919|561468812|FG000|Overall Study|Protocol Violation|1|||
155557448|NCT02518919|561468813|FG001|Overall Study|Protocol Violation|1|||
155557449|NCT02518919|561468814|FG002|Overall Study|Protocol Violation|2|||
155557450|NCT04498403|561468815|FG000|Overall Study|Adverse Event|1|||
155557451|NCT04498403|561468816|FG001|Overall Study|Adverse Event|0|||
155557452|NCT04498403|561468815|FG000|Overall Study|Study Terminated By Sponsor|29|||
155557453|NCT04498403|561468816|FG001|Overall Study|Study Terminated By Sponsor|10|||
155557454|NCT01951885|561468817|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
155557455|NCT01951885|561468818|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
155557456|NCT01951885|561468817|FG000|Overall Study|Adverse Event|1|||
155557457|NCT01951885|561468818|FG001|Overall Study|Adverse Event|0|||
155557458|NCT01951885|561468817|FG000|Overall Study|Withdrawal by Subject|0|||
155557459|NCT01951885|561468818|FG001|Overall Study|Withdrawal by Subject|1|||
155557460|NCT01951885|561468817|FG000|Overall Study|ineligible due to a change in donor|0|||
155557461|NCT01951885|561468818|FG001|Overall Study|ineligible due to a change in donor|1|||
155557462|NCT01951885|561468817|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
155557463|NCT01951885|561468818|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
155557464|NCT01687478|561468821|FG000|Overall Study|Adverse Event|3|||
155557465|NCT01687478|561468822|FG001|Overall Study|Adverse Event|10|||
155557466|NCT01687478|561468821|FG000|Overall Study|Lost to Follow-up|1|||
155557467|NCT01687478|561468822|FG001|Overall Study|Lost to Follow-up|3|||
155557468|NCT01687478|561468821|FG000|Overall Study|Protocol Violation|0|||
155557469|NCT01687478|561468822|FG001|Overall Study|Protocol Violation|2|||
155557470|NCT01687478|561468821|FG000|Overall Study|Withdrawal by Subject|21|||
155557471|NCT01687478|561468822|FG001|Overall Study|Withdrawal by Subject|19|||
155557472|NCT01687478|561468821|FG000|Overall Study|Physician Decision|1|||
155557473|NCT01687478|561468822|FG001|Overall Study|Physician Decision|3|||
155557474|NCT01687478|561468821|FG000|Overall Study|Entry Criteria Not Met|6|||
155557475|NCT01687478|561468822|FG001|Overall Study|Entry Criteria Not Met|2|||
155557476|NCT03188718|561468823|FG000|Overall Study|Participant noncompliance|4|||
155557477|NCT03188718|561468823|FG000|Overall Study|Withdrawal by Subject|1|||
155557478|NCT03188718|561468823|FG000|Overall Study|Device failure|3|||
155557479|NCT04322149|561468824|FG000|Overall Study|Adverse Event|1|||
155557480|NCT04322149|561468825|FG001|Overall Study|Adverse Event|1|||
155557481|NCT04322149|561468826|FG002|Overall Study|Adverse Event|0|||
155557482|NCT04322149|561468827|FG003|Overall Study|Adverse Event|0|||
155557483|NCT04322149|561468824|FG000|Overall Study|Withdrawal by Subject|0|||
155557484|NCT04322149|561468825|FG001|Overall Study|Withdrawal by Subject|0|||
155557485|NCT04322149|561468826|FG002|Overall Study|Withdrawal by Subject|0|||
155557486|NCT04322149|561468827|FG003|Overall Study|Withdrawal by Subject|2|||
155557487|NCT04322149|561468824|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
155557488|NCT04322149|561468825|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
155557489|NCT04322149|561468826|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
155557490|NCT04322149|561468827|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
155557491|NCT00368979|561468830|FG000|Overall Study|Adverse Event|9|||
155557492|NCT00368979|561468831|FG001|Overall Study|Adverse Event|16|||
155557493|NCT00368979|561468830|FG000|Overall Study|Lack of Efficacy|5|||
155557494|NCT00368979|561468831|FG001|Overall Study|Lack of Efficacy|3|||
155557495|NCT00368979|561468830|FG000|Overall Study|Other|3|||
155557496|NCT00368979|561468831|FG001|Overall Study|Other|1|||
155557497|NCT00368979|561468830|FG000|Overall Study|Lost to Follow-up|1|||
155557498|NCT00368979|561468831|FG001|Overall Study|Lost to Follow-up|0|||
155557499|NCT00368979|561468830|FG000|Overall Study|Protocol Violation|2|||
155557500|NCT00368979|561468831|FG001|Overall Study|Protocol Violation|1|||
155557501|NCT00368979|561468830|FG000|Overall Study|Withdrawal by Subject|5|||
155557502|NCT00368979|561468831|FG001|Overall Study|Withdrawal by Subject|9|||
155557503|NCT00394524|561468832|FG000|Overall Study|Protocol Violation|2|||
155557504|NCT00394524|561468833|FG001|Overall Study|Protocol Violation|3|||
155557505|NCT00394524|561468832|FG000|Overall Study|Death|1|||
155557506|NCT00394524|561468833|FG001|Overall Study|Death|0|||
155557507|NCT00394524|561468832|FG000|Overall Study|Withdrawal by Subject|0|||
155557508|NCT00394524|561468833|FG001|Overall Study|Withdrawal by Subject|1|||
155557509|NCT01462318|561468834|FG000|Main Study / TP-DI Study|Other|2|||
155557510|NCT01462318|561468835|FG001|Main Study / TP-DI Study|Other|0|||
155557511|NCT01462318|561468836|FG002|Main Study / TP-DI Study|Other|0|||
155557512|NCT01462318|561468834|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
155557513|NCT01462318|561468835|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
155557514|NCT01462318|561468836|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
155557515|NCT01462318|561468834|FG000|Main Study / TP-DI Study|Adverse Event|4|||
155557516|NCT01462318|561468835|FG001|Main Study / TP-DI Study|Adverse Event|0|||
155557517|NCT01462318|561468836|FG002|Main Study / TP-DI Study|Adverse Event|0|||
155557518|NCT01462318|561468834|FG000|Extension Phase|Lost to Follow-up|0|||
155557519|NCT01462318|561468835|FG001|Extension Phase|Lost to Follow-up|0|||
155557520|NCT01462318|561468836|FG002|Extension Phase|Lost to Follow-up|1|||
155557521|NCT01462318|561468834|FG000|Extension Phase|Other|0|||
155557522|NCT01462318|561468835|FG001|Extension Phase|Other|0|||
155557523|NCT01462318|561468836|FG002|Extension Phase|Other|1|||
155557524|NCT01462318|561468834|FG000|Extension Phase|Disease Progression|0|||
155557525|NCT01462318|561468835|FG001|Extension Phase|Disease Progression|0|||
155557526|NCT01462318|561468836|FG002|Extension Phase|Disease Progression|1|||
155557527|NCT01462318|561468834|FG000|Extension Phase|Withdrawal by Subject|0|||
155557528|NCT01462318|561468835|FG001|Extension Phase|Withdrawal by Subject|0|||
155557529|NCT01462318|561468836|FG002|Extension Phase|Withdrawal by Subject|15|||
155557530|NCT01462318|561468834|FG000|Extension Phase|Investigator Decision|0|||
155557531|NCT01462318|561468835|FG001|Extension Phase|Investigator Decision|0|||
155557532|NCT01462318|561468836|FG002|Extension Phase|Investigator Decision|5|||
155557533|NCT01462318|561468834|FG000|Extension Phase|Adverse Event|0|||
155557534|NCT01462318|561468835|FG001|Extension Phase|Adverse Event|0|||
155557535|NCT01462318|561468836|FG002|Extension Phase|Adverse Event|22|||
155557536|NCT02238626|561468837|FG000|Overall Study|Adverse Event|3|||
155557537|NCT02238626|561468838|FG001|Overall Study|Adverse Event|5|||
155557538|NCT02238626|561468839|FG002|Overall Study|Adverse Event|0|||
155557539|NCT02238626|561468840|FG003|Overall Study|Adverse Event|3|||
155557540|NCT02238626|561468837|FG000|Overall Study|Lost to Follow-up|2|||
155557541|NCT02238626|561468838|FG001|Overall Study|Lost to Follow-up|4|||
155557542|NCT02238626|561468839|FG002|Overall Study|Lost to Follow-up|2|||
155557543|NCT02238626|561468840|FG003|Overall Study|Lost to Follow-up|2|||
155557544|NCT02238626|561468837|FG000|Overall Study|Withdrawal by Subject|0|||
155557545|NCT02238626|561468838|FG001|Overall Study|Withdrawal by Subject|3|||
155557546|NCT02238626|561468839|FG002|Overall Study|Withdrawal by Subject|0|||
155557547|NCT02238626|561468840|FG003|Overall Study|Withdrawal by Subject|1|||
155557548|NCT02238626|561468837|FG000|Overall Study|Death|0|||
155557549|NCT02238626|561468838|FG001|Overall Study|Death|0|||
155557550|NCT02238626|561468839|FG002|Overall Study|Death|1|||
155557551|NCT02238626|561468840|FG003|Overall Study|Death|1|||
155557552|NCT02238626|561468837|FG000|Overall Study|Other|0|||
155557553|NCT02238626|561468838|FG001|Overall Study|Other|2|||
155557554|NCT02238626|561468839|FG002|Overall Study|Other|0|||
155557555|NCT02238626|561468840|FG003|Overall Study|Other|0|||
155557556|NCT00270257|561468841|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
155557557|NCT00270257|561468842|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
155557558|NCT01195103|561468845|FG000|Overall Study|Withdrawal by Subject|1|||
155557559|NCT01195103|561468846|FG001|Overall Study|Withdrawal by Subject|0|||
155557560|NCT01195103|561468847|FG002|Overall Study|Withdrawal by Subject|0|||
155557561|NCT00974974|561468853|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
155557562|NCT00974974|561468854|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
155557563|NCT00974974|561468853|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
155557564|NCT00974974|561468854|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
155557565|NCT00974974|561468853|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
155557566|NCT00974974|561468854|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
155557567|NCT00974974|561468853|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
155557568|NCT00974974|561468854|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
155557569|NCT00974974|561468853|FG000|IR CD-LD Dose Adjustment|Various|0|||
155557570|NCT00974974|561468854|FG001|IR CD-LD Dose Adjustment|Various|9|||
155557571|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Adverse Event|23|||
155557572|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Adverse Event|0|||
155557573|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Death|2|||
155557574|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Death|0|||
155557575|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
155557576|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
155557577|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
155557578|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
155557579|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Various|3|||
155557580|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Various|0|||
155557581|NCT00974974|561468853|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
155557582|NCT00974974|561468854|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
155557583|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
155557584|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
155557585|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
155557586|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
155557587|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
155557588|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
155557589|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
155557590|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
155557591|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
155557592|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
155557593|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
155557594|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
155557595|NCT00974974|561468853|FG000|Maintenance - Double Blind Treatment|Various|4|||
155557596|NCT00974974|561468854|FG001|Maintenance - Double Blind Treatment|Various|0|||
155557597|NCT01959035|561468855|FG000|Overall Study|Adverse Event|5|||
155557598|NCT01959035|561468855|FG000|Overall Study|Withdrawal by Subject|4|||
155557599|NCT01959035|561468855|FG000|Overall Study|Lost to Follow-up|1|||
155557600|NCT01959035|561468855|FG000|Overall Study|Other (no primary reason given)|1|||
155557601|NCT02227147|561468858|FG000|Controlled Treatment Period|Adverse Event|4|||
155557602|NCT02227147|561468859|FG001|Controlled Treatment Period|Adverse Event|3|||
155557603|NCT02227147|561468858|FG000|Controlled Treatment Period|Other|2|||
155557604|NCT02227147|561468859|FG001|Controlled Treatment Period|Other|0|||
155557605|NCT02227147|561468858|FG000|Follow-up Period|Other|3|||
155557606|NCT02227147|561468859|FG001|Follow-up Period|Other|5|||
155557607|NCT00158600|561468860|FG000|Overall Study|unable to commit time to study|0|||
155557608|NCT00158600|561468861|FG001|Overall Study|unable to commit time to study|1|||
155557609|NCT00158600|561468860|FG000|Overall Study|Adverse Event|2|||
155557610|NCT00158600|561468861|FG001|Overall Study|Adverse Event|1|||
155557611|NCT00158600|561468860|FG000|Overall Study|Death|1|||
155557612|NCT00158600|561468861|FG001|Overall Study|Death|0|||
155557613|NCT00158600|561468860|FG000|Overall Study|Withdrawal by Subject|2|||
155557614|NCT00158600|561468861|FG001|Overall Study|Withdrawal by Subject|2|||
155557615|NCT00622466|561468866|FG000|Overall Study|Death|1|||
155557616|NCT00622466|561468866|FG000|Overall Study|Adverse Event|1|||
155557617|NCT00622466|561468866|FG000|Overall Study|Withdrawal by Subject|2|||
155557618|NCT05183217|561468867|FG000|Overall Study|Withdrawal by Subject|1|||
155557619|NCT05183217|561468868|FG001|Overall Study|Withdrawal by Subject|1|||
155557620|NCT01593696|561468869|FG000|Dose Escalation|Progressive Disease|2|||
155557621|NCT01593696|561468870|FG001|Dose Escalation|Progressive Disease|0|||
155557622|NCT01593696|561468871|FG002|Dose Escalation|Progressive Disease|0|||
155557623|NCT01593696|561468872|FG003|Dose Escalation|Progressive Disease|0|||
155557624|NCT01593696|561468869|FG000|Dose Expansion|Fungal infection|0|||
155557625|NCT01593696|561468870|FG001|Dose Expansion|Fungal infection|0|||
155557626|NCT01593696|561468871|FG002|Dose Expansion|Fungal infection|1|||
155557627|NCT01593696|561468872|FG003|Dose Expansion|Fungal infection|0|||
155557628|NCT01936623|561468873|FG000|Overall Study|Lost to Follow-up|0|||
155557629|NCT01936623|561468874|FG001|Overall Study|Lost to Follow-up|5|||
155557630|NCT00369655|561468878|FG000|Overall Study|Refusal of further treatment|2|||
155557631|NCT02669758|561468879|FG000|Overall Study|Withdrawal by Subject|43|||
155557632|NCT02669758|561468879|FG000|Overall Study|Lost to Follow-up|19|||
155557633|NCT02669758|561468879|FG000|Overall Study|Adverse Event|16|||
155557634|NCT02669758|561468879|FG000|Overall Study|Non-Compliance with Study Drug|8|||
155557635|NCT02669758|561468879|FG000|Overall Study|Lack of Efficacy|5|||
155557636|NCT02669758|561468879|FG000|Overall Study|Pregnancy|1|||
155557637|NCT02669758|561468879|FG000|Overall Study|Study noncompliance|1|||
155557638|NCT02669758|561468879|FG000|Overall Study|Protocol Violation|1|||
155557639|NCT03393806|561468882|FG000|Overall Study|Physician Decision|1|||
155557640|NCT03393806|561468883|FG001|Overall Study|Physician Decision|0|||
155557641|NCT02534844|561468884|FG000|Part B|Withdrawal by Subject|0|||
155557642|NCT02534844|561468885|FG001|Part B|Withdrawal by Subject|0|||
155557643|NCT02534844|561468886|FG002|Part B|Withdrawal by Subject|0|||
155557644|NCT02534844|561468887|FG003|Part B|Withdrawal by Subject|0|||
155557645|NCT02534844|561468888|FG004|Part B|Withdrawal by Subject|2|||
155557646|NCT02534844|561468889|FG005|Part B|Withdrawal by Subject|1|||
155557647|NCT00507130|561468890|FG000|Overall Study|Lost to Follow-up|0|||
155557648|NCT00507130|561468891|FG001|Overall Study|Lost to Follow-up|0|||
155557649|NCT00507130|561468892|FG002|Overall Study|Lost to Follow-up|1|||
155557650|NCT00507130|561468893|FG003|Overall Study|Lost to Follow-up|1|||
155557651|NCT00507130|561468890|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
155557652|NCT00507130|561468891|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
155657933|NCT02546323|561842771|FG001|Overall Study|Adverse Event|11|||
155557653|NCT00507130|561468892|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
155557654|NCT00507130|561468893|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
155557655|NCT00080938|561468896|FG000|Overall Study|Adverse Event|3|||
155557656|NCT00080938|561468896|FG000|Overall Study|Withdrawal by Subject|6|||
155557657|NCT00080938|561468896|FG000|Overall Study|Death|2|||
155557658|NCT00080938|561468896|FG000|Overall Study|Lack of Efficacy|7|||
155557659|NCT00080938|561468896|FG000|Overall Study|other disease|1|||
155557660|NCT00080938|561468896|FG000|Overall Study|Not started protocol therapy|1|||
155557661|NCT00080938|561468896|FG000|Overall Study|Ineligible|4|||
155557662|NCT00117325|561468897|FG000|Overall Study|Adverse Event|3|||
155557663|NCT00117325|561468898|FG001|Overall Study|Adverse Event|3|||
155557664|NCT00117325|561468897|FG000|Overall Study|Lost to Follow-up|1|||
155557665|NCT00117325|561468898|FG001|Overall Study|Lost to Follow-up|1|||
155557666|NCT00117325|561468897|FG000|Overall Study|Protocol Violation|2|||
155557667|NCT00117325|561468898|FG001|Overall Study|Protocol Violation|3|||
155557668|NCT00117325|561468897|FG000|Overall Study|Withdrawal by Subject|3|||
155557669|NCT00117325|561468898|FG001|Overall Study|Withdrawal by Subject|2|||
155557670|NCT00117325|561468897|FG000|Overall Study|Lack of Efficacy|1|||
155557671|NCT00117325|561468898|FG001|Overall Study|Lack of Efficacy|0|||
155557672|NCT00117325|561468897|FG000|Overall Study|Use of prohibited medicine|1|||
155557673|NCT00117325|561468898|FG001|Overall Study|Use of prohibited medicine|2|||
155557674|NCT00117325|561468897|FG000|Overall Study|Early termination|1|||
155557675|NCT00117325|561468898|FG001|Overall Study|Early termination|1|||
155557676|NCT00117325|561468897|FG000|Overall Study|Admisnitrative|1|||
155557677|NCT00117325|561468898|FG001|Overall Study|Admisnitrative|0|||
155557678|NCT01359644|561468899|FG000|Treatment Period|Lack of Efficacy|0|||
155557679|NCT01359644|561468900|FG001|Treatment Period|Lack of Efficacy|1|||
155557680|NCT01359644|561468901|FG002|Treatment Period|Lack of Efficacy|0|||
155557681|NCT01359644|561468902|FG003|Treatment Period|Lack of Efficacy|0|||
155557682|NCT01359644|561468903|FG004|Treatment Period|Lack of Efficacy|0|||
155557683|NCT01359644|561468904|FG005|Treatment Period|Lack of Efficacy|0|||
155557684|NCT01359644|561468905|FG006|Treatment Period|Lack of Efficacy|0|||
155557685|NCT01359644|561468906|FG007|Treatment Period|Lack of Efficacy|0|||
155557686|NCT01359644|561468907|FG008|Treatment Period|Lack of Efficacy|0|||
155557687|NCT01359644|561468908|FG009|Treatment Period|Lack of Efficacy|0|||
155557688|NCT01359644|561468899|FG000|Treatment Period|Adverse Event|0|||
155557689|NCT01359644|561468900|FG001|Treatment Period|Adverse Event|0|||
155557690|NCT01359644|561468901|FG002|Treatment Period|Adverse Event|1|||
155557691|NCT01359644|561468902|FG003|Treatment Period|Adverse Event|0|||
155557692|NCT01359644|561468903|FG004|Treatment Period|Adverse Event|0|||
155557693|NCT01359644|561468904|FG005|Treatment Period|Adverse Event|1|||
155557694|NCT01359644|561468905|FG006|Treatment Period|Adverse Event|0|||
155557695|NCT01359644|561468906|FG007|Treatment Period|Adverse Event|0|||
155557696|NCT01359644|561468907|FG008|Treatment Period|Adverse Event|0|||
155557697|NCT01359644|561468908|FG009|Treatment Period|Adverse Event|0|||
155557698|NCT01359644|561468899|FG000|Treatment Period|Lost to Follow-up|0|||
155557699|NCT01359644|561468900|FG001|Treatment Period|Lost to Follow-up|0|||
155557700|NCT01359644|561468901|FG002|Treatment Period|Lost to Follow-up|0|||
155557701|NCT01359644|561468902|FG003|Treatment Period|Lost to Follow-up|0|||
155557702|NCT01359644|561468903|FG004|Treatment Period|Lost to Follow-up|0|||
155557703|NCT01359644|561468904|FG005|Treatment Period|Lost to Follow-up|1|||
155557704|NCT01359644|561468905|FG006|Treatment Period|Lost to Follow-up|0|||
155557705|NCT01359644|561468906|FG007|Treatment Period|Lost to Follow-up|0|||
155657934|NCT02546323|561842770|FG000|Overall Study|Patient Specific Reasons|1|||
155657935|NCT02546323|561842771|FG001|Overall Study|Patient Specific Reasons|2|||
155657936|NCT02546323|561842770|FG000|Overall Study|Lost to Follow-up|2|||
155657937|NCT02546323|561842771|FG001|Overall Study|Lost to Follow-up|3|||
155657938|NCT02546323|561842770|FG000|Overall Study|Non-compliance with Study Drug|2|||
155657939|NCT02546323|561842771|FG001|Overall Study|Non-compliance with Study Drug|2|||
155657940|NCT02546323|561842770|FG000|Overall Study|Met Withdrawal Criteria|2|||
155657941|NCT02546323|561842771|FG001|Overall Study|Met Withdrawal Criteria|14|||
155657942|NCT04023487|561842773|FG000|Overall Study|Lost to Follow-up|5|||
155657943|NCT04023487|561842774|FG001|Overall Study|Lost to Follow-up|4|||
155657944|NCT04023487|561842773|FG000|Overall Study|Pregnancy|1|||
155657945|NCT04023487|561842774|FG001|Overall Study|Pregnancy|2|||
155657946|NCT04023487|561842773|FG000|Overall Study|Withdrawal by Subject|4|||
155557706|NCT01359644|561468907|FG008|Treatment Period|Lost to Follow-up|0|||
155557707|NCT01359644|561468908|FG009|Treatment Period|Lost to Follow-up|0|||
155557708|NCT01359644|561468899|FG000|Follow-up Period|Withdrawal by Subject|0|||
155557709|NCT01359644|561468900|FG001|Follow-up Period|Withdrawal by Subject|0|||
155557710|NCT01359644|561468901|FG002|Follow-up Period|Withdrawal by Subject|0|||
155557711|NCT01359644|561468902|FG003|Follow-up Period|Withdrawal by Subject|0|||
155557712|NCT01359644|561468903|FG004|Follow-up Period|Withdrawal by Subject|0|||
155557713|NCT01359644|561468904|FG005|Follow-up Period|Withdrawal by Subject|1|||
155557714|NCT01359644|561468905|FG006|Follow-up Period|Withdrawal by Subject|0|||
155557715|NCT01359644|561468906|FG007|Follow-up Period|Withdrawal by Subject|0|||
155557716|NCT01359644|561468907|FG008|Follow-up Period|Withdrawal by Subject|0|||
155657947|NCT04023487|561842774|FG001|Overall Study|Withdrawal by Subject|5|||
155557717|NCT01359644|561468908|FG009|Follow-up Period|Withdrawal by Subject|0|||
155557718|NCT01359644|561468899|FG000|Follow-up Period|Lost to Follow-up|0|||
155557719|NCT01359644|561468900|FG001|Follow-up Period|Lost to Follow-up|0|||
155557720|NCT01359644|561468901|FG002|Follow-up Period|Lost to Follow-up|0|||
155557721|NCT01359644|561468902|FG003|Follow-up Period|Lost to Follow-up|0|||
155557722|NCT01359644|561468903|FG004|Follow-up Period|Lost to Follow-up|0|||
155557723|NCT01359644|561468904|FG005|Follow-up Period|Lost to Follow-up|0|||
155557724|NCT01359644|561468905|FG006|Follow-up Period|Lost to Follow-up|1|||
155557725|NCT01359644|561468906|FG007|Follow-up Period|Lost to Follow-up|2|||
155557726|NCT01359644|561468907|FG008|Follow-up Period|Lost to Follow-up|0|||
155557727|NCT01359644|561468908|FG009|Follow-up Period|Lost to Follow-up|0|||
155557728|NCT00311311|561468910|FG000|Overall Study|Adverse Event|3|||
155557729|NCT00311311|561468911|FG001|Overall Study|Adverse Event|2|||
155557730|NCT00311311|561468910|FG000|Overall Study|Withdrawal by Subject|1|||
155557731|NCT00311311|561468911|FG001|Overall Study|Withdrawal by Subject|1|||
155557732|NCT00311311|561468910|FG000|Overall Study|Noncompliance|0|||
155557733|NCT00311311|561468911|FG001|Overall Study|Noncompliance|1|||
155557734|NCT00311311|561468910|FG000|Overall Study|Study Termination by Sponsor|3|||
155557735|NCT00311311|561468911|FG001|Overall Study|Study Termination by Sponsor|4|||
155557736|NCT00311311|561468910|FG000|Overall Study|Death|1|||
155557737|NCT00311311|561468911|FG001|Overall Study|Death|0|||
155557738|NCT00311311|561468910|FG000|Overall Study|Lack of ancillary assistance|0|||
155557739|NCT00311311|561468911|FG001|Overall Study|Lack of ancillary assistance|1|||
155557740|NCT00546572|561468912|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
155557741|NCT00546572|561468913|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
155557742|NCT00546572|561468912|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
155557743|NCT00546572|561468913|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
155557744|NCT00546572|561468912|FG000|Vax 1 / Year 0|Protocol Violation|3|||
155557745|NCT00546572|561468913|FG001|Vax 1 / Year 0|Protocol Violation|4|||
155557746|NCT00546572|561468912|FG000|Vax 1 / Year 0|Death|2|||
155557747|NCT00546572|561468913|FG001|Vax 1 / Year 0|Death|2|||
155557748|NCT00546572|561468912|FG000|Vax 1 / Year 0|Adverse Event|0|||
155557749|NCT00546572|561468913|FG001|Vax 1 / Year 0|Adverse Event|1|||
155557750|NCT00546572|561468912|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
155557751|NCT00546572|561468913|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
155557752|NCT00546572|561468912|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
155557753|NCT00546572|561468913|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
155557754|NCT00546572|561468912|FG000|Vax 2 / Year 1|Other|1|||
155557755|NCT00546572|561468913|FG001|Vax 2 / Year 1|Other|1|||
155557756|NCT00546572|561468912|FG000|Vax 2 / Year 1|Adverse Event|1|||
155557757|NCT00546572|561468913|FG001|Vax 2 / Year 1|Adverse Event|0|||
155557758|NCT00546572|561468912|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
155557759|NCT00546572|561468913|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
155557760|NCT03979820|561468914|FG000|Overall Study|Protocol Violation|1|||
155557761|NCT03979820|561468915|FG001|Overall Study|Protocol Violation|0|||
155557762|NCT03979820|561468916|FG002|Overall Study|Protocol Violation|0|||
155557763|NCT03979820|561468917|FG003|Overall Study|Protocol Violation|0|||
155557764|NCT03979820|561468914|FG000|Overall Study|Withdrawal by Subject|0|||
155557765|NCT03979820|561468915|FG001|Overall Study|Withdrawal by Subject|0|||
155557766|NCT03979820|561468916|FG002|Overall Study|Withdrawal by Subject|1|||
155557767|NCT03979820|561468917|FG003|Overall Study|Withdrawal by Subject|0|||
155557768|NCT03979820|561468914|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
155606940|NCT00236899|561649604|FG000|Overall Study|Death (Study Disease)|1|||
155557769|NCT03979820|561468915|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
155557770|NCT03979820|561468916|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
155557771|NCT03979820|561468917|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
155557772|NCT00536263|561468918|FG000|Overall Study|Adverse Event|5|||
155557773|NCT00536263|561468919|FG001|Overall Study|Adverse Event|5|||
155557774|NCT00536263|561468920|FG002|Overall Study|Adverse Event|7|||
155557775|NCT00536263|561468918|FG000|Overall Study|Lost to Follow-up|3|||
155557776|NCT00536263|561468919|FG001|Overall Study|Lost to Follow-up|4|||
155557777|NCT00536263|561468920|FG002|Overall Study|Lost to Follow-up|4|||
155557778|NCT00536263|561468918|FG000|Overall Study|Subject withdrew - not treatment related|2|||
155557779|NCT00536263|561468919|FG001|Overall Study|Subject withdrew - not treatment related|0|||
155557780|NCT00536263|561468920|FG002|Overall Study|Subject withdrew - not treatment related|5|||
155557781|NCT00536263|561468918|FG000|Overall Study|Subject withdrew - treatment related|0|||
155557782|NCT00536263|561468919|FG001|Overall Study|Subject withdrew - treatment related|3|||
155557783|NCT00536263|561468920|FG002|Overall Study|Subject withdrew - treatment related|2|||
155557784|NCT00536263|561468918|FG000|Overall Study|Noncompliance with protocol|0|||
155557785|NCT00536263|561468919|FG001|Overall Study|Noncompliance with protocol|0|||
155557786|NCT00536263|561468920|FG002|Overall Study|Noncompliance with protocol|1|||
155557787|NCT00536263|561468918|FG000|Overall Study|Did not meet protocol eligibility|1|||
155557788|NCT00536263|561468919|FG001|Overall Study|Did not meet protocol eligibility|2|||
155557789|NCT00536263|561468920|FG002|Overall Study|Did not meet protocol eligibility|2|||
155557790|NCT02989168|561468939|FG000|Overall Study|Withdrawal by Subject|2|||
155557791|NCT02989168|561468940|FG001|Overall Study|Withdrawal by Subject|0|||
155557792|NCT02989168|561468939|FG000|Overall Study|Physician Decision|0|||
155557793|NCT02989168|561468940|FG001|Overall Study|Physician Decision|1|||
155557794|NCT02989168|561468939|FG000|Overall Study|Adverse Event|1|||
155557795|NCT02989168|561468940|FG001|Overall Study|Adverse Event|2|||
155557796|NCT02989168|561468939|FG000|Overall Study|Sponsor stopped study.|1|||
155557797|NCT02989168|561468940|FG001|Overall Study|Sponsor stopped study.|0|||
155557798|NCT03456960|561468941|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155557799|NCT03456960|561468942|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155557800|NCT03456960|561468943|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
155557801|NCT03456960|561468944|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
155557802|NCT03456960|561468945|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155557803|NCT03456960|561468946|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155557804|NCT03456960|561468941|FG000|Period 2 (1 Day)|Adverse Event|1|||
155557805|NCT03456960|561468942|FG001|Period 2 (1 Day)|Adverse Event|0|||
155557806|NCT03456960|561468943|FG002|Period 2 (1 Day)|Adverse Event|0|||
155557807|NCT03456960|561468944|FG003|Period 2 (1 Day)|Adverse Event|1|||
155557808|NCT03456960|561468945|FG004|Period 2 (1 Day)|Adverse Event|0|||
155557809|NCT03456960|561468946|FG005|Period 2 (1 Day)|Adverse Event|0|||
155557810|NCT00532935|561468947|FG000|Overall Study|Adverse Event|11|||
155557811|NCT00532935|561468948|FG001|Overall Study|Adverse Event|12|||
155557812|NCT00532935|561468947|FG000|Overall Study|Lack of Efficacy|0|||
155557813|NCT00532935|561468948|FG001|Overall Study|Lack of Efficacy|3|||
155557814|NCT00532935|561468947|FG000|Overall Study|Lost to Follow-up|10|||
155557815|NCT00532935|561468948|FG001|Overall Study|Lost to Follow-up|6|||
155557816|NCT00532935|561468947|FG000|Overall Study|Physician Decision|4|||
155557817|NCT00532935|561468948|FG001|Overall Study|Physician Decision|5|||
155557818|NCT00532935|561468947|FG000|Overall Study|Pregnancy|1|||
155557819|NCT00532935|561468948|FG001|Overall Study|Pregnancy|0|||
155557820|NCT00532935|561468947|FG000|Overall Study|Protocol Violation|4|||
155557821|NCT00532935|561468948|FG001|Overall Study|Protocol Violation|2|||
155557822|NCT00532935|561468947|FG000|Overall Study|Withdrawal by Subject|10|||
155557823|NCT00532935|561468948|FG001|Overall Study|Withdrawal by Subject|9|||
155557824|NCT00532935|561468947|FG000|Overall Study|Protocol Specific Criteria|11|||
155557825|NCT00532935|561468948|FG001|Overall Study|Protocol Specific Criteria|15|||
155557826|NCT00502801|561468949|FG000|Treatment Period|Withdrawal by Subject|3|||
155557827|NCT00502801|561468949|FG000|Treatment Period|Adverse Event|7|||
155557828|NCT00502801|561468949|FG000|Treatment Period|Death|14|||
155557829|NCT00502801|561468949|FG000|Treatment Period|OTHER|30|||
155557830|NCT00502801|561468949|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
155557831|NCT00502801|561468949|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
155557832|NCT00502801|561468949|FG000|End of Therapy to Test of Cure|Death|3|||
155557833|NCT00502801|561468949|FG000|End of Therapy to Test of Cure|OTHER|2|||
155557834|NCT05011123|561470565|FG000|Overall Study|Withdrawal by Subject|4|||
155557835|NCT05011123|561470566|FG001|Overall Study|Withdrawal by Subject|2|||
155557836|NCT05011123|561470565|FG000|Overall Study|Lost to Follow-up|7|||
155557837|NCT05011123|561470566|FG001|Overall Study|Lost to Follow-up|6|||
155557838|NCT05011123|561470565|FG000|Overall Study|Ongoing at the time of DBL date|36|||
155557839|NCT05011123|561470566|FG001|Overall Study|Ongoing at the time of DBL date|10|||
155557840|NCT05011123|561470565|FG000|Overall Study|Randomized but did not receive vaccination|1|||
155557841|NCT05011123|561470566|FG001|Overall Study|Randomized but did not receive vaccination|0|||
155557842|NCT03653507|561470567|FG000|Overall Study|Miscellaneous|28|||
155557843|NCT03653507|561470568|FG001|Overall Study|Miscellaneous|19|||
155557844|NCT03653507|561470567|FG000|Overall Study|Withdrawal by Subject|37|||
155557845|NCT03653507|561470568|FG001|Overall Study|Withdrawal by Subject|22|||
155557846|NCT03653507|561470567|FG000|Overall Study|Protocol Deviation|2|||
155557847|NCT03653507|561470568|FG001|Overall Study|Protocol Deviation|1|||
155557848|NCT03653507|561470567|FG000|Overall Study|Progressive disease|117|||
155557849|NCT03653507|561470568|FG001|Overall Study|Progressive disease|168|||
155557850|NCT03653507|561470567|FG000|Overall Study|Lost to Follow-up|1|||
155557851|NCT03653507|561470568|FG001|Overall Study|Lost to Follow-up|1|||
155557852|NCT03653507|561470567|FG000|Overall Study|Death|25|||
155557853|NCT03653507|561470568|FG001|Overall Study|Death|22|||
155557854|NCT03653507|561470567|FG000|Overall Study|Adverse Event|35|||
155557855|NCT03653507|561470568|FG001|Overall Study|Adverse Event|14|||
155557856|NCT01288053|561470569|FG000|Overall Study|Death|1|||
155557857|NCT03188666|561470570|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
155557858|NCT03188666|561470571|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
155557859|NCT03188666|561470572|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
155557860|NCT03188666|561470573|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
155557861|NCT03188666|561470570|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
155557862|NCT03188666|561470571|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
155557863|NCT03188666|561470572|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
155557864|NCT03188666|561470573|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
155557865|NCT03188666|561470570|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
155557866|NCT03188666|561470571|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
155557867|NCT03188666|561470572|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
155557868|NCT03188666|561470573|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
155557869|NCT03188666|561470570|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
155557870|NCT03188666|561470571|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
155557871|NCT03188666|561470572|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
155557872|NCT03188666|561470573|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
155557873|NCT04092894|561470574|FG000|Overall Study|Withdrawal by Subject|2|||
155557874|NCT04092894|561470575|FG001|Overall Study|Withdrawal by Subject|4|||
155557875|NCT04092894|561470574|FG000|Overall Study|Discontinued EEG after randomization|10|||
155557876|NCT04092894|561470575|FG001|Overall Study|Discontinued EEG after randomization|6|||
155557877|NCT01106014|561470576|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
155557878|NCT01106014|561470577|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
155557879|NCT01106014|561470576|FG000|Overall Study|Adverse Event|78|||
155557880|NCT01106014|561470577|FG001|Overall Study|Adverse Event|42|||
155557881|NCT01106014|561470576|FG000|Overall Study|Withdrawal by Subject|43|||
155557882|NCT01106014|561470577|FG001|Overall Study|Withdrawal by Subject|37|||
155557883|NCT01106014|561470576|FG000|Overall Study|Administrative reason|7|||
155557884|NCT01106014|561470577|FG001|Overall Study|Administrative reason|6|||
155557885|NCT01106014|561470576|FG000|Overall Study|Lost to Follow-up|2|||
155557886|NCT01106014|561470577|FG001|Overall Study|Lost to Follow-up|3|||
155557887|NCT05071313|561470578|FG000|Overall Study|Lost to Follow-up|17|||
155557888|NCT05071313|561470579|FG001|Overall Study|Lost to Follow-up|10|||
155557889|NCT05071313|561470578|FG000|Overall Study|Physician Decision|1|||
155557890|NCT05071313|561470579|FG001|Overall Study|Physician Decision|6|||
155557891|NCT05071313|561470578|FG000|Overall Study|Death|1|||
155557892|NCT05071313|561470579|FG001|Overall Study|Death|0|||
155557893|NCT05071313|561470578|FG000|Overall Study|Withdrawal by Subject|10|||
155557894|NCT05071313|561470579|FG001|Overall Study|Withdrawal by Subject|15|||
155557895|NCT05071313|561470578|FG000|Overall Study|Other|1|||
155557896|NCT05071313|561470579|FG001|Overall Study|Other|0|||
155557897|NCT05071313|561470578|FG000|Overall Study|Randomized but not vaccinated|4|||
155557898|NCT05071313|561470579|FG001|Overall Study|Randomized but not vaccinated|2|||
155557899|NCT03596151|561470580|FG000|Overall Study|Withdrawal by Subject|1|||
155557900|NCT02444793|561470582|FG000|Overall Study|Lost to Follow-up|2|||
155557901|NCT02444793|561470583|FG001|Overall Study|Lost to Follow-up|2|||
155557902|NCT02444793|561470584|FG002|Overall Study|Lost to Follow-up|0|||
155557903|NCT02444793|561470585|FG003|Overall Study|Lost to Follow-up|0|||
155557904|NCT02444793|561470582|FG000|Overall Study|Death|0|||
155557905|NCT02444793|561470583|FG001|Overall Study|Death|3|||
155557906|NCT02444793|561470584|FG002|Overall Study|Death|0|||
155557907|NCT02444793|561470585|FG003|Overall Study|Death|0|||
155557908|NCT02444793|561470582|FG000|Overall Study|Other|0|||
155557909|NCT02444793|561470583|FG001|Overall Study|Other|0|||
155557910|NCT02444793|561470584|FG002|Overall Study|Other|2|||
155557911|NCT02444793|561470585|FG003|Overall Study|Other|0|||
155557912|NCT02444793|561470582|FG000|Overall Study|Objective progression or relapse|9|||
155557913|NCT02444793|561470583|FG001|Overall Study|Objective progression or relapse|1|||
155557914|NCT02444793|561470584|FG002|Overall Study|Objective progression or relapse|2|||
155557915|NCT02444793|561470585|FG003|Overall Study|Objective progression or relapse|3|||
155557916|NCT02504671|561470590|FG000|Overall Study|Withdrawal by Subject|1|||
155557917|NCT02504671|561470591|FG001|Overall Study|Withdrawal by Subject|5|||
155557918|NCT02504671|561470592|FG002|Overall Study|Withdrawal by Subject|4|||
155557919|NCT02504671|561470593|FG003|Overall Study|Withdrawal by Subject|4|||
155557920|NCT02504671|561470594|FG004|Overall Study|Withdrawal by Subject|5|||
155557921|NCT02504671|561470595|FG005|Overall Study|Withdrawal by Subject|3|||
155557922|NCT02504671|561470590|FG000|Overall Study|Lack of Efficacy|1|||
155557923|NCT02504671|561470591|FG001|Overall Study|Lack of Efficacy|3|||
155557924|NCT02504671|561470592|FG002|Overall Study|Lack of Efficacy|1|||
155557925|NCT02504671|561470593|FG003|Overall Study|Lack of Efficacy|0|||
155557926|NCT02504671|561470594|FG004|Overall Study|Lack of Efficacy|4|||
155557927|NCT02504671|561470595|FG005|Overall Study|Lack of Efficacy|4|||
155557928|NCT02504671|561470590|FG000|Overall Study|Adverse Event|1|||
155557929|NCT02504671|561470591|FG001|Overall Study|Adverse Event|1|||
155557930|NCT02504671|561470592|FG002|Overall Study|Adverse Event|0|||
155557931|NCT02504671|561470593|FG003|Overall Study|Adverse Event|1|||
155557932|NCT02504671|561470594|FG004|Overall Study|Adverse Event|0|||
155557933|NCT02504671|561470595|FG005|Overall Study|Adverse Event|2|||
155557934|NCT02504671|561470590|FG000|Overall Study|Protocol Violation|2|||
155557935|NCT02504671|561470591|FG001|Overall Study|Protocol Violation|1|||
155557936|NCT02504671|561470592|FG002|Overall Study|Protocol Violation|0|||
155557937|NCT02504671|561470593|FG003|Overall Study|Protocol Violation|0|||
155557938|NCT02504671|561470594|FG004|Overall Study|Protocol Violation|0|||
155557939|NCT02504671|561470595|FG005|Overall Study|Protocol Violation|1|||
155557940|NCT02504671|561470590|FG000|Overall Study|Lost to Follow-up|0|||
155557941|NCT02504671|561470591|FG001|Overall Study|Lost to Follow-up|0|||
155557942|NCT02504671|561470592|FG002|Overall Study|Lost to Follow-up|2|||
155557943|NCT02504671|561470593|FG003|Overall Study|Lost to Follow-up|0|||
155557944|NCT02504671|561470594|FG004|Overall Study|Lost to Follow-up|0|||
155557945|NCT02504671|561470595|FG005|Overall Study|Lost to Follow-up|1|||
155557946|NCT02504671|561470590|FG000|Overall Study|Protocol defined stopping criteria|7|||
155557947|NCT02504671|561470591|FG001|Overall Study|Protocol defined stopping criteria|4|||
155557948|NCT02504671|561470592|FG002|Overall Study|Protocol defined stopping criteria|3|||
155557949|NCT02504671|561470593|FG003|Overall Study|Protocol defined stopping criteria|5|||
155557950|NCT02504671|561470594|FG004|Overall Study|Protocol defined stopping criteria|3|||
155557951|NCT02504671|561470595|FG005|Overall Study|Protocol defined stopping criteria|3|||
155557952|NCT00210249|561470596|FG000|Overall Study|Lost to Follow-up|5|||
155557953|NCT00210249|561470596|FG000|Overall Study|Protocol Violation|11|||
155557954|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
155557955|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
155557956|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
155557957|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
155557958|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
155557959|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
155557960|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
155557961|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
155557962|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
155557963|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
155557964|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
155557965|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
155557966|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
155557967|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
155557968|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
155557969|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
155557970|NCT03182244|561470598|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
155557971|NCT03182244|561470599|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
155557972|NCT03182244|561470598|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
155557973|NCT03182244|561470599|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
155557974|NCT03182244|561470598|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
155557975|NCT03182244|561470599|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
155557976|NCT03182244|561470598|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
155557977|NCT03182244|561470599|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
155557978|NCT03182244|561470598|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
155557979|NCT03182244|561470599|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
155557980|NCT02049450|561470600|FG000|Overall Study|Adverse Event|2|||
155557981|NCT02049450|561470600|FG000|Overall Study|Withdrawal by Subject|1|||
155557982|NCT02049450|561470600|FG000|Overall Study|Patients/guardian decision|1|||
155557983|NCT02492880|561470601|FG000|Overall Study|Lost to Follow-up|1|||
155557984|NCT02492880|561470601|FG000|Overall Study|Protocol Violation|1|||
155557985|NCT00292188|561470605|FG000|Single-Blind|Adverse Event|14|||
155557986|NCT00292188|561470606|FG001|Single-Blind|Adverse Event|0|||
155557987|NCT00292188|561470607|FG002|Single-Blind|Adverse Event|0|||
155557988|NCT00292188|561470605|FG000|Single-Blind|Lack of Efficacy|2|||
155557989|NCT00292188|561470606|FG001|Single-Blind|Lack of Efficacy|0|||
155557990|NCT00292188|561470607|FG002|Single-Blind|Lack of Efficacy|0|||
155557991|NCT00292188|561470605|FG000|Single-Blind|Laboratory Abnormality|5|||
155557992|NCT00292188|561470606|FG001|Single-Blind|Laboratory Abnormality|0|||
155557993|NCT00292188|561470607|FG002|Single-Blind|Laboratory Abnormality|0|||
155557994|NCT00292188|561470605|FG000|Single-Blind|Lost to Follow-up|3|||
155557995|NCT00292188|561470606|FG001|Single-Blind|Lost to Follow-up|0|||
155557996|NCT00292188|561470607|FG002|Single-Blind|Lost to Follow-up|0|||
155557997|NCT00292188|561470605|FG000|Single-Blind|Other|77|||
155557998|NCT00292188|561470606|FG001|Single-Blind|Other|0|||
155557999|NCT00292188|561470607|FG002|Single-Blind|Other|0|||
155558000|NCT00292188|561470605|FG000|Single-Blind|Withdrawal by Subject|12|||
155558001|NCT00292188|561470606|FG001|Single-Blind|Withdrawal by Subject|0|||
155558002|NCT00292188|561470607|FG002|Single-Blind|Withdrawal by Subject|0|||
155558003|NCT00292188|561470605|FG000|Single-Blind|Did not receive treatment|1|||
155558004|NCT00292188|561470606|FG001|Single-Blind|Did not receive treatment|0|||
155558005|NCT00292188|561470607|FG002|Single-Blind|Did not receive treatment|0|||
155558006|NCT00292188|561470605|FG000|Double-Blind|Adverse Event|0|||
155558007|NCT00292188|561470606|FG001|Double-Blind|Adverse Event|25|||
155558008|NCT00292188|561470607|FG002|Double-Blind|Adverse Event|9|||
155558009|NCT00292188|561470605|FG000|Double-Blind|Lack of Efficacy|0|||
155558010|NCT00292188|561470606|FG001|Double-Blind|Lack of Efficacy|2|||
155558011|NCT00292188|561470607|FG002|Double-Blind|Lack of Efficacy|12|||
155558012|NCT00292188|561470605|FG000|Double-Blind|Lost to Follow-up|0|||
155558013|NCT00292188|561470606|FG001|Double-Blind|Lost to Follow-up|1|||
155558014|NCT00292188|561470607|FG002|Double-Blind|Lost to Follow-up|0|||
155558015|NCT00292188|561470605|FG000|Double-Blind|Other|0|||
155558016|NCT00292188|561470606|FG001|Double-Blind|Other|3|||
155558017|NCT00292188|561470607|FG002|Double-Blind|Other|4|||
155558018|NCT00292188|561470605|FG000|Double-Blind|Withdrawal by Subject|0|||
155558019|NCT00292188|561470606|FG001|Double-Blind|Withdrawal by Subject|0|||
155558020|NCT00292188|561470607|FG002|Double-Blind|Withdrawal by Subject|3|||
155558021|NCT00292188|561470605|FG000|Double-Blind|Laboratory Abnormality|0|||
155558022|NCT00292188|561470606|FG001|Double-Blind|Laboratory Abnormality|0|||
155657948|NCT04023487|561842773|FG000|Overall Study|Partially completed testing|8|||
155657949|NCT04023487|561842774|FG001|Overall Study|Partially completed testing|4|||
155657950|NCT03898180|561842775|FG000|Overall Study|Death|178|||
155657951|NCT03898180|561842776|FG001|Overall Study|Death|173|||
155657952|NCT03898180|561842775|FG000|Overall Study|Physician Decision|1|||
155657953|NCT03898180|561842776|FG001|Overall Study|Physician Decision|0|||
155657954|NCT03898180|561842775|FG000|Overall Study|Sponsor Decision|3|||
155657955|NCT03898180|561842776|FG001|Overall Study|Sponsor Decision|0|||
155657956|NCT03898180|561842775|FG000|Overall Study|Lost to Follow-up|1|||
155657957|NCT03898180|561842776|FG001|Overall Study|Lost to Follow-up|0|||
155657958|NCT03898180|561842775|FG000|Overall Study|Withdrawal by Subject|5|||
155657959|NCT03898180|561842776|FG001|Overall Study|Withdrawal by Subject|4|||
155657960|NCT02507934|561842777|FG000|Overall Study|Lost to Follow-up|2|||
155657961|NCT02507934|561842778|FG001|Overall Study|Lost to Follow-up|0|||
155657962|NCT02507934|561842777|FG000|Overall Study|Withdrawal by Subject|2|||
155657963|NCT02507934|561842778|FG001|Overall Study|Withdrawal by Subject|0|||
155657964|NCT03766399|561842780|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657965|NCT03766399|561842781|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657966|NCT03766399|561842782|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657967|NCT03766399|561842783|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657968|NCT03766399|561842784|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657969|NCT03766399|561842785|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657970|NCT03766399|561842786|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657971|NCT03766399|561842787|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657972|NCT03766399|561842788|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657973|NCT03766399|561842789|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657974|NCT03766399|561842790|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657975|NCT03766399|561842791|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657976|NCT03766399|561842792|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657977|NCT03766399|561842793|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
155657978|NCT03766399|561842794|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657979|NCT03766399|561842795|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657980|NCT03766399|561842796|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657981|NCT03766399|561842797|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155657982|NCT05030766|561842798|FG000|Phase 1 Participants|Lost to Follow-up|12|||
155657983|NCT05030766|561842799|FG001|Phase 1 Participants|Lost to Follow-up|22|||
155657984|NCT05030766|561842800|FG002|Phase 1 Participants|Lost to Follow-up|0|||
155657985|NCT05030766|561842801|FG003|Phase 1 Participants|Lost to Follow-up|0|||
155657986|NCT05030766|561842798|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
155558023|NCT00292188|561470607|FG002|Double-Blind|Laboratory Abnormality|1|||
155558024|NCT00824616|561470608|FG000|Overall Study|Adverse Event|2|||
155558025|NCT00824616|561470609|FG001|Overall Study|Adverse Event|1|||
155558026|NCT00824616|561470608|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
155558027|NCT00824616|561470609|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
155558028|NCT00824616|561470608|FG000|Overall Study|Hyperglycemia|1|||
155558029|NCT00824616|561470609|FG001|Overall Study|Hyperglycemia|1|||
155558030|NCT00824616|561470608|FG000|Overall Study|Lack of Efficacy|2|||
155657987|NCT05030766|561842799|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
155558031|NCT00824616|561470609|FG001|Overall Study|Lack of Efficacy|1|||
155558032|NCT00824616|561470608|FG000|Overall Study|Lost to Follow-up|0|||
155558033|NCT00824616|561470609|FG001|Overall Study|Lost to Follow-up|1|||
155558034|NCT00824616|561470608|FG000|Overall Study|Withdrawal by Subject|1|||
155558035|NCT00824616|561470609|FG001|Overall Study|Withdrawal by Subject|1|||
155558036|NCT01200992|561470610|FG000|Overall Study|Study terminated early|35|||
155558037|NCT01200992|561470611|FG001|Overall Study|Study terminated early|41|||
155558038|NCT01200992|561470610|FG000|Overall Study|Randomized but not treated|2|||
155558039|NCT01200992|561470611|FG001|Overall Study|Randomized but not treated|0|||
155558040|NCT00792935|561470612|FG000|Overall Study|Adverse Event|2|||
155558041|NCT00792935|561470613|FG001|Overall Study|Adverse Event|1|||
155558042|NCT00792935|561470612|FG000|Overall Study|Lost to Follow-up|0|||
155558043|NCT00792935|561470613|FG001|Overall Study|Lost to Follow-up|1|||
155558044|NCT00792935|561470612|FG000|Overall Study|Protocol Violation|2|||
155558045|NCT00792935|561470613|FG001|Overall Study|Protocol Violation|0|||
155558046|NCT00792935|561470612|FG000|Overall Study|Withdrawal by Subject|0|||
155558047|NCT00792935|561470613|FG001|Overall Study|Withdrawal by Subject|1|||
155558048|NCT03186781|561470614|FG000|Overall Study|Lost to Follow-up|0|||
155558049|NCT03186781|561470615|FG001|Overall Study|Lost to Follow-up|0|||
155558050|NCT03186781|561470616|FG002|Overall Study|Lost to Follow-up|1|||
155558051|NCT03186781|561470617|FG003|Overall Study|Lost to Follow-up|0|||
155558052|NCT03186781|561470618|FG004|Overall Study|Lost to Follow-up|1|||
155558053|NCT03186781|561470619|FG005|Overall Study|Lost to Follow-up|0|||
155558054|NCT03186781|561470614|FG000|Overall Study|Moved from Area|0|||
155558055|NCT03186781|561470615|FG001|Overall Study|Moved from Area|0|||
155657988|NCT05030766|561842800|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
155657989|NCT05030766|561842801|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
155657990|NCT05030766|561842798|FG000|Phase 2 Participants|Lost to Follow-up|0|||
155657991|NCT05030766|561842799|FG001|Phase 2 Participants|Lost to Follow-up|0|||
155657992|NCT05030766|561842800|FG002|Phase 2 Participants|Lost to Follow-up|6|||
155657993|NCT05030766|561842801|FG003|Phase 2 Participants|Lost to Follow-up|2|||
155657994|NCT01559935|561842804|FG000|Car Phase|Toxicity|4|||
155657995|NCT01559935|561842804|FG000|Car Phase|Death|1|||
155657996|NCT01559935|561842804|FG000|Car Phase|Lack of Efficacy|2|||
155657997|NCT01559935|561842804|FG000|Car Phase|Lost to Follow-up|1|||
155657998|NCT01559935|561842804|FG000|Car Phase|Physician Decision|1|||
155657999|NCT01559935|561842804|FG000|Car Phase|Withdrawal by Subject|2|||
155658000|NCT01559935|561842804|FG000|Car Phase|Per protocol|1|||
155658001|NCT01559935|561842804|FG000|Car Phase|Insurance|1|||
155658002|NCT01559935|561842804|FG000|Car Phase|non-compliance|1|||
155658003|NCT01559935|561842804|FG000|BiRD Phase|Toxicity|1|||
155658004|NCT01559935|561842804|FG000|BiRD Phase|Lack of Efficacy|1|||
155658005|NCT01559935|561842804|FG000|BiRD Phase|Withdrawal by Subject|2|||
155658006|NCT01559935|561842804|FG000|Maintenance Phase|Remains on study|28|||
155658007|NCT01559935|561842804|FG000|Maintenance Phase|Toxicity|1|||
155658008|NCT01559935|561842804|FG000|Maintenance Phase|Lack of Efficacy|18|||
155658009|NCT01559935|561842804|FG000|Maintenance Phase|Withdrawal by Subject|5|||
155658010|NCT01559935|561842804|FG000|Maintenance Phase|Non-compliance|2|||
155658011|NCT05889468|561842806|FG000|Overall Study|Lost to Follow-up|9|||
155658012|NCT05889468|561842807|FG001|Overall Study|Lost to Follow-up|2|||
155658013|NCT05889468|561842806|FG000|Overall Study|Withdrawal by Subject|2|||
155658014|NCT05889468|561842807|FG001|Overall Study|Withdrawal by Subject|2|||
155658015|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658016|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
155658017|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658018|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
155558056|NCT03186781|561470616|FG002|Overall Study|Moved from Area|0|||
155558057|NCT03186781|561470617|FG003|Overall Study|Moved from Area|0|||
155558058|NCT03186781|561470618|FG004|Overall Study|Moved from Area|1|||
155558059|NCT03186781|561470619|FG005|Overall Study|Moved from Area|0|||
155558060|NCT03186781|561470614|FG000|Overall Study|Withdrawal by Subject|0|||
155558061|NCT03186781|561470615|FG001|Overall Study|Withdrawal by Subject|0|||
155658019|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
155658020|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
155658021|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
155658022|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658023|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155558062|NCT03186781|561470616|FG002|Overall Study|Withdrawal by Subject|0|||
155558063|NCT03186781|561470617|FG003|Overall Study|Withdrawal by Subject|0|||
155558064|NCT03186781|561470618|FG004|Overall Study|Withdrawal by Subject|1|||
155658024|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658025|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155558065|NCT03186781|561470619|FG005|Overall Study|Withdrawal by Subject|0|||
155558066|NCT04709835|561470620|FG000|Overall Study|Withdrawal by Subject|0|||
155558067|NCT04709835|561470621|FG001|Overall Study|Withdrawal by Subject|1|||
155558068|NCT04709835|561470622|FG002|Overall Study|Withdrawal by Subject|0|||
155558069|NCT01383135|561470628|FG000|Overall Study|Not Scanned / Imaged|1|||
155558070|NCT01383135|561470629|FG001|Overall Study|Not Scanned / Imaged|0|||
155558071|NCT01383135|561470630|FG002|Overall Study|Not Scanned / Imaged|1|||
155558072|NCT01383135|561470631|FG003|Overall Study|Not Scanned / Imaged|0|||
155558073|NCT03167723|561470632|FG000|Overall Study|Protocol Violation|4|||
155558074|NCT03167723|561470633|FG001|Overall Study|Protocol Violation|6|||
155558075|NCT03397771|561470634|FG000|Overall Study|2 erroneously randomized, never treated|3|||
155558076|NCT03397771|561470635|FG001|Overall Study|2 erroneously randomized, never treated|1|||
155558077|NCT03397771|561470634|FG000|Overall Study|Withdrawal by Subject|1|||
155558078|NCT03397771|561470635|FG001|Overall Study|Withdrawal by Subject|3|||
155558079|NCT03397771|561470634|FG000|Overall Study|Protocol Violation|2|||
155558080|NCT03397771|561470635|FG001|Overall Study|Protocol Violation|2|||
155658026|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658027|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658028|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658029|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155658030|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155558081|NCT03397771|561470634|FG000|Overall Study|Adverse Event|2|||
155558082|NCT03397771|561470635|FG001|Overall Study|Adverse Event|1|||
155558083|NCT01259115|561470638|FG000|Period 1|Adverse Event|1|||
155558084|NCT01259115|561470639|FG001|Period 1|Adverse Event|0|||
155558085|NCT01259115|561470638|FG000|Period 1|Protocol Violation|2|||
155558086|NCT01259115|561470639|FG001|Period 1|Protocol Violation|0|||
155558087|NCT01259115|561470638|FG000|Period 1|Lost to Follow-up|0|||
155558088|NCT01259115|561470639|FG001|Period 1|Lost to Follow-up|1|||
155558089|NCT01259115|561470638|FG000|Period 2|Adverse Event|1|||
155558090|NCT01259115|561470639|FG001|Period 2|Adverse Event|0|||
155558091|NCT01971970|561470640|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
155558092|NCT01971970|561470641|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
155558093|NCT01971970|561470640|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
155558094|NCT01971970|561470641|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
155558095|NCT01971970|561470640|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
155558096|NCT01971970|561470641|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
155558097|NCT01971970|561470640|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
155558098|NCT01971970|561470641|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
155558099|NCT01971970|561470640|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
155558100|NCT01971970|561470641|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
155558101|NCT01971970|561470640|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
155558102|NCT01971970|561470641|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
155558103|NCT01971970|561470640|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
155558104|NCT01971970|561470641|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
155558105|NCT00848107|561470642|FG000|Overall Study|Lost to Follow-up|2|||
155558106|NCT00848107|561470642|FG000|Overall Study|Withdrawal by Subject|8|||
155558107|NCT00848107|561470642|FG000|Overall Study|Adverse Event|9|||
155558108|NCT00848107|561470642|FG000|Overall Study|Death|1|||
155558109|NCT00848107|561470642|FG000|Overall Study|Pregnancy|1|||
155558110|NCT02524730|561470643|FG000|Overall Study|Lost to Follow-up|5|||
155558111|NCT02524730|561470643|FG000|Overall Study|Withdrawal by Subject|18|||
155558112|NCT02524730|561470643|FG000|Overall Study|Death|10|||
155558113|NCT02524730|561470643|FG000|Overall Study|Adverse Event|8|||
155558114|NCT02524730|561470643|FG000|Overall Study|Protocol Violation|1|||
155558115|NCT02524730|561470643|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
155558116|NCT00859586|561470644|FG000|Overall Study|Donors|4|||
155558117|NCT02605993|561470645|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
155558118|NCT02605993|561470646|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
155558119|NCT02605993|561470647|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
155558120|NCT02605993|561470648|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
155558121|NCT01468818|561470655|FG000|Overall Study|Death during treatment|2|||
155558122|NCT02266134|561470656|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
155558123|NCT02266134|561470657|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
155558124|NCT02266134|561470658|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
155558125|NCT02266134|561470659|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
155558126|NCT02266134|561470656|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
155558127|NCT02266134|561470657|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
155558128|NCT02266134|561470658|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
155558129|NCT02266134|561470659|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
155558130|NCT02266134|561470656|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
155558131|NCT02266134|561470657|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
155558132|NCT02266134|561470658|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
155558133|NCT02266134|561470659|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
155558134|NCT02266134|561470656|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
155558135|NCT02266134|561470657|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
155558136|NCT02266134|561470658|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
155558137|NCT02266134|561470659|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
155558138|NCT02266134|561470656|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
155558139|NCT02266134|561470657|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
155558140|NCT02266134|561470658|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
155558141|NCT02266134|561470659|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
155558142|NCT02266134|561470656|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
155558143|NCT02266134|561470657|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
155558144|NCT02266134|561470658|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
155558145|NCT02266134|561470659|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
155558146|NCT01442688|561470660|FG000|First Intervention|Withdrawal by Subject|1|||
155558147|NCT01442688|561470661|FG001|First Intervention|Withdrawal by Subject|0|||
155558148|NCT01442688|561470660|FG000|First Intervention|subject incarcerated|1|||
155558149|NCT01442688|561470661|FG001|First Intervention|subject incarcerated|0|||
155558150|NCT01442688|561470660|FG000|Second Intervention|Adverse Event|1|||
155558151|NCT01442688|561470661|FG001|Second Intervention|Adverse Event|0|||
155558152|NCT00302081|561470662|FG000|Overall Study|Adverse Event|6|||
155558153|NCT00302081|561470663|FG001|Overall Study|Adverse Event|5|||
155558154|NCT00302081|561470664|FG002|Overall Study|Adverse Event|4|||
155558155|NCT00302081|561470662|FG000|Overall Study|Lost to Follow-up|21|||
155558156|NCT00302081|561470663|FG001|Overall Study|Lost to Follow-up|18|||
155558157|NCT00302081|561470664|FG002|Overall Study|Lost to Follow-up|28|||
155558158|NCT00302081|561470662|FG000|Overall Study|Withdrawal by Subject|8|||
155558159|NCT00302081|561470663|FG001|Overall Study|Withdrawal by Subject|12|||
155558160|NCT00302081|561470664|FG002|Overall Study|Withdrawal by Subject|8|||
155558161|NCT00302081|561470662|FG000|Overall Study|Protocol Violation|5|||
155558162|NCT00302081|561470663|FG001|Overall Study|Protocol Violation|1|||
155558163|NCT00302081|561470664|FG002|Overall Study|Protocol Violation|2|||
155558164|NCT00302081|561470662|FG000|Overall Study|Lack of Efficacy|1|||
155558165|NCT00302081|561470663|FG001|Overall Study|Lack of Efficacy|0|||
155558166|NCT00302081|561470664|FG002|Overall Study|Lack of Efficacy|5|||
155558167|NCT00302081|561470662|FG000|Overall Study|Death|2|||
155558168|NCT00302081|561470663|FG001|Overall Study|Death|1|||
155558169|NCT00302081|561470664|FG002|Overall Study|Death|0|||
155558170|NCT00302081|561470662|FG000|Overall Study|Other|13|||
155558171|NCT00302081|561470663|FG001|Overall Study|Other|6|||
155558172|NCT00302081|561470664|FG002|Overall Study|Other|5|||
155558173|NCT02685202|561470665|FG000|Overall Study|Lost to Follow-up|9|||
155558174|NCT01229735|561470666|FG000|Overall Study|Lack of Efficacy|8|||
155558175|NCT01229735|561470667|FG001|Overall Study|Lack of Efficacy|8|||
155558176|NCT01229735|561470666|FG000|Overall Study|Protocol Violation|13|||
155558177|NCT01229735|561470667|FG001|Overall Study|Protocol Violation|8|||
155558178|NCT01229735|561470666|FG000|Overall Study|Lost to Follow-up|0|||
155558179|NCT01229735|561470667|FG001|Overall Study|Lost to Follow-up|2|||
155558180|NCT01229735|561470666|FG000|Overall Study|Withdrawal by Subject|18|||
155558181|NCT01229735|561470667|FG001|Overall Study|Withdrawal by Subject|17|||
155558182|NCT01229735|561470666|FG000|Overall Study|Other Reason|13|||
155558183|NCT01229735|561470667|FG001|Overall Study|Other Reason|10|||
155558184|NCT01229735|561470666|FG000|Overall Study|SAE, non-fatal|0|||
155558185|NCT01229735|561470667|FG001|Overall Study|SAE, non-fatal|4|||
155558186|NCT01229735|561470666|FG000|Overall Study|AE, non-serious non-fatal|13|||
155558187|NCT01229735|561470667|FG001|Overall Study|AE, non-serious non-fatal|17|||
155558188|NCT01229735|561470666|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155558189|NCT01229735|561470667|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155558190|NCT02130882|561470668|FG000|Overall Study|Withdrawal by Subject|0|||
155558191|NCT02130882|561470669|FG001|Overall Study|Withdrawal by Subject|1|||
155558192|NCT00826449|561470674|FG000|Overall Study|Disease Progression|4|||
155558193|NCT00826449|561470674|FG000|Overall Study|Withdrawal by Subject|1|||
155558194|NCT02331368|561470675|FG000|Overall Study|Withdrawal by Subject|3|||
155558195|NCT02302859|561470681|FG000|Overall Study|Lost Phone|1|||
155558196|NCT02302859|561470682|FG001|Overall Study|Lost Phone|1|||
155558197|NCT02302859|561470681|FG000|Overall Study|Withdrawal by Subject|0|||
155558198|NCT02302859|561470682|FG001|Overall Study|Withdrawal by Subject|1|||
155558199|NCT04453202|561470689|FG000|Overall Study|Adverse Event|0|||
155558200|NCT04453202|561470690|FG001|Overall Study|Adverse Event|0|||
155558201|NCT04453202|561470691|FG002|Overall Study|Adverse Event|0|||
155558202|NCT04453202|561470692|FG003|Overall Study|Adverse Event|0|||
155558203|NCT04453202|561470693|FG004|Overall Study|Adverse Event|0|||
155558204|NCT04453202|561470694|FG005|Overall Study|Adverse Event|0|||
155558205|NCT04453202|561470695|FG006|Overall Study|Adverse Event|1|||
155558206|NCT04453202|561470696|FG007|Overall Study|Adverse Event|0|||
155558207|NCT04453202|561470697|FG008|Overall Study|Adverse Event|0|||
155558208|NCT04453202|561470698|FG009|Overall Study|Adverse Event|0|||
155558209|NCT04453202|561470699|FG010|Overall Study|Adverse Event|0|||
155558210|NCT04453202|561470689|FG000|Overall Study|Death|0|||
155558211|NCT04453202|561470690|FG001|Overall Study|Death|0|||
155558212|NCT04453202|561470691|FG002|Overall Study|Death|0|||
155558213|NCT04453202|561470692|FG003|Overall Study|Death|0|||
155558214|NCT04453202|561470693|FG004|Overall Study|Death|0|||
155558215|NCT04453202|561470694|FG005|Overall Study|Death|0|||
155558216|NCT04453202|561470695|FG006|Overall Study|Death|0|||
155558217|NCT04453202|561470696|FG007|Overall Study|Death|0|||
155558218|NCT04453202|561470697|FG008|Overall Study|Death|0|||
155558219|NCT04453202|561470698|FG009|Overall Study|Death|1|||
155558220|NCT04453202|561470699|FG010|Overall Study|Death|0|||
155558221|NCT04453202|561470689|FG000|Overall Study|Lost to Follow-up|0|||
155558222|NCT04453202|561470690|FG001|Overall Study|Lost to Follow-up|1|||
155558223|NCT04453202|561470691|FG002|Overall Study|Lost to Follow-up|0|||
155558224|NCT04453202|561470692|FG003|Overall Study|Lost to Follow-up|1|||
155558225|NCT04453202|561470693|FG004|Overall Study|Lost to Follow-up|0|||
155558226|NCT04453202|561470694|FG005|Overall Study|Lost to Follow-up|0|||
155558227|NCT04453202|561470695|FG006|Overall Study|Lost to Follow-up|0|||
155558228|NCT04453202|561470696|FG007|Overall Study|Lost to Follow-up|0|||
155558229|NCT04453202|561470697|FG008|Overall Study|Lost to Follow-up|0|||
155558230|NCT04453202|561470698|FG009|Overall Study|Lost to Follow-up|1|||
155558231|NCT04453202|561470699|FG010|Overall Study|Lost to Follow-up|1|||
155558232|NCT04453202|561470689|FG000|Overall Study|Withdrawal by Subject|1|||
155558233|NCT04453202|561470690|FG001|Overall Study|Withdrawal by Subject|2|||
155558234|NCT04453202|561470691|FG002|Overall Study|Withdrawal by Subject|1|||
155558235|NCT04453202|561470692|FG003|Overall Study|Withdrawal by Subject|2|||
155558236|NCT04453202|561470693|FG004|Overall Study|Withdrawal by Subject|1|||
155558237|NCT04453202|561470694|FG005|Overall Study|Withdrawal by Subject|1|||
155558238|NCT04453202|561470695|FG006|Overall Study|Withdrawal by Subject|0|||
155558239|NCT04453202|561470696|FG007|Overall Study|Withdrawal by Subject|0|||
155558240|NCT04453202|561470697|FG008|Overall Study|Withdrawal by Subject|0|||
155558241|NCT04453202|561470698|FG009|Overall Study|Withdrawal by Subject|1|||
155558242|NCT04453202|561470699|FG010|Overall Study|Withdrawal by Subject|0|||
155558243|NCT04453202|561470689|FG000|Overall Study|Adverse Event|0|||
155558244|NCT04453202|561470690|FG001|Overall Study|Adverse Event|0|||
155558245|NCT04453202|561470691|FG002|Overall Study|Adverse Event|0|||
155558246|NCT04453202|561470692|FG003|Overall Study|Adverse Event|0|||
155558247|NCT04453202|561470693|FG004|Overall Study|Adverse Event|0|||
155558248|NCT04453202|561470694|FG005|Overall Study|Adverse Event|1|||
155558249|NCT04453202|561470695|FG006|Overall Study|Adverse Event|0|||
155558250|NCT04453202|561470696|FG007|Overall Study|Adverse Event|0|||
155558251|NCT04453202|561470697|FG008|Overall Study|Adverse Event|0|||
155558252|NCT04453202|561470698|FG009|Overall Study|Adverse Event|0|||
155558253|NCT04453202|561470699|FG010|Overall Study|Adverse Event|0|||
155558254|NCT02615171|561470700|FG000|Overall Study|Lost to Follow-up|2|||
155558255|NCT02615171|561470701|FG001|Overall Study|Lost to Follow-up|1|||
155558256|NCT00741936|561470703|FG000|Overall Study|Lost to Follow-up|1|||
155558257|NCT00741936|561470704|FG001|Overall Study|Lost to Follow-up|1|||
155558258|NCT00741936|561470703|FG000|Overall Study|Adverse Event|3|||
155558259|NCT00741936|561470704|FG001|Overall Study|Adverse Event|4|||
155558260|NCT00741936|561470703|FG000|Overall Study|Pregnancy|0|||
155558261|NCT00741936|561470704|FG001|Overall Study|Pregnancy|1|||
155558262|NCT00741936|561470703|FG000|Overall Study|Protocol Violation|2|||
155558263|NCT00741936|561470704|FG001|Overall Study|Protocol Violation|0|||
155558264|NCT00741936|561470703|FG000|Overall Study|Lack of Efficacy|0|||
155558265|NCT00741936|561470704|FG001|Overall Study|Lack of Efficacy|2|||
155558266|NCT00741936|561470703|FG000|Overall Study|Low compliance|3|||
155558267|NCT00741936|561470704|FG001|Overall Study|Low compliance|0|||
155558268|NCT03176459|561470705|FG000|Overall Study|Lost to Follow-up|5|||
155558269|NCT03176459|561470706|FG001|Overall Study|Lost to Follow-up|7|||
155558270|NCT00446199|561470707|FG000|Overall Study|Adverse Event|7|||
155558271|NCT00446199|561470708|FG001|Overall Study|Adverse Event|4|||
155558272|NCT00446199|561470709|FG002|Overall Study|Adverse Event|6|||
155558273|NCT00446199|561470710|FG003|Overall Study|Adverse Event|4|||
155558274|NCT00446199|561470707|FG000|Overall Study|Lost to Follow-up|4|||
155558275|NCT00446199|561470708|FG001|Overall Study|Lost to Follow-up|5|||
155558276|NCT00446199|561470709|FG002|Overall Study|Lost to Follow-up|2|||
155558277|NCT00446199|561470710|FG003|Overall Study|Lost to Follow-up|6|||
155558278|NCT00446199|561470707|FG000|Overall Study|Protocol Violation|1|||
155558279|NCT00446199|561470708|FG001|Overall Study|Protocol Violation|2|||
155558280|NCT00446199|561470709|FG002|Overall Study|Protocol Violation|1|||
155558281|NCT00446199|561470710|FG003|Overall Study|Protocol Violation|3|||
155558282|NCT00446199|561470707|FG000|Overall Study|Withdrawal by Subject|2|||
155558283|NCT00446199|561470708|FG001|Overall Study|Withdrawal by Subject|5|||
155558284|NCT00446199|561470709|FG002|Overall Study|Withdrawal by Subject|9|||
155658031|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
155658032|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
155558285|NCT00446199|561470710|FG003|Overall Study|Withdrawal by Subject|10|||
155558286|NCT00446199|561470707|FG000|Overall Study|Site termination|2|||
155558287|NCT00446199|561470708|FG001|Overall Study|Site termination|0|||
155558288|NCT00446199|561470709|FG002|Overall Study|Site termination|0|||
155558289|NCT00446199|561470710|FG003|Overall Study|Site termination|1|||
155558290|NCT00446199|561470707|FG000|Overall Study|Randomization in Error|2|||
155558291|NCT00446199|561470708|FG001|Overall Study|Randomization in Error|0|||
155558292|NCT00446199|561470709|FG002|Overall Study|Randomization in Error|1|||
155558293|NCT00446199|561470710|FG003|Overall Study|Randomization in Error|1|||
155558294|NCT00446199|561470707|FG000|Overall Study|Lack of Efficacy|1|||
155558295|NCT00446199|561470708|FG001|Overall Study|Lack of Efficacy|0|||
155558296|NCT00446199|561470709|FG002|Overall Study|Lack of Efficacy|0|||
155558297|NCT00446199|561470710|FG003|Overall Study|Lack of Efficacy|1|||
155558298|NCT00446199|561470707|FG000|Overall Study|Non-compliant with study drug|1|||
155558299|NCT00446199|561470708|FG001|Overall Study|Non-compliant with study drug|0|||
155558300|NCT00446199|561470709|FG002|Overall Study|Non-compliant with study drug|5|||
155558301|NCT00446199|561470710|FG003|Overall Study|Non-compliant with study drug|0|||
155558302|NCT00446199|561470707|FG000|Overall Study|Non-compliant with visit schedule|1|||
155558303|NCT00446199|561470708|FG001|Overall Study|Non-compliant with visit schedule|1|||
155558304|NCT00446199|561470709|FG002|Overall Study|Non-compliant with visit schedule|1|||
155558305|NCT00446199|561470710|FG003|Overall Study|Non-compliant with visit schedule|2|||
155558306|NCT00446199|561470707|FG000|Overall Study|Hormone fear|0|||
155558307|NCT00446199|561470708|FG001|Overall Study|Hormone fear|0|||
155558308|NCT00446199|561470709|FG002|Overall Study|Hormone fear|0|||
155558309|NCT00446199|561470710|FG003|Overall Study|Hormone fear|1|||
155558310|NCT00446199|561470707|FG000|Overall Study|Lost interest in study participation|0|||
155558311|NCT00446199|561470708|FG001|Overall Study|Lost interest in study participation|1|||
155558312|NCT00446199|561470709|FG002|Overall Study|Lost interest in study participation|0|||
155558313|NCT00446199|561470710|FG003|Overall Study|Lost interest in study participation|0|||
155558314|NCT00446199|561470707|FG000|Overall Study|In-/Exclusion criterion violated|2|||
155558315|NCT00446199|561470708|FG001|Overall Study|In-/Exclusion criterion violated|1|||
155558316|NCT00446199|561470709|FG002|Overall Study|In-/Exclusion criterion violated|2|||
155558317|NCT00446199|561470710|FG003|Overall Study|In-/Exclusion criterion violated|1|||
155558318|NCT00446199|561470707|FG000|Overall Study|Move|0|||
155558319|NCT00446199|561470708|FG001|Overall Study|Move|1|||
155558320|NCT00446199|561470709|FG002|Overall Study|Move|0|||
155658033|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
155658034|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
155658035|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
155658036|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
155658037|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
155658038|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
155658039|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
155658040|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
155658041|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
155658042|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
155658043|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
155658044|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
155658045|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
155658046|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
155658047|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
155658048|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
155658049|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658050|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658051|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658052|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658053|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658054|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658055|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658056|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658057|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658058|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658059|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658060|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658061|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658062|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155658063|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
155558321|NCT00446199|561470710|FG003|Overall Study|Move|0|||
155558322|NCT03071094|561470714|FG000|Overall Study|Death|1|||
155558323|NCT03071094|561470715|FG001|Overall Study|Death|1|||
155558324|NCT03071094|561470714|FG000|Overall Study|Adverse Event|1|||
155558325|NCT03071094|561470715|FG001|Overall Study|Adverse Event|0|||
155558326|NCT01079832|561470716|FG000|Overall Study|Withdrawal by Subject|1|||
155558327|NCT04969861|561470717|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
155558328|NCT04969861|561470718|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
155558329|NCT00290251|561470719|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
155558330|NCT00290251|561470720|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
155558331|NCT00290251|561470721|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
155558332|NCT00290251|561470722|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
155558333|NCT00290251|561470723|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
155558334|NCT00290251|561470724|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
155558335|NCT00290251|561470719|FG000|Treatment 1 (Months 2-4)|headache|0|||
155558336|NCT00290251|561470720|FG001|Treatment 1 (Months 2-4)|headache|0|||
155558337|NCT00290251|561470721|FG002|Treatment 1 (Months 2-4)|headache|0|||
155558338|NCT00290251|561470722|FG003|Treatment 1 (Months 2-4)|headache|0|||
155558339|NCT00290251|561470723|FG004|Treatment 1 (Months 2-4)|headache|1|||
155558340|NCT00290251|561470724|FG005|Treatment 1 (Months 2-4)|headache|0|||
155558341|NCT00290251|561470719|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
155558342|NCT00290251|561470720|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
155558343|NCT00290251|561470721|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
155558344|NCT00290251|561470722|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
155558345|NCT00290251|561470723|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
155558346|NCT00290251|561470724|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
155558347|NCT02799095|561473275|FG000|Part A|Adverse Event|1|||
155558348|NCT02799095|561473276|FG001|Part A|Adverse Event|0|||
155558349|NCT02799095|561473277|FG002|Part A|Adverse Event|1|||
155558350|NCT02799095|561473278|FG003|Part A|Adverse Event|4|||
155558351|NCT02799095|561473279|FG004|Part A|Adverse Event|1|||
155558352|NCT02799095|561473280|FG005|Part A|Adverse Event|0|||
155558353|NCT02799095|561473281|FG006|Part A|Adverse Event|0|||
155558354|NCT02799095|561473282|FG007|Part A|Adverse Event|0|||
155558355|NCT02799095|561473283|FG008|Part A|Adverse Event|0|||
155558356|NCT02799095|561473284|FG009|Part A|Adverse Event|0|||
155558357|NCT02799095|561473285|FG010|Part A|Adverse Event|0|||
155558358|NCT02799095|561473286|FG011|Part A|Adverse Event|0|||
155558359|NCT02799095|561473287|FG012|Part A|Adverse Event|0|||
155558360|NCT02799095|561473288|FG013|Part A|Adverse Event|0|||
155558361|NCT02799095|561473289|FG014|Part A|Adverse Event|0|||
155558362|NCT02799095|561473290|FG015|Part A|Adverse Event|0|||
155558363|NCT02799095|561473291|FG016|Part A|Adverse Event|0|||
155558364|NCT02799095|561473275|FG000|Part A|Death|0|||
155558365|NCT02799095|561473276|FG001|Part A|Death|0|||
155558366|NCT02799095|561473277|FG002|Part A|Death|0|||
155558367|NCT02799095|561473278|FG003|Part A|Death|0|||
155558368|NCT02799095|561473279|FG004|Part A|Death|0|||
155558369|NCT02799095|561473280|FG005|Part A|Death|0|||
155558370|NCT02799095|561473281|FG006|Part A|Death|3|||
155558371|NCT02799095|561473282|FG007|Part A|Death|0|||
155558372|NCT02799095|561473283|FG008|Part A|Death|0|||
155558373|NCT02799095|561473284|FG009|Part A|Death|0|||
155558374|NCT02799095|561473285|FG010|Part A|Death|0|||
155558375|NCT02799095|561473286|FG011|Part A|Death|0|||
155558376|NCT02799095|561473287|FG012|Part A|Death|0|||
155558377|NCT02799095|561473288|FG013|Part A|Death|0|||
155558378|NCT02799095|561473289|FG014|Part A|Death|0|||
155558379|NCT02799095|561473290|FG015|Part A|Death|0|||
155558380|NCT02799095|561473291|FG016|Part A|Death|0|||
155558381|NCT02799095|561473275|FG000|Part A|Lost to Follow-up|0|||
155558382|NCT02799095|561473276|FG001|Part A|Lost to Follow-up|1|||
155558383|NCT02799095|561473277|FG002|Part A|Lost to Follow-up|0|||
155558384|NCT02799095|561473278|FG003|Part A|Lost to Follow-up|0|||
155558385|NCT02799095|561473279|FG004|Part A|Lost to Follow-up|0|||
155558386|NCT02799095|561473280|FG005|Part A|Lost to Follow-up|0|||
155558387|NCT02799095|561473281|FG006|Part A|Lost to Follow-up|1|||
155558388|NCT02799095|561473282|FG007|Part A|Lost to Follow-up|0|||
155558389|NCT02799095|561473283|FG008|Part A|Lost to Follow-up|0|||
155558390|NCT02799095|561473284|FG009|Part A|Lost to Follow-up|0|||
155558391|NCT02799095|561473285|FG010|Part A|Lost to Follow-up|0|||
155558392|NCT02799095|561473286|FG011|Part A|Lost to Follow-up|0|||
155558393|NCT02799095|561473287|FG012|Part A|Lost to Follow-up|0|||
155558394|NCT02799095|561473288|FG013|Part A|Lost to Follow-up|0|||
155558395|NCT02799095|561473289|FG014|Part A|Lost to Follow-up|0|||
155558396|NCT02799095|561473290|FG015|Part A|Lost to Follow-up|0|||
155558397|NCT02799095|561473291|FG016|Part A|Lost to Follow-up|0|||
155558398|NCT02799095|561473275|FG000|Part A|Progressive Disease|3|||
155558399|NCT02799095|561473276|FG001|Part A|Progressive Disease|3|||
155558400|NCT02799095|561473277|FG002|Part A|Progressive Disease|3|||
155558401|NCT02799095|561473278|FG003|Part A|Progressive Disease|2|||
155558402|NCT02799095|561473279|FG004|Part A|Progressive Disease|2|||
155558403|NCT02799095|561473280|FG005|Part A|Progressive Disease|0|||
155558404|NCT02799095|561473281|FG006|Part A|Progressive Disease|0|||
155558405|NCT02799095|561473282|FG007|Part A|Progressive Disease|0|||
155558406|NCT02799095|561473283|FG008|Part A|Progressive Disease|0|||
155558407|NCT02799095|561473284|FG009|Part A|Progressive Disease|0|||
155558408|NCT02799095|561473285|FG010|Part A|Progressive Disease|0|||
155558409|NCT02799095|561473286|FG011|Part A|Progressive Disease|0|||
155558410|NCT02799095|561473287|FG012|Part A|Progressive Disease|0|||
155558411|NCT02799095|561473288|FG013|Part A|Progressive Disease|0|||
155558412|NCT02799095|561473289|FG014|Part A|Progressive Disease|0|||
155558413|NCT02799095|561473290|FG015|Part A|Progressive Disease|0|||
155558414|NCT02799095|561473291|FG016|Part A|Progressive Disease|0|||
155558415|NCT02799095|561473275|FG000|Part A|Clinical Progression|1|||
155558416|NCT02799095|561473276|FG001|Part A|Clinical Progression|0|||
155558417|NCT02799095|561473277|FG002|Part A|Clinical Progression|2|||
155558418|NCT02799095|561473278|FG003|Part A|Clinical Progression|1|||
155558419|NCT02799095|561473279|FG004|Part A|Clinical Progression|5|||
155558420|NCT02799095|561473280|FG005|Part A|Clinical Progression|0|||
155558421|NCT02799095|561473281|FG006|Part A|Clinical Progression|0|||
155558422|NCT02799095|561473282|FG007|Part A|Clinical Progression|0|||
155558423|NCT02799095|561473283|FG008|Part A|Clinical Progression|0|||
155558424|NCT02799095|561473284|FG009|Part A|Clinical Progression|0|||
155558425|NCT02799095|561473285|FG010|Part A|Clinical Progression|0|||
155558426|NCT02799095|561473286|FG011|Part A|Clinical Progression|0|||
155558427|NCT02799095|561473287|FG012|Part A|Clinical Progression|0|||
155558428|NCT02799095|561473288|FG013|Part A|Clinical Progression|0|||
155558429|NCT02799095|561473289|FG014|Part A|Clinical Progression|0|||
155558430|NCT02799095|561473290|FG015|Part A|Clinical Progression|0|||
155558431|NCT02799095|561473291|FG016|Part A|Clinical Progression|0|||
155558432|NCT02799095|561473275|FG000|Part A|Protocol Deviation|0|||
155558433|NCT02799095|561473276|FG001|Part A|Protocol Deviation|0|||
155558434|NCT02799095|561473277|FG002|Part A|Protocol Deviation|1|||
155558435|NCT02799095|561473278|FG003|Part A|Protocol Deviation|0|||
155558436|NCT02799095|561473279|FG004|Part A|Protocol Deviation|0|||
155558437|NCT02799095|561473280|FG005|Part A|Protocol Deviation|0|||
155558438|NCT02799095|561473281|FG006|Part A|Protocol Deviation|0|||
155558439|NCT02799095|561473282|FG007|Part A|Protocol Deviation|0|||
155558440|NCT02799095|561473283|FG008|Part A|Protocol Deviation|0|||
155558441|NCT02799095|561473284|FG009|Part A|Protocol Deviation|0|||
155558442|NCT02799095|561473285|FG010|Part A|Protocol Deviation|0|||
155558443|NCT02799095|561473286|FG011|Part A|Protocol Deviation|0|||
155558444|NCT02799095|561473287|FG012|Part A|Protocol Deviation|0|||
155558445|NCT02799095|561473288|FG013|Part A|Protocol Deviation|0|||
155558446|NCT02799095|561473289|FG014|Part A|Protocol Deviation|0|||
155558447|NCT02799095|561473290|FG015|Part A|Protocol Deviation|0|||
155558448|NCT02799095|561473291|FG016|Part A|Protocol Deviation|0|||
155558449|NCT02799095|561473275|FG000|Part A|Withdrawal by Subject|0|||
155558450|NCT02799095|561473276|FG001|Part A|Withdrawal by Subject|0|||
155558451|NCT02799095|561473277|FG002|Part A|Withdrawal by Subject|0|||
155558452|NCT02799095|561473278|FG003|Part A|Withdrawal by Subject|1|||
155558453|NCT02799095|561473279|FG004|Part A|Withdrawal by Subject|3|||
155558454|NCT02799095|561473280|FG005|Part A|Withdrawal by Subject|1|||
155558455|NCT02799095|561473281|FG006|Part A|Withdrawal by Subject|1|||
155558456|NCT02799095|561473282|FG007|Part A|Withdrawal by Subject|0|||
155558457|NCT02799095|561473283|FG008|Part A|Withdrawal by Subject|0|||
155558458|NCT02799095|561473284|FG009|Part A|Withdrawal by Subject|0|||
155558459|NCT02799095|561473285|FG010|Part A|Withdrawal by Subject|0|||
155558460|NCT02799095|561473286|FG011|Part A|Withdrawal by Subject|0|||
155558461|NCT02799095|561473287|FG012|Part A|Withdrawal by Subject|0|||
155558462|NCT02799095|561473288|FG013|Part A|Withdrawal by Subject|0|||
155558463|NCT02799095|561473289|FG014|Part A|Withdrawal by Subject|0|||
155558464|NCT02799095|561473290|FG015|Part A|Withdrawal by Subject|0|||
155558465|NCT02799095|561473291|FG016|Part A|Withdrawal by Subject|0|||
155558466|NCT02799095|561473275|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
155558467|NCT02799095|561473276|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
155558468|NCT02799095|561473277|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
155558469|NCT02799095|561473278|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
155558470|NCT02799095|561473279|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
155558471|NCT02799095|561473280|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
155558472|NCT02799095|561473281|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
155558473|NCT02799095|561473282|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
155558474|NCT02799095|561473283|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
155558475|NCT02799095|561473284|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
155558476|NCT02799095|561473285|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
155558477|NCT02799095|561473286|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
155558478|NCT02799095|561473287|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
155558479|NCT02799095|561473288|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
155558480|NCT02799095|561473289|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
155558481|NCT02799095|561473290|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
155558482|NCT02799095|561473291|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
155558483|NCT02799095|561473275|FG000|Part B|Death|0|||
155558484|NCT02799095|561473276|FG001|Part B|Death|0|||
155558485|NCT02799095|561473277|FG002|Part B|Death|0|||
155558486|NCT02799095|561473278|FG003|Part B|Death|0|||
155558487|NCT02799095|561473279|FG004|Part B|Death|0|||
155558488|NCT02799095|561473280|FG005|Part B|Death|0|||
155558489|NCT02799095|561473281|FG006|Part B|Death|0|||
155558490|NCT02799095|561473282|FG007|Part B|Death|7|||
155558491|NCT02799095|561473283|FG008|Part B|Death|7|||
155558492|NCT02799095|561473284|FG009|Part B|Death|0|||
155558493|NCT02799095|561473285|FG010|Part B|Death|0|||
155558494|NCT02799095|561473286|FG011|Part B|Death|0|||
155558495|NCT02799095|561473287|FG012|Part B|Death|0|||
155558496|NCT02799095|561473288|FG013|Part B|Death|0|||
155558497|NCT02799095|561473289|FG014|Part B|Death|0|||
155558498|NCT02799095|561473290|FG015|Part B|Death|0|||
155558499|NCT02799095|561473291|FG016|Part B|Death|0|||
155558500|NCT02799095|561473275|FG000|Part B|Progressive Disease|0|||
155558501|NCT02799095|561473276|FG001|Part B|Progressive Disease|0|||
155558502|NCT02799095|561473277|FG002|Part B|Progressive Disease|0|||
155558503|NCT02799095|561473278|FG003|Part B|Progressive Disease|0|||
155558504|NCT02799095|561473279|FG004|Part B|Progressive Disease|0|||
155558505|NCT02799095|561473280|FG005|Part B|Progressive Disease|0|||
155558506|NCT02799095|561473281|FG006|Part B|Progressive Disease|0|||
155558507|NCT02799095|561473282|FG007|Part B|Progressive Disease|1|||
155558508|NCT02799095|561473283|FG008|Part B|Progressive Disease|0|||
155558509|NCT02799095|561473284|FG009|Part B|Progressive Disease|0|||
155558510|NCT02799095|561473285|FG010|Part B|Progressive Disease|0|||
155558511|NCT02799095|561473286|FG011|Part B|Progressive Disease|0|||
155558512|NCT02799095|561473287|FG012|Part B|Progressive Disease|0|||
155558513|NCT02799095|561473288|FG013|Part B|Progressive Disease|0|||
155558514|NCT02799095|561473289|FG014|Part B|Progressive Disease|0|||
155558515|NCT02799095|561473290|FG015|Part B|Progressive Disease|0|||
155558516|NCT02799095|561473291|FG016|Part B|Progressive Disease|0|||
155558517|NCT02799095|561473275|FG000|Part B|Withdrawal by Subject|0|||
155558518|NCT02799095|561473276|FG001|Part B|Withdrawal by Subject|0|||
155558519|NCT02799095|561473277|FG002|Part B|Withdrawal by Subject|0|||
155558520|NCT02799095|561473278|FG003|Part B|Withdrawal by Subject|0|||
155558521|NCT02799095|561473279|FG004|Part B|Withdrawal by Subject|0|||
155558522|NCT02799095|561473280|FG005|Part B|Withdrawal by Subject|0|||
155558523|NCT02799095|561473281|FG006|Part B|Withdrawal by Subject|0|||
155558524|NCT02799095|561473282|FG007|Part B|Withdrawal by Subject|10|||
155558525|NCT02799095|561473283|FG008|Part B|Withdrawal by Subject|7|||
155558526|NCT02799095|561473284|FG009|Part B|Withdrawal by Subject|0|||
155558527|NCT02799095|561473285|FG010|Part B|Withdrawal by Subject|0|||
155558528|NCT02799095|561473286|FG011|Part B|Withdrawal by Subject|0|||
155558529|NCT02799095|561473287|FG012|Part B|Withdrawal by Subject|0|||
155558530|NCT02799095|561473288|FG013|Part B|Withdrawal by Subject|0|||
155558531|NCT02799095|561473289|FG014|Part B|Withdrawal by Subject|0|||
155558532|NCT02799095|561473290|FG015|Part B|Withdrawal by Subject|0|||
155558533|NCT02799095|561473291|FG016|Part B|Withdrawal by Subject|0|||
155558534|NCT02799095|561473275|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
155558535|NCT02799095|561473276|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
155558536|NCT02799095|561473277|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
155558537|NCT02799095|561473278|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
155558538|NCT02799095|561473279|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
155558539|NCT02799095|561473280|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
155558540|NCT02799095|561473281|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
155558541|NCT02799095|561473282|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
155558542|NCT02799095|561473283|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
155558543|NCT02799095|561473284|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
155558544|NCT02799095|561473285|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
155558545|NCT02799095|561473286|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
155558546|NCT02799095|561473287|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
155558547|NCT02799095|561473288|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
155558548|NCT02799095|561473289|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
155558549|NCT02799095|561473290|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
155558550|NCT02799095|561473291|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
155558551|NCT02799095|561473275|FG000|Part C|Adverse Event|0|||
155558552|NCT02799095|561473276|FG001|Part C|Adverse Event|0|||
155558553|NCT02799095|561473277|FG002|Part C|Adverse Event|0|||
155558554|NCT02799095|561473278|FG003|Part C|Adverse Event|0|||
155558555|NCT02799095|561473279|FG004|Part C|Adverse Event|0|||
155558556|NCT02799095|561473280|FG005|Part C|Adverse Event|0|||
155558557|NCT02799095|561473281|FG006|Part C|Adverse Event|0|||
155558558|NCT02799095|561473282|FG007|Part C|Adverse Event|0|||
155558559|NCT02799095|561473283|FG008|Part C|Adverse Event|0|||
155558560|NCT02799095|561473284|FG009|Part C|Adverse Event|0|||
155558561|NCT02799095|561473285|FG010|Part C|Adverse Event|3|||
155558562|NCT02799095|561473286|FG011|Part C|Adverse Event|1|||
155558563|NCT02799095|561473287|FG012|Part C|Adverse Event|0|||
155558564|NCT02799095|561473288|FG013|Part C|Adverse Event|1|||
155558565|NCT02799095|561473289|FG014|Part C|Adverse Event|0|||
155558566|NCT02799095|561473290|FG015|Part C|Adverse Event|0|||
155558567|NCT02799095|561473291|FG016|Part C|Adverse Event|0|||
155558568|NCT02799095|561473275|FG000|Part C|Death|0|||
155558569|NCT02799095|561473276|FG001|Part C|Death|0|||
155558570|NCT02799095|561473277|FG002|Part C|Death|0|||
155558571|NCT02799095|561473278|FG003|Part C|Death|0|||
155558572|NCT02799095|561473279|FG004|Part C|Death|0|||
155558573|NCT02799095|561473280|FG005|Part C|Death|0|||
155558574|NCT02799095|561473281|FG006|Part C|Death|0|||
155558575|NCT02799095|561473282|FG007|Part C|Death|0|||
155558576|NCT02799095|561473283|FG008|Part C|Death|0|||
155558577|NCT02799095|561473284|FG009|Part C|Death|0|||
155558578|NCT02799095|561473285|FG010|Part C|Death|7|||
155558579|NCT02799095|561473286|FG011|Part C|Death|5|||
155558580|NCT02799095|561473287|FG012|Part C|Death|6|||
155558581|NCT02799095|561473288|FG013|Part C|Death|8|||
155558582|NCT02799095|561473289|FG014|Part C|Death|1|||
155558583|NCT02799095|561473290|FG015|Part C|Death|8|||
155558584|NCT02799095|561473291|FG016|Part C|Death|1|||
155558585|NCT02799095|561473275|FG000|Part C|Lost to Follow-up|0|||
155558586|NCT02799095|561473276|FG001|Part C|Lost to Follow-up|0|||
155558587|NCT02799095|561473277|FG002|Part C|Lost to Follow-up|0|||
155558588|NCT02799095|561473278|FG003|Part C|Lost to Follow-up|0|||
155558589|NCT02799095|561473279|FG004|Part C|Lost to Follow-up|0|||
155558590|NCT02799095|561473280|FG005|Part C|Lost to Follow-up|0|||
155558591|NCT02799095|561473281|FG006|Part C|Lost to Follow-up|0|||
155558592|NCT02799095|561473282|FG007|Part C|Lost to Follow-up|0|||
155558593|NCT02799095|561473283|FG008|Part C|Lost to Follow-up|0|||
155558594|NCT02799095|561473284|FG009|Part C|Lost to Follow-up|0|||
155558595|NCT02799095|561473285|FG010|Part C|Lost to Follow-up|1|||
155558596|NCT02799095|561473286|FG011|Part C|Lost to Follow-up|1|||
155558597|NCT02799095|561473287|FG012|Part C|Lost to Follow-up|1|||
155558598|NCT02799095|561473288|FG013|Part C|Lost to Follow-up|3|||
155558599|NCT02799095|561473289|FG014|Part C|Lost to Follow-up|0|||
155558600|NCT02799095|561473290|FG015|Part C|Lost to Follow-up|0|||
155558601|NCT02799095|561473291|FG016|Part C|Lost to Follow-up|0|||
155558602|NCT02799095|561473275|FG000|Part C|Progressive Disease|0|||
155558603|NCT02799095|561473276|FG001|Part C|Progressive Disease|0|||
155558604|NCT02799095|561473277|FG002|Part C|Progressive Disease|0|||
155558605|NCT02799095|561473278|FG003|Part C|Progressive Disease|0|||
155558606|NCT02799095|561473279|FG004|Part C|Progressive Disease|0|||
155558607|NCT02799095|561473280|FG005|Part C|Progressive Disease|0|||
155558608|NCT02799095|561473281|FG006|Part C|Progressive Disease|0|||
155558609|NCT02799095|561473282|FG007|Part C|Progressive Disease|0|||
155558610|NCT02799095|561473283|FG008|Part C|Progressive Disease|0|||
155558611|NCT02799095|561473284|FG009|Part C|Progressive Disease|2|||
155558612|NCT02799095|561473285|FG010|Part C|Progressive Disease|13|||
155558613|NCT02799095|561473286|FG011|Part C|Progressive Disease|2|||
155558614|NCT02799095|561473287|FG012|Part C|Progressive Disease|0|||
155558615|NCT02799095|561473288|FG013|Part C|Progressive Disease|1|||
155558616|NCT02799095|561473289|FG014|Part C|Progressive Disease|0|||
155558617|NCT02799095|561473290|FG015|Part C|Progressive Disease|0|||
155558618|NCT02799095|561473291|FG016|Part C|Progressive Disease|0|||
155558619|NCT02799095|561473275|FG000|Part C|Clinical Progression|0|||
155558620|NCT02799095|561473276|FG001|Part C|Clinical Progression|0|||
155558621|NCT02799095|561473277|FG002|Part C|Clinical Progression|0|||
155558622|NCT02799095|561473278|FG003|Part C|Clinical Progression|0|||
155558623|NCT02799095|561473279|FG004|Part C|Clinical Progression|0|||
155558624|NCT02799095|561473280|FG005|Part C|Clinical Progression|0|||
155558625|NCT02799095|561473281|FG006|Part C|Clinical Progression|0|||
155558626|NCT02799095|561473282|FG007|Part C|Clinical Progression|0|||
155558627|NCT02799095|561473283|FG008|Part C|Clinical Progression|0|||
155558628|NCT02799095|561473284|FG009|Part C|Clinical Progression|1|||
155558629|NCT02799095|561473285|FG010|Part C|Clinical Progression|3|||
155558630|NCT02799095|561473286|FG011|Part C|Clinical Progression|0|||
155558631|NCT02799095|561473287|FG012|Part C|Clinical Progression|0|||
155558632|NCT02799095|561473288|FG013|Part C|Clinical Progression|1|||
155558633|NCT02799095|561473289|FG014|Part C|Clinical Progression|0|||
155558634|NCT02799095|561473290|FG015|Part C|Clinical Progression|0|||
155558635|NCT02799095|561473291|FG016|Part C|Clinical Progression|0|||
155558636|NCT02799095|561473275|FG000|Part C|Withdrawal by Subject|0|||
155558637|NCT02799095|561473276|FG001|Part C|Withdrawal by Subject|0|||
155558638|NCT02799095|561473277|FG002|Part C|Withdrawal by Subject|0|||
155558639|NCT02799095|561473278|FG003|Part C|Withdrawal by Subject|0|||
155558640|NCT02799095|561473279|FG004|Part C|Withdrawal by Subject|0|||
155558641|NCT02799095|561473280|FG005|Part C|Withdrawal by Subject|0|||
155558642|NCT02799095|561473281|FG006|Part C|Withdrawal by Subject|0|||
155558643|NCT02799095|561473282|FG007|Part C|Withdrawal by Subject|0|||
155558644|NCT02799095|561473283|FG008|Part C|Withdrawal by Subject|0|||
155558645|NCT02799095|561473284|FG009|Part C|Withdrawal by Subject|0|||
155558646|NCT02799095|561473285|FG010|Part C|Withdrawal by Subject|13|||
155558647|NCT02799095|561473286|FG011|Part C|Withdrawal by Subject|15|||
155558648|NCT02799095|561473287|FG012|Part C|Withdrawal by Subject|13|||
155558649|NCT02799095|561473288|FG013|Part C|Withdrawal by Subject|21|||
155558650|NCT02799095|561473289|FG014|Part C|Withdrawal by Subject|0|||
155558651|NCT02799095|561473290|FG015|Part C|Withdrawal by Subject|12|||
155558652|NCT02799095|561473291|FG016|Part C|Withdrawal by Subject|1|||
155558653|NCT02799095|561473275|FG000|Part C|Physician Decision|0|||
155558654|NCT02799095|561473276|FG001|Part C|Physician Decision|0|||
155558655|NCT02799095|561473277|FG002|Part C|Physician Decision|0|||
155558656|NCT02799095|561473278|FG003|Part C|Physician Decision|0|||
155558657|NCT02799095|561473279|FG004|Part C|Physician Decision|0|||
155558658|NCT02799095|561473280|FG005|Part C|Physician Decision|0|||
155558659|NCT02799095|561473281|FG006|Part C|Physician Decision|0|||
155558660|NCT02799095|561473282|FG007|Part C|Physician Decision|0|||
155558661|NCT02799095|561473283|FG008|Part C|Physician Decision|0|||
155558662|NCT02799095|561473284|FG009|Part C|Physician Decision|0|||
155558663|NCT02799095|561473285|FG010|Part C|Physician Decision|1|||
155558664|NCT02799095|561473286|FG011|Part C|Physician Decision|0|||
155558665|NCT02799095|561473287|FG012|Part C|Physician Decision|0|||
155558666|NCT02799095|561473288|FG013|Part C|Physician Decision|0|||
155558667|NCT02799095|561473289|FG014|Part C|Physician Decision|0|||
155558668|NCT02799095|561473290|FG015|Part C|Physician Decision|0|||
155558669|NCT02799095|561473291|FG016|Part C|Physician Decision|0|||
155558670|NCT02799095|561473275|FG000|Part C|Other|0|||
155558671|NCT02799095|561473276|FG001|Part C|Other|0|||
155558672|NCT02799095|561473277|FG002|Part C|Other|0|||
155558673|NCT02799095|561473278|FG003|Part C|Other|0|||
155558674|NCT02799095|561473279|FG004|Part C|Other|0|||
155558675|NCT02799095|561473280|FG005|Part C|Other|0|||
155558676|NCT02799095|561473281|FG006|Part C|Other|0|||
155558677|NCT02799095|561473282|FG007|Part C|Other|0|||
155558678|NCT02799095|561473283|FG008|Part C|Other|0|||
155558679|NCT02799095|561473284|FG009|Part C|Other|0|||
155558680|NCT02799095|561473285|FG010|Part C|Other|0|||
155558681|NCT02799095|561473286|FG011|Part C|Other|2|||
155558682|NCT02799095|561473287|FG012|Part C|Other|2|||
155558683|NCT02799095|561473288|FG013|Part C|Other|0|||
155558684|NCT02799095|561473289|FG014|Part C|Other|0|||
155558685|NCT02799095|561473290|FG015|Part C|Other|0|||
155558686|NCT02799095|561473291|FG016|Part C|Other|0|||
155558687|NCT02128217|561473300|FG000|Overall Study|Lost to Follow-up|0|||
155558688|NCT02128217|561473301|FG001|Overall Study|Lost to Follow-up|1|||
155558689|NCT00541970|561473302|FG000|Month 7|Protocol Violation|9|||
155558690|NCT00541970|561473303|FG001|Month 7|Protocol Violation|13|||
155558691|NCT00541970|561473304|FG002|Month 7|Protocol Violation|11|||
155558692|NCT00541970|561473305|FG003|Month 7|Protocol Violation|5|||
155558693|NCT00541970|561473302|FG000|Month 12|Adverse Event|0|||
155558694|NCT00541970|561473303|FG001|Month 12|Adverse Event|1|||
155558695|NCT00541970|561473304|FG002|Month 12|Adverse Event|1|||
155558696|NCT00541970|561473305|FG003|Month 12|Adverse Event|1|||
155558697|NCT00541970|561473302|FG000|Month 12|Protocol Violation|12|||
155558698|NCT00541970|561473303|FG001|Month 12|Protocol Violation|21|||
155558699|NCT00541970|561473304|FG002|Month 12|Protocol Violation|20|||
155558700|NCT00541970|561473305|FG003|Month 12|Protocol Violation|15|||
155558701|NCT00541970|561473302|FG000|Month 18|Adverse Event|0|||
155558702|NCT00541970|561473303|FG001|Month 18|Adverse Event|1|||
155558703|NCT00541970|561473304|FG002|Month 18|Adverse Event|1|||
155558704|NCT00541970|561473305|FG003|Month 18|Adverse Event|1|||
155558705|NCT00541970|561473302|FG000|Month 18|Protocol Violation|14|||
155558706|NCT00541970|561473303|FG001|Month 18|Protocol Violation|23|||
155558707|NCT00541970|561473304|FG002|Month 18|Protocol Violation|24|||
155558708|NCT00541970|561473305|FG003|Month 18|Protocol Violation|16|||
155558709|NCT00541970|561473302|FG000|Month 24|Adverse Event|0|||
155558710|NCT00541970|561473303|FG001|Month 24|Adverse Event|1|||
155558711|NCT00541970|561473304|FG002|Month 24|Adverse Event|1|||
155558712|NCT00541970|561473305|FG003|Month 24|Adverse Event|1|||
155558713|NCT00541970|561473302|FG000|Month 24|Protocol Violation|29|||
155558714|NCT00541970|561473303|FG001|Month 24|Protocol Violation|31|||
155558715|NCT00541970|561473304|FG002|Month 24|Protocol Violation|31|||
155558716|NCT00541970|561473305|FG003|Month 24|Protocol Violation|21|||
155558717|NCT00541970|561473302|FG000|Month 36|Protocol Violation|61|||
155558718|NCT00541970|561473303|FG001|Month 36|Protocol Violation|66|||
155558719|NCT00541970|561473304|FG002|Month 36|Protocol Violation|66|||
155558720|NCT00541970|561473305|FG003|Month 36|Protocol Violation|60|||
155558721|NCT00541970|561473302|FG000|Month 48|Withdrawal by Subject|2|||
155558722|NCT00541970|561473303|FG001|Month 48|Withdrawal by Subject|4|||
155558723|NCT00541970|561473304|FG002|Month 48|Withdrawal by Subject|4|||
155558724|NCT00541970|561473305|FG003|Month 48|Withdrawal by Subject|2|||
155558725|NCT00541970|561473302|FG000|Month 48|Other|3|||
155558726|NCT00541970|561473303|FG001|Month 48|Other|1|||
155558727|NCT00541970|561473304|FG002|Month 48|Other|1|||
155558728|NCT00541970|561473305|FG003|Month 48|Other|0|||
155558729|NCT00541970|561473302|FG000|Month 48|Lost to Follow-up|66|||
155558730|NCT00541970|561473303|FG001|Month 48|Lost to Follow-up|68|||
155558731|NCT00541970|561473304|FG002|Month 48|Lost to Follow-up|68|||
155558732|NCT00541970|561473305|FG003|Month 48|Lost to Follow-up|73|||
155558733|NCT00541970|561473302|FG000|Month 60|Protocol Violation|78|||
155558734|NCT00541970|561473303|FG001|Month 60|Protocol Violation|77|||
155558735|NCT00541970|561473304|FG002|Month 60|Protocol Violation|82|||
155558736|NCT00541970|561473305|FG003|Month 60|Protocol Violation|72|||
155558737|NCT04280705|561473306|FG000|Overall Study|Enrolled but not treated|4|||
155558738|NCT04280705|561473307|FG001|Overall Study|Enrolled but not treated|10|||
155558739|NCT04280705|561473306|FG000|Overall Study|Physician Decision|1|||
155558740|NCT04280705|561473307|FG001|Overall Study|Physician Decision|0|||
155558741|NCT04280705|561473306|FG000|Overall Study|Withdrawal by Subject|7|||
155558742|NCT04280705|561473307|FG001|Overall Study|Withdrawal by Subject|9|||
155558743|NCT04280705|561473306|FG000|Overall Study|Adverse Event|0|||
155558744|NCT04280705|561473307|FG001|Overall Study|Adverse Event|4|||
155558745|NCT04280705|561473306|FG000|Overall Study|Transferred to another hospital|1|||
155558746|NCT04280705|561473307|FG001|Overall Study|Transferred to another hospital|1|||
155558747|NCT03222583|561473308|FG000|Overall Study|Withdrawal by Subject|3|||
155558748|NCT03222583|561473309|FG001|Overall Study|Withdrawal by Subject|3|||
155558749|NCT03222583|561473308|FG000|Overall Study|Lost to Follow-up|1|||
155558750|NCT03222583|561473309|FG001|Overall Study|Lost to Follow-up|0|||
155558751|NCT03222583|561473308|FG000|Overall Study|Other|1|||
155558752|NCT03222583|561473309|FG001|Overall Study|Other|3|||
155558753|NCT03986138|561473310|FG000|First MRI Examination|Physician Decision|0|||
155558754|NCT03986138|561473311|FG001|First MRI Examination|Physician Decision|1|||
155558755|NCT03986138|561473310|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
155558756|NCT03986138|561473311|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
155558757|NCT03986138|561473310|FG000|Washout|Withdrawal by Subject|4|||
155558758|NCT03986138|561473311|FG001|Washout|Withdrawal by Subject|5|||
155558759|NCT03986138|561473310|FG000|Washout|Lost to Follow-up|0|||
155558760|NCT03986138|561473311|FG001|Washout|Lost to Follow-up|2|||
155558761|NCT03986138|561473310|FG000|Washout|Adverse Event|1|||
155558762|NCT03986138|561473311|FG001|Washout|Adverse Event|1|||
155558763|NCT03986138|561473310|FG000|Washout|Other reason|5|||
155558764|NCT03986138|561473311|FG001|Washout|Other reason|5|||
155558765|NCT03986138|561473310|FG000|Second MRI Examination|Withdrawal by Subject|0|||
155558766|NCT03986138|561473311|FG001|Second MRI Examination|Withdrawal by Subject|2|||
155558767|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Death|89|||
155558768|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Death|193|||
155558769|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Death|198|||
155558770|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
155558771|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
155558772|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
155558773|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
155558774|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
155558775|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
155558776|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
155558777|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
155558778|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
155558779|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
155558780|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
155558781|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
155558782|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
155558783|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
155558784|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
155558785|NCT02031458|561473312|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
155558786|NCT02031458|561473313|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
155558787|NCT02031458|561473314|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
155558788|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Death|36|||
155558789|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Death|87|||
155558790|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Death|100|||
155558791|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
155558792|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
155558793|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
155558794|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Physician Decision|0|||
155558795|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Physician Decision|1|||
155558796|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Physician Decision|0|||
155558797|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
155558798|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
155558799|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
155558800|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
155558801|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
155558802|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
155558803|NCT02031458|561473312|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
155558804|NCT02031458|561473313|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
155558805|NCT02031458|561473314|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
155558806|NCT02031458|561473312|FG000|Baseline to May 8, 2015|On Treatment|43|||
155558807|NCT02031458|561473313|FG001|Baseline to May 8, 2015|On Treatment|81|||
155558808|NCT02031458|561473314|FG002|Baseline to May 8, 2015|On Treatment|73|||
155558809|NCT02031458|561473312|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
155558810|NCT02031458|561473313|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
155558811|NCT02031458|561473314|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
155558812|NCT00721630|561473315|FG000|Overall Study|Participant found to be ineligible|1|||
155558813|NCT00667810|561473318|FG000|Overall Study|Adverse Event|13|||
155558814|NCT00667810|561473319|FG001|Overall Study|Adverse Event|14|||
155558815|NCT00667810|561473320|FG002|Overall Study|Adverse Event|19|||
155558816|NCT00667810|561473321|FG003|Overall Study|Adverse Event|1|||
155558817|NCT00667810|561473318|FG000|Overall Study|Death|1|||
155558818|NCT00667810|561473319|FG001|Overall Study|Death|1|||
155558819|NCT00667810|561473320|FG002|Overall Study|Death|3|||
155558820|NCT00667810|561473321|FG003|Overall Study|Death|0|||
155558821|NCT00667810|561473318|FG000|Overall Study|Lack of Efficacy|1|||
155558822|NCT00667810|561473319|FG001|Overall Study|Lack of Efficacy|0|||
155558823|NCT00667810|561473320|FG002|Overall Study|Lack of Efficacy|2|||
155558824|NCT00667810|561473321|FG003|Overall Study|Lack of Efficacy|0|||
155558825|NCT00667810|561473318|FG000|Overall Study|Lost to Follow-up|1|||
155558826|NCT00667810|561473319|FG001|Overall Study|Lost to Follow-up|4|||
155558827|NCT00667810|561473320|FG002|Overall Study|Lost to Follow-up|2|||
155558828|NCT00667810|561473321|FG003|Overall Study|Lost to Follow-up|0|||
155558829|NCT00667810|561473318|FG000|Overall Study|Physician Decision|1|||
155558830|NCT00667810|561473319|FG001|Overall Study|Physician Decision|1|||
155558831|NCT00667810|561473320|FG002|Overall Study|Physician Decision|2|||
155558832|NCT00667810|561473321|FG003|Overall Study|Physician Decision|0|||
155558833|NCT00667810|561473318|FG000|Overall Study|Protocol Violation|0|||
155558834|NCT00667810|561473319|FG001|Overall Study|Protocol Violation|2|||
155558835|NCT00667810|561473320|FG002|Overall Study|Protocol Violation|0|||
155558836|NCT00667810|561473321|FG003|Overall Study|Protocol Violation|0|||
155558837|NCT00667810|561473318|FG000|Overall Study|Withdrawal by Subject|14|||
155558838|NCT00667810|561473319|FG001|Overall Study|Withdrawal by Subject|20|||
155558839|NCT00667810|561473320|FG002|Overall Study|Withdrawal by Subject|29|||
155558840|NCT00667810|561473321|FG003|Overall Study|Withdrawal by Subject|1|||
155558841|NCT00667810|561473318|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
155558842|NCT00667810|561473319|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
155558843|NCT00667810|561473320|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
155558844|NCT00667810|561473321|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155558845|NCT00667810|561473318|FG000|Overall Study|Failed to Return|0|||
155558846|NCT00667810|561473319|FG001|Overall Study|Failed to Return|0|||
155558847|NCT00667810|561473320|FG002|Overall Study|Failed to Return|2|||
155558848|NCT00667810|561473321|FG003|Overall Study|Failed to Return|0|||
155558849|NCT00667810|561473318|FG000|Overall Study|Loss of Caregiver|0|||
155558850|NCT00667810|561473319|FG001|Overall Study|Loss of Caregiver|1|||
155558851|NCT00667810|561473320|FG002|Overall Study|Loss of Caregiver|3|||
155558852|NCT00667810|561473321|FG003|Overall Study|Loss of Caregiver|0|||
155558853|NCT00667810|561473318|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
155558854|NCT00667810|561473319|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
155558855|NCT00667810|561473320|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
155558856|NCT00667810|561473321|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
155558857|NCT00667810|561473318|FG000|Overall Study|Other|6|||
155558858|NCT00667810|561473319|FG001|Overall Study|Other|6|||
155558859|NCT00667810|561473320|FG002|Overall Study|Other|5|||
155558860|NCT00667810|561473321|FG003|Overall Study|Other|0|||
155558861|NCT03412396|561473332|FG000|Overall Study|Withdrawal by Subject|2|||
155558862|NCT03412396|561473332|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
155558863|NCT03412396|561473332|FG000|Overall Study|Did not undergo RP|2|||
155558864|NCT03493386|561473337|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155558865|NCT03493386|561473338|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
155558866|NCT03493386|561473339|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155558867|NCT03493386|561473340|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155558868|NCT01447420|561473355|FG000|Overall Study|Adverse Event|2|||
155558869|NCT01447420|561473356|FG001|Overall Study|Adverse Event|4|||
155558870|NCT01447420|561473357|FG002|Overall Study|Adverse Event|2|||
155558871|NCT01447420|561473355|FG000|Overall Study|Protocol Violation|3|||
155558872|NCT01447420|561473356|FG001|Overall Study|Protocol Violation|3|||
155558873|NCT01447420|561473357|FG002|Overall Study|Protocol Violation|0|||
155558874|NCT01447420|561473355|FG000|Overall Study|Withdrawal by Subject|4|||
155558875|NCT01447420|561473356|FG001|Overall Study|Withdrawal by Subject|1|||
155558876|NCT01447420|561473357|FG002|Overall Study|Withdrawal by Subject|0|||
155558877|NCT01447420|561473355|FG000|Overall Study|Lack of Efficacy|1|||
155558878|NCT01447420|561473356|FG001|Overall Study|Lack of Efficacy|19|||
155558879|NCT01447420|561473357|FG002|Overall Study|Lack of Efficacy|8|||
155558880|NCT02731326|561473358|FG000|Overall Study|Withdrawal by Subject|4|||
155558881|NCT02731326|561473359|FG001|Overall Study|Withdrawal by Subject|1|||
155558882|NCT02731326|561473358|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
155558883|NCT02731326|561473359|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
155558884|NCT02731326|561473358|FG000|Overall Study|Discharged without AliveCor|10|||
155558885|NCT02731326|561473359|FG001|Overall Study|Discharged without AliveCor|0|||
155558886|NCT02731326|561473358|FG000|Overall Study|Duplicate Participant|1|||
155558887|NCT02731326|561473359|FG001|Overall Study|Duplicate Participant|1|||
155558888|NCT04480710|561473364|FG000|Overall Study|Adverse Event|0|||
155558889|NCT04480710|561473365|FG001|Overall Study|Adverse Event|2|||
155558890|NCT04480710|561473366|FG002|Overall Study|Adverse Event|0|||
155558891|NCT04480710|561473367|FG003|Overall Study|Adverse Event|0|||
155558892|NCT04480710|561473364|FG000|Overall Study|Withdrawal by Subject|0|||
155558893|NCT04480710|561473365|FG001|Overall Study|Withdrawal by Subject|1|||
155558894|NCT04480710|561473366|FG002|Overall Study|Withdrawal by Subject|0|||
155558895|NCT04480710|561473367|FG003|Overall Study|Withdrawal by Subject|0|||
155558896|NCT04480710|561473364|FG000|Overall Study|Physician Decision|0|||
155558897|NCT04480710|561473365|FG001|Overall Study|Physician Decision|0|||
155558898|NCT04480710|561473366|FG002|Overall Study|Physician Decision|1|||
155558899|NCT04480710|561473367|FG003|Overall Study|Physician Decision|0|||
155558900|NCT04480021|561473368|FG000|Overall Study|Lost to Follow-up|3|||
155558901|NCT04480021|561473369|FG001|Overall Study|Lost to Follow-up|4|||
155558902|NCT05084963|561473370|FG000|Overall Study|Withdrawal by Subject|0|||
155558903|NCT05084963|561473371|FG001|Overall Study|Withdrawal by Subject|0|||
155558904|NCT05084963|561473372|FG002|Overall Study|Withdrawal by Subject|1|||
155558905|NCT03569228|561473373|FG000|Overall Study|Withdrawal by PI|0|||
155558906|NCT03569228|561473374|FG001|Overall Study|Withdrawal by PI|0|||
155558907|NCT03569228|561473375|FG002|Overall Study|Withdrawal by PI|2|||
155558908|NCT03569228|561473376|FG003|Overall Study|Withdrawal by PI|2|||
155558909|NCT03569228|561473377|FG004|Overall Study|Withdrawal by PI|1|||
155558910|NCT03569228|561473378|FG005|Overall Study|Withdrawal by PI|0|||
155558911|NCT03569228|561473379|FG006|Overall Study|Withdrawal by PI|0|||
155558912|NCT03569228|561473380|FG007|Overall Study|Withdrawal by PI|0|||
155558913|NCT03569228|561473381|FG008|Overall Study|Withdrawal by PI|0|||
155558914|NCT03569228|561473373|FG000|Overall Study|Lost to Follow-up|0|||
155558915|NCT03569228|561473374|FG001|Overall Study|Lost to Follow-up|0|||
155558916|NCT03569228|561473375|FG002|Overall Study|Lost to Follow-up|0|||
155558917|NCT03569228|561473376|FG003|Overall Study|Lost to Follow-up|0|||
155558918|NCT03569228|561473377|FG004|Overall Study|Lost to Follow-up|0|||
155558919|NCT03569228|561473378|FG005|Overall Study|Lost to Follow-up|0|||
155658064|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155558920|NCT03569228|561473379|FG006|Overall Study|Lost to Follow-up|0|||
155558921|NCT03569228|561473380|FG007|Overall Study|Lost to Follow-up|0|||
155558922|NCT03569228|561473381|FG008|Overall Study|Lost to Follow-up|1|||
155558923|NCT03569228|561473373|FG000|Overall Study|Screen Fail|2|||
155558924|NCT03569228|561473374|FG001|Overall Study|Screen Fail|2|||
155558925|NCT03569228|561473375|FG002|Overall Study|Screen Fail|1|||
155558926|NCT03569228|561473376|FG003|Overall Study|Screen Fail|1|||
155558927|NCT03569228|561473377|FG004|Overall Study|Screen Fail|1|||
155558928|NCT03569228|561473378|FG005|Overall Study|Screen Fail|3|||
155558929|NCT03569228|561473379|FG006|Overall Study|Screen Fail|1|||
155558930|NCT03569228|561473380|FG007|Overall Study|Screen Fail|5|||
155558931|NCT03569228|561473381|FG008|Overall Study|Screen Fail|2|||
155558932|NCT03819049|561473382|FG000|Overall Study|Lost to Follow-up|1|||
155558933|NCT03819049|561473383|FG001|Overall Study|Lost to Follow-up|2|||
155558934|NCT03819049|561473384|FG002|Overall Study|Lost to Follow-up|9|||
155558935|NCT03819049|561473385|FG003|Overall Study|Lost to Follow-up|0|||
155558936|NCT03819049|561473386|FG004|Overall Study|Lost to Follow-up|3|||
155558937|NCT03819049|561473387|FG005|Overall Study|Lost to Follow-up|1|||
155558938|NCT03819049|561473388|FG006|Overall Study|Lost to Follow-up|0|||
155558939|NCT03819049|561473382|FG000|Overall Study|Withdrawal by Subject|0|||
155558940|NCT03819049|561473383|FG001|Overall Study|Withdrawal by Subject|0|||
155558941|NCT03819049|561473384|FG002|Overall Study|Withdrawal by Subject|18|||
155558942|NCT03819049|561473385|FG003|Overall Study|Withdrawal by Subject|0|||
155558943|NCT03819049|561473386|FG004|Overall Study|Withdrawal by Subject|10|||
155558944|NCT03819049|561473387|FG005|Overall Study|Withdrawal by Subject|9|||
155558945|NCT03819049|561473388|FG006|Overall Study|Withdrawal by Subject|1|||
155558946|NCT03819049|561473382|FG000|Overall Study|Ongoing|0|||
155558947|NCT03819049|561473383|FG001|Overall Study|Ongoing|0|||
155558948|NCT03819049|561473384|FG002|Overall Study|Ongoing|75|||
155558949|NCT03819049|561473385|FG003|Overall Study|Ongoing|0|||
155558950|NCT03819049|561473386|FG004|Overall Study|Ongoing|41|||
155558951|NCT03819049|561473387|FG005|Overall Study|Ongoing|0|||
155558952|NCT03819049|561473388|FG006|Overall Study|Ongoing|0|||
155558953|NCT03819049|561473382|FG000|Overall Study|Other|0|||
155558954|NCT03819049|561473383|FG001|Overall Study|Other|0|||
155558955|NCT03819049|561473384|FG002|Overall Study|Other|2|||
155558956|NCT03819049|561473385|FG003|Overall Study|Other|0|||
155558957|NCT03819049|561473386|FG004|Overall Study|Other|0|||
155558958|NCT03819049|561473387|FG005|Overall Study|Other|0|||
155558959|NCT03819049|561473388|FG006|Overall Study|Other|0|||
155558960|NCT03819049|561473382|FG000|Overall Study|Randomized but not vaccinated|0|||
155558961|NCT03819049|561473383|FG001|Overall Study|Randomized but not vaccinated|0|||
155558962|NCT03819049|561473384|FG002|Overall Study|Randomized but not vaccinated|0|||
155558963|NCT03819049|561473385|FG003|Overall Study|Randomized but not vaccinated|1|||
155558964|NCT03819049|561473386|FG004|Overall Study|Randomized but not vaccinated|0|||
155558965|NCT03819049|561473387|FG005|Overall Study|Randomized but not vaccinated|2|||
155558966|NCT03819049|561473388|FG006|Overall Study|Randomized but not vaccinated|1|||
155558967|NCT03819049|561473382|FG000|Overall Study|Physician Decision|0|||
155558968|NCT03819049|561473383|FG001|Overall Study|Physician Decision|0|||
155558969|NCT03819049|561473384|FG002|Overall Study|Physician Decision|0|||
155558970|NCT03819049|561473385|FG003|Overall Study|Physician Decision|0|||
155558971|NCT03819049|561473386|FG004|Overall Study|Physician Decision|0|||
155558972|NCT03819049|561473387|FG005|Overall Study|Physician Decision|0|||
155558973|NCT03819049|561473388|FG006|Overall Study|Physician Decision|1|||
155558974|NCT01986010|561473389|FG000|Overall Study|Adverse Event|0|||
155558975|NCT01986010|561473390|FG001|Overall Study|Adverse Event|1|||
155558976|NCT01986010|561473391|FG002|Overall Study|Adverse Event|0|||
155558977|NCT01986010|561473392|FG003|Overall Study|Adverse Event|0|||
155558978|NCT01986010|561473393|FG004|Overall Study|Adverse Event|0|||
155558979|NCT01986010|561473394|FG005|Overall Study|Adverse Event|0|||
155558980|NCT01986010|561473395|FG006|Overall Study|Adverse Event|0|||
155558981|NCT01986010|561473396|FG007|Overall Study|Adverse Event|0|||
155558982|NCT01986010|561473397|FG008|Overall Study|Adverse Event|0|||
155558983|NCT01986010|561473398|FG009|Overall Study|Adverse Event|0|||
155558984|NCT01986010|561473399|FG010|Overall Study|Adverse Event|0|||
155558985|NCT01986010|561473400|FG011|Overall Study|Adverse Event|0|||
155558986|NCT01986010|561473401|FG012|Overall Study|Adverse Event|0|||
155558987|NCT01986010|561473402|FG013|Overall Study|Adverse Event|0|||
155558988|NCT01986010|561473403|FG014|Overall Study|Adverse Event|0|||
155558989|NCT01986010|561473404|FG015|Overall Study|Adverse Event|1|||
155558990|NCT01986010|561473405|FG016|Overall Study|Adverse Event|0|||
155558991|NCT01986010|561473389|FG000|Overall Study|Lost to Follow-up|2|||
155558992|NCT01986010|561473390|FG001|Overall Study|Lost to Follow-up|1|||
155558993|NCT01986010|561473391|FG002|Overall Study|Lost to Follow-up|2|||
155558994|NCT01986010|561473392|FG003|Overall Study|Lost to Follow-up|2|||
155558995|NCT01986010|561473393|FG004|Overall Study|Lost to Follow-up|2|||
155558996|NCT01986010|561473394|FG005|Overall Study|Lost to Follow-up|2|||
155558997|NCT01986010|561473395|FG006|Overall Study|Lost to Follow-up|0|||
155558998|NCT01986010|561473396|FG007|Overall Study|Lost to Follow-up|0|||
155558999|NCT01986010|561473397|FG008|Overall Study|Lost to Follow-up|4|||
155559000|NCT01986010|561473398|FG009|Overall Study|Lost to Follow-up|2|||
155559001|NCT01986010|561473399|FG010|Overall Study|Lost to Follow-up|0|||
155559002|NCT01986010|561473400|FG011|Overall Study|Lost to Follow-up|1|||
155559003|NCT01986010|561473401|FG012|Overall Study|Lost to Follow-up|1|||
155559004|NCT01986010|561473402|FG013|Overall Study|Lost to Follow-up|1|||
155559005|NCT01986010|561473403|FG014|Overall Study|Lost to Follow-up|2|||
155559006|NCT01986010|561473404|FG015|Overall Study|Lost to Follow-up|0|||
155559007|NCT01986010|561473405|FG016|Overall Study|Lost to Follow-up|0|||
155559008|NCT01986010|561473389|FG000|Overall Study|Physician Decision|0|||
155559009|NCT01986010|561473390|FG001|Overall Study|Physician Decision|0|||
155559010|NCT01986010|561473391|FG002|Overall Study|Physician Decision|0|||
155559011|NCT01986010|561473392|FG003|Overall Study|Physician Decision|0|||
155559012|NCT01986010|561473393|FG004|Overall Study|Physician Decision|0|||
155559013|NCT01986010|561473394|FG005|Overall Study|Physician Decision|0|||
155559014|NCT01986010|561473395|FG006|Overall Study|Physician Decision|0|||
155559015|NCT01986010|561473396|FG007|Overall Study|Physician Decision|0|||
155559016|NCT01986010|561473397|FG008|Overall Study|Physician Decision|0|||
155559017|NCT01986010|561473398|FG009|Overall Study|Physician Decision|0|||
155559018|NCT01986010|561473399|FG010|Overall Study|Physician Decision|0|||
155559019|NCT01986010|561473400|FG011|Overall Study|Physician Decision|0|||
155559020|NCT01986010|561473401|FG012|Overall Study|Physician Decision|0|||
155559021|NCT01986010|561473402|FG013|Overall Study|Physician Decision|0|||
155559022|NCT01986010|561473403|FG014|Overall Study|Physician Decision|1|||
155559023|NCT01986010|561473404|FG015|Overall Study|Physician Decision|0|||
155559024|NCT01986010|561473405|FG016|Overall Study|Physician Decision|0|||
155559025|NCT01986010|561473389|FG000|Overall Study|Withdrawal by Subject|2|||
155559026|NCT01986010|561473390|FG001|Overall Study|Withdrawal by Subject|2|||
155559027|NCT01986010|561473391|FG002|Overall Study|Withdrawal by Subject|3|||
155559028|NCT01986010|561473392|FG003|Overall Study|Withdrawal by Subject|0|||
155559029|NCT01986010|561473393|FG004|Overall Study|Withdrawal by Subject|2|||
155559030|NCT01986010|561473394|FG005|Overall Study|Withdrawal by Subject|4|||
155559031|NCT01986010|561473395|FG006|Overall Study|Withdrawal by Subject|0|||
155559032|NCT01986010|561473396|FG007|Overall Study|Withdrawal by Subject|0|||
155559033|NCT01986010|561473397|FG008|Overall Study|Withdrawal by Subject|0|||
155559034|NCT01986010|561473398|FG009|Overall Study|Withdrawal by Subject|0|||
155559035|NCT01986010|561473399|FG010|Overall Study|Withdrawal by Subject|0|||
155559036|NCT01986010|561473400|FG011|Overall Study|Withdrawal by Subject|2|||
155559037|NCT01986010|561473401|FG012|Overall Study|Withdrawal by Subject|0|||
155559038|NCT01986010|561473402|FG013|Overall Study|Withdrawal by Subject|1|||
155559039|NCT01986010|561473403|FG014|Overall Study|Withdrawal by Subject|2|||
155559040|NCT01986010|561473404|FG015|Overall Study|Withdrawal by Subject|0|||
155559041|NCT01986010|561473405|FG016|Overall Study|Withdrawal by Subject|0|||
155559042|NCT01986010|561473389|FG000|Overall Study|Status Not Recorded|2|||
155559043|NCT01986010|561473390|FG001|Overall Study|Status Not Recorded|4|||
155559044|NCT01986010|561473391|FG002|Overall Study|Status Not Recorded|2|||
155559045|NCT01986010|561473392|FG003|Overall Study|Status Not Recorded|0|||
155559046|NCT01986010|561473393|FG004|Overall Study|Status Not Recorded|1|||
155559047|NCT01986010|561473394|FG005|Overall Study|Status Not Recorded|2|||
155559048|NCT01986010|561473395|FG006|Overall Study|Status Not Recorded|0|||
155559049|NCT01986010|561473396|FG007|Overall Study|Status Not Recorded|0|||
155559050|NCT01986010|561473397|FG008|Overall Study|Status Not Recorded|2|||
155559051|NCT01986010|561473398|FG009|Overall Study|Status Not Recorded|1|||
155559052|NCT01986010|561473399|FG010|Overall Study|Status Not Recorded|7|||
155559053|NCT01986010|561473400|FG011|Overall Study|Status Not Recorded|7|||
155559054|NCT01986010|561473401|FG012|Overall Study|Status Not Recorded|9|||
155559055|NCT01986010|561473402|FG013|Overall Study|Status Not Recorded|9|||
155559056|NCT01986010|561473403|FG014|Overall Study|Status Not Recorded|5|||
155559057|NCT01986010|561473404|FG015|Overall Study|Status Not Recorded|10|||
155559058|NCT01986010|561473405|FG016|Overall Study|Status Not Recorded|4|||
155559059|NCT01335997|561473408|FG000|Period I and II|Adverse Event|63|||
155559060|NCT01335997|561473409|FG001|Period I and II|Adverse Event|43|||
155559061|NCT01335997|561473408|FG000|Period I and II|Noncompliance with Study Drug|1|||
155559062|NCT01335997|561473409|FG001|Period I and II|Noncompliance with Study Drug|1|||
155559063|NCT01335997|561473408|FG000|Period I and II|Lost to Follow-up|3|||
155559064|NCT01335997|561473409|FG001|Period I and II|Lost to Follow-up|5|||
155559065|NCT01335997|561473408|FG000|Period I and II|Withdrawal by Subject|9|||
155559066|NCT01335997|561473409|FG001|Period I and II|Withdrawal by Subject|4|||
155559067|NCT01335997|561473408|FG000|Period I and II|Study Terminated by Sponsor|406|||
155559068|NCT01335997|561473409|FG001|Period I and II|Study Terminated by Sponsor|415|||
155559069|NCT01335997|561473408|FG000|Period I and II|Protocol Violation|9|||
155559070|NCT01335997|561473409|FG001|Period I and II|Protocol Violation|10|||
155559071|NCT01335997|561473408|FG000|Period I and II|Physician Decision|2|||
155559072|NCT01335997|561473409|FG001|Period I and II|Physician Decision|1|||
155559073|NCT01335997|561473408|FG000|Period III|Adverse Event|0|||
155559074|NCT01335997|561473409|FG001|Period III|Adverse Event|2|||
155559075|NCT01335997|561473408|FG000|Period III|Study Terminated by Sponsor|77|||
155559076|NCT01335997|561473409|FG001|Period III|Study Terminated by Sponsor|76|||
155559077|NCT01335997|561473408|FG000|Period III|Protocol Violation|0|||
155559078|NCT01335997|561473409|FG001|Period III|Protocol Violation|1|||
155559079|NCT01335997|561473408|FG000|Period III|Lost to Follow-up|1|||
155559080|NCT01335997|561473409|FG001|Period III|Lost to Follow-up|0|||
155559081|NCT01103466|561473410|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
155559082|NCT01103466|561473411|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
155559083|NCT01103466|561473412|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
155559084|NCT01103466|561473410|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
155559085|NCT01103466|561473411|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
155559086|NCT01103466|561473412|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
155559087|NCT01103466|561473410|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
155559088|NCT01103466|561473411|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
155559089|NCT01103466|561473412|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
155559090|NCT01103466|561473410|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
155559091|NCT01103466|561473411|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
155559092|NCT01103466|561473412|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
155559093|NCT01103466|561473410|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
155559094|NCT01103466|561473411|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
155559095|NCT01103466|561473412|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
155559096|NCT01103466|561473410|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
155559097|NCT01103466|561473411|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
155559098|NCT01103466|561473412|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
155559099|NCT02994940|561473415|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
155559100|NCT02994940|561473416|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
155559101|NCT02994940|561473415|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
155559102|NCT02994940|561473416|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
155559103|NCT02994940|561473415|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
155559104|NCT02994940|561473416|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
155559105|NCT02853370|561473421|FG000|Overall Study|Physician Decision|1|||
155559106|NCT02853370|561473421|FG000|Overall Study|Lack of Efficacy|2|||
155559107|NCT02853370|561473421|FG000|Overall Study|Death|1|||
155559108|NCT02853370|561473421|FG000|Overall Study|Adverse Event|4|||
155559109|NCT02853370|561473421|FG000|Overall Study|Withdrawal by Subject|3|||
155559110|NCT00643565|561473424|FG000|Overall Study|Death|12|||
155559111|NCT00643565|561473425|FG001|Overall Study|Death|11|||
155559112|NCT00643565|561473424|FG000|Overall Study|Withdrawal by Subject|4|||
155658065|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
155658066|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155658067|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155658068|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155658069|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155658070|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155658071|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155658072|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155559113|NCT00643565|561473425|FG001|Overall Study|Withdrawal by Subject|1|||
155559114|NCT00643565|561473424|FG000|Overall Study|Lost to Follow-up|0|||
155559115|NCT00643565|561473425|FG001|Overall Study|Lost to Follow-up|6|||
155559116|NCT00643565|561473424|FG000|Overall Study|Other|7|||
155559117|NCT00643565|561473425|FG001|Overall Study|Other|8|||
155559118|NCT00643565|561473424|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
155559119|NCT00643565|561473425|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
155559120|NCT00643565|561473424|FG000|Overall Study|Recurrence of Disease|2|||
155559121|NCT00643565|561473425|FG001|Overall Study|Recurrence of Disease|1|||
155559122|NCT00643565|561473424|FG000|Overall Study|Progression of Disease|18|||
155559123|NCT00643565|561473425|FG001|Overall Study|Progression of Disease|14|||
155559124|NCT00643565|561473424|FG000|Overall Study|Protocol Violation|3|||
155559125|NCT00643565|561473425|FG001|Overall Study|Protocol Violation|0|||
155559126|NCT00643565|561473424|FG000|Overall Study|Did Not Cooperate|0|||
155559127|NCT00643565|561473425|FG001|Overall Study|Did Not Cooperate|1|||
155559128|NCT00643565|561473424|FG000|Overall Study|Administrative|22|||
155559129|NCT00643565|561473425|FG001|Overall Study|Administrative|16|||
155559130|NCT00643565|561473424|FG000|Overall Study|Adverse Event|5|||
155559131|NCT00643565|561473425|FG001|Overall Study|Adverse Event|8|||
155559132|NCT02317614|561473426|FG000|Overall Study|Lost to Follow-up|1|||
155559133|NCT02317614|561473427|FG001|Overall Study|Lost to Follow-up|1|||
155559134|NCT02317614|561473426|FG000|Overall Study|Withdrawal by Subject|1|||
155559135|NCT02317614|561473427|FG001|Overall Study|Withdrawal by Subject|0|||
155559136|NCT02317614|561473426|FG000|Overall Study|Death|1|||
155559137|NCT02317614|561473427|FG001|Overall Study|Death|1|||
155559138|NCT03283761|561473428|FG000|Study Treatment|Patient Non-Compliance|1|||
155559139|NCT03283761|561473428|FG000|Study Treatment|Alternative Cancer Therapy|7|||
155559140|NCT03283761|561473428|FG000|Study Treatment|Disease progression|21|||
155559141|NCT03283761|561473428|FG000|Study Treatment|Adverse Event|3|||
155559142|NCT03283761|561473428|FG000|Study Treatment|Withdrawal by Subject|4|||
155559143|NCT03283761|561473428|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
155559144|NCT03283761|561473428|FG000|Study Treatment|Symptomatic Deterioration|1|||
155559145|NCT03283761|561473428|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
155559146|NCT03283761|561473428|FG000|Follow up|Lost to Follow-up|1|||
155559147|NCT03283761|561473428|FG000|Follow up|Symptomatic Deterioration|1|||
155559148|NCT03283761|561473428|FG000|Follow up|Death|29|||
155559149|NCT03283761|561473428|FG000|Follow up|study terminated|4|||
155559150|NCT03283761|561473428|FG000|Follow up|Primary Investigator Withdrawal|1|||
155559151|NCT03283761|561473428|FG000|Follow up|Switched to alternative therapy|1|||
155559152|NCT03283761|561473428|FG000|Follow up|Subject is now in Hospice|1|||
155559153|NCT01355159|561473435|FG000|Overall Study|Withdrew consent|39|||
155559154|NCT01355159|561473436|FG001|Overall Study|Withdrew consent|47|||
155559155|NCT01355159|561473435|FG000|Overall Study|No primary outcome data|17|||
155559156|NCT01355159|561473436|FG001|Overall Study|No primary outcome data|11|||
155559157|NCT01355159|561473435|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
155559158|NCT01355159|561473436|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
155559159|NCT01355159|561473435|FG000|Overall Study|Early intrauterine fetal death|6|||
155559160|NCT01355159|561473436|FG001|Overall Study|Early intrauterine fetal death|6|||
155559161|NCT03276221|561473437|FG000|Overall Study|Lost to Follow-up|6|||
155559162|NCT03276221|561473438|FG001|Overall Study|Lost to Follow-up|2|||
155559163|NCT03276221|561473439|FG002|Overall Study|Lost to Follow-up|0|||
155559164|NCT03276221|561473437|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
155559165|NCT03276221|561473438|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
155559166|NCT03276221|561473439|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
155559167|NCT00681590|561473440|FG000|Overall Study|Withdrawal by Subject|2|||
155559168|NCT00681590|561473441|FG001|Overall Study|Withdrawal by Subject|12|||
155559169|NCT02912650|561473442|FG000|Overall Study|Withdrawal by Subject|1|||
155559170|NCT02912650|561473443|FG001|Overall Study|Withdrawal by Subject|0|||
155559171|NCT02912650|561473444|FG002|Overall Study|Withdrawal by Subject|1|||
155559172|NCT02912650|561473445|FG003|Overall Study|Withdrawal by Subject|5|||
155559173|NCT02912650|561473442|FG000|Overall Study|Adverse Event|0|||
155559174|NCT02912650|561473443|FG001|Overall Study|Adverse Event|0|||
155559175|NCT02912650|561473444|FG002|Overall Study|Adverse Event|1|||
155559176|NCT02912650|561473445|FG003|Overall Study|Adverse Event|0|||
155559177|NCT02562482|561473446|FG000|Overall Study|Enrolled, but did not receive product|4|||
155559178|NCT02562482|561473447|FG001|Overall Study|Enrolled, but did not receive product|0|||
155559179|NCT02562482|561473446|FG000|Overall Study|Lost to Follow-up|9|||
155559180|NCT02562482|561473447|FG001|Overall Study|Lost to Follow-up|6|||
155559181|NCT02562482|561473446|FG000|Overall Study|Moved from area|2|||
155559182|NCT02562482|561473447|FG001|Overall Study|Moved from area|3|||
155559183|NCT02562482|561473446|FG000|Overall Study|Withdrawal by Subject|5|||
155559184|NCT02562482|561473447|FG001|Overall Study|Withdrawal by Subject|3|||
155559185|NCT02562482|561473446|FG000|Overall Study|Physician Decision|1|||
155559186|NCT02562482|561473447|FG001|Overall Study|Physician Decision|3|||
155559187|NCT02562482|561473446|FG000|Overall Study|Illness/Injury unrelated to product|0|||
155559188|NCT02562482|561473447|FG001|Overall Study|Illness/Injury unrelated to product|1|||
155559189|NCT00975286|561473450|FG000|Overall Study|Adverse Event|9|||
155559190|NCT00975286|561473451|FG001|Overall Study|Adverse Event|19|||
155559191|NCT00975286|561473450|FG000|Overall Study|Protocol Violation|1|||
155559192|NCT00975286|561473451|FG001|Overall Study|Protocol Violation|2|||
155559193|NCT00975286|561473450|FG000|Overall Study|Withdrawal by Subject|0|||
155559194|NCT00975286|561473451|FG001|Overall Study|Withdrawal by Subject|2|||
155559195|NCT00975286|561473450|FG000|Overall Study|Familial and Personal Reasons|2|||
155559196|NCT00975286|561473451|FG001|Overall Study|Familial and Personal Reasons|2|||
155559197|NCT00975286|561473450|FG000|Overall Study|Poor Compliance to Protocol|0|||
155559198|NCT00975286|561473451|FG001|Overall Study|Poor Compliance to Protocol|2|||
155559199|NCT00975286|561473450|FG000|Overall Study|Sponsor Decision|0|||
155559200|NCT00975286|561473451|FG001|Overall Study|Sponsor Decision|2|||
155559201|NCT01674647|561473452|FG000|Treatment Period|Death|4|||
155559202|NCT01674647|561473453|FG001|Treatment Period|Death|1|||
155559203|NCT01674647|561473452|FG000|Treatment Period|Efficacy outcome reached|0|||
155559204|NCT01674647|561473453|FG001|Treatment Period|Efficacy outcome reached|1|||
155559205|NCT01674647|561473452|FG000|Treatment Period|Physician Decision|3|||
155559206|NCT01674647|561473453|FG001|Treatment Period|Physician Decision|1|||
155559207|NCT01674647|561473452|FG000|Treatment Period|Adverse Event|60|||
155559208|NCT01674647|561473453|FG001|Treatment Period|Adverse Event|22|||
155559209|NCT01674647|561473452|FG000|Treatment Period|Non-compliance with study drug|3|||
155559210|NCT01674647|561473453|FG001|Treatment Period|Non-compliance with study drug|0|||
155559211|NCT01674647|561473452|FG000|Treatment Period|Lost to Follow-up|1|||
155559212|NCT01674647|561473453|FG001|Treatment Period|Lost to Follow-up|1|||
155559213|NCT01674647|561473452|FG000|Treatment Period|Withdrawal by Subject|19|||
155559214|NCT01674647|561473453|FG001|Treatment Period|Withdrawal by Subject|16|||
155559215|NCT01674647|561473452|FG000|Treatment Period|Switching to other therapy|5|||
155559216|NCT01674647|561473453|FG001|Treatment Period|Switching to other therapy|2|||
155559217|NCT01674647|561473452|FG000|Treatment Period|Logistical difficulties|5|||
155559218|NCT01674647|561473453|FG001|Treatment Period|Logistical difficulties|8|||
155559219|NCT01674647|561473452|FG000|Treatment Period|Treatment failure|0|||
155559220|NCT01674647|561473453|FG001|Treatment Period|Treatment failure|14|||
155559221|NCT01674647|561473452|FG000|Treatment Period|Protocol Violation|56|||
155559222|NCT01674647|561473453|FG001|Treatment Period|Protocol Violation|36|||
155559223|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Death|3|||
155559224|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Death|2|||
155559225|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
155559226|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
155559227|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
155559228|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
155559229|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
155559230|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
155559231|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
155559232|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
155559233|NCT01674647|561473452|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
155559234|NCT01674647|561473453|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
155559235|NCT01941940|561473454|FG000|Overall Study|Adverse Event|11|||
155559236|NCT01941940|561473454|FG000|Overall Study|Lost to Follow-up|2|||
155559237|NCT01941940|561473454|FG000|Overall Study|Physician Decision|2|||
155559238|NCT01941940|561473454|FG000|Overall Study|Withdrawal by Subject|15|||
155559239|NCT01941940|561473454|FG000|Overall Study|Death|1|||
155559240|NCT01941940|561473454|FG000|Overall Study|Other|1|||
155559241|NCT01941940|561473454|FG000|Overall Study|Other|1|||
155559242|NCT04135196|561473455|FG000|Overall Study|Lost to Follow-up|8|||
155559243|NCT04135196|561473456|FG001|Overall Study|Lost to Follow-up|7|||
155559244|NCT04135196|561473457|FG002|Overall Study|Lost to Follow-up|8|||
155559245|NCT04135196|561473458|FG003|Overall Study|Lost to Follow-up|9|||
155559246|NCT04135196|561473459|FG004|Overall Study|Lost to Follow-up|1|||
155559247|NCT04135196|561473455|FG000|Overall Study|Pregnancy|0|||
155559248|NCT04135196|561473456|FG001|Overall Study|Pregnancy|0|||
155559249|NCT04135196|561473457|FG002|Overall Study|Pregnancy|1|||
155559250|NCT04135196|561473458|FG003|Overall Study|Pregnancy|0|||
155559251|NCT04135196|561473459|FG004|Overall Study|Pregnancy|0|||
155559252|NCT04135196|561473455|FG000|Overall Study|Withdrawal by Subject|0|||
155559253|NCT04135196|561473456|FG001|Overall Study|Withdrawal by Subject|0|||
155559254|NCT04135196|561473457|FG002|Overall Study|Withdrawal by Subject|0|||
155559255|NCT04135196|561473458|FG003|Overall Study|Withdrawal by Subject|0|||
155559256|NCT04135196|561473459|FG004|Overall Study|Withdrawal by Subject|1|||
155559257|NCT03212521|561473463|FG000|Overall Study|Adverse Event|1|||
155559258|NCT03212521|561473463|FG000|Overall Study|Lost to Follow-up|4|||
155559259|NCT03212521|561473463|FG000|Overall Study|Withdrawal by Subject|1|||
155559260|NCT03212521|561473463|FG000|Overall Study|Other|1|||
155559261|NCT00444457|561473464|FG000|Infant Series|Other|0|||
155559262|NCT00444457|561473465|FG001|Infant Series|Other|1|||
155559263|NCT00444457|561473466|FG002|Infant Series|Other|0|||
155559264|NCT00444457|561473467|FG003|Infant Series|Other|0|||
155559265|NCT00444457|561473464|FG000|Infant Series|Parent or legal guardian request|18|||
155559266|NCT00444457|561473465|FG001|Infant Series|Parent or legal guardian request|29|||
155559267|NCT00444457|561473466|FG002|Infant Series|Parent or legal guardian request|34|||
155559268|NCT00444457|561473467|FG003|Infant Series|Parent or legal guardian request|14|||
155559269|NCT00444457|561473464|FG000|Infant Series|Lost to Follow-up|10|||
155559270|NCT00444457|561473465|FG001|Infant Series|Lost to Follow-up|11|||
155559271|NCT00444457|561473466|FG002|Infant Series|Lost to Follow-up|7|||
155559272|NCT00444457|561473467|FG003|Infant Series|Lost to Follow-up|6|||
155559273|NCT00444457|561473464|FG000|Infant Series|Protocol Violation|16|||
155559274|NCT00444457|561473465|FG001|Infant Series|Protocol Violation|8|||
155559275|NCT00444457|561473466|FG002|Infant Series|Protocol Violation|6|||
155559276|NCT00444457|561473467|FG003|Infant Series|Protocol Violation|3|||
155559277|NCT00444457|561473464|FG000|Infant Series|Failed to return|5|||
155559278|NCT00444457|561473465|FG001|Infant Series|Failed to return|4|||
155559279|NCT00444457|561473466|FG002|Infant Series|Failed to return|4|||
155559280|NCT00444457|561473467|FG003|Infant Series|Failed to return|2|||
155559281|NCT00444457|561473464|FG000|Infant Series|Investigator request|4|||
155559282|NCT00444457|561473465|FG001|Infant Series|Investigator request|3|||
155559283|NCT00444457|561473466|FG002|Infant Series|Investigator request|3|||
155559284|NCT00444457|561473467|FG003|Infant Series|Investigator request|2|||
155559285|NCT00444457|561473464|FG000|Infant Series|Other|0|||
155559286|NCT00444457|561473465|FG001|Infant Series|Other|2|||
155559287|NCT00444457|561473466|FG002|Infant Series|Other|4|||
155559288|NCT00444457|561473467|FG003|Infant Series|Other|0|||
155559289|NCT00444457|561473464|FG000|Infant Series|Adverse Event|1|||
155559290|NCT00444457|561473465|FG001|Infant Series|Adverse Event|2|||
155559291|NCT00444457|561473466|FG002|Infant Series|Adverse Event|2|||
155559292|NCT00444457|561473467|FG003|Infant Series|Adverse Event|0|||
155658073|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155559293|NCT00444457|561473464|FG000|Infant Series|Death|0|||
155559294|NCT00444457|561473465|FG001|Infant Series|Death|1|||
155559295|NCT00444457|561473466|FG002|Infant Series|Death|1|||
155559296|NCT00444457|561473467|FG003|Infant Series|Death|1|||
155559297|NCT00444457|561473464|FG000|After Infant Series|Other|0|||
155658074|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155559298|NCT00444457|561473465|FG001|After Infant Series|Other|1|||
155559299|NCT00444457|561473466|FG002|After Infant Series|Other|1|||
155559300|NCT00444457|561473467|FG003|After Infant Series|Other|1|||
155559301|NCT00444457|561473464|FG000|After Infant Series|Parent or legal guardian request|4|||
155559302|NCT00444457|561473465|FG001|After Infant Series|Parent or legal guardian request|11|||
155559303|NCT00444457|561473466|FG002|After Infant Series|Parent or legal guardian request|6|||
155559304|NCT00444457|561473467|FG003|After Infant Series|Parent or legal guardian request|3|||
155559305|NCT00444457|561473464|FG000|After Infant Series|Failed to return|7|||
155559306|NCT00444457|561473465|FG001|After Infant Series|Failed to return|6|||
155559307|NCT00444457|561473466|FG002|After Infant Series|Failed to return|5|||
155559308|NCT00444457|561473467|FG003|After Infant Series|Failed to return|1|||
155559309|NCT00444457|561473464|FG000|After Infant Series|Lost to Follow-up|5|||
155559310|NCT00444457|561473465|FG001|After Infant Series|Lost to Follow-up|5|||
155559311|NCT00444457|561473466|FG002|After Infant Series|Lost to Follow-up|5|||
155559312|NCT00444457|561473467|FG003|After Infant Series|Lost to Follow-up|2|||
155559313|NCT00444457|561473464|FG000|After Infant Series|Protocol Violation|2|||
155559314|NCT00444457|561473465|FG001|After Infant Series|Protocol Violation|4|||
155559315|NCT00444457|561473466|FG002|After Infant Series|Protocol Violation|2|||
155559316|NCT00444457|561473467|FG003|After Infant Series|Protocol Violation|2|||
155559317|NCT00444457|561473464|FG000|After Infant Series|Adverse Event|2|||
155559318|NCT00444457|561473465|FG001|After Infant Series|Adverse Event|2|||
155559319|NCT00444457|561473466|FG002|After Infant Series|Adverse Event|0|||
155559320|NCT00444457|561473467|FG003|After Infant Series|Adverse Event|0|||
155559321|NCT00444457|561473464|FG000|After Infant Series|Investigator request|0|||
155559322|NCT00444457|561473465|FG001|After Infant Series|Investigator request|0|||
155559323|NCT00444457|561473466|FG002|After Infant Series|Investigator request|0|||
155559324|NCT00444457|561473467|FG003|After Infant Series|Investigator request|1|||
155559325|NCT00444457|561473464|FG000|After Infant Series|Other|0|||
155559326|NCT00444457|561473465|FG001|After Infant Series|Other|1|||
155559327|NCT00444457|561473466|FG002|After Infant Series|Other|0|||
155559328|NCT00444457|561473467|FG003|After Infant Series|Other|0|||
155559329|NCT00444457|561473464|FG000|Toddler Dose|Lost to Follow-up|4|||
155559330|NCT00444457|561473465|FG001|Toddler Dose|Lost to Follow-up|1|||
155559331|NCT00444457|561473466|FG002|Toddler Dose|Lost to Follow-up|1|||
155559332|NCT00444457|561473467|FG003|Toddler Dose|Lost to Follow-up|3|||
155559333|NCT00444457|561473464|FG000|Toddler Dose|Failed to return|2|||
155559334|NCT00444457|561473465|FG001|Toddler Dose|Failed to return|2|||
155559335|NCT00444457|561473466|FG002|Toddler Dose|Failed to return|1|||
155559336|NCT00444457|561473467|FG003|Toddler Dose|Failed to return|3|||
155559337|NCT00444457|561473464|FG000|Toddler Dose|Parent or legal guardian request|0|||
155559338|NCT00444457|561473465|FG001|Toddler Dose|Parent or legal guardian request|3|||
155559339|NCT00444457|561473466|FG002|Toddler Dose|Parent or legal guardian request|2|||
155559340|NCT00444457|561473467|FG003|Toddler Dose|Parent or legal guardian request|1|||
155559341|NCT00444457|561473464|FG000|Toddler Dose|Protocol Violation|1|||
155559342|NCT00444457|561473465|FG001|Toddler Dose|Protocol Violation|0|||
155559343|NCT00444457|561473466|FG002|Toddler Dose|Protocol Violation|0|||
155559344|NCT00444457|561473467|FG003|Toddler Dose|Protocol Violation|1|||
155559345|NCT00914459|561473470|FG000|Overall Study|Protocol Violation|0|||
155559346|NCT00914459|561473471|FG001|Overall Study|Protocol Violation|1|||
155559347|NCT00914459|561473470|FG000|Overall Study|Parent/Legal guardian request|1|||
155559348|NCT00914459|561473471|FG001|Overall Study|Parent/Legal guardian request|0|||
155559349|NCT01661179|561473472|FG000|Overall Study|Death|1|||
155559350|NCT01661179|561473472|FG000|Overall Study|Withdrawal by Subject|1|||
155559351|NCT01661179|561473472|FG000|Overall Study|Other Eligibility criteria|4|||
155559352|NCT01083810|561473473|FG000|Overall Study|Lost to Follow-up|23|||
155559353|NCT01083810|561473474|FG001|Overall Study|Lost to Follow-up|11|||
155559354|NCT01083810|561473475|FG002|Overall Study|Lost to Follow-up|4|||
155559355|NCT01083810|561473473|FG000|Overall Study|Adverse Event|15|||
155559356|NCT01083810|561473474|FG001|Overall Study|Adverse Event|11|||
155559357|NCT01083810|561473475|FG002|Overall Study|Adverse Event|4|||
155559358|NCT01083810|561473473|FG000|Overall Study|Withdrawal by Subject|7|||
155559359|NCT01083810|561473474|FG001|Overall Study|Withdrawal by Subject|2|||
155559360|NCT01083810|561473475|FG002|Overall Study|Withdrawal by Subject|4|||
155559361|NCT01083810|561473473|FG000|Overall Study|Reason not reported|6|||
155559362|NCT01083810|561473474|FG001|Overall Study|Reason not reported|1|||
155559363|NCT01083810|561473475|FG002|Overall Study|Reason not reported|1|||
155559364|NCT01083810|561473473|FG000|Overall Study|Non-compliance|4|||
155559365|NCT01083810|561473474|FG001|Overall Study|Non-compliance|7|||
155559366|NCT01083810|561473475|FG002|Overall Study|Non-compliance|2|||
155559367|NCT01083810|561473473|FG000|Overall Study|Simplification|4|||
155559368|NCT01083810|561473474|FG001|Overall Study|Simplification|1|||
155559369|NCT01083810|561473475|FG002|Overall Study|Simplification|0|||
155559370|NCT01083810|561473473|FG000|Overall Study|Death|2|||
155559371|NCT01083810|561473474|FG001|Overall Study|Death|2|||
155658075|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155658076|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155658077|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155658078|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155559372|NCT01083810|561473475|FG002|Overall Study|Death|3|||
155559373|NCT01083810|561473473|FG000|Overall Study|Co-morbidities|1|||
155559374|NCT01083810|561473474|FG001|Overall Study|Co-morbidities|0|||
155559375|NCT01083810|561473475|FG002|Overall Study|Co-morbidities|0|||
155559376|NCT01083810|561473473|FG000|Overall Study|Participation in study|1|||
155559377|NCT01083810|561473474|FG001|Overall Study|Participation in study|0|||
155559378|NCT01083810|561473475|FG002|Overall Study|Participation in study|0|||
155559379|NCT01083810|561473473|FG000|Overall Study|Therapy break|1|||
155559380|NCT01083810|561473474|FG001|Overall Study|Therapy break|2|||
155559381|NCT01083810|561473475|FG002|Overall Study|Therapy break|2|||
155559382|NCT01083810|561473473|FG000|Overall Study|Virologic failure|1|||
155559383|NCT01083810|561473474|FG001|Overall Study|Virologic failure|8|||
155559384|NCT01083810|561473475|FG002|Overall Study|Virologic failure|0|||
155559385|NCT01602965|561473476|FG000|Overall Study|Lost to Follow-up|4|||
155559386|NCT01602965|561473477|FG001|Overall Study|Lost to Follow-up|2|||
155559387|NCT02312063|561473478|FG000|Overall Study|Withdrawal by Subject|0|||
155559388|NCT02312063|561473479|FG001|Overall Study|Withdrawal by Subject|1|||
155559389|NCT01769339|561473483|FG000|Overall Study|Lost to Follow-up|42|||
155559390|NCT01769339|561473483|FG000|Overall Study|Adverse Event|1|||
155559391|NCT01195272|561473484|FG000|Overall Study|Adverse Event|1|||
155559392|NCT01195272|561473484|FG000|Overall Study|Lack of Efficacy|3|||
155559393|NCT03548064|561475594|FG000|Overall Study|Withdrawal by Subject|0|||
155559394|NCT03548064|561475595|FG001|Overall Study|Withdrawal by Subject|0|||
155559395|NCT03548064|561475596|FG002|Overall Study|Withdrawal by Subject|0|||
155559396|NCT03548064|561475597|FG003|Overall Study|Withdrawal by Subject|1|||
155559397|NCT03548064|561475598|FG004|Overall Study|Withdrawal by Subject|0|||
155559398|NCT03548064|561475599|FG005|Overall Study|Withdrawal by Subject|0|||
155559399|NCT03548064|561475600|FG006|Overall Study|Withdrawal by Subject|0|||
155559400|NCT03548064|561475601|FG007|Overall Study|Withdrawal by Subject|0|||
155559401|NCT03548064|561475594|FG000|Overall Study|Lost to Follow-up|0|||
155559402|NCT03548064|561475595|FG001|Overall Study|Lost to Follow-up|0|||
155559403|NCT03548064|561475596|FG002|Overall Study|Lost to Follow-up|0|||
155559404|NCT03548064|561475597|FG003|Overall Study|Lost to Follow-up|0|||
155559405|NCT03548064|561475598|FG004|Overall Study|Lost to Follow-up|2|||
155559406|NCT03548064|561475599|FG005|Overall Study|Lost to Follow-up|0|||
155559407|NCT03548064|561475600|FG006|Overall Study|Lost to Follow-up|0|||
155559408|NCT03548064|561475601|FG007|Overall Study|Lost to Follow-up|0|||
155559409|NCT03548064|561475594|FG000|Overall Study|Covid-19 Pandemic|0|||
155559410|NCT03548064|561475595|FG001|Overall Study|Covid-19 Pandemic|0|||
155559411|NCT03548064|561475596|FG002|Overall Study|Covid-19 Pandemic|0|||
155559412|NCT03548064|561475597|FG003|Overall Study|Covid-19 Pandemic|0|||
155559413|NCT03548064|561475598|FG004|Overall Study|Covid-19 Pandemic|10|||
155559414|NCT03548064|561475599|FG005|Overall Study|Covid-19 Pandemic|3|||
155559415|NCT03548064|561475600|FG006|Overall Study|Covid-19 Pandemic|0|||
155559416|NCT03548064|561475601|FG007|Overall Study|Covid-19 Pandemic|0|||
155559417|NCT04941729|561475604|FG000|Overall Study|Death|0|||
155559418|NCT04941729|561475605|FG001|Overall Study|Death|1|||
155559419|NCT04941729|561475604|FG000|Overall Study|Study terminated by sponsor|11|||
155559420|NCT04941729|561475605|FG001|Overall Study|Study terminated by sponsor|10|||
155559421|NCT00759902|561475611|FG000|Overall Study|Adverse Event|0|||
155559422|NCT00759902|561475612|FG001|Overall Study|Adverse Event|1|||
155559423|NCT04305587|561475613|FG000|Overall Study|Withdrawal by Subject|0|||
155559424|NCT04305587|561475614|FG001|Overall Study|Withdrawal by Subject|0|||
155559425|NCT04305587|561475615|FG002|Overall Study|Withdrawal by Subject|0|||
155559426|NCT04305587|561475616|FG003|Overall Study|Withdrawal by Subject|1|||
155559427|NCT04305587|561475617|FG004|Overall Study|Withdrawal by Subject|0|||
155559428|NCT04305587|561475618|FG005|Overall Study|Withdrawal by Subject|0|||
155559429|NCT04305587|561475619|FG006|Overall Study|Withdrawal by Subject|0|||
155559430|NCT04305587|561475620|FG007|Overall Study|Withdrawal by Subject|0|||
155559431|NCT04305587|561475621|FG008|Overall Study|Withdrawal by Subject|0|||
155559432|NCT01523457|561475622|FG000|Overall Study|Withdrawal by Subject|7|||
155559433|NCT01523457|561475623|FG001|Overall Study|Withdrawal by Subject|2|||
155559434|NCT02752906|561475624|FG000|Overall Study|Protocol Violation|2|||
155559435|NCT02752906|561475625|FG001|Overall Study|Protocol Violation|1|||
155559436|NCT02752906|561475624|FG000|Overall Study|Withdrawal by Subject|2|||
155559437|NCT02752906|561475625|FG001|Overall Study|Withdrawal by Subject|2|||
155559438|NCT02752906|561475624|FG000|Overall Study|Lost to Follow-up|3|||
155559439|NCT02752906|561475625|FG001|Overall Study|Lost to Follow-up|2|||
155559440|NCT04711902|561475630|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
155559441|NCT04711902|561475631|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
155559442|NCT04711902|561475632|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
155559443|NCT04711902|561475633|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
155559444|NCT04711902|561475634|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
155559445|NCT04711902|561475635|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
155559446|NCT03786718|561475636|FG000|Overall Study|Lost to Follow-up|3|||
155559447|NCT03786718|561475636|FG000|Overall Study|Withdrawal by Subject|1|||
155559448|NCT03786718|561475636|FG000|Overall Study|Did not use the intervention|2|||
155559449|NCT03786718|561475636|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
155559450|NCT00372411|561475641|FG000|Overall Study|Withdrawal by Subject|3|||
155559451|NCT00372411|561475642|FG001|Overall Study|Withdrawal by Subject|4|||
155559452|NCT00372411|561475643|FG002|Overall Study|Withdrawal by Subject|1|||
155559453|NCT00372411|561475641|FG000|Overall Study|Death|0|||
155559454|NCT00372411|561475642|FG001|Overall Study|Death|2|||
155559455|NCT00372411|561475643|FG002|Overall Study|Death|1|||
155559456|NCT00372411|561475641|FG000|Overall Study|Lost to Follow-up|1|||
155559457|NCT00372411|561475642|FG001|Overall Study|Lost to Follow-up|1|||
155559458|NCT00372411|561475643|FG002|Overall Study|Lost to Follow-up|1|||
155559459|NCT00372411|561475641|FG000|Overall Study|Adverse Event|1|||
155559460|NCT00372411|561475642|FG001|Overall Study|Adverse Event|1|||
155559461|NCT00372411|561475643|FG002|Overall Study|Adverse Event|0|||
155559462|NCT01398514|561475644|FG000|Overall Study|Adverse Event|1|||
155559463|NCT01398514|561475645|FG001|Overall Study|Adverse Event|0|||
155559464|NCT01398514|561475644|FG000|Overall Study|Non-compliance with study procedures|2|||
155559465|NCT01398514|561475645|FG001|Overall Study|Non-compliance with study procedures|0|||
155559466|NCT01398514|561475644|FG000|Overall Study|Physiologic non-responsiveness|1|||
155559467|NCT01398514|561475645|FG001|Overall Study|Physiologic non-responsiveness|3|||
155658079|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155559468|NCT01398514|561475644|FG000|Overall Study|Failure to show a conditioned response|4|||
155559469|NCT01398514|561475645|FG001|Overall Study|Failure to show a conditioned response|3|||
155559470|NCT02622113|561475647|FG000|Overall Study|Adverse Event|4|||
155559471|NCT02622113|561475648|FG001|Overall Study|Adverse Event|4|||
155559472|NCT02622113|561475647|FG000|Overall Study|Physician Decision|0|||
155559473|NCT02622113|561475648|FG001|Overall Study|Physician Decision|1|||
155559474|NCT02622113|561475647|FG000|Overall Study|Withdrawal by Subject|0|||
155559475|NCT02622113|561475648|FG001|Overall Study|Withdrawal by Subject|2|||
155559476|NCT02622113|561475647|FG000|Overall Study|Stopping Criteria|1|||
155559477|NCT02622113|561475648|FG001|Overall Study|Stopping Criteria|3|||
155559478|NCT01570686|561475651|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155559479|NCT01570686|561475652|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155559480|NCT01570686|561475651|FG000|Overall Study|Administrative problems|0|||
155559481|NCT01570686|561475652|FG001|Overall Study|Administrative problems|1|||
155559482|NCT01570686|561475651|FG000|Overall Study|Adverse Event|8|||
155559483|NCT01570686|561475652|FG001|Overall Study|Adverse Event|6|||
155559484|NCT01570686|561475651|FG000|Overall Study|Lost to Follow-up|4|||
155559485|NCT01570686|561475652|FG001|Overall Study|Lost to Follow-up|3|||
155559486|NCT01570686|561475651|FG000|Overall Study|Protocol Deviation|3|||
155559487|NCT01570686|561475652|FG001|Overall Study|Protocol Deviation|0|||
155559488|NCT01570686|561475651|FG000|Overall Study|Withdrawal by Subject|4|||
155559489|NCT01570686|561475652|FG001|Overall Study|Withdrawal by Subject|4|||
155559490|NCT01570686|561475651|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155559491|NCT01570686|561475652|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155559492|NCT00505375|561475655|FG000|Overall Study|Death|1|||
155559493|NCT00505375|561475656|FG001|Overall Study|Death|0|||
155559494|NCT00505375|561475655|FG000|Overall Study|Withdrawal by Subject|2|||
155559495|NCT00505375|561475656|FG001|Overall Study|Withdrawal by Subject|2|||
155559496|NCT00505375|561475655|FG000|Overall Study|Lost to Follow-up|0|||
155559497|NCT00505375|561475656|FG001|Overall Study|Lost to Follow-up|2|||
155559498|NCT00505375|561475655|FG000|Overall Study|Pregnancy|1|||
155559499|NCT00505375|561475656|FG001|Overall Study|Pregnancy|0|||
155559500|NCT00505375|561475655|FG000|Overall Study|Travel issues|0|||
155559501|NCT00505375|561475656|FG001|Overall Study|Travel issues|1|||
155559502|NCT01345175|561475657|FG000|Overall Study|Physician Decision|0|||
155559503|NCT01345175|561475658|FG001|Overall Study|Physician Decision|1|||
155559504|NCT01345175|561475657|FG000|Overall Study|Withdrawal by Subject|1|||
155559505|NCT01345175|561475658|FG001|Overall Study|Withdrawal by Subject|1|||
155559506|NCT01345175|561475657|FG000|Overall Study|Failed to complete BFI|3|||
155559507|NCT01345175|561475658|FG001|Overall Study|Failed to complete BFI|2|||
155559508|NCT01345175|561475657|FG000|Overall Study|Stopped taking medication|2|||
155559509|NCT01345175|561475658|FG001|Overall Study|Stopped taking medication|2|||
155559510|NCT01561430|561475660|FG000|Overall Study|Adverse Event|0|||
155559511|NCT01561430|561475661|FG001|Overall Study|Adverse Event|0|||
155559512|NCT01561430|561475662|FG002|Overall Study|Adverse Event|3|||
155559513|NCT01561430|561475663|FG003|Overall Study|Adverse Event|1|||
155559514|NCT01561430|561475660|FG000|Overall Study|Withdrawal by Subject|0|||
155559515|NCT01561430|561475661|FG001|Overall Study|Withdrawal by Subject|0|||
155559516|NCT01561430|561475662|FG002|Overall Study|Withdrawal by Subject|1|||
155559517|NCT01561430|561475663|FG003|Overall Study|Withdrawal by Subject|0|||
155559518|NCT01561430|561475660|FG000|Overall Study|Physician Decision|0|||
155559519|NCT01561430|561475661|FG001|Overall Study|Physician Decision|1|||
155559520|NCT01561430|561475662|FG002|Overall Study|Physician Decision|0|||
155559521|NCT01561430|561475663|FG003|Overall Study|Physician Decision|0|||
155559522|NCT01561430|561475660|FG000|Overall Study|Sponsor Decision|1|||
155559523|NCT01561430|561475661|FG001|Overall Study|Sponsor Decision|14|||
155559524|NCT01561430|561475662|FG002|Overall Study|Sponsor Decision|13|||
155559525|NCT01561430|561475663|FG003|Overall Study|Sponsor Decision|12|||
155559526|NCT04112173|561475664|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
155559527|NCT01055132|561475665|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
155559528|NCT01055132|561475666|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
155559529|NCT01055132|561475665|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
155559530|NCT01055132|561475666|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
155559531|NCT02746471|561475667|FG000|Overall Study|Death|43|||
155559532|NCT02746471|561475667|FG000|Overall Study|Exited before 36 months|1119|||
155559533|NCT01007942|561475669|FG000|Overall Study|Adverse Event|29|||
155559534|NCT01007942|561475670|FG001|Overall Study|Adverse Event|14|||
155559535|NCT01007942|561475669|FG000|Overall Study|Abnormal test procedure|0|||
155559536|NCT01007942|561475670|FG001|Overall Study|Abnormal test procedure|1|||
155559537|NCT01007942|561475669|FG000|Overall Study|Disease progression|217|||
155559538|NCT01007942|561475670|FG001|Overall Study|Disease progression|242|||
155559539|NCT01007942|561475669|FG000|Overall Study|New cancer therapy|5|||
155559540|NCT01007942|561475670|FG001|Overall Study|New cancer therapy|1|||
155559541|NCT01007942|561475669|FG000|Overall Study|Protocol Violation|1|||
155559542|NCT01007942|561475670|FG001|Overall Study|Protocol Violation|1|||
155559543|NCT01007942|561475669|FG000|Overall Study|Withdrawal by Subject|19|||
155559544|NCT01007942|561475670|FG001|Overall Study|Withdrawal by Subject|14|||
155559545|NCT01007942|561475669|FG000|Overall Study|Lost to Follow-up|1|||
155559546|NCT01007942|561475670|FG001|Overall Study|Lost to Follow-up|0|||
155559547|NCT01007942|561475669|FG000|Overall Study|Administrative problems|2|||
155559548|NCT01007942|561475670|FG001|Overall Study|Administrative problems|0|||
155559549|NCT01007942|561475669|FG000|Overall Study|Death|3|||
155559550|NCT01007942|561475670|FG001|Overall Study|Death|2|||
155559551|NCT01007942|561475669|FG000|Overall Study|Patients untreated|4|||
155559552|NCT01007942|561475670|FG001|Overall Study|Patients untreated|3|||
155559553|NCT04492020|561475671|FG000|Overall Study|Adverse Event|1|||
155559554|NCT04492020|561475672|FG001|Overall Study|Adverse Event|3|||
155559555|NCT04492020|561475671|FG000|Overall Study|Withdrawal by Subject|4|||
155559556|NCT04492020|561475672|FG001|Overall Study|Withdrawal by Subject|3|||
155559557|NCT04492020|561475671|FG000|Overall Study|Lost to Follow-up|4|||
155559558|NCT04492020|561475672|FG001|Overall Study|Lost to Follow-up|3|||
155559559|NCT04492020|561475671|FG000|Overall Study|Protocol Violation|5|||
155559560|NCT04492020|561475672|FG001|Overall Study|Protocol Violation|2|||
155559561|NCT04492020|561475671|FG000|Overall Study|Lack of Qualifying Event|25|||
155559562|NCT04492020|561475672|FG001|Overall Study|Lack of Qualifying Event|27|||
155559563|NCT04492020|561475671|FG000|Overall Study|Non-compliance with Study Drug|2|||
155559564|NCT04492020|561475672|FG001|Overall Study|Non-compliance with Study Drug|1|||
155559565|NCT04645966|561475676|FG000|Vaccination Phase|Adverse Event|1|||
155559566|NCT04645966|561475677|FG001|Vaccination Phase|Adverse Event|0|||
155559567|NCT04645966|561475678|FG002|Vaccination Phase|Adverse Event|0|||
155559568|NCT04645966|561475679|FG003|Vaccination Phase|Adverse Event|0|||
155559569|NCT04645966|561475680|FG004|Vaccination Phase|Adverse Event|0|||
155559570|NCT04645966|561475681|FG005|Vaccination Phase|Adverse Event|0|||
155559571|NCT04645966|561475682|FG006|Vaccination Phase|Adverse Event|1|||
155559572|NCT04645966|561475683|FG007|Vaccination Phase|Adverse Event|0|||
155559573|NCT04645966|561475684|FG008|Vaccination Phase|Adverse Event|0|||
155559574|NCT04645966|561475676|FG000|Vaccination Phase|Death|0|||
155559575|NCT04645966|561475677|FG001|Vaccination Phase|Death|0|||
155559576|NCT04645966|561475678|FG002|Vaccination Phase|Death|0|||
155559577|NCT04645966|561475679|FG003|Vaccination Phase|Death|0|||
155559578|NCT04645966|561475680|FG004|Vaccination Phase|Death|0|||
155559579|NCT04645966|561475681|FG005|Vaccination Phase|Death|1|||
155559580|NCT04645966|561475682|FG006|Vaccination Phase|Death|0|||
155559581|NCT04645966|561475683|FG007|Vaccination Phase|Death|0|||
155559582|NCT04645966|561475684|FG008|Vaccination Phase|Death|0|||
155559583|NCT04645966|561475676|FG000|Vaccination Phase|Protocol Violation|0|||
155559584|NCT04645966|561475677|FG001|Vaccination Phase|Protocol Violation|0|||
155559585|NCT04645966|561475678|FG002|Vaccination Phase|Protocol Violation|0|||
155559586|NCT04645966|561475679|FG003|Vaccination Phase|Protocol Violation|0|||
155559587|NCT04645966|561475680|FG004|Vaccination Phase|Protocol Violation|1|||
155559588|NCT04645966|561475681|FG005|Vaccination Phase|Protocol Violation|0|||
155559589|NCT04645966|561475682|FG006|Vaccination Phase|Protocol Violation|0|||
155559590|NCT04645966|561475683|FG007|Vaccination Phase|Protocol Violation|0|||
155559591|NCT04645966|561475684|FG008|Vaccination Phase|Protocol Violation|0|||
155559592|NCT04645966|561475676|FG000|Vaccination Phase|Study terminated by sponsor|0|||
155559593|NCT04645966|561475677|FG001|Vaccination Phase|Study terminated by sponsor|0|||
155559594|NCT04645966|561475678|FG002|Vaccination Phase|Study terminated by sponsor|14|||
155559595|NCT04645966|561475679|FG003|Vaccination Phase|Study terminated by sponsor|15|||
155559596|NCT04645966|561475680|FG004|Vaccination Phase|Study terminated by sponsor|47|||
155559597|NCT04645966|561475681|FG005|Vaccination Phase|Study terminated by sponsor|43|||
155559598|NCT04645966|561475682|FG006|Vaccination Phase|Study terminated by sponsor|29|||
155559599|NCT04645966|561475683|FG007|Vaccination Phase|Study terminated by sponsor|29|||
155559600|NCT04645966|561475684|FG008|Vaccination Phase|Study terminated by sponsor|12|||
155559601|NCT04645966|561475676|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
155559602|NCT04645966|561475677|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
155559603|NCT04645966|561475678|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
155559604|NCT04645966|561475679|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
155559605|NCT04645966|561475680|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
155559606|NCT04645966|561475681|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
155559607|NCT04645966|561475682|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
155559608|NCT04645966|561475683|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
155559609|NCT04645966|561475684|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
155559610|NCT04645966|561475676|FG000|Vaccination Phase|Other|0|||
155559611|NCT04645966|561475677|FG001|Vaccination Phase|Other|0|||
155559612|NCT04645966|561475678|FG002|Vaccination Phase|Other|0|||
155559613|NCT04645966|561475679|FG003|Vaccination Phase|Other|0|||
155559614|NCT04645966|561475680|FG004|Vaccination Phase|Other|0|||
155559615|NCT04645966|561475681|FG005|Vaccination Phase|Other|2|||
155559616|NCT04645966|561475682|FG006|Vaccination Phase|Other|0|||
155559617|NCT04645966|561475683|FG007|Vaccination Phase|Other|0|||
155559618|NCT04645966|561475684|FG008|Vaccination Phase|Other|0|||
155559619|NCT04645966|561475676|FG000|Vaccination Phase|Lost to Follow-up|0|||
155559620|NCT04645966|561475677|FG001|Vaccination Phase|Lost to Follow-up|0|||
155559621|NCT04645966|561475678|FG002|Vaccination Phase|Lost to Follow-up|0|||
155559622|NCT04645966|561475679|FG003|Vaccination Phase|Lost to Follow-up|0|||
155559623|NCT04645966|561475680|FG004|Vaccination Phase|Lost to Follow-up|0|||
155559624|NCT04645966|561475681|FG005|Vaccination Phase|Lost to Follow-up|0|||
155559625|NCT04645966|561475682|FG006|Vaccination Phase|Lost to Follow-up|0|||
155559626|NCT04645966|561475683|FG007|Vaccination Phase|Lost to Follow-up|1|||
155559627|NCT04645966|561475684|FG008|Vaccination Phase|Lost to Follow-up|0|||
155559628|NCT04645966|561475676|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
155559629|NCT04645966|561475677|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
155559630|NCT04645966|561475678|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
155559631|NCT04645966|561475679|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
155559632|NCT04645966|561475680|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
155559633|NCT04645966|561475681|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
155559634|NCT04645966|561475682|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
155559635|NCT04645966|561475683|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
155559636|NCT04645966|561475684|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
155559637|NCT04645966|561475676|FG000|Follow-up Phase|Lost to Follow-up|0|||
155559638|NCT04645966|561475677|FG001|Follow-up Phase|Lost to Follow-up|0|||
155559639|NCT04645966|561475678|FG002|Follow-up Phase|Lost to Follow-up|0|||
155559640|NCT04645966|561475679|FG003|Follow-up Phase|Lost to Follow-up|0|||
155559641|NCT04645966|561475680|FG004|Follow-up Phase|Lost to Follow-up|0|||
155559642|NCT04645966|561475681|FG005|Follow-up Phase|Lost to Follow-up|0|||
155559643|NCT04645966|561475682|FG006|Follow-up Phase|Lost to Follow-up|0|||
155559644|NCT04645966|561475683|FG007|Follow-up Phase|Lost to Follow-up|1|||
155559645|NCT04645966|561475684|FG008|Follow-up Phase|Lost to Follow-up|0|||
155559646|NCT00470067|561475685|FG000|Overall Study|Death|1|||
155559647|NCT00470067|561475685|FG000|Overall Study|Disease Progression|6|||
155559648|NCT01460901|561475686|FG000|Overall Study|Withdrawal by Subject|2|||
155559649|NCT00895947|561475690|FG000|Overall Study|Adverse Event|3|||
155559650|NCT00895947|561475691|FG001|Overall Study|Adverse Event|4|||
155559651|NCT00895947|561475690|FG000|Overall Study|Lost to Follow-up|3|||
155559652|NCT00895947|561475691|FG001|Overall Study|Lost to Follow-up|4|||
155559653|NCT00895947|561475690|FG000|Overall Study|Protocol Violation|4|||
155559654|NCT00895947|561475691|FG001|Overall Study|Protocol Violation|2|||
155559655|NCT00895947|561475690|FG000|Overall Study|Withdrawal by Subject|2|||
155559656|NCT00895947|561475691|FG001|Overall Study|Withdrawal by Subject|0|||
155559657|NCT01059344|561475700|FG000|Overall Study|Adverse Event|12|||
155559658|NCT01059344|561475701|FG001|Overall Study|Adverse Event|30|||
155559659|NCT01059344|561475700|FG000|Overall Study|Withdrawal by Subject|6|||
155559660|NCT01059344|561475701|FG001|Overall Study|Withdrawal by Subject|9|||
155559661|NCT01059344|561475700|FG000|Overall Study|Lost to Follow-up|1|||
155559662|NCT01059344|561475701|FG001|Overall Study|Lost to Follow-up|1|||
155559663|NCT01059344|561475700|FG000|Overall Study|Other|3|||
155559664|NCT01059344|561475701|FG001|Overall Study|Other|6|||
155559665|NCT01739348|561475702|FG000|Part I (Base Study)|Adverse Event|41|||
155559666|NCT01739348|561475703|FG001|Part I (Base Study)|Adverse Event|52|||
155559667|NCT01739348|561475704|FG002|Part I (Base Study)|Adverse Event|8|||
155559668|NCT01739348|561475705|FG003|Part I (Base Study)|Adverse Event|33|||
155559669|NCT01739348|561475702|FG000|Part I (Base Study)|Death|10|||
155559670|NCT01739348|561475703|FG001|Part I (Base Study)|Death|7|||
155559671|NCT01739348|561475704|FG002|Part I (Base Study)|Death|2|||
155559672|NCT01739348|561475705|FG003|Part I (Base Study)|Death|8|||
155559673|NCT01739348|561475702|FG000|Part I (Base Study)|Lack of Efficacy|3|||
155559674|NCT01739348|561475703|FG001|Part I (Base Study)|Lack of Efficacy|8|||
155559675|NCT01739348|561475704|FG002|Part I (Base Study)|Lack of Efficacy|0|||
155559676|NCT01739348|561475705|FG003|Part I (Base Study)|Lack of Efficacy|7|||
155559677|NCT01739348|561475702|FG000|Part I (Base Study)|Lost to Follow-up|4|||
155559678|NCT01739348|561475703|FG001|Part I (Base Study)|Lost to Follow-up|2|||
155559679|NCT01739348|561475704|FG002|Part I (Base Study)|Lost to Follow-up|4|||
155559680|NCT01739348|561475705|FG003|Part I (Base Study)|Lost to Follow-up|4|||
155559681|NCT01739348|561475702|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
155559682|NCT01739348|561475703|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
155559683|NCT01739348|561475704|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
155559684|NCT01739348|561475705|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
155559685|NCT01739348|561475702|FG000|Part I (Base Study)|Physician Decision|10|||
155559686|NCT01739348|561475703|FG001|Part I (Base Study)|Physician Decision|7|||
155559687|NCT01739348|561475704|FG002|Part I (Base Study)|Physician Decision|1|||
155559688|NCT01739348|561475705|FG003|Part I (Base Study)|Physician Decision|4|||
155559689|NCT01739348|561475702|FG000|Part I (Base Study)|Protocol Violation|2|||
155559690|NCT01739348|561475703|FG001|Part I (Base Study)|Protocol Violation|0|||
155559691|NCT01739348|561475704|FG002|Part I (Base Study)|Protocol Violation|1|||
155559692|NCT01739348|561475705|FG003|Part I (Base Study)|Protocol Violation|2|||
155559693|NCT01739348|561475702|FG000|Part I (Base Study)|Screen Failure|2|||
155559694|NCT01739348|561475703|FG001|Part I (Base Study)|Screen Failure|0|||
155559695|NCT01739348|561475704|FG002|Part I (Base Study)|Screen Failure|0|||
155559696|NCT01739348|561475705|FG003|Part I (Base Study)|Screen Failure|0|||
155559697|NCT01739348|561475702|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
155559698|NCT01739348|561475703|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
155559699|NCT01739348|561475704|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
155559700|NCT01739348|561475705|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
155559701|NCT01739348|561475702|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
155559702|NCT01739348|561475703|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
155658080|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155559703|NCT01739348|561475704|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
155559704|NCT01739348|561475705|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
155559705|NCT01739348|561475702|FG000|Part I (Base Study)|Participant Moved|4|||
155559706|NCT01739348|561475703|FG001|Part I (Base Study)|Participant Moved|3|||
155559707|NCT01739348|561475704|FG002|Part I (Base Study)|Participant Moved|1|||
155559708|NCT01739348|561475705|FG003|Part I (Base Study)|Participant Moved|7|||
155559709|NCT01739348|561475702|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
155559710|NCT01739348|561475703|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
155559711|NCT01739348|561475704|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
155559712|NCT01739348|561475705|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
155559713|NCT01739348|561475702|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
155559714|NCT01739348|561475703|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
155559715|NCT01739348|561475704|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
155559716|NCT01739348|561475705|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
155559717|NCT01739348|561475702|FG000|Part II (Extension Study)|Adverse Event|10|||
155559718|NCT01739348|561475703|FG001|Part II (Extension Study)|Adverse Event|11|||
155559719|NCT01739348|561475704|FG002|Part II (Extension Study)|Adverse Event|7|||
155559720|NCT01739348|561475705|FG003|Part II (Extension Study)|Adverse Event|26|||
155559721|NCT01739348|561475702|FG000|Part II (Extension Study)|Death|3|||
155559722|NCT01739348|561475703|FG001|Part II (Extension Study)|Death|3|||
155559723|NCT01739348|561475704|FG002|Part II (Extension Study)|Death|2|||
155559724|NCT01739348|561475705|FG003|Part II (Extension Study)|Death|6|||
155559725|NCT01739348|561475702|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
155559726|NCT01739348|561475703|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
155559727|NCT01739348|561475704|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
155559728|NCT01739348|561475705|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
155559729|NCT01739348|561475702|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
155559730|NCT01739348|561475703|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
155559731|NCT01739348|561475704|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
155559732|NCT01739348|561475705|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
155559733|NCT01739348|561475702|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
155559734|NCT01739348|561475703|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
155559735|NCT01739348|561475704|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
155559736|NCT01739348|561475705|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
155559737|NCT01739348|561475702|FG000|Part II (Extension Study)|Physician Decision|7|||
155559738|NCT01739348|561475703|FG001|Part II (Extension Study)|Physician Decision|11|||
155559739|NCT01739348|561475704|FG002|Part II (Extension Study)|Physician Decision|6|||
155559740|NCT01739348|561475705|FG003|Part II (Extension Study)|Physician Decision|12|||
155559741|NCT01739348|561475702|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
155559742|NCT01739348|561475703|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
155559743|NCT01739348|561475704|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
155559744|NCT01739348|561475705|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
155559745|NCT01739348|561475702|FG000|Part II (Extension Study)|Participant Moved|3|||
155559746|NCT01739348|561475703|FG001|Part II (Extension Study)|Participant Moved|3|||
155559747|NCT01739348|561475704|FG002|Part II (Extension Study)|Participant Moved|0|||
155559748|NCT01739348|561475705|FG003|Part II (Extension Study)|Participant Moved|3|||
155559749|NCT01739348|561475702|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
155559750|NCT01739348|561475703|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
155559751|NCT01739348|561475704|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
155559752|NCT01739348|561475705|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
155559753|NCT01739348|561475702|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
155559754|NCT01739348|561475703|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
155559755|NCT01739348|561475704|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
155559756|NCT01739348|561475705|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
155559757|NCT02695537|561475706|FG000|Overall Study|Adverse Event|3|||
155559758|NCT02695537|561475706|FG000|Overall Study|Lack of Efficacy|28|||
155559759|NCT02695537|561475706|FG000|Overall Study|Withdrawal by Subject|4|||
155559760|NCT02695537|561475706|FG000|Overall Study|Protocol Violation|3|||
155559761|NCT02792699|561475707|FG000|Overall Study|Adverse Event|1|||
155559762|NCT02792699|561475708|FG001|Overall Study|Adverse Event|2|||
155559763|NCT02792699|561475709|FG002|Overall Study|Adverse Event|4|||
155559764|NCT02792699|561475707|FG000|Overall Study|Withdrawal by Subject|4|||
155559765|NCT02792699|561475708|FG001|Overall Study|Withdrawal by Subject|4|||
155559766|NCT02792699|561475709|FG002|Overall Study|Withdrawal by Subject|3|||
155559767|NCT02792699|561475707|FG000|Overall Study|Lost to Follow-up|0|||
155559768|NCT02792699|561475708|FG001|Overall Study|Lost to Follow-up|1|||
155559769|NCT02792699|561475709|FG002|Overall Study|Lost to Follow-up|2|||
155559770|NCT02792699|561475707|FG000|Overall Study|Physician Decision|2|||
155559771|NCT02792699|561475708|FG001|Overall Study|Physician Decision|0|||
155559772|NCT02792699|561475709|FG002|Overall Study|Physician Decision|0|||
155559773|NCT02792699|561475707|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
155559774|NCT02792699|561475708|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
155559775|NCT02792699|561475709|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
155559776|NCT02792699|561475707|FG000|Overall Study|Other|1|||
155559777|NCT02792699|561475708|FG001|Overall Study|Other|0|||
155559778|NCT02792699|561475709|FG002|Overall Study|Other|0|||
155559779|NCT02440568|561475712|FG000|Overall Study|Death|1|||
155559780|NCT02440568|561475713|FG001|Overall Study|Death|3|||
155559781|NCT02440568|561475714|FG002|Overall Study|Death|4|||
155559782|NCT02440568|561475715|FG003|Overall Study|Death|2|||
155559783|NCT02440568|561475712|FG000|Overall Study|Lack of Efficacy|2|||
155559784|NCT02440568|561475713|FG001|Overall Study|Lack of Efficacy|0|||
155559785|NCT02440568|561475714|FG002|Overall Study|Lack of Efficacy|1|||
155559786|NCT02440568|561475715|FG003|Overall Study|Lack of Efficacy|0|||
155559787|NCT02440568|561475712|FG000|Overall Study|Lost to Follow-up|1|||
155559788|NCT02440568|561475713|FG001|Overall Study|Lost to Follow-up|0|||
155559789|NCT02440568|561475714|FG002|Overall Study|Lost to Follow-up|0|||
155559790|NCT02440568|561475715|FG003|Overall Study|Lost to Follow-up|0|||
155559791|NCT02987959|561475716|FG000|Overall Study|Grantor stopped supply of drugs|6|||
155559792|NCT03285308|561475719|FG000|Overall Study|Adverse Event|3|||
155559793|NCT03285308|561475720|FG001|Overall Study|Adverse Event|7|||
155559794|NCT03285308|561475719|FG000|Overall Study|Withdrawal by Subject|8|||
155559795|NCT03285308|561475720|FG001|Overall Study|Withdrawal by Subject|9|||
155559796|NCT03285308|561475719|FG000|Overall Study|Lost to Follow-up|3|||
155559797|NCT03285308|561475720|FG001|Overall Study|Lost to Follow-up|1|||
155559798|NCT03285308|561475719|FG000|Overall Study|Protocol Deviation|6|||
155559799|NCT03285308|561475720|FG001|Overall Study|Protocol Deviation|5|||
155559800|NCT03285308|561475719|FG000|Overall Study|Reason not Specified|0|||
155559801|NCT03285308|561475720|FG001|Overall Study|Reason not Specified|1|||
155559802|NCT02283983|561475721|FG000|Overall Study|Inclusion criteria not met|0|||
155559803|NCT02283983|561475722|FG001|Overall Study|Inclusion criteria not met|1|||
155559804|NCT02283983|561475721|FG000|Overall Study|Withdrawal by Subject|4|||
155559805|NCT02283983|561475722|FG001|Overall Study|Withdrawal by Subject|2|||
155559806|NCT02283983|561475721|FG000|Overall Study|Protocol Violation|0|||
155559807|NCT02283983|561475722|FG001|Overall Study|Protocol Violation|4|||
155559808|NCT02283983|561475721|FG000|Overall Study|Physician Decision|2|||
155559809|NCT02283983|561475722|FG001|Overall Study|Physician Decision|4|||
155559810|NCT02283983|561475721|FG000|Overall Study|Death|1|||
155559811|NCT02283983|561475722|FG001|Overall Study|Death|0|||
155559812|NCT02283983|561475721|FG000|Overall Study|Adverse Event|1|||
155559813|NCT02283983|561475722|FG001|Overall Study|Adverse Event|0|||
155559814|NCT02283983|561475721|FG000|Overall Study|Lost to Follow-up|9|||
155559815|NCT02283983|561475722|FG001|Overall Study|Lost to Follow-up|8|||
155559816|NCT02283983|561475721|FG000|Overall Study|Relapse|1|||
155559817|NCT02283983|561475722|FG001|Overall Study|Relapse|0|||
155559818|NCT00669071|561475727|FG000|Overall Study|Lost to Follow-up|3|||
155559819|NCT00669071|561475727|FG000|Overall Study|Final visit 40 days out of window|1|||
155559820|NCT00424775|561475728|FG000|Overall Study|Adverse Event|2|||
155559821|NCT00424775|561475729|FG001|Overall Study|Adverse Event|0|||
155559822|NCT00424775|561475728|FG000|Overall Study|Lack of Efficacy|1|||
155559823|NCT00424775|561475729|FG001|Overall Study|Lack of Efficacy|0|||
155559824|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
155559825|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
155559826|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
155559827|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
155559828|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
155559829|NCT01490866|561475735|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
155559830|NCT01490866|561475735|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
155559831|NCT01490866|561475735|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
155559832|NCT01490866|561475735|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
155559833|NCT01490866|561475735|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
155559834|NCT01490866|561475735|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
155559835|NCT03201211|561475738|FG000|Overall Study|Adverse Event|1|||
155559836|NCT03201211|561475739|FG001|Overall Study|Adverse Event|0|||
155559837|NCT03201211|561475740|FG002|Overall Study|Adverse Event|0|||
155559838|NCT03201211|561475738|FG000|Overall Study|Protocol Violation|1|||
155559839|NCT03201211|561475739|FG001|Overall Study|Protocol Violation|0|||
155559840|NCT03201211|561475740|FG002|Overall Study|Protocol Violation|0|||
155559841|NCT03201211|561475738|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155559842|NCT03201211|561475739|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155559843|NCT03201211|561475740|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155559844|NCT03201211|561475738|FG000|Overall Study|OTHER unknown reasons|0|||
155559845|NCT03201211|561475739|FG001|Overall Study|OTHER unknown reasons|1|||
155559846|NCT03201211|561475740|FG002|Overall Study|OTHER unknown reasons|0|||
155559847|NCT01970865|561475741|FG000|Overall Study|Death|3|||
155559848|NCT01970865|561475742|FG001|Overall Study|Death|2|||
155559849|NCT01970865|561475743|FG002|Overall Study|Death|3|||
155559850|NCT01970865|561475744|FG003|Overall Study|Death|6|||
155559851|NCT01970865|561475745|FG004|Overall Study|Death|9|||
155559852|NCT01970865|561475746|FG005|Overall Study|Death|3|||
155559853|NCT01970865|561475747|FG006|Overall Study|Death|2|||
155559854|NCT01970865|561475748|FG007|Overall Study|Death|3|||
155559855|NCT01970865|561475749|FG008|Overall Study|Death|2|||
155559856|NCT01970865|561475750|FG009|Overall Study|Death|2|||
155559857|NCT01970865|561475751|FG010|Overall Study|Death|8|||
155559858|NCT01970865|561475752|FG011|Overall Study|Death|13|||
155559859|NCT01970865|561475753|FG012|Overall Study|Death|25|||
155559860|NCT01970865|561475754|FG013|Overall Study|Death|46|||
155559861|NCT01970865|561475755|FG014|Overall Study|Death|37|||
155559862|NCT01970865|561475756|FG015|Overall Study|Death|22|||
155559863|NCT01970865|561475757|FG016|Overall Study|Death|1|||
155559864|NCT01970865|561475758|FG017|Overall Study|Death|17|||
155559865|NCT01970865|561475741|FG000|Overall Study|Lost to Follow-up|0|||
155559866|NCT01970865|561475742|FG001|Overall Study|Lost to Follow-up|0|||
155559867|NCT01970865|561475743|FG002|Overall Study|Lost to Follow-up|0|||
155559868|NCT01970865|561475744|FG003|Overall Study|Lost to Follow-up|1|||
155559869|NCT01970865|561475745|FG004|Overall Study|Lost to Follow-up|1|||
155559870|NCT01970865|561475746|FG005|Overall Study|Lost to Follow-up|0|||
155559871|NCT01970865|561475747|FG006|Overall Study|Lost to Follow-up|0|||
155559872|NCT01970865|561475748|FG007|Overall Study|Lost to Follow-up|0|||
155559873|NCT01970865|561475749|FG008|Overall Study|Lost to Follow-up|0|||
155559874|NCT01970865|561475750|FG009|Overall Study|Lost to Follow-up|0|||
155559875|NCT01970865|561475751|FG010|Overall Study|Lost to Follow-up|1|||
155559876|NCT01970865|561475752|FG011|Overall Study|Lost to Follow-up|0|||
155559877|NCT01970865|561475753|FG012|Overall Study|Lost to Follow-up|2|||
155559878|NCT01970865|561475754|FG013|Overall Study|Lost to Follow-up|0|||
155559879|NCT01970865|561475755|FG014|Overall Study|Lost to Follow-up|1|||
155559880|NCT01970865|561475756|FG015|Overall Study|Lost to Follow-up|4|||
155559881|NCT01970865|561475757|FG016|Overall Study|Lost to Follow-up|0|||
155559882|NCT01970865|561475758|FG017|Overall Study|Lost to Follow-up|1|||
155559883|NCT01970865|561475741|FG000|Overall Study|Other|0|||
155559884|NCT01970865|561475742|FG001|Overall Study|Other|1|||
155559885|NCT01970865|561475743|FG002|Overall Study|Other|0|||
155559886|NCT01970865|561475744|FG003|Overall Study|Other|1|||
155559887|NCT01970865|561475745|FG004|Overall Study|Other|1|||
155559888|NCT01970865|561475746|FG005|Overall Study|Other|0|||
155559889|NCT01970865|561475747|FG006|Overall Study|Other|1|||
155559890|NCT01970865|561475748|FG007|Overall Study|Other|0|||
155559891|NCT01970865|561475749|FG008|Overall Study|Other|0|||
155559892|NCT01970865|561475750|FG009|Overall Study|Other|0|||
155559893|NCT01970865|561475751|FG010|Overall Study|Other|2|||
155559894|NCT01970865|561475752|FG011|Overall Study|Other|3|||
155559895|NCT01970865|561475753|FG012|Overall Study|Other|8|||
155559896|NCT01970865|561475754|FG013|Overall Study|Other|3|||
155559897|NCT01970865|561475755|FG014|Overall Study|Other|2|||
155559898|NCT01970865|561475756|FG015|Overall Study|Other|3|||
155559899|NCT01970865|561475757|FG016|Overall Study|Other|0|||
155559900|NCT01970865|561475758|FG017|Overall Study|Other|2|||
155559901|NCT01970865|561475741|FG000|Overall Study|Participant refused further follow-up|0|||
155559902|NCT01970865|561475742|FG001|Overall Study|Participant refused further follow-up|0|||
155559903|NCT01970865|561475743|FG002|Overall Study|Participant refused further follow-up|0|||
155559904|NCT01970865|561475744|FG003|Overall Study|Participant refused further follow-up|2|||
155559905|NCT01970865|561475745|FG004|Overall Study|Participant refused further follow-up|3|||
155559906|NCT01970865|561475746|FG005|Overall Study|Participant refused further follow-up|0|||
155559907|NCT01970865|561475747|FG006|Overall Study|Participant refused further follow-up|0|||
155559908|NCT01970865|561475748|FG007|Overall Study|Participant refused further follow-up|0|||
155559909|NCT01970865|561475749|FG008|Overall Study|Participant refused further follow-up|0|||
155559910|NCT01970865|561475750|FG009|Overall Study|Participant refused further follow-up|0|||
155559911|NCT01970865|561475751|FG010|Overall Study|Participant refused further follow-up|1|||
155559912|NCT01970865|561475752|FG011|Overall Study|Participant refused further follow-up|4|||
155559913|NCT01970865|561475753|FG012|Overall Study|Participant refused further follow-up|7|||
155559914|NCT01970865|561475754|FG013|Overall Study|Participant refused further follow-up|8|||
155559915|NCT01970865|561475755|FG014|Overall Study|Participant refused further follow-up|3|||
155559916|NCT01970865|561475756|FG015|Overall Study|Participant refused further follow-up|11|||
155559917|NCT01970865|561475757|FG016|Overall Study|Participant refused further follow-up|0|||
155559918|NCT01970865|561475758|FG017|Overall Study|Participant refused further follow-up|6|||
155559919|NCT02041091|561475760|FG000|Treatment|Adverse Event|3|||
155559920|NCT02041091|561475761|FG001|Treatment|Adverse Event|3|||
155559921|NCT02041091|561475760|FG000|Treatment|Withdrawal by Subject|2|||
155559922|NCT02041091|561475761|FG001|Treatment|Withdrawal by Subject|4|||
155559923|NCT02041091|561475760|FG000|Treatment|Physician Decision|1|||
155559924|NCT02041091|561475761|FG001|Treatment|Physician Decision|0|||
155559925|NCT02041091|561475760|FG000|Treatment|Sponsor Decision|15|||
155559926|NCT02041091|561475761|FG001|Treatment|Sponsor Decision|16|||
155559927|NCT02041091|561475760|FG000|Treatment|Lost to Follow-up|1|||
155559928|NCT02041091|561475761|FG001|Treatment|Lost to Follow-up|0|||
155559929|NCT02041091|561475760|FG000|Optional Safety Extension Period|Adverse Event|4|||
155559930|NCT02041091|561475761|FG001|Optional Safety Extension Period|Adverse Event|2|||
155559931|NCT02041091|561475760|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
155559932|NCT02041091|561475761|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
155559933|NCT02041091|561475760|FG000|Optional Safety Extension Period|Protocol Violation|2|||
155559934|NCT02041091|561475761|FG001|Optional Safety Extension Period|Protocol Violation|0|||
155559935|NCT02041091|561475760|FG000|Optional Safety Extension Period|Physician Decision|2|||
155559936|NCT02041091|561475761|FG001|Optional Safety Extension Period|Physician Decision|1|||
155559937|NCT02041091|561475760|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
155559938|NCT02041091|561475761|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
155559939|NCT02041091|561475760|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
155559940|NCT02041091|561475761|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
155559941|NCT03118570|561475762|FG000|Overall Study|Adverse Event|2|||
155559942|NCT03118570|561475763|FG001|Overall Study|Adverse Event|0|||
155559943|NCT03118570|561475764|FG002|Overall Study|Adverse Event|0|||
155559944|NCT03118570|561475765|FG003|Overall Study|Adverse Event|0|||
155559945|NCT03118570|561475766|FG004|Overall Study|Adverse Event|3|||
155559946|NCT03118570|561475762|FG000|Overall Study|Withdrawal by Subject|0|||
155559947|NCT03118570|561475763|FG001|Overall Study|Withdrawal by Subject|1|||
155559948|NCT03118570|561475764|FG002|Overall Study|Withdrawal by Subject|4|||
155559949|NCT03118570|561475765|FG003|Overall Study|Withdrawal by Subject|0|||
155559950|NCT03118570|561475766|FG004|Overall Study|Withdrawal by Subject|1|||
155559951|NCT03118570|561475762|FG000|Overall Study|Lost to Follow-up|2|||
155559952|NCT03118570|561475763|FG001|Overall Study|Lost to Follow-up|3|||
155559953|NCT03118570|561475764|FG002|Overall Study|Lost to Follow-up|1|||
155559954|NCT03118570|561475765|FG003|Overall Study|Lost to Follow-up|0|||
155559955|NCT03118570|561475766|FG004|Overall Study|Lost to Follow-up|1|||
155559956|NCT03118570|561475762|FG000|Overall Study|Other, Not Specified|1|||
155559957|NCT03118570|561475763|FG001|Overall Study|Other, Not Specified|3|||
155559958|NCT03118570|561475764|FG002|Overall Study|Other, Not Specified|0|||
155559959|NCT03118570|561475765|FG003|Overall Study|Other, Not Specified|0|||
155559960|NCT03118570|561475766|FG004|Overall Study|Other, Not Specified|0|||
155559961|NCT00321737|561475771|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
155559962|NCT00321737|561475772|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
155559963|NCT00321737|561475773|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
155559964|NCT00321737|561475771|FG000|Overall Study|Adverse Event|11|||
155559965|NCT00321737|561475772|FG001|Overall Study|Adverse Event|3|||
155559966|NCT00321737|561475773|FG002|Overall Study|Adverse Event|6|||
155559967|NCT00321737|561475771|FG000|Overall Study|Lost to Follow-up|5|||
155559968|NCT00321737|561475772|FG001|Overall Study|Lost to Follow-up|5|||
155559969|NCT00321737|561475773|FG002|Overall Study|Lost to Follow-up|6|||
155559970|NCT00321737|561475771|FG000|Overall Study|Withdrawal by Subject|19|||
155559971|NCT00321737|561475772|FG001|Overall Study|Withdrawal by Subject|12|||
155559972|NCT00321737|561475773|FG002|Overall Study|Withdrawal by Subject|17|||
155559973|NCT00321737|561475771|FG000|Overall Study|Protocol Violation|0|||
155559974|NCT00321737|561475772|FG001|Overall Study|Protocol Violation|0|||
155559975|NCT00321737|561475773|FG002|Overall Study|Protocol Violation|1|||
155559976|NCT00321737|561475771|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
155559977|NCT00321737|561475772|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155559978|NCT00321737|561475773|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155559979|NCT00321737|561475771|FG000|Overall Study|Possible Barrett's Esophagus|2|||
155559980|NCT00321737|561475772|FG001|Overall Study|Possible Barrett's Esophagus|1|||
155559981|NCT00321737|561475773|FG002|Overall Study|Possible Barrett's Esophagus|1|||
155559982|NCT00321737|561475771|FG000|Overall Study|Therapeutic Failure|6|||
155559983|NCT00321737|561475772|FG001|Overall Study|Therapeutic Failure|0|||
155559984|NCT00321737|561475773|FG002|Overall Study|Therapeutic Failure|2|||
155559985|NCT00321737|561475771|FG000|Overall Study|Pregnancy|0|||
155559986|NCT00321737|561475772|FG001|Overall Study|Pregnancy|2|||
155559987|NCT00321737|561475773|FG002|Overall Study|Pregnancy|0|||
155559988|NCT00321737|561475771|FG000|Overall Study|Noncompliance|2|||
155559989|NCT00321737|561475772|FG001|Overall Study|Noncompliance|0|||
155559990|NCT00321737|561475773|FG002|Overall Study|Noncompliance|0|||
155559991|NCT00321737|561475771|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
155559992|NCT00321737|561475772|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
155559993|NCT00321737|561475773|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
155559994|NCT02283294|561475774|FG000|Overall Study|Lost to Follow-up|1|||
155559995|NCT02283294|561475775|FG001|Overall Study|Lost to Follow-up|1|||
155559996|NCT02283294|561475774|FG000|Overall Study|Withdrawal by Subject|1|||
155559997|NCT02283294|561475775|FG001|Overall Study|Withdrawal by Subject|6|||
155559998|NCT02283294|561475774|FG000|Overall Study|Protocol Violation|1|||
155559999|NCT02283294|561475775|FG001|Overall Study|Protocol Violation|0|||
155560000|NCT02283294|561475774|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
155560001|NCT02283294|561475775|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
155560002|NCT00594646|561475776|FG000|Overall Study|Withdrawal by Subject|1|||
155560003|NCT00594646|561475776|FG000|Overall Study|Lost to Follow-up|15|||
155560004|NCT03845296|561478531|FG000|Overall Study|On Treatment|2|||
155560005|NCT03845296|561478532|FG001|Overall Study|On Treatment|1|||
155560006|NCT03845296|561478531|FG000|Overall Study|Adverse Event|4|||
155560007|NCT03845296|561478532|FG001|Overall Study|Adverse Event|11|||
155560008|NCT03845296|561478531|FG000|Overall Study|Refusal unrelated to adverse event|0|||
155560009|NCT03845296|561478532|FG001|Overall Study|Refusal unrelated to adverse event|1|||
155560010|NCT03845296|561478531|FG000|Overall Study|Progression/relapse|14|||
155560011|NCT03845296|561478532|FG001|Overall Study|Progression/relapse|18|||
155560012|NCT03845296|561478531|FG000|Overall Study|Death|4|||
155560013|NCT03845296|561478532|FG001|Overall Study|Death|0|||
155560014|NCT03845296|561478531|FG000|Overall Study|Other - not protocol specified|1|||
155560015|NCT03845296|561478532|FG001|Overall Study|Other - not protocol specified|3|||
155560016|NCT05091307|561478533|FG000|Overall Study|Death|0|||
155560017|NCT05091307|561478534|FG001|Overall Study|Death|0|||
155560018|NCT05091307|561478535|FG002|Overall Study|Death|1|||
155560019|NCT05091307|561478536|FG003|Overall Study|Death|0|||
155560020|NCT05091307|561478533|FG000|Overall Study|Lost to Follow-up|33|||
155560021|NCT05091307|561478534|FG001|Overall Study|Lost to Follow-up|33|||
155560022|NCT05091307|561478535|FG002|Overall Study|Lost to Follow-up|2|||
155560023|NCT05091307|561478536|FG003|Overall Study|Lost to Follow-up|0|||
155560024|NCT05091307|561478533|FG000|Overall Study|Physician Decision|1|||
155560025|NCT05091307|561478534|FG001|Overall Study|Physician Decision|0|||
155560026|NCT05091307|561478535|FG002|Overall Study|Physician Decision|0|||
155560027|NCT05091307|561478536|FG003|Overall Study|Physician Decision|0|||
155560028|NCT05091307|561478533|FG000|Overall Study|Protocol Violation|1|||
155560029|NCT05091307|561478534|FG001|Overall Study|Protocol Violation|0|||
155560030|NCT05091307|561478535|FG002|Overall Study|Protocol Violation|0|||
155560031|NCT05091307|561478536|FG003|Overall Study|Protocol Violation|0|||
155560032|NCT05091307|561478533|FG000|Overall Study|Withdrawal by Subject|16|||
155560033|NCT05091307|561478534|FG001|Overall Study|Withdrawal by Subject|16|||
155560034|NCT05091307|561478535|FG002|Overall Study|Withdrawal by Subject|0|||
155560035|NCT05091307|561478536|FG003|Overall Study|Withdrawal by Subject|1|||
155560036|NCT05091307|561478533|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
155560037|NCT05091307|561478534|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
155560038|NCT05091307|561478535|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
155560039|NCT05091307|561478536|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
155560040|NCT05091307|561478533|FG000|Overall Study|Initiated Prohibited Medication|1|||
155560041|NCT05091307|561478534|FG001|Overall Study|Initiated Prohibited Medication|0|||
155560042|NCT05091307|561478535|FG002|Overall Study|Initiated Prohibited Medication|0|||
155560043|NCT05091307|561478536|FG003|Overall Study|Initiated Prohibited Medication|0|||
155560044|NCT05091307|561478533|FG000|Overall Study|Other|4|||
155560045|NCT05091307|561478534|FG001|Overall Study|Other|4|||
155560046|NCT05091307|561478535|FG002|Overall Study|Other|0|||
155560047|NCT05091307|561478536|FG003|Overall Study|Other|0|||
155560048|NCT05091307|561478533|FG000|Overall Study|Randomized but not vaccinated|0|||
155560049|NCT05091307|561478534|FG001|Overall Study|Randomized but not vaccinated|2|||
155560050|NCT05091307|561478535|FG002|Overall Study|Randomized but not vaccinated|0|||
155560051|NCT05091307|561478536|FG003|Overall Study|Randomized but not vaccinated|0|||
155560052|NCT04732221|561478539|FG000|Base Period|Death|2|||
155560053|NCT04732221|561478540|FG001|Base Period|Death|0|||
155560054|NCT04732221|561478541|FG002|Base Period|Death|0|||
155560055|NCT04732221|561478542|FG003|Base Period|Death|0|||
155560056|NCT04732221|561478543|FG004|Base Period|Death|0|||
155560057|NCT04732221|561478544|FG005|Base Period|Death|0|||
155658081|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155560058|NCT04732221|561478545|FG006|Base Period|Death|0|||
155560059|NCT04732221|561478539|FG000|Base Period|Withdrawal by Subject|0|||
155560060|NCT04732221|561478540|FG001|Base Period|Withdrawal by Subject|1|||
155560061|NCT04732221|561478541|FG002|Base Period|Withdrawal by Subject|1|||
155658082|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
155560062|NCT04732221|561478542|FG003|Base Period|Withdrawal by Subject|0|||
155658083|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155560063|NCT04732221|561478543|FG004|Base Period|Withdrawal by Subject|0|||
155560064|NCT04732221|561478544|FG005|Base Period|Withdrawal by Subject|0|||
155560065|NCT04732221|561478545|FG006|Base Period|Withdrawal by Subject|0|||
155560066|NCT04732221|561478539|FG000|Extension Period|Adverse Event|0|||
155560067|NCT04732221|561478540|FG001|Extension Period|Adverse Event|0|||
155560068|NCT04732221|561478541|FG002|Extension Period|Adverse Event|0|||
155560069|NCT04732221|561478542|FG003|Extension Period|Adverse Event|0|||
155560070|NCT04732221|561478543|FG004|Extension Period|Adverse Event|0|||
155560071|NCT04732221|561478544|FG005|Extension Period|Adverse Event|1|||
155560072|NCT04732221|561478545|FG006|Extension Period|Adverse Event|0|||
155560073|NCT04732221|561478539|FG000|Extension Period|Death|0|||
155560074|NCT04732221|561478540|FG001|Extension Period|Death|0|||
155560075|NCT04732221|561478541|FG002|Extension Period|Death|0|||
155560076|NCT04732221|561478542|FG003|Extension Period|Death|0|||
155560077|NCT04732221|561478543|FG004|Extension Period|Death|1|||
155560078|NCT04732221|561478544|FG005|Extension Period|Death|0|||
155560079|NCT04732221|561478545|FG006|Extension Period|Death|2|||
155560080|NCT04732221|561478539|FG000|Extension Period|Pregnancy|0|||
155560081|NCT04732221|561478540|FG001|Extension Period|Pregnancy|0|||
155560082|NCT04732221|561478541|FG002|Extension Period|Pregnancy|0|||
155560083|NCT04732221|561478542|FG003|Extension Period|Pregnancy|0|||
155560084|NCT04732221|561478543|FG004|Extension Period|Pregnancy|1|||
155560085|NCT04732221|561478544|FG005|Extension Period|Pregnancy|0|||
155560086|NCT04732221|561478545|FG006|Extension Period|Pregnancy|0|||
155560087|NCT04732221|561478539|FG000|Extension Period|Sponsors Decision|0|||
155560088|NCT04732221|561478540|FG001|Extension Period|Sponsors Decision|0|||
155560089|NCT04732221|561478541|FG002|Extension Period|Sponsors Decision|0|||
155560090|NCT04732221|561478542|FG003|Extension Period|Sponsors Decision|0|||
155560091|NCT04732221|561478543|FG004|Extension Period|Sponsors Decision|41|||
155560092|NCT04732221|561478544|FG005|Extension Period|Sponsors Decision|40|||
155560093|NCT04732221|561478545|FG006|Extension Period|Sponsors Decision|40|||
155560094|NCT04732221|561478539|FG000|Extension Period|Withdrawal by Subject|0|||
155560095|NCT04732221|561478540|FG001|Extension Period|Withdrawal by Subject|0|||
155560096|NCT04732221|561478541|FG002|Extension Period|Withdrawal by Subject|0|||
155560097|NCT04732221|561478542|FG003|Extension Period|Withdrawal by Subject|0|||
155560098|NCT04732221|561478543|FG004|Extension Period|Withdrawal by Subject|1|||
155560099|NCT04732221|561478544|FG005|Extension Period|Withdrawal by Subject|5|||
155560100|NCT04732221|561478545|FG006|Extension Period|Withdrawal by Subject|2|||
155560101|NCT00379340|561478550|FG000|Overall Study|Death|0|||
155560102|NCT00379340|561478551|FG001|Overall Study|Death|0|||
155560103|NCT00379340|561478552|FG002|Overall Study|Death|0|||
155560104|NCT00379340|561478553|FG003|Overall Study|Death|2|||
155560105|NCT00379340|561478554|FG004|Overall Study|Death|0|||
155560106|NCT00379340|561478550|FG000|Overall Study|Lack of Efficacy|6|||
155560107|NCT00379340|561478551|FG001|Overall Study|Lack of Efficacy|1|||
155560108|NCT00379340|561478552|FG002|Overall Study|Lack of Efficacy|0|||
155560109|NCT00379340|561478553|FG003|Overall Study|Lack of Efficacy|4|||
155560110|NCT00379340|561478554|FG004|Overall Study|Lack of Efficacy|3|||
155560111|NCT00379340|561478550|FG000|Overall Study|Physician Decision|6|||
155560112|NCT00379340|561478551|FG001|Overall Study|Physician Decision|2|||
155560113|NCT00379340|561478552|FG002|Overall Study|Physician Decision|1|||
155560114|NCT00379340|561478553|FG003|Overall Study|Physician Decision|2|||
155560115|NCT00379340|561478554|FG004|Overall Study|Physician Decision|3|||
155560116|NCT00379340|561478550|FG000|Overall Study|Withdrawal by Subject|0|||
155560117|NCT00379340|561478551|FG001|Overall Study|Withdrawal by Subject|0|||
155560118|NCT00379340|561478552|FG002|Overall Study|Withdrawal by Subject|0|||
155560119|NCT00379340|561478553|FG003|Overall Study|Withdrawal by Subject|1|||
155560120|NCT00379340|561478554|FG004|Overall Study|Withdrawal by Subject|0|||
155560121|NCT00379340|561478550|FG000|Overall Study|Refusal of further protocol therapy|1|||
155560122|NCT00379340|561478551|FG001|Overall Study|Refusal of further protocol therapy|0|||
155560123|NCT00379340|561478552|FG002|Overall Study|Refusal of further protocol therapy|1|||
155560124|NCT00379340|561478553|FG003|Overall Study|Refusal of further protocol therapy|1|||
155560125|NCT00379340|561478554|FG004|Overall Study|Refusal of further protocol therapy|7|||
155560126|NCT00379340|561478550|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
155560127|NCT00379340|561478551|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
155560128|NCT00379340|561478552|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
155560129|NCT00379340|561478553|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
155560130|NCT00379340|561478554|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
155560131|NCT00379340|561478550|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
155560132|NCT00379340|561478551|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
155560133|NCT00379340|561478552|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
155560134|NCT00379340|561478553|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
155560135|NCT00379340|561478554|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
155560136|NCT05327816|561478558|FG000|Overall Study|Lost to Follow-up|1|||
155560137|NCT05327816|561478559|FG001|Overall Study|Lost to Follow-up|0|||
155560138|NCT05327816|561478560|FG002|Overall Study|Lost to Follow-up|0|||
155560139|NCT05327816|561478561|FG003|Overall Study|Lost to Follow-up|0|||
155560140|NCT05327816|561478562|FG004|Overall Study|Lost to Follow-up|0|||
155560141|NCT05327816|561478563|FG005|Overall Study|Lost to Follow-up|0|||
155560142|NCT05327816|561478564|FG006|Overall Study|Lost to Follow-up|0|||
155560143|NCT05327816|561478565|FG007|Overall Study|Lost to Follow-up|0|||
155560144|NCT05327816|561478566|FG008|Overall Study|Lost to Follow-up|0|||
155560145|NCT05327816|561478567|FG009|Overall Study|Lost to Follow-up|1|||
155560146|NCT05327816|561478568|FG010|Overall Study|Lost to Follow-up|0|||
155560147|NCT05327816|561478558|FG000|Overall Study|Withdrawal by Subject|0|||
155560148|NCT05327816|561478559|FG001|Overall Study|Withdrawal by Subject|0|||
155560149|NCT05327816|561478560|FG002|Overall Study|Withdrawal by Subject|0|||
155560150|NCT05327816|561478561|FG003|Overall Study|Withdrawal by Subject|0|||
155560151|NCT05327816|561478562|FG004|Overall Study|Withdrawal by Subject|1|||
155560152|NCT05327816|561478563|FG005|Overall Study|Withdrawal by Subject|1|||
155560153|NCT05327816|561478564|FG006|Overall Study|Withdrawal by Subject|0|||
155560154|NCT05327816|561478565|FG007|Overall Study|Withdrawal by Subject|0|||
155560155|NCT05327816|561478566|FG008|Overall Study|Withdrawal by Subject|0|||
155560156|NCT05327816|561478567|FG009|Overall Study|Withdrawal by Subject|0|||
155560157|NCT05327816|561478568|FG010|Overall Study|Withdrawal by Subject|0|||
155560158|NCT05327816|561478558|FG000|Overall Study|Study Terminated by Sponsor|11|||
155560159|NCT05327816|561478559|FG001|Overall Study|Study Terminated by Sponsor|12|||
155560160|NCT05327816|561478560|FG002|Overall Study|Study Terminated by Sponsor|12|||
155560161|NCT05327816|561478561|FG003|Overall Study|Study Terminated by Sponsor|12|||
155560162|NCT05327816|561478562|FG004|Overall Study|Study Terminated by Sponsor|11|||
155560163|NCT05327816|561478563|FG005|Overall Study|Study Terminated by Sponsor|11|||
155560164|NCT05327816|561478564|FG006|Overall Study|Study Terminated by Sponsor|11|||
155560165|NCT05327816|561478565|FG007|Overall Study|Study Terminated by Sponsor|11|||
155560166|NCT05327816|561478566|FG008|Overall Study|Study Terminated by Sponsor|11|||
155560167|NCT05327816|561478567|FG009|Overall Study|Study Terminated by Sponsor|11|||
155560168|NCT05327816|561478568|FG010|Overall Study|Study Terminated by Sponsor|12|||
155560169|NCT05327816|561478558|FG000|Overall Study|Randomized but not treated|0|||
155560170|NCT05327816|561478559|FG001|Overall Study|Randomized but not treated|0|||
155560171|NCT05327816|561478560|FG002|Overall Study|Randomized but not treated|0|||
155560172|NCT05327816|561478561|FG003|Overall Study|Randomized but not treated|0|||
155560173|NCT05327816|561478562|FG004|Overall Study|Randomized but not treated|0|||
155560174|NCT05327816|561478563|FG005|Overall Study|Randomized but not treated|0|||
155560175|NCT05327816|561478564|FG006|Overall Study|Randomized but not treated|1|||
155560176|NCT05327816|561478565|FG007|Overall Study|Randomized but not treated|1|||
155560177|NCT05327816|561478566|FG008|Overall Study|Randomized but not treated|1|||
155560178|NCT05327816|561478567|FG009|Overall Study|Randomized but not treated|0|||
155560179|NCT05327816|561478568|FG010|Overall Study|Randomized but not treated|0|||
155560180|NCT00658658|561478575|FG000|Overall Study|Withdrawal by Subject|0|||
155560181|NCT00658658|561478576|FG001|Overall Study|Withdrawal by Subject|1|||
155560182|NCT00658658|561478577|FG002|Overall Study|Withdrawal by Subject|0|||
155560183|NCT00658658|561478578|FG003|Overall Study|Withdrawal by Subject|0|||
155560184|NCT00658658|561478579|FG004|Overall Study|Withdrawal by Subject|0|||
155560185|NCT00658658|561478575|FG000|Overall Study|Death|4|||
155560186|NCT00658658|561478576|FG001|Overall Study|Death|0|||
155560187|NCT00658658|561478577|FG002|Overall Study|Death|0|||
155560188|NCT00658658|561478578|FG003|Overall Study|Death|1|||
155560189|NCT00658658|561478579|FG004|Overall Study|Death|1|||
155560190|NCT00658658|561478575|FG000|Overall Study|Disease Progression|0|||
155560191|NCT00658658|561478576|FG001|Overall Study|Disease Progression|1|||
155560192|NCT00658658|561478577|FG002|Overall Study|Disease Progression|0|||
155560193|NCT00658658|561478578|FG003|Overall Study|Disease Progression|1|||
155560194|NCT00658658|561478579|FG004|Overall Study|Disease Progression|3|||
155560195|NCT00658658|561478575|FG000|Overall Study|Protocol-specified Criteria|1|||
155560196|NCT00658658|561478576|FG001|Overall Study|Protocol-specified Criteria|0|||
155560197|NCT00658658|561478577|FG002|Overall Study|Protocol-specified Criteria|0|||
155560198|NCT00658658|561478578|FG003|Overall Study|Protocol-specified Criteria|0|||
155560199|NCT00658658|561478579|FG004|Overall Study|Protocol-specified Criteria|0|||
155560200|NCT00658658|561478575|FG000|Overall Study|Other|0|||
155560201|NCT00658658|561478576|FG001|Overall Study|Other|0|||
155560202|NCT00658658|561478577|FG002|Overall Study|Other|0|||
155560203|NCT00658658|561478578|FG003|Overall Study|Other|0|||
155560204|NCT00658658|561478579|FG004|Overall Study|Other|1|||
155560205|NCT01367665|561478580|FG000|Overall Study|Death|102|||
155560206|NCT01367665|561478581|FG001|Overall Study|Death|19|||
155560207|NCT01367665|561478580|FG000|Overall Study|Lost to Follow-up|222|||
155560208|NCT01367665|561478581|FG001|Overall Study|Lost to Follow-up|22|||
155560209|NCT01367665|561478580|FG000|Overall Study|Not Done|118|||
155560210|NCT01367665|561478581|FG001|Overall Study|Not Done|14|||
155560211|NCT03283319|561478582|FG000|Overall Study|Lost to Follow-up|5|||
155560212|NCT03283319|561478583|FG001|Overall Study|Lost to Follow-up|4|||
155560213|NCT03283319|561478584|FG002|Overall Study|Lost to Follow-up|5|||
155560214|NCT03283319|561478585|FG003|Overall Study|Lost to Follow-up|5|||
155560215|NCT03283319|561478586|FG004|Overall Study|Lost to Follow-up|4|||
155560216|NCT03283319|561478587|FG005|Overall Study|Lost to Follow-up|3|||
155560217|NCT03283319|561478582|FG000|Overall Study|Withdrawal by Subject|2|||
155560218|NCT03283319|561478583|FG001|Overall Study|Withdrawal by Subject|2|||
155560219|NCT03283319|561478584|FG002|Overall Study|Withdrawal by Subject|2|||
155560220|NCT03283319|561478585|FG003|Overall Study|Withdrawal by Subject|1|||
155560221|NCT03283319|561478586|FG004|Overall Study|Withdrawal by Subject|0|||
155560222|NCT03283319|561478587|FG005|Overall Study|Withdrawal by Subject|1|||
155560223|NCT03283319|561478582|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
155560224|NCT03283319|561478583|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
155560225|NCT03283319|561478584|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
155560226|NCT03283319|561478585|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
155560227|NCT03283319|561478586|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
155560228|NCT03283319|561478587|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
155560229|NCT03954834|561478589|FG000|Overall Study|Adverse Event|1|||
155560230|NCT03954834|561478590|FG001|Overall Study|Adverse Event|3|||
155560231|NCT03954834|561478591|FG002|Overall Study|Adverse Event|1|||
155560232|NCT03954834|561478592|FG003|Overall Study|Adverse Event|1|||
155560233|NCT03954834|561478589|FG000|Overall Study|Death|0|||
155560234|NCT03954834|561478590|FG001|Overall Study|Death|0|||
155560235|NCT03954834|561478591|FG002|Overall Study|Death|0|||
155560236|NCT03954834|561478592|FG003|Overall Study|Death|1|||
155560237|NCT03954834|561478589|FG000|Overall Study|Physician Decision|0|||
155560238|NCT03954834|561478590|FG001|Overall Study|Physician Decision|1|||
155560239|NCT03954834|561478591|FG002|Overall Study|Physician Decision|0|||
155560240|NCT03954834|561478592|FG003|Overall Study|Physician Decision|2|||
155560241|NCT03954834|561478589|FG000|Overall Study|Protocol Violation|1|||
155560242|NCT03954834|561478590|FG001|Overall Study|Protocol Violation|0|||
155560243|NCT03954834|561478591|FG002|Overall Study|Protocol Violation|0|||
155560244|NCT03954834|561478592|FG003|Overall Study|Protocol Violation|1|||
155560245|NCT03954834|561478589|FG000|Overall Study|Withdrawal by Subject|2|||
155560246|NCT03954834|561478590|FG001|Overall Study|Withdrawal by Subject|3|||
155560247|NCT03954834|561478591|FG002|Overall Study|Withdrawal by Subject|13|||
155560248|NCT03954834|561478592|FG003|Overall Study|Withdrawal by Subject|6|||
155560249|NCT03954834|561478589|FG000|Overall Study|Participant left the country|0|||
155560250|NCT03954834|561478590|FG001|Overall Study|Participant left the country|0|||
155560251|NCT03954834|561478591|FG002|Overall Study|Participant left the country|1|||
155560252|NCT03954834|561478592|FG003|Overall Study|Participant left the country|0|||
155560253|NCT03954834|561478589|FG000|Overall Study|Lost to Follow-up|3|||
155560254|NCT03954834|561478590|FG001|Overall Study|Lost to Follow-up|2|||
155560255|NCT03954834|561478591|FG002|Overall Study|Lost to Follow-up|3|||
155560256|NCT03954834|561478592|FG003|Overall Study|Lost to Follow-up|5|||
155560257|NCT00754650|561478595|FG000|Overall Study|Disease Progression|2|||
155560258|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
155560259|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
155560260|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
155560261|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
155560262|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
155560263|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
155560264|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
155560265|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
155560266|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
155560267|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
155560268|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
155560269|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
155560270|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
155560271|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
155560272|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
155560273|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
155560274|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
155560275|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
155560276|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
155560277|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
155560278|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
155560279|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
155560280|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
155560281|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
155560282|NCT03514641|561478600|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
155560283|NCT03514641|561478601|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
155560284|NCT03514641|561478602|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
155560285|NCT03514641|561478603|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
155560286|NCT03514641|561478600|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
155560287|NCT03514641|561478601|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
155560288|NCT03514641|561478602|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
155560289|NCT03514641|561478603|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
155560290|NCT03514641|561478600|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
155560291|NCT03514641|561478601|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
155560292|NCT03514641|561478602|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
155560293|NCT03514641|561478603|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
155560294|NCT03514641|561478600|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
155560295|NCT03514641|561478601|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
155560296|NCT03514641|561478602|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
155658084|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658085|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
155658086|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155560297|NCT03514641|561478603|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
155560298|NCT03514641|561478600|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
155560299|NCT03514641|561478601|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
155560300|NCT03514641|561478602|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
155560301|NCT03514641|561478603|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
155560302|NCT03514641|561478600|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
155560303|NCT03514641|561478601|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
155560304|NCT03514641|561478602|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
155560305|NCT03514641|561478603|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
155560306|NCT02906930|561478606|FG000|Overall Study|Withdrawal by Subject|0|||
155560307|NCT02906930|561478607|FG001|Overall Study|Withdrawal by Subject|5|||
155560308|NCT02906930|561478608|FG002|Overall Study|Withdrawal by Subject|5|||
155560309|NCT02906930|561478609|FG003|Overall Study|Withdrawal by Subject|4|||
155560310|NCT02906930|561478606|FG000|Overall Study|Lost to Follow-up|5|||
155560311|NCT02906930|561478607|FG001|Overall Study|Lost to Follow-up|7|||
155560312|NCT02906930|561478608|FG002|Overall Study|Lost to Follow-up|5|||
155560313|NCT02906930|561478609|FG003|Overall Study|Lost to Follow-up|2|||
155560314|NCT02906930|561478606|FG000|Overall Study|Death|0|||
155560315|NCT02906930|561478607|FG001|Overall Study|Death|0|||
155560316|NCT02906930|561478608|FG002|Overall Study|Death|1|||
155560317|NCT02906930|561478609|FG003|Overall Study|Death|0|||
155560318|NCT02906930|561478606|FG000|Overall Study|Other|1|||
155560319|NCT02906930|561478607|FG001|Overall Study|Other|2|||
155560320|NCT02906930|561478608|FG002|Overall Study|Other|1|||
155658087|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658088|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658089|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658090|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658091|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658092|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658093|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658094|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155658095|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658096|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658097|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
155658098|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658099|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658100|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658101|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658102|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658103|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658104|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658105|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658106|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658107|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658108|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658109|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658110|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155658111|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155560321|NCT02906930|561478609|FG003|Overall Study|Other|2|||
155560322|NCT04234984|561478617|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
155560323|NCT04234984|561478617|FG000|Follow-up at the Second Time Point|Death|1|||
155560324|NCT04234984|561478617|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
155560325|NCT02570113|561478620|FG000|Overall Study|Withdrawal by Subject|3|||
155560326|NCT02564211|561478621|FG000|Overall Study|Adverse Event|4|||
155560327|NCT00910091|561478623|FG000|Pre-assignment|Withdrawal by Subject|0|||
155560328|NCT00910091|561478624|FG001|Pre-assignment|Withdrawal by Subject|2|||
155560329|NCT00910091|561478623|FG000|Treatment and Survival|Withdrawal by Subject|3|||
155560330|NCT00910091|561478624|FG001|Treatment and Survival|Withdrawal by Subject|4|||
155560331|NCT00910091|561478623|FG000|Treatment and Survival|Adverse Event|1|||
155560332|NCT00910091|561478624|FG001|Treatment and Survival|Adverse Event|0|||
155560333|NCT01908816|561478625|FG000|Overall Study|Subject's no longer requires study drug|0|||
155560334|NCT01908816|561478626|FG001|Overall Study|Subject's no longer requires study drug|0|||
155560335|NCT01908816|561478627|FG002|Overall Study|Subject's no longer requires study drug|0|||
155560336|NCT01908816|561478628|FG003|Overall Study|Subject's no longer requires study drug|1|||
155560337|NCT01908816|561478625|FG000|Overall Study|Protocol deviation|1|||
155560338|NCT01908816|561478626|FG001|Overall Study|Protocol deviation|2|||
155560339|NCT01908816|561478627|FG002|Overall Study|Protocol deviation|1|||
155560340|NCT01908816|561478628|FG003|Overall Study|Protocol deviation|1|||
155560341|NCT01908816|561478625|FG000|Overall Study|Withdrawal by Subject|0|||
155560342|NCT01908816|561478626|FG001|Overall Study|Withdrawal by Subject|4|||
155560343|NCT01908816|561478627|FG002|Overall Study|Withdrawal by Subject|2|||
155560344|NCT01908816|561478628|FG003|Overall Study|Withdrawal by Subject|2|||
155560345|NCT01908816|561478625|FG000|Overall Study|Lost to Follow-up|3|||
155560346|NCT01908816|561478626|FG001|Overall Study|Lost to Follow-up|5|||
155560347|NCT01908816|561478627|FG002|Overall Study|Lost to Follow-up|4|||
155560348|NCT01908816|561478628|FG003|Overall Study|Lost to Follow-up|2|||
155560349|NCT01908816|561478625|FG000|Overall Study|Death|1|||
155560350|NCT01908816|561478626|FG001|Overall Study|Death|0|||
155560351|NCT01908816|561478627|FG002|Overall Study|Death|7|||
155560352|NCT01908816|561478628|FG003|Overall Study|Death|1|||
155560353|NCT01908816|561478625|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155560354|NCT01908816|561478626|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
155560355|NCT01908816|561478627|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
155560356|NCT01908816|561478628|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155560357|NCT01908816|561478625|FG000|Overall Study|Early termination|87|||
155560358|NCT01908816|561478626|FG001|Overall Study|Early termination|60|||
155560359|NCT01908816|561478627|FG002|Overall Study|Early termination|43|||
155560360|NCT01908816|561478628|FG003|Overall Study|Early termination|28|||
155560361|NCT04594707|561478629|FG000|Overall Study|Adverse Event|0|||
155560362|NCT04594707|561478630|FG001|Overall Study|Adverse Event|0|||
155560363|NCT04594707|561478631|FG002|Overall Study|Adverse Event|1|||
155560364|NCT04594707|561478629|FG000|Overall Study|Death|0|||
155560365|NCT04594707|561478630|FG001|Overall Study|Death|2|||
155560366|NCT04594707|561478631|FG002|Overall Study|Death|2|||
155560367|NCT04594707|561478629|FG000|Overall Study|Lung Transplant|0|||
155560368|NCT04594707|561478630|FG001|Overall Study|Lung Transplant|0|||
155560369|NCT04594707|561478631|FG002|Overall Study|Lung Transplant|1|||
155560370|NCT04594707|561478629|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
155560371|NCT04594707|561478630|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
155560372|NCT04594707|561478631|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
155560373|NCT04594707|561478629|FG000|Overall Study|Study Terminated By Sponsor|19|||
155560374|NCT04594707|561478630|FG001|Overall Study|Study Terminated By Sponsor|47|||
155560375|NCT04594707|561478631|FG002|Overall Study|Study Terminated By Sponsor|41|||
155560376|NCT04594707|561478629|FG000|Overall Study|Withdrawal by Subject|1|||
155560377|NCT04594707|561478630|FG001|Overall Study|Withdrawal by Subject|0|||
155560378|NCT04594707|561478631|FG002|Overall Study|Withdrawal by Subject|2|||
155560379|NCT04585789|561478632|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
155560380|NCT04585789|561478633|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
155560381|NCT04585789|561478634|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
155560382|NCT04585789|561478632|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
155560383|NCT04585789|561478633|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
155560384|NCT04585789|561478634|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
155560385|NCT01175811|561478635|FG000|Overall Study|Adverse Event|1|||
155560386|NCT01175811|561478636|FG001|Overall Study|Adverse Event|1|||
155560387|NCT01175811|561478635|FG000|Overall Study|Entry criteria not met|3|||
155560388|NCT01175811|561478636|FG001|Overall Study|Entry criteria not met|1|||
155560389|NCT01175811|561478635|FG000|Overall Study|Lack of Efficacy|1|||
155560390|NCT01175811|561478636|FG001|Overall Study|Lack of Efficacy|0|||
155560391|NCT01175811|561478635|FG000|Overall Study|Lost to Follow-up|3|||
155560392|NCT01175811|561478636|FG001|Overall Study|Lost to Follow-up|2|||
155560393|NCT01175811|561478635|FG000|Overall Study|Physician Decision|1|||
155560394|NCT01175811|561478636|FG001|Overall Study|Physician Decision|1|||
155560395|NCT01175811|561478635|FG000|Overall Study|Protocol Violation|1|||
155560396|NCT01175811|561478636|FG001|Overall Study|Protocol Violation|2|||
155560397|NCT01175811|561478635|FG000|Overall Study|Withdrawal by Subject|6|||
155560398|NCT01175811|561478636|FG001|Overall Study|Withdrawal by Subject|7|||
155560399|NCT02628743|561478638|FG000|Overall Study|Other|3|||
155560400|NCT02628743|561478638|FG000|Overall Study|Withdrawal by Subject|50|||
155560401|NCT02628743|561478638|FG000|Overall Study|Study Terminated by Sponsor|76|||
155560402|NCT02628743|561478638|FG000|Overall Study|Physician Decision|2|||
155560403|NCT00655876|561478639|FG000|Overall Study|Protocol Violation|9|||
155560404|NCT00655876|561478640|FG001|Overall Study|Protocol Violation|7|||
155560405|NCT00326963|561478641|FG000|Overall Study|Adverse Event|2|||
155560406|NCT00326963|561478641|FG000|Overall Study|Injection site reaction|1|||
155560407|NCT00326963|561478641|FG000|Overall Study|Death|1|||
155560408|NCT00326963|561478641|FG000|Overall Study|Failure to return|10|||
155560409|NCT00326963|561478641|FG000|Overall Study|Withdrawal by Subject|10|||
155560410|NCT00326963|561478641|FG000|Overall Study|Refused treatment / did not cooperate|5|||
155560411|NCT00326963|561478641|FG000|Overall Study|Violation of selection criteria at entry|2|||
155560412|NCT00326963|561478641|FG000|Overall Study|Other protocol violation|1|||
155560413|NCT00326963|561478641|FG000|Overall Study|Administrative / other|1|||
155560414|NCT00552578|561478645|FG000|Overall Study|Lost to Follow-up|1|||
155560415|NCT00552578|561478646|FG001|Overall Study|Lost to Follow-up|1|||
155560416|NCT04091659|561478648|FG000|Overall Study|Protocol Violation|3|||
155560417|NCT04091659|561478649|FG001|Overall Study|Protocol Violation|0|||
155560418|NCT04091659|561478648|FG000|Overall Study|Lost to Follow-up|0|||
155560419|NCT04091659|561478649|FG001|Overall Study|Lost to Follow-up|1|||
155560420|NCT03678285|561478650|FG000|Overall Study|Adverse Event|2|||
155560421|NCT03678285|561478650|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
155560422|NCT03678285|561478650|FG000|Overall Study|Dehydrated prior to start of workout|1|||
155560423|NCT00123474|561478651|FG000|Randomized to Treatment|Randomized, never treated|1|||
155560424|NCT00123474|561478652|FG001|Randomized to Treatment|Randomized, never treated|4|||
155560425|NCT00123474|561478653|FG002|Randomized to Treatment|Randomized, never treated|2|||
155560426|NCT00123474|561478654|FG003|Randomized to Treatment|Randomized, never treated|1|||
155560427|NCT00123474|561478651|FG000|As Treated at Study Closure|not reported when site closed|1|||
155560428|NCT00123474|561478652|FG001|As Treated at Study Closure|not reported when site closed|0|||
155560429|NCT00123474|561478653|FG002|As Treated at Study Closure|not reported when site closed|1|||
155560430|NCT00123474|561478654|FG003|As Treated at Study Closure|not reported when site closed|0|||
155560431|NCT00123474|561478651|FG000|As Treated at Study Closure|Adverse Event|10|||
155560432|NCT00123474|561478652|FG001|As Treated at Study Closure|Adverse Event|4|||
155560433|NCT00123474|561478653|FG002|As Treated at Study Closure|Adverse Event|10|||
155560434|NCT00123474|561478654|FG003|As Treated at Study Closure|Adverse Event|8|||
155560435|NCT00123474|561478651|FG000|As Treated at Study Closure|Disease Progression|35|||
155560436|NCT00123474|561478652|FG001|As Treated at Study Closure|Disease Progression|42|||
155560437|NCT00123474|561478653|FG002|As Treated at Study Closure|Disease Progression|29|||
155560438|NCT00123474|561478654|FG003|As Treated at Study Closure|Disease Progression|27|||
155560439|NCT00123474|561478651|FG000|As Treated at Study Closure|Investigator Request|12|||
155560440|NCT00123474|561478652|FG001|As Treated at Study Closure|Investigator Request|6|||
155560441|NCT00123474|561478653|FG002|As Treated at Study Closure|Investigator Request|7|||
155560442|NCT00123474|561478654|FG003|As Treated at Study Closure|Investigator Request|5|||
155560443|NCT00123474|561478651|FG000|As Treated at Study Closure|non-specified|54|||
155560444|NCT00123474|561478652|FG001|As Treated at Study Closure|non-specified|47|||
155560445|NCT00123474|561478653|FG002|As Treated at Study Closure|non-specified|57|||
155560446|NCT00123474|561478654|FG003|As Treated at Study Closure|non-specified|60|||
155560447|NCT00123474|561478651|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
155560448|NCT00123474|561478652|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
155560449|NCT00123474|561478653|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
155560450|NCT00123474|561478654|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
155560451|NCT00123474|561478651|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
155560452|NCT00123474|561478652|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
155560453|NCT00123474|561478653|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
155560454|NCT00123474|561478654|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
155560455|NCT00616629|561478655|FG000|Overall Study|Protocol Violation|1|||
155560456|NCT00616629|561478656|FG001|Overall Study|Protocol Violation|2|||
155560457|NCT00616629|561478657|FG002|Overall Study|Protocol Violation|1|||
155560458|NCT00616629|561478658|FG003|Overall Study|Protocol Violation|0|||
155560459|NCT00616629|561478659|FG004|Overall Study|Protocol Violation|0|||
155560460|NCT00616629|561478655|FG000|Overall Study|AV-block|1|||
155560461|NCT00616629|561478656|FG001|Overall Study|AV-block|0|||
155560462|NCT00616629|561478657|FG002|Overall Study|AV-block|0|||
155560463|NCT00616629|561478658|FG003|Overall Study|AV-block|0|||
155658112|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155560464|NCT00616629|561478659|FG004|Overall Study|AV-block|0|||
155560465|NCT01085201|561478662|FG000|Overall Study|Scheduling conflict|1|||
155560466|NCT01085201|561478663|FG001|Overall Study|Scheduling conflict|0|||
155560467|NCT01085201|561478664|FG002|Overall Study|Scheduling conflict|1|||
155560468|NCT01085201|561478665|FG003|Overall Study|Scheduling conflict|0|||
155560469|NCT01085201|561478666|FG004|Overall Study|Scheduling conflict|0|||
155560470|NCT01085201|561478662|FG000|Overall Study|Unknown- no study drug|2|||
155560471|NCT01085201|561478663|FG001|Overall Study|Unknown- no study drug|0|||
155560472|NCT01085201|561478664|FG002|Overall Study|Unknown- no study drug|0|||
155560473|NCT01085201|561478665|FG003|Overall Study|Unknown- no study drug|0|||
155560474|NCT01085201|561478666|FG004|Overall Study|Unknown- no study drug|0|||
155560475|NCT01085201|561478662|FG000|Overall Study|Fond ineligible after consent|0|||
155560476|NCT01085201|561478663|FG001|Overall Study|Fond ineligible after consent|1|||
155560477|NCT01085201|561478664|FG002|Overall Study|Fond ineligible after consent|1|||
155560478|NCT01085201|561478665|FG003|Overall Study|Fond ineligible after consent|0|||
155560479|NCT01085201|561478666|FG004|Overall Study|Fond ineligible after consent|0|||
155560480|NCT00528411|561478667|FG000|Overall Study|Adverse Event|4|||
155560481|NCT00528411|561478668|FG001|Overall Study|Adverse Event|0|||
155560482|NCT00528411|561478669|FG002|Overall Study|Adverse Event|1|||
155560483|NCT00528411|561478667|FG000|Overall Study|Incorrect Enrolment|1|||
155560484|NCT00528411|561478668|FG001|Overall Study|Incorrect Enrolment|1|||
155560485|NCT00528411|561478669|FG002|Overall Study|Incorrect Enrolment|0|||
155560486|NCT00528411|561478667|FG000|Overall Study|Severe non-compliance to protocol|0|||
155560487|NCT00528411|561478668|FG001|Overall Study|Severe non-compliance to protocol|1|||
155560488|NCT00528411|561478669|FG002|Overall Study|Severe non-compliance to protocol|0|||
155560489|NCT00528411|561478667|FG000|Overall Study|Prior commitment medication|0|||
155560490|NCT00528411|561478668|FG001|Overall Study|Prior commitment medication|1|||
155560491|NCT00528411|561478669|FG002|Overall Study|Prior commitment medication|0|||
155560492|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
155560493|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
155560494|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560495|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560496|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
155560497|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560498|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560499|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560500|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
155560501|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560502|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
155560503|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560504|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560505|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560506|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560507|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560508|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560509|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
155560510|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560511|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
155560512|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560513|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
155560514|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560515|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560516|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560517|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560518|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560519|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560520|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
155560521|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560522|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
155560523|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560524|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560525|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560526|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560527|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
155560528|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
155560529|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
155560530|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
155560531|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560532|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
155560533|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560534|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560535|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560536|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560537|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560538|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
155560539|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560540|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560541|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560542|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560543|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560544|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560545|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
155560546|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560547|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560548|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560549|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
155560550|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560551|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560552|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560553|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560554|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560555|NCT03893565|561478670|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560556|NCT03893565|561478671|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
155560557|NCT03893565|561478672|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
155560558|NCT03893565|561478673|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
155560559|NCT03893565|561478674|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560560|NCT03893565|561478675|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560561|NCT03893565|561478676|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560562|NCT03893565|561478677|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560563|NCT03893565|561478678|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
155560564|NCT03893565|561478670|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
155560565|NCT03893565|561478671|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
155560566|NCT03893565|561478672|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
155560567|NCT03893565|561478673|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
155560568|NCT03893565|561478674|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
155560569|NCT03893565|561478675|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
155560570|NCT03893565|561478676|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
155560571|NCT03893565|561478677|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
155560572|NCT03893565|561478678|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
155560573|NCT03893565|561478670|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560574|NCT03893565|561478671|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560575|NCT03893565|561478672|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560576|NCT03893565|561478673|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560577|NCT03893565|561478674|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560578|NCT03893565|561478675|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560579|NCT03893565|561478676|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
155560580|NCT03893565|561478677|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560581|NCT03893565|561478678|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
155560582|NCT03893565|561478670|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560583|NCT03893565|561478671|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560584|NCT03893565|561478672|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560585|NCT03893565|561478673|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560586|NCT03893565|561478674|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560587|NCT03893565|561478675|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
155560588|NCT03893565|561478676|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
155560589|NCT03893565|561478677|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560590|NCT03893565|561478678|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155560591|NCT03893565|561478670|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
155560592|NCT03893565|561478671|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
155560593|NCT03893565|561478672|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
155560594|NCT03893565|561478673|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
155560595|NCT03893565|561478674|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
155560596|NCT03893565|561478675|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
155560597|NCT03893565|561478676|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
155560598|NCT03893565|561478677|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
155560599|NCT03893565|561478678|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
155560600|NCT03893565|561478670|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560601|NCT03893565|561478671|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560602|NCT03893565|561478672|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560603|NCT03893565|561478673|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560604|NCT03893565|561478674|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560605|NCT03893565|561478675|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560606|NCT03893565|561478676|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560607|NCT03893565|561478677|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
155560608|NCT03893565|561478678|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
155560609|NCT03893565|561478670|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560610|NCT03893565|561478671|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560611|NCT03893565|561478672|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560612|NCT03893565|561478673|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560613|NCT03893565|561478674|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560614|NCT03893565|561478675|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560615|NCT03893565|561478676|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560616|NCT03893565|561478677|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
155560617|NCT03893565|561478678|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
155560618|NCT03893565|561478670|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560619|NCT03893565|561478671|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560620|NCT03893565|561478672|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560621|NCT03893565|561478673|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560622|NCT03893565|561478674|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560623|NCT03893565|561478675|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560624|NCT03893565|561478676|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560625|NCT03893565|561478677|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
155560626|NCT03893565|561478678|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
155560627|NCT03893565|561478670|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560628|NCT03893565|561478671|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560629|NCT03893565|561478672|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560630|NCT03893565|561478673|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560631|NCT03893565|561478674|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560632|NCT03893565|561478675|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560633|NCT03893565|561478676|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560634|NCT03893565|561478677|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
155560635|NCT03893565|561478678|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
155560636|NCT05005312|561478679|FG000|Overall Study|Enrolled, but not treated|0|||
155560637|NCT05005312|561478680|FG001|Overall Study|Enrolled, but not treated|1|||
155560638|NCT01283035|561478681|FG000|Overall Study|Subject later found ineligible|1|||
155560639|NCT00851318|561478682|FG000|Overall Study|Withdrawal by Subject|7|||
155560640|NCT00851318|561478683|FG001|Overall Study|Withdrawal by Subject|1|||
155560641|NCT00851318|561478684|FG002|Overall Study|Withdrawal by Subject|5|||
155560642|NCT00851318|561478685|FG003|Overall Study|Withdrawal by Subject|3|||
155560643|NCT00851318|561478682|FG000|Overall Study|Adverse Event|13|||
155560644|NCT00851318|561478683|FG001|Overall Study|Adverse Event|2|||
155560645|NCT00851318|561478684|FG002|Overall Study|Adverse Event|9|||
155658113|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155560646|NCT00851318|561478685|FG003|Overall Study|Adverse Event|12|||
155560647|NCT00851318|561478682|FG000|Overall Study|Pregnancy|0|||
155560648|NCT00851318|561478683|FG001|Overall Study|Pregnancy|0|||
155560649|NCT00851318|561478684|FG002|Overall Study|Pregnancy|1|||
155560650|NCT00851318|561478685|FG003|Overall Study|Pregnancy|1|||
155560651|NCT00851318|561478682|FG000|Overall Study|Lack of Efficacy|8|||
155560652|NCT00851318|561478683|FG001|Overall Study|Lack of Efficacy|2|||
155560653|NCT00851318|561478684|FG002|Overall Study|Lack of Efficacy|4|||
155560654|NCT00851318|561478685|FG003|Overall Study|Lack of Efficacy|2|||
155560655|NCT00851318|561478682|FG000|Overall Study|Non-compliance with Study Procedures|2|||
155560656|NCT00851318|561478683|FG001|Overall Study|Non-compliance with Study Procedures|0|||
155560657|NCT00851318|561478684|FG002|Overall Study|Non-compliance with Study Procedures|1|||
155560658|NCT00851318|561478685|FG003|Overall Study|Non-compliance with Study Procedures|0|||
155560659|NCT00851318|561478682|FG000|Overall Study|Physician Decision|0|||
155560660|NCT00851318|561478683|FG001|Overall Study|Physician Decision|0|||
155560661|NCT00851318|561478684|FG002|Overall Study|Physician Decision|1|||
155560662|NCT00851318|561478685|FG003|Overall Study|Physician Decision|1|||
155560663|NCT01715571|561478695|FG000|Overall Study|Lost to Follow-up|8|||
155560664|NCT03870477|561478702|FG000|Overall Study|Early Study Termination|1|||
155560665|NCT02256436|561478707|FG000|Overall Study|Adverse Event|9|||
155560666|NCT02256436|561478708|FG001|Overall Study|Adverse Event|14|||
155560667|NCT02256436|561478707|FG000|Overall Study|Death|216|||
155560668|NCT02256436|561478708|FG001|Overall Study|Death|208|||
155560669|NCT02256436|561478707|FG000|Overall Study|Lost to Follow-up|1|||
155560670|NCT02256436|561478708|FG001|Overall Study|Lost to Follow-up|2|||
155560671|NCT02256436|561478707|FG000|Overall Study|Physician Decision|1|||
155560672|NCT02256436|561478708|FG001|Overall Study|Physician Decision|0|||
155560673|NCT02256436|561478707|FG000|Overall Study|Protocol Violation|0|||
155560674|NCT02256436|561478708|FG001|Overall Study|Protocol Violation|1|||
155560675|NCT02256436|561478707|FG000|Overall Study|Withdrawal by Subject|26|||
155560676|NCT02256436|561478708|FG001|Overall Study|Withdrawal by Subject|10|||
155560677|NCT02256436|561478707|FG000|Overall Study|Transferred to Extension Study|11|||
155560678|NCT02256436|561478708|FG001|Overall Study|Transferred to Extension Study|23|||
155560679|NCT02256436|561478707|FG000|Overall Study|Did Not Continue on Extension Study|8|||
155560680|NCT02256436|561478708|FG001|Overall Study|Did Not Continue on Extension Study|12|||
155560681|NCT05961215|561478709|FG000|Overall Study|Withdrawal by Subject|1|||
155560682|NCT01394952|561478713|FG000|Overall Study|Lost to Follow-up|0|||
155560683|NCT01394952|561478714|FG001|Overall Study|Lost to Follow-up|5|||
155560684|NCT01394952|561478713|FG000|Overall Study|Withdrawal by Subject|10|||
155560685|NCT01394952|561478714|FG001|Overall Study|Withdrawal by Subject|5|||
155560686|NCT01394952|561478713|FG000|Overall Study|Physician Decision|2|||
155560687|NCT01394952|561478714|FG001|Overall Study|Physician Decision|0|||
155560688|NCT01394952|561478713|FG000|Overall Study|Sponsor Decision|5|||
155560689|NCT01394952|561478714|FG001|Overall Study|Sponsor Decision|7|||
155560690|NCT04740814|561478715|FG000|Overall Study|Adverse Event|3|||
155560691|NCT04740814|561478715|FG000|Overall Study|Protocol Violation|2|||
155560692|NCT04740814|561478715|FG000|Overall Study|Lost to Follow-up|2|||
155560693|NCT04740814|561478715|FG000|Overall Study|Withdrawal by Subject|3|||
155560694|NCT00085423|561478716|FG000|Overall Study|Withdrawal by Subject|1|||
155560695|NCT00085423|561478716|FG000|Overall Study|screen failure|1|||
155560696|NCT01763684|561478723|FG000|Overall Study|Study terminated early due to low enrollment|126|||
155560697|NCT01763684|561478724|FG001|Overall Study|Study terminated early due to low enrollment|127|||
155560698|NCT01763684|561478723|FG000|Overall Study|Study surgery not performed|7|||
155560699|NCT01763684|561478724|FG001|Overall Study|Study surgery not performed|6|||
155560700|NCT04305496|561478727|FG000|Global Cohort|Withdrawal by Subject|13|||
155560701|NCT04305496|561478728|FG001|Global Cohort|Withdrawal by Subject|6|||
155560702|NCT04305496|561478727|FG000|Global Cohort|Physician Decision|1|||
155560703|NCT04305496|561478728|FG001|Global Cohort|Physician Decision|1|||
155560704|NCT04305496|561478727|FG000|Global Cohort|Subjective disease progression|16|||
155560705|NCT04305496|561478728|FG001|Global Cohort|Subjective disease progression|17|||
155560706|NCT04305496|561478727|FG000|Global Cohort|Condition under investigation worsened|209|||
155560707|NCT04305496|561478728|FG001|Global Cohort|Condition under investigation worsened|273|||
155560708|NCT04305496|561478727|FG000|Global Cohort|Protocol Violation|2|||
155560709|NCT04305496|561478728|FG001|Global Cohort|Protocol Violation|0|||
155560710|NCT04305496|561478727|FG000|Global Cohort|Adverse Event|44|||
155560711|NCT04305496|561478728|FG001|Global Cohort|Adverse Event|6|||
155560712|NCT04305496|561478727|FG000|Global Cohort|Death|3|||
155560713|NCT04305496|561478728|FG001|Global Cohort|Death|2|||
155560714|NCT04305496|561478727|FG000|Global Cohort|Any reason not specifically recorded|4|||
155560715|NCT04305496|561478728|FG001|Global Cohort|Any reason not specifically recorded|5|||
155560716|NCT04305496|561478727|FG000|China Cohort|Any reason not specifically recorded|1|||
155560717|NCT04305496|561478728|FG001|China Cohort|Any reason not specifically recorded|1|||
155560718|NCT04305496|561478727|FG000|China Cohort|Adverse Event|8|||
155560719|NCT04305496|561478728|FG001|China Cohort|Adverse Event|2|||
155560720|NCT04305496|561478727|FG000|China Cohort|Condition under investigation worsened|40|||
155560721|NCT04305496|561478728|FG001|China Cohort|Condition under investigation worsened|47|||
155560722|NCT04305496|561478727|FG000|China Cohort|Subjective disease progression|2|||
155560723|NCT04305496|561478728|FG001|China Cohort|Subjective disease progression|2|||
155560724|NCT04305496|561478727|FG000|China Cohort|Withdrawal by Subject|2|||
155560725|NCT04305496|561478728|FG001|China Cohort|Withdrawal by Subject|1|||
155560726|NCT02357342|561478729|FG000|First 6 Months|Death|2|||
155560727|NCT02357342|561478730|FG001|First 6 Months|Death|0|||
155560728|NCT02582866|561478731|FG000|Overall Study|Death|1|||
155560729|NCT02582866|561478731|FG000|Overall Study|Lack of Efficacy|2|||
155560730|NCT02582866|561478731|FG000|Overall Study|Lost to Follow-up|2|||
155560731|NCT02582866|561478731|FG000|Overall Study|Withdrawal by Subject|7|||
155560732|NCT02582866|561478731|FG000|Overall Study|Investigator decision|5|||
155560733|NCT02582866|561478731|FG000|Overall Study|Participant wants to get pregnant|1|||
155560734|NCT02582866|561478731|FG000|Overall Study|Pregnancy|2|||
155560735|NCT02582866|561478731|FG000|Overall Study|Sponsor decision|1|||
155560736|NCT02582866|561478731|FG000|Overall Study|Withdrawal due to personal reasons|1|||
155560737|NCT02011386|561478740|FG000|Overall Study|Non-compliance|2|||
155560738|NCT02011386|561478740|FG000|Overall Study|Lack of Efficacy|3|||
155560739|NCT01193127|561478741|FG000|Randomized|Surgery Cancelled|0|||
155560740|NCT01193127|561478742|FG001|Randomized|Surgery Cancelled|0|||
155560741|NCT01193127|561478743|FG002|Randomized|Surgery Cancelled|0|||
155560742|NCT01193127|561478744|FG003|Randomized|Surgery Cancelled|1|||
155560743|NCT01193127|561478741|FG000|Treated|Withdrawal by Subject|0|||
155560744|NCT01193127|561478742|FG001|Treated|Withdrawal by Subject|0|||
155560745|NCT01193127|561478743|FG002|Treated|Withdrawal by Subject|0|||
155560746|NCT01193127|561478744|FG003|Treated|Withdrawal by Subject|1|||
155560747|NCT02352779|561478752|FG000|Overall Study|Personal Issues|1|||
155560748|NCT02352779|561478753|FG001|Overall Study|Personal Issues|1|||
155560749|NCT02352779|561478754|FG002|Overall Study|Personal Issues|0|||
155560750|NCT02352779|561478752|FG000|Overall Study|Too Many Forms|2|||
155560751|NCT02352779|561478753|FG001|Overall Study|Too Many Forms|0|||
155560752|NCT02352779|561478754|FG002|Overall Study|Too Many Forms|0|||
155560753|NCT02352779|561478752|FG000|Overall Study|Feeling Overwhelmed|1|||
155560754|NCT02352779|561478753|FG001|Overall Study|Feeling Overwhelmed|0|||
155560755|NCT02352779|561478754|FG002|Overall Study|Feeling Overwhelmed|0|||
155560756|NCT02352779|561478752|FG000|Overall Study|Disliked Intervention|1|||
155560757|NCT02352779|561478753|FG001|Overall Study|Disliked Intervention|0|||
155560758|NCT02352779|561478754|FG002|Overall Study|Disliked Intervention|0|||
155560759|NCT02352779|561478752|FG000|Overall Study|Changed Mind|1|||
155560760|NCT02352779|561478753|FG001|Overall Study|Changed Mind|0|||
155560761|NCT02352779|561478754|FG002|Overall Study|Changed Mind|0|||
155560762|NCT02352779|561478752|FG000|Overall Study|Study Related Symptoms|1|||
155560763|NCT02352779|561478753|FG001|Overall Study|Study Related Symptoms|0|||
155560764|NCT02352779|561478754|FG002|Overall Study|Study Related Symptoms|0|||
155560765|NCT02352779|561478752|FG000|Overall Study|Absence of Symptoms|1|||
155560766|NCT02352779|561478753|FG001|Overall Study|Absence of Symptoms|0|||
155560767|NCT02352779|561478754|FG002|Overall Study|Absence of Symptoms|0|||
155560768|NCT02352779|561478752|FG000|Overall Study|Other Medical Reason|0|||
155560769|NCT02352779|561478753|FG001|Overall Study|Other Medical Reason|0|||
155560770|NCT02352779|561478754|FG002|Overall Study|Other Medical Reason|1|||
155560771|NCT02352779|561478752|FG000|Overall Study|No Reason|0|||
155560772|NCT02352779|561478753|FG001|Overall Study|No Reason|0|||
155560773|NCT02352779|561478754|FG002|Overall Study|No Reason|1|||
155560774|NCT00006721|561481289|FG000|Overall Study|Adverse Event|0|||
155560775|NCT00006721|561481290|FG001|Overall Study|Adverse Event|4|||
155560776|NCT00006721|561481291|FG002|Overall Study|Adverse Event|4|||
155658114|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155560777|NCT00006721|561481289|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155560778|NCT00006721|561481290|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
155560779|NCT00006721|561481291|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
155560780|NCT00006721|561481289|FG000|Overall Study|Progression/Relapse|0|||
155560781|NCT00006721|561481290|FG001|Overall Study|Progression/Relapse|1|||
155560782|NCT00006721|561481291|FG002|Overall Study|Progression/Relapse|2|||
155560783|NCT00006721|561481289|FG000|Overall Study|Death|0|||
155560784|NCT00006721|561481290|FG001|Overall Study|Death|1|||
155560785|NCT00006721|561481291|FG002|Overall Study|Death|2|||
155560786|NCT00006721|561481289|FG000|Overall Study|Other - Not Protocol Specified|0|||
155560787|NCT00006721|561481290|FG001|Overall Study|Other - Not Protocol Specified|7|||
155560788|NCT00006721|561481291|FG002|Overall Study|Other - Not Protocol Specified|7|||
155658115|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155560789|NCT00006721|561481289|FG000|Overall Study|Ineligible|2|||
155560790|NCT00006721|561481290|FG001|Overall Study|Ineligible|12|||
155658116|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155560791|NCT00006721|561481291|FG002|Overall Study|Ineligible|10|||
155560792|NCT00006721|561481289|FG000|Overall Study|Eligible but no Treatment Received|1|||
155560793|NCT00006721|561481290|FG001|Overall Study|Eligible but no Treatment Received|0|||
155560794|NCT00006721|561481291|FG002|Overall Study|Eligible but no Treatment Received|0|||
155560795|NCT05424042|561481292|FG000|Overall Study|Withdrawal by Subject|2|||
155560796|NCT05424042|561481293|FG001|Overall Study|Withdrawal by Subject|0|||
155560797|NCT05424042|561481294|FG002|Overall Study|Withdrawal by Subject|4|||
155560798|NCT05424042|561481292|FG000|Overall Study|Lost to Follow-up|0|||
155560799|NCT05424042|561481293|FG001|Overall Study|Lost to Follow-up|0|||
155560800|NCT05424042|561481294|FG002|Overall Study|Lost to Follow-up|1|||
155560801|NCT03611543|561481295|FG000|Overall Study|Withdrawal by Subject|4|||
155560802|NCT03611543|561481296|FG001|Overall Study|Withdrawal by Subject|4|||
155560803|NCT03611543|561481295|FG000|Overall Study|Physician Decision|1|||
155560804|NCT03611543|561481296|FG001|Overall Study|Physician Decision|1|||
155560805|NCT03611543|561481295|FG000|Overall Study|Protocol Violation|2|||
155560806|NCT03611543|561481296|FG001|Overall Study|Protocol Violation|2|||
155560807|NCT03611543|561481295|FG000|Overall Study|Device failure|2|||
155560808|NCT03611543|561481296|FG001|Overall Study|Device failure|2|||
155560809|NCT03611543|561481295|FG000|Overall Study|Missing information|5|||
155560810|NCT03611543|561481296|FG001|Overall Study|Missing information|5|||
155560811|NCT03047473|561481297|FG000|Overall Study|Lost to Follow-up|2|||
155560812|NCT01167257|561481298|FG000|Overall Study|Lost to Follow-up|2|||
155560813|NCT01167257|561481299|FG001|Overall Study|Lost to Follow-up|2|||
155560814|NCT01167257|561481298|FG000|Overall Study|Withdrew consent|1|||
155560815|NCT01167257|561481299|FG001|Overall Study|Withdrew consent|1|||
155560816|NCT02213510|561481301|FG000|Overall Study|Death|0|||
155560817|NCT02213510|561481302|FG001|Overall Study|Death|1|||
155560818|NCT02213510|561481301|FG000|Overall Study|Lost to Follow-up|1|||
155560819|NCT02213510|561481302|FG001|Overall Study|Lost to Follow-up|0|||
155560820|NCT04590040|561481310|FG000|Treatment Period|Lost to Follow-up|2|||
155560821|NCT04590040|561481311|FG001|Treatment Period|Lost to Follow-up|5|||
155560822|NCT04590040|561481312|FG002|Treatment Period|Lost to Follow-up|0|||
155560823|NCT04590040|561481310|FG000|Treatment Period|Physician Decision|0|||
155560824|NCT04590040|561481311|FG001|Treatment Period|Physician Decision|0|||
155560825|NCT04590040|561481312|FG002|Treatment Period|Physician Decision|2|||
155560826|NCT00000378|561481315|FG000|Overall Study|Lack of Efficacy|16|||
155560827|NCT00000378|561481316|FG001|Overall Study|Lack of Efficacy|14|||
155560828|NCT01284361|561481319|FG000|Overall Study|Withdrawal by Subject|1|||
155560829|NCT01284361|561481319|FG000|Overall Study|Protocol Violation|5|||
155560830|NCT01284361|561481319|FG000|Overall Study|Adverse Event|1|||
155560831|NCT01284361|561481319|FG000|Overall Study|Lost to Follow-up|2|||
155560832|NCT00805675|561481320|FG000|Overall Study|Adverse Event|0|||
155560833|NCT00805675|561481321|FG001|Overall Study|Adverse Event|0|||
155560834|NCT00805675|561481322|FG002|Overall Study|Adverse Event|1|||
155560835|NCT01957397|561481326|FG000|Test Period 1|sudden leakage/small bag|1|||
155560836|NCT01957397|561481327|FG001|Test Period 1|sudden leakage/small bag|1|||
155560837|NCT01957397|561481326|FG000|Test Period 1|Withdrawal by Subject|1|||
155560838|NCT01957397|561481327|FG001|Test Period 1|Withdrawal by Subject|0|||
155560839|NCT01957397|561481326|FG000|Test Period 2|Adverse Event|0|||
155560840|NCT01957397|561481327|FG001|Test Period 2|Adverse Event|1|||
155560841|NCT01957397|561481326|FG000|Test Period 3|Adverse Event|1|||
155560842|NCT01957397|561481327|FG001|Test Period 3|Adverse Event|2|||
155560843|NCT01957397|561481326|FG000|Test Period 3|the adhesive did not work|1|||
155560844|NCT01957397|561481327|FG001|Test Period 3|the adhesive did not work|0|||
155560845|NCT00540293|561481328|FG000|Overall Study|Adverse event related to study drug|10|||
155560846|NCT00540293|561481328|FG000|Overall Study|Adverse event not related to study drug|7|||
155560847|NCT00540293|561481328|FG000|Overall Study|Withdrawal by Subject|6|||
155560848|NCT00540293|561481328|FG000|Overall Study|Protocol violation, & subject schedule|12|||
155560849|NCT00325195|561481331|FG000|Randomized|Not dosed|5|||
155560850|NCT00325195|561481332|FG001|Randomized|Not dosed|5|||
155560851|NCT00325195|561481333|FG002|Randomized|Not dosed|3|||
155560852|NCT00325195|561481331|FG000|Received Intervention: ITT Population|Adverse Event|15|||
155560853|NCT00325195|561481332|FG001|Received Intervention: ITT Population|Adverse Event|17|||
155560854|NCT00325195|561481333|FG002|Received Intervention: ITT Population|Adverse Event|1|||
155560855|NCT00325195|561481331|FG000|Received Intervention: ITT Population|Death|3|||
155560856|NCT00325195|561481332|FG001|Received Intervention: ITT Population|Death|1|||
155560857|NCT00325195|561481333|FG002|Received Intervention: ITT Population|Death|0|||
155560858|NCT00325195|561481331|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
155560859|NCT00325195|561481332|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
155560860|NCT00325195|561481333|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
155560861|NCT00325195|561481331|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
155560862|NCT00325195|561481332|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
155560863|NCT00325195|561481333|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
155560864|NCT00325195|561481331|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
155560865|NCT00325195|561481332|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
155560866|NCT00325195|561481333|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
155560867|NCT04715932|561481334|FG000|Overall Study|Lost to Follow-up|1|||
155560868|NCT04715932|561481335|FG001|Overall Study|Lost to Follow-up|0|||
155560869|NCT03560986|561481336|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
155560870|NCT03560986|561481337|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
155560871|NCT03560986|561481336|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
155560872|NCT03560986|561481337|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
155560873|NCT03560986|561481336|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
155560874|NCT03560986|561481337|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
155560875|NCT03560986|561481336|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
155560876|NCT03560986|561481337|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
155560877|NCT03560986|561481336|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
155560878|NCT03560986|561481337|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
155560879|NCT03560986|561481336|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
155560880|NCT03560986|561481337|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
155560881|NCT03560986|561481336|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
155560882|NCT03560986|561481337|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
155560883|NCT01059539|561481338|FG000|Overall Study|Adverse Event|66|||
155560884|NCT01059539|561481338|FG000|Overall Study|Insufficient Therapeutic Response|26|||
155560885|NCT01059539|561481338|FG000|Overall Study|Protocol Violation|55|||
155560886|NCT01059539|561481338|FG000|Overall Study|Withdrawal of Consent|80|||
155560887|NCT01059539|561481338|FG000|Overall Study|Lost to Follow-up|42|||
155560888|NCT01059539|561481338|FG000|Overall Study|Reason Not Specified|2|||
155560889|NCT00626392|561481344|FG000|Run-in Period|Adverse Event|0|||
155560890|NCT00626392|561481345|FG001|Run-in Period|Adverse Event|0|||
155560891|NCT00626392|561481346|FG002|Run-in Period|Adverse Event|1|||
155560892|NCT00626392|561481347|FG003|Run-in Period|Adverse Event|0|||
155560893|NCT00626392|561481348|FG004|Run-in Period|Adverse Event|1|||
155560894|NCT00626392|561481349|FG005|Run-in Period|Adverse Event|0|||
155560895|NCT00626392|561481344|FG000|Run-in Period|Withdrawal by Subject|0|||
155560896|NCT00626392|561481345|FG001|Run-in Period|Withdrawal by Subject|1|||
155560897|NCT00626392|561481346|FG002|Run-in Period|Withdrawal by Subject|1|||
155560898|NCT00626392|561481347|FG003|Run-in Period|Withdrawal by Subject|1|||
155560899|NCT00626392|561481348|FG004|Run-in Period|Withdrawal by Subject|3|||
155560900|NCT00626392|561481349|FG005|Run-in Period|Withdrawal by Subject|1|||
155560901|NCT00626392|561481344|FG000|Run-in Period|Noncompliance|1|||
155560902|NCT00626392|561481345|FG001|Run-in Period|Noncompliance|0|||
155560903|NCT00626392|561481346|FG002|Run-in Period|Noncompliance|1|||
155560904|NCT00626392|561481347|FG003|Run-in Period|Noncompliance|0|||
155560905|NCT00626392|561481348|FG004|Run-in Period|Noncompliance|0|||
155560906|NCT00626392|561481349|FG005|Run-in Period|Noncompliance|0|||
155560907|NCT00626392|561481344|FG000|Coadministration Period|Adverse Event|3|||
155560908|NCT00626392|561481345|FG001|Coadministration Period|Adverse Event|1|||
155560909|NCT00626392|561481346|FG002|Coadministration Period|Adverse Event|7|||
155560910|NCT00626392|561481347|FG003|Coadministration Period|Adverse Event|4|||
155560911|NCT00626392|561481348|FG004|Coadministration Period|Adverse Event|3|||
155560912|NCT00626392|561481349|FG005|Coadministration Period|Adverse Event|4|||
155560913|NCT00626392|561481344|FG000|Coadministration Period|Withdrawal by Subject|1|||
155560914|NCT00626392|561481345|FG001|Coadministration Period|Withdrawal by Subject|1|||
155560915|NCT00626392|561481346|FG002|Coadministration Period|Withdrawal by Subject|0|||
155560916|NCT00626392|561481347|FG003|Coadministration Period|Withdrawal by Subject|1|||
155560917|NCT00626392|561481348|FG004|Coadministration Period|Withdrawal by Subject|0|||
155560918|NCT00626392|561481349|FG005|Coadministration Period|Withdrawal by Subject|1|||
155560919|NCT00626392|561481344|FG000|Coadministration Period|Protocol Violation|0|||
155560920|NCT00626392|561481345|FG001|Coadministration Period|Protocol Violation|1|||
155560921|NCT00626392|561481346|FG002|Coadministration Period|Protocol Violation|0|||
155560922|NCT00626392|561481347|FG003|Coadministration Period|Protocol Violation|1|||
155560923|NCT00626392|561481348|FG004|Coadministration Period|Protocol Violation|1|||
155560924|NCT00626392|561481349|FG005|Coadministration Period|Protocol Violation|0|||
155560925|NCT00626392|561481344|FG000|Coadministration Period|Other|0|||
155560926|NCT00626392|561481345|FG001|Coadministration Period|Other|2|||
155560927|NCT00626392|561481346|FG002|Coadministration Period|Other|3|||
155560928|NCT00626392|561481347|FG003|Coadministration Period|Other|1|||
155560929|NCT00626392|561481348|FG004|Coadministration Period|Other|1|||
155560930|NCT00626392|561481349|FG005|Coadministration Period|Other|1|||
155560931|NCT00338455|561481350|FG000|Overall Study|Death|2|||
155560932|NCT00338455|561481351|FG001|Overall Study|Death|1|||
155560933|NCT00338455|561481350|FG000|Overall Study|Physician Decision|1|||
155560934|NCT00338455|561481351|FG001|Overall Study|Physician Decision|0|||
155560935|NCT01517373|561481352|FG000|Run-in Period|Death|1|||
155560936|NCT01517373|561481353|FG001|Run-in Period|Death|0|||
155560937|NCT01517373|561481354|FG002|Run-in Period|Death|0|||
155560938|NCT01517373|561481355|FG003|Run-in Period|Death|0|||
155560939|NCT01517373|561481356|FG004|Run-in Period|Death|0|||
155560940|NCT01517373|561481357|FG005|Run-in Period|Death|0|||
155560941|NCT01517373|561481352|FG000|Run-in Period|Adverse Event|5|||
155560942|NCT01517373|561481353|FG001|Run-in Period|Adverse Event|0|||
155560943|NCT01517373|561481354|FG002|Run-in Period|Adverse Event|0|||
155560944|NCT01517373|561481355|FG003|Run-in Period|Adverse Event|0|||
155560945|NCT01517373|561481356|FG004|Run-in Period|Adverse Event|0|||
155560946|NCT01517373|561481357|FG005|Run-in Period|Adverse Event|0|||
155560947|NCT01517373|561481352|FG000|Run-in Period|Did not meet eligibility criteria|34|||
155560948|NCT01517373|561481353|FG001|Run-in Period|Did not meet eligibility criteria|0|||
155560949|NCT01517373|561481354|FG002|Run-in Period|Did not meet eligibility criteria|0|||
155560950|NCT01517373|561481355|FG003|Run-in Period|Did not meet eligibility criteria|0|||
155560951|NCT01517373|561481356|FG004|Run-in Period|Did not meet eligibility criteria|0|||
155560952|NCT01517373|561481357|FG005|Run-in Period|Did not meet eligibility criteria|0|||
155560953|NCT01517373|561481352|FG000|Run-in Period|Lost to Follow-up|1|||
155560954|NCT01517373|561481353|FG001|Run-in Period|Lost to Follow-up|0|||
155560955|NCT01517373|561481354|FG002|Run-in Period|Lost to Follow-up|0|||
155560956|NCT01517373|561481355|FG003|Run-in Period|Lost to Follow-up|0|||
155560957|NCT01517373|561481356|FG004|Run-in Period|Lost to Follow-up|0|||
155560958|NCT01517373|561481357|FG005|Run-in Period|Lost to Follow-up|0|||
155560959|NCT01517373|561481352|FG000|Run-in Period|Withdrawal by Subject|12|||
155560960|NCT01517373|561481353|FG001|Run-in Period|Withdrawal by Subject|0|||
155560961|NCT01517373|561481354|FG002|Run-in Period|Withdrawal by Subject|0|||
155560962|NCT01517373|561481355|FG003|Run-in Period|Withdrawal by Subject|0|||
155560963|NCT01517373|561481356|FG004|Run-in Period|Withdrawal by Subject|0|||
155560964|NCT01517373|561481357|FG005|Run-in Period|Withdrawal by Subject|0|||
155560965|NCT01517373|561481352|FG000|Run-in Period|Sponsor Decision|3|||
155560966|NCT01517373|561481353|FG001|Run-in Period|Sponsor Decision|0|||
155560967|NCT01517373|561481354|FG002|Run-in Period|Sponsor Decision|0|||
155560968|NCT01517373|561481355|FG003|Run-in Period|Sponsor Decision|0|||
155560969|NCT01517373|561481356|FG004|Run-in Period|Sponsor Decision|0|||
155560970|NCT01517373|561481357|FG005|Run-in Period|Sponsor Decision|0|||
155560971|NCT01517373|561481352|FG000|Run-in Period|Other|1|||
155560972|NCT01517373|561481353|FG001|Run-in Period|Other|0|||
155560973|NCT01517373|561481354|FG002|Run-in Period|Other|0|||
155560974|NCT01517373|561481355|FG003|Run-in Period|Other|0|||
155560975|NCT01517373|561481356|FG004|Run-in Period|Other|0|||
155560976|NCT01517373|561481357|FG005|Run-in Period|Other|0|||
155560977|NCT01517373|561481352|FG000|Treatment Period|Adverse Event|0|||
155560978|NCT01517373|561481353|FG001|Treatment Period|Adverse Event|0|||
155560979|NCT01517373|561481354|FG002|Treatment Period|Adverse Event|0|||
155560980|NCT01517373|561481355|FG003|Treatment Period|Adverse Event|0|||
155560981|NCT01517373|561481356|FG004|Treatment Period|Adverse Event|0|||
155560982|NCT01517373|561481357|FG005|Treatment Period|Adverse Event|2|||
155560983|NCT01517373|561481352|FG000|Treatment Period|Lost to Follow-up|0|||
155560984|NCT01517373|561481353|FG001|Treatment Period|Lost to Follow-up|0|||
155560985|NCT01517373|561481354|FG002|Treatment Period|Lost to Follow-up|1|||
155560986|NCT01517373|561481355|FG003|Treatment Period|Lost to Follow-up|1|||
155560987|NCT01517373|561481356|FG004|Treatment Period|Lost to Follow-up|0|||
155560988|NCT01517373|561481357|FG005|Treatment Period|Lost to Follow-up|0|||
155560989|NCT01517373|561481352|FG000|Treatment Period|Withdrawal by Subject|0|||
155560990|NCT01517373|561481353|FG001|Treatment Period|Withdrawal by Subject|3|||
155560991|NCT01517373|561481354|FG002|Treatment Period|Withdrawal by Subject|2|||
155560992|NCT01517373|561481355|FG003|Treatment Period|Withdrawal by Subject|2|||
155560993|NCT01517373|561481356|FG004|Treatment Period|Withdrawal by Subject|2|||
155560994|NCT01517373|561481357|FG005|Treatment Period|Withdrawal by Subject|3|||
155560995|NCT01517373|561481352|FG000|Treatment Period|Other|0|||
155560996|NCT01517373|561481353|FG001|Treatment Period|Other|0|||
155560997|NCT01517373|561481354|FG002|Treatment Period|Other|0|||
155560998|NCT01517373|561481355|FG003|Treatment Period|Other|0|||
155560999|NCT01517373|561481356|FG004|Treatment Period|Other|1|||
155561000|NCT01517373|561481357|FG005|Treatment Period|Other|0|||
155561001|NCT01517373|561481352|FG000|Treatment Period|Protocol Violation|0|||
155561002|NCT01517373|561481353|FG001|Treatment Period|Protocol Violation|0|||
155561003|NCT01517373|561481354|FG002|Treatment Period|Protocol Violation|0|||
155561004|NCT01517373|561481355|FG003|Treatment Period|Protocol Violation|0|||
155561005|NCT01517373|561481356|FG004|Treatment Period|Protocol Violation|1|||
155561006|NCT01517373|561481357|FG005|Treatment Period|Protocol Violation|0|||
155561007|NCT01517373|561481352|FG000|Treatment Period|Lack of Efficacy|0|||
155561008|NCT01517373|561481353|FG001|Treatment Period|Lack of Efficacy|1|||
155561009|NCT01517373|561481354|FG002|Treatment Period|Lack of Efficacy|1|||
155561010|NCT01517373|561481355|FG003|Treatment Period|Lack of Efficacy|3|||
155561011|NCT01517373|561481356|FG004|Treatment Period|Lack of Efficacy|2|||
155561012|NCT01517373|561481357|FG005|Treatment Period|Lack of Efficacy|0|||
155561013|NCT01517373|561481352|FG000|Treatment Period|Medication error without AEs|0|||
155561014|NCT01517373|561481353|FG001|Treatment Period|Medication error without AEs|0|||
155561015|NCT01517373|561481354|FG002|Treatment Period|Medication error without AEs|2|||
155561016|NCT01517373|561481355|FG003|Treatment Period|Medication error without AEs|1|||
155561017|NCT01517373|561481356|FG004|Treatment Period|Medication error without AEs|0|||
155561018|NCT01517373|561481357|FG005|Treatment Period|Medication error without AEs|2|||
155561019|NCT01085734|561481358|FG000|Overall Study|Adverse Event|0|||
155561020|NCT01085734|561481359|FG001|Overall Study|Adverse Event|2|||
155561021|NCT01085734|561481358|FG000|Overall Study|Death|1|||
155561022|NCT01085734|561481359|FG001|Overall Study|Death|0|||
155561023|NCT01085734|561481358|FG000|Overall Study|Lost to Follow-up|0|||
155561024|NCT01085734|561481359|FG001|Overall Study|Lost to Follow-up|1|||
155561025|NCT01085734|561481358|FG000|Overall Study|Withdrawal by Subject|0|||
155561026|NCT01085734|561481359|FG001|Overall Study|Withdrawal by Subject|1|||
155561027|NCT04005352|561481369|FG000|Overall Study|Adverse Event|4|||
155561028|NCT04005352|561481370|FG001|Overall Study|Adverse Event|5|||
155561029|NCT04005352|561481369|FG000|Overall Study|Death|4|||
155561030|NCT04005352|561481370|FG001|Overall Study|Death|2|||
155561031|NCT04005352|561481369|FG000|Overall Study|Lost to Follow-up|6|||
155561032|NCT04005352|561481370|FG001|Overall Study|Lost to Follow-up|2|||
155561033|NCT04005352|561481369|FG000|Overall Study|Physician Decision|7|||
155561034|NCT04005352|561481370|FG001|Overall Study|Physician Decision|13|||
155561035|NCT04005352|561481369|FG000|Overall Study|Protocol Violation|0|||
155561036|NCT04005352|561481370|FG001|Overall Study|Protocol Violation|1|||
155561037|NCT04005352|561481369|FG000|Overall Study|Withdrawal by Subject|28|||
155561038|NCT04005352|561481370|FG001|Overall Study|Withdrawal by Subject|38|||
155561039|NCT00077857|561481377|FG000|Overall Study|Adverse Event|30|||
155561040|NCT00077857|561481378|FG001|Overall Study|Adverse Event|32|||
155561041|NCT00077857|561481377|FG000|Overall Study|Death|7|||
155561042|NCT00077857|561481378|FG001|Overall Study|Death|3|||
155561043|NCT00077857|561481377|FG000|Overall Study|Insufficient therapeutic response|112|||
155561044|NCT00077857|561481378|FG001|Overall Study|Insufficient therapeutic response|128|||
155561045|NCT00077857|561481377|FG000|Overall Study|Violation of selection criteria at entry|3|||
155561046|NCT00077857|561481378|FG001|Overall Study|Violation of selection criteria at entry|1|||
155561047|NCT00077857|561481377|FG000|Overall Study|Other protocol violation|0|||
155561048|NCT00077857|561481378|FG001|Overall Study|Other protocol violation|1|||
155561049|NCT00077857|561481377|FG000|Overall Study|Refused treatment|29|||
155561050|NCT00077857|561481378|FG001|Overall Study|Refused treatment|21|||
155561051|NCT00077857|561481377|FG000|Overall Study|Failure to return|5|||
155561052|NCT00077857|561481378|FG001|Overall Study|Failure to return|5|||
155561053|NCT00077857|561481377|FG000|Overall Study|Other|15|||
155561054|NCT00077857|561481378|FG001|Overall Study|Other|13|||
155561055|NCT01096368|561481379|FG000|Overall Study|Death|0|||
155561056|NCT01096368|561481380|FG001|Overall Study|Death|1|||
155561057|NCT01096368|561481381|FG002|Overall Study|Death|0|||
155561058|NCT01096368|561481382|FG003|Overall Study|Death|0|||
155561059|NCT01096368|561481383|FG004|Overall Study|Death|0|||
155561060|NCT01096368|561481379|FG000|Overall Study|Physician Decision|0|||
155561061|NCT01096368|561481380|FG001|Overall Study|Physician Decision|13|||
155561062|NCT01096368|561481381|FG002|Overall Study|Physician Decision|2|||
155561063|NCT01096368|561481382|FG003|Overall Study|Physician Decision|4|||
155561064|NCT01096368|561481383|FG004|Overall Study|Physician Decision|6|||
155561065|NCT01096368|561481379|FG000|Overall Study|Withdrawal by Subject|0|||
155561066|NCT01096368|561481380|FG001|Overall Study|Withdrawal by Subject|52|||
155561067|NCT01096368|561481381|FG002|Overall Study|Withdrawal by Subject|0|||
155561068|NCT01096368|561481382|FG003|Overall Study|Withdrawal by Subject|10|||
155561069|NCT01096368|561481383|FG004|Overall Study|Withdrawal by Subject|14|||
155561070|NCT01096368|561481379|FG000|Overall Study|Ineligible|0|||
155561071|NCT01096368|561481380|FG001|Overall Study|Ineligible|3|||
155561072|NCT01096368|561481381|FG002|Overall Study|Ineligible|2|||
155561073|NCT01096368|561481382|FG003|Overall Study|Ineligible|0|||
155561074|NCT01096368|561481383|FG004|Overall Study|Ineligible|25|||
155561075|NCT01096368|561481379|FG000|Overall Study|Did not start treatment|0|||
155561076|NCT01096368|561481380|FG001|Overall Study|Did not start treatment|4|||
155561077|NCT01096368|561481381|FG002|Overall Study|Did not start treatment|4|||
155561078|NCT01096368|561481382|FG003|Overall Study|Did not start treatment|0|||
155561079|NCT01096368|561481383|FG004|Overall Study|Did not start treatment|0|||
155561080|NCT01096368|561481379|FG000|Overall Study|Progressive disease|0|||
155561081|NCT01096368|561481380|FG001|Overall Study|Progressive disease|6|||
155561082|NCT01096368|561481381|FG002|Overall Study|Progressive disease|0|||
155561083|NCT01096368|561481382|FG003|Overall Study|Progressive disease|10|||
155561084|NCT01096368|561481383|FG004|Overall Study|Progressive disease|3|||
155658117|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658118|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658119|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658120|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658121|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658122|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155561085|NCT01096368|561481379|FG000|Overall Study|Other|0|||
155561086|NCT01096368|561481380|FG001|Overall Study|Other|0|||
155561087|NCT01096368|561481381|FG002|Overall Study|Other|1|||
155561088|NCT01096368|561481382|FG003|Overall Study|Other|0|||
155561089|NCT01096368|561481383|FG004|Overall Study|Other|0|||
155561090|NCT01096368|561481379|FG000|Overall Study|Treated with institutional review|0|||
155561091|NCT01096368|561481380|FG001|Overall Study|Treated with institutional review|0|||
155561092|NCT01096368|561481381|FG002|Overall Study|Treated with institutional review|0|||
155561093|NCT01096368|561481382|FG003|Overall Study|Treated with institutional review|0|||
155561094|NCT01096368|561481383|FG004|Overall Study|Treated with institutional review|1|||
155561095|NCT06187909|561481384|FG000|Overall Study|Withdrawal by Subject|2|||
155561096|NCT06187909|561481385|FG001|Overall Study|Withdrawal by Subject|2|||
155561097|NCT06354998|561481386|FG000|Overall Study|Withdrawal by Subject|3|||
155561098|NCT06354998|561481387|FG001|Overall Study|Withdrawal by Subject|0|||
155561099|NCT05442866|561481388|FG000|Overall Study|Death|1|||
155561100|NCT05442866|561481388|FG000|Overall Study|Lost to Follow-up|9|||
155561101|NCT05442866|561481388|FG000|Overall Study|Protocol Violation|1|||
155561102|NCT04126213|561481394|FG000|Overall Study|Lost to Follow-up|9|||
155561103|NCT04126213|561481395|FG001|Overall Study|Lost to Follow-up|1|||
155561104|NCT04126213|561481396|FG002|Overall Study|Lost to Follow-up|5|||
155561105|NCT04126213|561481397|FG003|Overall Study|Lost to Follow-up|10|||
155561106|NCT04126213|561481398|FG004|Overall Study|Lost to Follow-up|4|||
155561107|NCT04126213|561481399|FG005|Overall Study|Lost to Follow-up|7|||
155561108|NCT04126213|561481394|FG000|Overall Study|Withdrawal by Subject|3|||
155561109|NCT04126213|561481395|FG001|Overall Study|Withdrawal by Subject|2|||
155561110|NCT04126213|561481396|FG002|Overall Study|Withdrawal by Subject|1|||
155561111|NCT04126213|561481397|FG003|Overall Study|Withdrawal by Subject|1|||
155561112|NCT04126213|561481398|FG004|Overall Study|Withdrawal by Subject|1|||
155561113|NCT04126213|561481399|FG005|Overall Study|Withdrawal by Subject|1|||
155561114|NCT04126213|561481394|FG000|Overall Study|Other|0|||
155561115|NCT04126213|561481395|FG001|Overall Study|Other|0|||
155561116|NCT04126213|561481396|FG002|Overall Study|Other|2|||
155561117|NCT04126213|561481397|FG003|Overall Study|Other|2|||
155561118|NCT04126213|561481398|FG004|Overall Study|Other|0|||
155561119|NCT04126213|561481399|FG005|Overall Study|Other|1|||
155561120|NCT04126213|561481394|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155561121|NCT04126213|561481395|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155561122|NCT04126213|561481396|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155561123|NCT04126213|561481397|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155561124|NCT04126213|561481398|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155561125|NCT04126213|561481399|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155561126|NCT02196701|561481402|FG000|Overall Study|Adverse Event|1|||
155561127|NCT02196701|561481402|FG000|Overall Study|Lost to Follow-up|1|||
155561128|NCT02196701|561481402|FG000|Overall Study|Non-adherence to Protocol|1|||
155561129|NCT03275064|561481403|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
155561130|NCT03275064|561481404|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
155606941|NCT00236899|561649605|FG001|Overall Study|Death (Study Disease)|4|||
155561131|NCT03275064|561481405|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
155561132|NCT03275064|561481406|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
155561133|NCT03275064|561481407|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
155561134|NCT03275064|561481403|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
155561135|NCT03275064|561481404|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
155561136|NCT03275064|561481405|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
155561137|NCT03275064|561481406|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
155561138|NCT03275064|561481407|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
155561139|NCT03275064|561481403|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
155561140|NCT03275064|561481404|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
155561141|NCT03275064|561481405|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
155561142|NCT03275064|561481406|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
155561143|NCT03275064|561481407|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
155561144|NCT03275064|561481403|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
155561145|NCT03275064|561481404|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
155561146|NCT03275064|561481405|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
155561147|NCT03275064|561481406|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
155561148|NCT03275064|561481407|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
155561149|NCT03275064|561481403|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
155561150|NCT03275064|561481404|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
155561151|NCT03275064|561481405|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
155561152|NCT03275064|561481406|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
155561153|NCT03275064|561481407|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
155561154|NCT00620555|561481409|FG000|Overall Study|Adverse Event|4|||
155561155|NCT00620555|561481409|FG000|Overall Study|Protocol Violation|2|||
155561156|NCT00620555|561481409|FG000|Overall Study|Lack of Efficacy|12|||
155561157|NCT00620555|561481409|FG000|Overall Study|Withdrawal by Subject|1|||
155561158|NCT00620555|561481409|FG000|Overall Study|Choice of other treatment|1|||
155561159|NCT00620555|561481409|FG000|Overall Study|Visit failure against planned|1|||
155561160|NCT03796039|561481410|FG000|Overall Study|Death|2|||
155561161|NCT03796039|561481411|FG001|Overall Study|Death|1|||
155561162|NCT03796039|561481410|FG000|Overall Study|Withdrawal by Subject|7|||
155561163|NCT03796039|561481411|FG001|Overall Study|Withdrawal by Subject|4|||
155561164|NCT01140503|561481412|FG000|Overall Study|Withdrawal by Subject|1|||
155561165|NCT01157897|561481414|FG000|Overall Study|Lost to Follow-up|2|||
155561166|NCT01157897|561481415|FG001|Overall Study|Lost to Follow-up|0|||
155561167|NCT01157897|561481416|FG002|Overall Study|Lost to Follow-up|0|||
155561168|NCT01157897|561481417|FG003|Overall Study|Lost to Follow-up|1|||
155561169|NCT01157897|561481414|FG000|Overall Study|Relocated|0|||
155561170|NCT01157897|561481415|FG001|Overall Study|Relocated|2|||
155561171|NCT01157897|561481416|FG002|Overall Study|Relocated|0|||
155561172|NCT01157897|561481417|FG003|Overall Study|Relocated|0|||
155561173|NCT03734666|561481418|FG000|Overall Study|Other|7|||
155561174|NCT03734666|561481419|FG001|Overall Study|Other|4|||
155561175|NCT03734666|561481418|FG000|Overall Study|Lost to Follow-up|12|||
155561176|NCT03734666|561481419|FG001|Overall Study|Lost to Follow-up|12|||
155561177|NCT01910389|561481420|FG000|Overall Study|Withdrawal by Subject|2|||
155561178|NCT01910389|561481421|FG001|Overall Study|Withdrawal by Subject|0|||
155561179|NCT01910389|561481420|FG000|Overall Study|Study Closed|13|||
155561180|NCT01910389|561481421|FG001|Overall Study|Study Closed|8|||
155561181|NCT01898650|561481423|FG000|Overall Study|the subject would not lie still for imaging|1|||
155561182|NCT01791153|561481426|FG000|Part 1: Blinded Period|Adverse Event|7|||
155561183|NCT01791153|561481427|FG001|Part 1: Blinded Period|Adverse Event|3|||
155561184|NCT01791153|561481428|FG002|Part 1: Blinded Period|Adverse Event|2|||
155561185|NCT01791153|561481429|FG003|Part 1: Blinded Period|Adverse Event|0|||
155561186|NCT01791153|561481430|FG004|Part 1: Blinded Period|Adverse Event|0|||
155561187|NCT01791153|561481431|FG005|Part 1: Blinded Period|Adverse Event|0|||
155561188|NCT01791153|561481432|FG006|Part 1: Blinded Period|Adverse Event|0|||
155561189|NCT01791153|561481433|FG007|Part 1: Blinded Period|Adverse Event|0|||
155561190|NCT01791153|561481426|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
155561191|NCT01791153|561481427|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
155561192|NCT01791153|561481428|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
155561193|NCT01791153|561481429|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
155561194|NCT01791153|561481430|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
155561195|NCT01791153|561481431|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
155561196|NCT01791153|561481432|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
155561197|NCT01791153|561481433|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
155561198|NCT01791153|561481426|FG000|Part 1: Blinded Period|Non-Compliance|1|||
155561199|NCT01791153|561481427|FG001|Part 1: Blinded Period|Non-Compliance|0|||
155561200|NCT01791153|561481428|FG002|Part 1: Blinded Period|Non-Compliance|0|||
155561201|NCT01791153|561481429|FG003|Part 1: Blinded Period|Non-Compliance|0|||
155561202|NCT01791153|561481430|FG004|Part 1: Blinded Period|Non-Compliance|0|||
155561203|NCT01791153|561481431|FG005|Part 1: Blinded Period|Non-Compliance|0|||
155561204|NCT01791153|561481432|FG006|Part 1: Blinded Period|Non-Compliance|0|||
155561205|NCT01791153|561481433|FG007|Part 1: Blinded Period|Non-Compliance|0|||
155561206|NCT01791153|561481426|FG000|Part 1: Blinded Period|Physician Decision|0|||
155561207|NCT01791153|561481427|FG001|Part 1: Blinded Period|Physician Decision|0|||
155561208|NCT01791153|561481428|FG002|Part 1: Blinded Period|Physician Decision|0|||
155561209|NCT01791153|561481429|FG003|Part 1: Blinded Period|Physician Decision|1|||
155561210|NCT01791153|561481430|FG004|Part 1: Blinded Period|Physician Decision|0|||
155561211|NCT01791153|561481431|FG005|Part 1: Blinded Period|Physician Decision|0|||
155561212|NCT01791153|561481432|FG006|Part 1: Blinded Period|Physician Decision|0|||
155561213|NCT01791153|561481433|FG007|Part 1: Blinded Period|Physician Decision|0|||
155561214|NCT01791153|561481426|FG000|Part 1: Blinded Period|Protocol Violation|0|||
155561215|NCT01791153|561481427|FG001|Part 1: Blinded Period|Protocol Violation|0|||
155561216|NCT01791153|561481428|FG002|Part 1: Blinded Period|Protocol Violation|0|||
155561217|NCT01791153|561481429|FG003|Part 1: Blinded Period|Protocol Violation|1|||
155561218|NCT01791153|561481430|FG004|Part 1: Blinded Period|Protocol Violation|0|||
155561219|NCT01791153|561481431|FG005|Part 1: Blinded Period|Protocol Violation|0|||
155561220|NCT01791153|561481432|FG006|Part 1: Blinded Period|Protocol Violation|0|||
155561221|NCT01791153|561481433|FG007|Part 1: Blinded Period|Protocol Violation|0|||
155561222|NCT01791153|561481426|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
155561223|NCT01791153|561481427|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
155561224|NCT01791153|561481428|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
155561225|NCT01791153|561481429|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
155561226|NCT01791153|561481430|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
155561227|NCT01791153|561481431|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
155561228|NCT01791153|561481432|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
155561229|NCT01791153|561481433|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
155561230|NCT01791153|561481426|FG000|Part 2: Open-label Period|Adverse Event|0|||
155561231|NCT01791153|561481427|FG001|Part 2: Open-label Period|Adverse Event|0|||
155561232|NCT01791153|561481428|FG002|Part 2: Open-label Period|Adverse Event|0|||
155561233|NCT01791153|561481429|FG003|Part 2: Open-label Period|Adverse Event|0|||
155561234|NCT01791153|561481430|FG004|Part 2: Open-label Period|Adverse Event|0|||
155561235|NCT01791153|561481431|FG005|Part 2: Open-label Period|Adverse Event|1|||
155561236|NCT01791153|561481432|FG006|Part 2: Open-label Period|Adverse Event|1|||
155561237|NCT01791153|561481433|FG007|Part 2: Open-label Period|Adverse Event|2|||
155561238|NCT01791153|561481426|FG000|Part 2: Open-label Period|Death|0|||
155561239|NCT01791153|561481427|FG001|Part 2: Open-label Period|Death|0|||
155561240|NCT01791153|561481428|FG002|Part 2: Open-label Period|Death|0|||
155561241|NCT01791153|561481429|FG003|Part 2: Open-label Period|Death|0|||
155561242|NCT01791153|561481430|FG004|Part 2: Open-label Period|Death|0|||
155561243|NCT01791153|561481431|FG005|Part 2: Open-label Period|Death|1|||
155561244|NCT01791153|561481432|FG006|Part 2: Open-label Period|Death|1|||
155561245|NCT01791153|561481433|FG007|Part 2: Open-label Period|Death|1|||
155561246|NCT01791153|561481426|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
155561247|NCT01791153|561481427|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
155561248|NCT01791153|561481428|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
155561249|NCT01791153|561481429|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
155561250|NCT01791153|561481430|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
155561251|NCT01791153|561481431|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
155561252|NCT01791153|561481432|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
155561253|NCT01791153|561481433|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
155561254|NCT01791153|561481426|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
155561255|NCT01791153|561481427|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
155561256|NCT01791153|561481428|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
155561257|NCT01791153|561481429|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
155561258|NCT01791153|561481430|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
155561259|NCT01791153|561481431|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
155561260|NCT01791153|561481432|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
155561261|NCT01791153|561481433|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
155561262|NCT01791153|561481426|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
155561263|NCT01791153|561481427|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
155658123|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155561264|NCT01791153|561481428|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
155561265|NCT01791153|561481429|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
155561266|NCT01791153|561481430|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
155561267|NCT01791153|561481431|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
155561268|NCT01791153|561481432|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
155561269|NCT01791153|561481433|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
155561270|NCT01791153|561481426|FG000|Part 2: Open-label Period|Physician Decision|0|||
155561271|NCT01791153|561481427|FG001|Part 2: Open-label Period|Physician Decision|0|||
155561272|NCT01791153|561481428|FG002|Part 2: Open-label Period|Physician Decision|0|||
155561273|NCT01791153|561481429|FG003|Part 2: Open-label Period|Physician Decision|0|||
155561274|NCT01791153|561481430|FG004|Part 2: Open-label Period|Physician Decision|1|||
155561275|NCT01791153|561481431|FG005|Part 2: Open-label Period|Physician Decision|1|||
155561276|NCT01791153|561481432|FG006|Part 2: Open-label Period|Physician Decision|0|||
155561277|NCT01791153|561481433|FG007|Part 2: Open-label Period|Physician Decision|0|||
155561278|NCT05896202|561481436|FG000|Overall Study|Lost to Follow-up|2|||
155561279|NCT05896202|561481437|FG001|Overall Study|Lost to Follow-up|2|||
155561280|NCT02435836|561481438|FG000|Overall Study|Lost to Follow-up|21|||
155561281|NCT02435836|561481438|FG000|Overall Study|Lack of Efficacy|1|||
155561282|NCT02435836|561481438|FG000|Overall Study|Withdrawal by Subject|236|||
155561283|NCT02435836|561481438|FG000|Overall Study|Insufficient Clinical Response|26|||
155561284|NCT02435836|561481438|FG000|Overall Study|Adverse Event|44|||
155561285|NCT02435836|561481438|FG000|Overall Study|Sponsor discontinued trial|167|||
155561286|NCT02435836|561481438|FG000|Overall Study|Noncompliance|27|||
155561287|NCT02435836|561481438|FG000|Overall Study|Protocol Violation|6|||
155561288|NCT02435836|561481438|FG000|Overall Study|Met Withdrawal Criteria|7|||
155561289|NCT02435836|561481438|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
155561290|NCT01946191|561481439|FG000|Allocation|Did not complete orientation|1|||
155561291|NCT01946191|561481440|FG001|Allocation|Did not complete orientation|1|||
155561292|NCT01946191|561481439|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
155561293|NCT01946191|561481440|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
155561294|NCT01946191|561481439|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
155561295|NCT01946191|561481440|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
155561296|NCT01946191|561481439|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
155561297|NCT01946191|561481440|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
155561298|NCT01855074|561481441|FG000|Overall Study|Adverse Event|1|||
155561299|NCT01855074|561481441|FG000|Overall Study|Lost to Follow-up|4|||
155561300|NCT01855074|561481441|FG000|Overall Study|Withdrawal by Subject|8|||
155561301|NCT01855074|561481441|FG000|Overall Study|Started but not treated|1|||
155561302|NCT02991430|561481442|FG000|Treatment Period 1|Adverse Event|1|||
155561303|NCT02991430|561481443|FG001|Treatment Period 1|Adverse Event|0|||
155561304|NCT02991430|561481444|FG002|Treatment Period 1|Adverse Event|2|||
155561305|NCT02991430|561481442|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155561306|NCT02991430|561481443|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155561307|NCT02991430|561481444|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155561308|NCT02991430|561481442|FG000|Treatment Period 2|Study Termination|6|||
155561309|NCT02991430|561481443|FG001|Treatment Period 2|Study Termination|3|||
155561310|NCT02991430|561481444|FG002|Treatment Period 2|Study Termination|3|||
155561311|NCT02991430|561481442|FG000|Treatment Period 2|Lost to Follow-up|0|||
155561312|NCT02991430|561481443|FG001|Treatment Period 2|Lost to Follow-up|0|||
155561313|NCT02991430|561481444|FG002|Treatment Period 2|Lost to Follow-up|1|||
155561314|NCT02991430|561481442|FG000|Post-treatment Observation Period|Study Termination|3|||
155561315|NCT02991430|561481443|FG001|Post-treatment Observation Period|Study Termination|6|||
155561316|NCT02991430|561481444|FG002|Post-treatment Observation Period|Study Termination|5|||
155561317|NCT01150890|561481445|FG000|Overall Study|Other|0|||
155561318|NCT01150890|561481446|FG001|Overall Study|Other|1|||
155561319|NCT01150890|561481447|FG002|Overall Study|Other|0|||
155561320|NCT01150890|561481448|FG003|Overall Study|Other|2|||
155561321|NCT01150890|561481445|FG000|Overall Study|Pregnancy|0|||
155561322|NCT01150890|561481446|FG001|Overall Study|Pregnancy|0|||
155561323|NCT01150890|561481447|FG002|Overall Study|Pregnancy|0|||
155561324|NCT01150890|561481448|FG003|Overall Study|Pregnancy|1|||
155561325|NCT01150890|561481445|FG000|Overall Study|Administrative Decision|4|||
155561326|NCT01150890|561481446|FG001|Overall Study|Administrative Decision|4|||
155658124|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658125|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658126|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155658127|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
155561327|NCT01150890|561481447|FG002|Overall Study|Administrative Decision|5|||
155561328|NCT01150890|561481448|FG003|Overall Study|Administrative Decision|6|||
155561329|NCT01150890|561481445|FG000|Overall Study|Ineligibility determined|0|||
155561330|NCT01150890|561481446|FG001|Overall Study|Ineligibility determined|1|||
155561331|NCT01150890|561481447|FG002|Overall Study|Ineligibility determined|0|||
155561332|NCT01150890|561481448|FG003|Overall Study|Ineligibility determined|0|||
155561333|NCT01150890|561481445|FG000|Overall Study|Adverse Event|0|||
155561334|NCT01150890|561481446|FG001|Overall Study|Adverse Event|0|||
155561335|NCT01150890|561481447|FG002|Overall Study|Adverse Event|2|||
155561336|NCT01150890|561481448|FG003|Overall Study|Adverse Event|0|||
155561337|NCT01150890|561481445|FG000|Overall Study|Withdrawal by Subject|0|||
155561338|NCT01150890|561481446|FG001|Overall Study|Withdrawal by Subject|0|||
155561339|NCT01150890|561481447|FG002|Overall Study|Withdrawal by Subject|2|||
155561340|NCT01150890|561481448|FG003|Overall Study|Withdrawal by Subject|1|||
155561341|NCT01150890|561481445|FG000|Overall Study|Disease progression|0|||
155561342|NCT01150890|561481446|FG001|Overall Study|Disease progression|7|||
155561343|NCT01150890|561481447|FG002|Overall Study|Disease progression|3|||
155561344|NCT01150890|561481448|FG003|Overall Study|Disease progression|7|||
155561345|NCT03970837|561481449|FG000|Overall Study|Adverse Event|23|||
155561346|NCT03970837|561481450|FG001|Overall Study|Adverse Event|20|||
155561347|NCT03970837|561481451|FG002|Overall Study|Adverse Event|16|||
155561348|NCT03970837|561481452|FG003|Overall Study|Adverse Event|6|||
155561349|NCT03970837|561481453|FG004|Overall Study|Adverse Event|4|||
155561350|NCT03970837|561481454|FG005|Overall Study|Adverse Event|5|||
155561351|NCT03970837|561481455|FG006|Overall Study|Adverse Event|1|||
155561352|NCT03970837|561481456|FG007|Overall Study|Adverse Event|5|||
155561353|NCT03970837|561481457|FG008|Overall Study|Adverse Event|0|||
155561354|NCT03970837|561481458|FG009|Overall Study|Adverse Event|0|||
155658128|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
155561355|NCT03970837|561481459|FG010|Overall Study|Adverse Event|1|||
155561356|NCT03970837|561481460|FG011|Overall Study|Adverse Event|1|||
155561357|NCT03970837|561481449|FG000|Overall Study|Lack of Efficacy|14|||
155561358|NCT03970837|561481450|FG001|Overall Study|Lack of Efficacy|12|||
155561359|NCT03970837|561481451|FG002|Overall Study|Lack of Efficacy|1|||
155561360|NCT03970837|561481452|FG003|Overall Study|Lack of Efficacy|2|||
155561361|NCT03970837|561481453|FG004|Overall Study|Lack of Efficacy|3|||
155561362|NCT03970837|561481454|FG005|Overall Study|Lack of Efficacy|4|||
155561363|NCT03970837|561481455|FG006|Overall Study|Lack of Efficacy|6|||
155561364|NCT03970837|561481456|FG007|Overall Study|Lack of Efficacy|1|||
155561365|NCT03970837|561481457|FG008|Overall Study|Lack of Efficacy|1|||
155561366|NCT03970837|561481458|FG009|Overall Study|Lack of Efficacy|0|||
155561367|NCT03970837|561481459|FG010|Overall Study|Lack of Efficacy|0|||
155561368|NCT03970837|561481460|FG011|Overall Study|Lack of Efficacy|0|||
155561369|NCT03970837|561481449|FG000|Overall Study|Lost to Follow-up|6|||
155561370|NCT03970837|561481450|FG001|Overall Study|Lost to Follow-up|5|||
155561371|NCT03970837|561481451|FG002|Overall Study|Lost to Follow-up|5|||
155561372|NCT03970837|561481452|FG003|Overall Study|Lost to Follow-up|1|||
155561373|NCT03970837|561481453|FG004|Overall Study|Lost to Follow-up|0|||
155561374|NCT03970837|561481454|FG005|Overall Study|Lost to Follow-up|2|||
155561375|NCT03970837|561481455|FG006|Overall Study|Lost to Follow-up|0|||
155561376|NCT03970837|561481456|FG007|Overall Study|Lost to Follow-up|0|||
155561377|NCT03970837|561481457|FG008|Overall Study|Lost to Follow-up|0|||
155561378|NCT03970837|561481458|FG009|Overall Study|Lost to Follow-up|0|||
155561379|NCT03970837|561481459|FG010|Overall Study|Lost to Follow-up|0|||
155561380|NCT03970837|561481460|FG011|Overall Study|Lost to Follow-up|0|||
155561381|NCT03970837|561481449|FG000|Overall Study|Protocol Violation|1|||
155561382|NCT03970837|561481450|FG001|Overall Study|Protocol Violation|0|||
155561383|NCT03970837|561481451|FG002|Overall Study|Protocol Violation|0|||
155561384|NCT03970837|561481452|FG003|Overall Study|Protocol Violation|0|||
155561385|NCT03970837|561481453|FG004|Overall Study|Protocol Violation|0|||
155561386|NCT03970837|561481454|FG005|Overall Study|Protocol Violation|0|||
155561387|NCT03970837|561481455|FG006|Overall Study|Protocol Violation|0|||
155561388|NCT03970837|561481456|FG007|Overall Study|Protocol Violation|0|||
155561389|NCT03970837|561481457|FG008|Overall Study|Protocol Violation|0|||
155561390|NCT03970837|561481458|FG009|Overall Study|Protocol Violation|0|||
155561391|NCT03970837|561481459|FG010|Overall Study|Protocol Violation|0|||
155561392|NCT03970837|561481460|FG011|Overall Study|Protocol Violation|0|||
155561393|NCT03970837|561481449|FG000|Overall Study|Physician Decision|5|||
155561394|NCT03970837|561481450|FG001|Overall Study|Physician Decision|8|||
155561395|NCT03970837|561481451|FG002|Overall Study|Physician Decision|4|||
155561396|NCT03970837|561481452|FG003|Overall Study|Physician Decision|1|||
155561397|NCT03970837|561481453|FG004|Overall Study|Physician Decision|5|||
155561398|NCT03970837|561481454|FG005|Overall Study|Physician Decision|2|||
155561399|NCT03970837|561481455|FG006|Overall Study|Physician Decision|4|||
155561400|NCT03970837|561481456|FG007|Overall Study|Physician Decision|5|||
155561401|NCT03970837|561481457|FG008|Overall Study|Physician Decision|0|||
155561402|NCT03970837|561481458|FG009|Overall Study|Physician Decision|1|||
155561403|NCT03970837|561481459|FG010|Overall Study|Physician Decision|0|||
155561404|NCT03970837|561481460|FG011|Overall Study|Physician Decision|0|||
155561405|NCT03970837|561481449|FG000|Overall Study|Withdrawal by Subject|32|||
155561406|NCT03970837|561481450|FG001|Overall Study|Withdrawal by Subject|35|||
155561407|NCT03970837|561481451|FG002|Overall Study|Withdrawal by Subject|12|||
155561408|NCT03970837|561481452|FG003|Overall Study|Withdrawal by Subject|8|||
155561409|NCT03970837|561481453|FG004|Overall Study|Withdrawal by Subject|6|||
155561410|NCT03970837|561481454|FG005|Overall Study|Withdrawal by Subject|8|||
155561411|NCT03970837|561481455|FG006|Overall Study|Withdrawal by Subject|2|||
155561412|NCT03970837|561481456|FG007|Overall Study|Withdrawal by Subject|3|||
155561413|NCT03970837|561481457|FG008|Overall Study|Withdrawal by Subject|0|||
155561414|NCT03970837|561481458|FG009|Overall Study|Withdrawal by Subject|0|||
155561415|NCT03970837|561481459|FG010|Overall Study|Withdrawal by Subject|0|||
155561416|NCT03970837|561481460|FG011|Overall Study|Withdrawal by Subject|1|||
155561417|NCT03970837|561481449|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
155561418|NCT03970837|561481450|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
155561419|NCT03970837|561481451|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
155561420|NCT03970837|561481452|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155561421|NCT03970837|561481453|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
155561422|NCT03970837|561481454|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155561423|NCT03970837|561481455|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155561424|NCT03970837|561481456|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155561425|NCT03970837|561481457|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155561426|NCT03970837|561481458|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155561427|NCT03970837|561481459|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155561428|NCT03970837|561481460|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155561429|NCT03970837|561481449|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561430|NCT03970837|561481450|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561431|NCT03970837|561481451|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561432|NCT03970837|561481452|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561433|NCT03970837|561481453|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561434|NCT03970837|561481454|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155561435|NCT03970837|561481455|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
155561436|NCT03970837|561481456|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
155561437|NCT03970837|561481457|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
155561438|NCT03970837|561481458|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
155561439|NCT03970837|561481459|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
155561440|NCT03970837|561481460|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
155561441|NCT03567382|561481468|FG000|Overall Study|Lost to Follow-up|1|||
155561442|NCT03567382|561481469|FG001|Overall Study|Lost to Follow-up|21|||
155561443|NCT03567382|561481470|FG002|Overall Study|Lost to Follow-up|1|||
155561444|NCT03567382|561481471|FG003|Overall Study|Lost to Follow-up|21|||
155561445|NCT03567382|561481468|FG000|Overall Study|Withdrawal by Subject|2|||
155561446|NCT03567382|561481469|FG001|Overall Study|Withdrawal by Subject|14|||
155561447|NCT03567382|561481470|FG002|Overall Study|Withdrawal by Subject|1|||
155561448|NCT03567382|561481471|FG003|Overall Study|Withdrawal by Subject|12|||
155561449|NCT04555720|561481472|FG000|Overall Study|Lost to Follow-up|2|||
155561450|NCT04555720|561481473|FG001|Overall Study|Lost to Follow-up|0|||
155561451|NCT04555720|561481474|FG002|Overall Study|Lost to Follow-up|0|||
155561452|NCT04555720|561481475|FG003|Overall Study|Lost to Follow-up|0|||
155561453|NCT04555720|561481472|FG000|Overall Study|Withdrawal by Subject|4|||
155561454|NCT04555720|561481473|FG001|Overall Study|Withdrawal by Subject|6|||
155561455|NCT04555720|561481474|FG002|Overall Study|Withdrawal by Subject|0|||
155561456|NCT04555720|561481475|FG003|Overall Study|Withdrawal by Subject|0|||
155561457|NCT00719849|561481476|FG000|Overall Study|Death|0|||
155561458|NCT00719849|561481477|FG001|Overall Study|Death|1|||
155561459|NCT01868893|561484155|FG000|Overall Study|Adverse Event|2|||
155561460|NCT01868893|561484155|FG000|Overall Study|Commercial availability of study drug|17|||
155561461|NCT01868893|561484155|FG000|Overall Study|Neutropenia|1|||
155561462|NCT01783548|561484156|FG000|Overall Study|Adverse Event|8|||
155561463|NCT01783548|561484157|FG001|Overall Study|Adverse Event|4|||
155561464|NCT01783548|561484156|FG000|Overall Study|Withdrawal by Subject|11|||
155561465|NCT01783548|561484157|FG001|Overall Study|Withdrawal by Subject|8|||
155561466|NCT01783548|561484156|FG000|Overall Study|Non-compliance|4|||
155561467|NCT01783548|561484157|FG001|Overall Study|Non-compliance|0|||
155561468|NCT01783548|561484156|FG000|Overall Study|Protocol Violation|2|||
155561469|NCT01783548|561484157|FG001|Overall Study|Protocol Violation|2|||
155561470|NCT01783548|561484156|FG000|Overall Study|Lost to Follow-up|8|||
155561471|NCT01783548|561484157|FG001|Overall Study|Lost to Follow-up|3|||
155561472|NCT01783548|561484156|FG000|Overall Study|Lack of Efficacy|1|||
155561473|NCT01783548|561484157|FG001|Overall Study|Lack of Efficacy|1|||
155561474|NCT03825341|561484158|FG000|Overall Study|Withdrawal by Subject|0|||
155561475|NCT03825341|561484159|FG001|Overall Study|Withdrawal by Subject|1|||
155561476|NCT04283500|561484162|FG000|Overall Study|Lost to Follow-up|8|||
155561477|NCT04283500|561484162|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
155561478|NCT04053465|561484169|FG000|Overall Study|Withdrawal by Subject|4|||
155561479|NCT04053465|561484170|FG001|Overall Study|Withdrawal by Subject|4|||
155561480|NCT02085135|561484171|FG000|Overall Study|Adverse Event|4|||
155561481|NCT02085135|561484172|FG001|Overall Study|Adverse Event|7|||
155561482|NCT02085135|561484171|FG000|Overall Study|Lost to Follow-up|2|||
155561483|NCT02085135|561484172|FG001|Overall Study|Lost to Follow-up|2|||
155561484|NCT02085135|561484171|FG000|Overall Study|Withdrawal by Subject|3|||
155561485|NCT02085135|561484172|FG001|Overall Study|Withdrawal by Subject|0|||
155561486|NCT02085135|561484171|FG000|Overall Study|Lack of Efficacy|2|||
155561487|NCT02085135|561484172|FG001|Overall Study|Lack of Efficacy|0|||
155561488|NCT01212588|561484173|FG000|Overall Study|Physician Decision|0|||
155561489|NCT01212588|561484174|FG001|Overall Study|Physician Decision|1|||
155561490|NCT01212588|561484173|FG000|Overall Study|Protocol Violation|1|||
155561491|NCT01212588|561484174|FG001|Overall Study|Protocol Violation|1|||
155561492|NCT02885181|561484175|FG000|Overall Study|Investigator's Discretion|0|||
155561493|NCT02885181|561484176|FG001|Overall Study|Investigator's Discretion|1|||
155561494|NCT02885181|561484177|FG002|Overall Study|Investigator's Discretion|0|||
155561495|NCT02885181|561484178|FG003|Overall Study|Investigator's Discretion|1|||
155561496|NCT02885181|561484175|FG000|Overall Study|Adverse Event|0|||
155561497|NCT02885181|561484176|FG001|Overall Study|Adverse Event|0|||
155561498|NCT02885181|561484177|FG002|Overall Study|Adverse Event|0|||
155561499|NCT02885181|561484178|FG003|Overall Study|Adverse Event|1|||
155561500|NCT02885181|561484175|FG000|Overall Study|Withdrawal by Subject|0|||
155561501|NCT02885181|561484176|FG001|Overall Study|Withdrawal by Subject|0|||
155561502|NCT02885181|561484177|FG002|Overall Study|Withdrawal by Subject|0|||
155561503|NCT02885181|561484178|FG003|Overall Study|Withdrawal by Subject|1|||
155561504|NCT03317834|561484179|FG000|Overall Study|Death|2|||
155561505|NCT03317834|561484179|FG000|Overall Study|Device Revision|5|||
155561506|NCT03317834|561484179|FG000|Overall Study|Withdrawal by Subject|13|||
155561507|NCT03317834|561484179|FG000|Overall Study|Lost to Follow-up|13|||
155561508|NCT04228783|561484180|FG000|Overall Study|Adverse Event|1|||
155561509|NCT04228783|561484181|FG001|Overall Study|Adverse Event|0|||
155561510|NCT04228783|561484182|FG002|Overall Study|Adverse Event|2|||
155561511|NCT04228783|561484183|FG003|Overall Study|Adverse Event|0|||
155561512|NCT04228783|561484184|FG004|Overall Study|Adverse Event|0|||
155561513|NCT04228783|561484185|FG005|Overall Study|Adverse Event|1|||
155561514|NCT04228783|561484180|FG000|Overall Study|Death|0|||
155561515|NCT04228783|561484181|FG001|Overall Study|Death|0|||
155561516|NCT04228783|561484182|FG002|Overall Study|Death|0|||
155561517|NCT04228783|561484183|FG003|Overall Study|Death|0|||
155561518|NCT04228783|561484184|FG004|Overall Study|Death|1|||
155561519|NCT04228783|561484185|FG005|Overall Study|Death|0|||
155561520|NCT04228783|561484180|FG000|Overall Study|Lost to Follow-up|36|||
155561521|NCT04228783|561484181|FG001|Overall Study|Lost to Follow-up|36|||
155561522|NCT04228783|561484182|FG002|Overall Study|Lost to Follow-up|28|||
155561523|NCT04228783|561484183|FG003|Overall Study|Lost to Follow-up|6|||
155561524|NCT04228783|561484184|FG004|Overall Study|Lost to Follow-up|14|||
155561525|NCT04228783|561484185|FG005|Overall Study|Lost to Follow-up|3|||
155561526|NCT04228783|561484180|FG000|Overall Study|Physician Decision|1|||
155561527|NCT04228783|561484181|FG001|Overall Study|Physician Decision|2|||
155561528|NCT04228783|561484182|FG002|Overall Study|Physician Decision|0|||
155561529|NCT04228783|561484183|FG003|Overall Study|Physician Decision|0|||
155561530|NCT04228783|561484184|FG004|Overall Study|Physician Decision|0|||
155561531|NCT04228783|561484185|FG005|Overall Study|Physician Decision|0|||
155561532|NCT04228783|561484180|FG000|Overall Study|Protocol Violation|0|||
155561533|NCT04228783|561484181|FG001|Overall Study|Protocol Violation|0|||
155561534|NCT04228783|561484182|FG002|Overall Study|Protocol Violation|0|||
155561535|NCT04228783|561484183|FG003|Overall Study|Protocol Violation|1|||
155561536|NCT04228783|561484184|FG004|Overall Study|Protocol Violation|0|||
155561537|NCT04228783|561484185|FG005|Overall Study|Protocol Violation|0|||
155561538|NCT04228783|561484180|FG000|Overall Study|Withdrawal by Subject|6|||
155561539|NCT04228783|561484181|FG001|Overall Study|Withdrawal by Subject|10|||
155561540|NCT04228783|561484182|FG002|Overall Study|Withdrawal by Subject|19|||
155561541|NCT04228783|561484183|FG003|Overall Study|Withdrawal by Subject|1|||
155561542|NCT04228783|561484184|FG004|Overall Study|Withdrawal by Subject|2|||
155561543|NCT04228783|561484185|FG005|Overall Study|Withdrawal by Subject|0|||
155561544|NCT04228783|561484180|FG000|Overall Study|Other|4|||
155561545|NCT04228783|561484181|FG001|Overall Study|Other|3|||
155561546|NCT04228783|561484182|FG002|Overall Study|Other|2|||
155561547|NCT04228783|561484183|FG003|Overall Study|Other|1|||
155561548|NCT04228783|561484184|FG004|Overall Study|Other|0|||
155561549|NCT04228783|561484185|FG005|Overall Study|Other|0|||
155561550|NCT03151811|561484190|FG000|Overall Study|Randomized But Not Treated|18|||
155561551|NCT03151811|561484191|FG001|Overall Study|Randomized But Not Treated|3|||
155561552|NCT03151811|561484190|FG000|Overall Study|Progressive Disease|130|||
155561553|NCT03151811|561484191|FG001|Overall Study|Progressive Disease|170|||
155561554|NCT03151811|561484190|FG000|Overall Study|Adverse Event|49|||
155561555|NCT03151811|561484191|FG001|Overall Study|Adverse Event|40|||
155561556|NCT03151811|561484190|FG000|Overall Study|Lack of Efficacy|6|||
155561557|NCT03151811|561484191|FG001|Overall Study|Lack of Efficacy|8|||
155561558|NCT03151811|561484190|FG000|Overall Study|Physician Decision|21|||
155561559|NCT03151811|561484191|FG001|Overall Study|Physician Decision|9|||
155561560|NCT03151811|561484190|FG000|Overall Study|Withdrawal by Subject|17|||
155561561|NCT03151811|561484191|FG001|Overall Study|Withdrawal by Subject|7|||
155561562|NCT03151811|561484190|FG000|Overall Study|Lost to Follow-up|0|||
155561563|NCT03151811|561484191|FG001|Overall Study|Lost to Follow-up|1|||
155561564|NCT03151811|561484190|FG000|Overall Study|Study Terminated by Sponsor|5|||
155561565|NCT03151811|561484191|FG001|Overall Study|Study Terminated by Sponsor|11|||
155561566|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
155561567|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
155561568|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
155561569|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
155561570|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
155561571|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
155561572|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
155561573|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
155561574|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
155561575|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
155561576|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Death|1|||
155561577|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Death|0|||
155561578|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Death|0|||
155561579|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Death|0|||
155561580|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Death|0|||
155561581|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
155658129|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
155658130|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
155658131|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
155658132|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
155658133|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
155658134|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
155658135|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
155658136|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
155658137|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
155658138|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
155658139|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
155658140|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
155658141|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
155658142|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
155658143|NCT02958865|561842808|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658144|NCT02958865|561842809|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658145|NCT02958865|561842810|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658146|NCT02958865|561842811|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658147|NCT02958865|561842812|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
155658148|NCT02958865|561842813|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658149|NCT02958865|561842814|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658150|NCT02958865|561842815|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658151|NCT02958865|561842816|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658152|NCT02958865|561842817|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658153|NCT02958865|561842818|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658154|NCT02958865|561842819|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658155|NCT02958865|561842820|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658156|NCT02958865|561842821|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658157|NCT02958865|561842822|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658158|NCT02958865|561842823|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155658159|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658160|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658161|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658162|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658163|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658164|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658165|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658166|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155658167|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155658168|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
155658169|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155658170|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155658171|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
155658172|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155658173|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155658174|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
155561582|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
155561583|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
155561584|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
155561585|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
155561586|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
155561587|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
155561588|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
155561589|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
155561590|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
155658175|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658176|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658177|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658178|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658179|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658180|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658181|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658182|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658183|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
155658184|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
155658185|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658186|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
155658187|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155561591|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
155561592|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
155561593|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
155561594|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
155561595|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
155561596|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
155561597|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
155561598|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
155561599|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
155561600|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155561601|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
155561602|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155561603|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155561604|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155561605|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155561606|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Other|4|||
155561607|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Other|4|||
155561608|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Other|3|||
155561609|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Other|1|||
155561610|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Other|0|||
155561611|NCT01081834|561484198|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
155561612|NCT01081834|561484199|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
155561613|NCT01081834|561484200|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155561614|NCT01081834|561484201|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155561615|NCT01081834|561484202|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155561616|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155561617|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155561618|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155561619|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155561620|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155561621|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Death|1|||
155561622|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Death|0|||
155561623|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Death|0|||
155561624|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Death|0|||
155561625|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Death|0|||
155561626|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
155561627|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
155561628|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155561629|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155561630|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155561631|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155561632|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155561633|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155561634|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155561635|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155561636|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155561637|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
155561638|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155561639|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155561640|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155561641|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155561642|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155561643|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155561644|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155561645|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155561646|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
155561647|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
155561648|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
155561649|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
155561650|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
155561651|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Other|4|||
155561652|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Other|5|||
155561653|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Other|4|||
155561654|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Other|0|||
155561655|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Other|0|||
155561656|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
155561657|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
155561658|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
155561659|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
155658188|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
155658189|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155658190|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
155658191|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658192|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658193|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658194|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658195|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658196|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658197|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658198|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658199|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658200|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
155658201|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658202|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658203|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658204|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658205|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155658206|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
155658207|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658208|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658209|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155561660|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
155561661|NCT01081834|561484198|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155561662|NCT01081834|561484199|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
155561663|NCT01081834|561484200|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155561664|NCT01081834|561484201|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155561665|NCT01081834|561484202|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155561666|NCT00742924|561484205|FG000|Overall Study|Adverse Event|0|||
155561667|NCT00742924|561484206|FG001|Overall Study|Adverse Event|0|||
155561668|NCT00742924|561484207|FG002|Overall Study|Adverse Event|1|||
155561669|NCT00742924|561484208|FG003|Overall Study|Adverse Event|1|||
155561670|NCT00742924|561484205|FG000|Overall Study|Lack of Efficacy|5|||
155561671|NCT00742924|561484206|FG001|Overall Study|Lack of Efficacy|1|||
155561672|NCT00742924|561484207|FG002|Overall Study|Lack of Efficacy|2|||
155561673|NCT00742924|561484208|FG003|Overall Study|Lack of Efficacy|4|||
155561674|NCT00742924|561484205|FG000|Overall Study|Physician Decision|0|||
155561675|NCT00742924|561484206|FG001|Overall Study|Physician Decision|0|||
155561676|NCT00742924|561484207|FG002|Overall Study|Physician Decision|0|||
155561677|NCT00742924|561484208|FG003|Overall Study|Physician Decision|1|||
155561678|NCT00742924|561484205|FG000|Overall Study|Withdrawal by Subject|0|||
155561679|NCT00742924|561484206|FG001|Overall Study|Withdrawal by Subject|1|||
155561680|NCT00742924|561484207|FG002|Overall Study|Withdrawal by Subject|1|||
155561681|NCT00742924|561484208|FG003|Overall Study|Withdrawal by Subject|0|||
155658210|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658211|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658212|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658213|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658214|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658215|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658216|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658217|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155658218|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
155658219|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
155658220|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
155658221|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
155658222|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
155658223|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
155658224|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
155658225|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
155658226|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
155658227|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
155658228|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
155658229|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
155658230|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
155658231|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
155658232|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
155658233|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
155658234|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
155658235|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
155658236|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
155658237|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
155658238|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
155658239|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658240|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658241|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658242|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658243|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658244|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658245|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658246|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658247|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658248|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658249|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658250|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658251|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658252|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
155658253|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658254|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155658255|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658256|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658257|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658258|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658259|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658260|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658261|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658262|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658263|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658264|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658265|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658266|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658267|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658268|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
155658269|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658270|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155658271|NCT02958865|561842808|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658272|NCT02958865|561842809|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658273|NCT02958865|561842810|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155561682|NCT00660400|561484209|FG000|Overall Study|Lack of insurance approval|1|||
155561683|NCT00660400|561484209|FG000|Overall Study|Suboptimal organ function|1|||
155561684|NCT00660400|561484209|FG000|Overall Study|Intracranial hemorrhage|1|||
155561685|NCT00660400|561484209|FG000|Overall Study|Withdrawal by Subject|1|||
155561686|NCT01161407|561484210|FG000|Overall Study|Protocol Violation|3|||
155561687|NCT01161407|561484211|FG001|Overall Study|Protocol Violation|1|||
155561688|NCT01777620|561484212|FG000|Overall Study|Subject Withdrawal|1|||
155561689|NCT01777620|561484213|FG001|Overall Study|Subject Withdrawal|0|||
155561690|NCT04562155|561484214|FG000|Overall Study|COVID-19 pandemic|0|||
155561691|NCT04562155|561484215|FG001|Overall Study|COVID-19 pandemic|0|||
155561692|NCT04562155|561484216|FG002|Overall Study|COVID-19 pandemic|0|||
155561693|NCT04562155|561484217|FG003|Overall Study|COVID-19 pandemic|1|||
155561694|NCT04562155|561484214|FG000|Overall Study|Adverse Event|7|||
155561695|NCT04562155|561484215|FG001|Overall Study|Adverse Event|3|||
155561696|NCT04562155|561484216|FG002|Overall Study|Adverse Event|8|||
155561697|NCT04562155|561484217|FG003|Overall Study|Adverse Event|1|||
155561698|NCT04562155|561484214|FG000|Overall Study|Withdrawal by Subject|3|||
155561699|NCT04562155|561484215|FG001|Overall Study|Withdrawal by Subject|6|||
155561700|NCT04562155|561484216|FG002|Overall Study|Withdrawal by Subject|3|||
155561701|NCT04562155|561484217|FG003|Overall Study|Withdrawal by Subject|3|||
155561702|NCT04562155|561484214|FG000|Overall Study|Participant personal reason|1|||
155561703|NCT04562155|561484215|FG001|Overall Study|Participant personal reason|0|||
155561704|NCT04562155|561484216|FG002|Overall Study|Participant personal reason|2|||
155561705|NCT04562155|561484217|FG003|Overall Study|Participant personal reason|1|||
155561706|NCT00849186|561484230|FG000|Overall Study|Adverse Event|2|||
155561707|NCT00849186|561484230|FG000|Overall Study|Withdrawal by Subject|1|||
155561708|NCT00849186|561484230|FG000|Overall Study|not treated|6|||
155561709|NCT00849186|561484230|FG000|Overall Study|Other|1|||
155561710|NCT00936897|561484233|FG000|Overall Study|Withdrawal by Subject|9|||
155561711|NCT00936897|561484234|FG001|Overall Study|Withdrawal by Subject|19|||
155561712|NCT00936897|561484233|FG000|Overall Study|Adverse Event|4|||
155561713|NCT00936897|561484234|FG001|Overall Study|Adverse Event|13|||
155561714|NCT00936897|561484233|FG000|Overall Study|Other|3|||
155561715|NCT00936897|561484234|FG001|Overall Study|Other|9|||
155561716|NCT00936897|561484233|FG000|Overall Study|Lost to Follow-up|1|||
155561717|NCT00936897|561484234|FG001|Overall Study|Lost to Follow-up|10|||
155561718|NCT00936897|561484233|FG000|Overall Study|Administrative Decision|1|||
155561719|NCT00936897|561484234|FG001|Overall Study|Administrative Decision|2|||
155561720|NCT00936897|561484233|FG000|Overall Study|Protocol Violation|1|||
155561721|NCT00936897|561484234|FG001|Overall Study|Protocol Violation|1|||
155561722|NCT00936897|561484233|FG000|Overall Study|Ineligibility Determined|0|||
155561723|NCT00936897|561484234|FG001|Overall Study|Ineligibility Determined|3|||
155561724|NCT00936897|561484233|FG000|Overall Study|Noncompliance|0|||
155561725|NCT00936897|561484234|FG001|Overall Study|Noncompliance|2|||
155561726|NCT00936897|561484233|FG000|Overall Study|Death|0|||
155561727|NCT00936897|561484234|FG001|Overall Study|Death|1|||
155561728|NCT00417170|561484235|FG000|Overall Study|Adverse Event|1|||
155561729|NCT00417170|561484236|FG001|Overall Study|Adverse Event|1|||
155561730|NCT00417170|561484235|FG000|Overall Study|Withdrawal by Subject|1|||
155561731|NCT00417170|561484236|FG001|Overall Study|Withdrawal by Subject|1|||
155561732|NCT00417170|561484235|FG000|Overall Study|Lost to Follow-up|0|||
155561733|NCT00417170|561484236|FG001|Overall Study|Lost to Follow-up|1|||
155561734|NCT01756079|561484237|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
155561735|NCT01756079|561484237|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
155561736|NCT01756079|561484237|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
155561737|NCT01756079|561484237|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
155561738|NCT01756079|561484237|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
155561739|NCT04015908|561484238|FG000|Overall Study|Lost to Follow-up|0|||
155561740|NCT04015908|561484239|FG001|Overall Study|Lost to Follow-up|1|||
155561741|NCT03464630|561484240|FG000|Overall Study|Lost to Follow-up|62|||
155561742|NCT03464630|561484241|FG001|Overall Study|Lost to Follow-up|52|||
155561743|NCT03464630|561484240|FG000|Overall Study|Withdrawal by Subject|16|||
155561744|NCT03464630|561484241|FG001|Overall Study|Withdrawal by Subject|10|||
155561745|NCT03464630|561484240|FG000|Overall Study|Passive Disengagement|8|||
155561746|NCT03464630|561484241|FG001|Overall Study|Passive Disengagement|4|||
155561747|NCT02865460|561484242|FG000|Overall Study|Adverse Event|1|||
155561748|NCT02865460|561484243|FG001|Overall Study|Adverse Event|0|||
155561749|NCT02865460|561484242|FG000|Overall Study|Withdrawal by Subject|1|||
155561750|NCT02865460|561484243|FG001|Overall Study|Withdrawal by Subject|1|||
155561751|NCT02865460|561484242|FG000|Overall Study|Lost to Follow-up|7|||
155561752|NCT02865460|561484243|FG001|Overall Study|Lost to Follow-up|4|||
155561753|NCT02865460|561484242|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
155561754|NCT02865460|561484243|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
155561755|NCT00901576|561484244|FG000|Second Intervention|Withdrawal by Subject|0|||
155561756|NCT00901576|561484245|FG001|Second Intervention|Withdrawal by Subject|0|||
155561757|NCT00901576|561484246|FG002|Second Intervention|Withdrawal by Subject|0|||
155561758|NCT00901576|561484247|FG003|Second Intervention|Withdrawal by Subject|1|||
155561759|NCT00901576|561484248|FG004|Second Intervention|Withdrawal by Subject|0|||
155561760|NCT00901576|561484249|FG005|Second Intervention|Withdrawal by Subject|1|||
155561761|NCT00901576|561484244|FG000|Second Intervention|Physician Decision|1|||
155561762|NCT00901576|561484245|FG001|Second Intervention|Physician Decision|0|||
155561763|NCT00901576|561484246|FG002|Second Intervention|Physician Decision|0|||
155561764|NCT00901576|561484247|FG003|Second Intervention|Physician Decision|0|||
155561765|NCT00901576|561484248|FG004|Second Intervention|Physician Decision|0|||
155561766|NCT00901576|561484249|FG005|Second Intervention|Physician Decision|0|||
155561767|NCT01696279|561484252|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
155561768|NCT01696279|561484253|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
155561769|NCT01696279|561484254|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
155561770|NCT01696279|561484255|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
155561771|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
155561772|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
155561773|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
155561774|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
155561775|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
155561776|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
155561777|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
155561778|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
155561779|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
155561780|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
155561781|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
155561782|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
155561783|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
155561784|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
155561785|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
155561786|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
155561787|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
155561788|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
155561789|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
155561790|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
155561791|NCT01696279|561484252|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
155561792|NCT01696279|561484253|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
155561793|NCT01696279|561484254|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
155658274|NCT02958865|561842811|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658275|NCT02958865|561842812|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658276|NCT02958865|561842813|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658277|NCT02958865|561842814|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658278|NCT02958865|561842815|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658279|NCT02958865|561842816|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658280|NCT02958865|561842817|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
155658281|NCT02958865|561842818|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658282|NCT02958865|561842819|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658283|NCT02958865|561842820|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658284|NCT02958865|561842821|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658285|NCT02958865|561842822|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658286|NCT02958865|561842823|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155658287|NCT01309230|561842824|FG000|Overall Study|Withdrawal by Subject|0|||
155658288|NCT01309230|561842825|FG001|Overall Study|Withdrawal by Subject|2|||
155658289|NCT01309230|561842824|FG000|Overall Study|Observation arm closed|0|||
155658290|NCT01309230|561842825|FG001|Overall Study|Observation arm closed|2|||
155561794|NCT01696279|561484255|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
155561795|NCT01696279|561484252|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
155658291|NCT02661815|561842826|FG000|Overall Study|Withdrawal by Subject|1|||
155561796|NCT01696279|561484253|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
155658292|NCT02661815|561842827|FG001|Overall Study|Withdrawal by Subject|0|||
155561797|NCT01696279|561484254|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
155561798|NCT01696279|561484255|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
155561799|NCT01696279|561484252|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
155561800|NCT01696279|561484253|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
155561801|NCT01696279|561484254|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
155561802|NCT01696279|561484255|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
155561803|NCT01696279|561484252|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
155561804|NCT01696279|561484253|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
155561805|NCT01696279|561484254|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
155561806|NCT01696279|561484255|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
155561807|NCT01696279|561484252|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
155561808|NCT01696279|561484253|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
155561809|NCT01696279|561484254|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
155561810|NCT01696279|561484255|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
155561811|NCT00171951|561484256|FG000|Overall Study|Adverse Event|1|||
155561812|NCT00171951|561484256|FG000|Overall Study|Abnormal Laboratory Values|2|||
155561813|NCT00171951|561484256|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155561814|NCT00171951|561484256|FG000|Overall Study|Participants Withdrew Consent|3|||
155561815|NCT00171951|561484256|FG000|Overall Study|New Cancer Therapy|5|||
155561816|NCT00171951|561484256|FG000|Overall Study|Reason not Specified|2|||
155561817|NCT06077149|561484257|FG000|Overall Study|Death|1|||
155561818|NCT06077149|561484258|FG001|Overall Study|Death|0|||
155561819|NCT06077149|561484257|FG000|Overall Study|Withdrawal by Subject|2|||
155561820|NCT06077149|561484258|FG001|Overall Study|Withdrawal by Subject|0|||
155561821|NCT06077149|561484257|FG000|Overall Study|RSV infection before vaccination|3|||
155561822|NCT06077149|561484258|FG001|Overall Study|RSV infection before vaccination|0|||
155561823|NCT04658095|561484259|FG000|Overall Study|Study terminated|5|||
155561824|NCT04658095|561484260|FG001|Overall Study|Study terminated|1|||
155561825|NCT04658095|561484261|FG002|Overall Study|Study terminated|4|||
155561826|NCT05788289|561484262|FG000|Overall Study|Death|3|||
155561827|NCT02970318|561484265|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
155561828|NCT02970318|561484266|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
155561829|NCT02970318|561484267|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
155561830|NCT02970318|561484268|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
155561831|NCT02970318|561484265|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
155561832|NCT02970318|561484266|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
155561833|NCT02970318|561484267|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
155561834|NCT02970318|561484268|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
155561835|NCT02970318|561484265|FG000|Overall for Arm A & Main for Arm B|Death|41|||
155561836|NCT02970318|561484266|FG001|Overall for Arm A & Main for Arm B|Death|33|||
155561837|NCT02970318|561484267|FG002|Overall for Arm A & Main for Arm B|Death|0|||
155561838|NCT02970318|561484268|FG003|Overall for Arm A & Main for Arm B|Death|0|||
155561839|NCT02970318|561484265|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
155561840|NCT02970318|561484266|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
155561841|NCT02970318|561484267|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
155561842|NCT02970318|561484268|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
155561843|NCT02970318|561484265|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
155561844|NCT02970318|561484266|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
155561845|NCT02970318|561484267|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
155561846|NCT02970318|561484268|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
155561847|NCT02970318|561484265|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
155561848|NCT02970318|561484266|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
155561849|NCT02970318|561484267|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
155561850|NCT02970318|561484268|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
155561851|NCT02970318|561484265|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
155561852|NCT02970318|561484266|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
155561853|NCT02970318|561484267|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
155561854|NCT02970318|561484268|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
155561855|NCT03384654|561484269|FG000|Overall Study|Withdrawal by Subject|0|||
155561856|NCT03384654|561484270|FG001|Overall Study|Withdrawal by Subject|0|||
155561857|NCT03384654|561484271|FG002|Overall Study|Withdrawal by Subject|1|||
155561858|NCT03384654|561484272|FG003|Overall Study|Withdrawal by Subject|0|||
155561859|NCT01568320|561484273|FG000|Overall Study|Death|20|||
155561860|NCT01568320|561484273|FG000|Overall Study|Lost to Follow-up|9|||
155561861|NCT01568320|561484273|FG000|Overall Study|Withdrawal by Subject|10|||
155561862|NCT01568320|561484273|FG000|Overall Study|Conversion to open repair|1|||
155561863|NCT01568320|561484273|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
155561864|NCT01616953|561484274|FG000|Overall Study|Lost to Follow-up|1|||
155561865|NCT01616953|561484275|FG001|Overall Study|Lost to Follow-up|0|||
155561866|NCT01616953|561484274|FG000|Overall Study|lack of bone and soft tissue|1|||
155561867|NCT01616953|561484275|FG001|Overall Study|lack of bone and soft tissue|0|||
155561868|NCT00816361|561484277|FG000|Overall Study|Withdrawal by Subject|0|||
155561869|NCT00816361|561484278|FG001|Overall Study|Withdrawal by Subject|0|||
155561870|NCT00816361|561484279|FG002|Overall Study|Withdrawal by Subject|0|||
155561871|NCT00816361|561484280|FG003|Overall Study|Withdrawal by Subject|0|||
155561872|NCT00816361|561484281|FG004|Overall Study|Withdrawal by Subject|1|||
155561873|NCT00816361|561484282|FG005|Overall Study|Withdrawal by Subject|2|||
155561874|NCT00816361|561484283|FG006|Overall Study|Withdrawal by Subject|0|||
155561875|NCT00816361|561484284|FG007|Overall Study|Withdrawal by Subject|2|||
155561876|NCT00816361|561484285|FG008|Overall Study|Withdrawal by Subject|1|||
155561877|NCT00816361|561484277|FG000|Overall Study|Death|4|||
155561878|NCT00816361|561484278|FG001|Overall Study|Death|3|||
155561879|NCT00816361|561484279|FG002|Overall Study|Death|3|||
155561880|NCT00816361|561484280|FG003|Overall Study|Death|3|||
155561881|NCT00816361|561484281|FG004|Overall Study|Death|1|||
155561882|NCT00816361|561484282|FG005|Overall Study|Death|1|||
155561883|NCT00816361|561484283|FG006|Overall Study|Death|3|||
155561884|NCT00816361|561484284|FG007|Overall Study|Death|7|||
155561885|NCT00816361|561484285|FG008|Overall Study|Death|8|||
155561886|NCT00816361|561484277|FG000|Overall Study|Other|0|||
155561887|NCT00816361|561484278|FG001|Overall Study|Other|0|||
155561888|NCT00816361|561484279|FG002|Overall Study|Other|0|||
155561889|NCT00816361|561484280|FG003|Overall Study|Other|0|||
155561890|NCT00816361|561484281|FG004|Overall Study|Other|0|||
155561891|NCT00816361|561484282|FG005|Overall Study|Other|0|||
155561892|NCT00816361|561484283|FG006|Overall Study|Other|0|||
155561893|NCT00816361|561484284|FG007|Overall Study|Other|0|||
155561894|NCT00816361|561484285|FG008|Overall Study|Other|1|||
155561895|NCT02500641|561484288|FG000|Overall Study|Adverse Event|0|||
155561896|NCT02500641|561484289|FG001|Overall Study|Adverse Event|2|||
155561897|NCT02500641|561484288|FG000|Overall Study|Withdrawal by Subject|4|||
155561898|NCT02500641|561484289|FG001|Overall Study|Withdrawal by Subject|5|||
155561899|NCT02500641|561484288|FG000|Overall Study|Unable to follow study procedures|3|||
155561900|NCT02500641|561484289|FG001|Overall Study|Unable to follow study procedures|2|||
155561901|NCT02500641|561484288|FG000|Overall Study|Protocol Violation|1|||
155561902|NCT02500641|561484289|FG001|Overall Study|Protocol Violation|2|||
155561903|NCT02500641|561484288|FG000|Overall Study|Lost to Follow-up|1|||
155561904|NCT02500641|561484289|FG001|Overall Study|Lost to Follow-up|0|||
155561905|NCT02500641|561484288|FG000|Overall Study|Sponsor decision|1|||
155561906|NCT02500641|561484289|FG001|Overall Study|Sponsor decision|0|||
155561907|NCT02500641|561484288|FG000|Overall Study|Non compliance to study drug|0|||
155561908|NCT02500641|561484289|FG001|Overall Study|Non compliance to study drug|1|||
155561909|NCT03233230|561484290|FG000|Overall Study|Adverse Event|6|||
155561910|NCT03233230|561484291|FG001|Overall Study|Adverse Event|3|||
155561911|NCT03233230|561484292|FG002|Overall Study|Adverse Event|6|||
155561912|NCT03233230|561484293|FG003|Overall Study|Adverse Event|3|||
155561913|NCT03233230|561484290|FG000|Overall Study|Protocol Violation|1|||
155658293|NCT02661815|561842828|FG002|Overall Study|Withdrawal by Subject|0|||
155561914|NCT03233230|561484291|FG001|Overall Study|Protocol Violation|2|||
155561915|NCT03233230|561484292|FG002|Overall Study|Protocol Violation|1|||
155561916|NCT03233230|561484293|FG003|Overall Study|Protocol Violation|1|||
155561917|NCT03233230|561484290|FG000|Overall Study|Lack of Efficacy|1|||
155561918|NCT03233230|561484291|FG001|Overall Study|Lack of Efficacy|0|||
155561919|NCT03233230|561484292|FG002|Overall Study|Lack of Efficacy|0|||
155561920|NCT03233230|561484293|FG003|Overall Study|Lack of Efficacy|0|||
155561921|NCT03233230|561484290|FG000|Overall Study|Other|5|||
155561922|NCT03233230|561484291|FG001|Overall Study|Other|5|||
155561923|NCT03233230|561484292|FG002|Overall Study|Other|5|||
155561924|NCT03233230|561484293|FG003|Overall Study|Other|3|||
155561925|NCT03233230|561484290|FG000|Overall Study|Withdrawal by Subject|2|||
155561926|NCT03233230|561484291|FG001|Overall Study|Withdrawal by Subject|2|||
155561927|NCT03233230|561484292|FG002|Overall Study|Withdrawal by Subject|0|||
155561928|NCT03233230|561484293|FG003|Overall Study|Withdrawal by Subject|1|||
155561929|NCT03233230|561484290|FG000|Overall Study|Lost to Follow-up|0|||
155561930|NCT03233230|561484291|FG001|Overall Study|Lost to Follow-up|3|||
155561931|NCT03233230|561484292|FG002|Overall Study|Lost to Follow-up|0|||
155561932|NCT03233230|561484293|FG003|Overall Study|Lost to Follow-up|0|||
155561933|NCT01584843|561484294|FG000|First Treatment Period|Adverse Event|0|||
155561934|NCT01584843|561484295|FG001|First Treatment Period|Adverse Event|0|||
155561935|NCT01584843|561484296|FG002|First Treatment Period|Adverse Event|1|||
155561936|NCT01584843|561484297|FG003|First Treatment Period|Adverse Event|0|||
155561937|NCT01584843|561484298|FG004|First Treatment Period|Adverse Event|0|||
155561938|NCT01584843|561484299|FG005|First Treatment Period|Adverse Event|0|||
155561939|NCT01584843|561484294|FG000|First Treatment Period|Protocol Violation|0|||
155561940|NCT01584843|561484295|FG001|First Treatment Period|Protocol Violation|0|||
155561941|NCT01584843|561484296|FG002|First Treatment Period|Protocol Violation|0|||
155561942|NCT01584843|561484297|FG003|First Treatment Period|Protocol Violation|0|||
155658294|NCT02661815|561842829|FG003|Overall Study|Withdrawal by Subject|0|||
155561943|NCT01584843|561484298|FG004|First Treatment Period|Protocol Violation|0|||
155561944|NCT01584843|561484299|FG005|First Treatment Period|Protocol Violation|1|||
155561945|NCT01584843|561484294|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155561946|NCT01584843|561484295|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155561947|NCT01584843|561484296|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155561948|NCT01584843|561484297|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155561949|NCT01584843|561484298|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155561950|NCT01584843|561484299|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
155561951|NCT01584843|561484294|FG000|Second Treatment Period|Withdrawal by Subject|0|||
155561952|NCT01584843|561484295|FG001|Second Treatment Period|Withdrawal by Subject|0|||
155561953|NCT01584843|561484296|FG002|Second Treatment Period|Withdrawal by Subject|0|||
155561954|NCT01584843|561484297|FG003|Second Treatment Period|Withdrawal by Subject|0|||
155561955|NCT01584843|561484298|FG004|Second Treatment Period|Withdrawal by Subject|0|||
155561956|NCT01584843|561484299|FG005|Second Treatment Period|Withdrawal by Subject|1|||
155561957|NCT03923530|561484300|FG000|Overall Study|Withdrawal by Subject|1|||
155561958|NCT03923530|561484300|FG000|Overall Study|screen failure|3|||
155561959|NCT01181271|561484303|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
155561960|NCT01181271|561484303|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
155561961|NCT01181271|561484303|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
155561962|NCT01181271|561484303|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
155561963|NCT01408628|561484304|FG000|Consented|Withdrawal by Subject|12|||
155561964|NCT01408628|561484304|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
155561965|NCT01408628|561484304|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
155561966|NCT01408628|561484304|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
155561967|NCT04156620|561484305|FG000|Overall Study|Adverse event - TP 1|5|||
155561968|NCT04156620|561484306|FG001|Overall Study|Adverse event - TP 1|2|||
155561969|NCT04156620|561484305|FG000|Overall Study|Lost to follow-up TP 1|1|||
155561970|NCT04156620|561484306|FG001|Overall Study|Lost to follow-up TP 1|1|||
155561971|NCT04156620|561484305|FG000|Overall Study|Progressive disease - TP 1|0|||
155561972|NCT04156620|561484306|FG001|Overall Study|Progressive disease - TP 1|1|||
155561973|NCT04156620|561484305|FG000|Overall Study|Subject decision - TP 1|3|||
155561974|NCT04156620|561484306|FG001|Overall Study|Subject decision - TP 1|5|||
155561975|NCT04156620|561484305|FG000|Overall Study|Adverse event - TP 2|5|||
155561976|NCT04156620|561484306|FG001|Overall Study|Adverse event - TP 2|6|||
155561977|NCT04156620|561484305|FG000|Overall Study|Death - TP 2|1|||
155561978|NCT04156620|561484306|FG001|Overall Study|Death - TP 2|0|||
155561979|NCT04156620|561484305|FG000|Overall Study|Lost to follow-up - TP 2|5|||
155561980|NCT04156620|561484306|FG001|Overall Study|Lost to follow-up - TP 2|2|||
155561981|NCT04156620|561484305|FG000|Overall Study|Physician decision - TP 2|4|||
155561982|NCT04156620|561484306|FG001|Overall Study|Physician decision - TP 2|2|||
155561983|NCT04156620|561484305|FG000|Overall Study|Pregnancy - TP 2|1|||
155561984|NCT04156620|561484306|FG001|Overall Study|Pregnancy - TP 2|1|||
155561985|NCT04156620|561484305|FG000|Overall Study|Subject decision - TP 2|11|||
155561986|NCT04156620|561484306|FG001|Overall Study|Subject decision - TP 2|9|||
155561987|NCT04156620|561484305|FG000|Overall Study|New therapy for study indication - TP 2|1|||
155561988|NCT04156620|561484306|FG001|Overall Study|New therapy for study indication - TP 2|0|||
155561989|NCT01753336|561484307|FG000|Overall Study|Patient decision|12|||
155561990|NCT01753336|561484307|FG000|Overall Study|Lost to Follow-up|3|||
155561991|NCT01753336|561484307|FG000|Overall Study|Physician Decision|2|||
155561992|NCT01753336|561484307|FG000|Overall Study|Sponsor's decision|2|||
155561993|NCT01753336|561484307|FG000|Overall Study|Withdrawal by Subject|1|||
155658295|NCT01605097|561842836|FG000|Overall Study|Protocol Violation|1|||
155658296|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Adverse Event|3|||
155658297|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Adverse Event|0|||
155658298|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Adverse Event|0|||
155561994|NCT01121666|561484308|FG000|Overall Study|Protocol Violation|29|||
155561995|NCT01121666|561484309|FG001|Overall Study|Protocol Violation|10|||
155561996|NCT01629966|561484312|FG000|Overall Study|Pregnancy|0|||
155561997|NCT01629966|561484313|FG001|Overall Study|Pregnancy|1|||
155561998|NCT01629966|561484314|FG002|Overall Study|Pregnancy|0|||
155561999|NCT01629966|561484312|FG000|Overall Study|Lost to Follow-up|10|||
155562000|NCT01629966|561484313|FG001|Overall Study|Lost to Follow-up|13|||
155562001|NCT01629966|561484314|FG002|Overall Study|Lost to Follow-up|9|||
155562002|NCT01629966|561484312|FG000|Overall Study|Withdrawal by Subject|8|||
155562003|NCT01629966|561484313|FG001|Overall Study|Withdrawal by Subject|9|||
155562004|NCT01629966|561484314|FG002|Overall Study|Withdrawal by Subject|16|||
155562005|NCT01629966|561484312|FG000|Overall Study|Protocol Violation|7|||
155562006|NCT01629966|561484313|FG001|Overall Study|Protocol Violation|9|||
155562007|NCT01629966|561484314|FG002|Overall Study|Protocol Violation|7|||
155562008|NCT01629966|561484312|FG000|Overall Study|Lack of Efficacy|5|||
155562009|NCT01629966|561484313|FG001|Overall Study|Lack of Efficacy|2|||
155562010|NCT01629966|561484314|FG002|Overall Study|Lack of Efficacy|4|||
155562011|NCT01629966|561484312|FG000|Overall Study|Adverse Event|11|||
155658299|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
155562012|NCT01629966|561484313|FG001|Overall Study|Adverse Event|18|||
155562013|NCT01629966|561484314|FG002|Overall Study|Adverse Event|30|||
155562014|NCT01672970|561484315|FG000|Overall Study|Lack of Efficacy|12|||
155562015|NCT01672970|561484315|FG000|Overall Study|Adverse Event|18|||
155562016|NCT01672970|561484315|FG000|Overall Study|Withdrawal by Subject|2|||
155562017|NCT01672970|561484315|FG000|Overall Study|Lost to Follow-up|5|||
155562018|NCT01672970|561484315|FG000|Overall Study|Other|9|||
155562019|NCT01672970|561484315|FG000|Overall Study|Enrolled but not treated|1|||
155562020|NCT02132754|561484316|FG000|Overall Study|Adverse Event|0|||
155562021|NCT02132754|561484317|FG001|Overall Study|Adverse Event|0|||
155562022|NCT02132754|561484318|FG002|Overall Study|Adverse Event|0|||
155562023|NCT02132754|561484319|FG003|Overall Study|Adverse Event|0|||
155562024|NCT02132754|561484320|FG004|Overall Study|Adverse Event|0|||
155562025|NCT02132754|561484321|FG005|Overall Study|Adverse Event|0|||
155562026|NCT02132754|561484322|FG006|Overall Study|Adverse Event|0|||
155562027|NCT02132754|561484323|FG007|Overall Study|Adverse Event|0|||
155562028|NCT02132754|561484324|FG008|Overall Study|Adverse Event|0|||
155562029|NCT02132754|561484325|FG009|Overall Study|Adverse Event|0|||
155562030|NCT02132754|561484326|FG010|Overall Study|Adverse Event|0|||
155562031|NCT02132754|561484327|FG011|Overall Study|Adverse Event|0|||
155562032|NCT02132754|561484328|FG012|Overall Study|Adverse Event|0|||
155562033|NCT02132754|561484329|FG013|Overall Study|Adverse Event|0|||
155562034|NCT02132754|561484330|FG014|Overall Study|Adverse Event|0|||
155562035|NCT02132754|561484331|FG015|Overall Study|Adverse Event|0|||
155562036|NCT02132754|561484332|FG016|Overall Study|Adverse Event|0|||
155562037|NCT02132754|561484333|FG017|Overall Study|Adverse Event|1|||
155562038|NCT02132754|561484334|FG018|Overall Study|Adverse Event|0|||
155562039|NCT02132754|561484335|FG019|Overall Study|Adverse Event|0|||
155562040|NCT02132754|561484336|FG020|Overall Study|Adverse Event|0|||
155562041|NCT02132754|561484337|FG021|Overall Study|Adverse Event|0|||
155562042|NCT02132754|561484338|FG022|Overall Study|Adverse Event|0|||
155562043|NCT02132754|561484339|FG023|Overall Study|Adverse Event|0|||
155562044|NCT02132754|561484340|FG024|Overall Study|Adverse Event|0|||
155562045|NCT02132754|561484341|FG025|Overall Study|Adverse Event|1|||
155562046|NCT02132754|561484342|FG026|Overall Study|Adverse Event|1|||
155562047|NCT02132754|561484343|FG027|Overall Study|Adverse Event|0|||
155562048|NCT02132754|561484344|FG028|Overall Study|Adverse Event|0|||
155562049|NCT02132754|561484345|FG029|Overall Study|Adverse Event|0|||
155562050|NCT02132754|561484346|FG030|Overall Study|Adverse Event|1|||
155562051|NCT02132754|561484347|FG031|Overall Study|Adverse Event|0|||
155562052|NCT02132754|561484348|FG032|Overall Study|Adverse Event|1|||
155562053|NCT02132754|561484349|FG033|Overall Study|Adverse Event|1|||
155562054|NCT02132754|561484316|FG000|Overall Study|Clinical Progression|0|||
155562055|NCT02132754|561484317|FG001|Overall Study|Clinical Progression|0|||
155562056|NCT02132754|561484318|FG002|Overall Study|Clinical Progression|0|||
155562057|NCT02132754|561484319|FG003|Overall Study|Clinical Progression|0|||
155562058|NCT02132754|561484320|FG004|Overall Study|Clinical Progression|0|||
155562059|NCT02132754|561484321|FG005|Overall Study|Clinical Progression|0|||
155562060|NCT02132754|561484322|FG006|Overall Study|Clinical Progression|0|||
155562061|NCT02132754|561484323|FG007|Overall Study|Clinical Progression|0|||
155562062|NCT02132754|561484324|FG008|Overall Study|Clinical Progression|0|||
155562063|NCT02132754|561484325|FG009|Overall Study|Clinical Progression|1|||
155562064|NCT02132754|561484326|FG010|Overall Study|Clinical Progression|0|||
155562065|NCT02132754|561484327|FG011|Overall Study|Clinical Progression|0|||
155562066|NCT02132754|561484328|FG012|Overall Study|Clinical Progression|0|||
155562067|NCT02132754|561484329|FG013|Overall Study|Clinical Progression|0|||
155562068|NCT02132754|561484330|FG014|Overall Study|Clinical Progression|0|||
155562069|NCT02132754|561484331|FG015|Overall Study|Clinical Progression|0|||
155562070|NCT02132754|561484332|FG016|Overall Study|Clinical Progression|1|||
155562071|NCT02132754|561484333|FG017|Overall Study|Clinical Progression|1|||
155562072|NCT02132754|561484334|FG018|Overall Study|Clinical Progression|0|||
155562073|NCT02132754|561484335|FG019|Overall Study|Clinical Progression|1|||
155562074|NCT02132754|561484336|FG020|Overall Study|Clinical Progression|0|||
155562075|NCT02132754|561484337|FG021|Overall Study|Clinical Progression|0|||
155562076|NCT02132754|561484338|FG022|Overall Study|Clinical Progression|1|||
155562077|NCT02132754|561484339|FG023|Overall Study|Clinical Progression|0|||
155658300|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
155658301|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
155562078|NCT02132754|561484340|FG024|Overall Study|Clinical Progression|1|||
155562079|NCT02132754|561484341|FG025|Overall Study|Clinical Progression|1|||
155562080|NCT02132754|561484342|FG026|Overall Study|Clinical Progression|0|||
155562081|NCT02132754|561484343|FG027|Overall Study|Clinical Progression|1|||
155562082|NCT02132754|561484344|FG028|Overall Study|Clinical Progression|1|||
155562083|NCT02132754|561484345|FG029|Overall Study|Clinical Progression|0|||
155562084|NCT02132754|561484346|FG030|Overall Study|Clinical Progression|1|||
155562085|NCT02132754|561484347|FG031|Overall Study|Clinical Progression|0|||
155562086|NCT02132754|561484348|FG032|Overall Study|Clinical Progression|0|||
155562087|NCT02132754|561484349|FG033|Overall Study|Clinical Progression|2|||
155562088|NCT02132754|561484316|FG000|Overall Study|Death|0|||
155562089|NCT02132754|561484317|FG001|Overall Study|Death|0|||
155562090|NCT02132754|561484318|FG002|Overall Study|Death|0|||
155562091|NCT02132754|561484319|FG003|Overall Study|Death|0|||
155562092|NCT02132754|561484320|FG004|Overall Study|Death|0|||
155562093|NCT02132754|561484321|FG005|Overall Study|Death|0|||
155562094|NCT02132754|561484322|FG006|Overall Study|Death|0|||
155562095|NCT02132754|561484323|FG007|Overall Study|Death|0|||
155562096|NCT02132754|561484324|FG008|Overall Study|Death|0|||
155562097|NCT02132754|561484325|FG009|Overall Study|Death|0|||
155562098|NCT02132754|561484326|FG010|Overall Study|Death|0|||
155562099|NCT02132754|561484327|FG011|Overall Study|Death|0|||
155562100|NCT02132754|561484328|FG012|Overall Study|Death|0|||
155562101|NCT02132754|561484329|FG013|Overall Study|Death|0|||
155562102|NCT02132754|561484330|FG014|Overall Study|Death|0|||
155562103|NCT02132754|561484331|FG015|Overall Study|Death|1|||
155562104|NCT02132754|561484332|FG016|Overall Study|Death|0|||
155562105|NCT02132754|561484333|FG017|Overall Study|Death|0|||
155562106|NCT02132754|561484334|FG018|Overall Study|Death|0|||
155562107|NCT02132754|561484335|FG019|Overall Study|Death|1|||
155562108|NCT02132754|561484336|FG020|Overall Study|Death|0|||
155562109|NCT02132754|561484337|FG021|Overall Study|Death|1|||
155562110|NCT02132754|561484338|FG022|Overall Study|Death|0|||
155562111|NCT02132754|561484339|FG023|Overall Study|Death|0|||
155562112|NCT02132754|561484340|FG024|Overall Study|Death|0|||
155562113|NCT02132754|561484341|FG025|Overall Study|Death|0|||
155562114|NCT02132754|561484342|FG026|Overall Study|Death|1|||
155562115|NCT02132754|561484343|FG027|Overall Study|Death|0|||
155562116|NCT02132754|561484344|FG028|Overall Study|Death|0|||
155562117|NCT02132754|561484345|FG029|Overall Study|Death|0|||
155562118|NCT02132754|561484346|FG030|Overall Study|Death|0|||
155562119|NCT02132754|561484347|FG031|Overall Study|Death|0|||
155562120|NCT02132754|561484348|FG032|Overall Study|Death|0|||
155562121|NCT02132754|561484349|FG033|Overall Study|Death|2|||
155562122|NCT02132754|561484316|FG000|Overall Study|Excluded Medication|0|||
155562123|NCT02132754|561484317|FG001|Overall Study|Excluded Medication|0|||
155562124|NCT02132754|561484318|FG002|Overall Study|Excluded Medication|0|||
155562125|NCT02132754|561484319|FG003|Overall Study|Excluded Medication|0|||
155562126|NCT02132754|561484320|FG004|Overall Study|Excluded Medication|0|||
155562127|NCT02132754|561484321|FG005|Overall Study|Excluded Medication|0|||
155562128|NCT02132754|561484322|FG006|Overall Study|Excluded Medication|0|||
155562129|NCT02132754|561484323|FG007|Overall Study|Excluded Medication|0|||
155562130|NCT02132754|561484324|FG008|Overall Study|Excluded Medication|0|||
155562131|NCT02132754|561484325|FG009|Overall Study|Excluded Medication|0|||
155562132|NCT02132754|561484326|FG010|Overall Study|Excluded Medication|0|||
155562133|NCT02132754|561484327|FG011|Overall Study|Excluded Medication|0|||
155562134|NCT02132754|561484328|FG012|Overall Study|Excluded Medication|0|||
155658302|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
155562135|NCT02132754|561484329|FG013|Overall Study|Excluded Medication|0|||
155562136|NCT02132754|561484330|FG014|Overall Study|Excluded Medication|0|||
155562137|NCT02132754|561484331|FG015|Overall Study|Excluded Medication|0|||
155562138|NCT02132754|561484332|FG016|Overall Study|Excluded Medication|0|||
155562139|NCT02132754|561484333|FG017|Overall Study|Excluded Medication|0|||
155562140|NCT02132754|561484334|FG018|Overall Study|Excluded Medication|0|||
155562141|NCT02132754|561484335|FG019|Overall Study|Excluded Medication|0|||
155562142|NCT02132754|561484336|FG020|Overall Study|Excluded Medication|1|||
155562143|NCT02132754|561484337|FG021|Overall Study|Excluded Medication|0|||
155562144|NCT02132754|561484338|FG022|Overall Study|Excluded Medication|0|||
155562145|NCT02132754|561484339|FG023|Overall Study|Excluded Medication|0|||
155562146|NCT02132754|561484340|FG024|Overall Study|Excluded Medication|0|||
155562147|NCT02132754|561484341|FG025|Overall Study|Excluded Medication|0|||
155562148|NCT02132754|561484342|FG026|Overall Study|Excluded Medication|0|||
155562149|NCT02132754|561484343|FG027|Overall Study|Excluded Medication|0|||
155562150|NCT02132754|561484344|FG028|Overall Study|Excluded Medication|0|||
155562151|NCT02132754|561484345|FG029|Overall Study|Excluded Medication|0|||
155562152|NCT02132754|561484346|FG030|Overall Study|Excluded Medication|0|||
155562153|NCT02132754|561484347|FG031|Overall Study|Excluded Medication|0|||
155562154|NCT02132754|561484348|FG032|Overall Study|Excluded Medication|0|||
155562155|NCT02132754|561484349|FG033|Overall Study|Excluded Medication|1|||
155562156|NCT02132754|561484316|FG000|Overall Study|Physician Decision|0|||
155562157|NCT02132754|561484317|FG001|Overall Study|Physician Decision|0|||
155562158|NCT02132754|561484318|FG002|Overall Study|Physician Decision|0|||
155562159|NCT02132754|561484319|FG003|Overall Study|Physician Decision|0|||
155562160|NCT02132754|561484320|FG004|Overall Study|Physician Decision|0|||
155562161|NCT02132754|561484321|FG005|Overall Study|Physician Decision|0|||
155562162|NCT02132754|561484322|FG006|Overall Study|Physician Decision|0|||
155562163|NCT02132754|561484323|FG007|Overall Study|Physician Decision|0|||
155562164|NCT02132754|561484324|FG008|Overall Study|Physician Decision|0|||
155562165|NCT02132754|561484325|FG009|Overall Study|Physician Decision|1|||
155562166|NCT02132754|561484326|FG010|Overall Study|Physician Decision|0|||
155562167|NCT02132754|561484327|FG011|Overall Study|Physician Decision|1|||
155562168|NCT02132754|561484328|FG012|Overall Study|Physician Decision|1|||
155562169|NCT02132754|561484329|FG013|Overall Study|Physician Decision|0|||
155562170|NCT02132754|561484330|FG014|Overall Study|Physician Decision|0|||
155562171|NCT02132754|561484331|FG015|Overall Study|Physician Decision|1|||
155562172|NCT02132754|561484332|FG016|Overall Study|Physician Decision|0|||
155562173|NCT02132754|561484333|FG017|Overall Study|Physician Decision|0|||
155562174|NCT02132754|561484334|FG018|Overall Study|Physician Decision|0|||
155562175|NCT02132754|561484335|FG019|Overall Study|Physician Decision|0|||
155562176|NCT02132754|561484336|FG020|Overall Study|Physician Decision|0|||
155562177|NCT02132754|561484337|FG021|Overall Study|Physician Decision|0|||
155562178|NCT02132754|561484338|FG022|Overall Study|Physician Decision|0|||
155562179|NCT02132754|561484339|FG023|Overall Study|Physician Decision|0|||
155562180|NCT02132754|561484340|FG024|Overall Study|Physician Decision|1|||
155562181|NCT02132754|561484341|FG025|Overall Study|Physician Decision|0|||
155562182|NCT02132754|561484342|FG026|Overall Study|Physician Decision|0|||
155562183|NCT02132754|561484343|FG027|Overall Study|Physician Decision|0|||
155562184|NCT02132754|561484344|FG028|Overall Study|Physician Decision|0|||
155562185|NCT02132754|561484345|FG029|Overall Study|Physician Decision|0|||
155562186|NCT02132754|561484346|FG030|Overall Study|Physician Decision|0|||
155562187|NCT02132754|561484347|FG031|Overall Study|Physician Decision|1|||
155562188|NCT02132754|561484348|FG032|Overall Study|Physician Decision|0|||
155562189|NCT02132754|561484349|FG033|Overall Study|Physician Decision|3|||
155562190|NCT02132754|561484316|FG000|Overall Study|Progressive Disease|1|||
155562191|NCT02132754|561484317|FG001|Overall Study|Progressive Disease|1|||
155562192|NCT02132754|561484318|FG002|Overall Study|Progressive Disease|1|||
155562193|NCT02132754|561484319|FG003|Overall Study|Progressive Disease|1|||
155562194|NCT02132754|561484320|FG004|Overall Study|Progressive Disease|1|||
155562195|NCT02132754|561484321|FG005|Overall Study|Progressive Disease|1|||
155562196|NCT02132754|561484322|FG006|Overall Study|Progressive Disease|1|||
155562197|NCT02132754|561484323|FG007|Overall Study|Progressive Disease|1|||
155562198|NCT02132754|561484324|FG008|Overall Study|Progressive Disease|1|||
155562199|NCT02132754|561484325|FG009|Overall Study|Progressive Disease|3|||
155562200|NCT02132754|561484326|FG010|Overall Study|Progressive Disease|3|||
155562201|NCT02132754|561484327|FG011|Overall Study|Progressive Disease|2|||
155562202|NCT02132754|561484328|FG012|Overall Study|Progressive Disease|2|||
155562203|NCT02132754|561484329|FG013|Overall Study|Progressive Disease|3|||
155562204|NCT02132754|561484330|FG014|Overall Study|Progressive Disease|2|||
155562205|NCT02132754|561484331|FG015|Overall Study|Progressive Disease|1|||
155562206|NCT02132754|561484332|FG016|Overall Study|Progressive Disease|2|||
155562207|NCT02132754|561484333|FG017|Overall Study|Progressive Disease|1|||
155562208|NCT02132754|561484334|FG018|Overall Study|Progressive Disease|3|||
155562209|NCT02132754|561484335|FG019|Overall Study|Progressive Disease|1|||
155562210|NCT02132754|561484336|FG020|Overall Study|Progressive Disease|1|||
155562211|NCT02132754|561484337|FG021|Overall Study|Progressive Disease|3|||
155562212|NCT02132754|561484338|FG022|Overall Study|Progressive Disease|2|||
155562213|NCT02132754|561484339|FG023|Overall Study|Progressive Disease|3|||
155562214|NCT02132754|561484340|FG024|Overall Study|Progressive Disease|0|||
155562215|NCT02132754|561484341|FG025|Overall Study|Progressive Disease|1|||
155562216|NCT02132754|561484342|FG026|Overall Study|Progressive Disease|2|||
155562217|NCT02132754|561484343|FG027|Overall Study|Progressive Disease|1|||
155562218|NCT02132754|561484344|FG028|Overall Study|Progressive Disease|2|||
155562219|NCT02132754|561484345|FG029|Overall Study|Progressive Disease|3|||
155562220|NCT02132754|561484346|FG030|Overall Study|Progressive Disease|1|||
155562221|NCT02132754|561484347|FG031|Overall Study|Progressive Disease|1|||
155562222|NCT02132754|561484348|FG032|Overall Study|Progressive Disease|3|||
155562223|NCT02132754|561484349|FG033|Overall Study|Progressive Disease|6|||
155562224|NCT02132754|561484316|FG000|Overall Study|Screen Failure|0|||
155562225|NCT02132754|561484317|FG001|Overall Study|Screen Failure|0|||
155562226|NCT02132754|561484318|FG002|Overall Study|Screen Failure|0|||
155562227|NCT02132754|561484319|FG003|Overall Study|Screen Failure|0|||
155562228|NCT02132754|561484320|FG004|Overall Study|Screen Failure|0|||
155562229|NCT02132754|561484321|FG005|Overall Study|Screen Failure|0|||
155562230|NCT02132754|561484322|FG006|Overall Study|Screen Failure|0|||
155562231|NCT02132754|561484323|FG007|Overall Study|Screen Failure|0|||
155562232|NCT02132754|561484324|FG008|Overall Study|Screen Failure|0|||
155562233|NCT02132754|561484325|FG009|Overall Study|Screen Failure|0|||
155562234|NCT02132754|561484326|FG010|Overall Study|Screen Failure|0|||
155562235|NCT02132754|561484327|FG011|Overall Study|Screen Failure|0|||
155562236|NCT02132754|561484328|FG012|Overall Study|Screen Failure|0|||
155562237|NCT02132754|561484329|FG013|Overall Study|Screen Failure|0|||
155562238|NCT02132754|561484330|FG014|Overall Study|Screen Failure|0|||
155562239|NCT02132754|561484331|FG015|Overall Study|Screen Failure|0|||
155562240|NCT02132754|561484332|FG016|Overall Study|Screen Failure|0|||
155562241|NCT02132754|561484333|FG017|Overall Study|Screen Failure|0|||
155562242|NCT02132754|561484334|FG018|Overall Study|Screen Failure|0|||
155562243|NCT02132754|561484335|FG019|Overall Study|Screen Failure|1|||
155562244|NCT02132754|561484336|FG020|Overall Study|Screen Failure|0|||
155562245|NCT02132754|561484337|FG021|Overall Study|Screen Failure|1|||
155562246|NCT02132754|561484338|FG022|Overall Study|Screen Failure|0|||
155562247|NCT02132754|561484339|FG023|Overall Study|Screen Failure|0|||
155562248|NCT02132754|561484340|FG024|Overall Study|Screen Failure|0|||
155562249|NCT02132754|561484341|FG025|Overall Study|Screen Failure|0|||
155562250|NCT02132754|561484342|FG026|Overall Study|Screen Failure|0|||
155562251|NCT02132754|561484343|FG027|Overall Study|Screen Failure|0|||
155562252|NCT02132754|561484344|FG028|Overall Study|Screen Failure|0|||
155562253|NCT02132754|561484345|FG029|Overall Study|Screen Failure|0|||
155562254|NCT02132754|561484346|FG030|Overall Study|Screen Failure|0|||
155562255|NCT02132754|561484347|FG031|Overall Study|Screen Failure|0|||
155562256|NCT02132754|561484348|FG032|Overall Study|Screen Failure|0|||
155562257|NCT02132754|561484349|FG033|Overall Study|Screen Failure|0|||
155562258|NCT02132754|561484316|FG000|Overall Study|Transferred to Extension Study|0|||
155562259|NCT02132754|561484317|FG001|Overall Study|Transferred to Extension Study|0|||
155562260|NCT02132754|561484318|FG002|Overall Study|Transferred to Extension Study|0|||
155562261|NCT02132754|561484319|FG003|Overall Study|Transferred to Extension Study|0|||
155562262|NCT02132754|561484320|FG004|Overall Study|Transferred to Extension Study|0|||
155562263|NCT02132754|561484321|FG005|Overall Study|Transferred to Extension Study|0|||
155562264|NCT02132754|561484322|FG006|Overall Study|Transferred to Extension Study|0|||
155562265|NCT02132754|561484323|FG007|Overall Study|Transferred to Extension Study|0|||
155562266|NCT02132754|561484324|FG008|Overall Study|Transferred to Extension Study|0|||
155562267|NCT02132754|561484325|FG009|Overall Study|Transferred to Extension Study|0|||
155562268|NCT02132754|561484326|FG010|Overall Study|Transferred to Extension Study|0|||
155562269|NCT02132754|561484327|FG011|Overall Study|Transferred to Extension Study|0|||
155562270|NCT02132754|561484328|FG012|Overall Study|Transferred to Extension Study|0|||
155562271|NCT02132754|561484329|FG013|Overall Study|Transferred to Extension Study|0|||
155562272|NCT02132754|561484330|FG014|Overall Study|Transferred to Extension Study|0|||
155562273|NCT02132754|561484331|FG015|Overall Study|Transferred to Extension Study|0|||
155562274|NCT02132754|561484332|FG016|Overall Study|Transferred to Extension Study|0|||
155562275|NCT02132754|561484333|FG017|Overall Study|Transferred to Extension Study|0|||
155562276|NCT02132754|561484334|FG018|Overall Study|Transferred to Extension Study|0|||
155562277|NCT02132754|561484335|FG019|Overall Study|Transferred to Extension Study|0|||
155562278|NCT02132754|561484336|FG020|Overall Study|Transferred to Extension Study|0|||
155562279|NCT02132754|561484337|FG021|Overall Study|Transferred to Extension Study|0|||
155562280|NCT02132754|561484338|FG022|Overall Study|Transferred to Extension Study|0|||
155562281|NCT02132754|561484339|FG023|Overall Study|Transferred to Extension Study|0|||
155562282|NCT02132754|561484340|FG024|Overall Study|Transferred to Extension Study|0|||
155562283|NCT02132754|561484341|FG025|Overall Study|Transferred to Extension Study|0|||
155562284|NCT02132754|561484342|FG026|Overall Study|Transferred to Extension Study|0|||
155562285|NCT02132754|561484343|FG027|Overall Study|Transferred to Extension Study|0|||
155562286|NCT02132754|561484344|FG028|Overall Study|Transferred to Extension Study|0|||
155562287|NCT02132754|561484345|FG029|Overall Study|Transferred to Extension Study|0|||
155562288|NCT02132754|561484346|FG030|Overall Study|Transferred to Extension Study|0|||
155562289|NCT02132754|561484347|FG031|Overall Study|Transferred to Extension Study|0|||
155562290|NCT02132754|561484348|FG032|Overall Study|Transferred to Extension Study|0|||
155562291|NCT02132754|561484349|FG033|Overall Study|Transferred to Extension Study|6|||
155562292|NCT02132754|561484316|FG000|Overall Study|Withdrawal by Subject|0|||
155562293|NCT02132754|561484317|FG001|Overall Study|Withdrawal by Subject|0|||
155562294|NCT02132754|561484318|FG002|Overall Study|Withdrawal by Subject|0|||
155562295|NCT02132754|561484319|FG003|Overall Study|Withdrawal by Subject|0|||
155562296|NCT02132754|561484320|FG004|Overall Study|Withdrawal by Subject|0|||
155562297|NCT02132754|561484321|FG005|Overall Study|Withdrawal by Subject|0|||
155562298|NCT02132754|561484322|FG006|Overall Study|Withdrawal by Subject|0|||
155562299|NCT02132754|561484323|FG007|Overall Study|Withdrawal by Subject|0|||
155562300|NCT02132754|561484324|FG008|Overall Study|Withdrawal by Subject|0|||
155562301|NCT02132754|561484325|FG009|Overall Study|Withdrawal by Subject|1|||
155562302|NCT02132754|561484326|FG010|Overall Study|Withdrawal by Subject|0|||
155562303|NCT02132754|561484327|FG011|Overall Study|Withdrawal by Subject|0|||
155562304|NCT02132754|561484328|FG012|Overall Study|Withdrawal by Subject|1|||
155562305|NCT02132754|561484329|FG013|Overall Study|Withdrawal by Subject|0|||
155562306|NCT02132754|561484330|FG014|Overall Study|Withdrawal by Subject|1|||
155562307|NCT02132754|561484331|FG015|Overall Study|Withdrawal by Subject|2|||
155562308|NCT02132754|561484332|FG016|Overall Study|Withdrawal by Subject|1|||
155562309|NCT02132754|561484333|FG017|Overall Study|Withdrawal by Subject|0|||
155562310|NCT02132754|561484334|FG018|Overall Study|Withdrawal by Subject|0|||
155562311|NCT02132754|561484335|FG019|Overall Study|Withdrawal by Subject|0|||
155562312|NCT02132754|561484336|FG020|Overall Study|Withdrawal by Subject|1|||
155562313|NCT02132754|561484337|FG021|Overall Study|Withdrawal by Subject|0|||
155562314|NCT02132754|561484338|FG022|Overall Study|Withdrawal by Subject|0|||
155562315|NCT02132754|561484339|FG023|Overall Study|Withdrawal by Subject|0|||
155562316|NCT02132754|561484340|FG024|Overall Study|Withdrawal by Subject|1|||
155562317|NCT02132754|561484341|FG025|Overall Study|Withdrawal by Subject|0|||
155562318|NCT02132754|561484342|FG026|Overall Study|Withdrawal by Subject|0|||
155562319|NCT02132754|561484343|FG027|Overall Study|Withdrawal by Subject|1|||
155562320|NCT02132754|561484344|FG028|Overall Study|Withdrawal by Subject|0|||
155562321|NCT02132754|561484345|FG029|Overall Study|Withdrawal by Subject|0|||
155562322|NCT02132754|561484346|FG030|Overall Study|Withdrawal by Subject|0|||
155562323|NCT02132754|561484347|FG031|Overall Study|Withdrawal by Subject|1|||
155562324|NCT02132754|561484348|FG032|Overall Study|Withdrawal by Subject|0|||
155562325|NCT02132754|561484349|FG033|Overall Study|Withdrawal by Subject|2|||
155562326|NCT04430855|561484350|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
155562327|NCT04430855|561484351|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
155562328|NCT04430855|561484350|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
155562329|NCT04430855|561484351|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
155562330|NCT04430855|561484350|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
155562331|NCT04430855|561484351|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
155562332|NCT04430855|561484350|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
155562333|NCT04430855|561484351|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
155562334|NCT04430855|561484350|FG000|Period 1 (Weeks 1-12)|Other|0|||
155562335|NCT04430855|561484351|FG001|Period 1 (Weeks 1-12)|Other|1|||
155562336|NCT04430855|561484350|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
155562337|NCT04430855|561484351|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
155562338|NCT04430855|561484350|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
155562339|NCT04430855|561484351|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
155562340|NCT04430855|561484350|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
155562341|NCT04430855|561484351|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
155562342|NCT01770392|561484352|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
155562343|NCT03401450|561484353|FG000|Overall Study|Lost to Follow-up|4|||
155562344|NCT03401450|561484354|FG001|Overall Study|Lost to Follow-up|6|||
155562345|NCT03401450|561484353|FG000|Overall Study|Anesthesia plan changed|2|||
155562346|NCT03401450|561484354|FG001|Overall Study|Anesthesia plan changed|2|||
155562347|NCT03401450|561484353|FG000|Overall Study|Did not complete medication diary|4|||
155562348|NCT03401450|561484354|FG001|Overall Study|Did not complete medication diary|2|||
155562349|NCT03401450|561484353|FG000|Overall Study|post surgery medication change|2|||
155562350|NCT03401450|561484354|FG001|Overall Study|post surgery medication change|1|||
155562351|NCT03401450|561484353|FG000|Overall Study|Cancelled surgery|0|||
155562352|NCT03401450|561484354|FG001|Overall Study|Cancelled surgery|2|||
155562353|NCT00390221|561484357|FG000|Overall Study|Lost to Follow-up|0|||
155562354|NCT00390221|561484358|FG001|Overall Study|Lost to Follow-up|3|||
155562355|NCT00390221|561484359|FG002|Overall Study|Lost to Follow-up|0|||
155562356|NCT00390221|561484357|FG000|Overall Study|Adverse Event|1|||
155562357|NCT00390221|561484358|FG001|Overall Study|Adverse Event|4|||
155562358|NCT00390221|561484359|FG002|Overall Study|Adverse Event|3|||
155562359|NCT00390221|561484357|FG000|Overall Study|Investigator Decision|0|||
155562360|NCT00390221|561484358|FG001|Overall Study|Investigator Decision|0|||
155562361|NCT00390221|561484359|FG002|Overall Study|Investigator Decision|1|||
155562362|NCT00390221|561484357|FG000|Overall Study|Withdrawal by Subject|13|||
155562363|NCT00390221|561484358|FG001|Overall Study|Withdrawal by Subject|9|||
155562364|NCT00390221|561484359|FG002|Overall Study|Withdrawal by Subject|7|||
155562365|NCT00390221|561484357|FG000|Overall Study|Subject Non-compliance|1|||
155562366|NCT00390221|561484358|FG001|Overall Study|Subject Non-compliance|0|||
155562367|NCT00390221|561484359|FG002|Overall Study|Subject Non-compliance|2|||
155562368|NCT00390221|561484357|FG000|Overall Study|Other|3|||
155562369|NCT00390221|561484358|FG001|Overall Study|Other|4|||
155562370|NCT00390221|561484359|FG002|Overall Study|Other|2|||
155562371|NCT00761865|561484366|FG000|Overall Study|Lost to Follow-up|8|||
155562372|NCT00761865|561484367|FG001|Overall Study|Lost to Follow-up|7|||
155562373|NCT01372774|561484370|FG000|Overall Study|Withdrawal prior to treatment|4|||
155562374|NCT01372774|561484371|FG001|Overall Study|Withdrawal prior to treatment|5|||
155562375|NCT00389831|561484372|FG000|Overall Study|Lack of Efficacy|0|||
155562376|NCT00389831|561484373|FG001|Overall Study|Lack of Efficacy|2|||
155562377|NCT00389831|561484372|FG000|Overall Study|Did not receive treatment.|0|||
155562378|NCT00389831|561484373|FG001|Overall Study|Did not receive treatment.|2|||
155562379|NCT00389831|561484372|FG000|Overall Study|Other reasons|0|||
155562380|NCT00389831|561484373|FG001|Overall Study|Other reasons|2|||
155562381|NCT00389831|561484372|FG000|Overall Study|Lost to Follow-up|0|||
155562382|NCT00389831|561484373|FG001|Overall Study|Lost to Follow-up|1|||
155562383|NCT02201290|561484374|FG000|Overall Study|Withdrawal by Subject|2|||
155562384|NCT02201290|561484374|FG000|Overall Study|Lack of Efficacy|2|||
155562385|NCT02201290|561484374|FG000|Overall Study|Adverse Event|1|||
155562386|NCT03190330|561486613|FG000|Overall Study|Adverse Event|2|||
155562387|NCT03190330|561486613|FG000|Overall Study|Death|10|||
155562388|NCT03190330|561486613|FG000|Overall Study|Lost to Follow-up|1|||
155562389|NCT03190330|561486613|FG000|Overall Study|Withdrawal by Subject|6|||
155562390|NCT03190330|561486613|FG000|Overall Study|Progressive Disease|1|||
155562391|NCT02081209|561486614|FG000|Overall Study|Withdrawal by Subject|1|||
155562392|NCT02370329|561486615|FG000|Overall Study|Alternate treatment|1|||
155562393|NCT02370329|561486615|FG000|Overall Study|Adverse Event|1|||
155562394|NCT02370329|561486615|FG000|Overall Study|Disease progression|3|||
155562395|NCT02370329|561486615|FG000|Overall Study|Physician Decision|2|||
155562396|NCT02370329|561486615|FG000|Overall Study|Study closure|4|||
155562397|NCT00633243|561486616|FG000|Overall Study|Withdrawal by Subject|0|||
155562398|NCT00633243|561486617|FG001|Overall Study|Withdrawal by Subject|1|||
155562399|NCT00633243|561486616|FG000|Overall Study|incarceration|0|||
155562400|NCT00633243|561486617|FG001|Overall Study|incarceration|2|||
155562401|NCT00633243|561486616|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
155562402|NCT00633243|561486617|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
155562403|NCT00633243|561486616|FG000|Overall Study|Not comfortable with self-injecting|0|||
155562404|NCT00633243|561486617|FG001|Overall Study|Not comfortable with self-injecting|1|||
155562405|NCT00633243|561486616|FG000|Overall Study|Mental Health--Depression|0|||
155562406|NCT00633243|561486617|FG001|Overall Study|Mental Health--Depression|1|||
155562407|NCT00633243|561486616|FG000|Overall Study|Couldn't tolerate side-effects|1|||
155562408|NCT00633243|561486617|FG001|Overall Study|Couldn't tolerate side-effects|1|||
155562409|NCT02022748|561486618|FG000|Overall Study|Adverse Event|1|||
155562410|NCT02022748|561486619|FG001|Overall Study|Adverse Event|1|||
155562411|NCT02022748|561486620|FG002|Overall Study|Adverse Event|0|||
155562412|NCT02022748|561486618|FG000|Overall Study|Withdrawal by Subject|0|||
155562413|NCT02022748|561486619|FG001|Overall Study|Withdrawal by Subject|1|||
155562414|NCT02022748|561486620|FG002|Overall Study|Withdrawal by Subject|0|||
155562415|NCT04347122|561486622|FG000|Overall Study|Physician Decision|0|||
155562416|NCT04347122|561486623|FG001|Overall Study|Physician Decision|3|||
155562417|NCT04347122|561486624|FG002|Overall Study|Physician Decision|3|||
155562418|NCT04347122|561486625|FG003|Overall Study|Physician Decision|6|||
155562419|NCT03510598|561486626|FG000|Overall Study|Withdrawal by Subject|1|||
155562420|NCT04994483|561486627|FG000|Overall Study|Adverse Event|26|||
155562421|NCT04994483|561486628|FG001|Overall Study|Adverse Event|17|||
155562422|NCT04994483|561486627|FG000|Overall Study|Lost to Follow-up|6|||
155562423|NCT04994483|561486628|FG001|Overall Study|Lost to Follow-up|10|||
155562424|NCT04994483|561486627|FG000|Overall Study|Noncompliance with study drug|8|||
155562425|NCT04994483|561486628|FG001|Overall Study|Noncompliance with study drug|5|||
155562426|NCT04994483|561486627|FG000|Overall Study|Physician Decision|5|||
155562427|NCT04994483|561486628|FG001|Overall Study|Physician Decision|0|||
155562428|NCT04994483|561486627|FG000|Overall Study|Withdrawal by Subject|41|||
155562429|NCT04994483|561486628|FG001|Overall Study|Withdrawal by Subject|38|||
155562430|NCT04994483|561486627|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
155562431|NCT04994483|561486628|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
155562432|NCT04994483|561486627|FG000|Overall Study|Met stopping criteria|1|||
155562433|NCT04994483|561486628|FG001|Overall Study|Met stopping criteria|0|||
155562434|NCT04994483|561486627|FG000|Overall Study|Randomized in error, not treated|4|||
155562435|NCT04994483|561486628|FG001|Overall Study|Randomized in error, not treated|3|||
155562436|NCT04994483|561486627|FG000|Overall Study|Lack of a reliable study partner|0|||
155562437|NCT04994483|561486628|FG001|Overall Study|Lack of a reliable study partner|1|||
155562438|NCT04994483|561486627|FG000|Overall Study|Met MRI exclusion criteria|0|||
155562439|NCT04994483|561486628|FG001|Overall Study|Met MRI exclusion criteria|1|||
155562440|NCT03589768|561486629|FG000|Overall Study|Death|1|||
155562441|NCT03589768|561486630|FG001|Overall Study|Death|0|||
155562442|NCT03589768|561486631|FG002|Overall Study|Death|8|||
155562443|NCT03589768|561486632|FG003|Overall Study|Death|3|||
155562444|NCT03589768|561486629|FG000|Overall Study|Withdrawal by Subject|2|||
155562445|NCT03589768|561486630|FG001|Overall Study|Withdrawal by Subject|0|||
155562446|NCT03589768|561486631|FG002|Overall Study|Withdrawal by Subject|0|||
155562447|NCT03589768|561486632|FG003|Overall Study|Withdrawal by Subject|0|||
155562448|NCT03589768|561486629|FG000|Overall Study|Protocol Violation|1|||
155562449|NCT03589768|561486630|FG001|Overall Study|Protocol Violation|0|||
155562450|NCT03589768|561486631|FG002|Overall Study|Protocol Violation|0|||
155562451|NCT03589768|561486632|FG003|Overall Study|Protocol Violation|0|||
155562452|NCT00112866|561486633|FG000|Overall Study|Protocol Violation|1|||
155562453|NCT00112866|561486634|FG001|Overall Study|Protocol Violation|0|||
155562454|NCT00112866|561486633|FG000|Overall Study|did not start treatment post-op|1|||
155562455|NCT00112866|561486634|FG001|Overall Study|did not start treatment post-op|2|||
155562456|NCT04663295|561486637|FG000|Run-in Period|Withdrawal by Subject|3|||
155562457|NCT04663295|561486637|FG000|Overall Study Period|Pregnancy|1|||
155562458|NCT04663295|561486637|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
155562459|NCT00554190|561486638|FG000|Overall Study|Termination forms not completed|10|||
155562460|NCT00191113|561486639|FG000|Core Study|Withdrawal by Subject|25|||
155562461|NCT00191113|561486640|FG001|Core Study|Withdrawal by Subject|9|||
155562462|NCT00191113|561486639|FG000|Core Study|Protocol Violation|6|||
155562463|NCT00191113|561486640|FG001|Core Study|Protocol Violation|2|||
155562464|NCT00191113|561486639|FG000|Core Study|Lost to Follow-up|3|||
155562465|NCT00191113|561486640|FG001|Core Study|Lost to Follow-up|0|||
155562466|NCT00191113|561486639|FG000|Core Study|Adverse Event|0|||
155562467|NCT00191113|561486640|FG001|Core Study|Adverse Event|2|||
155562468|NCT00191113|561486639|FG000|Core Study|Lack of Efficacy|0|||
155562469|NCT00191113|561486640|FG001|Core Study|Lack of Efficacy|2|||
155562470|NCT00191113|561486639|FG000|Core Study|Death|1|||
155562471|NCT00191113|561486640|FG001|Core Study|Death|0|||
155562472|NCT01502410|561486641|FG000|Overall Study|Adverse Event|1|||
155562473|NCT01502410|561486642|FG001|Overall Study|Adverse Event|2|||
155562474|NCT01502410|561486643|FG002|Overall Study|Adverse Event|0|||
155562475|NCT01502410|561486644|FG003|Overall Study|Adverse Event|0|||
155562476|NCT01502410|561486641|FG000|Overall Study|Lack of Efficacy|7|||
155562477|NCT01502410|561486642|FG001|Overall Study|Lack of Efficacy|7|||
155562478|NCT01502410|561486643|FG002|Overall Study|Lack of Efficacy|0|||
155562479|NCT01502410|561486644|FG003|Overall Study|Lack of Efficacy|0|||
155562480|NCT01502410|561486641|FG000|Overall Study|Physician Decision|0|||
155562481|NCT01502410|561486642|FG001|Overall Study|Physician Decision|1|||
155562482|NCT01502410|561486643|FG002|Overall Study|Physician Decision|0|||
155562483|NCT01502410|561486644|FG003|Overall Study|Physician Decision|0|||
155562484|NCT01502410|561486641|FG000|Overall Study|Withdrawal by Subject|2|||
155562485|NCT01502410|561486642|FG001|Overall Study|Withdrawal by Subject|0|||
155562486|NCT01502410|561486643|FG002|Overall Study|Withdrawal by Subject|0|||
155562487|NCT01502410|561486644|FG003|Overall Study|Withdrawal by Subject|0|||
155562488|NCT02903030|561486645|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155562489|NCT02903030|561486646|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155562490|NCT03700385|561486648|FG000|Overall Study|Lost to Follow-up|1|||
155562491|NCT00699283|561486649|FG000|Overall Study|Lack of Efficacy|15|||
155562492|NCT00699283|561486650|FG001|Overall Study|Lack of Efficacy|5|||
155562493|NCT00699283|561486649|FG000|Overall Study|Lost to Follow-up|2|||
155562494|NCT00699283|561486650|FG001|Overall Study|Lost to Follow-up|0|||
155562495|NCT00699283|561486649|FG000|Overall Study|Withdrawal by Subject|1|||
155562496|NCT00699283|561486650|FG001|Overall Study|Withdrawal by Subject|0|||
155562497|NCT00699283|561486649|FG000|Overall Study|Other Reason|5|||
155562498|NCT00699283|561486650|FG001|Overall Study|Other Reason|1|||
155562499|NCT00699283|561486649|FG000|Overall Study|SAE, non-fatal|1|||
155562500|NCT00699283|561486650|FG001|Overall Study|SAE, non-fatal|1|||
155562501|NCT00699283|561486649|FG000|Overall Study|AE, non-serious non-fatal|8|||
155562502|NCT00699283|561486650|FG001|Overall Study|AE, non-serious non-fatal|1|||
155562503|NCT00699283|561486649|FG000|Overall Study|AE of unknown type|1|||
155562504|NCT00699283|561486650|FG001|Overall Study|AE of unknown type|0|||
155562505|NCT02771795|561486658|FG000|Overall Study|Withdrawal by Subject|47|||
155562506|NCT02771795|561486659|FG001|Overall Study|Withdrawal by Subject|37|||
155562507|NCT02771795|561486658|FG000|Overall Study|Termination by premature discontinuation of study|168|||
155562508|NCT02771795|561486659|FG001|Overall Study|Termination by premature discontinuation of study|185|||
155562509|NCT03537599|561486660|FG000|Overall Study|Disease Progression|2|||
155562510|NCT03537599|561486661|FG001|Overall Study|Disease Progression|1|||
155562511|NCT03537599|561486660|FG000|Overall Study|Death|0|||
155562512|NCT03537599|561486661|FG001|Overall Study|Death|1|||
155562513|NCT05083585|561486662|FG000|Overall Study|Death|1|||
155562514|NCT05083585|561486663|FG001|Overall Study|Death|1|||
155562515|NCT05083585|561486662|FG000|Overall Study|Lost to Follow-up|1|||
155562516|NCT05083585|561486663|FG001|Overall Study|Lost to Follow-up|1|||
155562517|NCT05083585|561486662|FG000|Overall Study|Withdrawal by Subject|2|||
155562518|NCT05083585|561486663|FG001|Overall Study|Withdrawal by Subject|0|||
155562519|NCT05083585|561486662|FG000|Overall Study|Randomized but not vaccinated|2|||
155562520|NCT05083585|561486663|FG001|Overall Study|Randomized but not vaccinated|0|||
155562521|NCT00114166|561486664|FG000|Overall Study|Wrong primary|0|||
155562522|NCT00114166|561486665|FG001|Overall Study|Wrong primary|1|||
155562523|NCT03469336|561486666|FG000|Overall Study|Adverse Event|1|||
155562524|NCT02740699|561486668|FG000|Overall Study|Lost to Follow-up|5|||
155562525|NCT02740699|561486668|FG000|Overall Study|Withdrawal by Subject|14|||
155562526|NCT02740699|561486668|FG000|Overall Study|Physician Decision|5|||
155562527|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562528|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
155562529|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562530|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562531|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562532|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
155562533|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
155562534|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562535|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562536|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562537|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562538|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562539|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562540|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562541|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562542|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562543|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562544|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562545|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562546|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562547|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562548|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562549|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562550|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562551|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155562552|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562553|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
155562554|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562555|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562556|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562557|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562558|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562559|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562560|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562561|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562562|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562563|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562564|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562565|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562566|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562567|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562568|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562569|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562570|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562571|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562572|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562573|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562574|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562575|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562576|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155562577|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
155562578|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
155562579|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
155562580|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
155562581|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
155562582|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
155562583|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
155562584|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
155562585|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
155562586|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
155562587|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
155562588|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
155562589|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
155562590|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
155562591|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
155562592|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
155562593|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
155562594|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
155562595|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
155562596|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
155562597|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
155562598|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
155562599|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
155562600|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
155562601|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
155562602|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
155562603|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562604|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562605|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562606|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562607|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562608|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562609|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562610|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562611|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562612|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562613|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562614|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562615|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562616|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562617|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562618|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562619|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562620|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562621|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562622|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562623|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562624|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562625|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562626|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
155562627|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562628|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562629|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562630|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562631|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562632|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
155562633|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
155562634|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562635|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562636|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
155562637|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562638|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562639|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562640|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562641|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562642|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562643|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562644|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562645|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562646|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562647|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562648|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562649|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562650|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155562651|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
155658303|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
155562652|NCT02393248|561486670|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562653|NCT02393248|561486671|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562654|NCT02393248|561486672|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562655|NCT02393248|561486673|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562656|NCT02393248|561486674|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562657|NCT02393248|561486675|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562658|NCT02393248|561486676|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
155562659|NCT02393248|561486677|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562660|NCT02393248|561486678|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562661|NCT02393248|561486679|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562662|NCT02393248|561486680|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562663|NCT02393248|561486681|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562664|NCT02393248|561486682|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562665|NCT02393248|561486683|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562666|NCT02393248|561486684|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562667|NCT02393248|561486685|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562668|NCT02393248|561486686|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562669|NCT02393248|561486687|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562670|NCT02393248|561486688|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562671|NCT02393248|561486689|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562672|NCT02393248|561486690|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562673|NCT02393248|561486691|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562674|NCT02393248|561486692|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562675|NCT02393248|561486693|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562676|NCT02393248|561486694|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155562677|NCT02393248|561486670|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562678|NCT02393248|561486671|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562679|NCT02393248|561486672|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562680|NCT02393248|561486673|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562681|NCT02393248|561486674|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562682|NCT02393248|561486675|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562683|NCT02393248|561486676|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562684|NCT02393248|561486677|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562685|NCT02393248|561486678|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562686|NCT02393248|561486679|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562687|NCT02393248|561486680|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562688|NCT02393248|561486681|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
155562689|NCT02393248|561486682|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
155562690|NCT02393248|561486683|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
155562691|NCT02393248|561486684|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
155562692|NCT02393248|561486685|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562693|NCT02393248|561486686|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562694|NCT02393248|561486687|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562695|NCT02393248|561486688|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562696|NCT02393248|561486689|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562697|NCT02393248|561486690|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562698|NCT02393248|561486691|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562699|NCT02393248|561486692|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562700|NCT02393248|561486693|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562701|NCT02393248|561486694|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
155562702|NCT02393248|561486670|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562703|NCT02393248|561486671|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562704|NCT02393248|561486672|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562705|NCT02393248|561486673|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562706|NCT02393248|561486674|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562707|NCT02393248|561486675|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562708|NCT02393248|561486676|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155658304|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
155658305|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
155562709|NCT02393248|561486677|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562710|NCT02393248|561486678|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562711|NCT02393248|561486679|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562712|NCT02393248|561486680|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
155562713|NCT02393248|561486681|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
155562714|NCT02393248|561486682|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562715|NCT02393248|561486683|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562716|NCT02393248|561486684|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562717|NCT02393248|561486685|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562718|NCT02393248|561486686|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562719|NCT02393248|561486687|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562720|NCT02393248|561486688|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562721|NCT02393248|561486689|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562722|NCT02393248|561486690|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562723|NCT02393248|561486691|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562724|NCT02393248|561486692|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562725|NCT02393248|561486693|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562726|NCT02393248|561486694|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155562727|NCT02393248|561486670|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
155562728|NCT02393248|561486671|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
155562729|NCT02393248|561486672|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
155562730|NCT02393248|561486673|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
155562731|NCT02393248|561486674|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
155562732|NCT02393248|561486675|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
155562733|NCT02393248|561486676|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
155562734|NCT02393248|561486677|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
155562735|NCT02393248|561486678|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
155562736|NCT02393248|561486679|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
155562737|NCT02393248|561486680|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
155562738|NCT02393248|561486681|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
155562739|NCT02393248|561486682|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
155562740|NCT02393248|561486683|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
155562741|NCT02393248|561486684|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
155562742|NCT02393248|561486685|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
155562743|NCT02393248|561486686|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
155562744|NCT02393248|561486687|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
155562745|NCT02393248|561486688|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
155562746|NCT02393248|561486689|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
155562747|NCT02393248|561486690|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
155562748|NCT02393248|561486691|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
155562749|NCT02393248|561486692|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
155562750|NCT02393248|561486693|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
155562751|NCT02393248|561486694|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
155562752|NCT02393248|561486670|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562753|NCT02393248|561486671|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562754|NCT02393248|561486672|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562755|NCT02393248|561486673|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562756|NCT02393248|561486674|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562757|NCT02393248|561486675|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562758|NCT02393248|561486676|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562759|NCT02393248|561486677|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562760|NCT02393248|561486678|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562761|NCT02393248|561486679|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562762|NCT02393248|561486680|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562763|NCT02393248|561486681|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
155562764|NCT02393248|561486682|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562765|NCT02393248|561486683|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
155562766|NCT02393248|561486684|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562767|NCT02393248|561486685|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562768|NCT02393248|561486686|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562769|NCT02393248|561486687|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562770|NCT02393248|561486688|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562771|NCT02393248|561486689|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562772|NCT02393248|561486690|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562773|NCT02393248|561486691|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562774|NCT02393248|561486692|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562775|NCT02393248|561486693|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155658306|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
155658307|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
155658308|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
155658309|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
155658310|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
155658311|NCT04380142|561842839|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
155658312|NCT04380142|561842840|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
155658313|NCT04380142|561842841|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
155658314|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155658315|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155658316|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Adverse Event|14|||
155658317|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
155658318|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
155658319|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
155658320|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155658321|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155658322|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
155658323|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
155658324|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
155658325|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
155658326|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
155658327|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
155658328|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
155658329|NCT04380142|561842839|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
155658330|NCT04380142|561842840|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
155658331|NCT04380142|561842841|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
155658332|NCT01506726|561842846|FG000|Overall Study|Adverse Event|1|||
155658333|NCT01506726|561842847|FG001|Overall Study|Adverse Event|2|||
155658334|NCT04079738|561842848|FG000|Study Treatment|Death|1|||
155658335|NCT04079738|561842849|FG001|Study Treatment|Death|0|||
155658336|NCT04079738|561842850|FG002|Study Treatment|Death|0|||
155658337|NCT04079738|561842851|FG003|Study Treatment|Death|0|||
155658338|NCT04079738|561842848|FG000|Study Treatment|Adverse Event|2|||
155658339|NCT04079738|561842849|FG001|Study Treatment|Adverse Event|0|||
155658340|NCT04079738|561842850|FG002|Study Treatment|Adverse Event|0|||
155658341|NCT04079738|561842851|FG003|Study Treatment|Adverse Event|0|||
155658342|NCT04079738|561842848|FG000|Study Treatment|withdrawal before treatment|1|||
155658343|NCT04079738|561842849|FG001|Study Treatment|withdrawal before treatment|0|||
155658344|NCT04079738|561842850|FG002|Study Treatment|withdrawal before treatment|0|||
155658345|NCT04079738|561842851|FG003|Study Treatment|withdrawal before treatment|0|||
155658346|NCT04079738|561842848|FG000|Study Treatment|symptomatic deterioration|2|||
155658347|NCT04079738|561842849|FG001|Study Treatment|symptomatic deterioration|0|||
155658348|NCT04079738|561842850|FG002|Study Treatment|symptomatic deterioration|0|||
155658349|NCT04079738|561842851|FG003|Study Treatment|symptomatic deterioration|0|||
155658350|NCT04079738|561842848|FG000|Study Treatment|Disease Progression|1|||
155658351|NCT04079738|561842849|FG001|Study Treatment|Disease Progression|0|||
155658352|NCT04079738|561842850|FG002|Study Treatment|Disease Progression|0|||
155658353|NCT04079738|561842851|FG003|Study Treatment|Disease Progression|0|||
155658354|NCT04079738|561842848|FG000|Study Treatment|withdrawal after treatment|1|||
155658355|NCT04079738|561842849|FG001|Study Treatment|withdrawal after treatment|0|||
155658356|NCT04079738|561842850|FG002|Study Treatment|withdrawal after treatment|0|||
155658357|NCT04079738|561842851|FG003|Study Treatment|withdrawal after treatment|0|||
155658358|NCT04079738|561842848|FG000|Follow up|Withdrawal by Subject|3|||
155658359|NCT04079738|561842849|FG001|Follow up|Withdrawal by Subject|0|||
155658360|NCT04079738|561842850|FG002|Follow up|Withdrawal by Subject|0|||
155658361|NCT04079738|561842851|FG003|Follow up|Withdrawal by Subject|0|||
155658362|NCT04079738|561842848|FG000|Follow up|Death|5|||
155658363|NCT04079738|561842849|FG001|Follow up|Death|0|||
155658364|NCT04079738|561842850|FG002|Follow up|Death|0|||
155658365|NCT04079738|561842851|FG003|Follow up|Death|0|||
155658366|NCT05552859|561842852|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
155658367|NCT05552859|561842853|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
155658368|NCT01380080|561842854|FG000|Overall Study|Death|36|||
155658369|NCT01380080|561842855|FG001|Overall Study|Death|44|||
155658370|NCT01380080|561842854|FG000|Overall Study|Site is closing|28|||
155658371|NCT01380080|561842855|FG001|Overall Study|Site is closing|31|||
155658372|NCT01380080|561842854|FG000|Overall Study|Not able to get to clinic|7|||
155658373|NCT01380080|561842855|FG001|Overall Study|Not able to get to clinic|1|||
155658374|NCT01380080|561842854|FG000|Overall Study|Not willing to adhere to requirements|6|||
155658375|NCT01380080|561842855|FG001|Overall Study|Not willing to adhere to requirements|2|||
155658376|NCT01380080|561842854|FG000|Overall Study|Withdrawal by Subject|5|||
155658377|NCT01380080|561842855|FG001|Overall Study|Withdrawal by Subject|2|||
155658378|NCT01380080|561842854|FG000|Overall Study|Lost to Follow-up|3|||
155658379|NCT01380080|561842855|FG001|Overall Study|Lost to Follow-up|3|||
155658380|NCT00210132|561842856|FG000|Overall Study|Protocol Violation|1|||
155658381|NCT00210132|561842857|FG001|Overall Study|Protocol Violation|4|||
155658382|NCT00432965|561842858|FG000|Overall Study|Lost to Follow-up|22|||
155658383|NCT00432965|561842859|FG001|Overall Study|Lost to Follow-up|19|||
155658384|NCT00432965|561842858|FG000|Overall Study|Withdrawal by Subject|13|||
155658385|NCT00432965|561842859|FG001|Overall Study|Withdrawal by Subject|13|||
155658386|NCT00432965|561842858|FG000|Overall Study|Physician Decision|14|||
155658387|NCT00432965|561842859|FG001|Overall Study|Physician Decision|13|||
155658388|NCT00432965|561842858|FG000|Overall Study|Lack of Efficacy|8|||
155658389|NCT00432965|561842859|FG001|Overall Study|Lack of Efficacy|13|||
155658390|NCT00432965|561842858|FG000|Overall Study|Non-compliance|7|||
155658391|NCT00432965|561842859|FG001|Overall Study|Non-compliance|0|||
155658392|NCT00432965|561842858|FG000|Overall Study|Adverse Event|22|||
155658393|NCT00432965|561842859|FG001|Overall Study|Adverse Event|19|||
155658394|NCT00432965|561842858|FG000|Overall Study|Death|3|||
155658395|NCT00432965|561842859|FG001|Overall Study|Death|4|||
155658396|NCT00432965|561842858|FG000|Overall Study|Exclusionary Methods|1|||
155658397|NCT00432965|561842859|FG001|Overall Study|Exclusionary Methods|2|||
155658398|NCT00432965|561842858|FG000|Overall Study|Incomplete Data|4|||
155658399|NCT00432965|561842859|FG001|Overall Study|Incomplete Data|3|||
155658400|NCT00071032|561842861|FG000|Overall Study|Lost to Follow-up|1|||
155658401|NCT00071032|561842862|FG001|Overall Study|Lost to Follow-up|1|||
155658402|NCT00071032|561842861|FG000|Overall Study|Withdrawal by Subject|8|||
155658403|NCT00071032|561842862|FG001|Overall Study|Withdrawal by Subject|6|||
155658404|NCT00071032|561842861|FG000|Overall Study|Missing Primary Outcome|0|||
155658405|NCT00071032|561842862|FG001|Overall Study|Missing Primary Outcome|1|||
155658406|NCT01889251|561842863|FG000|Overall Study|Adverse Event|1|||
155658407|NCT01889251|561842864|FG001|Overall Study|Adverse Event|0|||
155658408|NCT01722669|561842867|FG000|Overall Study|Withdrawal by Subject|0|||
155658409|NCT01722669|561842868|FG001|Overall Study|Withdrawal by Subject|0|||
155658410|NCT01722669|561842869|FG002|Overall Study|Withdrawal by Subject|0|||
155658411|NCT01722669|561842870|FG003|Overall Study|Withdrawal by Subject|0|||
155658412|NCT01722669|561842871|FG004|Overall Study|Withdrawal by Subject|0|||
155658413|NCT01722669|561842872|FG005|Overall Study|Withdrawal by Subject|2|||
155658414|NCT02496000|561842877|FG000|Overall Study|Withdrawal by Subject|1|||
155658415|NCT02496000|561842878|FG001|Overall Study|Withdrawal by Subject|2|||
155658416|NCT02496000|561842879|FG002|Overall Study|Withdrawal by Subject|0|||
155658417|NCT02496000|561842877|FG000|Overall Study|Lost to Follow-up|1|||
155658418|NCT02496000|561842878|FG001|Overall Study|Lost to Follow-up|0|||
155658419|NCT02496000|561842879|FG002|Overall Study|Lost to Follow-up|1|||
155658420|NCT02496000|561842877|FG000|Overall Study|Protocol Violation|0|||
155658421|NCT02496000|561842878|FG001|Overall Study|Protocol Violation|0|||
155658422|NCT02496000|561842879|FG002|Overall Study|Protocol Violation|1|||
155658423|NCT02496000|561842877|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
155658424|NCT02496000|561842878|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
155658425|NCT02496000|561842879|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
155658426|NCT02496000|561842877|FG000|Overall Study|undetermined|0|||
155658427|NCT02496000|561842878|FG001|Overall Study|undetermined|1|||
155658428|NCT02496000|561842879|FG002|Overall Study|undetermined|0|||
155658429|NCT02255656|561842880|FG000|Overall Study|Adverse Event|11|||
155658430|NCT02255656|561842880|FG000|Overall Study|Poor compliance to protocol|3|||
155658431|NCT02255656|561842880|FG000|Overall Study|Lost to Follow-up|30|||
155658432|NCT02255656|561842880|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
155658433|NCT02255656|561842880|FG000|Overall Study|Other|126|||
155658434|NCT03909971|561842881|FG000|Overall Study|Participant transition to rollover study|26|||
155658435|NCT03909971|561842882|FG001|Overall Study|Participant transition to rollover study|9|||
155658436|NCT03909971|561842881|FG000|Overall Study|Global Deterioration of Health Status|2|||
155658437|NCT03909971|561842882|FG001|Overall Study|Global Deterioration of Health Status|2|||
155658438|NCT03909971|561842881|FG000|Overall Study|Progressive Disease|28|||
155658439|NCT03909971|561842882|FG001|Overall Study|Progressive Disease|21|||
155658440|NCT03909971|561842881|FG000|Overall Study|Death|6|||
155658441|NCT03909971|561842882|FG001|Overall Study|Death|6|||
155658442|NCT03909971|561842881|FG000|Overall Study|Adverse Event|1|||
155658443|NCT03909971|561842882|FG001|Overall Study|Adverse Event|2|||
155658444|NCT03909971|561842881|FG000|Overall Study|Withdrawal by Subject|2|||
155658445|NCT03909971|561842882|FG001|Overall Study|Withdrawal by Subject|1|||
155658446|NCT03909971|561842881|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
155658447|NCT03909971|561842882|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
155658448|NCT03909971|561842881|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
155658449|NCT03909971|561842882|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
155658450|NCT03734536|561842883|FG000|Overall Study|Withdrew Consent|1|||
155658451|NCT03734536|561842884|FG001|Overall Study|Withdrew Consent|5|||
155658452|NCT03734536|561842883|FG000|Overall Study|Lost to Follow-up|10|||
155562776|NCT02393248|561486694|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
155562777|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562778|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562779|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562780|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562781|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562782|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562783|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562784|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562785|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562786|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562787|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562788|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562789|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562790|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562791|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562792|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562793|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562794|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562795|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
155562796|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562797|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
155562798|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
155562799|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562800|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
155562801|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
155562802|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Death|0|||
155562803|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Death|0|||
155562804|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Death|0|||
155562805|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Death|0|||
155562806|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Death|0|||
155562807|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Death|0|||
155562808|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Death|0|||
155562809|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Death|0|||
155562810|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Death|0|||
155562811|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Death|0|||
155562812|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Death|0|||
155562813|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Death|0|||
155562814|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Death|0|||
155562815|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Death|0|||
155562816|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Death|0|||
155562817|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Death|1|||
155562818|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Death|7|||
155562819|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Death|5|||
155562820|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Death|5|||
155562821|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Death|3|||
155562822|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Death|7|||
155562823|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Death|5|||
155562824|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Death|6|||
155562825|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Death|3|||
155562826|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Death|0|||
155562827|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562828|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562829|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562830|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562831|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562832|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562833|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562834|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562835|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562836|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562837|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562838|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562839|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562840|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562841|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562842|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562843|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562844|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562845|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562846|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
155562847|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562848|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562849|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562850|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
155562851|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
155562852|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Disease Progression|0|||
155562853|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Disease Progression|0|||
155562854|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Disease Progression|0|||
155562855|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Disease Progression|0|||
155562856|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Disease Progression|0|||
155562857|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Disease Progression|0|||
155562858|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Disease Progression|0|||
155562859|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Disease Progression|0|||
155562860|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Disease Progression|0|||
155562861|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Disease Progression|0|||
155562862|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Disease Progression|0|||
155562863|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Disease Progression|0|||
155562864|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Disease Progression|0|||
155562865|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Disease Progression|0|||
155562866|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Disease Progression|0|||
155562867|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Disease Progression|0|||
155562868|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Disease Progression|0|||
155562869|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Disease Progression|0|||
155562870|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Disease Progression|0|||
155562871|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Disease Progression|0|||
155562872|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Disease Progression|2|||
155562873|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Disease Progression|1|||
155562874|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Disease Progression|0|||
155562875|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Disease Progression|0|||
155562876|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Disease Progression|0|||
155562877|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562878|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562879|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562880|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562881|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562882|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562883|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562884|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562885|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562886|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562887|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562888|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562889|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562890|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562891|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562892|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562893|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562894|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562895|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562896|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562897|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
155562898|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
155562899|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562900|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562901|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
155562902|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155606942|NCT00236899|561649606|FG002|Overall Study|Death (Study Disease)|0|||
155606943|NCT00236899|561649607|FG003|Overall Study|Death (Study Disease)|0|||
155606944|NCT00236899|561649604|FG000|Overall Study|Death (Not Study Related)|2|||
155606945|NCT00236899|561649605|FG001|Overall Study|Death (Not Study Related)|0|||
155606946|NCT00236899|561649606|FG002|Overall Study|Death (Not Study Related)|0|||
155606947|NCT00236899|561649607|FG003|Overall Study|Death (Not Study Related)|0|||
155606948|NCT00236899|561649604|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
155606949|NCT00236899|561649605|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
155606950|NCT00236899|561649606|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
155606951|NCT00236899|561649607|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
155658453|NCT03734536|561842884|FG001|Overall Study|Lost to Follow-up|7|||
155658454|NCT01877278|561842885|FG000|Overall Study|Lost to Follow-up|3|||
155658455|NCT01877278|561842886|FG001|Overall Study|Lost to Follow-up|3|||
155658456|NCT04727151|561842890|FG000|Overall Study|Death|0|||
155658457|NCT04727151|561842891|FG001|Overall Study|Death|0|||
155658458|NCT04727151|561842892|FG002|Overall Study|Death|0|||
155562903|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562904|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562905|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562906|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562907|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562908|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562909|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562910|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562911|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562912|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562913|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562914|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562915|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562916|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562917|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562918|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562919|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562920|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562921|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562922|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
155562923|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562924|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562925|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562926|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155562927|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Adverse Event|0|||
155562928|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Adverse Event|0|||
155562929|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Adverse Event|0|||
155658459|NCT04727151|561842893|FG003|Overall Study|Death|0|||
155658460|NCT04727151|561842894|FG004|Overall Study|Death|3|||
155658461|NCT04727151|561842890|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155658462|NCT04727151|561842891|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155658463|NCT04727151|561842892|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155658464|NCT04727151|561842893|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155658465|NCT04727151|561842894|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
155658466|NCT00642759|561842895|FG000|Overall Study|Protocol Violation|1|||
155658467|NCT05185453|561842904|FG000|Overall Study|Lost to Follow-up|13|||
155658468|NCT05185453|561842905|FG001|Overall Study|Lost to Follow-up|3|||
155658469|NCT01972659|561842918|FG000|Overall Study|Protocol Violation|2|||
155658470|NCT01972659|561842919|FG001|Overall Study|Protocol Violation|2|||
155658471|NCT01972659|561842918|FG000|Overall Study|problems realted to acceleromyograph|2|||
155658472|NCT01972659|561842919|FG001|Overall Study|problems realted to acceleromyograph|1|||
155658473|NCT03814044|561842926|FG000|Overall Study|Protocol deviation|1|||
155658474|NCT02757768|561842927|FG000|Overall Study|Randomized Never Received Study Drug|3|||
155658475|NCT02757768|561842928|FG001|Overall Study|Randomized Never Received Study Drug|4|||
155658476|NCT02757768|561842927|FG000|Overall Study|Adverse Event|5|||
155658477|NCT02757768|561842928|FG001|Overall Study|Adverse Event|3|||
155658478|NCT02757768|561842927|FG000|Overall Study|Lack of Efficacy|2|||
155658479|NCT02757768|561842928|FG001|Overall Study|Lack of Efficacy|1|||
155658480|NCT02757768|561842927|FG000|Overall Study|Lost to Follow-up|1|||
155658481|NCT02757768|561842928|FG001|Overall Study|Lost to Follow-up|0|||
155658482|NCT02757768|561842927|FG000|Overall Study|Protocol Deviation|2|||
155658483|NCT02757768|561842928|FG001|Overall Study|Protocol Deviation|9|||
155658484|NCT02757768|561842927|FG000|Overall Study|Withdrawal by Subject|16|||
155658485|NCT02757768|561842928|FG001|Overall Study|Withdrawal by Subject|9|||
155658486|NCT02757768|561842927|FG000|Overall Study|Miscellaneous|4|||
155658487|NCT02757768|561842928|FG001|Overall Study|Miscellaneous|2|||
155658488|NCT00835367|561842940|FG000|Washout|Adverse Event|2|||
155562930|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Adverse Event|0|||
155562931|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Adverse Event|0|||
155562932|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Adverse Event|0|||
155562933|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Adverse Event|0|||
155562934|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Adverse Event|0|||
155562935|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Adverse Event|0|||
155562936|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Adverse Event|0|||
155562937|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Adverse Event|0|||
155562938|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Adverse Event|0|||
155562939|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Adverse Event|0|||
155562940|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Adverse Event|0|||
155562941|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Adverse Event|0|||
155562942|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Adverse Event|0|||
155562943|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Adverse Event|0|||
155562944|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Adverse Event|0|||
155562945|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Adverse Event|0|||
155562946|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Adverse Event|0|||
155562947|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Adverse Event|0|||
155606952|NCT00236899|561649604|FG000|Overall Study|Lost to Follow-up|0|||
155606953|NCT00236899|561649605|FG001|Overall Study|Lost to Follow-up|1|||
155606954|NCT00236899|561649606|FG002|Overall Study|Lost to Follow-up|0|||
155606955|NCT00236899|561649607|FG003|Overall Study|Lost to Follow-up|0|||
155606956|NCT00236899|561649604|FG000|Overall Study|Entry Criteria Exclusion|0|||
155606957|NCT00236899|561649605|FG001|Overall Study|Entry Criteria Exclusion|1|||
155606958|NCT00236899|561649606|FG002|Overall Study|Entry Criteria Exclusion|1|||
155606959|NCT00236899|561649607|FG003|Overall Study|Entry Criteria Exclusion|0|||
155606960|NCT00236899|561649604|FG000|Overall Study|Protocol Violation|1|||
155606961|NCT00236899|561649605|FG001|Overall Study|Protocol Violation|0|||
155606962|NCT00236899|561649606|FG002|Overall Study|Protocol Violation|0|||
155606963|NCT00236899|561649607|FG003|Overall Study|Protocol Violation|0|||
155606964|NCT00236899|561649604|FG000|Overall Study|Withdrawal by Subject|6|||
155606965|NCT00236899|561649605|FG001|Overall Study|Withdrawal by Subject|4|||
155606966|NCT00236899|561649606|FG002|Overall Study|Withdrawal by Subject|5|||
155606967|NCT00236899|561649607|FG003|Overall Study|Withdrawal by Subject|2|||
155606968|NCT00236899|561649604|FG000|Overall Study|Physician Decision|7|||
155606969|NCT00236899|561649605|FG001|Overall Study|Physician Decision|8|||
155606970|NCT00236899|561649606|FG002|Overall Study|Physician Decision|7|||
155606971|NCT00236899|561649607|FG003|Overall Study|Physician Decision|6|||
155606972|NCT00236899|561649604|FG000|Overall Study|Satisfactory Response|2|||
155606973|NCT00236899|561649605|FG001|Overall Study|Satisfactory Response|0|||
155606974|NCT00236899|561649606|FG002|Overall Study|Satisfactory Response|0|||
155606975|NCT00236899|561649607|FG003|Overall Study|Satisfactory Response|1|||
155606976|NCT00236899|561649604|FG000|Overall Study|Lack of Efficacy|18|||
155606977|NCT00236899|561649605|FG001|Overall Study|Lack of Efficacy|18|||
155606978|NCT00236899|561649606|FG002|Overall Study|Lack of Efficacy|25|||
155606979|NCT00236899|561649607|FG003|Overall Study|Lack of Efficacy|23|||
155606980|NCT02854605|561649608|FG000|Overall Study|Adverse Event|1|||
155606981|NCT02854605|561649609|FG001|Overall Study|Adverse Event|5|||
155606982|NCT02854605|561649610|FG002|Overall Study|Adverse Event|2|||
155606983|NCT02854605|561649608|FG000|Overall Study|Lost to Follow-up|0|||
155606984|NCT02854605|561649609|FG001|Overall Study|Lost to Follow-up|2|||
155606985|NCT02854605|561649610|FG002|Overall Study|Lost to Follow-up|0|||
155606986|NCT02854605|561649608|FG000|Overall Study|Withdrew Consent|1|||
155606987|NCT02854605|561649609|FG001|Overall Study|Withdrew Consent|0|||
155606988|NCT02854605|561649610|FG002|Overall Study|Withdrew Consent|1|||
155606989|NCT02854605|561649608|FG000|Overall Study|Investigator's Discretion|1|||
155606990|NCT02854605|561649609|FG001|Overall Study|Investigator's Discretion|0|||
155606991|NCT02854605|561649610|FG002|Overall Study|Investigator's Discretion|0|||
155606992|NCT02854605|561649608|FG000|Overall Study|Protocol Violation|0|||
155606993|NCT02854605|561649609|FG001|Overall Study|Protocol Violation|0|||
155606994|NCT02854605|561649610|FG002|Overall Study|Protocol Violation|1|||
155606995|NCT00568334|561649611|FG000|Overall Study|Withdrawal by Subject|0|||
155606996|NCT00568334|561649612|FG001|Overall Study|Withdrawal by Subject|1|||
155606997|NCT00568334|561649611|FG000|Overall Study|Lost to Follow-up|1|||
155606998|NCT00568334|561649612|FG001|Overall Study|Lost to Follow-up|0|||
155606999|NCT01897571|561649613|FG000|Overall Study|Lost to Follow-up|3|||
155607000|NCT01897571|561649614|FG001|Overall Study|Lost to Follow-up|0|||
155607001|NCT01897571|561649615|FG002|Overall Study|Lost to Follow-up|0|||
155607002|NCT01897571|561649616|FG003|Overall Study|Lost to Follow-up|0|||
155607003|NCT01897571|561649617|FG004|Overall Study|Lost to Follow-up|2|||
155607004|NCT01897571|561649618|FG005|Overall Study|Lost to Follow-up|0|||
155607005|NCT01897571|561649619|FG006|Overall Study|Lost to Follow-up|0|||
155607006|NCT01897571|561649620|FG007|Overall Study|Lost to Follow-up|0|||
155607007|NCT01897571|561649621|FG008|Overall Study|Lost to Follow-up|1|||
155562948|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Adverse Event|0|||
155562949|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Adverse Event|0|||
155562950|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Adverse Event|1|||
155562951|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Adverse Event|0|||
155562952|NCT02393248|561486670|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562953|NCT02393248|561486671|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562954|NCT02393248|561486672|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562955|NCT02393248|561486673|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562956|NCT02393248|561486674|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562957|NCT02393248|561486675|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562958|NCT02393248|561486676|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562959|NCT02393248|561486677|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562960|NCT02393248|561486678|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562961|NCT02393248|561486679|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562962|NCT02393248|561486680|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562963|NCT02393248|561486681|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562964|NCT02393248|561486682|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562965|NCT02393248|561486683|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562966|NCT02393248|561486684|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562967|NCT02393248|561486685|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562968|NCT02393248|561486686|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562969|NCT02393248|561486687|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562970|NCT02393248|561486688|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562971|NCT02393248|561486689|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562972|NCT02393248|561486690|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562973|NCT02393248|561486691|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562974|NCT02393248|561486692|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562975|NCT02393248|561486693|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
155562976|NCT02393248|561486694|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155562977|NCT02585934|561486695|FG000|Overall Study|Lost to Follow-up|2|||
155562978|NCT02585934|561486696|FG001|Overall Study|Lost to Follow-up|2|||
155562979|NCT02585934|561486695|FG000|Overall Study|Protocol Violation|14|||
155562980|NCT02585934|561486696|FG001|Overall Study|Protocol Violation|11|||
155562981|NCT02585934|561486695|FG000|Overall Study|Adverse Event|21|||
155562982|NCT02585934|561486696|FG001|Overall Study|Adverse Event|22|||
155562983|NCT02585934|561486695|FG000|Overall Study|Physician Decision|3|||
155562984|NCT02585934|561486696|FG001|Overall Study|Physician Decision|2|||
155562985|NCT02585934|561486695|FG000|Overall Study|Withdrawal by Subject|7|||
155562986|NCT02585934|561486696|FG001|Overall Study|Withdrawal by Subject|21|||
155562987|NCT02585934|561486695|FG000|Overall Study|Lack of Efficacy|2|||
155562988|NCT02585934|561486696|FG001|Overall Study|Lack of Efficacy|1|||
155562989|NCT02585934|561486695|FG000|Overall Study|Death|2|||
155562990|NCT02585934|561486696|FG001|Overall Study|Death|0|||
155562991|NCT02585934|561486695|FG000|Overall Study|Caregiver Withdrew Consent|7|||
155562992|NCT02585934|561486696|FG001|Overall Study|Caregiver Withdrew Consent|7|||
155562993|NCT02585934|561486695|FG000|Overall Study|Sponsor Termination|1|||
155562994|NCT02585934|561486696|FG001|Overall Study|Sponsor Termination|2|||
155562995|NCT02585934|561486695|FG000|Overall Study|Another Reason|10|||
155562996|NCT02585934|561486696|FG001|Overall Study|Another Reason|5|||
155562997|NCT04713553|561486697|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
155562998|NCT04713553|561486698|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
155562999|NCT04713553|561486699|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
155563000|NCT04713553|561486700|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
155563001|NCT04713553|561486701|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
155563002|NCT04713553|561486702|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
155563003|NCT04713553|561486703|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
155563004|NCT04713553|561486697|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563005|NCT04713553|561486698|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563006|NCT04713553|561486699|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563007|NCT04713553|561486700|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
155563008|NCT04713553|561486701|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563009|NCT04713553|561486702|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563010|NCT04713553|561486703|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
155563011|NCT04713553|561486697|FG000|Primary Study (2 Months)|Other|1|||
155563012|NCT04713553|561486698|FG001|Primary Study (2 Months)|Other|2|||
155563013|NCT04713553|561486699|FG002|Primary Study (2 Months)|Other|0|||
155563014|NCT04713553|561486700|FG003|Primary Study (2 Months)|Other|0|||
155563015|NCT04713553|561486701|FG004|Primary Study (2 Months)|Other|1|||
155563016|NCT04713553|561486702|FG005|Primary Study (2 Months)|Other|0|||
155563017|NCT04713553|561486703|FG006|Primary Study (2 Months)|Other|0|||
155563018|NCT04713553|561486697|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
155563019|NCT04713553|561486698|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
155563020|NCT04713553|561486699|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
155563021|NCT04713553|561486700|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
155563022|NCT04713553|561486701|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
155563023|NCT04713553|561486702|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
155563024|NCT04713553|561486703|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
155563025|NCT04713553|561486697|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563026|NCT04713553|561486698|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563027|NCT04713553|561486699|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
155563028|NCT04713553|561486700|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563029|NCT04713553|561486701|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563030|NCT04713553|561486702|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563031|NCT04713553|561486703|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
155563032|NCT02603393|561486716|FG000|Overall Study|Patient/guardian decision|32|||
155563033|NCT02603393|561486717|FG001|Overall Study|Patient/guardian decision|18|||
155563034|NCT02603393|561486716|FG000|Overall Study|Adverse Event|17|||
155563035|NCT02603393|561486717|FG001|Overall Study|Adverse Event|15|||
155563036|NCT02603393|561486716|FG000|Overall Study|Technical problems|4|||
155563037|NCT02603393|561486717|FG001|Overall Study|Technical problems|7|||
155563038|NCT02603393|561486716|FG000|Overall Study|Lack of Efficacy|7|||
155563039|NCT02603393|561486717|FG001|Overall Study|Lack of Efficacy|2|||
155563040|NCT02603393|561486716|FG000|Overall Study|Death|3|||
155563041|NCT02603393|561486717|FG001|Overall Study|Death|4|||
155563042|NCT02603393|561486716|FG000|Overall Study|Physician Decision|3|||
155563043|NCT02603393|561486717|FG001|Overall Study|Physician Decision|3|||
155563044|NCT02603393|561486716|FG000|Overall Study|Protocol deviation|2|||
155563045|NCT02603393|561486717|FG001|Overall Study|Protocol deviation|3|||
155563046|NCT02603393|561486716|FG000|Overall Study|Lost to Follow-up|1|||
155563047|NCT02603393|561486717|FG001|Overall Study|Lost to Follow-up|2|||
155563048|NCT02603393|561486716|FG000|Overall Study|Non-compliance with study treatment|1|||
155563049|NCT02603393|561486717|FG001|Overall Study|Non-compliance with study treatment|0|||
155563050|NCT02603393|561486716|FG000|Overall Study|Sponsor decision|1|||
155563051|NCT02603393|561486717|FG001|Overall Study|Sponsor decision|0|||
155563052|NCT00699374|561486718|FG000|Overall Study|Death|93|||
155563053|NCT00699374|561486719|FG001|Overall Study|Death|83|||
155563054|NCT00699374|561486718|FG000|Overall Study|Adverse Event|70|||
155563055|NCT00699374|561486719|FG001|Overall Study|Adverse Event|67|||
155563056|NCT00699374|561486718|FG000|Overall Study|Global deterioration of health status|7|||
155563057|NCT00699374|561486719|FG001|Overall Study|Global deterioration of health status|8|||
155658489|NCT00835367|561842941|FG001|Washout|Adverse Event|0|||
155658490|NCT00835367|561842940|FG000|Washout|Withdrawal by Subject|1|||
155658491|NCT00835367|561842941|FG001|Washout|Withdrawal by Subject|0|||
155658492|NCT00835367|561842940|FG000|Second Intervention|Adverse Event|1|||
155658493|NCT00835367|561842941|FG001|Second Intervention|Adverse Event|1|||
155658494|NCT05929326|561842942|FG000|Overall Study|unqualified sample|2|||
155658495|NCT05929326|561842943|FG001|Overall Study|unqualified sample|3|||
155658496|NCT05929326|561842944|FG002|Overall Study|unqualified sample|7|||
155658513|NCT02495883|561842954|FG000|Overall Study|Excessive head motion|1|||
155563058|NCT00699374|561486718|FG000|Overall Study|Lost to Follow-up|3|||
155563059|NCT00699374|561486719|FG001|Overall Study|Lost to Follow-up|5|||
155563060|NCT00699374|561486718|FG000|Overall Study|Withdrawal by Subject|34|||
155658514|NCT02495883|561842955|FG001|Overall Study|Excessive head motion|0|||
155658515|NCT03557502|561842956|FG000|Protocol 2|Withdrawal by Subject|1|||
155658516|NCT03557502|561842957|FG001|Protocol 2|Withdrawal by Subject|1|||
155563061|NCT00699374|561486719|FG001|Overall Study|Withdrawal by Subject|44|||
155563062|NCT00699374|561486718|FG000|Overall Study|Objective progression or relapse|281|||
155563063|NCT00699374|561486719|FG001|Overall Study|Objective progression or relapse|277|||
155563064|NCT00699374|561486718|FG000|Overall Study|Other|18|||
155563065|NCT00699374|561486719|FG001|Overall Study|Other|15|||
155563066|NCT00699374|561486718|FG000|Overall Study|Protocol Violation|2|||
155563067|NCT00699374|561486719|FG001|Overall Study|Protocol Violation|6|||
155563068|NCT00699374|561486718|FG000|Overall Study|Study terminated by sponsor|13|||
155563069|NCT00699374|561486719|FG001|Overall Study|Study terminated by sponsor|28|||
155563070|NCT00699374|561486718|FG000|Overall Study|Randomized but not treated|4|||
155563071|NCT00699374|561486719|FG001|Overall Study|Randomized but not treated|2|||
155563072|NCT00699374|561486718|FG000|Overall Study|Died 28 days after last dose|5|||
155563073|NCT00699374|561486719|FG001|Overall Study|Died 28 days after last dose|9|||
155563074|NCT01359969|561486723|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
155563075|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
155563076|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
155563077|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
155563078|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
155563079|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
155563080|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
155563081|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
155563082|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
155563083|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
155563084|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
155563085|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
155563086|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
155563087|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
155563088|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
155563089|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
155563090|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
155563091|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
155563092|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
155563093|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
155563094|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
155563095|NCT00593736|561486727|FG000|Screening Period and Placebo Run-in|Various|0|||
155563096|NCT00593736|561486728|FG001|Screening Period and Placebo Run-in|Various|0|||
155563097|NCT00593736|561486729|FG002|Screening Period and Placebo Run-in|Various|0|||
155563098|NCT00593736|561486730|FG003|Screening Period and Placebo Run-in|Various|25|||
155563099|NCT00593736|561486727|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
155563100|NCT00593736|561486728|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
155563101|NCT00593736|561486729|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
155563102|NCT00593736|561486730|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
155563103|NCT00593736|561486727|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
155563104|NCT00593736|561486728|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
155563105|NCT00593736|561486729|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
155563106|NCT00593736|561486730|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
155563107|NCT00593736|561486727|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
155563108|NCT00593736|561486728|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
155563109|NCT00593736|561486729|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
155563110|NCT00593736|561486730|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
155563111|NCT00593736|561486727|FG000|Treatment Period and Placebo Run-out|Various|1|||
155563112|NCT00593736|561486728|FG001|Treatment Period and Placebo Run-out|Various|1|||
155563113|NCT00593736|561486729|FG002|Treatment Period and Placebo Run-out|Various|1|||
155563114|NCT00593736|561486730|FG003|Treatment Period and Placebo Run-out|Various|0|||
155563115|NCT01857271|561486731|FG000|Overall Study|Lost to Follow-up|1|||
155563116|NCT04729309|561486736|FG000|Period 1|Subject unable to return for Period 2|3|||
155563117|NCT04729309|561486737|FG001|Period 1|Subject unable to return for Period 2|0|||
155563118|NCT04729309|561486736|FG000|Period 1|Lost to Follow-up|1|||
155563119|NCT04729309|561486737|FG001|Period 1|Lost to Follow-up|0|||
155563120|NCT03597529|561486742|FG000|Overall Study|Lost to Follow-up|10|||
155563121|NCT03597529|561486743|FG001|Overall Study|Lost to Follow-up|12|||
155563122|NCT03597529|561486742|FG000|Overall Study|Physician Decision|3|||
155563123|NCT03597529|561486743|FG001|Overall Study|Physician Decision|1|||
155563124|NCT03597529|561486742|FG000|Overall Study|Withdrawal by Subject|6|||
155563125|NCT03597529|561486743|FG001|Overall Study|Withdrawal by Subject|3|||
155563126|NCT03597529|561486742|FG000|Overall Study|Non-compliant with study activities|1|||
155563127|NCT03597529|561486743|FG001|Overall Study|Non-compliant with study activities|2|||
155563128|NCT04623086|561486746|FG000|Overall Study|Withdrawal by Subject|0|||
155563129|NCT04623086|561486747|FG001|Overall Study|Withdrawal by Subject|0|||
155563130|NCT04623086|561486748|FG002|Overall Study|Withdrawal by Subject|10|||
155563131|NCT03196635|561486750|FG000|Overall Study|Withdrawal by Subject|1|||
155563132|NCT04154631|561486756|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
155563133|NCT04154631|561486757|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
155563134|NCT01441947|561486758|FG000|Overall Study|Withdrawal by Subject|3|||
155563135|NCT01441947|561486759|FG001|Overall Study|Withdrawal by Subject|0|||
155563136|NCT02238795|561486760|FG000|Overall Study|Patient without purpura fulminans|1|||
155563137|NCT05187013|561486762|FG000|Overall Study|Withdrawal by Subject|1|||
155563138|NCT05187013|561486763|FG001|Overall Study|Withdrawal by Subject|1|||
155563139|NCT05187013|561486764|FG002|Overall Study|Withdrawal by Subject|0|||
155563140|NCT05187013|561486762|FG000|Overall Study|Death|0|||
155563141|NCT05187013|561486763|FG001|Overall Study|Death|1|||
155563142|NCT05187013|561486764|FG002|Overall Study|Death|0|||
155563143|NCT05187013|561486762|FG000|Overall Study|Lost to Follow-up|20|||
155563144|NCT05187013|561486763|FG001|Overall Study|Lost to Follow-up|17|||
155563145|NCT05187013|561486764|FG002|Overall Study|Lost to Follow-up|0|||
155563146|NCT05187013|561486762|FG000|Overall Study|Ongoing Participants|3|||
155563147|NCT05187013|561486763|FG001|Overall Study|Ongoing Participants|5|||
155563148|NCT05187013|561486764|FG002|Overall Study|Ongoing Participants|0|||
155563149|NCT02387983|561486765|FG000|Overall Study|Adverse Event|4|||
155563150|NCT02387983|561486765|FG000|Overall Study|Protocol Violation|1|||
155563151|NCT02387983|561486765|FG000|Overall Study|Withdrawal by Subject|2|||
155563152|NCT04159935|561486766|FG000|Overall Study|Study terminated due to COVID-19|1|||
155563153|NCT04159935|561486767|FG001|Overall Study|Study terminated due to COVID-19|3|||
155563154|NCT01341782|561486768|FG000|Overall Study|Adverse Event|1|||
155563155|NCT01341782|561486769|FG001|Overall Study|Adverse Event|1|||
155563156|NCT01341782|561486768|FG000|Overall Study|Withdrawal by Subject|6|||
155563157|NCT01341782|561486769|FG001|Overall Study|Withdrawal by Subject|5|||
155563158|NCT01341782|561486768|FG000|Overall Study|Missed 3 consecutive doses|0|||
155563159|NCT01341782|561486769|FG001|Overall Study|Missed 3 consecutive doses|4|||
155563160|NCT01341782|561486768|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
155563161|NCT01341782|561486769|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
155563162|NCT01341782|561486768|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
155563163|NCT01341782|561486769|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
155563164|NCT01341782|561486768|FG000|Overall Study|Other|5|||
155563165|NCT01341782|561486769|FG001|Overall Study|Other|0|||
155563166|NCT00724048|561486772|FG000|Overall Study|Adverse Event|1|||
155563167|NCT00724048|561486773|FG001|Overall Study|Adverse Event|1|||
155563168|NCT00724048|561486774|FG002|Overall Study|Adverse Event|1|||
155563169|NCT00724048|561486775|FG003|Overall Study|Adverse Event|0|||
155563170|NCT00724048|561486772|FG000|Overall Study|Lost to Follow-up|0|||
155563171|NCT00724048|561486773|FG001|Overall Study|Lost to Follow-up|1|||
155563172|NCT00724048|561486774|FG002|Overall Study|Lost to Follow-up|0|||
155563173|NCT00724048|561486775|FG003|Overall Study|Lost to Follow-up|0|||
155563174|NCT00724048|561486772|FG000|Overall Study|Withdrawal by Subject|1|||
155563175|NCT00724048|561486773|FG001|Overall Study|Withdrawal by Subject|2|||
155563176|NCT00724048|561486774|FG002|Overall Study|Withdrawal by Subject|1|||
155563177|NCT00724048|561486775|FG003|Overall Study|Withdrawal by Subject|2|||
155563178|NCT00724048|561486772|FG000|Overall Study|Investigator decision|0|||
155563179|NCT00724048|561486773|FG001|Overall Study|Investigator decision|0|||
155563180|NCT00724048|561486774|FG002|Overall Study|Investigator decision|1|||
155563181|NCT00724048|561486775|FG003|Overall Study|Investigator decision|0|||
155563182|NCT00724048|561486772|FG000|Overall Study|Did not tolerate study drug|0|||
155563183|NCT00724048|561486773|FG001|Overall Study|Did not tolerate study drug|0|||
155563184|NCT00724048|561486774|FG002|Overall Study|Did not tolerate study drug|0|||
155563185|NCT00724048|561486775|FG003|Overall Study|Did not tolerate study drug|1|||
155563186|NCT00724048|561486772|FG000|Overall Study|Other than specified|1|||
155563187|NCT00724048|561486773|FG001|Overall Study|Other than specified|1|||
155563188|NCT00724048|561486774|FG002|Overall Study|Other than specified|0|||
155563189|NCT00724048|561486775|FG003|Overall Study|Other than specified|0|||
155563190|NCT00587990|561486778|FG000|Overall Study|Death|0|||
155563191|NCT00587990|561486779|FG001|Overall Study|Death|0|||
155563192|NCT00587990|561486780|FG002|Overall Study|Death|1|||
155563193|NCT00206323|561486783|FG000|Overall Study|Lack of Efficacy|4|||
155563194|NCT00206323|561486784|FG001|Overall Study|Lack of Efficacy|1|||
155563195|NCT00206323|561486783|FG000|Overall Study|Adverse Event|1|||
155563196|NCT00206323|561486784|FG001|Overall Study|Adverse Event|1|||
155658517|NCT03557502|561842956|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
155563197|NCT00206323|561486783|FG000|Overall Study|Lost to Follow-up|1|||
155563198|NCT00206323|561486784|FG001|Overall Study|Lost to Follow-up|1|||
155563199|NCT03334617|561486785|FG000|Overall Study|Adverse Event|0|||
155563200|NCT03334617|561486786|FG001|Overall Study|Adverse Event|0|||
155563201|NCT03334617|561486787|FG002|Overall Study|Adverse Event|0|||
155563202|NCT03334617|561486788|FG003|Overall Study|Adverse Event|0|||
155563203|NCT03334617|561486789|FG004|Overall Study|Adverse Event|0|||
155563204|NCT03334617|561486790|FG005|Overall Study|Adverse Event|0|||
155563205|NCT03334617|561486791|FG006|Overall Study|Adverse Event|0|||
155563206|NCT03334617|561486792|FG007|Overall Study|Adverse Event|0|||
155563207|NCT03334617|561486793|FG008|Overall Study|Adverse Event|1|||
155563208|NCT03334617|561486794|FG009|Overall Study|Adverse Event|0|||
155563209|NCT03334617|561486795|FG010|Overall Study|Adverse Event|0|||
155563210|NCT03334617|561486796|FG011|Overall Study|Adverse Event|0|||
155563211|NCT03334617|561486797|FG012|Overall Study|Adverse Event|1|||
155563212|NCT03334617|561486798|FG013|Overall Study|Adverse Event|0|||
155563213|NCT03334617|561486799|FG014|Overall Study|Adverse Event|0|||
155563214|NCT03334617|561486800|FG015|Overall Study|Adverse Event|0|||
155563215|NCT03334617|561486801|FG016|Overall Study|Adverse Event|0|||
155563216|NCT03334617|561486802|FG017|Overall Study|Adverse Event|0|||
155563217|NCT03334617|561486803|FG018|Overall Study|Adverse Event|0|||
155563218|NCT03334617|561486804|FG019|Overall Study|Adverse Event|0|||
155563219|NCT03334617|561486805|FG020|Overall Study|Adverse Event|0|||
155563220|NCT03334617|561486806|FG021|Overall Study|Adverse Event|0|||
155563221|NCT03334617|561486785|FG000|Overall Study|Death|18|||
155563222|NCT03334617|561486786|FG001|Overall Study|Death|18|||
155563223|NCT03334617|561486787|FG002|Overall Study|Death|20|||
155563224|NCT03334617|561486788|FG003|Overall Study|Death|21|||
155563225|NCT03334617|561486789|FG004|Overall Study|Death|20|||
155563226|NCT03334617|561486790|FG005|Overall Study|Death|16|||
155563227|NCT03334617|561486791|FG006|Overall Study|Death|28|||
155563228|NCT03334617|561486792|FG007|Overall Study|Death|35|||
155563229|NCT03334617|561486793|FG008|Overall Study|Death|47|||
155563230|NCT03334617|561486794|FG009|Overall Study|Death|0|||
155563231|NCT03334617|561486795|FG010|Overall Study|Death|19|||
155563232|NCT03334617|561486796|FG011|Overall Study|Death|6|||
155563233|NCT03334617|561486797|FG012|Overall Study|Death|20|||
155563234|NCT03334617|561486798|FG013|Overall Study|Death|22|||
155563235|NCT03334617|561486799|FG014|Overall Study|Death|17|||
155563236|NCT03334617|561486800|FG015|Overall Study|Death|18|||
155563237|NCT03334617|561486801|FG016|Overall Study|Death|12|||
155563238|NCT03334617|561486802|FG017|Overall Study|Death|15|||
155563239|NCT03334617|561486803|FG018|Overall Study|Death|16|||
155563240|NCT03334617|561486804|FG019|Overall Study|Death|27|||
155563241|NCT03334617|561486805|FG020|Overall Study|Death|14|||
155563242|NCT03334617|561486806|FG021|Overall Study|Death|27|||
155563243|NCT03334617|561486785|FG000|Overall Study|Lost to Follow-up|0|||
155563244|NCT03334617|561486786|FG001|Overall Study|Lost to Follow-up|0|||
155563245|NCT03334617|561486787|FG002|Overall Study|Lost to Follow-up|0|||
155563246|NCT03334617|561486788|FG003|Overall Study|Lost to Follow-up|1|||
155563247|NCT03334617|561486789|FG004|Overall Study|Lost to Follow-up|0|||
155563248|NCT03334617|561486790|FG005|Overall Study|Lost to Follow-up|1|||
155563249|NCT03334617|561486791|FG006|Overall Study|Lost to Follow-up|0|||
155563250|NCT03334617|561486792|FG007|Overall Study|Lost to Follow-up|0|||
155563251|NCT03334617|561486793|FG008|Overall Study|Lost to Follow-up|1|||
155563252|NCT03334617|561486794|FG009|Overall Study|Lost to Follow-up|0|||
155563253|NCT03334617|561486795|FG010|Overall Study|Lost to Follow-up|0|||
155563254|NCT03334617|561486796|FG011|Overall Study|Lost to Follow-up|0|||
155563255|NCT03334617|561486797|FG012|Overall Study|Lost to Follow-up|0|||
155563256|NCT03334617|561486798|FG013|Overall Study|Lost to Follow-up|0|||
155563257|NCT03334617|561486799|FG014|Overall Study|Lost to Follow-up|0|||
155563258|NCT03334617|561486800|FG015|Overall Study|Lost to Follow-up|0|||
155563259|NCT03334617|561486801|FG016|Overall Study|Lost to Follow-up|0|||
155563260|NCT03334617|561486802|FG017|Overall Study|Lost to Follow-up|0|||
155563261|NCT03334617|561486803|FG018|Overall Study|Lost to Follow-up|0|||
155563262|NCT03334617|561486804|FG019|Overall Study|Lost to Follow-up|0|||
155563263|NCT03334617|561486805|FG020|Overall Study|Lost to Follow-up|0|||
155563264|NCT03334617|561486806|FG021|Overall Study|Lost to Follow-up|0|||
155563265|NCT03334617|561486785|FG000|Overall Study|Withdrawal by Subject|0|||
155563266|NCT03334617|561486786|FG001|Overall Study|Withdrawal by Subject|1|||
155563267|NCT03334617|561486787|FG002|Overall Study|Withdrawal by Subject|0|||
155563268|NCT03334617|561486788|FG003|Overall Study|Withdrawal by Subject|0|||
155563269|NCT03334617|561486789|FG004|Overall Study|Withdrawal by Subject|1|||
155563270|NCT03334617|561486790|FG005|Overall Study|Withdrawal by Subject|1|||
155563271|NCT03334617|561486791|FG006|Overall Study|Withdrawal by Subject|1|||
155563272|NCT03334617|561486792|FG007|Overall Study|Withdrawal by Subject|2|||
155563273|NCT03334617|561486793|FG008|Overall Study|Withdrawal by Subject|0|||
155563274|NCT03334617|561486794|FG009|Overall Study|Withdrawal by Subject|0|||
155563275|NCT03334617|561486795|FG010|Overall Study|Withdrawal by Subject|0|||
155563276|NCT03334617|561486796|FG011|Overall Study|Withdrawal by Subject|1|||
155563277|NCT03334617|561486797|FG012|Overall Study|Withdrawal by Subject|1|||
155563278|NCT03334617|561486798|FG013|Overall Study|Withdrawal by Subject|0|||
155563279|NCT03334617|561486799|FG014|Overall Study|Withdrawal by Subject|2|||
155563280|NCT03334617|561486800|FG015|Overall Study|Withdrawal by Subject|1|||
155563281|NCT03334617|561486801|FG016|Overall Study|Withdrawal by Subject|0|||
155563282|NCT03334617|561486802|FG017|Overall Study|Withdrawal by Subject|1|||
155563283|NCT03334617|561486803|FG018|Overall Study|Withdrawal by Subject|1|||
155563284|NCT03334617|561486804|FG019|Overall Study|Withdrawal by Subject|1|||
155563285|NCT03334617|561486805|FG020|Overall Study|Withdrawal by Subject|0|||
155563286|NCT03334617|561486806|FG021|Overall Study|Withdrawal by Subject|1|||
155563287|NCT03334617|561486785|FG000|Overall Study|Other|1|||
155563288|NCT03334617|561486786|FG001|Overall Study|Other|2|||
155563289|NCT03334617|561486787|FG002|Overall Study|Other|0|||
155563290|NCT03334617|561486788|FG003|Overall Study|Other|1|||
155563291|NCT03334617|561486789|FG004|Overall Study|Other|1|||
155563292|NCT03334617|561486790|FG005|Overall Study|Other|0|||
155563293|NCT03334617|561486791|FG006|Overall Study|Other|2|||
155563294|NCT03334617|561486792|FG007|Overall Study|Other|1|||
155563295|NCT03334617|561486793|FG008|Overall Study|Other|8|||
155563296|NCT03334617|561486794|FG009|Overall Study|Other|0|||
155563297|NCT03334617|561486795|FG010|Overall Study|Other|3|||
155563298|NCT03334617|561486796|FG011|Overall Study|Other|1|||
155563299|NCT03334617|561486797|FG012|Overall Study|Other|3|||
155563300|NCT03334617|561486798|FG013|Overall Study|Other|1|||
155563301|NCT03334617|561486799|FG014|Overall Study|Other|1|||
155563302|NCT03334617|561486800|FG015|Overall Study|Other|3|||
155563303|NCT03334617|561486801|FG016|Overall Study|Other|3|||
155563304|NCT03334617|561486802|FG017|Overall Study|Other|3|||
155563305|NCT03334617|561486803|FG018|Overall Study|Other|7|||
155563306|NCT03334617|561486804|FG019|Overall Study|Other|4|||
155563307|NCT03334617|561486805|FG020|Overall Study|Other|1|||
155563308|NCT03334617|561486806|FG021|Overall Study|Other|4|||
155563309|NCT03334617|561486785|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
155563310|NCT03334617|561486786|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
155563311|NCT03334617|561486787|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
155563312|NCT03334617|561486788|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
155563313|NCT03334617|561486789|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
155563314|NCT03334617|561486790|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
155563315|NCT03334617|561486791|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
155563316|NCT03334617|561486792|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
155563317|NCT03334617|561486793|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
155563318|NCT03334617|561486794|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
155563319|NCT03334617|561486795|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
155563320|NCT03334617|561486796|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
155563321|NCT03334617|561486797|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
155563322|NCT03334617|561486798|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
155563323|NCT03334617|561486799|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
155563324|NCT03334617|561486800|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
155563325|NCT03334617|561486801|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
155563326|NCT03334617|561486802|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
155563327|NCT03334617|561486803|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
155563328|NCT03334617|561486804|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
155563329|NCT03334617|561486805|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
155563330|NCT03334617|561486806|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
155563331|NCT02329847|561486807|FG000|Overall Study|Death|4|||
155563332|NCT02329847|561486808|FG001|Overall Study|Death|4|||
155563333|NCT02329847|561486809|FG002|Overall Study|Death|22|||
155563334|NCT02329847|561486810|FG003|Overall Study|Death|12|||
155563335|NCT02329847|561486811|FG004|Overall Study|Death|20|||
155563336|NCT02329847|561486812|FG005|Overall Study|Death|13|||
155563337|NCT02329847|561486807|FG000|Overall Study|Lost to Follow-up|0|||
155563338|NCT02329847|561486808|FG001|Overall Study|Lost to Follow-up|0|||
155563339|NCT02329847|561486809|FG002|Overall Study|Lost to Follow-up|2|||
155563340|NCT02329847|561486810|FG003|Overall Study|Lost to Follow-up|3|||
155563341|NCT02329847|561486811|FG004|Overall Study|Lost to Follow-up|0|||
155563342|NCT02329847|561486812|FG005|Overall Study|Lost to Follow-up|1|||
155563343|NCT02329847|561486807|FG000|Overall Study|Physician Decision|0|||
155563344|NCT02329847|561486808|FG001|Overall Study|Physician Decision|0|||
155563345|NCT02329847|561486809|FG002|Overall Study|Physician Decision|0|||
155563346|NCT02329847|561486810|FG003|Overall Study|Physician Decision|0|||
155563347|NCT02329847|561486811|FG004|Overall Study|Physician Decision|1|||
155563348|NCT02329847|561486812|FG005|Overall Study|Physician Decision|0|||
155563349|NCT02329847|561486807|FG000|Overall Study|Withdrawal by Subject|2|||
155563350|NCT02329847|561486808|FG001|Overall Study|Withdrawal by Subject|1|||
155563351|NCT02329847|561486809|FG002|Overall Study|Withdrawal by Subject|5|||
155563352|NCT02329847|561486810|FG003|Overall Study|Withdrawal by Subject|7|||
155563353|NCT02329847|561486811|FG004|Overall Study|Withdrawal by Subject|8|||
155563354|NCT02329847|561486812|FG005|Overall Study|Withdrawal by Subject|3|||
155563355|NCT02329847|561486807|FG000|Overall Study|Other|1|||
155563356|NCT02329847|561486808|FG001|Overall Study|Other|2|||
155563357|NCT02329847|561486809|FG002|Overall Study|Other|6|||
155563358|NCT02329847|561486810|FG003|Overall Study|Other|13|||
155563359|NCT02329847|561486811|FG004|Overall Study|Other|10|||
155563360|NCT02329847|561486812|FG005|Overall Study|Other|3|||
155563361|NCT03657342|561486813|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
155563362|NCT03657342|561486814|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
155563363|NCT03657342|561486813|FG000|Overall Study|Withdrawal by Subject|4|||
155563364|NCT03657342|561486814|FG001|Overall Study|Withdrawal by Subject|4|||
155563365|NCT03657342|561486813|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
155563366|NCT03657342|561486814|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
155563367|NCT03657342|561486813|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
155563368|NCT03657342|561486814|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
155563369|NCT00407758|561486815|FG000|Overall Study|ineligible -improper prior treatment|1|||
155563370|NCT00750308|561486816|FG000|First Treatment|Adverse Event|0|||
155563371|NCT00750308|561486817|FG001|First Treatment|Adverse Event|1|||
155563372|NCT00750308|561486818|FG002|First Treatment|Adverse Event|0|||
155563373|NCT00750308|561486819|FG003|First Treatment|Adverse Event|0|||
155563374|NCT00750308|561486820|FG004|First Treatment|Adverse Event|0|||
155563375|NCT00750308|561486821|FG005|First Treatment|Adverse Event|0|||
155563376|NCT00750308|561486822|FG006|First Treatment|Adverse Event|0|||
155563377|NCT00750308|561486823|FG007|First Treatment|Adverse Event|0|||
155563378|NCT00750308|561486824|FG008|First Treatment|Adverse Event|0|||
155563379|NCT00750308|561486825|FG009|First Treatment|Adverse Event|0|||
155563380|NCT00750308|561486826|FG010|First Treatment|Adverse Event|1|||
155563381|NCT00750308|561486827|FG011|First Treatment|Adverse Event|1|||
155563382|NCT00750308|561486816|FG000|First Treatment|Withdrawal by Subject|0|||
155563383|NCT00750308|561486817|FG001|First Treatment|Withdrawal by Subject|0|||
155563384|NCT00750308|561486818|FG002|First Treatment|Withdrawal by Subject|0|||
155563385|NCT00750308|561486819|FG003|First Treatment|Withdrawal by Subject|1|||
155563386|NCT00750308|561486820|FG004|First Treatment|Withdrawal by Subject|0|||
155563387|NCT00750308|561486821|FG005|First Treatment|Withdrawal by Subject|0|||
155563388|NCT00750308|561486822|FG006|First Treatment|Withdrawal by Subject|0|||
155563389|NCT00750308|561486823|FG007|First Treatment|Withdrawal by Subject|1|||
155563390|NCT00750308|561486824|FG008|First Treatment|Withdrawal by Subject|0|||
155563391|NCT00750308|561486825|FG009|First Treatment|Withdrawal by Subject|0|||
155563392|NCT00750308|561486826|FG010|First Treatment|Withdrawal by Subject|0|||
155563393|NCT00750308|561486827|FG011|First Treatment|Withdrawal by Subject|0|||
155563394|NCT00750308|561486816|FG000|Second Treatment|Adverse Event|0|||
155563395|NCT00750308|561486817|FG001|Second Treatment|Adverse Event|0|||
155563396|NCT00750308|561486818|FG002|Second Treatment|Adverse Event|0|||
155563397|NCT00750308|561486819|FG003|Second Treatment|Adverse Event|0|||
155563398|NCT00750308|561486820|FG004|Second Treatment|Adverse Event|0|||
155563399|NCT00750308|561486821|FG005|Second Treatment|Adverse Event|1|||
155563400|NCT00750308|561486822|FG006|Second Treatment|Adverse Event|0|||
155563401|NCT00750308|561486823|FG007|Second Treatment|Adverse Event|0|||
155563402|NCT00750308|561486824|FG008|Second Treatment|Adverse Event|1|||
155563403|NCT00750308|561486825|FG009|Second Treatment|Adverse Event|0|||
155563404|NCT00750308|561486826|FG010|Second Treatment|Adverse Event|0|||
155563405|NCT00750308|561486827|FG011|Second Treatment|Adverse Event|0|||
155563406|NCT00750308|561486816|FG000|Second Treatment|Withdrawal by Subject|0|||
155563407|NCT00750308|561486817|FG001|Second Treatment|Withdrawal by Subject|0|||
155563408|NCT00750308|561486818|FG002|Second Treatment|Withdrawal by Subject|0|||
155563409|NCT00750308|561486819|FG003|Second Treatment|Withdrawal by Subject|0|||
155563410|NCT00750308|561486820|FG004|Second Treatment|Withdrawal by Subject|1|||
155563411|NCT00750308|561486821|FG005|Second Treatment|Withdrawal by Subject|0|||
155563412|NCT00750308|561486822|FG006|Second Treatment|Withdrawal by Subject|0|||
155563413|NCT00750308|561486823|FG007|Second Treatment|Withdrawal by Subject|0|||
155563414|NCT00750308|561486824|FG008|Second Treatment|Withdrawal by Subject|0|||
155563415|NCT00750308|561486825|FG009|Second Treatment|Withdrawal by Subject|0|||
155563416|NCT00750308|561486826|FG010|Second Treatment|Withdrawal by Subject|0|||
155563417|NCT00750308|561486827|FG011|Second Treatment|Withdrawal by Subject|0|||
155563418|NCT00750308|561486816|FG000|Third Treatment|Withdrawal by Subject|0|||
155563419|NCT00750308|561486817|FG001|Third Treatment|Withdrawal by Subject|1|||
155563420|NCT00750308|561486818|FG002|Third Treatment|Withdrawal by Subject|0|||
155563421|NCT00750308|561486819|FG003|Third Treatment|Withdrawal by Subject|0|||
155563422|NCT00750308|561486820|FG004|Third Treatment|Withdrawal by Subject|0|||
155563423|NCT00750308|561486821|FG005|Third Treatment|Withdrawal by Subject|0|||
155563424|NCT00750308|561486822|FG006|Third Treatment|Withdrawal by Subject|0|||
155563425|NCT00750308|561486823|FG007|Third Treatment|Withdrawal by Subject|0|||
155563426|NCT00750308|561486824|FG008|Third Treatment|Withdrawal by Subject|0|||
155563427|NCT00750308|561486825|FG009|Third Treatment|Withdrawal by Subject|0|||
155563428|NCT00750308|561486826|FG010|Third Treatment|Withdrawal by Subject|0|||
155563429|NCT00750308|561486827|FG011|Third Treatment|Withdrawal by Subject|0|||
155563430|NCT02980874|561486828|FG000|Overall Study|Adverse Event|2|||
155563431|NCT02980874|561486829|FG001|Overall Study|Adverse Event|7|||
155563432|NCT02980874|561486828|FG000|Overall Study|Withdrawal by Subject|7|||
155563433|NCT02980874|561486829|FG001|Overall Study|Withdrawal by Subject|2|||
155563434|NCT02980874|561486828|FG000|Overall Study|Lost to Follow-up|5|||
155563435|NCT02980874|561486829|FG001|Overall Study|Lost to Follow-up|5|||
155607008|NCT01897571|561649622|FG009|Overall Study|Lost to Follow-up|2|||
155563436|NCT02980874|561486828|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
155563437|NCT02980874|561486829|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
155563438|NCT02980874|561486828|FG000|Overall Study|Unknown study completion status|1|||
155563439|NCT02980874|561486829|FG001|Overall Study|Unknown study completion status|0|||
155563440|NCT03258853|561486838|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
155563441|NCT03258853|561486839|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
155563442|NCT01709838|561486840|FG000|Overall Study|Withdrawal by Subject|21|||
155563443|NCT01709838|561486840|FG000|Overall Study|Lost to Follow-up|16|||
155563444|NCT01709838|561486840|FG000|Overall Study|Pregnancy|10|||
155563445|NCT01709838|561486840|FG000|Overall Study|Subject/guardian decision|8|||
155563446|NCT01709838|561486840|FG000|Overall Study|Adverse Event|4|||
155563447|NCT01709838|561486840|FG000|Overall Study|Physician Decision|4|||
155563448|NCT01709838|561486840|FG000|Overall Study|Death|3|||
155563449|NCT01709838|561486840|FG000|Overall Study|Protocol Violation|1|||
155563450|NCT00968799|561486841|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
155563451|NCT03907462|561486844|FG000|Overall Study|Physician Decision|1|||
155563452|NCT03907462|561486845|FG001|Overall Study|Physician Decision|3|||
155563453|NCT03907462|561486846|FG002|Overall Study|Physician Decision|1|||
155563454|NCT03907462|561486844|FG000|Overall Study|Withdrawal by Subject|6|||
155563455|NCT03907462|561486845|FG001|Overall Study|Withdrawal by Subject|3|||
155563456|NCT03907462|561486846|FG002|Overall Study|Withdrawal by Subject|3|||
155563457|NCT03907462|561486844|FG000|Overall Study|Pregnancy|4|||
155563458|NCT03907462|561486845|FG001|Overall Study|Pregnancy|2|||
155563459|NCT03907462|561486846|FG002|Overall Study|Pregnancy|6|||
155563460|NCT03907462|561486844|FG000|Overall Study|Lost to Follow-up|16|||
155563461|NCT03907462|561486845|FG001|Overall Study|Lost to Follow-up|18|||
155563462|NCT03907462|561486846|FG002|Overall Study|Lost to Follow-up|22|||
155563463|NCT04639713|561486847|FG000|Overall Study|Protocol Noncompliance|2|||
155563464|NCT04639713|561486847|FG000|Overall Study|Withdrawal by Subject|1|||
155563465|NCT01555671|561488987|FG000|Overall Study|Physician Decision|20|||
155563466|NCT01555671|561488988|FG001|Overall Study|Physician Decision|25|||
155563467|NCT03047330|561488989|FG000|Sleep Block 1|Withdrawal by Subject|3|||
155563468|NCT03929757|561488990|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
155563469|NCT03929757|561488991|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
155563470|NCT03929757|561488992|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
155563471|NCT03929757|561488990|FG000|Main Study: Up to Day 365|Other|1|||
155563472|NCT03929757|561488991|FG001|Main Study: Up to Day 365|Other|0|||
155563473|NCT03929757|561488992|FG002|Main Study: Up to Day 365|Other|0|||
155563474|NCT03929757|561488990|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
155563475|NCT03929757|561488991|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
155563476|NCT03929757|561488992|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
155563477|NCT01154816|561488993|FG000|Overall Study|Withdrawal by Subject|1|||
155563478|NCT01154816|561488994|FG001|Overall Study|Withdrawal by Subject|0|||
155563479|NCT01154816|561488995|FG002|Overall Study|Withdrawal by Subject|0|||
155563480|NCT01154816|561488996|FG003|Overall Study|Withdrawal by Subject|1|||
155563481|NCT01154816|561488997|FG004|Overall Study|Withdrawal by Subject|0|||
155563482|NCT01154816|561488998|FG005|Overall Study|Withdrawal by Subject|0|||
155563483|NCT01154816|561488999|FG006|Overall Study|Withdrawal by Subject|0|||
155563484|NCT01154816|561489000|FG007|Overall Study|Withdrawal by Subject|0|||
155563485|NCT01154816|561489001|FG008|Overall Study|Withdrawal by Subject|1|||
155563486|NCT01154816|561489002|FG009|Overall Study|Withdrawal by Subject|3|||
155563487|NCT01154816|561489003|FG010|Overall Study|Withdrawal by Subject|0|||
155563488|NCT01154816|561489004|FG011|Overall Study|Withdrawal by Subject|0|||
155563489|NCT01154816|561488993|FG000|Overall Study|Progressive Disease|13|||
155563490|NCT01154816|561488994|FG001|Overall Study|Progressive Disease|8|||
155563491|NCT01154816|561488995|FG002|Overall Study|Progressive Disease|9|||
155563492|NCT01154816|561488996|FG003|Overall Study|Progressive Disease|9|||
155563493|NCT01154816|561488997|FG004|Overall Study|Progressive Disease|8|||
155563494|NCT01154816|561488998|FG005|Overall Study|Progressive Disease|8|||
155563495|NCT01154816|561488999|FG006|Overall Study|Progressive Disease|5|||
155563496|NCT01154816|561489000|FG007|Overall Study|Progressive Disease|6|||
155563497|NCT01154816|561489001|FG008|Overall Study|Progressive Disease|8|||
155563498|NCT01154816|561489002|FG009|Overall Study|Progressive Disease|6|||
155563499|NCT01154816|561489003|FG010|Overall Study|Progressive Disease|10|||
155563500|NCT01154816|561489004|FG011|Overall Study|Progressive Disease|3|||
155563501|NCT01154816|561488993|FG000|Overall Study|Physician Decision|1|||
155563502|NCT01154816|561488994|FG001|Overall Study|Physician Decision|0|||
155563503|NCT01154816|561488995|FG002|Overall Study|Physician Decision|1|||
155563504|NCT01154816|561488996|FG003|Overall Study|Physician Decision|0|||
155563505|NCT01154816|561488997|FG004|Overall Study|Physician Decision|2|||
155563506|NCT01154816|561488998|FG005|Overall Study|Physician Decision|0|||
155563507|NCT01154816|561488999|FG006|Overall Study|Physician Decision|0|||
155563508|NCT01154816|561489000|FG007|Overall Study|Physician Decision|0|||
155563509|NCT01154816|561489001|FG008|Overall Study|Physician Decision|0|||
155563510|NCT01154816|561489002|FG009|Overall Study|Physician Decision|1|||
155563511|NCT01154816|561489003|FG010|Overall Study|Physician Decision|1|||
155563512|NCT01154816|561489004|FG011|Overall Study|Physician Decision|1|||
155563513|NCT01154816|561488993|FG000|Overall Study|Adverse Event|5|||
155563514|NCT01154816|561488994|FG001|Overall Study|Adverse Event|2|||
155563515|NCT01154816|561488995|FG002|Overall Study|Adverse Event|0|||
155563516|NCT01154816|561488996|FG003|Overall Study|Adverse Event|0|||
155563517|NCT01154816|561488997|FG004|Overall Study|Adverse Event|0|||
155563518|NCT01154816|561488998|FG005|Overall Study|Adverse Event|0|||
155563519|NCT01154816|561488999|FG006|Overall Study|Adverse Event|1|||
155563520|NCT01154816|561489000|FG007|Overall Study|Adverse Event|1|||
155563521|NCT01154816|561489001|FG008|Overall Study|Adverse Event|0|||
155563522|NCT01154816|561489002|FG009|Overall Study|Adverse Event|0|||
155563523|NCT01154816|561489003|FG010|Overall Study|Adverse Event|0|||
155563524|NCT01154816|561489004|FG011|Overall Study|Adverse Event|0|||
155563525|NCT00806286|561489005|FG000|Overall Study|Adverse Event|5|||
155563526|NCT00806286|561489006|FG001|Overall Study|Adverse Event|2|||
155563527|NCT00806286|561489007|FG002|Overall Study|Adverse Event|0|||
155563528|NCT00806286|561489005|FG000|Overall Study|Disease progression|31|||
155563529|NCT00806286|561489006|FG001|Overall Study|Disease progression|38|||
155563530|NCT00806286|561489007|FG002|Overall Study|Disease progression|1|||
155563531|NCT00806286|561489005|FG000|Overall Study|Death|1|||
155563532|NCT00806286|561489006|FG001|Overall Study|Death|6|||
155563533|NCT00806286|561489007|FG002|Overall Study|Death|0|||
155563534|NCT00806286|561489005|FG000|Overall Study|Lost to Follow-up|0|||
155563535|NCT00806286|561489006|FG001|Overall Study|Lost to Follow-up|1|||
155563536|NCT00806286|561489007|FG002|Overall Study|Lost to Follow-up|0|||
155563537|NCT00806286|561489005|FG000|Overall Study|Withdrawal by Subject|8|||
155563538|NCT00806286|561489006|FG001|Overall Study|Withdrawal by Subject|3|||
155563539|NCT00806286|561489007|FG002|Overall Study|Withdrawal by Subject|1|||
155563540|NCT00806286|561489005|FG000|Overall Study|Physician Decision|2|||
155563541|NCT00806286|561489006|FG001|Overall Study|Physician Decision|2|||
155563542|NCT00806286|561489007|FG002|Overall Study|Physician Decision|0|||
155563543|NCT00806286|561489005|FG000|Overall Study|Due to a variety of reasons|7|||
155563544|NCT00806286|561489006|FG001|Overall Study|Due to a variety of reasons|2|||
155563545|NCT00806286|561489007|FG002|Overall Study|Due to a variety of reasons|1|||
155563546|NCT00686075|561489008|FG000|Overall Study|Withdrawal by Subject|4|||
155563547|NCT00686075|561489009|FG001|Overall Study|Withdrawal by Subject|3|||
155563548|NCT00686075|561489010|FG002|Overall Study|Withdrawal by Subject|3|||
155563549|NCT00686075|561489011|FG003|Overall Study|Withdrawal by Subject|7|||
155563550|NCT00686075|561489012|FG004|Overall Study|Withdrawal by Subject|1|||
155563551|NCT00686075|561489013|FG005|Overall Study|Withdrawal by Subject|0|||
155563552|NCT00686075|561489014|FG006|Overall Study|Withdrawal by Subject|0|||
155563553|NCT00686075|561489015|FG007|Overall Study|Withdrawal by Subject|2|||
155563554|NCT00686075|561489016|FG008|Overall Study|Withdrawal by Subject|4|||
155563555|NCT00686075|561489017|FG009|Overall Study|Withdrawal by Subject|6|||
155563556|NCT00686075|561489008|FG000|Overall Study|Lost to Follow-up|3|||
155563557|NCT00686075|561489009|FG001|Overall Study|Lost to Follow-up|6|||
155563558|NCT00686075|561489010|FG002|Overall Study|Lost to Follow-up|3|||
155563559|NCT00686075|561489011|FG003|Overall Study|Lost to Follow-up|2|||
155563560|NCT00686075|561489012|FG004|Overall Study|Lost to Follow-up|3|||
155563561|NCT00686075|561489013|FG005|Overall Study|Lost to Follow-up|3|||
155563562|NCT00686075|561489014|FG006|Overall Study|Lost to Follow-up|0|||
155563563|NCT00686075|561489015|FG007|Overall Study|Lost to Follow-up|0|||
155563564|NCT00686075|561489016|FG008|Overall Study|Lost to Follow-up|2|||
155563565|NCT00686075|561489017|FG009|Overall Study|Lost to Follow-up|3|||
155563566|NCT00686075|561489008|FG000|Overall Study|Other|1|||
155563567|NCT00686075|561489009|FG001|Overall Study|Other|1|||
155563568|NCT00686075|561489010|FG002|Overall Study|Other|0|||
155563569|NCT00686075|561489011|FG003|Overall Study|Other|0|||
155563570|NCT00686075|561489012|FG004|Overall Study|Other|0|||
155563571|NCT00686075|561489013|FG005|Overall Study|Other|0|||
155563572|NCT00686075|561489014|FG006|Overall Study|Other|0|||
155563573|NCT00686075|561489015|FG007|Overall Study|Other|0|||
155563574|NCT00686075|561489016|FG008|Overall Study|Other|0|||
155563575|NCT00686075|561489017|FG009|Overall Study|Other|1|||
155563576|NCT01682863|561489018|FG000|Overall Study|Subject/guardian decision|19|||
155563577|NCT01682863|561489019|FG001|Overall Study|Subject/guardian decision|12|||
155563578|NCT01682863|561489020|FG002|Overall Study|Subject/guardian decision|10|||
155563579|NCT01682863|561489018|FG000|Overall Study|Lost to Follow-up|5|||
155563580|NCT01682863|561489019|FG001|Overall Study|Lost to Follow-up|1|||
155563581|NCT01682863|561489020|FG002|Overall Study|Lost to Follow-up|6|||
155563582|NCT01682863|561489018|FG000|Overall Study|Death|1|||
155563583|NCT01682863|561489019|FG001|Overall Study|Death|3|||
155563584|NCT01682863|561489020|FG002|Overall Study|Death|4|||
155563585|NCT01682863|561489018|FG000|Overall Study|Protocol deviation|1|||
155563586|NCT01682863|561489019|FG001|Overall Study|Protocol deviation|0|||
155563587|NCT01682863|561489020|FG002|Overall Study|Protocol deviation|1|||
155563588|NCT01682863|561489018|FG000|Overall Study|Technical problems|1|||
155563589|NCT01682863|561489019|FG001|Overall Study|Technical problems|0|||
155563590|NCT01682863|561489020|FG002|Overall Study|Technical problems|0|||
155563591|NCT01682863|561489018|FG000|Overall Study|Adverse Event|0|||
155563592|NCT01682863|561489019|FG001|Overall Study|Adverse Event|1|||
155563593|NCT01682863|561489020|FG002|Overall Study|Adverse Event|2|||
155563594|NCT01682863|561489018|FG000|Overall Study|Physician Decision|0|||
155563595|NCT01682863|561489019|FG001|Overall Study|Physician Decision|0|||
155563596|NCT01682863|561489020|FG002|Overall Study|Physician Decision|1|||
155563597|NCT00918138|561489021|FG000|Overall Study|Subject withdrew consent|1|||
155563598|NCT00918138|561489022|FG001|Overall Study|Subject withdrew consent|1|||
155563599|NCT00918138|561489021|FG000|Overall Study|Death|1|||
155563600|NCT00918138|561489022|FG001|Overall Study|Death|0|||
155563601|NCT00977379|561489023|FG000|Overall Study|Withdrawal by Subject|1|||
155563602|NCT00977379|561489024|FG001|Overall Study|Withdrawal by Subject|1|||
155563603|NCT00977379|561489023|FG000|Overall Study|Death|7|||
155563604|NCT00977379|561489024|FG001|Overall Study|Death|9|||
155563605|NCT00977379|561489023|FG000|Overall Study|Premature Study Termination|4|||
155563606|NCT00977379|561489024|FG001|Overall Study|Premature Study Termination|0|||
155563607|NCT00977379|561489023|FG000|Overall Study|Participant Moving House|0|||
155563608|NCT00977379|561489024|FG001|Overall Study|Participant Moving House|1|||
155563609|NCT00977379|561489023|FG000|Overall Study|Randomization Error|0|||
155563610|NCT00977379|561489024|FG001|Overall Study|Randomization Error|1|||
155563611|NCT03972163|561489025|FG000|Overall Study|Death|0|||
155563612|NCT03972163|561489026|FG001|Overall Study|Death|1|||
155563613|NCT02006693|561489027|FG000|Overall Study|No Reason Specified|6|||
155563614|NCT02006693|561489028|FG001|Overall Study|No Reason Specified|8|||
155563615|NCT02006693|561489027|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
155563616|NCT02006693|561489028|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
155563617|NCT02006693|561489027|FG000|Overall Study|XEN Implant Explantation|0|||
155563618|NCT02006693|561489028|FG001|Overall Study|XEN Implant Explantation|1|||
155563619|NCT02006693|561489027|FG000|Overall Study|Death|2|||
155563620|NCT02006693|561489028|FG001|Overall Study|Death|2|||
155563621|NCT02006693|561489027|FG000|Overall Study|Lost to Follow-up|4|||
155563622|NCT02006693|561489028|FG001|Overall Study|Lost to Follow-up|1|||
155563623|NCT02006693|561489027|FG000|Overall Study|Patient Decision|4|||
155563624|NCT02006693|561489028|FG001|Overall Study|Patient Decision|0|||
155563625|NCT01119508|561489029|FG000|Overall Study|Adverse Event|56|||
155563626|NCT01119508|561489029|FG000|Overall Study|Withdrawal by Subject|2|||
155563627|NCT01119508|561489029|FG000|Overall Study|Died before tumor response evaluation|1|||
155563628|NCT00265395|561489030|FG000|Overall Study|Adverse Event|3|||
155563629|NCT00265395|561489031|FG001|Overall Study|Adverse Event|6|||
155563630|NCT00265395|561489030|FG000|Overall Study|Lost to Follow-up|2|||
155563631|NCT00265395|561489031|FG001|Overall Study|Lost to Follow-up|1|||
155563632|NCT00265395|561489030|FG000|Overall Study|Withdrawal by Subject|1|||
155563633|NCT00265395|561489031|FG001|Overall Study|Withdrawal by Subject|6|||
155563634|NCT00265395|561489030|FG000|Overall Study|Protocol Violation|2|||
155563635|NCT00265395|561489031|FG001|Overall Study|Protocol Violation|2|||
155563636|NCT00265395|561489030|FG000|Overall Study|Lack of Efficacy|0|||
155563637|NCT00265395|561489031|FG001|Overall Study|Lack of Efficacy|1|||
155563638|NCT00265395|561489030|FG000|Overall Study|Administrative|0|||
155563639|NCT00265395|561489031|FG001|Overall Study|Administrative|1|||
155563640|NCT02563106|561489034|FG000|Overall Study|Withdrawal by Subject|7|||
155563641|NCT02563106|561489035|FG001|Overall Study|Withdrawal by Subject|8|||
155563642|NCT02563106|561489034|FG000|Overall Study|Adverse Event|17|||
155563643|NCT02563106|561489035|FG001|Overall Study|Adverse Event|15|||
155563644|NCT02563106|561489034|FG000|Overall Study|Protocol Violation|1|||
155563645|NCT02563106|561489035|FG001|Overall Study|Protocol Violation|0|||
155563646|NCT02563106|561489034|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
155563647|NCT02563106|561489035|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
155563648|NCT02563106|561489034|FG000|Overall Study|Lost to Follow-up|3|||
155563649|NCT02563106|561489035|FG001|Overall Study|Lost to Follow-up|2|||
155563650|NCT02563106|561489034|FG000|Overall Study|Physician Decision|3|||
155563651|NCT02563106|561489035|FG001|Overall Study|Physician Decision|1|||
155563652|NCT02563106|561489034|FG000|Overall Study|Other reason - not specified|2|||
155563653|NCT02563106|561489035|FG001|Overall Study|Other reason - not specified|1|||
155563654|NCT02338193|561489036|FG000|Overall Study|Withdrawal by Subject|0|||
155563655|NCT02338193|561489037|FG001|Overall Study|Withdrawal by Subject|0|||
155563656|NCT02338193|561489038|FG002|Overall Study|Withdrawal by Subject|2|||
155563657|NCT02338193|561489036|FG000|Overall Study|Pregnancy|0|||
155563658|NCT02338193|561489037|FG001|Overall Study|Pregnancy|1|||
155563659|NCT02338193|561489038|FG002|Overall Study|Pregnancy|1|||
155563660|NCT02338193|561489036|FG000|Overall Study|Noncompliant with visits|2|||
155563661|NCT02338193|561489037|FG001|Overall Study|Noncompliant with visits|2|||
155563662|NCT02338193|561489038|FG002|Overall Study|Noncompliant with visits|7|||
155563663|NCT02338193|561489036|FG000|Overall Study|moved out of state|0|||
155563664|NCT02338193|561489037|FG001|Overall Study|moved out of state|1|||
155563665|NCT02338193|561489038|FG002|Overall Study|moved out of state|0|||
155563666|NCT02338193|561489036|FG000|Overall Study|intolerant of side effects|1|||
155563667|NCT02338193|561489037|FG001|Overall Study|intolerant of side effects|0|||
155563668|NCT02338193|561489038|FG002|Overall Study|intolerant of side effects|0|||
155563669|NCT01136967|561489040|FG000|Overall Study|Adverse Event|9|||
155563670|NCT01136967|561489041|FG001|Overall Study|Adverse Event|12|||
155563671|NCT01136967|561489040|FG000|Overall Study|Participant Choice|8|||
155563672|NCT01136967|561489041|FG001|Overall Study|Participant Choice|3|||
155563673|NCT01136967|561489040|FG000|Overall Study|Lost to Follow-up|0|||
155563674|NCT01136967|561489041|FG001|Overall Study|Lost to Follow-up|1|||
155563675|NCT01136967|561489040|FG000|Overall Study|Withdrawal by Subject|1|||
155563676|NCT01136967|561489041|FG001|Overall Study|Withdrawal by Subject|2|||
155563677|NCT01136967|561489040|FG000|Overall Study|Clinical Progression|3|||
155563678|NCT01136967|561489041|FG001|Overall Study|Clinical Progression|5|||
155563679|NCT01136967|561489040|FG000|Overall Study|Radiation|1|||
155563680|NCT01136967|561489041|FG001|Overall Study|Radiation|0|||
155563681|NCT01136967|561489040|FG000|Overall Study|Non-compliance|1|||
155563682|NCT01136967|561489041|FG001|Overall Study|Non-compliance|0|||
155563683|NCT01136967|561489040|FG000|Overall Study|Investigator's Choice|1|||
155563684|NCT01136967|561489041|FG001|Overall Study|Investigator's Choice|1|||
155563685|NCT01136967|561489040|FG000|Overall Study|Increase in Lesion Size|0|||
155563686|NCT01136967|561489041|FG001|Overall Study|Increase in Lesion Size|2|||
155563687|NCT01136967|561489040|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
155563688|NCT01136967|561489041|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
155563689|NCT01735955|561489045|FG000|Overall Study|Administrative problems|1|||
155563690|NCT01735955|561489045|FG000|Overall Study|Patient/guardian decision|1|||
155563691|NCT01735955|561489045|FG000|Overall Study|Patient withdrew consent|2|||
155563692|NCT01735955|561489045|FG000|Overall Study|Physician Decision|4|||
155563693|NCT01735955|561489045|FG000|Overall Study|Disease progression|24|||
155563694|NCT01735955|561489045|FG000|Overall Study|Adverse Event|5|||
155563695|NCT03839823|561489049|FG000|Overall Study|Adverse Event|8|||
155563696|NCT03839823|561489050|FG001|Overall Study|Adverse Event|4|||
155563697|NCT03839823|561489049|FG000|Overall Study|Death|1|||
155563698|NCT03839823|561489050|FG001|Overall Study|Death|0|||
155563699|NCT03839823|561489049|FG000|Overall Study|Physician Decision|1|||
155563700|NCT03839823|561489050|FG001|Overall Study|Physician Decision|5|||
155563701|NCT03839823|561489049|FG000|Overall Study|Progressive Disease (PD)|65|||
155563702|NCT03839823|561489050|FG001|Overall Study|Progressive Disease (PD)|65|||
155563703|NCT03839823|561489049|FG000|Overall Study|Subject Decision|2|||
155563704|NCT03839823|561489050|FG001|Overall Study|Subject Decision|9|||
155563705|NCT03839823|561489049|FG000|Overall Study|Not Treated|0|||
155563706|NCT03839823|561489050|FG001|Overall Study|Not Treated|10|||
155563707|NCT01716715|561489051|FG000|Overall Study|Never Treated|2|||
155563708|NCT01716715|561489052|FG001|Overall Study|Never Treated|4|||
155563709|NCT03327792|561489053|FG000|Overall Study|Adverse Event|4|||
155563710|NCT03327792|561489054|FG001|Overall Study|Adverse Event|0|||
155563711|NCT03327792|561489053|FG000|Overall Study|Family/Personal issues|3|||
155563712|NCT03327792|561489054|FG001|Overall Study|Family/Personal issues|2|||
155563713|NCT03327792|561489053|FG000|Overall Study|Lost to Follow-up|0|||
155563714|NCT03327792|561489054|FG001|Overall Study|Lost to Follow-up|1|||
155563715|NCT03511326|561489061|FG000|Overall Study|Withdrawal by Subject|1|||
155563716|NCT04058067|561489064|FG000|Overall Study|Adverse Event|2|||
155563717|NCT04058067|561489065|FG001|Overall Study|Adverse Event|0|||
155563718|NCT04058067|561489064|FG000|Overall Study|Death|0|||
155563719|NCT04058067|561489065|FG001|Overall Study|Death|1|||
155563720|NCT04058067|561489064|FG000|Overall Study|Physician Decision|3|||
155563721|NCT04058067|561489065|FG001|Overall Study|Physician Decision|1|||
155563722|NCT04058067|561489064|FG000|Overall Study|Protocol Violation|0|||
155563723|NCT04058067|561489065|FG001|Overall Study|Protocol Violation|1|||
155563724|NCT04058067|561489064|FG000|Overall Study|Withdrawal by Subject|7|||
155563725|NCT04058067|561489065|FG001|Overall Study|Withdrawal by Subject|8|||
155563726|NCT00867503|561489067|FG000|Overall Study|Withdrawal by Subject|1|||
155563727|NCT01001988|561489076|FG000|Overall Study|Protocol Violation|84|||
155563728|NCT01001988|561489076|FG000|Overall Study|Withdrawal by Subject|18|||
155563729|NCT01001988|561489076|FG000|Overall Study|Lost to Follow-up|15|||
155658518|NCT03557502|561842957|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
155658519|NCT00964678|561842958|FG000|Overall Study|Physician Decision|4|||
155658520|NCT03359395|561842959|FG000|First Intervention A / B|Withdrawal by Subject|1|||
155563730|NCT01844856|561489077|FG000|Overall Study|Lost to Follow-up|15|||
155563731|NCT01844856|561489078|FG001|Overall Study|Lost to Follow-up|3|||
155563732|NCT01844856|561489077|FG000|Overall Study|Adverse Event|3|||
155563733|NCT01844856|561489078|FG001|Overall Study|Adverse Event|6|||
155563734|NCT01844856|561489077|FG000|Overall Study|Withdrawal by Subject|3|||
155563735|NCT01844856|561489078|FG001|Overall Study|Withdrawal by Subject|2|||
155563736|NCT01844856|561489077|FG000|Overall Study|Noncompliance|2|||
155658521|NCT03359395|561842960|FG001|First Intervention A / B|Withdrawal by Subject|0|||
155563737|NCT01844856|561489078|FG001|Overall Study|Noncompliance|3|||
155563738|NCT01844856|561489077|FG000|Overall Study|Enterococcus Resistant|0|||
155563739|NCT01844856|561489078|FG001|Overall Study|Enterococcus Resistant|1|||
155563740|NCT01844856|561489077|FG000|Overall Study|Inadvertently Not Scheduled|1|||
155563741|NCT01844856|561489078|FG001|Overall Study|Inadvertently Not Scheduled|0|||
155563742|NCT01844856|561489077|FG000|Overall Study|Randomized but was a Screen Failure|0|||
155563743|NCT01844856|561489078|FG001|Overall Study|Randomized but was a Screen Failure|1|||
155563744|NCT00927394|561489081|FG000|Overall Study|Adverse Event|14|||
155563745|NCT00927394|561489082|FG001|Overall Study|Adverse Event|9|||
155563746|NCT00927394|561489081|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
155563747|NCT00927394|561489082|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
155563748|NCT00927394|561489081|FG000|Overall Study|Withdrawal by Subject|20|||
155563749|NCT00927394|561489082|FG001|Overall Study|Withdrawal by Subject|24|||
155563750|NCT00927394|561489081|FG000|Overall Study|Lost to Follow-up|8|||
155563751|NCT00927394|561489082|FG001|Overall Study|Lost to Follow-up|14|||
155563752|NCT00927394|561489081|FG000|Overall Study|Administrative Problem|1|||
155563753|NCT00927394|561489082|FG001|Overall Study|Administrative Problem|0|||
155563754|NCT00927394|561489081|FG000|Overall Study|Death|1|||
155563755|NCT00927394|561489082|FG001|Overall Study|Death|1|||
155563756|NCT00927394|561489081|FG000|Overall Study|Protocol deviation|16|||
155563757|NCT00927394|561489082|FG001|Overall Study|Protocol deviation|13|||
155563758|NCT00927394|561489081|FG000|Overall Study|Randomized in error|0|||
155563759|NCT00927394|561489082|FG001|Overall Study|Randomized in error|1|||
155563760|NCT01221363|561489083|FG000|Overall Study|Pregnancy|1|||
155563761|NCT01221363|561489084|FG001|Overall Study|Pregnancy|0|||
155563762|NCT01221363|561489083|FG000|Overall Study|Withdrawal by Subject|11|||
155563763|NCT01221363|561489084|FG001|Overall Study|Withdrawal by Subject|5|||
155563764|NCT04628793|561489085|FG000|Overall Study|Study terminated by sponsor|0|||
155563765|NCT04628793|561489086|FG001|Overall Study|Study terminated by sponsor|0|||
155563766|NCT04628793|561489087|FG002|Overall Study|Study terminated by sponsor|8|||
155563767|NCT04628793|561489085|FG000|Overall Study|Withdrawal by Subject|2|||
155563768|NCT04628793|561489086|FG001|Overall Study|Withdrawal by Subject|3|||
155563769|NCT04628793|561489087|FG002|Overall Study|Withdrawal by Subject|0|||
155563770|NCT04628793|561489085|FG000|Overall Study|Lost to Follow-up|0|||
155563771|NCT04628793|561489086|FG001|Overall Study|Lost to Follow-up|1|||
155563772|NCT04628793|561489087|FG002|Overall Study|Lost to Follow-up|0|||
155563773|NCT01329549|561489093|FG000|Overall Study|Withdrawal by Subject|1|||
155563774|NCT01329549|561489093|FG000|Overall Study|Adverse Event|1|||
155563775|NCT01755767|561489096|FG000|Overall Study|Progressive Disease|8|||
155563776|NCT01755767|561489097|FG001|Overall Study|Progressive Disease|7|||
155563777|NCT01755767|561489098|FG002|Overall Study|Progressive Disease|91|||
155563778|NCT01755767|561489099|FG003|Overall Study|Progressive Disease|43|||
155563779|NCT01755767|561489096|FG000|Overall Study|Clinical Disease Progression|4|||
155563780|NCT01755767|561489097|FG001|Overall Study|Clinical Disease Progression|2|||
155563781|NCT01755767|561489098|FG002|Overall Study|Clinical Disease Progression|29|||
155563782|NCT01755767|561489099|FG003|Overall Study|Clinical Disease Progression|20|||
155563783|NCT01755767|561489096|FG000|Overall Study|Radiographic Disease Progression|9|||
155563784|NCT01755767|561489097|FG001|Overall Study|Radiographic Disease Progression|4|||
155563785|NCT01755767|561489098|FG002|Overall Study|Radiographic Disease Progression|44|||
155563786|NCT01755767|561489099|FG003|Overall Study|Radiographic Disease Progression|27|||
155563787|NCT01755767|561489096|FG000|Overall Study|Adverse Event|6|||
155563788|NCT01755767|561489097|FG001|Overall Study|Adverse Event|0|||
155563789|NCT01755767|561489098|FG002|Overall Study|Adverse Event|28|||
155563790|NCT01755767|561489099|FG003|Overall Study|Adverse Event|11|||
155563791|NCT01755767|561489096|FG000|Overall Study|Death|1|||
155563792|NCT01755767|561489097|FG001|Overall Study|Death|2|||
155563793|NCT01755767|561489098|FG002|Overall Study|Death|15|||
155563794|NCT01755767|561489099|FG003|Overall Study|Death|4|||
155563795|NCT01755767|561489096|FG000|Overall Study|Subject Decision|0|||
155563796|NCT01755767|561489097|FG001|Overall Study|Subject Decision|0|||
155563797|NCT01755767|561489098|FG002|Overall Study|Subject Decision|10|||
155563798|NCT01755767|561489099|FG003|Overall Study|Subject Decision|3|||
155563799|NCT01755767|561489096|FG000|Overall Study|Withdrawal by Subject|0|||
155563800|NCT01755767|561489097|FG001|Overall Study|Withdrawal by Subject|0|||
155563801|NCT01755767|561489098|FG002|Overall Study|Withdrawal by Subject|2|||
155563802|NCT01755767|561489099|FG003|Overall Study|Withdrawal by Subject|1|||
155563803|NCT01755767|561489096|FG000|Overall Study|Other|0|||
155563804|NCT01755767|561489097|FG001|Overall Study|Other|0|||
155563805|NCT01755767|561489098|FG002|Overall Study|Other|2|||
155563806|NCT01755767|561489099|FG003|Overall Study|Other|3|||
155563807|NCT01755767|561489096|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
155563808|NCT01755767|561489097|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
155563809|NCT01755767|561489098|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
155563810|NCT01755767|561489099|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
155563811|NCT00191165|561489100|FG000|Overall Study|Adverse Event|2|||
155563812|NCT00191165|561489101|FG001|Overall Study|Adverse Event|0|||
155563813|NCT00191165|561489100|FG000|Overall Study|Protocol Violation|0|||
155563814|NCT00191165|561489101|FG001|Overall Study|Protocol Violation|1|||
155563815|NCT00191165|561489100|FG000|Overall Study|Participant Moved Away|0|||
155563816|NCT00191165|561489101|FG001|Overall Study|Participant Moved Away|1|||
155563817|NCT00715624|561489102|FG000|Overall Study|Adverse Event|12|||
155563818|NCT00715624|561489103|FG001|Overall Study|Adverse Event|37|||
155563819|NCT00715624|561489102|FG000|Overall Study|Lack of Efficacy|11|||
155563820|NCT00715624|561489103|FG001|Overall Study|Lack of Efficacy|11|||
155563821|NCT00715624|561489102|FG000|Overall Study|Lost to Follow-up|1|||
155563822|NCT00715624|561489103|FG001|Overall Study|Lost to Follow-up|2|||
155563823|NCT00715624|561489102|FG000|Overall Study|Protocol Violation|1|||
155563824|NCT00715624|561489103|FG001|Overall Study|Protocol Violation|0|||
155563825|NCT00715624|561489102|FG000|Overall Study|Withdrawal by Subject|11|||
155563826|NCT00715624|561489103|FG001|Overall Study|Withdrawal by Subject|25|||
155658522|NCT03359395|561842959|FG000|First Intervention A / B|Lost to Follow-up|2|||
155658523|NCT03359395|561842960|FG001|First Intervention A / B|Lost to Follow-up|3|||
155658524|NCT03359395|561842959|FG000|Second Intervention B/A|Exclusion criteria|0|||
155658525|NCT03359395|561842960|FG001|Second Intervention B/A|Exclusion criteria|1|||
155658526|NCT03359395|561842959|FG000|Second Intervention B/A|Lost to Follow-up|3|||
155658527|NCT03359395|561842960|FG001|Second Intervention B/A|Lost to Follow-up|2|||
155658528|NCT03164356|561842963|FG000|Overall Study|Lost to Follow-up|1|||
155658529|NCT03164356|561842964|FG001|Overall Study|Lost to Follow-up|1|||
155658530|NCT03164356|561842965|FG002|Overall Study|Lost to Follow-up|2|||
155658531|NCT03164356|561842966|FG003|Overall Study|Lost to Follow-up|1|||
155658532|NCT03164356|561842963|FG000|Overall Study|Physician Decision|0|||
155658533|NCT03164356|561842964|FG001|Overall Study|Physician Decision|0|||
155658534|NCT03164356|561842965|FG002|Overall Study|Physician Decision|3|||
155658535|NCT03164356|561842966|FG003|Overall Study|Physician Decision|0|||
155658536|NCT03164356|561842963|FG000|Overall Study|Protocol Violation|2|||
155658537|NCT03164356|561842964|FG001|Overall Study|Protocol Violation|1|||
155658538|NCT03164356|561842965|FG002|Overall Study|Protocol Violation|0|||
155658539|NCT03164356|561842966|FG003|Overall Study|Protocol Violation|0|||
155658540|NCT03164356|561842963|FG000|Overall Study|Withdrawal by Subject|1|||
155658541|NCT03164356|561842964|FG001|Overall Study|Withdrawal by Subject|0|||
155658542|NCT03164356|561842965|FG002|Overall Study|Withdrawal by Subject|0|||
155658543|NCT03164356|561842966|FG003|Overall Study|Withdrawal by Subject|0|||
155658544|NCT03164356|561842963|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
155658545|NCT03164356|561842964|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
155658546|NCT03164356|561842965|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
155658547|NCT03164356|561842966|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
155658548|NCT03164356|561842963|FG000|Overall Study|Subject Incarcerated|0|||
155658549|NCT03164356|561842964|FG001|Overall Study|Subject Incarcerated|1|||
155658550|NCT03164356|561842965|FG002|Overall Study|Subject Incarcerated|0|||
155658551|NCT03164356|561842966|FG003|Overall Study|Subject Incarcerated|0|||
155658552|NCT03164356|561842963|FG000|Overall Study|Prosthetist unable to participate|0|||
155658553|NCT03164356|561842964|FG001|Overall Study|Prosthetist unable to participate|2|||
155658554|NCT03164356|561842965|FG002|Overall Study|Prosthetist unable to participate|1|||
155658555|NCT03164356|561842966|FG003|Overall Study|Prosthetist unable to participate|0|||
155658556|NCT03396445|561844688|FG000|Treatment Period|Death|2|||
155658557|NCT03396445|561844689|FG001|Treatment Period|Death|2|||
155658558|NCT03396445|561844690|FG002|Treatment Period|Death|1|||
155658559|NCT03396445|561844691|FG003|Treatment Period|Death|1|||
155658560|NCT03396445|561844692|FG004|Treatment Period|Death|3|||
155658561|NCT03396445|561844693|FG005|Treatment Period|Death|2|||
155658562|NCT03396445|561844694|FG006|Treatment Period|Death|5|||
155658563|NCT03396445|561844695|FG007|Treatment Period|Death|3|||
155658564|NCT03396445|561844696|FG008|Treatment Period|Death|3|||
155658565|NCT03396445|561844697|FG009|Treatment Period|Death|3|||
155658566|NCT03396445|561844698|FG010|Treatment Period|Death|7|||
155658567|NCT03396445|561844699|FG011|Treatment Period|Death|12|||
155658568|NCT03396445|561844700|FG012|Treatment Period|Death|28|||
155658569|NCT03396445|561844701|FG013|Treatment Period|Death|14|||
155658570|NCT03396445|561844702|FG014|Treatment Period|Death|10|||
155658571|NCT03396445|561844703|FG015|Treatment Period|Death|8|||
155658572|NCT03396445|561844704|FG016|Treatment Period|Death|18|||
155658573|NCT03396445|561844705|FG017|Treatment Period|Death|0|||
155658574|NCT03396445|561844706|FG018|Treatment Period|Death|0|||
155658575|NCT03396445|561844707|FG019|Treatment Period|Death|0|||
155658576|NCT03396445|561844708|FG020|Treatment Period|Death|0|||
155658577|NCT03396445|561844709|FG021|Treatment Period|Death|0|||
155658578|NCT03396445|561844710|FG022|Treatment Period|Death|0|||
155658579|NCT03396445|561844711|FG023|Treatment Period|Death|0|||
155658580|NCT03396445|561844712|FG024|Treatment Period|Death|0|||
155563827|NCT00715624|561489102|FG000|Overall Study|Familial and personal reasons|10|||
155563828|NCT00715624|561489103|FG001|Overall Study|Familial and personal reasons|22|||
155563829|NCT00715624|561489102|FG000|Overall Study|Poor compliance|6|||
155658581|NCT03396445|561844713|FG025|Treatment Period|Death|0|||
155658582|NCT03396445|561844688|FG000|Treatment Period|Lost to Follow-up|0|||
155658583|NCT03396445|561844689|FG001|Treatment Period|Lost to Follow-up|0|||
155658584|NCT03396445|561844690|FG002|Treatment Period|Lost to Follow-up|0|||
155658585|NCT03396445|561844691|FG003|Treatment Period|Lost to Follow-up|0|||
155658586|NCT03396445|561844692|FG004|Treatment Period|Lost to Follow-up|0|||
155658587|NCT03396445|561844693|FG005|Treatment Period|Lost to Follow-up|0|||
155658588|NCT03396445|561844694|FG006|Treatment Period|Lost to Follow-up|0|||
155658589|NCT03396445|561844695|FG007|Treatment Period|Lost to Follow-up|0|||
155658590|NCT03396445|561844696|FG008|Treatment Period|Lost to Follow-up|0|||
155658591|NCT03396445|561844697|FG009|Treatment Period|Lost to Follow-up|0|||
155658592|NCT03396445|561844698|FG010|Treatment Period|Lost to Follow-up|0|||
155658593|NCT03396445|561844699|FG011|Treatment Period|Lost to Follow-up|0|||
155658594|NCT03396445|561844700|FG012|Treatment Period|Lost to Follow-up|1|||
155658595|NCT03396445|561844701|FG013|Treatment Period|Lost to Follow-up|0|||
155658596|NCT03396445|561844702|FG014|Treatment Period|Lost to Follow-up|1|||
155658597|NCT03396445|561844703|FG015|Treatment Period|Lost to Follow-up|0|||
155658598|NCT03396445|561844704|FG016|Treatment Period|Lost to Follow-up|0|||
155658599|NCT03396445|561844705|FG017|Treatment Period|Lost to Follow-up|0|||
155658600|NCT03396445|561844706|FG018|Treatment Period|Lost to Follow-up|0|||
155658601|NCT03396445|561844707|FG019|Treatment Period|Lost to Follow-up|0|||
155658602|NCT03396445|561844708|FG020|Treatment Period|Lost to Follow-up|0|||
155658603|NCT03396445|561844709|FG021|Treatment Period|Lost to Follow-up|0|||
155658604|NCT03396445|561844710|FG022|Treatment Period|Lost to Follow-up|0|||
155658605|NCT03396445|561844711|FG023|Treatment Period|Lost to Follow-up|0|||
155658606|NCT03396445|561844712|FG024|Treatment Period|Lost to Follow-up|0|||
155658607|NCT03396445|561844713|FG025|Treatment Period|Lost to Follow-up|0|||
155658608|NCT03396445|561844688|FG000|Treatment Period|Physician Decision|0|||
155658609|NCT03396445|561844689|FG001|Treatment Period|Physician Decision|0|||
155658610|NCT03396445|561844690|FG002|Treatment Period|Physician Decision|0|||
155658611|NCT03396445|561844691|FG003|Treatment Period|Physician Decision|0|||
155658612|NCT03396445|561844692|FG004|Treatment Period|Physician Decision|1|||
155658613|NCT03396445|561844693|FG005|Treatment Period|Physician Decision|0|||
155658614|NCT03396445|561844694|FG006|Treatment Period|Physician Decision|0|||
155658615|NCT03396445|561844695|FG007|Treatment Period|Physician Decision|0|||
155658616|NCT03396445|561844696|FG008|Treatment Period|Physician Decision|0|||
155658617|NCT03396445|561844697|FG009|Treatment Period|Physician Decision|1|||
155658618|NCT03396445|561844698|FG010|Treatment Period|Physician Decision|0|||
155658619|NCT03396445|561844699|FG011|Treatment Period|Physician Decision|0|||
155658620|NCT03396445|561844700|FG012|Treatment Period|Physician Decision|0|||
155658621|NCT03396445|561844701|FG013|Treatment Period|Physician Decision|0|||
155658622|NCT03396445|561844702|FG014|Treatment Period|Physician Decision|0|||
155658623|NCT03396445|561844703|FG015|Treatment Period|Physician Decision|0|||
155658624|NCT03396445|561844704|FG016|Treatment Period|Physician Decision|0|||
155658625|NCT03396445|561844705|FG017|Treatment Period|Physician Decision|0|||
155658626|NCT03396445|561844706|FG018|Treatment Period|Physician Decision|0|||
155658627|NCT03396445|561844707|FG019|Treatment Period|Physician Decision|0|||
155658628|NCT03396445|561844708|FG020|Treatment Period|Physician Decision|0|||
155658629|NCT03396445|561844709|FG021|Treatment Period|Physician Decision|0|||
155658630|NCT03396445|561844710|FG022|Treatment Period|Physician Decision|0|||
155658631|NCT03396445|561844711|FG023|Treatment Period|Physician Decision|0|||
155658632|NCT03396445|561844712|FG024|Treatment Period|Physician Decision|0|||
155658633|NCT03396445|561844713|FG025|Treatment Period|Physician Decision|0|||
155658634|NCT03396445|561844688|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658635|NCT03396445|561844689|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658636|NCT03396445|561844690|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658637|NCT03396445|561844691|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658638|NCT03396445|561844692|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658639|NCT03396445|561844693|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658640|NCT03396445|561844694|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658641|NCT03396445|561844695|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658642|NCT03396445|561844696|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658643|NCT03396445|561844697|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658644|NCT03396445|561844698|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658645|NCT03396445|561844699|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658646|NCT03396445|561844700|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
155658647|NCT03396445|561844701|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658648|NCT03396445|561844702|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
155658649|NCT03396445|561844703|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658650|NCT03396445|561844704|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658651|NCT03396445|561844705|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658652|NCT03396445|561844706|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658653|NCT03396445|561844707|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658654|NCT03396445|561844708|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658655|NCT03396445|561844709|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658656|NCT03396445|561844710|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658657|NCT03396445|561844711|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658658|NCT03396445|561844712|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658659|NCT03396445|561844713|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155658660|NCT03396445|561844688|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
155658661|NCT03396445|561844689|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
155658662|NCT03396445|561844690|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
155658663|NCT03396445|561844691|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
155658664|NCT03396445|561844692|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
155658665|NCT03396445|561844693|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155563830|NCT00715624|561489103|FG001|Overall Study|Poor compliance|13|||
155563831|NCT00715624|561489102|FG000|Overall Study|Sponsor decision|0|||
155563832|NCT00715624|561489103|FG001|Overall Study|Sponsor decision|4|||
155563833|NCT00715624|561489102|FG000|Overall Study|Incorrect randomization (not treated)|0|||
155563834|NCT00715624|561489103|FG001|Overall Study|Incorrect randomization (not treated)|1|||
155563835|NCT00715624|561489102|FG000|Overall Study|Other|0|||
155563836|NCT00715624|561489103|FG001|Overall Study|Other|1|||
155563837|NCT03200912|561489104|FG000|Overall Study|Adverse Event|3|||
155563838|NCT03200912|561489105|FG001|Overall Study|Adverse Event|0|||
155563839|NCT03200912|561489106|FG002|Overall Study|Adverse Event|0|||
155563840|NCT03200912|561489104|FG000|Overall Study|Withdrawal by Subject|1|||
155563841|NCT03200912|561489105|FG001|Overall Study|Withdrawal by Subject|2|||
155563842|NCT03200912|561489106|FG002|Overall Study|Withdrawal by Subject|4|||
155563843|NCT03200912|561489104|FG000|Overall Study|Non-compliance with study drug|0|||
155563844|NCT03200912|561489105|FG001|Overall Study|Non-compliance with study drug|1|||
155563845|NCT03200912|561489106|FG002|Overall Study|Non-compliance with study drug|0|||
155563846|NCT00229723|561489108|FG000|Concomitant Phase|Adverse Event|4|||
155563847|NCT00229723|561489109|FG001|Concomitant Phase|Adverse Event|2|||
155563848|NCT00229723|561489110|FG002|Concomitant Phase|Adverse Event|5|||
155563849|NCT00229723|561489111|FG003|Concomitant Phase|Adverse Event|2|||
155563850|NCT00229723|561489112|FG004|Concomitant Phase|Adverse Event|0|||
155563851|NCT00229723|561489113|FG005|Concomitant Phase|Adverse Event|1|||
155563852|NCT00229723|561489114|FG006|Concomitant Phase|Adverse Event|2|||
155563853|NCT00229723|561489108|FG000|Concomitant Phase|Objective disease progression|0|||
155563854|NCT00229723|561489109|FG001|Concomitant Phase|Objective disease progression|0|||
155563855|NCT00229723|561489110|FG002|Concomitant Phase|Objective disease progression|0|||
155563856|NCT00229723|561489111|FG003|Concomitant Phase|Objective disease progression|0|||
155563857|NCT00229723|561489112|FG004|Concomitant Phase|Objective disease progression|0|||
155563858|NCT00229723|561489113|FG005|Concomitant Phase|Objective disease progression|0|||
155563859|NCT00229723|561489114|FG006|Concomitant Phase|Objective disease progression|0|||
155563860|NCT00229723|561489108|FG000|Concomitant Phase|Clinical progression|0|||
155563861|NCT00229723|561489109|FG001|Concomitant Phase|Clinical progression|0|||
155563862|NCT00229723|561489110|FG002|Concomitant Phase|Clinical progression|0|||
155563863|NCT00229723|561489111|FG003|Concomitant Phase|Clinical progression|0|||
155563864|NCT00229723|561489112|FG004|Concomitant Phase|Clinical progression|0|||
155563865|NCT00229723|561489113|FG005|Concomitant Phase|Clinical progression|0|||
155563866|NCT00229723|561489114|FG006|Concomitant Phase|Clinical progression|1|||
155563867|NCT00229723|561489108|FG000|Concomitant Phase|Lost to Follow-up|0|||
155563868|NCT00229723|561489109|FG001|Concomitant Phase|Lost to Follow-up|0|||
155563869|NCT00229723|561489110|FG002|Concomitant Phase|Lost to Follow-up|0|||
155563870|NCT00229723|561489111|FG003|Concomitant Phase|Lost to Follow-up|0|||
155563871|NCT00229723|561489112|FG004|Concomitant Phase|Lost to Follow-up|1|||
155563872|NCT00229723|561489113|FG005|Concomitant Phase|Lost to Follow-up|0|||
155563873|NCT00229723|561489114|FG006|Concomitant Phase|Lost to Follow-up|0|||
155563874|NCT00229723|561489108|FG000|Concomitant Phase|Informed consent withdrawn|3|||
155563875|NCT00229723|561489109|FG001|Concomitant Phase|Informed consent withdrawn|2|||
155563876|NCT00229723|561489110|FG002|Concomitant Phase|Informed consent withdrawn|0|||
155563877|NCT00229723|561489111|FG003|Concomitant Phase|Informed consent withdrawn|2|||
155563878|NCT00229723|561489112|FG004|Concomitant Phase|Informed consent withdrawn|0|||
155563879|NCT00229723|561489113|FG005|Concomitant Phase|Informed consent withdrawn|0|||
155563880|NCT00229723|561489114|FG006|Concomitant Phase|Informed consent withdrawn|0|||
155563881|NCT00229723|561489108|FG000|Concomitant Phase|Severe non-compliance|0|||
155563882|NCT00229723|561489109|FG001|Concomitant Phase|Severe non-compliance|1|||
155563883|NCT00229723|561489110|FG002|Concomitant Phase|Severe non-compliance|0|||
155563884|NCT00229723|561489111|FG003|Concomitant Phase|Severe non-compliance|0|||
155658666|NCT03396445|561844694|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
155658667|NCT03396445|561844695|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658668|NCT03396445|561844696|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658669|NCT03396445|561844697|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658670|NCT03396445|561844698|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658671|NCT03396445|561844699|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658672|NCT03396445|561844700|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658673|NCT03396445|561844701|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658674|NCT03396445|561844702|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658675|NCT03396445|561844703|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658676|NCT03396445|561844704|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658677|NCT03396445|561844705|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658678|NCT03396445|561844706|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658679|NCT03396445|561844707|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658680|NCT03396445|561844708|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658681|NCT03396445|561844709|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658682|NCT03396445|561844710|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658683|NCT03396445|561844711|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658684|NCT03396445|561844712|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658685|NCT03396445|561844713|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155658686|NCT03396445|561844688|FG000|Treatment Period|Withdrawal by Subject|0|||
155658687|NCT03396445|561844689|FG001|Treatment Period|Withdrawal by Subject|0|||
155658688|NCT03396445|561844690|FG002|Treatment Period|Withdrawal by Subject|0|||
155658689|NCT03396445|561844691|FG003|Treatment Period|Withdrawal by Subject|0|||
155658690|NCT03396445|561844692|FG004|Treatment Period|Withdrawal by Subject|0|||
155658691|NCT03396445|561844693|FG005|Treatment Period|Withdrawal by Subject|0|||
155658692|NCT03396445|561844694|FG006|Treatment Period|Withdrawal by Subject|0|||
155658693|NCT03396445|561844695|FG007|Treatment Period|Withdrawal by Subject|0|||
155658694|NCT03396445|561844696|FG008|Treatment Period|Withdrawal by Subject|0|||
155563885|NCT00229723|561489112|FG004|Concomitant Phase|Severe non-compliance|1|||
155563886|NCT00229723|561489113|FG005|Concomitant Phase|Severe non-compliance|0|||
155563887|NCT00229723|561489114|FG006|Concomitant Phase|Severe non-compliance|0|||
155563888|NCT00229723|561489108|FG000|Concomitant Phase|Other|3|||
155563889|NCT00229723|561489109|FG001|Concomitant Phase|Other|0|||
155563890|NCT00229723|561489110|FG002|Concomitant Phase|Other|1|||
155563891|NCT00229723|561489111|FG003|Concomitant Phase|Other|1|||
155563892|NCT00229723|561489112|FG004|Concomitant Phase|Other|0|||
155563893|NCT00229723|561489113|FG005|Concomitant Phase|Other|2|||
155658695|NCT03396445|561844697|FG009|Treatment Period|Withdrawal by Subject|0|||
155658696|NCT03396445|561844698|FG010|Treatment Period|Withdrawal by Subject|0|||
155658697|NCT03396445|561844699|FG011|Treatment Period|Withdrawal by Subject|0|||
155658698|NCT03396445|561844700|FG012|Treatment Period|Withdrawal by Subject|0|||
155658699|NCT03396445|561844701|FG013|Treatment Period|Withdrawal by Subject|0|||
155658700|NCT03396445|561844702|FG014|Treatment Period|Withdrawal by Subject|1|||
155658701|NCT03396445|561844703|FG015|Treatment Period|Withdrawal by Subject|0|||
155658702|NCT03396445|561844704|FG016|Treatment Period|Withdrawal by Subject|1|||
155658703|NCT03396445|561844705|FG017|Treatment Period|Withdrawal by Subject|0|||
155658704|NCT03396445|561844706|FG018|Treatment Period|Withdrawal by Subject|0|||
155658705|NCT03396445|561844707|FG019|Treatment Period|Withdrawal by Subject|0|||
155658706|NCT03396445|561844708|FG020|Treatment Period|Withdrawal by Subject|0|||
155658707|NCT03396445|561844709|FG021|Treatment Period|Withdrawal by Subject|0|||
155658708|NCT03396445|561844710|FG022|Treatment Period|Withdrawal by Subject|0|||
155658709|NCT03396445|561844711|FG023|Treatment Period|Withdrawal by Subject|0|||
155658710|NCT03396445|561844712|FG024|Treatment Period|Withdrawal by Subject|0|||
155658711|NCT03396445|561844713|FG025|Treatment Period|Withdrawal by Subject|0|||
155658712|NCT03396445|561844688|FG000|Switch-over Period|Death|0|||
155658713|NCT03396445|561844689|FG001|Switch-over Period|Death|0|||
155563894|NCT00229723|561489114|FG006|Concomitant Phase|Other|0|||
155563895|NCT00229723|561489108|FG000|Maintenance Phase|Adverse Event|7|||
155563896|NCT00229723|561489109|FG001|Maintenance Phase|Adverse Event|2|||
155563897|NCT00229723|561489110|FG002|Maintenance Phase|Adverse Event|1|||
155563898|NCT00229723|561489111|FG003|Maintenance Phase|Adverse Event|4|||
155563899|NCT00229723|561489112|FG004|Maintenance Phase|Adverse Event|7|||
155563900|NCT00229723|561489113|FG005|Maintenance Phase|Adverse Event|5|||
155563901|NCT00229723|561489114|FG006|Maintenance Phase|Adverse Event|2|||
155563902|NCT00229723|561489108|FG000|Maintenance Phase|Objective disease progression|5|||
155563903|NCT00229723|561489109|FG001|Maintenance Phase|Objective disease progression|5|||
155563904|NCT00229723|561489110|FG002|Maintenance Phase|Objective disease progression|3|||
155563905|NCT00229723|561489111|FG003|Maintenance Phase|Objective disease progression|6|||
155563906|NCT00229723|561489112|FG004|Maintenance Phase|Objective disease progression|2|||
155563907|NCT00229723|561489113|FG005|Maintenance Phase|Objective disease progression|9|||
155563908|NCT00229723|561489114|FG006|Maintenance Phase|Objective disease progression|5|||
155563909|NCT00229723|561489108|FG000|Maintenance Phase|Clinical progression|4|||
155658714|NCT03396445|561844690|FG002|Switch-over Period|Death|0|||
155658715|NCT03396445|561844691|FG003|Switch-over Period|Death|0|||
155658716|NCT03396445|561844692|FG004|Switch-over Period|Death|0|||
155658717|NCT03396445|561844693|FG005|Switch-over Period|Death|0|||
155658718|NCT03396445|561844694|FG006|Switch-over Period|Death|0|||
155658719|NCT03396445|561844695|FG007|Switch-over Period|Death|0|||
155658720|NCT03396445|561844696|FG008|Switch-over Period|Death|0|||
155658721|NCT03396445|561844697|FG009|Switch-over Period|Death|0|||
155658722|NCT03396445|561844698|FG010|Switch-over Period|Death|0|||
155658723|NCT03396445|561844699|FG011|Switch-over Period|Death|0|||
155658724|NCT03396445|561844700|FG012|Switch-over Period|Death|0|||
155658725|NCT03396445|561844701|FG013|Switch-over Period|Death|0|||
155658726|NCT03396445|561844702|FG014|Switch-over Period|Death|0|||
155658727|NCT03396445|561844703|FG015|Switch-over Period|Death|0|||
155658728|NCT03396445|561844704|FG016|Switch-over Period|Death|0|||
155658729|NCT03396445|561844705|FG017|Switch-over Period|Death|0|||
155658730|NCT03396445|561844706|FG018|Switch-over Period|Death|1|||
155658731|NCT03396445|561844707|FG019|Switch-over Period|Death|2|||
155658732|NCT03396445|561844708|FG020|Switch-over Period|Death|2|||
155658733|NCT03396445|561844709|FG021|Switch-over Period|Death|1|||
155658734|NCT03396445|561844710|FG022|Switch-over Period|Death|2|||
155658735|NCT03396445|561844711|FG023|Switch-over Period|Death|0|||
155658736|NCT03396445|561844712|FG024|Switch-over Period|Death|1|||
155658737|NCT03396445|561844713|FG025|Switch-over Period|Death|6|||
155658738|NCT03396445|561844688|FG000|Switch-over Period|Lost to Follow-up|0|||
155658739|NCT03396445|561844689|FG001|Switch-over Period|Lost to Follow-up|0|||
155658740|NCT03396445|561844690|FG002|Switch-over Period|Lost to Follow-up|0|||
155658741|NCT03396445|561844691|FG003|Switch-over Period|Lost to Follow-up|0|||
155658742|NCT03396445|561844692|FG004|Switch-over Period|Lost to Follow-up|0|||
155658743|NCT03396445|561844693|FG005|Switch-over Period|Lost to Follow-up|0|||
155658744|NCT03396445|561844694|FG006|Switch-over Period|Lost to Follow-up|0|||
155658745|NCT03396445|561844695|FG007|Switch-over Period|Lost to Follow-up|0|||
155658746|NCT03396445|561844696|FG008|Switch-over Period|Lost to Follow-up|0|||
155658747|NCT03396445|561844697|FG009|Switch-over Period|Lost to Follow-up|0|||
155658748|NCT03396445|561844698|FG010|Switch-over Period|Lost to Follow-up|0|||
155658749|NCT03396445|561844699|FG011|Switch-over Period|Lost to Follow-up|0|||
155658750|NCT03396445|561844700|FG012|Switch-over Period|Lost to Follow-up|0|||
155658751|NCT03396445|561844701|FG013|Switch-over Period|Lost to Follow-up|0|||
155658752|NCT03396445|561844702|FG014|Switch-over Period|Lost to Follow-up|0|||
155658753|NCT03396445|561844703|FG015|Switch-over Period|Lost to Follow-up|0|||
155658754|NCT03396445|561844704|FG016|Switch-over Period|Lost to Follow-up|0|||
155658755|NCT03396445|561844705|FG017|Switch-over Period|Lost to Follow-up|0|||
155658756|NCT03396445|561844706|FG018|Switch-over Period|Lost to Follow-up|0|||
155658757|NCT03396445|561844707|FG019|Switch-over Period|Lost to Follow-up|0|||
155658758|NCT03396445|561844708|FG020|Switch-over Period|Lost to Follow-up|0|||
155658759|NCT03396445|561844709|FG021|Switch-over Period|Lost to Follow-up|0|||
155658760|NCT03396445|561844710|FG022|Switch-over Period|Lost to Follow-up|0|||
155658761|NCT03396445|561844711|FG023|Switch-over Period|Lost to Follow-up|1|||
155658762|NCT03396445|561844712|FG024|Switch-over Period|Lost to Follow-up|0|||
155658763|NCT03396445|561844713|FG025|Switch-over Period|Lost to Follow-up|0|||
155658764|NCT03552029|561844717|FG000|Overall Study|Death|3|||
155658765|NCT03552029|561844718|FG001|Overall Study|Death|0|||
155658766|NCT03552029|561844717|FG000|Overall Study|Adverse Event|1|||
155658767|NCT03552029|561844718|FG001|Overall Study|Adverse Event|0|||
155658768|NCT03552029|561844717|FG000|Overall Study|Lack of Efficacy|0|||
155658769|NCT03552029|561844718|FG001|Overall Study|Lack of Efficacy|2|||
155658770|NCT03552029|561844717|FG000|Overall Study|Physician Decision|0|||
155563910|NCT00229723|561489109|FG001|Maintenance Phase|Clinical progression|1|||
155563911|NCT00229723|561489110|FG002|Maintenance Phase|Clinical progression|2|||
155658771|NCT03552029|561844718|FG001|Overall Study|Physician Decision|1|||
155658772|NCT03552029|561844717|FG000|Overall Study|Study terminated by Sponsor|0|||
155658773|NCT03552029|561844718|FG001|Overall Study|Study terminated by Sponsor|1|||
155658774|NCT03552029|561844717|FG000|Overall Study|Other|0|||
155658775|NCT03552029|561844718|FG001|Overall Study|Other|2|||
155658776|NCT00876447|561844726|FG000|Overall Study|Other miscellaneous reasons|3|||
155658777|NCT00876447|561844727|FG001|Overall Study|Other miscellaneous reasons|8|||
155658778|NCT00876447|561844726|FG000|Overall Study|Site closure|19|||
155658779|NCT00876447|561844727|FG001|Overall Study|Site closure|14|||
155658780|NCT00876447|561844726|FG000|Overall Study|Protocol Violation|9|||
155563912|NCT00229723|561489111|FG003|Maintenance Phase|Clinical progression|2|||
155563913|NCT00229723|561489112|FG004|Maintenance Phase|Clinical progression|1|||
155563914|NCT00229723|561489113|FG005|Maintenance Phase|Clinical progression|1|||
155563915|NCT00229723|561489114|FG006|Maintenance Phase|Clinical progression|1|||
155563916|NCT00229723|561489108|FG000|Maintenance Phase|Lost to Follow-up|0|||
155563917|NCT00229723|561489109|FG001|Maintenance Phase|Lost to Follow-up|1|||
155563918|NCT00229723|561489110|FG002|Maintenance Phase|Lost to Follow-up|2|||
155563919|NCT00229723|561489111|FG003|Maintenance Phase|Lost to Follow-up|2|||
155563920|NCT00229723|561489112|FG004|Maintenance Phase|Lost to Follow-up|0|||
155563921|NCT00229723|561489113|FG005|Maintenance Phase|Lost to Follow-up|0|||
155563922|NCT00229723|561489114|FG006|Maintenance Phase|Lost to Follow-up|1|||
155563923|NCT00229723|561489108|FG000|Maintenance Phase|Informed consent withdrawn|1|||
155563924|NCT00229723|561489109|FG001|Maintenance Phase|Informed consent withdrawn|0|||
155563925|NCT00229723|561489110|FG002|Maintenance Phase|Informed consent withdrawn|0|||
155563926|NCT00229723|561489111|FG003|Maintenance Phase|Informed consent withdrawn|1|||
155563927|NCT00229723|561489112|FG004|Maintenance Phase|Informed consent withdrawn|1|||
155563928|NCT00229723|561489113|FG005|Maintenance Phase|Informed consent withdrawn|1|||
155563929|NCT00229723|561489114|FG006|Maintenance Phase|Informed consent withdrawn|0|||
155563930|NCT00229723|561489108|FG000|Maintenance Phase|Severe non-compliance|3|||
155563931|NCT00229723|561489109|FG001|Maintenance Phase|Severe non-compliance|1|||
155563932|NCT00229723|561489110|FG002|Maintenance Phase|Severe non-compliance|0|||
155563933|NCT00229723|561489111|FG003|Maintenance Phase|Severe non-compliance|0|||
155563934|NCT00229723|561489112|FG004|Maintenance Phase|Severe non-compliance|1|||
155563935|NCT00229723|561489113|FG005|Maintenance Phase|Severe non-compliance|0|||
155563936|NCT00229723|561489114|FG006|Maintenance Phase|Severe non-compliance|0|||
155563937|NCT00229723|561489108|FG000|Maintenance Phase|Other|5|||
155563938|NCT00229723|561489109|FG001|Maintenance Phase|Other|4|||
155563939|NCT00229723|561489110|FG002|Maintenance Phase|Other|1|||
155563940|NCT00229723|561489111|FG003|Maintenance Phase|Other|2|||
155563941|NCT00229723|561489112|FG004|Maintenance Phase|Other|3|||
155563942|NCT00229723|561489113|FG005|Maintenance Phase|Other|3|||
155563943|NCT00229723|561489114|FG006|Maintenance Phase|Other|1|||
155563944|NCT00998309|561489117|FG000|Overall Study|Protocol Violation|4|||
155563945|NCT00735397|561489119|FG000|Overall Study|Adverse Event|194|||
155563946|NCT00735397|561489119|FG000|Overall Study|Lost to Follow-up|33|||
155563947|NCT00735397|561489119|FG000|Overall Study|Participant choice|252|||
155563948|NCT00735397|561489119|FG000|Overall Study|Inadequate therapeutic effect|202|||
155563949|NCT00735397|561489119|FG000|Overall Study|Administrative/Other|502|||
155563950|NCT02677714|561489120|FG000|Overall Study|Withdrawal by Subject|2|||
155563951|NCT02677714|561489121|FG001|Overall Study|Withdrawal by Subject|0|||
155563952|NCT03421730|561489122|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563953|NCT03421730|561489123|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
155563954|NCT03421730|561489124|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563955|NCT03421730|561489125|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563956|NCT03421730|561489126|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563957|NCT03421730|561489127|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563958|NCT03421730|561489128|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563959|NCT03421730|561489129|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563960|NCT03421730|561489130|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563961|NCT03421730|561489131|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563962|NCT03421730|561489132|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563963|NCT03421730|561489133|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
155563964|NCT03421730|561489122|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563965|NCT03421730|561489123|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563966|NCT03421730|561489124|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563967|NCT03421730|561489125|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563968|NCT03421730|561489126|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
155563969|NCT03421730|561489127|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155658781|NCT00876447|561844727|FG001|Overall Study|Protocol Violation|3|||
155563970|NCT03421730|561489128|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563971|NCT03421730|561489129|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563972|NCT03421730|561489130|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563973|NCT03421730|561489131|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563974|NCT03421730|561489132|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563975|NCT03421730|561489133|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155563976|NCT00513682|561489134|FG000|Washout Phase|Adverse Event|2|||
155563977|NCT02450526|561489135|FG000|DB Period (Cycle 1)|Adverse Event|0|||
155563978|NCT02450526|561489136|FG001|DB Period (Cycle 1)|Adverse Event|0|||
155563979|NCT02450526|561489137|FG002|DB Period (Cycle 1)|Adverse Event|2|||
155563980|NCT02450526|561489138|FG003|DB Period (Cycle 1)|Adverse Event|0|||
155563981|NCT02450526|561489139|FG004|DB Period (Cycle 1)|Adverse Event|0|||
155563982|NCT02450526|561489135|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
155563983|NCT02450526|561489136|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
155563984|NCT02450526|561489137|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
155563985|NCT02450526|561489138|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
155563986|NCT02450526|561489139|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
155563987|NCT02450526|561489135|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
155563988|NCT02450526|561489136|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
155563989|NCT02450526|561489137|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
155563990|NCT02450526|561489138|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
155563991|NCT02450526|561489139|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
155563992|NCT02450526|561489135|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
155563993|NCT02450526|561489136|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
155563994|NCT02450526|561489137|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
155563995|NCT02450526|561489138|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
155563996|NCT02450526|561489139|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
155563997|NCT02450526|561489135|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
155563998|NCT02450526|561489136|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
155563999|NCT02450526|561489137|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
155564000|NCT02450526|561489138|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
155564001|NCT02450526|561489139|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
155564002|NCT02450526|561489135|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
155564003|NCT02450526|561489136|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
155564004|NCT02450526|561489137|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
155564005|NCT02450526|561489138|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
155564006|NCT02450526|561489139|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
155564007|NCT02450526|561489135|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
155564008|NCT02450526|561489136|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
155564009|NCT02450526|561489137|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
155564010|NCT02450526|561489138|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
155564011|NCT02450526|561489139|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
155564012|NCT02450526|561489135|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
155564013|NCT02450526|561489136|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
155564014|NCT02450526|561489137|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
155564015|NCT02450526|561489138|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
155564016|NCT02450526|561489139|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
155564017|NCT02722148|561489140|FG000|Overall Study|Lost to Follow-up|2|||
155564018|NCT02722148|561489140|FG000|Overall Study|Non compliant with treatment regimen|3|||
155564019|NCT00911807|561489141|FG000|Overall Study|Adverse Event|2|||
155564020|NCT00911807|561489142|FG001|Overall Study|Adverse Event|1|||
155564021|NCT00911807|561489143|FG002|Overall Study|Adverse Event|5|||
155564022|NCT00911807|561489141|FG000|Overall Study|Death|0|||
155564023|NCT00911807|561489142|FG001|Overall Study|Death|0|||
155564024|NCT00911807|561489143|FG002|Overall Study|Death|1|||
155564025|NCT00911807|561489141|FG000|Overall Study|Protocol Violation|6|||
155564026|NCT00911807|561489142|FG001|Overall Study|Protocol Violation|4|||
155564027|NCT00911807|561489143|FG002|Overall Study|Protocol Violation|9|||
155564028|NCT00911807|561489141|FG000|Overall Study|Withdrawal by Subject|8|||
155564029|NCT00911807|561489142|FG001|Overall Study|Withdrawal by Subject|10|||
155564030|NCT00911807|561489143|FG002|Overall Study|Withdrawal by Subject|7|||
155564031|NCT00911807|561489141|FG000|Overall Study|Organizational reasons|1|||
155564032|NCT00911807|561489142|FG001|Overall Study|Organizational reasons|3|||
155564033|NCT00911807|561489143|FG002|Overall Study|Organizational reasons|1|||
155564034|NCT00855803|561489145|FG000|Overall Study|Death|2|||
155564035|NCT00855803|561489145|FG000|Overall Study|Lost to Follow-up|2|||
155564036|NCT00855803|561489145|FG000|Overall Study|Technical inability to undergo procedure|2|||
155564037|NCT00855803|561489145|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
155564038|NCT00855803|561489145|FG000|Overall Study|Withdrawal by Subject|3|||
155564039|NCT00855803|561489145|FG000|Overall Study|Physician Decision|3|||
155564040|NCT04568031|561489148|FG000|Overall Study|Lost to Follow-up|1|||
155564041|NCT04568031|561489149|FG001|Overall Study|Lost to Follow-up|0|||
155564042|NCT04568031|561489150|FG002|Overall Study|Lost to Follow-up|0|||
155564043|NCT04568031|561489151|FG003|Overall Study|Lost to Follow-up|0|||
155564044|NCT04568031|561489148|FG000|Overall Study|Physician Decision|1|||
155564045|NCT04568031|561489149|FG001|Overall Study|Physician Decision|0|||
155564046|NCT04568031|561489150|FG002|Overall Study|Physician Decision|1|||
155564047|NCT04568031|561489151|FG003|Overall Study|Physician Decision|0|||
155564048|NCT04568031|561489148|FG000|Overall Study|Withdrawal by Subject|1|||
155564049|NCT04568031|561489149|FG001|Overall Study|Withdrawal by Subject|0|||
155607009|NCT01897571|561649623|FG010|Overall Study|Lost to Follow-up|4|||
155564050|NCT04568031|561489150|FG002|Overall Study|Withdrawal by Subject|4|||
155564051|NCT04568031|561489151|FG003|Overall Study|Withdrawal by Subject|1|||
155564052|NCT02304458|561489152|FG000|Overall Study|Adverse Event|0|||
155564053|NCT02304458|561489153|FG001|Overall Study|Adverse Event|0|||
155564054|NCT02304458|561489154|FG002|Overall Study|Adverse Event|7|||
155564055|NCT02304458|561489155|FG003|Overall Study|Adverse Event|0|||
155564056|NCT02304458|561489156|FG004|Overall Study|Adverse Event|0|||
155564057|NCT02304458|561489157|FG005|Overall Study|Adverse Event|0|||
155564058|NCT02304458|561489158|FG006|Overall Study|Adverse Event|3|||
155564059|NCT02304458|561489159|FG007|Overall Study|Adverse Event|4|||
155564060|NCT02304458|561489152|FG000|Overall Study|Death|0|||
155564061|NCT02304458|561489153|FG001|Overall Study|Death|0|||
155564062|NCT02304458|561489154|FG002|Overall Study|Death|2|||
155564063|NCT02304458|561489155|FG003|Overall Study|Death|0|||
155564064|NCT02304458|561489156|FG004|Overall Study|Death|0|||
155564065|NCT02304458|561489157|FG005|Overall Study|Death|0|||
155564066|NCT02304458|561489158|FG006|Overall Study|Death|1|||
155564067|NCT02304458|561489159|FG007|Overall Study|Death|0|||
155564068|NCT02304458|561489152|FG000|Overall Study|Lack of Efficacy|4|||
155564069|NCT02304458|561489153|FG001|Overall Study|Lack of Efficacy|6|||
155564070|NCT02304458|561489154|FG002|Overall Study|Lack of Efficacy|38|||
155564071|NCT02304458|561489155|FG003|Overall Study|Lack of Efficacy|5|||
155564072|NCT02304458|561489156|FG004|Overall Study|Lack of Efficacy|6|||
155564073|NCT02304458|561489157|FG005|Overall Study|Lack of Efficacy|6|||
155564074|NCT02304458|561489158|FG006|Overall Study|Lack of Efficacy|21|||
155564075|NCT02304458|561489159|FG007|Overall Study|Lack of Efficacy|4|||
155564076|NCT02304458|561489152|FG000|Overall Study|Physician Decision|2|||
155564077|NCT02304458|561489153|FG001|Overall Study|Physician Decision|0|||
155564078|NCT02304458|561489154|FG002|Overall Study|Physician Decision|16|||
155564079|NCT02304458|561489155|FG003|Overall Study|Physician Decision|1|||
155564080|NCT02304458|561489156|FG004|Overall Study|Physician Decision|0|||
155564081|NCT02304458|561489157|FG005|Overall Study|Physician Decision|0|||
155564082|NCT02304458|561489158|FG006|Overall Study|Physician Decision|3|||
155564083|NCT02304458|561489159|FG007|Overall Study|Physician Decision|0|||
155564084|NCT02304458|561489152|FG000|Overall Study|Protocol Violation|0|||
155564085|NCT02304458|561489153|FG001|Overall Study|Protocol Violation|0|||
155564086|NCT02304458|561489154|FG002|Overall Study|Protocol Violation|1|||
155564087|NCT02304458|561489155|FG003|Overall Study|Protocol Violation|0|||
155564088|NCT02304458|561489156|FG004|Overall Study|Protocol Violation|0|||
155564089|NCT02304458|561489157|FG005|Overall Study|Protocol Violation|0|||
155564090|NCT02304458|561489158|FG006|Overall Study|Protocol Violation|0|||
155564091|NCT02304458|561489159|FG007|Overall Study|Protocol Violation|0|||
155564092|NCT02304458|561489152|FG000|Overall Study|Withdrawal by Subject|1|||
155564093|NCT02304458|561489153|FG001|Overall Study|Withdrawal by Subject|0|||
155564094|NCT02304458|561489154|FG002|Overall Study|Withdrawal by Subject|7|||
155564095|NCT02304458|561489155|FG003|Overall Study|Withdrawal by Subject|0|||
155564096|NCT02304458|561489156|FG004|Overall Study|Withdrawal by Subject|0|||
155564097|NCT02304458|561489157|FG005|Overall Study|Withdrawal by Subject|0|||
155564098|NCT02304458|561489158|FG006|Overall Study|Withdrawal by Subject|1|||
155564099|NCT02304458|561489159|FG007|Overall Study|Withdrawal by Subject|0|||
155564100|NCT00186043|561489160|FG000|Overall Study|Lack of Efficacy|1|||
155564101|NCT00186043|561489161|FG001|Overall Study|Lack of Efficacy|3|||
155564102|NCT00186043|561489160|FG000|Overall Study|Lost to Follow-up|4|||
155564103|NCT00186043|561489161|FG001|Overall Study|Lost to Follow-up|6|||
155564104|NCT00186043|561489160|FG000|Overall Study|Withdrawal by Subject|1|||
155564105|NCT00186043|561489161|FG001|Overall Study|Withdrawal by Subject|0|||
155564106|NCT00186043|561489160|FG000|Overall Study|Adverse Event|7|||
155564107|NCT00186043|561489161|FG001|Overall Study|Adverse Event|3|||
155564108|NCT00186043|561489160|FG000|Overall Study|Protocol Violation|2|||
155564109|NCT00186043|561489161|FG001|Overall Study|Protocol Violation|1|||
155564110|NCT04874636|561489162|FG000|Overall Study|Adverse Event|17|||
155564111|NCT04874636|561489163|FG001|Overall Study|Adverse Event|7|||
155564112|NCT04874636|561489162|FG000|Overall Study|Lost to Follow-up|1|||
155564113|NCT04874636|561489163|FG001|Overall Study|Lost to Follow-up|0|||
155564114|NCT04874636|561489162|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155564115|NCT04874636|561489163|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155564116|NCT04874636|561489162|FG000|Overall Study|Physician Decision|1|||
155564117|NCT04874636|561489163|FG001|Overall Study|Physician Decision|0|||
155564118|NCT04874636|561489162|FG000|Overall Study|Withdrawal by Subject|6|||
155564119|NCT04874636|561489163|FG001|Overall Study|Withdrawal by Subject|5|||
155564120|NCT04188301|561489166|FG000|Month 3|Lost to Follow-up|0|||
155564121|NCT04188301|561489167|FG001|Month 3|Lost to Follow-up|0|||
155564122|NCT04188301|561489168|FG002|Month 3|Lost to Follow-up|1|||
155564123|NCT04188301|561489166|FG000|Month 12|Lost to Follow-up|0|||
155564124|NCT04188301|561489167|FG001|Month 12|Lost to Follow-up|0|||
155564125|NCT04188301|561489168|FG002|Month 12|Lost to Follow-up|2|||
155564126|NCT04188301|561489166|FG000|Month 12|Death|1|||
155564127|NCT04188301|561489167|FG001|Month 12|Death|1|||
155564128|NCT04188301|561489168|FG002|Month 12|Death|0|||
155564129|NCT04188301|561489166|FG000|Month 18|Lost to Follow-up|6|||
155564130|NCT04188301|561489167|FG001|Month 18|Lost to Follow-up|0|||
155564131|NCT04188301|561489168|FG002|Month 18|Lost to Follow-up|0|||
155564132|NCT00228423|561489169|FG000|Overall Study|Adverse Event|2|||
155564133|NCT00228423|561489170|FG001|Overall Study|Adverse Event|5|||
155564134|NCT00228423|561489169|FG000|Overall Study|Withdrawal by Subject|7|||
155564135|NCT00228423|561489170|FG001|Overall Study|Withdrawal by Subject|3|||
155564136|NCT00228423|561489169|FG000|Overall Study|Protocol Violation|1|||
155564137|NCT00228423|561489170|FG001|Overall Study|Protocol Violation|3|||
155564138|NCT00228423|561489169|FG000|Overall Study|Physician Decision|0|||
155564139|NCT00228423|561489170|FG001|Overall Study|Physician Decision|1|||
155564140|NCT00620659|561489175|FG000|Treatment Period 1|Adverse Event|1|||
155564141|NCT00620659|561489176|FG001|Treatment Period 1|Adverse Event|0|||
155564142|NCT00620659|561489177|FG002|Treatment Period 1|Adverse Event|0|||
155564143|NCT00620659|561489178|FG003|Treatment Period 1|Adverse Event|3|||
155564144|NCT00620659|561489179|FG004|Treatment Period 1|Adverse Event|0|||
155564145|NCT00620659|561489180|FG005|Treatment Period 1|Adverse Event|0|||
155564146|NCT00620659|561489175|FG000|Treatment Period 1|Protocol Violation|1|||
155564147|NCT00620659|561489176|FG001|Treatment Period 1|Protocol Violation|0|||
155564148|NCT00620659|561489177|FG002|Treatment Period 1|Protocol Violation|0|||
155564149|NCT00620659|561489178|FG003|Treatment Period 1|Protocol Violation|0|||
155564150|NCT00620659|561489179|FG004|Treatment Period 1|Protocol Violation|0|||
155564151|NCT00620659|561489180|FG005|Treatment Period 1|Protocol Violation|0|||
155564152|NCT00620659|561489175|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155564153|NCT00620659|561489176|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155564154|NCT00620659|561489177|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155564155|NCT00620659|561489178|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155564156|NCT00620659|561489179|FG004|Treatment Period 1|Withdrawal by Subject|1|||
155564157|NCT00620659|561489180|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155564158|NCT00620659|561489175|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
155564159|NCT00620659|561489176|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
155564160|NCT00620659|561489177|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
155564161|NCT00620659|561489178|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
155564162|NCT00620659|561489179|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
155564163|NCT00620659|561489180|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
155564164|NCT00620659|561489175|FG000|Treatment Period 2|Adverse Event|0|||
155564165|NCT00620659|561489176|FG001|Treatment Period 2|Adverse Event|3|||
155564166|NCT00620659|561489177|FG002|Treatment Period 2|Adverse Event|0|||
155564167|NCT00620659|561489178|FG003|Treatment Period 2|Adverse Event|0|||
155564168|NCT00620659|561489179|FG004|Treatment Period 2|Adverse Event|2|||
155564169|NCT00620659|561489180|FG005|Treatment Period 2|Adverse Event|0|||
155564170|NCT00620659|561489175|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155564171|NCT00620659|561489176|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155564172|NCT00620659|561489177|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155564173|NCT00620659|561489178|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155564174|NCT00620659|561489179|FG004|Treatment Period 2|Withdrawal by Subject|3|||
155564175|NCT00620659|561489180|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155564176|NCT00620659|561489175|FG000|Placebo Washout Period 2|Adverse Event|2|||
155564177|NCT00620659|561489176|FG001|Placebo Washout Period 2|Adverse Event|0|||
155564178|NCT00620659|561489177|FG002|Placebo Washout Period 2|Adverse Event|0|||
155564179|NCT00620659|561489178|FG003|Placebo Washout Period 2|Adverse Event|0|||
155564180|NCT00620659|561489179|FG004|Placebo Washout Period 2|Adverse Event|0|||
155564181|NCT00620659|561489180|FG005|Placebo Washout Period 2|Adverse Event|0|||
155564182|NCT00620659|561489175|FG000|Treatment Period 3|Adverse Event|0|||
155564183|NCT00620659|561489176|FG001|Treatment Period 3|Adverse Event|2|||
155564184|NCT00620659|561489177|FG002|Treatment Period 3|Adverse Event|0|||
155564185|NCT00620659|561489178|FG003|Treatment Period 3|Adverse Event|0|||
155564186|NCT00620659|561489179|FG004|Treatment Period 3|Adverse Event|0|||
155564187|NCT00620659|561489180|FG005|Treatment Period 3|Adverse Event|0|||
155564188|NCT00620659|561489175|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155564189|NCT00620659|561489176|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155564190|NCT00620659|561489177|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155564191|NCT00620659|561489178|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155564192|NCT00620659|561489179|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155564193|NCT00620659|561489180|FG005|Treatment Period 3|Withdrawal by Subject|0|||
155564194|NCT03246646|561489183|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
155564195|NCT03246646|561489184|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
155564196|NCT03246646|561489183|FG000|Overall Study|Withdrawal by Subject|3|||
155564197|NCT03246646|561489184|FG001|Overall Study|Withdrawal by Subject|0|||
155564198|NCT03246646|561489183|FG000|Overall Study|Lost to Follow-up|7|||
155564199|NCT03246646|561489184|FG001|Overall Study|Lost to Follow-up|0|||
155564200|NCT04241315|561491332|FG000|Overall Study|Withdrawal by Subject|0|||
155564201|NCT04241315|561491333|FG001|Overall Study|Withdrawal by Subject|1|||
155564202|NCT00663026|561491334|FG000|Overall Study|Lost to Follow-up|1|||
155564203|NCT00663026|561491335|FG001|Overall Study|Lost to Follow-up|0|||
155564204|NCT00663026|561491336|FG002|Overall Study|Lost to Follow-up|0|||
155564205|NCT00663026|561491334|FG000|Overall Study|Other|1|||
155564206|NCT00663026|561491335|FG001|Overall Study|Other|2|||
155564207|NCT00663026|561491336|FG002|Overall Study|Other|0|||
155564208|NCT00663026|561491334|FG000|Overall Study|Adverse Event|0|||
155564209|NCT00663026|561491335|FG001|Overall Study|Adverse Event|2|||
155564210|NCT00663026|561491336|FG002|Overall Study|Adverse Event|3|||
155564211|NCT00663026|561491334|FG000|Overall Study|Caregiver Request|0|||
155564212|NCT00663026|561491335|FG001|Overall Study|Caregiver Request|2|||
155564213|NCT00663026|561491336|FG002|Overall Study|Caregiver Request|0|||
155564214|NCT00663026|561491334|FG000|Overall Study|Withdrawal by Subject|0|||
155564215|NCT00663026|561491335|FG001|Overall Study|Withdrawal by Subject|0|||
155564216|NCT00663026|561491336|FG002|Overall Study|Withdrawal by Subject|1|||
155564217|NCT03783039|561491347|FG000|Overall Study|Death|2|||
155564218|NCT03783039|561491348|FG001|Overall Study|Death|1|||
155564219|NCT00837473|561491349|FG000|Overall Study|Lost to Follow-up|1|||
155564220|NCT00837473|561491349|FG000|Overall Study|Withdrawal by Subject|2|||
155564221|NCT03400943|561491350|FG000|Treatment Period 1|Adverse Event|0|||
155564222|NCT03400943|561491351|FG001|Treatment Period 1|Adverse Event|0|||
155564223|NCT03400943|561491352|FG002|Treatment Period 1|Adverse Event|0|||
155564224|NCT03400943|561491353|FG003|Treatment Period 1|Adverse Event|1|||
155564225|NCT03400943|561491350|FG000|Treatment Period 1|Lost to Follow-up|1|||
155564226|NCT03400943|561491351|FG001|Treatment Period 1|Lost to Follow-up|0|||
155564227|NCT03400943|561491352|FG002|Treatment Period 1|Lost to Follow-up|0|||
155564228|NCT03400943|561491353|FG003|Treatment Period 1|Lost to Follow-up|0|||
155564229|NCT03400943|561491350|FG000|Treatment Period 1|Protocol Violation|0|||
155564230|NCT03400943|561491351|FG001|Treatment Period 1|Protocol Violation|1|||
155564231|NCT03400943|561491352|FG002|Treatment Period 1|Protocol Violation|1|||
155564232|NCT03400943|561491353|FG003|Treatment Period 1|Protocol Violation|0|||
155564233|NCT03400943|561491350|FG000|Treatment Period 1|Study terminated by sponsor|2|||
155564234|NCT03400943|561491351|FG001|Treatment Period 1|Study terminated by sponsor|0|||
155564235|NCT03400943|561491352|FG002|Treatment Period 1|Study terminated by sponsor|0|||
155564236|NCT03400943|561491353|FG003|Treatment Period 1|Study terminated by sponsor|1|||
155564237|NCT03400943|561491350|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155564238|NCT03400943|561491351|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155564239|NCT03400943|561491352|FG002|Treatment Period 1|Withdrawal by Subject|3|||
155564240|NCT03400943|561491353|FG003|Treatment Period 1|Withdrawal by Subject|1|||
155564241|NCT03400943|561491350|FG000|Treatment Period 1|Other|2|||
155564242|NCT03400943|561491351|FG001|Treatment Period 1|Other|1|||
155564243|NCT03400943|561491352|FG002|Treatment Period 1|Other|2|||
155564244|NCT03400943|561491353|FG003|Treatment Period 1|Other|2|||
155564245|NCT03400943|561491350|FG000|Post-treatment Period 1|Adverse Event|2|||
155564246|NCT03400943|561491351|FG001|Post-treatment Period 1|Adverse Event|0|||
155564247|NCT03400943|561491352|FG002|Post-treatment Period 1|Adverse Event|0|||
155564248|NCT03400943|561491353|FG003|Post-treatment Period 1|Adverse Event|0|||
155564249|NCT03400943|561491350|FG000|Post-treatment Period 1|Protocol Violation|1|||
155564250|NCT03400943|561491351|FG001|Post-treatment Period 1|Protocol Violation|0|||
155564251|NCT03400943|561491352|FG002|Post-treatment Period 1|Protocol Violation|0|||
155564252|NCT03400943|561491353|FG003|Post-treatment Period 1|Protocol Violation|0|||
155564253|NCT03400943|561491350|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
155564254|NCT03400943|561491351|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
155564255|NCT03400943|561491352|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
155564256|NCT03400943|561491353|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
155564257|NCT03400943|561491350|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
155564258|NCT03400943|561491351|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
155564259|NCT03400943|561491352|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
155564260|NCT03400943|561491353|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
155564261|NCT03400943|561491350|FG000|Post-treatment Period 1|Other|2|||
155564262|NCT03400943|561491351|FG001|Post-treatment Period 1|Other|0|||
155564263|NCT03400943|561491352|FG002|Post-treatment Period 1|Other|4|||
155564264|NCT03400943|561491353|FG003|Post-treatment Period 1|Other|5|||
155564265|NCT03400943|561491350|FG000|Treatment Period 2|Study terminated by sponsor|0|||
155564266|NCT03400943|561491351|FG001|Treatment Period 2|Study terminated by sponsor|1|||
155564267|NCT03400943|561491352|FG002|Treatment Period 2|Study terminated by sponsor|0|||
155564268|NCT03400943|561491353|FG003|Treatment Period 2|Study terminated by sponsor|0|||
155564269|NCT03400943|561491350|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155564270|NCT03400943|561491351|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155564271|NCT03400943|561491352|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155564272|NCT03400943|561491353|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155564273|NCT03400943|561491350|FG000|Treatment Period 2|Other|1|||
155564274|NCT03400943|561491351|FG001|Treatment Period 2|Other|6|||
155564275|NCT03400943|561491352|FG002|Treatment Period 2|Other|0|||
155564276|NCT03400943|561491353|FG003|Treatment Period 2|Other|0|||
155564277|NCT03400943|561491350|FG000|Follow-up Period|Withdrawal by Subject|1|||
155564278|NCT03400943|561491351|FG001|Follow-up Period|Withdrawal by Subject|0|||
155564279|NCT03400943|561491352|FG002|Follow-up Period|Withdrawal by Subject|0|||
155658782|NCT00876447|561844726|FG000|Overall Study|Personal reasons|30|||
155658783|NCT00876447|561844727|FG001|Overall Study|Personal reasons|28|||
155658784|NCT00876447|561844726|FG000|Overall Study|Lost to Follow-up|6|||
155658785|NCT00876447|561844727|FG001|Overall Study|Lost to Follow-up|15|||
155658786|NCT00876447|561844726|FG000|Overall Study|Pregnancy|4|||
155658787|NCT00876447|561844727|FG001|Overall Study|Pregnancy|2|||
155658788|NCT00876447|561844726|FG000|Overall Study|Lack of Efficacy|5|||
155658789|NCT00876447|561844727|FG001|Overall Study|Lack of Efficacy|3|||
155658790|NCT00876447|561844726|FG000|Overall Study|Adverse Event|4|||
155658791|NCT00876447|561844727|FG001|Overall Study|Adverse Event|8|||
155658792|NCT00567502|561844728|FG000|Overall Study|Lost to Follow-up|91|||
155658793|NCT00567502|561844729|FG001|Overall Study|Lost to Follow-up|14|||
155658794|NCT00567502|561844730|FG002|Overall Study|Lost to Follow-up|351|||
155658795|NCT00567502|561844731|FG003|Overall Study|Lost to Follow-up|2|||
155658796|NCT00567502|561844728|FG000|Overall Study|Death|65|||
155658797|NCT00567502|561844729|FG001|Overall Study|Death|16|||
155658798|NCT00567502|561844730|FG002|Overall Study|Death|360|||
155658799|NCT00567502|561844731|FG003|Overall Study|Death|5|||
155658800|NCT00567502|561844728|FG000|Overall Study|Other|64|||
155658801|NCT00567502|561844729|FG001|Overall Study|Other|2|||
155658802|NCT00567502|561844730|FG002|Overall Study|Other|134|||
155658803|NCT00567502|561844731|FG003|Overall Study|Other|6|||
155658804|NCT00567502|561844728|FG000|Overall Study|Participant request|12|||
155658805|NCT00567502|561844729|FG001|Overall Study|Participant request|1|||
155658806|NCT00567502|561844730|FG002|Overall Study|Participant request|33|||
155658807|NCT00567502|561844731|FG003|Overall Study|Participant request|1|||
155658808|NCT00567502|561844728|FG000|Overall Study|Sponsor request|9|||
155658809|NCT00567502|561844729|FG001|Overall Study|Sponsor request|0|||
155658810|NCT00567502|561844730|FG002|Overall Study|Sponsor request|30|||
155658811|NCT00567502|561844731|FG003|Overall Study|Sponsor request|1|||
155658812|NCT00567502|561844728|FG000|Overall Study|Never Initiated Treatment|0|||
155658813|NCT00567502|561844729|FG001|Overall Study|Never Initiated Treatment|0|||
155658814|NCT00567502|561844730|FG002|Overall Study|Never Initiated Treatment|0|||
155658815|NCT00567502|561844731|FG003|Overall Study|Never Initiated Treatment|72|||
155658816|NCT02297516|561844732|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
155658817|NCT02297516|561844733|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
155658818|NCT02297516|561844732|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
155658819|NCT02297516|561844733|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
155658820|NCT02297516|561844732|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
155658821|NCT02297516|561844733|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
155658822|NCT00710593|561844734|FG000|Overall Study|Incarceration|1|||
155658823|NCT00710593|561844735|FG001|Overall Study|Incarceration|0|||
155658824|NCT00710593|561844734|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
155658825|NCT00710593|561844735|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
155658826|NCT00710593|561844734|FG000|Overall Study|Lost to Follow-up|3|||
155658827|NCT00710593|561844735|FG001|Overall Study|Lost to Follow-up|1|||
155658828|NCT00710593|561844734|FG000|Overall Study|Moved out of area|1|||
155658829|NCT00710593|561844735|FG001|Overall Study|Moved out of area|0|||
155658830|NCT00710593|561844734|FG000|Overall Study|Failure to adhere or complete study eval|1|||
155658831|NCT00710593|561844735|FG001|Overall Study|Failure to adhere or complete study eval|1|||
155658832|NCT00710593|561844734|FG000|Overall Study|Protocol Violation|1|||
155658833|NCT00710593|561844735|FG001|Overall Study|Protocol Violation|1|||
155658834|NCT00710593|561844734|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
155658835|NCT00710593|561844735|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
155658836|NCT04490278|561844736|FG000|Overall Study|Lost to Follow-up|6|||
155658837|NCT00366457|561844740|FG000|Overall Study|never began study therapy|2|||
155658838|NCT02538614|561844741|FG000|Overall Study|Progressive Disease|2|||
155658839|NCT00183248|561844750|FG000|Overall Study|Lost to Follow-up|0|||
155658840|NCT00183248|561844751|FG001|Overall Study|Lost to Follow-up|1|||
155658841|NCT00183248|561844750|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
155658842|NCT00183248|561844751|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
155658843|NCT04734210|561844752|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
155658844|NCT04734210|561844753|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
155658845|NCT04734210|561844754|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
155658846|NCT04734210|561844752|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
155658847|NCT04734210|561844753|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
155658848|NCT04734210|561844754|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
155658849|NCT04734210|561844752|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
155658850|NCT04734210|561844753|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
155658851|NCT04734210|561844754|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
155721140|NCT02587221|562077763|FG001|Overall Study|Withdrawal by Subject|61|||
155721141|NCT02587221|562077762|FG000|Overall Study|Lost to Follow-up|21|||
155721142|NCT02587221|562077763|FG001|Overall Study|Lost to Follow-up|19|||
155658852|NCT04734210|561844752|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
155658853|NCT04734210|561844753|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
155658854|NCT04734210|561844754|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
155658855|NCT01358734|561844755|FG000|Overall Study|Adverse Event|4|||
155658856|NCT01358734|561844756|FG001|Overall Study|Adverse Event|7|||
155658857|NCT01358734|561844757|FG002|Overall Study|Adverse Event|3|||
155658858|NCT01358734|561844755|FG000|Overall Study|Lack of Efficacy|0|||
155658859|NCT01358734|561844756|FG001|Overall Study|Lack of Efficacy|1|||
155658860|NCT01358734|561844757|FG002|Overall Study|Lack of Efficacy|3|||
155658861|NCT01358734|561844755|FG000|Overall Study|Withdrawal by Subject|1|||
155658862|NCT01358734|561844756|FG001|Overall Study|Withdrawal by Subject|6|||
155658863|NCT01358734|561844757|FG002|Overall Study|Withdrawal by Subject|3|||
155658864|NCT01358734|561844755|FG000|Overall Study|Death|3|||
155658865|NCT01358734|561844756|FG001|Overall Study|Death|7|||
155658866|NCT01358734|561844757|FG002|Overall Study|Death|2|||
155658867|NCT01358734|561844755|FG000|Overall Study|Progressive Disease|5|||
155658868|NCT01358734|561844756|FG001|Overall Study|Progressive Disease|13|||
155658869|NCT01358734|561844757|FG002|Overall Study|Progressive Disease|16|||
155658870|NCT01358734|561844755|FG000|Overall Study|Non-compliance with study drug|0|||
155658871|NCT01358734|561844756|FG001|Overall Study|Non-compliance with study drug|0|||
155658872|NCT01358734|561844757|FG002|Overall Study|Non-compliance with study drug|1|||
155658873|NCT01358734|561844755|FG000|Overall Study|Other|2|||
155658874|NCT01358734|561844756|FG001|Overall Study|Other|5|||
155658875|NCT01358734|561844757|FG002|Overall Study|Other|4|||
155658876|NCT01358734|561844755|FG000|Overall Study|Protocol Violation|0|||
155658877|NCT01358734|561844756|FG001|Overall Study|Protocol Violation|0|||
155658878|NCT01358734|561844757|FG002|Overall Study|Protocol Violation|2|||
155658879|NCT03847519|561844764|FG000|Overall Study|Death|5|||
155658880|NCT03847519|561844765|FG001|Overall Study|Death|8|||
155658881|NCT03847519|561844766|FG002|Overall Study|Death|1|||
155658882|NCT03847519|561844764|FG000|Overall Study|Lost to Follow-up|1|||
155658883|NCT03847519|561844765|FG001|Overall Study|Lost to Follow-up|2|||
155658884|NCT03847519|561844766|FG002|Overall Study|Lost to Follow-up|0|||
155658885|NCT03847519|561844764|FG000|Overall Study|Study Terminated by Sponsor|0|||
155658886|NCT03847519|561844765|FG001|Overall Study|Study Terminated by Sponsor|3|||
155658887|NCT03847519|561844766|FG002|Overall Study|Study Terminated by Sponsor|2|||
155658888|NCT02095106|561844767|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155658889|NCT02095106|561844768|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155658890|NCT00023595|561844776|FG000|5 Year Follow up|Lost to Follow-up|2|||
155658891|NCT00023595|561844777|FG001|5 Year Follow up|Lost to Follow-up|2|||
155658892|NCT00023595|561844778|FG002|5 Year Follow up|Lost to Follow-up|1|||
155658893|NCT00023595|561844779|FG003|5 Year Follow up|Lost to Follow-up|7|||
155658894|NCT00023595|561844780|FG004|5 Year Follow up|Lost to Follow-up|3|||
155658895|NCT00023595|561844776|FG000|10 Year Follow up|Lost to Follow-up|12|||
155658896|NCT00023595|561844777|FG001|10 Year Follow up|Lost to Follow-up|10|||
155658897|NCT00023595|561844778|FG002|10 Year Follow up|Lost to Follow-up|3|||
155658898|NCT00023595|561844779|FG003|10 Year Follow up|Lost to Follow-up|0|||
155658899|NCT00023595|561844780|FG004|10 Year Follow up|Lost to Follow-up|0|||
155658900|NCT02284893|561844781|FG000|26 Week (Short Term)|Adverse Event|1|||
155658901|NCT02284893|561844782|FG001|26 Week (Short Term)|Adverse Event|9|||
155658902|NCT02284893|561844781|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
155658903|NCT02284893|561844782|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
155658904|NCT02284893|561844781|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
155658905|NCT02284893|561844782|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
155658906|NCT02284893|561844781|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
155658907|NCT02284893|561844782|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
155658908|NCT02284893|561844781|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
155658909|NCT02284893|561844782|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
155658910|NCT02284893|561844781|FG000|26 Week (Short Term)|Other|1|||
155658911|NCT02284893|561844782|FG001|26 Week (Short Term)|Other|1|||
155658912|NCT02284893|561844781|FG000|52 Week (Long Term)|Adverse Event|3|||
155658913|NCT02284893|561844782|FG001|52 Week (Long Term)|Adverse Event|1|||
155564280|NCT03400943|561491353|FG003|Follow-up Period|Withdrawal by Subject|0|||
155564281|NCT00537303|561491354|FG000|Overall Study|Adverse Event|1|||
155564282|NCT00537303|561491355|FG001|Overall Study|Adverse Event|4|||
155564283|NCT00537303|561491354|FG000|Overall Study|Lack of Efficacy|6|||
155564284|NCT00537303|561491355|FG001|Overall Study|Lack of Efficacy|7|||
155564285|NCT00537303|561491354|FG000|Overall Study|Protocol Violation|8|||
155564286|NCT00537303|561491355|FG001|Overall Study|Protocol Violation|4|||
155564287|NCT00537303|561491354|FG000|Overall Study|Withdrawal criteria|3|||
155564288|NCT00537303|561491355|FG001|Overall Study|Withdrawal criteria|3|||
155564289|NCT00537303|561491354|FG000|Overall Study|Unclassified|8|||
155564290|NCT00537303|561491355|FG001|Overall Study|Unclassified|7|||
155564291|NCT04524364|561491358|FG000|Overall Study|Physician Decision|3|||
155564292|NCT04524364|561491359|FG001|Overall Study|Physician Decision|6|||
155564293|NCT04524364|561491358|FG000|Overall Study|Adverse Event|0|||
155564294|NCT04524364|561491359|FG001|Overall Study|Adverse Event|1|||
155564295|NCT04524364|561491358|FG000|Overall Study|Investigational device deficiency|0|||
155564296|NCT04524364|561491359|FG001|Overall Study|Investigational device deficiency|1|||
155564297|NCT04524364|561491358|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
155564298|NCT04524364|561491359|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
155564299|NCT04524364|561491358|FG000|Overall Study|Device unavailability|0|||
155564300|NCT04524364|561491359|FG001|Overall Study|Device unavailability|2|||
155564301|NCT04524364|561491358|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
155564302|NCT04524364|561491359|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
155564303|NCT04524364|561491358|FG000|Overall Study|Low International normalized ratio (INR)|1|||
155564304|NCT04524364|561491359|FG001|Overall Study|Low International normalized ratio (INR)|0|||
155564305|NCT00380744|561491362|FG000|Overall Study|Death|0|||
155564306|NCT00380744|561491363|FG001|Overall Study|Death|0|||
155564307|NCT00380744|561491364|FG002|Overall Study|Death|0|||
155564308|NCT00380744|561491365|FG003|Overall Study|Death|0|||
155564309|NCT00380744|561491366|FG004|Overall Study|Death|0|||
155564310|NCT00380744|561491367|FG005|Overall Study|Death|0|||
155564311|NCT00380744|561491368|FG006|Overall Study|Death|1|||
155564312|NCT00380744|561491362|FG000|Overall Study|Withdrawal by Subject|1|||
155564313|NCT00380744|561491363|FG001|Overall Study|Withdrawal by Subject|0|||
155564314|NCT00380744|561491364|FG002|Overall Study|Withdrawal by Subject|0|||
155564315|NCT00380744|561491365|FG003|Overall Study|Withdrawal by Subject|0|||
155564316|NCT00380744|561491366|FG004|Overall Study|Withdrawal by Subject|0|||
155564317|NCT00380744|561491367|FG005|Overall Study|Withdrawal by Subject|0|||
155564318|NCT00380744|561491368|FG006|Overall Study|Withdrawal by Subject|0|||
155564319|NCT01338870|561491376|FG000|Overall Study|Lost to Follow-up|0|||
155564320|NCT01338870|561491377|FG001|Overall Study|Lost to Follow-up|0|||
155564321|NCT01338870|561491378|FG002|Overall Study|Lost to Follow-up|1|||
155564322|NCT01338870|561491379|FG003|Overall Study|Lost to Follow-up|0|||
155564323|NCT01338870|561491380|FG004|Overall Study|Lost to Follow-up|1|||
155564324|NCT01338870|561491381|FG005|Overall Study|Lost to Follow-up|0|||
155564325|NCT01338870|561491376|FG000|Overall Study|Withdrawal by Subject|2|||
155564326|NCT01338870|561491377|FG001|Overall Study|Withdrawal by Subject|3|||
155564327|NCT01338870|561491378|FG002|Overall Study|Withdrawal by Subject|4|||
155564328|NCT01338870|561491379|FG003|Overall Study|Withdrawal by Subject|0|||
155564329|NCT01338870|561491380|FG004|Overall Study|Withdrawal by Subject|0|||
155564330|NCT01338870|561491381|FG005|Overall Study|Withdrawal by Subject|2|||
155564331|NCT01338870|561491376|FG000|Overall Study|Other|3|||
155564332|NCT01338870|561491377|FG001|Overall Study|Other|3|||
155564333|NCT01338870|561491378|FG002|Overall Study|Other|3|||
155564334|NCT01338870|561491379|FG003|Overall Study|Other|2|||
155564335|NCT01338870|561491380|FG004|Overall Study|Other|0|||
155658914|NCT02284893|561844781|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
155658915|NCT02284893|561844782|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
155564336|NCT01338870|561491381|FG005|Overall Study|Other|2|||
155564337|NCT01338870|561491376|FG000|Overall Study|Protocol Violation|0|||
155564338|NCT01338870|561491377|FG001|Overall Study|Protocol Violation|2|||
155564339|NCT01338870|561491378|FG002|Overall Study|Protocol Violation|2|||
155564340|NCT01338870|561491379|FG003|Overall Study|Protocol Violation|2|||
155564341|NCT01338870|561491380|FG004|Overall Study|Protocol Violation|1|||
155564342|NCT01338870|561491381|FG005|Overall Study|Protocol Violation|1|||
155564343|NCT01338870|561491376|FG000|Overall Study|Adverse Event|4|||
155564344|NCT01338870|561491377|FG001|Overall Study|Adverse Event|4|||
155564345|NCT01338870|561491378|FG002|Overall Study|Adverse Event|1|||
155564346|NCT01338870|561491379|FG003|Overall Study|Adverse Event|5|||
155564347|NCT01338870|561491380|FG004|Overall Study|Adverse Event|4|||
155564348|NCT01338870|561491381|FG005|Overall Study|Adverse Event|1|||
155564349|NCT01955083|561491386|FG000|Overall Study|Lost to Follow-up|1|||
155564350|NCT01955083|561491387|FG001|Overall Study|Lost to Follow-up|1|||
155564351|NCT01559389|561491396|FG000|Overall Study|Withdrawal by Subject|20|||
155564352|NCT01559389|561491397|FG001|Overall Study|Withdrawal by Subject|20|||
155564353|NCT02871492|561491398|FG000|Overall Study|Lost to Follow-up|6|||
155564354|NCT02871492|561491399|FG001|Overall Study|Lost to Follow-up|3|||
155564355|NCT02871492|561491400|FG002|Overall Study|Lost to Follow-up|5|||
155564356|NCT02871492|561491398|FG000|Overall Study|Withdrawal by Subject|0|||
155564357|NCT02871492|561491399|FG001|Overall Study|Withdrawal by Subject|0|||
155564358|NCT02871492|561491400|FG002|Overall Study|Withdrawal by Subject|1|||
155564359|NCT04546724|561491401|FG000|Overall Study|Withdrawal by Subject|145|||
155564360|NCT04546724|561491402|FG001|Overall Study|Withdrawal by Subject|41|||
155564361|NCT04546724|561491401|FG000|Overall Study|Adverse Event|1|||
155564362|NCT04546724|561491402|FG001|Overall Study|Adverse Event|1|||
155564363|NCT04546724|561491401|FG000|Overall Study|Lost to Follow-up|186|||
155564364|NCT04546724|561491402|FG001|Overall Study|Lost to Follow-up|63|||
155564365|NCT04546724|561491401|FG000|Overall Study|Physician Decision|8|||
155564366|NCT04546724|561491402|FG001|Overall Study|Physician Decision|2|||
155564367|NCT04546724|561491401|FG000|Overall Study|Death|2|||
155564368|NCT04546724|561491402|FG001|Overall Study|Death|1|||
155564369|NCT04546724|561491401|FG000|Overall Study|subject has been out of town|1|||
155564370|NCT04546724|561491402|FG001|Overall Study|subject has been out of town|0|||
155564371|NCT04546724|561491401|FG000|Overall Study|subject is incarcerated|2|||
155564372|NCT04546724|561491402|FG001|Overall Study|subject is incarcerated|0|||
155564373|NCT04546724|561491401|FG000|Overall Study|subject is relocating|12|||
155564374|NCT04546724|561491402|FG001|Overall Study|subject is relocating|4|||
155564375|NCT04546724|561491401|FG000|Overall Study|Subject in another study|1|||
155564376|NCT04546724|561491402|FG001|Overall Study|Subject in another study|1|||
155564377|NCT03583086|561491403|FG000|Overall Study|Death|2|||
155564378|NCT03583086|561491404|FG001|Overall Study|Death|6|||
155564379|NCT03583086|561491405|FG002|Overall Study|Death|12|||
155564380|NCT03583086|561491406|FG003|Overall Study|Death|10|||
155564381|NCT03583086|561491407|FG004|Overall Study|Death|14|||
155564382|NCT03583086|561491408|FG005|Overall Study|Death|14|||
155564383|NCT03583086|561491409|FG006|Overall Study|Death|4|||
155564384|NCT03583086|561491403|FG000|Overall Study|Withdrawal by Subject|0|||
155564385|NCT03583086|561491404|FG001|Overall Study|Withdrawal by Subject|0|||
155564386|NCT03583086|561491405|FG002|Overall Study|Withdrawal by Subject|1|||
155564387|NCT03583086|561491406|FG003|Overall Study|Withdrawal by Subject|0|||
155564388|NCT03583086|561491407|FG004|Overall Study|Withdrawal by Subject|0|||
155564389|NCT03583086|561491408|FG005|Overall Study|Withdrawal by Subject|0|||
155564390|NCT03583086|561491409|FG006|Overall Study|Withdrawal by Subject|1|||
155564391|NCT03583086|561491403|FG000|Overall Study|Refused follow-up|0|||
155564392|NCT03583086|561491404|FG001|Overall Study|Refused follow-up|0|||
155564393|NCT03583086|561491405|FG002|Overall Study|Refused follow-up|1|||
155564394|NCT03583086|561491406|FG003|Overall Study|Refused follow-up|0|||
155564395|NCT03583086|561491407|FG004|Overall Study|Refused follow-up|1|||
155564396|NCT03583086|561491408|FG005|Overall Study|Refused follow-up|0|||
155564397|NCT03583086|561491409|FG006|Overall Study|Refused follow-up|0|||
155564398|NCT03583086|561491403|FG000|Overall Study|Declining Performance Status|0|||
155564399|NCT03583086|561491404|FG001|Overall Study|Declining Performance Status|0|||
155564400|NCT03583086|561491405|FG002|Overall Study|Declining Performance Status|1|||
155564401|NCT03583086|561491406|FG003|Overall Study|Declining Performance Status|0|||
155564402|NCT03583086|561491407|FG004|Overall Study|Declining Performance Status|0|||
155564403|NCT03583086|561491408|FG005|Overall Study|Declining Performance Status|0|||
155564404|NCT03583086|561491409|FG006|Overall Study|Declining Performance Status|0|||
155564405|NCT03583086|561491403|FG000|Overall Study|Still on study|0|||
155564406|NCT03583086|561491404|FG001|Overall Study|Still on study|0|||
155564407|NCT03583086|561491405|FG002|Overall Study|Still on study|0|||
155564408|NCT03583086|561491406|FG003|Overall Study|Still on study|1|||
155564409|NCT03583086|561491407|FG004|Overall Study|Still on study|0|||
155564410|NCT03583086|561491408|FG005|Overall Study|Still on study|0|||
155564411|NCT03583086|561491409|FG006|Overall Study|Still on study|1|||
155564412|NCT03583086|561491403|FG000|Overall Study|Disease progression|0|||
155564413|NCT03583086|561491404|FG001|Overall Study|Disease progression|0|||
155564414|NCT03583086|561491405|FG002|Overall Study|Disease progression|0|||
155564415|NCT03583086|561491406|FG003|Overall Study|Disease progression|0|||
155564416|NCT03583086|561491407|FG004|Overall Study|Disease progression|0|||
155564417|NCT03583086|561491408|FG005|Overall Study|Disease progression|0|||
155564418|NCT03583086|561491409|FG006|Overall Study|Disease progression|1|||
155564419|NCT03583086|561491403|FG000|Overall Study|Undergoing radiation therapy|0|||
155564420|NCT03583086|561491404|FG001|Overall Study|Undergoing radiation therapy|0|||
155564421|NCT03583086|561491405|FG002|Overall Study|Undergoing radiation therapy|0|||
155564422|NCT03583086|561491406|FG003|Overall Study|Undergoing radiation therapy|0|||
155564423|NCT03583086|561491407|FG004|Overall Study|Undergoing radiation therapy|0|||
155564424|NCT03583086|561491408|FG005|Overall Study|Undergoing radiation therapy|0|||
155564425|NCT03583086|561491409|FG006|Overall Study|Undergoing radiation therapy|1|||
155564426|NCT03583086|561491403|FG000|Overall Study|Lost to Follow-up|0|||
155564427|NCT03583086|561491404|FG001|Overall Study|Lost to Follow-up|0|||
155564428|NCT03583086|561491405|FG002|Overall Study|Lost to Follow-up|0|||
155564429|NCT03583086|561491406|FG003|Overall Study|Lost to Follow-up|0|||
155564430|NCT03583086|561491407|FG004|Overall Study|Lost to Follow-up|0|||
155564431|NCT03583086|561491408|FG005|Overall Study|Lost to Follow-up|1|||
155564432|NCT03583086|561491409|FG006|Overall Study|Lost to Follow-up|0|||
155564433|NCT03583086|561491403|FG000|Overall Study|Adverse Event|0|||
155564434|NCT03583086|561491404|FG001|Overall Study|Adverse Event|0|||
155564435|NCT03583086|561491405|FG002|Overall Study|Adverse Event|0|||
155564436|NCT03583086|561491406|FG003|Overall Study|Adverse Event|0|||
155564437|NCT03583086|561491407|FG004|Overall Study|Adverse Event|0|||
155564438|NCT03583086|561491408|FG005|Overall Study|Adverse Event|1|||
155564439|NCT03583086|561491409|FG006|Overall Study|Adverse Event|0|||
155564440|NCT00396812|561491411|FG000|Overall Study|Physician Decision|1|||
155564441|NCT03201445|561491415|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
155564442|NCT03201445|561491416|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
155564443|NCT03201445|561491415|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
155564444|NCT03201445|561491416|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
155564445|NCT03201445|561491415|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
155564446|NCT03201445|561491416|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
155564447|NCT03201445|561491415|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
155564448|NCT03201445|561491416|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
155564449|NCT03201445|561491415|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
155564450|NCT03201445|561491416|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
155564451|NCT03201445|561491415|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
155564452|NCT03201445|561491416|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
155564453|NCT03201445|561491415|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
155564454|NCT03201445|561491416|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
155564455|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
155564456|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
155564457|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
155564458|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
155564459|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
155564460|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
155564461|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
155564462|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
155564463|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
155564464|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
155564465|NCT03201445|561491415|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
155564466|NCT03201445|561491416|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
155564467|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
155564468|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
155564469|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
155564470|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
155564471|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
155564472|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
155564473|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
155564474|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
155564475|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
155564476|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
155564477|NCT03201445|561491415|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
155564478|NCT03201445|561491416|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
155564479|NCT03201445|561491415|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
155564480|NCT03201445|561491416|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
155564481|NCT03201445|561491415|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
155564482|NCT03201445|561491416|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
155564483|NCT01228019|561491417|FG000|Overall Study|Dose Violation|70|||
155564484|NCT01228019|561491417|FG000|Overall Study|Duplicate enrollment|1|||
155564485|NCT01228019|561491417|FG000|Overall Study|Missing pre-treatment data|72|||
155564486|NCT01228019|561491417|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
155564487|NCT01228019|561491417|FG000|Overall Study|Violation of Entry Criterion|9|||
155564488|NCT01346293|561491420|FG000|Overall Study|Protocol Violation|30|||
155564489|NCT01346293|561491421|FG001|Overall Study|Protocol Violation|9|||
155564490|NCT01346293|561491420|FG000|Overall Study|Lost to Follow-up|21|||
155564491|NCT01346293|561491421|FG001|Overall Study|Lost to Follow-up|8|||
155564492|NCT01346293|561491420|FG000|Overall Study|Withdrawal by Subject|15|||
155564493|NCT01346293|561491421|FG001|Overall Study|Withdrawal by Subject|4|||
155564494|NCT01346293|561491420|FG000|Overall Study|Other|1|||
155564495|NCT01346293|561491421|FG001|Overall Study|Other|0|||
155564496|NCT01844505|561491424|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
155658916|NCT02284893|561844781|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
155658917|NCT02284893|561844782|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
155564497|NCT01844505|561491425|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
155564498|NCT01844505|561491426|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
155564499|NCT01844505|561491424|FG000|Treatment Period|Other Reasons|120|||
155564500|NCT01844505|561491425|FG001|Treatment Period|Other Reasons|136|||
155564501|NCT01844505|561491426|FG002|Treatment Period|Other Reasons|58|||
155564502|NCT01844505|561491424|FG000|Treatment Period|Lost to Follow-up|9|||
155564503|NCT01844505|561491425|FG001|Treatment Period|Lost to Follow-up|11|||
155564504|NCT01844505|561491426|FG002|Treatment Period|Lost to Follow-up|6|||
155564505|NCT01844505|561491424|FG000|Treatment Period|Death|175|||
155564506|NCT01844505|561491425|FG001|Treatment Period|Death|154|||
155564507|NCT01844505|561491426|FG002|Treatment Period|Death|228|||
155564508|NCT00128830|561491427|FG000|Overall Study|Adverse Event|10|||
155564509|NCT00128830|561491427|FG000|Overall Study|Withdrawal by Subject|14|||
155564510|NCT00128830|561491427|FG000|Overall Study|Lost to Follow-up|4|||
155564511|NCT00128830|561491427|FG000|Overall Study|Reached a virologic endpoint|29|||
155564512|NCT00128830|561491427|FG000|Overall Study|Non-compliant|4|||
155564513|NCT00128830|561491427|FG000|Overall Study|Discontinued or ineligible for study|2|||
155564514|NCT00128830|561491427|FG000|Overall Study|Other|9|||
155564515|NCT02730351|561491428|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
155564516|NCT02730351|561491429|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
155564517|NCT02730351|561491428|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
155564518|NCT02730351|561491429|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
155564519|NCT02730351|561491428|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
155564520|NCT02730351|561491429|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
155564521|NCT02730351|561491428|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
155564522|NCT02730351|561491429|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
155564523|NCT02730351|561491428|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
155564524|NCT02730351|561491429|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
155564525|NCT00311402|561491430|FG000|Overall Study|Adverse Event|118|||
155564526|NCT00311402|561491431|FG001|Overall Study|Adverse Event|105|||
155564527|NCT00311402|561491430|FG000|Overall Study|Lost to Follow-up|0|||
155564528|NCT00311402|561491431|FG001|Overall Study|Lost to Follow-up|3|||
155564529|NCT00311402|561491430|FG000|Overall Study|Withdrawal by Subject|17|||
155564530|NCT00311402|561491431|FG001|Overall Study|Withdrawal by Subject|18|||
155564531|NCT00311402|561491430|FG000|Overall Study|Lack of Efficacy|58|||
155564532|NCT00311402|561491431|FG001|Overall Study|Lack of Efficacy|42|||
155564533|NCT00311402|561491430|FG000|Overall Study|Protocol Violation|7|||
155564534|NCT00311402|561491431|FG001|Overall Study|Protocol Violation|6|||
155564535|NCT00311402|561491430|FG000|Overall Study|IRB's rejection etc.|10|||
155564536|NCT00311402|561491431|FG001|Overall Study|IRB's rejection etc.|3|||
155564537|NCT02640053|561491432|FG000|Overall Study|Withdrawal by Subject|2|||
155564538|NCT02640053|561491433|FG001|Overall Study|Withdrawal by Subject|1|||
155564539|NCT02640053|561491432|FG000|Overall Study|Adverse Event|1|||
155658918|NCT02284893|561844781|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
155658919|NCT02284893|561844782|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
155658920|NCT02284893|561844781|FG000|52 Week (Long Term)|Non-Compliance|2|||
155658921|NCT02284893|561844782|FG001|52 Week (Long Term)|Non-Compliance|3|||
155658922|NCT03078868|561844785|FG000|Overall Study|Physician Decision|3|||
155658923|NCT01983111|561844786|FG000|Overall Study|Withdrawal by Subject|8|||
155658924|NCT01983111|561844787|FG001|Overall Study|Withdrawal by Subject|6|||
155658925|NCT01983111|561844786|FG000|Overall Study|Adverse Event|4|||
155658926|NCT01983111|561844787|FG001|Overall Study|Adverse Event|0|||
155658927|NCT01983111|561844786|FG000|Overall Study|Protocol Violation|0|||
155658928|NCT01983111|561844787|FG001|Overall Study|Protocol Violation|1|||
155564540|NCT02640053|561491433|FG001|Overall Study|Adverse Event|1|||
155564541|NCT02640053|561491432|FG000|Overall Study|Alternative Therapy|1|||
155564542|NCT02640053|561491433|FG001|Overall Study|Alternative Therapy|1|||
155564543|NCT02640053|561491432|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
155564544|NCT02640053|561491433|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
155564545|NCT02036775|561491434|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
155564546|NCT02036775|561491435|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
155564547|NCT02036775|561491436|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
155564548|NCT02036775|561491437|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
155658929|NCT03038620|561844788|FG000|Overall Study|Lost to Follow-up|18|||
155658930|NCT03038620|561844789|FG001|Overall Study|Lost to Follow-up|23|||
155564549|NCT02036775|561491438|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
155564550|NCT02036775|561491439|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
155658931|NCT03038620|561844788|FG000|Overall Study|Withdrawal by Subject|0|||
155564551|NCT01268501|561491440|FG000|Overall Study|Lost to Follow-up|1|||
155564552|NCT01268501|561491440|FG000|Overall Study|Withdrawal by Subject|3|||
155564553|NCT01268501|561491440|FG000|Overall Study|Unacceptable Subjective Vision|3|||
155564554|NCT01268501|561491440|FG000|Overall Study|Handling Difficulties|2|||
155564555|NCT02927366|561491442|FG000|Overall Study|Adverse Event|1|||
155564556|NCT02927366|561491443|FG001|Overall Study|Adverse Event|0|||
155564557|NCT02927366|561491442|FG000|Overall Study|Patient schedule|1|||
155564558|NCT02927366|561491443|FG001|Overall Study|Patient schedule|0|||
155564559|NCT02910063|561491446|FG000|Phase 2|Withdrawal by Subject|3|||
155564560|NCT02910063|561491447|FG001|Phase 2|Withdrawal by Subject|0|||
155564561|NCT02910063|561491448|FG002|Phase 2|Withdrawal by Subject|0|||
155564562|NCT02910063|561491446|FG000|Phase 2|Lost to Follow-up|1|||
155564563|NCT02910063|561491447|FG001|Phase 2|Lost to Follow-up|0|||
155564564|NCT02910063|561491448|FG002|Phase 2|Lost to Follow-up|0|||
155564565|NCT02910063|561491446|FG000|Phase 2|Death|24|||
155564566|NCT02910063|561491447|FG001|Phase 2|Death|0|||
155564567|NCT02910063|561491448|FG002|Phase 2|Death|0|||
155564568|NCT03496610|561491449|FG000|Overall Study|Lost to Follow-up|3|||
155564569|NCT03496610|561491450|FG001|Overall Study|Lost to Follow-up|2|||
155564570|NCT03496610|561491449|FG000|Overall Study|Physician Decision|1|||
155564571|NCT03496610|561491450|FG001|Overall Study|Physician Decision|0|||
155564572|NCT03496610|561491449|FG000|Overall Study|Withdrawal by Subject|1|||
155564573|NCT03496610|561491450|FG001|Overall Study|Withdrawal by Subject|0|||
155564574|NCT02774642|561491454|FG000|Overall Study|Lost to Follow-up|9|||
155564575|NCT02774642|561491455|FG001|Overall Study|Lost to Follow-up|7|||
155658932|NCT03038620|561844789|FG001|Overall Study|Withdrawal by Subject|15|||
155658933|NCT03038620|561844788|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
155658934|NCT03038620|561844789|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
155658935|NCT00105066|561844790|FG000|Overall Study|Adverse Event|2|||
155658936|NCT00105066|561844791|FG001|Overall Study|Adverse Event|5|||
155658937|NCT03261505|561844798|FG000|Overall Study|Withdrawal by Subject|2|||
155658938|NCT03261505|561844799|FG001|Overall Study|Withdrawal by Subject|3|||
155658939|NCT03261505|561844800|FG002|Overall Study|Withdrawal by Subject|4|||
155658940|NCT03261505|561844801|FG003|Overall Study|Withdrawal by Subject|3|||
155658941|NCT03261505|561844798|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155658942|NCT03261505|561844799|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155658943|NCT03261505|561844800|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
155658944|NCT03261505|561844801|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155658945|NCT03261505|561844798|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155658946|NCT03261505|561844799|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155658947|NCT03261505|561844800|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
155658948|NCT03261505|561844801|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155658949|NCT03261505|561844798|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
155658950|NCT03261505|561844799|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155658951|NCT03261505|561844800|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155658952|NCT03261505|561844801|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155658953|NCT02231580|561844807|FG000|Overall Study|Adverse Event|5|||
155658954|NCT02231580|561844808|FG001|Overall Study|Adverse Event|0|||
155658955|NCT02711202|561844809|FG000|Overall Study|Adverse Event|3|||
155658956|NCT02711202|561844810|FG001|Overall Study|Adverse Event|0|||
155658957|NCT02711202|561844809|FG000|Overall Study|graft loss|1|||
155658958|NCT02711202|561844810|FG001|Overall Study|graft loss|0|||
155658959|NCT05852470|561844811|FG000|Overall Study|Withdrawal by Subject|0|||
155658960|NCT05852470|561844812|FG001|Overall Study|Withdrawal by Subject|1|||
155564576|NCT00827632|561491456|FG000|Overall Study|Lost to Follow-up|8|||
155564577|NCT00827632|561491457|FG001|Overall Study|Lost to Follow-up|12|||
155564578|NCT00827632|561491456|FG000|Overall Study|Early withdrawal|14|||
155564579|NCT00827632|561491457|FG001|Overall Study|Early withdrawal|11|||
155564580|NCT06281171|561491459|FG000|Timepoint 2|Lost to Follow-up|6|||
155564581|NCT06281171|561491460|FG001|Timepoint 2|Lost to Follow-up|4|||
155564582|NCT06281171|561491459|FG000|Timepoint 3|Lost to Follow-up|0|||
155564583|NCT06281171|561491460|FG001|Timepoint 3|Lost to Follow-up|5|||
155564584|NCT04669691|561491473|FG000|Overall Study|Death|0|||
155564585|NCT04669691|561491474|FG001|Overall Study|Death|1|||
155564586|NCT04669691|561491475|FG002|Overall Study|Death|0|||
155564587|NCT04669691|561491476|FG003|Overall Study|Death|0|||
155564588|NCT04669691|561491477|FG004|Overall Study|Death|0|||
155564589|NCT04669691|561491478|FG005|Overall Study|Death|0|||
155564590|NCT01822275|561491480|FG000|Overall Study|Withdrawal by Subject|3|||
155564591|NCT01822275|561491480|FG000|Overall Study|Adverse Event|3|||
155564592|NCT01822275|561491480|FG000|Overall Study|Progression|14|||
155564593|NCT01822275|561491480|FG000|Overall Study|Physician Decision|2|||
155564594|NCT00073021|561491482|FG000|Overall Study|Protocol Violation|2|||
155564595|NCT00073021|561491483|FG001|Overall Study|Protocol Violation|1|||
155564596|NCT00073021|561491482|FG000|Overall Study|Adverse Event|4|||
155564597|NCT00073021|561491483|FG001|Overall Study|Adverse Event|4|||
155564598|NCT00073021|561491482|FG000|Overall Study|Withdrawal by Subject|6|||
155564599|NCT00073021|561491483|FG001|Overall Study|Withdrawal by Subject|5|||
155564600|NCT00073021|561491482|FG000|Overall Study|Physician Decision|3|||
155564601|NCT00073021|561491483|FG001|Overall Study|Physician Decision|1|||
155564602|NCT00073021|561491482|FG000|Overall Study|Lack of Efficacy|11|||
155564603|NCT00073021|561491483|FG001|Overall Study|Lack of Efficacy|5|||
155564604|NCT00809159|561491484|FG000|Part 1|Adverse Event|1|||
155564605|NCT00809159|561491485|FG001|Part 1|Adverse Event|1|||
155564606|NCT00809159|561491486|FG002|Part 1|Adverse Event|0|||
155564607|NCT00809159|561491487|FG003|Part 1|Adverse Event|0|||
155564608|NCT00809159|561491488|FG004|Part 1|Adverse Event|0|||
155564609|NCT00809159|561491489|FG005|Part 1|Adverse Event|0|||
155564610|NCT00809159|561491484|FG000|Part 1|Lost to Follow-up|1|||
155564611|NCT00809159|561491485|FG001|Part 1|Lost to Follow-up|0|||
155564612|NCT00809159|561491486|FG002|Part 1|Lost to Follow-up|0|||
155564613|NCT00809159|561491487|FG003|Part 1|Lost to Follow-up|0|||
155564614|NCT00809159|561491488|FG004|Part 1|Lost to Follow-up|0|||
155564615|NCT00809159|561491489|FG005|Part 1|Lost to Follow-up|0|||
155564616|NCT00809159|561491484|FG000|Part 1|Withdrawal by Subject|3|||
155564617|NCT00809159|561491485|FG001|Part 1|Withdrawal by Subject|1|||
155564618|NCT00809159|561491486|FG002|Part 1|Withdrawal by Subject|0|||
155564619|NCT00809159|561491487|FG003|Part 1|Withdrawal by Subject|0|||
155564620|NCT00809159|561491488|FG004|Part 1|Withdrawal by Subject|0|||
155564621|NCT00809159|561491489|FG005|Part 1|Withdrawal by Subject|0|||
155564622|NCT00809159|561491484|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
155564623|NCT00809159|561491485|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
155564624|NCT00809159|561491486|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
155564625|NCT00809159|561491487|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
155564626|NCT00809159|561491488|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
155564627|NCT00809159|561491489|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
155564628|NCT00809159|561491484|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
155564629|NCT00809159|561491485|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
155564630|NCT00809159|561491486|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
155564631|NCT00809159|561491487|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
155564632|NCT00809159|561491488|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
155564633|NCT00809159|561491489|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
155564634|NCT00809159|561491484|FG000|Part 1 and 2|Administrative problems|0|||
155564635|NCT00809159|561491485|FG001|Part 1 and 2|Administrative problems|0|||
155564636|NCT00809159|561491486|FG002|Part 1 and 2|Administrative problems|0|||
155564637|NCT00809159|561491487|FG003|Part 1 and 2|Administrative problems|1|||
155564638|NCT00809159|561491488|FG004|Part 1 and 2|Administrative problems|0|||
155564639|NCT00809159|561491489|FG005|Part 1 and 2|Administrative problems|0|||
155564640|NCT00809159|561491484|FG000|Part 1 and 2|Adverse Event|0|||
155564641|NCT00809159|561491485|FG001|Part 1 and 2|Adverse Event|0|||
155564642|NCT00809159|561491486|FG002|Part 1 and 2|Adverse Event|1|||
155564643|NCT00809159|561491487|FG003|Part 1 and 2|Adverse Event|0|||
155564644|NCT00809159|561491488|FG004|Part 1 and 2|Adverse Event|1|||
155564645|NCT00809159|561491489|FG005|Part 1 and 2|Adverse Event|1|||
155564646|NCT00809159|561491484|FG000|Part 1 and 2|Lost to Follow-up|0|||
155564647|NCT00809159|561491485|FG001|Part 1 and 2|Lost to Follow-up|0|||
155564648|NCT00809159|561491486|FG002|Part 1 and 2|Lost to Follow-up|1|||
155564649|NCT00809159|561491487|FG003|Part 1 and 2|Lost to Follow-up|1|||
155564650|NCT00809159|561491488|FG004|Part 1 and 2|Lost to Follow-up|0|||
155564651|NCT00809159|561491489|FG005|Part 1 and 2|Lost to Follow-up|0|||
155564652|NCT00809159|561491484|FG000|Part 1 and 2|Withdrawal by Subject|0|||
155564653|NCT00809159|561491485|FG001|Part 1 and 2|Withdrawal by Subject|0|||
155564654|NCT00809159|561491486|FG002|Part 1 and 2|Withdrawal by Subject|4|||
155564655|NCT00809159|561491487|FG003|Part 1 and 2|Withdrawal by Subject|0|||
155564656|NCT00809159|561491488|FG004|Part 1 and 2|Withdrawal by Subject|0|||
155564657|NCT00809159|561491489|FG005|Part 1 and 2|Withdrawal by Subject|1|||
155564658|NCT03918109|561491495|FG000|Overall Study|Withdrawal by Subject|0|||
155564659|NCT03918109|561491496|FG001|Overall Study|Withdrawal by Subject|0|||
155564660|NCT03918109|561491497|FG002|Overall Study|Withdrawal by Subject|2|||
155564661|NCT03918109|561491498|FG003|Overall Study|Withdrawal by Subject|1|||
155564662|NCT03918109|561491495|FG000|Overall Study|Lost to Follow-up|0|||
155564663|NCT03918109|561491496|FG001|Overall Study|Lost to Follow-up|0|||
155564664|NCT03918109|561491497|FG002|Overall Study|Lost to Follow-up|0|||
155564665|NCT03918109|561491498|FG003|Overall Study|Lost to Follow-up|1|||
155658961|NCT01903863|561844813|FG000|Overall Study|Physician Decision|2|||
155658962|NCT01903863|561844814|FG001|Overall Study|Physician Decision|0|||
155658963|NCT01107496|561844815|FG000|Overall Study|Adverse Event|1|||
155658964|NCT01107496|561844816|FG001|Overall Study|Adverse Event|0|||
155658965|NCT01107496|561844815|FG000|Overall Study|Lack of Efficacy|1|||
155658966|NCT01107496|561844816|FG001|Overall Study|Lack of Efficacy|0|||
155658967|NCT01107496|561844815|FG000|Overall Study|Protocol Violation|0|||
155658968|NCT01107496|561844816|FG001|Overall Study|Protocol Violation|1|||
155658969|NCT01107496|561844815|FG000|Overall Study|Lost to Follow-up|0|||
155658970|NCT01107496|561844816|FG001|Overall Study|Lost to Follow-up|1|||
155658971|NCT03448393|561844817|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658972|NCT03448393|561844818|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658973|NCT03448393|561844819|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
155658974|NCT03448393|561844820|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658975|NCT03448393|561844821|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658976|NCT03448393|561844822|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658977|NCT03448393|561844823|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658978|NCT03448393|561844824|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155658979|NCT03448393|561844825|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
155658980|NCT03448393|561844817|FG000|Dose Expansion|Not treated - screen failure|0|||
155658981|NCT03448393|561844818|FG001|Dose Expansion|Not treated - screen failure|0|||
155658982|NCT03448393|561844819|FG002|Dose Expansion|Not treated - screen failure|0|||
155658983|NCT03448393|561844820|FG003|Dose Expansion|Not treated - screen failure|0|||
155658984|NCT03448393|561844821|FG004|Dose Expansion|Not treated - screen failure|0|||
155658985|NCT03448393|561844822|FG005|Dose Expansion|Not treated - screen failure|0|||
155658986|NCT03448393|561844823|FG006|Dose Expansion|Not treated - screen failure|0|||
155658987|NCT03448393|561844824|FG007|Dose Expansion|Not treated - screen failure|0|||
155658988|NCT03448393|561844825|FG008|Dose Expansion|Not treated - screen failure|7|||
155658989|NCT01587196|561844826|FG000|Overall Study|Lost to Follow-up|50|||
155658990|NCT01587196|561844826|FG000|Overall Study|Withdrawal by Subject|4|||
155658991|NCT03612570|561844831|FG000|Overall Study|Lost to Follow-up|1|||
155658992|NCT05318287|561844832|FG000|Overall Study|Lost to Follow-up|8|||
155564666|NCT00477295|561491503|FG000|Overall Study|Adverse Event|31|||
155564667|NCT00477295|561491504|FG001|Overall Study|Adverse Event|35|||
155564668|NCT00477295|561491503|FG000|Overall Study|Withdrawal by Subject|35|||
155564669|NCT00477295|561491504|FG001|Overall Study|Withdrawal by Subject|24|||
155564670|NCT00477295|561491503|FG000|Overall Study|Lack of Efficacy|23|||
155564671|NCT00477295|561491504|FG001|Overall Study|Lack of Efficacy|23|||
155564672|NCT00477295|561491503|FG000|Overall Study|Protocol Violation|3|||
155564673|NCT00477295|561491504|FG001|Overall Study|Protocol Violation|8|||
155564674|NCT00477295|561491503|FG000|Overall Study|Physician Decision|4|||
155564675|NCT00477295|561491504|FG001|Overall Study|Physician Decision|5|||
155564676|NCT00477295|561491503|FG000|Overall Study|Lost to Follow-up|21|||
155564677|NCT00477295|561491504|FG001|Overall Study|Lost to Follow-up|11|||
155564678|NCT00477295|561491503|FG000|Overall Study|Other|4|||
155564679|NCT00477295|561491504|FG001|Overall Study|Other|3|||
155564680|NCT03276780|561491507|FG000|Overall Study|Withdrawal by Subject|5|||
155564681|NCT03276780|561491508|FG001|Overall Study|Withdrawal by Subject|3|||
155564682|NCT03276780|561491507|FG000|Overall Study|Lost to Follow-up|3|||
155564683|NCT03276780|561491508|FG001|Overall Study|Lost to Follow-up|5|||
155564684|NCT03276780|561491507|FG000|Overall Study|Moved out of state|1|||
155564685|NCT03276780|561491508|FG001|Overall Study|Moved out of state|1|||
155564686|NCT03276780|561491507|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
155564687|NCT03276780|561491508|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
155564688|NCT03276780|561491507|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
155658993|NCT03537508|561844835|FG000|Overall Study|Adverse Event|2|||
155658994|NCT03537508|561844836|FG001|Overall Study|Adverse Event|1|||
155658995|NCT03537508|561844835|FG000|Overall Study|Protocol Violation|65|||
155658996|NCT03537508|561844836|FG001|Overall Study|Protocol Violation|48|||
155658997|NCT03537508|561844835|FG000|Overall Study|Lost to Follow-up|86|||
155658998|NCT03537508|561844836|FG001|Overall Study|Lost to Follow-up|60|||
155658999|NCT03537508|561844835|FG000|Overall Study|Withdrawal by parent/guardian|263|||
155659000|NCT03537508|561844836|FG001|Overall Study|Withdrawal by parent/guardian|149|||
155659001|NCT02520154|561844846|FG000|Overall Study|Death|1|||
155659002|NCT02520154|561844846|FG000|Overall Study|Withdrawal by Subject|2|||
155564689|NCT03276780|561491508|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
155564690|NCT00510289|561491509|FG000|Overall Study|Withdrawal by Subject|7|||
155564691|NCT00510289|561491509|FG000|Overall Study|Refused bone marrow biopsy|2|||
155564692|NCT00510289|561491509|FG000|Overall Study|Lost to Follow-up|1|||
155564693|NCT00510289|561491509|FG000|Overall Study|Progressed prior to starting drug|2|||
155564694|NCT01425723|561491510|FG000|Overall Study|Lack of Efficacy|0|||
155564695|NCT01425723|561491511|FG001|Overall Study|Lack of Efficacy|1|||
155564696|NCT01425723|561491510|FG000|Overall Study|Withdrawal by Subject|1|||
155564697|NCT01425723|561491511|FG001|Overall Study|Withdrawal by Subject|4|||
155564698|NCT01425723|561491510|FG000|Overall Study|Lost to Follow-up|0|||
155564699|NCT01425723|561491511|FG001|Overall Study|Lost to Follow-up|3|||
155564700|NCT01425723|561491510|FG000|Overall Study|Physician Decision|2|||
155564701|NCT01425723|561491511|FG001|Overall Study|Physician Decision|0|||
155564702|NCT01425723|561491510|FG000|Overall Study|Other|1|||
155564703|NCT01425723|561491511|FG001|Overall Study|Other|10|||
155564704|NCT00861198|561491512|FG000|Overall Study|SpyGlass Failed|5|||
155564705|NCT02288182|561491513|FG000|Overall Study|Adverse Event|0|||
155564706|NCT02288182|561491514|FG001|Overall Study|Adverse Event|1|||
155564707|NCT02288182|561491513|FG000|Overall Study|Lost to Follow-up|0|||
155564708|NCT02288182|561491514|FG001|Overall Study|Lost to Follow-up|1|||
155564709|NCT04619992|561491516|FG000|Overall Study|Withdrawal by Subject|1|||
155564710|NCT04619992|561491517|FG001|Overall Study|Withdrawal by Subject|0|||
155564711|NCT01197755|561491518|FG000|Overall Study|Adverse Event|8|||
155564712|NCT01197755|561491519|FG001|Overall Study|Adverse Event|10|||
155564713|NCT01197755|561491520|FG002|Overall Study|Adverse Event|10|||
155564714|NCT01197755|561491518|FG000|Overall Study|Study-specific discontinuation criteria|2|||
155564715|NCT01197755|561491519|FG001|Overall Study|Study-specific discontinuation criteria|1|||
155564716|NCT01197755|561491520|FG002|Overall Study|Study-specific discontinuation criteria|0|||
155564717|NCT01197755|561491518|FG000|Overall Study|Entered the long-term extension study|18|||
155564718|NCT01197755|561491519|FG001|Overall Study|Entered the long-term extension study|21|||
155564719|NCT01197755|561491520|FG002|Overall Study|Entered the long-term extension study|35|||
155564720|NCT01197755|561491518|FG000|Overall Study|Lack of therapeutic response|0|||
155564721|NCT01197755|561491519|FG001|Overall Study|Lack of therapeutic response|7|||
155564722|NCT01197755|561491520|FG002|Overall Study|Lack of therapeutic response|4|||
155564723|NCT01197755|561491518|FG000|Overall Study|Severe non-compliance to the protocol|2|||
155564724|NCT01197755|561491519|FG001|Overall Study|Severe non-compliance to the protocol|1|||
155564725|NCT01197755|561491520|FG002|Overall Study|Severe non-compliance to the protocol|2|||
155564726|NCT01197755|561491518|FG000|Overall Study|Withdrawal by Subject|1|||
155564727|NCT01197755|561491519|FG001|Overall Study|Withdrawal by Subject|0|||
155564728|NCT01197755|561491520|FG002|Overall Study|Withdrawal by Subject|0|||
155564729|NCT01197755|561491518|FG000|Overall Study|Lost to Follow-up|0|||
155564730|NCT01197755|561491519|FG001|Overall Study|Lost to Follow-up|0|||
155564731|NCT01197755|561491520|FG002|Overall Study|Lost to Follow-up|1|||
155564732|NCT01197755|561491518|FG000|Overall Study|eg, change in circumstances|7|||
155564733|NCT01197755|561491519|FG001|Overall Study|eg, change in circumstances|3|||
155564734|NCT01197755|561491520|FG002|Overall Study|eg, change in circumstances|2|||
155564735|NCT03365011|561491521|FG000|Overall Study|Withdrawal by Subject|1|||
155564736|NCT03365011|561491522|FG001|Overall Study|Withdrawal by Subject|2|||
155564737|NCT03582826|561491523|FG000|Overall Study|Lost to Follow-up|39|||
155564738|NCT03582826|561491524|FG001|Overall Study|Lost to Follow-up|0|||
155564739|NCT03582826|561491523|FG000|Overall Study|Withdrawal by Subject|2|||
155564740|NCT03582826|561491524|FG001|Overall Study|Withdrawal by Subject|0|||
155564741|NCT00758680|561491528|FG000|Overall Study|Adverse Event|0|||
155564742|NCT00758680|561491529|FG001|Overall Study|Adverse Event|0|||
155564743|NCT00758680|561491530|FG002|Overall Study|Adverse Event|0|||
155564744|NCT00758680|561491531|FG003|Overall Study|Adverse Event|0|||
155564745|NCT00758680|561491532|FG004|Overall Study|Adverse Event|0|||
155564746|NCT00758680|561491533|FG005|Overall Study|Adverse Event|0|||
155564747|NCT00758680|561491534|FG006|Overall Study|Adverse Event|0|||
155564748|NCT00758680|561491535|FG007|Overall Study|Adverse Event|1|||
155564749|NCT00758680|561491536|FG008|Overall Study|Adverse Event|0|||
155564750|NCT00758680|561491537|FG009|Overall Study|Adverse Event|1|||
155564751|NCT00758680|561491528|FG000|Overall Study|Laboratory Adverse Event|0|||
155564752|NCT00758680|561491529|FG001|Overall Study|Laboratory Adverse Event|0|||
155564753|NCT00758680|561491530|FG002|Overall Study|Laboratory Adverse Event|0|||
155564754|NCT00758680|561491531|FG003|Overall Study|Laboratory Adverse Event|0|||
155564755|NCT00758680|561491532|FG004|Overall Study|Laboratory Adverse Event|0|||
155564756|NCT00758680|561491533|FG005|Overall Study|Laboratory Adverse Event|0|||
155564757|NCT00758680|561491534|FG006|Overall Study|Laboratory Adverse Event|0|||
155564758|NCT00758680|561491535|FG007|Overall Study|Laboratory Adverse Event|0|||
155564759|NCT00758680|561491536|FG008|Overall Study|Laboratory Adverse Event|1|||
155564760|NCT00758680|561491537|FG009|Overall Study|Laboratory Adverse Event|0|||
155564761|NCT00758680|561491528|FG000|Overall Study|Withdrawal by Subject|0|||
155564762|NCT00758680|561491529|FG001|Overall Study|Withdrawal by Subject|0|||
155564763|NCT00758680|561491530|FG002|Overall Study|Withdrawal by Subject|0|||
155564764|NCT00758680|561491531|FG003|Overall Study|Withdrawal by Subject|0|||
155564765|NCT00758680|561491532|FG004|Overall Study|Withdrawal by Subject|0|||
155564766|NCT00758680|561491533|FG005|Overall Study|Withdrawal by Subject|0|||
155564767|NCT00758680|561491534|FG006|Overall Study|Withdrawal by Subject|1|||
155564768|NCT00758680|561491535|FG007|Overall Study|Withdrawal by Subject|0|||
155564769|NCT00758680|561491536|FG008|Overall Study|Withdrawal by Subject|1|||
155564770|NCT00758680|561491537|FG009|Overall Study|Withdrawal by Subject|0|||
155564771|NCT00319982|561491538|FG000|Overall Study|Withdrawal by Subject|1|||
155564772|NCT00319982|561491539|FG001|Overall Study|Withdrawal by Subject|0|||
155564773|NCT03480386|561491540|FG000|Overall Study|Did not complete measures at 3-months|17|||
155564774|NCT03480386|561491541|FG001|Overall Study|Did not complete measures at 3-months|14|||
155564775|NCT03480386|561491540|FG000|Overall Study|No baseline measures|11|||
155564776|NCT03480386|561491541|FG001|Overall Study|No baseline measures|14|||
155564777|NCT03480386|561491540|FG000|Overall Study|Death|0|||
155564778|NCT03480386|561491541|FG001|Overall Study|Death|5|||
155564779|NCT03480386|561491540|FG000|Overall Study|Withdrawal by Subject|12|||
155564780|NCT03480386|561491541|FG001|Overall Study|Withdrawal by Subject|8|||
155564781|NCT03480386|561491540|FG000|Overall Study|Lost to Follow-up|2|||
155564782|NCT03480386|561491541|FG001|Overall Study|Lost to Follow-up|1|||
155564783|NCT03480386|561491540|FG000|Overall Study|Complicating disease|0|||
155564784|NCT03480386|561491541|FG001|Overall Study|Complicating disease|1|||
155564785|NCT03480386|561491540|FG000|Overall Study|Disease progression|3|||
155564786|NCT03480386|561491541|FG001|Overall Study|Disease progression|0|||
155564787|NCT03480386|561491540|FG000|Overall Study|Became ineligible|0|||
155564788|NCT03480386|561491541|FG001|Overall Study|Became ineligible|2|||
155564789|NCT00574912|561491542|FG000|Overall Study|Could not place IV lines.|3|||
155564790|NCT00574912|561491542|FG000|Overall Study|scheduling conflicts|3|||
155564791|NCT00574912|561491542|FG000|Overall Study|Physician Decision|2|||
155564792|NCT03753763|561491544|FG000|Overall Study|Adverse Event|2|||
155564793|NCT03753763|561491545|FG001|Overall Study|Adverse Event|0|||
155564794|NCT03753763|561491544|FG000|Overall Study|Withdrawal by Subject|3|||
155564795|NCT03753763|561491545|FG001|Overall Study|Withdrawal by Subject|1|||
155564796|NCT03753763|561491544|FG000|Overall Study|clinical deterioration|1|||
155564797|NCT03753763|561491545|FG001|Overall Study|clinical deterioration|0|||
155564798|NCT01104779|561491546|FG000|Overall Study|Protocol Violation|1|||
155564799|NCT01104779|561491547|FG001|Overall Study|Protocol Violation|2|||
155564800|NCT01104779|561491548|FG002|Overall Study|Protocol Violation|2|||
155564801|NCT01104779|561491546|FG000|Overall Study|Lack of Efficacy|26|||
155564802|NCT01104779|561491547|FG001|Overall Study|Lack of Efficacy|12|||
155564803|NCT01104779|561491548|FG002|Overall Study|Lack of Efficacy|13|||
155564804|NCT01104779|561491546|FG000|Overall Study|Adverse Event|13|||
155564805|NCT01104779|561491547|FG001|Overall Study|Adverse Event|14|||
155564806|NCT01104779|561491548|FG002|Overall Study|Adverse Event|13|||
155564807|NCT01104779|561491546|FG000|Overall Study|Did not meet inc/exc criteria|1|||
155564808|NCT01104779|561491547|FG001|Overall Study|Did not meet inc/exc criteria|1|||
155564809|NCT01104779|561491548|FG002|Overall Study|Did not meet inc/exc criteria|1|||
155564810|NCT01104779|561491546|FG000|Overall Study|Other reasons|0|||
155564811|NCT01104779|561491547|FG001|Overall Study|Other reasons|1|||
155564812|NCT01104779|561491548|FG002|Overall Study|Other reasons|0|||
155564813|NCT01104779|561491546|FG000|Overall Study|Lost to Follow-up|2|||
155564814|NCT01104779|561491547|FG001|Overall Study|Lost to Follow-up|0|||
155564815|NCT01104779|561491548|FG002|Overall Study|Lost to Follow-up|1|||
155564816|NCT01104779|561491546|FG000|Overall Study|Withdrawal by Subject|16|||
155564817|NCT01104779|561491547|FG001|Overall Study|Withdrawal by Subject|25|||
155564818|NCT01104779|561491548|FG002|Overall Study|Withdrawal by Subject|32|||
155564819|NCT04240392|561493032|FG000|Overall Study|Withdrawal by Subject|13|||
155564820|NCT04240392|561493033|FG001|Overall Study|Withdrawal by Subject|4|||
155564821|NCT04240392|561493032|FG000|Overall Study|Lost to Follow-up|11|||
155564822|NCT04240392|561493033|FG001|Overall Study|Lost to Follow-up|12|||
155564823|NCT03665441|561493041|FG000|Overall Study|survival follow up ongoing|23|||
155564824|NCT03665441|561493042|FG001|Overall Study|survival follow up ongoing|0|||
155564825|NCT03665441|561493041|FG000|Overall Study|Patients ongoing on treatment|9|||
155564826|NCT03665441|561493042|FG001|Overall Study|Patients ongoing on treatment|6|||
155564827|NCT03665441|561493041|FG000|Overall Study|Randomized but not treated|7|||
155564828|NCT03665441|561493042|FG001|Overall Study|Randomized but not treated|11|||
155564829|NCT05307510|561493043|FG000|Overall Study|Lost to Follow-up|3|||
155564830|NCT05307510|561493044|FG001|Overall Study|Lost to Follow-up|6|||
155564831|NCT05307510|561493043|FG000|Overall Study|Withdrawal by Subject|0|||
155564832|NCT05307510|561493044|FG001|Overall Study|Withdrawal by Subject|1|||
155564833|NCT04345601|561493045|FG000|Overall Study|Death|0|||
155564834|NCT04345601|561493046|FG001|Overall Study|Death|3|||
155564835|NCT04345601|561493047|FG002|Overall Study|Death|2|||
155564836|NCT04345601|561493045|FG000|Overall Study|Lost to Follow-up|0|||
155564837|NCT04345601|561493046|FG001|Overall Study|Lost to Follow-up|0|||
155564838|NCT04345601|561493047|FG002|Overall Study|Lost to Follow-up|2|||
155564839|NCT03610516|561493048|FG000|Treatment Epoch|Adverse Event|3|||
155564840|NCT03610516|561493049|FG001|Treatment Epoch|Adverse Event|1|||
155564841|NCT03610516|561493048|FG000|Treatment Epoch|Death|1|||
155564842|NCT03610516|561493049|FG001|Treatment Epoch|Death|0|||
155564843|NCT03610516|561493048|FG000|Treatment Epoch|Lack of Efficacy|0|||
155564844|NCT03610516|561493049|FG001|Treatment Epoch|Lack of Efficacy|1|||
155564845|NCT03610516|561493048|FG000|Treatment Epoch|No longer requires treatment|1|||
155564846|NCT03610516|561493049|FG001|Treatment Epoch|No longer requires treatment|0|||
155564847|NCT03610516|561493048|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
155564848|NCT03610516|561493049|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
155564849|NCT03610516|561493048|FG000|Treatment Epoch|Physician Decision|8|||
155564850|NCT03610516|561493049|FG001|Treatment Epoch|Physician Decision|5|||
155564851|NCT03610516|561493048|FG000|Treatment Epoch|Protocol Deviation|1|||
155564852|NCT03610516|561493049|FG001|Treatment Epoch|Protocol Deviation|0|||
155564853|NCT03610516|561493048|FG000|Treatment Epoch|Withdrawal by Subject|3|||
155564854|NCT03610516|561493049|FG001|Treatment Epoch|Withdrawal by Subject|1|||
155564855|NCT03610516|561493048|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
155564856|NCT03610516|561493049|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
155564857|NCT03610516|561493048|FG000|Post-Treatment Follow-up|Death|1|||
155564858|NCT03610516|561493049|FG001|Post-Treatment Follow-up|Death|0|||
155564859|NCT00631657|561493050|FG000|6-Month Treatment Period|Adverse Event|47|||
155564860|NCT00631657|561493051|FG001|6-Month Treatment Period|Adverse Event|0|||
155564861|NCT00631657|561493052|FG002|6-Month Treatment Period|Adverse Event|7|||
155564862|NCT00631657|561493050|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
155564863|NCT00631657|561493051|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
155564864|NCT00631657|561493052|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
155564865|NCT00631657|561493050|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
155564866|NCT00631657|561493051|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
155564867|NCT00631657|561493052|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
155564868|NCT00631657|561493050|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
155564869|NCT00631657|561493051|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
155564870|NCT00631657|561493052|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
155564871|NCT00631657|561493050|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
155564872|NCT00631657|561493051|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
155564873|NCT00631657|561493052|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
155564874|NCT00631657|561493050|FG000|6-Month Treatment Period|Other|16|||
155564875|NCT00631657|561493051|FG001|6-Month Treatment Period|Other|0|||
155564876|NCT00631657|561493052|FG002|6-Month Treatment Period|Other|4|||
155564877|NCT00631657|561493050|FG000|6-Month Treatment Period|Not Treated|2|||
155564878|NCT00631657|561493051|FG001|6-Month Treatment Period|Not Treated|0|||
155564879|NCT00631657|561493052|FG002|6-Month Treatment Period|Not Treated|1|||
155564880|NCT00631657|561493050|FG000|7-Day Discontinuation Period|Not Treated|1|||
155564881|NCT00631657|561493051|FG001|7-Day Discontinuation Period|Not Treated|1|||
155564882|NCT00631657|561493052|FG002|7-Day Discontinuation Period|Not Treated|1|||
155564883|NCT00631657|561493050|FG000|7-Day Discontinuation Period|Other|1|||
155564884|NCT00631657|561493051|FG001|7-Day Discontinuation Period|Other|0|||
155564885|NCT00631657|561493052|FG002|7-Day Discontinuation Period|Other|0|||
155564886|NCT04003896|561493071|FG000|Overall Study|Withdrawal by Subject|3|||
155564887|NCT04003896|561493071|FG000|Overall Study|Physician Decision|1|||
155564888|NCT01199471|561493072|FG000|Overall Study|Protocol Violation|4|||
155564889|NCT01199471|561493072|FG000|Overall Study|Withdrawal by Subject|1|||
155564890|NCT01199471|561493072|FG000|Overall Study|Physician Decision|1|||
155564891|NCT03151408|561493073|FG000|Overall Study|Adverse Event|24|||
155564892|NCT03151408|561493074|FG001|Overall Study|Adverse Event|23|||
155564893|NCT03151408|561493073|FG000|Overall Study|Death|46|||
155564894|NCT03151408|561493074|FG001|Overall Study|Death|26|||
155564895|NCT03151408|561493073|FG000|Overall Study|Physician Decision|13|||
155564896|NCT03151408|561493074|FG001|Overall Study|Physician Decision|19|||
155564897|NCT03151408|561493073|FG000|Overall Study|Withdrawal by Subject|16|||
155564898|NCT03151408|561493074|FG001|Overall Study|Withdrawal by Subject|20|||
155564899|NCT03151408|561493073|FG000|Overall Study|Progressive disease|45|||
155564900|NCT03151408|561493074|FG001|Overall Study|Progressive disease|61|||
155564901|NCT03151408|561493073|FG000|Overall Study|non-compliance by patient|1|||
155564902|NCT03151408|561493074|FG001|Overall Study|non-compliance by patient|0|||
155564903|NCT03151408|561493073|FG000|Overall Study|other reasons|56|||
155564904|NCT03151408|561493074|FG001|Overall Study|other reasons|52|||
155564905|NCT03151408|561493073|FG000|Overall Study|randomized and not treated|2|||
155564906|NCT03151408|561493074|FG001|Overall Study|randomized and not treated|2|||
155564907|NCT02315196|561493077|FG000|Overall Study|Withdrew consent|9|||
155564908|NCT04576923|561493078|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
155564909|NCT01475097|561493079|FG000|Overall Study|Protocol Violation|1|||
155564910|NCT01475097|561493080|FG001|Overall Study|Protocol Violation|1|||
155564911|NCT02383810|561493081|FG000|Overall Study|Physician Decision|1|||
155659003|NCT02520154|561844846|FG000|Overall Study|Physician Decision|2|||
155659004|NCT06022107|561844847|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
155659005|NCT06022107|561844847|FG000|Overall Study|Dropped out of study for higher level of care|1|||
155659006|NCT06022107|561844847|FG000|Overall Study|Lost to Follow-up|2|||
155659007|NCT02333799|561846707|FG000|Treatment Period|Withdrawal by Subject|1|||
155659008|NCT02333799|561846707|FG000|Treatment Period|Death|6|||
155659009|NCT02333799|561846707|FG000|6 Month Follow Up Period|Physician Decision|1|||
155659010|NCT02333799|561846707|FG000|6 Month Follow Up Period|Death|1|||
155659011|NCT02333799|561846707|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
155659012|NCT02333799|561846707|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
155659013|NCT03716830|561846708|FG000|Overall Study|Withdrawal by Subject|2|||
155659014|NCT03716830|561846709|FG001|Overall Study|Withdrawal by Subject|2|||
155659015|NCT03716830|561846710|FG002|Overall Study|Withdrawal by Subject|6|||
155659016|NCT03716830|561846711|FG003|Overall Study|Withdrawal by Subject|5|||
155659017|NCT03716830|561846708|FG000|Overall Study|Adverse Event|1|||
155659018|NCT03716830|561846709|FG001|Overall Study|Adverse Event|2|||
155659019|NCT03716830|561846710|FG002|Overall Study|Adverse Event|0|||
155659020|NCT03716830|561846711|FG003|Overall Study|Adverse Event|1|||
155659021|NCT03716830|561846708|FG000|Overall Study|Lost to Follow-up|1|||
155659022|NCT03716830|561846709|FG001|Overall Study|Lost to Follow-up|1|||
155659023|NCT03716830|561846710|FG002|Overall Study|Lost to Follow-up|0|||
155659024|NCT03716830|561846711|FG003|Overall Study|Lost to Follow-up|0|||
155659025|NCT05484895|561846712|FG000|Overall Study|Lost to Follow-up|63|||
155659026|NCT05484895|561846713|FG001|Overall Study|Lost to Follow-up|64|||
155659027|NCT04795531|561846714|FG000|Overall Study|Withdrawal by Subject|4|||
155659028|NCT04795531|561846715|FG001|Overall Study|Withdrawal by Subject|4|||
155659029|NCT04795531|561846714|FG000|Overall Study|Lost to Follow-up|0|||
155659030|NCT04795531|561846715|FG001|Overall Study|Lost to Follow-up|1|||
155659031|NCT04795531|561846714|FG000|Overall Study|Physician Decision|0|||
155659032|NCT04795531|561846715|FG001|Overall Study|Physician Decision|2|||
155659033|NCT04795531|561846714|FG000|Overall Study|Death|2|||
155659034|NCT04795531|561846715|FG001|Overall Study|Death|1|||
155659035|NCT04887831|561846716|FG000|Overall Study|Death|26|||
155659036|NCT04887831|561846717|FG001|Overall Study|Death|26|||
155659037|NCT04887831|561846716|FG000|Overall Study|Lost to Follow-up|0|||
155659038|NCT04887831|561846717|FG001|Overall Study|Lost to Follow-up|1|||
155659039|NCT04887831|561846716|FG000|Overall Study|Withdrawal by Subject|2|||
155659040|NCT04887831|561846717|FG001|Overall Study|Withdrawal by Subject|1|||
155659041|NCT04887831|561846716|FG000|Overall Study|Study Terminated by Sponsor|18|||
155659042|NCT04887831|561846717|FG001|Overall Study|Study Terminated by Sponsor|17|||
155659043|NCT04887831|561846716|FG000|Overall Study|Other|1|||
155659044|NCT04887831|561846717|FG001|Overall Study|Other|0|||
155659045|NCT02552225|561846718|FG000|Overall Study|Withdrawal by Subject|1|||
155659046|NCT02552225|561846719|FG001|Overall Study|Withdrawal by Subject|0|||
155659047|NCT03122184|561846720|FG000|Overall Study|Lost to Follow-up|4|||
155659048|NCT03122184|561846721|FG001|Overall Study|Lost to Follow-up|6|||
155659049|NCT03122184|561846720|FG000|Overall Study|Withdrawal by Subject|3|||
155659050|NCT03122184|561846721|FG001|Overall Study|Withdrawal by Subject|0|||
155659051|NCT03122184|561846720|FG000|Overall Study|Terminated due to cognitive problem|1|||
155659052|NCT03122184|561846721|FG001|Overall Study|Terminated due to cognitive problem|0|||
155659053|NCT00633126|561846722|FG000|Overall Study|Did not receive full dose|1|||
155659054|NCT01168596|561846723|FG000|Overall Study|Withdrawal by Subject|3|||
155659055|NCT01168596|561846724|FG001|Overall Study|Withdrawal by Subject|1|||
155659056|NCT02829996|561846727|FG000|Overall Study|Withdrawal by Subject|1|||
155659057|NCT02829996|561846728|FG001|Overall Study|Withdrawal by Subject|0|||
155659058|NCT02829996|561846729|FG002|Overall Study|Withdrawal by Subject|0|||
155659059|NCT02829996|561846730|FG003|Overall Study|Withdrawal by Subject|0|||
155659060|NCT02829996|561846731|FG004|Overall Study|Withdrawal by Subject|0|||
155659061|NCT00189423|561846737|FG000|Overall Study|Death|746|||
155659062|NCT00189423|561846738|FG001|Overall Study|Death|747|||
155659063|NCT00189423|561846737|FG000|Overall Study|Withdrawal by Subject|9|||
155659064|NCT00189423|561846738|FG001|Overall Study|Withdrawal by Subject|9|||
155659065|NCT00189423|561846737|FG000|Overall Study|Lost to Follow-up|10|||
155659066|NCT00189423|561846738|FG001|Overall Study|Lost to Follow-up|10|||
155659067|NCT00806585|561846752|FG000|Overall Study|Study terminated by Sponsor|0|||
155659068|NCT00806585|561846753|FG001|Overall Study|Study terminated by Sponsor|0|||
155659069|NCT00806585|561846754|FG002|Overall Study|Study terminated by Sponsor|1|||
155659070|NCT00806585|561846755|FG003|Overall Study|Study terminated by Sponsor|2|||
155659071|NCT00806585|561846756|FG004|Overall Study|Study terminated by Sponsor|0|||
155659072|NCT00806585|561846752|FG000|Overall Study|Protocol Violation|3|||
155659073|NCT00806585|561846753|FG001|Overall Study|Protocol Violation|1|||
155659074|NCT00806585|561846754|FG002|Overall Study|Protocol Violation|2|||
155659075|NCT00806585|561846755|FG003|Overall Study|Protocol Violation|0|||
155659076|NCT00806585|561846756|FG004|Overall Study|Protocol Violation|0|||
155659077|NCT00806585|561846752|FG000|Overall Study|Physician Decision|0|||
155659078|NCT00806585|561846753|FG001|Overall Study|Physician Decision|2|||
155659079|NCT00806585|561846754|FG002|Overall Study|Physician Decision|3|||
155659080|NCT00806585|561846755|FG003|Overall Study|Physician Decision|0|||
155659081|NCT00806585|561846756|FG004|Overall Study|Physician Decision|1|||
155659082|NCT00806585|561846752|FG000|Overall Study|Lost to Follow-up|2|||
155659083|NCT00806585|561846753|FG001|Overall Study|Lost to Follow-up|1|||
155659084|NCT00806585|561846754|FG002|Overall Study|Lost to Follow-up|2|||
155659085|NCT00806585|561846755|FG003|Overall Study|Lost to Follow-up|2|||
155659086|NCT00806585|561846756|FG004|Overall Study|Lost to Follow-up|5|||
155659087|NCT00806585|561846752|FG000|Overall Study|Lack of Efficacy|1|||
155659088|NCT00806585|561846753|FG001|Overall Study|Lack of Efficacy|0|||
155659089|NCT00806585|561846754|FG002|Overall Study|Lack of Efficacy|0|||
155659090|NCT00806585|561846755|FG003|Overall Study|Lack of Efficacy|0|||
155659091|NCT00806585|561846756|FG004|Overall Study|Lack of Efficacy|0|||
155659092|NCT00806585|561846752|FG000|Overall Study|Adverse Event|1|||
155659093|NCT00806585|561846753|FG001|Overall Study|Adverse Event|5|||
155659094|NCT00806585|561846754|FG002|Overall Study|Adverse Event|3|||
155659095|NCT00806585|561846755|FG003|Overall Study|Adverse Event|4|||
155659096|NCT00806585|561846756|FG004|Overall Study|Adverse Event|2|||
155659097|NCT00806585|561846752|FG000|Overall Study|Withdrawal by Subject|10|||
155659098|NCT00806585|561846753|FG001|Overall Study|Withdrawal by Subject|8|||
155659099|NCT00806585|561846754|FG002|Overall Study|Withdrawal by Subject|9|||
155659100|NCT00806585|561846755|FG003|Overall Study|Withdrawal by Subject|3|||
155659101|NCT00806585|561846756|FG004|Overall Study|Withdrawal by Subject|11|||
155659102|NCT00806585|561846752|FG000|Overall Study|Completion status unknown|15|||
155659103|NCT00806585|561846753|FG001|Overall Study|Completion status unknown|14|||
155659104|NCT00806585|561846754|FG002|Overall Study|Completion status unknown|12|||
155659105|NCT00806585|561846755|FG003|Overall Study|Completion status unknown|4|||
155564912|NCT02383810|561493082|FG001|Overall Study|Physician Decision|1|||
155564913|NCT02383810|561493083|FG002|Overall Study|Physician Decision|0|||
155564914|NCT02383810|561493084|FG003|Overall Study|Physician Decision|0|||
155564915|NCT02383810|561493085|FG004|Overall Study|Physician Decision|0|||
155564916|NCT02383810|561493086|FG005|Overall Study|Physician Decision|0|||
155564917|NCT02383810|561493087|FG006|Overall Study|Physician Decision|0|||
155564918|NCT02383810|561493088|FG007|Overall Study|Physician Decision|0|||
155564919|NCT02383810|561493081|FG000|Overall Study|Withdrawal by Subject|2|||
155564920|NCT02383810|561493082|FG001|Overall Study|Withdrawal by Subject|3|||
155564921|NCT02383810|561493083|FG002|Overall Study|Withdrawal by Subject|3|||
155564922|NCT02383810|561493084|FG003|Overall Study|Withdrawal by Subject|3|||
155564923|NCT02383810|561493085|FG004|Overall Study|Withdrawal by Subject|0|||
155564924|NCT02383810|561493086|FG005|Overall Study|Withdrawal by Subject|0|||
155564925|NCT02383810|561493087|FG006|Overall Study|Withdrawal by Subject|0|||
155564926|NCT02383810|561493088|FG007|Overall Study|Withdrawal by Subject|0|||
155564927|NCT02383810|561493081|FG000|Overall Study|Adverse Event|0|||
155564928|NCT02383810|561493082|FG001|Overall Study|Adverse Event|2|||
155564929|NCT02383810|561493083|FG002|Overall Study|Adverse Event|4|||
155564930|NCT02383810|561493084|FG003|Overall Study|Adverse Event|5|||
155564931|NCT02383810|561493085|FG004|Overall Study|Adverse Event|0|||
155564932|NCT02383810|561493086|FG005|Overall Study|Adverse Event|1|||
155564933|NCT02383810|561493087|FG006|Overall Study|Adverse Event|1|||
155564934|NCT02383810|561493088|FG007|Overall Study|Adverse Event|0|||
155564935|NCT02383810|561493081|FG000|Overall Study|Lost to Follow-up|0|||
155564936|NCT02383810|561493082|FG001|Overall Study|Lost to Follow-up|1|||
155564937|NCT02383810|561493083|FG002|Overall Study|Lost to Follow-up|0|||
155564938|NCT02383810|561493084|FG003|Overall Study|Lost to Follow-up|1|||
155659106|NCT00806585|561846756|FG004|Overall Study|Completion status unknown|12|||
155659107|NCT02038647|561846761|FG000|Overall Study|Progressive Disease|50|||
155659108|NCT02038647|561846762|FG001|Overall Study|Progressive Disease|59|||
155659109|NCT02038647|561846761|FG000|Overall Study|Adverse Event|18|||
155659110|NCT02038647|561846762|FG001|Overall Study|Adverse Event|10|||
155659111|NCT02038647|561846761|FG000|Overall Study|Symptomatic Deterioration|7|||
155659112|NCT02038647|561846762|FG001|Overall Study|Symptomatic Deterioration|7|||
155659113|NCT02038647|561846761|FG000|Overall Study|Withdrawal by Subject|5|||
155659114|NCT02038647|561846762|FG001|Overall Study|Withdrawal by Subject|2|||
155659115|NCT02038647|561846761|FG000|Overall Study|Not Reported|0|||
155659116|NCT02038647|561846762|FG001|Overall Study|Not Reported|1|||
155564939|NCT02383810|561493085|FG004|Overall Study|Lost to Follow-up|0|||
155564940|NCT02383810|561493086|FG005|Overall Study|Lost to Follow-up|0|||
155564941|NCT02383810|561493087|FG006|Overall Study|Lost to Follow-up|0|||
155659117|NCT02038647|561846761|FG000|Overall Study|Ongoing at Datacut|9|||
155659118|NCT02038647|561846762|FG001|Overall Study|Ongoing at Datacut|10|||
155564942|NCT02383810|561493088|FG007|Overall Study|Lost to Follow-up|0|||
155564943|NCT02383810|561493081|FG000|Overall Study|other|0|||
155564944|NCT02383810|561493082|FG001|Overall Study|other|0|||
155564945|NCT02383810|561493083|FG002|Overall Study|other|0|||
155659119|NCT04462471|561846763|FG000|Overall Study|Adverse Event|0|||
155659120|NCT04462471|561846764|FG001|Overall Study|Adverse Event|1|||
155659121|NCT04462471|561846765|FG002|Overall Study|Adverse Event|0|||
155659122|NCT04462471|561846766|FG003|Overall Study|Adverse Event|0|||
155659123|NCT04462471|561846763|FG000|Overall Study|Disease progression|1|||
155659124|NCT04462471|561846764|FG001|Overall Study|Disease progression|0|||
155659125|NCT04462471|561846765|FG002|Overall Study|Disease progression|0|||
155659126|NCT04462471|561846766|FG003|Overall Study|Disease progression|0|||
155659127|NCT00855335|561846769|FG000|Overall Study|Lost to Follow-up|0|||
155659128|NCT00855335|561846770|FG001|Overall Study|Lost to Follow-up|0|||
155659129|NCT00855335|561846771|FG002|Overall Study|Lost to Follow-up|3|||
155659130|NCT00855335|561846772|FG003|Overall Study|Lost to Follow-up|1|||
155659131|NCT00855335|561846773|FG004|Overall Study|Lost to Follow-up|0|||
155659132|NCT00855335|561846769|FG000|Overall Study|Withdrawal by Subject|0|||
155659133|NCT00855335|561846770|FG001|Overall Study|Withdrawal by Subject|0|||
155659134|NCT00855335|561846771|FG002|Overall Study|Withdrawal by Subject|0|||
155659135|NCT00855335|561846772|FG003|Overall Study|Withdrawal by Subject|1|||
155659136|NCT00855335|561846773|FG004|Overall Study|Withdrawal by Subject|0|||
155659137|NCT00855335|561846769|FG000|Overall Study|Adverse Event|2|||
155659138|NCT00855335|561846770|FG001|Overall Study|Adverse Event|0|||
155659139|NCT00855335|561846771|FG002|Overall Study|Adverse Event|0|||
155659140|NCT00855335|561846772|FG003|Overall Study|Adverse Event|0|||
155659141|NCT00855335|561846773|FG004|Overall Study|Adverse Event|0|||
155659142|NCT00855335|561846769|FG000|Overall Study|Physician Decision|1|||
155659143|NCT00855335|561846770|FG001|Overall Study|Physician Decision|1|||
155659144|NCT00855335|561846771|FG002|Overall Study|Physician Decision|0|||
155659145|NCT00855335|561846772|FG003|Overall Study|Physician Decision|0|||
155659146|NCT00855335|561846773|FG004|Overall Study|Physician Decision|0|||
155659147|NCT00855335|561846769|FG000|Overall Study|Other|2|||
155659148|NCT00855335|561846770|FG001|Overall Study|Other|1|||
155659149|NCT00855335|561846771|FG002|Overall Study|Other|2|||
155659150|NCT00855335|561846772|FG003|Overall Study|Other|5|||
155659151|NCT00855335|561846773|FG004|Overall Study|Other|1|||
155659152|NCT02526290|561846776|FG000|Overall Study|Adverse Event|3|||
155659153|NCT02526290|561846776|FG000|Overall Study|Withdrawal by Subject|4|||
155659154|NCT02526290|561846776|FG000|Overall Study|Physician Decision|1|||
155659155|NCT02082977|561846777|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
155659156|NCT02082977|561846778|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
155659157|NCT02082977|561846779|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
155659158|NCT02082977|561846780|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
155659159|NCT02082977|561846781|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
155659160|NCT02082977|561846782|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
155659161|NCT02082977|561846783|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
155659162|NCT02082977|561846784|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
155659163|NCT02082977|561846785|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
155659164|NCT02082977|561846786|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
155659165|NCT02082977|561846777|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659166|NCT02082977|561846778|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659167|NCT02082977|561846779|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659168|NCT02082977|561846780|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659169|NCT02082977|561846781|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659170|NCT02082977|561846782|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155564946|NCT02383810|561493084|FG003|Overall Study|other|2|||
155564947|NCT02383810|561493085|FG004|Overall Study|other|0|||
155564948|NCT02383810|561493086|FG005|Overall Study|other|0|||
155564949|NCT02383810|561493087|FG006|Overall Study|other|0|||
155564950|NCT02383810|561493088|FG007|Overall Study|other|0|||
155564951|NCT02383810|561493081|FG000|Overall Study|subject did not receive study treatment|0|||
155564952|NCT02383810|561493082|FG001|Overall Study|subject did not receive study treatment|1|||
155564953|NCT02383810|561493083|FG002|Overall Study|subject did not receive study treatment|0|||
155564954|NCT02383810|561493084|FG003|Overall Study|subject did not receive study treatment|0|||
155564955|NCT02383810|561493085|FG004|Overall Study|subject did not receive study treatment|0|||
155564956|NCT02383810|561493086|FG005|Overall Study|subject did not receive study treatment|0|||
155564957|NCT02383810|561493087|FG006|Overall Study|subject did not receive study treatment|0|||
155564958|NCT02383810|561493088|FG007|Overall Study|subject did not receive study treatment|0|||
155659171|NCT02082977|561846783|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659172|NCT02082977|561846784|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
155659173|NCT02082977|561846785|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659174|NCT02082977|561846786|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155659175|NCT02082977|561846777|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659176|NCT02082977|561846778|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659177|NCT02082977|561846779|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659178|NCT02082977|561846780|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659179|NCT02082977|561846781|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659180|NCT02082977|561846782|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
155659181|NCT02082977|561846783|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659182|NCT02082977|561846784|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659183|NCT02082977|561846785|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155564959|NCT01635283|561493091|FG000|Overall Study|Tumor Progression|3|||
155564960|NCT01635283|561493091|FG000|Overall Study|Lost to Follow-up|1|||
155564961|NCT04516759|561493092|FG000|Overall Study|Withdrawal by Subject|1|||
155564962|NCT04516759|561493093|FG001|Overall Study|Withdrawal by Subject|1|||
155564963|NCT04516759|561493092|FG000|Overall Study|Other|0|||
155564964|NCT04516759|561493093|FG001|Overall Study|Other|1|||
155564965|NCT01305044|561493094|FG000|Overall Study|Withdrawal by Subject|3|||
155564966|NCT01305044|561493095|FG001|Overall Study|Withdrawal by Subject|6|||
155564967|NCT02309138|561493096|FG000|Overall Study|Withdrawal by Subject|44|||
155564968|NCT02309138|561493097|FG001|Overall Study|Withdrawal by Subject|15|||
155564969|NCT02309138|561493096|FG000|Overall Study|Protocol Violation|4|||
155564970|NCT02309138|561493097|FG001|Overall Study|Protocol Violation|2|||
155564971|NCT02309138|561493096|FG000|Overall Study|delivered before visit 2|0|||
155564972|NCT02309138|561493097|FG001|Overall Study|delivered before visit 2|1|||
155564973|NCT01661062|561493104|FG000|Overall Study|Completed Treatment Off Study|3|||
155564974|NCT01661062|561493104|FG000|Overall Study|Withdrawal by Subject|2|||
155564975|NCT00838435|561493106|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
155564976|NCT00838435|561493106|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
155564977|NCT00838435|561493106|FG000|Part 2 (7 Years)|Adverse Event|2|||
155564978|NCT00838435|561493106|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
155564979|NCT00838435|561493106|FG000|Part 2 (7 Years)|Physician Decision|1|||
155564980|NCT00838435|561493106|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
155564981|NCT00838435|561493106|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
155564982|NCT02754856|561493108|FG000|Overall Study|Withdrawal by Subject|1|||
155564983|NCT04874155|561493109|FG000|Overall Study|Lost to Follow-up|1|||
155564984|NCT04874155|561493110|FG001|Overall Study|Lost to Follow-up|1|||
155564985|NCT04874155|561493109|FG000|Overall Study|Withdrawal by Subject|2|||
155564986|NCT04874155|561493110|FG001|Overall Study|Withdrawal by Subject|2|||
155564987|NCT00530218|561493113|FG000|Overall Study|CMV Not Detected|13|||
155564988|NCT00530218|561493113|FG000|Overall Study|Death|12|||
155564989|NCT00678886|561493116|FG000|Overall Study|Withdrawal by Subject|0|||
155564990|NCT00678886|561493117|FG001|Overall Study|Withdrawal by Subject|0|||
155564991|NCT00678886|561493118|FG002|Overall Study|Withdrawal by Subject|4|||
155564992|NCT00678886|561493119|FG003|Overall Study|Withdrawal by Subject|6|||
155564993|NCT00678886|561493116|FG000|Overall Study|Physician Decision|0|||
155564994|NCT00678886|561493117|FG001|Overall Study|Physician Decision|0|||
155564995|NCT00678886|561493118|FG002|Overall Study|Physician Decision|1|||
155564996|NCT00678886|561493119|FG003|Overall Study|Physician Decision|1|||
155564997|NCT00678886|561493116|FG000|Overall Study|Lost to Follow-up|0|||
155564998|NCT00678886|561493117|FG001|Overall Study|Lost to Follow-up|0|||
155564999|NCT00678886|561493118|FG002|Overall Study|Lost to Follow-up|3|||
155565000|NCT00678886|561493119|FG003|Overall Study|Lost to Follow-up|2|||
155565001|NCT00678886|561493116|FG000|Overall Study|Other|0|||
155565002|NCT00678886|561493117|FG001|Overall Study|Other|0|||
155565003|NCT00678886|561493118|FG002|Overall Study|Other|1|||
155565004|NCT00678886|561493119|FG003|Overall Study|Other|0|||
155565005|NCT03477903|561493120|FG000|Overall Study|Study Terminated by Sponsor|1|||
155565006|NCT01147107|561493121|FG000|Overall Study|Lack of Efficacy|5|||
155565007|NCT01147107|561493122|FG001|Overall Study|Lack of Efficacy|0|||
155565008|NCT01147107|561493121|FG000|Overall Study|Withdrawal by Subject|1|||
155565009|NCT01147107|561493122|FG001|Overall Study|Withdrawal by Subject|1|||
155565010|NCT04435184|561493123|FG000|Overall Study|follow-up blood draws missing|3|||
155565011|NCT04435184|561493124|FG001|Overall Study|follow-up blood draws missing|5|||
155565012|NCT04693416|561493125|FG000|Overall Study|Lost to Follow-up|13|||
155565013|NCT04693416|561493126|FG001|Overall Study|Lost to Follow-up|0|||
155565014|NCT00474266|561493127|FG000|Overall Study|Withdrawal by Subject|7|||
155565015|NCT00474266|561493128|FG001|Overall Study|Withdrawal by Subject|20|||
155565016|NCT00474266|561493129|FG002|Overall Study|Withdrawal by Subject|4|||
155565017|NCT00474266|561493130|FG003|Overall Study|Withdrawal by Subject|7|||
155565018|NCT05330468|561493133|FG000|Overall Study|Death|6|||
155565019|NCT05330468|561493133|FG000|Overall Study|Withdrawal by Subject|4|||
155565020|NCT05330468|561493133|FG000|Overall Study|Lost to Follow-up|4|||
155565021|NCT00369317|561493134|FG000|Overall Study|Adverse Event|3|||
155565022|NCT00369317|561493134|FG000|Overall Study|Death|1|||
155565023|NCT00369317|561493134|FG000|Overall Study|Lack of Efficacy|5|||
155565024|NCT00369317|561493134|FG000|Overall Study|Physician Decision|2|||
155565025|NCT00369317|561493134|FG000|Overall Study|Withdrawal by Subject|8|||
155565026|NCT00369317|561493134|FG000|Overall Study|Ineligible|1|||
155565027|NCT02365558|561493135|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
155565028|NCT02365558|561493136|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
155565029|NCT02365558|561493135|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
155565030|NCT02365558|561493136|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
155565031|NCT00426361|561493143|FG000|Overall Study|Lost to Follow-up|3|||
155565032|NCT00426361|561493144|FG001|Overall Study|Lost to Follow-up|2|||
155565033|NCT00426361|561493145|FG002|Overall Study|Lost to Follow-up|5|||
155565034|NCT00426361|561493143|FG000|Overall Study|Withdrawal by Subject|1|||
155565035|NCT00426361|561493144|FG001|Overall Study|Withdrawal by Subject|3|||
155565036|NCT00426361|561493145|FG002|Overall Study|Withdrawal by Subject|0|||
155565037|NCT02828241|561493146|FG000|Overall Study|Adverse Event|7|||
155565038|NCT02828241|561493147|FG001|Overall Study|Adverse Event|2|||
155565039|NCT02828241|561493146|FG000|Overall Study|Protocol Violation|1|||
155565040|NCT02828241|561493147|FG001|Overall Study|Protocol Violation|0|||
155565041|NCT03050060|561493162|FG000|Overall Study|Adverse Event|7|||
155565042|NCT03050060|561493162|FG000|Overall Study|Withdrawal by Subject|1|||
155565043|NCT03050060|561493162|FG000|Overall Study|Progression|7|||
155565044|NCT03835221|561493163|FG000|Methafilcon A|Withdrawal by Subject|1|||
155565045|NCT00499174|561493164|FG000|Overall Study|Physician Decision|78|||
155565046|NCT00499174|561493165|FG001|Overall Study|Physician Decision|9|||
155565047|NCT01214915|561493166|FG000|Overall Study|Adverse Event|8|||
155565048|NCT01214915|561493166|FG000|Overall Study|Lack of Efficacy|3|||
155565049|NCT00871741|561493167|FG000|Overall Study|Premature study termination|9|||
155565050|NCT00871741|561493168|FG001|Overall Study|Premature study termination|7|||
155565051|NCT05323123|561493169|FG000|Overall Study|Withdrawal by Subject|2|||
155565052|NCT05323123|561493170|FG001|Overall Study|Withdrawal by Subject|1|||
155565053|NCT05323123|561493169|FG000|Overall Study|Lost to Follow-up|4|||
155565054|NCT05323123|561493170|FG001|Overall Study|Lost to Follow-up|2|||
155565055|NCT05323123|561493169|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
155565056|NCT05323123|561493170|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
155565057|NCT05529472|561493171|FG000|Overall Study|Withdrawal by Subject|1|||
155565058|NCT05529472|561493172|FG001|Overall Study|Withdrawal by Subject|1|||
155565059|NCT04975191|561495072|FG000|Overall Study|Protocol Violation|1|||
155565060|NCT04975191|561495073|FG001|Overall Study|Protocol Violation|2|||
155565061|NCT04975191|561495074|FG002|Overall Study|Protocol Violation|2|||
155565062|NCT04975191|561495075|FG003|Overall Study|Protocol Violation|2|||
155565063|NCT04975191|561495072|FG000|Overall Study|Lost to Follow-up|13|||
155565064|NCT04975191|561495073|FG001|Overall Study|Lost to Follow-up|3|||
155565065|NCT04975191|561495074|FG002|Overall Study|Lost to Follow-up|8|||
155565066|NCT04975191|561495075|FG003|Overall Study|Lost to Follow-up|8|||
155565067|NCT00761657|561495076|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
155565068|NCT00761657|561495077|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
155565069|NCT00761657|561495078|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
155565070|NCT00761657|561495079|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
155565071|NCT00761657|561495080|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
155565072|NCT00761657|561495081|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
155565073|NCT00761657|561495082|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
155565074|NCT00761657|561495083|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
155565075|NCT00761657|561495084|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
155565076|NCT00761657|561495076|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565077|NCT00761657|561495077|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565078|NCT00761657|561495078|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
155565079|NCT00761657|561495079|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
155565080|NCT00761657|561495080|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565081|NCT00761657|561495081|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565082|NCT00761657|561495082|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565083|NCT00761657|561495083|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565084|NCT00761657|561495084|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
155565085|NCT00761657|561495076|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
155565086|NCT00761657|561495077|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
155565087|NCT00761657|561495078|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
155565088|NCT00761657|561495079|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
155565089|NCT00761657|561495080|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
155565090|NCT00761657|561495081|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
155565091|NCT00761657|561495082|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
155565092|NCT00761657|561495083|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
155565093|NCT00761657|561495084|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
155565094|NCT00761657|561495076|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
155565095|NCT00761657|561495077|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
155565096|NCT00761657|561495078|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
155565097|NCT00761657|561495079|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
155565098|NCT00761657|561495080|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
155565099|NCT00761657|561495081|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
155565100|NCT00761657|561495082|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
155565101|NCT00761657|561495083|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
155565102|NCT00761657|561495084|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
155565103|NCT00359801|561495088|FG000|Overall Study|Lost to Follow-up|72|||
155565104|NCT00359801|561495089|FG001|Overall Study|Lost to Follow-up|58|||
155565105|NCT00359801|561495088|FG000|Overall Study|Withdrawal by Subject|143|||
155565106|NCT00359801|561495089|FG001|Overall Study|Withdrawal by Subject|96|||
155565107|NCT00359801|561495088|FG000|Overall Study|Other|66|||
155565108|NCT00359801|561495089|FG001|Overall Study|Other|46|||
155565109|NCT00359801|561495088|FG000|Overall Study|Final Status Unknown: missing data|7|||
155565110|NCT00359801|561495089|FG001|Overall Study|Final Status Unknown: missing data|4|||
155565111|NCT00359801|561495088|FG000|Overall Study|Sponsor Decision|17|||
155565112|NCT00359801|561495089|FG001|Overall Study|Sponsor Decision|16|||
155565113|NCT01564537|561495090|FG000|Overall Study|Site Terminated by Sponsor|1|||
155565114|NCT01564537|561495091|FG001|Overall Study|Site Terminated by Sponsor|0|||
155565115|NCT01564537|561495090|FG000|Overall Study|Withdrawal by Subject|12|||
155565116|NCT01564537|561495091|FG001|Overall Study|Withdrawal by Subject|14|||
155565117|NCT01564537|561495090|FG000|Overall Study|Lost to Follow-up|7|||
155565118|NCT01564537|561495091|FG001|Overall Study|Lost to Follow-up|3|||
155565119|NCT01564537|561495090|FG000|Overall Study|Reason not specified|81|||
155565120|NCT01564537|561495091|FG001|Overall Study|Reason not specified|82|||
155565121|NCT02932306|561495092|FG000|Overall Study|Withdrawal by Subject|16|||
155565122|NCT02932306|561495093|FG001|Overall Study|Withdrawal by Subject|25|||
155565123|NCT02932306|561495092|FG000|Overall Study|Adverse Event|3|||
155565124|NCT02932306|561495093|FG001|Overall Study|Adverse Event|0|||
155565125|NCT02932306|561495092|FG000|Overall Study|Pregnancy|2|||
155565126|NCT02932306|561495093|FG001|Overall Study|Pregnancy|0|||
155565127|NCT02932306|561495092|FG000|Overall Study|Protocol Violation|1|||
155565128|NCT02932306|561495093|FG001|Overall Study|Protocol Violation|1|||
155565129|NCT02932306|561495092|FG000|Overall Study|Noncompliance with Study Drug|1|||
155565130|NCT02932306|561495093|FG001|Overall Study|Noncompliance with Study Drug|1|||
155565131|NCT02932306|561495092|FG000|Overall Study|Lost to Follow-up|36|||
155565132|NCT02932306|561495093|FG001|Overall Study|Lost to Follow-up|40|||
155659184|NCT02082977|561846786|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155659185|NCT02082977|561846777|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155659186|NCT02082977|561846778|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155659187|NCT02082977|561846779|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155659188|NCT02082977|561846780|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155659189|NCT02082977|561846781|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155659190|NCT02082977|561846782|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155659191|NCT02082977|561846783|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
155659192|NCT02082977|561846784|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155659193|NCT02082977|561846785|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
155659194|NCT02082977|561846786|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155659195|NCT02082977|561846777|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659196|NCT02082977|561846778|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659197|NCT02082977|561846779|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659198|NCT02082977|561846780|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659199|NCT02082977|561846781|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659200|NCT02082977|561846782|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659201|NCT02082977|561846783|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659202|NCT02082977|561846784|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
155659203|NCT02082977|561846785|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659204|NCT02082977|561846786|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155659205|NCT02106832|561846790|FG000|Overall Study|Adverse Event|1|||
155659206|NCT02106832|561846791|FG001|Overall Study|Adverse Event|2|||
155659207|NCT02106832|561846792|FG002|Overall Study|Adverse Event|3|||
155659208|NCT02106832|561846793|FG003|Overall Study|Adverse Event|0|||
155659209|NCT02106832|561846790|FG000|Overall Study|Death|4|||
155565133|NCT02932306|561495092|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
155565134|NCT02932306|561495093|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
155659210|NCT02106832|561846791|FG001|Overall Study|Death|4|||
155565135|NCT02932306|561495092|FG000|Overall Study|Lack of Efficacy|0|||
155565136|NCT02932306|561495093|FG001|Overall Study|Lack of Efficacy|2|||
155565137|NCT02932306|561495092|FG000|Overall Study|Worsening condition|2|||
155565138|NCT02932306|561495093|FG001|Overall Study|Worsening condition|0|||
155565139|NCT02932306|561495092|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
155565140|NCT02932306|561495093|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
155565141|NCT05776862|561495094|FG000|Overall Study|Adverse Event|0|||
155565142|NCT05776862|561495095|FG001|Overall Study|Adverse Event|1|||
155565143|NCT05776862|561495094|FG000|Overall Study|non-compliance|1|||
155565144|NCT05776862|561495095|FG001|Overall Study|non-compliance|0|||
155565145|NCT02448706|561495096|FG000|Overall Study|Withdrawal by Subject|4|||
155565146|NCT02448706|561495097|FG001|Overall Study|Withdrawal by Subject|3|||
155565147|NCT02448706|561495096|FG000|Overall Study|Protocol Violation|1|||
155565148|NCT02448706|561495097|FG001|Overall Study|Protocol Violation|1|||
155565149|NCT02065700|561495098|FG000|Overall Study|Adverse Event|165|||
155565150|NCT02065700|561495099|FG001|Overall Study|Adverse Event|101|||
155565151|NCT02065700|561495098|FG000|Overall Study|Withdrawal by Subject|90|||
155565152|NCT02065700|561495099|FG001|Overall Study|Withdrawal by Subject|29|||
155565153|NCT02065700|561495098|FG000|Overall Study|Lost to Follow-up|12|||
155565154|NCT02065700|561495099|FG001|Overall Study|Lost to Follow-up|9|||
155565155|NCT02065700|561495098|FG000|Overall Study|Physician Decision|2|||
155565156|NCT02065700|561495099|FG001|Overall Study|Physician Decision|0|||
155565157|NCT02065700|561495098|FG000|Overall Study|Sponsor Request|38|||
155565158|NCT02065700|561495099|FG001|Overall Study|Sponsor Request|15|||
155565159|NCT02065700|561495098|FG000|Overall Study|Treatment Failure|3|||
155565160|NCT02065700|561495099|FG001|Overall Study|Treatment Failure|2|||
155565161|NCT02065700|561495098|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
155565162|NCT02065700|561495099|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
155565163|NCT02065700|561495098|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
155565164|NCT02065700|561495099|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
155565165|NCT02065700|561495098|FG000|Overall Study|Non-compliance with Study Procedures|2|||
155565166|NCT02065700|561495099|FG001|Overall Study|Non-compliance with Study Procedures|0|||
155565167|NCT02065700|561495098|FG000|Overall Study|Not Defined|21|||
155565168|NCT02065700|561495099|FG001|Overall Study|Not Defined|3|||
155565169|NCT01635218|561495100|FG000|Overall Study|Lost to Follow-up|3|||
155565170|NCT01635218|561495101|FG001|Overall Study|Lost to Follow-up|7|||
155565171|NCT01635218|561495102|FG002|Overall Study|Lost to Follow-up|6|||
155565172|NCT03559400|561495103|FG000|Overall Study|Lost to Follow-up|9|||
155565173|NCT03559400|561495104|FG001|Overall Study|Lost to Follow-up|7|||
155565174|NCT03559400|561495103|FG000|Overall Study|Death|0|||
155565175|NCT03559400|561495104|FG001|Overall Study|Death|2|||
155565176|NCT03262038|561495109|FG000|Overall Study|Withdrawal by Subject|0|||
155565177|NCT03262038|561495110|FG001|Overall Study|Withdrawal by Subject|1|||
155565178|NCT04933968|561495111|FG000|Overall Study|Adverse Event|0|||
155565179|NCT04933968|561495112|FG001|Overall Study|Adverse Event|0|||
155565180|NCT04933968|561495113|FG002|Overall Study|Adverse Event|1|||
155565181|NCT04933968|561495114|FG003|Overall Study|Adverse Event|1|||
155565182|NCT04933968|561495115|FG004|Overall Study|Adverse Event|0|||
155565183|NCT04933968|561495116|FG005|Overall Study|Adverse Event|0|||
155565184|NCT04933968|561495111|FG000|Overall Study|Lost to Follow-up|1|||
155565185|NCT04933968|561495112|FG001|Overall Study|Lost to Follow-up|0|||
155565186|NCT04933968|561495113|FG002|Overall Study|Lost to Follow-up|1|||
155565187|NCT04933968|561495114|FG003|Overall Study|Lost to Follow-up|0|||
155565188|NCT04933968|561495115|FG004|Overall Study|Lost to Follow-up|0|||
155565189|NCT04933968|561495116|FG005|Overall Study|Lost to Follow-up|0|||
155565190|NCT04933968|561495111|FG000|Overall Study|Randomized not treated|1|||
155565191|NCT04933968|561495112|FG001|Overall Study|Randomized not treated|0|||
155565192|NCT04933968|561495113|FG002|Overall Study|Randomized not treated|0|||
155565193|NCT04933968|561495114|FG003|Overall Study|Randomized not treated|0|||
155565194|NCT04933968|561495115|FG004|Overall Study|Randomized not treated|0|||
155565195|NCT04933968|561495116|FG005|Overall Study|Randomized not treated|0|||
155565196|NCT04933968|561495111|FG000|Overall Study|Sponsor terminated study|0|||
155565197|NCT04933968|561495112|FG001|Overall Study|Sponsor terminated study|0|||
155565198|NCT04933968|561495113|FG002|Overall Study|Sponsor terminated study|0|||
155565199|NCT04933968|561495114|FG003|Overall Study|Sponsor terminated study|1|||
155565200|NCT04933968|561495115|FG004|Overall Study|Sponsor terminated study|2|||
155565201|NCT04933968|561495116|FG005|Overall Study|Sponsor terminated study|0|||
155565202|NCT04933968|561495111|FG000|Overall Study|Other|0|||
155565203|NCT04933968|561495112|FG001|Overall Study|Other|0|||
155565204|NCT04933968|561495113|FG002|Overall Study|Other|0|||
155565205|NCT04933968|561495114|FG003|Overall Study|Other|1|||
155565206|NCT04933968|561495115|FG004|Overall Study|Other|0|||
155565207|NCT04933968|561495116|FG005|Overall Study|Other|0|||
155565208|NCT04933968|561495111|FG000|Overall Study|Missing|1|||
155565209|NCT04933968|561495112|FG001|Overall Study|Missing|3|||
155565210|NCT04933968|561495113|FG002|Overall Study|Missing|2|||
155565211|NCT04933968|561495114|FG003|Overall Study|Missing|1|||
155565212|NCT04933968|561495115|FG004|Overall Study|Missing|1|||
155565213|NCT04933968|561495116|FG005|Overall Study|Missing|0|||
155565214|NCT01724489|561495117|FG000|Overall Study|Adverse Event|8|||
155565215|NCT01724489|561495118|FG001|Overall Study|Adverse Event|3|||
155565216|NCT01724489|561495117|FG000|Overall Study|Surgery, medication|1|||
155565217|NCT01724489|561495118|FG001|Overall Study|Surgery, medication|1|||
155565218|NCT01724489|561495117|FG000|Overall Study|Lost to Follow-up|1|||
155565219|NCT01724489|561495118|FG001|Overall Study|Lost to Follow-up|2|||
155565220|NCT01724489|561495117|FG000|Overall Study|Withdrawal by Subject|6|||
155565221|NCT01724489|561495118|FG001|Overall Study|Withdrawal by Subject|6|||
155565222|NCT01664130|561495121|FG000|Overall Study|competing secondary disease|2|||
155565223|NCT03323437|561495122|FG000|Overall Study|Withdrawal by Subject|0|||
155565224|NCT03323437|561495123|FG001|Overall Study|Withdrawal by Subject|4|||
155565225|NCT01473524|561495126|FG000|DB Phase|Adverse Event|4|||
155565226|NCT01473524|561495127|FG001|DB Phase|Adverse Event|8|||
155565227|NCT01473524|561495128|FG002|DB Phase|Adverse Event|2|||
155565228|NCT01473524|561495129|FG003|DB Phase|Adverse Event|0|||
155565229|NCT01473524|561495130|FG004|DB Phase|Adverse Event|0|||
155565230|NCT01473524|561495131|FG005|DB Phase|Adverse Event|0|||
155565231|NCT01473524|561495126|FG000|DB Phase|Death|1|||
155565232|NCT01473524|561495127|FG001|DB Phase|Death|0|||
155565233|NCT01473524|561495128|FG002|DB Phase|Death|0|||
155565234|NCT01473524|561495129|FG003|DB Phase|Death|0|||
155565235|NCT01473524|561495130|FG004|DB Phase|Death|0|||
155565236|NCT01473524|561495131|FG005|DB Phase|Death|0|||
155565237|NCT01473524|561495126|FG000|DB Phase|Withdrawal by Subject|2|||
155565238|NCT01473524|561495127|FG001|DB Phase|Withdrawal by Subject|1|||
155565239|NCT01473524|561495128|FG002|DB Phase|Withdrawal by Subject|1|||
155565240|NCT01473524|561495129|FG003|DB Phase|Withdrawal by Subject|0|||
155565241|NCT01473524|561495130|FG004|DB Phase|Withdrawal by Subject|0|||
155565242|NCT01473524|561495131|FG005|DB Phase|Withdrawal by Subject|0|||
155565243|NCT01473524|561495126|FG000|LTSE Phase|Withdrawal by Subject|0|||
155565244|NCT01473524|561495127|FG001|LTSE Phase|Withdrawal by Subject|0|||
155565245|NCT01473524|561495128|FG002|LTSE Phase|Withdrawal by Subject|0|||
155565246|NCT01473524|561495129|FG003|LTSE Phase|Withdrawal by Subject|3|||
155565247|NCT01473524|561495130|FG004|LTSE Phase|Withdrawal by Subject|3|||
155565248|NCT01473524|561495131|FG005|LTSE Phase|Withdrawal by Subject|6|||
155565249|NCT01473524|561495126|FG000|LTSE Phase|Death|0|||
155565250|NCT01473524|561495127|FG001|LTSE Phase|Death|0|||
155565251|NCT01473524|561495128|FG002|LTSE Phase|Death|0|||
155565252|NCT01473524|561495129|FG003|LTSE Phase|Death|0|||
155565253|NCT01473524|561495130|FG004|LTSE Phase|Death|1|||
155565254|NCT01473524|561495131|FG005|LTSE Phase|Death|0|||
155565255|NCT01473524|561495126|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
155565256|NCT01473524|561495127|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
155565257|NCT01473524|561495128|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
155565258|NCT01473524|561495129|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
155565259|NCT01473524|561495130|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
155565260|NCT01473524|561495131|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
155565261|NCT01473524|561495126|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
155565262|NCT01473524|561495127|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
155565263|NCT01473524|561495128|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
155565264|NCT01473524|561495129|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
155565265|NCT01473524|561495130|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
155565266|NCT01473524|561495131|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
155565267|NCT01473524|561495126|FG000|LTSE Phase|Lost to Follow-up|0|||
155565268|NCT01473524|561495127|FG001|LTSE Phase|Lost to Follow-up|0|||
155565269|NCT01473524|561495128|FG002|LTSE Phase|Lost to Follow-up|0|||
155565270|NCT01473524|561495129|FG003|LTSE Phase|Lost to Follow-up|1|||
155565271|NCT01473524|561495130|FG004|LTSE Phase|Lost to Follow-up|3|||
155565272|NCT01473524|561495131|FG005|LTSE Phase|Lost to Follow-up|2|||
155565273|NCT01473524|561495126|FG000|LTSE Phase|Principal Investigator Decision|0|||
155565274|NCT01473524|561495127|FG001|LTSE Phase|Principal Investigator Decision|0|||
155565275|NCT01473524|561495128|FG002|LTSE Phase|Principal Investigator Decision|0|||
155565276|NCT01473524|561495129|FG003|LTSE Phase|Principal Investigator Decision|1|||
155565277|NCT01473524|561495130|FG004|LTSE Phase|Principal Investigator Decision|1|||
155565278|NCT01473524|561495131|FG005|LTSE Phase|Principal Investigator Decision|3|||
155565279|NCT01473524|561495126|FG000|LTSE Phase|Liver Transplantation|0|||
155565280|NCT01473524|561495127|FG001|LTSE Phase|Liver Transplantation|0|||
155565281|NCT01473524|561495128|FG002|LTSE Phase|Liver Transplantation|0|||
155565282|NCT01473524|561495129|FG003|LTSE Phase|Liver Transplantation|0|||
155565283|NCT01473524|561495130|FG004|LTSE Phase|Liver Transplantation|0|||
155565284|NCT01473524|561495131|FG005|LTSE Phase|Liver Transplantation|1|||
155565285|NCT01473524|561495126|FG000|LTSE Phase|Pregnancy|0|||
155565286|NCT01473524|561495127|FG001|LTSE Phase|Pregnancy|0|||
155565287|NCT01473524|561495128|FG002|LTSE Phase|Pregnancy|0|||
155565288|NCT01473524|561495129|FG003|LTSE Phase|Pregnancy|1|||
155565289|NCT01473524|561495130|FG004|LTSE Phase|Pregnancy|0|||
155565290|NCT01473524|561495131|FG005|LTSE Phase|Pregnancy|0|||
155565291|NCT01473524|561495126|FG000|LTSE Phase|Protocol Violation|0|||
155565292|NCT01473524|561495127|FG001|LTSE Phase|Protocol Violation|0|||
155565293|NCT01473524|561495128|FG002|LTSE Phase|Protocol Violation|0|||
155565294|NCT01473524|561495129|FG003|LTSE Phase|Protocol Violation|0|||
155565295|NCT01473524|561495130|FG004|LTSE Phase|Protocol Violation|0|||
155565296|NCT01473524|561495131|FG005|LTSE Phase|Protocol Violation|1|||
155565297|NCT01544179|561495132|FG000|Overall Study|Death|50|||
155565298|NCT01544179|561495133|FG001|Overall Study|Death|37|||
155565299|NCT01544179|561495132|FG000|Overall Study|Lost to Follow-up|0|||
155565300|NCT01544179|561495133|FG001|Overall Study|Lost to Follow-up|1|||
155565301|NCT01544179|561495132|FG000|Overall Study|Adverse Event|0|||
155565302|NCT01544179|561495133|FG001|Overall Study|Adverse Event|1|||
155565303|NCT01544179|561495132|FG000|Overall Study|Withdrawal by Subject|12|||
155565304|NCT01544179|561495133|FG001|Overall Study|Withdrawal by Subject|7|||
155565305|NCT01544179|561495132|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
155565306|NCT01544179|561495133|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155565307|NCT02045147|561495134|FG000|Overall Study|Withdrawal by Subject|2|||
155565308|NCT02045147|561495135|FG001|Overall Study|Withdrawal by Subject|0|||
155565309|NCT02045147|561495136|FG002|Overall Study|Withdrawal by Subject|0|||
155565310|NCT02045147|561495137|FG003|Overall Study|Withdrawal by Subject|0|||
155565311|NCT02045147|561495138|FG004|Overall Study|Withdrawal by Subject|0|||
155565312|NCT02045147|561495139|FG005|Overall Study|Withdrawal by Subject|0|||
155565313|NCT02045147|561495140|FG006|Overall Study|Withdrawal by Subject|0|||
155565314|NCT02045147|561495141|FG007|Overall Study|Withdrawal by Subject|1|||
155565315|NCT02045147|561495134|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
155565316|NCT02045147|561495135|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
155565317|NCT02045147|561495136|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
155565318|NCT02045147|561495137|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
155565319|NCT02045147|561495138|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
155565320|NCT02045147|561495139|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
155565321|NCT02045147|561495140|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
155565322|NCT02045147|561495141|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
155565323|NCT04839692|561495142|FG000|Overall Study|Withdrawal by Subject|0|||
155565324|NCT04839692|561495143|FG001|Overall Study|Withdrawal by Subject|3|||
155565325|NCT04839692|561495142|FG000|Overall Study|Physician Decision|1|||
155565326|NCT04839692|561495143|FG001|Overall Study|Physician Decision|0|||
155565327|NCT03146962|561495146|FG000|Overall Study|Lost to Follow-up|1|||
155565328|NCT03146962|561495147|FG001|Overall Study|Lost to Follow-up|1|||
155565329|NCT03146962|561495148|FG002|Overall Study|Lost to Follow-up|0|||
155565330|NCT03146962|561495149|FG003|Overall Study|Lost to Follow-up|0|||
155565331|NCT03146962|561495150|FG004|Overall Study|Lost to Follow-up|0|||
155565332|NCT03146962|561495151|FG005|Overall Study|Lost to Follow-up|0|||
155565333|NCT03146962|561495152|FG006|Overall Study|Lost to Follow-up|0|||
155565334|NCT03146962|561495153|FG007|Overall Study|Lost to Follow-up|0|||
155565335|NCT03146962|561495154|FG008|Overall Study|Lost to Follow-up|0|||
155565336|NCT03146962|561495155|FG009|Overall Study|Lost to Follow-up|0|||
155565337|NCT03146962|561495146|FG000|Overall Study|Adverse Event|0|||
155565338|NCT03146962|561495147|FG001|Overall Study|Adverse Event|3|||
155565339|NCT03146962|561495148|FG002|Overall Study|Adverse Event|0|||
155565340|NCT03146962|561495149|FG003|Overall Study|Adverse Event|0|||
155565341|NCT03146962|561495150|FG004|Overall Study|Adverse Event|0|||
155565342|NCT03146962|561495151|FG005|Overall Study|Adverse Event|0|||
155565343|NCT03146962|561495152|FG006|Overall Study|Adverse Event|0|||
155565344|NCT03146962|561495153|FG007|Overall Study|Adverse Event|1|||
155565345|NCT03146962|561495154|FG008|Overall Study|Adverse Event|0|||
155565346|NCT03146962|561495155|FG009|Overall Study|Adverse Event|0|||
155565347|NCT03146962|561495146|FG000|Overall Study|Withdrawal by Subject|0|||
155565348|NCT03146962|561495147|FG001|Overall Study|Withdrawal by Subject|0|||
155565349|NCT03146962|561495148|FG002|Overall Study|Withdrawal by Subject|0|||
155565350|NCT03146962|561495149|FG003|Overall Study|Withdrawal by Subject|0|||
155565351|NCT03146962|561495150|FG004|Overall Study|Withdrawal by Subject|1|||
155565352|NCT03146962|561495151|FG005|Overall Study|Withdrawal by Subject|0|||
155565353|NCT03146962|561495152|FG006|Overall Study|Withdrawal by Subject|0|||
155565354|NCT03146962|561495153|FG007|Overall Study|Withdrawal by Subject|0|||
155565355|NCT03146962|561495154|FG008|Overall Study|Withdrawal by Subject|0|||
155565356|NCT03146962|561495155|FG009|Overall Study|Withdrawal by Subject|0|||
155565357|NCT03146962|561495146|FG000|Overall Study|Death|0|||
155565358|NCT03146962|561495147|FG001|Overall Study|Death|1|||
155565359|NCT03146962|561495148|FG002|Overall Study|Death|0|||
155565360|NCT03146962|561495149|FG003|Overall Study|Death|0|||
155565361|NCT03146962|561495150|FG004|Overall Study|Death|0|||
155565362|NCT03146962|561495151|FG005|Overall Study|Death|0|||
155565363|NCT03146962|561495152|FG006|Overall Study|Death|0|||
155565364|NCT03146962|561495153|FG007|Overall Study|Death|0|||
155565365|NCT03146962|561495154|FG008|Overall Study|Death|0|||
155565366|NCT03146962|561495155|FG009|Overall Study|Death|0|||
155565367|NCT03146962|561495146|FG000|Overall Study|COVID Precautions|1|||
155565368|NCT03146962|561495147|FG001|Overall Study|COVID Precautions|0|||
155565369|NCT03146962|561495148|FG002|Overall Study|COVID Precautions|0|||
155565370|NCT03146962|561495149|FG003|Overall Study|COVID Precautions|0|||
155565371|NCT03146962|561495150|FG004|Overall Study|COVID Precautions|0|||
155565372|NCT03146962|561495151|FG005|Overall Study|COVID Precautions|0|||
155565373|NCT03146962|561495152|FG006|Overall Study|COVID Precautions|0|||
155659211|NCT02106832|561846792|FG002|Overall Study|Death|1|||
155565374|NCT03146962|561495153|FG007|Overall Study|COVID Precautions|0|||
155565375|NCT03146962|561495154|FG008|Overall Study|COVID Precautions|0|||
155565376|NCT03146962|561495155|FG009|Overall Study|COVID Precautions|0|||
155565377|NCT03146962|561495146|FG000|Overall Study|Physician Decision|0|||
155565378|NCT03146962|561495147|FG001|Overall Study|Physician Decision|0|||
155565379|NCT03146962|561495148|FG002|Overall Study|Physician Decision|0|||
155565380|NCT03146962|561495149|FG003|Overall Study|Physician Decision|0|||
155565381|NCT03146962|561495150|FG004|Overall Study|Physician Decision|0|||
155565382|NCT03146962|561495151|FG005|Overall Study|Physician Decision|0|||
155565383|NCT03146962|561495152|FG006|Overall Study|Physician Decision|0|||
155565384|NCT03146962|561495153|FG007|Overall Study|Physician Decision|0|||
155565385|NCT03146962|561495154|FG008|Overall Study|Physician Decision|0|||
155565386|NCT03146962|561495155|FG009|Overall Study|Physician Decision|1|||
155565387|NCT03146962|561495146|FG000|Overall Study|Started New Treatment|0|||
155565388|NCT03146962|561495147|FG001|Overall Study|Started New Treatment|1|||
155565389|NCT03146962|561495148|FG002|Overall Study|Started New Treatment|0|||
155565390|NCT03146962|561495149|FG003|Overall Study|Started New Treatment|0|||
155565391|NCT03146962|561495150|FG004|Overall Study|Started New Treatment|0|||
155565392|NCT03146962|561495151|FG005|Overall Study|Started New Treatment|0|||
155565393|NCT03146962|561495152|FG006|Overall Study|Started New Treatment|0|||
155565394|NCT03146962|561495153|FG007|Overall Study|Started New Treatment|0|||
155565395|NCT03146962|561495154|FG008|Overall Study|Started New Treatment|0|||
155565396|NCT03146962|561495155|FG009|Overall Study|Started New Treatment|0|||
155565397|NCT00049530|561495156|FG000|Overall Study|Lack of Efficacy|25|||
155565398|NCT00049530|561495156|FG000|Overall Study|Adverse Event|2|||
155565399|NCT00049530|561495156|FG000|Overall Study|Death|1|||
155565400|NCT00049530|561495156|FG000|Overall Study|symptomatic deterioration|1|||
155565401|NCT00049530|561495156|FG000|Overall Study|ineligible|3|||
155565402|NCT00492024|561495159|FG000|Treatment|Adverse Event|3|||
155565403|NCT00492024|561495160|FG001|Treatment|Adverse Event|1|||
155565404|NCT00492024|561495159|FG000|Treatment|Lack of Efficacy|21|||
155565405|NCT00492024|561495160|FG001|Treatment|Lack of Efficacy|20|||
155565406|NCT00492024|561495159|FG000|Treatment|Lost to Follow-up|3|||
155565407|NCT00492024|561495160|FG001|Treatment|Lost to Follow-up|1|||
155565408|NCT00492024|561495159|FG000|Treatment|Withdrawal by Subject|2|||
155565409|NCT00492024|561495160|FG001|Treatment|Withdrawal by Subject|0|||
155565410|NCT00492024|561495159|FG000|Follow up|Lack of Efficacy|0|||
155565411|NCT00492024|561495160|FG001|Follow up|Lack of Efficacy|1|||
155565412|NCT00492024|561495159|FG000|Follow up|Lost to Follow-up|1|||
155565413|NCT00492024|561495160|FG001|Follow up|Lost to Follow-up|1|||
155565414|NCT03247816|561495161|FG000|Overall Study|Adverse Event|12|||
155565415|NCT03247816|561495161|FG000|Overall Study|Physician Decision|3|||
155565416|NCT03247816|561495161|FG000|Overall Study|Lack of Efficacy|1|||
155565417|NCT03247816|561495161|FG000|Overall Study|Lost to Follow-up|10|||
155565418|NCT03247816|561495161|FG000|Overall Study|Missing Feraccru stop date|3|||
155565419|NCT02861014|561495167|FG000|Primary Analysis|Adverse Event|7|||
155565420|NCT02861014|561495167|FG000|Primary Analysis|Death|1|||
155565421|NCT02861014|561495167|FG000|Primary Analysis|Lack of Efficacy|3|||
155565422|NCT02861014|561495167|FG000|Primary Analysis|Physician Decision|2|||
155565423|NCT02861014|561495167|FG000|Primary Analysis|Pregnancy|4|||
155565424|NCT02861014|561495167|FG000|Primary Analysis|Protocol Violation|2|||
155565425|NCT02861014|561495167|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
155565426|NCT02861014|561495167|FG000|Primary Analysis|Withdrawal by Subject|14|||
155565427|NCT02861014|561495167|FG000|Primary Analysis|Commercial ocrelizumab|3|||
155565428|NCT02861014|561495167|FG000|Safety Follow-up|Adverse Event|1|||
155565429|NCT02861014|561495167|FG000|Safety Follow-up|Pregnancy|1|||
155659212|NCT02106832|561846793|FG003|Overall Study|Death|4|||
155659213|NCT02106832|561846790|FG000|Overall Study|Deterioration of general conditions|0|||
155659214|NCT02106832|561846791|FG001|Overall Study|Deterioration of general conditions|0|||
155565430|NCT02861014|561495167|FG000|Safety Follow-up|Withdrawal by Subject|9|||
155565431|NCT02861014|561495167|FG000|Safety Follow-up|Study terminated by sponsor|1|||
155565432|NCT02861014|561495167|FG000|Safety Follow-up|Physician Decision|1|||
155565433|NCT02861014|561495167|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
155659215|NCT02106832|561846792|FG002|Overall Study|Deterioration of general conditions|1|||
155565434|NCT02861014|561495167|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
155565435|NCT00926783|561495168|FG000|Overall Study|Incomplete CFAE Procedures|3|||
155659216|NCT02106832|561846793|FG003|Overall Study|Deterioration of general conditions|0|||
155659217|NCT02106832|561846790|FG000|Overall Study|Lost to Follow-up|0|||
155659218|NCT02106832|561846791|FG001|Overall Study|Lost to Follow-up|1|||
155659219|NCT02106832|561846792|FG002|Overall Study|Lost to Follow-up|1|||
155565436|NCT00926783|561495169|FG001|Overall Study|Incomplete CFAE Procedures|3|||
155659220|NCT02106832|561846793|FG003|Overall Study|Lost to Follow-up|3|||
155565437|NCT00696787|561495172|FG000|Overall Study|Adverse Event|1|||
155565438|NCT00696787|561495173|FG001|Overall Study|Adverse Event|0|||
155565439|NCT00696787|561495174|FG002|Overall Study|Adverse Event|6|||
155565440|NCT00696787|561495172|FG000|Overall Study|Discontinuation by Sponsor|9|||
155565441|NCT00696787|561495173|FG001|Overall Study|Discontinuation by Sponsor|13|||
155565442|NCT00696787|561495174|FG002|Overall Study|Discontinuation by Sponsor|14|||
155565443|NCT00696787|561495172|FG000|Overall Study|Lack of Efficacy|0|||
155565444|NCT00696787|561495173|FG001|Overall Study|Lack of Efficacy|1|||
155565445|NCT00696787|561495174|FG002|Overall Study|Lack of Efficacy|0|||
155565446|NCT00696787|561495172|FG000|Overall Study|Lost to Follow-up|4|||
155565447|NCT00696787|561495173|FG001|Overall Study|Lost to Follow-up|0|||
155565448|NCT00696787|561495174|FG002|Overall Study|Lost to Follow-up|3|||
155565449|NCT00696787|561495172|FG000|Overall Study|Withdrawal by Subject|0|||
155565450|NCT00696787|561495173|FG001|Overall Study|Withdrawal by Subject|3|||
155565451|NCT00696787|561495174|FG002|Overall Study|Withdrawal by Subject|2|||
155565452|NCT00696787|561495172|FG000|Overall Study|Failed to return|1|||
155565453|NCT00696787|561495173|FG001|Overall Study|Failed to return|3|||
155565454|NCT00696787|561495174|FG002|Overall Study|Failed to return|1|||
155565455|NCT02704403|561495175|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
155565456|NCT02704403|561495176|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
155565457|NCT02704403|561495175|FG000|Overall Study|Administrative reasons by sponsor|1251|||
155565458|NCT02704403|561495176|FG001|Overall Study|Administrative reasons by sponsor|616|||
155565459|NCT02704403|561495175|FG000|Overall Study|Death|4|||
155565460|NCT02704403|561495176|FG001|Overall Study|Death|3|||
155565461|NCT02704403|561495175|FG000|Overall Study|Endpoint event|52|||
155565462|NCT02704403|561495176|FG001|Overall Study|Endpoint event|24|||
155565463|NCT02704403|561495175|FG000|Overall Study|Lost to Follow-up|22|||
155565464|NCT02704403|561495176|FG001|Overall Study|Lost to Follow-up|11|||
155565465|NCT02704403|561495175|FG000|Overall Study|Protocol Violation|15|||
155565466|NCT02704403|561495176|FG001|Overall Study|Protocol Violation|15|||
155565467|NCT02704403|561495175|FG000|Overall Study|Adverse Event|2|||
155565468|NCT02704403|561495176|FG001|Overall Study|Adverse Event|0|||
155565469|NCT02704403|561495175|FG000|Overall Study|Withdrawal by Subject|85|||
155565470|NCT02704403|561495176|FG001|Overall Study|Withdrawal by Subject|45|||
155565471|NCT02704403|561495175|FG000|Overall Study|Investigator decision|1|||
155565472|NCT02704403|561495176|FG001|Overall Study|Investigator decision|1|||
155565473|NCT02704403|561495175|FG000|Overall Study|Follow-up not possible|1|||
155565474|NCT02704403|561495176|FG001|Overall Study|Follow-up not possible|2|||
155565475|NCT01377987|561495179|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
155565476|NCT01377987|561495180|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
155565477|NCT00469144|561495181|FG000|Overall Study|Death|0|||
155565478|NCT00469144|561495182|FG001|Overall Study|Death|1|||
155565479|NCT00469144|561495181|FG000|Overall Study|No Response|5|||
155565480|NCT00469144|561495182|FG001|Overall Study|No Response|5|||
155565481|NCT00469144|561495181|FG000|Overall Study|Progressive Disease|1|||
155565482|NCT00469144|561495182|FG001|Overall Study|Progressive Disease|0|||
155565483|NCT01994291|561495183|FG000|Overall Study|Adverse Event|4|||
155565484|NCT01994291|561495184|FG001|Overall Study|Adverse Event|1|||
155565485|NCT01994291|561495185|FG002|Overall Study|Adverse Event|3|||
155565486|NCT01994291|561495183|FG000|Overall Study|Lost to Follow-up|1|||
155565487|NCT01994291|561495184|FG001|Overall Study|Lost to Follow-up|1|||
155565488|NCT01994291|561495185|FG002|Overall Study|Lost to Follow-up|0|||
155565489|NCT01994291|561495183|FG000|Overall Study|Does not meet entrance criteria|1|||
155565490|NCT01994291|561495184|FG001|Overall Study|Does not meet entrance criteria|0|||
155565491|NCT01994291|561495185|FG002|Overall Study|Does not meet entrance criteria|0|||
155565492|NCT01994291|561495183|FG000|Overall Study|Medication error without associated AE|1|||
155565493|NCT01994291|561495184|FG001|Overall Study|Medication error without associated AE|0|||
155565494|NCT01994291|561495185|FG002|Overall Study|Medication error without associated AE|1|||
155565495|NCT01994291|561495183|FG000|Overall Study|Protocol Violation|1|||
155565496|NCT01994291|561495184|FG001|Overall Study|Protocol Violation|0|||
155565497|NCT01994291|561495185|FG002|Overall Study|Protocol Violation|0|||
155565498|NCT01994291|561495183|FG000|Overall Study|Withdrawal by Subject|6|||
155565499|NCT01994291|561495184|FG001|Overall Study|Withdrawal by Subject|3|||
155565500|NCT01994291|561495185|FG002|Overall Study|Withdrawal by Subject|5|||
155565501|NCT01994291|561495183|FG000|Overall Study|Other|1|||
155565502|NCT01994291|561495184|FG001|Overall Study|Other|2|||
155565503|NCT01994291|561495185|FG002|Overall Study|Other|0|||
155565504|NCT01775189|561495186|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155565505|NCT01775189|561495187|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
155565506|NCT01775189|561495188|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155565507|NCT01775189|561495189|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155565508|NCT01775189|561495190|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155659221|NCT02106832|561846790|FG000|Overall Study|Physician Decision|1|||
155565509|NCT01775189|561495191|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155565510|NCT01775189|561495192|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155565511|NCT01775189|561495186|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565512|NCT01775189|561495187|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
155565513|NCT01775189|561495188|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565514|NCT01775189|561495189|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565515|NCT01775189|561495190|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565516|NCT01775189|561495191|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565517|NCT01775189|561495192|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155565518|NCT01775189|561495186|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
155565519|NCT01775189|561495187|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
155565520|NCT01775189|561495188|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
155565521|NCT01775189|561495189|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
155565522|NCT01775189|561495190|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
155565523|NCT01775189|561495191|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
155565524|NCT01775189|561495192|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
155565525|NCT01775189|561495186|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565526|NCT01775189|561495187|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565527|NCT01775189|561495188|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565528|NCT01775189|561495189|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565529|NCT01775189|561495190|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565530|NCT01775189|561495191|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
155565531|NCT01775189|561495192|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
155565532|NCT01775189|561495186|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565533|NCT01775189|561495187|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565534|NCT01775189|561495188|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565535|NCT01775189|561495189|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
155565536|NCT01775189|561495190|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565537|NCT01775189|561495191|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565538|NCT01775189|561495192|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
155565539|NCT01775189|561495186|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
155565540|NCT01775189|561495187|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
155565541|NCT01775189|561495188|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
155565542|NCT01775189|561495189|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
155565543|NCT01775189|561495190|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
155565544|NCT01775189|561495191|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
155565545|NCT01775189|561495192|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
155565546|NCT02227446|561495194|FG000|Overall Study|not eligible post randomization|18|||
155565547|NCT02227446|561495195|FG001|Overall Study|not eligible post randomization|29|||
155565548|NCT02227446|561495194|FG000|Overall Study|Withdrawal by Subject|4|||
155565549|NCT02227446|561495195|FG001|Overall Study|Withdrawal by Subject|5|||
155565550|NCT02121392|561495196|FG000|Prior to Intervention|Protocol Violation|40|||
155565551|NCT02121392|561495197|FG001|Prior to Intervention|Protocol Violation|35|||
155565552|NCT02121392|561495196|FG000|Prior to Intervention|Withdrawal by Subject|8|||
155565553|NCT02121392|561495197|FG001|Prior to Intervention|Withdrawal by Subject|6|||
155565554|NCT02121392|561495196|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
155565555|NCT02121392|561495197|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
155565556|NCT02121392|561495196|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
155565557|NCT02121392|561495197|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
155565558|NCT01352416|561495198|FG000|Overall Study|Physician Decision|1|||
155565559|NCT01352416|561495199|FG001|Overall Study|Physician Decision|2|||
155565560|NCT01352416|561495200|FG002|Overall Study|Physician Decision|2|||
155565561|NCT01352416|561495201|FG003|Overall Study|Physician Decision|1|||
155565562|NCT03016975|561495211|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
155565563|NCT03016975|561495212|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
155565564|NCT03016975|561495213|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
155565565|NCT03016975|561495211|FG000|At 6 Months Follow-up|Death|2|||
155565566|NCT03016975|561495212|FG001|At 6 Months Follow-up|Death|0|||
155565567|NCT03016975|561495213|FG002|At 6 Months Follow-up|Death|0|||
155659222|NCT02106832|561846791|FG001|Overall Study|Physician Decision|0|||
155565568|NCT03016975|561495211|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
155565569|NCT03016975|561495212|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
155565570|NCT03016975|561495213|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
155565571|NCT03016975|561495211|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
155565572|NCT03016975|561495212|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
155565573|NCT03016975|561495213|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
155565574|NCT03016975|561495211|FG000|At 6 Months Follow-up|Aborted implant|1|||
155565575|NCT03016975|561495212|FG001|At 6 Months Follow-up|Aborted implant|0|||
155565576|NCT03016975|561495213|FG002|At 6 Months Follow-up|Aborted implant|0|||
155565577|NCT03016975|561495211|FG000|At 2 Year Follow-up|Death|1|||
155565578|NCT03016975|561495212|FG001|At 2 Year Follow-up|Death|0|||
155565579|NCT03016975|561495213|FG002|At 2 Year Follow-up|Death|0|||
155565580|NCT03016975|561495211|FG000|At 3 Year Follow-up|Death|1|||
155565581|NCT03016975|561495212|FG001|At 3 Year Follow-up|Death|0|||
155565582|NCT03016975|561495213|FG002|At 3 Year Follow-up|Death|0|||
155565583|NCT03016975|561495211|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
155565584|NCT03016975|561495212|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
155565585|NCT03016975|561495213|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
155565586|NCT03016975|561495211|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
155565587|NCT03016975|561495212|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
155565588|NCT03016975|561495213|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
155565589|NCT02901548|561495214|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
155565590|NCT02348723|561495215|FG000|Overall Study|No ablation|21|||
155565591|NCT02348723|561495216|FG001|Overall Study|No ablation|20|||
155565592|NCT02348723|561495215|FG000|Overall Study|Non-compliant with Protocol|1|||
155565593|NCT02348723|561495216|FG001|Overall Study|Non-compliant with Protocol|0|||
155565594|NCT02348723|561495215|FG000|Overall Study|Lost to Follow-up|1|||
155565595|NCT02348723|561495216|FG001|Overall Study|Lost to Follow-up|1|||
155565596|NCT02348723|561495215|FG000|Overall Study|Consent withdrawn|1|||
155565597|NCT02348723|561495216|FG001|Overall Study|Consent withdrawn|3|||
155565598|NCT02348723|561495215|FG000|Overall Study|Reason other than specified|1|||
155565599|NCT02348723|561495216|FG001|Overall Study|Reason other than specified|1|||
155565600|NCT02348723|561495215|FG000|Overall Study|Adverse Event|3|||
155565601|NCT02348723|561495216|FG001|Overall Study|Adverse Event|1|||
155565602|NCT01671332|561495218|FG000|Overall Study|Withdrawal by Subject|1|||
155565603|NCT01671332|561495219|FG001|Overall Study|Withdrawal by Subject|1|||
155565604|NCT04572893|561495225|FG000|Part A|Adverse Event|1|||
155565605|NCT04572893|561495226|FG001|Part A|Adverse Event|0|||
155565606|NCT04572893|561495227|FG002|Part A|Adverse Event|0|||
155565607|NCT04572893|561495228|FG003|Part A|Adverse Event|0|||
155565608|NCT04572893|561495229|FG004|Part A|Adverse Event|0|||
155565609|NCT04572893|561495230|FG005|Part A|Adverse Event|0|||
155565610|NCT04572893|561495231|FG006|Part A|Adverse Event|0|||
155565611|NCT04572893|561495225|FG000|Part B|Withdrawal by Subject|0|||
155565612|NCT04572893|561495226|FG001|Part B|Withdrawal by Subject|0|||
155565613|NCT04572893|561495227|FG002|Part B|Withdrawal by Subject|0|||
155565614|NCT04572893|561495228|FG003|Part B|Withdrawal by Subject|0|||
155565615|NCT04572893|561495229|FG004|Part B|Withdrawal by Subject|0|||
155565616|NCT04572893|561495230|FG005|Part B|Withdrawal by Subject|1|||
155565617|NCT04572893|561495231|FG006|Part B|Withdrawal by Subject|0|||
155565618|NCT04572893|561495225|FG000|Part B|Study terminated by sponsor|0|||
155565619|NCT04572893|561495226|FG001|Part B|Study terminated by sponsor|0|||
155565620|NCT04572893|561495227|FG002|Part B|Study terminated by sponsor|0|||
155565621|NCT04572893|561495228|FG003|Part B|Study terminated by sponsor|0|||
155565622|NCT04572893|561495229|FG004|Part B|Study terminated by sponsor|7|||
155565623|NCT04572893|561495230|FG005|Part B|Study terminated by sponsor|5|||
155565624|NCT04572893|561495231|FG006|Part B|Study terminated by sponsor|3|||
155565625|NCT04572893|561495225|FG000|Part B|Lost to Follow-up|0|||
155565626|NCT04572893|561495226|FG001|Part B|Lost to Follow-up|0|||
155565627|NCT04572893|561495227|FG002|Part B|Lost to Follow-up|0|||
155565628|NCT04572893|561495228|FG003|Part B|Lost to Follow-up|0|||
155565629|NCT04572893|561495229|FG004|Part B|Lost to Follow-up|0|||
155565630|NCT04572893|561495230|FG005|Part B|Lost to Follow-up|0|||
155565631|NCT04572893|561495231|FG006|Part B|Lost to Follow-up|1|||
155565632|NCT04572893|561495225|FG000|Part B|Adverse Event|0|||
155565633|NCT04572893|561495226|FG001|Part B|Adverse Event|0|||
155565634|NCT04572893|561495227|FG002|Part B|Adverse Event|0|||
155565635|NCT04572893|561495228|FG003|Part B|Adverse Event|0|||
155565636|NCT04572893|561495229|FG004|Part B|Adverse Event|1|||
155565637|NCT04572893|561495230|FG005|Part B|Adverse Event|1|||
155565638|NCT04572893|561495231|FG006|Part B|Adverse Event|0|||
155659223|NCT02106832|561846792|FG002|Overall Study|Physician Decision|0|||
155659224|NCT02106832|561846793|FG003|Overall Study|Physician Decision|0|||
155565639|NCT02269163|561495234|FG000|Overall Study|Lost to Follow-up|1|||
155565640|NCT02269163|561495235|FG001|Overall Study|Lost to Follow-up|0|||
155565641|NCT02269163|561495234|FG000|Overall Study|Major protocol violation|0|||
155565642|NCT02269163|561495235|FG001|Overall Study|Major protocol violation|1|||
155565643|NCT02269163|561495234|FG000|Overall Study|Other|2|||
155565644|NCT02269163|561495235|FG001|Overall Study|Other|2|||
155565645|NCT02269163|561495234|FG000|Overall Study|Withdrawal by Subject|0|||
155565646|NCT02269163|561495235|FG001|Overall Study|Withdrawal by Subject|3|||
155565647|NCT02269163|561495234|FG000|Overall Study|Physician Decision|0|||
155565648|NCT02269163|561495235|FG001|Overall Study|Physician Decision|1|||
155565649|NCT04730349|561495241|FG000|Overall Study|Participant withdrew consent|1|||
155565650|NCT04730349|561495242|FG001|Overall Study|Participant withdrew consent|0|||
155565651|NCT04730349|561495241|FG000|Overall Study|Disease progression|6|||
155565652|NCT04730349|561495242|FG001|Overall Study|Disease progression|4|||
155565653|NCT04730349|561495241|FG000|Overall Study|Study drug toxicity|0|||
155565654|NCT04730349|561495242|FG001|Overall Study|Study drug toxicity|1|||
155565655|NCT00638027|561495245|FG000|Overall Study|Adverse Event|0|||
155565656|NCT00638027|561495246|FG001|Overall Study|Adverse Event|2|||
155565657|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
155565658|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
155565659|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565660|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565661|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565662|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565663|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565664|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565665|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565666|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565667|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565668|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565669|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565670|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
155565671|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
155565672|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
155565673|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565674|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565675|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565676|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565677|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565678|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565679|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565680|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565681|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565682|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565683|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565684|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155565685|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
155565686|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
155565687|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565688|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565689|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565690|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565691|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565692|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565693|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565694|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565695|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565696|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565697|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565698|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
155565699|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
155565700|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
155565701|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565702|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565703|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565704|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565705|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565706|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565707|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565708|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565709|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565710|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565711|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565712|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
155565713|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
155565714|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
155565715|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565716|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565717|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565718|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565719|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565720|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565721|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565722|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565723|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565724|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565725|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565726|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
155565727|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
155565728|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
155565729|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565730|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565731|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565732|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565733|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565734|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565735|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565736|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565737|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565738|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565739|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565740|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
155565741|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
155565742|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
155565743|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565744|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565745|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565746|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565747|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565748|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565749|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565750|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565751|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565752|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565753|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565754|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155565755|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
155565756|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
155565757|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565758|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565759|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565760|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565761|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565762|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155659225|NCT02106832|561846790|FG000|Overall Study|Protocol Violation|0|||
155659226|NCT02106832|561846791|FG001|Overall Study|Protocol Violation|0|||
155565763|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565764|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155659227|NCT02106832|561846792|FG002|Overall Study|Protocol Violation|0|||
155565765|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565766|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565767|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565768|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
155565769|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
155565770|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
155565771|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565772|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565773|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565774|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565775|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565776|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565777|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565778|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565779|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565780|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565781|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565782|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
155565783|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
155565784|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
155565785|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565786|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565787|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565788|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565789|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565790|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565791|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565792|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565793|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565794|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565795|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565796|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155565797|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
155565798|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
155565799|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565800|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565801|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565802|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565803|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565804|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565805|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565806|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565807|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565808|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565809|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565810|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
155565811|NCT03982199|561495255|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
155565812|NCT03982199|561495256|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
155565813|NCT03982199|561495257|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565814|NCT03982199|561495258|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565815|NCT03982199|561495259|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565816|NCT03982199|561495260|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565817|NCT03982199|561495261|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565818|NCT03982199|561495262|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565819|NCT03982199|561495263|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565820|NCT03982199|561495264|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565821|NCT03982199|561495265|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565822|NCT03982199|561495266|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565823|NCT03982199|561495267|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565824|NCT03982199|561495268|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
155565825|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565826|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155659228|NCT02106832|561846793|FG003|Overall Study|Protocol Violation|1|||
155659229|NCT02106832|561846790|FG000|Overall Study|Withdrawal by Subject|17|||
155565827|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565828|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
155565829|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565830|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565831|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565832|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565833|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565834|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565835|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565836|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565837|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565838|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
155565839|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565840|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565841|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
155565842|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565843|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565844|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565845|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565846|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565847|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565848|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565849|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565850|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565851|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565852|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
155565853|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565854|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565855|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
155565856|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565857|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565858|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565859|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565860|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565861|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565862|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565863|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565864|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565865|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565866|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155565867|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565868|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565869|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
155565870|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
155565871|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565872|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565873|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565874|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565875|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565876|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565877|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565878|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565879|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565880|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
155565881|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565882|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565883|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565884|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
155565885|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565886|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565887|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565888|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565889|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565890|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565891|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565892|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565893|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565894|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
155565895|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565896|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565897|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
155565898|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
155565899|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565900|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565901|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565902|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565903|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565904|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565905|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565906|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565907|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565908|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155565909|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565910|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565911|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565912|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565913|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565914|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565915|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565916|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565917|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
155565918|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565919|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565920|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565921|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565922|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155565923|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565924|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565925|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565926|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565927|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565928|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565929|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565930|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565931|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
155565932|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565933|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565934|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565935|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565936|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
155565937|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565938|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565939|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565940|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565941|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565942|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565943|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565944|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565945|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
155565946|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565947|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565948|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565949|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155565950|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
155721143|NCT02587221|562077762|FG000|Overall Study|Protocol Violation|6|||
155721144|NCT02587221|562077763|FG001|Overall Study|Protocol Violation|5|||
155659230|NCT02106832|561846791|FG001|Overall Study|Withdrawal by Subject|17|||
155659231|NCT02106832|561846792|FG002|Overall Study|Withdrawal by Subject|10|||
155659232|NCT02106832|561846793|FG003|Overall Study|Withdrawal by Subject|7|||
155659233|NCT02106832|561846790|FG000|Overall Study|Technical problems|0|||
155659234|NCT02106832|561846791|FG001|Overall Study|Technical problems|1|||
155659235|NCT02106832|561846792|FG002|Overall Study|Technical problems|0|||
155659236|NCT02106832|561846793|FG003|Overall Study|Technical problems|0|||
155659237|NCT02706392|561846808|FG000|Overall Study|Death|1|||
155659238|NCT02706392|561846809|FG001|Overall Study|Death|0|||
155565951|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565952|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565953|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565954|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565955|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565956|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565957|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565958|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565959|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
155565960|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565961|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565962|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565963|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565964|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
155565965|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565966|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565967|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565968|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565969|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565970|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565971|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565972|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565973|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
155565974|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565975|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565976|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565977|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565978|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155565979|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565980|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565981|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565982|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565983|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565984|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
155565985|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565986|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
155565987|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
155565988|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565989|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565990|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565991|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565992|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155565993|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565994|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565995|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565996|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565997|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565998|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155565999|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566000|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566001|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
155566002|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566003|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566004|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566005|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155659239|NCT02706392|561846810|FG002|Overall Study|Death|2|||
155659240|NCT02706392|561846811|FG003|Overall Study|Death|2|||
155659241|NCT02706392|561846812|FG004|Overall Study|Death|5|||
155566006|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
155566007|NCT03982199|561495255|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566008|NCT03982199|561495256|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566009|NCT03982199|561495257|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566010|NCT03982199|561495258|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566011|NCT03982199|561495259|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566012|NCT03982199|561495260|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
155566013|NCT03982199|561495261|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566014|NCT03982199|561495262|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
155566015|NCT03982199|561495263|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
155566016|NCT03982199|561495264|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566017|NCT03982199|561495265|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566018|NCT03982199|561495266|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566019|NCT03982199|561495267|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566020|NCT03982199|561495268|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
155566021|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566022|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566023|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566024|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566025|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566026|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566027|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566028|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566029|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
155566030|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
155566031|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
155566032|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
155566033|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
155566034|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
155566035|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566036|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566037|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566038|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566039|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566040|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566041|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566042|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566043|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566044|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
155566045|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566046|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566047|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566048|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155566049|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566050|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566051|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566052|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566053|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566054|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566055|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566056|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566057|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566058|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566059|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566060|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566061|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
155566062|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
155566063|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155659242|NCT02706392|561846813|FG005|Overall Study|Death|2|||
155566064|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566065|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566066|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566067|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566068|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566069|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566070|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566071|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566072|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566073|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
155566074|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
155566075|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
155566076|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155566077|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566078|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566079|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566080|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566081|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566082|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566083|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566084|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566085|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566086|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566087|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566088|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566089|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155566090|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
155566091|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566092|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566093|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566094|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566095|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566096|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566097|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566098|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566099|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566100|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566101|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566102|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
155566103|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
155566104|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
155566105|NCT03982199|561495255|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566106|NCT03982199|561495256|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566107|NCT03982199|561495257|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566108|NCT03982199|561495258|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566109|NCT03982199|561495259|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566110|NCT03982199|561495260|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566111|NCT03982199|561495261|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566112|NCT03982199|561495262|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566113|NCT03982199|561495263|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566114|NCT03982199|561495264|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566115|NCT03982199|561495265|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566116|NCT03982199|561495266|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566117|NCT03982199|561495267|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
155566118|NCT03982199|561495268|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
155566119|NCT01565850|561495269|FG000|Overall Study|Adverse Event|0|||
155566120|NCT01565850|561495270|FG001|Overall Study|Adverse Event|1|||
155566121|NCT01565850|561495269|FG000|Overall Study|Lost to Follow-up|12|||
155566122|NCT01565850|561495270|FG001|Overall Study|Lost to Follow-up|4|||
155566123|NCT01565850|561495269|FG000|Overall Study|Investigator's Discretion|2|||
155566124|NCT01565850|561495270|FG001|Overall Study|Investigator's Discretion|1|||
155566125|NCT01565850|561495269|FG000|Overall Study|Participant noncompliance|2|||
155566126|NCT01565850|561495270|FG001|Overall Study|Participant noncompliance|0|||
155566127|NCT01565850|561495269|FG000|Overall Study|Withdrew Consent|4|||
155566128|NCT01565850|561495270|FG001|Overall Study|Withdrew Consent|2|||
155659243|NCT00619866|561846814|FG000|Weeks 1 - 12|Adverse Event|0|||
155659244|NCT00619866|561846815|FG001|Weeks 1 - 12|Adverse Event|1|||
155659245|NCT00619866|561846816|FG002|Weeks 1 - 12|Adverse Event|2|||
155659246|NCT00619866|561846817|FG003|Weeks 1 - 12|Adverse Event|0|||
155659247|NCT00619866|561846818|FG004|Weeks 1 - 12|Adverse Event|0|||
155659248|NCT00619866|561846814|FG000|Weeks 1 - 12|Non-compliance|0|||
155659249|NCT00619866|561846815|FG001|Weeks 1 - 12|Non-compliance|0|||
155659250|NCT00619866|561846816|FG002|Weeks 1 - 12|Non-compliance|1|||
155659251|NCT00619866|561846817|FG003|Weeks 1 - 12|Non-compliance|0|||
155659252|NCT00619866|561846818|FG004|Weeks 1 - 12|Non-compliance|0|||
155659253|NCT00619866|561846814|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
155659254|NCT00619866|561846815|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
155659255|NCT00619866|561846816|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
155659256|NCT00619866|561846817|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
155659257|NCT00619866|561846818|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
155659258|NCT00619866|561846814|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
155659259|NCT00619866|561846815|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
155659260|NCT00619866|561846816|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
155659261|NCT00619866|561846817|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
155659262|NCT00619866|561846818|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
155659263|NCT00619866|561846814|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
155659264|NCT00619866|561846815|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
155659265|NCT00619866|561846816|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
155659266|NCT00619866|561846817|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
155659267|NCT00619866|561846818|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
155659268|NCT00619866|561846814|FG000|Weeks 1 - 12|Sponsor Decision|0|||
155659269|NCT00619866|561846815|FG001|Weeks 1 - 12|Sponsor Decision|1|||
155659270|NCT00619866|561846816|FG002|Weeks 1 - 12|Sponsor Decision|0|||
155659271|NCT00619866|561846817|FG003|Weeks 1 - 12|Sponsor Decision|0|||
155659272|NCT00619866|561846818|FG004|Weeks 1 - 12|Sponsor Decision|0|||
155659273|NCT00619866|561846814|FG000|Weeks 13 - 24|Adverse Event|0|||
155659274|NCT00619866|561846815|FG001|Weeks 13 - 24|Adverse Event|0|||
155659275|NCT00619866|561846816|FG002|Weeks 13 - 24|Adverse Event|2|||
155659276|NCT00619866|561846817|FG003|Weeks 13 - 24|Adverse Event|1|||
155659277|NCT00619866|561846818|FG004|Weeks 13 - 24|Adverse Event|0|||
155566129|NCT05065567|561495271|FG000|Overall Study|Lost to Follow-up|10|||
155566130|NCT05065567|561495272|FG001|Overall Study|Lost to Follow-up|9|||
155566131|NCT05065567|561495273|FG002|Overall Study|Lost to Follow-up|6|||
155566132|NCT03395405|561496729|FG000|Overall Study|Death|0|||
155566133|NCT03395405|561496730|FG001|Overall Study|Death|2|||
155566134|NCT03395405|561496729|FG000|Overall Study|Lost to Follow-up|0|||
155566135|NCT03395405|561496730|FG001|Overall Study|Lost to Follow-up|1|||
155566136|NCT03395405|561496729|FG000|Overall Study|Protocol Violation|0|||
155566137|NCT03395405|561496730|FG001|Overall Study|Protocol Violation|1|||
155566138|NCT03395405|561496729|FG000|Overall Study|Withdrawal by Subject|3|||
155566139|NCT03395405|561496730|FG001|Overall Study|Withdrawal by Subject|1|||
155566140|NCT03395405|561496729|FG000|Overall Study|COVID-19 Pandemic|1|||
155566141|NCT03395405|561496730|FG001|Overall Study|COVID-19 Pandemic|0|||
155566142|NCT00213135|561496731|FG000|Overall Study|Adverse Event|9|||
155566143|NCT00213135|561496732|FG001|Overall Study|Adverse Event|5|||
155566144|NCT00213135|561496733|FG002|Overall Study|Adverse Event|5|||
155566145|NCT00213135|561496731|FG000|Overall Study|Lost to Follow-up|11|||
155566146|NCT00213135|561496732|FG001|Overall Study|Lost to Follow-up|8|||
155659278|NCT00619866|561846814|FG000|Weeks 13 - 24|Protocol Deviation|0|||
155659279|NCT00619866|561846815|FG001|Weeks 13 - 24|Protocol Deviation|0|||
155659280|NCT00619866|561846816|FG002|Weeks 13 - 24|Protocol Deviation|0|||
155659281|NCT00619866|561846817|FG003|Weeks 13 - 24|Protocol Deviation|1|||
155659282|NCT00619866|561846818|FG004|Weeks 13 - 24|Protocol Deviation|0|||
155566147|NCT00213135|561496733|FG002|Overall Study|Lost to Follow-up|4|||
155566148|NCT00213135|561496731|FG000|Overall Study|Protocol Violation|4|||
155659283|NCT00619866|561846814|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
155659284|NCT00619866|561846815|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
155659285|NCT00619866|561846816|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
155659286|NCT00619866|561846817|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
155659287|NCT00619866|561846818|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
155566149|NCT00213135|561496732|FG001|Overall Study|Protocol Violation|4|||
155566150|NCT00213135|561496733|FG002|Overall Study|Protocol Violation|10|||
155566151|NCT00213135|561496731|FG000|Overall Study|Death|1|||
155566152|NCT00213135|561496732|FG001|Overall Study|Death|1|||
155566153|NCT00213135|561496733|FG002|Overall Study|Death|2|||
155659288|NCT00619866|561846814|FG000|Weeks 13 - 24|Non-compliance|0|||
155659289|NCT00619866|561846815|FG001|Weeks 13 - 24|Non-compliance|1|||
155659290|NCT00619866|561846816|FG002|Weeks 13 - 24|Non-compliance|1|||
155659291|NCT00619866|561846817|FG003|Weeks 13 - 24|Non-compliance|0|||
155659292|NCT00619866|561846818|FG004|Weeks 13 - 24|Non-compliance|0|||
155659293|NCT00619866|561846814|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
155566154|NCT00213135|561496731|FG000|Overall Study|Disease progression|4|||
155566155|NCT00213135|561496732|FG001|Overall Study|Disease progression|5|||
155566156|NCT00213135|561496733|FG002|Overall Study|Disease progression|21|||
155659294|NCT00619866|561846815|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
155659295|NCT00619866|561846816|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
155566157|NCT00213135|561496731|FG000|Overall Study|Other|21|||
155566158|NCT00213135|561496732|FG001|Overall Study|Other|12|||
155566159|NCT00213135|561496733|FG002|Overall Study|Other|15|||
155566160|NCT02886624|561496736|FG000|12-week Post Treatment Follow-up|Death|1|||
155566161|NCT02886624|561496736|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
155566162|NCT01392963|561496740|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
155566163|NCT01392963|561496741|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
155566164|NCT01392963|561496740|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
155566165|NCT01392963|561496741|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
155566166|NCT01392963|561496740|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
155566167|NCT01392963|561496741|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
155566168|NCT00450801|561496744|FG000|Overall Study|Death|1|||
155566169|NCT00324649|561496745|FG000|Overall Study|Adverse Event|1|||
155566170|NCT00324649|561496746|FG001|Overall Study|Adverse Event|4|||
155566171|NCT00324649|561496745|FG000|Overall Study|Withdrawal by Subject|0|||
155566172|NCT00324649|561496746|FG001|Overall Study|Withdrawal by Subject|1|||
155566173|NCT00324649|561496745|FG000|Overall Study|Noncompliance|1|||
155566174|NCT00324649|561496746|FG001|Overall Study|Noncompliance|0|||
155566175|NCT01396512|561496749|FG000|Overall Study|Withdrawal by Subject|0|||
155566176|NCT01396512|561496750|FG001|Overall Study|Withdrawal by Subject|1|||
155566177|NCT02618759|561496753|FG000|Overall Study|Lost to Follow-up|0|||
155566178|NCT02618759|561496754|FG001|Overall Study|Lost to Follow-up|1|||
155566179|NCT02618759|561496753|FG000|Overall Study|Withdrawal by Subject|1|||
155566180|NCT02618759|561496754|FG001|Overall Study|Withdrawal by Subject|0|||
155566181|NCT02618759|561496753|FG000|Overall Study|Other Reasons|1|||
155566182|NCT02618759|561496754|FG001|Overall Study|Other Reasons|4|||
155566183|NCT02152605|561496755|FG000|Overall Study|Adverse Event|6|||
155566184|NCT02152605|561496756|FG001|Overall Study|Adverse Event|8|||
155566185|NCT02152605|561496755|FG000|Overall Study|Lack of Efficacy|7|||
155566186|NCT02152605|561496756|FG001|Overall Study|Lack of Efficacy|4|||
155566187|NCT02152605|561496755|FG000|Overall Study|Protocol deviation|1|||
155566188|NCT02152605|561496756|FG001|Overall Study|Protocol deviation|4|||
155566189|NCT02152605|561496755|FG000|Overall Study|Lost to Follow-up|1|||
155566190|NCT02152605|561496756|FG001|Overall Study|Lost to Follow-up|0|||
155566191|NCT02152605|561496755|FG000|Overall Study|Withdrew consent|4|||
155566192|NCT02152605|561496756|FG001|Overall Study|Withdrew consent|2|||
155566193|NCT02500043|561496763|FG000|Overall Study|Randomized, but not Treated|2|||
155566194|NCT02500043|561496764|FG001|Overall Study|Randomized, but not Treated|2|||
155566195|NCT02500043|561496763|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
155566196|NCT02500043|561496764|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
155566197|NCT02500043|561496763|FG000|Overall Study|Adverse Event|33|||
155566198|NCT02500043|561496764|FG001|Overall Study|Adverse Event|11|||
155566199|NCT02500043|561496763|FG000|Overall Study|Clinical Progression|54|||
155566200|NCT02500043|561496764|FG001|Overall Study|Clinical Progression|35|||
155566201|NCT02500043|561496763|FG000|Overall Study|Radiological Progression|192|||
155566202|NCT02500043|561496764|FG001|Overall Study|Radiological Progression|110|||
155566203|NCT02500043|561496763|FG000|Overall Study|Physician's Decision|11|||
155566204|NCT02500043|561496764|FG001|Overall Study|Physician's Decision|3|||
155566205|NCT02500043|561496763|FG000|Overall Study|Withdrawal by Subject|14|||
155566206|NCT02500043|561496764|FG001|Overall Study|Withdrawal by Subject|4|||
155566207|NCT02500043|561496763|FG000|Overall Study|Death|11|||
155566208|NCT02500043|561496764|FG001|Overall Study|Death|2|||
155566209|NCT02500043|561496763|FG000|Overall Study|Protocol Deviation|1|||
155566210|NCT02500043|561496764|FG001|Overall Study|Protocol Deviation|0|||
155566211|NCT00580788|561496765|FG000|Overall Study|Adverse Event|0|||
155566212|NCT00580788|561496766|FG001|Overall Study|Adverse Event|0|||
155566213|NCT00580788|561496767|FG002|Overall Study|Adverse Event|0|||
155566214|NCT00580788|561496768|FG003|Overall Study|Adverse Event|1|||
155566215|NCT01439009|561496778|FG000|Overall Study|Physician Decision|5|||
155566216|NCT01439009|561496779|FG001|Overall Study|Physician Decision|3|||
155566217|NCT01439009|561496778|FG000|Overall Study|Protocol Violation|2|||
155566218|NCT01439009|561496779|FG001|Overall Study|Protocol Violation|0|||
155566219|NCT01439009|561496778|FG000|Overall Study|Deviation of exclusion criteria|1|||
155566220|NCT01439009|561496779|FG001|Overall Study|Deviation of exclusion criteria|0|||
155566221|NCT02278055|561496780|FG000|Overall Study|Adverse Event|1|||
155566222|NCT02278055|561496780|FG000|Overall Study|Lost to Follow-up|1|||
155566223|NCT02278055|561496780|FG000|Overall Study|Withdrawal by Subject|2|||
155566224|NCT02278055|561496780|FG000|Overall Study|Progressive Disease|4|||
155566225|NCT01934335|561496781|FG000|Overall Study|Withdrawal by Subject|1|||
155566226|NCT01934335|561496782|FG001|Overall Study|Withdrawal by Subject|1|||
155566227|NCT01111825|561496783|FG000|Overall Study|Withdrawal by Subject|0|||
155566228|NCT01111825|561496784|FG001|Overall Study|Withdrawal by Subject|0|||
155566229|NCT01111825|561496785|FG002|Overall Study|Withdrawal by Subject|1|||
155566230|NCT01111825|561496786|FG003|Overall Study|Withdrawal by Subject|0|||
155566231|NCT01111825|561496783|FG000|Overall Study|Lost to Follow-up|0|||
155566232|NCT01111825|561496784|FG001|Overall Study|Lost to Follow-up|0|||
155566233|NCT01111825|561496785|FG002|Overall Study|Lost to Follow-up|3|||
155566234|NCT01111825|561496786|FG003|Overall Study|Lost to Follow-up|1|||
155566235|NCT01111825|561496783|FG000|Overall Study|Adverse Event|2|||
155566236|NCT01111825|561496784|FG001|Overall Study|Adverse Event|1|||
155566237|NCT01111825|561496785|FG002|Overall Study|Adverse Event|4|||
155566238|NCT01111825|561496786|FG003|Overall Study|Adverse Event|0|||
155566239|NCT01111825|561496783|FG000|Overall Study|Disease Progression|1|||
155566240|NCT01111825|561496784|FG001|Overall Study|Disease Progression|0|||
155566241|NCT01111825|561496785|FG002|Overall Study|Disease Progression|0|||
155566242|NCT01111825|561496786|FG003|Overall Study|Disease Progression|0|||
155566243|NCT01111825|561496783|FG000|Overall Study|Discontinuation by Sponsor|0|||
155566244|NCT01111825|561496784|FG001|Overall Study|Discontinuation by Sponsor|0|||
155566245|NCT01111825|561496785|FG002|Overall Study|Discontinuation by Sponsor|0|||
155566246|NCT01111825|561496786|FG003|Overall Study|Discontinuation by Sponsor|20|||
155566247|NCT02087189|561496792|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
155566248|NCT01458106|561496795|FG000|Overall Study|Withdrawal by Subject|2|||
155566249|NCT01458106|561496796|FG001|Overall Study|Withdrawal by Subject|0|||
155566250|NCT01458106|561496795|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
155566251|NCT01458106|561496796|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
155566252|NCT01458106|561496795|FG000|Overall Study|Withdrawn Per Protocol|0|||
155566253|NCT01458106|561496796|FG001|Overall Study|Withdrawn Per Protocol|1|||
155566254|NCT04428333|561496800|FG000|Overall Study|Physician Decision|5|||
155566255|NCT04428333|561496801|FG001|Overall Study|Physician Decision|6|||
155566256|NCT04428333|561496800|FG000|Overall Study|Withdrawal by Subject|1|||
155566257|NCT04428333|561496801|FG001|Overall Study|Withdrawal by Subject|3|||
155566258|NCT04428333|561496800|FG000|Overall Study|Study Terminated By Sponsor|14|||
155566259|NCT04428333|561496801|FG001|Overall Study|Study Terminated By Sponsor|16|||
155566260|NCT04853992|561496802|FG000|Treatment Period A|Adverse Event|0|||
155566261|NCT04853992|561496803|FG001|Treatment Period A|Adverse Event|1|||
155566262|NCT04853992|561496802|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
155566263|NCT04853992|561496803|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
155566264|NCT02351960|561496804|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
155566265|NCT02351960|561496805|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
155566266|NCT02351960|561496804|FG000|Overall Study|Voluntary Withdrawal|5|||
155566267|NCT02351960|561496805|FG001|Overall Study|Voluntary Withdrawal|4|||
155566268|NCT02351960|561496804|FG000|Overall Study|Significant Protocol Deviation|0|||
155566269|NCT02351960|561496805|FG001|Overall Study|Significant Protocol Deviation|5|||
155566270|NCT01094886|561496806|FG000|Overall Study|Adverse Event|2|||
155566271|NCT01094886|561496806|FG000|Overall Study|Withdrawal by Subject|5|||
155566272|NCT03866902|561496807|FG000|Overall Study|Lost to Follow-up|98|||
155566273|NCT03866902|561496808|FG001|Overall Study|Lost to Follow-up|82|||
155566274|NCT03866902|561496807|FG000|Overall Study|Pregnancy|18|||
155566275|NCT03866902|561496808|FG001|Overall Study|Pregnancy|24|||
155566276|NCT02092467|561496813|FG000|Overall Study|Death|49|||
155566277|NCT02092467|561496814|FG001|Overall Study|Death|66|||
155566278|NCT02092467|561496815|FG002|Overall Study|Death|38|||
155566279|NCT02092467|561496813|FG000|Overall Study|Lost to Follow-up|38|||
155566280|NCT02092467|561496814|FG001|Overall Study|Lost to Follow-up|35|||
155566281|NCT02092467|561496815|FG002|Overall Study|Lost to Follow-up|40|||
155566282|NCT02092467|561496813|FG000|Overall Study|Global Deterioration of Health Status|1|||
155566283|NCT02092467|561496814|FG001|Overall Study|Global Deterioration of Health Status|0|||
155566284|NCT02092467|561496815|FG002|Overall Study|Global Deterioration of Health Status|0|||
155566285|NCT02092467|561496813|FG000|Overall Study|Other|32|||
155566286|NCT02092467|561496814|FG001|Overall Study|Other|30|||
155566287|NCT02092467|561496815|FG002|Overall Study|Other|24|||
155566288|NCT02092467|561496813|FG000|Overall Study|Withdrawal by Subject|282|||
155566289|NCT02092467|561496814|FG001|Overall Study|Withdrawal by Subject|327|||
155566290|NCT02092467|561496815|FG002|Overall Study|Withdrawal by Subject|289|||
155566291|NCT02092467|561496813|FG000|Overall Study|Randomized but not treated|2|||
155566292|NCT02092467|561496814|FG001|Overall Study|Randomized but not treated|1|||
155566293|NCT02092467|561496815|FG002|Overall Study|Randomized but not treated|7|||
155566294|NCT00371397|561496816|FG000|Session 1|Withdrawal by Subject|1|||
155566295|NCT00371397|561496817|FG001|Session 1|Withdrawal by Subject|0|||
155566296|NCT00371397|561496818|FG002|Session 1|Withdrawal by Subject|0|||
155566297|NCT00371397|561496819|FG003|Session 1|Withdrawal by Subject|0|||
155566298|NCT00371397|561496820|FG004|Session 1|Withdrawal by Subject|0|||
155566299|NCT00371397|561496821|FG005|Session 1|Withdrawal by Subject|0|||
155566300|NCT00371397|561496822|FG006|Session 1|Withdrawal by Subject|0|||
155566301|NCT00371397|561496823|FG007|Session 1|Withdrawal by Subject|1|||
155566302|NCT00371397|561496824|FG008|Session 1|Withdrawal by Subject|0|||
155566303|NCT00371397|561496825|FG009|Session 1|Withdrawal by Subject|0|||
155566304|NCT00371397|561496826|FG010|Session 1|Withdrawal by Subject|0|||
155566305|NCT00371397|561496827|FG011|Session 1|Withdrawal by Subject|0|||
155566306|NCT01284621|561496828|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
155566307|NCT01284621|561496829|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
155566308|NCT01284621|561496830|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
155566309|NCT01284621|561496831|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
155566310|NCT01284621|561496832|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
155566311|NCT01284621|561496833|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
155566312|NCT02377427|561496836|FG000|Part A (Up to Week 20)|Physician Decision|1|||
155566313|NCT02377427|561496837|FG001|Part A (Up to Week 20)|Physician Decision|0|||
155566314|NCT02377427|561496838|FG002|Part A (Up to Week 20)|Physician Decision|0|||
155566315|NCT02377427|561496839|FG003|Part A (Up to Week 20)|Physician Decision|0|||
155566316|NCT02377427|561496840|FG004|Part A (Up to Week 20)|Physician Decision|0|||
155566317|NCT02377427|561496836|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
155566318|NCT02377427|561496837|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
155566319|NCT02377427|561496838|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
155566320|NCT02377427|561496839|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
155566321|NCT02377427|561496840|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
155566322|NCT02377427|561496836|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
155566323|NCT02377427|561496837|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
155566324|NCT02377427|561496838|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
155566325|NCT02377427|561496839|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
155566326|NCT02377427|561496840|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
155566327|NCT02377427|561496836|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
155566328|NCT02377427|561496837|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
155566329|NCT02377427|561496838|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
155566330|NCT02377427|561496839|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
155566331|NCT02377427|561496840|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
155566332|NCT02342639|561496841|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
155566333|NCT02342639|561496842|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
155566334|NCT02342639|561496841|FG000|Overall Study|Protocol Violation|0|||
155566335|NCT02342639|561496842|FG001|Overall Study|Protocol Violation|2|||
155566336|NCT02293863|561496843|FG000|Overall Study|Death|4|||
155566337|NCT02293863|561496844|FG001|Overall Study|Death|6|||
155566338|NCT02293863|561496845|FG002|Overall Study|Death|4|||
155566339|NCT02293863|561496843|FG000|Overall Study|Lost to Follow-up|2|||
155566340|NCT02293863|561496844|FG001|Overall Study|Lost to Follow-up|2|||
155566341|NCT02293863|561496845|FG002|Overall Study|Lost to Follow-up|2|||
155566342|NCT02293863|561496843|FG000|Overall Study|Withdrawal by Subject|3|||
155566343|NCT02293863|561496844|FG001|Overall Study|Withdrawal by Subject|3|||
155566344|NCT02293863|561496845|FG002|Overall Study|Withdrawal by Subject|1|||
155566345|NCT02293863|561496843|FG000|Overall Study|Reason Not Specified|0|||
155566346|NCT02293863|561496844|FG001|Overall Study|Reason Not Specified|2|||
155566347|NCT02293863|561496845|FG002|Overall Study|Reason Not Specified|2|||
155566348|NCT00416884|561496848|FG000|Overall Study|Study terminated due to low accrual|1|||
155566349|NCT03433755|561496851|FG000|Overall Study|Lost to Follow-up|1|||
155566350|NCT03433755|561496852|FG001|Overall Study|Lost to Follow-up|0|||
155566351|NCT03433755|561496853|FG002|Overall Study|Lost to Follow-up|0|||
155566352|NCT03433755|561496854|FG003|Overall Study|Lost to Follow-up|0|||
155566353|NCT03433755|561496851|FG000|Overall Study|Decision by Sponsor|1|||
155566354|NCT03433755|561496852|FG001|Overall Study|Decision by Sponsor|0|||
155566355|NCT03433755|561496853|FG002|Overall Study|Decision by Sponsor|0|||
155566356|NCT03433755|561496854|FG003|Overall Study|Decision by Sponsor|0|||
155566357|NCT02245412|561498228|FG000|Treatment Period|Death|1|||
155566358|NCT02245412|561498229|FG001|Treatment Period|Death|1|||
155566359|NCT02245412|561498230|FG002|Treatment Period|Death|0|||
155566360|NCT02245412|561498228|FG000|Treatment Period|Physician Decision|1|||
155566361|NCT02245412|561498229|FG001|Treatment Period|Physician Decision|1|||
155566362|NCT02245412|561498230|FG002|Treatment Period|Physician Decision|0|||
155566363|NCT02245412|561498228|FG000|Treatment Period|Withdrawal by Subject|2|||
155566364|NCT02245412|561498229|FG001|Treatment Period|Withdrawal by Subject|1|||
155566365|NCT02245412|561498230|FG002|Treatment Period|Withdrawal by Subject|0|||
155566366|NCT02245412|561498228|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
155566367|NCT02245412|561498229|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
155566368|NCT02245412|561498230|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
155566369|NCT02245412|561498228|FG000|Follow-Up Period|Death|4|||
155566370|NCT02245412|561498229|FG001|Follow-Up Period|Death|2|||
155566371|NCT02245412|561498230|FG002|Follow-Up Period|Death|1|||
155566372|NCT02245412|561498228|FG000|Follow-Up Period|Physician Decision|1|||
155566373|NCT02245412|561498229|FG001|Follow-Up Period|Physician Decision|0|||
155566374|NCT02245412|561498230|FG002|Follow-Up Period|Physician Decision|0|||
155566375|NCT02245412|561498228|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
155566376|NCT02245412|561498229|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
155566377|NCT02245412|561498230|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
155566378|NCT01056289|561498231|FG000|Open-label Phase|Adverse Event|29|||
155566379|NCT01056289|561498232|FG001|Open-label Phase|Adverse Event|0|||
155566380|NCT01056289|561498233|FG002|Open-label Phase|Adverse Event|0|||
155566381|NCT01056289|561498234|FG003|Open-label Phase|Adverse Event|0|||
155566382|NCT01056289|561498231|FG000|Open-label Phase|Lost to Follow-up|30|||
155566383|NCT01056289|561498232|FG001|Open-label Phase|Lost to Follow-up|0|||
155566384|NCT01056289|561498233|FG002|Open-label Phase|Lost to Follow-up|0|||
155566385|NCT01056289|561498234|FG003|Open-label Phase|Lost to Follow-up|0|||
155566386|NCT01056289|561498231|FG000|Open-label Phase|Other|9|||
155566387|NCT01056289|561498232|FG001|Open-label Phase|Other|0|||
155566388|NCT01056289|561498233|FG002|Open-label Phase|Other|0|||
155566389|NCT01056289|561498234|FG003|Open-label Phase|Other|0|||
155566390|NCT01056289|561498231|FG000|Open-label Phase|Protocol Violation|6|||
155566391|NCT01056289|561498232|FG001|Open-label Phase|Protocol Violation|0|||
155566392|NCT01056289|561498233|FG002|Open-label Phase|Protocol Violation|0|||
155566393|NCT01056289|561498234|FG003|Open-label Phase|Protocol Violation|0|||
155566394|NCT01056289|561498231|FG000|Open-label Phase|Withdrawal by Subject|26|||
155566395|NCT01056289|561498232|FG001|Open-label Phase|Withdrawal by Subject|0|||
155566396|NCT01056289|561498233|FG002|Open-label Phase|Withdrawal by Subject|0|||
155566397|NCT01056289|561498234|FG003|Open-label Phase|Withdrawal by Subject|0|||
155566398|NCT01056289|561498231|FG000|Open-label Phase|Lack of Efficacy|18|||
155566399|NCT01056289|561498232|FG001|Open-label Phase|Lack of Efficacy|0|||
155566400|NCT01056289|561498233|FG002|Open-label Phase|Lack of Efficacy|0|||
155566401|NCT01056289|561498234|FG003|Open-label Phase|Lack of Efficacy|0|||
155566402|NCT01056289|561498231|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
155566403|NCT01056289|561498232|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
155566404|NCT01056289|561498233|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
155566405|NCT01056289|561498234|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
155566406|NCT01056289|561498231|FG000|Double-blind Phase|Adverse Event|0|||
155566407|NCT01056289|561498232|FG001|Double-blind Phase|Adverse Event|1|||
155566408|NCT01056289|561498233|FG002|Double-blind Phase|Adverse Event|2|||
155566409|NCT01056289|561498234|FG003|Double-blind Phase|Adverse Event|1|||
155566410|NCT01056289|561498231|FG000|Double-blind Phase|Lost to Follow-up|0|||
155566411|NCT01056289|561498232|FG001|Double-blind Phase|Lost to Follow-up|2|||
155566412|NCT01056289|561498233|FG002|Double-blind Phase|Lost to Follow-up|2|||
155566413|NCT01056289|561498234|FG003|Double-blind Phase|Lost to Follow-up|2|||
155566414|NCT01056289|561498231|FG000|Double-blind Phase|Other|0|||
155566415|NCT01056289|561498232|FG001|Double-blind Phase|Other|0|||
155566416|NCT01056289|561498233|FG002|Double-blind Phase|Other|1|||
155566417|NCT01056289|561498234|FG003|Double-blind Phase|Other|2|||
155566418|NCT01056289|561498231|FG000|Double-blind Phase|Protocol Violation|0|||
155566419|NCT01056289|561498232|FG001|Double-blind Phase|Protocol Violation|0|||
155566420|NCT01056289|561498233|FG002|Double-blind Phase|Protocol Violation|1|||
155566421|NCT01056289|561498234|FG003|Double-blind Phase|Protocol Violation|1|||
155566422|NCT01056289|561498231|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155566423|NCT01056289|561498232|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155566424|NCT01056289|561498233|FG002|Double-blind Phase|Withdrawal by Subject|4|||
155566425|NCT01056289|561498234|FG003|Double-blind Phase|Withdrawal by Subject|2|||
155566426|NCT01056289|561498231|FG000|Double-blind Phase|Discontinuation symptom|0|||
155566427|NCT01056289|561498232|FG001|Double-blind Phase|Discontinuation symptom|1|||
155566428|NCT01056289|561498233|FG002|Double-blind Phase|Discontinuation symptom|2|||
155566429|NCT01056289|561498234|FG003|Double-blind Phase|Discontinuation symptom|2|||
155566430|NCT01056289|561498231|FG000|Double-blind Phase|Physician Decision|0|||
155566431|NCT01056289|561498232|FG001|Double-blind Phase|Physician Decision|0|||
155566432|NCT01056289|561498233|FG002|Double-blind Phase|Physician Decision|1|||
155566433|NCT01056289|561498234|FG003|Double-blind Phase|Physician Decision|0|||
155566434|NCT00270855|561498243|FG000|Overall Study|Withdrawal by Subject|8|||
155566435|NCT00270855|561498244|FG001|Overall Study|Withdrawal by Subject|8|||
155566436|NCT03301649|561498247|FG000|Overall Study|Need alternate therapy due to live lice|17|||
155566437|NCT03301649|561498248|FG001|Overall Study|Need alternate therapy due to live lice|25|||
155566438|NCT03301649|561498249|FG002|Overall Study|Need alternate therapy due to live lice|81|||
155566439|NCT03301649|561498247|FG000|Overall Study|Lost to Follow-up|11|||
155566440|NCT03301649|561498248|FG001|Overall Study|Lost to Follow-up|11|||
155566441|NCT03301649|561498249|FG002|Overall Study|Lost to Follow-up|3|||
155566442|NCT03301649|561498247|FG000|Overall Study|Protocol Violation|0|||
155566443|NCT03301649|561498248|FG001|Overall Study|Protocol Violation|1|||
155566444|NCT03301649|561498249|FG002|Overall Study|Protocol Violation|1|||
155566445|NCT03301649|561498247|FG000|Overall Study|Withdrawal by Subject|10|||
155566446|NCT03301649|561498248|FG001|Overall Study|Withdrawal by Subject|4|||
155566447|NCT03301649|561498249|FG002|Overall Study|Withdrawal by Subject|0|||
155566448|NCT03301649|561498247|FG000|Overall Study|Other than specified|5|||
155566449|NCT03301649|561498248|FG001|Overall Study|Other than specified|3|||
155566450|NCT03301649|561498249|FG002|Overall Study|Other than specified|0|||
155566451|NCT00887289|561498253|FG000|Overall Study|Lack of Efficacy|14|||
155659296|NCT00619866|561846817|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
155659297|NCT00619866|561846818|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
155659298|NCT00265122|561846820|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155659299|NCT00265122|561846821|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155659300|NCT00265122|561846822|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
155659301|NCT00265122|561846823|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
155659302|NCT00265122|561846824|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155659303|NCT00265122|561846825|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
155659304|NCT00265122|561846820|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
155659305|NCT00265122|561846821|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155659306|NCT00265122|561846822|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155659307|NCT00265122|561846823|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
155659308|NCT00265122|561846824|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155659309|NCT00265122|561846825|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155659310|NCT00265122|561846820|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155659311|NCT00265122|561846821|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
155659312|NCT00265122|561846822|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
155659313|NCT00265122|561846823|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
155659314|NCT00265122|561846824|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155659315|NCT00265122|561846825|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155659316|NCT00265122|561846820|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
155659317|NCT00265122|561846821|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
155659318|NCT00265122|561846822|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
155659319|NCT00265122|561846823|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
155659320|NCT00265122|561846824|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
155659321|NCT00265122|561846825|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
155659322|NCT00265122|561846820|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
155659323|NCT00265122|561846821|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
155659324|NCT00265122|561846822|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
155659325|NCT00265122|561846823|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
155659326|NCT00265122|561846824|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
155659327|NCT00265122|561846825|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
155659328|NCT00265122|561846820|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
155659329|NCT00265122|561846821|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155659330|NCT00265122|561846822|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
155659331|NCT00265122|561846823|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
155659332|NCT00265122|561846824|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155659333|NCT00265122|561846825|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155566452|NCT00887289|561498253|FG000|Overall Study|Adverse Event|27|||
155566453|NCT00887289|561498253|FG000|Overall Study|Withdrawal by Subject|26|||
155566454|NCT00887289|561498253|FG000|Overall Study|Lost to Follow-up|8|||
155566455|NCT00887289|561498253|FG000|Overall Study|Other|20|||
155566456|NCT03022084|561498260|FG000|Overall Study|Lost to Follow-up|2|||
155566457|NCT03022084|561498261|FG001|Overall Study|Lost to Follow-up|3|||
155566458|NCT02679235|561498266|FG000|Overall Study|Withdrawal by Subject|3|||
155566459|NCT02679235|561498266|FG000|Overall Study|Adverse Event|1|||
155566460|NCT00554606|561498268|FG000|Overall Study|Adverse Event|3|||
155566461|NCT00554606|561498268|FG000|Overall Study|Abnormal laboratory values|1|||
155566462|NCT00554606|561498268|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
155566463|NCT00554606|561498268|FG000|Overall Study|Subject withdrew consent|2|||
155566464|NCT00554606|561498268|FG000|Overall Study|Lost to Follow-up|2|||
155566465|NCT00554606|561498268|FG000|Overall Study|Administrative problems|60|||
155566466|NCT00554606|561498268|FG000|Overall Study|Death|1|||
155566467|NCT00554606|561498268|FG000|Overall Study|Protocol deviation|2|||
155566468|NCT00923273|561498269|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
155566469|NCT00923273|561498270|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
155566470|NCT00923273|561498271|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
155566471|NCT00923273|561498272|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
155566472|NCT00923273|561498273|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
155566473|NCT00923273|561498269|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
155659334|NCT04716894|561846826|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
155659335|NCT04716894|561846826|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
155659336|NCT05205616|561846833|FG000|Overall Study|Lost to Follow-up|4|||
155659337|NCT05205616|561846834|FG001|Overall Study|Lost to Follow-up|4|||
155659338|NCT01467466|561846843|FG000|Overall Study|Withdrawal by Subject|15|||
155566474|NCT00923273|561498270|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
155566475|NCT00923273|561498271|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
155566476|NCT00923273|561498272|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
155659339|NCT01467466|561846844|FG001|Overall Study|Withdrawal by Subject|18|||
155659340|NCT01467466|561846845|FG002|Overall Study|Withdrawal by Subject|13|||
155659341|NCT01467466|561846846|FG003|Overall Study|Withdrawal by Subject|11|||
155659342|NCT01467466|561846843|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
155659343|NCT01467466|561846844|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
155659344|NCT01467466|561846845|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
155659345|NCT01467466|561846846|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
155659346|NCT01467466|561846843|FG000|Overall Study|Procedure Cancelled|46|||
155659347|NCT01467466|561846844|FG001|Overall Study|Procedure Cancelled|45|||
155659348|NCT01467466|561846845|FG002|Overall Study|Procedure Cancelled|25|||
155659349|NCT01467466|561846846|FG003|Overall Study|Procedure Cancelled|29|||
155659350|NCT01467466|561846843|FG000|Overall Study|No Endpoint Blood Draw|38|||
155659351|NCT01467466|561846844|FG001|Overall Study|No Endpoint Blood Draw|32|||
155659352|NCT01467466|561846845|FG002|Overall Study|No Endpoint Blood Draw|51|||
155659353|NCT01467466|561846846|FG003|Overall Study|No Endpoint Blood Draw|43|||
155659354|NCT00982280|561846857|FG000|Observation Period|Not eligible to be dosed|19|||
155659355|NCT00982280|561846857|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
155659356|NCT00982280|561846857|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
155659357|NCT00982280|561846857|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
155659358|NCT00982280|561846857|FG000|Maintenance Period|Adverse Event|1|||
155659359|NCT04724837|561846858|FG000|Overall Study|Other|4|||
155659360|NCT04724837|561846859|FG001|Overall Study|Other|16|||
155659361|NCT04724837|561846860|FG002|Overall Study|Other|0|||
155659362|NCT04724837|561846858|FG000|Overall Study|Withdrawal by Subject|2|||
155659363|NCT04724837|561846859|FG001|Overall Study|Withdrawal by Subject|9|||
155659364|NCT04724837|561846860|FG002|Overall Study|Withdrawal by Subject|9|||
155659365|NCT04724837|561846858|FG000|Overall Study|Adverse Event|2|||
155659366|NCT04724837|561846859|FG001|Overall Study|Adverse Event|7|||
155659367|NCT04724837|561846860|FG002|Overall Study|Adverse Event|4|||
155659368|NCT04724837|561846858|FG000|Overall Study|Lost to Follow-up|0|||
155659369|NCT04724837|561846859|FG001|Overall Study|Lost to Follow-up|1|||
155659370|NCT04724837|561846860|FG002|Overall Study|Lost to Follow-up|3|||
155659371|NCT04724837|561846858|FG000|Overall Study|Physician Decision|1|||
155659372|NCT04724837|561846859|FG001|Overall Study|Physician Decision|2|||
155659373|NCT04724837|561846860|FG002|Overall Study|Physician Decision|0|||
155659374|NCT04724837|561846858|FG000|Overall Study|Death|0|||
155659375|NCT04724837|561846859|FG001|Overall Study|Death|0|||
155659376|NCT04724837|561846860|FG002|Overall Study|Death|1|||
155659377|NCT04724837|561846858|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155659378|NCT04724837|561846859|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155659379|NCT04724837|561846860|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
155659380|NCT04724837|561846858|FG000|Overall Study|Study Terminated by Sponsor|0|||
155659381|NCT04724837|561846859|FG001|Overall Study|Study Terminated by Sponsor|1|||
155566477|NCT00923273|561498273|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
155566478|NCT00605540|561498274|FG000|Overall Study|Death|15|||
155566479|NCT00605540|561498274|FG000|Overall Study|Lost to Follow-up|23|||
155566480|NCT00509366|561498275|FG000|Overall Study|Not Treated (Screen Failure)|1|||
155566481|NCT00509366|561498276|FG001|Overall Study|Not Treated (Screen Failure)|1|||
155566482|NCT00509366|561498277|FG002|Overall Study|Not Treated (Screen Failure)|1|||
155566483|NCT00509366|561498278|FG003|Overall Study|Not Treated (Screen Failure)|0|||
155566484|NCT00509366|561498279|FG004|Overall Study|Not Treated (Screen Failure)|0|||
155566485|NCT02119819|561498282|FG000|Overall Study|Adverse Event|3|||
155566486|NCT02119819|561498283|FG001|Overall Study|Adverse Event|1|||
155566487|NCT02119819|561498284|FG002|Overall Study|Adverse Event|2|||
155566488|NCT02119819|561498285|FG003|Overall Study|Adverse Event|3|||
155566489|NCT02119819|561498286|FG004|Overall Study|Adverse Event|0|||
155566490|NCT02119819|561498287|FG005|Overall Study|Adverse Event|1|||
155566491|NCT02119819|561498282|FG000|Overall Study|Lack of Efficacy|0|||
155566492|NCT02119819|561498283|FG001|Overall Study|Lack of Efficacy|0|||
155566493|NCT02119819|561498284|FG002|Overall Study|Lack of Efficacy|0|||
155659382|NCT04724837|561846860|FG002|Overall Study|Study Terminated by Sponsor|0|||
155659383|NCT03213509|561846861|FG000|Overall Study|Did not consent for verbal autopsy|4|||
155659384|NCT03213509|561846862|FG001|Overall Study|Did not consent for verbal autopsy|5|||
155659385|NCT06071104|561846863|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
155659386|NCT01344226|561846868|FG000|Overall Study|Protocol Violation|2|||
155659387|NCT01344226|561846868|FG000|Overall Study|Withdrawal by Subject|3|||
155659388|NCT01344226|561846868|FG000|Overall Study|Lack of Efficacy|3|||
155566494|NCT02119819|561498285|FG003|Overall Study|Lack of Efficacy|0|||
155659389|NCT02420717|561846874|FG000|Overall Study|Did not receive all study medication|2|||
155659390|NCT02420717|561846875|FG001|Overall Study|Did not receive all study medication|0|||
155659391|NCT02420717|561846876|FG002|Overall Study|Did not receive all study medication|0|||
155659392|NCT03781570|561846877|FG000|Overall Study|Technical Issues (equipment failure)|31|||
155659393|NCT03781570|561846877|FG000|Overall Study|Withdrawal by Subject|7|||
155566495|NCT02119819|561498286|FG004|Overall Study|Lack of Efficacy|0|||
155566496|NCT02119819|561498287|FG005|Overall Study|Lack of Efficacy|1|||
155566497|NCT02119819|561498282|FG000|Overall Study|Lost to Follow-up|0|||
155566498|NCT02119819|561498283|FG001|Overall Study|Lost to Follow-up|0|||
155566499|NCT02119819|561498284|FG002|Overall Study|Lost to Follow-up|1|||
155566500|NCT02119819|561498285|FG003|Overall Study|Lost to Follow-up|2|||
155659394|NCT03781570|561846877|FG000|Overall Study|Physical Constraints|11|||
155659395|NCT03636022|561846881|FG000|Overall Study|Withdrawal by Subject|1|||
155659396|NCT03636022|561846882|FG001|Overall Study|Withdrawal by Subject|3|||
155659397|NCT01346592|561846883|FG000|Overall Study|Lost to Follow-up|62|||
155659398|NCT01346592|561846884|FG001|Overall Study|Lost to Follow-up|29|||
155659399|NCT01346592|561846885|FG002|Overall Study|Lost to Follow-up|29|||
155659400|NCT01346592|561846883|FG000|Overall Study|Protocol Violation|2|||
155659401|NCT01346592|561846884|FG001|Overall Study|Protocol Violation|1|||
155659402|NCT01346592|561846885|FG002|Overall Study|Protocol Violation|0|||
155659403|NCT01346592|561846883|FG000|Overall Study|Death|1|||
155659404|NCT01346592|561846884|FG001|Overall Study|Death|3|||
155659405|NCT01346592|561846885|FG002|Overall Study|Death|4|||
155659406|NCT01346592|561846883|FG000|Overall Study|Adverse Event|0|||
155659407|NCT01346592|561846884|FG001|Overall Study|Adverse Event|1|||
155659408|NCT01346592|561846885|FG002|Overall Study|Adverse Event|0|||
155659409|NCT01346592|561846883|FG000|Overall Study|Withdrawal by Subject|77|||
155659410|NCT01346592|561846884|FG001|Overall Study|Withdrawal by Subject|51|||
155659411|NCT01346592|561846885|FG002|Overall Study|Withdrawal by Subject|38|||
155659412|NCT01346592|561846883|FG000|Overall Study|Inappropriate enrollment|3|||
155659413|NCT01346592|561846884|FG001|Overall Study|Inappropriate enrollment|1|||
155659414|NCT01346592|561846885|FG002|Overall Study|Inappropriate enrollment|1|||
155659415|NCT01346592|561846883|FG000|Overall Study|Administrative reason|1|||
155659416|NCT01346592|561846884|FG001|Overall Study|Administrative reason|0|||
155659417|NCT01346592|561846885|FG002|Overall Study|Administrative reason|0|||
155659418|NCT01346592|561846883|FG000|Overall Study|Unable to Classify|7|||
155659419|NCT01346592|561846884|FG001|Overall Study|Unable to Classify|3|||
155659420|NCT01346592|561846885|FG002|Overall Study|Unable to Classify|6|||
155659421|NCT04890509|561846888|FG000|Overall Study|Death|4|||
155659422|NCT04890509|561846889|FG001|Overall Study|Death|4|||
155659423|NCT05943990|561846892|FG000|Overall Study|Study Terminated by Sponsor|0|||
155659424|NCT05943990|561846893|FG001|Overall Study|Study Terminated by Sponsor|0|||
155659425|NCT05943990|561846894|FG002|Overall Study|Study Terminated by Sponsor|1|||
155659426|NCT02776735|561846895|FG000|Overall Study|Adverse Event|0|||
155659427|NCT02776735|561846896|FG001|Overall Study|Adverse Event|0|||
155659428|NCT02776735|561846897|FG002|Overall Study|Adverse Event|0|||
155659429|NCT02776735|561846898|FG003|Overall Study|Adverse Event|1|||
155659430|NCT02776735|561846899|FG004|Overall Study|Adverse Event|0|||
155659431|NCT02776735|561846900|FG005|Overall Study|Adverse Event|1|||
155659432|NCT02776735|561846895|FG000|Overall Study|Lost to Follow-up|0|||
155659433|NCT02776735|561846896|FG001|Overall Study|Lost to Follow-up|0|||
155659434|NCT02776735|561846897|FG002|Overall Study|Lost to Follow-up|0|||
155659435|NCT02776735|561846898|FG003|Overall Study|Lost to Follow-up|1|||
155659436|NCT02776735|561846899|FG004|Overall Study|Lost to Follow-up|0|||
155659437|NCT02776735|561846900|FG005|Overall Study|Lost to Follow-up|0|||
155659438|NCT02776735|561846895|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155659439|NCT02776735|561846896|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155659440|NCT02776735|561846897|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155659441|NCT02776735|561846898|FG003|Overall Study|Withdrawal by parent/guardian|2|||
155659442|NCT02776735|561846899|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155659443|NCT02776735|561846900|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155659444|NCT02776735|561846895|FG000|Overall Study|Withdrawal by Subject|1|||
155659445|NCT02776735|561846896|FG001|Overall Study|Withdrawal by Subject|0|||
155659446|NCT02776735|561846897|FG002|Overall Study|Withdrawal by Subject|0|||
155659447|NCT02776735|561846898|FG003|Overall Study|Withdrawal by Subject|0|||
155659448|NCT02776735|561846899|FG004|Overall Study|Withdrawal by Subject|0|||
155659449|NCT02776735|561846900|FG005|Overall Study|Withdrawal by Subject|1|||
155659450|NCT02776735|561846895|FG000|Overall Study|Other|0|||
155659451|NCT02776735|561846896|FG001|Overall Study|Other|0|||
155566501|NCT02119819|561498286|FG004|Overall Study|Lost to Follow-up|1|||
155566502|NCT02119819|561498287|FG005|Overall Study|Lost to Follow-up|2|||
155566503|NCT02119819|561498282|FG000|Overall Study|Physician Decision|1|||
155566504|NCT02119819|561498283|FG001|Overall Study|Physician Decision|1|||
155659452|NCT02776735|561846897|FG002|Overall Study|Other|3|||
155659453|NCT02776735|561846898|FG003|Overall Study|Other|0|||
155659454|NCT02776735|561846899|FG004|Overall Study|Other|0|||
155659455|NCT02776735|561846900|FG005|Overall Study|Other|0|||
155659456|NCT05847686|561847938|FG000|Overall Study|Withdrawal by Subject|3|||
155659457|NCT04617860|561847942|FG000|Overall Study|Adverse Event|0|||
155659458|NCT04617860|561847943|FG001|Overall Study|Adverse Event|2|||
155659459|NCT04617860|561847944|FG002|Overall Study|Adverse Event|2|||
155566505|NCT02119819|561498284|FG002|Overall Study|Physician Decision|0|||
155566506|NCT02119819|561498285|FG003|Overall Study|Physician Decision|0|||
155659460|NCT04617860|561847942|FG000|Overall Study|Withdrawal by Subject|0|||
155659461|NCT04617860|561847943|FG001|Overall Study|Withdrawal by Subject|0|||
155659462|NCT04617860|561847944|FG002|Overall Study|Withdrawal by Subject|2|||
155659463|NCT04617860|561847942|FG000|Overall Study|Physician Decision|0|||
155566507|NCT02119819|561498286|FG004|Overall Study|Physician Decision|0|||
155566508|NCT02119819|561498287|FG005|Overall Study|Physician Decision|1|||
155566509|NCT02119819|561498282|FG000|Overall Study|Withdrawal by Subject|5|||
155566510|NCT02119819|561498283|FG001|Overall Study|Withdrawal by Subject|3|||
155566511|NCT02119819|561498284|FG002|Overall Study|Withdrawal by Subject|0|||
155566512|NCT02119819|561498285|FG003|Overall Study|Withdrawal by Subject|0|||
155566513|NCT02119819|561498286|FG004|Overall Study|Withdrawal by Subject|6|||
155566514|NCT02119819|561498287|FG005|Overall Study|Withdrawal by Subject|10|||
155566515|NCT02119819|561498282|FG000|Overall Study|Jury Duty|0|||
155566516|NCT02119819|561498283|FG001|Overall Study|Jury Duty|0|||
155566517|NCT02119819|561498284|FG002|Overall Study|Jury Duty|1|||
155566518|NCT02119819|561498285|FG003|Overall Study|Jury Duty|0|||
155566519|NCT02119819|561498286|FG004|Overall Study|Jury Duty|0|||
155566520|NCT02119819|561498287|FG005|Overall Study|Jury Duty|0|||
155566521|NCT02119819|561498282|FG000|Overall Study|Protocol Violation|0|||
155566522|NCT02119819|561498283|FG001|Overall Study|Protocol Violation|0|||
155566523|NCT02119819|561498284|FG002|Overall Study|Protocol Violation|0|||
155566524|NCT02119819|561498285|FG003|Overall Study|Protocol Violation|1|||
155566525|NCT02119819|561498286|FG004|Overall Study|Protocol Violation|0|||
155566526|NCT02119819|561498287|FG005|Overall Study|Protocol Violation|0|||
155566527|NCT02119819|561498282|FG000|Overall Study|Left the city to get a job|0|||
155566528|NCT02119819|561498283|FG001|Overall Study|Left the city to get a job|0|||
155566529|NCT02119819|561498284|FG002|Overall Study|Left the city to get a job|0|||
155566530|NCT02119819|561498285|FG003|Overall Study|Left the city to get a job|1|||
155566531|NCT02119819|561498286|FG004|Overall Study|Left the city to get a job|0|||
155566532|NCT02119819|561498287|FG005|Overall Study|Left the city to get a job|0|||
155566533|NCT00282919|561498289|FG000|Overall Study|Lack of Efficacy|4|||
155566534|NCT00282919|561498289|FG000|Overall Study|Withdrawal by Subject|1|||
155566535|NCT00282919|561498289|FG000|Overall Study|Asymptomatic Parasitemia|2|||
155566536|NCT01438996|561498292|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
155566537|NCT01438996|561498293|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
155566538|NCT01438996|561498294|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
155566539|NCT04497948|561498299|FG000|Overall Study|Death|2|||
155566540|NCT02246114|561498300|FG000|Overall Study|miscarriage|1|||
155566541|NCT02246114|561498301|FG001|Overall Study|miscarriage|0|||
155566542|NCT03257865|561498304|FG000|Overall Study|Adverse Event|4|||
155566543|NCT03257865|561498305|FG001|Overall Study|Adverse Event|8|||
155566544|NCT03257865|561498304|FG000|Overall Study|Lack of Efficacy|1|||
155566545|NCT03257865|561498305|FG001|Overall Study|Lack of Efficacy|2|||
155566546|NCT03257865|561498304|FG000|Overall Study|Non-compliance with Study Drug|0|||
155566547|NCT03257865|561498305|FG001|Overall Study|Non-compliance with Study Drug|2|||
155566548|NCT03257865|561498304|FG000|Overall Study|Withdrawal by Subject|23|||
155566549|NCT03257865|561498305|FG001|Overall Study|Withdrawal by Subject|17|||
155566550|NCT03257865|561498304|FG000|Overall Study|Physician Decision|3|||
155566551|NCT03257865|561498305|FG001|Overall Study|Physician Decision|1|||
155566552|NCT03257865|561498304|FG000|Overall Study|Other|0|||
155566553|NCT03257865|561498305|FG001|Overall Study|Other|1|||
155566554|NCT03257865|561498304|FG000|Overall Study|Lost to Follow-up|4|||
155566555|NCT03257865|561498305|FG001|Overall Study|Lost to Follow-up|4|||
155566556|NCT01421511|561498309|FG000|Overall Study|Lost to Follow-up|11|||
155566557|NCT01421511|561498310|FG001|Overall Study|Lost to Follow-up|14|||
155566558|NCT01421511|561498309|FG000|Overall Study|Randomized but didn't receive study drug|1|||
155566559|NCT01421511|561498310|FG001|Overall Study|Randomized but didn't receive study drug|7|||
155566560|NCT01421511|561498309|FG000|Overall Study|Physician Decision|0|||
155566561|NCT01421511|561498310|FG001|Overall Study|Physician Decision|1|||
155566562|NCT01421511|561498309|FG000|Overall Study|Withdrawal by Subject|6|||
155566563|NCT01421511|561498310|FG001|Overall Study|Withdrawal by Subject|5|||
155566564|NCT01421511|561498309|FG000|Overall Study|Death|1|||
155566565|NCT01421511|561498310|FG001|Overall Study|Death|1|||
155566566|NCT05384171|561498311|FG000|Overall Study|Lost to Follow-up|9|||
155566567|NCT05384171|561498312|FG001|Overall Study|Lost to Follow-up|9|||
155566568|NCT05384171|561498311|FG000|Overall Study|Withdrawal by Subject|3|||
155566569|NCT05384171|561498312|FG001|Overall Study|Withdrawal by Subject|0|||
155566570|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
155566571|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
155566572|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
155566573|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
155566574|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
155566575|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
155566576|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
155566577|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
155566578|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
155566579|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
155566580|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
155566581|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
155659464|NCT04617860|561847943|FG001|Overall Study|Physician Decision|1|||
155566582|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
155566583|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
155566584|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
155566585|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
155566586|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
155566587|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
155566588|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
155566589|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
155566590|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
155566591|NCT04040192|561498313|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
155566592|NCT04040192|561498314|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
155566593|NCT04040192|561498315|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
155566594|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
155566595|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
155566596|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
155566597|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
155566598|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
155566599|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
155566600|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
155566601|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
155566602|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
155566603|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
155566604|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
155566605|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
155566606|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155566607|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
155566608|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
155566609|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
155566610|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
155566611|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
155566612|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
155566613|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
155566614|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
155566615|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
155566616|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
155566617|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
155566618|NCT04040192|561498313|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
155566619|NCT04040192|561498314|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
155566620|NCT04040192|561498315|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
155566621|NCT00875797|561498318|FG000|Overall Study|Protocol Violation|6|||
155566622|NCT00875797|561498319|FG001|Overall Study|Protocol Violation|3|||
155566623|NCT04893018|561498322|FG000|Overall Study|Lost to Follow-up|1|||
155566624|NCT04893018|561498323|FG001|Overall Study|Lost to Follow-up|0|||
155566625|NCT04893018|561498322|FG000|Overall Study|Withdrawal by Subject|2|||
155566626|NCT04893018|561498323|FG001|Overall Study|Withdrawal by Subject|0|||
155566627|NCT04893018|561498322|FG000|Overall Study|Study Terminated|1|||
155566628|NCT04893018|561498323|FG001|Overall Study|Study Terminated|2|||
155566629|NCT00195338|561498329|FG000|Overall Study|Lost to Follow-up|2|||
155566630|NCT00195338|561498329|FG000|Overall Study|Adverse Event|5|||
155566631|NCT00195338|561498329|FG000|Overall Study|Lack of Efficacy|1|||
155566632|NCT00195338|561498329|FG000|Overall Study|Early closure of the site|4|||
155566633|NCT01085357|561498330|FG000|Overall Study|Adverse Event|1|||
155566634|NCT01085357|561498331|FG001|Overall Study|Adverse Event|1|||
155566635|NCT01085357|561498330|FG000|Overall Study|Subject Decision|4|||
155566636|NCT01085357|561498331|FG001|Overall Study|Subject Decision|3|||
155566637|NCT01085357|561498330|FG000|Overall Study|Investigator Decision|1|||
155566638|NCT01085357|561498331|FG001|Overall Study|Investigator Decision|1|||
155566639|NCT01085357|561498330|FG000|Overall Study|Death|11|||
155566640|NCT01085357|561498331|FG001|Overall Study|Death|1|||
155566641|NCT01085357|561498330|FG000|Overall Study|Lost to Follow-up|2|||
155566642|NCT01085357|561498331|FG001|Overall Study|Lost to Follow-up|0|||
155566643|NCT00314951|561498332|FG000|Treatment|Didn't meet criteria for mITT population|16|||
155566644|NCT00314951|561498333|FG001|Treatment|Didn't meet criteria for mITT population|11|||
155566645|NCT00314951|561498332|FG000|Follow-up|mITT failure|44|||
155566646|NCT00314951|561498333|FG001|Follow-up|mITT failure|34|||
155566647|NCT02910011|561498334|FG000|Overall Study|Physician Decision|2|||
155566648|NCT00182325|561498339|FG000|Overall Study|Lost to Follow-up|7|||
155566649|NCT00182325|561498340|FG001|Overall Study|Lost to Follow-up|7|||
155566650|NCT00182325|561498339|FG000|Overall Study|Miscarriage|5|||
155566651|NCT00182325|561498340|FG001|Overall Study|Miscarriage|3|||
155566652|NCT00182325|561498339|FG000|Overall Study|Did not complete survey|22|||
155566653|NCT00182325|561498340|FG001|Overall Study|Did not complete survey|43|||
155566654|NCT01420965|561498341|FG000|Overall Study|Withdrawal by Subject|1|||
155566655|NCT01420965|561498342|FG001|Overall Study|Withdrawal by Subject|0|||
155566656|NCT01420965|561498343|FG002|Overall Study|Withdrawal by Subject|0|||
155566657|NCT01420965|561498341|FG000|Overall Study|Adverse Event|0|||
155566658|NCT01420965|561498342|FG001|Overall Study|Adverse Event|1|||
155566659|NCT01420965|561498343|FG002|Overall Study|Adverse Event|0|||
155566660|NCT02015065|561498344|FG000|Overall Study|Death on study|1|||
155566661|NCT02015065|561498345|FG001|Overall Study|Death on study|2|||
155566662|NCT02015065|561498346|FG002|Overall Study|Death on study|1|||
155566663|NCT01292226|561498379|FG000|Overall Study|Adverse Event|5|||
155566664|NCT01292226|561498379|FG000|Overall Study|Death|1|||
155566665|NCT01292226|561498379|FG000|Overall Study|Graft loss|1|||
155566666|NCT01292226|561498379|FG000|Overall Study|Protocol Violation|3|||
155566667|NCT01292226|561498379|FG000|Overall Study|Withdrawal by Subject|1|||
155566668|NCT01292226|561498379|FG000|Overall Study|Other|2|||
155566669|NCT04106661|561498380|FG000|Overall Study|Protocol Violation|3|||
155566670|NCT04106661|561498381|FG001|Overall Study|Protocol Violation|0|||
155566671|NCT04106661|561498380|FG000|Overall Study|Scheduling difficulties|1|||
155566672|NCT04106661|561498381|FG001|Overall Study|Scheduling difficulties|1|||
155566673|NCT01210612|561498385|FG000|Overall Study|Withdrawal by Subject|0|||
155566674|NCT01210612|561498386|FG001|Overall Study|Withdrawal by Subject|2|||
155566675|NCT00813800|561498390|FG000|Overall Study|Screen Failure after Consent|2|||
155566676|NCT00813800|561498390|FG000|Overall Study|Adverse Event|1|||
155566677|NCT00813800|561498390|FG000|Overall Study|Worsening of depression|2|||
155566678|NCT00813800|561498390|FG000|Overall Study|Physician Decision|1|||
155566679|NCT01860677|561498391|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
155566680|NCT01860677|561498392|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
155566681|NCT00418821|561498394|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
155566682|NCT02823652|561498395|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
155566683|NCT02823652|561498396|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
155566684|NCT02823652|561498397|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
155566685|NCT02823652|561498395|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
155566686|NCT02823652|561498396|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
155566687|NCT02823652|561498397|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
155566688|NCT02823652|561498395|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
155566689|NCT02823652|561498396|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
155566690|NCT02823652|561498397|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
155566691|NCT02823652|561498395|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
155566692|NCT02823652|561498396|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
155566693|NCT02823652|561498397|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
155566694|NCT03155945|561498398|FG000|Overall Study|Lost to Follow-up|0|||
155566695|NCT03155945|561498399|FG001|Overall Study|Lost to Follow-up|1|||
155566696|NCT03155945|561498398|FG000|Overall Study|Withdrawal by Subject|0|||
155566697|NCT03155945|561498399|FG001|Overall Study|Withdrawal by Subject|1|||
155566698|NCT03155945|561498398|FG000|Overall Study|Other Reason|0|||
155566699|NCT03155945|561498399|FG001|Overall Study|Other Reason|1|||
155566700|NCT02013674|561498400|FG000|Overall Study|Death|0|||
155566701|NCT02013674|561498401|FG001|Overall Study|Death|1|||
155566702|NCT02013674|561498400|FG000|Overall Study|Lost to Follow-up|1|||
155566703|NCT02013674|561498401|FG001|Overall Study|Lost to Follow-up|0|||
155566704|NCT04324073|561500448|FG000|Overall Study|withdrew consent|0|||
155566705|NCT04324073|561500449|FG001|Overall Study|withdrew consent|4|||
155566706|NCT04324073|561500450|FG002|Overall Study|withdrew consent|2|||
155566707|NCT04324073|561500451|FG003|Overall Study|withdrew consent|8|||
155566708|NCT01200069|561500457|FG000|Overall Study|Withdrawal by Subject|0|||
155566709|NCT01200069|561500458|FG001|Overall Study|Withdrawal by Subject|1|||
155566710|NCT04998851|561500459|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
155566711|NCT04998851|561500460|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
155566712|NCT04998851|561500459|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
155566713|NCT04998851|561500460|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
155566714|NCT00070499|561500461|FG000|Overall Study|Adverse Event|6|||
155566715|NCT00070499|561500462|FG001|Overall Study|Adverse Event|6|||
155566716|NCT00070499|561500463|FG002|Overall Study|Adverse Event|19|||
155566717|NCT00070499|561500464|FG003|Overall Study|Adverse Event|15|||
155566718|NCT00070499|561500461|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
155566719|NCT00070499|561500462|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
155566720|NCT00070499|561500463|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
155566721|NCT00070499|561500464|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
155659465|NCT04617860|561847944|FG002|Overall Study|Physician Decision|0|||
155566722|NCT00070499|561500461|FG000|Overall Study|Progression/relapse|4|||
155566723|NCT00070499|561500462|FG001|Overall Study|Progression/relapse|2|||
155566724|NCT00070499|561500463|FG002|Overall Study|Progression/relapse|1|||
155566725|NCT00070499|561500464|FG003|Overall Study|Progression/relapse|4|||
155566726|NCT00070499|561500461|FG000|Overall Study|Death|1|||
155566727|NCT00070499|561500462|FG001|Overall Study|Death|1|||
155566728|NCT00070499|561500463|FG002|Overall Study|Death|1|||
155566729|NCT00070499|561500464|FG003|Overall Study|Death|2|||
155566730|NCT00070499|561500461|FG000|Overall Study|Other - not protocol specified|7|||
155566731|NCT00070499|561500462|FG001|Overall Study|Other - not protocol specified|3|||
155566732|NCT00070499|561500463|FG002|Overall Study|Other - not protocol specified|12|||
155566733|NCT00070499|561500464|FG003|Overall Study|Other - not protocol specified|20|||
155566734|NCT00070499|561500461|FG000|Overall Study|Still on protocol treatment|10|||
155566735|NCT00070499|561500462|FG001|Overall Study|Still on protocol treatment|4|||
155566736|NCT00070499|561500463|FG002|Overall Study|Still on protocol treatment|79|||
155566737|NCT00070499|561500464|FG003|Overall Study|Still on protocol treatment|57|||
155566738|NCT00070499|561500461|FG000|Overall Study|Did not start treatment|1|||
155566739|NCT00070499|561500462|FG001|Overall Study|Did not start treatment|0|||
155566740|NCT00070499|561500463|FG002|Overall Study|Did not start treatment|0|||
155566741|NCT00070499|561500464|FG003|Overall Study|Did not start treatment|2|||
155566742|NCT00070499|561500461|FG000|Overall Study|Not eligible|2|||
155566743|NCT00070499|561500462|FG001|Overall Study|Not eligible|5|||
155566744|NCT00070499|561500463|FG002|Overall Study|Not eligible|3|||
155566745|NCT00070499|561500464|FG003|Overall Study|Not eligible|2|||
155566746|NCT00805467|561500465|FG000|Overall Study|Lack of Efficacy|0|||
155566747|NCT00805467|561500466|FG001|Overall Study|Lack of Efficacy|8|||
155566748|NCT00805467|561500467|FG002|Overall Study|Lack of Efficacy|13|||
155566749|NCT00805467|561500468|FG003|Overall Study|Lack of Efficacy|86|||
155566750|NCT00805467|561500465|FG000|Overall Study|Lost to Follow-up|0|||
155566751|NCT00805467|561500466|FG001|Overall Study|Lost to Follow-up|1|||
155566752|NCT00805467|561500467|FG002|Overall Study|Lost to Follow-up|7|||
155566753|NCT00805467|561500468|FG003|Overall Study|Lost to Follow-up|21|||
155566754|NCT00805467|561500465|FG000|Overall Study|Withdrawal by Subject|0|||
155566755|NCT00805467|561500466|FG001|Overall Study|Withdrawal by Subject|6|||
155566756|NCT00805467|561500467|FG002|Overall Study|Withdrawal by Subject|45|||
155566757|NCT00805467|561500468|FG003|Overall Study|Withdrawal by Subject|50|||
155566758|NCT00805467|561500465|FG000|Overall Study|Protocol Violation|0|||
155566759|NCT00805467|561500466|FG001|Overall Study|Protocol Violation|3|||
155566760|NCT00805467|561500467|FG002|Overall Study|Protocol Violation|0|||
155566761|NCT00805467|561500468|FG003|Overall Study|Protocol Violation|5|||
155566762|NCT00805467|561500465|FG000|Overall Study|Adverse Event|0|||
155566763|NCT00805467|561500466|FG001|Overall Study|Adverse Event|13|||
155566764|NCT00805467|561500467|FG002|Overall Study|Adverse Event|26|||
155566765|NCT00805467|561500468|FG003|Overall Study|Adverse Event|57|||
155566766|NCT00805467|561500465|FG000|Overall Study|Death|0|||
155566767|NCT00805467|561500466|FG001|Overall Study|Death|2|||
155566768|NCT00805467|561500467|FG002|Overall Study|Death|7|||
155566769|NCT00805467|561500468|FG003|Overall Study|Death|5|||
155566770|NCT00805467|561500465|FG000|Overall Study|Physician Decision|0|||
155566771|NCT00805467|561500466|FG001|Overall Study|Physician Decision|1|||
155566772|NCT00805467|561500467|FG002|Overall Study|Physician Decision|2|||
155566773|NCT00805467|561500468|FG003|Overall Study|Physician Decision|6|||
155566774|NCT00805467|561500465|FG000|Overall Study|Not reported|0|||
155566775|NCT00805467|561500466|FG001|Overall Study|Not reported|0|||
155566776|NCT00805467|561500467|FG002|Overall Study|Not reported|3|||
155566777|NCT00805467|561500468|FG003|Overall Study|Not reported|7|||
155566778|NCT01908907|561500471|FG000|Overall Study|Physician Decision|1|||
155566779|NCT01908907|561500472|FG001|Overall Study|Physician Decision|0|||
155566780|NCT01908907|561500471|FG000|Overall Study|Protocol Violation|1|||
155566781|NCT01908907|561500472|FG001|Overall Study|Protocol Violation|0|||
155566782|NCT00660907|561500473|FG000|Overall Study|Incorrect Enrollment|1|||
155566783|NCT00660907|561500474|FG001|Overall Study|Incorrect Enrollment|1|||
155566784|NCT00660907|561500473|FG000|Overall Study|Adverse Event|33|||
155566785|NCT00660907|561500474|FG001|Overall Study|Adverse Event|19|||
155566786|NCT00660907|561500473|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
155566787|NCT00660907|561500474|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
155566788|NCT00660907|561500473|FG000|Overall Study|Withdrawal by Subject|23|||
155566789|NCT00660907|561500474|FG001|Overall Study|Withdrawal by Subject|32|||
155566790|NCT00660907|561500473|FG000|Overall Study|Lost to Follow-up|3|||
155566791|NCT00660907|561500474|FG001|Overall Study|Lost to Follow-up|3|||
155566792|NCT00660907|561500473|FG000|Overall Study|Poor/Non-Compliance|5|||
155566793|NCT00660907|561500474|FG001|Overall Study|Poor/Non-Compliance|1|||
155566794|NCT00660907|561500473|FG000|Overall Study|Safety|1|||
155566795|NCT00660907|561500474|FG001|Overall Study|Safety|0|||
155566796|NCT00660907|561500473|FG000|Overall Study|Death|1|||
155566797|NCT00660907|561500474|FG001|Overall Study|Death|3|||
155566798|NCT00660907|561500473|FG000|Overall Study|Various|11|||
155659466|NCT04617860|561847942|FG000|Overall Study|Sponsor Decision|0|||
155659467|NCT04617860|561847943|FG001|Overall Study|Sponsor Decision|3|||
155659468|NCT04617860|561847944|FG002|Overall Study|Sponsor Decision|1|||
155659469|NCT04617860|561847942|FG000|Overall Study|Termination of Study by Sponsor|8|||
155659470|NCT04617860|561847943|FG001|Overall Study|Termination of Study by Sponsor|4|||
155659471|NCT04617860|561847944|FG002|Overall Study|Termination of Study by Sponsor|13|||
155659472|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155659473|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
155659474|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155659475|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155659476|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
155659477|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155659478|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
155659479|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
155659480|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
155659481|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
155659482|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
155659483|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
155659484|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155659485|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155659486|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155659487|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155659488|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
155659489|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
155659490|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
155659491|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
155659492|NCT02836249|561847945|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
155659493|NCT02836249|561847946|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155659494|NCT02836249|561847947|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155659495|NCT02836249|561847948|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155659496|NCT02836249|561847945|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155659497|NCT02836249|561847946|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155659498|NCT02836249|561847947|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
155659499|NCT02836249|561847948|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
155659500|NCT02836249|561847945|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155659501|NCT02836249|561847946|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155659502|NCT02836249|561847947|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
155659503|NCT02836249|561847948|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
155659504|NCT02836249|561847945|FG000|Open-Label TAF Treatment Phase|Death|0|||
155659505|NCT02836249|561847946|FG001|Open-Label TAF Treatment Phase|Death|0|||
155659506|NCT02836249|561847947|FG002|Open-Label TAF Treatment Phase|Death|1|||
155659507|NCT02836249|561847948|FG003|Open-Label TAF Treatment Phase|Death|0|||
155659508|NCT02836249|561847945|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155659509|NCT02836249|561847946|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155659510|NCT02836249|561847947|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
155659511|NCT02836249|561847948|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155659512|NCT02836249|561847945|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
155659513|NCT02836249|561847946|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
155659514|NCT02836249|561847947|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
155659515|NCT02836249|561847948|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
155659516|NCT04752566|561847949|FG000|Overall Study|Protocol Violation|0|||
155659517|NCT04752566|561847950|FG001|Overall Study|Protocol Violation|1|||
155659518|NCT04752566|561847949|FG000|Overall Study|Death|1|||
155659519|NCT04752566|561847950|FG001|Overall Study|Death|0|||
155659520|NCT04752566|561847949|FG000|Overall Study|Adverse Event|1|||
155659521|NCT04752566|561847950|FG001|Overall Study|Adverse Event|0|||
155659522|NCT04752566|561847949|FG000|Overall Study|Withdrawal by Subject|2|||
155659523|NCT04752566|561847950|FG001|Overall Study|Withdrawal by Subject|0|||
155659524|NCT04752566|561847949|FG000|Overall Study|Physician Decision|1|||
155659525|NCT04752566|561847950|FG001|Overall Study|Physician Decision|1|||
155659526|NCT03331354|561847951|FG000|Overall Study|Withdrawal by Subject|1|||
155659527|NCT03331354|561847952|FG001|Overall Study|Withdrawal by Subject|3|||
155659528|NCT03331354|561847951|FG000|Overall Study|Lost to Follow-up|3|||
155659529|NCT03331354|561847952|FG001|Overall Study|Lost to Follow-up|3|||
155659530|NCT03331354|561847951|FG000|Overall Study|Found employment before initiated active intervention|0|||
155659531|NCT03331354|561847952|FG001|Overall Study|Found employment before initiated active intervention|4|||
155659532|NCT01646827|561847953|FG000|Overall Study|Lost to Follow-up|0|||
155659533|NCT01646827|561847954|FG001|Overall Study|Lost to Follow-up|3|||
155659534|NCT01646827|561847953|FG000|Overall Study|Physician Decision|1|||
155659535|NCT01646827|561847954|FG001|Overall Study|Physician Decision|2|||
155659536|NCT01646827|561847953|FG000|Overall Study|Withdrawal by Subject|1|||
155659537|NCT01646827|561847954|FG001|Overall Study|Withdrawal by Subject|0|||
155566799|NCT00660907|561500474|FG001|Overall Study|Various|8|||
155566800|NCT00478244|561500477|FG000|Overall Study|Did not receive transplant|1|||
155566801|NCT02929056|561500478|FG000|Overall Study|Lost to Follow-up|0|||
155566802|NCT02929056|561500479|FG001|Overall Study|Lost to Follow-up|1|||
155566803|NCT00459043|561500480|FG000|Overall Study|Withdrawal by Subject|1|||
155566804|NCT00459043|561500481|FG001|Overall Study|Withdrawal by Subject|0|||
155566805|NCT05048329|561500482|FG000|Overall Study|Withdrawal by Subject|1|||
155566806|NCT05048329|561500482|FG000|Overall Study|Screenfail|1|||
155566807|NCT01403051|561500483|FG000|Overall Study|Protocol Violation|2|||
155566808|NCT01403051|561500484|FG001|Overall Study|Protocol Violation|0|||
155566809|NCT01403051|561500483|FG000|Overall Study|Death|1|||
155566810|NCT01403051|561500484|FG001|Overall Study|Death|0|||
155566811|NCT01403051|561500483|FG000|Overall Study|Withdrawal by Subject|2|||
155566812|NCT01403051|561500484|FG001|Overall Study|Withdrawal by Subject|1|||
155566813|NCT01403051|561500483|FG000|Overall Study|Lost to Follow-up|5|||
155566814|NCT01403051|561500484|FG001|Overall Study|Lost to Follow-up|5|||
155566815|NCT00591773|561500485|FG000|Overall Study|Adverse Event|9|||
155566816|NCT00591773|561500486|FG001|Overall Study|Adverse Event|9|||
155566817|NCT00591773|561500487|FG002|Overall Study|Adverse Event|6|||
155566818|NCT00591773|561500485|FG000|Overall Study|Protocol Violation|2|||
155566819|NCT00591773|561500486|FG001|Overall Study|Protocol Violation|3|||
155566820|NCT00591773|561500487|FG002|Overall Study|Protocol Violation|0|||
155566821|NCT00591773|561500485|FG000|Overall Study|Lost to Follow-up|1|||
155566822|NCT00591773|561500486|FG001|Overall Study|Lost to Follow-up|4|||
155566823|NCT00591773|561500487|FG002|Overall Study|Lost to Follow-up|1|||
155566824|NCT00591773|561500485|FG000|Overall Study|Withdrawal by Subject|2|||
155566825|NCT00591773|561500486|FG001|Overall Study|Withdrawal by Subject|5|||
155566826|NCT00591773|561500487|FG002|Overall Study|Withdrawal by Subject|3|||
155566827|NCT00591773|561500485|FG000|Overall Study|Lack of Efficacy|1|||
155566828|NCT00591773|561500486|FG001|Overall Study|Lack of Efficacy|2|||
155566829|NCT00591773|561500487|FG002|Overall Study|Lack of Efficacy|2|||
155566830|NCT00591773|561500485|FG000|Overall Study|Other|1|||
155566831|NCT00591773|561500486|FG001|Overall Study|Other|1|||
155566832|NCT00591773|561500487|FG002|Overall Study|Other|4|||
155566833|NCT02135614|561500488|FG000|Overall Study|Randomized but Not Treated|2|||
155566834|NCT02135614|561500489|FG001|Overall Study|Randomized but Not Treated|1|||
155566835|NCT02135614|561500488|FG000|Overall Study|Adverse Event|0|||
155566836|NCT02135614|561500489|FG001|Overall Study|Adverse Event|1|||
155566837|NCT02135614|561500488|FG000|Overall Study|Death|1|||
155566838|NCT02135614|561500489|FG001|Overall Study|Death|0|||
155566839|NCT02135614|561500488|FG000|Overall Study|Investigator's Discretion|0|||
155566840|NCT02135614|561500489|FG001|Overall Study|Investigator's Discretion|1|||
155566841|NCT02135614|561500488|FG000|Overall Study|Withdrew Consent|2|||
155566842|NCT02135614|561500489|FG001|Overall Study|Withdrew Consent|2|||
155566843|NCT02135614|561500488|FG000|Overall Study|Lost to Follow-up|3|||
155566844|NCT02135614|561500489|FG001|Overall Study|Lost to Follow-up|0|||
155566845|NCT01433549|561500490|FG000|Phase 2: Second Study Product|Adverse Event|0|||
155566846|NCT01433549|561500491|FG001|Phase 2: Second Study Product|Adverse Event|1|||
155566847|NCT02549027|561500494|FG000|Washout After Period 4|Withdrawal by Subject|0|||
155566848|NCT02549027|561500495|FG001|Washout After Period 4|Withdrawal by Subject|1|||
155566849|NCT02549027|561500496|FG002|Washout After Period 4|Withdrawal by Subject|1|||
155566850|NCT02549027|561500497|FG003|Washout After Period 4|Withdrawal by Subject|1|||
155566851|NCT02549027|561500498|FG004|Washout After Period 4|Withdrawal by Subject|0|||
155566852|NCT02549027|561500499|FG005|Washout After Period 4|Withdrawal by Subject|0|||
155566853|NCT02549027|561500494|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
155566854|NCT02549027|561500495|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
155566855|NCT02549027|561500496|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
155566856|NCT02549027|561500497|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
155566857|NCT02549027|561500498|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
155566858|NCT02549027|561500499|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
155566859|NCT02242045|561500502|FG000|Overall Study|Investigator's Discretion|1|||
155566860|NCT02242045|561500502|FG000|Overall Study|Progressive Disease|2|||
155659538|NCT05134649|561847955|FG000|Overall Study|Lost to Follow-up|12|||
155566861|NCT02242045|561500502|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
155566862|NCT02242045|561500502|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
155566863|NCT00749892|561500503|FG000|Overall Study|Withdrawal by Subject|3|||
155566864|NCT04581369|561500504|FG000|Overall Study|Death|7|||
155566865|NCT04581369|561500505|FG001|Overall Study|Death|6|||
155566866|NCT04581369|561500506|FG002|Overall Study|Death|0|||
155566867|NCT04581369|561500504|FG000|Overall Study|Lost to Follow-up|7|||
155566868|NCT04581369|561500505|FG001|Overall Study|Lost to Follow-up|3|||
155566869|NCT04581369|561500506|FG002|Overall Study|Lost to Follow-up|0|||
155566870|NCT04581369|561500504|FG000|Overall Study|liver transplant|2|||
155566871|NCT04581369|561500505|FG001|Overall Study|liver transplant|2|||
155566872|NCT04581369|561500506|FG002|Overall Study|liver transplant|0|||
155566873|NCT04581369|561500504|FG000|Overall Study|transitioned to hospice care|0|||
155566874|NCT04581369|561500505|FG001|Overall Study|transitioned to hospice care|5|||
155659539|NCT05134649|561847955|FG000|Overall Study|Withdrawal by Subject|14|||
155566875|NCT04581369|561500506|FG002|Overall Study|transitioned to hospice care|0|||
155566876|NCT00780910|561500507|FG000|Overall Study|Adverse Event|2|||
155566877|NCT00106964|561500509|FG000|Overall Study|Lost to Follow-up|8|||
155566878|NCT00106964|561500510|FG001|Overall Study|Lost to Follow-up|6|||
155566879|NCT00106964|561500511|FG002|Overall Study|Lost to Follow-up|2|||
155566880|NCT00106964|561500509|FG000|Overall Study|Pregnancy|2|||
155566881|NCT00106964|561500510|FG001|Overall Study|Pregnancy|3|||
155566882|NCT00106964|561500511|FG002|Overall Study|Pregnancy|2|||
155566883|NCT00106964|561500509|FG000|Overall Study|Death|1|||
155566884|NCT00106964|561500510|FG001|Overall Study|Death|1|||
155566885|NCT00106964|561500511|FG002|Overall Study|Death|0|||
155566886|NCT00106964|561500509|FG000|Overall Study|Incarceration|0|||
155566887|NCT00106964|561500510|FG001|Overall Study|Incarceration|1|||
155566888|NCT00106964|561500511|FG002|Overall Study|Incarceration|0|||
155566889|NCT00106964|561500509|FG000|Overall Study|Site Funding Terminated|0|||
155566890|NCT00106964|561500510|FG001|Overall Study|Site Funding Terminated|1|||
155566891|NCT00106964|561500511|FG002|Overall Study|Site Funding Terminated|1|||
155566892|NCT00106964|561500509|FG000|Overall Study|Failure to adhere|2|||
155566893|NCT00106964|561500510|FG001|Overall Study|Failure to adhere|0|||
155566894|NCT00106964|561500511|FG002|Overall Study|Failure to adhere|0|||
155566895|NCT00106964|561500509|FG000|Overall Study|Did not meet eligibility criteria|0|||
155566896|NCT00106964|561500510|FG001|Overall Study|Did not meet eligibility criteria|2|||
155566897|NCT00106964|561500511|FG002|Overall Study|Did not meet eligibility criteria|2|||
155566898|NCT00106964|561500509|FG000|Overall Study|Required disallowed medication|0|||
155566899|NCT00106964|561500510|FG001|Overall Study|Required disallowed medication|1|||
155566900|NCT00106964|561500511|FG002|Overall Study|Required disallowed medication|0|||
155566901|NCT03207243|561500512|FG000|Overall Study|Adverse Event|2|||
155566902|NCT03207243|561500513|FG001|Overall Study|Adverse Event|2|||
155566903|NCT03207243|561500512|FG000|Overall Study|Loss of Asthma Control|47|||
155566904|NCT03207243|561500513|FG001|Overall Study|Loss of Asthma Control|31|||
155566905|NCT03207243|561500512|FG000|Overall Study|Withdrawal by Subject|2|||
155566906|NCT03207243|561500513|FG001|Overall Study|Withdrawal by Subject|4|||
155566907|NCT03207243|561500512|FG000|Overall Study|Physician Decision|1|||
155566908|NCT03207243|561500513|FG001|Overall Study|Physician Decision|1|||
155566909|NCT03207243|561500512|FG000|Overall Study|Lost to Follow-up|0|||
155566910|NCT03207243|561500513|FG001|Overall Study|Lost to Follow-up|1|||
155566911|NCT03207243|561500512|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
155566912|NCT03207243|561500513|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
155566913|NCT03207243|561500512|FG000|Overall Study|Protocol Violation|0|||
155566914|NCT03207243|561500513|FG001|Overall Study|Protocol Violation|3|||
155566915|NCT00168818|561500518|FG000|Overall Study|Adverse Event|23|||
155566916|NCT00168818|561500519|FG001|Overall Study|Adverse Event|29|||
155566917|NCT00168818|561500520|FG002|Overall Study|Adverse Event|31|||
155566918|NCT00168818|561500518|FG000|Overall Study|Protocol Violation|16|||
155566919|NCT00168818|561500519|FG001|Overall Study|Protocol Violation|11|||
155566920|NCT00168818|561500520|FG002|Overall Study|Protocol Violation|11|||
155566921|NCT00168818|561500518|FG000|Overall Study|Lost to Follow-up|13|||
155566922|NCT00168818|561500519|FG001|Overall Study|Lost to Follow-up|4|||
155566923|NCT00168818|561500520|FG002|Overall Study|Lost to Follow-up|15|||
155566924|NCT00168818|561500518|FG000|Overall Study|Withdrawal by Subject|43|||
155566925|NCT00168818|561500519|FG001|Overall Study|Withdrawal by Subject|41|||
155566926|NCT00168818|561500520|FG002|Overall Study|Withdrawal by Subject|37|||
155566927|NCT00168818|561500518|FG000|Overall Study|Other|22|||
155566928|NCT00168818|561500519|FG001|Overall Study|Other|24|||
155566929|NCT00168818|561500520|FG002|Overall Study|Other|30|||
155566930|NCT00168818|561500518|FG000|Treatment|Adverse Event|77|||
155566931|NCT00168818|561500519|FG001|Treatment|Adverse Event|89|||
155566932|NCT00168818|561500520|FG002|Treatment|Adverse Event|68|||
155566933|NCT00168818|561500518|FG000|Treatment|Protocol Violation|8|||
155566934|NCT00168818|561500519|FG001|Treatment|Protocol Violation|11|||
155659540|NCT05134649|561847955|FG000|Overall Study|Pregnancy|1|||
155659541|NCT05134649|561847955|FG000|Overall Study|Other, not specified|3|||
155566935|NCT00168818|561500520|FG002|Treatment|Protocol Violation|11|||
155566936|NCT00168818|561500518|FG000|Treatment|Lost to Follow-up|0|||
155566937|NCT00168818|561500519|FG001|Treatment|Lost to Follow-up|2|||
155566938|NCT00168818|561500520|FG002|Treatment|Lost to Follow-up|1|||
155566939|NCT00168818|561500518|FG000|Treatment|Withdrawal by Subject|25|||
155566940|NCT00168818|561500519|FG001|Treatment|Withdrawal by Subject|20|||
155566941|NCT00168818|561500520|FG002|Treatment|Withdrawal by Subject|22|||
155566942|NCT00168818|561500518|FG000|Treatment|Other|23|||
155566943|NCT00168818|561500519|FG001|Treatment|Other|29|||
155566944|NCT00168818|561500520|FG002|Treatment|Other|31|||
155566945|NCT00603837|561500523|FG000|Overall Study|Physician Decision|3|||
155566946|NCT00603837|561500524|FG001|Overall Study|Physician Decision|0|||
155566947|NCT00856375|561500585|FG000|Overall Study|Other|0|||
155659542|NCT00928668|561847956|FG000|Overall Study|Adverse Event|1|||
155566948|NCT00856375|561500586|FG001|Overall Study|Other|1|||
155566949|NCT00856375|561500585|FG000|Overall Study|Death|32|||
155566950|NCT00856375|561500586|FG001|Overall Study|Death|30|||
155566951|NCT00856375|561500585|FG000|Overall Study|Sponsor Terminated Study|7|||
155659543|NCT00928668|561847957|FG001|Overall Study|Adverse Event|0|||
155659544|NCT00928668|561847958|FG002|Overall Study|Adverse Event|0|||
155659545|NCT00928668|561847959|FG003|Overall Study|Adverse Event|0|||
155659546|NCT00928668|561847960|FG004|Overall Study|Adverse Event|0|||
155659547|NCT00928668|561847956|FG000|Overall Study|Protocol Violation|0|||
155659548|NCT00928668|561847957|FG001|Overall Study|Protocol Violation|0|||
155659549|NCT00928668|561847958|FG002|Overall Study|Protocol Violation|0|||
155659550|NCT00928668|561847959|FG003|Overall Study|Protocol Violation|0|||
155659551|NCT00928668|561847960|FG004|Overall Study|Protocol Violation|1|||
155659552|NCT00928668|561847956|FG000|Overall Study|Withdrawal by Subject|0|||
155659553|NCT00928668|561847957|FG001|Overall Study|Withdrawal by Subject|1|||
155659554|NCT00928668|561847958|FG002|Overall Study|Withdrawal by Subject|1|||
155659555|NCT00928668|561847959|FG003|Overall Study|Withdrawal by Subject|0|||
155659556|NCT00928668|561847960|FG004|Overall Study|Withdrawal by Subject|0|||
155659557|NCT00928668|561847956|FG000|Overall Study|Other reasons not listed above|0|||
155659558|NCT00928668|561847957|FG001|Overall Study|Other reasons not listed above|0|||
155659559|NCT00928668|561847958|FG002|Overall Study|Other reasons not listed above|0|||
155659560|NCT00928668|561847959|FG003|Overall Study|Other reasons not listed above|1|||
155659561|NCT00928668|561847960|FG004|Overall Study|Other reasons not listed above|0|||
155659562|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
155659563|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
155659564|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
155659565|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
155659566|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155659567|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
155659568|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155566952|NCT00856375|561500586|FG001|Overall Study|Sponsor Terminated Study|7|||
155566953|NCT00856375|561500585|FG000|Overall Study|Withdrawal by Subject|2|||
155566954|NCT00856375|561500586|FG001|Overall Study|Withdrawal by Subject|1|||
155566955|NCT00856375|561500585|FG000|Overall Study|Lost to Follow-up|1|||
155566956|NCT00856375|561500586|FG001|Overall Study|Lost to Follow-up|2|||
155566957|NCT02538965|561500587|FG000|Treatment Period|Other = Death due to disease progression|1|||
155566958|NCT02538965|561500587|FG000|Treatment Period|Adverse Event|2|||
155566959|NCT02538965|561500587|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
155566960|NCT02538965|561500587|FG000|Treatment Period|Treatment Failure|9|||
155566961|NCT02538965|561500587|FG000|Treatment Period|Disease Progression|1|||
155566962|NCT02538965|561500587|FG000|Treatment Period|Physician Decision|2|||
155566963|NCT02538965|561500587|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
155659569|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155659570|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
155659571|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
155659572|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
155659573|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
155659574|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
155659575|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
155659576|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
155659577|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
155659578|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
155659579|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
155659580|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
155659581|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
155659582|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
155659583|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
155659584|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
155659585|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
155659586|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
155659587|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
155659588|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
155566964|NCT02538965|561500587|FG000|Follow-Up Period|Withdrawal by Parent|4|||
155566965|NCT00811928|561500589|FG000|Overall Study|AEs and SAEs Including Death|7|||
155566966|NCT00811928|561500590|FG001|Overall Study|AEs and SAEs Including Death|11|||
155566967|NCT00811928|561500589|FG000|Overall Study|Withdrawal by Subject|18|||
155566968|NCT00811928|561500590|FG001|Overall Study|Withdrawal by Subject|12|||
155566969|NCT00811928|561500589|FG000|Overall Study|Did Not Take Study Drug|3|||
155566970|NCT00811928|561500590|FG001|Overall Study|Did Not Take Study Drug|0|||
155659589|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
155659590|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
155659591|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
155659592|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
155566971|NCT00811928|561500589|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
155566972|NCT00811928|561500590|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
155566973|NCT00811928|561500589|FG000|Overall Study|Investigator Decision|2|||
155566974|NCT00811928|561500590|FG001|Overall Study|Investigator Decision|1|||
155566975|NCT00811928|561500589|FG000|Overall Study|Poor Compliance|2|||
155566976|NCT00811928|561500590|FG001|Overall Study|Poor Compliance|5|||
155566977|NCT04411914|561500591|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
155566978|NCT04411914|561500592|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
155566979|NCT00233402|561500594|FG000|Overall Study|No pathology data|12|||
155566980|NCT00233402|561500595|FG001|Overall Study|No pathology data|9|||
155566981|NCT00233402|561500594|FG000|Overall Study|No Ta/T1|89|||
155566982|NCT00233402|561500595|FG001|Overall Study|No Ta/T1|94|||
155566983|NCT00233402|561500594|FG000|Overall Study|Lost to follow up etc|3|||
155566984|NCT00233402|561500595|FG001|Overall Study|Lost to follow up etc|21|||
155566985|NCT03280381|561500596|FG000|Overall Study|Physician Decision|0|||
155566986|NCT03280381|561500597|FG001|Overall Study|Physician Decision|2|||
155566987|NCT03503864|561500598|FG000|Overall Study|Protocol Violation|6|||
155566988|NCT03503864|561500598|FG000|Overall Study|Withdrawal by Subject|7|||
155566989|NCT00423319|561500599|FG000|Overall Study|Death|2|||
155566990|NCT00423319|561500600|FG001|Overall Study|Death|0|||
155566991|NCT00423319|561500599|FG000|Overall Study|Adverse Event|93|||
155566992|NCT00423319|561500600|FG001|Overall Study|Adverse Event|112|||
155566993|NCT00423319|561500599|FG000|Overall Study|Withdrawal by Subject|86|||
155566994|NCT00423319|561500600|FG001|Overall Study|Withdrawal by Subject|99|||
155566995|NCT00423319|561500599|FG000|Overall Study|Lost to Follow-up|4|||
155566996|NCT00423319|561500600|FG001|Overall Study|Lost to Follow-up|3|||
155566997|NCT00423319|561500599|FG000|Overall Study|Poor compliance or noncompliance|1|||
155566998|NCT00423319|561500600|FG001|Overall Study|Poor compliance or noncompliance|1|||
155566999|NCT00423319|561500599|FG000|Overall Study|No longer meets study criteria|15|||
155567000|NCT00423319|561500600|FG001|Overall Study|No longer meets study criteria|15|||
155567001|NCT00423319|561500599|FG000|Overall Study|Other|23|||
155567002|NCT00423319|561500600|FG001|Overall Study|Other|22|||
155567003|NCT02639052|561500601|FG000|Overall Study|Lost to Follow-up|1|||
155567004|NCT00895414|561500602|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
155567005|NCT00895414|561500603|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
155567006|NCT00895414|561500602|FG000|First Intervention (14 Days)|Physician Decision|0|||
155567007|NCT00895414|561500603|FG001|First Intervention (14 Days)|Physician Decision|1|||
155567008|NCT00478426|561500604|FG000|Overall Study|Withdrawal by Subject|1|||
155567009|NCT01189487|561500605|FG000|Overall Study|Lack of Efficacy|2|||
155567010|NCT01189487|561500605|FG000|Overall Study|Adverse Event|1|||
155567011|NCT04630158|561500606|FG000|Overall Study|Adverse Event|1|||
155567012|NCT04630158|561500607|FG001|Overall Study|Adverse Event|1|||
155567013|NCT04630158|561500608|FG002|Overall Study|Adverse Event|1|||
155567014|NCT04630158|561500606|FG000|Overall Study|Physician Decision|0|||
155567015|NCT04630158|561500607|FG001|Overall Study|Physician Decision|2|||
155567016|NCT04630158|561500608|FG002|Overall Study|Physician Decision|0|||
155567017|NCT04630158|561500606|FG000|Overall Study|Protocol Violation|1|||
155567018|NCT04630158|561500607|FG001|Overall Study|Protocol Violation|0|||
155567019|NCT04630158|561500608|FG002|Overall Study|Protocol Violation|1|||
155567020|NCT04630158|561500606|FG000|Overall Study|Withdrawal by Subject|2|||
155567021|NCT04630158|561500607|FG001|Overall Study|Withdrawal by Subject|1|||
155567022|NCT04630158|561500608|FG002|Overall Study|Withdrawal by Subject|2|||
155567023|NCT02752087|561500613|FG000|Washout|Physician Decision|1|||
155567024|NCT02752087|561500614|FG001|Washout|Physician Decision|0|||
155567025|NCT02458287|561500615|FG000|Overall Study|Adverse Event|0|||
155567026|NCT02458287|561500616|FG001|Overall Study|Adverse Event|0|||
155567027|NCT02458287|561500617|FG002|Overall Study|Adverse Event|0|||
155567028|NCT02458287|561500618|FG003|Overall Study|Adverse Event|1|||
155567029|NCT02458287|561500615|FG000|Overall Study|Lost to Follow-up|0|||
155567030|NCT02458287|561500616|FG001|Overall Study|Lost to Follow-up|1|||
155567031|NCT02458287|561500617|FG002|Overall Study|Lost to Follow-up|1|||
155567032|NCT02458287|561500618|FG003|Overall Study|Lost to Follow-up|0|||
155567033|NCT02458287|561500615|FG000|Overall Study|Protocol Violation|0|||
155567034|NCT02458287|561500616|FG001|Overall Study|Protocol Violation|1|||
155567035|NCT02458287|561500617|FG002|Overall Study|Protocol Violation|0|||
155567036|NCT02458287|561500618|FG003|Overall Study|Protocol Violation|0|||
155567037|NCT02458287|561500615|FG000|Overall Study|Withdrawal by Subject|0|||
155567038|NCT02458287|561500616|FG001|Overall Study|Withdrawal by Subject|2|||
155567039|NCT02458287|561500617|FG002|Overall Study|Withdrawal by Subject|2|||
155567040|NCT02458287|561500618|FG003|Overall Study|Withdrawal by Subject|1|||
155567041|NCT02458287|561500615|FG000|Overall Study|Relocated Out of State|0|||
155567042|NCT02458287|561500616|FG001|Overall Study|Relocated Out of State|0|||
155567043|NCT02458287|561500617|FG002|Overall Study|Relocated Out of State|0|||
155567044|NCT02458287|561500618|FG003|Overall Study|Relocated Out of State|1|||
155567045|NCT00843635|561500619|FG000|Overall Study|Adverse Event|2|||
155567046|NCT00843635|561500620|FG001|Overall Study|Adverse Event|2|||
155567047|NCT00843635|561500621|FG002|Overall Study|Adverse Event|0|||
155567048|NCT02290223|561500622|FG000|6 Months|Lost to Follow-up|9|||
155567049|NCT02290223|561500623|FG001|6 Months|Lost to Follow-up|6|||
155567050|NCT02290223|561500622|FG000|6 Months|Withdrawal by Subject|5|||
155567051|NCT02290223|561500623|FG001|6 Months|Withdrawal by Subject|0|||
155567052|NCT02290223|561500622|FG000|6 Months|deceased (not related to study)|2|||
155567053|NCT02290223|561500623|FG001|6 Months|deceased (not related to study)|0|||
155567054|NCT02290223|561500622|FG000|12 Months|Lost to Follow-up|16|||
155567055|NCT02290223|561500623|FG001|12 Months|Lost to Follow-up|10|||
155567056|NCT02290223|561500622|FG000|12 Months|Refusal|0|||
155567057|NCT02290223|561500623|FG001|12 Months|Refusal|1|||
155567058|NCT05293639|561500624|FG000|Overall Study|Withdrawal by Subject|1|||
155567059|NCT05293639|561500625|FG001|Overall Study|Withdrawal by Subject|1|||
155567060|NCT05293639|561500626|FG002|Overall Study|Withdrawal by Subject|2|||
155567061|NCT05293639|561500624|FG000|Overall Study|Death|0|||
155567062|NCT05293639|561500625|FG001|Overall Study|Death|1|||
155567063|NCT05293639|561500626|FG002|Overall Study|Death|0|||
155567064|NCT05293639|561500624|FG000|Overall Study|Lost to Follow-up|0|||
155567065|NCT05293639|561500625|FG001|Overall Study|Lost to Follow-up|0|||
155567066|NCT05293639|561500626|FG002|Overall Study|Lost to Follow-up|5|||
155567067|NCT05293639|561500624|FG000|Overall Study|Other|0|||
155567068|NCT05293639|561500625|FG001|Overall Study|Other|0|||
155567069|NCT05293639|561500626|FG002|Overall Study|Other|1|||
155567070|NCT00090363|561500631|FG000|Overall Study|Lost to Follow-up|1|||
155567071|NCT00090363|561500632|FG001|Overall Study|Lost to Follow-up|2|||
155567072|NCT00090363|561500633|FG002|Overall Study|Lost to Follow-up|1|||
155567073|NCT00090363|561500631|FG000|Overall Study|Withdrawal by Subject|7|||
155567074|NCT00090363|561500632|FG001|Overall Study|Withdrawal by Subject|7|||
155567075|NCT00090363|561500633|FG002|Overall Study|Withdrawal by Subject|6|||
155567076|NCT00090363|561500631|FG000|Overall Study|Study-specific discontinuation criteria|75|||
155567077|NCT00090363|561500632|FG001|Overall Study|Study-specific discontinuation criteria|74|||
155567078|NCT00090363|561500633|FG002|Overall Study|Study-specific discontinuation criteria|62|||
155567079|NCT00090363|561500631|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155567080|NCT00090363|561500632|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155567081|NCT00090363|561500633|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155567082|NCT00090363|561500631|FG000|Overall Study|Consent expired|7|||
155567083|NCT00090363|561500632|FG001|Overall Study|Consent expired|10|||
155567084|NCT00090363|561500633|FG002|Overall Study|Consent expired|9|||
155567085|NCT00090363|561500631|FG000|Overall Study|Reasons not specified|2|||
155567086|NCT00090363|561500632|FG001|Overall Study|Reasons not specified|1|||
155567087|NCT00090363|561500633|FG002|Overall Study|Reasons not specified|1|||
155567088|NCT00090363|561500631|FG000|Overall Study|Continuing on study off treatment|14|||
155567089|NCT00090363|561500632|FG001|Overall Study|Continuing on study off treatment|13|||
155567090|NCT00090363|561500633|FG002|Overall Study|Continuing on study off treatment|16|||
155567091|NCT05038800|561500636|FG000|Overall Study|Death|1|||
155567092|NCT05038800|561500637|FG001|Overall Study|Death|1|||
155567093|NCT05038800|561500638|FG002|Overall Study|Death|5|||
155567094|NCT05038800|561500639|FG003|Overall Study|Death|3|||
155567095|NCT05038800|561500640|FG004|Overall Study|Death|1|||
155567096|NCT05038800|561500636|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155567097|NCT05038800|561500637|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155567098|NCT05038800|561500638|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155567099|NCT05038800|561500639|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155567100|NCT05038800|561500640|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155567101|NCT05038800|561500636|FG000|Overall Study|Lack of Efficacy|0|||
155567102|NCT05038800|561500637|FG001|Overall Study|Lack of Efficacy|0|||
155567103|NCT05038800|561500638|FG002|Overall Study|Lack of Efficacy|0|||
155567104|NCT05038800|561500639|FG003|Overall Study|Lack of Efficacy|0|||
155567105|NCT05038800|561500640|FG004|Overall Study|Lack of Efficacy|1|||
155567106|NCT00121134|561500641|FG000|Overall Study|Progression of Disease|5|||
155567107|NCT00121134|561500642|FG001|Overall Study|Progression of Disease|3|||
155567108|NCT00121134|561500643|FG002|Overall Study|Progression of Disease|4|||
155567109|NCT00121134|561500644|FG003|Overall Study|Progression of Disease|2|||
155567110|NCT00121134|561500641|FG000|Overall Study|Toxicity|4|||
155567111|NCT00121134|561500642|FG001|Overall Study|Toxicity|7|||
155567112|NCT00121134|561500643|FG002|Overall Study|Toxicity|13|||
155567113|NCT00121134|561500644|FG003|Overall Study|Toxicity|5|||
155567114|NCT00121134|561500641|FG000|Overall Study|Physician Decision|6|||
155567115|NCT00121134|561500642|FG001|Overall Study|Physician Decision|4|||
155567116|NCT00121134|561500643|FG002|Overall Study|Physician Decision|4|||
155567117|NCT00121134|561500644|FG003|Overall Study|Physician Decision|1|||
155567118|NCT00121134|561500641|FG000|Overall Study|Treatment Delay|1|||
155567119|NCT00121134|561500642|FG001|Overall Study|Treatment Delay|0|||
155567120|NCT00121134|561500643|FG002|Overall Study|Treatment Delay|0|||
155567121|NCT00121134|561500644|FG003|Overall Study|Treatment Delay|0|||
155567122|NCT00121134|561500641|FG000|Overall Study|Intercurrent Illness|0|||
155567123|NCT00121134|561500642|FG001|Overall Study|Intercurrent Illness|0|||
155567124|NCT00121134|561500643|FG002|Overall Study|Intercurrent Illness|0|||
155567125|NCT00121134|561500644|FG003|Overall Study|Intercurrent Illness|1|||
155567126|NCT00121134|561500641|FG000|Overall Study|Patient Personal Reasons|0|||
155659593|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
155659594|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
155659595|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
155659596|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
155659597|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
155659598|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
155659599|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
155659600|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
155659601|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
155659602|NCT04392154|561847961|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155659603|NCT04392154|561847962|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
155659604|NCT04392154|561847963|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155659605|NCT04392154|561847964|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155659606|NCT04392154|561847961|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155659607|NCT04392154|561847962|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155659608|NCT04392154|561847963|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155659609|NCT04392154|561847964|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
155659610|NCT04392154|561847961|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155659611|NCT04392154|561847962|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155659612|NCT04392154|561847963|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
155659613|NCT04392154|561847964|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155659614|NCT04392154|561847961|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155659615|NCT04392154|561847962|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155659616|NCT04392154|561847963|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155659617|NCT04392154|561847964|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
155659618|NCT03620981|561847981|FG000|Overall Study|Adverse Event|14|||
155659619|NCT03620981|561847982|FG001|Overall Study|Adverse Event|38|||
155659620|NCT03620981|561847983|FG002|Overall Study|Adverse Event|25|||
155659621|NCT03620981|561847981|FG000|Overall Study|Lack of Efficacy|2|||
155659622|NCT03620981|561847982|FG001|Overall Study|Lack of Efficacy|1|||
155659623|NCT03620981|561847983|FG002|Overall Study|Lack of Efficacy|1|||
155659624|NCT03620981|561847981|FG000|Overall Study|Physician Decision|7|||
155659625|NCT03620981|561847982|FG001|Overall Study|Physician Decision|4|||
155659626|NCT03620981|561847983|FG002|Overall Study|Physician Decision|4|||
155659627|NCT03620981|561847981|FG000|Overall Study|Protocol Violation|1|||
155659628|NCT03620981|561847982|FG001|Overall Study|Protocol Violation|2|||
155659629|NCT03620981|561847983|FG002|Overall Study|Protocol Violation|1|||
155659630|NCT03620981|561847981|FG000|Overall Study|Withdrawal by Legal Representative|2|||
155659631|NCT03620981|561847982|FG001|Overall Study|Withdrawal by Legal Representative|1|||
155659632|NCT03620981|561847983|FG002|Overall Study|Withdrawal by Legal Representative|1|||
155659633|NCT03620981|561847981|FG000|Overall Study|Withdrawal by Care Giver|2|||
155659634|NCT03620981|561847982|FG001|Overall Study|Withdrawal by Care Giver|0|||
155659635|NCT03620981|561847983|FG002|Overall Study|Withdrawal by Care Giver|1|||
155659636|NCT03620981|561847981|FG000|Overall Study|Non-compliance with Study Drug|1|||
155659637|NCT03620981|561847982|FG001|Overall Study|Non-compliance with Study Drug|1|||
155659638|NCT03620981|561847983|FG002|Overall Study|Non-compliance with Study Drug|0|||
155659639|NCT04251533|561847990|FG000|Overall Study|Progressive disease|33|||
155659640|NCT04251533|561847991|FG001|Overall Study|Progressive disease|29|||
155659641|NCT04251533|561847992|FG002|Overall Study|Progressive disease|22|||
155567127|NCT00121134|561500642|FG001|Overall Study|Patient Personal Reasons|1|||
155567128|NCT00121134|561500643|FG002|Overall Study|Patient Personal Reasons|0|||
155567129|NCT00121134|561500644|FG003|Overall Study|Patient Personal Reasons|0|||
155567130|NCT00857584|561500650|FG000|Overall Study|Lack of Efficacy|1|||
155567131|NCT00857584|561500651|FG001|Overall Study|Lack of Efficacy|2|||
155567132|NCT00857584|561500650|FG000|Overall Study|Adverse Event|2|||
155567133|NCT00857584|561500651|FG001|Overall Study|Adverse Event|2|||
155567134|NCT00857584|561500650|FG000|Overall Study|Physician Decision|1|||
155567135|NCT00857584|561500651|FG001|Overall Study|Physician Decision|1|||
155567136|NCT02533375|561500652|FG000|Overall Study|Lack of Efficacy|3|||
155567137|NCT02533375|561500652|FG000|Overall Study|Adverse Event|2|||
155567138|NCT00673387|561500653|FG000|Overall Study|Withdrawal by Subject|15|||
155567139|NCT00673387|561500654|FG001|Overall Study|Withdrawal by Subject|16|||
155567140|NCT00673387|561500655|FG002|Overall Study|Withdrawal by Subject|20|||
155567141|NCT00673387|561500656|FG003|Overall Study|Withdrawal by Subject|16|||
155567142|NCT00673387|561500657|FG004|Overall Study|Withdrawal by Subject|18|||
155567143|NCT00673387|561500658|FG005|Overall Study|Withdrawal by Subject|21|||
155567144|NCT00673387|561500659|FG006|Overall Study|Withdrawal by Subject|15|||
155567145|NCT00673387|561500660|FG007|Overall Study|Withdrawal by Subject|21|||
155567146|NCT00673387|561500653|FG000|Overall Study|Adverse Event|3|||
155567147|NCT00673387|561500654|FG001|Overall Study|Adverse Event|1|||
155567148|NCT00673387|561500655|FG002|Overall Study|Adverse Event|5|||
155567149|NCT00673387|561500656|FG003|Overall Study|Adverse Event|2|||
155567150|NCT00673387|561500657|FG004|Overall Study|Adverse Event|6|||
155567151|NCT00673387|561500658|FG005|Overall Study|Adverse Event|2|||
155567152|NCT00673387|561500659|FG006|Overall Study|Adverse Event|5|||
155567153|NCT00673387|561500660|FG007|Overall Study|Adverse Event|5|||
155567154|NCT00673387|561500653|FG000|Overall Study|Physician Decision|0|||
155567155|NCT00673387|561500654|FG001|Overall Study|Physician Decision|0|||
155567156|NCT00673387|561500655|FG002|Overall Study|Physician Decision|0|||
155567157|NCT00673387|561500656|FG003|Overall Study|Physician Decision|0|||
155567158|NCT00673387|561500657|FG004|Overall Study|Physician Decision|0|||
155567159|NCT00673387|561500658|FG005|Overall Study|Physician Decision|5|||
155567160|NCT00673387|561500659|FG006|Overall Study|Physician Decision|1|||
155567161|NCT00673387|561500660|FG007|Overall Study|Physician Decision|1|||
155567162|NCT00673387|561500653|FG000|Overall Study|Protocol Violation|3|||
155567163|NCT00673387|561500654|FG001|Overall Study|Protocol Violation|0|||
155567164|NCT00673387|561500655|FG002|Overall Study|Protocol Violation|1|||
155567165|NCT00673387|561500656|FG003|Overall Study|Protocol Violation|2|||
155567166|NCT00673387|561500657|FG004|Overall Study|Protocol Violation|0|||
155659642|NCT04251533|561847990|FG000|Overall Study|Death|5|||
155659643|NCT04251533|561847991|FG001|Overall Study|Death|1|||
155659644|NCT04251533|561847992|FG002|Overall Study|Death|3|||
155659645|NCT04251533|561847990|FG000|Overall Study|Physician Decision|3|||
155659646|NCT04251533|561847991|FG001|Overall Study|Physician Decision|2|||
155659647|NCT04251533|561847992|FG002|Overall Study|Physician Decision|4|||
155659648|NCT04251533|561847990|FG000|Overall Study|Participant decision|1|||
155659649|NCT04251533|561847991|FG001|Overall Study|Participant decision|3|||
155659650|NCT04251533|561847992|FG002|Overall Study|Participant decision|1|||
155659651|NCT04251533|561847990|FG000|Overall Study|Adverse Event|2|||
155659652|NCT04251533|561847991|FG001|Overall Study|Adverse Event|1|||
155659653|NCT04251533|561847992|FG002|Overall Study|Adverse Event|1|||
155567167|NCT00673387|561500658|FG005|Overall Study|Protocol Violation|1|||
155567168|NCT00673387|561500659|FG006|Overall Study|Protocol Violation|1|||
155567169|NCT00673387|561500660|FG007|Overall Study|Protocol Violation|3|||
155659654|NCT02303821|561847995|FG000|Overall Study|Withdrawal by Subject|0|||
155659655|NCT02303821|561847996|FG001|Overall Study|Withdrawal by Subject|0|||
155659656|NCT02303821|561847997|FG002|Overall Study|Withdrawal by Subject|0|||
155659657|NCT02303821|561847998|FG003|Overall Study|Withdrawal by Subject|0|||
155659658|NCT02303821|561847999|FG004|Overall Study|Withdrawal by Subject|0|||
155659659|NCT02303821|561848000|FG005|Overall Study|Withdrawal by Subject|0|||
155659660|NCT02303821|561848001|FG006|Overall Study|Withdrawal by Subject|0|||
155659661|NCT02303821|561848002|FG007|Overall Study|Withdrawal by Subject|2|||
155659662|NCT02303821|561847995|FG000|Overall Study|Death|0|||
155659663|NCT02303821|561847996|FG001|Overall Study|Death|2|||
155659664|NCT02303821|561847997|FG002|Overall Study|Death|0|||
155659665|NCT02303821|561847998|FG003|Overall Study|Death|0|||
155659666|NCT02303821|561847999|FG004|Overall Study|Death|0|||
155659667|NCT02303821|561848000|FG005|Overall Study|Death|3|||
155659668|NCT02303821|561848001|FG006|Overall Study|Death|41|||
155659669|NCT02303821|561848002|FG007|Overall Study|Death|29|||
155659670|NCT02303821|561847995|FG000|Overall Study|Lost to Follow-up|0|||
155659671|NCT02303821|561847996|FG001|Overall Study|Lost to Follow-up|0|||
155659672|NCT02303821|561847997|FG002|Overall Study|Lost to Follow-up|0|||
155659673|NCT02303821|561847998|FG003|Overall Study|Lost to Follow-up|0|||
155659674|NCT02303821|561847999|FG004|Overall Study|Lost to Follow-up|0|||
155659675|NCT02303821|561848000|FG005|Overall Study|Lost to Follow-up|0|||
155659676|NCT02303821|561848001|FG006|Overall Study|Lost to Follow-up|1|||
155659677|NCT02303821|561848002|FG007|Overall Study|Lost to Follow-up|0|||
155659678|NCT02303821|561847995|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659679|NCT02303821|561847996|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659680|NCT02303821|561847997|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659681|NCT02303821|561847998|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659682|NCT02303821|561847999|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659683|NCT02303821|561848000|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659684|NCT02303821|561848001|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
155659685|NCT02303821|561848002|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155659686|NCT02303821|561847995|FG000|Overall Study|Decision by sponsor|0|||
155659687|NCT02303821|561847996|FG001|Overall Study|Decision by sponsor|0|||
155659688|NCT02303821|561847997|FG002|Overall Study|Decision by sponsor|0|||
155659689|NCT02303821|561847998|FG003|Overall Study|Decision by sponsor|0|||
155659690|NCT02303821|561847999|FG004|Overall Study|Decision by sponsor|0|||
155659691|NCT02303821|561848000|FG005|Overall Study|Decision by sponsor|1|||
155659692|NCT02303821|561848001|FG006|Overall Study|Decision by sponsor|0|||
155659693|NCT02303821|561848002|FG007|Overall Study|Decision by sponsor|0|||
155659694|NCT02303821|561847995|FG000|Overall Study|Protocol-specified criteria|0|||
155659695|NCT02303821|561847996|FG001|Overall Study|Protocol-specified criteria|1|||
155659696|NCT02303821|561847997|FG002|Overall Study|Protocol-specified criteria|0|||
155659697|NCT02303821|561847998|FG003|Overall Study|Protocol-specified criteria|0|||
155659698|NCT02303821|561847999|FG004|Overall Study|Protocol-specified criteria|0|||
155659699|NCT02303821|561848000|FG005|Overall Study|Protocol-specified criteria|1|||
155659700|NCT02303821|561848001|FG006|Overall Study|Protocol-specified criteria|0|||
155659701|NCT02303821|561848002|FG007|Overall Study|Protocol-specified criteria|0|||
155659702|NCT04116489|561848006|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
155659703|NCT04116489|561848006|FG000|Overall Study|Withdrawal by Subject|1|||
155659704|NCT03138564|561848007|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
155659705|NCT03138564|561848008|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
155659706|NCT03138564|561848007|FG000|Overall Study|Lost to Follow-up|16|||
155659707|NCT03138564|561848008|FG001|Overall Study|Lost to Follow-up|2|||
155659708|NCT03138564|561848007|FG000|Overall Study|Withdrawal by Subject|48|||
155659709|NCT03138564|561848008|FG001|Overall Study|Withdrawal by Subject|4|||
155659710|NCT03138564|561848007|FG000|Overall Study|No longer met eligibility criteria|2|||
155659711|NCT03138564|561848008|FG001|Overall Study|No longer met eligibility criteria|0|||
155659712|NCT03138564|561848007|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
155659713|NCT03138564|561848008|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
155659714|NCT03138564|561848007|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
155659715|NCT03138564|561848008|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
155659716|NCT03138564|561848007|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
155659717|NCT03138564|561848008|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
155659718|NCT03138564|561848007|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
155659719|NCT03138564|561848008|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
155659720|NCT05177354|561848010|FG000|Implant to 30-day Visit|Physician Decision|1|||
155659721|NCT05177354|561848010|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
155659722|NCT05177354|561848010|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
155659723|NCT05177354|561848010|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
155659724|NCT06028464|561848011|FG000|Washout|Positive drug test.|1|||
155659725|NCT03330847|561848014|FG000|Overall Study|Patients ongoing study|62|||
155567170|NCT00673387|561500653|FG000|Overall Study|Lost to Follow-up|8|||
155567171|NCT00673387|561500654|FG001|Overall Study|Lost to Follow-up|6|||
155567172|NCT00673387|561500655|FG002|Overall Study|Lost to Follow-up|5|||
155567173|NCT00673387|561500656|FG003|Overall Study|Lost to Follow-up|6|||
155567174|NCT00673387|561500657|FG004|Overall Study|Lost to Follow-up|6|||
155567175|NCT00673387|561500658|FG005|Overall Study|Lost to Follow-up|5|||
155567176|NCT00673387|561500659|FG006|Overall Study|Lost to Follow-up|8|||
155567177|NCT00673387|561500660|FG007|Overall Study|Lost to Follow-up|5|||
155567178|NCT01102374|561500661|FG000|Overall Study|Death|9|||
155567179|NCT01102374|561500662|FG001|Overall Study|Death|13|||
155567180|NCT01102374|561500661|FG000|Overall Study|Lost to Follow-up|7|||
155567181|NCT01102374|561500662|FG001|Overall Study|Lost to Follow-up|6|||
155567182|NCT02952898|561500667|FG000|Overall Study|Withdrawal by Subject|10|||
155567183|NCT02952898|561500668|FG001|Overall Study|Withdrawal by Subject|8|||
155567184|NCT02952898|561500669|FG002|Overall Study|Withdrawal by Subject|8|||
155567185|NCT02952898|561500667|FG000|Overall Study|Adverse Event|8|||
155567186|NCT02952898|561500668|FG001|Overall Study|Adverse Event|8|||
155567187|NCT02952898|561500669|FG002|Overall Study|Adverse Event|3|||
155567188|NCT02952898|561500667|FG000|Overall Study|Lost to Follow-up|3|||
155567189|NCT02952898|561500668|FG001|Overall Study|Lost to Follow-up|2|||
155567190|NCT02952898|561500669|FG002|Overall Study|Lost to Follow-up|2|||
155567191|NCT02952898|561500667|FG000|Overall Study|Non-compliance with study drug|1|||
155567192|NCT02952898|561500668|FG001|Overall Study|Non-compliance with study drug|1|||
155567193|NCT02952898|561500669|FG002|Overall Study|Non-compliance with study drug|2|||
155567194|NCT02802631|561500670|FG000|Overall Study|Withdrawal by Subject|1|||
155567195|NCT02802631|561500671|FG001|Overall Study|Withdrawal by Subject|0|||
155567196|NCT02802631|561500672|FG002|Overall Study|Withdrawal by Subject|0|||
155567197|NCT02802631|561500673|FG003|Overall Study|Withdrawal by Subject|0|||
155567198|NCT02802631|561500674|FG004|Overall Study|Withdrawal by Subject|0|||
155567199|NCT02802631|561500675|FG005|Overall Study|Withdrawal by Subject|0|||
155567200|NCT02802631|561500676|FG006|Overall Study|Withdrawal by Subject|0|||
155567201|NCT02802631|561500677|FG007|Overall Study|Withdrawal by Subject|0|||
155567202|NCT02802631|561500670|FG000|Overall Study|Physician Decision|1|||
155567203|NCT02802631|561500671|FG001|Overall Study|Physician Decision|0|||
155567204|NCT02802631|561500672|FG002|Overall Study|Physician Decision|0|||
155567205|NCT02802631|561500673|FG003|Overall Study|Physician Decision|0|||
155567206|NCT02802631|561500674|FG004|Overall Study|Physician Decision|0|||
155567207|NCT02802631|561500675|FG005|Overall Study|Physician Decision|0|||
155567208|NCT02802631|561500676|FG006|Overall Study|Physician Decision|1|||
155567209|NCT02802631|561500677|FG007|Overall Study|Physician Decision|0|||
155567210|NCT02802631|561500670|FG000|Overall Study|Adverse Event|0|||
155567211|NCT02802631|561500671|FG001|Overall Study|Adverse Event|2|||
155567212|NCT02802631|561500672|FG002|Overall Study|Adverse Event|0|||
155567213|NCT02802631|561500673|FG003|Overall Study|Adverse Event|1|||
155567214|NCT02802631|561500674|FG004|Overall Study|Adverse Event|6|||
155567215|NCT02802631|561500675|FG005|Overall Study|Adverse Event|1|||
155567216|NCT02802631|561500676|FG006|Overall Study|Adverse Event|4|||
155567217|NCT02802631|561500677|FG007|Overall Study|Adverse Event|0|||
155567218|NCT02802631|561500670|FG000|Overall Study|Sponsor Decision|0|||
155567219|NCT02802631|561500671|FG001|Overall Study|Sponsor Decision|0|||
155567220|NCT02802631|561500672|FG002|Overall Study|Sponsor Decision|6|||
155567221|NCT02802631|561500673|FG003|Overall Study|Sponsor Decision|0|||
155567222|NCT02802631|561500674|FG004|Overall Study|Sponsor Decision|2|||
155567223|NCT02802631|561500675|FG005|Overall Study|Sponsor Decision|0|||
155567224|NCT02802631|561500676|FG006|Overall Study|Sponsor Decision|0|||
155567225|NCT02802631|561500677|FG007|Overall Study|Sponsor Decision|4|||
155567226|NCT02212379|561500678|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
155567227|NCT02212379|561500678|FG000|From Baseline to Week 48|Adverse Event|7|||
155567228|NCT02212379|561500678|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
155567229|NCT02212379|561500678|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
155567230|NCT02212379|561500678|FG000|From Week 48 to Week 96|Adverse Event|1|||
155567231|NCT02212379|561500678|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
155567232|NCT02105974|561500679|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
155567233|NCT02105974|561500680|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
155567234|NCT02105974|561500681|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
155567235|NCT02105974|561500679|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
155567236|NCT02105974|561500680|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
155567237|NCT02105974|561500681|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
155567238|NCT02105974|561500679|FG000|2 Week Run-in Period|Adverse Event|6|||
155567239|NCT02105974|561500680|FG001|2 Week Run-in Period|Adverse Event|0|||
155567240|NCT02105974|561500681|FG002|2 Week Run-in Period|Adverse Event|0|||
155567241|NCT02105974|561500679|FG000|2 Week Run-in Period|Study closed/terminated|1|||
155567242|NCT02105974|561500680|FG001|2 Week Run-in Period|Study closed/terminated|0|||
155567243|NCT02105974|561500681|FG002|2 Week Run-in Period|Study closed/terminated|0|||
155567244|NCT02105974|561500679|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
155567245|NCT02105974|561500680|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
155567246|NCT02105974|561500681|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
155659726|NCT03330847|561848015|FG001|Overall Study|Patients ongoing study|65|||
155659727|NCT03330847|561848016|FG002|Overall Study|Patients ongoing study|15|||
155659728|NCT02769481|561848019|FG000|Overall Study|Protocol Violation|1|||
155659729|NCT02769481|561848020|FG001|Overall Study|Protocol Violation|0|||
155659730|NCT02769481|561848019|FG000|Overall Study|Adverse Event|3|||
155659731|NCT02769481|561848020|FG001|Overall Study|Adverse Event|6|||
155659732|NCT02769481|561848019|FG000|Overall Study|Entry Criteria Not Met|1|||
155659733|NCT02769481|561848020|FG001|Overall Study|Entry Criteria Not Met|2|||
155659734|NCT02769481|561848019|FG000|Overall Study|Withdrawal by Subject|14|||
155659735|NCT02769481|561848020|FG001|Overall Study|Withdrawal by Subject|16|||
155659736|NCT02769481|561848019|FG000|Overall Study|Lost to Follow-up|9|||
155567247|NCT02105974|561500679|FG000|2 Week Run-in Period|Withdrew consent|23|||
155567248|NCT02105974|561500680|FG001|2 Week Run-in Period|Withdrew consent|0|||
155567249|NCT02105974|561500681|FG002|2 Week Run-in Period|Withdrew consent|0|||
155567250|NCT02105974|561500679|FG000|2 Week Run-in Period|Investigator discretion|8|||
155567251|NCT02105974|561500680|FG001|2 Week Run-in Period|Investigator discretion|0|||
155567252|NCT02105974|561500681|FG002|2 Week Run-in Period|Investigator discretion|0|||
155567253|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
155567254|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
155567255|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
155567256|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
155567257|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
155567258|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
155567259|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
155567260|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
155567261|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
155567262|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
155567263|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
155567264|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
155567265|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
155567266|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
155567267|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
155567268|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
155567269|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
155567270|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
155567271|NCT02105974|561500679|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
155567272|NCT02105974|561500680|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
155567273|NCT02105974|561500681|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
155567274|NCT02968849|561500682|FG000|Overall Study|Death|8|||
155567275|NCT02968849|561500683|FG001|Overall Study|Death|10|||
155567276|NCT02968849|561500682|FG000|Overall Study|Lost to Follow-up|31|||
155567277|NCT02968849|561500683|FG001|Overall Study|Lost to Follow-up|29|||
155567278|NCT02968849|561500682|FG000|Overall Study|Withdrawal by Subject|73|||
155567279|NCT02968849|561500683|FG001|Overall Study|Withdrawal by Subject|64|||
155567280|NCT02968849|561500682|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
155567281|NCT02968849|561500683|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
155567282|NCT02968849|561500682|FG000|Overall Study|Physician Decision|6|||
155567283|NCT02968849|561500683|FG001|Overall Study|Physician Decision|9|||
155567284|NCT02968849|561500682|FG000|Overall Study|Other|16|||
155567285|NCT02968849|561500683|FG001|Overall Study|Other|10|||
155567286|NCT00704730|561500686|FG000|Overall Study|Adverse Event|35|||
155567287|NCT00704730|561500687|FG001|Overall Study|Adverse Event|9|||
155567288|NCT00704730|561500686|FG000|Overall Study|Death|11|||
155567289|NCT00704730|561500687|FG001|Overall Study|Death|5|||
155567290|NCT00704730|561500686|FG000|Overall Study|Physician Decision|2|||
155659737|NCT02769481|561848020|FG001|Overall Study|Lost to Follow-up|9|||
155659738|NCT02769481|561848019|FG000|Overall Study|Physician Decision|0|||
155659739|NCT02769481|561848020|FG001|Overall Study|Physician Decision|1|||
155659740|NCT02769481|561848019|FG000|Overall Study|Terminated by Sponsor|1|||
155659741|NCT02769481|561848020|FG001|Overall Study|Terminated by Sponsor|0|||
155659742|NCT02769481|561848019|FG000|Overall Study|Death|0|||
155659743|NCT02769481|561848020|FG001|Overall Study|Death|1|||
155659744|NCT02769481|561848019|FG000|Overall Study|Undefined|4|||
155567291|NCT00704730|561500687|FG001|Overall Study|Physician Decision|0|||
155567292|NCT00704730|561500686|FG000|Overall Study|Did not receive drug|5|||
155567293|NCT00704730|561500687|FG001|Overall Study|Did not receive drug|2|||
155567294|NCT00704730|561500686|FG000|Overall Study|Disease progression per PI|58|||
155567295|NCT00704730|561500687|FG001|Overall Study|Disease progression per PI|67|||
155567296|NCT00704730|561500686|FG000|Overall Study|data unavailable|1|||
155567297|NCT00704730|561500687|FG001|Overall Study|data unavailable|0|||
155659745|NCT02769481|561848020|FG001|Overall Study|Undefined|1|||
155659746|NCT00643279|561848021|FG000|Overall Study|Death|13|||
155659747|NCT00643279|561848022|FG001|Overall Study|Death|11|||
155659748|NCT00643279|561848021|FG000|Overall Study|Withdrawal by Subject|3|||
155567298|NCT00704730|561500686|FG000|Overall Study|Withdrawal by Subject|9|||
155567299|NCT00704730|561500687|FG001|Overall Study|Withdrawal by Subject|13|||
155567300|NCT00402116|561502775|FG000|Overall Study|Jaw infection after surgery-other|1|||
155567301|NCT00402116|561502776|FG001|Overall Study|Jaw infection after surgery-other|0|||
155567302|NCT00402116|561502777|FG002|Overall Study|Jaw infection after surgery-other|0|||
155567303|NCT00402116|561502775|FG000|Overall Study|Withdrawal by Subject|1|||
155567304|NCT00402116|561502776|FG001|Overall Study|Withdrawal by Subject|0|||
155567305|NCT00402116|561502777|FG002|Overall Study|Withdrawal by Subject|5|||
155567306|NCT00402116|561502775|FG000|Overall Study|Treatment completed per protocol|1|||
155567307|NCT00402116|561502776|FG001|Overall Study|Treatment completed per protocol|1|||
155567308|NCT00402116|561502777|FG002|Overall Study|Treatment completed per protocol|2|||
155567309|NCT00402116|561502775|FG000|Overall Study|other complicating disease|0|||
155567310|NCT00402116|561502776|FG001|Overall Study|other complicating disease|0|||
155567311|NCT00402116|561502777|FG002|Overall Study|other complicating disease|2|||
155567312|NCT00402116|561502775|FG000|Overall Study|Disease Progression|0|||
155567313|NCT00402116|561502776|FG001|Overall Study|Disease Progression|4|||
155567314|NCT00402116|561502777|FG002|Overall Study|Disease Progression|38|||
155567315|NCT00402116|561502775|FG000|Overall Study|mistaken thrombocytopenia|0|||
155567316|NCT00402116|561502776|FG001|Overall Study|mistaken thrombocytopenia|0|||
155567317|NCT00402116|561502777|FG002|Overall Study|mistaken thrombocytopenia|1|||
155567318|NCT00402116|561502775|FG000|Overall Study|decline related hyponatremia/tumor|0|||
155567319|NCT00402116|561502776|FG001|Overall Study|decline related hyponatremia/tumor|0|||
155567320|NCT00402116|561502777|FG002|Overall Study|decline related hyponatremia/tumor|1|||
155567321|NCT00402116|561502775|FG000|Overall Study|Adverse Event|0|||
155567322|NCT00402116|561502776|FG001|Overall Study|Adverse Event|1|||
155567323|NCT00402116|561502777|FG002|Overall Study|Adverse Event|6|||
155567324|NCT02899195|561502778|FG000|Concurrent Durvalumab|Adverse Event|4|||
155567325|NCT02899195|561502778|FG000|Concurrent Durvalumab|Physician Decision|1|||
155567326|NCT02899195|561502778|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
155567327|NCT02899195|561502778|FG000|Concurrent Durvalumab|Progressive Disease|5|||
155567328|NCT02899195|561502778|FG000|Maintenance Durvalumab|Adverse Event|1|||
155567329|NCT02899195|561502778|FG000|Maintenance Durvalumab|Physician Decision|1|||
155567330|NCT02899195|561502778|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
155567331|NCT02899195|561502778|FG000|Maintenance Durvalumab|Progressive Disease|31|||
155567332|NCT04778904|561502780|FG000|Overall Study|Protocol Violation|1|||
155567333|NCT04778904|561502781|FG001|Overall Study|Protocol Violation|0|||
155567334|NCT04778904|561502782|FG002|Overall Study|Protocol Violation|0|||
155567335|NCT04778904|561502783|FG003|Overall Study|Protocol Violation|0|||
155567336|NCT04778904|561502780|FG000|Overall Study|Withdrawal by Subject|0|||
155567337|NCT04778904|561502781|FG001|Overall Study|Withdrawal by Subject|0|||
155567338|NCT04778904|561502782|FG002|Overall Study|Withdrawal by Subject|1|||
155567339|NCT04778904|561502783|FG003|Overall Study|Withdrawal by Subject|0|||
155567340|NCT03156504|561502784|FG000|Overall Study|Withdrawal by Subject|1|||
155567341|NCT03452137|561502785|FG000|Overall Study|Death|67|||
155567342|NCT03452137|561502786|FG001|Overall Study|Death|70|||
155567343|NCT03452137|561502785|FG000|Overall Study|Lost to Follow-up|4|||
155567344|NCT03452137|561502786|FG001|Overall Study|Lost to Follow-up|2|||
155567345|NCT03452137|561502785|FG000|Overall Study|Physician Decision|0|||
155567346|NCT03452137|561502786|FG001|Overall Study|Physician Decision|1|||
155567347|NCT03452137|561502785|FG000|Overall Study|Study Terminated by Sponsor|120|||
155567348|NCT03452137|561502786|FG001|Overall Study|Study Terminated by Sponsor|121|||
155567349|NCT03452137|561502785|FG000|Overall Study|Withdrawal by Subject|12|||
155567350|NCT03452137|561502786|FG001|Overall Study|Withdrawal by Subject|9|||
155567351|NCT02856802|561502787|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
155567352|NCT02856802|561502788|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
155567353|NCT02856802|561502787|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
155567354|NCT02856802|561502788|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
155567355|NCT02856802|561502787|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
155567356|NCT02856802|561502788|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
155567357|NCT02856802|561502787|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
155567358|NCT02856802|561502788|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
155567359|NCT02856802|561502787|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
155567360|NCT02856802|561502788|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
155567361|NCT02856802|561502787|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
155567362|NCT02856802|561502788|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
155567363|NCT03772717|561502789|FG000|Overall Study|Withdrawal by Subject|2|||
155567364|NCT04138043|561502790|FG000|Overall Study|Withdrawal by Subject|0|||
155567365|NCT04138043|561502791|FG001|Overall Study|Withdrawal by Subject|1|||
155567366|NCT00587860|561502792|FG000|Overall Study|Lost to Follow-up|2|||
155567367|NCT00587860|561502793|FG001|Overall Study|Lost to Follow-up|2|||
155659749|NCT00643279|561848022|FG001|Overall Study|Withdrawal by Subject|0|||
155659750|NCT00643279|561848021|FG000|Overall Study|Lost to Follow-up|0|||
155659751|NCT00643279|561848022|FG001|Overall Study|Lost to Follow-up|1|||
155659752|NCT00643279|561848021|FG000|Overall Study|Physician Decision|0|||
155659753|NCT00643279|561848022|FG001|Overall Study|Physician Decision|1|||
155659754|NCT06272383|561848023|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
155659755|NCT06272383|561848024|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
155659756|NCT05715827|561848025|FG000|Overall Study|Physician Decision|0|||
155659757|NCT05715827|561848026|FG001|Overall Study|Physician Decision|1|||
155659758|NCT05715827|561848025|FG000|Overall Study|console communication error|0|||
155659759|NCT05715827|561848026|FG001|Overall Study|console communication error|1|||
155659760|NCT04846868|561848027|FG000|Overall Study|Adverse Event|12|||
155659761|NCT04846868|561848028|FG001|Overall Study|Adverse Event|11|||
155659762|NCT04846868|561848027|FG000|Overall Study|Protocol deviation|6|||
155659763|NCT04846868|561848028|FG001|Overall Study|Protocol deviation|2|||
155659764|NCT04846868|561848027|FG000|Overall Study|Perceived lack of efficacy|3|||
155659765|NCT04846868|561848028|FG001|Overall Study|Perceived lack of efficacy|2|||
155659766|NCT04846868|561848027|FG000|Overall Study|Change of residence|2|||
155659767|NCT04846868|561848028|FG001|Overall Study|Change of residence|3|||
155659768|NCT04846868|561848027|FG000|Overall Study|Burden of study procedures|1|||
155659769|NCT04846868|561848028|FG001|Overall Study|Burden of study procedures|1|||
155659770|NCT04846868|561848027|FG000|Overall Study|No reason available|2|||
155659771|NCT04846868|561848028|FG001|Overall Study|No reason available|5|||
155659772|NCT04846868|561848027|FG000|Overall Study|Other reason listed|20|||
155659773|NCT04846868|561848028|FG001|Overall Study|Other reason listed|10|||
155659774|NCT04846868|561848027|FG000|Overall Study|Not treated|0|||
155659775|NCT04846868|561848028|FG001|Overall Study|Not treated|1|||
155659776|NCT05212168|561848029|FG000|Overall Study|Lost to Follow-up|0|||
155659777|NCT05212168|561848030|FG001|Overall Study|Lost to Follow-up|3|||
155659778|NCT05212168|561848029|FG000|Overall Study|Study terminated by sponsor|30|||
155659779|NCT05212168|561848030|FG001|Overall Study|Study terminated by sponsor|27|||
155659780|NCT05212168|561848029|FG000|Overall Study|Other|4|||
155659781|NCT05212168|561848030|FG001|Overall Study|Other|7|||
155659782|NCT03274466|561848031|FG000|Overall Study|Withdrawal by Subject|7|||
155659783|NCT03274466|561848032|FG001|Overall Study|Withdrawal by Subject|3|||
155659784|NCT03274466|561848031|FG000|Overall Study|Protocol Specified Withdrawal|5|||
155659785|NCT03274466|561848032|FG001|Overall Study|Protocol Specified Withdrawal|11|||
155659786|NCT03274466|561848031|FG000|Overall Study|Lost to Follow-up|5|||
155659787|NCT03274466|561848032|FG001|Overall Study|Lost to Follow-up|7|||
155659788|NCT03274466|561848031|FG000|Overall Study|Subject Non-compliance|0|||
155659789|NCT03274466|561848032|FG001|Overall Study|Subject Non-compliance|1|||
155659790|NCT03274466|561848031|FG000|Overall Study|Adverse Event|3|||
155659791|NCT03274466|561848032|FG001|Overall Study|Adverse Event|3|||
155659792|NCT03274466|561848031|FG000|Overall Study|Physician Decision|0|||
155659793|NCT03274466|561848032|FG001|Overall Study|Physician Decision|1|||
155659794|NCT03274466|561848031|FG000|Overall Study|Protocol Violation|3|||
155659795|NCT03274466|561848032|FG001|Overall Study|Protocol Violation|3|||
155659796|NCT00618787|561848035|FG000|Overall Study|Adverse Event|0|||
155659797|NCT00618787|561848036|FG001|Overall Study|Adverse Event|1|||
155659798|NCT00618787|561848035|FG000|Overall Study|Withdrawal by Subject|2|||
155659799|NCT00618787|561848036|FG001|Overall Study|Withdrawal by Subject|1|||
155659800|NCT00618787|561848035|FG000|Overall Study|Lost to Follow-up|1|||
155659801|NCT00618787|561848036|FG001|Overall Study|Lost to Follow-up|0|||
155659802|NCT01107886|561848037|FG000|Overall Study|Lost to Follow-up|15|||
155659803|NCT01107886|561848038|FG001|Overall Study|Lost to Follow-up|13|||
155659804|NCT01107886|561848037|FG000|Overall Study|Withdrawal by Subject|180|||
155659805|NCT01107886|561848038|FG001|Overall Study|Withdrawal by Subject|196|||
155659806|NCT01107886|561848037|FG000|Overall Study|Administrative withdrawal of consent|7|||
155659807|NCT01107886|561848038|FG001|Overall Study|Administrative withdrawal of consent|5|||
155659808|NCT05819398|561848039|FG000|Overall Study|Withdrawal by Subject|11|||
155659809|NCT05819398|561848040|FG001|Overall Study|Withdrawal by Subject|7|||
155659810|NCT05819398|561848041|FG002|Overall Study|Withdrawal by Subject|6|||
155659811|NCT05819398|561848042|FG003|Overall Study|Withdrawal by Subject|6|||
155567368|NCT00587860|561502792|FG000|Overall Study|Withdrawal by Subject|3|||
155567369|NCT00587860|561502793|FG001|Overall Study|Withdrawal by Subject|3|||
155567370|NCT01659125|561502794|FG000|Overall Study|Withdrawal by Subject|2|||
155567371|NCT01659125|561502794|FG000|Overall Study|Lost to Follow-up|7|||
155567372|NCT01659125|561502794|FG000|Overall Study|Technical Problem|1|||
155567373|NCT01659125|561502794|FG000|Overall Study|Time Constraints|2|||
155567374|NCT01659125|561502794|FG000|Overall Study|Failed to Start Treatment|2|||
155567375|NCT02755649|561502795|FG000|Overall Study|Transitioned into OLE study|99|||
155567376|NCT02755649|561502796|FG001|Overall Study|Transitioned into OLE study|98|||
155567377|NCT02755649|561502797|FG002|Overall Study|Transitioned into OLE study|100|||
155567378|NCT02755649|561502795|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
155567379|NCT02755649|561502796|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
155567380|NCT02755649|561502797|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
155567381|NCT02755649|561502795|FG000|Overall Study|Physician Decision|0|||
155567382|NCT02755649|561502796|FG001|Overall Study|Physician Decision|0|||
155567383|NCT02755649|561502797|FG002|Overall Study|Physician Decision|2|||
155567384|NCT02755649|561502795|FG000|Overall Study|Withdrawal by Subject|0|||
155567385|NCT02755649|561502796|FG001|Overall Study|Withdrawal by Subject|1|||
155567386|NCT02755649|561502797|FG002|Overall Study|Withdrawal by Subject|0|||
155567387|NCT02755649|561502795|FG000|Overall Study|Undecided|1|||
155567388|NCT02755649|561502796|FG001|Overall Study|Undecided|0|||
155567389|NCT02755649|561502797|FG002|Overall Study|Undecided|0|||
155567390|NCT01286753|561502798|FG000|Overall Study|Adverse Event|7|||
155567391|NCT01286753|561502799|FG001|Overall Study|Adverse Event|6|||
155567392|NCT01286753|561502798|FG000|Overall Study|Progression|11|||
155567393|NCT01286753|561502799|FG001|Overall Study|Progression|13|||
155567394|NCT01286753|561502798|FG000|Overall Study|Refused Treatment|1|||
155567395|NCT01286753|561502799|FG001|Overall Study|Refused Treatment|0|||
155567396|NCT01286753|561502798|FG000|Overall Study|Withdrawal of Consent|0|||
155567397|NCT01286753|561502799|FG001|Overall Study|Withdrawal of Consent|2|||
155567398|NCT01286753|561502798|FG000|Overall Study|Discontinued to Join Extension Study|6|||
155567399|NCT01286753|561502799|FG001|Overall Study|Discontinued to Join Extension Study|4|||
155567400|NCT01286753|561502798|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
155567401|NCT01286753|561502799|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
155567402|NCT02126826|561502803|FG000|Overall Study|Withdrawal by Subject|0|||
155567403|NCT02126826|561502804|FG001|Overall Study|Withdrawal by Subject|0|||
155567404|NCT02126826|561502805|FG002|Overall Study|Withdrawal by Subject|0|||
155567405|NCT02126826|561502806|FG003|Overall Study|Withdrawal by Subject|1|||
155567406|NCT02126826|561502807|FG004|Overall Study|Withdrawal by Subject|0|||
155567407|NCT02126826|561502808|FG005|Overall Study|Withdrawal by Subject|0|||
155567408|NCT02126826|561502809|FG006|Overall Study|Withdrawal by Subject|0|||
155567409|NCT01371747|561502810|FG000|Overall Study|Adverse Event|4|||
155567410|NCT01371747|561502811|FG001|Overall Study|Adverse Event|2|||
155567411|NCT01371747|561502812|FG002|Overall Study|Adverse Event|7|||
155567412|NCT01371747|561502813|FG003|Overall Study|Adverse Event|2|||
155567413|NCT01371747|561502814|FG004|Overall Study|Adverse Event|2|||
155567414|NCT01371747|561502815|FG005|Overall Study|Adverse Event|2|||
155567415|NCT01371747|561502810|FG000|Overall Study|Death|1|||
155567416|NCT01371747|561502811|FG001|Overall Study|Death|0|||
155567417|NCT01371747|561502812|FG002|Overall Study|Death|4|||
155567418|NCT01371747|561502813|FG003|Overall Study|Death|1|||
155567419|NCT01371747|561502814|FG004|Overall Study|Death|2|||
155567420|NCT01371747|561502815|FG005|Overall Study|Death|0|||
155567421|NCT01371747|561502810|FG000|Overall Study|Abnormal Renal Function|0|||
155567422|NCT01371747|561502811|FG001|Overall Study|Abnormal Renal Function|2|||
155567423|NCT01371747|561502812|FG002|Overall Study|Abnormal Renal Function|0|||
155567424|NCT01371747|561502813|FG003|Overall Study|Abnormal Renal Function|1|||
155567425|NCT01371747|561502814|FG004|Overall Study|Abnormal Renal Function|0|||
155567426|NCT01371747|561502815|FG005|Overall Study|Abnormal Renal Function|1|||
155567427|NCT01371747|561502810|FG000|Overall Study|High Serum Potassium Results|1|||
155567428|NCT01371747|561502811|FG001|Overall Study|High Serum Potassium Results|1|||
155567429|NCT01371747|561502812|FG002|Overall Study|High Serum Potassium Results|1|||
155567430|NCT01371747|561502813|FG003|Overall Study|High Serum Potassium Results|2|||
155567431|NCT01371747|561502814|FG004|Overall Study|High Serum Potassium Results|0|||
155567432|NCT01371747|561502815|FG005|Overall Study|High Serum Potassium Results|2|||
155567433|NCT01371747|561502810|FG000|Overall Study|Low Serum Potassium Results|1|||
155567434|NCT01371747|561502811|FG001|Overall Study|Low Serum Potassium Results|1|||
155567435|NCT01371747|561502812|FG002|Overall Study|Low Serum Potassium Results|1|||
155567436|NCT01371747|561502813|FG003|Overall Study|Low Serum Potassium Results|1|||
155567437|NCT01371747|561502814|FG004|Overall Study|Low Serum Potassium Results|0|||
155567438|NCT01371747|561502815|FG005|Overall Study|Low Serum Potassium Results|3|||
155567439|NCT01371747|561502810|FG000|Overall Study|Protocol Violation|0|||
155659812|NCT05819398|561848039|FG000|Overall Study|Lost to Follow-up|0|||
155659813|NCT05819398|561848040|FG001|Overall Study|Lost to Follow-up|2|||
155659814|NCT05819398|561848041|FG002|Overall Study|Lost to Follow-up|0|||
155659815|NCT05819398|561848042|FG003|Overall Study|Lost to Follow-up|1|||
155659816|NCT05819398|561848039|FG000|Overall Study|Adverse Event|1|||
155659817|NCT05819398|561848040|FG001|Overall Study|Adverse Event|3|||
155659818|NCT05819398|561848041|FG002|Overall Study|Adverse Event|4|||
155659819|NCT05819398|561848042|FG003|Overall Study|Adverse Event|5|||
155659820|NCT05819398|561848039|FG000|Overall Study|Other than listed|0|||
155659821|NCT05819398|561848040|FG001|Overall Study|Other than listed|2|||
155659822|NCT05819398|561848041|FG002|Overall Study|Other than listed|2|||
155659823|NCT05819398|561848042|FG003|Overall Study|Other than listed|0|||
155659824|NCT05819398|561848039|FG000|Overall Study|Lack of Efficacy|0|||
155659825|NCT05819398|561848040|FG001|Overall Study|Lack of Efficacy|1|||
155659826|NCT05819398|561848041|FG002|Overall Study|Lack of Efficacy|0|||
155659827|NCT05819398|561848042|FG003|Overall Study|Lack of Efficacy|0|||
155659828|NCT05819398|561848039|FG000|Overall Study|Study terminated by sponsor|20|||
155659829|NCT05819398|561848040|FG001|Overall Study|Study terminated by sponsor|18|||
155659830|NCT05819398|561848041|FG002|Overall Study|Study terminated by sponsor|20|||
155659831|NCT05819398|561848042|FG003|Overall Study|Study terminated by sponsor|22|||
155659832|NCT01649869|561848046|FG000|Overall Study|Family member illness|1|||
155659833|NCT01649869|561848047|FG001|Overall Study|Family member illness|0|||
155659834|NCT01649869|561848046|FG000|Overall Study|Required treatment outside protocol|1|||
155659835|NCT01649869|561848047|FG001|Overall Study|Required treatment outside protocol|0|||
155659836|NCT01649869|561848046|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
155659837|NCT01649869|561848047|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
155659838|NCT01323192|561850461|FG000|Overall Study|Adverse Event|6|||
155659839|NCT01323192|561850462|FG001|Overall Study|Adverse Event|1|||
155659840|NCT01323192|561850461|FG000|Overall Study|Withdrawal by Subject|3|||
155659841|NCT01323192|561850462|FG001|Overall Study|Withdrawal by Subject|1|||
155659842|NCT01323192|561850461|FG000|Overall Study|Noncompliance with study medication|0|||
155659843|NCT01323192|561850462|FG001|Overall Study|Noncompliance with study medication|3|||
155659844|NCT01323192|561850461|FG000|Overall Study|Nonmedical reasons|0|||
155659845|NCT01323192|561850462|FG001|Overall Study|Nonmedical reasons|1|||
155659846|NCT03698279|561850463|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155659847|NCT03698279|561850464|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155659848|NCT03698279|561850465|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155659849|NCT03698279|561850466|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155659850|NCT03698279|561850467|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155659851|NCT03698279|561850468|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155659852|NCT03698279|561850463|FG000|Overall Study|Protocol deviation|1|||
155659853|NCT03698279|561850464|FG001|Overall Study|Protocol deviation|0|||
155659854|NCT03698279|561850465|FG002|Overall Study|Protocol deviation|1|||
155659855|NCT03698279|561850466|FG003|Overall Study|Protocol deviation|0|||
155659856|NCT03698279|561850467|FG004|Overall Study|Protocol deviation|0|||
155659857|NCT03698279|561850468|FG005|Overall Study|Protocol deviation|0|||
155659858|NCT03698279|561850463|FG000|Overall Study|Withdrawal by Subject|0|||
155659859|NCT03698279|561850464|FG001|Overall Study|Withdrawal by Subject|0|||
155659860|NCT03698279|561850465|FG002|Overall Study|Withdrawal by Subject|1|||
155659861|NCT03698279|561850466|FG003|Overall Study|Withdrawal by Subject|0|||
155659862|NCT03698279|561850467|FG004|Overall Study|Withdrawal by Subject|0|||
155659863|NCT03698279|561850468|FG005|Overall Study|Withdrawal by Subject|0|||
155659864|NCT03698279|561850463|FG000|Overall Study|Lost to Follow-up|3|||
155659865|NCT03698279|561850464|FG001|Overall Study|Lost to Follow-up|1|||
155659866|NCT03698279|561850465|FG002|Overall Study|Lost to Follow-up|4|||
155659867|NCT03698279|561850466|FG003|Overall Study|Lost to Follow-up|5|||
155659868|NCT03698279|561850467|FG004|Overall Study|Lost to Follow-up|0|||
155659869|NCT03698279|561850468|FG005|Overall Study|Lost to Follow-up|0|||
155659870|NCT02276040|561850469|FG000|Overall Study|Physician Decision|15|||
155659871|NCT02835690|561850470|FG000|Overall Study|Death|12|||
155659872|NCT02835690|561850471|FG001|Overall Study|Death|11|||
155659873|NCT02835690|561850472|FG002|Overall Study|Death|13|||
155659874|NCT02835690|561850470|FG000|Overall Study|Transferred to Extension Study|2|||
155659875|NCT02835690|561850471|FG001|Overall Study|Transferred to Extension Study|2|||
155659876|NCT02835690|561850472|FG002|Overall Study|Transferred to Extension Study|1|||
155659877|NCT02835690|561850470|FG000|Overall Study|Did Not Continue on Extension Study|0|||
155659878|NCT02835690|561850471|FG001|Overall Study|Did Not Continue on Extension Study|0|||
155659879|NCT02835690|561850472|FG002|Overall Study|Did Not Continue on Extension Study|1|||
155659880|NCT02835690|561850470|FG000|Overall Study|Not Treated|0|||
155659881|NCT02835690|561850471|FG001|Overall Study|Not Treated|2|||
155659882|NCT02835690|561850472|FG002|Overall Study|Not Treated|0|||
155659883|NCT00582907|561850473|FG000|1st Course|Withdrawal by Subject|1|||
155659884|NCT00582907|561850474|FG001|1st Course|Withdrawal by Subject|0|||
155659885|NCT00582907|561850475|FG002|1st Course|Withdrawal by Subject|0|||
155659886|NCT00582907|561850476|FG003|1st Course|Withdrawal by Subject|0|||
155659887|NCT00582907|561850473|FG000|1st Course|Lost to Follow-up|0|||
155659888|NCT00582907|561850474|FG001|1st Course|Lost to Follow-up|0|||
155659889|NCT00582907|561850475|FG002|1st Course|Lost to Follow-up|0|||
155567440|NCT01371747|561502811|FG001|Overall Study|Protocol Violation|0|||
155567441|NCT01371747|561502812|FG002|Overall Study|Protocol Violation|1|||
155567442|NCT01371747|561502813|FG003|Overall Study|Protocol Violation|0|||
155567443|NCT01371747|561502814|FG004|Overall Study|Protocol Violation|0|||
155567444|NCT01371747|561502815|FG005|Overall Study|Protocol Violation|0|||
155567445|NCT01371747|561502810|FG000|Overall Study|Non-Compliance|3|||
155567446|NCT01371747|561502811|FG001|Overall Study|Non-Compliance|4|||
155567447|NCT01371747|561502812|FG002|Overall Study|Non-Compliance|3|||
155567448|NCT01371747|561502813|FG003|Overall Study|Non-Compliance|0|||
155567449|NCT01371747|561502814|FG004|Overall Study|Non-Compliance|0|||
155567450|NCT01371747|561502815|FG005|Overall Study|Non-Compliance|1|||
155567451|NCT01371747|561502810|FG000|Overall Study|Physician Decision|0|||
155567452|NCT01371747|561502811|FG001|Overall Study|Physician Decision|0|||
155567453|NCT01371747|561502812|FG002|Overall Study|Physician Decision|0|||
155567454|NCT01371747|561502813|FG003|Overall Study|Physician Decision|0|||
155567455|NCT01371747|561502814|FG004|Overall Study|Physician Decision|1|||
155567456|NCT01371747|561502815|FG005|Overall Study|Physician Decision|0|||
155567457|NCT01371747|561502810|FG000|Overall Study|Withdrawal by Subject|6|||
155567458|NCT01371747|561502811|FG001|Overall Study|Withdrawal by Subject|12|||
155567459|NCT01371747|561502812|FG002|Overall Study|Withdrawal by Subject|5|||
155567460|NCT01371747|561502813|FG003|Overall Study|Withdrawal by Subject|2|||
155567461|NCT01371747|561502814|FG004|Overall Study|Withdrawal by Subject|2|||
155567462|NCT01371747|561502815|FG005|Overall Study|Withdrawal by Subject|4|||
155567463|NCT01371747|561502810|FG000|Overall Study|Other Reasons|2|||
155567464|NCT01371747|561502811|FG001|Overall Study|Other Reasons|1|||
155567465|NCT01371747|561502812|FG002|Overall Study|Other Reasons|2|||
155567466|NCT01371747|561502813|FG003|Overall Study|Other Reasons|0|||
155567467|NCT01371747|561502814|FG004|Overall Study|Other Reasons|0|||
155567468|NCT01371747|561502815|FG005|Overall Study|Other Reasons|1|||
155567469|NCT03092219|561502816|FG000|Overall Study|Protocol Violation|7|||
155567470|NCT03092219|561502817|FG001|Overall Study|Protocol Violation|4|||
155567471|NCT03278626|561502818|FG000|Overall Study|Death|2|||
155567472|NCT03278626|561502818|FG000|Overall Study|Toxicity|1|||
155567473|NCT03278626|561502818|FG000|Overall Study|Disease Progression|2|||
155567474|NCT05013008|561502819|FG000|Overall Study|Exclusion from mBFAS|5|||
155567475|NCT05013008|561502820|FG001|Overall Study|Exclusion from mBFAS|25|||
155567476|NCT02856555|561502824|FG000|Overall Study|Adverse Event|1|||
155567477|NCT02856555|561502825|FG001|Overall Study|Adverse Event|0|||
155567478|NCT02856555|561502826|FG002|Overall Study|Adverse Event|0|||
155567479|NCT02856555|561502824|FG000|Overall Study|Lost to Follow-up|1|||
155567480|NCT02856555|561502825|FG001|Overall Study|Lost to Follow-up|3|||
155567481|NCT02856555|561502826|FG002|Overall Study|Lost to Follow-up|0|||
155567482|NCT02856555|561502824|FG000|Overall Study|Withdrawal by Subject|3|||
155567483|NCT02856555|561502825|FG001|Overall Study|Withdrawal by Subject|0|||
155567484|NCT02856555|561502826|FG002|Overall Study|Withdrawal by Subject|0|||
155567485|NCT02856555|561502824|FG000|Overall Study|Randomized but Never Treated|0|||
155567486|NCT02856555|561502825|FG001|Overall Study|Randomized but Never Treated|1|||
155567487|NCT02856555|561502826|FG002|Overall Study|Randomized but Never Treated|0|||
155567488|NCT03333941|561502827|FG000|Overall Study|Lost to Follow-up|10|||
155567489|NCT03333941|561502827|FG000|Overall Study|Death|2|||
155567490|NCT03333941|561502827|FG000|Overall Study|Adverse Event|1|||
155567491|NCT04971187|561502828|FG000|Overall Study|Screen failures|2|||
155567492|NCT01207583|561502838|FG000|Overall Study|Withdrawal by Subject|0|||
155567493|NCT01207583|561502839|FG001|Overall Study|Withdrawal by Subject|3|||
155567494|NCT01207583|561502840|FG002|Overall Study|Withdrawal by Subject|1|||
155567495|NCT01207583|561502838|FG000|Overall Study|Participant failed to return|1|||
155567496|NCT01207583|561502839|FG001|Overall Study|Participant failed to return|0|||
155567497|NCT01207583|561502840|FG002|Overall Study|Participant failed to return|0|||
155567498|NCT01207583|561502838|FG000|Overall Study|Lost to Follow-up|0|||
155567499|NCT01207583|561502839|FG001|Overall Study|Lost to Follow-up|2|||
155567500|NCT01207583|561502840|FG002|Overall Study|Lost to Follow-up|0|||
155567501|NCT01696058|561502842|FG000|Overall Study|Adverse Event|21|||
155567502|NCT01696058|561502843|FG001|Overall Study|Adverse Event|11|||
155567503|NCT01696058|561502842|FG000|Overall Study|Lack of Efficacy|2|||
155659890|NCT00582907|561850476|FG003|1st Course|Lost to Follow-up|1|||
155567504|NCT01696058|561502843|FG001|Overall Study|Lack of Efficacy|3|||
155567505|NCT01696058|561502842|FG000|Overall Study|Protocol Violation|9|||
155567506|NCT01696058|561502843|FG001|Overall Study|Protocol Violation|3|||
155567507|NCT01696058|561502842|FG000|Overall Study|Lost to Follow-up|2|||
155567508|NCT01696058|561502843|FG001|Overall Study|Lost to Follow-up|5|||
155567509|NCT01696058|561502842|FG000|Overall Study|Withdrawal by Subject|4|||
155567510|NCT01696058|561502843|FG001|Overall Study|Withdrawal by Subject|6|||
155567511|NCT01696058|561502842|FG000|Overall Study|Other reason prematurely discontinued|5|||
155567512|NCT01696058|561502843|FG001|Overall Study|Other reason prematurely discontinued|3|||
155567513|NCT02186834|561502845|FG000|Dose Escalation|Death|0|||
155567514|NCT02186834|561502846|FG001|Dose Escalation|Death|0|||
155567515|NCT02186834|561502847|FG002|Dose Escalation|Death|0|||
155567516|NCT02186834|561502848|FG003|Dose Escalation|Death|1|||
155567517|NCT02186834|561502849|FG004|Dose Escalation|Death|0|||
155567518|NCT02186834|561502850|FG005|Dose Escalation|Death|0|||
155567519|NCT02186834|561502845|FG000|Treatment at RP2D|Died prior to treatment|0|||
155567520|NCT02186834|561502846|FG001|Treatment at RP2D|Died prior to treatment|0|||
155567521|NCT02186834|561502847|FG002|Treatment at RP2D|Died prior to treatment|0|||
155567522|NCT02186834|561502848|FG003|Treatment at RP2D|Died prior to treatment|0|||
155567523|NCT02186834|561502849|FG004|Treatment at RP2D|Died prior to treatment|0|||
155567524|NCT02186834|561502850|FG005|Treatment at RP2D|Died prior to treatment|1|||
155567525|NCT04746794|561502853|FG000|Overall Study|Did not complete any study assessment|50303|||
155567526|NCT04746794|561502854|FG001|Overall Study|Did not complete any study assessment|44997|||
155567527|NCT01422187|561502855|FG000|Overall Study|Personal reason|1|||
155567528|NCT01422187|561502856|FG001|Overall Study|Personal reason|0|||
155567529|NCT01422187|561502857|FG002|Overall Study|Personal reason|0|||
155567530|NCT01422187|561502855|FG000|Overall Study|Lost to Follow-up|0|||
155567531|NCT01422187|561502856|FG001|Overall Study|Lost to Follow-up|1|||
155567532|NCT01422187|561502857|FG002|Overall Study|Lost to Follow-up|0|||
155567533|NCT04611529|561502859|FG000|2-day Follow up|Lost to Follow-up|5|||
155567534|NCT04611529|561502860|FG001|2-day Follow up|Lost to Follow-up|6|||
155567535|NCT04611529|561502861|FG002|2-day Follow up|Lost to Follow-up|3|||
155567536|NCT00425373|561502866|FG000|Overall Study|Adverse Event|2|||
155567537|NCT00425373|561502867|FG001|Overall Study|Adverse Event|2|||
155567538|NCT00425373|561502868|FG002|Overall Study|Adverse Event|0|||
155567539|NCT00425373|561502869|FG003|Overall Study|Adverse Event|1|||
155567540|NCT00425373|561502870|FG004|Overall Study|Adverse Event|4|||
155567541|NCT00425373|561502871|FG005|Overall Study|Adverse Event|6|||
155567542|NCT00425373|561502872|FG006|Overall Study|Adverse Event|2|||
155567543|NCT00425373|561502873|FG007|Overall Study|Adverse Event|3|||
155567544|NCT00425373|561502874|FG008|Overall Study|Adverse Event|8|||
155567545|NCT00425373|561502866|FG000|Overall Study|Lost to Follow-up|0|||
155567546|NCT00425373|561502867|FG001|Overall Study|Lost to Follow-up|1|||
155567547|NCT00425373|561502868|FG002|Overall Study|Lost to Follow-up|0|||
155567548|NCT00425373|561502869|FG003|Overall Study|Lost to Follow-up|0|||
155567549|NCT00425373|561502870|FG004|Overall Study|Lost to Follow-up|1|||
155567550|NCT00425373|561502871|FG005|Overall Study|Lost to Follow-up|0|||
155567551|NCT00425373|561502872|FG006|Overall Study|Lost to Follow-up|0|||
155567552|NCT00425373|561502873|FG007|Overall Study|Lost to Follow-up|0|||
155567553|NCT00425373|561502874|FG008|Overall Study|Lost to Follow-up|0|||
155567554|NCT00425373|561502866|FG000|Overall Study|Protocol Violation|1|||
155567555|NCT00425373|561502867|FG001|Overall Study|Protocol Violation|0|||
155567556|NCT00425373|561502868|FG002|Overall Study|Protocol Violation|1|||
155567557|NCT00425373|561502869|FG003|Overall Study|Protocol Violation|0|||
155567558|NCT00425373|561502870|FG004|Overall Study|Protocol Violation|0|||
155567559|NCT00425373|561502871|FG005|Overall Study|Protocol Violation|0|||
155567560|NCT00425373|561502872|FG006|Overall Study|Protocol Violation|0|||
155567561|NCT00425373|561502873|FG007|Overall Study|Protocol Violation|5|||
155567562|NCT00425373|561502874|FG008|Overall Study|Protocol Violation|3|||
155567563|NCT00425373|561502866|FG000|Overall Study|Withdrawal by Subject|2|||
155567564|NCT00425373|561502867|FG001|Overall Study|Withdrawal by Subject|0|||
155567565|NCT00425373|561502868|FG002|Overall Study|Withdrawal by Subject|2|||
155567566|NCT00425373|561502869|FG003|Overall Study|Withdrawal by Subject|1|||
155567567|NCT00425373|561502870|FG004|Overall Study|Withdrawal by Subject|4|||
155567568|NCT00425373|561502871|FG005|Overall Study|Withdrawal by Subject|0|||
155567569|NCT00425373|561502872|FG006|Overall Study|Withdrawal by Subject|2|||
155567570|NCT00425373|561502873|FG007|Overall Study|Withdrawal by Subject|2|||
155567571|NCT00425373|561502874|FG008|Overall Study|Withdrawal by Subject|2|||
155567572|NCT00425373|561502866|FG000|Overall Study|Lack of Efficacy|0|||
155567573|NCT00425373|561502867|FG001|Overall Study|Lack of Efficacy|0|||
155567574|NCT00425373|561502868|FG002|Overall Study|Lack of Efficacy|0|||
155567575|NCT00425373|561502869|FG003|Overall Study|Lack of Efficacy|0|||
155567576|NCT00425373|561502870|FG004|Overall Study|Lack of Efficacy|1|||
155567577|NCT00425373|561502871|FG005|Overall Study|Lack of Efficacy|3|||
155567578|NCT00425373|561502872|FG006|Overall Study|Lack of Efficacy|3|||
155567579|NCT00425373|561502873|FG007|Overall Study|Lack of Efficacy|0|||
155567580|NCT00425373|561502874|FG008|Overall Study|Lack of Efficacy|5|||
155567581|NCT02960490|561502876|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
155567582|NCT02960490|561502877|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
155567583|NCT02960490|561502878|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567584|NCT02960490|561502879|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567585|NCT02960490|561502880|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567586|NCT02960490|561502881|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567587|NCT02960490|561502882|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567588|NCT02960490|561502883|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567589|NCT02960490|561502884|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567590|NCT02960490|561502885|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155567591|NCT02960490|561502876|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567592|NCT02960490|561502877|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
155567593|NCT02960490|561502878|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567594|NCT02960490|561502879|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567595|NCT02960490|561502880|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567596|NCT02960490|561502881|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567597|NCT02960490|561502882|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567598|NCT02960490|561502883|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567599|NCT02960490|561502884|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567600|NCT02960490|561502885|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
155567601|NCT02960490|561502876|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
155567602|NCT02960490|561502877|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
155567603|NCT02960490|561502878|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567604|NCT02960490|561502879|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567605|NCT02960490|561502880|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567606|NCT02960490|561502881|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567607|NCT02960490|561502882|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567608|NCT02960490|561502883|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567609|NCT02960490|561502884|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567610|NCT02960490|561502885|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
155567611|NCT02960490|561502876|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
155567612|NCT02960490|561502877|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
155567613|NCT02960490|561502878|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567614|NCT02960490|561502879|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567615|NCT02960490|561502880|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567616|NCT02960490|561502881|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567617|NCT02960490|561502882|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567618|NCT02960490|561502883|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567619|NCT02960490|561502884|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567620|NCT02960490|561502885|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155567621|NCT02960490|561502876|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567622|NCT02960490|561502877|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567623|NCT02960490|561502878|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
155567624|NCT02960490|561502879|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
155567625|NCT02960490|561502880|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567626|NCT02960490|561502881|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
155567627|NCT02960490|561502882|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567628|NCT02960490|561502883|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567629|NCT02960490|561502884|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567630|NCT02960490|561502885|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
155567631|NCT02960490|561502876|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567632|NCT02960490|561502877|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567633|NCT02960490|561502878|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
155567634|NCT02960490|561502879|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567635|NCT02960490|561502880|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
155567636|NCT02960490|561502881|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567637|NCT02960490|561502882|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567638|NCT02960490|561502883|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567639|NCT02960490|561502884|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567640|NCT02960490|561502885|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
155567641|NCT02960490|561502876|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
155567642|NCT02960490|561502877|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
155567643|NCT02960490|561502878|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
155567644|NCT02960490|561502879|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
155567645|NCT02960490|561502880|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
155567646|NCT02960490|561502881|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
155567647|NCT02960490|561502882|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
155567648|NCT02960490|561502883|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
155567649|NCT02960490|561502884|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
155567650|NCT02960490|561502885|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
155567651|NCT02960490|561502876|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567652|NCT02960490|561502877|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567653|NCT02960490|561502878|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567654|NCT02960490|561502879|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567655|NCT02960490|561502880|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155659891|NCT00582907|561850473|FG000|2nd Course|Lack of Efficacy|1|||
155659892|NCT00582907|561850474|FG001|2nd Course|Lack of Efficacy|0|||
155659893|NCT00582907|561850475|FG002|2nd Course|Lack of Efficacy|0|||
155567656|NCT02960490|561502881|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567657|NCT02960490|561502882|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
155567658|NCT02960490|561502883|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
155567659|NCT02960490|561502884|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
155567660|NCT02960490|561502885|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
155567661|NCT02960490|561502876|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567662|NCT02960490|561502877|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567663|NCT02960490|561502878|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567664|NCT02960490|561502879|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567665|NCT02960490|561502880|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567666|NCT02960490|561502881|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567667|NCT02960490|561502882|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567668|NCT02960490|561502883|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
155567669|NCT02960490|561502884|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567670|NCT02960490|561502885|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
155567671|NCT02960490|561502876|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567672|NCT02960490|561502877|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567673|NCT02960490|561502878|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567674|NCT02960490|561502879|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567675|NCT02960490|561502880|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567676|NCT02960490|561502881|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
155567677|NCT02960490|561502882|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
155567678|NCT02960490|561502883|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
155567679|NCT02960490|561502884|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
155567680|NCT02960490|561502885|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
155567681|NCT02960490|561502876|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567682|NCT02960490|561502877|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567683|NCT02960490|561502878|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567684|NCT02960490|561502879|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567685|NCT02960490|561502880|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567686|NCT02960490|561502881|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567687|NCT02960490|561502882|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
155567688|NCT02960490|561502883|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567689|NCT02960490|561502884|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567690|NCT02960490|561502885|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155567691|NCT02960490|561502876|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567692|NCT02960490|561502877|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567693|NCT02960490|561502878|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567694|NCT02960490|561502879|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567695|NCT02960490|561502880|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567696|NCT02960490|561502881|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567697|NCT02960490|561502882|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567698|NCT02960490|561502883|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
155567699|NCT02960490|561502884|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567700|NCT02960490|561502885|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
155567701|NCT01590797|561502888|FG000|Overall Study|Adverse Event|4|||
155567702|NCT01590797|561502889|FG001|Overall Study|Adverse Event|3|||
155567703|NCT01590797|561502888|FG000|Overall Study|Lack of Efficacy|0|||
155567704|NCT01590797|561502889|FG001|Overall Study|Lack of Efficacy|2|||
155567705|NCT01590797|561502888|FG000|Overall Study|Lost to Follow-up|0|||
155567706|NCT01590797|561502889|FG001|Overall Study|Lost to Follow-up|1|||
155567707|NCT01590797|561502888|FG000|Overall Study|Protocol Violation|4|||
155567708|NCT01590797|561502889|FG001|Overall Study|Protocol Violation|1|||
155567709|NCT01590797|561502888|FG000|Overall Study|Withdrawal by Subject|7|||
155567710|NCT01590797|561502889|FG001|Overall Study|Withdrawal by Subject|5|||
155567711|NCT01590797|561502888|FG000|Overall Study|Other Protocol Specified Criteria|2|||
155567712|NCT01590797|561502889|FG001|Overall Study|Other Protocol Specified Criteria|4|||
155567713|NCT03106987|561502890|FG000|Overall Study|Death|37|||
155567714|NCT03106987|561502891|FG001|Overall Study|Death|22|||
155567715|NCT03106987|561502892|FG002|Overall Study|Death|12|||
155567716|NCT03106987|561502893|FG003|Overall Study|Death|8|||
155567717|NCT03106987|561502890|FG000|Overall Study|Lost to Follow-up|2|||
155567718|NCT03106987|561502891|FG001|Overall Study|Lost to Follow-up|0|||
155567719|NCT03106987|561502892|FG002|Overall Study|Lost to Follow-up|2|||
155567720|NCT03106987|561502893|FG003|Overall Study|Lost to Follow-up|2|||
155567721|NCT03106987|561502890|FG000|Overall Study|Withdrawal by Subject|5|||
155567722|NCT03106987|561502891|FG001|Overall Study|Withdrawal by Subject|1|||
155567723|NCT03106987|561502892|FG002|Overall Study|Withdrawal by Subject|4|||
155567724|NCT03106987|561502893|FG003|Overall Study|Withdrawal by Subject|1|||
155567725|NCT03336528|561502894|FG000|Overall Study|Protocol Violation|1|||
155567726|NCT03336528|561502895|FG001|Overall Study|Protocol Violation|1|||
155567727|NCT03336528|561502894|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
155567728|NCT03336528|561502895|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
155567729|NCT03336528|561502894|FG000|Overall Study|Did not receive study medication|1|||
155567730|NCT03336528|561502895|FG001|Overall Study|Did not receive study medication|2|||
155567731|NCT02460679|561502898|FG000|Overall Study|Investigator Decision|1|||
155567732|NCT02460679|561502898|FG000|Overall Study|Withdrawal by Subject|4|||
155567733|NCT00920790|561502899|FG000|Overall Study|aggravation of general condition|14|||
155567734|NCT00468650|561502903|FG000|Overall Study|Lost to Follow-up|4|||
155567735|NCT00468650|561502903|FG000|Overall Study|Withdrawal by Subject|2|||
155567736|NCT00468650|561502903|FG000|Overall Study|Protocol Violation|1|||
155567737|NCT02655666|561502904|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
155567738|NCT00789737|561502909|FG000|Overall Study|Withdrawal by Subject|13|||
155567739|NCT00789737|561502910|FG001|Overall Study|Withdrawal by Subject|22|||
155567740|NCT00789737|561502909|FG000|Overall Study|Lost to Follow-up|10|||
155567741|NCT00789737|561502910|FG001|Overall Study|Lost to Follow-up|14|||
155567742|NCT00789737|561502909|FG000|Overall Study|Adverse Event|8|||
155567743|NCT00789737|561502910|FG001|Overall Study|Adverse Event|8|||
155567744|NCT00789737|561502909|FG000|Overall Study|Protocol Violation|3|||
155567745|NCT00789737|561502910|FG001|Overall Study|Protocol Violation|0|||
155567746|NCT00789737|561502909|FG000|Overall Study|Lack of Efficacy|3|||
155567747|NCT00789737|561502910|FG001|Overall Study|Lack of Efficacy|0|||
155567748|NCT00789737|561502909|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
155567749|NCT00789737|561502910|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
155567750|NCT00789737|561502909|FG000|Overall Study|Other|11|||
155567751|NCT00789737|561502910|FG001|Overall Study|Other|7|||
155567752|NCT03136965|561502911|FG000|Overall Study|Lost to Follow-up|0|||
155567753|NCT03136965|561502912|FG001|Overall Study|Lost to Follow-up|1|||
155567754|NCT03136965|561502913|FG002|Overall Study|Lost to Follow-up|0|||
155567755|NCT02785952|561502914|FG000|Overall Study|Adverse Event|31|||
155567756|NCT02785952|561502915|FG001|Overall Study|Adverse Event|19|||
155567757|NCT02785952|561502914|FG000|Overall Study|Refusal unrelated to adverse events|10|||
155567758|NCT02785952|561502915|FG001|Overall Study|Refusal unrelated to adverse events|5|||
155567759|NCT02785952|561502914|FG000|Overall Study|Disease progression/relapse|61|||
155567760|NCT02785952|561502915|FG001|Overall Study|Disease progression/relapse|89|||
155567761|NCT02785952|561502914|FG000|Overall Study|Death|11|||
155567762|NCT02785952|561502915|FG001|Overall Study|Death|7|||
155567763|NCT02785952|561502914|FG000|Overall Study|Other- not protocol specified|6|||
155567764|NCT02785952|561502915|FG001|Overall Study|Other- not protocol specified|4|||
155567765|NCT02785952|561502914|FG000|Overall Study|On protocol treatment|6|||
155567766|NCT02785952|561502915|FG001|Overall Study|On protocol treatment|3|||
155567767|NCT00642278|561502916|FG000|Overall Study|Adverse Event|2|||
155567768|NCT00642278|561502917|FG001|Overall Study|Adverse Event|1|||
155567769|NCT00642278|561502918|FG002|Overall Study|Adverse Event|3|||
155567770|NCT00642278|561502919|FG003|Overall Study|Adverse Event|1|||
155567771|NCT00642278|561502920|FG004|Overall Study|Adverse Event|2|||
155567772|NCT00642278|561502921|FG005|Overall Study|Adverse Event|2|||
155567773|NCT00642278|561502922|FG006|Overall Study|Adverse Event|0|||
155567774|NCT00642278|561502916|FG000|Overall Study|Lack of Efficacy|0|||
155567775|NCT00642278|561502917|FG001|Overall Study|Lack of Efficacy|1|||
155567776|NCT00642278|561502918|FG002|Overall Study|Lack of Efficacy|0|||
155567777|NCT00642278|561502919|FG003|Overall Study|Lack of Efficacy|0|||
155567778|NCT00642278|561502920|FG004|Overall Study|Lack of Efficacy|0|||
155567779|NCT00642278|561502921|FG005|Overall Study|Lack of Efficacy|0|||
155567780|NCT00642278|561502922|FG006|Overall Study|Lack of Efficacy|0|||
155567781|NCT00642278|561502916|FG000|Overall Study|Lost to Follow-up|5|||
155567782|NCT00642278|561502917|FG001|Overall Study|Lost to Follow-up|1|||
155567783|NCT00642278|561502918|FG002|Overall Study|Lost to Follow-up|0|||
155567784|NCT00642278|561502919|FG003|Overall Study|Lost to Follow-up|1|||
155567785|NCT00642278|561502920|FG004|Overall Study|Lost to Follow-up|0|||
155567786|NCT00642278|561502921|FG005|Overall Study|Lost to Follow-up|1|||
155567787|NCT00642278|561502922|FG006|Overall Study|Lost to Follow-up|1|||
155567788|NCT00642278|561502916|FG000|Overall Study|Physician Decision|0|||
155567789|NCT00642278|561502917|FG001|Overall Study|Physician Decision|0|||
155567790|NCT00642278|561502918|FG002|Overall Study|Physician Decision|0|||
155567791|NCT00642278|561502919|FG003|Overall Study|Physician Decision|1|||
155567792|NCT00642278|561502920|FG004|Overall Study|Physician Decision|0|||
155567793|NCT00642278|561502921|FG005|Overall Study|Physician Decision|0|||
155567794|NCT00642278|561502922|FG006|Overall Study|Physician Decision|0|||
155567795|NCT00642278|561502916|FG000|Overall Study|Protocol Violation|0|||
155567796|NCT00642278|561502917|FG001|Overall Study|Protocol Violation|0|||
155567797|NCT00642278|561502918|FG002|Overall Study|Protocol Violation|1|||
155567798|NCT00642278|561502919|FG003|Overall Study|Protocol Violation|1|||
155567799|NCT00642278|561502920|FG004|Overall Study|Protocol Violation|0|||
155567800|NCT00642278|561502921|FG005|Overall Study|Protocol Violation|1|||
155567801|NCT00642278|561502922|FG006|Overall Study|Protocol Violation|2|||
155567802|NCT00642278|561502916|FG000|Overall Study|Withdrawal by Subject|1|||
155567803|NCT00642278|561502917|FG001|Overall Study|Withdrawal by Subject|1|||
155567804|NCT00642278|561502918|FG002|Overall Study|Withdrawal by Subject|1|||
155567805|NCT00642278|561502919|FG003|Overall Study|Withdrawal by Subject|3|||
155567806|NCT00642278|561502920|FG004|Overall Study|Withdrawal by Subject|6|||
155567807|NCT00642278|561502921|FG005|Overall Study|Withdrawal by Subject|2|||
155567808|NCT00642278|561502922|FG006|Overall Study|Withdrawal by Subject|2|||
155567809|NCT00642278|561502916|FG000|Overall Study|Noncompliance with study drug regimen|0|||
155567810|NCT00642278|561502917|FG001|Overall Study|Noncompliance with study drug regimen|0|||
155567811|NCT00642278|561502918|FG002|Overall Study|Noncompliance with study drug regimen|0|||
155567812|NCT00642278|561502919|FG003|Overall Study|Noncompliance with study drug regimen|1|||
155567813|NCT00642278|561502920|FG004|Overall Study|Noncompliance with study drug regimen|0|||
155567814|NCT00642278|561502921|FG005|Overall Study|Noncompliance with study drug regimen|0|||
155567815|NCT00642278|561502922|FG006|Overall Study|Noncompliance with study drug regimen|0|||
155567816|NCT00642278|561502916|FG000|Overall Study|Other|2|||
155567817|NCT00642278|561502917|FG001|Overall Study|Other|1|||
155567818|NCT00642278|561502918|FG002|Overall Study|Other|0|||
155567819|NCT00642278|561502919|FG003|Overall Study|Other|1|||
155567820|NCT00642278|561502920|FG004|Overall Study|Other|0|||
155567821|NCT00642278|561502921|FG005|Overall Study|Other|1|||
155567822|NCT00642278|561502922|FG006|Overall Study|Other|0|||
155567823|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
155567824|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155567825|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
155567826|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155567827|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155567828|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
155567829|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155567830|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155567831|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155567832|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155567833|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
155567834|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
155567835|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
155567836|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
155567837|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
155567838|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
155567839|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155567840|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155567841|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155567842|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155567843|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
155567844|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
155567845|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
155567846|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155567847|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155567848|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
155567849|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
155567850|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
155567851|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
155567852|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
155567853|NCT03713619|561502923|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
155567854|NCT03713619|561502924|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
155567855|NCT03713619|561502925|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
155567856|NCT03713619|561502926|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
155567857|NCT03713619|561502927|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
155567858|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
155567859|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
155567860|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
155567861|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
155567862|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
155567863|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
155567864|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155567865|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155567866|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
155567867|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155567868|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
155567869|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
155567870|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
155567871|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
155567872|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
155567873|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
155567874|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
155567875|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
155567876|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
155567877|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
155567878|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
155567879|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
155567880|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
155567881|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
155567882|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
155567883|NCT03713619|561502923|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155567884|NCT03713619|561502924|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
155567885|NCT03713619|561502925|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155567886|NCT03713619|561502926|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
155567887|NCT03713619|561502927|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
155567888|NCT04642365|561502929|FG000|Overall Study|Death|3|||
155567889|NCT04642365|561502930|FG001|Overall Study|Death|2|||
155567890|NCT04642365|561502931|FG002|Overall Study|Death|4|||
155567891|NCT04642365|561502932|FG003|Overall Study|Death|5|||
155567892|NCT04642365|561502933|FG004|Overall Study|Death|5|||
155567893|NCT04642365|561502934|FG005|Overall Study|Death|3|||
155567894|NCT04642365|561502935|FG006|Overall Study|Death|2|||
155567895|NCT04642365|561502936|FG007|Overall Study|Death|1|||
155567896|NCT04642365|561502929|FG000|Overall Study|Physician Decision|1|||
155567897|NCT04642365|561502930|FG001|Overall Study|Physician Decision|0|||
155567898|NCT04642365|561502931|FG002|Overall Study|Physician Decision|0|||
155567899|NCT04642365|561502932|FG003|Overall Study|Physician Decision|0|||
155567900|NCT04642365|561502933|FG004|Overall Study|Physician Decision|0|||
155567901|NCT04642365|561502934|FG005|Overall Study|Physician Decision|0|||
155567902|NCT04642365|561502935|FG006|Overall Study|Physician Decision|0|||
155567903|NCT04642365|561502936|FG007|Overall Study|Physician Decision|0|||
155567904|NCT04642365|561502929|FG000|Overall Study|Progressive Disease|1|||
155567905|NCT04642365|561502930|FG001|Overall Study|Progressive Disease|1|||
155567906|NCT04642365|561502931|FG002|Overall Study|Progressive Disease|1|||
155567907|NCT04642365|561502932|FG003|Overall Study|Progressive Disease|0|||
155567908|NCT04642365|561502933|FG004|Overall Study|Progressive Disease|0|||
155567909|NCT04642365|561502934|FG005|Overall Study|Progressive Disease|0|||
155567910|NCT04642365|561502935|FG006|Overall Study|Progressive Disease|1|||
155567911|NCT04642365|561502936|FG007|Overall Study|Progressive Disease|0|||
155567912|NCT04642365|561502929|FG000|Overall Study|Study Terminated By Sponsor|0|||
155567913|NCT04642365|561502930|FG001|Overall Study|Study Terminated By Sponsor|2|||
155567914|NCT04642365|561502931|FG002|Overall Study|Study Terminated By Sponsor|1|||
155567915|NCT04642365|561502932|FG003|Overall Study|Study Terminated By Sponsor|1|||
155567916|NCT04642365|561502933|FG004|Overall Study|Study Terminated By Sponsor|1|||
155567917|NCT04642365|561502934|FG005|Overall Study|Study Terminated By Sponsor|2|||
155567918|NCT04642365|561502935|FG006|Overall Study|Study Terminated By Sponsor|2|||
155567919|NCT04642365|561502936|FG007|Overall Study|Study Terminated By Sponsor|1|||
155567920|NCT04642365|561502929|FG000|Overall Study|Symptomatic Deterioration|1|||
155567921|NCT04642365|561502930|FG001|Overall Study|Symptomatic Deterioration|1|||
155567922|NCT04642365|561502931|FG002|Overall Study|Symptomatic Deterioration|0|||
155567923|NCT04642365|561502932|FG003|Overall Study|Symptomatic Deterioration|0|||
155567924|NCT04642365|561502933|FG004|Overall Study|Symptomatic Deterioration|0|||
155567925|NCT04642365|561502934|FG005|Overall Study|Symptomatic Deterioration|1|||
155567926|NCT04642365|561502935|FG006|Overall Study|Symptomatic Deterioration|0|||
155567927|NCT04642365|561502936|FG007|Overall Study|Symptomatic Deterioration|0|||
155567928|NCT04642365|561502929|FG000|Overall Study|Withdrawal by Subject|0|||
155567929|NCT04642365|561502930|FG001|Overall Study|Withdrawal by Subject|0|||
155567930|NCT04642365|561502931|FG002|Overall Study|Withdrawal by Subject|1|||
155567931|NCT04642365|561502932|FG003|Overall Study|Withdrawal by Subject|1|||
155567932|NCT04642365|561502933|FG004|Overall Study|Withdrawal by Subject|0|||
155567933|NCT04642365|561502934|FG005|Overall Study|Withdrawal by Subject|0|||
155567934|NCT04642365|561502935|FG006|Overall Study|Withdrawal by Subject|2|||
155567935|NCT04642365|561502936|FG007|Overall Study|Withdrawal by Subject|0|||
155567936|NCT04642365|561502929|FG000|Overall Study|Adverse Event|0|||
155567937|NCT04642365|561502930|FG001|Overall Study|Adverse Event|0|||
155567938|NCT04642365|561502931|FG002|Overall Study|Adverse Event|0|||
155567939|NCT04642365|561502932|FG003|Overall Study|Adverse Event|0|||
155567940|NCT04642365|561502933|FG004|Overall Study|Adverse Event|0|||
155567941|NCT04642365|561502934|FG005|Overall Study|Adverse Event|0|||
155567942|NCT04642365|561502935|FG006|Overall Study|Adverse Event|0|||
155567943|NCT04642365|561502936|FG007|Overall Study|Adverse Event|1|||
155567944|NCT01144715|561502937|FG000|Overall Study|Lost to Follow-up|2|||
155567945|NCT01144715|561502938|FG001|Overall Study|Lost to Follow-up|1|||
155567946|NCT01144715|561502937|FG000|Overall Study|Withdrawal by Subject|2|||
155567947|NCT01144715|561502938|FG001|Overall Study|Withdrawal by Subject|1|||
155659894|NCT00582907|561850476|FG003|2nd Course|Lack of Efficacy|0|||
155659895|NCT04622592|561850477|FG000|Overall Study|Death|0|||
155659896|NCT04622592|561850478|FG001|Overall Study|Death|0|||
155659897|NCT04622592|561850479|FG002|Overall Study|Death|1|||
155659898|NCT04622592|561850480|FG003|Overall Study|Death|0|||
155659899|NCT04622592|561850481|FG004|Overall Study|Death|0|||
155659900|NCT04622592|561850482|FG005|Overall Study|Death|0|||
155659901|NCT04622592|561850483|FG006|Overall Study|Death|0|||
155659902|NCT04622592|561850484|FG007|Overall Study|Death|1|||
155659903|NCT04622592|561850477|FG000|Overall Study|Lost to Follow-up|0|||
155659904|NCT04622592|561850478|FG001|Overall Study|Lost to Follow-up|0|||
155659905|NCT04622592|561850479|FG002|Overall Study|Lost to Follow-up|0|||
155659906|NCT04622592|561850480|FG003|Overall Study|Lost to Follow-up|3|||
155659907|NCT04622592|561850481|FG004|Overall Study|Lost to Follow-up|1|||
155659908|NCT04622592|561850482|FG005|Overall Study|Lost to Follow-up|0|||
155659909|NCT04622592|561850483|FG006|Overall Study|Lost to Follow-up|2|||
155659910|NCT04622592|561850484|FG007|Overall Study|Lost to Follow-up|2|||
155659911|NCT04622592|561850477|FG000|Overall Study|Physician Decision|0|||
155659912|NCT04622592|561850478|FG001|Overall Study|Physician Decision|0|||
155659913|NCT04622592|561850479|FG002|Overall Study|Physician Decision|0|||
155659914|NCT04622592|561850480|FG003|Overall Study|Physician Decision|0|||
155659915|NCT04622592|561850481|FG004|Overall Study|Physician Decision|1|||
155659916|NCT04622592|561850482|FG005|Overall Study|Physician Decision|0|||
155659917|NCT04622592|561850483|FG006|Overall Study|Physician Decision|0|||
155659918|NCT04622592|561850484|FG007|Overall Study|Physician Decision|0|||
155659919|NCT04622592|561850477|FG000|Overall Study|Withdrawal by Subject|1|||
155659920|NCT04622592|561850478|FG001|Overall Study|Withdrawal by Subject|0|||
155659921|NCT04622592|561850479|FG002|Overall Study|Withdrawal by Subject|2|||
155659922|NCT04622592|561850480|FG003|Overall Study|Withdrawal by Subject|0|||
155659923|NCT04622592|561850481|FG004|Overall Study|Withdrawal by Subject|0|||
155659924|NCT04622592|561850482|FG005|Overall Study|Withdrawal by Subject|0|||
155659925|NCT04622592|561850483|FG006|Overall Study|Withdrawal by Subject|1|||
155659926|NCT04622592|561850484|FG007|Overall Study|Withdrawal by Subject|4|||
155659927|NCT04622592|561850477|FG000|Overall Study|Other than specified above|0|||
155659928|NCT04622592|561850478|FG001|Overall Study|Other than specified above|0|||
155659929|NCT04622592|561850479|FG002|Overall Study|Other than specified above|1|||
155659930|NCT04622592|561850480|FG003|Overall Study|Other than specified above|0|||
155659931|NCT04622592|561850481|FG004|Overall Study|Other than specified above|0|||
155659932|NCT04622592|561850482|FG005|Overall Study|Other than specified above|0|||
155659933|NCT04622592|561850483|FG006|Overall Study|Other than specified above|0|||
155659934|NCT04622592|561850484|FG007|Overall Study|Other than specified above|0|||
155659935|NCT03309202|561850485|FG000|Overall Study|Lost to Follow-up|1|||
155659936|NCT03309202|561850486|FG001|Overall Study|Lost to Follow-up|0|||
155659937|NCT03309202|561850487|FG002|Overall Study|Lost to Follow-up|0|||
155659938|NCT03309202|561850488|FG003|Overall Study|Lost to Follow-up|0|||
155659939|NCT00415636|561850489|FG000|Overall Study|Symptomatic deterioration|1|||
155659940|NCT00415636|561850490|FG001|Overall Study|Symptomatic deterioration|0|||
155659941|NCT00415636|561850491|FG002|Overall Study|Symptomatic deterioration|1|||
155659942|NCT00415636|561850492|FG003|Overall Study|Symptomatic deterioration|2|||
155659943|NCT00415636|561850493|FG004|Overall Study|Symptomatic deterioration|0|||
155659944|NCT00415636|561850494|FG005|Overall Study|Symptomatic deterioration|1|||
155659945|NCT00415636|561850489|FG000|Overall Study|Adverse Event|0|||
155659946|NCT00415636|561850490|FG001|Overall Study|Adverse Event|0|||
155659947|NCT00415636|561850491|FG002|Overall Study|Adverse Event|0|||
155659948|NCT00415636|561850492|FG003|Overall Study|Adverse Event|1|||
155659949|NCT00415636|561850493|FG004|Overall Study|Adverse Event|1|||
155659950|NCT00415636|561850494|FG005|Overall Study|Adverse Event|0|||
155659951|NCT00415636|561850489|FG000|Overall Study|Withdrawal by Subject|0|||
155659952|NCT00415636|561850490|FG001|Overall Study|Withdrawal by Subject|0|||
155659953|NCT00415636|561850491|FG002|Overall Study|Withdrawal by Subject|0|||
155659954|NCT00415636|561850492|FG003|Overall Study|Withdrawal by Subject|0|||
155659955|NCT00415636|561850493|FG004|Overall Study|Withdrawal by Subject|1|||
155659956|NCT00415636|561850494|FG005|Overall Study|Withdrawal by Subject|0|||
155659957|NCT00415636|561850489|FG000|Overall Study|Disease progression|0|||
155659958|NCT00415636|561850490|FG001|Overall Study|Disease progression|0|||
155659959|NCT00415636|561850491|FG002|Overall Study|Disease progression|0|||
155659960|NCT00415636|561850492|FG003|Overall Study|Disease progression|3|||
155659961|NCT00415636|561850493|FG004|Overall Study|Disease progression|0|||
155659962|NCT00415636|561850494|FG005|Overall Study|Disease progression|1|||
155659963|NCT02138825|561850495|FG000|Main Study Treatment|Adverse Event|11|||
155659964|NCT02138825|561850496|FG001|Main Study Treatment|Adverse Event|3|||
155659965|NCT02138825|561850495|FG000|Main Study Treatment|Death|1|||
155659966|NCT02138825|561850496|FG001|Main Study Treatment|Death|2|||
155659967|NCT02138825|561850495|FG000|Main Study Treatment|Protocol Violation|2|||
155659968|NCT02138825|561850496|FG001|Main Study Treatment|Protocol Violation|2|||
155659969|NCT02138825|561850495|FG000|Main Study Treatment|Sponsor decision|12|||
155659970|NCT02138825|561850496|FG001|Main Study Treatment|Sponsor decision|18|||
155659971|NCT02138825|561850495|FG000|Main Study Treatment|Study terminated by sponsor|10|||
155659972|NCT02138825|561850496|FG001|Main Study Treatment|Study terminated by sponsor|9|||
155659973|NCT02138825|561850495|FG000|Main Study Treatment|Withdrawal by Subject|3|||
155659974|NCT02138825|561850496|FG001|Main Study Treatment|Withdrawal by Subject|1|||
155659975|NCT02138825|561850495|FG000|Main Study Treatment|Medical decision|1|||
155659976|NCT02138825|561850496|FG001|Main Study Treatment|Medical decision|0|||
155659977|NCT02138825|561850495|FG000|Long-term Extension|Study termination by sponsor|32|||
155659978|NCT02138825|561850496|FG001|Long-term Extension|Study termination by sponsor|38|||
155659979|NCT02138825|561850495|FG000|Safety Follow-up|Adverse Event|4|||
155659980|NCT02138825|561850496|FG001|Safety Follow-up|Adverse Event|3|||
155659981|NCT02138825|561850495|FG000|Safety Follow-up|Death|11|||
155659982|NCT02138825|561850496|FG001|Safety Follow-up|Death|5|||
155659983|NCT02138825|561850495|FG000|Safety Follow-up|Withdrawal by Subject|5|||
155659984|NCT02138825|561850496|FG001|Safety Follow-up|Withdrawal by Subject|3|||
155659985|NCT02138825|561850495|FG000|Safety Follow-up|clinic worsening|1|||
155659986|NCT02138825|561850496|FG001|Safety Follow-up|clinic worsening|0|||
155659987|NCT02138825|561850495|FG000|Safety Follow-up|withdrawal by PI|1|||
155659988|NCT02138825|561850496|FG001|Safety Follow-up|withdrawal by PI|0|||
155659989|NCT02138825|561850495|FG000|Safety Follow-up|logistical difficulties|0|||
155659990|NCT02138825|561850496|FG001|Safety Follow-up|logistical difficulties|1|||
155659991|NCT02138825|561850495|FG000|Safety Follow-up|progressive disease|0|||
155659992|NCT02138825|561850496|FG001|Safety Follow-up|progressive disease|2|||
155659993|NCT02138825|561850495|FG000|Safety Follow-up|too unwell to attend the visit|0|||
155659994|NCT02138825|561850496|FG001|Safety Follow-up|too unwell to attend the visit|1|||
155659995|NCT02138825|561850495|FG000|Safety Follow-up|treatment unblinded|0|||
155659996|NCT02138825|561850496|FG001|Safety Follow-up|treatment unblinded|1|||
155659997|NCT02138825|561850495|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
155659998|NCT02138825|561850496|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
155659999|NCT01702298|561850499|FG000|Overall Study|Withdrawal by Subject|1|||
155660000|NCT01664624|561850505|FG000|Overall Study|Adverse Event|0|||
155660001|NCT01664624|561850506|FG001|Overall Study|Adverse Event|1|||
155660002|NCT01664624|561850507|FG002|Overall Study|Adverse Event|0|||
155660003|NCT01664624|561850508|FG003|Overall Study|Adverse Event|0|||
155660004|NCT00560508|561850509|FG000|12 Week Double-blind Period|Adverse Event|3|||
155660005|NCT00560508|561850510|FG001|12 Week Double-blind Period|Adverse Event|2|||
155660006|NCT00560508|561850509|FG000|12 Week Double-blind Period|Protocol Violation|1|||
155660007|NCT00560508|561850510|FG001|12 Week Double-blind Period|Protocol Violation|0|||
155660008|NCT00560508|561850509|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
155660009|NCT00560508|561850510|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
155660010|NCT00560508|561850509|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
155660011|NCT00560508|561850510|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
155660012|NCT00560508|561850509|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
155660013|NCT00560508|561850510|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
155660014|NCT00560508|561850509|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
155660015|NCT00560508|561850510|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
155660016|NCT00560508|561850509|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
155660017|NCT00560508|561850510|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
155660018|NCT03493958|561850511|FG000|Overall Study|Withdrawal by Subject|6|||
155660019|NCT03493958|561850511|FG000|Overall Study|Lost to Follow-up|7|||
155660020|NCT03493958|561850511|FG000|Overall Study|Did not complete all required study procedures|2|||
155660021|NCT02367456|561850512|FG000|Overall Study|Death|8|||
155660022|NCT02367456|561850513|FG001|Overall Study|Death|24|||
155660023|NCT02367456|561850514|FG002|Overall Study|Death|17|||
155660024|NCT02367456|561850512|FG000|Overall Study|Lost to Follow-up|1|||
155660025|NCT02367456|561850513|FG001|Overall Study|Lost to Follow-up|3|||
155660026|NCT02367456|561850514|FG002|Overall Study|Lost to Follow-up|1|||
155660027|NCT02367456|561850512|FG000|Overall Study|Other reason|3|||
155660028|NCT02367456|561850513|FG001|Overall Study|Other reason|3|||
155660029|NCT02367456|561850514|FG002|Overall Study|Other reason|9|||
155660030|NCT02367456|561850512|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
155660031|NCT02367456|561850513|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
155660032|NCT02367456|561850514|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
155660033|NCT01645176|561850516|FG000|Overall Study|Lack of Efficacy|4|||
155660034|NCT01645176|561850516|FG000|Overall Study|did not complete final MRI|1|||
155660035|NCT04903288|561850519|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
155660036|NCT04903288|561850519|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
155660037|NCT04903288|561850519|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
155660038|NCT04903288|561850519|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
155660039|NCT00573768|561850520|FG000|Overall Study|Adverse Event|1|||
155660040|NCT00573768|561850521|FG001|Overall Study|Adverse Event|1|||
155660041|NCT00573768|561850522|FG002|Overall Study|Adverse Event|2|||
155660042|NCT00573768|561850520|FG000|Overall Study|Protocol Violation|1|||
155660043|NCT00573768|561850521|FG001|Overall Study|Protocol Violation|0|||
155660044|NCT00573768|561850522|FG002|Overall Study|Protocol Violation|1|||
155660045|NCT00573768|561850520|FG000|Overall Study|Withdrawal by Subject|0|||
155567948|NCT01144715|561502937|FG000|Overall Study|Adverse Event|0|||
155567949|NCT01144715|561502938|FG001|Overall Study|Adverse Event|1|||
155567950|NCT03553576|561502939|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
155567951|NCT03553576|561502940|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
155567952|NCT03553576|561502939|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
155567953|NCT03553576|561502940|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
155567954|NCT03553576|561502939|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
155567955|NCT03553576|561502940|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
155567956|NCT03553576|561502939|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
155567957|NCT03553576|561502940|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
155567958|NCT03553576|561502939|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
155567959|NCT03553576|561502940|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
155567960|NCT03553576|561502939|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
155567961|NCT03553576|561502940|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
155567962|NCT03553576|561502939|FG000|Overall Study|Physician Decision|2|||
155567963|NCT03553576|561502940|FG001|Overall Study|Physician Decision|5|||
155567964|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
155567965|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
155567966|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
155567967|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
155567968|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
155567969|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
155567970|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
155567971|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
155567972|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
155567973|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
155567974|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
155567975|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
155567976|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
155567977|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
155567978|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
155567979|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
155567980|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
155567981|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
155567982|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
155567983|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
155567984|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
155567985|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
155567986|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
155567987|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
155567988|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
155567989|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
155567990|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
155567991|NCT02552212|561502941|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
155567992|NCT02552212|561502942|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
155567993|NCT02552212|561502943|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
155567994|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
155567995|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
155567996|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
155567997|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
155567998|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
155567999|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
155568000|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
155568001|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
155568002|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
155568003|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
155568004|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
155568005|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
155568006|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
155568007|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
155568008|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
155568009|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
155568010|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
155568011|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
155568012|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
155568013|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
155568014|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
155568015|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
155568016|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
155568017|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
155568018|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
155568019|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
155568020|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
155568021|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
155568022|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
155568023|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
155660046|NCT00573768|561850521|FG001|Overall Study|Withdrawal by Subject|1|||
155660047|NCT00573768|561850522|FG002|Overall Study|Withdrawal by Subject|0|||
155660048|NCT00573768|561850520|FG000|Overall Study|Lost to Follow-up|0|||
155660049|NCT00573768|561850521|FG001|Overall Study|Lost to Follow-up|0|||
155660050|NCT00573768|561850522|FG002|Overall Study|Lost to Follow-up|1|||
155660051|NCT00904371|561850523|FG000|Overall Study|Adverse Event|2|||
155660052|NCT00904371|561850523|FG000|Overall Study|Lost to Follow-up|4|||
155660053|NCT00904371|561850523|FG000|Overall Study|Discontinued at target blood pressure|2|||
155660054|NCT00904371|561850523|FG000|Overall Study|Continued with Tritace|1|||
155660055|NCT01668004|561850526|FG000|Overall Study|Adverse Event|7|||
155660056|NCT01668004|561850526|FG000|Overall Study|Withdrawal by Subject|2|||
155660057|NCT01668004|561850526|FG000|Overall Study|Lost to Follow-up|5|||
155660058|NCT01668004|561850526|FG000|Overall Study|Lack of Efficacy|9|||
155660059|NCT01668004|561850526|FG000|Overall Study|Non-compliance with treatment|2|||
155660060|NCT01500317|561850532|FG000|Overall Study|Withdrawal by Subject|3|||
155660061|NCT01500317|561850533|FG001|Overall Study|Withdrawal by Subject|2|||
155660062|NCT01500317|561850534|FG002|Overall Study|Withdrawal by Subject|0|||
155660063|NCT00976456|561850535|FG000|Overall Study|Adverse Event|17|||
155660064|NCT00976456|561850536|FG001|Overall Study|Adverse Event|22|||
155660065|NCT00976456|561850535|FG000|Overall Study|Death|7|||
155660066|NCT00976456|561850536|FG001|Overall Study|Death|9|||
155660067|NCT00976456|561850535|FG000|Overall Study|Lack of Efficacy|5|||
155660068|NCT00976456|561850536|FG001|Overall Study|Lack of Efficacy|2|||
155660069|NCT00976456|561850535|FG000|Overall Study|Withdrawal by Subject|3|||
155660070|NCT00976456|561850536|FG001|Overall Study|Withdrawal by Subject|1|||
155660071|NCT00976456|561850535|FG000|Overall Study|screening failure, unknown|11|||
155660072|NCT00976456|561850536|FG001|Overall Study|screening failure, unknown|4|||
155660073|NCT00335829|561850537|FG000|Overall Study|Withdrawal by Subject|1|||
155660074|NCT00335829|561850537|FG000|Overall Study|Lost to Follow-up|1|||
155660075|NCT00335829|561850537|FG000|Overall Study|Adverse Event|1|||
155660076|NCT02090764|561850540|FG000|Overall Study|Adverse Event|1|||
155660077|NCT02090764|561850541|FG001|Overall Study|Adverse Event|3|||
155660078|NCT02090764|561850540|FG000|Overall Study|Lack of Efficacy|0|||
155660079|NCT02090764|561850541|FG001|Overall Study|Lack of Efficacy|13|||
155660080|NCT02090764|561850540|FG000|Overall Study|Withdrawal by Subject|2|||
155660081|NCT02090764|561850541|FG001|Overall Study|Withdrawal by Subject|1|||
155660082|NCT02090764|561850540|FG000|Overall Study|Intercurrent illness and other|1|||
155660083|NCT02090764|561850541|FG001|Overall Study|Intercurrent illness and other|1|||
155660084|NCT02090764|561850540|FG000|Overall Study|Lost to Follow-up|2|||
155660085|NCT02090764|561850541|FG001|Overall Study|Lost to Follow-up|2|||
155660086|NCT00673920|561850552|FG000|Baseline up to Week 48|Withdrew consent|1|||
155660087|NCT00673920|561850553|FG001|Baseline up to Week 48|Withdrew consent|0|||
155660088|NCT00673920|561850554|FG002|Baseline up to Week 48|Withdrew consent|2|||
155660089|NCT00673920|561850555|FG003|Baseline up to Week 48|Withdrew consent|0|||
155660090|NCT00673920|561850556|FG004|Baseline up to Week 48|Withdrew consent|0|||
155568024|NCT02552212|561502941|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
155568025|NCT02552212|561502942|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
155568026|NCT02552212|561502943|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
155568027|NCT02728843|561502944|FG000|Overall Study|Adverse Event|0|||
155660091|NCT00673920|561850557|FG005|Baseline up to Week 48|Withdrew consent|0|||
155660092|NCT00673920|561850558|FG006|Baseline up to Week 48|Withdrew consent|0|||
155660093|NCT00673920|561850559|FG007|Baseline up to Week 48|Withdrew consent|0|||
155660094|NCT00673920|561850552|FG000|Baseline up to Week 48|Refused treatment|1|||
155660095|NCT00673920|561850553|FG001|Baseline up to Week 48|Refused treatment|0|||
155660096|NCT00673920|561850554|FG002|Baseline up to Week 48|Refused treatment|0|||
155660097|NCT00673920|561850555|FG003|Baseline up to Week 48|Refused treatment|0|||
155660098|NCT00673920|561850556|FG004|Baseline up to Week 48|Refused treatment|0|||
155660099|NCT00673920|561850557|FG005|Baseline up to Week 48|Refused treatment|0|||
155660100|NCT00673920|561850558|FG006|Baseline up to Week 48|Refused treatment|0|||
155660101|NCT00673920|561850559|FG007|Baseline up to Week 48|Refused treatment|0|||
155660102|NCT00673920|561850552|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
155660103|NCT00673920|561850553|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
155660104|NCT00673920|561850554|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660105|NCT00673920|561850555|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660106|NCT00673920|561850556|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660107|NCT00673920|561850557|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660108|NCT00673920|561850558|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660109|NCT00673920|561850559|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
155660110|NCT00673920|561850552|FG000|Baseline up to Week 48|Protocol Violation|0|||
155660111|NCT00673920|561850553|FG001|Baseline up to Week 48|Protocol Violation|0|||
155660112|NCT00673920|561850554|FG002|Baseline up to Week 48|Protocol Violation|1|||
155660113|NCT00673920|561850555|FG003|Baseline up to Week 48|Protocol Violation|0|||
155660114|NCT00673920|561850556|FG004|Baseline up to Week 48|Protocol Violation|0|||
155660115|NCT00673920|561850557|FG005|Baseline up to Week 48|Protocol Violation|0|||
155660116|NCT00673920|561850558|FG006|Baseline up to Week 48|Protocol Violation|0|||
155660117|NCT00673920|561850559|FG007|Baseline up to Week 48|Protocol Violation|0|||
155660118|NCT00673920|561850552|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660119|NCT00673920|561850553|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660120|NCT00673920|561850554|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
155660121|NCT00673920|561850555|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660122|NCT00673920|561850556|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660123|NCT00673920|561850557|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660124|NCT00673920|561850558|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660125|NCT00673920|561850559|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155660126|NCT00673920|561850552|FG000|Baseline up to Week 48|Administrative/Other|0|||
155660127|NCT00673920|561850553|FG001|Baseline up to Week 48|Administrative/Other|1|||
155660128|NCT00673920|561850554|FG002|Baseline up to Week 48|Administrative/Other|2|||
155660129|NCT00673920|561850555|FG003|Baseline up to Week 48|Administrative/Other|0|||
155660130|NCT00673920|561850556|FG004|Baseline up to Week 48|Administrative/Other|0|||
155660131|NCT00673920|561850557|FG005|Baseline up to Week 48|Administrative/Other|0|||
155660132|NCT00673920|561850558|FG006|Baseline up to Week 48|Administrative/Other|0|||
155660133|NCT00673920|561850559|FG007|Baseline up to Week 48|Administrative/Other|0|||
155660134|NCT00673920|561850552|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660135|NCT00673920|561850553|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
155660136|NCT00673920|561850554|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
155660137|NCT00673920|561850555|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660138|NCT00673920|561850556|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660139|NCT00673920|561850557|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660140|NCT00673920|561850558|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660141|NCT00673920|561850559|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155660142|NCT00673920|561850552|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155660143|NCT00673920|561850553|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155660144|NCT00673920|561850554|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155660145|NCT00673920|561850555|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155660146|NCT00673920|561850556|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155568028|NCT02728843|561502945|FG001|Overall Study|Adverse Event|2|||
155568029|NCT02728843|561502946|FG002|Overall Study|Adverse Event|3|||
155568030|NCT02728843|561502947|FG003|Overall Study|Adverse Event|1|||
155568031|NCT02728843|561502948|FG004|Overall Study|Adverse Event|2|||
155568032|NCT02728843|561502944|FG000|Overall Study|Lack of Efficacy|0|||
155568033|NCT02728843|561502945|FG001|Overall Study|Lack of Efficacy|1|||
155568034|NCT02728843|561502946|FG002|Overall Study|Lack of Efficacy|1|||
155568035|NCT02728843|561502947|FG003|Overall Study|Lack of Efficacy|0|||
155568036|NCT02728843|561502948|FG004|Overall Study|Lack of Efficacy|0|||
155568037|NCT02728843|561502944|FG000|Overall Study|Protocol Violation|2|||
155568038|NCT02728843|561502945|FG001|Overall Study|Protocol Violation|0|||
155568039|NCT02728843|561502946|FG002|Overall Study|Protocol Violation|4|||
155568040|NCT02728843|561502947|FG003|Overall Study|Protocol Violation|2|||
155568041|NCT02728843|561502948|FG004|Overall Study|Protocol Violation|2|||
155568042|NCT02728843|561502944|FG000|Overall Study|Withdrawal by Subject|1|||
155568043|NCT02728843|561502945|FG001|Overall Study|Withdrawal by Subject|0|||
155568044|NCT02728843|561502946|FG002|Overall Study|Withdrawal by Subject|0|||
155568045|NCT02728843|561502947|FG003|Overall Study|Withdrawal by Subject|1|||
155568046|NCT02728843|561502948|FG004|Overall Study|Withdrawal by Subject|0|||
155568047|NCT02728843|561502944|FG000|Overall Study|Use of rescue medication|0|||
155568048|NCT02728843|561502945|FG001|Overall Study|Use of rescue medication|2|||
155568049|NCT02728843|561502946|FG002|Overall Study|Use of rescue medication|0|||
155568050|NCT02728843|561502947|FG003|Overall Study|Use of rescue medication|2|||
155568051|NCT02728843|561502948|FG004|Overall Study|Use of rescue medication|1|||
155568052|NCT02478320|561502949|FG000|Overall Study|Adverse Event|2|||
155568053|NCT02478320|561502950|FG001|Overall Study|Adverse Event|0|||
155568054|NCT02478320|561502949|FG000|Overall Study|Death|1|||
155568055|NCT02478320|561502950|FG001|Overall Study|Death|0|||
155568056|NCT02478320|561502949|FG000|Overall Study|Lack of Efficacy|4|||
155568057|NCT02478320|561502950|FG001|Overall Study|Lack of Efficacy|0|||
155568058|NCT02478320|561502949|FG000|Overall Study|Withdrawal by Subject|2|||
155568059|NCT02478320|561502950|FG001|Overall Study|Withdrawal by Subject|0|||
155568060|NCT02478320|561502949|FG000|Overall Study|Screen Failure|3|||
155568061|NCT02478320|561502950|FG001|Overall Study|Screen Failure|0|||
155568062|NCT00197496|561502954|FG000|Baseline to Discharge|not interested|1|||
155568063|NCT00197496|561502955|FG001|Baseline to Discharge|not interested|0|||
155568064|NCT00197496|561502954|FG000|Baseline to Discharge|MRSA|1|||
155568065|NCT00197496|561502955|FG001|Baseline to Discharge|MRSA|0|||
155568066|NCT00197496|561502954|FG000|Baseline to Discharge|Physician Decision|0|||
155568067|NCT00197496|561502955|FG001|Baseline to Discharge|Physician Decision|1|||
155568068|NCT00197496|561502954|FG000|Baseline to Discharge|Protocol Violation|0|||
155568069|NCT00197496|561502955|FG001|Baseline to Discharge|Protocol Violation|1|||
155568070|NCT00197496|561502954|FG000|Follow-up|Lost to Follow-up|2|||
155568071|NCT00197496|561502955|FG001|Follow-up|Lost to Follow-up|1|||
155568072|NCT00960115|561502956|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
155568073|NCT00960115|561502957|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
155568074|NCT03014180|561502959|FG000|Overall Study|Protocol Violation|2|||
155568075|NCT02099682|561502962|FG000|Overall Study|Data Not Available|51|||
155568076|NCT02099682|561502962|FG000|Overall Study|Lost to Follow-up|31|||
155568077|NCT02099682|561502962|FG000|Overall Study|Other|29|||
155568078|NCT03408639|561504634|FG000|Overall Study|Death|5|||
155568079|NCT03408639|561504635|FG001|Overall Study|Death|5|||
155568080|NCT03408639|561504634|FG000|Overall Study|Lost to Follow-up|1|||
155568081|NCT03408639|561504635|FG001|Overall Study|Lost to Follow-up|4|||
155568082|NCT03408639|561504634|FG000|Overall Study|Withdrawal by Subject|2|||
155568083|NCT03408639|561504635|FG001|Overall Study|Withdrawal by Subject|7|||
155568084|NCT03408639|561504634|FG000|Overall Study|Physician Decision|3|||
155568085|NCT03408639|561504635|FG001|Overall Study|Physician Decision|6|||
155568086|NCT01924754|561504637|FG000|Overall Study|Lost to Follow-up|1|||
155568087|NCT01924754|561504638|FG001|Overall Study|Lost to Follow-up|2|||
155568088|NCT01924754|561504639|FG002|Overall Study|Lost to Follow-up|1|||
155568089|NCT01924754|561504637|FG000|Overall Study|Pregnancy|0|||
155568090|NCT01924754|561504638|FG001|Overall Study|Pregnancy|1|||
155660147|NCT00673920|561850557|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155568091|NCT01924754|561504639|FG002|Overall Study|Pregnancy|2|||
155660148|NCT00673920|561850558|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
155568092|NCT03132155|561504640|FG000|Overall Study|Lack of Efficacy|6|||
155568093|NCT03132155|561504640|FG000|Overall Study|Lost to Follow-up|1|||
155568094|NCT03132155|561504640|FG000|Overall Study|Withdrawal by Subject|1|||
155568095|NCT02925403|561504643|FG000|Overall Study|Lost to Follow-up|0|||
155568096|NCT02925403|561504644|FG001|Overall Study|Lost to Follow-up|1|||
155568097|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
155568098|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
155568099|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
155568100|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
155568101|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
155568102|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
155568103|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
155568104|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
155568105|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
155568106|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
155568107|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
155568108|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
155568109|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
155568110|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
155568111|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
155568112|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
155568113|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
155568114|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
155568115|NCT00261443|561504645|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
155568116|NCT00261443|561504646|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
155568117|NCT00261443|561504647|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
155568118|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
155568119|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
155568120|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
155568121|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
155568122|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
155568123|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
155568124|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
155568125|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
155568126|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
155568127|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
155568128|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
155568129|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
155568130|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
155568131|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
155568132|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
155568133|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
155568134|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
155568135|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
155568136|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
155568137|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
155568138|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
155568139|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
155568140|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
155568141|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
155568142|NCT00261443|561504645|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
155568143|NCT00261443|561504646|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
155568144|NCT00261443|561504647|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
155568145|NCT00261443|561504645|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
155568146|NCT00261443|561504646|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
155568147|NCT00261443|561504647|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
155568148|NCT00261443|561504645|FG000|3: Assessment of Relapse|Adverse Event|0|||
155568149|NCT00261443|561504646|FG001|3: Assessment of Relapse|Adverse Event|15|||
155568150|NCT00261443|561504647|FG002|3: Assessment of Relapse|Adverse Event|19|||
155568151|NCT00261443|561504645|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
155568152|NCT00261443|561504646|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
155568153|NCT00261443|561504647|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
155568154|NCT00261443|561504645|FG000|3: Assessment of Relapse|Death|0|||
155568155|NCT00261443|561504646|FG001|3: Assessment of Relapse|Death|0|||
155568156|NCT00261443|561504647|FG002|3: Assessment of Relapse|Death|1|||
155568157|NCT00261443|561504645|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
155568158|NCT00261443|561504646|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
155568159|NCT00261443|561504647|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
155568160|NCT00261443|561504645|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
155568161|NCT00261443|561504646|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
155568162|NCT00261443|561504647|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
155568163|NCT00261443|561504645|FG000|3: Assessment of Relapse|Pregnancy|0|||
155568164|NCT00261443|561504646|FG001|3: Assessment of Relapse|Pregnancy|2|||
155568165|NCT00261443|561504647|FG002|3: Assessment of Relapse|Pregnancy|1|||
155568166|NCT00261443|561504645|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
155568167|NCT00261443|561504646|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
155568168|NCT00261443|561504647|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
155568169|NCT00261443|561504645|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
155568170|NCT00261443|561504646|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
155568171|NCT00261443|561504647|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
155568172|NCT00261443|561504645|FG000|3: Assessment of Relapse|Other Reasons|0|||
155568173|NCT00261443|561504646|FG001|3: Assessment of Relapse|Other Reasons|4|||
155568174|NCT00261443|561504647|FG002|3: Assessment of Relapse|Other Reasons|3|||
155568175|NCT00261443|561504645|FG000|4: Extension Phase|Adverse Event|0|||
155568176|NCT00261443|561504646|FG001|4: Extension Phase|Adverse Event|1|||
155568177|NCT00261443|561504647|FG002|4: Extension Phase|Adverse Event|0|||
155568178|NCT00261443|561504645|FG000|4: Extension Phase|Withdrawal by Subject|0|||
155568179|NCT00261443|561504646|FG001|4: Extension Phase|Withdrawal by Subject|1|||
155568180|NCT00261443|561504647|FG002|4: Extension Phase|Withdrawal by Subject|2|||
155568181|NCT00261443|561504645|FG000|4: Extension Phase|Lost to Follow-up|0|||
155568182|NCT00261443|561504646|FG001|4: Extension Phase|Lost to Follow-up|1|||
155568183|NCT00261443|561504647|FG002|4: Extension Phase|Lost to Follow-up|0|||
155568184|NCT02094417|561504650|FG000|Overall Study|Adverse Event|0|||
155568185|NCT02094417|561504651|FG001|Overall Study|Adverse Event|0|||
155568186|NCT02094417|561504652|FG002|Overall Study|Adverse Event|0|||
155568187|NCT02094417|561504653|FG003|Overall Study|Adverse Event|1|||
155568188|NCT02094417|561504650|FG000|Overall Study|Eligibility criteria|0|||
155568189|NCT02094417|561504651|FG001|Overall Study|Eligibility criteria|1|||
155568190|NCT02094417|561504652|FG002|Overall Study|Eligibility criteria|0|||
155568191|NCT02094417|561504653|FG003|Overall Study|Eligibility criteria|0|||
155568192|NCT02094417|561504650|FG000|Overall Study|No responder|4|||
155568193|NCT02094417|561504651|FG001|Overall Study|No responder|4|||
155568194|NCT02094417|561504652|FG002|Overall Study|No responder|4|||
155568195|NCT02094417|561504653|FG003|Overall Study|No responder|3|||
155568196|NCT02094417|561504650|FG000|Overall Study|Unable to conduct observations or assess|0|||
155568197|NCT02094417|561504651|FG001|Overall Study|Unable to conduct observations or assess|1|||
155568198|NCT02094417|561504652|FG002|Overall Study|Unable to conduct observations or assess|0|||
155568199|NCT02094417|561504653|FG003|Overall Study|Unable to conduct observations or assess|0|||
155568200|NCT02094417|561504650|FG000|Overall Study|Withdrawal by Subject|1|||
155568201|NCT02094417|561504651|FG001|Overall Study|Withdrawal by Subject|2|||
155568202|NCT02094417|561504652|FG002|Overall Study|Withdrawal by Subject|1|||
155568203|NCT02094417|561504653|FG003|Overall Study|Withdrawal by Subject|3|||
155568204|NCT01443728|561504654|FG000|Overall Study|Lost to Follow-up|2|||
155568205|NCT01443728|561504655|FG001|Overall Study|Lost to Follow-up|0|||
155568206|NCT01443728|561504654|FG000|Overall Study|Withdrawal by Subject|1|||
155568207|NCT01443728|561504655|FG001|Overall Study|Withdrawal by Subject|1|||
155568208|NCT01443728|561504654|FG000|Overall Study|Adverse Event|0|||
155568209|NCT01443728|561504655|FG001|Overall Study|Adverse Event|2|||
155568210|NCT00741286|561504659|FG000|Overall Study|Lost to Follow-up|15|||
155568211|NCT00741286|561504660|FG001|Overall Study|Lost to Follow-up|10|||
155568212|NCT00741286|561504659|FG000|Overall Study|Adverse Event|1|||
155568213|NCT00741286|561504660|FG001|Overall Study|Adverse Event|6|||
155568214|NCT00741286|561504659|FG000|Overall Study|Protocol Violation|3|||
155568215|NCT00741286|561504660|FG001|Overall Study|Protocol Violation|2|||
155568216|NCT00741286|561504659|FG000|Overall Study|Primary Outcome|1|||
155568217|NCT00741286|561504660|FG001|Overall Study|Primary Outcome|1|||
155568218|NCT00253448|561504669|FG000|Overall Study|Withdrawal by Subject|1|||
155568219|NCT02564887|561504671|FG000|Overall Study|Lost to Follow-up|6|||
155568220|NCT02564887|561504672|FG001|Overall Study|Lost to Follow-up|0|||
155568221|NCT00000620|561504673|FG000|Overall Study|Death|86|||
155568222|NCT00000620|561504674|FG001|Overall Study|Death|67|||
155568223|NCT00000620|561504675|FG002|Overall Study|Death|112|||
155568224|NCT00000620|561504676|FG003|Overall Study|Death|126|||
155568225|NCT00000620|561504677|FG004|Overall Study|Death|64|||
155568226|NCT00000620|561504678|FG005|Overall Study|Death|77|||
155568227|NCT00000620|561504679|FG006|Overall Study|Death|91|||
155568228|NCT00000620|561504680|FG007|Overall Study|Death|95|||
155568229|NCT00000620|561504673|FG000|Overall Study|Lost to Follow-up|14|||
155568230|NCT00000620|561504674|FG001|Overall Study|Lost to Follow-up|14|||
155568231|NCT00000620|561504675|FG002|Overall Study|Lost to Follow-up|14|||
155568232|NCT00000620|561504676|FG003|Overall Study|Lost to Follow-up|14|||
155568233|NCT00000620|561504677|FG004|Overall Study|Lost to Follow-up|15|||
155568234|NCT00000620|561504678|FG005|Overall Study|Lost to Follow-up|15|||
155568235|NCT00000620|561504679|FG006|Overall Study|Lost to Follow-up|13|||
155568236|NCT00000620|561504680|FG007|Overall Study|Lost to Follow-up|14|||
155568237|NCT00000620|561504673|FG000|Overall Study|Withdrawal by Subject|40|||
155568238|NCT00000620|561504674|FG001|Overall Study|Withdrawal by Subject|27|||
155568239|NCT00000620|561504675|FG002|Overall Study|Withdrawal by Subject|28|||
155660149|NCT00673920|561850559|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155568240|NCT00000620|561504676|FG003|Overall Study|Withdrawal by Subject|27|||
155660150|NCT00673920|561850552|FG000|Week 24 to Week 48|Failure to return|0|||
155568241|NCT00000620|561504677|FG004|Overall Study|Withdrawal by Subject|30|||
155568242|NCT00000620|561504678|FG005|Overall Study|Withdrawal by Subject|32|||
155568243|NCT00000620|561504679|FG006|Overall Study|Withdrawal by Subject|32|||
155568244|NCT00000620|561504680|FG007|Overall Study|Withdrawal by Subject|21|||
155660151|NCT00673920|561850553|FG001|Week 24 to Week 48|Failure to return|0|||
155660152|NCT00673920|561850554|FG002|Week 24 to Week 48|Failure to return|0|||
155660153|NCT00673920|561850555|FG003|Week 24 to Week 48|Failure to return|0|||
155660154|NCT00673920|561850556|FG004|Week 24 to Week 48|Failure to return|0|||
155660155|NCT00673920|561850557|FG005|Week 24 to Week 48|Failure to return|1|||
155660156|NCT00673920|561850558|FG006|Week 24 to Week 48|Failure to return|0|||
155660157|NCT00673920|561850559|FG007|Week 24 to Week 48|Failure to return|0|||
155660158|NCT00673920|561850552|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660159|NCT00673920|561850553|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660160|NCT00673920|561850554|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660161|NCT00673920|561850555|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660162|NCT00673920|561850556|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660163|NCT00673920|561850557|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
155660164|NCT00673920|561850558|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660165|NCT00673920|561850559|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
155660166|NCT00673920|561850552|FG000|Week 24 to Week 48|Death|0|||
155660167|NCT00673920|561850553|FG001|Week 24 to Week 48|Death|0|||
155660168|NCT00673920|561850554|FG002|Week 24 to Week 48|Death|0|||
155660169|NCT00673920|561850555|FG003|Week 24 to Week 48|Death|0|||
155660170|NCT00673920|561850556|FG004|Week 24 to Week 48|Death|0|||
155660171|NCT00673920|561850557|FG005|Week 24 to Week 48|Death|1|||
155660172|NCT00673920|561850558|FG006|Week 24 to Week 48|Death|0|||
155660173|NCT00673920|561850559|FG007|Week 24 to Week 48|Death|0|||
155660174|NCT00673920|561850552|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
155660175|NCT00673920|561850553|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
155660176|NCT00673920|561850554|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
155660177|NCT00673920|561850555|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
155660178|NCT00673920|561850556|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
155660179|NCT00673920|561850557|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
155660180|NCT00673920|561850558|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
155660181|NCT00673920|561850559|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
155660182|NCT02300233|561850563|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
155660183|NCT02300233|561850564|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155660184|NCT02300233|561850565|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
155660185|NCT02300233|561850563|FG000|Overall Study|Withdrawal by Subject|1|||
155660186|NCT02300233|561850564|FG001|Overall Study|Withdrawal by Subject|0|||
155660187|NCT02300233|561850565|FG002|Overall Study|Withdrawal by Subject|3|||
155660188|NCT02300233|561850563|FG000|Overall Study|Investigator Judgement|0|||
155660189|NCT02300233|561850564|FG001|Overall Study|Investigator Judgement|0|||
155660190|NCT02300233|561850565|FG002|Overall Study|Investigator Judgement|1|||
155660191|NCT02300233|561850563|FG000|Overall Study|Reason Not Specified|0|||
155660192|NCT02300233|561850564|FG001|Overall Study|Reason Not Specified|0|||
155660193|NCT02300233|561850565|FG002|Overall Study|Reason Not Specified|5|||
155660194|NCT00833690|561850566|FG000|Overall Study|Withdrawal by Subject|1|||
155660195|NCT00833690|561850567|FG001|Overall Study|Withdrawal by Subject|0|||
155660196|NCT00833690|561850568|FG002|Overall Study|Withdrawal by Subject|0|||
155660197|NCT00833690|561850566|FG000|Overall Study|Discontinued study drug|3|||
155660198|NCT00833690|561850567|FG001|Overall Study|Discontinued study drug|2|||
155660199|NCT00833690|561850568|FG002|Overall Study|Discontinued study drug|0|||
155660200|NCT05448950|561850574|FG000|Overall Study|Death|2|||
155660201|NCT05448950|561850574|FG000|Overall Study|Withdrawal by Subject|1|||
155660202|NCT05448950|561850574|FG000|Overall Study|AVG abandoned|4|||
155660203|NCT03605693|561850575|FG000|Overall Study|Lost to Follow-up|4|||
155660204|NCT03605693|561850576|FG001|Overall Study|Lost to Follow-up|0|||
155660205|NCT03605693|561850575|FG000|Overall Study|Physician Decision|1|||
155660206|NCT03605693|561850576|FG001|Overall Study|Physician Decision|0|||
155660207|NCT04562116|561850577|FG000|Overall Study|Lost to Follow-up|1|||
155660208|NCT04562116|561850577|FG000|Overall Study|Withdrawal by Subject|3|||
155660209|NCT02757430|561850579|FG000|Overall Study|Physician Decision|6|||
155660210|NCT02757430|561850579|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
155660211|NCT02757430|561850579|FG000|Overall Study|No informed consent|1|||
155660212|NCT02757430|561850579|FG000|Overall Study|No procedure performed|2|||
155660213|NCT03502200|561850580|FG000|Overall Study|Adverse Event|1|||
155660214|NCT03502200|561850581|FG001|Overall Study|Adverse Event|0|||
155660215|NCT03502200|561850580|FG000|Overall Study|Lost to Follow-up|36|||
155660216|NCT03502200|561850581|FG001|Overall Study|Lost to Follow-up|38|||
155660217|NCT03502200|561850580|FG000|Overall Study|Study Team Decision|1|||
155660218|NCT03502200|561850581|FG001|Overall Study|Study Team Decision|1|||
155660219|NCT03502200|561850580|FG000|Overall Study|Withdrawal by Subject|5|||
155660220|NCT03502200|561850581|FG001|Overall Study|Withdrawal by Subject|7|||
155568245|NCT00000620|561504673|FG000|Overall Study|missed closeout visit|22|||
155568246|NCT00000620|561504674|FG001|Overall Study|missed closeout visit|28|||
155568247|NCT00000620|561504675|FG002|Overall Study|missed closeout visit|16|||
155568248|NCT00000620|561504676|FG003|Overall Study|missed closeout visit|11|||
155568249|NCT00000620|561504677|FG004|Overall Study|missed closeout visit|26|||
155568250|NCT00000620|561504678|FG005|Overall Study|missed closeout visit|28|||
155568251|NCT00000620|561504679|FG006|Overall Study|missed closeout visit|13|||
155568252|NCT00000620|561504680|FG007|Overall Study|missed closeout visit|16|||
155568253|NCT02648932|561504681|FG000|Overall Study|No transplant|3|||
155568254|NCT02648932|561504682|FG001|Overall Study|No transplant|1|||
155568255|NCT01199016|561504683|FG000|Overall Study|No longer meets eligibility criteria|4|||
155568256|NCT01199016|561504683|FG000|Overall Study|Entrance criteria|5|||
155568257|NCT01199016|561504683|FG000|Overall Study|Protocol Violation|9|||
155568258|NCT01199016|561504683|FG000|Overall Study|Other|13|||
155568259|NCT01199016|561504683|FG000|Overall Study|Withdrawal by Subject|21|||
155568260|NCT01199016|561504683|FG000|Overall Study|Lost to Follow-up|25|||
155568261|NCT02368314|561504687|FG000|Overall Study|Withdrawal by Subject|2|||
155568262|NCT02368314|561504688|FG001|Overall Study|Withdrawal by Subject|1|||
155568263|NCT02368314|561504687|FG000|Overall Study|Adverse Event|1|||
155568264|NCT02368314|561504688|FG001|Overall Study|Adverse Event|2|||
155568265|NCT01266031|561504689|FG000|Overall Study|Not treated|0|||
155568266|NCT01266031|561504690|FG001|Overall Study|Not treated|3|||
155568267|NCT01266031|561504691|FG002|Overall Study|Not treated|2|||
155568268|NCT01307111|561504692|FG000|IUD Insertion|Lost to Follow-up|2|||
155568269|NCT01307111|561504693|FG001|IUD Insertion|Lost to Follow-up|0|||
155568270|NCT01307111|561504692|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
155568271|NCT01307111|561504693|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
155568272|NCT02842073|561504695|FG000|Overall Study|Withdrawal by Subject|1|||
155568273|NCT01333397|561504698|FG000|Overall Study|Lost to Follow-up|1|||
155568274|NCT01333397|561504699|FG001|Overall Study|Lost to Follow-up|0|||
155568275|NCT01333397|561504700|FG002|Overall Study|Lost to Follow-up|0|||
155568276|NCT01333397|561504701|FG003|Overall Study|Lost to Follow-up|1|||
155568277|NCT01333397|561504702|FG004|Overall Study|Lost to Follow-up|0|||
155568278|NCT01994850|561504712|FG000|Overall Study|Physician Decision|1|||
155568279|NCT01994850|561504712|FG000|Overall Study|Withdrawal by Subject|1|||
155568280|NCT03485365|561504724|FG000|Overall Study|Protocol Violation|0|||
155568281|NCT03485365|561504725|FG001|Overall Study|Protocol Violation|0|||
155568282|NCT03485365|561504726|FG002|Overall Study|Protocol Violation|0|||
155568283|NCT03485365|561504727|FG003|Overall Study|Protocol Violation|1|||
155568284|NCT03485365|561504728|FG004|Overall Study|Protocol Violation|0|||
155568285|NCT03485365|561504729|FG005|Overall Study|Protocol Violation|0|||
155568286|NCT03485365|561504730|FG006|Overall Study|Protocol Violation|1|||
155568287|NCT03485365|561504731|FG007|Overall Study|Protocol Violation|0|||
155568288|NCT03485365|561504732|FG008|Overall Study|Protocol Violation|0|||
155568289|NCT01275430|561504737|FG000|Overall Study|Adverse Event|1|||
155568290|NCT01275430|561504737|FG000|Overall Study|No Contrast Injection|6|||
155568291|NCT01275430|561504737|FG000|Overall Study|Device Malfunction|1|||
155568292|NCT01275430|561504737|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
155568293|NCT04988087|561504738|FG000|Overall Study|Adverse Event|4|||
155568294|NCT04988087|561504739|FG001|Overall Study|Adverse Event|0|||
155568295|NCT04988087|561504740|FG002|Overall Study|Adverse Event|0|||
155568296|NCT04988087|561504741|FG003|Overall Study|Adverse Event|0|||
155568297|NCT04988087|561504738|FG000|Overall Study|Withdrawal by Subject|1|||
155568298|NCT04988087|561504739|FG001|Overall Study|Withdrawal by Subject|1|||
155568299|NCT04988087|561504740|FG002|Overall Study|Withdrawal by Subject|0|||
155568300|NCT04988087|561504741|FG003|Overall Study|Withdrawal by Subject|0|||
155568301|NCT04988087|561504738|FG000|Overall Study|Technical problems|7|||
155568302|NCT04988087|561504739|FG001|Overall Study|Technical problems|9|||
155568303|NCT04988087|561504740|FG002|Overall Study|Technical problems|1|||
155568304|NCT04988087|561504741|FG003|Overall Study|Technical problems|2|||
155568305|NCT02613182|561504742|FG000|Overall Study|Death|6|||
155660221|NCT03502200|561850580|FG000|Overall Study|Death|0|||
155660222|NCT03502200|561850581|FG001|Overall Study|Death|2|||
155568306|NCT02613182|561504742|FG000|Overall Study|Physician Decision|1|||
155568307|NCT02613182|561504742|FG000|Overall Study|Study Terminated by Sponsor|21|||
155568308|NCT02613182|561504742|FG000|Overall Study|Withdrawal by Subject|6|||
155660223|NCT03097289|561850583|FG000|Overall Study|Adverse Event|1|||
155660224|NCT03097289|561850583|FG000|Overall Study|Equipment failure|2|||
155568309|NCT00863772|561504743|FG000|Overall Study|Adverse Event|1|||
155568310|NCT00863772|561504744|FG001|Overall Study|Adverse Event|4|||
155568311|NCT00863772|561504745|FG002|Overall Study|Adverse Event|0|||
155568312|NCT00863772|561504743|FG000|Overall Study|Lack of Efficacy|4|||
155568313|NCT00863772|561504744|FG001|Overall Study|Lack of Efficacy|2|||
155568314|NCT00863772|561504745|FG002|Overall Study|Lack of Efficacy|4|||
155568315|NCT00863772|561504743|FG000|Overall Study|Lost to Follow-up|5|||
155568316|NCT00863772|561504744|FG001|Overall Study|Lost to Follow-up|1|||
155568317|NCT00863772|561504745|FG002|Overall Study|Lost to Follow-up|1|||
155568318|NCT00863772|561504743|FG000|Overall Study|Protocol Violation|2|||
155568319|NCT00863772|561504744|FG001|Overall Study|Protocol Violation|0|||
155568320|NCT00863772|561504745|FG002|Overall Study|Protocol Violation|2|||
155568321|NCT00863772|561504743|FG000|Overall Study|Withdrawal by Subject|4|||
155568322|NCT00863772|561504744|FG001|Overall Study|Withdrawal by Subject|7|||
155568323|NCT00863772|561504745|FG002|Overall Study|Withdrawal by Subject|5|||
155568324|NCT00863772|561504743|FG000|Overall Study|Study terminated by sponsor|44|||
155568325|NCT00863772|561504744|FG001|Overall Study|Study terminated by sponsor|45|||
155568326|NCT00863772|561504745|FG002|Overall Study|Study terminated by sponsor|36|||
155568327|NCT00863772|561504743|FG000|Overall Study|Entered extension study|6|||
155568328|NCT00863772|561504744|FG001|Overall Study|Entered extension study|4|||
155568329|NCT00863772|561504745|FG002|Overall Study|Entered extension study|9|||
155568330|NCT00863772|561504743|FG000|Overall Study|Other|1|||
155568331|NCT00863772|561504744|FG001|Overall Study|Other|2|||
155568332|NCT00863772|561504745|FG002|Overall Study|Other|4|||
155568333|NCT00863772|561504743|FG000|Overall Study|Randomized but not Treated|1|||
155568334|NCT00863772|561504744|FG001|Overall Study|Randomized but not Treated|0|||
155568335|NCT00863772|561504745|FG002|Overall Study|Randomized but not Treated|0|||
155568336|NCT04844762|561504756|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568337|NCT04844762|561504757|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568338|NCT04844762|561504758|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
155568339|NCT04844762|561504759|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568340|NCT04844762|561504760|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568341|NCT04844762|561504761|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568342|NCT04844762|561504756|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
155568343|NCT04844762|561504757|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
155568344|NCT04844762|561504758|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
155568345|NCT04844762|561504759|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
155568346|NCT04844762|561504760|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
155568347|NCT04844762|561504761|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
155568348|NCT04844762|561504756|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568349|NCT04844762|561504757|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568350|NCT04844762|561504758|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
155568351|NCT04844762|561504759|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
155568352|NCT04844762|561504760|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568353|NCT04844762|561504761|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
155568354|NCT04844762|561504756|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568355|NCT04844762|561504757|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568356|NCT04844762|561504758|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
155568357|NCT04844762|561504759|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
155568358|NCT04844762|561504760|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
155568359|NCT04844762|561504761|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568360|NCT04844762|561504756|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
155568361|NCT04844762|561504757|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
155568362|NCT04844762|561504758|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568363|NCT04844762|561504759|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568364|NCT04844762|561504760|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568365|NCT04844762|561504761|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568366|NCT04844762|561504756|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
155568367|NCT04844762|561504757|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568368|NCT04844762|561504758|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568369|NCT04844762|561504759|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568370|NCT04844762|561504760|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568371|NCT04844762|561504761|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568372|NCT04844762|561504756|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568373|NCT04844762|561504757|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568374|NCT04844762|561504758|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568375|NCT04844762|561504759|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568376|NCT04844762|561504760|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
155568377|NCT04844762|561504761|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
155568378|NCT04844762|561504756|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
155568379|NCT04844762|561504757|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568380|NCT04844762|561504758|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568381|NCT04844762|561504759|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568382|NCT04844762|561504760|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568383|NCT04844762|561504761|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
155568384|NCT04844762|561504756|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
155568385|NCT04844762|561504757|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568386|NCT04844762|561504758|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568387|NCT04844762|561504759|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568388|NCT04844762|561504760|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155568389|NCT04844762|561504761|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
155568390|NCT04844762|561504756|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
155568391|NCT04844762|561504757|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
155568392|NCT04844762|561504758|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
155568393|NCT04844762|561504759|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
155568394|NCT04844762|561504760|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
155568395|NCT04844762|561504761|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
155568396|NCT04844762|561504756|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
155568397|NCT04844762|561504757|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
155568398|NCT04844762|561504758|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
155568399|NCT04844762|561504759|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
155568400|NCT04844762|561504760|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
155568401|NCT04844762|561504761|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
155568402|NCT04400682|561504764|FG000|Period 1|Withdrawal by Subject|1|||
155568403|NCT04400682|561504765|FG001|Period 1|Withdrawal by Subject|4|||
155568404|NCT00477633|561504766|FG000|Overall Study|Did not receive treatment|23|||
155568405|NCT00477633|561504766|FG000|Overall Study|Adverse Event|143|||
155568406|NCT00477633|561504766|FG000|Overall Study|Pregnancy|23|||
155568407|NCT00477633|561504766|FG000|Overall Study|Lost to Follow-up|271|||
155568408|NCT00477633|561504766|FG000|Overall Study|Withdrawal by Subject|149|||
155568409|NCT00477633|561504766|FG000|Overall Study|Protocol Violation|25|||
155568410|NCT00477633|561504766|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
155568411|NCT02542605|561504774|FG000|Part B: Challenge Phase|Sponsor decision|1|||
155568412|NCT02542605|561504775|FG001|Part B: Challenge Phase|Sponsor decision|0|||
155568413|NCT02542605|561504776|FG002|Part B: Challenge Phase|Sponsor decision|0|||
155568414|NCT02542605|561504774|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
155568415|NCT02542605|561504775|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
155568416|NCT02542605|561504776|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
155568417|NCT05833139|561506185|FG000|Study Period 2|Adverse Event|1|||
155568418|NCT03996447|561506186|FG000|First MRI Examination|Adverse Event|2|||
155568419|NCT03996447|561506187|FG001|First MRI Examination|Adverse Event|0|||
155568420|NCT03996447|561506186|FG000|First MRI Examination|Withdrawal by Subject|1|||
155568421|NCT03996447|561506187|FG001|First MRI Examination|Withdrawal by Subject|2|||
155568422|NCT03996447|561506186|FG000|First MRI Examination|Protocol Violation|0|||
155568423|NCT03996447|561506187|FG001|First MRI Examination|Protocol Violation|1|||
155568424|NCT03996447|561506186|FG000|Washout|Adverse Event|2|||
155568425|NCT03996447|561506187|FG001|Washout|Adverse Event|0|||
155568426|NCT03996447|561506186|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
155568427|NCT03996447|561506187|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
155568428|NCT03996447|561506186|FG000|Washout|Withdrawal by Subject|0|||
155568429|NCT03996447|561506187|FG001|Washout|Withdrawal by Subject|1|||
155568430|NCT03996447|561506186|FG000|Washout|Other reason|1|||
155568431|NCT03996447|561506187|FG001|Washout|Other reason|1|||
155568432|NCT01810302|561506194|FG000|Overall Study|Death|1|||
155568433|NCT01810302|561506195|FG001|Overall Study|Death|0|||
155568434|NCT01810302|561506194|FG000|Overall Study|Physician Decision|0|||
155568435|NCT01810302|561506195|FG001|Overall Study|Physician Decision|1|||
155568436|NCT04981717|561506197|FG000|Overall Study|Protocol Violation|0|||
155568437|NCT04981717|561506198|FG001|Overall Study|Protocol Violation|3|||
155568438|NCT04981717|561506197|FG000|Overall Study|Adverse Event|1|||
155568439|NCT04981717|561506198|FG001|Overall Study|Adverse Event|3|||
155568440|NCT04981717|561506197|FG000|Overall Study|Pregnancy|1|||
155568441|NCT04981717|561506198|FG001|Overall Study|Pregnancy|0|||
155568442|NCT04981717|561506197|FG000|Overall Study|Physician Decision|1|||
155568443|NCT04981717|561506198|FG001|Overall Study|Physician Decision|0|||
155568444|NCT04981717|561506197|FG000|Overall Study|Sponsor Request|157|||
155568445|NCT04981717|561506198|FG001|Overall Study|Sponsor Request|172|||
155568446|NCT04981717|561506197|FG000|Overall Study|Lost to Follow-up|4|||
155568447|NCT04981717|561506198|FG001|Overall Study|Lost to Follow-up|5|||
155568448|NCT04981717|561506197|FG000|Overall Study|Withdrawal by Subject|50|||
155660225|NCT03097289|561850583|FG000|Overall Study|Collected platelet product unusable|3|||
155568449|NCT04981717|561506198|FG001|Overall Study|Withdrawal by Subject|37|||
155568450|NCT02207634|561506199|FG000|Overall Study|Withdrawal by Subject|21|||
155568451|NCT02207634|561506200|FG001|Overall Study|Withdrawal by Subject|31|||
155568452|NCT02207634|561506199|FG000|Overall Study|Lost to Follow-up|1|||
155568453|NCT02207634|561506200|FG001|Overall Study|Lost to Follow-up|0|||
155660226|NCT00049543|561850586|FG000|Overall Study|still on treatment|2|||
155660227|NCT00049543|561850587|FG001|Overall Study|still on treatment|9|||
155660228|NCT01656161|561850590|FG000|Overall Study|Death|3|||
155660229|NCT01656161|561850590|FG000|Overall Study|Adverse Event|2|||
155660230|NCT01656161|561850590|FG000|Overall Study|Protocol Violation|1|||
155660231|NCT01656161|561850590|FG000|Overall Study|Withdrawal by Subject|1|||
155660232|NCT03510273|561850596|FG000|Overall Study|Withdrawal by Subject|2|||
155660233|NCT03510273|561850596|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
155660234|NCT03510273|561850596|FG000|Overall Study|Moved away from study area|4|||
155660235|NCT00862940|561850597|FG000|Overall Study|Adverse Event|15|||
155660236|NCT00862940|561850598|FG001|Overall Study|Adverse Event|12|||
155660237|NCT00862940|561850597|FG000|Overall Study|Lack of Efficacy|1|||
155660238|NCT00862940|561850598|FG001|Overall Study|Lack of Efficacy|3|||
155660239|NCT00862940|561850597|FG000|Overall Study|Protocol Violation|2|||
155660240|NCT00862940|561850598|FG001|Overall Study|Protocol Violation|5|||
155660241|NCT00862940|561850597|FG000|Overall Study|Withdrawal by Subject|4|||
155660242|NCT00862940|561850598|FG001|Overall Study|Withdrawal by Subject|6|||
155660243|NCT00862940|561850597|FG000|Overall Study|Non-compliance|4|||
155660244|NCT00862940|561850598|FG001|Overall Study|Non-compliance|0|||
155660245|NCT00862940|561850597|FG000|Overall Study|Lost to Follow-up|0|||
155660246|NCT00862940|561850598|FG001|Overall Study|Lost to Follow-up|1|||
155660247|NCT00862940|561850597|FG000|Overall Study|Administrative or other reason(s)|4|||
155660248|NCT00862940|561850598|FG001|Overall Study|Administrative or other reason(s)|3|||
155568454|NCT02052011|561506201|FG000|Overall Study|Lost to Follow-up|3|||
155568455|NCT02052011|561506202|FG001|Overall Study|Lost to Follow-up|0|||
155568456|NCT02052011|561506201|FG000|Overall Study|Withdrawal by Subject|1|||
155568457|NCT02052011|561506202|FG001|Overall Study|Withdrawal by Subject|2|||
155568458|NCT01851330|561506204|FG000|Overall Study|Lack of Efficacy|10|||
155568459|NCT01851330|561506205|FG001|Overall Study|Lack of Efficacy|9|||
155568460|NCT01851330|561506206|FG002|Overall Study|Lack of Efficacy|2|||
155568461|NCT01851330|561506204|FG000|Overall Study|Lost to Follow-up|1|||
155568462|NCT01851330|561506205|FG001|Overall Study|Lost to Follow-up|6|||
155568463|NCT01851330|561506206|FG002|Overall Study|Lost to Follow-up|9|||
155568464|NCT01851330|561506204|FG000|Overall Study|Withdrew Consent|2|||
155568465|NCT01851330|561506205|FG001|Overall Study|Withdrew Consent|1|||
155568466|NCT01851330|561506206|FG002|Overall Study|Withdrew Consent|0|||
155568467|NCT01851330|561506204|FG000|Overall Study|Investigator's Discretion|0|||
155568468|NCT01851330|561506205|FG001|Overall Study|Investigator's Discretion|0|||
155568469|NCT01851330|561506206|FG002|Overall Study|Investigator's Discretion|1|||
155568470|NCT02114385|561506217|FG000|Overall Study|Withdrawal by Subject|3|||
155568471|NCT02114385|561506218|FG001|Overall Study|Withdrawal by Subject|2|||
155568472|NCT02114385|561506217|FG000|Overall Study|Lost to Follow-up|0|||
155568473|NCT02114385|561506218|FG001|Overall Study|Lost to Follow-up|6|||
155568474|NCT02047734|561506222|FG000|Overall Study|Adverse Event|18|||
155568475|NCT02047734|561506223|FG001|Overall Study|Adverse Event|13|||
155568476|NCT02047734|561506224|FG002|Overall Study|Adverse Event|13|||
155568477|NCT02047734|561506222|FG000|Overall Study|Lack of Efficacy|4|||
155568478|NCT02047734|561506223|FG001|Overall Study|Lack of Efficacy|5|||
155568479|NCT02047734|561506224|FG002|Overall Study|Lack of Efficacy|1|||
155568480|NCT02047734|561506222|FG000|Overall Study|Protocol Violation|3|||
155568481|NCT02047734|561506223|FG001|Overall Study|Protocol Violation|1|||
155568482|NCT02047734|561506224|FG002|Overall Study|Protocol Violation|1|||
155568483|NCT02047734|561506222|FG000|Overall Study|Lost to Follow-up|1|||
155568484|NCT02047734|561506223|FG001|Overall Study|Lost to Follow-up|4|||
155568485|NCT02047734|561506224|FG002|Overall Study|Lost to Follow-up|0|||
155568486|NCT02047734|561506222|FG000|Overall Study|Death|0|||
155568487|NCT02047734|561506223|FG001|Overall Study|Death|1|||
155568488|NCT02047734|561506224|FG002|Overall Study|Death|0|||
155568489|NCT02047734|561506222|FG000|Overall Study|Withdrawal by Subject|30|||
155568490|NCT02047734|561506223|FG001|Overall Study|Withdrawal by Subject|31|||
155568491|NCT02047734|561506224|FG002|Overall Study|Withdrawal by Subject|19|||
155568492|NCT02047734|561506222|FG000|Overall Study|Physician Decision|7|||
155568493|NCT02047734|561506223|FG001|Overall Study|Physician Decision|6|||
155568494|NCT02047734|561506224|FG002|Overall Study|Physician Decision|5|||
155568495|NCT02047734|561506222|FG000|Overall Study|Miscellaneous|2|||
155568496|NCT02047734|561506223|FG001|Overall Study|Miscellaneous|4|||
155568497|NCT02047734|561506224|FG002|Overall Study|Miscellaneous|6|||
155568498|NCT02047734|561506222|FG000|Overall Study|Did Not Receive Study Drug|2|||
155568499|NCT02047734|561506223|FG001|Overall Study|Did Not Receive Study Drug|4|||
155568500|NCT02047734|561506224|FG002|Overall Study|Did Not Receive Study Drug|1|||
155660249|NCT00879398|561850601|FG000|Overall Study|Visit Stop|399|||
155660250|NCT00879398|561850601|FG000|Overall Study|Lack of Efficacy|64|||
155568501|NCT01174043|561506225|FG000|Overall Study|Disease progression|5|||
155568502|NCT01174043|561506225|FG000|Overall Study|Adverse Event|3|||
155568503|NCT01174043|561506225|FG000|Overall Study|Death|1|||
155568504|NCT01174043|561506225|FG000|Overall Study|Withdrawal by Subject|2|||
155660251|NCT00879398|561850601|FG000|Overall Study|Adverse Event|41|||
155568505|NCT00582010|561506228|FG000|Overall Study|Death|0|||
155568506|NCT00582010|561506229|FG001|Overall Study|Death|1|||
155568507|NCT05320887|561506239|FG000|Overall Study|Lost to Follow-up|0|||
155568508|NCT05320887|561506240|FG001|Overall Study|Lost to Follow-up|3|||
155568509|NCT05320887|561506241|FG002|Overall Study|Lost to Follow-up|0|||
155568510|NCT05320887|561506242|FG003|Overall Study|Lost to Follow-up|0|||
155568511|NCT02289456|561506245|FG000|Induction Period|Death|2|||
155568512|NCT02289456|561506245|FG000|Induction Period|Adverse Event|11|||
155568513|NCT02289456|561506245|FG000|Induction Period|Progressive Disease (PD)|4|||
155568514|NCT02289456|561506245|FG000|Induction Period|Symptomatic Deterioration|4|||
155568515|NCT02289456|561506245|FG000|Induction Period|Withdrawal by Subject|2|||
155568516|NCT02289456|561506245|FG000|Induction Period|Miscellaneous|1|||
155568517|NCT02289456|561506245|FG000|Monotherapy Period|Death|1|||
155568518|NCT02289456|561506245|FG000|Monotherapy Period|Adverse Event|1|||
155568519|NCT02289456|561506245|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
155568520|NCT02289456|561506245|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
155568521|NCT02289456|561506245|FG000|Monotherapy Period|Withdrawal by Subject|2|||
155568522|NCT02289456|561506245|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
155568523|NCT02289456|561506245|FG000|Monotherapy Period|Miscellaneous|1|||
155568524|NCT02463357|561506246|FG000|Overall Study|Withdrawal by Subject|1|||
155568525|NCT02463357|561506247|FG001|Overall Study|Withdrawal by Subject|0|||
155568526|NCT02463357|561506248|FG002|Overall Study|Withdrawal by Subject|0|||
155568527|NCT02463357|561506249|FG003|Overall Study|Withdrawal by Subject|0|||
155568528|NCT02463357|561506250|FG004|Overall Study|Withdrawal by Subject|0|||
155568529|NCT02463357|561506246|FG000|Overall Study|Withdrawal by Subject|0|||
155568530|NCT02463357|561506247|FG001|Overall Study|Withdrawal by Subject|0|||
155568531|NCT02463357|561506248|FG002|Overall Study|Withdrawal by Subject|0|||
155568532|NCT02463357|561506249|FG003|Overall Study|Withdrawal by Subject|0|||
155568533|NCT02463357|561506250|FG004|Overall Study|Withdrawal by Subject|1|||
155568534|NCT01371539|561506253|FG000|Period One: One Week|Lost to Follow-up|0|||
155568535|NCT01371539|561506254|FG001|Period One: One Week|Lost to Follow-up|1|||
155568536|NCT01371539|561506253|FG000|Period Two: One Week|Lost to Follow-up|0|||
155568537|NCT01371539|561506254|FG001|Period Two: One Week|Lost to Follow-up|1|||
155568538|NCT01371539|561506253|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
155568539|NCT01371539|561506254|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
155568540|NCT01371539|561506253|FG000|Period Two: One Week|Time/job conflict|0|||
155568541|NCT01371539|561506254|FG001|Period Two: One Week|Time/job conflict|1|||
155568542|NCT01721317|561506257|FG000|Overall Study|Study Closed / Terminated|2|||
155568543|NCT01721317|561506258|FG001|Overall Study|Study Closed / Terminated|2|||
155568544|NCT01721317|561506257|FG000|Overall Study|Physician Decision|0|||
155568545|NCT01721317|561506258|FG001|Overall Study|Physician Decision|1|||
155568546|NCT01721317|561506257|FG000|Overall Study|Withdrawal by Subject|0|||
155568547|NCT01721317|561506258|FG001|Overall Study|Withdrawal by Subject|1|||
155568548|NCT00958893|561506262|FG000|Overall Study|Study prematurely terminated|4|||
155568549|NCT00378573|561506264|FG000|Treatment Period|Adverse Event|9|||
155568550|NCT00378573|561506264|FG000|Treatment Period|Physician Decision|1|||
155568551|NCT00378573|561506264|FG000|Treatment Period|Withdrawal by Subject|2|||
155568552|NCT00378573|561506264|FG000|Treatment Period|Disease Progression|4|||
155568553|NCT00378573|561506264|FG000|Treatment Period|Sponsor decision to close study|1|||
155568554|NCT00378573|561506264|FG000|Follow-up|Death|12|||
155568555|NCT00378573|561506264|FG000|Follow-up|Lost to Follow-up|1|||
155568556|NCT00378573|561506264|FG000|Follow-up|Withdrawal by Subject|1|||
155568557|NCT00711880|561506270|FG000|Overall Study|Adverse Event|11|||
155568558|NCT00711880|561506271|FG001|Overall Study|Adverse Event|2|||
155568559|NCT00711880|561506270|FG000|Overall Study|Patient non-compliance|1|||
155568560|NCT00711880|561506271|FG001|Overall Study|Patient non-compliance|0|||
155568561|NCT00711880|561506270|FG000|Overall Study|Lack of Efficacy|1|||
155568562|NCT00711880|561506271|FG001|Overall Study|Lack of Efficacy|5|||
155568563|NCT00704132|561506272|FG000|Overall Study|Clinical Adverse Experience|1|||
155568564|NCT00704132|561506273|FG001|Overall Study|Clinical Adverse Experience|0|||
155568565|NCT00704132|561506272|FG000|Overall Study|Lack of Efficacy|0|||
155568566|NCT00704132|561506273|FG001|Overall Study|Lack of Efficacy|1|||
155568567|NCT00704132|561506272|FG000|Overall Study|Withdrawal by Subject|0|||
155568568|NCT00704132|561506273|FG001|Overall Study|Withdrawal by Subject|1|||
155568569|NCT00442962|561506274|FG000|Overall Study|Pregnancy|1|||
155568570|NCT00442962|561506274|FG000|Overall Study|Lost to Follow-up|7|||
155568571|NCT03348163|561506275|FG000|Overall Study|Withdrawal by Subject|2|||
155568572|NCT03348163|561506276|FG001|Overall Study|Withdrawal by Subject|0|||
155568573|NCT00339144|561506277|FG000|Overall Study|Disease progression|5|||
155568574|NCT00339144|561506278|FG001|Overall Study|Disease progression|2|||
155568575|NCT00339144|561506279|FG002|Overall Study|Disease progression|2|||
155568576|NCT00339144|561506277|FG000|Overall Study|Study drug toxicity|3|||
155568577|NCT00339144|561506278|FG001|Overall Study|Study drug toxicity|1|||
155568578|NCT00339144|561506279|FG002|Overall Study|Study drug toxicity|1|||
155568579|NCT00339144|561506277|FG000|Overall Study|Participant's request to discontinuation|1|||
155568580|NCT00339144|561506278|FG001|Overall Study|Participant's request to discontinuation|0|||
155568581|NCT00339144|561506279|FG002|Overall Study|Participant's request to discontinuation|1|||
155660252|NCT00879398|561850601|FG000|Overall Study|Other Reasons|171|||
155660253|NCT04222673|561850603|FG000|Overall Study|Lost to Follow-up|5|||
155660254|NCT04398706|561850604|FG000|Overall Study|Adverse Event|0|||
155568582|NCT02181790|561506280|FG000|Overall Study|study terminated|2|||
155568583|NCT02181790|561506281|FG001|Overall Study|study terminated|0|||
155660255|NCT04398706|561850605|FG001|Overall Study|Adverse Event|0|||
155660256|NCT04398706|561850606|FG002|Overall Study|Adverse Event|0|||
155660257|NCT04398706|561850607|FG003|Overall Study|Adverse Event|0|||
155660258|NCT04398706|561850608|FG004|Overall Study|Adverse Event|0|||
155660259|NCT04398706|561850609|FG005|Overall Study|Adverse Event|1|||
155660260|NCT04398706|561850610|FG006|Overall Study|Adverse Event|1|||
155660261|NCT04398706|561850611|FG007|Overall Study|Adverse Event|0|||
155660262|NCT04398706|561850604|FG000|Overall Study|Lost to Follow-up|0|||
155660263|NCT04398706|561850605|FG001|Overall Study|Lost to Follow-up|1|||
155660264|NCT04398706|561850606|FG002|Overall Study|Lost to Follow-up|2|||
155660265|NCT04398706|561850607|FG003|Overall Study|Lost to Follow-up|1|||
155660266|NCT04398706|561850608|FG004|Overall Study|Lost to Follow-up|6|||
155660267|NCT04398706|561850609|FG005|Overall Study|Lost to Follow-up|3|||
155660268|NCT04398706|561850610|FG006|Overall Study|Lost to Follow-up|8|||
155660269|NCT04398706|561850611|FG007|Overall Study|Lost to Follow-up|2|||
155660270|NCT04398706|561850604|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155660271|NCT04398706|561850605|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155660272|NCT04398706|561850606|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155660273|NCT04398706|561850607|FG003|Overall Study|Withdrawal by parent/guardian|2|||
155660274|NCT04398706|561850608|FG004|Overall Study|Withdrawal by parent/guardian|19|||
155660275|NCT04398706|561850609|FG005|Overall Study|Withdrawal by parent/guardian|23|||
155660276|NCT04398706|561850610|FG006|Overall Study|Withdrawal by parent/guardian|13|||
155660277|NCT04398706|561850611|FG007|Overall Study|Withdrawal by parent/guardian|11|||
155660278|NCT04398706|561850604|FG000|Overall Study|Protocol deviation|0|||
155660279|NCT04398706|561850605|FG001|Overall Study|Protocol deviation|1|||
155660280|NCT04398706|561850606|FG002|Overall Study|Protocol deviation|0|||
155660281|NCT04398706|561850607|FG003|Overall Study|Protocol deviation|0|||
155660282|NCT04398706|561850608|FG004|Overall Study|Protocol deviation|6|||
155660283|NCT04398706|561850609|FG005|Overall Study|Protocol deviation|4|||
155660284|NCT04398706|561850610|FG006|Overall Study|Protocol deviation|6|||
155660285|NCT04398706|561850611|FG007|Overall Study|Protocol deviation|3|||
155660286|NCT04116853|561850612|FG000|Overall Study|Adverse Event|1|||
155660287|NCT04116853|561850613|FG001|Overall Study|Adverse Event|3|||
155568584|NCT02714426|561506286|FG000|Overall Study|Withdrawal by Subject|2|||
155568585|NCT02714426|561506287|FG001|Overall Study|Withdrawal by Subject|2|||
155568586|NCT00896480|561506288|FG000|Overall Study|Disease progression/recurrence|21|||
155568587|NCT03185013|561506291|FG000|Overall Study|Withdrawal by Subject|5|||
155568588|NCT03185013|561506292|FG001|Overall Study|Withdrawal by Subject|3|||
155568589|NCT03185013|561506291|FG000|Overall Study|Adverse Event|1|||
155568590|NCT03185013|561506292|FG001|Overall Study|Adverse Event|0|||
155568591|NCT03185013|561506291|FG000|Overall Study|Progressive Disease|1|||
155568592|NCT03185013|561506292|FG001|Overall Study|Progressive Disease|0|||
155568593|NCT03185013|561506291|FG000|Overall Study|Lost to Follow-up|8|||
155568594|NCT03185013|561506292|FG001|Overall Study|Lost to Follow-up|2|||
155568595|NCT03185013|561506291|FG000|Overall Study|Physician Decision|1|||
155568596|NCT03185013|561506292|FG001|Overall Study|Physician Decision|0|||
155568597|NCT03185013|561506291|FG000|Overall Study|Protocol Deviation|2|||
155568598|NCT03185013|561506292|FG001|Overall Study|Protocol Deviation|0|||
155568599|NCT03185013|561506291|FG000|Overall Study|Reason not Specified|3|||
155568600|NCT03185013|561506292|FG001|Overall Study|Reason not Specified|2|||
155568601|NCT03185013|561506291|FG000|Overall Study|Death|1|||
155568602|NCT03185013|561506292|FG001|Overall Study|Death|0|||
155568603|NCT01104792|561506298|FG000|Overall Study|Adverse Event|77|||
155568604|NCT01104792|561506298|FG000|Overall Study|Insufficient Therapeutic Response|22|||
155568605|NCT01104792|561506298|FG000|Overall Study|Protocol Violation|45|||
155568606|NCT01104792|561506298|FG000|Overall Study|Withdrawal of Consent|179|||
155660288|NCT04116853|561850612|FG000|Overall Study|Lost to Follow-up|2|||
155660289|NCT04116853|561850613|FG001|Overall Study|Lost to Follow-up|0|||
155660290|NCT04116853|561850612|FG000|Overall Study|Incarceration|0|||
155660291|NCT04116853|561850613|FG001|Overall Study|Incarceration|1|||
155660292|NCT04116853|561850612|FG000|Overall Study|Pregnancy|1|||
155660293|NCT04116853|561850613|FG001|Overall Study|Pregnancy|1|||
155660294|NCT04116853|561850612|FG000|Overall Study|Began Other Weight Loss program|4|||
155660295|NCT04116853|561850613|FG001|Overall Study|Began Other Weight Loss program|8|||
155660296|NCT04116853|561850612|FG000|Overall Study|Began Anti-Obesity Medication|3|||
155660297|NCT04116853|561850613|FG001|Overall Study|Began Anti-Obesity Medication|3|||
155660298|NCT04116853|561850612|FG000|Overall Study|Protocol Violation|0|||
155660299|NCT04116853|561850613|FG001|Overall Study|Protocol Violation|1|||
155660300|NCT01346176|561850615|FG000|Recruited|Protocol Violation|1|||
155660301|NCT01346176|561850616|FG001|Recruited|Protocol Violation|0|||
155660302|NCT01346176|561850617|FG002|Recruited|Protocol Violation|0|||
155660303|NCT01346176|561850615|FG000|Completed Advance Directive|Death|3|||
155660304|NCT01346176|561850616|FG001|Completed Advance Directive|Death|2|||
155660305|NCT01346176|561850617|FG002|Completed Advance Directive|Death|2|||
155660306|NCT01346176|561850615|FG000|Completed Advance Directive|Became Ineligible|3|||
155660307|NCT01346176|561850616|FG001|Completed Advance Directive|Became Ineligible|0|||
155660308|NCT01346176|561850617|FG002|Completed Advance Directive|Became Ineligible|1|||
155660309|NCT01346176|561850615|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
155660310|NCT01346176|561850616|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
155660311|NCT01346176|561850617|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
155660312|NCT01346176|561850615|FG000|Completed Satisfaction Survey|Death|3|||
155660313|NCT01346176|561850616|FG001|Completed Satisfaction Survey|Death|0|||
155660314|NCT01346176|561850617|FG002|Completed Satisfaction Survey|Death|2|||
155660315|NCT01346176|561850615|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
155660316|NCT01346176|561850616|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
155660317|NCT01346176|561850617|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
155660318|NCT01994876|561850618|FG000|Test Period 1|Withdrawal by Subject|0|||
155660319|NCT01994876|561850619|FG001|Test Period 1|Withdrawal by Subject|1|||
155660320|NCT01994876|561850618|FG000|Test Period 1|Adverse Event|0|||
155660321|NCT01994876|561850619|FG001|Test Period 1|Adverse Event|1|||
155660322|NCT01994876|561850618|FG000|Test Period 2|Adverse Event|1|||
155660323|NCT01994876|561850619|FG001|Test Period 2|Adverse Event|0|||
155660324|NCT01994876|561850618|FG000|Test Period 2|Protocol Violation|0|||
155660325|NCT01994876|561850619|FG001|Test Period 2|Protocol Violation|1|||
155660326|NCT04522973|561850620|FG000|Overall Study|Lost to Follow-up|4|||
155660327|NCT04522973|561850620|FG000|Overall Study|Could not adhere to study schedule|1|||
155660328|NCT02581930|561850630|FG000|Overall Study|Withdrawal by Subject|1|||
155660329|NCT02581930|561850630|FG000|Overall Study|patient declined further treatment|1|||
155660330|NCT03021486|561852542|FG000|Overall Study|Withdrawal by Subject|1|||
155660331|NCT03021486|561852543|FG001|Overall Study|Withdrawal by Subject|1|||
155660332|NCT03021486|561852544|FG002|Overall Study|Withdrawal by Subject|3|||
155660333|NCT03021486|561852542|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
155660334|NCT03021486|561852543|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
155660335|NCT03021486|561852544|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
155660336|NCT04043286|561852545|FG000|Overall Study|Withdrawal by Subject|2|||
155660337|NCT04043286|561852546|FG001|Overall Study|Withdrawal by Subject|2|||
155660338|NCT01276704|561852552|FG000|Overall Study|Lost to Follow-up|2|||
155660339|NCT01276704|561852553|FG001|Overall Study|Lost to Follow-up|3|||
155660340|NCT01276704|561852552|FG000|Overall Study|Non-compliant|2|||
155660341|NCT01276704|561852553|FG001|Overall Study|Non-compliant|2|||
155660342|NCT01276704|561852552|FG000|Overall Study|Withdrawal by Subject|7|||
155660343|NCT01276704|561852553|FG001|Overall Study|Withdrawal by Subject|1|||
155660344|NCT01276704|561852552|FG000|Overall Study|Physician Decision|3|||
155660345|NCT01276704|561852553|FG001|Overall Study|Physician Decision|5|||
155660346|NCT03728933|561852554|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155660347|NCT03728933|561852555|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155660348|NCT03728933|561852556|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155568607|NCT01104792|561506298|FG000|Overall Study|Lost to Follow-up|43|||
155568608|NCT01104792|561506298|FG000|Overall Study|Reasons Not Specified|27|||
155568609|NCT01104792|561506298|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
155568610|NCT02071849|561506300|FG000|6-month Primary Endpoint|Did not receive device|4|||
155568611|NCT02071849|561506300|FG000|6-month Primary Endpoint|Adverse Event|1|||
155568612|NCT02071849|561506300|FG000|2-year Extended Follow-up|Adverse Event|1|||
155568613|NCT03255655|561506301|FG000|Overall Study|Lost to Follow-up|7|||
155568614|NCT03255655|561506302|FG001|Overall Study|Lost to Follow-up|4|||
155568615|NCT00658021|561506303|FG000|28-Week Treatment Period|Adverse Event|3|||
155568616|NCT00658021|561506304|FG001|28-Week Treatment Period|Adverse Event|1|||
155568617|NCT00658021|561506305|FG002|28-Week Treatment Period|Adverse Event|0|||
155568618|NCT00658021|561506303|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
155568619|NCT00658021|561506304|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
155568620|NCT00658021|561506305|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
155568621|NCT00658021|561506303|FG000|28-Week Treatment Period|Protocol Violation|0|||
155568622|NCT00658021|561506304|FG001|28-Week Treatment Period|Protocol Violation|2|||
155568623|NCT00658021|561506305|FG002|28-Week Treatment Period|Protocol Violation|1|||
155568624|NCT00658021|561506303|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
155568625|NCT00658021|561506304|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
155568626|NCT00658021|561506305|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
155568627|NCT00658021|561506303|FG000|28-Week Treatment Period|Physician Decision|1|||
155568628|NCT00658021|561506304|FG001|28-Week Treatment Period|Physician Decision|2|||
155568629|NCT00658021|561506305|FG002|28-Week Treatment Period|Physician Decision|1|||
155568630|NCT00658021|561506303|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
155568631|NCT00658021|561506304|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
155568632|NCT00658021|561506305|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
155568633|NCT00658021|561506303|FG000|28-Week Treatment Period|Loss of glucose control|1|||
155568634|NCT00658021|561506304|FG001|28-Week Treatment Period|Loss of glucose control|1|||
155568635|NCT00658021|561506305|FG002|28-Week Treatment Period|Loss of glucose control|10|||
155568636|NCT00658021|561506303|FG000|28-Week Treatment Period|Other|2|||
155568637|NCT00658021|561506304|FG001|28-Week Treatment Period|Other|3|||
155568638|NCT00658021|561506305|FG002|28-Week Treatment Period|Other|1|||
155568639|NCT00658021|561506303|FG000|28-Week Treatment Period|Did not receive treatment|2|||
155568640|NCT00658021|561506304|FG001|28-Week Treatment Period|Did not receive treatment|0|||
155568641|NCT00658021|561506305|FG002|28-Week Treatment Period|Did not receive treatment|0|||
155568642|NCT00658021|561506303|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
155568643|NCT00658021|561506304|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
155568644|NCT00658021|561506305|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
155568645|NCT00658021|561506303|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
155568646|NCT00658021|561506304|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
155568647|NCT00658021|561506305|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
155568648|NCT01806506|561506306|FG000|Overall Study|Lost to Follow-up|2|||
155568649|NCT01806506|561506307|FG001|Overall Study|Lost to Follow-up|1|||
155568650|NCT00725205|561506308|FG000|Overall Study|Adverse Event|22|||
155568651|NCT00725205|561506308|FG000|Overall Study|Investigator Discontinued|1|||
155568652|NCT00725205|561506308|FG000|Overall Study|Non-compliance With Protocol|14|||
155568653|NCT00725205|561506308|FG000|Overall Study|Other|8|||
155568654|NCT00725205|561506308|FG000|Overall Study|Protocol Defined Clinical Event|1|||
155568655|NCT00725205|561506308|FG000|Overall Study|Treatment Failure|41|||
155568656|NCT01680497|561506309|FG000|Overall Study|Lost to Follow-up|2|||
155568657|NCT05819203|561506311|FG000|Overall Study|Protocol Violation|1|||
155568658|NCT05819203|561506312|FG001|Overall Study|Protocol Violation|2|||
155568659|NCT05819203|561506311|FG000|Overall Study|Withdrawal by Subject|1|||
155568660|NCT05819203|561506312|FG001|Overall Study|Withdrawal by Subject|0|||
155568661|NCT01243775|561506313|FG000|Overall Study|Withdrawal by Subject|2|||
155568662|NCT01177059|561506314|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
155568663|NCT01177059|561506314|FG000|Overall Study|Withdrew consent|2|||
155568664|NCT01177059|561506314|FG000|Overall Study|Lost to Follow-up|18|||
155568665|NCT04051619|561506315|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
155568666|NCT04051619|561506316|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
155568667|NCT04051619|561506315|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
155568668|NCT04051619|561506316|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
155568669|NCT00974922|561508109|FG000|Overall Study|study terminated|24|||
155568670|NCT00287586|561508110|FG000|Overall Study|Withdrew Consent|19|||
155568671|NCT00287586|561508111|FG001|Overall Study|Withdrew Consent|30|||
155568672|NCT00287586|561508110|FG000|Overall Study|Lost to Follow-up|5|||
155568673|NCT00287586|561508111|FG001|Overall Study|Lost to Follow-up|4|||
155568674|NCT00287586|561508110|FG000|Overall Study|Death|2|||
155568675|NCT00287586|561508111|FG001|Overall Study|Death|3|||
155568676|NCT00287586|561508110|FG000|Overall Study|Elevated Hematocrit|3|||
155568677|NCT00287586|561508111|FG001|Overall Study|Elevated Hematocrit|0|||
155660349|NCT03728933|561852554|FG000|Overall Study|Withdrawal by Subject|0|||
155660350|NCT03728933|561852555|FG001|Overall Study|Withdrawal by Subject|0|||
155660351|NCT03728933|561852556|FG002|Overall Study|Withdrawal by Subject|1|||
155660352|NCT03728933|561852554|FG000|Overall Study|Lost to Follow-up|0|||
155660353|NCT03728933|561852555|FG001|Overall Study|Lost to Follow-up|1|||
155660354|NCT03728933|561852556|FG002|Overall Study|Lost to Follow-up|0|||
155660355|NCT03728933|561852554|FG000|Overall Study|Adverse Event|1|||
155660356|NCT03728933|561852555|FG001|Overall Study|Adverse Event|0|||
155660357|NCT03728933|561852556|FG002|Overall Study|Adverse Event|0|||
155660358|NCT03674281|561852557|FG000|Overall Study|screen failure|2|||
155660359|NCT03674281|561852558|FG001|Overall Study|screen failure|0|||
155660360|NCT03674281|561852559|FG002|Overall Study|screen failure|0|||
155660361|NCT03674281|561852557|FG000|Overall Study|Withdrawal by Subject|1|||
155660362|NCT03674281|561852558|FG001|Overall Study|Withdrawal by Subject|3|||
155660363|NCT03674281|561852559|FG002|Overall Study|Withdrawal by Subject|3|||
155660364|NCT01441960|561852560|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
155568678|NCT00287586|561508110|FG000|Overall Study|Rash|3|||
155568679|NCT00287586|561508111|FG001|Overall Study|Rash|0|||
155568680|NCT00287586|561508110|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
155568681|NCT00287586|561508111|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
155568682|NCT00287586|561508110|FG000|Overall Study|Stroke|2|||
155568683|NCT00287586|561508111|FG001|Overall Study|Stroke|0|||
155568684|NCT00287586|561508110|FG000|Overall Study|Myocardial Infarction|1|||
155568685|NCT00287586|561508111|FG001|Overall Study|Myocardial Infarction|0|||
155568686|NCT00287586|561508110|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
155568687|NCT00287586|561508111|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
155568688|NCT00287586|561508110|FG000|Overall Study|Cognitive Impairment|1|||
155568689|NCT00287586|561508111|FG001|Overall Study|Cognitive Impairment|0|||
155568690|NCT00287586|561508110|FG000|Overall Study|Pancreatic Cancer|1|||
155568691|NCT00287586|561508111|FG001|Overall Study|Pancreatic Cancer|3|||
155568692|NCT00287586|561508110|FG000|Overall Study|Sleep Apnea|1|||
155568693|NCT00287586|561508111|FG001|Overall Study|Sleep Apnea|0|||
155568694|NCT00287586|561508110|FG000|Overall Study|Shoulder Pain|1|||
155568695|NCT00287586|561508111|FG001|Overall Study|Shoulder Pain|0|||
155568696|NCT00287586|561508110|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
155568697|NCT00287586|561508111|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
155568698|NCT00287586|561508110|FG000|Overall Study|Nonadherence|1|||
155568699|NCT00287586|561508111|FG001|Overall Study|Nonadherence|1|||
155568700|NCT00287586|561508110|FG000|Overall Study|Enrolled in Another Study|1|||
155568701|NCT00287586|561508111|FG001|Overall Study|Enrolled in Another Study|0|||
155568702|NCT00287586|561508110|FG000|Overall Study|Major Depression|0|||
155568703|NCT00287586|561508111|FG001|Overall Study|Major Depression|2|||
155568704|NCT00287586|561508110|FG000|Overall Study|Lung Cancer|0|||
155568705|NCT00287586|561508111|FG001|Overall Study|Lung Cancer|2|||
155568706|NCT00287586|561508110|FG000|Overall Study|Elevated IPSS Score|0|||
155568707|NCT00287586|561508111|FG001|Overall Study|Elevated IPSS Score|1|||
155568708|NCT00287586|561508110|FG000|Overall Study|Retroperitoneal Cancer|0|||
155568709|NCT00287586|561508111|FG001|Overall Study|Retroperitoneal Cancer|1|||
155568710|NCT00287586|561508110|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
155568711|NCT00287586|561508111|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
155568712|NCT00287586|561508110|FG000|Overall Study|Mood Swings and Irritability|0|||
155568713|NCT00287586|561508111|FG001|Overall Study|Mood Swings and Irritability|1|||
155568714|NCT00287586|561508110|FG000|Overall Study|Bradycardia|0|||
155568715|NCT00287586|561508111|FG001|Overall Study|Bradycardia|1|||
155568716|NCT00287586|561508110|FG000|Overall Study|Itchy Swollen Eyes|0|||
155568717|NCT00287586|561508111|FG001|Overall Study|Itchy Swollen Eyes|1|||
155568718|NCT00287586|561508110|FG000|Overall Study|Recurrent Melanoma|0|||
155568719|NCT00287586|561508111|FG001|Overall Study|Recurrent Melanoma|1|||
155568720|NCT01762800|561508113|FG000|Overall Study|Adverse Event|8|||
155568721|NCT01762800|561508114|FG001|Overall Study|Adverse Event|13|||
155660365|NCT01441960|561852561|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
155568722|NCT01762800|561508113|FG000|Overall Study|Lack of Efficacy|3|||
155568723|NCT01762800|561508114|FG001|Overall Study|Lack of Efficacy|2|||
155568724|NCT01762800|561508113|FG000|Overall Study|Study Closed/Terminated|0|||
155568725|NCT01762800|561508114|FG001|Overall Study|Study Closed/Terminated|1|||
155568726|NCT01762800|561508113|FG000|Overall Study|Physician Decision|1|||
155568727|NCT01762800|561508114|FG001|Overall Study|Physician Decision|1|||
155568728|NCT01762800|561508113|FG000|Overall Study|Withdrawal by Subject|7|||
155568729|NCT01762800|561508114|FG001|Overall Study|Withdrawal by Subject|4|||
155660366|NCT01441960|561852560|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
155660367|NCT01441960|561852561|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
155568730|NCT02640482|561508115|FG000|Overall Study|Lost to Follow-up|3|||
155568731|NCT02640482|561508116|FG001|Overall Study|Lost to Follow-up|0|||
155568732|NCT00517881|561508117|FG000|Overall Study|Protocol Violation|2|||
155568733|NCT00517881|561508117|FG000|Overall Study|Adverse Event|1|||
155568734|NCT00517881|561508117|FG000|Overall Study|Renal transplantation|2|||
155568735|NCT00113763|561508118|FG000|Overall Study|Adverse Event|5|||
155568736|NCT00113763|561508119|FG001|Overall Study|Adverse Event|2|||
155568737|NCT00113763|561508118|FG000|Overall Study|Disease Progression|28|||
155568738|NCT00113763|561508119|FG001|Overall Study|Disease Progression|14|||
155568739|NCT00113763|561508118|FG000|Overall Study|Lost to Follow-up|10|||
155568740|NCT00113763|561508119|FG001|Overall Study|Lost to Follow-up|0|||
155568741|NCT00113763|561508118|FG000|Overall Study|Withdrawal by Subject|1|||
155568742|NCT00113763|561508119|FG001|Overall Study|Withdrawal by Subject|4|||
155568743|NCT00113763|561508118|FG000|Overall Study|Other|27|||
155568744|NCT00113763|561508119|FG001|Overall Study|Other|6|||
155568745|NCT00113763|561508118|FG000|Overall Study|Non-compliance|1|||
155568746|NCT00113763|561508119|FG001|Overall Study|Non-compliance|0|||
155568747|NCT00113763|561508118|FG000|Overall Study|Ongoing|1|||
155568748|NCT00113763|561508119|FG001|Overall Study|Ongoing|0|||
155568749|NCT03743415|561508120|FG000|Overall Study|Death|5|||
155568750|NCT03743415|561508121|FG001|Overall Study|Death|3|||
155568751|NCT03743415|561508122|FG002|Overall Study|Death|1|||
155568752|NCT03743415|561508123|FG003|Overall Study|Death|4|||
155568753|NCT03743415|561508124|FG004|Overall Study|Death|0|||
155568754|NCT03743415|561508125|FG005|Overall Study|Death|0|||
155568755|NCT03743415|561508126|FG006|Overall Study|Death|0|||
155568756|NCT03743415|561508127|FG007|Overall Study|Death|0|||
155568757|NCT03743415|561508128|FG008|Overall Study|Death|1|||
155568758|NCT03743415|561508129|FG009|Overall Study|Death|0|||
155568759|NCT03743415|561508120|FG000|Overall Study|Withdrawal by Subject|1|||
155568760|NCT03743415|561508121|FG001|Overall Study|Withdrawal by Subject|0|||
155568761|NCT03743415|561508122|FG002|Overall Study|Withdrawal by Subject|4|||
155568762|NCT03743415|561508123|FG003|Overall Study|Withdrawal by Subject|5|||
155568763|NCT03743415|561508124|FG004|Overall Study|Withdrawal by Subject|5|||
155568764|NCT03743415|561508125|FG005|Overall Study|Withdrawal by Subject|2|||
155568765|NCT03743415|561508126|FG006|Overall Study|Withdrawal by Subject|2|||
155568766|NCT03743415|561508127|FG007|Overall Study|Withdrawal by Subject|5|||
155568767|NCT03743415|561508128|FG008|Overall Study|Withdrawal by Subject|9|||
155568768|NCT03743415|561508129|FG009|Overall Study|Withdrawal by Subject|10|||
155568769|NCT03743415|561508120|FG000|Overall Study|Lost to Follow-up|2|||
155568770|NCT03743415|561508121|FG001|Overall Study|Lost to Follow-up|0|||
155568771|NCT03743415|561508122|FG002|Overall Study|Lost to Follow-up|2|||
155568772|NCT03743415|561508123|FG003|Overall Study|Lost to Follow-up|1|||
155568773|NCT03743415|561508124|FG004|Overall Study|Lost to Follow-up|1|||
155568774|NCT03743415|561508125|FG005|Overall Study|Lost to Follow-up|0|||
155568775|NCT03743415|561508126|FG006|Overall Study|Lost to Follow-up|1|||
155568776|NCT03743415|561508127|FG007|Overall Study|Lost to Follow-up|4|||
155568777|NCT03743415|561508128|FG008|Overall Study|Lost to Follow-up|13|||
155568778|NCT03743415|561508129|FG009|Overall Study|Lost to Follow-up|13|||
155568779|NCT02847260|561508130|FG000|Overall Study|Adverse Event|3|||
155568780|NCT02847260|561508130|FG000|Overall Study|Withdrawal by Subject|2|||
155568781|NCT02847260|561508130|FG000|Overall Study|Clinical Deterioration|1|||
155568782|NCT02847260|561508130|FG000|Overall Study|Physician Decision|1|||
155568783|NCT00094861|561508133|FG000|Overall Study|Adverse Event|5|||
155568784|NCT00094861|561508134|FG001|Overall Study|Adverse Event|2|||
155568785|NCT00094861|561508133|FG000|Overall Study|Withdrawal by Subject|5|||
155568786|NCT00094861|561508134|FG001|Overall Study|Withdrawal by Subject|3|||
155568787|NCT00094861|561508133|FG000|Overall Study|Physician Decision|1|||
155568788|NCT00094861|561508134|FG001|Overall Study|Physician Decision|1|||
155568789|NCT00094861|561508133|FG000|Overall Study|Lost to Follow-up|0|||
155568790|NCT00094861|561508134|FG001|Overall Study|Lost to Follow-up|1|||
155568791|NCT00094861|561508133|FG000|Overall Study|Death|4|||
155568792|NCT00094861|561508134|FG001|Overall Study|Death|2|||
155568793|NCT00094861|561508133|FG000|Overall Study|Other|3|||
155568794|NCT00094861|561508134|FG001|Overall Study|Other|0|||
155568795|NCT00264550|561508135|FG000|Overall Study|Death|0|||
155568796|NCT00264550|561508136|FG001|Overall Study|Death|3|||
155568797|NCT00264550|561508137|FG002|Overall Study|Death|0|||
155568798|NCT00264550|561508138|FG003|Overall Study|Death|0|||
155568799|NCT00264550|561508135|FG000|Overall Study|Lost to Follow-up|3|||
155568800|NCT00264550|561508136|FG001|Overall Study|Lost to Follow-up|1|||
155568801|NCT00264550|561508137|FG002|Overall Study|Lost to Follow-up|1|||
155568802|NCT00264550|561508138|FG003|Overall Study|Lost to Follow-up|1|||
155568803|NCT00264550|561508135|FG000|Overall Study|Adverse Event|23|||
155568804|NCT00264550|561508136|FG001|Overall Study|Adverse Event|18|||
155568805|NCT00264550|561508137|FG002|Overall Study|Adverse Event|9|||
155568806|NCT00264550|561508138|FG003|Overall Study|Adverse Event|14|||
155568807|NCT00264550|561508135|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155568808|NCT00264550|561508136|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
155568809|NCT00264550|561508137|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
155568810|NCT00264550|561508138|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
155568811|NCT00264550|561508135|FG000|Overall Study|Discontinued oral study agent|0|||
155568812|NCT00264550|561508136|FG001|Overall Study|Discontinued oral study agent|1|||
155568813|NCT00264550|561508137|FG002|Overall Study|Discontinued oral study agent|0|||
155568814|NCT00264550|561508138|FG003|Overall Study|Discontinued oral study agent|0|||
155568815|NCT00264550|561508135|FG000|Overall Study|Other|13|||
155568816|NCT00264550|561508136|FG001|Overall Study|Other|7|||
155568817|NCT00264550|561508137|FG002|Overall Study|Other|3|||
155568818|NCT00264550|561508138|FG003|Overall Study|Other|9|||
155568819|NCT00129389|561508139|FG000|Overall Study|Adverse Event|19|||
155568820|NCT00129389|561508140|FG001|Overall Study|Adverse Event|87|||
155568821|NCT00129389|561508139|FG000|Overall Study|Death|0|||
155568822|NCT00129389|561508140|FG001|Overall Study|Death|1|||
155568823|NCT00129389|561508139|FG000|Overall Study|Lost to Follow-up|2|||
155568824|NCT00129389|561508140|FG001|Overall Study|Lost to Follow-up|1|||
155568825|NCT00129389|561508139|FG000|Overall Study|Physician Decision|0|||
155568826|NCT00129389|561508140|FG001|Overall Study|Physician Decision|4|||
155568827|NCT00129389|561508139|FG000|Overall Study|Protocol Violation|0|||
155568828|NCT00129389|561508140|FG001|Overall Study|Protocol Violation|6|||
155568829|NCT00129389|561508139|FG000|Overall Study|Withdrawal by Subject|9|||
155568830|NCT00129389|561508140|FG001|Overall Study|Withdrawal by Subject|23|||
155568831|NCT00129389|561508139|FG000|Overall Study|Relapse|1|||
155568832|NCT00129389|561508140|FG001|Overall Study|Relapse|0|||
155568833|NCT00129389|561508139|FG000|Overall Study|Not eligible|1|||
155568834|NCT00129389|561508140|FG001|Overall Study|Not eligible|2|||
155568835|NCT00129389|561508139|FG000|Overall Study|Crossed to the other arm|1|||
155568836|NCT00129389|561508140|FG001|Overall Study|Crossed to the other arm|16|||
155568837|NCT00451204|561508141|FG000|Overall Study|Adverse Event|4|||
155568838|NCT00451204|561508142|FG001|Overall Study|Adverse Event|6|||
155568839|NCT00451204|561508141|FG000|Overall Study|Lack of Efficacy|4|||
155568840|NCT00451204|561508142|FG001|Overall Study|Lack of Efficacy|4|||
155568841|NCT00451204|561508141|FG000|Overall Study|Lost to Follow-up|4|||
155568842|NCT00451204|561508142|FG001|Overall Study|Lost to Follow-up|4|||
155568843|NCT00451204|561508141|FG000|Overall Study|Protocol Violation|1|||
155568844|NCT00451204|561508142|FG001|Overall Study|Protocol Violation|0|||
155568845|NCT00451204|561508141|FG000|Overall Study|Patient refusal|8|||
155568846|NCT00451204|561508142|FG001|Overall Study|Patient refusal|4|||
155568847|NCT00451204|561508141|FG000|Overall Study|Other|1|||
155568848|NCT00451204|561508142|FG001|Overall Study|Other|2|||
155568849|NCT03760185|561508143|FG000|Overall Study|Lost to Follow-up|1|||
155568850|NCT03760185|561508144|FG001|Overall Study|Lost to Follow-up|1|||
155568851|NCT00976911|561508150|FG000|Overall Study|Withdrawal by Subject|4|||
155568852|NCT00976911|561508151|FG001|Overall Study|Withdrawal by Subject|6|||
155568853|NCT00976911|561508150|FG000|Overall Study|Death|138|||
155568854|NCT00976911|561508151|FG001|Overall Study|Death|126|||
155568855|NCT00976911|561508150|FG000|Overall Study|Adverse Event|0|||
155568856|NCT00976911|561508151|FG001|Overall Study|Adverse Event|1|||
155568857|NCT00976911|561508150|FG000|Overall Study|Protocol Violation|2|||
155568858|NCT00976911|561508151|FG001|Overall Study|Protocol Violation|0|||
155568859|NCT00976911|561508150|FG000|Overall Study|Other|8|||
155568860|NCT00976911|561508151|FG001|Overall Study|Other|9|||
155568861|NCT00976911|561508150|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
155568862|NCT00976911|561508151|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
155568863|NCT01191944|561508152|FG000|Overall Study|Adverse Event|11|||
155568864|NCT01191944|561508153|FG001|Overall Study|Adverse Event|12|||
155568865|NCT01191944|561508152|FG000|Overall Study|Protocol Violation|1|||
155568866|NCT01191944|561508153|FG001|Overall Study|Protocol Violation|2|||
155568867|NCT01191944|561508152|FG000|Overall Study|Withdrawal by Subject|4|||
155568868|NCT01191944|561508153|FG001|Overall Study|Withdrawal by Subject|2|||
155568869|NCT01191944|561508152|FG000|Overall Study|Other|1|||
155568870|NCT01191944|561508153|FG001|Overall Study|Other|3|||
155568871|NCT02954991|561508156|FG000|Overall Study|Death|92|||
155568872|NCT02954991|561508157|FG001|Overall Study|Death|11|||
155568873|NCT02954991|561508158|FG002|Overall Study|Death|2|||
155568874|NCT02954991|561508156|FG000|Overall Study|Lost to Follow-up|3|||
155568875|NCT02954991|561508157|FG001|Overall Study|Lost to Follow-up|2|||
155660368|NCT01441960|561852560|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
155660369|NCT01441960|561852561|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
155568876|NCT02954991|561508158|FG002|Overall Study|Lost to Follow-up|0|||
155568877|NCT02954991|561508156|FG000|Overall Study|Withdrawal by Subject|9|||
155568878|NCT02954991|561508157|FG001|Overall Study|Withdrawal by Subject|8|||
155568879|NCT02954991|561508158|FG002|Overall Study|Withdrawal by Subject|1|||
155568880|NCT02954991|561508156|FG000|Overall Study|Study Terminated by Sponsor|18|||
155568881|NCT02954991|561508157|FG001|Overall Study|Study Terminated by Sponsor|10|||
155568882|NCT02954991|561508158|FG002|Overall Study|Study Terminated by Sponsor|1|||
155568883|NCT02954991|561508156|FG000|Overall Study|Miscellaneous|2|||
155660370|NCT00276419|561852563|FG000|First Intervention|Adverse Event|1|||
155568884|NCT02954991|561508157|FG001|Overall Study|Miscellaneous|1|||
155568885|NCT02954991|561508158|FG002|Overall Study|Miscellaneous|1|||
155568886|NCT00576316|561508159|FG000|Overall Study|Adverse Event|9|||
155568887|NCT00576316|561508159|FG000|Overall Study|Withdrawal by Subject|2|||
155568888|NCT00576316|561508159|FG000|Overall Study|Protocol Violation|9|||
155568889|NCT02794246|561508166|FG000|Overall Study|Withdrawal by Subject|2|||
155568890|NCT02794246|561508166|FG000|Overall Study|Physician Decision|4|||
155568891|NCT04602546|561508167|FG000|Overall Study|Training|2|||
155568892|NCT04602546|561508168|FG001|Overall Study|Training|2|||
155568893|NCT04602546|561508169|FG002|Overall Study|Training|1|||
155568894|NCT04602546|561508170|FG003|Overall Study|Training|2|||
155568895|NCT04602546|561508171|FG004|Overall Study|Training|0|||
155568896|NCT04602546|561508167|FG000|Overall Study|Randomized with disqualified data|2|||
155568897|NCT04602546|561508168|FG001|Overall Study|Randomized with disqualified data|0|||
155568898|NCT04602546|561508169|FG002|Overall Study|Randomized with disqualified data|2|||
155568899|NCT04602546|561508170|FG003|Overall Study|Randomized with disqualified data|5|||
155568900|NCT04602546|561508171|FG004|Overall Study|Randomized with disqualified data|3|||
155568901|NCT00005957|561508175|FG000|Overall Study|No treated|3|||
155568902|NCT00005957|561508176|FG001|Overall Study|No treated|9|||
155568903|NCT00005957|561508175|FG000|Overall Study|Crossover to the other arm|5|||
155568904|NCT00005957|561508176|FG001|Overall Study|Crossover to the other arm|19|||
155568905|NCT01609023|561508177|FG000|Overall Study|Lack of Efficacy|3|||
155568906|NCT01609023|561508177|FG000|Overall Study|Withdrawal by Subject|4|||
155568907|NCT01609023|561508177|FG000|Overall Study|Lost to Follow-up|8|||
155568908|NCT01609023|561508177|FG000|Overall Study|Toxicity|3|||
155568909|NCT01609023|561508177|FG000|Overall Study|Disease progression|10|||
155568910|NCT01609023|561508177|FG000|Overall Study|Physician Decision|2|||
155568911|NCT01609023|561508177|FG000|Overall Study|Death|2|||
155568912|NCT01609023|561508177|FG000|Overall Study|Personal reasons|1|||
155568913|NCT04172597|561508181|FG000|Overall Study|Disease Progression|0|||
155568914|NCT04172597|561508182|FG001|Overall Study|Disease Progression|0|||
155568915|NCT04172597|561508183|FG002|Overall Study|Disease Progression|0|||
155568916|NCT04172597|561508184|FG003|Overall Study|Disease Progression|0|||
155568917|NCT04172597|561508185|FG004|Overall Study|Disease Progression|1|||
155568918|NCT03717012|561508186|FG000|Overall Study|Due to trial termination|1|||
155568919|NCT03717012|561508187|FG001|Overall Study|Due to trial termination|2|||
155568920|NCT03717012|561508186|FG000|Overall Study|Protocol Violation|0|||
155568921|NCT03717012|561508187|FG001|Overall Study|Protocol Violation|2|||
155568922|NCT03717012|561508186|FG000|Overall Study|Adverse Event|0|||
155568923|NCT03717012|561508187|FG001|Overall Study|Adverse Event|1|||
155568924|NCT03717012|561508186|FG000|Overall Study|Lung transplant|0|||
155568925|NCT03717012|561508187|FG001|Overall Study|Lung transplant|1|||
155568926|NCT00789035|561508188|FG000|Overall Study|Adverse Event|0|||
155568927|NCT00789035|561508189|FG001|Overall Study|Adverse Event|2|||
155568928|NCT00789035|561508190|FG002|Overall Study|Adverse Event|0|||
155568929|NCT00789035|561508191|FG003|Overall Study|Adverse Event|1|||
155568930|NCT00789035|561508192|FG004|Overall Study|Adverse Event|3|||
155568931|NCT00789035|561508188|FG000|Overall Study|Lack of Efficacy|3|||
155568932|NCT00789035|561508189|FG001|Overall Study|Lack of Efficacy|0|||
155568933|NCT00789035|561508190|FG002|Overall Study|Lack of Efficacy|0|||
155568934|NCT00789035|561508191|FG003|Overall Study|Lack of Efficacy|0|||
155568935|NCT00789035|561508192|FG004|Overall Study|Lack of Efficacy|2|||
155568936|NCT00789035|561508188|FG000|Overall Study|Protocol Violation|1|||
155568937|NCT00789035|561508189|FG001|Overall Study|Protocol Violation|0|||
155568938|NCT00789035|561508190|FG002|Overall Study|Protocol Violation|0|||
155568939|NCT00789035|561508191|FG003|Overall Study|Protocol Violation|0|||
155568940|NCT00789035|561508192|FG004|Overall Study|Protocol Violation|0|||
155568941|NCT00789035|561508188|FG000|Overall Study|Withdrawal by Subject|0|||
155568942|NCT00789035|561508189|FG001|Overall Study|Withdrawal by Subject|2|||
155568943|NCT00789035|561508190|FG002|Overall Study|Withdrawal by Subject|0|||
155568944|NCT00789035|561508191|FG003|Overall Study|Withdrawal by Subject|0|||
155568945|NCT00789035|561508192|FG004|Overall Study|Withdrawal by Subject|0|||
155568946|NCT00789035|561508188|FG000|Overall Study|Other reason not defined above|2|||
155568947|NCT00789035|561508189|FG001|Overall Study|Other reason not defined above|3|||
155568948|NCT00789035|561508190|FG002|Overall Study|Other reason not defined above|1|||
155568949|NCT00789035|561508191|FG003|Overall Study|Other reason not defined above|0|||
155568950|NCT00789035|561508192|FG004|Overall Study|Other reason not defined above|1|||
155568951|NCT01520870|561508193|FG000|Overall Study|Withdrawal by Subject|2|||
155568952|NCT02797171|561508196|FG000|Overall Study|Lost to Follow-up|2|||
155568953|NCT02797171|561508197|FG001|Overall Study|Lost to Follow-up|0|||
155568954|NCT02797171|561508198|FG002|Overall Study|Lost to Follow-up|2|||
155568955|NCT02797171|561508199|FG003|Overall Study|Lost to Follow-up|1|||
155568956|NCT02797171|561508200|FG004|Overall Study|Lost to Follow-up|2|||
155568957|NCT02797171|561508201|FG005|Overall Study|Lost to Follow-up|0|||
155568958|NCT02797171|561508196|FG000|Overall Study|Withdrawal by Subject|1|||
155568959|NCT02797171|561508197|FG001|Overall Study|Withdrawal by Subject|1|||
155568960|NCT02797171|561508198|FG002|Overall Study|Withdrawal by Subject|0|||
155568961|NCT02797171|561508199|FG003|Overall Study|Withdrawal by Subject|0|||
155568962|NCT02797171|561508200|FG004|Overall Study|Withdrawal by Subject|0|||
155660371|NCT00276419|561852564|FG001|First Intervention|Adverse Event|0|||
155568963|NCT02797171|561508201|FG005|Overall Study|Withdrawal by Subject|0|||
155568964|NCT02797171|561508196|FG000|Overall Study|Protocol Violation|1|||
155568965|NCT02797171|561508197|FG001|Overall Study|Protocol Violation|0|||
155568966|NCT02797171|561508198|FG002|Overall Study|Protocol Violation|0|||
155568967|NCT02797171|561508199|FG003|Overall Study|Protocol Violation|0|||
155568968|NCT02797171|561508200|FG004|Overall Study|Protocol Violation|0|||
155568969|NCT02797171|561508201|FG005|Overall Study|Protocol Violation|0|||
155568970|NCT02797171|561508196|FG000|Overall Study|Participant unable to adhere|0|||
155568971|NCT02797171|561508197|FG001|Overall Study|Participant unable to adhere|1|||
155568972|NCT02797171|561508198|FG002|Overall Study|Participant unable to adhere|0|||
155568973|NCT02797171|561508199|FG003|Overall Study|Participant unable to adhere|0|||
155568974|NCT02797171|561508200|FG004|Overall Study|Participant unable to adhere|0|||
155568975|NCT02797171|561508201|FG005|Overall Study|Participant unable to adhere|0|||
155568976|NCT02797171|561508196|FG000|Overall Study|Not Randomized|0|||
155568977|NCT02797171|561508197|FG001|Overall Study|Not Randomized|0|||
155568978|NCT02797171|561508198|FG002|Overall Study|Not Randomized|0|||
155568979|NCT02797171|561508199|FG003|Overall Study|Not Randomized|0|||
155568980|NCT02797171|561508200|FG004|Overall Study|Not Randomized|0|||
155568981|NCT02797171|561508201|FG005|Overall Study|Not Randomized|1|||
155568982|NCT02585778|561508202|FG000|Overall Study|Adverse Event|17|||
155568983|NCT02585778|561508203|FG001|Overall Study|Adverse Event|4|||
155568984|NCT02585778|561508202|FG000|Overall Study|Participant did not wish to continue|9|||
155568985|NCT02585778|561508203|FG001|Overall Study|Participant did not wish to continue|4|||
155568986|NCT02585778|561508202|FG000|Overall Study|Poor compliance to study protocol|0|||
155568987|NCT02585778|561508203|FG001|Overall Study|Poor compliance to study protocol|2|||
155568988|NCT02585778|561508202|FG000|Overall Study|Death|0|||
155568989|NCT02585778|561508203|FG001|Overall Study|Death|1|||
155568990|NCT02585778|561508202|FG000|Overall Study|Randomized but not treated|1|||
155568991|NCT02585778|561508203|FG001|Overall Study|Randomized but not treated|2|||
155568992|NCT02585778|561508202|FG000|Overall Study|Other than specified above|6|||
155568993|NCT02585778|561508203|FG001|Overall Study|Other than specified above|2|||
155568994|NCT04841577|561508204|FG000|Overall Study|Adverse Event|5|||
155568995|NCT04841577|561508205|FG001|Overall Study|Adverse Event|10|||
155568996|NCT04841577|561508204|FG000|Overall Study|Lost to Follow-up|8|||
155568997|NCT04841577|561508205|FG001|Overall Study|Lost to Follow-up|7|||
155568998|NCT04841577|561508204|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
155568999|NCT04841577|561508205|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
155569000|NCT04841577|561508204|FG000|Overall Study|Other|0|||
155569001|NCT04841577|561508205|FG001|Overall Study|Other|1|||
155569002|NCT05211726|561508213|FG000|Overall Study|Withdrawal by Subject|2|||
155569003|NCT05211726|561508214|FG001|Overall Study|Withdrawal by Subject|3|||
155569004|NCT05211726|561508213|FG000|Overall Study|Protocol Violation|0|||
155569005|NCT05211726|561508214|FG001|Overall Study|Protocol Violation|1|||
155569006|NCT01267994|561508216|FG000|Overall Study|Adverse Event|2|||
155569007|NCT03276078|561508219|FG000|Overall Study|Adverse Event|1|||
155569008|NCT03968978|561508221|FG000|Overall Study|Adverse Event|1|||
155569009|NCT03968978|561508222|FG001|Overall Study|Adverse Event|0|||
155569010|NCT00086281|561508223|FG000|Phase 1|Adverse Event|0|||
155569011|NCT00086281|561508224|FG001|Phase 1|Adverse Event|0|||
155569012|NCT00086281|561508225|FG002|Phase 1|Adverse Event|0|||
155569013|NCT00086281|561508226|FG003|Phase 1|Adverse Event|0|||
155569014|NCT00086281|561508227|FG004|Phase 1|Adverse Event|0|||
155569015|NCT00086281|561508228|FG005|Phase 1|Adverse Event|0|||
155569016|NCT00086281|561508229|FG006|Phase 1|Adverse Event|0|||
155569017|NCT00086281|561508230|FG007|Phase 1|Adverse Event|0|||
155660372|NCT00276419|561852563|FG000|First Intervention|Withdrawal by Subject|0|||
155660373|NCT00276419|561852564|FG001|First Intervention|Withdrawal by Subject|2|||
155660374|NCT03186638|561852565|FG000|Overall Study|Withdrawal by Subject|4|||
155660375|NCT03186638|561852566|FG001|Overall Study|Withdrawal by Subject|4|||
155660376|NCT03186638|561852565|FG000|Overall Study|Withdrawn due to medical problem|3|||
155660377|NCT03186638|561852566|FG001|Overall Study|Withdrawn due to medical problem|2|||
155660378|NCT03186638|561852565|FG000|Overall Study|Lost to Follow-up|1|||
155569018|NCT00086281|561508231|FG008|Phase 1|Adverse Event|0|||
155569019|NCT00086281|561508232|FG009|Phase 1|Adverse Event|1|||
155569020|NCT00086281|561508233|FG010|Phase 1|Adverse Event|2|||
155569021|NCT00086281|561508234|FG011|Phase 1|Adverse Event|1|||
155569022|NCT00086281|561508235|FG012|Phase 1|Adverse Event|1|||
155569023|NCT00086281|561508236|FG013|Phase 1|Adverse Event|1|||
155569024|NCT00086281|561508237|FG014|Phase 1|Adverse Event|2|||
155569025|NCT00086281|561508223|FG000|Phase 1|Protocol Violation|0|||
155569026|NCT00086281|561508224|FG001|Phase 1|Protocol Violation|0|||
155569027|NCT00086281|561508225|FG002|Phase 1|Protocol Violation|0|||
155569028|NCT00086281|561508226|FG003|Phase 1|Protocol Violation|0|||
155569029|NCT00086281|561508227|FG004|Phase 1|Protocol Violation|0|||
155569030|NCT00086281|561508228|FG005|Phase 1|Protocol Violation|0|||
155660379|NCT03186638|561852566|FG001|Overall Study|Lost to Follow-up|0|||
155569031|NCT00086281|561508229|FG006|Phase 1|Protocol Violation|0|||
155569032|NCT00086281|561508230|FG007|Phase 1|Protocol Violation|0|||
155569033|NCT00086281|561508231|FG008|Phase 1|Protocol Violation|0|||
155569034|NCT00086281|561508232|FG009|Phase 1|Protocol Violation|0|||
155569035|NCT00086281|561508233|FG010|Phase 1|Protocol Violation|1|||
155569036|NCT00086281|561508234|FG011|Phase 1|Protocol Violation|0|||
155569037|NCT00086281|561508235|FG012|Phase 1|Protocol Violation|0|||
155569038|NCT00086281|561508236|FG013|Phase 1|Protocol Violation|0|||
155569039|NCT00086281|561508237|FG014|Phase 1|Protocol Violation|0|||
155569040|NCT00086281|561508223|FG000|Phase 1|Serious Adverse Event|0|||
155569041|NCT00086281|561508224|FG001|Phase 1|Serious Adverse Event|0|||
155569042|NCT00086281|561508225|FG002|Phase 1|Serious Adverse Event|0|||
155569043|NCT00086281|561508226|FG003|Phase 1|Serious Adverse Event|0|||
155569044|NCT00086281|561508227|FG004|Phase 1|Serious Adverse Event|0|||
155569045|NCT00086281|561508228|FG005|Phase 1|Serious Adverse Event|0|||
155569046|NCT00086281|561508229|FG006|Phase 1|Serious Adverse Event|0|||
155569047|NCT00086281|561508230|FG007|Phase 1|Serious Adverse Event|0|||
155569048|NCT00086281|561508231|FG008|Phase 1|Serious Adverse Event|0|||
155569049|NCT00086281|561508232|FG009|Phase 1|Serious Adverse Event|0|||
155569050|NCT00086281|561508233|FG010|Phase 1|Serious Adverse Event|0|||
155569051|NCT00086281|561508234|FG011|Phase 1|Serious Adverse Event|0|||
155569052|NCT00086281|561508235|FG012|Phase 1|Serious Adverse Event|0|||
155569053|NCT00086281|561508236|FG013|Phase 1|Serious Adverse Event|0|||
155569054|NCT00086281|561508237|FG014|Phase 1|Serious Adverse Event|1|||
155569055|NCT00086281|561508223|FG000|Phase 2|Adverse Event|0|||
155569056|NCT00086281|561508224|FG001|Phase 2|Adverse Event|0|||
155569057|NCT00086281|561508225|FG002|Phase 2|Adverse Event|0|||
155569058|NCT00086281|561508226|FG003|Phase 2|Adverse Event|0|||
155569059|NCT00086281|561508227|FG004|Phase 2|Adverse Event|0|||
155569060|NCT00086281|561508228|FG005|Phase 2|Adverse Event|0|||
155569061|NCT00086281|561508229|FG006|Phase 2|Adverse Event|0|||
155569062|NCT00086281|561508230|FG007|Phase 2|Adverse Event|0|||
155569063|NCT00086281|561508231|FG008|Phase 2|Adverse Event|0|||
155569064|NCT00086281|561508232|FG009|Phase 2|Adverse Event|0|||
155569065|NCT00086281|561508233|FG010|Phase 2|Adverse Event|0|||
155569066|NCT00086281|561508234|FG011|Phase 2|Adverse Event|0|||
155569067|NCT00086281|561508235|FG012|Phase 2|Adverse Event|1|||
155569068|NCT00086281|561508236|FG013|Phase 2|Adverse Event|1|||
155569069|NCT00086281|561508237|FG014|Phase 2|Adverse Event|0|||
155569070|NCT00205803|561508240|FG000|Infant Series|Lost to Follow-up|10|||
155569071|NCT00205803|561508241|FG001|Infant Series|Lost to Follow-up|4|||
155569072|NCT00205803|561508240|FG000|Infant Series|Withdrawal by Subject|2|||
155569073|NCT00205803|561508241|FG001|Infant Series|Withdrawal by Subject|5|||
155569074|NCT00205803|561508240|FG000|Infant Series|Physician Decision|3|||
155569075|NCT00205803|561508241|FG001|Infant Series|Physician Decision|1|||
155569076|NCT00205803|561508240|FG000|Infant Series|Protocol Violation|1|||
155569077|NCT00205803|561508241|FG001|Infant Series|Protocol Violation|0|||
155569078|NCT00205803|561508240|FG000|Infant Series|Lost Kaiser coverage|0|||
155569079|NCT00205803|561508241|FG001|Infant Series|Lost Kaiser coverage|1|||
155569080|NCT00205803|561508240|FG000|Infant Series|Non-compliant|1|||
155569081|NCT00205803|561508241|FG001|Infant Series|Non-compliant|0|||
155569082|NCT00205803|561508240|FG000|Infant Series|Sponsor request|1|||
155569083|NCT00205803|561508241|FG001|Infant Series|Sponsor request|0|||
155569084|NCT00205803|561508240|FG000|After Infant Series|Adverse Event|1|||
155569085|NCT00205803|561508241|FG001|After Infant Series|Adverse Event|1|||
155569086|NCT00205803|561508240|FG000|After Infant Series|Protocol Violation|1|||
155569087|NCT00205803|561508241|FG001|After Infant Series|Protocol Violation|1|||
155569088|NCT00205803|561508240|FG000|After Infant Series|Lost to Follow-up|2|||
155569089|NCT00205803|561508241|FG001|After Infant Series|Lost to Follow-up|1|||
155569090|NCT00205803|561508240|FG000|After Infant Series|Physician Decision|3|||
155569091|NCT00205803|561508241|FG001|After Infant Series|Physician Decision|2|||
155569092|NCT00205803|561508240|FG000|After Infant Series|Withdrawal by Subject|1|||
155569093|NCT00205803|561508241|FG001|After Infant Series|Withdrawal by Subject|4|||
155569094|NCT00205803|561508240|FG000|After Infant Series|Other|10|||
155569095|NCT00205803|561508241|FG001|After Infant Series|Other|4|||
155569096|NCT00205803|561508240|FG000|Toddler Dose|Lost to Follow-up|2|||
155569097|NCT00205803|561508241|FG001|Toddler Dose|Lost to Follow-up|3|||
155569098|NCT00351533|561508242|FG000|Overall Study|Extubated before first BAL|1|||
155569099|NCT00351533|561508243|FG001|Overall Study|Extubated before first BAL|0|||
155569100|NCT00351533|561508242|FG000|Overall Study|Lost to Follow-up|1|||
155569101|NCT00351533|561508243|FG001|Overall Study|Lost to Follow-up|3|||
155569102|NCT00351533|561508242|FG000|Overall Study|Physician Decision|0|||
155569103|NCT00351533|561508243|FG001|Overall Study|Physician Decision|1|||
155569104|NCT00351533|561508242|FG000|Overall Study|Withdrawal by Subject|0|||
155569105|NCT00351533|561508243|FG001|Overall Study|Withdrawal by Subject|1|||
155569106|NCT02056392|561508244|FG000|Overall Study|Lost to Follow-up|0|||
155569107|NCT02056392|561508245|FG001|Overall Study|Lost to Follow-up|1|||
155569108|NCT02056392|561508246|FG002|Overall Study|Lost to Follow-up|2|||
155569109|NCT02056392|561508247|FG003|Overall Study|Lost to Follow-up|0|||
155569110|NCT02056392|561508248|FG004|Overall Study|Lost to Follow-up|0|||
155569111|NCT02056392|561508249|FG005|Overall Study|Lost to Follow-up|0|||
155569112|NCT02056392|561508244|FG000|Overall Study|Protocol Violation|1|||
155569113|NCT02056392|561508245|FG001|Overall Study|Protocol Violation|0|||
155569114|NCT02056392|561508246|FG002|Overall Study|Protocol Violation|1|||
155569115|NCT02056392|561508247|FG003|Overall Study|Protocol Violation|0|||
155569116|NCT02056392|561508248|FG004|Overall Study|Protocol Violation|0|||
155569117|NCT02056392|561508249|FG005|Overall Study|Protocol Violation|0|||
155569118|NCT02056392|561508244|FG000|Overall Study|Withdrawal by Subject|1|||
155569119|NCT02056392|561508245|FG001|Overall Study|Withdrawal by Subject|0|||
155569120|NCT02056392|561508246|FG002|Overall Study|Withdrawal by Subject|0|||
155569121|NCT02056392|561508247|FG003|Overall Study|Withdrawal by Subject|0|||
155569122|NCT02056392|561508248|FG004|Overall Study|Withdrawal by Subject|1|||
155569123|NCT02056392|561508249|FG005|Overall Study|Withdrawal by Subject|0|||
155569124|NCT00103610|561508252|FG000|Overall Study|Entered Rescue Procedure|10|||
155569125|NCT00103610|561508253|FG001|Overall Study|Entered Rescue Procedure|52|||
155569126|NCT00103610|561508252|FG000|Overall Study|Death|16|||
155569127|NCT00103610|561508253|FG001|Overall Study|Death|12|||
155569128|NCT00103610|561508252|FG000|Overall Study|Elective Withdrawal|4|||
155569129|NCT00103610|561508253|FG001|Overall Study|Elective Withdrawal|0|||
155569130|NCT00103610|561508252|FG000|Overall Study|Lost to Follow-up|3|||
155569131|NCT00103610|561508253|FG001|Overall Study|Lost to Follow-up|1|||
155569132|NCT00103610|561508252|FG000|Overall Study|Adverse Event|2|||
155569133|NCT00103610|561508253|FG001|Overall Study|Adverse Event|2|||
155569134|NCT00103610|561508252|FG000|Overall Study|Other|2|||
155569135|NCT00103610|561508253|FG001|Overall Study|Other|7|||
155569136|NCT00103610|561508252|FG000|Overall Study|Failed mobilization|1|||
155569137|NCT00103610|561508253|FG001|Overall Study|Failed mobilization|5|||
155569138|NCT00103610|561508252|FG000|Overall Study|Noncompliance|0|||
155569139|NCT00103610|561508253|FG001|Overall Study|Noncompliance|1|||
155569140|NCT00315731|561508258|FG000|Overall Study|Lost to Follow-up|1|||
155569141|NCT00315731|561508258|FG000|Overall Study|Death|5|||
155569142|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
155569143|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
155569144|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569145|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569146|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569147|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569148|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569149|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569150|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569151|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155569152|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
155660380|NCT03801525|561852567|FG000|Overall Study|Adverse Event|17|||
155660381|NCT03801525|561852568|FG001|Overall Study|Adverse Event|1|||
155569153|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
155569154|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569155|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569156|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569157|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569158|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569159|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569160|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155569161|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155660382|NCT03801525|561852569|FG002|Overall Study|Adverse Event|0|||
155569162|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569163|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
155569164|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569165|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569166|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569167|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569168|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569169|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569170|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569171|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155569172|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
155569173|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569174|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569175|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569176|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569177|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569178|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569179|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569180|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569181|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155569182|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
155569183|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
155569184|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569185|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569186|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569187|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569188|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569189|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569190|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569191|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155569192|NCT04784533|561508259|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
155569193|NCT04784533|561508260|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
155569194|NCT04784533|561508261|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569195|NCT04784533|561508262|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569196|NCT04784533|561508263|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569197|NCT04784533|561508264|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569198|NCT04784533|561508265|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569199|NCT04784533|561508266|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569200|NCT04784533|561508267|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569201|NCT04784533|561508268|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155569202|NCT04784533|561508259|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569203|NCT04784533|561508260|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569204|NCT04784533|561508261|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
155569205|NCT04784533|561508262|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569206|NCT04784533|561508263|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569207|NCT04784533|561508264|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569208|NCT04784533|561508265|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569209|NCT04784533|561508266|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569210|NCT04784533|561508267|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569211|NCT04784533|561508268|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155569212|NCT04784533|561508259|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569213|NCT04784533|561508260|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569214|NCT04784533|561508261|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569215|NCT04784533|561508262|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569216|NCT04784533|561508263|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569217|NCT04784533|561508264|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569218|NCT04784533|561508265|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569219|NCT04784533|561508266|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569220|NCT04784533|561508267|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
155569221|NCT04784533|561508268|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155569222|NCT04784533|561508259|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569223|NCT04784533|561508260|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569224|NCT04784533|561508261|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569225|NCT04784533|561508262|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569226|NCT04784533|561508263|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155660383|NCT03801525|561852567|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
155660384|NCT03801525|561852568|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
155660385|NCT03801525|561852569|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
155660386|NCT03801525|561852567|FG000|Overall Study|Death|29|||
155660387|NCT03801525|561852568|FG001|Overall Study|Death|1|||
155660388|NCT03801525|561852569|FG002|Overall Study|Death|4|||
155660389|NCT03801525|561852567|FG000|Overall Study|Disease Progression|6|||
155660390|NCT03801525|561852568|FG001|Overall Study|Disease Progression|0|||
155660391|NCT03801525|561852569|FG002|Overall Study|Disease Progression|1|||
155660392|NCT03801525|561852567|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
155660393|NCT03801525|561852568|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
155660394|NCT03801525|561852569|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
155660395|NCT03801525|561852567|FG000|Overall Study|Investigator Decision|18|||
155660396|NCT03801525|561852568|FG001|Overall Study|Investigator Decision|1|||
155660397|NCT03801525|561852569|FG002|Overall Study|Investigator Decision|0|||
155660398|NCT03801525|561852567|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
155660399|NCT03801525|561852568|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
155660400|NCT03801525|561852569|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
155660401|NCT03801525|561852567|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
155660402|NCT03801525|561852568|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
155660403|NCT03801525|561852569|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
155660404|NCT03801525|561852567|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
155660405|NCT03801525|561852568|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
155660406|NCT03801525|561852569|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
155660407|NCT03801525|561852567|FG000|Overall Study|Withdrawal of Subject Consent|38|||
155660408|NCT03801525|561852568|FG001|Overall Study|Withdrawal of Subject Consent|2|||
155660409|NCT03801525|561852569|FG002|Overall Study|Withdrawal of Subject Consent|1|||
155660410|NCT03801525|561852567|FG000|Overall Study|Reason not Specified|4|||
155660411|NCT03801525|561852568|FG001|Overall Study|Reason not Specified|0|||
155660412|NCT03801525|561852569|FG002|Overall Study|Reason not Specified|4|||
155660413|NCT01263119|561852570|FG000|Period 1|Protocol Violation|2|||
155660414|NCT01263119|561852570|FG000|Period 2|Adverse Event|2|||
155660415|NCT05201807|561852574|FG000|Overall Study|Adverse Event|1|||
155660416|NCT05201807|561852574|FG000|Overall Study|COVID-19 Related|1|||
155660417|NCT01029535|561852577|FG000|Overall Study|Lost to Follow-up|24|||
155660418|NCT01029535|561852577|FG000|Overall Study|Protocol Violation|2|||
155660419|NCT01029535|561852577|FG000|Overall Study|Participant Withdrew Consent|2|||
155660420|NCT01029535|561852577|FG000|Overall Study|Adverse Event|1|||
155660421|NCT01029535|561852577|FG000|Overall Study|Use of Another Treatment|1|||
155660422|NCT01029535|561852577|FG000|Overall Study|Death|1|||
155660423|NCT02862574|561852578|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155660424|NCT02862574|561852579|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155660425|NCT02862574|561852580|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155660426|NCT02862574|561852578|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
155660427|NCT02862574|561852579|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
155660428|NCT02862574|561852580|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
155660429|NCT02862574|561852578|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
155660430|NCT02862574|561852579|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
155660431|NCT02862574|561852580|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
155660432|NCT01870869|561852595|FG000|Overall Study|Implanted with nonstudy device|1|||
155660433|NCT01870869|561852596|FG001|Overall Study|Implanted with nonstudy device|3|||
155569227|NCT04784533|561508264|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569228|NCT04784533|561508265|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569229|NCT04784533|561508266|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155569230|NCT04784533|561508267|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
155569231|NCT04784533|561508268|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
155569232|NCT04123561|561508273|FG000|Overall Study|Lost to Follow-up|20|||
155569233|NCT04123561|561508274|FG001|Overall Study|Lost to Follow-up|12|||
155569234|NCT04123561|561508275|FG002|Overall Study|Lost to Follow-up|5|||
155569235|NCT04123561|561508273|FG000|Overall Study|Withdrawal by Subject|9|||
155569236|NCT04123561|561508274|FG001|Overall Study|Withdrawal by Subject|7|||
155569237|NCT04123561|561508275|FG002|Overall Study|Withdrawal by Subject|9|||
155569238|NCT04123561|561508273|FG000|Overall Study|Lack of Efficacy|7|||
155569239|NCT04123561|561508274|FG001|Overall Study|Lack of Efficacy|8|||
155569240|NCT04123561|561508275|FG002|Overall Study|Lack of Efficacy|6|||
155569241|NCT04123561|561508273|FG000|Overall Study|Adverse Event|5|||
155660434|NCT01870869|561852597|FG002|Overall Study|Implanted with nonstudy device|14|||
155660435|NCT01870869|561852598|FG003|Overall Study|Implanted with nonstudy device|4|||
155569242|NCT04123561|561508274|FG001|Overall Study|Adverse Event|2|||
155569243|NCT04123561|561508275|FG002|Overall Study|Adverse Event|3|||
155660436|NCT01870869|561852595|FG000|Overall Study|Death|0|||
155660437|NCT01870869|561852596|FG001|Overall Study|Death|0|||
155569244|NCT04123561|561508273|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
155569245|NCT04123561|561508274|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
155569246|NCT04123561|561508275|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
155569247|NCT04123561|561508273|FG000|Overall Study|Death|0|||
155569248|NCT04123561|561508274|FG001|Overall Study|Death|0|||
155569249|NCT04123561|561508275|FG002|Overall Study|Death|1|||
155569250|NCT04123561|561508273|FG000|Overall Study|Protocol Violation|0|||
155569251|NCT04123561|561508274|FG001|Overall Study|Protocol Violation|1|||
155569252|NCT04123561|561508275|FG002|Overall Study|Protocol Violation|0|||
155569253|NCT02203331|561508280|FG000|Overall Study|Pregnancy|1|||
155569254|NCT02203331|561508281|FG001|Overall Study|Pregnancy|0|||
155569255|NCT02203331|561508282|FG002|Overall Study|Pregnancy|0|||
155569256|NCT02203331|561508283|FG003|Overall Study|Pregnancy|0|||
155569257|NCT02203331|561508284|FG004|Overall Study|Pregnancy|2|||
155569258|NCT02203331|561508285|FG005|Overall Study|Pregnancy|0|||
155569259|NCT02203331|561508280|FG000|Overall Study|Withdrawal by Subject|1|||
155569260|NCT02203331|561508281|FG001|Overall Study|Withdrawal by Subject|0|||
155569261|NCT02203331|561508282|FG002|Overall Study|Withdrawal by Subject|1|||
155569262|NCT02203331|561508283|FG003|Overall Study|Withdrawal by Subject|0|||
155569263|NCT02203331|561508284|FG004|Overall Study|Withdrawal by Subject|0|||
155569264|NCT02203331|561508285|FG005|Overall Study|Withdrawal by Subject|3|||
155569265|NCT02203331|561508280|FG000|Overall Study|Adverse Event|4|||
155569266|NCT02203331|561508281|FG001|Overall Study|Adverse Event|8|||
155569267|NCT02203331|561508282|FG002|Overall Study|Adverse Event|3|||
155569268|NCT02203331|561508283|FG003|Overall Study|Adverse Event|4|||
155569269|NCT02203331|561508284|FG004|Overall Study|Adverse Event|3|||
155569270|NCT02203331|561508285|FG005|Overall Study|Adverse Event|3|||
155569271|NCT02203331|561508280|FG000|Overall Study|Other Reasons|1|||
155569272|NCT02203331|561508281|FG001|Overall Study|Other Reasons|2|||
155569273|NCT02203331|561508282|FG002|Overall Study|Other Reasons|0|||
155569274|NCT02203331|561508283|FG003|Overall Study|Other Reasons|2|||
155569275|NCT02203331|561508284|FG004|Overall Study|Other Reasons|0|||
155569276|NCT02203331|561508285|FG005|Overall Study|Other Reasons|0|||
155569277|NCT02203331|561508280|FG000|Overall Study|Lack of Efficacy|0|||
155569278|NCT02203331|561508281|FG001|Overall Study|Lack of Efficacy|2|||
155569279|NCT02203331|561508282|FG002|Overall Study|Lack of Efficacy|1|||
155569280|NCT02203331|561508283|FG003|Overall Study|Lack of Efficacy|0|||
155569281|NCT02203331|561508284|FG004|Overall Study|Lack of Efficacy|0|||
155569282|NCT02203331|561508285|FG005|Overall Study|Lack of Efficacy|1|||
155569283|NCT02203331|561508280|FG000|Overall Study|Protocol Violation|0|||
155569284|NCT02203331|561508281|FG001|Overall Study|Protocol Violation|2|||
155569285|NCT02203331|561508282|FG002|Overall Study|Protocol Violation|0|||
155569286|NCT02203331|561508283|FG003|Overall Study|Protocol Violation|1|||
155569287|NCT02203331|561508284|FG004|Overall Study|Protocol Violation|1|||
155569288|NCT02203331|561508285|FG005|Overall Study|Protocol Violation|0|||
155569289|NCT02203331|561508280|FG000|Overall Study|Lost to Follow-up|0|||
155569290|NCT02203331|561508281|FG001|Overall Study|Lost to Follow-up|0|||
155569291|NCT02203331|561508282|FG002|Overall Study|Lost to Follow-up|0|||
155569292|NCT02203331|561508283|FG003|Overall Study|Lost to Follow-up|0|||
155569293|NCT02203331|561508284|FG004|Overall Study|Lost to Follow-up|1|||
155569294|NCT02203331|561508285|FG005|Overall Study|Lost to Follow-up|0|||
155660438|NCT01870869|561852597|FG002|Overall Study|Death|7|||
155660439|NCT01870869|561852598|FG003|Overall Study|Death|1|||
155660440|NCT01870869|561852595|FG000|Overall Study|Subject choice|6|||
155660441|NCT01870869|561852596|FG001|Overall Study|Subject choice|2|||
155660442|NCT01870869|561852597|FG002|Overall Study|Subject choice|22|||
155660443|NCT01870869|561852598|FG003|Overall Study|Subject choice|8|||
155569295|NCT03597464|561508290|FG000|Overall Study|Withdrawal by Subject|4|||
155569296|NCT03597464|561508291|FG001|Overall Study|Withdrawal by Subject|5|||
155569297|NCT03597464|561508290|FG000|Overall Study|Lost to Follow-up|3|||
155569298|NCT03597464|561508291|FG001|Overall Study|Lost to Follow-up|1|||
155569299|NCT03597464|561508290|FG000|Overall Study|Pregnancy|3|||
155569300|NCT03597464|561508291|FG001|Overall Study|Pregnancy|1|||
155569301|NCT03597464|561508290|FG000|Overall Study|Lack of Efficacy|2|||
155569302|NCT03597464|561508291|FG001|Overall Study|Lack of Efficacy|0|||
155569303|NCT03597464|561508290|FG000|Overall Study|Physician Decision|2|||
155569304|NCT03597464|561508291|FG001|Overall Study|Physician Decision|2|||
155569305|NCT03597464|561508290|FG000|Overall Study|Protocol Violation|1|||
155569306|NCT03597464|561508291|FG001|Overall Study|Protocol Violation|1|||
155569307|NCT03597464|561508290|FG000|Overall Study|Adverse Event|0|||
155569308|NCT03597464|561508291|FG001|Overall Study|Adverse Event|2|||
155569309|NCT03597464|561508290|FG000|Overall Study|Death|0|||
155569310|NCT03597464|561508291|FG001|Overall Study|Death|3|||
155569311|NCT02682927|561508294|FG000|Overall Study|Adverse Event|0|||
155569312|NCT02682927|561508295|FG001|Overall Study|Adverse Event|0|||
155569313|NCT02682927|561508296|FG002|Overall Study|Adverse Event|5|||
155569314|NCT02682927|561508297|FG003|Overall Study|Adverse Event|1|||
155660444|NCT01870869|561852595|FG000|Overall Study|Lost to Follow-up|10|||
155660445|NCT01870869|561852596|FG001|Overall Study|Lost to Follow-up|2|||
155569315|NCT02682927|561508298|FG004|Overall Study|Adverse Event|0|||
155569316|NCT02682927|561508299|FG005|Overall Study|Adverse Event|2|||
155569317|NCT02682927|561508294|FG000|Overall Study|Death|0|||
155569318|NCT02682927|561508295|FG001|Overall Study|Death|0|||
155569319|NCT02682927|561508296|FG002|Overall Study|Death|0|||
155569320|NCT02682927|561508297|FG003|Overall Study|Death|1|||
155569321|NCT02682927|561508298|FG004|Overall Study|Death|0|||
155569322|NCT02682927|561508299|FG005|Overall Study|Death|0|||
155569323|NCT02682927|561508294|FG000|Overall Study|Lack of Efficacy|1|||
155569324|NCT02682927|561508295|FG001|Overall Study|Lack of Efficacy|0|||
155569325|NCT02682927|561508296|FG002|Overall Study|Lack of Efficacy|0|||
155569326|NCT02682927|561508297|FG003|Overall Study|Lack of Efficacy|1|||
155569327|NCT02682927|561508298|FG004|Overall Study|Lack of Efficacy|0|||
155569328|NCT02682927|561508299|FG005|Overall Study|Lack of Efficacy|0|||
155569329|NCT02682927|561508294|FG000|Overall Study|Other|0|||
155569330|NCT02682927|561508295|FG001|Overall Study|Other|0|||
155569331|NCT02682927|561508296|FG002|Overall Study|Other|0|||
155569332|NCT02682927|561508297|FG003|Overall Study|Other|2|||
155569333|NCT02682927|561508298|FG004|Overall Study|Other|0|||
155569334|NCT02682927|561508299|FG005|Overall Study|Other|0|||
155569335|NCT02682927|561508294|FG000|Overall Study|Withdrawal by Subject|2|||
155569336|NCT02682927|561508295|FG001|Overall Study|Withdrawal by Subject|0|||
155569337|NCT02682927|561508296|FG002|Overall Study|Withdrawal by Subject|1|||
155569338|NCT02682927|561508297|FG003|Overall Study|Withdrawal by Subject|0|||
155569339|NCT02682927|561508298|FG004|Overall Study|Withdrawal by Subject|1|||
155569340|NCT02682927|561508299|FG005|Overall Study|Withdrawal by Subject|1|||
155569341|NCT03316547|561508302|FG000|Overall Study|Death|3|||
155569342|NCT03316547|561508303|FG001|Overall Study|Death|1|||
155569343|NCT03316547|561508302|FG000|Overall Study|Lost to Follow-up|6|||
155569344|NCT03316547|561508303|FG001|Overall Study|Lost to Follow-up|6|||
155569345|NCT03316547|561508302|FG000|Overall Study|Withdrawal by Subject|3|||
155569346|NCT03316547|561508303|FG001|Overall Study|Withdrawal by Subject|2|||
155569347|NCT03316547|561508302|FG000|Overall Study|Transfer to another hospital|6|||
155569348|NCT03316547|561508303|FG001|Overall Study|Transfer to another hospital|4|||
155569349|NCT00278889|561508304|FG000|Overall Study|Withdrawal by Subject|0|||
155569350|NCT00278889|561508305|FG001|Overall Study|Withdrawal by Subject|5|||
155569351|NCT00278889|561508306|FG002|Overall Study|Withdrawal by Subject|3|||
155569352|NCT00278889|561508304|FG000|Overall Study|Lost to Follow-up|1|||
155569353|NCT00278889|561508305|FG001|Overall Study|Lost to Follow-up|1|||
155569354|NCT00278889|561508306|FG002|Overall Study|Lost to Follow-up|0|||
155569355|NCT00278889|561508304|FG000|Overall Study|Death|24|||
155569356|NCT00278889|561508305|FG001|Overall Study|Death|21|||
155569357|NCT00278889|561508306|FG002|Overall Study|Death|17|||
155569358|NCT03462459|561508307|FG000|Overall Study|Death|1|||
155569359|NCT03462459|561508308|FG001|Overall Study|Death|0|||
155569360|NCT03462459|561508307|FG000|Overall Study|Lack of Efficacy|2|||
155569361|NCT03462459|561508308|FG001|Overall Study|Lack of Efficacy|4|||
155569362|NCT03462459|561508307|FG000|Overall Study|Lost to Follow-up|1|||
155569363|NCT03462459|561508308|FG001|Overall Study|Lost to Follow-up|3|||
155569364|NCT03462459|561508307|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
155569365|NCT03462459|561508308|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
155569366|NCT03462459|561508307|FG000|Overall Study|Withdrawal by Subject|3|||
155569367|NCT03462459|561508308|FG001|Overall Study|Withdrawal by Subject|2|||
155569368|NCT03462459|561508307|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
155569369|NCT03462459|561508308|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
155660446|NCT01870869|561852597|FG002|Overall Study|Lost to Follow-up|25|||
155660447|NCT01870869|561852598|FG003|Overall Study|Lost to Follow-up|3|||
155660448|NCT01870869|561852595|FG000|Overall Study|Reason not Specified|1|||
155660449|NCT01870869|561852596|FG001|Overall Study|Reason not Specified|2|||
155660450|NCT01870869|561852597|FG002|Overall Study|Reason not Specified|20|||
155660451|NCT01870869|561852598|FG003|Overall Study|Reason not Specified|4|||
155660452|NCT01870869|561852595|FG000|Overall Study|Not evaluable|10|||
155660453|NCT01870869|561852596|FG001|Overall Study|Not evaluable|5|||
155660454|NCT01870869|561852597|FG002|Overall Study|Not evaluable|42|||
155660455|NCT01870869|561852598|FG003|Overall Study|Not evaluable|10|||
155660456|NCT02569853|561852599|FG000|Overall Study|Adverse Event|2|||
155660457|NCT02569853|561852600|FG001|Overall Study|Adverse Event|0|||
155660458|NCT02569853|561852599|FG000|Overall Study|Withdrawal by Subject|3|||
155660459|NCT02569853|561852600|FG001|Overall Study|Withdrawal by Subject|2|||
155660460|NCT02569853|561852599|FG000|Overall Study|Lost to Follow-up|3|||
155660461|NCT02569853|561852600|FG001|Overall Study|Lost to Follow-up|3|||
155660462|NCT02569853|561852599|FG000|Overall Study|Protocol Violation|1|||
155660463|NCT02569853|561852600|FG001|Overall Study|Protocol Violation|1|||
155660464|NCT02569853|561852599|FG000|Overall Study|Did not experience migraine attack|10|||
155660465|NCT02569853|561852600|FG001|Overall Study|Did not experience migraine attack|7|||
155660466|NCT02569853|561852599|FG000|Overall Study|Physician Decision|1|||
155660467|NCT02569853|561852600|FG001|Overall Study|Physician Decision|1|||
155660468|NCT00402987|561852601|FG000|Overall Study|Lack of Efficacy|0|||
155660469|NCT00402987|561852602|FG001|Overall Study|Lack of Efficacy|0|||
155660470|NCT00402987|561852603|FG002|Overall Study|Lack of Efficacy|1|||
155660471|NCT00402987|561852604|FG003|Overall Study|Lack of Efficacy|0|||
155660472|NCT00419744|561852605|FG000|Overall Study|Adverse Event|39|||
155660473|NCT00419744|561852606|FG001|Overall Study|Adverse Event|40|||
155660474|NCT00419744|561852607|FG002|Overall Study|Adverse Event|50|||
155660475|NCT00419744|561852605|FG000|Overall Study|Withdrawal by Subject|45|||
155660476|NCT00419744|561852606|FG001|Overall Study|Withdrawal by Subject|49|||
155660477|NCT00419744|561852607|FG002|Overall Study|Withdrawal by Subject|52|||
155660478|NCT00419744|561852605|FG000|Overall Study|Lost to Follow-up|8|||
155660479|NCT00419744|561852606|FG001|Overall Study|Lost to Follow-up|10|||
155660480|NCT00419744|561852607|FG002|Overall Study|Lost to Follow-up|6|||
155660481|NCT00419744|561852605|FG000|Overall Study|Protocol Violation|4|||
155660482|NCT00419744|561852606|FG001|Overall Study|Protocol Violation|7|||
155660483|NCT00419744|561852607|FG002|Overall Study|Protocol Violation|8|||
155660484|NCT00419744|561852605|FG000|Overall Study|Randomized in error|9|||
155660485|NCT00419744|561852606|FG001|Overall Study|Randomized in error|6|||
155660486|NCT00419744|561852607|FG002|Overall Study|Randomized in error|7|||
155660487|NCT00419744|561852605|FG000|Overall Study|Moving out of state|2|||
155660488|NCT00419744|561852606|FG001|Overall Study|Moving out of state|0|||
155660489|NCT00419744|561852607|FG002|Overall Study|Moving out of state|1|||
155660490|NCT00419744|561852605|FG000|Overall Study|Physician Decision|10|||
155660491|NCT00419744|561852606|FG001|Overall Study|Physician Decision|5|||
155660492|NCT00419744|561852607|FG002|Overall Study|Physician Decision|6|||
155660493|NCT00419744|561852605|FG000|Overall Study|Spirometry mouthpiece issues|0|||
155660494|NCT00419744|561852606|FG001|Overall Study|Spirometry mouthpiece issues|1|||
155660495|NCT00419744|561852607|FG002|Overall Study|Spirometry mouthpiece issues|2|||
155660496|NCT00419744|561852605|FG000|Overall Study|Incorrect medication kit dispensed|0|||
155660497|NCT00419744|561852606|FG001|Overall Study|Incorrect medication kit dispensed|0|||
155660498|NCT00419744|561852607|FG002|Overall Study|Incorrect medication kit dispensed|1|||
155660499|NCT00583219|561852608|FG000|Phase 2|Withdrawal by Subject|1|||
155660500|NCT02037529|561852609|FG000|Overall Study|Withdrawal by Subject|1|||
155660501|NCT02037529|561852610|FG001|Overall Study|Withdrawal by Subject|3|||
155660502|NCT02037529|561852609|FG000|Overall Study|Adverse Event|0|||
155660503|NCT02037529|561852610|FG001|Overall Study|Adverse Event|1|||
155660504|NCT02131766|561852611|FG000|Overall Study|Withdrawal by Subject|4|||
155660505|NCT00754572|561852612|FG000|Overall Study|Adverse Event|19|||
155660506|NCT00754572|561852612|FG000|Overall Study|Other|39|||
155660507|NCT00754572|561852612|FG000|Overall Study|Protocol Violation|3|||
155660508|NCT00754572|561852612|FG000|Overall Study|Withdrawal by Subject|3|||
155660509|NCT00754572|561852612|FG000|Overall Study|Lack of Efficacy|2|||
155660510|NCT00754572|561852612|FG000|Overall Study|Death|1|||
155660511|NCT00754572|561852612|FG000|Overall Study|Administrative Reason|3|||
155660512|NCT00754572|561852612|FG000|Overall Study|Lost to Follow-up|1|||
155660513|NCT00718315|561852614|FG000|Overall Study|Adverse Event|1|||
155660514|NCT00718315|561852615|FG001|Overall Study|Adverse Event|2|||
155660515|NCT00718315|561852616|FG002|Overall Study|Adverse Event|3|||
155660516|NCT00718315|561852614|FG000|Overall Study|Death|6|||
155660517|NCT00718315|561852615|FG001|Overall Study|Death|6|||
155660518|NCT00718315|561852616|FG002|Overall Study|Death|5|||
155660519|NCT00718315|561852614|FG000|Overall Study|Lost to Follow-up|2|||
155660520|NCT00718315|561852615|FG001|Overall Study|Lost to Follow-up|3|||
155660521|NCT00718315|561852616|FG002|Overall Study|Lost to Follow-up|4|||
155660522|NCT00718315|561852614|FG000|Overall Study|Protocol Violation|5|||
155660523|NCT00718315|561852615|FG001|Overall Study|Protocol Violation|5|||
155569370|NCT05292183|561510546|FG000|Overall Study|Adverse Event|1|||
155569371|NCT00369486|561510552|FG000|4-Week Visit|Missed visit|2|||
155569372|NCT00369486|561510553|FG001|4-Week Visit|Missed visit|2|||
155569373|NCT00369486|561510554|FG002|4-Week Visit|Missed visit|0|||
155569374|NCT00369486|561510555|FG003|4-Week Visit|Missed visit|2|||
155569375|NCT00369486|561510556|FG004|4-Week Visit|Missed visit|1|||
155569376|NCT00369486|561510552|FG000|4-Week Visit|Dropped|0|||
155569377|NCT00369486|561510553|FG001|4-Week Visit|Dropped|0|||
155569378|NCT00369486|561510554|FG002|4-Week Visit|Dropped|1|||
155569379|NCT00369486|561510555|FG003|4-Week Visit|Dropped|0|||
155569380|NCT00369486|561510556|FG004|4-Week Visit|Dropped|0|||
155569381|NCT00369486|561510552|FG000|8-Week Visit|Missed visit|0|||
155569382|NCT00369486|561510553|FG001|8-Week Visit|Missed visit|1|||
155569383|NCT00369486|561510554|FG002|8-Week Visit|Missed visit|0|||
155569384|NCT00369486|561510555|FG003|8-Week Visit|Missed visit|0|||
155569385|NCT00369486|561510556|FG004|8-Week Visit|Missed visit|1|||
155569386|NCT00369486|561510552|FG000|8-Week Visit|Dropped|0|||
155569387|NCT00369486|561510553|FG001|8-Week Visit|Dropped|0|||
155569388|NCT00369486|561510554|FG002|8-Week Visit|Dropped|0|||
155569389|NCT00369486|561510555|FG003|8-Week Visit|Dropped|1|||
155569390|NCT00369486|561510556|FG004|8-Week Visit|Dropped|0|||
155569391|NCT00369486|561510552|FG000|17-Week Visit|Missed visit|0|||
155569392|NCT00369486|561510553|FG001|17-Week Visit|Missed visit|0|||
155569393|NCT00369486|561510554|FG002|17-Week Visit|Missed visit|1|||
155569394|NCT00369486|561510555|FG003|17-Week Visit|Missed visit|1|||
155569395|NCT00369486|561510556|FG004|17-Week Visit|Missed visit|1|||
155569396|NCT00369486|561510552|FG000|34-Week Visit|Dropped|0|||
155569397|NCT00369486|561510553|FG001|34-Week Visit|Dropped|1|||
155569398|NCT00369486|561510554|FG002|34-Week Visit|Dropped|1|||
155569399|NCT00369486|561510555|FG003|34-Week Visit|Dropped|3|||
155569400|NCT00369486|561510556|FG004|34-Week Visit|Dropped|3|||
155569401|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #1|24|||
155569402|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #1|0|||
155569403|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
155569404|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
155569405|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569406|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569407|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
155569408|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
155569409|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
155569410|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
155569411|NCT03888066|561510557|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569412|NCT03888066|561510558|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569413|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569414|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569415|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
155569416|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
155569417|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569418|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569419|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
155569420|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569421|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #2|5|||
155569422|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #2|0|||
155569423|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
155569424|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
155569425|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
155569426|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
155569427|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
155569428|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
155569429|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #3|11|||
155569430|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #3|0|||
155569431|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
155569432|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
155569433|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
155569434|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155569435|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569436|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569437|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #4|3|||
155569438|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #4|0|||
155569439|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
155569440|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
155569441|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
155569442|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
155569443|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
155569444|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155569445|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
155569446|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
155569447|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
155569448|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569449|NCT03888066|561510557|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
155569450|NCT03888066|561510558|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155569451|NCT03888066|561510557|FG000|Run-in Phase|AE (Adverse Event)|17|||
155569452|NCT03888066|561510558|FG001|Run-in Phase|AE (Adverse Event)|0|||
155569453|NCT03888066|561510557|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
155569454|NCT03888066|561510558|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
155569455|NCT03888066|561510557|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569456|NCT03888066|561510558|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569457|NCT03888066|561510557|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155569458|NCT03888066|561510558|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569459|NCT03888066|561510557|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
155569460|NCT03888066|561510558|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155569461|NCT03888066|561510557|FG000|Run-in Phase|Withdrawal by Subject|43|||
155569462|NCT03888066|561510558|FG001|Run-in Phase|Withdrawal by Subject|0|||
155569463|NCT03888066|561510557|FG000|Run-in Phase|AE; Physician Decision|1|||
155569464|NCT03888066|561510558|FG001|Run-in Phase|AE; Physician Decision|0|||
155569465|NCT03888066|561510557|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
155569466|NCT03888066|561510558|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155569467|NCT03888066|561510557|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
155569468|NCT03888066|561510558|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
155569469|NCT03888066|561510557|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
155569470|NCT03888066|561510558|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155569471|NCT03888066|561510557|FG000|Run-in Phase|Death|1|||
155569472|NCT03888066|561510558|FG001|Run-in Phase|Death|0|||
155569473|NCT03888066|561510557|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
155569474|NCT03888066|561510558|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
155569475|NCT03888066|561510557|FG000|Run-in Phase|Physician Decision|1|||
155569476|NCT03888066|561510558|FG001|Run-in Phase|Physician Decision|0|||
155569477|NCT03888066|561510557|FG000|Run-in Phase|Protocol Violation|13|||
155569478|NCT03888066|561510558|FG001|Run-in Phase|Protocol Violation|0|||
155569479|NCT03888066|561510557|FG000|Run-in Phase|Sponsor Request|34|||
155569480|NCT03888066|561510558|FG001|Run-in Phase|Sponsor Request|0|||
155569481|NCT03888066|561510557|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
155569482|NCT03888066|561510558|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
155569483|NCT03888066|561510557|FG000|Run-in Phase|Withdrawal Of Consent|1|||
155569484|NCT03888066|561510558|FG001|Run-in Phase|Withdrawal Of Consent|0|||
155569485|NCT03888066|561510557|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
155569486|NCT03888066|561510558|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
155569487|NCT03888066|561510557|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
155569488|NCT03888066|561510558|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
155569489|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
155569490|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
155569491|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
155569492|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
155569493|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
155569494|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
155569495|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
155569496|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
155569497|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
155569498|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
155569499|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
155569500|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
155569501|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
155569502|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
155569503|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
155569504|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
155569505|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
155569506|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
155569507|NCT03888066|561510557|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
155569508|NCT03888066|561510558|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
155569509|NCT02077140|561510559|FG000|Overall Study|Lost to Follow-up|4|||
155569510|NCT02077140|561510560|FG001|Overall Study|Lost to Follow-up|1|||
155569511|NCT02077140|561510561|FG002|Overall Study|Lost to Follow-up|2|||
155569512|NCT02077140|561510562|FG003|Overall Study|Lost to Follow-up|2|||
155569513|NCT02077140|561510563|FG004|Overall Study|Lost to Follow-up|3|||
155569514|NCT02077140|561510559|FG000|Overall Study|Withdrawal by Subject|0|||
155569515|NCT02077140|561510560|FG001|Overall Study|Withdrawal by Subject|1|||
155569516|NCT02077140|561510561|FG002|Overall Study|Withdrawal by Subject|0|||
155569517|NCT02077140|561510562|FG003|Overall Study|Withdrawal by Subject|2|||
155569518|NCT02077140|561510563|FG004|Overall Study|Withdrawal by Subject|2|||
155569519|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
155569520|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
155569521|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
155569522|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
155569523|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
155569524|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
155569525|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
155569526|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
155569527|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
155569528|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
155569529|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
155569530|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
155569531|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
155569532|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
155569533|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
155569534|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155569535|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155569536|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155569537|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155569538|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155569539|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
155569540|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
155569541|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
155569542|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
155569543|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
155569544|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155569545|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155569546|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155569547|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155569548|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155569549|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
155569550|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
155569551|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
155569552|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
155569553|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
155569554|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155569555|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155569556|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155569557|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155569558|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155569559|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569560|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569561|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569562|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
155569563|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569564|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569565|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569566|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569567|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569568|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155569569|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
155569570|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
155569571|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
155569572|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
155569573|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
155569574|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
155569575|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
155569576|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
155569577|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
155569578|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
155569579|NCT03104400|561510566|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569580|NCT03104400|561510567|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569581|NCT03104400|561510568|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569582|NCT03104400|561510569|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
155569583|NCT03104400|561510570|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569584|NCT03104400|561510571|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569585|NCT03104400|561510572|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569586|NCT03104400|561510573|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569587|NCT03104400|561510574|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569588|NCT03104400|561510575|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155569589|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
155569590|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
155569591|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
155569592|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
155569593|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
155569594|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
155569595|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
155569596|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
155569597|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
155569598|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
155569599|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155569600|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155569601|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155569602|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155569603|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155569604|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
155569605|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
155569606|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
155569607|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
155569608|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
155569609|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155569610|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155569611|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155569612|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155569613|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155569614|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
155569615|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
155569616|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
155569617|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
155569618|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
155569619|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155569620|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155569621|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155569622|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155569623|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155569624|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
155569625|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
155569626|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
155569627|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
155569628|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
155569629|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569630|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155660524|NCT00718315|561852616|FG002|Overall Study|Protocol Violation|3|||
155569631|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569632|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569633|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569634|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569635|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
155569636|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155569637|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
155569638|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
155569639|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569640|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569641|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569642|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569643|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569644|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569645|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569646|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
155569647|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
155569648|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155569649|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
155569650|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
155569651|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
155569652|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
155569653|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
155569654|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
155569655|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
155569656|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
155569657|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
155569658|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
155569659|NCT03104400|561510566|FG000|Period 2 Week 56 - 260)|Other|0|||
155569660|NCT03104400|561510567|FG001|Period 2 Week 56 - 260)|Other|0|||
155569661|NCT03104400|561510568|FG002|Period 2 Week 56 - 260)|Other|0|||
155569662|NCT03104400|561510569|FG003|Period 2 Week 56 - 260)|Other|0|||
155569663|NCT03104400|561510570|FG004|Period 2 Week 56 - 260)|Other|0|||
155569664|NCT03104400|561510571|FG005|Period 2 Week 56 - 260)|Other|0|||
155569665|NCT03104400|561510572|FG006|Period 2 Week 56 - 260)|Other|0|||
155569666|NCT03104400|561510573|FG007|Period 2 Week 56 - 260)|Other|0|||
155569667|NCT03104400|561510574|FG008|Period 2 Week 56 - 260)|Other|1|||
155569668|NCT03104400|561510575|FG009|Period 2 Week 56 - 260)|Other|1|||
155569669|NCT02540850|561510578|FG000|Overall Study|Lost to Follow-up|69|||
155569670|NCT02540850|561510579|FG001|Overall Study|Lost to Follow-up|66|||
155569671|NCT02540850|561510580|FG002|Overall Study|Lost to Follow-up|34|||
155569672|NCT02129608|561510583|FG000|Overall Study|Lost to Follow-up|0|||
155569673|NCT02129608|561510584|FG001|Overall Study|Lost to Follow-up|1|||
155569674|NCT02129608|561510585|FG002|Overall Study|Lost to Follow-up|1|||
155569675|NCT02129608|561510583|FG000|Overall Study|Withdrawal by Subject|0|||
155569676|NCT02129608|561510584|FG001|Overall Study|Withdrawal by Subject|0|||
155569677|NCT02129608|561510585|FG002|Overall Study|Withdrawal by Subject|2|||
155569678|NCT02473523|561510586|FG000|Overall Study|Death|1|||
155569679|NCT02473523|561510586|FG000|Overall Study|Lost to Follow-up|1|||
155569680|NCT02552303|561510587|FG000|Allocation|Withdrawal by Subject|2|||
155569681|NCT02552303|561510588|FG001|Allocation|Withdrawal by Subject|1|||
155569682|NCT02552303|561510589|FG002|Allocation|Withdrawal by Subject|1|||
155569683|NCT02552303|561510590|FG003|Allocation|Withdrawal by Subject|1|||
155569684|NCT02552303|561510587|FG000|Allocation|ineligible|1|||
155569685|NCT02552303|561510588|FG001|Allocation|ineligible|1|||
155569686|NCT02552303|561510589|FG002|Allocation|ineligible|0|||
155569687|NCT02552303|561510590|FG003|Allocation|ineligible|0|||
155569688|NCT02552303|561510587|FG000|Follow-Up|Lost to Follow-up|0|||
155569689|NCT02552303|561510588|FG001|Follow-Up|Lost to Follow-up|0|||
155569690|NCT02552303|561510589|FG002|Follow-Up|Lost to Follow-up|1|||
155569691|NCT02552303|561510590|FG003|Follow-Up|Lost to Follow-up|0|||
155569692|NCT02552303|561510587|FG000|Follow-Up|ineligible|0|||
155569693|NCT02552303|561510588|FG001|Follow-Up|ineligible|2|||
155569694|NCT02552303|561510589|FG002|Follow-Up|ineligible|0|||
155569695|NCT02552303|561510590|FG003|Follow-Up|ineligible|0|||
155569696|NCT01831258|561510593|FG000|Overall Study|Withdrawal by Subject|2|||
155569697|NCT01831258|561510594|FG001|Overall Study|Withdrawal by Subject|1|||
155569698|NCT01831258|561510593|FG000|Overall Study|Lost to Follow-up|3|||
155569699|NCT01831258|561510594|FG001|Overall Study|Lost to Follow-up|2|||
155569700|NCT01753297|561510599|FG000|Overall Study|Lost to Follow-up|7|||
155569701|NCT01753297|561510600|FG001|Overall Study|Lost to Follow-up|2|||
155569702|NCT01753297|561510599|FG000|Overall Study|Withdrawal by Subject|26|||
155569703|NCT01753297|561510600|FG001|Overall Study|Withdrawal by Subject|23|||
155569704|NCT01753297|561510599|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
155569705|NCT01753297|561510600|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
155569706|NCT01753297|561510599|FG000|Overall Study|Death|0|||
155569707|NCT01753297|561510600|FG001|Overall Study|Death|2|||
155569708|NCT01753297|561510599|FG000|Overall Study|Did not attend end of study visit|7|||
155569709|NCT01753297|561510600|FG001|Overall Study|Did not attend end of study visit|8|||
155569710|NCT01275729|561510601|FG000|Overall Study|Death|3|||
155569711|NCT01275729|561510601|FG000|Overall Study|Withdrawal by Subject|1|||
155569712|NCT02533180|561510602|FG000|Overall Study|Death|0|||
155569713|NCT02533180|561510603|FG001|Overall Study|Death|2|||
155569714|NCT02533180|561510602|FG000|Overall Study|Lost to Follow-up|0|||
155569715|NCT02533180|561510603|FG001|Overall Study|Lost to Follow-up|1|||
155569716|NCT02533180|561510602|FG000|Overall Study|Physician Decision|0|||
155569717|NCT02533180|561510603|FG001|Overall Study|Physician Decision|1|||
155569718|NCT02533180|561510602|FG000|Overall Study|Withdrawal by Subject|2|||
155569719|NCT02533180|561510603|FG001|Overall Study|Withdrawal by Subject|5|||
155569720|NCT02533180|561510602|FG000|Overall Study|Screen Failure|37|||
155569721|NCT02533180|561510603|FG001|Overall Study|Screen Failure|0|||
155569722|NCT02533180|561510602|FG000|Overall Study|Protocol Deviation|0|||
155569723|NCT02533180|561510603|FG001|Overall Study|Protocol Deviation|1|||
155569724|NCT02533180|561510602|FG000|Overall Study|Non-compliance|0|||
155569725|NCT02533180|561510603|FG001|Overall Study|Non-compliance|1|||
155569726|NCT00447876|561510604|FG000|Overall Study|Withdrawal by Subject|1|||
155569727|NCT00447876|561510605|FG001|Overall Study|Withdrawal by Subject|4|||
155569728|NCT00447876|561510604|FG000|Overall Study|Lost to Follow-up|1|||
155569729|NCT00447876|561510605|FG001|Overall Study|Lost to Follow-up|0|||
155569730|NCT00447876|561510604|FG000|Overall Study|Deterioration of symptomology|1|||
155569731|NCT00447876|561510605|FG001|Overall Study|Deterioration of symptomology|0|||
155569732|NCT02640690|561510618|FG000|Overall Study|Lost to Follow-up|7|||
155569733|NCT02640690|561510619|FG001|Overall Study|Lost to Follow-up|7|||
155569734|NCT02640690|561510618|FG000|Overall Study|Withdrawal by Subject|16|||
155569735|NCT02640690|561510619|FG001|Overall Study|Withdrawal by Subject|20|||
155569736|NCT02640690|561510618|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
155569737|NCT02640690|561510619|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
155569738|NCT01118975|561510620|FG000|Overall Study|Adverse Event|0|||
155569739|NCT01118975|561510621|FG001|Overall Study|Adverse Event|1|||
155569740|NCT01645787|561510622|FG000|Washout (2 Weeks)|Adverse Event|1|||
155569741|NCT01645787|561510623|FG001|Washout (2 Weeks)|Adverse Event|0|||
155569742|NCT02620579|561510624|FG000|Overall Study|Physician Decision|0|||
155569743|NCT02620579|561510625|FG001|Overall Study|Physician Decision|0|||
155569744|NCT02620579|561510626|FG002|Overall Study|Physician Decision|0|||
155569745|NCT02620579|561510627|FG003|Overall Study|Physician Decision|1|||
155569746|NCT02620579|561510624|FG000|Overall Study|Withdrawal by Subject|0|||
155569747|NCT02620579|561510625|FG001|Overall Study|Withdrawal by Subject|1|||
155569748|NCT02620579|561510626|FG002|Overall Study|Withdrawal by Subject|1|||
155569749|NCT02620579|561510627|FG003|Overall Study|Withdrawal by Subject|0|||
155569750|NCT02892149|561510628|FG000|Overall Study|Death|262|||
155569751|NCT02892149|561510629|FG001|Overall Study|Death|278|||
155569752|NCT02892149|561510628|FG000|Overall Study|Withdrawal by Subject|53|||
155569753|NCT02892149|561510629|FG001|Overall Study|Withdrawal by Subject|47|||
155569754|NCT02892149|561510628|FG000|Overall Study|Lost to Follow-up|37|||
155569755|NCT02892149|561510629|FG001|Overall Study|Lost to Follow-up|31|||
155569756|NCT01098474|561510634|FG000|Active Phase|Other|0|||
155569757|NCT01098474|561510635|FG001|Active Phase|Other|0|||
155569758|NCT01098474|561510636|FG002|Active Phase|Other|3|||
155569759|NCT01098474|561510637|FG003|Active Phase|Other|0|||
155569760|NCT01098474|561510638|FG004|Active Phase|Other|0|||
155569761|NCT01098474|561510639|FG005|Active Phase|Other|0|||
155569762|NCT01098474|561510634|FG000|Active Phase|Withdrawal by Subject|1|||
155569763|NCT01098474|561510635|FG001|Active Phase|Withdrawal by Subject|1|||
155569764|NCT01098474|561510636|FG002|Active Phase|Withdrawal by Subject|2|||
155569765|NCT01098474|561510637|FG003|Active Phase|Withdrawal by Subject|0|||
155569766|NCT01098474|561510638|FG004|Active Phase|Withdrawal by Subject|0|||
155569767|NCT01098474|561510639|FG005|Active Phase|Withdrawal by Subject|0|||
155569768|NCT01098474|561510634|FG000|Active Phase|Lost to Follow-up|1|||
155569769|NCT01098474|561510635|FG001|Active Phase|Lost to Follow-up|0|||
155569770|NCT01098474|561510636|FG002|Active Phase|Lost to Follow-up|0|||
155569771|NCT01098474|561510637|FG003|Active Phase|Lost to Follow-up|0|||
155569772|NCT01098474|561510638|FG004|Active Phase|Lost to Follow-up|0|||
155569773|NCT01098474|561510639|FG005|Active Phase|Lost to Follow-up|0|||
155569774|NCT01098474|561510634|FG000|Follow Up Phase|Travelled out of study area|0|||
155569775|NCT01098474|561510635|FG001|Follow Up Phase|Travelled out of study area|0|||
155569776|NCT01098474|561510636|FG002|Follow Up Phase|Travelled out of study area|0|||
155569777|NCT01098474|561510637|FG003|Follow Up Phase|Travelled out of study area|0|||
155569778|NCT01098474|561510638|FG004|Follow Up Phase|Travelled out of study area|1|||
155569779|NCT01098474|561510639|FG005|Follow Up Phase|Travelled out of study area|0|||
155569780|NCT01098474|561510634|FG000|Follow Up Phase|Other|0|||
155569781|NCT01098474|561510635|FG001|Follow Up Phase|Other|0|||
155569782|NCT01098474|561510636|FG002|Follow Up Phase|Other|0|||
155569783|NCT01098474|561510637|FG003|Follow Up Phase|Other|0|||
155569784|NCT01098474|561510638|FG004|Follow Up Phase|Other|0|||
155569785|NCT01098474|561510639|FG005|Follow Up Phase|Other|4|||
155569786|NCT01098474|561510634|FG000|Follow Up Phase|Withdrawal by Subject|0|||
155569787|NCT01098474|561510635|FG001|Follow Up Phase|Withdrawal by Subject|0|||
155569788|NCT01098474|561510636|FG002|Follow Up Phase|Withdrawal by Subject|0|||
155569789|NCT01098474|561510637|FG003|Follow Up Phase|Withdrawal by Subject|2|||
155569790|NCT01098474|561510638|FG004|Follow Up Phase|Withdrawal by Subject|0|||
155569791|NCT01098474|561510639|FG005|Follow Up Phase|Withdrawal by Subject|1|||
155569792|NCT01098474|561510634|FG000|Follow Up Phase|Lost to Follow-up|0|||
155569793|NCT01098474|561510635|FG001|Follow Up Phase|Lost to Follow-up|0|||
155569794|NCT01098474|561510636|FG002|Follow Up Phase|Lost to Follow-up|0|||
155569795|NCT01098474|561510637|FG003|Follow Up Phase|Lost to Follow-up|0|||
155569796|NCT01098474|561510638|FG004|Follow Up Phase|Lost to Follow-up|1|||
155569797|NCT01098474|561510639|FG005|Follow Up Phase|Lost to Follow-up|0|||
155569798|NCT02165735|561510640|FG000|Overall Study|Lost to Follow-up|12|||
155569799|NCT02165735|561510641|FG001|Overall Study|Lost to Follow-up|10|||
155569800|NCT02165735|561510640|FG000|Overall Study|Withdrawal by Subject|3|||
155569801|NCT02165735|561510641|FG001|Overall Study|Withdrawal by Subject|0|||
155569802|NCT02165735|561510640|FG000|Overall Study|Participant indicated lack of time|1|||
155569803|NCT02165735|561510641|FG001|Overall Study|Participant indicated lack of time|3|||
155569804|NCT02165735|561510640|FG000|Overall Study|Protocol Violation|0|||
155569805|NCT02165735|561510641|FG001|Overall Study|Protocol Violation|1|||
155569806|NCT03066258|561510642|FG000|Overall Study|Death|1|||
155569807|NCT03066258|561510643|FG001|Overall Study|Death|0|||
155569808|NCT03066258|561510644|FG002|Overall Study|Death|0|||
155569809|NCT03066258|561510645|FG003|Overall Study|Death|0|||
155569810|NCT03066258|561510646|FG004|Overall Study|Death|1|||
155569811|NCT02784795|561510647|FG000|Overall Study|Progressive Disease|2|||
155569812|NCT02784795|561510648|FG001|Overall Study|Progressive Disease|1|||
155569813|NCT02784795|561510649|FG002|Overall Study|Progressive Disease|1|||
155569814|NCT02784795|561510650|FG003|Overall Study|Progressive Disease|0|||
155569815|NCT02784795|561510651|FG004|Overall Study|Progressive Disease|2|||
155569816|NCT02784795|561510652|FG005|Overall Study|Progressive Disease|0|||
155569817|NCT02784795|561510653|FG006|Overall Study|Progressive Disease|2|||
155569818|NCT02784795|561510654|FG007|Overall Study|Progressive Disease|0|||
155569819|NCT02784795|561510655|FG008|Overall Study|Progressive Disease|0|||
155569820|NCT02784795|561510656|FG009|Overall Study|Progressive Disease|0|||
155569821|NCT02784795|561510657|FG010|Overall Study|Progressive Disease|1|||
155569822|NCT02784795|561510658|FG011|Overall Study|Progressive Disease|0|||
155569823|NCT02784795|561510647|FG000|Overall Study|Adverse Event|1|||
155569824|NCT02784795|561510648|FG001|Overall Study|Adverse Event|0|||
155569825|NCT02784795|561510649|FG002|Overall Study|Adverse Event|0|||
155569826|NCT02784795|561510650|FG003|Overall Study|Adverse Event|1|||
155569827|NCT02784795|561510651|FG004|Overall Study|Adverse Event|0|||
155569828|NCT02784795|561510652|FG005|Overall Study|Adverse Event|0|||
155569829|NCT02784795|561510653|FG006|Overall Study|Adverse Event|1|||
155569830|NCT02784795|561510654|FG007|Overall Study|Adverse Event|0|||
155569831|NCT02784795|561510655|FG008|Overall Study|Adverse Event|0|||
155569832|NCT02784795|561510656|FG009|Overall Study|Adverse Event|0|||
155569833|NCT02784795|561510657|FG010|Overall Study|Adverse Event|0|||
155569834|NCT02784795|561510658|FG011|Overall Study|Adverse Event|2|||
155569835|NCT02784795|561510647|FG000|Overall Study|Withdrawal by Subject|1|||
155569836|NCT02784795|561510648|FG001|Overall Study|Withdrawal by Subject|0|||
155569837|NCT02784795|561510649|FG002|Overall Study|Withdrawal by Subject|2|||
155569838|NCT02784795|561510650|FG003|Overall Study|Withdrawal by Subject|1|||
155569839|NCT02784795|561510651|FG004|Overall Study|Withdrawal by Subject|3|||
155569840|NCT02784795|561510652|FG005|Overall Study|Withdrawal by Subject|0|||
155569841|NCT02784795|561510653|FG006|Overall Study|Withdrawal by Subject|0|||
155569842|NCT02784795|561510654|FG007|Overall Study|Withdrawal by Subject|1|||
155569843|NCT02784795|561510655|FG008|Overall Study|Withdrawal by Subject|0|||
155569844|NCT02784795|561510656|FG009|Overall Study|Withdrawal by Subject|0|||
155569845|NCT02784795|561510657|FG010|Overall Study|Withdrawal by Subject|0|||
155569846|NCT02784795|561510658|FG011|Overall Study|Withdrawal by Subject|2|||
155569847|NCT02784795|561510647|FG000|Overall Study|Death|0|||
155569848|NCT02784795|561510648|FG001|Overall Study|Death|0|||
155569849|NCT02784795|561510649|FG002|Overall Study|Death|0|||
155569850|NCT02784795|561510650|FG003|Overall Study|Death|0|||
155569851|NCT02784795|561510651|FG004|Overall Study|Death|1|||
155569852|NCT02784795|561510652|FG005|Overall Study|Death|0|||
155569853|NCT02784795|561510653|FG006|Overall Study|Death|0|||
155569854|NCT02784795|561510654|FG007|Overall Study|Death|0|||
155569855|NCT02784795|561510655|FG008|Overall Study|Death|0|||
155569856|NCT02784795|561510656|FG009|Overall Study|Death|0|||
155569857|NCT02784795|561510657|FG010|Overall Study|Death|0|||
155569858|NCT02784795|561510658|FG011|Overall Study|Death|0|||
155569859|NCT02784795|561510647|FG000|Overall Study|Physician Decision|0|||
155569860|NCT02784795|561510648|FG001|Overall Study|Physician Decision|0|||
155569861|NCT02784795|561510649|FG002|Overall Study|Physician Decision|0|||
155660525|NCT00718315|561852614|FG000|Overall Study|Erlotinib dose decreased|4|||
155660526|NCT00718315|561852615|FG001|Overall Study|Erlotinib dose decreased|3|||
155660527|NCT00718315|561852616|FG002|Overall Study|Erlotinib dose decreased|1|||
155660528|NCT00718315|561852614|FG000|Overall Study|Use of Minocyclin|1|||
155660529|NCT00718315|561852615|FG001|Overall Study|Use of Minocyclin|1|||
155660530|NCT00718315|561852616|FG002|Overall Study|Use of Minocyclin|1|||
155660531|NCT00718315|561852614|FG000|Overall Study|Disease progression|0|||
155660532|NCT00718315|561852615|FG001|Overall Study|Disease progression|1|||
155660533|NCT00718315|561852616|FG002|Overall Study|Disease progression|1|||
155660534|NCT00718315|561852614|FG000|Overall Study|Other|0|||
155660535|NCT00718315|561852615|FG001|Overall Study|Other|0|||
155660536|NCT00718315|561852616|FG002|Overall Study|Other|1|||
155660537|NCT00718315|561852614|FG000|Overall Study|Use of ATB and Corticoids|0|||
155660538|NCT00718315|561852615|FG001|Overall Study|Use of ATB and Corticoids|1|||
155660539|NCT00718315|561852616|FG002|Overall Study|Use of ATB and Corticoids|2|||
155660540|NCT02271880|561852618|FG000|Overall Study|Premature discontinuation of study|3|||
155660541|NCT02271880|561852619|FG001|Overall Study|Premature discontinuation of study|4|||
155660542|NCT00474903|561852621|FG000|Overall Study|Protocol Violation|1|||
155660543|NCT00474903|561852622|FG001|Overall Study|Protocol Violation|5|||
155660544|NCT00474903|561852623|FG002|Overall Study|Protocol Violation|2|||
155660545|NCT02735200|561852624|FG000|Overall Study|Lost to Follow-up|0|||
155660546|NCT02735200|561852625|FG001|Overall Study|Lost to Follow-up|5|||
155660547|NCT02735200|561852624|FG000|Overall Study|Withdrawal by Subject|8|||
155660548|NCT02735200|561852625|FG001|Overall Study|Withdrawal by Subject|0|||
155660549|NCT04856527|561852628|FG000|Overall Study|Unable to complete experimental task|2|||
155660550|NCT04856527|561852629|FG001|Overall Study|Unable to complete experimental task|0|||
155660551|NCT02115321|561852630|FG000|Overall Study|Death|1|||
155660552|NCT02115321|561852631|FG001|Overall Study|Death|0|||
155569862|NCT02784795|561510650|FG003|Overall Study|Physician Decision|0|||
155569863|NCT02784795|561510651|FG004|Overall Study|Physician Decision|0|||
155569864|NCT02784795|561510652|FG005|Overall Study|Physician Decision|0|||
155569865|NCT02784795|561510653|FG006|Overall Study|Physician Decision|1|||
155569866|NCT02784795|561510654|FG007|Overall Study|Physician Decision|0|||
155569867|NCT02784795|561510655|FG008|Overall Study|Physician Decision|0|||
155569868|NCT02784795|561510656|FG009|Overall Study|Physician Decision|0|||
155569869|NCT02784795|561510657|FG010|Overall Study|Physician Decision|0|||
155569870|NCT02784795|561510658|FG011|Overall Study|Physician Decision|0|||
155569871|NCT00101283|561510659|FG000|Overall Study|Withdrawal by Subject|0|||
155569872|NCT00101283|561510660|FG001|Overall Study|Withdrawal by Subject|1|||
155569873|NCT00101283|561510659|FG000|Overall Study|Insurance Refusal|0|||
155569874|NCT00101283|561510660|FG001|Overall Study|Insurance Refusal|1|||
155569875|NCT00101283|561510659|FG000|Overall Study|Prostate Cancer Recurrence|0|||
155569876|NCT00101283|561510660|FG001|Overall Study|Prostate Cancer Recurrence|1|||
155569877|NCT00595309|561510661|FG000|Overall Study|Lost to Follow-up|1|||
155569878|NCT00595309|561510661|FG000|Overall Study|planned vaccination against yellow fever|1|||
155569879|NCT00595309|561510661|FG000|Overall Study|acute infection after V0|1|||
155569880|NCT00595309|561510661|FG000|Overall Study|personal reason|1|||
155569881|NCT04238650|561510662|FG000|Overall Study|Withdrawal by Subject|0|||
155569882|NCT04238650|561510663|FG001|Overall Study|Withdrawal by Subject|1|||
155569883|NCT02756208|561510664|FG000|Overall Study|Withdrawal by Subject|1|||
155660553|NCT01463527|561852634|FG000|Overall Study|Protocol Violation|1|||
155660554|NCT01463527|561852635|FG001|Overall Study|Protocol Violation|1|||
155660555|NCT01463527|561852634|FG000|Overall Study|Crying >20% of sedation|5|||
155660556|NCT01463527|561852635|FG001|Overall Study|Crying >20% of sedation|6|||
155660557|NCT01493414|561852636|FG000|Overall Study|Adverse Event|405|||
155660558|NCT01493414|561852636|FG000|Overall Study|Disease progression|204|||
155660559|NCT01493414|561852636|FG000|Overall Study|Death|101|||
155569884|NCT02756208|561510665|FG001|Overall Study|Withdrawal by Subject|0|||
155569885|NCT02756208|561510666|FG002|Overall Study|Withdrawal by Subject|1|||
155569886|NCT02756208|561510667|FG003|Overall Study|Withdrawal by Subject|3|||
155660560|NCT01493414|561852636|FG000|Overall Study|Physician Decision|93|||
155660561|NCT01493414|561852636|FG000|Overall Study|Withdrawal by Subject|79|||
155660562|NCT01493414|561852636|FG000|Overall Study|Protocol deviation|27|||
155660563|NCT01493414|561852636|FG000|Overall Study|Administrative problems|25|||
155660564|NCT01493414|561852636|FG000|Overall Study|Lost to Follow-up|16|||
155660565|NCT04403919|561852637|FG000|Overall Study|Lost to Follow-up|0|||
155660566|NCT04403919|561852638|FG001|Overall Study|Lost to Follow-up|0|||
155569887|NCT02756208|561510664|FG000|Overall Study|Lost to Follow-up|3|||
155569888|NCT02756208|561510665|FG001|Overall Study|Lost to Follow-up|1|||
155569889|NCT02756208|561510666|FG002|Overall Study|Lost to Follow-up|1|||
155569890|NCT02756208|561510667|FG003|Overall Study|Lost to Follow-up|1|||
155569891|NCT02756208|561510664|FG000|Overall Study|Physician Decision|1|||
155569892|NCT02756208|561510665|FG001|Overall Study|Physician Decision|0|||
155569893|NCT02756208|561510666|FG002|Overall Study|Physician Decision|0|||
155569894|NCT02756208|561510667|FG003|Overall Study|Physician Decision|0|||
155569895|NCT02756208|561510664|FG000|Overall Study|Protocol Violation|0|||
155569896|NCT02756208|561510665|FG001|Overall Study|Protocol Violation|1|||
155569897|NCT02756208|561510666|FG002|Overall Study|Protocol Violation|0|||
155569898|NCT02756208|561510667|FG003|Overall Study|Protocol Violation|0|||
155569899|NCT00356525|561510670|FG000|Overall Study|Progressive Disease|8|||
155569900|NCT00356525|561510671|FG001|Overall Study|Progressive Disease|5|||
155569901|NCT00356525|561510672|FG002|Overall Study|Progressive Disease|4|||
155569902|NCT00356525|561510673|FG003|Overall Study|Progressive Disease|2|||
155569903|NCT00356525|561510670|FG000|Overall Study|Adverse Event|1|||
155569904|NCT00356525|561510671|FG001|Overall Study|Adverse Event|3|||
155569905|NCT00356525|561510672|FG002|Overall Study|Adverse Event|1|||
155569906|NCT00356525|561510673|FG003|Overall Study|Adverse Event|1|||
155569907|NCT00356525|561510670|FG000|Overall Study|Lost to Follow-up|1|||
155569908|NCT00356525|561510671|FG001|Overall Study|Lost to Follow-up|0|||
155569909|NCT00356525|561510672|FG002|Overall Study|Lost to Follow-up|0|||
155569910|NCT00356525|561510673|FG003|Overall Study|Lost to Follow-up|0|||
155569911|NCT00356525|561510670|FG000|Overall Study|Physician Decision|2|||
155569912|NCT00356525|561510671|FG001|Overall Study|Physician Decision|2|||
155569913|NCT00356525|561510672|FG002|Overall Study|Physician Decision|2|||
155569914|NCT00356525|561510673|FG003|Overall Study|Physician Decision|1|||
155569915|NCT00356525|561510670|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
155569916|NCT00356525|561510671|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
155569917|NCT00356525|561510672|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
155569918|NCT00356525|561510673|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
155569919|NCT00356525|561510670|FG000|Overall Study|Withdrawal by Subject|1|||
155569920|NCT00356525|561510671|FG001|Overall Study|Withdrawal by Subject|1|||
155569921|NCT00356525|561510672|FG002|Overall Study|Withdrawal by Subject|0|||
155569922|NCT00356525|561510673|FG003|Overall Study|Withdrawal by Subject|3|||
155569923|NCT00356525|561510670|FG000|Overall Study|Death|0|||
155569924|NCT00356525|561510671|FG001|Overall Study|Death|0|||
155569925|NCT00356525|561510672|FG002|Overall Study|Death|0|||
155569926|NCT00356525|561510673|FG003|Overall Study|Death|1|||
155569927|NCT00356525|561510670|FG000|Overall Study|Sponsor Decision|0|||
155569928|NCT00356525|561510671|FG001|Overall Study|Sponsor Decision|0|||
155569929|NCT00356525|561510672|FG002|Overall Study|Sponsor Decision|0|||
155569930|NCT00356525|561510673|FG003|Overall Study|Sponsor Decision|1|||
155569931|NCT00652340|561510674|FG000|Overall Study|Had not progressed.|4|||
155569932|NCT00652340|561510675|FG001|Overall Study|Had not progressed.|3|||
155569933|NCT03682107|561510676|FG000|Overall Study|Withdrawal by Subject|0|||
155569934|NCT03682107|561510677|FG001|Overall Study|Withdrawal by Subject|1|||
155569935|NCT03682107|561510678|FG002|Overall Study|Withdrawal by Subject|0|||
155569936|NCT03682107|561510679|FG003|Overall Study|Withdrawal by Subject|0|||
155569937|NCT03682107|561510680|FG004|Overall Study|Withdrawal by Subject|0|||
155569938|NCT00214383|561510683|FG000|Overall Study|Lost to Follow-up|16|||
155569939|NCT00214383|561510684|FG001|Overall Study|Lost to Follow-up|26|||
155569940|NCT04152291|561510685|FG000|Overall Study|Covid-19 restrictions|27|||
155569941|NCT04152291|561510685|FG000|Overall Study|Withdrawal by Subject|3|||
155569942|NCT03597295|561510686|FG000|Overall Study|Death|70|||
155569943|NCT03597295|561510686|FG000|Overall Study|Lost to Follow-up|7|||
155569944|NCT00879411|561510687|FG000|Overall Study|lost to follow-up (non-AE)|162|||
155569945|NCT05124691|561510688|FG000|Phase II|Eligibility criteria|0|||
155569946|NCT05124691|561510689|FG001|Phase II|Eligibility criteria|1|||
155569947|NCT05124691|561510690|FG002|Phase II|Eligibility criteria|0|||
155569948|NCT05124691|561510688|FG000|Phase II|Withdrawal by Subject|6|||
155569949|NCT05124691|561510689|FG001|Phase II|Withdrawal by Subject|2|||
155569950|NCT05124691|561510690|FG002|Phase II|Withdrawal by Subject|3|||
155569951|NCT05124691|561510688|FG000|Phase III|Withdrawal by Subject|6|||
155569952|NCT05124691|561510689|FG001|Phase III|Withdrawal by Subject|4|||
155569953|NCT05124691|561510690|FG002|Phase III|Withdrawal by Subject|4|||
155569954|NCT05124691|561510688|FG000|Phase III|Lost to Follow-up|1|||
155569955|NCT05124691|561510689|FG001|Phase III|Lost to Follow-up|0|||
155660567|NCT04403919|561852639|FG002|Overall Study|Lost to Follow-up|0|||
155660568|NCT04403919|561852640|FG003|Overall Study|Lost to Follow-up|1|||
155569956|NCT05124691|561510690|FG002|Phase III|Lost to Follow-up|0|||
155569957|NCT01890434|561510691|FG000|Overall Study|Adverse Event|8|||
155569958|NCT01890434|561510691|FG000|Overall Study|PCI at external hospital|1|||
155569959|NCT01890434|561510691|FG000|Overall Study|Assessment discrepancy|1|||
155569960|NCT01890434|561510691|FG000|Overall Study|CRC didn't contact participant for FU|1|||
155569961|NCT01890434|561510691|FG000|Overall Study|Could not get whole set of images|1|||
155569962|NCT01890434|561510691|FG000|Overall Study|Decline to return for GSPECT|1|||
155569963|NCT01890434|561510691|FG000|Overall Study|GSPECT at rest was not done|1|||
155569964|NCT01890434|561510691|FG000|Overall Study|Participant didn't complete MRI|1|||
155569965|NCT01890434|561510691|FG000|Overall Study|Uncontactable by phone|1|||
155569966|NCT01890434|561510691|FG000|Overall Study|Moved out of position|1|||
155569967|NCT01890434|561510691|FG000|Overall Study|Unable to contact|1|||
155569968|NCT01890434|561510691|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
155569969|NCT00428116|561510692|FG000|Overall Study|Death|1|||
155569970|NCT00428116|561510693|FG001|Overall Study|Death|0|||
155569971|NCT00428116|561510692|FG000|Overall Study|Withdrawal by Subject|1|||
155569972|NCT00428116|561510693|FG001|Overall Study|Withdrawal by Subject|0|||
155569973|NCT00428116|561510692|FG000|Overall Study|Lost to Follow-up|1|||
155569974|NCT00428116|561510693|FG001|Overall Study|Lost to Follow-up|0|||
155569975|NCT01038297|561510694|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
155569976|NCT01038297|561510695|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
155569977|NCT01038297|561510696|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
155569978|NCT00252239|561510707|FG000|Overall Study|Withdrawal by Subject|1|||
155569979|NCT00252239|561510708|FG001|Overall Study|Withdrawal by Subject|0|||
155569980|NCT00252239|561510709|FG002|Overall Study|Withdrawal by Subject|0|||
155569981|NCT00252239|561510710|FG003|Overall Study|Withdrawal by Subject|1|||
155569982|NCT00252239|561510707|FG000|Overall Study|Lost to Follow-up|0|||
155569983|NCT00252239|561510708|FG001|Overall Study|Lost to Follow-up|0|||
155569984|NCT00252239|561510709|FG002|Overall Study|Lost to Follow-up|2|||
155569985|NCT00252239|561510710|FG003|Overall Study|Lost to Follow-up|0|||
155569986|NCT02257385|561510712|FG000|Overall Study|Adverse Event|12|||
155569987|NCT02257385|561510713|FG001|Overall Study|Adverse Event|8|||
155569988|NCT02257385|561510712|FG000|Overall Study|Lack of Efficacy|1|||
155569989|NCT02257385|561510713|FG001|Overall Study|Lack of Efficacy|2|||
155569990|NCT02257385|561510712|FG000|Overall Study|Protocol Violation|5|||
155569991|NCT02257385|561510713|FG001|Overall Study|Protocol Violation|7|||
155569992|NCT02257385|561510712|FG000|Overall Study|Lost to Follow-up|0|||
155569993|NCT02257385|561510713|FG001|Overall Study|Lost to Follow-up|1|||
155569994|NCT02257385|561510712|FG000|Overall Study|Withdrawal by Subject|4|||
155569995|NCT02257385|561510713|FG001|Overall Study|Withdrawal by Subject|4|||
155569996|NCT01449370|561510722|FG000|Overall Study|Disease Progression|5|||
155569997|NCT01449370|561510723|FG001|Overall Study|Disease Progression|4|||
155569998|NCT01449370|561510724|FG002|Overall Study|Disease Progression|8|||
155569999|NCT01449370|561510725|FG003|Overall Study|Disease Progression|3|||
155570000|NCT01449370|561510726|FG004|Overall Study|Disease Progression|3|||
155570001|NCT01449370|561510727|FG005|Overall Study|Disease Progression|3|||
155570002|NCT01449370|561510728|FG006|Overall Study|Disease Progression|3|||
155570003|NCT01449370|561510729|FG007|Overall Study|Disease Progression|2|||
155570004|NCT01449370|561510730|FG008|Overall Study|Disease Progression|9|||
155570005|NCT01449370|561510731|FG009|Overall Study|Disease Progression|1|||
155570006|NCT01449370|561510732|FG010|Overall Study|Disease Progression|3|||
155570007|NCT01449370|561510733|FG011|Overall Study|Disease Progression|3|||
155570008|NCT01449370|561510734|FG012|Overall Study|Disease Progression|2|||
155570009|NCT01449370|561510735|FG013|Overall Study|Disease Progression|8|||
155570010|NCT01449370|561510736|FG014|Overall Study|Disease Progression|3|||
155570011|NCT01449370|561510737|FG015|Overall Study|Disease Progression|1|||
155570012|NCT01449370|561510738|FG016|Overall Study|Disease Progression|4|||
155570013|NCT01449370|561510739|FG017|Overall Study|Disease Progression|3|||
155570014|NCT01449370|561510740|FG018|Overall Study|Disease Progression|1|||
155570015|NCT01449370|561510741|FG019|Overall Study|Disease Progression|2|||
155570016|NCT01449370|561510742|FG020|Overall Study|Disease Progression|5|||
155570017|NCT01449370|561510743|FG021|Overall Study|Disease Progression|2|||
155570018|NCT01449370|561510744|FG022|Overall Study|Disease Progression|3|||
155570019|NCT01449370|561510745|FG023|Overall Study|Disease Progression|7|||
155570020|NCT01449370|561510746|FG024|Overall Study|Disease Progression|3|||
155570021|NCT01449370|561510722|FG000|Overall Study|Adverse Event|1|||
155570022|NCT01449370|561510723|FG001|Overall Study|Adverse Event|2|||
155570023|NCT01449370|561510724|FG002|Overall Study|Adverse Event|0|||
155570024|NCT01449370|561510725|FG003|Overall Study|Adverse Event|1|||
155570025|NCT01449370|561510726|FG004|Overall Study|Adverse Event|0|||
155570026|NCT01449370|561510727|FG005|Overall Study|Adverse Event|0|||
155570027|NCT01449370|561510728|FG006|Overall Study|Adverse Event|0|||
155570028|NCT01449370|561510729|FG007|Overall Study|Adverse Event|0|||
155570029|NCT01449370|561510730|FG008|Overall Study|Adverse Event|1|||
155570030|NCT01449370|561510731|FG009|Overall Study|Adverse Event|1|||
155570031|NCT01449370|561510732|FG010|Overall Study|Adverse Event|0|||
155570032|NCT01449370|561510733|FG011|Overall Study|Adverse Event|0|||
155570033|NCT01449370|561510734|FG012|Overall Study|Adverse Event|0|||
155570034|NCT01449370|561510735|FG013|Overall Study|Adverse Event|2|||
155570035|NCT01449370|561510736|FG014|Overall Study|Adverse Event|0|||
155660569|NCT03746015|561852641|FG000|Overall Study|Withdrawal of Consent|1|||
155570036|NCT01449370|561510737|FG015|Overall Study|Adverse Event|1|||
155570037|NCT01449370|561510738|FG016|Overall Study|Adverse Event|0|||
155570038|NCT01449370|561510739|FG017|Overall Study|Adverse Event|0|||
155570039|NCT01449370|561510740|FG018|Overall Study|Adverse Event|1|||
155570040|NCT01449370|561510741|FG019|Overall Study|Adverse Event|1|||
155570041|NCT01449370|561510742|FG020|Overall Study|Adverse Event|0|||
155570042|NCT01449370|561510743|FG021|Overall Study|Adverse Event|1|||
155570043|NCT01449370|561510744|FG022|Overall Study|Adverse Event|0|||
155570044|NCT01449370|561510745|FG023|Overall Study|Adverse Event|1|||
155570045|NCT01449370|561510746|FG024|Overall Study|Adverse Event|3|||
155570046|NCT01449370|561510722|FG000|Overall Study|Participant Decision|0|||
155570047|NCT01449370|561510723|FG001|Overall Study|Participant Decision|0|||
155570048|NCT01449370|561510724|FG002|Overall Study|Participant Decision|0|||
155570049|NCT01449370|561510725|FG003|Overall Study|Participant Decision|0|||
155570050|NCT01449370|561510726|FG004|Overall Study|Participant Decision|0|||
155570051|NCT01449370|561510727|FG005|Overall Study|Participant Decision|0|||
155570052|NCT01449370|561510728|FG006|Overall Study|Participant Decision|0|||
155570053|NCT01449370|561510729|FG007|Overall Study|Participant Decision|1|||
155570054|NCT01449370|561510730|FG008|Overall Study|Participant Decision|1|||
155570055|NCT01449370|561510731|FG009|Overall Study|Participant Decision|0|||
155570056|NCT01449370|561510732|FG010|Overall Study|Participant Decision|0|||
155570057|NCT01449370|561510733|FG011|Overall Study|Participant Decision|0|||
155570058|NCT01449370|561510734|FG012|Overall Study|Participant Decision|1|||
155570059|NCT01449370|561510735|FG013|Overall Study|Participant Decision|1|||
155570060|NCT01449370|561510736|FG014|Overall Study|Participant Decision|0|||
155570061|NCT01449370|561510737|FG015|Overall Study|Participant Decision|1|||
155570062|NCT01449370|561510738|FG016|Overall Study|Participant Decision|3|||
155570063|NCT01449370|561510739|FG017|Overall Study|Participant Decision|0|||
155570064|NCT01449370|561510740|FG018|Overall Study|Participant Decision|1|||
155570065|NCT01449370|561510741|FG019|Overall Study|Participant Decision|0|||
155570066|NCT01449370|561510742|FG020|Overall Study|Participant Decision|0|||
155570067|NCT01449370|561510743|FG021|Overall Study|Participant Decision|1|||
155570068|NCT01449370|561510744|FG022|Overall Study|Participant Decision|0|||
155570069|NCT01449370|561510745|FG023|Overall Study|Participant Decision|0|||
155570070|NCT01449370|561510746|FG024|Overall Study|Participant Decision|1|||
155570071|NCT01449370|561510722|FG000|Overall Study|Lost to Follow-up|0|||
155570072|NCT01449370|561510723|FG001|Overall Study|Lost to Follow-up|0|||
155570073|NCT01449370|561510724|FG002|Overall Study|Lost to Follow-up|0|||
155570074|NCT01449370|561510725|FG003|Overall Study|Lost to Follow-up|0|||
155570075|NCT01449370|561510726|FG004|Overall Study|Lost to Follow-up|0|||
155570076|NCT01449370|561510727|FG005|Overall Study|Lost to Follow-up|0|||
155570077|NCT01449370|561510728|FG006|Overall Study|Lost to Follow-up|0|||
155570078|NCT01449370|561510729|FG007|Overall Study|Lost to Follow-up|0|||
155570079|NCT01449370|561510730|FG008|Overall Study|Lost to Follow-up|0|||
155570080|NCT01449370|561510731|FG009|Overall Study|Lost to Follow-up|0|||
155570081|NCT01449370|561510732|FG010|Overall Study|Lost to Follow-up|0|||
155570082|NCT01449370|561510733|FG011|Overall Study|Lost to Follow-up|0|||
155570083|NCT01449370|561510734|FG012|Overall Study|Lost to Follow-up|0|||
155570084|NCT01449370|561510735|FG013|Overall Study|Lost to Follow-up|0|||
155570085|NCT01449370|561510736|FG014|Overall Study|Lost to Follow-up|0|||
155570086|NCT01449370|561510737|FG015|Overall Study|Lost to Follow-up|0|||
155570087|NCT01449370|561510738|FG016|Overall Study|Lost to Follow-up|0|||
155570088|NCT01449370|561510739|FG017|Overall Study|Lost to Follow-up|0|||
155570089|NCT01449370|561510740|FG018|Overall Study|Lost to Follow-up|0|||
155570090|NCT01449370|561510741|FG019|Overall Study|Lost to Follow-up|0|||
155570091|NCT01449370|561510742|FG020|Overall Study|Lost to Follow-up|1|||
155570092|NCT01449370|561510743|FG021|Overall Study|Lost to Follow-up|0|||
155570093|NCT01449370|561510744|FG022|Overall Study|Lost to Follow-up|0|||
155570094|NCT01449370|561510745|FG023|Overall Study|Lost to Follow-up|0|||
155570095|NCT01449370|561510746|FG024|Overall Study|Lost to Follow-up|0|||
155570096|NCT01449370|561510722|FG000|Overall Study|Other|0|||
155570097|NCT01449370|561510723|FG001|Overall Study|Other|0|||
155570098|NCT01449370|561510724|FG002|Overall Study|Other|0|||
155570099|NCT01449370|561510725|FG003|Overall Study|Other|0|||
155570100|NCT01449370|561510726|FG004|Overall Study|Other|0|||
155570101|NCT01449370|561510727|FG005|Overall Study|Other|0|||
155570102|NCT01449370|561510728|FG006|Overall Study|Other|0|||
155570103|NCT01449370|561510729|FG007|Overall Study|Other|0|||
155660570|NCT03746015|561852642|FG001|Overall Study|Withdrawal of Consent|0|||
155660571|NCT03746015|561852643|FG002|Overall Study|Withdrawal of Consent|0|||
155570104|NCT01449370|561510730|FG008|Overall Study|Other|1|||
155570105|NCT01449370|561510731|FG009|Overall Study|Other|1|||
155570106|NCT01449370|561510732|FG010|Overall Study|Other|0|||
155570107|NCT01449370|561510733|FG011|Overall Study|Other|0|||
155570108|NCT01449370|561510734|FG012|Overall Study|Other|0|||
155570109|NCT01449370|561510735|FG013|Overall Study|Other|0|||
155570110|NCT01449370|561510736|FG014|Overall Study|Other|0|||
155570111|NCT01449370|561510737|FG015|Overall Study|Other|0|||
155570112|NCT01449370|561510738|FG016|Overall Study|Other|0|||
155570113|NCT01449370|561510739|FG017|Overall Study|Other|0|||
155570114|NCT01449370|561510740|FG018|Overall Study|Other|0|||
155660572|NCT02303262|561852646|FG000|Overall Study|Withdrawal by Subject|2|||
155660573|NCT01143402|561852649|FG000|Overall Study|Rapid clinical decline|1|||
155660574|NCT01143402|561852650|FG001|Overall Study|Rapid clinical decline|1|||
155660575|NCT01143402|561852651|FG002|Overall Study|Rapid clinical decline|0|||
155660576|NCT01143402|561852649|FG000|Overall Study|Not Treated|0|||
155570115|NCT01449370|561510741|FG019|Overall Study|Other|0|||
155570116|NCT01449370|561510742|FG020|Overall Study|Other|0|||
155570117|NCT01449370|561510743|FG021|Overall Study|Other|0|||
155660577|NCT01143402|561852650|FG001|Overall Study|Not Treated|0|||
155660578|NCT01143402|561852651|FG002|Overall Study|Not Treated|1|||
155660579|NCT00397540|561852657|FG000|Overall Study|short follow-up duration < 12 months|1|||
155660580|NCT00397540|561852658|FG001|Overall Study|short follow-up duration < 12 months|0|||
155660581|NCT01968980|561852660|FG000|Overall Study|Death|0|||
155660582|NCT01968980|561852661|FG001|Overall Study|Death|1|||
155660583|NCT01968980|561852660|FG000|Overall Study|Adverse Event|1|||
155660584|NCT01968980|561852661|FG001|Overall Study|Adverse Event|3|||
155660585|NCT01968980|561852660|FG000|Overall Study|Does not meet entry criteria|1|||
155660586|NCT01968980|561852661|FG001|Overall Study|Does not meet entry criteria|3|||
155660587|NCT01968980|561852660|FG000|Overall Study|Withdrawal by Subject|13|||
155660588|NCT01968980|561852661|FG001|Overall Study|Withdrawal by Subject|5|||
155660589|NCT01968980|561852660|FG000|Overall Study|Other unspecified|1|||
155660590|NCT01968980|561852661|FG001|Overall Study|Other unspecified|2|||
155660591|NCT00776230|561852662|FG000|Overall Study|Lost to Follow-up|2|||
155660592|NCT00776230|561852663|FG001|Overall Study|Lost to Follow-up|1|||
155660593|NCT00776230|561852664|FG002|Overall Study|Lost to Follow-up|5|||
155660594|NCT00776230|561852662|FG000|Overall Study|Not vaccinated at Day 0|1|||
155660595|NCT00776230|561852663|FG001|Overall Study|Not vaccinated at Day 0|0|||
155660596|NCT00776230|561852664|FG002|Overall Study|Not vaccinated at Day 0|0|||
155660597|NCT00776230|561852662|FG000|Overall Study|Withdrawal by Subject|0|||
155660598|NCT00776230|561852663|FG001|Overall Study|Withdrawal by Subject|1|||
155660599|NCT00776230|561852664|FG002|Overall Study|Withdrawal by Subject|0|||
155660600|NCT00776230|561852662|FG000|Overall Study|Subject missed Visit 4|0|||
155660601|NCT00776230|561852663|FG001|Overall Study|Subject missed Visit 4|1|||
155660602|NCT00776230|561852664|FG002|Overall Study|Subject missed Visit 4|0|||
155660603|NCT01215851|561852665|FG000|Treatment Period|Adverse Event|1|||
155660604|NCT01215851|561852666|FG001|Treatment Period|Adverse Event|1|||
155660605|NCT01215851|561852667|FG002|Treatment Period|Adverse Event|1|||
155660606|NCT01215851|561852668|FG003|Treatment Period|Adverse Event|3|||
155660607|NCT01215851|561852669|FG004|Treatment Period|Adverse Event|0|||
155660608|NCT01215851|561852670|FG005|Treatment Period|Adverse Event|1|||
155660609|NCT01215851|561852665|FG000|Follow up Period|Lost to Follow-up|0|||
155570118|NCT01449370|561510744|FG022|Overall Study|Other|1|||
155570119|NCT01449370|561510745|FG023|Overall Study|Other|1|||
155570120|NCT01449370|561510746|FG024|Overall Study|Other|0|||
155570121|NCT01449370|561510722|FG000|Overall Study|Medication Prohibited by Protocol|0|||
155570122|NCT01449370|561510723|FG001|Overall Study|Medication Prohibited by Protocol|0|||
155570123|NCT01449370|561510724|FG002|Overall Study|Medication Prohibited by Protocol|0|||
155570124|NCT01449370|561510725|FG003|Overall Study|Medication Prohibited by Protocol|0|||
155570125|NCT01449370|561510726|FG004|Overall Study|Medication Prohibited by Protocol|0|||
155660610|NCT01215851|561852666|FG001|Follow up Period|Lost to Follow-up|0|||
155660611|NCT01215851|561852667|FG002|Follow up Period|Lost to Follow-up|0|||
155660612|NCT01215851|561852668|FG003|Follow up Period|Lost to Follow-up|0|||
155660613|NCT01215851|561852669|FG004|Follow up Period|Lost to Follow-up|0|||
155660614|NCT01215851|561852670|FG005|Follow up Period|Lost to Follow-up|1|||
155660615|NCT02589938|561852676|FG000|Overall Study|Withdrawal by Subject|11|||
155660616|NCT02589938|561852677|FG001|Overall Study|Withdrawal by Subject|5|||
155660617|NCT02589938|561852678|FG002|Overall Study|Withdrawal by Subject|6|||
155660618|NCT02589938|561852676|FG000|Overall Study|Lost to Follow-up|3|||
155660619|NCT02589938|561852677|FG001|Overall Study|Lost to Follow-up|3|||
155660620|NCT02589938|561852678|FG002|Overall Study|Lost to Follow-up|3|||
155660621|NCT02589938|561852676|FG000|Overall Study|Death|1|||
155660622|NCT02589938|561852677|FG001|Overall Study|Death|0|||
155660623|NCT02589938|561852678|FG002|Overall Study|Death|1|||
155660624|NCT02589938|561852676|FG000|Overall Study|Protocol Violation|6|||
155660625|NCT02589938|561852677|FG001|Overall Study|Protocol Violation|2|||
155660626|NCT02589938|561852678|FG002|Overall Study|Protocol Violation|3|||
155570126|NCT01449370|561510727|FG005|Overall Study|Medication Prohibited by Protocol|0|||
155570127|NCT01449370|561510728|FG006|Overall Study|Medication Prohibited by Protocol|0|||
155660627|NCT02589938|561852676|FG000|Overall Study|Physician Decision|1|||
155660628|NCT02589938|561852677|FG001|Overall Study|Physician Decision|0|||
155660629|NCT02589938|561852678|FG002|Overall Study|Physician Decision|0|||
155660630|NCT02589938|561852676|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
155660631|NCT02589938|561852677|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
155660632|NCT02589938|561852678|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
155660633|NCT01276106|561852679|FG000|Overall Study|Adverse Event|3|||
155570128|NCT01449370|561510729|FG007|Overall Study|Medication Prohibited by Protocol|0|||
155570129|NCT01449370|561510730|FG008|Overall Study|Medication Prohibited by Protocol|0|||
155570130|NCT01449370|561510731|FG009|Overall Study|Medication Prohibited by Protocol|0|||
155570131|NCT01449370|561510732|FG010|Overall Study|Medication Prohibited by Protocol|0|||
155570132|NCT01449370|561510733|FG011|Overall Study|Medication Prohibited by Protocol|0|||
155570133|NCT01449370|561510734|FG012|Overall Study|Medication Prohibited by Protocol|0|||
155570134|NCT01449370|561510735|FG013|Overall Study|Medication Prohibited by Protocol|0|||
155570135|NCT01449370|561510736|FG014|Overall Study|Medication Prohibited by Protocol|0|||
155570136|NCT01449370|561510737|FG015|Overall Study|Medication Prohibited by Protocol|0|||
155570137|NCT01449370|561510738|FG016|Overall Study|Medication Prohibited by Protocol|0|||
155570138|NCT01449370|561510739|FG017|Overall Study|Medication Prohibited by Protocol|0|||
155570139|NCT01449370|561510740|FG018|Overall Study|Medication Prohibited by Protocol|0|||
155570140|NCT01449370|561510741|FG019|Overall Study|Medication Prohibited by Protocol|0|||
155570141|NCT01449370|561510742|FG020|Overall Study|Medication Prohibited by Protocol|0|||
155570142|NCT01449370|561510743|FG021|Overall Study|Medication Prohibited by Protocol|0|||
155570143|NCT01449370|561510744|FG022|Overall Study|Medication Prohibited by Protocol|0|||
155570144|NCT01449370|561510745|FG023|Overall Study|Medication Prohibited by Protocol|1|||
155570145|NCT01449370|561510746|FG024|Overall Study|Medication Prohibited by Protocol|0|||
155570146|NCT01449370|561510722|FG000|Overall Study|Death|0|||
155570147|NCT01449370|561510723|FG001|Overall Study|Death|0|||
155570148|NCT01449370|561510724|FG002|Overall Study|Death|0|||
155570149|NCT01449370|561510725|FG003|Overall Study|Death|0|||
155570150|NCT01449370|561510726|FG004|Overall Study|Death|0|||
155570151|NCT01449370|561510727|FG005|Overall Study|Death|0|||
155570152|NCT01449370|561510728|FG006|Overall Study|Death|0|||
155570153|NCT01449370|561510729|FG007|Overall Study|Death|0|||
155570154|NCT01449370|561510730|FG008|Overall Study|Death|0|||
155570155|NCT01449370|561510731|FG009|Overall Study|Death|0|||
155570156|NCT01449370|561510732|FG010|Overall Study|Death|0|||
155570157|NCT01449370|561510733|FG011|Overall Study|Death|0|||
155570158|NCT01449370|561510734|FG012|Overall Study|Death|0|||
155570159|NCT01449370|561510735|FG013|Overall Study|Death|0|||
155570160|NCT01449370|561510736|FG014|Overall Study|Death|0|||
155570161|NCT01449370|561510737|FG015|Overall Study|Death|0|||
155570162|NCT01449370|561510738|FG016|Overall Study|Death|0|||
155570163|NCT01449370|561510739|FG017|Overall Study|Death|0|||
155570164|NCT01449370|561510740|FG018|Overall Study|Death|0|||
155570165|NCT01449370|561510741|FG019|Overall Study|Death|0|||
155570166|NCT01449370|561510742|FG020|Overall Study|Death|0|||
155570167|NCT01449370|561510743|FG021|Overall Study|Death|0|||
155570168|NCT01449370|561510744|FG022|Overall Study|Death|0|||
155570169|NCT01449370|561510745|FG023|Overall Study|Death|0|||
155570170|NCT01449370|561510746|FG024|Overall Study|Death|1|||
155570171|NCT00710866|561510747|FG000|Overall Study|Protocol Violation|5|||
155570172|NCT00710866|561510748|FG001|Overall Study|Protocol Violation|4|||
155570173|NCT00710866|561510747|FG000|Overall Study|Withdrawal by Subject|2|||
155570174|NCT00710866|561510748|FG001|Overall Study|Withdrawal by Subject|1|||
155570175|NCT00710866|561510747|FG000|Overall Study|Lost to Follow-up|1|||
155570176|NCT00710866|561510748|FG001|Overall Study|Lost to Follow-up|0|||
155570177|NCT00710866|561510747|FG000|Overall Study|Failed to meet eligibility|1|||
155570178|NCT00710866|561510748|FG001|Overall Study|Failed to meet eligibility|1|||
155570179|NCT00908310|561510750|FG000|Overall Study|Death|37|||
155570180|NCT00908310|561510750|FG000|Overall Study|Withdrawal by Subject|7|||
155570181|NCT00908310|561510750|FG000|Overall Study|Lost to Follow-up|7|||
155570182|NCT00908310|561510750|FG000|Overall Study|Screening failure|5|||
155570183|NCT00908310|561510750|FG000|Overall Study|Other reasons|4|||
155570184|NCT00246324|561510753|FG000|Overall Study|Withdrawal by Subject|1|||
155570185|NCT03456453|561510754|FG000|Overall Study|Withdrawal by Subject|2|||
155570186|NCT03456453|561510755|FG001|Overall Study|Withdrawal by Subject|0|||
155570187|NCT03456453|561510754|FG000|Overall Study|Not released to community|1|||
155570188|NCT03456453|561510755|FG001|Overall Study|Not released to community|5|||
155570189|NCT03456453|561510754|FG000|Overall Study|Lost to Follow-up|0|||
155570190|NCT03456453|561510755|FG001|Overall Study|Lost to Follow-up|2|||
155570191|NCT02551666|561510762|FG000|Overall Study|Withdrawal by Subject|1|||
155570192|NCT02551666|561510763|FG001|Overall Study|Withdrawal by Subject|3|||
155570193|NCT02017015|561512497|FG000|Overall Study|Adverse Event|9|||
155570194|NCT02017015|561512497|FG000|Overall Study|Withdrawal by Subject|21|||
155570195|NCT02017015|561512497|FG000|Overall Study|Death|4|||
155570196|NCT02017015|561512497|FG000|Overall Study|Progressive Disease|31|||
155570197|NCT02017015|561512497|FG000|Overall Study|Non-compliance with study drug|2|||
155570198|NCT02017015|561512497|FG000|Overall Study|Physician Decision|2|||
155570199|NCT01277601|561512500|FG000|Overall Study|Adverse Event|5|||
155570200|NCT01277601|561512501|FG001|Overall Study|Adverse Event|3|||
155570201|NCT01277601|561512502|FG002|Overall Study|Adverse Event|0|||
155570202|NCT01277601|561512503|FG003|Overall Study|Adverse Event|7|||
155570203|NCT01277601|561512500|FG000|Overall Study|Withdrawal by Subject|18|||
155570204|NCT01277601|561512501|FG001|Overall Study|Withdrawal by Subject|21|||
155570205|NCT01277601|561512502|FG002|Overall Study|Withdrawal by Subject|8|||
155570206|NCT01277601|561512503|FG003|Overall Study|Withdrawal by Subject|17|||
155570207|NCT01277601|561512500|FG000|Overall Study|Lost to Follow-up|7|||
155570208|NCT01277601|561512501|FG001|Overall Study|Lost to Follow-up|9|||
155570209|NCT01277601|561512502|FG002|Overall Study|Lost to Follow-up|4|||
155570210|NCT01277601|561512503|FG003|Overall Study|Lost to Follow-up|2|||
155570211|NCT01277601|561512500|FG000|Overall Study|Physician Decision|3|||
155570212|NCT01277601|561512501|FG001|Overall Study|Physician Decision|5|||
155570213|NCT01277601|561512502|FG002|Overall Study|Physician Decision|1|||
155570214|NCT01277601|561512503|FG003|Overall Study|Physician Decision|6|||
155570215|NCT01277601|561512500|FG000|Overall Study|Pregnancy|2|||
155570216|NCT01277601|561512501|FG001|Overall Study|Pregnancy|2|||
155570217|NCT01277601|561512502|FG002|Overall Study|Pregnancy|4|||
155570218|NCT01277601|561512503|FG003|Overall Study|Pregnancy|1|||
155570219|NCT01277601|561512500|FG000|Overall Study|Noncompliance with Study Drug|1|||
155570220|NCT01277601|561512501|FG001|Overall Study|Noncompliance with Study Drug|3|||
155570221|NCT01277601|561512502|FG002|Overall Study|Noncompliance with Study Drug|2|||
155570222|NCT01277601|561512503|FG003|Overall Study|Noncompliance with Study Drug|0|||
155570223|NCT01277601|561512500|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
155570224|NCT01277601|561512501|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
155570225|NCT01277601|561512502|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
155570226|NCT01277601|561512503|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
155570227|NCT01277601|561512500|FG000|Overall Study|Protocol Violation|0|||
155570228|NCT01277601|561512501|FG001|Overall Study|Protocol Violation|2|||
155570229|NCT01277601|561512502|FG002|Overall Study|Protocol Violation|5|||
155570230|NCT01277601|561512503|FG003|Overall Study|Protocol Violation|0|||
155570231|NCT01277601|561512500|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
155570232|NCT01277601|561512501|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
155570233|NCT01277601|561512502|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
155570234|NCT01277601|561512503|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
155570235|NCT02260570|561512505|FG000|Overall Study|Withdrawal by Subject|2|||
155570236|NCT02260570|561512506|FG001|Overall Study|Withdrawal by Subject|1|||
155570237|NCT02260570|561512505|FG000|Overall Study|Physician Decision|1|||
155570238|NCT02260570|561512506|FG001|Overall Study|Physician Decision|1|||
155570239|NCT04034927|561512507|FG000|Overall Study|Adverse Event|4|||
155570240|NCT04034927|561512508|FG001|Overall Study|Adverse Event|9|||
155570241|NCT04034927|561512507|FG000|Overall Study|Death|0|||
155570242|NCT04034927|561512508|FG001|Overall Study|Death|1|||
155570243|NCT04034927|561512507|FG000|Overall Study|Withdrawal by Subject|0|||
155570244|NCT04034927|561512508|FG001|Overall Study|Withdrawal by Subject|3|||
155570245|NCT04034927|561512507|FG000|Overall Study|Still on Treatment|2|||
155570246|NCT04034927|561512508|FG001|Overall Study|Still on Treatment|1|||
155570247|NCT04034927|561512507|FG000|Overall Study|Other|1|||
155570248|NCT04034927|561512508|FG001|Overall Study|Other|1|||
155570249|NCT00230178|561512511|FG000|Overall Study|Adverse Event|1|||
155570250|NCT00230178|561512512|FG001|Overall Study|Adverse Event|5|||
155570251|NCT00230178|561512513|FG002|Overall Study|Adverse Event|2|||
155570252|NCT00230178|561512511|FG000|Overall Study|Withdrawal by Subject|0|||
155570253|NCT00230178|561512512|FG001|Overall Study|Withdrawal by Subject|0|||
155570254|NCT00230178|561512513|FG002|Overall Study|Withdrawal by Subject|1|||
155570255|NCT00230178|561512511|FG000|Overall Study|Various other reasons|3|||
155570256|NCT00230178|561512512|FG001|Overall Study|Various other reasons|2|||
155570257|NCT00230178|561512513|FG002|Overall Study|Various other reasons|4|||
155570258|NCT02252406|561512520|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
155570259|NCT02252406|561512521|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
155570260|NCT02252406|561512520|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
155570261|NCT02252406|561512521|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
155570262|NCT02252406|561512520|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
155570263|NCT02252406|561512521|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
155570264|NCT02252406|561512520|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
155570265|NCT02252406|561512521|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
155570266|NCT02252406|561512520|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
155570267|NCT02252406|561512521|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
155570268|NCT00794339|561512524|FG000|Overall Study|Withdrawal by Subject|3|||
155570269|NCT00794339|561512524|FG000|Overall Study|Ineligible|4|||
155570270|NCT00794339|561512524|FG000|Overall Study|Tx prior to ATSM|3|||
155570271|NCT00794339|561512524|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
155570272|NCT00794339|561512524|FG000|Overall Study|Tx not per protocol|1|||
155570273|NCT02952586|561512530|FG000|Lead-In Phase (7 Days)|Death|0|||
155570274|NCT02952586|561512531|FG001|Lead-In Phase (7 Days)|Death|1|||
155570275|NCT02952586|561512530|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
155570276|NCT02952586|561512531|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
155570277|NCT02952586|561512530|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
155570278|NCT02952586|561512531|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
155570279|NCT02952586|561512530|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
155660634|NCT01276106|561852680|FG001|Overall Study|Adverse Event|3|||
155570280|NCT02952586|561512531|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
155570281|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
155570282|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
155570283|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
155570284|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
155570285|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
155570286|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
155570287|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
155570288|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
155570289|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
155570290|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
155570291|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
155570292|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
155570293|NCT02952586|561512530|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
155570294|NCT02952586|561512531|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
155570295|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Death|3|||
155570296|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Death|8|||
155570297|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
155570298|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
155570299|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
155570300|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
155570301|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
155570302|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
155570303|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
155570304|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
155570305|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
155570306|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
155570307|NCT02952586|561512530|FG000|CRT for Cisplatin (63 Days)|Other|1|||
155570308|NCT02952586|561512531|FG001|CRT for Cisplatin (63 Days)|Other|1|||
155570309|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Death|5|||
155570310|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Death|8|||
155570311|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
155570312|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
155570313|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
155570314|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
155570315|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
155570316|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
155570317|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
155570318|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
155570319|NCT02952586|561512530|FG000|CRT for IMRT (63 Days)|Other|1|||
155570320|NCT02952586|561512531|FG001|CRT for IMRT (63 Days)|Other|0|||
155570321|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Death|17|||
155570322|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Death|11|||
155570323|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
155570324|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
155570325|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
155570326|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
155570327|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
155570328|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
155570329|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
155570330|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
155570331|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
155570332|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
155570333|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
155570334|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
155570335|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
155570336|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
155570337|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Other|2|||
155570338|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Other|1|||
155570339|NCT02952586|561512530|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
155570340|NCT02952586|561512531|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
155570341|NCT02952586|561512530|FG000|Follow-Up Phase (90 Days)|Death|12|||
155570342|NCT02952586|561512531|FG001|Follow-Up Phase (90 Days)|Death|10|||
155570343|NCT02952586|561512530|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
155570344|NCT02952586|561512531|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
155570345|NCT02952586|561512530|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
155570346|NCT02952586|561512531|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
155570347|NCT02952586|561512530|FG000|Follow-Up Phase (90 Days)|Other|7|||
155570348|NCT02952586|561512531|FG001|Follow-Up Phase (90 Days)|Other|5|||
155570349|NCT02952586|561512530|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
155570350|NCT02952586|561512531|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
155570351|NCT02952586|561512530|FG000|LT Follow-up (up to 45 Months)|Death|51|||
155570352|NCT02952586|561512531|FG001|LT Follow-up (up to 45 Months)|Death|31|||
155570353|NCT02952586|561512530|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
155570354|NCT02952586|561512531|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
155570355|NCT02952586|561512530|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
155570356|NCT02952586|561512531|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
155570357|NCT02952586|561512530|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
155570358|NCT02952586|561512531|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
155570359|NCT00492778|561512534|FG000|Overall Study|Ineligible by Pathology Review|8|||
155570360|NCT00492778|561512535|FG001|Overall Study|Ineligible by Pathology Review|1|||
155570361|NCT00362336|561512538|FG000|Overall Study|Serious Adverse Event|1|||
155570362|NCT00362336|561512539|FG001|Overall Study|Serious Adverse Event|0|||
155570363|NCT00362336|561512540|FG002|Overall Study|Serious Adverse Event|1|||
155570364|NCT00362336|561512538|FG000|Overall Study|Protocol Violation|0|||
155570365|NCT00362336|561512539|FG001|Overall Study|Protocol Violation|0|||
155570366|NCT00362336|561512540|FG002|Overall Study|Protocol Violation|1|||
155570367|NCT00362336|561512538|FG000|Overall Study|Lost to Follow-up|6|||
155570368|NCT00362336|561512539|FG001|Overall Study|Lost to Follow-up|4|||
155570369|NCT00362336|561512540|FG002|Overall Study|Lost to Follow-up|0|||
155570370|NCT00362336|561512538|FG000|Overall Study|Withdrawal by Subject|3|||
155570371|NCT00362336|561512539|FG001|Overall Study|Withdrawal by Subject|3|||
155570372|NCT00362336|561512540|FG002|Overall Study|Withdrawal by Subject|1|||
155570373|NCT04974749|561512541|FG000|Overall Study|Withdrawal by Subject|2|||
155570374|NCT04974749|561512541|FG000|Overall Study|Gestation|1|||
155570375|NCT04414618|561512542|FG000|Overall Study|Death|3|||
155570376|NCT04414618|561512543|FG001|Overall Study|Death|3|||
155570377|NCT04414618|561512542|FG000|Overall Study|Withdrawal by Subject|2|||
155570378|NCT04414618|561512543|FG001|Overall Study|Withdrawal by Subject|1|||
155570379|NCT04414618|561512542|FG000|Overall Study|Lost to Follow-up|2|||
155570380|NCT04414618|561512543|FG001|Overall Study|Lost to Follow-up|3|||
155570381|NCT04414618|561512542|FG000|Overall Study|Physician Decision|1|||
155570382|NCT04414618|561512543|FG001|Overall Study|Physician Decision|0|||
155570383|NCT00658879|561512544|FG000|Overall Study|Protocol Violation|1|||
155570384|NCT01399658|561512545|FG000|Overall Study|Ineligible|1|||
155570385|NCT01399658|561512545|FG000|Overall Study|Machine Technical Issue|3|||
155570386|NCT01399658|561512545|FG000|Overall Study|Alternative therapy|1|||
155570387|NCT01399658|561512545|FG000|Overall Study|No reason given|1|||
155570388|NCT00796107|561512551|FG000|Overall Study|Lack of Efficacy|1|||
155570389|NCT00796107|561512551|FG000|Overall Study|Progressive Disease|5|||
155570390|NCT02681510|561512559|FG000|Overall Study|Withdrawal by Subject|1|||
155570391|NCT02681510|561512559|FG000|Overall Study|Lost to Follow-up|9|||
155570392|NCT04315506|561512561|FG000|Overall Study|Lost to Follow-up|74|||
155570393|NCT04315506|561512562|FG001|Overall Study|Lost to Follow-up|82|||
155570394|NCT04315506|561512561|FG000|Overall Study|Withdrawal by Subject|8|||
155570395|NCT04315506|561512562|FG001|Overall Study|Withdrawal by Subject|8|||
155570396|NCT04315506|561512561|FG000|Overall Study|Physician Decision|0|||
155570397|NCT04315506|561512562|FG001|Overall Study|Physician Decision|1|||
155570398|NCT02661217|561512565|FG000|Overall Study|Physician Decision|12|||
155570399|NCT02661217|561512566|FG001|Overall Study|Physician Decision|15|||
155570400|NCT02661217|561512565|FG000|Overall Study|Lost to Follow-up|1|||
155570401|NCT02661217|561512566|FG001|Overall Study|Lost to Follow-up|4|||
155570402|NCT02661217|561512565|FG000|Overall Study|Protocol Deviation|0|||
155570403|NCT02661217|561512566|FG001|Overall Study|Protocol Deviation|4|||
155570404|NCT02661217|561512565|FG000|Overall Study|Non-compliance with study treatment|5|||
155570405|NCT02661217|561512566|FG001|Overall Study|Non-compliance with study treatment|5|||
155570406|NCT02661217|561512565|FG000|Overall Study|Death|21|||
155570407|NCT02661217|561512566|FG001|Overall Study|Death|15|||
155570408|NCT02661217|561512565|FG000|Overall Study|Adverse Event|10|||
155570409|NCT02661217|561512566|FG001|Overall Study|Adverse Event|8|||
155570410|NCT02661217|561512565|FG000|Overall Study|Withdrawal by Subject|15|||
155570411|NCT02661217|561512566|FG001|Overall Study|Withdrawal by Subject|19|||
155570412|NCT02661217|561512565|FG000|Overall Study|Did not enter follow-up epoch|7|||
155570413|NCT02661217|561512566|FG001|Overall Study|Did not enter follow-up epoch|10|||
155570414|NCT02661217|561512565|FG000|Overall Study|Death - no study drug received|1|||
155570415|NCT02661217|561512566|FG001|Overall Study|Death - no study drug received|2|||
155570416|NCT02661217|561512565|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
155570417|NCT02661217|561512566|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
155570418|NCT02075515|561512569|FG000|Overall Study|Serious Adverse Event|1|||
155570419|NCT02075515|561512570|FG001|Overall Study|Serious Adverse Event|1|||
155570420|NCT02075515|561512571|FG002|Overall Study|Serious Adverse Event|1|||
155570421|NCT02075515|561512569|FG000|Overall Study|Non-Serious Adverse Event|0|||
155570422|NCT02075515|561512570|FG001|Overall Study|Non-Serious Adverse Event|1|||
155570423|NCT02075515|561512571|FG002|Overall Study|Non-Serious Adverse Event|0|||
155570424|NCT02075515|561512569|FG000|Overall Study|Withdrawal by Subject|2|||
155570425|NCT02075515|561512570|FG001|Overall Study|Withdrawal by Subject|0|||
155570426|NCT02075515|561512571|FG002|Overall Study|Withdrawal by Subject|1|||
155570427|NCT02075515|561512569|FG000|Overall Study|Lost to Follow-up|1|||
155570428|NCT02075515|561512570|FG001|Overall Study|Lost to Follow-up|3|||
155570429|NCT02075515|561512571|FG002|Overall Study|Lost to Follow-up|6|||
155570430|NCT03593395|561512582|FG000|Overall Study|Lost to Follow-up|48|||
155570431|NCT03593395|561512583|FG001|Overall Study|Lost to Follow-up|3|||
155570432|NCT03593395|561512582|FG000|Overall Study|Withdrawal by Subject|5|||
155570433|NCT03593395|561512583|FG001|Overall Study|Withdrawal by Subject|24|||
155570434|NCT03593395|561512582|FG000|Overall Study|Death|2|||
155570435|NCT03593395|561512583|FG001|Overall Study|Death|3|||
155570436|NCT03593395|561512582|FG000|Overall Study|Physician Decision|0|||
155570437|NCT03593395|561512583|FG001|Overall Study|Physician Decision|6|||
155570438|NCT03593395|561512582|FG000|Overall Study|Participant Relocated|19|||
155570439|NCT03593395|561512583|FG001|Overall Study|Participant Relocated|3|||
155570440|NCT03593395|561512582|FG000|Overall Study|No Information|1|||
155570441|NCT03593395|561512583|FG001|Overall Study|No Information|7|||
155570442|NCT02806024|561512584|FG000|Overall Study|Night Delivery|1|||
155570443|NCT02806024|561512585|FG001|Overall Study|Night Delivery|1|||
155570444|NCT02806024|561512584|FG000|Overall Study|DVT during antepartum admission|0|||
155570445|NCT02806024|561512585|FG001|Overall Study|DVT during antepartum admission|1|||
155570446|NCT00626561|561512588|FG000|Overall Study|Withdrawal by Subject|2|||
155570447|NCT00626561|561512588|FG000|Overall Study|Disease Progression|2|||
155570448|NCT01372748|561512591|FG000|Overall Study|Lost to Follow-up|16|||
155570449|NCT01372748|561512592|FG001|Overall Study|Lost to Follow-up|34|||
155570450|NCT01372748|561512591|FG000|Overall Study|Withdrawal by Subject|7|||
155570451|NCT01372748|561512592|FG001|Overall Study|Withdrawal by Subject|5|||
155570452|NCT00134901|561512593|FG000|Overall Study|Lost to Follow-up|5|||
155570453|NCT00134901|561512594|FG001|Overall Study|Lost to Follow-up|5|||
155570454|NCT00134901|561512593|FG000|Overall Study|discontinued intervention|12|||
155570455|NCT00134901|561512594|FG001|Overall Study|discontinued intervention|10|||
155570456|NCT00606632|561512595|FG000|Overall Study|Withdrawal by Subject|13|||
155570457|NCT00606632|561512595|FG000|Overall Study|Miscellaneous reasons|9|||
155570458|NCT03908437|561512596|FG000|Overall Study|Death|0|||
155660635|NCT01276106|561852681|FG002|Overall Study|Adverse Event|11|||
155660636|NCT01276106|561852682|FG003|Overall Study|Adverse Event|3|||
155660637|NCT01276106|561852679|FG000|Overall Study|Withdrawal by Subject|6|||
155570459|NCT03908437|561512597|FG001|Overall Study|Death|1|||
155570460|NCT03908437|561512596|FG000|Overall Study|Lost to Follow-up|31|||
155570461|NCT03908437|561512597|FG001|Overall Study|Lost to Follow-up|24|||
155660638|NCT01276106|561852680|FG001|Overall Study|Withdrawal by Subject|3|||
155660639|NCT01276106|561852681|FG002|Overall Study|Withdrawal by Subject|1|||
155660640|NCT01276106|561852682|FG003|Overall Study|Withdrawal by Subject|6|||
155660641|NCT01276106|561852679|FG000|Overall Study|Lack of Efficacy|0|||
155570462|NCT03633825|561512598|FG000|Enrollment|Did not post on network|5066|||
155570463|NCT03633825|561512599|FG001|Enrollment|Did not post on network|5080|||
155570464|NCT03633825|561512598|FG000|Enrollment|Post not classified as crisis|13967|||
155570465|NCT03633825|561512599|FG001|Enrollment|Post not classified as crisis|13757|||
155570466|NCT03633825|561512598|FG000|Follow up|Lost to Follow-up|478|||
155570467|NCT03633825|561512599|FG001|Follow up|Lost to Follow-up|450|||
155570468|NCT05246670|561512600|FG000|Overall Study|Withdrawal by Subject|2|||
155570469|NCT05246670|561512601|FG001|Overall Study|Withdrawal by Subject|3|||
155660642|NCT01276106|561852680|FG001|Overall Study|Lack of Efficacy|1|||
155570470|NCT05246670|561512602|FG002|Overall Study|Withdrawal by Subject|0|||
155570471|NCT05246670|561512603|FG003|Overall Study|Withdrawal by Subject|1|||
155570472|NCT05246670|561512600|FG000|Overall Study|Adverse Event|0|||
155570473|NCT05246670|561512601|FG001|Overall Study|Adverse Event|0|||
155570474|NCT05246670|561512602|FG002|Overall Study|Adverse Event|1|||
155570475|NCT05246670|561512603|FG003|Overall Study|Adverse Event|0|||
155570476|NCT05246670|561512600|FG000|Overall Study|Physician Decision|1|||
155570477|NCT05246670|561512601|FG001|Overall Study|Physician Decision|0|||
155570478|NCT05246670|561512602|FG002|Overall Study|Physician Decision|0|||
155570479|NCT05246670|561512603|FG003|Overall Study|Physician Decision|0|||
155570480|NCT05246670|561512600|FG000|Overall Study|Protocol Violation|1|||
155570481|NCT05246670|561512601|FG001|Overall Study|Protocol Violation|0|||
155570482|NCT05246670|561512602|FG002|Overall Study|Protocol Violation|0|||
155570483|NCT05246670|561512603|FG003|Overall Study|Protocol Violation|0|||
155570484|NCT03837743|561512604|FG000|Overall Study|Adverse Event|1|||
155570485|NCT03837743|561512604|FG000|Overall Study|Withdrawal by Subject|2|||
155570486|NCT01822366|561512605|FG000|Overall Study|Lost to Follow-up|5|||
155570487|NCT01822366|561512606|FG001|Overall Study|Lost to Follow-up|1|||
155570488|NCT01822366|561512607|FG002|Overall Study|Lost to Follow-up|5|||
155570489|NCT01822366|561512608|FG003|Overall Study|Lost to Follow-up|1|||
155570490|NCT01822366|561512605|FG000|Overall Study|Withdrawal by Subject|0|||
155570491|NCT01822366|561512606|FG001|Overall Study|Withdrawal by Subject|6|||
155570492|NCT01822366|561512607|FG002|Overall Study|Withdrawal by Subject|0|||
155570493|NCT01822366|561512608|FG003|Overall Study|Withdrawal by Subject|6|||
155570494|NCT01822366|561512605|FG000|Overall Study|Partial Intervention Completion|0|||
155570495|NCT01822366|561512606|FG001|Overall Study|Partial Intervention Completion|15|||
155570496|NCT01822366|561512607|FG002|Overall Study|Partial Intervention Completion|0|||
155570497|NCT01822366|561512608|FG003|Overall Study|Partial Intervention Completion|15|||
155570498|NCT05199090|561512609|FG000|Overall Study|Adverse Event|1|||
155570499|NCT05199090|561512610|FG001|Overall Study|Adverse Event|4|||
155570500|NCT05199090|561512611|FG002|Overall Study|Adverse Event|0|||
155570501|NCT05199090|561512612|FG003|Overall Study|Adverse Event|0|||
155570502|NCT05199090|561512613|FG004|Overall Study|Adverse Event|0|||
155570503|NCT05199090|561512614|FG005|Overall Study|Adverse Event|0|||
155570504|NCT05199090|561512609|FG000|Overall Study|Lost to Follow-up|1|||
155570505|NCT05199090|561512610|FG001|Overall Study|Lost to Follow-up|0|||
155570506|NCT05199090|561512611|FG002|Overall Study|Lost to Follow-up|1|||
155570507|NCT05199090|561512612|FG003|Overall Study|Lost to Follow-up|4|||
155570508|NCT05199090|561512613|FG004|Overall Study|Lost to Follow-up|0|||
155570509|NCT05199090|561512614|FG005|Overall Study|Lost to Follow-up|5|||
155570510|NCT05199090|561512609|FG000|Overall Study|Physician Decision|0|||
155570511|NCT05199090|561512610|FG001|Overall Study|Physician Decision|0|||
155570512|NCT05199090|561512611|FG002|Overall Study|Physician Decision|0|||
155570513|NCT05199090|561512612|FG003|Overall Study|Physician Decision|0|||
155570514|NCT05199090|561512613|FG004|Overall Study|Physician Decision|0|||
155570515|NCT05199090|561512614|FG005|Overall Study|Physician Decision|1|||
155570516|NCT05199090|561512609|FG000|Overall Study|Study terminated by sponsor|0|||
155570517|NCT05199090|561512610|FG001|Overall Study|Study terminated by sponsor|6|||
155570518|NCT05199090|561512611|FG002|Overall Study|Study terminated by sponsor|0|||
155570519|NCT05199090|561512612|FG003|Overall Study|Study terminated by sponsor|0|||
155570520|NCT05199090|561512613|FG004|Overall Study|Study terminated by sponsor|0|||
155570521|NCT05199090|561512614|FG005|Overall Study|Study terminated by sponsor|5|||
155570522|NCT05199090|561512609|FG000|Overall Study|Subject decision|0|||
155570523|NCT05199090|561512610|FG001|Overall Study|Subject decision|4|||
155570524|NCT05199090|561512611|FG002|Overall Study|Subject decision|0|||
155570525|NCT05199090|561512612|FG003|Overall Study|Subject decision|2|||
155570526|NCT05199090|561512613|FG004|Overall Study|Subject decision|5|||
155570527|NCT05199090|561512614|FG005|Overall Study|Subject decision|2|||
155570528|NCT03489109|561512615|FG000|Overall Study|Lost to Follow-up|1|||
155660643|NCT01276106|561852681|FG002|Overall Study|Lack of Efficacy|0|||
155660644|NCT01276106|561852682|FG003|Overall Study|Lack of Efficacy|1|||
155660645|NCT01276106|561852679|FG000|Overall Study|Lost to Follow-up|2|||
155570529|NCT03489109|561512616|FG001|Overall Study|Lost to Follow-up|2|||
155570530|NCT04868968|561512619|FG000|Overall Study|Lost to Follow-up|1|||
155570531|NCT00384930|561512620|FG000|Overall Study|Adverse Event|5|||
155570532|NCT00384930|561512621|FG001|Overall Study|Adverse Event|4|||
155570533|NCT00384930|561512622|FG002|Overall Study|Adverse Event|12|||
155570534|NCT00384930|561512623|FG003|Overall Study|Adverse Event|11|||
155570535|NCT00384930|561512624|FG004|Overall Study|Adverse Event|14|||
155570536|NCT00384930|561512620|FG000|Overall Study|Entry Criteria Not Met|2|||
155570537|NCT00384930|561512621|FG001|Overall Study|Entry Criteria Not Met|6|||
155570538|NCT00384930|561512622|FG002|Overall Study|Entry Criteria Not Met|7|||
155570539|NCT00384930|561512623|FG003|Overall Study|Entry Criteria Not Met|8|||
155570540|NCT00384930|561512624|FG004|Overall Study|Entry Criteria Not Met|4|||
155570541|NCT00384930|561512620|FG000|Overall Study|Lack of Efficacy|1|||
155570542|NCT00384930|561512621|FG001|Overall Study|Lack of Efficacy|1|||
155570543|NCT00384930|561512622|FG002|Overall Study|Lack of Efficacy|2|||
155660646|NCT01276106|561852680|FG001|Overall Study|Lost to Follow-up|1|||
155570544|NCT00384930|561512623|FG003|Overall Study|Lack of Efficacy|1|||
155570545|NCT00384930|561512624|FG004|Overall Study|Lack of Efficacy|2|||
155570546|NCT00384930|561512620|FG000|Overall Study|Lost to Follow-up|5|||
155570547|NCT00384930|561512621|FG001|Overall Study|Lost to Follow-up|3|||
155570548|NCT00384930|561512622|FG002|Overall Study|Lost to Follow-up|0|||
155570549|NCT00384930|561512623|FG003|Overall Study|Lost to Follow-up|4|||
155570550|NCT00384930|561512624|FG004|Overall Study|Lost to Follow-up|6|||
155570551|NCT00384930|561512620|FG000|Overall Study|Physician Decision|0|||
155570552|NCT00384930|561512621|FG001|Overall Study|Physician Decision|1|||
155570553|NCT00384930|561512622|FG002|Overall Study|Physician Decision|1|||
155570554|NCT00384930|561512623|FG003|Overall Study|Physician Decision|0|||
155570555|NCT00384930|561512624|FG004|Overall Study|Physician Decision|1|||
155570556|NCT00384930|561512620|FG000|Overall Study|Protocol Violation|1|||
155570557|NCT00384930|561512621|FG001|Overall Study|Protocol Violation|0|||
155570558|NCT00384930|561512622|FG002|Overall Study|Protocol Violation|1|||
155570559|NCT00384930|561512623|FG003|Overall Study|Protocol Violation|6|||
155570560|NCT00384930|561512624|FG004|Overall Study|Protocol Violation|4|||
155570561|NCT00384930|561512620|FG000|Overall Study|Sponsor Decision|3|||
155570562|NCT00384930|561512621|FG001|Overall Study|Sponsor Decision|4|||
155570563|NCT00384930|561512622|FG002|Overall Study|Sponsor Decision|0|||
155570564|NCT00384930|561512623|FG003|Overall Study|Sponsor Decision|5|||
155570565|NCT00384930|561512624|FG004|Overall Study|Sponsor Decision|0|||
155570566|NCT00384930|561512620|FG000|Overall Study|Withdrawal by Subject|9|||
155570567|NCT00384930|561512621|FG001|Overall Study|Withdrawal by Subject|7|||
155570568|NCT00384930|561512622|FG002|Overall Study|Withdrawal by Subject|7|||
155570569|NCT00384930|561512623|FG003|Overall Study|Withdrawal by Subject|6|||
155570570|NCT00384930|561512624|FG004|Overall Study|Withdrawal by Subject|16|||
155570571|NCT00384930|561512620|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
155570572|NCT00384930|561512621|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
155570573|NCT00384930|561512622|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155570574|NCT00384930|561512623|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155570575|NCT00384930|561512624|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155570576|NCT02552732|561512627|FG000|Overall Study|Lost to Follow-up|2|||
155570577|NCT02552732|561512627|FG000|Overall Study|Physician Decision|1|||
155570578|NCT02552732|561512627|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
155570579|NCT02552732|561512627|FG000|Overall Study|Withdrawal by Subject|6|||
155570580|NCT01547130|561512630|FG000|Overall Study|Lost to Follow-up|9|||
155570581|NCT01547130|561512631|FG001|Overall Study|Lost to Follow-up|5|||
155570582|NCT00025259|561512633|FG000|Overall Study|Death|1|||
155570583|NCT00025259|561512634|FG001|Overall Study|Death|3|||
155570584|NCT00025259|561512635|FG002|Overall Study|Death|0|||
155570585|NCT00025259|561512636|FG003|Overall Study|Death|3|||
155570586|NCT00025259|561512637|FG004|Overall Study|Death|0|||
155570587|NCT00025259|561512638|FG005|Overall Study|Death|1|||
155570588|NCT00025259|561512639|FG006|Overall Study|Death|2|||
155570589|NCT00025259|561512633|FG000|Overall Study|Lack of Efficacy|2|||
155570590|NCT00025259|561512634|FG001|Overall Study|Lack of Efficacy|46|||
155570591|NCT00025259|561512635|FG002|Overall Study|Lack of Efficacy|60|||
155570592|NCT00025259|561512636|FG003|Overall Study|Lack of Efficacy|78|||
155570593|NCT00025259|561512637|FG004|Overall Study|Lack of Efficacy|11|||
155570594|NCT00025259|561512638|FG005|Overall Study|Lack of Efficacy|30|||
155570595|NCT00025259|561512639|FG006|Overall Study|Lack of Efficacy|38|||
155570596|NCT00025259|561512633|FG000|Overall Study|Lost to Follow-up|2|||
155570597|NCT00025259|561512634|FG001|Overall Study|Lost to Follow-up|9|||
155570598|NCT00025259|561512635|FG002|Overall Study|Lost to Follow-up|13|||
155570599|NCT00025259|561512636|FG003|Overall Study|Lost to Follow-up|13|||
155570600|NCT00025259|561512637|FG004|Overall Study|Lost to Follow-up|1|||
155570601|NCT00025259|561512638|FG005|Overall Study|Lost to Follow-up|3|||
155570602|NCT00025259|561512639|FG006|Overall Study|Lost to Follow-up|1|||
155570603|NCT00025259|561512633|FG000|Overall Study|Physician Decision|12|||
155570604|NCT00025259|561512634|FG001|Overall Study|Physician Decision|1|||
155570605|NCT00025259|561512635|FG002|Overall Study|Physician Decision|0|||
155570606|NCT00025259|561512636|FG003|Overall Study|Physician Decision|5|||
155570607|NCT00025259|561512637|FG004|Overall Study|Physician Decision|4|||
155570608|NCT00025259|561512638|FG005|Overall Study|Physician Decision|2|||
155570609|NCT00025259|561512639|FG006|Overall Study|Physician Decision|1|||
155570610|NCT00025259|561512633|FG000|Overall Study|Protocol Violation|3|||
155570611|NCT00025259|561512634|FG001|Overall Study|Protocol Violation|2|||
155570612|NCT00025259|561512635|FG002|Overall Study|Protocol Violation|2|||
155570613|NCT00025259|561512636|FG003|Overall Study|Protocol Violation|1|||
155570614|NCT00025259|561512637|FG004|Overall Study|Protocol Violation|2|||
155570615|NCT00025259|561512638|FG005|Overall Study|Protocol Violation|1|||
155570616|NCT00025259|561512639|FG006|Overall Study|Protocol Violation|3|||
155570617|NCT00025259|561512633|FG000|Overall Study|Withdrawal by Subject|9|||
155570618|NCT00025259|561512634|FG001|Overall Study|Withdrawal by Subject|27|||
155570619|NCT00025259|561512635|FG002|Overall Study|Withdrawal by Subject|6|||
155570620|NCT00025259|561512636|FG003|Overall Study|Withdrawal by Subject|14|||
155570621|NCT00025259|561512637|FG004|Overall Study|Withdrawal by Subject|11|||
155570622|NCT00025259|561512638|FG005|Overall Study|Withdrawal by Subject|8|||
155570623|NCT00025259|561512639|FG006|Overall Study|Withdrawal by Subject|3|||
155570624|NCT00025259|561512633|FG000|Overall Study|Ineligible|14|||
155570625|NCT00025259|561512634|FG001|Overall Study|Ineligible|1|||
155570626|NCT00025259|561512635|FG002|Overall Study|Ineligible|0|||
155570627|NCT00025259|561512636|FG003|Overall Study|Ineligible|0|||
155570628|NCT00025259|561512637|FG004|Overall Study|Ineligible|6|||
155570629|NCT00025259|561512638|FG005|Overall Study|Ineligible|0|||
155570630|NCT00025259|561512639|FG006|Overall Study|Ineligible|1|||
155570631|NCT00025259|561512633|FG000|Overall Study|Randomization error|1|||
155570632|NCT00025259|561512634|FG001|Overall Study|Randomization error|0|||
155570633|NCT00025259|561512635|FG002|Overall Study|Randomization error|0|||
155570634|NCT00025259|561512636|FG003|Overall Study|Randomization error|0|||
155570635|NCT00025259|561512637|FG004|Overall Study|Randomization error|1|||
155570636|NCT00025259|561512638|FG005|Overall Study|Randomization error|7|||
155570637|NCT00025259|561512639|FG006|Overall Study|Randomization error|2|||
155570638|NCT00025259|561512633|FG000|Overall Study|Adverse Event|1|||
155570639|NCT00025259|561512634|FG001|Overall Study|Adverse Event|0|||
155570640|NCT00025259|561512635|FG002|Overall Study|Adverse Event|0|||
155570641|NCT00025259|561512636|FG003|Overall Study|Adverse Event|0|||
155570642|NCT00025259|561512637|FG004|Overall Study|Adverse Event|0|||
155570643|NCT00025259|561512638|FG005|Overall Study|Adverse Event|0|||
155570644|NCT00025259|561512639|FG006|Overall Study|Adverse Event|0|||
155570645|NCT01685840|561512640|FG000|Overall Study|Death|77|||
155570646|NCT01685840|561512641|FG001|Overall Study|Death|66|||
155570647|NCT01685840|561512640|FG000|Overall Study|Lost to Follow-up|27|||
155570648|NCT01685840|561512641|FG001|Overall Study|Lost to Follow-up|25|||
155570649|NCT01685840|561512640|FG000|Overall Study|Physician Decision|3|||
155570650|NCT01685840|561512641|FG001|Overall Study|Physician Decision|7|||
155570651|NCT01685840|561512640|FG000|Overall Study|Withdrawal by Subject|14|||
155570652|NCT01685840|561512641|FG001|Overall Study|Withdrawal by Subject|17|||
155570653|NCT01685840|561512640|FG000|Overall Study|Futility|197|||
155570654|NCT01685840|561512641|FG001|Overall Study|Futility|200|||
155570655|NCT01685840|561512640|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
155570656|NCT01685840|561512641|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
155570657|NCT01004003|561512642|FG000|Overall Study|Progressive disease|2|||
155570658|NCT01004003|561512643|FG001|Overall Study|Progressive disease|1|||
155570659|NCT01004003|561512644|FG002|Overall Study|Progressive disease|1|||
155570660|NCT01004003|561512645|FG003|Overall Study|Progressive disease|0|||
155570661|NCT01004003|561512646|FG004|Overall Study|Progressive disease|2|||
155570662|NCT01004003|561512647|FG005|Overall Study|Progressive disease|1|||
155570663|NCT01004003|561512648|FG006|Overall Study|Progressive disease|1|||
155570664|NCT01004003|561512649|FG007|Overall Study|Progressive disease|39|||
155570665|NCT01004003|561512650|FG008|Overall Study|Progressive disease|22|||
155570666|NCT01004003|561512642|FG000|Overall Study|Adverse Event|4|||
155570667|NCT01004003|561512643|FG001|Overall Study|Adverse Event|2|||
155570668|NCT01004003|561512644|FG002|Overall Study|Adverse Event|3|||
155570669|NCT01004003|561512645|FG003|Overall Study|Adverse Event|3|||
155570670|NCT01004003|561512646|FG004|Overall Study|Adverse Event|2|||
155570671|NCT01004003|561512647|FG005|Overall Study|Adverse Event|2|||
155570672|NCT01004003|561512648|FG006|Overall Study|Adverse Event|7|||
155570673|NCT01004003|561512649|FG007|Overall Study|Adverse Event|21|||
155570674|NCT01004003|561512650|FG008|Overall Study|Adverse Event|6|||
155570675|NCT01004003|561512642|FG000|Overall Study|Refused to continue taking trial med.|0|||
155570676|NCT01004003|561512643|FG001|Overall Study|Refused to continue taking trial med.|0|||
155570677|NCT01004003|561512644|FG002|Overall Study|Refused to continue taking trial med.|0|||
155570678|NCT01004003|561512645|FG003|Overall Study|Refused to continue taking trial med.|0|||
155570679|NCT01004003|561512646|FG004|Overall Study|Refused to continue taking trial med.|0|||
155570680|NCT01004003|561512647|FG005|Overall Study|Refused to continue taking trial med.|0|||
155570681|NCT01004003|561512648|FG006|Overall Study|Refused to continue taking trial med.|0|||
155570682|NCT01004003|561512649|FG007|Overall Study|Refused to continue taking trial med.|0|||
155570683|NCT01004003|561512650|FG008|Overall Study|Refused to continue taking trial med.|2|||
155570684|NCT01004003|561512642|FG000|Overall Study|Other|0|||
155570685|NCT01004003|561512643|FG001|Overall Study|Other|0|||
155570686|NCT01004003|561512644|FG002|Overall Study|Other|0|||
155570687|NCT01004003|561512645|FG003|Overall Study|Other|0|||
155570688|NCT01004003|561512646|FG004|Overall Study|Other|0|||
155570689|NCT01004003|561512647|FG005|Overall Study|Other|1|||
155570690|NCT01004003|561512648|FG006|Overall Study|Other|0|||
155570691|NCT01004003|561512649|FG007|Overall Study|Other|0|||
155570692|NCT01004003|561512650|FG008|Overall Study|Other|0|||
155570693|NCT02521376|561512653|FG000|Overall Study|Enrolled, But Not Treated|1|||
155570694|NCT02521376|561512654|FG001|Overall Study|Enrolled, But Not Treated|0|||
155570695|NCT02521376|561512655|FG002|Overall Study|Enrolled, But Not Treated|0|||
155570696|NCT02521376|561512656|FG003|Overall Study|Enrolled, But Not Treated|0|||
155570697|NCT01374269|561512658|FG000|Overall Study|Withdrawal by Subject|4|||
155570698|NCT01374269|561512659|FG001|Overall Study|Withdrawal by Subject|0|||
155570699|NCT01374269|561512658|FG000|Overall Study|Lost to Follow-up|1|||
155570700|NCT01374269|561512659|FG001|Overall Study|Lost to Follow-up|3|||
155570701|NCT01374269|561512658|FG000|Overall Study|closed research|1|||
155570702|NCT01374269|561512659|FG001|Overall Study|closed research|2|||
155570703|NCT01987479|561512660|FG000|Overall Study|Protocol Violation|1|||
155570704|NCT01987479|561512660|FG000|Overall Study|Physician Decision|2|||
155570705|NCT01987479|561512660|FG000|Overall Study|Participant/legal guardian decision|1|||
155570706|NCT01987479|561512660|FG000|Overall Study|Other|5|||
155570707|NCT01987479|561512660|FG000|Overall Study|Lost to Follow-up|1|||
155570708|NCT01987479|561512660|FG000|Overall Study|Adverse Event|7|||
155570709|NCT01954745|561512661|FG000|Overall Study|Radiological Progression|11|||
155570710|NCT01954745|561512661|FG000|Overall Study|Clinical Progression|5|||
155570711|NCT01954745|561512661|FG000|Overall Study|Adverse Event|2|||
155570712|NCT01954745|561512661|FG000|Overall Study|Death|1|||
155570713|NCT03654599|561512664|FG000|Overall Study|Lost to Follow-up|14|||
155570714|NCT03654599|561512665|FG001|Overall Study|Lost to Follow-up|12|||
155570715|NCT03654599|561512664|FG000|Overall Study|Death|8|||
155570716|NCT03654599|561512665|FG001|Overall Study|Death|6|||
155570717|NCT03654599|561512664|FG000|Overall Study|Withdrawal by Subject|6|||
155570718|NCT03654599|561512665|FG001|Overall Study|Withdrawal by Subject|4|||
155570719|NCT03922529|561513972|FG000|Overall Study|Withdrawal by Subject|13|||
155570720|NCT03922529|561513973|FG001|Overall Study|Withdrawal by Subject|12|||
155570721|NCT03922529|561513972|FG000|Overall Study|Death|7|||
155570722|NCT03922529|561513973|FG001|Overall Study|Death|12|||
155570723|NCT03922529|561513972|FG000|Overall Study|Lost to Follow-up|12|||
155570724|NCT03922529|561513973|FG001|Overall Study|Lost to Follow-up|19|||
155570725|NCT03922529|561513972|FG000|Overall Study|Adverse Event|1|||
155570726|NCT03922529|561513973|FG001|Overall Study|Adverse Event|0|||
155570727|NCT03922529|561513972|FG000|Overall Study|Death after withdrawal|1|||
155570728|NCT03922529|561513973|FG001|Overall Study|Death after withdrawal|0|||
155570729|NCT03922529|561513972|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
155570730|NCT03922529|561513973|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
155570731|NCT03922529|561513972|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
155570732|NCT03922529|561513973|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
155570733|NCT03355469|561513976|FG000|Overall Study|COVID-19|3|||
155570734|NCT03355469|561513977|FG001|Overall Study|COVID-19|2|||
155570735|NCT03355469|561513978|FG002|Overall Study|COVID-19|3|||
155570736|NCT03355469|561513979|FG003|Overall Study|COVID-19|3|||
155570737|NCT03355469|561513976|FG000|Overall Study|Lost to Follow-up|1|||
155570738|NCT03355469|561513977|FG001|Overall Study|Lost to Follow-up|0|||
155570739|NCT03355469|561513978|FG002|Overall Study|Lost to Follow-up|1|||
155570740|NCT03355469|561513979|FG003|Overall Study|Lost to Follow-up|0|||
155570741|NCT03355469|561513976|FG000|Overall Study|Withdrawal by Subject|2|||
155570742|NCT03355469|561513977|FG001|Overall Study|Withdrawal by Subject|1|||
155570743|NCT03355469|561513978|FG002|Overall Study|Withdrawal by Subject|0|||
155570744|NCT03355469|561513979|FG003|Overall Study|Withdrawal by Subject|3|||
155570745|NCT02731638|561513980|FG000|Overall Study|Lost to Follow-up|6|||
155570746|NCT02731638|561513981|FG001|Overall Study|Lost to Follow-up|9|||
155570747|NCT04158245|561513982|FG000|Overall Study|Lost to Follow-up|1|||
155570748|NCT02291510|561513983|FG000|Overall Study|Adverse Event|0|||
155570749|NCT02291510|561513984|FG001|Overall Study|Adverse Event|0|||
155570750|NCT02291510|561513985|FG002|Overall Study|Adverse Event|0|||
155570751|NCT02291510|561513986|FG003|Overall Study|Adverse Event|1|||
155570752|NCT02454608|561513987|FG000|Double-Blind Period|Lack of Efficacy|0|||
155570753|NCT02454608|561513988|FG001|Double-Blind Period|Lack of Efficacy|2|||
155570754|NCT02454608|561513989|FG002|Double-Blind Period|Lack of Efficacy|0|||
155570755|NCT02454608|561513987|FG000|Open Label Period|Lost to Follow-up|0|||
155570756|NCT02454608|561513988|FG001|Open Label Period|Lost to Follow-up|0|||
155570757|NCT02454608|561513989|FG002|Open Label Period|Lost to Follow-up|11|||
155570758|NCT02454608|561513987|FG000|Open Label Period|Withdrawal by Subject|0|||
155570759|NCT02454608|561513988|FG001|Open Label Period|Withdrawal by Subject|0|||
155570760|NCT02454608|561513989|FG002|Open Label Period|Withdrawal by Subject|8|||
155570761|NCT02465398|561513990|FG000|Overall Study|Death|7|||
155570762|NCT02465398|561513990|FG000|Overall Study|Revision|7|||
155570763|NCT02465398|561513990|FG000|Overall Study|did not receive study device|1|||
155570764|NCT02465398|561513990|FG000|Overall Study|Withdrawal by Subject|1|||
155570765|NCT02465398|561513990|FG000|Overall Study|Lost to Follow-up|14|||
155570766|NCT02906358|561513991|FG000|Overall Study|Withdrawal by Subject|10|||
155660647|NCT01276106|561852681|FG002|Overall Study|Lost to Follow-up|1|||
155660648|NCT01276106|561852682|FG003|Overall Study|Lost to Follow-up|0|||
155660649|NCT01276106|561852679|FG000|Overall Study|Physician Decision|0|||
155660650|NCT01276106|561852680|FG001|Overall Study|Physician Decision|0|||
155660651|NCT01276106|561852681|FG002|Overall Study|Physician Decision|1|||
155660652|NCT01276106|561852682|FG003|Overall Study|Physician Decision|1|||
155660653|NCT01276106|561852679|FG000|Overall Study|Protocol Violation|1|||
155660654|NCT01276106|561852680|FG001|Overall Study|Protocol Violation|1|||
155660655|NCT01276106|561852681|FG002|Overall Study|Protocol Violation|0|||
155660656|NCT01276106|561852682|FG003|Overall Study|Protocol Violation|2|||
155660657|NCT01276106|561852679|FG000|Overall Study|Insufficient therapeutic effects|0|||
155660658|NCT01276106|561852680|FG001|Overall Study|Insufficient therapeutic effects|0|||
155660659|NCT01276106|561852681|FG002|Overall Study|Insufficient therapeutic effects|2|||
155660660|NCT01276106|561852682|FG003|Overall Study|Insufficient therapeutic effects|0|||
155660661|NCT01242514|561852685|FG000|Overall Study|e.g., project closure|1042|||
155660662|NCT01242514|561852686|FG001|Overall Study|e.g., project closure|305|||
155660663|NCT01242514|561852687|FG002|Overall Study|e.g., project closure|171|||
155660664|NCT01242514|561852685|FG000|Overall Study|Subject decision|33|||
155660665|NCT01242514|561852686|FG001|Overall Study|Subject decision|8|||
155660666|NCT01242514|561852687|FG002|Overall Study|Subject decision|2|||
155660667|NCT01242514|561852685|FG000|Overall Study|Severe non-compliance to protocol|5|||
155660668|NCT01242514|561852686|FG001|Overall Study|Severe non-compliance to protocol|2|||
155660669|NCT01242514|561852687|FG002|Overall Study|Severe non-compliance to protocol|1|||
155660670|NCT01242514|561852685|FG000|Overall Study|Lack of therapeutic response|99|||
155660671|NCT01242514|561852686|FG001|Overall Study|Lack of therapeutic response|16|||
155660672|NCT01242514|561852687|FG002|Overall Study|Lack of therapeutic response|10|||
155660673|NCT01242514|561852685|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
155660674|NCT01242514|561852686|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
155660675|NCT01242514|561852687|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
155660676|NCT01242514|561852685|FG000|Overall Study|Lost to Follow-up|14|||
155660677|NCT01242514|561852686|FG001|Overall Study|Lost to Follow-up|5|||
155660678|NCT01242514|561852687|FG002|Overall Study|Lost to Follow-up|4|||
155660679|NCT01242514|561852685|FG000|Overall Study|Adverse Event|129|||
155660680|NCT01242514|561852686|FG001|Overall Study|Adverse Event|18|||
155660681|NCT01242514|561852687|FG002|Overall Study|Adverse Event|19|||
155660682|NCT00787150|561852689|FG000|Overall Study|Adverse Event|4|||
155660683|NCT00787150|561852690|FG001|Overall Study|Adverse Event|4|||
155660684|NCT00787150|561852691|FG002|Overall Study|Adverse Event|4|||
155660685|NCT00787150|561852689|FG000|Overall Study|Physician Decision|1|||
155660686|NCT00787150|561852690|FG001|Overall Study|Physician Decision|2|||
155660687|NCT00787150|561852691|FG002|Overall Study|Physician Decision|1|||
155660688|NCT00787150|561852689|FG000|Overall Study|Withdrawal by Subject|2|||
155660689|NCT00787150|561852690|FG001|Overall Study|Withdrawal by Subject|1|||
155660690|NCT00787150|561852691|FG002|Overall Study|Withdrawal by Subject|0|||
155660691|NCT00787150|561852689|FG000|Overall Study|Dosing incorrect study durg|2|||
155660692|NCT00787150|561852690|FG001|Overall Study|Dosing incorrect study durg|0|||
155660693|NCT00787150|561852691|FG002|Overall Study|Dosing incorrect study durg|0|||
155660694|NCT01121757|561852698|FG000|First Drug|Death|1|||
155660695|NCT01121757|561852699|FG001|First Drug|Death|0|||
155660696|NCT01121757|561852698|FG000|First Drug|Disease Progression|0|||
155660697|NCT01121757|561852699|FG001|First Drug|Disease Progression|2|||
155660698|NCT01121757|561852698|FG000|Combination|Physician Decision|0|||
155660699|NCT01121757|561852699|FG001|Combination|Physician Decision|1|||
155660700|NCT01121757|561852698|FG000|Combination|Disease Progression|2|||
155660701|NCT01121757|561852699|FG001|Combination|Disease Progression|0|||
155660702|NCT03773484|561852700|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
155660703|NCT05901636|561852713|FG000|Overall Study|Lost to Follow-up|0|||
155660704|NCT05901636|561852714|FG001|Overall Study|Lost to Follow-up|1|||
155660705|NCT05901636|561852715|FG002|Overall Study|Lost to Follow-up|0|||
155660706|NCT05901636|561852716|FG003|Overall Study|Lost to Follow-up|1|||
155660707|NCT05901636|561852717|FG004|Overall Study|Lost to Follow-up|1|||
155660708|NCT05901636|561852718|FG005|Overall Study|Lost to Follow-up|3|||
155660709|NCT05901636|561852719|FG006|Overall Study|Lost to Follow-up|1|||
155660710|NCT05901636|561852713|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
155660711|NCT05901636|561852714|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
155660712|NCT05901636|561852715|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
155660713|NCT05901636|561852716|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
155660714|NCT05901636|561852717|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
155660715|NCT05901636|561852718|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
155660716|NCT05901636|561852719|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
155660717|NCT05901636|561852713|FG000|Overall Study|Withdrawal by Subject|1|||
155660718|NCT05901636|561852714|FG001|Overall Study|Withdrawal by Subject|1|||
155660719|NCT05901636|561852715|FG002|Overall Study|Withdrawal by Subject|0|||
155660720|NCT05901636|561852716|FG003|Overall Study|Withdrawal by Subject|0|||
155660721|NCT05901636|561852717|FG004|Overall Study|Withdrawal by Subject|1|||
155660722|NCT05901636|561852718|FG005|Overall Study|Withdrawal by Subject|1|||
155660723|NCT05901636|561852719|FG006|Overall Study|Withdrawal by Subject|0|||
155660724|NCT05901636|561852713|FG000|Overall Study|Other|0|||
155660725|NCT05901636|561852714|FG001|Overall Study|Other|0|||
155660726|NCT05901636|561852715|FG002|Overall Study|Other|1|||
155660727|NCT05901636|561852716|FG003|Overall Study|Other|1|||
155660728|NCT05901636|561852717|FG004|Overall Study|Other|0|||
155660729|NCT05901636|561852718|FG005|Overall Study|Other|0|||
155660730|NCT05901636|561852719|FG006|Overall Study|Other|0|||
155660731|NCT05211596|561852720|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
155660732|NCT05211596|561852720|FG000|Baseline to 6 Months|Death|1|||
155660733|NCT05211596|561852720|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
155660734|NCT05211596|561852720|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
155660735|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
155660736|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
155660737|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
155660738|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
155660739|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
155660740|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
155660741|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
155660742|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
155660743|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
155660744|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
155660745|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
155660746|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
155660747|NCT04532749|561852721|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
155660748|NCT04532749|561852722|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
155660749|NCT04532749|561852721|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
155660750|NCT04532749|561852722|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
155660751|NCT04532749|561852721|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
155660752|NCT04532749|561852722|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
155660753|NCT04532749|561852721|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
155660754|NCT04532749|561852722|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
155660755|NCT04696146|561854465|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
155660756|NCT04696146|561854466|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
155660757|NCT04696146|561854465|FG000|Overall Study|Off hours issue with product|1|||
155660758|NCT04696146|561854466|FG001|Overall Study|Off hours issue with product|0|||
155660759|NCT01576783|561854467|FG000|Overall Study|Change in Medical Care|1|||
155660760|NCT01576783|561854468|FG001|Overall Study|Change in Medical Care|0|||
155660761|NCT01576783|561854467|FG000|Overall Study|Lost to Follow-up|14|||
155660762|NCT01576783|561854468|FG001|Overall Study|Lost to Follow-up|16|||
155660763|NCT01576783|561854467|FG000|Overall Study|Withdrawal by Subject|5|||
155660764|NCT01576783|561854468|FG001|Overall Study|Withdrawal by Subject|1|||
155660765|NCT05489328|561854469|FG000|Overall Study|Lost to Follow-up|0|||
155660766|NCT05489328|561854470|FG001|Overall Study|Lost to Follow-up|0|||
155660767|NCT05489328|561854471|FG002|Overall Study|Lost to Follow-up|1|||
155660768|NCT05489328|561854472|FG003|Overall Study|Lost to Follow-up|0|||
155660769|NCT05489328|561854473|FG004|Overall Study|Lost to Follow-up|2|||
155660770|NCT05489328|561854474|FG005|Overall Study|Lost to Follow-up|0|||
155660771|NCT05489328|561854475|FG006|Overall Study|Lost to Follow-up|0|||
155660772|NCT05489328|561854476|FG007|Overall Study|Lost to Follow-up|1|||
155660773|NCT05489328|561854477|FG008|Overall Study|Lost to Follow-up|0|||
155660774|NCT05489328|561854469|FG000|Overall Study|Withdrawal by Subject|0|||
155660775|NCT05489328|561854470|FG001|Overall Study|Withdrawal by Subject|0|||
155660776|NCT05489328|561854471|FG002|Overall Study|Withdrawal by Subject|0|||
155660777|NCT05489328|561854472|FG003|Overall Study|Withdrawal by Subject|0|||
155660778|NCT05489328|561854473|FG004|Overall Study|Withdrawal by Subject|0|||
155660779|NCT05489328|561854474|FG005|Overall Study|Withdrawal by Subject|0|||
155660780|NCT05489328|561854475|FG006|Overall Study|Withdrawal by Subject|1|||
155660781|NCT05489328|561854476|FG007|Overall Study|Withdrawal by Subject|1|||
155660782|NCT05489328|561854477|FG008|Overall Study|Withdrawal by Subject|0|||
155660783|NCT05489328|561854469|FG000|Overall Study|Other|0|||
155660784|NCT05489328|561854470|FG001|Overall Study|Other|0|||
155660785|NCT05489328|561854471|FG002|Overall Study|Other|0|||
155660786|NCT05489328|561854472|FG003|Overall Study|Other|0|||
155660787|NCT05489328|561854473|FG004|Overall Study|Other|0|||
155660788|NCT05489328|561854474|FG005|Overall Study|Other|0|||
155660789|NCT05489328|561854475|FG006|Overall Study|Other|0|||
155660790|NCT05489328|561854476|FG007|Overall Study|Other|1|||
155660791|NCT05489328|561854477|FG008|Overall Study|Other|1|||
155660792|NCT01083602|561854478|FG000|Overall Study|Adverse Event|11|||
155660793|NCT01083602|561854478|FG000|Overall Study|New Cancer Therapy|2|||
155660794|NCT01083602|561854478|FG000|Overall Study|Death|1|||
155660795|NCT01083602|561854478|FG000|Overall Study|Withdrawal by Subject|5|||
155570767|NCT02906358|561513992|FG001|Overall Study|Withdrawal by Subject|7|||
155570768|NCT02906358|561513991|FG000|Overall Study|Lost to Follow-up|12|||
155570769|NCT02906358|561513992|FG001|Overall Study|Lost to Follow-up|15|||
155570770|NCT02699684|561513993|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
155570771|NCT02699684|561513994|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
155570772|NCT02111603|561513997|FG000|Overall Study|Withdrawal by Subject|1|||
155570773|NCT01582152|561513998|FG000|Overall Study|Disease Progression|4|||
155570774|NCT01582152|561513999|FG001|Overall Study|Disease Progression|5|||
155570775|NCT01582152|561513998|FG000|Overall Study|Adverse Event|2|||
155570776|NCT01582152|561513999|FG001|Overall Study|Adverse Event|1|||
155570777|NCT02437903|561514000|FG000|Overall Study|Adverse Event|1|||
155570778|NCT02437903|561514000|FG000|Overall Study|Withdrawal by Subject|1|||
155570779|NCT02437903|561514000|FG000|Overall Study|Lost to Follow-up|3|||
155570780|NCT01611857|561514003|FG000|Overall Study|Withdrawal by Subject|0|||
155570781|NCT01611857|561514004|FG001|Overall Study|Withdrawal by Subject|2|||
155570782|NCT02439970|561514005|FG000|Overall Study|Study Terminated|2|||
155570783|NCT02439970|561514006|FG001|Overall Study|Study Terminated|3|||
155570784|NCT00741338|561514009|FG000|Overall Study|Adverse Event|0|||
155570785|NCT00741338|561514010|FG001|Overall Study|Adverse Event|1|||
155570786|NCT01141205|561514011|FG000|Overall Study|Physician Decision|1|||
155570787|NCT01141205|561514012|FG001|Overall Study|Physician Decision|1|||
155570788|NCT01141205|561514011|FG000|Overall Study|Lost to Follow-up|1|||
155570789|NCT01141205|561514012|FG001|Overall Study|Lost to Follow-up|0|||
155570790|NCT01141205|561514011|FG000|Overall Study|Withdrawal by Subject|1|||
155570791|NCT01141205|561514012|FG001|Overall Study|Withdrawal by Subject|1|||
155570792|NCT00534404|561514022|FG000|Overall Study|Death|0|||
155570793|NCT00534404|561514023|FG001|Overall Study|Death|0|||
155570794|NCT00534404|561514024|FG002|Overall Study|Death|2|||
155570795|NCT00534404|561514022|FG000|Overall Study|Withdrawal by Subject|8|||
155570796|NCT00534404|561514023|FG001|Overall Study|Withdrawal by Subject|2|||
155570797|NCT00534404|561514024|FG002|Overall Study|Withdrawal by Subject|38|||
155570798|NCT00534404|561514022|FG000|Overall Study|Removed by study staff|2|||
155570799|NCT00534404|561514023|FG001|Overall Study|Removed by study staff|3|||
155570800|NCT00534404|561514024|FG002|Overall Study|Removed by study staff|1|||
155570801|NCT00534404|561514022|FG000|Overall Study|Lost to Follow-up|170|||
155570802|NCT00534404|561514023|FG001|Overall Study|Lost to Follow-up|138|||
155570803|NCT00534404|561514024|FG002|Overall Study|Lost to Follow-up|201|||
155570804|NCT02996487|561514025|FG000|Overall Study|Lost to Follow-up|1|||
155570805|NCT02996487|561514026|FG001|Overall Study|Lost to Follow-up|1|||
155570806|NCT02996487|561514027|FG002|Overall Study|Lost to Follow-up|0|||
155570807|NCT02996487|561514025|FG000|Overall Study|Death|0|||
155570808|NCT02996487|561514026|FG001|Overall Study|Death|1|||
155570809|NCT02996487|561514027|FG002|Overall Study|Death|0|||
155570810|NCT02996487|561514025|FG000|Overall Study|Withdrawal by Subject|2|||
155570811|NCT02996487|561514026|FG001|Overall Study|Withdrawal by Subject|3|||
155570812|NCT02996487|561514027|FG002|Overall Study|Withdrawal by Subject|0|||
155570813|NCT02027428|561514028|FG000|Induction|Never treated|7|||
155570814|NCT02027428|561514029|FG001|Induction|Never treated|0|||
155570815|NCT02027428|561514030|FG002|Induction|Never treated|0|||
155570816|NCT02027428|561514028|FG000|Induction|Progressive disease|77|||
155570817|NCT02027428|561514029|FG001|Induction|Progressive disease|0|||
155570818|NCT02027428|561514030|FG002|Induction|Progressive disease|0|||
155570819|NCT02027428|561514028|FG000|Induction|Adverse Event|51|||
155570820|NCT02027428|561514029|FG001|Induction|Adverse Event|0|||
155570821|NCT02027428|561514030|FG002|Induction|Adverse Event|0|||
155570822|NCT02027428|561514028|FG000|Induction|Withdrawal by Subject|22|||
155570823|NCT02027428|561514029|FG001|Induction|Withdrawal by Subject|0|||
155570824|NCT02027428|561514030|FG002|Induction|Withdrawal by Subject|0|||
155570825|NCT02027428|561514028|FG000|Induction|Death|21|||
155570826|NCT02027428|561514029|FG001|Induction|Death|0|||
155570827|NCT02027428|561514030|FG002|Induction|Death|0|||
155570828|NCT02027428|561514028|FG000|Induction|Symptomatic deterioration|16|||
155570829|NCT02027428|561514029|FG001|Induction|Symptomatic deterioration|0|||
155570830|NCT02027428|561514030|FG002|Induction|Symptomatic deterioration|0|||
155660796|NCT01083602|561854478|FG000|Overall Study|Lack of Efficacy|36|||
155660797|NCT01359956|561854479|FG000|Overall Study|Death|58|||
155660798|NCT01359956|561854480|FG001|Overall Study|Death|60|||
155570831|NCT02027428|561514028|FG000|Induction|Study terminated by sponsor|12|||
155570832|NCT02027428|561514029|FG001|Induction|Study terminated by sponsor|0|||
155570833|NCT02027428|561514030|FG002|Induction|Study terminated by sponsor|0|||
155570834|NCT02027428|561514028|FG000|Induction|Protocol Violation|1|||
155570835|NCT02027428|561514029|FG001|Induction|Protocol Violation|0|||
155570836|NCT02027428|561514030|FG002|Induction|Protocol Violation|0|||
155570837|NCT02027428|561514028|FG000|Induction|Miscellaneous|14|||
155570838|NCT02027428|561514029|FG001|Induction|Miscellaneous|0|||
155570839|NCT02027428|561514030|FG002|Induction|Miscellaneous|0|||
155570840|NCT02027428|561514028|FG000|Induction|Induction Treatment Ongoing|4|||
155570841|NCT02027428|561514029|FG001|Induction|Induction Treatment Ongoing|0|||
155570842|NCT02027428|561514030|FG002|Induction|Induction Treatment Ongoing|0|||
155570843|NCT02027428|561514028|FG000|Maintenance|Death|0|||
155570844|NCT02027428|561514029|FG001|Maintenance|Death|3|||
155570845|NCT02027428|561514030|FG002|Maintenance|Death|2|||
155570846|NCT02027428|561514028|FG000|Maintenance|Adverse Event|0|||
155570847|NCT02027428|561514029|FG001|Maintenance|Adverse Event|21|||
155570848|NCT02027428|561514030|FG002|Maintenance|Adverse Event|1|||
155570849|NCT02027428|561514028|FG000|Maintenance|Progressive disease|0|||
155570850|NCT02027428|561514029|FG001|Maintenance|Progressive disease|84|||
155570851|NCT02027428|561514030|FG002|Maintenance|Progressive disease|47|||
155570852|NCT02027428|561514028|FG000|Maintenance|Symptomatic deterioration|0|||
155570853|NCT02027428|561514029|FG001|Maintenance|Symptomatic deterioration|4|||
155570854|NCT02027428|561514030|FG002|Maintenance|Symptomatic deterioration|1|||
155570855|NCT02027428|561514028|FG000|Maintenance|Withdrawal by Subject|0|||
155570856|NCT02027428|561514029|FG001|Maintenance|Withdrawal by Subject|6|||
155570857|NCT02027428|561514030|FG002|Maintenance|Withdrawal by Subject|5|||
155570858|NCT02027428|561514028|FG000|Maintenance|Protocol Violation|0|||
155570859|NCT02027428|561514029|FG001|Maintenance|Protocol Violation|0|||
155570860|NCT02027428|561514030|FG002|Maintenance|Protocol Violation|1|||
155570861|NCT02027428|561514028|FG000|Maintenance|Other|0|||
155570862|NCT02027428|561514029|FG001|Maintenance|Other|6|||
155570863|NCT02027428|561514030|FG002|Maintenance|Other|3|||
155570864|NCT02027428|561514028|FG000|Survival Follow-up|Death|0|||
155570865|NCT02027428|561514029|FG001|Survival Follow-up|Death|78|||
155570866|NCT02027428|561514030|FG002|Survival Follow-up|Death|45|||
155570867|NCT02027428|561514028|FG000|Survival Follow-up|Lost to Follow-up|0|||
155570868|NCT02027428|561514029|FG001|Survival Follow-up|Lost to Follow-up|1|||
155570869|NCT02027428|561514030|FG002|Survival Follow-up|Lost to Follow-up|1|||
155570870|NCT01128543|561514034|FG000|Overall Study|Withdrawal by Subject|3|||
155570871|NCT01128543|561514034|FG000|Overall Study|Protocol Violation|1|||
155570872|NCT04487067|561514035|FG000|Overall Study|Adverse Event|3|||
155570873|NCT04487067|561514035|FG000|Overall Study|Death Other Than Progressive Disease|60|||
155570874|NCT04487067|561514035|FG000|Overall Study|Death Due To Progressive Disease|40|||
155570875|NCT04487067|561514035|FG000|Overall Study|Lost to Follow-up|3|||
155570876|NCT04487067|561514035|FG000|Overall Study|Progressive Disease|1|||
155570877|NCT04487067|561514035|FG000|Overall Study|Protocol Violation|3|||
155570878|NCT04487067|561514035|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
155570879|NCT04487067|561514035|FG000|Overall Study|Withdrawal by Subject|15|||
155570880|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
155570881|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
155570882|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
155570883|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Death|1|||
155570884|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Death|3|||
155570885|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Death|1|||
155570886|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
155570887|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
155570888|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
155570889|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
155570890|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
155660799|NCT01359956|561854481|FG002|Overall Study|Death|66|||
155660800|NCT01359956|561854482|FG003|Overall Study|Death|57|||
155570891|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
155570892|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
155570893|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
155570894|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
155570895|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
155570896|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
155570897|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
155570898|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
155570899|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
155570900|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
155570901|NCT00299130|561514036|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
155570902|NCT00299130|561514037|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
155660801|NCT01359956|561854479|FG000|Overall Study|Lost to Follow-up|3|||
155660802|NCT01359956|561854480|FG001|Overall Study|Lost to Follow-up|4|||
155570903|NCT00299130|561514038|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
155570904|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
155570905|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
155570906|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
155570907|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
155570908|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
155570909|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
155660803|NCT01359956|561854481|FG002|Overall Study|Lost to Follow-up|1|||
155570910|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
155570911|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
155570912|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
155570913|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
155570914|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
155570915|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
155570916|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
155570917|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
155570918|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
155570919|NCT00299130|561514036|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
155570920|NCT00299130|561514037|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
155570921|NCT00299130|561514038|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
155570922|NCT00299130|561514036|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
155570923|NCT00299130|561514037|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
155570924|NCT00299130|561514038|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
155570925|NCT00299130|561514036|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
155570926|NCT00299130|561514037|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
155570927|NCT00299130|561514038|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
155570928|NCT00299130|561514036|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
155570929|NCT00299130|561514037|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
155570930|NCT00299130|561514038|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
155570931|NCT03516513|561514039|FG000|Overall Study|Withdrawal by Subject|2|||
155570932|NCT03516513|561514040|FG001|Overall Study|Withdrawal by Subject|2|||
155570933|NCT03516513|561514041|FG002|Overall Study|Withdrawal by Subject|0|||
155570934|NCT03516513|561514042|FG003|Overall Study|Withdrawal by Subject|0|||
155570935|NCT01098487|561514044|FG000|Overall Study|Adverse Event|22|||
155570936|NCT01098487|561514044|FG000|Overall Study|Lack of Efficacy|11|||
155570937|NCT01098487|561514044|FG000|Overall Study|Withdrawal by Subject|7|||
155570938|NCT01098487|561514044|FG000|Overall Study|Lost to Follow-up|3|||
155570939|NCT01098487|561514044|FG000|Overall Study|Physician Decision|1|||
155570940|NCT00345631|561514045|FG000|Overall Study|Withdrawal by Subject|1|||
155570941|NCT00345631|561514046|FG001|Overall Study|Withdrawal by Subject|0|||
155570942|NCT00345631|561514047|FG002|Overall Study|Withdrawal by Subject|1|||
155570943|NCT00345631|561514045|FG000|Overall Study|Adverse Event|0|||
155570944|NCT00345631|561514046|FG001|Overall Study|Adverse Event|1|||
155570945|NCT00345631|561514047|FG002|Overall Study|Adverse Event|0|||
155570946|NCT00345631|561514045|FG000|Overall Study|Lost to Follow-up|3|||
155570947|NCT00345631|561514046|FG001|Overall Study|Lost to Follow-up|7|||
155570948|NCT00345631|561514047|FG002|Overall Study|Lost to Follow-up|4|||
155570949|NCT00345631|561514045|FG000|Overall Study|Other reasons|0|||
155570950|NCT00345631|561514046|FG001|Overall Study|Other reasons|0|||
155570951|NCT00345631|561514047|FG002|Overall Study|Other reasons|1|||
155570952|NCT01589497|561514054|FG000|Overall Study|Withdrawal by Subject|0|||
155570953|NCT01589497|561514055|FG001|Overall Study|Withdrawal by Subject|1|||
155570954|NCT01589497|561514056|FG002|Overall Study|Withdrawal by Subject|0|||
155570955|NCT01589497|561514057|FG003|Overall Study|Withdrawal by Subject|1|||
155570956|NCT01589497|561514054|FG000|Overall Study|Death|1|||
155570957|NCT01589497|561514055|FG001|Overall Study|Death|0|||
155570958|NCT01589497|561514056|FG002|Overall Study|Death|0|||
155570959|NCT01589497|561514057|FG003|Overall Study|Death|0|||
155570960|NCT01589497|561514054|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155570961|NCT01589497|561514055|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155570962|NCT01589497|561514056|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
155570963|NCT01589497|561514057|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155570964|NCT03390426|561514060|FG000|Overall Study|Protocol Violation|0|||
155570965|NCT03390426|561514061|FG001|Overall Study|Protocol Violation|1|||
155570966|NCT00259272|561514068|FG000|Overall Study|Adverse Event|2|||
155570967|NCT00259272|561514069|FG001|Overall Study|Adverse Event|1|||
155570968|NCT00259272|561514070|FG002|Overall Study|Adverse Event|0|||
155570969|NCT00259272|561514071|FG003|Overall Study|Adverse Event|3|||
155570970|NCT00259272|561514068|FG000|Overall Study|Lack of Efficacy|5|||
155570971|NCT00259272|561514069|FG001|Overall Study|Lack of Efficacy|1|||
155570972|NCT00259272|561514070|FG002|Overall Study|Lack of Efficacy|2|||
155570973|NCT00259272|561514071|FG003|Overall Study|Lack of Efficacy|6|||
155570974|NCT00259272|561514068|FG000|Overall Study|Physician Decision|1|||
155570975|NCT00259272|561514069|FG001|Overall Study|Physician Decision|2|||
155570976|NCT00259272|561514070|FG002|Overall Study|Physician Decision|1|||
155570977|NCT00259272|561514071|FG003|Overall Study|Physician Decision|3|||
155570978|NCT00259272|561514068|FG000|Overall Study|Protocol Violation|2|||
155570979|NCT00259272|561514069|FG001|Overall Study|Protocol Violation|0|||
155570980|NCT00259272|561514070|FG002|Overall Study|Protocol Violation|0|||
155570981|NCT00259272|561514071|FG003|Overall Study|Protocol Violation|1|||
155570982|NCT00259272|561514068|FG000|Overall Study|Sponsor Decision|0|||
155570983|NCT00259272|561514069|FG001|Overall Study|Sponsor Decision|1|||
155570984|NCT00259272|561514070|FG002|Overall Study|Sponsor Decision|0|||
155570985|NCT00259272|561514071|FG003|Overall Study|Sponsor Decision|0|||
155570986|NCT00259272|561514068|FG000|Overall Study|Withdrawal by Subject|4|||
155570987|NCT00259272|561514069|FG001|Overall Study|Withdrawal by Subject|2|||
155570988|NCT00259272|561514070|FG002|Overall Study|Withdrawal by Subject|2|||
155570989|NCT00259272|561514071|FG003|Overall Study|Withdrawal by Subject|7|||
155570990|NCT00259272|561514068|FG000|Overall Study|Lost to Follow-up|1|||
155570991|NCT00259272|561514069|FG001|Overall Study|Lost to Follow-up|0|||
155570992|NCT00259272|561514070|FG002|Overall Study|Lost to Follow-up|0|||
155570993|NCT00259272|561514071|FG003|Overall Study|Lost to Follow-up|1|||
155570994|NCT03301623|561514074|FG000|Overall Study|Death|3|||
155570995|NCT03301623|561514075|FG001|Overall Study|Death|1|||
155570996|NCT03301623|561514074|FG000|Overall Study|Withdrawal by Subject|11|||
155570997|NCT03301623|561514075|FG001|Overall Study|Withdrawal by Subject|13|||
155570998|NCT03301623|561514074|FG000|Overall Study|Lost to Follow-up|3|||
155570999|NCT03301623|561514075|FG001|Overall Study|Lost to Follow-up|1|||
155571000|NCT01653912|561514077|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155571001|NCT01653912|561514078|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
155571002|NCT01653912|561514079|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155571003|NCT01653912|561514080|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155571004|NCT01653912|561514081|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155571005|NCT01653912|561514082|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155571006|NCT01653912|561514077|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155571007|NCT01653912|561514078|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155571008|NCT01653912|561514079|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
155571009|NCT01653912|561514080|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155571010|NCT01653912|561514081|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155571011|NCT01653912|561514082|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155571012|NCT01653912|561514077|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155571013|NCT01653912|561514078|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155571014|NCT01653912|561514079|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155571015|NCT01653912|561514080|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
155571016|NCT01653912|561514081|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155571017|NCT01653912|561514082|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155571018|NCT01653912|561514077|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571019|NCT01653912|561514078|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571020|NCT01653912|561514079|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571021|NCT01653912|561514080|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
155571022|NCT01653912|561514081|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571023|NCT01653912|561514082|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571024|NCT01653912|561514077|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155571025|NCT01653912|561514078|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155571026|NCT01653912|561514079|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155571027|NCT01653912|561514080|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155571028|NCT01653912|561514081|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155571029|NCT01653912|561514082|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
155571030|NCT01653912|561514077|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155571031|NCT01653912|561514078|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155571032|NCT01653912|561514079|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155571033|NCT01653912|561514080|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155571034|NCT01653912|561514081|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155571035|NCT01653912|561514082|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
155571036|NCT01653912|561514077|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571037|NCT01653912|561514078|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571038|NCT01653912|561514079|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571039|NCT01653912|561514080|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571040|NCT01653912|561514081|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155571041|NCT01653912|561514082|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
155571042|NCT00708227|561514083|FG000|Overall Study|Physician Decision|0|||
155571043|NCT00708227|561514084|FG001|Overall Study|Physician Decision|3|||
155571044|NCT00708227|561514085|FG002|Overall Study|Physician Decision|1|||
155571045|NCT00708227|561514086|FG003|Overall Study|Physician Decision|2|||
155571046|NCT00708227|561514083|FG000|Overall Study|Withdrawal by Subject|1|||
155571047|NCT00708227|561514084|FG001|Overall Study|Withdrawal by Subject|2|||
155571048|NCT00708227|561514085|FG002|Overall Study|Withdrawal by Subject|0|||
155571049|NCT00708227|561514086|FG003|Overall Study|Withdrawal by Subject|1|||
155571050|NCT04007991|561514087|FG000|Overall Study|Withdrawal by Subject|1|||
155571051|NCT04007991|561514088|FG001|Overall Study|Withdrawal by Subject|1|||
155571052|NCT04007991|561514087|FG000|Overall Study|Physician Decision|1|||
155571053|NCT04007991|561514088|FG001|Overall Study|Physician Decision|1|||
155660804|NCT01359956|561854482|FG003|Overall Study|Lost to Follow-up|1|||
155660805|NCT01784029|561854483|FG000|Overall Study|Lost to Follow-up|19|||
155660806|NCT01784029|561854484|FG001|Overall Study|Lost to Follow-up|20|||
155660807|NCT01784029|561854485|FG002|Overall Study|Lost to Follow-up|22|||
155660808|NCT01209767|561854492|FG000|Overall Study|Withdrawal by Subject|1|||
155660809|NCT01209767|561854492|FG000|Overall Study|Lost to Follow-up|3|||
155660810|NCT02410772|561854496|FG000|Overall Study|Death|3|||
155660811|NCT02410772|561854497|FG001|Overall Study|Death|4|||
155660812|NCT02410772|561854498|FG002|Overall Study|Death|8|||
155660813|NCT02410772|561854496|FG000|Overall Study|Lost to Follow-up|31|||
155660814|NCT02410772|561854497|FG001|Overall Study|Lost to Follow-up|23|||
155660815|NCT02410772|561854498|FG002|Overall Study|Lost to Follow-up|22|||
155660816|NCT02410772|561854496|FG000|Overall Study|Pregnancy|8|||
155660817|NCT02410772|561854497|FG001|Overall Study|Pregnancy|4|||
155660818|NCT02410772|561854498|FG002|Overall Study|Pregnancy|5|||
155660819|NCT02410772|561854496|FG000|Overall Study|Protocol Violation|8|||
155660820|NCT02410772|561854497|FG001|Overall Study|Protocol Violation|8|||
155660821|NCT02410772|561854498|FG002|Overall Study|Protocol Violation|4|||
155660822|NCT02410772|561854496|FG000|Overall Study|Baseline Drug Resistance|49|||
155660823|NCT02410772|561854497|FG001|Overall Study|Baseline Drug Resistance|40|||
155660824|NCT02410772|561854498|FG002|Overall Study|Baseline Drug Resistance|51|||
155660825|NCT02410772|561854496|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
155660826|NCT02410772|561854497|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
155660827|NCT02410772|561854498|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
155660828|NCT02410772|561854496|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
155660829|NCT02410772|561854497|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
155660830|NCT02410772|561854498|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
155660831|NCT04573972|561854499|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
155660832|NCT04573972|561854500|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
155660833|NCT01517984|561854501|FG000|Overall Study|Lost to Follow-up|0|||
155660834|NCT01517984|561854502|FG001|Overall Study|Lost to Follow-up|1|||
155660835|NCT01517984|561854503|FG002|Overall Study|Lost to Follow-up|0|||
155660836|NCT01517984|561854504|FG003|Overall Study|Lost to Follow-up|0|||
155660837|NCT01517984|561854501|FG000|Overall Study|Withdrawal by Subject|1|||
155571054|NCT04007991|561514087|FG000|Overall Study|Non-compliance with Study Drug|0|||
155571055|NCT04007991|561514088|FG001|Overall Study|Non-compliance with Study Drug|1|||
155571056|NCT04007991|561514087|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
155571057|NCT04007991|561514088|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
155571058|NCT04007991|561514087|FG000|Overall Study|Adverse event, non-fatal|5|||
155571059|NCT04007991|561514088|FG001|Overall Study|Adverse event, non-fatal|0|||
155571060|NCT04007991|561514087|FG000|Overall Study|Lost to Follow-up|2|||
155571061|NCT04007991|561514088|FG001|Overall Study|Lost to Follow-up|1|||
155571062|NCT05314816|561514089|FG000|Overall Study|Lost to Follow-up|5|||
155571063|NCT05314816|561514090|FG001|Overall Study|Lost to Follow-up|0|||
155571064|NCT05314816|561514091|FG002|Overall Study|Lost to Follow-up|1|||
155571065|NCT05314816|561514089|FG000|Overall Study|Protocol Violation|13|||
155571066|NCT05314816|561514090|FG001|Overall Study|Protocol Violation|8|||
155571067|NCT05314816|561514091|FG002|Overall Study|Protocol Violation|0|||
155571068|NCT01290302|561516152|FG000|Overall Study|Adverse Event|2|||
155571069|NCT01290302|561516153|FG001|Overall Study|Adverse Event|0|||
155571070|NCT01290302|561516152|FG000|Overall Study|Withdrawal by Subject|1|||
155571071|NCT01290302|561516153|FG001|Overall Study|Withdrawal by Subject|0|||
155571072|NCT01290302|561516152|FG000|Overall Study|Physician Decision|0|||
155571073|NCT01290302|561516153|FG001|Overall Study|Physician Decision|2|||
155571074|NCT01290302|561516152|FG000|Overall Study|Expiration of time for screening window|1|||
155571075|NCT01290302|561516153|FG001|Overall Study|Expiration of time for screening window|0|||
155571076|NCT05938621|561516154|FG000|Overall Study|Lost to Follow-up|1|||
155571077|NCT05938621|561516155|FG001|Overall Study|Lost to Follow-up|5|||
155571078|NCT05938621|561516156|FG002|Overall Study|Lost to Follow-up|2|||
155571079|NCT05938621|561516157|FG003|Overall Study|Lost to Follow-up|2|||
155571080|NCT00678210|561516158|FG000|Overall Study|Adverse Event|1|||
155571081|NCT00678210|561516159|FG001|Overall Study|Adverse Event|2|||
155571082|NCT00678210|561516160|FG002|Overall Study|Adverse Event|3|||
155571083|NCT00678210|561516161|FG003|Overall Study|Adverse Event|3|||
155660838|NCT01517984|561854502|FG001|Overall Study|Withdrawal by Subject|8|||
155660839|NCT01517984|561854503|FG002|Overall Study|Withdrawal by Subject|4|||
155660840|NCT01517984|561854504|FG003|Overall Study|Withdrawal by Subject|1|||
155660841|NCT01517984|561854501|FG000|Overall Study|Screen Failure|4|||
155660842|NCT01517984|561854502|FG001|Overall Study|Screen Failure|0|||
155660843|NCT01517984|561854503|FG002|Overall Study|Screen Failure|0|||
155660844|NCT01517984|561854504|FG003|Overall Study|Screen Failure|0|||
155660845|NCT01517984|561854501|FG000|Overall Study|Ineligible for randomization|0|||
155660846|NCT01517984|561854502|FG001|Overall Study|Ineligible for randomization|14|||
155660847|NCT01517984|561854503|FG002|Overall Study|Ineligible for randomization|0|||
155571084|NCT00678210|561516158|FG000|Overall Study|Lack of Efficacy|2|||
155571085|NCT00678210|561516159|FG001|Overall Study|Lack of Efficacy|3|||
155571086|NCT00678210|561516160|FG002|Overall Study|Lack of Efficacy|1|||
155571087|NCT00678210|561516161|FG003|Overall Study|Lack of Efficacy|9|||
155571088|NCT00678210|561516158|FG000|Overall Study|Lost to Follow-up|4|||
155571089|NCT00678210|561516159|FG001|Overall Study|Lost to Follow-up|2|||
155571090|NCT00678210|561516160|FG002|Overall Study|Lost to Follow-up|0|||
155571091|NCT00678210|561516161|FG003|Overall Study|Lost to Follow-up|1|||
155571092|NCT00678210|561516158|FG000|Overall Study|Withdrawal by Subject|3|||
155571093|NCT00678210|561516159|FG001|Overall Study|Withdrawal by Subject|4|||
155571094|NCT00678210|561516160|FG002|Overall Study|Withdrawal by Subject|1|||
155571095|NCT00678210|561516161|FG003|Overall Study|Withdrawal by Subject|7|||
155571096|NCT00678210|561516158|FG000|Overall Study|Other|1|||
155571097|NCT00678210|561516159|FG001|Overall Study|Other|0|||
155571098|NCT00678210|561516160|FG002|Overall Study|Other|1|||
155571099|NCT00678210|561516161|FG003|Overall Study|Other|0|||
155571100|NCT04825912|561516162|FG000|Overall Study|Death|3|||
155571101|NCT04825912|561516162|FG000|Overall Study|Withdrawal by Subject|1|||
155571102|NCT00459355|561516163|FG000|Overall Study|Subject no longer met inc criteria|20|||
155571103|NCT00459355|561516164|FG001|Overall Study|Subject no longer met inc criteria|18|||
155571104|NCT00618371|561516167|FG000|Overall Study|Withdrawal by Subject|2|||
155571105|NCT03965689|561516168|FG000|Overall Study|Too sick to get study intervention|2|||
155571106|NCT01173120|561516170|FG000|Overall Study|Lack of Efficacy|2|||
155571107|NCT01173120|561516170|FG000|Overall Study|Lost to Follow-up|1|||
155571108|NCT01173120|561516170|FG000|Overall Study|Participant Decision|2|||
155571109|NCT01173120|561516170|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
155571110|NCT01173120|561516170|FG000|Overall Study|Switch-Participant Decision|12|||
155571111|NCT01173120|561516170|FG000|Overall Study|Switch-Difficulty With Device|12|||
155571112|NCT01383707|561516178|FG000|Overall Study|Consent withdrawal|6|||
155571113|NCT01383707|561516178|FG000|Overall Study|Death|19|||
155571114|NCT01383707|561516178|FG000|Overall Study|Other|8|||
155571115|NCT01383707|561516178|FG000|Overall Study|Sponsor's decision|2|||
155571116|NCT01383707|561516178|FG000|Overall Study|Adverse Event|14|||
155571117|NCT01383707|561516178|FG000|Overall Study|Progressive disease|23|||
155571118|NCT02013817|561516181|FG000|Overall Study|Adverse Event|12|||
155571119|NCT02013817|561516181|FG000|Overall Study|Withdrawal by Subject|4|||
155571120|NCT02013817|561516181|FG000|Overall Study|Death|2|||
155571121|NCT02013817|561516181|FG000|Overall Study|Other|9|||
155571122|NCT01434810|561516193|FG000|Overall Study|Did not receive treatment|11|||
155571123|NCT01434810|561516194|FG001|Overall Study|Did not receive treatment|3|||
155571124|NCT01434810|561516193|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
155571125|NCT01434810|561516194|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
155571126|NCT00799825|561516197|FG000|Overall Study|Adverse Event|1|||
155571127|NCT00799825|561516197|FG000|Overall Study|Withdrawal by Subject|6|||
155571128|NCT00799825|561516197|FG000|Overall Study|Lost to Follow-up|38|||
155571129|NCT00799825|561516197|FG000|Overall Study|Pregnancy|3|||
155571130|NCT01121562|561516198|FG000|Overall Study|Objective progression or relapse|8|||
155571131|NCT01121562|561516198|FG000|Overall Study|Withdrawal by Subject|1|||
155571132|NCT01121562|561516198|FG000|Overall Study|Adverse Event|1|||
155571133|NCT01121562|561516198|FG000|Overall Study|Sponsor Decision|1|||
155571134|NCT01121562|561516198|FG000|Overall Study|Met study discontinuation criteria|1|||
155571135|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
155571136|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
155571137|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
155571138|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155571139|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155571140|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
155571141|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
155571142|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
155571143|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155571144|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155571145|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155571146|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155571147|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155571148|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155571149|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155571150|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
155571151|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155571152|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
155571153|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155571154|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155571155|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
155571156|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155571157|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
155571158|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155571159|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155571160|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155571161|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155571162|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
155571163|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155571164|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155571165|NCT03713632|561516199|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
155571166|NCT03713632|561516200|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155571167|NCT03713632|561516201|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155571168|NCT03713632|561516202|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155571169|NCT03713632|561516203|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155571170|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
155571171|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
155571172|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
155571173|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
155571174|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
155571175|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
155571176|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
155571177|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
155571178|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
155571179|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
155571180|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
155571181|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
155571182|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
155571183|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
155571184|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
155571185|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
155571186|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
155571187|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
155571188|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
155571189|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
155571190|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
155571191|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
155571192|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155571193|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155571194|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
155571195|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
155571196|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155571197|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155571198|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155571199|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155571200|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Death|0|||
155571201|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Death|1|||
155571202|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Death|0|||
155571203|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Death|0|||
155571204|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Death|0|||
155571205|NCT03713632|561516199|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155571206|NCT03713632|561516200|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
155571207|NCT03713632|561516201|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155571208|NCT03713632|561516202|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155571209|NCT03713632|561516203|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155571210|NCT03971474|561516207|FG000|Overall Study|Adverse Event|11|||
155571211|NCT03971474|561516208|FG001|Overall Study|Adverse Event|7|||
155571212|NCT03971474|561516207|FG000|Overall Study|Refusal unrelated to adverse event|5|||
155571213|NCT03971474|561516208|FG001|Overall Study|Refusal unrelated to adverse event|1|||
155571214|NCT03971474|561516207|FG000|Overall Study|Progression/relapse|40|||
155571215|NCT03971474|561516208|FG001|Overall Study|Progression/relapse|47|||
155571216|NCT03971474|561516207|FG000|Overall Study|Death|6|||
155571217|NCT03971474|561516208|FG001|Overall Study|Death|3|||
155571218|NCT03971474|561516207|FG000|Overall Study|Other - not protocol specified|5|||
155571219|NCT03971474|561516208|FG001|Overall Study|Other - not protocol specified|4|||
155571220|NCT03971474|561516207|FG000|Overall Study|On treatment|0|||
155571221|NCT03971474|561516208|FG001|Overall Study|On treatment|7|||
155571222|NCT02370238|561516215|FG000|Overall Study|Death|42|||
155571223|NCT02370238|561516216|FG001|Overall Study|Death|35|||
155571224|NCT02370238|561516215|FG000|Overall Study|Lost to Follow-up|1|||
155571225|NCT02370238|561516216|FG001|Overall Study|Lost to Follow-up|3|||
155571226|NCT02370238|561516215|FG000|Overall Study|Withdrawal by Subject|2|||
155571227|NCT02370238|561516216|FG001|Overall Study|Withdrawal by Subject|6|||
155571228|NCT02370238|561516215|FG000|Overall Study|Other|2|||
155571229|NCT02370238|561516216|FG001|Overall Study|Other|1|||
155571230|NCT01153425|561516217|FG000|Overall Study|Withdrawal by Subject|3|||
155571231|NCT01153425|561516218|FG001|Overall Study|Withdrawal by Subject|3|||
155571232|NCT01482312|561516219|FG000|Period 1, 90 Minutes of Wear|Other|1|||
155571233|NCT01482312|561516220|FG001|Period 1, 90 Minutes of Wear|Other|0|||
155571234|NCT01482312|561516221|FG002|Period 1, 90 Minutes of Wear|Other|0|||
155571235|NCT01482312|561516219|FG000|Period 2, 90 Minutes of Wear|Other|1|||
155571236|NCT01482312|561516220|FG001|Period 2, 90 Minutes of Wear|Other|0|||
155571237|NCT01482312|561516221|FG002|Period 2, 90 Minutes of Wear|Other|0|||
155571238|NCT03154125|561516222|FG000|Overall Study|Lost to Follow-up|11|||
155571239|NCT03154125|561516223|FG001|Overall Study|Lost to Follow-up|11|||
155571240|NCT03154125|561516224|FG002|Overall Study|Lost to Follow-up|0|||
155571241|NCT03154125|561516222|FG000|Overall Study|Withdrawal by Subject|49|||
155571242|NCT03154125|561516223|FG001|Overall Study|Withdrawal by Subject|55|||
155571243|NCT03154125|561516224|FG002|Overall Study|Withdrawal by Subject|8|||
155571244|NCT03154125|561516222|FG000|Overall Study|Physician Decision|13|||
155571245|NCT03154125|561516223|FG001|Overall Study|Physician Decision|6|||
155571246|NCT03154125|561516224|FG002|Overall Study|Physician Decision|0|||
155571247|NCT03154125|561516222|FG000|Overall Study|Protocol Violation|3|||
155571248|NCT03154125|561516223|FG001|Overall Study|Protocol Violation|5|||
155571249|NCT03154125|561516224|FG002|Overall Study|Protocol Violation|0|||
155571250|NCT01295320|561516225|FG000|Overall Study|Adverse Event|2|||
155571251|NCT01295320|561516225|FG000|Overall Study|Lost to Follow-up|4|||
155571252|NCT01295320|561516225|FG000|Overall Study|Withdrawal by Subject|2|||
155571253|NCT01295320|561516225|FG000|Overall Study|Subject was bedridden|1|||
155571254|NCT01295320|561516225|FG000|Overall Study|Unable to travel|1|||
155571255|NCT00462904|561516226|FG000|Overall Study|Lost to Follow-up|1|||
155571256|NCT01569295|561516227|FG000|Overall Study|Progressive Disease|75|||
155571257|NCT01569295|561516228|FG001|Overall Study|Progressive Disease|139|||
155571258|NCT01569295|561516227|FG000|Overall Study|Adverse Event|39|||
155571259|NCT01569295|561516228|FG001|Overall Study|Adverse Event|14|||
155571260|NCT01569295|561516227|FG000|Overall Study|Withdrawal by Subject|25|||
155571261|NCT01569295|561516228|FG001|Overall Study|Withdrawal by Subject|12|||
155571262|NCT01569295|561516227|FG000|Overall Study|Death|19|||
155571263|NCT01569295|561516228|FG001|Overall Study|Death|15|||
155571264|NCT01569295|561516227|FG000|Overall Study|Physician Decision|13|||
155571265|NCT01569295|561516228|FG001|Overall Study|Physician Decision|18|||
155571266|NCT01569295|561516227|FG000|Overall Study|Study Terminated by Sponsor|24|||
155571267|NCT01569295|561516228|FG001|Overall Study|Study Terminated by Sponsor|2|||
155571268|NCT01569295|561516227|FG000|Overall Study|Other Reason not Specified|3|||
155571269|NCT01569295|561516228|FG001|Overall Study|Other Reason not Specified|5|||
155571270|NCT01569295|561516227|FG000|Overall Study|Non-Compliance with Study Drug|6|||
155571271|NCT01569295|561516228|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155571272|NCT01569295|561516227|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
155571273|NCT01569295|561516228|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
155571274|NCT01569295|561516227|FG000|Overall Study|Lost to Follow-up|1|||
155571275|NCT01569295|561516228|FG001|Overall Study|Lost to Follow-up|1|||
155571276|NCT02125877|561516229|FG000|Overall Study|Physician Decision|1|||
155571277|NCT02125877|561516230|FG001|Overall Study|Physician Decision|0|||
155571278|NCT02125877|561516229|FG000|Overall Study|Death|0|||
155571279|NCT02125877|561516230|FG001|Overall Study|Death|1|||
155571280|NCT02125877|561516229|FG000|Overall Study|Administrative problems|0|||
155571281|NCT02125877|561516230|FG001|Overall Study|Administrative problems|1|||
155571282|NCT02125877|561516229|FG000|Overall Study|Participant/guardian decision|0|||
155571283|NCT02125877|561516230|FG001|Overall Study|Participant/guardian decision|2|||
155571284|NCT02125877|561516229|FG000|Overall Study|Withdrawal by Subject|2|||
155571285|NCT02125877|561516230|FG001|Overall Study|Withdrawal by Subject|1|||
155571286|NCT02125877|561516229|FG000|Overall Study|Protocol deviation|4|||
155571287|NCT02125877|561516230|FG001|Overall Study|Protocol deviation|1|||
155571288|NCT02125877|561516229|FG000|Overall Study|Adverse Event|6|||
155571289|NCT02125877|561516230|FG001|Overall Study|Adverse Event|4|||
155571290|NCT01973595|561516231|FG000|Washout|Withdrawal by Subject|1|||
155571291|NCT01973595|561516232|FG001|Washout|Withdrawal by Subject|0|||
155571292|NCT01973595|561516233|FG002|Washout|Withdrawal by Subject|1|||
155571293|NCT01973595|561516234|FG003|Washout|Withdrawal by Subject|0|||
155571294|NCT03138655|561516238|FG000|Overall Study|Adverse Event|2|||
155571295|NCT03138655|561516239|FG001|Overall Study|Adverse Event|1|||
155571296|NCT03138655|561516240|FG002|Overall Study|Adverse Event|2|||
155571297|NCT03138655|561516241|FG003|Overall Study|Adverse Event|1|||
155571298|NCT03138655|561516242|FG004|Overall Study|Adverse Event|1|||
155660848|NCT01517984|561854504|FG003|Overall Study|Ineligible for randomization|0|||
155660849|NCT05067335|561854505|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
155571299|NCT03138655|561516243|FG005|Overall Study|Adverse Event|4|||
155571300|NCT03138655|561516244|FG006|Overall Study|Adverse Event|2|||
155571301|NCT03138655|561516245|FG007|Overall Study|Adverse Event|2|||
155571302|NCT03138655|561516238|FG000|Overall Study|Withdrawal by Subject|0|||
155571303|NCT03138655|561516239|FG001|Overall Study|Withdrawal by Subject|1|||
155571304|NCT03138655|561516240|FG002|Overall Study|Withdrawal by Subject|0|||
155660850|NCT05067335|561854506|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
155660851|NCT05067335|561854507|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
155660852|NCT05067335|561854508|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
155660853|NCT05067335|561854505|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
155660854|NCT05067335|561854506|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
155660855|NCT05067335|561854507|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
155660856|NCT05067335|561854508|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
155660857|NCT05067335|561854505|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
155660858|NCT05067335|561854506|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
155660859|NCT05067335|561854507|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
155660860|NCT05067335|561854508|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
155660861|NCT05067335|561854505|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
155660862|NCT05067335|561854506|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155660863|NCT05067335|561854507|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155660864|NCT05067335|561854508|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155660865|NCT05067335|561854505|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155660866|NCT05067335|561854506|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
155660867|NCT05067335|561854507|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155660868|NCT05067335|561854508|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155660869|NCT05067335|561854505|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
155660870|NCT05067335|561854506|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
155660871|NCT05067335|561854507|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
155660872|NCT05067335|561854508|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
155660873|NCT05067335|561854505|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155660874|NCT05067335|561854506|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155660875|NCT05067335|561854507|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
155660876|NCT05067335|561854508|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155660877|NCT05067335|561854505|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155660878|NCT05067335|561854506|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155660879|NCT05067335|561854507|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155660880|NCT05067335|561854508|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
155660881|NCT05067335|561854505|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155660882|NCT05067335|561854506|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155660883|NCT05067335|561854507|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
155660884|NCT05067335|561854508|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155660885|NCT05067335|561854505|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155660886|NCT05067335|561854506|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155660887|NCT05067335|561854507|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
155660888|NCT05067335|561854508|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155660889|NCT02724839|561854509|FG000|Overall Study|Withdrawal by Subject|1|||
155660890|NCT02724839|561854510|FG001|Overall Study|Withdrawal by Subject|1|||
155660891|NCT02724839|561854511|FG002|Overall Study|Withdrawal by Subject|0|||
155660892|NCT02724839|561854509|FG000|Overall Study|Lost to Follow-up|0|||
155660893|NCT02724839|561854510|FG001|Overall Study|Lost to Follow-up|3|||
155571305|NCT03138655|561516241|FG003|Overall Study|Withdrawal by Subject|0|||
155571306|NCT03138655|561516242|FG004|Overall Study|Withdrawal by Subject|0|||
155571307|NCT03138655|561516243|FG005|Overall Study|Withdrawal by Subject|0|||
155571308|NCT03138655|561516244|FG006|Overall Study|Withdrawal by Subject|1|||
155660894|NCT02724839|561854511|FG002|Overall Study|Lost to Follow-up|2|||
155660895|NCT02724839|561854509|FG000|Overall Study|Physician Decision|0|||
155660896|NCT02724839|561854510|FG001|Overall Study|Physician Decision|0|||
155660897|NCT02724839|561854511|FG002|Overall Study|Physician Decision|3|||
155660898|NCT00949533|561854513|FG000|Overall Study|Lost to Follow-up|0|||
155660899|NCT00949533|561854514|FG001|Overall Study|Lost to Follow-up|1|||
155660900|NCT01948427|561854517|FG000|Overall Study|Serious Adverse Event|3|||
155660901|NCT01948427|561854518|FG001|Overall Study|Serious Adverse Event|0|||
155660902|NCT01948427|561854519|FG002|Overall Study|Serious Adverse Event|0|||
155660903|NCT01948427|561854520|FG003|Overall Study|Serious Adverse Event|0|||
155660904|NCT01948427|561854521|FG004|Overall Study|Serious Adverse Event|1|||
155660905|NCT01948427|561854517|FG000|Overall Study|Investigator Request|0|||
155660906|NCT01948427|561854518|FG001|Overall Study|Investigator Request|8|||
155660907|NCT01948427|561854519|FG002|Overall Study|Investigator Request|0|||
155660908|NCT01948427|561854520|FG003|Overall Study|Investigator Request|0|||
155660909|NCT01948427|561854521|FG004|Overall Study|Investigator Request|6|||
155660910|NCT01948427|561854517|FG000|Overall Study|Lost to Follow-up|1|||
155660911|NCT01948427|561854518|FG001|Overall Study|Lost to Follow-up|0|||
155660912|NCT01948427|561854519|FG002|Overall Study|Lost to Follow-up|0|||
155660913|NCT01948427|561854520|FG003|Overall Study|Lost to Follow-up|0|||
155660914|NCT01948427|561854521|FG004|Overall Study|Lost to Follow-up|4|||
155660915|NCT01948427|561854517|FG000|Overall Study|Withdrawal by Subject|2|||
155660916|NCT01948427|561854518|FG001|Overall Study|Withdrawal by Subject|0|||
155660917|NCT01948427|561854519|FG002|Overall Study|Withdrawal by Subject|0|||
155660918|NCT01948427|561854520|FG003|Overall Study|Withdrawal by Subject|0|||
155660919|NCT01948427|561854521|FG004|Overall Study|Withdrawal by Subject|1|||
155660920|NCT01948427|561854517|FG000|Overall Study|Other, Not Specified|1|||
155660921|NCT01948427|561854518|FG001|Overall Study|Other, Not Specified|9|||
155660922|NCT01948427|561854519|FG002|Overall Study|Other, Not Specified|0|||
155660923|NCT01948427|561854520|FG003|Overall Study|Other, Not Specified|0|||
155660924|NCT01948427|561854521|FG004|Overall Study|Other, Not Specified|2|||
155660925|NCT02434081|561854522|FG000|Overall Study|Death (never started treatment)|2|||
155660926|NCT02434081|561854522|FG000|Overall Study|Death|2|||
155660927|NCT02434081|561854522|FG000|Overall Study|Progression|20|||
155660928|NCT02434081|561854522|FG000|Overall Study|Adverse Event|20|||
155660929|NCT02434081|561854522|FG000|Overall Study|Physician Decision|2|||
155660930|NCT02434081|561854522|FG000|Overall Study|Withdrawal by Subject|1|||
155660931|NCT02434081|561854522|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
155660932|NCT02448381|561854529|FG000|Overall Study|Adverse Event|2|||
155660933|NCT02448381|561854530|FG001|Overall Study|Adverse Event|0|||
155660934|NCT02448381|561854529|FG000|Overall Study|Lost to Follow-up|16|||
155660935|NCT02448381|561854530|FG001|Overall Study|Lost to Follow-up|9|||
155660936|NCT02448381|561854529|FG000|Overall Study|Physician Decision|1|||
155660937|NCT02448381|561854530|FG001|Overall Study|Physician Decision|1|||
155660938|NCT02448381|561854529|FG000|Overall Study|Pregnancy|1|||
155660939|NCT02448381|561854530|FG001|Overall Study|Pregnancy|0|||
155660940|NCT02448381|561854529|FG000|Overall Study|Withdrawal by Subject|13|||
155660941|NCT02448381|561854530|FG001|Overall Study|Withdrawal by Subject|9|||
155660942|NCT02448381|561854529|FG000|Overall Study|Noncompliance with Study Procedures|2|||
155660943|NCT02448381|561854530|FG001|Overall Study|Noncompliance with Study Procedures|0|||
155660944|NCT02519842|561854531|FG000|Base Study: Cycle 1|Screening Failure|1|||
155571309|NCT03138655|561516245|FG007|Overall Study|Withdrawal by Subject|0|||
155571310|NCT03138655|561516238|FG000|Overall Study|Reason not Specified|1|||
155571311|NCT03138655|561516239|FG001|Overall Study|Reason not Specified|0|||
155571312|NCT03138655|561516240|FG002|Overall Study|Reason not Specified|0|||
155571313|NCT03138655|561516241|FG003|Overall Study|Reason not Specified|2|||
155571314|NCT03138655|561516242|FG004|Overall Study|Reason not Specified|1|||
155571315|NCT03138655|561516243|FG005|Overall Study|Reason not Specified|1|||
155571316|NCT03138655|561516244|FG006|Overall Study|Reason not Specified|0|||
155571317|NCT03138655|561516245|FG007|Overall Study|Reason not Specified|0|||
155571318|NCT04759768|561516246|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155571319|NCT04759768|561516247|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
155571320|NCT04759768|561516246|FG000|Washout (7 Days)|Physician Decision|0|||
155571321|NCT04759768|561516247|FG001|Washout (7 Days)|Physician Decision|1|||
155571322|NCT04868500|561516248|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
155571323|NCT04868500|561516249|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
155571324|NCT04868500|561516248|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
155571325|NCT04868500|561516249|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
155571326|NCT02859142|561516250|FG000|Overall Study|Adverse Event|1|||
155660945|NCT02519842|561854532|FG001|Base Study: Cycle 1|Screening Failure|1|||
155660946|NCT02519842|561854533|FG002|Base Study: Cycle 1|Screening Failure|0|||
155660947|NCT02519842|561854531|FG000|Base Study: Cycle 1|Adverse Event|1|||
155660948|NCT02519842|561854532|FG001|Base Study: Cycle 1|Adverse Event|0|||
155660949|NCT02519842|561854533|FG002|Base Study: Cycle 1|Adverse Event|0|||
155660950|NCT02519842|561854531|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
155571327|NCT02859142|561516251|FG001|Overall Study|Adverse Event|2|||
155571328|NCT02859142|561516250|FG000|Overall Study|Lost to Follow-up|1|||
155571329|NCT02859142|561516251|FG001|Overall Study|Lost to Follow-up|4|||
155571330|NCT02859142|561516250|FG000|Overall Study|Withdrawal by Subject|2|||
155571331|NCT02859142|561516251|FG001|Overall Study|Withdrawal by Subject|0|||
155571332|NCT02859142|561516250|FG000|Overall Study|Scheduling difficulties|0|||
155571333|NCT02859142|561516251|FG001|Overall Study|Scheduling difficulties|3|||
155571334|NCT02676765|561516252|FG000|Overall Study|Lost to Follow-up|0|||
155571335|NCT02676765|561516253|FG001|Overall Study|Lost to Follow-up|1|||
155571336|NCT03340974|561516254|FG000|Completion of Study -Long Term Follow up|Death|8|||
155571337|NCT03340974|561516255|FG001|Completion of Study -Long Term Follow up|Death|5|||
155571338|NCT03340974|561516256|FG002|Completion of Study -Long Term Follow up|Death|5|||
155571339|NCT03340974|561516257|FG003|Completion of Study -Long Term Follow up|Death|7|||
155571340|NCT03340974|561516254|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
155571341|NCT03340974|561516255|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
155571342|NCT03340974|561516256|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
155571343|NCT03340974|561516257|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
155571344|NCT03340974|561516254|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
155571345|NCT03340974|561516255|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
155571346|NCT03340974|561516256|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
155571347|NCT03340974|561516257|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
155571348|NCT03340974|561516254|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
155571349|NCT03340974|561516255|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
155571350|NCT03340974|561516256|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
155571351|NCT03340974|561516257|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
155571352|NCT02374346|561516261|FG000|Overall Study|operated or discharged during weekend|48|||
155571353|NCT00396565|561516267|FG000|Overall Study|Physician Decision|3|||
155571354|NCT00396565|561516268|FG001|Overall Study|Physician Decision|1|||
155571355|NCT00396565|561516269|FG002|Overall Study|Physician Decision|2|||
155571356|NCT00396565|561516267|FG000|Overall Study|Adverse Event|5|||
155571357|NCT00396565|561516268|FG001|Overall Study|Adverse Event|13|||
155571358|NCT00396565|561516269|FG002|Overall Study|Adverse Event|3|||
155571359|NCT00396565|561516267|FG000|Overall Study|Withdrawal by Subject|8|||
155571360|NCT00396565|561516268|FG001|Overall Study|Withdrawal by Subject|13|||
155571361|NCT00396565|561516269|FG002|Overall Study|Withdrawal by Subject|1|||
155571362|NCT00396565|561516267|FG000|Overall Study|Lack of Efficacy|32|||
155571363|NCT00396565|561516268|FG001|Overall Study|Lack of Efficacy|64|||
155571364|NCT00396565|561516269|FG002|Overall Study|Lack of Efficacy|11|||
155571365|NCT04324021|561516273|FG000|Overall Study|Adverse Event|1|||
155571366|NCT04324021|561516274|FG001|Overall Study|Adverse Event|0|||
155571367|NCT04324021|561516275|FG002|Overall Study|Adverse Event|0|||
155571368|NCT04324021|561516273|FG000|Overall Study|Lack of Efficacy|0|||
155571369|NCT04324021|561516274|FG001|Overall Study|Lack of Efficacy|0|||
155571370|NCT04324021|561516275|FG002|Overall Study|Lack of Efficacy|1|||
155571371|NCT04324021|561516273|FG000|Overall Study|Death|1|||
155571372|NCT04324021|561516274|FG001|Overall Study|Death|1|||
155571373|NCT04324021|561516275|FG002|Overall Study|Death|0|||
155571374|NCT04877457|561516276|FG000|Overall Study|Early termination of study due to low enrollment|2|||
155571375|NCT04877457|561516277|FG001|Overall Study|Early termination of study due to low enrollment|1|||
155571376|NCT02211417|561516278|FG000|Overall Study|Withdrawal by Subject|11|||
155571377|NCT02211417|561516279|FG001|Overall Study|Withdrawal by Subject|8|||
155571378|NCT02211417|561516278|FG000|Overall Study|Protocol Violation|1|||
155571379|NCT02211417|561516279|FG001|Overall Study|Protocol Violation|0|||
155571380|NCT02211417|561516278|FG000|Overall Study|Pregnancy|0|||
155571381|NCT02211417|561516279|FG001|Overall Study|Pregnancy|1|||
155571382|NCT02211417|561516278|FG000|Overall Study|Lost to Follow-up|2|||
155571383|NCT02211417|561516279|FG001|Overall Study|Lost to Follow-up|3|||
155571384|NCT02211417|561516278|FG000|Overall Study|Adverse Event|1|||
155571385|NCT02211417|561516279|FG001|Overall Study|Adverse Event|4|||
155571386|NCT01198132|561516280|FG000|Overall Study|Withdrawal by Subject|4|||
155571387|NCT01198132|561516281|FG001|Overall Study|Withdrawal by Subject|5|||
155571388|NCT01198132|561516280|FG000|Overall Study|Physician Decision|5|||
155571389|NCT01198132|561516281|FG001|Overall Study|Physician Decision|4|||
155571390|NCT01198132|561516280|FG000|Overall Study|Other Unspecified|3|||
155571391|NCT01198132|561516281|FG001|Overall Study|Other Unspecified|6|||
155571392|NCT01198132|561516280|FG000|Overall Study|Lack of Efficacy|2|||
155571393|NCT01198132|561516281|FG001|Overall Study|Lack of Efficacy|3|||
155571394|NCT01198132|561516280|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
155571395|NCT01198132|561516281|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
155571396|NCT01198132|561516280|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
155571397|NCT01198132|561516281|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
155571398|NCT01198132|561516280|FG000|Overall Study|Adverse Event|0|||
155571399|NCT01198132|561516281|FG001|Overall Study|Adverse Event|1|||
155571400|NCT01198132|561516280|FG000|Overall Study|Protocol Violation|1|||
155571401|NCT01198132|561516281|FG001|Overall Study|Protocol Violation|0|||
155571402|NCT00490841|561516282|FG000|Overall Study|Death|5|||
155571403|NCT00490841|561516282|FG000|Overall Study|Withdrawal by Subject|4|||
155571404|NCT00490841|561516282|FG000|Overall Study|Lost to Follow-up|1|||
155571405|NCT00490841|561516282|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
155571406|NCT01277211|561516283|FG000|Overall Study|Adverse Event|60|||
155571407|NCT01277211|561516284|FG001|Overall Study|Adverse Event|22|||
155571408|NCT01277211|561516283|FG000|Overall Study|Pregnancy|9|||
155571409|NCT01277211|561516284|FG001|Overall Study|Pregnancy|4|||
155571410|NCT01277211|561516283|FG000|Overall Study|Lost to Follow-up|14|||
155571411|NCT01277211|561516284|FG001|Overall Study|Lost to Follow-up|9|||
155571412|NCT01277211|561516283|FG000|Overall Study|Did not wish to continue|17|||
155571413|NCT01277211|561516284|FG001|Overall Study|Did not wish to continue|0|||
155571414|NCT01277211|561516283|FG000|Overall Study|Withdrew Consent|9|||
155571415|NCT01277211|561516284|FG001|Overall Study|Withdrew Consent|9|||
155571416|NCT01277211|561516283|FG000|Overall Study|Non-compliance with protocol|13|||
155571417|NCT01277211|561516284|FG001|Overall Study|Non-compliance with protocol|4|||
155571418|NCT01277211|561516283|FG000|Overall Study|Did not meet protocol eligibility|1|||
155571419|NCT01277211|561516284|FG001|Overall Study|Did not meet protocol eligibility|0|||
155571420|NCT01277211|561516283|FG000|Overall Study|Administrative|3|||
155571421|NCT01277211|561516284|FG001|Overall Study|Administrative|0|||
155571422|NCT01277211|561516283|FG000|Overall Study|Pregnancy wish|0|||
155571423|NCT01277211|561516284|FG001|Overall Study|Pregnancy wish|2|||
155571424|NCT01277211|561516283|FG000|Overall Study|Discontinued prior to treatment|24|||
155571425|NCT01277211|561516284|FG001|Overall Study|Discontinued prior to treatment|13|||
155571426|NCT03452943|561516285|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
155571427|NCT03452943|561516286|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
155571428|NCT03452943|561516285|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
155571429|NCT03452943|561516286|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
155571430|NCT03452943|561516285|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
155571431|NCT03452943|561516286|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
155571432|NCT03452943|561516285|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
155571433|NCT03452943|561516286|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
155571434|NCT03452943|561516285|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
155571435|NCT03452943|561516286|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
155571436|NCT03452943|561516285|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
155571437|NCT03452943|561516286|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
155571438|NCT04697069|561516292|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
155571439|NCT04697069|561516293|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
155571440|NCT04697069|561516292|FG000|Overall Study|Study termination|2|||
155571441|NCT04697069|561516293|FG001|Overall Study|Study termination|1|||
155571442|NCT05180227|561516294|FG000|Overall Study|Hypertension at screening|1|||
155571443|NCT05180227|561516294|FG000|Overall Study|Lost to Follow-up|1|||
155571444|NCT01130597|561516296|FG000|Overall Study|Protocol-specified (High K+)|1|||
155571445|NCT01130597|561516296|FG000|Overall Study|Adverse Event|4|||
155571446|NCT01130597|561516296|FG000|Overall Study|Death|1|||
155571447|NCT01130597|561516296|FG000|Overall Study|Protocol Violation|1|||
155571448|NCT03371459|561516297|FG000|Washout|Lost to Follow-up|0|||
155571449|NCT03371459|561516298|FG001|Washout|Lost to Follow-up|1|||
155571450|NCT01885195|561516301|FG000|Overall Study|Adverse Event|29|||
155571451|NCT01885195|561516301|FG000|Overall Study|Death|1|||
155571452|NCT01885195|561516301|FG000|Overall Study|Disease Progression|67|||
155571453|NCT01885195|561516301|FG000|Overall Study|Protocol Deviation|2|||
155571454|NCT01885195|561516301|FG000|Overall Study|Physician Decision|3|||
155571455|NCT01885195|561516301|FG000|Overall Study|Patient/guardian decision|8|||
155571456|NCT02516553|561516302|FG000|Overall Study|Progressive disease|2|||
155571457|NCT02516553|561516303|FG001|Overall Study|Progressive disease|2|||
155571458|NCT02516553|561516304|FG002|Overall Study|Progressive disease|3|||
155571459|NCT02516553|561516305|FG003|Overall Study|Progressive disease|5|||
155571460|NCT02516553|561516306|FG004|Overall Study|Progressive disease|3|||
155571461|NCT02516553|561516307|FG005|Overall Study|Progressive disease|0|||
155571462|NCT02516553|561516308|FG006|Overall Study|Progressive disease|5|||
155571463|NCT02516553|561516309|FG007|Overall Study|Progressive disease|5|||
155571464|NCT02516553|561516310|FG008|Overall Study|Progressive disease|11|||
155571465|NCT02516553|561516311|FG009|Overall Study|Progressive disease|3|||
155571466|NCT02516553|561516312|FG010|Overall Study|Progressive disease|10|||
155571467|NCT02516553|561516313|FG011|Overall Study|Progressive disease|8|||
155571468|NCT02516553|561516314|FG012|Overall Study|Progressive disease|8|||
155571469|NCT02516553|561516315|FG013|Overall Study|Progressive disease|2|||
155571470|NCT02516553|561516316|FG014|Overall Study|Progressive disease|2|||
155571471|NCT02516553|561516317|FG015|Overall Study|Progressive disease|2|||
155571472|NCT02516553|561516318|FG016|Overall Study|Progressive disease|1|||
155571473|NCT02516553|561516319|FG017|Overall Study|Progressive disease|9|||
155571474|NCT02516553|561516320|FG018|Overall Study|Progressive disease|12|||
155571475|NCT02516553|561516321|FG019|Overall Study|Progressive disease|7|||
155571476|NCT02516553|561516322|FG020|Overall Study|Progressive disease|16|||
155571477|NCT02516553|561516323|FG021|Overall Study|Progressive disease|18|||
155571478|NCT02516553|561516302|FG000|Overall Study|Dose limiting toxicity|0|||
155571479|NCT02516553|561516303|FG001|Overall Study|Dose limiting toxicity|0|||
155571480|NCT02516553|561516304|FG002|Overall Study|Dose limiting toxicity|0|||
155571481|NCT02516553|561516305|FG003|Overall Study|Dose limiting toxicity|0|||
155571482|NCT02516553|561516306|FG004|Overall Study|Dose limiting toxicity|3|||
155571483|NCT02516553|561516307|FG005|Overall Study|Dose limiting toxicity|1|||
155571484|NCT02516553|561516308|FG006|Overall Study|Dose limiting toxicity|1|||
155571485|NCT02516553|561516309|FG007|Overall Study|Dose limiting toxicity|0|||
155571486|NCT02516553|561516310|FG008|Overall Study|Dose limiting toxicity|1|||
155571487|NCT02516553|561516311|FG009|Overall Study|Dose limiting toxicity|0|||
155571488|NCT02516553|561516312|FG010|Overall Study|Dose limiting toxicity|0|||
155571489|NCT02516553|561516313|FG011|Overall Study|Dose limiting toxicity|1|||
155571490|NCT02516553|561516314|FG012|Overall Study|Dose limiting toxicity|0|||
155571491|NCT02516553|561516315|FG013|Overall Study|Dose limiting toxicity|1|||
155571492|NCT02516553|561516316|FG014|Overall Study|Dose limiting toxicity|0|||
155571493|NCT02516553|561516317|FG015|Overall Study|Dose limiting toxicity|0|||
155571494|NCT02516553|561516318|FG016|Overall Study|Dose limiting toxicity|1|||
155571495|NCT02516553|561516319|FG017|Overall Study|Dose limiting toxicity|1|||
155571496|NCT02516553|561516320|FG018|Overall Study|Dose limiting toxicity|0|||
155571497|NCT02516553|561516321|FG019|Overall Study|Dose limiting toxicity|2|||
155571498|NCT02516553|561516322|FG020|Overall Study|Dose limiting toxicity|0|||
155571499|NCT02516553|561516323|FG021|Overall Study|Dose limiting toxicity|0|||
155571500|NCT02516553|561516302|FG000|Overall Study|Other Adverse Events|0|||
155571501|NCT02516553|561516303|FG001|Overall Study|Other Adverse Events|0|||
155571502|NCT02516553|561516304|FG002|Overall Study|Other Adverse Events|0|||
155571503|NCT02516553|561516305|FG003|Overall Study|Other Adverse Events|1|||
155571504|NCT02516553|561516306|FG004|Overall Study|Other Adverse Events|0|||
155571505|NCT02516553|561516307|FG005|Overall Study|Other Adverse Events|1|||
155571506|NCT02516553|561516308|FG006|Overall Study|Other Adverse Events|0|||
155571507|NCT02516553|561516309|FG007|Overall Study|Other Adverse Events|0|||
155571508|NCT02516553|561516310|FG008|Overall Study|Other Adverse Events|0|||
155571509|NCT02516553|561516311|FG009|Overall Study|Other Adverse Events|1|||
155571510|NCT02516553|561516312|FG010|Overall Study|Other Adverse Events|3|||
155571511|NCT02516553|561516313|FG011|Overall Study|Other Adverse Events|2|||
155571512|NCT02516553|561516314|FG012|Overall Study|Other Adverse Events|0|||
155571513|NCT02516553|561516315|FG013|Overall Study|Other Adverse Events|1|||
155571514|NCT02516553|561516316|FG014|Overall Study|Other Adverse Events|0|||
155571515|NCT02516553|561516317|FG015|Overall Study|Other Adverse Events|0|||
155571516|NCT02516553|561516318|FG016|Overall Study|Other Adverse Events|0|||
155571517|NCT02516553|561516319|FG017|Overall Study|Other Adverse Events|2|||
155571518|NCT02516553|561516320|FG018|Overall Study|Other Adverse Events|1|||
155571519|NCT02516553|561516321|FG019|Overall Study|Other Adverse Events|2|||
155571520|NCT02516553|561516322|FG020|Overall Study|Other Adverse Events|2|||
155571521|NCT02516553|561516323|FG021|Overall Study|Other Adverse Events|1|||
155571522|NCT02516553|561516302|FG000|Overall Study|Refused to continue trial medication|0|||
155571523|NCT02516553|561516303|FG001|Overall Study|Refused to continue trial medication|0|||
155571524|NCT02516553|561516304|FG002|Overall Study|Refused to continue trial medication|0|||
155571525|NCT02516553|561516305|FG003|Overall Study|Refused to continue trial medication|0|||
155571526|NCT02516553|561516306|FG004|Overall Study|Refused to continue trial medication|0|||
155571527|NCT02516553|561516307|FG005|Overall Study|Refused to continue trial medication|0|||
155571528|NCT02516553|561516308|FG006|Overall Study|Refused to continue trial medication|0|||
155660951|NCT02519842|561854532|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
155660952|NCT02519842|561854533|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
155571529|NCT02516553|561516309|FG007|Overall Study|Refused to continue trial medication|0|||
155571530|NCT02516553|561516310|FG008|Overall Study|Refused to continue trial medication|0|||
155571531|NCT02516553|561516311|FG009|Overall Study|Refused to continue trial medication|0|||
155571532|NCT02516553|561516312|FG010|Overall Study|Refused to continue trial medication|1|||
155571533|NCT02516553|561516313|FG011|Overall Study|Refused to continue trial medication|0|||
155571534|NCT02516553|561516314|FG012|Overall Study|Refused to continue trial medication|0|||
155571535|NCT02516553|561516315|FG013|Overall Study|Refused to continue trial medication|0|||
155571536|NCT02516553|561516316|FG014|Overall Study|Refused to continue trial medication|0|||
155571537|NCT02516553|561516317|FG015|Overall Study|Refused to continue trial medication|0|||
155571538|NCT02516553|561516318|FG016|Overall Study|Refused to continue trial medication|0|||
155571539|NCT02516553|561516319|FG017|Overall Study|Refused to continue trial medication|0|||
155571540|NCT02516553|561516320|FG018|Overall Study|Refused to continue trial medication|1|||
155571541|NCT02516553|561516321|FG019|Overall Study|Refused to continue trial medication|0|||
155571542|NCT02516553|561516322|FG020|Overall Study|Refused to continue trial medication|0|||
155571543|NCT02516553|561516323|FG021|Overall Study|Refused to continue trial medication|1|||
155571544|NCT02516553|561516302|FG000|Overall Study|other reasons than listed|0|||
155571545|NCT02516553|561516303|FG001|Overall Study|other reasons than listed|0|||
155571546|NCT02516553|561516304|FG002|Overall Study|other reasons than listed|0|||
155571547|NCT02516553|561516305|FG003|Overall Study|other reasons than listed|0|||
155571548|NCT02516553|561516306|FG004|Overall Study|other reasons than listed|0|||
155571549|NCT02516553|561516307|FG005|Overall Study|other reasons than listed|0|||
155571550|NCT02516553|561516308|FG006|Overall Study|other reasons than listed|0|||
155571551|NCT02516553|561516309|FG007|Overall Study|other reasons than listed|1|||
155571552|NCT02516553|561516310|FG008|Overall Study|other reasons than listed|1|||
155571553|NCT02516553|561516311|FG009|Overall Study|other reasons than listed|0|||
155571554|NCT02516553|561516312|FG010|Overall Study|other reasons than listed|1|||
155571555|NCT02516553|561516313|FG011|Overall Study|other reasons than listed|1|||
155571556|NCT02516553|561516314|FG012|Overall Study|other reasons than listed|0|||
155571557|NCT02516553|561516315|FG013|Overall Study|other reasons than listed|0|||
155571558|NCT02516553|561516316|FG014|Overall Study|other reasons than listed|0|||
155571559|NCT02516553|561516317|FG015|Overall Study|other reasons than listed|0|||
155660953|NCT02519842|561854531|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
155571560|NCT02516553|561516318|FG016|Overall Study|other reasons than listed|0|||
155571561|NCT02516553|561516319|FG017|Overall Study|other reasons than listed|0|||
155571562|NCT02516553|561516320|FG018|Overall Study|other reasons than listed|0|||
155571563|NCT02516553|561516321|FG019|Overall Study|other reasons than listed|0|||
155571564|NCT02516553|561516322|FG020|Overall Study|other reasons than listed|2|||
155571565|NCT02516553|561516323|FG021|Overall Study|other reasons than listed|2|||
155571566|NCT04614246|561516324|FG000|Overall Study|Adverse Event|0|||
155571567|NCT04614246|561516325|FG001|Overall Study|Adverse Event|1|||
155571568|NCT04614246|561516326|FG002|Overall Study|Adverse Event|1|||
155571569|NCT04614246|561516327|FG003|Overall Study|Adverse Event|2|||
155571570|NCT04614246|561516328|FG004|Overall Study|Adverse Event|1|||
155571571|NCT04614246|561516324|FG000|Overall Study|Lost to Follow-up|0|||
155571572|NCT04614246|561516325|FG001|Overall Study|Lost to Follow-up|1|||
155571573|NCT04614246|561516326|FG002|Overall Study|Lost to Follow-up|0|||
155571574|NCT04614246|561516327|FG003|Overall Study|Lost to Follow-up|1|||
155571575|NCT04614246|561516328|FG004|Overall Study|Lost to Follow-up|3|||
155571576|NCT04614246|561516324|FG000|Overall Study|Other reason|0|||
155571577|NCT04614246|561516325|FG001|Overall Study|Other reason|1|||
155571578|NCT04614246|561516326|FG002|Overall Study|Other reason|2|||
155571579|NCT04614246|561516327|FG003|Overall Study|Other reason|0|||
155571580|NCT04614246|561516328|FG004|Overall Study|Other reason|0|||
155571581|NCT04614246|561516324|FG000|Overall Study|Withdrawal by Subject|4|||
155571582|NCT04614246|561516325|FG001|Overall Study|Withdrawal by Subject|2|||
155571583|NCT04614246|561516326|FG002|Overall Study|Withdrawal by Subject|4|||
155571584|NCT04614246|561516327|FG003|Overall Study|Withdrawal by Subject|3|||
155571585|NCT04614246|561516328|FG004|Overall Study|Withdrawal by Subject|4|||
155571586|NCT04614246|561516324|FG000|Overall Study|Physician Decision|0|||
155571587|NCT04614246|561516325|FG001|Overall Study|Physician Decision|2|||
155571588|NCT04614246|561516326|FG002|Overall Study|Physician Decision|1|||
155571589|NCT04614246|561516327|FG003|Overall Study|Physician Decision|0|||
155571590|NCT04614246|561516328|FG004|Overall Study|Physician Decision|0|||
155571591|NCT04614246|561516324|FG000|Overall Study|Study terminated by sponsor|10|||
155571592|NCT04614246|561516325|FG001|Overall Study|Study terminated by sponsor|15|||
155571593|NCT04614246|561516326|FG002|Overall Study|Study terminated by sponsor|12|||
155571594|NCT04614246|561516327|FG003|Overall Study|Study terminated by sponsor|13|||
155571595|NCT04614246|561516328|FG004|Overall Study|Study terminated by sponsor|9|||
155571596|NCT04614246|561516324|FG000|Overall Study|Pregnancy|2|||
155571597|NCT04614246|561516325|FG001|Overall Study|Pregnancy|0|||
155571598|NCT04614246|561516326|FG002|Overall Study|Pregnancy|1|||
155571599|NCT04614246|561516327|FG003|Overall Study|Pregnancy|0|||
155571600|NCT04614246|561516328|FG004|Overall Study|Pregnancy|0|||
155571601|NCT02185053|561516329|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
155571602|NCT02185053|561516330|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
155571603|NCT02185053|561516331|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
155571604|NCT02185053|561516329|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
155571605|NCT02185053|561516330|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155571606|NCT02185053|561516331|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155571607|NCT02185053|561516329|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
155571608|NCT02185053|561516330|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
155571609|NCT02185053|561516331|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
155571610|NCT02185053|561516329|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
155571611|NCT02185053|561516330|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
155571612|NCT02185053|561516331|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
155571613|NCT02185053|561516329|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155571614|NCT02185053|561516330|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
155571615|NCT02185053|561516331|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155571616|NCT02185053|561516329|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
155571617|NCT02185053|561516330|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
155571618|NCT02185053|561516331|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
155571619|NCT02185053|561516329|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
155571620|NCT02185053|561516330|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
155571621|NCT02185053|561516331|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
155571622|NCT02185053|561516329|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
155571623|NCT02185053|561516330|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
155660954|NCT02519842|561854532|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
155571624|NCT02185053|561516331|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
155571625|NCT00340678|561516337|FG000|Overall Study|Lost to Follow-up|1|||
155571626|NCT00340678|561516338|FG001|Overall Study|Lost to Follow-up|0|||
155571627|NCT00340678|561516339|FG002|Overall Study|Lost to Follow-up|0|||
155571628|NCT00340678|561516340|FG003|Overall Study|Lost to Follow-up|0|||
155571629|NCT00996892|561516344|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
155571630|NCT00996892|561516345|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
155571631|NCT00996892|561516346|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
155571632|NCT00996892|561516347|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
155571633|NCT00996892|561516348|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
155571634|NCT00996892|561516349|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
155660955|NCT02519842|561854533|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
155571635|NCT00996892|561516350|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
155571636|NCT00996892|561516351|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
155571637|NCT00996892|561516352|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
155571638|NCT00996892|561516353|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
155571639|NCT00996892|561516354|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
155571640|NCT00996892|561516355|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
155571641|NCT00996892|561516356|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
155571642|NCT00996892|561516357|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
155571643|NCT00996892|561516358|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
155571644|NCT00996892|561516359|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
155571645|NCT00996892|561516360|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
155571646|NCT00996892|561516361|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
155571647|NCT00996892|561516362|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
155571648|NCT00996892|561516363|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
155571649|NCT00996892|561516344|FG000|Dose-Escalation Stage 1|Death|1|||
155571650|NCT00996892|561516345|FG001|Dose-Escalation Stage 1|Death|0|||
155571651|NCT00996892|561516346|FG002|Dose-Escalation Stage 1|Death|0|||
155571652|NCT00996892|561516347|FG003|Dose-Escalation Stage 1|Death|0|||
155571653|NCT00996892|561516348|FG004|Dose-Escalation Stage 1|Death|0|||
155571654|NCT00996892|561516349|FG005|Dose-Escalation Stage 1|Death|1|||
155571655|NCT00996892|561516350|FG006|Dose-Escalation Stage 1|Death|0|||
155571656|NCT00996892|561516351|FG007|Dose-Escalation Stage 1|Death|0|||
155571657|NCT00996892|561516352|FG008|Dose-Escalation Stage 1|Death|0|||
155571658|NCT00996892|561516353|FG009|Dose-Escalation Stage 1|Death|0|||
155571659|NCT00996892|561516354|FG010|Dose-Escalation Stage 1|Death|0|||
155571660|NCT00996892|561516355|FG011|Dose-Escalation Stage 1|Death|0|||
155571661|NCT00996892|561516356|FG012|Dose-Escalation Stage 1|Death|0|||
155571662|NCT00996892|561516357|FG013|Dose-Escalation Stage 1|Death|0|||
155571663|NCT00996892|561516358|FG014|Dose-Escalation Stage 1|Death|0|||
155571664|NCT00996892|561516359|FG015|Dose-Escalation Stage 1|Death|0|||
155571665|NCT00996892|561516360|FG016|Dose-Escalation Stage 1|Death|0|||
155571666|NCT00996892|561516361|FG017|Dose-Escalation Stage 1|Death|0|||
155571667|NCT00996892|561516362|FG018|Dose-Escalation Stage 1|Death|0|||
155571668|NCT00996892|561516363|FG019|Dose-Escalation Stage 1|Death|0|||
155571669|NCT00996892|561516344|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
155571670|NCT00996892|561516345|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
155571671|NCT00996892|561516346|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
155571672|NCT00996892|561516347|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
155571673|NCT00996892|561516348|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
155571674|NCT00996892|561516349|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
155571675|NCT00996892|561516350|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
155571676|NCT00996892|561516351|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
155571677|NCT00996892|561516352|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
155571678|NCT00996892|561516353|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
155571679|NCT00996892|561516354|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
155571680|NCT00996892|561516355|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
155571681|NCT00996892|561516356|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
155571682|NCT00996892|561516357|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
155571683|NCT00996892|561516358|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
155571684|NCT00996892|561516359|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
155571685|NCT00996892|561516360|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
155571686|NCT00996892|561516361|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
155571687|NCT00996892|561516362|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
155571688|NCT00996892|561516363|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
155571689|NCT00996892|561516344|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571690|NCT00996892|561516345|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155571691|NCT00996892|561516346|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571692|NCT00996892|561516347|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
155571693|NCT00996892|561516348|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155571694|NCT00996892|561516349|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155571695|NCT00996892|561516350|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155571696|NCT00996892|561516351|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571697|NCT00996892|561516352|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571698|NCT00996892|561516353|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571699|NCT00996892|561516354|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571700|NCT00996892|561516355|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571701|NCT00996892|561516356|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571702|NCT00996892|561516357|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571703|NCT00996892|561516358|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571704|NCT00996892|561516359|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571705|NCT00996892|561516360|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571706|NCT00996892|561516361|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571707|NCT00996892|561516362|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571708|NCT00996892|561516363|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155571709|NCT00996892|561516344|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
155571710|NCT00996892|561516345|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
155571711|NCT00996892|561516346|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
155571712|NCT00996892|561516347|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
155571713|NCT00996892|561516348|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
155571714|NCT00996892|561516349|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
155571715|NCT00996892|561516350|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
155571716|NCT00996892|561516351|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
155571717|NCT00996892|561516352|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
155571718|NCT00996892|561516353|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
155571719|NCT00996892|561516354|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
155571720|NCT00996892|561516355|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
155571721|NCT00996892|561516356|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
155571722|NCT00996892|561516357|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
155571723|NCT00996892|561516358|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
155571724|NCT00996892|561516359|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
155571725|NCT00996892|561516360|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
155571726|NCT00996892|561516361|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
155571727|NCT00996892|561516362|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
155571728|NCT00996892|561516363|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
155571729|NCT00996892|561516344|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
155571730|NCT00996892|561516345|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
155571731|NCT00996892|561516346|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
155571732|NCT00996892|561516347|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
155571733|NCT00996892|561516348|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
155571734|NCT00996892|561516349|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
155571735|NCT00996892|561516350|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
155571736|NCT00996892|561516351|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
155571737|NCT00996892|561516352|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
155571738|NCT00996892|561516353|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
155571739|NCT00996892|561516354|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
155571740|NCT00996892|561516355|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
155571741|NCT00996892|561516356|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
155571742|NCT00996892|561516357|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
155571743|NCT00996892|561516358|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
155571744|NCT00996892|561516359|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
155571745|NCT00996892|561516360|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
155571746|NCT00996892|561516361|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
155571747|NCT00996892|561516362|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
155571748|NCT00996892|561516363|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
155571749|NCT00996892|561516344|FG000|Dose-Escalation Stage 1A|Death|0|||
155571750|NCT00996892|561516345|FG001|Dose-Escalation Stage 1A|Death|0|||
155571751|NCT00996892|561516346|FG002|Dose-Escalation Stage 1A|Death|0|||
155571752|NCT00996892|561516347|FG003|Dose-Escalation Stage 1A|Death|0|||
155571753|NCT00996892|561516348|FG004|Dose-Escalation Stage 1A|Death|0|||
155571754|NCT00996892|561516349|FG005|Dose-Escalation Stage 1A|Death|0|||
155571755|NCT00996892|561516350|FG006|Dose-Escalation Stage 1A|Death|0|||
155571756|NCT00996892|561516351|FG007|Dose-Escalation Stage 1A|Death|0|||
155571757|NCT00996892|561516352|FG008|Dose-Escalation Stage 1A|Death|0|||
155571758|NCT00996892|561516353|FG009|Dose-Escalation Stage 1A|Death|2|||
155571759|NCT00996892|561516354|FG010|Dose-Escalation Stage 1A|Death|0|||
155571760|NCT00996892|561516355|FG011|Dose-Escalation Stage 1A|Death|1|||
155571761|NCT00996892|561516356|FG012|Dose-Escalation Stage 1A|Death|1|||
155571762|NCT00996892|561516357|FG013|Dose-Escalation Stage 1A|Death|0|||
155571763|NCT00996892|561516358|FG014|Dose-Escalation Stage 1A|Death|0|||
155571764|NCT00996892|561516359|FG015|Dose-Escalation Stage 1A|Death|0|||
155571765|NCT00996892|561516360|FG016|Dose-Escalation Stage 1A|Death|0|||
155571766|NCT00996892|561516361|FG017|Dose-Escalation Stage 1A|Death|0|||
155571767|NCT00996892|561516362|FG018|Dose-Escalation Stage 1A|Death|0|||
155571768|NCT00996892|561516363|FG019|Dose-Escalation Stage 1A|Death|0|||
155571769|NCT00996892|561516344|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
155571770|NCT00996892|561516345|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
155571771|NCT00996892|561516346|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
155571772|NCT00996892|561516347|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
155571773|NCT00996892|561516348|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
155571774|NCT00996892|561516349|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
155571775|NCT00996892|561516350|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
155571776|NCT00996892|561516351|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
155571777|NCT00996892|561516352|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
155571778|NCT00996892|561516353|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
155571779|NCT00996892|561516354|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
155571780|NCT00996892|561516355|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
155571781|NCT00996892|561516356|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
155571782|NCT00996892|561516357|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
155571783|NCT00996892|561516358|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
155571784|NCT00996892|561516359|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
155571785|NCT00996892|561516360|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
155571786|NCT00996892|561516361|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
155571787|NCT00996892|561516362|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
155571788|NCT00996892|561516363|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
155571789|NCT00996892|561516344|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571790|NCT00996892|561516345|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571791|NCT00996892|561516346|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155660956|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
155660957|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
155571792|NCT00996892|561516347|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571793|NCT00996892|561516348|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571794|NCT00996892|561516349|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571795|NCT00996892|561516350|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571796|NCT00996892|561516351|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571797|NCT00996892|561516352|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571798|NCT00996892|561516353|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155571799|NCT00996892|561516354|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155571800|NCT00996892|561516355|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155571801|NCT00996892|561516356|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155571802|NCT00996892|561516357|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571803|NCT00996892|561516358|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571804|NCT00996892|561516359|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571805|NCT00996892|561516360|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571806|NCT00996892|561516361|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571807|NCT00996892|561516362|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571808|NCT00996892|561516363|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155571809|NCT00996892|561516344|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
155571810|NCT00996892|561516345|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
155571811|NCT00996892|561516346|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
155571812|NCT00996892|561516347|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
155571813|NCT00996892|561516348|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
155571814|NCT00996892|561516349|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
155571815|NCT00996892|561516350|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
155571816|NCT00996892|561516351|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
155571817|NCT00996892|561516352|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
155571818|NCT00996892|561516353|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
155571819|NCT00996892|561516354|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
155571820|NCT00996892|561516355|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
155571821|NCT00996892|561516356|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
155571822|NCT00996892|561516357|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
155571823|NCT00996892|561516358|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
155571824|NCT00996892|561516359|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
155571825|NCT00996892|561516360|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
155571826|NCT00996892|561516361|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
155571827|NCT00996892|561516362|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
155571828|NCT00996892|561516363|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
155571829|NCT00996892|561516344|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
155571830|NCT00996892|561516345|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
155571831|NCT00996892|561516346|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
155571832|NCT00996892|561516347|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
155571833|NCT00996892|561516348|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
155571834|NCT00996892|561516349|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
155571835|NCT00996892|561516350|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
155571836|NCT00996892|561516351|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
155571837|NCT00996892|561516352|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
155571838|NCT00996892|561516353|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
155571839|NCT00996892|561516354|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
155571840|NCT00996892|561516355|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
155571841|NCT00996892|561516356|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
155571842|NCT00996892|561516357|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
155571843|NCT00996892|561516358|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
155571844|NCT00996892|561516359|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
155571845|NCT00996892|561516360|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
155571846|NCT00996892|561516361|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
155571847|NCT00996892|561516362|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
155571848|NCT00996892|561516363|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
155571849|NCT00996892|561516344|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
155571850|NCT00996892|561516345|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
155571851|NCT00996892|561516346|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
155571852|NCT00996892|561516347|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
155571853|NCT00996892|561516348|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
155571854|NCT00996892|561516349|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
155571855|NCT00996892|561516350|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
155571856|NCT00996892|561516351|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
155571857|NCT00996892|561516352|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
155571858|NCT00996892|561516353|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
155571859|NCT00996892|561516354|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
155571860|NCT00996892|561516355|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
155571861|NCT00996892|561516356|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
155571862|NCT00996892|561516357|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
155571863|NCT00996892|561516358|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
155571864|NCT00996892|561516359|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
155571865|NCT00996892|561516360|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
155571866|NCT00996892|561516361|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
155571867|NCT00996892|561516362|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
155571868|NCT00996892|561516363|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
155571869|NCT00996892|561516344|FG000|Expansion Stage 2|Adverse Event|0|||
155571870|NCT00996892|561516345|FG001|Expansion Stage 2|Adverse Event|0|||
155571871|NCT00996892|561516346|FG002|Expansion Stage 2|Adverse Event|0|||
155571872|NCT00996892|561516347|FG003|Expansion Stage 2|Adverse Event|0|||
155571873|NCT00996892|561516348|FG004|Expansion Stage 2|Adverse Event|0|||
155571874|NCT00996892|561516349|FG005|Expansion Stage 2|Adverse Event|0|||
155571875|NCT00996892|561516350|FG006|Expansion Stage 2|Adverse Event|0|||
155571876|NCT00996892|561516351|FG007|Expansion Stage 2|Adverse Event|0|||
155571877|NCT00996892|561516352|FG008|Expansion Stage 2|Adverse Event|0|||
155571878|NCT00996892|561516353|FG009|Expansion Stage 2|Adverse Event|0|||
155571879|NCT00996892|561516354|FG010|Expansion Stage 2|Adverse Event|0|||
155571880|NCT00996892|561516355|FG011|Expansion Stage 2|Adverse Event|0|||
155571881|NCT00996892|561516356|FG012|Expansion Stage 2|Adverse Event|0|||
155571882|NCT00996892|561516357|FG013|Expansion Stage 2|Adverse Event|0|||
155571883|NCT00996892|561516358|FG014|Expansion Stage 2|Adverse Event|0|||
155571884|NCT00996892|561516359|FG015|Expansion Stage 2|Adverse Event|0|||
155571885|NCT00996892|561516360|FG016|Expansion Stage 2|Adverse Event|0|||
155571886|NCT00996892|561516361|FG017|Expansion Stage 2|Adverse Event|0|||
155571887|NCT00996892|561516362|FG018|Expansion Stage 2|Adverse Event|3|||
155571888|NCT00996892|561516363|FG019|Expansion Stage 2|Adverse Event|0|||
155571889|NCT00996892|561516344|FG000|Expansion Stage 2|Death|0|||
155571890|NCT00996892|561516345|FG001|Expansion Stage 2|Death|0|||
155571891|NCT00996892|561516346|FG002|Expansion Stage 2|Death|0|||
155571892|NCT00996892|561516347|FG003|Expansion Stage 2|Death|0|||
155571893|NCT00996892|561516348|FG004|Expansion Stage 2|Death|0|||
155571894|NCT00996892|561516349|FG005|Expansion Stage 2|Death|0|||
155571895|NCT00996892|561516350|FG006|Expansion Stage 2|Death|0|||
155571896|NCT00996892|561516351|FG007|Expansion Stage 2|Death|0|||
155571897|NCT00996892|561516352|FG008|Expansion Stage 2|Death|0|||
155571898|NCT00996892|561516353|FG009|Expansion Stage 2|Death|0|||
155571899|NCT00996892|561516354|FG010|Expansion Stage 2|Death|0|||
155571900|NCT00996892|561516355|FG011|Expansion Stage 2|Death|0|||
155571901|NCT00996892|561516356|FG012|Expansion Stage 2|Death|0|||
155571902|NCT00996892|561516357|FG013|Expansion Stage 2|Death|0|||
155571903|NCT00996892|561516358|FG014|Expansion Stage 2|Death|0|||
155571904|NCT00996892|561516359|FG015|Expansion Stage 2|Death|0|||
155571905|NCT00996892|561516360|FG016|Expansion Stage 2|Death|0|||
155571906|NCT00996892|561516361|FG017|Expansion Stage 2|Death|0|||
155571907|NCT00996892|561516362|FG018|Expansion Stage 2|Death|2|||
155571908|NCT00996892|561516363|FG019|Expansion Stage 2|Death|0|||
155571909|NCT00996892|561516344|FG000|Expansion Stage 2|Physician Decision|0|||
155571910|NCT00996892|561516345|FG001|Expansion Stage 2|Physician Decision|0|||
155571911|NCT00996892|561516346|FG002|Expansion Stage 2|Physician Decision|0|||
155571912|NCT00996892|561516347|FG003|Expansion Stage 2|Physician Decision|0|||
155571913|NCT00996892|561516348|FG004|Expansion Stage 2|Physician Decision|0|||
155571914|NCT00996892|561516349|FG005|Expansion Stage 2|Physician Decision|0|||
155571915|NCT00996892|561516350|FG006|Expansion Stage 2|Physician Decision|0|||
155571916|NCT00996892|561516351|FG007|Expansion Stage 2|Physician Decision|0|||
155571917|NCT00996892|561516352|FG008|Expansion Stage 2|Physician Decision|0|||
155660958|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
155660959|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
155660960|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
155660961|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
155660962|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155660963|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155660964|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
155660965|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
155660966|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
155660967|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
155660968|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Death|0|||
155660969|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Death|0|||
155660970|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Death|1|||
155660971|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
155660972|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
155660973|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
155660974|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
155660975|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
155660976|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
155571918|NCT00996892|561516353|FG009|Expansion Stage 2|Physician Decision|0|||
155571919|NCT00996892|561516354|FG010|Expansion Stage 2|Physician Decision|0|||
155571920|NCT00996892|561516355|FG011|Expansion Stage 2|Physician Decision|0|||
155571921|NCT00996892|561516356|FG012|Expansion Stage 2|Physician Decision|0|||
155571922|NCT00996892|561516357|FG013|Expansion Stage 2|Physician Decision|0|||
155660977|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
155571923|NCT00996892|561516358|FG014|Expansion Stage 2|Physician Decision|0|||
155571924|NCT00996892|561516359|FG015|Expansion Stage 2|Physician Decision|0|||
155571925|NCT00996892|561516360|FG016|Expansion Stage 2|Physician Decision|0|||
155571926|NCT00996892|561516361|FG017|Expansion Stage 2|Physician Decision|0|||
155571927|NCT00996892|561516362|FG018|Expansion Stage 2|Physician Decision|1|||
155571928|NCT00996892|561516363|FG019|Expansion Stage 2|Physician Decision|0|||
155571929|NCT00996892|561516344|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
155571930|NCT00996892|561516345|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
155571931|NCT00996892|561516346|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
155571932|NCT00996892|561516347|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
155571933|NCT00996892|561516348|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
155571934|NCT00996892|561516349|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
155571935|NCT00996892|561516350|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
155571936|NCT00996892|561516351|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
155571937|NCT00996892|561516352|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
155571938|NCT00996892|561516353|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
155571939|NCT00996892|561516354|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
155571940|NCT00996892|561516355|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
155571941|NCT00996892|561516356|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
155571942|NCT00996892|561516357|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
155571943|NCT00996892|561516358|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
155571944|NCT00996892|561516359|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
155571945|NCT00996892|561516360|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
155571946|NCT00996892|561516361|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
155571947|NCT00996892|561516362|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
155571948|NCT00996892|561516363|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
155571949|NCT00996892|561516344|FG000|Expansion Stage 2|Disease Progression|0|||
155571950|NCT00996892|561516345|FG001|Expansion Stage 2|Disease Progression|0|||
155571951|NCT00996892|561516346|FG002|Expansion Stage 2|Disease Progression|0|||
155571952|NCT00996892|561516347|FG003|Expansion Stage 2|Disease Progression|0|||
155571953|NCT00996892|561516348|FG004|Expansion Stage 2|Disease Progression|0|||
155571954|NCT00996892|561516349|FG005|Expansion Stage 2|Disease Progression|0|||
155571955|NCT00996892|561516350|FG006|Expansion Stage 2|Disease Progression|0|||
155571956|NCT00996892|561516351|FG007|Expansion Stage 2|Disease Progression|0|||
155571957|NCT00996892|561516352|FG008|Expansion Stage 2|Disease Progression|0|||
155571958|NCT00996892|561516353|FG009|Expansion Stage 2|Disease Progression|0|||
155571959|NCT00996892|561516354|FG010|Expansion Stage 2|Disease Progression|0|||
155571960|NCT00996892|561516355|FG011|Expansion Stage 2|Disease Progression|0|||
155571961|NCT00996892|561516356|FG012|Expansion Stage 2|Disease Progression|0|||
155571962|NCT00996892|561516357|FG013|Expansion Stage 2|Disease Progression|0|||
155571963|NCT00996892|561516358|FG014|Expansion Stage 2|Disease Progression|0|||
155571964|NCT00996892|561516359|FG015|Expansion Stage 2|Disease Progression|0|||
155571965|NCT00996892|561516360|FG016|Expansion Stage 2|Disease Progression|0|||
155571966|NCT00996892|561516361|FG017|Expansion Stage 2|Disease Progression|0|||
155571967|NCT00996892|561516362|FG018|Expansion Stage 2|Disease Progression|28|||
155571968|NCT00996892|561516363|FG019|Expansion Stage 2|Disease Progression|0|||
155571969|NCT00996892|561516344|FG000|Expansion Stage 2A|Adverse Event|0|||
155571970|NCT00996892|561516345|FG001|Expansion Stage 2A|Adverse Event|0|||
155571971|NCT00996892|561516346|FG002|Expansion Stage 2A|Adverse Event|0|||
155571972|NCT00996892|561516347|FG003|Expansion Stage 2A|Adverse Event|0|||
155571973|NCT00996892|561516348|FG004|Expansion Stage 2A|Adverse Event|0|||
155571974|NCT00996892|561516349|FG005|Expansion Stage 2A|Adverse Event|0|||
155571975|NCT00996892|561516350|FG006|Expansion Stage 2A|Adverse Event|0|||
155571976|NCT00996892|561516351|FG007|Expansion Stage 2A|Adverse Event|0|||
155571977|NCT00996892|561516352|FG008|Expansion Stage 2A|Adverse Event|0|||
155571978|NCT00996892|561516353|FG009|Expansion Stage 2A|Adverse Event|0|||
155571979|NCT00996892|561516354|FG010|Expansion Stage 2A|Adverse Event|0|||
155571980|NCT00996892|561516355|FG011|Expansion Stage 2A|Adverse Event|0|||
155571981|NCT00996892|561516356|FG012|Expansion Stage 2A|Adverse Event|0|||
155571982|NCT00996892|561516357|FG013|Expansion Stage 2A|Adverse Event|0|||
155571983|NCT00996892|561516358|FG014|Expansion Stage 2A|Adverse Event|0|||
155571984|NCT00996892|561516359|FG015|Expansion Stage 2A|Adverse Event|0|||
155571985|NCT00996892|561516360|FG016|Expansion Stage 2A|Adverse Event|0|||
155571986|NCT00996892|561516361|FG017|Expansion Stage 2A|Adverse Event|0|||
155571987|NCT00996892|561516362|FG018|Expansion Stage 2A|Adverse Event|0|||
155571988|NCT00996892|561516363|FG019|Expansion Stage 2A|Adverse Event|8|||
155571989|NCT00996892|561516344|FG000|Expansion Stage 2A|Physician Decision|0|||
155571990|NCT00996892|561516345|FG001|Expansion Stage 2A|Physician Decision|0|||
155571991|NCT00996892|561516346|FG002|Expansion Stage 2A|Physician Decision|0|||
155571992|NCT00996892|561516347|FG003|Expansion Stage 2A|Physician Decision|0|||
155571993|NCT00996892|561516348|FG004|Expansion Stage 2A|Physician Decision|0|||
155660978|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
155571994|NCT00996892|561516349|FG005|Expansion Stage 2A|Physician Decision|0|||
155571995|NCT00996892|561516350|FG006|Expansion Stage 2A|Physician Decision|0|||
155571996|NCT00996892|561516351|FG007|Expansion Stage 2A|Physician Decision|0|||
155571997|NCT00996892|561516352|FG008|Expansion Stage 2A|Physician Decision|0|||
155571998|NCT00996892|561516353|FG009|Expansion Stage 2A|Physician Decision|0|||
155571999|NCT00996892|561516354|FG010|Expansion Stage 2A|Physician Decision|0|||
155572000|NCT00996892|561516355|FG011|Expansion Stage 2A|Physician Decision|0|||
155572001|NCT00996892|561516356|FG012|Expansion Stage 2A|Physician Decision|0|||
155572002|NCT00996892|561516357|FG013|Expansion Stage 2A|Physician Decision|0|||
155572003|NCT00996892|561516358|FG014|Expansion Stage 2A|Physician Decision|0|||
155572004|NCT00996892|561516359|FG015|Expansion Stage 2A|Physician Decision|0|||
155572005|NCT00996892|561516360|FG016|Expansion Stage 2A|Physician Decision|0|||
155572006|NCT00996892|561516361|FG017|Expansion Stage 2A|Physician Decision|0|||
155572007|NCT00996892|561516362|FG018|Expansion Stage 2A|Physician Decision|0|||
155572008|NCT00996892|561516363|FG019|Expansion Stage 2A|Physician Decision|2|||
155572009|NCT00996892|561516344|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
155572010|NCT00996892|561516345|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
155572011|NCT00996892|561516346|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
155572012|NCT00996892|561516347|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
155572013|NCT00996892|561516348|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
155572014|NCT00996892|561516349|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
155572015|NCT00996892|561516350|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
155572016|NCT00996892|561516351|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
155572017|NCT00996892|561516352|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
155572018|NCT00996892|561516353|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
155572019|NCT00996892|561516354|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
155572020|NCT00996892|561516355|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
155572021|NCT00996892|561516356|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
155572022|NCT00996892|561516357|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
155572023|NCT00996892|561516358|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
155572024|NCT00996892|561516359|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
155572025|NCT00996892|561516360|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
155572026|NCT00996892|561516361|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
155572027|NCT00996892|561516362|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
155572028|NCT00996892|561516363|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
155572029|NCT00996892|561516344|FG000|Expansion Stage 2A|Disease Progression|0|||
155572030|NCT00996892|561516345|FG001|Expansion Stage 2A|Disease Progression|0|||
155572031|NCT00996892|561516346|FG002|Expansion Stage 2A|Disease Progression|0|||
155572032|NCT00996892|561516347|FG003|Expansion Stage 2A|Disease Progression|0|||
155572033|NCT00996892|561516348|FG004|Expansion Stage 2A|Disease Progression|0|||
155572034|NCT00996892|561516349|FG005|Expansion Stage 2A|Disease Progression|0|||
155572035|NCT00996892|561516350|FG006|Expansion Stage 2A|Disease Progression|0|||
155572036|NCT00996892|561516351|FG007|Expansion Stage 2A|Disease Progression|0|||
155572037|NCT00996892|561516352|FG008|Expansion Stage 2A|Disease Progression|0|||
155572038|NCT00996892|561516353|FG009|Expansion Stage 2A|Disease Progression|0|||
155572039|NCT00996892|561516354|FG010|Expansion Stage 2A|Disease Progression|0|||
155572040|NCT00996892|561516355|FG011|Expansion Stage 2A|Disease Progression|0|||
155572041|NCT00996892|561516356|FG012|Expansion Stage 2A|Disease Progression|0|||
155572042|NCT00996892|561516357|FG013|Expansion Stage 2A|Disease Progression|0|||
155572043|NCT00996892|561516358|FG014|Expansion Stage 2A|Disease Progression|0|||
155572044|NCT00996892|561516359|FG015|Expansion Stage 2A|Disease Progression|0|||
155572045|NCT00996892|561516360|FG016|Expansion Stage 2A|Disease Progression|0|||
155572046|NCT00996892|561516361|FG017|Expansion Stage 2A|Disease Progression|0|||
155572047|NCT00996892|561516362|FG018|Expansion Stage 2A|Disease Progression|0|||
155572048|NCT00996892|561516363|FG019|Expansion Stage 2A|Disease Progression|31|||
155572049|NCT02759692|561516364|FG000|Period 1|Test article no longer available|1|||
155572050|NCT02759692|561516365|FG001|Period 1|Test article no longer available|1|||
155572051|NCT02759692|561516364|FG000|Period 1|No longer meets eligibility criteria.|1|||
155572052|NCT02759692|561516365|FG001|Period 1|No longer meets eligibility criteria.|0|||
155572053|NCT02759692|561516364|FG000|Period 1|Miss-Randomized|1|||
155572054|NCT02759692|561516365|FG001|Period 1|Miss-Randomized|1|||
155572055|NCT02759692|561516364|FG000|Period 2|Lost to Follow-up|1|||
155572056|NCT02759692|561516365|FG001|Period 2|Lost to Follow-up|0|||
155572057|NCT02759692|561516364|FG000|Period 2|Test article no longer available|0|||
155572058|NCT02759692|561516365|FG001|Period 2|Test article no longer available|1|||
155572059|NCT04042376|561516371|FG000|Overall Study|Withdrawal by Subject|1|||
155572060|NCT04042376|561516371|FG000|Overall Study|Death|3|||
155572061|NCT01059786|561518409|FG000|Overall Study|Did not receive 6 cycles.|0|||
155572062|NCT01059786|561518410|FG001|Overall Study|Did not receive 6 cycles.|0|||
155572063|NCT01059786|561518411|FG002|Overall Study|Did not receive 6 cycles.|4|||
155572064|NCT01059786|561518412|FG003|Overall Study|Did not receive 6 cycles.|1|||
155572065|NCT01059786|561518413|FG004|Overall Study|Did not receive 6 cycles.|0|||
155572066|NCT04205812|561518414|FG000|Randomized Treatment Period|Ongoing|28|||
155572067|NCT04205812|561518415|FG001|Randomized Treatment Period|Ongoing|138|||
155572068|NCT04205812|561518414|FG000|Randomized Treatment Period|Death|94|||
155572069|NCT04205812|561518415|FG001|Randomized Treatment Period|Death|226|||
155572070|NCT04205812|561518414|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
155572071|NCT04205812|561518415|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
155572072|NCT04205812|561518414|FG000|Randomized Treatment Period|Physician Decision|1|||
155572073|NCT04205812|561518415|FG001|Randomized Treatment Period|Physician Decision|4|||
155572074|NCT04205812|561518414|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
155572075|NCT04205812|561518415|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
155572076|NCT04205812|561518414|FG000|Randomized Treatment Period|Progressive Disease|0|||
155572077|NCT04205812|561518415|FG001|Randomized Treatment Period|Progressive Disease|1|||
155572078|NCT04205812|561518414|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
155572079|NCT04205812|561518415|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
155572080|NCT04205812|561518414|FG000|Monotherapy Treatment Period|Ongoing|17|||
155572081|NCT04205812|561518415|FG001|Monotherapy Treatment Period|Ongoing|0|||
155572082|NCT04205812|561518414|FG000|Monotherapy Treatment Period|Death|39|||
155572083|NCT04205812|561518415|FG001|Monotherapy Treatment Period|Death|0|||
155572084|NCT04205812|561518414|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
155572085|NCT04205812|561518415|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
155572086|NCT04205812|561518414|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
155572087|NCT04205812|561518415|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
155572088|NCT04559347|561518416|FG000|Overall Study|Death|1|||
155572089|NCT04559347|561518417|FG001|Overall Study|Death|0|||
155572090|NCT04559347|561518416|FG000|Overall Study|Thoracotomy conversion|1|||
155572091|NCT04559347|561518417|FG001|Overall Study|Thoracotomy conversion|1|||
155572092|NCT04559347|561518416|FG000|Overall Study|Provider unavailable|2|||
155572093|NCT04559347|561518417|FG001|Overall Study|Provider unavailable|1|||
155572094|NCT04559347|561518416|FG000|Overall Study|Other|2|||
155572095|NCT04559347|561518417|FG001|Overall Study|Other|1|||
155572096|NCT00371033|561518418|FG000|Overall Study|Lost to Follow-up|3|||
155572097|NCT00371033|561518419|FG001|Overall Study|Lost to Follow-up|2|||
155572098|NCT00371033|561518418|FG000|Overall Study|No longer interested|2|||
155572099|NCT00371033|561518419|FG001|Overall Study|No longer interested|0|||
155572100|NCT00371033|561518418|FG000|Overall Study|Uknown|3|||
155572101|NCT00371033|561518419|FG001|Overall Study|Uknown|1|||
155572102|NCT05929651|561518426|FG000|Overall Study|Protocol Deviation|1|||
155572103|NCT05929651|561518426|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
155572104|NCT05026177|561518427|FG000|Overall Study|Adverse Event|33|||
155572105|NCT05026177|561518428|FG001|Overall Study|Adverse Event|33|||
155572106|NCT05026177|561518429|FG002|Overall Study|Adverse Event|17|||
155572107|NCT05026177|561518427|FG000|Overall Study|Lost to Follow-up|7|||
155572108|NCT05026177|561518428|FG001|Overall Study|Lost to Follow-up|6|||
155572109|NCT05026177|561518429|FG002|Overall Study|Lost to Follow-up|8|||
155572110|NCT05026177|561518427|FG000|Overall Study|Noncompliance with study drug|6|||
155572111|NCT05026177|561518428|FG001|Overall Study|Noncompliance with study drug|2|||
155572112|NCT05026177|561518429|FG002|Overall Study|Noncompliance with study drug|1|||
155572113|NCT05026177|561518427|FG000|Overall Study|Physician Decision|4|||
155572114|NCT05026177|561518428|FG001|Overall Study|Physician Decision|1|||
155572115|NCT05026177|561518429|FG002|Overall Study|Physician Decision|0|||
155572116|NCT05026177|561518427|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
155572117|NCT05026177|561518428|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
155572118|NCT05026177|561518429|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
155572119|NCT05026177|561518427|FG000|Overall Study|Withdrawal by Subject|53|||
155572120|NCT05026177|561518428|FG001|Overall Study|Withdrawal by Subject|51|||
155572121|NCT05026177|561518429|FG002|Overall Study|Withdrawal by Subject|55|||
155572122|NCT05026177|561518427|FG000|Overall Study|Protocol Violation|0|||
155572123|NCT05026177|561518428|FG001|Overall Study|Protocol Violation|1|||
155572124|NCT05026177|561518429|FG002|Overall Study|Protocol Violation|0|||
155572125|NCT05026177|561518427|FG000|Overall Study|Study terminated by sponsor|70|||
155572126|NCT05026177|561518428|FG001|Overall Study|Study terminated by sponsor|74|||
155572127|NCT05026177|561518429|FG002|Overall Study|Study terminated by sponsor|67|||
155572128|NCT05026177|561518427|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
155572129|NCT05026177|561518428|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
155572130|NCT05026177|561518429|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
155572131|NCT05026177|561518427|FG000|Overall Study|Starting alternative treatment|0|||
155572132|NCT05026177|561518428|FG001|Overall Study|Starting alternative treatment|1|||
155572133|NCT05026177|561518429|FG002|Overall Study|Starting alternative treatment|1|||
155572134|NCT05026177|561518427|FG000|Overall Study|Noncompliance with study procedures|0|||
155572135|NCT05026177|561518428|FG001|Overall Study|Noncompliance with study procedures|1|||
155572136|NCT05026177|561518429|FG002|Overall Study|Noncompliance with study procedures|1|||
155572137|NCT05026177|561518427|FG000|Overall Study|Met stopping criteria|0|||
155572138|NCT05026177|561518428|FG001|Overall Study|Met stopping criteria|0|||
155572139|NCT05026177|561518429|FG002|Overall Study|Met stopping criteria|1|||
155572140|NCT05026177|561518427|FG000|Overall Study|Health issues preventing continuation|0|||
155572141|NCT05026177|561518428|FG001|Overall Study|Health issues preventing continuation|0|||
155572142|NCT05026177|561518429|FG002|Overall Study|Health issues preventing continuation|1|||
155572143|NCT05026177|561518427|FG000|Overall Study|Randomized in error, not treated|0|||
155572144|NCT05026177|561518428|FG001|Overall Study|Randomized in error, not treated|0|||
155572145|NCT05026177|561518429|FG002|Overall Study|Randomized in error, not treated|2|||
155572146|NCT03816878|561518432|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
155572147|NCT03816878|561518433|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
155572148|NCT03816878|561518432|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
155572149|NCT03816878|561518433|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
155572150|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
155572151|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
155572152|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
155572153|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
155572154|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
155572155|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
155572156|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
155572157|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
155572158|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
155572159|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
155572160|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
155572161|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
155572162|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
155572163|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
155572164|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
155572165|NCT04856930|561518438|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155660979|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
155660980|NCT02519842|561854531|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
155660981|NCT02519842|561854532|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
155660982|NCT02519842|561854533|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
155660983|NCT00744861|561854534|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
155660984|NCT00744861|561854535|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
155660985|NCT00744861|561854536|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
155660986|NCT00744861|561854537|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
155660987|NCT00744861|561854534|FG000|Feasibility Stage 1|Pregnancy|0|||
155660988|NCT00744861|561854535|FG001|Feasibility Stage 1|Pregnancy|1|||
155660989|NCT00744861|561854536|FG002|Feasibility Stage 1|Pregnancy|0|||
155660990|NCT00744861|561854537|FG003|Feasibility Stage 1|Pregnancy|0|||
155660991|NCT00744861|561854534|FG000|Pivotal Stage 2|Adverse Event|0|||
155660992|NCT00744861|561854535|FG001|Pivotal Stage 2|Adverse Event|0|||
155660993|NCT00744861|561854536|FG002|Pivotal Stage 2|Adverse Event|6|||
155660994|NCT00744861|561854537|FG003|Pivotal Stage 2|Adverse Event|11|||
155660995|NCT00744861|561854534|FG000|Pivotal Stage 2|Death|0|||
155660996|NCT00744861|561854535|FG001|Pivotal Stage 2|Death|0|||
155660997|NCT00744861|561854536|FG002|Pivotal Stage 2|Death|0|||
155660998|NCT00744861|561854537|FG003|Pivotal Stage 2|Death|1|||
155660999|NCT00744861|561854534|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
155661000|NCT00744861|561854535|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
155661001|NCT00744861|561854536|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
155661002|NCT00744861|561854537|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
155661003|NCT00744861|561854534|FG000|Pivotal Stage 2|Physician Decision|0|||
155661004|NCT00744861|561854535|FG001|Pivotal Stage 2|Physician Decision|0|||
155661005|NCT00744861|561854536|FG002|Pivotal Stage 2|Physician Decision|3|||
155661006|NCT00744861|561854537|FG003|Pivotal Stage 2|Physician Decision|1|||
155661007|NCT00744861|561854534|FG000|Pivotal Stage 2|Protocol Violation|0|||
155661008|NCT00744861|561854535|FG001|Pivotal Stage 2|Protocol Violation|0|||
155661009|NCT00744861|561854536|FG002|Pivotal Stage 2|Protocol Violation|0|||
155661010|NCT00744861|561854537|FG003|Pivotal Stage 2|Protocol Violation|1|||
155661011|NCT00744861|561854534|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
155661012|NCT00744861|561854535|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
155661013|NCT00744861|561854536|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
155661014|NCT00744861|561854537|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
155661015|NCT00744861|561854534|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
155661016|NCT00744861|561854535|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
155661017|NCT00744861|561854536|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
155661018|NCT00744861|561854537|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
155661019|NCT02493764|561854538|FG000|Overall Study|Adverse Event|2|||
155661020|NCT02493764|561854539|FG001|Overall Study|Adverse Event|2|||
155661021|NCT02493764|561854538|FG000|Overall Study|Death|44|||
155661022|NCT02493764|561854539|FG001|Overall Study|Death|58|||
155661023|NCT02493764|561854538|FG000|Overall Study|Lost to Follow-up|2|||
155661024|NCT02493764|561854539|FG001|Overall Study|Lost to Follow-up|1|||
155661025|NCT02493764|561854538|FG000|Overall Study|Protocol Violation|6|||
155661026|NCT02493764|561854539|FG001|Overall Study|Protocol Violation|7|||
155661027|NCT02493764|561854538|FG000|Overall Study|Physician Decision|1|||
155661028|NCT02493764|561854539|FG001|Overall Study|Physician Decision|1|||
155661029|NCT02493764|561854538|FG000|Overall Study|Participant moved|17|||
155661030|NCT02493764|561854539|FG001|Overall Study|Participant moved|5|||
155661031|NCT02493764|561854538|FG000|Overall Study|Withdrawal parent/guardian|0|||
155661032|NCT02493764|561854539|FG001|Overall Study|Withdrawal parent/guardian|1|||
155661033|NCT02493764|561854538|FG000|Overall Study|Withdrawal by Subject|11|||
155661034|NCT02493764|561854539|FG001|Overall Study|Withdrawal by Subject|7|||
155661035|NCT01561976|561854540|FG000|Period 1|Adverse Event|0|||
155661036|NCT01561976|561854541|FG001|Period 1|Adverse Event|0|||
155661037|NCT01561976|561854542|FG002|Period 1|Adverse Event|1|||
155661038|NCT01561976|561854543|FG003|Period 1|Adverse Event|0|||
155661039|NCT01561976|561854544|FG004|Period 1|Adverse Event|0|||
155661040|NCT01561976|561854545|FG005|Period 1|Adverse Event|0|||
155661041|NCT01561976|561854540|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155661042|NCT01561976|561854541|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
155661043|NCT01561976|561854542|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155661044|NCT01561976|561854543|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
155661045|NCT01561976|561854544|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
155661046|NCT01561976|561854545|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
155661047|NCT01561976|561854540|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155661048|NCT01561976|561854541|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155661049|NCT01561976|561854542|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155661050|NCT01561976|561854543|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155661051|NCT01561976|561854544|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155661052|NCT01561976|561854545|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155661053|NCT01561976|561854540|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
155661054|NCT01561976|561854541|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
155661055|NCT01561976|561854542|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
155661056|NCT01561976|561854543|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
155661057|NCT01561976|561854544|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
155661058|NCT01561976|561854545|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
155661059|NCT01977222|561854552|FG000|Overall Study|Withdrawal by Subject|1|||
155661064|NCT04846231|561854557|FG000|Overall Study|Lost to Follow-up|1|||
155661065|NCT04846231|561854558|FG001|Overall Study|Lost to Follow-up|0|||
155661066|NCT04846231|561854559|FG002|Overall Study|Lost to Follow-up|0|||
155572166|NCT04856930|561518439|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
155572167|NCT04856930|561518440|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155572168|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
155572169|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
155572170|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
155572171|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
155572172|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
155572173|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
155572174|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
155572175|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
155572176|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
155572177|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
155572178|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
155572179|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
155572180|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
155572181|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155572182|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155572183|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
155572184|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
155572185|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
155572186|NCT04856930|561518438|FG000|Extension Period (16 Weeks)|Other than specified|0|||
155572187|NCT04856930|561518439|FG001|Extension Period (16 Weeks)|Other than specified|0|||
155572188|NCT04856930|561518440|FG002|Extension Period (16 Weeks)|Other than specified|1|||
155572189|NCT04856930|561518438|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
155572190|NCT04856930|561518439|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
155572191|NCT04856930|561518440|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
155572192|NCT04856930|561518438|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
155572193|NCT04856930|561518439|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
155572194|NCT04856930|561518440|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
155572195|NCT04856930|561518438|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
155572196|NCT04856930|561518439|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
155572197|NCT04856930|561518440|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
155572198|NCT04856930|561518438|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
155661067|NCT04846231|561854560|FG003|Overall Study|Lost to Follow-up|0|||
155661068|NCT04846231|561854561|FG004|Overall Study|Lost to Follow-up|0|||
155661069|NCT04846231|561854562|FG005|Overall Study|Lost to Follow-up|0|||
155661070|NCT04846231|561854563|FG006|Overall Study|Lost to Follow-up|0|||
155661071|NCT04846231|561854564|FG007|Overall Study|Lost to Follow-up|1|||
155661072|NCT04846231|561854557|FG000|Overall Study|Withdrawal by Subject|0|||
155661073|NCT04846231|561854558|FG001|Overall Study|Withdrawal by Subject|1|||
155661074|NCT04846231|561854559|FG002|Overall Study|Withdrawal by Subject|2|||
155572199|NCT04856930|561518439|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
155572200|NCT04856930|561518440|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
155572201|NCT01433055|561518442|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
155572202|NCT01433055|561518443|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
155572203|NCT01433055|561518442|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
155572204|NCT01433055|561518443|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
155572205|NCT00733005|561518449|FG000|Overall Study|Adverse Event|0|||
155572206|NCT00733005|561518450|FG001|Overall Study|Adverse Event|1|||
155572207|NCT00733005|561518449|FG000|Overall Study|Treatment Failure|0|||
155572208|NCT00733005|561518450|FG001|Overall Study|Treatment Failure|1|||
155572209|NCT00733005|561518449|FG000|Overall Study|Withdrawal by Subject|0|||
155572210|NCT00733005|561518450|FG001|Overall Study|Withdrawal by Subject|1|||
155572211|NCT00733005|561518449|FG000|Overall Study|Protocol Violation|2|||
155572212|NCT00733005|561518450|FG001|Overall Study|Protocol Violation|0|||
155572213|NCT01009814|561518461|FG000|Overall Study|No longer met study criteria|1|||
155572214|NCT01009814|561518462|FG001|Overall Study|No longer met study criteria|1|||
155572215|NCT01009814|561518463|FG002|Overall Study|No longer met study criteria|0|||
155572216|NCT01009814|561518464|FG003|Overall Study|No longer met study criteria|0|||
155572217|NCT01009814|561518465|FG004|Overall Study|No longer met study criteria|0|||
155572218|NCT01977417|561518467|FG000|Overall Study|Adverse Event|1|||
155572219|NCT01977417|561518468|FG001|Overall Study|Adverse Event|0|||
155572220|NCT01977417|561518467|FG000|Overall Study|Withdrawal by Subject|2|||
155572221|NCT01977417|561518468|FG001|Overall Study|Withdrawal by Subject|4|||
155572222|NCT01977417|561518467|FG000|Overall Study|Female enrollment goal met|0|||
155572223|NCT01977417|561518468|FG001|Overall Study|Female enrollment goal met|2|||
155572224|NCT01145508|561518469|FG000|Overall Study|Adverse Event|1|||
155572225|NCT01145508|561518470|FG001|Overall Study|Adverse Event|0|||
155572226|NCT01145508|561518469|FG000|Overall Study|Death|1|||
155572227|NCT01145508|561518470|FG001|Overall Study|Death|0|||
155572228|NCT01145508|561518469|FG000|Overall Study|Physician Decision|2|||
155572229|NCT01145508|561518470|FG001|Overall Study|Physician Decision|1|||
155572230|NCT01145508|561518469|FG000|Overall Study|Never started treatment|1|||
155572231|NCT01145508|561518470|FG001|Overall Study|Never started treatment|1|||
155572232|NCT03055624|561518471|FG000|Overall Study|Study closed|9|||
155572233|NCT01495702|561518472|FG000|Randomized Phase|Randomized But Not Treated|1|||
155572234|NCT01495702|561518473|FG001|Randomized Phase|Randomized But Not Treated|4|||
155572235|NCT01495702|561518472|FG000|Randomized Phase|Adverse Event|2|||
155572236|NCT01495702|561518473|FG001|Randomized Phase|Adverse Event|2|||
155572237|NCT01495702|561518472|FG000|Randomized Phase|Death|1|||
155572238|NCT01495702|561518473|FG001|Randomized Phase|Death|0|||
155572239|NCT01495702|561518472|FG000|Randomized Phase|Lack of Efficacy|2|||
155572240|NCT01495702|561518473|FG001|Randomized Phase|Lack of Efficacy|0|||
155572241|NCT01495702|561518472|FG000|Randomized Phase|Investigators Discretion|2|||
155572242|NCT01495702|561518473|FG001|Randomized Phase|Investigators Discretion|0|||
155572243|NCT01495702|561518472|FG000|Randomized Phase|Withdrew Consent|10|||
155572244|NCT01495702|561518473|FG001|Randomized Phase|Withdrew Consent|18|||
155572245|NCT01495702|561518472|FG000|Randomized Phase|Lost to Follow-up|4|||
155572246|NCT01495702|561518473|FG001|Randomized Phase|Lost to Follow-up|3|||
155572247|NCT01495702|561518472|FG000|Randomized Phase|Participant Noncompliance|1|||
155572248|NCT01495702|561518473|FG001|Randomized Phase|Participant Noncompliance|0|||
155572249|NCT01495702|561518472|FG000|Randomized Phase|Protocol Violation|3|||
155572250|NCT01495702|561518473|FG001|Randomized Phase|Protocol Violation|1|||
155572251|NCT04152863|561518474|FG000|Overall Study|Death|13|||
155572252|NCT04152863|561518475|FG001|Overall Study|Death|12|||
155572253|NCT04152863|561518476|FG002|Overall Study|Death|7|||
155572254|NCT04152863|561518474|FG000|Overall Study|Physician Decision|1|||
155572255|NCT04152863|561518475|FG001|Overall Study|Physician Decision|1|||
155572256|NCT04152863|561518476|FG002|Overall Study|Physician Decision|1|||
155572257|NCT04152863|561518474|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
155572258|NCT04152863|561518475|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
155572259|NCT04152863|561518476|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
155572260|NCT04152863|561518474|FG000|Overall Study|Withdrawal by Subject|2|||
155572261|NCT04152863|561518475|FG001|Overall Study|Withdrawal by Subject|1|||
155572262|NCT04152863|561518476|FG002|Overall Study|Withdrawal by Subject|3|||
155572263|NCT01644617|561518480|FG000|Overall Study|Withdrawal by Subject|3|||
155572264|NCT01644617|561518481|FG001|Overall Study|Withdrawal by Subject|4|||
155572265|NCT01644617|561518482|FG002|Overall Study|Withdrawal by Subject|1|||
155572266|NCT01644617|561518480|FG000|Overall Study|Lost to Follow-up|0|||
155572267|NCT01644617|561518481|FG001|Overall Study|Lost to Follow-up|1|||
155572268|NCT01644617|561518482|FG002|Overall Study|Lost to Follow-up|0|||
155572269|NCT01644617|561518480|FG000|Overall Study|Adverse Event|3|||
155572270|NCT01644617|561518481|FG001|Overall Study|Adverse Event|0|||
155572271|NCT01644617|561518482|FG002|Overall Study|Adverse Event|6|||
155572272|NCT01524978|561518486|FG000|Overall Study|Other|16|||
155661075|NCT04846231|561854560|FG003|Overall Study|Withdrawal by Subject|1|||
155661076|NCT04846231|561854561|FG004|Overall Study|Withdrawal by Subject|0|||
155661077|NCT04846231|561854562|FG005|Overall Study|Withdrawal by Subject|0|||
155661078|NCT04846231|561854563|FG006|Overall Study|Withdrawal by Subject|0|||
155661079|NCT04846231|561854564|FG007|Overall Study|Withdrawal by Subject|0|||
155661080|NCT04846231|561854557|FG000|Overall Study|Protocol Violation|0|||
155661081|NCT04846231|561854558|FG001|Overall Study|Protocol Violation|1|||
155661082|NCT04846231|561854559|FG002|Overall Study|Protocol Violation|0|||
155661083|NCT04846231|561854560|FG003|Overall Study|Protocol Violation|0|||
155661084|NCT04846231|561854561|FG004|Overall Study|Protocol Violation|0|||
155661085|NCT04846231|561854562|FG005|Overall Study|Protocol Violation|0|||
155661086|NCT04846231|561854563|FG006|Overall Study|Protocol Violation|0|||
155661087|NCT04846231|561854564|FG007|Overall Study|Protocol Violation|0|||
155661088|NCT04846231|561854557|FG000|Overall Study|Adverse Event|0|||
155661089|NCT04846231|561854558|FG001|Overall Study|Adverse Event|0|||
155661090|NCT04846231|561854559|FG002|Overall Study|Adverse Event|0|||
155661091|NCT04846231|561854560|FG003|Overall Study|Adverse Event|0|||
155661092|NCT04846231|561854561|FG004|Overall Study|Adverse Event|0|||
155661093|NCT04846231|561854562|FG005|Overall Study|Adverse Event|0|||
155661094|NCT04846231|561854563|FG006|Overall Study|Adverse Event|1|||
155572273|NCT01524978|561518487|FG001|Overall Study|Other|2|||
155572274|NCT01524978|561518488|FG002|Overall Study|Other|1|||
155572275|NCT01524978|561518489|FG003|Overall Study|Other|2|||
155572276|NCT01524978|561518490|FG004|Overall Study|Other|1|||
155572277|NCT01524978|561518491|FG005|Overall Study|Other|3|||
155572278|NCT01524978|561518492|FG006|Overall Study|Other|17|||
155572279|NCT01524978|561518493|FG007|Overall Study|Other|1|||
155572280|NCT01524978|561518494|FG008|Overall Study|Other|2|||
155572281|NCT01524978|561518495|FG009|Overall Study|Other|2|||
155572282|NCT01524978|561518496|FG010|Overall Study|Other|5|||
155572283|NCT01524978|561518486|FG000|Overall Study|Withdrawal by Subject|12|||
155572284|NCT01524978|561518487|FG001|Overall Study|Withdrawal by Subject|0|||
155572285|NCT01524978|561518488|FG002|Overall Study|Withdrawal by Subject|1|||
155572286|NCT01524978|561518489|FG003|Overall Study|Withdrawal by Subject|1|||
155572287|NCT01524978|561518490|FG004|Overall Study|Withdrawal by Subject|3|||
155572288|NCT01524978|561518491|FG005|Overall Study|Withdrawal by Subject|1|||
155572289|NCT01524978|561518492|FG006|Overall Study|Withdrawal by Subject|6|||
155572290|NCT01524978|561518493|FG007|Overall Study|Withdrawal by Subject|2|||
155572291|NCT01524978|561518494|FG008|Overall Study|Withdrawal by Subject|4|||
155572292|NCT01524978|561518495|FG009|Overall Study|Withdrawal by Subject|0|||
155572293|NCT01524978|561518496|FG010|Overall Study|Withdrawal by Subject|5|||
155572294|NCT01524978|561518486|FG000|Overall Study|Lost to Follow-up|0|||
155572295|NCT01524978|561518487|FG001|Overall Study|Lost to Follow-up|0|||
155572296|NCT01524978|561518488|FG002|Overall Study|Lost to Follow-up|3|||
155572297|NCT01524978|561518489|FG003|Overall Study|Lost to Follow-up|0|||
155572298|NCT01524978|561518490|FG004|Overall Study|Lost to Follow-up|1|||
155572299|NCT01524978|561518491|FG005|Overall Study|Lost to Follow-up|1|||
155572300|NCT01524978|561518492|FG006|Overall Study|Lost to Follow-up|2|||
155572301|NCT01524978|561518493|FG007|Overall Study|Lost to Follow-up|0|||
155572302|NCT01524978|561518494|FG008|Overall Study|Lost to Follow-up|1|||
155572303|NCT01524978|561518495|FG009|Overall Study|Lost to Follow-up|1|||
155572304|NCT01524978|561518496|FG010|Overall Study|Lost to Follow-up|1|||
155572305|NCT01524978|561518486|FG000|Overall Study|Death|34|||
155572306|NCT01524978|561518487|FG001|Overall Study|Death|2|||
155572307|NCT01524978|561518488|FG002|Overall Study|Death|5|||
155572308|NCT01524978|561518489|FG003|Overall Study|Death|24|||
155572309|NCT01524978|561518490|FG004|Overall Study|Death|4|||
155572310|NCT01524978|561518491|FG005|Overall Study|Death|4|||
155572311|NCT01524978|561518492|FG006|Overall Study|Death|1|||
155572312|NCT01524978|561518493|FG007|Overall Study|Death|9|||
155572313|NCT01524978|561518494|FG008|Overall Study|Death|5|||
155661095|NCT04846231|561854564|FG007|Overall Study|Adverse Event|1|||
155661096|NCT02980107|561854565|FG000|Overall Study|Withdrawal by Subject|51|||
155661097|NCT02980107|561854566|FG001|Overall Study|Withdrawal by Subject|62|||
155661098|NCT02412670|561854567|FG000|Overall Study|Adverse Event|4|||
155661099|NCT02412670|561854568|FG001|Overall Study|Adverse Event|1|||
155661100|NCT02412670|561854567|FG000|Overall Study|Physician Decision|1|||
155572314|NCT01524978|561518495|FG009|Overall Study|Death|6|||
155572315|NCT01524978|561518496|FG010|Overall Study|Death|17|||
155572316|NCT02540083|561518501|FG000|Overall Study|Withdrawal by Subject|16|||
155572317|NCT00185588|561518502|FG000|Overall Study|Adverse Event|3|||
155572318|NCT00185588|561518503|FG001|Overall Study|Adverse Event|1|||
155572319|NCT00185588|561518504|FG002|Overall Study|Adverse Event|4|||
155572320|NCT00185588|561518505|FG003|Overall Study|Adverse Event|2|||
155661101|NCT02412670|561854568|FG001|Overall Study|Physician Decision|0|||
155661102|NCT02412670|561854567|FG000|Overall Study|Withdrawal by Subject|1|||
155661103|NCT02412670|561854568|FG001|Overall Study|Withdrawal by Subject|0|||
155661104|NCT02412670|561854567|FG000|Overall Study|Ineligible|1|||
155661105|NCT02412670|561854568|FG001|Overall Study|Ineligible|0|||
155572321|NCT00185588|561518502|FG000|Overall Study|Lost to Follow-up|0|||
155572322|NCT00185588|561518503|FG001|Overall Study|Lost to Follow-up|0|||
155572323|NCT00185588|561518504|FG002|Overall Study|Lost to Follow-up|1|||
155572324|NCT00185588|561518505|FG003|Overall Study|Lost to Follow-up|2|||
155572325|NCT00185588|561518502|FG000|Overall Study|Withdrawal by Subject|0|||
155572326|NCT00185588|561518503|FG001|Overall Study|Withdrawal by Subject|1|||
155572327|NCT00185588|561518504|FG002|Overall Study|Withdrawal by Subject|0|||
155572328|NCT00185588|561518505|FG003|Overall Study|Withdrawal by Subject|0|||
155572329|NCT00185588|561518502|FG000|Overall Study|Physician Decision|0|||
155572330|NCT00185588|561518503|FG001|Overall Study|Physician Decision|0|||
155572331|NCT00185588|561518504|FG002|Overall Study|Physician Decision|1|||
155572332|NCT00185588|561518505|FG003|Overall Study|Physician Decision|0|||
155572333|NCT02604407|561518506|FG000|Overall Study|Adverse Event|0|||
155572334|NCT02604407|561518507|FG001|Overall Study|Adverse Event|7|||
155572335|NCT02604407|561518508|FG002|Overall Study|Adverse Event|5|||
155572336|NCT02604407|561518506|FG000|Overall Study|Protocol Violation|2|||
155572337|NCT02604407|561518507|FG001|Overall Study|Protocol Violation|0|||
155572338|NCT02604407|561518508|FG002|Overall Study|Protocol Violation|0|||
155572339|NCT02604407|561518506|FG000|Overall Study|Withdrawal by Subject|3|||
155572340|NCT02604407|561518507|FG001|Overall Study|Withdrawal by Subject|3|||
155572341|NCT02604407|561518508|FG002|Overall Study|Withdrawal by Subject|5|||
155572342|NCT02604407|561518506|FG000|Overall Study|Lost to Follow-up|2|||
155572343|NCT02604407|561518507|FG001|Overall Study|Lost to Follow-up|1|||
155572344|NCT02604407|561518508|FG002|Overall Study|Lost to Follow-up|2|||
155572345|NCT02604407|561518506|FG000|Overall Study|Lack of Efficacy|1|||
155572346|NCT02604407|561518507|FG001|Overall Study|Lack of Efficacy|0|||
155572347|NCT02604407|561518508|FG002|Overall Study|Lack of Efficacy|0|||
155572348|NCT02604407|561518506|FG000|Overall Study|Other|3|||
155572349|NCT02604407|561518507|FG001|Overall Study|Other|1|||
155572350|NCT02604407|561518508|FG002|Overall Study|Other|4|||
155572351|NCT00398866|561518509|FG000|Overall Study|Adverse Event|1|||
155572352|NCT00398866|561518510|FG001|Overall Study|Adverse Event|0|||
155572353|NCT00398866|561518511|FG002|Overall Study|Adverse Event|0|||
155572354|NCT00398866|561518509|FG000|Overall Study|Lack of Efficacy|0|||
155572355|NCT00398866|561518510|FG001|Overall Study|Lack of Efficacy|0|||
155572356|NCT00398866|561518511|FG002|Overall Study|Lack of Efficacy|1|||
155572357|NCT00398866|561518509|FG000|Overall Study|Lost to Follow-up|7|||
155572358|NCT00398866|561518510|FG001|Overall Study|Lost to Follow-up|6|||
155572359|NCT00398866|561518511|FG002|Overall Study|Lost to Follow-up|4|||
155572360|NCT00398866|561518509|FG000|Overall Study|Withdrawal by Subject|5|||
155572361|NCT00398866|561518510|FG001|Overall Study|Withdrawal by Subject|1|||
155572362|NCT00398866|561518511|FG002|Overall Study|Withdrawal by Subject|2|||
155572363|NCT00398866|561518509|FG000|Overall Study|Unable to complete requirements of study|1|||
155572364|NCT00398866|561518510|FG001|Overall Study|Unable to complete requirements of study|1|||
155572365|NCT00398866|561518511|FG002|Overall Study|Unable to complete requirements of study|1|||
155572366|NCT02481869|561518514|FG000|Overall Study|Lost to Follow-up|3|||
155572367|NCT02481869|561518515|FG001|Overall Study|Lost to Follow-up|4|||
155572368|NCT02481869|561518514|FG000|Overall Study|Withdrawal by Subject|2|||
155572369|NCT02481869|561518515|FG001|Overall Study|Withdrawal by Subject|0|||
155572370|NCT05445492|561518520|FG000|Overall Study|Physician Decision|1|||
155572371|NCT04289363|561518522|FG000|Overall Study|Lost to Follow-up|14|||
155572372|NCT04289363|561518523|FG001|Overall Study|Lost to Follow-up|0|||
155572373|NCT03790657|561518527|FG000|Overall Study|Adverse Event|1|||
155572374|NCT03790657|561518528|FG001|Overall Study|Adverse Event|1|||
155572375|NCT03790657|561518527|FG000|Overall Study|Withdrawal by Subject|1|||
155572376|NCT03790657|561518528|FG001|Overall Study|Withdrawal by Subject|1|||
155572377|NCT03126435|561518529|FG000|Overall Study|Death|90|||
155572378|NCT03126435|561518530|FG001|Overall Study|Death|84|||
155572379|NCT03126435|561518529|FG000|Overall Study|Lost to Follow-up|4|||
155572380|NCT03126435|561518530|FG001|Overall Study|Lost to Follow-up|3|||
155572381|NCT03126435|561518529|FG000|Overall Study|Physician Decision|0|||
155572382|NCT03126435|561518530|FG001|Overall Study|Physician Decision|1|||
155572383|NCT03126435|561518529|FG000|Overall Study|Withdrawal by Subject|6|||
155572384|NCT03126435|561518530|FG001|Overall Study|Withdrawal by Subject|12|||
155572385|NCT03126435|561518529|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
155572386|NCT03126435|561518530|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
155572387|NCT01807065|561518531|FG000|Overall Study|Receive no sip-T due to IV access|1|||
155572388|NCT01807065|561518532|FG001|Overall Study|Receive no sip-T due to IV access|1|||
155572389|NCT01937871|561518534|FG000|Overall Study|Adverse Event|6|||
155572390|NCT01937871|561518535|FG001|Overall Study|Adverse Event|6|||
155572391|NCT01937871|561518536|FG002|Overall Study|Adverse Event|2|||
155572392|NCT01937871|561518534|FG000|Overall Study|Lost to Follow-up|8|||
155572393|NCT01937871|561518535|FG001|Overall Study|Lost to Follow-up|2|||
155572394|NCT01937871|561518536|FG002|Overall Study|Lost to Follow-up|4|||
155572395|NCT01937871|561518534|FG000|Overall Study|Withdrawal by Subject|9|||
155572396|NCT01937871|561518535|FG001|Overall Study|Withdrawal by Subject|6|||
155572397|NCT01937871|561518536|FG002|Overall Study|Withdrawal by Subject|4|||
155572398|NCT01937871|561518534|FG000|Overall Study|Physician Decision|0|||
155572399|NCT01937871|561518535|FG001|Overall Study|Physician Decision|1|||
155572400|NCT01937871|561518536|FG002|Overall Study|Physician Decision|0|||
155572401|NCT01937871|561518534|FG000|Overall Study|Entry Criteria Not Met|1|||
155572402|NCT01937871|561518535|FG001|Overall Study|Entry Criteria Not Met|2|||
155572403|NCT01937871|561518536|FG002|Overall Study|Entry Criteria Not Met|1|||
155572404|NCT01699815|561518537|FG000|Overall Study|Protocol Violation|4|||
155572405|NCT01699815|561518538|FG001|Overall Study|Protocol Violation|7|||
155572406|NCT01699815|561518537|FG000|Overall Study|record could not be located|1|||
155572407|NCT01699815|561518538|FG001|Overall Study|record could not be located|0|||
155572408|NCT01699815|561518537|FG000|Overall Study|Adverse Event|0|||
155572409|NCT01699815|561518538|FG001|Overall Study|Adverse Event|1|||
155572410|NCT00810511|561518539|FG000|Overall Study|Protocol Violation|0|||
155572411|NCT00810511|561518540|FG001|Overall Study|Protocol Violation|1|||
155572412|NCT00810511|561518539|FG000|Overall Study|Lack of Efficacy|9|||
155572413|NCT00810511|561518540|FG001|Overall Study|Lack of Efficacy|1|||
155572414|NCT00810511|561518539|FG000|Overall Study|death in the family|0|||
155572415|NCT00810511|561518540|FG001|Overall Study|death in the family|1|||
155572416|NCT00810511|561518539|FG000|Overall Study|Lost to Follow-up|1|||
155572417|NCT00810511|561518540|FG001|Overall Study|Lost to Follow-up|0|||
155572418|NCT00810511|561518539|FG000|Overall Study|deposits on contact lens|0|||
155572419|NCT00810511|561518540|FG001|Overall Study|deposits on contact lens|1|||
155572420|NCT02652949|561518541|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
155572421|NCT02652949|561518541|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
155572422|NCT02652949|561518541|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
155572423|NCT02652949|561518541|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
155572424|NCT02652949|561518541|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
155572425|NCT02652949|561518541|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
155572426|NCT02652949|561518541|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
155572427|NCT02652949|561518541|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
155572428|NCT02652949|561518541|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
155572429|NCT02652949|561518541|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
155572430|NCT02652949|561518541|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
155572431|NCT02652949|561518541|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
155572432|NCT02652949|561518541|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
155572433|NCT02652949|561518541|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
155572434|NCT02652949|561518541|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155572435|NCT02652949|561518541|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
155572436|NCT02652949|561518541|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155572437|NCT00911300|561518542|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
155572438|NCT00911300|561518543|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
155572439|NCT00911300|561518542|FG000|Overall Study|Death|1|||
155572440|NCT00911300|561518543|FG001|Overall Study|Death|0|||
155572441|NCT00911300|561518542|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
155572442|NCT00911300|561518543|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
155572443|NCT00911300|561518542|FG000|Overall Study|Adverse Event|14|||
155572444|NCT00911300|561518543|FG001|Overall Study|Adverse Event|6|||
155572445|NCT00911300|561518542|FG000|Overall Study|Protocol Violation|3|||
155572446|NCT00911300|561518543|FG001|Overall Study|Protocol Violation|2|||
155572447|NCT00911300|561518542|FG000|Overall Study|Consent Withdrawn|4|||
155572448|NCT00911300|561518543|FG001|Overall Study|Consent Withdrawn|12|||
155572449|NCT00911300|561518542|FG000|Overall Study|Coronary Angiography Performed|1|||
155572450|NCT00911300|561518543|FG001|Overall Study|Coronary Angiography Performed|0|||
155572451|NCT00911300|561518542|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
155572452|NCT00911300|561518543|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
155572453|NCT00911300|561518542|FG000|Overall Study|Received Commercial Treatment|1|||
155572454|NCT00911300|561518543|FG001|Overall Study|Received Commercial Treatment|0|||
155572455|NCT00911300|561518542|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
155572456|NCT00911300|561518543|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
155572457|NCT00911300|561518542|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
155572458|NCT00911300|561518543|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
155572459|NCT00911300|561518542|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
155572460|NCT00911300|561518543|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
155572461|NCT00911300|561518542|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
155572462|NCT00911300|561518543|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
155572463|NCT00911300|561518542|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
155572464|NCT00911300|561518543|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
155572465|NCT00911300|561518542|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
155572466|NCT00911300|561518543|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
155572467|NCT00911300|561518542|FG000|Overall Study|International Normalized Ratio Too High|0|||
155572468|NCT00911300|561518543|FG001|Overall Study|International Normalized Ratio Too High|1|||
155572469|NCT00911300|561518542|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
155572470|NCT00911300|561518543|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
155572471|NCT00911300|561518542|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
155572472|NCT00911300|561518543|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
155572473|NCT00911300|561518542|FG000|Overall Study|Physician Decision|0|||
155572474|NCT00911300|561518543|FG001|Overall Study|Physician Decision|1|||
155572475|NCT00911300|561518542|FG000|Overall Study|Treatment Stopped by Mistake|0|||
155572476|NCT00911300|561518543|FG001|Overall Study|Treatment Stopped by Mistake|1|||
155572477|NCT00911300|561518542|FG000|Overall Study|Randomized; No Study Medication Received|0|||
155572478|NCT00911300|561518543|FG001|Overall Study|Randomized; No Study Medication Received|2|||
155572479|NCT00699816|561518544|FG000|Overall Study|Protocol Violation|1|||
155572480|NCT00699816|561518545|FG001|Overall Study|Protocol Violation|3|||
155572481|NCT01895777|561518546|FG000|Overall Study|Adverse Event|1|||
155572482|NCT01895777|561518547|FG001|Overall Study|Adverse Event|2|||
155572483|NCT01895777|561518546|FG000|Overall Study|Lost to Follow-up|2|||
155572484|NCT01895777|561518547|FG001|Overall Study|Lost to Follow-up|0|||
155572485|NCT01895777|561518546|FG000|Overall Study|Not treated|1|||
155572486|NCT01895777|561518547|FG001|Overall Study|Not treated|0|||
155572487|NCT01895777|561518546|FG000|Overall Study|Other reasons|3|||
155572488|NCT01895777|561518547|FG001|Overall Study|Other reasons|2|||
155572489|NCT01895777|561518546|FG000|Overall Study|Non-compliance with the CTP|2|||
155572490|NCT01895777|561518547|FG001|Overall Study|Non-compliance with the CTP|1|||
155572491|NCT02508935|561518551|FG000|Overall Study|Withdrawal by Subject|1|||
155572492|NCT02508935|561518551|FG000|Overall Study|Withdrawal by Caregiver|8|||
155572493|NCT02508935|561518551|FG000|Overall Study|Pain Score <4|1|||
155572494|NCT02508935|561518551|FG000|Overall Study|Emesis|3|||
155572495|NCT02508935|561518551|FG000|Overall Study|Adverse Event|3|||
155572496|NCT02508935|561518551|FG000|Overall Study|Protocol Violation|1|||
155572497|NCT02508935|561518551|FG000|Overall Study|Physician Decision|1|||
155572498|NCT02508935|561518551|FG000|Overall Study|Trial terminated by sponsor|5|||
155572499|NCT04223752|561518555|FG000|Overall Study|Participant enrolled in error|0|||
155572500|NCT04223752|561518556|FG001|Overall Study|Participant enrolled in error|0|||
155572501|NCT04223752|561518557|FG002|Overall Study|Participant enrolled in error|0|||
155572502|NCT04223752|561518558|FG003|Overall Study|Participant enrolled in error|0|||
155572503|NCT04223752|561518559|FG004|Overall Study|Participant enrolled in error|1|||
155572504|NCT04223752|561518555|FG000|Overall Study|Death|0|||
155572505|NCT04223752|561518556|FG001|Overall Study|Death|0|||
155572506|NCT04223752|561518557|FG002|Overall Study|Death|0|||
155572507|NCT04223752|561518558|FG003|Overall Study|Death|2|||
155572508|NCT04223752|561518559|FG004|Overall Study|Death|1|||
155572509|NCT04759703|561518560|FG000|Overall Study|Withdrawal by Subject|4|||
155572510|NCT04759703|561518561|FG001|Overall Study|Withdrawal by Subject|9|||
155572511|NCT04759703|561518560|FG000|Overall Study|Adverse Event|1|||
155572512|NCT04759703|561518561|FG001|Overall Study|Adverse Event|0|||
155572513|NCT04759703|561518560|FG000|Overall Study|Lost to Follow-up|2|||
155572514|NCT04759703|561518561|FG001|Overall Study|Lost to Follow-up|0|||
155572515|NCT02800642|561518569|FG000|Overall Study|Death|3|||
155572516|NCT02800642|561518569|FG000|Overall Study|Other|10|||
155572517|NCT02800642|561518569|FG000|Overall Study|Physician Decision|2|||
155572518|NCT02800642|561518569|FG000|Overall Study|Adverse Event|6|||
155572519|NCT02800642|561518569|FG000|Overall Study|Withdrawal by Subject|3|||
155572520|NCT02800642|561518569|FG000|Overall Study|Lost to Follow-up|1|||
155572521|NCT05299528|561518573|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572522|NCT05299528|561518574|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
155572523|NCT05299528|561518575|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572524|NCT05299528|561518576|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572525|NCT05299528|561518577|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572526|NCT05299528|561518578|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572527|NCT05299528|561518579|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155572528|NCT05299528|561518573|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572529|NCT05299528|561518574|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572530|NCT05299528|561518575|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572531|NCT05299528|561518576|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572532|NCT05299528|561518577|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572533|NCT05299528|561518578|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
155572534|NCT05299528|561518579|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155572535|NCT05299528|561518573|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
155572536|NCT05299528|561518574|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
155572537|NCT05299528|561518575|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
155572538|NCT05299528|561518576|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
155572539|NCT05299528|561518577|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
155572540|NCT05299528|561518578|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
155572541|NCT05299528|561518579|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
155572542|NCT03097991|561518580|FG000|Overall Study|Didn't meet study criteria|8|||
155572543|NCT03097991|561518581|FG001|Overall Study|Didn't meet study criteria|0|||
155572544|NCT03097991|561518580|FG000|Overall Study|Withdrawal by Subject|12|||
155572545|NCT03097991|561518581|FG001|Overall Study|Withdrawal by Subject|6|||
155572546|NCT03097991|561518580|FG000|Overall Study|Death of Baby|3|||
155572547|NCT03097991|561518581|FG001|Overall Study|Death of Baby|1|||
155572548|NCT03097991|561518580|FG000|Overall Study|Lost to Follow-up|24|||
155572549|NCT03097991|561518581|FG001|Overall Study|Lost to Follow-up|38|||
155572550|NCT03097991|561518580|FG000|Overall Study|Adverse Event|3|||
155572551|NCT03097991|561518581|FG001|Overall Study|Adverse Event|5|||
155572552|NCT02006732|561518582|FG000|Overall Study|Adverse Event|10|||
155572553|NCT02006732|561518583|FG001|Overall Study|Adverse Event|7|||
155572554|NCT02006732|561518584|FG002|Overall Study|Adverse Event|4|||
155572555|NCT02006732|561518585|FG003|Overall Study|Adverse Event|2|||
155572556|NCT02006732|561518582|FG000|Overall Study|Lack of Efficacy|6|||
155572557|NCT02006732|561518583|FG001|Overall Study|Lack of Efficacy|3|||
155572558|NCT02006732|561518584|FG002|Overall Study|Lack of Efficacy|1|||
155572559|NCT02006732|561518585|FG003|Overall Study|Lack of Efficacy|1|||
155572560|NCT02006732|561518582|FG000|Overall Study|Protocol Violation|1|||
155572561|NCT02006732|561518583|FG001|Overall Study|Protocol Violation|1|||
155572562|NCT02006732|561518584|FG002|Overall Study|Protocol Violation|0|||
155572563|NCT02006732|561518585|FG003|Overall Study|Protocol Violation|0|||
155572564|NCT02006732|561518582|FG000|Overall Study|Lost to Follow-up|0|||
155572565|NCT02006732|561518583|FG001|Overall Study|Lost to Follow-up|1|||
155572566|NCT02006732|561518584|FG002|Overall Study|Lost to Follow-up|0|||
155572567|NCT02006732|561518585|FG003|Overall Study|Lost to Follow-up|0|||
155572568|NCT02006732|561518582|FG000|Overall Study|Withdrawal by Subject|3|||
155572569|NCT02006732|561518583|FG001|Overall Study|Withdrawal by Subject|0|||
155572570|NCT02006732|561518584|FG002|Overall Study|Withdrawal by Subject|4|||
155572571|NCT02006732|561518585|FG003|Overall Study|Withdrawal by Subject|1|||
155572572|NCT01755091|561518586|FG000|Overall Study|Withdrawal by Subject|6|||
155572573|NCT01755091|561518587|FG001|Overall Study|Withdrawal by Subject|1|||
155572574|NCT01755091|561518588|FG002|Overall Study|Withdrawal by Subject|3|||
155572575|NCT01755091|561518586|FG000|Overall Study|Adverse Event|1|||
155572576|NCT01755091|561518587|FG001|Overall Study|Adverse Event|1|||
155572577|NCT01755091|561518588|FG002|Overall Study|Adverse Event|1|||
155572578|NCT01755091|561518586|FG000|Overall Study|Lost to Follow-up|1|||
155572579|NCT01755091|561518587|FG001|Overall Study|Lost to Follow-up|0|||
155572580|NCT01755091|561518588|FG002|Overall Study|Lost to Follow-up|1|||
155572581|NCT01755091|561518586|FG000|Overall Study|Physician Decision|1|||
155572582|NCT01755091|561518587|FG001|Overall Study|Physician Decision|1|||
155572583|NCT01755091|561518588|FG002|Overall Study|Physician Decision|2|||
155572584|NCT01107197|561518590|FG000|Overall Study|Death|12|||
155572585|NCT01107197|561518591|FG001|Overall Study|Death|10|||
155572586|NCT01107197|561518590|FG000|Overall Study|Lost to Follow-up|5|||
155572587|NCT01107197|561518591|FG001|Overall Study|Lost to Follow-up|8|||
155572588|NCT01107197|561518590|FG000|Overall Study|Withdrawal by Subject|3|||
155572589|NCT01107197|561518591|FG001|Overall Study|Withdrawal by Subject|5|||
155572590|NCT03071276|561518592|FG000|Overall Study|Adverse Event|1|||
155572591|NCT03071276|561518592|FG000|Overall Study|Lack of Efficacy|14|||
155572592|NCT03052127|561518593|FG000|Overall Study|Withdrawal by Subject|0|||
155572593|NCT03052127|561518594|FG001|Overall Study|Withdrawal by Subject|0|||
155572594|NCT03052127|561518595|FG002|Overall Study|Withdrawal by Subject|0|||
155572595|NCT03052127|561518596|FG003|Overall Study|Withdrawal by Subject|0|||
155572596|NCT03052127|561518597|FG004|Overall Study|Withdrawal by Subject|0|||
155572597|NCT03052127|561518598|FG005|Overall Study|Withdrawal by Subject|0|||
155661106|NCT01728246|561854572|FG000|Overall Study|Participant needed rescue medication|1|||
155661107|NCT01728246|561854573|FG001|Overall Study|Participant needed rescue medication|5|||
155661108|NCT01728246|561854572|FG000|Overall Study|Protocol Violation|1|||
155572598|NCT03052127|561518599|FG006|Overall Study|Withdrawal by Subject|0|||
155572599|NCT03052127|561518600|FG007|Overall Study|Withdrawal by Subject|1|||
155572600|NCT03052127|561518601|FG008|Overall Study|Withdrawal by Subject|1|||
155572601|NCT03052127|561518602|FG009|Overall Study|Withdrawal by Subject|1|||
155572602|NCT03052127|561518603|FG010|Overall Study|Withdrawal by Subject|0|||
155572603|NCT03052127|561518604|FG011|Overall Study|Withdrawal by Subject|0|||
155572604|NCT03052127|561518593|FG000|Overall Study|Discontinuation by Sponsor|0|||
155572605|NCT03052127|561518594|FG001|Overall Study|Discontinuation by Sponsor|0|||
155572606|NCT03052127|561518595|FG002|Overall Study|Discontinuation by Sponsor|0|||
155572607|NCT03052127|561518596|FG003|Overall Study|Discontinuation by Sponsor|0|||
155572608|NCT03052127|561518597|FG004|Overall Study|Discontinuation by Sponsor|0|||
155572609|NCT03052127|561518598|FG005|Overall Study|Discontinuation by Sponsor|0|||
155572610|NCT03052127|561518599|FG006|Overall Study|Discontinuation by Sponsor|0|||
155572611|NCT03052127|561518600|FG007|Overall Study|Discontinuation by Sponsor|0|||
155572612|NCT03052127|561518601|FG008|Overall Study|Discontinuation by Sponsor|4|||
155572613|NCT03052127|561518602|FG009|Overall Study|Discontinuation by Sponsor|2|||
155572614|NCT03052127|561518603|FG010|Overall Study|Discontinuation by Sponsor|5|||
155572615|NCT03052127|561518604|FG011|Overall Study|Discontinuation by Sponsor|13|||
155572616|NCT03052127|561518593|FG000|Overall Study|Inability to comply with trial requirements|0|||
155572617|NCT03052127|561518594|FG001|Overall Study|Inability to comply with trial requirements|0|||
155572618|NCT03052127|561518595|FG002|Overall Study|Inability to comply with trial requirements|1|||
155572619|NCT03052127|561518596|FG003|Overall Study|Inability to comply with trial requirements|0|||
155572620|NCT03052127|561518597|FG004|Overall Study|Inability to comply with trial requirements|0|||
155572621|NCT03052127|561518598|FG005|Overall Study|Inability to comply with trial requirements|0|||
155572622|NCT03052127|561518599|FG006|Overall Study|Inability to comply with trial requirements|0|||
155572623|NCT03052127|561518600|FG007|Overall Study|Inability to comply with trial requirements|0|||
155572624|NCT03052127|561518601|FG008|Overall Study|Inability to comply with trial requirements|0|||
155572625|NCT03052127|561518602|FG009|Overall Study|Inability to comply with trial requirements|0|||
155572626|NCT03052127|561518603|FG010|Overall Study|Inability to comply with trial requirements|0|||
155572627|NCT03052127|561518604|FG011|Overall Study|Inability to comply with trial requirements|0|||
155572628|NCT03052127|561518593|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155572629|NCT03052127|561518594|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572630|NCT03052127|561518595|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572631|NCT03052127|561518596|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572632|NCT03052127|561518597|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155572633|NCT03052127|561518598|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155572634|NCT03052127|561518599|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155572635|NCT03052127|561518600|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572636|NCT03052127|561518601|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572637|NCT03052127|561518602|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572638|NCT03052127|561518603|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572639|NCT03052127|561518604|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155572640|NCT03694327|561518605|FG000|Overall Study|Lost to Follow-up|13|||
155572641|NCT03694327|561518606|FG001|Overall Study|Lost to Follow-up|23|||
155572642|NCT05109611|561520152|FG000|Overall Study|Adverse Event|13|||
155572643|NCT05109611|561520153|FG001|Overall Study|Adverse Event|10|||
155572644|NCT05109611|561520152|FG000|Overall Study|Withdrawal by Subject|1|||
155572645|NCT05109611|561520153|FG001|Overall Study|Withdrawal by Subject|0|||
155572646|NCT05109611|561520152|FG000|Overall Study|Lost to Follow-up|1|||
155572647|NCT05109611|561520153|FG001|Overall Study|Lost to Follow-up|2|||
155572648|NCT05109611|561520152|FG000|Overall Study|Protocol Violation|0|||
155572649|NCT05109611|561520153|FG001|Overall Study|Protocol Violation|4|||
155572650|NCT05109611|561520152|FG000|Overall Study|Information unavailable|1|||
155572651|NCT05109611|561520153|FG001|Overall Study|Information unavailable|1|||
155572652|NCT03203850|561520157|FG000|Overall Study|Subject/guardian decision|4|||
155572653|NCT03203850|561520158|FG001|Overall Study|Subject/guardian decision|3|||
155572654|NCT03203850|561520157|FG000|Overall Study|Adverse Event|3|||
155572655|NCT03203850|561520158|FG001|Overall Study|Adverse Event|0|||
155572656|NCT03203850|561520157|FG000|Overall Study|Death|1|||
155572657|NCT03203850|561520158|FG001|Overall Study|Death|0|||
155572658|NCT02717455|561520159|FG000|Overall Study|Adverse Event|1|||
155572659|NCT02717455|561520160|FG001|Overall Study|Adverse Event|0|||
155572660|NCT02717455|561520161|FG002|Overall Study|Adverse Event|0|||
155572661|NCT02717455|561520162|FG003|Overall Study|Adverse Event|2|||
155572662|NCT02717455|561520163|FG004|Overall Study|Adverse Event|2|||
155572663|NCT02717455|561520164|FG005|Overall Study|Adverse Event|2|||
155572664|NCT02717455|561520159|FG000|Overall Study|Withdrawal by Subject|1|||
155572665|NCT02717455|561520160|FG001|Overall Study|Withdrawal by Subject|1|||
155572666|NCT02717455|561520161|FG002|Overall Study|Withdrawal by Subject|0|||
155572667|NCT02717455|561520162|FG003|Overall Study|Withdrawal by Subject|2|||
155572668|NCT02717455|561520163|FG004|Overall Study|Withdrawal by Subject|2|||
155572669|NCT02717455|561520164|FG005|Overall Study|Withdrawal by Subject|1|||
155572670|NCT02717455|561520159|FG000|Overall Study|Death|1|||
155572671|NCT02717455|561520160|FG001|Overall Study|Death|0|||
155572672|NCT02717455|561520161|FG002|Overall Study|Death|0|||
155572673|NCT02717455|561520162|FG003|Overall Study|Death|0|||
155572674|NCT02717455|561520163|FG004|Overall Study|Death|1|||
155572675|NCT02717455|561520164|FG005|Overall Study|Death|0|||
155572676|NCT02717455|561520159|FG000|Overall Study|Did not receive study drug|0|||
155572677|NCT02717455|561520160|FG001|Overall Study|Did not receive study drug|0|||
155572678|NCT02717455|561520161|FG002|Overall Study|Did not receive study drug|0|||
155572679|NCT02717455|561520162|FG003|Overall Study|Did not receive study drug|1|||
155572680|NCT02717455|561520163|FG004|Overall Study|Did not receive study drug|0|||
155572681|NCT02717455|561520164|FG005|Overall Study|Did not receive study drug|1|||
155572682|NCT02717455|561520159|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155572683|NCT02717455|561520160|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155572684|NCT02717455|561520161|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155607010|NCT01897571|561649613|FG000|Overall Study|Withdrawal by Subject|0|||
155661109|NCT01728246|561854573|FG001|Overall Study|Protocol Violation|0|||
155661110|NCT01728246|561854572|FG000|Overall Study|Withdrawal by Subject|2|||
155661111|NCT01728246|561854573|FG001|Overall Study|Withdrawal by Subject|3|||
155661112|NCT01728246|561854572|FG000|Overall Study|Lost to Follow-up|23|||
155661113|NCT01728246|561854573|FG001|Overall Study|Lost to Follow-up|22|||
155661114|NCT01728246|561854572|FG000|Overall Study|Lack of Efficacy|1|||
155661115|NCT01728246|561854573|FG001|Overall Study|Lack of Efficacy|1|||
155661116|NCT01728246|561854572|FG000|Overall Study|Adverse Event|8|||
155661117|NCT01728246|561854573|FG001|Overall Study|Adverse Event|5|||
155661118|NCT05805150|561854574|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
155661119|NCT05805150|561854575|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
155661120|NCT04138056|561854581|FG000|Primary Study|Lost to Follow-up|3|||
155661121|NCT04138056|561854582|FG001|Primary Study|Lost to Follow-up|4|||
155661122|NCT04138056|561854583|FG002|Primary Study|Lost to Follow-up|1|||
155661123|NCT04138056|561854584|FG003|Primary Study|Lost to Follow-up|1|||
155661124|NCT04138056|561854585|FG004|Primary Study|Lost to Follow-up|4|||
155661125|NCT04138056|561854581|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
155661126|NCT04138056|561854582|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
155661127|NCT04138056|561854583|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
155661128|NCT04138056|561854584|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
155661129|NCT04138056|561854585|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
155661130|NCT04138056|561854581|FG000|Extension Study|Lost to Follow-up|1|||
155661131|NCT04138056|561854582|FG001|Extension Study|Lost to Follow-up|2|||
155661132|NCT04138056|561854583|FG002|Extension Study|Lost to Follow-up|1|||
155661133|NCT04138056|561854584|FG003|Extension Study|Lost to Follow-up|0|||
155661134|NCT04138056|561854585|FG004|Extension Study|Lost to Follow-up|1|||
155661135|NCT01959932|561854587|FG000|Overall Study|Withdrawal by Subject|1|||
155661136|NCT01959932|561854588|FG001|Overall Study|Withdrawal by Subject|0|||
155661137|NCT01959932|561854589|FG002|Overall Study|Withdrawal by Subject|0|||
155661138|NCT00485173|561854592|FG000|Overall Study|Death|4|||
155661139|NCT00485173|561854593|FG001|Overall Study|Death|3|||
155661140|NCT00485173|561854592|FG000|Overall Study|Lost to Follow-up|32|||
155661141|NCT00485173|561854593|FG001|Overall Study|Lost to Follow-up|61|||
155661142|NCT00829244|561854594|FG000|Overall Study|Adverse Event|1|||
155661143|NCT00829244|561854595|FG001|Overall Study|Adverse Event|3|||
155661144|NCT00829244|561854594|FG000|Overall Study|Protocol Violation|1|||
155661145|NCT00829244|561854595|FG001|Overall Study|Protocol Violation|0|||
155661146|NCT00829244|561854594|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
155661147|NCT00829244|561854595|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
155661148|NCT00829244|561854594|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
155661149|NCT00829244|561854595|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
155661150|NCT00829244|561854594|FG000|Overall Study|No fertilization|2|||
155661151|NCT00829244|561854595|FG001|Overall Study|No fertilization|2|||
155661152|NCT00829244|561854594|FG000|Overall Study|All embryos discarded|0|||
155661153|NCT00829244|561854595|FG001|Overall Study|All embryos discarded|3|||
155661154|NCT00829244|561854594|FG000|Overall Study|No embryo cleavage|0|||
155661155|NCT00829244|561854595|FG001|Overall Study|No embryo cleavage|2|||
155661156|NCT02297412|561854596|FG000|Overall Study|Canceled|1|||
155661157|NCT02297412|561854597|FG001|Overall Study|Canceled|1|||
155661158|NCT04583618|561854609|FG000|Overall Study|Adverse Event|0|||
155661159|NCT04583618|561854610|FG001|Overall Study|Adverse Event|0|||
155661160|NCT04583618|561854611|FG002|Overall Study|Adverse Event|1|||
155661161|NCT04583618|561854612|FG003|Overall Study|Adverse Event|0|||
155661162|NCT04583618|561854613|FG004|Overall Study|Adverse Event|0|||
155661163|NCT04583618|561854609|FG000|Overall Study|Protocol deviation|1|||
155661164|NCT04583618|561854610|FG001|Overall Study|Protocol deviation|1|||
155661165|NCT04583618|561854611|FG002|Overall Study|Protocol deviation|1|||
155661166|NCT04583618|561854612|FG003|Overall Study|Protocol deviation|0|||
155661167|NCT04583618|561854613|FG004|Overall Study|Protocol deviation|0|||
155661168|NCT04583618|561854609|FG000|Overall Study|Withdrawal by Subject|2|||
155661169|NCT04583618|561854610|FG001|Overall Study|Withdrawal by Subject|1|||
155661170|NCT04583618|561854611|FG002|Overall Study|Withdrawal by Subject|3|||
155572685|NCT02717455|561520162|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155572686|NCT02717455|561520163|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155572687|NCT02717455|561520164|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
155572688|NCT02717455|561520159|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
155572689|NCT02717455|561520160|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
155572690|NCT02717455|561520161|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
155572691|NCT02717455|561520162|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
155572692|NCT02717455|561520163|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
155572693|NCT02717455|561520164|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
155572694|NCT01769456|561520165|FG000|Overall Study|Lost to Follow-up|19|||
155572695|NCT01769456|561520165|FG000|Overall Study|Withdrawal by Subject|3|||
155572696|NCT01769456|561520165|FG000|Overall Study|Did not receive PCC intervention|6|||
155572697|NCT01769456|561520165|FG000|Overall Study|Moved out of the area|3|||
155572698|NCT01769456|561520165|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
155572699|NCT01769456|561520165|FG000|Overall Study|Parental request to youth to withdraw|1|||
155572700|NCT05244122|561520168|FG000|Overall Study|Withdrawal by Subject|318|||
155572701|NCT00615199|561520169|FG000|Overall Study|Adverse Event|3|||
155572702|NCT00615199|561520170|FG001|Overall Study|Adverse Event|1|||
155572703|NCT00615199|561520171|FG002|Overall Study|Adverse Event|1|||
155572704|NCT00615199|561520172|FG003|Overall Study|Adverse Event|0|||
155572705|NCT00615199|561520169|FG000|Overall Study|Lack of Efficacy|2|||
155572706|NCT00615199|561520170|FG001|Overall Study|Lack of Efficacy|0|||
155572707|NCT00615199|561520171|FG002|Overall Study|Lack of Efficacy|0|||
155572708|NCT00615199|561520172|FG003|Overall Study|Lack of Efficacy|1|||
155572709|NCT00615199|561520169|FG000|Overall Study|Lost to Follow-up|1|||
155572710|NCT00615199|561520170|FG001|Overall Study|Lost to Follow-up|0|||
155572711|NCT00615199|561520171|FG002|Overall Study|Lost to Follow-up|0|||
155572712|NCT00615199|561520172|FG003|Overall Study|Lost to Follow-up|0|||
155572713|NCT00615199|561520169|FG000|Overall Study|Other|0|||
155572714|NCT00615199|561520170|FG001|Overall Study|Other|0|||
155572715|NCT00615199|561520171|FG002|Overall Study|Other|0|||
155572716|NCT00615199|561520172|FG003|Overall Study|Other|1|||
155572717|NCT00615199|561520169|FG000|Overall Study|Withdrawal by Subject|2|||
155572718|NCT00615199|561520170|FG001|Overall Study|Withdrawal by Subject|1|||
155572719|NCT00615199|561520171|FG002|Overall Study|Withdrawal by Subject|0|||
155572720|NCT00615199|561520172|FG003|Overall Study|Withdrawal by Subject|0|||
155572721|NCT02653625|561520173|FG000|Overall Study|Adverse Event|1|||
155572722|NCT02653625|561520173|FG000|Overall Study|Non-compliance with Study Drug|1|||
155572723|NCT02653625|561520173|FG000|Overall Study|Protocol Violation|1|||
155572724|NCT02653625|561520173|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
155572725|NCT05377749|561520176|FG000|3 Weeks|Lost to Follow-up|2|||
155572726|NCT05377749|561520177|FG001|3 Weeks|Lost to Follow-up|4|||
155572727|NCT05377749|561520176|FG000|3 Weeks|Withdrawal by Subject|1|||
155572728|NCT05377749|561520177|FG001|3 Weeks|Withdrawal by Subject|1|||
155572729|NCT02969382|561520178|FG000|Overall Study|Adverse Event|8|||
155572730|NCT02969382|561520179|FG001|Overall Study|Adverse Event|10|||
155572731|NCT02969382|561520178|FG000|Overall Study|Lack of Efficacy|4|||
155572732|NCT02969382|561520179|FG001|Overall Study|Lack of Efficacy|5|||
155572733|NCT02969382|561520178|FG000|Overall Study|Death|0|||
155572734|NCT02969382|561520179|FG001|Overall Study|Death|1|||
155572735|NCT02969382|561520178|FG000|Overall Study|PROTOCOL DEVIATION|0|||
155572736|NCT02969382|561520179|FG001|Overall Study|PROTOCOL DEVIATION|1|||
155572737|NCT02969382|561520178|FG000|Overall Study|Withdrawal by Subject|14|||
155572738|NCT02969382|561520179|FG001|Overall Study|Withdrawal by Subject|9|||
155572739|NCT02090725|561520180|FG000|Overall Study|Withdrawal by Subject|1|||
155572740|NCT02090725|561520180|FG000|Overall Study|participants moved from area|3|||
155572741|NCT00764881|561520181|FG000|Overall Study|Adverse Event|5|||
155572742|NCT00764881|561520182|FG001|Overall Study|Adverse Event|1|||
155572743|NCT00764881|561520181|FG000|Overall Study|Withdrawal by Subject|1|||
155572744|NCT00764881|561520182|FG001|Overall Study|Withdrawal by Subject|3|||
155572745|NCT00764881|561520181|FG000|Overall Study|Protocol Violation|2|||
155572746|NCT00764881|561520182|FG001|Overall Study|Protocol Violation|2|||
155572747|NCT00764881|561520181|FG000|Overall Study|Lost to Follow-up|2|||
155572748|NCT00764881|561520182|FG001|Overall Study|Lost to Follow-up|0|||
155572749|NCT00764881|561520181|FG000|Overall Study|Noncompliant|1|||
155572750|NCT00764881|561520182|FG001|Overall Study|Noncompliant|0|||
155572751|NCT00764881|561520181|FG000|Overall Study|Accidentally discontinued study drug|1|||
155572752|NCT00764881|561520182|FG001|Overall Study|Accidentally discontinued study drug|0|||
155572753|NCT00764881|561520181|FG000|Overall Study|Wished to become pregnant|1|||
155572754|NCT00764881|561520182|FG001|Overall Study|Wished to become pregnant|0|||
155572755|NCT00764881|561520181|FG000|Overall Study|Carcinoma detected|1|||
155572756|NCT00764881|561520182|FG001|Overall Study|Carcinoma detected|0|||
155572757|NCT00764881|561520181|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
155572758|NCT00764881|561520182|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
155572759|NCT00764881|561520181|FG000|Overall Study|no treatment or no observation|2|||
155572760|NCT00764881|561520182|FG001|Overall Study|no treatment or no observation|2|||
155572761|NCT01214655|561520183|FG000|Part A|Progressive Disease|7|||
155572762|NCT01214655|561520184|FG001|Part A|Progressive Disease|0|||
155572763|NCT01214655|561520185|FG002|Part A|Progressive Disease|0|||
155572764|NCT01214655|561520183|FG000|Part A|Physician Decision|1|||
155572765|NCT01214655|561520184|FG001|Part A|Physician Decision|0|||
155572766|NCT01214655|561520185|FG002|Part A|Physician Decision|0|||
155572767|NCT01214655|561520183|FG000|Part B|Progressive disease|0|||
155572768|NCT01214655|561520184|FG001|Part B|Progressive disease|10|||
155572769|NCT01214655|561520185|FG002|Part B|Progressive disease|0|||
155572770|NCT01214655|561520183|FG000|Part B|Death|0|||
155572771|NCT01214655|561520184|FG001|Part B|Death|1|||
155572772|NCT01214655|561520185|FG002|Part B|Death|0|||
155572773|NCT01214655|561520183|FG000|Part B|Withdrawal by Subject|0|||
155572774|NCT01214655|561520184|FG001|Part B|Withdrawal by Subject|2|||
155572775|NCT01214655|561520185|FG002|Part B|Withdrawal by Subject|0|||
155572776|NCT01214655|561520183|FG000|Part C|Progressive Disease|0|||
155572777|NCT01214655|561520184|FG001|Part C|Progressive Disease|0|||
155572778|NCT01214655|561520185|FG002|Part C|Progressive Disease|5|||
155572779|NCT01214655|561520183|FG000|Part C|Death|0|||
155572780|NCT01214655|561520184|FG001|Part C|Death|0|||
155572781|NCT01214655|561520185|FG002|Part C|Death|1|||
155572782|NCT01214655|561520183|FG000|Part C|Physician Decision|0|||
155572783|NCT01214655|561520184|FG001|Part C|Physician Decision|0|||
155572784|NCT01214655|561520185|FG002|Part C|Physician Decision|1|||
155572785|NCT05256134|561520190|FG000|Overall Study|Study Terminated by Sponsor|11|||
155572786|NCT05256134|561520191|FG001|Overall Study|Study Terminated by Sponsor|10|||
155572787|NCT05256134|561520190|FG000|Overall Study|Withdrawal by Subject|1|||
155572788|NCT05256134|561520191|FG001|Overall Study|Withdrawal by Subject|3|||
155572789|NCT00886015|561520192|FG000|Overall Study|Death|0|||
155572790|NCT00886015|561520193|FG001|Overall Study|Death|2|||
155572791|NCT01692626|561520194|FG000|Overall Study|Death|0|||
155572792|NCT01692626|561520195|FG001|Overall Study|Death|1|||
155572793|NCT01692626|561520194|FG000|Overall Study|Adverse Event|2|||
155572794|NCT01692626|561520195|FG001|Overall Study|Adverse Event|3|||
155572795|NCT01692626|561520194|FG000|Overall Study|Protocol Violation|1|||
155572796|NCT01692626|561520195|FG001|Overall Study|Protocol Violation|2|||
155572797|NCT01692626|561520194|FG000|Overall Study|Withdrawal by Subject|1|||
155572798|NCT01692626|561520195|FG001|Overall Study|Withdrawal by Subject|0|||
155572799|NCT00855894|561520196|FG000|Overall Study|Death|31|||
155572800|NCT00855894|561520196|FG000|Overall Study|Patient's decision|1|||
155572801|NCT00855894|561520196|FG000|Overall Study|Disease progression|1|||
155572802|NCT02794870|561520209|FG000|Overall Study|Withdrawal by Subject|2|||
155572803|NCT02794870|561520210|FG001|Overall Study|Withdrawal by Subject|0|||
155572804|NCT01625988|561520215|FG000|Overall Study|Lost to Follow-up|5|||
155572805|NCT01625988|561520216|FG001|Overall Study|Lost to Follow-up|6|||
155572806|NCT01625988|561520215|FG000|Overall Study|Withdrawal by Subject|8|||
155572807|NCT01625988|561520216|FG001|Overall Study|Withdrawal by Subject|3|||
155572808|NCT01625988|561520215|FG000|Overall Study|Adverse Event|0|||
155572809|NCT01625988|561520216|FG001|Overall Study|Adverse Event|1|||
155572810|NCT01625988|561520215|FG000|Overall Study|Lack of Efficacy|0|||
155572811|NCT01625988|561520216|FG001|Overall Study|Lack of Efficacy|1|||
155572812|NCT01625988|561520215|FG000|Overall Study|Randomized Inappropriately|1|||
155572813|NCT01625988|561520216|FG001|Overall Study|Randomized Inappropriately|0|||
155572814|NCT01625988|561520215|FG000|Overall Study|Protocol Violation|0|||
155572815|NCT01625988|561520216|FG001|Overall Study|Protocol Violation|2|||
155572816|NCT00616421|561520217|FG000|Overall Study|Withdrawal by Subject|9|||
155572817|NCT00616421|561520218|FG001|Overall Study|Withdrawal by Subject|11|||
155572818|NCT00616421|561520219|FG002|Overall Study|Withdrawal by Subject|8|||
155572819|NCT00616421|561520217|FG000|Overall Study|Lost to Follow-up|12|||
155572820|NCT00616421|561520218|FG001|Overall Study|Lost to Follow-up|26|||
155572821|NCT00616421|561520219|FG002|Overall Study|Lost to Follow-up|30|||
155572822|NCT00616421|561520217|FG000|Overall Study|Inappropriate enrollment|3|||
155572823|NCT00616421|561520218|FG001|Overall Study|Inappropriate enrollment|0|||
155572824|NCT00616421|561520219|FG002|Overall Study|Inappropriate enrollment|1|||
155572825|NCT00616421|561520217|FG000|Overall Study|Administrative reason|1|||
155572826|NCT00616421|561520218|FG001|Overall Study|Administrative reason|0|||
155572827|NCT00616421|561520219|FG002|Overall Study|Administrative reason|0|||
155572828|NCT00616421|561520217|FG000|Overall Study|Protocol Violation|0|||
155572829|NCT00616421|561520218|FG001|Overall Study|Protocol Violation|1|||
155572830|NCT00616421|561520219|FG002|Overall Study|Protocol Violation|2|||
155572831|NCT00616421|561520217|FG000|Overall Study|Unable to classify|1|||
155572832|NCT00616421|561520218|FG001|Overall Study|Unable to classify|0|||
155572833|NCT00616421|561520219|FG002|Overall Study|Unable to classify|0|||
155572834|NCT02301390|561520220|FG000|Overall Study|Withdrawal by Subject|3|||
155572835|NCT02301390|561520221|FG001|Overall Study|Withdrawal by Subject|5|||
155572836|NCT02301390|561520220|FG000|Overall Study|Protocol Violation|1|||
155572837|NCT02301390|561520221|FG001|Overall Study|Protocol Violation|0|||
155572838|NCT02301390|561520220|FG000|Overall Study|Physician Decision|1|||
155572839|NCT02301390|561520221|FG001|Overall Study|Physician Decision|0|||
155572840|NCT02301390|561520220|FG000|Overall Study|Lost to Follow-up|0|||
155572841|NCT02301390|561520221|FG001|Overall Study|Lost to Follow-up|1|||
155572842|NCT02301390|561520220|FG000|Overall Study|Death|2|||
155572843|NCT02301390|561520221|FG001|Overall Study|Death|2|||
155572844|NCT02301390|561520220|FG000|Overall Study|Procedure not completed|0|||
155572845|NCT02301390|561520221|FG001|Overall Study|Procedure not completed|4|||
155572846|NCT02301390|561520220|FG000|Overall Study|Missed multiple visits|1|||
155572847|NCT02301390|561520221|FG001|Overall Study|Missed multiple visits|1|||
155572848|NCT02301390|561520220|FG000|Overall Study|study terminated|2|||
155572849|NCT02301390|561520221|FG001|Overall Study|study terminated|0|||
155572850|NCT00191191|561520222|FG000|Overall Study|Entry Criteria Exclusion|2|||
155572851|NCT00191191|561520223|FG001|Overall Study|Entry Criteria Exclusion|0|||
155572852|NCT00191191|561520222|FG000|Overall Study|Treated with Another Systemic Agent|1|||
155572853|NCT00191191|561520223|FG001|Overall Study|Treated with Another Systemic Agent|1|||
155572854|NCT00191191|561520222|FG000|Overall Study|Adverse Event|11|||
155572855|NCT00191191|561520223|FG001|Overall Study|Adverse Event|21|||
155572856|NCT00191191|561520222|FG000|Overall Study|Progressive Disease|84|||
155572857|NCT00191191|561520223|FG001|Overall Study|Progressive Disease|72|||
155572858|NCT00191191|561520222|FG000|Overall Study|Toxicity After Dose Reduction|7|||
155572859|NCT00191191|561520223|FG001|Overall Study|Toxicity After Dose Reduction|8|||
155572860|NCT00191191|561520222|FG000|Overall Study|Family/Caregiver Decision|5|||
155572861|NCT00191191|561520223|FG001|Overall Study|Family/Caregiver Decision|7|||
155572862|NCT00191191|561520222|FG000|Overall Study|Lost to Follow-up|1|||
155572863|NCT00191191|561520223|FG001|Overall Study|Lost to Follow-up|0|||
155572864|NCT00191191|561520222|FG000|Overall Study|Physician Decision|3|||
155572865|NCT00191191|561520223|FG001|Overall Study|Physician Decision|2|||
155572866|NCT00191191|561520222|FG000|Overall Study|Good Clinical Practice Violation|0|||
155572867|NCT00191191|561520223|FG001|Overall Study|Good Clinical Practice Violation|1|||
155572868|NCT01023035|561520225|FG000|Treatment Period|Adverse Event|27|||
155572869|NCT01023035|561520226|FG001|Treatment Period|Adverse Event|32|||
155572870|NCT01023035|561520227|FG002|Treatment Period|Adverse Event|50|||
155572871|NCT01023035|561520225|FG000|Treatment Period|Non-Medical Reasons|19|||
155572872|NCT01023035|561520226|FG001|Treatment Period|Non-Medical Reasons|22|||
155572873|NCT01023035|561520227|FG002|Treatment Period|Non-Medical Reasons|44|||
155572874|NCT01023035|561520225|FG000|Treatment Period|Treatment Failure|26|||
155572875|NCT01023035|561520226|FG001|Treatment Period|Treatment Failure|31|||
155572876|NCT01023035|561520227|FG002|Treatment Period|Treatment Failure|24|||
155572877|NCT01023035|561520225|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
155572878|NCT01023035|561520226|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
155572879|NCT01023035|561520227|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
155572880|NCT01023035|561520225|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
155572881|NCT01023035|561520226|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
155572882|NCT01023035|561520227|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
155572883|NCT04342819|561520228|FG000|Overall Study|Declined|4|||
155572884|NCT04342819|561520228|FG000|Overall Study|Not meeeting selection criteria|1|||
155572885|NCT00560391|561520232|FG000|Overall Study|Still on treatment|0|||
155572886|NCT00560391|561520233|FG001|Overall Study|Still on treatment|0|||
155572887|NCT00560391|561520234|FG002|Overall Study|Still on treatment|0|||
155572888|NCT00560391|561520235|FG003|Overall Study|Still on treatment|1|||
155572889|NCT00560391|561520236|FG004|Overall Study|Still on treatment|2|||
155572890|NCT03607487|561520237|FG000|Overall Study|Withdrawal by Subject|2|||
155572891|NCT03607487|561520238|FG001|Overall Study|Withdrawal by Subject|0|||
155572892|NCT03607487|561520239|FG002|Overall Study|Withdrawal by Subject|0|||
155572893|NCT03607487|561520240|FG003|Overall Study|Withdrawal by Subject|1|||
155572894|NCT05061420|561520241|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
155572895|NCT05061420|561520242|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155572896|NCT05061420|561520243|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155572897|NCT05061420|561520241|FG000|Overall Study|Progressive disease|11|||
155572898|NCT05061420|561520242|FG001|Overall Study|Progressive disease|15|||
155572899|NCT05061420|561520243|FG002|Overall Study|Progressive disease|14|||
155572900|NCT05061420|561520241|FG000|Overall Study|Withdrawal by Subject|2|||
155572901|NCT05061420|561520242|FG001|Overall Study|Withdrawal by Subject|0|||
155572902|NCT05061420|561520243|FG002|Overall Study|Withdrawal by Subject|1|||
155572903|NCT05061420|561520241|FG000|Overall Study|Not related to COVID-19|2|||
155572904|NCT05061420|561520242|FG001|Overall Study|Not related to COVID-19|0|||
155572905|NCT05061420|561520243|FG002|Overall Study|Not related to COVID-19|0|||
155572906|NCT01814553|561520244|FG000|Overall Study|PD per clinical progression|6|||
155572907|NCT01814553|561520245|FG001|Overall Study|PD per clinical progression|8|||
155572908|NCT01814553|561520244|FG000|Overall Study|Other Adverse Event|4|||
155572909|NCT01814553|561520245|FG001|Overall Study|Other Adverse Event|5|||
155572910|NCT01814553|561520244|FG000|Overall Study|Withdrawal by Subject|1|||
155572911|NCT01814553|561520245|FG001|Overall Study|Withdrawal by Subject|1|||
155572912|NCT01814553|561520244|FG000|Overall Study|Other than stated|7|||
155572913|NCT01814553|561520245|FG001|Overall Study|Other than stated|8|||
155572914|NCT04036110|561520246|FG000|Overall Study|Lost to Follow-up|3|||
155572915|NCT04036110|561520247|FG001|Overall Study|Lost to Follow-up|2|||
155572916|NCT04036110|561520248|FG002|Overall Study|Lost to Follow-up|1|||
155572917|NCT04036110|561520246|FG000|Overall Study|Study Suspended|4|||
155572918|NCT04036110|561520247|FG001|Overall Study|Study Suspended|5|||
155572919|NCT04036110|561520248|FG002|Overall Study|Study Suspended|1|||
155572920|NCT01941498|561520249|FG000|Overall Study|Relocated out of state|1|||
155572921|NCT01301729|561520250|FG000|Overall Study|Withdrawal by Subject|2|||
155572922|NCT01301729|561520250|FG000|Overall Study|Participant did not Return for Treatment|1|||
155572923|NCT01301729|561520250|FG000|Overall Study|Violated Selection Criteria|1|||
155572924|NCT05794503|561520251|FG000|Overall Study|Operation Cancelled|2|||
155572925|NCT05794503|561520252|FG001|Overall Study|Operation Cancelled|0|||
155572926|NCT05794503|561520251|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
155572927|NCT05794503|561520252|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
155572928|NCT05794503|561520251|FG000|Overall Study|Protocol Violation|1|||
155572929|NCT05794503|561520252|FG001|Overall Study|Protocol Violation|0|||
155572930|NCT00447993|561520253|FG000|Overall Study|Lost to Follow-up|0|||
155572931|NCT00447993|561520254|FG001|Overall Study|Lost to Follow-up|0|||
155572932|NCT00447993|561520255|FG002|Overall Study|Lost to Follow-up|2|||
155572933|NCT00447993|561520256|FG003|Overall Study|Lost to Follow-up|2|||
155572934|NCT00447993|561520253|FG000|Overall Study|Withdrawal by Subject|0|||
155572935|NCT00447993|561520254|FG001|Overall Study|Withdrawal by Subject|0|||
155572936|NCT00447993|561520255|FG002|Overall Study|Withdrawal by Subject|2|||
155572937|NCT00447993|561520256|FG003|Overall Study|Withdrawal by Subject|2|||
155572938|NCT02924727|561520257|FG000|Overall Study|Withdrawal by Subject|2|||
155572939|NCT02924727|561520258|FG001|Overall Study|Withdrawal by Subject|4|||
155572940|NCT02924727|561520257|FG000|Overall Study|Lost to Follow-up|2|||
155572941|NCT02924727|561520258|FG001|Overall Study|Lost to Follow-up|5|||
155572942|NCT02924727|561520257|FG000|Overall Study|Death|221|||
155572943|NCT02924727|561520258|FG001|Overall Study|Death|247|||
155572944|NCT02924727|561520257|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
155572945|NCT02924727|561520258|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
155572946|NCT01464931|561520261|FG000|Overall Study|Withdrawal by Subject|1|||
155572947|NCT01464931|561520262|FG001|Overall Study|Withdrawal by Subject|0|||
155572948|NCT01982812|561520263|FG000|Overall Study|Death|1|||
155572949|NCT01982812|561520264|FG001|Overall Study|Death|5|||
155572950|NCT01982812|561520263|FG000|Overall Study|Adverse Event|0|||
155572951|NCT01982812|561520264|FG001|Overall Study|Adverse Event|5|||
155572952|NCT00307437|561520266|FG000|Controlled Period|Adverse Event|7|||
155572953|NCT00307437|561520267|FG001|Controlled Period|Adverse Event|2|||
155572954|NCT00307437|561520268|FG002|Controlled Period|Adverse Event|5|||
155572955|NCT00307437|561520269|FG003|Controlled Period|Adverse Event|0|||
155572956|NCT00307437|561520270|FG004|Controlled Period|Adverse Event|0|||
155572957|NCT00307437|561520271|FG005|Controlled Period|Adverse Event|0|||
155572958|NCT00307437|561520272|FG006|Controlled Period|Adverse Event|0|||
155572959|NCT00307437|561520266|FG000|Controlled Period|Death|0|||
155572960|NCT00307437|561520267|FG001|Controlled Period|Death|0|||
155572961|NCT00307437|561520268|FG002|Controlled Period|Death|1|||
155572962|NCT00307437|561520269|FG003|Controlled Period|Death|0|||
155661171|NCT04583618|561854612|FG003|Overall Study|Withdrawal by Subject|1|||
155572963|NCT00307437|561520270|FG004|Controlled Period|Death|0|||
155572964|NCT00307437|561520271|FG005|Controlled Period|Death|0|||
155572965|NCT00307437|561520272|FG006|Controlled Period|Death|0|||
155572966|NCT00307437|561520266|FG000|Controlled Period|Lack of Efficacy|2|||
155572967|NCT00307437|561520267|FG001|Controlled Period|Lack of Efficacy|0|||
155572968|NCT00307437|561520268|FG002|Controlled Period|Lack of Efficacy|0|||
155572969|NCT00307437|561520269|FG003|Controlled Period|Lack of Efficacy|0|||
155572970|NCT00307437|561520270|FG004|Controlled Period|Lack of Efficacy|0|||
155572971|NCT00307437|561520271|FG005|Controlled Period|Lack of Efficacy|0|||
155572972|NCT00307437|561520272|FG006|Controlled Period|Lack of Efficacy|0|||
155572973|NCT00307437|561520266|FG000|Controlled Period|Lost to Follow-up|2|||
155572974|NCT00307437|561520267|FG001|Controlled Period|Lost to Follow-up|3|||
155572975|NCT00307437|561520268|FG002|Controlled Period|Lost to Follow-up|0|||
155572976|NCT00307437|561520269|FG003|Controlled Period|Lost to Follow-up|0|||
155572977|NCT00307437|561520270|FG004|Controlled Period|Lost to Follow-up|0|||
155572978|NCT00307437|561520271|FG005|Controlled Period|Lost to Follow-up|0|||
155572979|NCT00307437|561520272|FG006|Controlled Period|Lost to Follow-up|0|||
155572980|NCT00307437|561520266|FG000|Controlled Period|Other|5|||
155572981|NCT00307437|561520267|FG001|Controlled Period|Other|1|||
155572982|NCT00307437|561520268|FG002|Controlled Period|Other|3|||
155572983|NCT00307437|561520269|FG003|Controlled Period|Other|0|||
155572984|NCT00307437|561520270|FG004|Controlled Period|Other|0|||
155572985|NCT00307437|561520271|FG005|Controlled Period|Other|0|||
155572986|NCT00307437|561520272|FG006|Controlled Period|Other|0|||
155572987|NCT00307437|561520266|FG000|After Controlled Period|Adverse Event|0|||
155661172|NCT04583618|561854613|FG004|Overall Study|Withdrawal by Subject|1|||
155572988|NCT00307437|561520267|FG001|After Controlled Period|Adverse Event|0|||
155572989|NCT00307437|561520268|FG002|After Controlled Period|Adverse Event|0|||
155572990|NCT00307437|561520269|FG003|After Controlled Period|Adverse Event|18|||
155572991|NCT00307437|561520270|FG004|After Controlled Period|Adverse Event|16|||
155572992|NCT00307437|561520271|FG005|After Controlled Period|Adverse Event|31|||
155572993|NCT00307437|561520272|FG006|After Controlled Period|Adverse Event|40|||
155572994|NCT00307437|561520266|FG000|After Controlled Period|Death|0|||
155572995|NCT00307437|561520267|FG001|After Controlled Period|Death|0|||
155572996|NCT00307437|561520268|FG002|After Controlled Period|Death|0|||
155572997|NCT00307437|561520269|FG003|After Controlled Period|Death|3|||
155572998|NCT00307437|561520270|FG004|After Controlled Period|Death|1|||
155572999|NCT00307437|561520271|FG005|After Controlled Period|Death|1|||
155573000|NCT00307437|561520272|FG006|After Controlled Period|Death|3|||
155573001|NCT00307437|561520266|FG000|After Controlled Period|Lack of Efficacy|0|||
155573002|NCT00307437|561520267|FG001|After Controlled Period|Lack of Efficacy|0|||
155573003|NCT00307437|561520268|FG002|After Controlled Period|Lack of Efficacy|0|||
155573004|NCT00307437|561520269|FG003|After Controlled Period|Lack of Efficacy|15|||
155573005|NCT00307437|561520270|FG004|After Controlled Period|Lack of Efficacy|17|||
155573006|NCT00307437|561520271|FG005|After Controlled Period|Lack of Efficacy|37|||
155573007|NCT00307437|561520272|FG006|After Controlled Period|Lack of Efficacy|24|||
155573008|NCT00307437|561520266|FG000|After Controlled Period|Lost to Follow-up|0|||
155573009|NCT00307437|561520267|FG001|After Controlled Period|Lost to Follow-up|0|||
155573010|NCT00307437|561520268|FG002|After Controlled Period|Lost to Follow-up|0|||
155573011|NCT00307437|561520269|FG003|After Controlled Period|Lost to Follow-up|7|||
155573012|NCT00307437|561520270|FG004|After Controlled Period|Lost to Follow-up|12|||
155573013|NCT00307437|561520271|FG005|After Controlled Period|Lost to Follow-up|13|||
155573014|NCT00307437|561520272|FG006|After Controlled Period|Lost to Follow-up|18|||
155573015|NCT00307437|561520266|FG000|After Controlled Period|Other|0|||
155573016|NCT00307437|561520267|FG001|After Controlled Period|Other|0|||
155573017|NCT00307437|561520268|FG002|After Controlled Period|Other|0|||
155573018|NCT00307437|561520269|FG003|After Controlled Period|Other|15|||
155573019|NCT00307437|561520270|FG004|After Controlled Period|Other|9|||
155573020|NCT00307437|561520271|FG005|After Controlled Period|Other|40|||
155573021|NCT00307437|561520272|FG006|After Controlled Period|Other|28|||
155573022|NCT00338728|561520273|FG000|Overall Study|Screen Failure|14|||
155573023|NCT04380961|561520276|FG000|Overall Study|Lost to Follow-up|17|||
155573024|NCT04380961|561520277|FG001|Overall Study|Lost to Follow-up|11|||
155573025|NCT04380961|561520276|FG000|Overall Study|Withdrawal by Subject|3|||
155573026|NCT04380961|561520277|FG001|Overall Study|Withdrawal by Subject|0|||
155573027|NCT04380961|561520276|FG000|Overall Study|Death|22|||
155573028|NCT04380961|561520277|FG001|Overall Study|Death|16|||
155573029|NCT04380961|561520276|FG000|Overall Study|Other|1|||
155573030|NCT04380961|561520277|FG001|Overall Study|Other|0|||
155573031|NCT04380961|561520276|FG000|Overall Study|Randomized but Not Treated|1|||
155573032|NCT04380961|561520277|FG001|Overall Study|Randomized but Not Treated|2|||
155573033|NCT01862484|561520278|FG000|Overall Study|Lack of Efficacy|1|||
155573034|NCT01862484|561520279|FG001|Overall Study|Lack of Efficacy|1|||
155573035|NCT01862484|561520278|FG000|Overall Study|Lost to Follow-up|1|||
155573036|NCT01862484|561520279|FG001|Overall Study|Lost to Follow-up|2|||
155573037|NCT01862484|561520278|FG000|Overall Study|Protocol Violation|0|||
155573038|NCT01862484|561520279|FG001|Overall Study|Protocol Violation|2|||
155573039|NCT01862484|561520278|FG000|Overall Study|Withdrawal by Subject|0|||
155573040|NCT01862484|561520279|FG001|Overall Study|Withdrawal by Subject|3|||
155573041|NCT00721227|561520280|FG000|Overall Study|Lost to Follow-up|3|||
155573042|NCT00721227|561520281|FG001|Overall Study|Lost to Follow-up|0|||
155573043|NCT00721227|561520280|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
155573044|NCT00721227|561520281|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
155573045|NCT05422625|561520282|FG000|Overall Study|Withdrawal by Subject|1|||
155573046|NCT05422625|561520283|FG001|Overall Study|Withdrawal by Subject|0|||
155573047|NCT06419907|561522621|FG000|Overall Study|Protocol Violation|0|||
155573048|NCT06419907|561522622|FG001|Overall Study|Protocol Violation|3|||
155573049|NCT06419907|561522623|FG002|Overall Study|Protocol Violation|0|||
155573050|NCT06419907|561522624|FG003|Overall Study|Protocol Violation|1|||
155573051|NCT06419907|561522621|FG000|Overall Study|Lost to Follow-up|0|||
155573052|NCT06419907|561522622|FG001|Overall Study|Lost to Follow-up|0|||
155573053|NCT06419907|561522623|FG002|Overall Study|Lost to Follow-up|2|||
155573054|NCT06419907|561522624|FG003|Overall Study|Lost to Follow-up|1|||
155573055|NCT01427608|561522625|FG000|Overall Study|Death|1|||
155573056|NCT01427608|561522626|FG001|Overall Study|Death|0|||
155573057|NCT01427608|561522625|FG000|Overall Study|Withdrawal by Subject|7|||
155573058|NCT01427608|561522626|FG001|Overall Study|Withdrawal by Subject|3|||
155573059|NCT01427608|561522625|FG000|Overall Study|Relapsed-all cause|13|||
155573060|NCT01427608|561522626|FG001|Overall Study|Relapsed-all cause|34|||
155573061|NCT01427608|561522625|FG000|Overall Study|Events not attributed to study meds|0|||
155573062|NCT01427608|561522626|FG001|Overall Study|Events not attributed to study meds|1|||
155573063|NCT01473407|561522627|FG000|Overall Study|Physician Decision|1|||
155573064|NCT01473407|561522628|FG001|Overall Study|Physician Decision|4|||
155573065|NCT01473407|561522627|FG000|Overall Study|Lost to Follow-up|10|||
155573066|NCT01473407|561522628|FG001|Overall Study|Lost to Follow-up|4|||
155573067|NCT01473407|561522627|FG000|Overall Study|Adverse Event|8|||
155573068|NCT01473407|561522628|FG001|Overall Study|Adverse Event|8|||
155573069|NCT01473407|561522627|FG000|Overall Study|Randomization Error|3|||
155573070|NCT01473407|561522628|FG001|Overall Study|Randomization Error|1|||
155573071|NCT01473407|561522627|FG000|Overall Study|Withdrawal by Subject|4|||
155573072|NCT01473407|561522628|FG001|Overall Study|Withdrawal by Subject|7|||
155573073|NCT01473407|561522627|FG000|Overall Study|Kidney Transplant|7|||
155573074|NCT01473407|561522628|FG001|Overall Study|Kidney Transplant|6|||
155573075|NCT01473407|561522627|FG000|Overall Study|Vacation/Travel|1|||
155573076|NCT01473407|561522628|FG001|Overall Study|Vacation/Travel|1|||
155573077|NCT01473407|561522627|FG000|Overall Study|Elevated Hemoglobin|1|||
155573078|NCT01473407|561522628|FG001|Overall Study|Elevated Hemoglobin|0|||
155573079|NCT01473407|561522627|FG000|Overall Study|Patient Received Aranesp|1|||
155573080|NCT01473407|561522628|FG001|Overall Study|Patient Received Aranesp|0|||
155573081|NCT01473407|561522627|FG000|Overall Study|Patient Lost Green Card Status|1|||
155573082|NCT01473407|561522628|FG001|Overall Study|Patient Lost Green Card Status|0|||
155573083|NCT01473407|561522627|FG000|Overall Study|Temperature Excursion|2|||
155573084|NCT01473407|561522628|FG001|Overall Study|Temperature Excursion|3|||
155573085|NCT01473407|561522627|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
155573086|NCT01473407|561522628|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
155573087|NCT01473407|561522627|FG000|Overall Study|Sponsor's Decision|10|||
155573088|NCT01473407|561522628|FG001|Overall Study|Sponsor's Decision|10|||
155573089|NCT01473407|561522627|FG000|Overall Study|Site Closure|1|||
155573090|NCT01473407|561522628|FG001|Overall Study|Site Closure|0|||
155573091|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
155573092|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
155573093|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
155573094|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
155573095|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
155661173|NCT04583618|561854609|FG000|Overall Study|Lost to Follow-up|0|||
155661174|NCT04583618|561854610|FG001|Overall Study|Lost to Follow-up|1|||
155661175|NCT04583618|561854611|FG002|Overall Study|Lost to Follow-up|3|||
155661176|NCT04583618|561854612|FG003|Overall Study|Lost to Follow-up|1|||
155661177|NCT04583618|561854613|FG004|Overall Study|Lost to Follow-up|1|||
155661178|NCT02302222|561854616|FG000|Overall Study|Physician Decision|0|||
155661179|NCT02302222|561854617|FG001|Overall Study|Physician Decision|4|||
155661180|NCT02302222|561854616|FG000|Overall Study|Lost to Follow-up|1|||
155661181|NCT02302222|561854617|FG001|Overall Study|Lost to Follow-up|0|||
155661182|NCT02302222|561854616|FG000|Overall Study|Treatment discontinued before day 5|0|||
155661183|NCT02302222|561854617|FG001|Overall Study|Treatment discontinued before day 5|1|||
155661184|NCT02302222|561854616|FG000|Overall Study|Withdrawn prior to any treatment|0|||
155661185|NCT02302222|561854617|FG001|Overall Study|Withdrawn prior to any treatment|1|||
155661186|NCT02293551|561854620|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
155661187|NCT02293551|561854621|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
155661188|NCT02293551|561854622|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
155661189|NCT02293551|561854623|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
155661190|NCT02293551|561854624|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
155661191|NCT02293551|561854625|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
155573096|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
155573097|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155573098|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155573099|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
155573100|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
155573101|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
155573102|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
155661192|NCT02293551|561854620|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
155661193|NCT02293551|561854621|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
155661194|NCT02293551|561854622|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
155661195|NCT02293551|561854623|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
155661196|NCT02293551|561854624|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
155661197|NCT02293551|561854625|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
155661198|NCT02293551|561854620|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
155661199|NCT02293551|561854621|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
155573103|NCT02422797|561522629|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
155573104|NCT02422797|561522630|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
155573105|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
155573106|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
155573107|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
155573108|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
155573109|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
155573110|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
155573111|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
155573112|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
155573113|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
155573114|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
155573115|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
155573116|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
155573117|NCT02422797|561522629|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155573118|NCT02422797|561522630|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
155573119|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
155573120|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
155573121|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
155573122|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
155573123|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
155573124|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
155573125|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
155573126|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
155573127|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
155573128|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
155573129|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
155573130|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
155573131|NCT02422797|561522629|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
155573132|NCT02422797|561522630|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
155573133|NCT04071405|561522631|FG000|Overall Study|Protocol Violation|3|||
155573134|NCT01027702|561522636|FG000|Overall Study|Received subsequent therapy|1|||
155573135|NCT01027702|561522637|FG001|Overall Study|Received subsequent therapy|2|||
155573136|NCT01027702|561522638|FG002|Overall Study|Received subsequent therapy|0|||
155573137|NCT01027702|561522639|FG003|Overall Study|Received subsequent therapy|4|||
155573138|NCT01027702|561522640|FG004|Overall Study|Received subsequent therapy|1|||
155573139|NCT01027702|561522641|FG005|Overall Study|Received subsequent therapy|0|||
155573140|NCT01027702|561522642|FG006|Overall Study|Received subsequent therapy|1|||
155573141|NCT01027702|561522636|FG000|Overall Study|Death|0|||
155573142|NCT01027702|561522637|FG001|Overall Study|Death|0|||
155573143|NCT01027702|561522638|FG002|Overall Study|Death|1|||
155573144|NCT01027702|561522639|FG003|Overall Study|Death|0|||
155573145|NCT01027702|561522640|FG004|Overall Study|Death|0|||
155573146|NCT01027702|561522641|FG005|Overall Study|Death|0|||
155573147|NCT01027702|561522642|FG006|Overall Study|Death|0|||
155573148|NCT00403585|561522643|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
155573149|NCT00403585|561522643|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
155573150|NCT00403585|561522643|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
155573151|NCT03685344|561522648|FG000|Overall Study|Withdrawal by Subject|1|||
155573152|NCT03685344|561522649|FG001|Overall Study|Withdrawal by Subject|1|||
155573153|NCT03685344|561522650|FG002|Overall Study|Withdrawal by Subject|2|||
155573154|NCT03685344|561522651|FG003|Overall Study|Withdrawal by Subject|0|||
155573155|NCT03685344|561522648|FG000|Overall Study|Physician Decision|1|||
155573156|NCT03685344|561522649|FG001|Overall Study|Physician Decision|1|||
155573157|NCT03685344|561522650|FG002|Overall Study|Physician Decision|5|||
155573158|NCT03685344|561522651|FG003|Overall Study|Physician Decision|0|||
155573159|NCT03685344|561522648|FG000|Overall Study|Death|1|||
155573160|NCT03685344|561522649|FG001|Overall Study|Death|1|||
155573161|NCT03685344|561522650|FG002|Overall Study|Death|0|||
155573162|NCT03685344|561522651|FG003|Overall Study|Death|0|||
155573163|NCT02121652|561522654|FG000|Overall Study|Lost to Follow-up|2|||
155573164|NCT02121652|561522655|FG001|Overall Study|Lost to Follow-up|1|||
155573165|NCT02121652|561522654|FG000|Overall Study|Death|1|||
155573166|NCT02121652|561522655|FG001|Overall Study|Death|0|||
155573167|NCT02121652|561522654|FG000|Overall Study|Withdrawal by Subject|3|||
155573168|NCT02121652|561522655|FG001|Overall Study|Withdrawal by Subject|3|||
155573169|NCT02276807|561522656|FG000|Overall Study|Withdrawal by Subject|8|||
155573170|NCT02276807|561522657|FG001|Overall Study|Withdrawal by Subject|7|||
155573171|NCT02276807|561522656|FG000|Overall Study|Lost to Follow-up|10|||
155573172|NCT02276807|561522657|FG001|Overall Study|Lost to Follow-up|10|||
155573173|NCT00261950|561522659|FG000|Overall Study|Lost to Follow-up|2|||
155661200|NCT02293551|561854622|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
155661201|NCT02293551|561854623|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
155661202|NCT02293551|561854624|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
155661203|NCT02293551|561854625|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
155661204|NCT02936323|561854626|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661205|NCT02936323|561854627|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155661206|NCT02936323|561854628|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661207|NCT02936323|561854629|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155661208|NCT02936323|561854630|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155661209|NCT02936323|561854631|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155661210|NCT02936323|561854632|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661211|NCT02936323|561854633|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661212|NCT02936323|561854634|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661213|NCT02936323|561854635|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155661214|NCT02936323|561854626|FG000|Phase 1 Dose Escalation|Death|2|||
155661215|NCT02936323|561854627|FG001|Phase 1 Dose Escalation|Death|1|||
155661216|NCT02936323|561854628|FG002|Phase 1 Dose Escalation|Death|3|||
155661217|NCT02936323|561854629|FG003|Phase 1 Dose Escalation|Death|1|||
155661218|NCT02936323|561854630|FG004|Phase 1 Dose Escalation|Death|2|||
155661219|NCT02936323|561854631|FG005|Phase 1 Dose Escalation|Death|3|||
155661220|NCT02936323|561854632|FG006|Phase 1 Dose Escalation|Death|3|||
155661221|NCT02936323|561854633|FG007|Phase 1 Dose Escalation|Death|0|||
155661222|NCT02936323|561854634|FG008|Phase 1 Dose Escalation|Death|0|||
155661223|NCT02936323|561854635|FG009|Phase 1 Dose Escalation|Death|0|||
155661224|NCT02936323|561854626|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661225|NCT02936323|561854627|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661226|NCT02936323|561854628|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661227|NCT02936323|561854629|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661228|NCT02936323|561854630|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661229|NCT02936323|561854631|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
155661230|NCT02936323|561854632|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661231|NCT02936323|561854633|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661232|NCT02936323|561854634|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661233|NCT02936323|561854635|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155661234|NCT02936323|561854626|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661235|NCT02936323|561854627|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661236|NCT02936323|561854628|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661237|NCT02936323|561854629|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661238|NCT02936323|561854630|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661239|NCT02936323|561854631|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661240|NCT02936323|561854632|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155661241|NCT02936323|561854633|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
155661242|NCT02936323|561854634|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
155661243|NCT02936323|561854635|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
155661244|NCT02936323|561854626|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
155661245|NCT02936323|561854627|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
155661246|NCT02936323|561854628|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
155661247|NCT02936323|561854629|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
155661248|NCT02936323|561854630|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
155661249|NCT02936323|561854631|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
155661250|NCT02936323|561854632|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
155661251|NCT02936323|561854633|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
155661252|NCT02936323|561854634|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
155661253|NCT02936323|561854635|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
155661254|NCT02936323|561854626|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661255|NCT02936323|561854627|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661256|NCT02936323|561854628|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661257|NCT02936323|561854629|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661258|NCT02936323|561854630|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661259|NCT02936323|561854631|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661260|NCT02936323|561854632|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661261|NCT02936323|561854633|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
155661262|NCT02936323|561854634|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
155661263|NCT02936323|561854635|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155661264|NCT02936323|561854626|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661265|NCT02936323|561854627|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661266|NCT02936323|561854628|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661267|NCT02936323|561854629|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155573174|NCT00261950|561522659|FG000|Overall Study|Death|6|||
155573175|NCT00261950|561522659|FG000|Overall Study|Withdrawal by Subject|5|||
155573176|NCT00261950|561522659|FG000|Overall Study|Other|1|||
155573177|NCT00261950|561522659|FG000|Overall Study|Physician Decision|1|||
155573178|NCT00261950|561522659|FG000|Overall Study|Protocol specified Criteria|11|||
155573179|NCT00247676|561522664|FG000|Overall Study|Death|5|||
155573180|NCT00247676|561522664|FG000|Overall Study|Adverse Event|11|||
155573181|NCT00247676|561522664|FG000|Overall Study|Lack of Efficacy|15|||
155573182|NCT00247676|561522664|FG000|Overall Study|Other|3|||
155573183|NCT00247676|561522664|FG000|Overall Study|Withdrawal by Subject|2|||
155573184|NCT00668317|561522665|FG000|Overall Study|Adverse Event|2|||
155573185|NCT01526655|561522670|FG000|Overall Study|Withdrawal by Subject|0|||
155573186|NCT01526655|561522671|FG001|Overall Study|Withdrawal by Subject|1|||
155573187|NCT00280735|561522672|FG000|Overall Study|Adverse Event|5|||
155573188|NCT00280735|561522672|FG000|Overall Study|Lack of Efficacy|3|||
155573189|NCT00280735|561522672|FG000|Overall Study|Withdrawal by Subject|8|||
155573190|NCT00280735|561522672|FG000|Overall Study|Intercurrent Illness|2|||
155573191|NCT04753216|561522673|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
155573192|NCT04753216|561522673|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
155573193|NCT04753216|561522673|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
155573194|NCT01965860|561522675|FG000|Overall Study|Pregnancy|1|||
155573195|NCT01965860|561522676|FG001|Overall Study|Pregnancy|0|||
155573196|NCT01965860|561522677|FG002|Overall Study|Pregnancy|1|||
155573197|NCT01965860|561522675|FG000|Overall Study|Logistics|1|||
155573198|NCT01965860|561522676|FG001|Overall Study|Logistics|0|||
155573199|NCT01965860|561522677|FG002|Overall Study|Logistics|0|||
155573200|NCT02064296|561522681|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
155573201|NCT02064296|561522682|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
155573202|NCT02064296|561522683|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
155573203|NCT02064296|561522681|FG000|Intervention|Withdrawal by Subject|0|||
155573204|NCT02064296|561522682|FG001|Intervention|Withdrawal by Subject|1|||
155573205|NCT02064296|561522683|FG002|Intervention|Withdrawal by Subject|2|||
155573206|NCT00666328|561522697|FG000|Overall Study|Death|2|||
155573207|NCT00666328|561522697|FG000|Overall Study|Lost to Follow-up|2|||
155573208|NCT00666328|561522697|FG000|Overall Study|No longer met eligibility criteria|1|||
155573209|NCT02288325|561522698|FG000|Run-in Period|Adverse Event|48|||
155573210|NCT02288325|561522699|FG001|Run-in Period|Adverse Event|0|||
155573211|NCT02288325|561522700|FG002|Run-in Period|Adverse Event|0|||
155573212|NCT02288325|561522698|FG000|Run-in Period|Lack of Efficacy|16|||
155573213|NCT02288325|561522699|FG001|Run-in Period|Lack of Efficacy|0|||
155573214|NCT02288325|561522700|FG002|Run-in Period|Lack of Efficacy|0|||
155573215|NCT02288325|561522698|FG000|Run-in Period|Withdrawal of Consent|28|||
155573216|NCT02288325|561522699|FG001|Run-in Period|Withdrawal of Consent|0|||
155573217|NCT02288325|561522700|FG002|Run-in Period|Withdrawal of Consent|0|||
155573218|NCT02288325|561522698|FG000|Run-in Period|Lost to Follow-up|25|||
155573219|NCT02288325|561522699|FG001|Run-in Period|Lost to Follow-up|0|||
155573220|NCT02288325|561522700|FG002|Run-in Period|Lost to Follow-up|0|||
155573221|NCT02288325|561522698|FG000|Run-in Period|Protocol Violation|17|||
155573222|NCT02288325|561522699|FG001|Run-in Period|Protocol Violation|0|||
155573223|NCT02288325|561522700|FG002|Run-in Period|Protocol Violation|0|||
155573224|NCT02288325|561522698|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
155573225|NCT02288325|561522699|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
155573226|NCT02288325|561522700|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
155573227|NCT02288325|561522698|FG000|Run-in Period|Reason not Specified|8|||
155573228|NCT02288325|561522699|FG001|Run-in Period|Reason not Specified|0|||
155573229|NCT02288325|561522700|FG002|Run-in Period|Reason not Specified|0|||
155573230|NCT02288325|561522698|FG000|Stabilization Period|Adverse Event|13|||
155573231|NCT02288325|561522699|FG001|Stabilization Period|Adverse Event|0|||
155573232|NCT02288325|561522700|FG002|Stabilization Period|Adverse Event|0|||
155573233|NCT02288325|561522698|FG000|Stabilization Period|Lack of Efficacy|22|||
155573234|NCT02288325|561522699|FG001|Stabilization Period|Lack of Efficacy|0|||
155573235|NCT02288325|561522700|FG002|Stabilization Period|Lack of Efficacy|0|||
155573236|NCT02288325|561522698|FG000|Stabilization Period|Withdrawal of Consent|23|||
155573237|NCT02288325|561522699|FG001|Stabilization Period|Withdrawal of Consent|0|||
155573238|NCT02288325|561522700|FG002|Stabilization Period|Withdrawal of Consent|0|||
155573239|NCT02288325|561522698|FG000|Stabilization Period|Lost to Follow-up|12|||
155573240|NCT02288325|561522699|FG001|Stabilization Period|Lost to Follow-up|0|||
155573241|NCT02288325|561522700|FG002|Stabilization Period|Lost to Follow-up|0|||
155573242|NCT02288325|561522698|FG000|Stabilization Period|Protocol Violation|8|||
155573243|NCT02288325|561522699|FG001|Stabilization Period|Protocol Violation|0|||
155573244|NCT02288325|561522700|FG002|Stabilization Period|Protocol Violation|0|||
155573245|NCT02288325|561522698|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
155573246|NCT02288325|561522699|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
155573247|NCT02288325|561522700|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
155573248|NCT02288325|561522698|FG000|Stabilization Period|Reason not Specified|15|||
155573249|NCT02288325|561522699|FG001|Stabilization Period|Reason not Specified|0|||
155573250|NCT02288325|561522700|FG002|Stabilization Period|Reason not Specified|0|||
155573251|NCT02288325|561522698|FG000|Double-blind Treatment Period|Adverse Event|0|||
155573252|NCT02288325|561522699|FG001|Double-blind Treatment Period|Adverse Event|2|||
155573253|NCT02288325|561522700|FG002|Double-blind Treatment Period|Adverse Event|5|||
155573254|NCT02288325|561522698|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
155573255|NCT02288325|561522699|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
155573256|NCT02288325|561522700|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
155573257|NCT02288325|561522698|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155573258|NCT02288325|561522699|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
155573259|NCT02288325|561522700|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155573260|NCT02288325|561522698|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155573261|NCT02288325|561522699|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155573262|NCT02288325|561522700|FG002|Double-blind Treatment Period|Protocol Violation|2|||
155573263|NCT02288325|561522698|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
155573264|NCT02288325|561522699|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
155573265|NCT02288325|561522700|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
155573266|NCT02288325|561522698|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
155573267|NCT02288325|561522699|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
155573268|NCT02288325|561522700|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
155573269|NCT01884337|561522703|FG000|Treatment|Adverse Event|2|||
155573270|NCT01884337|561522704|FG001|Treatment|Adverse Event|2|||
155573271|NCT01884337|561522703|FG000|Treatment|Subj. request to discont. treatment|2|||
155573272|NCT01884337|561522704|FG001|Treatment|Subj. request to discont. treatment|0|||
155573273|NCT01884337|561522703|FG000|Follow-up Period|Lost to Follow-up|1|||
155573274|NCT01884337|561522704|FG001|Follow-up Period|Lost to Follow-up|1|||
155573275|NCT02455518|561522705|FG000|Overall Study|Protocol Violation|0|||
155573276|NCT02455518|561522706|FG001|Overall Study|Protocol Violation|1|||
155573277|NCT02455518|561522707|FG002|Overall Study|Protocol Violation|1|||
155573278|NCT02455518|561522708|FG003|Overall Study|Protocol Violation|3|||
155573279|NCT04186845|561522710|FG000|Overall Study|Death|2|||
155573280|NCT04186845|561522710|FG000|Overall Study|Lost to Follow-up|1|||
155573281|NCT04186845|561522710|FG000|Overall Study|Physician Decision|1|||
155573282|NCT04186845|561522710|FG000|Overall Study|Protocol Violation|1|||
155573283|NCT04186845|561522710|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
155573284|NCT04186845|561522710|FG000|Overall Study|Biopsy ordered but not done|1|||
155573285|NCT04186845|561522710|FG000|Overall Study|It was previously confirmed|1|||
155573286|NCT04186845|561522710|FG000|Overall Study|Patient cancelled scheduled scans|2|||
155573287|NCT04186845|561522710|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
155573288|NCT04186845|561522710|FG000|Overall Study|Subject refused confirmatory imaging|1|||
155573289|NCT04186845|561522710|FG000|Overall Study|Too small to biopsy|1|||
155573290|NCT03151304|561522711|FG000|Overall Study|Termination of study by Sponsor|23|||
155573291|NCT03151304|561522711|FG000|Overall Study|missing|3|||
155573292|NCT03151304|561522711|FG000|Overall Study|Withdrawal by Subject|8|||
155573293|NCT03151304|561522711|FG000|Overall Study|multiple reasons|30|||
155573294|NCT01332292|561522713|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155573295|NCT01332292|561522714|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155573296|NCT01332292|561522713|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155573297|NCT01332292|561522714|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155573298|NCT01332292|561522713|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
155573299|NCT01332292|561522714|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
155573300|NCT00098774|561522716|FG000|Overall Study|Adverse Event|2|||
155573301|NCT00098774|561522716|FG000|Overall Study|Disease Progression|9|||
155573302|NCT00098774|561522716|FG000|Overall Study|Withdrawal by Subject|1|||
155573303|NCT00098774|561522716|FG000|Overall Study|Failed (to respond) during induction|4|||
155573304|NCT00098774|561522716|FG000|Overall Study|Physician Decision|2|||
155573305|NCT00796757|561522717|FG000|Overall Study|Withdrawal by Subject|14|||
155573306|NCT00796757|561522717|FG000|Overall Study|Death|61|||
155573307|NCT00796757|561522717|FG000|Overall Study|Protocol Violation|1|||
155573308|NCT00796757|561522717|FG000|Overall Study|Participant noncompliance|1|||
155573309|NCT00796757|561522717|FG000|Overall Study|Investigator's decision|2|||
155573310|NCT00796757|561522717|FG000|Overall Study|Other|7|||
155661268|NCT02936323|561854630|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661269|NCT02936323|561854631|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155573311|NCT00174954|561522721|FG000|Overall Study|Adverse Event|2|||
155573312|NCT00174954|561522721|FG000|Overall Study|No tophi found in MRI|1|||
155573313|NCT00174954|561522721|FG000|Overall Study|Physician Decision|1|||
155573314|NCT00839254|561522722|FG000|Overall Study|Protocol Violation|0|||
155573315|NCT00839254|561522723|FG001|Overall Study|Protocol Violation|1|||
155573316|NCT00839254|561522724|FG002|Overall Study|Protocol Violation|1|||
155573317|NCT00839254|561522725|FG003|Overall Study|Protocol Violation|1|||
155573318|NCT00839254|561522726|FG004|Overall Study|Protocol Violation|0|||
155573319|NCT00839254|561522727|FG005|Overall Study|Protocol Violation|0|||
155573320|NCT00839254|561522728|FG006|Overall Study|Protocol Violation|1|||
155573321|NCT00839254|561522729|FG007|Overall Study|Protocol Violation|2|||
155573322|NCT00839254|561522722|FG000|Overall Study|Physician Decision|0|||
155573323|NCT00839254|561522723|FG001|Overall Study|Physician Decision|1|||
155573324|NCT00839254|561522724|FG002|Overall Study|Physician Decision|0|||
155573325|NCT00839254|561522725|FG003|Overall Study|Physician Decision|0|||
155573326|NCT00839254|561522726|FG004|Overall Study|Physician Decision|0|||
155573327|NCT00839254|561522727|FG005|Overall Study|Physician Decision|0|||
155573328|NCT00839254|561522728|FG006|Overall Study|Physician Decision|0|||
155573329|NCT00839254|561522729|FG007|Overall Study|Physician Decision|1|||
155573330|NCT00839254|561522722|FG000|Overall Study|Wrong treatment number allocation|0|||
155573331|NCT00839254|561522723|FG001|Overall Study|Wrong treatment number allocation|1|||
155573332|NCT00839254|561522724|FG002|Overall Study|Wrong treatment number allocation|0|||
155573333|NCT00839254|561522725|FG003|Overall Study|Wrong treatment number allocation|0|||
155573334|NCT00839254|561522726|FG004|Overall Study|Wrong treatment number allocation|0|||
155573335|NCT00839254|561522727|FG005|Overall Study|Wrong treatment number allocation|1|||
155573336|NCT00839254|561522728|FG006|Overall Study|Wrong treatment number allocation|0|||
155573337|NCT00839254|561522729|FG007|Overall Study|Wrong treatment number allocation|0|||
155573338|NCT00839254|561522722|FG000|Overall Study|Adverse Event|12|||
155573339|NCT00839254|561522723|FG001|Overall Study|Adverse Event|6|||
155573340|NCT00839254|561522724|FG002|Overall Study|Adverse Event|3|||
155573341|NCT00839254|561522725|FG003|Overall Study|Adverse Event|5|||
155573342|NCT00839254|561522726|FG004|Overall Study|Adverse Event|2|||
155573343|NCT00839254|561522727|FG005|Overall Study|Adverse Event|1|||
155573344|NCT00839254|561522728|FG006|Overall Study|Adverse Event|0|||
155573345|NCT00839254|561522729|FG007|Overall Study|Adverse Event|1|||
155573346|NCT00839254|561522722|FG000|Overall Study|Withdrawal by Subject|87|||
155573347|NCT00839254|561522723|FG001|Overall Study|Withdrawal by Subject|53|||
155573348|NCT00839254|561522724|FG002|Overall Study|Withdrawal by Subject|54|||
155573349|NCT00839254|561522725|FG003|Overall Study|Withdrawal by Subject|32|||
155573350|NCT00839254|561522726|FG004|Overall Study|Withdrawal by Subject|27|||
155573351|NCT00839254|561522727|FG005|Overall Study|Withdrawal by Subject|15|||
155573352|NCT00839254|561522728|FG006|Overall Study|Withdrawal by Subject|22|||
155573353|NCT00839254|561522729|FG007|Overall Study|Withdrawal by Subject|9|||
155573354|NCT00839254|561522722|FG000|Overall Study|Wrong group allocation|0|||
155573355|NCT00839254|561522723|FG001|Overall Study|Wrong group allocation|0|||
155573356|NCT00839254|561522724|FG002|Overall Study|Wrong group allocation|0|||
155573357|NCT00839254|561522725|FG003|Overall Study|Wrong group allocation|0|||
155573358|NCT00839254|561522726|FG004|Overall Study|Wrong group allocation|0|||
155573359|NCT00839254|561522727|FG005|Overall Study|Wrong group allocation|0|||
155573360|NCT00839254|561522728|FG006|Overall Study|Wrong group allocation|1|||
155573361|NCT00839254|561522729|FG007|Overall Study|Wrong group allocation|0|||
155573362|NCT00839254|561522722|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
155573363|NCT00839254|561522723|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573364|NCT00839254|561522724|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573365|NCT00839254|561522725|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573366|NCT00839254|561522726|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573367|NCT00839254|561522727|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
155573368|NCT00839254|561522728|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573369|NCT00839254|561522729|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
155573370|NCT00839254|561522722|FG000|Overall Study|Withdrawn due to non-compliance|2|||
155573371|NCT00839254|561522723|FG001|Overall Study|Withdrawn due to non-compliance|0|||
155573372|NCT00839254|561522724|FG002|Overall Study|Withdrawn due to non-compliance|0|||
155573373|NCT00839254|561522725|FG003|Overall Study|Withdrawn due to non-compliance|0|||
155573374|NCT00839254|561522726|FG004|Overall Study|Withdrawn due to non-compliance|0|||
155573375|NCT00839254|561522727|FG005|Overall Study|Withdrawn due to non-compliance|0|||
155573376|NCT00839254|561522728|FG006|Overall Study|Withdrawn due to non-compliance|0|||
155573377|NCT00839254|561522729|FG007|Overall Study|Withdrawn due to non-compliance|0|||
155573378|NCT00839254|561522722|FG000|Overall Study|Lost to Follow-up|51|||
155573379|NCT00839254|561522723|FG001|Overall Study|Lost to Follow-up|30|||
155573380|NCT00839254|561522724|FG002|Overall Study|Lost to Follow-up|32|||
155573381|NCT00839254|561522725|FG003|Overall Study|Lost to Follow-up|24|||
155573382|NCT00839254|561522726|FG004|Overall Study|Lost to Follow-up|8|||
155573383|NCT00839254|561522727|FG005|Overall Study|Lost to Follow-up|8|||
155573384|NCT00839254|561522728|FG006|Overall Study|Lost to Follow-up|4|||
155573385|NCT00839254|561522729|FG007|Overall Study|Lost to Follow-up|2|||
155573386|NCT00143247|561522735|FG000|Overall Study|Death|8|||
155573387|NCT00143247|561522735|FG000|Overall Study|Adverse Event|19|||
155573388|NCT00143247|561522735|FG000|Overall Study|Lack of Efficacy|3|||
155573389|NCT00143247|561522735|FG000|Overall Study|Withdrawal by Subject|55|||
155661270|NCT02936323|561854632|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661271|NCT02936323|561854633|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661272|NCT02936323|561854634|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155661273|NCT02936323|561854635|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
155661274|NCT02936323|561854626|FG000|Phase 2a Dose Expansion|Death|0|||
155661275|NCT02936323|561854627|FG001|Phase 2a Dose Expansion|Death|0|||
155661276|NCT02936323|561854628|FG002|Phase 2a Dose Expansion|Death|0|||
155661277|NCT02936323|561854629|FG003|Phase 2a Dose Expansion|Death|0|||
155661278|NCT02936323|561854630|FG004|Phase 2a Dose Expansion|Death|0|||
155661279|NCT02936323|561854631|FG005|Phase 2a Dose Expansion|Death|0|||
155661280|NCT02936323|561854632|FG006|Phase 2a Dose Expansion|Death|0|||
155661281|NCT02936323|561854633|FG007|Phase 2a Dose Expansion|Death|4|||
155661282|NCT02936323|561854634|FG008|Phase 2a Dose Expansion|Death|8|||
155661283|NCT02936323|561854635|FG009|Phase 2a Dose Expansion|Death|10|||
155573390|NCT00143247|561522735|FG000|Overall Study|Study terminated by sponsor|31|||
155573391|NCT00143247|561522735|FG000|Overall Study|Protocol Violation|15|||
155573392|NCT00143247|561522735|FG000|Overall Study|Lost to Follow-up|12|||
155573393|NCT00143247|561522735|FG000|Overall Study|following inaccurate lab adverse event|1|||
155573394|NCT00143247|561522735|FG000|Overall Study|Other|12|||
155573395|NCT02933255|561522738|FG000|Overall Study|Discontinued due to study closure.|1|||
155573396|NCT02933255|561522739|FG001|Overall Study|Discontinued due to study closure.|0|||
155573397|NCT02766283|561522740|FG000|Overall Study|Lost to Follow-up|27|||
155573398|NCT00805961|561522741|FG000|Modality Therapy|Withdrawal by Subject|1|||
155573399|NCT00805961|561522741|FG000|Modality Therapy|Adverse Event|1|||
155573400|NCT00805961|561522741|FG000|Modality Therapy|Disease Progression|2|||
155573401|NCT00805961|561522741|FG000|Treatment-Free Interval|Adverse Event|3|||
155573402|NCT00805961|561522741|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
155573403|NCT00805961|561522741|FG000|Treatment-Free Interval|Physician Decision|1|||
155573404|NCT00805961|561522741|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
155573405|NCT00805961|561522741|FG000|Maintenance Treatment|Lack of Efficacy|13|||
155573406|NCT00805961|561522741|FG000|Maintenance Treatment|Intercurrent Illness|7|||
155573407|NCT00805961|561522741|FG000|Maintenance Treatment|Adverse Event|6|||
155573408|NCT00805961|561522741|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
155573409|NCT00805961|561522741|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
155573410|NCT00805961|561522741|FG000|Maintenance Treatment|Withdrawn Consent|1|||
155573411|NCT04803305|561522742|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
155573412|NCT04803305|561522743|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
155573413|NCT04803305|561522742|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
155573414|NCT04803305|561522743|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
155573415|NCT04803305|561522742|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
155573416|NCT04803305|561522743|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
155573417|NCT04803305|561522742|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
155573418|NCT04803305|561522743|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
155573419|NCT04803305|561522742|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
155573420|NCT04803305|561522743|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
155573421|NCT04803305|561522742|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
155573422|NCT04803305|561522743|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
155573423|NCT04803305|561522742|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
155573424|NCT04803305|561522743|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
155573425|NCT04803305|561522742|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
155573426|NCT04803305|561522743|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
155573427|NCT00993421|561522744|FG000|Overall Study|Adverse Event|2|||
155573428|NCT00993421|561522745|FG001|Overall Study|Adverse Event|7|||
155573429|NCT00993421|561522746|FG002|Overall Study|Adverse Event|6|||
155573430|NCT00993421|561522747|FG003|Overall Study|Adverse Event|9|||
155573431|NCT00993421|561522748|FG004|Overall Study|Adverse Event|5|||
155661284|NCT05239221|561854636|FG000|Overall Study|Adverse Event|0|||
155573432|NCT00993421|561522749|FG005|Overall Study|Adverse Event|7|||
155573433|NCT00993421|561522750|FG006|Overall Study|Adverse Event|1|||
155573434|NCT00993421|561522744|FG000|Overall Study|Sponsor Decision|36|||
155661285|NCT05239221|561854637|FG001|Overall Study|Adverse Event|0|||
155661286|NCT05239221|561854638|FG002|Overall Study|Adverse Event|0|||
155661287|NCT05239221|561854639|FG003|Overall Study|Adverse Event|0|||
155661288|NCT05239221|561854640|FG004|Overall Study|Adverse Event|0|||
155573435|NCT00993421|561522745|FG001|Overall Study|Sponsor Decision|31|||
155573436|NCT00993421|561522746|FG002|Overall Study|Sponsor Decision|28|||
155573437|NCT00993421|561522747|FG003|Overall Study|Sponsor Decision|30|||
155661289|NCT05239221|561854641|FG005|Overall Study|Adverse Event|0|||
155661290|NCT05239221|561854642|FG006|Overall Study|Adverse Event|1|||
155573438|NCT00993421|561522748|FG004|Overall Study|Sponsor Decision|38|||
155661291|NCT05239221|561854643|FG007|Overall Study|Adverse Event|0|||
155661292|NCT05239221|561854644|FG008|Overall Study|Adverse Event|0|||
155661293|NCT05239221|561854645|FG009|Overall Study|Adverse Event|0|||
155661294|NCT05239221|561854646|FG010|Overall Study|Adverse Event|1|||
155661295|NCT05239221|561854647|FG011|Overall Study|Adverse Event|1|||
155661296|NCT05239221|561854648|FG012|Overall Study|Adverse Event|0|||
155661297|NCT05239221|561854649|FG013|Overall Study|Adverse Event|0|||
155661298|NCT05239221|561854650|FG014|Overall Study|Adverse Event|0|||
155661299|NCT05239221|561854651|FG015|Overall Study|Adverse Event|0|||
155661300|NCT05239221|561854636|FG000|Overall Study|Withdrawal by Subject|0|||
155661301|NCT05239221|561854637|FG001|Overall Study|Withdrawal by Subject|0|||
155661302|NCT05239221|561854638|FG002|Overall Study|Withdrawal by Subject|0|||
155661303|NCT05239221|561854639|FG003|Overall Study|Withdrawal by Subject|0|||
155661304|NCT05239221|561854640|FG004|Overall Study|Withdrawal by Subject|0|||
155661305|NCT05239221|561854641|FG005|Overall Study|Withdrawal by Subject|0|||
155661306|NCT05239221|561854642|FG006|Overall Study|Withdrawal by Subject|0|||
155661307|NCT05239221|561854643|FG007|Overall Study|Withdrawal by Subject|0|||
155661308|NCT05239221|561854644|FG008|Overall Study|Withdrawal by Subject|0|||
155661309|NCT05239221|561854645|FG009|Overall Study|Withdrawal by Subject|0|||
155661310|NCT05239221|561854646|FG010|Overall Study|Withdrawal by Subject|1|||
155661311|NCT05239221|561854647|FG011|Overall Study|Withdrawal by Subject|0|||
155661312|NCT05239221|561854648|FG012|Overall Study|Withdrawal by Subject|0|||
155661313|NCT05239221|561854649|FG013|Overall Study|Withdrawal by Subject|0|||
155661314|NCT05239221|561854650|FG014|Overall Study|Withdrawal by Subject|0|||
155661315|NCT05239221|561854651|FG015|Overall Study|Withdrawal by Subject|1|||
155661316|NCT01400412|561854652|FG000|Overall Study|Lost to Follow-up|4|||
155661317|NCT01400412|561854653|FG001|Overall Study|Lost to Follow-up|7|||
155661318|NCT01400412|561854652|FG000|Overall Study|Withdrawal by Subject|3|||
155661319|NCT01400412|561854653|FG001|Overall Study|Withdrawal by Subject|4|||
155661320|NCT01400412|561854652|FG000|Overall Study|Unable to complete|3|||
155661321|NCT01400412|561854653|FG001|Overall Study|Unable to complete|3|||
155661322|NCT01400412|561854652|FG000|Overall Study|Never started study treatment|0|||
155661323|NCT01400412|561854653|FG001|Overall Study|Never started study treatment|3|||
155661324|NCT00529633|561856489|FG000|Overall Study|Withdrawal by Subject|1|||
155661325|NCT00529633|561856490|FG001|Overall Study|Withdrawal by Subject|1|||
155661326|NCT01334918|561856491|FG000|Overall Study|Did not receive study drug|6|||
155661327|NCT01334918|561856492|FG001|Overall Study|Did not receive study drug|0|||
155661328|NCT01334918|561856491|FG000|Overall Study|Adverse Event|2|||
155661329|NCT01334918|561856492|FG001|Overall Study|Adverse Event|0|||
155661330|NCT01334918|561856491|FG000|Overall Study|Withdrawal by Subject|0|||
155661331|NCT01334918|561856492|FG001|Overall Study|Withdrawal by Subject|1|||
155661332|NCT01657370|561856498|FG000|Overall Study|Withdrawal by Subject|0|||
155661333|NCT01657370|561856499|FG001|Overall Study|Withdrawal by Subject|0|||
155661334|NCT01657370|561856500|FG002|Overall Study|Withdrawal by Subject|1|||
155661335|NCT01657370|561856501|FG003|Overall Study|Withdrawal by Subject|0|||
155661336|NCT01657370|561856502|FG004|Overall Study|Withdrawal by Subject|0|||
155573439|NCT00993421|561522749|FG005|Overall Study|Sponsor Decision|30|||
155573440|NCT00993421|561522750|FG006|Overall Study|Sponsor Decision|29|||
155573441|NCT00993421|561522744|FG000|Overall Study|Lost to Follow-up|3|||
155573442|NCT00993421|561522745|FG001|Overall Study|Lost to Follow-up|5|||
155573443|NCT00993421|561522746|FG002|Overall Study|Lost to Follow-up|5|||
155573444|NCT00993421|561522747|FG003|Overall Study|Lost to Follow-up|0|||
155573445|NCT00993421|561522748|FG004|Overall Study|Lost to Follow-up|0|||
155573446|NCT00993421|561522749|FG005|Overall Study|Lost to Follow-up|0|||
155573447|NCT00993421|561522750|FG006|Overall Study|Lost to Follow-up|6|||
155573448|NCT00993421|561522744|FG000|Overall Study|Withdrawal by Subject|3|||
155573449|NCT00993421|561522745|FG001|Overall Study|Withdrawal by Subject|2|||
155573450|NCT00993421|561522746|FG002|Overall Study|Withdrawal by Subject|3|||
155573451|NCT00993421|561522747|FG003|Overall Study|Withdrawal by Subject|3|||
155661337|NCT01657370|561856503|FG005|Overall Study|Withdrawal by Subject|1|||
155661338|NCT01657370|561856498|FG000|Overall Study|Physician Decision|2|||
155661339|NCT01657370|561856499|FG001|Overall Study|Physician Decision|3|||
155661340|NCT01657370|561856500|FG002|Overall Study|Physician Decision|1|||
155573452|NCT00993421|561522748|FG004|Overall Study|Withdrawal by Subject|3|||
155573453|NCT00993421|561522749|FG005|Overall Study|Withdrawal by Subject|5|||
155661341|NCT01657370|561856501|FG003|Overall Study|Physician Decision|2|||
155661342|NCT01657370|561856502|FG004|Overall Study|Physician Decision|5|||
155661343|NCT01657370|561856503|FG005|Overall Study|Physician Decision|0|||
155661344|NCT01657370|561856498|FG000|Overall Study|Lack of Qualifying Event|1|||
155573454|NCT00993421|561522750|FG006|Overall Study|Withdrawal by Subject|3|||
155661345|NCT01657370|561856499|FG001|Overall Study|Lack of Qualifying Event|0|||
155661346|NCT01657370|561856500|FG002|Overall Study|Lack of Qualifying Event|3|||
155661347|NCT01657370|561856501|FG003|Overall Study|Lack of Qualifying Event|2|||
155661348|NCT01657370|561856502|FG004|Overall Study|Lack of Qualifying Event|1|||
155661349|NCT01657370|561856503|FG005|Overall Study|Lack of Qualifying Event|2|||
155661350|NCT01657370|561856498|FG000|Overall Study|Adverse Event|0|||
155661351|NCT01657370|561856499|FG001|Overall Study|Adverse Event|0|||
155661352|NCT01657370|561856500|FG002|Overall Study|Adverse Event|0|||
155573455|NCT00993421|561522744|FG000|Overall Study|Death|0|||
155661353|NCT01657370|561856501|FG003|Overall Study|Adverse Event|0|||
155661354|NCT01657370|561856502|FG004|Overall Study|Adverse Event|1|||
155573456|NCT00993421|561522745|FG001|Overall Study|Death|0|||
155573457|NCT00993421|561522746|FG002|Overall Study|Death|0|||
155573458|NCT00993421|561522747|FG003|Overall Study|Death|0|||
155573459|NCT00993421|561522748|FG004|Overall Study|Death|0|||
155573460|NCT00993421|561522749|FG005|Overall Study|Death|0|||
155573461|NCT00993421|561522750|FG006|Overall Study|Death|1|||
155573462|NCT00993421|561522744|FG000|Overall Study|Entry Criteria Exclusion|0|||
155573463|NCT00993421|561522745|FG001|Overall Study|Entry Criteria Exclusion|0|||
155573464|NCT00993421|561522746|FG002|Overall Study|Entry Criteria Exclusion|1|||
155573465|NCT00993421|561522747|FG003|Overall Study|Entry Criteria Exclusion|3|||
155573466|NCT00993421|561522748|FG004|Overall Study|Entry Criteria Exclusion|0|||
155573467|NCT00993421|561522749|FG005|Overall Study|Entry Criteria Exclusion|1|||
155573468|NCT00993421|561522750|FG006|Overall Study|Entry Criteria Exclusion|0|||
155573469|NCT00993421|561522744|FG000|Overall Study|Physician Decision|0|||
155573470|NCT00993421|561522745|FG001|Overall Study|Physician Decision|0|||
155573471|NCT00993421|561522746|FG002|Overall Study|Physician Decision|0|||
155573472|NCT00993421|561522747|FG003|Overall Study|Physician Decision|0|||
155573473|NCT00993421|561522748|FG004|Overall Study|Physician Decision|0|||
155573474|NCT00993421|561522749|FG005|Overall Study|Physician Decision|1|||
155573475|NCT00993421|561522750|FG006|Overall Study|Physician Decision|1|||
155573476|NCT00993421|561522744|FG000|Overall Study|Protocol Violation|0|||
155573477|NCT00993421|561522745|FG001|Overall Study|Protocol Violation|0|||
155573478|NCT00993421|561522746|FG002|Overall Study|Protocol Violation|0|||
155573479|NCT00993421|561522747|FG003|Overall Study|Protocol Violation|0|||
155573480|NCT00993421|561522748|FG004|Overall Study|Protocol Violation|0|||
155573481|NCT00993421|561522749|FG005|Overall Study|Protocol Violation|2|||
155573482|NCT00993421|561522750|FG006|Overall Study|Protocol Violation|1|||
155573483|NCT00352417|561522756|FG000|Overall Study|Adverse Event|1|||
155573484|NCT00352417|561522757|FG001|Overall Study|Adverse Event|0|||
155573485|NCT00352417|561522756|FG000|Overall Study|Protocol Violation|0|||
155573486|NCT00352417|561522757|FG001|Overall Study|Protocol Violation|2|||
155573487|NCT00352417|561522756|FG000|Overall Study|Withdrawal by Subject|1|||
155573488|NCT00352417|561522757|FG001|Overall Study|Withdrawal by Subject|2|||
155573489|NCT00352417|561522756|FG000|Overall Study|Lost to Follow-up|1|||
155573490|NCT00352417|561522757|FG001|Overall Study|Lost to Follow-up|0|||
155573491|NCT00352417|561522756|FG000|Overall Study|Schedule Change|2|||
155573492|NCT00352417|561522757|FG001|Overall Study|Schedule Change|1|||
155573493|NCT03207867|561522758|FG000|Overall Study|Adverse Event|1|||
155573494|NCT03207867|561522759|FG001|Overall Study|Adverse Event|0|||
155573495|NCT03207867|561522760|FG002|Overall Study|Adverse Event|1|||
155573496|NCT03207867|561522761|FG003|Overall Study|Adverse Event|0|||
155573497|NCT03207867|561522762|FG004|Overall Study|Adverse Event|0|||
155573498|NCT03207867|561522763|FG005|Overall Study|Adverse Event|2|||
155573499|NCT03207867|561522764|FG006|Overall Study|Adverse Event|1|||
155573500|NCT03207867|561522765|FG007|Overall Study|Adverse Event|1|||
155573501|NCT03207867|561522766|FG008|Overall Study|Adverse Event|2|||
155573502|NCT03207867|561522767|FG009|Overall Study|Adverse Event|2|||
155573503|NCT03207867|561522768|FG010|Overall Study|Adverse Event|0|||
155573504|NCT03207867|561522769|FG011|Overall Study|Adverse Event|0|||
155573505|NCT03207867|561522770|FG012|Overall Study|Adverse Event|0|||
155573506|NCT03207867|561522771|FG013|Overall Study|Adverse Event|0|||
155573507|NCT03207867|561522772|FG014|Overall Study|Adverse Event|0|||
155573508|NCT03207867|561522773|FG015|Overall Study|Adverse Event|0|||
155573509|NCT03207867|561522774|FG016|Overall Study|Adverse Event|3|||
155573510|NCT03207867|561522775|FG017|Overall Study|Adverse Event|1|||
155573511|NCT03207867|561522776|FG018|Overall Study|Adverse Event|2|||
155573512|NCT03207867|561522777|FG019|Overall Study|Adverse Event|1|||
155573513|NCT03207867|561522778|FG020|Overall Study|Adverse Event|0|||
155573514|NCT03207867|561522779|FG021|Overall Study|Adverse Event|0|||
155573515|NCT03207867|561522780|FG022|Overall Study|Adverse Event|0|||
155573516|NCT03207867|561522781|FG023|Overall Study|Adverse Event|0|||
155573517|NCT03207867|561522758|FG000|Overall Study|Death|0|||
155573518|NCT03207867|561522759|FG001|Overall Study|Death|0|||
155573519|NCT03207867|561522760|FG002|Overall Study|Death|0|||
155573520|NCT03207867|561522761|FG003|Overall Study|Death|0|||
155573521|NCT03207867|561522762|FG004|Overall Study|Death|0|||
155573522|NCT03207867|561522763|FG005|Overall Study|Death|1|||
155573523|NCT03207867|561522764|FG006|Overall Study|Death|0|||
155573524|NCT03207867|561522765|FG007|Overall Study|Death|3|||
155573525|NCT03207867|561522766|FG008|Overall Study|Death|1|||
155573526|NCT03207867|561522767|FG009|Overall Study|Death|2|||
155573527|NCT03207867|561522768|FG010|Overall Study|Death|0|||
155573528|NCT03207867|561522769|FG011|Overall Study|Death|1|||
155573529|NCT03207867|561522770|FG012|Overall Study|Death|0|||
155573530|NCT03207867|561522771|FG013|Overall Study|Death|1|||
155573531|NCT03207867|561522772|FG014|Overall Study|Death|0|||
155573532|NCT03207867|561522773|FG015|Overall Study|Death|0|||
155573533|NCT03207867|561522774|FG016|Overall Study|Death|0|||
155573534|NCT03207867|561522775|FG017|Overall Study|Death|2|||
155573535|NCT03207867|561522776|FG018|Overall Study|Death|0|||
155573536|NCT03207867|561522777|FG019|Overall Study|Death|1|||
155573537|NCT03207867|561522778|FG020|Overall Study|Death|0|||
155573538|NCT03207867|561522779|FG021|Overall Study|Death|0|||
155573539|NCT03207867|561522780|FG022|Overall Study|Death|0|||
155573540|NCT03207867|561522781|FG023|Overall Study|Death|0|||
155573541|NCT03207867|561522758|FG000|Overall Study|Physician Decision|3|||
155573542|NCT03207867|561522759|FG001|Overall Study|Physician Decision|5|||
155573543|NCT03207867|561522760|FG002|Overall Study|Physician Decision|0|||
155573544|NCT03207867|561522761|FG003|Overall Study|Physician Decision|3|||
155573545|NCT03207867|561522762|FG004|Overall Study|Physician Decision|2|||
155573546|NCT03207867|561522763|FG005|Overall Study|Physician Decision|0|||
155573547|NCT03207867|561522764|FG006|Overall Study|Physician Decision|0|||
155573548|NCT03207867|561522765|FG007|Overall Study|Physician Decision|0|||
155573549|NCT03207867|561522766|FG008|Overall Study|Physician Decision|4|||
155573550|NCT03207867|561522767|FG009|Overall Study|Physician Decision|2|||
155573551|NCT03207867|561522768|FG010|Overall Study|Physician Decision|0|||
155573552|NCT03207867|561522769|FG011|Overall Study|Physician Decision|4|||
155573553|NCT03207867|561522770|FG012|Overall Study|Physician Decision|0|||
155573554|NCT03207867|561522771|FG013|Overall Study|Physician Decision|0|||
155573555|NCT03207867|561522772|FG014|Overall Study|Physician Decision|2|||
155573556|NCT03207867|561522773|FG015|Overall Study|Physician Decision|1|||
155573557|NCT03207867|561522774|FG016|Overall Study|Physician Decision|1|||
155573558|NCT03207867|561522775|FG017|Overall Study|Physician Decision|2|||
155573559|NCT03207867|561522776|FG018|Overall Study|Physician Decision|1|||
155573560|NCT03207867|561522777|FG019|Overall Study|Physician Decision|3|||
155573561|NCT03207867|561522778|FG020|Overall Study|Physician Decision|0|||
155573562|NCT03207867|561522779|FG021|Overall Study|Physician Decision|0|||
155573563|NCT03207867|561522780|FG022|Overall Study|Physician Decision|0|||
155573564|NCT03207867|561522781|FG023|Overall Study|Physician Decision|0|||
155573565|NCT03207867|561522758|FG000|Overall Study|Progressive Disease|7|||
155573566|NCT03207867|561522759|FG001|Overall Study|Progressive Disease|7|||
155573567|NCT03207867|561522760|FG002|Overall Study|Progressive Disease|9|||
155573568|NCT03207867|561522761|FG003|Overall Study|Progressive Disease|10|||
155573569|NCT03207867|561522762|FG004|Overall Study|Progressive Disease|11|||
155573570|NCT03207867|561522763|FG005|Overall Study|Progressive Disease|10|||
155573571|NCT03207867|561522764|FG006|Overall Study|Progressive Disease|9|||
155573572|NCT03207867|561522765|FG007|Overall Study|Progressive Disease|8|||
155573573|NCT03207867|561522766|FG008|Overall Study|Progressive Disease|19|||
155573574|NCT03207867|561522767|FG009|Overall Study|Progressive Disease|23|||
155573575|NCT03207867|561522768|FG010|Overall Study|Progressive Disease|2|||
155573576|NCT03207867|561522769|FG011|Overall Study|Progressive Disease|24|||
155573577|NCT03207867|561522770|FG012|Overall Study|Progressive Disease|3|||
155573578|NCT03207867|561522771|FG013|Overall Study|Progressive Disease|11|||
155573579|NCT03207867|561522772|FG014|Overall Study|Progressive Disease|9|||
155573580|NCT03207867|561522773|FG015|Overall Study|Progressive Disease|5|||
155573581|NCT03207867|561522774|FG016|Overall Study|Progressive Disease|10|||
155573582|NCT03207867|561522775|FG017|Overall Study|Progressive Disease|14|||
155573583|NCT03207867|561522776|FG018|Overall Study|Progressive Disease|13|||
155573584|NCT03207867|561522777|FG019|Overall Study|Progressive Disease|14|||
155573585|NCT03207867|561522778|FG020|Overall Study|Progressive Disease|6|||
155573586|NCT03207867|561522779|FG021|Overall Study|Progressive Disease|3|||
155573587|NCT03207867|561522780|FG022|Overall Study|Progressive Disease|3|||
155573588|NCT03207867|561522781|FG023|Overall Study|Progressive Disease|3|||
155573589|NCT03207867|561522758|FG000|Overall Study|Patient/guardian Decision|0|||
155573590|NCT03207867|561522759|FG001|Overall Study|Patient/guardian Decision|0|||
155573591|NCT03207867|561522760|FG002|Overall Study|Patient/guardian Decision|1|||
155573592|NCT03207867|561522761|FG003|Overall Study|Patient/guardian Decision|1|||
155573593|NCT03207867|561522762|FG004|Overall Study|Patient/guardian Decision|1|||
155573594|NCT03207867|561522763|FG005|Overall Study|Patient/guardian Decision|2|||
155573595|NCT03207867|561522764|FG006|Overall Study|Patient/guardian Decision|1|||
155573596|NCT03207867|561522765|FG007|Overall Study|Patient/guardian Decision|0|||
155573597|NCT03207867|561522766|FG008|Overall Study|Patient/guardian Decision|1|||
155573598|NCT03207867|561522767|FG009|Overall Study|Patient/guardian Decision|0|||
155573599|NCT03207867|561522768|FG010|Overall Study|Patient/guardian Decision|0|||
155573600|NCT03207867|561522769|FG011|Overall Study|Patient/guardian Decision|1|||
155573601|NCT03207867|561522770|FG012|Overall Study|Patient/guardian Decision|0|||
155573602|NCT03207867|561522771|FG013|Overall Study|Patient/guardian Decision|1|||
155573603|NCT03207867|561522772|FG014|Overall Study|Patient/guardian Decision|2|||
155573604|NCT03207867|561522773|FG015|Overall Study|Patient/guardian Decision|0|||
155573605|NCT03207867|561522774|FG016|Overall Study|Patient/guardian Decision|1|||
155573606|NCT03207867|561522775|FG017|Overall Study|Patient/guardian Decision|3|||
155573607|NCT03207867|561522776|FG018|Overall Study|Patient/guardian Decision|4|||
155573608|NCT03207867|561522777|FG019|Overall Study|Patient/guardian Decision|1|||
155573609|NCT03207867|561522778|FG020|Overall Study|Patient/guardian Decision|0|||
155573610|NCT03207867|561522779|FG021|Overall Study|Patient/guardian Decision|0|||
155573611|NCT03207867|561522780|FG022|Overall Study|Patient/guardian Decision|0|||
155573612|NCT03207867|561522781|FG023|Overall Study|Patient/guardian Decision|0|||
155573613|NCT00912912|561522782|FG000|Overall Study|Withdrawal by Subject|1|||
155573614|NCT00912912|561522782|FG000|Overall Study|Disease Progression|3|||
155573615|NCT02447744|561522783|FG000|Overall Study|Withdrawal by Subject|3|||
155573616|NCT02447744|561522784|FG001|Overall Study|Withdrawal by Subject|1|||
155573617|NCT02447744|561522783|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
155661355|NCT01657370|561856503|FG005|Overall Study|Adverse Event|0|||
155661356|NCT01657370|561856498|FG000|Overall Study|Protocol Violation|1|||
155661357|NCT01657370|561856499|FG001|Overall Study|Protocol Violation|1|||
155661358|NCT01657370|561856500|FG002|Overall Study|Protocol Violation|1|||
155661359|NCT01657370|561856501|FG003|Overall Study|Protocol Violation|1|||
155661360|NCT01657370|561856502|FG004|Overall Study|Protocol Violation|0|||
155661361|NCT01657370|561856503|FG005|Overall Study|Protocol Violation|0|||
155661362|NCT01657370|561856498|FG000|Overall Study|Lost to Follow-up|2|||
155661363|NCT01657370|561856499|FG001|Overall Study|Lost to Follow-up|0|||
155661364|NCT01657370|561856500|FG002|Overall Study|Lost to Follow-up|1|||
155661365|NCT01657370|561856501|FG003|Overall Study|Lost to Follow-up|0|||
155661366|NCT01657370|561856502|FG004|Overall Study|Lost to Follow-up|0|||
155661367|NCT01657370|561856503|FG005|Overall Study|Lost to Follow-up|1|||
155661368|NCT02777086|561856504|FG000|Overall Study|Lost to Follow-up|96|||
155661369|NCT02777086|561856505|FG001|Overall Study|Lost to Follow-up|99|||
155661370|NCT01133665|561856506|FG000|Overall Study|Physician Decision|2|||
155661371|NCT01819272|561856507|FG000|Overall Study|Adverse Event|1|||
155661372|NCT01819272|561856508|FG001|Overall Study|Adverse Event|0|||
155661373|NCT01819272|561856509|FG002|Overall Study|Adverse Event|0|||
155661374|NCT01819272|561856510|FG003|Overall Study|Adverse Event|2|||
155661375|NCT01819272|561856511|FG004|Overall Study|Adverse Event|0|||
155661376|NCT01819272|561856512|FG005|Overall Study|Adverse Event|0|||
155661377|NCT01819272|561856507|FG000|Overall Study|Lost to Follow-up|3|||
155661378|NCT01819272|561856508|FG001|Overall Study|Lost to Follow-up|0|||
155661379|NCT01819272|561856509|FG002|Overall Study|Lost to Follow-up|1|||
155661380|NCT01819272|561856510|FG003|Overall Study|Lost to Follow-up|0|||
155661381|NCT01819272|561856511|FG004|Overall Study|Lost to Follow-up|0|||
155661382|NCT01819272|561856512|FG005|Overall Study|Lost to Follow-up|3|||
155661383|NCT01819272|561856507|FG000|Overall Study|Protocol Violation|0|||
155661384|NCT01819272|561856508|FG001|Overall Study|Protocol Violation|0|||
155661385|NCT01819272|561856509|FG002|Overall Study|Protocol Violation|0|||
155661386|NCT01819272|561856510|FG003|Overall Study|Protocol Violation|1|||
155661387|NCT01819272|561856511|FG004|Overall Study|Protocol Violation|2|||
155661388|NCT01819272|561856512|FG005|Overall Study|Protocol Violation|3|||
155661389|NCT01819272|561856507|FG000|Overall Study|Physician Decision|0|||
155661390|NCT01819272|561856508|FG001|Overall Study|Physician Decision|1|||
155661391|NCT01819272|561856509|FG002|Overall Study|Physician Decision|0|||
155661392|NCT01819272|561856510|FG003|Overall Study|Physician Decision|0|||
155661393|NCT01819272|561856511|FG004|Overall Study|Physician Decision|0|||
155661394|NCT01819272|561856512|FG005|Overall Study|Physician Decision|0|||
155661395|NCT01819272|561856507|FG000|Overall Study|Withdrawal of Consent|0|||
155661396|NCT01819272|561856508|FG001|Overall Study|Withdrawal of Consent|1|||
155661397|NCT01819272|561856509|FG002|Overall Study|Withdrawal of Consent|2|||
155661398|NCT01819272|561856510|FG003|Overall Study|Withdrawal of Consent|1|||
155661399|NCT01819272|561856511|FG004|Overall Study|Withdrawal of Consent|0|||
155661400|NCT01819272|561856512|FG005|Overall Study|Withdrawal of Consent|1|||
155661401|NCT01819272|561856507|FG000|Overall Study|Loss of Glucose Control|2|||
155661402|NCT01819272|561856508|FG001|Overall Study|Loss of Glucose Control|1|||
155661403|NCT01819272|561856509|FG002|Overall Study|Loss of Glucose Control|0|||
155661404|NCT01819272|561856510|FG003|Overall Study|Loss of Glucose Control|1|||
155661405|NCT01819272|561856511|FG004|Overall Study|Loss of Glucose Control|2|||
155661406|NCT01819272|561856512|FG005|Overall Study|Loss of Glucose Control|0|||
155661407|NCT01732536|561856513|FG000|Overall Study|Withdrawal by Subject|1|||
155661408|NCT01732536|561856514|FG001|Overall Study|Withdrawal by Subject|1|||
155661409|NCT00805389|561856515|FG000|Overall Study|Adverse Event|0|||
155661410|NCT00805389|561856516|FG001|Overall Study|Adverse Event|0|||
155661411|NCT00805389|561856517|FG002|Overall Study|Adverse Event|1|||
155661412|NCT00805389|561856518|FG003|Overall Study|Adverse Event|2|||
155661413|NCT00805389|561856519|FG004|Overall Study|Adverse Event|0|||
155661414|NCT00805389|561856515|FG000|Overall Study|Lost to Follow-up|4|||
155661415|NCT00805389|561856516|FG001|Overall Study|Lost to Follow-up|3|||
155661416|NCT00805389|561856517|FG002|Overall Study|Lost to Follow-up|6|||
155661417|NCT00805389|561856518|FG003|Overall Study|Lost to Follow-up|10|||
155661418|NCT00805389|561856519|FG004|Overall Study|Lost to Follow-up|9|||
155661419|NCT00805389|561856515|FG000|Overall Study|Protocol Violation|0|||
155661420|NCT00805389|561856516|FG001|Overall Study|Protocol Violation|0|||
155661421|NCT00805389|561856517|FG002|Overall Study|Protocol Violation|1|||
155661422|NCT00805389|561856518|FG003|Overall Study|Protocol Violation|0|||
155661423|NCT00805389|561856519|FG004|Overall Study|Protocol Violation|0|||
155661424|NCT00805389|561856515|FG000|Overall Study|Withdrawal by Subject|3|||
155661425|NCT00805389|561856516|FG001|Overall Study|Withdrawal by Subject|2|||
155661426|NCT00805389|561856517|FG002|Overall Study|Withdrawal by Subject|4|||
155661427|NCT00805389|561856518|FG003|Overall Study|Withdrawal by Subject|5|||
155661428|NCT00805389|561856519|FG004|Overall Study|Withdrawal by Subject|4|||
155661429|NCT02336815|561856524|FG000|Overall Study|Disease Progression|45|||
155661430|NCT02336815|561856525|FG001|Overall Study|Disease Progression|70|||
155661431|NCT02336815|561856524|FG000|Overall Study|Adverse Event|18|||
155661432|NCT02336815|561856525|FG001|Overall Study|Adverse Event|39|||
155661433|NCT02336815|561856524|FG000|Overall Study|Physician Decision|11|||
155661434|NCT02336815|561856525|FG001|Overall Study|Physician Decision|4|||
155573618|NCT02447744|561522784|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
155573619|NCT00306995|561522785|FG000|Study Part I|Withdrawal by Subject|0|||
155573620|NCT00306995|561522786|FG001|Study Part I|Withdrawal by Subject|0|||
155573621|NCT00306995|561522787|FG002|Study Part I|Withdrawal by Subject|0|||
155573622|NCT00306995|561522788|FG003|Study Part I|Withdrawal by Subject|0|||
155573623|NCT00306995|561522789|FG004|Study Part I|Withdrawal by Subject|0|||
155573624|NCT00306995|561522790|FG005|Study Part I|Withdrawal by Subject|0|||
155573625|NCT00306995|561522791|FG006|Study Part I|Withdrawal by Subject|1|||
155573626|NCT00306995|561522785|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
155573627|NCT00306995|561522786|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
155573628|NCT00306995|561522787|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
155573629|NCT00306995|561522788|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
155573630|NCT00306995|561522789|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
155573631|NCT00306995|561522790|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
155573632|NCT00306995|561522791|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
155573633|NCT03130777|561524370|FG000|Overall Study|Death|0|||
155573634|NCT03130777|561524371|FG001|Overall Study|Death|1|||
155573635|NCT03130777|561524370|FG000|Overall Study|Did not meet eligibility criteria|1|||
155573636|NCT03130777|561524371|FG001|Overall Study|Did not meet eligibility criteria|0|||
155573637|NCT02586688|561524372|FG000|Overall Study|Lost to Follow-up|2|||
155573638|NCT02586688|561524373|FG001|Overall Study|Lost to Follow-up|1|||
155573639|NCT02586688|561524372|FG000|Overall Study|Withdrawal by Subject|1|||
155573640|NCT02586688|561524373|FG001|Overall Study|Withdrawal by Subject|1|||
155573641|NCT02586688|561524372|FG000|Overall Study|Adverse Event|3|||
155573642|NCT02586688|561524373|FG001|Overall Study|Adverse Event|1|||
155573643|NCT04856917|561524374|FG000|Overall Study|Withdrawal by Subject|4|||
155573644|NCT04856917|561524375|FG001|Overall Study|Withdrawal by Subject|3|||
155573645|NCT04856917|561524376|FG002|Overall Study|Withdrawal by Subject|1|||
155573646|NCT04856917|561524374|FG000|Overall Study|Lost to Follow-up|3|||
155573647|NCT04856917|561524375|FG001|Overall Study|Lost to Follow-up|1|||
155573648|NCT04856917|561524376|FG002|Overall Study|Lost to Follow-up|1|||
155573649|NCT04856917|561524374|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
155573650|NCT04856917|561524375|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
155573651|NCT04856917|561524376|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
155573652|NCT04856917|561524374|FG000|Overall Study|Other|1|||
155573653|NCT04856917|561524375|FG001|Overall Study|Other|1|||
155573654|NCT04856917|561524376|FG002|Overall Study|Other|0|||
155573655|NCT03560037|561524377|FG000|Overall Study|Protocol Violation|1|||
155573656|NCT03560037|561524378|FG001|Overall Study|Protocol Violation|0|||
155573657|NCT03560037|561524377|FG000|Overall Study|Physician Decision|0|||
155573658|NCT03560037|561524378|FG001|Overall Study|Physician Decision|1|||
155573659|NCT00233948|561524379|FG000|Overall Study|Adverse Event|1|||
155573660|NCT00233948|561524380|FG001|Overall Study|Adverse Event|0|||
155573661|NCT00233948|561524381|FG002|Overall Study|Adverse Event|0|||
155573662|NCT00233948|561524382|FG003|Overall Study|Adverse Event|0|||
155573663|NCT00233948|561524383|FG004|Overall Study|Adverse Event|0|||
155573664|NCT00233948|561524384|FG005|Overall Study|Adverse Event|0|||
155573665|NCT00064987|561524385|FG000|Overall Study|Physician Decision|3|||
155573666|NCT00064987|561524386|FG001|Overall Study|Physician Decision|0|||
155573667|NCT01567462|561524387|FG000|Overall Study|Withdrawal by Subject|4|||
155573668|NCT01567462|561524388|FG001|Overall Study|Withdrawal by Subject|7|||
155573669|NCT05223920|561524391|FG000|Overall Study|Adverse Event|6|||
155573670|NCT05223920|561524392|FG001|Overall Study|Adverse Event|3|||
155573671|NCT05223920|561524391|FG000|Overall Study|Death|2|||
155573672|NCT05223920|561524392|FG001|Overall Study|Death|0|||
155573673|NCT05223920|561524391|FG000|Overall Study|Disease Progression|1|||
155573674|NCT05223920|561524392|FG001|Overall Study|Disease Progression|2|||
155573675|NCT05223920|561524391|FG000|Overall Study|Physician Decision|1|||
155573676|NCT05223920|561524392|FG001|Overall Study|Physician Decision|2|||
155573677|NCT05223920|561524391|FG000|Overall Study|Sponsor decision|11|||
155573678|NCT05223920|561524392|FG001|Overall Study|Sponsor decision|9|||
155573679|NCT05223920|561524391|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
155573680|NCT05223920|561524392|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
155573681|NCT05223920|561524391|FG000|Overall Study|Subject decision|1|||
155573682|NCT05223920|561524392|FG001|Overall Study|Subject decision|0|||
155573683|NCT05223920|561524391|FG000|Overall Study|Withdrawal by Subject|1|||
155573684|NCT05223920|561524392|FG001|Overall Study|Withdrawal by Subject|6|||
155573685|NCT02862730|561524393|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573686|NCT02862730|561524394|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573687|NCT02862730|561524395|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
155573688|NCT02862730|561524396|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573689|NCT02862730|561524397|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573690|NCT02862730|561524398|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573691|NCT02862730|561524399|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155573692|NCT02862730|561524393|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
155573693|NCT02862730|561524394|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573694|NCT02862730|561524395|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573695|NCT02862730|561524396|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573696|NCT02862730|561524397|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573697|NCT02862730|561524398|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573698|NCT02862730|561524399|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155573699|NCT02862730|561524393|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155573700|NCT02862730|561524394|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155573701|NCT02862730|561524395|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
155573702|NCT02862730|561524396|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155573703|NCT02862730|561524397|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
155573704|NCT02862730|561524398|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155573705|NCT02862730|561524399|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155573706|NCT02862730|561524393|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573707|NCT02862730|561524394|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573708|NCT02862730|561524395|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573709|NCT02862730|561524396|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
155573710|NCT02862730|561524397|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573711|NCT02862730|561524398|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573712|NCT02862730|561524399|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155573713|NCT00445432|561524402|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
155573714|NCT00445432|561524403|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
155573715|NCT00445432|561524404|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
155573716|NCT00445432|561524405|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
155573717|NCT00445432|561524402|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155573718|NCT00445432|561524403|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155573719|NCT00445432|561524404|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
155573720|NCT00445432|561524405|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155573721|NCT00445432|561524402|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
155573722|NCT00445432|561524403|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
155573723|NCT00445432|561524404|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
155573724|NCT00445432|561524405|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
155573725|NCT00445432|561524402|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
155573726|NCT00445432|561524403|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
155573727|NCT00445432|561524404|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
155573728|NCT00445432|561524405|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
155573729|NCT00445432|561524402|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155573730|NCT00445432|561524403|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155573731|NCT00445432|561524404|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155573732|NCT00445432|561524405|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
155573733|NCT00445432|561524402|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155573734|NCT00445432|561524403|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155573735|NCT00445432|561524404|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155573736|NCT00445432|561524405|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
155573737|NCT00445432|561524402|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
155573738|NCT00445432|561524403|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
155573739|NCT00445432|561524404|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
155661435|NCT02336815|561856524|FG000|Overall Study|Withdrawal by Subject|3|||
155661436|NCT02336815|561856525|FG001|Overall Study|Withdrawal by Subject|2|||
155661437|NCT02336815|561856524|FG000|Overall Study|Lost to Follow-up|1|||
155661438|NCT02336815|561856525|FG001|Overall Study|Lost to Follow-up|3|||
155661439|NCT02336815|561856524|FG000|Overall Study|Other|1|||
155661440|NCT02336815|561856525|FG001|Overall Study|Other|5|||
155661441|NCT00370292|561856526|FG000|Overall Study|Disease Progression|4|||
155661442|NCT00370292|561856526|FG000|Overall Study|Adverse Event|7|||
155661443|NCT00370292|561856526|FG000|Overall Study|Physician Decision|2|||
155661444|NCT00069641|561856527|FG000|Overall Study|Death|1|||
155661445|NCT00069641|561856528|FG001|Overall Study|Death|0|||
155661446|NCT00069641|561856529|FG002|Overall Study|Death|1|||
155661447|NCT02704208|561856530|FG000|Overall Study|Lost to Follow-up|42|||
155661448|NCT02704208|561856531|FG001|Overall Study|Lost to Follow-up|37|||
155661449|NCT03545672|561856532|FG000|Overall Study|Uncertain diagnosis|2|||
155661450|NCT03545672|561856533|FG001|Overall Study|Uncertain diagnosis|1|||
155661451|NCT03545672|561856532|FG000|Overall Study|Protocol Violation|2|||
155661452|NCT03545672|561856533|FG001|Overall Study|Protocol Violation|2|||
155661453|NCT02234362|561856537|FG000|Overall Study|Not eligible after first screening visit|17|||
155661454|NCT02234362|561856537|FG000|Overall Study|Lost to Follow-up|6|||
155661455|NCT02234362|561856537|FG000|Overall Study|Withdrawal by Subject|3|||
155661456|NCT01959529|561856538|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
155661457|NCT01959529|561856539|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
155661458|NCT01959529|561856538|FG000|Overall Study|Lost to Follow-up|4|||
155661459|NCT01959529|561856539|FG001|Overall Study|Lost to Follow-up|1|||
155661460|NCT01959529|561856538|FG000|Overall Study|Other|70|||
155661461|NCT01959529|561856539|FG001|Overall Study|Other|68|||
155661462|NCT01959529|561856538|FG000|Overall Study|Hypoglycaemia|1|||
155661463|NCT01959529|561856539|FG001|Overall Study|Hypoglycaemia|1|||
155661464|NCT01959529|561856538|FG000|Overall Study|Lack of glycaemic control|1|||
155661465|NCT01959529|561856539|FG001|Overall Study|Lack of glycaemic control|1|||
155661466|NCT00560417|561856540|FG000|Overall Study|Adverse Event|3|||
155661467|NCT00560417|561856541|FG001|Overall Study|Adverse Event|2|||
155661468|NCT00560417|561856540|FG000|Overall Study|Entry Criteria Not Met|1|||
155661469|NCT00560417|561856541|FG001|Overall Study|Entry Criteria Not Met|0|||
155661470|NCT00560417|561856540|FG000|Overall Study|Lost to Follow-up|0|||
155661471|NCT00560417|561856541|FG001|Overall Study|Lost to Follow-up|1|||
155661472|NCT00560417|561856540|FG000|Overall Study|Physician Decision|2|||
155661473|NCT00560417|561856541|FG001|Overall Study|Physician Decision|6|||
155661474|NCT00560417|561856540|FG000|Overall Study|Protocol Violation|6|||
155661475|NCT00560417|561856541|FG001|Overall Study|Protocol Violation|5|||
155661476|NCT00560417|561856540|FG000|Overall Study|Sponsor Decision|2|||
155661477|NCT00560417|561856541|FG001|Overall Study|Sponsor Decision|0|||
155661478|NCT00560417|561856540|FG000|Overall Study|Withdrawal by Subject|3|||
155661479|NCT00560417|561856541|FG001|Overall Study|Withdrawal by Subject|3|||
155661480|NCT02164864|561856542|FG000|Overall Study|Trial disease worsening|7|||
155661481|NCT02164864|561856543|FG001|Overall Study|Trial disease worsening|5|||
155661482|NCT02164864|561856544|FG002|Overall Study|Trial disease worsening|1|||
155661483|NCT02164864|561856542|FG000|Overall Study|Other pre-existing disease worsening|6|||
155661484|NCT02164864|561856543|FG001|Overall Study|Other pre-existing disease worsening|4|||
155661485|NCT02164864|561856544|FG002|Overall Study|Other pre-existing disease worsening|9|||
155661486|NCT02164864|561856542|FG000|Overall Study|Other Adverse Event (AE)|52|||
155661487|NCT02164864|561856543|FG001|Overall Study|Other Adverse Event (AE)|32|||
155661488|NCT02164864|561856544|FG002|Overall Study|Other Adverse Event (AE)|49|||
155661489|NCT02164864|561856542|FG000|Overall Study|Protocol Violation|2|||
155661490|NCT02164864|561856543|FG001|Overall Study|Protocol Violation|4|||
155661491|NCT02164864|561856544|FG002|Overall Study|Protocol Violation|1|||
155661492|NCT02164864|561856542|FG000|Overall Study|Lost to Follow-up|4|||
155661493|NCT02164864|561856543|FG001|Overall Study|Lost to Follow-up|3|||
155661494|NCT02164864|561856544|FG002|Overall Study|Lost to Follow-up|2|||
155661495|NCT02164864|561856542|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
155661496|NCT02164864|561856543|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
155661497|NCT02164864|561856544|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
155661498|NCT02164864|561856542|FG000|Overall Study|Other than stated|3|||
155661499|NCT02164864|561856543|FG001|Overall Study|Other than stated|4|||
155661500|NCT02164864|561856544|FG002|Overall Study|Other than stated|14|||
155661501|NCT00320606|561856545|FG000|Overall Study|Adverse Event|1|||
155661502|NCT00320606|561856545|FG000|Overall Study|Protocol Violation|1|||
155661503|NCT00320606|561856545|FG000|Overall Study|Withdrawal by Subject|1|||
155661504|NCT03984825|561856546|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
155661505|NCT03984825|561856546|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
155661506|NCT03984825|561856546|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
155661507|NCT00261833|561856547|FG000|Overall Study|Death|1|||
155661508|NCT00261833|561856548|FG001|Overall Study|Death|3|||
155661509|NCT00261833|561856547|FG000|Overall Study|Adverse Event|1|||
155661510|NCT00261833|561856548|FG001|Overall Study|Adverse Event|4|||
155661511|NCT00261833|561856547|FG000|Overall Study|Withdrawal by Subject|5|||
155661512|NCT00261833|561856548|FG001|Overall Study|Withdrawal by Subject|7|||
155661513|NCT00261833|561856547|FG000|Overall Study|Protocol Violation|0|||
155661514|NCT00261833|561856548|FG001|Overall Study|Protocol Violation|1|||
155661515|NCT00261833|561856547|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
155661516|NCT00261833|561856548|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
155661517|NCT00261833|561856547|FG000|Overall Study|Lung transplantation|1|||
155661518|NCT00261833|561856548|FG001|Overall Study|Lung transplantation|1|||
155661519|NCT00261833|561856547|FG000|Overall Study|Missing reason|1|||
155661520|NCT00261833|561856548|FG001|Overall Study|Missing reason|0|||
155661521|NCT00261833|561856547|FG000|Overall Study|Not interested in being participant|0|||
155661522|NCT00261833|561856548|FG001|Overall Study|Not interested in being participant|1|||
155661523|NCT00622726|561856549|FG000|March, 2008 to August, 2010|Death|5|||
155661524|NCT00622726|561856550|FG001|March, 2008 to August, 2010|Death|2|||
155661525|NCT00622726|561856549|FG000|August, 2010 to April, 2013|Death|1|||
155661526|NCT00622726|561856550|FG001|August, 2010 to April, 2013|Death|5|||
155573740|NCT00445432|561524405|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
155573741|NCT02789137|561524406|FG000|Overall Study|Dropped out/Died|58|||
155573742|NCT01090414|561524407|FG000|Study 101-99|Progressive Disease|28|||
155573743|NCT01090414|561524408|FG001|Study 101-99|Progressive Disease|48|||
155573744|NCT01090414|561524409|FG002|Study 101-99|Progressive Disease|10|||
155573745|NCT01090414|561524410|FG003|Study 101-99|Progressive Disease|4|||
155573746|NCT01090414|561524407|FG000|Study 101-99|Adverse Event|10|||
155573747|NCT01090414|561524408|FG001|Study 101-99|Adverse Event|28|||
155573748|NCT01090414|561524409|FG002|Study 101-99|Adverse Event|18|||
155573749|NCT01090414|561524410|FG003|Study 101-99|Adverse Event|0|||
155573750|NCT01090414|561524407|FG000|Study 101-99|Investigator Request|1|||
155573751|NCT01090414|561524408|FG001|Study 101-99|Investigator Request|11|||
155573752|NCT01090414|561524409|FG002|Study 101-99|Investigator Request|4|||
155573753|NCT01090414|561524410|FG003|Study 101-99|Investigator Request|0|||
155573754|NCT01090414|561524407|FG000|Study 101-99|Death|3|||
155573755|NCT01090414|561524408|FG001|Study 101-99|Death|8|||
155573756|NCT01090414|561524409|FG002|Study 101-99|Death|1|||
155573757|NCT01090414|561524410|FG003|Study 101-99|Death|0|||
155573758|NCT01090414|561524407|FG000|Study 101-99|Sponsor Discontinued Study|0|||
155573759|NCT01090414|561524408|FG001|Study 101-99|Sponsor Discontinued Study|7|||
155573760|NCT01090414|561524409|FG002|Study 101-99|Sponsor Discontinued Study|5|||
155573761|NCT01090414|561524410|FG003|Study 101-99|Sponsor Discontinued Study|0|||
155573762|NCT01090414|561524407|FG000|Study 101-99|Other (Unknown Reasons)|3|||
155573763|NCT01090414|561524408|FG001|Study 101-99|Other (Unknown Reasons)|3|||
155573764|NCT01090414|561524409|FG002|Study 101-99|Other (Unknown Reasons)|0|||
155573765|NCT01090414|561524410|FG003|Study 101-99|Other (Unknown Reasons)|0|||
155573766|NCT01090414|561524407|FG000|Study 101-99|Withdrew Consent|0|||
155573767|NCT01090414|561524408|FG001|Study 101-99|Withdrew Consent|2|||
155573768|NCT01090414|561524409|FG002|Study 101-99|Withdrew Consent|3|||
155573769|NCT01090414|561524410|FG003|Study 101-99|Withdrew Consent|1|||
155573770|NCT01090414|561524407|FG000|Study 101-99|Participant Request|3|||
155573771|NCT01090414|561524408|FG001|Study 101-99|Participant Request|1|||
155573772|NCT01090414|561524409|FG002|Study 101-99|Participant Request|0|||
155573773|NCT01090414|561524410|FG003|Study 101-99|Participant Request|0|||
155573774|NCT00799058|561524417|FG000|Overall Study|Withdrawal by Subject|2|||
155573775|NCT00799058|561524418|FG001|Overall Study|Withdrawal by Subject|2|||
155573776|NCT00799058|561524419|FG002|Overall Study|Withdrawal by Subject|2|||
155573777|NCT00799058|561524417|FG000|Overall Study|Lost to Follow-up|1|||
155573778|NCT00799058|561524418|FG001|Overall Study|Lost to Follow-up|2|||
155573779|NCT00799058|561524419|FG002|Overall Study|Lost to Follow-up|1|||
155573780|NCT00799058|561524417|FG000|Overall Study|Adverse Event|0|||
155573781|NCT00799058|561524418|FG001|Overall Study|Adverse Event|2|||
155573782|NCT00799058|561524419|FG002|Overall Study|Adverse Event|0|||
155573783|NCT00799058|561524417|FG000|Overall Study|Pregnancy|1|||
155573784|NCT00799058|561524418|FG001|Overall Study|Pregnancy|0|||
155573785|NCT00799058|561524419|FG002|Overall Study|Pregnancy|0|||
155573786|NCT00799058|561524417|FG000|Overall Study|Not adherent|3|||
155573787|NCT00799058|561524418|FG001|Overall Study|Not adherent|2|||
155573788|NCT00799058|561524419|FG002|Overall Study|Not adherent|1|||
155573789|NCT00799058|561524417|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
155573790|NCT00799058|561524418|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
155573791|NCT00799058|561524419|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
155573792|NCT00799058|561524417|FG000|Overall Study|IP dispensing error|1|||
155573793|NCT00799058|561524418|FG001|Overall Study|IP dispensing error|0|||
155573794|NCT00799058|561524419|FG002|Overall Study|IP dispensing error|0|||
155573795|NCT00799058|561524417|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
155573796|NCT00799058|561524418|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
155573797|NCT00799058|561524419|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
155573798|NCT00799058|561524417|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
155573799|NCT00799058|561524418|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
155573800|NCT00799058|561524419|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
155573801|NCT00799058|561524417|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
155573802|NCT00799058|561524418|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
155573803|NCT00799058|561524419|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
155573804|NCT00799058|561524417|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
155573805|NCT00799058|561524418|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
155573806|NCT00799058|561524419|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
155573807|NCT02088697|561524424|FG000|Period I|Physician Decision|1|||
155573808|NCT02088697|561524425|FG001|Period I|Physician Decision|4|||
155573809|NCT02088697|561524424|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
155573810|NCT02088697|561524425|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
155573811|NCT03594071|561524426|FG000|Overall Study|Re-operation|3|||
155573812|NCT03594071|561524426|FG000|Overall Study|Missed visit|2|||
155573813|NCT02287922|561524427|FG000|Overall Study|Adverse Event|1|||
155573814|NCT02287922|561524428|FG001|Overall Study|Adverse Event|1|||
155573815|NCT02287922|561524429|FG002|Overall Study|Adverse Event|3|||
155573816|NCT02287922|561524430|FG003|Overall Study|Adverse Event|4|||
155573817|NCT02287922|561524427|FG000|Overall Study|Withdrawal by Subject|1|||
155573818|NCT02287922|561524428|FG001|Overall Study|Withdrawal by Subject|1|||
155573819|NCT02287922|561524429|FG002|Overall Study|Withdrawal by Subject|1|||
155573820|NCT02287922|561524430|FG003|Overall Study|Withdrawal by Subject|2|||
155573821|NCT02287922|561524427|FG000|Overall Study|Lost to Follow-up|0|||
155573822|NCT02287922|561524428|FG001|Overall Study|Lost to Follow-up|0|||
155573823|NCT02287922|561524429|FG002|Overall Study|Lost to Follow-up|1|||
155573824|NCT02287922|561524430|FG003|Overall Study|Lost to Follow-up|0|||
155573825|NCT02287922|561524427|FG000|Overall Study|Sponsor's decision|0|||
155573826|NCT02287922|561524428|FG001|Overall Study|Sponsor's decision|0|||
155573827|NCT02287922|561524429|FG002|Overall Study|Sponsor's decision|0|||
155573828|NCT02287922|561524430|FG003|Overall Study|Sponsor's decision|1|||
155573829|NCT02287922|561524427|FG000|Overall Study|Other|1|||
155573830|NCT02287922|561524428|FG001|Overall Study|Other|0|||
155573831|NCT02287922|561524429|FG002|Overall Study|Other|2|||
155573832|NCT02287922|561524430|FG003|Overall Study|Other|0|||
155573833|NCT03022370|561524431|FG000|Overall Study|Death|6|||
155573834|NCT03022370|561524432|FG001|Overall Study|Death|12|||
155573835|NCT03022370|561524431|FG000|Overall Study|Lost to Follow-up|174|||
155573836|NCT03022370|561524432|FG001|Overall Study|Lost to Follow-up|109|||
155573837|NCT03668808|561524434|FG000|First Intervention|Withdrawal by Subject|2|||
155573838|NCT03668808|561524435|FG001|First Intervention|Withdrawal by Subject|2|||
155573839|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
155573840|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Death|1|||
155573841|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
155573842|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
155573843|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
155573844|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
155573845|NCT02001987|561524436|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
155573846|NCT02001987|561524436|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
155573847|NCT02001987|561524436|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
155573848|NCT02001987|561524436|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
155573849|NCT02001987|561524436|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
155573850|NCT02001987|561524436|FG000|LTE Period (52 Weeks)|Other|3|||
155573851|NCT01330303|561524437|FG000|Period 1|Adverse Event|1|||
155573852|NCT01330303|561524438|FG001|Period 1|Adverse Event|0|||
155573853|NCT01330303|561524437|FG000|Period 1|Protocol Violation|0|||
155573854|NCT01330303|561524438|FG001|Period 1|Protocol Violation|1|||
155573855|NCT01330303|561524437|FG000|Period 1|Withdrawal by Subject|0|||
155573856|NCT01330303|561524438|FG001|Period 1|Withdrawal by Subject|1|||
155573857|NCT02593110|561524440|FG000|Overall Study|Withdrawal by Subject|0|||
155573858|NCT02593110|561524441|FG001|Overall Study|Withdrawal by Subject|3|||
155573859|NCT02593110|561524442|FG002|Overall Study|Withdrawal by Subject|3|||
155573860|NCT02593110|561524443|FG003|Overall Study|Withdrawal by Subject|2|||
155573861|NCT02593110|561524440|FG000|Overall Study|Death|0|||
155573862|NCT02593110|561524441|FG001|Overall Study|Death|0|||
155573863|NCT02593110|561524442|FG002|Overall Study|Death|1|||
155573864|NCT02593110|561524443|FG003|Overall Study|Death|0|||
155573865|NCT03548337|561524444|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
155573866|NCT03548337|561524445|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
155573867|NCT03548337|561524444|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
155573868|NCT03548337|561524445|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
155573869|NCT03548337|561524444|FG000|Infant Series|Lost to Follow-up|2|||
155573870|NCT03548337|561524445|FG001|Infant Series|Lost to Follow-up|1|||
155573871|NCT03548337|561524444|FG000|Infant Series|Adverse Event|0|||
155573872|NCT03548337|561524445|FG001|Infant Series|Adverse Event|2|||
155573873|NCT03548337|561524444|FG000|Infant Series|Randomized but Not Vaccinated|1|||
155573874|NCT03548337|561524445|FG001|Infant Series|Randomized but Not Vaccinated|0|||
155573875|NCT03548337|561524444|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
155573876|NCT03548337|561524445|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
155573877|NCT04502212|561524448|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
155573878|NCT04502212|561524448|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
155661527|NCT00854360|561856553|FG000|Overall Study|Adverse Event|0|||
155573879|NCT01911273|561524453|FG000|Overall Study|Progression of Disease|1|||
155573880|NCT01911273|561524454|FG001|Overall Study|Progression of Disease|0|||
155573881|NCT01911273|561524453|FG000|Overall Study|Withdrawal by Subject|0|||
155573882|NCT01911273|561524454|FG001|Overall Study|Withdrawal by Subject|2|||
155573883|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
155573884|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Off-label use|283|||
155661528|NCT00854360|561856554|FG001|Overall Study|Adverse Event|1|||
155573885|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
155573886|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
155573887|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
155573888|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
155573889|NCT01070953|561524459|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
155573890|NCT01070953|561524459|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
155573891|NCT01070953|561524459|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
155573892|NCT01070953|561524459|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
155573893|NCT04700137|561524460|FG000|Overall Study|Lost to Follow-up|1|||
155573894|NCT04700137|561524461|FG001|Overall Study|Lost to Follow-up|6|||
155573895|NCT04700137|561524462|FG002|Overall Study|Lost to Follow-up|1|||
155573896|NCT04700137|561524463|FG003|Overall Study|Lost to Follow-up|1|||
155573897|NCT04700137|561524460|FG000|Overall Study|Withdrawal by Subject|0|||
155573898|NCT04700137|561524461|FG001|Overall Study|Withdrawal by Subject|0|||
155573899|NCT04700137|561524462|FG002|Overall Study|Withdrawal by Subject|1|||
155573900|NCT04700137|561524463|FG003|Overall Study|Withdrawal by Subject|0|||
155573901|NCT04700137|561524460|FG000|Overall Study|Death|0|||
155573902|NCT04700137|561524461|FG001|Overall Study|Death|0|||
155573903|NCT04700137|561524462|FG002|Overall Study|Death|1|||
155573904|NCT04700137|561524463|FG003|Overall Study|Death|0|||
155573905|NCT02503787|561524464|FG000|Enrollment|Withdrawal by Subject|6|||
155573906|NCT02503787|561524464|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
155573907|NCT02503787|561524464|FG000|Enrollment|Physician Decision|2|||
155573908|NCT02503787|561524464|FG000|Enrollment|Insurance issue|2|||
155573909|NCT02503787|561524464|FG000|Enrollment|Lost to Follow-up|1|||
155573910|NCT02503787|561524464|FG000|Enrollment|Study closure|1|||
155573911|NCT02503787|561524464|FG000|Enrollment|Adverse Event|1|||
155573912|NCT02503787|561524464|FG000|Enrollment|Protocol Violation|1|||
155573913|NCT02503787|561524464|FG000|Enrollment|Inability to implant system|1|||
155573914|NCT02503787|561524464|FG000|Enrollment|Unable to be programmed|1|||
155573915|NCT02503787|561524464|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
155573916|NCT02503787|561524464|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
155573917|NCT02503787|561524464|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
155573918|NCT02503787|561524464|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
155573919|NCT02503787|561524464|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
155573920|NCT02503787|561524464|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
155573921|NCT04787627|561524465|FG000|Overall Study|Withdrawal by Subject|3|||
155573922|NCT04787627|561524466|FG001|Overall Study|Withdrawal by Subject|0|||
155573923|NCT04787627|561524465|FG000|Overall Study|Physician Decision|2|||
155573924|NCT04787627|561524466|FG001|Overall Study|Physician Decision|0|||
155573925|NCT04787627|561524465|FG000|Overall Study|Excluded|0|||
155573926|NCT04787627|561524466|FG001|Overall Study|Excluded|1|||
155573927|NCT03017612|561524470|FG000|Overall Study|Adverse Event|2|||
155573928|NCT02517463|561524471|FG000|Overall Study|Lost to Follow-up|5|||
155573929|NCT02517463|561524472|FG001|Overall Study|Lost to Follow-up|2|||
155573930|NCT00489827|561524480|FG000|Overall Study|Intraoperative exclusion criteria|1|||
155573931|NCT00489827|561524481|FG001|Overall Study|Intraoperative exclusion criteria|1|||
155573932|NCT00489827|561524480|FG000|Overall Study|Intraoperative exclusion criteria|1|||
155573933|NCT00489827|561524481|FG001|Overall Study|Intraoperative exclusion criteria|1|||
155573934|NCT02296931|561524482|FG000|Overall Study|Protocol Violation|0|||
155573935|NCT02296931|561524483|FG001|Overall Study|Protocol Violation|2|||
155573936|NCT01590277|561524484|FG000|Overall Study|Withdrawal by Subject|3|||
155573937|NCT01590277|561524484|FG000|Overall Study|Withdrawal by Subject|2|||
155573938|NCT01590277|561524484|FG000|Overall Study|Withdrawal by Subject|1|||
155573939|NCT01590277|561524484|FG000|Overall Study|Withdrawal by Subject|1|||
155573940|NCT04386616|561524485|FG000|Overall Study|Death|22|||
155573941|NCT04386616|561524486|FG001|Overall Study|Death|22|||
155573942|NCT04386616|561524487|FG002|Overall Study|Death|21|||
155573943|NCT04386616|561524485|FG000|Overall Study|Lost to Follow-up|5|||
155573944|NCT04386616|561524486|FG001|Overall Study|Lost to Follow-up|8|||
155573945|NCT04386616|561524487|FG002|Overall Study|Lost to Follow-up|6|||
155573946|NCT04386616|561524485|FG000|Overall Study|Withdrawal by Subject|2|||
155573947|NCT04386616|561524486|FG001|Overall Study|Withdrawal by Subject|4|||
155573948|NCT04386616|561524487|FG002|Overall Study|Withdrawal by Subject|1|||
155573949|NCT04386616|561524485|FG000|Overall Study|Adverse Event|1|||
155573950|NCT04386616|561524486|FG001|Overall Study|Adverse Event|1|||
155573951|NCT04386616|561524487|FG002|Overall Study|Adverse Event|0|||
155573952|NCT01377012|561524488|FG000|Core Study|Study terminated by Sponsor|47|||
155573953|NCT01377012|561524489|FG001|Core Study|Study terminated by Sponsor|54|||
155573954|NCT01377012|561524490|FG002|Core Study|Study terminated by Sponsor|46|||
155573955|NCT01377012|561524488|FG000|Core Study|Technical problems|1|||
155573956|NCT01377012|561524489|FG001|Core Study|Technical problems|0|||
155573957|NCT01377012|561524490|FG002|Core Study|Technical problems|0|||
155573958|NCT01377012|561524488|FG000|Core Study|Withdrawal by Subject|15|||
155573959|NCT01377012|561524489|FG001|Core Study|Withdrawal by Subject|23|||
155573960|NCT01377012|561524490|FG002|Core Study|Withdrawal by Subject|18|||
155573961|NCT01377012|561524488|FG000|Core Study|Protocol Violation|7|||
155573962|NCT01377012|561524489|FG001|Core Study|Protocol Violation|3|||
155573963|NCT01377012|561524490|FG002|Core Study|Protocol Violation|2|||
155573964|NCT01377012|561524488|FG000|Core Study|Pregnancy|0|||
155573965|NCT01377012|561524489|FG001|Core Study|Pregnancy|0|||
155573966|NCT01377012|561524490|FG002|Core Study|Pregnancy|1|||
155573967|NCT01377012|561524488|FG000|Core Study|Physician Decision|5|||
155573968|NCT01377012|561524489|FG001|Core Study|Physician Decision|4|||
155573969|NCT01377012|561524490|FG002|Core Study|Physician Decision|10|||
155573970|NCT01377012|561524488|FG000|Core Study|Non-Compliant with study treatment|0|||
155573971|NCT01377012|561524489|FG001|Core Study|Non-Compliant with study treatment|0|||
155573972|NCT01377012|561524490|FG002|Core Study|Non-Compliant with study treatment|1|||
155573973|NCT01377012|561524488|FG000|Core Study|No Longer require treatment|0|||
155573974|NCT01377012|561524489|FG001|Core Study|No Longer require treatment|0|||
155573975|NCT01377012|561524490|FG002|Core Study|No Longer require treatment|1|||
155573976|NCT01377012|561524488|FG000|Core Study|Lost to Follow-up|7|||
155573977|NCT01377012|561524489|FG001|Core Study|Lost to Follow-up|5|||
155573978|NCT01377012|561524490|FG002|Core Study|Lost to Follow-up|4|||
155573979|NCT01377012|561524488|FG000|Core Study|Lack of Efficacy|41|||
155573980|NCT01377012|561524489|FG001|Core Study|Lack of Efficacy|28|||
155573981|NCT01377012|561524490|FG002|Core Study|Lack of Efficacy|37|||
155573982|NCT01377012|561524488|FG000|Core Study|Death|1|||
155573983|NCT01377012|561524489|FG001|Core Study|Death|1|||
155573984|NCT01377012|561524490|FG002|Core Study|Death|1|||
155573985|NCT01377012|561524488|FG000|Core Study|Adverse Event|10|||
155573986|NCT01377012|561524489|FG001|Core Study|Adverse Event|14|||
155573987|NCT01377012|561524490|FG002|Core Study|Adverse Event|13|||
155573988|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
155573989|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
155573990|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
155573991|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
155573992|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
155573993|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
155573994|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
155573995|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
155573996|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
155573997|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
155573998|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
155573999|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
155574000|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
155574001|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
155574002|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
155574003|NCT01377012|561524488|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
155574004|NCT01377012|561524489|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
155574005|NCT01377012|561524490|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
155574006|NCT01632280|561524512|FG000|Overall Study|Withdrawal by Subject|1|||
155574007|NCT01632280|561524513|FG001|Overall Study|Withdrawal by Subject|0|||
155574008|NCT03086551|561524519|FG000|First Intervention|Failure to meet inclusion criterion|1|||
155574009|NCT03086551|561524520|FG001|First Intervention|Failure to meet inclusion criterion|0|||
155574010|NCT03086551|561524519|FG000|First Intervention|Lost to Follow-up|0|||
155574011|NCT03086551|561524520|FG001|First Intervention|Lost to Follow-up|1|||
155574012|NCT03086551|561524519|FG000|Washout|Lost to Follow-up|1|||
155574013|NCT03086551|561524520|FG001|Washout|Lost to Follow-up|2|||
155574014|NCT03086551|561524519|FG000|Washout|Withdrawal by Subject|2|||
155574015|NCT03086551|561524520|FG001|Washout|Withdrawal by Subject|1|||
155574016|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
155574017|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
155574018|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
155574019|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
155574020|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
155574021|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
155574022|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
155574023|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
155574024|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
155574025|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
155574026|NCT00451178|561524523|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
155574027|NCT00451178|561524524|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
155574028|NCT00451178|561524523|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
155574029|NCT00451178|561524524|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
155574030|NCT00451178|561524523|FG000|Prior to Maintenance Therapy|PD|2|||
155574031|NCT00451178|561524524|FG001|Prior to Maintenance Therapy|PD|0|||
155574032|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
155574033|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
155574034|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
155574035|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
155574036|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
155574037|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
155574038|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
155574039|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
155574040|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
155574041|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
155574042|NCT00451178|561524523|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
155574043|NCT00451178|561524524|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
155574044|NCT00451178|561524523|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
155574045|NCT00451178|561524524|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
155574046|NCT02215967|561524525|FG000|Overall Study|Patient became ineligible for treatment|0|||
155574047|NCT02215967|561524526|FG001|Overall Study|Patient became ineligible for treatment|0|||
155574048|NCT02215967|561524527|FG002|Overall Study|Patient became ineligible for treatment|0|||
155574049|NCT02215967|561524528|FG003|Overall Study|Patient became ineligible for treatment|3|||
155574050|NCT02215967|561524525|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
155574051|NCT02215967|561524526|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
155574052|NCT02215967|561524527|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
155574053|NCT02215967|561524528|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
155574054|NCT06473519|561526168|FG000|Overall Study|Lost to Follow-up|2|||
155574055|NCT06473519|561526169|FG001|Overall Study|Lost to Follow-up|5|||
155574056|NCT06473519|561526168|FG000|Overall Study|Withdrawal by Subject|1|||
155574057|NCT06473519|561526169|FG001|Overall Study|Withdrawal by Subject|4|||
155574058|NCT06473519|561526168|FG000|Overall Study|Randomized but not vaccinated|1|||
155574059|NCT06473519|561526169|FG001|Overall Study|Randomized but not vaccinated|2|||
155574060|NCT05626231|561526171|FG000|Provider Enrollment|Worked part-time|4|||
155574061|NCT05626231|561526171|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
155574062|NCT05626231|561526171|FG000|Provider Enrollment|Non-clinical employee|1|||
155574063|NCT05626231|561526171|FG000|Provider Enrollment|Provider does not see clients|3|||
155574064|NCT05626231|561526171|FG000|Provider Enrollment|Other|5|||
155574065|NCT03765788|561526172|FG000|Overall Study|Subject decision|2|||
155574066|NCT03765788|561526173|FG001|Overall Study|Subject decision|3|||
155574067|NCT03765788|561526172|FG000|Overall Study|Physician Decision|2|||
155574068|NCT03765788|561526173|FG001|Overall Study|Physician Decision|4|||
155574069|NCT03765788|561526172|FG000|Overall Study|Death|0|||
155574070|NCT03765788|561526173|FG001|Overall Study|Death|1|||
155574071|NCT03765788|561526172|FG000|Overall Study|Lost to Follow-up|1|||
155574072|NCT03765788|561526173|FG001|Overall Study|Lost to Follow-up|0|||
155574073|NCT03573830|561526182|FG000|Overall Study|Dropped without completing treatment|0|||
155574074|NCT03573830|561526183|FG001|Overall Study|Dropped without completing treatment|7|||
155574075|NCT03573830|561526182|FG000|Overall Study|Lost to Follow-up|4|||
155574076|NCT03573830|561526183|FG001|Overall Study|Lost to Follow-up|0|||
155574077|NCT04909853|561526189|FG000|Part 1|Assigned but not treated|0|||
155574078|NCT04909853|561526190|FG001|Part 1|Assigned but not treated|0|||
155574079|NCT04909853|561526191|FG002|Part 1|Assigned but not treated|1|||
155574080|NCT04909853|561526192|FG003|Part 1|Assigned but not treated|0|||
155574081|NCT04909853|561526189|FG000|Part 2|Adverse Event|0|||
155574082|NCT04909853|561526190|FG001|Part 2|Adverse Event|0|||
155574083|NCT04909853|561526191|FG002|Part 2|Adverse Event|0|||
155574084|NCT04909853|561526192|FG003|Part 2|Adverse Event|1|||
155574085|NCT00444587|561526197|FG000|Overall Study|Death|2|||
155574086|NCT00444587|561526198|FG001|Overall Study|Death|1|||
155574087|NCT00444587|561526197|FG000|Overall Study|Progression of the disease|73|||
155574088|NCT00444587|561526198|FG001|Overall Study|Progression of the disease|8|||
155574089|NCT00444587|561526197|FG000|Overall Study|Refused treatment/did not cooperate|4|||
155574090|NCT00444587|561526198|FG001|Overall Study|Refused treatment/did not cooperate|1|||
155574091|NCT00444587|561526197|FG000|Overall Study|Investigator decision|3|||
155574092|NCT00444587|561526198|FG001|Overall Study|Investigator decision|0|||
155574093|NCT00444587|561526197|FG000|Overall Study|Protocol Violation|1|||
155574094|NCT00444587|561526198|FG001|Overall Study|Protocol Violation|0|||
155574095|NCT00444587|561526197|FG000|Overall Study|Missing|0|||
155574096|NCT00444587|561526198|FG001|Overall Study|Missing|5|||
155574097|NCT00196326|561526199|FG000|Overall Study|Did not meet protocol requirements|64|||
155574098|NCT00196326|561526199|FG000|Overall Study|Non-compliance with the protocol|81|||
155574099|NCT00196326|561526199|FG000|Overall Study|Physician Decision|3|||
155574100|NCT00196326|561526199|FG000|Overall Study|Withdrawal by Subject|225|||
155574101|NCT00196326|561526199|FG000|Overall Study|Adverse Event|253|||
155574102|NCT00196326|561526199|FG000|Overall Study|Pregnancy|34|||
155574103|NCT00196326|561526199|FG000|Overall Study|Lost to Follow-up|304|||
155574104|NCT00196326|561526199|FG000|Overall Study|Other|22|||
155574105|NCT01720225|561526202|FG000|Overall Study|Withdrawal by Subject|0|||
155574106|NCT01720225|561526203|FG001|Overall Study|Withdrawal by Subject|1|||
155574107|NCT01720225|561526202|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
155574108|NCT01720225|561526203|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
155574109|NCT00369941|561526204|FG000|Overall Study|Never Treated|1|||
155574110|NCT00369941|561526205|FG001|Overall Study|Never Treated|2|||
155574111|NCT00369941|561526204|FG000|Overall Study|Adverse Event|14|||
155574112|NCT00369941|561526205|FG001|Overall Study|Adverse Event|28|||
155574113|NCT00369941|561526204|FG000|Overall Study|Lack of Efficacy|6|||
155574114|NCT00369941|561526205|FG001|Overall Study|Lack of Efficacy|10|||
155574115|NCT00369941|561526204|FG000|Overall Study|Lost to Follow-up|12|||
155574116|NCT00369941|561526205|FG001|Overall Study|Lost to Follow-up|22|||
155574117|NCT00369941|561526204|FG000|Overall Study|Protocol Violation|5|||
155574118|NCT00369941|561526205|FG001|Overall Study|Protocol Violation|3|||
155574119|NCT00369941|561526204|FG000|Overall Study|Withdrawal by Subject|5|||
155574120|NCT00369941|561526205|FG001|Overall Study|Withdrawal by Subject|18|||
155574121|NCT00369941|561526204|FG000|Overall Study|Pregnancy|4|||
155574122|NCT00369941|561526205|FG001|Overall Study|Pregnancy|2|||
155574123|NCT00369941|561526204|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
155574124|NCT00369941|561526205|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
155574125|NCT00369941|561526204|FG000|Overall Study|Moved|11|||
155574126|NCT00369941|561526205|FG001|Overall Study|Moved|5|||
155574127|NCT00369941|561526204|FG000|Overall Study|Treatment with Prohibited Medication|3|||
155574128|NCT00369941|561526205|FG001|Overall Study|Treatment with Prohibited Medication|1|||
155574129|NCT00369941|561526204|FG000|Overall Study|Employment Interfered with Study Visits|1|||
155574130|NCT00369941|561526205|FG001|Overall Study|Employment Interfered with Study Visits|0|||
155574131|NCT00369941|561526204|FG000|Overall Study|Study Site Terminated|2|||
155574132|NCT00369941|561526205|FG001|Overall Study|Study Site Terminated|0|||
155574133|NCT00369941|561526204|FG000|Overall Study|Miscellaneous|3|||
155574134|NCT00369941|561526205|FG001|Overall Study|Miscellaneous|3|||
155574135|NCT02964312|561526212|FG000|Overall Study|Lost to Follow-up|28|||
155574136|NCT02964312|561526212|FG000|Overall Study|Withdrawal by Subject|11|||
155574137|NCT02964312|561526212|FG000|Overall Study|Lack of Efficacy|10|||
155574138|NCT02964312|561526212|FG000|Overall Study|Did not consent to long-term FU|14|||
155574139|NCT02964312|561526212|FG000|Overall Study|Death|1|||
155574140|NCT02738138|561526213|FG000|Overall Study|Adverse Event|0|||
155574141|NCT02738138|561526214|FG001|Overall Study|Adverse Event|1|||
155574142|NCT02738138|561526213|FG000|Overall Study|Lost to Follow-up|2|||
155574143|NCT02738138|561526214|FG001|Overall Study|Lost to Follow-up|0|||
155574144|NCT02738138|561526213|FG000|Overall Study|Other - not further specified|1|||
155574145|NCT02738138|561526214|FG001|Overall Study|Other - not further specified|0|||
155574146|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Other|34|||
155574147|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Other|0|||
155574148|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Other|0|||
155574149|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Other|0|||
155574150|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Death|14|||
155574151|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Death|0|||
155574152|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Death|0|||
155574153|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Death|0|||
155574154|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
155574155|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
155574156|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
155574157|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
155574158|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
155574159|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155574160|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155574161|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155574162|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
155574163|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
155574164|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
155574165|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
155574166|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
155574167|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155574168|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155574169|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155574170|NCT01995513|561526218|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
155574171|NCT01995513|561526219|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155574172|NCT01995513|561526220|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155574173|NCT01995513|561526221|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155574174|NCT01995513|561526218|FG000|Period 1: Second Open Label Treatment|Other|0|||
155574175|NCT01995513|561526219|FG001|Period 1: Second Open Label Treatment|Other|2|||
155574176|NCT01995513|561526220|FG002|Period 1: Second Open Label Treatment|Other|0|||
155574177|NCT01995513|561526221|FG003|Period 1: Second Open Label Treatment|Other|0|||
155574178|NCT01995513|561526218|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
155574179|NCT01995513|561526219|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
155574180|NCT01995513|561526220|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
155574181|NCT01995513|561526221|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
155574182|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Death|0|||
155574183|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Death|0|||
155574184|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Death|0|||
155574185|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Death|1|||
155574186|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Other|0|||
155574187|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Other|0|||
155574188|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Other|3|||
155574189|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Other|3|||
155574190|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
155574191|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
155574192|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
155574193|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
155574194|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
155574195|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
155574196|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
155574197|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
155574198|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
155574199|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
155574200|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
155574201|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
155574202|NCT01995513|561526218|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155574203|NCT01995513|561526219|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155574204|NCT01995513|561526220|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155574205|NCT01995513|561526221|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
155574206|NCT01232452|561526222|FG000|Overall Study|Adverse Event|17|||
155574207|NCT01232452|561526223|FG001|Overall Study|Adverse Event|15|||
155574208|NCT01232452|561526222|FG000|Overall Study|Withdrawal by Subject|11|||
155574209|NCT01232452|561526223|FG001|Overall Study|Withdrawal by Subject|8|||
155574210|NCT01232452|561526222|FG000|Overall Study|Physician Decision|8|||
155574211|NCT01232452|561526223|FG001|Overall Study|Physician Decision|12|||
155574212|NCT01232452|561526222|FG000|Overall Study|Protocol entry criterion not met|0|||
155574213|NCT01232452|561526223|FG001|Overall Study|Protocol entry criterion not met|2|||
155574214|NCT01232452|561526222|FG000|Overall Study|Sponsor Decision|3|||
155574215|NCT01232452|561526223|FG001|Overall Study|Sponsor Decision|1|||
155574216|NCT01232452|561526222|FG000|Overall Study|Protocol Violation|0|||
155574217|NCT01232452|561526223|FG001|Overall Study|Protocol Violation|1|||
155574218|NCT05219448|561526228|FG000|Overall Study|Lost to Follow-up|9|||
155574219|NCT05219448|561526229|FG001|Overall Study|Lost to Follow-up|0|||
155574220|NCT01750190|561526230|FG000|Overall Study|Adverse Event|47|||
155574221|NCT01750190|561526231|FG001|Overall Study|Adverse Event|19|||
155574222|NCT01750190|561526230|FG000|Overall Study|Death|38|||
155574223|NCT01750190|561526231|FG001|Overall Study|Death|11|||
155574224|NCT01750190|561526230|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
155574225|NCT01750190|561526231|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
155574226|NCT01750190|561526230|FG000|Overall Study|Lost to Follow-up|28|||
155574227|NCT01750190|561526231|FG001|Overall Study|Lost to Follow-up|7|||
155574228|NCT01750190|561526230|FG000|Overall Study|Physician Decision|16|||
155574229|NCT01750190|561526231|FG001|Overall Study|Physician Decision|17|||
155574230|NCT01750190|561526230|FG000|Overall Study|Protocol Violation|6|||
155574231|NCT01750190|561526231|FG001|Overall Study|Protocol Violation|5|||
155574232|NCT01750190|561526230|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
155574233|NCT01750190|561526231|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
155574234|NCT01750190|561526230|FG000|Overall Study|Withdrawal by Subject|83|||
155574235|NCT01750190|561526231|FG001|Overall Study|Withdrawal by Subject|89|||
155574236|NCT01750190|561526230|FG000|Overall Study|Kidney Transplant|8|||
155574237|NCT01750190|561526231|FG001|Overall Study|Kidney Transplant|4|||
155574238|NCT01750190|561526230|FG000|Overall Study|Dialysis|22|||
155574239|NCT01750190|561526231|FG001|Overall Study|Dialysis|8|||
155574240|NCT01750190|561526230|FG000|Overall Study|Other than Specified|13|||
155574241|NCT01750190|561526231|FG001|Overall Study|Other than Specified|4|||
155574242|NCT03571828|561526236|FG000|Overall Study|Withdrawal by Subject|1|||
155574243|NCT03571828|561526237|FG001|Overall Study|Withdrawal by Subject|0|||
155574244|NCT03571828|561526236|FG000|Overall Study|Decision by sponsor|5|||
155574245|NCT03571828|561526237|FG001|Overall Study|Decision by sponsor|1|||
155574246|NCT03571828|561526236|FG000|Overall Study|Death|2|||
155574247|NCT03571828|561526237|FG001|Overall Study|Death|0|||
155574248|NCT04138823|561526252|FG000|Overall Study|Clinical disease progression|0|||
155574249|NCT04138823|561526253|FG001|Overall Study|Clinical disease progression|0|||
155574250|NCT04138823|561526254|FG002|Overall Study|Clinical disease progression|1|||
155574251|NCT04138823|561526252|FG000|Overall Study|Objective disease progression|3|||
155574252|NCT04138823|561526253|FG001|Overall Study|Objective disease progression|2|||
155574253|NCT04138823|561526254|FG002|Overall Study|Objective disease progression|5|||
155574254|NCT02466685|561526256|FG000|Overall Study|Adverse Event|5|||
155574255|NCT02466685|561526257|FG001|Overall Study|Adverse Event|2|||
155574256|NCT02466685|561526256|FG000|Overall Study|Lost to Follow-up|1|||
155574257|NCT02466685|561526257|FG001|Overall Study|Lost to Follow-up|1|||
155574258|NCT02466685|561526256|FG000|Overall Study|Withdrawal by Subject|1|||
155574259|NCT02466685|561526257|FG001|Overall Study|Withdrawal by Subject|0|||
155574260|NCT02466685|561526256|FG000|Overall Study|Physician Decision|1|||
155574261|NCT02466685|561526257|FG001|Overall Study|Physician Decision|1|||
155574262|NCT02565511|561526258|FG000|Overall Study|Study terminated by Sponsor|35|||
155574263|NCT02565511|561526259|FG001|Overall Study|Study terminated by Sponsor|22|||
155574264|NCT02565511|561526260|FG002|Overall Study|Study terminated by Sponsor|235|||
155574265|NCT02565511|561526261|FG003|Overall Study|Study terminated by Sponsor|156|||
155574266|NCT02565511|561526258|FG000|Overall Study|Withdrawal by Subject|3|||
155574267|NCT02565511|561526259|FG001|Overall Study|Withdrawal by Subject|0|||
155574268|NCT02565511|561526260|FG002|Overall Study|Withdrawal by Subject|12|||
155574269|NCT02565511|561526261|FG003|Overall Study|Withdrawal by Subject|5|||
155574270|NCT02565511|561526258|FG000|Overall Study|Adverse Event|0|||
155574271|NCT02565511|561526259|FG001|Overall Study|Adverse Event|0|||
155574272|NCT02565511|561526260|FG002|Overall Study|Adverse Event|1|||
155574273|NCT02565511|561526261|FG003|Overall Study|Adverse Event|1|||
155574274|NCT02565511|561526258|FG000|Overall Study|Lost to Follow-up|4|||
155574275|NCT02565511|561526259|FG001|Overall Study|Lost to Follow-up|1|||
155574276|NCT02565511|561526260|FG002|Overall Study|Lost to Follow-up|0|||
155574277|NCT02565511|561526261|FG003|Overall Study|Lost to Follow-up|1|||
155574278|NCT02565511|561526258|FG000|Overall Study|Physician Decision|0|||
155574279|NCT02565511|561526259|FG001|Overall Study|Physician Decision|0|||
155574280|NCT02565511|561526260|FG002|Overall Study|Physician Decision|0|||
155574281|NCT02565511|561526261|FG003|Overall Study|Physician Decision|1|||
155574282|NCT02565511|561526258|FG000|Overall Study|Protocol deviation|0|||
155574283|NCT02565511|561526259|FG001|Overall Study|Protocol deviation|0|||
155574284|NCT02565511|561526260|FG002|Overall Study|Protocol deviation|3|||
155574285|NCT02565511|561526261|FG003|Overall Study|Protocol deviation|0|||
155574286|NCT00104572|561526262|FG000|Overall Study|Withdrawal by Subject|3|||
155574287|NCT00104572|561526263|FG001|Overall Study|Withdrawal by Subject|3|||
155574288|NCT00104572|561526264|FG002|Overall Study|Withdrawal by Subject|0|||
155574289|NCT02969044|561526265|FG000|Overall Study|Withdrawal by Subject|2|||
155574290|NCT02969044|561526266|FG001|Overall Study|Withdrawal by Subject|6|||
155574291|NCT02969044|561526265|FG000|Overall Study|Adverse Event|3|||
155574292|NCT02969044|561526266|FG001|Overall Study|Adverse Event|0|||
155574293|NCT04650204|561526267|FG000|Overall Study|Study was Terminated|2|||
155574294|NCT04650204|561526268|FG001|Overall Study|Study was Terminated|1|||
155574295|NCT00548093|561526269|FG000|Overall Study|Death|33|||
155574296|NCT00548093|561526270|FG001|Overall Study|Death|13|||
155574297|NCT00548093|561526269|FG000|Overall Study|Lost to Follow-up|3|||
155574298|NCT00548093|561526270|FG001|Overall Study|Lost to Follow-up|1|||
155574299|NCT00548093|561526269|FG000|Overall Study|Objective progression or relapse|1|||
155574300|NCT00548093|561526270|FG001|Overall Study|Objective progression or relapse|1|||
155574301|NCT00548093|561526269|FG000|Overall Study|Other|11|||
155574302|NCT00548093|561526270|FG001|Overall Study|Other|1|||
155574303|NCT00548093|561526269|FG000|Overall Study|Withdrawal by Subject|1|||
155574304|NCT00548093|561526270|FG001|Overall Study|Withdrawal by Subject|0|||
155574305|NCT00548093|561526269|FG000|Overall Study|Completed post-treatment follow-up|1|||
155574306|NCT00548093|561526270|FG001|Overall Study|Completed post-treatment follow-up|0|||
155574307|NCT02359994|561526273|FG000|Overall Population Study|Adverse Event|1|||
155574308|NCT02359994|561526274|FG001|Overall Population Study|Adverse Event|1|||
155574309|NCT02359994|561526273|FG000|Overall Population Study|Death|1|||
155574310|NCT02359994|561526274|FG001|Overall Population Study|Death|5|||
155574311|NCT02359994|561526273|FG000|Overall Population Study|Lost to Follow-up|1|||
155574312|NCT02359994|561526274|FG001|Overall Population Study|Lost to Follow-up|1|||
155661529|NCT00854360|561856555|FG002|Overall Study|Adverse Event|2|||
155574313|NCT02359994|561526273|FG000|Overall Population Study|Withdrawal by Subject|1|||
155574314|NCT02359994|561526274|FG001|Overall Population Study|Withdrawal by Subject|0|||
155574315|NCT02359994|561526273|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
155661530|NCT00854360|561856556|FG003|Overall Study|Adverse Event|6|||
155574316|NCT02359994|561526274|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
155574317|NCT02359994|561526273|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
155574318|NCT02359994|561526274|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
155574319|NCT02359994|561526273|FG000|Extended Oncology 24-Month Survival|Death|19|||
155574320|NCT02359994|561526274|FG001|Extended Oncology 24-Month Survival|Death|21|||
155574321|NCT02359994|561526273|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
155574322|NCT02359994|561526274|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
155574323|NCT04597632|561526275|FG000|Overall Study|Withdrawal by Subject|10|||
155574324|NCT04597632|561526275|FG000|Overall Study|Lost to Follow-up|1|||
155574325|NCT04597632|561526275|FG000|Overall Study|Death|1|||
155574326|NCT04597632|561526275|FG000|Overall Study|Adverse Event|5|||
155574327|NCT01823835|561526276|FG000|Overall Study|Adverse Event|0|||
155574328|NCT01823835|561526277|FG001|Overall Study|Adverse Event|0|||
155574329|NCT01823835|561526278|FG002|Overall Study|Adverse Event|0|||
155574330|NCT01823835|561526279|FG003|Overall Study|Adverse Event|0|||
155574331|NCT01823835|561526280|FG004|Overall Study|Adverse Event|1|||
155574332|NCT01823835|561526281|FG005|Overall Study|Adverse Event|0|||
155574333|NCT01823835|561526282|FG006|Overall Study|Adverse Event|1|||
155574334|NCT01823835|561526283|FG007|Overall Study|Adverse Event|0|||
155574335|NCT01823835|561526284|FG008|Overall Study|Adverse Event|0|||
155574336|NCT01823835|561526285|FG009|Overall Study|Adverse Event|0|||
155574337|NCT01823835|561526286|FG010|Overall Study|Adverse Event|1|||
155574338|NCT01823835|561526287|FG011|Overall Study|Adverse Event|2|||
155574339|NCT01823835|561526288|FG012|Overall Study|Adverse Event|0|||
155574340|NCT01823835|561526289|FG013|Overall Study|Adverse Event|0|||
155574341|NCT01823835|561526290|FG014|Overall Study|Adverse Event|0|||
155574342|NCT01823835|561526276|FG000|Overall Study|Physician Decision|0|||
155574343|NCT01823835|561526277|FG001|Overall Study|Physician Decision|0|||
155574344|NCT01823835|561526278|FG002|Overall Study|Physician Decision|0|||
155574345|NCT01823835|561526279|FG003|Overall Study|Physician Decision|0|||
155574346|NCT01823835|561526280|FG004|Overall Study|Physician Decision|0|||
155574347|NCT01823835|561526281|FG005|Overall Study|Physician Decision|0|||
155574348|NCT01823835|561526282|FG006|Overall Study|Physician Decision|0|||
155574349|NCT01823835|561526283|FG007|Overall Study|Physician Decision|0|||
155574350|NCT01823835|561526284|FG008|Overall Study|Physician Decision|0|||
155574351|NCT01823835|561526285|FG009|Overall Study|Physician Decision|0|||
155574352|NCT01823835|561526286|FG010|Overall Study|Physician Decision|0|||
155574353|NCT01823835|561526287|FG011|Overall Study|Physician Decision|2|||
155574354|NCT01823835|561526288|FG012|Overall Study|Physician Decision|0|||
155574355|NCT01823835|561526289|FG013|Overall Study|Physician Decision|0|||
155574356|NCT01823835|561526290|FG014|Overall Study|Physician Decision|0|||
155574357|NCT01823835|561526276|FG000|Overall Study|Progressive Disease|3|||
155574358|NCT01823835|561526277|FG001|Overall Study|Progressive Disease|4|||
155574359|NCT01823835|561526278|FG002|Overall Study|Progressive Disease|3|||
155574360|NCT01823835|561526279|FG003|Overall Study|Progressive Disease|6|||
155574361|NCT01823835|561526280|FG004|Overall Study|Progressive Disease|4|||
155574362|NCT01823835|561526281|FG005|Overall Study|Progressive Disease|6|||
155574363|NCT01823835|561526282|FG006|Overall Study|Progressive Disease|5|||
155574364|NCT01823835|561526283|FG007|Overall Study|Progressive Disease|3|||
155574365|NCT01823835|561526284|FG008|Overall Study|Progressive Disease|3|||
155574366|NCT01823835|561526285|FG009|Overall Study|Progressive Disease|18|||
155574367|NCT01823835|561526286|FG010|Overall Study|Progressive Disease|8|||
155574368|NCT01823835|561526287|FG011|Overall Study|Progressive Disease|46|||
155574369|NCT01823835|561526288|FG012|Overall Study|Progressive Disease|18|||
155574370|NCT01823835|561526289|FG013|Overall Study|Progressive Disease|4|||
155574371|NCT01823835|561526290|FG014|Overall Study|Progressive Disease|6|||
155574372|NCT01823835|561526276|FG000|Overall Study|Study Termination|0|||
155574373|NCT01823835|561526277|FG001|Overall Study|Study Termination|0|||
155574374|NCT01823835|561526278|FG002|Overall Study|Study Termination|0|||
155574375|NCT01823835|561526279|FG003|Overall Study|Study Termination|0|||
155574376|NCT01823835|561526280|FG004|Overall Study|Study Termination|1|||
155574377|NCT01823835|561526281|FG005|Overall Study|Study Termination|0|||
155574378|NCT01823835|561526282|FG006|Overall Study|Study Termination|0|||
155574379|NCT01823835|561526283|FG007|Overall Study|Study Termination|0|||
155661531|NCT00854360|561856553|FG000|Overall Study|Withdrawal by Subject|0|||
155574380|NCT01823835|561526284|FG008|Overall Study|Study Termination|0|||
155574381|NCT01823835|561526285|FG009|Overall Study|Study Termination|0|||
155574382|NCT01823835|561526286|FG010|Overall Study|Study Termination|0|||
155574383|NCT01823835|561526287|FG011|Overall Study|Study Termination|1|||
155574384|NCT01823835|561526288|FG012|Overall Study|Study Termination|0|||
155574385|NCT01823835|561526289|FG013|Overall Study|Study Termination|0|||
155661532|NCT00854360|561856554|FG001|Overall Study|Withdrawal by Subject|0|||
155574386|NCT01823835|561526290|FG014|Overall Study|Study Termination|0|||
155574387|NCT01823835|561526276|FG000|Overall Study|Withdrawal by Subject|0|||
155574388|NCT01823835|561526277|FG001|Overall Study|Withdrawal by Subject|0|||
155574389|NCT01823835|561526278|FG002|Overall Study|Withdrawal by Subject|1|||
155574390|NCT01823835|561526279|FG003|Overall Study|Withdrawal by Subject|0|||
155574391|NCT01823835|561526280|FG004|Overall Study|Withdrawal by Subject|0|||
155574392|NCT01823835|561526281|FG005|Overall Study|Withdrawal by Subject|0|||
155574393|NCT01823835|561526282|FG006|Overall Study|Withdrawal by Subject|0|||
155574394|NCT01823835|561526283|FG007|Overall Study|Withdrawal by Subject|0|||
155574395|NCT01823835|561526284|FG008|Overall Study|Withdrawal by Subject|0|||
155574396|NCT01823835|561526285|FG009|Overall Study|Withdrawal by Subject|1|||
155574397|NCT01823835|561526286|FG010|Overall Study|Withdrawal by Subject|1|||
155574398|NCT01823835|561526287|FG011|Overall Study|Withdrawal by Subject|2|||
155574399|NCT01823835|561526288|FG012|Overall Study|Withdrawal by Subject|1|||
155574400|NCT01823835|561526289|FG013|Overall Study|Withdrawal by Subject|0|||
155574401|NCT01823835|561526290|FG014|Overall Study|Withdrawal by Subject|0|||
155574402|NCT00509795|561526291|FG000|Overall Study|Adverse Event|4|||
155574403|NCT00509795|561526292|FG001|Overall Study|Adverse Event|3|||
155574404|NCT00509795|561526293|FG002|Overall Study|Adverse Event|5|||
155574405|NCT00509795|561526294|FG003|Overall Study|Adverse Event|4|||
155574406|NCT00509795|561526291|FG000|Overall Study|Death|3|||
155574407|NCT00509795|561526292|FG001|Overall Study|Death|1|||
155574408|NCT00509795|561526293|FG002|Overall Study|Death|2|||
155574409|NCT00509795|561526294|FG003|Overall Study|Death|7|||
155574410|NCT00509795|561526291|FG000|Overall Study|Lack of Efficacy|0|||
155574411|NCT00509795|561526292|FG001|Overall Study|Lack of Efficacy|0|||
155574412|NCT00509795|561526293|FG002|Overall Study|Lack of Efficacy|2|||
155574413|NCT00509795|561526294|FG003|Overall Study|Lack of Efficacy|2|||
155574414|NCT00509795|561526291|FG000|Overall Study|Lost to Follow-up|1|||
155574415|NCT00509795|561526292|FG001|Overall Study|Lost to Follow-up|2|||
155574416|NCT00509795|561526293|FG002|Overall Study|Lost to Follow-up|4|||
155574417|NCT00509795|561526294|FG003|Overall Study|Lost to Follow-up|4|||
155574418|NCT00509795|561526291|FG000|Overall Study|OTHER|1|||
155574419|NCT00509795|561526292|FG001|Overall Study|OTHER|0|||
155574420|NCT00509795|561526293|FG002|Overall Study|OTHER|4|||
155574421|NCT00509795|561526294|FG003|Overall Study|OTHER|1|||
155574422|NCT00509795|561526291|FG000|Overall Study|Protocol Violation|3|||
155574423|NCT00509795|561526292|FG001|Overall Study|Protocol Violation|0|||
155574424|NCT00509795|561526293|FG002|Overall Study|Protocol Violation|3|||
155574425|NCT00509795|561526294|FG003|Overall Study|Protocol Violation|1|||
155574426|NCT00509795|561526291|FG000|Overall Study|Withdrawal by Subject|10|||
155574427|NCT00509795|561526292|FG001|Overall Study|Withdrawal by Subject|5|||
155574428|NCT00509795|561526293|FG002|Overall Study|Withdrawal by Subject|7|||
155574429|NCT00509795|561526294|FG003|Overall Study|Withdrawal by Subject|8|||
155574430|NCT01320150|561526295|FG000|Overall Study|Protocol Violation|15|||
155574431|NCT01320150|561526295|FG000|Overall Study|Withdrawal by Subject|5|||
155574432|NCT01320150|561526295|FG000|Overall Study|Death|2|||
155574433|NCT01320150|561526295|FG000|Overall Study|Lost to Follow-up|44|||
155574434|NCT04895982|561526296|FG000|Overall Study|Withdrawal by Subject|0|||
155574435|NCT04895982|561526297|FG001|Overall Study|Withdrawal by Subject|0|||
155574436|NCT04895982|561526298|FG002|Overall Study|Withdrawal by Subject|0|||
155574437|NCT04895982|561526299|FG003|Overall Study|Withdrawal by Subject|0|||
155574438|NCT04895982|561526300|FG004|Overall Study|Withdrawal by Subject|0|||
155574439|NCT04895982|561526301|FG005|Overall Study|Withdrawal by Subject|1|||
155574440|NCT04895982|561526302|FG006|Overall Study|Withdrawal by Subject|1|||
155574441|NCT04895982|561526303|FG007|Overall Study|Withdrawal by Subject|0|||
155574442|NCT04895982|561526304|FG008|Overall Study|Withdrawal by Subject|0|||
155574443|NCT04895982|561526305|FG009|Overall Study|Withdrawal by Subject|1|||
155574444|NCT04895982|561526306|FG010|Overall Study|Withdrawal by Subject|0|||
155574445|NCT04895982|561526307|FG011|Overall Study|Withdrawal by Subject|1|||
155574446|NCT04895982|561526296|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155574447|NCT04895982|561526297|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155574448|NCT04895982|561526298|FG002|Overall Study|Withdrawal by parent/guardian|3|||
155574449|NCT04895982|561526299|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155574450|NCT04895982|561526300|FG004|Overall Study|Withdrawal by parent/guardian|3|||
155574451|NCT04895982|561526301|FG005|Overall Study|Withdrawal by parent/guardian|2|||
155574452|NCT04895982|561526302|FG006|Overall Study|Withdrawal by parent/guardian|1|||
155574453|NCT04895982|561526303|FG007|Overall Study|Withdrawal by parent/guardian|0|||
155574454|NCT04895982|561526304|FG008|Overall Study|Withdrawal by parent/guardian|3|||
155574455|NCT04895982|561526305|FG009|Overall Study|Withdrawal by parent/guardian|0|||
155574456|NCT04895982|561526306|FG010|Overall Study|Withdrawal by parent/guardian|0|||
155574457|NCT04895982|561526307|FG011|Overall Study|Withdrawal by parent/guardian|0|||
155574458|NCT04895982|561526296|FG000|Overall Study|Other|0|||
155574459|NCT04895982|561526297|FG001|Overall Study|Other|0|||
155574460|NCT04895982|561526298|FG002|Overall Study|Other|1|||
155574461|NCT04895982|561526299|FG003|Overall Study|Other|1|||
155574462|NCT04895982|561526300|FG004|Overall Study|Other|0|||
155574463|NCT04895982|561526301|FG005|Overall Study|Other|0|||
155574464|NCT04895982|561526302|FG006|Overall Study|Other|0|||
155574465|NCT04895982|561526303|FG007|Overall Study|Other|0|||
155574466|NCT04895982|561526304|FG008|Overall Study|Other|0|||
155574467|NCT04895982|561526305|FG009|Overall Study|Other|1|||
155574468|NCT04895982|561526306|FG010|Overall Study|Other|0|||
155574469|NCT04895982|561526307|FG011|Overall Study|Other|0|||
155574470|NCT04895982|561526296|FG000|Overall Study|Protocol Violation|0|||
155574471|NCT04895982|561526297|FG001|Overall Study|Protocol Violation|0|||
155574472|NCT04895982|561526298|FG002|Overall Study|Protocol Violation|1|||
155574473|NCT04895982|561526299|FG003|Overall Study|Protocol Violation|1|||
155574474|NCT04895982|561526300|FG004|Overall Study|Protocol Violation|1|||
155574475|NCT04895982|561526301|FG005|Overall Study|Protocol Violation|0|||
155574476|NCT04895982|561526302|FG006|Overall Study|Protocol Violation|0|||
155574477|NCT04895982|561526303|FG007|Overall Study|Protocol Violation|1|||
155574478|NCT04895982|561526304|FG008|Overall Study|Protocol Violation|0|||
155574479|NCT04895982|561526305|FG009|Overall Study|Protocol Violation|0|||
155574480|NCT04895982|561526306|FG010|Overall Study|Protocol Violation|0|||
155574481|NCT04895982|561526307|FG011|Overall Study|Protocol Violation|0|||
155574482|NCT04895982|561526296|FG000|Overall Study|Lost to Follow-up|0|||
155574483|NCT04895982|561526297|FG001|Overall Study|Lost to Follow-up|0|||
155574484|NCT04895982|561526298|FG002|Overall Study|Lost to Follow-up|1|||
155574485|NCT04895982|561526299|FG003|Overall Study|Lost to Follow-up|0|||
155574486|NCT04895982|561526300|FG004|Overall Study|Lost to Follow-up|0|||
155574487|NCT04895982|561526301|FG005|Overall Study|Lost to Follow-up|1|||
155574488|NCT04895982|561526302|FG006|Overall Study|Lost to Follow-up|0|||
155574489|NCT04895982|561526303|FG007|Overall Study|Lost to Follow-up|0|||
155574490|NCT04895982|561526304|FG008|Overall Study|Lost to Follow-up|1|||
155574491|NCT04895982|561526305|FG009|Overall Study|Lost to Follow-up|0|||
155574492|NCT04895982|561526306|FG010|Overall Study|Lost to Follow-up|0|||
155574493|NCT04895982|561526307|FG011|Overall Study|Lost to Follow-up|0|||
155574494|NCT04895982|561526296|FG000|Overall Study|Refused further study procedures|0|||
155574495|NCT04895982|561526297|FG001|Overall Study|Refused further study procedures|0|||
155574496|NCT04895982|561526298|FG002|Overall Study|Refused further study procedures|1|||
155574497|NCT04895982|561526299|FG003|Overall Study|Refused further study procedures|0|||
155574498|NCT04895982|561526300|FG004|Overall Study|Refused further study procedures|0|||
155574499|NCT04895982|561526301|FG005|Overall Study|Refused further study procedures|0|||
155574500|NCT04895982|561526302|FG006|Overall Study|Refused further study procedures|0|||
155574501|NCT04895982|561526303|FG007|Overall Study|Refused further study procedures|0|||
155574502|NCT04895982|561526304|FG008|Overall Study|Refused further study procedures|0|||
155574503|NCT04895982|561526305|FG009|Overall Study|Refused further study procedures|0|||
155574504|NCT04895982|561526306|FG010|Overall Study|Refused further study procedures|0|||
155574505|NCT04895982|561526307|FG011|Overall Study|Refused further study procedures|0|||
155574506|NCT00919854|561526310|FG000|Overall Study|Adverse Event|1|||
155574507|NCT00985491|561526313|FG000|Overall Study|Adverse Event|8|||
155574508|NCT00985491|561526313|FG000|Overall Study|device migration|7|||
155574509|NCT00985491|561526313|FG000|Overall Study|Withdrawal by Subject|1|||
155574510|NCT00985491|561526313|FG000|Overall Study|implant failure|3|||
155574511|NCT01893346|561526314|FG000|Overall Study|Lost to Follow-up|0|||
155574512|NCT01893346|561526315|FG001|Overall Study|Lost to Follow-up|1|||
155574513|NCT01893346|561526316|FG002|Overall Study|Lost to Follow-up|0|||
155574514|NCT01893346|561526317|FG003|Overall Study|Lost to Follow-up|0|||
155574515|NCT01893346|561526314|FG000|Overall Study|Protocol Violation|1|||
155574516|NCT01893346|561526315|FG001|Overall Study|Protocol Violation|0|||
155574517|NCT01893346|561526316|FG002|Overall Study|Protocol Violation|0|||
155574518|NCT01893346|561526317|FG003|Overall Study|Protocol Violation|0|||
155574519|NCT01893346|561526314|FG000|Overall Study|Withdrawal by Subject|2|||
155574520|NCT01893346|561526315|FG001|Overall Study|Withdrawal by Subject|0|||
155574521|NCT01893346|561526316|FG002|Overall Study|Withdrawal by Subject|0|||
155574522|NCT01893346|561526317|FG003|Overall Study|Withdrawal by Subject|0|||
155574523|NCT03736031|561526323|FG000|Overall Study|Death|2|||
155574524|NCT03736031|561526324|FG001|Overall Study|Death|4|||
155574525|NCT03736031|561526323|FG000|Overall Study|Lost to Follow-up|21|||
155574526|NCT03736031|561526324|FG001|Overall Study|Lost to Follow-up|2|||
155574527|NCT03736031|561526323|FG000|Overall Study|Withdrawal by Subject|9|||
155574528|NCT03736031|561526324|FG001|Overall Study|Withdrawal by Subject|0|||
155574529|NCT05221320|561528839|FG000|Overall Study|Lack of Efficacy|3|||
155661533|NCT00854360|561856555|FG002|Overall Study|Withdrawal by Subject|0|||
155661534|NCT00854360|561856556|FG003|Overall Study|Withdrawal by Subject|1|||
155574530|NCT05221320|561528840|FG001|Overall Study|Lack of Efficacy|7|||
155574531|NCT05221320|561528841|FG002|Overall Study|Lack of Efficacy|10|||
155574532|NCT05221320|561528842|FG003|Overall Study|Lack of Efficacy|1|||
155661535|NCT00854360|561856553|FG000|Overall Study|Pregnancy|0|||
155661536|NCT00854360|561856554|FG001|Overall Study|Pregnancy|1|||
155574533|NCT05221320|561528843|FG004|Overall Study|Lack of Efficacy|0|||
155574534|NCT05221320|561528844|FG005|Overall Study|Lack of Efficacy|0|||
155574535|NCT05221320|561528839|FG000|Overall Study|Physician Decision|1|||
155574536|NCT05221320|561528840|FG001|Overall Study|Physician Decision|0|||
155574537|NCT05221320|561528841|FG002|Overall Study|Physician Decision|3|||
155574538|NCT05221320|561528842|FG003|Overall Study|Physician Decision|1|||
155574539|NCT05221320|561528843|FG004|Overall Study|Physician Decision|0|||
155661537|NCT00854360|561856555|FG002|Overall Study|Pregnancy|0|||
155574540|NCT05221320|561528844|FG005|Overall Study|Physician Decision|0|||
155574541|NCT05221320|561528839|FG000|Overall Study|Withdrawal by Subject|0|||
155574542|NCT05221320|561528840|FG001|Overall Study|Withdrawal by Subject|3|||
155661538|NCT00854360|561856556|FG003|Overall Study|Pregnancy|0|||
155574543|NCT05221320|561528841|FG002|Overall Study|Withdrawal by Subject|1|||
155574544|NCT05221320|561528842|FG003|Overall Study|Withdrawal by Subject|0|||
155574545|NCT05221320|561528843|FG004|Overall Study|Withdrawal by Subject|0|||
155574546|NCT05221320|561528844|FG005|Overall Study|Withdrawal by Subject|0|||
155574547|NCT05221320|561528839|FG000|Overall Study|Death|0|||
155574548|NCT05221320|561528840|FG001|Overall Study|Death|5|||
155574549|NCT05221320|561528841|FG002|Overall Study|Death|6|||
155574550|NCT05221320|561528842|FG003|Overall Study|Death|0|||
155574551|NCT05221320|561528843|FG004|Overall Study|Death|1|||
155574552|NCT05221320|561528844|FG005|Overall Study|Death|0|||
155574553|NCT02514447|561528848|FG000|Overall Study|Withdrawal by Subject|3|||
155574554|NCT02514447|561528849|FG001|Overall Study|Withdrawal by Subject|1|||
155574555|NCT02514447|561528850|FG002|Overall Study|Withdrawal by Subject|1|||
155574556|NCT02514447|561528851|FG003|Overall Study|Withdrawal by Subject|0|||
155574557|NCT02514447|561528852|FG004|Overall Study|Withdrawal by Subject|0|||
155574558|NCT02514447|561528853|FG005|Overall Study|Withdrawal by Subject|0|||
155574559|NCT02514447|561528854|FG006|Overall Study|Withdrawal by Subject|0|||
155574560|NCT02514447|561528855|FG007|Overall Study|Withdrawal by Subject|1|||
155574561|NCT02514447|561528856|FG008|Overall Study|Withdrawal by Subject|1|||
155574562|NCT02514447|561528848|FG000|Overall Study|Death|24|||
155574563|NCT02514447|561528849|FG001|Overall Study|Death|28|||
155574564|NCT02514447|561528850|FG002|Overall Study|Death|29|||
155574565|NCT02514447|561528851|FG003|Overall Study|Death|0|||
155574566|NCT02514447|561528852|FG004|Overall Study|Death|3|||
155574567|NCT02514447|561528853|FG005|Overall Study|Death|4|||
155574568|NCT02514447|561528854|FG006|Overall Study|Death|8|||
155574569|NCT02514447|561528855|FG007|Overall Study|Death|6|||
155574570|NCT02514447|561528856|FG008|Overall Study|Death|5|||
155574571|NCT02514447|561528848|FG000|Overall Study|Lost to Follow-up|1|||
155574572|NCT02514447|561528849|FG001|Overall Study|Lost to Follow-up|0|||
155574573|NCT02514447|561528850|FG002|Overall Study|Lost to Follow-up|0|||
155574574|NCT02514447|561528851|FG003|Overall Study|Lost to Follow-up|0|||
155574575|NCT02514447|561528852|FG004|Overall Study|Lost to Follow-up|0|||
155574576|NCT02514447|561528853|FG005|Overall Study|Lost to Follow-up|0|||
155574577|NCT02514447|561528854|FG006|Overall Study|Lost to Follow-up|0|||
155574578|NCT02514447|561528855|FG007|Overall Study|Lost to Follow-up|0|||
155574579|NCT02514447|561528856|FG008|Overall Study|Lost to Follow-up|1|||
155574580|NCT02514447|561528848|FG000|Overall Study|Sponsor Termination of Study|0|||
155574581|NCT02514447|561528849|FG001|Overall Study|Sponsor Termination of Study|1|||
155574582|NCT02514447|561528850|FG002|Overall Study|Sponsor Termination of Study|1|||
155574583|NCT02514447|561528851|FG003|Overall Study|Sponsor Termination of Study|0|||
155574584|NCT02514447|561528852|FG004|Overall Study|Sponsor Termination of Study|0|||
155574585|NCT02514447|561528853|FG005|Overall Study|Sponsor Termination of Study|0|||
155574586|NCT02514447|561528854|FG006|Overall Study|Sponsor Termination of Study|0|||
155574587|NCT02514447|561528855|FG007|Overall Study|Sponsor Termination of Study|0|||
155574588|NCT02514447|561528856|FG008|Overall Study|Sponsor Termination of Study|0|||
155574589|NCT02514447|561528848|FG000|Overall Study|Study completion per Investigator|1|||
155574590|NCT02514447|561528849|FG001|Overall Study|Study completion per Investigator|0|||
155574591|NCT02514447|561528850|FG002|Overall Study|Study completion per Investigator|1|||
155574592|NCT02514447|561528851|FG003|Overall Study|Study completion per Investigator|2|||
155574593|NCT02514447|561528852|FG004|Overall Study|Study completion per Investigator|0|||
155574594|NCT02514447|561528853|FG005|Overall Study|Study completion per Investigator|0|||
155574595|NCT02514447|561528854|FG006|Overall Study|Study completion per Investigator|0|||
155574596|NCT02514447|561528855|FG007|Overall Study|Study completion per Investigator|0|||
155574597|NCT02514447|561528856|FG008|Overall Study|Study completion per Investigator|1|||
155574598|NCT03620708|561528857|FG000|Overall Study|Lost to Follow-up|1|||
155574599|NCT03620708|561528858|FG001|Overall Study|Lost to Follow-up|1|||
155574600|NCT03620708|561528859|FG002|Overall Study|Lost to Follow-up|2|||
155574601|NCT03620708|561528857|FG000|Overall Study|Withdrawal by Subject|0|||
155574602|NCT03620708|561528858|FG001|Overall Study|Withdrawal by Subject|0|||
155574603|NCT03620708|561528859|FG002|Overall Study|Withdrawal by Subject|1|||
155574604|NCT02498613|561528860|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
155661539|NCT00854360|561856553|FG000|Overall Study|Lack of Efficacy|2|||
155661540|NCT00854360|561856554|FG001|Overall Study|Lack of Efficacy|1|||
155661541|NCT00854360|561856555|FG002|Overall Study|Lack of Efficacy|0|||
155574605|NCT02498613|561528861|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
155574606|NCT02498613|561528862|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
155574607|NCT02498613|561528863|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
155574608|NCT02498613|561528860|FG000|Overall Study|Withdrawal by Subject|3|||
155574609|NCT02498613|561528861|FG001|Overall Study|Withdrawal by Subject|1|||
155574610|NCT02498613|561528862|FG002|Overall Study|Withdrawal by Subject|0|||
155574611|NCT02498613|561528863|FG003|Overall Study|Withdrawal by Subject|0|||
155574612|NCT05168202|561528864|FG000|Overall Study|Progressive Disease|4|||
155574613|NCT05168202|561528865|FG001|Overall Study|Progressive Disease|4|||
155574614|NCT05168202|561528866|FG002|Overall Study|Progressive Disease|2|||
155574615|NCT05168202|561528867|FG003|Overall Study|Progressive Disease|3|||
155574616|NCT05168202|561528868|FG004|Overall Study|Progressive Disease|2|||
155574617|NCT05168202|561528869|FG005|Overall Study|Progressive Disease|3|||
155574618|NCT05168202|561528870|FG006|Overall Study|Progressive Disease|2|||
155574619|NCT05168202|561528864|FG000|Overall Study|Adverse Event|2|||
155574620|NCT05168202|561528865|FG001|Overall Study|Adverse Event|1|||
155574621|NCT05168202|561528866|FG002|Overall Study|Adverse Event|4|||
155574622|NCT05168202|561528867|FG003|Overall Study|Adverse Event|4|||
155574623|NCT05168202|561528868|FG004|Overall Study|Adverse Event|3|||
155574624|NCT05168202|561528869|FG005|Overall Study|Adverse Event|2|||
155574625|NCT05168202|561528870|FG006|Overall Study|Adverse Event|0|||
155574626|NCT05168202|561528864|FG000|Overall Study|Lack of Efficacy|0|||
155574627|NCT05168202|561528865|FG001|Overall Study|Lack of Efficacy|1|||
155574628|NCT05168202|561528866|FG002|Overall Study|Lack of Efficacy|1|||
155574629|NCT05168202|561528867|FG003|Overall Study|Lack of Efficacy|0|||
155574630|NCT05168202|561528868|FG004|Overall Study|Lack of Efficacy|1|||
155574631|NCT05168202|561528869|FG005|Overall Study|Lack of Efficacy|2|||
155574632|NCT05168202|561528870|FG006|Overall Study|Lack of Efficacy|2|||
155574633|NCT05168202|561528864|FG000|Overall Study|Withdrawal by Subject|0|||
155574634|NCT05168202|561528865|FG001|Overall Study|Withdrawal by Subject|0|||
155574635|NCT05168202|561528866|FG002|Overall Study|Withdrawal by Subject|1|||
155574636|NCT05168202|561528867|FG003|Overall Study|Withdrawal by Subject|1|||
155574637|NCT05168202|561528868|FG004|Overall Study|Withdrawal by Subject|1|||
155574638|NCT05168202|561528869|FG005|Overall Study|Withdrawal by Subject|1|||
155574639|NCT05168202|561528870|FG006|Overall Study|Withdrawal by Subject|0|||
155574640|NCT05168202|561528864|FG000|Overall Study|Disease Relapse|0|||
155574641|NCT05168202|561528865|FG001|Overall Study|Disease Relapse|1|||
155574642|NCT05168202|561528866|FG002|Overall Study|Disease Relapse|0|||
155574643|NCT05168202|561528867|FG003|Overall Study|Disease Relapse|1|||
155574644|NCT05168202|561528868|FG004|Overall Study|Disease Relapse|1|||
155574645|NCT05168202|561528869|FG005|Overall Study|Disease Relapse|0|||
155574646|NCT05168202|561528870|FG006|Overall Study|Disease Relapse|0|||
155574647|NCT05168202|561528864|FG000|Overall Study|Other Reasons|0|||
155574648|NCT05168202|561528865|FG001|Overall Study|Other Reasons|0|||
155574649|NCT05168202|561528866|FG002|Overall Study|Other Reasons|0|||
155574650|NCT05168202|561528867|FG003|Overall Study|Other Reasons|0|||
155574651|NCT05168202|561528868|FG004|Overall Study|Other Reasons|0|||
155574652|NCT05168202|561528869|FG005|Overall Study|Other Reasons|2|||
155574653|NCT05168202|561528870|FG006|Overall Study|Other Reasons|1|||
155574654|NCT05168202|561528864|FG000|Overall Study|Physician Decision|0|||
155574655|NCT05168202|561528865|FG001|Overall Study|Physician Decision|1|||
155574656|NCT05168202|561528866|FG002|Overall Study|Physician Decision|1|||
155574657|NCT05168202|561528867|FG003|Overall Study|Physician Decision|0|||
155574658|NCT05168202|561528868|FG004|Overall Study|Physician Decision|0|||
155574659|NCT05168202|561528869|FG005|Overall Study|Physician Decision|0|||
155574660|NCT05168202|561528870|FG006|Overall Study|Physician Decision|0|||
155574661|NCT05168202|561528864|FG000|Overall Study|Study Terminated by Sponsor|0|||
155574662|NCT05168202|561528865|FG001|Overall Study|Study Terminated by Sponsor|0|||
155574663|NCT05168202|561528866|FG002|Overall Study|Study Terminated by Sponsor|0|||
155574664|NCT05168202|561528867|FG003|Overall Study|Study Terminated by Sponsor|1|||
155574665|NCT05168202|561528868|FG004|Overall Study|Study Terminated by Sponsor|0|||
155574666|NCT05168202|561528869|FG005|Overall Study|Study Terminated by Sponsor|0|||
155574667|NCT05168202|561528870|FG006|Overall Study|Study Terminated by Sponsor|0|||
155574668|NCT06195930|561528880|FG000|Overall Study|Adverse Event|4|||
155574669|NCT03631199|561528881|FG000|Overall Study|Progressive disease|9|||
155574670|NCT03631199|561528882|FG001|Overall Study|Progressive disease|5|||
155574671|NCT03631199|561528883|FG002|Overall Study|Progressive disease|5|||
155574672|NCT03631199|561528884|FG003|Overall Study|Progressive disease|149|||
155574673|NCT03631199|561528885|FG004|Overall Study|Progressive disease|148|||
155661542|NCT00854360|561856556|FG003|Overall Study|Lack of Efficacy|0|||
155661543|NCT00854360|561856553|FG000|Overall Study|Other|0|||
155661544|NCT00854360|561856554|FG001|Overall Study|Other|0|||
155661545|NCT00854360|561856555|FG002|Overall Study|Other|0|||
155661546|NCT00854360|561856556|FG003|Overall Study|Other|3|||
155661547|NCT02006927|561856557|FG000|Overall Study|Adverse Event|2|||
155661548|NCT02006927|561856557|FG000|Overall Study|Withdrawal by Subject|1|||
155574674|NCT03631199|561528881|FG000|Overall Study|Physician Decision|0|||
155574675|NCT03631199|561528882|FG001|Overall Study|Physician Decision|2|||
155574676|NCT03631199|561528883|FG002|Overall Study|Physician Decision|3|||
155574677|NCT03631199|561528884|FG003|Overall Study|Physician Decision|19|||
155574678|NCT03631199|561528885|FG004|Overall Study|Physician Decision|13|||
155574679|NCT03631199|561528881|FG000|Overall Study|Adverse Event|1|||
155574680|NCT03631199|561528882|FG001|Overall Study|Adverse Event|1|||
155574681|NCT03631199|561528883|FG002|Overall Study|Adverse Event|0|||
155574682|NCT03631199|561528884|FG003|Overall Study|Adverse Event|28|||
155574683|NCT03631199|561528885|FG004|Overall Study|Adverse Event|29|||
155574684|NCT03631199|561528881|FG000|Overall Study|Death|0|||
155574685|NCT03631199|561528882|FG001|Overall Study|Death|1|||
155574686|NCT03631199|561528883|FG002|Overall Study|Death|0|||
155574687|NCT03631199|561528884|FG003|Overall Study|Death|35|||
155661549|NCT02943473|561856561|FG000|Overall Study|enrolled but not dosed|1|||
155574688|NCT03631199|561528885|FG004|Overall Study|Death|48|||
155574689|NCT03631199|561528881|FG000|Overall Study|Subject decision|0|||
155574690|NCT03631199|561528882|FG001|Overall Study|Subject decision|1|||
155574691|NCT03631199|561528883|FG002|Overall Study|Subject decision|0|||
155574692|NCT03631199|561528884|FG003|Overall Study|Subject decision|12|||
155574693|NCT03631199|561528885|FG004|Overall Study|Subject decision|12|||
155574694|NCT03631199|561528881|FG000|Overall Study|No treated|0|||
155574695|NCT03631199|561528882|FG001|Overall Study|No treated|0|||
155574696|NCT03631199|561528883|FG002|Overall Study|No treated|0|||
155574697|NCT03631199|561528884|FG003|Overall Study|No treated|0|||
155574698|NCT03631199|561528885|FG004|Overall Study|No treated|1|||
155574699|NCT03631199|561528881|FG000|Overall Study|Treatment ongoing|0|||
155574700|NCT03631199|561528882|FG001|Overall Study|Treatment ongoing|1|||
155574701|NCT03631199|561528883|FG002|Overall Study|Treatment ongoing|1|||
155574702|NCT03631199|561528884|FG003|Overall Study|Treatment ongoing|76|||
155574703|NCT03631199|561528885|FG004|Overall Study|Treatment ongoing|71|||
155574704|NCT03631199|561528881|FG000|Overall Study|Guardian decision|0|||
155574705|NCT03631199|561528882|FG001|Overall Study|Guardian decision|0|||
155574706|NCT03631199|561528883|FG002|Overall Study|Guardian decision|0|||
155574707|NCT03631199|561528884|FG003|Overall Study|Guardian decision|1|||
155574708|NCT03631199|561528885|FG004|Overall Study|Guardian decision|1|||
155574709|NCT03999996|561528886|FG000|Prior to Booster|Adverse Event|2|||
155574710|NCT03999996|561528887|FG001|Prior to Booster|Adverse Event|0|||
155574711|NCT03999996|561528888|FG002|Prior to Booster|Adverse Event|0|||
155574712|NCT03999996|561528889|FG003|Prior to Booster|Adverse Event|0|||
155574713|NCT03999996|561528886|FG000|Prior to Booster|Lost to Follow-up|17|||
155574714|NCT03999996|561528887|FG001|Prior to Booster|Lost to Follow-up|22|||
155574715|NCT03999996|561528888|FG002|Prior to Booster|Lost to Follow-up|0|||
155574716|NCT03999996|561528889|FG003|Prior to Booster|Lost to Follow-up|0|||
155574717|NCT03999996|561528886|FG000|Prior to Booster|Withdrawal of Consent|51|||
155574718|NCT03999996|561528887|FG001|Prior to Booster|Withdrawal of Consent|8|||
155574719|NCT03999996|561528888|FG002|Prior to Booster|Withdrawal of Consent|0|||
155574720|NCT03999996|561528889|FG003|Prior to Booster|Withdrawal of Consent|0|||
155574721|NCT03999996|561528886|FG000|Prior to Booster|Death|0|||
155574722|NCT03999996|561528887|FG001|Prior to Booster|Death|1|||
155574723|NCT03999996|561528888|FG002|Prior to Booster|Death|0|||
155574724|NCT03999996|561528889|FG003|Prior to Booster|Death|0|||
155574725|NCT03999996|561528886|FG000|Prior to Booster|Reason Not Specified|27|||
155574726|NCT03999996|561528887|FG001|Prior to Booster|Reason Not Specified|4|||
155574727|NCT03999996|561528888|FG002|Prior to Booster|Reason Not Specified|0|||
155574728|NCT03999996|561528889|FG003|Prior to Booster|Reason Not Specified|0|||
155574729|NCT03999996|561528886|FG000|Booster Phase|Lost to Follow-up|0|||
155574730|NCT03999996|561528887|FG001|Booster Phase|Lost to Follow-up|0|||
155574731|NCT03999996|561528888|FG002|Booster Phase|Lost to Follow-up|3|||
155574732|NCT03999996|561528889|FG003|Booster Phase|Lost to Follow-up|3|||
155574733|NCT03999996|561528886|FG000|Booster Phase|Withdrawal of Consent|0|||
155574734|NCT03999996|561528887|FG001|Booster Phase|Withdrawal of Consent|0|||
155574735|NCT03999996|561528888|FG002|Booster Phase|Withdrawal of Consent|0|||
155574736|NCT03999996|561528889|FG003|Booster Phase|Withdrawal of Consent|1|||
155574737|NCT03999996|561528886|FG000|Booster Phase|Reason Not Specified|0|||
155574738|NCT03999996|561528887|FG001|Booster Phase|Reason Not Specified|0|||
155574739|NCT03999996|561528888|FG002|Booster Phase|Reason Not Specified|0|||
155574740|NCT03999996|561528889|FG003|Booster Phase|Reason Not Specified|1|||
155574741|NCT03690388|561528890|FG000|Overall Study|Adverse Event|8|||
155574742|NCT03690388|561528891|FG001|Overall Study|Adverse Event|1|||
155574743|NCT03690388|561528890|FG000|Overall Study|Radiographic Progression|14|||
155574744|NCT03690388|561528891|FG001|Overall Study|Radiographic Progression|29|||
155574745|NCT03690388|561528890|FG000|Overall Study|Clinical deterioration|10|||
155574746|NCT03690388|561528891|FG001|Overall Study|Clinical deterioration|6|||
155574747|NCT03690388|561528890|FG000|Overall Study|Withdrawal by Subject|2|||
155574748|NCT03690388|561528891|FG001|Overall Study|Withdrawal by Subject|0|||
155574749|NCT03690388|561528890|FG000|Overall Study|Lack of Efficacy|1|||
155574750|NCT03690388|561528891|FG001|Overall Study|Lack of Efficacy|0|||
155574751|NCT03690388|561528890|FG000|Overall Study|Lost to Follow-up|1|||
155574752|NCT03690388|561528891|FG001|Overall Study|Lost to Follow-up|0|||
155574753|NCT00001521|561528892|FG000|Overall Study|Withdrawal by Subject|3|||
155574754|NCT00001521|561528893|FG001|Overall Study|Withdrawal by Subject|3|||
155574755|NCT00001521|561528892|FG000|Overall Study|Physician Decision|1|||
155574756|NCT00001521|561528893|FG001|Overall Study|Physician Decision|1|||
155574757|NCT00001521|561528892|FG000|Overall Study|Noncompliant|6|||
155574758|NCT00001521|561528893|FG001|Overall Study|Noncompliant|3|||
155574759|NCT00266630|561528894|FG000|Overall Study|Adverse Event|8|||
155574760|NCT00266630|561528895|FG001|Overall Study|Adverse Event|6|||
155574761|NCT00266630|561528894|FG000|Overall Study|Lack of Efficacy|1|||
155574762|NCT00266630|561528895|FG001|Overall Study|Lack of Efficacy|4|||
155574763|NCT00266630|561528894|FG000|Overall Study|Entry Criteria not met|1|||
155574764|NCT00266630|561528895|FG001|Overall Study|Entry Criteria not met|0|||
155574765|NCT00266630|561528894|FG000|Overall Study|Protocol Violation|1|||
155574766|NCT00266630|561528895|FG001|Overall Study|Protocol Violation|3|||
155574767|NCT00266630|561528894|FG000|Overall Study|Physician Decision|1|||
155574768|NCT00266630|561528895|FG001|Overall Study|Physician Decision|2|||
155574769|NCT00266630|561528894|FG000|Overall Study|Withdrawal by Subject|10|||
155574770|NCT00266630|561528895|FG001|Overall Study|Withdrawal by Subject|2|||
155574771|NCT00266630|561528894|FG000|Overall Study|Lost to Follow-up|1|||
155574772|NCT00266630|561528895|FG001|Overall Study|Lost to Follow-up|0|||
155574773|NCT00266630|561528894|FG000|Overall Study|Other|19|||
155574774|NCT00266630|561528895|FG001|Overall Study|Other|11|||
155574775|NCT03284723|561528900|FG000|Overall Study|Death|0|||
155574776|NCT03284723|561528901|FG001|Overall Study|Death|0|||
155574777|NCT03284723|561528902|FG002|Overall Study|Death|0|||
155574778|NCT03284723|561528903|FG003|Overall Study|Death|1|||
155574779|NCT03284723|561528904|FG004|Overall Study|Death|0|||
155574780|NCT03284723|561528905|FG005|Overall Study|Death|0|||
155574781|NCT03284723|561528906|FG006|Overall Study|Death|1|||
155574782|NCT03284723|561528907|FG007|Overall Study|Death|0|||
155574783|NCT03284723|561528908|FG008|Overall Study|Death|0|||
155574784|NCT03284723|561528909|FG009|Overall Study|Death|2|||
155574785|NCT03284723|561528910|FG010|Overall Study|Death|1|||
155574786|NCT03284723|561528911|FG011|Overall Study|Death|0|||
155574787|NCT03284723|561528900|FG000|Overall Study|Lost to Follow-up|0|||
155574788|NCT03284723|561528901|FG001|Overall Study|Lost to Follow-up|0|||
155574789|NCT03284723|561528902|FG002|Overall Study|Lost to Follow-up|0|||
155574790|NCT03284723|561528903|FG003|Overall Study|Lost to Follow-up|0|||
155574791|NCT03284723|561528904|FG004|Overall Study|Lost to Follow-up|0|||
155574792|NCT03284723|561528905|FG005|Overall Study|Lost to Follow-up|2|||
155574793|NCT03284723|561528906|FG006|Overall Study|Lost to Follow-up|1|||
155574794|NCT03284723|561528907|FG007|Overall Study|Lost to Follow-up|0|||
155574795|NCT03284723|561528908|FG008|Overall Study|Lost to Follow-up|0|||
155574796|NCT03284723|561528909|FG009|Overall Study|Lost to Follow-up|2|||
155574797|NCT03284723|561528910|FG010|Overall Study|Lost to Follow-up|0|||
155574798|NCT03284723|561528911|FG011|Overall Study|Lost to Follow-up|0|||
155574799|NCT03284723|561528900|FG000|Overall Study|Study Terminated By Sponsor|0|||
155574800|NCT03284723|561528901|FG001|Overall Study|Study Terminated By Sponsor|0|||
155574801|NCT03284723|561528902|FG002|Overall Study|Study Terminated By Sponsor|0|||
155574802|NCT03284723|561528903|FG003|Overall Study|Study Terminated By Sponsor|0|||
155574803|NCT03284723|561528904|FG004|Overall Study|Study Terminated By Sponsor|1|||
155574804|NCT03284723|561528905|FG005|Overall Study|Study Terminated By Sponsor|0|||
155574805|NCT03284723|561528906|FG006|Overall Study|Study Terminated By Sponsor|0|||
155574806|NCT03284723|561528907|FG007|Overall Study|Study Terminated By Sponsor|0|||
155574807|NCT03284723|561528908|FG008|Overall Study|Study Terminated By Sponsor|1|||
155574808|NCT03284723|561528909|FG009|Overall Study|Study Terminated By Sponsor|1|||
155574809|NCT03284723|561528910|FG010|Overall Study|Study Terminated By Sponsor|1|||
155574810|NCT03284723|561528911|FG011|Overall Study|Study Terminated By Sponsor|1|||
155574811|NCT03284723|561528900|FG000|Overall Study|Withdrawal by Subject|0|||
155574812|NCT03284723|561528901|FG001|Overall Study|Withdrawal by Subject|0|||
155574813|NCT03284723|561528902|FG002|Overall Study|Withdrawal by Subject|0|||
155574814|NCT03284723|561528903|FG003|Overall Study|Withdrawal by Subject|0|||
155574815|NCT03284723|561528904|FG004|Overall Study|Withdrawal by Subject|5|||
155574816|NCT03284723|561528905|FG005|Overall Study|Withdrawal by Subject|3|||
155574817|NCT03284723|561528906|FG006|Overall Study|Withdrawal by Subject|1|||
155574818|NCT03284723|561528907|FG007|Overall Study|Withdrawal by Subject|0|||
155574819|NCT03284723|561528908|FG008|Overall Study|Withdrawal by Subject|6|||
155574820|NCT03284723|561528909|FG009|Overall Study|Withdrawal by Subject|0|||
155574821|NCT03284723|561528910|FG010|Overall Study|Withdrawal by Subject|3|||
155574822|NCT03284723|561528911|FG011|Overall Study|Withdrawal by Subject|1|||
155574823|NCT03284723|561528900|FG000|Overall Study|Other|1|||
155574824|NCT03284723|561528901|FG001|Overall Study|Other|0|||
155574825|NCT03284723|561528902|FG002|Overall Study|Other|1|||
155574826|NCT03284723|561528903|FG003|Overall Study|Other|0|||
155574827|NCT03284723|561528904|FG004|Overall Study|Other|1|||
155574828|NCT03284723|561528905|FG005|Overall Study|Other|0|||
155574829|NCT03284723|561528906|FG006|Overall Study|Other|0|||
155574830|NCT03284723|561528907|FG007|Overall Study|Other|0|||
155574831|NCT03284723|561528908|FG008|Overall Study|Other|0|||
155574832|NCT03284723|561528909|FG009|Overall Study|Other|0|||
155574833|NCT03284723|561528910|FG010|Overall Study|Other|1|||
155574834|NCT03284723|561528911|FG011|Overall Study|Other|0|||
155574835|NCT03284723|561528900|FG000|Overall Study|Adverse Event|0|||
155574836|NCT03284723|561528901|FG001|Overall Study|Adverse Event|0|||
155574837|NCT03284723|561528902|FG002|Overall Study|Adverse Event|0|||
155574838|NCT03284723|561528903|FG003|Overall Study|Adverse Event|0|||
155661550|NCT02943473|561856561|FG000|Overall Study|screen failure|1|||
155574839|NCT03284723|561528904|FG004|Overall Study|Adverse Event|0|||
155574840|NCT03284723|561528905|FG005|Overall Study|Adverse Event|0|||
155574841|NCT03284723|561528906|FG006|Overall Study|Adverse Event|0|||
155574842|NCT03284723|561528907|FG007|Overall Study|Adverse Event|0|||
155574843|NCT03284723|561528908|FG008|Overall Study|Adverse Event|1|||
155574844|NCT03284723|561528909|FG009|Overall Study|Adverse Event|0|||
155574845|NCT03284723|561528910|FG010|Overall Study|Adverse Event|0|||
155574846|NCT03284723|561528911|FG011|Overall Study|Adverse Event|0|||
155574847|NCT01499095|561528912|FG000|Overall Study|Randomized But Not Treated|1|||
155574848|NCT01499095|561528913|FG001|Overall Study|Randomized But Not Treated|1|||
155574849|NCT01499095|561528912|FG000|Overall Study|Adverse Event|12|||
155574850|NCT01499095|561528913|FG001|Overall Study|Adverse Event|7|||
155574851|NCT01499095|561528912|FG000|Overall Study|Lack of Efficacy|2|||
155574852|NCT01499095|561528913|FG001|Overall Study|Lack of Efficacy|1|||
155574853|NCT01499095|561528912|FG000|Overall Study|Protocol Violation|6|||
155574854|NCT01499095|561528913|FG001|Overall Study|Protocol Violation|7|||
155574855|NCT01499095|561528912|FG000|Overall Study|Received Rescue Therapy|32|||
155574856|NCT01499095|561528913|FG001|Overall Study|Received Rescue Therapy|40|||
155574857|NCT01499095|561528912|FG000|Overall Study|Diverse Reasons|22|||
155574858|NCT01499095|561528913|FG001|Overall Study|Diverse Reasons|25|||
155574859|NCT01499095|561528912|FG000|Overall Study|Lost to Follow-up|6|||
155574860|NCT01499095|561528913|FG001|Overall Study|Lost to Follow-up|4|||
155574861|NCT01499095|561528912|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
155574862|NCT01499095|561528913|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
155574863|NCT01499095|561528912|FG000|Overall Study|Hypoglycemia|3|||
155574864|NCT01499095|561528913|FG001|Overall Study|Hypoglycemia|1|||
155574865|NCT01499095|561528912|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
155574866|NCT01499095|561528913|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
155574867|NCT01499095|561528912|FG000|Overall Study|Change in Injection Schedule|2|||
155574868|NCT01499095|561528913|FG001|Overall Study|Change in Injection Schedule|0|||
155574869|NCT01499095|561528912|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155574870|NCT01499095|561528913|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155574871|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
155574872|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
155574873|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
155574874|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
155574875|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
155574876|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
155574877|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
155574878|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
155574879|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
155574880|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
155574881|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
155574882|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
155574883|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
155574884|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
155574885|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
155574886|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
155574887|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
155574888|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
155574889|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
155574890|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
155574891|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
155574892|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
155574893|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
155574894|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
155574895|NCT01130532|561528914|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
155574896|NCT01130532|561528915|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
155574897|NCT01130532|561528916|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
155574898|NCT01130532|561528917|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
155574899|NCT01130532|561528914|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
155574900|NCT01130532|561528915|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
155574901|NCT01130532|561528916|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
155574902|NCT01130532|561528917|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
155574903|NCT01130532|561528914|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155574904|NCT01130532|561528915|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155574905|NCT01130532|561528916|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155574906|NCT01130532|561528917|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
155574907|NCT01130532|561528914|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155574908|NCT01130532|561528915|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155574909|NCT01130532|561528916|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155574910|NCT01130532|561528917|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
155574911|NCT01130532|561528914|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155574912|NCT01130532|561528915|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155574913|NCT01130532|561528916|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155574914|NCT01130532|561528917|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
155574915|NCT02762929|561528918|FG000|Overall Study|Adverse Event|0|||
155574916|NCT02762929|561528919|FG001|Overall Study|Adverse Event|0|||
155574917|NCT02762929|561528920|FG002|Overall Study|Adverse Event|0|||
155574918|NCT02762929|561528921|FG003|Overall Study|Adverse Event|1|||
155574919|NCT02762929|561528922|FG004|Overall Study|Adverse Event|0|||
155574920|NCT02762929|561528923|FG005|Overall Study|Adverse Event|0|||
155574921|NCT02762929|561528918|FG000|Overall Study|Lost to Follow-up|1|||
155574922|NCT02762929|561528919|FG001|Overall Study|Lost to Follow-up|2|||
155574923|NCT02762929|561528920|FG002|Overall Study|Lost to Follow-up|0|||
155574924|NCT02762929|561528921|FG003|Overall Study|Lost to Follow-up|1|||
155574925|NCT02762929|561528922|FG004|Overall Study|Lost to Follow-up|0|||
155574926|NCT02762929|561528923|FG005|Overall Study|Lost to Follow-up|0|||
155574927|NCT02762929|561528918|FG000|Overall Study|Withdrawal by Subject|0|||
155574928|NCT02762929|561528919|FG001|Overall Study|Withdrawal by Subject|1|||
155574929|NCT02762929|561528920|FG002|Overall Study|Withdrawal by Subject|0|||
155574930|NCT02762929|561528921|FG003|Overall Study|Withdrawal by Subject|0|||
155574931|NCT02762929|561528922|FG004|Overall Study|Withdrawal by Subject|0|||
155574932|NCT02762929|561528923|FG005|Overall Study|Withdrawal by Subject|0|||
155574933|NCT02762929|561528918|FG000|Overall Study|exclusionary medication disclosed late|0|||
155574934|NCT02762929|561528919|FG001|Overall Study|exclusionary medication disclosed late|0|||
155574935|NCT02762929|561528920|FG002|Overall Study|exclusionary medication disclosed late|0|||
155574936|NCT02762929|561528921|FG003|Overall Study|exclusionary medication disclosed late|1|||
155574937|NCT02762929|561528922|FG004|Overall Study|exclusionary medication disclosed late|0|||
155574938|NCT02762929|561528923|FG005|Overall Study|exclusionary medication disclosed late|0|||
155574939|NCT00077207|561528925|FG000|Overall Study|Adverse Event|5|||
155574940|NCT00077207|561528925|FG000|Overall Study|Lack of Efficacy|12|||
155574941|NCT00077207|561528925|FG000|Overall Study|Physician Decision|6|||
155574942|NCT00077207|561528925|FG000|Overall Study|Withdrawal by Subject|6|||
155574943|NCT00077207|561528925|FG000|Overall Study|Ineligible|1|||
155574944|NCT03052751|561528928|FG000|Dosing Period 1|Adverse Event|0|||
155574945|NCT03052751|561528929|FG001|Dosing Period 1|Adverse Event|1|||
155574946|NCT03052751|561528930|FG002|Dosing Period 1|Adverse Event|0|||
155574947|NCT03052751|561528931|FG003|Dosing Period 1|Adverse Event|0|||
155574948|NCT03052751|561528932|FG004|Dosing Period 1|Adverse Event|0|||
155574949|NCT03052751|561528933|FG005|Dosing Period 1|Adverse Event|0|||
155574950|NCT03052751|561528928|FG000|Dosing Period 2|Adverse Event|0|||
155574951|NCT03052751|561528929|FG001|Dosing Period 2|Adverse Event|0|||
155574952|NCT03052751|561528930|FG002|Dosing Period 2|Adverse Event|3|||
155574953|NCT03052751|561528931|FG003|Dosing Period 2|Adverse Event|0|||
155574954|NCT03052751|561528932|FG004|Dosing Period 2|Adverse Event|0|||
155574955|NCT03052751|561528933|FG005|Dosing Period 2|Adverse Event|0|||
155574956|NCT03052751|561528928|FG000|Observation Period|Adverse Event|0|||
155574957|NCT03052751|561528929|FG001|Observation Period|Adverse Event|0|||
155574958|NCT03052751|561528930|FG002|Observation Period|Adverse Event|0|||
155574959|NCT03052751|561528931|FG003|Observation Period|Adverse Event|0|||
155574960|NCT03052751|561528932|FG004|Observation Period|Adverse Event|1|||
155574961|NCT03052751|561528933|FG005|Observation Period|Adverse Event|0|||
155574962|NCT00524420|561528948|FG000|Overall Study|Lack of Efficacy|1|||
155574963|NCT00524420|561528949|FG001|Overall Study|Lack of Efficacy|0|||
155574964|NCT00577863|561528950|FG000|Overall Study|Adverse Event|4|||
155574965|NCT00577863|561528951|FG001|Overall Study|Adverse Event|2|||
155574966|NCT00577863|561528950|FG000|Overall Study|Death|1|||
155574967|NCT00577863|561528951|FG001|Overall Study|Death|0|||
155574968|NCT00577863|561528950|FG000|Overall Study|Lost to Follow-up|2|||
155574969|NCT00577863|561528951|FG001|Overall Study|Lost to Follow-up|2|||
155574970|NCT00577863|561528950|FG000|Overall Study|Entry Criteria Exclusion|1|||
155574971|NCT00577863|561528951|FG001|Overall Study|Entry Criteria Exclusion|0|||
155574972|NCT00577863|561528950|FG000|Overall Study|Withdrawal by Subject|0|||
155574973|NCT00577863|561528951|FG001|Overall Study|Withdrawal by Subject|2|||
155574974|NCT00577863|561528950|FG000|Overall Study|Sponsor Decision|2|||
155574975|NCT00577863|561528951|FG001|Overall Study|Sponsor Decision|7|||
155574976|NCT00577863|561528950|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
155574977|NCT00577863|561528951|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
155574978|NCT03639779|561528959|FG000|Overall Study|Lost to Follow-up|1|||
155574979|NCT02932462|561528962|FG000|Overall Study|Adverse Event|1|||
155574980|NCT02932462|561528963|FG001|Overall Study|Adverse Event|2|||
155574981|NCT02932462|561528962|FG000|Overall Study|Lost to Follow-up|4|||
155574982|NCT02932462|561528963|FG001|Overall Study|Lost to Follow-up|1|||
155574983|NCT02932462|561528962|FG000|Overall Study|Protocol Violation|0|||
155574984|NCT02932462|561528963|FG001|Overall Study|Protocol Violation|5|||
155574985|NCT02932462|561528962|FG000|Overall Study|Withdrawal by Subject|1|||
155574986|NCT02932462|561528963|FG001|Overall Study|Withdrawal by Subject|4|||
155574987|NCT02932462|561528962|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155574988|NCT02932462|561528963|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155574989|NCT02932462|561528962|FG000|Overall Study|Progressive Disease|1|||
155574990|NCT02932462|561528963|FG001|Overall Study|Progressive Disease|0|||
155574991|NCT02413229|561528964|FG000|Overall Study|Adverse Event|0|||
155574992|NCT02413229|561528965|FG001|Overall Study|Adverse Event|0|||
155574993|NCT02413229|561528966|FG002|Overall Study|Adverse Event|0|||
155574994|NCT02413229|561528967|FG003|Overall Study|Adverse Event|1|||
155574995|NCT02413229|561528968|FG004|Overall Study|Adverse Event|0|||
155574996|NCT02413229|561528969|FG005|Overall Study|Adverse Event|0|||
155574997|NCT02413229|561528970|FG006|Overall Study|Adverse Event|0|||
155574998|NCT02413229|561528971|FG007|Overall Study|Adverse Event|1|||
155574999|NCT02413229|561528964|FG000|Overall Study|Lost to Follow-up|0|||
155575000|NCT02413229|561528965|FG001|Overall Study|Lost to Follow-up|0|||
155575001|NCT02413229|561528966|FG002|Overall Study|Lost to Follow-up|1|||
155575002|NCT02413229|561528967|FG003|Overall Study|Lost to Follow-up|0|||
155575003|NCT02413229|561528968|FG004|Overall Study|Lost to Follow-up|2|||
155575004|NCT02413229|561528969|FG005|Overall Study|Lost to Follow-up|0|||
155575005|NCT02413229|561528970|FG006|Overall Study|Lost to Follow-up|0|||
155575006|NCT02413229|561528971|FG007|Overall Study|Lost to Follow-up|0|||
155575007|NCT02413229|561528964|FG000|Overall Study|Withdrawal by Subject|1|||
155575008|NCT02413229|561528965|FG001|Overall Study|Withdrawal by Subject|1|||
155575009|NCT02413229|561528966|FG002|Overall Study|Withdrawal by Subject|0|||
155575010|NCT02413229|561528967|FG003|Overall Study|Withdrawal by Subject|0|||
155575011|NCT02413229|561528968|FG004|Overall Study|Withdrawal by Subject|1|||
155575012|NCT02413229|561528969|FG005|Overall Study|Withdrawal by Subject|0|||
155575013|NCT02413229|561528970|FG006|Overall Study|Withdrawal by Subject|0|||
155575014|NCT02413229|561528971|FG007|Overall Study|Withdrawal by Subject|2|||
155575015|NCT02413229|561528964|FG000|Overall Study|Progressive Disease|0|||
155575016|NCT02413229|561528965|FG001|Overall Study|Progressive Disease|0|||
155575017|NCT02413229|561528966|FG002|Overall Study|Progressive Disease|0|||
155575018|NCT02413229|561528967|FG003|Overall Study|Progressive Disease|0|||
155575019|NCT02413229|561528968|FG004|Overall Study|Progressive Disease|0|||
155575020|NCT02413229|561528969|FG005|Overall Study|Progressive Disease|0|||
155575021|NCT02413229|561528970|FG006|Overall Study|Progressive Disease|0|||
155575022|NCT02413229|561528971|FG007|Overall Study|Progressive Disease|1|||
155575023|NCT02955212|561528978|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
155575024|NCT02955212|561528979|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
155575025|NCT02955212|561528978|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
155575026|NCT02955212|561528979|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
155575027|NCT02955212|561528978|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
155575028|NCT02955212|561528979|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
155575029|NCT02955212|561528978|FG000|Period 1: Double-blind Treatment Period|Other|3|||
155575030|NCT02955212|561528979|FG001|Period 1: Double-blind Treatment Period|Other|2|||
155575031|NCT02955212|561528978|FG000|Period 2: Open-label Extension|Adverse Event|11|||
155575032|NCT02955212|561528979|FG001|Period 2: Open-label Extension|Adverse Event|7|||
155575033|NCT02955212|561528978|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
155575034|NCT02955212|561528979|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
155575035|NCT02955212|561528978|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
155575036|NCT02955212|561528979|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
155575037|NCT02955212|561528978|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
155575038|NCT02955212|561528979|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
155575039|NCT02955212|561528978|FG000|Period 2: Open-label Extension|Other|2|||
155575040|NCT02955212|561528979|FG001|Period 2: Open-label Extension|Other|4|||
155575041|NCT02009722|561528980|FG000|Overall Study|Protocol Violation|1|||
155575042|NCT02009722|561528981|FG001|Overall Study|Protocol Violation|2|||
155575043|NCT02009722|561528980|FG000|Overall Study|Did not receive intervention|0|||
155575044|NCT02009722|561528981|FG001|Overall Study|Did not receive intervention|1|||
155575045|NCT02454933|561528982|FG000|Overall Study|Progressive disease|10|||
155575046|NCT02454933|561528983|FG001|Overall Study|Progressive disease|7|||
155575047|NCT02454933|561528982|FG000|Overall Study|Adverse Event|1|||
155575048|NCT02454933|561528983|FG001|Overall Study|Adverse Event|1|||
155575049|NCT02454933|561528982|FG000|Overall Study|Withdrawal by Subject|0|||
155575050|NCT02454933|561528983|FG001|Overall Study|Withdrawal by Subject|3|||
155575051|NCT02454933|561528982|FG000|Overall Study|Lost to Follow-up|1|||
155575052|NCT02454933|561528983|FG001|Overall Study|Lost to Follow-up|0|||
155575053|NCT02071225|561528989|FG000|Overall Study|Withdrawal of Consent|2|||
155575054|NCT02071225|561528989|FG000|Overall Study|Protocol Deviation|1|||
155575055|NCT02071225|561528989|FG000|Overall Study|Lost to Follow-up|2|||
155575056|NCT02071225|561528989|FG000|Overall Study|Death|25|||
155575057|NCT02232984|561528995|FG000|Overall Study|Withdrawal by Subject|5|||
155575058|NCT02232984|561528995|FG000|Overall Study|Death|1|||
155575059|NCT02232984|561528995|FG000|Overall Study|Investigator withdrawal|10|||
155575060|NCT02232984|561528995|FG000|Overall Study|Device implant unsuccessful|53|||
155575061|NCT02232984|561528995|FG000|Overall Study|not disclosed by site|7|||
155575062|NCT02232984|561528995|FG000|Overall Study|Protocol Violation|1|||
155575063|NCT00769379|561528998|FG000|Overall Study|No follow up data mapped to Other.|3|||
155575064|NCT00769379|561528999|FG001|Overall Study|No follow up data mapped to Other.|13|||
155575065|NCT03762239|561529006|FG000|Overall Study|Appointment to the doctor|1|||
155575066|NCT03762239|561529007|FG001|Overall Study|Appointment to the doctor|1|||
155575067|NCT00535405|561529008|FG000|Overall Study|Adverse Event|6|||
155575068|NCT00535405|561529009|FG001|Overall Study|Adverse Event|8|||
155575069|NCT00535405|561529010|FG002|Overall Study|Adverse Event|3|||
155575070|NCT00535405|561529011|FG003|Overall Study|Adverse Event|8|||
155575071|NCT00535405|561529012|FG004|Overall Study|Adverse Event|6|||
155575072|NCT00535405|561529008|FG000|Overall Study|Lost to Follow-up|1|||
155575073|NCT00535405|561529009|FG001|Overall Study|Lost to Follow-up|3|||
155575074|NCT00535405|561529010|FG002|Overall Study|Lost to Follow-up|3|||
155575075|NCT00535405|561529011|FG003|Overall Study|Lost to Follow-up|2|||
155575076|NCT00535405|561529012|FG004|Overall Study|Lost to Follow-up|1|||
155575077|NCT00535405|561529008|FG000|Overall Study|Physician Decision|3|||
155575078|NCT00535405|561529009|FG001|Overall Study|Physician Decision|2|||
155575079|NCT00535405|561529010|FG002|Overall Study|Physician Decision|0|||
155575080|NCT00535405|561529011|FG003|Overall Study|Physician Decision|1|||
155575081|NCT00535405|561529012|FG004|Overall Study|Physician Decision|1|||
155575082|NCT00535405|561529008|FG000|Overall Study|Protocol Violation|2|||
155575083|NCT00535405|561529009|FG001|Overall Study|Protocol Violation|2|||
155575084|NCT00535405|561529010|FG002|Overall Study|Protocol Violation|2|||
155575085|NCT00535405|561529011|FG003|Overall Study|Protocol Violation|1|||
155575086|NCT00535405|561529012|FG004|Overall Study|Protocol Violation|0|||
155575087|NCT00535405|561529008|FG000|Overall Study|Withdrawal by Subject|5|||
155575088|NCT00535405|561529009|FG001|Overall Study|Withdrawal by Subject|11|||
155575089|NCT00535405|561529010|FG002|Overall Study|Withdrawal by Subject|10|||
155575090|NCT00535405|561529011|FG003|Overall Study|Withdrawal by Subject|10|||
155575091|NCT00535405|561529012|FG004|Overall Study|Withdrawal by Subject|8|||
155575092|NCT03910673|561529015|FG000|Overall Study|Adverse Event|0|||
155575093|NCT03910673|561529016|FG001|Overall Study|Adverse Event|0|||
155575094|NCT03910673|561529017|FG002|Overall Study|Adverse Event|0|||
155575095|NCT03910673|561529018|FG003|Overall Study|Adverse Event|2|||
155575096|NCT03910673|561529019|FG004|Overall Study|Adverse Event|0|||
155575097|NCT02290405|561529020|FG000|Overall Study|Withdrawal by Subject|1|||
155575098|NCT02290405|561529021|FG001|Overall Study|Withdrawal by Subject|0|||
155575099|NCT02016183|561529022|FG000|Overall Study|Case Report Forms Uncollected|13|||
155575100|NCT02016183|561529022|FG000|Overall Study|Protocol Violation|52|||
155575101|NCT03142191|561529023|FG000|Placebo Controlled Period|Death|0|||
155575102|NCT03142191|561529024|FG001|Placebo Controlled Period|Death|1|||
155575103|NCT03142191|561529025|FG002|Placebo Controlled Period|Death|1|||
155575104|NCT03142191|561529026|FG003|Placebo Controlled Period|Death|0|||
155575105|NCT03142191|561529027|FG004|Placebo Controlled Period|Death|0|||
155575106|NCT03142191|561529023|FG000|Placebo Controlled Period|Adverse Event|4|||
155575107|NCT03142191|561529024|FG001|Placebo Controlled Period|Adverse Event|5|||
155575108|NCT03142191|561529025|FG002|Placebo Controlled Period|Adverse Event|1|||
155575109|NCT03142191|561529026|FG003|Placebo Controlled Period|Adverse Event|0|||
155575110|NCT03142191|561529027|FG004|Placebo Controlled Period|Adverse Event|0|||
155575111|NCT03142191|561529023|FG000|Placebo Controlled Period|Progressive Disease|1|||
155575112|NCT03142191|561529024|FG001|Placebo Controlled Period|Progressive Disease|0|||
155575113|NCT03142191|561529025|FG002|Placebo Controlled Period|Progressive Disease|1|||
155575114|NCT03142191|561529026|FG003|Placebo Controlled Period|Progressive Disease|0|||
155575115|NCT03142191|561529027|FG004|Placebo Controlled Period|Progressive Disease|0|||
155575116|NCT03142191|561529023|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
155575117|NCT03142191|561529024|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
155575118|NCT03142191|561529025|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
155575119|NCT03142191|561529026|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
155575120|NCT03142191|561529027|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
155575121|NCT03142191|561529023|FG000|Placebo Controlled Period|Other Reasons|1|||
155575122|NCT03142191|561529024|FG001|Placebo Controlled Period|Other Reasons|0|||
155575123|NCT03142191|561529025|FG002|Placebo Controlled Period|Other Reasons|0|||
155575124|NCT03142191|561529026|FG003|Placebo Controlled Period|Other Reasons|0|||
155575125|NCT03142191|561529027|FG004|Placebo Controlled Period|Other Reasons|0|||
155575126|NCT03142191|561529023|FG000|Active Treatment Extension Period|Death|2|||
155575127|NCT03142191|561529024|FG001|Active Treatment Extension Period|Death|1|||
155575128|NCT03142191|561529025|FG002|Active Treatment Extension Period|Death|1|||
155575129|NCT03142191|561529026|FG003|Active Treatment Extension Period|Death|1|||
155575130|NCT03142191|561529027|FG004|Active Treatment Extension Period|Death|0|||
155575131|NCT03142191|561529023|FG000|Active Treatment Extension Period|Adverse Event|6|||
155575132|NCT03142191|561529024|FG001|Active Treatment Extension Period|Adverse Event|5|||
155575133|NCT03142191|561529025|FG002|Active Treatment Extension Period|Adverse Event|4|||
155575134|NCT03142191|561529026|FG003|Active Treatment Extension Period|Adverse Event|1|||
155575135|NCT03142191|561529027|FG004|Active Treatment Extension Period|Adverse Event|0|||
155575136|NCT03142191|561529023|FG000|Active Treatment Extension Period|Progressive Disease|10|||
155575137|NCT03142191|561529024|FG001|Active Treatment Extension Period|Progressive Disease|5|||
155575138|NCT03142191|561529025|FG002|Active Treatment Extension Period|Progressive Disease|4|||
155575139|NCT03142191|561529026|FG003|Active Treatment Extension Period|Progressive Disease|1|||
155575140|NCT03142191|561529027|FG004|Active Treatment Extension Period|Progressive Disease|2|||
155575141|NCT03142191|561529023|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
155575142|NCT03142191|561529024|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
155575143|NCT03142191|561529025|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
155575144|NCT03142191|561529026|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
155575145|NCT03142191|561529027|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
155575146|NCT03142191|561529023|FG000|Active Treatment Extension Period|Physician Decision|2|||
155575147|NCT03142191|561529024|FG001|Active Treatment Extension Period|Physician Decision|0|||
155575148|NCT03142191|561529025|FG002|Active Treatment Extension Period|Physician Decision|0|||
155575149|NCT03142191|561529026|FG003|Active Treatment Extension Period|Physician Decision|0|||
155575150|NCT03142191|561529027|FG004|Active Treatment Extension Period|Physician Decision|0|||
155575151|NCT03142191|561529023|FG000|Active Treatment Extension Period|Other Reasons|3|||
155575152|NCT03142191|561529024|FG001|Active Treatment Extension Period|Other Reasons|3|||
155575153|NCT03142191|561529025|FG002|Active Treatment Extension Period|Other Reasons|3|||
155575154|NCT03142191|561529026|FG003|Active Treatment Extension Period|Other Reasons|8|||
155575155|NCT03142191|561529027|FG004|Active Treatment Extension Period|Other Reasons|3|||
155575156|NCT03142191|561529023|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
155575157|NCT03142191|561529024|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
155575158|NCT03142191|561529025|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
155575159|NCT03142191|561529026|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
155575160|NCT03142191|561529027|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
155575161|NCT00770328|561529043|FG000|Overall Study|Adverse Event|11|||
155575162|NCT00770328|561529044|FG001|Overall Study|Adverse Event|2|||
155575163|NCT00770328|561529043|FG000|Overall Study|Lost to Follow-up|2|||
155575164|NCT00770328|561529044|FG001|Overall Study|Lost to Follow-up|2|||
155575165|NCT03164616|561529047|FG000|Overall Study|Death|250|||
155575166|NCT03164616|561529048|FG001|Overall Study|Death|264|||
155575167|NCT03164616|561529049|FG002|Overall Study|Death|279|||
155575168|NCT03164616|561529047|FG000|Overall Study|Lost to Follow-up|2|||
155575169|NCT03164616|561529048|FG001|Overall Study|Lost to Follow-up|2|||
155575170|NCT03164616|561529049|FG002|Overall Study|Lost to Follow-up|2|||
155575171|NCT03164616|561529047|FG000|Overall Study|Withdrawal by Subject|6|||
155575172|NCT03164616|561529048|FG001|Overall Study|Withdrawal by Subject|7|||
155575173|NCT03164616|561529049|FG002|Overall Study|Withdrawal by Subject|16|||
155575174|NCT04388553|561529050|FG000|Overall Study|Protocol Violation|1|||
155575175|NCT04388553|561529051|FG001|Overall Study|Protocol Violation|0|||
155575176|NCT04604795|561529052|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
155575177|NCT04604795|561529053|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
155575178|NCT04604795|561529054|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575179|NCT04604795|561529055|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575180|NCT04604795|561529056|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575181|NCT04604795|561529057|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575182|NCT04604795|561529058|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575183|NCT04604795|561529059|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575184|NCT04604795|561529060|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575185|NCT04604795|561529061|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155575186|NCT04604795|561529052|FG000|Part B: Up to Day 14|Adverse Event|0|||
155575187|NCT04604795|561529053|FG001|Part B: Up to Day 14|Adverse Event|0|||
155575188|NCT04604795|561529054|FG002|Part B: Up to Day 14|Adverse Event|0|||
155575189|NCT04604795|561529055|FG003|Part B: Up to Day 14|Adverse Event|0|||
155575190|NCT04604795|561529056|FG004|Part B: Up to Day 14|Adverse Event|2|||
155575191|NCT04604795|561529057|FG005|Part B: Up to Day 14|Adverse Event|1|||
155575192|NCT04604795|561529058|FG006|Part B: Up to Day 14|Adverse Event|0|||
155575193|NCT04604795|561529059|FG007|Part B: Up to Day 14|Adverse Event|0|||
155575194|NCT04604795|561529060|FG008|Part B: Up to Day 14|Adverse Event|0|||
155575195|NCT04604795|561529061|FG009|Part B: Up to Day 14|Adverse Event|0|||
155575196|NCT04604795|561529052|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575197|NCT04604795|561529053|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575198|NCT04604795|561529054|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575199|NCT04604795|561529055|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575200|NCT04604795|561529056|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155661551|NCT02943473|561856561|FG000|Overall Study|Physician Decision|4|||
155575201|NCT04604795|561529057|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575202|NCT04604795|561529058|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575203|NCT04604795|561529059|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575204|NCT04604795|561529060|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155575205|NCT04604795|561529061|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
155575206|NCT04604795|561529052|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155661552|NCT00431964|561856562|FG000|Overall Study|Adverse Event|1|||
155575207|NCT04604795|561529053|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575208|NCT04604795|561529054|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575209|NCT04604795|561529055|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575210|NCT04604795|561529056|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575211|NCT04604795|561529057|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575212|NCT04604795|561529058|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575213|NCT04604795|561529059|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575214|NCT04604795|561529060|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
155575215|NCT04604795|561529061|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155575216|NCT04604795|561529052|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575217|NCT04604795|561529053|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575218|NCT04604795|561529054|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575219|NCT04604795|561529055|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575220|NCT04604795|561529056|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575221|NCT04604795|561529057|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575222|NCT04604795|561529058|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575223|NCT04604795|561529059|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575224|NCT04604795|561529060|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
155575225|NCT04604795|561529061|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155575226|NCT04604795|561529052|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575227|NCT04604795|561529053|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575228|NCT04604795|561529054|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575229|NCT04604795|561529055|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575230|NCT04604795|561529056|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575231|NCT04604795|561529057|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575232|NCT04604795|561529058|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575233|NCT04604795|561529059|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575234|NCT04604795|561529060|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
155575235|NCT04604795|561529061|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
155575236|NCT01260701|561529070|FG000|Overall Study|Adverse Event|9|||
155575237|NCT01260701|561529070|FG000|Overall Study|Withdrawal by Subject|2|||
155575238|NCT01260701|561529070|FG000|Overall Study|Progression|53|||
155575239|NCT01260701|561529070|FG000|Overall Study|Death|2|||
155575240|NCT01260701|561529070|FG000|Overall Study|Not protocol specified|3|||
155575241|NCT01260701|561529070|FG000|Overall Study|Under review|1|||
155575242|NCT01260701|561529070|FG000|Overall Study|Ineligible|4|||
155575243|NCT01260701|561529070|FG000|Overall Study|Did not begin protocol therapy|1|||
155575244|NCT03300817|561530731|FG000|Overall Study|Withdrawal by Subject|1|||
155575245|NCT03300817|561530731|FG000|Overall Study|Adverse Event|1|||
155575246|NCT03300817|561530731|FG000|Overall Study|Subject Found to be Ineligible|2|||
155575247|NCT03729596|561530733|FG000|Overall Study|Death|3|||
155575248|NCT03729596|561530734|FG001|Overall Study|Death|5|||
155575249|NCT03729596|561530735|FG002|Overall Study|Death|4|||
155575250|NCT03729596|561530736|FG003|Overall Study|Death|1|||
155575251|NCT03729596|561530737|FG004|Overall Study|Death|0|||
155575252|NCT03729596|561530738|FG005|Overall Study|Death|34|||
155575253|NCT03729596|561530739|FG006|Overall Study|Death|18|||
155575254|NCT03729596|561530740|FG007|Overall Study|Death|14|||
155575255|NCT03729596|561530741|FG008|Overall Study|Death|19|||
155575256|NCT03729596|561530742|FG009|Overall Study|Death|9|||
155575257|NCT03729596|561530733|FG000|Overall Study|Lost to Follow-up|0|||
155575258|NCT03729596|561530734|FG001|Overall Study|Lost to Follow-up|0|||
155575259|NCT03729596|561530735|FG002|Overall Study|Lost to Follow-up|0|||
155575260|NCT03729596|561530736|FG003|Overall Study|Lost to Follow-up|0|||
155575261|NCT03729596|561530737|FG004|Overall Study|Lost to Follow-up|0|||
155575262|NCT03729596|561530738|FG005|Overall Study|Lost to Follow-up|0|||
155575263|NCT03729596|561530739|FG006|Overall Study|Lost to Follow-up|1|||
155575264|NCT03729596|561530740|FG007|Overall Study|Lost to Follow-up|0|||
155575265|NCT03729596|561530741|FG008|Overall Study|Lost to Follow-up|0|||
155575266|NCT03729596|561530742|FG009|Overall Study|Lost to Follow-up|1|||
155575267|NCT03729596|561530733|FG000|Overall Study|protocol amendment|0|||
155575268|NCT03729596|561530734|FG001|Overall Study|protocol amendment|1|||
155575269|NCT03729596|561530735|FG002|Overall Study|protocol amendment|3|||
155575270|NCT03729596|561530736|FG003|Overall Study|protocol amendment|6|||
155575271|NCT03729596|561530737|FG004|Overall Study|protocol amendment|5|||
155661553|NCT00431964|561856563|FG001|Overall Study|Adverse Event|0|||
155575272|NCT03729596|561530738|FG005|Overall Study|protocol amendment|0|||
155575273|NCT03729596|561530739|FG006|Overall Study|protocol amendment|0|||
155575274|NCT03729596|561530740|FG007|Overall Study|protocol amendment|0|||
155575275|NCT03729596|561530741|FG008|Overall Study|protocol amendment|0|||
155575276|NCT03729596|561530742|FG009|Overall Study|protocol amendment|0|||
155575277|NCT03729596|561530733|FG000|Overall Study|Withdrawal by Subject|0|||
155575278|NCT03729596|561530734|FG001|Overall Study|Withdrawal by Subject|0|||
155575279|NCT03729596|561530735|FG002|Overall Study|Withdrawal by Subject|0|||
155575280|NCT03729596|561530736|FG003|Overall Study|Withdrawal by Subject|0|||
155575281|NCT03729596|561530737|FG004|Overall Study|Withdrawal by Subject|0|||
155575282|NCT03729596|561530738|FG005|Overall Study|Withdrawal by Subject|4|||
155575283|NCT03729596|561530739|FG006|Overall Study|Withdrawal by Subject|2|||
155575284|NCT03729596|561530740|FG007|Overall Study|Withdrawal by Subject|3|||
155575285|NCT03729596|561530741|FG008|Overall Study|Withdrawal by Subject|2|||
155575286|NCT03729596|561530742|FG009|Overall Study|Withdrawal by Subject|3|||
155575287|NCT03729596|561530733|FG000|Overall Study|study terminated by sponsor|0|||
155575288|NCT03729596|561530734|FG001|Overall Study|study terminated by sponsor|0|||
155575289|NCT03729596|561530735|FG002|Overall Study|study terminated by sponsor|0|||
155575290|NCT03729596|561530736|FG003|Overall Study|study terminated by sponsor|0|||
155575291|NCT03729596|561530737|FG004|Overall Study|study terminated by sponsor|1|||
155575292|NCT03729596|561530738|FG005|Overall Study|study terminated by sponsor|3|||
155575293|NCT03729596|561530739|FG006|Overall Study|study terminated by sponsor|0|||
155575294|NCT03729596|561530740|FG007|Overall Study|study terminated by sponsor|1|||
155575295|NCT03729596|561530741|FG008|Overall Study|study terminated by sponsor|0|||
155575296|NCT03729596|561530742|FG009|Overall Study|study terminated by sponsor|0|||
155575297|NCT04011722|561530743|FG000|30 Days|Death|5|||
155575298|NCT04011722|561530744|FG001|30 Days|Death|1|||
155575299|NCT04011722|561530743|FG000|1 Year|Death|13|||
155575300|NCT04011722|561530744|FG001|1 Year|Death|5|||
155575301|NCT04011722|561530743|FG000|1 Year|Withdrawal by Subject|8|||
155575302|NCT04011722|561530744|FG001|1 Year|Withdrawal by Subject|2|||
155575303|NCT04011722|561530743|FG000|1 Year|Missed Visit|6|||
155575304|NCT04011722|561530744|FG001|1 Year|Missed Visit|1|||
155575305|NCT04011722|561530743|FG000|1 Year|Pending Visit|0|||
155575306|NCT04011722|561530744|FG001|1 Year|Pending Visit|11|||
155575307|NCT04011722|561530743|FG000|1 Year|Not Yet Due|0|||
155575308|NCT04011722|561530744|FG001|1 Year|Not Yet Due|9|||
155575309|NCT04011722|561530743|FG000|2 Year|Death|16|||
155575310|NCT04011722|561530744|FG001|2 Year|Death|1|||
155575311|NCT04011722|561530743|FG000|2 Year|Withdrawal by Subject|10|||
155575312|NCT04011722|561530744|FG001|2 Year|Withdrawal by Subject|1|||
155575313|NCT04011722|561530743|FG000|2 Year|Missed Visit|9|||
155575314|NCT04011722|561530744|FG001|2 Year|Missed Visit|0|||
155575315|NCT04011722|561530743|FG000|2 Year|Visit Pending|1|||
155575316|NCT04011722|561530744|FG001|2 Year|Visit Pending|3|||
155575317|NCT04011722|561530743|FG000|2 Year|Not Yet Due|43|||
155575318|NCT04011722|561530744|FG001|2 Year|Not Yet Due|54|||
155575319|NCT04011722|561530743|FG000|3 Year|Death|10|||
155575320|NCT04011722|561530744|FG001|3 Year|Death|0|||
155575321|NCT04011722|561530743|FG000|3 Year|Withdrawal by Subject|2|||
155575322|NCT04011722|561530744|FG001|3 Year|Withdrawal by Subject|0|||
155575323|NCT04011722|561530743|FG000|3 Year|Missed Visit|2|||
155575324|NCT04011722|561530744|FG001|3 Year|Missed Visit|0|||
155575325|NCT04011722|561530743|FG000|3 Year|Pending Visit|34|||
155575326|NCT04011722|561530744|FG001|3 Year|Pending Visit|0|||
155575327|NCT04011722|561530743|FG000|3 Year|Not Yet Due|99|||
155575328|NCT04011722|561530744|FG001|3 Year|Not Yet Due|0|||
155575329|NCT01368497|561530749|FG000|Overall Study|Lost to Follow-up|2|||
155575330|NCT02656303|561530750|FG000|Overall Study|Adverse Event|3|||
155575331|NCT02656303|561530751|FG001|Overall Study|Adverse Event|2|||
155575332|NCT02656303|561530752|FG002|Overall Study|Adverse Event|0|||
155575333|NCT02656303|561530750|FG000|Overall Study|Death|12|||
155575334|NCT02656303|561530751|FG001|Overall Study|Death|4|||
155575335|NCT02656303|561530752|FG002|Overall Study|Death|1|||
155575336|NCT02656303|561530750|FG000|Overall Study|Lack of Efficacy|1|||
155575337|NCT02656303|561530751|FG001|Overall Study|Lack of Efficacy|0|||
155575338|NCT02656303|561530752|FG002|Overall Study|Lack of Efficacy|0|||
155575339|NCT02656303|561530750|FG000|Overall Study|Non-Compliance with Study|1|||
155575340|NCT02656303|561530751|FG001|Overall Study|Non-Compliance with Study|1|||
155575341|NCT02656303|561530752|FG002|Overall Study|Non-Compliance with Study|0|||
155575342|NCT02656303|561530750|FG000|Overall Study|Investigator Decision|2|||
155575343|NCT02656303|561530751|FG001|Overall Study|Investigator Decision|1|||
155575344|NCT02656303|561530752|FG002|Overall Study|Investigator Decision|0|||
155575345|NCT02656303|561530750|FG000|Overall Study|Progressive Disease|25|||
155575346|NCT02656303|561530751|FG001|Overall Study|Progressive Disease|14|||
155575347|NCT02656303|561530752|FG002|Overall Study|Progressive Disease|10|||
155575348|NCT02656303|561530750|FG000|Overall Study|Study Terminated by Sponsor|20|||
155575349|NCT02656303|561530751|FG001|Overall Study|Study Terminated by Sponsor|7|||
155575350|NCT02656303|561530752|FG002|Overall Study|Study Terminated by Sponsor|5|||
155575351|NCT02656303|561530750|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
155575352|NCT02656303|561530751|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
155575353|NCT02656303|561530752|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
155575354|NCT02656303|561530750|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
155575355|NCT02656303|561530751|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
155575356|NCT02656303|561530752|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
155575357|NCT02656303|561530750|FG000|Overall Study|Reason not Specified|1|||
155575358|NCT02656303|561530751|FG001|Overall Study|Reason not Specified|1|||
155575359|NCT02656303|561530752|FG002|Overall Study|Reason not Specified|2|||
155575360|NCT03041311|561530755|FG000|Overall Study|Death|39|||
155575361|NCT03041311|561530756|FG001|Overall Study|Death|42|||
155575362|NCT03041311|561530755|FG000|Overall Study|Lost to Follow-up|0|||
155575363|NCT03041311|561530756|FG001|Overall Study|Lost to Follow-up|1|||
155575364|NCT03041311|561530755|FG000|Overall Study|Withdrawal by Subject|8|||
155575365|NCT03041311|561530756|FG001|Overall Study|Withdrawal by Subject|5|||
155575366|NCT03041311|561530755|FG000|Overall Study|Sponsor Terminated Study|2|||
155575367|NCT03041311|561530756|FG001|Overall Study|Sponsor Terminated Study|4|||
155575368|NCT03041311|561530755|FG000|Overall Study|Disease Progression|3|||
155575369|NCT03041311|561530756|FG001|Overall Study|Disease Progression|1|||
155575370|NCT03041311|561530755|FG000|Overall Study|Randomized in error, did not receive drug|2|||
155575371|NCT03041311|561530756|FG001|Overall Study|Randomized in error, did not receive drug|0|||
155575372|NCT00443729|561530757|FG000|Overall Study|Never Treated|0|||
155575373|NCT00443729|561530758|FG001|Overall Study|Never Treated|1|||
155575374|NCT00443729|561530757|FG000|Overall Study|Lack of Efficacy|4|||
155575375|NCT00443729|561530758|FG001|Overall Study|Lack of Efficacy|2|||
155575376|NCT00443729|561530757|FG000|Overall Study|Lost to Follow-up|0|||
155575377|NCT00443729|561530758|FG001|Overall Study|Lost to Follow-up|1|||
155575378|NCT00443729|561530757|FG000|Overall Study|Physician Decision|2|||
155575379|NCT00443729|561530758|FG001|Overall Study|Physician Decision|1|||
155575380|NCT00443729|561530757|FG000|Overall Study|Protocol Violation|1|||
155575381|NCT00443729|561530758|FG001|Overall Study|Protocol Violation|1|||
155575382|NCT00443729|561530757|FG000|Overall Study|Withdrawal by Subject|3|||
155575383|NCT00443729|561530758|FG001|Overall Study|Withdrawal by Subject|1|||
155575384|NCT01842438|561530759|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
155575385|NCT01842438|561530760|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
155575386|NCT01842438|561530759|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
155575387|NCT01842438|561530760|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
155575388|NCT01842438|561530759|FG000|T2: 6month Follow-up|Death|0|||
155575389|NCT01842438|561530760|FG001|T2: 6month Follow-up|Death|1|||
155575390|NCT00782626|561530764|FG000|Overall Study|Adverse Event|1|||
155575391|NCT00782626|561530764|FG000|Overall Study|Progressive Disease|5|||
155575392|NCT00782626|561530764|FG000|Overall Study|Other Complicating Disease|1|||
155575393|NCT03718832|561530765|FG000|Analysis Sample|Withdrawal by Subject|18|||
155575394|NCT03718832|561530766|FG001|Analysis Sample|Withdrawal by Subject|15|||
155575395|NCT03718832|561530765|FG000|Analysis Sample|Legal hold on data|1|||
155575396|NCT03718832|561530766|FG001|Analysis Sample|Legal hold on data|0|||
155575397|NCT03718832|561530765|FG000|Analysis Sample|Participant from treated household|0|||
155575398|NCT03718832|561530766|FG001|Analysis Sample|Participant from treated household|1|||
155575399|NCT03718832|561530765|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
155575400|NCT03718832|561530766|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
155575401|NCT02548156|561530768|FG000|Washout Period 1|Lost to Follow-up|0|||
155575402|NCT02548156|561530769|FG001|Washout Period 1|Lost to Follow-up|0|||
155575403|NCT02548156|561530770|FG002|Washout Period 1|Lost to Follow-up|0|||
155575404|NCT02548156|561530771|FG003|Washout Period 1|Lost to Follow-up|0|||
155575405|NCT02548156|561530772|FG004|Washout Period 1|Lost to Follow-up|1|||
155575406|NCT02548156|561530773|FG005|Washout Period 1|Lost to Follow-up|0|||
155575407|NCT03288714|561530774|FG000|Overall Study|Lost to Follow-up|2|||
155575408|NCT03288714|561530775|FG001|Overall Study|Lost to Follow-up|1|||
155575409|NCT03288714|561530774|FG000|Overall Study|Non-compliance with study schedule|2|||
155575410|NCT03288714|561530775|FG001|Overall Study|Non-compliance with study schedule|0|||
155575411|NCT03288714|561530774|FG000|Overall Study|Withdrawal by Subject|3|||
155575412|NCT03288714|561530775|FG001|Overall Study|Withdrawal by Subject|1|||
155575413|NCT03288714|561530774|FG000|Overall Study|Clinical Worsening|2|||
155575414|NCT03288714|561530775|FG001|Overall Study|Clinical Worsening|1|||
155575415|NCT03288714|561530774|FG000|Overall Study|Adverse Event|1|||
155575416|NCT03288714|561530775|FG001|Overall Study|Adverse Event|0|||
155575417|NCT03280264|561530776|FG000|Overall Study|Adverse Event|1|||
155575418|NCT03280264|561530776|FG000|Overall Study|Physician Decision|1|||
155575419|NCT03280264|561530776|FG000|Overall Study|Withdrawal by Subject|1|||
155575420|NCT01342081|561530787|FG000|Overall Study|Did not receive allocated intervention|0|||
155575421|NCT01342081|561530788|FG001|Overall Study|Did not receive allocated intervention|0|||
155575422|NCT01342081|561530789|FG002|Overall Study|Did not receive allocated intervention|1|||
155575423|NCT01342081|561530787|FG000|Overall Study|Adverse Event|1|||
155575424|NCT01342081|561530788|FG001|Overall Study|Adverse Event|0|||
155575425|NCT01342081|561530789|FG002|Overall Study|Adverse Event|0|||
155575426|NCT01342081|561530787|FG000|Overall Study|Physician Decision|0|||
155575427|NCT01342081|561530788|FG001|Overall Study|Physician Decision|1|||
155575428|NCT01342081|561530789|FG002|Overall Study|Physician Decision|0|||
155575429|NCT01342081|561530787|FG000|Overall Study|Withdrawal by Subject|1|||
155575430|NCT01342081|561530788|FG001|Overall Study|Withdrawal by Subject|1|||
155575431|NCT01342081|561530789|FG002|Overall Study|Withdrawal by Subject|0|||
155575432|NCT04720053|561530794|FG000|Overall Study|Lost to Follow-up|12|||
155575433|NCT01960257|561530795|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
155575434|NCT01960257|561530796|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
155575435|NCT01960257|561530797|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
155575436|NCT01960257|561530795|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
155575437|NCT01960257|561530796|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
155575438|NCT01960257|561530797|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
155575439|NCT01960257|561530795|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
155575440|NCT01960257|561530796|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
155575441|NCT01960257|561530797|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
155575442|NCT01942993|561530798|FG000|Overall Study|Lost to Follow-up|1|||
155575443|NCT01942993|561530798|FG000|Overall Study|Physician Decision|1|||
155575444|NCT01350271|561530802|FG000|Overall Study|Lost to Follow-up|21|||
155575445|NCT01350271|561530803|FG001|Overall Study|Lost to Follow-up|17|||
155575446|NCT01350271|561530804|FG002|Overall Study|Lost to Follow-up|26|||
155575447|NCT02906670|561530805|FG000|Cohort 1, QW|Radiological Progression|1|||
155575448|NCT02906670|561530806|FG001|Cohort 1, QW|Radiological Progression|0|||
155575449|NCT02906670|561530807|FG002|Cohort 1, QW|Radiological Progression|0|||
155575450|NCT02906670|561530808|FG003|Cohort 1, QW|Radiological Progression|0|||
155575451|NCT02906670|561530809|FG004|Cohort 1, QW|Radiological Progression|0|||
155575452|NCT02906670|561530810|FG005|Cohort 1, QW|Radiological Progression|0|||
155575453|NCT02906670|561530811|FG006|Cohort 1, QW|Radiological Progression|0|||
155575454|NCT02906670|561530812|FG007|Cohort 1, QW|Radiological Progression|0|||
155575455|NCT02906670|561530813|FG008|Cohort 1, QW|Radiological Progression|0|||
155575456|NCT02906670|561530814|FG009|Cohort 1, QW|Radiological Progression|0|||
155575457|NCT02906670|561530805|FG000|Cohort 2, QW|Radiological Progression|0|||
155575458|NCT02906670|561530806|FG001|Cohort 2, QW|Radiological Progression|1|||
155575459|NCT02906670|561530807|FG002|Cohort 2, QW|Radiological Progression|0|||
155575460|NCT02906670|561530808|FG003|Cohort 2, QW|Radiological Progression|0|||
155575461|NCT02906670|561530809|FG004|Cohort 2, QW|Radiological Progression|0|||
155575462|NCT02906670|561530810|FG005|Cohort 2, QW|Radiological Progression|0|||
155575463|NCT02906670|561530811|FG006|Cohort 2, QW|Radiological Progression|0|||
155575464|NCT02906670|561530812|FG007|Cohort 2, QW|Radiological Progression|0|||
155575465|NCT02906670|561530813|FG008|Cohort 2, QW|Radiological Progression|0|||
155575466|NCT02906670|561530814|FG009|Cohort 2, QW|Radiological Progression|0|||
155575467|NCT02906670|561530805|FG000|Cohort 3, QW|Radiological Progression|0|||
155575468|NCT02906670|561530806|FG001|Cohort 3, QW|Radiological Progression|0|||
155575469|NCT02906670|561530807|FG002|Cohort 3, QW|Radiological Progression|2|||
155575470|NCT02906670|561530808|FG003|Cohort 3, QW|Radiological Progression|0|||
155575471|NCT02906670|561530809|FG004|Cohort 3, QW|Radiological Progression|0|||
155575472|NCT02906670|561530810|FG005|Cohort 3, QW|Radiological Progression|0|||
155575473|NCT02906670|561530811|FG006|Cohort 3, QW|Radiological Progression|0|||
155575474|NCT02906670|561530812|FG007|Cohort 3, QW|Radiological Progression|0|||
155575475|NCT02906670|561530813|FG008|Cohort 3, QW|Radiological Progression|0|||
155575476|NCT02906670|561530814|FG009|Cohort 3, QW|Radiological Progression|0|||
155575477|NCT02906670|561530805|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575478|NCT02906670|561530806|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575479|NCT02906670|561530807|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
155575480|NCT02906670|561530808|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575481|NCT02906670|561530809|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575482|NCT02906670|561530810|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575483|NCT02906670|561530811|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575484|NCT02906670|561530812|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575485|NCT02906670|561530813|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575486|NCT02906670|561530814|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
155575487|NCT02906670|561530805|FG000|Cohort 4, Q2W|Radiological Progression|0|||
155575488|NCT02906670|561530806|FG001|Cohort 4, Q2W|Radiological Progression|0|||
155575489|NCT02906670|561530807|FG002|Cohort 4, Q2W|Radiological Progression|0|||
155575490|NCT02906670|561530808|FG003|Cohort 4, Q2W|Radiological Progression|0|||
155575491|NCT02906670|561530809|FG004|Cohort 4, Q2W|Radiological Progression|0|||
155575492|NCT02906670|561530810|FG005|Cohort 4, Q2W|Radiological Progression|1|||
155575493|NCT02906670|561530811|FG006|Cohort 4, Q2W|Radiological Progression|0|||
155575494|NCT02906670|561530812|FG007|Cohort 4, Q2W|Radiological Progression|0|||
155575495|NCT02906670|561530813|FG008|Cohort 4, Q2W|Radiological Progression|0|||
155575496|NCT02906670|561530814|FG009|Cohort 4, Q2W|Radiological Progression|0|||
155575497|NCT02906670|561530805|FG000|Cohort 4, Q2W|Clinical Progression|0|||
155575498|NCT02906670|561530806|FG001|Cohort 4, Q2W|Clinical Progression|0|||
155575499|NCT02906670|561530807|FG002|Cohort 4, Q2W|Clinical Progression|0|||
155575500|NCT02906670|561530808|FG003|Cohort 4, Q2W|Clinical Progression|0|||
155575501|NCT02906670|561530809|FG004|Cohort 4, Q2W|Clinical Progression|0|||
155575502|NCT02906670|561530810|FG005|Cohort 4, Q2W|Clinical Progression|2|||
155575503|NCT02906670|561530811|FG006|Cohort 4, Q2W|Clinical Progression|0|||
155575504|NCT02906670|561530812|FG007|Cohort 4, Q2W|Clinical Progression|0|||
155575505|NCT02906670|561530813|FG008|Cohort 4, Q2W|Clinical Progression|0|||
155575506|NCT02906670|561530814|FG009|Cohort 4, Q2W|Clinical Progression|0|||
155575507|NCT02906670|561530805|FG000|Cohort 5, Q2W|Radiological Progression|0|||
155575508|NCT02906670|561530806|FG001|Cohort 5, Q2W|Radiological Progression|0|||
155575509|NCT02906670|561530807|FG002|Cohort 5, Q2W|Radiological Progression|0|||
155575510|NCT02906670|561530808|FG003|Cohort 5, Q2W|Radiological Progression|0|||
155575511|NCT02906670|561530809|FG004|Cohort 5, Q2W|Radiological Progression|0|||
155575512|NCT02906670|561530810|FG005|Cohort 5, Q2W|Radiological Progression|0|||
155575513|NCT02906670|561530811|FG006|Cohort 5, Q2W|Radiological Progression|4|||
155575514|NCT02906670|561530812|FG007|Cohort 5, Q2W|Radiological Progression|0|||
155575515|NCT02906670|561530813|FG008|Cohort 5, Q2W|Radiological Progression|0|||
155575516|NCT02906670|561530814|FG009|Cohort 5, Q2W|Radiological Progression|0|||
155575517|NCT02906670|561530805|FG000|Cohort 5, Q2W|Clinical Progression|0|||
155575518|NCT02906670|561530806|FG001|Cohort 5, Q2W|Clinical Progression|0|||
155575519|NCT02906670|561530807|FG002|Cohort 5, Q2W|Clinical Progression|0|||
155575520|NCT02906670|561530808|FG003|Cohort 5, Q2W|Clinical Progression|0|||
155575521|NCT02906670|561530809|FG004|Cohort 5, Q2W|Clinical Progression|0|||
155575522|NCT02906670|561530810|FG005|Cohort 5, Q2W|Clinical Progression|0|||
155575523|NCT02906670|561530811|FG006|Cohort 5, Q2W|Clinical Progression|1|||
155575524|NCT02906670|561530812|FG007|Cohort 5, Q2W|Clinical Progression|0|||
155575525|NCT02906670|561530813|FG008|Cohort 5, Q2W|Clinical Progression|0|||
155575526|NCT02906670|561530814|FG009|Cohort 5, Q2W|Clinical Progression|0|||
155575527|NCT02906670|561530805|FG000|Cohort 5, Q2W|Adverse Event|0|||
155575528|NCT02906670|561530806|FG001|Cohort 5, Q2W|Adverse Event|0|||
155575529|NCT02906670|561530807|FG002|Cohort 5, Q2W|Adverse Event|0|||
155575530|NCT02906670|561530808|FG003|Cohort 5, Q2W|Adverse Event|0|||
155575531|NCT02906670|561530809|FG004|Cohort 5, Q2W|Adverse Event|0|||
155575532|NCT02906670|561530810|FG005|Cohort 5, Q2W|Adverse Event|0|||
155575533|NCT02906670|561530811|FG006|Cohort 5, Q2W|Adverse Event|1|||
155575534|NCT02906670|561530812|FG007|Cohort 5, Q2W|Adverse Event|0|||
155575535|NCT02906670|561530813|FG008|Cohort 5, Q2W|Adverse Event|0|||
155575536|NCT02906670|561530814|FG009|Cohort 5, Q2W|Adverse Event|0|||
155575537|NCT02906670|561530805|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575538|NCT02906670|561530806|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575539|NCT02906670|561530807|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575540|NCT02906670|561530808|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575541|NCT02906670|561530809|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575542|NCT02906670|561530810|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575543|NCT02906670|561530811|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
155575544|NCT02906670|561530812|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575545|NCT02906670|561530813|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575546|NCT02906670|561530814|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155575547|NCT02906670|561530805|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
155575548|NCT02906670|561530806|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
155575549|NCT02906670|561530807|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
155575550|NCT02906670|561530808|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
155575551|NCT02906670|561530809|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
155575552|NCT02906670|561530810|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
155575553|NCT02906670|561530811|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
155575554|NCT02906670|561530812|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
155575555|NCT02906670|561530813|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
155575556|NCT02906670|561530814|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
155575557|NCT02906670|561530805|FG000|Cohort 5P, Q2W|Adverse Event|0|||
155575558|NCT02906670|561530806|FG001|Cohort 5P, Q2W|Adverse Event|0|||
155575559|NCT02906670|561530807|FG002|Cohort 5P, Q2W|Adverse Event|0|||
155575560|NCT02906670|561530808|FG003|Cohort 5P, Q2W|Adverse Event|0|||
155575561|NCT02906670|561530809|FG004|Cohort 5P, Q2W|Adverse Event|0|||
155575562|NCT02906670|561530810|FG005|Cohort 5P, Q2W|Adverse Event|0|||
155575563|NCT02906670|561530811|FG006|Cohort 5P, Q2W|Adverse Event|0|||
155575564|NCT02906670|561530812|FG007|Cohort 5P, Q2W|Adverse Event|1|||
155575565|NCT02906670|561530813|FG008|Cohort 5P, Q2W|Adverse Event|0|||
155661554|NCT00431964|561856562|FG000|Overall Study|Lost to Follow-up|1|||
155661555|NCT00431964|561856563|FG001|Overall Study|Lost to Follow-up|2|||
155661556|NCT00431964|561856562|FG000|Overall Study|Physician Decision|2|||
155575566|NCT02906670|561530814|FG009|Cohort 5P, Q2W|Adverse Event|0|||
155575567|NCT02906670|561530805|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
155661557|NCT00431964|561856563|FG001|Overall Study|Physician Decision|2|||
155575568|NCT02906670|561530806|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
155575569|NCT02906670|561530807|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
155575570|NCT02906670|561530808|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
155575571|NCT02906670|561530809|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
155661558|NCT00431964|561856562|FG000|Overall Study|Withdrawal by Subject|2|||
155575572|NCT02906670|561530810|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
155575573|NCT02906670|561530811|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
155575574|NCT02906670|561530812|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
155575575|NCT02906670|561530813|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
155575576|NCT02906670|561530814|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
155575577|NCT02906670|561530805|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
155575578|NCT02906670|561530806|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
155575579|NCT02906670|561530807|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
155575580|NCT02906670|561530808|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
155575581|NCT02906670|561530809|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
155575582|NCT02906670|561530810|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
155575583|NCT02906670|561530811|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
155575584|NCT02906670|561530812|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
155575585|NCT02906670|561530813|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
155575586|NCT02906670|561530814|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
155575587|NCT02906670|561530805|FG000|Cohort 4P, QW|Radiological Progression|0|||
155575588|NCT02906670|561530806|FG001|Cohort 4P, QW|Radiological Progression|0|||
155575589|NCT02906670|561530807|FG002|Cohort 4P, QW|Radiological Progression|0|||
155575590|NCT02906670|561530808|FG003|Cohort 4P, QW|Radiological Progression|3|||
155575591|NCT02906670|561530809|FG004|Cohort 4P, QW|Radiological Progression|0|||
155575592|NCT02906670|561530810|FG005|Cohort 4P, QW|Radiological Progression|0|||
155575593|NCT02906670|561530811|FG006|Cohort 4P, QW|Radiological Progression|0|||
155575594|NCT02906670|561530812|FG007|Cohort 4P, QW|Radiological Progression|0|||
155575595|NCT02906670|561530813|FG008|Cohort 4P, QW|Radiological Progression|0|||
155575596|NCT02906670|561530814|FG009|Cohort 4P, QW|Radiological Progression|0|||
155575597|NCT02906670|561530805|FG000|Cohort 7P, Q2W|Adverse Event|0|||
155575598|NCT02906670|561530806|FG001|Cohort 7P, Q2W|Adverse Event|0|||
155575599|NCT02906670|561530807|FG002|Cohort 7P, Q2W|Adverse Event|0|||
155575600|NCT02906670|561530808|FG003|Cohort 7P, Q2W|Adverse Event|0|||
155575601|NCT02906670|561530809|FG004|Cohort 7P, Q2W|Adverse Event|0|||
155575602|NCT02906670|561530810|FG005|Cohort 7P, Q2W|Adverse Event|0|||
155575603|NCT02906670|561530811|FG006|Cohort 7P, Q2W|Adverse Event|0|||
155575604|NCT02906670|561530812|FG007|Cohort 7P, Q2W|Adverse Event|0|||
155575605|NCT02906670|561530813|FG008|Cohort 7P, Q2W|Adverse Event|0|||
155575606|NCT02906670|561530814|FG009|Cohort 7P, Q2W|Adverse Event|1|||
155575607|NCT02906670|561530805|FG000|Cohort 7P, Q2W|Physician Decision|0|||
155575608|NCT02906670|561530806|FG001|Cohort 7P, Q2W|Physician Decision|0|||
155575609|NCT02906670|561530807|FG002|Cohort 7P, Q2W|Physician Decision|0|||
155575610|NCT02906670|561530808|FG003|Cohort 7P, Q2W|Physician Decision|0|||
155575611|NCT02906670|561530809|FG004|Cohort 7P, Q2W|Physician Decision|0|||
155575612|NCT02906670|561530810|FG005|Cohort 7P, Q2W|Physician Decision|0|||
155575613|NCT02906670|561530811|FG006|Cohort 7P, Q2W|Physician Decision|0|||
155575614|NCT02906670|561530812|FG007|Cohort 7P, Q2W|Physician Decision|0|||
155575615|NCT02906670|561530813|FG008|Cohort 7P, Q2W|Physician Decision|0|||
155575616|NCT02906670|561530814|FG009|Cohort 7P, Q2W|Physician Decision|1|||
155575617|NCT02906670|561530805|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575618|NCT02906670|561530806|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575619|NCT02906670|561530807|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575620|NCT02906670|561530808|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575621|NCT02906670|561530809|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575622|NCT02906670|561530810|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575623|NCT02906670|561530811|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575624|NCT02906670|561530812|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575625|NCT02906670|561530813|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155575626|NCT02906670|561530814|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
155575627|NCT02906670|561530805|FG000|Cohort 5P, QW|Radiological Progression|0|||
155575628|NCT02906670|561530806|FG001|Cohort 5P, QW|Radiological Progression|0|||
155575629|NCT02906670|561530807|FG002|Cohort 5P, QW|Radiological Progression|0|||
155575630|NCT02906670|561530808|FG003|Cohort 5P, QW|Radiological Progression|0|||
155575631|NCT02906670|561530809|FG004|Cohort 5P, QW|Radiological Progression|3|||
155575632|NCT02906670|561530810|FG005|Cohort 5P, QW|Radiological Progression|0|||
155575633|NCT02906670|561530811|FG006|Cohort 5P, QW|Radiological Progression|0|||
155575634|NCT02906670|561530812|FG007|Cohort 5P, QW|Radiological Progression|0|||
155575635|NCT02906670|561530813|FG008|Cohort 5P, QW|Radiological Progression|0|||
155575636|NCT02906670|561530814|FG009|Cohort 5P, QW|Radiological Progression|0|||
155575637|NCT01349192|561530815|FG000|Overall Study|Protocol Violation|0|||
155575638|NCT01349192|561530816|FG001|Overall Study|Protocol Violation|1|||
155575639|NCT01349192|561530815|FG000|Overall Study|Withdrawal by Subject|0|||
155575640|NCT01349192|561530816|FG001|Overall Study|Withdrawal by Subject|2|||
155575641|NCT01349192|561530815|FG000|Overall Study|Lost to Follow-up|1|||
155575642|NCT01349192|561530816|FG001|Overall Study|Lost to Follow-up|3|||
155575643|NCT01349192|561530815|FG000|Overall Study|Failure to adhere to Protocol|2|||
155575644|NCT01349192|561530816|FG001|Overall Study|Failure to adhere to Protocol|0|||
155575645|NCT03749330|561530817|FG000|Overall Study|Clinicians left work in the CICU|0|||
155575646|NCT03749330|561530818|FG001|Overall Study|Clinicians left work in the CICU|2|||
155575647|NCT03749330|561530819|FG002|Overall Study|Clinicians left work in the CICU|0|||
155575648|NCT03749330|561530820|FG003|Overall Study|Clinicians left work in the CICU|0|||
155575649|NCT03749330|561530821|FG004|Overall Study|Clinicians left work in the CICU|0|||
155575650|NCT03749330|561530822|FG005|Overall Study|Clinicians left work in the CICU|0|||
155575651|NCT01973439|561530823|FG000|Overall Study|Lost samples from one PK Day|2|||
155575652|NCT01973439|561530823|FG000|Overall Study|Vomiting after commencing once daily|1|||
155575653|NCT01973439|561530823|FG000|Overall Study|PK curve incomplete|2|||
155575654|NCT02038010|561530824|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155575655|NCT02038010|561530825|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
155575656|NCT02038010|561530826|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155575657|NCT02038010|561530827|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155575658|NCT02038010|561530824|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
155575659|NCT02038010|561530825|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155575660|NCT02038010|561530826|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155575661|NCT02038010|561530827|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155575662|NCT02038010|561530824|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155575663|NCT02038010|561530825|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
155575664|NCT02038010|561530826|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155575665|NCT02038010|561530827|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155575666|NCT02038010|561530824|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
155575667|NCT02038010|561530825|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
155575668|NCT02038010|561530826|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
155575669|NCT02038010|561530827|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
155575670|NCT02038010|561530824|FG000|Follow Up|Death|4|||
155575671|NCT02038010|561530825|FG001|Follow Up|Death|3|||
155575672|NCT02038010|561530826|FG002|Follow Up|Death|0|||
155575673|NCT02038010|561530827|FG003|Follow Up|Death|0|||
155575674|NCT02038010|561530824|FG000|Follow Up|Other|3|||
155575675|NCT02038010|561530825|FG001|Follow Up|Other|0|||
155575676|NCT02038010|561530826|FG002|Follow Up|Other|0|||
155575677|NCT02038010|561530827|FG003|Follow Up|Other|0|||
155575678|NCT02673775|561530833|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
155575679|NCT02673775|561530834|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
155575680|NCT02673775|561530833|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
155575681|NCT02673775|561530834|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
155575682|NCT02673775|561530833|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
155575683|NCT02673775|561530834|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
155575684|NCT02673775|561530833|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
155575685|NCT02673775|561530834|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
155575686|NCT03519087|561530835|FG000|Clinic Evaluation|Physician Decision|15|||
155575687|NCT03519087|561530836|FG001|Clinic Evaluation|Physician Decision|18|||
155575688|NCT03519087|561530837|FG002|Clinic Evaluation|Physician Decision|0|||
155575689|NCT03519087|561530838|FG003|Clinic Evaluation|Physician Decision|0|||
155575690|NCT03519087|561530839|FG004|Clinic Evaluation|Physician Decision|0|||
155575691|NCT03519087|561530835|FG000|Clinic Evaluation|Protocol Violation|1|||
155575692|NCT03519087|561530836|FG001|Clinic Evaluation|Protocol Violation|0|||
155575693|NCT03519087|561530837|FG002|Clinic Evaluation|Protocol Violation|0|||
155575694|NCT03519087|561530838|FG003|Clinic Evaluation|Protocol Violation|0|||
155575695|NCT03519087|561530839|FG004|Clinic Evaluation|Protocol Violation|0|||
155575696|NCT03519087|561530835|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
155575697|NCT03519087|561530836|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
155575698|NCT03519087|561530837|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
155575699|NCT03519087|561530838|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
155575700|NCT03519087|561530839|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
155575701|NCT03519087|561530835|FG000|Re-randomization for Treatment|Not appropriate|2|||
155575702|NCT03519087|561530836|FG001|Re-randomization for Treatment|Not appropriate|3|||
155575703|NCT03519087|561530837|FG002|Re-randomization for Treatment|Not appropriate|0|||
155575704|NCT03519087|561530838|FG003|Re-randomization for Treatment|Not appropriate|0|||
155575705|NCT03519087|561530839|FG004|Re-randomization for Treatment|Not appropriate|0|||
155575706|NCT03519087|561530835|FG000|Laboratory Testing|Lost to Follow-up|0|||
155575707|NCT03519087|561530836|FG001|Laboratory Testing|Lost to Follow-up|0|||
155575708|NCT03519087|561530837|FG002|Laboratory Testing|Lost to Follow-up|2|||
155575709|NCT03519087|561530838|FG003|Laboratory Testing|Lost to Follow-up|3|||
155575710|NCT03519087|561530839|FG004|Laboratory Testing|Lost to Follow-up|6|||
155575711|NCT03519087|561530835|FG000|Laboratory Testing|Protocol Violation|0|||
155575712|NCT03519087|561530836|FG001|Laboratory Testing|Protocol Violation|0|||
155575713|NCT03519087|561530837|FG002|Laboratory Testing|Protocol Violation|0|||
155575714|NCT03519087|561530838|FG003|Laboratory Testing|Protocol Violation|1|||
155575715|NCT03519087|561530839|FG004|Laboratory Testing|Protocol Violation|0|||
155575716|NCT01137071|561530840|FG000|Overall Study|Disease Progression|11|||
155575717|NCT01137071|561530840|FG000|Overall Study|Withdrawal by Subject|2|||
155575718|NCT01137071|561530840|FG000|Overall Study|Wrongly Included|1|||
155575719|NCT04807400|561530841|FG000|Overall Study|Adverse Event|2|||
155575720|NCT04807400|561530842|FG001|Overall Study|Adverse Event|3|||
155575721|NCT04807400|561530843|FG002|Overall Study|Adverse Event|3|||
155575722|NCT04807400|561530841|FG000|Overall Study|Death|2|||
155575723|NCT04807400|561530842|FG001|Overall Study|Death|0|||
155575724|NCT04807400|561530843|FG002|Overall Study|Death|0|||
155575725|NCT04807400|561530841|FG000|Overall Study|Lost to Follow-up|8|||
155575726|NCT04807400|561530842|FG001|Overall Study|Lost to Follow-up|6|||
155575727|NCT04807400|561530843|FG002|Overall Study|Lost to Follow-up|6|||
155575728|NCT04807400|561530841|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155575729|NCT04807400|561530842|FG001|Overall Study|Non-Compliance With Study Drug|4|||
155575730|NCT04807400|561530843|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155575731|NCT04807400|561530841|FG000|Overall Study|Participant Decision|20|||
155575732|NCT04807400|561530842|FG001|Overall Study|Participant Decision|19|||
155575733|NCT04807400|561530843|FG002|Overall Study|Participant Decision|26|||
155575734|NCT04807400|561530841|FG000|Overall Study|Physician Decision|0|||
155575735|NCT04807400|561530842|FG001|Overall Study|Physician Decision|1|||
155575736|NCT04807400|561530843|FG002|Overall Study|Physician Decision|0|||
155575737|NCT04807400|561530841|FG000|Overall Study|Protocol Violation|4|||
155575738|NCT04807400|561530842|FG001|Overall Study|Protocol Violation|3|||
155575739|NCT04807400|561530843|FG002|Overall Study|Protocol Violation|7|||
155575740|NCT04807400|561530841|FG000|Overall Study|Withdrawal by Subject|13|||
155575741|NCT04807400|561530842|FG001|Overall Study|Withdrawal by Subject|9|||
155575742|NCT04807400|561530843|FG002|Overall Study|Withdrawal by Subject|20|||
155575743|NCT04807400|561530841|FG000|Overall Study|Mis-randomized|1|||
155575744|NCT04807400|561530842|FG001|Overall Study|Mis-randomized|0|||
155575745|NCT04807400|561530843|FG002|Overall Study|Mis-randomized|0|||
155575746|NCT01130493|561530844|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
155575747|NCT01130493|561530845|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
155575748|NCT01130493|561530846|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
155575749|NCT01130493|561530844|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
155575750|NCT01130493|561530845|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
155575751|NCT01130493|561530846|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
155575752|NCT01130493|561530844|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
155575753|NCT01130493|561530845|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
155575754|NCT01130493|561530846|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
155575755|NCT01130493|561530844|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
155575756|NCT01130493|561530845|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
155575757|NCT01130493|561530846|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
155575758|NCT01130493|561530844|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
155575759|NCT01130493|561530845|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
155575760|NCT01130493|561530846|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
155575761|NCT01130493|561530844|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
155575762|NCT01130493|561530845|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
155575763|NCT01130493|561530846|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
155575764|NCT01130493|561530844|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
155575765|NCT01130493|561530845|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
155575766|NCT01130493|561530846|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
155575767|NCT01130493|561530844|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
155575768|NCT01130493|561530845|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
155575769|NCT01130493|561530846|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
155575770|NCT01130493|561530844|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
155575771|NCT01130493|561530845|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
155575772|NCT01130493|561530846|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
155575773|NCT01130493|561530844|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
155661559|NCT00431964|561856563|FG001|Overall Study|Withdrawal by Subject|1|||
155575774|NCT01130493|561530845|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
155575775|NCT01130493|561530846|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
155575776|NCT01130493|561530844|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
155575777|NCT01130493|561530845|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
155575778|NCT01130493|561530846|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155575779|NCT01130493|561530844|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
155575780|NCT01130493|561530845|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
155575781|NCT01130493|561530846|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
155575782|NCT01130493|561530844|FG000|Part 2: OLE|Adverse Event|0|||
155575783|NCT01130493|561530845|FG001|Part 2: OLE|Adverse Event|2|||
155575784|NCT01130493|561530846|FG002|Part 2: OLE|Adverse Event|1|||
155575785|NCT01130493|561530844|FG000|Part 2: OLE|Withdrawal by Subject|0|||
155575786|NCT01130493|561530845|FG001|Part 2: OLE|Withdrawal by Subject|1|||
155575787|NCT01130493|561530846|FG002|Part 2: OLE|Withdrawal by Subject|4|||
155575788|NCT04728802|561530852|FG000|Overall Study|Withdrawal by Subject|4|||
155575789|NCT04728802|561530853|FG001|Overall Study|Withdrawal by Subject|20|||
155575790|NCT04728802|561530852|FG000|Overall Study|Physician Decision|7|||
155575791|NCT04728802|561530853|FG001|Overall Study|Physician Decision|7|||
155575792|NCT04728802|561530852|FG000|Overall Study|Protocol Violation|10|||
155575793|NCT04728802|561530853|FG001|Overall Study|Protocol Violation|4|||
155575794|NCT04728802|561530852|FG000|Overall Study|Transfer|1|||
155575795|NCT04728802|561530853|FG001|Overall Study|Transfer|0|||
155575796|NCT04728802|561530852|FG000|Overall Study|Death|4|||
155575797|NCT04728802|561530853|FG001|Overall Study|Death|5|||
155575798|NCT04728802|561530852|FG000|Overall Study|Other|3|||
155575799|NCT04728802|561530853|FG001|Overall Study|Other|0|||
155575800|NCT02123446|561530854|FG000|Washout Period (1 Day)|Physician Decision|1|||
155575801|NCT02123446|561530855|FG001|Washout Period (1 Day)|Physician Decision|0|||
155575802|NCT02096744|561530866|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
155575803|NCT02096744|561530867|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
155575804|NCT02096744|561530866|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
155575805|NCT02096744|561530867|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
155575806|NCT02096744|561530866|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
155575807|NCT02096744|561530867|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
155575808|NCT05022212|561530870|FG000|Overall Study|Lost to Follow-up|0|||
155575809|NCT05022212|561530871|FG001|Overall Study|Lost to Follow-up|2|||
155575810|NCT02905032|561530872|FG000|Overall Study|Withdrawal by Subject|2|||
155575811|NCT02905032|561530873|FG001|Overall Study|Withdrawal by Subject|0|||
155575812|NCT02905032|561530874|FG002|Overall Study|Withdrawal by Subject|0|||
155575813|NCT02905032|561530872|FG000|Overall Study|Protocol Violation|6|||
155575814|NCT02905032|561530873|FG001|Overall Study|Protocol Violation|12|||
155575815|NCT02905032|561530874|FG002|Overall Study|Protocol Violation|0|||
155575816|NCT02729909|561530875|FG000|Overall Study|Lost to Follow-up|0|||
155575817|NCT02729909|561530876|FG001|Overall Study|Lost to Follow-up|1|||
155575818|NCT02729909|561530875|FG000|Overall Study|Lack of Efficacy|0|||
155575819|NCT02729909|561530876|FG001|Overall Study|Lack of Efficacy|2|||
155575820|NCT02729909|561530875|FG000|Overall Study|Significant Protocol Deviation|0|||
155575821|NCT02729909|561530876|FG001|Overall Study|Significant Protocol Deviation|2|||
155575822|NCT02729909|561530875|FG000|Overall Study|Voluntary Withdrawal|1|||
155575823|NCT02729909|561530876|FG001|Overall Study|Voluntary Withdrawal|0|||
155575824|NCT00739063|561530877|FG000|Overall Study|Screen failures|8|||
155575825|NCT00866359|561530879|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
155575826|NCT00866359|561530880|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
155575827|NCT00866359|561530881|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
155575828|NCT00866359|561530882|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
155575829|NCT00866359|561530879|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
155575830|NCT00866359|561530880|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155575831|NCT00866359|561530881|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155575832|NCT00866359|561530882|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155575833|NCT00866359|561530879|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
155575834|NCT00866359|561530880|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155575835|NCT00866359|561530881|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155575836|NCT00866359|561530882|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155575837|NCT00866359|561530879|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
155575838|NCT00866359|561530880|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
155575839|NCT00866359|561530881|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
155575840|NCT00866359|561530882|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
155575841|NCT00866359|561530879|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
155575842|NCT00866359|561530880|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
155575843|NCT00866359|561530881|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
155575844|NCT00866359|561530882|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
155575845|NCT00866359|561530879|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
155575846|NCT00866359|561530880|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
155575847|NCT00866359|561530881|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
155575848|NCT00866359|561530882|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
155575849|NCT02163057|561530883|FG000|Overall Study|Participant Refusal to Continue|2|||
155575850|NCT02163057|561530884|FG001|Overall Study|Participant Refusal to Continue|2|||
155575851|NCT02163057|561530883|FG000|Overall Study|Participant Significant Noncompliance|0|||
155575852|NCT02163057|561530884|FG001|Overall Study|Participant Significant Noncompliance|1|||
155575853|NCT02163057|561530883|FG000|Overall Study|Progression of Disease|1|||
155575854|NCT02163057|561530884|FG001|Overall Study|Progression of Disease|2|||
155575855|NCT01625091|561530885|FG000|Intervention|Death|1|||
155575856|NCT01625091|561530886|FG001|Intervention|Death|1|||
155575857|NCT01625091|561530885|FG000|Intervention|Withdrawal by Subject|4|||
155575858|NCT01625091|561530886|FG001|Intervention|Withdrawal by Subject|1|||
155575859|NCT01625091|561530885|FG000|Intervention|Adverse Event|0|||
155575860|NCT01625091|561530886|FG001|Intervention|Adverse Event|2|||
155575861|NCT01625091|561530885|FG000|Intervention|Lost to Follow-up|4|||
155575862|NCT01625091|561530886|FG001|Intervention|Lost to Follow-up|4|||
155575863|NCT01625091|561530885|FG000|Intervention|Study termination|2|||
155575864|NCT01625091|561530886|FG001|Intervention|Study termination|3|||
155575865|NCT01625091|561530885|FG000|Post-intervention|Death|0|||
155575866|NCT01625091|561530886|FG001|Post-intervention|Death|1|||
155575867|NCT01625091|561530885|FG000|Post-intervention|Lost to Follow-up|2|||
155575868|NCT01625091|561530886|FG001|Post-intervention|Lost to Follow-up|0|||
155575869|NCT01625091|561530885|FG000|Post-intervention|Study termination|2|||
155575870|NCT01625091|561530886|FG001|Post-intervention|Study termination|1|||
155575871|NCT01547390|561530890|FG000|Overall Study|Withdrawal by Subject|10|||
155575872|NCT01547390|561530891|FG001|Overall Study|Withdrawal by Subject|7|||
155575873|NCT01547390|561530890|FG000|Overall Study|termination of pregnancy|0|||
155575874|NCT01547390|561530891|FG001|Overall Study|termination of pregnancy|1|||
155575875|NCT01547390|561530890|FG000|Overall Study|Lost to Follow-up|0|||
155575876|NCT01547390|561530891|FG001|Overall Study|Lost to Follow-up|2|||
155575877|NCT01547390|561530890|FG000|Overall Study|Adverse Event|3|||
155575878|NCT01547390|561530891|FG001|Overall Study|Adverse Event|0|||
155575879|NCT04917861|561530895|FG000|Main Study (196 Days)|Adverse Event|0|||
155575880|NCT04917861|561530896|FG001|Main Study (196 Days)|Adverse Event|1|||
155575881|NCT04917861|561530897|FG002|Main Study (196 Days)|Adverse Event|0|||
155575882|NCT04917861|561530898|FG003|Main Study (196 Days)|Adverse Event|0|||
155575883|NCT04917861|561530895|FG000|Main Study (196 Days)|Death|0|||
155575884|NCT04917861|561530896|FG001|Main Study (196 Days)|Death|0|||
155575885|NCT04917861|561530897|FG002|Main Study (196 Days)|Death|0|||
155575886|NCT04917861|561530898|FG003|Main Study (196 Days)|Death|1|||
155575887|NCT04917861|561530895|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
155575888|NCT04917861|561530896|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
155575889|NCT04917861|561530897|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
155575890|NCT04917861|561530898|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
155575891|NCT04917861|561530895|FG000|Main Study (196 Days)|Physician Decision|0|||
155575892|NCT04917861|561530896|FG001|Main Study (196 Days)|Physician Decision|0|||
155575893|NCT04917861|561530897|FG002|Main Study (196 Days)|Physician Decision|0|||
155575894|NCT04917861|561530898|FG003|Main Study (196 Days)|Physician Decision|1|||
155575895|NCT04917861|561530895|FG000|Main Study (196 Days)|Pregnancy|1|||
155575896|NCT04917861|561530896|FG001|Main Study (196 Days)|Pregnancy|1|||
155575897|NCT04917861|561530897|FG002|Main Study (196 Days)|Pregnancy|0|||
155575898|NCT04917861|561530898|FG003|Main Study (196 Days)|Pregnancy|0|||
155575899|NCT04917861|561530895|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
155575900|NCT04917861|561530896|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
155575901|NCT04917861|561530897|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
155575902|NCT04917861|561530898|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
155575903|NCT04917861|561530895|FG000|Main Study (196 Days)|Other Than Specified|1|||
155575904|NCT04917861|561530896|FG001|Main Study (196 Days)|Other Than Specified|0|||
155575905|NCT04917861|561530897|FG002|Main Study (196 Days)|Other Than Specified|1|||
155575906|NCT04917861|561530898|FG003|Main Study (196 Days)|Other Than Specified|2|||
155575907|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
155661560|NCT00431964|561856562|FG000|Overall Study|Parental Consent Withdrawn|0|||
155661561|NCT00431964|561856563|FG001|Overall Study|Parental Consent Withdrawn|2|||
155661562|NCT00431964|561856562|FG000|Overall Study|Due to Unstable Health|0|||
155661563|NCT00431964|561856563|FG001|Overall Study|Due to Unstable Health|1|||
155661564|NCT00016354|561856573|FG000|Overall Study|Lack of Efficacy|0|||
155661565|NCT00016354|561856574|FG001|Overall Study|Lack of Efficacy|0|||
155661566|NCT00016354|561856575|FG002|Overall Study|Lack of Efficacy|0|||
155661567|NCT00016354|561856576|FG003|Overall Study|Lack of Efficacy|0|||
155661568|NCT00016354|561856577|FG004|Overall Study|Lack of Efficacy|0|||
155575908|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
155575909|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
155575910|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
155575911|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155661569|NCT00016354|561856578|FG005|Overall Study|Lack of Efficacy|0|||
155661570|NCT00016354|561856579|FG006|Overall Study|Lack of Efficacy|0|||
155575912|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
155575913|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155575914|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155575915|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155661571|NCT00016354|561856580|FG007|Overall Study|Lack of Efficacy|1|||
155575916|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
155575917|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155575918|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155575919|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
155575920|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
155575921|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
155575922|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
155575923|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155575924|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
155575925|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155575926|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155575927|NCT04917861|561530895|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
155575928|NCT04917861|561530896|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
155575929|NCT04917861|561530897|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
155575930|NCT04917861|561530898|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
155575931|NCT01128179|561530899|FG000|Overall Study|Death|1|||
155575932|NCT01128179|561530900|FG001|Overall Study|Death|0|||
155575933|NCT01128179|561530899|FG000|Overall Study|Protocol Violation|1|||
155575934|NCT01128179|561530900|FG001|Overall Study|Protocol Violation|0|||
155575935|NCT02694328|561530902|FG000|Overall Study|Adverse Event|27|||
155575936|NCT02694328|561530903|FG001|Overall Study|Adverse Event|33|||
155575937|NCT02694328|561530902|FG000|Overall Study|Withdrawal by Subject|27|||
155575938|NCT02694328|561530903|FG001|Overall Study|Withdrawal by Subject|23|||
155575939|NCT02694328|561530902|FG000|Overall Study|Lost to Follow-up|26|||
155575940|NCT02694328|561530903|FG001|Overall Study|Lost to Follow-up|22|||
155575941|NCT02694328|561530902|FG000|Overall Study|Noncompliant with study drug|11|||
155575942|NCT02694328|561530903|FG001|Overall Study|Noncompliant with study drug|8|||
155575943|NCT02694328|561530902|FG000|Overall Study|Incarceration|1|||
155575944|NCT02694328|561530903|FG001|Overall Study|Incarceration|1|||
155575945|NCT02694328|561530902|FG000|Overall Study|Lack of Efficacy|1|||
155575946|NCT02694328|561530903|FG001|Overall Study|Lack of Efficacy|2|||
155575947|NCT02694328|561530902|FG000|Overall Study|Pregnancy|1|||
155575948|NCT02694328|561530903|FG001|Overall Study|Pregnancy|1|||
155575949|NCT02694328|561530902|FG000|Overall Study|Protocol Violation|6|||
155575950|NCT02694328|561530903|FG001|Overall Study|Protocol Violation|5|||
155575951|NCT02694328|561530902|FG000|Overall Study|Abnormal Laboratory Value|0|||
155575952|NCT02694328|561530903|FG001|Overall Study|Abnormal Laboratory Value|3|||
155575953|NCT00720382|561530905|FG000|Overall Study|Adverse Event|54|||
155575954|NCT00720382|561530906|FG001|Overall Study|Adverse Event|17|||
155575955|NCT00720382|561530905|FG000|Overall Study|Lack of Efficacy|18|||
155575956|NCT00720382|561530906|FG001|Overall Study|Lack of Efficacy|7|||
155575957|NCT00720382|561530905|FG000|Overall Study|Non-Compliance|15|||
155575958|NCT00720382|561530906|FG001|Overall Study|Non-Compliance|5|||
155575959|NCT00720382|561530905|FG000|Overall Study|Withdrawal by Subject|47|||
155575960|NCT00720382|561530906|FG001|Overall Study|Withdrawal by Subject|11|||
155575961|NCT00720382|561530905|FG000|Overall Study|Lost to Follow-up|28|||
155575962|NCT00720382|561530906|FG001|Overall Study|Lost to Follow-up|14|||
155575963|NCT00720382|561530905|FG000|Overall Study|administrative|14|||
155575964|NCT00720382|561530906|FG001|Overall Study|administrative|5|||
155575965|NCT05192889|561530907|FG000|Block 1: All Eligible Patients|Death|2|||
155575966|NCT05192889|561530908|FG001|Block 1: All Eligible Patients|Death|0|||
155575967|NCT05192889|561530909|FG002|Block 1: All Eligible Patients|Death|0|||
155575968|NCT05192889|561530907|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
155575969|NCT05192889|561530908|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
155575970|NCT05192889|561530909|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
155575971|NCT05192889|561530907|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
155575972|NCT05192889|561530908|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
155575973|NCT05192889|561530909|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
155575974|NCT00265759|561532784|FG000|Overall Study|Withdrawal by Subject|0|||
155575975|NCT00265759|561532785|FG001|Overall Study|Withdrawal by Subject|1|||
155575976|NCT00265759|561532786|FG002|Overall Study|Withdrawal by Subject|2|||
155575977|NCT00265759|561532787|FG003|Overall Study|Withdrawal by Subject|2|||
155575978|NCT00265759|561532784|FG000|Overall Study|Cancel|0|||
155575979|NCT00265759|561532785|FG001|Overall Study|Cancel|0|||
155575980|NCT00265759|561532786|FG002|Overall Study|Cancel|0|||
155575981|NCT00265759|561532787|FG003|Overall Study|Cancel|3|||
155575982|NCT00265759|561532784|FG000|Overall Study|Ineligible|0|||
155575983|NCT00265759|561532785|FG001|Overall Study|Ineligible|0|||
155575984|NCT00265759|561532786|FG002|Overall Study|Ineligible|0|||
155575985|NCT00265759|561532787|FG003|Overall Study|Ineligible|1|||
155575986|NCT00265759|561532784|FG000|Overall Study|Bilateral disease|0|||
155575987|NCT00265759|561532785|FG001|Overall Study|Bilateral disease|0|||
155575988|NCT00265759|561532786|FG002|Overall Study|Bilateral disease|0|||
155575989|NCT00265759|561532787|FG003|Overall Study|Bilateral disease|2|||
155575990|NCT00265759|561532784|FG000|Overall Study|Discontinued due to intolerability|0|||
155575991|NCT00265759|561532785|FG001|Overall Study|Discontinued due to intolerability|0|||
155575992|NCT00265759|561532786|FG002|Overall Study|Discontinued due to intolerability|0|||
155575993|NCT00265759|561532787|FG003|Overall Study|Discontinued due to intolerability|1|||
155575994|NCT03713593|561532789|FG000|Overall Study|Sponsor Decision|73|||
155575995|NCT03713593|561532790|FG001|Overall Study|Sponsor Decision|41|||
155575996|NCT03713593|561532789|FG000|Overall Study|Lost to Follow-up|2|||
155575997|NCT03713593|561532790|FG001|Overall Study|Lost to Follow-up|1|||
155575998|NCT03713593|561532789|FG000|Overall Study|Death|314|||
155575999|NCT03713593|561532790|FG001|Overall Study|Death|349|||
155576000|NCT03713593|561532789|FG000|Overall Study|Withdrawal by Subject|6|||
155576001|NCT03713593|561532790|FG001|Overall Study|Withdrawal by Subject|8|||
155576002|NCT05061134|561532791|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
155576003|NCT05061134|561532792|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
155576004|NCT05061134|561532793|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
155576005|NCT05061134|561532791|FG000|Overall Study|Subject not treated|0|||
155576006|NCT05061134|561532792|FG001|Overall Study|Subject not treated|0|||
155576007|NCT05061134|561532793|FG002|Overall Study|Subject not treated|2|||
155576008|NCT05061134|561532791|FG000|Overall Study|Other|0|||
155576009|NCT05061134|561532792|FG001|Overall Study|Other|0|||
155576010|NCT05061134|561532793|FG002|Overall Study|Other|9|||
155576011|NCT05061134|561532791|FG000|Overall Study|Withdrawal by Subject|9|||
155576012|NCT05061134|561532792|FG001|Overall Study|Withdrawal by Subject|8|||
155576013|NCT05061134|561532793|FG002|Overall Study|Withdrawal by Subject|5|||
155576014|NCT05061134|561532791|FG000|Overall Study|Study Terminated by Sponsor|22|||
155576015|NCT05061134|561532792|FG001|Overall Study|Study Terminated by Sponsor|14|||
155576016|NCT05061134|561532793|FG002|Overall Study|Study Terminated by Sponsor|7|||
155576017|NCT05061134|561532791|FG000|Overall Study|Progressive Disease|1|||
155576018|NCT05061134|561532792|FG001|Overall Study|Progressive Disease|2|||
155576019|NCT05061134|561532793|FG002|Overall Study|Progressive Disease|0|||
155576020|NCT05061134|561532791|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
155576021|NCT05061134|561532792|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
155576022|NCT05061134|561532793|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
155576023|NCT05061134|561532791|FG000|Overall Study|Lost to Follow-up|1|||
155576024|NCT05061134|561532792|FG001|Overall Study|Lost to Follow-up|0|||
155576025|NCT05061134|561532793|FG002|Overall Study|Lost to Follow-up|0|||
155576026|NCT05061134|561532791|FG000|Overall Study|Physician Decision|1|||
155576027|NCT05061134|561532792|FG001|Overall Study|Physician Decision|1|||
155576028|NCT05061134|561532793|FG002|Overall Study|Physician Decision|0|||
155576029|NCT05061134|561532791|FG000|Overall Study|Disease progression|1|||
155576030|NCT05061134|561532792|FG001|Overall Study|Disease progression|0|||
155576031|NCT05061134|561532793|FG002|Overall Study|Disease progression|0|||
155576032|NCT05061134|561532791|FG000|Overall Study|Death|43|||
155576033|NCT05061134|561532792|FG001|Overall Study|Death|23|||
155576034|NCT05061134|561532793|FG002|Overall Study|Death|14|||
155576035|NCT05061134|561532791|FG000|Overall Study|Database lock|2|||
155576036|NCT05061134|561532792|FG001|Overall Study|Database lock|0|||
155576037|NCT05061134|561532793|FG002|Overall Study|Database lock|0|||
155576038|NCT03176134|561532794|FG000|Overall Study|Lost to Follow-up|0|||
155576039|NCT03176134|561532795|FG001|Overall Study|Lost to Follow-up|2|||
155576040|NCT03176134|561532796|FG002|Overall Study|Lost to Follow-up|0|||
155576041|NCT03176134|561532797|FG003|Overall Study|Lost to Follow-up|0|||
155661572|NCT03193801|561856581|FG000|Overall Study|Physician Decision|2|||
155576042|NCT03176134|561532798|FG004|Overall Study|Lost to Follow-up|0|||
155576043|NCT03176134|561532799|FG005|Overall Study|Lost to Follow-up|0|||
155576044|NCT03176134|561532800|FG006|Overall Study|Lost to Follow-up|0|||
155576045|NCT03176134|561532801|FG007|Overall Study|Lost to Follow-up|0|||
155576046|NCT03176134|561532794|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155576047|NCT03176134|561532795|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155576048|NCT03176134|561532796|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155576049|NCT03176134|561532797|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155576050|NCT03176134|561532798|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155576051|NCT03176134|561532799|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155576052|NCT03176134|561532800|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
155576053|NCT03176134|561532801|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
155576054|NCT03410056|561532806|FG000|Overall Study|Decision by Sponsor|0|||
155576055|NCT03410056|561532807|FG001|Overall Study|Decision by Sponsor|0|||
155576056|NCT03410056|561532808|FG002|Overall Study|Decision by Sponsor|3|||
155576057|NCT03410056|561532809|FG003|Overall Study|Decision by Sponsor|0|||
155576058|NCT03410056|561532810|FG004|Overall Study|Decision by Sponsor|0|||
155576059|NCT03410056|561532811|FG005|Overall Study|Decision by Sponsor|0|||
155576060|NCT03410056|561532812|FG006|Overall Study|Decision by Sponsor|0|||
155576061|NCT03410056|561532806|FG000|Overall Study|Withdrawal by Subject|0|||
155576062|NCT03410056|561532807|FG001|Overall Study|Withdrawal by Subject|2|||
155576063|NCT03410056|561532808|FG002|Overall Study|Withdrawal by Subject|5|||
155576064|NCT03410056|561532809|FG003|Overall Study|Withdrawal by Subject|5|||
155576065|NCT03410056|561532810|FG004|Overall Study|Withdrawal by Subject|0|||
155576066|NCT03410056|561532811|FG005|Overall Study|Withdrawal by Subject|0|||
155576067|NCT03410056|561532812|FG006|Overall Study|Withdrawal by Subject|0|||
155576068|NCT01996241|561532814|FG000|Overall Study|Lost to Follow-up|252|||
155576069|NCT01996241|561532815|FG001|Overall Study|Lost to Follow-up|235|||
155576070|NCT01811472|561532816|FG000|Overall Study|Adverse Event|1|||
155576071|NCT01811472|561532817|FG001|Overall Study|Adverse Event|0|||
155576072|NCT01811472|561532818|FG002|Overall Study|Adverse Event|4|||
155576073|NCT01811472|561532816|FG000|Overall Study|Lost to Follow-up|0|||
155576074|NCT01811472|561532817|FG001|Overall Study|Lost to Follow-up|0|||
155576075|NCT01811472|561532818|FG002|Overall Study|Lost to Follow-up|1|||
155576076|NCT01811472|561532816|FG000|Overall Study|Subject/guardian decision|1|||
155576077|NCT01811472|561532817|FG001|Overall Study|Subject/guardian decision|0|||
155576078|NCT01811472|561532818|FG002|Overall Study|Subject/guardian decision|0|||
155576079|NCT04882241|561532821|FG000|Overall Study|Ongoing in study|46|||
155576080|NCT04882241|561532822|FG001|Overall Study|Ongoing in study|48|||
155576081|NCT04882241|561532823|FG002|Overall Study|Ongoing in study|0|||
155576082|NCT04882241|561532824|FG003|Overall Study|Ongoing in study|0|||
155576083|NCT04882241|561532821|FG000|Overall Study|Death|13|||
155576084|NCT04882241|561532822|FG001|Overall Study|Death|13|||
155576085|NCT04882241|561532823|FG002|Overall Study|Death|0|||
155576086|NCT04882241|561532824|FG003|Overall Study|Death|0|||
155576087|NCT04108299|561532830|FG000|Overall Study|Not interested in participating|2|||
155576088|NCT04108299|561532831|FG001|Overall Study|Not interested in participating|1|||
155576089|NCT04108299|561532832|FG002|Overall Study|Not interested in participating|2|||
155576090|NCT04108299|561532833|FG003|Overall Study|Not interested in participating|1|||
155576091|NCT02105467|561532841|FG000|Period 1|Lost to Follow-up|1|||
155576092|NCT02105467|561532842|FG001|Period 1|Lost to Follow-up|0|||
155576093|NCT02105467|561532841|FG000|Period 1|Death|1|||
155576094|NCT02105467|561532842|FG001|Period 1|Death|0|||
155576095|NCT02105467|561532841|FG000|Period 2|Lost to Follow-up|1|||
155576096|NCT02105467|561532842|FG001|Period 2|Lost to Follow-up|0|||
155576097|NCT02105467|561532841|FG000|Period 2|Death|1|||
155576098|NCT02105467|561532842|FG001|Period 2|Death|0|||
155576099|NCT02105467|561532841|FG000|Period 2|Withdrawal by Subject|0|||
155576100|NCT02105467|561532842|FG001|Period 2|Withdrawal by Subject|2|||
155576101|NCT02105467|561532841|FG000|Period 3|Lost to Follow-up|0|||
155576102|NCT02105467|561532842|FG001|Period 3|Lost to Follow-up|1|||
155576103|NCT03908125|561532843|FG000|Overall Study|Withdrawal by Subject|92|||
155576104|NCT03908125|561532843|FG000|Overall Study|Lost to Follow-up|8|||
155576105|NCT02676882|561532844|FG000|Overall Study|Adverse Event|1|||
155576106|NCT02676882|561532845|FG001|Overall Study|Adverse Event|0|||
155576107|NCT02676882|561532844|FG000|Overall Study|Lost to Follow-up|1|||
155576108|NCT02676882|561532845|FG001|Overall Study|Lost to Follow-up|0|||
155576109|NCT02676882|561532844|FG000|Overall Study|Withdrawal by Subject|1|||
155576110|NCT02676882|561532845|FG001|Overall Study|Withdrawal by Subject|2|||
155576111|NCT01071915|561532849|FG000|Overall Study|Adverse Event|3|||
155576112|NCT01071915|561532849|FG000|Overall Study|Physician Decision|2|||
155576113|NCT01071915|561532849|FG000|Overall Study|Withdrawal by Subject|2|||
155576114|NCT01071915|561532849|FG000|Overall Study|Miscellaneous Reasons|2|||
155576115|NCT00958828|561532851|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
155576116|NCT00958828|561532852|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
155576117|NCT00958828|561532851|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
155576118|NCT00958828|561532852|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
155576119|NCT03885661|561532855|FG000|Overall Study|Withdrawal by Subject|0|||
155576120|NCT03885661|561532856|FG001|Overall Study|Withdrawal by Subject|1|||
155576121|NCT03885661|561532855|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
155576122|NCT03885661|561532856|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
155576123|NCT00344448|561532857|FG000|Screening|Withdrawal by Subject|0|||
155576124|NCT00344448|561532858|FG001|Screening|Withdrawal by Subject|1|||
155576125|NCT00344448|561532857|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
155576126|NCT00344448|561532858|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
155576127|NCT00344448|561532857|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
155576128|NCT00344448|561532858|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
155576129|NCT00344448|561532857|FG000|Open Label|Withdrawal by Subject|1|||
155576130|NCT00344448|561532858|FG001|Open Label|Withdrawal by Subject|1|||
155576131|NCT00344448|561532857|FG000|Open Label|Study terminated|1|||
155576132|NCT00344448|561532858|FG001|Open Label|Study terminated|0|||
155576133|NCT02441686|561532859|FG000|Induction|Adverse Event|4|||
155576134|NCT02441686|561532859|FG000|Induction|Complicating disease|1|||
155576135|NCT02441686|561532859|FG000|Induction|Physician Decision|1|||
155576136|NCT02441686|561532859|FG000|Induction|Withdrawal by Subject|1|||
155576137|NCT02441686|561532859|FG000|Induction|Did not receive treatment|1|||
155576138|NCT02441686|561532859|FG000|Maintenance|Remaining on Treatment|23|||
155576139|NCT02441686|561532859|FG000|Maintenance|Physician Decision|1|||
155576140|NCT02441686|561532859|FG000|Maintenance|Adverse Event|3|||
155576141|NCT02441686|561532859|FG000|Maintenance|Progressive Disease|10|||
155576142|NCT02441686|561532859|FG000|Maintenance|Withdrawal by Subject|1|||
155576143|NCT04194645|561532862|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576144|NCT04194645|561532863|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576145|NCT04194645|561532864|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576146|NCT04194645|561532865|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576147|NCT04194645|561532866|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576148|NCT04194645|561532867|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576149|NCT04194645|561532868|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576150|NCT04194645|561532869|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576151|NCT04194645|561532870|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576152|NCT04194645|561532871|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
155576153|NCT04194645|561532872|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576154|NCT04194645|561532873|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576155|NCT04194645|561532874|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576156|NCT04194645|561532875|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576157|NCT04194645|561532876|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155576158|NCT03656744|561532877|FG000|Overall Study|Adverse Event|1|||
155576159|NCT03656744|561532878|FG001|Overall Study|Adverse Event|4|||
155576160|NCT03656744|561532879|FG002|Overall Study|Adverse Event|1|||
155576161|NCT03656744|561532877|FG000|Overall Study|Protocol Violation|1|||
155576162|NCT03656744|561532878|FG001|Overall Study|Protocol Violation|0|||
155576163|NCT03656744|561532879|FG002|Overall Study|Protocol Violation|0|||
155576164|NCT03656744|561532877|FG000|Overall Study|Lost to Follow-up|2|||
155576165|NCT03656744|561532878|FG001|Overall Study|Lost to Follow-up|2|||
155576166|NCT03656744|561532879|FG002|Overall Study|Lost to Follow-up|0|||
155576167|NCT03656744|561532877|FG000|Overall Study|Withdrawal by Subject|0|||
155576168|NCT03656744|561532878|FG001|Overall Study|Withdrawal by Subject|1|||
155576169|NCT03656744|561532879|FG002|Overall Study|Withdrawal by Subject|0|||
155576170|NCT03656744|561532877|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
155661573|NCT03193801|561856581|FG000|Overall Study|Withdrawal by Subject|1|||
155576171|NCT03656744|561532878|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
155576172|NCT03656744|561532879|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
155576173|NCT03076775|561532880|FG000|Overall Study|Lost to Follow-up|1|||
155576174|NCT03076775|561532881|FG001|Overall Study|Lost to Follow-up|0|||
155576175|NCT00940316|561532882|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
155661574|NCT03110562|561856582|FG000|Initial Treatment Period|Disease Progression|1|||
155661575|NCT03110562|561856583|FG001|Initial Treatment Period|Disease Progression|1|||
155661576|NCT03110562|561856584|FG002|Initial Treatment Period|Disease Progression|0|||
155576176|NCT00940316|561532883|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
155576177|NCT00940316|561532884|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
155576178|NCT00940316|561532882|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
155576179|NCT00940316|561532883|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
155576180|NCT00940316|561532884|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
155576181|NCT00940316|561532882|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
155661577|NCT03110562|561856585|FG003|Initial Treatment Period|Disease Progression|0|||
155576182|NCT00940316|561532883|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
155661578|NCT03110562|561856582|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
155661579|NCT03110562|561856583|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
155661580|NCT03110562|561856584|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
155661581|NCT03110562|561856585|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
155661582|NCT03110562|561856582|FG000|Initial Treatment Period|Adverse Event|1|||
155661583|NCT03110562|561856583|FG001|Initial Treatment Period|Adverse Event|0|||
155661584|NCT03110562|561856584|FG002|Initial Treatment Period|Adverse Event|0|||
155661585|NCT03110562|561856585|FG003|Initial Treatment Period|Adverse Event|0|||
155661586|NCT03110562|561856582|FG000|Initial Treatment Period|Death|74|||
155661587|NCT03110562|561856583|FG001|Initial Treatment Period|Death|82|||
155661588|NCT03110562|561856584|FG002|Initial Treatment Period|Death|0|||
155661589|NCT03110562|561856585|FG003|Initial Treatment Period|Death|0|||
155661590|NCT03110562|561856582|FG000|Initial Treatment Period|Lost to Follow-up|13|||
155661591|NCT03110562|561856583|FG001|Initial Treatment Period|Lost to Follow-up|8|||
155661592|NCT03110562|561856584|FG002|Initial Treatment Period|Lost to Follow-up|0|||
155661593|NCT03110562|561856585|FG003|Initial Treatment Period|Lost to Follow-up|0|||
155661594|NCT03110562|561856582|FG000|Initial Treatment Period|Protocol Deviation|1|||
155661595|NCT03110562|561856583|FG001|Initial Treatment Period|Protocol Deviation|0|||
155661596|NCT03110562|561856584|FG002|Initial Treatment Period|Protocol Deviation|0|||
155661597|NCT03110562|561856585|FG003|Initial Treatment Period|Protocol Deviation|0|||
155661598|NCT03110562|561856582|FG000|Initial Treatment Period|Physician Decision|2|||
155661599|NCT03110562|561856583|FG001|Initial Treatment Period|Physician Decision|1|||
155576183|NCT00940316|561532884|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
155576184|NCT00940316|561532882|FG000|Treated After Cycle 5|Adverse Event|0|||
155576185|NCT00940316|561532883|FG001|Treated After Cycle 5|Adverse Event|0|||
155576186|NCT00940316|561532884|FG002|Treated After Cycle 5|Adverse Event|1|||
155576187|NCT00940316|561532882|FG000|Treated After Cycle 5|Progressive disease|0|||
155576188|NCT00940316|561532883|FG001|Treated After Cycle 5|Progressive disease|1|||
155576189|NCT00940316|561532884|FG002|Treated After Cycle 5|Progressive disease|0|||
155576190|NCT00996489|561532887|FG000|Overall Study|Device failure|45|||
155576191|NCT00996489|561532887|FG000|Overall Study|Discontinued|116|||
155576192|NCT00129545|561532890|FG000|Overall Study|Death|5|||
155576193|NCT00129545|561532891|FG001|Overall Study|Death|60|||
155576194|NCT00129545|561532892|FG002|Overall Study|Death|44|||
155576195|NCT00129545|561532890|FG000|Overall Study|Withdrawal by Subject|3|||
155576196|NCT00129545|561532891|FG001|Overall Study|Withdrawal by Subject|18|||
155576197|NCT00129545|561532892|FG002|Overall Study|Withdrawal by Subject|44|||
155576198|NCT00129545|561532890|FG000|Overall Study|Lost to Follow-up|2|||
155576199|NCT00129545|561532891|FG001|Overall Study|Lost to Follow-up|22|||
155576200|NCT00129545|561532892|FG002|Overall Study|Lost to Follow-up|13|||
155576201|NCT00129545|561532890|FG000|Overall Study|Physician Decision|0|||
155576202|NCT00129545|561532891|FG001|Overall Study|Physician Decision|3|||
155576203|NCT00129545|561532892|FG002|Overall Study|Physician Decision|10|||
155576204|NCT00129545|561532890|FG000|Overall Study|Device not implanted|16|||
155576205|NCT00129545|561532891|FG001|Overall Study|Device not implanted|61|||
155576206|NCT00129545|561532892|FG002|Overall Study|Device not implanted|0|||
155576207|NCT03541317|561532897|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
155576208|NCT03541317|561532898|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155576209|NCT03541317|561532899|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155576210|NCT03541317|561532900|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155576211|NCT03541317|561532901|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155576212|NCT03541317|561532902|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155576213|NCT00879086|561532903|FG000|Overall Study|Adverse Event|3|||
155576214|NCT00879086|561532904|FG001|Overall Study|Adverse Event|15|||
155576215|NCT00879086|561532903|FG000|Overall Study|Participant choice|2|||
155576216|NCT00879086|561532904|FG001|Overall Study|Participant choice|2|||
155576217|NCT00879086|561532903|FG000|Overall Study|Progression of disease|40|||
155576218|NCT00879086|561532904|FG001|Overall Study|Progression of disease|26|||
155576219|NCT00879086|561532903|FG000|Overall Study|Withdrawal of consent|2|||
155576220|NCT00879086|561532904|FG001|Overall Study|Withdrawal of consent|1|||
155576221|NCT00879086|561532903|FG000|Overall Study|Other|4|||
155576222|NCT00879086|561532904|FG001|Overall Study|Other|6|||
155576223|NCT00879086|561532903|FG000|Overall Study|Death|1|||
155576224|NCT00879086|561532904|FG001|Overall Study|Death|2|||
155576225|NCT02286843|561532907|FG000|Overall Study|Not Treated|4|||
155576226|NCT02286843|561532907|FG000|Overall Study|Protocol Violation|1|||
155576227|NCT02286843|561532907|FG000|Overall Study|Withdrawal by Subject|1|||
155576228|NCT02536846|561532908|FG000|Overall Study|Withdrawal by Subject|1|||
155576229|NCT00111241|561532910|FG000|Overall Study|Lost to Follow-up|1|||
155576230|NCT00111241|561532911|FG001|Overall Study|Lost to Follow-up|0|||
155661600|NCT03110562|561856584|FG002|Initial Treatment Period|Physician Decision|0|||
155661601|NCT03110562|561856585|FG003|Initial Treatment Period|Physician Decision|0|||
155576231|NCT00111241|561532910|FG000|Overall Study|Withdrawal by Subject|4|||
155576232|NCT00111241|561532911|FG001|Overall Study|Withdrawal by Subject|0|||
155576233|NCT00111241|561532910|FG000|Overall Study|Protocol Violation|9|||
155576234|NCT00111241|561532911|FG001|Overall Study|Protocol Violation|8|||
155576235|NCT00111241|561532910|FG000|Overall Study|Adverse Event|1|||
155576236|NCT00111241|561532911|FG001|Overall Study|Adverse Event|0|||
155576237|NCT02445963|561532913|FG000|Overall Study|Lost to Follow-up|1|||
155576238|NCT02445963|561532914|FG001|Overall Study|Lost to Follow-up|0|||
155576239|NCT02445963|561532915|FG002|Overall Study|Lost to Follow-up|0|||
155576240|NCT02445963|561532916|FG003|Overall Study|Lost to Follow-up|0|||
155576241|NCT02445963|561532913|FG000|Overall Study|Change in employment|1|||
155576242|NCT02445963|561532914|FG001|Overall Study|Change in employment|0|||
155576243|NCT02445963|561532915|FG002|Overall Study|Change in employment|0|||
155576244|NCT02445963|561532916|FG003|Overall Study|Change in employment|0|||
155576245|NCT02445963|561532913|FG000|Overall Study|Symptoms post-vaccination|0|||
155576246|NCT02445963|561532914|FG001|Overall Study|Symptoms post-vaccination|0|||
155576247|NCT02445963|561532915|FG002|Overall Study|Symptoms post-vaccination|1|||
155576248|NCT02445963|561532916|FG003|Overall Study|Symptoms post-vaccination|0|||
155576249|NCT01957176|561532920|FG000|Overall Study|Adverse Event|2|||
155576250|NCT01957176|561532921|FG001|Overall Study|Adverse Event|0|||
155576251|NCT01957176|561532920|FG000|Overall Study|Physician Decision|2|||
155576252|NCT01957176|561532921|FG001|Overall Study|Physician Decision|1|||
155576253|NCT01957176|561532920|FG000|Overall Study|Withdrawal by Subject|1|||
155576254|NCT01957176|561532921|FG001|Overall Study|Withdrawal by Subject|0|||
155576255|NCT01449812|561532922|FG000|Overall Study|Migrated/moved from study area|1|||
155576256|NCT01449812|561532923|FG001|Overall Study|Migrated/moved from study area|0|||
155576257|NCT01449812|561532924|FG002|Overall Study|Migrated/moved from study area|0|||
155576258|NCT01449812|561532922|FG000|Overall Study|Withdrawal by Subject|0|||
155576259|NCT01449812|561532923|FG001|Overall Study|Withdrawal by Subject|0|||
155576260|NCT01449812|561532924|FG002|Overall Study|Withdrawal by Subject|1|||
155576261|NCT01449812|561532922|FG000|Overall Study|Lost to Follow-up|1|||
155576262|NCT01449812|561532923|FG001|Overall Study|Lost to Follow-up|0|||
155576263|NCT01449812|561532924|FG002|Overall Study|Lost to Follow-up|0|||
155576264|NCT03449446|561532925|FG000|Overall Study|Randomized but Never Treated|0|||
155576265|NCT03449446|561532926|FG001|Overall Study|Randomized but Never Treated|0|||
155576266|NCT03449446|561532927|FG002|Overall Study|Randomized but Never Treated|1|||
155576267|NCT03449446|561532928|FG003|Overall Study|Randomized but Never Treated|1|||
155576268|NCT03449446|561532929|FG004|Overall Study|Randomized but Never Treated|1|||
155576269|NCT03449446|561532930|FG005|Overall Study|Randomized but Never Treated|0|||
155576270|NCT03449446|561532931|FG006|Overall Study|Randomized but Never Treated|0|||
155576271|NCT03449446|561532925|FG000|Overall Study|Unknown Reason|33|||
155576272|NCT03449446|561532926|FG001|Overall Study|Unknown Reason|1|||
155576273|NCT03449446|561532927|FG002|Overall Study|Unknown Reason|1|||
155576274|NCT03449446|561532928|FG003|Overall Study|Unknown Reason|1|||
155576275|NCT03449446|561532929|FG004|Overall Study|Unknown Reason|2|||
155576276|NCT03449446|561532930|FG005|Overall Study|Unknown Reason|2|||
155576277|NCT03449446|561532931|FG006|Overall Study|Unknown Reason|0|||
155576278|NCT03449446|561532925|FG000|Overall Study|Withdrew Consent|1|||
155576279|NCT03449446|561532926|FG001|Overall Study|Withdrew Consent|3|||
155576280|NCT03449446|561532927|FG002|Overall Study|Withdrew Consent|1|||
155576281|NCT03449446|561532928|FG003|Overall Study|Withdrew Consent|4|||
155576282|NCT03449446|561532929|FG004|Overall Study|Withdrew Consent|4|||
155576283|NCT03449446|561532930|FG005|Overall Study|Withdrew Consent|4|||
155576284|NCT03449446|561532931|FG006|Overall Study|Withdrew Consent|1|||
155576285|NCT03449446|561532925|FG000|Overall Study|Adverse Event|1|||
155576286|NCT03449446|561532926|FG001|Overall Study|Adverse Event|2|||
155576287|NCT03449446|561532927|FG002|Overall Study|Adverse Event|1|||
155576288|NCT03449446|561532928|FG003|Overall Study|Adverse Event|0|||
155576289|NCT03449446|561532929|FG004|Overall Study|Adverse Event|0|||
155576290|NCT03449446|561532930|FG005|Overall Study|Adverse Event|2|||
155576291|NCT03449446|561532931|FG006|Overall Study|Adverse Event|0|||
155576292|NCT03449446|561532925|FG000|Overall Study|Lost to Follow-up|0|||
155576293|NCT03449446|561532926|FG001|Overall Study|Lost to Follow-up|0|||
155576294|NCT03449446|561532927|FG002|Overall Study|Lost to Follow-up|2|||
155576295|NCT03449446|561532928|FG003|Overall Study|Lost to Follow-up|1|||
155576296|NCT03449446|561532929|FG004|Overall Study|Lost to Follow-up|3|||
155576297|NCT03449446|561532930|FG005|Overall Study|Lost to Follow-up|0|||
155576298|NCT03449446|561532931|FG006|Overall Study|Lost to Follow-up|0|||
155576299|NCT03449446|561532925|FG000|Overall Study|Investigator's Discretion|0|||
155576300|NCT03449446|561532926|FG001|Overall Study|Investigator's Discretion|1|||
155576301|NCT03449446|561532927|FG002|Overall Study|Investigator's Discretion|1|||
155576302|NCT03449446|561532928|FG003|Overall Study|Investigator's Discretion|2|||
155576303|NCT03449446|561532929|FG004|Overall Study|Investigator's Discretion|0|||
155576304|NCT03449446|561532930|FG005|Overall Study|Investigator's Discretion|0|||
155576305|NCT03449446|561532931|FG006|Overall Study|Investigator's Discretion|0|||
155576306|NCT03449446|561532925|FG000|Overall Study|Non Compliance with Study Drug|1|||
155576307|NCT03449446|561532926|FG001|Overall Study|Non Compliance with Study Drug|0|||
155661602|NCT03110562|561856582|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
155661603|NCT03110562|561856583|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
155661604|NCT03110562|561856584|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
155661605|NCT03110562|561856585|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
155661606|NCT03110562|561856582|FG000|Initial Treatment Period|Other|5|||
155661607|NCT03110562|561856583|FG001|Initial Treatment Period|Other|4|||
155661608|NCT03110562|561856584|FG002|Initial Treatment Period|Other|0|||
155661609|NCT03110562|561856585|FG003|Initial Treatment Period|Other|0|||
155661610|NCT03110562|561856582|FG000|Initial Treatment Period|Randomized but never treated|0|||
155661611|NCT03110562|561856583|FG001|Initial Treatment Period|Randomized but never treated|3|||
155661612|NCT03110562|561856584|FG002|Initial Treatment Period|Randomized but never treated|0|||
155661613|NCT03110562|561856585|FG003|Initial Treatment Period|Randomized but never treated|0|||
155661614|NCT03110562|561856582|FG000|Crossover Period|Disease Progression|0|||
155661615|NCT03110562|561856583|FG001|Crossover Period|Disease Progression|0|||
155661616|NCT03110562|561856584|FG002|Crossover Period|Disease Progression|1|||
155661617|NCT03110562|561856585|FG003|Crossover Period|Disease Progression|0|||
155661618|NCT03110562|561856582|FG000|Crossover Period|Withdrawal by Subject|0|||
155661619|NCT03110562|561856583|FG001|Crossover Period|Withdrawal by Subject|0|||
155661620|NCT03110562|561856584|FG002|Crossover Period|Withdrawal by Subject|8|||
155661621|NCT03110562|561856585|FG003|Crossover Period|Withdrawal by Subject|6|||
155661622|NCT03110562|561856582|FG000|Crossover Period|Death|0|||
155661623|NCT03110562|561856583|FG001|Crossover Period|Death|0|||
155661624|NCT03110562|561856584|FG002|Crossover Period|Death|37|||
155661625|NCT03110562|561856585|FG003|Crossover Period|Death|3|||
155661626|NCT03110562|561856582|FG000|Crossover Period|Lost to Follow-up|0|||
155661627|NCT03110562|561856583|FG001|Crossover Period|Lost to Follow-up|0|||
155661628|NCT03110562|561856584|FG002|Crossover Period|Lost to Follow-up|0|||
155661629|NCT03110562|561856585|FG003|Crossover Period|Lost to Follow-up|1|||
155661630|NCT03110562|561856582|FG000|Crossover Period|Other|0|||
155661631|NCT03110562|561856583|FG001|Crossover Period|Other|0|||
155661632|NCT03110562|561856584|FG002|Crossover Period|Other|1|||
155661633|NCT03110562|561856585|FG003|Crossover Period|Other|1|||
155661634|NCT03110562|561856582|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
155661635|NCT03110562|561856583|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
155661636|NCT03110562|561856584|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
155661637|NCT03110562|561856585|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
155661638|NCT03189719|561856591|FG000|Overall Study|Death|325|||
155661639|NCT03189719|561856592|FG001|Overall Study|Death|361|||
155661640|NCT03189719|561856591|FG000|Overall Study|Physician Decision|1|||
155661641|NCT03189719|561856592|FG001|Overall Study|Physician Decision|0|||
155661642|NCT03189719|561856591|FG000|Overall Study|Sponsor Decision|40|||
155661643|NCT03189719|561856592|FG001|Overall Study|Sponsor Decision|12|||
155661644|NCT03189719|561856591|FG000|Overall Study|Withdrawal by Subject|7|||
155661645|NCT03189719|561856592|FG001|Overall Study|Withdrawal by Subject|3|||
155661646|NCT03012880|561856593|FG000|Overall Study|Withdrawal by Subject|1|||
155661647|NCT03012880|561856594|FG001|Overall Study|Withdrawal by Subject|0|||
155661648|NCT03012880|561856593|FG000|Overall Study|Ineligible|1|||
155661649|NCT03012880|561856594|FG001|Overall Study|Ineligible|0|||
155661650|NCT01355627|561856595|FG000|Overall Study|Request By the Patient to Discontinue|5|||
155661651|NCT01355627|561856596|FG001|Overall Study|Request By the Patient to Discontinue|7|||
155661652|NCT01355627|561856595|FG000|Overall Study|Lost to Follow-up|8|||
155661653|NCT01355627|561856596|FG001|Overall Study|Lost to Follow-up|7|||
155661654|NCT01355627|561856595|FG000|Overall Study|Fatal Adverse Event|19|||
155661655|NCT01355627|561856596|FG001|Overall Study|Fatal Adverse Event|23|||
155661656|NCT01355627|561856595|FG000|Overall Study|Other|1|||
155661657|NCT01355627|561856596|FG001|Overall Study|Other|1|||
155661658|NCT02781558|561856597|FG000|Overall Study|Lost to Follow-up|2|||
155661659|NCT02781558|561856598|FG001|Overall Study|Lost to Follow-up|2|||
155661660|NCT02781558|561856597|FG000|Overall Study|Adverse Event|1|||
155661661|NCT02781558|561856598|FG001|Overall Study|Adverse Event|0|||
155576308|NCT03449446|561532927|FG002|Overall Study|Non Compliance with Study Drug|0|||
155576309|NCT03449446|561532928|FG003|Overall Study|Non Compliance with Study Drug|0|||
155576310|NCT03449446|561532929|FG004|Overall Study|Non Compliance with Study Drug|0|||
155576311|NCT03449446|561532930|FG005|Overall Study|Non Compliance with Study Drug|0|||
155576312|NCT03449446|561532931|FG006|Overall Study|Non Compliance with Study Drug|0|||
155576313|NCT03449446|561532925|FG000|Overall Study|Protocol Violation|0|||
155576314|NCT03449446|561532926|FG001|Overall Study|Protocol Violation|0|||
155576315|NCT03449446|561532927|FG002|Overall Study|Protocol Violation|0|||
155576316|NCT03449446|561532928|FG003|Overall Study|Protocol Violation|0|||
155576317|NCT03449446|561532929|FG004|Overall Study|Protocol Violation|1|||
155576318|NCT03449446|561532930|FG005|Overall Study|Protocol Violation|1|||
155576319|NCT03449446|561532931|FG006|Overall Study|Protocol Violation|0|||
155576320|NCT03449446|561532925|FG000|Overall Study|Death|0|||
155576321|NCT03449446|561532926|FG001|Overall Study|Death|0|||
155576322|NCT03449446|561532927|FG002|Overall Study|Death|0|||
155576323|NCT03449446|561532928|FG003|Overall Study|Death|0|||
155576324|NCT03449446|561532929|FG004|Overall Study|Death|1|||
155576325|NCT03449446|561532930|FG005|Overall Study|Death|0|||
155576326|NCT03449446|561532931|FG006|Overall Study|Death|0|||
155576327|NCT03180645|561532936|FG000|Overall Study|Adverse Event|0|||
155576328|NCT03180645|561532937|FG001|Overall Study|Adverse Event|1|||
155576329|NCT03180645|561532938|FG002|Overall Study|Adverse Event|2|||
155576330|NCT00625872|561532939|FG000|Overall Study|Withdrawal by Subject|1|||
155576331|NCT00625872|561532940|FG001|Overall Study|Withdrawal by Subject|0|||
155576332|NCT00625872|561532939|FG000|Overall Study|Does not meet inclusion criteria|1|||
155576333|NCT00625872|561532940|FG001|Overall Study|Does not meet inclusion criteria|0|||
155576334|NCT00625872|561532939|FG000|Overall Study|Terminated by sponsor|2|||
155576335|NCT00625872|561532940|FG001|Overall Study|Terminated by sponsor|5|||
155576336|NCT00625872|561532939|FG000|Overall Study|Randomized but not treated|0|||
155576337|NCT00625872|561532940|FG001|Overall Study|Randomized but not treated|1|||
155576338|NCT04208750|561532941|FG000|Overall Study|Lost to Follow-up|16|||
155576339|NCT04208750|561532942|FG001|Overall Study|Lost to Follow-up|15|||
155576340|NCT02201277|561532946|FG000|Overall Study|Death|3|||
155576341|NCT02201277|561532947|FG001|Overall Study|Death|4|||
155576342|NCT02201277|561532946|FG000|Overall Study|Lost to Follow-up|2|||
155576343|NCT02201277|561532947|FG001|Overall Study|Lost to Follow-up|1|||
155576344|NCT02201277|561532946|FG000|Overall Study|Failed retrieval|1|||
155576345|NCT02201277|561532947|FG001|Overall Study|Failed retrieval|0|||
155576346|NCT02201277|561532946|FG000|Overall Study|Physician Decision|1|||
155576347|NCT02201277|561532947|FG001|Overall Study|Physician Decision|0|||
155576348|NCT01512160|561532948|FG000|Overall Study|Lost to Follow-up|1|||
155576349|NCT01512160|561532949|FG001|Overall Study|Lost to Follow-up|0|||
155576350|NCT01512160|561532950|FG002|Overall Study|Lost to Follow-up|0|||
155576351|NCT01512160|561532951|FG003|Overall Study|Lost to Follow-up|0|||
155576352|NCT01512160|561532948|FG000|Overall Study|Withdrawal by Subject|1|||
155576353|NCT01512160|561532949|FG001|Overall Study|Withdrawal by Subject|0|||
155576354|NCT01512160|561532950|FG002|Overall Study|Withdrawal by Subject|0|||
155576355|NCT01512160|561532951|FG003|Overall Study|Withdrawal by Subject|1|||
155576356|NCT05101343|561532953|FG000|Overall Study|Withdrawal by Subject|2|||
155576357|NCT05101343|561532954|FG001|Overall Study|Withdrawal by Subject|1|||
155576358|NCT04779879|561532955|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155576359|NCT04779879|561532956|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155576360|NCT04779879|561532957|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155576361|NCT04779879|561532958|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
155576362|NCT04779879|561532959|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155576363|NCT04779879|561532960|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155576364|NCT04779879|561532955|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
155576365|NCT04779879|561532956|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
155576366|NCT04779879|561532957|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
155576367|NCT04779879|561532958|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
155576368|NCT04779879|561532959|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
155576369|NCT04779879|561532960|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
155576370|NCT04779879|561532955|FG000|Part C: Up to Week 36|Death|0|||
155576371|NCT04779879|561532956|FG001|Part C: Up to Week 36|Death|0|||
155576372|NCT04779879|561532957|FG002|Part C: Up to Week 36|Death|0|||
155576373|NCT04779879|561532958|FG003|Part C: Up to Week 36|Death|0|||
155576374|NCT04779879|561532959|FG004|Part C: Up to Week 36|Death|0|||
155576375|NCT04779879|561532960|FG005|Part C: Up to Week 36|Death|1|||
155576376|NCT04779879|561532955|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
155576377|NCT04779879|561532956|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
155576378|NCT04779879|561532957|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
155576379|NCT04779879|561532958|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
155576380|NCT04779879|561532959|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
155576381|NCT04779879|561532960|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
155576382|NCT02854527|561532961|FG000|Overall Study|Adverse Event|0|||
155576383|NCT02854527|561532962|FG001|Overall Study|Adverse Event|0|||
155576384|NCT02854527|561532963|FG002|Overall Study|Adverse Event|0|||
155576385|NCT02854527|561532964|FG003|Overall Study|Adverse Event|0|||
155576386|NCT02854527|561532965|FG004|Overall Study|Adverse Event|1|||
155576387|NCT02854527|561532966|FG005|Overall Study|Adverse Event|0|||
155576388|NCT02854527|561532967|FG006|Overall Study|Adverse Event|0|||
155576389|NCT02854527|561532968|FG007|Overall Study|Adverse Event|0|||
155576390|NCT02854527|561532969|FG008|Overall Study|Adverse Event|0|||
155576391|NCT02854527|561532970|FG009|Overall Study|Adverse Event|0|||
155576392|NCT02854527|561532961|FG000|Overall Study|Lost to Follow-up|0|||
155576393|NCT02854527|561532962|FG001|Overall Study|Lost to Follow-up|0|||
155576394|NCT02854527|561532963|FG002|Overall Study|Lost to Follow-up|0|||
155576395|NCT02854527|561532964|FG003|Overall Study|Lost to Follow-up|1|||
155576396|NCT02854527|561532965|FG004|Overall Study|Lost to Follow-up|0|||
155576397|NCT02854527|561532966|FG005|Overall Study|Lost to Follow-up|0|||
155576398|NCT02854527|561532967|FG006|Overall Study|Lost to Follow-up|0|||
155576399|NCT02854527|561532968|FG007|Overall Study|Lost to Follow-up|0|||
155576400|NCT02854527|561532969|FG008|Overall Study|Lost to Follow-up|0|||
155576401|NCT02854527|561532970|FG009|Overall Study|Lost to Follow-up|0|||
155576402|NCT02603146|561535031|FG000|Overall Study|Lost to Follow-up|5|||
155576403|NCT02603146|561535032|FG001|Overall Study|Lost to Follow-up|6|||
155576404|NCT02603146|561535031|FG000|Overall Study|Withdrawal by Subject|8|||
155576405|NCT02603146|561535032|FG001|Overall Study|Withdrawal by Subject|10|||
155576406|NCT02603146|561535031|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
155576407|NCT02603146|561535032|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
155576408|NCT02603146|561535031|FG000|Overall Study|Participant moved|2|||
155576409|NCT02603146|561535032|FG001|Overall Study|Participant moved|0|||
155576410|NCT02603146|561535031|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
155576411|NCT02603146|561535032|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
155576412|NCT02366689|561535039|FG000|Overall Study|Withdrawal by Subject|1|||
155576413|NCT02366689|561535040|FG001|Overall Study|Withdrawal by Subject|0|||
155576414|NCT02366689|561535041|FG002|Overall Study|Withdrawal by Subject|1|||
155576415|NCT02366689|561535039|FG000|Overall Study|Lost to Follow-up|3|||
155576416|NCT02366689|561535040|FG001|Overall Study|Lost to Follow-up|2|||
155576417|NCT02366689|561535041|FG002|Overall Study|Lost to Follow-up|0|||
155576418|NCT02366689|561535039|FG000|Overall Study|Pregnancy|0|||
155576419|NCT02366689|561535040|FG001|Overall Study|Pregnancy|1|||
155576420|NCT02366689|561535041|FG002|Overall Study|Pregnancy|1|||
155576421|NCT01068262|561535047|FG000|Overall Study|Adverse Event|2|||
155576422|NCT01068262|561535048|FG001|Overall Study|Adverse Event|0|||
155576423|NCT01068262|561535049|FG002|Overall Study|Adverse Event|1|||
155576424|NCT01068262|561535050|FG003|Overall Study|Adverse Event|0|||
155576425|NCT01068262|561535047|FG000|Overall Study|Protocol Violation|1|||
155576426|NCT01068262|561535048|FG001|Overall Study|Protocol Violation|0|||
155576427|NCT01068262|561535049|FG002|Overall Study|Protocol Violation|0|||
155576428|NCT01068262|561535050|FG003|Overall Study|Protocol Violation|0|||
155576429|NCT01068262|561535047|FG000|Overall Study|Withdrawal by Subject|0|||
155576430|NCT01068262|561535048|FG001|Overall Study|Withdrawal by Subject|1|||
155576431|NCT01068262|561535049|FG002|Overall Study|Withdrawal by Subject|0|||
155576432|NCT01068262|561535050|FG003|Overall Study|Withdrawal by Subject|0|||
155576433|NCT04182490|561535051|FG000|Overall Study|Withdrawal by Subject|3|||
155576434|NCT04182490|561535052|FG001|Overall Study|Withdrawal by Subject|3|||
155576435|NCT04182490|561535051|FG000|Overall Study|Lost to Follow-up|0|||
155576436|NCT04182490|561535052|FG001|Overall Study|Lost to Follow-up|1|||
155576437|NCT04182490|561535051|FG000|Overall Study|Physician Decision|0|||
155576438|NCT04182490|561535052|FG001|Overall Study|Physician Decision|1|||
155576439|NCT00661193|561535064|FG000|Overall Study|Adverse Event|2|||
155576440|NCT00661193|561535065|FG001|Overall Study|Adverse Event|1|||
155576441|NCT00661193|561535064|FG000|Overall Study|Withdrawal by Subject|3|||
155576442|NCT00661193|561535065|FG001|Overall Study|Withdrawal by Subject|1|||
155576443|NCT00661193|561535064|FG000|Overall Study|Progression|27|||
155576444|NCT00661193|561535065|FG001|Overall Study|Progression|24|||
155576445|NCT00661193|561535064|FG000|Overall Study|Not protocol specified|1|||
155576446|NCT00661193|561535065|FG001|Overall Study|Not protocol specified|0|||
155576447|NCT02719184|561535070|FG000|Overall Study|Other than listed|1|||
155576448|NCT02719184|561535071|FG001|Overall Study|Other than listed|12|||
155576449|NCT02719184|561535072|FG002|Overall Study|Other than listed|13|||
155576450|NCT02719184|561535073|FG003|Overall Study|Other than listed|22|||
155576451|NCT02719184|561535074|FG004|Overall Study|Other than listed|9|||
155576452|NCT02719184|561535070|FG000|Overall Study|Withdrawal by Subject|5|||
155576453|NCT02719184|561535071|FG001|Overall Study|Withdrawal by Subject|3|||
155576454|NCT02719184|561535072|FG002|Overall Study|Withdrawal by Subject|6|||
155576455|NCT02719184|561535073|FG003|Overall Study|Withdrawal by Subject|6|||
155576456|NCT02719184|561535074|FG004|Overall Study|Withdrawal by Subject|0|||
155576457|NCT02719184|561535070|FG000|Overall Study|Lost to Follow-up|0|||
155576458|NCT02719184|561535071|FG001|Overall Study|Lost to Follow-up|4|||
155661662|NCT04756531|561856603|FG000|Overall Study|Adverse Event|0|||
155661663|NCT04756531|561856604|FG001|Overall Study|Adverse Event|0|||
155661664|NCT04756531|561856605|FG002|Overall Study|Adverse Event|0|||
155661665|NCT04756531|561856606|FG003|Overall Study|Adverse Event|0|||
155661666|NCT04756531|561856607|FG004|Overall Study|Adverse Event|1|||
155661667|NCT04756531|561856608|FG005|Overall Study|Adverse Event|0|||
155576459|NCT02719184|561535072|FG002|Overall Study|Lost to Follow-up|1|||
155576460|NCT02719184|561535073|FG003|Overall Study|Lost to Follow-up|3|||
155576461|NCT02719184|561535074|FG004|Overall Study|Lost to Follow-up|0|||
155576462|NCT02719184|561535070|FG000|Overall Study|Protocol Violation|0|||
155576463|NCT02719184|561535071|FG001|Overall Study|Protocol Violation|3|||
155576464|NCT02719184|561535072|FG002|Overall Study|Protocol Violation|0|||
155576465|NCT02719184|561535073|FG003|Overall Study|Protocol Violation|2|||
155576466|NCT02719184|561535074|FG004|Overall Study|Protocol Violation|0|||
155576467|NCT02719184|561535070|FG000|Overall Study|Adverse Event|0|||
155576468|NCT02719184|561535071|FG001|Overall Study|Adverse Event|0|||
155576469|NCT02719184|561535072|FG002|Overall Study|Adverse Event|0|||
155576470|NCT02719184|561535073|FG003|Overall Study|Adverse Event|3|||
155576471|NCT02719184|561535074|FG004|Overall Study|Adverse Event|0|||
155576472|NCT05024747|561535076|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
155576473|NCT05024747|561535077|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
155576474|NCT05024747|561535076|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
155576475|NCT05024747|561535077|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
155576476|NCT05024747|561535076|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
155576477|NCT05024747|561535077|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
155576478|NCT00662649|561535079|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
155576479|NCT00662649|561535080|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
155576480|NCT00662649|561535081|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
155576481|NCT00662649|561535082|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
155576482|NCT00662649|561535083|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
155576483|NCT00662649|561535079|FG000|Core Study (24 Months)|Adverse Event|22|||
155576484|NCT00662649|561535080|FG001|Core Study (24 Months)|Adverse Event|13|||
155576485|NCT00662649|561535081|FG002|Core Study (24 Months)|Adverse Event|18|||
155576486|NCT00662649|561535082|FG003|Core Study (24 Months)|Adverse Event|0|||
155576487|NCT00662649|561535083|FG004|Core Study (24 Months)|Adverse Event|0|||
155576488|NCT00662649|561535079|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
155576489|NCT00662649|561535080|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
155576490|NCT00662649|561535081|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
155576491|NCT00662649|561535082|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
155576492|NCT00662649|561535083|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
155576493|NCT00662649|561535079|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
155576494|NCT00662649|561535080|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
155576495|NCT00662649|561535081|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
155576496|NCT00662649|561535082|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
155576497|NCT00662649|561535083|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
155576498|NCT00662649|561535079|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
155576499|NCT00662649|561535080|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
155576500|NCT00662649|561535081|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
155576501|NCT00662649|561535082|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
155576502|NCT00662649|561535083|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
155576503|NCT00662649|561535079|FG000|Core Study (24 Months)|Protocol Violation|5|||
155576504|NCT00662649|561535080|FG001|Core Study (24 Months)|Protocol Violation|5|||
155576505|NCT00662649|561535081|FG002|Core Study (24 Months)|Protocol Violation|4|||
155576506|NCT00662649|561535082|FG003|Core Study (24 Months)|Protocol Violation|0|||
155576507|NCT00662649|561535083|FG004|Core Study (24 Months)|Protocol Violation|0|||
155576508|NCT00662649|561535079|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
155576509|NCT00662649|561535080|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
155576510|NCT00662649|561535081|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
155576511|NCT00662649|561535082|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
155661668|NCT04756531|561856609|FG006|Overall Study|Adverse Event|0|||
155661669|NCT04756531|561856610|FG007|Overall Study|Adverse Event|0|||
155661670|NCT04756531|561856611|FG008|Overall Study|Adverse Event|0|||
155661671|NCT04756531|561856612|FG009|Overall Study|Adverse Event|0|||
155661672|NCT04756531|561856613|FG010|Overall Study|Adverse Event|0|||
155661673|NCT04756531|561856614|FG011|Overall Study|Adverse Event|0|||
155661674|NCT04756531|561856615|FG012|Overall Study|Adverse Event|0|||
155661675|NCT04756531|561856616|FG013|Overall Study|Adverse Event|0|||
155576512|NCT00662649|561535083|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
155661676|NCT04756531|561856617|FG014|Overall Study|Adverse Event|0|||
155576513|NCT00662649|561535079|FG000|Core Study (24 Months)|Death|1|||
155576514|NCT00662649|561535080|FG001|Core Study (24 Months)|Death|0|||
155576515|NCT00662649|561535081|FG002|Core Study (24 Months)|Death|2|||
155576516|NCT00662649|561535082|FG003|Core Study (24 Months)|Death|0|||
155576517|NCT00662649|561535083|FG004|Core Study (24 Months)|Death|0|||
155576518|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
155576519|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
155576520|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
155576521|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
155576522|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
155576523|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
155576524|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
155576525|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
155576526|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
155576527|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
155576528|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
155576529|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
155576530|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
155576531|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
155576532|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
155576533|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
155576534|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
155576535|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
155576536|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
155576537|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
155576538|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
155576539|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
155576540|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
155576541|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
155576542|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
155576543|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
155576544|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
155576545|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155576546|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155576547|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155576548|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
155576549|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
155661677|NCT04756531|561856618|FG015|Overall Study|Adverse Event|0|||
155661678|NCT04756531|561856619|FG016|Overall Study|Adverse Event|0|||
155661679|NCT04756531|561856620|FG017|Overall Study|Adverse Event|0|||
155661680|NCT04756531|561856603|FG000|Overall Study|Withdrawal by Subject|0|||
155661681|NCT04756531|561856604|FG001|Overall Study|Withdrawal by Subject|0|||
155661682|NCT04756531|561856605|FG002|Overall Study|Withdrawal by Subject|0|||
155661683|NCT04756531|561856606|FG003|Overall Study|Withdrawal by Subject|0|||
155661684|NCT04756531|561856607|FG004|Overall Study|Withdrawal by Subject|0|||
155661685|NCT04756531|561856608|FG005|Overall Study|Withdrawal by Subject|0|||
155661686|NCT04756531|561856609|FG006|Overall Study|Withdrawal by Subject|1|||
155661687|NCT04756531|561856610|FG007|Overall Study|Withdrawal by Subject|0|||
155661688|NCT04756531|561856611|FG008|Overall Study|Withdrawal by Subject|0|||
155661689|NCT04756531|561856612|FG009|Overall Study|Withdrawal by Subject|0|||
155661690|NCT04756531|561856613|FG010|Overall Study|Withdrawal by Subject|0|||
155661691|NCT04756531|561856614|FG011|Overall Study|Withdrawal by Subject|0|||
155661692|NCT04756531|561856615|FG012|Overall Study|Withdrawal by Subject|0|||
155661693|NCT04756531|561856616|FG013|Overall Study|Withdrawal by Subject|0|||
155661694|NCT04756531|561856617|FG014|Overall Study|Withdrawal by Subject|0|||
155661695|NCT04756531|561856618|FG015|Overall Study|Withdrawal by Subject|0|||
155661696|NCT04756531|561856619|FG016|Overall Study|Withdrawal by Subject|0|||
155661697|NCT04756531|561856620|FG017|Overall Study|Withdrawal by Subject|0|||
155661698|NCT02257528|561856621|FG000|Overall Study|Never received study treatment|1|||
155661699|NCT04237584|561856624|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
155661700|NCT04237584|561856625|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
155661701|NCT04237584|561856626|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
155661702|NCT04237584|561856627|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
155576550|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
155576551|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
155576552|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
155576553|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155576554|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
155576555|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155576556|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155576557|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155576558|NCT00662649|561535079|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
155576559|NCT00662649|561535080|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
155576560|NCT00662649|561535081|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
155576561|NCT00662649|561535082|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
155576562|NCT00662649|561535083|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
155576563|NCT01026194|561535084|FG000|Period 1：Double Blind Period|Adverse Event|2|||
155576564|NCT01026194|561535085|FG001|Period 1：Double Blind Period|Adverse Event|1|||
155576565|NCT01026194|561535084|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
155576566|NCT01026194|561535085|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
155576567|NCT01026194|561535084|FG000|Period 1：Double Blind Period|Physician Decision|0|||
155576568|NCT01026194|561535085|FG001|Period 1：Double Blind Period|Physician Decision|4|||
155576569|NCT01026194|561535084|FG000|Period 2：Open-label Period|Adverse Event|4|||
155576570|NCT01026194|561535085|FG001|Period 2：Open-label Period|Adverse Event|5|||
155576571|NCT01026194|561535084|FG000|Period 2：Open-label Period|Physician Decision|3|||
155576572|NCT01026194|561535085|FG001|Period 2：Open-label Period|Physician Decision|1|||
155576573|NCT01026194|561535084|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
155576574|NCT01026194|561535085|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
155576575|NCT04428034|561535088|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
155576576|NCT02556801|561535091|FG000|Overall Study|Lost to Follow-up|1|||
155576577|NCT02556801|561535092|FG001|Overall Study|Lost to Follow-up|0|||
155576578|NCT02556801|561535093|FG002|Overall Study|Lost to Follow-up|2|||
155576579|NCT02556801|561535094|FG003|Overall Study|Lost to Follow-up|0|||
155576580|NCT02556801|561535091|FG000|Overall Study|Withdrawal by Subject|1|||
155576581|NCT02556801|561535092|FG001|Overall Study|Withdrawal by Subject|1|||
155576582|NCT02556801|561535093|FG002|Overall Study|Withdrawal by Subject|1|||
155576583|NCT02556801|561535094|FG003|Overall Study|Withdrawal by Subject|0|||
155576584|NCT02556801|561535091|FG000|Overall Study|Protocol Violation|0|||
155576585|NCT02556801|561535092|FG001|Overall Study|Protocol Violation|3|||
155576586|NCT02556801|561535093|FG002|Overall Study|Protocol Violation|1|||
155576587|NCT02556801|561535094|FG003|Overall Study|Protocol Violation|1|||
155576588|NCT02556801|561535091|FG000|Overall Study|Adverse Event|0|||
155576589|NCT02556801|561535092|FG001|Overall Study|Adverse Event|2|||
155576590|NCT02556801|561535093|FG002|Overall Study|Adverse Event|0|||
155576591|NCT02556801|561535094|FG003|Overall Study|Adverse Event|3|||
155576592|NCT02556801|561535091|FG000|Overall Study|Pregnancy|0|||
155576593|NCT02556801|561535092|FG001|Overall Study|Pregnancy|1|||
155576594|NCT02556801|561535093|FG002|Overall Study|Pregnancy|0|||
155576595|NCT02556801|561535094|FG003|Overall Study|Pregnancy|0|||
155576596|NCT02556801|561535091|FG000|Overall Study|Personal reasons patient|0|||
155576597|NCT02556801|561535092|FG001|Overall Study|Personal reasons patient|0|||
155576598|NCT02556801|561535093|FG002|Overall Study|Personal reasons patient|0|||
155576599|NCT02556801|561535094|FG003|Overall Study|Personal reasons patient|1|||
155576600|NCT02515331|561535099|FG000|Overall Study|Withdrawal by Subject|0|||
155576601|NCT02515331|561535100|FG001|Overall Study|Withdrawal by Subject|0|||
155576602|NCT02515331|561535101|FG002|Overall Study|Withdrawal by Subject|1|||
155576603|NCT02515331|561535099|FG000|Overall Study|Protocol deviation|0|||
155576604|NCT02515331|561535100|FG001|Overall Study|Protocol deviation|0|||
155576605|NCT02515331|561535101|FG002|Overall Study|Protocol deviation|3|||
155576606|NCT02515331|561535099|FG000|Overall Study|Adverse Event|2|||
155576607|NCT02515331|561535100|FG001|Overall Study|Adverse Event|0|||
155576608|NCT02515331|561535101|FG002|Overall Study|Adverse Event|0|||
155576609|NCT00124748|561535102|FG000|Overall Study|Adverse Event|8|||
155576610|NCT00124748|561535103|FG001|Overall Study|Adverse Event|39|||
155576611|NCT00124748|561535102|FG000|Overall Study|Abnormal laboratory Value|2|||
155576612|NCT00124748|561535103|FG001|Overall Study|Abnormal laboratory Value|2|||
155576613|NCT00124748|561535102|FG000|Overall Study|Abnormal Procedure|0|||
155576614|NCT00124748|561535103|FG001|Overall Study|Abnormal Procedure|1|||
155576615|NCT00124748|561535102|FG000|Overall Study|Lack of Efficacy|20|||
155576616|NCT00124748|561535103|FG001|Overall Study|Lack of Efficacy|41|||
155576617|NCT00124748|561535102|FG000|Overall Study|No longer requires study drug|1|||
155576618|NCT00124748|561535103|FG001|Overall Study|No longer requires study drug|1|||
155576619|NCT00124748|561535102|FG000|Overall Study|Protocol Violation|3|||
155576620|NCT00124748|561535103|FG001|Overall Study|Protocol Violation|1|||
155576621|NCT00124748|561535102|FG000|Overall Study|Withdrawal by Subject|5|||
155576622|NCT00124748|561535103|FG001|Overall Study|Withdrawal by Subject|15|||
155576623|NCT00124748|561535102|FG000|Overall Study|Lost to Follow-up|2|||
155576624|NCT00124748|561535103|FG001|Overall Study|Lost to Follow-up|7|||
155576625|NCT00124748|561535102|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
155576626|NCT00124748|561535103|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
155576627|NCT00124748|561535102|FG000|Overall Study|Death|1|||
155576628|NCT00124748|561535103|FG001|Overall Study|Death|3|||
155576629|NCT00322712|561535104|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
155576630|NCT04176250|561535107|FG000|Overall Study|Adverse Event|0|||
155576631|NCT04176250|561535108|FG001|Overall Study|Adverse Event|1|||
155576632|NCT04176250|561535109|FG002|Overall Study|Adverse Event|0|||
155576633|NCT04176250|561535110|FG003|Overall Study|Adverse Event|1|||
155576634|NCT04176250|561535111|FG004|Overall Study|Adverse Event|0|||
155576635|NCT04176250|561535112|FG005|Overall Study|Adverse Event|1|||
155576636|NCT04176250|561535107|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155576637|NCT04176250|561535108|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155576638|NCT04176250|561535109|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
155576639|NCT04176250|561535110|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
155576640|NCT04176250|561535111|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155576641|NCT04176250|561535112|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155576642|NCT04176250|561535107|FG000|Overall Study|Withdrawal by Subject|0|||
155576643|NCT04176250|561535108|FG001|Overall Study|Withdrawal by Subject|0|||
155576644|NCT04176250|561535109|FG002|Overall Study|Withdrawal by Subject|0|||
155576645|NCT04176250|561535110|FG003|Overall Study|Withdrawal by Subject|0|||
155576646|NCT04176250|561535111|FG004|Overall Study|Withdrawal by Subject|0|||
155576647|NCT04176250|561535112|FG005|Overall Study|Withdrawal by Subject|1|||
155576648|NCT04176250|561535107|FG000|Overall Study|Randomized in error|0|||
155576649|NCT04176250|561535108|FG001|Overall Study|Randomized in error|0|||
155576650|NCT04176250|561535109|FG002|Overall Study|Randomized in error|0|||
155576651|NCT04176250|561535110|FG003|Overall Study|Randomized in error|0|||
155576652|NCT04176250|561535111|FG004|Overall Study|Randomized in error|1|||
155576653|NCT04176250|561535112|FG005|Overall Study|Randomized in error|0|||
155576654|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
155576655|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
155576656|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
155576657|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576658|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
155576659|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
155576660|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576661|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576662|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576663|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576664|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576665|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576666|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576667|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576668|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576669|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576670|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155576671|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155576672|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576673|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
155576674|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155576675|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
155576676|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155576677|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576678|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576679|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576680|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576681|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576682|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576683|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155661703|NCT04237584|561856624|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155661704|NCT04237584|561856625|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155661705|NCT04237584|561856626|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
155661706|NCT04237584|561856627|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155661707|NCT04237584|561856624|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155661708|NCT04237584|561856625|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155661709|NCT04237584|561856626|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
155661710|NCT04237584|561856627|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155661711|NCT04237584|561856624|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
155661712|NCT04237584|561856625|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
155661713|NCT04237584|561856626|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
155661714|NCT04237584|561856627|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
155661715|NCT04237584|561856624|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155661716|NCT04237584|561856625|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155661717|NCT04237584|561856626|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
155661718|NCT04237584|561856627|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155661719|NCT02114177|561858090|FG000|Overall Study|Lost to Follow-up|1|||
155661720|NCT02114177|561858091|FG001|Overall Study|Lost to Follow-up|2|||
155661721|NCT02114177|561858090|FG000|Overall Study|Withdrawal by Subject|6|||
155661722|NCT02114177|561858091|FG001|Overall Study|Withdrawal by Subject|1|||
155661723|NCT02114177|561858090|FG000|Overall Study|Other|2|||
155661724|NCT02114177|561858091|FG001|Overall Study|Other|1|||
155661725|NCT01897493|561858092|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
155661726|NCT01246960|561858097|FG000|Overall Study|Lost to Follow-up|3|||
155661727|NCT01246960|561858098|FG001|Overall Study|Lost to Follow-up|1|||
155661728|NCT01246960|561858097|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
155661729|NCT01246960|561858098|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
155661730|NCT05111145|561858099|FG000|Overall Study|Commercial drug is available for participant|76|||
155661731|NCT05111145|561858099|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
155661732|NCT03376516|561858100|FG000|Overall Study|Not treated|1|||
155661733|NCT03376516|561858100|FG000|Overall Study|Consent withdrawn|1|||
155661734|NCT01581684|561858101|FG000|Overall Study|Other reason not defined|0|||
155661735|NCT01581684|561858102|FG001|Overall Study|Other reason not defined|0|||
155661736|NCT01581684|561858103|FG002|Overall Study|Other reason not defined|0|||
155661737|NCT01581684|561858104|FG003|Overall Study|Other reason not defined|0|||
155576684|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576685|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576686|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576687|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155576688|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
155576689|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155576690|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155576691|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
155576692|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
155576693|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155576694|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576695|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576696|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576697|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576698|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576699|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576700|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155661738|NCT01581684|561858105|FG004|Overall Study|Other reason not defined|0|||
155661739|NCT01581684|561858106|FG005|Overall Study|Other reason not defined|0|||
155661740|NCT01581684|561858107|FG006|Overall Study|Other reason not defined|0|||
155661741|NCT01581684|561858108|FG007|Overall Study|Other reason not defined|0|||
155661742|NCT01581684|561858109|FG008|Overall Study|Other reason not defined|1|||
155661743|NCT01581684|561858110|FG009|Overall Study|Other reason not defined|0|||
155661744|NCT03235050|561858111|FG000|Overall Study|Adverse Event|0|||
155661745|NCT03235050|561858112|FG001|Overall Study|Adverse Event|0|||
155576701|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576702|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576703|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155661746|NCT03235050|561858113|FG002|Overall Study|Adverse Event|1|||
155661747|NCT03235050|561858114|FG003|Overall Study|Adverse Event|4|||
155661748|NCT03235050|561858115|FG004|Overall Study|Adverse Event|1|||
155661749|NCT03235050|561858111|FG000|Overall Study|Death|0|||
155661750|NCT03235050|561858112|FG001|Overall Study|Death|0|||
155661751|NCT03235050|561858113|FG002|Overall Study|Death|0|||
155576704|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155576705|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576706|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
155576707|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
155576708|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576709|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
155576710|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
155576711|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576712|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576713|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576714|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576715|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576716|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576717|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576718|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576719|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576720|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576721|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155576722|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576723|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576724|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
155576725|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
155576726|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576727|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576728|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576729|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576730|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576731|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576732|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576733|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576734|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576735|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576736|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576737|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576738|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155576739|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576740|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576741|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576742|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576743|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
155576744|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576745|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576746|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576747|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576748|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576749|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576750|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576751|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576752|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576753|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576754|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576755|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155576756|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576757|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
155576758|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576759|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576760|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576761|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576762|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576763|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576764|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576765|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576766|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576767|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155661752|NCT03235050|561858114|FG003|Overall Study|Death|2|||
155661753|NCT03235050|561858115|FG004|Overall Study|Death|1|||
155576768|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576769|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576770|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576771|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576772|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155576773|NCT00758524|561535113|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576774|NCT00758524|561535114|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
155576775|NCT00758524|561535115|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576776|NCT00758524|561535116|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576777|NCT00758524|561535117|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576778|NCT00758524|561535118|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576779|NCT00758524|561535119|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576780|NCT00758524|561535120|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576781|NCT00758524|561535121|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576782|NCT00758524|561535122|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576783|NCT00758524|561535123|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576784|NCT00758524|561535124|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576785|NCT00758524|561535125|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576786|NCT00758524|561535126|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576787|NCT00758524|561535127|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576788|NCT00758524|561535128|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576789|NCT00758524|561535129|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155576790|NCT00758524|561535113|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576791|NCT00758524|561535114|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576792|NCT00758524|561535115|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576793|NCT00758524|561535116|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576794|NCT00758524|561535117|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576795|NCT00758524|561535118|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576796|NCT00758524|561535119|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576797|NCT00758524|561535120|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576798|NCT00758524|561535121|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
155576799|NCT00758524|561535122|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576800|NCT00758524|561535123|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576801|NCT00758524|561535124|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576802|NCT00758524|561535125|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576803|NCT00758524|561535126|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576804|NCT00758524|561535127|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576805|NCT00758524|561535128|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576806|NCT00758524|561535129|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155576807|NCT00758524|561535113|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576808|NCT00758524|561535114|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576809|NCT00758524|561535115|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576810|NCT00758524|561535116|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576811|NCT00758524|561535117|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576812|NCT00758524|561535118|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576813|NCT00758524|561535119|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
155576814|NCT00758524|561535120|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576815|NCT00758524|561535121|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576816|NCT00758524|561535122|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576817|NCT00758524|561535123|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576818|NCT00758524|561535124|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576819|NCT00758524|561535125|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576820|NCT00758524|561535126|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576821|NCT00758524|561535127|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576822|NCT00758524|561535128|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576823|NCT00758524|561535129|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155576824|NCT04747470|561535134|FG000|Overall Study|Death|0|||
155576825|NCT04747470|561535135|FG001|Overall Study|Death|3|||
155576826|NCT04747470|561535136|FG002|Overall Study|Death|2|||
155576827|NCT04747470|561535137|FG003|Overall Study|Death|2|||
155576828|NCT04747470|561535138|FG004|Overall Study|Death|2|||
155576829|NCT04747470|561535139|FG005|Overall Study|Death|0|||
155576830|NCT04747470|561535140|FG006|Overall Study|Death|0|||
155576831|NCT04747470|561535141|FG007|Overall Study|Death|0|||
155576832|NCT04747470|561535142|FG008|Overall Study|Death|0|||
155661754|NCT03235050|561858111|FG000|Overall Study|Lost to Follow-up|1|||
155661755|NCT03235050|561858112|FG001|Overall Study|Lost to Follow-up|2|||
155661756|NCT03235050|561858113|FG002|Overall Study|Lost to Follow-up|1|||
155661757|NCT03235050|561858114|FG003|Overall Study|Lost to Follow-up|2|||
155661758|NCT03235050|561858115|FG004|Overall Study|Lost to Follow-up|0|||
155661759|NCT03235050|561858111|FG000|Overall Study|Withdrawal by Subject|3|||
155661760|NCT03235050|561858112|FG001|Overall Study|Withdrawal by Subject|2|||
155661761|NCT03235050|561858113|FG002|Overall Study|Withdrawal by Subject|2|||
155661762|NCT03235050|561858114|FG003|Overall Study|Withdrawal by Subject|5|||
155661763|NCT03235050|561858115|FG004|Overall Study|Withdrawal by Subject|7|||
155661764|NCT03235050|561858111|FG000|Overall Study|Other reasons|0|||
155661765|NCT03235050|561858112|FG001|Overall Study|Other reasons|1|||
155661766|NCT03235050|561858113|FG002|Overall Study|Other reasons|0|||
155661767|NCT03235050|561858114|FG003|Overall Study|Other reasons|1|||
155661768|NCT03235050|561858115|FG004|Overall Study|Other reasons|2|||
155661769|NCT02986074|561858116|FG000|First Trial Period|Adverse Event|1|||
155661770|NCT02986074|561858117|FG001|First Trial Period|Adverse Event|0|||
155661771|NCT02986074|561858118|FG002|First Trial Period|Adverse Event|0|||
155661772|NCT02986074|561858119|FG003|First Trial Period|Adverse Event|0|||
155661773|NCT02986074|561858116|FG000|Follow up Period|system explant|0|||
155576833|NCT04747470|561535143|FG009|Overall Study|Death|0|||
155576834|NCT04747470|561535144|FG010|Overall Study|Death|0|||
155576835|NCT04747470|561535134|FG000|Overall Study|Withdrew Consent|0|||
155576836|NCT04747470|561535135|FG001|Overall Study|Withdrew Consent|0|||
155576837|NCT04747470|561535136|FG002|Overall Study|Withdrew Consent|0|||
155576838|NCT04747470|561535137|FG003|Overall Study|Withdrew Consent|1|||
155576839|NCT04747470|561535138|FG004|Overall Study|Withdrew Consent|0|||
155576840|NCT04747470|561535139|FG005|Overall Study|Withdrew Consent|0|||
155576841|NCT04747470|561535140|FG006|Overall Study|Withdrew Consent|0|||
155576842|NCT04747470|561535141|FG007|Overall Study|Withdrew Consent|0|||
155576843|NCT04747470|561535142|FG008|Overall Study|Withdrew Consent|0|||
155576844|NCT04747470|561535143|FG009|Overall Study|Withdrew Consent|0|||
155576845|NCT04747470|561535144|FG010|Overall Study|Withdrew Consent|0|||
155576846|NCT04747470|561535134|FG000|Overall Study|Study Terminated by Sponsor|0|||
155576847|NCT04747470|561535135|FG001|Overall Study|Study Terminated by Sponsor|0|||
155576848|NCT04747470|561535136|FG002|Overall Study|Study Terminated by Sponsor|1|||
155576849|NCT04747470|561535137|FG003|Overall Study|Study Terminated by Sponsor|0|||
155576850|NCT04747470|561535138|FG004|Overall Study|Study Terminated by Sponsor|2|||
155576851|NCT04747470|561535139|FG005|Overall Study|Study Terminated by Sponsor|0|||
155576852|NCT04747470|561535140|FG006|Overall Study|Study Terminated by Sponsor|0|||
155576853|NCT04747470|561535141|FG007|Overall Study|Study Terminated by Sponsor|0|||
155576854|NCT04747470|561535142|FG008|Overall Study|Study Terminated by Sponsor|0|||
155576855|NCT04747470|561535143|FG009|Overall Study|Study Terminated by Sponsor|0|||
155576856|NCT04747470|561535144|FG010|Overall Study|Study Terminated by Sponsor|0|||
155576857|NCT04688671|561535145|FG000|Overall Study|Adverse Event|3|||
155576858|NCT04688671|561535146|FG001|Overall Study|Adverse Event|1|||
155576859|NCT04688671|561535145|FG000|Overall Study|Withdrawal by Subject|3|||
155576860|NCT04688671|561535146|FG001|Overall Study|Withdrawal by Subject|1|||
155576861|NCT04688671|561535145|FG000|Overall Study|Lack of Efficacy|1|||
155576862|NCT04688671|561535146|FG001|Overall Study|Lack of Efficacy|1|||
155576863|NCT04688671|561535145|FG000|Overall Study|Protocol Violation|1|||
155576864|NCT04688671|561535146|FG001|Overall Study|Protocol Violation|0|||
155576865|NCT04688671|561535145|FG000|Overall Study|Lost to Follow-up|0|||
155576866|NCT04688671|561535146|FG001|Overall Study|Lost to Follow-up|1|||
155576867|NCT02262325|561535149|FG000|Overall Study|Death|16|||
155576868|NCT02262325|561535149|FG000|Overall Study|Lost to Follow-up|1|||
155576869|NCT02815995|561535150|FG000|Overall Study|Disease Progression|3|||
155576870|NCT02815995|561535151|FG001|Overall Study|Disease Progression|7|||
155576871|NCT02815995|561535152|FG002|Overall Study|Disease Progression|2|||
155576872|NCT02815995|561535153|FG003|Overall Study|Disease Progression|4|||
155661774|NCT02986074|561858117|FG001|Follow up Period|system explant|0|||
155661775|NCT02986074|561858118|FG002|Follow up Period|system explant|1|||
155576873|NCT02815995|561535154|FG004|Overall Study|Disease Progression|3|||
155661776|NCT02986074|561858119|FG003|Follow up Period|system explant|2|||
155661777|NCT02986074|561858116|FG000|Follow up Period|Physician Decision|0|||
155661778|NCT02986074|561858117|FG001|Follow up Period|Physician Decision|0|||
155661779|NCT02986074|561858118|FG002|Follow up Period|Physician Decision|0|||
155661780|NCT02986074|561858119|FG003|Follow up Period|Physician Decision|1|||
155661781|NCT02239926|561858122|FG000|Overall Study|Withdrawal by Subject|0|||
155661782|NCT02239926|561858123|FG001|Overall Study|Withdrawal by Subject|1|||
155661783|NCT04099277|561858124|FG000|Overall Study|Physician Decision|1|||
155661784|NCT04099277|561858124|FG000|Overall Study|Withdrawal by Subject|1|||
155661785|NCT00598650|561858125|FG000|Overall Study|Withdrawal by Subject|3|||
155661786|NCT00598650|561858125|FG000|Overall Study|Adverse Event|18|||
155661787|NCT00598650|561858125|FG000|Overall Study|No treatment for 3 weeks|1|||
155661788|NCT00598650|561858125|FG000|Overall Study|Not eligible|1|||
155661789|NCT00598650|561858125|FG000|Overall Study|Prohibited Concomitant Medication|2|||
155661790|NCT00598650|561858125|FG000|Overall Study|Physician Decision|2|||
155661791|NCT01628913|561858126|FG000|Overall Study|Adverse Event|12|||
155661792|NCT01628913|561858127|FG001|Overall Study|Adverse Event|5|||
155661793|NCT01628913|561858126|FG000|Overall Study|Disease Progression|11|||
155661794|NCT01628913|561858127|FG001|Overall Study|Disease Progression|14|||
155661795|NCT01628913|561858126|FG000|Overall Study|Protocol Violation|1|||
155661796|NCT01628913|561858127|FG001|Overall Study|Protocol Violation|0|||
155661797|NCT01628913|561858126|FG000|Overall Study|Death|1|||
155661798|NCT01628913|561858127|FG001|Overall Study|Death|0|||
155661799|NCT01628913|561858126|FG000|Overall Study|study terminated by Sponsor|4|||
155661800|NCT01628913|561858127|FG001|Overall Study|study terminated by Sponsor|9|||
155661801|NCT01628913|561858126|FG000|Overall Study|Withdrawal by Subject|1|||
155661802|NCT01628913|561858127|FG001|Overall Study|Withdrawal by Subject|0|||
155661803|NCT01628913|561858126|FG000|Overall Study|Physician Decision|1|||
155661804|NCT01628913|561858127|FG001|Overall Study|Physician Decision|3|||
155661805|NCT02415556|561858131|FG000|Overall Study|Adverse Event|3|||
155661806|NCT02415556|561858132|FG001|Overall Study|Adverse Event|4|||
155661807|NCT02415556|561858133|FG002|Overall Study|Adverse Event|2|||
155661808|NCT02415556|561858134|FG003|Overall Study|Adverse Event|4|||
155661809|NCT02415556|561858131|FG000|Overall Study|Lost to Follow-up|4|||
155661810|NCT02415556|561858132|FG001|Overall Study|Lost to Follow-up|5|||
155661811|NCT02415556|561858133|FG002|Overall Study|Lost to Follow-up|4|||
155661812|NCT02415556|561858134|FG003|Overall Study|Lost to Follow-up|1|||
155661813|NCT02415556|561858131|FG000|Overall Study|Withdrawal by Subject|13|||
155661814|NCT02415556|561858132|FG001|Overall Study|Withdrawal by Subject|4|||
155661815|NCT02415556|561858133|FG002|Overall Study|Withdrawal by Subject|14|||
155661816|NCT02415556|561858134|FG003|Overall Study|Withdrawal by Subject|12|||
155661817|NCT02415556|561858131|FG000|Overall Study|Physician Decision|1|||
155661818|NCT02415556|561858132|FG001|Overall Study|Physician Decision|3|||
155661819|NCT02415556|561858133|FG002|Overall Study|Physician Decision|1|||
155661820|NCT02415556|561858134|FG003|Overall Study|Physician Decision|2|||
155661821|NCT02415556|561858131|FG000|Overall Study|Censored - study completion|4|||
155661822|NCT02415556|561858132|FG001|Overall Study|Censored - study completion|5|||
155661823|NCT02415556|561858133|FG002|Overall Study|Censored - study completion|1|||
155661824|NCT02415556|561858134|FG003|Overall Study|Censored - study completion|0|||
155661825|NCT02415556|561858131|FG000|Overall Study|Family-related issues|0|||
155661826|NCT02415556|561858132|FG001|Overall Study|Family-related issues|0|||
155661827|NCT02415556|561858133|FG002|Overall Study|Family-related issues|0|||
155661828|NCT02415556|561858134|FG003|Overall Study|Family-related issues|1|||
155661829|NCT00105534|561858135|FG000|Overall Study|Adverse Event|2|||
155661830|NCT00105534|561858136|FG001|Overall Study|Adverse Event|5|||
155661831|NCT00105534|561858135|FG000|Overall Study|Protocol Violation|1|||
155661832|NCT00105534|561858136|FG001|Overall Study|Protocol Violation|4|||
155661833|NCT00105534|561858135|FG000|Overall Study|Withdrawal by Subject|6|||
155661834|NCT00105534|561858136|FG001|Overall Study|Withdrawal by Subject|6|||
155661835|NCT00105534|561858135|FG000|Overall Study|Lost to Follow-up|5|||
155661836|NCT00105534|561858136|FG001|Overall Study|Lost to Follow-up|1|||
155661837|NCT00105534|561858135|FG000|Overall Study|Lack of Efficacy|7|||
155661838|NCT00105534|561858136|FG001|Overall Study|Lack of Efficacy|15|||
155661839|NCT00105534|561858135|FG000|Overall Study|Treatment unmasked|1|||
155661840|NCT00105534|561858136|FG001|Overall Study|Treatment unmasked|0|||
155661841|NCT00105534|561858135|FG000|Overall Study|Other Reason|0|||
155661842|NCT00105534|561858136|FG001|Overall Study|Other Reason|2|||
155661843|NCT04102007|561858137|FG000|Overall Study|Adverse Event|4|||
155661844|NCT04102007|561858137|FG000|Overall Study|Lost to Follow-up|3|||
155661845|NCT04102007|561858137|FG000|Overall Study|Withdrawal by Subject|12|||
155661846|NCT04102007|561858137|FG000|Overall Study|Eligibility Violation|5|||
155661847|NCT04102007|561858137|FG000|Overall Study|Lack of Efficacy|6|||
155661848|NCT04102007|561858137|FG000|Overall Study|Protocol Deviation|5|||
155661849|NCT04102007|561858137|FG000|Overall Study|Protocol Compliance|1|||
155661850|NCT04102007|561858137|FG000|Overall Study|Withdrew Treatment|2|||
155661851|NCT04102007|561858137|FG000|Overall Study|Pregnancy|1|||
155661852|NCT05173974|561858138|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155661853|NCT05173974|561858139|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155576874|NCT02815995|561535155|FG005|Overall Study|Disease Progression|9|||
155576875|NCT02815995|561535156|FG006|Overall Study|Disease Progression|3|||
155576876|NCT02815995|561535157|FG007|Overall Study|Disease Progression|1|||
155576877|NCT02815995|561535150|FG000|Overall Study|Adverse Event|1|||
155576878|NCT02815995|561535151|FG001|Overall Study|Adverse Event|2|||
155576879|NCT02815995|561535152|FG002|Overall Study|Adverse Event|2|||
155576880|NCT02815995|561535153|FG003|Overall Study|Adverse Event|0|||
155576881|NCT02815995|561535154|FG004|Overall Study|Adverse Event|0|||
155576882|NCT02815995|561535155|FG005|Overall Study|Adverse Event|1|||
155576883|NCT02815995|561535156|FG006|Overall Study|Adverse Event|0|||
155576884|NCT02815995|561535157|FG007|Overall Study|Adverse Event|0|||
155576885|NCT02815995|561535150|FG000|Overall Study|Pregnancy|0|||
155576886|NCT02815995|561535151|FG001|Overall Study|Pregnancy|0|||
155576887|NCT02815995|561535152|FG002|Overall Study|Pregnancy|0|||
155576888|NCT02815995|561535153|FG003|Overall Study|Pregnancy|0|||
155576889|NCT02815995|561535154|FG004|Overall Study|Pregnancy|0|||
155576890|NCT02815995|561535155|FG005|Overall Study|Pregnancy|0|||
155576891|NCT02815995|561535156|FG006|Overall Study|Pregnancy|1|||
155576892|NCT02815995|561535157|FG007|Overall Study|Pregnancy|0|||
155576893|NCT01125189|561535158|FG000|Treatment Period|Lack of Efficacy|15|||
155576894|NCT01125189|561535159|FG001|Treatment Period|Lack of Efficacy|18|||
155576895|NCT01125189|561535160|FG002|Treatment Period|Lack of Efficacy|25|||
155576896|NCT01125189|561535158|FG000|Treatment Period|Adverse Event|7|||
155576897|NCT01125189|561535159|FG001|Treatment Period|Adverse Event|8|||
155576898|NCT01125189|561535160|FG002|Treatment Period|Adverse Event|8|||
155576899|NCT01125189|561535158|FG000|Treatment Period|Withdrawal by Subject|3|||
155576900|NCT01125189|561535159|FG001|Treatment Period|Withdrawal by Subject|1|||
155576901|NCT01125189|561535160|FG002|Treatment Period|Withdrawal by Subject|1|||
155576902|NCT01125189|561535158|FG000|Treatment Period|Death|1|||
155576903|NCT01125189|561535159|FG001|Treatment Period|Death|0|||
155576904|NCT01125189|561535160|FG002|Treatment Period|Death|0|||
155576905|NCT01125189|561535158|FG000|Treatment Period|Lost to Follow-up|1|||
155576906|NCT01125189|561535159|FG001|Treatment Period|Lost to Follow-up|2|||
155576907|NCT01125189|561535160|FG002|Treatment Period|Lost to Follow-up|1|||
155576908|NCT01125189|561535158|FG000|Treatment Period|Poor compliance/noncompliance|0|||
155576909|NCT01125189|561535159|FG001|Treatment Period|Poor compliance/noncompliance|1|||
155576910|NCT01125189|561535160|FG002|Treatment Period|Poor compliance/noncompliance|0|||
155576911|NCT01125189|561535158|FG000|Treatment Period|Participants requested to discontinue|1|||
155576912|NCT01125189|561535159|FG001|Treatment Period|Participants requested to discontinue|3|||
155576913|NCT01125189|561535160|FG002|Treatment Period|Participants requested to discontinue|4|||
155576914|NCT01125189|561535158|FG000|Treatment Period|Other reasons|1|||
155576915|NCT01125189|561535159|FG001|Treatment Period|Other reasons|1|||
155576916|NCT01125189|561535160|FG002|Treatment Period|Other reasons|0|||
155576917|NCT01125189|561535158|FG000|Treatment Period|Completed 24 week treatment period only|2|||
155576918|NCT01125189|561535159|FG001|Treatment Period|Completed 24 week treatment period only|1|||
155576919|NCT01125189|561535160|FG002|Treatment Period|Completed 24 week treatment period only|2|||
155576920|NCT01125189|561535158|FG000|Follow up Period|Withdrawal by Subject|3|||
155576921|NCT01125189|561535159|FG001|Follow up Period|Withdrawal by Subject|2|||
155576922|NCT01125189|561535160|FG002|Follow up Period|Withdrawal by Subject|5|||
155576923|NCT01125189|561535158|FG000|Follow up Period|Death|1|||
155576924|NCT01125189|561535159|FG001|Follow up Period|Death|0|||
155576925|NCT01125189|561535160|FG002|Follow up Period|Death|0|||
155576926|NCT01125189|561535158|FG000|Follow up Period|Lost to Follow-up|12|||
155576927|NCT01125189|561535159|FG001|Follow up Period|Lost to Follow-up|9|||
155576928|NCT01125189|561535160|FG002|Follow up Period|Lost to Follow-up|6|||
155576929|NCT01125189|561535158|FG000|Follow up Period|Other reasons|4|||
155576930|NCT01125189|561535159|FG001|Follow up Period|Other reasons|4|||
155576931|NCT01125189|561535160|FG002|Follow up Period|Other reasons|5|||
155576932|NCT00114140|561535161|FG000|Overall Study|Protocol Violation|7|||
155576933|NCT00110396|561535162|FG000|Overall Study|Adverse Event|15|||
155576934|NCT00110396|561535162|FG000|Overall Study|Lost to Follow-up|1|||
155576935|NCT00110396|561535162|FG000|Overall Study|Administration of plasmapheresis|1|||
155576936|NCT00110396|561535162|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
155576937|NCT00110396|561535162|FG000|Overall Study|Lack of Efficacy|1|||
155576938|NCT00110396|561535162|FG000|Overall Study|Decided not to continue treatment|1|||
155576939|NCT00110396|561535162|FG000|Overall Study|Patient non-compliance|1|||
155576940|NCT00110396|561535162|FG000|Overall Study|Patient refused to continue|1|||
155576941|NCT00110396|561535162|FG000|Overall Study|Patient refused to participate|1|||
155576942|NCT00110396|561535162|FG000|Overall Study|Patient will|1|||
155576943|NCT00110396|561535162|FG000|Overall Study|Patient's decision|1|||
155576944|NCT00110396|561535162|FG000|Overall Study|Participation in MS vaccine study|1|||
155576945|NCT00110396|561535162|FG000|Overall Study|Pregnancy|1|||
155576946|NCT00110396|561535162|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
155576947|NCT00110396|561535162|FG000|Overall Study|Protocol Violation|2|||
155576948|NCT00110396|561535162|FG000|Overall Study|Patient refused to come back|1|||
155576949|NCT00110396|561535162|FG000|Overall Study|The patient has refused|2|||
155576950|NCT00110396|561535162|FG000|Overall Study|The patient has refused to visit site|1|||
155576951|NCT00110396|561535162|FG000|Overall Study|Patient is to be administered copaxone|1|||
155576952|NCT02414958|561535163|FG000|Overall Study|Adverse Event|6|||
155576953|NCT02414958|561535164|FG001|Overall Study|Adverse Event|6|||
155576954|NCT02414958|561535165|FG002|Overall Study|Adverse Event|3|||
155576955|NCT02414958|561535163|FG000|Overall Study|Protocol Violation|10|||
155576956|NCT02414958|561535164|FG001|Overall Study|Protocol Violation|3|||
155576957|NCT02414958|561535165|FG002|Overall Study|Protocol Violation|1|||
155576958|NCT02414958|561535163|FG000|Overall Study|Lost to Follow-up|7|||
155576959|NCT02414958|561535164|FG001|Overall Study|Lost to Follow-up|4|||
155576960|NCT02414958|561535165|FG002|Overall Study|Lost to Follow-up|0|||
155576961|NCT02414958|561535163|FG000|Overall Study|Withdrawal by Subject|5|||
155576962|NCT02414958|561535164|FG001|Overall Study|Withdrawal by Subject|3|||
155576963|NCT02414958|561535165|FG002|Overall Study|Withdrawal by Subject|5|||
155576964|NCT02414958|561535163|FG000|Overall Study|Other than specified|4|||
155576965|NCT02414958|561535164|FG001|Overall Study|Other than specified|4|||
155576966|NCT02414958|561535165|FG002|Overall Study|Other than specified|5|||
155576967|NCT01269918|561535166|FG000|Overall Study|Did not receive study drug|0|||
155576968|NCT01269918|561535167|FG001|Overall Study|Did not receive study drug|3|||
155576969|NCT02500589|561535169|FG000|Overall Study|Withdrawal by Subject|11|||
155576970|NCT02500589|561535170|FG001|Overall Study|Withdrawal by Subject|14|||
155576971|NCT02500589|561535169|FG000|Overall Study|Lost to Follow-up|10|||
155576972|NCT02500589|561535170|FG001|Overall Study|Lost to Follow-up|12|||
155576973|NCT02500589|561535169|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
155576974|NCT02500589|561535170|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
155576975|NCT02500589|561535169|FG000|Overall Study|Death|7|||
155576976|NCT02500589|561535170|FG001|Overall Study|Death|5|||
155576977|NCT00245466|561535171|FG000|Overall Study|Adverse Event|2|||
155576978|NCT00245466|561535172|FG001|Overall Study|Adverse Event|8|||
155576979|NCT00245466|561535173|FG002|Overall Study|Adverse Event|4|||
155576980|NCT00245466|561535171|FG000|Overall Study|Low prostate specific antigen suppr|16|||
155576981|NCT00245466|561535172|FG001|Overall Study|Low prostate specific antigen suppr|14|||
155576982|NCT00245466|561535173|FG002|Overall Study|Low prostate specific antigen suppr|5|||
155576983|NCT00245466|561535171|FG000|Overall Study|Insufficient testosterone suppr|12|||
155576984|NCT00245466|561535172|FG001|Overall Study|Insufficient testosterone suppr|12|||
155576985|NCT00245466|561535173|FG002|Overall Study|Insufficient testosterone suppr|21|||
155576986|NCT00245466|561535171|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
155576987|NCT00245466|561535172|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
155576988|NCT00245466|561535173|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
155576989|NCT00245466|561535171|FG000|Overall Study|Withdrawal by Subject|2|||
155576990|NCT00245466|561535172|FG001|Overall Study|Withdrawal by Subject|2|||
155576991|NCT00245466|561535173|FG002|Overall Study|Withdrawal by Subject|1|||
155576992|NCT00245466|561535171|FG000|Overall Study|Lost to Follow-up|3|||
155576993|NCT00245466|561535172|FG001|Overall Study|Lost to Follow-up|0|||
155576994|NCT00245466|561535173|FG002|Overall Study|Lost to Follow-up|0|||
155576995|NCT00245466|561535171|FG000|Overall Study|Disease progression|0|||
155576996|NCT00245466|561535172|FG001|Overall Study|Disease progression|3|||
155576997|NCT00245466|561535173|FG002|Overall Study|Disease progression|1|||
155576998|NCT00245466|561535171|FG000|Overall Study|Protocol Violation|1|||
155576999|NCT00245466|561535172|FG001|Overall Study|Protocol Violation|2|||
155577000|NCT00245466|561535173|FG002|Overall Study|Protocol Violation|2|||
155577001|NCT00245466|561535171|FG000|Overall Study|Death|0|||
155577002|NCT00245466|561535172|FG001|Overall Study|Death|2|||
155577003|NCT00245466|561535173|FG002|Overall Study|Death|0|||
155577004|NCT00245466|561535171|FG000|Overall Study|Administrative reasons|0|||
155577005|NCT00245466|561535172|FG001|Overall Study|Administrative reasons|1|||
155577006|NCT00245466|561535173|FG002|Overall Study|Administrative reasons|0|||
155577007|NCT00856193|561535174|FG000|Period 2|Abnormal test procedure results|0|||
155577008|NCT00856193|561535175|FG001|Period 2|Abnormal test procedure results|1|||
155577009|NCT00856193|561535174|FG000|Period 2|Lost to Follow-up|0|||
155661854|NCT05173974|561858140|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155661855|NCT05173974|561858141|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
155661856|NCT05173974|561858138|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155577010|NCT00856193|561535175|FG001|Period 2|Lost to Follow-up|1|||
155577011|NCT05064397|561535176|FG000|Overall Study|Adverse Event|4|||
155661857|NCT05173974|561858139|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
155661858|NCT05173974|561858140|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155577012|NCT05064397|561535176|FG000|Overall Study|Lack of Efficacy|12|||
155577013|NCT05064397|561535176|FG000|Overall Study|Withdrawal by Subject|3|||
155577014|NCT05064397|561535176|FG000|Overall Study|Lost to Follow-up|1|||
155577015|NCT05064397|561535176|FG000|Overall Study|Other reasons|3|||
155577016|NCT03934541|561535179|FG000|Overall Study|Study Terminated by Sponsor|0|||
155577017|NCT03934541|561535180|FG001|Overall Study|Study Terminated by Sponsor|1|||
155577018|NCT03934541|561535181|FG002|Overall Study|Study Terminated by Sponsor|0|||
155577019|NCT03934541|561535182|FG003|Overall Study|Study Terminated by Sponsor|0|||
155577020|NCT01783886|561535189|FG000|Overall Study|Lost to Follow-up|0|||
155661859|NCT05173974|561858141|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155661860|NCT03289143|561858142|FG000|Overall Study|Caregiver Unavailability|1|||
155661861|NCT03289143|561858143|FG001|Overall Study|Caregiver Unavailability|1|||
155661862|NCT03289143|561858144|FG002|Overall Study|Caregiver Unavailability|0|||
155661863|NCT03289143|561858145|FG003|Overall Study|Caregiver Unavailability|0|||
155661864|NCT03289143|561858142|FG000|Overall Study|Research Department Closure|0|||
155661865|NCT03289143|561858143|FG001|Overall Study|Research Department Closure|0|||
155661866|NCT03289143|561858144|FG002|Overall Study|Research Department Closure|1|||
155661867|NCT03289143|561858145|FG003|Overall Study|Research Department Closure|0|||
155661868|NCT03289143|561858142|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155661869|NCT03289143|561858143|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155661870|NCT03289143|561858144|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
155661871|NCT03289143|561858145|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155661872|NCT03289143|561858142|FG000|Overall Study|Medical Monitor Decision|1|||
155661873|NCT03289143|561858143|FG001|Overall Study|Medical Monitor Decision|0|||
155661874|NCT03289143|561858144|FG002|Overall Study|Medical Monitor Decision|0|||
155661875|NCT03289143|561858145|FG003|Overall Study|Medical Monitor Decision|0|||
155661876|NCT03289143|561858142|FG000|Overall Study|Participant Non-Compliance|0|||
155661877|NCT03289143|561858143|FG001|Overall Study|Participant Non-Compliance|0|||
155661878|NCT03289143|561858144|FG002|Overall Study|Participant Non-Compliance|1|||
155661879|NCT03289143|561858145|FG003|Overall Study|Participant Non-Compliance|0|||
155661880|NCT03289143|561858142|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155661881|NCT03289143|561858143|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155661882|NCT03289143|561858144|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
155661883|NCT03289143|561858145|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155661884|NCT03289143|561858142|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155661885|NCT03289143|561858143|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155661886|NCT03289143|561858144|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
155661887|NCT03289143|561858145|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155661888|NCT03289143|561858142|FG000|Overall Study|Caregiver Passed Away|1|||
155661889|NCT03289143|561858143|FG001|Overall Study|Caregiver Passed Away|0|||
155661890|NCT03289143|561858144|FG002|Overall Study|Caregiver Passed Away|0|||
155661891|NCT03289143|561858145|FG003|Overall Study|Caregiver Passed Away|0|||
155661892|NCT03289143|561858142|FG000|Overall Study|Physician Decision|0|||
155661893|NCT03289143|561858143|FG001|Overall Study|Physician Decision|2|||
155661894|NCT03289143|561858144|FG002|Overall Study|Physician Decision|2|||
155661895|NCT03289143|561858145|FG003|Overall Study|Physician Decision|2|||
155661896|NCT03289143|561858142|FG000|Overall Study|Protocol Deviation|2|||
155661897|NCT03289143|561858143|FG001|Overall Study|Protocol Deviation|1|||
155661898|NCT03289143|561858144|FG002|Overall Study|Protocol Deviation|3|||
155661899|NCT03289143|561858145|FG003|Overall Study|Protocol Deviation|1|||
155661900|NCT03289143|561858142|FG000|Overall Study|Study Terminated By Sponsor|101|||
155661901|NCT03289143|561858143|FG001|Overall Study|Study Terminated By Sponsor|75|||
155661902|NCT03289143|561858144|FG002|Overall Study|Study Terminated By Sponsor|100|||
155661903|NCT03289143|561858145|FG003|Overall Study|Study Terminated By Sponsor|69|||
155661904|NCT03289143|561858142|FG000|Overall Study|Withdrawal by Subject|14|||
155661905|NCT03289143|561858143|FG001|Overall Study|Withdrawal by Subject|6|||
155661906|NCT03289143|561858144|FG002|Overall Study|Withdrawal by Subject|14|||
155661907|NCT03289143|561858145|FG003|Overall Study|Withdrawal by Subject|12|||
155661908|NCT03289143|561858142|FG000|Overall Study|Adverse Event|10|||
155661909|NCT03289143|561858143|FG001|Overall Study|Adverse Event|7|||
155661910|NCT03289143|561858144|FG002|Overall Study|Adverse Event|6|||
155661911|NCT03289143|561858145|FG003|Overall Study|Adverse Event|5|||
155661912|NCT03289143|561858142|FG000|Overall Study|Death|2|||
155661913|NCT03289143|561858143|FG001|Overall Study|Death|0|||
155661914|NCT03289143|561858144|FG002|Overall Study|Death|2|||
155661915|NCT03289143|561858145|FG003|Overall Study|Death|1|||
155661916|NCT03289143|561858142|FG000|Overall Study|Lost to Follow-up|2|||
155661917|NCT03289143|561858143|FG001|Overall Study|Lost to Follow-up|1|||
155661918|NCT03289143|561858144|FG002|Overall Study|Lost to Follow-up|1|||
155661919|NCT03289143|561858145|FG003|Overall Study|Lost to Follow-up|0|||
155661920|NCT03289143|561858142|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
155661921|NCT03289143|561858143|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
155661922|NCT03289143|561858144|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
155661923|NCT03289143|561858145|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
155661924|NCT03289143|561858142|FG000|Overall Study|Withdrawal by Caregiver|0|||
155661925|NCT03289143|561858143|FG001|Overall Study|Withdrawal by Caregiver|1|||
155661926|NCT03289143|561858144|FG002|Overall Study|Withdrawal by Caregiver|0|||
155661927|NCT03289143|561858145|FG003|Overall Study|Withdrawal by Caregiver|0|||
155661928|NCT03289143|561858142|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155661929|NCT03289143|561858143|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155661930|NCT03289143|561858144|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
155577021|NCT01783886|561535190|FG001|Overall Study|Lost to Follow-up|3|||
155577022|NCT01783886|561535191|FG002|Overall Study|Lost to Follow-up|0|||
155577023|NCT01783886|561535189|FG000|Overall Study|Protocol deviation|0|||
155577024|NCT01783886|561535190|FG001|Overall Study|Protocol deviation|0|||
155577025|NCT01783886|561535191|FG002|Overall Study|Protocol deviation|2|||
155577026|NCT01783886|561535189|FG000|Overall Study|Withdrawal of consent by participant|1|||
155577027|NCT01783886|561535190|FG001|Overall Study|Withdrawal of consent by participant|3|||
155577028|NCT01783886|561535191|FG002|Overall Study|Withdrawal of consent by participant|4|||
155577029|NCT01783886|561535189|FG000|Overall Study|Adverse Event|4|||
155577030|NCT01783886|561535190|FG001|Overall Study|Adverse Event|5|||
155577031|NCT01783886|561535191|FG002|Overall Study|Adverse Event|4|||
155577032|NCT02324582|561535194|FG000|Overall Study|Screen Failures|0|||
155577033|NCT02324582|561535195|FG001|Overall Study|Screen Failures|5|||
155577034|NCT03624192|561535196|FG000|Overall Study|Lost to Follow-up|1|||
155577035|NCT03624192|561535197|FG001|Overall Study|Lost to Follow-up|1|||
155577036|NCT04660331|561535198|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
155577037|NCT04660331|561535199|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
155577038|NCT04660331|561535200|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
155577039|NCT00786409|561535203|FG000|Overall Study|Withdrawal by Subject|2|||
155577040|NCT00786409|561535203|FG000|Overall Study|Adverse Event|2|||
155577041|NCT00786409|561535203|FG000|Overall Study|Pregnancy|2|||
155577042|NCT00786409|561535203|FG000|Overall Study|Lost to Follow-up|1|||
155577043|NCT00610129|561535204|FG000|Overall Study|Not treated since patients ineligible|3|||
155577044|NCT00952731|561535207|FG000|Overall Study|Drug supply expired|1|||
155577045|NCT00952731|561535208|FG001|Overall Study|Drug supply expired|0|||
155577046|NCT01329900|561535209|FG000|Overall Study|Elevated creatinine/renal function|1|||
155577047|NCT01866098|561535214|FG000|Overall Study|Lost to Follow-up|11|||
155577048|NCT01866098|561535215|FG001|Overall Study|Lost to Follow-up|18|||
155577049|NCT01866098|561535216|FG002|Overall Study|Lost to Follow-up|13|||
155577050|NCT01866098|561535214|FG000|Overall Study|Physician Decision|0|||
155577051|NCT01866098|561535215|FG001|Overall Study|Physician Decision|1|||
155577052|NCT01866098|561535216|FG002|Overall Study|Physician Decision|2|||
155577053|NCT01866098|561535214|FG000|Overall Study|Adverse Event|1|||
155577054|NCT01866098|561535215|FG001|Overall Study|Adverse Event|5|||
155577055|NCT01866098|561535216|FG002|Overall Study|Adverse Event|4|||
155577056|NCT01866098|561535214|FG000|Overall Study|Protocol Violation|1|||
155577057|NCT01866098|561535215|FG001|Overall Study|Protocol Violation|0|||
155577058|NCT01866098|561535216|FG002|Overall Study|Protocol Violation|0|||
155577059|NCT01866098|561535214|FG000|Overall Study|Withdrawal by Subject|1|||
155577060|NCT01866098|561535215|FG001|Overall Study|Withdrawal by Subject|2|||
155577061|NCT01866098|561535216|FG002|Overall Study|Withdrawal by Subject|0|||
155577062|NCT01866098|561535214|FG000|Overall Study|Unrelated Hospitalization|2|||
155577063|NCT01866098|561535215|FG001|Overall Study|Unrelated Hospitalization|0|||
155577064|NCT01866098|561535216|FG002|Overall Study|Unrelated Hospitalization|1|||
155577065|NCT01866098|561535214|FG000|Overall Study|Non-compliance|1|||
155577066|NCT01866098|561535215|FG001|Overall Study|Non-compliance|0|||
155577067|NCT01866098|561535216|FG002|Overall Study|Non-compliance|1|||
155577068|NCT01866098|561535214|FG000|Overall Study|Pregnancy|2|||
155577069|NCT01866098|561535215|FG001|Overall Study|Pregnancy|0|||
155577070|NCT01866098|561535216|FG002|Overall Study|Pregnancy|0|||
155577071|NCT01866098|561535214|FG000|Overall Study|Death|0|||
155577072|NCT01866098|561535215|FG001|Overall Study|Death|1|||
155577073|NCT01866098|561535216|FG002|Overall Study|Death|0|||
155577074|NCT01184079|561535217|FG000|Overall Study|Lost to Follow-up|14|||
155577075|NCT01184079|561535218|FG001|Overall Study|Lost to Follow-up|2|||
155577076|NCT03172494|561535219|FG000|Overall Study|Adverse Event|5|||
155577077|NCT03172494|561535220|FG001|Overall Study|Adverse Event|1|||
155577078|NCT03172494|561535221|FG002|Overall Study|Adverse Event|15|||
155577079|NCT03172494|561535219|FG000|Overall Study|Protocol Violation|3|||
155577080|NCT03172494|561535220|FG001|Overall Study|Protocol Violation|2|||
155577081|NCT03172494|561535221|FG002|Overall Study|Protocol Violation|1|||
155577082|NCT03172494|561535219|FG000|Overall Study|Lack of Efficacy|0|||
155577083|NCT03172494|561535220|FG001|Overall Study|Lack of Efficacy|0|||
155577084|NCT03172494|561535221|FG002|Overall Study|Lack of Efficacy|4|||
155577085|NCT03172494|561535219|FG000|Overall Study|Pregnancy|0|||
155577086|NCT03172494|561535220|FG001|Overall Study|Pregnancy|1|||
155577087|NCT03172494|561535221|FG002|Overall Study|Pregnancy|0|||
155577088|NCT03172494|561535219|FG000|Overall Study|Withdrawal by Subject|10|||
155577089|NCT03172494|561535220|FG001|Overall Study|Withdrawal by Subject|8|||
155577090|NCT03172494|561535221|FG002|Overall Study|Withdrawal by Subject|8|||
155577091|NCT03172494|561535219|FG000|Overall Study|Severe hypoglycaemic episode|0|||
155577092|NCT03172494|561535220|FG001|Overall Study|Severe hypoglycaemic episode|0|||
155577093|NCT03172494|561535221|FG002|Overall Study|Severe hypoglycaemic episode|1|||
155577094|NCT03172494|561535219|FG000|Overall Study|Non-compliance towards treatment|2|||
155577095|NCT03172494|561535220|FG001|Overall Study|Non-compliance towards treatment|0|||
155577096|NCT03172494|561535221|FG002|Overall Study|Non-compliance towards treatment|0|||
155577097|NCT00041132|561535223|FG000|Overall Study|Adverse Event|19|||
155577098|NCT00041132|561535223|FG000|Overall Study|Death|1|||
155577099|NCT00041132|561535223|FG000|Overall Study|Not Eligible|7|||
155577100|NCT00041132|561535223|FG000|Overall Study|Withdrawal by Subject|1|||
155577101|NCT00041132|561535223|FG000|Overall Study|Physician Decision|2|||
155577102|NCT04467840|561536995|FG000|Overall Study|Death|35|||
155577103|NCT04467840|561536996|FG001|Overall Study|Death|39|||
155577104|NCT04467840|561536995|FG000|Overall Study|Withdrawal by Subject|8|||
155577105|NCT04467840|561536996|FG001|Overall Study|Withdrawal by Subject|4|||
155577106|NCT04467840|561536995|FG000|Overall Study|Adverse Event|2|||
155577107|NCT04467840|561536996|FG001|Overall Study|Adverse Event|0|||
155577108|NCT04467840|561536995|FG000|Overall Study|Lost to Follow-up|1|||
155577109|NCT04467840|561536996|FG001|Overall Study|Lost to Follow-up|3|||
155577110|NCT04467840|561536995|FG000|Overall Study|Physician Decision|1|||
155577111|NCT04467840|561536996|FG001|Overall Study|Physician Decision|0|||
155577112|NCT04467840|561536995|FG000|Overall Study|Other|1|||
155577113|NCT04467840|561536996|FG001|Overall Study|Other|5|||
155577114|NCT04467840|561536995|FG000|Overall Study|Missing study completion status|3|||
155577115|NCT04467840|561536996|FG001|Overall Study|Missing study completion status|1|||
155577116|NCT06082843|561537001|FG000|Overall Study|Withdrawal by Subject|0|||
155577117|NCT06082843|561537002|FG001|Overall Study|Withdrawal by Subject|2|||
155577118|NCT06082843|561537001|FG000|Overall Study|Study terminated by sponsor|12|||
155577119|NCT06082843|561537002|FG001|Overall Study|Study terminated by sponsor|8|||
155577120|NCT04054765|561537006|FG000|Baseline|Withdrawal by Subject|5|||
155577121|NCT04054765|561537007|FG001|Baseline|Withdrawal by Subject|3|||
155577122|NCT04054765|561537006|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
155577123|NCT04054765|561537007|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
155577124|NCT04054765|561537006|FG000|3-month Follow up|Withdrawal by Subject|0|||
155577125|NCT04054765|561537007|FG001|3-month Follow up|Withdrawal by Subject|3|||
155577126|NCT04054765|561537006|FG000|6-month Follow up|Lost to Follow-up|32|||
155577127|NCT04054765|561537007|FG001|6-month Follow up|Lost to Follow-up|32|||
155577128|NCT01290068|561537011|FG000|Overall Study|Adverse Event|1|||
155577129|NCT01290068|561537012|FG001|Overall Study|Adverse Event|3|||
155577130|NCT01290068|561537011|FG000|Overall Study|Lost to Follow-up|3|||
155577131|NCT01290068|561537012|FG001|Overall Study|Lost to Follow-up|0|||
155577132|NCT01290068|561537011|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
155577133|NCT01290068|561537012|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
155577134|NCT01290068|561537011|FG000|Overall Study|Other|3|||
155577135|NCT01290068|561537012|FG001|Overall Study|Other|1|||
155577136|NCT00793871|561537015|FG000|Overall Study|Death|50|||
155577137|NCT00793871|561537015|FG000|Overall Study|Lost to Follow-up|3|||
155577138|NCT00793871|561537015|FG000|Overall Study|Study terminated by the Sponsor|7|||
155577139|NCT01928472|561537016|FG000|Overall Study|Death|0|||
155577140|NCT01928472|561537017|FG001|Overall Study|Death|0|||
155577141|NCT01928472|561537018|FG002|Overall Study|Death|1|||
155577142|NCT01928472|561537019|FG003|Overall Study|Death|0|||
155577143|NCT01928472|561537016|FG000|Overall Study|Withdrawal by Subject|4|||
155577144|NCT01928472|561537017|FG001|Overall Study|Withdrawal by Subject|4|||
155577145|NCT01928472|561537018|FG002|Overall Study|Withdrawal by Subject|1|||
155577146|NCT01928472|561537019|FG003|Overall Study|Withdrawal by Subject|2|||
155577147|NCT01928472|561537016|FG000|Overall Study|Lost to Follow-up|2|||
155577148|NCT01928472|561537017|FG001|Overall Study|Lost to Follow-up|3|||
155577149|NCT01928472|561537018|FG002|Overall Study|Lost to Follow-up|4|||
155577150|NCT01928472|561537019|FG003|Overall Study|Lost to Follow-up|0|||
155577151|NCT01928472|561537016|FG000|Overall Study|Administrative Reason|2|||
155577152|NCT01928472|561537017|FG001|Overall Study|Administrative Reason|1|||
155577153|NCT01928472|561537018|FG002|Overall Study|Administrative Reason|0|||
155577154|NCT01928472|561537019|FG003|Overall Study|Administrative Reason|0|||
155577155|NCT01928472|561537016|FG000|Overall Study|Unclassified|0|||
155577156|NCT01928472|561537017|FG001|Overall Study|Unclassified|0|||
155577157|NCT01928472|561537018|FG002|Overall Study|Unclassified|1|||
155577158|NCT01928472|561537019|FG003|Overall Study|Unclassified|0|||
155577159|NCT00307086|561537020|FG000|Overall Study|ineligible|5|||
155577160|NCT00065156|561537021|FG000|Overall Study|Adverse Event|37|||
155577161|NCT00065156|561537021|FG000|Overall Study|Lack of Efficacy|52|||
155577162|NCT00065156|561537021|FG000|Overall Study|Withdrawal by Subject|8|||
155577163|NCT00065156|561537021|FG000|Overall Study|Lost to Follow-up|1|||
155577164|NCT00065156|561537021|FG000|Overall Study|Death|11|||
155577165|NCT00065156|561537021|FG000|Overall Study|Study Closed by Sponsor|2|||
155577166|NCT00065156|561537021|FG000|Overall Study|Disease Progression|7|||
155577167|NCT00065156|561537021|FG000|Overall Study|Investigator Decision|2|||
155577168|NCT00065156|561537021|FG000|Overall Study|Non-Compliance|2|||
155577169|NCT00065156|561537021|FG000|Overall Study|Loss of Response|1|||
155577170|NCT00065156|561537021|FG000|Overall Study|Secondary Malign Disease|1|||
155577171|NCT04583735|561537022|FG000|Double-masked Treatment Period|Adverse Event|0|||
155577172|NCT04583735|561537023|FG001|Double-masked Treatment Period|Adverse Event|1|||
155577173|NCT04583735|561537022|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
155577174|NCT04583735|561537023|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
155577175|NCT04583735|561537022|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
155577176|NCT04583735|561537023|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
155577177|NCT04583735|561537022|FG000|Open-label Treatment Period|Adverse Event|1|||
155577178|NCT04583735|561537023|FG001|Open-label Treatment Period|Adverse Event|1|||
155577179|NCT04583735|561537022|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
155577180|NCT04583735|561537023|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155577181|NCT04583735|561537022|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155577182|NCT04583735|561537023|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
155577183|NCT01176513|561537024|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
155577184|NCT01197911|561537025|FG000|Overall Study|Adverse Event|0|||
155577185|NCT01197911|561537026|FG001|Overall Study|Adverse Event|0|||
155577186|NCT01197911|561537027|FG002|Overall Study|Adverse Event|1|||
155577187|NCT00838526|561537030|FG000|Overall Study|Adverse Event|3|||
155577188|NCT00838526|561537031|FG001|Overall Study|Adverse Event|12|||
155577189|NCT00838526|561537030|FG000|Overall Study|Lost to Follow-up|4|||
155577190|NCT00838526|561537031|FG001|Overall Study|Lost to Follow-up|12|||
155577191|NCT00838526|561537030|FG000|Overall Study|Withdrawal by Subject|4|||
155577192|NCT00838526|561537031|FG001|Overall Study|Withdrawal by Subject|5|||
155577193|NCT00838526|561537030|FG000|Overall Study|Lack of Efficacy|2|||
155577194|NCT00838526|561537031|FG001|Overall Study|Lack of Efficacy|3|||
155577195|NCT00838526|561537030|FG000|Overall Study|Other|11|||
155577196|NCT00838526|561537031|FG001|Overall Study|Other|7|||
155577197|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
155577198|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
155577199|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
155577200|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
155577201|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
155577202|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
155577203|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
155577204|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
155577205|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
155577206|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
155577207|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
155577208|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
155577209|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
155577210|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
155577211|NCT04338022|561537034|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
155577212|NCT04338022|561537035|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
155577213|NCT04338022|561537034|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
155577214|NCT04338022|561537035|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
155577215|NCT04338022|561537034|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
155577216|NCT04338022|561537035|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
155577217|NCT04338022|561537034|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
155577218|NCT04338022|561537035|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
155577219|NCT04338022|561537034|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
155577220|NCT04338022|561537035|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
155577221|NCT04338022|561537034|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
155577222|NCT04338022|561537035|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
155577223|NCT04338022|561537034|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
155577224|NCT04338022|561537035|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
155577225|NCT05724589|561537040|FG000|Overall Study|Lost to Follow-up|1|||
155577226|NCT02466321|561537041|FG000|Overall Study|Death|26|||
155577227|NCT02466321|561537041|FG000|Overall Study|Revision|6|||
155577228|NCT02466321|561537041|FG000|Overall Study|Lost to Follow-up|60|||
155577229|NCT02466321|561537041|FG000|Overall Study|Did not receive study device|1|||
155577230|NCT02273388|561537043|FG000|Overall Study|Adverse Event|0|||
155577231|NCT02273388|561537044|FG001|Overall Study|Adverse Event|0|||
155577232|NCT02273388|561537045|FG002|Overall Study|Adverse Event|0|||
155577233|NCT02273388|561537046|FG003|Overall Study|Adverse Event|0|||
155577234|NCT02273388|561537047|FG004|Overall Study|Adverse Event|0|||
155577235|NCT02273388|561537048|FG005|Overall Study|Adverse Event|0|||
155577236|NCT02273388|561537049|FG006|Overall Study|Adverse Event|1|||
155577237|NCT02273388|561537050|FG007|Overall Study|Adverse Event|2|||
155577238|NCT02273388|561537051|FG008|Overall Study|Adverse Event|0|||
155577239|NCT02273388|561537052|FG009|Overall Study|Adverse Event|0|||
155577240|NCT02273388|561537053|FG010|Overall Study|Adverse Event|0|||
155577241|NCT02273388|561537054|FG011|Overall Study|Adverse Event|0|||
155577242|NCT02273388|561537043|FG000|Overall Study|Adverse Event study disease worse|4|||
155577243|NCT02273388|561537044|FG001|Overall Study|Adverse Event study disease worse|3|||
155577244|NCT02273388|561537045|FG002|Overall Study|Adverse Event study disease worse|3|||
155577245|NCT02273388|561537046|FG003|Overall Study|Adverse Event study disease worse|2|||
155577246|NCT02273388|561537047|FG004|Overall Study|Adverse Event study disease worse|4|||
155577247|NCT02273388|561537048|FG005|Overall Study|Adverse Event study disease worse|3|||
155577248|NCT02273388|561537049|FG006|Overall Study|Adverse Event study disease worse|14|||
155577249|NCT02273388|561537050|FG007|Overall Study|Adverse Event study disease worse|6|||
155577250|NCT02273388|561537051|FG008|Overall Study|Adverse Event study disease worse|6|||
155577251|NCT02273388|561537052|FG009|Overall Study|Adverse Event study disease worse|5|||
155577252|NCT02273388|561537053|FG010|Overall Study|Adverse Event study disease worse|10|||
155577253|NCT02273388|561537054|FG011|Overall Study|Adverse Event study disease worse|1|||
155577254|NCT02273388|561537043|FG000|Overall Study|Sponsor decision|0|||
155577255|NCT02273388|561537044|FG001|Overall Study|Sponsor decision|0|||
155577256|NCT02273388|561537045|FG002|Overall Study|Sponsor decision|0|||
155577257|NCT02273388|561537046|FG003|Overall Study|Sponsor decision|0|||
155577258|NCT02273388|561537047|FG004|Overall Study|Sponsor decision|0|||
155577259|NCT02273388|561537048|FG005|Overall Study|Sponsor decision|0|||
155577260|NCT02273388|561537049|FG006|Overall Study|Sponsor decision|0|||
155577261|NCT02273388|561537050|FG007|Overall Study|Sponsor decision|0|||
155577262|NCT02273388|561537051|FG008|Overall Study|Sponsor decision|0|||
155577263|NCT02273388|561537052|FG009|Overall Study|Sponsor decision|0|||
155577264|NCT02273388|561537053|FG010|Overall Study|Sponsor decision|0|||
155577265|NCT02273388|561537054|FG011|Overall Study|Sponsor decision|1|||
155577266|NCT04331808|561537055|FG000|Overall Study|Withdrew consent|1|||
155577267|NCT04331808|561537056|FG001|Overall Study|Withdrew consent|0|||
155577268|NCT04331808|561537057|FG002|Overall Study|Withdrew consent|2|||
155577269|NCT04331808|561537058|FG003|Overall Study|Withdrew consent|3|||
155577270|NCT01855828|561537059|FG000|Overall Study|Adverse Event|1|||
155577271|NCT01855828|561537059|FG000|Overall Study|Withdrawal by Subject|1|||
155577272|NCT04239027|561537063|FG000|Overall Study|Adverse Event|4|||
155577273|NCT04239027|561537063|FG000|Overall Study|Withdrawal by Subject|9|||
155577274|NCT04239027|561537063|FG000|Overall Study|Death|1|||
155577275|NCT04239027|561537063|FG000|Overall Study|Physician Decision|9|||
155577276|NCT04239027|561537063|FG000|Overall Study|Lost to Follow-up|2|||
155577277|NCT04239027|561537063|FG000|Overall Study|Lack of Efficacy|1|||
155577278|NCT04233073|561537070|FG000|Overall Study|Death|5|||
155577279|NCT00243412|561537071|FG000|Overall Study|Death|0|||
155577280|NCT00243412|561537072|FG001|Overall Study|Death|1|||
155577281|NCT00243412|561537071|FG000|Overall Study|Adverse Event|4|||
155577282|NCT00243412|561537072|FG001|Overall Study|Adverse Event|2|||
155577283|NCT00243412|561537071|FG000|Overall Study|Lost to Follow-up|0|||
155577284|NCT00243412|561537072|FG001|Overall Study|Lost to Follow-up|1|||
155577285|NCT00243412|561537071|FG000|Overall Study|Physician Decision|1|||
155577286|NCT00243412|561537072|FG001|Overall Study|Physician Decision|1|||
155577287|NCT00243412|561537071|FG000|Overall Study|Withdrawal by Subject|4|||
155577288|NCT00243412|561537072|FG001|Overall Study|Withdrawal by Subject|5|||
155577289|NCT00243412|561537071|FG000|Overall Study|Other|1|||
155577290|NCT00243412|561537072|FG001|Overall Study|Other|1|||
155577291|NCT00143390|561537073|FG000|Overall Study|Death|2|||
155577292|NCT00143390|561537074|FG001|Overall Study|Death|0|||
155577293|NCT00143390|561537073|FG000|Overall Study|Not meeting entry criteria|2|||
155577294|NCT00143390|561537074|FG001|Overall Study|Not meeting entry criteria|5|||
155577295|NCT00143390|561537073|FG000|Overall Study|Withdrawal by Subject|4|||
155577296|NCT00143390|561537074|FG001|Overall Study|Withdrawal by Subject|4|||
155577297|NCT00143390|561537073|FG000|Overall Study|Progressive disease|119|||
155577298|NCT00143390|561537074|FG001|Overall Study|Progressive disease|115|||
155577299|NCT00143390|561537073|FG000|Overall Study|Protocol Violation|2|||
155577300|NCT00143390|561537074|FG001|Overall Study|Protocol Violation|0|||
155577301|NCT00143390|561537073|FG000|Overall Study|Study termination|10|||
155577302|NCT00143390|561537074|FG001|Overall Study|Study termination|15|||
155577303|NCT00143390|561537073|FG000|Overall Study|Adverse Event|9|||
155577304|NCT00143390|561537074|FG001|Overall Study|Adverse Event|8|||
155577305|NCT00143390|561537073|FG000|Overall Study|Other|1|||
155577306|NCT00143390|561537074|FG001|Overall Study|Other|2|||
155577307|NCT02764151|561537078|FG000|Overall Study|Subject refused further follow-up|0|||
155577308|NCT02764151|561537079|FG001|Overall Study|Subject refused further follow-up|0|||
155577309|NCT02764151|561537080|FG002|Overall Study|Subject refused further follow-up|0|||
155577310|NCT02764151|561537081|FG003|Overall Study|Subject refused further follow-up|1|||
155577311|NCT02764151|561537078|FG000|Overall Study|Other|0|||
155577312|NCT02764151|561537079|FG001|Overall Study|Other|0|||
155577313|NCT02764151|561537080|FG002|Overall Study|Other|0|||
155577314|NCT02764151|561537081|FG003|Overall Study|Other|2|||
155577315|NCT01450683|561537082|FG000|Overall Study|Adverse Event|2|||
155577316|NCT02108912|561537084|FG000|Overall Study|Lost to Follow-up|1|||
155577317|NCT02108912|561537085|FG001|Overall Study|Lost to Follow-up|1|||
155577318|NCT02108912|561537084|FG000|Overall Study|lack of transportation|1|||
155577319|NCT02108912|561537085|FG001|Overall Study|lack of transportation|0|||
155577320|NCT02108912|561537084|FG000|Overall Study|high blood pressure|1|||
155577321|NCT02108912|561537085|FG001|Overall Study|high blood pressure|0|||
155577322|NCT01523002|561537091|FG000|Period 1|Withdrawal by Subject|1|||
155577323|NCT01523002|561537092|FG001|Period 1|Withdrawal by Subject|3|||
155577324|NCT01523002|561537091|FG000|Period 1|Lost to Follow-up|1|||
155577325|NCT01523002|561537092|FG001|Period 1|Lost to Follow-up|0|||
155577326|NCT01523002|561537091|FG000|Period 1|Adverse Event|0|||
155577327|NCT01523002|561537092|FG001|Period 1|Adverse Event|8|||
155577328|NCT01523002|561537091|FG000|Period 2|Withdrawal by Subject|4|||
155577329|NCT01523002|561537092|FG001|Period 2|Withdrawal by Subject|1|||
155577330|NCT01523002|561537091|FG000|Period 2|Adverse Event|2|||
155577331|NCT01523002|561537092|FG001|Period 2|Adverse Event|5|||
155577332|NCT01523002|561537091|FG000|Period 3|Withdrawal by Subject|1|||
155577333|NCT01523002|561537092|FG001|Period 3|Withdrawal by Subject|0|||
155577334|NCT01523002|561537091|FG000|Period 3|Adverse Event|3|||
155577335|NCT01523002|561537092|FG001|Period 3|Adverse Event|0|||
155577336|NCT01256502|561537093|FG000|Overall Study|Had scaffold removed|4|||
155577337|NCT01256502|561537093|FG000|Overall Study|Personal reasons|5|||
155577338|NCT01256502|561537093|FG000|Overall Study|Protocol deviation|1|||
155577339|NCT00489255|561537094|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
155577340|NCT00489255|561537095|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
155577341|NCT00489255|561537094|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
155577342|NCT00489255|561537095|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
155577343|NCT00489255|561537094|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
155577344|NCT00489255|561537095|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
155577345|NCT00489255|561537094|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
155577346|NCT00489255|561537095|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
155577347|NCT00489255|561537094|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
155577348|NCT00489255|561537095|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
155577349|NCT00489255|561537094|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
155577350|NCT00489255|561537095|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
155577351|NCT00489255|561537094|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
155577352|NCT00489255|561537095|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
155577353|NCT00489255|561537094|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
155577354|NCT00489255|561537095|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
155577355|NCT00489255|561537094|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
155577356|NCT00489255|561537095|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
155577357|NCT00489255|561537094|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
155577358|NCT00489255|561537095|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
155577359|NCT03485352|561537096|FG000|Overall Study|Lost to Follow-up|9|||
155661931|NCT03289143|561858145|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155661932|NCT03289143|561858142|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155577360|NCT00852202|561537107|FG000|Overall Study|Adverse Event|2|||
155577361|NCT00852202|561537108|FG001|Overall Study|Adverse Event|3|||
155577362|NCT00852202|561537109|FG002|Overall Study|Adverse Event|7|||
155577363|NCT00852202|561537107|FG000|Overall Study|Lack of Efficacy|4|||
155577364|NCT00852202|561537108|FG001|Overall Study|Lack of Efficacy|1|||
155577365|NCT00852202|561537109|FG002|Overall Study|Lack of Efficacy|2|||
155577366|NCT00852202|561537107|FG000|Overall Study|Protocol Violation|2|||
155577367|NCT00852202|561537108|FG001|Overall Study|Protocol Violation|2|||
155577368|NCT00852202|561537109|FG002|Overall Study|Protocol Violation|7|||
155577369|NCT00852202|561537107|FG000|Overall Study|Withdrawal by Subject|3|||
155577370|NCT00852202|561537108|FG001|Overall Study|Withdrawal by Subject|1|||
155577371|NCT00852202|561537109|FG002|Overall Study|Withdrawal by Subject|2|||
155577372|NCT00852202|561537107|FG000|Overall Study|Lost to Follow-up|5|||
155661933|NCT03289143|561858143|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155661934|NCT03289143|561858144|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155661935|NCT03289143|561858145|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
155661936|NCT00730756|561858146|FG000|Overall Study|Adverse Event|2|||
155661937|NCT00730756|561858147|FG001|Overall Study|Adverse Event|0|||
155661938|NCT00730756|561858146|FG000|Overall Study|Lack of Efficacy|1|||
155661939|NCT00730756|561858147|FG001|Overall Study|Lack of Efficacy|1|||
155661940|NCT00730756|561858146|FG000|Overall Study|Protocol Deviation|1|||
155661941|NCT00730756|561858147|FG001|Overall Study|Protocol Deviation|2|||
155661942|NCT00730756|561858146|FG000|Overall Study|Lost to Follow-up|0|||
155661943|NCT00730756|561858147|FG001|Overall Study|Lost to Follow-up|1|||
155661944|NCT00730756|561858146|FG000|Overall Study|Withdrew Consent|0|||
155661945|NCT00730756|561858147|FG001|Overall Study|Withdrew Consent|1|||
155661946|NCT00948688|561858148|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
155661947|NCT00948688|561858149|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
155661948|NCT00948688|561858148|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
155661949|NCT00948688|561858149|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
155661950|NCT00948688|561858148|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
155661951|NCT00948688|561858149|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
155661952|NCT04388826|561858150|FG000|Overall Study|Lost to Follow-up|3|||
155661953|NCT04388826|561858151|FG001|Overall Study|Lost to Follow-up|2|||
155661954|NCT04388826|561858150|FG000|Overall Study|Adverse Event|1|||
155661955|NCT04388826|561858151|FG001|Overall Study|Adverse Event|0|||
155661956|NCT01146613|561858154|FG000|Overall Study|Lost to Follow-up|3|||
155661957|NCT01146613|561858155|FG001|Overall Study|Lost to Follow-up|8|||
155661958|NCT01146613|561858154|FG000|Overall Study|Lack of Efficacy|0|||
155661959|NCT01146613|561858155|FG001|Overall Study|Lack of Efficacy|1|||
155661960|NCT01146613|561858154|FG000|Overall Study|Death|1|||
155661961|NCT01146613|561858155|FG001|Overall Study|Death|0|||
155661962|NCT01146613|561858154|FG000|Overall Study|Physician Decision|1|||
155661963|NCT01146613|561858155|FG001|Overall Study|Physician Decision|0|||
155661964|NCT01146613|561858154|FG000|Overall Study|Withdrawal by Subject|0|||
155661965|NCT01146613|561858155|FG001|Overall Study|Withdrawal by Subject|3|||
155661966|NCT01146613|561858154|FG000|Overall Study|schedule conflict|1|||
155661967|NCT01146613|561858155|FG001|Overall Study|schedule conflict|0|||
155661968|NCT01146613|561858154|FG000|Overall Study|Outpatient detox|1|||
155661969|NCT01146613|561858155|FG001|Overall Study|Outpatient detox|0|||
155661970|NCT05878067|561858156|FG000|Overall Study|Lost to Follow-up|2|||
155661971|NCT01198587|561858157|FG000|Overall Study|Lost to Follow-up|8|||
155661972|NCT01198587|561858158|FG001|Overall Study|Lost to Follow-up|0|||
155661973|NCT01198587|561858159|FG002|Overall Study|Lost to Follow-up|9|||
155661974|NCT01198587|561858160|FG003|Overall Study|Lost to Follow-up|0|||
155661975|NCT01493089|561858161|FG000|Overall Study|Protocol Violation|2|||
155661976|NCT01493089|561858162|FG001|Overall Study|Protocol Violation|2|||
155661977|NCT01493089|561858161|FG000|Overall Study|Withdrawal by Subject|1|||
155661978|NCT01493089|561858162|FG001|Overall Study|Withdrawal by Subject|0|||
155661979|NCT01493089|561858161|FG000|Overall Study|Physician Decision|0|||
155661980|NCT01493089|561858162|FG001|Overall Study|Physician Decision|1|||
155661981|NCT00652834|561858170|FG000|Overall Study|Withdrawal by Subject|3|||
155661982|NCT00652834|561858170|FG000|Overall Study|Lost to Follow-up|2|||
155661983|NCT00399529|561858172|FG000|Overall Study|Off Study Prior to Treatment|2|||
155661984|NCT01170663|561858173|FG000|Overall Study|Lost to Follow-up|3|||
155661985|NCT01170663|561858174|FG001|Overall Study|Lost to Follow-up|9|||
155661986|NCT01170663|561858173|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
155661987|NCT01170663|561858174|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
155661988|NCT02746809|561858175|FG000|Enrollment|Inclusion Exclusion not met|9|||
155661989|NCT02746809|561858175|FG000|Enrollment|Withdrawal by Subject|1|||
155661990|NCT02746809|561858175|FG000|Enrollment|Expected Enrollment Met|2|||
155577373|NCT00852202|561537108|FG001|Overall Study|Lost to Follow-up|5|||
155577374|NCT00852202|561537109|FG002|Overall Study|Lost to Follow-up|6|||
155577375|NCT00852202|561537107|FG000|Overall Study|pregnancy,moving away and surgery|1|||
155577376|NCT00852202|561537108|FG001|Overall Study|pregnancy,moving away and surgery|0|||
155577377|NCT00852202|561537109|FG002|Overall Study|pregnancy,moving away and surgery|2|||
155577378|NCT00141778|561537114|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
155577379|NCT00141778|561537115|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
155577380|NCT00141778|561537116|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
155577381|NCT00141778|561537114|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
155661991|NCT02746809|561858175|FG000|Procedure|Death|1|||
155661992|NCT02746809|561858175|FG000|1-Month|Death|5|||
155661993|NCT02746809|561858175|FG000|6-Month|Death|2|||
155661994|NCT02746809|561858175|FG000|6-Month|Withdrawal by Subject|1|||
155661995|NCT02746809|561858175|FG000|12-Month|Death|3|||
155661996|NCT02746809|561858175|FG000|12-Month|Withdrawal by Subject|2|||
155661997|NCT02746809|561858175|FG000|24-Month|Death|1|||
155661998|NCT02746809|561858175|FG000|24-Month|Withdrawal by Subject|1|||
155661999|NCT02746809|561858175|FG000|36-Month|Death|8|||
155662000|NCT02746809|561858175|FG000|36-Month|Withdrawal by Subject|1|||
155662001|NCT02746809|561858175|FG000|48-Month|Death|7|||
155662002|NCT02746809|561858175|FG000|48-Month|Withdrawal by Subject|1|||
155662003|NCT02746809|561858175|FG000|60-Month|Death|1|||
155662004|NCT02746809|561858175|FG000|60-Month|Lost to Follow-up|2|||
155662005|NCT00742625|561858179|FG000|Remission Induction|Progression|6|||
155662006|NCT00742625|561858179|FG000|Remission Induction|Failed induction|8|||
155662007|NCT00742625|561858179|FG000|Remission Induction|Adverse Event|3|||
155662008|NCT00742625|561858179|FG000|Remission Induction|Death|10|||
155662009|NCT00742625|561858179|FG000|Remission Induction|Refusal|5|||
155662010|NCT00742625|561858179|FG000|Remission Induction|Non protocol treatment|17|||
155662011|NCT00742625|561858179|FG000|Remission Induction|Other, not specified|5|||
155662012|NCT00742625|561858179|FG000|Consolidation|Progression|5|||
155662013|NCT00742625|561858179|FG000|Consolidation|Adverse Event|1|||
155662014|NCT00742625|561858179|FG000|Consolidation|Death|1|||
155662015|NCT00742625|561858179|FG000|Consolidation|Refused|1|||
155662016|NCT00742625|561858179|FG000|Consolidation|Non protocol therapy|13|||
155662017|NCT01164007|561858180|FG000|Overall Study|Adverse Event|5|||
155662018|NCT01164007|561858180|FG000|Overall Study|Progression of Disease|30|||
155662019|NCT01164007|561858180|FG000|Overall Study|Protocol Violation|1|||
155662020|NCT01164007|561858180|FG000|Overall Study|Withdrawal by Subject|1|||
155662021|NCT01164007|561858180|FG000|Overall Study|Medical Decision|3|||
155662022|NCT00894387|561858181|FG000|Overall Study|Adverse Event|44|||
155662023|NCT00894387|561858182|FG001|Overall Study|Adverse Event|45|||
155662024|NCT00894387|561858181|FG000|Overall Study|Abnormal Laboratory values|2|||
155662025|NCT00894387|561858182|FG001|Overall Study|Abnormal Laboratory values|2|||
155662026|NCT00894387|561858181|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155662027|NCT00894387|561858182|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155662028|NCT00894387|561858181|FG000|Overall Study|Lost to Follow-up|3|||
155662029|NCT00894387|561858182|FG001|Overall Study|Lost to Follow-up|5|||
155662030|NCT00894387|561858181|FG000|Overall Study|Administrative problems|2|||
155662031|NCT00894387|561858182|FG001|Overall Study|Administrative problems|2|||
155662032|NCT00894387|561858181|FG000|Overall Study|Death|77|||
155662033|NCT00894387|561858182|FG001|Overall Study|Death|76|||
155662034|NCT00894387|561858181|FG000|Overall Study|Protocol Deviation|4|||
155662035|NCT00894387|561858182|FG001|Overall Study|Protocol Deviation|0|||
155662036|NCT00894387|561858181|FG000|Overall Study|Patient's request|25|||
155662037|NCT00894387|561858182|FG001|Overall Study|Patient's request|30|||
155662038|NCT00894387|561858181|FG000|Overall Study|Other (Missing)|5|||
155662039|NCT00894387|561858182|FG001|Overall Study|Other (Missing)|3|||
155662040|NCT00894387|561858181|FG000|Overall Study|Mis-randomized|13|||
155662041|NCT00894387|561858182|FG001|Overall Study|Mis-randomized|9|||
155662042|NCT00894387|561858181|FG000|Overall Study|GCP non-compliance|0|||
155662043|NCT00894387|561858182|FG001|Overall Study|GCP non-compliance|2|||
155662044|NCT01076010|561858183|FG000|Overall Study|Death|15|||
155662045|NCT01076010|561858184|FG001|Overall Study|Death|1|||
155662046|NCT01076010|561858185|FG002|Overall Study|Death|0|||
155662047|NCT01076010|561858183|FG000|Overall Study|Adverse Event|7|||
155662048|NCT01076010|561858184|FG001|Overall Study|Adverse Event|2|||
155662049|NCT01076010|561858185|FG002|Overall Study|Adverse Event|0|||
155662050|NCT01076010|561858183|FG000|Overall Study|Progressive disease|90|||
155662051|NCT01076010|561858184|FG001|Overall Study|Progressive disease|30|||
155662052|NCT01076010|561858185|FG002|Overall Study|Progressive disease|1|||
155662053|NCT01076010|561858183|FG000|Overall Study|Lack of Efficacy|4|||
155662054|NCT01076010|561858184|FG001|Overall Study|Lack of Efficacy|0|||
155662055|NCT01076010|561858185|FG002|Overall Study|Lack of Efficacy|0|||
155662056|NCT01076010|561858183|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
155662057|NCT01076010|561858184|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
155662058|NCT01076010|561858185|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
155662059|NCT01076010|561858183|FG000|Overall Study|Significant Surgical Procedure|0|||
155662060|NCT01076010|561858184|FG001|Overall Study|Significant Surgical Procedure|1|||
155662061|NCT01076010|561858185|FG002|Overall Study|Significant Surgical Procedure|0|||
155662062|NCT01076010|561858183|FG000|Overall Study|Protocol Violation|0|||
155662063|NCT01076010|561858184|FG001|Overall Study|Protocol Violation|1|||
155662064|NCT01076010|561858185|FG002|Overall Study|Protocol Violation|0|||
155662065|NCT01076010|561858183|FG000|Overall Study|Noncompliance|1|||
155662066|NCT01076010|561858184|FG001|Overall Study|Noncompliance|1|||
155662067|NCT01076010|561858185|FG002|Overall Study|Noncompliance|0|||
155662068|NCT01076010|561858183|FG000|Overall Study|Withdrawal by Subject|3|||
155662069|NCT01076010|561858184|FG001|Overall Study|Withdrawal by Subject|0|||
155662070|NCT01076010|561858185|FG002|Overall Study|Withdrawal by Subject|1|||
155662071|NCT01076010|561858183|FG000|Overall Study|Other|5|||
155662072|NCT01076010|561858184|FG001|Overall Study|Other|2|||
155662073|NCT01076010|561858185|FG002|Overall Study|Other|0|||
155662074|NCT01612676|561858186|FG000|Overall Study|Adverse Event|2|||
155662075|NCT01612676|561858187|FG001|Overall Study|Adverse Event|3|||
155662076|NCT01612676|561858188|FG002|Overall Study|Adverse Event|1|||
155662077|NCT01612676|561858189|FG003|Overall Study|Adverse Event|3|||
155662078|NCT01612676|561858186|FG000|Overall Study|Protocol Violation|0|||
155662079|NCT01612676|561858187|FG001|Overall Study|Protocol Violation|1|||
155577382|NCT00141778|561537115|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
155577383|NCT00141778|561537116|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
155577384|NCT00141778|561537114|FG000|Started Study Medication|Withdrawal by Subject|0|||
155577385|NCT00141778|561537115|FG001|Started Study Medication|Withdrawal by Subject|2|||
155577386|NCT00141778|561537116|FG002|Started Study Medication|Withdrawal by Subject|0|||
155577387|NCT00141778|561537114|FG000|Started Study Medication|Difficulty Swallowing|0|||
155577388|NCT00141778|561537115|FG001|Started Study Medication|Difficulty Swallowing|1|||
155577389|NCT00141778|561537116|FG002|Started Study Medication|Difficulty Swallowing|0|||
155577390|NCT00141778|561537114|FG000|Started Study Medication|Chest Discomfort|0|||
155577391|NCT00141778|561537115|FG001|Started Study Medication|Chest Discomfort|0|||
155577392|NCT00141778|561537116|FG002|Started Study Medication|Chest Discomfort|1|||
155577393|NCT00768248|561537117|FG000|Overall Study|Research coordinator didn't collect data|1|||
155577394|NCT00768248|561537118|FG001|Overall Study|Research coordinator didn't collect data|1|||
155577395|NCT01959295|561537121|FG000|Overall Study|Adverse Event|2|||
155577396|NCT01959295|561537122|FG001|Overall Study|Adverse Event|0|||
155577397|NCT01959295|561537121|FG000|Overall Study|Lost to Follow-up|0|||
155577398|NCT01959295|561537122|FG001|Overall Study|Lost to Follow-up|2|||
155577399|NCT01959295|561537121|FG000|Overall Study|Physician Decision|2|||
155577400|NCT01959295|561537122|FG001|Overall Study|Physician Decision|3|||
155577401|NCT01959295|561537121|FG000|Overall Study|Protocol Violation|16|||
155577402|NCT01959295|561537122|FG001|Overall Study|Protocol Violation|5|||
155577403|NCT01959295|561537121|FG000|Overall Study|Withdrawal by Subject|3|||
155577404|NCT01959295|561537122|FG001|Overall Study|Withdrawal by Subject|1|||
155577405|NCT01959295|561537121|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
155577406|NCT01959295|561537122|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
155577407|NCT04075487|561539329|FG000|Overall Study|Withdrawal by Subject|1|||
155577408|NCT05016960|561539332|FG000|Overall Study|Withdrawal by Subject|1|||
155577409|NCT05016960|561539333|FG001|Overall Study|Withdrawal by Subject|9|||
155577410|NCT05126693|561539338|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
155577411|NCT05126693|561539339|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
155577412|NCT05126693|561539338|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
155577413|NCT05126693|561539339|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
155577414|NCT05126693|561539338|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
155577415|NCT05126693|561539339|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
155577416|NCT04100018|561539343|FG000|Pre-Treatment Period|Not Reported|0|||
155577417|NCT04100018|561539344|FG001|Pre-Treatment Period|Not Reported|4|||
155577418|NCT04100018|561539343|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
155577419|NCT04100018|561539344|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
155577420|NCT04100018|561539343|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
155577421|NCT04100018|561539344|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
155577422|NCT04100018|561539343|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
155577423|NCT04100018|561539344|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155577424|NCT04100018|561539343|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155577425|NCT04100018|561539344|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
155577426|NCT04100018|561539343|FG000|Treatment Period|Ongoing Treatment|1|||
155577427|NCT04100018|561539344|FG001|Treatment Period|Ongoing Treatment|0|||
155577428|NCT04100018|561539343|FG000|Treatment Period|Other Reason|26|||
155577429|NCT04100018|561539344|FG001|Treatment Period|Other Reason|37|||
155577430|NCT04100018|561539343|FG000|Treatment Period|Completed treatment as per protocol|1|||
155577431|NCT04100018|561539344|FG001|Treatment Period|Completed treatment as per protocol|2|||
155577432|NCT04100018|561539343|FG000|Treatment Period|Maximum clinical benefit|3|||
155577433|NCT04100018|561539344|FG001|Treatment Period|Maximum clinical benefit|0|||
155577434|NCT04100018|561539343|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
155577435|NCT04100018|561539344|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
155577436|NCT04100018|561539343|FG000|Treatment Period|Study drug toxicity|67|||
155577437|NCT04100018|561539344|FG001|Treatment Period|Study drug toxicity|28|||
155577438|NCT04100018|561539343|FG000|Treatment Period|Disease Progression|284|||
155577439|NCT04100018|561539344|FG001|Treatment Period|Disease Progression|327|||
155577440|NCT04100018|561539343|FG000|Treatment Period|Administrative reasons by sponsor|16|||
155577441|NCT04100018|561539344|FG001|Treatment Period|Administrative reasons by sponsor|30|||
155577442|NCT04100018|561539343|FG000|Treatment Period|Poor/Non-Compliance|1|||
155577443|NCT04100018|561539344|FG001|Treatment Period|Poor/Non-Compliance|0|||
155577444|NCT04100018|561539343|FG000|Treatment Period|Lost to Follow-up|2|||
155577445|NCT04100018|561539344|FG001|Treatment Period|Lost to Follow-up|2|||
155577446|NCT04100018|561539343|FG000|Treatment Period|Death|16|||
155577447|NCT04100018|561539344|FG001|Treatment Period|Death|11|||
155577448|NCT04100018|561539343|FG000|Treatment Period|Participant withdrew consent|10|||
155577449|NCT04100018|561539344|FG001|Treatment Period|Participant withdrew consent|10|||
155577450|NCT04100018|561539343|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
155577451|NCT04100018|561539344|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
155577452|NCT04100018|561539343|FG000|Treatment Period|Adverse Event|14|||
155577453|NCT04100018|561539344|FG001|Treatment Period|Adverse Event|6|||
155577454|NCT04100018|561539343|FG000|Treatment Period|Lack of Efficacy|4|||
155577455|NCT04100018|561539344|FG001|Treatment Period|Lack of Efficacy|2|||
155577456|NCT02848001|561539345|FG000|Overall Study|other reasons|0|||
155577457|NCT02848001|561539346|FG001|Overall Study|other reasons|0|||
155577458|NCT02848001|561539347|FG002|Overall Study|other reasons|1|||
155577459|NCT02848001|561539348|FG003|Overall Study|other reasons|0|||
155577460|NCT02848001|561539349|FG004|Overall Study|other reasons|4|||
155577461|NCT02848001|561539350|FG005|Overall Study|other reasons|1|||
155577462|NCT02848001|561539351|FG006|Overall Study|other reasons|0|||
155577463|NCT02848001|561539352|FG007|Overall Study|other reasons|2|||
155577464|NCT02848001|561539353|FG008|Overall Study|other reasons|2|||
155577465|NCT02848001|561539354|FG009|Overall Study|other reasons|3|||
155577466|NCT02848001|561539355|FG010|Overall Study|other reasons|0|||
155577467|NCT02848001|561539356|FG011|Overall Study|other reasons|1|||
155577468|NCT02848001|561539357|FG012|Overall Study|other reasons|1|||
155577469|NCT02848001|561539358|FG013|Overall Study|other reasons|0|||
155577470|NCT02848001|561539359|FG014|Overall Study|other reasons|0|||
155577471|NCT02848001|561539360|FG015|Overall Study|other reasons|2|||
155577472|NCT02848001|561539361|FG016|Overall Study|other reasons|1|||
155577473|NCT02848001|561539345|FG000|Overall Study|Lack of Efficacy|0|||
155577474|NCT02848001|561539346|FG001|Overall Study|Lack of Efficacy|1|||
155577475|NCT02848001|561539347|FG002|Overall Study|Lack of Efficacy|1|||
155577476|NCT02848001|561539348|FG003|Overall Study|Lack of Efficacy|2|||
155577477|NCT02848001|561539349|FG004|Overall Study|Lack of Efficacy|3|||
155577478|NCT02848001|561539350|FG005|Overall Study|Lack of Efficacy|0|||
155577479|NCT02848001|561539351|FG006|Overall Study|Lack of Efficacy|1|||
155577480|NCT02848001|561539352|FG007|Overall Study|Lack of Efficacy|0|||
155577481|NCT02848001|561539353|FG008|Overall Study|Lack of Efficacy|0|||
155577482|NCT02848001|561539354|FG009|Overall Study|Lack of Efficacy|1|||
155577483|NCT02848001|561539355|FG010|Overall Study|Lack of Efficacy|0|||
155577484|NCT02848001|561539356|FG011|Overall Study|Lack of Efficacy|2|||
155577485|NCT02848001|561539357|FG012|Overall Study|Lack of Efficacy|0|||
155577486|NCT02848001|561539358|FG013|Overall Study|Lack of Efficacy|2|||
155577487|NCT02848001|561539359|FG014|Overall Study|Lack of Efficacy|2|||
155577488|NCT02848001|561539360|FG015|Overall Study|Lack of Efficacy|0|||
155577489|NCT02848001|561539361|FG016|Overall Study|Lack of Efficacy|0|||
155577490|NCT02848001|561539345|FG000|Overall Study|Progressive Disease|2|||
155577491|NCT02848001|561539346|FG001|Overall Study|Progressive Disease|1|||
155577492|NCT02848001|561539347|FG002|Overall Study|Progressive Disease|0|||
155577493|NCT02848001|561539348|FG003|Overall Study|Progressive Disease|4|||
155577494|NCT02848001|561539349|FG004|Overall Study|Progressive Disease|3|||
155577495|NCT02848001|561539350|FG005|Overall Study|Progressive Disease|0|||
155577496|NCT02848001|561539351|FG006|Overall Study|Progressive Disease|4|||
155577497|NCT02848001|561539352|FG007|Overall Study|Progressive Disease|1|||
155577498|NCT02848001|561539353|FG008|Overall Study|Progressive Disease|0|||
155577499|NCT02848001|561539354|FG009|Overall Study|Progressive Disease|2|||
155577500|NCT02848001|561539355|FG010|Overall Study|Progressive Disease|3|||
155577501|NCT02848001|561539356|FG011|Overall Study|Progressive Disease|2|||
155577502|NCT02848001|561539357|FG012|Overall Study|Progressive Disease|1|||
155577503|NCT02848001|561539358|FG013|Overall Study|Progressive Disease|0|||
155577504|NCT02848001|561539359|FG014|Overall Study|Progressive Disease|2|||
155577505|NCT02848001|561539360|FG015|Overall Study|Progressive Disease|4|||
155577506|NCT02848001|561539361|FG016|Overall Study|Progressive Disease|0|||
155577507|NCT02848001|561539345|FG000|Overall Study|Adverse Event|0|||
155577508|NCT02848001|561539346|FG001|Overall Study|Adverse Event|0|||
155577509|NCT02848001|561539347|FG002|Overall Study|Adverse Event|0|||
155577510|NCT02848001|561539348|FG003|Overall Study|Adverse Event|0|||
155577511|NCT02848001|561539349|FG004|Overall Study|Adverse Event|2|||
155577512|NCT02848001|561539350|FG005|Overall Study|Adverse Event|0|||
155577513|NCT02848001|561539351|FG006|Overall Study|Adverse Event|0|||
155577514|NCT02848001|561539352|FG007|Overall Study|Adverse Event|0|||
155577515|NCT02848001|561539353|FG008|Overall Study|Adverse Event|0|||
155577516|NCT02848001|561539354|FG009|Overall Study|Adverse Event|1|||
155577517|NCT02848001|561539355|FG010|Overall Study|Adverse Event|0|||
155577518|NCT02848001|561539356|FG011|Overall Study|Adverse Event|1|||
155577519|NCT02848001|561539357|FG012|Overall Study|Adverse Event|1|||
155577520|NCT02848001|561539358|FG013|Overall Study|Adverse Event|0|||
155577521|NCT02848001|561539359|FG014|Overall Study|Adverse Event|2|||
155577522|NCT02848001|561539360|FG015|Overall Study|Adverse Event|0|||
155577523|NCT02848001|561539361|FG016|Overall Study|Adverse Event|0|||
155577524|NCT02848001|561539345|FG000|Overall Study|Death|0|||
155577525|NCT02848001|561539346|FG001|Overall Study|Death|0|||
155577526|NCT02848001|561539347|FG002|Overall Study|Death|0|||
155577527|NCT02848001|561539348|FG003|Overall Study|Death|1|||
155577528|NCT02848001|561539349|FG004|Overall Study|Death|3|||
155577529|NCT02848001|561539350|FG005|Overall Study|Death|1|||
155577530|NCT02848001|561539351|FG006|Overall Study|Death|2|||
155577531|NCT02848001|561539352|FG007|Overall Study|Death|3|||
155577532|NCT02848001|561539353|FG008|Overall Study|Death|4|||
155577533|NCT02848001|561539354|FG009|Overall Study|Death|1|||
155577534|NCT02848001|561539355|FG010|Overall Study|Death|0|||
155577535|NCT02848001|561539356|FG011|Overall Study|Death|1|||
155577536|NCT02848001|561539357|FG012|Overall Study|Death|3|||
155577537|NCT02848001|561539358|FG013|Overall Study|Death|0|||
155577538|NCT02848001|561539359|FG014|Overall Study|Death|2|||
155577539|NCT02848001|561539360|FG015|Overall Study|Death|3|||
155577540|NCT02848001|561539361|FG016|Overall Study|Death|0|||
155577541|NCT02848001|561539345|FG000|Overall Study|Physician Decision|0|||
155577542|NCT02848001|561539346|FG001|Overall Study|Physician Decision|0|||
155577543|NCT02848001|561539347|FG002|Overall Study|Physician Decision|0|||
155577544|NCT02848001|561539348|FG003|Overall Study|Physician Decision|0|||
155577545|NCT02848001|561539349|FG004|Overall Study|Physician Decision|0|||
155577546|NCT02848001|561539350|FG005|Overall Study|Physician Decision|0|||
155577547|NCT02848001|561539351|FG006|Overall Study|Physician Decision|0|||
155577548|NCT02848001|561539352|FG007|Overall Study|Physician Decision|0|||
155577549|NCT02848001|561539353|FG008|Overall Study|Physician Decision|1|||
155577550|NCT02848001|561539354|FG009|Overall Study|Physician Decision|1|||
155577551|NCT02848001|561539355|FG010|Overall Study|Physician Decision|0|||
155577552|NCT02848001|561539356|FG011|Overall Study|Physician Decision|0|||
155577553|NCT02848001|561539357|FG012|Overall Study|Physician Decision|2|||
155577554|NCT02848001|561539358|FG013|Overall Study|Physician Decision|0|||
155577555|NCT02848001|561539359|FG014|Overall Study|Physician Decision|0|||
155577556|NCT02848001|561539360|FG015|Overall Study|Physician Decision|0|||
155577557|NCT02848001|561539361|FG016|Overall Study|Physician Decision|0|||
155577558|NCT02848001|561539345|FG000|Overall Study|Withdrawal by Subject|0|||
155577559|NCT02848001|561539346|FG001|Overall Study|Withdrawal by Subject|0|||
155577560|NCT02848001|561539347|FG002|Overall Study|Withdrawal by Subject|0|||
155577561|NCT02848001|561539348|FG003|Overall Study|Withdrawal by Subject|0|||
155577562|NCT02848001|561539349|FG004|Overall Study|Withdrawal by Subject|0|||
155577563|NCT02848001|561539350|FG005|Overall Study|Withdrawal by Subject|1|||
155577564|NCT02848001|561539351|FG006|Overall Study|Withdrawal by Subject|1|||
155577565|NCT02848001|561539352|FG007|Overall Study|Withdrawal by Subject|1|||
155577566|NCT02848001|561539353|FG008|Overall Study|Withdrawal by Subject|0|||
155577567|NCT02848001|561539354|FG009|Overall Study|Withdrawal by Subject|0|||
155577568|NCT02848001|561539355|FG010|Overall Study|Withdrawal by Subject|0|||
155577569|NCT02848001|561539356|FG011|Overall Study|Withdrawal by Subject|0|||
155577570|NCT02848001|561539357|FG012|Overall Study|Withdrawal by Subject|0|||
155577571|NCT02848001|561539358|FG013|Overall Study|Withdrawal by Subject|0|||
155577572|NCT02848001|561539359|FG014|Overall Study|Withdrawal by Subject|0|||
155577573|NCT02848001|561539360|FG015|Overall Study|Withdrawal by Subject|0|||
155577574|NCT02848001|561539361|FG016|Overall Study|Withdrawal by Subject|0|||
155577575|NCT03283566|561539362|FG000|Overall Study|Lost to Follow-up|1|||
155577576|NCT03283566|561539363|FG001|Overall Study|Lost to Follow-up|2|||
155577577|NCT04515147|561539364|FG000|Overall Study|Withdrawal by Subject|1|||
155577578|NCT04515147|561539365|FG001|Overall Study|Withdrawal by Subject|0|||
155577579|NCT04515147|561539366|FG002|Overall Study|Withdrawal by Subject|10|||
155577580|NCT04515147|561539367|FG003|Overall Study|Withdrawal by Subject|18|||
155577581|NCT04515147|561539368|FG004|Overall Study|Withdrawal by Subject|1|||
155577582|NCT04515147|561539369|FG005|Overall Study|Withdrawal by Subject|8|||
155577583|NCT04515147|561539364|FG000|Overall Study|Lost to Follow-up|0|||
155577584|NCT04515147|561539365|FG001|Overall Study|Lost to Follow-up|1|||
155577585|NCT04515147|561539366|FG002|Overall Study|Lost to Follow-up|5|||
155577586|NCT04515147|561539367|FG003|Overall Study|Lost to Follow-up|6|||
155577587|NCT04515147|561539368|FG004|Overall Study|Lost to Follow-up|2|||
155577588|NCT04515147|561539369|FG005|Overall Study|Lost to Follow-up|1|||
155577589|NCT04515147|561539364|FG000|Overall Study|Adverse Event|0|||
155577590|NCT04515147|561539365|FG001|Overall Study|Adverse Event|0|||
155577591|NCT04515147|561539366|FG002|Overall Study|Adverse Event|0|||
155577592|NCT04515147|561539367|FG003|Overall Study|Adverse Event|2|||
155577593|NCT04515147|561539368|FG004|Overall Study|Adverse Event|0|||
155577594|NCT04515147|561539369|FG005|Overall Study|Adverse Event|0|||
155577595|NCT04515147|561539364|FG000|Overall Study|Miscellaneous|0|||
155577596|NCT04515147|561539365|FG001|Overall Study|Miscellaneous|0|||
155577597|NCT04515147|561539366|FG002|Overall Study|Miscellaneous|0|||
155577598|NCT04515147|561539367|FG003|Overall Study|Miscellaneous|1|||
155577599|NCT04515147|561539368|FG004|Overall Study|Miscellaneous|0|||
155577600|NCT04515147|561539369|FG005|Overall Study|Miscellaneous|1|||
155577601|NCT01431079|561539377|FG000|Overall Study|Lost to Follow-up|35|||
155577602|NCT01431079|561539378|FG001|Overall Study|Lost to Follow-up|39|||
155577603|NCT02790437|561539379|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
155577604|NCT02790437|561539380|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
155577605|NCT02790437|561539379|FG000|Overall Study|Adverse Event|1|||
155577606|NCT02790437|561539380|FG001|Overall Study|Adverse Event|0|||
155577607|NCT02790437|561539379|FG000|Overall Study|Withdrawal by Subject|1|||
155577608|NCT02790437|561539380|FG001|Overall Study|Withdrawal by Subject|0|||
155577609|NCT01202175|561539381|FG000|Overall Study|Lost to Follow-up|2|||
155577610|NCT01202175|561539381|FG000|Overall Study|Withdrawal by Subject|1|||
155577611|NCT01202175|561539381|FG000|Overall Study|Adverse Event|2|||
155577612|NCT01626690|561539384|FG000|Overall Study|Protocol Violation|1|||
155577613|NCT01626690|561539385|FG001|Overall Study|Protocol Violation|0|||
155577614|NCT01626690|561539384|FG000|Overall Study|Adverse Event|1|||
155577615|NCT01626690|561539385|FG001|Overall Study|Adverse Event|0|||
155577616|NCT00942357|561539386|FG000|Overall Study|Ineligible|37|||
155577617|NCT00942357|561539387|FG001|Overall Study|Ineligible|40|||
155577618|NCT01321879|561539391|FG000|Overall Study|Lack of Efficacy|5|||
155577619|NCT01321879|561539391|FG000|Overall Study|Adverse Event|5|||
155577620|NCT01321879|561539391|FG000|Overall Study|Death|3|||
155577621|NCT01321879|561539391|FG000|Overall Study|Withdrawal by Subject|1|||
155577622|NCT01518322|561539398|FG000|Overall Study|FeNO measurement was missing|13|||
155577623|NCT00811733|561539408|FG000|Overall Study|Investigator Discretion|10|||
155577624|NCT00811733|561539409|FG001|Overall Study|Investigator Discretion|8|||
155577625|NCT00811733|561539408|FG000|Overall Study|Withdrawal by Subject|1|||
155577626|NCT00811733|561539409|FG001|Overall Study|Withdrawal by Subject|2|||
155577627|NCT04542057|561539412|FG000|Overall Study|Death|3|||
155577628|NCT04542057|561539413|FG001|Overall Study|Death|1|||
155577629|NCT04542057|561539412|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
155577630|NCT04542057|561539413|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
155577631|NCT04542057|561539412|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
155577632|NCT04542057|561539413|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
155577633|NCT04542057|561539412|FG000|Overall Study|Adverse Event|15|||
155577634|NCT04542057|561539413|FG001|Overall Study|Adverse Event|6|||
155577635|NCT04542057|561539412|FG000|Overall Study|COVID-19 adverse event|6|||
155577636|NCT04542057|561539413|FG001|Overall Study|COVID-19 adverse event|4|||
155577637|NCT04542057|561539412|FG000|Overall Study|Lack of Efficacy|2|||
155577638|NCT04542057|561539413|FG001|Overall Study|Lack of Efficacy|5|||
155577639|NCT04542057|561539412|FG000|Overall Study|Study terminated by sponsor|1|||
155577640|NCT04542057|561539413|FG001|Overall Study|Study terminated by sponsor|0|||
155577641|NCT04542057|561539412|FG000|Overall Study|Investigator discretion|2|||
155577642|NCT04542057|561539413|FG001|Overall Study|Investigator discretion|1|||
155577643|NCT04542057|561539412|FG000|Overall Study|Withdrawal by Subject|52|||
155577644|NCT04542057|561539413|FG001|Overall Study|Withdrawal by Subject|30|||
155577645|NCT04542057|561539412|FG000|Overall Study|Lost to Follow-up|8|||
155577646|NCT04542057|561539413|FG001|Overall Study|Lost to Follow-up|11|||
155577647|NCT04542057|561539412|FG000|Overall Study|Other|2|||
155577648|NCT04542057|561539413|FG001|Overall Study|Other|2|||
155577649|NCT02635984|561539418|FG000|Overall Study|Lost to Follow-up|2|||
155577650|NCT02635984|561539419|FG001|Overall Study|Lost to Follow-up|4|||
155577651|NCT02635984|561539418|FG000|Overall Study|Study Arm Closed|1|||
155577652|NCT02635984|561539419|FG001|Overall Study|Study Arm Closed|0|||
155577653|NCT01640249|561539420|FG000|Period 1|Withdrawal by Subject|1|||
155577654|NCT01640249|561539421|FG001|Period 1|Withdrawal by Subject|0|||
155577655|NCT01640249|561539422|FG002|Period 1|Withdrawal by Subject|0|||
155577656|NCT01640249|561539423|FG003|Period 1|Withdrawal by Subject|0|||
155577657|NCT01640249|561539424|FG004|Period 1|Withdrawal by Subject|0|||
155577658|NCT01640249|561539425|FG005|Period 1|Withdrawal by Subject|1|||
155577659|NCT01640249|561539426|FG006|Period 1|Withdrawal by Subject|0|||
155577660|NCT01870778|561539428|FG000|Overall Study|Withdrawal by Subject|8|||
155577661|NCT01870778|561539429|FG001|Overall Study|Withdrawal by Subject|7|||
155577662|NCT01870778|561539428|FG000|Overall Study|Lost to Follow-up|0|||
155577663|NCT01870778|561539429|FG001|Overall Study|Lost to Follow-up|2|||
155577664|NCT00312338|561539430|FG000|Overall Study|Adverse Event|7|||
155577665|NCT00312338|561539431|FG001|Overall Study|Adverse Event|2|||
155577666|NCT00312338|561539430|FG000|Overall Study|Lost to Follow-up|9|||
155577667|NCT00312338|561539431|FG001|Overall Study|Lost to Follow-up|1|||
155577668|NCT00312338|561539430|FG000|Overall Study|Withdrawal by Subject|4|||
155577669|NCT00312338|561539431|FG001|Overall Study|Withdrawal by Subject|0|||
155577670|NCT00312338|561539430|FG000|Overall Study|Subsequent infection|2|||
155577671|NCT00312338|561539431|FG001|Overall Study|Subsequent infection|0|||
155577672|NCT00100828|561539432|FG000|Overall Study|Physician Decision|6|||
155577673|NCT01215136|561539433|FG000|Overall Study|Adverse Event|2|||
155577674|NCT01215136|561539434|FG001|Overall Study|Adverse Event|9|||
155577675|NCT01215136|561539433|FG000|Overall Study|Disease Progression|3|||
155198471|NCT00745823|560164973|FG001|Overall Study|Study Terminated by Sponsor|349|||
155577676|NCT01215136|561539434|FG001|Overall Study|Disease Progression|14|||
155577677|NCT01215136|561539433|FG000|Overall Study|Symptomatic Deterioration|1|||
155577678|NCT01215136|561539434|FG001|Overall Study|Symptomatic Deterioration|1|||
155577679|NCT01215136|561539433|FG000|Overall Study|Death|0|||
155577680|NCT01215136|561539434|FG001|Overall Study|Death|2|||
155577681|NCT01215136|561539433|FG000|Overall Study|Withdrawal by Subject|0|||
155577682|NCT01215136|561539434|FG001|Overall Study|Withdrawal by Subject|1|||
155577683|NCT01125917|561539439|FG000|Overall Study|Adverse Event|43|||
155577684|NCT01125917|561539439|FG000|Overall Study|Lost to Follow-up|23|||
155577685|NCT01125917|561539439|FG000|Overall Study|Withdrawal by Subject|31|||
155577686|NCT01125917|561539439|FG000|Overall Study|Administrative|223|||
155577687|NCT01125917|561539439|FG000|Overall Study|Lack of Efficacy|19|||
155577688|NCT04421131|561539443|FG000|Overall Study|Lost to Follow-up|1|||
155577689|NCT04421131|561539443|FG000|Overall Study|Protocol Violation|2|||
155577690|NCT04421131|561539443|FG000|Overall Study|App crashed|5|||
155577691|NCT02308124|561539444|FG000|Overall Study|Lost to Follow-up|6|||
155577692|NCT02308124|561539445|FG001|Overall Study|Lost to Follow-up|6|||
155577693|NCT02308124|561539446|FG002|Overall Study|Lost to Follow-up|6|||
155577694|NCT02308124|561539444|FG000|Overall Study|Adverse Event|0|||
155577695|NCT02308124|561539445|FG001|Overall Study|Adverse Event|2|||
155577696|NCT02308124|561539446|FG002|Overall Study|Adverse Event|2|||
155577697|NCT02501928|561539451|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155577698|NCT02501928|561539452|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155577699|NCT02501928|561539453|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
155577700|NCT02501928|561539454|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
155577701|NCT02501928|561539455|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
155577702|NCT02501928|561539456|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
155577703|NCT01526057|561539458|FG000|Overall Study|Withdrawal by Subject|3|||
155577704|NCT01526057|561539459|FG001|Overall Study|Withdrawal by Subject|2|||
155577705|NCT01526057|561539460|FG002|Overall Study|Withdrawal by Subject|2|||
155577706|NCT01526057|561539458|FG000|Overall Study|Adverse Event|3|||
155577707|NCT01526057|561539459|FG001|Overall Study|Adverse Event|1|||
155577708|NCT01526057|561539460|FG002|Overall Study|Adverse Event|1|||
155577709|NCT01526057|561539458|FG000|Overall Study|Death|1|||
155577710|NCT01526057|561539459|FG001|Overall Study|Death|0|||
155577711|NCT01526057|561539460|FG002|Overall Study|Death|0|||
155577712|NCT01526057|561539458|FG000|Overall Study|Lost to Follow-up|1|||
155577713|NCT01526057|561539459|FG001|Overall Study|Lost to Follow-up|0|||
155577714|NCT01526057|561539460|FG002|Overall Study|Lost to Follow-up|1|||
155577715|NCT01526057|561539458|FG000|Overall Study|Other|1|||
155577716|NCT01526057|561539459|FG001|Overall Study|Other|0|||
155577717|NCT01526057|561539460|FG002|Overall Study|Other|1|||
155577718|NCT01526057|561539458|FG000|Overall Study|Protocol Violation|0|||
155577719|NCT01526057|561539459|FG001|Overall Study|Protocol Violation|0|||
155577720|NCT01526057|561539460|FG002|Overall Study|Protocol Violation|1|||
155577721|NCT02553772|561539461|FG000|Overall Study|Adverse Event|2|||
155577722|NCT02553772|561539462|FG001|Overall Study|Adverse Event|3|||
155577723|NCT02553772|561539461|FG000|Overall Study|Lost to Follow-up|2|||
155577724|NCT02553772|561539462|FG001|Overall Study|Lost to Follow-up|1|||
155577725|NCT02553772|561539461|FG000|Overall Study|Withdrawal of Consent|1|||
155577726|NCT02553772|561539462|FG001|Overall Study|Withdrawal of Consent|1|||
155577727|NCT02553772|561539461|FG000|Overall Study|Lack of Efficacy|1|||
155577728|NCT02553772|561539462|FG001|Overall Study|Lack of Efficacy|0|||
155577729|NCT02553772|561539461|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155577730|NCT02553772|561539462|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155577731|NCT02189837|561539465|FG000|Overall Study|Withdrawal by Subject|2|||
155577732|NCT02189837|561539466|FG001|Overall Study|Withdrawal by Subject|1|||
155577733|NCT02189837|561539467|FG002|Overall Study|Withdrawal by Subject|3|||
155577734|NCT02189837|561539468|FG003|Overall Study|Withdrawal by Subject|1|||
155577735|NCT02189837|561539465|FG000|Overall Study|Sponsor Decision|0|||
155577736|NCT02189837|561539466|FG001|Overall Study|Sponsor Decision|0|||
155577737|NCT02189837|561539467|FG002|Overall Study|Sponsor Decision|0|||
155577738|NCT02189837|561539468|FG003|Overall Study|Sponsor Decision|1|||
155577739|NCT01808573|561539474|FG000|Overall Study|Death|212|||
155577740|NCT01808573|561539475|FG001|Overall Study|Death|240|||
155577741|NCT01808573|561539474|FG000|Overall Study|Withdrawal by Subject|12|||
155577742|NCT01808573|561539475|FG001|Overall Study|Withdrawal by Subject|10|||
155577743|NCT01808573|561539474|FG000|Overall Study|Lost to Follow-up|3|||
155577744|NCT01808573|561539475|FG001|Overall Study|Lost to Follow-up|0|||
155577745|NCT01808573|561539474|FG000|Overall Study|Discontinuation of study by sponsor|79|||
155577746|NCT01808573|561539475|FG001|Overall Study|Discontinuation of study by sponsor|64|||
155577747|NCT01808573|561539474|FG000|Overall Study|Randomized in Error|1|||
155577748|NCT01808573|561539475|FG001|Overall Study|Randomized in Error|0|||
155577749|NCT03953612|561539476|FG000|Overall Study|Randomized but did not start|1|||
155577750|NCT03953612|561539477|FG001|Overall Study|Randomized but did not start|1|||
155577751|NCT03953612|561539478|FG002|Overall Study|Randomized but did not start|1|||
155577752|NCT03953612|561539476|FG000|Overall Study|Withdrawal by Subject|2|||
155577753|NCT03953612|561539477|FG001|Overall Study|Withdrawal by Subject|1|||
155577754|NCT03953612|561539478|FG002|Overall Study|Withdrawal by Subject|0|||
155577755|NCT01682811|561539482|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577756|NCT01682811|561539483|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577757|NCT01682811|561539484|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577758|NCT01682811|561539485|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577759|NCT01682811|561539486|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
155577760|NCT01682811|561539487|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577761|NCT01682811|561539488|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155577762|NCT01682811|561539482|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
155577763|NCT01682811|561539483|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
155577764|NCT01682811|561539484|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
155577765|NCT01682811|561539485|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
155662080|NCT01612676|561858188|FG002|Overall Study|Protocol Violation|0|||
155662081|NCT01612676|561858189|FG003|Overall Study|Protocol Violation|0|||
155577766|NCT01682811|561539486|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
155577767|NCT01682811|561539487|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
155577768|NCT01682811|561539488|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
155577769|NCT01682811|561539482|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577770|NCT01682811|561539483|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577771|NCT01682811|561539484|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577772|NCT01682811|561539485|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577773|NCT01682811|561539486|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
155577774|NCT01682811|561539487|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577775|NCT01682811|561539488|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
155577776|NCT01682811|561539482|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577777|NCT01682811|561539483|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577778|NCT01682811|561539484|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577779|NCT01682811|561539485|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577780|NCT01682811|561539486|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577781|NCT01682811|561539487|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
155577782|NCT01682811|561539488|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
155577783|NCT04358081|561541248|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
155577784|NCT04358081|561541249|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
155577785|NCT04358081|561541250|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
155577786|NCT04358081|561541248|FG000|Treatment Phase of Study|Adverse Event|1|||
155577787|NCT04358081|561541249|FG001|Treatment Phase of Study|Adverse Event|0|||
155577788|NCT04358081|561541250|FG002|Treatment Phase of Study|Adverse Event|1|||
155577789|NCT04358081|561541248|FG000|Treatment Phase of Study|Physician Decision|2|||
155577790|NCT04358081|561541249|FG001|Treatment Phase of Study|Physician Decision|0|||
155577791|NCT04358081|561541250|FG002|Treatment Phase of Study|Physician Decision|1|||
155577792|NCT04358081|561541248|FG000|Treatment Phase of Study|Protocol Violation|1|||
155577793|NCT04358081|561541249|FG001|Treatment Phase of Study|Protocol Violation|0|||
155577794|NCT04358081|561541250|FG002|Treatment Phase of Study|Protocol Violation|0|||
155577795|NCT04358081|561541248|FG000|Study Completion Phase|Death|0|||
155577796|NCT04358081|561541249|FG001|Study Completion Phase|Death|0|||
155577797|NCT04358081|561541250|FG002|Study Completion Phase|Death|1|||
155577798|NCT04358081|561541248|FG000|Study Completion Phase|Lost to Follow-up|1|||
155577799|NCT04358081|561541249|FG001|Study Completion Phase|Lost to Follow-up|0|||
155577800|NCT04358081|561541250|FG002|Study Completion Phase|Lost to Follow-up|1|||
155577801|NCT00696423|561541254|FG000|Overall Study|Lost to Follow-up|0|||
155577802|NCT00696423|561541255|FG001|Overall Study|Lost to Follow-up|5|||
155577803|NCT03989102|561541256|FG000|Year 1|Withdrawal by Subject|6|||
155577804|NCT03989102|561541257|FG001|Year 1|Withdrawal by Subject|2|||
155577805|NCT03989102|561541258|FG002|Year 1|Withdrawal by Subject|7|||
155577806|NCT03989102|561541256|FG000|Year 1|Lost to Follow-up|5|||
155577807|NCT03989102|561541257|FG001|Year 1|Lost to Follow-up|2|||
155577808|NCT03989102|561541258|FG002|Year 1|Lost to Follow-up|5|||
155577809|NCT03989102|561541256|FG000|Year 1|Subject met withdrawal criteria|1|||
155577810|NCT03989102|561541257|FG001|Year 1|Subject met withdrawal criteria|0|||
155577811|NCT03989102|561541258|FG002|Year 1|Subject met withdrawal criteria|1|||
155577812|NCT03989102|561541256|FG000|Year 2|Lost to Follow-up|7|||
155577813|NCT03989102|561541257|FG001|Year 2|Lost to Follow-up|3|||
155577814|NCT03989102|561541258|FG002|Year 2|Lost to Follow-up|4|||
155577815|NCT03989102|561541256|FG000|Year 2|Withdrawal by Subject|3|||
155577816|NCT03989102|561541257|FG001|Year 2|Withdrawal by Subject|1|||
155577817|NCT03989102|561541258|FG002|Year 2|Withdrawal by Subject|2|||
155577818|NCT03989102|561541256|FG000|Year 2|Subject non-compliant|3|||
155577819|NCT03989102|561541257|FG001|Year 2|Subject non-compliant|2|||
155577820|NCT03989102|561541258|FG002|Year 2|Subject non-compliant|0|||
155577821|NCT03989102|561541256|FG000|Year 2|Travel|1|||
155577822|NCT03989102|561541257|FG001|Year 2|Travel|0|||
155577823|NCT03989102|561541258|FG002|Year 2|Travel|1|||
155577824|NCT03989102|561541256|FG000|Year 2|P16 missing|4|||
155577825|NCT03989102|561541257|FG001|Year 2|P16 missing|2|||
155662082|NCT04661033|561858193|FG000|Overall Study|Adverse Event|0|||
155577826|NCT03989102|561541258|FG002|Year 2|P16 missing|1|||
155577827|NCT03989102|561541256|FG000|Year 2|P11 missing|1|||
155577828|NCT03989102|561541257|FG001|Year 2|P11 missing|3|||
155577829|NCT03989102|561541258|FG002|Year 2|P11 missing|7|||
155577830|NCT03989102|561541256|FG000|Year 2|Definitive displacement outside the study site|0|||
155577831|NCT03989102|561541257|FG001|Year 2|Definitive displacement outside the study site|1|||
155662083|NCT04661033|561858194|FG001|Overall Study|Adverse Event|0|||
155577832|NCT03989102|561541258|FG002|Year 2|Definitive displacement outside the study site|0|||
155577833|NCT03989102|561541256|FG000|Year 2|Subject missed last study visit|0|||
155577834|NCT03989102|561541257|FG001|Year 2|Subject missed last study visit|1|||
155577835|NCT03989102|561541258|FG002|Year 2|Subject missed last study visit|0|||
155577836|NCT03989102|561541256|FG000|Year 2|Death|0|||
155577837|NCT03989102|561541257|FG001|Year 2|Death|1|||
155577838|NCT03989102|561541258|FG002|Year 2|Death|0|||
155577839|NCT03989102|561541256|FG000|Year 2|Subject not reachable|0|||
155577840|NCT03989102|561541257|FG001|Year 2|Subject not reachable|0|||
155577841|NCT03989102|561541258|FG002|Year 2|Subject not reachable|1|||
155577842|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
155577843|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
155577844|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
155577845|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155577846|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155577847|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155577848|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
155577849|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
155577850|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
155577851|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
155577852|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
155577853|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
155577854|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
155577855|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
155577856|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
155577857|NCT03989102|561541256|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
155577858|NCT03989102|561541257|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
155577859|NCT03989102|561541258|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
155577860|NCT01321749|561541259|FG000|Overall Study|Lost to Follow-up|4|||
155577861|NCT01321749|561541260|FG001|Overall Study|Lost to Follow-up|11|||
155577862|NCT01321749|561541259|FG000|Overall Study|Protocol Violation|4|||
155577863|NCT01321749|561541260|FG001|Overall Study|Protocol Violation|7|||
155577864|NCT01321749|561541259|FG000|Overall Study|Withdrawal by Subject|5|||
155577865|NCT01321749|561541260|FG001|Overall Study|Withdrawal by Subject|4|||
155577866|NCT04179838|561541261|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155577867|NCT04179838|561541262|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
155577868|NCT04179838|561541261|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
155577869|NCT04179838|561541262|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
155577870|NCT02760004|561541267|FG000|Overall Study|Lost to Follow-up|13|||
155577871|NCT02760004|561541268|FG001|Overall Study|Lost to Follow-up|22|||
155577872|NCT00970593|561541269|FG000|Overall Study|Adverse Event|1|||
155577873|NCT00970593|561541270|FG001|Overall Study|Adverse Event|1|||
155577874|NCT00970593|561541271|FG002|Overall Study|Adverse Event|0|||
155577875|NCT00970593|561541272|FG003|Overall Study|Adverse Event|0|||
155577876|NCT00970593|561541273|FG004|Overall Study|Adverse Event|0|||
155577877|NCT00970593|561541274|FG005|Overall Study|Adverse Event|0|||
155577878|NCT00970593|561541275|FG006|Overall Study|Adverse Event|0|||
155577879|NCT00970593|561541269|FG000|Overall Study|Discontinuation of study by sponsor|0|||
155577880|NCT00970593|561541270|FG001|Overall Study|Discontinuation of study by sponsor|0|||
155577881|NCT00970593|561541271|FG002|Overall Study|Discontinuation of study by sponsor|5|||
155577882|NCT00970593|561541272|FG003|Overall Study|Discontinuation of study by sponsor|0|||
155577883|NCT00970593|561541273|FG004|Overall Study|Discontinuation of study by sponsor|0|||
155577884|NCT00970593|561541274|FG005|Overall Study|Discontinuation of study by sponsor|0|||
155577885|NCT00970593|561541275|FG006|Overall Study|Discontinuation of study by sponsor|2|||
155577886|NCT00970593|561541269|FG000|Overall Study|Withdrawal by Subject|0|||
155577887|NCT00970593|561541270|FG001|Overall Study|Withdrawal by Subject|0|||
155577888|NCT00970593|561541271|FG002|Overall Study|Withdrawal by Subject|1|||
155577889|NCT00970593|561541272|FG003|Overall Study|Withdrawal by Subject|0|||
155577890|NCT00970593|561541273|FG004|Overall Study|Withdrawal by Subject|0|||
155577891|NCT00970593|561541274|FG005|Overall Study|Withdrawal by Subject|0|||
155577892|NCT00970593|561541275|FG006|Overall Study|Withdrawal by Subject|0|||
155577893|NCT02439216|561541282|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
155577894|NCT02439216|561541283|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577895|NCT02439216|561541284|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577896|NCT02439216|561541285|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577897|NCT02439216|561541286|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577898|NCT02439216|561541287|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577899|NCT02439216|561541288|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577900|NCT02439216|561541289|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577901|NCT02439216|561541290|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155577902|NCT02439216|561541282|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155662084|NCT04661033|561858195|FG002|Overall Study|Adverse Event|1|||
155662085|NCT04661033|561858196|FG003|Overall Study|Adverse Event|0|||
155662086|NCT04661033|561858193|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
155662087|NCT04661033|561858194|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155662088|NCT04661033|561858195|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155662089|NCT04661033|561858196|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155662090|NCT04661033|561858193|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
155662091|NCT04661033|561858194|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
155662092|NCT04661033|561858195|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
155662093|NCT04661033|561858196|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
155662094|NCT04661033|561858193|FG000|Overall Study|Early discontinuation as per PI|1|||
155662095|NCT04661033|561858194|FG001|Overall Study|Early discontinuation as per PI|0|||
155662096|NCT04661033|561858195|FG002|Overall Study|Early discontinuation as per PI|0|||
155662097|NCT04661033|561858196|FG003|Overall Study|Early discontinuation as per PI|0|||
155662098|NCT05200845|561858197|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
155662099|NCT05200845|561858198|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
155662100|NCT05200845|561858199|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
155662101|NCT05200845|561858200|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
155662102|NCT05200845|561858197|FG000|Overall Study|Withdrawal by Subject|0|||
155662103|NCT05200845|561858198|FG001|Overall Study|Withdrawal by Subject|1|||
155662104|NCT05200845|561858199|FG002|Overall Study|Withdrawal by Subject|1|||
155662105|NCT05200845|561858200|FG003|Overall Study|Withdrawal by Subject|0|||
155662106|NCT00565409|561858203|FG000|Period 1 Open Label|Adverse Event|17|||
155662107|NCT00565409|561858204|FG001|Period 1 Open Label|Adverse Event|0|||
155662108|NCT00565409|561858205|FG002|Period 1 Open Label|Adverse Event|0|||
155662109|NCT00565409|561858206|FG003|Period 1 Open Label|Adverse Event|0|||
155662110|NCT00565409|561858203|FG000|Period 1 Open Label|Death|2|||
155662111|NCT00565409|561858204|FG001|Period 1 Open Label|Death|0|||
155662112|NCT00565409|561858205|FG002|Period 1 Open Label|Death|0|||
155662113|NCT00565409|561858206|FG003|Period 1 Open Label|Death|0|||
155662114|NCT00565409|561858203|FG000|Period 1 Open Label|Lost to Follow-up|1|||
155662115|NCT00565409|561858204|FG001|Period 1 Open Label|Lost to Follow-up|0|||
155662116|NCT00565409|561858205|FG002|Period 1 Open Label|Lost to Follow-up|0|||
155662117|NCT00565409|561858206|FG003|Period 1 Open Label|Lost to Follow-up|0|||
155662118|NCT00565409|561858203|FG000|Period 1 Open Label|Other|21|||
155662119|NCT00565409|561858204|FG001|Period 1 Open Label|Other|0|||
155662120|NCT00565409|561858205|FG002|Period 1 Open Label|Other|0|||
155662121|NCT00565409|561858206|FG003|Period 1 Open Label|Other|0|||
155662122|NCT00565409|561858203|FG000|Period 1 Open Label|Protocol Violation|14|||
155662123|NCT00565409|561858204|FG001|Period 1 Open Label|Protocol Violation|0|||
155662124|NCT00565409|561858205|FG002|Period 1 Open Label|Protocol Violation|0|||
155662125|NCT00565409|561858206|FG003|Period 1 Open Label|Protocol Violation|0|||
155662126|NCT00565409|561858203|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
155662127|NCT00565409|561858204|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155662128|NCT00565409|561858205|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155662129|NCT00565409|561858206|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155662130|NCT00565409|561858203|FG000|Period 1 Open Label|no conclusion of participation record|1|||
155577903|NCT02439216|561541283|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577904|NCT02439216|561541284|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577905|NCT02439216|561541285|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577906|NCT02439216|561541286|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577907|NCT02439216|561541287|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577908|NCT02439216|561541288|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577909|NCT02439216|561541289|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
155577910|NCT02439216|561541290|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155577911|NCT02439216|561541282|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155577912|NCT02439216|561541283|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155577913|NCT02439216|561541284|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155577914|NCT02439216|561541285|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155662131|NCT00565409|561858204|FG001|Period 1 Open Label|no conclusion of participation record|0|||
155662132|NCT00565409|561858205|FG002|Period 1 Open Label|no conclusion of participation record|0|||
155662133|NCT00565409|561858206|FG003|Period 1 Open Label|no conclusion of participation record|0|||
155662134|NCT00565409|561858203|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
155662135|NCT00565409|561858204|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
155662136|NCT00565409|561858205|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
155662137|NCT00565409|561858206|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
155662138|NCT00565409|561858203|FG000|Period 2 Double-Blind|Adverse Event|0|||
155662139|NCT00565409|561858204|FG001|Period 2 Double-Blind|Adverse Event|7|||
155662140|NCT00565409|561858205|FG002|Period 2 Double-Blind|Adverse Event|4|||
155662141|NCT00565409|561858206|FG003|Period 2 Double-Blind|Adverse Event|5|||
155577915|NCT02439216|561541286|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155662142|NCT00565409|561858203|FG000|Period 2 Double-Blind|Death|0|||
155662143|NCT00565409|561858204|FG001|Period 2 Double-Blind|Death|2|||
155662144|NCT00565409|561858205|FG002|Period 2 Double-Blind|Death|0|||
155662145|NCT00565409|561858206|FG003|Period 2 Double-Blind|Death|0|||
155662146|NCT00565409|561858203|FG000|Period 2 Double-Blind|Protocol Violation|0|||
155662147|NCT00565409|561858204|FG001|Period 2 Double-Blind|Protocol Violation|4|||
155662148|NCT00565409|561858205|FG002|Period 2 Double-Blind|Protocol Violation|6|||
155662149|NCT00565409|561858206|FG003|Period 2 Double-Blind|Protocol Violation|2|||
155662150|NCT00565409|561858203|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
155662151|NCT00565409|561858204|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
155662152|NCT00565409|561858205|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
155662153|NCT00565409|561858206|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
155662154|NCT00565409|561858203|FG000|Period 2 Double-Blind|Other|0|||
155662155|NCT00565409|561858204|FG001|Period 2 Double-Blind|Other|4|||
155662156|NCT00565409|561858205|FG002|Period 2 Double-Blind|Other|5|||
155662157|NCT00565409|561858206|FG003|Period 2 Double-Blind|Other|9|||
155662158|NCT00565409|561858203|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
155662159|NCT00565409|561858204|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
155662160|NCT00565409|561858205|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
155662161|NCT00565409|561858206|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
155662162|NCT04064905|561858207|FG000|Overall Study|Lost to Follow-up|0|||
155662163|NCT04064905|561858208|FG001|Overall Study|Lost to Follow-up|3|||
155662164|NCT04064905|561858209|FG002|Overall Study|Lost to Follow-up|1|||
155577916|NCT02439216|561541287|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155577917|NCT02439216|561541288|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155577918|NCT02439216|561541289|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
155577919|NCT02439216|561541290|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
155577920|NCT02439216|561541282|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577921|NCT02439216|561541283|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577922|NCT02439216|561541284|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577923|NCT02439216|561541285|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577924|NCT02439216|561541286|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577925|NCT02439216|561541287|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577926|NCT02439216|561541288|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577927|NCT02439216|561541289|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155577928|NCT02439216|561541290|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
155577929|NCT02439216|561541282|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577930|NCT02439216|561541283|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577931|NCT02439216|561541284|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577932|NCT02439216|561541285|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577933|NCT02439216|561541286|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577934|NCT02439216|561541287|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577935|NCT02439216|561541288|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155577936|NCT02439216|561541289|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
155577937|NCT02439216|561541290|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
155577938|NCT00470535|561541294|FG000|Overall Study|Disease Progression|13|||
155577939|NCT00470535|561541294|FG000|Overall Study|Withdrawal by Subject|1|||
155577940|NCT00470535|561541294|FG000|Overall Study|Adverse Event|1|||
155577941|NCT00470535|561541294|FG000|Overall Study|Death|1|||
155577942|NCT00470535|561541294|FG000|Overall Study|Other|2|||
155577943|NCT02094300|561541295|FG000|Overall Study|Death|7|||
155577944|NCT02094300|561541295|FG000|Overall Study|Lost to Follow-up|10|||
155577945|NCT02094300|561541295|FG000|Overall Study|Still be eligible for follow-up|3|||
155577946|NCT04123405|561541300|FG000|Overall Study|Adverse Event|1|||
155577947|NCT04123405|561541301|FG001|Overall Study|Adverse Event|2|||
155577948|NCT04123405|561541302|FG002|Overall Study|Adverse Event|3|||
155577949|NCT04123405|561541303|FG003|Overall Study|Adverse Event|3|||
155577950|NCT04123405|561541300|FG000|Overall Study|Exclusion criteria met|1|||
155577951|NCT04123405|561541301|FG001|Overall Study|Exclusion criteria met|2|||
155577952|NCT04123405|561541302|FG002|Overall Study|Exclusion criteria met|0|||
155577953|NCT04123405|561541303|FG003|Overall Study|Exclusion criteria met|2|||
155577954|NCT04123405|561541300|FG000|Overall Study|Withdrawal by Subject|1|||
155577955|NCT04123405|561541301|FG001|Overall Study|Withdrawal by Subject|3|||
155577956|NCT04123405|561541302|FG002|Overall Study|Withdrawal by Subject|0|||
155577957|NCT04123405|561541303|FG003|Overall Study|Withdrawal by Subject|2|||
155577958|NCT04123405|561541300|FG000|Overall Study|Contact to subject lost|0|||
155577959|NCT04123405|561541301|FG001|Overall Study|Contact to subject lost|0|||
155577960|NCT04123405|561541302|FG002|Overall Study|Contact to subject lost|0|||
155577961|NCT04123405|561541303|FG003|Overall Study|Contact to subject lost|1|||
155577962|NCT04123405|561541300|FG000|Overall Study|screening failure|1|||
155577963|NCT04123405|561541301|FG001|Overall Study|screening failure|0|||
155577964|NCT04123405|561541302|FG002|Overall Study|screening failure|0|||
155577965|NCT04123405|561541303|FG003|Overall Study|screening failure|0|||
155577966|NCT01050530|561541304|FG000|Overall Study|Adverse Event|6|||
155577967|NCT01050530|561541305|FG001|Overall Study|Adverse Event|3|||
155577968|NCT01050530|561541304|FG000|Overall Study|Lack of Efficacy|1|||
155577969|NCT01050530|561541305|FG001|Overall Study|Lack of Efficacy|4|||
155577970|NCT01050530|561541304|FG000|Overall Study|Withdrawal by Subject|0|||
155577971|NCT01050530|561541305|FG001|Overall Study|Withdrawal by Subject|3|||
155577972|NCT01050530|561541304|FG000|Overall Study|Protocol Violation|1|||
155577973|NCT01050530|561541305|FG001|Overall Study|Protocol Violation|0|||
155577974|NCT00545714|561541306|FG000|Induction Phase (6 Months)|Physician Decision|3|||
155577975|NCT00545714|561541306|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
155577976|NCT00545714|561541306|FG000|Induction Phase (6 Months)|Disease Progression|1|||
155577977|NCT00545714|561541306|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
155577978|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
155577979|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
155577980|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
155577981|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
155577982|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
155577983|NCT00545714|561541306|FG000|Maintenance Phase (36 Months)|Death|2|||
155577984|NCT03889886|561541308|FG000|Overall Study|Other|0|||
155577985|NCT03889886|561541309|FG001|Overall Study|Other|1|||
155577986|NCT03889886|561541310|FG002|Overall Study|Other|0|||
155577987|NCT03889886|561541311|FG003|Overall Study|Other|1|||
155577988|NCT03889886|561541308|FG000|Overall Study|Withdrawal by Subject|0|||
155577989|NCT03889886|561541309|FG001|Overall Study|Withdrawal by Subject|0|||
155577990|NCT03889886|561541310|FG002|Overall Study|Withdrawal by Subject|1|||
155577991|NCT03889886|561541311|FG003|Overall Study|Withdrawal by Subject|0|||
155577992|NCT03889886|561541308|FG000|Overall Study|Adverse Event|0|||
155577993|NCT03889886|561541309|FG001|Overall Study|Adverse Event|0|||
155577994|NCT03889886|561541310|FG002|Overall Study|Adverse Event|0|||
155577995|NCT03889886|561541311|FG003|Overall Study|Adverse Event|6|||
155577996|NCT00276484|561541312|FG000|Overall Study|Adverse Event|4|||
155577997|NCT00276484|561541313|FG001|Overall Study|Adverse Event|7|||
155577998|NCT00276484|561541312|FG000|Overall Study|Lost to Follow-up|1|||
155577999|NCT00276484|561541313|FG001|Overall Study|Lost to Follow-up|1|||
155578000|NCT00276484|561541312|FG000|Overall Study|Protocol Violation|0|||
155578001|NCT00276484|561541313|FG001|Overall Study|Protocol Violation|1|||
155578002|NCT00276484|561541312|FG000|Overall Study|Withdrawal by Subject|4|||
155578003|NCT00276484|561541313|FG001|Overall Study|Withdrawal by Subject|3|||
155578004|NCT00276484|561541312|FG000|Overall Study|Could not take time off work|0|||
155578005|NCT00276484|561541313|FG001|Overall Study|Could not take time off work|1|||
155578006|NCT03347110|561541327|FG000|Overall Study|Other (Participant is incarcerated)|1|||
155578007|NCT03347110|561541327|FG000|Overall Study|Withdrawal by Subject|9|||
155578008|NCT03347110|561541327|FG000|Overall Study|Lost to Follow-up|1|||
155578009|NCT03347110|561541327|FG000|Overall Study|Lack of Efficacy|2|||
155578010|NCT03347110|561541327|FG000|Overall Study|Adverse Event, non-fatal|9|||
155578011|NCT00116779|561541328|FG000|Overall Study|Adverse Event|4|||
155578012|NCT00116779|561541329|FG001|Overall Study|Adverse Event|2|||
155578013|NCT00116779|561541328|FG000|Overall Study|Protocol Violation|1|||
155578014|NCT00116779|561541329|FG001|Overall Study|Protocol Violation|4|||
155578015|NCT00116779|561541328|FG000|Overall Study|Withdrawal by Subject|4|||
155578016|NCT00116779|561541329|FG001|Overall Study|Withdrawal by Subject|1|||
155578017|NCT00116779|561541328|FG000|Overall Study|Inadequate testosterone suppression|7|||
155578018|NCT00116779|561541329|FG001|Overall Study|Inadequate testosterone suppression|9|||
155578019|NCT00116779|561541328|FG000|Overall Study|Physician Decision|3|||
155578020|NCT00116779|561541329|FG001|Overall Study|Physician Decision|1|||
155578021|NCT00116779|561541328|FG000|Overall Study|Elevated PSA levels|2|||
155578022|NCT00116779|561541329|FG001|Overall Study|Elevated PSA levels|2|||
155578023|NCT00707239|561541330|FG000|Overall Study|Adverse Event|5|||
155578024|NCT00707239|561541331|FG001|Overall Study|Adverse Event|3|||
155578025|NCT00707239|561541332|FG002|Overall Study|Adverse Event|2|||
155578026|NCT00707239|561541330|FG000|Overall Study|Death|3|||
155578027|NCT00707239|561541331|FG001|Overall Study|Death|1|||
155578028|NCT00707239|561541332|FG002|Overall Study|Death|3|||
155578029|NCT00707239|561541330|FG000|Overall Study|Physician Decision|1|||
155578030|NCT00707239|561541331|FG001|Overall Study|Physician Decision|1|||
155578031|NCT00707239|561541332|FG002|Overall Study|Physician Decision|2|||
155578032|NCT00707239|561541330|FG000|Overall Study|Protocol Violation|0|||
155578033|NCT00707239|561541331|FG001|Overall Study|Protocol Violation|0|||
155578034|NCT00707239|561541332|FG002|Overall Study|Protocol Violation|1|||
155578035|NCT00707239|561541330|FG000|Overall Study|Lack of Efficacy|1|||
155578036|NCT00707239|561541331|FG001|Overall Study|Lack of Efficacy|2|||
155578037|NCT00707239|561541332|FG002|Overall Study|Lack of Efficacy|0|||
155578038|NCT00707239|561541330|FG000|Overall Study|Randomized, but not treated|1|||
155578039|NCT00707239|561541331|FG001|Overall Study|Randomized, but not treated|1|||
155578040|NCT00707239|561541332|FG002|Overall Study|Randomized, but not treated|1|||
155662165|NCT04064905|561858210|FG003|Overall Study|Lost to Follow-up|4|||
155662166|NCT04064905|561858211|FG004|Overall Study|Lost to Follow-up|2|||
155662167|NCT03961308|561858217|FG000|Overall Study|Withdrawal by Subject|1|||
155662168|NCT03961308|561858218|FG001|Overall Study|Withdrawal by Subject|0|||
155662169|NCT03961308|561858217|FG000|Overall Study|Other|1|||
155662170|NCT03961308|561858218|FG001|Overall Study|Other|0|||
155662171|NCT03961308|561858217|FG000|Overall Study|Lost to Follow-up|0|||
155662172|NCT03961308|561858218|FG001|Overall Study|Lost to Follow-up|1|||
155662173|NCT03961308|561858217|FG000|Overall Study|Adverse Event|0|||
155662174|NCT03961308|561858218|FG001|Overall Study|Adverse Event|1|||
155662175|NCT05643495|561858223|FG000|Overall Study|Adverse Event|0|||
155662176|NCT05643495|561858224|FG001|Overall Study|Adverse Event|1|||
155662177|NCT05643495|561858223|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155662178|NCT05643495|561858224|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155662179|NCT01729039|561858225|FG000|Overall Study|disqualified|2|||
155662180|NCT01729039|561858226|FG001|Overall Study|disqualified|5|||
155662181|NCT01729039|561858225|FG000|Overall Study|Withdrawal by Subject|8|||
155662182|NCT01729039|561858226|FG001|Overall Study|Withdrawal by Subject|7|||
155662183|NCT00698841|561858229|FG000|Overall Study|Withdrawal by Subject|2|||
155662184|NCT00698841|561858229|FG000|Overall Study|Adverse Event|3|||
155662185|NCT00698841|561858229|FG000|Overall Study|Disease progression|7|||
155662186|NCT00698841|561858229|FG000|Overall Study|Failure to meet eligibility criteria|2|||
155662187|NCT00698841|561858229|FG000|Overall Study|Study drug toxicity|2|||
155662188|NCT00698841|561858229|FG000|Overall Study|Other|2|||
155662189|NCT00789555|561858230|FG000|Overall Study|Protocol Amendment|78|||
155662190|NCT00789555|561858231|FG001|Overall Study|Protocol Amendment|76|||
155662191|NCT00789555|561858232|FG002|Overall Study|Protocol Amendment|80|||
155662192|NCT00789555|561858230|FG000|Overall Study|Adverse Event|17|||
155662193|NCT00789555|561858231|FG001|Overall Study|Adverse Event|7|||
155662194|NCT00789555|561858232|FG002|Overall Study|Adverse Event|10|||
155662195|NCT00789555|561858230|FG000|Overall Study|Lost to Follow-up|9|||
155662196|NCT00789555|561858231|FG001|Overall Study|Lost to Follow-up|10|||
155662197|NCT00789555|561858232|FG002|Overall Study|Lost to Follow-up|18|||
155662198|NCT00789555|561858230|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
155662199|NCT00789555|561858231|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
155662200|NCT00789555|561858232|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
155662201|NCT00789555|561858230|FG000|Overall Study|Treatment failure|11|||
155662202|NCT00789555|561858231|FG001|Overall Study|Treatment failure|8|||
155662203|NCT00789555|561858232|FG002|Overall Study|Treatment failure|12|||
155662204|NCT00789555|561858230|FG000|Overall Study|Protocol Violation|6|||
155662205|NCT00789555|561858231|FG001|Overall Study|Protocol Violation|9|||
155578041|NCT00707239|561541330|FG000|Overall Study|Other|8|||
155578042|NCT00707239|561541331|FG001|Overall Study|Other|3|||
155578043|NCT00707239|561541332|FG002|Overall Study|Other|5|||
155578044|NCT01778530|561541333|FG000|Overall Study|Progression on study|1|||
155578045|NCT01778530|561541333|FG000|Overall Study|Adverse event/side effect|1|||
155578046|NCT03472014|561541334|FG000|Overall Study|Lost to Follow-up|4|||
155578047|NCT00711087|561541335|FG000|Overall Study|Lost to Follow-up|1|||
155578048|NCT00711087|561541336|FG001|Overall Study|Lost to Follow-up|0|||
155578049|NCT01958437|561541337|FG000|Overall Study|Incidental MRI findings|0|||
155578050|NCT01958437|561541338|FG001|Overall Study|Incidental MRI findings|0|||
155578051|NCT01958437|561541339|FG002|Overall Study|Incidental MRI findings|1|||
155578052|NCT01958437|561541340|FG003|Overall Study|Incidental MRI findings|1|||
155578053|NCT02394600|561541343|FG000|Overall Study|Adverse Event|3|||
155578054|NCT02394600|561541344|FG001|Overall Study|Adverse Event|0|||
155578055|NCT02394600|561541343|FG000|Overall Study|Lost to Follow-up|0|||
155578056|NCT02394600|561541344|FG001|Overall Study|Lost to Follow-up|1|||
155578057|NCT02394600|561541343|FG000|Overall Study|Withdrawal by Subject|0|||
155662206|NCT00789555|561858232|FG002|Overall Study|Protocol Violation|13|||
155662207|NCT00404248|561858233|FG000|Overall Study|pts declining status|0|||
155662208|NCT00404248|561858234|FG001|Overall Study|pts declining status|1|||
155662209|NCT00404248|561858235|FG002|Overall Study|pts declining status|0|||
155662210|NCT00404248|561858236|FG003|Overall Study|pts declining status|0|||
155662211|NCT00404248|561858237|FG004|Overall Study|pts declining status|0|||
155662212|NCT00404248|561858238|FG005|Overall Study|pts declining status|0|||
155662213|NCT00404248|561858239|FG006|Overall Study|pts declining status|0|||
155662214|NCT00404248|561858240|FG007|Overall Study|pts declining status|0|||
155662215|NCT00404248|561858241|FG008|Overall Study|pts declining status|0|||
155662216|NCT04646005|561858245|FG000|Overall Study|Adverse Event|1|||
155662217|NCT04646005|561858245|FG000|Overall Study|Progressive Disease|71|||
155662218|NCT04646005|561858245|FG000|Overall Study|Death|20|||
155662219|NCT04646005|561858245|FG000|Overall Study|Withdrawal by Subject|12|||
155662220|NCT04646005|561858245|FG000|Overall Study|Sponsor Request|9|||
155662221|NCT02661672|561858247|FG000|Overall Study|Lost to Follow-up|1|||
155662222|NCT02661672|561858247|FG000|Overall Study|Death|4|||
155662223|NCT01621178|561860250|FG000|Overall Study|Adverse Event|5|||
155662224|NCT01621178|561860251|FG001|Overall Study|Adverse Event|2|||
155662225|NCT01621178|561860252|FG002|Overall Study|Adverse Event|8|||
155662226|NCT01621178|561860250|FG000|Overall Study|Death|6|||
155662227|NCT01621178|561860251|FG001|Overall Study|Death|7|||
155662228|NCT01621178|561860252|FG002|Overall Study|Death|2|||
155662229|NCT01621178|561860250|FG000|Overall Study|Lost to Follow-up|1|||
155662230|NCT01621178|561860251|FG001|Overall Study|Lost to Follow-up|2|||
155662231|NCT01621178|561860252|FG002|Overall Study|Lost to Follow-up|1|||
155662232|NCT01621178|561860250|FG000|Overall Study|Withdrawal by Subject|14|||
155662233|NCT01621178|561860251|FG001|Overall Study|Withdrawal by Subject|17|||
155662234|NCT01621178|561860252|FG002|Overall Study|Withdrawal by Subject|18|||
155662235|NCT01621178|561860250|FG000|Overall Study|Physician Decision|5|||
155662236|NCT01621178|561860251|FG001|Overall Study|Physician Decision|2|||
155662237|NCT01621178|561860252|FG002|Overall Study|Physician Decision|7|||
155662238|NCT02935192|561860253|FG000|Overall Study|Withdrawal by Subject|8|||
155662239|NCT02935192|561860254|FG001|Overall Study|Withdrawal by Subject|4|||
155662240|NCT02465931|561860255|FG000|Overall Study|Lost to Follow-up|9|||
155662241|NCT02465931|561860256|FG001|Overall Study|Lost to Follow-up|11|||
155662242|NCT02465931|561860255|FG000|Overall Study|Protocol Violation|1|||
155662243|NCT02465931|561860256|FG001|Overall Study|Protocol Violation|0|||
155662244|NCT02465931|561860255|FG000|Overall Study|Withdrawal by Subject|1|||
155662245|NCT02465931|561860256|FG001|Overall Study|Withdrawal by Subject|0|||
155662246|NCT00492557|561860258|FG000|Overall Study|Subject request|12|||
155662247|NCT00492557|561860259|FG001|Overall Study|Subject request|11|||
155662248|NCT00492557|561860258|FG000|Overall Study|Protocol Violation|7|||
155662249|NCT00492557|561860259|FG001|Overall Study|Protocol Violation|8|||
155662250|NCT00492557|561860258|FG000|Overall Study|Other|2|||
155662251|NCT00492557|561860259|FG001|Overall Study|Other|2|||
155662252|NCT00492557|561860258|FG000|Overall Study|Death|1|||
155662253|NCT00492557|561860259|FG001|Overall Study|Death|1|||
155662254|NCT00492557|561860258|FG000|Overall Study|Adverse Event|1|||
155662255|NCT00492557|561860259|FG001|Overall Study|Adverse Event|0|||
155662256|NCT00492557|561860258|FG000|Overall Study|Failed to return|1|||
155662257|NCT00492557|561860259|FG001|Overall Study|Failed to return|0|||
155662258|NCT00492557|561860258|FG000|Overall Study|Lost to Follow-up|0|||
155662259|NCT00492557|561860259|FG001|Overall Study|Lost to Follow-up|1|||
155662260|NCT04778592|561860264|FG000|Overall Study|Adverse Event|1|||
155662261|NCT04778592|561860265|FG001|Overall Study|Adverse Event|2|||
155662262|NCT04778592|561860264|FG000|Overall Study|Withdrawal by Subject|1|||
155662263|NCT04778592|561860265|FG001|Overall Study|Withdrawal by Subject|2|||
155662264|NCT03423121|561860266|FG000|Overall Study|Lost to Follow-up|2|||
155662265|NCT03423121|561860267|FG001|Overall Study|Lost to Follow-up|6|||
155662266|NCT03423121|561860266|FG000|Overall Study|Adverse Event|1|||
155662267|NCT03423121|561860267|FG001|Overall Study|Adverse Event|0|||
155578058|NCT02394600|561541344|FG001|Overall Study|Withdrawal by Subject|1|||
155578059|NCT02394600|561541343|FG000|Overall Study|Protocol Violation|1|||
155578060|NCT02394600|561541344|FG001|Overall Study|Protocol Violation|0|||
155578061|NCT02569801|561541345|FG000|Overall Study|Withdrawal by Subject|9|||
155578062|NCT02569801|561541346|FG001|Overall Study|Withdrawal by Subject|9|||
155578063|NCT02569801|561541345|FG000|Overall Study|Sponsor Decision|13|||
155578064|NCT02569801|561541346|FG001|Overall Study|Sponsor Decision|14|||
155578065|NCT02569801|561541345|FG000|Overall Study|Progressive Disease|2|||
155578066|NCT02569801|561541346|FG001|Overall Study|Progressive Disease|7|||
155578067|NCT02569801|561541345|FG000|Overall Study|Lost to Follow-up|0|||
155578068|NCT02569801|561541346|FG001|Overall Study|Lost to Follow-up|1|||
155578069|NCT02569801|561541345|FG000|Overall Study|Death|12|||
155578070|NCT02569801|561541346|FG001|Overall Study|Death|4|||
155578071|NCT00428246|561541347|FG000|Overall Study|Withdrawal by Subject|0|||
155578072|NCT00428246|561541348|FG001|Overall Study|Withdrawal by Subject|0|||
155578073|NCT00428246|561541349|FG002|Overall Study|Withdrawal by Subject|1|||
155578074|NCT00428246|561541347|FG000|Overall Study|Adverse Event|1|||
155578075|NCT00428246|561541348|FG001|Overall Study|Adverse Event|0|||
155578076|NCT00428246|561541349|FG002|Overall Study|Adverse Event|0|||
155578077|NCT03442751|561541353|FG000|Overall Study|Withdrawal by Subject|3|||
155662268|NCT01354223|561860268|FG000|Overall Study|Withdrawal by Subject|3|||
155662269|NCT01354223|561860269|FG001|Overall Study|Withdrawal by Subject|1|||
155578078|NCT03442751|561541354|FG001|Overall Study|Withdrawal by Subject|1|||
155578079|NCT03442751|561541353|FG000|Overall Study|Lost to Follow-up|3|||
155578080|NCT03442751|561541354|FG001|Overall Study|Lost to Follow-up|0|||
155578081|NCT02603887|561541357|FG000|Stage 1|Adverse Event|4|||
155578082|NCT02603887|561541357|FG000|Stage 1|Disease progression|1|||
155662270|NCT00524121|561860279|FG000|Overall Study|Disease progression|6|||
155662271|NCT00524121|561860279|FG000|Overall Study|Adverse Event|4|||
155662272|NCT00524121|561860279|FG000|Overall Study|Patient refused|2|||
155662273|NCT00524121|561860279|FG000|Overall Study|Other|1|||
155662274|NCT00524121|561860279|FG000|Overall Study|Death|1|||
155662275|NCT00524121|561860279|FG000|Overall Study|Not treated (became ineligible)|4|||
155662276|NCT00524121|561860279|FG000|Overall Study|Not treated (changed mind)|1|||
155662277|NCT04047446|561860280|FG000|Overall Study|Physician Decision|1|||
155578083|NCT02603887|561541357|FG000|Stage 2|FDA guidance|1|||
155578084|NCT01308424|561541360|FG000|Baseline Eligibility|Screen Failures|71|||
155578085|NCT01308424|561541361|FG001|Baseline Eligibility|Screen Failures|0|||
155578086|NCT01308424|561541362|FG002|Baseline Eligibility|Screen Failures|0|||
155578087|NCT01308424|561541360|FG000|Randomization|Adverse Event|0|||
155578088|NCT01308424|561541361|FG001|Randomization|Adverse Event|1|||
155578089|NCT01308424|561541362|FG002|Randomization|Adverse Event|1|||
155578090|NCT01308424|561541360|FG000|Randomization|Lost to Follow-up|0|||
155578091|NCT01308424|561541361|FG001|Randomization|Lost to Follow-up|1|||
155578092|NCT01308424|561541362|FG002|Randomization|Lost to Follow-up|0|||
155578093|NCT01308424|561541360|FG000|Randomization|Physician Decision|0|||
155578094|NCT01308424|561541361|FG001|Randomization|Physician Decision|1|||
155578095|NCT01308424|561541362|FG002|Randomization|Physician Decision|1|||
155578096|NCT00948155|561541363|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
155578097|NCT00948155|561541364|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
155578098|NCT00948155|561541363|FG000|Washout 14 Days|Lost to Follow-up|1|||
155578099|NCT00948155|561541364|FG001|Washout 14 Days|Lost to Follow-up|2|||
155578100|NCT04620746|561541365|FG000|Overall Study|Adverse Event|2|||
155578101|NCT04620746|561541366|FG001|Overall Study|Adverse Event|0|||
155578102|NCT04620746|561541365|FG000|Overall Study|Uniterpretable skin test|1|||
155578103|NCT04620746|561541366|FG001|Overall Study|Uniterpretable skin test|0|||
155578104|NCT04620746|561541365|FG000|Overall Study|Withdrawal by Subject|0|||
155578105|NCT04620746|561541366|FG001|Overall Study|Withdrawal by Subject|1|||
155578106|NCT05767905|561541369|FG000|Overall Study|Adverse Event|0|||
155578107|NCT05767905|561541370|FG001|Overall Study|Adverse Event|0|||
155578108|NCT05767905|561541371|FG002|Overall Study|Adverse Event|1|||
155578109|NCT03404674|561541373|FG000|Overall Study|Inability to Attend Future Visits|0|||
155578110|NCT03404674|561541374|FG001|Overall Study|Inability to Attend Future Visits|1|||
155578111|NCT03404674|561541375|FG002|Overall Study|Inability to Attend Future Visits|1|||
155578112|NCT03404674|561541376|FG003|Overall Study|Inability to Attend Future Visits|0|||
155578113|NCT03404674|561541377|FG004|Overall Study|Inability to Attend Future Visits|0|||
155578114|NCT03404674|561541378|FG005|Overall Study|Inability to Attend Future Visits|0|||
155578115|NCT03404674|561541373|FG000|Overall Study|Behavioral Problems|0|||
155578116|NCT03404674|561541374|FG001|Overall Study|Behavioral Problems|0|||
155578117|NCT03404674|561541375|FG002|Overall Study|Behavioral Problems|1|||
155578118|NCT03404674|561541376|FG003|Overall Study|Behavioral Problems|0|||
155578119|NCT03404674|561541377|FG004|Overall Study|Behavioral Problems|0|||
155578120|NCT03404674|561541378|FG005|Overall Study|Behavioral Problems|0|||
155578121|NCT03404674|561541373|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
155578122|NCT03404674|561541374|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
155578123|NCT03404674|561541375|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
155578124|NCT03404674|561541376|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
155578125|NCT03404674|561541377|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
155578126|NCT03404674|561541378|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
155578127|NCT01841593|561541379|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
155578128|NCT01841593|561541380|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
155578129|NCT01841593|561541379|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
155578130|NCT01841593|561541380|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
155578131|NCT03125798|561541382|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
155578132|NCT03125798|561541383|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
155578133|NCT03125798|561541382|FG000|Overall Study|Conversion to thoracotomy|7|||
155578134|NCT03125798|561541383|FG001|Overall Study|Conversion to thoracotomy|7|||
155578135|NCT01487525|561541386|FG000|Overall Study|Withdrawal by Subject|0|||
155578136|NCT01487525|561541387|FG001|Overall Study|Withdrawal by Subject|1|||
155578137|NCT00262028|561541396|FG000|Overall Study|Withdrawal by Subject|6|||
155578138|NCT00262028|561541397|FG001|Overall Study|Withdrawal by Subject|3|||
155578139|NCT00262028|561541398|FG002|Overall Study|Withdrawal by Subject|6|||
155578140|NCT00262028|561541399|FG003|Overall Study|Withdrawal by Subject|5|||
155578141|NCT00262028|561541400|FG004|Overall Study|Withdrawal by Subject|2|||
155578142|NCT00262028|561541401|FG005|Overall Study|Withdrawal by Subject|3|||
155578143|NCT00262028|561541402|FG006|Overall Study|Withdrawal by Subject|5|||
155578144|NCT00262028|561541403|FG007|Overall Study|Withdrawal by Subject|7|||
155578145|NCT00262028|561541404|FG008|Overall Study|Withdrawal by Subject|2|||
155578146|NCT00262028|561541396|FG000|Overall Study|Lost to Follow-up|7|||
155578147|NCT00262028|561541397|FG001|Overall Study|Lost to Follow-up|7|||
155578148|NCT00262028|561541398|FG002|Overall Study|Lost to Follow-up|5|||
155578149|NCT00262028|561541399|FG003|Overall Study|Lost to Follow-up|5|||
155578150|NCT00262028|561541400|FG004|Overall Study|Lost to Follow-up|4|||
155578151|NCT00262028|561541401|FG005|Overall Study|Lost to Follow-up|3|||
155578152|NCT00262028|561541402|FG006|Overall Study|Lost to Follow-up|3|||
155578153|NCT00262028|561541403|FG007|Overall Study|Lost to Follow-up|5|||
155578154|NCT00262028|561541404|FG008|Overall Study|Lost to Follow-up|6|||
155578155|NCT00262028|561541396|FG000|Overall Study|Administrative Reason|11|||
155198472|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
155578156|NCT00262028|561541397|FG001|Overall Study|Administrative Reason|14|||
155578157|NCT00262028|561541398|FG002|Overall Study|Administrative Reason|9|||
155578158|NCT00262028|561541399|FG003|Overall Study|Administrative Reason|12|||
155578159|NCT00262028|561541400|FG004|Overall Study|Administrative Reason|6|||
155578160|NCT00262028|561541401|FG005|Overall Study|Administrative Reason|7|||
155578161|NCT00262028|561541402|FG006|Overall Study|Administrative Reason|4|||
155578162|NCT00262028|561541403|FG007|Overall Study|Administrative Reason|6|||
155578163|NCT00262028|561541404|FG008|Overall Study|Administrative Reason|10|||
155578164|NCT00262028|561541396|FG000|Overall Study|Protocol Violation|0|||
155578165|NCT00262028|561541397|FG001|Overall Study|Protocol Violation|0|||
155578166|NCT00262028|561541398|FG002|Overall Study|Protocol Violation|0|||
155578167|NCT00262028|561541399|FG003|Overall Study|Protocol Violation|1|||
155578168|NCT00262028|561541400|FG004|Overall Study|Protocol Violation|0|||
155578169|NCT00262028|561541401|FG005|Overall Study|Protocol Violation|0|||
155578170|NCT00262028|561541402|FG006|Overall Study|Protocol Violation|0|||
155578171|NCT00262028|561541403|FG007|Overall Study|Protocol Violation|0|||
155578172|NCT00262028|561541404|FG008|Overall Study|Protocol Violation|0|||
155578173|NCT00262028|561541396|FG000|Overall Study|Unable to classify|0|||
155578174|NCT00262028|561541397|FG001|Overall Study|Unable to classify|3|||
155578175|NCT00262028|561541398|FG002|Overall Study|Unable to classify|0|||
155578176|NCT00262028|561541399|FG003|Overall Study|Unable to classify|0|||
155578177|NCT00262028|561541400|FG004|Overall Study|Unable to classify|0|||
155578178|NCT00262028|561541401|FG005|Overall Study|Unable to classify|0|||
155578179|NCT00262028|561541402|FG006|Overall Study|Unable to classify|0|||
155578180|NCT00262028|561541403|FG007|Overall Study|Unable to classify|0|||
155578181|NCT00262028|561541404|FG008|Overall Study|Unable to classify|1|||
155578182|NCT03518008|561541405|FG000|Period 2, Second Week of Wear|Family emergency|0|||
155578183|NCT03518008|561541406|FG001|Period 2, Second Week of Wear|Family emergency|1|||
155578184|NCT01515423|561541407|FG000|Open Label Phase|Adverse Event|57|||
155578185|NCT01515423|561541408|FG001|Open Label Phase|Adverse Event|0|||
155578186|NCT01515423|561541409|FG002|Open Label Phase|Adverse Event|0|||
155578187|NCT01515423|561541407|FG000|Open Label Phase|Death|2|||
155578188|NCT01515423|561541408|FG001|Open Label Phase|Death|0|||
155578189|NCT01515423|561541409|FG002|Open Label Phase|Death|0|||
155578190|NCT01515423|561541407|FG000|Open Label Phase|Lack of Efficacy|117|||
155578191|NCT01515423|561541408|FG001|Open Label Phase|Lack of Efficacy|0|||
155578192|NCT01515423|561541409|FG002|Open Label Phase|Lack of Efficacy|0|||
155578193|NCT01515423|561541407|FG000|Open Label Phase|Lost to Follow-up|21|||
155578194|NCT01515423|561541408|FG001|Open Label Phase|Lost to Follow-up|0|||
155578195|NCT01515423|561541409|FG002|Open Label Phase|Lost to Follow-up|0|||
155578196|NCT01515423|561541407|FG000|Open Label Phase|Withdrawal by Subject|118|||
155578197|NCT01515423|561541408|FG001|Open Label Phase|Withdrawal by Subject|0|||
155578198|NCT01515423|561541409|FG002|Open Label Phase|Withdrawal by Subject|0|||
155578199|NCT01515423|561541407|FG000|Open Label Phase|excluded from DB Phase|70|||
155578200|NCT01515423|561541408|FG001|Open Label Phase|excluded from DB Phase|0|||
155578201|NCT01515423|561541409|FG002|Open Label Phase|excluded from DB Phase|0|||
155578202|NCT01515423|561541407|FG000|Open Label Phase|Other|28|||
155578203|NCT01515423|561541408|FG001|Open Label Phase|Other|0|||
155578204|NCT01515423|561541409|FG002|Open Label Phase|Other|0|||
155578205|NCT01515423|561541407|FG000|DOUBLE BLIND|Adverse Event|0|||
155578206|NCT01515423|561541408|FG001|DOUBLE BLIND|Adverse Event|15|||
155578207|NCT01515423|561541409|FG002|DOUBLE BLIND|Adverse Event|13|||
155578208|NCT01515423|561541407|FG000|DOUBLE BLIND|Death|0|||
155578209|NCT01515423|561541408|FG001|DOUBLE BLIND|Death|1|||
155578210|NCT01515423|561541409|FG002|DOUBLE BLIND|Death|2|||
155578211|NCT01515423|561541407|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
155662278|NCT04047446|561860281|FG001|Overall Study|Physician Decision|0|||
155662279|NCT01840943|561860282|FG000|Overall Study|Withdrawal by Subject|5|||
155662280|NCT01840943|561860283|FG001|Overall Study|Withdrawal by Subject|6|||
155662281|NCT01840943|561860282|FG000|Overall Study|Physician Decision|4|||
155662282|NCT01840943|561860283|FG001|Overall Study|Physician Decision|2|||
155662283|NCT01840943|561860282|FG000|Overall Study|Lost to Follow-up|4|||
155662284|NCT01840943|561860283|FG001|Overall Study|Lost to Follow-up|4|||
155662285|NCT00329420|561860284|FG000|Re-induction Phase|Lack of Efficacy|0|||
155662286|NCT00329420|561860285|FG001|Re-induction Phase|Lack of Efficacy|1|||
155662287|NCT00329420|561860286|FG002|Re-induction Phase|Lack of Efficacy|0|||
155662288|NCT00329420|561860284|FG000|Re-induction Phase|Withdrawal of Consent|0|||
155578212|NCT01515423|561541408|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
155578213|NCT01515423|561541409|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
155578214|NCT01515423|561541407|FG000|DOUBLE BLIND|Pregnancy|0|||
155578215|NCT01515423|561541408|FG001|DOUBLE BLIND|Pregnancy|2|||
155578216|NCT01515423|561541409|FG002|DOUBLE BLIND|Pregnancy|0|||
155578217|NCT01515423|561541407|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
155662289|NCT00329420|561860285|FG001|Re-induction Phase|Withdrawal of Consent|0|||
155578218|NCT01515423|561541408|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
155578219|NCT01515423|561541409|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
155578220|NCT01515423|561541407|FG000|DOUBLE BLIND|Other|0|||
155578221|NCT01515423|561541408|FG001|DOUBLE BLIND|Other|6|||
155578222|NCT01515423|561541409|FG002|DOUBLE BLIND|Other|12|||
155662290|NCT00329420|561860286|FG002|Re-induction Phase|Withdrawal of Consent|1|||
155578223|NCT01515423|561541407|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
155578224|NCT01515423|561541408|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
155578225|NCT01515423|561541409|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
155578226|NCT00613171|561541414|FG000|Overall Study|Adverse Event|7|||
155578227|NCT00613171|561541414|FG000|Overall Study|Withdrawal by Subject|3|||
155578228|NCT00613171|561541414|FG000|Overall Study|Reason not Specified|4|||
155578229|NCT01876446|561541424|FG000|Overall Study|Death|0|||
155578230|NCT01876446|561541425|FG001|Overall Study|Death|1|||
155578231|NCT01876446|561541424|FG000|Overall Study|Withdrawal by Subject|1|||
155578232|NCT01876446|561541425|FG001|Overall Study|Withdrawal by Subject|2|||
155578233|NCT01876446|561541424|FG000|Overall Study|Physician Decision|1|||
155578234|NCT01876446|561541425|FG001|Overall Study|Physician Decision|3|||
155578235|NCT03629184|561541432|FG000|Overall Study|Withdrawal by Subject|2|||
155578236|NCT03629184|561541433|FG001|Overall Study|Withdrawal by Subject|1|||
155578237|NCT03629184|561541432|FG000|Overall Study|Physician Decision|1|||
155578238|NCT03629184|561541433|FG001|Overall Study|Physician Decision|0|||
155578239|NCT01461538|561541434|FG000|Overall Study|Death|15|||
155578240|NCT01461538|561541435|FG001|Overall Study|Death|6|||
155578241|NCT01461538|561541436|FG002|Overall Study|Death|2|||
155578242|NCT01461538|561541434|FG000|Overall Study|Study Stopped by Sponsor|2|||
155578243|NCT01461538|561541435|FG001|Overall Study|Study Stopped by Sponsor|1|||
155578244|NCT01461538|561541436|FG002|Overall Study|Study Stopped by Sponsor|0|||
155578245|NCT01461538|561541434|FG000|Overall Study|Withdrawal by Subject|1|||
155578246|NCT01461538|561541435|FG001|Overall Study|Withdrawal by Subject|1|||
155578247|NCT01461538|561541436|FG002|Overall Study|Withdrawal by Subject|0|||
155578248|NCT01982955|561541437|FG000|Overall Study|Randomized but not treated|0|||
155578249|NCT01982955|561541438|FG001|Overall Study|Randomized but not treated|0|||
155578250|NCT01982955|561541439|FG002|Overall Study|Randomized but not treated|0|||
155578251|NCT01982955|561541440|FG003|Overall Study|Randomized but not treated|1|||
155578252|NCT01982955|561541441|FG004|Overall Study|Randomized but not treated|0|||
155578253|NCT05655546|561542795|FG000|Overall Study|Withdrawal by Subject|2|||
155578254|NCT05655546|561542796|FG001|Overall Study|Withdrawal by Subject|4|||
155578255|NCT03493685|561542797|FG000|Overall Study|Death|4|||
155578256|NCT03493685|561542798|FG001|Overall Study|Death|3|||
155578257|NCT03493685|561542797|FG000|Overall Study|Lost to Follow-up|3|||
155578258|NCT03493685|561542798|FG001|Overall Study|Lost to Follow-up|2|||
155578259|NCT03493685|561542797|FG000|Overall Study|Physician Decision|2|||
155578260|NCT03493685|561542798|FG001|Overall Study|Physician Decision|0|||
155578261|NCT03493685|561542797|FG000|Overall Study|Withdrawal by Subject|7|||
155578262|NCT03493685|561542798|FG001|Overall Study|Withdrawal by Subject|11|||
155578263|NCT04452669|561542799|FG000|Overall Study|Death|1|||
155578264|NCT04452669|561542800|FG001|Overall Study|Death|4|||
155578265|NCT04576507|561542804|FG000|Overall Study|Adverse Event|4|||
155578266|NCT04576507|561542804|FG000|Overall Study|Withdrawal by Subject|1|||
155578267|NCT04653454|561542809|FG000|Overall Study|Withdrawal by Subject|1|||
155578268|NCT04653454|561542809|FG000|Overall Study|Physician Decision|40|||
155578269|NCT05525520|561542810|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
155578270|NCT05525520|561542811|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
155578271|NCT05525520|561542810|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
155578272|NCT05525520|561542811|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
155578273|NCT05878093|561542814|FG000|Overall Study|Withdrawal by Subject|3|||
155578274|NCT05878093|561542815|FG001|Overall Study|Withdrawal by Subject|1|||
155578275|NCT02721732|561542816|FG000|Overall Study|Adverse Event|2|||
155578276|NCT02721732|561542817|FG001|Overall Study|Adverse Event|0|||
155578277|NCT02721732|561542818|FG002|Overall Study|Adverse Event|2|||
155578278|NCT02721732|561542819|FG003|Overall Study|Adverse Event|0|||
155578279|NCT02721732|561542820|FG004|Overall Study|Adverse Event|1|||
155578280|NCT02721732|561542821|FG005|Overall Study|Adverse Event|0|||
155578281|NCT02721732|561542822|FG006|Overall Study|Adverse Event|1|||
155578282|NCT02721732|561542823|FG007|Overall Study|Adverse Event|0|||
155578283|NCT02721732|561542824|FG008|Overall Study|Adverse Event|1|||
155578284|NCT02721732|561542825|FG009|Overall Study|Adverse Event|1|||
155578285|NCT02721732|561542816|FG000|Overall Study|Death|0|||
155578286|NCT02721732|561542817|FG001|Overall Study|Death|0|||
155578287|NCT02721732|561542818|FG002|Overall Study|Death|0|||
155578288|NCT02721732|561542819|FG003|Overall Study|Death|0|||
155578289|NCT02721732|561542820|FG004|Overall Study|Death|1|||
155578290|NCT02721732|561542821|FG005|Overall Study|Death|0|||
155578291|NCT02721732|561542822|FG006|Overall Study|Death|1|||
155578292|NCT02721732|561542823|FG007|Overall Study|Death|0|||
155578293|NCT02721732|561542824|FG008|Overall Study|Death|0|||
155578294|NCT02721732|561542825|FG009|Overall Study|Death|1|||
155578295|NCT02721732|561542816|FG000|Overall Study|Lack of Efficacy|12|||
155578296|NCT02721732|561542817|FG001|Overall Study|Lack of Efficacy|11|||
155578297|NCT02721732|561542818|FG002|Overall Study|Lack of Efficacy|18|||
155578298|NCT02721732|561542819|FG003|Overall Study|Lack of Efficacy|5|||
155578299|NCT02721732|561542820|FG004|Overall Study|Lack of Efficacy|21|||
155578300|NCT02721732|561542821|FG005|Overall Study|Lack of Efficacy|2|||
155578301|NCT02721732|561542822|FG006|Overall Study|Lack of Efficacy|8|||
155578302|NCT02721732|561542823|FG007|Overall Study|Lack of Efficacy|11|||
155662291|NCT00329420|561860284|FG000|Re-induction Phase|Did not respond to re-induction|6|||
155662292|NCT00329420|561860285|FG001|Re-induction Phase|Did not respond to re-induction|5|||
155662293|NCT00329420|561860286|FG002|Re-induction Phase|Did not respond to re-induction|7|||
155662294|NCT00329420|561860284|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
155662295|NCT00329420|561860285|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
155662296|NCT00329420|561860286|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
155662297|NCT00329420|561860284|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
155662298|NCT00329420|561860285|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
155662299|NCT00329420|561860286|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
155662300|NCT00329420|561860284|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
155662301|NCT00329420|561860285|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
155662302|NCT00329420|561860286|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
155662303|NCT01446874|561860287|FG000|Overall Study|Not eligible|1|||
155662304|NCT01446874|561860288|FG001|Overall Study|Not eligible|0|||
155662305|NCT01446874|561860289|FG002|Overall Study|Not eligible|0|||
155662306|NCT01446874|561860287|FG000|Overall Study|No surgery/No qualifying surgery|1|||
155662307|NCT01446874|561860288|FG001|Overall Study|No surgery/No qualifying surgery|0|||
155662308|NCT01446874|561860289|FG002|Overall Study|No surgery/No qualifying surgery|12|||
155662309|NCT01446874|561860287|FG000|Overall Study|Non-compliance|0|||
155662310|NCT01446874|561860288|FG001|Overall Study|Non-compliance|4|||
155662311|NCT01446874|561860289|FG002|Overall Study|Non-compliance|0|||
155662312|NCT01446874|561860287|FG000|Overall Study|Antibiotics for pre-op infection|0|||
155578303|NCT02721732|561542824|FG008|Overall Study|Lack of Efficacy|10|||
155662313|NCT01446874|561860288|FG001|Overall Study|Antibiotics for pre-op infection|0|||
155662314|NCT01446874|561860289|FG002|Overall Study|Antibiotics for pre-op infection|2|||
155578304|NCT02721732|561542825|FG009|Overall Study|Lack of Efficacy|20|||
155578305|NCT02721732|561542816|FG000|Overall Study|Physician Decision|0|||
155578306|NCT02721732|561542817|FG001|Overall Study|Physician Decision|0|||
155578307|NCT02721732|561542818|FG002|Overall Study|Physician Decision|1|||
155578308|NCT02721732|561542819|FG003|Overall Study|Physician Decision|0|||
155578309|NCT02721732|561542820|FG004|Overall Study|Physician Decision|0|||
155578310|NCT02721732|561542821|FG005|Overall Study|Physician Decision|0|||
155578311|NCT02721732|561542822|FG006|Overall Study|Physician Decision|0|||
155578312|NCT02721732|561542823|FG007|Overall Study|Physician Decision|0|||
155578313|NCT02721732|561542824|FG008|Overall Study|Physician Decision|0|||
155578314|NCT02721732|561542825|FG009|Overall Study|Physician Decision|0|||
155578315|NCT02721732|561542816|FG000|Overall Study|Withdrawal by Subject|1|||
155578316|NCT02721732|561542817|FG001|Overall Study|Withdrawal by Subject|0|||
155578317|NCT02721732|561542818|FG002|Overall Study|Withdrawal by Subject|0|||
155578318|NCT02721732|561542819|FG003|Overall Study|Withdrawal by Subject|0|||
155578319|NCT02721732|561542820|FG004|Overall Study|Withdrawal by Subject|3|||
155578320|NCT02721732|561542821|FG005|Overall Study|Withdrawal by Subject|0|||
155578321|NCT02721732|561542822|FG006|Overall Study|Withdrawal by Subject|1|||
155578322|NCT02721732|561542823|FG007|Overall Study|Withdrawal by Subject|1|||
155578323|NCT02721732|561542824|FG008|Overall Study|Withdrawal by Subject|0|||
155578324|NCT02721732|561542825|FG009|Overall Study|Withdrawal by Subject|1|||
155578325|NCT02721732|561542816|FG000|Overall Study|Participant Choice|1|||
155578326|NCT02721732|561542817|FG001|Overall Study|Participant Choice|0|||
155578327|NCT02721732|561542818|FG002|Overall Study|Participant Choice|0|||
155578328|NCT02721732|561542819|FG003|Overall Study|Participant Choice|0|||
155578329|NCT02721732|561542820|FG004|Overall Study|Participant Choice|0|||
155578330|NCT02721732|561542821|FG005|Overall Study|Participant Choice|0|||
155578331|NCT02721732|561542822|FG006|Overall Study|Participant Choice|0|||
155578332|NCT02721732|561542823|FG007|Overall Study|Participant Choice|0|||
155578333|NCT02721732|561542824|FG008|Overall Study|Participant Choice|0|||
155578334|NCT02721732|561542825|FG009|Overall Study|Participant Choice|1|||
155578335|NCT02721732|561542816|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578336|NCT02721732|561542817|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578337|NCT02721732|561542818|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
155578338|NCT02721732|561542819|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578339|NCT02721732|561542820|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155662315|NCT01446874|561860287|FG000|Overall Study|Withdrawal by Subject|0|||
155662316|NCT01446874|561860288|FG001|Overall Study|Withdrawal by Subject|0|||
155662317|NCT01446874|561860289|FG002|Overall Study|Withdrawal by Subject|4|||
155662318|NCT01135992|561860290|FG000|Overall Study|Adverse Event|1|||
155662319|NCT01135992|561860290|FG000|Overall Study|Lack of Efficacy|1|||
155578340|NCT02721732|561542821|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578341|NCT02721732|561542822|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578342|NCT02721732|561542823|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578343|NCT02721732|561542824|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578344|NCT02721732|561542825|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155578345|NCT02721732|561542816|FG000|Overall Study|Progression and withdrew consent|1|||
155578346|NCT02721732|561542817|FG001|Overall Study|Progression and withdrew consent|1|||
155578347|NCT02721732|561542818|FG002|Overall Study|Progression and withdrew consent|0|||
155578348|NCT02721732|561542819|FG003|Overall Study|Progression and withdrew consent|0|||
155578349|NCT02721732|561542820|FG004|Overall Study|Progression and withdrew consent|0|||
155578350|NCT02721732|561542821|FG005|Overall Study|Progression and withdrew consent|0|||
155578351|NCT02721732|561542822|FG006|Overall Study|Progression and withdrew consent|0|||
155578352|NCT02721732|561542823|FG007|Overall Study|Progression and withdrew consent|0|||
155578353|NCT02721732|561542824|FG008|Overall Study|Progression and withdrew consent|0|||
155578354|NCT02721732|561542825|FG009|Overall Study|Progression and withdrew consent|1|||
155578355|NCT02721732|561542816|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
155578356|NCT02721732|561542817|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
155578357|NCT02721732|561542818|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
155578358|NCT02721732|561542819|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
155578359|NCT02721732|561542820|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
155578360|NCT02721732|561542821|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
155578361|NCT02721732|561542822|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
155578362|NCT02721732|561542823|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
155578363|NCT02721732|561542824|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
155578364|NCT02721732|561542825|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
155578365|NCT00725283|561542826|FG000|Overall Study|Missing Code|3|||
155578366|NCT00725283|561542826|FG000|Overall Study|Death|5|||
155578367|NCT00725283|561542826|FG000|Overall Study|Other|6|||
155578368|NCT00725283|561542826|FG000|Overall Study|Withdrawal by Subject|10|||
155578369|NCT00118157|561542827|FG000|Overall Study|Adverse Event|2|||
155578370|NCT00118157|561542827|FG000|Overall Study|Death|8|||
155578371|NCT00118157|561542827|FG000|Overall Study|Withdrawal by Subject|2|||
155578372|NCT01557504|561542830|FG000|Overall Study|Physician Decision|1|||
155578373|NCT01557504|561542831|FG001|Overall Study|Physician Decision|0|||
155578374|NCT01962103|561542837|FG000|Phase 1|Adverse Event|4|||
155578375|NCT01962103|561542838|FG001|Phase 1|Adverse Event|0|||
155578376|NCT01962103|561542839|FG002|Phase 1|Adverse Event|2|||
155578377|NCT01962103|561542840|FG003|Phase 1|Adverse Event|1|||
155578378|NCT01962103|561542841|FG004|Phase 1|Adverse Event|2|||
155578379|NCT01962103|561542842|FG005|Phase 1|Adverse Event|2|||
155578380|NCT01962103|561542843|FG006|Phase 1|Adverse Event|0|||
155578381|NCT01962103|561542844|FG007|Phase 1|Adverse Event|0|||
155578382|NCT01962103|561542845|FG008|Phase 1|Adverse Event|0|||
155578383|NCT01962103|561542837|FG000|Phase 1|Progressive Disease|8|||
155578384|NCT01962103|561542838|FG001|Phase 1|Progressive Disease|6|||
155578385|NCT01962103|561542839|FG002|Phase 1|Progressive Disease|8|||
155578386|NCT01962103|561542840|FG003|Phase 1|Progressive Disease|4|||
155578387|NCT01962103|561542841|FG004|Phase 1|Progressive Disease|5|||
155578388|NCT01962103|561542842|FG005|Phase 1|Progressive Disease|4|||
155578389|NCT01962103|561542843|FG006|Phase 1|Progressive Disease|0|||
155578390|NCT01962103|561542844|FG007|Phase 1|Progressive Disease|0|||
155578391|NCT01962103|561542845|FG008|Phase 1|Progressive Disease|0|||
155578392|NCT01962103|561542837|FG000|Phase 1|Withdrawal by Subject|0|||
155578393|NCT01962103|561542838|FG001|Phase 1|Withdrawal by Subject|0|||
155578394|NCT01962103|561542839|FG002|Phase 1|Withdrawal by Subject|0|||
155578395|NCT01962103|561542840|FG003|Phase 1|Withdrawal by Subject|2|||
155578396|NCT01962103|561542841|FG004|Phase 1|Withdrawal by Subject|0|||
155578397|NCT01962103|561542842|FG005|Phase 1|Withdrawal by Subject|0|||
155578398|NCT01962103|561542843|FG006|Phase 1|Withdrawal by Subject|0|||
155578399|NCT01962103|561542844|FG007|Phase 1|Withdrawal by Subject|0|||
155578400|NCT01962103|561542845|FG008|Phase 1|Withdrawal by Subject|0|||
155578401|NCT01962103|561542837|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
155578402|NCT01962103|561542838|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
155578403|NCT01962103|561542839|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
155578404|NCT01962103|561542840|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
155578405|NCT01962103|561542841|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
155578406|NCT01962103|561542842|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
155578407|NCT01962103|561542843|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
155578408|NCT01962103|561542844|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
155578409|NCT01962103|561542845|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
155578410|NCT01962103|561542837|FG000|Phase 1|Physician Decision|0|||
155578411|NCT01962103|561542838|FG001|Phase 1|Physician Decision|0|||
155578412|NCT01962103|561542839|FG002|Phase 1|Physician Decision|0|||
155578413|NCT01962103|561542840|FG003|Phase 1|Physician Decision|1|||
155578414|NCT01962103|561542841|FG004|Phase 1|Physician Decision|0|||
155578415|NCT01962103|561542842|FG005|Phase 1|Physician Decision|0|||
155578416|NCT01962103|561542843|FG006|Phase 1|Physician Decision|0|||
155578417|NCT01962103|561542844|FG007|Phase 1|Physician Decision|0|||
155578418|NCT01962103|561542845|FG008|Phase 1|Physician Decision|0|||
155578419|NCT01962103|561542837|FG000|Phase 1|Symptomatic Deterioration|3|||
155578420|NCT01962103|561542838|FG001|Phase 1|Symptomatic Deterioration|2|||
155578421|NCT01962103|561542839|FG002|Phase 1|Symptomatic Deterioration|2|||
155578422|NCT01962103|561542840|FG003|Phase 1|Symptomatic Deterioration|2|||
155578423|NCT01962103|561542841|FG004|Phase 1|Symptomatic Deterioration|1|||
155578424|NCT01962103|561542842|FG005|Phase 1|Symptomatic Deterioration|1|||
155578425|NCT01962103|561542843|FG006|Phase 1|Symptomatic Deterioration|0|||
155578426|NCT01962103|561542844|FG007|Phase 1|Symptomatic Deterioration|0|||
155578427|NCT01962103|561542845|FG008|Phase 1|Symptomatic Deterioration|0|||
155578428|NCT01962103|561542837|FG000|Phase 1|Miscellaneous|1|||
155578429|NCT01962103|561542838|FG001|Phase 1|Miscellaneous|0|||
155578430|NCT01962103|561542839|FG002|Phase 1|Miscellaneous|0|||
155578431|NCT01962103|561542840|FG003|Phase 1|Miscellaneous|0|||
155578432|NCT01962103|561542841|FG004|Phase 1|Miscellaneous|0|||
155578433|NCT01962103|561542842|FG005|Phase 1|Miscellaneous|0|||
155578434|NCT01962103|561542843|FG006|Phase 1|Miscellaneous|0|||
155578435|NCT01962103|561542844|FG007|Phase 1|Miscellaneous|0|||
155578436|NCT01962103|561542845|FG008|Phase 1|Miscellaneous|0|||
155578437|NCT01962103|561542837|FG000|Phase 2|Adverse Event|0|||
155578438|NCT01962103|561542838|FG001|Phase 2|Adverse Event|0|||
155578439|NCT01962103|561542839|FG002|Phase 2|Adverse Event|0|||
155578440|NCT01962103|561542840|FG003|Phase 2|Adverse Event|0|||
155578441|NCT01962103|561542841|FG004|Phase 2|Adverse Event|0|||
155578442|NCT01962103|561542842|FG005|Phase 2|Adverse Event|0|||
155578443|NCT01962103|561542843|FG006|Phase 2|Adverse Event|1|||
155578444|NCT01962103|561542844|FG007|Phase 2|Adverse Event|0|||
155578445|NCT01962103|561542845|FG008|Phase 2|Adverse Event|3|||
155578446|NCT01962103|561542837|FG000|Phase 2|Progressive Disease|0|||
155578447|NCT01962103|561542838|FG001|Phase 2|Progressive Disease|0|||
155578448|NCT01962103|561542839|FG002|Phase 2|Progressive Disease|0|||
155578449|NCT01962103|561542840|FG003|Phase 2|Progressive Disease|0|||
155578450|NCT01962103|561542841|FG004|Phase 2|Progressive Disease|0|||
155578451|NCT01962103|561542842|FG005|Phase 2|Progressive Disease|0|||
155578452|NCT01962103|561542843|FG006|Phase 2|Progressive Disease|11|||
155578453|NCT01962103|561542844|FG007|Phase 2|Progressive Disease|12|||
155578454|NCT01962103|561542845|FG008|Phase 2|Progressive Disease|11|||
155578455|NCT01962103|561542837|FG000|Phase 2|Symptomatic Deterioration|0|||
155578456|NCT01962103|561542838|FG001|Phase 2|Symptomatic Deterioration|0|||
155578457|NCT01962103|561542839|FG002|Phase 2|Symptomatic Deterioration|0|||
155578458|NCT01962103|561542840|FG003|Phase 2|Symptomatic Deterioration|0|||
155578459|NCT01962103|561542841|FG004|Phase 2|Symptomatic Deterioration|0|||
155578460|NCT01962103|561542842|FG005|Phase 2|Symptomatic Deterioration|0|||
155578461|NCT01962103|561542843|FG006|Phase 2|Symptomatic Deterioration|2|||
155578462|NCT01962103|561542844|FG007|Phase 2|Symptomatic Deterioration|2|||
155578463|NCT01962103|561542845|FG008|Phase 2|Symptomatic Deterioration|0|||
155578464|NCT02763046|561542855|FG000|Overall Study|Adverse Event|5|||
155578465|NCT02763046|561542856|FG001|Overall Study|Adverse Event|4|||
155578466|NCT02763046|561542857|FG002|Overall Study|Adverse Event|0|||
155578467|NCT02763046|561542855|FG000|Overall Study|Lack of Efficacy|1|||
155578468|NCT02763046|561542856|FG001|Overall Study|Lack of Efficacy|1|||
155578469|NCT02763046|561542857|FG002|Overall Study|Lack of Efficacy|3|||
155578470|NCT02763046|561542855|FG000|Overall Study|Physician Decision|1|||
155578471|NCT02763046|561542856|FG001|Overall Study|Physician Decision|0|||
155578472|NCT02763046|561542857|FG002|Overall Study|Physician Decision|1|||
155578473|NCT02763046|561542855|FG000|Overall Study|Subject/guardian decision|2|||
155578474|NCT02763046|561542856|FG001|Overall Study|Subject/guardian decision|0|||
155578475|NCT02763046|561542857|FG002|Overall Study|Subject/guardian decision|4|||
155578476|NCT00818766|561542860|FG000|Overall Study|Could not be Contacted on Day 28|11|||
155578477|NCT00818766|561542861|FG001|Overall Study|Could not be Contacted on Day 28|10|||
155578478|NCT00818766|561542860|FG000|Overall Study|Death|1|||
155578479|NCT00818766|561542861|FG001|Overall Study|Death|0|||
155578480|NCT00818766|561542860|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
155578481|NCT00818766|561542861|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
155578482|NCT00086684|561542862|FG000|Overall Study|Adverse Event|12|||
155578483|NCT00086684|561542863|FG001|Overall Study|Adverse Event|17|||
155578484|NCT00086684|561542864|FG002|Overall Study|Adverse Event|14|||
155578485|NCT00086684|561542862|FG000|Overall Study|Lack of Efficacy|6|||
155578486|NCT00086684|561542863|FG001|Overall Study|Lack of Efficacy|6|||
155578487|NCT00086684|561542864|FG002|Overall Study|Lack of Efficacy|5|||
155578488|NCT00086684|561542862|FG000|Overall Study|Lost to Follow-up|15|||
155578489|NCT00086684|561542863|FG001|Overall Study|Lost to Follow-up|8|||
155578490|NCT00086684|561542864|FG002|Overall Study|Lost to Follow-up|10|||
155578491|NCT00086684|561542862|FG000|Overall Study|Protocol Violation|8|||
155578492|NCT00086684|561542863|FG001|Overall Study|Protocol Violation|3|||
155578493|NCT00086684|561542864|FG002|Overall Study|Protocol Violation|0|||
155578494|NCT00086684|561542862|FG000|Overall Study|Withdrawal by Subject|0|||
155662320|NCT01135992|561860290|FG000|Overall Study|Protocol Violation|2|||
155578495|NCT00086684|561542863|FG001|Overall Study|Withdrawal by Subject|4|||
155578496|NCT00086684|561542864|FG002|Overall Study|Withdrawal by Subject|10|||
155578497|NCT00086684|561542862|FG000|Overall Study|NONCOMPLIANCE|5|||
155578498|NCT00086684|561542863|FG001|Overall Study|NONCOMPLIANCE|7|||
155662321|NCT01135992|561860290|FG000|Overall Study|Withdrawal criteria|10|||
155662322|NCT01135992|561860290|FG000|Overall Study|Unclassified|7|||
155662323|NCT01977898|561860291|FG000|Overall Study|Non functioning catheter|1|||
155662324|NCT01977898|561860292|FG001|Overall Study|Non functioning catheter|1|||
155662325|NCT03386773|561860297|FG000|Overall Study|Lost to Follow-up|24|||
155662326|NCT03386773|561860298|FG001|Overall Study|Lost to Follow-up|33|||
155662327|NCT03386773|561860297|FG000|Overall Study|Withdrawal by Subject|3|||
155662328|NCT03386773|561860298|FG001|Overall Study|Withdrawal by Subject|2|||
155662329|NCT03983421|561860299|FG000|Overall Study|Lost to Follow-up|1|||
155662330|NCT03639610|561860300|FG000|Overall Study|Adverse Event|7|||
155662331|NCT03639610|561860301|FG001|Overall Study|Adverse Event|1|||
155662332|NCT03639610|561860302|FG002|Overall Study|Adverse Event|0|||
155662333|NCT03639610|561860300|FG000|Overall Study|Physician Decision|3|||
155662334|NCT03639610|561860301|FG001|Overall Study|Physician Decision|1|||
155662335|NCT03639610|561860302|FG002|Overall Study|Physician Decision|0|||
155662336|NCT03639610|561860300|FG000|Overall Study|Disease progression|8|||
155662337|NCT03639610|561860301|FG001|Overall Study|Disease progression|5|||
155662338|NCT03639610|561860302|FG002|Overall Study|Disease progression|3|||
155662339|NCT03639610|561860300|FG000|Overall Study|Study terminated by sponsor|2|||
155662340|NCT03639610|561860301|FG001|Overall Study|Study terminated by sponsor|1|||
155662341|NCT03639610|561860302|FG002|Overall Study|Study terminated by sponsor|1|||
155662342|NCT03639610|561860300|FG000|Overall Study|Patient request to stop treatment|1|||
155662343|NCT03639610|561860301|FG001|Overall Study|Patient request to stop treatment|2|||
155662344|NCT03639610|561860302|FG002|Overall Study|Patient request to stop treatment|0|||
155662345|NCT02660229|561860303|FG000|Overall Study|Adverse Event|2|||
155662346|NCT02660229|561860304|FG001|Overall Study|Adverse Event|0|||
155662347|NCT02660229|561860303|FG000|Overall Study|Withdrawal by Subject|0|||
155662348|NCT02660229|561860304|FG001|Overall Study|Withdrawal by Subject|1|||
155662349|NCT01049373|561860308|FG000|Overall Study|Protocol Violation|9|||
155662350|NCT01049373|561860309|FG001|Overall Study|Protocol Violation|9|||
155662351|NCT01049373|561860308|FG000|Overall Study|Withdrawal by Subject|8|||
155662352|NCT01049373|561860309|FG001|Overall Study|Withdrawal by Subject|5|||
155662353|NCT01049373|561860308|FG000|Overall Study|Adverse Event|3|||
155662354|NCT01049373|561860309|FG001|Overall Study|Adverse Event|3|||
155662355|NCT01049373|561860308|FG000|Overall Study|Lost to Follow-up|9|||
155662356|NCT01049373|561860309|FG001|Overall Study|Lost to Follow-up|4|||
155662357|NCT01049373|561860308|FG000|Overall Study|no evaluable study values|9|||
155662358|NCT01049373|561860309|FG001|Overall Study|no evaluable study values|21|||
155662359|NCT01049373|561860308|FG000|Overall Study|Other|1|||
155662360|NCT01049373|561860309|FG001|Overall Study|Other|1|||
155662361|NCT01049373|561860308|FG000|Overall Study|Non-cooperation|0|||
155662362|NCT01049373|561860309|FG001|Overall Study|Non-cooperation|1|||
155662363|NCT03610048|561860310|FG000|Overall Study|Study terminated by sponsor|84|||
155662364|NCT03610048|561860310|FG000|Overall Study|Adverse Event|32|||
155662365|NCT03610048|561860310|FG000|Overall Study|Withdrawal by Subject|31|||
155662366|NCT03610048|561860310|FG000|Overall Study|Lost to Follow-up|8|||
155662367|NCT03610048|561860310|FG000|Overall Study|Other|4|||
155662368|NCT03610048|561860310|FG000|Overall Study|Physician Decision|1|||
155662369|NCT03610048|561860310|FG000|Overall Study|Pregnancy|1|||
155662370|NCT01155050|561860311|FG000|Overall Study|Lost to Follow-up|15|||
155578499|NCT00086684|561542864|FG002|Overall Study|NONCOMPLIANCE|6|||
155578500|NCT00086684|561542862|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155578501|NCT00086684|561542863|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
155578502|NCT00086684|561542864|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155578503|NCT00086684|561542862|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
155578504|NCT00086684|561542863|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
155578505|NCT00086684|561542864|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
155578506|NCT00086684|561542862|FG000|Overall Study|Other|4|||
155578507|NCT00086684|561542863|FG001|Overall Study|Other|2|||
155662371|NCT01155050|561860312|FG001|Overall Study|Lost to Follow-up|20|||
155662372|NCT01155050|561860313|FG002|Overall Study|Lost to Follow-up|19|||
155662373|NCT01155050|561860314|FG003|Overall Study|Lost to Follow-up|22|||
155662374|NCT02136914|561860315|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
155662375|NCT02136914|561860316|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
155578508|NCT00086684|561542864|FG002|Overall Study|Other|3|||
155662376|NCT02136914|561860315|FG000|Overall Study|Withdrawal by Subject|3|||
155662377|NCT02136914|561860316|FG001|Overall Study|Withdrawal by Subject|10|||
155662378|NCT02136914|561860315|FG000|Overall Study|Subject Unwilling to Proceed|7|||
155662379|NCT02136914|561860316|FG001|Overall Study|Subject Unwilling to Proceed|2|||
155662380|NCT02136914|561860315|FG000|Overall Study|Lost to Follow-up|1|||
155662381|NCT02136914|561860316|FG001|Overall Study|Lost to Follow-up|1|||
155662382|NCT02136914|561860315|FG000|Overall Study|Did Not Receive Study Drug|2|||
155662383|NCT02136914|561860316|FG001|Overall Study|Did Not Receive Study Drug|0|||
155662384|NCT02136914|561860315|FG000|Overall Study|Lack of Efficacy|1|||
155662385|NCT02136914|561860316|FG001|Overall Study|Lack of Efficacy|0|||
155662386|NCT02136914|561860315|FG000|Overall Study|Death|0|||
155662387|NCT02136914|561860316|FG001|Overall Study|Death|1|||
155662388|NCT00557193|561860319|FG000|Induction|Adverse Event|2|||
155662389|NCT00557193|561860320|FG001|Induction|Adverse Event|0|||
155662390|NCT00557193|561860321|FG002|Induction|Adverse Event|0|||
155662391|NCT00557193|561860322|FG003|Induction|Adverse Event|0|||
155662392|NCT00557193|561860323|FG004|Induction|Adverse Event|0|||
155662393|NCT00557193|561860324|FG005|Induction|Adverse Event|0|||
155662394|NCT00557193|561860319|FG000|Induction|Death|6|||
155662395|NCT00557193|561860320|FG001|Induction|Death|0|||
155662396|NCT00557193|561860321|FG002|Induction|Death|0|||
155662397|NCT00557193|561860322|FG003|Induction|Death|0|||
155578509|NCT01103180|561542865|FG000|Overall Study|Withdrawal by Subject|8|||
155578510|NCT01103180|561542866|FG001|Overall Study|Withdrawal by Subject|13|||
155578511|NCT01103180|561542865|FG000|Overall Study|Lost to Follow-up|13|||
155578512|NCT01103180|561542866|FG001|Overall Study|Lost to Follow-up|7|||
155578513|NCT01103180|561542865|FG000|Overall Study|Physician Decision|1|||
155578514|NCT01103180|561542866|FG001|Overall Study|Physician Decision|0|||
155578515|NCT01103180|561542865|FG000|Overall Study|Protocol Violation|0|||
155578516|NCT01103180|561542866|FG001|Overall Study|Protocol Violation|1|||
155578517|NCT01067105|561542867|FG000|Overall Study|Adverse Event|14|||
155578518|NCT01067105|561542867|FG000|Overall Study|Protocol Violation|48|||
155578519|NCT01067105|561542867|FG000|Overall Study|Withdrawal by Subject|36|||
155578520|NCT01067105|561542867|FG000|Overall Study|Lost to Follow-up|6|||
155578521|NCT01067105|561542867|FG000|Overall Study|Physician Decision|6|||
155578522|NCT01067105|561542867|FG000|Overall Study|Other|31|||
155578523|NCT00853099|561542868|FG000|Double-blind Period|Adverse Event|7|||
155578524|NCT00853099|561542869|FG001|Double-blind Period|Adverse Event|9|||
155578525|NCT00853099|561542870|FG002|Double-blind Period|Adverse Event|13|||
155578526|NCT00853099|561542871|FG003|Double-blind Period|Adverse Event|0|||
155578527|NCT00853099|561542868|FG000|Double-blind Period|Withdrawal by Subject|2|||
155578528|NCT00853099|561542869|FG001|Double-blind Period|Withdrawal by Subject|3|||
155578529|NCT00853099|561542870|FG002|Double-blind Period|Withdrawal by Subject|0|||
155578530|NCT00853099|561542871|FG003|Double-blind Period|Withdrawal by Subject|0|||
155578531|NCT00853099|561542868|FG000|Double-blind Period|Lack of Efficacy|14|||
155578532|NCT00853099|561542869|FG001|Double-blind Period|Lack of Efficacy|17|||
155578533|NCT00853099|561542870|FG002|Double-blind Period|Lack of Efficacy|16|||
155578534|NCT00853099|561542871|FG003|Double-blind Period|Lack of Efficacy|0|||
155578535|NCT00853099|561542868|FG000|Double-blind Period|Other|0|||
155578536|NCT00853099|561542869|FG001|Double-blind Period|Other|0|||
155578537|NCT00853099|561542870|FG002|Double-blind Period|Other|1|||
155578538|NCT00853099|561542871|FG003|Double-blind Period|Other|0|||
155578539|NCT00853099|561542868|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
155578540|NCT00853099|561542869|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
155578541|NCT00853099|561542870|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
155578542|NCT00853099|561542871|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
155578543|NCT00853099|561542868|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155578544|NCT00853099|561542869|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155578545|NCT00853099|561542870|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155578546|NCT00853099|561542871|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
155578547|NCT00853099|561542868|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
155578548|NCT00853099|561542869|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
155578549|NCT00853099|561542870|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
155578550|NCT00853099|561542871|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
155662398|NCT00557193|561860323|FG004|Induction|Death|0|||
155662399|NCT00557193|561860324|FG005|Induction|Death|0|||
155578551|NCT00853099|561542868|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155578552|NCT00853099|561542869|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155662400|NCT00557193|561860319|FG000|Induction|Physician Decision|3|||
155578553|NCT00853099|561542870|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155578554|NCT00853099|561542871|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
155578555|NCT00853099|561542868|FG000|Double-blind + Open-label Periods|Other|0|||
155662401|NCT00557193|561860320|FG001|Induction|Physician Decision|0|||
155662402|NCT00557193|561860321|FG002|Induction|Physician Decision|0|||
155662403|NCT00557193|561860322|FG003|Induction|Physician Decision|0|||
155662404|NCT00557193|561860323|FG004|Induction|Physician Decision|0|||
155662405|NCT00557193|561860324|FG005|Induction|Physician Decision|0|||
155578556|NCT00853099|561542869|FG001|Double-blind + Open-label Periods|Other|0|||
155578557|NCT00853099|561542870|FG002|Double-blind + Open-label Periods|Other|0|||
155578558|NCT00853099|561542871|FG003|Double-blind + Open-label Periods|Other|6|||
155578559|NCT02203357|561542875|FG000|Overall Study|Lost to Follow-up|58|||
155578560|NCT02203357|561542876|FG001|Overall Study|Lost to Follow-up|66|||
155578561|NCT02203357|561542877|FG002|Overall Study|Lost to Follow-up|70|||
155578562|NCT02687451|561542880|FG000|Overall Study|Withdrawal by Subject|1|||
155578563|NCT02687451|561542881|FG001|Overall Study|Withdrawal by Subject|0|||
155578564|NCT02687451|561542882|FG002|Overall Study|Withdrawal by Subject|0|||
155578565|NCT02687451|561542883|FG003|Overall Study|Withdrawal by Subject|0|||
155578566|NCT02687451|561542884|FG004|Overall Study|Withdrawal by Subject|0|||
155578567|NCT02687451|561542885|FG005|Overall Study|Withdrawal by Subject|1|||
155578568|NCT03652051|561542886|FG000|Stage 1|Adverse Event|0|||
155578569|NCT03652051|561542887|FG001|Stage 1|Adverse Event|5|||
155578570|NCT03652051|561542888|FG002|Stage 1|Adverse Event|7|||
155578571|NCT03652051|561542889|FG003|Stage 1|Adverse Event|1|||
155578572|NCT03652051|561542886|FG000|Stage 1|Withdrawal by Subject|0|||
155578573|NCT03652051|561542887|FG001|Stage 1|Withdrawal by Subject|0|||
155578574|NCT03652051|561542888|FG002|Stage 1|Withdrawal by Subject|1|||
155578575|NCT03652051|561542889|FG003|Stage 1|Withdrawal by Subject|0|||
155578576|NCT03652051|561542886|FG000|Stage 2|Adverse Event|0|||
155578577|NCT03652051|561542887|FG001|Stage 2|Adverse Event|2|||
155578578|NCT03652051|561542888|FG002|Stage 2|Adverse Event|1|||
155578579|NCT03652051|561542889|FG003|Stage 2|Adverse Event|0|||
155578580|NCT03652051|561542886|FG000|Stage 2|Protocol Violation|0|||
155578581|NCT03652051|561542887|FG001|Stage 2|Protocol Violation|1|||
155578582|NCT03652051|561542888|FG002|Stage 2|Protocol Violation|6|||
155578583|NCT03652051|561542889|FG003|Stage 2|Protocol Violation|0|||
155578584|NCT03652051|561542886|FG000|Stage 2|Lost to Follow-up|0|||
155578585|NCT03652051|561542887|FG001|Stage 2|Lost to Follow-up|2|||
155578586|NCT03652051|561542888|FG002|Stage 2|Lost to Follow-up|0|||
155578587|NCT03652051|561542889|FG003|Stage 2|Lost to Follow-up|3|||
155578588|NCT03652051|561542886|FG000|Stage 2|Withdrawal by Subject|0|||
155578589|NCT03652051|561542887|FG001|Stage 2|Withdrawal by Subject|11|||
155578590|NCT03652051|561542888|FG002|Stage 2|Withdrawal by Subject|9|||
155578591|NCT03652051|561542889|FG003|Stage 2|Withdrawal by Subject|3|||
155578592|NCT03473925|561542890|FG000|Overall Study|Death|48|||
155578593|NCT03473925|561542891|FG001|Overall Study|Death|44|||
155578594|NCT03473925|561542890|FG000|Overall Study|Sponsor Decision|2|||
155578595|NCT03473925|561542891|FG001|Overall Study|Sponsor Decision|7|||
155578596|NCT03473925|561542890|FG000|Overall Study|Withdrawal by Subject|1|||
155578597|NCT03473925|561542891|FG001|Overall Study|Withdrawal by Subject|3|||
155578598|NCT03473925|561542890|FG000|Overall Study|Not Treated|1|||
155578599|NCT03473925|561542891|FG001|Overall Study|Not Treated|1|||
155578600|NCT05198518|561542894|FG000|Screening Visit|Deemed unable to participate|58|||
155578601|NCT05198518|561542895|FG001|Screening Visit|Deemed unable to participate|0|||
155578602|NCT05198518|561542896|FG002|Screening Visit|Deemed unable to participate|0|||
155578603|NCT03645863|561542898|FG000|Overall Study|Withdrawal by Subject|1|||
155578604|NCT03645863|561542899|FG001|Overall Study|Withdrawal by Subject|0|||
155578605|NCT03645863|561542900|FG002|Overall Study|Withdrawal by Subject|0|||
155578606|NCT02756611|561542902|FG000|Overall Study|Death|70|||
155578607|NCT02756611|561542902|FG000|Overall Study|Withdrawal by Subject|2|||
155578608|NCT02756611|561542902|FG000|Overall Study|Lost to Follow-up|3|||
155578609|NCT02756611|561542902|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
155578610|NCT02756611|561542902|FG000|Overall Study|Other|10|||
155578611|NCT00124917|561542903|FG000|Overall Study|Physician Decision|3|||
155578612|NCT01422213|561542904|FG000|Overall Study|Adverse Event|8|||
155578613|NCT01422213|561542905|FG001|Overall Study|Adverse Event|7|||
155578614|NCT01422213|561542906|FG002|Overall Study|Adverse Event|11|||
155578615|NCT01422213|561542904|FG000|Overall Study|Lack of Efficacy|10|||
155578616|NCT01422213|561542905|FG001|Overall Study|Lack of Efficacy|2|||
155578617|NCT01422213|561542906|FG002|Overall Study|Lack of Efficacy|2|||
155578618|NCT01422213|561542904|FG000|Overall Study|Non-compliance with study drug|0|||
155578619|NCT01422213|561542905|FG001|Overall Study|Non-compliance with study drug|1|||
155578620|NCT01422213|561542906|FG002|Overall Study|Non-compliance with study drug|0|||
155578621|NCT01422213|561542904|FG000|Overall Study|Protocol Violation|0|||
155578622|NCT01422213|561542905|FG001|Overall Study|Protocol Violation|2|||
155578623|NCT01422213|561542906|FG002|Overall Study|Protocol Violation|4|||
155578624|NCT01422213|561542904|FG000|Overall Study|Withdrawal of Consent|7|||
155662406|NCT00557193|561860319|FG000|Induction|Withdrawal by Subject|1|||
155662407|NCT00557193|561860320|FG001|Induction|Withdrawal by Subject|0|||
155662408|NCT00557193|561860321|FG002|Induction|Withdrawal by Subject|0|||
155662409|NCT00557193|561860322|FG003|Induction|Withdrawal by Subject|0|||
155662410|NCT00557193|561860323|FG004|Induction|Withdrawal by Subject|0|||
155662411|NCT00557193|561860324|FG005|Induction|Withdrawal by Subject|0|||
155662412|NCT00557193|561860319|FG000|Induction|Refusal of Further Protocol Therapy|2|||
155662413|NCT00557193|561860320|FG001|Induction|Refusal of Further Protocol Therapy|0|||
155662414|NCT00557193|561860321|FG002|Induction|Refusal of Further Protocol Therapy|0|||
155662415|NCT00557193|561860322|FG003|Induction|Refusal of Further Protocol Therapy|0|||
155662416|NCT00557193|561860323|FG004|Induction|Refusal of Further Protocol Therapy|0|||
155662417|NCT00557193|561860324|FG005|Induction|Refusal of Further Protocol Therapy|0|||
155662418|NCT00557193|561860319|FG000|Induction|Ineligible|8|||
155662419|NCT00557193|561860320|FG001|Induction|Ineligible|0|||
155662420|NCT00557193|561860321|FG002|Induction|Ineligible|0|||
155662421|NCT00557193|561860322|FG003|Induction|Ineligible|0|||
155662422|NCT00557193|561860323|FG004|Induction|Ineligible|0|||
155662423|NCT00557193|561860324|FG005|Induction|Ineligible|0|||
155662424|NCT00557193|561860319|FG000|Induction|Inevaluable for post Induction|2|||
155662425|NCT00557193|561860320|FG001|Induction|Inevaluable for post Induction|0|||
155662426|NCT00557193|561860321|FG002|Induction|Inevaluable for post Induction|0|||
155662427|NCT00557193|561860322|FG003|Induction|Inevaluable for post Induction|0|||
155662428|NCT00557193|561860323|FG004|Induction|Inevaluable for post Induction|0|||
155662429|NCT00557193|561860324|FG005|Induction|Inevaluable for post Induction|0|||
155662430|NCT00557193|561860319|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
155662431|NCT00557193|561860320|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155662432|NCT00557193|561860321|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155662433|NCT00557193|561860322|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155662434|NCT00557193|561860323|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155662435|NCT00557193|561860324|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155662436|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155662437|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
155662438|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
155662439|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
155662440|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155662441|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
155662442|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
155662443|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
155662444|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
155662445|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
155662446|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
155662447|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
155662448|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
155662449|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
155662450|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
155662451|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
155662452|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
155662453|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
155662454|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
155662455|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
155662456|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
155662457|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
155662458|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
155662459|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
155662460|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
155662461|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
155662462|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
155662463|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
155662464|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
155578625|NCT01422213|561542905|FG001|Overall Study|Withdrawal of Consent|3|||
155578626|NCT01422213|561542906|FG002|Overall Study|Withdrawal of Consent|5|||
155578627|NCT01422213|561542904|FG000|Overall Study|Lost to Follow-up|3|||
155578628|NCT01422213|561542905|FG001|Overall Study|Lost to Follow-up|3|||
155578629|NCT01422213|561542906|FG002|Overall Study|Lost to Follow-up|5|||
155578630|NCT01422213|561542904|FG000|Overall Study|Administrative or Other Reason(s)|5|||
155578631|NCT01422213|561542905|FG001|Overall Study|Administrative or Other Reason(s)|4|||
155578632|NCT01422213|561542906|FG002|Overall Study|Administrative or Other Reason(s)|2|||
155578633|NCT00951496|561542907|FG000|Overall Study|Did not initiate study treatment|10|||
155578634|NCT00951496|561542908|FG001|Overall Study|Did not initiate study treatment|8|||
155578635|NCT00951496|561542909|FG002|Overall Study|Did not initiate study treatment|13|||
155578636|NCT01169350|561542920|FG000|Overall Study|Physician Decision|3|||
155578637|NCT01169350|561542920|FG000|Overall Study|Lost to Follow-up|2|||
155578638|NCT04870710|561542924|FG000|Overall Study|Lost to Follow-up|3|||
155578639|NCT00476190|561542925|FG000|Overall Study|Ineligible|1|||
155578640|NCT00476190|561542926|FG001|Overall Study|Ineligible|1|||
155578641|NCT00476190|561542925|FG000|Overall Study|Induction Death|2|||
155578642|NCT00476190|561542926|FG001|Overall Study|Induction Death|0|||
155578643|NCT00476190|561542925|FG000|Overall Study|Induction Failure|2|||
155578644|NCT00476190|561542926|FG001|Overall Study|Induction Failure|4|||
155578645|NCT00476190|561542925|FG000|Overall Study|Lost to Follow-up|1|||
155578646|NCT00476190|561542926|FG001|Overall Study|Lost to Follow-up|0|||
155578647|NCT00476190|561542925|FG000|Overall Study|Relapse/Progression|5|||
155578648|NCT00476190|561542926|FG001|Overall Study|Relapse/Progression|2|||
155578649|NCT00476190|561542925|FG000|Overall Study|Remission Death|0|||
155578650|NCT00476190|561542926|FG001|Overall Study|Remission Death|1|||
155578651|NCT00476190|561542925|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
155578652|NCT00476190|561542926|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
155578653|NCT00476190|561542925|FG000|Overall Study|Withdrawal by Subject|6|||
155578654|NCT00476190|561542926|FG001|Overall Study|Withdrawal by Subject|2|||
155578655|NCT00476190|561542925|FG000|Overall Study|Other|9|||
155578656|NCT00476190|561542926|FG001|Overall Study|Other|10|||
155578657|NCT04782076|561542927|FG000|Overall Study|Family Emergency|1|||
155578658|NCT02860546|561542928|FG000|Overall Study|Clinical Progression|6|||
155578659|NCT02860546|561542928|FG000|Overall Study|Radiological Progression|12|||
155578660|NCT01042093|561542929|FG000|Overall Study|Protocol Violation|2|||
155578661|NCT01042093|561542930|FG001|Overall Study|Protocol Violation|2|||
155578662|NCT01042093|561542931|FG002|Overall Study|Protocol Violation|2|||
155578663|NCT01042093|561542932|FG003|Overall Study|Protocol Violation|3|||
155578664|NCT01042093|561542929|FG000|Overall Study|Withdrawal by Subject|0|||
155578665|NCT01042093|561542930|FG001|Overall Study|Withdrawal by Subject|0|||
155578666|NCT01042093|561542931|FG002|Overall Study|Withdrawal by Subject|0|||
155578667|NCT01042093|561542932|FG003|Overall Study|Withdrawal by Subject|1|||
155578668|NCT02198963|561542938|FG000|Overall Study|Adverse Event|1|||
155578669|NCT02198963|561542938|FG000|Overall Study|Withdrawal by Subject|6|||
155578670|NCT00995774|561542939|FG000|Training Period 2|Withdrawal by Subject|2|||
155578671|NCT00995774|561542940|FG001|Training Period 2|Withdrawal by Subject|0|||
155578672|NCT00683657|561542941|FG000|Overall Study|Adverse Event|0|||
155578673|NCT00683657|561542942|FG001|Overall Study|Adverse Event|1|||
155578674|NCT00683657|561542941|FG000|Overall Study|Subject Withdrew Consent|1|||
155578675|NCT00683657|561542942|FG001|Overall Study|Subject Withdrew Consent|0|||
155578676|NCT04135937|561542943|FG000|Overall Study|Lost to Follow-up|2|||
155578677|NCT04135937|561542943|FG000|Overall Study|Withdrawal by Subject|1|||
155578678|NCT04796961|561544912|FG000|Overall Study|Lost to Follow-up|10|||
155578679|NCT04796961|561544912|FG000|Overall Study|Withdrawal by Subject|3|||
155578680|NCT04796961|561544912|FG000|Overall Study|Left Organization|10|||
155578681|NCT03657797|561544913|FG000|Overall Study|Lost to Follow-up|0|||
155578682|NCT03657797|561544914|FG001|Overall Study|Lost to Follow-up|1|||
155578683|NCT03657797|561544915|FG002|Overall Study|Lost to Follow-up|1|||
155578684|NCT03657797|561544916|FG003|Overall Study|Lost to Follow-up|0|||
155578685|NCT03657797|561544913|FG000|Overall Study|Physician Decision|0|||
155578686|NCT03657797|561544914|FG001|Overall Study|Physician Decision|1|||
155578687|NCT03657797|561544915|FG002|Overall Study|Physician Decision|0|||
155578688|NCT03657797|561544916|FG003|Overall Study|Physician Decision|0|||
155578689|NCT03657797|561544913|FG000|Overall Study|Withdrawal by Subject|0|||
155578690|NCT03657797|561544914|FG001|Overall Study|Withdrawal by Subject|1|||
155578691|NCT03657797|561544915|FG002|Overall Study|Withdrawal by Subject|2|||
155578692|NCT03657797|561544916|FG003|Overall Study|Withdrawal by Subject|0|||
155578693|NCT03657797|561544913|FG000|Overall Study|Adverse Event|0|||
155578694|NCT03657797|561544914|FG001|Overall Study|Adverse Event|0|||
155578695|NCT03657797|561544915|FG002|Overall Study|Adverse Event|2|||
155578696|NCT03657797|561544916|FG003|Overall Study|Adverse Event|0|||
155578697|NCT03103087|561544917|FG000|Overall Study|Did not receive any study drug|1|||
155578698|NCT03103087|561544918|FG001|Overall Study|Did not receive any study drug|0|||
155578699|NCT03103087|561544919|FG002|Overall Study|Did not receive any study drug|0|||
155578700|NCT03103087|561544917|FG000|Overall Study|Protocol Violation|1|||
155578701|NCT03103087|561544918|FG001|Overall Study|Protocol Violation|2|||
155578702|NCT03103087|561544919|FG002|Overall Study|Protocol Violation|1|||
155578703|NCT03103087|561544917|FG000|Overall Study|Lack of Efficacy|2|||
155578704|NCT03103087|561544918|FG001|Overall Study|Lack of Efficacy|1|||
155578705|NCT03103087|561544919|FG002|Overall Study|Lack of Efficacy|1|||
155578706|NCT03103087|561544917|FG000|Overall Study|Pregnancy|0|||
155578707|NCT03103087|561544918|FG001|Overall Study|Pregnancy|0|||
155578708|NCT03103087|561544919|FG002|Overall Study|Pregnancy|1|||
155578709|NCT03103087|561544917|FG000|Overall Study|Adverse Event|2|||
155578710|NCT03103087|561544918|FG001|Overall Study|Adverse Event|15|||
155578711|NCT03103087|561544919|FG002|Overall Study|Adverse Event|6|||
155578712|NCT03103087|561544917|FG000|Overall Study|Withdrawal by Subject|13|||
155578713|NCT03103087|561544918|FG001|Overall Study|Withdrawal by Subject|6|||
155578714|NCT03103087|561544919|FG002|Overall Study|Withdrawal by Subject|6|||
155578715|NCT03103087|561544917|FG000|Overall Study|Lost to Follow-up|4|||
155578716|NCT03103087|561544918|FG001|Overall Study|Lost to Follow-up|2|||
155578717|NCT03103087|561544919|FG002|Overall Study|Lost to Follow-up|7|||
155578718|NCT03103087|561544917|FG000|Overall Study|Other reason not reported|1|||
155578719|NCT03103087|561544918|FG001|Overall Study|Other reason not reported|3|||
155578720|NCT03103087|561544919|FG002|Overall Study|Other reason not reported|5|||
155578721|NCT00413699|561544920|FG000|Initial Period|Death|25|||
155578722|NCT00413699|561544921|FG001|Initial Period|Death|30|||
155578723|NCT00413699|561544922|FG002|Initial Period|Death|0|||
155578724|NCT00413699|561544920|FG000|Initial Period|Lack of Efficacy|59|||
155578725|NCT00413699|561544921|FG001|Initial Period|Lack of Efficacy|115|||
155578726|NCT00413699|561544922|FG002|Initial Period|Lack of Efficacy|0|||
155578727|NCT00413699|561544920|FG000|Initial Period|Lost to Follow-up|31|||
155578728|NCT00413699|561544921|FG001|Initial Period|Lost to Follow-up|101|||
155578729|NCT00413699|561544922|FG002|Initial Period|Lost to Follow-up|0|||
155578730|NCT00413699|561544920|FG000|Initial Period|Protocol Violation|38|||
155578731|NCT00413699|561544921|FG001|Initial Period|Protocol Violation|89|||
155578732|NCT00413699|561544922|FG002|Initial Period|Protocol Violation|0|||
155578733|NCT00413699|561544920|FG000|Initial Period|Pregnancy|10|||
155578734|NCT00413699|561544921|FG001|Initial Period|Pregnancy|8|||
155578735|NCT00413699|561544922|FG002|Initial Period|Pregnancy|0|||
155578736|NCT00413699|561544920|FG000|Initial Period|Did not meet entrance criteria|2|||
155578737|NCT00413699|561544921|FG001|Initial Period|Did not meet entrance criteria|2|||
155578738|NCT00413699|561544922|FG002|Initial Period|Did not meet entrance criteria|0|||
155578739|NCT00413699|561544920|FG000|Initial Period|Medication error without adverse event|0|||
155578740|NCT00413699|561544921|FG001|Initial Period|Medication error without adverse event|1|||
155578741|NCT00413699|561544922|FG002|Initial Period|Medication error without adverse event|0|||
155578742|NCT00413699|561544920|FG000|Initial Period|Study terminated by Sponsor|0|||
155578743|NCT00413699|561544921|FG001|Initial Period|Study terminated by Sponsor|1|||
155578744|NCT00413699|561544922|FG002|Initial Period|Study terminated by Sponsor|0|||
155578745|NCT00413699|561544920|FG000|Initial Period|Other|67|||
155578746|NCT00413699|561544921|FG001|Initial Period|Other|211|||
155578747|NCT00413699|561544922|FG002|Initial Period|Other|0|||
155578748|NCT00413699|561544920|FG000|Initial Period|Adverse event related to study drug|178|||
155578749|NCT00413699|561544921|FG001|Initial Period|Adverse event related to study drug|527|||
155578750|NCT00413699|561544922|FG002|Initial Period|Adverse event related to study drug|0|||
155578751|NCT00413699|561544920|FG000|Initial Period|Adverse event not related to study drug|113|||
155578752|NCT00413699|561544921|FG001|Initial Period|Adverse event not related to study drug|248|||
155578753|NCT00413699|561544922|FG002|Initial Period|Adverse event not related to study drug|0|||
155578754|NCT00413699|561544920|FG000|Initial Period|Missing end of study page|0|||
155578755|NCT00413699|561544921|FG001|Initial Period|Missing end of study page|4|||
155578756|NCT00413699|561544922|FG002|Initial Period|Missing end of study page|0|||
155578757|NCT00413699|561544920|FG000|Initial Period|No longer willing to participate|116|||
155578758|NCT00413699|561544921|FG001|Initial Period|No longer willing to participate|368|||
155578759|NCT00413699|561544922|FG002|Initial Period|No longer willing to participate|0|||
155578760|NCT00413699|561544920|FG000|Extension Period|No Longer Willing to Participate|0|||
155578761|NCT00413699|561544921|FG001|Extension Period|No Longer Willing to Participate|0|||
155578762|NCT00413699|561544922|FG002|Extension Period|No Longer Willing to Participate|2|||
155578763|NCT00413699|561544920|FG000|Extension Period|Protocol Violation|0|||
155578764|NCT00413699|561544921|FG001|Extension Period|Protocol Violation|0|||
155578765|NCT00413699|561544922|FG002|Extension Period|Protocol Violation|1|||
155578766|NCT00413699|561544920|FG000|Extension Period|Adverse Event|0|||
155578767|NCT00413699|561544921|FG001|Extension Period|Adverse Event|0|||
155578768|NCT00413699|561544922|FG002|Extension Period|Adverse Event|2|||
155578769|NCT02115269|561544923|FG000|Overall Study|Lost to Follow-up|43|||
155578770|NCT02115269|561544923|FG000|Overall Study|Did not complete patient diary|3|||
155578771|NCT02115269|561544923|FG000|Overall Study|Moved to another city|7|||
155578772|NCT02115269|561544923|FG000|Overall Study|Withdrawal by Subject|2|||
155578773|NCT02115269|561544923|FG000|Overall Study|Didn't take study drug|2|||
155578774|NCT00711243|561544925|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
155578775|NCT00711243|561544926|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
155578776|NCT00711243|561544927|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
155578777|NCT00711243|561544928|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
155578778|NCT00711243|561544929|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
155578779|NCT00711243|561544930|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
155578780|NCT00711243|561544925|FG000|Reached First Response/4 Cycles|Death|0|||
155578781|NCT00711243|561544926|FG001|Reached First Response/4 Cycles|Death|0|||
155578782|NCT00711243|561544927|FG002|Reached First Response/4 Cycles|Death|0|||
155578783|NCT00711243|561544928|FG003|Reached First Response/4 Cycles|Death|0|||
155578784|NCT00711243|561544929|FG004|Reached First Response/4 Cycles|Death|0|||
155578785|NCT00711243|561544930|FG005|Reached First Response/4 Cycles|Death|2|||
155578786|NCT00711243|561544925|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
155578787|NCT00711243|561544926|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
155578788|NCT00711243|561544927|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
155578789|NCT00711243|561544928|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
155578790|NCT00711243|561544929|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
155578791|NCT00711243|561544930|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
155578792|NCT00711243|561544925|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
155578793|NCT00711243|561544926|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
155578794|NCT00711243|561544927|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
155578795|NCT00711243|561544928|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
155578796|NCT00711243|561544929|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
155578797|NCT00711243|561544930|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
155578798|NCT00711243|561544925|FG000|Treated Cycle 5 After First Response|Death|0|||
155578799|NCT00711243|561544926|FG001|Treated Cycle 5 After First Response|Death|0|||
155578800|NCT00711243|561544927|FG002|Treated Cycle 5 After First Response|Death|0|||
155578801|NCT00711243|561544928|FG003|Treated Cycle 5 After First Response|Death|0|||
155578802|NCT00711243|561544929|FG004|Treated Cycle 5 After First Response|Death|0|||
155578803|NCT00711243|561544930|FG005|Treated Cycle 5 After First Response|Death|2|||
155578804|NCT00711243|561544925|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
155578805|NCT00711243|561544926|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
155578806|NCT00711243|561544927|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
155578807|NCT00711243|561544928|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
155578808|NCT00711243|561544929|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
155578809|NCT00711243|561544930|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
155578810|NCT00711243|561544925|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155578811|NCT00711243|561544926|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155578812|NCT00711243|561544927|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155578813|NCT00711243|561544928|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155578814|NCT00711243|561544929|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155578815|NCT00711243|561544930|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
155578816|NCT05989672|561544931|FG000|Overall Study|Adverse Event|3|||
155578817|NCT05989672|561544932|FG001|Overall Study|Adverse Event|0|||
155578818|NCT05989672|561544933|FG002|Overall Study|Adverse Event|0|||
155578819|NCT03511105|561544934|FG000|Overall Study|Adverse Event|1|||
155578820|NCT03511105|561544935|FG001|Overall Study|Adverse Event|0|||
155578821|NCT03511105|561544934|FG000|Overall Study|Withdrew consent|1|||
155578822|NCT03511105|561544935|FG001|Overall Study|Withdrew consent|0|||
155578823|NCT02810457|561544936|FG000|Overall Study|Randomised but no treatment received|2|||
155578824|NCT02810457|561544937|FG001|Overall Study|Randomised but no treatment received|1|||
155578825|NCT02810457|561544936|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
155578826|NCT02810457|561544937|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
155578827|NCT02810457|561544936|FG000|Overall Study|Adverse Event|37|||
155578828|NCT02810457|561544937|FG001|Overall Study|Adverse Event|43|||
155578829|NCT02810457|561544936|FG000|Overall Study|Patient decision|31|||
155578830|NCT02810457|561544937|FG001|Overall Study|Patient decision|35|||
155578831|NCT02810457|561544936|FG000|Overall Study|Patient lost to follow-up|2|||
155578832|NCT02810457|561544937|FG001|Overall Study|Patient lost to follow-up|2|||
155578833|NCT02810457|561544936|FG000|Overall Study|Death|39|||
155578834|NCT02810457|561544937|FG001|Overall Study|Death|28|||
155578835|NCT02810457|561544936|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
155578836|NCT02810457|561544937|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
155578837|NCT02810457|561544936|FG000|Overall Study|Clinical progression|15|||
155578838|NCT02810457|561544937|FG001|Overall Study|Clinical progression|16|||
155578839|NCT02810457|561544936|FG000|Overall Study|Investigator decision|3|||
155578840|NCT02810457|561544937|FG001|Overall Study|Investigator decision|2|||
155578841|NCT02810457|561544936|FG000|Overall Study|Patient ineligibility|3|||
155578842|NCT02810457|561544937|FG001|Overall Study|Patient ineligibility|0|||
155578843|NCT02810457|561544936|FG000|Overall Study|Miscalculated PD|1|||
155578844|NCT02810457|561544937|FG001|Overall Study|Miscalculated PD|0|||
155578845|NCT02810457|561544936|FG000|Overall Study|Physician Decision|0|||
155578846|NCT02810457|561544937|FG001|Overall Study|Physician Decision|1|||
155578847|NCT02750618|561544938|FG000|Overall Study|Withdrawal by Subject|1|||
155578848|NCT02019472|561544939|FG000|Overall Study|Adverse Event|14|||
155578849|NCT02019472|561544940|FG001|Overall Study|Adverse Event|23|||
155578850|NCT02019472|561544941|FG002|Overall Study|Adverse Event|17|||
155578851|NCT02019472|561544939|FG000|Overall Study|Death|0|||
155578852|NCT02019472|561544940|FG001|Overall Study|Death|1|||
155578853|NCT02019472|561544941|FG002|Overall Study|Death|1|||
155578854|NCT02019472|561544939|FG000|Overall Study|Lack of Efficacy|7|||
155578855|NCT02019472|561544940|FG001|Overall Study|Lack of Efficacy|4|||
155578856|NCT02019472|561544941|FG002|Overall Study|Lack of Efficacy|4|||
155578857|NCT02019472|561544939|FG000|Overall Study|Lost to Follow-up|0|||
155578858|NCT02019472|561544940|FG001|Overall Study|Lost to Follow-up|2|||
155578859|NCT02019472|561544941|FG002|Overall Study|Lost to Follow-up|1|||
155578860|NCT02019472|561544939|FG000|Overall Study|Physician Decision|1|||
155578861|NCT02019472|561544940|FG001|Overall Study|Physician Decision|2|||
155578862|NCT02019472|561544941|FG002|Overall Study|Physician Decision|0|||
155578863|NCT02019472|561544939|FG000|Overall Study|Pregnancy|1|||
155578864|NCT02019472|561544940|FG001|Overall Study|Pregnancy|2|||
155578865|NCT02019472|561544941|FG002|Overall Study|Pregnancy|2|||
155578866|NCT02019472|561544939|FG000|Overall Study|Withdrawal by Subject|11|||
155578867|NCT02019472|561544940|FG001|Overall Study|Withdrawal by Subject|10|||
155578868|NCT02019472|561544941|FG002|Overall Study|Withdrawal by Subject|11|||
155578869|NCT02019472|561544939|FG000|Overall Study|Other|3|||
155578870|NCT02019472|561544940|FG001|Overall Study|Other|8|||
155578871|NCT02019472|561544941|FG002|Overall Study|Other|6|||
155578872|NCT00513695|561544942|FG000|Overall Study|Discontinued therapy|2|||
155578873|NCT00513695|561544942|FG000|Overall Study|Progression prior to surgery|3|||
155578874|NCT02157935|561544943|FG000|Overall Study|Withdrawal by Subject|25|||
155578875|NCT02157935|561544944|FG001|Overall Study|Withdrawal by Subject|39|||
155578876|NCT02157935|561544943|FG000|Overall Study|Screen failure|1|||
155662465|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
155662466|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155662467|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155662468|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
155662469|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155662470|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155662471|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155662472|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155662473|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155662474|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
155662475|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155662476|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155662477|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155662478|NCT00557193|561860319|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155662479|NCT00557193|561860320|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155662480|NCT00557193|561860321|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
155662481|NCT00557193|561860322|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155662482|NCT00557193|561860323|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155662483|NCT00557193|561860324|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
155662484|NCT01156844|561860327|FG000|Overall Study|Adverse Event|0|||
155662485|NCT01156844|561860328|FG001|Overall Study|Adverse Event|0|||
155662486|NCT01156844|561860329|FG002|Overall Study|Adverse Event|1|||
155662487|NCT01156844|561860330|FG003|Overall Study|Adverse Event|1|||
155662488|NCT01156844|561860327|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155662489|NCT01156844|561860328|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155662490|NCT01156844|561860329|FG002|Overall Study|Abnormal test procedure result(s)|2|||
155662491|NCT01156844|561860330|FG003|Overall Study|Abnormal test procedure result(s)|2|||
155662492|NCT01156844|561860327|FG000|Overall Study|Withdrawal by Subject|0|||
155662493|NCT01156844|561860328|FG001|Overall Study|Withdrawal by Subject|0|||
155578877|NCT02157935|561544944|FG001|Overall Study|Screen failure|2|||
155578878|NCT02157935|561544943|FG000|Overall Study|Protocol Violation|1|||
155578879|NCT02157935|561544944|FG001|Overall Study|Protocol Violation|0|||
155578880|NCT02157935|561544943|FG000|Overall Study|Progressive disease|0|||
155578881|NCT02157935|561544944|FG001|Overall Study|Progressive disease|2|||
155578882|NCT02157935|561544943|FG000|Overall Study|Other|5|||
155578883|NCT02157935|561544944|FG001|Overall Study|Other|12|||
155662494|NCT01156844|561860329|FG002|Overall Study|Withdrawal by Subject|2|||
155662495|NCT01156844|561860330|FG003|Overall Study|Withdrawal by Subject|2|||
155662496|NCT01156844|561860327|FG000|Overall Study|Lost to Follow-up|0|||
155662497|NCT01156844|561860328|FG001|Overall Study|Lost to Follow-up|0|||
155662498|NCT01156844|561860329|FG002|Overall Study|Lost to Follow-up|1|||
155662499|NCT01156844|561860330|FG003|Overall Study|Lost to Follow-up|0|||
155662500|NCT01156844|561860327|FG000|Overall Study|Administrative problems|0|||
155662501|NCT01156844|561860328|FG001|Overall Study|Administrative problems|1|||
155662502|NCT01156844|561860329|FG002|Overall Study|Administrative problems|0|||
155662503|NCT01156844|561860330|FG003|Overall Study|Administrative problems|1|||
155662504|NCT01156844|561860327|FG000|Overall Study|Protocol deviation|2|||
155662505|NCT01156844|561860328|FG001|Overall Study|Protocol deviation|0|||
155662506|NCT01156844|561860329|FG002|Overall Study|Protocol deviation|0|||
155662507|NCT01156844|561860330|FG003|Overall Study|Protocol deviation|0|||
155662508|NCT01130337|561860332|FG000|Overall Study|Withdrawal by Subject|3|||
155662509|NCT01130337|561860332|FG000|Overall Study|Principal investigator decision|1|||
155578884|NCT02157935|561544943|FG000|Overall Study|Lack of Efficacy|0|||
155578885|NCT02157935|561544944|FG001|Overall Study|Lack of Efficacy|1|||
155578886|NCT02157935|561544943|FG000|Overall Study|Death|4|||
155578887|NCT02157935|561544944|FG001|Overall Study|Death|4|||
155578888|NCT02157935|561544943|FG000|Overall Study|Adverse Event|3|||
155578889|NCT02157935|561544944|FG001|Overall Study|Adverse Event|5|||
155578890|NCT01866826|561544945|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
155578891|NCT01866826|561544946|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
155578892|NCT01866826|561544945|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
155578893|NCT01866826|561544946|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
155578894|NCT01866826|561544945|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
155578895|NCT01866826|561544946|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
155578896|NCT02493660|561544949|FG000|Overall Study|Physician Decision|0|||
155578897|NCT02493660|561544950|FG001|Overall Study|Physician Decision|1|||
155578898|NCT02493660|561544949|FG000|Overall Study|Adverse Event|4|||
155578899|NCT02493660|561544950|FG001|Overall Study|Adverse Event|2|||
155578900|NCT02493660|561544949|FG000|Overall Study|Withdrawal by Subject|2|||
155578901|NCT02493660|561544950|FG001|Overall Study|Withdrawal by Subject|3|||
155578902|NCT02493660|561544949|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
155578903|NCT02493660|561544950|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
155578904|NCT02493660|561544949|FG000|Overall Study|Protocol Violation|0|||
155578905|NCT02493660|561544950|FG001|Overall Study|Protocol Violation|1|||
155578906|NCT02493660|561544949|FG000|Overall Study|Death|0|||
155578907|NCT02493660|561544950|FG001|Overall Study|Death|1|||
155578908|NCT02493660|561544949|FG000|Overall Study|Lost to Follow-up|2|||
155578909|NCT02493660|561544950|FG001|Overall Study|Lost to Follow-up|4|||
155578910|NCT02288312|561544951|FG000|Overall Study|Pregnancy|1|||
155578911|NCT02288312|561544952|FG001|Overall Study|Pregnancy|0|||
155578912|NCT02288312|561544953|FG002|Overall Study|Pregnancy|0|||
155578913|NCT01276041|561544955|FG000|Overall Study|Adverse Event|2|||
155578914|NCT01276041|561544955|FG000|Overall Study|Protocol Violation|1|||
155578915|NCT00725491|561544956|FG000|Overall Study|Adverse Event|3|||
155578916|NCT00725491|561544957|FG001|Overall Study|Adverse Event|2|||
155662510|NCT01130337|561860332|FG000|Overall Study|Death|1|||
155662511|NCT01130337|561860332|FG000|Overall Study|Disease progression|1|||
155662512|NCT01130337|561860332|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
155662513|NCT01130337|561860332|FG000|Overall Study|Surgical resection (R2)|1|||
155662514|NCT03886493|561860333|FG000|Overall Study|Adverse Event|1|||
155578917|NCT00725491|561544956|FG000|Overall Study|Pregnancy|0|||
155578918|NCT00725491|561544957|FG001|Overall Study|Pregnancy|3|||
155578919|NCT00725491|561544956|FG000|Overall Study|Risk for hyperstimulation|2|||
155578920|NCT00725491|561544957|FG001|Overall Study|Risk for hyperstimulation|9|||
155578921|NCT00725491|561544956|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
155578922|NCT00725491|561544957|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
155578923|NCT00725491|561544956|FG000|Overall Study|Fertilization failure|0|||
155578924|NCT00725491|561544957|FG001|Overall Study|Fertilization failure|1|||
155578925|NCT00725491|561544956|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
155662515|NCT04067011|561860334|FG000|Overall Study|Not Treated|8|||
155662516|NCT04067011|561860335|FG001|Overall Study|Not Treated|7|||
155662517|NCT04067011|561860336|FG002|Overall Study|Not Treated|5|||
155662518|NCT04067011|561860334|FG000|Overall Study|Adverse Event|2|||
155662519|NCT04067011|561860335|FG001|Overall Study|Adverse Event|1|||
155662520|NCT04067011|561860336|FG002|Overall Study|Adverse Event|0|||
155662521|NCT04067011|561860334|FG000|Overall Study|Withdrawal by Subject|6|||
155662522|NCT04067011|561860335|FG001|Overall Study|Withdrawal by Subject|2|||
155662523|NCT04067011|561860336|FG002|Overall Study|Withdrawal by Subject|1|||
155662524|NCT04067011|561860334|FG000|Overall Study|Lost to Follow-up|0|||
155662525|NCT04067011|561860335|FG001|Overall Study|Lost to Follow-up|0|||
155662526|NCT04067011|561860336|FG002|Overall Study|Lost to Follow-up|1|||
155662527|NCT04067011|561860334|FG000|Overall Study|Physician Decision|1|||
155662528|NCT04067011|561860335|FG001|Overall Study|Physician Decision|1|||
155662529|NCT04067011|561860336|FG002|Overall Study|Physician Decision|0|||
155662530|NCT04067011|561860334|FG000|Overall Study|Other Reasons|2|||
155662531|NCT04067011|561860335|FG001|Overall Study|Other Reasons|0|||
155662532|NCT04067011|561860336|FG002|Overall Study|Other Reasons|1|||
155662533|NCT04067011|561860334|FG000|Overall Study|Missing|0|||
155662534|NCT04067011|561860335|FG001|Overall Study|Missing|2|||
155662535|NCT04067011|561860336|FG002|Overall Study|Missing|0|||
155662536|NCT00760552|561860343|FG000|Overall Study|Death|2|||
155662537|NCT00760552|561860344|FG001|Overall Study|Death|0|||
155662538|NCT00760552|561860343|FG000|Overall Study|Lost to Follow-up|11|||
155662539|NCT00760552|561860344|FG001|Overall Study|Lost to Follow-up|10|||
155662540|NCT01038323|561860345|FG000|Overall Study|Withdrawal by Subject|3|||
155662541|NCT01038323|561860346|FG001|Overall Study|Withdrawal by Subject|2|||
155662542|NCT01038323|561860347|FG002|Overall Study|Withdrawal by Subject|4|||
155662543|NCT04211363|561860349|FG000|Overall Study|Adverse Event|5|||
155662544|NCT04211363|561860350|FG001|Overall Study|Adverse Event|2|||
155662545|NCT04211363|561860349|FG000|Overall Study|Physician Decision|0|||
155662546|NCT04211363|561860350|FG001|Overall Study|Physician Decision|1|||
155662547|NCT04211363|561860349|FG000|Overall Study|Protocol Violation|1|||
155662548|NCT04211363|561860350|FG001|Overall Study|Protocol Violation|0|||
155662549|NCT04211363|561860349|FG000|Overall Study|Pregnancy|1|||
155662550|NCT04211363|561860350|FG001|Overall Study|Pregnancy|0|||
155662551|NCT04211363|561860349|FG000|Overall Study|Lost to Follow-up|12|||
155662552|NCT04211363|561860350|FG001|Overall Study|Lost to Follow-up|4|||
155662553|NCT04211363|561860349|FG000|Overall Study|Withdrawal by Subject|11|||
155662554|NCT04211363|561860350|FG001|Overall Study|Withdrawal by Subject|11|||
155662555|NCT04211363|561860349|FG000|Overall Study|Other|1|||
155662556|NCT04211363|561860350|FG001|Overall Study|Other|2|||
155662557|NCT01736917|561860351|FG000|Overall Study|Adverse Event|1|||
155662558|NCT01736917|561860351|FG000|Overall Study|Protocol Violation|10|||
155662559|NCT01734902|561860352|FG000|Overall Study|Other than listed|0|||
155662560|NCT01734902|561860353|FG001|Overall Study|Other than listed|2|||
155662561|NCT00060944|561860354|FG000|Overall Study|Adverse Event|12|||
155662562|NCT00060944|561860355|FG001|Overall Study|Adverse Event|10|||
155662563|NCT00060944|561860354|FG000|Overall Study|Death|2|||
155578926|NCT00725491|561544957|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
155578927|NCT01495000|561544960|FG000|Overall Study|Lost to Follow-up|2|||
155578928|NCT01495000|561544961|FG001|Overall Study|Lost to Follow-up|2|||
155578929|NCT01495000|561544960|FG000|Overall Study|Protocol Violation|1|||
155578930|NCT01495000|561544961|FG001|Overall Study|Protocol Violation|0|||
155578931|NCT01495000|561544960|FG000|Overall Study|Withdrawal by Subject|10|||
155578932|NCT01495000|561544961|FG001|Overall Study|Withdrawal by Subject|10|||
155578933|NCT02070965|561544962|FG000|Overall Study|Lost to Follow-up|0|||
155578934|NCT02070965|561544963|FG001|Overall Study|Lost to Follow-up|1|||
155578935|NCT02070965|561544964|FG002|Overall Study|Lost to Follow-up|0|||
155578936|NCT02070965|561544962|FG000|Overall Study|Withdrawal by Subject|1|||
155662564|NCT00060944|561860355|FG001|Overall Study|Death|3|||
155578937|NCT02070965|561544963|FG001|Overall Study|Withdrawal by Subject|1|||
155578938|NCT02070965|561544964|FG002|Overall Study|Withdrawal by Subject|1|||
155662565|NCT00060944|561860354|FG000|Overall Study|Withdrawal by Subject|18|||
155578939|NCT02070965|561544962|FG000|Overall Study|Subject moved|1|||
155578940|NCT02070965|561544963|FG001|Overall Study|Subject moved|0|||
155662566|NCT00060944|561860355|FG001|Overall Study|Withdrawal by Subject|5|||
155662567|NCT00060944|561860354|FG000|Overall Study|Disease Progression|93|||
155662568|NCT00060944|561860355|FG001|Overall Study|Disease Progression|94|||
155662569|NCT00060944|561860354|FG000|Overall Study|Lost to Follow-up|1|||
155662570|NCT00060944|561860355|FG001|Overall Study|Lost to Follow-up|0|||
155578941|NCT02070965|561544964|FG002|Overall Study|Subject moved|0|||
155662571|NCT00060944|561860354|FG000|Overall Study|Subject Ineligible To Continue|2|||
155662572|NCT00060944|561860355|FG001|Overall Study|Subject Ineligible To Continue|1|||
155662573|NCT00060944|561860354|FG000|Overall Study|Treatment Switch|0|||
155662574|NCT00060944|561860355|FG001|Overall Study|Treatment Switch|13|||
155662575|NCT00060944|561860354|FG000|Overall Study|Other|2|||
155662576|NCT00060944|561860355|FG001|Overall Study|Other|4|||
155662577|NCT00060944|561860354|FG000|Overall Study|randomized but not treated|6|||
155662578|NCT00060944|561860355|FG001|Overall Study|randomized but not treated|4|||
155662579|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
155662580|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
155662581|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
155662582|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Death|0|||
155662583|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Death|0|||
155662584|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Death|1|||
155662585|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
155662586|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
155662587|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
155662588|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
155662589|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
155662590|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
155662591|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
155662592|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
155662593|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
155662594|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Graft loss|0|||
155662595|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Graft loss|0|||
155662596|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Graft loss|7|||
155662597|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
155662598|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
155662599|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
155662600|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
155662601|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
155662602|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
155662603|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
155662604|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
155662605|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
155662606|NCT00956293|561860359|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
155662607|NCT00956293|561860360|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
155662608|NCT00956293|561860361|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
155662609|NCT00956293|561860359|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
155662610|NCT00956293|561860360|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
155662611|NCT00956293|561860361|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
155662612|NCT00956293|561860359|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
155662613|NCT00956293|561860360|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
155662614|NCT00956293|561860361|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
155662615|NCT00956293|561860359|FG000|Main Period (Randomization)|Adverse Event|0|||
155662616|NCT00956293|561860360|FG001|Main Period (Randomization)|Adverse Event|15|||
155662617|NCT00956293|561860361|FG002|Main Period (Randomization)|Adverse Event|0|||
155662618|NCT00956293|561860359|FG000|Follow-up Period|Follow-up period was terminated.|20|||
155662619|NCT00956293|561860360|FG001|Follow-up Period|Follow-up period was terminated.|32|||
155662620|NCT00956293|561860361|FG002|Follow-up Period|Follow-up period was terminated.|0|||
155662621|NCT02536664|561860362|FG000|Overall Study|Inadequate completion of documentation|2|||
155662622|NCT02536664|561860363|FG001|Overall Study|Inadequate completion of documentation|4|||
155662623|NCT02536664|561860362|FG000|Overall Study|Progression|13|||
155662624|NCT02536664|561860363|FG001|Overall Study|Progression|18|||
155662625|NCT02536664|561860362|FG000|Overall Study|Death due to lymphoma|2|||
155662626|NCT02536664|561860363|FG001|Overall Study|Death due to lymphoma|1|||
155662627|NCT02536664|561860362|FG000|Overall Study|Death due to other reason|3|||
155662628|NCT02536664|561860363|FG001|Overall Study|Death due to other reason|2|||
155662629|NCT02536664|561860362|FG000|Overall Study|Intolerability|8|||
155662630|NCT02536664|561860363|FG001|Overall Study|Intolerability|6|||
155662631|NCT02536664|561860362|FG000|Overall Study|Withdrawal by Subject|8|||
155662632|NCT02536664|561860363|FG001|Overall Study|Withdrawal by Subject|5|||
155662633|NCT02536664|561860362|FG000|Overall Study|Other|18|||
155662634|NCT02536664|561860363|FG001|Overall Study|Other|24|||
155662635|NCT02536664|561860362|FG000|Overall Study|Missing|53|||
155662636|NCT02536664|561860363|FG001|Overall Study|Missing|20|||
155662637|NCT03383666|561860364|FG000|Overall Study|Withdrawal by Subject|2|||
155662638|NCT03383666|561860364|FG000|Overall Study|Lost to Follow-up|2|||
155662639|NCT00659425|561860366|FG000|Overall Study|Disease progression|1|||
155662640|NCT00659425|561860367|FG001|Overall Study|Disease progression|0|||
155662641|NCT00659425|561860368|FG002|Overall Study|Disease progression|0|||
155662642|NCT00659425|561860369|FG003|Overall Study|Disease progression|1|||
155662643|NCT00659425|561860370|FG004|Overall Study|Disease progression|0|||
155662644|NCT00659425|561860371|FG005|Overall Study|Disease progression|2|||
155662645|NCT00659425|561860372|FG006|Overall Study|Disease progression|4|||
155662646|NCT00659425|561860373|FG007|Overall Study|Disease progression|3|||
155662647|NCT00659425|561860374|FG008|Overall Study|Disease progression|5|||
155662648|NCT00659425|561860375|FG009|Overall Study|Disease progression|3|||
155662649|NCT00659425|561860366|FG000|Overall Study|Death|0|||
155662650|NCT00659425|561860367|FG001|Overall Study|Death|0|||
155662651|NCT00659425|561860368|FG002|Overall Study|Death|0|||
155662652|NCT00659425|561860369|FG003|Overall Study|Death|1|||
155662653|NCT00659425|561860370|FG004|Overall Study|Death|0|||
155662654|NCT00659425|561860371|FG005|Overall Study|Death|0|||
155662655|NCT00659425|561860372|FG006|Overall Study|Death|1|||
155662656|NCT00659425|561860373|FG007|Overall Study|Death|0|||
155662657|NCT00659425|561860374|FG008|Overall Study|Death|0|||
155662658|NCT00659425|561860375|FG009|Overall Study|Death|0|||
155662659|NCT00659425|561860366|FG000|Overall Study|Adverse Event|0|||
155662660|NCT00659425|561860367|FG001|Overall Study|Adverse Event|0|||
155662661|NCT00659425|561860368|FG002|Overall Study|Adverse Event|0|||
155662662|NCT00659425|561860369|FG003|Overall Study|Adverse Event|0|||
155662663|NCT00659425|561860370|FG004|Overall Study|Adverse Event|0|||
155662664|NCT00659425|561860371|FG005|Overall Study|Adverse Event|1|||
155662665|NCT00659425|561860372|FG006|Overall Study|Adverse Event|0|||
155662666|NCT00659425|561860373|FG007|Overall Study|Adverse Event|3|||
155662667|NCT00659425|561860374|FG008|Overall Study|Adverse Event|1|||
155662668|NCT00659425|561860375|FG009|Overall Study|Adverse Event|4|||
155662669|NCT00659425|561860366|FG000|Overall Study|Investigator Discretion|0|||
155662670|NCT00659425|561860367|FG001|Overall Study|Investigator Discretion|0|||
155662671|NCT00659425|561860368|FG002|Overall Study|Investigator Discretion|0|||
155662672|NCT00659425|561860369|FG003|Overall Study|Investigator Discretion|0|||
155662673|NCT00659425|561860370|FG004|Overall Study|Investigator Discretion|0|||
155662674|NCT00659425|561860371|FG005|Overall Study|Investigator Discretion|1|||
155662675|NCT00659425|561860372|FG006|Overall Study|Investigator Discretion|0|||
155662676|NCT00659425|561860373|FG007|Overall Study|Investigator Discretion|3|||
155662677|NCT00659425|561860374|FG008|Overall Study|Investigator Discretion|0|||
155662678|NCT00659425|561860375|FG009|Overall Study|Investigator Discretion|0|||
155662679|NCT00659425|561860366|FG000|Overall Study|Other|0|||
155662680|NCT00659425|561860367|FG001|Overall Study|Other|1|||
155662681|NCT00659425|561860368|FG002|Overall Study|Other|1|||
155662682|NCT00659425|561860369|FG003|Overall Study|Other|2|||
155662683|NCT00659425|561860370|FG004|Overall Study|Other|4|||
155662684|NCT00659425|561860371|FG005|Overall Study|Other|0|||
155662685|NCT00659425|561860372|FG006|Overall Study|Other|3|||
155662686|NCT00659425|561860373|FG007|Overall Study|Other|2|||
155662687|NCT00659425|561860374|FG008|Overall Study|Other|0|||
155662688|NCT00659425|561860375|FG009|Overall Study|Other|6|||
155662689|NCT03358030|561860376|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
155662690|NCT03358030|561860377|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155662691|NCT03358030|561860378|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
155662692|NCT03358030|561860379|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
155662693|NCT03358030|561860376|FG000|Overall Study|Ineligibility|0|||
155662694|NCT03358030|561860377|FG001|Overall Study|Ineligibility|0|||
155662695|NCT03358030|561860378|FG002|Overall Study|Ineligibility|0|||
155662696|NCT03358030|561860379|FG003|Overall Study|Ineligibility|2|||
155578942|NCT02058069|561544965|FG000|Overall Study|Exclusion due to implant size|5|||
155578943|NCT02058069|561544965|FG000|Overall Study|Withdrawal by Subject|6|||
155578944|NCT02222922|561544966|FG000|Overall Study|Death|0|||
155578945|NCT02222922|561544967|FG001|Overall Study|Death|0|||
155578946|NCT02222922|561544968|FG002|Overall Study|Death|0|||
155578947|NCT02222922|561544969|FG003|Overall Study|Death|0|||
155578948|NCT02222922|561544970|FG004|Overall Study|Death|13|||
155578949|NCT02222922|561544971|FG005|Overall Study|Death|0|||
155578950|NCT02222922|561544972|FG006|Overall Study|Death|0|||
155662697|NCT03358030|561860376|FG000|Overall Study|Voluntary Withdrawal|1|||
155662698|NCT03358030|561860377|FG001|Overall Study|Voluntary Withdrawal|1|||
155662699|NCT03358030|561860378|FG002|Overall Study|Voluntary Withdrawal|3|||
155662700|NCT03358030|561860379|FG003|Overall Study|Voluntary Withdrawal|1|||
155662701|NCT03358030|561860376|FG000|Overall Study|Other|0|||
155662702|NCT03358030|561860377|FG001|Overall Study|Other|0|||
155662703|NCT03358030|561860378|FG002|Overall Study|Other|1|||
155662704|NCT03358030|561860379|FG003|Overall Study|Other|0|||
155662705|NCT03342560|561860380|FG000|Overall Study|Lost to Follow-up|2|||
155662706|NCT03770286|561860381|FG000|Overall Study|Lost to Follow-up|6|||
155662707|NCT03770286|561860382|FG001|Overall Study|Lost to Follow-up|4|||
155578951|NCT02222922|561544973|FG007|Overall Study|Death|0|||
155578952|NCT02222922|561544974|FG008|Overall Study|Death|2|||
155662708|NCT03770286|561860383|FG002|Overall Study|Lost to Follow-up|3|||
155662709|NCT03770286|561860381|FG000|Overall Study|Protocol Violation|1|||
155662710|NCT03770286|561860382|FG001|Overall Study|Protocol Violation|0|||
155662711|NCT03770286|561860383|FG002|Overall Study|Protocol Violation|2|||
155662712|NCT02505425|561860384|FG000|Overall Study|Lost to Follow-up|41|||
155662713|NCT02505425|561860385|FG001|Overall Study|Lost to Follow-up|61|||
155662714|NCT02505425|561860386|FG002|Overall Study|Lost to Follow-up|31|||
155662715|NCT02505425|561860387|FG003|Overall Study|Lost to Follow-up|19|||
155662716|NCT02505425|561860384|FG000|Overall Study|Withdrawal by Subject|39|||
155662717|NCT02505425|561860385|FG001|Overall Study|Withdrawal by Subject|9|||
155578953|NCT02222922|561544966|FG000|Overall Study|Lost to Follow-up|0|||
155578954|NCT02222922|561544967|FG001|Overall Study|Lost to Follow-up|0|||
155578955|NCT02222922|561544968|FG002|Overall Study|Lost to Follow-up|1|||
155578956|NCT02222922|561544969|FG003|Overall Study|Lost to Follow-up|0|||
155578957|NCT02222922|561544970|FG004|Overall Study|Lost to Follow-up|9|||
155578958|NCT02222922|561544971|FG005|Overall Study|Lost to Follow-up|1|||
155578959|NCT02222922|561544972|FG006|Overall Study|Lost to Follow-up|0|||
155578960|NCT02222922|561544973|FG007|Overall Study|Lost to Follow-up|0|||
155578961|NCT02222922|561544974|FG008|Overall Study|Lost to Follow-up|0|||
155578962|NCT02222922|561544966|FG000|Overall Study|Other|0|||
155578963|NCT02222922|561544967|FG001|Overall Study|Other|0|||
155578964|NCT02222922|561544968|FG002|Overall Study|Other|0|||
155578965|NCT02222922|561544969|FG003|Overall Study|Other|2|||
155578966|NCT02222922|561544970|FG004|Overall Study|Other|10|||
155578967|NCT02222922|561544971|FG005|Overall Study|Other|2|||
155578968|NCT02222922|561544972|FG006|Overall Study|Other|2|||
155578969|NCT02222922|561544973|FG007|Overall Study|Other|4|||
155578970|NCT02222922|561544974|FG008|Overall Study|Other|1|||
155578971|NCT02222922|561544966|FG000|Overall Study|Participant refused further follow-up|1|||
155578972|NCT02222922|561544967|FG001|Overall Study|Participant refused further follow-up|0|||
155578973|NCT02222922|561544968|FG002|Overall Study|Participant refused further follow-up|0|||
155578974|NCT02222922|561544969|FG003|Overall Study|Participant refused further follow-up|1|||
155578975|NCT02222922|561544970|FG004|Overall Study|Participant refused further follow-up|6|||
155578976|NCT02222922|561544971|FG005|Overall Study|Participant refused further follow-up|0|||
155578977|NCT02222922|561544972|FG006|Overall Study|Participant refused further follow-up|0|||
155578978|NCT02222922|561544973|FG007|Overall Study|Participant refused further follow-up|0|||
155578979|NCT02222922|561544974|FG008|Overall Study|Participant refused further follow-up|3|||
155578980|NCT01930162|561544975|FG000|Overall Study|Abnormal test procedure result(s)|4|||
155578981|NCT01930162|561544975|FG000|Overall Study|Death|1|||
155578982|NCT00840749|561544976|FG000|Overall Study|Death|1|||
155578983|NCT00840749|561544977|FG001|Overall Study|Death|2|||
155578984|NCT00840749|561544976|FG000|Overall Study|not treated on study arm|11|||
155578985|NCT00840749|561544977|FG001|Overall Study|not treated on study arm|11|||
155578986|NCT00840749|561544976|FG000|Overall Study|study closed|19|||
155578987|NCT00840749|561544977|FG001|Overall Study|study closed|14|||
155578988|NCT03411863|561544978|FG000|Overall Study|Withdrawal by Subject|3|||
155578989|NCT03411863|561544979|FG001|Overall Study|Withdrawal by Subject|1|||
155578990|NCT03411863|561544978|FG000|Overall Study|Physician Decision|0|||
155578991|NCT03411863|561544979|FG001|Overall Study|Physician Decision|1|||
155578992|NCT03164551|561544980|FG000|Overall Study|Imaging discontinued prior completion|8|||
155578993|NCT03164551|561544981|FG001|Overall Study|Imaging discontinued prior completion|0|||
155578994|NCT03164551|561544980|FG000|Overall Study|Participant was non-compliant|1|||
155578995|NCT03164551|561544981|FG001|Overall Study|Participant was non-compliant|0|||
155578996|NCT03164551|561544980|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
155578997|NCT03164551|561544981|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
155578998|NCT03164551|561544980|FG000|Overall Study|Other|8|||
155578999|NCT03164551|561544981|FG001|Overall Study|Other|2|||
155579000|NCT00729937|561544988|FG000|Overall Study|Lost to Follow-up|49|||
155579001|NCT00729937|561544989|FG001|Overall Study|Lost to Follow-up|58|||
155579002|NCT00729937|561544990|FG002|Overall Study|Lost to Follow-up|18|||
155579003|NCT00729937|561544991|FG003|Overall Study|Lost to Follow-up|33|||
155579004|NCT00729937|561544992|FG004|Overall Study|Lost to Follow-up|18|||
155579005|NCT00729937|561544993|FG005|Overall Study|Lost to Follow-up|23|||
155579006|NCT00729937|561544988|FG000|Overall Study|Physician Decision|7|||
155579007|NCT00729937|561544989|FG001|Overall Study|Physician Decision|16|||
155579008|NCT00729937|561544990|FG002|Overall Study|Physician Decision|2|||
155579009|NCT00729937|561544991|FG003|Overall Study|Physician Decision|0|||
155579010|NCT00729937|561544992|FG004|Overall Study|Physician Decision|5|||
155579011|NCT00729937|561544993|FG005|Overall Study|Physician Decision|8|||
155579012|NCT00729937|561544988|FG000|Overall Study|Death|1|||
155579013|NCT00729937|561544989|FG001|Overall Study|Death|0|||
155579014|NCT00729937|561544990|FG002|Overall Study|Death|1|||
155579015|NCT00729937|561544991|FG003|Overall Study|Death|0|||
155579016|NCT00729937|561544992|FG004|Overall Study|Death|0|||
155579017|NCT00729937|561544993|FG005|Overall Study|Death|1|||
155579018|NCT00729937|561544988|FG000|Overall Study|Withdrawal by Subject|3|||
155579019|NCT00729937|561544989|FG001|Overall Study|Withdrawal by Subject|5|||
155579020|NCT00729937|561544990|FG002|Overall Study|Withdrawal by Subject|6|||
155579021|NCT00729937|561544991|FG003|Overall Study|Withdrawal by Subject|0|||
155579022|NCT00729937|561544992|FG004|Overall Study|Withdrawal by Subject|4|||
155579023|NCT00729937|561544993|FG005|Overall Study|Withdrawal by Subject|2|||
155579024|NCT00729937|561544988|FG000|Overall Study|Randomized but not treated|12|||
155579025|NCT00729937|561544989|FG001|Overall Study|Randomized but not treated|6|||
155579026|NCT00729937|561544990|FG002|Overall Study|Randomized but not treated|1|||
155579027|NCT00729937|561544991|FG003|Overall Study|Randomized but not treated|0|||
155579028|NCT00729937|561544992|FG004|Overall Study|Randomized but not treated|1|||
155579029|NCT00729937|561544993|FG005|Overall Study|Randomized but not treated|3|||
155579030|NCT00729937|561544988|FG000|Overall Study|Did not meet eligibility criteria|2|||
155662718|NCT02505425|561860386|FG002|Overall Study|Withdrawal by Subject|19|||
155662719|NCT02505425|561860387|FG003|Overall Study|Withdrawal by Subject|7|||
155662720|NCT02505425|561860384|FG000|Overall Study|Death|8|||
155662721|NCT02505425|561860385|FG001|Overall Study|Death|12|||
155662722|NCT02505425|561860386|FG002|Overall Study|Death|0|||
155662723|NCT02505425|561860387|FG003|Overall Study|Death|0|||
155662724|NCT03549338|561861550|FG000|Overall Study|Progressive Disease|1|||
155662725|NCT03549338|561861551|FG001|Overall Study|Progressive Disease|0|||
155662726|NCT03549338|561861552|FG002|Overall Study|Progressive Disease|0|||
155662727|NCT03549338|561861550|FG000|Overall Study|Clinical Progression|0|||
155662728|NCT03549338|561861551|FG001|Overall Study|Clinical Progression|1|||
155662729|NCT03549338|561861552|FG002|Overall Study|Clinical Progression|0|||
155662730|NCT01492426|561861553|FG000|Treatment|Death|0|||
155662731|NCT01492426|561861554|FG001|Treatment|Death|1|||
155662732|NCT01492426|561861553|FG000|Treatment|Other|1|||
155662733|NCT01492426|561861554|FG001|Treatment|Other|0|||
155662734|NCT01492426|561861553|FG000|Treatment|Adverse Event|25|||
155662735|NCT01492426|561861554|FG001|Treatment|Adverse Event|25|||
155662736|NCT01492426|561861553|FG000|Treatment|Lack of Efficacy|38|||
155662737|NCT01492426|561861554|FG001|Treatment|Lack of Efficacy|5|||
155662738|NCT01492426|561861553|FG000|Treatment|Participant withdrew consent|1|||
155662739|NCT01492426|561861554|FG001|Treatment|Participant withdrew consent|2|||
155662740|NCT01492426|561861553|FG000|Treatment|Poor compliance/noncompliance|1|||
155662741|NCT01492426|561861554|FG001|Treatment|Poor compliance/noncompliance|0|||
155662742|NCT01492426|561861553|FG000|Treatment|Subject requested discontinue study drug|7|||
155662743|NCT01492426|561861554|FG001|Treatment|Subject requested discontinue study drug|3|||
155662744|NCT01492426|561861553|FG000|Treatment|Lost to Follow-up|9|||
155662745|NCT01492426|561861554|FG001|Treatment|Lost to Follow-up|4|||
155662746|NCT01492426|561861553|FG000|Treatment|Participant does not meet study criteria|1|||
155662747|NCT01492426|561861554|FG001|Treatment|Participant does not meet study criteria|0|||
155662748|NCT01492426|561861553|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
155662749|NCT01492426|561861554|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
155662750|NCT01492426|561861553|FG000|Follow-Up|Death|1|||
155662751|NCT01492426|561861554|FG001|Follow-Up|Death|0|||
155662752|NCT01492426|561861553|FG000|Follow-Up|Other|4|||
155662753|NCT01492426|561861554|FG001|Follow-Up|Other|2|||
155662754|NCT01492426|561861553|FG000|Follow-Up|Participant Withdrew Consent|6|||
155662755|NCT01492426|561861554|FG001|Follow-Up|Participant Withdrew Consent|1|||
155662756|NCT01492426|561861553|FG000|Follow-Up|Lost to Follow-up|12|||
155662757|NCT01492426|561861554|FG001|Follow-Up|Lost to Follow-up|6|||
155662758|NCT00269113|561861555|FG000|Overall Study|Adverse Event|14|||
155662759|NCT00269113|561861556|FG001|Overall Study|Adverse Event|7|||
155662760|NCT00269113|561861555|FG000|Overall Study|Lack of Efficacy|35|||
155662761|NCT00269113|561861556|FG001|Overall Study|Lack of Efficacy|18|||
155662762|NCT00269113|561861555|FG000|Overall Study|Early Improvement|2|||
155662763|NCT00269113|561861556|FG001|Overall Study|Early Improvement|0|||
155662764|NCT00269113|561861555|FG000|Overall Study|Withdrawal by Subject|0|||
155662765|NCT00269113|561861556|FG001|Overall Study|Withdrawal by Subject|2|||
155662766|NCT00269113|561861555|FG000|Overall Study|Death|6|||
155662767|NCT00269113|561861556|FG001|Overall Study|Death|2|||
155662768|NCT00269113|561861555|FG000|Overall Study|Lost to Follow-up|2|||
155579031|NCT00729937|561544989|FG001|Overall Study|Did not meet eligibility criteria|1|||
155579032|NCT00729937|561544990|FG002|Overall Study|Did not meet eligibility criteria|0|||
155579033|NCT00729937|561544991|FG003|Overall Study|Did not meet eligibility criteria|0|||
155579034|NCT00729937|561544992|FG004|Overall Study|Did not meet eligibility criteria|0|||
155579035|NCT00729937|561544993|FG005|Overall Study|Did not meet eligibility criteria|0|||
155579036|NCT00729937|561544988|FG000|Overall Study|Incarcerated|0|||
155579037|NCT00729937|561544989|FG001|Overall Study|Incarcerated|2|||
155579038|NCT00729937|561544990|FG002|Overall Study|Incarcerated|1|||
155662769|NCT00269113|561861556|FG001|Overall Study|Lost to Follow-up|1|||
155662770|NCT00269113|561861555|FG000|Overall Study|Protocol Violation|15|||
155662771|NCT00269113|561861556|FG001|Overall Study|Protocol Violation|5|||
155662772|NCT00269113|561861555|FG000|Overall Study|Other|0|||
155662773|NCT00269113|561861556|FG001|Overall Study|Other|2|||
155662774|NCT01770743|561861557|FG000|Overall Study|Adverse Event|1|||
155662775|NCT01770743|561861558|FG001|Overall Study|Adverse Event|0|||
155662776|NCT01770743|561861559|FG002|Overall Study|Adverse Event|0|||
155662777|NCT01770743|561861560|FG003|Overall Study|Adverse Event|0|||
155662778|NCT01770743|561861561|FG004|Overall Study|Adverse Event|0|||
155662779|NCT01770743|561861557|FG000|Overall Study|Withdrawal by Subject|0|||
155662780|NCT01770743|561861558|FG001|Overall Study|Withdrawal by Subject|0|||
155662781|NCT01770743|561861559|FG002|Overall Study|Withdrawal by Subject|1|||
155662782|NCT01770743|561861560|FG003|Overall Study|Withdrawal by Subject|1|||
155662783|NCT01770743|561861561|FG004|Overall Study|Withdrawal by Subject|1|||
155662784|NCT01770743|561861557|FG000|Overall Study|Lost to Follow-up|0|||
155662785|NCT01770743|561861558|FG001|Overall Study|Lost to Follow-up|2|||
155662786|NCT01770743|561861559|FG002|Overall Study|Lost to Follow-up|0|||
155662787|NCT01770743|561861560|FG003|Overall Study|Lost to Follow-up|0|||
155662788|NCT01770743|561861561|FG004|Overall Study|Lost to Follow-up|1|||
155662789|NCT01770743|561861557|FG000|Overall Study|Sponsor Terminated Subject|1|||
155662790|NCT01770743|561861558|FG001|Overall Study|Sponsor Terminated Subject|0|||
155662791|NCT01770743|561861559|FG002|Overall Study|Sponsor Terminated Subject|0|||
155662792|NCT01770743|561861560|FG003|Overall Study|Sponsor Terminated Subject|1|||
155662793|NCT01770743|561861561|FG004|Overall Study|Sponsor Terminated Subject|0|||
155662794|NCT01770743|561861557|FG000|Overall Study|Moving Out of State|0|||
155662795|NCT01770743|561861558|FG001|Overall Study|Moving Out of State|1|||
155662796|NCT01770743|561861559|FG002|Overall Study|Moving Out of State|0|||
155662797|NCT01770743|561861560|FG003|Overall Study|Moving Out of State|0|||
155662798|NCT01770743|561861561|FG004|Overall Study|Moving Out of State|0|||
155662799|NCT02122380|561861565|FG000|First Intervention (30 Days)|Adverse Event|1|||
155662800|NCT02122380|561861566|FG001|First Intervention (30 Days)|Adverse Event|0|||
155662801|NCT02122380|561861565|FG000|First Intervention (30 Days)|Physician Decision|0|||
155662802|NCT02122380|561861566|FG001|First Intervention (30 Days)|Physician Decision|1|||
155662803|NCT02122380|561861565|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
155662804|NCT02122380|561861566|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
155662805|NCT02122380|561861565|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
155662806|NCT02122380|561861566|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
155662807|NCT02122380|561861565|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
155662808|NCT02122380|561861566|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
155662809|NCT01126190|561861567|FG000|Double-Blind Phase|Death|0|||
155662810|NCT01126190|561861568|FG001|Double-Blind Phase|Death|1|||
155662811|NCT01126190|561861569|FG002|Double-Blind Phase|Death|0|||
155662812|NCT01126190|561861567|FG000|Double-Blind Phase|Adverse Event|1|||
155662813|NCT01126190|561861568|FG001|Double-Blind Phase|Adverse Event|2|||
155662814|NCT01126190|561861569|FG002|Double-Blind Phase|Adverse Event|0|||
155662815|NCT01126190|561861567|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155662816|NCT01126190|561861568|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
155662817|NCT01126190|561861569|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155662818|NCT01126190|561861567|FG000|Double-Blind Phase|Request of Investigator|1|||
155662819|NCT01126190|561861568|FG001|Double-Blind Phase|Request of Investigator|0|||
155662820|NCT01126190|561861569|FG002|Double-Blind Phase|Request of Investigator|0|||
155662821|NCT01126190|561861567|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
155662822|NCT01126190|561861568|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
155662823|NCT01126190|561861569|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
155662824|NCT01126190|561861567|FG000|Double-Blind Phase|Non-compliance|1|||
155662825|NCT01126190|561861568|FG001|Double-Blind Phase|Non-compliance|0|||
155662826|NCT01126190|561861569|FG002|Double-Blind Phase|Non-compliance|0|||
155662827|NCT01126190|561861567|FG000|Double-Blind Phase|Lost to Follow-up|1|||
155662828|NCT01126190|561861568|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155662829|NCT01126190|561861569|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155662830|NCT01126190|561861567|FG000|Open-Label Phase|Death|0|||
155662831|NCT01126190|561861568|FG001|Open-Label Phase|Death|0|||
155662832|NCT01126190|561861569|FG002|Open-Label Phase|Death|1|||
155662833|NCT01126190|561861567|FG000|Open-Label Phase|Adverse Event|0|||
155662834|NCT01126190|561861568|FG001|Open-Label Phase|Adverse Event|0|||
155662835|NCT01126190|561861569|FG002|Open-Label Phase|Adverse Event|4|||
155662836|NCT01126190|561861567|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155662837|NCT01126190|561861568|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155662838|NCT01126190|561861569|FG002|Open-Label Phase|Withdrawal by Subject|6|||
155662839|NCT00892008|561861570|FG000|Overall Study|Death|5|||
155662840|NCT00892008|561861570|FG000|Overall Study|Lack of Efficacy|3|||
155662841|NCT00892008|561861570|FG000|Overall Study|Lost to Follow-up|142|||
155662842|NCT00892008|561861570|FG000|Overall Study|Other|378|||
155662843|NCT00892008|561861570|FG000|Overall Study|Adverse Event|37|||
155662844|NCT01466491|561861571|FG000|Overall Study|Protocol Violation|0|||
155662845|NCT01466491|561861572|FG001|Overall Study|Protocol Violation|3|||
155662846|NCT01466491|561861573|FG002|Overall Study|Protocol Violation|2|||
155662847|NCT01466491|561861574|FG003|Overall Study|Protocol Violation|0|||
155662848|NCT01466491|561861571|FG000|Overall Study|Missing Data|0|||
155662849|NCT01466491|561861572|FG001|Overall Study|Missing Data|0|||
155662850|NCT01466491|561861573|FG002|Overall Study|Missing Data|1|||
155662851|NCT01466491|561861574|FG003|Overall Study|Missing Data|0|||
155662852|NCT01496287|561861575|FG000|Overall Study|Lost to Follow-up|1|||
155662853|NCT01496287|561861575|FG000|Overall Study|Incomplete anesthesia|5|||
155662854|NCT00329030|561861576|FG000|Overall Study|Withdrawal by Subject|1|||
155662855|NCT00329030|561861577|FG001|Overall Study|Withdrawal by Subject|3|||
155662856|NCT00329030|561861576|FG000|Overall Study|Progressive Disease|6|||
155662857|NCT00329030|561861577|FG001|Overall Study|Progressive Disease|2|||
155662858|NCT00329030|561861576|FG000|Overall Study|Ineligible Pathology|1|||
155662859|NCT00329030|561861577|FG001|Overall Study|Ineligible Pathology|1|||
155662860|NCT03036852|561861578|FG000|Overall Study|Death|2|||
155662861|NCT03036852|561861578|FG000|Overall Study|Lack of Efficacy|2|||
155662862|NCT03036852|561861578|FG000|Overall Study|Adverse Event|1|||
155662863|NCT03036852|561861578|FG000|Overall Study|Lost to Follow-up|1|||
155662864|NCT03338400|561861589|FG000|Overall Study|Lost to Follow-up|1|||
155662865|NCT03338400|561861590|FG001|Overall Study|Lost to Follow-up|2|||
155662866|NCT02639390|561861592|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
155662867|NCT02639390|561861593|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
155662868|NCT01531998|561861597|FG000|Overall Study|Withdrawal by Subject|3|||
155662869|NCT02581891|561861598|FG000|Overall Study|Adverse Event|4|||
155662870|NCT02581891|561861599|FG001|Overall Study|Adverse Event|6|||
155662871|NCT02581891|561861598|FG000|Overall Study|Death|3|||
155662872|NCT02581891|561861599|FG001|Overall Study|Death|4|||
155662873|NCT02581891|561861598|FG000|Overall Study|Lost to Follow-up|1|||
155662874|NCT02581891|561861599|FG001|Overall Study|Lost to Follow-up|2|||
155662875|NCT02581891|561861598|FG000|Overall Study|Physician Decision|0|||
155662876|NCT02581891|561861599|FG001|Overall Study|Physician Decision|1|||
155662877|NCT02581891|561861598|FG000|Overall Study|Withdrawal by Subject|4|||
155662878|NCT02581891|561861599|FG001|Overall Study|Withdrawal by Subject|5|||
155662879|NCT02581891|561861598|FG000|Overall Study|Other Reasons|3|||
155662880|NCT02581891|561861599|FG001|Overall Study|Other Reasons|1|||
155662881|NCT02581891|561861598|FG000|Overall Study|Discontinued during followup|1|||
155662882|NCT02581891|561861599|FG001|Overall Study|Discontinued during followup|0|||
155662883|NCT02927795|561861600|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
155662884|NCT02927795|561861600|FG000|Overall Study|Not Treated|4|||
155662885|NCT05525910|561861602|FG000|Period 4|Per sponsor due to study timelines|0|||
155662886|NCT05525910|561861603|FG001|Period 4|Per sponsor due to study timelines|0|||
155662887|NCT05525910|561861604|FG002|Period 4|Per sponsor due to study timelines|1|||
155662888|NCT05525910|561861605|FG003|Period 4|Per sponsor due to study timelines|1|||
155662889|NCT05525910|561861606|FG004|Period 4|Per sponsor due to study timelines|1|||
155662890|NCT00181844|561861608|FG000|Signed Consent|Withdrawal by Subject|5|||
155662891|NCT00181844|561861608|FG000|Signed Consent|Did not meet entrance criteria|7|||
155662892|NCT00181844|561861608|FG000|Exposed to Study Medication|Adverse Event|10|||
155662893|NCT00181844|561861608|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
155662894|NCT00181844|561861608|FG000|Exposed to Study Medication|Non-compliance|2|||
155662895|NCT00181844|561861608|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
155662896|NCT00181844|561861608|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
155662897|NCT00107276|561861610|FG000|Overall Study|Progression|46|||
155662898|NCT00107276|561861610|FG000|Overall Study|Adverse Event|6|||
155662899|NCT00107276|561861610|FG000|Overall Study|M.D. decision|2|||
155662900|NCT00107276|561861610|FG000|Overall Study|Patient refusal|1|||
155662901|NCT00107276|561861610|FG000|Overall Study|Death|1|||
155662902|NCT00107276|561861610|FG000|Overall Study|Ineligible|16|||
155662903|NCT05209386|561861611|FG000|Overall Study|Withdrawal by Subject|8|||
155662904|NCT05209386|561861611|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
155662905|NCT03179761|561861612|FG000|Overall Study|Death|2|||
155662906|NCT03179761|561861613|FG001|Overall Study|Death|5|||
155662907|NCT03179761|561861612|FG000|Overall Study|Lost to Follow-up|2|||
155662908|NCT03179761|561861613|FG001|Overall Study|Lost to Follow-up|2|||
155662909|NCT03179761|561861612|FG000|Overall Study|Protocol Violation|1|||
155662910|NCT03179761|561861613|FG001|Overall Study|Protocol Violation|0|||
155662911|NCT03179761|561861612|FG000|Overall Study|Withdrawal by Subject|1|||
155662912|NCT03179761|561861613|FG001|Overall Study|Withdrawal by Subject|4|||
155662913|NCT03179761|561861612|FG000|Overall Study|Investigator Request|0|||
155662914|NCT03179761|561861613|FG001|Overall Study|Investigator Request|2|||
155662915|NCT03440008|561861616|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
155662916|NCT03440008|561861617|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
155662917|NCT03440008|561861616|FG000|Overall Study|Withdrawal by Subject|1|||
155662918|NCT03440008|561861617|FG001|Overall Study|Withdrawal by Subject|0|||
155662919|NCT02170064|561861618|FG000|Overall Study|Withdrawal by Subject|5|||
155662920|NCT02170064|561861619|FG001|Overall Study|Withdrawal by Subject|1|||
155662921|NCT02170064|561861620|FG002|Overall Study|Withdrawal by Subject|1|||
155662922|NCT02170064|561861618|FG000|Overall Study|Physician Decision|1|||
155662923|NCT02170064|561861619|FG001|Overall Study|Physician Decision|1|||
155662924|NCT02170064|561861620|FG002|Overall Study|Physician Decision|0|||
155662925|NCT02359903|561861621|FG000|Overall Study|Adverse Event|0|||
155662926|NCT02359903|561861622|FG001|Overall Study|Adverse Event|2|||
155662927|NCT03507127|561861630|FG000|Overall Study|Withdrawal by Subject|1|||
155662928|NCT03507127|561861631|FG001|Overall Study|Withdrawal by Subject|0|||
155579039|NCT00729937|561544991|FG003|Overall Study|Incarcerated|1|||
155579040|NCT00729937|561544992|FG004|Overall Study|Incarcerated|0|||
155579041|NCT00729937|561544993|FG005|Overall Study|Incarcerated|0|||
155579042|NCT01998841|561545002|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
155579043|NCT01998841|561545003|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
155579044|NCT01998841|561545004|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
155579045|NCT01998841|561545005|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155579046|NCT01998841|561545006|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155579047|NCT01998841|561545002|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155579048|NCT01998841|561545003|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155579049|NCT01998841|561545004|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155579050|NCT01998841|561545005|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
155579051|NCT01998841|561545006|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
155579052|NCT00972595|561545007|FG000|Period 1|Adverse Event|1|||
155579053|NCT00972595|561545008|FG001|Period 1|Adverse Event|0|||
155579054|NCT03552380|561545010|FG000|Study Treatment|Disease Progression|3|||
155579055|NCT03552380|561545011|FG001|Study Treatment|Disease Progression|4|||
155579056|NCT03552380|561545010|FG000|Study Treatment|Adverse Event|2|||
155579057|NCT03552380|561545011|FG001|Study Treatment|Adverse Event|2|||
155579058|NCT03552380|561545010|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
155579059|NCT03552380|561545011|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
155579060|NCT03552380|561545010|FG000|Follow up|Death|3|||
155579061|NCT03552380|561545011|FG001|Follow up|Death|4|||
155579062|NCT03552380|561545010|FG000|Follow up|Site IRB terminated|0|||
155579063|NCT03552380|561545011|FG001|Follow up|Site IRB terminated|1|||
155579064|NCT03447743|561545012|FG000|Overall Study|Withdrawal by Subject|2|||
155579065|NCT03447743|561545012|FG000|Overall Study|Lost to Follow-up|3|||
155579066|NCT03447743|561545012|FG000|Overall Study|Adverse Event|1|||
155579067|NCT03447743|561545012|FG000|Overall Study|Did not meet criteria to continue|1|||
155579068|NCT02461160|561545013|FG000|Overall Study|Lost to Follow-up|0|||
155579069|NCT02461160|561545014|FG001|Overall Study|Lost to Follow-up|0|||
155579070|NCT02461160|561545015|FG002|Overall Study|Lost to Follow-up|0|||
155579071|NCT02461160|561545016|FG003|Overall Study|Lost to Follow-up|0|||
155579072|NCT02461160|561545017|FG004|Overall Study|Lost to Follow-up|0|||
155579073|NCT02461160|561545018|FG005|Overall Study|Lost to Follow-up|0|||
155579074|NCT02461160|561545019|FG006|Overall Study|Lost to Follow-up|0|||
155579075|NCT02461160|561545020|FG007|Overall Study|Lost to Follow-up|1|||
155579076|NCT02461160|561545021|FG008|Overall Study|Lost to Follow-up|0|||
155579077|NCT02461160|561545022|FG009|Overall Study|Lost to Follow-up|0|||
155579078|NCT02461160|561545023|FG010|Overall Study|Lost to Follow-up|0|||
155579079|NCT02461160|561545024|FG011|Overall Study|Lost to Follow-up|0|||
155579080|NCT02461160|561545025|FG012|Overall Study|Lost to Follow-up|0|||
155579081|NCT01112059|561545026|FG000|Overall Study|Withdrawal by Subject|1|||
155579082|NCT01112059|561545027|FG001|Overall Study|Withdrawal by Subject|0|||
155579083|NCT03567980|561545030|FG000|Overall Study|Adverse Event|1|||
155579084|NCT02575833|561545033|FG000|Overall Study|Withdrawal by Subject|0|||
155579085|NCT02575833|561545034|FG001|Overall Study|Withdrawal by Subject|1|||
155579086|NCT02575833|561545033|FG000|Overall Study|Lost to Follow-up|1|||
155579087|NCT02575833|561545034|FG001|Overall Study|Lost to Follow-up|0|||
155579088|NCT00967330|561545035|FG000|Overall Study|Protocol Violation|3|||
155579089|NCT00967330|561545036|FG001|Overall Study|Protocol Violation|4|||
155579090|NCT00967330|561545035|FG000|Overall Study|Regular|10|||
155579091|NCT00967330|561545036|FG001|Overall Study|Regular|3|||
155579092|NCT00967330|561545035|FG000|Overall Study|Withdrawal by Subject|6|||
155579093|NCT00967330|561545036|FG001|Overall Study|Withdrawal by Subject|0|||
155579094|NCT00967330|561545035|FG000|Overall Study|Lost to Follow-up|1|||
155579095|NCT00967330|561545036|FG001|Overall Study|Lost to Follow-up|1|||
155579096|NCT00967330|561545035|FG000|Overall Study|Death|102|||
155579097|NCT00967330|561545036|FG001|Overall Study|Death|51|||
155579098|NCT00967330|561545035|FG000|Overall Study|Severe protocol deviation|0|||
155579099|NCT00967330|561545036|FG001|Overall Study|Severe protocol deviation|1|||
155579100|NCT02698163|561545039|FG000|Overall Study|Lost to Follow-up|0|||
155579101|NCT02698163|561545040|FG001|Overall Study|Lost to Follow-up|1|||
155579102|NCT01133067|561545041|FG000|Overall Study|Death|136|||
155579103|NCT01133067|561545041|FG000|Overall Study|Lost to Follow-up|3|||
155579104|NCT00752128|561545042|FG000|Overall Study|Withdrawal by Subject|4|||
155579105|NCT00349973|561545046|FG000|Overall Study|Adverse Event|3|||
155579106|NCT00349973|561545047|FG001|Overall Study|Adverse Event|3|||
155579107|NCT00349973|561545046|FG000|Overall Study|Withdrawal by Subject|1|||
155579108|NCT00349973|561545047|FG001|Overall Study|Withdrawal by Subject|0|||
155579109|NCT02548143|561545048|FG000|Overall Study|Adverse Event|1|||
155579110|NCT02548143|561545049|FG001|Overall Study|Adverse Event|0|||
155579111|NCT02548143|561545048|FG000|Overall Study|Withdrawal by Subject|0|||
155662929|NCT03507127|561861630|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
155662930|NCT03507127|561861631|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
155579112|NCT02548143|561545049|FG001|Overall Study|Withdrawal by Subject|1|||
155579113|NCT05620082|561545053|FG000|Overall Study|Discharged before study end|1|||
155579114|NCT05620082|561545054|FG001|Overall Study|Discharged before study end|4|||
155579115|NCT05620082|561545055|FG002|Overall Study|Discharged before study end|0|||
155579116|NCT05620082|561545053|FG000|Overall Study|Moved to a different ward|1|||
155579117|NCT05620082|561545054|FG001|Overall Study|Moved to a different ward|0|||
155579118|NCT05620082|561545055|FG002|Overall Study|Moved to a different ward|0|||
155579119|NCT05620082|561545053|FG000|Overall Study|Feeling too unwell|1|||
155579120|NCT05620082|561545054|FG001|Overall Study|Feeling too unwell|0|||
155579121|NCT05620082|561545055|FG002|Overall Study|Feeling too unwell|0|||
155579122|NCT00625820|561545060|FG000|Overall Study|Withdrawal by Subject|1|||
155579123|NCT05201794|561547009|FG000|Overall Study|Withdrawal by Subject|13|||
155579124|NCT05201794|561547010|FG001|Overall Study|Withdrawal by Subject|12|||
155579125|NCT05201794|561547011|FG002|Overall Study|Withdrawal by Subject|14|||
155579126|NCT05201794|561547012|FG003|Overall Study|Withdrawal by Subject|0|||
155579127|NCT05201794|561547009|FG000|Overall Study|Adverse Event|5|||
155579128|NCT05201794|561547010|FG001|Overall Study|Adverse Event|5|||
155579129|NCT05201794|561547011|FG002|Overall Study|Adverse Event|4|||
155579130|NCT05201794|561547012|FG003|Overall Study|Adverse Event|0|||
155579131|NCT05201794|561547009|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
155579132|NCT05201794|561547010|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155579133|NCT05201794|561547011|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
155579134|NCT05201794|561547012|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155579135|NCT05201794|561547009|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155579136|NCT05201794|561547010|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155579137|NCT05201794|561547011|FG002|Overall Study|Non-Compliance With Study Drug|3|||
155579138|NCT05201794|561547012|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155579139|NCT05201794|561547009|FG000|Overall Study|Physician Decision|1|||
155579140|NCT05201794|561547010|FG001|Overall Study|Physician Decision|3|||
155579141|NCT05201794|561547011|FG002|Overall Study|Physician Decision|2|||
155579142|NCT05201794|561547012|FG003|Overall Study|Physician Decision|0|||
155579143|NCT05201794|561547009|FG000|Overall Study|Lost to Follow-up|2|||
155579144|NCT05201794|561547010|FG001|Overall Study|Lost to Follow-up|2|||
155579145|NCT05201794|561547011|FG002|Overall Study|Lost to Follow-up|0|||
155579146|NCT05201794|561547012|FG003|Overall Study|Lost to Follow-up|0|||
155579147|NCT05201794|561547009|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
155579148|NCT05201794|561547010|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
155579149|NCT05201794|561547011|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
155579150|NCT05201794|561547012|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
155579151|NCT05201794|561547009|FG000|Overall Study|Protocol Violation|2|||
155579152|NCT05201794|561547010|FG001|Overall Study|Protocol Violation|0|||
155579153|NCT05201794|561547011|FG002|Overall Study|Protocol Violation|1|||
155579154|NCT05201794|561547012|FG003|Overall Study|Protocol Violation|0|||
155579155|NCT05201794|561547009|FG000|Overall Study|Death|1|||
155579156|NCT05201794|561547010|FG001|Overall Study|Death|0|||
155579157|NCT05201794|561547011|FG002|Overall Study|Death|0|||
155579158|NCT05201794|561547012|FG003|Overall Study|Death|0|||
155579159|NCT05201794|561547009|FG000|Overall Study|Site Terminated By Sponsor|0|||
155579160|NCT05201794|561547010|FG001|Overall Study|Site Terminated By Sponsor|1|||
155579161|NCT05201794|561547011|FG002|Overall Study|Site Terminated By Sponsor|0|||
155579162|NCT05201794|561547012|FG003|Overall Study|Site Terminated By Sponsor|0|||
155579163|NCT05201794|561547009|FG000|Overall Study|Other|3|||
155579164|NCT05201794|561547010|FG001|Overall Study|Other|3|||
155579165|NCT05201794|561547011|FG002|Overall Study|Other|3|||
155579166|NCT05201794|561547012|FG003|Overall Study|Other|0|||
155579167|NCT05201794|561547009|FG000|Overall Study|Randomized But Not Treated|1|||
155579168|NCT05201794|561547010|FG001|Overall Study|Randomized But Not Treated|2|||
155579169|NCT05201794|561547011|FG002|Overall Study|Randomized But Not Treated|1|||
155579170|NCT05201794|561547012|FG003|Overall Study|Randomized But Not Treated|0|||
155579171|NCT01490086|561547013|FG000|Overall Study|Consent withdrawn|4|||
155579172|NCT01490086|561547014|FG001|Overall Study|Consent withdrawn|4|||
155579173|NCT01490086|561547015|FG002|Overall Study|Consent withdrawn|3|||
155579174|NCT01490086|561547016|FG003|Overall Study|Consent withdrawn|0|||
155579175|NCT01490086|561547017|FG004|Overall Study|Consent withdrawn|1|||
155579176|NCT01490086|561547013|FG000|Overall Study|Non-compliance|0|||
155579177|NCT01490086|561547014|FG001|Overall Study|Non-compliance|1|||
155662931|NCT01240863|561861632|FG000|Open-label Titration Period|Adverse Event|47|||
155662932|NCT01240863|561861633|FG001|Open-label Titration Period|Adverse Event|0|||
155662933|NCT01240863|561861634|FG002|Open-label Titration Period|Adverse Event|0|||
155662934|NCT01240863|561861632|FG000|Open-label Titration Period|Lack of Efficacy|19|||
155662935|NCT01240863|561861633|FG001|Open-label Titration Period|Lack of Efficacy|0|||
155579178|NCT01490086|561547015|FG002|Overall Study|Non-compliance|0|||
155579179|NCT01490086|561547016|FG003|Overall Study|Non-compliance|0|||
155579180|NCT01490086|561547017|FG004|Overall Study|Non-compliance|0|||
155579181|NCT01490086|561547013|FG000|Overall Study|Abnormal laboratory findings|1|||
155662936|NCT01240863|561861634|FG002|Open-label Titration Period|Lack of Efficacy|0|||
155662937|NCT01240863|561861632|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
155662938|NCT01240863|561861633|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
155579182|NCT01490086|561547014|FG001|Overall Study|Abnormal laboratory findings|0|||
155579183|NCT01490086|561547015|FG002|Overall Study|Abnormal laboratory findings|0|||
155579184|NCT01490086|561547016|FG003|Overall Study|Abnormal laboratory findings|0|||
155579185|NCT01490086|561547017|FG004|Overall Study|Abnormal laboratory findings|0|||
155579186|NCT01490086|561547013|FG000|Overall Study|Lost to Follow-up|0|||
155579187|NCT01490086|561547014|FG001|Overall Study|Lost to Follow-up|0|||
155579188|NCT01490086|561547015|FG002|Overall Study|Lost to Follow-up|0|||
155579189|NCT01490086|561547016|FG003|Overall Study|Lost to Follow-up|0|||
155579190|NCT01490086|561547017|FG004|Overall Study|Lost to Follow-up|1|||
155579191|NCT01490086|561547013|FG000|Overall Study|Physician Decision|3|||
155579192|NCT01490086|561547014|FG001|Overall Study|Physician Decision|4|||
155579193|NCT01490086|561547015|FG002|Overall Study|Physician Decision|2|||
155579194|NCT01490086|561547016|FG003|Overall Study|Physician Decision|3|||
155579195|NCT01490086|561547017|FG004|Overall Study|Physician Decision|1|||
155579196|NCT01490086|561547013|FG000|Overall Study|Adverse Event|0|||
155579197|NCT01490086|561547014|FG001|Overall Study|Adverse Event|0|||
155579198|NCT01490086|561547015|FG002|Overall Study|Adverse Event|1|||
155579199|NCT01490086|561547016|FG003|Overall Study|Adverse Event|2|||
155579200|NCT01490086|561547017|FG004|Overall Study|Adverse Event|0|||
155579201|NCT01490086|561547013|FG000|Overall Study|Lack of Efficacy|0|||
155579202|NCT01490086|561547014|FG001|Overall Study|Lack of Efficacy|3|||
155579203|NCT01490086|561547015|FG002|Overall Study|Lack of Efficacy|1|||
155579204|NCT01490086|561547016|FG003|Overall Study|Lack of Efficacy|0|||
155579205|NCT01490086|561547017|FG004|Overall Study|Lack of Efficacy|8|||
155579206|NCT01490086|561547013|FG000|Overall Study|Worsening of symptoms|0|||
155579207|NCT01490086|561547014|FG001|Overall Study|Worsening of symptoms|1|||
155579208|NCT01490086|561547015|FG002|Overall Study|Worsening of symptoms|0|||
155579209|NCT01490086|561547016|FG003|Overall Study|Worsening of symptoms|1|||
155579210|NCT01490086|561547017|FG004|Overall Study|Worsening of symptoms|0|||
155579211|NCT01490086|561547013|FG000|Overall Study|Subject uncontrollable and abusive|0|||
155579212|NCT01490086|561547014|FG001|Overall Study|Subject uncontrollable and abusive|1|||
155579213|NCT01490086|561547015|FG002|Overall Study|Subject uncontrollable and abusive|0|||
155579214|NCT01490086|561547016|FG003|Overall Study|Subject uncontrollable and abusive|0|||
155579215|NCT01490086|561547017|FG004|Overall Study|Subject uncontrollable and abusive|0|||
155579216|NCT01490086|561547013|FG000|Overall Study|Subject left hospital|0|||
155579217|NCT01490086|561547014|FG001|Overall Study|Subject left hospital|1|||
155579218|NCT01490086|561547015|FG002|Overall Study|Subject left hospital|0|||
155579219|NCT01490086|561547016|FG003|Overall Study|Subject left hospital|1|||
155579220|NCT01490086|561547017|FG004|Overall Study|Subject left hospital|0|||
155579221|NCT04510090|561547020|FG000|FE-HS|Withdrawal by Subject|0|||
155579222|NCT04510090|561547021|FG001|FE-HS|Withdrawal by Subject|0|||
155579223|NCT04510090|561547022|FG002|FE-HS|Withdrawal by Subject|0|||
155579224|NCT04510090|561547023|FG003|FE-HS|Withdrawal by Subject|0|||
155579225|NCT04510090|561547024|FG004|FE-HS|Withdrawal by Subject|1|||
155579226|NCT04510090|561547025|FG005|FE-HS|Withdrawal by Subject|0|||
155579227|NCT04510090|561547026|FG006|FE-HS|Withdrawal by Subject|0|||
155579228|NCT04510090|561547027|FG007|FE-HS|Withdrawal by Subject|0|||
155579229|NCT05825404|561547028|FG000|First Intervention (Weeks 2-5)|Death|0|||
155579230|NCT05825404|561547029|FG001|First Intervention (Weeks 2-5)|Death|1|||
155579231|NCT05825404|561547028|FG000|Second Intervention (Weeks 8-11)|Death|0|||
155579232|NCT05825404|561547029|FG001|Second Intervention (Weeks 8-11)|Death|1|||
155579233|NCT01127256|561547030|FG000|Overall Study|Adverse Event|13|||
155579234|NCT01127256|561547031|FG001|Overall Study|Adverse Event|13|||
155579235|NCT01127256|561547030|FG000|Overall Study|Lack of Efficacy|4|||
155579236|NCT01127256|561547031|FG001|Overall Study|Lack of Efficacy|0|||
155579237|NCT01127256|561547030|FG000|Overall Study|Lost to Follow-up|16|||
155579238|NCT01127256|561547031|FG001|Overall Study|Lost to Follow-up|17|||
155579239|NCT01127256|561547030|FG000|Overall Study|Withdrawal by Subject|5|||
155579240|NCT01127256|561547031|FG001|Overall Study|Withdrawal by Subject|9|||
155579241|NCT01127256|561547030|FG000|Overall Study|Protocol Violation|1|||
155579242|NCT01127256|561547031|FG001|Overall Study|Protocol Violation|0|||
155579243|NCT01749826|561547032|FG000|Overall Study|Study Terminated|20|||
155579244|NCT01749826|561547033|FG001|Overall Study|Study Terminated|0|||
155579245|NCT00679211|561547034|FG000|Overall Study|Progressive disease|82|||
155579246|NCT00679211|561547034|FG000|Overall Study|Adverse Event|7|||
155579247|NCT00679211|561547034|FG000|Overall Study|Withdrawal by Subject|2|||
155579248|NCT00679211|561547034|FG000|Overall Study|Physician Decision|5|||
155579249|NCT00679211|561547034|FG000|Overall Study|Refused to undergo protocol procedures|1|||
155579250|NCT00679211|561547034|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
155579251|NCT00679211|561547034|FG000|Overall Study|Other|1|||
155579252|NCT00931528|561547035|FG000|Overall Study|Protocol Violation|9|||
155579253|NCT00931528|561547036|FG001|Overall Study|Protocol Violation|12|||
155579254|NCT00931528|561547035|FG000|Overall Study|Withdrawal by Subject|4|||
155579255|NCT00931528|561547036|FG001|Overall Study|Withdrawal by Subject|12|||
155579256|NCT00931528|561547035|FG000|Overall Study|Lost to Follow-up|6|||
155579257|NCT00931528|561547036|FG001|Overall Study|Lost to Follow-up|13|||
155579258|NCT00931528|561547035|FG000|Overall Study|Assessment outside of Time Frame|22|||
155579259|NCT00931528|561547036|FG001|Overall Study|Assessment outside of Time Frame|23|||
155579260|NCT01470248|561547037|FG000|Overall Study|Withdrawal by Subject|1|||
155579261|NCT05085834|561547038|FG000|Overall Study|Lost to Follow-up|9|||
155579262|NCT05085834|561547039|FG001|Overall Study|Lost to Follow-up|2|||
155579263|NCT05085834|561547038|FG000|Overall Study|Adverse Event|6|||
155579264|NCT05085834|561547039|FG001|Overall Study|Adverse Event|0|||
155579265|NCT05085834|561547038|FG000|Overall Study|Death|1|||
155579266|NCT05085834|561547039|FG001|Overall Study|Death|0|||
155579267|NCT05085834|561547038|FG000|Overall Study|Inability to swallow the pill|0|||
155579268|NCT05085834|561547039|FG001|Overall Study|Inability to swallow the pill|1|||
155579269|NCT05842967|561547042|FG000|Period 1: SSA|Adverse Event|1|||
155579270|NCT05842967|561547043|FG001|Period 1: SSA|Adverse Event|1|||
155579271|NCT05842967|561547044|FG002|Period 1: SSA|Adverse Event|0|||
155579272|NCT05842967|561547045|FG003|Period 1: SSA|Adverse Event|0|||
155579273|NCT05842967|561547042|FG000|Period 1: SSA|Death|1|||
155579274|NCT05842967|561547043|FG001|Period 1: SSA|Death|0|||
155579275|NCT05842967|561547044|FG002|Period 1: SSA|Death|0|||
155579276|NCT05842967|561547045|FG003|Period 1: SSA|Death|0|||
155579277|NCT05842967|561547042|FG000|Period 1: SSA|Lost to Follow-up|16|||
155579278|NCT05842967|561547043|FG001|Period 1: SSA|Lost to Follow-up|4|||
155579279|NCT05842967|561547044|FG002|Period 1: SSA|Lost to Follow-up|0|||
155579280|NCT05842967|561547045|FG003|Period 1: SSA|Lost to Follow-up|0|||
155579281|NCT05842967|561547042|FG000|Period 1: SSA|Physician Decision|1|||
155579282|NCT05842967|561547043|FG001|Period 1: SSA|Physician Decision|0|||
155579283|NCT05842967|561547044|FG002|Period 1: SSA|Physician Decision|0|||
155579284|NCT05842967|561547045|FG003|Period 1: SSA|Physician Decision|0|||
155579285|NCT05842967|561547042|FG000|Period 1: SSA|Withdrawal by Subject|2|||
155579286|NCT05842967|561547043|FG001|Period 1: SSA|Withdrawal by Subject|2|||
155579287|NCT05842967|561547044|FG002|Period 1: SSA|Withdrawal by Subject|0|||
155579288|NCT05842967|561547045|FG003|Period 1: SSA|Withdrawal by Subject|0|||
155579289|NCT05842967|561547042|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
155579290|NCT05842967|561547043|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
155579291|NCT05842967|561547044|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
155579292|NCT05842967|561547045|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
155579293|NCT05842967|561547042|FG000|Period 2: SSB|Adverse Event|0|||
155579294|NCT05842967|561547043|FG001|Period 2: SSB|Adverse Event|0|||
155662939|NCT01240863|561861634|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
155579295|NCT05842967|561547044|FG002|Period 2: SSB|Adverse Event|2|||
155579296|NCT05842967|561547045|FG003|Period 2: SSB|Adverse Event|0|||
155579297|NCT05842967|561547042|FG000|Period 2: SSB|Lost to Follow-up|0|||
155579298|NCT05842967|561547043|FG001|Period 2: SSB|Lost to Follow-up|0|||
155579299|NCT05842967|561547044|FG002|Period 2: SSB|Lost to Follow-up|4|||
155579300|NCT05842967|561547045|FG003|Period 2: SSB|Lost to Follow-up|3|||
155579301|NCT05842967|561547042|FG000|Period 2: SSB|Withdrawal by Subject|0|||
155579302|NCT05842967|561547043|FG001|Period 2: SSB|Withdrawal by Subject|0|||
155579303|NCT05842967|561547044|FG002|Period 2: SSB|Withdrawal by Subject|1|||
155662940|NCT01240863|561861632|FG000|Open-label Titration Period|Protocol Violation|7|||
155662941|NCT01240863|561861633|FG001|Open-label Titration Period|Protocol Violation|0|||
155662942|NCT01240863|561861634|FG002|Open-label Titration Period|Protocol Violation|0|||
155662943|NCT01240863|561861632|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
155662944|NCT01240863|561861633|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
155662945|NCT01240863|561861634|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
155662946|NCT01240863|561861632|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
155662947|NCT01240863|561861633|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
155662948|NCT01240863|561861634|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
155662949|NCT01240863|561861632|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
155662950|NCT01240863|561861633|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
155662951|NCT01240863|561861634|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
155662952|NCT01240863|561861632|FG000|Open-label Titration Period|Other|7|||
155662953|NCT01240863|561861633|FG001|Open-label Titration Period|Other|0|||
155662954|NCT01240863|561861634|FG002|Open-label Titration Period|Other|0|||
155662955|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
155662956|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
155662957|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
155662958|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155662959|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
155662960|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
155662961|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155662962|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155662963|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155662964|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155662965|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
155662966|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
155662967|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
155662968|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
155662969|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
155662970|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
155662971|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
155662972|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
155662973|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
155662974|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
155662975|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
155662976|NCT01240863|561861632|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
155662977|NCT01240863|561861633|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
155662978|NCT01240863|561861634|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
155662979|NCT00746811|561861637|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
155662980|NCT00746811|561861638|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
155662981|NCT02604511|561861639|FG000|Overall Study|Adverse Event|3|||
155662982|NCT02604511|561861639|FG000|Overall Study|Disease Progression|4|||
155662983|NCT02604511|561861639|FG000|Overall Study|Withdrawal by Subject|3|||
155662984|NCT02604511|561861639|FG000|Overall Study|Participant ineligible|1|||
155662985|NCT02604511|561861639|FG000|Overall Study|Intercurrent illness|1|||
155662986|NCT00545779|561861645|FG000|Overall Study|Violation of selection criteria at entry|8|||
155662987|NCT00545779|561861645|FG000|Overall Study|Other protocol violation|1|||
155662988|NCT00545779|561861645|FG000|Overall Study|Did not cooperate|7|||
155662989|NCT00545779|561861645|FG000|Overall Study|Withdrawal by Subject|20|||
155662990|NCT00545779|561861645|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
155662991|NCT00545779|561861645|FG000|Overall Study|Failure to return|3|||
155662992|NCT01405196|561861646|FG000|Overall Study|Study Terminated by Sponsor|0|||
155662993|NCT01405196|561861647|FG001|Overall Study|Study Terminated by Sponsor|0|||
155662994|NCT01405196|561861648|FG002|Overall Study|Study Terminated by Sponsor|9|||
155662995|NCT01405196|561861649|FG003|Overall Study|Study Terminated by Sponsor|0|||
155662996|NCT01405196|561861646|FG000|Overall Study|Other|2|||
155662997|NCT01405196|561861647|FG001|Overall Study|Other|2|||
155579304|NCT05842967|561547045|FG003|Period 2: SSB|Withdrawal by Subject|0|||
155579305|NCT05842967|561547042|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
155579306|NCT05842967|561547043|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
155579307|NCT05842967|561547044|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
155579308|NCT05842967|561547045|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
155579309|NCT05842967|561547042|FG000|Period 2: SSB|Protocol Violation|0|||
155579310|NCT05842967|561547043|FG001|Period 2: SSB|Protocol Violation|0|||
155579311|NCT05842967|561547044|FG002|Period 2: SSB|Protocol Violation|0|||
155579312|NCT05842967|561547045|FG003|Period 2: SSB|Protocol Violation|1|||
155579313|NCT01402570|561547055|FG000|Overall Study|Adverse Event|1|||
155579314|NCT03642262|561547056|FG000|Period 1|Withdrawal by Subject|1|||
155579315|NCT03642262|561547057|FG001|Period 1|Withdrawal by Subject|1|||
155579316|NCT03642262|561547056|FG000|Period 1|Adverse Event|0|||
155579317|NCT03642262|561547057|FG001|Period 1|Adverse Event|1|||
155579318|NCT01173523|561547058|FG000|Overall Study|Clinical Progression|1|||
155579319|NCT01173523|561547059|FG001|Overall Study|Clinical Progression|1|||
155579320|NCT01173523|561547058|FG000|Overall Study|Progressive Disease|10|||
155579321|NCT01173523|561547059|FG001|Overall Study|Progressive Disease|8|||
155579322|NCT01173523|561547058|FG000|Overall Study|Other|2|||
155579323|NCT01173523|561547059|FG001|Overall Study|Other|3|||
155579324|NCT02302833|561547066|FG000|Overall Study|Lost to Follow-up|3|||
155579325|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
155579326|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
155579327|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155579328|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155579329|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155579330|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155579331|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
155579332|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
155579333|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
155579334|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
155579335|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
155579336|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
155579337|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
155579338|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
155579339|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
155579340|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155579341|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155579342|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155579343|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
155579344|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
155579345|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
155579346|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155579347|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155579348|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155579349|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
155579350|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
155579351|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
155579352|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155579353|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155579354|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155579355|NCT04429503|561547067|FG000|Main Study (Up to Wk 96)|Death|9|||
155579356|NCT04429503|561547068|FG001|Main Study (Up to Wk 96)|Death|18|||
155579357|NCT04429503|561547069|FG002|Main Study (Up to Wk 96)|Death|5|||
155579358|NCT04429503|561547070|FG003|Main Study (Up to Wk 96)|Death|0|||
155579359|NCT04429503|561547071|FG004|Main Study (Up to Wk 96)|Death|0|||
155579360|NCT04429503|561547072|FG005|Main Study (Up to Wk 96)|Death|0|||
155579361|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155579362|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155579363|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155579364|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
155579365|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155579366|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155579367|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155579368|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155579369|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155579370|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155662998|NCT01405196|561861648|FG002|Overall Study|Other|5|||
155662999|NCT01405196|561861649|FG003|Overall Study|Other|0|||
155663000|NCT01405196|561861646|FG000|Overall Study|Withdrawal by Subject|4|||
155663001|NCT01405196|561861647|FG001|Overall Study|Withdrawal by Subject|6|||
155663002|NCT01405196|561861648|FG002|Overall Study|Withdrawal by Subject|3|||
155663003|NCT01405196|561861649|FG003|Overall Study|Withdrawal by Subject|6|||
155663004|NCT01405196|561861646|FG000|Overall Study|Adverse Event|2|||
155663005|NCT01405196|561861647|FG001|Overall Study|Adverse Event|2|||
155663006|NCT01405196|561861648|FG002|Overall Study|Adverse Event|0|||
155663007|NCT01405196|561861649|FG003|Overall Study|Adverse Event|2|||
155663008|NCT01405196|561861646|FG000|Overall Study|Death|1|||
155663009|NCT01405196|561861647|FG001|Overall Study|Death|0|||
155663010|NCT01405196|561861648|FG002|Overall Study|Death|3|||
155663011|NCT01405196|561861649|FG003|Overall Study|Death|0|||
155663012|NCT01405196|561861646|FG000|Overall Study|Lost to Follow-up|2|||
155663013|NCT01405196|561861647|FG001|Overall Study|Lost to Follow-up|2|||
155663014|NCT01405196|561861648|FG002|Overall Study|Lost to Follow-up|3|||
155663015|NCT01405196|561861649|FG003|Overall Study|Lost to Follow-up|1|||
155663016|NCT01542788|561861650|FG000|Overall Study|Randomized but Not Treated|2|||
155663017|NCT01542788|561861651|FG001|Overall Study|Randomized but Not Treated|0|||
155663018|NCT01542788|561861650|FG000|Overall Study|Lack of Efficacy|41|||
155663019|NCT01542788|561861651|FG001|Overall Study|Lack of Efficacy|71|||
155663020|NCT01542788|561861650|FG000|Overall Study|Lost to Follow-up|5|||
155663021|NCT01542788|561861651|FG001|Overall Study|Lost to Follow-up|0|||
155663022|NCT01542788|561861650|FG000|Overall Study|Death|3|||
155663023|NCT01542788|561861651|FG001|Overall Study|Death|0|||
155663024|NCT01542788|561861650|FG000|Overall Study|Protocol Violation|2|||
155663025|NCT01542788|561861651|FG001|Overall Study|Protocol Violation|0|||
155663026|NCT01542788|561861650|FG000|Overall Study|Physician Decision|1|||
155663027|NCT01542788|561861651|FG001|Overall Study|Physician Decision|0|||
155663028|NCT01542788|561861650|FG000|Overall Study|Withdrawal by Subject|1|||
155663029|NCT01542788|561861651|FG001|Overall Study|Withdrawal by Subject|0|||
155663030|NCT03802396|561861652|FG000|Overall Study|Withdrawal by Subject|2|||
155663031|NCT03802396|561861653|FG001|Overall Study|Withdrawal by Subject|0|||
155663032|NCT03802396|561861652|FG000|Overall Study|Surgery Cancelled|1|||
155663033|NCT03802396|561861653|FG001|Overall Study|Surgery Cancelled|0|||
155663040|NCT02561962|561861655|FG000|Overall Study|Withdrawal by Subject|1|||
155663041|NCT02561962|561861656|FG001|Overall Study|Withdrawal by Subject|0|||
155663042|NCT02561962|561861657|FG002|Overall Study|Withdrawal by Subject|0|||
155663043|NCT02561962|561861658|FG003|Overall Study|Withdrawal by Subject|0|||
155663044|NCT02561962|561861659|FG004|Overall Study|Withdrawal by Subject|1|||
155663045|NCT02561962|561861660|FG005|Overall Study|Withdrawal by Subject|1|||
155663046|NCT02561962|561861661|FG006|Overall Study|Withdrawal by Subject|2|||
155663047|NCT02561962|561861662|FG007|Overall Study|Withdrawal by Subject|1|||
155663048|NCT02561962|561861663|FG008|Overall Study|Withdrawal by Subject|0|||
155663049|NCT02561962|561861655|FG000|Overall Study|Decision by sponsor|0|||
155663050|NCT02561962|561861656|FG001|Overall Study|Decision by sponsor|0|||
155663051|NCT02561962|561861657|FG002|Overall Study|Decision by sponsor|0|||
155663052|NCT02561962|561861658|FG003|Overall Study|Decision by sponsor|0|||
155663053|NCT02561962|561861659|FG004|Overall Study|Decision by sponsor|1|||
155663054|NCT02561962|561861660|FG005|Overall Study|Decision by sponsor|1|||
155663055|NCT02561962|561861661|FG006|Overall Study|Decision by sponsor|0|||
155663056|NCT02561962|561861662|FG007|Overall Study|Decision by sponsor|3|||
155663057|NCT02561962|561861663|FG008|Overall Study|Decision by sponsor|0|||
155663058|NCT02561962|561861655|FG000|Overall Study|Lost to Follow-up|0|||
155663059|NCT02561962|561861656|FG001|Overall Study|Lost to Follow-up|0|||
155663060|NCT02561962|561861657|FG002|Overall Study|Lost to Follow-up|0|||
155663061|NCT02561962|561861658|FG003|Overall Study|Lost to Follow-up|0|||
155663062|NCT02561962|561861659|FG004|Overall Study|Lost to Follow-up|0|||
155663063|NCT02561962|561861660|FG005|Overall Study|Lost to Follow-up|1|||
155663064|NCT02561962|561861661|FG006|Overall Study|Lost to Follow-up|0|||
155663065|NCT02561962|561861662|FG007|Overall Study|Lost to Follow-up|0|||
155663066|NCT02561962|561861663|FG008|Overall Study|Lost to Follow-up|0|||
155663067|NCT03586973|561861664|FG000|Overall Study|Death|15|||
155663068|NCT03586973|561861665|FG001|Overall Study|Death|8|||
155663069|NCT03586973|561861664|FG000|Overall Study|Site Terminated by Sponsor|3|||
155663070|NCT03586973|561861665|FG001|Overall Study|Site Terminated by Sponsor|6|||
155663071|NCT03586973|561861664|FG000|Overall Study|Withdrawal by Subject|1|||
155663072|NCT03586973|561861665|FG001|Overall Study|Withdrawal by Subject|0|||
155663073|NCT03586973|561861664|FG000|Overall Study|Lost to Follow-up|1|||
155663074|NCT03586973|561861665|FG001|Overall Study|Lost to Follow-up|0|||
155663075|NCT01150357|561861671|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
155663076|NCT01150357|561861672|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
155663077|NCT01150357|561861673|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
155663078|NCT01150357|561861671|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
155663079|NCT01150357|561861672|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
155663080|NCT01150357|561861673|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
155663081|NCT01150357|561861671|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
155663082|NCT01150357|561861672|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
155663083|NCT01150357|561861673|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
155663084|NCT01150357|561861671|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
155663085|NCT01150357|561861672|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
155663086|NCT01150357|561861673|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
155663087|NCT01150357|561861671|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
155663088|NCT01150357|561861672|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
155663089|NCT01150357|561861673|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
155663090|NCT01150357|561861671|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
155663091|NCT01150357|561861672|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
155663092|NCT01150357|561861673|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
155663093|NCT01150357|561861671|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
155663094|NCT01150357|561861672|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
155663095|NCT01150357|561861673|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
155663096|NCT00652743|561863341|FG000|Months 12-18|Lost to Follow-up|1|||
155663097|NCT00652743|561863342|FG001|Months 12-18|Lost to Follow-up|2|||
155663098|NCT00652743|561863343|FG002|Months 12-18|Lost to Follow-up|7|||
155663099|NCT00652743|561863341|FG000|Months 24-30|Other|5|||
155663100|NCT00652743|561863342|FG001|Months 24-30|Other|1|||
155663101|NCT00652743|561863343|FG002|Months 24-30|Other|11|||
155663102|NCT00652743|561863341|FG000|Months 36-42|Serious Adverse Events|0|||
155663103|NCT00652743|561863342|FG001|Months 36-42|Serious Adverse Events|1|||
155663104|NCT00652743|561863343|FG002|Months 36-42|Serious Adverse Events|1|||
155663105|NCT00652743|561863341|FG000|Months 36-42|Withdrawal by Subject|1|||
155663106|NCT00652743|561863342|FG001|Months 36-42|Withdrawal by Subject|1|||
155663107|NCT00652743|561863343|FG002|Months 36-42|Withdrawal by Subject|0|||
155663108|NCT00652743|561863341|FG000|Months 36-42|Lost to Follow-up|0|||
155663109|NCT00652743|561863342|FG001|Months 36-42|Lost to Follow-up|1|||
155663110|NCT00652743|561863343|FG002|Months 36-42|Lost to Follow-up|0|||
155663111|NCT00652743|561863341|FG000|Months 36-42|Migrated/moved from study area|1|||
155663112|NCT00652743|561863342|FG001|Months 36-42|Migrated/moved from study area|0|||
155663113|NCT00652743|561863343|FG002|Months 36-42|Migrated/moved from study area|0|||
155663114|NCT00652743|561863341|FG000|Months 36-42|Other|4|||
155663115|NCT00652743|561863342|FG001|Months 36-42|Other|2|||
155663116|NCT00652743|561863343|FG002|Months 36-42|Other|8|||
155663117|NCT01585025|561863348|FG000|Overall Study|Withdrawal by Subject|0|||
155663118|NCT01585025|561863349|FG001|Overall Study|Withdrawal by Subject|3|||
155663119|NCT01585025|561863350|FG002|Overall Study|Withdrawal by Subject|4|||
155663120|NCT00503984|561863351|FG000|Overall Study|Protocol Violation|0|||
155663121|NCT00503984|561863352|FG001|Overall Study|Protocol Violation|1|||
155663122|NCT00503984|561863353|FG002|Overall Study|Protocol Violation|0|||
155663123|NCT00503984|561863354|FG003|Overall Study|Protocol Violation|0|||
155663124|NCT00503984|561863355|FG004|Overall Study|Protocol Violation|0|||
155663125|NCT00503984|561863356|FG005|Overall Study|Protocol Violation|0|||
155663126|NCT00503984|561863351|FG000|Overall Study|Adverse Event|0|||
155663127|NCT00503984|561863352|FG001|Overall Study|Adverse Event|1|||
155663128|NCT00503984|561863353|FG002|Overall Study|Adverse Event|0|||
155663129|NCT00503984|561863354|FG003|Overall Study|Adverse Event|0|||
155663130|NCT00503984|561863355|FG004|Overall Study|Adverse Event|0|||
155663131|NCT00503984|561863356|FG005|Overall Study|Adverse Event|0|||
155663132|NCT00503984|561863351|FG000|Overall Study|Death|0|||
155663133|NCT00503984|561863352|FG001|Overall Study|Death|0|||
155663134|NCT00503984|561863353|FG002|Overall Study|Death|0|||
155663135|NCT00503984|561863354|FG003|Overall Study|Death|0|||
155663136|NCT00503984|561863355|FG004|Overall Study|Death|1|||
155663137|NCT00503984|561863356|FG005|Overall Study|Death|0|||
155663138|NCT00952705|561863359|FG000|Overall Study|Lost to Follow-up|24|||
155663139|NCT00952705|561863360|FG001|Overall Study|Lost to Follow-up|8|||
155663140|NCT00952705|561863361|FG002|Overall Study|Lost to Follow-up|9|||
155663141|NCT00952705|561863359|FG000|Overall Study|Withdrawal by Subject|2|||
155663142|NCT00952705|561863360|FG001|Overall Study|Withdrawal by Subject|1|||
155663143|NCT00952705|561863361|FG002|Overall Study|Withdrawal by Subject|1|||
155663144|NCT00952705|561863359|FG000|Overall Study|Death|2|||
155663145|NCT00952705|561863360|FG001|Overall Study|Death|0|||
155579371|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155579372|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155579373|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155579374|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155579375|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155579376|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155579377|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
155579378|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
155579379|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155579380|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155579381|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155579382|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
155579383|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
155579384|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
155579385|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155579386|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155579387|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155579388|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
155579389|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
155579390|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
155579391|NCT04429503|561547067|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155579392|NCT04429503|561547068|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155579393|NCT04429503|561547069|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155579394|NCT04429503|561547070|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
155579395|NCT04429503|561547071|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
155579396|NCT04429503|561547072|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
155579397|NCT05516108|561547073|FG000|Overall Study|Time Commitment|3|||
155579398|NCT05516108|561547074|FG001|Overall Study|Time Commitment|1|||
155579399|NCT05516108|561547073|FG000|Overall Study|Reason Unknown|2|||
155579400|NCT05516108|561547074|FG001|Overall Study|Reason Unknown|4|||
155579401|NCT02717507|561547075|FG000|Overall Study|Lost to Follow-up|5|||
155579402|NCT02717507|561547076|FG001|Overall Study|Lost to Follow-up|8|||
155579403|NCT02717507|561547075|FG000|Overall Study|Pregnancy|1|||
155579404|NCT02717507|561547076|FG001|Overall Study|Pregnancy|1|||
155579405|NCT02717507|561547075|FG000|Overall Study|Protocol Violation|2|||
155579406|NCT02717507|561547076|FG001|Overall Study|Protocol Violation|2|||
155579407|NCT02717507|561547075|FG000|Overall Study|Withdrawal by Subject|20|||
155579408|NCT02717507|561547076|FG001|Overall Study|Withdrawal by Subject|20|||
155579409|NCT02717507|561547075|FG000|Overall Study|Relapse|1|||
155579410|NCT02717507|561547076|FG001|Overall Study|Relapse|1|||
155579411|NCT02717507|561547075|FG000|Overall Study|Cardiac Event|2|||
155579412|NCT02717507|561547076|FG001|Overall Study|Cardiac Event|6|||
155579413|NCT05017246|561547077|FG000|Overall Study|Withdrawal by Subject|5|||
155579414|NCT05017246|561547078|FG001|Overall Study|Withdrawal by Subject|3|||
155579415|NCT05017246|561547077|FG000|Overall Study|Determined to be ineligible|0|||
155579416|NCT05017246|561547078|FG001|Overall Study|Determined to be ineligible|1|||
155579417|NCT05017246|561547077|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
155579418|NCT05017246|561547078|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
155579419|NCT05017246|561547077|FG000|Overall Study|Technical failure|1|||
155579420|NCT05017246|561547078|FG001|Overall Study|Technical failure|3|||
155579421|NCT00709995|561547079|FG000|Overall Study|Adverse Event|4|||
155579422|NCT00709995|561547080|FG001|Overall Study|Adverse Event|2|||
155579423|NCT00709995|561547079|FG000|Overall Study|Withdrawal by Subject|1|||
155579424|NCT00709995|561547080|FG001|Overall Study|Withdrawal by Subject|3|||
155579425|NCT02968576|561547085|FG000|Overall Study|Pregnancy|0|||
155579426|NCT02968576|561547086|FG001|Overall Study|Pregnancy|1|||
155579427|NCT02002221|561547089|FG000|Overall Study|Adverse Event|2|||
155579428|NCT02002221|561547090|FG001|Overall Study|Adverse Event|1|||
155579429|NCT02002221|561547089|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155579430|NCT02002221|561547090|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155579431|NCT02002221|561547089|FG000|Overall Study|Patient withdrew consent|0|||
155579432|NCT02002221|561547090|FG001|Overall Study|Patient withdrew consent|1|||
155579433|NCT01998919|561547091|FG000|Overall Study|Death|2|||
155663146|NCT00952705|561863361|FG002|Overall Study|Death|0|||
155663147|NCT00952705|561863359|FG000|Overall Study|Incarcerated post dose|5|||
155663148|NCT00952705|561863360|FG001|Overall Study|Incarcerated post dose|0|||
155663149|NCT00952705|561863361|FG002|Overall Study|Incarcerated post dose|0|||
155663150|NCT00952705|561863359|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
155663151|NCT00952705|561863360|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
155663152|NCT00952705|561863361|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
155663153|NCT00140140|561863362|FG000|Overall Study|Unacceptable toxicity|1|||
155663154|NCT00140140|561863363|FG001|Overall Study|Unacceptable toxicity|1|||
155663155|NCT00140140|561863364|FG002|Overall Study|Unacceptable toxicity|2|||
155663156|NCT00140140|561863362|FG000|Overall Study|Physician Decision|1|||
155663157|NCT00140140|561863363|FG001|Overall Study|Physician Decision|1|||
155663158|NCT00140140|561863364|FG002|Overall Study|Physician Decision|0|||
155663159|NCT00639457|561863365|FG000|Overall Study|Withdrawal by Subject|2|||
155663160|NCT00639457|561863366|FG001|Overall Study|Withdrawal by Subject|3|||
155663161|NCT02727322|561863369|FG000|Overall Study|Withdrawal by Subject|1|||
155663162|NCT02727322|561863370|FG001|Overall Study|Withdrawal by Subject|1|||
155663163|NCT02727322|561863369|FG000|Overall Study|Protocol Violation|1|||
155663164|NCT02727322|561863370|FG001|Overall Study|Protocol Violation|0|||
155579434|NCT01998919|561547092|FG001|Overall Study|Death|2|||
155579435|NCT01998919|561547091|FG000|Overall Study|Adverse Event|0|||
155579436|NCT01998919|561547092|FG001|Overall Study|Adverse Event|5|||
155579437|NCT01998919|561547091|FG000|Overall Study|Disease progression|31|||
155579438|NCT01998919|561547092|FG001|Overall Study|Disease progression|22|||
155579439|NCT01998919|561547091|FG000|Overall Study|Withdrawal by Subject|2|||
155579440|NCT01998919|561547092|FG001|Overall Study|Withdrawal by Subject|4|||
155579441|NCT01998919|561547091|FG000|Overall Study|Lost to Follow-up|2|||
155579442|NCT01998919|561547092|FG001|Overall Study|Lost to Follow-up|0|||
155579443|NCT01998919|561547091|FG000|Overall Study|Other|5|||
155579444|NCT01998919|561547092|FG001|Overall Study|Other|2|||
155579445|NCT01068860|561547093|FG000|Overall Study|Withdrawal by Subject|0|||
155579446|NCT01068860|561547094|FG001|Overall Study|Withdrawal by Subject|0|||
155579447|NCT01068860|561547095|FG002|Overall Study|Withdrawal by Subject|0|||
155579448|NCT01068860|561547096|FG003|Overall Study|Withdrawal by Subject|0|||
155579449|NCT01068860|561547097|FG004|Overall Study|Withdrawal by Subject|0|||
155579450|NCT01068860|561547098|FG005|Overall Study|Withdrawal by Subject|2|||
155579451|NCT01068860|561547099|FG006|Overall Study|Withdrawal by Subject|0|||
155579452|NCT01068860|561547100|FG007|Overall Study|Withdrawal by Subject|0|||
155579453|NCT01068860|561547101|FG008|Overall Study|Withdrawal by Subject|0|||
155579454|NCT01068860|561547102|FG009|Overall Study|Withdrawal by Subject|3|||
155579455|NCT01068860|561547093|FG000|Overall Study|Administrative problems; misrandomized|0|||
155579456|NCT01068860|561547094|FG001|Overall Study|Administrative problems; misrandomized|0|||
155579457|NCT01068860|561547095|FG002|Overall Study|Administrative problems; misrandomized|0|||
155579458|NCT01068860|561547096|FG003|Overall Study|Administrative problems; misrandomized|1|||
155579459|NCT01068860|561547097|FG004|Overall Study|Administrative problems; misrandomized|0|||
155579460|NCT01068860|561547098|FG005|Overall Study|Administrative problems; misrandomized|0|||
155579461|NCT01068860|561547099|FG006|Overall Study|Administrative problems; misrandomized|0|||
155579462|NCT01068860|561547100|FG007|Overall Study|Administrative problems; misrandomized|0|||
155579463|NCT01068860|561547101|FG008|Overall Study|Administrative problems; misrandomized|0|||
155579464|NCT01068860|561547102|FG009|Overall Study|Administrative problems; misrandomized|1|||
155579465|NCT01068860|561547093|FG000|Overall Study|Lost to Follow-up|0|||
155579466|NCT01068860|561547094|FG001|Overall Study|Lost to Follow-up|1|||
155663165|NCT00399035|561863371|FG000|Overall Study|Death|289|||
155663166|NCT00399035|561863372|FG001|Overall Study|Death|141|||
155663167|NCT00399035|561863373|FG002|Overall Study|Death|234|||
155579467|NCT01068860|561547095|FG002|Overall Study|Lost to Follow-up|0|||
155579468|NCT01068860|561547096|FG003|Overall Study|Lost to Follow-up|0|||
155579469|NCT01068860|561547097|FG004|Overall Study|Lost to Follow-up|0|||
155579470|NCT01068860|561547098|FG005|Overall Study|Lost to Follow-up|0|||
155579471|NCT01068860|561547099|FG006|Overall Study|Lost to Follow-up|0|||
155579472|NCT01068860|561547100|FG007|Overall Study|Lost to Follow-up|0|||
155663168|NCT00399035|561863371|FG000|Overall Study|Lost to Follow-up|2|||
155663169|NCT00399035|561863372|FG001|Overall Study|Lost to Follow-up|1|||
155663170|NCT00399035|561863373|FG002|Overall Study|Lost to Follow-up|5|||
155579473|NCT01068860|561547101|FG008|Overall Study|Lost to Follow-up|0|||
155579474|NCT01068860|561547102|FG009|Overall Study|Lost to Follow-up|0|||
155579475|NCT00897715|561547106|FG000|Overall Study|Lost to Follow-up|0|||
155579476|NCT00897715|561547107|FG001|Overall Study|Lost to Follow-up|1|||
155579477|NCT00897715|561547106|FG000|Overall Study|Physician Decision|1|||
155579478|NCT00897715|561547107|FG001|Overall Study|Physician Decision|0|||
155579479|NCT00897715|561547106|FG000|Overall Study|increased risk of infection|1|||
155579480|NCT00897715|561547107|FG001|Overall Study|increased risk of infection|0|||
155579481|NCT00513240|561547108|FG000|Overall Study|Did not have intended surgery|3|||
155579482|NCT00513240|561547109|FG001|Overall Study|Did not have intended surgery|0|||
155579483|NCT00513240|561547108|FG000|Overall Study|Death|3|||
155579484|NCT00513240|561547109|FG001|Overall Study|Death|3|||
155579485|NCT00513240|561547108|FG000|Overall Study|Withdrawal by Subject|7|||
155579486|NCT00513240|561547109|FG001|Overall Study|Withdrawal by Subject|4|||
155663171|NCT00399035|561863371|FG000|Overall Study|Withdrawal by Subject|19|||
155663172|NCT00399035|561863372|FG001|Overall Study|Withdrawal by Subject|15|||
155663173|NCT00399035|561863373|FG002|Overall Study|Withdrawal by Subject|12|||
155663174|NCT00399035|561863371|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
155663175|NCT00399035|561863372|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
155663176|NCT00399035|561863373|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
155663177|NCT00399035|561863371|FG000|Overall Study|Severe non-compliance with protocol|2|||
155663178|NCT00399035|561863372|FG001|Overall Study|Severe non-compliance with protocol|1|||
155663179|NCT00399035|561863373|FG002|Overall Study|Severe non-compliance with protocol|0|||
155663180|NCT02949011|561863376|FG000|Overall Study|Adverse Event|6|||
155663181|NCT02949011|561863377|FG001|Overall Study|Adverse Event|7|||
155663182|NCT02949011|561863378|FG002|Overall Study|Adverse Event|3|||
155663183|NCT02949011|561863376|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155663184|NCT02949011|561863377|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155663185|NCT02949011|561863378|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
155663186|NCT02949011|561863376|FG000|Overall Study|Protocol Deviation|5|||
155663187|NCT02949011|561863377|FG001|Overall Study|Protocol Deviation|3|||
155663188|NCT02949011|561863378|FG002|Overall Study|Protocol Deviation|3|||
155663189|NCT02949011|561863376|FG000|Overall Study|Lack of Efficacy|0|||
155663190|NCT02949011|561863377|FG001|Overall Study|Lack of Efficacy|2|||
155663191|NCT02949011|561863378|FG002|Overall Study|Lack of Efficacy|0|||
155663192|NCT02949011|561863376|FG000|Overall Study|Withdrawal by Subject|13|||
155663193|NCT02949011|561863377|FG001|Overall Study|Withdrawal by Subject|13|||
155663194|NCT02949011|561863378|FG002|Overall Study|Withdrawal by Subject|21|||
155663195|NCT02949011|561863376|FG000|Overall Study|Lost to Follow-up|7|||
155663196|NCT02949011|561863377|FG001|Overall Study|Lost to Follow-up|5|||
155663197|NCT02949011|561863378|FG002|Overall Study|Lost to Follow-up|5|||
155663198|NCT02949011|561863376|FG000|Overall Study|Death|0|||
155663199|NCT02949011|561863377|FG001|Overall Study|Death|0|||
155663200|NCT02949011|561863378|FG002|Overall Study|Death|1|||
155663201|NCT02949011|561863376|FG000|Overall Study|Miscellaneous|2|||
155663202|NCT02949011|561863377|FG001|Overall Study|Miscellaneous|4|||
155663203|NCT02949011|561863378|FG002|Overall Study|Miscellaneous|6|||
155663204|NCT01541371|561863379|FG000|Overall Study|Withdrawal by Subject|14|||
155663205|NCT01541371|561863379|FG000|Overall Study|Lost to Follow-up|21|||
155663206|NCT01541371|561863379|FG000|Overall Study|Adverse Event|15|||
155663207|NCT01541371|561863379|FG000|Overall Study|Lack of Efficacy|12|||
155663208|NCT01541371|561863379|FG000|Overall Study|Protocol Violation|6|||
155663209|NCT01541371|561863379|FG000|Overall Study|Study medication non-compliance|3|||
155663210|NCT01541371|561863379|FG000|Overall Study|Other|6|||
155663211|NCT02441218|561863380|FG000|Overall Study|Death|503|||
155663212|NCT02441218|561863381|FG001|Overall Study|Death|553|||
155663213|NCT02441218|561863380|FG000|Overall Study|Withdrawal by Subject|73|||
155663214|NCT02441218|561863381|FG001|Overall Study|Withdrawal by Subject|58|||
155663215|NCT02441218|561863380|FG000|Overall Study|Lost to Follow-up|2|||
155663216|NCT02441218|561863381|FG001|Overall Study|Lost to Follow-up|1|||
155663217|NCT00163189|561863384|FG000|Overall Study|Other|6|||
155663218|NCT00163189|561863384|FG000|Overall Study|Lost to Follow-up|1|||
155663219|NCT00163189|561863384|FG000|Overall Study|Protocol Violation|2|||
155663220|NCT00163189|561863384|FG000|Overall Study|Death|3|||
155663221|NCT00163189|561863384|FG000|Overall Study|Adverse Event|6|||
155663222|NCT00163189|561863384|FG000|Overall Study|Lack of Efficacy|7|||
155663223|NCT00163189|561863384|FG000|Overall Study|Study terminated by sponsor|11|||
155663224|NCT00163189|561863384|FG000|Overall Study|Withdrawal by Subject|11|||
155663225|NCT00163189|561863384|FG000|Overall Study|Did not meet continuation criterion|16|||
155663226|NCT03435380|561863385|FG000|Overall Study|Death|1|||
155663227|NCT03435380|561863386|FG001|Overall Study|Death|2|||
155663228|NCT03435380|561863387|FG002|Overall Study|Death|1|||
155663229|NCT03435380|561863385|FG000|Overall Study|Lost to Follow-up|12|||
155663230|NCT03435380|561863386|FG001|Overall Study|Lost to Follow-up|8|||
155663231|NCT03435380|561863387|FG002|Overall Study|Lost to Follow-up|6|||
155663232|NCT03435380|561863385|FG000|Overall Study|Physician Decision|1|||
155663233|NCT03435380|561863386|FG001|Overall Study|Physician Decision|0|||
155663234|NCT03435380|561863387|FG002|Overall Study|Physician Decision|0|||
155663235|NCT03435380|561863385|FG000|Overall Study|Withdrawal by Subject|0|||
155663236|NCT03435380|561863386|FG001|Overall Study|Withdrawal by Subject|1|||
155663237|NCT03435380|561863387|FG002|Overall Study|Withdrawal by Subject|1|||
155663238|NCT03435380|561863385|FG000|Overall Study|Ineligible|0|||
155663239|NCT03435380|561863386|FG001|Overall Study|Ineligible|1|||
155663240|NCT03435380|561863387|FG002|Overall Study|Ineligible|1|||
155579487|NCT00882518|561547119|FG000|Overall Study|Adverse Event|9|||
155579488|NCT00882518|561547120|FG001|Overall Study|Adverse Event|18|||
155579489|NCT00882518|561547119|FG000|Overall Study|Withdrawal by Subject|9|||
155579490|NCT00882518|561547120|FG001|Overall Study|Withdrawal by Subject|13|||
155579491|NCT00882518|561547119|FG000|Overall Study|Lack of Efficacy|12|||
155579492|NCT00882518|561547120|FG001|Overall Study|Lack of Efficacy|9|||
155579493|NCT00882518|561547119|FG000|Overall Study|Severe non-compliance to protocol|3|||
155579494|NCT00882518|561547120|FG001|Overall Study|Severe non-compliance to protocol|1|||
155579495|NCT00882518|561547119|FG000|Overall Study|Incorrect enrolment|4|||
155579496|NCT00882518|561547120|FG001|Overall Study|Incorrect enrolment|2|||
155579497|NCT00882518|561547119|FG000|Overall Study|Central lab closure for National day|1|||
155579498|NCT00882518|561547120|FG001|Overall Study|Central lab closure for National day|0|||
155579499|NCT00882518|561547119|FG000|Overall Study|Allocating random number by mistake|0|||
155579500|NCT00882518|561547120|FG001|Overall Study|Allocating random number by mistake|1|||
155579501|NCT03238651|561547121|FG000|Overall Study|Other|0|||
155579502|NCT03238651|561547122|FG001|Overall Study|Other|0|||
155579503|NCT03238651|561547123|FG002|Overall Study|Other|0|||
155579504|NCT03238651|561547124|FG003|Overall Study|Other|0|||
155579505|NCT03238651|561547125|FG004|Overall Study|Other|1|||
155579506|NCT03238651|561547121|FG000|Overall Study|Progressive Disease|2|||
155579507|NCT03238651|561547122|FG001|Overall Study|Progressive Disease|2|||
155579508|NCT03238651|561547123|FG002|Overall Study|Progressive Disease|2|||
155579509|NCT03238651|561547124|FG003|Overall Study|Progressive Disease|2|||
155579510|NCT03238651|561547125|FG004|Overall Study|Progressive Disease|0|||
155579511|NCT03238651|561547121|FG000|Overall Study|Withdrawal by Subject|0|||
155579512|NCT03238651|561547122|FG001|Overall Study|Withdrawal by Subject|1|||
155579513|NCT03238651|561547123|FG002|Overall Study|Withdrawal by Subject|0|||
155579514|NCT03238651|561547124|FG003|Overall Study|Withdrawal by Subject|1|||
155579515|NCT03238651|561547125|FG004|Overall Study|Withdrawal by Subject|0|||
155579516|NCT03238651|561547121|FG000|Overall Study|Adverse Event|1|||
155579517|NCT03238651|561547122|FG001|Overall Study|Adverse Event|3|||
155579518|NCT03238651|561547123|FG002|Overall Study|Adverse Event|2|||
155579519|NCT03238651|561547124|FG003|Overall Study|Adverse Event|0|||
155579520|NCT03238651|561547125|FG004|Overall Study|Adverse Event|0|||
155579521|NCT03743051|561547126|FG000|Overall Study|Adverse Event|5|||
155579522|NCT03743051|561547127|FG001|Overall Study|Adverse Event|9|||
155579523|NCT03743051|561547126|FG000|Overall Study|Death|27|||
155579524|NCT03743051|561547127|FG001|Overall Study|Death|26|||
155579525|NCT03743051|561547126|FG000|Overall Study|Lost to Follow-up|4|||
155579526|NCT03743051|561547127|FG001|Overall Study|Lost to Follow-up|8|||
155579527|NCT03743051|561547126|FG000|Overall Study|Withdrawal by Subject|32|||
155579528|NCT03743051|561547127|FG001|Overall Study|Withdrawal by Subject|19|||
155579529|NCT03743051|561547126|FG000|Overall Study|Physician Decision|10|||
155579530|NCT03743051|561547127|FG001|Overall Study|Physician Decision|15|||
155579531|NCT03743051|561547126|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
155579532|NCT03743051|561547127|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
155579533|NCT02137252|561547130|FG000|Overall Study|trial terminated early|2|||
155579534|NCT02137252|561547131|FG001|Overall Study|trial terminated early|1|||
155579535|NCT02550561|561547133|FG000|Overall Study|Lost to Follow-up|5|||
155579536|NCT02550561|561547133|FG000|Overall Study|Withdrawal by Subject|1|||
155579537|NCT03535740|561547134|FG000|Overall Study|Death|44|||
155579538|NCT03535740|561547134|FG000|Overall Study|Lost to Follow-up|1|||
155579539|NCT03535740|561547134|FG000|Overall Study|Withdrawal by Subject|13|||
155579540|NCT03535740|561547134|FG000|Overall Study|Site terminated by Sponsor|45|||
155579541|NCT05317312|561547136|FG000|Overall Study|Withdrawal by Subject|0|||
155579542|NCT05317312|561547137|FG001|Overall Study|Withdrawal by Subject|1|||
155579543|NCT05317312|561547138|FG002|Overall Study|Withdrawal by Subject|0|||
155579544|NCT05317312|561547139|FG003|Overall Study|Withdrawal by Subject|0|||
155579545|NCT05317312|561547136|FG000|Overall Study|Lost to Follow-up|0|||
155579546|NCT05317312|561547137|FG001|Overall Study|Lost to Follow-up|0|||
155579547|NCT05317312|561547138|FG002|Overall Study|Lost to Follow-up|0|||
155579548|NCT05317312|561547139|FG003|Overall Study|Lost to Follow-up|1|||
155579549|NCT05317312|561547136|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
155579550|NCT05317312|561547137|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
155579551|NCT05317312|561547138|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
155579552|NCT05317312|561547139|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
155579553|NCT02857816|561547140|FG000|Overall Study|Screen Failure|33|||
155579554|NCT02857816|561547140|FG000|Overall Study|Withdrawal by Subject|4|||
155579555|NCT02857816|561547140|FG000|Overall Study|Lost to Follow-up|1|||
155579556|NCT00822692|561547147|FG000|Overall Study|Lost to Follow-up|17|||
155579557|NCT00822692|561547148|FG001|Overall Study|Lost to Follow-up|25|||
155579558|NCT02208089|561547149|FG000|Overall Study|Withdrawal by Subject|1|||
155579559|NCT02208089|561547150|FG001|Overall Study|Withdrawal by Subject|0|||
155579560|NCT02208089|561547149|FG000|Overall Study|Lost to Follow-up|6|||
155579561|NCT02208089|561547150|FG001|Overall Study|Lost to Follow-up|0|||
155579562|NCT02443740|561547151|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579563|NCT02443740|561547152|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579564|NCT02443740|561547153|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579565|NCT02443740|561547154|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579566|NCT02443740|561547155|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579567|NCT02443740|561547156|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
155579568|NCT02443740|561547157|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579569|NCT02443740|561547158|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579570|NCT02443740|561547159|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579571|NCT02443740|561547160|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579572|NCT02443740|561547161|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
155579573|NCT02443740|561547151|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
155579574|NCT02443740|561547152|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579575|NCT02443740|561547153|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579576|NCT02443740|561547154|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579577|NCT02443740|561547155|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579578|NCT02443740|561547156|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579579|NCT02443740|561547157|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
155579580|NCT02443740|561547158|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579581|NCT02443740|561547159|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579582|NCT02443740|561547160|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579583|NCT02443740|561547161|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155579584|NCT02443740|561547151|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579585|NCT02443740|561547152|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579586|NCT02443740|561547153|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579587|NCT02443740|561547154|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579588|NCT02443740|561547155|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579589|NCT02443740|561547156|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
155579590|NCT02443740|561547157|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579591|NCT02443740|561547158|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579592|NCT02443740|561547159|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579593|NCT02443740|561547160|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579594|NCT02443740|561547161|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155579595|NCT00456300|561547162|FG000|Overall Study|Adverse Event|1|||
155579596|NCT00456300|561547163|FG001|Overall Study|Adverse Event|0|||
155579597|NCT03200717|561547169|FG000|Overall Study|Progressive disease|24|||
155579598|NCT03200717|561547170|FG001|Overall Study|Progressive disease|5|||
155579599|NCT03200717|561547169|FG000|Overall Study|Adverse Event|11|||
155579600|NCT03200717|561547170|FG001|Overall Study|Adverse Event|8|||
155579601|NCT03200717|561547169|FG000|Overall Study|Physician Decision|3|||
155579602|NCT03200717|561547170|FG001|Overall Study|Physician Decision|2|||
155579603|NCT03200717|561547169|FG000|Overall Study|Death|2|||
155579604|NCT03200717|561547170|FG001|Overall Study|Death|0|||
155579605|NCT03200717|561547169|FG000|Overall Study|Subject/Guardian Decision|1|||
155579606|NCT03200717|561547170|FG001|Overall Study|Subject/Guardian Decision|0|||
155579607|NCT02046603|561547171|FG000|Overall Study|Other|11|||
155579608|NCT02046603|561547172|FG001|Overall Study|Other|66|||
155579609|NCT02046603|561547171|FG000|Overall Study|Protocol Violation|0|||
155579610|NCT02046603|561547172|FG001|Overall Study|Protocol Violation|1|||
155579611|NCT02046603|561547171|FG000|Overall Study|Participant/legal guardian decision|1|||
155579612|NCT02046603|561547172|FG001|Overall Study|Participant/legal guardian decision|3|||
155579613|NCT02046603|561547171|FG000|Overall Study|Physician Decision|2|||
155579614|NCT02046603|561547172|FG001|Overall Study|Physician Decision|1|||
155579615|NCT02046603|561547171|FG000|Overall Study|Lost to Follow-up|1|||
155579616|NCT02046603|561547172|FG001|Overall Study|Lost to Follow-up|2|||
155579617|NCT02046603|561547171|FG000|Overall Study|Death|0|||
155579618|NCT02046603|561547172|FG001|Overall Study|Death|1|||
155579619|NCT02046603|561547171|FG000|Overall Study|Adverse Event|0|||
155579620|NCT02046603|561547172|FG001|Overall Study|Adverse Event|1|||
155579621|NCT02431364|561547173|FG000|Overall Study|Adverse Event|0|||
155579622|NCT02431364|561547174|FG001|Overall Study|Adverse Event|1|||
155579623|NCT02431364|561547175|FG002|Overall Study|Adverse Event|0|||
155579624|NCT02431364|561547176|FG003|Overall Study|Adverse Event|0|||
155579625|NCT02431364|561547177|FG004|Overall Study|Adverse Event|0|||
155579626|NCT02431364|561547173|FG000|Overall Study|Randomized but never treated|0|||
155579627|NCT02431364|561547174|FG001|Overall Study|Randomized but never treated|0|||
155579628|NCT02431364|561547175|FG002|Overall Study|Randomized but never treated|0|||
155579629|NCT02431364|561547176|FG003|Overall Study|Randomized but never treated|1|||
155579630|NCT02431364|561547177|FG004|Overall Study|Randomized but never treated|0|||
155579631|NCT00061932|561547178|FG000|Overall Study|Withdrawal by Subject|13|||
155579632|NCT00061932|561547179|FG001|Overall Study|Withdrawal by Subject|4|||
155579633|NCT00916383|561547180|FG000|Overall Study|Adverse Event|1|||
155579634|NCT00916383|561547180|FG000|Overall Study|Death|1|||
155579635|NCT00916383|561547180|FG000|Overall Study|Protocol Violation|1|||
155579636|NCT02899962|561547181|FG000|Open-label Phase|Adverse Event|2|||
155663241|NCT02431325|561863388|FG000|Overall Study|Adverse Event|3|||
155663242|NCT02431325|561863389|FG001|Overall Study|Adverse Event|0|||
155663243|NCT02431325|561863388|FG000|Overall Study|Lost to Follow-up|0|||
155663244|NCT02431325|561863389|FG001|Overall Study|Lost to Follow-up|1|||
155663245|NCT02431325|561863388|FG000|Overall Study|Withdrawal by Subject|1|||
155663246|NCT02431325|561863389|FG001|Overall Study|Withdrawal by Subject|2|||
155663247|NCT02431325|561863388|FG000|Overall Study|Declined to take study medication|1|||
155663248|NCT02431325|561863389|FG001|Overall Study|Declined to take study medication|0|||
155663249|NCT02431325|561863388|FG000|Overall Study|Withdrew before starting study medication|1|||
155663250|NCT02431325|561863389|FG001|Overall Study|Withdrew before starting study medication|0|||
155663251|NCT02431325|561863388|FG000|Overall Study|Placebo shortage|2|||
155663252|NCT02431325|561863389|FG001|Overall Study|Placebo shortage|0|||
155663253|NCT01917318|561863390|FG000|First Treatment|Withdrawal by Subject|0|||
155663254|NCT01917318|561863391|FG001|First Treatment|Withdrawal by Subject|1|||
155663255|NCT01008618|561863392|FG000|Period 1 (Titration Period)|Physician Decision|2|||
155663256|NCT01008618|561863393|FG001|Period 1 (Titration Period)|Physician Decision|0|||
155663257|NCT01008618|561863394|FG002|Period 1 (Titration Period)|Physician Decision|0|||
155663258|NCT01008618|561863392|FG000|Period 1 (Titration Period)|Adverse Event|33|||
155663259|NCT01008618|561863393|FG001|Period 1 (Titration Period)|Adverse Event|0|||
155663260|NCT01008618|561863394|FG002|Period 1 (Titration Period)|Adverse Event|0|||
155663261|NCT01008618|561863392|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
155663262|NCT01008618|561863393|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155663263|NCT01008618|561863394|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155663264|NCT01008618|561863392|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
155663265|NCT01008618|561863393|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155663266|NCT01008618|561863394|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155663267|NCT01008618|561863392|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
155663268|NCT01008618|561863393|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
155663269|NCT01008618|561863394|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
155663270|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
155663271|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
155579637|NCT02899962|561547182|FG001|Open-label Phase|Adverse Event|0|||
155579638|NCT02899962|561547183|FG002|Open-label Phase|Adverse Event|0|||
155579639|NCT02899962|561547181|FG000|Open-label Phase|Lost to Follow-up|9|||
155579640|NCT02899962|561547182|FG001|Open-label Phase|Lost to Follow-up|0|||
155579641|NCT02899962|561547183|FG002|Open-label Phase|Lost to Follow-up|0|||
155579642|NCT02899962|561547181|FG000|Open-label Phase|Other reasons|9|||
155579643|NCT02899962|561547182|FG001|Open-label Phase|Other reasons|0|||
155579644|NCT02899962|561547183|FG002|Open-label Phase|Other reasons|0|||
155579645|NCT02899962|561547181|FG000|Open-label Phase|Withdrawal by Subject|7|||
155579646|NCT02899962|561547182|FG001|Open-label Phase|Withdrawal by Subject|0|||
155579647|NCT02899962|561547183|FG002|Open-label Phase|Withdrawal by Subject|0|||
155579648|NCT02899962|561547181|FG000|Maintenance Phase|Adverse Event|0|||
155579649|NCT02899962|561547182|FG001|Maintenance Phase|Adverse Event|2|||
155579650|NCT02899962|561547183|FG002|Maintenance Phase|Adverse Event|1|||
155579651|NCT02899962|561547181|FG000|Maintenance Phase|Death|0|||
155579652|NCT02899962|561547182|FG001|Maintenance Phase|Death|0|||
155579653|NCT02899962|561547183|FG002|Maintenance Phase|Death|1|||
155579654|NCT02899962|561547181|FG000|Maintenance Phase|Lack of Efficacy|0|||
155579655|NCT02899962|561547182|FG001|Maintenance Phase|Lack of Efficacy|20|||
155579656|NCT02899962|561547183|FG002|Maintenance Phase|Lack of Efficacy|16|||
155579657|NCT02899962|561547181|FG000|Maintenance Phase|Lost to Follow-up|0|||
155579658|NCT02899962|561547182|FG001|Maintenance Phase|Lost to Follow-up|12|||
155579659|NCT02899962|561547183|FG002|Maintenance Phase|Lost to Follow-up|14|||
155663272|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
155663273|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
155663274|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
155663275|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155663276|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
155663277|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
155663278|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
155663279|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155663280|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155663281|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
155663282|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155579660|NCT02899962|561547181|FG000|Maintenance Phase|Other reasons|0|||
155579661|NCT02899962|561547182|FG001|Maintenance Phase|Other reasons|9|||
155579662|NCT02899962|561547183|FG002|Maintenance Phase|Other reasons|13|||
155663283|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155663284|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
155663285|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
155579663|NCT02899962|561547181|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
155663286|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
155663287|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
155663288|NCT01008618|561863392|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
155663289|NCT01008618|561863393|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
155663290|NCT01008618|561863394|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
155663291|NCT01128569|561863395|FG000|Washout Period 1|Adverse Event|0|||
155663292|NCT01128569|561863396|FG001|Washout Period 1|Adverse Event|0|||
155663293|NCT01128569|561863397|FG002|Washout Period 1|Adverse Event|1|||
155663294|NCT01128569|561863398|FG003|Washout Period 1|Adverse Event|0|||
155663295|NCT01128569|561863399|FG004|Washout Period 1|Adverse Event|0|||
155663296|NCT01128569|561863400|FG005|Washout Period 1|Adverse Event|0|||
155663297|NCT01128569|561863395|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155663298|NCT01128569|561863396|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155663299|NCT01128569|561863397|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155663300|NCT01128569|561863398|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155663301|NCT01128569|561863399|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155663302|NCT01128569|561863400|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155663303|NCT00487981|561863403|FG000|Overall Study|Hypothyroidism diagnosis|1|||
155663304|NCT01865487|561863404|FG000|Overall Study|Lost to Follow-up|0|||
155663305|NCT01865487|561863405|FG001|Overall Study|Lost to Follow-up|0|||
155663306|NCT01865487|561863406|FG002|Overall Study|Lost to Follow-up|0|||
155663307|NCT01865487|561863407|FG003|Overall Study|Lost to Follow-up|1|||
155663308|NCT01865487|561863408|FG004|Overall Study|Lost to Follow-up|0|||
155663309|NCT01865487|561863409|FG005|Overall Study|Lost to Follow-up|0|||
155663310|NCT01865487|561863410|FG006|Overall Study|Lost to Follow-up|1|||
155663311|NCT01865487|561863411|FG007|Overall Study|Lost to Follow-up|0|||
155663312|NCT01865487|561863412|FG008|Overall Study|Lost to Follow-up|0|||
155663313|NCT01865487|561863413|FG009|Overall Study|Lost to Follow-up|0|||
155663314|NCT01865487|561863404|FG000|Overall Study|Withdrawal by Subject|0|||
155663315|NCT01865487|561863405|FG001|Overall Study|Withdrawal by Subject|0|||
155663316|NCT01865487|561863406|FG002|Overall Study|Withdrawal by Subject|0|||
155663317|NCT01865487|561863407|FG003|Overall Study|Withdrawal by Subject|0|||
155663318|NCT01865487|561863408|FG004|Overall Study|Withdrawal by Subject|1|||
155663319|NCT01865487|561863409|FG005|Overall Study|Withdrawal by Subject|0|||
155663320|NCT01865487|561863410|FG006|Overall Study|Withdrawal by Subject|0|||
155663321|NCT01865487|561863411|FG007|Overall Study|Withdrawal by Subject|0|||
155663322|NCT01865487|561863412|FG008|Overall Study|Withdrawal by Subject|0|||
155663323|NCT01865487|561863413|FG009|Overall Study|Withdrawal by Subject|0|||
155663324|NCT01627691|561863418|FG000|Overall Study|Death|11|||
155663325|NCT01627691|561863418|FG000|Overall Study|Lost to Follow-up|3|||
155663326|NCT01627691|561863418|FG000|Overall Study|Withdrawal by Subject|1|||
155663327|NCT01627691|561863418|FG000|Overall Study|Missed the visit|3|||
155663328|NCT01908140|561863419|FG000|Overall Study|Other or Progressive Disease|5|||
155663329|NCT01908140|561863420|FG001|Overall Study|Other or Progressive Disease|12|||
155663330|NCT01908140|561863419|FG000|Overall Study|Lack of Efficacy|7|||
155579664|NCT02899962|561547182|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
155579665|NCT02899962|561547183|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
155579666|NCT02899962|561547181|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
155579667|NCT02899962|561547182|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
155579668|NCT02899962|561547183|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
155579669|NCT02899962|561547181|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155579670|NCT02899962|561547182|FG001|Maintenance Phase|Withdrawal by Subject|30|||
155579671|NCT02899962|561547183|FG002|Maintenance Phase|Withdrawal by Subject|36|||
155579672|NCT00258960|561547184|FG000|Overall Study|Death|2|||
155579673|NCT00258960|561547184|FG000|Overall Study|Disease Progression|7|||
155579674|NCT00258960|561547184|FG000|Overall Study|Adverse Event|4|||
155579675|NCT00258960|561547184|FG000|Overall Study|Physician Decision|1|||
155579676|NCT00258960|561547184|FG000|Overall Study|Withdrawal by Subject|1|||
155579677|NCT00258960|561547184|FG000|Overall Study|Mistake|2|||
155579678|NCT03367819|561547187|FG000|Overall Study|Adverse Event|4|||
155663331|NCT01908140|561863420|FG001|Overall Study|Lack of Efficacy|5|||
155579679|NCT03367819|561547188|FG001|Overall Study|Adverse Event|4|||
155579680|NCT03367819|561547187|FG000|Overall Study|Progressive Disease|15|||
155579681|NCT03367819|561547188|FG001|Overall Study|Progressive Disease|13|||
155579682|NCT03367819|561547187|FG000|Overall Study|Withdrawal by Subject|1|||
155579683|NCT03367819|561547188|FG001|Overall Study|Withdrawal by Subject|0|||
155579684|NCT03367819|561547187|FG000|Overall Study|Other|4|||
155663332|NCT01908140|561863419|FG000|Overall Study|Withdrawal by Subject|23|||
155663333|NCT01908140|561863420|FG001|Overall Study|Withdrawal by Subject|24|||
155663334|NCT01908140|561863419|FG000|Overall Study|Lost to Follow-up|1|||
155663335|NCT01908140|561863420|FG001|Overall Study|Lost to Follow-up|6|||
155663336|NCT01908140|561863419|FG000|Overall Study|Protocol Violation|8|||
155663337|NCT01908140|561863420|FG001|Overall Study|Protocol Violation|9|||
155579685|NCT03367819|561547188|FG001|Overall Study|Other|2|||
155663338|NCT01908140|561863419|FG000|Overall Study|Adverse Event|22|||
155579686|NCT00550459|561547189|FG000|Overall Study|Adverse Event|0|||
155579687|NCT00550459|561547190|FG001|Overall Study|Adverse Event|2|||
155579688|NCT00550459|561547189|FG000|Overall Study|Withdrawal by Subject|1|||
155579689|NCT00550459|561547190|FG001|Overall Study|Withdrawal by Subject|1|||
155579690|NCT02633787|561547191|FG000|Overall Study|Withdrawal by Subject|1|||
155579691|NCT02404805|561547192|FG000|Overall Study|Withdrawal by Subject|1|||
155579692|NCT02404805|561547193|FG001|Overall Study|Withdrawal by Subject|0|||
155579693|NCT02404805|561547194|FG002|Overall Study|Withdrawal by Subject|0|||
155579694|NCT02404805|561547195|FG003|Overall Study|Withdrawal by Subject|0|||
155579695|NCT02404805|561547196|FG004|Overall Study|Withdrawal by Subject|0|||
155579696|NCT02404805|561547197|FG005|Overall Study|Withdrawal by Subject|0|||
155579697|NCT01742897|561547198|FG000|Overall Study|Adverse Event|3|||
155579698|NCT01742897|561547198|FG000|Overall Study|Withdrawal by Subject|1|||
155579699|NCT01742897|561547198|FG000|Overall Study|Other|1|||
155579700|NCT04211831|561547201|FG000|Overall Study|Withdrawal by Subject|4|||
155579701|NCT04211831|561547202|FG001|Overall Study|Withdrawal by Subject|1|||
155579702|NCT04211831|561547203|FG002|Overall Study|Withdrawal by Subject|1|||
155579703|NCT04211831|561547201|FG000|Overall Study|Protocol Violation|0|||
155579704|NCT04211831|561547202|FG001|Overall Study|Protocol Violation|0|||
155579705|NCT04211831|561547203|FG002|Overall Study|Protocol Violation|1|||
155579706|NCT04211831|561547201|FG000|Overall Study|Adverse Event|0|||
155579707|NCT04211831|561547202|FG001|Overall Study|Adverse Event|1|||
155579708|NCT04211831|561547203|FG002|Overall Study|Adverse Event|0|||
155579709|NCT04211831|561547201|FG000|Overall Study|Lack of Efficacy|0|||
155579710|NCT04211831|561547202|FG001|Overall Study|Lack of Efficacy|0|||
155579711|NCT04211831|561547203|FG002|Overall Study|Lack of Efficacy|1|||
155579712|NCT04211831|561547201|FG000|Overall Study|Lost to Follow-up|0|||
155579713|NCT04211831|561547202|FG001|Overall Study|Lost to Follow-up|0|||
155579714|NCT04211831|561547203|FG002|Overall Study|Lost to Follow-up|2|||
155579715|NCT04211831|561547201|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
155579716|NCT04211831|561547202|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
155579717|NCT04211831|561547203|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
155579718|NCT04211831|561547201|FG000|Overall Study|Other|0|||
155579719|NCT04211831|561547202|FG001|Overall Study|Other|1|||
155579720|NCT04211831|561547203|FG002|Overall Study|Other|0|||
155579721|NCT05373108|561547205|FG000|Overall Study|Withdrawal by Subject|2|||
155579722|NCT04871776|561547206|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
155579723|NCT04871776|561547207|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
155579724|NCT04871776|561547208|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
155579725|NCT04871776|561547206|FG000|Overall Study|Did not meet eligibility criteria|1|||
155579726|NCT04871776|561547207|FG001|Overall Study|Did not meet eligibility criteria|1|||
155579727|NCT04871776|561547208|FG002|Overall Study|Did not meet eligibility criteria|1|||
155607011|NCT01897571|561649614|FG001|Overall Study|Withdrawal by Subject|0|||
155607012|NCT01897571|561649615|FG002|Overall Study|Withdrawal by Subject|0|||
155607013|NCT01897571|561649616|FG003|Overall Study|Withdrawal by Subject|0|||
155607014|NCT01897571|561649617|FG004|Overall Study|Withdrawal by Subject|0|||
155607015|NCT01897571|561649618|FG005|Overall Study|Withdrawal by Subject|0|||
155607016|NCT01897571|561649619|FG006|Overall Study|Withdrawal by Subject|0|||
155607017|NCT01897571|561649620|FG007|Overall Study|Withdrawal by Subject|1|||
155607018|NCT01897571|561649621|FG008|Overall Study|Withdrawal by Subject|4|||
155607019|NCT01897571|561649622|FG009|Overall Study|Withdrawal by Subject|3|||
155607020|NCT01897571|561649623|FG010|Overall Study|Withdrawal by Subject|1|||
155607021|NCT01897571|561649613|FG000|Overall Study|Other|1|||
155607022|NCT01897571|561649614|FG001|Overall Study|Other|0|||
155607023|NCT01897571|561649615|FG002|Overall Study|Other|0|||
155607024|NCT01897571|561649616|FG003|Overall Study|Other|3|||
155607025|NCT01897571|561649617|FG004|Overall Study|Other|3|||
155607026|NCT01897571|561649618|FG005|Overall Study|Other|4|||
155607027|NCT01897571|561649619|FG006|Overall Study|Other|7|||
155607028|NCT01897571|561649620|FG007|Overall Study|Other|0|||
155607029|NCT01897571|561649621|FG008|Overall Study|Other|0|||
155607030|NCT01897571|561649622|FG009|Overall Study|Other|0|||
155607031|NCT01897571|561649623|FG010|Overall Study|Other|0|||
155607032|NCT01897571|561649613|FG000|Overall Study|Enrolled in rollover study|0|||
155607033|NCT01897571|561649614|FG001|Overall Study|Enrolled in rollover study|0|||
155607034|NCT01897571|561649615|FG002|Overall Study|Enrolled in rollover study|0|||
155607035|NCT01897571|561649616|FG003|Overall Study|Enrolled in rollover study|0|||
155607036|NCT01897571|561649617|FG004|Overall Study|Enrolled in rollover study|0|||
155607037|NCT01897571|561649618|FG005|Overall Study|Enrolled in rollover study|0|||
155607038|NCT01897571|561649619|FG006|Overall Study|Enrolled in rollover study|0|||
155579728|NCT00070564|561549574|FG000|Overall Study|Progression|2|||
155579729|NCT00070564|561549575|FG001|Overall Study|Progression|4|||
155579730|NCT00070564|561549576|FG002|Overall Study|Progression|7|||
155579731|NCT00070564|561549577|FG003|Overall Study|Progression|7|||
155579732|NCT00070564|561549578|FG004|Overall Study|Progression|1|||
155579733|NCT00070564|561549579|FG005|Overall Study|Progression|0|||
155579734|NCT00070564|561549574|FG000|Overall Study|Delinquent|1|||
155579735|NCT00070564|561549575|FG001|Overall Study|Delinquent|4|||
155579736|NCT00070564|561549576|FG002|Overall Study|Delinquent|2|||
155579737|NCT00070564|561549577|FG003|Overall Study|Delinquent|0|||
155579738|NCT00070564|561549578|FG004|Overall Study|Delinquent|0|||
155579739|NCT00070564|561549579|FG005|Overall Study|Delinquent|0|||
155579740|NCT00070564|561549574|FG000|Overall Study|Adverse Event|150|||
155579741|NCT00070564|561549575|FG001|Overall Study|Adverse Event|142|||
155579742|NCT00070564|561549576|FG002|Overall Study|Adverse Event|120|||
155579743|NCT00070564|561549577|FG003|Overall Study|Adverse Event|108|||
155579744|NCT00070564|561549578|FG004|Overall Study|Adverse Event|63|||
155579745|NCT00070564|561549579|FG005|Overall Study|Adverse Event|36|||
155579746|NCT00070564|561549574|FG000|Overall Study|Death|4|||
155579747|NCT00070564|561549575|FG001|Overall Study|Death|1|||
155579748|NCT00070564|561549576|FG002|Overall Study|Death|5|||
155579749|NCT00070564|561549577|FG003|Overall Study|Death|3|||
155579750|NCT00070564|561549578|FG004|Overall Study|Death|0|||
155663339|NCT01908140|561863420|FG001|Overall Study|Adverse Event|23|||
155663340|NCT01307449|561863421|FG000|Overall Study|Adverse Event|1|||
155663341|NCT01307449|561863422|FG001|Overall Study|Adverse Event|0|||
155663342|NCT01307449|561863423|FG002|Overall Study|Adverse Event|0|||
155663343|NCT01307449|561863424|FG003|Overall Study|Adverse Event|0|||
155663344|NCT03218917|561863425|FG000|Overall Study|Adverse Event|3|||
155663345|NCT03218917|561863426|FG001|Overall Study|Adverse Event|3|||
155663346|NCT03218917|561863427|FG002|Overall Study|Adverse Event|2|||
155663347|NCT03218917|561863425|FG000|Overall Study|Subject withdrew consent|2|||
155663348|NCT03218917|561863426|FG001|Overall Study|Subject withdrew consent|4|||
155663349|NCT03218917|561863427|FG002|Overall Study|Subject withdrew consent|10|||
155663350|NCT03218917|561863425|FG000|Overall Study|Physician Decision|0|||
155663351|NCT03218917|561863426|FG001|Overall Study|Physician Decision|1|||
155663352|NCT03218917|561863427|FG002|Overall Study|Physician Decision|1|||
155663353|NCT03218917|561863425|FG000|Overall Study|Lost to Follow-up|1|||
155663354|NCT03218917|561863426|FG001|Overall Study|Lost to Follow-up|0|||
155663355|NCT03218917|561863427|FG002|Overall Study|Lost to Follow-up|0|||
155663356|NCT03218917|561863425|FG000|Overall Study|Reason Missing|0|||
155663357|NCT03218917|561863426|FG001|Overall Study|Reason Missing|2|||
155663358|NCT03218917|561863427|FG002|Overall Study|Reason Missing|0|||
155663359|NCT03218917|561863425|FG000|Overall Study|Death|0|||
155663360|NCT03218917|561863426|FG001|Overall Study|Death|1|||
155663361|NCT03218917|561863427|FG002|Overall Study|Death|0|||
155663362|NCT03218917|561863425|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155663363|NCT03218917|561863426|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155663364|NCT03218917|561863427|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155663365|NCT00698828|561863430|FG000|Overall Study|Adverse Event|3|||
155663366|NCT00698828|561863431|FG001|Overall Study|Adverse Event|4|||
155663367|NCT00698828|561863432|FG002|Overall Study|Adverse Event|4|||
155663368|NCT00698828|561863430|FG000|Overall Study|Death|0|||
155663369|NCT00698828|561863431|FG001|Overall Study|Death|0|||
155663370|NCT00698828|561863432|FG002|Overall Study|Death|1|||
155663371|NCT00698828|561863430|FG000|Overall Study|Exacerbation of COPD|1|||
155663372|NCT00698828|561863431|FG001|Overall Study|Exacerbation of COPD|3|||
155663373|NCT00698828|561863432|FG002|Overall Study|Exacerbation of COPD|0|||
155663374|NCT00698828|561863430|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
155663375|NCT00698828|561863431|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
155663376|NCT00698828|561863432|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
155663377|NCT00698828|561863430|FG000|Overall Study|Investigator/Sponsor decision|1|||
155663378|NCT00698828|561863431|FG001|Overall Study|Investigator/Sponsor decision|0|||
155663379|NCT00698828|561863432|FG002|Overall Study|Investigator/Sponsor decision|2|||
155663380|NCT00698828|561863430|FG000|Overall Study|Lost to Follow-up|1|||
155579751|NCT00070564|561549579|FG005|Overall Study|Death|1|||
155579752|NCT00070564|561549574|FG000|Overall Study|Other, not protocol specified|17|||
155579753|NCT00070564|561549575|FG001|Overall Study|Other, not protocol specified|15|||
155579754|NCT00070564|561549576|FG002|Overall Study|Other, not protocol specified|14|||
155579755|NCT00070564|561549577|FG003|Overall Study|Other, not protocol specified|19|||
155579756|NCT00070564|561549578|FG004|Overall Study|Other, not protocol specified|6|||
155663381|NCT00698828|561863431|FG001|Overall Study|Lost to Follow-up|1|||
155663382|NCT00698828|561863432|FG002|Overall Study|Lost to Follow-up|0|||
155663383|NCT00698828|561863430|FG000|Overall Study|Withdrew consent|0|||
155663384|NCT00698828|561863431|FG001|Overall Study|Withdrew consent|7|||
155663385|NCT00698828|561863432|FG002|Overall Study|Withdrew consent|4|||
155663386|NCT00698828|561863430|FG000|Overall Study|Withdrew consent (not treated)|2|||
155579757|NCT00070564|561549579|FG005|Overall Study|Other, not protocol specified|7|||
155579758|NCT00070564|561549574|FG000|Overall Study|Withdrawal by Subject|26|||
155579759|NCT00070564|561549575|FG001|Overall Study|Withdrawal by Subject|37|||
155579760|NCT00070564|561549576|FG002|Overall Study|Withdrawal by Subject|23|||
155579761|NCT00070564|561549577|FG003|Overall Study|Withdrawal by Subject|30|||
155579762|NCT00070564|561549578|FG004|Overall Study|Withdrawal by Subject|8|||
155579763|NCT00070564|561549579|FG005|Overall Study|Withdrawal by Subject|8|||
155579764|NCT00070564|561549574|FG000|Overall Study|Not reported|0|||
155579765|NCT00070564|561549575|FG001|Overall Study|Not reported|0|||
155579766|NCT00070564|561549576|FG002|Overall Study|Not reported|0|||
155579767|NCT00070564|561549577|FG003|Overall Study|Not reported|0|||
155579768|NCT00070564|561549578|FG004|Overall Study|Not reported|1|||
155579769|NCT00070564|561549579|FG005|Overall Study|Not reported|0|||
155579770|NCT01168232|561549580|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
155579771|NCT01168232|561549580|FG000|Overall Study|Ineligible- Wrong cell type|6|||
155579772|NCT01168232|561549580|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
155579773|NCT03018288|561549590|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
155579774|NCT03018288|561549591|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
155579775|NCT03018288|561549592|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
155579776|NCT03018288|561549593|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
155579777|NCT03018288|561549590|FG000|Overall Study|Participant withdrew consent.|0|||
155579778|NCT03018288|561549591|FG001|Overall Study|Participant withdrew consent.|0|||
155579779|NCT03018288|561549592|FG002|Overall Study|Participant withdrew consent.|1|||
155579780|NCT03018288|561549593|FG003|Overall Study|Participant withdrew consent.|0|||
155579781|NCT03018288|561549590|FG000|Overall Study|Switched to alternative treatment.|0|||
155579782|NCT03018288|561549591|FG001|Overall Study|Switched to alternative treatment.|0|||
155579783|NCT03018288|561549592|FG002|Overall Study|Switched to alternative treatment.|1|||
155579784|NCT03018288|561549593|FG003|Overall Study|Switched to alternative treatment.|0|||
155579785|NCT03018288|561549590|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
155579786|NCT03018288|561549591|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
155579787|NCT03018288|561549592|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
155579788|NCT03018288|561549593|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
155579789|NCT03018288|561549590|FG000|Overall Study|Screen failures|0|||
155579790|NCT03018288|561549591|FG001|Overall Study|Screen failures|0|||
155579791|NCT03018288|561549592|FG002|Overall Study|Screen failures|0|||
155579792|NCT03018288|561549593|FG003|Overall Study|Screen failures|51|||
155579793|NCT03018288|561549590|FG000|Overall Study|Chose treatment outside of UNC|0|||
155579794|NCT03018288|561549591|FG001|Overall Study|Chose treatment outside of UNC|0|||
155579795|NCT03018288|561549592|FG002|Overall Study|Chose treatment outside of UNC|0|||
155579796|NCT03018288|561549593|FG003|Overall Study|Chose treatment outside of UNC|1|||
155579797|NCT03018288|561549590|FG000|Overall Study|Unable to comply with protocol requirements|1|||
155579798|NCT03018288|561549591|FG001|Overall Study|Unable to comply with protocol requirements|1|||
155579799|NCT03018288|561549592|FG002|Overall Study|Unable to comply with protocol requirements|0|||
155579800|NCT03018288|561549593|FG003|Overall Study|Unable to comply with protocol requirements|1|||
155579801|NCT03018288|561549590|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
155579802|NCT03018288|561549591|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
155579803|NCT03018288|561549592|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
155579804|NCT03018288|561549593|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
155579805|NCT03018288|561549590|FG000|Overall Study|Physician Decision|0|||
155579806|NCT03018288|561549591|FG001|Overall Study|Physician Decision|0|||
155579807|NCT03018288|561549592|FG002|Overall Study|Physician Decision|0|||
155579808|NCT03018288|561549593|FG003|Overall Study|Physician Decision|1|||
155579809|NCT01922037|561549597|FG000|Overall Study|Withdrawal by Subject|2|||
155579810|NCT01922037|561549598|FG001|Overall Study|Withdrawal by Subject|44|||
155579811|NCT01922037|561549597|FG000|Overall Study|Adverse Event|1|||
155579812|NCT01922037|561549598|FG001|Overall Study|Adverse Event|7|||
155579813|NCT01922037|561549597|FG000|Overall Study|Death|0|||
155579814|NCT01922037|561549598|FG001|Overall Study|Death|5|||
155579815|NCT01922037|561549597|FG000|Overall Study|Pregnancy|0|||
155579816|NCT01922037|561549598|FG001|Overall Study|Pregnancy|2|||
155579817|NCT01922037|561549597|FG000|Overall Study|Participant non-compliance|4|||
155579818|NCT01922037|561549598|FG001|Overall Study|Participant non-compliance|46|||
155579819|NCT01922037|561549597|FG000|Overall Study|Investigator/Sponsor decision|1|||
155579820|NCT01922037|561549598|FG001|Overall Study|Investigator/Sponsor decision|4|||
155579821|NCT01922037|561549597|FG000|Overall Study|Other unspecified|2|||
155579822|NCT01922037|561549598|FG001|Overall Study|Other unspecified|66|||
155579823|NCT01730053|561549599|FG000|Overall Study|Participant moved|0|||
155579824|NCT01730053|561549600|FG001|Overall Study|Participant moved|0|||
155579825|NCT01730053|561549601|FG002|Overall Study|Participant moved|1|||
155579826|NCT01730053|561549602|FG003|Overall Study|Participant moved|0|||
155579827|NCT01730053|561549603|FG004|Overall Study|Participant moved|0|||
155579828|NCT01730053|561549604|FG005|Overall Study|Participant moved|0|||
155579829|NCT01730053|561549599|FG000|Overall Study|Physician Decision|0|||
155579830|NCT01730053|561549600|FG001|Overall Study|Physician Decision|0|||
155579831|NCT01730053|561549601|FG002|Overall Study|Physician Decision|0|||
155579832|NCT01730053|561549602|FG003|Overall Study|Physician Decision|1|||
155579833|NCT01730053|561549603|FG004|Overall Study|Physician Decision|0|||
155579834|NCT01730053|561549604|FG005|Overall Study|Physician Decision|0|||
155579835|NCT01730053|561549599|FG000|Overall Study|Adverse Event|2|||
155579836|NCT01730053|561549600|FG001|Overall Study|Adverse Event|6|||
155579837|NCT01730053|561549601|FG002|Overall Study|Adverse Event|3|||
155579838|NCT01730053|561549602|FG003|Overall Study|Adverse Event|3|||
155579839|NCT01730053|561549603|FG004|Overall Study|Adverse Event|2|||
155579840|NCT01730053|561549604|FG005|Overall Study|Adverse Event|2|||
155579841|NCT01730053|561549599|FG000|Overall Study|Poor compliance to protocol|1|||
155579842|NCT01730053|561549600|FG001|Overall Study|Poor compliance to protocol|2|||
155579843|NCT01730053|561549601|FG002|Overall Study|Poor compliance to protocol|2|||
155579844|NCT01730053|561549602|FG003|Overall Study|Poor compliance to protocol|0|||
155579845|NCT01730053|561549603|FG004|Overall Study|Poor compliance to protocol|0|||
155579846|NCT01730053|561549604|FG005|Overall Study|Poor compliance to protocol|2|||
155579847|NCT01730053|561549599|FG000|Overall Study|Other than specified|2|||
155579848|NCT01730053|561549600|FG001|Overall Study|Other than specified|6|||
155579849|NCT01730053|561549601|FG002|Overall Study|Other than specified|5|||
155579850|NCT01730053|561549602|FG003|Overall Study|Other than specified|4|||
155579851|NCT01730053|561549603|FG004|Overall Study|Other than specified|7|||
155579852|NCT01730053|561549604|FG005|Overall Study|Other than specified|9|||
155579853|NCT02572570|561549605|FG000|Overall Study|Study Terminated|27|||
155579854|NCT00742209|561549611|FG000|Overall Study|Adverse Event|11|||
155579855|NCT00742209|561549612|FG001|Overall Study|Adverse Event|4|||
155579856|NCT00742209|561549613|FG002|Overall Study|Adverse Event|17|||
155579857|NCT00742209|561549614|FG003|Overall Study|Adverse Event|16|||
155579858|NCT00742209|561549615|FG004|Overall Study|Adverse Event|13|||
155579859|NCT00742209|561549611|FG000|Overall Study|Participant Withdrew Consent|8|||
155579860|NCT00742209|561549612|FG001|Overall Study|Participant Withdrew Consent|4|||
155579861|NCT00742209|561549613|FG002|Overall Study|Participant Withdrew Consent|14|||
155579862|NCT00742209|561549614|FG003|Overall Study|Participant Withdrew Consent|7|||
155579863|NCT00742209|561549615|FG004|Overall Study|Participant Withdrew Consent|4|||
155579864|NCT00742209|561549611|FG000|Overall Study|Protocol Violation|6|||
155579865|NCT00742209|561549612|FG001|Overall Study|Protocol Violation|5|||
155579866|NCT00742209|561549613|FG002|Overall Study|Protocol Violation|4|||
155579867|NCT00742209|561549614|FG003|Overall Study|Protocol Violation|5|||
155579868|NCT00742209|561549615|FG004|Overall Study|Protocol Violation|3|||
155579869|NCT00742209|561549611|FG000|Overall Study|Lost to Follow-up|3|||
155579870|NCT00742209|561549612|FG001|Overall Study|Lost to Follow-up|4|||
155579871|NCT00742209|561549613|FG002|Overall Study|Lost to Follow-up|5|||
155579872|NCT00742209|561549614|FG003|Overall Study|Lost to Follow-up|5|||
155579873|NCT00742209|561549615|FG004|Overall Study|Lost to Follow-up|3|||
155579874|NCT00742209|561549611|FG000|Overall Study|Lack of Efficacy|6|||
155579875|NCT00742209|561549612|FG001|Overall Study|Lack of Efficacy|1|||
155579876|NCT00742209|561549613|FG002|Overall Study|Lack of Efficacy|1|||
155579877|NCT00742209|561549614|FG003|Overall Study|Lack of Efficacy|3|||
155579878|NCT00742209|561549615|FG004|Overall Study|Lack of Efficacy|1|||
155579879|NCT00742209|561549611|FG000|Overall Study|Investigator Discretion|0|||
155579880|NCT00742209|561549612|FG001|Overall Study|Investigator Discretion|0|||
155579881|NCT00742209|561549613|FG002|Overall Study|Investigator Discretion|5|||
155579882|NCT00742209|561549614|FG003|Overall Study|Investigator Discretion|1|||
155579883|NCT00742209|561549615|FG004|Overall Study|Investigator Discretion|1|||
155579884|NCT00485264|561549616|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
155579885|NCT00485264|561549617|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
155579886|NCT00485264|561549618|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
155579887|NCT00485264|561549619|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
155579888|NCT00485264|561549620|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
155579889|NCT00485264|561549621|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
155579890|NCT00485264|561549616|FG000|Overall Study|Death|1|||
155579891|NCT00485264|561549617|FG001|Overall Study|Death|0|||
155579892|NCT00485264|561549618|FG002|Overall Study|Death|0|||
155579893|NCT00485264|561549619|FG003|Overall Study|Death|0|||
155579894|NCT00485264|561549620|FG004|Overall Study|Death|1|||
155579895|NCT00485264|561549621|FG005|Overall Study|Death|0|||
155579896|NCT00485264|561549616|FG000|Overall Study|Adverse Event|1|||
155579897|NCT00485264|561549617|FG001|Overall Study|Adverse Event|0|||
155579898|NCT00485264|561549618|FG002|Overall Study|Adverse Event|2|||
155579899|NCT00485264|561549619|FG003|Overall Study|Adverse Event|3|||
155579900|NCT00485264|561549620|FG004|Overall Study|Adverse Event|1|||
155579901|NCT00485264|561549621|FG005|Overall Study|Adverse Event|3|||
155579902|NCT00485264|561549616|FG000|Overall Study|Pregnancy|4|||
155579903|NCT00485264|561549617|FG001|Overall Study|Pregnancy|0|||
155579904|NCT00485264|561549618|FG002|Overall Study|Pregnancy|0|||
155579905|NCT00485264|561549619|FG003|Overall Study|Pregnancy|0|||
155579906|NCT00485264|561549620|FG004|Overall Study|Pregnancy|0|||
155579907|NCT00485264|561549621|FG005|Overall Study|Pregnancy|0|||
155579908|NCT00485264|561549616|FG000|Overall Study|Disallowed Medication|0|||
155579909|NCT00485264|561549617|FG001|Overall Study|Disallowed Medication|0|||
155579910|NCT00485264|561549618|FG002|Overall Study|Disallowed Medication|0|||
155579911|NCT00485264|561549619|FG003|Overall Study|Disallowed Medication|0|||
155579912|NCT00485264|561549620|FG004|Overall Study|Disallowed Medication|0|||
155579913|NCT00485264|561549621|FG005|Overall Study|Disallowed Medication|1|||
155579914|NCT00485264|561549616|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
155579915|NCT00485264|561549617|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
155579916|NCT00485264|561549618|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
155579917|NCT00485264|561549619|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
155579918|NCT00485264|561549620|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
155579919|NCT00485264|561549621|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
155579920|NCT00485264|561549616|FG000|Overall Study|Lack of Efficacy|0|||
155579921|NCT00485264|561549617|FG001|Overall Study|Lack of Efficacy|1|||
155579922|NCT00485264|561549618|FG002|Overall Study|Lack of Efficacy|0|||
155579923|NCT00485264|561549619|FG003|Overall Study|Lack of Efficacy|0|||
155579924|NCT00485264|561549620|FG004|Overall Study|Lack of Efficacy|0|||
155579925|NCT00485264|561549621|FG005|Overall Study|Lack of Efficacy|0|||
155579926|NCT00485264|561549616|FG000|Overall Study|Guardian Consent Withdrawn|1|||
155579927|NCT00485264|561549617|FG001|Overall Study|Guardian Consent Withdrawn|0|||
155579928|NCT00485264|561549618|FG002|Overall Study|Guardian Consent Withdrawn|0|||
155579929|NCT00485264|561549619|FG003|Overall Study|Guardian Consent Withdrawn|0|||
155579930|NCT00485264|561549620|FG004|Overall Study|Guardian Consent Withdrawn|1|||
155579931|NCT00485264|561549621|FG005|Overall Study|Guardian Consent Withdrawn|0|||
155579932|NCT00485264|561549616|FG000|Overall Study|Physician Decision|0|||
155579933|NCT00485264|561549617|FG001|Overall Study|Physician Decision|2|||
155579934|NCT00485264|561549618|FG002|Overall Study|Physician Decision|0|||
155579935|NCT00485264|561549619|FG003|Overall Study|Physician Decision|0|||
155579936|NCT00485264|561549620|FG004|Overall Study|Physician Decision|0|||
155579937|NCT00485264|561549621|FG005|Overall Study|Physician Decision|0|||
155579938|NCT00485264|561549616|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155579939|NCT00485264|561549617|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155579940|NCT00485264|561549618|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
155579941|NCT00485264|561549619|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155579942|NCT00485264|561549620|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155579943|NCT00485264|561549621|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155579944|NCT00485264|561549616|FG000|Overall Study|Not Able to Attend Clinic|5|||
155579945|NCT00485264|561549617|FG001|Overall Study|Not Able to Attend Clinic|0|||
155579946|NCT00485264|561549618|FG002|Overall Study|Not Able to Attend Clinic|0|||
155579947|NCT00485264|561549619|FG003|Overall Study|Not Able to Attend Clinic|1|||
155579948|NCT00485264|561549620|FG004|Overall Study|Not Able to Attend Clinic|1|||
155579949|NCT00485264|561549621|FG005|Overall Study|Not Able to Attend Clinic|2|||
155579950|NCT00485264|561549616|FG000|Overall Study|Non-Compliant|17|||
155579951|NCT00485264|561549617|FG001|Overall Study|Non-Compliant|2|||
155579952|NCT00485264|561549618|FG002|Overall Study|Non-Compliant|1|||
155579953|NCT00485264|561549619|FG003|Overall Study|Non-Compliant|0|||
155579954|NCT00485264|561549620|FG004|Overall Study|Non-Compliant|1|||
155579955|NCT00485264|561549621|FG005|Overall Study|Non-Compliant|0|||
155579956|NCT00485264|561549616|FG000|Overall Study|Lost to Follow-up|2|||
155579957|NCT00485264|561549617|FG001|Overall Study|Lost to Follow-up|1|||
155579958|NCT00485264|561549618|FG002|Overall Study|Lost to Follow-up|1|||
155579959|NCT00485264|561549619|FG003|Overall Study|Lost to Follow-up|0|||
155579960|NCT00485264|561549620|FG004|Overall Study|Lost to Follow-up|0|||
155579961|NCT00485264|561549621|FG005|Overall Study|Lost to Follow-up|1|||
155579962|NCT00485264|561549616|FG000|Overall Study|Other Reason|3|||
155579963|NCT00485264|561549617|FG001|Overall Study|Other Reason|0|||
155579964|NCT00485264|561549618|FG002|Overall Study|Other Reason|0|||
155579965|NCT00485264|561549619|FG003|Overall Study|Other Reason|0|||
155579966|NCT00485264|561549620|FG004|Overall Study|Other Reason|0|||
155579967|NCT00485264|561549621|FG005|Overall Study|Other Reason|0|||
155579968|NCT01514461|561549622|FG000|Overall Study|Adverse Event|2|||
155579969|NCT01514461|561549623|FG001|Overall Study|Adverse Event|1|||
155579970|NCT01514461|561549624|FG002|Overall Study|Adverse Event|3|||
155579971|NCT01514461|561549622|FG000|Overall Study|Physician Decision|1|||
155579972|NCT01514461|561549623|FG001|Overall Study|Physician Decision|1|||
155579973|NCT01514461|561549624|FG002|Overall Study|Physician Decision|0|||
155579974|NCT01514461|561549622|FG000|Overall Study|Patient/guardian decision|1|||
155579975|NCT01514461|561549623|FG001|Overall Study|Patient/guardian decision|1|||
155579976|NCT01514461|561549624|FG002|Overall Study|Patient/guardian decision|1|||
155579977|NCT01514461|561549622|FG000|Overall Study|Death|1|||
155579978|NCT01514461|561549623|FG001|Overall Study|Death|0|||
155579979|NCT01514461|561549624|FG002|Overall Study|Death|0|||
155579980|NCT03565900|561549625|FG000|Overall Study|Disposition Unknown|4|||
155579981|NCT03565900|561549626|FG001|Overall Study|Disposition Unknown|1|||
155579982|NCT03565900|561549625|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155579983|NCT03565900|561549626|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
155579984|NCT03565900|561549625|FG000|Overall Study|Withdrawal by Subject|4|||
155579985|NCT03565900|561549626|FG001|Overall Study|Withdrawal by Subject|5|||
155579986|NCT03565900|561549625|FG000|Overall Study|Randomized By Mistake|0|||
155579987|NCT03565900|561549626|FG001|Overall Study|Randomized By Mistake|2|||
155579988|NCT03565900|561549625|FG000|Overall Study|Physician Decision|7|||
155579989|NCT03565900|561549626|FG001|Overall Study|Physician Decision|11|||
155579990|NCT03565900|561549625|FG000|Overall Study|Death|9|||
155579991|NCT03565900|561549626|FG001|Overall Study|Death|7|||
155579992|NCT03359850|561549629|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
155579993|NCT03359850|561549630|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
155579994|NCT03359850|561549629|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
155579995|NCT03359850|561549630|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
155579996|NCT03359850|561549629|FG000|Extension Phase (Up to 28 Months)|Death|2|||
155579997|NCT03359850|561549630|FG001|Extension Phase (Up to 28 Months)|Death|4|||
155579998|NCT03359850|561549629|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
155579999|NCT03359850|561549630|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
155580000|NCT03359850|561549629|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
155580001|NCT03359850|561549630|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
155580002|NCT03817125|561549648|FG000|Overall Study|Adverse Event|1|||
155580003|NCT03817125|561549649|FG001|Overall Study|Adverse Event|0|||
155580004|NCT03817125|561549648|FG000|Overall Study|Physician Decision|0|||
155580005|NCT03817125|561549649|FG001|Overall Study|Physician Decision|1|||
155580006|NCT03817125|561549648|FG000|Overall Study|Lack of Efficacy|1|||
155580007|NCT03817125|561549649|FG001|Overall Study|Lack of Efficacy|5|||
155580008|NCT00942084|561549650|FG000|Overall Study|Death|2|||
155580009|NCT01037218|561549653|FG000|Overall Study|Adverse Event|4|||
155580010|NCT01037218|561549654|FG001|Overall Study|Adverse Event|2|||
155580011|NCT01037218|561549655|FG002|Overall Study|Adverse Event|2|||
155580012|NCT01037218|561549656|FG003|Overall Study|Adverse Event|1|||
155580013|NCT01037218|561549653|FG000|Overall Study|Lack of Efficacy|0|||
155580014|NCT01037218|561549654|FG001|Overall Study|Lack of Efficacy|2|||
155580015|NCT01037218|561549655|FG002|Overall Study|Lack of Efficacy|1|||
155580016|NCT01037218|561549656|FG003|Overall Study|Lack of Efficacy|5|||
155580017|NCT01037218|561549653|FG000|Overall Study|Lost to Follow-up|3|||
155580018|NCT01037218|561549654|FG001|Overall Study|Lost to Follow-up|5|||
155580019|NCT01037218|561549655|FG002|Overall Study|Lost to Follow-up|4|||
155580020|NCT01037218|561549656|FG003|Overall Study|Lost to Follow-up|2|||
155580021|NCT01037218|561549653|FG000|Overall Study|Withdrawal by Subject|6|||
155580022|NCT01037218|561549654|FG001|Overall Study|Withdrawal by Subject|7|||
155580023|NCT01037218|561549655|FG002|Overall Study|Withdrawal by Subject|7|||
155580024|NCT01037218|561549656|FG003|Overall Study|Withdrawal by Subject|4|||
155580025|NCT01037218|561549653|FG000|Overall Study|Partner Withdrew Consent|0|||
155580026|NCT01037218|561549654|FG001|Overall Study|Partner Withdrew Consent|3|||
155580027|NCT01037218|561549655|FG002|Overall Study|Partner Withdrew Consent|2|||
155580028|NCT01037218|561549656|FG003|Overall Study|Partner Withdrew Consent|1|||
155580029|NCT01037218|561549653|FG000|Overall Study|Protocol Violation|0|||
155580030|NCT01037218|561549654|FG001|Overall Study|Protocol Violation|0|||
155580031|NCT01037218|561549655|FG002|Overall Study|Protocol Violation|2|||
155580032|NCT01037218|561549656|FG003|Overall Study|Protocol Violation|2|||
155580033|NCT01037218|561549653|FG000|Overall Study|Various|3|||
155580034|NCT01037218|561549654|FG001|Overall Study|Various|2|||
155580035|NCT01037218|561549655|FG002|Overall Study|Various|3|||
155580036|NCT01037218|561549656|FG003|Overall Study|Various|1|||
155580037|NCT02568072|561549657|FG000|Overall Study|Unavailable for appointment|23|||
155580038|NCT02568072|561549657|FG000|Overall Study|Unable to contact|3|||
155580039|NCT02568072|561549657|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
155580040|NCT02568072|561549657|FG000|Overall Study|Withdrawal by Subject|1|||
155580041|NCT02568072|561549657|FG000|Overall Study|Sustained injury, marathon not run|24|||
155580042|NCT00927589|561549659|FG000|Overall Study|Death|1|||
155580043|NCT00927589|561549659|FG000|Overall Study|Physician Decision|1|||
155580044|NCT00927589|561549659|FG000|Overall Study|Withdrawal by Subject|3|||
155580045|NCT00927589|561549659|FG000|Overall Study|Adverse Event|2|||
155580046|NCT00927589|561549659|FG000|Overall Study|Disease Progression|8|||
155580047|NCT00927589|561549659|FG000|Overall Study|Non-compliance|1|||
155663387|NCT00698828|561863431|FG001|Overall Study|Withdrew consent (not treated)|0|||
155663388|NCT00698828|561863432|FG002|Overall Study|Withdrew consent (not treated)|0|||
155580048|NCT05263908|561549661|FG000|Overall Study|No informed consent for publication of study results|397|||
155580049|NCT05263908|561549661|FG000|Overall Study|CRF not collected|1|||
155580050|NCT02714218|561549662|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155580051|NCT02714218|561549663|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155580052|NCT02714218|561549664|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155580053|NCT02714218|561549662|FG000|Pre-Treatment Period|Other reasons|0|||
155580054|NCT02714218|561549663|FG001|Pre-Treatment Period|Other reasons|1|||
155580055|NCT02714218|561549664|FG002|Pre-Treatment Period|Other reasons|0|||
155580056|NCT02714218|561549662|FG000|Treatment Period|Disease Progression|55|||
155580057|NCT02714218|561549663|FG001|Treatment Period|Disease Progression|52|||
155580058|NCT02714218|561549664|FG002|Treatment Period|Disease Progression|14|||
155580059|NCT02714218|561549662|FG000|Treatment Period|Study drug toxicity|46|||
155663389|NCT02013609|561863433|FG000|Overall Study|Withdrawal by Subject|9|||
155663390|NCT02013609|561863433|FG000|Overall Study|Lost to Follow-up|3|||
155580060|NCT02714218|561549663|FG001|Treatment Period|Study drug toxicity|70|||
155580061|NCT02714218|561549664|FG002|Treatment Period|Study drug toxicity|6|||
155580062|NCT02714218|561549662|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
155580063|NCT02714218|561549663|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
155580064|NCT02714218|561549664|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
155580065|NCT02714218|561549662|FG000|Treatment Period|Request to discontinue treatment|1|||
155580066|NCT02714218|561549663|FG001|Treatment Period|Request to discontinue treatment|4|||
155580067|NCT02714218|561549664|FG002|Treatment Period|Request to discontinue treatment|1|||
155580068|NCT02714218|561549662|FG000|Treatment Period|Participant withdrew consent|2|||
155580069|NCT02714218|561549663|FG001|Treatment Period|Participant withdrew consent|2|||
155580070|NCT02714218|561549664|FG002|Treatment Period|Participant withdrew consent|0|||
155580071|NCT02714218|561549662|FG000|Treatment Period|Maximum clinical benefit|4|||
155580072|NCT02714218|561549663|FG001|Treatment Period|Maximum clinical benefit|2|||
155580073|NCT02714218|561549664|FG002|Treatment Period|Maximum clinical benefit|0|||
155580074|NCT02714218|561549662|FG000|Treatment Period|Administrative reason by sponsor|2|||
155580075|NCT02714218|561549663|FG001|Treatment Period|Administrative reason by sponsor|1|||
155580076|NCT02714218|561549664|FG002|Treatment Period|Administrative reason by sponsor|0|||
155580077|NCT02714218|561549662|FG000|Treatment Period|Other reasons|6|||
155580078|NCT02714218|561549663|FG001|Treatment Period|Other reasons|6|||
155580079|NCT02714218|561549664|FG002|Treatment Period|Other reasons|0|||
155580080|NCT02714218|561549662|FG000|Treatment Period|Completed treatment as per protocol|36|||
155580081|NCT02714218|561549663|FG001|Treatment Period|Completed treatment as per protocol|27|||
155580082|NCT02714218|561549664|FG002|Treatment Period|Completed treatment as per protocol|3|||
155580083|NCT02714218|561549662|FG000|Treatment Period|Not reported|9|||
155580084|NCT02714218|561549663|FG001|Treatment Period|Not reported|6|||
155580085|NCT02714218|561549664|FG002|Treatment Period|Not reported|0|||
155580086|NCT01641640|561549665|FG000|Overall Study|Enrolled but not treated|1|||
155580087|NCT01641640|561549665|FG000|Overall Study|Efficacy failure|29|||
155580088|NCT01641640|561549665|FG000|Overall Study|Lost to Follow-up|3|||
155580089|NCT01641640|561549665|FG000|Overall Study|Withdrawal by Subject|2|||
155580090|NCT01641640|561549665|FG000|Overall Study|Adverse Event|1|||
155580091|NCT01199939|561549667|FG000|Overall Study|Adverse Event|4|||
155580092|NCT01199939|561549667|FG000|Overall Study|Protocol Violation|3|||
155580093|NCT01199939|561549667|FG000|Overall Study|Lost to Follow-up|2|||
155580094|NCT01199939|561549667|FG000|Overall Study|Reached a virologic endpoint|4|||
155580095|NCT02792517|561549668|FG000|Overall Study|Withdrawal by Subject|10|||
155580096|NCT02792517|561549668|FG000|Overall Study|Decision by Sponsor|7|||
155580097|NCT02792517|561549668|FG000|Overall Study|Lost to Follow-up|3|||
155580098|NCT03875508|561549669|FG000|Overall Study|Adverse Event|1|||
155580099|NCT03875508|561549669|FG000|Overall Study|Lost to Follow-up|8|||
155580100|NCT03875508|561549669|FG000|Overall Study|Lack of Efficacy|1|||
155580101|NCT03875508|561549669|FG000|Overall Study|Other, not specified|2|||
155580102|NCT01113892|561549670|FG000|Overall Study|Lost to Follow-up|2|||
155580103|NCT01113892|561549671|FG001|Overall Study|Lost to Follow-up|2|||
155580104|NCT01113892|561549670|FG000|Overall Study|Withdrawal by Subject|1|||
155580105|NCT01113892|561549671|FG001|Overall Study|Withdrawal by Subject|1|||
155580106|NCT01113892|561549670|FG000|Overall Study|Death|2|||
155580107|NCT01113892|561549671|FG001|Overall Study|Death|4|||
155580108|NCT01113892|561549670|FG000|Overall Study|Graft no longer evaluable|9|||
155663391|NCT02013609|561863433|FG000|Overall Study|Adverse Event|3|||
155663392|NCT02013609|561863433|FG000|Overall Study|Met Withdrawal Criteria|3|||
155663393|NCT01816295|561863434|FG000|Double Blind Phase|Adverse Event|11|||
155663394|NCT01816295|561863435|FG001|Double Blind Phase|Adverse Event|8|||
155663395|NCT01816295|561863434|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
155663396|NCT01816295|561863435|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
155663397|NCT01816295|561863434|FG000|Double Blind Phase|Lost to Follow-up|3|||
155663398|NCT01816295|561863435|FG001|Double Blind Phase|Lost to Follow-up|5|||
155580109|NCT01113892|561549671|FG001|Overall Study|Graft no longer evaluable|9|||
155580110|NCT00789854|561549680|FG000|Overall Study|Adverse Event|28|||
155580111|NCT00789854|561549681|FG001|Overall Study|Adverse Event|23|||
155580112|NCT00789854|561549682|FG002|Overall Study|Adverse Event|18|||
155580113|NCT00789854|561549680|FG000|Overall Study|Lost to Follow-up|1|||
155580114|NCT00789854|561549681|FG001|Overall Study|Lost to Follow-up|1|||
155580115|NCT00789854|561549682|FG002|Overall Study|Lost to Follow-up|4|||
155580116|NCT00789854|561549680|FG000|Overall Study|Withdrawal by Subject|9|||
155663399|NCT01816295|561863434|FG000|Double Blind Phase|Physician Decision|2|||
155663400|NCT01816295|561863435|FG001|Double Blind Phase|Physician Decision|2|||
155663401|NCT01816295|561863434|FG000|Double Blind Phase|Protocol Violation|17|||
155580117|NCT00789854|561549681|FG001|Overall Study|Withdrawal by Subject|6|||
155580118|NCT00789854|561549682|FG002|Overall Study|Withdrawal by Subject|17|||
155580119|NCT00789854|561549680|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155580120|NCT00789854|561549681|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
155580121|NCT00789854|561549682|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155580122|NCT00789854|561549680|FG000|Overall Study|Severe non-compliance to the protocol|3|||
155580123|NCT00789854|561549681|FG001|Overall Study|Severe non-compliance to the protocol|0|||
155580124|NCT00789854|561549682|FG002|Overall Study|Severe non-compliance to the protocol|0|||
155580125|NCT00789854|561549680|FG000|Overall Study|Safety reasons|0|||
155580126|NCT00789854|561549681|FG001|Overall Study|Safety reasons|0|||
155580127|NCT00789854|561549682|FG002|Overall Study|Safety reasons|2|||
155580128|NCT00789854|561549680|FG000|Overall Study|Other|6|||
155580129|NCT00789854|561549681|FG001|Overall Study|Other|0|||
155580130|NCT00789854|561549682|FG002|Overall Study|Other|5|||
155580131|NCT02766335|561549683|FG000|Initial Registration|Adverse Event|6|||
155580132|NCT02766335|561549684|FG001|Initial Registration|Adverse Event|3|||
155580133|NCT02766335|561549685|FG002|Initial Registration|Adverse Event|0|||
155580134|NCT02766335|561549683|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
155580135|NCT02766335|561549684|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
155580136|NCT02766335|561549685|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
155580137|NCT02766335|561549683|FG000|Initial Registration|Progression/relapse|49|||
155580138|NCT02766335|561549684|FG001|Initial Registration|Progression/relapse|15|||
155580139|NCT02766335|561549685|FG002|Initial Registration|Progression/relapse|0|||
155580140|NCT02766335|561549683|FG000|Initial Registration|Death|1|||
155580141|NCT02766335|561549684|FG001|Initial Registration|Death|3|||
155580142|NCT02766335|561549685|FG002|Initial Registration|Death|0|||
155580143|NCT02766335|561549683|FG000|Initial Registration|not protocol specified|1|||
155580144|NCT02766335|561549684|FG001|Initial Registration|not protocol specified|9|||
155580145|NCT02766335|561549685|FG002|Initial Registration|not protocol specified|0|||
155580146|NCT02766335|561549683|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
155580147|NCT02766335|561549684|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
155580148|NCT02766335|561549685|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
155580149|NCT02766335|561549683|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
155580150|NCT02766335|561549684|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
155580151|NCT02766335|561549685|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
155580152|NCT00281957|561549686|FG000|Overall Study|Adverse Event|7|||
155580153|NCT00281957|561549687|FG001|Overall Study|Adverse Event|2|||
155580154|NCT00281957|561549686|FG000|Overall Study|Death|1|||
155580155|NCT00281957|561549687|FG001|Overall Study|Death|0|||
155580156|NCT00281957|561549686|FG000|Overall Study|Progression/relapse|47|||
155580157|NCT00281957|561549687|FG001|Overall Study|Progression/relapse|35|||
155580158|NCT00281957|561549686|FG000|Overall Study|Not protocol specified|8|||
155580159|NCT00281957|561549687|FG001|Overall Study|Not protocol specified|1|||
155580160|NCT00281957|561549686|FG000|Overall Study|Not eligible|1|||
155580161|NCT00281957|561549687|FG001|Overall Study|Not eligible|2|||
155580162|NCT00281957|561549686|FG000|Overall Study|Did not start treatment|3|||
155580163|NCT00281957|561549687|FG001|Overall Study|Did not start treatment|1|||
155580164|NCT00281957|561549686|FG000|Overall Study|Refusal unrelated to adverse events|0|||
155580165|NCT00281957|561549687|FG001|Overall Study|Refusal unrelated to adverse events|1|||
155580166|NCT03281876|561549695|FG000|Overall Study|Adverse Event|4|||
155580167|NCT03281876|561549696|FG001|Overall Study|Adverse Event|15|||
155580168|NCT03281876|561549695|FG000|Overall Study|Lost to Follow-up|1|||
155580169|NCT03281876|561549696|FG001|Overall Study|Lost to Follow-up|4|||
155580170|NCT03281876|561549695|FG000|Overall Study|Withdrawal by Subject|11|||
155580171|NCT03281876|561549696|FG001|Overall Study|Withdrawal by Subject|15|||
155580172|NCT03281876|561549695|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155580173|NCT03281876|561549696|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155580174|NCT03281876|561549695|FG000|Overall Study|OTHER|5|||
155580175|NCT03281876|561549696|FG001|Overall Study|OTHER|5|||
155580176|NCT01964976|561549698|FG000|Overall Study|Protocol Violation|31|||
155580177|NCT02452476|561549699|FG000|Overall Study|Death|4|||
155580178|NCT02452476|561549700|FG001|Overall Study|Death|7|||
155580179|NCT02452476|561549699|FG000|Overall Study|Lost to Follow-up|1|||
155580180|NCT02452476|561549700|FG001|Overall Study|Lost to Follow-up|1|||
155580181|NCT02452476|561549699|FG000|Overall Study|Physician Decision|1|||
155580182|NCT02452476|561549700|FG001|Overall Study|Physician Decision|1|||
155580183|NCT02452476|561549699|FG000|Overall Study|Not treated|5|||
155580184|NCT02452476|561549700|FG001|Overall Study|Not treated|1|||
155580185|NCT01074944|561549703|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
155580186|NCT01074944|561549704|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155580187|NCT01074944|561549705|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155580188|NCT01074944|561549706|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155580189|NCT01074944|561549707|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155580190|NCT01074944|561549703|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
155580191|NCT01074944|561549704|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155580192|NCT01074944|561549705|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155580193|NCT01074944|561549706|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155580194|NCT01074944|561549707|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155580195|NCT01074944|561549703|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
155580196|NCT01074944|561549704|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155580197|NCT01074944|561549705|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155580198|NCT01074944|561549706|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155580199|NCT01074944|561549707|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155580200|NCT01074944|561549703|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
155580201|NCT01074944|561549704|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155580202|NCT01074944|561549705|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155580203|NCT01074944|561549706|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155580204|NCT01074944|561549707|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155580205|NCT01074944|561549703|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155580206|NCT01074944|561549704|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
155580207|NCT01074944|561549705|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
155580208|NCT01074944|561549706|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155580209|NCT01074944|561549707|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155580210|NCT01074944|561549703|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155580211|NCT01074944|561549704|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
155580212|NCT01074944|561549705|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
155580213|NCT01074944|561549706|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155580214|NCT01074944|561549707|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155580215|NCT01074944|561549703|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155580216|NCT01074944|561549704|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
155580217|NCT01074944|561549705|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
155580218|NCT01074944|561549706|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155580219|NCT01074944|561549707|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155580220|NCT01074944|561549703|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155580221|NCT01074944|561549704|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
155580222|NCT01074944|561549705|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155580223|NCT01074944|561549706|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155580224|NCT01074944|561549707|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155580225|NCT01074944|561549703|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155580226|NCT01074944|561549704|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
155580227|NCT01074944|561549705|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
155580228|NCT01074944|561549706|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155580229|NCT01074944|561549707|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155580230|NCT01074944|561549703|FG000|Long Term Treatment|Adverse Event|0|||
155580231|NCT01074944|561549704|FG001|Long Term Treatment|Adverse Event|0|||
155580232|NCT01074944|561549705|FG002|Long Term Treatment|Adverse Event|0|||
155580233|NCT01074944|561549706|FG003|Long Term Treatment|Adverse Event|3|||
155580234|NCT01074944|561549707|FG004|Long Term Treatment|Adverse Event|0|||
155580235|NCT01074944|561549703|FG000|Long Term Treatment|Lost to Follow-up|0|||
155580236|NCT01074944|561549704|FG001|Long Term Treatment|Lost to Follow-up|0|||
155580237|NCT01074944|561549705|FG002|Long Term Treatment|Lost to Follow-up|0|||
155580238|NCT01074944|561549706|FG003|Long Term Treatment|Lost to Follow-up|2|||
155580239|NCT01074944|561549707|FG004|Long Term Treatment|Lost to Follow-up|0|||
155580240|NCT01074944|561549703|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155580241|NCT01074944|561549704|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155580242|NCT01074944|561549705|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155580243|NCT01074944|561549706|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
155580244|NCT01074944|561549707|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155580245|NCT01074944|561549703|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
155580246|NCT01074944|561549704|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
155580247|NCT01074944|561549705|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
155580248|NCT01074944|561549706|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
155580249|NCT01074944|561549707|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
155580250|NCT01074944|561549703|FG000|Long Term Treatment|Withdrawal by Subject|0|||
155580251|NCT01074944|561549704|FG001|Long Term Treatment|Withdrawal by Subject|0|||
155580252|NCT01074944|561549705|FG002|Long Term Treatment|Withdrawal by Subject|0|||
155580253|NCT01074944|561549706|FG003|Long Term Treatment|Withdrawal by Subject|2|||
155580254|NCT01074944|561549707|FG004|Long Term Treatment|Withdrawal by Subject|0|||
155580255|NCT01074944|561549703|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155580256|NCT01074944|561549704|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155663402|NCT01816295|561863435|FG001|Double Blind Phase|Protocol Violation|11|||
155663403|NCT01816295|561863434|FG000|Double Blind Phase|Sponsor Decision|8|||
155663404|NCT01816295|561863435|FG001|Double Blind Phase|Sponsor Decision|8|||
155663405|NCT01816295|561863434|FG000|Double Blind Phase|Withdrawal by Subject|22|||
155663406|NCT01816295|561863435|FG001|Double Blind Phase|Withdrawal by Subject|20|||
155663407|NCT01816295|561863434|FG000|OLE Phase|Adverse Event|17|||
155663408|NCT01816295|561863435|FG001|OLE Phase|Adverse Event|15|||
155663409|NCT01816295|561863434|FG000|OLE Phase|Death|1|||
155663410|NCT01816295|561863435|FG001|OLE Phase|Death|0|||
155663411|NCT01816295|561863434|FG000|OLE Phase|Entry Criteria Not Met|3|||
155663412|NCT01816295|561863435|FG001|OLE Phase|Entry Criteria Not Met|5|||
155663413|NCT01816295|561863434|FG000|OLE Phase|Lost to Follow-up|5|||
155663414|NCT01816295|561863435|FG001|OLE Phase|Lost to Follow-up|5|||
155663415|NCT01816295|561863434|FG000|OLE Phase|Physician Decision|3|||
155663416|NCT01816295|561863435|FG001|OLE Phase|Physician Decision|1|||
155663417|NCT01816295|561863434|FG000|OLE Phase|Protocol Violation|4|||
155663418|NCT01816295|561863435|FG001|OLE Phase|Protocol Violation|4|||
155663419|NCT01816295|561863434|FG000|OLE Phase|Sponsor Decision|7|||
155663420|NCT01816295|561863435|FG001|OLE Phase|Sponsor Decision|9|||
155663421|NCT01816295|561863434|FG000|OLE Phase|Withdrawal by Subject|10|||
155663422|NCT01816295|561863435|FG001|OLE Phase|Withdrawal by Subject|10|||
155663423|NCT01816295|561863434|FG000|OLE Phase|Lack of Efficacy|3|||
155663424|NCT01816295|561863435|FG001|OLE Phase|Lack of Efficacy|7|||
155663425|NCT01119287|561863436|FG000|Overall Study|Patient Decision, not related to AE|0|||
155663426|NCT01119287|561863437|FG001|Overall Study|Patient Decision, not related to AE|0|||
155663427|NCT01119287|561863438|FG002|Overall Study|Patient Decision, not related to AE|2|||
155663428|NCT01119287|561863439|FG003|Overall Study|Patient Decision, not related to AE|2|||
155663429|NCT01119287|561863440|FG004|Overall Study|Patient Decision, not related to AE|1|||
155663430|NCT01119287|561863441|FG005|Overall Study|Patient Decision, not related to AE|0|||
155663431|NCT01534481|561863454|FG000|Overall Study|Lost to Follow-up|29|||
155663432|NCT01534481|561863455|FG001|Overall Study|Lost to Follow-up|24|||
155663433|NCT01534481|561863454|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
155663434|NCT01534481|561863455|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
155663435|NCT00945659|561863456|FG000|Overall Study|Lost to Follow-up|7|||
155663436|NCT00945659|561863457|FG001|Overall Study|Lost to Follow-up|20|||
155663437|NCT00945659|561863458|FG002|Overall Study|Lost to Follow-up|17|||
155663438|NCT03498716|561863473|FG000|Overall Study|Withdrawal by Subject|88|||
155663439|NCT03498716|561863474|FG001|Overall Study|Withdrawal by Subject|73|||
155663440|NCT03498716|561863473|FG000|Overall Study|Study Terminated By Sponsor|933|||
155663441|NCT03498716|561863474|FG001|Overall Study|Study Terminated By Sponsor|927|||
155663442|NCT03498716|561863473|FG000|Overall Study|Lost to Follow-up|15|||
155663443|NCT03498716|561863474|FG001|Overall Study|Lost to Follow-up|26|||
155663444|NCT03498716|561863473|FG000|Overall Study|Disease Relapse|0|||
155663445|NCT03498716|561863474|FG001|Overall Study|Disease Relapse|1|||
155663446|NCT03498716|561863473|FG000|Overall Study|Death|58|||
155663447|NCT03498716|561863474|FG001|Overall Study|Death|72|||
155663448|NCT03498716|561863473|FG000|Overall Study|Physician Decision|4|||
155663449|NCT03498716|561863474|FG001|Overall Study|Physician Decision|2|||
155663450|NCT02284191|561863475|FG000|Overall Study|Withdrawal by Subject|1|||
155663451|NCT02284191|561863476|FG001|Overall Study|Withdrawal by Subject|3|||
155663452|NCT02284191|561863475|FG000|Overall Study|Lost to Follow-up|1|||
155663453|NCT02284191|561863476|FG001|Overall Study|Lost to Follow-up|0|||
155663454|NCT02257684|561863479|FG000|Overall Study|Adverse Event|2|||
155663455|NCT02257684|561863479|FG000|Overall Study|Lack of Efficacy|1|||
155663456|NCT02257684|561863479|FG000|Overall Study|Sponsor's Decision|1|||
155663457|NCT01448616|561863483|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
155663458|NCT01448616|561863484|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155663459|NCT01448616|561863485|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155663460|NCT01448616|561863486|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155663461|NCT01448616|561863483|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
155663462|NCT01448616|561863484|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155663463|NCT01448616|561863485|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155663464|NCT01448616|561863486|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155663465|NCT01448616|561863483|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
155663466|NCT01448616|561863484|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
155663467|NCT01448616|561863485|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
155663468|NCT01448616|561863486|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
155663469|NCT01448616|561863483|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
155663470|NCT01448616|561863484|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
155663471|NCT01448616|561863485|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
155663472|NCT01448616|561863486|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
155663473|NCT01448616|561863483|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
155663474|NCT01448616|561863484|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
155663475|NCT01448616|561863485|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
155663476|NCT01448616|561863486|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
155580257|NCT01074944|561549705|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155580258|NCT01074944|561549706|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155580259|NCT01074944|561549707|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
155580260|NCT01074944|561549703|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155580261|NCT01074944|561549704|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155580262|NCT01074944|561549705|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155663477|NCT01570387|561863487|FG000|Overall Study|Adverse Event|1|||
155663478|NCT01570387|561863488|FG001|Overall Study|Adverse Event|0|||
155663479|NCT01570387|561863489|FG002|Overall Study|Adverse Event|0|||
155663480|NCT01570387|561863490|FG003|Overall Study|Adverse Event|0|||
155663481|NCT01570387|561863487|FG000|Overall Study|Death|0|||
155663482|NCT01570387|561863488|FG001|Overall Study|Death|0|||
155663483|NCT01570387|561863489|FG002|Overall Study|Death|0|||
155663484|NCT01570387|561863490|FG003|Overall Study|Death|1|||
155663485|NCT01570387|561863487|FG000|Overall Study|Withdrawal by Subject|0|||
155663486|NCT01570387|561863488|FG001|Overall Study|Withdrawal by Subject|0|||
155663487|NCT01570387|561863489|FG002|Overall Study|Withdrawal by Subject|0|||
155663488|NCT01570387|561863490|FG003|Overall Study|Withdrawal by Subject|1|||
155663489|NCT01987557|561863491|FG000|Overall Study|Protocol Violation|1|||
155663490|NCT01987557|561863492|FG001|Overall Study|Protocol Violation|0|||
155663491|NCT01987557|561863493|FG002|Overall Study|Protocol Violation|1|||
155663492|NCT01987557|561863491|FG000|Overall Study|Withdrawal by Subject|2|||
155663493|NCT01987557|561863492|FG001|Overall Study|Withdrawal by Subject|1|||
155663494|NCT01987557|561863493|FG002|Overall Study|Withdrawal by Subject|2|||
155663495|NCT01987557|561863491|FG000|Overall Study|Adverse Event|0|||
155663496|NCT01987557|561863492|FG001|Overall Study|Adverse Event|2|||
155663497|NCT01987557|561863493|FG002|Overall Study|Adverse Event|0|||
155663498|NCT03323164|561863494|FG000|Overall Study|Poor quality imaging/scans|2|||
155663499|NCT03323164|561863495|FG001|Overall Study|Poor quality imaging/scans|2|||
155663500|NCT00461708|561863496|FG000|Overall Study|Adverse Event|17|||
155663501|NCT00461708|561863497|FG001|Overall Study|Adverse Event|7|||
155663502|NCT00461708|561863496|FG000|Overall Study|Lack of Efficacy|68|||
155663503|NCT00461708|561863497|FG001|Overall Study|Lack of Efficacy|20|||
155663504|NCT00461708|561863496|FG000|Overall Study|Physician Decision|10|||
155663505|NCT00461708|561863497|FG001|Overall Study|Physician Decision|4|||
155663506|NCT00461708|561863496|FG000|Overall Study|Withdrawal by Subject|8|||
155663507|NCT00461708|561863497|FG001|Overall Study|Withdrawal by Subject|2|||
155663508|NCT00461708|561863496|FG000|Overall Study|Other|4|||
155663509|NCT00461708|561863497|FG001|Overall Study|Other|4|||
155663510|NCT00461708|561863496|FG000|Overall Study|Death|8|||
155663511|NCT00461708|561863497|FG001|Overall Study|Death|1|||
155663512|NCT02394561|561863498|FG000|CORE Phase|Adverse Event|7|||
155663513|NCT02394561|561863499|FG001|CORE Phase|Adverse Event|9|||
155663514|NCT02394561|561863498|FG000|CORE Phase|Death|0|||
155663515|NCT02394561|561863499|FG001|CORE Phase|Death|1|||
155663516|NCT02394561|561863498|FG000|CORE Phase|Pregnancy|1|||
155663517|NCT02394561|561863499|FG001|CORE Phase|Pregnancy|0|||
155663518|NCT02394561|561863498|FG000|CORE Phase|Lost to Follow-up|1|||
155663519|NCT02394561|561863499|FG001|CORE Phase|Lost to Follow-up|0|||
155663520|NCT02394561|561863498|FG000|CORE Phase|Physician Decision|1|||
155663521|NCT02394561|561863499|FG001|CORE Phase|Physician Decision|1|||
155663522|NCT02394561|561863498|FG000|CORE Phase|Withdrawal by Subject|2|||
155663523|NCT02394561|561863499|FG001|CORE Phase|Withdrawal by Subject|2|||
155663524|NCT02394561|561863498|FG000|CORE Phase|Lack of Efficacy|1|||
155663525|NCT02394561|561863499|FG001|CORE Phase|Lack of Efficacy|6|||
155663526|NCT02394561|561863498|FG000|Extension Phase|Adverse Event|6|||
155663527|NCT02394561|561863499|FG001|Extension Phase|Adverse Event|1|||
155663528|NCT02394561|561863498|FG000|Extension Phase|Death|0|||
155663529|NCT02394561|561863499|FG001|Extension Phase|Death|1|||
155663530|NCT02394561|561863498|FG000|Extension Phase|Protocol Violation|1|||
155663531|NCT02394561|561863499|FG001|Extension Phase|Protocol Violation|0|||
155663532|NCT02394561|561863498|FG000|Extension Phase|Lost to Follow-up|1|||
155663533|NCT02394561|561863499|FG001|Extension Phase|Lost to Follow-up|0|||
155663534|NCT02394561|561863498|FG000|Extension Phase|Physician Decision|0|||
155663535|NCT02394561|561863499|FG001|Extension Phase|Physician Decision|2|||
155663536|NCT02394561|561863498|FG000|Extension Phase|Withdrawal by Subject|0|||
155663537|NCT02394561|561863499|FG001|Extension Phase|Withdrawal by Subject|5|||
155663538|NCT02394561|561863498|FG000|Extension Phase|Lack of Efficacy|3|||
155663539|NCT02394561|561863499|FG001|Extension Phase|Lack of Efficacy|3|||
155663540|NCT05788991|561863500|FG000|Overall Study|Not treated with study medication|1|||
155663541|NCT05788991|561863501|FG001|Overall Study|Not treated with study medication|3|||
155663542|NCT05788991|561863500|FG000|Overall Study|Withdrawal by Subject|1|||
155663543|NCT05788991|561863501|FG001|Overall Study|Withdrawal by Subject|0|||
155663544|NCT05788991|561863500|FG000|Overall Study|Lack of Efficacy|0|||
155663545|NCT05788991|561863501|FG001|Overall Study|Lack of Efficacy|1|||
155663546|NCT05788991|561863500|FG000|Overall Study|Protocol Violation|1|||
155663547|NCT05788991|561863501|FG001|Overall Study|Protocol Violation|2|||
155663548|NCT04712669|561863502|FG000|Double Blind Phase|Adverse Event|4|||
155663549|NCT04712669|561863503|FG001|Double Blind Phase|Adverse Event|4|||
155663550|NCT04712669|561863504|FG002|Double Blind Phase|Adverse Event|3|||
155663551|NCT04712669|561863505|FG003|Double Blind Phase|Adverse Event|0|||
155663552|NCT04712669|561863506|FG004|Double Blind Phase|Adverse Event|0|||
155663553|NCT04712669|561863507|FG005|Double Blind Phase|Adverse Event|0|||
155663554|NCT04712669|561863508|FG006|Double Blind Phase|Adverse Event|0|||
155663555|NCT04712669|561863509|FG007|Double Blind Phase|Adverse Event|0|||
155663556|NCT04712669|561863502|FG000|Double Blind Phase|Physician Decision|1|||
155580263|NCT01074944|561549706|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155580264|NCT01074944|561549707|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
155580265|NCT02348112|561549708|FG000|Overall Study|Withdrawal by Subject|32|||
155580266|NCT02348112|561549709|FG001|Overall Study|Withdrawal by Subject|29|||
155580267|NCT02348112|561549708|FG000|Overall Study|Lost to Follow-up|24|||
155580268|NCT02348112|561549709|FG001|Overall Study|Lost to Follow-up|20|||
155580269|NCT02348112|561549708|FG000|Overall Study|Physician Decision|17|||
155580270|NCT02348112|561549709|FG001|Overall Study|Physician Decision|15|||
155580271|NCT02348112|561549708|FG000|Overall Study|Site closed due to PI leaving|0|||
155580272|NCT02348112|561549709|FG001|Overall Study|Site closed due to PI leaving|30|||
155580273|NCT02348112|561549708|FG000|Overall Study|Sponsor withdrawal|0|||
155580274|NCT02348112|561549709|FG001|Overall Study|Sponsor withdrawal|7|||
155580275|NCT02348112|561549708|FG000|Overall Study|Death|0|||
155580276|NCT02348112|561549709|FG001|Overall Study|Death|1|||
155580277|NCT02586155|561549712|FG000|Overall Study|Adverse Event|2|||
155580278|NCT02586155|561549713|FG001|Overall Study|Adverse Event|3|||
155580279|NCT02586155|561549712|FG000|Overall Study|Withdrawal by Subject|31|||
155580280|NCT02586155|561549713|FG001|Overall Study|Withdrawal by Subject|24|||
155580281|NCT02586155|561549712|FG000|Overall Study|Lost to Follow-up|7|||
155580282|NCT02586155|561549713|FG001|Overall Study|Lost to Follow-up|13|||
155580283|NCT02586155|561549712|FG000|Overall Study|Death|61|||
155580284|NCT02586155|561549713|FG001|Overall Study|Death|72|||
155580285|NCT02586155|561549712|FG000|Overall Study|Other reasons|26|||
155580286|NCT02586155|561549713|FG001|Overall Study|Other reasons|15|||
155580287|NCT02072980|561549715|FG000|Period 2, Second Wear|Adverse Event|0|||
155580288|NCT02072980|561549716|FG001|Period 2, Second Wear|Adverse Event|1|||
155580289|NCT01757275|561549718|FG000|Overall Study|Lost to Follow-up|1|||
155580290|NCT01757275|561549719|FG001|Overall Study|Lost to Follow-up|2|||
155580291|NCT01757275|561549718|FG000|Overall Study|Adverse Event|3|||
155580292|NCT01757275|561549719|FG001|Overall Study|Adverse Event|3|||
155580293|NCT01757275|561549718|FG000|Overall Study|Withdrawal by Subject|2|||
155580294|NCT01757275|561549719|FG001|Overall Study|Withdrawal by Subject|4|||
155580295|NCT01757275|561549718|FG000|Overall Study|Not treated|3|||
155580296|NCT01757275|561549719|FG001|Overall Study|Not treated|4|||
155580297|NCT01401452|561549721|FG000|Overall Study|Adverse reaction|9|||
155580298|NCT01401452|561549721|FG000|Overall Study|Lost to Follow-up|12|||
155580299|NCT01401452|561549721|FG000|Overall Study|Lack of Efficacy|30|||
155580300|NCT01401452|561549721|FG000|Overall Study|Participant developed breast cancer|1|||
155580301|NCT01401452|561549721|FG000|Overall Study|Tx stopped due to financial reasons|1|||
155580302|NCT01401452|561549721|FG000|Overall Study|Tx stopped by psychiatrist|1|||
155580303|NCT01401452|561549721|FG000|Overall Study|No more visits within the 36 wk followup|4|||
155580304|NCT01401452|561549721|FG000|Overall Study|Subject did not come to follow up visits|2|||
155580305|NCT01401452|561549721|FG000|Overall Study|Subject didn't return for routine visits|1|||
155580306|NCT01401452|561549721|FG000|Overall Study|Subject moved to another city|1|||
155580307|NCT01401452|561549721|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
155580308|NCT01401452|561549721|FG000|Overall Study|Psoriatic arthritis|1|||
155580309|NCT01401452|561549721|FG000|Overall Study|Participant stopped Tx|2|||
155580310|NCT01401452|561549721|FG000|Overall Study|Discontinuation for personal reasons|1|||
155580311|NCT01401452|561549721|FG000|Overall Study|Treatment failure|1|||
155580312|NCT01401452|561549721|FG000|Overall Study|Unsatisfactory output|1|||
155580313|NCT01401452|561549721|FG000|Overall Study|Subject withdrew because of Tx success|1|||
155580314|NCT01401452|561549721|FG000|Overall Study|Subject chose to discontinue treatment|1|||
155580315|NCT01401452|561549721|FG000|Overall Study|Participant withdrew consent|1|||
155580316|NCT00584454|561549722|FG000|Overall Study|Adverse Event|1|||
155663557|NCT04712669|561863503|FG001|Double Blind Phase|Physician Decision|0|||
155663558|NCT04712669|561863504|FG002|Double Blind Phase|Physician Decision|0|||
155663559|NCT04712669|561863505|FG003|Double Blind Phase|Physician Decision|0|||
155663560|NCT04712669|561863506|FG004|Double Blind Phase|Physician Decision|0|||
155663561|NCT04712669|561863507|FG005|Double Blind Phase|Physician Decision|0|||
155663562|NCT04712669|561863508|FG006|Double Blind Phase|Physician Decision|0|||
155663563|NCT04712669|561863509|FG007|Double Blind Phase|Physician Decision|0|||
155663564|NCT04712669|561863502|FG000|Double Blind Phase|Withdrawal by Subject|3|||
155663565|NCT04712669|561863503|FG001|Double Blind Phase|Withdrawal by Subject|6|||
155663566|NCT04712669|561863504|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155663567|NCT04712669|561863505|FG003|Double Blind Phase|Withdrawal by Subject|0|||
155580317|NCT00584454|561549722|FG000|Overall Study|Relocation|1|||
155580318|NCT00584454|561549722|FG000|Overall Study|Clinical Hold|2|||
155580319|NCT01459783|561549724|FG000|Baseline to 6 Months|Death|1|||
155580320|NCT01459783|561549725|FG001|Baseline to 6 Months|Death|0|||
155663568|NCT04712669|561863506|FG004|Double Blind Phase|Withdrawal by Subject|0|||
155580321|NCT01459783|561549724|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
155580322|NCT01459783|561549725|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
155580323|NCT01459783|561549724|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
155580324|NCT01459783|561549725|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
155580325|NCT01459783|561549724|FG000|6 Months to 12 Months|Death|0|||
155580326|NCT01459783|561549725|FG001|6 Months to 12 Months|Death|1|||
155580327|NCT01459783|561549724|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
155580328|NCT01459783|561549725|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
155580329|NCT01459783|561549724|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
155580330|NCT01459783|561549725|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
155580331|NCT01459783|561549724|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
155580332|NCT01459783|561549725|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
155580333|NCT02601014|561549726|FG000|Overall Study|Adverse Event|3|||
155580334|NCT02601014|561549727|FG001|Overall Study|Adverse Event|3|||
155580335|NCT02601014|561549726|FG000|Overall Study|Death|3|||
155580336|NCT02601014|561549727|FG001|Overall Study|Death|1|||
155580337|NCT02601014|561549726|FG000|Overall Study|Disease progression|4|||
155580338|NCT02601014|561549727|FG001|Overall Study|Disease progression|8|||
155580339|NCT00445146|561549730|FG000|Overall Study|Withdrew Consent|29|||
155580340|NCT00445146|561549730|FG000|Overall Study|Lack of Efficacy|28|||
155580341|NCT00445146|561549730|FG000|Overall Study|Investigator's Discretion|22|||
155580342|NCT00445146|561549730|FG000|Overall Study|Adverse Event|13|||
155580343|NCT00445146|561549730|FG000|Overall Study|Lost to Follow-up|13|||
155580344|NCT00445146|561549730|FG000|Overall Study|Death|9|||
155580345|NCT00445146|561549730|FG000|Overall Study|Protocol Violation|4|||
155580346|NCT00445146|561549730|FG000|Overall Study|Pregnancy|1|||
155580347|NCT02456740|561549731|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155580348|NCT02456740|561549732|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155580349|NCT02456740|561549733|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155580350|NCT02456740|561549734|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580351|NCT02456740|561549735|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580352|NCT02456740|561549736|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580353|NCT02456740|561549737|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580354|NCT02456740|561549738|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580355|NCT02456740|561549739|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155580356|NCT02456740|561549731|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
155580357|NCT02456740|561549732|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
155580358|NCT02456740|561549733|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
155580359|NCT02456740|561549734|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580360|NCT02456740|561549735|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580361|NCT02456740|561549736|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580362|NCT02456740|561549737|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580363|NCT02456740|561549738|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580364|NCT02456740|561549739|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155580365|NCT02456740|561549731|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
155580366|NCT02456740|561549732|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
155580367|NCT02456740|561549733|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
155580368|NCT02456740|561549734|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580369|NCT02456740|561549735|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580370|NCT02456740|561549736|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580371|NCT02456740|561549737|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580372|NCT02456740|561549738|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580373|NCT02456740|561549739|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155580374|NCT02456740|561549731|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580375|NCT02456740|561549732|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580376|NCT02456740|561549733|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580377|NCT02456740|561549734|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
155580378|NCT02456740|561549735|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
155580379|NCT02456740|561549736|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580380|NCT02456740|561549737|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580381|NCT02456740|561549738|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155580382|NCT02456740|561549739|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
155663569|NCT04712669|561863507|FG005|Double Blind Phase|Withdrawal by Subject|0|||
155663570|NCT04712669|561863508|FG006|Double Blind Phase|Withdrawal by Subject|0|||
155663571|NCT04712669|561863509|FG007|Double Blind Phase|Withdrawal by Subject|0|||
155663572|NCT04712669|561863502|FG000|Double Blind Phase|Termination by Sponsor|0|||
155663573|NCT04712669|561863503|FG001|Double Blind Phase|Termination by Sponsor|0|||
155663574|NCT04712669|561863504|FG002|Double Blind Phase|Termination by Sponsor|1|||
155663575|NCT04712669|561863505|FG003|Double Blind Phase|Termination by Sponsor|0|||
155663576|NCT04712669|561863506|FG004|Double Blind Phase|Termination by Sponsor|0|||
155663577|NCT04712669|561863507|FG005|Double Blind Phase|Termination by Sponsor|0|||
155663578|NCT04712669|561863508|FG006|Double Blind Phase|Termination by Sponsor|0|||
155663579|NCT04712669|561863509|FG007|Double Blind Phase|Termination by Sponsor|0|||
155663580|NCT04712669|561863502|FG000|Open Label Phase|Adverse Event|0|||
155663581|NCT04712669|561863503|FG001|Open Label Phase|Adverse Event|0|||
155663582|NCT04712669|561863504|FG002|Open Label Phase|Adverse Event|0|||
155663583|NCT04712669|561863505|FG003|Open Label Phase|Adverse Event|1|||
155663584|NCT04712669|561863506|FG004|Open Label Phase|Adverse Event|1|||
155663585|NCT04712669|561863507|FG005|Open Label Phase|Adverse Event|3|||
155663586|NCT04712669|561863508|FG006|Open Label Phase|Adverse Event|1|||
155663587|NCT04712669|561863509|FG007|Open Label Phase|Adverse Event|2|||
155663588|NCT04712669|561863502|FG000|Open Label Phase|Death|0|||
155663589|NCT04712669|561863503|FG001|Open Label Phase|Death|0|||
155663590|NCT04712669|561863504|FG002|Open Label Phase|Death|0|||
155663591|NCT04712669|561863505|FG003|Open Label Phase|Death|1|||
155663592|NCT04712669|561863506|FG004|Open Label Phase|Death|0|||
155663593|NCT04712669|561863507|FG005|Open Label Phase|Death|0|||
155663594|NCT04712669|561863508|FG006|Open Label Phase|Death|0|||
155663595|NCT04712669|561863509|FG007|Open Label Phase|Death|0|||
155663596|NCT04712669|561863502|FG000|Open Label Phase|Lack of Efficacy|0|||
155663597|NCT04712669|561863503|FG001|Open Label Phase|Lack of Efficacy|0|||
155663598|NCT04712669|561863504|FG002|Open Label Phase|Lack of Efficacy|0|||
155663599|NCT04712669|561863505|FG003|Open Label Phase|Lack of Efficacy|0|||
155663600|NCT04712669|561863506|FG004|Open Label Phase|Lack of Efficacy|1|||
155663601|NCT04712669|561863507|FG005|Open Label Phase|Lack of Efficacy|0|||
155663602|NCT04712669|561863508|FG006|Open Label Phase|Lack of Efficacy|0|||
155663603|NCT04712669|561863509|FG007|Open Label Phase|Lack of Efficacy|0|||
155663604|NCT04712669|561863502|FG000|Open Label Phase|Lost to Follow-up|0|||
155663605|NCT04712669|561863503|FG001|Open Label Phase|Lost to Follow-up|0|||
155663606|NCT04712669|561863504|FG002|Open Label Phase|Lost to Follow-up|0|||
155663607|NCT04712669|561863505|FG003|Open Label Phase|Lost to Follow-up|0|||
155663608|NCT04712669|561863506|FG004|Open Label Phase|Lost to Follow-up|0|||
155663609|NCT04712669|561863507|FG005|Open Label Phase|Lost to Follow-up|0|||
155663610|NCT04712669|561863508|FG006|Open Label Phase|Lost to Follow-up|1|||
155663611|NCT04712669|561863509|FG007|Open Label Phase|Lost to Follow-up|1|||
155663612|NCT04712669|561863502|FG000|Open Label Phase|Physician Decision|0|||
155663613|NCT04712669|561863503|FG001|Open Label Phase|Physician Decision|0|||
155663614|NCT04712669|561863504|FG002|Open Label Phase|Physician Decision|0|||
155663615|NCT04712669|561863505|FG003|Open Label Phase|Physician Decision|1|||
155663616|NCT04712669|561863506|FG004|Open Label Phase|Physician Decision|0|||
155663617|NCT04712669|561863507|FG005|Open Label Phase|Physician Decision|0|||
155663618|NCT04712669|561863508|FG006|Open Label Phase|Physician Decision|0|||
155663619|NCT04712669|561863509|FG007|Open Label Phase|Physician Decision|0|||
155663620|NCT04712669|561863502|FG000|Open Label Phase|Withdrawal by Subject|0|||
155663621|NCT04712669|561863503|FG001|Open Label Phase|Withdrawal by Subject|0|||
155663622|NCT04712669|561863504|FG002|Open Label Phase|Withdrawal by Subject|0|||
155663623|NCT04712669|561863505|FG003|Open Label Phase|Withdrawal by Subject|1|||
155663624|NCT04712669|561863506|FG004|Open Label Phase|Withdrawal by Subject|5|||
155663625|NCT04712669|561863507|FG005|Open Label Phase|Withdrawal by Subject|5|||
155663626|NCT04712669|561863508|FG006|Open Label Phase|Withdrawal by Subject|0|||
155663627|NCT04712669|561863509|FG007|Open Label Phase|Withdrawal by Subject|4|||
155663628|NCT04712669|561863502|FG000|Open Label Phase|Termination by Sponsor|0|||
155663629|NCT04712669|561863503|FG001|Open Label Phase|Termination by Sponsor|0|||
155663630|NCT04712669|561863504|FG002|Open Label Phase|Termination by Sponsor|0|||
155663631|NCT04712669|561863505|FG003|Open Label Phase|Termination by Sponsor|11|||
155663632|NCT04712669|561863506|FG004|Open Label Phase|Termination by Sponsor|9|||
155663633|NCT04712669|561863507|FG005|Open Label Phase|Termination by Sponsor|14|||
155663634|NCT04712669|561863508|FG006|Open Label Phase|Termination by Sponsor|0|||
155663635|NCT04712669|561863509|FG007|Open Label Phase|Termination by Sponsor|14|||
155663636|NCT04464473|561863510|FG000|Overall Study|New piercing could not be removed for scanning|0|||
155663637|NCT04464473|561863511|FG001|Overall Study|New piercing could not be removed for scanning|0|||
155663638|NCT04464473|561863512|FG002|Overall Study|New piercing could not be removed for scanning|0|||
155663639|NCT04464473|561863513|FG003|Overall Study|New piercing could not be removed for scanning|1|||
155663640|NCT04464473|561863514|FG004|Overall Study|New piercing could not be removed for scanning|0|||
155663641|NCT04464473|561863515|FG005|Overall Study|New piercing could not be removed for scanning|0|||
155663642|NCT04464473|561863510|FG000|Overall Study|Adverse Event|0|||
155663643|NCT04464473|561863511|FG001|Overall Study|Adverse Event|0|||
155663644|NCT04464473|561863512|FG002|Overall Study|Adverse Event|0|||
155663645|NCT04464473|561863513|FG003|Overall Study|Adverse Event|1|||
155663646|NCT04464473|561863514|FG004|Overall Study|Adverse Event|0|||
155663647|NCT04464473|561863515|FG005|Overall Study|Adverse Event|0|||
155663648|NCT04464473|561863510|FG000|Overall Study|Lost to Follow-up|0|||
155663649|NCT04464473|561863511|FG001|Overall Study|Lost to Follow-up|0|||
155663650|NCT04464473|561863512|FG002|Overall Study|Lost to Follow-up|0|||
155663651|NCT04464473|561863513|FG003|Overall Study|Lost to Follow-up|1|||
155663652|NCT04464473|561863514|FG004|Overall Study|Lost to Follow-up|0|||
155663653|NCT04464473|561863515|FG005|Overall Study|Lost to Follow-up|0|||
155663654|NCT01114737|561865160|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155663655|NCT01114737|561865161|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155663656|NCT01114737|561865160|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
155663657|NCT01114737|561865161|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
155663658|NCT01114737|561865160|FG000|Randomized Treatment Period|Pregnancy|1|||
155663659|NCT01114737|561865161|FG001|Randomized Treatment Period|Pregnancy|0|||
155663660|NCT01114737|561865160|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
155663661|NCT01114737|561865161|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
155663662|NCT01114737|561865160|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
155663663|NCT01114737|561865161|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155663664|NCT01114737|561865160|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
155663665|NCT01114737|561865161|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
155663666|NCT01123148|561865162|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
155663667|NCT01123148|561865162|FG000|Overall Study|Didn't meet milestone criteria|1|||
155663668|NCT01693367|561865163|FG000|Overall Study|Withdrawal by Subject|1|||
155663669|NCT01693367|561865164|FG001|Overall Study|Withdrawal by Subject|1|||
155663670|NCT01693367|561865163|FG000|Overall Study|Physician Decision|0|||
155663671|NCT01693367|561865164|FG001|Overall Study|Physician Decision|1|||
155663672|NCT00325143|561865165|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
155663673|NCT00325143|561865165|FG000|Overall Study|Migrated/moved from study area|1|||
155663674|NCT00325143|561865165|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
155663675|NCT00325143|561865165|FG000|Overall Study|Withdrawal by Subject|8|||
155663676|NCT02286895|561865166|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
155663677|NCT02286895|561865167|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
155663678|NCT02286895|561865166|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
155663679|NCT02286895|561865167|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
155663680|NCT02286895|561865166|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
155663681|NCT02286895|561865167|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
155663682|NCT00256126|561865168|FG000|Overall Study|Adverse Event|1|||
155663683|NCT00256126|561865169|FG001|Overall Study|Adverse Event|0|||
155663684|NCT00256126|561865168|FG000|Overall Study|Other|1|||
155663685|NCT00256126|561865169|FG001|Overall Study|Other|2|||
155663686|NCT04108273|561865171|FG000|Overall Study|COVID Pandemic|1|||
155663687|NCT04108273|561865172|FG001|Overall Study|COVID Pandemic|0|||
155663688|NCT02154061|561865174|FG000|Overall Study|Pregnancy|1|||
155663689|NCT02154061|561865175|FG001|Overall Study|Pregnancy|0|||
155663690|NCT02154061|561865174|FG000|Overall Study|enrolled but not vaccinated|1|||
155663691|NCT02154061|561865175|FG001|Overall Study|enrolled but not vaccinated|0|||
155663692|NCT00506142|561865176|FG000|Overall Study|Adverse Event|8|||
155663693|NCT00506142|561865177|FG001|Overall Study|Adverse Event|7|||
155663694|NCT00506142|561865176|FG000|Overall Study|Lack of Efficacy|21|||
155663695|NCT00506142|561865177|FG001|Overall Study|Lack of Efficacy|7|||
155663696|NCT00506142|561865176|FG000|Overall Study|Withdrawal by Subject|4|||
155663697|NCT00506142|561865177|FG001|Overall Study|Withdrawal by Subject|5|||
155663698|NCT00506142|561865176|FG000|Overall Study|Physician Decision|1|||
155663699|NCT00506142|561865177|FG001|Overall Study|Physician Decision|0|||
155663700|NCT00506142|561865176|FG000|Overall Study|New health condition|1|||
155663701|NCT00506142|561865177|FG001|Overall Study|New health condition|0|||
155663702|NCT01936831|561865183|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663703|NCT01936831|561865184|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663704|NCT01936831|561865185|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663705|NCT01936831|561865186|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663706|NCT01936831|561865187|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663707|NCT01936831|561865188|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
155663708|NCT01936831|561865189|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663709|NCT01936831|561865190|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663710|NCT01936831|561865191|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155663711|NCT00454116|561865192|FG000|Overall Study|Adverse Event|5|||
155663712|NCT00454116|561865193|FG001|Overall Study|Adverse Event|11|||
155663713|NCT00454116|561865194|FG002|Overall Study|Adverse Event|9|||
155663714|NCT00454116|561865192|FG000|Overall Study|Condition under investigation worsened|17|||
155663715|NCT00454116|561865193|FG001|Overall Study|Condition under investigation worsened|13|||
155663716|NCT00454116|561865194|FG002|Overall Study|Condition under investigation worsened|18|||
155663717|NCT00454116|561865192|FG000|Overall Study|Withdrawal by Subject|3|||
155663718|NCT00454116|561865193|FG001|Overall Study|Withdrawal by Subject|3|||
155580383|NCT02456740|561549731|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155580384|NCT02456740|561549732|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155580385|NCT02456740|561549733|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155580386|NCT02456740|561549734|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
155580387|NCT02456740|561549735|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
155580388|NCT02456740|561549736|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
155580389|NCT02456740|561549737|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
155580390|NCT02456740|561549738|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
155580391|NCT02456740|561549739|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
155580392|NCT02456740|561549731|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580393|NCT02456740|561549732|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580394|NCT02456740|561549733|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580395|NCT02456740|561549734|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580396|NCT02456740|561549735|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580397|NCT02456740|561549736|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580398|NCT02456740|561549737|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580399|NCT02456740|561549738|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
155580400|NCT02456740|561549739|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155580401|NCT02456740|561549731|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155580402|NCT02456740|561549732|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155580403|NCT02456740|561549733|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155580404|NCT02456740|561549734|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
155580405|NCT02456740|561549735|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
155580406|NCT02456740|561549736|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
155580407|NCT02456740|561549737|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155580408|NCT02456740|561549738|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
155580409|NCT02456740|561549739|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
155580410|NCT02623725|561549740|FG000|Overall Study|Non compliance with protocol|9|||
155580411|NCT02623725|561549741|FG001|Overall Study|Non compliance with protocol|3|||
155580412|NCT02623725|561549740|FG000|Overall Study|Serious adverse event|0|||
155580413|NCT02623725|561549741|FG001|Overall Study|Serious adverse event|2|||
155580414|NCT02623725|561549740|FG000|Overall Study|Withdrawal by Subject|7|||
155580415|NCT02623725|561549741|FG001|Overall Study|Withdrawal by Subject|1|||
155580416|NCT03918629|561549742|FG000|Overall Study|Adverse Event|19|||
155580417|NCT03918629|561549743|FG001|Overall Study|Adverse Event|20|||
155580418|NCT03918629|561549742|FG000|Overall Study|Death|14|||
155580419|NCT03918629|561549743|FG001|Overall Study|Death|7|||
155580420|NCT03918629|561549742|FG000|Overall Study|Lost to Follow-up|36|||
155580421|NCT03918629|561549743|FG001|Overall Study|Lost to Follow-up|28|||
155580422|NCT03918629|561549742|FG000|Overall Study|Physician Decision|1|||
155580423|NCT03918629|561549743|FG001|Overall Study|Physician Decision|0|||
155580424|NCT03918629|561549742|FG000|Overall Study|Protocol Violation|7|||
155580425|NCT03918629|561549743|FG001|Overall Study|Protocol Violation|4|||
155580426|NCT03918629|561549742|FG000|Overall Study|Withdrawal by Subject|47|||
155580427|NCT03918629|561549743|FG001|Overall Study|Withdrawal by Subject|47|||
155580428|NCT03918629|561549742|FG000|Overall Study|Other|7|||
155580429|NCT03918629|561549743|FG001|Overall Study|Other|11|||
155580430|NCT03918629|561549742|FG000|Overall Study|Randomized but not vaccinated|2|||
155580431|NCT03918629|561549743|FG001|Overall Study|Randomized but not vaccinated|1|||
155580432|NCT01891864|561549746|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
155580433|NCT01891864|561549747|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
155580434|NCT01891864|561549748|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155580435|NCT01891864|561549749|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155580436|NCT01891864|561549750|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155580437|NCT01891864|561549751|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155580438|NCT01891864|561549746|FG000|Treatment Period 1|Physician Decision|0|||
155580439|NCT01891864|561549747|FG001|Treatment Period 1|Physician Decision|1|||
155580440|NCT01891864|561549748|FG002|Treatment Period 1|Physician Decision|0|||
155580441|NCT01891864|561549749|FG003|Treatment Period 1|Physician Decision|0|||
155580442|NCT01891864|561549750|FG004|Treatment Period 1|Physician Decision|0|||
155580443|NCT01891864|561549751|FG005|Treatment Period 1|Physician Decision|0|||
155663719|NCT00454116|561865194|FG002|Overall Study|Withdrawal by Subject|1|||
155663720|NCT00454116|561865192|FG000|Overall Study|Other|2|||
155580444|NCT01891864|561549746|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155580445|NCT01891864|561549747|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
155580446|NCT01891864|561549748|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155580447|NCT01891864|561549749|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155580448|NCT01891864|561549750|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155663721|NCT00454116|561865193|FG001|Overall Study|Other|2|||
155663722|NCT00454116|561865194|FG002|Overall Study|Other|0|||
155580449|NCT01891864|561549751|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155580450|NCT01891864|561549746|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
155580451|NCT01891864|561549747|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
155580452|NCT01891864|561549748|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155580453|NCT01891864|561549749|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155580454|NCT01891864|561549750|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155580455|NCT01891864|561549751|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155580456|NCT01891864|561549746|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155580457|NCT01891864|561549747|FG001|Treatment Period 1|Withdrawal by Subject|5|||
155580458|NCT01891864|561549748|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155580459|NCT01891864|561549749|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155580460|NCT01891864|561549750|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155580461|NCT01891864|561549751|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155580462|NCT01891864|561549746|FG000|Treatment Period 1|Lost to Follow-up|1|||
155580463|NCT01891864|561549747|FG001|Treatment Period 1|Lost to Follow-up|0|||
155580464|NCT01891864|561549748|FG002|Treatment Period 1|Lost to Follow-up|0|||
155580465|NCT01891864|561549749|FG003|Treatment Period 1|Lost to Follow-up|0|||
155580466|NCT01891864|561549750|FG004|Treatment Period 1|Lost to Follow-up|0|||
155580467|NCT01891864|561549751|FG005|Treatment Period 1|Lost to Follow-up|0|||
155580468|NCT01891864|561549746|FG000|Treatment Period 2|Protocol Violation|0|||
155580469|NCT01891864|561549747|FG001|Treatment Period 2|Protocol Violation|0|||
155580470|NCT01891864|561549748|FG002|Treatment Period 2|Protocol Violation|0|||
155580471|NCT01891864|561549749|FG003|Treatment Period 2|Protocol Violation|1|||
155580472|NCT01891864|561549750|FG004|Treatment Period 2|Protocol Violation|0|||
155580473|NCT01891864|561549751|FG005|Treatment Period 2|Protocol Violation|0|||
155580474|NCT01891864|561549746|FG000|Treatment Period 2|Physician Decision|0|||
155580475|NCT01891864|561549747|FG001|Treatment Period 2|Physician Decision|0|||
155580476|NCT01891864|561549748|FG002|Treatment Period 2|Physician Decision|1|||
155580477|NCT01891864|561549749|FG003|Treatment Period 2|Physician Decision|0|||
155580478|NCT01891864|561549750|FG004|Treatment Period 2|Physician Decision|0|||
155580479|NCT01891864|561549751|FG005|Treatment Period 2|Physician Decision|0|||
155580480|NCT01891864|561549746|FG000|Treatment Period 2|Site Termination|0|||
155580481|NCT01891864|561549747|FG001|Treatment Period 2|Site Termination|0|||
155580482|NCT01891864|561549748|FG002|Treatment Period 2|Site Termination|1|||
155580483|NCT01891864|561549749|FG003|Treatment Period 2|Site Termination|2|||
155580484|NCT01891864|561549750|FG004|Treatment Period 2|Site Termination|0|||
155580485|NCT01891864|561549751|FG005|Treatment Period 2|Site Termination|0|||
155580486|NCT01891864|561549746|FG000|Treatment Period 2|Lack of Efficacy|0|||
155580487|NCT01891864|561549747|FG001|Treatment Period 2|Lack of Efficacy|0|||
155580488|NCT01891864|561549748|FG002|Treatment Period 2|Lack of Efficacy|1|||
155580489|NCT01891864|561549749|FG003|Treatment Period 2|Lack of Efficacy|0|||
155580490|NCT01891864|561549750|FG004|Treatment Period 2|Lack of Efficacy|1|||
155580491|NCT01891864|561549751|FG005|Treatment Period 2|Lack of Efficacy|0|||
155580492|NCT01891864|561549746|FG000|Treatment Period 2|Adverse Event|0|||
155580493|NCT01891864|561549747|FG001|Treatment Period 2|Adverse Event|0|||
155580494|NCT01891864|561549748|FG002|Treatment Period 2|Adverse Event|1|||
155580495|NCT01891864|561549749|FG003|Treatment Period 2|Adverse Event|2|||
155580496|NCT01891864|561549750|FG004|Treatment Period 2|Adverse Event|0|||
155580497|NCT01891864|561549751|FG005|Treatment Period 2|Adverse Event|4|||
155580498|NCT01891864|561549746|FG000|Treatment Period 2|Termination of Site|0|||
155580499|NCT01891864|561549747|FG001|Treatment Period 2|Termination of Site|0|||
155580500|NCT01891864|561549748|FG002|Treatment Period 2|Termination of Site|0|||
155580501|NCT01891864|561549749|FG003|Treatment Period 2|Termination of Site|0|||
155580502|NCT01891864|561549750|FG004|Treatment Period 2|Termination of Site|2|||
155580503|NCT01891864|561549751|FG005|Treatment Period 2|Termination of Site|0|||
155580504|NCT01891864|561549746|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155580505|NCT01891864|561549747|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155580506|NCT01891864|561549748|FG002|Treatment Period 2|Withdrawal by Subject|3|||
155580507|NCT01891864|561549749|FG003|Treatment Period 2|Withdrawal by Subject|4|||
155580508|NCT01891864|561549750|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155580509|NCT01891864|561549751|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155580510|NCT01891864|561549746|FG000|Extension Period|Lack of Efficacy|0|||
155580511|NCT01891864|561549747|FG001|Extension Period|Lack of Efficacy|0|||
155580512|NCT01891864|561549748|FG002|Extension Period|Lack of Efficacy|0|||
155580513|NCT01891864|561549749|FG003|Extension Period|Lack of Efficacy|1|||
155580514|NCT01891864|561549750|FG004|Extension Period|Lack of Efficacy|1|||
155580515|NCT01891864|561549751|FG005|Extension Period|Lack of Efficacy|0|||
155580516|NCT01891864|561549746|FG000|Extension Period|Pregnancy|0|||
155580517|NCT01891864|561549747|FG001|Extension Period|Pregnancy|0|||
155580518|NCT01891864|561549748|FG002|Extension Period|Pregnancy|1|||
155580519|NCT01891864|561549749|FG003|Extension Period|Pregnancy|0|||
155580520|NCT01891864|561549750|FG004|Extension Period|Pregnancy|0|||
155580521|NCT01891864|561549751|FG005|Extension Period|Pregnancy|0|||
155580522|NCT01891864|561549746|FG000|Extension Period|Adverse Event|0|||
155580523|NCT01891864|561549747|FG001|Extension Period|Adverse Event|0|||
155580524|NCT01891864|561549748|FG002|Extension Period|Adverse Event|4|||
155580525|NCT01891864|561549749|FG003|Extension Period|Adverse Event|2|||
155580526|NCT01891864|561549750|FG004|Extension Period|Adverse Event|2|||
155580527|NCT01891864|561549751|FG005|Extension Period|Adverse Event|0|||
155580528|NCT01891864|561549746|FG000|Extension Period|Withdrawal by Subject|0|||
155580529|NCT01891864|561549747|FG001|Extension Period|Withdrawal by Subject|0|||
155580530|NCT01891864|561549748|FG002|Extension Period|Withdrawal by Subject|1|||
155580531|NCT01891864|561549749|FG003|Extension Period|Withdrawal by Subject|2|||
155580532|NCT01891864|561549750|FG004|Extension Period|Withdrawal by Subject|4|||
155580533|NCT01891864|561549751|FG005|Extension Period|Withdrawal by Subject|0|||
155580534|NCT01891864|561549746|FG000|Extension Period|Lost to Follow-up|0|||
155580535|NCT01891864|561549747|FG001|Extension Period|Lost to Follow-up|0|||
155580536|NCT01891864|561549748|FG002|Extension Period|Lost to Follow-up|2|||
155580537|NCT01891864|561549749|FG003|Extension Period|Lost to Follow-up|0|||
155580538|NCT01891864|561549750|FG004|Extension Period|Lost to Follow-up|0|||
155580539|NCT01891864|561549751|FG005|Extension Period|Lost to Follow-up|0|||
155580540|NCT04720105|561549753|FG000|Overall Study|Lack of Efficacy|1|||
155580541|NCT04720105|561549753|FG000|Overall Study|Lost to Follow-up|1|||
155580542|NCT04720105|561549753|FG000|Overall Study|Withdrawal by Subject|3|||
155580543|NCT02892331|561549754|FG000|Overall Study|Withdrawal by Subject|0|||
155580544|NCT02892331|561549755|FG001|Overall Study|Withdrawal by Subject|1|||
155580545|NCT02892331|561549756|FG002|Overall Study|Withdrawal by Subject|1|||
155580546|NCT02892331|561549754|FG000|Overall Study|Sick family member|0|||
155580547|NCT02892331|561549755|FG001|Overall Study|Sick family member|0|||
155580548|NCT02892331|561549756|FG002|Overall Study|Sick family member|1|||
155580549|NCT02892331|561549754|FG000|Overall Study|Corona virus pandemic|1|||
155580550|NCT02892331|561549755|FG001|Overall Study|Corona virus pandemic|0|||
155580551|NCT02892331|561549756|FG002|Overall Study|Corona virus pandemic|1|||
155580552|NCT02892331|561549754|FG000|Overall Study|Lost to Follow-up|1|||
155580553|NCT02892331|561549755|FG001|Overall Study|Lost to Follow-up|0|||
155580554|NCT02892331|561549756|FG002|Overall Study|Lost to Follow-up|1|||
155580555|NCT02892331|561549754|FG000|Overall Study|Blood pressure was too elevated|0|||
155580556|NCT02892331|561549755|FG001|Overall Study|Blood pressure was too elevated|1|||
155580557|NCT02892331|561549756|FG002|Overall Study|Blood pressure was too elevated|0|||
155580558|NCT02892331|561549754|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
155580559|NCT02892331|561549755|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
155580560|NCT02892331|561549756|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
155580561|NCT04563754|561551414|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
155580562|NCT04563754|561551415|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
155580563|NCT04563754|561551416|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
155580564|NCT04563754|561551414|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
155580565|NCT04563754|561551415|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
155580566|NCT04563754|561551416|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
155580567|NCT04563754|561551414|FG000|Follow up|Lost to Follow-up|61|||
155580568|NCT04563754|561551415|FG001|Follow up|Lost to Follow-up|23|||
155580569|NCT04563754|561551416|FG002|Follow up|Lost to Follow-up|5|||
155580570|NCT04563754|561551414|FG000|Follow up|Death|0|||
155580571|NCT04563754|561551415|FG001|Follow up|Death|2|||
155580572|NCT04563754|561551416|FG002|Follow up|Death|0|||
155580573|NCT04563754|561551414|FG000|Follow up|Ongoing|0|||
155580574|NCT04563754|561551415|FG001|Follow up|Ongoing|28|||
155580575|NCT04563754|561551416|FG002|Follow up|Ongoing|0|||
155580576|NCT04023396|561551417|FG000|Overall Study|Adverse Event|16|||
155580577|NCT04023396|561551417|FG000|Overall Study|Death|1|||
155580578|NCT04023396|561551417|FG000|Overall Study|Lost to Follow-up|1|||
155580579|NCT04023396|561551417|FG000|Overall Study|Withdrawal by Subject|14|||
155580580|NCT04023396|561551417|FG000|Overall Study|Pregnancy|4|||
155580581|NCT04023396|561551417|FG000|Overall Study|Lack of Efficacy|3|||
155580582|NCT04023396|561551417|FG000|Overall Study|Physician Decision|4|||
155580583|NCT04023396|561551417|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
155580584|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
155580585|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155580586|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155580587|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155580588|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
155580589|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155580590|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155580591|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155580592|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
155580593|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155580594|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155580595|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155580596|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
155580597|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155580598|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155580599|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155580600|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
155580601|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155580602|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155580603|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155580604|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
155580605|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155580606|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155580607|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155580608|NCT02513160|561551418|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
155580609|NCT02513160|561551419|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155580610|NCT02513160|561551420|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155580611|NCT02513160|561551421|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155580612|NCT02513160|561551418|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
155580613|NCT02513160|561551419|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
155580614|NCT02513160|561551420|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
155580615|NCT02513160|561551421|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
155580616|NCT02513160|561551418|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
155580617|NCT02513160|561551419|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155580618|NCT02513160|561551420|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155580619|NCT02513160|561551421|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155580620|NCT02513160|561551418|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
155580621|NCT02513160|561551419|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155580622|NCT02513160|561551420|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155580623|NCT02513160|561551421|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155580624|NCT02513160|561551418|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
155580625|NCT02513160|561551419|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155580626|NCT02513160|561551420|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155580627|NCT02513160|561551421|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155580628|NCT02513160|561551418|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155580629|NCT02513160|561551419|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
155580630|NCT02513160|561551420|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155663723|NCT03500211|561865199|FG000|Overall Study|Withdrawal by Subject|1|||
155663724|NCT03500211|561865200|FG001|Overall Study|Withdrawal by Subject|1|||
155663725|NCT04460183|561865201|FG000|Overall Study|Lost to Follow-up|3|||
155580631|NCT02513160|561551421|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155580632|NCT02861586|561551425|FG000|Overall Study|Withdrawal by Subject|1|||
155663726|NCT04460183|561865202|FG001|Overall Study|Lost to Follow-up|1|||
155663727|NCT04460183|561865201|FG000|Overall Study|Withdrawal by Subject|1|||
155580633|NCT02861586|561551426|FG001|Overall Study|Withdrawal by Subject|2|||
155580634|NCT02861586|561551427|FG002|Overall Study|Withdrawal by Subject|0|||
155580635|NCT02861586|561551428|FG003|Overall Study|Withdrawal by Subject|0|||
155580636|NCT02861586|561551429|FG004|Overall Study|Withdrawal by Subject|0|||
155580637|NCT02861586|561551430|FG005|Overall Study|Withdrawal by Subject|1|||
155580638|NCT02861586|561551431|FG006|Overall Study|Withdrawal by Subject|1|||
155580639|NCT02861586|561551432|FG007|Overall Study|Withdrawal by Subject|0|||
155580640|NCT02861586|561551425|FG000|Overall Study|Lost to Follow-up|3|||
155580641|NCT02861586|561551426|FG001|Overall Study|Lost to Follow-up|1|||
155580642|NCT02861586|561551427|FG002|Overall Study|Lost to Follow-up|1|||
155580643|NCT02861586|561551428|FG003|Overall Study|Lost to Follow-up|0|||
155580644|NCT02861586|561551429|FG004|Overall Study|Lost to Follow-up|0|||
155580645|NCT02861586|561551430|FG005|Overall Study|Lost to Follow-up|3|||
155580646|NCT02861586|561551431|FG006|Overall Study|Lost to Follow-up|0|||
155580647|NCT02861586|561551432|FG007|Overall Study|Lost to Follow-up|0|||
155580648|NCT02861586|561551425|FG000|Overall Study|Adverse Event|0|||
155580649|NCT02861586|561551426|FG001|Overall Study|Adverse Event|0|||
155580650|NCT02861586|561551427|FG002|Overall Study|Adverse Event|0|||
155580651|NCT02861586|561551428|FG003|Overall Study|Adverse Event|0|||
155580652|NCT02861586|561551429|FG004|Overall Study|Adverse Event|0|||
155580653|NCT02861586|561551430|FG005|Overall Study|Adverse Event|1|||
155580654|NCT02861586|561551431|FG006|Overall Study|Adverse Event|0|||
155580655|NCT02861586|561551432|FG007|Overall Study|Adverse Event|0|||
155580656|NCT02243605|561551438|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
155580657|NCT02243605|561551439|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
155580658|NCT02243605|561551438|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
155580659|NCT02243605|561551439|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
155580660|NCT02243605|561551438|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
155580661|NCT02243605|561551439|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
155580662|NCT02243605|561551438|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
155580663|NCT02243605|561551439|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
155580664|NCT02243605|561551438|FG000|Stage 2 - Final Analysis Population|Progression|0|||
155580665|NCT02243605|561551439|FG001|Stage 2 - Final Analysis Population|Progression|1|||
155580666|NCT04173507|561551440|FG000|Overall Study|On Treatment|3|||
155580667|NCT04173507|561551440|FG000|Overall Study|Adverse Event|3|||
155580668|NCT04173507|561551440|FG000|Overall Study|Progression/Relapse|34|||
155580669|NCT04173507|561551440|FG000|Overall Study|Death|2|||
155580670|NCT01823328|561551441|FG000|Overall Study|Withdrawal by Subject|8|||
155580671|NCT01823328|561551442|FG001|Overall Study|Withdrawal by Subject|6|||
155580672|NCT01417156|561551443|FG000|Overall Study|Adverse Event|12|||
155580673|NCT01417156|561551443|FG000|Overall Study|Protocol Violation|2|||
155580674|NCT03192488|561551444|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
155580675|NCT03192488|561551445|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
155580676|NCT03192488|561551446|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
155580677|NCT03192488|561551447|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
155580678|NCT03192488|561551448|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
155580679|NCT03192488|561551449|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
155580680|NCT03192488|561551444|FG000|Third Intervention (d1)|Adverse Event|0|||
155580681|NCT03192488|561551445|FG001|Third Intervention (d1)|Adverse Event|0|||
155580682|NCT03192488|561551446|FG002|Third Intervention (d1)|Adverse Event|0|||
155580683|NCT03192488|561551447|FG003|Third Intervention (d1)|Adverse Event|0|||
155580684|NCT03192488|561551448|FG004|Third Intervention (d1)|Adverse Event|1|||
155580685|NCT03192488|561551449|FG005|Third Intervention (d1)|Adverse Event|0|||
155580686|NCT03664232|561551460|FG000|Overall Study|Withdrawal by Subject|0|||
155580687|NCT03664232|561551461|FG001|Overall Study|Withdrawal by Subject|1|||
155580688|NCT03664232|561551462|FG002|Overall Study|Withdrawal by Subject|0|||
155580689|NCT03664232|561551463|FG003|Overall Study|Withdrawal by Subject|1|||
155580690|NCT03664232|561551460|FG000|Overall Study|Adverse Event|0|||
155580691|NCT03664232|561551461|FG001|Overall Study|Adverse Event|0|||
155580692|NCT03664232|561551462|FG002|Overall Study|Adverse Event|1|||
155580693|NCT03664232|561551463|FG003|Overall Study|Adverse Event|0|||
155580694|NCT03664232|561551460|FG000|Overall Study|Other-Non-compliance with study drug|0|||
155580695|NCT03664232|561551461|FG001|Overall Study|Other-Non-compliance with study drug|1|||
155580696|NCT03664232|561551462|FG002|Overall Study|Other-Non-compliance with study drug|0|||
155580697|NCT03664232|561551463|FG003|Overall Study|Other-Non-compliance with study drug|2|||
155580698|NCT03664232|561551460|FG000|Overall Study|Other-Unspecified|0|||
155580699|NCT03664232|561551461|FG001|Overall Study|Other-Unspecified|3|||
155580700|NCT03664232|561551462|FG002|Overall Study|Other-Unspecified|0|||
155580701|NCT03664232|561551463|FG003|Overall Study|Other-Unspecified|1|||
155580702|NCT03664232|561551460|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
155580703|NCT03664232|561551461|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
155580704|NCT03664232|561551462|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
155580705|NCT03664232|561551463|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
155580706|NCT01439802|561551464|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
155580707|NCT01439802|561551464|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
155580708|NCT02003209|561551468|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
155580709|NCT02003209|561551469|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
155580710|NCT00638508|561551470|FG000|Overall Study|Physician Decision|5|||
155580711|NCT00638508|561551471|FG001|Overall Study|Physician Decision|2|||
155580712|NCT03500198|561551474|FG000|Overall Study|Lost to Follow-up|0|||
155580713|NCT03500198|561551475|FG001|Overall Study|Lost to Follow-up|1|||
155580714|NCT00654095|561551476|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
155580715|NCT00654095|561551476|FG000|Overall Study|Elevated triglyceride level (2)|1|||
155580716|NCT00654095|561551476|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
155580717|NCT00654095|561551476|FG000|Overall Study|Adverse Event|11|||
155580718|NCT00654095|561551476|FG000|Overall Study|Withdrawal by Subject|5|||
155580719|NCT00654095|561551476|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
155580720|NCT00654095|561551476|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
155580721|NCT00654095|561551476|FG000|Overall Study|Did not meet inclusion criteria|1|||
155580722|NCT00595621|561551482|FG000|Open Label Run in|Adverse Event|1|||
155580723|NCT00595621|561551483|FG001|Open Label Run in|Adverse Event|0|||
155580724|NCT00595621|561551482|FG000|Open Label Run in|Physician Decision|1|||
155580725|NCT00595621|561551483|FG001|Open Label Run in|Physician Decision|0|||
155580726|NCT00595621|561551482|FG000|Open Label Run in|Withdrawal by Subject|1|||
155580727|NCT00595621|561551483|FG001|Open Label Run in|Withdrawal by Subject|0|||
155580728|NCT00595621|561551482|FG000|Randomization and Study|Adverse Event|2|||
155580729|NCT00595621|561551483|FG001|Randomization and Study|Adverse Event|0|||
155580730|NCT00595621|561551482|FG000|Randomization and Study|Withdrawal by Subject|0|||
155580731|NCT00595621|561551483|FG001|Randomization and Study|Withdrawal by Subject|1|||
155580732|NCT00324987|561551484|FG000|Overall Study|Adverse Event|2|||
155580733|NCT00324987|561551485|FG001|Overall Study|Adverse Event|1|||
155580734|NCT00324987|561551484|FG000|Overall Study|Withdrawal by Subject|1|||
155580735|NCT00324987|561551485|FG001|Overall Study|Withdrawal by Subject|1|||
155580736|NCT00324987|561551484|FG000|Overall Study|Progression|1|||
155580737|NCT00324987|561551485|FG001|Overall Study|Progression|1|||
155580738|NCT00324987|561551484|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
155580739|NCT00324987|561551485|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
155580740|NCT01254643|561551487|FG000|Overall Study|Withdrawal by Subject|1|||
155580741|NCT01062425|561551488|FG000|Overall Study|Protocol Violation|3|||
155580742|NCT01062425|561551489|FG001|Overall Study|Protocol Violation|6|||
155580743|NCT02383017|561551490|FG000|Overall Study|Injury Sustained Outside Study|1|||
155580744|NCT02383017|561551491|FG001|Overall Study|Injury Sustained Outside Study|0|||
155580745|NCT02383017|561551490|FG000|Overall Study|Compliance|3|||
155580746|NCT02383017|561551491|FG001|Overall Study|Compliance|2|||
155580747|NCT02383017|561551490|FG000|Overall Study|Found to be Hypogonadal|1|||
155580748|NCT02383017|561551491|FG001|Overall Study|Found to be Hypogonadal|0|||
155580749|NCT01234350|561551492|FG000|Overall Study|Adverse Event|277|||
155580750|NCT01234350|561551493|FG001|Overall Study|Adverse Event|92|||
155580751|NCT01234350|561551492|FG000|Overall Study|Withdrawal by Subject|61|||
155580752|NCT01234350|561551493|FG001|Overall Study|Withdrawal by Subject|36|||
155580753|NCT01234350|561551492|FG000|Overall Study|Lost to Follow-up|115|||
155580754|NCT01234350|561551493|FG001|Overall Study|Lost to Follow-up|47|||
155580755|NCT01234350|561551492|FG000|Overall Study|Covers a diverse set of reasons|234|||
155580756|NCT01234350|561551493|FG001|Overall Study|Covers a diverse set of reasons|92|||
155580757|NCT01960413|561551494|FG000|Overall Study|Withdrawal by Subject|1|||
155580758|NCT01960413|561551495|FG001|Overall Study|Withdrawal by Subject|1|||
155580759|NCT01960413|561551494|FG000|Overall Study|Physician Decision|1|||
155580760|NCT01960413|561551495|FG001|Overall Study|Physician Decision|0|||
155580761|NCT01960413|561551494|FG000|Overall Study|Lost to Follow-up|2|||
155580762|NCT01960413|561551495|FG001|Overall Study|Lost to Follow-up|0|||
155580763|NCT00791778|561551496|FG000|Double-blind Treatment|Adverse Event|49|||
155580764|NCT00791778|561551497|FG001|Double-blind Treatment|Adverse Event|9|||
155580765|NCT00791778|561551496|FG000|Double-blind Treatment|Physician Decision|6|||
155663728|NCT04460183|561865202|FG001|Overall Study|Withdrawal by Subject|0|||
155663729|NCT01213082|561865203|FG000|Overall Study|Lost to Follow-up|6|||
155663730|NCT01213082|561865204|FG001|Overall Study|Lost to Follow-up|7|||
155663731|NCT01213082|561865205|FG002|Overall Study|Lost to Follow-up|4|||
155663732|NCT01213082|561865203|FG000|Overall Study|Physician Decision|0|||
155663733|NCT01213082|561865204|FG001|Overall Study|Physician Decision|0|||
155663734|NCT01213082|561865205|FG002|Overall Study|Physician Decision|1|||
155663735|NCT03139448|561865215|FG000|Overall Study|Lack of Efficacy|6|||
155663736|NCT03139448|561865216|FG001|Overall Study|Lack of Efficacy|7|||
155663737|NCT03139448|561865215|FG000|Overall Study|Location of procedure changed|2|||
155663738|NCT03139448|561865216|FG001|Overall Study|Location of procedure changed|8|||
155663739|NCT03139448|561865215|FG000|Overall Study|Withdrawal by Subject|3|||
155580766|NCT00791778|561551497|FG001|Double-blind Treatment|Physician Decision|26|||
155580767|NCT00791778|561551496|FG000|Double-blind Treatment|Protocol Violation|0|||
155580768|NCT00791778|561551497|FG001|Double-blind Treatment|Protocol Violation|4|||
155580769|NCT00791778|561551496|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
155580770|NCT00791778|561551497|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
155580771|NCT00791778|561551496|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
155580772|NCT00791778|561551497|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
155580773|NCT00791778|561551496|FG000|Follow-up|Withdrawal by Subject|3|||
155580774|NCT00791778|561551497|FG001|Follow-up|Withdrawal by Subject|0|||
155580775|NCT00791778|561551496|FG000|Follow-up|Lost to Follow-up|2|||
155580776|NCT00791778|561551497|FG001|Follow-up|Lost to Follow-up|1|||
155580777|NCT03051100|561551498|FG000|Overall Study|Withdrawal by Subject|1|||
155580778|NCT03051100|561551499|FG001|Overall Study|Withdrawal by Subject|0|||
155580779|NCT03335475|561551500|FG000|Overall Study|Did not wear accelerometer|4|||
155580780|NCT03335475|561551501|FG001|Overall Study|Did not wear accelerometer|0|||
155580781|NCT03335475|561551500|FG000|Overall Study|Withdrawal by Subject|0|||
155580782|NCT03335475|561551501|FG001|Overall Study|Withdrawal by Subject|1|||
155580783|NCT04886596|561551502|FG000|Overall Study|Adverse Event|442|||
155580784|NCT04886596|561551503|FG001|Overall Study|Adverse Event|441|||
155580785|NCT04886596|561551502|FG000|Overall Study|Lost to Follow-up|448|||
155580786|NCT04886596|561551503|FG001|Overall Study|Lost to Follow-up|465|||
155580787|NCT04886596|561551502|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
155580788|NCT04886596|561551503|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
155580789|NCT04886596|561551502|FG000|Overall Study|Migrated/moved from the study area|201|||
155580790|NCT04886596|561551503|FG001|Overall Study|Migrated/moved from the study area|184|||
155580791|NCT04886596|561551502|FG000|Overall Study|Other|298|||
155580792|NCT04886596|561551503|FG001|Overall Study|Other|326|||
155580793|NCT02411656|561551504|FG000|Overall Study|Adverse Event|4|||
155580794|NCT02411656|561551504|FG000|Overall Study|Clinical Progression|33|||
155580795|NCT03305848|561551505|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
155580796|NCT03305848|561551505|FG000|Overall Study|Physician Decision|2|||
155580797|NCT01949662|561551506|FG000|Overall Study|Death|9|||
155580798|NCT01949662|561551507|FG001|Overall Study|Death|7|||
155580799|NCT01949662|561551506|FG000|Overall Study|Discharged before an agitation event|8|||
155580800|NCT01949662|561551507|FG001|Overall Study|Discharged before an agitation event|3|||
155580801|NCT01949662|561551506|FG000|Overall Study|Dropped out|1|||
155580802|NCT01949662|561551507|FG001|Overall Study|Dropped out|3|||
155580803|NCT01949662|561551506|FG000|Overall Study|Ineligible|0|||
155580804|NCT01949662|561551507|FG001|Overall Study|Ineligible|1|||
155580805|NCT02291237|561551508|FG000|Overall Study|Study Terminated by Sponsor|72|||
155580806|NCT02291237|561551509|FG001|Overall Study|Study Terminated by Sponsor|67|||
155580807|NCT02291237|561551508|FG000|Overall Study|Adverse Event|1|||
155580808|NCT02291237|561551509|FG001|Overall Study|Adverse Event|3|||
155580809|NCT02291237|561551508|FG000|Overall Study|Investigator's Discretion|0|||
155580810|NCT02291237|561551509|FG001|Overall Study|Investigator's Discretion|3|||
155580811|NCT02291237|561551508|FG000|Overall Study|Withdrew Consent|11|||
155580812|NCT02291237|561551509|FG001|Overall Study|Withdrew Consent|11|||
155663740|NCT03139448|561865216|FG001|Overall Study|Withdrawal by Subject|6|||
155580813|NCT02291237|561551508|FG000|Overall Study|Lost to Follow-up|0|||
155580814|NCT02291237|561551509|FG001|Overall Study|Lost to Follow-up|2|||
155580815|NCT02291237|561551508|FG000|Overall Study|Subject Required Prohibited Medication|2|||
155580816|NCT02291237|561551509|FG001|Overall Study|Subject Required Prohibited Medication|0|||
155580817|NCT03326193|561551511|FG000|Overall Study|Sponsor decision|35|||
155580818|NCT01478373|561551514|FG000|Treatment Phase|Protocol Violation|1|||
155663741|NCT03139448|561865215|FG000|Overall Study|Screen fail|1|||
155580819|NCT01478373|561551514|FG000|Survival Phase|Adverse Event|8|||
155580820|NCT01478373|561551514|FG000|Survival Phase|Protocol Violation|1|||
155580821|NCT01478373|561551514|FG000|Survival Phase|crossover to another study|2|||
155580822|NCT01478373|561551514|FG000|Survival Phase|Progressive Disease|27|||
155580823|NCT01408043|561551517|FG000|Overall Study|unable to collect cells|1|||
155580824|NCT02552121|561551518|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
155580825|NCT02552121|561551519|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155663742|NCT03139448|561865216|FG001|Overall Study|Screen fail|3|||
155663743|NCT03139448|561865215|FG000|Overall Study|Physician Decision|0|||
155663744|NCT03139448|561865216|FG001|Overall Study|Physician Decision|2|||
155663745|NCT01832727|561865224|FG000|Overall Study|Adverse Event|4|||
155663746|NCT01832727|561865225|FG001|Overall Study|Adverse Event|6|||
155663747|NCT01832727|561865226|FG002|Overall Study|Adverse Event|1|||
155663748|NCT01832727|561865227|FG003|Overall Study|Adverse Event|0|||
155663749|NCT01832727|561865228|FG004|Overall Study|Adverse Event|1|||
155663750|NCT01832727|561865229|FG005|Overall Study|Adverse Event|1|||
155663751|NCT01832727|561865230|FG006|Overall Study|Adverse Event|2|||
155663752|NCT01832727|561865231|FG007|Overall Study|Adverse Event|1|||
155663753|NCT01832727|561865232|FG008|Overall Study|Adverse Event|9|||
155663754|NCT01832727|561865224|FG000|Overall Study|Disease progression|3|||
155663755|NCT01832727|561865225|FG001|Overall Study|Disease progression|0|||
155663756|NCT01832727|561865226|FG002|Overall Study|Disease progression|2|||
155663757|NCT01832727|561865227|FG003|Overall Study|Disease progression|1|||
155663758|NCT01832727|561865228|FG004|Overall Study|Disease progression|3|||
155663759|NCT01832727|561865229|FG005|Overall Study|Disease progression|3|||
155663760|NCT01832727|561865230|FG006|Overall Study|Disease progression|6|||
155663761|NCT01832727|561865231|FG007|Overall Study|Disease progression|2|||
155663762|NCT01832727|561865232|FG008|Overall Study|Disease progression|7|||
155663763|NCT01832727|561865224|FG000|Overall Study|Lost to Follow-up|0|||
155663764|NCT01832727|561865225|FG001|Overall Study|Lost to Follow-up|0|||
155663765|NCT01832727|561865226|FG002|Overall Study|Lost to Follow-up|0|||
155663766|NCT01832727|561865227|FG003|Overall Study|Lost to Follow-up|1|||
155663767|NCT01832727|561865228|FG004|Overall Study|Lost to Follow-up|0|||
155663768|NCT01832727|561865229|FG005|Overall Study|Lost to Follow-up|0|||
155663769|NCT01832727|561865230|FG006|Overall Study|Lost to Follow-up|0|||
155663770|NCT01832727|561865231|FG007|Overall Study|Lost to Follow-up|0|||
155663771|NCT01832727|561865232|FG008|Overall Study|Lost to Follow-up|0|||
155663772|NCT01832727|561865224|FG000|Overall Study|Physician Decision|1|||
155663773|NCT01832727|561865225|FG001|Overall Study|Physician Decision|0|||
155663774|NCT01832727|561865226|FG002|Overall Study|Physician Decision|0|||
155663775|NCT01832727|561865227|FG003|Overall Study|Physician Decision|1|||
155663776|NCT01832727|561865228|FG004|Overall Study|Physician Decision|0|||
155663777|NCT01832727|561865229|FG005|Overall Study|Physician Decision|1|||
155663778|NCT01832727|561865230|FG006|Overall Study|Physician Decision|0|||
155663779|NCT01832727|561865231|FG007|Overall Study|Physician Decision|0|||
155663780|NCT01832727|561865232|FG008|Overall Study|Physician Decision|0|||
155663781|NCT01832727|561865224|FG000|Overall Study|Withdrawal by Subject|1|||
155663782|NCT01832727|561865225|FG001|Overall Study|Withdrawal by Subject|1|||
155663783|NCT01832727|561865226|FG002|Overall Study|Withdrawal by Subject|0|||
155663784|NCT01832727|561865227|FG003|Overall Study|Withdrawal by Subject|1|||
155663785|NCT01832727|561865228|FG004|Overall Study|Withdrawal by Subject|0|||
155663786|NCT01832727|561865229|FG005|Overall Study|Withdrawal by Subject|1|||
155663787|NCT01832727|561865230|FG006|Overall Study|Withdrawal by Subject|0|||
155663788|NCT01832727|561865231|FG007|Overall Study|Withdrawal by Subject|2|||
155663789|NCT01832727|561865232|FG008|Overall Study|Withdrawal by Subject|1|||
155663790|NCT01832727|561865224|FG000|Overall Study|Study terminated by sponsor|0|||
155663791|NCT01832727|561865225|FG001|Overall Study|Study terminated by sponsor|0|||
155663792|NCT01832727|561865226|FG002|Overall Study|Study terminated by sponsor|0|||
155663793|NCT01832727|561865227|FG003|Overall Study|Study terminated by sponsor|0|||
155663794|NCT01832727|561865228|FG004|Overall Study|Study terminated by sponsor|0|||
155663795|NCT01832727|561865229|FG005|Overall Study|Study terminated by sponsor|0|||
155663796|NCT01832727|561865230|FG006|Overall Study|Study terminated by sponsor|0|||
155663797|NCT01832727|561865231|FG007|Overall Study|Study terminated by sponsor|1|||
155663798|NCT01832727|561865232|FG008|Overall Study|Study terminated by sponsor|1|||
155663799|NCT00501644|561865235|FG000|Overall Study|Adverse Event|4|||
155663800|NCT00501644|561865235|FG000|Overall Study|Withdrawal by Subject|1|||
155663801|NCT02553629|561865236|FG000|Overall Study|Logistic reasons|3|||
155663802|NCT02553629|561865237|FG001|Overall Study|Logistic reasons|6|||
155663803|NCT03434834|561865238|FG000|Overall Study|unable to swallow OCT probe|16|||
155663804|NCT01823289|561865243|FG000|Overall Study|Lost to Follow-up|5|||
155663805|NCT01823289|561865243|FG000|Overall Study|Adverse Event|5|||
155663806|NCT01823289|561865243|FG000|Overall Study|Lack of Efficacy|1|||
155663807|NCT01823289|561865243|FG000|Overall Study|Physician Decision|9|||
155663808|NCT01823289|561865243|FG000|Overall Study|Administered contraindicated medicine|1|||
155663809|NCT01823289|561865243|FG000|Overall Study|Transaminase increased more than 3 times|1|||
155663810|NCT01823289|561865243|FG000|Overall Study|Drug affected efficacy and safety|1|||
155663811|NCT01823289|561865243|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
155663812|NCT01812057|561865247|FG000|Overall Study|Protocol Violation|1|||
155663813|NCT01812057|561865248|FG001|Overall Study|Protocol Violation|0|||
155663814|NCT01812057|561865247|FG000|Overall Study|Physician Decision|1|||
155663815|NCT01812057|561865248|FG001|Overall Study|Physician Decision|0|||
155663816|NCT01911260|561865250|FG000|Supplementation Period|transference or evasion of school|7|||
155663817|NCT01911260|561865251|FG001|Supplementation Period|transference or evasion of school|9|||
155663818|NCT01911260|561865252|FG002|Supplementation Period|transference or evasion of school|7|||
155663819|NCT01911260|561865253|FG003|Supplementation Period|transference or evasion of school|6|||
155663820|NCT01911260|561865250|FG000|Supplementation Period|Adverse Event|2|||
155663821|NCT01911260|561865251|FG001|Supplementation Period|Adverse Event|0|||
155663822|NCT01911260|561865252|FG002|Supplementation Period|Adverse Event|1|||
155663823|NCT01911260|561865253|FG003|Supplementation Period|Adverse Event|0|||
155663824|NCT01911260|561865250|FG000|Supplementation Period|refused to receive supplement|1|||
155663825|NCT01911260|561865251|FG001|Supplementation Period|refused to receive supplement|0|||
155663826|NCT01911260|561865252|FG002|Supplementation Period|refused to receive supplement|1|||
155663827|NCT01911260|561865253|FG003|Supplementation Period|refused to receive supplement|0|||
155663828|NCT01911260|561865250|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
155663829|NCT01911260|561865251|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
155663830|NCT01911260|561865252|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
155663831|NCT01911260|561865253|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
155663832|NCT01911260|561865250|FG000|Follow-up Period|transference or evasion of school|13|||
155663833|NCT01911260|561865251|FG001|Follow-up Period|transference or evasion of school|20|||
155663834|NCT01911260|561865252|FG002|Follow-up Period|transference or evasion of school|15|||
155663835|NCT01911260|561865253|FG003|Follow-up Period|transference or evasion of school|12|||
155663836|NCT00654732|561865258|FG000|Overall Study|Adverse Event|4|||
155663837|NCT00654732|561865259|FG001|Overall Study|Adverse Event|6|||
155663838|NCT01133847|561865266|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
155663839|NCT01133847|561865267|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
155663840|NCT01133847|561865268|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
155663841|NCT01133847|561865266|FG000|Follow-Up Phase|Lost to Follow-up|1|||
155663842|NCT01133847|561865267|FG001|Follow-Up Phase|Lost to Follow-up|3|||
155663843|NCT01133847|561865268|FG002|Follow-Up Phase|Lost to Follow-up|7|||
155663844|NCT04436744|561865269|FG000|Overall Study|Adverse Event|1|||
155663845|NCT04436744|561865270|FG001|Overall Study|Adverse Event|1|||
155663846|NCT04436744|561865269|FG000|Overall Study|Death|1|||
155663847|NCT04436744|561865270|FG001|Overall Study|Death|0|||
155663848|NCT04436744|561865269|FG000|Overall Study|Lost to Follow-up|0|||
155663849|NCT04436744|561865270|FG001|Overall Study|Lost to Follow-up|2|||
155663850|NCT04436744|561865269|FG000|Overall Study|Physician Decision|0|||
155663851|NCT04436744|561865270|FG001|Overall Study|Physician Decision|1|||
155663852|NCT04436744|561865269|FG000|Overall Study|Progressive Disease|0|||
155663853|NCT04436744|561865270|FG001|Overall Study|Progressive Disease|4|||
155663854|NCT04436744|561865269|FG000|Overall Study|Protocol Deviation|1|||
155663855|NCT04436744|561865270|FG001|Overall Study|Protocol Deviation|1|||
155663856|NCT04436744|561865269|FG000|Overall Study|Withdrawal by Subject|1|||
155663857|NCT04436744|561865270|FG001|Overall Study|Withdrawal by Subject|2|||
155663858|NCT01880957|561865271|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
155663859|NCT01880957|561865272|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
155663860|NCT01880957|561865271|FG000|Overall Study|Lost to Follow-up|11|||
155663861|NCT01880957|561865272|FG001|Overall Study|Lost to Follow-up|0|||
155663862|NCT01880957|561865271|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
155663863|NCT01880957|561865272|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
155580826|NCT02552121|561551520|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580827|NCT02552121|561551521|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580828|NCT02552121|561551522|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580829|NCT02552121|561551523|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580830|NCT02552121|561551524|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580831|NCT02552121|561551525|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155580832|NCT02552121|561551518|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
155580833|NCT02552121|561551519|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580834|NCT02552121|561551520|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580835|NCT02552121|561551521|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580836|NCT02552121|561551522|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580837|NCT02552121|561551523|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580838|NCT02552121|561551524|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580839|NCT02552121|561551525|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155580840|NCT02552121|561551518|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580841|NCT02552121|561551519|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
155580842|NCT02552121|561551520|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155663864|NCT01378117|561865273|FG000|Overall Study|withdrawal|2|||
155663865|NCT01378117|561865274|FG001|Overall Study|withdrawal|1|||
155663866|NCT01378117|561865275|FG002|Overall Study|withdrawal|2|||
155663867|NCT01378117|561865273|FG000|Overall Study|discharged before med given|2|||
155663868|NCT01378117|561865274|FG001|Overall Study|discharged before med given|0|||
155663869|NCT01378117|561865275|FG002|Overall Study|discharged before med given|1|||
155663870|NCT01463033|561865276|FG000|Overall Study|Lost to Follow-up|4|||
155663871|NCT01463033|561865277|FG001|Overall Study|Lost to Follow-up|4|||
155663872|NCT01463033|561865276|FG000|Overall Study|Death|3|||
155663873|NCT01463033|561865277|FG001|Overall Study|Death|2|||
155663874|NCT01854528|561865278|FG000|Overall Study|Adverse Event|0|||
155663875|NCT01854528|561865279|FG001|Overall Study|Adverse Event|4|||
155663876|NCT01854528|561865278|FG000|Overall Study|Withdrawal by Subject|0|||
155663877|NCT01854528|561865279|FG001|Overall Study|Withdrawal by Subject|2|||
155663878|NCT01854528|561865278|FG000|Overall Study|Virologic Failure|0|||
155663879|NCT01854528|561865279|FG001|Overall Study|Virologic Failure|9|||
155663880|NCT03710889|561865288|FG000|Overall Study|Adverse Event|2|||
155663881|NCT03710889|561865288|FG000|Overall Study|Protocol Deviation|1|||
155663882|NCT02850978|561865290|FG000|Overall Study|Uncollectable CRF|27|||
155663883|NCT02850978|561865290|FG000|Overall Study|No visit since the first visit|35|||
155580843|NCT02552121|561551521|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580844|NCT02552121|561551522|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580845|NCT02552121|561551523|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580846|NCT02552121|561551524|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580847|NCT02552121|561551525|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155580848|NCT02552121|561551518|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580849|NCT02552121|561551519|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
155580850|NCT02552121|561551520|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580851|NCT02552121|561551521|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580852|NCT02552121|561551522|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580853|NCT02552121|561551523|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580854|NCT02552121|561551524|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580855|NCT02552121|561551525|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155580856|NCT02552121|561551518|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580857|NCT02552121|561551519|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
155580858|NCT02552121|561551520|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580859|NCT02552121|561551521|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580860|NCT02552121|561551522|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580861|NCT02552121|561551523|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580862|NCT02552121|561551524|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580863|NCT02552121|561551525|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155580864|NCT02552121|561551518|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580865|NCT02552121|561551519|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
155580866|NCT02552121|561551520|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580867|NCT02552121|561551521|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580868|NCT02552121|561551522|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580869|NCT02552121|561551523|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580870|NCT02552121|561551524|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580871|NCT02552121|561551525|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155580872|NCT02552121|561551518|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
155580873|NCT02552121|561551519|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
155580874|NCT02552121|561551520|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
155580875|NCT02552121|561551521|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
155580876|NCT02552121|561551522|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
155580877|NCT02552121|561551523|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
155580878|NCT02552121|561551524|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
155580879|NCT02552121|561551525|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
155580880|NCT02552121|561551518|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
155580881|NCT02552121|561551519|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
155580882|NCT02552121|561551520|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
155580883|NCT02552121|561551521|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
155580884|NCT02552121|561551522|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
155580885|NCT02552121|561551523|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
155580886|NCT02552121|561551524|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
155580887|NCT02552121|561551525|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
155580888|NCT02552121|561551518|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
155580889|NCT02552121|561551519|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
155663884|NCT02850978|561865290|FG000|Overall Study|Adverse Event|81|||
155663885|NCT02850978|561865290|FG000|Overall Study|Lack of Efficacy|40|||
155580890|NCT02552121|561551520|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
155663886|NCT02850978|561865290|FG000|Overall Study|Improvement in condition|34|||
155663887|NCT02850978|561865290|FG000|Overall Study|Lost to Follow-up|121|||
155663888|NCT02850978|561865290|FG000|Overall Study|Reason not listed|88|||
155663889|NCT00421148|561865291|FG000|Overall Study|Lost to Follow-up|0|||
155663890|NCT00421148|561865292|FG001|Overall Study|Lost to Follow-up|0|||
155663891|NCT00421148|561865293|FG002|Overall Study|Lost to Follow-up|0|||
155580891|NCT02552121|561551521|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
155580892|NCT02552121|561551522|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
155580893|NCT02552121|561551523|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
155580894|NCT02552121|561551524|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
155580895|NCT02552121|561551525|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
155580896|NCT02552121|561551518|FG000|Part 2: Cohort Expansion|Death|0|||
155580897|NCT02552121|561551519|FG001|Part 2: Cohort Expansion|Death|0|||
155580898|NCT02552121|561551520|FG002|Part 2: Cohort Expansion|Death|1|||
155580899|NCT02552121|561551521|FG003|Part 2: Cohort Expansion|Death|0|||
155580900|NCT02552121|561551522|FG004|Part 2: Cohort Expansion|Death|0|||
155580901|NCT02552121|561551523|FG005|Part 2: Cohort Expansion|Death|0|||
155580902|NCT02552121|561551524|FG006|Part 2: Cohort Expansion|Death|0|||
155580903|NCT02552121|561551525|FG007|Part 2: Cohort Expansion|Death|0|||
155580904|NCT01522456|561551526|FG000|Overall Study|Adverse Event|2|||
155580905|NCT01522456|561551526|FG000|Overall Study|Lost to Follow-up|2|||
155580906|NCT01522456|561551526|FG000|Overall Study|Withdrawal by Subject|2|||
155580907|NCT01522456|561551526|FG000|Overall Study|Pregnancy|1|||
155580908|NCT01522456|561551526|FG000|Overall Study|Tolerability Assessment|1|||
155580909|NCT04052620|561551527|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
155580910|NCT04052620|561551528|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
155580911|NCT04052620|561551527|FG000|Overall Study|Withdrawal by Subject|1|||
155580912|NCT04052620|561551528|FG001|Overall Study|Withdrawal by Subject|0|||
155580913|NCT04052620|561551527|FG000|Overall Study|Lost to Follow-up|1|||
155580914|NCT04052620|561551528|FG001|Overall Study|Lost to Follow-up|1|||
155580915|NCT04052620|561551527|FG000|Overall Study|Adverse Event|1|||
155580916|NCT04052620|561551528|FG001|Overall Study|Adverse Event|0|||
155580917|NCT04052620|561551527|FG000|Overall Study|Subject did not meet study Criteria|0|||
155580918|NCT04052620|561551528|FG001|Overall Study|Subject did not meet study Criteria|1|||
155580919|NCT04052620|561551527|FG000|Overall Study|Screened failure, randomized by mistake|0|||
155580920|NCT04052620|561551528|FG001|Overall Study|Screened failure, randomized by mistake|1|||
155580921|NCT04052620|561551527|FG000|Overall Study|Personal reasons|2|||
155580922|NCT04052620|561551528|FG001|Overall Study|Personal reasons|4|||
155580923|NCT04052620|561551527|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
155580924|NCT04052620|561551528|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
155580925|NCT01406574|561551529|FG000|Overall Study|Adverse Event|0|||
155580926|NCT01406574|561551530|FG001|Overall Study|Adverse Event|0|||
155580927|NCT01406574|561551531|FG002|Overall Study|Adverse Event|1|||
155580928|NCT01406574|561551532|FG003|Overall Study|Adverse Event|3|||
155580929|NCT01406574|561551529|FG000|Overall Study|Physician Decision|0|||
155580930|NCT01406574|561551530|FG001|Overall Study|Physician Decision|0|||
155580931|NCT01406574|561551531|FG002|Overall Study|Physician Decision|0|||
155580932|NCT01406574|561551532|FG003|Overall Study|Physician Decision|1|||
155580933|NCT01406574|561551529|FG000|Overall Study|Withdrawal by Subject|0|||
155580934|NCT01406574|561551530|FG001|Overall Study|Withdrawal by Subject|1|||
155580935|NCT01406574|561551531|FG002|Overall Study|Withdrawal by Subject|0|||
155580936|NCT01406574|561551532|FG003|Overall Study|Withdrawal by Subject|0|||
155580937|NCT01406574|561551529|FG000|Overall Study|Definite progression of primary disease|1|||
155580938|NCT01406574|561551530|FG001|Overall Study|Definite progression of primary disease|0|||
155580939|NCT01406574|561551531|FG002|Overall Study|Definite progression of primary disease|0|||
155580940|NCT01406574|561551532|FG003|Overall Study|Definite progression of primary disease|0|||
155580941|NCT02201784|561551534|FG000|Overall Study|Failure to achieve adequate block|2|||
155580942|NCT02201784|561551535|FG001|Overall Study|Failure to achieve adequate block|0|||
155580943|NCT00946920|561551536|FG000|Overall Study|Withdrawal by Subject|28|||
155580944|NCT00946920|561551537|FG001|Overall Study|Withdrawal by Subject|15|||
155580945|NCT00946920|561551536|FG000|Overall Study|Lost to Follow-up|2|||
155580946|NCT00946920|561551537|FG001|Overall Study|Lost to Follow-up|2|||
155580947|NCT00946920|561551536|FG000|Overall Study|Physician Decision|5|||
155580948|NCT00946920|561551537|FG001|Overall Study|Physician Decision|2|||
155580949|NCT00946920|561551536|FG000|Overall Study|Adverse Event|41|||
155580950|NCT00946920|561551537|FG001|Overall Study|Adverse Event|14|||
155580951|NCT00946920|561551536|FG000|Overall Study|Protocol Violation|16|||
155580952|NCT00946920|561551537|FG001|Overall Study|Protocol Violation|8|||
155580953|NCT00946920|561551536|FG000|Overall Study|Miscellaneous reasons|18|||
155580954|NCT00946920|561551537|FG001|Overall Study|Miscellaneous reasons|3|||
155580955|NCT00193050|561551538|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
155580956|NCT00193050|561551538|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
155580957|NCT00193050|561551538|FG000|Neoadjuvant Treatment|Physician Decision|2|||
155580958|NCT00193050|561551538|FG000|Neoadjuvant Treatment|Adverse Event|2|||
155580959|NCT00193050|561551538|FG000|Adjuvant|Physician Decision|5|||
155580960|NCT00193050|561551538|FG000|Adjuvant|Intercurrent Hospitalization|3|||
155580961|NCT00193050|561551538|FG000|Adjuvant|Lack of Efficacy|2|||
155580962|NCT00473590|561551539|FG000|Overall Study|Adverse Event|3|||
155580963|NCT00473590|561551540|FG001|Overall Study|Adverse Event|3|||
155580964|NCT00473590|561551539|FG000|Overall Study|Death|4|||
155580965|NCT00473590|561551540|FG001|Overall Study|Death|2|||
155580966|NCT00473590|561551539|FG000|Overall Study|Progression not resulting in death|24|||
155580967|NCT00473590|561551540|FG001|Overall Study|Progression not resulting in death|20|||
155580968|NCT00473590|561551539|FG000|Overall Study|Non-protocol-specified therapy|7|||
155580969|NCT00473590|561551540|FG001|Overall Study|Non-protocol-specified therapy|5|||
155580970|NCT00473590|561551539|FG000|Overall Study|Physician Decision|2|||
155580971|NCT00473590|561551540|FG001|Overall Study|Physician Decision|4|||
155580972|NCT00473590|561551539|FG000|Overall Study|Withdrawal by Subject|5|||
155580973|NCT00473590|561551540|FG001|Overall Study|Withdrawal by Subject|3|||
155580974|NCT00473590|561551539|FG000|Overall Study|Other|0|||
155580975|NCT00473590|561551540|FG001|Overall Study|Other|1|||
155580976|NCT01245283|561551543|FG000|Overall Study|Lost to Follow-up|14|||
155580977|NCT01245283|561551544|FG001|Overall Study|Lost to Follow-up|11|||
155580978|NCT01245283|561551545|FG002|Overall Study|Lost to Follow-up|11|||
155580979|NCT01610492|561551554|FG000|Overall Study|Adverse Event|1|||
155580980|NCT01610492|561551554|FG000|Overall Study|Lack of Efficacy|3|||
155580981|NCT01610492|561551554|FG000|Overall Study|Other: Reached stopping criteria|1|||
155580982|NCT01610492|561551554|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
155580983|NCT03093259|561551555|FG000|Overall Study|Adverse Event|1|||
155580984|NCT03093259|561551556|FG001|Overall Study|Adverse Event|0|||
155580985|NCT03093259|561551555|FG000|Overall Study|Withdrawal by Subject|1|||
155580986|NCT03093259|561551556|FG001|Overall Study|Withdrawal by Subject|0|||
155580987|NCT01821807|561551557|FG000|Overall Study|Lost to Follow-up|3|||
155580988|NCT01821807|561551558|FG001|Overall Study|Lost to Follow-up|1|||
155580989|NCT02325973|561553205|FG000|Overall Study|Death|5|||
155580990|NCT02325973|561553205|FG000|Overall Study|Withdrawal by subject or investigator|16|||
155580991|NCT03874117|561553209|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
155580992|NCT03874117|561553210|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
155580993|NCT03874117|561553209|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
155580994|NCT03874117|561553210|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
155580995|NCT03874117|561553209|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155580996|NCT03874117|561553210|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155580997|NCT03874117|561553209|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
155580998|NCT03874117|561553210|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
155580999|NCT03874117|561553209|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155581000|NCT03874117|561553210|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155581001|NCT05012098|561553211|FG000|Overall Study|Disease progression|5|||
155581002|NCT05012098|561553212|FG001|Overall Study|Disease progression|2|||
155581003|NCT05012098|561553211|FG000|Overall Study|Adverse Event|1|||
155581004|NCT05012098|561553212|FG001|Overall Study|Adverse Event|0|||
155581005|NCT05012098|561553211|FG000|Overall Study|Withdrawal by Subject|1|||
155581006|NCT05012098|561553212|FG001|Overall Study|Withdrawal by Subject|0|||
155581007|NCT05012098|561553211|FG000|Overall Study|Discontinuation per protocol|1|||
155581008|NCT05012098|561553212|FG001|Overall Study|Discontinuation per protocol|0|||
155581009|NCT04815083|561553213|FG000|Overall Study|Physician Decision|1|||
155581010|NCT04815083|561553213|FG000|Overall Study|Study pause|2|||
155581011|NCT04815083|561553213|FG000|Overall Study|Screening failure|4|||
155581012|NCT06025721|561553214|FG000|Overall Study|Physician Decision|1|||
155581013|NCT06025721|561553214|FG000|Overall Study|Protocol Violation|1|||
155581014|NCT06025721|561553214|FG000|Overall Study|Incarceration|1|||
155581015|NCT00075816|561553215|FG000|Overall Study|Did not undergo transplantation|14|||
155581016|NCT00075816|561553216|FG001|Overall Study|Did not undergo transplantation|11|||
155581017|NCT02832687|561553217|FG000|Overall Study|Adverse Event|0|||
155581018|NCT02832687|561553218|FG001|Overall Study|Adverse Event|2|||
155581019|NCT04231825|561553219|FG000|Overall Study|Protocol Violation|3|||
155581020|NCT04231825|561553220|FG001|Overall Study|Protocol Violation|3|||
155581021|NCT04231825|561553219|FG000|Overall Study|Lost to Follow-up|0|||
155581022|NCT04231825|561553220|FG001|Overall Study|Lost to Follow-up|1|||
155581023|NCT00611923|561553223|FG000|Overall Study|Withdrawal by Subject|2|||
155581024|NCT00611923|561553224|FG001|Overall Study|Withdrawal by Subject|2|||
155581025|NCT03588910|561553225|FG000|Overall Study|Withdrawal by Subject|1|||
155581026|NCT03588910|561553226|FG001|Overall Study|Withdrawal by Subject|0|||
155663892|NCT00421148|561865294|FG003|Overall Study|Lost to Follow-up|0|||
155663893|NCT00421148|561865295|FG004|Overall Study|Lost to Follow-up|0|||
155663894|NCT00421148|561865296|FG005|Overall Study|Lost to Follow-up|0|||
155581027|NCT03588910|561553225|FG000|Overall Study|Allergy|2|||
155581028|NCT03588910|561553226|FG001|Overall Study|Allergy|0|||
155581029|NCT03588910|561553225|FG000|Overall Study|Protocol Violation|0|||
155581030|NCT03588910|561553226|FG001|Overall Study|Protocol Violation|3|||
155581031|NCT03588910|561553225|FG000|Overall Study|Did not complete Day 1 Survey|5|||
155663895|NCT00421148|561865297|FG006|Overall Study|Lost to Follow-up|0|||
155581032|NCT03588910|561553226|FG001|Overall Study|Did not complete Day 1 Survey|10|||
155581033|NCT03588910|561553225|FG000|Overall Study|Did not complete Day 7 Survey|5|||
155581034|NCT03588910|561553226|FG001|Overall Study|Did not complete Day 7 Survey|2|||
155581035|NCT00471822|561553227|FG000|Overall Study|Protocol Violation|2|||
155581036|NCT03499067|561553228|FG000|First Intervention|Physician Decision|2|||
155581037|NCT03499067|561553229|FG001|First Intervention|Physician Decision|1|||
155581038|NCT03499067|561553228|FG000|First Intervention|Withdrawal by Subject|3|||
155581039|NCT03499067|561553229|FG001|First Intervention|Withdrawal by Subject|6|||
155581040|NCT02440464|561553230|FG000|Overall Study|Withdrawal by Subject|3|||
155581041|NCT02440464|561553231|FG001|Overall Study|Withdrawal by Subject|2|||
155581042|NCT02392481|561553232|FG000|Overall Study|Adverse Event|0|||
155581043|NCT02392481|561553233|FG001|Overall Study|Adverse Event|0|||
155581044|NCT02392481|561553234|FG002|Overall Study|Adverse Event|1|||
155581045|NCT02392481|561553235|FG003|Overall Study|Adverse Event|2|||
155581046|NCT02392481|561553232|FG000|Overall Study|Withdrawal by Subject|0|||
155581047|NCT02392481|561553233|FG001|Overall Study|Withdrawal by Subject|0|||
155581048|NCT02392481|561553234|FG002|Overall Study|Withdrawal by Subject|1|||
155581049|NCT02392481|561553235|FG003|Overall Study|Withdrawal by Subject|0|||
155581050|NCT02088177|561553245|FG000|Overall Study|Lost to Follow-up|3|||
155581051|NCT00289848|561553246|FG000|Overall Study|Adverse Event|6|||
155581052|NCT00289848|561553247|FG001|Overall Study|Adverse Event|4|||
155581053|NCT00289848|561553246|FG000|Overall Study|Death|1|||
155581054|NCT00289848|561553247|FG001|Overall Study|Death|0|||
155581055|NCT00289848|561553246|FG000|Overall Study|Lack of Efficacy|20|||
155581056|NCT00289848|561553247|FG001|Overall Study|Lack of Efficacy|24|||
155581057|NCT00289848|561553246|FG000|Overall Study|Lost to Follow-up|3|||
155581058|NCT00289848|561553247|FG001|Overall Study|Lost to Follow-up|1|||
155581059|NCT00289848|561553246|FG000|Overall Study|Protocol Violation|5|||
155581060|NCT00289848|561553247|FG001|Overall Study|Protocol Violation|2|||
155581061|NCT00289848|561553246|FG000|Overall Study|Withdrawal by Subject|5|||
155581062|NCT00289848|561553247|FG001|Overall Study|Withdrawal by Subject|11|||
155581063|NCT00289848|561553246|FG000|Overall Study|Patient Moved|6|||
155581064|NCT00289848|561553247|FG001|Overall Study|Patient Moved|2|||
155581065|NCT00289848|561553246|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
155581066|NCT00289848|561553247|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
155581067|NCT00063934|561553250|FG000|Overall Study|Ineligible|1|||
155581068|NCT00395629|561553251|FG000|Core Study|Adverse Event|0|||
155581069|NCT00395629|561553252|FG001|Core Study|Adverse Event|3|||
155581070|NCT00395629|561553253|FG002|Core Study|Adverse Event|4|||
155581071|NCT00395629|561553251|FG000|Core Study|Abnormal laboratory value(s)|0|||
155581072|NCT00395629|561553252|FG001|Core Study|Abnormal laboratory value(s)|0|||
155581073|NCT00395629|561553253|FG002|Core Study|Abnormal laboratory value(s)|1|||
155581074|NCT00395629|561553251|FG000|Core Study|Protocol Violation|1|||
155581075|NCT00395629|561553252|FG001|Core Study|Protocol Violation|0|||
155581076|NCT00395629|561553253|FG002|Core Study|Protocol Violation|0|||
155581077|NCT00395629|561553251|FG000|Core Study|Withdrawal by Subject|0|||
155581078|NCT00395629|561553252|FG001|Core Study|Withdrawal by Subject|1|||
155581079|NCT00395629|561553253|FG002|Core Study|Withdrawal by Subject|1|||
155581080|NCT00395629|561553251|FG000|Core Study|Lost to Follow-up|0|||
155581081|NCT00395629|561553252|FG001|Core Study|Lost to Follow-up|0|||
155581082|NCT00395629|561553253|FG002|Core Study|Lost to Follow-up|1|||
155581083|NCT00395629|561553251|FG000|Extension Study|Adverse Event|0|||
155581084|NCT00395629|561553252|FG001|Extension Study|Adverse Event|0|||
155581085|NCT00395629|561553253|FG002|Extension Study|Adverse Event|2|||
155581086|NCT00395629|561553251|FG000|Extension Study|Administrative problems|0|||
155581087|NCT00395629|561553252|FG001|Extension Study|Administrative problems|0|||
155581088|NCT00395629|561553253|FG002|Extension Study|Administrative problems|1|||
155581089|NCT03428152|561553254|FG000|Overall Study|Physician Decision|4|||
155581090|NCT03428152|561553255|FG001|Overall Study|Physician Decision|2|||
155581091|NCT03428152|561553254|FG000|Overall Study|Protocol Violation|3|||
155581092|NCT03428152|561553255|FG001|Overall Study|Protocol Violation|5|||
155581093|NCT03428152|561553254|FG000|Overall Study|Lack of Efficacy|0|||
155581094|NCT03428152|561553255|FG001|Overall Study|Lack of Efficacy|4|||
155581095|NCT01686373|561553256|FG000|Overall Study|Lost to Follow-up|3|||
155581096|NCT01686373|561553257|FG001|Overall Study|Lost to Follow-up|0|||
155581097|NCT01686373|561553256|FG000|Overall Study|Withdrawal by Subject|0|||
155581098|NCT01686373|561553257|FG001|Overall Study|Withdrawal by Subject|1|||
155581099|NCT01686373|561553256|FG000|Overall Study|Adverse Event|0|||
155581100|NCT01686373|561553257|FG001|Overall Study|Adverse Event|1|||
155581101|NCT01836471|561553264|FG000|Overall Study|Pregnancy|1|||
155581102|NCT01836471|561553265|FG001|Overall Study|Pregnancy|0|||
155581103|NCT01836471|561553266|FG002|Overall Study|Pregnancy|0|||
155581104|NCT01836471|561553267|FG003|Overall Study|Pregnancy|0|||
155581105|NCT01836471|561553268|FG004|Overall Study|Pregnancy|0|||
155581106|NCT01836471|561553264|FG000|Overall Study|Withdrawal by Subject|3|||
155581107|NCT01836471|561553265|FG001|Overall Study|Withdrawal by Subject|4|||
155581108|NCT01836471|561553266|FG002|Overall Study|Withdrawal by Subject|1|||
155581109|NCT01836471|561553267|FG003|Overall Study|Withdrawal by Subject|0|||
155581110|NCT01836471|561553268|FG004|Overall Study|Withdrawal by Subject|2|||
155581111|NCT01836471|561553264|FG000|Overall Study|Physician Decision|0|||
155581112|NCT01836471|561553265|FG001|Overall Study|Physician Decision|1|||
155581113|NCT01836471|561553266|FG002|Overall Study|Physician Decision|0|||
155581114|NCT01836471|561553267|FG003|Overall Study|Physician Decision|0|||
155581115|NCT01836471|561553268|FG004|Overall Study|Physician Decision|0|||
155581116|NCT01836471|561553264|FG000|Overall Study|Lost to Follow-up|0|||
155581117|NCT01836471|561553265|FG001|Overall Study|Lost to Follow-up|0|||
155581118|NCT01836471|561553266|FG002|Overall Study|Lost to Follow-up|0|||
155581119|NCT01836471|561553267|FG003|Overall Study|Lost to Follow-up|1|||
155581120|NCT01836471|561553268|FG004|Overall Study|Lost to Follow-up|1|||
155581121|NCT01836471|561553264|FG000|Overall Study|Adverse Event|6|||
155581122|NCT01836471|561553265|FG001|Overall Study|Adverse Event|3|||
155581123|NCT01836471|561553266|FG002|Overall Study|Adverse Event|1|||
155581124|NCT01836471|561553267|FG003|Overall Study|Adverse Event|1|||
155581125|NCT01836471|561553268|FG004|Overall Study|Adverse Event|2|||
155581126|NCT01836471|561553264|FG000|Overall Study|Non compliance with tx|1|||
155581127|NCT01836471|561553265|FG001|Overall Study|Non compliance with tx|1|||
155581128|NCT01836471|561553266|FG002|Overall Study|Non compliance with tx|0|||
155581129|NCT01836471|561553267|FG003|Overall Study|Non compliance with tx|0|||
155581130|NCT01836471|561553268|FG004|Overall Study|Non compliance with tx|0|||
155581131|NCT02570308|561553274|FG000|Overall Study|Death|1|||
155581132|NCT02570308|561553275|FG001|Overall Study|Death|5|||
155581133|NCT02570308|561553276|FG002|Overall Study|Death|4|||
155581134|NCT02570308|561553277|FG003|Overall Study|Death|4|||
155581135|NCT02570308|561553278|FG004|Overall Study|Death|69|||
155581136|NCT02570308|561553274|FG000|Overall Study|Lost to Follow-up|0|||
155581137|NCT02570308|561553275|FG001|Overall Study|Lost to Follow-up|0|||
155581138|NCT02570308|561553276|FG002|Overall Study|Lost to Follow-up|0|||
155581139|NCT02570308|561553277|FG003|Overall Study|Lost to Follow-up|0|||
155581140|NCT02570308|561553278|FG004|Overall Study|Lost to Follow-up|2|||
155581141|NCT02570308|561553274|FG000|Overall Study|Withdrawal by Subject|0|||
155581142|NCT02570308|561553275|FG001|Overall Study|Withdrawal by Subject|0|||
155581143|NCT02570308|561553276|FG002|Overall Study|Withdrawal by Subject|0|||
155581144|NCT02570308|561553277|FG003|Overall Study|Withdrawal by Subject|0|||
155581145|NCT02570308|561553278|FG004|Overall Study|Withdrawal by Subject|1|||
155581146|NCT02570308|561553274|FG000|Overall Study|Other|0|||
155581147|NCT02570308|561553275|FG001|Overall Study|Other|0|||
155581148|NCT02570308|561553276|FG002|Overall Study|Other|0|||
155581149|NCT02570308|561553277|FG003|Overall Study|Other|0|||
155581150|NCT02570308|561553278|FG004|Overall Study|Other|2|||
155581151|NCT01283464|561553280|FG000|Overall Study|Lost to Follow-up|0|||
155581152|NCT01283464|561553281|FG001|Overall Study|Lost to Follow-up|1|||
155581153|NCT01283464|561553280|FG000|Overall Study|Withdrawal by Subject|1|||
155581154|NCT01283464|561553281|FG001|Overall Study|Withdrawal by Subject|0|||
155581155|NCT01283464|561553280|FG000|Overall Study|Physician Decision|1|||
155581156|NCT01283464|561553281|FG001|Overall Study|Physician Decision|0|||
155581157|NCT06481709|561553282|FG000|Overall Study|Withdrawal by Subject|0|||
155581158|NCT06481709|561553283|FG001|Overall Study|Withdrawal by Subject|0|||
155581159|NCT06481709|561553284|FG002|Overall Study|Withdrawal by Subject|2|||
155581160|NCT06481709|561553285|FG003|Overall Study|Withdrawal by Subject|0|||
155581161|NCT05921903|561553286|FG000|Overall Study|Unsolicited non-SAE|0|||
155581162|NCT05921903|561553287|FG001|Overall Study|Unsolicited non-SAE|1|||
155581163|NCT05921903|561553288|FG002|Overall Study|Unsolicited non-SAE|0|||
155581164|NCT05921903|561553286|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
155581165|NCT05921903|561553287|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
155581166|NCT05921903|561553288|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
155581167|NCT05921903|561553286|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
155581168|NCT05921903|561553287|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
155581169|NCT05921903|561553288|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
155581170|NCT00923013|561553289|FG000|Overall Study|Refused further treatment|0|||
155581171|NCT00923013|561553290|FG001|Overall Study|Refused further treatment|1|||
155581172|NCT00923013|561553291|FG002|Overall Study|Refused further treatment|2|||
155581173|NCT00923013|561553292|FG003|Overall Study|Refused further treatment|0|||
155581174|NCT00923013|561553293|FG004|Overall Study|Refused further treatment|0|||
155581175|NCT00923013|561553294|FG005|Overall Study|Refused further treatment|0|||
155581176|NCT00923013|561553289|FG000|Overall Study|Switched to alternative treatment|0|||
155581177|NCT00923013|561553290|FG001|Overall Study|Switched to alternative treatment|1|||
155581178|NCT00923013|561553291|FG002|Overall Study|Switched to alternative treatment|0|||
155581179|NCT00923013|561553292|FG003|Overall Study|Switched to alternative treatment|0|||
155581180|NCT00923013|561553293|FG004|Overall Study|Switched to alternative treatment|0|||
155581181|NCT00923013|561553294|FG005|Overall Study|Switched to alternative treatment|0|||
155581182|NCT00923013|561553289|FG000|Overall Study|Death on study|2|||
155581183|NCT00923013|561553290|FG001|Overall Study|Death on study|2|||
155581184|NCT00923013|561553291|FG002|Overall Study|Death on study|0|||
155581185|NCT00923013|561553292|FG003|Overall Study|Death on study|1|||
155581186|NCT00923013|561553293|FG004|Overall Study|Death on study|0|||
155581187|NCT00923013|561553294|FG005|Overall Study|Death on study|0|||
155581188|NCT05366010|561553297|FG000|Overall Study|Withdrawal by Subject|1|||
155581189|NCT05366010|561553297|FG000|Overall Study|Protocol Violation|1|||
155581190|NCT05366010|561553297|FG000|Overall Study|Lost to Follow-up|2|||
155581191|NCT05366010|561553297|FG000|Overall Study|Screen Failure|2|||
155581192|NCT02224157|561553298|FG000|Overall Study|Severe non-compliance to protocol|2|||
155581193|NCT02224157|561553299|FG001|Overall Study|Severe non-compliance to protocol|2|||
155581194|NCT02224157|561553298|FG000|Overall Study|Other|13|||
155581195|NCT02224157|561553299|FG001|Overall Study|Other|10|||
155581196|NCT02224157|561553298|FG000|Overall Study|Subject decision|58|||
155581197|NCT02224157|561553299|FG001|Overall Study|Subject decision|50|||
155581198|NCT02224157|561553298|FG000|Overall Study|Prematurely closed site|4|||
155581199|NCT02224157|561553299|FG001|Overall Study|Prematurely closed site|2|||
155581200|NCT02224157|561553298|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
155581201|NCT02224157|561553299|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
155581202|NCT02224157|561553298|FG000|Overall Study|Lost to Follow-up|27|||
155581203|NCT02224157|561553299|FG001|Overall Study|Lost to Follow-up|35|||
155581204|NCT02224157|561553298|FG000|Overall Study|Death|1|||
155581205|NCT02224157|561553299|FG001|Overall Study|Death|1|||
155581206|NCT02224157|561553298|FG000|Overall Study|Adverse Event|1|||
155581207|NCT02224157|561553299|FG001|Overall Study|Adverse Event|3|||
155581208|NCT05906628|561553300|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
155581209|NCT05906628|561553301|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
155581210|NCT05906628|561553300|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
155581211|NCT05906628|561553301|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
155581212|NCT05906628|561553300|FG000|16-Week DBVC Period|Protocol Violation|4|||
155581213|NCT05906628|561553301|FG001|16-Week DBVC Period|Protocol Violation|2|||
155581214|NCT05906628|561553300|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
155581215|NCT05906628|561553301|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
155581216|NCT05906628|561553300|FG000|16-Week OLE Period|Death|1|||
155581217|NCT05906628|561553301|FG001|16-Week OLE Period|Death|0|||
155581218|NCT05906628|561553300|FG000|16-Week OLE Period|Lost to Follow-up|1|||
155581219|NCT05906628|561553301|FG001|16-Week OLE Period|Lost to Follow-up|1|||
155581220|NCT05906628|561553300|FG000|16-Week OLE Period|Protocol Violation|0|||
155581221|NCT05906628|561553301|FG001|16-Week OLE Period|Protocol Violation|1|||
155581222|NCT05906628|561553300|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
155581223|NCT05906628|561553301|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
155581224|NCT01108718|561553302|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
155581225|NCT01108718|561553303|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
155581226|NCT01060072|561553306|FG000|Overall Study|Adverse Event|1|||
155581227|NCT01060072|561553307|FG001|Overall Study|Adverse Event|1|||
155581228|NCT01060072|561553306|FG000|Overall Study|Physician Decision|0|||
155581229|NCT01060072|561553307|FG001|Overall Study|Physician Decision|2|||
155581230|NCT01060072|561553306|FG000|Overall Study|Protocol Violation|0|||
155581231|NCT01060072|561553307|FG001|Overall Study|Protocol Violation|1|||
155581232|NCT01060072|561553306|FG000|Overall Study|Acute cholecystitis|1|||
155581233|NCT01060072|561553307|FG001|Overall Study|Acute cholecystitis|0|||
155581234|NCT01060072|561553306|FG000|Overall Study|Excluded Medications|0|||
155581235|NCT01060072|561553307|FG001|Overall Study|Excluded Medications|1|||
155581236|NCT02301169|561553308|FG000|Overall Study|Adverse Event|1|||
155581237|NCT02301169|561553309|FG001|Overall Study|Adverse Event|0|||
155581238|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
155581239|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
155581240|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
155581241|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
155581242|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
155581243|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
155581244|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
155581245|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
155581246|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
155663896|NCT00421148|561865298|FG007|Overall Study|Lost to Follow-up|0|||
155663897|NCT00421148|561865299|FG008|Overall Study|Lost to Follow-up|0|||
155663898|NCT00421148|561865300|FG009|Overall Study|Lost to Follow-up|0|||
155581247|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
155581248|NCT03762265|561553310|FG000|BT Period: Weeks 1 to 37|Other|0|||
155581249|NCT03762265|561553311|FG001|BT Period: Weeks 1 to 37|Other|1|||
155581250|NCT03762265|561553310|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
155581251|NCT03762265|561553311|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
155663899|NCT00421148|561865301|FG010|Overall Study|Lost to Follow-up|0|||
155581252|NCT03762265|561553310|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
155581253|NCT03762265|561553311|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
155581254|NCT03762265|561553310|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
155581255|NCT03762265|561553311|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
155581256|NCT03762265|561553310|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
155581257|NCT03762265|561553311|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
155581258|NCT03762265|561553310|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
155581259|NCT03762265|561553311|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
155581260|NCT03762265|561553310|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
155581261|NCT03762265|561553311|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
155581262|NCT03762265|561553310|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
155581263|NCT03762265|561553311|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
155581264|NCT03762265|561553310|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
155581265|NCT03762265|561553311|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
155581266|NCT03762265|561553310|FG000|LTE Period: Weeks 61 to 109|Other|1|||
155581267|NCT03762265|561553311|FG001|LTE Period: Weeks 61 to 109|Other|0|||
155581268|NCT02289729|561553312|FG000|Overall Study|Lack of Efficacy|3|||
155581269|NCT02289729|561553312|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
155581270|NCT02289729|561553312|FG000|Overall Study|Withdrawal by Subject|1|||
155581271|NCT02289729|561553312|FG000|Overall Study|Death|1|||
155581272|NCT00470470|561553313|FG000|Overall Study|Adverse Event|2|||
155581273|NCT00470470|561553313|FG000|Overall Study|Death|2|||
155581274|NCT00470470|561553313|FG000|Overall Study|Not treated|1|||
155581275|NCT01149863|561553314|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
155581276|NCT00640315|561553315|FG000|Overall Study|Withdrawal by Subject|0|||
155581277|NCT00640315|561553316|FG001|Overall Study|Withdrawal by Subject|1|||
155581278|NCT01256879|561553317|FG000|Overall Study|Withdrawal by Subject|1|||
155581279|NCT00397514|561553318|FG000|Overall Study|Withdrawal by Subject|1|||
155581280|NCT00397514|561553318|FG000|Overall Study|Pacing wire malfunction|1|||
155581281|NCT00397514|561553318|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
155581282|NCT00397514|561553318|FG000|Overall Study|early extubation|2|||
155581283|NCT00397514|561553318|FG000|Overall Study|poor echocardiographic windows|1|||
155581284|NCT00725920|561553319|FG000|Overall Study|Lack of Efficacy|3|||
155581285|NCT00725920|561553320|FG001|Overall Study|Lack of Efficacy|6|||
155581286|NCT02286713|561553321|FG000|One Week Follow-Up|Death|1|||
155581287|NCT02286713|561553322|FG001|One Week Follow-Up|Death|0|||
155581288|NCT02286713|561553321|FG000|One Week Follow-Up|Lost to Follow-up|17|||
155581289|NCT02286713|561553322|FG001|One Week Follow-Up|Lost to Follow-up|21|||
155581290|NCT02286713|561553321|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
155581291|NCT02286713|561553322|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
155581292|NCT02286713|561553321|FG000|Three Month Follow-Up|Death|1|||
155581293|NCT02286713|561553322|FG001|Three Month Follow-Up|Death|1|||
155581294|NCT02286713|561553321|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
155581295|NCT02286713|561553322|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
155581296|NCT02286713|561553321|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
155581297|NCT02286713|561553322|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
155581298|NCT02286713|561553321|FG000|Six Month Follow-Up|Death|2|||
155581299|NCT02286713|561553322|FG001|Six Month Follow-Up|Death|0|||
155581300|NCT02286713|561553321|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
155581301|NCT02286713|561553322|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
155581302|NCT02654054|561553323|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155581303|NCT02654054|561553324|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
155581304|NCT02654054|561553325|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
155581305|NCT02654054|561553323|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155581306|NCT02654054|561553324|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155581307|NCT02654054|561553325|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
155581308|NCT02654054|561553323|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155581309|NCT02654054|561553324|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155581310|NCT02654054|561553325|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155581311|NCT02654054|561553323|FG000|Post-Treatment Follow-Up Period|Other|1|||
155581312|NCT02654054|561553324|FG001|Post-Treatment Follow-Up Period|Other|0|||
155581313|NCT02654054|561553325|FG002|Post-Treatment Follow-Up Period|Other|4|||
155581314|NCT02654054|561553323|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155581315|NCT02654054|561553324|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155581316|NCT02654054|561553325|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
155581317|NCT06018129|561553327|FG000|Overall Study|Death|1|||
155581318|NCT06018129|561553328|FG001|Overall Study|Death|1|||
155581319|NCT06018129|561553329|FG002|Overall Study|Death|2|||
155581320|NCT06018129|561553327|FG000|Overall Study|Sponsor Decision|2|||
155581321|NCT06018129|561553328|FG001|Overall Study|Sponsor Decision|2|||
155581322|NCT06018129|561553329|FG002|Overall Study|Sponsor Decision|1|||
155663900|NCT00421148|561865302|FG011|Overall Study|Lost to Follow-up|0|||
155581323|NCT03832686|561553330|FG000|Overall Study|Lost to Follow-up|6|||
155581324|NCT03832686|561553331|FG001|Overall Study|Lost to Follow-up|9|||
155663901|NCT00421148|561865303|FG012|Overall Study|Lost to Follow-up|0|||
155663902|NCT00421148|561865304|FG013|Overall Study|Lost to Follow-up|0|||
155663903|NCT00421148|561865305|FG014|Overall Study|Lost to Follow-up|0|||
155663904|NCT00421148|561865306|FG015|Overall Study|Lost to Follow-up|0|||
155663905|NCT00421148|561865307|FG016|Overall Study|Lost to Follow-up|0|||
155663906|NCT00421148|561865308|FG017|Overall Study|Lost to Follow-up|1|||
155663907|NCT00421148|561865309|FG018|Overall Study|Lost to Follow-up|0|||
155663908|NCT00421148|561865310|FG019|Overall Study|Lost to Follow-up|0|||
155663909|NCT00421148|561865291|FG000|Overall Study|Withdrawal by Subject|0|||
155663910|NCT00421148|561865292|FG001|Overall Study|Withdrawal by Subject|0|||
155663911|NCT00421148|561865293|FG002|Overall Study|Withdrawal by Subject|0|||
155663912|NCT00421148|561865294|FG003|Overall Study|Withdrawal by Subject|0|||
155663913|NCT00421148|561865295|FG004|Overall Study|Withdrawal by Subject|0|||
155663914|NCT00421148|561865296|FG005|Overall Study|Withdrawal by Subject|0|||
155663915|NCT00421148|561865297|FG006|Overall Study|Withdrawal by Subject|0|||
155663916|NCT00421148|561865298|FG007|Overall Study|Withdrawal by Subject|0|||
155663917|NCT00421148|561865299|FG008|Overall Study|Withdrawal by Subject|0|||
155663918|NCT00421148|561865300|FG009|Overall Study|Withdrawal by Subject|0|||
155663919|NCT00421148|561865301|FG010|Overall Study|Withdrawal by Subject|0|||
155663920|NCT00421148|561865302|FG011|Overall Study|Withdrawal by Subject|0|||
155663921|NCT00421148|561865303|FG012|Overall Study|Withdrawal by Subject|0|||
155663922|NCT00421148|561865304|FG013|Overall Study|Withdrawal by Subject|0|||
155663923|NCT00421148|561865305|FG014|Overall Study|Withdrawal by Subject|0|||
155663924|NCT00421148|561865306|FG015|Overall Study|Withdrawal by Subject|0|||
155663925|NCT00421148|561865307|FG016|Overall Study|Withdrawal by Subject|0|||
155663926|NCT00421148|561865308|FG017|Overall Study|Withdrawal by Subject|1|||
155663927|NCT00421148|561865309|FG018|Overall Study|Withdrawal by Subject|0|||
155663928|NCT00421148|561865310|FG019|Overall Study|Withdrawal by Subject|0|||
155663929|NCT00421148|561865291|FG000|Overall Study|Protocol Violation|0|||
155663930|NCT00421148|561865292|FG001|Overall Study|Protocol Violation|0|||
155663931|NCT00421148|561865293|FG002|Overall Study|Protocol Violation|0|||
155663932|NCT00421148|561865294|FG003|Overall Study|Protocol Violation|0|||
155663933|NCT00421148|561865295|FG004|Overall Study|Protocol Violation|0|||
155663934|NCT00421148|561865296|FG005|Overall Study|Protocol Violation|1|||
155663935|NCT00421148|561865297|FG006|Overall Study|Protocol Violation|0|||
155663936|NCT00421148|561865298|FG007|Overall Study|Protocol Violation|0|||
155663937|NCT00421148|561865299|FG008|Overall Study|Protocol Violation|0|||
155663938|NCT00421148|561865300|FG009|Overall Study|Protocol Violation|0|||
155663939|NCT00421148|561865301|FG010|Overall Study|Protocol Violation|0|||
155663940|NCT00421148|561865302|FG011|Overall Study|Protocol Violation|0|||
155663941|NCT00421148|561865303|FG012|Overall Study|Protocol Violation|0|||
155663942|NCT00421148|561865304|FG013|Overall Study|Protocol Violation|0|||
155663943|NCT00421148|561865305|FG014|Overall Study|Protocol Violation|0|||
155663944|NCT00421148|561865306|FG015|Overall Study|Protocol Violation|0|||
155663945|NCT00421148|561865307|FG016|Overall Study|Protocol Violation|0|||
155663946|NCT00421148|561865308|FG017|Overall Study|Protocol Violation|0|||
155663947|NCT00421148|561865309|FG018|Overall Study|Protocol Violation|1|||
155663948|NCT00421148|561865310|FG019|Overall Study|Protocol Violation|0|||
155663949|NCT04881760|561865311|FG000|Overall Study|Adverse Event|0|||
155663950|NCT04881760|561865312|FG001|Overall Study|Adverse Event|1|||
155663951|NCT04881760|561865313|FG002|Overall Study|Adverse Event|1|||
155663952|NCT04881760|561865314|FG003|Overall Study|Adverse Event|0|||
155663953|NCT04881760|561865315|FG004|Overall Study|Adverse Event|1|||
155663954|NCT04881760|561865316|FG005|Overall Study|Adverse Event|1|||
155663955|NCT04881760|561865317|FG006|Overall Study|Adverse Event|2|||
155663956|NCT04881760|561865311|FG000|Overall Study|Death|0|||
155663957|NCT04881760|561865312|FG001|Overall Study|Death|0|||
155663958|NCT04881760|561865313|FG002|Overall Study|Death|0|||
155663959|NCT04881760|561865314|FG003|Overall Study|Death|1|||
155663960|NCT04881760|561865315|FG004|Overall Study|Death|0|||
155663961|NCT04881760|561865316|FG005|Overall Study|Death|0|||
155663962|NCT04881760|561865317|FG006|Overall Study|Death|0|||
155663963|NCT04881760|561865311|FG000|Overall Study|Lost to Follow-up|5|||
155663964|NCT04881760|561865312|FG001|Overall Study|Lost to Follow-up|7|||
155663965|NCT04881760|561865313|FG002|Overall Study|Lost to Follow-up|5|||
155663966|NCT04881760|561865314|FG003|Overall Study|Lost to Follow-up|1|||
155663967|NCT04881760|561865315|FG004|Overall Study|Lost to Follow-up|2|||
155663968|NCT04881760|561865316|FG005|Overall Study|Lost to Follow-up|4|||
155663969|NCT04881760|561865317|FG006|Overall Study|Lost to Follow-up|4|||
155663970|NCT04881760|561865311|FG000|Overall Study|Withdrawal by Subject|13|||
155663971|NCT04881760|561865312|FG001|Overall Study|Withdrawal by Subject|1|||
155663972|NCT04881760|561865313|FG002|Overall Study|Withdrawal by Subject|1|||
155663973|NCT04881760|561865314|FG003|Overall Study|Withdrawal by Subject|4|||
155663974|NCT04881760|561865315|FG004|Overall Study|Withdrawal by Subject|2|||
155663975|NCT04881760|561865316|FG005|Overall Study|Withdrawal by Subject|1|||
155663976|NCT04881760|561865317|FG006|Overall Study|Withdrawal by Subject|2|||
155663977|NCT04881760|561865311|FG000|Overall Study|Randomized but Never Treated|0|||
155663978|NCT04881760|561865312|FG001|Overall Study|Randomized but Never Treated|0|||
155663979|NCT04881760|561865313|FG002|Overall Study|Randomized but Never Treated|0|||
155663980|NCT04881760|561865314|FG003|Overall Study|Randomized but Never Treated|1|||
155663981|NCT04881760|561865315|FG004|Overall Study|Randomized but Never Treated|0|||
155663982|NCT04881760|561865316|FG005|Overall Study|Randomized but Never Treated|0|||
155663983|NCT04881760|561865317|FG006|Overall Study|Randomized but Never Treated|0|||
155663984|NCT04881760|561865311|FG000|Overall Study|Inadvertent Enrollment|2|||
155663985|NCT04881760|561865312|FG001|Overall Study|Inadvertent Enrollment|0|||
155663986|NCT04881760|561865313|FG002|Overall Study|Inadvertent Enrollment|0|||
155581325|NCT03832686|561553330|FG000|Overall Study|Discontinued Intervention|5|||
155581326|NCT03832686|561553331|FG001|Overall Study|Discontinued Intervention|4|||
155663987|NCT04881760|561865314|FG003|Overall Study|Inadvertent Enrollment|0|||
155663988|NCT04881760|561865315|FG004|Overall Study|Inadvertent Enrollment|0|||
155663989|NCT04881760|561865316|FG005|Overall Study|Inadvertent Enrollment|0|||
155663990|NCT04881760|561865317|FG006|Overall Study|Inadvertent Enrollment|0|||
155663991|NCT04881760|561865311|FG000|Overall Study|Site Closure|0|||
155663992|NCT04881760|561865312|FG001|Overall Study|Site Closure|0|||
155663993|NCT04881760|561865313|FG002|Overall Study|Site Closure|0|||
155663994|NCT04881760|561865314|FG003|Overall Study|Site Closure|1|||
155663995|NCT04881760|561865315|FG004|Overall Study|Site Closure|0|||
155581327|NCT02235454|561553332|FG000|Overall Study|Withdrawal by Subject|2|||
155581328|NCT03323398|561553333|FG000|Overall Study|Other than Specified|0|||
155581329|NCT03323398|561553334|FG001|Overall Study|Other than Specified|1|||
155581330|NCT03323398|561553335|FG002|Overall Study|Other than Specified|2|||
155581331|NCT03323398|561553336|FG003|Overall Study|Other than Specified|0|||
155581332|NCT03323398|561553337|FG004|Overall Study|Other than Specified|0|||
155581333|NCT03323398|561553338|FG005|Overall Study|Other than Specified|0|||
155581334|NCT03323398|561553339|FG006|Overall Study|Other than Specified|1|||
155581335|NCT03323398|561553340|FG007|Overall Study|Other than Specified|0|||
155581336|NCT03323398|561553341|FG008|Overall Study|Other than Specified|2|||
155581337|NCT03323398|561553333|FG000|Overall Study|Lost to Follow-up|1|||
155581338|NCT03323398|561553334|FG001|Overall Study|Lost to Follow-up|2|||
155581339|NCT03323398|561553335|FG002|Overall Study|Lost to Follow-up|1|||
155581340|NCT03323398|561553336|FG003|Overall Study|Lost to Follow-up|0|||
155581341|NCT03323398|561553337|FG004|Overall Study|Lost to Follow-up|0|||
155581342|NCT03323398|561553338|FG005|Overall Study|Lost to Follow-up|0|||
155581343|NCT03323398|561553339|FG006|Overall Study|Lost to Follow-up|0|||
155581344|NCT03323398|561553340|FG007|Overall Study|Lost to Follow-up|0|||
155581345|NCT03323398|561553341|FG008|Overall Study|Lost to Follow-up|0|||
155581346|NCT03323398|561553333|FG000|Overall Study|Death|4|||
155581347|NCT03323398|561553334|FG001|Overall Study|Death|6|||
155581348|NCT03323398|561553335|FG002|Overall Study|Death|2|||
155581349|NCT03323398|561553336|FG003|Overall Study|Death|2|||
155581350|NCT03323398|561553337|FG004|Overall Study|Death|1|||
155581351|NCT03323398|561553338|FG005|Overall Study|Death|2|||
155581352|NCT03323398|561553339|FG006|Overall Study|Death|0|||
155581353|NCT03323398|561553340|FG007|Overall Study|Death|0|||
155581354|NCT03323398|561553341|FG008|Overall Study|Death|6|||
155581355|NCT03323398|561553333|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
155581356|NCT03323398|561553334|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
155581357|NCT03323398|561553335|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
155581358|NCT03323398|561553336|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
155663996|NCT04881760|561865316|FG005|Overall Study|Site Closure|0|||
155663997|NCT04881760|561865317|FG006|Overall Study|Site Closure|0|||
155663998|NCT01538199|561865318|FG000|Overall Study|Lost to Follow-up|1|||
155663999|NCT01538199|561865319|FG001|Overall Study|Lost to Follow-up|2|||
155664000|NCT01538199|561865320|FG002|Overall Study|Lost to Follow-up|1|||
155581359|NCT03323398|561553337|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
155581360|NCT03323398|561553338|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
155581361|NCT03323398|561553339|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
155581362|NCT03323398|561553340|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
155581363|NCT03323398|561553341|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
155664001|NCT01538199|561865321|FG003|Overall Study|Lost to Follow-up|0|||
155664002|NCT01538199|561865318|FG000|Overall Study|participant did not have time|1|||
155664003|NCT01538199|561865319|FG001|Overall Study|participant did not have time|0|||
155664004|NCT01538199|561865320|FG002|Overall Study|participant did not have time|0|||
155664005|NCT01538199|561865321|FG003|Overall Study|participant did not have time|2|||
155581364|NCT03323398|561553333|FG000|Overall Study|Withdrawal by Subject|2|||
155581365|NCT03323398|561553334|FG001|Overall Study|Withdrawal by Subject|1|||
155664006|NCT01538199|561865318|FG000|Overall Study|Lack of Efficacy|0|||
155664007|NCT01538199|561865319|FG001|Overall Study|Lack of Efficacy|1|||
155664008|NCT01538199|561865320|FG002|Overall Study|Lack of Efficacy|0|||
155581366|NCT03323398|561553335|FG002|Overall Study|Withdrawal by Subject|3|||
155664009|NCT01538199|561865321|FG003|Overall Study|Lack of Efficacy|0|||
155664010|NCT02081586|561865322|FG000|Overall Study|Lost to Follow-up|0|||
155664011|NCT02081586|561865323|FG001|Overall Study|Lost to Follow-up|1|||
155664012|NCT02081586|561865324|FG002|Overall Study|Lost to Follow-up|0|||
155664013|NCT02081586|561865325|FG003|Overall Study|Lost to Follow-up|1|||
155664014|NCT02081586|561865322|FG000|Overall Study|Head injury not related to study|0|||
155664015|NCT02081586|561865323|FG001|Overall Study|Head injury not related to study|0|||
155664016|NCT02081586|561865324|FG002|Overall Study|Head injury not related to study|1|||
155664017|NCT02081586|561865325|FG003|Overall Study|Head injury not related to study|0|||
155664018|NCT00636181|561865333|FG000|Overall Study|Withdrawal by Subject|8|||
155664019|NCT00636181|561865334|FG001|Overall Study|Withdrawal by Subject|6|||
155664020|NCT00636181|561865335|FG002|Overall Study|Withdrawal by Subject|10|||
155664021|NCT04549454|561865341|FG000|T1 to T2|Lost to Follow-up|22|||
155664022|NCT04549454|561865342|FG001|T1 to T2|Lost to Follow-up|26|||
155664023|NCT04549454|561865341|FG000|T1 to T3|Lost to Follow-up|31|||
155664024|NCT04549454|561865342|FG001|T1 to T3|Lost to Follow-up|36|||
155581367|NCT03323398|561553336|FG003|Overall Study|Withdrawal by Subject|0|||
155581368|NCT03323398|561553337|FG004|Overall Study|Withdrawal by Subject|0|||
155581369|NCT03323398|561553338|FG005|Overall Study|Withdrawal by Subject|1|||
155581370|NCT03323398|561553339|FG006|Overall Study|Withdrawal by Subject|0|||
155581371|NCT03323398|561553340|FG007|Overall Study|Withdrawal by Subject|0|||
155581372|NCT03323398|561553341|FG008|Overall Study|Withdrawal by Subject|0|||
155581373|NCT03323398|561553333|FG000|Overall Study|Participant was Put on Hospice|0|||
155581374|NCT03323398|561553334|FG001|Overall Study|Participant was Put on Hospice|0|||
155581375|NCT03323398|561553335|FG002|Overall Study|Participant was Put on Hospice|0|||
155581376|NCT03323398|561553336|FG003|Overall Study|Participant was Put on Hospice|0|||
155581377|NCT03323398|561553337|FG004|Overall Study|Participant was Put on Hospice|0|||
155581378|NCT03323398|561553338|FG005|Overall Study|Participant was Put on Hospice|0|||
155581379|NCT03323398|561553339|FG006|Overall Study|Participant was Put on Hospice|1|||
155581380|NCT03323398|561553340|FG007|Overall Study|Participant was Put on Hospice|0|||
155581381|NCT03323398|561553341|FG008|Overall Study|Participant was Put on Hospice|0|||
155581382|NCT03323398|561553333|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
155581383|NCT03323398|561553334|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
155581384|NCT03323398|561553335|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
155581385|NCT03323398|561553336|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
155581386|NCT03323398|561553337|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
155581387|NCT03323398|561553338|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
155581388|NCT03323398|561553339|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
155581389|NCT03323398|561553340|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
155581390|NCT03323398|561553341|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
155581391|NCT03641469|561553342|FG000|Overall Study|Ineligible|2|||
155581392|NCT03641469|561553342|FG000|Overall Study|Withdrawal by Subject|5|||
155581393|NCT03641469|561553342|FG000|Overall Study|Physician Decision|1|||
155581394|NCT03641469|561553342|FG000|Overall Study|Protocol Violation|1|||
155581395|NCT03641469|561553342|FG000|Overall Study|Lost to Follow-up|2|||
155581396|NCT06389487|561553343|FG000|Overall Study|Lost to Follow-up|9|||
155581397|NCT06389487|561553344|FG001|Overall Study|Lost to Follow-up|5|||
155581398|NCT06389487|561553345|FG002|Overall Study|Lost to Follow-up|13|||
155581399|NCT06389487|561553343|FG000|Overall Study|Protocol Violation|0|||
155581400|NCT06389487|561553344|FG001|Overall Study|Protocol Violation|0|||
155581401|NCT06389487|561553345|FG002|Overall Study|Protocol Violation|2|||
155581402|NCT06389487|561553343|FG000|Overall Study|Withdrawal by Subject|2|||
155664025|NCT05270863|561865353|FG000|Visit 2 First Intervention|Randomization error|0|||
155664026|NCT05270863|561865354|FG001|Visit 2 First Intervention|Randomization error|0|||
155664027|NCT05270863|561865355|FG002|Visit 2 First Intervention|Randomization error|0|||
155664028|NCT05270863|561865356|FG003|Visit 2 First Intervention|Randomization error|1|||
155664029|NCT05270863|561865357|FG004|Visit 2 First Intervention|Randomization error|0|||
155664030|NCT05270863|561865358|FG005|Visit 2 First Intervention|Randomization error|0|||
155664031|NCT05270863|561865353|FG000|First Washout|Withdrawal by Subject|0|||
155664032|NCT05270863|561865354|FG001|First Washout|Withdrawal by Subject|0|||
155581403|NCT06389487|561553344|FG001|Overall Study|Withdrawal by Subject|2|||
155581404|NCT06389487|561553345|FG002|Overall Study|Withdrawal by Subject|1|||
155664033|NCT05270863|561865355|FG002|First Washout|Withdrawal by Subject|0|||
155664034|NCT05270863|561865356|FG003|First Washout|Withdrawal by Subject|0|||
155664035|NCT05270863|561865357|FG004|First Washout|Withdrawal by Subject|1|||
155664036|NCT05270863|561865358|FG005|First Washout|Withdrawal by Subject|1|||
155581405|NCT06389487|561553343|FG000|Overall Study|Other|1|||
155664037|NCT05270863|561865353|FG000|First Washout|Lost to Follow-up|0|||
155664038|NCT05270863|561865354|FG001|First Washout|Lost to Follow-up|0|||
155664039|NCT05270863|561865355|FG002|First Washout|Lost to Follow-up|0|||
155581406|NCT06389487|561553344|FG001|Overall Study|Other|0|||
155581407|NCT06389487|561553345|FG002|Overall Study|Other|1|||
155581408|NCT05479435|561553346|FG000|Overall Study|Withdrawal by Subject|1|||
155581409|NCT05479435|561553347|FG001|Overall Study|Withdrawal by Subject|0|||
155581410|NCT05479435|561553348|FG002|Overall Study|Withdrawal by Subject|0|||
155581411|NCT05479435|561553346|FG000|Overall Study|Covid 19|0|||
155581412|NCT05479435|561553347|FG001|Overall Study|Covid 19|0|||
155581413|NCT05479435|561553348|FG002|Overall Study|Covid 19|2|||
155581414|NCT00955617|561553351|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
155581415|NCT00955617|561553352|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
155581416|NCT00955617|561553351|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
155581417|NCT00955617|561553352|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
155581418|NCT00955617|561553351|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
155581419|NCT00955617|561553352|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
155581420|NCT00955617|561553351|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
155581421|NCT00955617|561553352|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
155581422|NCT00982657|561553354|FG000|Overall Study|Death|1|||
155581423|NCT00982657|561553355|FG001|Overall Study|Death|0|||
155581424|NCT00982657|561553356|FG002|Overall Study|Death|1|||
155581425|NCT00982657|561553357|FG003|Overall Study|Death|1|||
155581426|NCT00982657|561553354|FG000|Overall Study|Withdrawal by Subject|0|||
155581427|NCT00982657|561553355|FG001|Overall Study|Withdrawal by Subject|0|||
155581428|NCT00982657|561553356|FG002|Overall Study|Withdrawal by Subject|1|||
155581429|NCT00982657|561553357|FG003|Overall Study|Withdrawal by Subject|3|||
155581430|NCT00982657|561553354|FG000|Overall Study|Other|0|||
155581431|NCT00982657|561553355|FG001|Overall Study|Other|0|||
155581432|NCT00982657|561553356|FG002|Overall Study|Other|0|||
155581433|NCT00982657|561553357|FG003|Overall Study|Other|4|||
155581434|NCT00982657|561553354|FG000|Overall Study|On going at date of cut-off|0|||
155581435|NCT00982657|561553355|FG001|Overall Study|On going at date of cut-off|0|||
155581436|NCT00982657|561553356|FG002|Overall Study|On going at date of cut-off|0|||
155581437|NCT00982657|561553357|FG003|Overall Study|On going at date of cut-off|1|||
155581438|NCT04199104|561555075|FG000|Overall Study|Death|148|||
155581439|NCT04199104|561555076|FG001|Overall Study|Death|134|||
155581440|NCT04199104|561555075|FG000|Overall Study|Lost to Follow-up|1|||
155581441|NCT04199104|561555076|FG001|Overall Study|Lost to Follow-up|1|||
155581442|NCT04199104|561555075|FG000|Overall Study|Withdrawal by Subject|4|||
155581443|NCT04199104|561555076|FG001|Overall Study|Withdrawal by Subject|4|||
155581444|NCT04199104|561555075|FG000|Overall Study|Participants Ongoing|103|||
155581445|NCT04199104|561555076|FG001|Overall Study|Participants Ongoing|116|||
155581446|NCT04075825|561555077|FG000|Overall Study|Withdrawal by Subject|6|||
155581447|NCT04075825|561555078|FG001|Overall Study|Withdrawal by Subject|8|||
155581448|NCT04075825|561555077|FG000|Overall Study|Physician Decision|3|||
155581449|NCT04075825|561555078|FG001|Overall Study|Physician Decision|1|||
155581450|NCT04075825|561555077|FG000|Overall Study|Lost to Follow-up|5|||
155581451|NCT04075825|561555078|FG001|Overall Study|Lost to Follow-up|1|||
155581452|NCT04075825|561555077|FG000|Overall Study|Participation in New Clinical Trial|1|||
155581453|NCT04075825|561555078|FG001|Overall Study|Participation in New Clinical Trial|1|||
155581454|NCT04075825|561555077|FG000|Overall Study|Reason Not Specified|2|||
155581455|NCT04075825|561555078|FG001|Overall Study|Reason Not Specified|2|||
155581456|NCT04581824|561555079|FG000|Overall Study|Lost to Follow-up|1|||
155581457|NCT04581824|561555080|FG001|Overall Study|Lost to Follow-up|0|||
155581458|NCT04581824|561555079|FG000|Overall Study|Withdrawal by Subject|2|||
155581459|NCT04581824|561555080|FG001|Overall Study|Withdrawal by Subject|7|||
155581460|NCT04581824|561555079|FG000|Overall Study|Study terminated by sponsor|37|||
155581461|NCT04581824|561555080|FG001|Overall Study|Study terminated by sponsor|23|||
155581462|NCT04796909|561555081|FG000|Overall Study|Withdrawal by Subject|1|||
155581463|NCT04796909|561555082|FG001|Overall Study|Withdrawal by Subject|1|||
155581464|NCT03879135|561555083|FG000|Overall Study|Physician Decision|0|||
155581465|NCT03879135|561555084|FG001|Overall Study|Physician Decision|0|||
155581466|NCT03879135|561555085|FG002|Overall Study|Physician Decision|0|||
155581467|NCT03879135|561555086|FG003|Overall Study|Physician Decision|1|||
155581468|NCT03879135|561555087|FG004|Overall Study|Physician Decision|0|||
155581469|NCT03879135|561555088|FG005|Overall Study|Physician Decision|0|||
155581470|NCT03879135|561555083|FG000|Overall Study|Withdrawal by Subject|0|||
155581471|NCT03879135|561555084|FG001|Overall Study|Withdrawal by Subject|0|||
155581472|NCT03879135|561555085|FG002|Overall Study|Withdrawal by Subject|0|||
155581473|NCT03879135|561555086|FG003|Overall Study|Withdrawal by Subject|0|||
155581474|NCT03879135|561555087|FG004|Overall Study|Withdrawal by Subject|0|||
155581475|NCT03879135|561555088|FG005|Overall Study|Withdrawal by Subject|1|||
155581476|NCT03879135|561555083|FG000|Overall Study|Site Closed by Sponsor|0|||
155581477|NCT03879135|561555084|FG001|Overall Study|Site Closed by Sponsor|0|||
155581478|NCT03879135|561555085|FG002|Overall Study|Site Closed by Sponsor|0|||
155581479|NCT03879135|561555086|FG003|Overall Study|Site Closed by Sponsor|1|||
155581480|NCT03879135|561555087|FG004|Overall Study|Site Closed by Sponsor|1|||
155581481|NCT03879135|561555088|FG005|Overall Study|Site Closed by Sponsor|0|||
155581482|NCT03428958|561555089|FG000|Overall Study|Adverse Event|0|||
155581483|NCT03428958|561555090|FG001|Overall Study|Adverse Event|0|||
155581484|NCT03428958|561555091|FG002|Overall Study|Adverse Event|0|||
155581485|NCT03428958|561555092|FG003|Overall Study|Adverse Event|1|||
155581486|NCT03428958|561555093|FG004|Overall Study|Adverse Event|0|||
155581487|NCT03428958|561555094|FG005|Overall Study|Adverse Event|2|||
155581488|NCT03428958|561555095|FG006|Overall Study|Adverse Event|1|||
155581489|NCT03428958|561555096|FG007|Overall Study|Adverse Event|0|||
155581490|NCT03428958|561555097|FG008|Overall Study|Adverse Event|0|||
155581491|NCT03428958|561555098|FG009|Overall Study|Adverse Event|0|||
155581492|NCT03428958|561555099|FG010|Overall Study|Adverse Event|0|||
155581493|NCT03428958|561555100|FG011|Overall Study|Adverse Event|0|||
155581494|NCT03428958|561555101|FG012|Overall Study|Adverse Event|0|||
155581495|NCT03428958|561555102|FG013|Overall Study|Adverse Event|0|||
155581496|NCT03428958|561555103|FG014|Overall Study|Adverse Event|0|||
155581497|NCT03428958|561555104|FG015|Overall Study|Adverse Event|0|||
155581498|NCT03428958|561555105|FG016|Overall Study|Adverse Event|0|||
155581499|NCT03428958|561555089|FG000|Overall Study|Clinical Progression|2|||
155581500|NCT03428958|561555090|FG001|Overall Study|Clinical Progression|3|||
155581501|NCT03428958|561555091|FG002|Overall Study|Clinical Progression|2|||
155581502|NCT03428958|561555092|FG003|Overall Study|Clinical Progression|1|||
155581503|NCT03428958|561555093|FG004|Overall Study|Clinical Progression|0|||
155581504|NCT03428958|561555094|FG005|Overall Study|Clinical Progression|2|||
155581505|NCT03428958|561555095|FG006|Overall Study|Clinical Progression|0|||
155581506|NCT03428958|561555096|FG007|Overall Study|Clinical Progression|0|||
155581507|NCT03428958|561555097|FG008|Overall Study|Clinical Progression|0|||
155581508|NCT03428958|561555098|FG009|Overall Study|Clinical Progression|0|||
155581509|NCT03428958|561555099|FG010|Overall Study|Clinical Progression|0|||
155581510|NCT03428958|561555100|FG011|Overall Study|Clinical Progression|0|||
155581511|NCT03428958|561555101|FG012|Overall Study|Clinical Progression|0|||
155581512|NCT03428958|561555102|FG013|Overall Study|Clinical Progression|0|||
155581513|NCT03428958|561555103|FG014|Overall Study|Clinical Progression|0|||
155581514|NCT03428958|561555104|FG015|Overall Study|Clinical Progression|0|||
155581515|NCT03428958|561555105|FG016|Overall Study|Clinical Progression|0|||
155581516|NCT03428958|561555089|FG000|Overall Study|Progression per RECIST|6|||
155581517|NCT03428958|561555090|FG001|Overall Study|Progression per RECIST|6|||
155581518|NCT03428958|561555091|FG002|Overall Study|Progression per RECIST|7|||
155581519|NCT03428958|561555092|FG003|Overall Study|Progression per RECIST|4|||
155581520|NCT03428958|561555093|FG004|Overall Study|Progression per RECIST|0|||
155581521|NCT03428958|561555094|FG005|Overall Study|Progression per RECIST|7|||
155581522|NCT03428958|561555095|FG006|Overall Study|Progression per RECIST|8|||
155581523|NCT03428958|561555096|FG007|Overall Study|Progression per RECIST|0|||
155581524|NCT03428958|561555097|FG008|Overall Study|Progression per RECIST|0|||
155581525|NCT03428958|561555098|FG009|Overall Study|Progression per RECIST|0|||
155581526|NCT03428958|561555099|FG010|Overall Study|Progression per RECIST|0|||
155581527|NCT03428958|561555100|FG011|Overall Study|Progression per RECIST|0|||
155581528|NCT03428958|561555101|FG012|Overall Study|Progression per RECIST|1|||
155581529|NCT03428958|561555102|FG013|Overall Study|Progression per RECIST|0|||
155581530|NCT03428958|561555103|FG014|Overall Study|Progression per RECIST|0|||
155581531|NCT03428958|561555104|FG015|Overall Study|Progression per RECIST|0|||
155581532|NCT03428958|561555105|FG016|Overall Study|Progression per RECIST|0|||
155581533|NCT03428958|561555089|FG000|Overall Study|Death|2|||
155581534|NCT03428958|561555090|FG001|Overall Study|Death|2|||
155581535|NCT03428958|561555091|FG002|Overall Study|Death|0|||
155581536|NCT03428958|561555092|FG003|Overall Study|Death|0|||
155581537|NCT03428958|561555093|FG004|Overall Study|Death|0|||
155581538|NCT03428958|561555094|FG005|Overall Study|Death|7|||
155581539|NCT03428958|561555095|FG006|Overall Study|Death|9|||
155581540|NCT03428958|561555096|FG007|Overall Study|Death|6|||
155581541|NCT03428958|561555097|FG008|Overall Study|Death|0|||
155581542|NCT03428958|561555098|FG009|Overall Study|Death|0|||
155581543|NCT03428958|561555099|FG010|Overall Study|Death|3|||
155581544|NCT03428958|561555100|FG011|Overall Study|Death|0|||
155581545|NCT03428958|561555101|FG012|Overall Study|Death|4|||
155581546|NCT03428958|561555102|FG013|Overall Study|Death|0|||
155581547|NCT03428958|561555103|FG014|Overall Study|Death|0|||
155581548|NCT03428958|561555104|FG015|Overall Study|Death|0|||
155581549|NCT03428958|561555105|FG016|Overall Study|Death|0|||
155581550|NCT03428958|561555089|FG000|Overall Study|Lost to Follow-up|0|||
155581551|NCT03428958|561555090|FG001|Overall Study|Lost to Follow-up|0|||
155581552|NCT03428958|561555091|FG002|Overall Study|Lost to Follow-up|0|||
155581553|NCT03428958|561555092|FG003|Overall Study|Lost to Follow-up|0|||
155581554|NCT03428958|561555093|FG004|Overall Study|Lost to Follow-up|0|||
155581555|NCT03428958|561555094|FG005|Overall Study|Lost to Follow-up|1|||
155581556|NCT03428958|561555095|FG006|Overall Study|Lost to Follow-up|1|||
155581557|NCT03428958|561555096|FG007|Overall Study|Lost to Follow-up|0|||
155581558|NCT03428958|561555097|FG008|Overall Study|Lost to Follow-up|0|||
155581559|NCT03428958|561555098|FG009|Overall Study|Lost to Follow-up|0|||
155581560|NCT03428958|561555099|FG010|Overall Study|Lost to Follow-up|0|||
155581561|NCT03428958|561555100|FG011|Overall Study|Lost to Follow-up|0|||
155581562|NCT03428958|561555101|FG012|Overall Study|Lost to Follow-up|0|||
155581563|NCT03428958|561555102|FG013|Overall Study|Lost to Follow-up|0|||
155581564|NCT03428958|561555103|FG014|Overall Study|Lost to Follow-up|0|||
155581565|NCT03428958|561555104|FG015|Overall Study|Lost to Follow-up|0|||
155581566|NCT03428958|561555105|FG016|Overall Study|Lost to Follow-up|0|||
155581567|NCT03428958|561555089|FG000|Overall Study|Physician/Sponsor Decision|1|||
155581568|NCT03428958|561555090|FG001|Overall Study|Physician/Sponsor Decision|0|||
155581569|NCT03428958|561555091|FG002|Overall Study|Physician/Sponsor Decision|1|||
155581570|NCT03428958|561555092|FG003|Overall Study|Physician/Sponsor Decision|0|||
155581571|NCT03428958|561555093|FG004|Overall Study|Physician/Sponsor Decision|0|||
155581572|NCT03428958|561555094|FG005|Overall Study|Physician/Sponsor Decision|2|||
155581573|NCT03428958|561555095|FG006|Overall Study|Physician/Sponsor Decision|2|||
155581574|NCT03428958|561555096|FG007|Overall Study|Physician/Sponsor Decision|2|||
155581575|NCT03428958|561555097|FG008|Overall Study|Physician/Sponsor Decision|0|||
155581576|NCT03428958|561555098|FG009|Overall Study|Physician/Sponsor Decision|0|||
155664040|NCT05270863|561865356|FG003|First Washout|Lost to Follow-up|0|||
155664041|NCT05270863|561865357|FG004|First Washout|Lost to Follow-up|0|||
155664042|NCT05270863|561865358|FG005|First Washout|Lost to Follow-up|1|||
155664043|NCT05270863|561865353|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
155664044|NCT05270863|561865354|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
155664045|NCT05270863|561865355|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
155664046|NCT05270863|561865356|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
155664047|NCT05270863|561865357|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
155664048|NCT05270863|561865358|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
155664049|NCT05270863|561865353|FG000|Second Washout|Withdrawal by Subject|1|||
155664050|NCT05270863|561865354|FG001|Second Washout|Withdrawal by Subject|1|||
155664051|NCT05270863|561865355|FG002|Second Washout|Withdrawal by Subject|0|||
155664052|NCT05270863|561865356|FG003|Second Washout|Withdrawal by Subject|0|||
155664053|NCT05270863|561865357|FG004|Second Washout|Withdrawal by Subject|0|||
155664054|NCT05270863|561865358|FG005|Second Washout|Withdrawal by Subject|0|||
155664055|NCT05270863|561865353|FG000|Second Washout|Lost to Follow-up|0|||
155664056|NCT05270863|561865354|FG001|Second Washout|Lost to Follow-up|0|||
155664057|NCT05270863|561865355|FG002|Second Washout|Lost to Follow-up|0|||
155664058|NCT05270863|561865356|FG003|Second Washout|Lost to Follow-up|1|||
155664059|NCT05270863|561865357|FG004|Second Washout|Lost to Follow-up|0|||
155664060|NCT05270863|561865358|FG005|Second Washout|Lost to Follow-up|0|||
155664061|NCT03384875|561865359|FG000|Overall Study|Death|1|||
155664062|NCT03384875|561865360|FG001|Overall Study|Death|1|||
155664063|NCT03384875|561865361|FG002|Overall Study|Death|0|||
155664064|NCT03384875|561865359|FG000|Overall Study|Reason not provided|1|||
155664065|NCT03384875|561865360|FG001|Overall Study|Reason not provided|0|||
155664066|NCT03384875|561865361|FG002|Overall Study|Reason not provided|0|||
155664067|NCT02735421|561866828|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
155664068|NCT02735421|561866828|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
155664069|NCT02735421|561866828|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
155664070|NCT02735421|561866828|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
155664071|NCT02735421|561866828|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
155664072|NCT02735421|561866828|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
155664073|NCT02735421|561866828|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
155664074|NCT01978145|561866830|FG000|Treatment Period 1|Adverse Event|1|||
155664075|NCT01978145|561866831|FG001|Treatment Period 1|Adverse Event|9|||
155664076|NCT01978145|561866830|FG000|Treatment Period 1|Physician Decision|1|||
155664077|NCT01978145|561866831|FG001|Treatment Period 1|Physician Decision|0|||
155664078|NCT01978145|561866830|FG000|Treatment Period 1|Withdrawal by Subject|5|||
155664079|NCT01978145|561866831|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155581577|NCT03428958|561555099|FG010|Overall Study|Physician/Sponsor Decision|2|||
155581578|NCT03428958|561555100|FG011|Overall Study|Physician/Sponsor Decision|0|||
155581579|NCT03428958|561555101|FG012|Overall Study|Physician/Sponsor Decision|4|||
155581580|NCT03428958|561555102|FG013|Overall Study|Physician/Sponsor Decision|0|||
155581581|NCT03428958|561555103|FG014|Overall Study|Physician/Sponsor Decision|0|||
155581582|NCT03428958|561555104|FG015|Overall Study|Physician/Sponsor Decision|0|||
155581583|NCT03428958|561555105|FG016|Overall Study|Physician/Sponsor Decision|0|||
155581584|NCT03428958|561555089|FG000|Overall Study|Withdrawal by Subject|0|||
155581585|NCT03428958|561555090|FG001|Overall Study|Withdrawal by Subject|0|||
155581586|NCT03428958|561555091|FG002|Overall Study|Withdrawal by Subject|2|||
155581587|NCT03428958|561555092|FG003|Overall Study|Withdrawal by Subject|0|||
155581588|NCT03428958|561555093|FG004|Overall Study|Withdrawal by Subject|0|||
155581589|NCT03428958|561555094|FG005|Overall Study|Withdrawal by Subject|2|||
155664080|NCT01978145|561866830|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
155581590|NCT03428958|561555095|FG006|Overall Study|Withdrawal by Subject|4|||
155581591|NCT03428958|561555096|FG007|Overall Study|Withdrawal by Subject|1|||
155581592|NCT03428958|561555097|FG008|Overall Study|Withdrawal by Subject|0|||
155581593|NCT03428958|561555098|FG009|Overall Study|Withdrawal by Subject|0|||
155664081|NCT01978145|561866831|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
155664082|NCT01978145|561866830|FG000|Washout Period 1|Adverse Event|0|||
155664083|NCT01978145|561866831|FG001|Washout Period 1|Adverse Event|1|||
155664084|NCT01978145|561866830|FG000|Washout Period 1|Withdrawal by Subject|1|||
155664085|NCT01978145|561866831|FG001|Washout Period 1|Withdrawal by Subject|1|||
155664086|NCT01978145|561866830|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
155664087|NCT01978145|561866831|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
155664088|NCT01978145|561866830|FG000|Treatment Period 2|Adverse Event|3|||
155664089|NCT01978145|561866831|FG001|Treatment Period 2|Adverse Event|3|||
155664090|NCT01978145|561866830|FG000|Treatment Period 2|Protocol Violation|0|||
155664091|NCT01978145|561866831|FG001|Treatment Period 2|Protocol Violation|1|||
155664092|NCT01978145|561866830|FG000|Treatment Period 2|Lost to Follow-up|1|||
155664093|NCT01978145|561866831|FG001|Treatment Period 2|Lost to Follow-up|1|||
155664094|NCT01978145|561866830|FG000|Treatment Period 2|Withdrawal by Subject|7|||
155664095|NCT01978145|561866831|FG001|Treatment Period 2|Withdrawal by Subject|4|||
155664096|NCT01978145|561866830|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
155664097|NCT01978145|561866831|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
155664098|NCT00322049|561866832|FG000|Overall Study|Moved out of area|0|||
155664099|NCT00322049|561866833|FG001|Overall Study|Moved out of area|0|||
155664100|NCT00322049|561866834|FG002|Overall Study|Moved out of area|0|||
155664101|NCT00322049|561866835|FG003|Overall Study|Moved out of area|1|||
155664102|NCT00322049|561866832|FG000|Overall Study|Infected with Dengue during study|0|||
155664103|NCT00322049|561866833|FG001|Overall Study|Infected with Dengue during study|1|||
155664104|NCT00322049|561866834|FG002|Overall Study|Infected with Dengue during study|0|||
155664105|NCT00322049|561866835|FG003|Overall Study|Infected with Dengue during study|0|||
155664106|NCT01250054|561866836|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
155664107|NCT01250054|561866837|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
155664108|NCT00755807|561866840|FG000|Acute Phase|Adverse Event|16|||
155664109|NCT00755807|561866841|FG001|Acute Phase|Adverse Event|5|||
155664110|NCT00755807|561866840|FG000|Acute Phase|Protocol Violation|1|||
155664111|NCT00755807|561866841|FG001|Acute Phase|Protocol Violation|3|||
155664112|NCT00755807|561866840|FG000|Acute Phase|Withdrawal by Subject|1|||
155664113|NCT00755807|561866841|FG001|Acute Phase|Withdrawal by Subject|2|||
155664114|NCT00755807|561866840|FG000|Acute Phase|Lack of Efficacy|0|||
155664115|NCT00755807|561866841|FG001|Acute Phase|Lack of Efficacy|1|||
155664116|NCT00755807|561866840|FG000|Acute Phase|Physician Decision|0|||
155664117|NCT00755807|561866841|FG001|Acute Phase|Physician Decision|1|||
155664118|NCT00755807|561866840|FG000|Open-label Extension Phase|Adverse Event|7|||
155664119|NCT00755807|561866841|FG001|Open-label Extension Phase|Adverse Event|7|||
155664120|NCT00755807|561866840|FG000|Open-label Extension Phase|Protocol Violation|5|||
155664121|NCT00755807|561866841|FG001|Open-label Extension Phase|Protocol Violation|2|||
155664122|NCT00755807|561866840|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
155664123|NCT00755807|561866841|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
155664124|NCT00755807|561866840|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
155664125|NCT00755807|561866841|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
155664126|NCT00755807|561866840|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
155664127|NCT00755807|561866841|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
155664128|NCT00755807|561866840|FG000|Open-label Extension Phase|Sponsor Decision|0|||
155664129|NCT00755807|561866841|FG001|Open-label Extension Phase|Sponsor Decision|1|||
155664130|NCT00939107|561866842|FG000|Overall Study|Lost to Follow-up|14|||
155664131|NCT00939107|561866843|FG001|Overall Study|Lost to Follow-up|12|||
155664132|NCT00427011|561866846|FG000|Overall Study|Adverse Event|10|||
155664133|NCT00427011|561866846|FG000|Overall Study|Withdrawal by Subject|1|||
155664134|NCT00427011|561866846|FG000|Overall Study|Lack of Efficacy|2|||
155664135|NCT00427011|561866846|FG000|Overall Study|Other|12|||
155664136|NCT02921789|561866847|FG000|Overall Study|Adverse Event|0|||
155664137|NCT02921789|561866848|FG001|Overall Study|Adverse Event|1|||
155664138|NCT02921789|561866847|FG000|Overall Study|Lost to Follow-up|1|||
155664139|NCT02921789|561866848|FG001|Overall Study|Lost to Follow-up|0|||
155664140|NCT02921789|561866847|FG000|Overall Study|Protocol Deviation|2|||
155664141|NCT02921789|561866848|FG001|Overall Study|Protocol Deviation|0|||
155664142|NCT02921789|561866847|FG000|Overall Study|Withdrawal by Subject|2|||
155664143|NCT02921789|561866848|FG001|Overall Study|Withdrawal by Subject|1|||
155664144|NCT02921789|561866847|FG000|Overall Study|Miscellaneous|3|||
155664145|NCT02921789|561866848|FG001|Overall Study|Miscellaneous|2|||
155664146|NCT01192126|561866849|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
155664147|NCT01192126|561866850|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
155664148|NCT01192126|561866849|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
155664149|NCT01192126|561866850|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
155664150|NCT01248793|561866851|FG000|Overall Study|Lost to Follow-up|0|||
155664151|NCT01248793|561866852|FG001|Overall Study|Lost to Follow-up|1|||
155664152|NCT01248793|561866851|FG000|Overall Study|Adverse Event|1|||
155664153|NCT01248793|561866852|FG001|Overall Study|Adverse Event|1|||
155664154|NCT01248793|561866851|FG000|Overall Study|Protocol Violation|0|||
155664155|NCT01248793|561866852|FG001|Overall Study|Protocol Violation|1|||
155664156|NCT01248793|561866851|FG000|Overall Study|Withdrawal by Subject|3|||
155664157|NCT01248793|561866852|FG001|Overall Study|Withdrawal by Subject|3|||
155664158|NCT00517699|561866853|FG000|Overall Study|Withdrawal by Subject|1|||
155664159|NCT00517699|561866853|FG000|Overall Study|Lack of Efficacy|1|||
155664160|NCT00517699|561866853|FG000|Overall Study|Administrative error|1|||
155664161|NCT00517699|561866853|FG000|Overall Study|Study terminated by Sponsor|2|||
155664162|NCT02332187|561866854|FG000|Overall Study|Withdrawal by Subject|2|||
155664163|NCT02332187|561866855|FG001|Overall Study|Withdrawal by Subject|2|||
155664164|NCT02332187|561866854|FG000|Overall Study|Adverse Event|0|||
155664165|NCT02332187|561866855|FG001|Overall Study|Adverse Event|1|||
155664166|NCT02580877|561866856|FG000|Overall Study|Withdrawal by Subject|1|||
155664167|NCT02580877|561866857|FG001|Overall Study|Withdrawal by Subject|3|||
155664168|NCT02580877|561866856|FG000|Overall Study|Adverse Event|0|||
155664169|NCT02580877|561866857|FG001|Overall Study|Adverse Event|1|||
155664170|NCT00355030|561866858|FG000|Study Period 1 Treatment|Adverse Event|1|||
155664171|NCT00355030|561866859|FG001|Study Period 1 Treatment|Adverse Event|1|||
155664172|NCT00355030|561866858|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
155664173|NCT00355030|561866859|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
155664174|NCT00355030|561866858|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
155664175|NCT00355030|561866859|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
155664176|NCT00355030|561866858|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
155664177|NCT00355030|561866859|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
155664178|NCT00355030|561866858|FG000|Study Period 1 Treatment|Physician Decision|0|||
155664179|NCT00355030|561866859|FG001|Study Period 1 Treatment|Physician Decision|1|||
155664180|NCT00355030|561866858|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
155664181|NCT00355030|561866859|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
155664182|NCT00355030|561866858|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
155664183|NCT00355030|561866859|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
155664184|NCT00355030|561866858|FG000|Study Period 1 Treatment|Other|2|||
155664185|NCT00355030|561866859|FG001|Study Period 1 Treatment|Other|6|||
155664186|NCT00355030|561866858|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
155664187|NCT00355030|561866859|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
155664188|NCT00355030|561866858|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
155664189|NCT00355030|561866859|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
155664190|NCT00339040|561866860|FG000|Stage I|Not able to attend clinic|1|||
155664191|NCT00339040|561866861|FG001|Stage I|Not able to attend clinic|0|||
155664192|NCT00339040|561866860|FG000|Stage I|Protocol Violation|1|||
155664193|NCT00339040|561866861|FG001|Stage I|Protocol Violation|1|||
155664194|NCT00339040|561866860|FG000|Stage II|Lost to Follow-up|3|||
155664195|NCT00339040|561866861|FG001|Stage II|Lost to Follow-up|0|||
155664196|NCT00339040|561866860|FG000|Stage II|Withdrawal by Subject|1|||
155664197|NCT00339040|561866861|FG001|Stage II|Withdrawal by Subject|2|||
155664198|NCT00339040|561866860|FG000|Stage II|Protocol Violation|3|||
155664199|NCT00339040|561866861|FG001|Stage II|Protocol Violation|0|||
155664200|NCT00339040|561866860|FG000|Stage II|Not able to attend clinic|1|||
155664201|NCT00339040|561866861|FG001|Stage II|Not able to attend clinic|0|||
155664202|NCT00339040|561866860|FG000|Stage II|Site closing|2|||
155664203|NCT00339040|561866861|FG001|Stage II|Site closing|0|||
155664204|NCT01462929|561866862|FG000|Overall Study|Adverse Event|3|||
155664205|NCT01462929|561866863|FG001|Overall Study|Adverse Event|3|||
155664206|NCT01462929|561866864|FG002|Overall Study|Adverse Event|4|||
155664207|NCT01462929|561866862|FG000|Overall Study|Withdrawal by Subject|2|||
155664208|NCT01462929|561866863|FG001|Overall Study|Withdrawal by Subject|1|||
155664209|NCT01462929|561866864|FG002|Overall Study|Withdrawal by Subject|0|||
155664210|NCT01462929|561866862|FG000|Overall Study|Lack of Efficacy|0|||
155664211|NCT01462929|561866863|FG001|Overall Study|Lack of Efficacy|0|||
155664212|NCT01462929|561866864|FG002|Overall Study|Lack of Efficacy|1|||
155664213|NCT02808897|561866867|FG000|Overall Study|Lost to Follow-up|9|||
155664214|NCT02808897|561866868|FG001|Overall Study|Lost to Follow-up|11|||
155664215|NCT02133573|561866874|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
155664216|NCT02133573|561866875|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
155664217|NCT02133573|561866874|FG000|Overall Study|Child Deaths|3|||
155664218|NCT02133573|561866875|FG001|Overall Study|Child Deaths|5|||
155664219|NCT02133573|561866874|FG000|Overall Study|Child Declined Follow Ups|2|||
155664220|NCT02133573|561866875|FG001|Overall Study|Child Declined Follow Ups|1|||
155664221|NCT02133573|561866874|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
155664222|NCT02133573|561866875|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
155664223|NCT02808429|561866879|FG000|Overall Study|Lost to Follow-up|1|||
155664224|NCT02808429|561866880|FG001|Overall Study|Lost to Follow-up|0|||
155664225|NCT02808429|561866881|FG002|Overall Study|Lost to Follow-up|0|||
155664226|NCT02808429|561866879|FG000|Overall Study|Protocol Violation|0|||
155664227|NCT02808429|561866880|FG001|Overall Study|Protocol Violation|1|||
155664228|NCT02808429|561866881|FG002|Overall Study|Protocol Violation|0|||
155664229|NCT02808429|561866879|FG000|Overall Study|Premature study termination by sponsor|2|||
155664230|NCT02808429|561866880|FG001|Overall Study|Premature study termination by sponsor|0|||
155664231|NCT02808429|561866881|FG002|Overall Study|Premature study termination by sponsor|1|||
155664232|NCT02808429|561866879|FG000|Overall Study|Relocation|0|||
155664233|NCT02808429|561866880|FG001|Overall Study|Relocation|0|||
155664234|NCT02808429|561866881|FG002|Overall Study|Relocation|1|||
155664235|NCT01788943|561866885|FG000|Overall Study|Withdrawal by Subject|1|||
155664236|NCT01788943|561866886|FG001|Overall Study|Withdrawal by Subject|0|||
155664237|NCT01567722|561866898|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
155664238|NCT01567722|561866899|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
155664239|NCT01567722|561866900|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
155664240|NCT01567722|561866898|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
155664241|NCT01567722|561866899|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
155664242|NCT01567722|561866900|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
155664243|NCT01567722|561866898|FG000|Overall Study|Protocol closure by the OCG|2|||
155664244|NCT01567722|561866899|FG001|Overall Study|Protocol closure by the OCG|0|||
155664245|NCT01567722|561866900|FG002|Overall Study|Protocol closure by the OCG|0|||
155664246|NCT01567722|561866898|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
155664247|NCT01567722|561866899|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
155664248|NCT01567722|561866900|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
155664249|NCT02259114|561866901|FG000|Overall Study|Progressive Disease|14|||
155664250|NCT02259114|561866902|FG001|Overall Study|Progressive Disease|2|||
155664251|NCT02259114|561866903|FG002|Overall Study|Progressive Disease|10|||
155664252|NCT02259114|561866904|FG003|Overall Study|Progressive Disease|2|||
155664253|NCT02259114|561866905|FG004|Overall Study|Progressive Disease|5|||
155664254|NCT02259114|561866901|FG000|Overall Study|Adverse Event|2|||
155664255|NCT02259114|561866902|FG001|Overall Study|Adverse Event|1|||
155664256|NCT02259114|561866903|FG002|Overall Study|Adverse Event|0|||
155664257|NCT02259114|561866904|FG003|Overall Study|Adverse Event|0|||
155664258|NCT02259114|561866905|FG004|Overall Study|Adverse Event|1|||
155664259|NCT02259114|561866901|FG000|Overall Study|Death|3|||
155664260|NCT02259114|561866902|FG001|Overall Study|Death|0|||
155664261|NCT02259114|561866903|FG002|Overall Study|Death|1|||
155664262|NCT02259114|561866904|FG003|Overall Study|Death|0|||
155664263|NCT02259114|561866905|FG004|Overall Study|Death|0|||
155664264|NCT02259114|561866901|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155664265|NCT02259114|561866902|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155664266|NCT02259114|561866903|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
155664267|NCT02259114|561866904|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155664268|NCT02259114|561866905|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155664269|NCT02259114|561866901|FG000|Overall Study|Withdrawal by Subject|0|||
155664270|NCT02259114|561866902|FG001|Overall Study|Withdrawal by Subject|0|||
155664271|NCT02259114|561866903|FG002|Overall Study|Withdrawal by Subject|1|||
155664272|NCT02259114|561866904|FG003|Overall Study|Withdrawal by Subject|1|||
155664273|NCT02259114|561866905|FG004|Overall Study|Withdrawal by Subject|0|||
155664274|NCT02259114|561866901|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
155664275|NCT02259114|561866902|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
155664276|NCT02259114|561866903|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155664277|NCT02259114|561866904|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155664278|NCT02259114|561866905|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155664279|NCT02259114|561866901|FG000|Overall Study|Not Treated|1|||
155664280|NCT02259114|561866902|FG001|Overall Study|Not Treated|0|||
155581594|NCT03428958|561555099|FG010|Overall Study|Withdrawal by Subject|0|||
155581595|NCT03428958|561555100|FG011|Overall Study|Withdrawal by Subject|0|||
155581596|NCT03428958|561555101|FG012|Overall Study|Withdrawal by Subject|0|||
155581597|NCT03428958|561555102|FG013|Overall Study|Withdrawal by Subject|0|||
155581598|NCT03428958|561555103|FG014|Overall Study|Withdrawal by Subject|0|||
155581599|NCT03428958|561555104|FG015|Overall Study|Withdrawal by Subject|0|||
155581600|NCT03428958|561555105|FG016|Overall Study|Withdrawal by Subject|0|||
155581601|NCT03985800|561555106|FG000|Overall Study|Death|1|||
155581602|NCT03985800|561555107|FG001|Overall Study|Death|2|||
155581603|NCT03985800|561555106|FG000|Overall Study|Withdrawal by Subject|3|||
155581604|NCT03985800|561555107|FG001|Overall Study|Withdrawal by Subject|6|||
155581605|NCT03985800|561555106|FG000|Overall Study|Protocol Violation|2|||
155581606|NCT03985800|561555107|FG001|Overall Study|Protocol Violation|0|||
155581607|NCT05258773|561555108|FG000|Overall Study|Screen Failure|1|||
155581608|NCT05258773|561555109|FG001|Overall Study|Screen Failure|1|||
155581609|NCT05258773|561555108|FG000|Overall Study|Adverse Event|1|||
155581610|NCT05258773|561555109|FG001|Overall Study|Adverse Event|0|||
155581611|NCT05258773|561555108|FG000|Overall Study|Withdrawal by Subject|0|||
155581612|NCT05258773|561555109|FG001|Overall Study|Withdrawal by Subject|1|||
155581613|NCT01662635|561555112|FG000|Overall Study|scarce samples for evaluation|30|||
155581614|NCT00595920|561555113|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
155581615|NCT00351468|561555114|FG000|Overall Study|Adverse Event|42|||
155581616|NCT00351468|561555114|FG000|Overall Study|Withdrawal by Subject|39|||
155581617|NCT00351468|561555114|FG000|Overall Study|Various -follow up w clinical team|39|||
155581618|NCT00351468|561555114|FG000|Overall Study|Lack of Efficacy|32|||
155581619|NCT00351468|561555114|FG000|Overall Study|Non-compliance|8|||
155581620|NCT00351468|561555114|FG000|Overall Study|Lost to Follow-up|4|||
155581621|NCT00351468|561555114|FG000|Overall Study|Protocol Violation|3|||
155581622|NCT04565145|561555115|FG000|Overall Study|Withdrawal by Subject|1|||
155581623|NCT04565145|561555116|FG001|Overall Study|Withdrawal by Subject|1|||
155581624|NCT03096314|561555117|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
155581625|NCT03096314|561555118|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
155581626|NCT02547428|561555119|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
155581627|NCT02547428|561555120|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
155581628|NCT02547428|561555119|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
155581629|NCT02547428|561555120|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
155581630|NCT02547428|561555119|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
155581631|NCT02547428|561555120|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
155581632|NCT02547428|561555119|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
155581633|NCT02547428|561555120|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
155581634|NCT02547428|561555119|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
155581635|NCT02547428|561555120|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
155581636|NCT02547428|561555119|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
155581637|NCT02547428|561555120|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
155581638|NCT02547428|561555119|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
155581639|NCT02547428|561555120|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
155581640|NCT02547428|561555119|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
155581641|NCT02547428|561555120|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
155581642|NCT03318861|561555121|FG000|Overall Study|Death|2|||
155581643|NCT03318861|561555122|FG001|Overall Study|Death|3|||
155581644|NCT03318861|561555123|FG002|Overall Study|Death|3|||
155581645|NCT03318861|561555124|FG003|Overall Study|Death|2|||
155581646|NCT03318861|561555125|FG004|Overall Study|Death|2|||
155581647|NCT03318861|561555121|FG000|Overall Study|Enrolled But Never Treated|0|||
155581648|NCT03318861|561555122|FG001|Overall Study|Enrolled But Never Treated|1|||
155581649|NCT03318861|561555123|FG002|Overall Study|Enrolled But Never Treated|0|||
155581650|NCT03318861|561555124|FG003|Overall Study|Enrolled But Never Treated|1|||
155581651|NCT03318861|561555125|FG004|Overall Study|Enrolled But Never Treated|1|||
155581652|NCT03318861|561555121|FG000|Overall Study|Informed Consent Withdraw|0|||
155581653|NCT03318861|561555122|FG001|Overall Study|Informed Consent Withdraw|0|||
155581654|NCT03318861|561555123|FG002|Overall Study|Informed Consent Withdraw|0|||
155581655|NCT03318861|561555124|FG003|Overall Study|Informed Consent Withdraw|1|||
155581656|NCT03318861|561555125|FG004|Overall Study|Informed Consent Withdraw|0|||
155581657|NCT03318861|561555121|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
155581658|NCT03318861|561555122|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155581659|NCT03318861|561555123|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155581660|NCT03318861|561555124|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155581661|NCT03318861|561555125|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155581662|NCT00917852|561555126|FG000|Overall Study|Death|6|||
155581663|NCT02502149|561555127|FG000|Intermediate|Discontinued prematurely|1|||
155581664|NCT02502149|561555128|FG001|Intermediate|Discontinued prematurely|0|||
155581665|NCT02502149|561555129|FG002|Intermediate|Discontinued prematurely|0|||
155581666|NCT02502149|561555130|FG003|Intermediate|Discontinued prematurely|0|||
155581667|NCT02502149|561555131|FG004|Intermediate|Discontinued prematurely|0|||
155581668|NCT02548832|561555132|FG000|Overall Study|Lost to Follow-up|2|||
155581669|NCT02548832|561555133|FG001|Overall Study|Lost to Follow-up|2|||
155581670|NCT02548832|561555134|FG002|Overall Study|Lost to Follow-up|2|||
155581671|NCT03711188|561555139|FG000|Overall Study|Disease progression|11|||
155581672|NCT03711188|561555139|FG000|Overall Study|Adverse Event|1|||
155581673|NCT01433471|561555140|FG000|Overall Study|Withdrawal by Subject|0|||
155581674|NCT01433471|561555141|FG001|Overall Study|Withdrawal by Subject|1|||
155581675|NCT00314340|561555144|FG000|Overall Study|lost interest|1|||
155581676|NCT02285361|561555145|FG000|Overall Study|Protocol Violation|43|||
155581677|NCT02285361|561555145|FG000|Overall Study|Lost to Follow-up|5|||
155581678|NCT02285361|561555145|FG000|Overall Study|Not taken GIOTRIF|2|||
155581679|NCT02285361|561555145|FG000|Overall Study|Consented prior to the contract date|1|||
155581680|NCT02059135|561555146|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
155581681|NCT02059135|561555147|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
155581682|NCT02059135|561555146|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
155581683|NCT02059135|561555147|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
155581684|NCT02059135|561555146|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
155581685|NCT02059135|561555147|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
155581686|NCT02059135|561555146|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
155581687|NCT02059135|561555147|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
155581688|NCT02059135|561555146|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
155581689|NCT02059135|561555147|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
155581690|NCT02059135|561555146|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
155581691|NCT02059135|561555147|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
155581692|NCT02059135|561555146|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
155581693|NCT02059135|561555147|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
155581694|NCT02059135|561555146|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
155581695|NCT02059135|561555147|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
155581696|NCT00191477|561555148|FG000|Overall Study|Tumor Recurrence|49|||
155581697|NCT00191477|561555149|FG001|Overall Study|Tumor Recurrence|48|||
155581698|NCT00191477|561555148|FG000|Overall Study|Death, Study Disease|1|||
155581699|NCT00191477|561555149|FG001|Overall Study|Death, Study Disease|1|||
155581700|NCT00191477|561555148|FG000|Overall Study|Death, Other Cause|3|||
155581701|NCT00191477|561555149|FG001|Overall Study|Death, Other Cause|6|||
155581702|NCT00191477|561555148|FG000|Overall Study|Lost to Follow-up|23|||
155581703|NCT00191477|561555149|FG001|Overall Study|Lost to Follow-up|21|||
155581704|NCT00191477|561555148|FG000|Overall Study|Protocol Violation|1|||
155581705|NCT00191477|561555149|FG001|Overall Study|Protocol Violation|1|||
155581706|NCT00191477|561555148|FG000|Overall Study|Treatment Change|2|||
155581707|NCT00191477|561555149|FG001|Overall Study|Treatment Change|0|||
155581708|NCT00191477|561555148|FG000|Overall Study|Withdrawal by Subject|2|||
155581709|NCT00191477|561555149|FG001|Overall Study|Withdrawal by Subject|0|||
155581710|NCT00191477|561555148|FG000|Overall Study|Other|2|||
155581711|NCT00191477|561555149|FG001|Overall Study|Other|0|||
155581712|NCT00191477|561555148|FG000|Overall Study|Not Eligible|41|||
155581713|NCT00191477|561555149|FG001|Overall Study|Not Eligible|38|||
155581714|NCT00191477|561555148|FG000|Overall Study|Pathological Specimen Lost|1|||
155581715|NCT00191477|561555149|FG001|Overall Study|Pathological Specimen Lost|0|||
155581716|NCT00191477|561555148|FG000|Overall Study|Discontinued Prior to Instillation|13|||
155581717|NCT00191477|561555149|FG001|Overall Study|Discontinued Prior to Instillation|14|||
155581718|NCT03776357|561555156|FG000|Overall Study|Lost to Follow-up|3|||
155581719|NCT03751098|561555159|FG000|Overall Study|Withdrawal by Subject|0|||
155581720|NCT03751098|561555160|FG001|Overall Study|Withdrawal by Subject|1|||
155664281|NCT02259114|561866903|FG002|Overall Study|Not Treated|0|||
155664282|NCT02259114|561866904|FG003|Overall Study|Not Treated|0|||
155664283|NCT02259114|561866905|FG004|Overall Study|Not Treated|0|||
155664284|NCT03937479|561866906|FG000|Overall Study|Adverse Event|2|||
155664285|NCT03937479|561866907|FG001|Overall Study|Adverse Event|3|||
155664286|NCT03937479|561866908|FG002|Overall Study|Adverse Event|0|||
155664287|NCT03937479|561866909|FG003|Overall Study|Adverse Event|0|||
155664288|NCT03937479|561866910|FG004|Overall Study|Adverse Event|1|||
155664289|NCT03937479|561866906|FG000|Overall Study|Withdrawal by Subject|3|||
155581721|NCT00837148|561555163|FG000|Overall Study|Adverse Event|1|||
155581722|NCT00837148|561555163|FG000|Overall Study|Death|1|||
155581723|NCT00931411|561555171|FG000|First Intervention - 42 Days|Adverse Event|2|||
155581724|NCT00931411|561555172|FG001|First Intervention - 42 Days|Adverse Event|3|||
155581725|NCT00931411|561555171|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
155581726|NCT00931411|561555172|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
155581727|NCT00931411|561555171|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
155581728|NCT00931411|561555172|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
155581729|NCT01306305|561555177|FG000|Overall Study|Lost to Follow-up|1|||
155581730|NCT01306305|561555178|FG001|Overall Study|Lost to Follow-up|0|||
155581731|NCT01306305|561555177|FG000|Overall Study|Withdrew consent|1|||
155581732|NCT01306305|561555178|FG001|Overall Study|Withdrew consent|0|||
155581733|NCT04030299|561555179|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
155581734|NCT04030299|561555179|FG000|Overall Study|Withdrawal by Subject|3|||
155581735|NCT00699998|561555180|FG000|Overall Study|Withdrawal by Subject|194|||
155581736|NCT00699998|561555181|FG001|Overall Study|Withdrawal by Subject|83|||
155581737|NCT00699998|561555182|FG002|Overall Study|Withdrawal by Subject|202|||
155581738|NCT00699998|561555183|FG003|Overall Study|Withdrawal by Subject|80|||
155581739|NCT00699998|561555180|FG000|Overall Study|Physician Decision|3|||
155581740|NCT00699998|561555181|FG001|Overall Study|Physician Decision|2|||
155581741|NCT00699998|561555182|FG002|Overall Study|Physician Decision|1|||
155581742|NCT00699998|561555183|FG003|Overall Study|Physician Decision|1|||
155581743|NCT00699998|561555180|FG000|Overall Study|Lost to Follow-up|2|||
155664290|NCT03937479|561866907|FG001|Overall Study|Withdrawal by Subject|5|||
155664291|NCT03937479|561866908|FG002|Overall Study|Withdrawal by Subject|2|||
155664292|NCT03937479|561866909|FG003|Overall Study|Withdrawal by Subject|2|||
155664293|NCT03937479|561866910|FG004|Overall Study|Withdrawal by Subject|1|||
155664294|NCT03937479|561866906|FG000|Overall Study|Protocol Violation|5|||
155581744|NCT00699998|561555181|FG001|Overall Study|Lost to Follow-up|1|||
155581745|NCT00699998|561555182|FG002|Overall Study|Lost to Follow-up|3|||
155581746|NCT00699998|561555183|FG003|Overall Study|Lost to Follow-up|1|||
155581747|NCT04616612|561555188|FG000|Overall Study|Lost to Follow-up|6|||
155581748|NCT04616612|561555189|FG001|Overall Study|Lost to Follow-up|3|||
155581749|NCT04740918|561555191|FG000|Overall Study|Study Terminated by Sponsor|41|||
155581750|NCT04740918|561555192|FG001|Overall Study|Study Terminated by Sponsor|32|||
155581751|NCT04740918|561555191|FG000|Overall Study|Death|3|||
155581752|NCT04740918|561555192|FG001|Overall Study|Death|6|||
155581753|NCT04740918|561555191|FG000|Overall Study|Withdrawal by Subject|5|||
155581754|NCT04740918|561555192|FG001|Overall Study|Withdrawal by Subject|4|||
155581755|NCT04740918|561555191|FG000|Overall Study|Lost to Follow-up|1|||
155581756|NCT04740918|561555192|FG001|Overall Study|Lost to Follow-up|3|||
155581757|NCT04740918|561555191|FG000|Overall Study|Progressive disease|0|||
155581758|NCT04740918|561555192|FG001|Overall Study|Progressive disease|1|||
155581759|NCT01168427|561555193|FG000|Overall Study|Patient exited prior to implant|1|||
155581760|NCT02964247|561555195|FG000|Overall Study|Lost to Follow-up|2|||
155581761|NCT02964247|561555196|FG001|Overall Study|Lost to Follow-up|0|||
155581762|NCT02964247|561555195|FG000|Overall Study|Withdrawal by Subject|1|||
155581763|NCT02964247|561555196|FG001|Overall Study|Withdrawal by Subject|2|||
155581764|NCT03759392|561555197|FG000|Overall Study|Adverse Event|12|||
155581765|NCT03759392|561555198|FG001|Overall Study|Adverse Event|4|||
155581766|NCT03759392|561555197|FG000|Overall Study|Death|2|||
155581767|NCT03759392|561555198|FG001|Overall Study|Death|1|||
155581768|NCT03759392|561555197|FG000|Overall Study|Withdrawal by Subject|2|||
155581769|NCT03759392|561555198|FG001|Overall Study|Withdrawal by Subject|0|||
155581770|NCT03759392|561555197|FG000|Overall Study|Protocol Violation|2|||
155581771|NCT03759392|561555198|FG001|Overall Study|Protocol Violation|0|||
155581772|NCT03759392|561555197|FG000|Overall Study|Physician Decision|0|||
155581773|NCT03759392|561555198|FG001|Overall Study|Physician Decision|1|||
155581774|NCT03759392|561555197|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
155581775|NCT03759392|561555198|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
155581776|NCT03759392|561555197|FG000|Overall Study|No longer able to take medicines|1|||
155581777|NCT03759392|561555198|FG001|Overall Study|No longer able to take medicines|0|||
155581778|NCT03759392|561555197|FG000|Overall Study|Stopped taking study drug|1|||
155581779|NCT03759392|561555198|FG001|Overall Study|Stopped taking study drug|0|||
155581780|NCT01288079|561555199|FG000|Overall Study|Withdrawal by Subject|2|||
155581781|NCT01288079|561555200|FG001|Overall Study|Withdrawal by Subject|4|||
155581782|NCT01288079|561555201|FG002|Overall Study|Withdrawal by Subject|1|||
155581783|NCT01288079|561555202|FG003|Overall Study|Withdrawal by Subject|0|||
155581784|NCT01288079|561555199|FG000|Overall Study|Adverse Event|2|||
155581785|NCT01288079|561555200|FG001|Overall Study|Adverse Event|1|||
155581786|NCT01288079|561555201|FG002|Overall Study|Adverse Event|2|||
155581787|NCT01288079|561555202|FG003|Overall Study|Adverse Event|3|||
155581788|NCT01288079|561555199|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155581789|NCT01288079|561555200|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
155581790|NCT01288079|561555201|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
155581791|NCT01288079|561555202|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
155581792|NCT01288079|561555199|FG000|Overall Study|Condition under Investigation Worsened|0|||
155581793|NCT01288079|561555200|FG001|Overall Study|Condition under Investigation Worsened|0|||
155581794|NCT01288079|561555201|FG002|Overall Study|Condition under Investigation Worsened|0|||
155581795|NCT01288079|561555202|FG003|Overall Study|Condition under Investigation Worsened|1|||
155581796|NCT01288079|561555199|FG000|Overall Study|Lack of Efficacy|2|||
155581797|NCT01288079|561555200|FG001|Overall Study|Lack of Efficacy|2|||
155581798|NCT01288079|561555201|FG002|Overall Study|Lack of Efficacy|0|||
155581799|NCT01288079|561555202|FG003|Overall Study|Lack of Efficacy|2|||
155581800|NCT01288079|561555199|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
155581801|NCT01288079|561555200|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155581802|NCT01288079|561555201|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
155664295|NCT03937479|561866907|FG001|Overall Study|Protocol Violation|6|||
155581803|NCT01288079|561555202|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
155581804|NCT01288079|561555199|FG000|Overall Study|Lost to Follow-up|1|||
155581805|NCT01288079|561555200|FG001|Overall Study|Lost to Follow-up|1|||
155581806|NCT01288079|561555201|FG002|Overall Study|Lost to Follow-up|1|||
155581807|NCT01288079|561555202|FG003|Overall Study|Lost to Follow-up|0|||
155581808|NCT01288079|561555199|FG000|Overall Study|Other or Study Termination|11|||
155581809|NCT01288079|561555200|FG001|Overall Study|Other or Study Termination|15|||
155581810|NCT01288079|561555201|FG002|Overall Study|Other or Study Termination|14|||
155581811|NCT01288079|561555202|FG003|Overall Study|Other or Study Termination|8|||
155581812|NCT01530464|561555203|FG000|Washout (24h)|Withdrawal by Subject|1|||
155581813|NCT01530464|561555204|FG001|Washout (24h)|Withdrawal by Subject|0|||
155581814|NCT01530464|561555203|FG000|Washout (24h)|Withdrawal by Subject|0|||
155581815|NCT01530464|561555204|FG001|Washout (24h)|Withdrawal by Subject|1|||
155581816|NCT01709500|561555205|FG000|Overall Study|Randomized but not treated|0|||
155581817|NCT01709500|561555206|FG001|Overall Study|Randomized but not treated|1|||
155581818|NCT01709500|561555205|FG000|Overall Study|Adverse Event|5|||
155581819|NCT01709500|561555206|FG001|Overall Study|Adverse Event|1|||
155581820|NCT01709500|561555205|FG000|Overall Study|Poor compliance to protocol|2|||
155581821|NCT01709500|561555206|FG001|Overall Study|Poor compliance to protocol|1|||
155581822|NCT01709500|561555205|FG000|Overall Study|Other|3|||
155581823|NCT01709500|561555206|FG001|Overall Study|Other|1|||
155581824|NCT01709500|561555205|FG000|Overall Study|Related to IMP administration|1|||
155581825|NCT01709500|561555206|FG001|Overall Study|Related to IMP administration|0|||
155581826|NCT01709500|561555205|FG000|Overall Study|Treatment ongoing|156|||
155581827|NCT01709500|561555206|FG001|Overall Study|Treatment ongoing|78|||
155581828|NCT03539302|561555213|FG000|Overall Study|Spontaneous cardio version|0|||
155581829|NCT03539302|561555214|FG001|Overall Study|Spontaneous cardio version|0|||
155581830|NCT03539302|561555215|FG002|Overall Study|Spontaneous cardio version|0|||
155581831|NCT03539302|561555216|FG003|Overall Study|Spontaneous cardio version|0|||
155581832|NCT03539302|561555217|FG004|Overall Study|Spontaneous cardio version|0|||
155581833|NCT03539302|561555218|FG005|Overall Study|Spontaneous cardio version|1|||
155581834|NCT03539302|561555219|FG006|Overall Study|Spontaneous cardio version|1|||
155581835|NCT02107131|561555221|FG000|Overall Study|Lost to Follow-up|4|||
155581836|NCT02107131|561555222|FG001|Overall Study|Lost to Follow-up|4|||
155581837|NCT02107131|561555221|FG000|Overall Study|Physician Decision|1|||
155581838|NCT02107131|561555222|FG001|Overall Study|Physician Decision|0|||
155581839|NCT02107131|561555221|FG000|Overall Study|Withdrawal by Subject|2|||
155581840|NCT02107131|561555222|FG001|Overall Study|Withdrawal by Subject|0|||
155581841|NCT02107131|561555221|FG000|Overall Study|mental instability|1|||
155581842|NCT02107131|561555222|FG001|Overall Study|mental instability|0|||
155581843|NCT02107131|561555221|FG000|Overall Study|Death|0|||
155581844|NCT02107131|561555222|FG001|Overall Study|Death|1|||
155581845|NCT02107131|561555221|FG000|Overall Study|Protocol Violation|0|||
155581846|NCT02107131|561555222|FG001|Overall Study|Protocol Violation|4|||
155581847|NCT04314037|561555223|FG000|Treatment Period 2|Adverse Event|1|||
155581848|NCT04314037|561555224|FG001|Treatment Period 2|Adverse Event|0|||
155581849|NCT04314037|561555223|FG000|Treatment Period 3|Protocol Violation|1|||
155581850|NCT04314037|561555224|FG001|Treatment Period 3|Protocol Violation|0|||
155664296|NCT03937479|561866908|FG002|Overall Study|Protocol Violation|4|||
155664297|NCT03937479|561866909|FG003|Overall Study|Protocol Violation|3|||
155664298|NCT03937479|561866910|FG004|Overall Study|Protocol Violation|2|||
155664299|NCT03937479|561866906|FG000|Overall Study|Lost to Follow-up|0|||
155664300|NCT03937479|561866907|FG001|Overall Study|Lost to Follow-up|1|||
155664301|NCT03937479|561866908|FG002|Overall Study|Lost to Follow-up|0|||
155581851|NCT04314037|561555223|FG000|Treatment Period 3|Adverse Event|0|||
155581852|NCT04314037|561555224|FG001|Treatment Period 3|Adverse Event|1|||
155581853|NCT00856492|561555228|FG000|Overall Study|Ineligible or withdrew consent|1|||
155581854|NCT00856492|561555229|FG001|Overall Study|Ineligible or withdrew consent|1|||
155581855|NCT00856492|561555230|FG002|Overall Study|Ineligible or withdrew consent|2|||
155581856|NCT00739882|561556858|FG000|Double-blind Period|Adverse Event|1|||
155581857|NCT00739882|561556859|FG001|Double-blind Period|Adverse Event|2|||
155581858|NCT00739882|561556858|FG000|Double-blind Period|Protocol Violation|1|||
155581859|NCT00739882|561556859|FG001|Double-blind Period|Protocol Violation|0|||
155581860|NCT00739882|561556858|FG000|Double-blind Period|Lack of Efficacy|1|||
155581861|NCT00739882|561556859|FG001|Double-blind Period|Lack of Efficacy|1|||
155581862|NCT00739882|561556858|FG000|Double-blind Period|Other|16|||
155581863|NCT00739882|561556859|FG001|Double-blind Period|Other|8|||
155581864|NCT00739882|561556858|FG000|Open-label Period|Adverse Event|1|||
155581865|NCT00739882|561556859|FG001|Open-label Period|Adverse Event|0|||
155581866|NCT00739882|561556858|FG000|Open-label Period|Other|9|||
155581867|NCT00739882|561556859|FG001|Open-label Period|Other|5|||
155581868|NCT04021914|561556860|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
155581869|NCT00955409|561556861|FG000|Overall Study|Lack of Efficacy|1|||
155581870|NCT00955409|561556862|FG001|Overall Study|Lack of Efficacy|0|||
155581871|NCT00955409|561556863|FG002|Overall Study|Lack of Efficacy|0|||
155581872|NCT00955409|561556864|FG003|Overall Study|Lack of Efficacy|0|||
155581873|NCT00955409|561556865|FG004|Overall Study|Lack of Efficacy|0|||
155581874|NCT00955409|561556866|FG005|Overall Study|Lack of Efficacy|0|||
155581875|NCT00955409|561556867|FG006|Overall Study|Lack of Efficacy|0|||
155581876|NCT00955409|561556868|FG007|Overall Study|Lack of Efficacy|0|||
155581877|NCT00955409|561556869|FG008|Overall Study|Lack of Efficacy|0|||
155581878|NCT00955409|561556870|FG009|Overall Study|Lack of Efficacy|0|||
155581879|NCT00955409|561556861|FG000|Overall Study|Withdrawal by Subject|1|||
155581880|NCT00955409|561556862|FG001|Overall Study|Withdrawal by Subject|0|||
155581881|NCT00955409|561556863|FG002|Overall Study|Withdrawal by Subject|5|||
155581882|NCT00955409|561556864|FG003|Overall Study|Withdrawal by Subject|2|||
155581883|NCT00955409|561556865|FG004|Overall Study|Withdrawal by Subject|0|||
155581884|NCT00955409|561556866|FG005|Overall Study|Withdrawal by Subject|0|||
155581885|NCT00955409|561556867|FG006|Overall Study|Withdrawal by Subject|2|||
155581886|NCT00955409|561556868|FG007|Overall Study|Withdrawal by Subject|0|||
155581887|NCT00955409|561556869|FG008|Overall Study|Withdrawal by Subject|1|||
155581888|NCT00955409|561556870|FG009|Overall Study|Withdrawal by Subject|0|||
155581889|NCT00955409|561556861|FG000|Overall Study|Caregiver Request|2|||
155581890|NCT00955409|561556862|FG001|Overall Study|Caregiver Request|0|||
155581891|NCT00955409|561556863|FG002|Overall Study|Caregiver Request|6|||
155581892|NCT00955409|561556864|FG003|Overall Study|Caregiver Request|5|||
155581893|NCT00955409|561556865|FG004|Overall Study|Caregiver Request|0|||
155581894|NCT00955409|561556866|FG005|Overall Study|Caregiver Request|2|||
155581895|NCT00955409|561556867|FG006|Overall Study|Caregiver Request|3|||
155581896|NCT00955409|561556868|FG007|Overall Study|Caregiver Request|1|||
155581897|NCT00955409|561556869|FG008|Overall Study|Caregiver Request|3|||
155581898|NCT00955409|561556870|FG009|Overall Study|Caregiver Request|0|||
155581899|NCT00955409|561556861|FG000|Overall Study|Investigator Request|0|||
155581900|NCT00955409|561556862|FG001|Overall Study|Investigator Request|0|||
155581901|NCT00955409|561556863|FG002|Overall Study|Investigator Request|1|||
155581902|NCT00955409|561556864|FG003|Overall Study|Investigator Request|0|||
155581903|NCT00955409|561556865|FG004|Overall Study|Investigator Request|0|||
155581904|NCT00955409|561556866|FG005|Overall Study|Investigator Request|0|||
155581905|NCT00955409|561556867|FG006|Overall Study|Investigator Request|0|||
155581906|NCT00955409|561556868|FG007|Overall Study|Investigator Request|0|||
155581907|NCT00955409|561556869|FG008|Overall Study|Investigator Request|0|||
155581908|NCT00955409|561556870|FG009|Overall Study|Investigator Request|0|||
155581909|NCT00955409|561556861|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155581910|NCT00955409|561556862|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155581911|NCT00955409|561556863|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155581912|NCT00955409|561556864|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155581913|NCT00955409|561556865|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155581914|NCT00955409|561556866|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155581915|NCT00955409|561556867|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
155581916|NCT00955409|561556868|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
155581917|NCT00955409|561556869|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
155581918|NCT00955409|561556870|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
155581919|NCT00955409|561556861|FG000|Overall Study|Lost to Follow-up|0|||
155581920|NCT00955409|561556862|FG001|Overall Study|Lost to Follow-up|0|||
155581921|NCT00955409|561556863|FG002|Overall Study|Lost to Follow-up|1|||
155581922|NCT00955409|561556864|FG003|Overall Study|Lost to Follow-up|0|||
155581923|NCT00955409|561556865|FG004|Overall Study|Lost to Follow-up|0|||
155581924|NCT00955409|561556866|FG005|Overall Study|Lost to Follow-up|0|||
155581925|NCT00955409|561556867|FG006|Overall Study|Lost to Follow-up|1|||
155581926|NCT00955409|561556868|FG007|Overall Study|Lost to Follow-up|0|||
155581927|NCT00955409|561556869|FG008|Overall Study|Lost to Follow-up|0|||
155581928|NCT00955409|561556870|FG009|Overall Study|Lost to Follow-up|0|||
155581929|NCT00955409|561556861|FG000|Overall Study|Failed to Return|2|||
155581930|NCT00955409|561556862|FG001|Overall Study|Failed to Return|0|||
155581931|NCT00955409|561556863|FG002|Overall Study|Failed to Return|0|||
155581932|NCT00955409|561556864|FG003|Overall Study|Failed to Return|0|||
155581933|NCT00955409|561556865|FG004|Overall Study|Failed to Return|0|||
155581934|NCT00955409|561556866|FG005|Overall Study|Failed to Return|0|||
155581935|NCT00955409|561556867|FG006|Overall Study|Failed to Return|0|||
155581936|NCT00955409|561556868|FG007|Overall Study|Failed to Return|2|||
155581937|NCT00955409|561556869|FG008|Overall Study|Failed to Return|0|||
155581938|NCT00955409|561556870|FG009|Overall Study|Failed to Return|0|||
155581939|NCT00955409|561556861|FG000|Overall Study|Adverse Event (AE)|2|||
155581940|NCT00955409|561556862|FG001|Overall Study|Adverse Event (AE)|0|||
155581941|NCT00955409|561556863|FG002|Overall Study|Adverse Event (AE)|0|||
155581942|NCT00955409|561556864|FG003|Overall Study|Adverse Event (AE)|0|||
155581943|NCT00955409|561556865|FG004|Overall Study|Adverse Event (AE)|0|||
155581944|NCT00955409|561556866|FG005|Overall Study|Adverse Event (AE)|1|||
155581945|NCT00955409|561556867|FG006|Overall Study|Adverse Event (AE)|2|||
155581946|NCT00955409|561556868|FG007|Overall Study|Adverse Event (AE)|0|||
155581947|NCT00955409|561556869|FG008|Overall Study|Adverse Event (AE)|2|||
155581948|NCT00955409|561556870|FG009|Overall Study|Adverse Event (AE)|0|||
155581949|NCT00955409|561556861|FG000|Overall Study|Reason not Specified|2|||
155581950|NCT00955409|561556862|FG001|Overall Study|Reason not Specified|1|||
155581951|NCT00955409|561556863|FG002|Overall Study|Reason not Specified|13|||
155581952|NCT00955409|561556864|FG003|Overall Study|Reason not Specified|1|||
155581953|NCT00955409|561556865|FG004|Overall Study|Reason not Specified|2|||
155581954|NCT00955409|561556866|FG005|Overall Study|Reason not Specified|0|||
155581955|NCT00955409|561556867|FG006|Overall Study|Reason not Specified|16|||
155581956|NCT00955409|561556868|FG007|Overall Study|Reason not Specified|0|||
155581957|NCT00955409|561556869|FG008|Overall Study|Reason not Specified|8|||
155581958|NCT00955409|561556870|FG009|Overall Study|Reason not Specified|1|||
155581959|NCT00803790|561556871|FG000|Period 1|Adverse Event|0|||
155581960|NCT00803790|561556872|FG001|Period 1|Adverse Event|1|||
155581961|NCT00803790|561556873|FG002|Period 1|Adverse Event|0|||
155581962|NCT00803790|561556874|FG003|Period 1|Adverse Event|0|||
155581963|NCT00803790|561556871|FG000|Period 1|Lost to Follow-up|1|||
155581964|NCT00803790|561556872|FG001|Period 1|Lost to Follow-up|2|||
155581965|NCT00803790|561556873|FG002|Period 1|Lost to Follow-up|0|||
155581966|NCT00803790|561556874|FG003|Period 1|Lost to Follow-up|0|||
155581967|NCT00803790|561556871|FG000|Period 1|Withdrawal by Subject|8|||
155581968|NCT00803790|561556872|FG001|Period 1|Withdrawal by Subject|6|||
155581969|NCT00803790|561556873|FG002|Period 1|Withdrawal by Subject|0|||
155581970|NCT00803790|561556874|FG003|Period 1|Withdrawal by Subject|0|||
155581971|NCT00803790|561556871|FG000|Period 1|positive drug screen or personal reasons|0|||
155581972|NCT00803790|561556872|FG001|Period 1|positive drug screen or personal reasons|3|||
155581973|NCT00803790|561556873|FG002|Period 1|positive drug screen or personal reasons|0|||
155581974|NCT00803790|561556874|FG003|Period 1|positive drug screen or personal reasons|4|||
155581975|NCT00803790|561556871|FG000|Period 1|Protocol Violation|0|||
155664302|NCT03937479|561866909|FG003|Overall Study|Lost to Follow-up|1|||
155664303|NCT03937479|561866910|FG004|Overall Study|Lost to Follow-up|0|||
155664304|NCT03937479|561866906|FG000|Overall Study|Physician Decision|0|||
155664305|NCT03937479|561866907|FG001|Overall Study|Physician Decision|0|||
155664306|NCT03937479|561866908|FG002|Overall Study|Physician Decision|1|||
155664307|NCT03937479|561866909|FG003|Overall Study|Physician Decision|0|||
155664308|NCT03937479|561866910|FG004|Overall Study|Physician Decision|1|||
155664309|NCT00940602|561866913|FG000|Overall Study|Administrative problems|1|||
155664310|NCT00940602|561866914|FG001|Overall Study|Administrative problems|1|||
155664311|NCT00940602|561866913|FG000|Overall Study|Patient/guardian decision|13|||
155664312|NCT00940602|561866914|FG001|Overall Study|Patient/guardian decision|28|||
155664313|NCT00940602|561866913|FG000|Overall Study|Physician Decision|8|||
155664314|NCT00940602|561866914|FG001|Overall Study|Physician Decision|5|||
155664315|NCT00940602|561866913|FG000|Overall Study|Pregnancy|1|||
155664316|NCT00940602|561866914|FG001|Overall Study|Pregnancy|0|||
155664317|NCT00940602|561866913|FG000|Overall Study|Protocol Deviation (untreated)|1|||
155664318|NCT00940602|561866914|FG001|Overall Study|Protocol Deviation (untreated)|0|||
155664319|NCT00940602|561866913|FG000|Overall Study|Disease progression|8|||
155664320|NCT00940602|561866914|FG001|Overall Study|Disease progression|2|||
155664321|NCT00940602|561866913|FG000|Overall Study|Death|38|||
155664322|NCT00940602|561866914|FG001|Overall Study|Death|19|||
155664323|NCT00940602|561866913|FG000|Overall Study|Lost to Follow-up|3|||
155664324|NCT00940602|561866914|FG001|Overall Study|Lost to Follow-up|1|||
155664325|NCT00940602|561866913|FG000|Overall Study|Patient withdrew consent|26|||
155664326|NCT00940602|561866914|FG001|Overall Study|Patient withdrew consent|13|||
155664327|NCT00940602|561866913|FG000|Overall Study|Adverse Event|7|||
155664328|NCT00940602|561866914|FG001|Overall Study|Adverse Event|2|||
155664329|NCT00940602|561866913|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
155664330|NCT00940602|561866914|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
155664331|NCT02961244|561866916|FG000|Overall Study|Protocol Violation|0|||
155664332|NCT02961244|561866917|FG001|Overall Study|Protocol Violation|1|||
155664333|NCT02961244|561866916|FG000|Overall Study|Withdrawal by Subject|1|||
155664334|NCT02961244|561866917|FG001|Overall Study|Withdrawal by Subject|2|||
155664335|NCT02961244|561866916|FG000|Overall Study|Surgery plan change after study approval|0|||
155664336|NCT02961244|561866917|FG001|Overall Study|Surgery plan change after study approval|2|||
155664337|NCT02961244|561866916|FG000|Overall Study|Lost to Follow-up|0|||
155664338|NCT02961244|561866917|FG001|Overall Study|Lost to Follow-up|2|||
155664339|NCT02961244|561866916|FG000|Overall Study|İnadequate data|0|||
155664340|NCT02961244|561866917|FG001|Overall Study|İnadequate data|2|||
155664341|NCT02951780|561866918|FG000|Period 1|Adverse Event|0|||
155664342|NCT02951780|561866919|FG001|Period 1|Adverse Event|0|||
155664343|NCT02951780|561866920|FG002|Period 1|Adverse Event|0|||
155664344|NCT02951780|561866921|FG003|Period 1|Adverse Event|1|||
155664345|NCT02951780|561866922|FG004|Period 1|Adverse Event|0|||
155581976|NCT00803790|561556872|FG001|Period 1|Protocol Violation|0|||
155581977|NCT00803790|561556873|FG002|Period 1|Protocol Violation|1|||
155581978|NCT00803790|561556874|FG003|Period 1|Protocol Violation|0|||
155664346|NCT02951780|561866923|FG005|Period 1|Adverse Event|0|||
155664347|NCT02951780|561866924|FG006|Period 1|Adverse Event|0|||
155581979|NCT00803790|561556871|FG000|Period 2|Adverse Event|0|||
155581980|NCT00803790|561556872|FG001|Period 2|Adverse Event|0|||
155581981|NCT00803790|561556873|FG002|Period 2|Adverse Event|1|||
155581982|NCT00803790|561556874|FG003|Period 2|Adverse Event|1|||
155581983|NCT00803790|561556871|FG000|Period 2|Withdrawal by Subject|1|||
155581984|NCT00803790|561556872|FG001|Period 2|Withdrawal by Subject|0|||
155581985|NCT00803790|561556873|FG002|Period 2|Withdrawal by Subject|0|||
155581986|NCT00803790|561556874|FG003|Period 2|Withdrawal by Subject|0|||
155581987|NCT00803790|561556871|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
155581988|NCT00803790|561556872|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
155581989|NCT00803790|561556873|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
155581990|NCT00803790|561556874|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
155581991|NCT04710576|561556875|FG000|Overall Study|Participants still in the study|73|||
155581992|NCT04710576|561556876|FG001|Overall Study|Participants still in the study|70|||
155581993|NCT04710576|561556877|FG002|Overall Study|Participants still in the study|60|||
155581994|NCT04710576|561556875|FG000|Overall Study|Death|2|||
155581995|NCT04710576|561556876|FG001|Overall Study|Death|7|||
155581996|NCT04710576|561556877|FG002|Overall Study|Death|12|||
155581997|NCT04710576|561556875|FG000|Overall Study|Withdrawal by Subject|4|||
155581998|NCT04710576|561556876|FG001|Overall Study|Withdrawal by Subject|3|||
155581999|NCT04710576|561556877|FG002|Overall Study|Withdrawal by Subject|7|||
155582000|NCT04710576|561556875|FG000|Overall Study|Sponsor decision|1|||
155582001|NCT04710576|561556876|FG001|Overall Study|Sponsor decision|0|||
155582002|NCT04710576|561556877|FG002|Overall Study|Sponsor decision|0|||
155582003|NCT04162847|561556878|FG000|Overall Study|Withdrawal by Subject|7|||
155582004|NCT04162847|561556879|FG001|Overall Study|Withdrawal by Subject|1|||
155582005|NCT05573464|561556880|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
155582006|NCT05573464|561556881|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
155582007|NCT05573464|561556880|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
155582008|NCT05573464|561556881|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
155582009|NCT05573464|561556880|FG000|12-week Treatment Period|Protocol Violation|3|||
155582010|NCT05573464|561556881|FG001|12-week Treatment Period|Protocol Violation|1|||
155582011|NCT05573464|561556880|FG000|12-week Treatment Period|Physician Decision|1|||
155582012|NCT05573464|561556881|FG001|12-week Treatment Period|Physician Decision|2|||
155582013|NCT05573464|561556880|FG000|12-week Treatment Period|Lost to Follow-up|2|||
155582014|NCT05573464|561556881|FG001|12-week Treatment Period|Lost to Follow-up|0|||
155582015|NCT05573464|561556880|FG000|12-week Treatment Period|Adverse Event|20|||
155582016|NCT05573464|561556881|FG001|12-week Treatment Period|Adverse Event|9|||
155582017|NCT05573464|561556880|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
155582018|NCT05573464|561556881|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
155582019|NCT05573464|561556880|FG000|12-week Treatment Period|Randomised, not treated|0|||
155582020|NCT05573464|561556881|FG001|12-week Treatment Period|Randomised, not treated|1|||
155582021|NCT05573464|561556880|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
155582022|NCT05573464|561556881|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
155582023|NCT05573464|561556880|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
155582024|NCT05573464|561556881|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
155582025|NCT05573464|561556880|FG000|52-week Treatment Period|Protocol Violation|1|||
155582026|NCT05573464|561556881|FG001|52-week Treatment Period|Protocol Violation|1|||
155582027|NCT05573464|561556880|FG000|52-week Treatment Period|Physician Decision|2|||
155582028|NCT05573464|561556881|FG001|52-week Treatment Period|Physician Decision|2|||
155582029|NCT05573464|561556880|FG000|52-week Treatment Period|Lost to Follow-up|1|||
155582030|NCT05573464|561556881|FG001|52-week Treatment Period|Lost to Follow-up|1|||
155582031|NCT05573464|561556880|FG000|52-week Treatment Period|Adverse Event|11|||
155582032|NCT05573464|561556881|FG001|52-week Treatment Period|Adverse Event|8|||
155582033|NCT05573464|561556880|FG000|52-week Treatment Period|Death|1|||
155582034|NCT05573464|561556881|FG001|52-week Treatment Period|Death|1|||
155582035|NCT05734157|561556882|FG000|Overall Study|Death|3|||
155582036|NCT05734157|561556882|FG000|Overall Study|Withdrawal by Subject|2|||
155582037|NCT05734157|561556882|FG000|Overall Study|Lost to Follow-up|1|||
155664348|NCT02951780|561866925|FG007|Period 1|Adverse Event|0|||
155664349|NCT02951780|561866926|FG008|Period 1|Adverse Event|0|||
155664350|NCT02951780|561866918|FG000|Period 1|Scheduling Conflicts|0|||
155664351|NCT02951780|561866919|FG001|Period 1|Scheduling Conflicts|0|||
155664352|NCT02951780|561866920|FG002|Period 1|Scheduling Conflicts|0|||
155664353|NCT02951780|561866921|FG003|Period 1|Scheduling Conflicts|0|||
155664354|NCT02951780|561866922|FG004|Period 1|Scheduling Conflicts|0|||
155664355|NCT02951780|561866923|FG005|Period 1|Scheduling Conflicts|0|||
155664356|NCT02951780|561866924|FG006|Period 1|Scheduling Conflicts|0|||
155664357|NCT02951780|561866925|FG007|Period 1|Scheduling Conflicts|1|||
155664358|NCT02951780|561866926|FG008|Period 1|Scheduling Conflicts|0|||
155664359|NCT02951780|561866918|FG000|Period 2|Scheduling Conflicts|0|||
155664360|NCT02951780|561866919|FG001|Period 2|Scheduling Conflicts|0|||
155664361|NCT02951780|561866920|FG002|Period 2|Scheduling Conflicts|0|||
155664362|NCT02951780|561866921|FG003|Period 2|Scheduling Conflicts|0|||
155664363|NCT02951780|561866922|FG004|Period 2|Scheduling Conflicts|0|||
155664364|NCT02951780|561866923|FG005|Period 2|Scheduling Conflicts|0|||
155664365|NCT02951780|561866924|FG006|Period 2|Scheduling Conflicts|0|||
155664366|NCT02951780|561866925|FG007|Period 2|Scheduling Conflicts|1|||
155664367|NCT02951780|561866926|FG008|Period 2|Scheduling Conflicts|0|||
155664368|NCT01957865|561866927|FG000|Overall Study|Found HIV negative|0|||
155664369|NCT01957865|561866928|FG001|Overall Study|Found HIV negative|0|||
155664370|NCT01957865|561866929|FG002|Overall Study|Found HIV negative|1|||
155664371|NCT01957865|561866927|FG000|Overall Study|Lost to Follow-up|0|||
155664372|NCT01957865|561866928|FG001|Overall Study|Lost to Follow-up|2|||
155664373|NCT01957865|561866929|FG002|Overall Study|Lost to Follow-up|2|||
155664374|NCT01082614|561866930|FG000|Overall Study|Adverse Event|1|||
155664375|NCT01082614|561866931|FG001|Overall Study|Adverse Event|4|||
155664376|NCT01082614|561866930|FG000|Overall Study|Equipment Malfunction|0|||
155664377|NCT01082614|561866931|FG001|Overall Study|Equipment Malfunction|1|||
155664378|NCT01082614|561866930|FG000|Overall Study|Physician Decision|2|||
155664379|NCT01082614|561866931|FG001|Overall Study|Physician Decision|0|||
155664380|NCT00811720|561866932|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
155664381|NCT00811720|561866933|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
155664382|NCT00811720|561866932|FG000|All Treated Patients|Adverse Event|20|||
155664383|NCT00811720|561866933|FG001|All Treated Patients|Adverse Event|62|||
155664384|NCT00811720|561866932|FG000|All Treated Patients|Lack of Efficacy|22|||
155664385|NCT00811720|561866933|FG001|All Treated Patients|Lack of Efficacy|18|||
155664386|NCT00811720|561866932|FG000|All Treated Patients|Non-compliance|0|||
155664387|NCT00811720|561866933|FG001|All Treated Patients|Non-compliance|14|||
155664388|NCT00811720|561866932|FG000|All Treated Patients|Protocol Violation|9|||
155664389|NCT00811720|561866933|FG001|All Treated Patients|Protocol Violation|16|||
155664390|NCT00811720|561866932|FG000|All Treated Patients|Withdrawal by Subject|28|||
155664391|NCT00811720|561866933|FG001|All Treated Patients|Withdrawal by Subject|34|||
155664392|NCT00811720|561866932|FG000|All Treated Patients|Lost to Follow-up|10|||
155664393|NCT00811720|561866933|FG001|All Treated Patients|Lost to Follow-up|16|||
155664394|NCT00811720|561866932|FG000|All Treated Patients|Other Reason|7|||
155664395|NCT00811720|561866933|FG001|All Treated Patients|Other Reason|4|||
155664396|NCT03783780|561866934|FG000|Overall Study|Withdrawn prior to completion|1|||
155664397|NCT03768427|561866935|FG000|Overall Study|Death|0|||
155664398|NCT03768427|561866936|FG001|Overall Study|Death|0|||
155664399|NCT03768427|561866937|FG002|Overall Study|Death|1|||
155664400|NCT03768427|561866938|FG003|Overall Study|Death|0|||
155664401|NCT03768427|561866935|FG000|Overall Study|Lost to Follow-up|2|||
155664402|NCT03768427|561866936|FG001|Overall Study|Lost to Follow-up|0|||
155664403|NCT03768427|561866937|FG002|Overall Study|Lost to Follow-up|0|||
155664404|NCT03768427|561866938|FG003|Overall Study|Lost to Follow-up|0|||
155664405|NCT03768427|561866935|FG000|Overall Study|Physician Decision|3|||
155664406|NCT03768427|561866936|FG001|Overall Study|Physician Decision|2|||
155664407|NCT03768427|561866937|FG002|Overall Study|Physician Decision|4|||
155664408|NCT03768427|561866938|FG003|Overall Study|Physician Decision|4|||
155664409|NCT03768427|561866935|FG000|Overall Study|Withdrawal by Subject|7|||
155664410|NCT03768427|561866936|FG001|Overall Study|Withdrawal by Subject|2|||
155664411|NCT03768427|561866937|FG002|Overall Study|Withdrawal by Subject|6|||
155664412|NCT03768427|561866938|FG003|Overall Study|Withdrawal by Subject|7|||
155664413|NCT04540367|561866948|FG000|Overall Study|Withdrawal by Subject|0|||
155664414|NCT04540367|561866949|FG001|Overall Study|Withdrawal by Subject|0|||
155664415|NCT04540367|561866950|FG002|Overall Study|Withdrawal by Subject|0|||
155664416|NCT04540367|561866951|FG003|Overall Study|Withdrawal by Subject|2|||
155664417|NCT04540367|561866948|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
155664418|NCT04540367|561866949|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
155664419|NCT04540367|561866950|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
155664420|NCT04540367|561866951|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
155664421|NCT04540367|561866948|FG000|Overall Study|Adverse Event|0|||
155664422|NCT04540367|561866949|FG001|Overall Study|Adverse Event|0|||
155664423|NCT04540367|561866950|FG002|Overall Study|Adverse Event|1|||
155582038|NCT05734157|561556882|FG000|Overall Study|Telephone call|3|||
155582039|NCT01415518|561556883|FG000|Overall Study|Withdrawal by Subject|2|||
155582040|NCT01415518|561556884|FG001|Overall Study|Withdrawal by Subject|12|||
155582041|NCT01415518|561556883|FG000|Overall Study|Protocol Violation|6|||
155582042|NCT01415518|561556884|FG001|Overall Study|Protocol Violation|8|||
155582043|NCT01415518|561556883|FG000|Overall Study|Lost to Follow-up|3|||
155582044|NCT01415518|561556884|FG001|Overall Study|Lost to Follow-up|5|||
155582045|NCT01415518|561556883|FG000|Overall Study|Adverse Event|3|||
155582046|NCT01415518|561556884|FG001|Overall Study|Adverse Event|4|||
155582047|NCT01415518|561556883|FG000|Overall Study|Death|1|||
155582048|NCT01415518|561556884|FG001|Overall Study|Death|1|||
155582049|NCT01415518|561556883|FG000|Overall Study|Condition under Investigation Worsened|1|||
155582050|NCT01415518|561556884|FG001|Overall Study|Condition under Investigation Worsened|1|||
155582051|NCT02068508|561556888|FG000|Overall Study|Case report forms uncollected|27|||
155582052|NCT02068508|561556888|FG000|Overall Study|Patient did not visit the study site|1|||
155582053|NCT02068508|561556888|FG000|Overall Study|Protocol Violation|4|||
155582054|NCT00813150|561556889|FG000|Treatment Period|Adverse Event|16|||
155582055|NCT00813150|561556890|FG001|Treatment Period|Adverse Event|15|||
155582056|NCT00813150|561556889|FG000|Treatment Period|Death|2|||
155582057|NCT00813150|561556890|FG001|Treatment Period|Death|0|||
155582058|NCT00813150|561556889|FG000|Treatment Period|Progressive disease|1|||
155582059|NCT00813150|561556890|FG001|Treatment Period|Progressive disease|0|||
155582060|NCT00813150|561556889|FG000|Treatment Period|Complete response|0|||
155582061|NCT00813150|561556890|FG001|Treatment Period|Complete response|1|||
155582062|NCT00813150|561556889|FG000|Treatment Period|Stable disease|1|||
155582063|NCT00813150|561556890|FG001|Treatment Period|Stable disease|2|||
155582064|NCT00813150|561556889|FG000|Treatment Period|Protocol Violation|3|||
155582065|NCT00813150|561556890|FG001|Treatment Period|Protocol Violation|4|||
155582066|NCT00813150|561556889|FG000|Treatment Period|Withdrawal by Subject|5|||
155582067|NCT00813150|561556890|FG001|Treatment Period|Withdrawal by Subject|3|||
155582068|NCT00813150|561556889|FG000|Treatment Period|Non compliance|0|||
155582069|NCT00813150|561556890|FG001|Treatment Period|Non compliance|1|||
155582070|NCT00813150|561556889|FG000|Treatment Period|Reason not specified|3|||
155582071|NCT00813150|561556890|FG001|Treatment Period|Reason not specified|4|||
155582072|NCT00813150|561556889|FG000|Treatment Period|Data not available|1|||
155582073|NCT00813150|561556890|FG001|Treatment Period|Data not available|2|||
155582074|NCT00813150|561556889|FG000|Long Term Follow-up|Death|0|||
155582075|NCT00813150|561556890|FG001|Long Term Follow-up|Death|4|||
155582076|NCT00813150|561556889|FG000|Long Term Follow-up|Other|0|||
155582077|NCT00813150|561556890|FG001|Long Term Follow-up|Other|3|||
155582078|NCT00813150|561556889|FG000|Long Term Follow-up|Lost to Follow-up|2|||
155582079|NCT00813150|561556890|FG001|Long Term Follow-up|Lost to Follow-up|0|||
155582080|NCT00813150|561556889|FG000|Long Term Follow-up|Progression/Relapse|22|||
155582081|NCT00813150|561556890|FG001|Long Term Follow-up|Progression/Relapse|24|||
155582082|NCT00210210|561556891|FG000|Overall Study|Withdrawal by Subject|3|||
155582083|NCT00210210|561556892|FG001|Overall Study|Withdrawal by Subject|2|||
155582084|NCT00210210|561556891|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
155582085|NCT00210210|561556892|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
155582086|NCT02445248|561556893|FG000|Overall Study|Death|45|||
155582087|NCT02445248|561556894|FG001|Overall Study|Death|12|||
155582088|NCT02445248|561556893|FG000|Overall Study|Progressive disease|13|||
155582089|NCT02445248|561556894|FG001|Overall Study|Progressive disease|1|||
155582090|NCT02445248|561556893|FG000|Overall Study|Subject decision|8|||
155582091|NCT02445248|561556894|FG001|Overall Study|Subject decision|0|||
155582092|NCT02445248|561556893|FG000|Overall Study|Physician Decision|5|||
155582093|NCT02445248|561556894|FG001|Overall Study|Physician Decision|0|||
155582094|NCT02445248|561556893|FG000|Overall Study|Adverse Event|1|||
155582095|NCT02445248|561556894|FG001|Overall Study|Adverse Event|0|||
155582096|NCT02445248|561556893|FG000|Overall Study|Lost to Follow-up|1|||
155582097|NCT02445248|561556894|FG001|Overall Study|Lost to Follow-up|0|||
155582098|NCT01217112|561556895|FG000|Overall Study|Adverse Event|0|||
155582099|NCT01217112|561556896|FG001|Overall Study|Adverse Event|2|||
155582100|NCT01217112|561556897|FG002|Overall Study|Adverse Event|0|||
155582101|NCT01217112|561556898|FG003|Overall Study|Adverse Event|2|||
155582102|NCT01217112|561556899|FG004|Overall Study|Adverse Event|0|||
155582103|NCT01217112|561556895|FG000|Overall Study|Withdrawal by Subject|0|||
155582104|NCT01217112|561556896|FG001|Overall Study|Withdrawal by Subject|0|||
155582105|NCT01217112|561556897|FG002|Overall Study|Withdrawal by Subject|1|||
155582106|NCT01217112|561556898|FG003|Overall Study|Withdrawal by Subject|0|||
155582107|NCT01217112|561556899|FG004|Overall Study|Withdrawal by Subject|0|||
155582108|NCT01217112|561556895|FG000|Overall Study|Physician Decision|0|||
155582109|NCT01217112|561556896|FG001|Overall Study|Physician Decision|0|||
155582110|NCT01217112|561556897|FG002|Overall Study|Physician Decision|0|||
155582111|NCT01217112|561556898|FG003|Overall Study|Physician Decision|0|||
155582112|NCT01217112|561556899|FG004|Overall Study|Physician Decision|1|||
155582113|NCT02596971|561556902|FG000|Overall Study|Death|5|||
155582114|NCT02596971|561556903|FG001|Overall Study|Death|1|||
155582115|NCT02596971|561556904|FG002|Overall Study|Death|5|||
155582116|NCT02596971|561556902|FG000|Overall Study|Withdrawal by Subject|5|||
155582117|NCT02596971|561556903|FG001|Overall Study|Withdrawal by Subject|1|||
155582118|NCT02596971|561556904|FG002|Overall Study|Withdrawal by Subject|4|||
155582119|NCT01401361|561556905|FG000|Overall Study|Withdrawal by Subject|16|||
155582120|NCT01401361|561556905|FG000|Overall Study|Lack of Efficacy|6|||
155582121|NCT01401361|561556905|FG000|Overall Study|Physician Decision|1|||
155582122|NCT01401361|561556905|FG000|Overall Study|Lost to Follow-up|3|||
155582123|NCT01401361|561556905|FG000|Overall Study|Subject/family decision post procedure|2|||
155582124|NCT02764762|561556908|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155582125|NCT02764762|561556908|FG000|Overall Study|Lost to Follow-up|4|||
155582126|NCT02764762|561556908|FG000|Overall Study|Voluntary Withdrawal|8|||
155582127|NCT02764762|561556908|FG000|Overall Study|Site Termination|1|||
155582128|NCT02764762|561556908|FG000|Overall Study|Lack of Efficacy|16|||
155582129|NCT02764762|561556908|FG000|Overall Study|Reason not Specified|1|||
155582130|NCT00471081|561556912|FG000|Active Phase|Protocol Violation|1|||
155582131|NCT00471081|561556913|FG001|Active Phase|Protocol Violation|1|||
155582132|NCT00471081|561556912|FG000|Active Phase|Withdrawal by Subject|0|||
155582133|NCT00471081|561556913|FG001|Active Phase|Withdrawal by Subject|3|||
155582134|NCT00471081|561556912|FG000|Active Phase|Lost to Follow-up|0|||
155582135|NCT00471081|561556913|FG001|Active Phase|Lost to Follow-up|1|||
155582136|NCT00471081|561556912|FG000|Active Phase|Lost health plan/insurance|1|||
155582137|NCT00471081|561556913|FG001|Active Phase|Lost health plan/insurance|8|||
155582138|NCT00471081|561556912|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
155582139|NCT00471081|561556913|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
155582140|NCT00471081|561556912|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
155582141|NCT00471081|561556913|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
155582142|NCT00471081|561556912|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
155582143|NCT00471081|561556913|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
155582144|NCT02844933|561556914|FG000|Overall Study|Discontinued due to premature termination of study|3|||
155582145|NCT02844933|561556915|FG001|Overall Study|Discontinued due to premature termination of study|2|||
155582146|NCT01479465|561556916|FG000|Overall Study|Disease Progression|9|||
155582147|NCT01479465|561556917|FG001|Overall Study|Disease Progression|61|||
155582148|NCT01479465|561556918|FG002|Overall Study|Disease Progression|65|||
155582149|NCT01479465|561556919|FG003|Overall Study|Disease Progression|70|||
155582150|NCT01479465|561556916|FG000|Overall Study|Study Discontinued by Sponsor|0|||
155582151|NCT01479465|561556917|FG001|Overall Study|Study Discontinued by Sponsor|7|||
155582152|NCT01479465|561556918|FG002|Overall Study|Study Discontinued by Sponsor|5|||
155582153|NCT01479465|561556919|FG003|Overall Study|Study Discontinued by Sponsor|3|||
155582154|NCT01479465|561556916|FG000|Overall Study|Adverse Event|0|||
155582155|NCT01479465|561556917|FG001|Overall Study|Adverse Event|3|||
155582156|NCT01479465|561556918|FG002|Overall Study|Adverse Event|6|||
155582157|NCT01479465|561556919|FG003|Overall Study|Adverse Event|4|||
155582158|NCT01479465|561556916|FG000|Overall Study|Investigator Discretion|1|||
155582159|NCT01479465|561556917|FG001|Overall Study|Investigator Discretion|4|||
155582160|NCT01479465|561556918|FG002|Overall Study|Investigator Discretion|2|||
155582161|NCT01479465|561556919|FG003|Overall Study|Investigator Discretion|4|||
155582162|NCT01479465|561556916|FG000|Overall Study|Subject Request|1|||
155582163|NCT01479465|561556917|FG001|Overall Study|Subject Request|3|||
155582164|NCT01479465|561556918|FG002|Overall Study|Subject Request|4|||
155582165|NCT01479465|561556919|FG003|Overall Study|Subject Request|2|||
155582166|NCT01479465|561556916|FG000|Overall Study|Subject Withdrew Consent|0|||
155582167|NCT01479465|561556917|FG001|Overall Study|Subject Withdrew Consent|5|||
155582168|NCT01479465|561556918|FG002|Overall Study|Subject Withdrew Consent|2|||
155582169|NCT01479465|561556919|FG003|Overall Study|Subject Withdrew Consent|1|||
155582170|NCT01479465|561556916|FG000|Overall Study|Protocol Violation|0|||
155582171|NCT01479465|561556917|FG001|Overall Study|Protocol Violation|1|||
155582172|NCT01479465|561556918|FG002|Overall Study|Protocol Violation|1|||
155582173|NCT01479465|561556919|FG003|Overall Study|Protocol Violation|0|||
155582174|NCT01479465|561556916|FG000|Overall Study|Death|0|||
155582175|NCT01479465|561556917|FG001|Overall Study|Death|0|||
155582176|NCT01479465|561556918|FG002|Overall Study|Death|0|||
155582177|NCT01479465|561556919|FG003|Overall Study|Death|1|||
155582178|NCT01479465|561556916|FG000|Overall Study|Lost to Follow-up|0|||
155582179|NCT01479465|561556917|FG001|Overall Study|Lost to Follow-up|0|||
155582180|NCT01479465|561556918|FG002|Overall Study|Lost to Follow-up|1|||
155582181|NCT01479465|561556919|FG003|Overall Study|Lost to Follow-up|0|||
155582182|NCT01892501|561556920|FG000|Overall Study|Protocol Violation|2|||
155582183|NCT01892501|561556920|FG000|Overall Study|Puncture not carried out|9|||
155582184|NCT01892501|561556920|FG000|Overall Study|Radiological monitoring not carried out|5|||
155582185|NCT01892501|561556920|FG000|Overall Study|Non-contributory histological result|12|||
155582186|NCT02393950|561556928|FG000|Overall Study|Adverse Event|1|||
155582187|NCT02393950|561556929|FG001|Overall Study|Adverse Event|0|||
155582188|NCT02393950|561556928|FG000|Overall Study|Withdrawal by Subject|0|||
155582189|NCT02393950|561556929|FG001|Overall Study|Withdrawal by Subject|1|||
155582190|NCT04335123|561556930|FG000|Overall Study|Withdrawal by Subject|2|||
155582191|NCT04335123|561556931|FG001|Overall Study|Withdrawal by Subject|0|||
155582192|NCT04335123|561556930|FG000|Overall Study|Physician Decision|2|||
155582193|NCT04335123|561556931|FG001|Overall Study|Physician Decision|0|||
155582194|NCT05486091|561556932|FG000|Overall Study|Withdrawal by Subject|1|||
155582195|NCT05486091|561556932|FG000|Overall Study|Lost to Follow-up|2|||
155582196|NCT00370552|561556933|FG000|Overall Study|Adverse Event|2|||
155582197|NCT00370552|561556934|FG001|Overall Study|Adverse Event|2|||
155582198|NCT00370552|561556935|FG002|Overall Study|Adverse Event|2|||
155582199|NCT00370552|561556933|FG000|Overall Study|Disease progression|23|||
155582200|NCT00370552|561556934|FG001|Overall Study|Disease progression|23|||
155582201|NCT00370552|561556935|FG002|Overall Study|Disease progression|15|||
155582202|NCT00370552|561556933|FG000|Overall Study|Maximum clinical benefit|3|||
155582203|NCT00370552|561556934|FG001|Overall Study|Maximum clinical benefit|5|||
155582204|NCT00370552|561556935|FG002|Overall Study|Maximum clinical benefit|5|||
155582205|NCT00370552|561556933|FG000|Overall Study|Poor or noncompliance|0|||
155582206|NCT00370552|561556934|FG001|Overall Study|Poor or noncompliance|0|||
155582207|NCT00370552|561556935|FG002|Overall Study|Poor or noncompliance|1|||
155582208|NCT00370552|561556933|FG000|Overall Study|Study drug toxicity|11|||
155582209|NCT00370552|561556934|FG001|Overall Study|Study drug toxicity|8|||
155582210|NCT00370552|561556935|FG002|Overall Study|Study drug toxicity|6|||
155582211|NCT00370552|561556933|FG000|Overall Study|Withdrawal by Subject|2|||
155582212|NCT00370552|561556934|FG001|Overall Study|Withdrawal by Subject|0|||
155582213|NCT00370552|561556935|FG002|Overall Study|Withdrawal by Subject|1|||
155582214|NCT00370552|561556933|FG000|Overall Study|Still on treatment|1|||
155582215|NCT00370552|561556934|FG001|Overall Study|Still on treatment|3|||
155582216|NCT00370552|561556935|FG002|Overall Study|Still on treatment|2|||
155582217|NCT00370552|561556933|FG000|Overall Study|Never treated|1|||
155582218|NCT00370552|561556934|FG001|Overall Study|Never treated|0|||
155582219|NCT00370552|561556935|FG002|Overall Study|Never treated|0|||
155582220|NCT00370552|561556933|FG000|Overall Study|Physician Decision|1|||
155582221|NCT00370552|561556934|FG001|Overall Study|Physician Decision|1|||
155582222|NCT00370552|561556935|FG002|Overall Study|Physician Decision|0|||
155582223|NCT00370552|561556933|FG000|Overall Study|Investigator decision|2|||
155582224|NCT00370552|561556934|FG001|Overall Study|Investigator decision|1|||
155582225|NCT00370552|561556935|FG002|Overall Study|Investigator decision|0|||
155582226|NCT00370552|561556933|FG000|Overall Study|High risk of allergic reaction|0|||
155582227|NCT00370552|561556934|FG001|Overall Study|High risk of allergic reaction|1|||
155582228|NCT00370552|561556935|FG002|Overall Study|High risk of allergic reaction|0|||
155582229|NCT00370552|561556933|FG000|Overall Study|Planned radiation for palliation|0|||
155582230|NCT00370552|561556934|FG001|Overall Study|Planned radiation for palliation|1|||
155582231|NCT00370552|561556935|FG002|Overall Study|Planned radiation for palliation|0|||
155582232|NCT01651117|561556947|FG000|Overall Study|Death|2|||
155582233|NCT01651117|561556948|FG001|Overall Study|Death|3|||
155582234|NCT01651117|561556949|FG002|Overall Study|Death|2|||
155582235|NCT01651117|561556950|FG003|Overall Study|Death|2|||
155582236|NCT03871543|561556951|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
155582237|NCT03871543|561556951|FG000|Period 1|Investigator Error|1|||
155582238|NCT03871543|561556951|FG000|Period 1|Protocol Violation|2|||
155582239|NCT03871543|561556951|FG000|Period 1|COVID-19 Related|1|||
155582240|NCT03871543|561556951|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
155582241|NCT03871543|561556951|FG000|Period 1|Withdrawal by Subject|10|||
155582242|NCT03871543|561556951|FG000|Period 2|Adverse Event|1|||
155582243|NCT03871543|561556951|FG000|Period 2|Withdrawal by Subject|1|||
155582244|NCT01894919|561556952|FG000|Overall Study|Withdrawal by Subject|1|||
155582245|NCT01894919|561556953|FG001|Overall Study|Withdrawal by Subject|0|||
155582246|NCT01894919|561556954|FG002|Overall Study|Withdrawal by Subject|0|||
155582247|NCT01894919|561556955|FG003|Overall Study|Withdrawal by Subject|0|||
155582248|NCT01894919|561556956|FG004|Overall Study|Withdrawal by Subject|1|||
155582249|NCT01894919|561556957|FG005|Overall Study|Withdrawal by Subject|0|||
155582250|NCT01894919|561556958|FG006|Overall Study|Withdrawal by Subject|0|||
155582251|NCT01894919|561556959|FG007|Overall Study|Withdrawal by Subject|0|||
155582252|NCT01894919|561556960|FG008|Overall Study|Withdrawal by Subject|0|||
155582253|NCT01894919|561556961|FG009|Overall Study|Withdrawal by Subject|1|||
155582254|NCT01894919|561556962|FG010|Overall Study|Withdrawal by Subject|1|||
155582255|NCT01894919|561556963|FG011|Overall Study|Withdrawal by Subject|0|||
155582256|NCT01894919|561556964|FG012|Overall Study|Withdrawal by Subject|0|||
155582257|NCT01894919|561556952|FG000|Overall Study|Adverse Event|0|||
155582258|NCT01894919|561556953|FG001|Overall Study|Adverse Event|0|||
155582259|NCT01894919|561556954|FG002|Overall Study|Adverse Event|0|||
155582260|NCT01894919|561556955|FG003|Overall Study|Adverse Event|0|||
155582261|NCT01894919|561556956|FG004|Overall Study|Adverse Event|0|||
155582262|NCT01894919|561556957|FG005|Overall Study|Adverse Event|0|||
155582263|NCT01894919|561556958|FG006|Overall Study|Adverse Event|0|||
155582264|NCT01894919|561556959|FG007|Overall Study|Adverse Event|0|||
155664424|NCT04540367|561866951|FG003|Overall Study|Adverse Event|1|||
155664425|NCT00165789|561866955|FG000|Overall Study|Adverse Event|0|||
155664426|NCT00165789|561866956|FG001|Overall Study|Adverse Event|3|||
155664427|NCT00165789|561866957|FG002|Overall Study|Adverse Event|0|||
155664428|NCT00165789|561866958|FG003|Overall Study|Adverse Event|12|||
155664429|NCT00165789|561866955|FG000|Overall Study|Withdrawal by Subject|0|||
155664430|NCT00165789|561866956|FG001|Overall Study|Withdrawal by Subject|1|||
155664431|NCT00165789|561866957|FG002|Overall Study|Withdrawal by Subject|1|||
155664432|NCT00165789|561866958|FG003|Overall Study|Withdrawal by Subject|2|||
155664433|NCT02031302|561866959|FG000|Overall Study|Death|115|||
155664434|NCT02031302|561866960|FG001|Overall Study|Death|0|||
155664435|NCT02031302|561866959|FG000|Overall Study|Not treated with study valve system|18|||
155664436|NCT02031302|561866960|FG001|Overall Study|Not treated with study valve system|0|||
155664437|NCT02031302|561866959|FG000|Overall Study|Missed Follow Up|27|||
155664438|NCT02031302|561866960|FG001|Overall Study|Missed Follow Up|0|||
155664439|NCT02031302|561866959|FG000|Overall Study|Lost to Follow-up|4|||
155664440|NCT02031302|561866960|FG001|Overall Study|Lost to Follow-up|0|||
155664441|NCT01816984|561866961|FG000|Overall Study|declining health status|1|||
155664442|NCT05899829|561866962|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
155664443|NCT05899829|561866963|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
155664444|NCT05899829|561866962|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
155664445|NCT05899829|561866963|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
155664446|NCT02121509|561866964|FG000|Washout Period (35 Days)|Adverse Event|1|||
155664447|NCT02121509|561866965|FG001|Washout Period (35 Days)|Adverse Event|1|||
155664448|NCT02121509|561866966|FG002|Washout Period (35 Days)|Adverse Event|0|||
155664449|NCT02121509|561866967|FG003|Washout Period (35 Days)|Adverse Event|0|||
155582265|NCT01894919|561556960|FG008|Overall Study|Adverse Event|0|||
155582266|NCT01894919|561556961|FG009|Overall Study|Adverse Event|0|||
155582267|NCT01894919|561556962|FG010|Overall Study|Adverse Event|1|||
155582268|NCT01894919|561556963|FG011|Overall Study|Adverse Event|0|||
155582269|NCT01894919|561556964|FG012|Overall Study|Adverse Event|0|||
155582270|NCT01894919|561556952|FG000|Overall Study|Other-Unspecified|1|||
155582271|NCT01894919|561556953|FG001|Overall Study|Other-Unspecified|0|||
155582272|NCT01894919|561556954|FG002|Overall Study|Other-Unspecified|0|||
155582273|NCT01894919|561556955|FG003|Overall Study|Other-Unspecified|0|||
155582274|NCT01894919|561556956|FG004|Overall Study|Other-Unspecified|0|||
155582275|NCT01894919|561556957|FG005|Overall Study|Other-Unspecified|0|||
155582276|NCT01894919|561556958|FG006|Overall Study|Other-Unspecified|0|||
155582277|NCT01894919|561556959|FG007|Overall Study|Other-Unspecified|0|||
155582278|NCT01894919|561556960|FG008|Overall Study|Other-Unspecified|0|||
155582279|NCT01894919|561556961|FG009|Overall Study|Other-Unspecified|0|||
155582280|NCT01894919|561556962|FG010|Overall Study|Other-Unspecified|0|||
155582281|NCT01894919|561556963|FG011|Overall Study|Other-Unspecified|0|||
155582282|NCT01894919|561556964|FG012|Overall Study|Other-Unspecified|0|||
155582283|NCT01894919|561556952|FG000|Overall Study|Lost to Follow-up|0|||
155582284|NCT01894919|561556953|FG001|Overall Study|Lost to Follow-up|0|||
155582285|NCT01894919|561556954|FG002|Overall Study|Lost to Follow-up|0|||
155582286|NCT01894919|561556955|FG003|Overall Study|Lost to Follow-up|0|||
155582287|NCT01894919|561556956|FG004|Overall Study|Lost to Follow-up|2|||
155582288|NCT01894919|561556957|FG005|Overall Study|Lost to Follow-up|0|||
155582289|NCT01894919|561556958|FG006|Overall Study|Lost to Follow-up|0|||
155582290|NCT01894919|561556959|FG007|Overall Study|Lost to Follow-up|0|||
155582291|NCT01894919|561556960|FG008|Overall Study|Lost to Follow-up|0|||
155582292|NCT01894919|561556961|FG009|Overall Study|Lost to Follow-up|0|||
155582293|NCT01894919|561556962|FG010|Overall Study|Lost to Follow-up|0|||
155582294|NCT01894919|561556963|FG011|Overall Study|Lost to Follow-up|0|||
155582295|NCT01894919|561556964|FG012|Overall Study|Lost to Follow-up|0|||
155582296|NCT04341363|561556969|FG000|Overall Study|Adverse Event|1|||
155582297|NCT04341363|561556969|FG000|Overall Study|Withdrawal by Subject|1|||
155582298|NCT03534687|561556971|FG000|Overall Study|Lost to Follow-up|7|||
155582299|NCT03534687|561556972|FG001|Overall Study|Lost to Follow-up|2|||
155664450|NCT02121509|561866964|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
155664451|NCT02121509|561866965|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
155664452|NCT02121509|561866966|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
155664453|NCT02121509|561866967|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
155664454|NCT02121509|561866964|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
155582300|NCT02069015|561556973|FG000|Overall Study|Lost to Follow-up|39|||
155582301|NCT02069015|561556974|FG001|Overall Study|Lost to Follow-up|32|||
155582302|NCT02069015|561556973|FG000|Overall Study|Withdrawal by Subject|1|||
155582303|NCT02069015|561556974|FG001|Overall Study|Withdrawal by Subject|1|||
155582304|NCT00957801|561556975|FG000|Overall Study|Withdrawal by Subject|0|||
155582305|NCT00957801|561556976|FG001|Overall Study|Withdrawal by Subject|0|||
155582306|NCT00957801|561556977|FG002|Overall Study|Withdrawal by Subject|0|||
155582307|NCT00957801|561556978|FG003|Overall Study|Withdrawal by Subject|1|||
155582308|NCT01778855|561556979|FG000|Overall Study|Death|0|||
155582309|NCT01778855|561556980|FG001|Overall Study|Death|1|||
155582310|NCT00806403|561556982|FG000|Overall Study|Death|4|||
155582311|NCT00806403|561556983|FG001|Overall Study|Death|3|||
155582312|NCT01609790|561556991|FG000|Overall Study|Protocol Violation|1|||
155582313|NCT01609790|561556992|FG001|Overall Study|Protocol Violation|7|||
155582314|NCT01609790|561556993|FG002|Overall Study|Protocol Violation|8|||
155582315|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Adverse Event|7|||
155582316|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
155582317|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Non-compliance|3|||
155582318|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Other|17|||
155582319|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Physician Decision|2|||
155582320|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Pregnancy|1|||
155582321|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
155582322|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
155582323|NCT05207865|561558613|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
155582324|NCT05207865|561558613|FG000|Follow-up Phase|Lost to Follow-up|1|||
155582325|NCT05207865|561558613|FG000|Follow-up Phase|Non-compliance|1|||
155582326|NCT05207865|561558613|FG000|Follow-up Phase|Not reported|2|||
155582327|NCT05207865|561558613|FG000|Follow-up Phase|Not collected|11|||
155582328|NCT02141438|561558614|FG000|Overall Study|Death|1308|||
155582329|NCT02141438|561558614|FG000|Overall Study|Lost to Follow-up|84|||
155582330|NCT02141438|561558614|FG000|Overall Study|Withdrawal by Subject|52|||
155582331|NCT02141438|561558614|FG000|Overall Study|Physician Decision|1|||
155582332|NCT02141438|561558614|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
155582333|NCT02546986|561558615|FG000|Treatment Period|Progressive Disease|20|||
155582334|NCT02546986|561558616|FG001|Treatment Period|Progressive Disease|22|||
155582335|NCT02546986|561558615|FG000|Treatment Period|Adverse Event|14|||
155582336|NCT02546986|561558616|FG001|Treatment Period|Adverse Event|6|||
155582337|NCT02546986|561558615|FG000|Treatment Period|Symptomatic Deterioration|4|||
155582338|NCT02546986|561558616|FG001|Treatment Period|Symptomatic Deterioration|3|||
155582339|NCT02546986|561558615|FG000|Treatment Period|Death|3|||
155582340|NCT02546986|561558616|FG001|Treatment Period|Death|4|||
155582341|NCT02546986|561558615|FG000|Treatment Period|Physician Decision|1|||
155582342|NCT02546986|561558616|FG001|Treatment Period|Physician Decision|2|||
155582343|NCT02546986|561558615|FG000|Treatment Period|Protocol Violation|1|||
155582344|NCT02546986|561558616|FG001|Treatment Period|Protocol Violation|0|||
155582345|NCT02546986|561558615|FG000|Treatment Period|Withdrawal by Subject|1|||
155582346|NCT02546986|561558616|FG001|Treatment Period|Withdrawal by Subject|1|||
155582347|NCT02546986|561558615|FG000|Treatment Period|Non-compliance with Study Drug|0|||
155582348|NCT02546986|561558616|FG001|Treatment Period|Non-compliance with Study Drug|1|||
155582349|NCT02546986|561558615|FG000|Treatment Period|Study Terminated by Sponsor|0|||
155582350|NCT02546986|561558616|FG001|Treatment Period|Study Terminated by Sponsor|1|||
155582351|NCT02546986|561558615|FG000|Treatment Period|Miscellaneous|7|||
155582352|NCT02546986|561558616|FG001|Treatment Period|Miscellaneous|9|||
155582353|NCT02546986|561558615|FG000|Survival Follow-Up Phase|Missing Status|3|||
155582354|NCT02546986|561558616|FG001|Survival Follow-Up Phase|Missing Status|5|||
155582355|NCT02546986|561558615|FG000|Survival Follow-Up Phase|Death|18|||
155582356|NCT02546986|561558616|FG001|Survival Follow-Up Phase|Death|12|||
155582357|NCT02546986|561558615|FG000|Survival Follow-Up Phase|Alive|13|||
155582358|NCT02546986|561558616|FG001|Survival Follow-Up Phase|Alive|16|||
155582359|NCT02546986|561558615|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
155582360|NCT02546986|561558616|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
155582361|NCT02844543|561558617|FG000|Overall Study|Withdrawal by Subject|4|||
155582362|NCT02844543|561558617|FG000|Overall Study|Did not meet eligibility criteria|1|||
155582363|NCT03349060|561558618|FG000|Overall Study|Adverse Event|9|||
155582364|NCT03349060|561558619|FG001|Overall Study|Adverse Event|9|||
155582365|NCT03349060|561558620|FG002|Overall Study|Adverse Event|7|||
155582366|NCT03349060|561558618|FG000|Overall Study|Lack of Efficacy|1|||
155582367|NCT03349060|561558619|FG001|Overall Study|Lack of Efficacy|0|||
155582368|NCT03349060|561558620|FG002|Overall Study|Lack of Efficacy|2|||
155582369|NCT03349060|561558618|FG000|Overall Study|Lost to Follow-up|2|||
155582370|NCT03349060|561558619|FG001|Overall Study|Lost to Follow-up|1|||
155582371|NCT03349060|561558620|FG002|Overall Study|Lost to Follow-up|1|||
155582372|NCT03349060|561558618|FG000|Overall Study|Protocol Violation|2|||
155582373|NCT03349060|561558619|FG001|Overall Study|Protocol Violation|2|||
155582374|NCT03349060|561558620|FG002|Overall Study|Protocol Violation|1|||
155582375|NCT03349060|561558618|FG000|Overall Study|Withdrawal by Subject|5|||
155582376|NCT03349060|561558619|FG001|Overall Study|Withdrawal by Subject|3|||
155582377|NCT03349060|561558620|FG002|Overall Study|Withdrawal by Subject|4|||
155582378|NCT03349060|561558618|FG000|Overall Study|Medication error,no linked adverse event|0|||
155582379|NCT03349060|561558619|FG001|Overall Study|Medication error,no linked adverse event|0|||
155582380|NCT03349060|561558620|FG002|Overall Study|Medication error,no linked adverse event|1|||
155582381|NCT03349060|561558618|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155582382|NCT03349060|561558619|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
155582383|NCT03349060|561558620|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
155582384|NCT03349060|561558618|FG000|Overall Study|Other|2|||
155582385|NCT03349060|561558619|FG001|Overall Study|Other|1|||
155582386|NCT03349060|561558620|FG002|Overall Study|Other|0|||
155582387|NCT00485732|561558621|FG000|Overall Study|Protocol Violation|1|||
155582388|NCT00485732|561558622|FG001|Overall Study|Protocol Violation|3|||
155582389|NCT00485732|561558621|FG000|Overall Study|Withdrawal by Subject|5|||
155582390|NCT00485732|561558622|FG001|Overall Study|Withdrawal by Subject|4|||
155582391|NCT00485732|561558621|FG000|Overall Study|Lost to Follow-up|2|||
155582392|NCT00485732|561558622|FG001|Overall Study|Lost to Follow-up|2|||
155582393|NCT00437021|561558623|FG000|Overall Study|Adverse Event|0|||
155582394|NCT00437021|561558624|FG001|Overall Study|Adverse Event|0|||
155582395|NCT00437021|561558625|FG002|Overall Study|Adverse Event|0|||
155582396|NCT00437021|561558626|FG003|Overall Study|Adverse Event|0|||
155582397|NCT00437021|561558627|FG004|Overall Study|Adverse Event|0|||
155582398|NCT00437021|561558628|FG005|Overall Study|Adverse Event|0|||
155582399|NCT00437021|561558629|FG006|Overall Study|Adverse Event|1|||
155582400|NCT00437021|561558630|FG007|Overall Study|Adverse Event|0|||
155582401|NCT00437021|561558631|FG008|Overall Study|Adverse Event|0|||
155582402|NCT00437021|561558632|FG009|Overall Study|Adverse Event|0|||
155582403|NCT00437021|561558633|FG010|Overall Study|Adverse Event|0|||
155582404|NCT00437021|561558634|FG011|Overall Study|Adverse Event|0|||
155582405|NCT00437021|561558623|FG000|Overall Study|Lost to Follow-up|0|||
155582406|NCT00437021|561558624|FG001|Overall Study|Lost to Follow-up|3|||
155582407|NCT00437021|561558625|FG002|Overall Study|Lost to Follow-up|0|||
155582408|NCT00437021|561558626|FG003|Overall Study|Lost to Follow-up|0|||
155582409|NCT00437021|561558627|FG004|Overall Study|Lost to Follow-up|0|||
155582410|NCT00437021|561558628|FG005|Overall Study|Lost to Follow-up|2|||
155582411|NCT00437021|561558629|FG006|Overall Study|Lost to Follow-up|0|||
155582412|NCT00437021|561558630|FG007|Overall Study|Lost to Follow-up|1|||
155582413|NCT00437021|561558631|FG008|Overall Study|Lost to Follow-up|0|||
155582414|NCT00437021|561558632|FG009|Overall Study|Lost to Follow-up|0|||
155582415|NCT00437021|561558633|FG010|Overall Study|Lost to Follow-up|0|||
155582416|NCT00437021|561558634|FG011|Overall Study|Lost to Follow-up|0|||
155582417|NCT00437021|561558623|FG000|Overall Study|Withdrawal by Subject|2|||
155582418|NCT00437021|561558624|FG001|Overall Study|Withdrawal by Subject|1|||
155582419|NCT00437021|561558625|FG002|Overall Study|Withdrawal by Subject|0|||
155582420|NCT00437021|561558626|FG003|Overall Study|Withdrawal by Subject|0|||
155582421|NCT00437021|561558627|FG004|Overall Study|Withdrawal by Subject|0|||
155582422|NCT00437021|561558628|FG005|Overall Study|Withdrawal by Subject|0|||
155582423|NCT00437021|561558629|FG006|Overall Study|Withdrawal by Subject|0|||
155582424|NCT00437021|561558630|FG007|Overall Study|Withdrawal by Subject|0|||
155582425|NCT00437021|561558631|FG008|Overall Study|Withdrawal by Subject|0|||
155582426|NCT00437021|561558632|FG009|Overall Study|Withdrawal by Subject|0|||
155582427|NCT00437021|561558633|FG010|Overall Study|Withdrawal by Subject|0|||
155582428|NCT00437021|561558634|FG011|Overall Study|Withdrawal by Subject|0|||
155582429|NCT05423093|561558642|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
155582430|NCT05423093|561558642|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
155582431|NCT05423093|561558642|FG000|Attended Intervention Session|Lost to Follow-up|3|||
155582432|NCT05423093|561558642|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
155582433|NCT05423093|561558642|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
155582434|NCT05364931|561558643|FG000|Overall Study|Adverse Event|0|||
155582435|NCT05364931|561558644|FG001|Overall Study|Adverse Event|2|||
155582436|NCT05364931|561558645|FG002|Overall Study|Adverse Event|1|||
155582437|NCT05364931|561558646|FG003|Overall Study|Adverse Event|0|||
155582438|NCT05364931|561558643|FG000|Overall Study|Lost to Follow-up|1|||
155582439|NCT05364931|561558644|FG001|Overall Study|Lost to Follow-up|0|||
155582440|NCT05364931|561558645|FG002|Overall Study|Lost to Follow-up|0|||
155582441|NCT05364931|561558646|FG003|Overall Study|Lost to Follow-up|0|||
155582442|NCT05364931|561558643|FG000|Overall Study|Withdrawal by Subject|1|||
155582443|NCT05364931|561558644|FG001|Overall Study|Withdrawal by Subject|1|||
155582444|NCT05364931|561558645|FG002|Overall Study|Withdrawal by Subject|3|||
155582445|NCT05364931|561558646|FG003|Overall Study|Withdrawal by Subject|2|||
155582446|NCT05364931|561558643|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155664455|NCT02121509|561866965|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155582447|NCT05364931|561558644|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
155582448|NCT05364931|561558645|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155582449|NCT05364931|561558646|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155582450|NCT05364931|561558643|FG000|Overall Study|Discontinued|1|||
155582451|NCT05364931|561558644|FG001|Overall Study|Discontinued|0|||
155582452|NCT05364931|561558645|FG002|Overall Study|Discontinued|0|||
155582453|NCT05364931|561558646|FG003|Overall Study|Discontinued|0|||
155582454|NCT03593525|561558647|FG000|Overall Study|Withdrawal by Subject|1|||
155582455|NCT03593525|561558648|FG001|Overall Study|Withdrawal by Subject|0|||
155582456|NCT03593525|561558647|FG000|Overall Study|Lost to Follow-up|7|||
155582457|NCT03593525|561558648|FG001|Overall Study|Lost to Follow-up|5|||
155582466|NCT04570670|561558658|FG000|Overall Study|Withdrawal by Subject|1|||
155582467|NCT04570670|561558659|FG001|Overall Study|Withdrawal by Subject|0|||
155582468|NCT04067050|561558660|FG000|One Month|Lost to Follow-up|4|||
155582469|NCT04067050|561558661|FG001|One Month|Lost to Follow-up|0|||
155582470|NCT04067050|561558660|FG000|Two Month|Lost to Follow-up|1|||
155582471|NCT04067050|561558661|FG001|Two Month|Lost to Follow-up|0|||
155582472|NCT04067050|561558660|FG000|Two Month|Adverse Event|1|||
155582473|NCT04067050|561558661|FG001|Two Month|Adverse Event|0|||
155582474|NCT00460603|561558664|FG000|Phase 1|Death|1|||
155582475|NCT00460603|561558665|FG001|Phase 1|Death|0|||
155582476|NCT00460603|561558666|FG002|Phase 1|Death|0|||
155582477|NCT00460603|561558667|FG003|Phase 1|Death|2|||
155582478|NCT00460603|561558668|FG004|Phase 1|Death|0|||
155582479|NCT00460603|561558669|FG005|Phase 1|Death|0|||
155582480|NCT00460603|561558670|FG006|Phase 1|Death|0|||
155582481|NCT00460603|561558671|FG007|Phase 1|Death|0|||
155582482|NCT00460603|561558672|FG008|Phase 1|Death|1|||
155582483|NCT00460603|561558673|FG009|Phase 1|Death|0|||
155582484|NCT00460603|561558674|FG010|Phase 1|Death|0|||
155582485|NCT00460603|561558675|FG011|Phase 1|Death|0|||
155582486|NCT00460603|561558664|FG000|Phase 1|Adverse Event|3|||
155582487|NCT00460603|561558665|FG001|Phase 1|Adverse Event|1|||
155582488|NCT00460603|561558666|FG002|Phase 1|Adverse Event|1|||
155582489|NCT00460603|561558667|FG003|Phase 1|Adverse Event|2|||
155582490|NCT00460603|561558668|FG004|Phase 1|Adverse Event|0|||
155582491|NCT00460603|561558669|FG005|Phase 1|Adverse Event|0|||
155582492|NCT00460603|561558670|FG006|Phase 1|Adverse Event|3|||
155582493|NCT00460603|561558671|FG007|Phase 1|Adverse Event|0|||
155582494|NCT00460603|561558672|FG008|Phase 1|Adverse Event|4|||
155582495|NCT00460603|561558673|FG009|Phase 1|Adverse Event|0|||
155582496|NCT00460603|561558674|FG010|Phase 1|Adverse Event|0|||
155582497|NCT00460603|561558675|FG011|Phase 1|Adverse Event|0|||
155582498|NCT00460603|561558664|FG000|Phase 1|Lack of Efficacy|1|||
155582499|NCT00460603|561558665|FG001|Phase 1|Lack of Efficacy|0|||
155582500|NCT00460603|561558666|FG002|Phase 1|Lack of Efficacy|1|||
155582501|NCT00460603|561558667|FG003|Phase 1|Lack of Efficacy|2|||
155582502|NCT00460603|561558668|FG004|Phase 1|Lack of Efficacy|2|||
155582503|NCT00460603|561558669|FG005|Phase 1|Lack of Efficacy|2|||
155582504|NCT00460603|561558670|FG006|Phase 1|Lack of Efficacy|2|||
155582505|NCT00460603|561558671|FG007|Phase 1|Lack of Efficacy|2|||
155582506|NCT00460603|561558672|FG008|Phase 1|Lack of Efficacy|11|||
155582507|NCT00460603|561558673|FG009|Phase 1|Lack of Efficacy|0|||
155582508|NCT00460603|561558674|FG010|Phase 1|Lack of Efficacy|0|||
155582509|NCT00460603|561558675|FG011|Phase 1|Lack of Efficacy|0|||
155582510|NCT00460603|561558664|FG000|Phase 1|Withdrawal by Subject|1|||
155582511|NCT00460603|561558665|FG001|Phase 1|Withdrawal by Subject|2|||
155582512|NCT00460603|561558666|FG002|Phase 1|Withdrawal by Subject|1|||
155582513|NCT00460603|561558667|FG003|Phase 1|Withdrawal by Subject|1|||
155582514|NCT00460603|561558668|FG004|Phase 1|Withdrawal by Subject|3|||
155582515|NCT00460603|561558669|FG005|Phase 1|Withdrawal by Subject|0|||
155582516|NCT00460603|561558670|FG006|Phase 1|Withdrawal by Subject|1|||
155582517|NCT00460603|561558671|FG007|Phase 1|Withdrawal by Subject|0|||
155582518|NCT00460603|561558672|FG008|Phase 1|Withdrawal by Subject|2|||
155582519|NCT00460603|561558673|FG009|Phase 1|Withdrawal by Subject|0|||
155582520|NCT00460603|561558674|FG010|Phase 1|Withdrawal by Subject|0|||
155582521|NCT00460603|561558675|FG011|Phase 1|Withdrawal by Subject|0|||
155582522|NCT00460603|561558664|FG000|Phase 1|Other|0|||
155582523|NCT00460603|561558665|FG001|Phase 1|Other|3|||
155582524|NCT00460603|561558666|FG002|Phase 1|Other|1|||
155582525|NCT00460603|561558667|FG003|Phase 1|Other|1|||
155582526|NCT00460603|561558668|FG004|Phase 1|Other|1|||
155582527|NCT00460603|561558669|FG005|Phase 1|Other|2|||
155582528|NCT00460603|561558670|FG006|Phase 1|Other|0|||
155582529|NCT00460603|561558671|FG007|Phase 1|Other|1|||
155582530|NCT00460603|561558672|FG008|Phase 1|Other|0|||
155582531|NCT00460603|561558673|FG009|Phase 1|Other|0|||
155582532|NCT00460603|561558674|FG010|Phase 1|Other|0|||
155582533|NCT00460603|561558675|FG011|Phase 1|Other|0|||
155582534|NCT00460603|561558664|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582535|NCT00460603|561558665|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582536|NCT00460603|561558666|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582537|NCT00460603|561558667|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582538|NCT00460603|561558668|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582539|NCT00460603|561558669|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582540|NCT00460603|561558670|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582541|NCT00460603|561558671|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582542|NCT00460603|561558672|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582543|NCT00460603|561558673|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
155582544|NCT00460603|561558674|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582545|NCT00460603|561558675|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155582546|NCT00460603|561558664|FG000|Phase 2|Adverse Event|0|||
155582547|NCT00460603|561558665|FG001|Phase 2|Adverse Event|0|||
155582548|NCT00460603|561558666|FG002|Phase 2|Adverse Event|0|||
155582549|NCT00460603|561558667|FG003|Phase 2|Adverse Event|0|||
155582550|NCT00460603|561558668|FG004|Phase 2|Adverse Event|0|||
155582551|NCT00460603|561558669|FG005|Phase 2|Adverse Event|0|||
155582552|NCT00460603|561558670|FG006|Phase 2|Adverse Event|0|||
155582553|NCT00460603|561558671|FG007|Phase 2|Adverse Event|0|||
155582554|NCT00460603|561558672|FG008|Phase 2|Adverse Event|0|||
155582555|NCT00460603|561558673|FG009|Phase 2|Adverse Event|12|||
155582556|NCT00460603|561558674|FG010|Phase 2|Adverse Event|9|||
155582557|NCT00460603|561558675|FG011|Phase 2|Adverse Event|10|||
155582558|NCT00460603|561558664|FG000|Phase 2|Death|0|||
155582559|NCT00460603|561558665|FG001|Phase 2|Death|0|||
155582560|NCT00460603|561558666|FG002|Phase 2|Death|0|||
155582561|NCT00460603|561558667|FG003|Phase 2|Death|0|||
155582562|NCT00460603|561558668|FG004|Phase 2|Death|0|||
155582563|NCT00460603|561558669|FG005|Phase 2|Death|0|||
155582564|NCT00460603|561558670|FG006|Phase 2|Death|0|||
155582565|NCT00460603|561558671|FG007|Phase 2|Death|0|||
155582566|NCT00460603|561558672|FG008|Phase 2|Death|0|||
155582567|NCT00460603|561558673|FG009|Phase 2|Death|4|||
155582568|NCT00460603|561558674|FG010|Phase 2|Death|2|||
155582569|NCT00460603|561558675|FG011|Phase 2|Death|2|||
155582570|NCT00460603|561558664|FG000|Phase 2|Protocol Violation|0|||
155582571|NCT00460603|561558665|FG001|Phase 2|Protocol Violation|0|||
155582572|NCT00460603|561558666|FG002|Phase 2|Protocol Violation|0|||
155582573|NCT00460603|561558667|FG003|Phase 2|Protocol Violation|0|||
155582574|NCT00460603|561558668|FG004|Phase 2|Protocol Violation|0|||
155582575|NCT00460603|561558669|FG005|Phase 2|Protocol Violation|0|||
155582576|NCT00460603|561558670|FG006|Phase 2|Protocol Violation|0|||
155582577|NCT00460603|561558671|FG007|Phase 2|Protocol Violation|0|||
155582578|NCT00460603|561558672|FG008|Phase 2|Protocol Violation|0|||
155582579|NCT00460603|561558673|FG009|Phase 2|Protocol Violation|1|||
155582580|NCT00460603|561558674|FG010|Phase 2|Protocol Violation|1|||
155582581|NCT00460603|561558675|FG011|Phase 2|Protocol Violation|0|||
155582582|NCT00460603|561558664|FG000|Phase 2|Lost to Follow-up|0|||
155582583|NCT00460603|561558665|FG001|Phase 2|Lost to Follow-up|0|||
155582584|NCT00460603|561558666|FG002|Phase 2|Lost to Follow-up|0|||
155582585|NCT00460603|561558667|FG003|Phase 2|Lost to Follow-up|0|||
155582586|NCT00460603|561558668|FG004|Phase 2|Lost to Follow-up|0|||
155582587|NCT00460603|561558669|FG005|Phase 2|Lost to Follow-up|0|||
155582588|NCT00460603|561558670|FG006|Phase 2|Lost to Follow-up|0|||
155582589|NCT00460603|561558671|FG007|Phase 2|Lost to Follow-up|0|||
155582590|NCT00460603|561558672|FG008|Phase 2|Lost to Follow-up|0|||
155582591|NCT00460603|561558673|FG009|Phase 2|Lost to Follow-up|1|||
155582592|NCT00460603|561558674|FG010|Phase 2|Lost to Follow-up|0|||
155582593|NCT00460603|561558675|FG011|Phase 2|Lost to Follow-up|0|||
155582594|NCT00460603|561558664|FG000|Phase 2|Other|0|||
155582595|NCT00460603|561558665|FG001|Phase 2|Other|0|||
155582596|NCT00460603|561558666|FG002|Phase 2|Other|0|||
155582597|NCT00460603|561558667|FG003|Phase 2|Other|0|||
155582598|NCT00460603|561558668|FG004|Phase 2|Other|0|||
155582599|NCT00460603|561558669|FG005|Phase 2|Other|0|||
155582600|NCT00460603|561558670|FG006|Phase 2|Other|0|||
155582601|NCT00460603|561558671|FG007|Phase 2|Other|0|||
155582602|NCT00460603|561558672|FG008|Phase 2|Other|0|||
155582603|NCT00460603|561558673|FG009|Phase 2|Other|6|||
155582604|NCT00460603|561558674|FG010|Phase 2|Other|16|||
155582605|NCT00460603|561558675|FG011|Phase 2|Other|7|||
155582606|NCT00460603|561558664|FG000|Phase 2|Objective Progression or Relapse|0|||
155582607|NCT00460603|561558665|FG001|Phase 2|Objective Progression or Relapse|0|||
155582608|NCT00460603|561558666|FG002|Phase 2|Objective Progression or Relapse|0|||
155582609|NCT00460603|561558667|FG003|Phase 2|Objective Progression or Relapse|0|||
155582610|NCT00460603|561558668|FG004|Phase 2|Objective Progression or Relapse|0|||
155582611|NCT00460603|561558669|FG005|Phase 2|Objective Progression or Relapse|0|||
155582612|NCT00460603|561558670|FG006|Phase 2|Objective Progression or Relapse|0|||
155582613|NCT00460603|561558671|FG007|Phase 2|Objective Progression or Relapse|0|||
155582614|NCT00460603|561558672|FG008|Phase 2|Objective Progression or Relapse|0|||
155582615|NCT00460603|561558673|FG009|Phase 2|Objective Progression or Relapse|9|||
155582616|NCT00460603|561558674|FG010|Phase 2|Objective Progression or Relapse|10|||
155582617|NCT00460603|561558675|FG011|Phase 2|Objective Progression or Relapse|17|||
155582618|NCT00460603|561558664|FG000|Phase 2|Global Deterioration of Health Status|0|||
155582619|NCT00460603|561558665|FG001|Phase 2|Global Deterioration of Health Status|0|||
155582620|NCT00460603|561558666|FG002|Phase 2|Global Deterioration of Health Status|0|||
155582621|NCT00460603|561558667|FG003|Phase 2|Global Deterioration of Health Status|0|||
155582622|NCT00460603|561558668|FG004|Phase 2|Global Deterioration of Health Status|0|||
155582623|NCT00460603|561558669|FG005|Phase 2|Global Deterioration of Health Status|0|||
155582624|NCT00460603|561558670|FG006|Phase 2|Global Deterioration of Health Status|0|||
155582625|NCT00460603|561558671|FG007|Phase 2|Global Deterioration of Health Status|0|||
155582626|NCT00460603|561558672|FG008|Phase 2|Global Deterioration of Health Status|0|||
155582627|NCT00460603|561558673|FG009|Phase 2|Global Deterioration of Health Status|0|||
155582628|NCT00460603|561558674|FG010|Phase 2|Global Deterioration of Health Status|1|||
155582629|NCT00460603|561558675|FG011|Phase 2|Global Deterioration of Health Status|0|||
155582630|NCT00460603|561558664|FG000|Phase 2|Withdrawal by Subject|0|||
155582631|NCT00460603|561558665|FG001|Phase 2|Withdrawal by Subject|0|||
155582632|NCT00460603|561558666|FG002|Phase 2|Withdrawal by Subject|0|||
155664456|NCT02121509|561866966|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155664457|NCT02121509|561866967|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155664458|NCT00867035|561866972|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
155664459|NCT00867035|561866973|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
155664460|NCT00867035|561866972|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
155664461|NCT00867035|561866973|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
155664462|NCT05076045|561866974|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
155664463|NCT05076045|561866975|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
155664464|NCT02993263|561866980|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
155664465|NCT04704193|561866983|FG000|Overall Study|Withdrawal by Subject|1|||
155582633|NCT00460603|561558667|FG003|Phase 2|Withdrawal by Subject|0|||
155582634|NCT00460603|561558668|FG004|Phase 2|Withdrawal by Subject|0|||
155582635|NCT00460603|561558669|FG005|Phase 2|Withdrawal by Subject|0|||
155582636|NCT00460603|561558670|FG006|Phase 2|Withdrawal by Subject|0|||
155582637|NCT00460603|561558671|FG007|Phase 2|Withdrawal by Subject|0|||
155582638|NCT00460603|561558672|FG008|Phase 2|Withdrawal by Subject|0|||
155582639|NCT00460603|561558673|FG009|Phase 2|Withdrawal by Subject|5|||
155582640|NCT00460603|561558674|FG010|Phase 2|Withdrawal by Subject|4|||
155582641|NCT00460603|561558675|FG011|Phase 2|Withdrawal by Subject|5|||
155582642|NCT00460603|561558664|FG000|Phase 2|Randomized, but not treated|0|||
155582643|NCT00460603|561558665|FG001|Phase 2|Randomized, but not treated|0|||
155582644|NCT00460603|561558666|FG002|Phase 2|Randomized, but not treated|0|||
155582645|NCT00460603|561558667|FG003|Phase 2|Randomized, but not treated|0|||
155582646|NCT00460603|561558668|FG004|Phase 2|Randomized, but not treated|0|||
155582647|NCT00460603|561558669|FG005|Phase 2|Randomized, but not treated|0|||
155582648|NCT00460603|561558670|FG006|Phase 2|Randomized, but not treated|0|||
155582649|NCT00460603|561558671|FG007|Phase 2|Randomized, but not treated|0|||
155582650|NCT00460603|561558672|FG008|Phase 2|Randomized, but not treated|0|||
155582651|NCT00460603|561558673|FG009|Phase 2|Randomized, but not treated|3|||
155582652|NCT00460603|561558674|FG010|Phase 2|Randomized, but not treated|0|||
155582653|NCT00460603|561558675|FG011|Phase 2|Randomized, but not treated|0|||
155582654|NCT01293695|561558679|FG000|Overall Study|Withdrawal by Subject|7|||
155582655|NCT01293695|561558680|FG001|Overall Study|Withdrawal by Subject|1|||
155582656|NCT01293695|561558679|FG000|Overall Study|Lost to Follow-up|8|||
155582657|NCT01293695|561558680|FG001|Overall Study|Lost to Follow-up|6|||
155582658|NCT01082328|561558684|FG000|Overall Study|Adverse Event|1|||
155582659|NCT00031590|561558685|FG000|Overall Study|Adverse Event|1|||
155582660|NCT00031590|561558685|FG000|Overall Study|Withdrawal by parents|2|||
155582661|NCT05506046|561558688|FG000|Overall Study|Lost to Follow-up|89|||
155582662|NCT05506046|561558689|FG001|Overall Study|Lost to Follow-up|101|||
155582663|NCT05506046|561558690|FG002|Overall Study|Lost to Follow-up|102|||
155582664|NCT05506046|561558691|FG003|Overall Study|Lost to Follow-up|99|||
155582665|NCT01286467|561558694|FG000|Overall Study|Death|1|||
155664466|NCT00542178|561866984|FG000|Overall Study|did not complete year 4 follow-up|75|||
155664467|NCT00542178|561866985|FG001|Overall Study|did not complete year 4 follow-up|80|||
155664468|NCT00542178|561866986|FG002|Overall Study|did not complete year 4 follow-up|74|||
155664469|NCT00542178|561866987|FG003|Overall Study|did not complete year 4 follow-up|62|||
155664470|NCT00542178|561866988|FG004|Overall Study|did not complete year 4 follow-up|64|||
155664471|NCT00542178|561866989|FG005|Overall Study|did not complete year 4 follow-up|89|||
155582666|NCT01286467|561558695|FG001|Overall Study|Death|1|||
155582667|NCT01286467|561558696|FG002|Overall Study|Death|1|||
155582668|NCT01286467|561558697|FG003|Overall Study|Death|0|||
155582669|NCT01286467|561558694|FG000|Overall Study|Lost to Follow-up|0|||
155582670|NCT01286467|561558695|FG001|Overall Study|Lost to Follow-up|0|||
155664472|NCT00542178|561866990|FG006|Overall Study|did not complete year 4 follow-up|87|||
155664473|NCT00542178|561866991|FG007|Overall Study|did not complete year 4 follow-up|85|||
155664474|NCT00829998|561866992|FG000|Washout|Adverse Event|0|||
155582671|NCT01286467|561558696|FG002|Overall Study|Lost to Follow-up|0|||
155582672|NCT01286467|561558697|FG003|Overall Study|Lost to Follow-up|1|||
155582673|NCT01286467|561558694|FG000|Overall Study|Withdrawal by Subject|0|||
155664475|NCT00829998|561866993|FG001|Washout|Adverse Event|1|||
155582674|NCT01286467|561558695|FG001|Overall Study|Withdrawal by Subject|0|||
155582675|NCT01286467|561558696|FG002|Overall Study|Withdrawal by Subject|1|||
155582676|NCT01286467|561558697|FG003|Overall Study|Withdrawal by Subject|0|||
155582677|NCT01286467|561558694|FG000|Overall Study|Physician Decision|0|||
155582678|NCT01286467|561558695|FG001|Overall Study|Physician Decision|0|||
155582679|NCT01286467|561558696|FG002|Overall Study|Physician Decision|0|||
155582680|NCT01286467|561558697|FG003|Overall Study|Physician Decision|1|||
155582681|NCT01286467|561558694|FG000|Overall Study|Disease progression|3|||
155582682|NCT01286467|561558695|FG001|Overall Study|Disease progression|2|||
155582683|NCT01286467|561558696|FG002|Overall Study|Disease progression|2|||
155582684|NCT01286467|561558697|FG003|Overall Study|Disease progression|3|||
155582685|NCT01286467|561558694|FG000|Overall Study|Adverse Event|0|||
155582686|NCT01286467|561558695|FG001|Overall Study|Adverse Event|1|||
155582687|NCT01286467|561558696|FG002|Overall Study|Adverse Event|2|||
155582688|NCT01286467|561558697|FG003|Overall Study|Adverse Event|3|||
155582689|NCT01286467|561558694|FG000|Overall Study|Study drug stop longer than 14 days|0|||
155582690|NCT01286467|561558695|FG001|Overall Study|Study drug stop longer than 14 days|0|||
155582691|NCT01286467|561558696|FG002|Overall Study|Study drug stop longer than 14 days|1|||
155582692|NCT01286467|561558697|FG003|Overall Study|Study drug stop longer than 14 days|0|||
155582693|NCT00765102|561558698|FG000|Overall Study|Progressive disease|18|||
155582694|NCT00765102|561558698|FG000|Overall Study|Adverse Event|6|||
155582695|NCT00765102|561558698|FG000|Overall Study|Physician Decision|4|||
155582696|NCT00765102|561558698|FG000|Overall Study|Withdrawal by Subject|2|||
155582697|NCT00765102|561558698|FG000|Overall Study|Protocol Violation|1|||
155582698|NCT01320293|561558701|FG000|Overall Study|Lack of Efficacy|1|||
155582699|NCT01320293|561558701|FG000|Overall Study|Adverse Event|1|||
155582700|NCT01827111|561558704|FG000|Overall Study|Disease Progression|1|||
155582701|NCT01147068|561558705|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
155582702|NCT01147068|561558706|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155582703|NCT01147068|561558707|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155582704|NCT01147068|561558708|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155582705|NCT01147068|561558709|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155582706|NCT01147068|561558710|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
155582707|NCT01147068|561558711|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155582708|NCT01147068|561558705|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
155582709|NCT01147068|561558706|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
155582710|NCT01147068|561558707|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
155582711|NCT01147068|561558708|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
155582712|NCT01147068|561558709|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
155582713|NCT01147068|561558710|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
155582714|NCT01147068|561558711|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
155582715|NCT01147068|561558705|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
155582716|NCT01147068|561558706|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
155582717|NCT01147068|561558707|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
155582718|NCT01147068|561558708|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
155582719|NCT01147068|561558709|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
155582720|NCT01147068|561558710|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
155582721|NCT01147068|561558711|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
155582722|NCT01147068|561558705|FG000|Subjects That Received 2nd Dose|Other|0|||
155582723|NCT01147068|561558706|FG001|Subjects That Received 2nd Dose|Other|3|||
155582724|NCT01147068|561558707|FG002|Subjects That Received 2nd Dose|Other|3|||
155582725|NCT01147068|561558708|FG003|Subjects That Received 2nd Dose|Other|0|||
155582726|NCT01147068|561558709|FG004|Subjects That Received 2nd Dose|Other|1|||
155582727|NCT01147068|561558710|FG005|Subjects That Received 2nd Dose|Other|0|||
155582728|NCT01147068|561558711|FG006|Subjects That Received 2nd Dose|Other|0|||
155582729|NCT01147068|561558705|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155582730|NCT01147068|561558706|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155582731|NCT01147068|561558707|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155582732|NCT01147068|561558708|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155582733|NCT01147068|561558709|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155582734|NCT01147068|561558710|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155582735|NCT01147068|561558711|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155582736|NCT01147068|561558705|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582737|NCT01147068|561558706|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582738|NCT01147068|561558707|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582739|NCT01147068|561558708|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
155582740|NCT01147068|561558709|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582741|NCT01147068|561558710|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582742|NCT01147068|561558711|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155582743|NCT01147068|561558705|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582744|NCT01147068|561558706|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
155582745|NCT01147068|561558707|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582746|NCT01147068|561558708|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582747|NCT01147068|561558709|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582748|NCT01147068|561558710|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582749|NCT01147068|561558711|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
155582750|NCT03181633|561558712|FG000|Overall Study|Withdrawal by Subject|1|||
155582751|NCT03181633|561558712|FG000|Overall Study|Missing follow-up visit|1|||
155582752|NCT04837196|561558717|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155582753|NCT04837196|561558718|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
155582754|NCT04837196|561558719|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155582755|NCT04837196|561558720|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155582756|NCT04837196|561558721|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
155582757|NCT04837196|561558717|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155582758|NCT04837196|561558718|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
155582759|NCT04837196|561558719|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
155582760|NCT04837196|561558720|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155582761|NCT04837196|561558721|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155582762|NCT04837196|561558717|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155582763|NCT04837196|561558718|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
155582764|NCT04837196|561558719|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155582765|NCT04837196|561558720|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155582766|NCT04837196|561558721|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155582767|NCT04837196|561558717|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155582768|NCT04837196|561558718|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155582769|NCT04837196|561558719|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
155582770|NCT04837196|561558720|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155582771|NCT04837196|561558721|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155582772|NCT04837196|561558717|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155582773|NCT04837196|561558718|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155582774|NCT04837196|561558719|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
155582775|NCT04837196|561558720|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155582776|NCT04837196|561558721|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155582777|NCT02387840|561558722|FG000|Overall Study|Death|0|||
155582778|NCT02387840|561558723|FG001|Overall Study|Death|0|||
155582779|NCT02387840|561558724|FG002|Overall Study|Death|0|||
155582780|NCT02387840|561558725|FG003|Overall Study|Death|0|||
155582781|NCT02387840|561558726|FG004|Overall Study|Death|0|||
155582782|NCT02387840|561558727|FG005|Overall Study|Death|1|||
155582783|NCT01213966|561558728|FG000|Overall Study|Protocol Violation|1|||
155582784|NCT01213966|561558729|FG001|Overall Study|Protocol Violation|0|||
155582785|NCT01213966|561558730|FG002|Overall Study|Protocol Violation|3|||
155582786|NCT01213966|561558731|FG003|Overall Study|Protocol Violation|1|||
155582787|NCT00273182|561558741|FG000|Overall Study|Death|450|||
155582788|NCT00273182|561558741|FG000|Overall Study|Lost to Follow-up|88|||
155582789|NCT00273182|561558741|FG000|Overall Study|Withdrawal by Subject|257|||
155582790|NCT00273182|561558741|FG000|Overall Study|Device/System Explant|154|||
155582791|NCT00273182|561558741|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
155582792|NCT02208362|561558742|FG000|Overall Study|Participant did not complete treatment|0|||
155582793|NCT02208362|561558743|FG001|Overall Study|Participant did not complete treatment|1|||
155582794|NCT02208362|561558744|FG002|Overall Study|Participant did not complete treatment|0|||
155582795|NCT02208362|561558745|FG003|Overall Study|Participant did not complete treatment|0|||
155582796|NCT02208362|561558746|FG004|Overall Study|Participant did not complete treatment|0|||
155582797|NCT02208362|561558747|FG005|Overall Study|Participant did not complete treatment|0|||
155582798|NCT02208362|561558748|FG006|Overall Study|Participant did not complete treatment|1|||
155582799|NCT02208362|561558749|FG007|Overall Study|Participant did not complete treatment|1|||
155582800|NCT02208362|561558750|FG008|Overall Study|Participant did not complete treatment|2|||
155582801|NCT02208362|561558751|FG009|Overall Study|Participant did not complete treatment|0|||
155582802|NCT02208362|561558752|FG010|Overall Study|Participant did not complete treatment|1|||
155582803|NCT02208362|561558753|FG011|Overall Study|Participant did not complete treatment|0|||
155582804|NCT02208362|561558742|FG000|Overall Study|Participant received disallowed treatment|0|||
155582805|NCT02208362|561558743|FG001|Overall Study|Participant received disallowed treatment|0|||
155582806|NCT02208362|561558744|FG002|Overall Study|Participant received disallowed treatment|0|||
155582807|NCT02208362|561558745|FG003|Overall Study|Participant received disallowed treatment|0|||
155582808|NCT02208362|561558746|FG004|Overall Study|Participant received disallowed treatment|0|||
155582809|NCT02208362|561558747|FG005|Overall Study|Participant received disallowed treatment|0|||
155582810|NCT02208362|561558748|FG006|Overall Study|Participant received disallowed treatment|0|||
155582811|NCT02208362|561558749|FG007|Overall Study|Participant received disallowed treatment|0|||
155582812|NCT02208362|561558750|FG008|Overall Study|Participant received disallowed treatment|1|||
155582813|NCT02208362|561558751|FG009|Overall Study|Participant received disallowed treatment|0|||
155582814|NCT02208362|561558752|FG010|Overall Study|Participant received disallowed treatment|0|||
155582815|NCT02208362|561558753|FG011|Overall Study|Participant received disallowed treatment|0|||
155582816|NCT00858273|561558756|FG000|Overall Study|Protocol Violation|3|||
155582817|NCT00858273|561558757|FG001|Overall Study|Protocol Violation|5|||
155582818|NCT00350207|561560688|FG000|Overall Study|Adverse Event|5|||
155582819|NCT00350207|561560689|FG001|Overall Study|Adverse Event|2|||
155582820|NCT00350207|561560690|FG002|Overall Study|Adverse Event|2|||
155582821|NCT00350207|561560688|FG000|Overall Study|Lack of Efficacy|1|||
155582822|NCT00350207|561560689|FG001|Overall Study|Lack of Efficacy|0|||
155582823|NCT00350207|561560690|FG002|Overall Study|Lack of Efficacy|2|||
155582824|NCT00350207|561560688|FG000|Overall Study|Lost to Follow-up|1|||
155582825|NCT00350207|561560689|FG001|Overall Study|Lost to Follow-up|0|||
155582826|NCT00350207|561560690|FG002|Overall Study|Lost to Follow-up|1|||
155582827|NCT00350207|561560688|FG000|Overall Study|Withdrawal by Subject|0|||
155582828|NCT00350207|561560689|FG001|Overall Study|Withdrawal by Subject|1|||
155582829|NCT00350207|561560690|FG002|Overall Study|Withdrawal by Subject|1|||
155582830|NCT00350207|561560688|FG000|Overall Study|Other|1|||
155582831|NCT00350207|561560689|FG001|Overall Study|Other|3|||
155582832|NCT00350207|561560690|FG002|Overall Study|Other|1|||
155582833|NCT02626026|561560691|FG000|Overall Study|Randomized but Never Treated|0|||
155582834|NCT02626026|561560692|FG001|Overall Study|Randomized but Never Treated|0|||
155582835|NCT02626026|561560693|FG002|Overall Study|Randomized but Never Treated|0|||
155582836|NCT02626026|561560694|FG003|Overall Study|Randomized but Never Treated|0|||
155582837|NCT02626026|561560695|FG004|Overall Study|Randomized but Never Treated|1|||
155582838|NCT02626026|561560696|FG005|Overall Study|Randomized but Never Treated|0|||
155582839|NCT01568892|561560697|FG000|Open-label Phase|Adverse Event|2|||
155582840|NCT01568892|561560698|FG001|Open-label Phase|Adverse Event|0|||
155582841|NCT01568892|561560697|FG000|Open-label Phase|Lack of Efficacy|4|||
155582842|NCT01568892|561560698|FG001|Open-label Phase|Lack of Efficacy|2|||
155582843|NCT01568892|561560697|FG000|Open-label Phase|Lost to Follow-up|0|||
155582844|NCT01568892|561560698|FG001|Open-label Phase|Lost to Follow-up|1|||
155582845|NCT01058642|561560707|FG000|Treatment Period 1|Adverse Event|0|||
155582846|NCT01058642|561560708|FG001|Treatment Period 1|Adverse Event|1|||
155582847|NCT01058642|561560709|FG002|Treatment Period 1|Adverse Event|1|||
155582848|NCT01058642|561560710|FG003|Treatment Period 1|Adverse Event|0|||
155582849|NCT01058642|561560707|FG000|Treatment Period 1|Physician Decision|0|||
155582850|NCT01058642|561560708|FG001|Treatment Period 1|Physician Decision|0|||
155582851|NCT01058642|561560709|FG002|Treatment Period 1|Physician Decision|1|||
155582852|NCT01058642|561560710|FG003|Treatment Period 1|Physician Decision|0|||
155582853|NCT01058642|561560707|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155582854|NCT01058642|561560708|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155582855|NCT01058642|561560709|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155582856|NCT01058642|561560710|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155582857|NCT01058642|561560707|FG000|Treatment Period 1|Lack of Efficacy|0|||
155582858|NCT01058642|561560708|FG001|Treatment Period 1|Lack of Efficacy|0|||
155582859|NCT01058642|561560709|FG002|Treatment Period 1|Lack of Efficacy|0|||
155582860|NCT01058642|561560710|FG003|Treatment Period 1|Lack of Efficacy|1|||
155582861|NCT01058642|561560707|FG000|Treatment Period 1|Protocol Violation|0|||
155582862|NCT01058642|561560708|FG001|Treatment Period 1|Protocol Violation|0|||
155582863|NCT01058642|561560709|FG002|Treatment Period 1|Protocol Violation|0|||
155582864|NCT01058642|561560710|FG003|Treatment Period 1|Protocol Violation|1|||
155582865|NCT01058642|561560707|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
155582866|NCT01058642|561560708|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155582867|NCT01058642|561560709|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155582868|NCT01058642|561560710|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155582869|NCT02375971|561560711|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
155582870|NCT02375971|561560712|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
155582871|NCT02375971|561560713|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
155582872|NCT02375971|561560711|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155582873|NCT02375971|561560712|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155582874|NCT02375971|561560713|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155582875|NCT02375971|561560711|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
155582876|NCT02375971|561560712|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
155582877|NCT02375971|561560713|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
155582878|NCT02375971|561560711|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
155582879|NCT02375971|561560712|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
155582880|NCT02375971|561560713|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
155582881|NCT02375971|561560711|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
155582882|NCT02375971|561560712|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
155582883|NCT02375971|561560713|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
155582884|NCT02375971|561560711|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
155582885|NCT02375971|561560712|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
155582886|NCT02375971|561560713|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
155582887|NCT02375971|561560711|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
155582888|NCT02375971|561560712|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
155582889|NCT02375971|561560713|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
155582890|NCT02375971|561560711|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
155582891|NCT02375971|561560712|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
155582892|NCT02375971|561560713|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
155582893|NCT02755103|561560715|FG000|Overall Study|Lost to Follow-up|17|||
155582894|NCT02755103|561560716|FG001|Overall Study|Lost to Follow-up|15|||
155582895|NCT02755103|561560715|FG000|Overall Study|Death|0|||
155582896|NCT02755103|561560716|FG001|Overall Study|Death|1|||
155582897|NCT02755103|561560715|FG000|Overall Study|Physician Decision|0|||
155582898|NCT02755103|561560716|FG001|Overall Study|Physician Decision|1|||
155582899|NCT02755103|561560715|FG000|Overall Study|Pregnancy|0|||
155582900|NCT02755103|561560716|FG001|Overall Study|Pregnancy|1|||
155582901|NCT02755103|561560715|FG000|Overall Study|Withdrawal by Subject|3|||
155582902|NCT02755103|561560716|FG001|Overall Study|Withdrawal by Subject|0|||
155582903|NCT01592786|561560721|FG000|Overall Study|Adverse Event|60|||
155582904|NCT01592786|561560721|FG000|Overall Study|Lack of Efficacy|19|||
155582905|NCT01592786|561560721|FG000|Overall Study|Protocol Violation|14|||
155582906|NCT01592786|561560721|FG000|Overall Study|Withdrawal by Subject|23|||
155582907|NCT01592786|561560721|FG000|Overall Study|Lost to Follow-up|19|||
155582908|NCT01592786|561560721|FG000|Overall Study|Other|3|||
155582909|NCT01909934|561560722|FG000|Overall Study|Withdrawal by Subject|3|||
155582910|NCT01909934|561560722|FG000|Overall Study|Lost to Follow-up|1|||
155582911|NCT01909934|561560722|FG000|Overall Study|Death|25|||
155582912|NCT01909934|561560722|FG000|Overall Study|Withdrawal of Informed Consent|1|||
155582913|NCT01909934|561560722|FG000|Overall Study|Reason Not Specified|1|||
155582914|NCT03810092|561560723|FG000|Overall Study|no ground support|17|||
155582915|NCT03810092|561560723|FG000|Overall Study|ADL not done at J0|16|||
155582916|NCT03810092|561560723|FG000|Overall Study|No hemoglobin measure at J5|27|||
155582917|NCT04578535|561560725|FG000|Overall Study|Lost to Follow-up|1|||
155582918|NCT04578535|561560726|FG001|Overall Study|Lost to Follow-up|0|||
155582919|NCT04578535|561560727|FG002|Overall Study|Lost to Follow-up|0|||
155582920|NCT04578535|561560728|FG003|Overall Study|Lost to Follow-up|1|||
155582921|NCT04578535|561560729|FG004|Overall Study|Lost to Follow-up|0|||
155582922|NCT04578535|561560730|FG005|Overall Study|Lost to Follow-up|2|||
155582923|NCT04578535|561560725|FG000|Overall Study|Pregnancy|1|||
155582924|NCT04578535|561560726|FG001|Overall Study|Pregnancy|0|||
155582925|NCT04578535|561560727|FG002|Overall Study|Pregnancy|0|||
155582926|NCT04578535|561560728|FG003|Overall Study|Pregnancy|0|||
155582927|NCT04578535|561560729|FG004|Overall Study|Pregnancy|0|||
155582928|NCT04578535|561560730|FG005|Overall Study|Pregnancy|0|||
155582929|NCT04578535|561560725|FG000|Overall Study|Withdrawal by Subject|0|||
155582930|NCT04578535|561560726|FG001|Overall Study|Withdrawal by Subject|0|||
155582931|NCT04578535|561560727|FG002|Overall Study|Withdrawal by Subject|0|||
155582932|NCT04578535|561560728|FG003|Overall Study|Withdrawal by Subject|1|||
155582933|NCT04578535|561560729|FG004|Overall Study|Withdrawal by Subject|1|||
155582934|NCT04578535|561560730|FG005|Overall Study|Withdrawal by Subject|5|||
155582935|NCT04578535|561560725|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
155582936|NCT04578535|561560726|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
155582937|NCT04578535|561560727|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
155582938|NCT04578535|561560728|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
155582939|NCT04578535|561560729|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
155582940|NCT04578535|561560730|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
155582941|NCT00235755|561560731|FG000|4-Week Titration Phase|Adverse Event|6|||
155582942|NCT00235755|561560732|FG001|4-Week Titration Phase|Adverse Event|14|||
155582943|NCT00235755|561560733|FG002|4-Week Titration Phase|Adverse Event|20|||
155582944|NCT00235755|561560731|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
155582945|NCT00235755|561560732|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
155582946|NCT00235755|561560733|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
155582947|NCT00235755|561560731|FG000|4-Week Titration Phase|Protocol Violation|2|||
155582948|NCT00235755|561560732|FG001|4-Week Titration Phase|Protocol Violation|2|||
155582949|NCT00235755|561560733|FG002|4-Week Titration Phase|Protocol Violation|1|||
155582950|NCT00235755|561560731|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
155582951|NCT00235755|561560732|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
155582952|NCT00235755|561560733|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
155582953|NCT00235755|561560731|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155582954|NCT00235755|561560732|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155582955|NCT00235755|561560733|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
155582956|NCT00235755|561560731|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
155582957|NCT00235755|561560732|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
155582958|NCT00235755|561560733|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
155582959|NCT00235755|561560731|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
155582960|NCT00235755|561560732|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
155582961|NCT00235755|561560733|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
155582962|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Adverse Event|8|||
155582963|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Adverse Event|12|||
155582964|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Adverse Event|26|||
155582965|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
155582966|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
155582967|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
155582968|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
155582969|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
155582970|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
155582971|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
155582972|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
155582973|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
155582974|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
155582975|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
155582976|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
155582977|NCT00235755|561560731|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
155582978|NCT00235755|561560732|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
155582979|NCT00235755|561560733|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
155582980|NCT01707290|561560736|FG000|Overall Study|Adverse event (AE)|1|||
155582981|NCT01707290|561560737|FG001|Overall Study|Adverse event (AE)|0|||
155582982|NCT01707290|561560736|FG000|Overall Study|Physician Decision|1|||
155582983|NCT01707290|561560737|FG001|Overall Study|Physician Decision|0|||
155582984|NCT01707290|561560736|FG000|Overall Study|Lost to Follow-up|3|||
155582985|NCT01707290|561560737|FG001|Overall Study|Lost to Follow-up|0|||
155582986|NCT01707290|561560736|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
155582987|NCT01707290|561560737|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
155582988|NCT01707290|561560736|FG000|Overall Study|Commercial drug available|60|||
155582989|NCT01707290|561560737|FG001|Overall Study|Commercial drug available|1|||
155582990|NCT01707290|561560736|FG000|Overall Study|Other unspecified|17|||
155582991|NCT01707290|561560737|FG001|Overall Study|Other unspecified|0|||
155582992|NCT01882985|561560740|FG000|Overall Study|Lost to Follow-up|1|||
155582993|NCT01882985|561560740|FG000|Overall Study|Withdrawal by Subject|1|||
155582994|NCT03193853|561560747|FG000|Overall Study|Death|6|||
155582995|NCT04129125|561560748|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
155582996|NCT04129125|561560748|FG000|Overall Study|Study device was not used|3|||
155582997|NCT01787292|561560754|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
155582998|NCT01787292|561560755|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
155664476|NCT02026011|561868987|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
155582999|NCT01787292|561560754|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
155583000|NCT01787292|561560755|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
155583001|NCT01532934|561560756|FG000|Overall Study|Lost to Follow-up|11|||
155583002|NCT01532934|561560757|FG001|Overall Study|Lost to Follow-up|11|||
155583003|NCT01532934|561560756|FG000|Overall Study|In controlled environment|3|||
155583004|NCT01532934|561560757|FG001|Overall Study|In controlled environment|2|||
155583005|NCT02962648|561560759|FG000|Overall Study|Withdrawal by Subject|3|||
155583006|NCT02962648|561560759|FG000|Overall Study|Lost to Follow-up|3|||
155583007|NCT02962648|561560759|FG000|Overall Study|Physician Decision|1|||
155583008|NCT02962648|561560759|FG000|Overall Study|Subject had problems with transportation|2|||
155583009|NCT01597778|561560761|FG000|Overall Study|Death|7|||
155664477|NCT02026011|561868988|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
155583010|NCT01597778|561560762|FG001|Overall Study|Death|10|||
155583011|NCT01597778|561560761|FG000|Overall Study|Withdrawal by Subject|3|||
155583012|NCT01597778|561560762|FG001|Overall Study|Withdrawal by Subject|4|||
155583013|NCT01597778|561560761|FG000|Overall Study|Adverse Event|1|||
155583014|NCT01597778|561560762|FG001|Overall Study|Adverse Event|1|||
155583015|NCT01597778|561560761|FG000|Overall Study|Protocol Violation|1|||
155583016|NCT01597778|561560762|FG001|Overall Study|Protocol Violation|11|||
155583017|NCT01597778|561560761|FG000|Overall Study|Transplanted off protocol|2|||
155664478|NCT02026011|561868987|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
155664479|NCT02026011|561868988|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
155664480|NCT02026011|561868987|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
155664481|NCT02026011|561868988|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
155664482|NCT02026011|561868987|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
155664483|NCT02026011|561868988|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
155664484|NCT05010070|561868989|FG000|Overall Study|Lost to Follow-up|1|||
155664485|NCT05010070|561868989|FG000|Overall Study|Withdrawal by Subject|1|||
155664486|NCT00529243|561868991|FG000|Overall Study|Adverse Event|1|||
155664487|NCT00529243|561868991|FG000|Overall Study|Death|1|||
155664488|NCT00529243|561868991|FG000|Overall Study|Relocated|1|||
155664489|NCT01783444|561868992|FG000|Treatment Phase|Adverse Event|9|||
155664490|NCT01783444|561868993|FG001|Treatment Phase|Adverse Event|20|||
155664491|NCT01783444|561868994|FG002|Treatment Phase|Adverse Event|19|||
155664492|NCT01783444|561868992|FG000|Treatment Phase|Disease Progression|76|||
155664493|NCT01783444|561868993|FG001|Treatment Phase|Disease Progression|66|||
155664494|NCT01783444|561868994|FG002|Treatment Phase|Disease Progression|64|||
155664495|NCT01783444|561868992|FG000|Treatment Phase|Death|2|||
155664496|NCT01783444|561868993|FG001|Treatment Phase|Death|2|||
155664497|NCT01783444|561868994|FG002|Treatment Phase|Death|2|||
155664498|NCT01783444|561868992|FG000|Treatment Phase|Protocol Violation|1|||
155664499|NCT01783444|561868993|FG001|Treatment Phase|Protocol Violation|1|||
155664500|NCT01783444|561868994|FG002|Treatment Phase|Protocol Violation|2|||
155664501|NCT01783444|561868992|FG000|Treatment Phase|Withdrawal by Subject|6|||
155664502|NCT01783444|561868993|FG001|Treatment Phase|Withdrawal by Subject|8|||
155664503|NCT01783444|561868994|FG002|Treatment Phase|Withdrawal by Subject|9|||
155664504|NCT01783444|561868992|FG000|Treatment Phase|Administrative problems|2|||
155664505|NCT01783444|561868993|FG001|Treatment Phase|Administrative problems|0|||
155664506|NCT01783444|561868994|FG002|Treatment Phase|Administrative problems|1|||
155664507|NCT01783444|561868992|FG000|Treatment Phase|Physician Decision|8|||
155664508|NCT01783444|561868993|FG001|Treatment Phase|Physician Decision|6|||
155664509|NCT01783444|561868994|FG002|Treatment Phase|Physician Decision|5|||
155664510|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
155664511|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
155664512|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
155664513|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
155664514|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
155664515|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
155664516|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
155664517|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
155664518|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
155664519|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
155664520|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
155664521|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
155664522|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
155664523|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
155664524|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
155664525|NCT01783444|561868992|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
155664526|NCT01783444|561868993|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
155664527|NCT01783444|561868994|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
155664528|NCT02896257|561868995|FG000|Providers|Without eligible patients|21|||
155664529|NCT02896257|561868996|FG001|Providers|Without eligible patients|28|||
155664530|NCT02896257|561868995|FG000|Patients|PFT entry criteria not met|43|||
155664531|NCT02896257|561868996|FG001|Patients|PFT entry criteria not met|50|||
155664532|NCT02896257|561868995|FG000|Patients|No capacity to review|8|||
155664533|NCT02896257|561868996|FG001|Patients|No capacity to review|11|||
155664534|NCT02896257|561868995|FG000|Patients|Appointment rescheduled/cancelled|5|||
155664535|NCT02896257|561868996|FG001|Patients|Appointment rescheduled/cancelled|7|||
155664536|NCT02896257|561868995|FG000|Patients|PCP not assigned a clinic|4|||
155664537|NCT02896257|561868996|FG001|Patients|PCP not assigned a clinic|0|||
155583018|NCT01597778|561560762|FG001|Overall Study|Transplanted off protocol|3|||
155583019|NCT03267212|561560763|FG000|First Intervention|Lost to Follow-up|0|||
155583020|NCT03267212|561560764|FG001|First Intervention|Lost to Follow-up|2|||
155583021|NCT03267212|561560763|FG000|First Intervention|Withdrawal by Subject|1|||
155583022|NCT03267212|561560764|FG001|First Intervention|Withdrawal by Subject|1|||
155583023|NCT03267212|561560763|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
155583024|NCT03267212|561560764|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
155583025|NCT04383327|561560766|FG000|Overall Study|Lost to Follow-up|112|||
155583026|NCT04383327|561560767|FG001|Overall Study|Lost to Follow-up|14|||
155583027|NCT04383327|561560768|FG002|Overall Study|Lost to Follow-up|78|||
155583028|NCT04383327|561560769|FG003|Overall Study|Lost to Follow-up|13|||
155583029|NCT04383327|561560770|FG004|Overall Study|Lost to Follow-up|110|||
155583030|NCT04383327|561560771|FG005|Overall Study|Lost to Follow-up|13|||
155583031|NCT04383327|561560772|FG006|Overall Study|Lost to Follow-up|74|||
155583032|NCT04383327|561560773|FG007|Overall Study|Lost to Follow-up|13|||
155583033|NCT04383327|561560774|FG008|Overall Study|Lost to Follow-up|78|||
155583034|NCT04383327|561560775|FG009|Overall Study|Lost to Follow-up|10|||
155583035|NCT04383327|561560776|FG010|Overall Study|Lost to Follow-up|160|||
155583036|NCT04383327|561560777|FG011|Overall Study|Lost to Follow-up|13|||
155583037|NCT05691712|561560778|FG000|Overall Study|Adverse Event|0|||
155583038|NCT05691712|561560779|FG001|Overall Study|Adverse Event|1|||
155583039|NCT05691712|561560780|FG002|Overall Study|Adverse Event|2|||
155583040|NCT05691712|561560781|FG003|Overall Study|Adverse Event|1|||
155583041|NCT05691712|561560778|FG000|Overall Study|Withdrawal by Subject|2|||
155583042|NCT05691712|561560779|FG001|Overall Study|Withdrawal by Subject|3|||
155583043|NCT05691712|561560780|FG002|Overall Study|Withdrawal by Subject|3|||
155583044|NCT05691712|561560781|FG003|Overall Study|Withdrawal by Subject|1|||
155583045|NCT05691712|561560778|FG000|Overall Study|Death|1|||
155583046|NCT05691712|561560779|FG001|Overall Study|Death|0|||
155583047|NCT05691712|561560780|FG002|Overall Study|Death|0|||
155583048|NCT05691712|561560781|FG003|Overall Study|Death|0|||
155583049|NCT05691712|561560778|FG000|Overall Study|Pregnancy|0|||
155583050|NCT05691712|561560779|FG001|Overall Study|Pregnancy|1|||
155583051|NCT05691712|561560780|FG002|Overall Study|Pregnancy|0|||
155583052|NCT05691712|561560781|FG003|Overall Study|Pregnancy|0|||
155583053|NCT05691712|561560778|FG000|Overall Study|Assigned Treatment by Mistake|1|||
155583054|NCT05691712|561560779|FG001|Overall Study|Assigned Treatment by Mistake|0|||
155583055|NCT05691712|561560780|FG002|Overall Study|Assigned Treatment by Mistake|0|||
155583056|NCT05691712|561560781|FG003|Overall Study|Assigned Treatment by Mistake|1|||
155583057|NCT05303194|561560782|FG000|Overall Study|Lost to Follow-up|1|||
155583058|NCT05303194|561560783|FG001|Overall Study|Lost to Follow-up|1|||
155583059|NCT05303194|561560782|FG000|Overall Study|Withdrawal by Subject|0|||
155583060|NCT05303194|561560783|FG001|Overall Study|Withdrawal by Subject|1|||
155583061|NCT01289678|561560793|FG000|Overall Study|Physician Decision|6|||
155583062|NCT00991887|561560794|FG000|Overall Study|Lost to Follow-up|2|||
155583063|NCT00991887|561560795|FG001|Overall Study|Lost to Follow-up|1|||
155583064|NCT00226499|561560796|FG000|Overall Study|Adverse Event|10|||
155583065|NCT00226499|561560797|FG001|Overall Study|Adverse Event|6|||
155583066|NCT00226499|561560798|FG002|Overall Study|Adverse Event|3|||
155583067|NCT00226499|561560796|FG000|Overall Study|Others|1064|||
155583068|NCT00226499|561560797|FG001|Overall Study|Others|1066|||
155664538|NCT02896257|561868995|FG000|Patients|No history of COPD|0|||
155664539|NCT02896257|561868996|FG001|Patients|No history of COPD|1|||
155664540|NCT02896257|561868995|FG000|Patients|Deceased between review and index date|0|||
155664541|NCT02896257|561868996|FG001|Patients|Deceased between review and index date|1|||
155664542|NCT02896257|561868995|FG000|Patients|No ICS Rx upon review|1|||
155664543|NCT02896257|561868996|FG001|Patients|No ICS Rx upon review|1|||
155664544|NCT02896257|561868995|FG000|Patients|Protocol Violation|2|||
155664545|NCT02896257|561868996|FG001|Patients|Protocol Violation|1|||
155664546|NCT02896257|561868995|FG000|Patients|Hospice care|0|||
155664547|NCT02896257|561868996|FG001|Patients|Hospice care|1|||
155664548|NCT03759600|561869001|FG000|Overall Study|Adverse Event|2|||
155664549|NCT03759600|561869001|FG000|Overall Study|Progressive Disease|15|||
155664550|NCT03759600|561869001|FG000|Overall Study|Site Terminated by Sponsor|3|||
155664551|NCT03257358|561869002|FG000|Overall Study|Adverse Event|25|||
155664552|NCT03257358|561869003|FG001|Overall Study|Adverse Event|12|||
155664553|NCT03257358|561869002|FG000|Overall Study|Lack of Efficacy|1|||
155583069|NCT00226499|561560798|FG002|Overall Study|Others|356|||
155583070|NCT02723344|561560801|FG000|Overall Study|Lost to Follow-up|0|||
155583071|NCT02723344|561560802|FG001|Overall Study|Lost to Follow-up|4|||
155583072|NCT02524847|561560804|FG000|Overall Study|Adverse Event|4|||
155583073|NCT02524847|561560804|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155583074|NCT02524847|561560804|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
155583075|NCT02524847|561560804|FG000|Overall Study|Death|1|||
155583076|NCT02524847|561560804|FG000|Overall Study|Reason not Specified|1|||
155583077|NCT04352101|561560805|FG000|Overall Study|Physician Decision|2|||
155583078|NCT04352101|561560806|FG001|Overall Study|Physician Decision|1|||
155583079|NCT03170544|561560813|FG000|Part 1|Lost to Follow-up|1|||
155583080|NCT03170544|561560814|FG001|Part 1|Lost to Follow-up|0|||
155583081|NCT03170544|561560815|FG002|Part 1|Lost to Follow-up|0|||
155583082|NCT03170544|561560816|FG003|Part 1|Lost to Follow-up|0|||
155583083|NCT03170544|561560817|FG004|Part 1|Lost to Follow-up|0|||
155583084|NCT03170544|561560818|FG005|Part 1|Lost to Follow-up|0|||
155583085|NCT03170544|561560819|FG006|Part 1|Lost to Follow-up|0|||
155583086|NCT03170544|561560820|FG007|Part 1|Lost to Follow-up|0|||
155583087|NCT03170544|561560821|FG008|Part 1|Lost to Follow-up|0|||
155583088|NCT03170544|561560822|FG009|Part 1|Lost to Follow-up|0|||
155583089|NCT03170544|561560823|FG010|Part 1|Lost to Follow-up|0|||
155583090|NCT03170544|561560824|FG011|Part 1|Lost to Follow-up|0|||
155583091|NCT03170544|561560813|FG000|Part 1|Not treated|0|||
155583092|NCT03170544|561560814|FG001|Part 1|Not treated|0|||
155583093|NCT03170544|561560815|FG002|Part 1|Not treated|0|||
155583094|NCT03170544|561560816|FG003|Part 1|Not treated|1|||
155583095|NCT03170544|561560817|FG004|Part 1|Not treated|0|||
155583096|NCT03170544|561560818|FG005|Part 1|Not treated|0|||
155583097|NCT03170544|561560819|FG006|Part 1|Not treated|0|||
155583098|NCT03170544|561560820|FG007|Part 1|Not treated|0|||
155583099|NCT03170544|561560821|FG008|Part 1|Not treated|0|||
155583100|NCT03170544|561560822|FG009|Part 1|Not treated|0|||
155583101|NCT03170544|561560823|FG010|Part 1|Not treated|0|||
155583102|NCT03170544|561560824|FG011|Part 1|Not treated|0|||
155583103|NCT04564092|561560827|FG000|Overall Study|Withdrawal by Subject|1|||
155583104|NCT00420420|561560828|FG000|Overall Study|Adverse Event|5|||
155664554|NCT03257358|561869003|FG001|Overall Study|Lack of Efficacy|1|||
155664555|NCT03257358|561869002|FG000|Overall Study|Lost to Follow-up|12|||
155664556|NCT03257358|561869003|FG001|Overall Study|Lost to Follow-up|4|||
155664557|NCT03257358|561869002|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
155664558|NCT03257358|561869003|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
155664559|NCT03257358|561869002|FG000|Overall Study|Physician Decision|2|||
155664560|NCT03257358|561869003|FG001|Overall Study|Physician Decision|2|||
155664561|NCT03257358|561869002|FG000|Overall Study|Protocol Violation|5|||
155664562|NCT03257358|561869003|FG001|Overall Study|Protocol Violation|3|||
155664563|NCT03257358|561869002|FG000|Overall Study|Technical problems|4|||
155664564|NCT03257358|561869003|FG001|Overall Study|Technical problems|1|||
155664565|NCT03257358|561869002|FG000|Overall Study|Withdrawal by Subject|8|||
155583105|NCT00420420|561560829|FG001|Overall Study|Adverse Event|3|||
155583106|NCT00420420|561560828|FG000|Overall Study|Protocol Violation|1|||
155583107|NCT00420420|561560829|FG001|Overall Study|Protocol Violation|1|||
155583108|NCT00420420|561560828|FG000|Overall Study|Withdrawal by Subject|1|||
155583109|NCT00420420|561560829|FG001|Overall Study|Withdrawal by Subject|0|||
155583110|NCT00420420|561560828|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
155583111|NCT00420420|561560829|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
155583112|NCT00359424|561560830|FG000|Overall Study|Death|99|||
155583113|NCT00359424|561560831|FG001|Overall Study|Death|58|||
155664566|NCT03257358|561869003|FG001|Overall Study|Withdrawal by Subject|3|||
155664567|NCT03257358|561869002|FG000|Overall Study|Withdrawal of informed consent|9|||
155583114|NCT00359424|561560830|FG000|Overall Study|Lost to Follow-up|19|||
155583115|NCT00359424|561560831|FG001|Overall Study|Lost to Follow-up|7|||
155583116|NCT00359424|561560830|FG000|Overall Study|Withdrawal by Subject|10|||
155583117|NCT00359424|561560831|FG001|Overall Study|Withdrawal by Subject|2|||
155583118|NCT00359424|561560830|FG000|Overall Study|follow up not conducted|2|||
155583119|NCT00359424|561560831|FG001|Overall Study|follow up not conducted|0|||
155583120|NCT04762160|561560832|FG000|Overall Study|Study terminated early due to business reasons|5|||
155583121|NCT02362360|561560838|FG000|Period 1|Lack of Efficacy|1|||
155583122|NCT02362360|561560839|FG001|Period 1|Lack of Efficacy|0|||
155583123|NCT02362360|561560838|FG000|Period 1|Withdrawal by Subject|2|||
155583124|NCT02362360|561560839|FG001|Period 1|Withdrawal by Subject|1|||
155583125|NCT00868530|561560843|FG000|Overall Study|Adverse Event|3|||
155583126|NCT00868530|561560843|FG000|Overall Study|Lost to Follow-up|1|||
155583127|NCT01880554|561562554|FG000|Overall Study|Protocol Violation|14|||
155583128|NCT01880554|561562554|FG000|Overall Study|Simon's design requirements|2|||
155583129|NCT03976362|561562558|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
155583130|NCT03976362|561562559|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155583131|NCT03976362|561562560|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155583132|NCT03976362|561562558|FG000|Induction Phase|Death|62|||
155583133|NCT03976362|561562559|FG001|Induction Phase|Death|0|||
155583134|NCT03976362|561562560|FG002|Induction Phase|Death|0|||
155583135|NCT03976362|561562558|FG000|Maintenance Phase|Participants Ongoing|0|||
155583136|NCT03976362|561562559|FG001|Maintenance Phase|Participants Ongoing|106|||
155583137|NCT03976362|561562560|FG002|Maintenance Phase|Participants Ongoing|103|||
155583138|NCT03976362|561562558|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155583139|NCT03976362|561562559|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155583140|NCT03976362|561562560|FG002|Maintenance Phase|Withdrawal by Subject|4|||
155583141|NCT03976362|561562558|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
155583142|NCT03976362|561562559|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
155583143|NCT03976362|561562560|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
155583144|NCT03976362|561562558|FG000|Maintenance Phase|Death|0|||
155583145|NCT03976362|561562559|FG001|Maintenance Phase|Death|186|||
155583146|NCT03976362|561562560|FG002|Maintenance Phase|Death|187|||
155583147|NCT04846569|561562561|FG000|Overall Study|Withdrawal by Subject|3|||
155583148|NCT04846569|561562562|FG001|Overall Study|Withdrawal by Subject|1|||
155583149|NCT02512302|561562563|FG000|Period 1|Adverse Event|0|||
155583150|NCT02512302|561562564|FG001|Period 1|Adverse Event|1|||
155583151|NCT02512302|561562565|FG002|Period 1|Adverse Event|0|||
155583152|NCT02512302|561562566|FG003|Period 1|Adverse Event|0|||
155583153|NCT02512302|561562567|FG004|Period 1|Adverse Event|0|||
155583154|NCT02512302|561562568|FG005|Period 1|Adverse Event|0|||
155583155|NCT02512302|561562569|FG006|Period 1|Adverse Event|0|||
155583156|NCT02512302|561562570|FG007|Period 1|Adverse Event|0|||
155583157|NCT02512302|561562571|FG008|Period 1|Adverse Event|0|||
155583158|NCT02512302|561562572|FG009|Period 1|Adverse Event|0|||
155583159|NCT02512302|561562563|FG000|Period 2|Adverse Event|0|||
155583160|NCT02512302|561562564|FG001|Period 2|Adverse Event|0|||
155583161|NCT02512302|561562565|FG002|Period 2|Adverse Event|0|||
155583162|NCT02512302|561562566|FG003|Period 2|Adverse Event|0|||
155583163|NCT02512302|561562567|FG004|Period 2|Adverse Event|0|||
155583164|NCT02512302|561562568|FG005|Period 2|Adverse Event|0|||
155583165|NCT02512302|561562569|FG006|Period 2|Adverse Event|0|||
155583166|NCT02512302|561562570|FG007|Period 2|Adverse Event|0|||
155583167|NCT02512302|561562571|FG008|Period 2|Adverse Event|0|||
155583168|NCT02512302|561562572|FG009|Period 2|Adverse Event|1|||
155583169|NCT02512302|561562563|FG000|Period 3|Lost to Follow-up|0|||
155583170|NCT02512302|561562564|FG001|Period 3|Lost to Follow-up|0|||
155583171|NCT02512302|561562565|FG002|Period 3|Lost to Follow-up|1|||
155583172|NCT02512302|561562566|FG003|Period 3|Lost to Follow-up|0|||
155583173|NCT02512302|561562567|FG004|Period 3|Lost to Follow-up|0|||
155583174|NCT02512302|561562568|FG005|Period 3|Lost to Follow-up|0|||
155583175|NCT02512302|561562569|FG006|Period 3|Lost to Follow-up|0|||
155583176|NCT02512302|561562570|FG007|Period 3|Lost to Follow-up|0|||
155583177|NCT02512302|561562571|FG008|Period 3|Lost to Follow-up|0|||
155583178|NCT02512302|561562572|FG009|Period 3|Lost to Follow-up|0|||
155583179|NCT02512302|561562563|FG000|Period 4|Adverse Event|0|||
155583180|NCT02512302|561562564|FG001|Period 4|Adverse Event|0|||
155583181|NCT02512302|561562565|FG002|Period 4|Adverse Event|0|||
155583182|NCT02512302|561562566|FG003|Period 4|Adverse Event|0|||
155583183|NCT02512302|561562567|FG004|Period 4|Adverse Event|0|||
155664568|NCT03257358|561869003|FG001|Overall Study|Withdrawal of informed consent|5|||
155664569|NCT03257358|561869002|FG000|Overall Study|New therapy for study indication|1|||
155664570|NCT03257358|561869003|FG001|Overall Study|New therapy for study indication|0|||
155664571|NCT03257358|561869002|FG000|Overall Study|No longer requires treatment|0|||
155664572|NCT03257358|561869003|FG001|Overall Study|No longer requires treatment|1|||
155664573|NCT01669902|561869004|FG000|Overall Study|Adverse Event|11|||
155583184|NCT02512302|561562568|FG005|Period 4|Adverse Event|0|||
155583185|NCT02512302|561562569|FG006|Period 4|Adverse Event|1|||
155583186|NCT02512302|561562570|FG007|Period 4|Adverse Event|0|||
155583187|NCT02512302|561562571|FG008|Period 4|Adverse Event|0|||
155583188|NCT02512302|561562572|FG009|Period 4|Adverse Event|0|||
155583189|NCT00683618|561562575|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
155583190|NCT00683618|561562576|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
155583191|NCT00683618|561562577|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
155583192|NCT00683618|561562575|FG000|Randomised Treatment Period|Protocol Violation|0|||
155583193|NCT00683618|561562576|FG001|Randomised Treatment Period|Protocol Violation|1|||
155583194|NCT00683618|561562577|FG002|Randomised Treatment Period|Protocol Violation|0|||
155583195|NCT00683618|561562575|FG000|Randomised Treatment Period|Adverse Event|2|||
155583196|NCT00683618|561562576|FG001|Randomised Treatment Period|Adverse Event|0|||
155583197|NCT00683618|561562577|FG002|Randomised Treatment Period|Adverse Event|2|||
155583198|NCT00683618|561562575|FG000|Randomised Treatment Period|Reason not provided|0|||
155583199|NCT00683618|561562576|FG001|Randomised Treatment Period|Reason not provided|0|||
155583200|NCT00683618|561562577|FG002|Randomised Treatment Period|Reason not provided|2|||
155583201|NCT00683618|561562575|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
155583202|NCT00683618|561562576|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155583203|NCT00683618|561562577|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155583204|NCT00683618|561562575|FG000|Extension Treatment Period|Adverse Event|1|||
155583205|NCT00683618|561562576|FG001|Extension Treatment Period|Adverse Event|0|||
155583206|NCT00683618|561562577|FG002|Extension Treatment Period|Adverse Event|0|||
155583207|NCT00683618|561562575|FG000|Extension Treatment Period|Protocol Violation|1|||
155583208|NCT00683618|561562576|FG001|Extension Treatment Period|Protocol Violation|0|||
155583209|NCT00683618|561562577|FG002|Extension Treatment Period|Protocol Violation|0|||
155583210|NCT02954601|561562578|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
155583211|NCT02954601|561562579|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
155583212|NCT02954601|561562580|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
155583213|NCT02954601|561562581|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
155583214|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
155583215|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
155583216|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
155583217|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
155583218|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
155583219|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583220|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583221|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583222|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583223|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583224|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583225|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583226|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583227|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583228|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155583229|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
155583230|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
155583231|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
155583232|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
155583233|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
155664574|NCT01669902|561869004|FG000|Overall Study|Lack of Efficacy|10|||
155664575|NCT01669902|561869004|FG000|Overall Study|Other|8|||
155664576|NCT02903823|561869005|FG000|Overall Study|Physician Decision|5|||
155583234|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583235|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583236|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583237|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583238|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583239|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583240|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583241|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583242|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583243|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155583244|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
155583245|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
155583246|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
155583247|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
155583248|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
155583249|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583250|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583251|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583252|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583253|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583254|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583255|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583256|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583257|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583258|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155583259|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
155583260|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
155583261|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
155583262|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
155583263|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
155583264|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583265|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583266|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583267|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583268|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583269|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583270|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583271|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583272|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583273|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155583274|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
155583275|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583276|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
155583277|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
155583278|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
155583279|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583280|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583281|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583282|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583283|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583284|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583285|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583286|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583287|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583288|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155583289|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583290|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583291|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583292|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
155583293|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583294|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583295|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583296|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
155664577|NCT02903823|561869005|FG000|Overall Study|Could not advance catheter|1|||
155664578|NCT02903823|561869005|FG000|Overall Study|Catheter dislodgement|1|||
155664579|NCT02852967|561869006|FG000|Overall Study|Adverse Event|3|||
155583297|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583298|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583299|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583300|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583301|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583302|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
155583303|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
155664580|NCT02852967|561869007|FG001|Overall Study|Adverse Event|1|||
155664581|NCT02852967|561869008|FG002|Overall Study|Adverse Event|0|||
155664582|NCT02852967|561869009|FG003|Overall Study|Adverse Event|1|||
155664583|NCT02852967|561869010|FG004|Overall Study|Adverse Event|0|||
155583304|NCT03334435|561562590|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583305|NCT03334435|561562591|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
155583306|NCT03334435|561562592|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
155583307|NCT03334435|561562593|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
155583308|NCT03334435|561562594|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
155583309|NCT03334435|561562595|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583310|NCT03334435|561562596|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583311|NCT03334435|561562597|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583312|NCT03334435|561562598|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583313|NCT03334435|561562599|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583314|NCT03334435|561562600|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583315|NCT03334435|561562601|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583316|NCT03334435|561562602|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583317|NCT03334435|561562603|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583318|NCT03334435|561562604|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
155583319|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155583320|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155583321|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155583322|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155583323|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155583324|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155583325|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
155583326|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155583327|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
155583328|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
155583329|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155583330|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
155583331|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
155583332|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
155583333|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
155583334|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155583335|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155583336|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155583337|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155583338|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155583339|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
155583340|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
155583341|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
155583342|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
155583343|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
155583344|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
155583345|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
155664584|NCT02852967|561869006|FG000|Overall Study|Death|1|||
155664585|NCT02852967|561869007|FG001|Overall Study|Death|0|||
155664586|NCT02852967|561869008|FG002|Overall Study|Death|0|||
155664587|NCT02852967|561869009|FG003|Overall Study|Death|0|||
155664588|NCT02852967|561869010|FG004|Overall Study|Death|0|||
155664589|NCT02852967|561869006|FG000|Overall Study|Lost to Follow-up|1|||
155583346|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
155664590|NCT02852967|561869007|FG001|Overall Study|Lost to Follow-up|2|||
155664591|NCT02852967|561869008|FG002|Overall Study|Lost to Follow-up|3|||
155664592|NCT02852967|561869009|FG003|Overall Study|Lost to Follow-up|4|||
155664593|NCT02852967|561869010|FG004|Overall Study|Lost to Follow-up|4|||
155664594|NCT02852967|561869006|FG000|Overall Study|Withdrawal by Subject|6|||
155583347|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
155583348|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
155583349|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583350|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583351|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583352|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583353|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583354|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
155583355|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
155583356|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
155583357|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
155583358|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
155583359|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
155583360|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
155583361|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155583362|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
155664595|NCT02852967|561869007|FG001|Overall Study|Withdrawal by Subject|12|||
155664596|NCT02852967|561869008|FG002|Overall Study|Withdrawal by Subject|7|||
155664597|NCT02852967|561869009|FG003|Overall Study|Withdrawal by Subject|10|||
155664598|NCT02852967|561869010|FG004|Overall Study|Withdrawal by Subject|10|||
155583363|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
155583364|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155664599|NCT02852967|561869006|FG000|Overall Study|SAE|0|||
155664600|NCT02852967|561869007|FG001|Overall Study|SAE|0|||
155664601|NCT02852967|561869008|FG002|Overall Study|SAE|0|||
155664602|NCT02852967|561869009|FG003|Overall Study|SAE|3|||
155664603|NCT02852967|561869010|FG004|Overall Study|SAE|0|||
155664604|NCT02852967|561869006|FG000|Overall Study|Elevated Liver Enzymes|2|||
155664605|NCT02852967|561869007|FG001|Overall Study|Elevated Liver Enzymes|0|||
155664606|NCT02852967|561869008|FG002|Overall Study|Elevated Liver Enzymes|0|||
155664607|NCT02852967|561869009|FG003|Overall Study|Elevated Liver Enzymes|2|||
155664608|NCT02852967|561869010|FG004|Overall Study|Elevated Liver Enzymes|2|||
155664609|NCT02852967|561869006|FG000|Overall Study|Physician Decision|0|||
155664610|NCT02852967|561869007|FG001|Overall Study|Physician Decision|0|||
155664611|NCT02852967|561869008|FG002|Overall Study|Physician Decision|0|||
155664612|NCT02852967|561869009|FG003|Overall Study|Physician Decision|1|||
155664613|NCT02852967|561869010|FG004|Overall Study|Physician Decision|0|||
155664614|NCT02852967|561869006|FG000|Overall Study|Lack of Efficacy|0|||
155664615|NCT02852967|561869007|FG001|Overall Study|Lack of Efficacy|1|||
155664616|NCT02852967|561869008|FG002|Overall Study|Lack of Efficacy|0|||
155664617|NCT02852967|561869009|FG003|Overall Study|Lack of Efficacy|0|||
155664618|NCT02852967|561869010|FG004|Overall Study|Lack of Efficacy|0|||
155664619|NCT02852967|561869006|FG000|Overall Study|Non-compliance|0|||
155583365|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155583366|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155583367|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155583368|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155583369|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
155583370|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
155583371|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155583372|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155583373|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
155583374|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
155583375|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
155583376|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155583377|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
155583378|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
155583379|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583380|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583381|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583382|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583383|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583384|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583385|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
155583386|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
155583387|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
155583388|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155583389|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155583390|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155583391|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155583392|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
155583393|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
155583394|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583395|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583396|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583397|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583398|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583399|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155664620|NCT02852967|561869007|FG001|Overall Study|Non-compliance|0|||
155664621|NCT02852967|561869008|FG002|Overall Study|Non-compliance|1|||
155664622|NCT02852967|561869009|FG003|Overall Study|Non-compliance|1|||
155664623|NCT02852967|561869010|FG004|Overall Study|Non-compliance|0|||
155664624|NCT02852967|561869006|FG000|Overall Study|Dispensing Drug Violation|0|||
155664625|NCT02852967|561869007|FG001|Overall Study|Dispensing Drug Violation|0|||
155664626|NCT02852967|561869008|FG002|Overall Study|Dispensing Drug Violation|1|||
155664627|NCT02852967|561869009|FG003|Overall Study|Dispensing Drug Violation|0|||
155583400|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583401|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583402|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583403|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583404|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583405|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
155583406|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583407|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
155583408|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155583409|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583410|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583411|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583412|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583413|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583414|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
155583415|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583416|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583417|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583418|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583419|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583420|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583421|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583422|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
155583423|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
155583424|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583425|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583426|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583427|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583428|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583429|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583430|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583431|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583432|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583433|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
155583434|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583435|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155583436|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583437|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583438|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155583439|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583440|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583441|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583442|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583443|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583444|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155583445|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155583446|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583447|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583448|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583449|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155583450|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155583451|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155583452|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
155583453|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
155583454|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583455|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583456|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583457|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583458|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583459|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155583460|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583461|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583462|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583463|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583464|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155583465|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583466|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583467|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155583468|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155583469|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583470|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583471|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583472|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583473|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583474|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583475|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583476|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155583477|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155583478|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583479|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155583480|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
155583481|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155583482|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583483|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155583484|NCT03334435|561562590|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583485|NCT03334435|561562591|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583486|NCT03334435|561562592|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583487|NCT03334435|561562593|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583488|NCT03334435|561562594|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583489|NCT03334435|561562595|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583490|NCT03334435|561562596|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583491|NCT03334435|561562597|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583492|NCT03334435|561562598|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583493|NCT03334435|561562599|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583494|NCT03334435|561562600|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583495|NCT03334435|561562601|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155583496|NCT03334435|561562602|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155583497|NCT03334435|561562603|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155583498|NCT03334435|561562604|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155583499|NCT03922321|561562605|FG000|Overall Study|Participant Moved|1|||
155583500|NCT03922321|561562605|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
155583501|NCT02342678|561562609|FG000|Overall Study|Lost to Follow-up|0|||
155583502|NCT02342678|561562610|FG001|Overall Study|Lost to Follow-up|1|||
155583503|NCT02342678|561562609|FG000|Overall Study|Too busy to complete study|0|||
155583504|NCT02342678|561562610|FG001|Overall Study|Too busy to complete study|2|||
155583505|NCT02342678|561562609|FG000|Overall Study|Family illness/emergency|0|||
155583506|NCT02342678|561562610|FG001|Overall Study|Family illness/emergency|1|||
155583507|NCT02342678|561562609|FG000|Overall Study|Illness/medical reason|1|||
155583508|NCT02342678|561562610|FG001|Overall Study|Illness/medical reason|1|||
155583509|NCT03214224|561562615|FG000|Overall Study|Protocol Violation|1|||
155583510|NCT03214224|561562615|FG000|Overall Study|Withdrawal by Subject|2|||
155583511|NCT03214224|561562615|FG000|Overall Study|Practice controls or therapists|6|||
155583512|NCT03802825|561562624|FG000|Overall Study|Lost to follow-up for intervention|12|||
155583513|NCT03802825|561562625|FG001|Overall Study|Lost to follow-up for intervention|3|||
155583514|NCT03802825|561562624|FG000|Overall Study|Received only 1 component of intervention|0|||
155583515|NCT03802825|561562625|FG001|Overall Study|Received only 1 component of intervention|13|||
155583516|NCT05266053|561562626|FG000|Overall Study|Withdrawal by Subject|8|||
155583517|NCT05266053|561562627|FG001|Overall Study|Withdrawal by Subject|4|||
155583518|NCT01051960|561562631|FG000|Overall Study|Adverse Event|1|||
155583519|NCT00360282|561562632|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
155583520|NCT00360282|561562633|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
155583521|NCT00360282|561562634|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
155583522|NCT00360282|561562635|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
155583523|NCT00360282|561562632|FG000|Second Intervention|Adverse Event|0|||
155583524|NCT00360282|561562633|FG001|Second Intervention|Adverse Event|1|||
155583525|NCT00360282|561562634|FG002|Second Intervention|Adverse Event|0|||
155583526|NCT00360282|561562635|FG003|Second Intervention|Adverse Event|0|||
155583527|NCT02996968|561562636|FG000|Overall Study|Withdrawal by Subject|1|||
155583528|NCT02996968|561562637|FG001|Overall Study|Withdrawal by Subject|0|||
155583529|NCT04537078|561562640|FG000|Overall Study|Protocol Violation|3|||
155583530|NCT04537078|561562641|FG001|Overall Study|Protocol Violation|2|||
155583531|NCT04537078|561562640|FG000|Overall Study|Lost to Follow-up|1|||
155583532|NCT04537078|561562641|FG001|Overall Study|Lost to Follow-up|0|||
155583533|NCT04537078|561562640|FG000|Overall Study|Withdrawal by Subject|0|||
155583534|NCT04537078|561562641|FG001|Overall Study|Withdrawal by Subject|1|||
155583535|NCT00444535|561562645|FG000|Overall Study|Withdrawal by Subject|5|||
155583536|NCT00444535|561562645|FG000|Overall Study|Physician Decision|5|||
155583537|NCT00444535|561562645|FG000|Overall Study|progressive disease|1|||
155583538|NCT00444535|561562645|FG000|Overall Study|Adverse Event|2|||
155583539|NCT05005507|561562646|FG000|Overall Study|Premature termination of study|1|||
155583540|NCT01704495|561562648|FG000|Subjects Randomized|Other Reason|3|||
155583541|NCT01704495|561562649|FG001|Subjects Randomized|Other Reason|2|||
155583542|NCT01704495|561562650|FG002|Subjects Randomized|Other Reason|3|||
155583543|NCT01704495|561562651|FG003|Subjects Randomized|Other Reason|2|||
155583544|NCT01704495|561562648|FG000|Subjects Randomized|Discontinuation criteria met|4|||
155583545|NCT01704495|561562649|FG001|Subjects Randomized|Discontinuation criteria met|2|||
155583546|NCT01704495|561562650|FG002|Subjects Randomized|Discontinuation criteria met|2|||
155583547|NCT01704495|561562651|FG003|Subjects Randomized|Discontinuation criteria met|0|||
155583548|NCT01704495|561562648|FG000|Subjects Randomized|Adverse Event|8|||
155583549|NCT01704495|561562649|FG001|Subjects Randomized|Adverse Event|2|||
155583550|NCT01704495|561562650|FG002|Subjects Randomized|Adverse Event|0|||
155583551|NCT01704495|561562651|FG003|Subjects Randomized|Adverse Event|7|||
155583552|NCT01704495|561562648|FG000|Subjects Randomized|Withdrawal by Subject|5|||
155583553|NCT01704495|561562649|FG001|Subjects Randomized|Withdrawal by Subject|5|||
155583554|NCT01704495|561562650|FG002|Subjects Randomized|Withdrawal by Subject|5|||
155583555|NCT01704495|561562651|FG003|Subjects Randomized|Withdrawal by Subject|5|||
155583556|NCT01704495|561562648|FG000|Subjects Randomized|Protocol Violation|1|||
155583557|NCT01704495|561562649|FG001|Subjects Randomized|Protocol Violation|1|||
155664628|NCT02852967|561869010|FG004|Overall Study|Dispensing Drug Violation|0|||
155583558|NCT01704495|561562650|FG002|Subjects Randomized|Protocol Violation|2|||
155583559|NCT01704495|561562651|FG003|Subjects Randomized|Protocol Violation|0|||
155583560|NCT01704495|561562648|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
155583561|NCT01704495|561562649|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
155583562|NCT01704495|561562650|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
155583563|NCT01704495|561562651|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
155583564|NCT01704495|561562648|FG000|Optional Safety Extension|Adverse Event|0|||
155583565|NCT01704495|561562649|FG001|Optional Safety Extension|Adverse Event|4|||
155583566|NCT01704495|561562650|FG002|Optional Safety Extension|Adverse Event|0|||
155583567|NCT01704495|561562651|FG003|Optional Safety Extension|Adverse Event|1|||
155583568|NCT01704495|561562648|FG000|Optional Safety Extension|Other reason|27|||
155583569|NCT01704495|561562649|FG001|Optional Safety Extension|Other reason|29|||
155583570|NCT01704495|561562650|FG002|Optional Safety Extension|Other reason|30|||
155583571|NCT01704495|561562651|FG003|Optional Safety Extension|Other reason|28|||
155583572|NCT01704495|561562648|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
155583573|NCT01704495|561562649|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
155583574|NCT01704495|561562650|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
155583575|NCT01704495|561562651|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
155583576|NCT04177095|561562658|FG000|Overall Study|Withdrawal by Subject|3|||
155583577|NCT04177095|561562658|FG000|Overall Study|Screen Failure|3|||
155583578|NCT04177095|561562658|FG000|Overall Study|Problems with the Trugraf assay|1|||
155583579|NCT01346059|561562659|FG000|Overall Study|Withdrawal by Subject|1|||
155583580|NCT01346059|561562660|FG001|Overall Study|Withdrawal by Subject|0|||
155583581|NCT00777296|561562661|FG000|Overall Study|Adverse Event|0|||
155583582|NCT00777296|561562662|FG001|Overall Study|Adverse Event|1|||
155583583|NCT00777296|561562663|FG002|Overall Study|Adverse Event|0|||
155583584|NCT00777296|561562664|FG003|Overall Study|Adverse Event|1|||
155583585|NCT00777296|561562661|FG000|Overall Study|Withdrawal by Subject|1|||
155583586|NCT00777296|561562662|FG001|Overall Study|Withdrawal by Subject|0|||
155583587|NCT00777296|561562663|FG002|Overall Study|Withdrawal by Subject|0|||
155583588|NCT00777296|561562664|FG003|Overall Study|Withdrawal by Subject|0|||
155583589|NCT00777296|561562661|FG000|Overall Study|CRF form not completed|0|||
155583590|NCT00777296|561562662|FG001|Overall Study|CRF form not completed|0|||
155583591|NCT00777296|561562663|FG002|Overall Study|CRF form not completed|2|||
155583592|NCT00777296|561562664|FG003|Overall Study|CRF form not completed|0|||
155583593|NCT02211209|561562665|FG000|Overall Study|Investigator judgment|0|||
155583594|NCT02211209|561562666|FG001|Overall Study|Investigator judgment|1|||
155583595|NCT02211209|561562665|FG000|Overall Study|Voluntary withdrawal|1|||
155583596|NCT02211209|561562666|FG001|Overall Study|Voluntary withdrawal|4|||
155583597|NCT02211209|561562665|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155583598|NCT02211209|561562666|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
155583599|NCT02211209|561562665|FG000|Overall Study|Reason Not Specified|1|||
155583600|NCT02211209|561562666|FG001|Overall Study|Reason Not Specified|0|||
155583601|NCT03876743|561562668|FG000|Overall Study|Lost to Follow-up|6|||
155583602|NCT03876743|561562669|FG001|Overall Study|Lost to Follow-up|4|||
155583603|NCT03876743|561562670|FG002|Overall Study|Lost to Follow-up|4|||
155583604|NCT03876743|561562671|FG003|Overall Study|Lost to Follow-up|7|||
155583605|NCT00092118|561562673|FG000|Overall Study|Adverse Event|35|||
155583606|NCT00092118|561562674|FG001|Overall Study|Adverse Event|32|||
155583607|NCT00092118|561562673|FG000|Overall Study|Lack of Efficacy|12|||
155583608|NCT00092118|561562674|FG001|Overall Study|Lack of Efficacy|14|||
155583609|NCT00092118|561562673|FG000|Overall Study|Lost to Follow-up|4|||
155583610|NCT00092118|561562674|FG001|Overall Study|Lost to Follow-up|3|||
155583611|NCT00092118|561562673|FG000|Overall Study|Protocol Violation|23|||
155583612|NCT00092118|561562674|FG001|Overall Study|Protocol Violation|25|||
155583613|NCT00092118|561562673|FG000|Overall Study|Withdrawal by Subject|4|||
155583614|NCT00092118|561562674|FG001|Overall Study|Withdrawal by Subject|10|||
155583615|NCT00092118|561562673|FG000|Overall Study|Other|6|||
155583616|NCT00092118|561562674|FG001|Overall Study|Other|5|||
155583617|NCT02025725|561562677|FG000|Overall Study|Adverse Event|5|||
155583618|NCT02025725|561562678|FG001|Overall Study|Adverse Event|0|||
155583619|NCT02025725|561562677|FG000|Overall Study|Lost to Follow-up|2|||
155583620|NCT02025725|561562678|FG001|Overall Study|Lost to Follow-up|0|||
155583621|NCT02025725|561562677|FG000|Overall Study|Protocol Violation|1|||
155583622|NCT02025725|561562678|FG001|Overall Study|Protocol Violation|1|||
155583623|NCT02025725|561562677|FG000|Overall Study|Withdrawal by Subject|3|||
155583624|NCT02025725|561562678|FG001|Overall Study|Withdrawal by Subject|2|||
155583625|NCT02025725|561562677|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
155664629|NCT02852967|561869006|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
155583626|NCT02025725|561562678|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
155583627|NCT02172664|561562686|FG000|Overall Study|Lost to Follow-up|4|||
155583628|NCT02172664|561562687|FG001|Overall Study|Lost to Follow-up|4|||
155583629|NCT02172664|561562686|FG000|Overall Study|Death|1|||
155583630|NCT02172664|561562687|FG001|Overall Study|Death|1|||
155583631|NCT02172664|561562686|FG000|Overall Study|Moved out of area|1|||
155583632|NCT02172664|561562687|FG001|Overall Study|Moved out of area|1|||
155583633|NCT03839628|561562688|FG000|Overall Study|Withdrawal by Subject|1|||
155583634|NCT00380874|561562689|FG000|Overall Study|Adverse Event|7|||
155583635|NCT00380874|561562690|FG001|Overall Study|Adverse Event|7|||
155583636|NCT00380874|561562689|FG000|Overall Study|Death|1|||
155583637|NCT00380874|561562690|FG001|Overall Study|Death|0|||
155583638|NCT00380874|561562689|FG000|Overall Study|Withdrawal by Subject|2|||
155583639|NCT00380874|561562690|FG001|Overall Study|Withdrawal by Subject|1|||
155583640|NCT00380874|561562689|FG000|Overall Study|Not related to study drug|3|||
155583641|NCT00380874|561562690|FG001|Overall Study|Not related to study drug|2|||
155583642|NCT02314026|561562691|FG000|Overall Study|Protocol Violation|28|||
155583643|NCT01139775|561562692|FG000|Overall Study|Adverse Event|0|||
155583644|NCT01139775|561562693|FG001|Overall Study|Adverse Event|6|||
155583645|NCT01139775|561562694|FG002|Overall Study|Adverse Event|2|||
155583646|NCT01139775|561562692|FG000|Overall Study|Protocol Violation|0|||
155583647|NCT01139775|561562693|FG001|Overall Study|Protocol Violation|5|||
155583648|NCT01139775|561562694|FG002|Overall Study|Protocol Violation|0|||
155583649|NCT01139775|561562692|FG000|Overall Study|Withdrawal by Subject|1|||
155583650|NCT01139775|561562693|FG001|Overall Study|Withdrawal by Subject|0|||
155583651|NCT01139775|561562694|FG002|Overall Study|Withdrawal by Subject|2|||
155583652|NCT01139775|561562692|FG000|Overall Study|Physician Decision|0|||
155583653|NCT01139775|561562693|FG001|Overall Study|Physician Decision|2|||
155583654|NCT01139775|561562694|FG002|Overall Study|Physician Decision|2|||
155583655|NCT00586703|561562695|FG000|Overall Study|Death|12|||
155583656|NCT02946463|561562696|FG000|Primary Evaluation Period|Physician Decision|0|||
155583657|NCT02946463|561562697|FG001|Primary Evaluation Period|Physician Decision|1|||
155583658|NCT02946463|561562698|FG002|Primary Evaluation Period|Physician Decision|0|||
155583659|NCT02946463|561562699|FG003|Primary Evaluation Period|Physician Decision|0|||
155583660|NCT02946463|561562696|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
155583661|NCT02946463|561562697|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
155583662|NCT02946463|561562698|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
155583663|NCT02946463|561562699|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
155583664|NCT02946463|561562696|FG000|Extension Period|Death|4|||
155583665|NCT02946463|561562697|FG001|Extension Period|Death|4|||
155583666|NCT02946463|561562698|FG002|Extension Period|Death|0|||
155583667|NCT02946463|561562699|FG003|Extension Period|Death|0|||
155583668|NCT02946463|561562696|FG000|Extension Period|Withdrawal by Subject|4|||
155583669|NCT02946463|561562697|FG001|Extension Period|Withdrawal by Subject|3|||
155583670|NCT02946463|561562698|FG002|Extension Period|Withdrawal by Subject|0|||
155583671|NCT02946463|561562699|FG003|Extension Period|Withdrawal by Subject|0|||
155583672|NCT02946463|561562696|FG000|Extension Period|Other than specified|2|||
155583673|NCT02946463|561562697|FG001|Extension Period|Other than specified|3|||
155583674|NCT02946463|561562698|FG002|Extension Period|Other than specified|2|||
155583675|NCT02946463|561562699|FG003|Extension Period|Other than specified|0|||
155583676|NCT02946463|561562696|FG000|Extension Period|Physician Decision|1|||
155583677|NCT02946463|561562697|FG001|Extension Period|Physician Decision|4|||
155583678|NCT02946463|561562698|FG002|Extension Period|Physician Decision|0|||
155664630|NCT02852967|561869007|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
155583679|NCT02946463|561562699|FG003|Extension Period|Physician Decision|0|||
155583680|NCT02946463|561562696|FG000|Extension Period|Pregnancy|3|||
155583681|NCT02946463|561562697|FG001|Extension Period|Pregnancy|1|||
155583682|NCT02946463|561562698|FG002|Extension Period|Pregnancy|0|||
155583683|NCT02946463|561562699|FG003|Extension Period|Pregnancy|0|||
155583684|NCT02946463|561562696|FG000|Extension Period|Adverse Event|1|||
155583685|NCT02946463|561562697|FG001|Extension Period|Adverse Event|2|||
155583686|NCT02946463|561562698|FG002|Extension Period|Adverse Event|0|||
155583687|NCT02946463|561562699|FG003|Extension Period|Adverse Event|0|||
155583688|NCT02946463|561562696|FG000|Extension Period|Lost to Follow-up|1|||
155583689|NCT02946463|561562697|FG001|Extension Period|Lost to Follow-up|0|||
155583690|NCT02946463|561562698|FG002|Extension Period|Lost to Follow-up|0|||
155583691|NCT02946463|561562699|FG003|Extension Period|Lost to Follow-up|0|||
155583692|NCT05271175|561562701|FG000|One Week Follow up|Lost to Follow-up|10|||
155583693|NCT05271175|561562702|FG001|One Week Follow up|Lost to Follow-up|7|||
155583694|NCT05271175|561562703|FG002|One Week Follow up|Lost to Follow-up|5|||
155583695|NCT05271175|561562701|FG000|One Month Follow up|Lost to Follow-up|12|||
155583696|NCT05271175|561562702|FG001|One Month Follow up|Lost to Follow-up|7|||
155583697|NCT05271175|561562703|FG002|One Month Follow up|Lost to Follow-up|9|||
155583698|NCT05271175|561562701|FG000|Six Months Follow up|Lost to Follow-up|8|||
155583699|NCT05271175|561562702|FG001|Six Months Follow up|Lost to Follow-up|2|||
155583700|NCT05271175|561562703|FG002|Six Months Follow up|Lost to Follow-up|2|||
155583701|NCT00682786|561562704|FG000|Overall Study|Withdrawal by Subject|2|||
155583702|NCT00682786|561562705|FG001|Overall Study|Withdrawal by Subject|2|||
155583703|NCT00682786|561562704|FG000|Overall Study|Did not receive irinotecan|0|||
155583704|NCT00682786|561562705|FG001|Overall Study|Did not receive irinotecan|1|||
155583705|NCT01831635|561562707|FG000|Overall Study|Withdrawal by Subject|0|||
155583706|NCT01831635|561562708|FG001|Overall Study|Withdrawal by Subject|2|||
155583707|NCT01831635|561562709|FG002|Overall Study|Withdrawal by Subject|0|||
155583708|NCT02859337|561562710|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
155583709|NCT02859337|561562711|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
155583710|NCT02859337|561562712|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
155583711|NCT02859337|561562710|FG000|Overall Study|Withdrawal by Subject|3|||
155583712|NCT02859337|561562711|FG001|Overall Study|Withdrawal by Subject|1|||
155583713|NCT02859337|561562712|FG002|Overall Study|Withdrawal by Subject|0|||
155583714|NCT02859337|561562710|FG000|Overall Study|Lost to Follow-up|1|||
155583715|NCT02859337|561562711|FG001|Overall Study|Lost to Follow-up|0|||
155583716|NCT02859337|561562712|FG002|Overall Study|Lost to Follow-up|0|||
155583717|NCT03817190|561562713|FG000|Overall Study|Early Termination|13|||
155583718|NCT03817190|561562714|FG001|Overall Study|Early Termination|20|||
155583719|NCT03817190|561562713|FG000|Overall Study|Adverse Event|10|||
155583720|NCT03817190|561562714|FG001|Overall Study|Adverse Event|17|||
155583721|NCT03817190|561562713|FG000|Overall Study|Withdrawal by Subject|12|||
155583722|NCT03817190|561562714|FG001|Overall Study|Withdrawal by Subject|8|||
155583723|NCT03817190|561562713|FG000|Overall Study|Lost to Follow-up|11|||
155583724|NCT03817190|561562714|FG001|Overall Study|Lost to Follow-up|7|||
155583725|NCT03817190|561562713|FG000|Overall Study|Lack of Efficacy|7|||
155583726|NCT03817190|561562714|FG001|Overall Study|Lack of Efficacy|5|||
155583727|NCT03817190|561562713|FG000|Overall Study|Investigator Decision|5|||
155583728|NCT03817190|561562714|FG001|Overall Study|Investigator Decision|1|||
155583729|NCT03817190|561562713|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
155583730|NCT03817190|561562714|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
155583731|NCT03817190|561562713|FG000|Overall Study|Lack of Contact|1|||
155583732|NCT03817190|561562714|FG001|Overall Study|Lack of Contact|0|||
155583733|NCT03817190|561562713|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
155583734|NCT03817190|561562714|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
155583735|NCT04146012|561562715|FG000|Overall Study|Study Terminated|30|||
155583736|NCT04146012|561562716|FG001|Overall Study|Study Terminated|15|||
155583737|NCT01546025|561562717|FG000|Overall Study|Lost to Follow-up|0|||
155583738|NCT01546025|561562718|FG001|Overall Study|Lost to Follow-up|1|||
155583739|NCT02729025|561562719|FG000|Overall Study|Sponsor Decision|0|||
155583740|NCT02729025|561562720|FG001|Overall Study|Sponsor Decision|1|||
155583741|NCT05142722|561564224|FG000|Overall Study|Lost to Follow-up|16|||
155583742|NCT05142722|561564225|FG001|Overall Study|Lost to Follow-up|38|||
155583743|NCT05142722|561564224|FG000|Overall Study|Withdrawal by Subject|20|||
155583744|NCT05142722|561564225|FG001|Overall Study|Withdrawal by Subject|27|||
155583745|NCT05142722|561564224|FG000|Overall Study|Death|11|||
155583746|NCT05142722|561564225|FG001|Overall Study|Death|17|||
155583747|NCT05142722|561564224|FG000|Overall Study|Physician Decision|0|||
155583748|NCT05142722|561564225|FG001|Overall Study|Physician Decision|1|||
155583749|NCT05142722|561564224|FG000|Overall Study|Participant Moved Away|0|||
155583750|NCT05142722|561564225|FG001|Overall Study|Participant Moved Away|2|||
155583751|NCT05142722|561564224|FG000|Overall Study|Adverse Event|2|||
155583752|NCT05142722|561564225|FG001|Overall Study|Adverse Event|1|||
155583753|NCT05086744|561564226|FG000|Part A|Adverse Event|0|||
155583754|NCT05086744|561564227|FG001|Part A|Adverse Event|1|||
155583755|NCT05086744|561564226|FG000|Part A|Lack of Efficacy|3|||
155583756|NCT05086744|561564227|FG001|Part A|Lack of Efficacy|0|||
155583757|NCT05086744|561564226|FG000|Part A|Protocol deviation|1|||
155583758|NCT05086744|561564227|FG001|Part A|Protocol deviation|0|||
155583759|NCT05086744|561564226|FG000|Part A|Subject decision|1|||
155583760|NCT05086744|561564227|FG001|Part A|Subject decision|0|||
155583761|NCT05086744|561564226|FG000|Part B|Adverse Event|0|||
155583762|NCT05086744|561564227|FG001|Part B|Adverse Event|1|||
155583763|NCT05086744|561564226|FG000|Part B|Lack of Efficacy|0|||
155583764|NCT05086744|561564227|FG001|Part B|Lack of Efficacy|1|||
155583765|NCT05086744|561564226|FG000|Part B|Study terminated by sponsor|1|||
155583766|NCT05086744|561564227|FG001|Part B|Study terminated by sponsor|6|||
155583767|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155583768|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155664631|NCT02852967|561869008|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
155664632|NCT02852967|561869009|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
155664633|NCT02852967|561869010|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
155664634|NCT00887159|561869017|FG000|Overall Study|Disease progression|6|||
155664635|NCT00887159|561869018|FG001|Overall Study|Disease progression|39|||
155664636|NCT00887159|561869019|FG002|Overall Study|Disease progression|33|||
155664637|NCT00887159|561869017|FG000|Overall Study|Adverse Event|3|||
155664638|NCT00887159|561869018|FG001|Overall Study|Adverse Event|4|||
155664639|NCT00887159|561869019|FG002|Overall Study|Adverse Event|17|||
155664640|NCT00887159|561869017|FG000|Overall Study|Death|2|||
155664641|NCT00887159|561869018|FG001|Overall Study|Death|2|||
155664642|NCT00887159|561869019|FG002|Overall Study|Death|0|||
155664643|NCT00887159|561869017|FG000|Overall Study|Withdrawal by Subject|4|||
155664644|NCT00887159|561869018|FG001|Overall Study|Withdrawal by Subject|4|||
155664645|NCT00887159|561869019|FG002|Overall Study|Withdrawal by Subject|2|||
155664646|NCT00887159|561869017|FG000|Overall Study|Alternative therapy|2|||
155664647|NCT00887159|561869018|FG001|Overall Study|Alternative therapy|0|||
155664648|NCT00887159|561869019|FG002|Overall Study|Alternative therapy|0|||
155664649|NCT00887159|561869017|FG000|Overall Study|Physician Decision|1|||
155664650|NCT00887159|561869018|FG001|Overall Study|Physician Decision|1|||
155664651|NCT00887159|561869019|FG002|Overall Study|Physician Decision|0|||
155664652|NCT00887159|561869017|FG000|Overall Study|Sympomatic deterioration|1|||
155664653|NCT00887159|561869018|FG001|Overall Study|Sympomatic deterioration|0|||
155664654|NCT00887159|561869019|FG002|Overall Study|Sympomatic deterioration|0|||
155664655|NCT00887159|561869017|FG000|Overall Study|Treatment delayed|1|||
155664656|NCT00887159|561869018|FG001|Overall Study|Treatment delayed|1|||
155664657|NCT00887159|561869019|FG002|Overall Study|Treatment delayed|0|||
155664658|NCT00887159|561869017|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
155664659|NCT00887159|561869018|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
155664660|NCT00887159|561869019|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
155664661|NCT00887159|561869017|FG000|Overall Study|Received more tx instead of observation|1|||
155664662|NCT00887159|561869018|FG001|Overall Study|Received more tx instead of observation|0|||
155664663|NCT00887159|561869019|FG002|Overall Study|Received more tx instead of observation|0|||
155664664|NCT00887159|561869017|FG000|Overall Study|Ineligible|5|||
155664665|NCT00887159|561869018|FG001|Overall Study|Ineligible|1|||
155664666|NCT00887159|561869019|FG002|Overall Study|Ineligible|0|||
155664667|NCT00887159|561869017|FG000|Overall Study|Never started assigned therapy|3|||
155664668|NCT00887159|561869018|FG001|Overall Study|Never started assigned therapy|3|||
155664669|NCT00887159|561869019|FG002|Overall Study|Never started assigned therapy|4|||
155664670|NCT00688467|561869020|FG000|Treatment Period 1|Adverse Event|2|||
155664671|NCT00688467|561869021|FG001|Treatment Period 1|Adverse Event|1|||
155664672|NCT00688467|561869020|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
155664673|NCT00688467|561869021|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
155664674|NCT00688467|561869020|FG000|Treatment Period 2|Protocol Violation|0|||
155664675|NCT00688467|561869021|FG001|Treatment Period 2|Protocol Violation|1|||
155664676|NCT00688467|561869020|FG000|Treatment Period 2|Adverse Event|0|||
155664677|NCT00688467|561869021|FG001|Treatment Period 2|Adverse Event|1|||
155664678|NCT00690794|561869022|FG000|Overall Study|Adverse Event|12|||
155664679|NCT00690794|561869023|FG001|Overall Study|Adverse Event|10|||
155664680|NCT00690794|561869022|FG000|Overall Study|Lost to Follow-up|1|||
155664681|NCT00690794|561869023|FG001|Overall Study|Lost to Follow-up|4|||
155664682|NCT00690794|561869022|FG000|Overall Study|Withdrawal by Subject|0|||
155583769|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155583770|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155583771|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155583772|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155583773|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155583774|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155583775|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155583776|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155583777|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
155583778|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155583779|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155664683|NCT00690794|561869023|FG001|Overall Study|Withdrawal by Subject|9|||
155664684|NCT00690794|561869022|FG000|Overall Study|Protocol Violation|6|||
155664685|NCT00690794|561869023|FG001|Overall Study|Protocol Violation|7|||
155664686|NCT00690794|561869022|FG000|Overall Study|Noncompliance|1|||
155664687|NCT00690794|561869023|FG001|Overall Study|Noncompliance|2|||
155664688|NCT00690794|561869022|FG000|Overall Study|Other not specified|1|||
155664689|NCT00690794|561869023|FG001|Overall Study|Other not specified|3|||
155664690|NCT03848416|561869024|FG000|Overall Study|Withdrawal by Subject|1|||
155664691|NCT03848416|561869025|FG001|Overall Study|Withdrawal by Subject|0|||
155664692|NCT03848416|561869026|FG002|Overall Study|Withdrawal by Subject|0|||
155664693|NCT03848416|561869024|FG000|Overall Study|Death|0|||
155664694|NCT03848416|561869025|FG001|Overall Study|Death|0|||
155664695|NCT03848416|561869026|FG002|Overall Study|Death|1|||
155664696|NCT00856609|561869027|FG000|Overall Study|Adverse Event|1|||
155664697|NCT00856609|561869028|FG001|Overall Study|Adverse Event|0|||
155583780|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
155583781|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155583782|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155583783|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155583784|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155583785|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155583786|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155583787|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155583788|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155583789|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155583790|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155583791|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155583792|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155583793|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155583794|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155583795|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155583796|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155583797|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155583798|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155583799|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583800|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583801|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
155583802|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583803|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583804|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583805|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
155583806|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583807|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155583808|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155583809|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
155583810|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155583811|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155583812|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
155583813|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155583814|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
155583815|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
155583816|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
155583817|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583818|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583819|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583820|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583821|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583822|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155583823|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583824|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
155583825|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583826|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583827|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583828|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583829|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155583830|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155664698|NCT00783432|561869029|FG000|Overall Study|Adverse Event|22|||
155664699|NCT00783432|561869030|FG001|Overall Study|Adverse Event|17|||
155583831|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583832|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583833|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583834|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583835|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
155583836|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583837|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583838|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155583839|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583840|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583841|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583842|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583843|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583844|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
155583845|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583846|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155583847|NCT03896503|561564228|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583848|NCT03896503|561564229|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583849|NCT03896503|561564230|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583850|NCT03896503|561564231|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583851|NCT03896503|561564232|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583852|NCT03896503|561564233|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
155583853|NCT03896503|561564234|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
155583854|NCT03896503|561564235|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155583855|NCT03055338|561564238|FG000|Overall Study|Lost to Follow-up|9|||
155583856|NCT03055338|561564239|FG001|Overall Study|Lost to Follow-up|2|||
155583857|NCT03055338|561564240|FG002|Overall Study|Lost to Follow-up|3|||
155583858|NCT03055338|561564238|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
155583859|NCT03055338|561564239|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
155583860|NCT03055338|561564240|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
155583861|NCT03055338|561564238|FG000|Overall Study|Physician Decision|0|||
155583862|NCT03055338|561564239|FG001|Overall Study|Physician Decision|0|||
155583863|NCT03055338|561564240|FG002|Overall Study|Physician Decision|2|||
155583864|NCT03055338|561564238|FG000|Overall Study|Withdrawal by Subject|9|||
155583865|NCT03055338|561564239|FG001|Overall Study|Withdrawal by Subject|8|||
155583866|NCT03055338|561564240|FG002|Overall Study|Withdrawal by Subject|7|||
155583867|NCT03058705|561564241|FG000|Overall Study|Withdrawal by Subject|2|||
155583868|NCT03058705|561564241|FG000|Overall Study|Physician Decision|2|||
155583869|NCT03752970|561564245|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
155583870|NCT03752970|561564246|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
155583871|NCT03752970|561564247|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
155583872|NCT03752970|561564245|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
155583873|NCT03752970|561564246|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
155583874|NCT03752970|561564247|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
155583875|NCT03752970|561564245|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
155583876|NCT03752970|561564246|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
155583877|NCT03752970|561564247|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
155583878|NCT03752970|561564245|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
155583879|NCT03752970|561564246|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
155583880|NCT03752970|561564247|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
155583881|NCT03752970|561564245|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
155583882|NCT03752970|561564246|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
155583883|NCT03752970|561564247|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
155583884|NCT04767282|561564248|FG000|Overall Study|Refused or did not begin surveys|6|||
155583885|NCT04767282|561564249|FG001|Overall Study|Refused or did not begin surveys|2|||
155583886|NCT04767282|561564250|FG002|Overall Study|Refused or did not begin surveys|2|||
155583887|NCT04767282|561564248|FG000|Overall Study|Duplicate household previously enrolled|2|||
155583888|NCT04767282|561564249|FG001|Overall Study|Duplicate household previously enrolled|0|||
155583889|NCT04767282|561564250|FG002|Overall Study|Duplicate household previously enrolled|8|||
155583890|NCT04767282|561564248|FG000|Overall Study|Unable to confirm legal guardian|0|||
155583891|NCT04767282|561564249|FG001|Overall Study|Unable to confirm legal guardian|2|||
155583892|NCT04767282|561564250|FG002|Overall Study|Unable to confirm legal guardian|8|||
155583893|NCT04767282|561564248|FG000|Overall Study|Withdrawal by Subject|0|||
155583894|NCT04767282|561564249|FG001|Overall Study|Withdrawal by Subject|0|||
155583895|NCT04767282|561564250|FG002|Overall Study|Withdrawal by Subject|6|||
155583896|NCT04767282|561564248|FG000|Overall Study|Survey comprehension challenges|4|||
155583897|NCT04767282|561564249|FG001|Overall Study|Survey comprehension challenges|0|||
155583898|NCT04767282|561564250|FG002|Overall Study|Survey comprehension challenges|0|||
155583899|NCT01120184|561564255|FG000|Overall Study|Adverse Event|0|||
155583900|NCT01120184|561564256|FG001|Overall Study|Adverse Event|1|||
155583901|NCT01120184|561564257|FG002|Overall Study|Adverse Event|0|||
155583902|NCT01120184|561564255|FG000|Overall Study|Lost to Follow-up|13|||
155583903|NCT01120184|561564256|FG001|Overall Study|Lost to Follow-up|13|||
155583904|NCT01120184|561564257|FG002|Overall Study|Lost to Follow-up|11|||
155583905|NCT01120184|561564255|FG000|Overall Study|Physician Decision|9|||
155583906|NCT01120184|561564256|FG001|Overall Study|Physician Decision|1|||
155583907|NCT01120184|561564257|FG002|Overall Study|Physician Decision|3|||
155583908|NCT01120184|561564255|FG000|Overall Study|Reason not Specified|8|||
155583909|NCT01120184|561564256|FG001|Overall Study|Reason not Specified|3|||
155583910|NCT01120184|561564257|FG002|Overall Study|Reason not Specified|12|||
155583911|NCT01120184|561564255|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
155583912|NCT01120184|561564256|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
155583913|NCT01120184|561564257|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
155583914|NCT01120184|561564255|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
155583915|NCT01120184|561564256|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
155583916|NCT01120184|561564257|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
155583917|NCT01120184|561564255|FG000|Overall Study|Death|170|||
155583918|NCT01120184|561564256|FG001|Overall Study|Death|176|||
155583919|NCT01120184|561564257|FG002|Overall Study|Death|169|||
155583920|NCT02525783|561564259|FG000|Overall Study|Lost to Follow-up|10|||
155583921|NCT00824772|561564260|FG000|Overall Study|Withdrawal by Subject|8|||
155583922|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
155583923|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
155583924|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
155583925|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
155583926|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
155583927|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
155583928|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
155583929|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
155583930|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
155583931|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
155583932|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
155583933|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
155583934|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155583935|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155583936|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
155583937|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155583938|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
155583939|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
155583940|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
155583941|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
155583942|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
155583943|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
155583944|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
155583945|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
155583946|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
155583947|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
155583948|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
155583949|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
155583950|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
155583951|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
155583952|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
155583953|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
155583954|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155583955|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
155583956|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155583957|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155583958|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155583959|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155583960|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155583961|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
155583962|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
155664700|NCT00783432|561869029|FG000|Overall Study|Lack of Efficacy|20|||
155664701|NCT00783432|561869030|FG001|Overall Study|Lack of Efficacy|21|||
155583963|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155583964|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155583965|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155583966|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
155583967|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
155583968|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
155583969|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
155583970|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155583971|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155583972|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
155583973|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155583974|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Site closed|0|||
155583975|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Site closed|0|||
155583976|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Site closed|1|||
155583977|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Site closed|0|||
155583978|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
155583979|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155583980|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155583981|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155583982|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
155583983|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
155583984|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
155583985|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
155583986|NCT00838903|561564261|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
155583987|NCT00838903|561564262|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155583988|NCT00838903|561564263|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155583989|NCT00838903|561564264|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155583990|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
155583991|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
155583992|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
155583993|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
155583994|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
155583995|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
155583996|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
155583997|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
155583998|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
155583999|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
155584000|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
155584001|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
155584002|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
155584003|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
155584004|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
155584005|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
155584006|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
155584007|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
155584008|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
155584009|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
155584010|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
155584011|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
155584012|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
155584013|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
155584014|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
155584015|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155584016|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
155584017|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155584018|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155584019|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
155584020|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155584021|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155584022|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155584023|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
155584024|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155584025|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155584026|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155584027|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155584028|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155584029|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
155584030|NCT00838903|561564261|FG000|Follow-up Period (8 Weeks)|Missing|1|||
155584031|NCT00838903|561564262|FG001|Follow-up Period (8 Weeks)|Missing|2|||
155584032|NCT00838903|561564263|FG002|Follow-up Period (8 Weeks)|Missing|1|||
155584033|NCT00838903|561564264|FG003|Follow-up Period (8 Weeks)|Missing|1|||
155584034|NCT01002989|561564270|FG000|Overall Study|exclusion criteria, no consent|5|||
155584035|NCT00318474|561564271|FG000|Overall Study|Adverse Event|1|||
155584036|NCT00318474|561564272|FG001|Overall Study|Adverse Event|1|||
155584037|NCT00318474|561564271|FG000|Overall Study|Lost to Follow-up|0|||
155584038|NCT00318474|561564272|FG001|Overall Study|Lost to Follow-up|1|||
155584039|NCT00318474|561564271|FG000|Overall Study|Pregnancy|0|||
155584040|NCT00318474|561564272|FG001|Overall Study|Pregnancy|2|||
155584041|NCT00318474|561564271|FG000|Overall Study|Protocol Violation|1|||
155584042|NCT00318474|561564272|FG001|Overall Study|Protocol Violation|0|||
155584043|NCT00318474|561564271|FG000|Overall Study|Withdrawal by Subject|3|||
155584044|NCT00318474|561564272|FG001|Overall Study|Withdrawal by Subject|2|||
155584045|NCT00318474|561564271|FG000|Overall Study|Fall in GFR|3|||
155584046|NCT00318474|561564272|FG001|Overall Study|Fall in GFR|3|||
155584047|NCT00318474|561564271|FG000|Overall Study|Post-therapy hyperflycemia|0|||
155584048|NCT00318474|561564272|FG001|Overall Study|Post-therapy hyperflycemia|1|||
155584049|NCT00318474|561564271|FG000|Overall Study|Trial terminated|10|||
155584050|NCT00318474|561564272|FG001|Overall Study|Trial terminated|7|||
155584051|NCT05177484|561564273|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
155584052|NCT05177484|561564274|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
155584053|NCT05177484|561564273|FG000|Overall Study|Inadvertently withdrawn|3|||
155584054|NCT05177484|561564274|FG001|Overall Study|Inadvertently withdrawn|1|||
155584055|NCT05177484|561564273|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
155584056|NCT05177484|561564274|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
155584057|NCT02075203|561564275|FG000|Overall Study|Withdrawal by Subject|1|||
155584058|NCT02075203|561564276|FG001|Overall Study|Withdrawal by Subject|0|||
155584059|NCT02075203|561564277|FG002|Overall Study|Withdrawal by Subject|1|||
155584060|NCT02075203|561564275|FG000|Overall Study|Adverse Event|1|||
155584061|NCT02075203|561564276|FG001|Overall Study|Adverse Event|0|||
155584062|NCT02075203|561564277|FG002|Overall Study|Adverse Event|0|||
155584063|NCT02075203|561564275|FG000|Overall Study|participant refused to use contraception|1|||
155584064|NCT02075203|561564276|FG001|Overall Study|participant refused to use contraception|0|||
155584065|NCT02075203|561564277|FG002|Overall Study|participant refused to use contraception|0|||
155584066|NCT00495391|561564278|FG000|Overall Study|Lack of Efficacy|34|||
155584067|NCT00495391|561564279|FG001|Overall Study|Lack of Efficacy|18|||
155584068|NCT00495391|561564278|FG000|Overall Study|Withdrawal by Subject|2|||
155584069|NCT00495391|561564279|FG001|Overall Study|Withdrawal by Subject|3|||
155584070|NCT02712320|561564280|FG000|Overall Study|Lost to Follow-up|1|||
155584071|NCT02712320|561564280|FG000|Overall Study|Withdrawal by Subject|1|||
155584072|NCT02712320|561564280|FG000|Overall Study|Transferred to another facility|1|||
155584073|NCT02712320|561564280|FG000|Overall Study|Treating with the prohibited medications|2|||
155584074|NCT00568451|561564281|FG000|Overall Study|Disease Progression|0|||
155584075|NCT00568451|561564282|FG001|Overall Study|Disease Progression|0|||
155584076|NCT00568451|561564283|FG002|Overall Study|Disease Progression|2|||
155584077|NCT00568451|561564284|FG003|Overall Study|Disease Progression|7|||
155584078|NCT05344560|561564285|FG000|Period 1|Subject out of visit window|1|||
155584079|NCT05344560|561564286|FG001|Period 1|Subject out of visit window|1|||
155584080|NCT05344560|561564285|FG000|Period 2|Covid-19 Related|1|||
155584081|NCT05344560|561564286|FG001|Period 2|Covid-19 Related|0|||
155584082|NCT05344560|561564285|FG000|Period 2|Adverse Event|1|||
155584083|NCT05344560|561564286|FG001|Period 2|Adverse Event|0|||
155584084|NCT05344560|561564285|FG000|Period 2|Subject out of visit window|1|||
155584085|NCT05344560|561564286|FG001|Period 2|Subject out of visit window|1|||
155584086|NCT05344560|561564285|FG000|Period 3|Subject out of visit window|1|||
155584087|NCT05344560|561564286|FG001|Period 3|Subject out of visit window|0|||
155584088|NCT01620138|561564287|FG000|Overall Study|Withdrawal by Subject|3|||
155584089|NCT01620138|561564288|FG001|Overall Study|Withdrawal by Subject|0|||
155584090|NCT01620138|561564287|FG000|Overall Study|Lack of Efficacy|1|||
155584091|NCT01620138|561564288|FG001|Overall Study|Lack of Efficacy|0|||
155664702|NCT00783432|561869029|FG000|Overall Study|Lost to Follow-up|11|||
155584092|NCT01620138|561564287|FG000|Overall Study|Adverse Event|2|||
155584093|NCT01620138|561564288|FG001|Overall Study|Adverse Event|0|||
155584094|NCT03922308|561564289|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
155584095|NCT03922308|561564290|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
155584096|NCT03922308|561564291|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
155584097|NCT03922308|561564289|FG000|Overall Study|Lost to Follow-up|1|||
155584098|NCT03922308|561564290|FG001|Overall Study|Lost to Follow-up|0|||
155584099|NCT03922308|561564291|FG002|Overall Study|Lost to Follow-up|0|||
155584100|NCT03922308|561564289|FG000|Overall Study|Reason not Specified|0|||
155584101|NCT03922308|561564290|FG001|Overall Study|Reason not Specified|2|||
155584102|NCT03922308|561564291|FG002|Overall Study|Reason not Specified|1|||
155584103|NCT03313180|561564295|FG000|Overall Study|Adverse Event|120|||
155584104|NCT03313180|561564295|FG000|Overall Study|Lost to Follow-up|3|||
155584105|NCT03313180|561564295|FG000|Overall Study|Withdrawal by Subject|39|||
155584106|NCT03313180|561564295|FG000|Overall Study|Other than listed above|15|||
155584107|NCT03313180|561564295|FG000|Overall Study|Covid-19 related|2|||
155584108|NCT01697748|561564296|FG000|Overall Study|ineligible skin incision|1|||
155584109|NCT01697748|561564297|FG001|Overall Study|ineligible skin incision|2|||
155584110|NCT01697748|561564296|FG000|Overall Study|ineligible uterine incision|4|||
155584111|NCT01697748|561564297|FG001|Overall Study|ineligible uterine incision|1|||
155584112|NCT01697748|561564296|FG000|Overall Study|Lost to Follow-up|53|||
155584113|NCT01697748|561564297|FG001|Overall Study|Lost to Follow-up|65|||
155584114|NCT00832455|561564299|FG000|Overall Study|Adverse Event|13|||
155584115|NCT00832455|561564299|FG000|Overall Study|Lost to Follow-up|26|||
155584116|NCT00832455|561564299|FG000|Overall Study|Protocol Violation|4|||
155584117|NCT00832455|561564299|FG000|Overall Study|Withdrawal by Subject|17|||
155584118|NCT00832455|561564299|FG000|Overall Study|Screening Failure|2|||
155584119|NCT00832455|561564299|FG000|Overall Study|Stopped Medication|4|||
155584120|NCT00832455|561564299|FG000|Overall Study|Parent misunderstood study|1|||
155584121|NCT00832455|561564299|FG000|Overall Study|Parent dissatisfied|1|||
155584122|NCT00832455|561564299|FG000|Overall Study|No improvement|3|||
155584123|NCT00832455|561564299|FG000|Overall Study|Patient moved|1|||
155584124|NCT02275819|561564306|FG000|Overall Study|Adverse Event|0|||
155584125|NCT02275819|561564307|FG001|Overall Study|Adverse Event|1|||
155584126|NCT02556775|561564308|FG000|Overall Study|Withdrawal by Subject|1|||
155584127|NCT02556775|561564309|FG001|Overall Study|Withdrawal by Subject|0|||
155584128|NCT02556775|561564310|FG002|Overall Study|Withdrawal by Subject|1|||
155584129|NCT02556775|561564311|FG003|Overall Study|Withdrawal by Subject|0|||
155584130|NCT02556775|561564308|FG000|Overall Study|Lost to Follow-up|1|||
155584131|NCT02556775|561564309|FG001|Overall Study|Lost to Follow-up|0|||
155584132|NCT02556775|561564310|FG002|Overall Study|Lost to Follow-up|0|||
155584133|NCT02556775|561564311|FG003|Overall Study|Lost to Follow-up|0|||
155584134|NCT00658723|561564314|FG000|Overall Study|Lost to Follow-up|0|||
155584135|NCT00658723|561564315|FG001|Overall Study|Lost to Follow-up|2|||
155584136|NCT00658723|561564316|FG002|Overall Study|Lost to Follow-up|2|||
155584137|NCT00658723|561564314|FG000|Overall Study|Death|2|||
155584138|NCT00658723|561564315|FG001|Overall Study|Death|1|||
155584139|NCT00658723|561564316|FG002|Overall Study|Death|4|||
155584140|NCT00658723|561564314|FG000|Overall Study|Scheduling Issue|1|||
155584141|NCT00658723|561564315|FG001|Overall Study|Scheduling Issue|1|||
155584142|NCT00658723|561564316|FG002|Overall Study|Scheduling Issue|0|||
155584143|NCT00658723|561564314|FG000|Overall Study|Withdrawal by Subject|1|||
155584144|NCT00658723|561564315|FG001|Overall Study|Withdrawal by Subject|0|||
155584145|NCT00658723|561564316|FG002|Overall Study|Withdrawal by Subject|1|||
155584146|NCT03889418|561564317|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
155584147|NCT03889418|561564318|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584148|NCT03889418|561564319|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584149|NCT03889418|561564320|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584150|NCT03889418|561564321|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584151|NCT03889418|561564322|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584152|NCT03889418|561564323|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584153|NCT03889418|561564324|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584154|NCT03889418|561564325|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584155|NCT03889418|561564326|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155584156|NCT03889418|561564317|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584157|NCT03889418|561564318|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
155584158|NCT03889418|561564319|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
155584159|NCT03889418|561564320|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584160|NCT03889418|561564321|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584161|NCT03889418|561564322|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584162|NCT03889418|561564323|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584163|NCT03889418|561564324|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584164|NCT03889418|561564325|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584165|NCT03889418|561564326|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155584166|NCT03889418|561564317|FG000|October-December 2019 (Month 7-9)|Death|0|||
155584167|NCT03889418|561564318|FG001|October-December 2019 (Month 7-9)|Death|0|||
155584168|NCT03889418|561564319|FG002|October-December 2019 (Month 7-9)|Death|0|||
155584169|NCT03889418|561564320|FG003|October-December 2019 (Month 7-9)|Death|0|||
155584170|NCT03889418|561564321|FG004|October-December 2019 (Month 7-9)|Death|0|||
155584171|NCT03889418|561564322|FG005|October-December 2019 (Month 7-9)|Death|0|||
155584172|NCT03889418|561564323|FG006|October-December 2019 (Month 7-9)|Death|0|||
155584173|NCT03889418|561564324|FG007|October-December 2019 (Month 7-9)|Death|0|||
155584174|NCT03889418|561564325|FG008|October-December 2019 (Month 7-9)|Death|1|||
155584175|NCT03889418|561564326|FG009|October-December 2019 (Month 7-9)|Death|0|||
155584176|NCT03889418|561564317|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584177|NCT03889418|561564318|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584178|NCT03889418|561564319|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584179|NCT03889418|561564320|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
155584180|NCT03889418|561564321|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584181|NCT03889418|561564322|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584182|NCT03889418|561564323|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584183|NCT03889418|561564324|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
155584184|NCT03889418|561564325|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584185|NCT03889418|561564326|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155584186|NCT03889418|561564317|FG000|April - June 2020 (Month 13-15)|Death|0|||
155584187|NCT03889418|561564318|FG001|April - June 2020 (Month 13-15)|Death|1|||
155584188|NCT03889418|561564319|FG002|April - June 2020 (Month 13-15)|Death|0|||
155584189|NCT03889418|561564320|FG003|April - June 2020 (Month 13-15)|Death|0|||
155584190|NCT03889418|561564321|FG004|April - June 2020 (Month 13-15)|Death|0|||
155584191|NCT03889418|561564322|FG005|April - June 2020 (Month 13-15)|Death|0|||
155584192|NCT03889418|561564323|FG006|April - June 2020 (Month 13-15)|Death|0|||
155584193|NCT03889418|561564324|FG007|April - June 2020 (Month 13-15)|Death|0|||
155584194|NCT03889418|561564325|FG008|April - June 2020 (Month 13-15)|Death|0|||
155584195|NCT03889418|561564326|FG009|April - June 2020 (Month 13-15)|Death|0|||
155584196|NCT03889418|561564317|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584197|NCT03889418|561564318|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584198|NCT03889418|561564319|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584199|NCT03889418|561564320|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
155584200|NCT03889418|561564321|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584201|NCT03889418|561564322|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584202|NCT03889418|561564323|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584203|NCT03889418|561564324|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584204|NCT03889418|561564325|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584205|NCT03889418|561564326|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155584206|NCT03889418|561564317|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
155584207|NCT03889418|561564318|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584208|NCT03889418|561564319|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
155584209|NCT03889418|561564320|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
155584210|NCT03889418|561564321|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584211|NCT03889418|561564322|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584212|NCT03889418|561564323|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584213|NCT03889418|561564324|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
155584214|NCT03889418|561564325|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584215|NCT03889418|561564326|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
155584216|NCT03889418|561564317|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155584217|NCT03889418|561564318|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
155584218|NCT03889418|561564319|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
155584219|NCT03889418|561564320|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
155584220|NCT03889418|561564321|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155584221|NCT03889418|561564322|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155584222|NCT03889418|561564323|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155584223|NCT03889418|561564324|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
155584224|NCT03889418|561564325|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155584225|NCT03889418|561564326|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
155584226|NCT01139125|561564327|FG000|Overall Study|Withdrawal by Subject|1|||
155584227|NCT00739661|561564328|FG000|Overall Study|Adverse Event|2|||
155584228|NCT00739661|561564329|FG001|Overall Study|Adverse Event|0|||
155584229|NCT00739661|561564328|FG000|Overall Study|Physician decision to withdraw patient|1|||
155584230|NCT00739661|561564329|FG001|Overall Study|Physician decision to withdraw patient|0|||
155584231|NCT00739661|561564328|FG000|Overall Study|Patient decision to withdraw|9|||
155584232|NCT00739661|561564329|FG001|Overall Study|Patient decision to withdraw|4|||
155664703|NCT00783432|561869030|FG001|Overall Study|Lost to Follow-up|6|||
155664704|NCT00783432|561869029|FG000|Overall Study|Withdrawal by Subject|23|||
155664705|NCT00783432|561869030|FG001|Overall Study|Withdrawal by Subject|20|||
155664706|NCT00783432|561869029|FG000|Overall Study|subject moved|3|||
155664707|NCT00783432|561869030|FG001|Overall Study|subject moved|5|||
155664708|NCT00783432|561869029|FG000|Overall Study|Protocol Violation|6|||
155584233|NCT00739661|561564328|FG000|Overall Study|Disease progression, radiographic|33|||
155584234|NCT00739661|561564329|FG001|Overall Study|Disease progression, radiographic|37|||
155584235|NCT00739661|561564328|FG000|Overall Study|Reason for discontinuation not available|1|||
155584236|NCT00739661|561564329|FG001|Overall Study|Reason for discontinuation not available|1|||
155664709|NCT00783432|561869030|FG001|Overall Study|Protocol Violation|9|||
155584237|NCT05600283|561564332|FG000|Overall Study|Withdrawal by Subject|3|||
155584238|NCT05600283|561564333|FG001|Overall Study|Withdrawal by Subject|8|||
155584239|NCT05600283|561564332|FG000|Overall Study|invalid individual swab|1|||
155584240|NCT05600283|561564333|FG001|Overall Study|invalid individual swab|0|||
155584241|NCT05600283|561564332|FG000|Overall Study|missing clinician collection|3|||
155584242|NCT05600283|561564333|FG001|Overall Study|missing clinician collection|0|||
155584243|NCT05600283|561564332|FG000|Overall Study|screening failure|0|||
155584244|NCT05600283|561564333|FG001|Overall Study|screening failure|2|||
155584245|NCT02883062|561564334|FG000|Overall Study|Withdrawal by Subject|6|||
155584246|NCT02883062|561564335|FG001|Overall Study|Withdrawal by Subject|0|||
155584247|NCT03380429|561564338|FG000|Overall Study|Physician Decision|0|||
155584248|NCT03380429|561564339|FG001|Overall Study|Physician Decision|1|||
155584249|NCT03380429|561564340|FG002|Overall Study|Physician Decision|0|||
155584250|NCT03380429|561564341|FG003|Overall Study|Physician Decision|1|||
155584251|NCT03380429|561564342|FG004|Overall Study|Physician Decision|1|||
155584252|NCT03380429|561564338|FG000|Overall Study|Withdrawal by Subject|3|||
155584253|NCT03380429|561564339|FG001|Overall Study|Withdrawal by Subject|3|||
155584254|NCT03380429|561564340|FG002|Overall Study|Withdrawal by Subject|5|||
155584255|NCT03380429|561564341|FG003|Overall Study|Withdrawal by Subject|2|||
155584256|NCT03380429|561564342|FG004|Overall Study|Withdrawal by Subject|1|||
155584257|NCT03380429|561564338|FG000|Overall Study|Lost to Follow-up|0|||
155584258|NCT03380429|561564339|FG001|Overall Study|Lost to Follow-up|2|||
155584259|NCT03380429|561564340|FG002|Overall Study|Lost to Follow-up|4|||
155584260|NCT03380429|561564341|FG003|Overall Study|Lost to Follow-up|3|||
155584261|NCT03380429|561564342|FG004|Overall Study|Lost to Follow-up|1|||
155584262|NCT03380429|561564338|FG000|Overall Study|Protocol Violation|1|||
155584263|NCT03380429|561564339|FG001|Overall Study|Protocol Violation|0|||
155584264|NCT03380429|561564340|FG002|Overall Study|Protocol Violation|1|||
155584265|NCT03380429|561564341|FG003|Overall Study|Protocol Violation|0|||
155584266|NCT03380429|561564342|FG004|Overall Study|Protocol Violation|1|||
155584267|NCT03380429|561564338|FG000|Overall Study|Lack of Efficacy|0|||
155584268|NCT03380429|561564339|FG001|Overall Study|Lack of Efficacy|0|||
155584269|NCT03380429|561564340|FG002|Overall Study|Lack of Efficacy|0|||
155584270|NCT03380429|561564341|FG003|Overall Study|Lack of Efficacy|2|||
155584271|NCT03380429|561564342|FG004|Overall Study|Lack of Efficacy|1|||
155584272|NCT03380429|561564338|FG000|Overall Study|Adverse Event|1|||
155584273|NCT03380429|561564339|FG001|Overall Study|Adverse Event|1|||
155584274|NCT03380429|561564340|FG002|Overall Study|Adverse Event|1|||
155584275|NCT03380429|561564341|FG003|Overall Study|Adverse Event|2|||
155584276|NCT03380429|561564342|FG004|Overall Study|Adverse Event|0|||
155584277|NCT01198470|561564347|FG000|Overall Study|Adverse Event|2|||
155584278|NCT02949973|561564348|FG000|Overall Study|Physician Decision|1|||
155584279|NCT04760626|561564349|FG000|Overall Study|Withdrawal by Subject|24|||
155584280|NCT04760626|561564350|FG001|Overall Study|Withdrawal by Subject|20|||
155584281|NCT04760626|561564349|FG000|Overall Study|Lost to Follow-up|14|||
155584282|NCT04760626|561564350|FG001|Overall Study|Lost to Follow-up|19|||
155584283|NCT04760626|561564349|FG000|Overall Study|Physician Decision|3|||
155584284|NCT04760626|561564350|FG001|Overall Study|Physician Decision|5|||
155584285|NCT04760626|561564349|FG000|Overall Study|Death|3|||
155584286|NCT04760626|561564350|FG001|Overall Study|Death|6|||
155584287|NCT04760626|561564349|FG000|Overall Study|Site closure|1|||
155584288|NCT04760626|561564350|FG001|Overall Study|Site closure|0|||
155584289|NCT01924689|561564353|FG000|Overall Study|Death|0|||
155584290|NCT01924689|561564354|FG001|Overall Study|Death|1|||
155584291|NCT01924689|561564355|FG002|Overall Study|Death|0|||
155584292|NCT01924689|561564356|FG003|Overall Study|Death|1|||
155584293|NCT01924689|561564357|FG004|Overall Study|Death|0|||
155584294|NCT01924689|561564358|FG005|Overall Study|Death|0|||
155584295|NCT01924689|561564353|FG000|Overall Study|Disease progression|0|||
155584296|NCT01924689|561564354|FG001|Overall Study|Disease progression|0|||
155584297|NCT01924689|561564355|FG002|Overall Study|Disease progression|2|||
155584298|NCT01924689|561564356|FG003|Overall Study|Disease progression|0|||
155584299|NCT01924689|561564357|FG004|Overall Study|Disease progression|3|||
155584300|NCT01924689|561564358|FG005|Overall Study|Disease progression|2|||
155584301|NCT01924689|561564353|FG000|Overall Study|New therapy or study|3|||
155584302|NCT01924689|561564354|FG001|Overall Study|New therapy or study|2|||
155584303|NCT01924689|561564355|FG002|Overall Study|New therapy or study|1|||
155584304|NCT01924689|561564356|FG003|Overall Study|New therapy or study|4|||
155584305|NCT01924689|561564357|FG004|Overall Study|New therapy or study|2|||
155584306|NCT01924689|561564358|FG005|Overall Study|New therapy or study|0|||
155584307|NCT01924689|561564353|FG000|Overall Study|Withdrawal of consent|0|||
155584308|NCT01924689|561564354|FG001|Overall Study|Withdrawal of consent|0|||
155584309|NCT01924689|561564355|FG002|Overall Study|Withdrawal of consent|1|||
155584310|NCT01924689|561564356|FG003|Overall Study|Withdrawal of consent|1|||
155584311|NCT01924689|561564357|FG004|Overall Study|Withdrawal of consent|0|||
155584312|NCT01924689|561564358|FG005|Overall Study|Withdrawal of consent|0|||
155584313|NCT01924689|561564353|FG000|Overall Study|Other|0|||
155584314|NCT01924689|561564354|FG001|Overall Study|Other|0|||
155584315|NCT01924689|561564355|FG002|Overall Study|Other|0|||
155584316|NCT01924689|561564356|FG003|Overall Study|Other|0|||
155584317|NCT01924689|561564357|FG004|Overall Study|Other|1|||
155584318|NCT01924689|561564358|FG005|Overall Study|Other|0|||
155584319|NCT00468819|561564359|FG000|Overall Study|Withdrawal by Subject|4|||
155584320|NCT00468819|561564360|FG001|Overall Study|Withdrawal by Subject|0|||
155584321|NCT00468819|561564361|FG002|Overall Study|Withdrawal by Subject|1|||
155584322|NCT00468819|561564359|FG000|Overall Study|Lost to Follow-up|0|||
155584323|NCT00468819|561564360|FG001|Overall Study|Lost to Follow-up|0|||
155584324|NCT00468819|561564361|FG002|Overall Study|Lost to Follow-up|1|||
155584325|NCT00468819|561564359|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
155584326|NCT00468819|561564360|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
155584327|NCT00468819|561564361|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
155584328|NCT02492867|561564362|FG000|Overall Study|Alternate therapy|1|||
155584329|NCT02492867|561564362|FG000|Overall Study|Withdrawal by Subject|2|||
155584330|NCT02492867|561564362|FG000|Overall Study|Disease progression after treatment started|1|||
155584331|NCT02492867|561564362|FG000|Overall Study|Death|1|||
155584332|NCT03296527|561564363|FG000|Overall Study|Adverse Event|15|||
155584333|NCT03296527|561564364|FG001|Overall Study|Adverse Event|33|||
155584334|NCT03296527|561564363|FG000|Overall Study|Protocol Deviation|4|||
155584335|NCT03296527|561564364|FG001|Overall Study|Protocol Deviation|0|||
155584336|NCT03296527|561564363|FG000|Overall Study|Participant withdrew consent|3|||
155584337|NCT03296527|561564364|FG001|Overall Study|Participant withdrew consent|1|||
155584338|NCT03296527|561564363|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
155584339|NCT03296527|561564364|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
155584340|NCT03296527|561564363|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
155584341|NCT03296527|561564364|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
155584342|NCT03296527|561564363|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
155584343|NCT03296527|561564364|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
155584344|NCT03296527|561564363|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
155584345|NCT03296527|561564364|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
155584346|NCT03296527|561564363|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
155584347|NCT03296527|561564364|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
155584348|NCT01597973|561564365|FG000|Overall Study|Found ineligible before study medication started|4|||
155584349|NCT01597973|561564366|FG001|Overall Study|Found ineligible before study medication started|2|||
155584350|NCT01597973|561564365|FG000|Overall Study|Eligible pathogen not confirmed|14|||
155584351|NCT01597973|561564366|FG001|Overall Study|Eligible pathogen not confirmed|15|||
155584352|NCT01597973|561564365|FG000|Overall Study|LAR not authorized to consent|0|||
155584353|NCT01597973|561564366|FG001|Overall Study|LAR not authorized to consent|1|||
155584354|NCT01597973|561564365|FG000|Overall Study|Ineligible due to early seizures|1|||
155584355|NCT01597973|561564366|FG001|Overall Study|Ineligible due to early seizures|0|||
155584356|NCT01597973|561564365|FG000|Overall Study|Ineligible due to non-target infection|1|||
155584357|NCT01597973|561564366|FG001|Overall Study|Ineligible due to non-target infection|1|||
155584358|NCT01326845|561564367|FG000|Overall Study|Administrative Problems|5|||
155584359|NCT01326845|561564368|FG001|Overall Study|Administrative Problems|2|||
155584360|NCT01326845|561564367|FG000|Overall Study|Adverse Event|1|||
155584361|NCT01326845|561564368|FG001|Overall Study|Adverse Event|0|||
155584362|NCT01326845|561564367|FG000|Overall Study|Misisng|1|||
155584363|NCT01326845|561564368|FG001|Overall Study|Misisng|3|||
155584364|NCT00908544|561564371|FG000|Overall Study|Withdrawal by Subject|2|||
155584365|NCT00908544|561564372|FG001|Overall Study|Withdrawal by Subject|4|||
155584366|NCT00908544|561564371|FG000|Overall Study|Lack of Efficacy|0|||
155584367|NCT00908544|561564372|FG001|Overall Study|Lack of Efficacy|1|||
155584368|NCT00908544|561564371|FG000|Overall Study|Pregnancy|1|||
155584369|NCT00908544|561564372|FG001|Overall Study|Pregnancy|0|||
155584370|NCT00908544|561564371|FG000|Overall Study|Relocation abroad|1|||
155584371|NCT00908544|561564372|FG001|Overall Study|Relocation abroad|1|||
155584372|NCT00908544|561564371|FG000|Overall Study|Unable to visit sutdy center|1|||
155584373|NCT00908544|561564372|FG001|Overall Study|Unable to visit sutdy center|0|||
155584374|NCT00740636|561564375|FG000|Overall Study|Adverse Event|0|||
155584375|NCT00740636|561564376|FG001|Overall Study|Adverse Event|2|||
155584376|NCT00740636|561564375|FG000|Overall Study|Patient Ineligible|0|||
155584377|NCT00740636|561564376|FG001|Overall Study|Patient Ineligible|1|||
155584378|NCT00740636|561564375|FG000|Overall Study|Patient Not Treated|0|||
155584379|NCT00740636|561564376|FG001|Overall Study|Patient Not Treated|1|||
155584380|NCT00740636|561564375|FG000|Overall Study|Progressive Disease|1|||
155584381|NCT00740636|561564376|FG001|Overall Study|Progressive Disease|0|||
155584382|NCT00740636|561564375|FG000|Overall Study|Death|1|||
155584383|NCT00740636|561564376|FG001|Overall Study|Death|0|||
155584384|NCT02462603|561564381|FG000|Overall Study|Investigator Decision|1|||
155584385|NCT02462603|561564381|FG000|Overall Study|Non-Compliance|1|||
155584386|NCT02462603|561564381|FG000|Overall Study|Withdrawal by Subject|2|||
155584387|NCT03760744|561566056|FG000|Overall Study|Lost to Follow-up|3|||
155584388|NCT03760744|561566057|FG001|Overall Study|Lost to Follow-up|0|||
155584389|NCT05731700|561566058|FG000|Overall Study|Death|1|||
155584390|NCT05400655|561566059|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
155584391|NCT05400655|561566060|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
155584392|NCT05400655|561566061|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
155584393|NCT05400655|561566062|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
155584394|NCT05400655|561566063|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
155584395|NCT05400655|561566064|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
155584396|NCT05400655|561566065|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
155584397|NCT05400655|561566066|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
155584398|NCT05400655|561566067|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
155584399|NCT05400655|561566068|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
155584400|NCT05400655|561566069|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
155584401|NCT05400655|561566070|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
155584402|NCT05400655|561566071|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
155584403|NCT05400655|561566072|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
155584404|NCT05400655|561566073|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
155584405|NCT05400655|561566074|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
155584406|NCT05400655|561566075|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
155584407|NCT05400655|561566076|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
155584408|NCT05400655|561566077|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
155584409|NCT05400655|561566078|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
155584410|NCT05400655|561566079|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
155584411|NCT05400655|561566080|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
155584412|NCT05400655|561566059|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584413|NCT05400655|561566060|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584414|NCT05400655|561566061|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584415|NCT05400655|561566062|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584416|NCT05400655|561566063|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584417|NCT05400655|561566064|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584418|NCT05400655|561566065|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584419|NCT05400655|561566066|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584420|NCT05400655|561566067|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584421|NCT05400655|561566068|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584422|NCT05400655|561566069|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584423|NCT05400655|561566070|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584424|NCT05400655|561566071|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155584425|NCT05400655|561566072|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584426|NCT05400655|561566073|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584427|NCT05400655|561566074|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584428|NCT05400655|561566075|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155584429|NCT05400655|561566076|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584430|NCT05400655|561566077|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155584431|NCT05400655|561566078|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
155584432|NCT05400655|561566079|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584433|NCT05400655|561566080|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155584434|NCT05400655|561566059|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584435|NCT05400655|561566060|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584436|NCT05400655|561566061|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584437|NCT05400655|561566062|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584438|NCT05400655|561566063|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584439|NCT05400655|561566064|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584440|NCT05400655|561566065|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584441|NCT05400655|561566066|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584442|NCT05400655|561566067|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584443|NCT05400655|561566068|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584444|NCT05400655|561566069|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584445|NCT05400655|561566070|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155664710|NCT01436110|561869031|FG000|Overall Study|Lack of Efficacy|23|||
155664711|NCT01436110|561869032|FG001|Overall Study|Lack of Efficacy|14|||
155664712|NCT01436110|561869033|FG002|Overall Study|Lack of Efficacy|9|||
155584446|NCT05400655|561566071|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584447|NCT05400655|561566072|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
155584448|NCT05400655|561566073|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584449|NCT05400655|561566074|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584450|NCT05400655|561566075|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
155584451|NCT05400655|561566076|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584452|NCT05400655|561566077|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
155584453|NCT05400655|561566078|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584454|NCT05400655|561566079|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584455|NCT05400655|561566080|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155584456|NCT05400655|561566059|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584457|NCT05400655|561566060|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584458|NCT05400655|561566061|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584459|NCT05400655|561566062|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584460|NCT05400655|561566063|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584461|NCT05400655|561566064|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584462|NCT05400655|561566065|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584463|NCT05400655|561566066|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584464|NCT05400655|561566067|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584465|NCT05400655|561566068|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584466|NCT05400655|561566069|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584467|NCT05400655|561566070|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584468|NCT05400655|561566071|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584469|NCT05400655|561566072|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584470|NCT05400655|561566073|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584471|NCT05400655|561566074|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584472|NCT05400655|561566075|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155584473|NCT05400655|561566076|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155584474|NCT05400655|561566077|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
155584475|NCT05400655|561566078|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155584476|NCT05400655|561566079|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
155584477|NCT05400655|561566080|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155584478|NCT05400655|561566059|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584479|NCT05400655|561566060|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584480|NCT05400655|561566061|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584481|NCT05400655|561566062|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584482|NCT05400655|561566063|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584483|NCT05400655|561566064|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584484|NCT05400655|561566065|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584485|NCT05400655|561566066|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584486|NCT05400655|561566067|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584487|NCT05400655|561566068|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584488|NCT05400655|561566069|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584489|NCT05400655|561566070|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584490|NCT05400655|561566071|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584491|NCT05400655|561566072|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584492|NCT05400655|561566073|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584493|NCT05400655|561566074|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584494|NCT05400655|561566075|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584495|NCT05400655|561566076|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
155584496|NCT05400655|561566077|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
155584497|NCT05400655|561566078|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584498|NCT05400655|561566079|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584499|NCT05400655|561566080|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155584500|NCT05400655|561566059|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584501|NCT05400655|561566060|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584502|NCT05400655|561566061|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584503|NCT05400655|561566062|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584504|NCT05400655|561566063|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584505|NCT05400655|561566064|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584506|NCT05400655|561566065|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584507|NCT05400655|561566066|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584508|NCT05400655|561566067|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584509|NCT05400655|561566068|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584510|NCT05400655|561566069|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584511|NCT05400655|561566070|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584512|NCT05400655|561566071|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584513|NCT05400655|561566072|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584514|NCT05400655|561566073|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584515|NCT05400655|561566074|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584516|NCT05400655|561566075|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155584517|NCT05400655|561566076|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155584518|NCT05400655|561566077|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155584519|NCT05400655|561566078|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
155584520|NCT05400655|561566079|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155584521|NCT05400655|561566080|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
155584522|NCT05161481|561566097|FG000|Overall Study|Withdrawal of consent|0|||
155664713|NCT01436110|561869031|FG000|Overall Study|Withdrawal by Subject|6|||
155664714|NCT01436110|561869032|FG001|Overall Study|Withdrawal by Subject|8|||
155664715|NCT01436110|561869033|FG002|Overall Study|Withdrawal by Subject|4|||
155664716|NCT01436110|561869031|FG000|Overall Study|Adverse Event|2|||
155664717|NCT01436110|561869032|FG001|Overall Study|Adverse Event|1|||
155664718|NCT01436110|561869033|FG002|Overall Study|Adverse Event|2|||
155664719|NCT01436110|561869031|FG000|Overall Study|Physician Decision|3|||
155664720|NCT01436110|561869032|FG001|Overall Study|Physician Decision|1|||
155664721|NCT01436110|561869033|FG002|Overall Study|Physician Decision|1|||
155664722|NCT01436110|561869031|FG000|Overall Study|Lost to Follow-up|1|||
155664723|NCT01436110|561869032|FG001|Overall Study|Lost to Follow-up|1|||
155664724|NCT01436110|561869033|FG002|Overall Study|Lost to Follow-up|3|||
155664725|NCT01436110|561869031|FG000|Overall Study|Protocol Violation|3|||
155664726|NCT01436110|561869032|FG001|Overall Study|Protocol Violation|1|||
155664727|NCT01436110|561869033|FG002|Overall Study|Protocol Violation|1|||
155664728|NCT01436110|561869031|FG000|Overall Study|Did Not Receive Trial Medication|1|||
155664729|NCT01436110|561869032|FG001|Overall Study|Did Not Receive Trial Medication|0|||
155664730|NCT01436110|561869033|FG002|Overall Study|Did Not Receive Trial Medication|3|||
155664731|NCT03273907|561869034|FG000|Overall Study|Death|1|||
155664732|NCT03273907|561869034|FG000|Overall Study|Lost to Follow-up|4|||
155664733|NCT03273907|561869034|FG000|Overall Study|Withdrawal by Subject|2|||
155664734|NCT03273907|561869034|FG000|Overall Study|COVID 19|2|||
155664735|NCT01088503|561869035|FG000|Overall Study|Withdrawal by Subject|118|||
155664736|NCT01088503|561869036|FG001|Overall Study|Withdrawal by Subject|327|||
155664737|NCT01088503|561869037|FG002|Overall Study|Withdrawal by Subject|10|||
155664738|NCT01088503|561869035|FG000|Overall Study|Death|64|||
155664739|NCT01088503|561869036|FG001|Overall Study|Death|358|||
155664740|NCT01088503|561869037|FG002|Overall Study|Death|7|||
155664741|NCT00110214|561869038|FG000|Overall Study|Never started treatment|21|||
155584523|NCT05161481|561566098|FG001|Overall Study|Withdrawal of consent|1|||
155584524|NCT05161481|561566099|FG002|Overall Study|Withdrawal of consent|1|||
155584525|NCT05161481|561566097|FG000|Overall Study|Study terminated by sponsor|3|||
155584526|NCT05161481|561566098|FG001|Overall Study|Study terminated by sponsor|3|||
155584527|NCT05161481|561566099|FG002|Overall Study|Study terminated by sponsor|2|||
155584528|NCT05161481|561566097|FG000|Overall Study|Adverse Event|3|||
155584529|NCT05161481|561566098|FG001|Overall Study|Adverse Event|0|||
155584530|NCT05161481|561566099|FG002|Overall Study|Adverse Event|6|||
155584531|NCT05161481|561566097|FG000|Overall Study|Randomised in error and was not treated|1|||
155584532|NCT05161481|561566098|FG001|Overall Study|Randomised in error and was not treated|0|||
155584533|NCT05161481|561566099|FG002|Overall Study|Randomised in error and was not treated|0|||
155584534|NCT05161481|561566097|FG000|Overall Study|Subject decision|0|||
155584535|NCT05161481|561566098|FG001|Overall Study|Subject decision|0|||
155584536|NCT05161481|561566099|FG002|Overall Study|Subject decision|1|||
155584537|NCT05468164|561566102|FG000|Treatment Period 4|Adverse Event|0|||
155584538|NCT05468164|561566103|FG001|Treatment Period 4|Adverse Event|0|||
155584539|NCT05468164|561566104|FG002|Treatment Period 4|Adverse Event|0|||
155584540|NCT05468164|561566105|FG003|Treatment Period 4|Adverse Event|1|||
155584541|NCT04632927|561566106|FG000|Overall Study|Adverse Event|0|||
155584542|NCT04632927|561566107|FG001|Overall Study|Adverse Event|1|||
155584543|NCT04632927|561566106|FG000|Overall Study|Lack of Efficacy|0|||
155584544|NCT04632927|561566107|FG001|Overall Study|Lack of Efficacy|4|||
155584545|NCT04632927|561566106|FG000|Overall Study|Loss of efficacy|0|||
155584546|NCT04632927|561566107|FG001|Overall Study|Loss of efficacy|1|||
155584547|NCT04632927|561566106|FG000|Overall Study|Non-compliance with study drug|0|||
155584548|NCT04632927|561566107|FG001|Overall Study|Non-compliance with study drug|1|||
155584549|NCT04632927|561566106|FG000|Overall Study|Physician Decision|0|||
155584550|NCT04632927|561566107|FG001|Overall Study|Physician Decision|1|||
155584551|NCT04632927|561566106|FG000|Overall Study|Subject decision|0|||
155584552|NCT04632927|561566107|FG001|Overall Study|Subject decision|1|||
155584553|NCT04632927|561566106|FG000|Overall Study|Withdrawal by Subject|0|||
155584554|NCT04632927|561566107|FG001|Overall Study|Withdrawal by Subject|1|||
155584555|NCT03827291|561566108|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
155584556|NCT03827291|561566109|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
155584557|NCT04795466|561566110|FG000|Overall Study|Adverse Event|3|||
155584558|NCT04795466|561566111|FG001|Overall Study|Adverse Event|1|||
155584559|NCT04795466|561566110|FG000|Overall Study|Physician Decision|1|||
155584560|NCT04795466|561566111|FG001|Overall Study|Physician Decision|0|||
155584561|NCT04795466|561566110|FG000|Overall Study|Withdrawal by Subject|2|||
155584562|NCT04795466|561566111|FG001|Overall Study|Withdrawal by Subject|1|||
155584563|NCT04652726|561566112|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
155584564|NCT04652726|561566113|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
155584565|NCT04652726|561566114|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
155584566|NCT04652726|561566112|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
155584567|NCT04652726|561566113|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
155584568|NCT04652726|561566114|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
155584569|NCT01102257|561566127|FG000|Overall Study|Adverse Event|1|||
155584570|NCT01102257|561566128|FG001|Overall Study|Adverse Event|0|||
155584571|NCT01102257|561566127|FG000|Overall Study|Adverse Event|1|||
155584572|NCT01102257|561566128|FG001|Overall Study|Adverse Event|0|||
155584573|NCT01467713|561566130|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
155584574|NCT01467713|561566131|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
155584575|NCT01467713|561566132|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
155584576|NCT01467713|561566133|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
155584577|NCT01467713|561566130|FG000|Overall Study|Major Protocol Deviation|2|||
155584578|NCT01467713|561566131|FG001|Overall Study|Major Protocol Deviation|4|||
155584579|NCT01467713|561566132|FG002|Overall Study|Major Protocol Deviation|4|||
155584580|NCT01467713|561566133|FG003|Overall Study|Major Protocol Deviation|1|||
155584581|NCT01467713|561566130|FG000|Overall Study|Lost to Follow-up|9|||
155584582|NCT01467713|561566131|FG001|Overall Study|Lost to Follow-up|12|||
155584583|NCT01467713|561566132|FG002|Overall Study|Lost to Follow-up|6|||
155584584|NCT01467713|561566133|FG003|Overall Study|Lost to Follow-up|9|||
155584585|NCT01467713|561566130|FG000|Overall Study|Voluntary Withdrawal|18|||
155584586|NCT01467713|561566131|FG001|Overall Study|Voluntary Withdrawal|14|||
155584587|NCT01467713|561566132|FG002|Overall Study|Voluntary Withdrawal|21|||
155584588|NCT01467713|561566133|FG003|Overall Study|Voluntary Withdrawal|20|||
155584589|NCT01467713|561566130|FG000|Overall Study|Study Termination|23|||
155584590|NCT01467713|561566131|FG001|Overall Study|Study Termination|33|||
155584591|NCT01467713|561566132|FG002|Overall Study|Study Termination|28|||
155584592|NCT01467713|561566133|FG003|Overall Study|Study Termination|29|||
155584593|NCT01467713|561566130|FG000|Overall Study|Pregnancy|0|||
155584594|NCT01467713|561566131|FG001|Overall Study|Pregnancy|1|||
155664742|NCT00110214|561869039|FG001|Overall Study|Never started treatment|20|||
155664743|NCT00110214|561869038|FG000|Overall Study|Disease progression or death|260|||
155664744|NCT00110214|561869039|FG001|Overall Study|Disease progression or death|151|||
155664745|NCT00110214|561869038|FG000|Overall Study|Adverse Event|115|||
155664746|NCT00110214|561869039|FG001|Overall Study|Adverse Event|192|||
155664747|NCT00110214|561869038|FG000|Overall Study|Refused further treatment|52|||
155664748|NCT00110214|561869039|FG001|Overall Study|Refused further treatment|65|||
155664749|NCT00110214|561869038|FG000|Overall Study|Other (not specified)|61|||
155664750|NCT00110214|561869039|FG001|Overall Study|Other (not specified)|75|||
155664751|NCT01847092|561869040|FG000|Overall Study|Adverse Event|12|||
155664752|NCT01847092|561869041|FG001|Overall Study|Adverse Event|3|||
155664753|NCT01847092|561869040|FG000|Overall Study|Withdrawal by Subject|5|||
155664754|NCT01847092|561869041|FG001|Overall Study|Withdrawal by Subject|5|||
155664755|NCT01847092|561869040|FG000|Overall Study|Protocol Specified|8|||
155664756|NCT01847092|561869041|FG001|Overall Study|Protocol Specified|0|||
155664757|NCT01847092|561869040|FG000|Overall Study|Physician Decision|1|||
155664758|NCT01847092|561869041|FG001|Overall Study|Physician Decision|1|||
155664759|NCT01847092|561869040|FG000|Overall Study|Protocol Violation|0|||
155664760|NCT01847092|561869041|FG001|Overall Study|Protocol Violation|2|||
155664761|NCT03604497|561869043|FG000|Overall Study|Protocol Violation|52|||
155664762|NCT00811954|561869044|FG000|Overall Study|Death|10|||
155664763|NCT00811954|561869045|FG001|Overall Study|Death|6|||
155664764|NCT00811954|561869046|FG002|Overall Study|Death|13|||
155664765|NCT00811954|561869044|FG000|Overall Study|Lost to Follow-up|29|||
155664766|NCT00811954|561869045|FG001|Overall Study|Lost to Follow-up|23|||
155664767|NCT00811954|561869046|FG002|Overall Study|Lost to Follow-up|34|||
155664768|NCT00811954|561869044|FG000|Overall Study|Not able to get to clinic|28|||
155664769|NCT00811954|561869045|FG001|Overall Study|Not able to get to clinic|35|||
155664770|NCT00811954|561869046|FG002|Overall Study|Not able to get to clinic|30|||
155664771|NCT00811954|561869044|FG000|Overall Study|Not willing to adhere to requirements|12|||
155664772|NCT00811954|561869045|FG001|Overall Study|Not willing to adhere to requirements|2|||
155664773|NCT00811954|561869046|FG002|Overall Study|Not willing to adhere to requirements|16|||
155664774|NCT00811954|561869044|FG000|Overall Study|Withdraw consent prior study completion|4|||
155664775|NCT00811954|561869045|FG001|Overall Study|Withdraw consent prior study completion|6|||
155664776|NCT00811954|561869046|FG002|Overall Study|Withdraw consent prior study completion|5|||
155664777|NCT00811954|561869044|FG000|Overall Study|Site Closure|4|||
155664778|NCT00811954|561869045|FG001|Overall Study|Site Closure|0|||
155664779|NCT00811954|561869046|FG002|Overall Study|Site Closure|1|||
155664780|NCT00811954|561869044|FG000|Overall Study|Severe Debilitation|2|||
155664781|NCT00811954|561869045|FG001|Overall Study|Severe Debilitation|0|||
155664782|NCT00811954|561869046|FG002|Overall Study|Severe Debilitation|1|||
155664783|NCT00811954|561869044|FG000|Overall Study|Complete Protocol: No follow-up|0|||
155664784|NCT00811954|561869045|FG001|Overall Study|Complete Protocol: No follow-up|0|||
155664785|NCT00811954|561869046|FG002|Overall Study|Complete Protocol: No follow-up|1|||
155664786|NCT01016067|561869047|FG000|Overall Study|Lost to Follow-up|1|||
155664787|NCT01016067|561869048|FG001|Overall Study|Lost to Follow-up|2|||
155664788|NCT01016067|561869047|FG000|Overall Study|Physician Decision|1|||
155664789|NCT01016067|561869048|FG001|Overall Study|Physician Decision|1|||
155664790|NCT01016067|561869047|FG000|Overall Study|Withdrew due to Relocation|0|||
155664791|NCT01016067|561869048|FG001|Overall Study|Withdrew due to Relocation|1|||
155664792|NCT00186628|561869050|FG000|Overall Study|Death|2|||
155664793|NCT00186628|561869050|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
155664794|NCT00658541|561869053|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
155664795|NCT00658541|561869054|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155664796|NCT00658541|561869053|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155664797|NCT00658541|561869054|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155664798|NCT04828707|561869055|FG000|Overall Study|Lost to Follow-up|3|||
155664799|NCT04828707|561869056|FG001|Overall Study|Lost to Follow-up|2|||
155664800|NCT04828707|561869055|FG000|Overall Study|Withdrawal by Subject|2|||
155664801|NCT04828707|561869056|FG001|Overall Study|Withdrawal by Subject|1|||
155664802|NCT01188967|561869061|FG000|Overall Study|Withdrawal by Subject|1|||
155664803|NCT01188967|561869062|FG001|Overall Study|Withdrawal by Subject|1|||
155664804|NCT01188967|561869061|FG000|Overall Study|Physician Decision|1|||
155664805|NCT01188967|561869062|FG001|Overall Study|Physician Decision|1|||
155664806|NCT01188967|561869061|FG000|Overall Study|Lost to Follow-up|3|||
155664807|NCT01188967|561869062|FG001|Overall Study|Lost to Follow-up|2|||
155664808|NCT01876381|561869063|FG000|Overall Study|Lack of Efficacy|5|||
155664809|NCT01876381|561869063|FG000|Overall Study|Physician Decision|1|||
155664810|NCT01876381|561869063|FG000|Overall Study|Withdrawal by Subject|1|||
155664811|NCT00523978|561869064|FG000|Overall Study|Withdrawal by Subject|3|||
155664812|NCT00523978|561869065|FG001|Overall Study|Withdrawal by Subject|7|||
155664813|NCT00523978|561869064|FG000|Overall Study|Screen Failures|5|||
155664814|NCT00523978|561869065|FG001|Overall Study|Screen Failures|1|||
155664815|NCT00523978|561869064|FG000|Overall Study|Death|1|||
155664816|NCT00523978|561869065|FG001|Overall Study|Death|0|||
155664817|NCT01464879|561869066|FG000|Overall Study|Physician Decision|1|||
155664818|NCT01464879|561869066|FG000|Overall Study|Non-compliance|1|||
155584595|NCT01467713|561566132|FG002|Overall Study|Pregnancy|1|||
155584596|NCT01467713|561566133|FG003|Overall Study|Pregnancy|3|||
155584597|NCT01467713|561566130|FG000|Overall Study|Relapse|35|||
155584598|NCT01467713|561566131|FG001|Overall Study|Relapse|25|||
155584599|NCT01467713|561566132|FG002|Overall Study|Relapse|28|||
155584600|NCT01467713|561566133|FG003|Overall Study|Relapse|35|||
155584601|NCT01467713|561566130|FG000|Overall Study|Reason not Specified|6|||
155584602|NCT01467713|561566131|FG001|Overall Study|Reason not Specified|11|||
155584603|NCT01467713|561566132|FG002|Overall Study|Reason not Specified|8|||
155584604|NCT01467713|561566133|FG003|Overall Study|Reason not Specified|7|||
155584605|NCT01894841|561566136|FG000|Overall Study|Withdrawal by Subject|9|||
155584606|NCT01894841|561566137|FG001|Overall Study|Withdrawal by Subject|4|||
155584607|NCT01894841|561566136|FG000|Overall Study|Withdrawn by investigator|2|||
155584608|NCT01894841|561566137|FG001|Overall Study|Withdrawn by investigator|2|||
155584609|NCT01894841|561566136|FG000|Overall Study|Lost to Follow-up|7|||
155584610|NCT01894841|561566137|FG001|Overall Study|Lost to Follow-up|3|||
155584611|NCT01100086|561566138|FG000|Period 1|Withdrawal by Subject|1|||
155584612|NCT01100086|561566139|FG001|Period 1|Withdrawal by Subject|0|||
155584613|NCT01611935|561566140|FG000|Overall Study|Family Declined Participation|1|||
155584614|NCT01611935|561566141|FG001|Overall Study|Family Declined Participation|0|||
155584615|NCT01735916|561566142|FG000|Overall Study|Subject not eligible to be randomized|11|||
155584616|NCT01735916|561566143|FG001|Overall Study|Subject not eligible to be randomized|0|||
155584617|NCT01735916|561566144|FG002|Overall Study|Subject not eligible to be randomized|0|||
155584618|NCT01735916|561566142|FG000|Overall Study|Early termination of study by sponsor|4|||
155584619|NCT01735916|561566143|FG001|Overall Study|Early termination of study by sponsor|19|||
155584620|NCT01735916|561566144|FG002|Overall Study|Early termination of study by sponsor|7|||
155584621|NCT01735916|561566142|FG000|Overall Study|Withdrawal by Subject|3|||
155584622|NCT01735916|561566143|FG001|Overall Study|Withdrawal by Subject|0|||
155584623|NCT01735916|561566144|FG002|Overall Study|Withdrawal by Subject|0|||
155584624|NCT04227197|561566145|FG000|Randomization|Protocol Violation|1|||
155584625|NCT04227197|561566146|FG001|Randomization|Protocol Violation|0|||
155584626|NCT04227197|561566145|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
155584627|NCT04227197|561566146|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
155584628|NCT04227197|561566145|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
155584629|NCT04227197|561566146|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
155584630|NCT04227197|561566145|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
155584631|NCT04227197|561566146|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
155584632|NCT04227197|561566145|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
155584633|NCT04227197|561566146|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
155584634|NCT04227197|561566145|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
155584635|NCT04227197|561566146|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
155584636|NCT04227197|561566145|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
155584637|NCT04227197|561566146|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
155584638|NCT02549859|561566151|FG000|Long-term 60 Hz DBS|Study Closed|1|||
155584639|NCT01379768|561566152|FG000|Overall Study|Adverse Event|1|||
155584640|NCT01379768|561566153|FG001|Overall Study|Adverse Event|1|||
155584641|NCT01379768|561566154|FG002|Overall Study|Adverse Event|0|||
155584642|NCT01379768|561566152|FG000|Overall Study|Lost to Follow-up|2|||
155584643|NCT01379768|561566153|FG001|Overall Study|Lost to Follow-up|0|||
155584644|NCT01379768|561566154|FG002|Overall Study|Lost to Follow-up|0|||
155584645|NCT01209949|561566162|FG000|Overall Study|Lost to Follow-up|3|||
155584646|NCT00729612|561566167|FG000|Overall Study|Non evaluable for response|10|||
155584647|NCT00708552|561566168|FG000|Overall Study|Adverse Event|10|||
155584648|NCT00708552|561566169|FG001|Overall Study|Adverse Event|3|||
155584649|NCT00708552|561566170|FG002|Overall Study|Adverse Event|4|||
155584650|NCT00708552|561566171|FG003|Overall Study|Adverse Event|6|||
155584651|NCT00708552|561566168|FG000|Overall Study|Lack of Efficacy|0|||
155584652|NCT00708552|561566169|FG001|Overall Study|Lack of Efficacy|4|||
155584653|NCT00708552|561566170|FG002|Overall Study|Lack of Efficacy|1|||
155584654|NCT00708552|561566171|FG003|Overall Study|Lack of Efficacy|0|||
155584655|NCT00708552|561566168|FG000|Overall Study|Protocol Violation|0|||
155584656|NCT00708552|561566169|FG001|Overall Study|Protocol Violation|0|||
155664819|NCT01657305|561869067|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
155584657|NCT00708552|561566170|FG002|Overall Study|Protocol Violation|2|||
155584658|NCT00708552|561566171|FG003|Overall Study|Protocol Violation|4|||
155584659|NCT00708552|561566168|FG000|Overall Study|Lost to Follow-up|4|||
155584660|NCT00708552|561566169|FG001|Overall Study|Lost to Follow-up|2|||
155584661|NCT00708552|561566170|FG002|Overall Study|Lost to Follow-up|0|||
155664820|NCT01657305|561869067|FG000|Overall Study|Withdrawal by Subject|4|||
155584662|NCT00708552|561566171|FG003|Overall Study|Lost to Follow-up|1|||
155584663|NCT00708552|561566168|FG000|Overall Study|Physician Decision|1|||
155664821|NCT01657305|561869067|FG000|Overall Study|Adverse Event|1|||
155664822|NCT01657305|561869067|FG000|Overall Study|Lost to Follow-up|1|||
155664823|NCT01657305|561869067|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
155664824|NCT00696878|561869068|FG000|Overall Study|Adverse Event|8|||
155584664|NCT00708552|561566169|FG001|Overall Study|Physician Decision|2|||
155584665|NCT00708552|561566170|FG002|Overall Study|Physician Decision|0|||
155584666|NCT00708552|561566171|FG003|Overall Study|Physician Decision|0|||
155584667|NCT00708552|561566168|FG000|Overall Study|Withdrawal by Subject|12|||
155584668|NCT00708552|561566169|FG001|Overall Study|Withdrawal by Subject|7|||
155584669|NCT00708552|561566170|FG002|Overall Study|Withdrawal by Subject|8|||
155584670|NCT00708552|561566171|FG003|Overall Study|Withdrawal by Subject|10|||
155584671|NCT03971071|561566173|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155584672|NCT03971071|561566174|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
155584673|NCT03971071|561566175|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155584674|NCT03971071|561566176|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155584675|NCT03971071|561566177|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155584676|NCT03971071|561566173|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
155584677|NCT03971071|561566174|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
155584678|NCT03971071|561566175|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
155584679|NCT03971071|561566176|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155584680|NCT03971071|561566177|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155584681|NCT03971071|561566173|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
155584682|NCT03971071|561566174|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
155584683|NCT03971071|561566175|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
155584684|NCT03971071|561566176|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
155584685|NCT03971071|561566177|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
155584686|NCT03971071|561566173|FG000|Open-label Treatment Period|Sponsor decision|0|||
155584687|NCT03971071|561566174|FG001|Open-label Treatment Period|Sponsor decision|0|||
155584688|NCT03971071|561566175|FG002|Open-label Treatment Period|Sponsor decision|0|||
155584689|NCT03971071|561566176|FG003|Open-label Treatment Period|Sponsor decision|0|||
155584690|NCT03971071|561566177|FG004|Open-label Treatment Period|Sponsor decision|1|||
155584691|NCT03971071|561566173|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155584692|NCT03971071|561566174|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155584693|NCT03971071|561566175|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155584694|NCT03971071|561566176|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
155584695|NCT03971071|561566177|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
155584696|NCT03971071|561566173|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155584697|NCT03971071|561566174|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155584698|NCT03971071|561566175|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155584699|NCT03971071|561566176|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155584700|NCT03971071|561566177|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
155584701|NCT00391768|561566178|FG000|Overall Study|Withdrawal by Subject|0|||
155584702|NCT00391768|561566179|FG001|Overall Study|Withdrawal by Subject|0|||
155584703|NCT00391768|561566180|FG002|Overall Study|Withdrawal by Subject|1|||
155584704|NCT00391768|561566181|FG003|Overall Study|Withdrawal by Subject|0|||
155584705|NCT00391768|561566182|FG004|Overall Study|Withdrawal by Subject|0|||
155584706|NCT00391768|561566183|FG005|Overall Study|Withdrawal by Subject|1|||
155584707|NCT00391768|561566184|FG006|Overall Study|Withdrawal by Subject|1|||
155584708|NCT00391768|561566178|FG000|Overall Study|Lost to Follow-up|0|||
155584709|NCT00391768|561566179|FG001|Overall Study|Lost to Follow-up|0|||
155584710|NCT00391768|561566180|FG002|Overall Study|Lost to Follow-up|0|||
155584711|NCT00391768|561566181|FG003|Overall Study|Lost to Follow-up|1|||
155584712|NCT00391768|561566182|FG004|Overall Study|Lost to Follow-up|2|||
155584713|NCT00391768|561566183|FG005|Overall Study|Lost to Follow-up|2|||
155584714|NCT00391768|561566184|FG006|Overall Study|Lost to Follow-up|3|||
155584715|NCT00891020|561566185|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
155584716|NCT00891020|561566186|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
155584717|NCT00891020|561566187|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
155584718|NCT00891020|561566185|FG000|24 Week Treatment Period|Death|0|||
155584719|NCT00891020|561566186|FG001|24 Week Treatment Period|Death|2|||
155584720|NCT00891020|561566187|FG002|24 Week Treatment Period|Death|0|||
155584721|NCT00891020|561566185|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
155584722|NCT00891020|561566186|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
155584723|NCT00891020|561566187|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
155584724|NCT00891020|561566185|FG000|24 Week Treatment Period|Failure to return|4|||
155584725|NCT00891020|561566186|FG001|24 Week Treatment Period|Failure to return|5|||
155584726|NCT00891020|561566187|FG002|24 Week Treatment Period|Failure to return|5|||
155584727|NCT00891020|561566185|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
155584728|NCT00891020|561566186|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
155584729|NCT00891020|561566187|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
155584730|NCT00891020|561566185|FG000|24 Week Treatment Period|Other protocol violation|1|||
155584731|NCT00891020|561566186|FG001|24 Week Treatment Period|Other protocol violation|1|||
155584732|NCT00891020|561566187|FG002|24 Week Treatment Period|Other protocol violation|2|||
155584733|NCT00891020|561566185|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
155584734|NCT00891020|561566186|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
155584735|NCT00891020|561566187|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
155584736|NCT00891020|561566185|FG000|24 Week Treatment Period|Withdrew consent|6|||
155584737|NCT00891020|561566186|FG001|24 Week Treatment Period|Withdrew consent|3|||
155584738|NCT00891020|561566187|FG002|24 Week Treatment Period|Withdrew consent|15|||
155584739|NCT00891020|561566185|FG000|24 Week Treatment Period|Administrative/Other|5|||
155584740|NCT00891020|561566186|FG001|24 Week Treatment Period|Administrative/Other|6|||
155584741|NCT00891020|561566187|FG002|24 Week Treatment Period|Administrative/Other|1|||
155584742|NCT00891020|561566185|FG000|Long-term Extension Period|Adverse Event|1|||
155584743|NCT00891020|561566186|FG001|Long-term Extension Period|Adverse Event|11|||
155584744|NCT00891020|561566187|FG002|Long-term Extension Period|Adverse Event|10|||
155584745|NCT00891020|561566185|FG000|Long-term Extension Period|Death|0|||
155584746|NCT00891020|561566186|FG001|Long-term Extension Period|Death|0|||
155584747|NCT00891020|561566187|FG002|Long-term Extension Period|Death|1|||
155584748|NCT00891020|561566185|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
155584749|NCT00891020|561566186|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
155584750|NCT00891020|561566187|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
155584751|NCT00891020|561566185|FG000|Long-term Extension Period|Protocol Violation|0|||
155584752|NCT00891020|561566186|FG001|Long-term Extension Period|Protocol Violation|1|||
155584753|NCT00891020|561566187|FG002|Long-term Extension Period|Protocol Violation|1|||
155584754|NCT00891020|561566185|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
155584755|NCT00891020|561566186|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
155584756|NCT00891020|561566187|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
155584757|NCT00891020|561566185|FG000|Long-term Extension Period|Failure to return|0|||
155584758|NCT00891020|561566186|FG001|Long-term Extension Period|Failure to return|2|||
155584759|NCT00891020|561566187|FG002|Long-term Extension Period|Failure to return|3|||
155584760|NCT00891020|561566185|FG000|Long-term Extension Period|Administrative|1|||
155584761|NCT00891020|561566186|FG001|Long-term Extension Period|Administrative|2|||
155584762|NCT00891020|561566187|FG002|Long-term Extension Period|Administrative|2|||
155584763|NCT00320710|561566188|FG000|Overall Study|Disease progression|24|||
155584764|NCT00320710|561566189|FG001|Overall Study|Disease progression|19|||
155584765|NCT00320710|561566190|FG002|Overall Study|Disease progression|2|||
155584766|NCT00320710|561566188|FG000|Overall Study|Death|10|||
155584767|NCT00320710|561566189|FG001|Overall Study|Death|7|||
155584768|NCT00320710|561566190|FG002|Overall Study|Death|1|||
155584769|NCT00320710|561566188|FG000|Overall Study|Administrative problems|1|||
155584770|NCT00320710|561566189|FG001|Overall Study|Administrative problems|2|||
155584771|NCT00320710|561566190|FG002|Overall Study|Administrative problems|0|||
155584772|NCT00320710|561566188|FG000|Overall Study|Withdrawal by Subject|20|||
155584773|NCT00320710|561566189|FG001|Overall Study|Withdrawal by Subject|26|||
155584774|NCT00320710|561566190|FG002|Overall Study|Withdrawal by Subject|1|||
155584775|NCT00320710|561566188|FG000|Overall Study|Protocol Violation|6|||
155584776|NCT00320710|561566189|FG001|Overall Study|Protocol Violation|5|||
155584777|NCT00320710|561566190|FG002|Overall Study|Protocol Violation|0|||
155584778|NCT00320710|561566188|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155584779|NCT00320710|561566189|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155584780|NCT00320710|561566190|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155584781|NCT00320710|561566188|FG000|Overall Study|Abnormal laboratory value(s)|12|||
155584782|NCT00320710|561566189|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155584783|NCT00320710|561566190|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155584784|NCT00320710|561566188|FG000|Overall Study|Adverse Event|18|||
155584785|NCT00320710|561566189|FG001|Overall Study|Adverse Event|14|||
155584786|NCT00320710|561566190|FG002|Overall Study|Adverse Event|1|||
155584787|NCT00320710|561566188|FG000|Overall Study|Lost to Follow-up|1|||
155584788|NCT00320710|561566189|FG001|Overall Study|Lost to Follow-up|0|||
155584789|NCT00320710|561566190|FG002|Overall Study|Lost to Follow-up|0|||
155584790|NCT04578457|561566191|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
155584791|NCT04578457|561566191|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
155584792|NCT04578457|561566191|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
155584793|NCT04578457|561566191|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
155584794|NCT03809663|561566199|FG000|Overall Study|Decision by sponsor|24|||
155584795|NCT03809663|561566200|FG001|Overall Study|Decision by sponsor|18|||
155584796|NCT03809663|561566201|FG002|Overall Study|Decision by sponsor|20|||
155584797|NCT03809663|561566202|FG003|Overall Study|Decision by sponsor|20|||
155584798|NCT03809663|561566203|FG004|Overall Study|Decision by sponsor|0|||
155584799|NCT03809663|561566204|FG005|Overall Study|Decision by sponsor|0|||
155584800|NCT03809663|561566199|FG000|Overall Study|Withdrawal by Subject|26|||
155584801|NCT03809663|561566200|FG001|Overall Study|Withdrawal by Subject|22|||
155584802|NCT03809663|561566201|FG002|Overall Study|Withdrawal by Subject|27|||
155584803|NCT03809663|561566202|FG003|Overall Study|Withdrawal by Subject|26|||
155584804|NCT03809663|561566203|FG004|Overall Study|Withdrawal by Subject|0|||
155584805|NCT03809663|561566204|FG005|Overall Study|Withdrawal by Subject|0|||
155584806|NCT03809663|561566199|FG000|Overall Study|Lost to Follow-up|1|||
155584807|NCT03809663|561566200|FG001|Overall Study|Lost to Follow-up|4|||
155584808|NCT03809663|561566201|FG002|Overall Study|Lost to Follow-up|1|||
155584809|NCT03809663|561566202|FG003|Overall Study|Lost to Follow-up|1|||
155584810|NCT03809663|561566203|FG004|Overall Study|Lost to Follow-up|0|||
155584811|NCT03809663|561566204|FG005|Overall Study|Lost to Follow-up|0|||
155584812|NCT03376789|561566207|FG000|Overall Study|Withdrawal by Subject|3|||
155584813|NCT03376789|561566208|FG001|Overall Study|Withdrawal by Subject|5|||
155584814|NCT03376789|561566207|FG000|Overall Study|Protocol Violation|0|||
155584815|NCT03376789|561566208|FG001|Overall Study|Protocol Violation|1|||
155584816|NCT03376789|561566207|FG000|Overall Study|Adverse Event|0|||
155584817|NCT03376789|561566208|FG001|Overall Study|Adverse Event|1|||
155584818|NCT03376789|561566207|FG000|Overall Study|Lost to Follow-up|1|||
155584819|NCT03376789|561566208|FG001|Overall Study|Lost to Follow-up|1|||
155584820|NCT03376789|561566207|FG000|Overall Study|Per sponsor due to noncompliance|1|||
155584821|NCT03376789|561566208|FG001|Overall Study|Per sponsor due to noncompliance|0|||
155584822|NCT03376789|561566207|FG000|Overall Study|Subject off study medication|0|||
155584823|NCT03376789|561566208|FG001|Overall Study|Subject off study medication|1|||
155584824|NCT01703260|561566209|FG000|Overall Study|Adverse Event|1|||
155584825|NCT01703260|561566210|FG001|Overall Study|Adverse Event|2|||
155584826|NCT01703260|561566211|FG002|Overall Study|Adverse Event|2|||
155584827|NCT01703260|561566209|FG000|Overall Study|Lost to Follow-up|1|||
155584828|NCT01703260|561566210|FG001|Overall Study|Lost to Follow-up|0|||
155584829|NCT01703260|561566211|FG002|Overall Study|Lost to Follow-up|0|||
155584830|NCT01703260|561566209|FG000|Overall Study|Withdrawal by Subject|0|||
155584831|NCT01703260|561566210|FG001|Overall Study|Withdrawal by Subject|0|||
155584832|NCT01703260|561566211|FG002|Overall Study|Withdrawal by Subject|1|||
155584833|NCT01703260|561566209|FG000|Overall Study|Study Termination|1|||
155584834|NCT01703260|561566210|FG001|Overall Study|Study Termination|2|||
155584835|NCT01703260|561566211|FG002|Overall Study|Study Termination|0|||
155584836|NCT01464424|561566217|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
155584837|NCT01464424|561566218|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
155584838|NCT02174627|561566221|FG000|Overall Study|Missing|0|||
155584839|NCT02174627|561566222|FG001|Overall Study|Missing|1|||
155584840|NCT02174627|561566221|FG000|Overall Study|Incorrect enrolment before randomization|0|||
155584841|NCT02174627|561566222|FG001|Overall Study|Incorrect enrolment before randomization|1|||
155584842|NCT02174627|561566221|FG000|Overall Study|Participant decision|84|||
155584843|NCT02174627|561566222|FG001|Overall Study|Participant decision|128|||
155584844|NCT00848718|561566225|FG000|Overall Study|Adverse Event|2|||
155584845|NCT00848718|561566226|FG001|Overall Study|Adverse Event|2|||
155584846|NCT00848718|561566227|FG002|Overall Study|Adverse Event|1|||
155584847|NCT00848718|561566228|FG003|Overall Study|Adverse Event|1|||
155584848|NCT00848718|561566229|FG004|Overall Study|Adverse Event|1|||
155584849|NCT00848718|561566230|FG005|Overall Study|Adverse Event|0|||
155584850|NCT00848718|561566231|FG006|Overall Study|Adverse Event|0|||
155584851|NCT00848718|561566232|FG007|Overall Study|Adverse Event|1|||
155584852|NCT00848718|561566233|FG008|Overall Study|Adverse Event|1|||
155584853|NCT00848718|561566234|FG009|Overall Study|Adverse Event|0|||
155584854|NCT00848718|561566235|FG010|Overall Study|Adverse Event|0|||
155584855|NCT00848718|561566236|FG011|Overall Study|Adverse Event|0|||
155584856|NCT00848718|561566237|FG012|Overall Study|Adverse Event|2|||
155584857|NCT00848718|561566225|FG000|Overall Study|Lack of Efficacy|0|||
155584858|NCT00848718|561566226|FG001|Overall Study|Lack of Efficacy|0|||
155584859|NCT00848718|561566227|FG002|Overall Study|Lack of Efficacy|1|||
155584860|NCT00848718|561566228|FG003|Overall Study|Lack of Efficacy|0|||
155584861|NCT00848718|561566229|FG004|Overall Study|Lack of Efficacy|0|||
155584862|NCT00848718|561566230|FG005|Overall Study|Lack of Efficacy|0|||
155584863|NCT00848718|561566231|FG006|Overall Study|Lack of Efficacy|1|||
155584864|NCT00848718|561566232|FG007|Overall Study|Lack of Efficacy|0|||
155584865|NCT00848718|561566233|FG008|Overall Study|Lack of Efficacy|0|||
155584866|NCT00848718|561566234|FG009|Overall Study|Lack of Efficacy|0|||
155584867|NCT00848718|561566235|FG010|Overall Study|Lack of Efficacy|0|||
155584868|NCT00848718|561566236|FG011|Overall Study|Lack of Efficacy|0|||
155584869|NCT00848718|561566237|FG012|Overall Study|Lack of Efficacy|0|||
155584870|NCT00848718|561566225|FG000|Overall Study|Physician Decision|0|||
155584871|NCT00848718|561566226|FG001|Overall Study|Physician Decision|1|||
155584872|NCT00848718|561566227|FG002|Overall Study|Physician Decision|0|||
155584873|NCT00848718|561566228|FG003|Overall Study|Physician Decision|0|||
155584874|NCT00848718|561566229|FG004|Overall Study|Physician Decision|1|||
155584875|NCT00848718|561566230|FG005|Overall Study|Physician Decision|1|||
155584876|NCT00848718|561566231|FG006|Overall Study|Physician Decision|0|||
155584877|NCT00848718|561566232|FG007|Overall Study|Physician Decision|0|||
155584878|NCT00848718|561566233|FG008|Overall Study|Physician Decision|1|||
155584879|NCT00848718|561566234|FG009|Overall Study|Physician Decision|2|||
155584880|NCT00848718|561566235|FG010|Overall Study|Physician Decision|0|||
155584881|NCT00848718|561566236|FG011|Overall Study|Physician Decision|0|||
155664825|NCT00696878|561869068|FG000|Overall Study|Withdrawal by Subject|87|||
155584882|NCT00848718|561566237|FG012|Overall Study|Physician Decision|1|||
155584883|NCT00848718|561566225|FG000|Overall Study|Progressive disease before treatment|1|||
155584884|NCT00848718|561566226|FG001|Overall Study|Progressive disease before treatment|5|||
155664826|NCT00696878|561869068|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
155584885|NCT00848718|561566227|FG002|Overall Study|Progressive disease before treatment|1|||
155584886|NCT00848718|561566228|FG003|Overall Study|Progressive disease before treatment|3|||
155584887|NCT00848718|561566229|FG004|Overall Study|Progressive disease before treatment|4|||
155584888|NCT00848718|561566230|FG005|Overall Study|Progressive disease before treatment|4|||
155584889|NCT00848718|561566231|FG006|Overall Study|Progressive disease before treatment|2|||
155584890|NCT00848718|561566232|FG007|Overall Study|Progressive disease before treatment|1|||
155584891|NCT00848718|561566233|FG008|Overall Study|Progressive disease before treatment|2|||
155584892|NCT00848718|561566234|FG009|Overall Study|Progressive disease before treatment|7|||
155584893|NCT00848718|561566235|FG010|Overall Study|Progressive disease before treatment|3|||
155584894|NCT00848718|561566236|FG011|Overall Study|Progressive disease before treatment|6|||
155584895|NCT00848718|561566237|FG012|Overall Study|Progressive disease before treatment|2|||
155584896|NCT00848718|561566225|FG000|Overall Study|Protocol Violation|0|||
155584897|NCT00848718|561566226|FG001|Overall Study|Protocol Violation|1|||
155584898|NCT00848718|561566227|FG002|Overall Study|Protocol Violation|0|||
155584899|NCT00848718|561566228|FG003|Overall Study|Protocol Violation|0|||
155584900|NCT00848718|561566229|FG004|Overall Study|Protocol Violation|0|||
155584901|NCT00848718|561566230|FG005|Overall Study|Protocol Violation|0|||
155584902|NCT00848718|561566231|FG006|Overall Study|Protocol Violation|0|||
155584903|NCT00848718|561566232|FG007|Overall Study|Protocol Violation|1|||
155584904|NCT00848718|561566233|FG008|Overall Study|Protocol Violation|0|||
155584905|NCT00848718|561566234|FG009|Overall Study|Protocol Violation|0|||
155584906|NCT00848718|561566235|FG010|Overall Study|Protocol Violation|0|||
155584907|NCT00848718|561566236|FG011|Overall Study|Protocol Violation|0|||
155584908|NCT00848718|561566237|FG012|Overall Study|Protocol Violation|1|||
155584909|NCT00848718|561566225|FG000|Overall Study|Withdrawal by Subject|1|||
155584910|NCT00848718|561566226|FG001|Overall Study|Withdrawal by Subject|0|||
155584911|NCT00848718|561566227|FG002|Overall Study|Withdrawal by Subject|0|||
155584912|NCT00848718|561566228|FG003|Overall Study|Withdrawal by Subject|1|||
155584913|NCT00848718|561566229|FG004|Overall Study|Withdrawal by Subject|0|||
155584914|NCT00848718|561566230|FG005|Overall Study|Withdrawal by Subject|0|||
155584915|NCT00848718|561566231|FG006|Overall Study|Withdrawal by Subject|0|||
155584916|NCT00848718|561566232|FG007|Overall Study|Withdrawal by Subject|0|||
155584917|NCT00848718|561566233|FG008|Overall Study|Withdrawal by Subject|0|||
155584918|NCT00848718|561566234|FG009|Overall Study|Withdrawal by Subject|0|||
155584919|NCT00848718|561566235|FG010|Overall Study|Withdrawal by Subject|1|||
155584920|NCT00848718|561566236|FG011|Overall Study|Withdrawal by Subject|0|||
155584921|NCT00848718|561566237|FG012|Overall Study|Withdrawal by Subject|0|||
155584922|NCT00848718|561566225|FG000|Overall Study|Progressive disease during treatment|3|||
155584923|NCT00848718|561566226|FG001|Overall Study|Progressive disease during treatment|0|||
155584924|NCT00848718|561566227|FG002|Overall Study|Progressive disease during treatment|3|||
155584925|NCT00848718|561566228|FG003|Overall Study|Progressive disease during treatment|0|||
155584926|NCT00848718|561566229|FG004|Overall Study|Progressive disease during treatment|0|||
155584927|NCT00848718|561566230|FG005|Overall Study|Progressive disease during treatment|0|||
155584928|NCT00848718|561566231|FG006|Overall Study|Progressive disease during treatment|0|||
155584929|NCT00848718|561566232|FG007|Overall Study|Progressive disease during treatment|2|||
155584930|NCT00848718|561566233|FG008|Overall Study|Progressive disease during treatment|0|||
155584931|NCT00848718|561566234|FG009|Overall Study|Progressive disease during treatment|0|||
155584932|NCT00848718|561566235|FG010|Overall Study|Progressive disease during treatment|0|||
155584933|NCT00848718|561566236|FG011|Overall Study|Progressive disease during treatment|0|||
155584934|NCT00848718|561566237|FG012|Overall Study|Progressive disease during treatment|2|||
155584935|NCT02389829|561566243|FG000|Overall Study|Lost to Follow-up|0|||
155584936|NCT02389829|561566244|FG001|Overall Study|Lost to Follow-up|1|||
155584937|NCT05514873|561566247|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
155584938|NCT05514873|561566247|FG000|Main Treatment Period|Adverse Event|2|||
155584939|NCT05514873|561566247|FG000|Extension Treatment Period|Lost to Follow-up|3|||
155584940|NCT04955691|561568626|FG000|Period 2|Discontinued intervention|1|||
155584941|NCT04955691|561568627|FG001|Period 2|Discontinued intervention|2|||
155584942|NCT05795153|561568628|FG000|Overall Study|Adverse Event|2|||
155584943|NCT05795153|561568628|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155584944|NCT05795153|561568628|FG000|Overall Study|Lost to Follow-up|1|||
155584945|NCT05795153|561568628|FG000|Overall Study|Subject decision|2|||
155584946|NCT03668119|561568629|FG000|Pre-treatment|Disease Progression|1|||
155584947|NCT03668119|561568630|FG001|Pre-treatment|Disease Progression|0|||
155584948|NCT03668119|561568629|FG000|Treatment|Disease Progression|76|||
155584949|NCT03668119|561568630|FG001|Treatment|Disease Progression|57|||
155584950|NCT03668119|561568629|FG000|Treatment|Study drug toxicity|19|||
155584951|NCT03668119|561568630|FG001|Treatment|Study drug toxicity|1|||
155584952|NCT03668119|561568629|FG000|Treatment|Death|3|||
155584953|NCT03668119|561568630|FG001|Treatment|Death|0|||
155584954|NCT03668119|561568629|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
155584955|NCT03668119|561568630|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
155584956|NCT03668119|561568629|FG000|Treatment|Withdrawal by Subject|1|||
155584957|NCT03668119|561568630|FG001|Treatment|Withdrawal by Subject|1|||
155584958|NCT03668119|561568629|FG000|Treatment|Participant request to discontinue study treatment|3|||
155584959|NCT03668119|561568630|FG001|Treatment|Participant request to discontinue study treatment|1|||
155584960|NCT03668119|561568629|FG000|Treatment|Maximum Clinical Benefit|0|||
155584961|NCT03668119|561568630|FG001|Treatment|Maximum Clinical Benefit|1|||
155584962|NCT03668119|561568629|FG000|Treatment|Participants completed treatment|27|||
155584963|NCT03668119|561568630|FG001|Treatment|Participants completed treatment|11|||
155584964|NCT03668119|561568629|FG000|Treatment|Other reasons|2|||
155584965|NCT03668119|561568630|FG001|Treatment|Other reasons|1|||
155584966|NCT03769168|561568631|FG000|Overall Study|Adverse Event|0|||
155584967|NCT03769168|561568632|FG001|Overall Study|Adverse Event|1|||
155584968|NCT03769168|561568631|FG000|Overall Study|Lack of Efficacy|2|||
155584969|NCT03769168|561568632|FG001|Overall Study|Lack of Efficacy|4|||
155584970|NCT03769168|561568631|FG000|Overall Study|Post study access to treatment|3|||
155584971|NCT03769168|561568632|FG001|Overall Study|Post study access to treatment|11|||
155584972|NCT03769168|561568631|FG000|Overall Study|Physician Decision|1|||
155584973|NCT03769168|561568632|FG001|Overall Study|Physician Decision|4|||
155584974|NCT03769168|561568631|FG000|Overall Study|Subject Decision|2|||
155584975|NCT03769168|561568632|FG001|Overall Study|Subject Decision|4|||
155584976|NCT03769168|561568631|FG000|Overall Study|Guardian decision|1|||
155584977|NCT03769168|561568632|FG001|Overall Study|Guardian decision|0|||
155584978|NCT05336227|561568633|FG000|Overall Study|Adverse Event|1|||
155584979|NCT05336227|561568634|FG001|Overall Study|Adverse Event|0|||
155584980|NCT05336227|561568633|FG000|Overall Study|Lost to Follow-up|2|||
155584981|NCT05336227|561568634|FG001|Overall Study|Lost to Follow-up|0|||
155584982|NCT05336227|561568633|FG000|Overall Study|Withdrawal by Subject|1|||
155584983|NCT05336227|561568634|FG001|Overall Study|Withdrawal by Subject|0|||
155584984|NCT04050462|561568635|FG000|Overall Study|Withdrawal by Subject|1|||
155584985|NCT04050462|561568636|FG001|Overall Study|Withdrawal by Subject|0|||
155584986|NCT04050462|561568637|FG002|Overall Study|Withdrawal by Subject|0|||
155584987|NCT05151744|561568640|FG000|Overall Study|Adverse Event|6|||
155584988|NCT05151744|561568641|FG001|Overall Study|Adverse Event|2|||
155584989|NCT05151744|561568640|FG000|Overall Study|Death|1|||
155584990|NCT05151744|561568641|FG001|Overall Study|Death|2|||
155584991|NCT05151744|561568640|FG000|Overall Study|Lack of Efficacy|1|||
155584992|NCT05151744|561568641|FG001|Overall Study|Lack of Efficacy|1|||
155584993|NCT05151744|561568640|FG000|Overall Study|Lost to Follow-up|2|||
155584994|NCT05151744|561568641|FG001|Overall Study|Lost to Follow-up|2|||
155584995|NCT05151744|561568640|FG000|Overall Study|Need for Rescue Treatment|0|||
155584996|NCT05151744|561568641|FG001|Overall Study|Need for Rescue Treatment|1|||
155584997|NCT05151744|561568640|FG000|Overall Study|Non-compliance with Study Drug|0|||
155584998|NCT05151744|561568641|FG001|Overall Study|Non-compliance with Study Drug|1|||
155584999|NCT05151744|561568640|FG000|Overall Study|Reason not Specified|10|||
155585000|NCT05151744|561568641|FG001|Overall Study|Reason not Specified|0|||
155585001|NCT05151744|561568640|FG000|Overall Study|Physician Decision|2|||
155585002|NCT05151744|561568641|FG001|Overall Study|Physician Decision|1|||
155585003|NCT05151744|561568640|FG000|Overall Study|Protocol Violation|1|||
155585004|NCT05151744|561568641|FG001|Overall Study|Protocol Violation|0|||
155585005|NCT05151744|561568640|FG000|Overall Study|Withdrawal by Subject|6|||
155585006|NCT05151744|561568641|FG001|Overall Study|Withdrawal by Subject|3|||
155585007|NCT05228470|561568642|FG000|Overall Study|Death|6|||
155585008|NCT05228470|561568643|FG001|Overall Study|Death|11|||
155585009|NCT05228470|561568642|FG000|Overall Study|Withdrawal by Subject|1|||
155585010|NCT05228470|561568643|FG001|Overall Study|Withdrawal by Subject|8|||
155585011|NCT05228470|561568642|FG000|Overall Study|Ongoing|1|||
155585012|NCT05228470|561568643|FG001|Overall Study|Ongoing|11|||
155585013|NCT04053868|561568644|FG000|Overall Study|Withdrawal by Subject|1|||
155585014|NCT04053868|561568645|FG001|Overall Study|Withdrawal by Subject|0|||
155585015|NCT01068678|561568648|FG000|Overall Study|Lack of Efficacy|3|||
155585016|NCT01068678|561568649|FG001|Overall Study|Lack of Efficacy|2|||
155585017|NCT01068678|561568648|FG000|Overall Study|Protocol Violation|5|||
155585018|NCT01068678|561568649|FG001|Overall Study|Protocol Violation|1|||
155585019|NCT01068678|561568648|FG000|Overall Study|Withdrawal criteria|12|||
155585020|NCT01068678|561568649|FG001|Overall Study|Withdrawal criteria|6|||
155585021|NCT01068678|561568648|FG000|Overall Study|Unclassified|18|||
155585022|NCT01068678|561568649|FG001|Overall Study|Unclassified|15|||
155585023|NCT00975611|561568652|FG000|Overall Study|Screen Fail|16|||
155664827|NCT00696878|561869068|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
155664828|NCT00696878|561869068|FG000|Overall Study|Trial stopped|32|||
155664829|NCT00696878|561869068|FG000|Overall Study|Other reason (not specified)|55|||
155664830|NCT04103450|561869069|FG000|Overall Study|Adverse Event|4|||
155664831|NCT04103450|561869070|FG001|Overall Study|Adverse Event|2|||
155664832|NCT04103450|561869069|FG000|Overall Study|Lack of Efficacy|3|||
155664833|NCT04103450|561869070|FG001|Overall Study|Lack of Efficacy|0|||
155664834|NCT04103450|561869069|FG000|Overall Study|Withdrawal by Subject|5|||
155664835|NCT04103450|561869070|FG001|Overall Study|Withdrawal by Subject|3|||
155585024|NCT00975611|561568652|FG000|Overall Study|Physician Decision|1|||
155585025|NCT03123120|561568653|FG000|Overall Study|Lost to Follow-up|0|||
155585026|NCT03123120|561568654|FG001|Overall Study|Lost to Follow-up|1|||
155585027|NCT03123120|561568653|FG000|Overall Study|Withdrawal by Subject|0|||
155585028|NCT03123120|561568654|FG001|Overall Study|Withdrawal by Subject|1|||
155585029|NCT02632175|561568655|FG000|Overall Study|Withdrawal by Subject|6|||
155585030|NCT02632175|561568655|FG000|Overall Study|Lost to Follow-up|1|||
155585031|NCT02632175|561568655|FG000|Overall Study|Lack of Efficacy|18|||
155585032|NCT02632175|561568655|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
155585033|NCT02632175|561568655|FG000|Overall Study|Subject noncompliance|3|||
155585034|NCT02632175|561568655|FG000|Overall Study|other|2|||
155585035|NCT02088554|561568656|FG000|Overall Study|Exited before procedure|130|||
155585036|NCT02088554|561568656|FG000|Overall Study|Attempted but not implanted|31|||
155585037|NCT02088554|561568656|FG000|Overall Study|Implant not attempted|19|||
155585038|NCT02088554|561568656|FG000|Overall Study|Pending next visit|532|||
155585039|NCT02088554|561568656|FG000|Overall Study|Death|170|||
155585040|NCT02088554|561568656|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
155585041|NCT02088554|561568656|FG000|Overall Study|Lost to Follow-up|23|||
155585042|NCT02088554|561568656|FG000|Overall Study|Explanted|32|||
155585043|NCT02088554|561568656|FG000|Overall Study|Any other reason not covered by previous categories|11|||
155585044|NCT04066244|561568658|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
155585045|NCT04066244|561568659|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
155585046|NCT04066244|561568660|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
155585047|NCT04066244|561568661|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
155585048|NCT04066244|561568662|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
155585049|NCT04066244|561568663|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
155585050|NCT04066244|561568658|FG000|Part 2 (Cohort 5)|Death|0|||
155585051|NCT04066244|561568659|FG001|Part 2 (Cohort 5)|Death|0|||
155585052|NCT04066244|561568660|FG002|Part 2 (Cohort 5)|Death|0|||
155585053|NCT04066244|561568661|FG003|Part 2 (Cohort 5)|Death|0|||
155585054|NCT04066244|561568662|FG004|Part 2 (Cohort 5)|Death|0|||
155585055|NCT04066244|561568663|FG005|Part 2 (Cohort 5)|Death|2|||
155585056|NCT04066244|561568658|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155585057|NCT04066244|561568659|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155585058|NCT04066244|561568660|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155585059|NCT04066244|561568661|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155585060|NCT04066244|561568662|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155585061|NCT04066244|561568663|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
155585062|NCT04066244|561568658|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155585063|NCT04066244|561568659|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155585064|NCT04066244|561568660|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155585065|NCT04066244|561568661|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155585066|NCT04066244|561568662|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
155585067|NCT04066244|561568663|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155585068|NCT00866281|561568664|FG000|Overall Study|Adverse Event|1|||
155585069|NCT00866281|561568665|FG001|Overall Study|Adverse Event|0|||
155585070|NCT00866281|561568664|FG000|Overall Study|Withdrawal by participants|3|||
155585071|NCT00866281|561568665|FG001|Overall Study|Withdrawal by participants|0|||
155585072|NCT00866281|561568664|FG000|Overall Study|Disease progression|3|||
155585073|NCT00866281|561568665|FG001|Overall Study|Disease progression|11|||
155585074|NCT00866281|561568664|FG000|Overall Study|New cancer therapy|0|||
155585075|NCT00866281|561568665|FG001|Overall Study|New cancer therapy|4|||
155585076|NCT00536939|561568666|FG000|Overall Study|Withdrawal by Subject|1|||
155585077|NCT00536939|561568667|FG001|Overall Study|Withdrawal by Subject|0|||
155585078|NCT00536939|561568666|FG000|Overall Study|Other Complicating Disease|1|||
155585079|NCT00536939|561568667|FG001|Overall Study|Other Complicating Disease|0|||
155585080|NCT04225715|561568668|FG000|Overall Study|Reason not Specified|1|||
155585081|NCT04225715|561568669|FG001|Overall Study|Reason not Specified|0|||
155585082|NCT04225715|561568670|FG002|Overall Study|Reason not Specified|0|||
155585083|NCT04225715|561568671|FG003|Overall Study|Reason not Specified|0|||
155585084|NCT04225715|561568672|FG004|Overall Study|Reason not Specified|0|||
155585085|NCT04225715|561568673|FG005|Overall Study|Reason not Specified|0|||
155585086|NCT04225715|561568674|FG006|Overall Study|Reason not Specified|0|||
155585087|NCT04225715|561568675|FG007|Overall Study|Reason not Specified|0|||
155585088|NCT04225715|561568676|FG008|Overall Study|Reason not Specified|0|||
155585089|NCT04225715|561568668|FG000|Overall Study|Protocol Violation|1|||
155585090|NCT04225715|561568669|FG001|Overall Study|Protocol Violation|0|||
155585091|NCT04225715|561568670|FG002|Overall Study|Protocol Violation|0|||
155585092|NCT04225715|561568671|FG003|Overall Study|Protocol Violation|0|||
155664836|NCT04103450|561869069|FG000|Overall Study|Lost to Follow-up|1|||
155664837|NCT04103450|561869070|FG001|Overall Study|Lost to Follow-up|2|||
155585093|NCT04225715|561568672|FG004|Overall Study|Protocol Violation|0|||
155585094|NCT04225715|561568673|FG005|Overall Study|Protocol Violation|9|||
155585095|NCT04225715|561568674|FG006|Overall Study|Protocol Violation|0|||
155585096|NCT04225715|561568675|FG007|Overall Study|Protocol Violation|0|||
155585097|NCT04225715|561568676|FG008|Overall Study|Protocol Violation|0|||
155585098|NCT04225715|561568668|FG000|Overall Study|Withdrawal by Subject|4|||
155585099|NCT04225715|561568669|FG001|Overall Study|Withdrawal by Subject|1|||
155585100|NCT04225715|561568670|FG002|Overall Study|Withdrawal by Subject|1|||
155585101|NCT04225715|561568671|FG003|Overall Study|Withdrawal by Subject|0|||
155585102|NCT04225715|561568672|FG004|Overall Study|Withdrawal by Subject|3|||
155664838|NCT04103450|561869069|FG000|Overall Study|Physician Decision|1|||
155585103|NCT04225715|561568673|FG005|Overall Study|Withdrawal by Subject|1|||
155585104|NCT04225715|561568674|FG006|Overall Study|Withdrawal by Subject|1|||
155585105|NCT04225715|561568675|FG007|Overall Study|Withdrawal by Subject|1|||
155585106|NCT04225715|561568676|FG008|Overall Study|Withdrawal by Subject|0|||
155585107|NCT04225715|561568668|FG000|Overall Study|Adverse Event|0|||
155585108|NCT04225715|561568669|FG001|Overall Study|Adverse Event|0|||
155585109|NCT04225715|561568670|FG002|Overall Study|Adverse Event|0|||
155585110|NCT04225715|561568671|FG003|Overall Study|Adverse Event|0|||
155585111|NCT04225715|561568672|FG004|Overall Study|Adverse Event|0|||
155585112|NCT04225715|561568673|FG005|Overall Study|Adverse Event|0|||
155585113|NCT04225715|561568674|FG006|Overall Study|Adverse Event|0|||
155585114|NCT04225715|561568675|FG007|Overall Study|Adverse Event|0|||
155585115|NCT04225715|561568676|FG008|Overall Study|Adverse Event|1|||
155585116|NCT04225715|561568668|FG000|Overall Study|Arm Terminated By Sponsor|0|||
155585117|NCT04225715|561568669|FG001|Overall Study|Arm Terminated By Sponsor|0|||
155585118|NCT04225715|561568670|FG002|Overall Study|Arm Terminated By Sponsor|0|||
155585119|NCT04225715|561568671|FG003|Overall Study|Arm Terminated By Sponsor|0|||
155585120|NCT04225715|561568672|FG004|Overall Study|Arm Terminated By Sponsor|0|||
155585121|NCT04225715|561568673|FG005|Overall Study|Arm Terminated By Sponsor|0|||
155585122|NCT04225715|561568674|FG006|Overall Study|Arm Terminated By Sponsor|0|||
155585123|NCT04225715|561568675|FG007|Overall Study|Arm Terminated By Sponsor|17|||
155585124|NCT04225715|561568676|FG008|Overall Study|Arm Terminated By Sponsor|18|||
155585125|NCT02275546|561568681|FG000|Treatment Period 2|Withdrawal by Subject|2|||
155585126|NCT02275546|561568682|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155585127|NCT02275546|561568681|FG000|Treatment Period 2|Protocol Violation|0|||
155585128|NCT02275546|561568682|FG001|Treatment Period 2|Protocol Violation|1|||
155585129|NCT02955355|561568691|FG000|Overall Study|Adverse Event|4|||
155585130|NCT02955355|561568691|FG000|Overall Study|Death|1|||
155585131|NCT02955355|561568691|FG000|Overall Study|Physician Decision|21|||
155585132|NCT02955355|561568691|FG000|Overall Study|Site Terminated by Sponsor|35|||
155585133|NCT02955355|561568691|FG000|Overall Study|Withdrawal by Subject|19|||
155585134|NCT02955355|561568691|FG000|Overall Study|Reason Not Specified|5|||
155585135|NCT02612623|561568692|FG000|Overall Study|Withdrawal by Subject|0|||
155585136|NCT02612623|561568693|FG001|Overall Study|Withdrawal by Subject|1|||
155585137|NCT02612623|561568694|FG002|Overall Study|Withdrawal by Subject|0|||
155585138|NCT02612623|561568695|FG003|Overall Study|Withdrawal by Subject|0|||
155585139|NCT02612623|561568692|FG000|Overall Study|Adverse Event|1|||
155585140|NCT02612623|561568693|FG001|Overall Study|Adverse Event|0|||
155585141|NCT02612623|561568694|FG002|Overall Study|Adverse Event|1|||
155585142|NCT02612623|561568695|FG003|Overall Study|Adverse Event|0|||
155585143|NCT00570141|561568700|FG000|Overall Study|Adverse Event|1|||
155585144|NCT00570141|561568700|FG000|Overall Study|Missed visits|1|||
155585145|NCT00570141|561568700|FG000|Overall Study|Lost to Follow-up|1|||
155585146|NCT02309411|561568701|FG000|Overall Study|Physician Decision|1|||
155585147|NCT02309411|561568702|FG001|Overall Study|Physician Decision|0|||
155585148|NCT02309411|561568703|FG002|Overall Study|Physician Decision|0|||
155585149|NCT02309411|561568701|FG000|Overall Study|Withdrawal by Subject|1|||
155585150|NCT02309411|561568702|FG001|Overall Study|Withdrawal by Subject|1|||
155585151|NCT02309411|561568703|FG002|Overall Study|Withdrawal by Subject|0|||
155585152|NCT04878432|561568706|FG000|Overall Study|Adverse Event|1|||
155585153|NCT04878432|561568706|FG000|Overall Study|Death|2|||
155585154|NCT04878432|561568706|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155585155|NCT04878432|561568706|FG000|Overall Study|Withdrawal by Subject|6|||
155585156|NCT04878432|561568706|FG000|Overall Study|Progressive Disease|7|||
155585157|NCT04878432|561568706|FG000|Overall Study|New Therapy for Study Indication|7|||
155585158|NCT04878432|561568706|FG000|Overall Study|Physician Decision|11|||
155585159|NCT00925704|561568707|FG000|First Intervention|Withdrew consent|0|||
155585160|NCT00925704|561568708|FG001|First Intervention|Withdrew consent|0|||
155585161|NCT00925704|561568709|FG002|First Intervention|Withdrew consent|0|||
155585162|NCT00925704|561568710|FG003|First Intervention|Withdrew consent|1|||
155585163|NCT00925704|561568711|FG004|First Intervention|Withdrew consent|1|||
155585164|NCT00925704|561568712|FG005|First Intervention|Withdrew consent|0|||
155585165|NCT00925704|561568707|FG000|Second Intervention|Withdrawal by Subject|1|||
155585166|NCT00925704|561568708|FG001|Second Intervention|Withdrawal by Subject|0|||
155585167|NCT00925704|561568709|FG002|Second Intervention|Withdrawal by Subject|0|||
155585168|NCT00925704|561568710|FG003|Second Intervention|Withdrawal by Subject|0|||
155585169|NCT00925704|561568711|FG004|Second Intervention|Withdrawal by Subject|1|||
155585170|NCT00925704|561568712|FG005|Second Intervention|Withdrawal by Subject|0|||
155585171|NCT00925704|561568707|FG000|Third Intervention|Withdrew consent|0|||
155585172|NCT00925704|561568708|FG001|Third Intervention|Withdrew consent|0|||
155585173|NCT00925704|561568709|FG002|Third Intervention|Withdrew consent|0|||
155585174|NCT00925704|561568710|FG003|Third Intervention|Withdrew consent|0|||
155585175|NCT00925704|561568711|FG004|Third Intervention|Withdrew consent|0|||
155585176|NCT00925704|561568712|FG005|Third Intervention|Withdrew consent|1|||
155585177|NCT03207815|561568713|FG000|Overall Study|Protocol Violation|3|||
155585178|NCT03207815|561568714|FG001|Overall Study|Protocol Violation|1|||
155585179|NCT03207815|561568713|FG000|Overall Study|Adverse Event|1|||
155585180|NCT03207815|561568714|FG001|Overall Study|Adverse Event|2|||
155585181|NCT03207815|561568713|FG000|Overall Study|Lost to Follow-up|1|||
155585182|NCT03207815|561568714|FG001|Overall Study|Lost to Follow-up|2|||
155585183|NCT03207815|561568713|FG000|Overall Study|Investigator's Discretion|1|||
155585184|NCT03207815|561568714|FG001|Overall Study|Investigator's Discretion|1|||
155585185|NCT03207815|561568713|FG000|Overall Study|Lack of Efficacy|0|||
155585186|NCT03207815|561568714|FG001|Overall Study|Lack of Efficacy|1|||
155585187|NCT03207815|561568713|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
155585188|NCT03207815|561568714|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
155585189|NCT03207815|561568713|FG000|Overall Study|Withdrew Consent|1|||
155585190|NCT03207815|561568714|FG001|Overall Study|Withdrew Consent|0|||
155585191|NCT03817853|561568715|FG000|Induction Phase|Adverse Event|5|||
155585192|NCT03817853|561568716|FG001|Induction Phase|Adverse Event|0|||
155585193|NCT03817853|561568717|FG002|Induction Phase|Adverse Event|0|||
155585194|NCT03817853|561568715|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
155585195|NCT03817853|561568716|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
155585196|NCT03817853|561568717|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
155585197|NCT03817853|561568715|FG000|Induction Phase|Physician Decision|2|||
155585198|NCT03817853|561568716|FG001|Induction Phase|Physician Decision|0|||
155585199|NCT03817853|561568717|FG002|Induction Phase|Physician Decision|0|||
155585200|NCT03817853|561568715|FG000|Induction Phase|Progressive Disease|6|||
155585201|NCT03817853|561568716|FG001|Induction Phase|Progressive Disease|0|||
155585202|NCT03817853|561568717|FG002|Induction Phase|Progressive Disease|0|||
155585203|NCT03817853|561568715|FG000|Induction Phase|Withdrawal by Subject|4|||
155585204|NCT03817853|561568716|FG001|Induction Phase|Withdrawal by Subject|0|||
155585205|NCT03817853|561568717|FG002|Induction Phase|Withdrawal by Subject|0|||
155585206|NCT03817853|561568715|FG000|Maintenance Phase|Adverse Event|0|||
155585207|NCT03817853|561568716|FG001|Maintenance Phase|Adverse Event|8|||
155585208|NCT03817853|561568717|FG002|Maintenance Phase|Adverse Event|0|||
155585209|NCT03817853|561568715|FG000|Maintenance Phase|Death|0|||
155585210|NCT03817853|561568716|FG001|Maintenance Phase|Death|5|||
155585211|NCT03817853|561568717|FG002|Maintenance Phase|Death|0|||
155585212|NCT03817853|561568715|FG000|Maintenance Phase|Progressive Disease|0|||
155585213|NCT03817853|561568716|FG001|Maintenance Phase|Progressive Disease|7|||
155585214|NCT03817853|561568717|FG002|Maintenance Phase|Progressive Disease|0|||
155585215|NCT03817853|561568715|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155585216|NCT03817853|561568716|FG001|Maintenance Phase|Withdrawal by Subject|2|||
155585217|NCT03817853|561568717|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155585218|NCT03817853|561568715|FG000|Maintenance Phase|Physician Decision|0|||
155585219|NCT03817853|561568716|FG001|Maintenance Phase|Physician Decision|1|||
155585220|NCT03817853|561568717|FG002|Maintenance Phase|Physician Decision|0|||
155585221|NCT03817853|561568715|FG000|Maintenance Phase|Various reasons|0|||
155585222|NCT03817853|561568716|FG001|Maintenance Phase|Various reasons|4|||
155585223|NCT03817853|561568717|FG002|Maintenance Phase|Various reasons|0|||
155585224|NCT03817853|561568715|FG000|Maintenance Phase|Protocol Deviation|0|||
155585225|NCT03817853|561568716|FG001|Maintenance Phase|Protocol Deviation|1|||
155585226|NCT03817853|561568717|FG002|Maintenance Phase|Protocol Deviation|0|||
155585227|NCT03817853|561568715|FG000|Follow-up Phase|Adverse Event|0|||
155585228|NCT03817853|561568716|FG001|Follow-up Phase|Adverse Event|0|||
155585229|NCT03817853|561568717|FG002|Follow-up Phase|Adverse Event|2|||
155585230|NCT03817853|561568715|FG000|Follow-up Phase|Death|0|||
155585231|NCT03817853|561568716|FG001|Follow-up Phase|Death|0|||
155585232|NCT03817853|561568717|FG002|Follow-up Phase|Death|1|||
155585233|NCT03817853|561568715|FG000|Follow-up Phase|Progressive Disease|0|||
155585234|NCT03817853|561568716|FG001|Follow-up Phase|Progressive Disease|0|||
155585235|NCT03817853|561568717|FG002|Follow-up Phase|Progressive Disease|3|||
155585236|NCT03817853|561568715|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155585237|NCT03817853|561568716|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155585238|NCT03817853|561568717|FG002|Follow-up Phase|Withdrawal by Subject|1|||
155585239|NCT01256450|561568720|FG000|Open-label Titration|Adverse Event|39|||
155585240|NCT01256450|561568721|FG001|Open-label Titration|Adverse Event|0|||
155585241|NCT01256450|561568722|FG002|Open-label Titration|Adverse Event|0|||
155585242|NCT01256450|561568720|FG000|Open-label Titration|Lost to Follow-up|7|||
155585243|NCT01256450|561568721|FG001|Open-label Titration|Lost to Follow-up|0|||
155585244|NCT01256450|561568722|FG002|Open-label Titration|Lost to Follow-up|0|||
155585245|NCT01256450|561568720|FG000|Open-label Titration|Lack of analgesic effect|30|||
155585246|NCT01256450|561568721|FG001|Open-label Titration|Lack of analgesic effect|0|||
155585247|NCT01256450|561568722|FG002|Open-label Titration|Lack of analgesic effect|0|||
155585248|NCT01256450|561568720|FG000|Open-label Titration|Non-compliance|9|||
155585249|NCT01256450|561568721|FG001|Open-label Titration|Non-compliance|0|||
155585250|NCT01256450|561568722|FG002|Open-label Titration|Non-compliance|0|||
155585251|NCT01256450|561568720|FG000|Open-label Titration|Screen failure|1|||
155585252|NCT01256450|561568721|FG001|Open-label Titration|Screen failure|0|||
155585253|NCT01256450|561568722|FG002|Open-label Titration|Screen failure|0|||
155585254|NCT01256450|561568720|FG000|Open-label Titration|Other|13|||
155585255|NCT01256450|561568721|FG001|Open-label Titration|Other|0|||
155585256|NCT01256450|561568722|FG002|Open-label Titration|Other|0|||
155585257|NCT01256450|561568720|FG000|Double-blind Treatment|Adverse Event|0|||
155585258|NCT01256450|561568721|FG001|Double-blind Treatment|Adverse Event|8|||
155585259|NCT01256450|561568722|FG002|Double-blind Treatment|Adverse Event|6|||
155585260|NCT01256450|561568720|FG000|Double-blind Treatment|Lost to Follow-up|0|||
155585261|NCT01256450|561568721|FG001|Double-blind Treatment|Lost to Follow-up|1|||
155585262|NCT01256450|561568722|FG002|Double-blind Treatment|Lost to Follow-up|7|||
155585263|NCT01256450|561568720|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
155585264|NCT01256450|561568721|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
155585265|NCT01256450|561568722|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
155585266|NCT01256450|561568720|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
155585267|NCT01256450|561568721|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
155585268|NCT01256450|561568722|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
155585269|NCT01256450|561568720|FG000|Double-blind Treatment|Non-compliance|0|||
155585270|NCT01256450|561568721|FG001|Double-blind Treatment|Non-compliance|5|||
155585271|NCT01256450|561568722|FG002|Double-blind Treatment|Non-compliance|4|||
155585272|NCT01256450|561568720|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
155585273|NCT01256450|561568721|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
155585274|NCT01256450|561568722|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
155585275|NCT01256450|561568720|FG000|Double-blind Treatment|Other|0|||
155585276|NCT01256450|561568721|FG001|Double-blind Treatment|Other|9|||
155585277|NCT01256450|561568722|FG002|Double-blind Treatment|Other|12|||
155585278|NCT03866512|561568725|FG000|Overall Study|Lost to Follow-up|1|||
155585279|NCT03866512|561568726|FG001|Overall Study|Lost to Follow-up|2|||
155585280|NCT03866512|561568727|FG002|Overall Study|Lost to Follow-up|1|||
155585281|NCT03866512|561568725|FG000|Overall Study|Cannulation issues|0|||
155585282|NCT03866512|561568726|FG001|Overall Study|Cannulation issues|1|||
155585283|NCT03866512|561568727|FG002|Overall Study|Cannulation issues|2|||
155585284|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
155585285|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585286|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585287|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585288|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
155585289|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155585290|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155585291|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155585292|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
155585293|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155585294|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155585295|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155585296|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
155585297|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585298|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585299|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585300|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
155585301|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585302|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585303|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585304|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
155585305|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585306|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585307|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585308|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
155585309|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155585310|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155585311|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155585312|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
155585313|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155585314|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155585315|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155585316|NCT00506415|561568729|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
155585317|NCT00506415|561568730|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585318|NCT00506415|561568731|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585319|NCT00506415|561568732|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585320|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
155585321|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
155585322|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
155585323|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
155585324|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
155585325|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
155585326|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
155585327|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
155585328|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
155585329|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
155585330|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
155585331|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
155585332|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
155585333|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
155585334|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
155585335|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
155585336|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
155585337|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
155585338|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
155585339|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
155585340|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
155585341|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
155585342|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
155585343|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
155585344|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
155585345|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
155585346|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
155585347|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
155585348|NCT00506415|561568729|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155585349|NCT00506415|561568730|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155585350|NCT00506415|561568731|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
155664839|NCT04103450|561869070|FG001|Overall Study|Physician Decision|2|||
155664840|NCT04103450|561869069|FG000|Overall Study|Protocol Violation|1|||
155664841|NCT04103450|561869070|FG001|Overall Study|Protocol Violation|0|||
155664842|NCT04103450|561869069|FG000|Overall Study|Other|1|||
155664843|NCT04103450|561869070|FG001|Overall Study|Other|1|||
155664844|NCT02712788|561869075|FG000|Overall Study|Physician Decision|1|||
155664845|NCT02712788|561869076|FG001|Overall Study|Physician Decision|0|||
155664846|NCT02712788|561869075|FG000|Overall Study|Protocol Violation|1|||
155664847|NCT02712788|561869076|FG001|Overall Study|Protocol Violation|0|||
155664848|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
155664849|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
155664850|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
155664851|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
155664852|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
155664853|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
155664854|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
155664855|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
155664856|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
155664857|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
155664858|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
155664859|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
155664860|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
155664861|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
155664862|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
155664863|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
155664864|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
155664865|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
155664866|NCT03789292|561869080|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
155664867|NCT03789292|561869081|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
155664868|NCT03789292|561869082|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
155664869|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
155664870|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
155664871|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
155664872|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
155664873|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
155664874|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
155664875|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
155664876|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
155664877|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
155664878|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
155664879|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
155664880|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
155664881|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
155664882|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
155664883|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
155664884|NCT03789292|561869080|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
155664885|NCT03789292|561869081|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
155664886|NCT03789292|561869082|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
155664887|NCT01696643|561869083|FG000|Overall Study|Adverse Event|15|||
155664888|NCT01696643|561869084|FG001|Overall Study|Adverse Event|7|||
155664889|NCT01696643|561869083|FG000|Overall Study|Death|1|||
155664890|NCT01696643|561869084|FG001|Overall Study|Death|2|||
155664891|NCT01696643|561869083|FG000|Overall Study|Lack of Efficacy|3|||
155664892|NCT01696643|561869084|FG001|Overall Study|Lack of Efficacy|0|||
155664893|NCT01696643|561869083|FG000|Overall Study|Lost to Follow-up|67|||
155664894|NCT01696643|561869084|FG001|Overall Study|Lost to Follow-up|67|||
155664895|NCT01696643|561869083|FG000|Overall Study|Physician Decision|3|||
155664896|NCT01696643|561869084|FG001|Overall Study|Physician Decision|2|||
155664897|NCT01696643|561869083|FG000|Overall Study|Pregnancy|0|||
155664898|NCT01696643|561869084|FG001|Overall Study|Pregnancy|1|||
155664899|NCT01696643|561869083|FG000|Overall Study|Protocol Violation|7|||
155664900|NCT01696643|561869084|FG001|Overall Study|Protocol Violation|7|||
155664901|NCT01696643|561869083|FG000|Overall Study|Study Terminated by Sponsor|286|||
155585351|NCT00506415|561568732|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155585352|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155585353|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155585354|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155585355|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
155585356|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585357|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585358|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155585359|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
155585360|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585361|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585362|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155585363|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
155585364|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585365|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585366|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155585367|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
155585368|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585369|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585370|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155585371|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
155585372|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585373|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585374|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155585375|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
155585376|NCT00506415|561568729|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155585377|NCT00506415|561568730|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155585378|NCT00506415|561568731|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155585379|NCT00506415|561568732|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
155585380|NCT00997373|561568733|FG000|Overall Study|Withdrawal by Subject|5|||
155585381|NCT00997373|561568734|FG001|Overall Study|Withdrawal by Subject|0|||
155585382|NCT00997373|561568733|FG000|Overall Study|wrong tumor type|4|||
155585383|NCT00997373|561568734|FG001|Overall Study|wrong tumor type|0|||
155585384|NCT00997373|561568733|FG000|Overall Study|could not have hysterectomy|6|||
155585385|NCT00997373|561568734|FG001|Overall Study|could not have hysterectomy|0|||
155585386|NCT02841995|561568735|FG000|Overall Study|Disease progression|5|||
155585387|NCT02841995|561568736|FG001|Overall Study|Disease progression|11|||
155585388|NCT02841995|561568737|FG002|Overall Study|Disease progression|8|||
155585389|NCT02841995|561568735|FG000|Overall Study|Withdrawal by Subject|2|||
155585390|NCT02841995|561568736|FG001|Overall Study|Withdrawal by Subject|4|||
155585391|NCT02841995|561568737|FG002|Overall Study|Withdrawal by Subject|4|||
155585392|NCT02841995|561568735|FG000|Overall Study|Adverse Event|2|||
155585393|NCT02841995|561568736|FG001|Overall Study|Adverse Event|0|||
155585394|NCT02841995|561568737|FG002|Overall Study|Adverse Event|1|||
155585395|NCT02841995|561568735|FG000|Overall Study|Investigator decision|2|||
155585396|NCT02841995|561568736|FG001|Overall Study|Investigator decision|0|||
155585397|NCT02841995|561568737|FG002|Overall Study|Investigator decision|1|||
155585398|NCT02841995|561568735|FG000|Overall Study|Death|0|||
155585399|NCT02841995|561568736|FG001|Overall Study|Death|0|||
155585400|NCT02841995|561568737|FG002|Overall Study|Death|2|||
155585401|NCT02841995|561568735|FG000|Overall Study|Noncompliance to protocol|1|||
155585402|NCT02841995|561568736|FG001|Overall Study|Noncompliance to protocol|0|||
155585403|NCT02841995|561568737|FG002|Overall Study|Noncompliance to protocol|0|||
155585404|NCT02841995|561568735|FG000|Overall Study|Sponsor decision|1|||
155585405|NCT02841995|561568736|FG001|Overall Study|Sponsor decision|0|||
155585406|NCT02841995|561568737|FG002|Overall Study|Sponsor decision|0|||
155585407|NCT02841995|561568735|FG000|Overall Study|Other|4|||
155585408|NCT02841995|561568736|FG001|Overall Study|Other|1|||
155585409|NCT02841995|561568737|FG002|Overall Study|Other|5|||
155585410|NCT02042014|561568738|FG000|Overall Study|Adverse Event|1|||
155585411|NCT02042014|561568738|FG000|Overall Study|Physician Decision|7|||
155585412|NCT02792062|561568739|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
155585413|NCT02792062|561568740|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155585414|NCT02792062|561568741|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155585415|NCT02792062|561568742|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155585416|NCT02792062|561568743|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155585417|NCT02792062|561568744|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155585418|NCT02632409|561568745|FG000|Randomized|AE unrelated to study Drug|0|||
155585419|NCT02632409|561568746|FG001|Randomized|AE unrelated to study Drug|1|||
155585420|NCT02632409|561568745|FG000|Randomized|Participant withdrew consent|2|||
155585421|NCT02632409|561568746|FG001|Randomized|Participant withdrew consent|1|||
155585422|NCT02632409|561568745|FG000|Randomized|No Longer meets study criteria|5|||
155585423|NCT02632409|561568746|FG001|Randomized|No Longer meets study criteria|0|||
155585424|NCT02632409|561568745|FG000|Randomized|other reasons|1|||
155585425|NCT02632409|561568746|FG001|Randomized|other reasons|0|||
155585426|NCT02632409|561568745|FG000|Treatment Period|Ongoing Treatment|20|||
155585427|NCT02632409|561568746|FG001|Treatment Period|Ongoing Treatment|21|||
155585428|NCT02632409|561568745|FG000|Treatment Period|Disease Recurrence|147|||
155585429|NCT02632409|561568746|FG001|Treatment Period|Disease Recurrence|90|||
155585430|NCT02632409|561568745|FG000|Treatment Period|Study Drug Toxicity|8|||
155585431|NCT02632409|561568746|FG001|Treatment Period|Study Drug Toxicity|49|||
155585432|NCT02632409|561568745|FG000|Treatment Period|Death|1|||
155585433|NCT02632409|561568746|FG001|Treatment Period|Death|0|||
155585434|NCT02632409|561568745|FG000|Treatment Period|AE unrelated to study drug|15|||
155585435|NCT02632409|561568746|FG001|Treatment Period|AE unrelated to study drug|16|||
155585436|NCT02632409|561568745|FG000|Treatment Period|Request to discontinue treatment|4|||
155585437|NCT02632409|561568746|FG001|Treatment Period|Request to discontinue treatment|19|||
155585438|NCT02632409|561568745|FG000|Treatment Period|Participant withdrew consent|7|||
155585439|NCT02632409|561568746|FG001|Treatment Period|Participant withdrew consent|5|||
155585440|NCT02632409|561568745|FG000|Treatment Period|Lost to Follow-up|0|||
155585441|NCT02632409|561568746|FG001|Treatment Period|Lost to Follow-up|1|||
155585442|NCT02632409|561568745|FG000|Treatment Period|Maximum clinical benefit|1|||
155585443|NCT02632409|561568746|FG001|Treatment Period|Maximum clinical benefit|0|||
155585444|NCT02632409|561568745|FG000|Treatment Period|No longer meets study criteria|3|||
155585445|NCT02632409|561568746|FG001|Treatment Period|No longer meets study criteria|0|||
155585446|NCT02632409|561568745|FG000|Treatment Period|Administrative Reason by sponsor|0|||
155585447|NCT02632409|561568746|FG001|Treatment Period|Administrative Reason by sponsor|1|||
155585448|NCT02632409|561568745|FG000|Treatment Period|Other Reasons|10|||
155585449|NCT02632409|561568746|FG001|Treatment Period|Other Reasons|6|||
155585450|NCT03331796|561568747|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
155585451|NCT03331796|561568748|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
155585452|NCT03331796|561568749|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
155585453|NCT03331796|561568747|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
155585454|NCT03331796|561568748|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
155585455|NCT03331796|561568749|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
155585456|NCT03331796|561568747|FG000|Extended Follow-up|Adverse Event|1|||
155585457|NCT03331796|561568748|FG001|Extended Follow-up|Adverse Event|0|||
155585458|NCT03331796|561568749|FG002|Extended Follow-up|Adverse Event|1|||
155585459|NCT03331796|561568747|FG000|Extended Follow-up|Lost to Follow-up|0|||
155585460|NCT03331796|561568748|FG001|Extended Follow-up|Lost to Follow-up|0|||
155585461|NCT03331796|561568749|FG002|Extended Follow-up|Lost to Follow-up|1|||
155585462|NCT03331796|561568747|FG000|Extended Follow-up|Withdrawal by Subject|1|||
155585463|NCT03331796|561568748|FG001|Extended Follow-up|Withdrawal by Subject|0|||
155585464|NCT03331796|561568749|FG002|Extended Follow-up|Withdrawal by Subject|0|||
155585465|NCT03331796|561568747|FG000|Extended Follow-up|Termination of Funding|0|||
155585466|NCT03331796|561568748|FG001|Extended Follow-up|Termination of Funding|1|||
155585467|NCT03331796|561568749|FG002|Extended Follow-up|Termination of Funding|0|||
155585468|NCT04426006|561568750|FG000|Inclusion|Protocol Violation|1|||
155585469|NCT04426006|561568750|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
155585470|NCT04426006|561568750|FG000|Inclusion|Blood sample at inclusion not done|1|||
155585471|NCT04426006|561568750|FG000|3 Months|Lost to Follow-up|17|||
155585472|NCT04426006|561568750|FG000|12 Months|Lost to Follow-up|38|||
155585473|NCT01262872|561568751|FG000|Step 2|Death|0|||
155585474|NCT01262872|561568752|FG001|Step 2|Death|0|||
155664902|NCT01696643|561869084|FG001|Overall Study|Study Terminated by Sponsor|294|||
155664903|NCT01696643|561869083|FG000|Overall Study|Withdrawal by Subject|142|||
155664904|NCT01696643|561869084|FG001|Overall Study|Withdrawal by Subject|149|||
155664905|NCT01696643|561869083|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
155664906|NCT01696643|561869084|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
155664907|NCT01696643|561869083|FG000|Overall Study|Site Error|2|||
155664908|NCT01696643|561869084|FG001|Overall Study|Site Error|1|||
155664909|NCT01696643|561869083|FG000|Overall Study|Participant Incarcerated|0|||
155664910|NCT01696643|561869084|FG001|Overall Study|Participant Incarcerated|1|||
155664911|NCT01696643|561869083|FG000|Overall Study|Medical Monitor Decision|0|||
155664912|NCT01696643|561869084|FG001|Overall Study|Medical Monitor Decision|2|||
155664913|NCT01696643|561869083|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
155664914|NCT01696643|561869084|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
155585475|NCT01262872|561568753|FG002|Step 2|Death|0|||
155585476|NCT01262872|561568754|FG003|Step 2|Death|1|||
155664915|NCT00518180|561869089|FG000|Overall Study|Withdrawal by Subject|29|||
155664916|NCT00518180|561869090|FG001|Overall Study|Withdrawal by Subject|30|||
155585477|NCT01262872|561568755|FG004|Step 2|Death|0|||
155585478|NCT01262872|561568756|FG005|Step 2|Death|2|||
155585479|NCT01262872|561568757|FG006|Step 2|Death|2|||
155585480|NCT01262872|561568758|FG007|Step 2|Death|1|||
155585481|NCT01262872|561568751|FG000|Step 2|Protocol Violation|0|||
155585482|NCT01262872|561568752|FG001|Step 2|Protocol Violation|0|||
155585483|NCT01262872|561568753|FG002|Step 2|Protocol Violation|1|||
155585484|NCT01262872|561568754|FG003|Step 2|Protocol Violation|0|||
155585485|NCT01262872|561568755|FG004|Step 2|Protocol Violation|0|||
155585486|NCT01262872|561568756|FG005|Step 2|Protocol Violation|0|||
155585487|NCT01262872|561568757|FG006|Step 2|Protocol Violation|3|||
155585488|NCT01262872|561568758|FG007|Step 2|Protocol Violation|1|||
155585489|NCT01262872|561568751|FG000|Step 2|Withdrawal by Subject|0|||
155585490|NCT01262872|561568752|FG001|Step 2|Withdrawal by Subject|0|||
155585491|NCT01262872|561568753|FG002|Step 2|Withdrawal by Subject|4|||
155664917|NCT00518180|561869091|FG002|Overall Study|Withdrawal by Subject|42|||
155664918|NCT00518180|561869089|FG000|Overall Study|Lost to Follow-up|30|||
155585492|NCT01262872|561568754|FG003|Step 2|Withdrawal by Subject|6|||
155585493|NCT01262872|561568755|FG004|Step 2|Withdrawal by Subject|3|||
155664919|NCT00518180|561869090|FG001|Overall Study|Lost to Follow-up|28|||
155585494|NCT01262872|561568756|FG005|Step 2|Withdrawal by Subject|1|||
155585495|NCT01262872|561568757|FG006|Step 2|Withdrawal by Subject|2|||
155585496|NCT01262872|561568758|FG007|Step 2|Withdrawal by Subject|1|||
155585497|NCT01262872|561568751|FG000|Step 2|Migrated/moved from study area|0|||
155585498|NCT01262872|561568752|FG001|Step 2|Migrated/moved from study area|0|||
155585499|NCT01262872|561568753|FG002|Step 2|Migrated/moved from study area|4|||
155585500|NCT01262872|561568754|FG003|Step 2|Migrated/moved from study area|3|||
155585501|NCT01262872|561568755|FG004|Step 2|Migrated/moved from study area|2|||
155585502|NCT01262872|561568756|FG005|Step 2|Migrated/moved from study area|6|||
155585503|NCT01262872|561568757|FG006|Step 2|Migrated/moved from study area|2|||
155585504|NCT01262872|561568758|FG007|Step 2|Migrated/moved from study area|3|||
155585505|NCT01000155|561568761|FG000|Overall Study|Withdrawal by Subject|1|||
155585506|NCT01000155|561568761|FG000|Overall Study|Adverse Event|1|||
155585507|NCT00720213|561568762|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
155585508|NCT00720213|561568763|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
155585509|NCT00720213|561568764|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
155585510|NCT01252095|561568774|FG000|Overall Study|Disease progression|1|||
155585511|NCT01252095|561568775|FG001|Overall Study|Disease progression|0|||
155585512|NCT01420068|561568776|FG000|Overall Study|Administrative problems|1|||
155585513|NCT01420068|561568777|FG001|Overall Study|Administrative problems|3|||
155585514|NCT01420068|561568776|FG000|Overall Study|Withdrawal by Subject|1|||
155585515|NCT01420068|561568777|FG001|Overall Study|Withdrawal by Subject|2|||
155585516|NCT00745901|561568778|FG000|Overall Study|Adverse Event|3|||
155585517|NCT00745901|561568779|FG001|Overall Study|Adverse Event|4|||
155585518|NCT00745901|561568778|FG000|Overall Study|Protocol Violation|0|||
155585519|NCT00745901|561568779|FG001|Overall Study|Protocol Violation|1|||
155585520|NCT00745901|561568778|FG000|Overall Study|Withdrawal by Subject|1|||
155585521|NCT00745901|561568779|FG001|Overall Study|Withdrawal by Subject|0|||
155585522|NCT00745901|561568778|FG000|Overall Study|Lost to Follow-up|7|||
155585523|NCT00745901|561568779|FG001|Overall Study|Lost to Follow-up|4|||
155585524|NCT00745901|561568778|FG000|Overall Study|Pregnancy|2|||
155585525|NCT00745901|561568779|FG001|Overall Study|Pregnancy|4|||
155585526|NCT00745901|561568778|FG000|Overall Study|Lack of compliance|2|||
155585527|NCT00745901|561568779|FG001|Overall Study|Lack of compliance|2|||
155585528|NCT00745901|561568778|FG000|Overall Study|Patient's next menses did not start with|1|||
155585529|NCT00745901|561568779|FG001|Overall Study|Patient's next menses did not start with|0|||
155585530|NCT00745901|561568778|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
155585531|NCT00745901|561568779|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
155585532|NCT00745901|561568778|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
155585533|NCT00745901|561568779|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
155585534|NCT00745901|561568778|FG000|Overall Study|Patient didn't take any study medication|7|||
155585535|NCT00745901|561568779|FG001|Overall Study|Patient didn't take any study medication|3|||
155585536|NCT02022202|561568782|FG000|Overall Study|Withdrawal by Subject|2|||
155585537|NCT02022202|561568782|FG000|Overall Study|Disease Progression|3|||
155585538|NCT02022202|561568782|FG000|Overall Study|Desire go to immediately to surgery|3|||
155585539|NCT01956773|561568788|FG000|Overall Study|Lost to Follow-up|628|||
155585540|NCT01956773|561568789|FG001|Overall Study|Lost to Follow-up|1|||
155585541|NCT01565889|561568790|FG000|Part A|Withdrawal by Subject|1|||
155585542|NCT01565889|561568791|FG001|Part A|Withdrawal by Subject|0|||
155585543|NCT01565889|561568792|FG002|Part A|Withdrawal by Subject|0|||
155585544|NCT01565889|561568793|FG003|Part A|Withdrawal by Subject|0|||
155585545|NCT01565889|561568794|FG004|Part A|Withdrawal by Subject|0|||
155585546|NCT01565889|561568795|FG005|Part A|Withdrawal by Subject|0|||
155585547|NCT01565889|561568790|FG000|Part B|Withdrawal by Subject|0|||
155585548|NCT01565889|561568791|FG001|Part B|Withdrawal by Subject|0|||
155585549|NCT01565889|561568792|FG002|Part B|Withdrawal by Subject|0|||
155585550|NCT01565889|561568793|FG003|Part B|Withdrawal by Subject|0|||
155585551|NCT01565889|561568794|FG004|Part B|Withdrawal by Subject|0|||
155585552|NCT01565889|561568795|FG005|Part B|Withdrawal by Subject|1|||
155585553|NCT01565889|561568790|FG000|Part B|Lack of Efficacy|0|||
155585554|NCT01565889|561568791|FG001|Part B|Lack of Efficacy|0|||
155585555|NCT01565889|561568792|FG002|Part B|Lack of Efficacy|0|||
155585556|NCT01565889|561568793|FG003|Part B|Lack of Efficacy|0|||
155585557|NCT01565889|561568794|FG004|Part B|Lack of Efficacy|0|||
155585558|NCT01565889|561568795|FG005|Part B|Lack of Efficacy|2|||
155585559|NCT01565889|561568790|FG000|Part B|Lost to Follow-up|0|||
155585560|NCT01565889|561568791|FG001|Part B|Lost to Follow-up|0|||
155585561|NCT01565889|561568792|FG002|Part B|Lost to Follow-up|0|||
155585562|NCT01565889|561568793|FG003|Part B|Lost to Follow-up|0|||
155585563|NCT01565889|561568794|FG004|Part B|Lost to Follow-up|0|||
155585564|NCT01565889|561568795|FG005|Part B|Lost to Follow-up|1|||
155585565|NCT00122382|561568796|FG000|Double-Blind Study|Adverse Event|9|||
155585566|NCT00122382|561568797|FG001|Double-Blind Study|Adverse Event|11|||
155585567|NCT00122382|561568798|FG002|Double-Blind Study|Adverse Event|0|||
155585568|NCT00122382|561568796|FG000|Double-Blind Study|Death|2|||
155585569|NCT00122382|561568797|FG001|Double-Blind Study|Death|2|||
155585570|NCT00122382|561568798|FG002|Double-Blind Study|Death|0|||
155585571|NCT00122382|561568796|FG000|Double-Blind Study|Lack of Efficacy|0|||
155585572|NCT00122382|561568797|FG001|Double-Blind Study|Lack of Efficacy|8|||
155585573|NCT00122382|561568798|FG002|Double-Blind Study|Lack of Efficacy|0|||
155585574|NCT00122382|561568796|FG000|Double-Blind Study|Lost to Follow-up|2|||
155585575|NCT00122382|561568797|FG001|Double-Blind Study|Lost to Follow-up|1|||
155585576|NCT00122382|561568798|FG002|Double-Blind Study|Lost to Follow-up|0|||
155585577|NCT00122382|561568796|FG000|Double-Blind Study|Pregnancy|2|||
155585578|NCT00122382|561568797|FG001|Double-Blind Study|Pregnancy|0|||
155585579|NCT00122382|561568798|FG002|Double-Blind Study|Pregnancy|0|||
155585580|NCT00122382|561568796|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
155585581|NCT00122382|561568797|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
155585582|NCT00122382|561568798|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
155585583|NCT00122382|561568796|FG000|Double-Blind Study|Withdrawal of Consent|7|||
155585584|NCT00122382|561568797|FG001|Double-Blind Study|Withdrawal of Consent|3|||
155585585|NCT00122382|561568798|FG002|Double-Blind Study|Withdrawal of Consent|0|||
155585586|NCT00122382|561568796|FG000|Double-Blind Study|Protocol Violation|1|||
155585587|NCT00122382|561568797|FG001|Double-Blind Study|Protocol Violation|0|||
155585588|NCT00122382|561568798|FG002|Double-Blind Study|Protocol Violation|0|||
155585589|NCT00122382|561568796|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
155585590|NCT00122382|561568797|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
155585591|NCT00122382|561568798|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
155585592|NCT00122382|561568796|FG000|Double-Blind Study|Randomized but not treated|0|||
155585593|NCT00122382|561568797|FG001|Double-Blind Study|Randomized but not treated|2|||
155585594|NCT00122382|561568798|FG002|Double-Blind Study|Randomized but not treated|0|||
155585595|NCT00122382|561568796|FG000|Open-Label Study|Adverse Event|0|||
155585596|NCT00122382|561568797|FG001|Open-Label Study|Adverse Event|0|||
155585597|NCT00122382|561568798|FG002|Open-Label Study|Adverse Event|11|||
155585598|NCT00122382|561568796|FG000|Open-Label Study|Death|0|||
155585599|NCT00122382|561568797|FG001|Open-Label Study|Death|0|||
155585600|NCT00122382|561568798|FG002|Open-Label Study|Death|2|||
155585601|NCT00122382|561568796|FG000|Open-Label Study|Lack of Efficacy|0|||
155585602|NCT00122382|561568797|FG001|Open-Label Study|Lack of Efficacy|0|||
155585603|NCT00122382|561568798|FG002|Open-Label Study|Lack of Efficacy|3|||
155585604|NCT00122382|561568796|FG000|Open-Label Study|Lost to Follow-up|0|||
155585605|NCT00122382|561568797|FG001|Open-Label Study|Lost to Follow-up|0|||
155585606|NCT00122382|561568798|FG002|Open-Label Study|Lost to Follow-up|3|||
155585607|NCT00122382|561568796|FG000|Open-Label Study|Pregnancy|0|||
155585608|NCT00122382|561568797|FG001|Open-Label Study|Pregnancy|0|||
155585609|NCT00122382|561568798|FG002|Open-Label Study|Pregnancy|2|||
155585610|NCT00122382|561568796|FG000|Open-Label Study|Poor/Non-Compliance|0|||
155585611|NCT00122382|561568797|FG001|Open-Label Study|Poor/Non-Compliance|0|||
155585612|NCT00122382|561568798|FG002|Open-Label Study|Poor/Non-Compliance|1|||
155585613|NCT00122382|561568796|FG000|Open-Label Study|Withdrawal of Consent|0|||
155585614|NCT00122382|561568797|FG001|Open-Label Study|Withdrawal of Consent|0|||
155585615|NCT00122382|561568798|FG002|Open-Label Study|Withdrawal of Consent|4|||
155585616|NCT02040805|561568799|FG000|Overall Study|Lost to Follow-up|14|||
155585617|NCT02040805|561568800|FG001|Overall Study|Lost to Follow-up|9|||
155585618|NCT02040805|561568799|FG000|Overall Study|Withdrawal by Subject|28|||
155585619|NCT02040805|561568800|FG001|Overall Study|Withdrawal by Subject|41|||
155585620|NCT01662492|561568803|FG000|Overall Study|Other miscellaneous reasons.|1|||
155585621|NCT01662492|561568804|FG001|Overall Study|Other miscellaneous reasons.|0|||
155585622|NCT01662492|561568805|FG002|Overall Study|Other miscellaneous reasons.|1|||
155585623|NCT01662492|561568803|FG000|Overall Study|Withdrawal by Subject|0|||
155585624|NCT01662492|561568804|FG001|Overall Study|Withdrawal by Subject|0|||
155585625|NCT01662492|561568805|FG002|Overall Study|Withdrawal by Subject|1|||
155585626|NCT01662492|561568803|FG000|Overall Study|Protocol Violation|1|||
155585627|NCT01662492|561568804|FG001|Overall Study|Protocol Violation|0|||
155585628|NCT01662492|561568805|FG002|Overall Study|Protocol Violation|0|||
155585629|NCT01662492|561568803|FG000|Overall Study|Lost to Follow-up|0|||
155585630|NCT01662492|561568804|FG001|Overall Study|Lost to Follow-up|0|||
155585631|NCT01662492|561568805|FG002|Overall Study|Lost to Follow-up|2|||
155585632|NCT01662492|561568803|FG000|Overall Study|Lack of Efficacy|1|||
155585633|NCT01662492|561568804|FG001|Overall Study|Lack of Efficacy|1|||
155585634|NCT01662492|561568805|FG002|Overall Study|Lack of Efficacy|2|||
155585635|NCT01591096|561568806|FG000|Overall Study|Adverse Event|1|||
155585636|NCT01167140|561568812|FG000|Overall Study|Withdrawal by Subject|1|||
155585637|NCT03805412|561568813|FG000|Overall Study|Lost to Follow-up|0|||
155585638|NCT03805412|561568814|FG001|Overall Study|Lost to Follow-up|1|||
155585639|NCT00571727|561568817|FG000|Overall Study|Did not enter in this study|1|||
155585640|NCT00571727|561568817|FG000|Overall Study|Non-compliance|4|||
155585641|NCT00571727|561568817|FG000|Overall Study|Lost to Follow-up|30|||
155585642|NCT00571727|561568817|FG000|Overall Study|Poor growth|1|||
155585643|NCT00571727|561568817|FG000|Overall Study|Parent/patient decision|2|||
155585644|NCT00571727|561568817|FG000|Overall Study|Participant transferred to commercial drug|14|||
155585645|NCT00571727|561568817|FG000|Overall Study|Unable to provide study drug|6|||
155585646|NCT00571727|561568817|FG000|Overall Study|On-treatment at end of study|8|||
155585647|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
155585648|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
155585649|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
155585650|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
155585651|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
155585652|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
155585653|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
155585654|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155585655|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155585656|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155585657|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
155585658|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
155585659|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
155585660|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
155585661|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
155585662|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
155585663|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
155585664|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
155585665|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
155585666|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
155585667|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
155585668|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
155585669|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
155585670|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
155585671|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
155585672|NCT03525678|561568820|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
155585673|NCT03525678|561568821|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
155585674|NCT03525678|561568822|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155585675|NCT03525678|561568823|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155585676|NCT03525678|561568824|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155585677|NCT03771898|561570442|FG000|Overall Study|Adverse Event|1|||
155585678|NCT03771898|561570443|FG001|Overall Study|Adverse Event|0|||
155585679|NCT03771898|561570444|FG002|Overall Study|Adverse Event|0|||
155585680|NCT03771898|561570445|FG003|Overall Study|Adverse Event|0|||
155585681|NCT03771898|561570446|FG004|Overall Study|Adverse Event|0|||
155585682|NCT03771898|561570442|FG000|Overall Study|Lost to Follow-up|1|||
155585683|NCT03771898|561570443|FG001|Overall Study|Lost to Follow-up|1|||
155585684|NCT03771898|561570444|FG002|Overall Study|Lost to Follow-up|1|||
155585685|NCT03771898|561570445|FG003|Overall Study|Lost to Follow-up|0|||
155585686|NCT03771898|561570446|FG004|Overall Study|Lost to Follow-up|0|||
155585687|NCT03771898|561570442|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155585688|NCT03771898|561570443|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155585689|NCT03771898|561570444|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155585690|NCT03771898|561570445|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155585691|NCT03771898|561570446|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155585692|NCT03771898|561570442|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155585693|NCT03771898|561570443|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155585694|NCT03771898|561570444|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155585695|NCT03771898|561570445|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155585696|NCT03771898|561570446|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
155585697|NCT03135548|561570447|FG000|Overall Study|Lost to Follow-up|3|||
155585698|NCT03135548|561570448|FG001|Overall Study|Lost to Follow-up|0|||
155585699|NCT03135548|561570449|FG002|Overall Study|Lost to Follow-up|0|||
155585700|NCT03135548|561570447|FG000|Overall Study|Withdrawal by Subject|2|||
155585701|NCT03135548|561570448|FG001|Overall Study|Withdrawal by Subject|2|||
155585702|NCT03135548|561570449|FG002|Overall Study|Withdrawal by Subject|1|||
155585703|NCT03135548|561570447|FG000|Overall Study|Other than listed|0|||
155585704|NCT03135548|561570448|FG001|Overall Study|Other than listed|2|||
155585705|NCT03135548|561570449|FG002|Overall Study|Other than listed|2|||
155585706|NCT04623216|561570450|FG000|Overall Study|Death|5|||
155585707|NCT04623216|561570451|FG001|Overall Study|Death|2|||
155585708|NCT04623216|561570452|FG002|Overall Study|Death|0|||
155585709|NCT04623216|561570453|FG003|Overall Study|Death|0|||
155585710|NCT04623216|561570450|FG000|Overall Study|Terminated by Sponsor|3|||
155585711|NCT04623216|561570451|FG001|Overall Study|Terminated by Sponsor|2|||
155585712|NCT04623216|561570452|FG002|Overall Study|Terminated by Sponsor|2|||
155664920|NCT00518180|561869091|FG002|Overall Study|Lost to Follow-up|34|||
155664921|NCT00518180|561869089|FG000|Overall Study|Administrative reason|0|||
155664922|NCT00518180|561869090|FG001|Overall Study|Administrative reason|2|||
155664923|NCT00518180|561869091|FG002|Overall Study|Administrative reason|2|||
155664924|NCT00518180|561869089|FG000|Overall Study|Protocol Violation|5|||
155664925|NCT00518180|561869090|FG001|Overall Study|Protocol Violation|7|||
155664926|NCT00518180|561869091|FG002|Overall Study|Protocol Violation|4|||
155664927|NCT00518180|561869089|FG000|Overall Study|Unable to classify|0|||
155664928|NCT00518180|561869090|FG001|Overall Study|Unable to classify|2|||
155664929|NCT00518180|561869091|FG002|Overall Study|Unable to classify|0|||
155664930|NCT00518180|561869089|FG000|Overall Study|Adverse Event|1|||
155664931|NCT00518180|561869090|FG001|Overall Study|Adverse Event|0|||
155664932|NCT00518180|561869091|FG002|Overall Study|Adverse Event|0|||
155664933|NCT01368614|561869092|FG000|Screening Period|Screen Failure|58|||
155664934|NCT01368614|561869093|FG001|Screening Period|Screen Failure|0|||
155664935|NCT01368614|561869094|FG002|Screening Period|Screen Failure|0|||
155664936|NCT01368614|561869095|FG003|Screening Period|Screen Failure|0|||
155664937|NCT01368614|561869092|FG000|Study Period|Withdrawal by Subject|0|||
155664938|NCT01368614|561869093|FG001|Study Period|Withdrawal by Subject|1|||
155664939|NCT01368614|561869094|FG002|Study Period|Withdrawal by Subject|1|||
155664940|NCT01368614|561869095|FG003|Study Period|Withdrawal by Subject|3|||
155664941|NCT01368614|561869092|FG000|Study Period|Lost to Follow-up|0|||
155664942|NCT01368614|561869093|FG001|Study Period|Lost to Follow-up|0|||
155664943|NCT01368614|561869094|FG002|Study Period|Lost to Follow-up|1|||
155664944|NCT01368614|561869095|FG003|Study Period|Lost to Follow-up|0|||
155664945|NCT00508482|561869096|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
155664946|NCT00508482|561869097|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
155664947|NCT00508482|561869098|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
155664948|NCT00508482|561869096|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
155664949|NCT00508482|561869097|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
155664950|NCT00508482|561869098|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
155664951|NCT00508482|561869096|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
155664952|NCT00508482|561869097|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
155664953|NCT00508482|561869098|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
155585713|NCT04623216|561570453|FG003|Overall Study|Terminated by Sponsor|0|||
155585714|NCT04623216|561570450|FG000|Overall Study|Physician Decision|1|||
155585715|NCT04623216|561570451|FG001|Overall Study|Physician Decision|0|||
155585716|NCT04623216|561570452|FG002|Overall Study|Physician Decision|0|||
155585717|NCT04623216|561570453|FG003|Overall Study|Physician Decision|0|||
155585718|NCT00529087|561570458|FG000|Overall Study|Adverse Event|10|||
155585719|NCT00529087|561570459|FG001|Overall Study|Adverse Event|13|||
155585720|NCT00529087|561570460|FG002|Overall Study|Adverse Event|4|||
155585721|NCT00529087|561570458|FG000|Overall Study|Lost to Follow-up|6|||
155585722|NCT00529087|561570459|FG001|Overall Study|Lost to Follow-up|4|||
155585723|NCT00529087|561570460|FG002|Overall Study|Lost to Follow-up|1|||
155585724|NCT00529087|561570458|FG000|Overall Study|Protocol Violation|8|||
155585725|NCT00529087|561570459|FG001|Overall Study|Protocol Violation|7|||
155585726|NCT00529087|561570460|FG002|Overall Study|Protocol Violation|6|||
155585727|NCT00529087|561570458|FG000|Overall Study|Withdrawal by Subject|3|||
155585728|NCT00529087|561570459|FG001|Overall Study|Withdrawal by Subject|3|||
155585729|NCT00529087|561570460|FG002|Overall Study|Withdrawal by Subject|3|||
155585730|NCT00529087|561570458|FG000|Overall Study|Protocol deviation|1|||
155585731|NCT00529087|561570459|FG001|Overall Study|Protocol deviation|1|||
155664954|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
155664955|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
155585732|NCT00529087|561570460|FG002|Overall Study|Protocol deviation|2|||
155585733|NCT01671007|561570471|FG000|Overall Study|Other reasons than listed|166|||
155585734|NCT01671007|561570472|FG001|Overall Study|Other reasons than listed|373|||
155585735|NCT01671007|561570473|FG002|Overall Study|Other reasons than listed|197|||
155585736|NCT01671007|561570474|FG003|Overall Study|Other reasons than listed|228|||
155664956|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
155585737|NCT01671007|561570475|FG004|Overall Study|Other reasons than listed|14|||
155585738|NCT01671007|561570476|FG005|Overall Study|Other reasons than listed|71|||
155664957|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
155664958|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
155664959|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
155664960|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
155664961|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
155585739|NCT01671007|561570477|FG006|Overall Study|Other reasons than listed|17|||
155585740|NCT01671007|561570478|FG007|Overall Study|Other reasons than listed|66|||
155585741|NCT01671007|561570479|FG008|Overall Study|Other reasons than listed|0|||
155585742|NCT01671007|561570471|FG000|Overall Study|Withdrawal by Subject|36|||
155585743|NCT01671007|561570472|FG001|Overall Study|Withdrawal by Subject|59|||
155585744|NCT01671007|561570473|FG002|Overall Study|Withdrawal by Subject|53|||
155585745|NCT01671007|561570474|FG003|Overall Study|Withdrawal by Subject|58|||
155585746|NCT01671007|561570475|FG004|Overall Study|Withdrawal by Subject|4|||
155585747|NCT01671007|561570476|FG005|Overall Study|Withdrawal by Subject|15|||
155585748|NCT01671007|561570477|FG006|Overall Study|Withdrawal by Subject|1|||
155585749|NCT01671007|561570478|FG007|Overall Study|Withdrawal by Subject|19|||
155585750|NCT01671007|561570479|FG008|Overall Study|Withdrawal by Subject|0|||
155585751|NCT01671007|561570471|FG000|Overall Study|Lost to Follow-up|93|||
155585752|NCT01671007|561570472|FG001|Overall Study|Lost to Follow-up|142|||
155585753|NCT01671007|561570473|FG002|Overall Study|Lost to Follow-up|91|||
155585754|NCT01671007|561570474|FG003|Overall Study|Lost to Follow-up|63|||
155585755|NCT01671007|561570475|FG004|Overall Study|Lost to Follow-up|7|||
155585756|NCT01671007|561570476|FG005|Overall Study|Lost to Follow-up|20|||
155585757|NCT01671007|561570477|FG006|Overall Study|Lost to Follow-up|2|||
155585758|NCT01671007|561570478|FG007|Overall Study|Lost to Follow-up|28|||
155585759|NCT01671007|561570479|FG008|Overall Study|Lost to Follow-up|0|||
155585760|NCT01671007|561570471|FG000|Overall Study|No end of study case report form|3|||
155585761|NCT01671007|561570472|FG001|Overall Study|No end of study case report form|1|||
155585762|NCT01671007|561570473|FG002|Overall Study|No end of study case report form|0|||
155585763|NCT01671007|561570474|FG003|Overall Study|No end of study case report form|2|||
155585764|NCT01671007|561570475|FG004|Overall Study|No end of study case report form|0|||
155585765|NCT01671007|561570476|FG005|Overall Study|No end of study case report form|0|||
155585766|NCT01671007|561570477|FG006|Overall Study|No end of study case report form|0|||
155585767|NCT01671007|561570478|FG007|Overall Study|No end of study case report form|0|||
155585768|NCT01671007|561570479|FG008|Overall Study|No end of study case report form|0|||
155585769|NCT01671007|561570471|FG000|Overall Study|Not eligible|23|||
155585770|NCT01671007|561570472|FG001|Overall Study|Not eligible|76|||
155585771|NCT01671007|561570473|FG002|Overall Study|Not eligible|25|||
155585772|NCT01671007|561570474|FG003|Overall Study|Not eligible|17|||
155585773|NCT01671007|561570475|FG004|Overall Study|Not eligible|0|||
155585774|NCT01671007|561570476|FG005|Overall Study|Not eligible|6|||
155585775|NCT01671007|561570477|FG006|Overall Study|Not eligible|1|||
155585776|NCT01671007|561570478|FG007|Overall Study|Not eligible|19|||
155585777|NCT01671007|561570479|FG008|Overall Study|Not eligible|0|||
155585778|NCT03877068|561570480|FG000|Overall Study|Physician Decision|9|||
155585779|NCT03877068|561570481|FG001|Overall Study|Physician Decision|3|||
155585780|NCT00406367|561570482|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
155585781|NCT00406367|561570483|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155585782|NCT00406367|561570482|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
155585783|NCT00406367|561570483|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
155585784|NCT00406367|561570482|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
155585785|NCT00406367|561570483|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
155585786|NCT00406367|561570482|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
155585787|NCT00406367|561570483|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
155585788|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
155585789|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
155585790|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
155585791|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
155585792|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
155585793|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
155585794|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
155585795|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
155585796|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
155585797|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
155585798|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
155585799|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
155585800|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
155585801|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
155585802|NCT00406367|561570482|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
155585803|NCT00406367|561570483|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
155585804|NCT03187301|561570486|FG000|Titration Period|Adverse Event|0|||
155585805|NCT03187301|561570487|FG001|Titration Period|Adverse Event|0|||
155585806|NCT03187301|561570488|FG002|Titration Period|Adverse Event|0|||
155585807|NCT03187301|561570489|FG003|Titration Period|Adverse Event|0|||
155585808|NCT03187301|561570490|FG004|Titration Period|Adverse Event|0|||
155585809|NCT03187301|561570491|FG005|Titration Period|Adverse Event|0|||
155585810|NCT03187301|561570492|FG006|Titration Period|Adverse Event|5|||
155585811|NCT03187301|561570486|FG000|Titration Period|Withdrawal by Subject|0|||
155585812|NCT03187301|561570487|FG001|Titration Period|Withdrawal by Subject|0|||
155585813|NCT03187301|561570488|FG002|Titration Period|Withdrawal by Subject|0|||
155585814|NCT03187301|561570489|FG003|Titration Period|Withdrawal by Subject|0|||
155585815|NCT03187301|561570490|FG004|Titration Period|Withdrawal by Subject|0|||
155585816|NCT03187301|561570491|FG005|Titration Period|Withdrawal by Subject|0|||
155585817|NCT03187301|561570492|FG006|Titration Period|Withdrawal by Subject|1|||
155585818|NCT03187301|561570486|FG000|Titration Period|Exclusion Criteria Met|0|||
155585819|NCT03187301|561570487|FG001|Titration Period|Exclusion Criteria Met|0|||
155585820|NCT03187301|561570488|FG002|Titration Period|Exclusion Criteria Met|0|||
155585821|NCT03187301|561570489|FG003|Titration Period|Exclusion Criteria Met|0|||
155585822|NCT03187301|561570490|FG004|Titration Period|Exclusion Criteria Met|0|||
155585823|NCT03187301|561570491|FG005|Titration Period|Exclusion Criteria Met|0|||
155585824|NCT03187301|561570492|FG006|Titration Period|Exclusion Criteria Met|1|||
155585825|NCT03187301|561570486|FG000|Pre-Intervention|Withdrawal by Subject|1|||
155585826|NCT03187301|561570487|FG001|Pre-Intervention|Withdrawal by Subject|0|||
155585827|NCT03187301|561570488|FG002|Pre-Intervention|Withdrawal by Subject|0|||
155585828|NCT03187301|561570489|FG003|Pre-Intervention|Withdrawal by Subject|0|||
155585829|NCT03187301|561570490|FG004|Pre-Intervention|Withdrawal by Subject|0|||
155585830|NCT03187301|561570491|FG005|Pre-Intervention|Withdrawal by Subject|0|||
155585831|NCT03187301|561570492|FG006|Pre-Intervention|Withdrawal by Subject|0|||
155585832|NCT01966120|561570493|FG000|Overall Study|Withdrawal by Subject|0|||
155585833|NCT01966120|561570494|FG001|Overall Study|Withdrawal by Subject|5|||
155585834|NCT01966120|561570493|FG000|Overall Study|Lost to Follow-up|1|||
155585835|NCT01966120|561570494|FG001|Overall Study|Lost to Follow-up|1|||
155585836|NCT00461630|561570495|FG000|Overall Study|Death|798|||
155585837|NCT00461630|561570496|FG001|Overall Study|Death|732|||
155585838|NCT00461630|561570495|FG000|Overall Study|Lost to Follow-up|108|||
155585839|NCT00461630|561570496|FG001|Overall Study|Lost to Follow-up|95|||
155585840|NCT02588612|561570503|FG000|Overall Study|Physician Decision|1|||
155585841|NCT02588612|561570503|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
155585842|NCT02588612|561570503|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
155585843|NCT02588612|561570503|FG000|Overall Study|Death prior to T-cell infusion|1|||
155585844|NCT03123393|561570506|FG000|Overall Study|Study Terminated by Sponsor|6|||
155585845|NCT03123393|561570507|FG001|Overall Study|Study Terminated by Sponsor|9|||
155585846|NCT03123393|561570506|FG000|Overall Study|Withdrawal by Subject|2|||
155585847|NCT03123393|561570507|FG001|Overall Study|Withdrawal by Subject|1|||
155585848|NCT03123393|561570506|FG000|Overall Study|Reason not Specified|13|||
155585849|NCT03123393|561570507|FG001|Overall Study|Reason not Specified|13|||
155585850|NCT00558701|561570509|FG000|Overall Study|Protocol Deviations|1|||
155585851|NCT00558701|561570510|FG001|Overall Study|Protocol Deviations|4|||
155585852|NCT00427648|561570511|FG000|Overall Study|Protocol Violation|1|||
155585853|NCT00427648|561570512|FG001|Overall Study|Protocol Violation|2|||
155585854|NCT00427648|561570511|FG000|Overall Study|Adverse Event|0|||
155585855|NCT00427648|561570512|FG001|Overall Study|Adverse Event|1|||
155585856|NCT02230904|561570513|FG000|Overall Study|Safety follow up could not take place|0|||
155585857|NCT02230904|561570514|FG001|Overall Study|Safety follow up could not take place|1|||
155585858|NCT01681212|561570515|FG000|Overall Study|No longer met study criteria|5|||
155585859|NCT01681212|561570515|FG000|Overall Study|Administrative reason by sponsor|1|||
155585860|NCT01464333|561570517|FG000|Overall Study|Adverse Event|34|||
155585861|NCT01464333|561570517|FG000|Overall Study|Lack of Efficacy|72|||
155585862|NCT01464333|561570517|FG000|Overall Study|Withdrawal by Subject|11|||
155585863|NCT01464333|561570517|FG000|Overall Study|Other|4|||
155585864|NCT01464333|561570517|FG000|Overall Study|No Hospital Visit|42|||
155585865|NCT05047211|561570520|FG000|Overall Study|Lost to Follow-up|8|||
155585866|NCT05047211|561570521|FG001|Overall Study|Lost to Follow-up|5|||
155585867|NCT00561392|561570522|FG000|Overall Study|Adverse Event|38|||
155585868|NCT00561392|561570522|FG000|Overall Study|Lack of Efficacy|2|||
155585869|NCT00561392|561570522|FG000|Overall Study|Protocol Violation|1|||
155585870|NCT00561392|561570522|FG000|Overall Study|Withdrawal by Subject|8|||
155585871|NCT00561392|561570522|FG000|Overall Study|Administrative problems|4|||
155585872|NCT03321968|561570523|FG000|Overall Study|Withdrawal by Subject|1|||
155585873|NCT03321968|561570524|FG001|Overall Study|Withdrawal by Subject|2|||
155585874|NCT03321968|561570525|FG002|Overall Study|Withdrawal by Subject|1|||
155585875|NCT03321968|561570523|FG000|Overall Study|Lost to Follow-up|2|||
155585876|NCT03321968|561570524|FG001|Overall Study|Lost to Follow-up|0|||
155585877|NCT03321968|561570525|FG002|Overall Study|Lost to Follow-up|1|||
155585878|NCT03321968|561570523|FG000|Overall Study|Other than specified|0|||
155585879|NCT03321968|561570524|FG001|Overall Study|Other than specified|0|||
155585880|NCT03321968|561570525|FG002|Overall Study|Other than specified|1|||
155585881|NCT03822468|561570526|FG000|Treatment Period|Progressive disease|98|||
155585882|NCT03822468|561570527|FG001|Treatment Period|Progressive disease|94|||
155585883|NCT03822468|561570526|FG000|Treatment Period|Adverse Event|21|||
155585884|NCT03822468|561570527|FG001|Treatment Period|Adverse Event|24|||
155585885|NCT03822468|561570526|FG000|Treatment Period|Withdrawal by Subject|9|||
155585886|NCT03822468|561570527|FG001|Treatment Period|Withdrawal by Subject|5|||
155585887|NCT03822468|561570526|FG000|Treatment Period|Physician Decision|9|||
155585888|NCT03822468|561570527|FG001|Treatment Period|Physician Decision|7|||
155585889|NCT03822468|561570526|FG000|Treatment Period|Protocol Violation|2|||
155585890|NCT03822468|561570527|FG001|Treatment Period|Protocol Violation|1|||
155585891|NCT03822468|561570526|FG000|Treatment Period|Death|2|||
155585892|NCT03822468|561570527|FG001|Treatment Period|Death|3|||
155585893|NCT03822468|561570526|FG000|Treatment Period|Lost to Follow-up|1|||
155585894|NCT03822468|561570527|FG001|Treatment Period|Lost to Follow-up|1|||
155585895|NCT03822468|561570526|FG000|Treatment Period|Sponsor decision|46|||
155585896|NCT03822468|561570527|FG001|Treatment Period|Sponsor decision|53|||
155585897|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
155585898|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
155585899|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
155585900|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
155585901|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Death|1|||
155585902|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Death|0|||
155585903|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155585904|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155585905|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155585906|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155585907|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155585908|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155585909|NCT03822468|561570526|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
155585910|NCT03822468|561570527|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
155585911|NCT02198664|561570528|FG000|Overall Study|Adverse Event|2|||
155585912|NCT02198664|561570529|FG001|Overall Study|Adverse Event|0|||
155585913|NCT02198664|561570528|FG000|Overall Study|Withdrawal by Subject|11|||
155585914|NCT02198664|561570529|FG001|Overall Study|Withdrawal by Subject|8|||
155585915|NCT02198664|561570528|FG000|Overall Study|Failure to tolerate|2|||
155585916|NCT02198664|561570529|FG001|Overall Study|Failure to tolerate|0|||
155585917|NCT02198664|561570528|FG000|Overall Study|Not stated|1|||
155585918|NCT02198664|561570529|FG001|Overall Study|Not stated|0|||
155585919|NCT00529308|561570530|FG000|Overall Study|Withdrawal by Subject|1|||
155585920|NCT00529308|561570531|FG001|Overall Study|Withdrawal by Subject|1|||
155585921|NCT01808066|561570532|FG000|Overall Study|Withdrawal by Subject|15|||
155585922|NCT00365794|561570533|FG000|Overall Study|Withdrawal by Subject|2|||
155585923|NCT02554682|561570534|FG000|Overall Study|Lost to Follow-up|11|||
155585924|NCT02554682|561570535|FG001|Overall Study|Lost to Follow-up|9|||
155585925|NCT02554682|561570536|FG002|Overall Study|Lost to Follow-up|4|||
155585926|NCT02554682|561570537|FG003|Overall Study|Lost to Follow-up|3|||
155585927|NCT02554682|561570538|FG004|Overall Study|Lost to Follow-up|2|||
155585928|NCT02554682|561570539|FG005|Overall Study|Lost to Follow-up|1|||
155585929|NCT02554682|561570540|FG006|Overall Study|Lost to Follow-up|6|||
155585930|NCT02554682|561570541|FG007|Overall Study|Lost to Follow-up|6|||
155585931|NCT02554682|561570542|FG008|Overall Study|Lost to Follow-up|2|||
155585932|NCT02554682|561570543|FG009|Overall Study|Lost to Follow-up|2|||
155585933|NCT02554682|561570534|FG000|Overall Study|Withdrawal by Subject|2|||
155585934|NCT02554682|561570535|FG001|Overall Study|Withdrawal by Subject|1|||
155585935|NCT02554682|561570536|FG002|Overall Study|Withdrawal by Subject|0|||
155585936|NCT02554682|561570537|FG003|Overall Study|Withdrawal by Subject|0|||
155585937|NCT02554682|561570538|FG004|Overall Study|Withdrawal by Subject|0|||
155585938|NCT02554682|561570539|FG005|Overall Study|Withdrawal by Subject|0|||
155585939|NCT02554682|561570540|FG006|Overall Study|Withdrawal by Subject|0|||
155585940|NCT02554682|561570541|FG007|Overall Study|Withdrawal by Subject|0|||
155585941|NCT02554682|561570542|FG008|Overall Study|Withdrawal by Subject|0|||
155585942|NCT02554682|561570543|FG009|Overall Study|Withdrawal by Subject|0|||
155585943|NCT02554682|561570534|FG000|Overall Study|Physician Decision|2|||
155585944|NCT02554682|561570535|FG001|Overall Study|Physician Decision|2|||
155585945|NCT02554682|561570536|FG002|Overall Study|Physician Decision|0|||
155585946|NCT02554682|561570537|FG003|Overall Study|Physician Decision|0|||
155585947|NCT02554682|561570538|FG004|Overall Study|Physician Decision|0|||
155585948|NCT02554682|561570539|FG005|Overall Study|Physician Decision|0|||
155585949|NCT02554682|561570540|FG006|Overall Study|Physician Decision|0|||
155664962|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
155664963|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
155664964|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
155585950|NCT02554682|561570541|FG007|Overall Study|Physician Decision|0|||
155585951|NCT02554682|561570542|FG008|Overall Study|Physician Decision|0|||
155585952|NCT02554682|561570543|FG009|Overall Study|Physician Decision|0|||
155585953|NCT00884117|561570544|FG000|Overall Study|Adverse Event|2|||
155585954|NCT00884117|561570544|FG000|Overall Study|Withdrawal by Subject|89|||
155585955|NCT00884117|561570544|FG000|Overall Study|Death|3|||
155585956|NCT00884117|561570544|FG000|Overall Study|Lost to Follow-up|143|||
155585957|NCT00884117|561570544|FG000|Overall Study|Other|12|||
155585958|NCT01753310|561570545|FG000|Overall Study|Entered into open label extension study|25|||
155585959|NCT01753310|561570546|FG001|Overall Study|Entered into open label extension study|22|||
155585960|NCT01753310|561570545|FG000|Overall Study|Adverse Event|1|||
155585961|NCT01753310|561570546|FG001|Overall Study|Adverse Event|0|||
155585962|NCT01753310|561570545|FG000|Overall Study|Lost to Follow-up|2|||
155585963|NCT01753310|561570546|FG001|Overall Study|Lost to Follow-up|0|||
155585964|NCT01753310|561570545|FG000|Overall Study|Subject decision|2|||
155585965|NCT01753310|561570546|FG001|Overall Study|Subject decision|2|||
155585966|NCT01753310|561570545|FG000|Overall Study|Sponsor decision|1|||
155585967|NCT01753310|561570546|FG001|Overall Study|Sponsor decision|0|||
155585968|NCT01753310|561570545|FG000|Overall Study|Withdrawal by Subject|1|||
155585969|NCT01753310|561570546|FG001|Overall Study|Withdrawal by Subject|0|||
155585970|NCT01580670|561570547|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
155585971|NCT01580670|561570547|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
155585972|NCT05581641|561570548|FG000|Overall Study|Withdrawal by Subject|0|||
155585973|NCT05581641|561570549|FG001|Overall Study|Withdrawal by Subject|1|||
155585974|NCT05581641|561570550|FG002|Overall Study|Withdrawal by Subject|3|||
155585975|NCT05581641|561570551|FG003|Overall Study|Withdrawal by Subject|1|||
155585976|NCT05581641|561570548|FG000|Overall Study|Lost to Follow-up|0|||
155585977|NCT05581641|561570549|FG001|Overall Study|Lost to Follow-up|1|||
155585978|NCT05581641|561570550|FG002|Overall Study|Lost to Follow-up|0|||
155585979|NCT05581641|561570551|FG003|Overall Study|Lost to Follow-up|1|||
155585980|NCT05581641|561570548|FG000|Overall Study|Protocol Violation|1|||
155585981|NCT05581641|561570549|FG001|Overall Study|Protocol Violation|0|||
155585982|NCT05581641|561570550|FG002|Overall Study|Protocol Violation|0|||
155585983|NCT05581641|561570551|FG003|Overall Study|Protocol Violation|0|||
155585984|NCT05581641|561570548|FG000|Overall Study|Other|1|||
155585985|NCT05581641|561570549|FG001|Overall Study|Other|0|||
155585986|NCT05581641|561570550|FG002|Overall Study|Other|2|||
155585987|NCT05581641|561570551|FG003|Overall Study|Other|1|||
155585988|NCT04390763|561570552|FG000|Safety run-in Part|Adverse Event|4|||
155585989|NCT04390763|561570553|FG001|Safety run-in Part|Adverse Event|0|||
155585990|NCT04390763|561570554|FG002|Safety run-in Part|Adverse Event|0|||
155585991|NCT04390763|561570555|FG003|Safety run-in Part|Adverse Event|0|||
155585992|NCT04390763|561570552|FG000|Safety run-in Part|Physician Decision|1|||
155585993|NCT04390763|561570553|FG001|Safety run-in Part|Physician Decision|0|||
155585994|NCT04390763|561570554|FG002|Safety run-in Part|Physician Decision|0|||
155585995|NCT04390763|561570555|FG003|Safety run-in Part|Physician Decision|0|||
155585996|NCT04390763|561570552|FG000|Safety run-in Part|Progressive Disease|6|||
155585997|NCT04390763|561570553|FG001|Safety run-in Part|Progressive Disease|0|||
155585998|NCT04390763|561570554|FG002|Safety run-in Part|Progressive Disease|0|||
155585999|NCT04390763|561570555|FG003|Safety run-in Part|Progressive Disease|0|||
155586000|NCT04390763|561570552|FG000|Randomized Part|Adverse Event|0|||
155586001|NCT04390763|561570553|FG001|Randomized Part|Adverse Event|11|||
155586002|NCT04390763|561570554|FG002|Randomized Part|Adverse Event|5|||
155586003|NCT04390763|561570555|FG003|Randomized Part|Adverse Event|5|||
155586004|NCT04390763|561570552|FG000|Randomized Part|Death|0|||
155586005|NCT04390763|561570553|FG001|Randomized Part|Death|3|||
155586006|NCT04390763|561570554|FG002|Randomized Part|Death|4|||
155586007|NCT04390763|561570555|FG003|Randomized Part|Death|2|||
155586008|NCT04390763|561570552|FG000|Randomized Part|Physician Decision|0|||
155586009|NCT04390763|561570553|FG001|Randomized Part|Physician Decision|2|||
155586010|NCT04390763|561570554|FG002|Randomized Part|Physician Decision|2|||
155586011|NCT04390763|561570555|FG003|Randomized Part|Physician Decision|9|||
155586012|NCT04390763|561570552|FG000|Randomized Part|Progressive Disease|0|||
155586013|NCT04390763|561570553|FG001|Randomized Part|Progressive Disease|24|||
155586014|NCT04390763|561570554|FG002|Randomized Part|Progressive Disease|31|||
155586015|NCT04390763|561570555|FG003|Randomized Part|Progressive Disease|23|||
155586016|NCT04390763|561570552|FG000|Randomized Part|Study terminated by sponsor|0|||
155586017|NCT04390763|561570553|FG001|Randomized Part|Study terminated by sponsor|1|||
155586018|NCT04390763|561570554|FG002|Randomized Part|Study terminated by sponsor|0|||
155586019|NCT04390763|561570555|FG003|Randomized Part|Study terminated by sponsor|0|||
155586020|NCT04390763|561570552|FG000|Randomized Part|Participant Decision|0|||
155586021|NCT04390763|561570553|FG001|Randomized Part|Participant Decision|5|||
155586022|NCT04390763|561570554|FG002|Randomized Part|Participant Decision|7|||
155586023|NCT04390763|561570555|FG003|Randomized Part|Participant Decision|6|||
155586024|NCT04390763|561570552|FG000|Randomized Part|Not treated|0|||
155586025|NCT04390763|561570553|FG001|Randomized Part|Not treated|4|||
155586026|NCT04390763|561570554|FG002|Randomized Part|Not treated|2|||
155586027|NCT04390763|561570555|FG003|Randomized Part|Not treated|7|||
155586028|NCT01383174|561570558|FG000|3 Month Assessment|Death|0|||
155586029|NCT01383174|561570559|FG001|3 Month Assessment|Death|1|||
155586030|NCT01383174|561570558|FG000|3 Month Assessment|Lost to Follow-up|2|||
155586031|NCT01383174|561570559|FG001|3 Month Assessment|Lost to Follow-up|0|||
155586032|NCT01383174|561570558|FG000|3 Month Assessment|Refused to complete|4|||
155586033|NCT01383174|561570559|FG001|3 Month Assessment|Refused to complete|0|||
155664965|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
155664966|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
155664967|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
155664968|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
155664969|NCT00546481|561869099|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
155664970|NCT00546481|561869100|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
155664971|NCT00546481|561869101|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
155664972|NCT00546481|561869099|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
155664973|NCT00546481|561869100|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
155664974|NCT00546481|561869101|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
155664975|NCT00546481|561869099|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
155664976|NCT00546481|561869100|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
155664977|NCT00546481|561869101|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
155664978|NCT00546481|561869099|FG000|Maintenance Phase (CERA)|Other Reason|0|||
155664979|NCT00546481|561869100|FG001|Maintenance Phase (CERA)|Other Reason|0|||
155664980|NCT00546481|561869101|FG002|Maintenance Phase (CERA)|Other Reason|1|||
155664981|NCT00244621|561869104|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155664982|NCT00244621|561869105|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155664983|NCT00244621|561869106|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155664984|NCT00244621|561869104|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155664985|NCT00244621|561869105|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155664986|NCT00244621|561869106|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155664987|NCT00244621|561869104|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155664988|NCT00244621|561869105|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
155664989|NCT00244621|561869106|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155664990|NCT00244621|561869104|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
155664991|NCT00244621|561869105|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
155664992|NCT00244621|561869106|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
155664993|NCT00244621|561869104|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155664994|NCT00244621|561869105|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
155586034|NCT01383174|561570558|FG000|6 Month Assessment|Lost to Follow-up|1|||
155586035|NCT01383174|561570559|FG001|6 Month Assessment|Lost to Follow-up|1|||
155586036|NCT01383174|561570558|FG000|6 Month Assessment|Refused to complete|4|||
155586037|NCT01383174|561570559|FG001|6 Month Assessment|Refused to complete|0|||
155586038|NCT01153815|561570562|FG000|Overall Study|Adverse Event|3|||
155586039|NCT01153815|561570563|FG001|Overall Study|Adverse Event|1|||
155586040|NCT01153815|561570562|FG000|Overall Study|Withdrawal by Subject|6|||
155586041|NCT01153815|561570563|FG001|Overall Study|Withdrawal by Subject|4|||
155586042|NCT01786993|561570564|FG000|Overall Study|Death|6|||
155586043|NCT01786993|561570565|FG001|Overall Study|Death|7|||
155586044|NCT01786993|561570564|FG000|Overall Study|Withdrawal by Subject|3|||
155586045|NCT01786993|561570565|FG001|Overall Study|Withdrawal by Subject|2|||
155586046|NCT01786993|561570564|FG000|Overall Study|Lost to Follow-up|0|||
155586047|NCT01786993|561570565|FG001|Overall Study|Lost to Follow-up|1|||
155586048|NCT01786993|561570564|FG000|Overall Study|Subject Non-Compliance|1|||
155586049|NCT01786993|561570565|FG001|Overall Study|Subject Non-Compliance|0|||
155586050|NCT01786993|561570564|FG000|Overall Study|System Explant|1|||
155586051|NCT01786993|561570565|FG001|Overall Study|System Explant|0|||
155586052|NCT01786993|561570564|FG000|Overall Study|Hospice Admission|1|||
155586053|NCT01786993|561570565|FG001|Overall Study|Hospice Admission|0|||
155586054|NCT00450437|561570566|FG000|Overall Study|Withdrawal by Subject|10|||
155586055|NCT00450437|561570567|FG001|Overall Study|Withdrawal by Subject|2|||
155586056|NCT00450437|561570568|FG002|Overall Study|Withdrawal by Subject|0|||
155586057|NCT00450437|561570569|FG003|Overall Study|Withdrawal by Subject|1|||
155586058|NCT00450437|561570566|FG000|Overall Study|Lost to Follow-up|31|||
155586059|NCT00450437|561570567|FG001|Overall Study|Lost to Follow-up|12|||
155586060|NCT00450437|561570568|FG002|Overall Study|Lost to Follow-up|19|||
155586061|NCT00450437|561570569|FG003|Overall Study|Lost to Follow-up|9|||
155586062|NCT00450437|561570566|FG000|Overall Study|Protocol Violation|0|||
155586063|NCT00450437|561570567|FG001|Overall Study|Protocol Violation|1|||
155586064|NCT00450437|561570568|FG002|Overall Study|Protocol Violation|0|||
155586065|NCT00450437|561570569|FG003|Overall Study|Protocol Violation|1|||
155586066|NCT00450437|561570566|FG000|Overall Study|Inappropriate enrollment|4|||
155586067|NCT00450437|561570567|FG001|Overall Study|Inappropriate enrollment|1|||
155586068|NCT00450437|561570568|FG002|Overall Study|Inappropriate enrollment|3|||
155586069|NCT00450437|561570569|FG003|Overall Study|Inappropriate enrollment|0|||
155586070|NCT00450437|561570566|FG000|Overall Study|Administrative reason|0|||
155586071|NCT00450437|561570567|FG001|Overall Study|Administrative reason|0|||
155586072|NCT00450437|561570568|FG002|Overall Study|Administrative reason|1|||
155586073|NCT00450437|561570569|FG003|Overall Study|Administrative reason|0|||
155586074|NCT00450437|561570566|FG000|Overall Study|Unable to Classify|1|||
155586075|NCT00450437|561570567|FG001|Overall Study|Unable to Classify|0|||
155586076|NCT00450437|561570568|FG002|Overall Study|Unable to Classify|1|||
155586077|NCT00450437|561570569|FG003|Overall Study|Unable to Classify|0|||
155586078|NCT01890122|561570570|FG000|Overall Study|Adverse Event|1|||
155586079|NCT01890122|561570571|FG001|Overall Study|Adverse Event|1|||
155586080|NCT01890122|561570572|FG002|Overall Study|Adverse Event|1|||
155586081|NCT01890122|561570573|FG003|Overall Study|Adverse Event|2|||
155586082|NCT01890122|561570570|FG000|Overall Study|Major Protocol Deviation|3|||
155586083|NCT01890122|561570571|FG001|Overall Study|Major Protocol Deviation|1|||
155586084|NCT01890122|561570572|FG002|Overall Study|Major Protocol Deviation|0|||
155586085|NCT01890122|561570573|FG003|Overall Study|Major Protocol Deviation|1|||
155586086|NCT01890122|561570570|FG000|Overall Study|Lost to Follow-up|0|||
155586087|NCT01890122|561570571|FG001|Overall Study|Lost to Follow-up|1|||
155586088|NCT01890122|561570572|FG002|Overall Study|Lost to Follow-up|2|||
155586089|NCT01890122|561570573|FG003|Overall Study|Lost to Follow-up|2|||
155586090|NCT01890122|561570570|FG000|Overall Study|Voluntary Withdrawal|8|||
155586091|NCT01890122|561570571|FG001|Overall Study|Voluntary Withdrawal|8|||
155586092|NCT01890122|561570572|FG002|Overall Study|Voluntary Withdrawal|2|||
155586093|NCT01890122|561570573|FG003|Overall Study|Voluntary Withdrawal|11|||
155586094|NCT01890122|561570570|FG000|Overall Study|Lack of Efficacy|14|||
155586095|NCT01890122|561570571|FG001|Overall Study|Lack of Efficacy|24|||
155586096|NCT01890122|561570572|FG002|Overall Study|Lack of Efficacy|7|||
155664995|NCT00244621|561869106|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155664996|NCT00244621|561869104|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
155664997|NCT00244621|561869105|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155664998|NCT00244621|561869106|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155664999|NCT00244621|561869104|FG000|Open-label Treatment Period|Adverse Event|0|||
155665000|NCT00244621|561869105|FG001|Open-label Treatment Period|Adverse Event|0|||
155665001|NCT00244621|561869106|FG002|Open-label Treatment Period|Adverse Event|1|||
155665002|NCT00244621|561869104|FG000|Open-label Treatment Period|Moved abroad|0|||
155665003|NCT00244621|561869105|FG001|Open-label Treatment Period|Moved abroad|0|||
155665004|NCT00244621|561869106|FG002|Open-label Treatment Period|Moved abroad|1|||
155665005|NCT01193101|561869110|FG000|Overall Study|Adverse Event|0|||
155665006|NCT01193101|561869111|FG001|Overall Study|Adverse Event|1|||
155665007|NCT01193101|561869112|FG002|Overall Study|Adverse Event|1|||
155665008|NCT01193101|561869113|FG003|Overall Study|Adverse Event|3|||
155665009|NCT01193101|561869110|FG000|Overall Study|Lack of Efficacy|3|||
155665010|NCT01193101|561869111|FG001|Overall Study|Lack of Efficacy|1|||
155665011|NCT01193101|561869112|FG002|Overall Study|Lack of Efficacy|0|||
155665012|NCT01193101|561869113|FG003|Overall Study|Lack of Efficacy|8|||
155665013|NCT01193101|561869110|FG000|Overall Study|Withdrawal by Subject|2|||
155665014|NCT01193101|561869111|FG001|Overall Study|Withdrawal by Subject|4|||
155665015|NCT01193101|561869112|FG002|Overall Study|Withdrawal by Subject|1|||
155665016|NCT01193101|561869113|FG003|Overall Study|Withdrawal by Subject|1|||
155665017|NCT01193101|561869110|FG000|Overall Study|Administrative problems|0|||
155586097|NCT01890122|561570573|FG003|Overall Study|Lack of Efficacy|41|||
155586098|NCT01890122|561570570|FG000|Overall Study|Reason not Specified|0|||
155586099|NCT01890122|561570571|FG001|Overall Study|Reason not Specified|1|||
155586100|NCT01890122|561570572|FG002|Overall Study|Reason not Specified|1|||
155586101|NCT01890122|561570573|FG003|Overall Study|Reason not Specified|2|||
155586102|NCT01890122|561570570|FG000|Overall Study|Randomized but not Treated|1|||
155586103|NCT01890122|561570571|FG001|Overall Study|Randomized but not Treated|1|||
155586104|NCT01890122|561570572|FG002|Overall Study|Randomized but not Treated|0|||
155586105|NCT01890122|561570573|FG003|Overall Study|Randomized but not Treated|0|||
155586106|NCT03591874|561570575|FG000|Overall Study|Adverse Event|4|||
155586107|NCT03591874|561570576|FG001|Overall Study|Adverse Event|0|||
155586108|NCT03591874|561570575|FG000|Overall Study|Withdrawal by Subject|2|||
155586109|NCT03591874|561570576|FG001|Overall Study|Withdrawal by Subject|1|||
155586110|NCT03591874|561570575|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
155586111|NCT03591874|561570576|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
155586112|NCT03591874|561570575|FG000|Overall Study|On Study at Time of Study Termination|12|||
155586113|NCT03591874|561570576|FG001|Overall Study|On Study at Time of Study Termination|6|||
155586114|NCT00071110|561570579|FG000|Overall Study|Protocol Violation|0|||
155586115|NCT00071110|561570580|FG001|Overall Study|Protocol Violation|4|||
155586116|NCT02166333|561570582|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
155586117|NCT02166333|561570583|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155586118|NCT02166333|561570584|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155586119|NCT02166333|561570585|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155586120|NCT02166333|561570586|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
155586121|NCT02166333|561570587|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
155586122|NCT02166333|561570582|FG000|Stage 1|Death|4|||
155586123|NCT02166333|561570583|FG001|Stage 1|Death|0|||
155586124|NCT02166333|561570584|FG002|Stage 1|Death|2|||
155586125|NCT02166333|561570585|FG003|Stage 1|Death|0|||
155586126|NCT02166333|561570586|FG004|Stage 1|Death|3|||
155586127|NCT02166333|561570587|FG005|Stage 1|Death|2|||
155586128|NCT02166333|561570582|FG000|Stage 1|Lost to Follow-up|12|||
155586129|NCT02166333|561570583|FG001|Stage 1|Lost to Follow-up|0|||
155586130|NCT02166333|561570584|FG002|Stage 1|Lost to Follow-up|6|||
155586131|NCT02166333|561570585|FG003|Stage 1|Lost to Follow-up|0|||
155586132|NCT02166333|561570586|FG004|Stage 1|Lost to Follow-up|3|||
155586133|NCT02166333|561570587|FG005|Stage 1|Lost to Follow-up|3|||
155586134|NCT02166333|561570582|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
155586135|NCT02166333|561570583|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
155586136|NCT02166333|561570584|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
155586137|NCT02166333|561570585|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
155586138|NCT02166333|561570586|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
155586139|NCT02166333|561570587|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
155586140|NCT02166333|561570582|FG000|Stage 2|Death|4|||
155586141|NCT02166333|561570583|FG001|Stage 2|Death|2|||
155586142|NCT02166333|561570584|FG002|Stage 2|Death|1|||
155586143|NCT02166333|561570585|FG003|Stage 2|Death|0|||
155586144|NCT02166333|561570586|FG004|Stage 2|Death|0|||
155586145|NCT02166333|561570587|FG005|Stage 2|Death|1|||
155586146|NCT02166333|561570582|FG000|Stage 2|Lost to Follow-up|23|||
155586147|NCT02166333|561570583|FG001|Stage 2|Lost to Follow-up|4|||
155586148|NCT02166333|561570584|FG002|Stage 2|Lost to Follow-up|11|||
155586149|NCT02166333|561570585|FG003|Stage 2|Lost to Follow-up|9|||
155586150|NCT02166333|561570586|FG004|Stage 2|Lost to Follow-up|3|||
155586151|NCT02166333|561570587|FG005|Stage 2|Lost to Follow-up|6|||
155586152|NCT00503698|561570588|FG000|Overall Study|Protocol Violation|5|||
155586153|NCT00503698|561570589|FG001|Overall Study|Protocol Violation|6|||
155586154|NCT00503698|561570588|FG000|Overall Study|Adverse Event|52|||
155586155|NCT00503698|561570589|FG001|Overall Study|Adverse Event|41|||
155586156|NCT00503698|561570588|FG000|Overall Study|Death|1|||
155586157|NCT00503698|561570589|FG001|Overall Study|Death|0|||
155586158|NCT00503698|561570588|FG000|Overall Study|Lack of Efficacy|3|||
155586159|NCT00503698|561570589|FG001|Overall Study|Lack of Efficacy|4|||
155586160|NCT00503698|561570588|FG000|Overall Study|Trial terminated|216|||
155586161|NCT00503698|561570589|FG001|Overall Study|Trial terminated|253|||
155586162|NCT00503698|561570588|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
155586163|NCT00503698|561570589|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
155586164|NCT00503698|561570588|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
155586165|NCT00503698|561570589|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
155586166|NCT00503698|561570588|FG000|Overall Study|Any condition in exclusion criteria|4|||
155586167|NCT00503698|561570589|FG001|Overall Study|Any condition in exclusion criteria|6|||
155586168|NCT00503698|561570588|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
155586169|NCT00503698|561570589|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
155586170|NCT00503698|561570588|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
155586171|NCT00503698|561570589|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
155586172|NCT00503698|561570588|FG000|Overall Study|Critically ill|2|||
155586173|NCT00503698|561570589|FG001|Overall Study|Critically ill|0|||
155586174|NCT00503698|561570588|FG000|Overall Study|Unclassified|48|||
155586175|NCT00503698|561570589|FG001|Overall Study|Unclassified|32|||
155586176|NCT00503698|561570588|FG000|Overall Study|Not exposed to trial drug|11|||
155586177|NCT00503698|561570589|FG001|Overall Study|Not exposed to trial drug|6|||
155586178|NCT02269098|561570590|FG000|Overall Study|Lost to Follow-up|14|||
155586179|NCT02269098|561570591|FG001|Overall Study|Lost to Follow-up|9|||
155586180|NCT03644342|561570596|FG000|Overall Study|Adverse Event|2|||
155586181|NCT03644342|561570597|FG001|Overall Study|Adverse Event|0|||
155586182|NCT03644342|561570596|FG000|Overall Study|Protocol Violation|0|||
155586183|NCT03644342|561570597|FG001|Overall Study|Protocol Violation|1|||
155586184|NCT02259010|561570598|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
155586185|NCT03655405|561570599|FG000|Overall Study|Death after initial data collection|4|||
155586186|NCT03655405|561570600|FG001|Overall Study|Death after initial data collection|2|||
155586187|NCT03655405|561570599|FG000|Overall Study|Died before initial data collection|1|||
155665018|NCT01193101|561869111|FG001|Overall Study|Administrative problems|0|||
155586188|NCT03655405|561570600|FG001|Overall Study|Died before initial data collection|2|||
155586189|NCT03655405|561570599|FG000|Overall Study|Protocol Violation|0|||
155586190|NCT03655405|561570600|FG001|Overall Study|Protocol Violation|1|||
155586191|NCT01991743|561570601|FG000|Overall Study|external cephalic version not performed|0|||
155586192|NCT01991743|561570602|FG001|Overall Study|external cephalic version not performed|0|||
155586193|NCT01991743|561570603|FG002|Overall Study|external cephalic version not performed|1|||
155586194|NCT01991743|561570604|FG003|Overall Study|external cephalic version not performed|0|||
155586195|NCT04390113|561570605|FG000|Overall Study|Not Treated|0|||
155665019|NCT01193101|561869112|FG002|Overall Study|Administrative problems|1|||
155586196|NCT04390113|561570606|FG001|Overall Study|Not Treated|1|||
155586197|NCT04390113|561570605|FG000|Overall Study|Adverse Event|1|||
155586198|NCT04390113|561570606|FG001|Overall Study|Adverse Event|0|||
155586199|NCT04390113|561570605|FG000|Overall Study|Death|2|||
155586200|NCT04390113|561570606|FG001|Overall Study|Death|1|||
155586201|NCT04390113|561570605|FG000|Overall Study|Physician Decision|1|||
155586202|NCT04390113|561570606|FG001|Overall Study|Physician Decision|3|||
155586203|NCT04390113|561570605|FG000|Overall Study|Study Terminated by Sponsor|5|||
155586204|NCT04390113|561570606|FG001|Overall Study|Study Terminated by Sponsor|3|||
155586205|NCT04390113|561570605|FG000|Overall Study|Withdrawal by Subject|10|||
155586206|NCT04390113|561570606|FG001|Overall Study|Withdrawal by Subject|5|||
155586207|NCT04390113|561570605|FG000|Overall Study|Other|1|||
155586208|NCT04390113|561570606|FG001|Overall Study|Other|0|||
155586209|NCT04390113|561570605|FG000|Overall Study|Missing|0|||
155586210|NCT04390113|561570606|FG001|Overall Study|Missing|1|||
155586211|NCT01682226|561571806|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
155586212|NCT01682226|561571806|FG000|Overall Study|Participants did not receive treatment|2|||
155586213|NCT01682226|561571806|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
155586214|NCT03521154|561571807|FG000|Overall Study|Ongoing study at data cut-off|111|||
155586215|NCT03521154|561571808|FG001|Overall Study|Ongoing study at data cut-off|52|||
155586216|NCT05386680|561571809|FG000|Overall Study|Guardian decision|2|||
155586217|NCT04168112|561571812|FG000|Overall Study|Lost to Follow-up|1|||
155586218|NCT04168112|561571813|FG001|Overall Study|Lost to Follow-up|0|||
155586219|NCT04168112|561571812|FG000|Overall Study|Withdrawal by Subject|1|||
155586220|NCT04168112|561571813|FG001|Overall Study|Withdrawal by Subject|0|||
155586221|NCT00455403|561571814|FG000|Overall Study|Lost to Follow-up|2|||
155586222|NCT00455403|561571815|FG001|Overall Study|Lost to Follow-up|1|||
155586223|NCT00455403|561571814|FG000|Overall Study|Withdrawal by Subject|1|||
155586224|NCT00455403|561571815|FG001|Overall Study|Withdrawal by Subject|3|||
155586225|NCT00455403|561571814|FG000|Overall Study|Protocol Violation|0|||
155586226|NCT00455403|561571815|FG001|Overall Study|Protocol Violation|2|||
155586227|NCT00449865|561571816|FG000|Overall Study|Withdrawal by Subject|110|||
155586228|NCT00449865|561571817|FG001|Overall Study|Withdrawal by Subject|110|||
155586229|NCT00449865|561571816|FG000|Overall Study|Lost to Follow-up|36|||
155586230|NCT00449865|561571817|FG001|Overall Study|Lost to Follow-up|37|||
155586231|NCT00449865|561571816|FG000|Overall Study|Physician Decision|13|||
155586232|NCT00449865|561571817|FG001|Overall Study|Physician Decision|12|||
155586233|NCT00449865|561571816|FG000|Overall Study|Death|31|||
155586234|NCT00449865|561571817|FG001|Overall Study|Death|40|||
155586235|NCT00449865|561571816|FG000|Overall Study|Protocol Violation|8|||
155586236|NCT00449865|561571817|FG001|Overall Study|Protocol Violation|7|||
155586237|NCT00449865|561571816|FG000|Overall Study|Study was stopped|324|||
155586238|NCT00449865|561571817|FG001|Overall Study|Study was stopped|328|||
155586239|NCT00171210|561571818|FG000|Overall Study|Adverse Event|16|||
155586240|NCT00171210|561571819|FG001|Overall Study|Adverse Event|27|||
155586241|NCT00171210|561571818|FG000|Overall Study|Abnormal laboratory value(s)|6|||
155586242|NCT00171210|561571819|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155586243|NCT00171210|561571818|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155586244|NCT00171210|561571819|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155586245|NCT00171210|561571818|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
155586246|NCT00171210|561571819|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
155586247|NCT00171210|561571818|FG000|Overall Study|Protocol Violation|0|||
155586248|NCT00171210|561571819|FG001|Overall Study|Protocol Violation|2|||
155586249|NCT00171210|561571818|FG000|Overall Study|Withdrawal by Subject|32|||
155586250|NCT00171210|561571819|FG001|Overall Study|Withdrawal by Subject|30|||
155586251|NCT00171210|561571818|FG000|Overall Study|Lost to Follow-up|1|||
155586252|NCT00171210|561571819|FG001|Overall Study|Lost to Follow-up|0|||
155586253|NCT00171210|561571818|FG000|Overall Study|Administrative problems|1|||
155586254|NCT00171210|561571819|FG001|Overall Study|Administrative problems|1|||
155665020|NCT01193101|561869113|FG003|Overall Study|Administrative problems|0|||
155586255|NCT00171210|561571818|FG000|Overall Study|Death|2|||
155586256|NCT00171210|561571819|FG001|Overall Study|Death|3|||
155665021|NCT01193101|561869110|FG000|Overall Study|Abnormal test procedure results|0|||
155586257|NCT00171210|561571818|FG000|Overall Study|Stopped at end of core|0|||
155586258|NCT00171210|561571819|FG001|Overall Study|Stopped at end of core|32|||
155586259|NCT00171210|561571818|FG000|Overall Study|Stopped at end of extension 1|0|||
155586260|NCT00171210|561571819|FG001|Overall Study|Stopped at end of extension 1|1|||
155586261|NCT03252535|561571821|FG000|Overall Study|Withdrawal by Subject|1|||
155586262|NCT03252535|561571822|FG001|Overall Study|Withdrawal by Subject|0|||
155586263|NCT03252535|561571823|FG002|Overall Study|Withdrawal by Subject|0|||
155586264|NCT03252535|561571821|FG000|Overall Study|Physician Decision|0|||
155586265|NCT03252535|561571822|FG001|Overall Study|Physician Decision|1|||
155586266|NCT03252535|561571823|FG002|Overall Study|Physician Decision|0|||
155586267|NCT03252535|561571821|FG000|Overall Study|Met discontinuation criteria|0|||
155586268|NCT03252535|561571822|FG001|Overall Study|Met discontinuation criteria|1|||
155586269|NCT03252535|561571823|FG002|Overall Study|Met discontinuation criteria|0|||
155586270|NCT00442897|561571831|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
155586271|NCT00442897|561571832|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
155586272|NCT00442897|561571831|FG000|Base Study (12 Week Follow-up)|Death|0|||
155586273|NCT00442897|561571832|FG001|Base Study (12 Week Follow-up)|Death|1|||
155586274|NCT00442897|561571831|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
155586275|NCT00442897|561571832|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
155586276|NCT00442897|561571831|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
155586277|NCT00442897|561571832|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
155586278|NCT00442897|561571831|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
155586279|NCT00442897|561571832|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
155586280|NCT00442897|561571831|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
155586281|NCT00442897|561571832|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
155586282|NCT00442897|561571831|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
155586283|NCT00442897|561571832|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
155586284|NCT00442897|561571831|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
155586285|NCT00442897|561571832|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
155586286|NCT04498182|561571834|FG000|Overall Study|Adverse Event|2|||
155586287|NCT04498182|561571835|FG001|Overall Study|Adverse Event|3|||
155586288|NCT04498182|561571836|FG002|Overall Study|Adverse Event|2|||
155586289|NCT04498182|561571834|FG000|Overall Study|Withdrawal of Consent|3|||
155586290|NCT04498182|561571835|FG001|Overall Study|Withdrawal of Consent|4|||
155586291|NCT04498182|561571836|FG002|Overall Study|Withdrawal of Consent|3|||
155586292|NCT04498182|561571834|FG000|Overall Study|Non-Compliant|1|||
155586293|NCT04498182|561571835|FG001|Overall Study|Non-Compliant|0|||
155586294|NCT04498182|561571836|FG002|Overall Study|Non-Compliant|1|||
155586295|NCT04498182|561571834|FG000|Overall Study|Lost to Follow-up|0|||
155586296|NCT04498182|561571835|FG001|Overall Study|Lost to Follow-up|0|||
155586297|NCT04498182|561571836|FG002|Overall Study|Lost to Follow-up|1|||
155586298|NCT04498182|561571834|FG000|Overall Study|Investigator Decision|0|||
155586299|NCT04498182|561571835|FG001|Overall Study|Investigator Decision|0|||
155586300|NCT04498182|561571836|FG002|Overall Study|Investigator Decision|1|||
155586301|NCT04498182|561571834|FG000|Overall Study|Protocol Violation|1|||
155586302|NCT04498182|561571835|FG001|Overall Study|Protocol Violation|0|||
155586303|NCT04498182|561571836|FG002|Overall Study|Protocol Violation|2|||
155586304|NCT02182843|561571838|FG000|Overall Study|Withdrawal by Subject|7|||
155586305|NCT02182843|561571838|FG000|Overall Study|Lost to Follow-up|2|||
155586306|NCT02182843|561571838|FG000|Overall Study|Adverse Event|1|||
155586307|NCT02187198|561571848|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
155586308|NCT02187198|561571849|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
155586309|NCT02187198|561571848|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
155586310|NCT02187198|561571849|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
155586311|NCT01532518|561571850|FG000|Overall Study|Withdrawal by Subject|0|||
155586312|NCT01532518|561571851|FG001|Overall Study|Withdrawal by Subject|0|||
155586313|NCT01532518|561571852|FG002|Overall Study|Withdrawal by Subject|1|||
155586314|NCT06509438|561571853|FG000|Overall Study|Adverse Event|1|||
155586315|NCT06509438|561571853|FG000|Overall Study|Lost to Follow-up|3|||
155586316|NCT00952068|561571854|FG000|Overall Study|Adverse Event|3|||
155586317|NCT00952068|561571854|FG000|Overall Study|Withdrawal by Subject|4|||
155586318|NCT00488644|561571855|FG000|Overall Study|Not Eligible|1|||
155586319|NCT00488644|561571855|FG000|Overall Study|Not Evaluable|1|||
155586320|NCT04025879|561571856|FG000|Randomization|Participant withdrew consent|0|||
155586321|NCT04025879|561571857|FG001|Randomization|Participant withdrew consent|1|||
155586322|NCT04025879|561571856|FG000|Randomization|Participant no longer met study criteria|1|||
155586323|NCT04025879|561571857|FG001|Randomization|Participant no longer met study criteria|1|||
155586324|NCT04025879|561571856|FG000|Treatment|Ongoing treatment|10|||
155586325|NCT04025879|561571857|FG001|Treatment|Ongoing treatment|8|||
155586326|NCT04025879|561571856|FG000|Treatment|Disease progression/recurrence|36|||
155586327|NCT04025879|561571857|FG001|Treatment|Disease progression/recurrence|72|||
155586328|NCT04025879|561571856|FG000|Treatment|Study drug toxicity|36|||
155586329|NCT04025879|561571857|FG001|Treatment|Study drug toxicity|13|||
155586330|NCT04025879|561571856|FG000|Treatment|Death|2|||
155586331|NCT04025879|561571857|FG001|Treatment|Death|0|||
155586332|NCT04025879|561571856|FG000|Treatment|Adverse event unrelated to study drug|21|||
155586333|NCT04025879|561571857|FG001|Treatment|Adverse event unrelated to study drug|14|||
155586334|NCT04025879|561571856|FG000|Treatment|Participant request to discontinue study treatment|16|||
155586335|NCT04025879|561571857|FG001|Treatment|Participant request to discontinue study treatment|8|||
155586336|NCT04025879|561571856|FG000|Treatment|Participant withdrew consent|1|||
155586337|NCT04025879|561571857|FG001|Treatment|Participant withdrew consent|3|||
155586338|NCT04025879|561571856|FG000|Treatment|Participant no longer meets study criteria|3|||
155586339|NCT04025879|561571857|FG001|Treatment|Participant no longer meets study criteria|2|||
155586340|NCT04025879|561571856|FG000|Treatment|Lost to Follow-up|1|||
155586341|NCT04025879|561571857|FG001|Treatment|Lost to Follow-up|0|||
155586342|NCT04025879|561571856|FG000|Treatment|Other reasons|15|||
155586343|NCT04025879|561571857|FG001|Treatment|Other reasons|17|||
155586344|NCT04025879|561571856|FG000|Treatment|Administrative reason by sponsor|0|||
155586345|NCT04025879|561571857|FG001|Treatment|Administrative reason by sponsor|1|||
155586346|NCT04025879|561571856|FG000|Treatment|Not reported|2|||
155586347|NCT04025879|561571857|FG001|Treatment|Not reported|0|||
155586348|NCT03194542|561571864|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
155586349|NCT03194542|561571865|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155586350|NCT03194542|561571866|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155586351|NCT03194542|561571867|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155586352|NCT03194542|561571864|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
155586353|NCT03194542|561571865|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
155586354|NCT03194542|561571866|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
155586355|NCT03194542|561571867|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
155586356|NCT03194542|561571864|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
155586357|NCT03194542|561571865|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
155586358|NCT03194542|561571866|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
155586359|NCT03194542|561571867|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
155586360|NCT03194542|561571864|FG000|Overall Study|Loss of Response|4|||
155586361|NCT03194542|561571865|FG001|Overall Study|Loss of Response|2|||
155586362|NCT03194542|561571866|FG002|Overall Study|Loss of Response|3|||
155586363|NCT03194542|561571867|FG003|Overall Study|Loss of Response|4|||
155586364|NCT03194542|561571864|FG000|Overall Study|Physician Decision|0|||
155586365|NCT03194542|561571865|FG001|Overall Study|Physician Decision|1|||
155586366|NCT03194542|561571866|FG002|Overall Study|Physician Decision|0|||
155586367|NCT03194542|561571867|FG003|Overall Study|Physician Decision|0|||
155586368|NCT03194542|561571864|FG000|Overall Study|Lack of Efficacy|2|||
155586369|NCT03194542|561571865|FG001|Overall Study|Lack of Efficacy|2|||
155586370|NCT03194542|561571866|FG002|Overall Study|Lack of Efficacy|2|||
155586371|NCT03194542|561571867|FG003|Overall Study|Lack of Efficacy|6|||
155586372|NCT03194542|561571864|FG000|Overall Study|Withdrawal by Subject|2|||
155586373|NCT03194542|561571865|FG001|Overall Study|Withdrawal by Subject|1|||
155586374|NCT03194542|561571866|FG002|Overall Study|Withdrawal by Subject|5|||
155586375|NCT03194542|561571867|FG003|Overall Study|Withdrawal by Subject|4|||
155586376|NCT03194542|561571864|FG000|Overall Study|Progressive Disease|1|||
155586377|NCT03194542|561571865|FG001|Overall Study|Progressive Disease|0|||
155586378|NCT03194542|561571866|FG002|Overall Study|Progressive Disease|1|||
155586379|NCT03194542|561571867|FG003|Overall Study|Progressive Disease|1|||
155586380|NCT03194542|561571864|FG000|Overall Study|Adverse Event|1|||
155586381|NCT03194542|561571865|FG001|Overall Study|Adverse Event|2|||
155586382|NCT03194542|561571866|FG002|Overall Study|Adverse Event|0|||
155586383|NCT03194542|561571867|FG003|Overall Study|Adverse Event|5|||
155586384|NCT03194542|561571864|FG000|Overall Study|Death|1|||
155586385|NCT03194542|561571865|FG001|Overall Study|Death|2|||
155586386|NCT03194542|561571866|FG002|Overall Study|Death|0|||
155586387|NCT03194542|561571867|FG003|Overall Study|Death|5|||
155586388|NCT03194542|561571864|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
155586389|NCT03194542|561571865|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
155586390|NCT03194542|561571866|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
155586391|NCT03194542|561571867|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
155586392|NCT02712554|561571870|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
155586393|NCT02712554|561571871|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
155586394|NCT02712554|561571870|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
155586395|NCT02712554|561571871|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
155586396|NCT02712554|561571870|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
155586397|NCT02712554|561571871|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
155586398|NCT02712554|561571870|FG000|Part B: Qualification Phase|Adverse Event|0|||
155586399|NCT02712554|561571871|FG001|Part B: Qualification Phase|Adverse Event|1|||
155665022|NCT01193101|561869111|FG001|Overall Study|Abnormal test procedure results|1|||
155665023|NCT01193101|561869112|FG002|Overall Study|Abnormal test procedure results|0|||
155665024|NCT01193101|561869113|FG003|Overall Study|Abnormal test procedure results|0|||
155665025|NCT02347085|561869114|FG000|Overall Study|Adverse Event|2|||
155665026|NCT02347085|561869114|FG000|Overall Study|Lack of Efficacy|1|||
155665027|NCT02347085|561869114|FG000|Overall Study|Withdrawal by Subject|4|||
155665028|NCT02347085|561869114|FG000|Overall Study|Lost to Follow-up|1|||
155665029|NCT02347085|561869114|FG000|Overall Study|Protocol Criteria|2|||
155665030|NCT02271529|561869115|FG000|Overall Study|Withdrawal by Subject|1|||
155665031|NCT03508050|561869117|FG000|Overall Study|Pleural adhesions|1|||
155665032|NCT03508050|561869118|FG001|Overall Study|Pleural adhesions|0|||
155665033|NCT03508050|561869117|FG000|Overall Study|Mucus plug|1|||
155665034|NCT03508050|561869118|FG001|Overall Study|Mucus plug|0|||
155665035|NCT03508050|561869117|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
155665036|NCT03508050|561869118|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
155665037|NCT03508050|561869117|FG000|Overall Study|Sustained desaturation|0|||
155665038|NCT03508050|561869118|FG001|Overall Study|Sustained desaturation|1|||
155665039|NCT00950651|561869123|FG000|Overall Study|Adverse Event|17|||
155665040|NCT00950651|561869124|FG001|Overall Study|Adverse Event|20|||
155665041|NCT00950651|561869123|FG000|Overall Study|Death|1|||
155665042|NCT00950651|561869124|FG001|Overall Study|Death|0|||
155665043|NCT00950651|561869123|FG000|Overall Study|Lack of Efficacy|2|||
155665044|NCT00950651|561869124|FG001|Overall Study|Lack of Efficacy|2|||
155665045|NCT00950651|561869123|FG000|Overall Study|Protocol Violation|3|||
155665046|NCT00950651|561869124|FG001|Overall Study|Protocol Violation|4|||
155665047|NCT00950651|561869123|FG000|Overall Study|Withdrawal by Subject|8|||
155665048|NCT00950651|561869124|FG001|Overall Study|Withdrawal by Subject|9|||
155665049|NCT00776789|561869127|FG000|Overall Study|Consent refusal|2|||
155665050|NCT00776789|561869128|FG001|Overall Study|Consent refusal|2|||
155665051|NCT00776789|561869127|FG000|Overall Study|Poor quality video|1|||
155665052|NCT00776789|561869128|FG001|Overall Study|Poor quality video|1|||
155665053|NCT00570713|561869129|FG000|Overall Study|Adverse Event|16|||
155665054|NCT00570713|561869130|FG001|Overall Study|Adverse Event|9|||
155665055|NCT00570713|561869129|FG000|Overall Study|Death|7|||
155665056|NCT00570713|561869130|FG001|Overall Study|Death|7|||
155665057|NCT00570713|561869129|FG000|Overall Study|Lack of Efficacy|40|||
155665058|NCT00570713|561869130|FG001|Overall Study|Lack of Efficacy|49|||
155665059|NCT00570713|561869129|FG000|Overall Study|Physician Decision|2|||
155665060|NCT00570713|561869130|FG001|Overall Study|Physician Decision|2|||
155665061|NCT00570713|561869129|FG000|Overall Study|Withdrawal by Subject|3|||
155665062|NCT00570713|561869130|FG001|Overall Study|Withdrawal by Subject|3|||
155665063|NCT00570713|561869129|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
155665064|NCT00570713|561869130|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
155665065|NCT03289533|561869131|FG000|Overall Study|Death|12|||
155665066|NCT03289533|561869131|FG000|Overall Study|Terminated from study by sponsor|10|||
155665067|NCT00539240|561869132|FG000|Overall Study|Withdrawal by Subject|0|||
155665068|NCT00539240|561869133|FG001|Overall Study|Withdrawal by Subject|2|||
155665069|NCT00539240|561869134|FG002|Overall Study|Withdrawal by Subject|0|||
155665070|NCT00539240|561869132|FG000|Overall Study|Protocol Violation|1|||
155665071|NCT00539240|561869133|FG001|Overall Study|Protocol Violation|1|||
155665072|NCT00539240|561869134|FG002|Overall Study|Protocol Violation|4|||
155665073|NCT00539240|561869132|FG000|Overall Study|Lost to Follow-up|2|||
155665074|NCT00539240|561869133|FG001|Overall Study|Lost to Follow-up|3|||
155665075|NCT00539240|561869134|FG002|Overall Study|Lost to Follow-up|1|||
155665076|NCT00539240|561869132|FG000|Overall Study|Adverse Event|3|||
155665077|NCT00539240|561869133|FG001|Overall Study|Adverse Event|1|||
155665078|NCT00539240|561869134|FG002|Overall Study|Adverse Event|10|||
155665079|NCT00902330|561869135|FG000|Overall Study|Too overwhelmed by treatment|2|||
155665080|NCT00902330|561869136|FG001|Overall Study|Too overwhelmed by treatment|5|||
155665081|NCT00902330|561869135|FG000|Overall Study|Adverse Event|1|||
155665082|NCT00902330|561869136|FG001|Overall Study|Adverse Event|0|||
155665083|NCT00902330|561869135|FG000|Overall Study|No post baseline data|1|||
155665084|NCT00902330|561869136|FG001|Overall Study|No post baseline data|0|||
155665085|NCT01816048|561869137|FG000|Overall Study|Adverse Event|1|||
155665086|NCT01816048|561869137|FG000|Overall Study|Death|1|||
155665087|NCT01816048|561869137|FG000|Overall Study|Withdrawal by Subject|1|||
155665088|NCT01816048|561869137|FG000|Overall Study|Disease Progression|3|||
155586400|NCT02712554|561571870|FG000|Part B: Treatment Phase|Adverse Event|0|||
155586401|NCT02712554|561571871|FG001|Part B: Treatment Phase|Adverse Event|1|||
155586402|NCT02712554|561571870|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
155586403|NCT02712554|561571871|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
155586404|NCT02712554|561571870|FG000|Part B: Treatment Phase|Other|0|||
155586405|NCT02712554|561571871|FG001|Part B: Treatment Phase|Other|1|||
155586406|NCT02503540|561571873|FG000|Overall Study|Death|2|||
155586407|NCT02503540|561571873|FG000|Overall Study|Withdrawal by Subject|1|||
155586408|NCT00979654|561571876|FG000|Overall Study|Lost to Follow-up|1|||
155586409|NCT00979654|561571876|FG000|Overall Study|Withdrawal by Subject|22|||
155586410|NCT00979654|561571876|FG000|Overall Study|Death|1|||
155586411|NCT00979654|561571876|FG000|Overall Study|Lack of Efficacy|6|||
155586412|NCT00979654|561571876|FG000|Overall Study|Adverse Event|1|||
155586413|NCT00979654|561571876|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
155586414|NCT00979654|561571876|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
155586415|NCT00979654|561571876|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
155586416|NCT00979654|561571876|FG000|Overall Study|Serious Adverse Event|1|||
155586417|NCT00979654|561571876|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
155586418|NCT01445730|561571880|FG000|Overall Study|Adverse Event|1|||
155586419|NCT01445730|561571880|FG000|Overall Study|For the advice of a dentist|1|||
155586420|NCT01445730|561571880|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
155586421|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
155586422|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
155586423|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
155586424|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
155586425|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
155586426|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
155586427|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
155586428|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
155586429|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
155586430|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
155586431|NCT03711786|561571881|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
155586432|NCT03711786|561571882|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
155586433|NCT01611883|561571883|FG000|Overall Study|Adverse Event|1|||
155586434|NCT01611883|561571884|FG001|Overall Study|Adverse Event|1|||
155586435|NCT00030901|561571886|FG000|Initial Registration|Ineligible|167|||
155586436|NCT00030901|561571887|FG001|Initial Registration|Ineligible|0|||
155586437|NCT00030901|561571888|FG002|Initial Registration|Ineligible|0|||
155586438|NCT00030901|561571886|FG000|Randomization|Adverse Event|0|||
155586439|NCT00030901|561571887|FG001|Randomization|Adverse Event|11|||
155586440|NCT00030901|561571888|FG002|Randomization|Adverse Event|7|||
155586441|NCT00030901|561571886|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
155586442|NCT00030901|561571887|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
155586443|NCT00030901|561571888|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
155586444|NCT00030901|561571886|FG000|Randomization|Progression/Relapse|0|||
155586445|NCT00030901|561571887|FG001|Randomization|Progression/Relapse|22|||
155586446|NCT00030901|561571888|FG002|Randomization|Progression/Relapse|21|||
155586447|NCT00030901|561571886|FG000|Randomization|Death|0|||
155586448|NCT00030901|561571887|FG001|Randomization|Death|1|||
155586449|NCT00030901|561571888|FG002|Randomization|Death|3|||
155586450|NCT00030901|561571886|FG000|Randomization|Other|0|||
155586451|NCT00030901|561571887|FG001|Randomization|Other|36|||
155586452|NCT00030901|561571888|FG002|Randomization|Other|33|||
155586453|NCT00030901|561571886|FG000|Randomization|Ineligible|0|||
155586454|NCT00030901|561571887|FG001|Randomization|Ineligible|15|||
155586455|NCT00030901|561571888|FG002|Randomization|Ineligible|14|||
155586456|NCT02576847|561571891|FG000|Overall Study|Adverse Event|27|||
155586457|NCT02576847|561571891|FG000|Overall Study|Lost to Follow-up|22|||
155586458|NCT02576847|561571891|FG000|Overall Study|Physician Decision|1|||
155586459|NCT02576847|561571891|FG000|Overall Study|Pregnancy|1|||
155586460|NCT02576847|561571891|FG000|Overall Study|Protocol Violation|3|||
155586461|NCT02576847|561571891|FG000|Overall Study|Withdrawal by Subject|78|||
155586462|NCT02576847|561571891|FG000|Overall Study|Other|5|||
155586463|NCT01806051|561571892|FG000|Overall Study|Withdrawal by Subject|6|||
155586464|NCT02418182|561571895|FG000|Overall Study|Unable to re-consent|18|||
155586465|NCT02418182|561571896|FG001|Overall Study|Unable to re-consent|15|||
155586466|NCT02418182|561571895|FG000|Overall Study|Lost to Follow-up|0|||
155586467|NCT02418182|561571896|FG001|Overall Study|Lost to Follow-up|2|||
155586468|NCT00734994|561571897|FG000|Overall Study|Withdrawal by Subject|1|||
155586469|NCT04031846|561571900|FG000|Overall Study|Lost to Follow-up|4|||
155586470|NCT04031846|561571901|FG001|Overall Study|Lost to Follow-up|4|||
155586471|NCT04031846|561571900|FG000|Overall Study|Physician Decision|0|||
155586472|NCT04031846|561571901|FG001|Overall Study|Physician Decision|1|||
155586473|NCT04031846|561571900|FG000|Overall Study|Protocol Violation|1|||
155586474|NCT04031846|561571901|FG001|Overall Study|Protocol Violation|1|||
155586475|NCT04031846|561571900|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
155586476|NCT04031846|561571901|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
155586477|NCT02431676|561571902|FG000|Overall Study|no lab obtained|0|||
155586478|NCT02431676|561571903|FG001|Overall Study|no lab obtained|1|||
155586479|NCT02431676|561571904|FG002|Overall Study|no lab obtained|2|||
155586480|NCT01622673|561571905|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155586481|NCT01622673|561571906|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155586482|NCT01622673|561571907|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155586483|NCT01622673|561571908|FG003|Treatment Period 1|Withdrawal by Subject|1|||
155586484|NCT01622673|561571909|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155586485|NCT01622673|561571910|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155586486|NCT01622673|561571905|FG000|Treatment Period 1|Protocol Violation|0|||
155586487|NCT01622673|561571906|FG001|Treatment Period 1|Protocol Violation|1|||
155586488|NCT01622673|561571907|FG002|Treatment Period 1|Protocol Violation|0|||
155586489|NCT01622673|561571908|FG003|Treatment Period 1|Protocol Violation|0|||
155586490|NCT01622673|561571909|FG004|Treatment Period 1|Protocol Violation|0|||
155586491|NCT01622673|561571910|FG005|Treatment Period 1|Protocol Violation|0|||
155586492|NCT01622673|561571905|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155586493|NCT01622673|561571906|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155586494|NCT01622673|561571907|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155586495|NCT01622673|561571908|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155586496|NCT01622673|561571909|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155586497|NCT01622673|561571910|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155586498|NCT01622673|561571905|FG000|Treatment Period 3|Protocol Violation|0|||
155586499|NCT01622673|561571906|FG001|Treatment Period 3|Protocol Violation|1|||
155586500|NCT01622673|561571907|FG002|Treatment Period 3|Protocol Violation|0|||
155586501|NCT01622673|561571908|FG003|Treatment Period 3|Protocol Violation|0|||
155586502|NCT01622673|561571909|FG004|Treatment Period 3|Protocol Violation|0|||
155586503|NCT01622673|561571910|FG005|Treatment Period 3|Protocol Violation|0|||
155586504|NCT05966584|561571916|FG000|Overall Study|Lost to Follow-up|1|||
155586505|NCT00570687|561573598|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586506|NCT00570687|561573599|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586507|NCT00570687|561573600|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586508|NCT00570687|561573601|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586509|NCT00570687|561573602|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155586510|NCT00570687|561573603|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155586511|NCT00570687|561573604|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
155586512|NCT00570687|561573605|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155586513|NCT00570687|561573606|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
155586514|NCT00570687|561573607|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155586515|NCT00570687|561573598|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586516|NCT00570687|561573599|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586517|NCT00570687|561573600|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586518|NCT00570687|561573601|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586519|NCT00570687|561573602|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586520|NCT00570687|561573603|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586521|NCT00570687|561573604|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586522|NCT00570687|561573605|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586523|NCT00570687|561573606|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
155586524|NCT00570687|561573607|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155665089|NCT01847443|561869138|FG000|Study Period 1|Withdrawal by Subject|0|||
155586525|NCT00570687|561573598|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586526|NCT00570687|561573599|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586527|NCT00570687|561573600|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586528|NCT00570687|561573601|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586529|NCT00570687|561573602|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586530|NCT00570687|561573603|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155665090|NCT01847443|561869139|FG001|Study Period 1|Withdrawal by Subject|1|||
155665091|NCT01847443|561869140|FG002|Study Period 1|Withdrawal by Subject|0|||
155665092|NCT01847443|561869141|FG003|Study Period 1|Withdrawal by Subject|0|||
155665093|NCT01847443|561869138|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
155665094|NCT01847443|561869139|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
155665095|NCT01847443|561869140|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
155665096|NCT01847443|561869141|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
155665097|NCT01847443|561869138|FG000|Washout Period Before Study Period 2|Other reason|1|||
155665098|NCT01847443|561869139|FG001|Washout Period Before Study Period 2|Other reason|0|||
155665099|NCT01847443|561869140|FG002|Washout Period Before Study Period 2|Other reason|0|||
155665100|NCT01847443|561869141|FG003|Washout Period Before Study Period 2|Other reason|0|||
155665101|NCT01847443|561869138|FG000|Washout Period Before Study Period 3|Other reason|1|||
155665102|NCT01847443|561869139|FG001|Washout Period Before Study Period 3|Other reason|0|||
155665103|NCT01847443|561869140|FG002|Washout Period Before Study Period 3|Other reason|0|||
155665104|NCT01847443|561869141|FG003|Washout Period Before Study Period 3|Other reason|0|||
155665105|NCT01847443|561869138|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
155665106|NCT01847443|561869139|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155665107|NCT01847443|561869140|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155665108|NCT01847443|561869141|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155665109|NCT01847443|561869138|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
155665110|NCT01847443|561869139|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
155665111|NCT01847443|561869140|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
155665112|NCT01847443|561869141|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
155665113|NCT03571971|561869142|FG000|Overall Study|Lost to Follow-up|2|||
155665114|NCT03571971|561869143|FG001|Overall Study|Lost to Follow-up|2|||
155665115|NCT03571971|561869142|FG000|Overall Study|Protocol Violation|2|||
155665116|NCT03571971|561869143|FG001|Overall Study|Protocol Violation|3|||
155665117|NCT03571971|561869142|FG000|Overall Study|Withdrawal by Subject|2|||
155665118|NCT03571971|561869143|FG001|Overall Study|Withdrawal by Subject|0|||
155665119|NCT03571971|561869142|FG000|Overall Study|Incomplete primary outcome data|2|||
155665120|NCT03571971|561869143|FG001|Overall Study|Incomplete primary outcome data|0|||
155665121|NCT04067492|561869144|FG000|Overall Study|Lost to Follow-up|0|||
155665122|NCT04067492|561869145|FG001|Overall Study|Lost to Follow-up|0|||
155665123|NCT04067492|561869146|FG002|Overall Study|Lost to Follow-up|0|||
155665124|NCT04067492|561869147|FG003|Overall Study|Lost to Follow-up|0|||
155665125|NCT04067492|561869148|FG004|Overall Study|Lost to Follow-up|0|||
155665126|NCT04067492|561869149|FG005|Overall Study|Lost to Follow-up|1|||
155665127|NCT04067492|561869144|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155665128|NCT04067492|561869145|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
155665129|NCT04067492|561869146|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155665130|NCT04067492|561869147|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155665131|NCT04067492|561869148|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155665132|NCT04067492|561869149|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155665133|NCT04067492|561869144|FG000|Overall Study|COVID-19 epidemiological situation|0|||
155665134|NCT04067492|561869145|FG001|Overall Study|COVID-19 epidemiological situation|0|||
155665135|NCT04067492|561869146|FG002|Overall Study|COVID-19 epidemiological situation|0|||
155665136|NCT04067492|561869147|FG003|Overall Study|COVID-19 epidemiological situation|1|||
155665137|NCT04067492|561869148|FG004|Overall Study|COVID-19 epidemiological situation|0|||
155665138|NCT04067492|561869149|FG005|Overall Study|COVID-19 epidemiological situation|0|||
155665139|NCT03950856|561869155|FG000|Overall Study|Death|1|||
155665140|NCT03950856|561869156|FG001|Overall Study|Death|2|||
155665141|NCT03950856|561869157|FG002|Overall Study|Death|0|||
155665142|NCT03950856|561869158|FG003|Overall Study|Death|0|||
155665143|NCT03950856|561869155|FG000|Overall Study|Lost to Follow-up|5|||
155665144|NCT03950856|561869156|FG001|Overall Study|Lost to Follow-up|6|||
155665145|NCT03950856|561869157|FG002|Overall Study|Lost to Follow-up|8|||
155665146|NCT03950856|561869158|FG003|Overall Study|Lost to Follow-up|2|||
155665147|NCT03950856|561869155|FG000|Overall Study|Protocol Violation|2|||
155665148|NCT03950856|561869156|FG001|Overall Study|Protocol Violation|0|||
155665149|NCT03950856|561869157|FG002|Overall Study|Protocol Violation|0|||
155665150|NCT03950856|561869158|FG003|Overall Study|Protocol Violation|1|||
155665151|NCT03950856|561869155|FG000|Overall Study|Withdrawal by Subject|4|||
155665152|NCT03950856|561869156|FG001|Overall Study|Withdrawal by Subject|1|||
155665153|NCT03950856|561869157|FG002|Overall Study|Withdrawal by Subject|3|||
155665154|NCT03950856|561869158|FG003|Overall Study|Withdrawal by Subject|1|||
155665155|NCT03950856|561869155|FG000|Overall Study|Unable to phone|7|||
155665156|NCT03950856|561869156|FG001|Overall Study|Unable to phone|6|||
155665157|NCT03950856|561869157|FG002|Overall Study|Unable to phone|7|||
155665158|NCT03950856|561869158|FG003|Overall Study|Unable to phone|2|||
155665159|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
155665160|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
155665161|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
155665162|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
155665163|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
155665164|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
155665165|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
155665166|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
155665167|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
155665168|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
155665169|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
155665170|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
155665171|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
155665172|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
155665173|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
155665174|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
155665175|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
155665176|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
155665177|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
155665178|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
155665179|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
155665180|NCT04021290|561869161|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
155665181|NCT04021290|561869162|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
155665182|NCT04021290|561869163|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
155665183|NCT04021290|561869161|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
155665184|NCT04021290|561869162|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
155665185|NCT04021290|561869163|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
155665186|NCT04021290|561869161|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
155665187|NCT04021290|561869162|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
155665188|NCT04021290|561869163|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
155665189|NCT04021290|561869161|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
155665190|NCT04021290|561869162|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
155665191|NCT04021290|561869163|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
155665192|NCT04021290|561869161|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
155665193|NCT04021290|561869162|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
155665194|NCT04021290|561869163|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
155665195|NCT03391882|561869164|FG000|Study Overall|Adverse Event|3|||
155665196|NCT03391882|561869165|FG001|Study Overall|Adverse Event|6|||
155665197|NCT03391882|561869166|FG002|Study Overall|Adverse Event|1|||
155665198|NCT03391882|561869167|FG003|Study Overall|Adverse Event|1|||
155665199|NCT03391882|561869168|FG004|Study Overall|Adverse Event|3|||
155665200|NCT03391882|561869169|FG005|Study Overall|Adverse Event|1|||
155665201|NCT03391882|561869164|FG000|Study Overall|Lack of Efficacy|13|||
155665202|NCT03391882|561869165|FG001|Study Overall|Lack of Efficacy|9|||
155665203|NCT03391882|561869166|FG002|Study Overall|Lack of Efficacy|0|||
155665204|NCT03391882|561869167|FG003|Study Overall|Lack of Efficacy|0|||
155665205|NCT03391882|561869168|FG004|Study Overall|Lack of Efficacy|0|||
155665206|NCT03391882|561869169|FG005|Study Overall|Lack of Efficacy|0|||
155665207|NCT03391882|561869164|FG000|Study Overall|Withdrawal by Subject|3|||
155665208|NCT03391882|561869165|FG001|Study Overall|Withdrawal by Subject|3|||
155665209|NCT03391882|561869166|FG002|Study Overall|Withdrawal by Subject|2|||
155665210|NCT03391882|561869167|FG003|Study Overall|Withdrawal by Subject|2|||
155665211|NCT03391882|561869168|FG004|Study Overall|Withdrawal by Subject|1|||
155665212|NCT03391882|561869169|FG005|Study Overall|Withdrawal by Subject|3|||
155665213|NCT03391882|561869164|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155665214|NCT03391882|561869165|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
155665215|NCT03391882|561869166|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155665216|NCT03391882|561869167|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155665217|NCT03391882|561869168|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155665218|NCT03391882|561869169|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155665219|NCT03391882|561869164|FG000|Study Overall|Protocol Violation|1|||
155665220|NCT03391882|561869165|FG001|Study Overall|Protocol Violation|0|||
155665221|NCT03391882|561869166|FG002|Study Overall|Protocol Violation|0|||
155665222|NCT03391882|561869167|FG003|Study Overall|Protocol Violation|0|||
155665223|NCT03391882|561869168|FG004|Study Overall|Protocol Violation|0|||
155665224|NCT03391882|561869169|FG005|Study Overall|Protocol Violation|0|||
155665225|NCT03391882|561869164|FG000|Part A - Titration Phase|Adverse Event|3|||
155586531|NCT00570687|561573604|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
155586532|NCT00570687|561573605|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586533|NCT00570687|561573606|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586534|NCT00570687|561573607|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155586535|NCT05343000|561573608|FG000|Overall Study|Physician Decision|2|||
155586536|NCT05271370|561573609|FG000|Overall Study|Study early termination|8|||
155586537|NCT05271370|561573610|FG001|Overall Study|Study early termination|16|||
155586538|NCT05271370|561573611|FG002|Overall Study|Study early termination|29|||
155586539|NCT00333983|561573617|FG000|Overall Study|Lost to Follow-up|2|||
155586540|NCT00333983|561573618|FG001|Overall Study|Lost to Follow-up|1|||
155586541|NCT00333983|561573619|FG002|Overall Study|Lost to Follow-up|0|||
155586542|NCT00333983|561573617|FG000|Overall Study|Adverse Event|1|||
155586543|NCT00333983|561573618|FG001|Overall Study|Adverse Event|1|||
155586544|NCT00333983|561573619|FG002|Overall Study|Adverse Event|1|||
155586545|NCT00333983|561573617|FG000|Overall Study|Withdrawal by Subject|0|||
155586546|NCT00333983|561573618|FG001|Overall Study|Withdrawal by Subject|3|||
155586547|NCT00333983|561573619|FG002|Overall Study|Withdrawal by Subject|1|||
155586548|NCT00833105|561573620|FG000|Overall Study|Withdrawal by Subject|1|||
155586549|NCT00833105|561573620|FG000|Overall Study|Adverse Event|2|||
155586550|NCT03656068|561573621|FG000|Overall Study|Withdrawal by Subject|4|||
155586551|NCT03656068|561573621|FG000|Overall Study|Adverse Event|1|||
155586552|NCT00154284|561573622|FG000|Overall Study|Adverse Event|6|||
155586553|NCT00154284|561573623|FG001|Overall Study|Adverse Event|9|||
155586554|NCT00154284|561573622|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155586555|NCT00154284|561573623|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155586556|NCT00154284|561573622|FG000|Overall Study|Lack of Efficacy|1|||
155586557|NCT00154284|561573623|FG001|Overall Study|Lack of Efficacy|2|||
155586558|NCT00154284|561573622|FG000|Overall Study|Protocol Violation|0|||
155586559|NCT00154284|561573623|FG001|Overall Study|Protocol Violation|1|||
155586560|NCT01780038|561573632|FG000|Overall Study|Lost to Follow-up|4|||
155586561|NCT01780038|561573633|FG001|Overall Study|Lost to Follow-up|1|||
155586562|NCT03168711|561573634|FG000|Overall Study|Adverse Event|2|||
155586563|NCT03168711|561573635|FG001|Overall Study|Adverse Event|0|||
155586564|NCT03168711|561573634|FG000|Overall Study|Withdrawal by Subject|0|||
155586565|NCT03168711|561573635|FG001|Overall Study|Withdrawal by Subject|1|||
155586566|NCT03168711|561573634|FG000|Overall Study|Death|0|||
155586567|NCT03168711|561573635|FG001|Overall Study|Death|1|||
155586568|NCT03270657|561573638|FG000|Overall Study|Withdrawal by Subject|1|||
155586569|NCT00162981|561573639|FG000|Overall Study|Adverse Event|2|||
155586570|NCT00162981|561573640|FG001|Overall Study|Adverse Event|5|||
155586571|NCT00162981|561573639|FG000|Overall Study|Withdrawal by Subject|1|||
155586572|NCT00162981|561573640|FG001|Overall Study|Withdrawal by Subject|1|||
155586573|NCT00162981|561573639|FG000|Overall Study|Physician Decision|1|||
155586574|NCT00162981|561573640|FG001|Overall Study|Physician Decision|0|||
155586575|NCT01343043|561573643|FG000|Overall Study|Disease progression before treatment|1|||
155586576|NCT01343043|561573644|FG001|Overall Study|Disease progression before treatment|0|||
155586577|NCT01343043|561573645|FG002|Overall Study|Disease progression before treatment|0|||
155586578|NCT01343043|561573646|FG003|Overall Study|Disease progression before treatment|0|||
155586579|NCT01343043|561573643|FG000|Overall Study|Withdrawal by Subject|1|||
155586580|NCT01343043|561573644|FG001|Overall Study|Withdrawal by Subject|0|||
155586581|NCT01343043|561573645|FG002|Overall Study|Withdrawal by Subject|0|||
155586582|NCT01343043|561573646|FG003|Overall Study|Withdrawal by Subject|0|||
155586583|NCT01343043|561573643|FG000|Overall Study|Death|1|||
155586584|NCT01343043|561573644|FG001|Overall Study|Death|1|||
155586585|NCT01343043|561573645|FG002|Overall Study|Death|0|||
155586586|NCT01343043|561573646|FG003|Overall Study|Death|1|||
155586587|NCT00502242|561573649|FG000|Overall Study|Lack of Efficacy|1|||
155586588|NCT00502242|561573650|FG001|Overall Study|Lack of Efficacy|11|||
155586589|NCT00502242|561573649|FG000|Overall Study|Adverse Event|31|||
155586590|NCT00502242|561573650|FG001|Overall Study|Adverse Event|20|||
155586591|NCT00502242|561573649|FG000|Overall Study|Physician Decision|2|||
155586592|NCT00502242|561573650|FG001|Overall Study|Physician Decision|3|||
155586593|NCT00502242|561573649|FG000|Overall Study|Other - Unspecified|8|||
155586594|NCT00502242|561573650|FG001|Overall Study|Other - Unspecified|14|||
155586595|NCT00502242|561573649|FG000|Overall Study|Protocol Violation|3|||
155586596|NCT00502242|561573650|FG001|Overall Study|Protocol Violation|1|||
155586597|NCT00502242|561573649|FG000|Overall Study|Withdrawal by Subject|6|||
155586598|NCT00502242|561573650|FG001|Overall Study|Withdrawal by Subject|7|||
155586599|NCT01812109|561573651|FG000|Overall Study|research personnel delay|16|||
155586600|NCT01812109|561573651|FG000|Overall Study|NIRS Unattainable|17|||
155586601|NCT01346696|561573652|FG000|Overall Study|Death|1|||
155586602|NCT04630002|561573653|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
155586603|NCT04630002|561573654|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155586604|NCT04630002|561573655|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155586605|NCT04630002|561573653|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
155665226|NCT03391882|561869165|FG001|Part A - Titration Phase|Adverse Event|6|||
155665227|NCT03391882|561869166|FG002|Part A - Titration Phase|Adverse Event|0|||
155665228|NCT03391882|561869167|FG003|Part A - Titration Phase|Adverse Event|0|||
155665229|NCT03391882|561869168|FG004|Part A - Titration Phase|Adverse Event|0|||
155665230|NCT03391882|561869169|FG005|Part A - Titration Phase|Adverse Event|0|||
155665231|NCT03391882|561869164|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
155665232|NCT03391882|561869165|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
155665233|NCT03391882|561869166|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
155665234|NCT03391882|561869167|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
155665235|NCT03391882|561869168|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
155665236|NCT03391882|561869169|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
155665237|NCT03391882|561869164|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
155665238|NCT03391882|561869165|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
155665239|NCT03391882|561869166|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
155665240|NCT03391882|561869167|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
155665241|NCT03391882|561869168|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
155665242|NCT03391882|561869169|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
155665243|NCT03391882|561869164|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155665244|NCT03391882|561869165|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
155665245|NCT03391882|561869166|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155665246|NCT03391882|561869167|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155665247|NCT03391882|561869168|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155665248|NCT03391882|561869169|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155665249|NCT03391882|561869164|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
155665250|NCT03391882|561869165|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
155665251|NCT03391882|561869166|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
155665252|NCT03391882|561869167|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
155665253|NCT03391882|561869168|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
155665254|NCT03391882|561869169|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
155665255|NCT03391882|561869164|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
155665256|NCT03391882|561869165|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
155665257|NCT03391882|561869166|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
155665258|NCT03391882|561869167|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
155665259|NCT03391882|561869168|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
155665260|NCT03391882|561869169|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
155665261|NCT03391882|561869164|FG000|Part B - Treatment Phase|Adverse Event|0|||
155665262|NCT03391882|561869165|FG001|Part B - Treatment Phase|Adverse Event|0|||
155665263|NCT03391882|561869166|FG002|Part B - Treatment Phase|Adverse Event|1|||
155665264|NCT03391882|561869167|FG003|Part B - Treatment Phase|Adverse Event|1|||
155665265|NCT03391882|561869168|FG004|Part B - Treatment Phase|Adverse Event|3|||
155665266|NCT03391882|561869169|FG005|Part B - Treatment Phase|Adverse Event|1|||
155665267|NCT03391882|561869164|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
155665268|NCT03391882|561869165|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
155665269|NCT03391882|561869166|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
155665270|NCT03391882|561869167|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
155665271|NCT03391882|561869168|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
155665272|NCT03391882|561869169|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
155665273|NCT03092479|561869170|FG000|Overall Study|Lost to Follow-up|3|||
155665274|NCT03092479|561869171|FG001|Overall Study|Lost to Follow-up|2|||
155665275|NCT03092479|561869170|FG000|Overall Study|Withdrawal by Subject|4|||
155665276|NCT03092479|561869171|FG001|Overall Study|Withdrawal by Subject|0|||
155665277|NCT01173679|561870821|FG000|Overall Study|Death|1|||
155665278|NCT03247829|561870826|FG000|Overall Study|Death|3|||
155665279|NCT03247829|561870827|FG001|Overall Study|Death|4|||
155665280|NCT03247829|561870826|FG000|Overall Study|Enter Hospice Care|1|||
155665281|NCT03247829|561870827|FG001|Overall Study|Enter Hospice Care|0|||
155665282|NCT03247829|561870826|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
155665283|NCT03247829|561870827|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
155665284|NCT03247829|561870826|FG000|Overall Study|LVAD Explant|1|||
155665285|NCT03247829|561870827|FG001|Overall Study|LVAD Explant|1|||
155665286|NCT03247829|561870826|FG000|Overall Study|Transplant|1|||
155665287|NCT03247829|561870827|FG001|Overall Study|Transplant|1|||
155665288|NCT00441272|561870828|FG000|Overall Study|Study terminated prior to enrollment|25|||
155665289|NCT00441272|561870829|FG001|Overall Study|Study terminated prior to enrollment|25|||
155665290|NCT00443703|561870830|FG000|Overall Study|Never Treated|3|||
155665291|NCT00443703|561870831|FG001|Overall Study|Never Treated|1|||
155665292|NCT00443703|561870830|FG000|Overall Study|Adverse Event|7|||
155665293|NCT00443703|561870831|FG001|Overall Study|Adverse Event|3|||
155665294|NCT00443703|561870830|FG000|Overall Study|Lack of Efficacy|3|||
155665295|NCT00443703|561870831|FG001|Overall Study|Lack of Efficacy|1|||
155665296|NCT00443703|561870830|FG000|Overall Study|Lost to Follow-up|0|||
155665297|NCT00443703|561870831|FG001|Overall Study|Lost to Follow-up|4|||
155665298|NCT00443703|561870830|FG000|Overall Study|Physician Decision|4|||
155665299|NCT00443703|561870831|FG001|Overall Study|Physician Decision|2|||
155586606|NCT04630002|561573654|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155586607|NCT04630002|561573655|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155586608|NCT04630002|561573653|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
155586609|NCT04630002|561573654|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155586610|NCT04630002|561573655|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155586611|NCT04630002|561573653|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155586612|NCT04630002|561573654|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
155586613|NCT04630002|561573655|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155586614|NCT04630002|561573653|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155586615|NCT04630002|561573654|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
155586616|NCT04630002|561573655|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155586617|NCT04630002|561573653|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155586618|NCT04630002|561573654|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
155586619|NCT04630002|561573655|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155586620|NCT04630002|561573653|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
155586621|NCT04630002|561573654|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
155586622|NCT04630002|561573655|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
155586623|NCT04630002|561573653|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
155586624|NCT04630002|561573654|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
155586625|NCT04630002|561573655|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
155586626|NCT04548193|561573670|FG000|Overall Study|Lost to Follow-up|0|||
155586627|NCT04548193|561573671|FG001|Overall Study|Lost to Follow-up|1|||
155586628|NCT04548193|561573670|FG000|Overall Study|Death|0|||
155586629|NCT04548193|561573671|FG001|Overall Study|Death|1|||
155586630|NCT04548193|561573670|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
155586631|NCT04548193|561573671|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
155586632|NCT04548193|561573670|FG000|Overall Study|Withdrawal by Subject|2|||
155586633|NCT04548193|561573671|FG001|Overall Study|Withdrawal by Subject|2|||
155586634|NCT00630825|561573672|FG000|Overall Study|Adverse Event|4|||
155586635|NCT00630825|561573673|FG001|Overall Study|Adverse Event|4|||
155586636|NCT00630825|561573674|FG002|Overall Study|Adverse Event|3|||
155586637|NCT00630825|561573675|FG003|Overall Study|Adverse Event|1|||
155586638|NCT00630825|561573672|FG000|Overall Study|Entry Criteria Not Met|1|||
155586639|NCT00630825|561573673|FG001|Overall Study|Entry Criteria Not Met|0|||
155586640|NCT00630825|561573674|FG002|Overall Study|Entry Criteria Not Met|2|||
155586641|NCT00630825|561573675|FG003|Overall Study|Entry Criteria Not Met|1|||
155586642|NCT00630825|561573672|FG000|Overall Study|Lost to Follow-up|1|||
155586643|NCT00630825|561573673|FG001|Overall Study|Lost to Follow-up|1|||
155586644|NCT00630825|561573674|FG002|Overall Study|Lost to Follow-up|1|||
155586645|NCT00630825|561573675|FG003|Overall Study|Lost to Follow-up|1|||
155586646|NCT00630825|561573672|FG000|Overall Study|Physician Decision|1|||
155586647|NCT00630825|561573673|FG001|Overall Study|Physician Decision|0|||
155586648|NCT00630825|561573674|FG002|Overall Study|Physician Decision|0|||
155586649|NCT00630825|561573675|FG003|Overall Study|Physician Decision|0|||
155586650|NCT00630825|561573672|FG000|Overall Study|Withdrawal by Subject|2|||
155586651|NCT00630825|561573673|FG001|Overall Study|Withdrawal by Subject|2|||
155586652|NCT00630825|561573674|FG002|Overall Study|Withdrawal by Subject|2|||
155586653|NCT00630825|561573675|FG003|Overall Study|Withdrawal by Subject|3|||
155586654|NCT01081769|561573678|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
155586655|NCT01081769|561573679|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
155586656|NCT01081769|561573678|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
155586657|NCT01081769|561573679|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
155586658|NCT01081769|561573678|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
155586659|NCT01081769|561573679|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
155586660|NCT01081769|561573678|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
155586661|NCT01081769|561573679|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
155586662|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Adverse Event|14|||
155586663|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Adverse Event|11|||
155586664|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Death|1|||
155586665|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Death|1|||
155586666|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
155586667|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
155586668|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
155586669|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
155586670|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Pregnancy|1|||
155586671|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Pregnancy|0|||
155586672|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
155586673|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
155586674|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
155586675|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
155586676|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Other|0|||
155586677|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Other|1|||
155586678|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Ineligibility|3|||
155586679|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Ineligibility|4|||
155586680|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
155586681|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
155586682|NCT01081769|561573678|FG000|CORE Intent-To-Treat|Patient Moved|2|||
155586683|NCT01081769|561573679|FG001|CORE Intent-To-Treat|Patient Moved|2|||
155586684|NCT03309943|561573680|FG000|Overall Study|Withdrawal by Subject|0|||
155586685|NCT03309943|561573681|FG001|Overall Study|Withdrawal by Subject|1|||
155586686|NCT03309943|561573680|FG000|Overall Study|Inappropriate behavior towards staff|0|||
155586687|NCT03309943|561573681|FG001|Overall Study|Inappropriate behavior towards staff|1|||
155586688|NCT02169271|561573689|FG000|Overall Study|Protocol Violation|1|||
155586689|NCT02169271|561573690|FG001|Overall Study|Protocol Violation|2|||
155586690|NCT04926831|561573691|FG000|Overall Study|Withdrawal by Subject|2|||
155586691|NCT04926831|561573691|FG000|Overall Study|Adverse Event|2|||
155586692|NCT03859427|561573696|FG000|Overall Study|Withdrawal by Subject|4|||
155586693|NCT03859427|561573697|FG001|Overall Study|Withdrawal by Subject|7|||
155586694|NCT03859427|561573696|FG000|Overall Study|Decision by sponsor|0|||
155586695|NCT03859427|561573697|FG001|Overall Study|Decision by sponsor|3|||
155586696|NCT03859427|561573696|FG000|Overall Study|Lost to Follow-up|3|||
155586697|NCT03859427|561573697|FG001|Overall Study|Lost to Follow-up|2|||
155586698|NCT03859427|561573696|FG000|Overall Study|Death|22|||
155586699|NCT03859427|561573697|FG001|Overall Study|Death|25|||
155586700|NCT00564850|561573698|FG000|Overall Study|Protocol Violation|2|||
155586701|NCT02640664|561573699|FG000|Epoch 1|Withdrawal of informed consent|1|||
155586702|NCT02640664|561573700|FG001|Epoch 1|Withdrawal of informed consent|0|||
155586703|NCT02640664|561573701|FG002|Epoch 1|Withdrawal of informed consent|0|||
155586704|NCT02640664|561573699|FG000|Epoch 1|Death|0|||
155586705|NCT02640664|561573700|FG001|Epoch 1|Death|0|||
155586706|NCT02640664|561573701|FG002|Epoch 1|Death|1|||
155586707|NCT02640664|561573699|FG000|Epoch 2|Withdrawal of informed consent|3|||
155586708|NCT02640664|561573700|FG001|Epoch 2|Withdrawal of informed consent|4|||
155586709|NCT02640664|561573701|FG002|Epoch 2|Withdrawal of informed consent|2|||
155586710|NCT02640664|561573699|FG000|Epoch 2|Subject/guardian decision|0|||
155586711|NCT02640664|561573700|FG001|Epoch 2|Subject/guardian decision|2|||
155586712|NCT02640664|561573701|FG002|Epoch 2|Subject/guardian decision|2|||
155586713|NCT02640664|561573699|FG000|Epoch 2|Lost to Follow-up|3|||
155586714|NCT02640664|561573700|FG001|Epoch 2|Lost to Follow-up|4|||
155586715|NCT02640664|561573701|FG002|Epoch 2|Lost to Follow-up|1|||
155586716|NCT02640664|561573699|FG000|Epoch 2|Death|0|||
155586717|NCT02640664|561573700|FG001|Epoch 2|Death|0|||
155586718|NCT02640664|561573701|FG002|Epoch 2|Death|1|||
155586719|NCT01804946|561573702|FG000|Overall Study|Protocol Violation|1|||
155586720|NCT01804946|561573703|FG001|Overall Study|Protocol Violation|0|||
155586721|NCT01804946|561573702|FG000|Overall Study|Adverse Event|0|||
155586722|NCT01804946|561573703|FG001|Overall Study|Adverse Event|1|||
155586723|NCT01804946|561573702|FG000|Overall Study|Insufficient data available|0|||
155586724|NCT01804946|561573703|FG001|Overall Study|Insufficient data available|1|||
155586725|NCT01804946|561573702|FG000|Overall Study|Do not meet inclusion criteria|1|||
155586726|NCT01804946|561573703|FG001|Overall Study|Do not meet inclusion criteria|2|||
155586727|NCT00722137|561573705|FG000|Overall Study|Overt Disease Progression|5|||
155586728|NCT00722137|561573706|FG001|Overall Study|Overt Disease Progression|4|||
155586729|NCT00722137|561573705|FG000|Overall Study|Adverse Event|17|||
155586730|NCT00722137|561573706|FG001|Overall Study|Adverse Event|21|||
155586731|NCT00722137|561573705|FG000|Overall Study|Death|12|||
155586732|NCT00722137|561573706|FG001|Overall Study|Death|7|||
155586733|NCT00722137|561573705|FG000|Overall Study|Withdrawal by Subject|6|||
155586734|NCT00722137|561573706|FG001|Overall Study|Withdrawal by Subject|9|||
155586735|NCT00722137|561573705|FG000|Overall Study|Other Reason Unknown|3|||
155665300|NCT00443703|561870830|FG000|Overall Study|Protocol Violation|1|||
155665301|NCT00443703|561870831|FG001|Overall Study|Protocol Violation|1|||
155665302|NCT00443703|561870830|FG000|Overall Study|Withdrawal by Subject|9|||
155665303|NCT00443703|561870831|FG001|Overall Study|Withdrawal by Subject|6|||
155665304|NCT00443703|561870830|FG000|Overall Study|Progressive Disease|1|||
155665305|NCT00443703|561870831|FG001|Overall Study|Progressive Disease|0|||
155665306|NCT01047007|561870832|FG000|Overall Study|Adverse Event|0|||
155665307|NCT01047007|561870833|FG001|Overall Study|Adverse Event|2|||
155665308|NCT01047007|561870834|FG002|Overall Study|Adverse Event|1|||
155665309|NCT01047007|561870835|FG003|Overall Study|Adverse Event|0|||
155665310|NCT01047007|561870832|FG000|Overall Study|Progressive Disease|2|||
155665311|NCT01047007|561870833|FG001|Overall Study|Progressive Disease|4|||
155665312|NCT01047007|561870834|FG002|Overall Study|Progressive Disease|1|||
155665313|NCT01047007|561870835|FG003|Overall Study|Progressive Disease|0|||
155665314|NCT03423602|561870837|FG000|Overall Study|Death|1|||
155665315|NCT03423602|561870837|FG000|Overall Study|Lost to Follow-up|6|||
155665316|NCT03423602|561870837|FG000|Overall Study|Protocol Violation|1|||
155665317|NCT03423602|561870837|FG000|Overall Study|Withdrawal by Subject|4|||
155665318|NCT03046446|561870845|FG000|Overall Study|Lack of Efficacy|7|||
155665319|NCT03046446|561870845|FG000|Overall Study|Adverse Event|6|||
155665320|NCT03046446|561870845|FG000|Overall Study|Lost to Follow-up|3|||
155665321|NCT03046446|561870845|FG000|Overall Study|Withdrawal by Subject|14|||
155665322|NCT03046446|561870845|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
155665323|NCT03046446|561870845|FG000|Overall Study|Disease Progression (see caveats)|25|||
155665324|NCT03046446|561870845|FG000|Overall Study|Non OA related knee surgery|1|||
155665325|NCT03012334|561870848|FG000|Period 1|Withdrawal by Subject|0|||
155665326|NCT03012334|561870849|FG001|Period 1|Withdrawal by Subject|0|||
155665327|NCT03012334|561870850|FG002|Period 1|Withdrawal by Subject|0|||
155665328|NCT03012334|561870851|FG003|Period 1|Withdrawal by Subject|0|||
155665329|NCT03012334|561870852|FG004|Period 1|Withdrawal by Subject|0|||
155665330|NCT03012334|561870853|FG005|Period 1|Withdrawal by Subject|0|||
155665331|NCT03012334|561870854|FG006|Period 1|Withdrawal by Subject|0|||
155665332|NCT03012334|561870855|FG007|Period 1|Withdrawal by Subject|0|||
155665333|NCT03012334|561870856|FG008|Period 1|Withdrawal by Subject|0|||
155665334|NCT03012334|561870857|FG009|Period 1|Withdrawal by Subject|1|||
155665335|NCT03012334|561870848|FG000|Period 2|Withdrawal by Subject|0|||
155665336|NCT03012334|561870849|FG001|Period 2|Withdrawal by Subject|1|||
155665337|NCT03012334|561870850|FG002|Period 2|Withdrawal by Subject|0|||
155665338|NCT03012334|561870851|FG003|Period 2|Withdrawal by Subject|0|||
155665339|NCT03012334|561870852|FG004|Period 2|Withdrawal by Subject|0|||
155665340|NCT03012334|561870853|FG005|Period 2|Withdrawal by Subject|0|||
155665341|NCT03012334|561870854|FG006|Period 2|Withdrawal by Subject|0|||
155665342|NCT03012334|561870855|FG007|Period 2|Withdrawal by Subject|0|||
155665343|NCT03012334|561870856|FG008|Period 2|Withdrawal by Subject|0|||
155665344|NCT03012334|561870857|FG009|Period 2|Withdrawal by Subject|0|||
155665345|NCT03012334|561870848|FG000|Period 2|Protocol Violation|0|||
155665346|NCT03012334|561870849|FG001|Period 2|Protocol Violation|0|||
155665347|NCT03012334|561870850|FG002|Period 2|Protocol Violation|1|||
155665348|NCT03012334|561870851|FG003|Period 2|Protocol Violation|0|||
155665349|NCT03012334|561870852|FG004|Period 2|Protocol Violation|0|||
155665350|NCT03012334|561870853|FG005|Period 2|Protocol Violation|0|||
155665351|NCT03012334|561870854|FG006|Period 2|Protocol Violation|0|||
155665352|NCT03012334|561870855|FG007|Period 2|Protocol Violation|1|||
155665353|NCT03012334|561870856|FG008|Period 2|Protocol Violation|0|||
155665354|NCT03012334|561870857|FG009|Period 2|Protocol Violation|0|||
155665355|NCT03012334|561870848|FG000|Period 4|Non-Compliance|0|||
155665356|NCT03012334|561870849|FG001|Period 4|Non-Compliance|0|||
155665357|NCT03012334|561870850|FG002|Period 4|Non-Compliance|0|||
155665358|NCT03012334|561870851|FG003|Period 4|Non-Compliance|0|||
155665359|NCT03012334|561870852|FG004|Period 4|Non-Compliance|0|||
155665360|NCT03012334|561870853|FG005|Period 4|Non-Compliance|0|||
155665361|NCT03012334|561870854|FG006|Period 4|Non-Compliance|1|||
155665362|NCT03012334|561870855|FG007|Period 4|Non-Compliance|0|||
155665363|NCT03012334|561870856|FG008|Period 4|Non-Compliance|0|||
155665364|NCT03012334|561870857|FG009|Period 4|Non-Compliance|0|||
155665365|NCT03012334|561870848|FG000|Period 4|Adverse Event|0|||
155665366|NCT03012334|561870849|FG001|Period 4|Adverse Event|0|||
155665367|NCT03012334|561870850|FG002|Period 4|Adverse Event|0|||
155665368|NCT03012334|561870851|FG003|Period 4|Adverse Event|0|||
155665369|NCT03012334|561870852|FG004|Period 4|Adverse Event|0|||
155665370|NCT03012334|561870853|FG005|Period 4|Adverse Event|0|||
155665371|NCT03012334|561870854|FG006|Period 4|Adverse Event|0|||
155665372|NCT03012334|561870855|FG007|Period 4|Adverse Event|0|||
155665373|NCT03012334|561870856|FG008|Period 4|Adverse Event|1|||
155665374|NCT03012334|561870857|FG009|Period 4|Adverse Event|0|||
155665375|NCT01823107|561870858|FG000|Overall Study|Withdrawal by Subject|1|||
155665376|NCT00305448|561870859|FG000|Overall Study|Protocol Violation|0|||
155665377|NCT00305448|561870860|FG001|Overall Study|Protocol Violation|1|||
155665378|NCT00305448|561870861|FG002|Overall Study|Protocol Violation|0|||
155665379|NCT00305448|561870859|FG000|Overall Study|Withdrawal by Subject|2|||
155665380|NCT00305448|561870860|FG001|Overall Study|Withdrawal by Subject|0|||
155665381|NCT00305448|561870861|FG002|Overall Study|Withdrawal by Subject|1|||
155665382|NCT00305448|561870859|FG000|Overall Study|Adverse Event|1|||
155665383|NCT00305448|561870860|FG001|Overall Study|Adverse Event|0|||
155665384|NCT00305448|561870861|FG002|Overall Study|Adverse Event|1|||
155665385|NCT00305448|561870859|FG000|Overall Study|Disease Progression|27|||
155665386|NCT00305448|561870860|FG001|Overall Study|Disease Progression|31|||
155665387|NCT00305448|561870861|FG002|Overall Study|Disease Progression|28|||
155665388|NCT00305448|561870859|FG000|Overall Study|Subjective Disease Progression|1|||
155665389|NCT00305448|561870860|FG001|Overall Study|Subjective Disease Progression|2|||
155665390|NCT00305448|561870861|FG002|Overall Study|Subjective Disease Progression|2|||
155665391|NCT00305448|561870859|FG000|Overall Study|Tumor Marker Elevation|0|||
155665392|NCT00305448|561870860|FG001|Overall Study|Tumor Marker Elevation|0|||
155665393|NCT00305448|561870861|FG002|Overall Study|Tumor Marker Elevation|1|||
155665394|NCT00002766|561870862|FG000|Overall Study|Withdrawal by Subject|0|||
155665395|NCT00002766|561870863|FG001|Overall Study|Withdrawal by Subject|1|||
155665396|NCT00002766|561870862|FG000|Overall Study|Patient Not Treated|1|||
155665397|NCT00002766|561870863|FG001|Overall Study|Patient Not Treated|2|||
155665398|NCT00002766|561870862|FG000|Overall Study|Adverse Event|1|||
155665399|NCT00002766|561870863|FG001|Overall Study|Adverse Event|1|||
155665400|NCT00002766|561870862|FG000|Overall Study|Protocol Violation|1|||
155665401|NCT00002766|561870863|FG001|Overall Study|Protocol Violation|0|||
155665402|NCT00328172|561870864|FG000|Overall Study|Adverse Event|3|||
155665403|NCT00328172|561870865|FG001|Overall Study|Adverse Event|2|||
155665404|NCT00328172|561870866|FG002|Overall Study|Adverse Event|1|||
155665405|NCT00328172|561870867|FG003|Overall Study|Adverse Event|2|||
155665406|NCT00328172|561870868|FG004|Overall Study|Adverse Event|1|||
155665407|NCT00328172|561870864|FG000|Overall Study|Protocol Violation|0|||
155665408|NCT00328172|561870865|FG001|Overall Study|Protocol Violation|1|||
155665409|NCT00328172|561870866|FG002|Overall Study|Protocol Violation|1|||
155665410|NCT00328172|561870867|FG003|Overall Study|Protocol Violation|0|||
155665411|NCT00328172|561870868|FG004|Overall Study|Protocol Violation|0|||
155665412|NCT00328172|561870864|FG000|Overall Study|Lost to Follow-up|1|||
155665413|NCT00328172|561870865|FG001|Overall Study|Lost to Follow-up|1|||
155665414|NCT00328172|561870866|FG002|Overall Study|Lost to Follow-up|2|||
155665415|NCT00328172|561870867|FG003|Overall Study|Lost to Follow-up|1|||
155665416|NCT00328172|561870868|FG004|Overall Study|Lost to Follow-up|1|||
155665417|NCT00328172|561870864|FG000|Overall Study|Withdrawal by Subject|1|||
155665418|NCT00328172|561870865|FG001|Overall Study|Withdrawal by Subject|1|||
155665419|NCT00328172|561870866|FG002|Overall Study|Withdrawal by Subject|1|||
155665420|NCT00328172|561870867|FG003|Overall Study|Withdrawal by Subject|6|||
155665421|NCT00328172|561870868|FG004|Overall Study|Withdrawal by Subject|0|||
155665422|NCT00328172|561870864|FG000|Overall Study|Lack of Efficacy|14|||
155665423|NCT00328172|561870865|FG001|Overall Study|Lack of Efficacy|9|||
155665424|NCT00328172|561870866|FG002|Overall Study|Lack of Efficacy|4|||
155665425|NCT00328172|561870867|FG003|Overall Study|Lack of Efficacy|4|||
155665426|NCT00328172|561870868|FG004|Overall Study|Lack of Efficacy|3|||
155665427|NCT00328172|561870864|FG000|Overall Study|Other reason (not specified)|3|||
155665428|NCT00328172|561870865|FG001|Overall Study|Other reason (not specified)|0|||
155665429|NCT00328172|561870866|FG002|Overall Study|Other reason (not specified)|1|||
155665430|NCT00328172|561870867|FG003|Overall Study|Other reason (not specified)|0|||
155665431|NCT00328172|561870868|FG004|Overall Study|Other reason (not specified)|0|||
155665432|NCT00077974|561870869|FG000|Overall Study|Adverse Event|22|||
155665433|NCT00077974|561870869|FG000|Overall Study|Protocol Violation|1|||
155665434|NCT00077974|561870869|FG000|Overall Study|Withdrawal by Subject|3|||
155586736|NCT00722137|561573706|FG001|Overall Study|Other Reason Unknown|4|||
155586737|NCT00722137|561573705|FG000|Overall Study|Randomized But Not Treated|2|||
155586738|NCT00722137|561573706|FG001|Overall Study|Randomized But Not Treated|3|||
155586739|NCT03830333|561573707|FG000|Overall Study|Death|0|||
155586740|NCT03830333|561573708|FG001|Overall Study|Death|1|||
155586741|NCT03830333|561573707|FG000|Overall Study|Withdrawal by Subject|5|||
155586742|NCT03830333|561573708|FG001|Overall Study|Withdrawal by Subject|1|||
155586743|NCT03830333|561573707|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
155586744|NCT03830333|561573708|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
155586745|NCT01129557|561573709|FG000|Overall Study|Adverse Event|1|||
155586746|NCT01129557|561573710|FG001|Overall Study|Adverse Event|2|||
155586747|NCT01129557|561573711|FG002|Overall Study|Adverse Event|2|||
155586748|NCT01129557|561573709|FG000|Overall Study|Novartis terminated study early|3|||
155586749|NCT01129557|561573710|FG001|Overall Study|Novartis terminated study early|3|||
155586750|NCT01129557|561573711|FG002|Overall Study|Novartis terminated study early|2|||
155586751|NCT01486446|561573712|FG000|Overall Study|Adverse Event|1|||
155586752|NCT01486446|561573713|FG001|Overall Study|Adverse Event|0|||
155586753|NCT01367886|561573716|FG000|Overall Study|Lost to Follow-up|4|||
155586754|NCT01367886|561573716|FG000|Overall Study|Lack of Efficacy|2|||
155586755|NCT01367886|561573716|FG000|Overall Study|Death|1|||
155586756|NCT00985504|561573721|FG000|Acute Treatment Period|Adverse Event|3|||
155586757|NCT00985504|561573722|FG001|Acute Treatment Period|Adverse Event|4|||
155586758|NCT00985504|561573721|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
155586759|NCT00985504|561573722|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
155586760|NCT00985504|561573721|FG000|Acute Treatment Period|Protocol Violation|2|||
155586761|NCT00985504|561573722|FG001|Acute Treatment Period|Protocol Violation|0|||
155586762|NCT00985504|561573721|FG000|Acute Treatment Period|Sponsor Decision|0|||
155586763|NCT00985504|561573722|FG001|Acute Treatment Period|Sponsor Decision|1|||
155586764|NCT00985504|561573721|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
155586765|NCT00985504|561573722|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
155586766|NCT00985504|561573721|FG000|Optimization Period|Adverse Event|7|||
155586767|NCT00985504|561573722|FG001|Optimization Period|Adverse Event|9|||
155586768|NCT00985504|561573721|FG000|Optimization Period|Death|0|||
155586769|NCT00985504|561573722|FG001|Optimization Period|Death|1|||
155586770|NCT00985504|561573721|FG000|Optimization Period|Lack of Efficacy|5|||
155586771|NCT00985504|561573722|FG001|Optimization Period|Lack of Efficacy|3|||
155586772|NCT00985504|561573721|FG000|Optimization Period|Lost to Follow-up|0|||
155586773|NCT00985504|561573722|FG001|Optimization Period|Lost to Follow-up|1|||
155586774|NCT00985504|561573721|FG000|Optimization Period|Physician Decision|1|||
155586775|NCT00985504|561573722|FG001|Optimization Period|Physician Decision|0|||
155586776|NCT00985504|561573721|FG000|Optimization Period|Protocol Violation|3|||
155586777|NCT00985504|561573722|FG001|Optimization Period|Protocol Violation|1|||
155586778|NCT00985504|561573721|FG000|Optimization Period|Withdrawal by Subject|10|||
155586779|NCT00985504|561573722|FG001|Optimization Period|Withdrawal by Subject|8|||
155586780|NCT03379727|561573723|FG000|Overall Study|Lack of Efficacy|73|||
155586781|NCT03379727|561573723|FG000|Overall Study|Adverse Event|32|||
155586782|NCT03379727|561573723|FG000|Overall Study|Death|18|||
155586783|NCT03379727|561573723|FG000|Overall Study|Patient/guardian decision|17|||
155586784|NCT03379727|561573723|FG000|Overall Study|Physician Decision|104|||
155586785|NCT03379727|561573723|FG000|Overall Study|Protocol Violation|4|||
155586786|NCT03379727|561573723|FG000|Overall Study|Lost to Follow-up|1|||
155586787|NCT01205776|561573727|FG000|Overall Study|Lost to Follow-up|53|||
155586788|NCT01205776|561573728|FG001|Overall Study|Lost to Follow-up|61|||
155586789|NCT01205776|561573727|FG000|Overall Study|Withdrawal by Subject|11|||
155586790|NCT01205776|561573728|FG001|Overall Study|Withdrawal by Subject|34|||
155586791|NCT02747108|561573731|FG000|Overall Study|Death|2|||
155586792|NCT02747108|561573732|FG001|Overall Study|Death|2|||
155586793|NCT02747108|561573731|FG000|Overall Study|Withdrawal by Subject|1|||
155586794|NCT02747108|561573732|FG001|Overall Study|Withdrawal by Subject|0|||
155586795|NCT02747108|561573731|FG000|Overall Study|Protocol Violation|2|||
155586796|NCT02747108|561573732|FG001|Overall Study|Protocol Violation|0|||
155586797|NCT04432831|561575828|FG000|Overall Study|Withdrawal by Subject|24|||
155586798|NCT04432831|561575829|FG001|Overall Study|Withdrawal by Subject|28|||
155586799|NCT04432831|561575830|FG002|Overall Study|Withdrawal by Subject|21|||
155586800|NCT04432831|561575828|FG000|Overall Study|Death|23|||
155586801|NCT04432831|561575829|FG001|Overall Study|Death|23|||
155586802|NCT04432831|561575830|FG002|Overall Study|Death|17|||
155586803|NCT04432831|561575828|FG000|Overall Study|Lost to Follow-up|15|||
155586804|NCT04432831|561575829|FG001|Overall Study|Lost to Follow-up|15|||
155586805|NCT04432831|561575830|FG002|Overall Study|Lost to Follow-up|12|||
155586806|NCT04432831|561575828|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
155586807|NCT04432831|561575829|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
155586808|NCT04432831|561575830|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
155586809|NCT04432831|561575828|FG000|Overall Study|Reason Not Specified|7|||
155586810|NCT04432831|561575829|FG001|Overall Study|Reason Not Specified|11|||
155586811|NCT04432831|561575830|FG002|Overall Study|Reason Not Specified|9|||
155665435|NCT00077974|561870869|FG000|Overall Study|Lack of Efficacy|76|||
155665436|NCT00077974|561870869|FG000|Overall Study|Decision of Sponsor|2|||
155665437|NCT01343888|561870870|FG000|Overall Study|Adverse Event|12|||
155665438|NCT01343888|561870871|FG001|Overall Study|Adverse Event|22|||
155665439|NCT01343888|561870872|FG002|Overall Study|Adverse Event|5|||
155665440|NCT01343888|561870870|FG000|Overall Study|Lack of Efficacy|9|||
155665441|NCT01343888|561870871|FG001|Overall Study|Lack of Efficacy|9|||
155665442|NCT01343888|561870872|FG002|Overall Study|Lack of Efficacy|13|||
155665443|NCT01343888|561870870|FG000|Overall Study|Lost to Follow-up|0|||
155665444|NCT01343888|561870871|FG001|Overall Study|Lost to Follow-up|2|||
155665445|NCT01343888|561870872|FG002|Overall Study|Lost to Follow-up|1|||
155665446|NCT01343888|561870870|FG000|Overall Study|Protocol Violation|0|||
155665447|NCT01343888|561870871|FG001|Overall Study|Protocol Violation|2|||
155665448|NCT01343888|561870872|FG002|Overall Study|Protocol Violation|0|||
155665449|NCT01343888|561870870|FG000|Overall Study|Withdrawal by Subject|4|||
155665450|NCT01343888|561870871|FG001|Overall Study|Withdrawal by Subject|4|||
155665451|NCT01343888|561870872|FG002|Overall Study|Withdrawal by Subject|2|||
155665452|NCT01343888|561870870|FG000|Overall Study|other than stated above|0|||
155665453|NCT01343888|561870871|FG001|Overall Study|other than stated above|0|||
155665454|NCT01343888|561870872|FG002|Overall Study|other than stated above|1|||
155665455|NCT00558636|561870878|FG000|Treatment|Adverse Event|9|||
155665456|NCT00558636|561870879|FG001|Treatment|Adverse Event|2|||
155665457|NCT00558636|561870878|FG000|Treatment|Withdrawal by Subject|2|||
155665458|NCT00558636|561870879|FG001|Treatment|Withdrawal by Subject|0|||
155665459|NCT00558636|561870878|FG000|Treatment|Premature termination of the study|35|||
155665460|NCT00558636|561870879|FG001|Treatment|Premature termination of the study|37|||
155665461|NCT00558636|561870878|FG000|Treatment|Disease progression|1|||
155665462|NCT00558636|561870879|FG001|Treatment|Disease progression|5|||
155665463|NCT00558636|561870878|FG000|Follow-up|Premature termination of the study|12|||
155665464|NCT00558636|561870879|FG001|Follow-up|Premature termination of the study|7|||
155665465|NCT00387088|561870880|FG000|Overall Study|Adverse Event|143|||
155665466|NCT00387088|561870881|FG001|Overall Study|Adverse Event|156|||
155665467|NCT00387088|561870880|FG000|Overall Study|Protocol Violation|47|||
155665468|NCT00387088|561870881|FG001|Overall Study|Protocol Violation|35|||
155665469|NCT00387088|561870880|FG000|Overall Study|Withdrawal by Subject|20|||
155665470|NCT00387088|561870881|FG001|Overall Study|Withdrawal by Subject|35|||
155665471|NCT00387088|561870880|FG000|Overall Study|Lack of Efficacy|28|||
155665472|NCT00387088|561870881|FG001|Overall Study|Lack of Efficacy|67|||
155665473|NCT00387088|561870880|FG000|Overall Study|Lost to Follow-up|22|||
155665474|NCT00387088|561870881|FG001|Overall Study|Lost to Follow-up|28|||
155665475|NCT00387088|561870880|FG000|Overall Study|Other|58|||
155665476|NCT00387088|561870881|FG001|Overall Study|Other|52|||
155665477|NCT01990742|561870882|FG000|Overall Study|Withdrawal by facility|407|||
155665478|NCT01990742|561870883|FG001|Overall Study|Withdrawal by facility|1083|||
155665479|NCT01990742|561870882|FG000|Overall Study|Facility closed|0|||
155665480|NCT01990742|561870883|FG001|Overall Study|Facility closed|270|||
155665481|NCT03443687|561870884|FG000|Overall Study|Lost to Follow-up|3|||
155665482|NCT03443687|561870885|FG001|Overall Study|Lost to Follow-up|5|||
155665483|NCT03443687|561870884|FG000|Overall Study|Withdrawal by Subject|1|||
155665484|NCT03443687|561870885|FG001|Overall Study|Withdrawal by Subject|0|||
155665485|NCT03443687|561870884|FG000|Overall Study|Discontinued intervention|1|||
155665486|NCT03443687|561870885|FG001|Overall Study|Discontinued intervention|1|||
155665487|NCT02805790|561870888|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
155665488|NCT02805790|561870889|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
155665489|NCT00800735|561870890|FG000|Overall Study|Administrative/Other|2|||
155665490|NCT00800735|561870890|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155665491|NCT00800735|561870890|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
155665492|NCT00800735|561870890|FG000|Overall Study|Withdrew Consent|3|||
155665493|NCT02071771|561870898|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
155665494|NCT02071771|561870899|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
155665495|NCT02071771|561870898|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
155665496|NCT02071771|561870899|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
155665497|NCT02078752|561870900|FG000|Overall Study|Death|0|||
155665498|NCT02078752|561870901|FG001|Overall Study|Death|3|||
155665499|NCT02078752|561870902|FG002|Overall Study|Death|0|||
155665500|NCT02078752|561870903|FG003|Overall Study|Death|0|||
155665501|NCT02078752|561870904|FG004|Overall Study|Death|0|||
155665502|NCT02078752|561870905|FG005|Overall Study|Death|1|||
155665503|NCT02078752|561870906|FG006|Overall Study|Death|0|||
155665504|NCT02078752|561870907|FG007|Overall Study|Death|1|||
155665505|NCT02078752|561870908|FG008|Overall Study|Death|0|||
155665506|NCT02078752|561870909|FG009|Overall Study|Death|4|||
155665507|NCT02078752|561870900|FG000|Overall Study|Lost to Follow-up|1|||
155665508|NCT02078752|561870901|FG001|Overall Study|Lost to Follow-up|0|||
155665509|NCT02078752|561870902|FG002|Overall Study|Lost to Follow-up|0|||
155665510|NCT02078752|561870903|FG003|Overall Study|Lost to Follow-up|1|||
155665511|NCT02078752|561870904|FG004|Overall Study|Lost to Follow-up|0|||
155665512|NCT02078752|561870905|FG005|Overall Study|Lost to Follow-up|0|||
155665513|NCT02078752|561870906|FG006|Overall Study|Lost to Follow-up|0|||
155665514|NCT02078752|561870907|FG007|Overall Study|Lost to Follow-up|0|||
155665515|NCT02078752|561870908|FG008|Overall Study|Lost to Follow-up|0|||
155665516|NCT02078752|561870909|FG009|Overall Study|Lost to Follow-up|0|||
155665517|NCT02078752|561870900|FG000|Overall Study|Withdrawal by Subject|1|||
155665518|NCT02078752|561870901|FG001|Overall Study|Withdrawal by Subject|1|||
155665519|NCT02078752|561870902|FG002|Overall Study|Withdrawal by Subject|1|||
155665520|NCT02078752|561870903|FG003|Overall Study|Withdrawal by Subject|1|||
155665521|NCT02078752|561870904|FG004|Overall Study|Withdrawal by Subject|0|||
155665522|NCT02078752|561870905|FG005|Overall Study|Withdrawal by Subject|3|||
155665523|NCT02078752|561870906|FG006|Overall Study|Withdrawal by Subject|2|||
155665524|NCT02078752|561870907|FG007|Overall Study|Withdrawal by Subject|1|||
155665525|NCT02078752|561870908|FG008|Overall Study|Withdrawal by Subject|0|||
155665526|NCT02078752|561870909|FG009|Overall Study|Withdrawal by Subject|1|||
155665527|NCT02078752|561870900|FG000|Overall Study|Other|0|||
155665528|NCT02078752|561870901|FG001|Overall Study|Other|3|||
155665529|NCT02078752|561870902|FG002|Overall Study|Other|0|||
155665530|NCT02078752|561870903|FG003|Overall Study|Other|0|||
155665531|NCT02078752|561870904|FG004|Overall Study|Other|1|||
155665532|NCT02078752|561870905|FG005|Overall Study|Other|0|||
155665533|NCT02078752|561870906|FG006|Overall Study|Other|0|||
155665534|NCT02078752|561870907|FG007|Overall Study|Other|1|||
155665535|NCT02078752|561870908|FG008|Overall Study|Other|0|||
155665536|NCT02078752|561870909|FG009|Overall Study|Other|0|||
155665537|NCT02078752|561870900|FG000|Overall Study|Study terminated by sponsor|0|||
155665538|NCT02078752|561870901|FG001|Overall Study|Study terminated by sponsor|0|||
155665539|NCT02078752|561870902|FG002|Overall Study|Study terminated by sponsor|0|||
155665540|NCT02078752|561870903|FG003|Overall Study|Study terminated by sponsor|0|||
155665541|NCT02078752|561870904|FG004|Overall Study|Study terminated by sponsor|0|||
155665542|NCT02078752|561870905|FG005|Overall Study|Study terminated by sponsor|0|||
155665543|NCT02078752|561870906|FG006|Overall Study|Study terminated by sponsor|0|||
155665544|NCT02078752|561870907|FG007|Overall Study|Study terminated by sponsor|0|||
155665545|NCT02078752|561870908|FG008|Overall Study|Study terminated by sponsor|0|||
155665546|NCT02078752|561870909|FG009|Overall Study|Study terminated by sponsor|5|||
155665547|NCT01331681|561870913|FG000|Overall Study|Adverse Event|10|||
155665548|NCT01331681|561870914|FG001|Overall Study|Adverse Event|13|||
155665549|NCT01331681|561870915|FG002|Overall Study|Adverse Event|10|||
155665550|NCT01331681|561870913|FG000|Overall Study|Death|6|||
155665551|NCT01331681|561870914|FG001|Overall Study|Death|6|||
155665552|NCT01331681|561870915|FG002|Overall Study|Death|2|||
155665553|NCT01331681|561870913|FG000|Overall Study|Lack of Efficacy|0|||
155665554|NCT01331681|561870914|FG001|Overall Study|Lack of Efficacy|1|||
155665555|NCT01331681|561870915|FG002|Overall Study|Lack of Efficacy|0|||
155665556|NCT01331681|561870913|FG000|Overall Study|Withdrawal by Subject|12|||
155665557|NCT01331681|561870914|FG001|Overall Study|Withdrawal by Subject|8|||
155665558|NCT01331681|561870915|FG002|Overall Study|Withdrawal by Subject|15|||
155665559|NCT01331681|561870913|FG000|Overall Study|Protocol Violation|1|||
155665560|NCT01331681|561870914|FG001|Overall Study|Protocol Violation|1|||
155665561|NCT01331681|561870915|FG002|Overall Study|Protocol Violation|0|||
155665562|NCT01331681|561870913|FG000|Overall Study|Lost to Follow-up|2|||
155665563|NCT01331681|561870914|FG001|Overall Study|Lost to Follow-up|4|||
155665564|NCT01331681|561870915|FG002|Overall Study|Lost to Follow-up|1|||
155665565|NCT01331681|561870913|FG000|Overall Study|Physician Decision|2|||
155665566|NCT01331681|561870914|FG001|Overall Study|Physician Decision|0|||
155665567|NCT01331681|561870915|FG002|Overall Study|Physician Decision|4|||
155665568|NCT01331681|561870913|FG000|Overall Study|Therapeutic procedure required|1|||
155665569|NCT01331681|561870914|FG001|Overall Study|Therapeutic procedure required|0|||
155665570|NCT01331681|561870915|FG002|Overall Study|Therapeutic procedure required|0|||
155665571|NCT01331681|561870913|FG000|Overall Study|Sponsor decision|1|||
155665572|NCT01331681|561870914|FG001|Overall Study|Sponsor decision|1|||
155665573|NCT01331681|561870915|FG002|Overall Study|Sponsor decision|0|||
155665574|NCT01331681|561870913|FG000|Overall Study|Switching to other therapy|0|||
155665575|NCT01331681|561870914|FG001|Overall Study|Switching to other therapy|0|||
155665576|NCT01331681|561870915|FG002|Overall Study|Switching to other therapy|1|||
155665577|NCT01331681|561870913|FG000|Overall Study|Not Received Study Treatment|0|||
155665578|NCT01331681|561870914|FG001|Overall Study|Not Received Study Treatment|0|||
155665579|NCT01331681|561870915|FG002|Overall Study|Not Received Study Treatment|2|||
155665580|NCT00616642|561870916|FG000|Overall Study|Withdrawal by Subject|0|||
155665581|NCT00616642|561870917|FG001|Overall Study|Withdrawal by Subject|1|||
155665582|NCT01664247|561870919|FG000|Overall Study|Adverse Event|5|||
155665583|NCT01664247|561870920|FG001|Overall Study|Adverse Event|3|||
155665584|NCT01664247|561870919|FG000|Overall Study|Protocol Violation|3|||
155665585|NCT01664247|561870920|FG001|Overall Study|Protocol Violation|5|||
155665586|NCT01664247|561870919|FG000|Overall Study|Withdrawal Criteria|1|||
155665587|NCT01664247|561870920|FG001|Overall Study|Withdrawal Criteria|4|||
155665588|NCT01664247|561870919|FG000|Overall Study|Unclassified|5|||
155665589|NCT01664247|561870920|FG001|Overall Study|Unclassified|29|||
155665590|NCT00382174|561870921|FG000|Overall Study|Lost to Follow-up|1|||
155665591|NCT00382174|561870922|FG001|Overall Study|Lost to Follow-up|4|||
155665592|NCT00382174|561870923|FG002|Overall Study|Lost to Follow-up|5|||
155665593|NCT00382174|561870921|FG000|Overall Study|Adverse Event|1|||
155665594|NCT00382174|561870922|FG001|Overall Study|Adverse Event|4|||
155665595|NCT00382174|561870923|FG002|Overall Study|Adverse Event|5|||
155665596|NCT00382174|561870921|FG000|Overall Study|Withdrawal by Subject|1|||
155665597|NCT00382174|561870922|FG001|Overall Study|Withdrawal by Subject|4|||
155665598|NCT00382174|561870923|FG002|Overall Study|Withdrawal by Subject|5|||
155665599|NCT00382174|561870921|FG000|Overall Study|Non compliance|1|||
155665600|NCT00382174|561870922|FG001|Overall Study|Non compliance|0|||
155665601|NCT00382174|561870923|FG002|Overall Study|Non compliance|1|||
155665602|NCT00382174|561870921|FG000|Overall Study|Physician Decision|0|||
155665603|NCT00382174|561870922|FG001|Overall Study|Physician Decision|2|||
155665604|NCT00382174|561870923|FG002|Overall Study|Physician Decision|2|||
155665605|NCT00382174|561870921|FG000|Overall Study|Failed to meet criteria|0|||
155665606|NCT00382174|561870922|FG001|Overall Study|Failed to meet criteria|1|||
155665607|NCT00382174|561870923|FG002|Overall Study|Failed to meet criteria|1|||
155665608|NCT00382174|561870921|FG000|Overall Study|Wounds merged|0|||
155665609|NCT00382174|561870922|FG001|Overall Study|Wounds merged|2|||
155665610|NCT00382174|561870923|FG002|Overall Study|Wounds merged|2|||
155665611|NCT04577781|561870926|FG000|Overall Study|Adverse Event|2|||
155665612|NCT04577781|561870927|FG001|Overall Study|Adverse Event|2|||
155665613|NCT04577781|561870926|FG000|Overall Study|Physician Decision|1|||
155665614|NCT04577781|561870927|FG001|Overall Study|Physician Decision|0|||
155665615|NCT00967616|561870933|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
155665616|NCT00967616|561870934|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
155665617|NCT00967616|561870933|FG000|Overall Study|Death|0|||
155665618|NCT00967616|561870934|FG001|Overall Study|Death|3|||
155665619|NCT00967616|561870933|FG000|Overall Study|Withdrawal by Subject|8|||
155665620|NCT00967616|561870934|FG001|Overall Study|Withdrawal by Subject|4|||
155665621|NCT00967616|561870933|FG000|Overall Study|Progressive Disease|31|||
155665622|NCT00967616|561870934|FG001|Overall Study|Progressive Disease|18|||
155665623|NCT00967616|561870933|FG000|Overall Study|Other|8|||
155665624|NCT00967616|561870934|FG001|Overall Study|Other|8|||
155665625|NCT00967616|561870933|FG000|Overall Study|Protocol Violation|1|||
155665626|NCT00967616|561870934|FG001|Overall Study|Protocol Violation|0|||
155665627|NCT00575666|561870935|FG000|Overall Study|Withdrawal by Subject|3|||
155665628|NCT00575666|561870936|FG001|Overall Study|Withdrawal by Subject|2|||
155665629|NCT00575666|561870935|FG000|Overall Study|Physician Decision|1|||
155665630|NCT00575666|561870936|FG001|Overall Study|Physician Decision|1|||
155665631|NCT01374425|561870937|FG000|Overall Study|Radiographic Disease Progression|86|||
155665632|NCT01374425|561870938|FG001|Overall Study|Radiographic Disease Progression|81|||
155665633|NCT01374425|561870937|FG000|Overall Study|Clinical Disease Progression|9|||
155665634|NCT01374425|561870938|FG001|Overall Study|Clinical Disease Progression|6|||
155665635|NCT01374425|561870937|FG000|Overall Study|Adverse Event|29|||
155665636|NCT01374425|561870938|FG001|Overall Study|Adverse Event|18|||
155665637|NCT01374425|561870937|FG000|Overall Study|Death (Progression of Disease)|1|||
155665638|NCT01374425|561870938|FG001|Overall Study|Death (Progression of Disease)|0|||
155665639|NCT01374425|561870937|FG000|Overall Study|Death (Adverse Event)|2|||
155665640|NCT01374425|561870938|FG001|Overall Study|Death (Adverse Event)|4|||
155665641|NCT01374425|561870937|FG000|Overall Study|Withdrawal by Subject|6|||
155665642|NCT01374425|561870938|FG001|Overall Study|Withdrawal by Subject|7|||
155665643|NCT01374425|561870937|FG000|Overall Study|Refused Treatment|10|||
155665644|NCT01374425|561870938|FG001|Overall Study|Refused Treatment|24|||
155665645|NCT01374425|561870937|FG000|Overall Study|Protocol Violation|2|||
155665646|NCT01374425|561870938|FG001|Overall Study|Protocol Violation|3|||
155665647|NCT01374425|561870937|FG000|Overall Study|Sponsor Decision|0|||
155665648|NCT01374425|561870938|FG001|Overall Study|Sponsor Decision|1|||
155665649|NCT01374425|561870937|FG000|Overall Study|Lost to Follow-up|2|||
155665650|NCT01374425|561870938|FG001|Overall Study|Lost to Follow-up|1|||
155665651|NCT01374425|561870937|FG000|Overall Study|Other|41|||
155665652|NCT01374425|561870938|FG001|Overall Study|Other|43|||
155665653|NCT02289469|561870939|FG000|Overall Study|Unable to match a control|6|||
155665654|NCT02289469|561870940|FG001|Overall Study|Unable to match a control|0|||
155665655|NCT02750930|561870941|FG000|Overall Study|Study closed/terminated|8|||
155665656|NCT00553631|561870942|FG000|Overall Study|Withdrawal by Subject|0|||
155665657|NCT00553631|561870943|FG001|Overall Study|Withdrawal by Subject|1|||
155665658|NCT00553631|561870942|FG000|Overall Study|Lost to Follow-up|1|||
155665659|NCT00553631|561870943|FG001|Overall Study|Lost to Follow-up|0|||
155665660|NCT02761642|561870944|FG000|Overall Study|Did not Receive Study Treatment|3|||
155665661|NCT02761642|561870944|FG000|Overall Study|Adverse Event|13|||
155665662|NCT02761642|561870944|FG000|Overall Study|Withdrawal by Subject|2|||
155665663|NCT02761642|561870944|FG000|Overall Study|Non-compliant|7|||
155665664|NCT02761642|561870944|FG000|Overall Study|Death|3|||
155665665|NCT02761642|561870944|FG000|Overall Study|Lack of Efficacy|20|||
155665666|NCT02761642|561870944|FG000|Overall Study|Physician Decision|1|||
155665667|NCT02761642|561870944|FG000|Overall Study|Reason Unspecified|21|||
155665668|NCT04940130|561870947|FG000|Overall Study|Travel|1|||
155665669|NCT04940130|561870948|FG001|Overall Study|Travel|0|||
155665670|NCT04940130|561870949|FG002|Overall Study|Travel|2|||
155665671|NCT04940130|561870947|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
155665672|NCT04940130|561870948|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
155665673|NCT04940130|561870949|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
155665674|NCT04940130|561870947|FG000|Overall Study|Adverse Event|0|||
155665675|NCT04940130|561870948|FG001|Overall Study|Adverse Event|0|||
155665676|NCT04940130|561870949|FG002|Overall Study|Adverse Event|2|||
155665677|NCT04940130|561870947|FG000|Overall Study|Disease progression/treatment failure|0|||
155665678|NCT04940130|561870948|FG001|Overall Study|Disease progression/treatment failure|0|||
155665679|NCT04940130|561870949|FG002|Overall Study|Disease progression/treatment failure|1|||
155665680|NCT04940130|561870947|FG000|Overall Study|Participant refusal|0|||
155665681|NCT04940130|561870948|FG001|Overall Study|Participant refusal|0|||
155665682|NCT04940130|561870949|FG002|Overall Study|Participant refusal|1|||
155665683|NCT00114127|561870952|FG000|Overall Study|Adverse Event|2|||
155665684|NCT00114127|561870953|FG001|Overall Study|Adverse Event|1|||
155665685|NCT00114127|561870952|FG000|Overall Study|Lost to Follow-up|1|||
155665686|NCT00114127|561870953|FG001|Overall Study|Lost to Follow-up|0|||
155665687|NCT00114127|561870952|FG000|Overall Study|Withdrawal by Subject|1|||
155665688|NCT00114127|561870953|FG001|Overall Study|Withdrawal by Subject|3|||
155665689|NCT00469833|561870954|FG000|Overall Study|No IV access|2|||
155665690|NCT04422431|561870963|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
155665691|NCT04422431|561870963|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
155665692|NCT04422431|561870963|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
155665693|NCT04422431|561870963|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
155665694|NCT04422431|561870963|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
155665695|NCT04422431|561870963|FG000|Extension Period (48 Weeks)|Other than specified|2|||
155665696|NCT03913130|561870964|FG000|Overall Study|Sponsor Decision|1|||
155665697|NCT01174563|561870967|FG000|Overall Study|Progressive Disease|45|||
155665698|NCT01174563|561870967|FG000|Overall Study|Death|5|||
155665699|NCT01174563|561870967|FG000|Overall Study|Investigator's Discretion|5|||
155665700|NCT01174563|561870967|FG000|Overall Study|Participant Withdrew Consent|3|||
155665701|NCT01174563|561870967|FG000|Overall Study|Rash Adverse Event|1|||
155665702|NCT01174563|561870967|FG000|Overall Study|Sponsor's decision|1|||
155665703|NCT03402841|561870968|FG000|Overall Study|Withdrawal by Subject|3|||
155665704|NCT03402841|561870968|FG000|Overall Study|Lost to Follow-up|2|||
155665705|NCT03402841|561870968|FG000|Overall Study|Death|146|||
155665706|NCT00444106|561870969|FG000|Overall Study|Lost to Follow-up|2|||
155665707|NCT00444106|561870970|FG001|Overall Study|Lost to Follow-up|1|||
155665708|NCT00444106|561870971|FG002|Overall Study|Lost to Follow-up|0|||
155665709|NCT00444106|561870969|FG000|Overall Study|Abnormal Test Procedure Results|0|||
155665710|NCT00444106|561870970|FG001|Overall Study|Abnormal Test Procedure Results|0|||
155665711|NCT00444106|561870971|FG002|Overall Study|Abnormal Test Procedure Results|1|||
155665712|NCT02317627|561870974|FG000|Overall Study|Withdrawal by Subject|0|||
155665713|NCT02317627|561870975|FG001|Overall Study|Withdrawal by Subject|1|||
155665714|NCT02317627|561870976|FG002|Overall Study|Withdrawal by Subject|1|||
155665715|NCT02317627|561870974|FG000|Overall Study|Lost to Follow-up|2|||
155665716|NCT02317627|561870975|FG001|Overall Study|Lost to Follow-up|0|||
155665717|NCT02317627|561870976|FG002|Overall Study|Lost to Follow-up|0|||
155665718|NCT02317627|561870974|FG000|Overall Study|Stopped by Investigator|0|||
155665719|NCT02317627|561870975|FG001|Overall Study|Stopped by Investigator|1|||
155665720|NCT02317627|561870976|FG002|Overall Study|Stopped by Investigator|0|||
155665721|NCT02317627|561870974|FG000|Overall Study|Adverse Event|0|||
155665722|NCT02317627|561870975|FG001|Overall Study|Adverse Event|2|||
155665723|NCT02317627|561870976|FG002|Overall Study|Adverse Event|3|||
155665724|NCT02317627|561870974|FG000|Overall Study|Non-compliance with study drug|0|||
155665725|NCT02317627|561870975|FG001|Overall Study|Non-compliance with study drug|1|||
155665726|NCT02317627|561870976|FG002|Overall Study|Non-compliance with study drug|0|||
155665727|NCT00279214|561870977|FG000|Overall Study|Physician Decision|3|||
155665728|NCT00279214|561870978|FG001|Overall Study|Physician Decision|2|||
155665729|NCT01280968|561870979|FG000|Overall Study|Lost to Follow-up|8|||
155665730|NCT01280968|561870980|FG001|Overall Study|Lost to Follow-up|2|||
155665731|NCT01280968|561870979|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
155665732|NCT01280968|561870980|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
155665733|NCT01280968|561870979|FG000|Overall Study|Commuting Problems|2|||
155665734|NCT01280968|561870980|FG001|Overall Study|Commuting Problems|0|||
155665735|NCT01280968|561870979|FG000|Overall Study|Anxiety|2|||
155665736|NCT01280968|561870980|FG001|Overall Study|Anxiety|0|||
155665737|NCT01280968|561870979|FG000|Overall Study|Adverse Event|1|||
155665738|NCT01280968|561870980|FG001|Overall Study|Adverse Event|0|||
155665739|NCT01280968|561870979|FG000|Overall Study|Scheduling Conflicts|1|||
155665740|NCT01280968|561870980|FG001|Overall Study|Scheduling Conflicts|1|||
155665741|NCT01280968|561870979|FG000|Overall Study|Pre-existing Neurological Condition|1|||
155665742|NCT01280968|561870980|FG001|Overall Study|Pre-existing Neurological Condition|0|||
155665743|NCT01280968|561870979|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
155665744|NCT01280968|561870980|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
155665745|NCT00038948|561870981|FG000|Overall Study|Adverse Event|131|||
155665746|NCT00038948|561870982|FG001|Overall Study|Adverse Event|43|||
155665747|NCT00038948|561870981|FG000|Overall Study|Lost to Follow-up|4|||
155665748|NCT00038948|561870982|FG001|Overall Study|Lost to Follow-up|4|||
155665749|NCT00038948|561870981|FG000|Overall Study|Nonmedical event|5|||
155665750|NCT00038948|561870982|FG001|Overall Study|Nonmedical event|7|||
155665751|NCT00038948|561870981|FG000|Overall Study|Withdrawal by Subject|23|||
155665752|NCT00038948|561870982|FG001|Overall Study|Withdrawal by Subject|10|||
155665753|NCT00038948|561870981|FG000|Overall Study|Protocol Violation|3|||
155665754|NCT00038948|561870982|FG001|Overall Study|Protocol Violation|7|||
155665755|NCT00038948|561870981|FG000|Overall Study|Lack of Efficacy|3|||
155665756|NCT00038948|561870982|FG001|Overall Study|Lack of Efficacy|6|||
155665757|NCT03984188|561870985|FG000|Overall Study|Death|2|||
155665758|NCT03984188|561870986|FG001|Overall Study|Death|4|||
155665759|NCT03984188|561870985|FG000|Overall Study|Physician Decision|0|||
155665760|NCT03984188|561870986|FG001|Overall Study|Physician Decision|2|||
155665761|NCT03984188|561870985|FG000|Overall Study|Lost to Follow-up|3|||
155665762|NCT03984188|561870986|FG001|Overall Study|Lost to Follow-up|2|||
155665763|NCT03984188|561870985|FG000|Overall Study|Withdrawal by Subject|6|||
155665764|NCT03984188|561870986|FG001|Overall Study|Withdrawal by Subject|0|||
155665765|NCT01747915|561872697|FG000|Overall Study|Other|1|||
155665766|NCT01747915|561872698|FG001|Overall Study|Other|1|||
155665767|NCT01747915|561872699|FG002|Overall Study|Other|1|||
155665768|NCT01747915|561872697|FG000|Overall Study|Adverse Event|8|||
155665769|NCT01747915|561872698|FG001|Overall Study|Adverse Event|5|||
155665770|NCT01747915|561872699|FG002|Overall Study|Adverse Event|2|||
155665771|NCT01747915|561872697|FG000|Overall Study|Death|0|||
155665772|NCT01747915|561872698|FG001|Overall Study|Death|0|||
155665773|NCT01747915|561872699|FG002|Overall Study|Death|1|||
155665774|NCT01747915|561872697|FG000|Overall Study|Lack of Efficacy|0|||
155665775|NCT01747915|561872698|FG001|Overall Study|Lack of Efficacy|1|||
155665776|NCT01747915|561872699|FG002|Overall Study|Lack of Efficacy|0|||
155665777|NCT01747915|561872697|FG000|Overall Study|Lost to Follow-up|1|||
155665778|NCT01747915|561872698|FG001|Overall Study|Lost to Follow-up|0|||
155665779|NCT01747915|561872699|FG002|Overall Study|Lost to Follow-up|0|||
155665780|NCT01747915|561872697|FG000|Overall Study|Withdrawal by Subject|4|||
155665781|NCT01747915|561872698|FG001|Overall Study|Withdrawal by Subject|4|||
155665782|NCT01747915|561872699|FG002|Overall Study|Withdrawal by Subject|1|||
155665783|NCT01747915|561872697|FG000|Overall Study|Protocol Violation|1|||
155665784|NCT01747915|561872698|FG001|Overall Study|Protocol Violation|0|||
155665785|NCT01747915|561872699|FG002|Overall Study|Protocol Violation|0|||
155665786|NCT01747915|561872697|FG000|Overall Study|Pregnancy|0|||
155665787|NCT01747915|561872698|FG001|Overall Study|Pregnancy|0|||
155665788|NCT01747915|561872699|FG002|Overall Study|Pregnancy|1|||
155665789|NCT03341637|561872700|FG000|Overall Study|Lost to Follow-up|1|||
155665790|NCT03341637|561872701|FG001|Overall Study|Lost to Follow-up|0|||
155665791|NCT03341637|561872700|FG000|Overall Study|Withdrawal by Subject|3|||
155665792|NCT03341637|561872701|FG001|Overall Study|Withdrawal by Subject|3|||
155665793|NCT03341637|561872700|FG000|Overall Study|Reason not Specified|1|||
155665794|NCT03341637|561872701|FG001|Overall Study|Reason not Specified|1|||
155665795|NCT06164691|561872703|FG000|Overall Study|Withdrawal by Subject|2|||
155665796|NCT06164691|561872704|FG001|Overall Study|Withdrawal by Subject|0|||
155665797|NCT06164691|561872705|FG002|Overall Study|Withdrawal by Subject|0|||
155665798|NCT02391311|561872706|FG000|Overall Study|Lost to Follow-up|2|||
155665799|NCT02391311|561872707|FG001|Overall Study|Lost to Follow-up|1|||
155665800|NCT02391311|561872706|FG000|Overall Study|deemed ineligible after baseline|1|||
155665801|NCT02391311|561872707|FG001|Overall Study|deemed ineligible after baseline|1|||
155665802|NCT03183063|561872708|FG000|Overall Study|Withdrawal by Subject|2|||
155665803|NCT03183063|561872709|FG001|Overall Study|Withdrawal by Subject|0|||
155665804|NCT03183063|561872710|FG002|Overall Study|Withdrawal by Subject|0|||
155665805|NCT03183063|561872708|FG000|Overall Study|Physician Decision|3|||
155665806|NCT03183063|561872709|FG001|Overall Study|Physician Decision|4|||
155665807|NCT03183063|561872710|FG002|Overall Study|Physician Decision|4|||
155665808|NCT00925002|561872711|FG000|Overall Study|Other|1|||
155665809|NCT00925002|561872712|FG001|Overall Study|Other|4|||
155665810|NCT00925002|561872713|FG002|Overall Study|Other|0|||
155665811|NCT00925002|561872711|FG000|Overall Study|Death|1|||
155665812|NCT00925002|561872712|FG001|Overall Study|Death|1|||
155665813|NCT00925002|561872713|FG002|Overall Study|Death|5|||
155665814|NCT00925002|561872711|FG000|Overall Study|Adverse Event|3|||
155665815|NCT00925002|561872712|FG001|Overall Study|Adverse Event|1|||
155665816|NCT00925002|561872713|FG002|Overall Study|Adverse Event|2|||
155665817|NCT00925002|561872711|FG000|Overall Study|Participant withdrew consent|1|||
155665818|NCT00925002|561872712|FG001|Overall Study|Participant withdrew consent|3|||
155665819|NCT00925002|561872713|FG002|Overall Study|Participant withdrew consent|3|||
155665820|NCT01073293|561872716|FG000|Overall Study|Lost to Follow-up|0|||
155665821|NCT01073293|561872717|FG001|Overall Study|Lost to Follow-up|1|||
155665822|NCT01073293|561872716|FG000|Overall Study|Withdrawal by Subject|5|||
155665823|NCT01073293|561872717|FG001|Overall Study|Withdrawal by Subject|10|||
155665824|NCT02897115|561872720|FG000|Overall Study|Early termination of study by sponsor|11|||
155665825|NCT02897115|561872721|FG001|Overall Study|Early termination of study by sponsor|8|||
155665826|NCT02776683|561872729|FG000|Pre-switch Period|Protocol Violation|1|||
155665827|NCT02776683|561872730|FG001|Pre-switch Period|Protocol Violation|0|||
155665828|NCT02776683|561872729|FG000|Pre-switch Period|Adverse Event|21|||
155665829|NCT02776683|561872730|FG001|Pre-switch Period|Adverse Event|0|||
155665830|NCT02776683|561872729|FG000|Pre-switch Period|Withdrawal by Subject|9|||
155665831|NCT02776683|561872730|FG001|Pre-switch Period|Withdrawal by Subject|0|||
155665832|NCT02776683|561872729|FG000|Pre-switch Period|Physician Decision|7|||
155665833|NCT02776683|561872730|FG001|Pre-switch Period|Physician Decision|0|||
155665834|NCT02776683|561872729|FG000|Pre-switch Period|Progressive disease|39|||
155665835|NCT02776683|561872730|FG001|Pre-switch Period|Progressive disease|0|||
155665836|NCT02776683|561872729|FG000|Pre-switch Period|Other than listed|3|||
155665837|NCT02776683|561872730|FG001|Pre-switch Period|Other than listed|0|||
155665838|NCT02776683|561872729|FG000|Post-switch Period|Adverse Event|0|||
155665839|NCT02776683|561872730|FG001|Post-switch Period|Adverse Event|3|||
155665840|NCT02776683|561872729|FG000|Post-switch Period|Withdrawal by Subject|0|||
155665841|NCT02776683|561872730|FG001|Post-switch Period|Withdrawal by Subject|2|||
155665842|NCT02776683|561872729|FG000|Post-switch Period|Physician Decision|0|||
155665843|NCT02776683|561872730|FG001|Post-switch Period|Physician Decision|3|||
155665844|NCT02776683|561872729|FG000|Post-switch Period|Progressive disease|0|||
155665845|NCT02776683|561872730|FG001|Post-switch Period|Progressive disease|20|||
155665846|NCT02776683|561872729|FG000|Post-switch Period|Other than listed|0|||
155665847|NCT02776683|561872730|FG001|Post-switch Period|Other than listed|15|||
155665848|NCT01023217|561872732|FG000|Overall Study|Withdrawal by Subject|1|||
155665849|NCT01023217|561872733|FG001|Overall Study|Withdrawal by Subject|0|||
155665850|NCT01673646|561872734|FG000|Overall Study|Adverse Event|2|||
155665851|NCT01673646|561872735|FG001|Overall Study|Adverse Event|1|||
155665852|NCT01673646|561872736|FG002|Overall Study|Adverse Event|1|||
155665853|NCT01673646|561872734|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155665854|NCT01673646|561872735|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155665855|NCT01673646|561872736|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155665856|NCT01673646|561872734|FG000|Overall Study|Condition no longer requires study drug|0|||
155665857|NCT01673646|561872735|FG001|Overall Study|Condition no longer requires study drug|1|||
155665858|NCT01673646|561872736|FG002|Overall Study|Condition no longer requires study drug|0|||
155665859|NCT01673646|561872734|FG000|Overall Study|Withdrawal by Subject|0|||
155665860|NCT01673646|561872735|FG001|Overall Study|Withdrawal by Subject|2|||
155665861|NCT01673646|561872736|FG002|Overall Study|Withdrawal by Subject|2|||
155665862|NCT01673646|561872734|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
155665863|NCT01673646|561872735|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
155665864|NCT01673646|561872736|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
155665865|NCT01000506|561872737|FG000|Overall Study|Adverse Event|6|||
155665866|NCT01000506|561872738|FG001|Overall Study|Adverse Event|5|||
155665867|NCT01000506|561872739|FG002|Overall Study|Adverse Event|8|||
155665868|NCT01000506|561872740|FG003|Overall Study|Adverse Event|9|||
155665869|NCT01000506|561872737|FG000|Overall Study|Lack of Efficacy|8|||
155665870|NCT01000506|561872738|FG001|Overall Study|Lack of Efficacy|6|||
155665871|NCT01000506|561872739|FG002|Overall Study|Lack of Efficacy|4|||
155665872|NCT01000506|561872740|FG003|Overall Study|Lack of Efficacy|4|||
155665873|NCT01000506|561872737|FG000|Overall Study|Protocol Violation|1|||
155665874|NCT01000506|561872738|FG001|Overall Study|Protocol Violation|1|||
155665875|NCT01000506|561872739|FG002|Overall Study|Protocol Violation|0|||
155665876|NCT01000506|561872740|FG003|Overall Study|Protocol Violation|0|||
155665877|NCT01000506|561872737|FG000|Overall Study|Lost to Follow-up|1|||
155665878|NCT01000506|561872738|FG001|Overall Study|Lost to Follow-up|1|||
155665879|NCT01000506|561872739|FG002|Overall Study|Lost to Follow-up|4|||
155665880|NCT01000506|561872740|FG003|Overall Study|Lost to Follow-up|0|||
155665881|NCT01000506|561872737|FG000|Overall Study|Physician Decision|1|||
155665882|NCT01000506|561872738|FG001|Overall Study|Physician Decision|3|||
155665883|NCT01000506|561872739|FG002|Overall Study|Physician Decision|3|||
155665884|NCT01000506|561872740|FG003|Overall Study|Physician Decision|3|||
155665885|NCT01000506|561872737|FG000|Overall Study|Withdrawal by Subject|11|||
155665886|NCT01000506|561872738|FG001|Overall Study|Withdrawal by Subject|8|||
155665887|NCT01000506|561872739|FG002|Overall Study|Withdrawal by Subject|2|||
155665888|NCT01000506|561872740|FG003|Overall Study|Withdrawal by Subject|7|||
155665889|NCT03064074|561872741|FG000|Overall Study|Physician Decision|0|||
155665890|NCT03064074|561872742|FG001|Overall Study|Physician Decision|0|||
155665891|NCT03064074|561872743|FG002|Overall Study|Physician Decision|0|||
155665892|NCT03064074|561872744|FG003|Overall Study|Physician Decision|1|||
155665893|NCT05518461|561872746|FG000|Overall Study|Lost to Follow-up|25|||
155665894|NCT00269087|561872747|FG000|Overall Study|Adverse Event|20|||
155665895|NCT00269087|561872747|FG000|Overall Study|Withdrawal by Subject|1|||
155665896|NCT00269087|561872747|FG000|Overall Study|Exacerbation of COPD|13|||
155665897|NCT00332696|561872750|FG000|Overall Study|Death|24|||
155665898|NCT00332696|561872751|FG001|Overall Study|Death|14|||
155665899|NCT00332696|561872750|FG000|Overall Study|Insufficient therapeutic effect|4|||
155665900|NCT00332696|561872751|FG001|Overall Study|Insufficient therapeutic effect|11|||
155665901|NCT00332696|561872750|FG000|Overall Study|Adverse Event|1|||
155665902|NCT00332696|561872751|FG001|Overall Study|Adverse Event|2|||
155665903|NCT00332696|561872750|FG000|Overall Study|Condition does not justify treatment|0|||
155665904|NCT00332696|561872751|FG001|Overall Study|Condition does not justify treatment|2|||
155665905|NCT00332696|561872750|FG000|Overall Study|Lost to Follow-up|0|||
155665906|NCT00332696|561872751|FG001|Overall Study|Lost to Follow-up|1|||
155665907|NCT00332696|561872750|FG000|Overall Study|Withdrawal by Subject|1|||
155665908|NCT00332696|561872751|FG001|Overall Study|Withdrawal by Subject|0|||
155665909|NCT02230189|561872754|FG000|Overall Study|Withdrawal by Subject|3|||
155665910|NCT02230189|561872755|FG001|Overall Study|Withdrawal by Subject|0|||
155665911|NCT02230189|561872756|FG002|Overall Study|Withdrawal by Subject|1|||
155665912|NCT02230189|561872754|FG000|Overall Study|Lost to Follow-up|1|||
155665913|NCT02230189|561872755|FG001|Overall Study|Lost to Follow-up|0|||
155665914|NCT02230189|561872756|FG002|Overall Study|Lost to Follow-up|0|||
155665915|NCT02230189|561872754|FG000|Overall Study|Physician Decision|1|||
155665916|NCT02230189|561872755|FG001|Overall Study|Physician Decision|0|||
155665917|NCT02230189|561872756|FG002|Overall Study|Physician Decision|0|||
155665918|NCT03824392|561872757|FG000|Overall Study|Adverse Event|1|||
155665919|NCT03824392|561872758|FG001|Overall Study|Adverse Event|0|||
155665920|NCT03824392|561872759|FG002|Overall Study|Adverse Event|0|||
155665921|NCT03824392|561872760|FG003|Overall Study|Adverse Event|0|||
155665922|NCT03824392|561872757|FG000|Overall Study|Investigator Decision|0|||
155665923|NCT03824392|561872758|FG001|Overall Study|Investigator Decision|1|||
155665924|NCT03824392|561872759|FG002|Overall Study|Investigator Decision|0|||
155665925|NCT03824392|561872760|FG003|Overall Study|Investigator Decision|0|||
155665926|NCT03824392|561872757|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
155665927|NCT03824392|561872758|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
155665928|NCT03824392|561872759|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
155665929|NCT03824392|561872760|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
155665930|NCT01847755|561872761|FG000|Overall Study|Adverse Event|2|||
155665931|NCT01847755|561872761|FG000|Overall Study|Withdrawal by Subject|2|||
155665932|NCT01847755|561872761|FG000|Overall Study|Physician Decision|1|||
155665933|NCT01904721|561872764|FG000|Overall Study|Other Reasons|0|||
155665934|NCT01904721|561872765|FG001|Overall Study|Other Reasons|0|||
155665935|NCT01904721|561872766|FG002|Overall Study|Other Reasons|1|||
155665936|NCT01904721|561872767|FG003|Overall Study|Other Reasons|1|||
155665937|NCT01904721|561872768|FG004|Overall Study|Other Reasons|2|||
155665938|NCT01904721|561872769|FG005|Overall Study|Other Reasons|2|||
155665939|NCT01904721|561872770|FG006|Overall Study|Other Reasons|2|||
155665940|NCT01904721|561872764|FG000|Overall Study|Personal Reasons|0|||
155665941|NCT01904721|561872765|FG001|Overall Study|Personal Reasons|0|||
155665942|NCT01904721|561872766|FG002|Overall Study|Personal Reasons|0|||
155665943|NCT01904721|561872767|FG003|Overall Study|Personal Reasons|0|||
155665944|NCT01904721|561872768|FG004|Overall Study|Personal Reasons|2|||
155665945|NCT01904721|561872769|FG005|Overall Study|Personal Reasons|3|||
155665946|NCT01904721|561872770|FG006|Overall Study|Personal Reasons|3|||
155665947|NCT01904721|561872764|FG000|Overall Study|Lost to Follow-up|0|||
155665948|NCT01904721|561872765|FG001|Overall Study|Lost to Follow-up|0|||
155665949|NCT01904721|561872766|FG002|Overall Study|Lost to Follow-up|0|||
155665950|NCT01904721|561872767|FG003|Overall Study|Lost to Follow-up|0|||
155665951|NCT01904721|561872768|FG004|Overall Study|Lost to Follow-up|1|||
155665952|NCT01904721|561872769|FG005|Overall Study|Lost to Follow-up|3|||
155665953|NCT01904721|561872770|FG006|Overall Study|Lost to Follow-up|1|||
155665954|NCT01904721|561872764|FG000|Overall Study|Lack of Efficacy|0|||
155665955|NCT01904721|561872765|FG001|Overall Study|Lack of Efficacy|0|||
155665956|NCT01904721|561872766|FG002|Overall Study|Lack of Efficacy|0|||
155665957|NCT01904721|561872767|FG003|Overall Study|Lack of Efficacy|0|||
155665958|NCT01904721|561872768|FG004|Overall Study|Lack of Efficacy|0|||
155665959|NCT01904721|561872769|FG005|Overall Study|Lack of Efficacy|0|||
155665960|NCT01904721|561872770|FG006|Overall Study|Lack of Efficacy|1|||
155665961|NCT01904721|561872764|FG000|Overall Study|Adverse Event|0|||
155665962|NCT01904721|561872765|FG001|Overall Study|Adverse Event|0|||
155665963|NCT01904721|561872766|FG002|Overall Study|Adverse Event|0|||
155665964|NCT01904721|561872767|FG003|Overall Study|Adverse Event|0|||
155665965|NCT01904721|561872768|FG004|Overall Study|Adverse Event|3|||
155665966|NCT01904721|561872769|FG005|Overall Study|Adverse Event|1|||
155665967|NCT01904721|561872770|FG006|Overall Study|Adverse Event|0|||
155665968|NCT01077063|561872772|FG000|Overall Study|Adverse Event|3|||
155665969|NCT01077063|561872773|FG001|Overall Study|Adverse Event|0|||
155665970|NCT01077063|561872772|FG000|Overall Study|Death|1|||
155665971|NCT01077063|561872773|FG001|Overall Study|Death|1|||
155665972|NCT01077063|561872772|FG000|Overall Study|Withdrawal by Subject|0|||
155665973|NCT01077063|561872773|FG001|Overall Study|Withdrawal by Subject|2|||
155665974|NCT01490918|561872776|FG000|Overall Study|Lost to Follow-up|2|||
155665975|NCT01490918|561872777|FG001|Overall Study|Lost to Follow-up|1|||
155665976|NCT01490918|561872778|FG002|Overall Study|Lost to Follow-up|0|||
155665977|NCT01490918|561872776|FG000|Overall Study|Withdrawal by Subject|7|||
155665978|NCT01490918|561872777|FG001|Overall Study|Withdrawal by Subject|8|||
155665979|NCT01490918|561872778|FG002|Overall Study|Withdrawal by Subject|3|||
155665980|NCT01490918|561872776|FG000|Overall Study|Adverse Event|0|||
155665981|NCT01490918|561872777|FG001|Overall Study|Adverse Event|0|||
155665982|NCT01490918|561872778|FG002|Overall Study|Adverse Event|1|||
155665983|NCT01490918|561872776|FG000|Overall Study|other cause|4|||
155665984|NCT01490918|561872777|FG001|Overall Study|other cause|5|||
155665985|NCT01490918|561872778|FG002|Overall Study|other cause|8|||
155665986|NCT00648037|561872781|FG000|Overall Study|Not Treated|1|||
155665987|NCT00648037|561872781|FG000|Overall Study|Withdrawal by Subject|1|||
155665988|NCT00648037|561872781|FG000|Overall Study|Adverse Event|11|||
155665989|NCT00648037|561872781|FG000|Overall Study|Relapse|2|||
155665990|NCT00648037|561872781|FG000|Overall Study|Other|1|||
155665991|NCT02967679|561872782|FG000|Overall Study|Adverse Event|1|||
155665992|NCT03188263|561872795|FG000|Overall Study|Withdrawal by Subject|3|||
155665993|NCT03188263|561872796|FG001|Overall Study|Withdrawal by Subject|0|||
155665994|NCT03188263|561872795|FG000|Overall Study|Physician Decision|1|||
155665995|NCT03188263|561872796|FG001|Overall Study|Physician Decision|0|||
155665996|NCT00699413|561872797|FG000|Overall Study|Withdrawal by Subject|0|||
155665997|NCT00699413|561872798|FG001|Overall Study|Withdrawal by Subject|2|||
155665998|NCT00699413|561872797|FG000|Overall Study|Study terminated by sponsor|4|||
155665999|NCT00699413|561872798|FG001|Overall Study|Study terminated by sponsor|2|||
155666000|NCT00251693|561872799|FG000|Overall Study|Adverse Event|17|||
155666001|NCT00251693|561872800|FG001|Overall Study|Adverse Event|9|||
155666002|NCT00251693|561872801|FG002|Overall Study|Adverse Event|9|||
155666003|NCT00251693|561872799|FG000|Overall Study|Protocol Violation|2|||
155666004|NCT00251693|561872800|FG001|Overall Study|Protocol Violation|0|||
155666005|NCT00251693|561872801|FG002|Overall Study|Protocol Violation|2|||
155666006|NCT00251693|561872799|FG000|Overall Study|Lost to Follow-up|12|||
155666007|NCT00251693|561872800|FG001|Overall Study|Lost to Follow-up|7|||
155666008|NCT00251693|561872801|FG002|Overall Study|Lost to Follow-up|8|||
155666009|NCT00251693|561872799|FG000|Overall Study|Withdrawal by Subject|11|||
155666010|NCT00251693|561872800|FG001|Overall Study|Withdrawal by Subject|17|||
155666011|NCT00251693|561872801|FG002|Overall Study|Withdrawal by Subject|14|||
155666012|NCT00251693|561872799|FG000|Overall Study|Lack of Efficacy|0|||
155666013|NCT00251693|561872800|FG001|Overall Study|Lack of Efficacy|1|||
155666014|NCT00251693|561872801|FG002|Overall Study|Lack of Efficacy|0|||
155666015|NCT00251693|561872799|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
155666016|NCT00251693|561872800|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
155666017|NCT00251693|561872801|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
155666018|NCT00251693|561872799|FG000|Overall Study|Noncompliant|0|||
155666019|NCT00251693|561872800|FG001|Overall Study|Noncompliant|0|||
155666020|NCT00251693|561872801|FG002|Overall Study|Noncompliant|2|||
155666021|NCT00251693|561872799|FG000|Overall Study|Possible Barrett's esophagus|3|||
155666022|NCT00251693|561872800|FG001|Overall Study|Possible Barrett's esophagus|5|||
155666023|NCT00251693|561872801|FG002|Overall Study|Possible Barrett's esophagus|2|||
155666024|NCT00251693|561872799|FG000|Overall Study|Subject request/subject unavailable|1|||
155666025|NCT00251693|561872800|FG001|Overall Study|Subject request/subject unavailable|2|||
155666026|NCT00251693|561872801|FG002|Overall Study|Subject request/subject unavailable|0|||
155666027|NCT00251693|561872799|FG000|Overall Study|Abnormal laboratory findings|0|||
155666028|NCT00251693|561872800|FG001|Overall Study|Abnormal laboratory findings|0|||
155666029|NCT00251693|561872801|FG002|Overall Study|Abnormal laboratory findings|1|||
155666030|NCT02779777|561872802|FG000|Overall Study|Disease Progression|1|||
155666031|NCT02779777|561872803|FG001|Overall Study|Disease Progression|0|||
155666032|NCT02779777|561872804|FG002|Overall Study|Disease Progression|0|||
155666033|NCT02779777|561872802|FG000|Overall Study|Adverse Event|3|||
155666034|NCT02779777|561872803|FG001|Overall Study|Adverse Event|1|||
155666035|NCT02779777|561872804|FG002|Overall Study|Adverse Event|0|||
155666036|NCT02779777|561872802|FG000|Overall Study|Physician Decision|9|||
155666037|NCT02779777|561872803|FG001|Overall Study|Physician Decision|0|||
155666038|NCT02779777|561872804|FG002|Overall Study|Physician Decision|1|||
155666039|NCT02779777|561872802|FG000|Overall Study|Withdrawal by Subject|1|||
155666040|NCT02779777|561872803|FG001|Overall Study|Withdrawal by Subject|0|||
155666041|NCT02779777|561872804|FG002|Overall Study|Withdrawal by Subject|0|||
155666042|NCT01030822|561872806|FG000|Overall Study|Moved/migrated from study area|6|||
155666043|NCT01030822|561872807|FG001|Overall Study|Moved/migrated from study area|7|||
155666044|NCT01030822|561872808|FG002|Overall Study|Moved/migrated from study area|3|||
155666045|NCT01030822|561872806|FG000|Overall Study|Withdrawal by Subject|16|||
155666046|NCT01030822|561872807|FG001|Overall Study|Withdrawal by Subject|13|||
155666047|NCT01030822|561872808|FG002|Overall Study|Withdrawal by Subject|16|||
155666048|NCT01030822|561872806|FG000|Overall Study|Lost to Follow-up|9|||
155666049|NCT01030822|561872807|FG001|Overall Study|Lost to Follow-up|4|||
155666050|NCT01030822|561872808|FG002|Overall Study|Lost to Follow-up|7|||
155666051|NCT01284959|561872810|FG000|Overall Study|Withdrawal by Subject|1|||
155666052|NCT01284959|561872811|FG001|Overall Study|Withdrawal by Subject|0|||
155666053|NCT01284959|561872812|FG002|Overall Study|Withdrawal by Subject|0|||
155666054|NCT01284959|561872810|FG000|Overall Study|Adverse Event|0|||
155666055|NCT01284959|561872811|FG001|Overall Study|Adverse Event|0|||
155666056|NCT01284959|561872812|FG002|Overall Study|Adverse Event|1|||
155666057|NCT01055613|561872813|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
155666058|NCT01055613|561872814|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155666059|NCT01055613|561872813|FG000|Overall Study|Unacceptable lens fit|1|||
155666060|NCT01055613|561872814|FG001|Overall Study|Unacceptable lens fit|0|||
155666061|NCT01055613|561872813|FG000|Overall Study|Discomfort|2|||
155666062|NCT01055613|561872814|FG001|Overall Study|Discomfort|1|||
155666063|NCT01055613|561872813|FG000|Overall Study|Lost to Follow-up|1|||
155666064|NCT01055613|561872814|FG001|Overall Study|Lost to Follow-up|1|||
155666065|NCT01055613|561872813|FG000|Overall Study|Protocol Violation|1|||
155666066|NCT01055613|561872814|FG001|Overall Study|Protocol Violation|1|||
155666067|NCT01055613|561872813|FG000|Overall Study|Subject Disinterest|1|||
155666068|NCT01055613|561872814|FG001|Overall Study|Subject Disinterest|1|||
155666069|NCT02765399|561872817|FG000|Overall Study|Nausea|1|||
155666070|NCT02765399|561872818|FG001|Overall Study|Nausea|0|||
155666071|NCT00363311|561872823|FG000|Overall Study|Adverse Event|6|||
155666072|NCT00363311|561872824|FG001|Overall Study|Adverse Event|4|||
155666073|NCT00363311|561872823|FG000|Overall Study|Lost to Follow-up|3|||
155666074|NCT00363311|561872824|FG001|Overall Study|Lost to Follow-up|0|||
155666075|NCT00363311|561872823|FG000|Overall Study|Protocol Violation|1|||
155666076|NCT00363311|561872824|FG001|Overall Study|Protocol Violation|2|||
155666077|NCT00363311|561872823|FG000|Overall Study|Withdrawal by Subject|12|||
155666078|NCT00363311|561872824|FG001|Overall Study|Withdrawal by Subject|6|||
155666079|NCT00363311|561872823|FG000|Overall Study|Physician Decision|1|||
155666080|NCT00363311|561872824|FG001|Overall Study|Physician Decision|1|||
155666081|NCT00363311|561872823|FG000|Overall Study|Sponsor Terminated Study|2|||
155666082|NCT00363311|561872824|FG001|Overall Study|Sponsor Terminated Study|2|||
155666083|NCT00363311|561872823|FG000|Overall Study|Disease Progression|46|||
155666084|NCT00363311|561872824|FG001|Overall Study|Disease Progression|26|||
155666085|NCT00363311|561872823|FG000|Overall Study|Non-Compliance|1|||
155666086|NCT00363311|561872824|FG001|Overall Study|Non-Compliance|1|||
155666087|NCT00363311|561872823|FG000|Overall Study|Participant Refused Biopsy|1|||
155666088|NCT00363311|561872824|FG001|Overall Study|Participant Refused Biopsy|0|||
155666089|NCT00363311|561872823|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
155666090|NCT00363311|561872824|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
155666091|NCT00363311|561872823|FG000|Overall Study|Participant Opted for Treatment|1|||
155666092|NCT00363311|561872824|FG001|Overall Study|Participant Opted for Treatment|0|||
155666093|NCT00363311|561872823|FG000|Overall Study|Participant Moved to Another Country|1|||
155666094|NCT00363311|561872824|FG001|Overall Study|Participant Moved to Another Country|0|||
155666095|NCT00363311|561872823|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
155666096|NCT00363311|561872824|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
155666097|NCT00363311|561872823|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
155666098|NCT00363311|561872824|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
155666099|NCT00363311|561872823|FG000|Overall Study|Participant Moved to Louisiana|0|||
155666100|NCT00363311|561872824|FG001|Overall Study|Participant Moved to Louisiana|1|||
155666101|NCT00401843|561872825|FG000|Overall Study|Achieved Complete Response|1|||
155666102|NCT00401843|561872826|FG001|Overall Study|Achieved Complete Response|5|||
155666103|NCT00401843|561872827|FG002|Overall Study|Achieved Complete Response|11|||
155666104|NCT00401843|561872825|FG000|Overall Study|Adverse Event|7|||
155666105|NCT00401843|561872826|FG001|Overall Study|Adverse Event|26|||
155666106|NCT00401843|561872827|FG002|Overall Study|Adverse Event|27|||
155666107|NCT00401843|561872825|FG000|Overall Study|Death|0|||
155666108|NCT00401843|561872826|FG001|Overall Study|Death|8|||
155666109|NCT00401843|561872827|FG002|Overall Study|Death|10|||
155666110|NCT00401843|561872825|FG000|Overall Study|Disease progression|10|||
155666111|NCT00401843|561872826|FG001|Overall Study|Disease progression|60|||
155666112|NCT00401843|561872827|FG002|Overall Study|Disease progression|49|||
155666113|NCT00401843|561872825|FG000|Overall Study|End of Study|1|||
155666114|NCT00401843|561872826|FG001|Overall Study|End of Study|1|||
155666115|NCT00401843|561872827|FG002|Overall Study|End of Study|2|||
155666116|NCT00401843|561872825|FG000|Overall Study|Lost to Follow-up|0|||
155666117|NCT00401843|561872826|FG001|Overall Study|Lost to Follow-up|0|||
155666118|NCT00401843|561872827|FG002|Overall Study|Lost to Follow-up|2|||
155666119|NCT00401843|561872825|FG000|Overall Study|Other Unspecified|0|||
155666120|NCT00401843|561872826|FG001|Overall Study|Other Unspecified|3|||
155666121|NCT00401843|561872827|FG002|Overall Study|Other Unspecified|5|||
155666122|NCT00401843|561872825|FG000|Overall Study|Physician Decision|0|||
155666123|NCT00401843|561872826|FG001|Overall Study|Physician Decision|16|||
155666124|NCT00401843|561872827|FG002|Overall Study|Physician Decision|10|||
155666125|NCT00401843|561872825|FG000|Overall Study|Protocol Violation|0|||
155666126|NCT00401843|561872826|FG001|Overall Study|Protocol Violation|0|||
155666127|NCT00401843|561872827|FG002|Overall Study|Protocol Violation|1|||
155666128|NCT00401843|561872825|FG000|Overall Study|Withdrawal by Subject|1|||
155666129|NCT00401843|561872826|FG001|Overall Study|Withdrawal by Subject|5|||
155666130|NCT00401843|561872827|FG002|Overall Study|Withdrawal by Subject|5|||
155666131|NCT00401843|561872825|FG000|Overall Study|Withdrawal of consent to study agent|1|||
155666132|NCT00401843|561872826|FG001|Overall Study|Withdrawal of consent to study agent|15|||
155666133|NCT00401843|561872827|FG002|Overall Study|Withdrawal of consent to study agent|17|||
155666134|NCT00401843|561872825|FG000|Overall Study|Randomized but not Treated|0|||
155666135|NCT00401843|561872826|FG001|Overall Study|Randomized but not Treated|2|||
155666136|NCT00401843|561872827|FG002|Overall Study|Randomized but not Treated|3|||
155666137|NCT00401843|561872825|FG000|Overall Study|Received incorrect treatment|0|||
155666138|NCT00401843|561872826|FG001|Overall Study|Received incorrect treatment|3|||
155666139|NCT00401843|561872827|FG002|Overall Study|Received incorrect treatment|0|||
155666140|NCT00120627|561872832|FG000|Overall Study|Withdrawal by Subject|5|||
155666141|NCT00120627|561872833|FG001|Overall Study|Withdrawal by Subject|5|||
155666142|NCT01182298|561872834|FG000|Overall Study|Lack of Efficacy|4|||
155666143|NCT01182298|561872834|FG000|Overall Study|Withdrawal by Subject|2|||
155666144|NCT01508910|561872835|FG000|Treatment|Death|2|||
155666145|NCT01508910|561872836|FG001|Treatment|Death|3|||
155666146|NCT01508910|561872837|FG002|Treatment|Death|2|||
155666147|NCT01508910|561872838|FG003|Treatment|Death|0|||
155666148|NCT01508910|561872835|FG000|Treatment|Lost to Follow-up|0|||
155586812|NCT04432831|561575828|FG000|Overall Study|Adverse Event|7|||
155586813|NCT04432831|561575829|FG001|Overall Study|Adverse Event|7|||
155666149|NCT01508910|561872836|FG001|Treatment|Lost to Follow-up|0|||
155666150|NCT01508910|561872837|FG002|Treatment|Lost to Follow-up|2|||
155666151|NCT01508910|561872838|FG003|Treatment|Lost to Follow-up|1|||
155666152|NCT01508910|561872835|FG000|Treatment|Withdrawal by Subject|0|||
155666153|NCT01508910|561872836|FG001|Treatment|Withdrawal by Subject|1|||
155666154|NCT01508910|561872837|FG002|Treatment|Withdrawal by Subject|6|||
155666155|NCT01508910|561872838|FG003|Treatment|Withdrawal by Subject|1|||
155666156|NCT01508910|561872835|FG000|Treatment|Sponsor Decision|0|||
155666157|NCT01508910|561872836|FG001|Treatment|Sponsor Decision|0|||
155666158|NCT01508910|561872837|FG002|Treatment|Sponsor Decision|0|||
155666159|NCT01508910|561872838|FG003|Treatment|Sponsor Decision|1|||
155666160|NCT01595529|561872839|FG000|Overall Study|Adverse Event|2|||
155666161|NCT01595529|561872840|FG001|Overall Study|Adverse Event|0|||
155666162|NCT01595529|561872839|FG000|Overall Study|Subject Non-Compliant|2|||
155586814|NCT04432831|561575830|FG002|Overall Study|Adverse Event|7|||
155586815|NCT04432831|561575828|FG000|Overall Study|Physician Decision|1|||
155586816|NCT04432831|561575829|FG001|Overall Study|Physician Decision|3|||
155586817|NCT04432831|561575830|FG002|Overall Study|Physician Decision|6|||
155586818|NCT04432831|561575828|FG000|Overall Study|Protocol Violation|1|||
155586819|NCT04432831|561575829|FG001|Overall Study|Protocol Violation|0|||
155586820|NCT04432831|561575830|FG002|Overall Study|Protocol Violation|2|||
155586821|NCT04432831|561575828|FG000|Overall Study|Pregnancy|0|||
155586822|NCT04432831|561575829|FG001|Overall Study|Pregnancy|1|||
155586823|NCT04432831|561575830|FG002|Overall Study|Pregnancy|0|||
155586824|NCT04432831|561575828|FG000|Overall Study|Lack of Efficacy|0|||
155586825|NCT04432831|561575829|FG001|Overall Study|Lack of Efficacy|0|||
155586826|NCT04432831|561575830|FG002|Overall Study|Lack of Efficacy|2|||
155586827|NCT03782792|561575831|FG000|Overall Study|Patient left the country|0|||
155586828|NCT03782792|561575832|FG001|Overall Study|Patient left the country|1|||
155586829|NCT03782792|561575831|FG000|Overall Study|Withdrawal by Subject|1|||
155586830|NCT03782792|561575832|FG001|Overall Study|Withdrawal by Subject|2|||
155586831|NCT00617890|561575835|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
155586832|NCT00617890|561575836|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
155586833|NCT00617890|561575837|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
155586834|NCT00617890|561575838|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
155586835|NCT00617890|561575835|FG000|Overall Study|Lack of Efficacy|23|||
155586836|NCT00617890|561575836|FG001|Overall Study|Lack of Efficacy|26|||
155586837|NCT00617890|561575837|FG002|Overall Study|Lack of Efficacy|30|||
155586838|NCT00617890|561575838|FG003|Overall Study|Lack of Efficacy|97|||
155586839|NCT00617890|561575835|FG000|Overall Study|Lost to Follow-up|0|||
155586840|NCT00617890|561575836|FG001|Overall Study|Lost to Follow-up|0|||
155586841|NCT00617890|561575837|FG002|Overall Study|Lost to Follow-up|1|||
155586842|NCT00617890|561575838|FG003|Overall Study|Lost to Follow-up|2|||
155586843|NCT00617890|561575835|FG000|Overall Study|Withdrawal by Subject|4|||
155586844|NCT00617890|561575836|FG001|Overall Study|Withdrawal by Subject|1|||
155586845|NCT00617890|561575837|FG002|Overall Study|Withdrawal by Subject|0|||
155586846|NCT00617890|561575838|FG003|Overall Study|Withdrawal by Subject|2|||
155586847|NCT00617890|561575835|FG000|Overall Study|Protocol Violation|2|||
155586848|NCT00617890|561575836|FG001|Overall Study|Protocol Violation|1|||
155586849|NCT00617890|561575837|FG002|Overall Study|Protocol Violation|0|||
155586850|NCT00617890|561575838|FG003|Overall Study|Protocol Violation|0|||
155586851|NCT00617890|561575835|FG000|Overall Study|Adverse Event|1|||
155586852|NCT00617890|561575836|FG001|Overall Study|Adverse Event|0|||
155586853|NCT00617890|561575837|FG002|Overall Study|Adverse Event|3|||
155586854|NCT00617890|561575838|FG003|Overall Study|Adverse Event|8|||
155666163|NCT01595529|561872840|FG001|Overall Study|Subject Non-Compliant|0|||
155666164|NCT01595529|561872839|FG000|Overall Study|Lost to Follow-up|8|||
155666165|NCT01595529|561872840|FG001|Overall Study|Lost to Follow-up|14|||
155666166|NCT01595529|561872839|FG000|Overall Study|Protocol Violation|1|||
155666167|NCT01595529|561872840|FG001|Overall Study|Protocol Violation|2|||
155666168|NCT01595529|561872839|FG000|Overall Study|Physician Decision|1|||
155666169|NCT01595529|561872840|FG001|Overall Study|Physician Decision|0|||
155666170|NCT01595529|561872839|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
155666171|NCT01595529|561872840|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
155666172|NCT01595529|561872839|FG000|Overall Study|Administrative Decision|1|||
155666173|NCT01595529|561872840|FG001|Overall Study|Administrative Decision|0|||
155666174|NCT01595529|561872839|FG000|Overall Study|Entry Failure/Screening Failure|6|||
155666175|NCT01595529|561872840|FG001|Overall Study|Entry Failure/Screening Failure|1|||
155666176|NCT04016714|561872841|FG000|Overall Study|Death|1|||
155666177|NCT04016714|561872842|FG001|Overall Study|Death|0|||
155666178|NCT04016714|561872841|FG000|Overall Study|Lost to Follow-up|3|||
155666179|NCT04016714|561872842|FG001|Overall Study|Lost to Follow-up|1|||
155666180|NCT04016714|561872841|FG000|Overall Study|Physician Decision|3|||
155666181|NCT04016714|561872842|FG001|Overall Study|Physician Decision|3|||
155666182|NCT04016714|561872841|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
155666183|NCT04016714|561872842|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
155586855|NCT00617890|561575835|FG000|Overall Study|Not treated|1|||
155586856|NCT00617890|561575836|FG001|Overall Study|Not treated|0|||
155586857|NCT00617890|561575837|FG002|Overall Study|Not treated|1|||
155586858|NCT00617890|561575838|FG003|Overall Study|Not treated|1|||
155586859|NCT02283268|561575847|FG000|Overall Study|Withdrawal by Subject|1|||
155586860|NCT02898597|561575848|FG000|Overall Study|Protocol Violation|4|||
155586861|NCT02898597|561575849|FG001|Overall Study|Protocol Violation|2|||
155586862|NCT02898597|561575848|FG000|Overall Study|Lost to Follow-up|0|||
155586863|NCT02898597|561575849|FG001|Overall Study|Lost to Follow-up|9|||
155586864|NCT02898597|561575848|FG000|Overall Study|Death|0|||
155586865|NCT02898597|561575849|FG001|Overall Study|Death|1|||
155586866|NCT00326716|561575850|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
155586867|NCT00326716|561575851|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
155586868|NCT00326716|561575852|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
155586869|NCT00326716|561575853|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
155586870|NCT00684411|561575854|FG000|Overall Study|New Primary Cancer|1|||
155586871|NCT00684411|561575854|FG000|Overall Study|Disease Progression|10|||
155586872|NCT00684411|561575854|FG000|Overall Study|Adverse Event|1|||
155586873|NCT05253573|561575855|FG000|Overall Study|Death|1|||
155666184|NCT01677988|561872843|FG000|Overall Study|Lack of Efficacy|2|||
155666185|NCT02629861|561872856|FG000|Overall Study|Adverse Event|7|||
155586874|NCT05253573|561575856|FG001|Overall Study|Death|0|||
155586875|NCT01344824|561575857|FG000|Overall Study|Adverse Event|15|||
155586876|NCT01344824|561575857|FG000|Overall Study|Withdrawal by Subject|6|||
155666186|NCT02629861|561872857|FG001|Overall Study|Adverse Event|5|||
155666187|NCT02629861|561872858|FG002|Overall Study|Adverse Event|4|||
155586877|NCT01344824|561575857|FG000|Overall Study|Other complicating disease|1|||
155586878|NCT01344824|561575857|FG000|Overall Study|Progression|15|||
155586879|NCT01295671|561575860|FG000|Overall Study|Lost to Follow-up|4|||
155586880|NCT01295671|561575861|FG001|Overall Study|Lost to Follow-up|6|||
155586881|NCT01295671|561575862|FG002|Overall Study|Lost to Follow-up|3|||
155586882|NCT01295671|561575860|FG000|Overall Study|Withdrawal by Subject|3|||
155586883|NCT01295671|561575861|FG001|Overall Study|Withdrawal by Subject|1|||
155586884|NCT01295671|561575862|FG002|Overall Study|Withdrawal by Subject|0|||
155586885|NCT01436370|561575865|FG000|Overall Study|Lost to Follow-up|0|||
155586886|NCT01436370|561575866|FG001|Overall Study|Lost to Follow-up|0|||
155586887|NCT01436370|561575867|FG002|Overall Study|Lost to Follow-up|0|||
155586888|NCT01436370|561575868|FG003|Overall Study|Lost to Follow-up|0|||
155586889|NCT01436370|561575869|FG004|Overall Study|Lost to Follow-up|1|||
155586890|NCT01436370|561575870|FG005|Overall Study|Lost to Follow-up|0|||
155586891|NCT01436370|561575871|FG006|Overall Study|Lost to Follow-up|0|||
155586892|NCT01436370|561575872|FG007|Overall Study|Lost to Follow-up|0|||
155586893|NCT02395848|561575873|FG000|Overall Study|Lost to Follow-up|2|||
155586894|NCT01754129|561575874|FG000|Overall Study|Death|13|||
155586895|NCT01754129|561575874|FG000|Overall Study|Duodopa discontinuation|9|||
155586896|NCT01754129|561575874|FG000|Overall Study|Lost to Follow-up|7|||
155586897|NCT01754129|561575874|FG000|Overall Study|Withdrew consent|1|||
155586898|NCT01754129|561575874|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
155586899|NCT02276560|561575875|FG000|Overall Study|Adverse Event|1|||
155586900|NCT02276560|561575876|FG001|Overall Study|Adverse Event|0|||
155586901|NCT02276560|561575877|FG002|Overall Study|Adverse Event|0|||
155586902|NCT02126579|561575879|FG000|Overall Study|disease progression|0|||
155586903|NCT02126579|561575880|FG001|Overall Study|disease progression|0|||
155586904|NCT02126579|561575881|FG002|Overall Study|disease progression|0|||
155586905|NCT02126579|561575882|FG003|Overall Study|disease progression|1|||
155586906|NCT02126579|561575883|FG004|Overall Study|disease progression|0|||
155586907|NCT02126579|561575884|FG005|Overall Study|disease progression|0|||
155586908|NCT02126579|561575885|FG006|Overall Study|disease progression|1|||
155586909|NCT01085630|561575886|FG000|Overall Study|Insufficient data|1|||
155586910|NCT01085630|561575887|FG001|Overall Study|Insufficient data|0|||
155586911|NCT01085630|561575886|FG000|Overall Study|Ineligible|3|||
155586912|NCT01085630|561575887|FG001|Overall Study|Ineligible|0|||
155586913|NCT02366637|561575888|FG000|First Intervention Period|Adverse Event|0|||
155586914|NCT02366637|561575889|FG001|First Intervention Period|Adverse Event|1|||
155586915|NCT02366637|561575888|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
155586916|NCT02366637|561575889|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
155586917|NCT02366637|561575888|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
155586918|NCT02366637|561575889|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
155586919|NCT03691207|561575890|FG000|Overall Study|Death|41|||
155586920|NCT03691207|561575891|FG001|Overall Study|Death|26|||
155586921|NCT03691207|561575890|FG000|Overall Study|Lost to Follow-up|1|||
155586922|NCT03691207|561575891|FG001|Overall Study|Lost to Follow-up|1|||
155666188|NCT02629861|561872856|FG000|Overall Study|Withdrawal by Subject|5|||
155666189|NCT02629861|561872857|FG001|Overall Study|Withdrawal by Subject|8|||
155666190|NCT02629861|561872858|FG002|Overall Study|Withdrawal by Subject|13|||
155666191|NCT02629861|561872856|FG000|Overall Study|Protocol Violation|2|||
155666192|NCT02629861|561872857|FG001|Overall Study|Protocol Violation|3|||
155666193|NCT02629861|561872858|FG002|Overall Study|Protocol Violation|7|||
155666194|NCT02629861|561872856|FG000|Overall Study|Lost to Follow-up|12|||
155666195|NCT02629861|561872857|FG001|Overall Study|Lost to Follow-up|9|||
155666196|NCT02629861|561872858|FG002|Overall Study|Lost to Follow-up|4|||
155666197|NCT02629861|561872856|FG000|Overall Study|Other|1|||
155666198|NCT02629861|561872857|FG001|Overall Study|Other|1|||
155666199|NCT02629861|561872858|FG002|Overall Study|Other|0|||
155666200|NCT02629861|561872856|FG000|Overall Study|Pregnancy|2|||
155666201|NCT02629861|561872857|FG001|Overall Study|Pregnancy|1|||
155666202|NCT02629861|561872858|FG002|Overall Study|Pregnancy|0|||
155666203|NCT01822665|561872859|FG000|Overall Study|Adverse Event|3|||
155666204|NCT01822665|561872859|FG000|Overall Study|Other Reason|5|||
155666205|NCT00271544|561872860|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
155666206|NCT00271544|561872860|FG000|Overall Study|Model 4196 lead not attempted|9|||
155666207|NCT00271544|561872860|FG000|Overall Study|Implant not attempted|4|||
155666208|NCT00907621|561872861|FG000|Overall Study|Lost to Follow-up|6|||
155666209|NCT00907621|561872862|FG001|Overall Study|Lost to Follow-up|3|||
155666210|NCT00907621|561872861|FG000|Overall Study|intercurrent febrile illness|1|||
155666211|NCT00907621|561872862|FG001|Overall Study|intercurrent febrile illness|1|||
155666212|NCT00730886|561872863|FG000|Overall Study|Lost to Follow-up|1|||
155666213|NCT00730886|561872864|FG001|Overall Study|Lost to Follow-up|0|||
155666214|NCT00730886|561872863|FG000|Overall Study|Physician Decision|1|||
155666215|NCT00730886|561872864|FG001|Overall Study|Physician Decision|0|||
155666216|NCT04290624|561872865|FG000|Overall Study|Adverse Event|1|||
155666217|NCT04290624|561872866|FG001|Overall Study|Adverse Event|0|||
155666218|NCT00656370|561872867|FG000|Overall Study|Screen Failures|7|||
155666219|NCT00656370|561872867|FG000|Overall Study|Alternates|3|||
155666220|NCT00552071|561874889|FG000|Overall Study|Adverse Event|1|||
155666221|NCT00552071|561874890|FG001|Overall Study|Adverse Event|0|||
155666222|NCT00552071|561874889|FG000|Overall Study|Lack of Efficacy|1|||
155666223|NCT00552071|561874890|FG001|Overall Study|Lack of Efficacy|0|||
155666224|NCT00552071|561874889|FG000|Overall Study|Physician Decision|1|||
155666225|NCT00552071|561874890|FG001|Overall Study|Physician Decision|0|||
155666226|NCT00552071|561874889|FG000|Overall Study|Pregnancy|1|||
155666227|NCT00552071|561874890|FG001|Overall Study|Pregnancy|0|||
155666228|NCT00552071|561874889|FG000|Overall Study|Death|0|||
155666229|NCT00552071|561874890|FG001|Overall Study|Death|1|||
155666230|NCT00552071|561874889|FG000|Overall Study|Withdrawal by Subject|0|||
155666231|NCT00552071|561874890|FG001|Overall Study|Withdrawal by Subject|1|||
155666232|NCT00272792|561874891|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
155666233|NCT00272792|561874892|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
155666234|NCT00272792|561874891|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
155666235|NCT00272792|561874892|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
155666236|NCT00272792|561874891|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
155666237|NCT00272792|561874892|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
155666238|NCT00272792|561874891|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
155666239|NCT00272792|561874892|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
155666240|NCT00937495|561874899|FG000|Overall Study|Protocol Violation|2|||
155666241|NCT01856322|561874900|FG000|Overall Study|off study due to lack of accrual|0|||
155666242|NCT01856322|561874901|FG001|Overall Study|off study due to lack of accrual|0|||
155666243|NCT01856322|561874902|FG002|Overall Study|off study due to lack of accrual|3|||
155666244|NCT00288015|561874903|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
155666245|NCT00288015|561874903|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
155666246|NCT00288015|561874903|FG000|First Response Assessment|Withdrawal by Subject|1|||
155666247|NCT00288015|561874903|FG000|First Response Assessment|Death|1|||
155666248|NCT00288015|561874903|FG000|First Response Assessment|Physician Decision|2|||
155666249|NCT00288015|561874903|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
155666250|NCT00288015|561874903|FG000|Follow up for Survival x 2 Years|Death|13|||
155666251|NCT00288015|561874903|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
155666252|NCT00288015|561874903|FG000|Follow up for Survival x 2 Years|Other|9|||
155666253|NCT04592341|561874906|FG000|Overall Study|Physician Decision|5|||
155666254|NCT04592341|561874906|FG000|Overall Study|Study Terminated by Sponsor|5|||
155666255|NCT04592341|561874906|FG000|Overall Study|Withdrawal by Subject|53|||
155666256|NCT04592341|561874906|FG000|Overall Study|Lost to Follow-up|3|||
155666257|NCT04592341|561874906|FG000|Overall Study|Death|1|||
155666258|NCT04592341|561874906|FG000|Overall Study|Adverse Event|5|||
155666259|NCT04592341|561874906|FG000|Overall Study|other|4|||
155666260|NCT01944020|561874907|FG000|Overall Study|Withdrawal by Subject|5|||
155666261|NCT01944020|561874908|FG001|Overall Study|Withdrawal by Subject|0|||
155666262|NCT00692003|561874909|FG000|Overall Study|Sponsor Decision|5|||
155666263|NCT00692003|561874910|FG001|Overall Study|Sponsor Decision|1|||
155666264|NCT01535287|561874911|FG000|Overall Study|drug not prepared in time|5|||
155666265|NCT01535287|561874912|FG001|Overall Study|drug not prepared in time|6|||
155666266|NCT00305877|561874913|FG000|Overall Study|Lack of Efficacy|6|||
155666267|NCT00305877|561874914|FG001|Overall Study|Lack of Efficacy|9|||
155666268|NCT00305877|561874913|FG000|Overall Study|Adverse Event|9|||
155586923|NCT03691207|561575890|FG000|Overall Study|Withdrawal by Subject|2|||
155586924|NCT03691207|561575891|FG001|Overall Study|Withdrawal by Subject|8|||
155586925|NCT03691207|561575890|FG000|Overall Study|Sponsor decision|1|||
155586926|NCT03691207|561575891|FG001|Overall Study|Sponsor decision|7|||
155586927|NCT01609010|561575894|FG000|Overall Study|Stable disease (SD)|22|||
155586928|NCT01609010|561575895|FG001|Overall Study|Stable disease (SD)|16|||
155586929|NCT01609010|561575894|FG000|Overall Study|Progressive disease (PD)|8|||
155586930|NCT01609010|561575895|FG001|Overall Study|Progressive disease (PD)|10|||
155586931|NCT01609010|561575894|FG000|Overall Study|Adverse Event|3|||
155586932|NCT01609010|561575895|FG001|Overall Study|Adverse Event|6|||
155586933|NCT01609010|561575894|FG000|Overall Study|Withdrawal by Subject|2|||
155586934|NCT01609010|561575895|FG001|Overall Study|Withdrawal by Subject|2|||
155586935|NCT01609010|561575894|FG000|Overall Study|Other|2|||
155586936|NCT01609010|561575895|FG001|Overall Study|Other|0|||
155586937|NCT01609010|561575894|FG000|Overall Study|Other malignancy|1|||
155586938|NCT01609010|561575895|FG001|Overall Study|Other malignancy|0|||
155586939|NCT01609010|561575894|FG000|Overall Study|Pathology review|2|||
155586940|NCT01609010|561575895|FG001|Overall Study|Pathology review|1|||
155586941|NCT01609010|561575894|FG000|Overall Study|Protocol Violation|1|||
155586942|NCT01609010|561575895|FG001|Overall Study|Protocol Violation|1|||
155586943|NCT01609010|561575894|FG000|Overall Study|New cancer|1|||
155586944|NCT01609010|561575895|FG001|Overall Study|New cancer|0|||
155586945|NCT01609010|561575894|FG000|Overall Study|Lost to Follow-up|1|||
155586946|NCT01609010|561575895|FG001|Overall Study|Lost to Follow-up|1|||
155586947|NCT01134107|561575896|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
155586948|NCT01134107|561575897|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
155586949|NCT01134107|561575896|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
155586950|NCT01134107|561575897|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
155586951|NCT01134107|561575896|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
155586952|NCT01134107|561575897|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
155586953|NCT01134107|561575896|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
155586954|NCT01134107|561575897|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
155586955|NCT01134107|561575896|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
155586956|NCT01134107|561575897|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
155586957|NCT01134107|561575896|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
155586958|NCT01134107|561575897|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
155586959|NCT01134107|561575896|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
155586960|NCT01134107|561575897|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
155586961|NCT02027545|561575899|FG000|Overall Study|Failed to sign HIPAA|0|||
155586962|NCT02027545|561575900|FG001|Overall Study|Failed to sign HIPAA|2|||
155586963|NCT02027545|561575899|FG000|Overall Study|Failed to attend study visit|2|||
155586964|NCT02027545|561575900|FG001|Overall Study|Failed to attend study visit|0|||
155586965|NCT02027545|561575899|FG000|Overall Study|Protocol Violation|1|||
155586966|NCT02027545|561575900|FG001|Overall Study|Protocol Violation|0|||
155586967|NCT04541589|561575905|FG000|Treatment Period|Adverse Event|8|||
155586968|NCT04541589|561575906|FG001|Treatment Period|Adverse Event|2|||
155586969|NCT04541589|561575905|FG000|Treatment Period|Physician Decision|3|||
155586970|NCT04541589|561575906|FG001|Treatment Period|Physician Decision|1|||
155586971|NCT04541589|561575905|FG000|Treatment Period|Subject decision|7|||
155586972|NCT04541589|561575906|FG001|Treatment Period|Subject decision|4|||
155586973|NCT04541589|561575905|FG000|Treatment Period|Withdrawal by Subject|1|||
155586974|NCT04541589|561575906|FG001|Treatment Period|Withdrawal by Subject|0|||
155586975|NCT04541589|561575905|FG000|Safety Follow-up Period|Adverse Event|2|||
155586976|NCT04541589|561575906|FG001|Safety Follow-up Period|Adverse Event|1|||
155586977|NCT04541589|561575905|FG000|Safety Follow-up Period|Physician Decision|1|||
155586978|NCT04541589|561575906|FG001|Safety Follow-up Period|Physician Decision|0|||
155586979|NCT04541589|561575905|FG000|Safety Follow-up Period|Subject decision|5|||
155586980|NCT04541589|561575906|FG001|Safety Follow-up Period|Subject decision|3|||
155586981|NCT04541589|561575905|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
155586982|NCT04541589|561575906|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
155586983|NCT02770170|561575907|FG000|Overall Study|Withdrawal by Subject|0|||
155586984|NCT02770170|561575908|FG001|Overall Study|Withdrawal by Subject|0|||
155586985|NCT02770170|561575909|FG002|Overall Study|Withdrawal by Subject|0|||
155586986|NCT02770170|561575910|FG003|Overall Study|Withdrawal by Subject|2|||
155586987|NCT02770170|561575907|FG000|Overall Study|due to pregnancy|1|||
155586988|NCT02770170|561575908|FG001|Overall Study|due to pregnancy|0|||
155586989|NCT02770170|561575909|FG002|Overall Study|due to pregnancy|0|||
155586990|NCT02770170|561575910|FG003|Overall Study|due to pregnancy|0|||
155586991|NCT02770170|561575907|FG000|Overall Study|Lack of Efficacy|2|||
155586992|NCT02770170|561575908|FG001|Overall Study|Lack of Efficacy|0|||
155586993|NCT02770170|561575909|FG002|Overall Study|Lack of Efficacy|0|||
155586994|NCT02770170|561575910|FG003|Overall Study|Lack of Efficacy|1|||
155586995|NCT02770170|561575907|FG000|Overall Study|Adverse Event|4|||
155586996|NCT02770170|561575908|FG001|Overall Study|Adverse Event|3|||
155586997|NCT02770170|561575909|FG002|Overall Study|Adverse Event|5|||
155586998|NCT02770170|561575910|FG003|Overall Study|Adverse Event|3|||
155586999|NCT02770170|561575907|FG000|Overall Study|due to disease worsening|0|||
155587000|NCT02770170|561575908|FG001|Overall Study|due to disease worsening|0|||
155587001|NCT02770170|561575909|FG002|Overall Study|due to disease worsening|0|||
155587002|NCT02770170|561575910|FG003|Overall Study|due to disease worsening|1|||
155587003|NCT03581123|561575913|FG000|2-month Follow-up|Withdrawal by Subject|5|||
155587004|NCT03581123|561575914|FG001|2-month Follow-up|Withdrawal by Subject|4|||
155587005|NCT03581123|561575915|FG002|2-month Follow-up|Withdrawal by Subject|6|||
155587006|NCT03581123|561575916|FG003|2-month Follow-up|Withdrawal by Subject|4|||
155587007|NCT03581123|561575913|FG000|2-month Follow-up|Lost to Follow-up|8|||
155587008|NCT03581123|561575914|FG001|2-month Follow-up|Lost to Follow-up|1|||
155587009|NCT03581123|561575915|FG002|2-month Follow-up|Lost to Follow-up|2|||
155587010|NCT03581123|561575916|FG003|2-month Follow-up|Lost to Follow-up|2|||
155587011|NCT03581123|561575913|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
155587012|NCT03581123|561575914|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
155587013|NCT03581123|561575915|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
155587014|NCT03581123|561575916|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
155587015|NCT03581123|561575913|FG000|6-Month Follow-up|Lost to Follow-up|3|||
155587016|NCT03581123|561575914|FG001|6-Month Follow-up|Lost to Follow-up|3|||
155587017|NCT03581123|561575915|FG002|6-Month Follow-up|Lost to Follow-up|1|||
155587018|NCT03581123|561575916|FG003|6-Month Follow-up|Lost to Follow-up|1|||
155587019|NCT03581123|561575913|FG000|12-Month Follow-up|Lost to Follow-up|4|||
155587020|NCT03581123|561575914|FG001|12-Month Follow-up|Lost to Follow-up|3|||
155587021|NCT03581123|561575915|FG002|12-Month Follow-up|Lost to Follow-up|4|||
155587022|NCT03581123|561575916|FG003|12-Month Follow-up|Lost to Follow-up|5|||
155587023|NCT04195685|561575917|FG000|Overall Study|Withdrawal by Subject|6|||
155587024|NCT04195685|561575918|FG001|Overall Study|Withdrawal by Subject|2|||
155587025|NCT04195685|561575917|FG000|Overall Study|Lost to Follow-up|1|||
155587026|NCT04195685|561575918|FG001|Overall Study|Lost to Follow-up|4|||
155587027|NCT04509076|561575925|FG000|Overall Study|Withdrawal by Subject|1|||
155587028|NCT04509076|561575926|FG001|Overall Study|Withdrawal by Subject|2|||
155587029|NCT04509076|561575925|FG000|Overall Study|Lost to Follow-up|1|||
155587030|NCT04509076|561575926|FG001|Overall Study|Lost to Follow-up|2|||
155587031|NCT03351608|561575927|FG000|Overall Study|Lost to Follow-up|0|||
155587032|NCT03351608|561575928|FG001|Overall Study|Lost to Follow-up|1|||
155587033|NCT03351608|561575929|FG002|Overall Study|Lost to Follow-up|1|||
155587034|NCT03351608|561575930|FG003|Overall Study|Lost to Follow-up|1|||
155587035|NCT03351608|561575931|FG004|Overall Study|Lost to Follow-up|1|||
155587036|NCT03351608|561575927|FG000|Overall Study|Physician Decision|1|||
155587037|NCT03351608|561575928|FG001|Overall Study|Physician Decision|0|||
155587038|NCT03351608|561575929|FG002|Overall Study|Physician Decision|0|||
155587039|NCT03351608|561575930|FG003|Overall Study|Physician Decision|2|||
155587040|NCT03351608|561575931|FG004|Overall Study|Physician Decision|1|||
155587041|NCT03351608|561575927|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
155587042|NCT03351608|561575928|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
155587043|NCT03351608|561575929|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
155587044|NCT03351608|561575930|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
155587045|NCT03351608|561575931|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
155587046|NCT03351608|561575927|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155587047|NCT03351608|561575928|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155587048|NCT03351608|561575929|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155666269|NCT00305877|561874914|FG001|Overall Study|Adverse Event|14|||
155666270|NCT00305877|561874913|FG000|Overall Study|Death|0|||
155666271|NCT00305877|561874914|FG001|Overall Study|Death|1|||
155666272|NCT00305877|561874913|FG000|Overall Study|Withdrawal by Subject|4|||
155666273|NCT00305877|561874914|FG001|Overall Study|Withdrawal by Subject|2|||
155666274|NCT00305877|561874913|FG000|Overall Study|Physician Decision|1|||
155666275|NCT00305877|561874914|FG001|Overall Study|Physician Decision|1|||
155666276|NCT00305877|561874913|FG000|Overall Study|Never start treatment|2|||
155666277|NCT00305877|561874914|FG001|Overall Study|Never start treatment|5|||
155666278|NCT00305877|561874913|FG000|Overall Study|Ineligible|2|||
155666279|NCT00305877|561874914|FG001|Overall Study|Ineligible|1|||
155666280|NCT00305877|561874913|FG000|Overall Study|Transportation issue with daily RT|0|||
155666281|NCT00305877|561874914|FG001|Overall Study|Transportation issue with daily RT|1|||
155666282|NCT00457392|561874915|FG000|Overall Study|Objective Progression or Relapse|229|||
155666283|NCT00457392|561874916|FG001|Overall Study|Objective Progression or Relapse|296|||
155666284|NCT00457392|561874915|FG000|Overall Study|Death|106|||
155666285|NCT00457392|561874916|FG001|Overall Study|Death|106|||
155666286|NCT00457392|561874915|FG000|Overall Study|Adverse Event|84|||
155666287|NCT00457392|561874916|FG001|Overall Study|Adverse Event|41|||
155666288|NCT00457392|561874915|FG000|Overall Study|Global Deterioration of Health Status|22|||
155666289|NCT00457392|561874916|FG001|Overall Study|Global Deterioration of Health Status|8|||
155666290|NCT00457392|561874915|FG000|Overall Study|Withdrawal by Subject|14|||
155666291|NCT00457392|561874916|FG001|Overall Study|Withdrawal by Subject|8|||
155666292|NCT00457392|561874915|FG000|Overall Study|Lost to Follow-up|6|||
155666293|NCT00457392|561874916|FG001|Overall Study|Lost to Follow-up|7|||
155666294|NCT00457392|561874915|FG000|Overall Study|Protocol Violation|4|||
155587049|NCT03351608|561575930|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155587050|NCT03351608|561575931|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155587051|NCT03351608|561575927|FG000|Overall Study|Other|0|||
155587052|NCT03351608|561575928|FG001|Overall Study|Other|1|||
155587053|NCT03351608|561575929|FG002|Overall Study|Other|1|||
155587054|NCT03351608|561575930|FG003|Overall Study|Other|3|||
155587055|NCT03351608|561575931|FG004|Overall Study|Other|0|||
155587056|NCT02877004|561575932|FG000|Overall Study|Pregnancy|0|||
155587057|NCT02877004|561575933|FG001|Overall Study|Pregnancy|0|||
155587058|NCT02877004|561575934|FG002|Overall Study|Pregnancy|1|||
155587059|NCT02727478|561575935|FG000|Overall Study|Withdrawal by Subject|8|||
155587060|NCT02727478|561575936|FG001|Overall Study|Withdrawal by Subject|10|||
155587061|NCT02356588|561575937|FG000|Overall Study|Lack of Efficacy|4|||
155587062|NCT02356588|561575938|FG001|Overall Study|Lack of Efficacy|10|||
155587063|NCT02356588|561575937|FG000|Overall Study|Adverse Event|0|||
155587064|NCT02356588|561575938|FG001|Overall Study|Adverse Event|2|||
155587065|NCT02356588|561575937|FG000|Overall Study|Withdrawal by Subject|1|||
155587066|NCT02356588|561575938|FG001|Overall Study|Withdrawal by Subject|0|||
155587067|NCT02356588|561575937|FG000|Overall Study|Protocol Violation|0|||
155587068|NCT02356588|561575938|FG001|Overall Study|Protocol Violation|1|||
155587069|NCT01418378|561575939|FG000|Overall Study|Death|1|||
155587070|NCT01418378|561575940|FG001|Overall Study|Death|2|||
155587071|NCT01418378|561575939|FG000|Overall Study|Physician Decision|0|||
155587072|NCT01418378|561575940|FG001|Overall Study|Physician Decision|1|||
155587073|NCT01418378|561575939|FG000|Overall Study|ligament imbalance|0|||
155587074|NCT01418378|561575940|FG001|Overall Study|ligament imbalance|1|||
155587075|NCT01418378|561575939|FG000|Overall Study|developed chronic myopathy|0|||
155587076|NCT01418378|561575940|FG001|Overall Study|developed chronic myopathy|1|||
155587077|NCT01051791|561575943|FG000|Overall Study|Failed screening|3|||
155587078|NCT01051791|561575943|FG000|Overall Study|Withdrawal by Subject|1|||
155587079|NCT00288626|561575944|FG000|Overall Study|Death|3|||
155587080|NCT00288626|561575944|FG000|Overall Study|Withdrawal by Subject|4|||
155587081|NCT01372618|561575947|FG000|Overall Study|PI Died. Study Terminated|9|||
155587082|NCT03448419|561575948|FG000|Overall Study|Adverse Event|10|||
155587083|NCT03448419|561575949|FG001|Overall Study|Adverse Event|9|||
155587084|NCT03448419|561575948|FG000|Overall Study|Lost to Follow-up|0|||
155666295|NCT00457392|561874916|FG001|Overall Study|Protocol Violation|3|||
155587085|NCT03448419|561575949|FG001|Overall Study|Lost to Follow-up|2|||
155587086|NCT03448419|561575948|FG000|Overall Study|Withdrawal by Subject|3|||
155587087|NCT03448419|561575949|FG001|Overall Study|Withdrawal by Subject|1|||
155666296|NCT00457392|561874915|FG000|Overall Study|Other|7|||
155666297|NCT00457392|561874916|FG001|Overall Study|Other|4|||
155666298|NCT00457392|561874915|FG000|Overall Study|Study Terminated by Sponsor|1|||
155666299|NCT00457392|561874916|FG001|Overall Study|Study Terminated by Sponsor|4|||
155666300|NCT00457392|561874915|FG000|Overall Study|Randomized, Not Treated|7|||
155666301|NCT00457392|561874916|FG001|Overall Study|Randomized, Not Treated|3|||
155666302|NCT00980148|561874917|FG000|Overall Study|Discharged from facility|89|||
155666303|NCT00980148|561874918|FG001|Overall Study|Discharged from facility|96|||
155666304|NCT00980148|561874917|FG000|Overall Study|Received other antichlamydia treatment|20|||
155666305|NCT00980148|561874918|FG001|Overall Study|Received other antichlamydia treatment|14|||
155666306|NCT00980148|561874917|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
155666307|NCT00980148|561874918|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
155666308|NCT00980148|561874917|FG000|Overall Study|Various other reasons|8|||
155666309|NCT00980148|561874918|FG001|Overall Study|Various other reasons|9|||
155666310|NCT00812955|561874926|FG000|Overall Study|Adverse Event|7|||
155666311|NCT00812955|561874927|FG001|Overall Study|Adverse Event|6|||
155666312|NCT00812955|561874928|FG002|Overall Study|Adverse Event|3|||
155666313|NCT00812955|561874929|FG003|Overall Study|Adverse Event|4|||
155666314|NCT00812955|561874926|FG000|Overall Study|Lost to Follow-up|2|||
155666315|NCT00812955|561874927|FG001|Overall Study|Lost to Follow-up|1|||
155666316|NCT00812955|561874928|FG002|Overall Study|Lost to Follow-up|1|||
155666317|NCT00812955|561874929|FG003|Overall Study|Lost to Follow-up|2|||
155666318|NCT00812955|561874926|FG000|Overall Study|Withdrawal by Subject|1|||
155666319|NCT00812955|561874927|FG001|Overall Study|Withdrawal by Subject|0|||
155666320|NCT00812955|561874928|FG002|Overall Study|Withdrawal by Subject|1|||
155666321|NCT00812955|561874929|FG003|Overall Study|Withdrawal by Subject|2|||
155666322|NCT00812955|561874926|FG000|Overall Study|randomized in error|0|||
155666323|NCT00812955|561874927|FG001|Overall Study|randomized in error|0|||
155666324|NCT00812955|561874928|FG002|Overall Study|randomized in error|1|||
155666325|NCT00812955|561874929|FG003|Overall Study|randomized in error|0|||
155666326|NCT01309204|561874930|FG000|Overall Study|Adverse Event|48|||
155666327|NCT01309204|561874931|FG001|Overall Study|Adverse Event|58|||
155666328|NCT01309204|561874930|FG000|Overall Study|Lost to Follow-up|2|||
155666329|NCT01309204|561874931|FG001|Overall Study|Lost to Follow-up|2|||
155666330|NCT01309204|561874930|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
155666331|NCT01309204|561874931|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
155666332|NCT01309204|561874930|FG000|Overall Study|Inadequate control of IOP|4|||
155666333|NCT01309204|561874931|FG001|Overall Study|Inadequate control of IOP|4|||
155666334|NCT01309204|561874930|FG000|Overall Study|Other|4|||
155666335|NCT01309204|561874931|FG001|Overall Study|Other|1|||
155666336|NCT04512001|561874935|FG000|Week 0 to Week 24|Adverse Event|14|||
155666337|NCT04512001|561874936|FG001|Week 0 to Week 24|Adverse Event|10|||
155666338|NCT04512001|561874937|FG002|Week 0 to Week 24|Adverse Event|0|||
155666339|NCT04512001|561874938|FG003|Week 0 to Week 24|Adverse Event|0|||
155666340|NCT04512001|561874939|FG004|Week 0 to Week 24|Adverse Event|0|||
155666341|NCT04512001|561874935|FG000|Week 0 to Week 24|Death|0|||
155666342|NCT04512001|561874936|FG001|Week 0 to Week 24|Death|2|||
155666343|NCT04512001|561874937|FG002|Week 0 to Week 24|Death|0|||
155666344|NCT04512001|561874938|FG003|Week 0 to Week 24|Death|0|||
155666345|NCT04512001|561874939|FG004|Week 0 to Week 24|Death|0|||
155666346|NCT04512001|561874935|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
155666347|NCT04512001|561874936|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
155666348|NCT04512001|561874937|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
155666349|NCT04512001|561874938|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
155666350|NCT04512001|561874939|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
155666351|NCT04512001|561874935|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
155666352|NCT04512001|561874936|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
155666353|NCT04512001|561874937|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
155666354|NCT04512001|561874938|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
155666355|NCT04512001|561874939|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
155666356|NCT04512001|561874935|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
155666357|NCT04512001|561874936|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155666358|NCT04512001|561874937|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155666359|NCT04512001|561874938|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155666360|NCT04512001|561874939|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155666361|NCT04512001|561874935|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155666362|NCT04512001|561874936|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
155666363|NCT04512001|561874937|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155666364|NCT04512001|561874938|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155666365|NCT04512001|561874939|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155666366|NCT04512001|561874935|FG000|Week 24 to Week 63|Adverse Event|0|||
155666367|NCT04512001|561874936|FG001|Week 24 to Week 63|Adverse Event|0|||
155666368|NCT04512001|561874937|FG002|Week 24 to Week 63|Adverse Event|13|||
155666369|NCT04512001|561874938|FG003|Week 24 to Week 63|Adverse Event|8|||
155666370|NCT04512001|561874939|FG004|Week 24 to Week 63|Adverse Event|6|||
155666371|NCT04512001|561874935|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
155666372|NCT04512001|561874936|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
155666373|NCT04512001|561874937|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
155666374|NCT04512001|561874938|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
155666375|NCT04512001|561874939|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
155666376|NCT04512001|561874935|FG000|Week 24 to Week 63|Death|0|||
155666377|NCT04512001|561874936|FG001|Week 24 to Week 63|Death|0|||
155666378|NCT04512001|561874937|FG002|Week 24 to Week 63|Death|0|||
155666379|NCT04512001|561874938|FG003|Week 24 to Week 63|Death|1|||
155666380|NCT04512001|561874939|FG004|Week 24 to Week 63|Death|1|||
155666381|NCT04512001|561874935|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
155666382|NCT04512001|561874936|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
155666383|NCT04512001|561874937|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
155666384|NCT04512001|561874938|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
155666385|NCT04512001|561874939|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
155666386|NCT04512001|561874935|FG000|Week 24 to Week 63|Miscellaneous|0|||
155666387|NCT04512001|561874936|FG001|Week 24 to Week 63|Miscellaneous|0|||
155666388|NCT04512001|561874937|FG002|Week 24 to Week 63|Miscellaneous|3|||
155666389|NCT04512001|561874938|FG003|Week 24 to Week 63|Miscellaneous|2|||
155666390|NCT04512001|561874939|FG004|Week 24 to Week 63|Miscellaneous|1|||
155666391|NCT03389308|561874940|FG000|Overall Study|Withdrawal by Subject|5|||
155666392|NCT03389308|561874940|FG000|Overall Study|Lost to Follow-up|3|||
155666393|NCT03389308|561874940|FG000|Overall Study|Adverse Event|2|||
155666394|NCT03389308|561874940|FG000|Overall Study|Sponsor Request|2|||
155666395|NCT00570323|561874942|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
155666396|NCT00570323|561874943|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
155666397|NCT00570323|561874942|FG000|Started Treatment After Randomization|Protocol Violation|1|||
155666398|NCT00570323|561874943|FG001|Started Treatment After Randomization|Protocol Violation|0|||
155666399|NCT00570323|561874942|FG000|Started Treatment After Randomization|Physician Decision|1|||
155666400|NCT00570323|561874943|FG001|Started Treatment After Randomization|Physician Decision|0|||
155666401|NCT00570323|561874942|FG000|Complete Study After Start|Lost to Follow-up|0|||
155666402|NCT00570323|561874943|FG001|Complete Study After Start|Lost to Follow-up|1|||
155666403|NCT00570323|561874942|FG000|Complete Study After Start|Withdrawal by Subject|2|||
155666404|NCT00570323|561874943|FG001|Complete Study After Start|Withdrawal by Subject|0|||
155666405|NCT00570323|561874942|FG000|Complete Study After Start|Physician Decision|1|||
155666406|NCT00570323|561874943|FG001|Complete Study After Start|Physician Decision|0|||
155666407|NCT04263766|561874944|FG000|Overall Study|Withdrawal by Subject|6|||
155587088|NCT03448419|561575948|FG000|Overall Study|Not treated|0|||
155587089|NCT03448419|561575949|FG001|Overall Study|Not treated|1|||
155587090|NCT03448419|561575948|FG000|Overall Study|Patient did not attend all visits|0|||
155587091|NCT03448419|561575949|FG001|Overall Study|Patient did not attend all visits|2|||
155587092|NCT03448419|561575948|FG000|Overall Study|Withdrawn by Sponsor|0|||
155587093|NCT03448419|561575949|FG001|Overall Study|Withdrawn by Sponsor|1|||
155587094|NCT04610346|561575950|FG000|Overall Study|Withdrawal by Subject|1|||
155587095|NCT04610346|561575951|FG001|Overall Study|Withdrawal by Subject|1|||
155587096|NCT04610346|561575950|FG000|Overall Study|did not complete shelter onboarding|2|||
155587097|NCT04610346|561575951|FG001|Overall Study|did not complete shelter onboarding|1|||
155587098|NCT02019264|561575952|FG000|Overall Study|Not treated|6|||
155587099|NCT02019264|561575953|FG001|Overall Study|Not treated|4|||
155587100|NCT02019264|561575952|FG000|Overall Study|Lost to Follow-up|50|||
155587101|NCT02019264|561575953|FG001|Overall Study|Lost to Follow-up|47|||
155587102|NCT02019264|561575952|FG000|Overall Study|Withdrawal by Subject|142|||
155587103|NCT02019264|561575953|FG001|Overall Study|Withdrawal by Subject|117|||
155587104|NCT02019264|561575952|FG000|Overall Study|Administrative reason|36|||
155587105|NCT02019264|561575953|FG001|Overall Study|Administrative reason|28|||
155587106|NCT02019264|561575952|FG000|Overall Study|Missing|14|||
155587107|NCT02019264|561575953|FG001|Overall Study|Missing|11|||
155587108|NCT01575834|561575958|FG000|Overall Study|Withdrawal by Subject|352|||
155587109|NCT01575834|561575959|FG001|Overall Study|Withdrawal by Subject|390|||
155587110|NCT01575834|561575958|FG000|Overall Study|Death|81|||
155587111|NCT01575834|561575959|FG001|Overall Study|Death|74|||
155587112|NCT01575834|561575958|FG000|Overall Study|Other|70|||
155587113|NCT01575834|561575959|FG001|Overall Study|Other|70|||
155587114|NCT01575834|561575958|FG000|Overall Study|Adverse Event|63|||
155587115|NCT01575834|561575959|FG001|Overall Study|Adverse Event|61|||
155587116|NCT01575834|561575958|FG000|Overall Study|Lost to Follow-up|55|||
155587117|NCT01575834|561575959|FG001|Overall Study|Lost to Follow-up|68|||
155587118|NCT01575834|561575958|FG000|Overall Study|Noncompliance|52|||
155587119|NCT01575834|561575959|FG001|Overall Study|Noncompliance|27|||
155587120|NCT01575834|561575958|FG000|Overall Study|Administrative decision|15|||
155587121|NCT01575834|561575959|FG001|Overall Study|Administrative decision|33|||
155587122|NCT01575834|561575958|FG000|Overall Study|Ineligibility Determined|5|||
155587123|NCT01575834|561575959|FG001|Overall Study|Ineligibility Determined|8|||
155587124|NCT01575834|561575958|FG000|Overall Study|Protocol Deviation|4|||
155587125|NCT01575834|561575959|FG001|Overall Study|Protocol Deviation|3|||
155587126|NCT01575834|561575958|FG000|Overall Study|Requirement for Alternative Therapy|2|||
155587127|NCT01575834|561575959|FG001|Overall Study|Requirement for Alternative Therapy|4|||
155587128|NCT02155283|561575960|FG000|Overall Study|Lost to Follow-up|3|||
155587129|NCT02155283|561575960|FG000|Overall Study|Withdrawal by Subject|1|||
155587130|NCT02155283|561575960|FG000|Overall Study|Protocol Violation|3|||
155587131|NCT02282813|561575962|FG000|Overall Study|Withdrawal by Subject|4|||
155587132|NCT02282813|561575963|FG001|Overall Study|Withdrawal by Subject|5|||
155587133|NCT02282813|561575964|FG002|Overall Study|Withdrawal by Subject|0|||
155587134|NCT02282813|561575962|FG000|Overall Study|Adverse Event|3|||
155587135|NCT02282813|561575963|FG001|Overall Study|Adverse Event|10|||
155587136|NCT02282813|561575964|FG002|Overall Study|Adverse Event|1|||
155587137|NCT02282813|561575962|FG000|Overall Study|Subject non-compliance|1|||
155587138|NCT02282813|561575963|FG001|Overall Study|Subject non-compliance|4|||
155587139|NCT02282813|561575964|FG002|Overall Study|Subject non-compliance|0|||
155587140|NCT02282813|561575962|FG000|Overall Study|Physician Decision|0|||
155587141|NCT02282813|561575963|FG001|Overall Study|Physician Decision|3|||
155587142|NCT02282813|561575964|FG002|Overall Study|Physician Decision|1|||
155587143|NCT02282813|561575962|FG000|Overall Study|Lost to Follow-up|2|||
155587144|NCT02282813|561575963|FG001|Overall Study|Lost to Follow-up|0|||
155587145|NCT02282813|561575964|FG002|Overall Study|Lost to Follow-up|1|||
155587146|NCT02282813|561575962|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
155587147|NCT02282813|561575963|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
155587148|NCT02282813|561575964|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
155587149|NCT02282813|561575962|FG000|Overall Study|Lack of Efficacy|1|||
155587150|NCT02282813|561575963|FG001|Overall Study|Lack of Efficacy|0|||
155587151|NCT02282813|561575964|FG002|Overall Study|Lack of Efficacy|0|||
155587152|NCT02282813|561575962|FG000|Overall Study|Administrative reasons|0|||
155587153|NCT02282813|561575963|FG001|Overall Study|Administrative reasons|1|||
155587154|NCT02282813|561575964|FG002|Overall Study|Administrative reasons|0|||
155587155|NCT05000164|561575969|FG000|Overall Study|Adverse Event|1|||
155587156|NCT05000164|561575969|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155587157|NCT05000164|561575969|FG000|Overall Study|Lens Discomfort|3|||
155587158|NCT05000164|561575969|FG000|Overall Study|Withdrew Consent during Study|2|||
155587159|NCT05000164|561575969|FG000|Overall Study|Subject Withdrawn by PI|2|||
155587160|NCT05000164|561575969|FG000|Overall Study|Other Fractured Test Article|1|||
155587161|NCT04278417|561575972|FG000|Overall Study|Withdrawal by Subject|20|||
155587162|NCT04278417|561575973|FG001|Overall Study|Withdrawal by Subject|20|||
155587163|NCT04278417|561575972|FG000|Overall Study|Progressive disease|0|||
155666408|NCT04263766|561874945|FG001|Overall Study|Withdrawal by Subject|4|||
155666409|NCT04263766|561874944|FG000|Overall Study|Lack of Efficacy|1|||
155666410|NCT04263766|561874945|FG001|Overall Study|Lack of Efficacy|3|||
155666411|NCT04232943|561874948|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
155666412|NCT04232943|561874949|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
155666413|NCT04232943|561874950|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
155666414|NCT04232943|561874948|FG000|Overall Study|Withdrawal by Subject|1|||
155666415|NCT04232943|561874949|FG001|Overall Study|Withdrawal by Subject|1|||
155666416|NCT04232943|561874950|FG002|Overall Study|Withdrawal by Subject|0|||
155666417|NCT02639247|561874951|FG000|Overall Study|Lost to Follow-up|2|||
155666418|NCT02639247|561874952|FG001|Overall Study|Lost to Follow-up|1|||
155666419|NCT02639247|561874951|FG000|Overall Study|Death|2|||
155666420|NCT02639247|561874952|FG001|Overall Study|Death|0|||
155666421|NCT02639247|561874951|FG000|Overall Study|Withdrew Consent|0|||
155666422|NCT02639247|561874952|FG001|Overall Study|Withdrew Consent|1|||
155666423|NCT02639247|561874951|FG000|Overall Study|Protocol Violation|1|||
155666424|NCT02639247|561874952|FG001|Overall Study|Protocol Violation|0|||
155666425|NCT01891396|561874953|FG000|Overall Study|Withdrawal by Subject|4|||
155666426|NCT01891396|561874954|FG001|Overall Study|Withdrawal by Subject|4|||
155666427|NCT01891396|561874955|FG002|Overall Study|Withdrawal by Subject|3|||
155666428|NCT01891396|561874953|FG000|Overall Study|Lost to Follow-up|0|||
155666429|NCT01891396|561874954|FG001|Overall Study|Lost to Follow-up|1|||
155666430|NCT01891396|561874955|FG002|Overall Study|Lost to Follow-up|0|||
155666431|NCT02266147|561874957|FG000|PART 1: Dose Escalation|Physician Decision|0|||
155666432|NCT02266147|561874958|FG001|PART 1: Dose Escalation|Physician Decision|0|||
155666433|NCT02266147|561874959|FG002|PART 1: Dose Escalation|Physician Decision|1|||
155666434|NCT02266147|561874960|FG003|PART 1: Dose Escalation|Physician Decision|0|||
155666435|NCT02266147|561874957|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
155666436|NCT02266147|561874958|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
155666437|NCT02266147|561874959|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
155666438|NCT02266147|561874960|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
155666439|NCT02266147|561874957|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
155666440|NCT02266147|561874958|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
155666441|NCT02266147|561874959|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
155666442|NCT02266147|561874960|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
155666443|NCT02266147|561874957|FG000|PART 1: Dose Escalation|Other|1|||
155666444|NCT02266147|561874958|FG001|PART 1: Dose Escalation|Other|1|||
155666445|NCT02266147|561874959|FG002|PART 1: Dose Escalation|Other|0|||
155666446|NCT02266147|561874960|FG003|PART 1: Dose Escalation|Other|0|||
155666447|NCT02266147|561874957|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
155666448|NCT02266147|561874958|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
155666449|NCT02266147|561874959|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
155666450|NCT02266147|561874960|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
155666451|NCT02266147|561874957|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
155666452|NCT02266147|561874958|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
155666453|NCT02266147|561874959|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
155666454|NCT02266147|561874960|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
155666455|NCT00573391|561874964|FG000|Overall Study|study stopped|2|||
155666456|NCT00573391|561874965|FG001|Overall Study|study stopped|2|||
155666457|NCT00573391|561874964|FG000|Overall Study|Death|1|||
155666458|NCT00573391|561874965|FG001|Overall Study|Death|0|||
155666459|NCT03896477|561874968|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
155666460|NCT03896477|561874969|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
155666461|NCT03896477|561874970|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
155666462|NCT03896477|561874968|FG000|Overall Study|Parent Requested Withdrawal|8|||
155666463|NCT03896477|561874969|FG001|Overall Study|Parent Requested Withdrawal|12|||
155666464|NCT03896477|561874970|FG002|Overall Study|Parent Requested Withdrawal|9|||
155666465|NCT03896477|561874968|FG000|Overall Study|Adverse Event|0|||
155666466|NCT03896477|561874969|FG001|Overall Study|Adverse Event|0|||
155666467|NCT03896477|561874970|FG002|Overall Study|Adverse Event|1|||
155666468|NCT03896477|561874968|FG000|Overall Study|Death|1|||
155666469|NCT03896477|561874969|FG001|Overall Study|Death|0|||
155666470|NCT03896477|561874970|FG002|Overall Study|Death|0|||
155666471|NCT03896477|561874968|FG000|Overall Study|Other|5|||
155666472|NCT03896477|561874969|FG001|Overall Study|Other|6|||
155666473|NCT03896477|561874970|FG002|Overall Study|Other|7|||
155666474|NCT03896477|561874968|FG000|Overall Study|Lost to Follow-up|2|||
155666475|NCT03896477|561874969|FG001|Overall Study|Lost to Follow-up|1|||
155666476|NCT03896477|561874970|FG002|Overall Study|Lost to Follow-up|1|||
155666477|NCT01881009|561874972|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
155666478|NCT01881009|561874973|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
155666479|NCT01063348|561874975|FG000|Overall Study|Lost to Follow-up|3|||
155666480|NCT01063348|561874976|FG001|Overall Study|Lost to Follow-up|10|||
155666481|NCT01118780|561874977|FG000|Overall Study|Adverse Event|15|||
155666482|NCT01118780|561874978|FG001|Overall Study|Adverse Event|15|||
155666483|NCT01118780|561874977|FG000|Overall Study|Death|1|||
155666484|NCT01118780|561874978|FG001|Overall Study|Death|0|||
155666485|NCT01118780|561874977|FG000|Overall Study|Lack of Efficacy|2|||
155666486|NCT01118780|561874978|FG001|Overall Study|Lack of Efficacy|6|||
155666487|NCT01118780|561874977|FG000|Overall Study|Physician Decision|2|||
155666488|NCT01118780|561874978|FG001|Overall Study|Physician Decision|0|||
155666489|NCT01118780|561874977|FG000|Overall Study|Protocol Violation|3|||
155666490|NCT01118780|561874978|FG001|Overall Study|Protocol Violation|6|||
155666491|NCT01118780|561874977|FG000|Overall Study|Withdrawal by Subject|13|||
155666492|NCT01118780|561874978|FG001|Overall Study|Withdrawal by Subject|8|||
155666493|NCT02457247|561874981|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
155666494|NCT02457247|561874982|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
155666495|NCT02457247|561874983|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
155666496|NCT02457247|561874984|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
155666497|NCT02457247|561874981|FG000|Period 1|Significant Protocol Deviation|1|||
155666498|NCT02457247|561874982|FG001|Period 1|Significant Protocol Deviation|1|||
155666499|NCT02457247|561874983|FG002|Period 1|Significant Protocol Deviation|0|||
155666500|NCT02457247|561874984|FG003|Period 1|Significant Protocol Deviation|0|||
155666501|NCT02457247|561874981|FG000|Period 1|Voluntary Withdrawal|1|||
155666502|NCT02457247|561874982|FG001|Period 1|Voluntary Withdrawal|0|||
155666503|NCT02457247|561874983|FG002|Period 1|Voluntary Withdrawal|0|||
155666504|NCT02457247|561874984|FG003|Period 1|Voluntary Withdrawal|0|||
155666505|NCT02457247|561874981|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
155666506|NCT02457247|561874982|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
155666507|NCT02457247|561874983|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
155666508|NCT02457247|561874984|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
155666509|NCT02457247|561874981|FG000|Period 2|Significant Protocol Deviation|1|||
155666510|NCT02457247|561874982|FG001|Period 2|Significant Protocol Deviation|0|||
155666511|NCT02457247|561874983|FG002|Period 2|Significant Protocol Deviation|0|||
155666512|NCT02457247|561874984|FG003|Period 2|Significant Protocol Deviation|0|||
155666513|NCT02457247|561874981|FG000|Period 2|Lost to Follow-up|0|||
155666514|NCT02457247|561874982|FG001|Period 2|Lost to Follow-up|1|||
155666515|NCT02457247|561874983|FG002|Period 2|Lost to Follow-up|0|||
155666516|NCT02457247|561874984|FG003|Period 2|Lost to Follow-up|0|||
155666517|NCT02457247|561874981|FG000|Period 2|Voluntary Withdrawal|1|||
155666518|NCT02457247|561874982|FG001|Period 2|Voluntary Withdrawal|1|||
155666519|NCT02457247|561874983|FG002|Period 2|Voluntary Withdrawal|0|||
155666520|NCT02457247|561874984|FG003|Period 2|Voluntary Withdrawal|0|||
155666521|NCT02216526|561874985|FG000|Overall Study|Adverse Event|1|||
155666522|NCT02216526|561874986|FG001|Overall Study|Adverse Event|1|||
155666523|NCT02216526|561874987|FG002|Overall Study|Adverse Event|0|||
155666524|NCT02216526|561874985|FG000|Overall Study|Death|0|||
155666525|NCT02216526|561874986|FG001|Overall Study|Death|1|||
155666526|NCT02216526|561874987|FG002|Overall Study|Death|3|||
155666527|NCT02216526|561874985|FG000|Overall Study|Protocol Violation|2|||
155666528|NCT02216526|561874986|FG001|Overall Study|Protocol Violation|0|||
155666529|NCT02216526|561874987|FG002|Overall Study|Protocol Violation|2|||
155666530|NCT02216526|561874985|FG000|Overall Study|Hospitalization|2|||
155666531|NCT02216526|561874986|FG001|Overall Study|Hospitalization|1|||
155666532|NCT02216526|561874987|FG002|Overall Study|Hospitalization|3|||
155666533|NCT02750514|561874988|FG000|Track 1|Disease progression|20|||
155666534|NCT02750514|561874989|FG001|Track 1|Disease progression|1|||
155666535|NCT02750514|561874990|FG002|Track 1|Disease progression|0|||
155666536|NCT02750514|561874991|FG003|Track 1|Disease progression|1|||
155666537|NCT02750514|561874992|FG004|Track 1|Disease progression|0|||
155666538|NCT02750514|561874988|FG000|Track 1|Adverse event unrelated to study drug|1|||
155587164|NCT04278417|561575973|FG001|Overall Study|Progressive disease|2|||
155587165|NCT04278417|561575972|FG000|Overall Study|Physician Decision|4|||
155587166|NCT04278417|561575973|FG001|Overall Study|Physician Decision|6|||
155587167|NCT04278417|561575972|FG000|Overall Study|Lost to Follow-up|11|||
155587168|NCT04278417|561575973|FG001|Overall Study|Lost to Follow-up|13|||
155587169|NCT04278417|561575972|FG000|Overall Study|Death|8|||
155587170|NCT04278417|561575973|FG001|Overall Study|Death|9|||
155587171|NCT04278417|561575972|FG000|Overall Study|Adverse Event|3|||
155587172|NCT04278417|561575973|FG001|Overall Study|Adverse Event|5|||
155666539|NCT02750514|561874989|FG001|Track 1|Adverse event unrelated to study drug|0|||
155666540|NCT02750514|561874990|FG002|Track 1|Adverse event unrelated to study drug|0|||
155666541|NCT02750514|561874991|FG003|Track 1|Adverse event unrelated to study drug|0|||
155666542|NCT02750514|561874992|FG004|Track 1|Adverse event unrelated to study drug|0|||
155666543|NCT02750514|561874988|FG000|Track 1|Study drug toxicity|4|||
155587173|NCT04830969|561575977|FG000|Overall Study|Withdrawal by Subject|6|||
155587174|NCT04830969|561575978|FG001|Overall Study|Withdrawal by Subject|2|||
155587175|NCT04830969|561575977|FG000|Overall Study|Protocol Violation|3|||
155587176|NCT04830969|561575978|FG001|Overall Study|Protocol Violation|9|||
155666544|NCT02750514|561874989|FG001|Track 1|Study drug toxicity|1|||
155666545|NCT02750514|561874990|FG002|Track 1|Study drug toxicity|0|||
155666546|NCT02750514|561874991|FG003|Track 1|Study drug toxicity|1|||
155666547|NCT02750514|561874992|FG004|Track 1|Study drug toxicity|0|||
155666548|NCT02750514|561874988|FG000|Track 1|Participant request to discontinue|1|||
155666549|NCT02750514|561874989|FG001|Track 1|Participant request to discontinue|0|||
155666550|NCT02750514|561874990|FG002|Track 1|Participant request to discontinue|0|||
155666551|NCT02750514|561874991|FG003|Track 1|Participant request to discontinue|0|||
155666552|NCT02750514|561874992|FG004|Track 1|Participant request to discontinue|0|||
155666553|NCT02750514|561874988|FG000|Track 1|Other reasons|1|||
155666554|NCT02750514|561874989|FG001|Track 1|Other reasons|0|||
155666555|NCT02750514|561874990|FG002|Track 1|Other reasons|0|||
155666556|NCT02750514|561874991|FG003|Track 1|Other reasons|0|||
155666557|NCT02750514|561874992|FG004|Track 1|Other reasons|0|||
155666558|NCT02750514|561874988|FG000|Track 2|Disease progression|4|||
155666559|NCT02750514|561874989|FG001|Track 2|Disease progression|5|||
155666560|NCT02750514|561874990|FG002|Track 2|Disease progression|2|||
155666561|NCT02750514|561874991|FG003|Track 2|Disease progression|5|||
155666562|NCT02750514|561874992|FG004|Track 2|Disease progression|0|||
155666563|NCT02750514|561874988|FG000|Track 2|Adverse event unrelated to study drug|1|||
155666564|NCT02750514|561874989|FG001|Track 2|Adverse event unrelated to study drug|0|||
155666565|NCT02750514|561874990|FG002|Track 2|Adverse event unrelated to study drug|0|||
155666566|NCT02750514|561874991|FG003|Track 2|Adverse event unrelated to study drug|0|||
155666567|NCT02750514|561874992|FG004|Track 2|Adverse event unrelated to study drug|0|||
155666568|NCT02750514|561874988|FG000|Track 2|Study drug toxicity|1|||
155666569|NCT02750514|561874989|FG001|Track 2|Study drug toxicity|2|||
155666570|NCT02750514|561874990|FG002|Track 2|Study drug toxicity|0|||
155666571|NCT02750514|561874991|FG003|Track 2|Study drug toxicity|2|||
155666572|NCT02750514|561874992|FG004|Track 2|Study drug toxicity|0|||
155666573|NCT02750514|561874988|FG000|Track 2|Participant withdrew consent|0|||
155666574|NCT02750514|561874989|FG001|Track 2|Participant withdrew consent|1|||
155666575|NCT02750514|561874990|FG002|Track 2|Participant withdrew consent|0|||
155666576|NCT02750514|561874991|FG003|Track 2|Participant withdrew consent|0|||
155666577|NCT02750514|561874992|FG004|Track 2|Participant withdrew consent|0|||
155666578|NCT02750514|561874988|FG000|Track 3|Disease progression|0|||
155666579|NCT02750514|561874989|FG001|Track 3|Disease progression|24|||
155666580|NCT02750514|561874990|FG002|Track 3|Disease progression|13|||
155666581|NCT02750514|561874991|FG003|Track 3|Disease progression|14|||
155666582|NCT02750514|561874992|FG004|Track 3|Disease progression|0|||
155666583|NCT02750514|561874988|FG000|Track 3|Adverse event unrelated to study drug|0|||
155666584|NCT02750514|561874989|FG001|Track 3|Adverse event unrelated to study drug|1|||
155666585|NCT02750514|561874990|FG002|Track 3|Adverse event unrelated to study drug|1|||
155666586|NCT02750514|561874991|FG003|Track 3|Adverse event unrelated to study drug|1|||
155666587|NCT02750514|561874992|FG004|Track 3|Adverse event unrelated to study drug|0|||
155666588|NCT02750514|561874988|FG000|Track 3|Study drug toxicity|0|||
155666589|NCT02750514|561874989|FG001|Track 3|Study drug toxicity|3|||
155666590|NCT02750514|561874990|FG002|Track 3|Study drug toxicity|0|||
155666591|NCT02750514|561874991|FG003|Track 3|Study drug toxicity|1|||
155666592|NCT02750514|561874992|FG004|Track 3|Study drug toxicity|0|||
155666593|NCT02750514|561874988|FG000|Track 3|Participant request to discontinue|0|||
155666594|NCT02750514|561874989|FG001|Track 3|Participant request to discontinue|2|||
155666595|NCT02750514|561874990|FG002|Track 3|Participant request to discontinue|0|||
155666596|NCT02750514|561874991|FG003|Track 3|Participant request to discontinue|0|||
155666597|NCT02750514|561874992|FG004|Track 3|Participant request to discontinue|0|||
155666598|NCT02750514|561874988|FG000|Track 3|Participant withdrew consent|0|||
155666599|NCT02750514|561874989|FG001|Track 3|Participant withdrew consent|3|||
155666600|NCT02750514|561874990|FG002|Track 3|Participant withdrew consent|1|||
155666601|NCT02750514|561874991|FG003|Track 3|Participant withdrew consent|0|||
155666602|NCT02750514|561874992|FG004|Track 3|Participant withdrew consent|0|||
155666603|NCT02750514|561874988|FG000|Track 3|Other reasons|0|||
155666604|NCT02750514|561874989|FG001|Track 3|Other reasons|3|||
155666605|NCT02750514|561874990|FG002|Track 3|Other reasons|0|||
155666606|NCT02750514|561874991|FG003|Track 3|Other reasons|0|||
155666607|NCT02750514|561874992|FG004|Track 3|Other reasons|0|||
155666608|NCT02750514|561874988|FG000|Track 4|Study drug toxicity|0|||
155666609|NCT02750514|561874989|FG001|Track 4|Study drug toxicity|6|||
155666610|NCT02750514|561874990|FG002|Track 4|Study drug toxicity|0|||
155666611|NCT02750514|561874991|FG003|Track 4|Study drug toxicity|5|||
155666612|NCT02750514|561874992|FG004|Track 4|Study drug toxicity|0|||
155666613|NCT02750514|561874988|FG000|Track 4|Participant request to discontinue|0|||
155666614|NCT02750514|561874989|FG001|Track 4|Participant request to discontinue|1|||
155666615|NCT02750514|561874990|FG002|Track 4|Participant request to discontinue|0|||
155666616|NCT02750514|561874991|FG003|Track 4|Participant request to discontinue|1|||
155666617|NCT02750514|561874992|FG004|Track 4|Participant request to discontinue|0|||
155587177|NCT04830969|561575977|FG000|Overall Study|Lost to Follow-up|4|||
155587178|NCT04830969|561575978|FG001|Overall Study|Lost to Follow-up|4|||
155587179|NCT00996125|561575979|FG000|Overall Study|Adverse Event|0|||
155587180|NCT00996125|561575980|FG001|Overall Study|Adverse Event|2|||
155587181|NCT00996125|561575979|FG000|Overall Study|Lost to Follow-up|1|||
155587182|NCT00996125|561575980|FG001|Overall Study|Lost to Follow-up|6|||
155587183|NCT00996125|561575979|FG000|Overall Study|Withdrawal by Subject|4|||
155587184|NCT00996125|561575980|FG001|Overall Study|Withdrawal by Subject|3|||
155587185|NCT01796392|561575983|FG000|Overall Study|Withdrawal by Subject|2|||
155587186|NCT01796392|561575984|FG001|Overall Study|Withdrawal by Subject|0|||
155587187|NCT01796392|561575983|FG000|Overall Study|Death|5|||
155587188|NCT01796392|561575984|FG001|Overall Study|Death|1|||
155587189|NCT01796392|561575983|FG000|Overall Study|Excluded for medical reasons|1|||
155587190|NCT01796392|561575984|FG001|Overall Study|Excluded for medical reasons|2|||
155587191|NCT01796392|561575983|FG000|Overall Study|Lost to Follow-up|1|||
155587192|NCT01796392|561575984|FG001|Overall Study|Lost to Follow-up|0|||
155587193|NCT04681066|561575985|FG000|Overall Study|Lost to Follow-up|3|||
155587194|NCT04681066|561575986|FG001|Overall Study|Lost to Follow-up|1|||
155587195|NCT04681066|561575987|FG002|Overall Study|Lost to Follow-up|2|||
155587196|NCT04681066|561575988|FG003|Overall Study|Lost to Follow-up|1|||
155587197|NCT04681066|561575985|FG000|Overall Study|Withdrawal by Subject|2|||
155587198|NCT04681066|561575986|FG001|Overall Study|Withdrawal by Subject|1|||
155587199|NCT04681066|561575987|FG002|Overall Study|Withdrawal by Subject|0|||
155587200|NCT04681066|561575988|FG003|Overall Study|Withdrawal by Subject|3|||
155587201|NCT04681066|561575985|FG000|Overall Study|Death|0|||
155587202|NCT04681066|561575986|FG001|Overall Study|Death|1|||
155587203|NCT04681066|561575987|FG002|Overall Study|Death|0|||
155587204|NCT04681066|561575988|FG003|Overall Study|Death|0|||
155587205|NCT04495829|561575989|FG000|Overall Study|Lost to Follow-up|2|||
155587206|NCT04495829|561575989|FG000|Overall Study|Inclusion criterion not met|3|||
155587207|NCT01205269|561575993|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155587208|NCT01205269|561575994|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155587209|NCT01205269|561575995|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155587210|NCT01205269|561575996|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
155587211|NCT01205269|561575997|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155587212|NCT01205269|561575998|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155587213|NCT00987337|561575999|FG000|Overall Study|Adverse Event|10|||
155587214|NCT00987337|561576000|FG001|Overall Study|Adverse Event|9|||
155587215|NCT00987337|561576001|FG002|Overall Study|Adverse Event|8|||
155587216|NCT00987337|561575999|FG000|Overall Study|Insufficient Virologic Response|10|||
155587217|NCT00987337|561576000|FG001|Overall Study|Insufficient Virologic Response|7|||
155587218|NCT00987337|561576001|FG002|Overall Study|Insufficient Virologic Response|12|||
155587219|NCT00987337|561575999|FG000|Overall Study|Virologic Breakthrough|2|||
155587220|NCT00987337|561576000|FG001|Overall Study|Virologic Breakthrough|2|||
155587221|NCT00987337|561576001|FG002|Overall Study|Virologic Breakthrough|8|||
155587222|NCT00987337|561575999|FG000|Overall Study|Lost to Follow-up|10|||
155587223|NCT00987337|561576000|FG001|Overall Study|Lost to Follow-up|6|||
155587224|NCT00987337|561576001|FG002|Overall Study|Lost to Follow-up|2|||
155587225|NCT00987337|561575999|FG000|Overall Study|Withdrawal by Subject|6|||
155587226|NCT00987337|561576000|FG001|Overall Study|Withdrawal by Subject|9|||
155587227|NCT00987337|561576001|FG002|Overall Study|Withdrawal by Subject|9|||
155587228|NCT00987337|561575999|FG000|Overall Study|Other|0|||
155587229|NCT00987337|561576000|FG001|Overall Study|Other|2|||
155587230|NCT00987337|561576001|FG002|Overall Study|Other|5|||
155587231|NCT00987337|561575999|FG000|Overall Study|Protocol Violation|1|||
155587232|NCT00987337|561576000|FG001|Overall Study|Protocol Violation|0|||
155587233|NCT00987337|561576001|FG002|Overall Study|Protocol Violation|2|||
155587234|NCT00987337|561575999|FG000|Overall Study|Participant Relapsed|18|||
155587235|NCT00987337|561576000|FG001|Overall Study|Participant Relapsed|20|||
155587236|NCT00987337|561576001|FG002|Overall Study|Participant Relapsed|5|||
155587237|NCT05678959|561578113|FG000|Overall Study|Study Terminated by Sponsor|76|||
155587238|NCT05678959|561578114|FG001|Overall Study|Study Terminated by Sponsor|76|||
155587239|NCT05678959|561578113|FG000|Overall Study|Physician Decision|2|||
155587240|NCT05678959|561578114|FG001|Overall Study|Physician Decision|3|||
155587241|NCT05678959|561578113|FG000|Overall Study|Adverse Event|1|||
155587242|NCT05678959|561578114|FG001|Overall Study|Adverse Event|1|||
155587243|NCT05678959|561578113|FG000|Overall Study|Guardian Decision|1|||
155587244|NCT05678959|561578114|FG001|Overall Study|Guardian Decision|0|||
155587245|NCT05678959|561578113|FG000|Overall Study|Protocol Deviation|0|||
155587246|NCT05678959|561578114|FG001|Overall Study|Protocol Deviation|1|||
155587247|NCT05678959|561578113|FG000|Overall Study|Subject Decision|1|||
155587248|NCT05678959|561578114|FG001|Overall Study|Subject Decision|0|||
155587249|NCT05678959|561578113|FG000|Overall Study|Technical Problem|0|||
155587250|NCT05678959|561578114|FG001|Overall Study|Technical Problem|1|||
155666618|NCT02750514|561874988|FG000|Track 4|Participant withdrew consent|0|||
155666619|NCT02750514|561874989|FG001|Track 4|Participant withdrew consent|1|||
155666620|NCT02750514|561874990|FG002|Track 4|Participant withdrew consent|0|||
155666621|NCT02750514|561874991|FG003|Track 4|Participant withdrew consent|0|||
155666622|NCT02750514|561874992|FG004|Track 4|Participant withdrew consent|0|||
155666623|NCT02750514|561874988|FG000|Track 4|Other reasons|0|||
155666624|NCT02750514|561874989|FG001|Track 4|Other reasons|5|||
155666625|NCT02750514|561874990|FG002|Track 4|Other reasons|0|||
155666626|NCT02750514|561874991|FG003|Track 4|Other reasons|3|||
155666627|NCT02750514|561874992|FG004|Track 4|Other reasons|0|||
155666628|NCT02750514|561874988|FG000|Track 4|Disease progression|0|||
155666629|NCT02750514|561874989|FG001|Track 4|Disease progression|33|||
155666630|NCT02750514|561874990|FG002|Track 4|Disease progression|0|||
155666631|NCT02750514|561874991|FG003|Track 4|Disease progression|32|||
155666632|NCT02750514|561874992|FG004|Track 4|Disease progression|0|||
155666633|NCT02750514|561874988|FG000|Track 4|Adverse event unrelated to study drug|0|||
155666634|NCT02750514|561874989|FG001|Track 4|Adverse event unrelated to study drug|5|||
155666635|NCT02750514|561874990|FG002|Track 4|Adverse event unrelated to study drug|0|||
155666636|NCT02750514|561874991|FG003|Track 4|Adverse event unrelated to study drug|0|||
155666637|NCT02750514|561874992|FG004|Track 4|Adverse event unrelated to study drug|0|||
155666638|NCT02750514|561874988|FG000|Track 4|Death|0|||
155666639|NCT02750514|561874989|FG001|Track 4|Death|0|||
155587251|NCT06360588|561578115|FG000|Overall Study|Adverse Event|3|||
155587252|NCT06360588|561578115|FG000|Overall Study|Death|2|||
155587253|NCT06360588|561578115|FG000|Overall Study|Disease Progression|14|||
155587254|NCT06360588|561578115|FG000|Overall Study|Withdrawal by Subject|1|||
155587255|NCT06360588|561578115|FG000|Overall Study|Lack of Efficacy|1|||
155587256|NCT06360588|561578115|FG000|Overall Study|Ineligible|1|||
155587257|NCT04010240|561578116|FG000|Overall Study|IHC not performed|2299|||
155587258|NCT03263936|561578117|FG000|Overall Study|Adverse Event|0|||
155666640|NCT02750514|561874990|FG002|Track 4|Death|0|||
155666641|NCT02750514|561874991|FG003|Track 4|Death|1|||
155666642|NCT02750514|561874992|FG004|Track 4|Death|0|||
155666643|NCT02750514|561874988|FG000|Track 5|Disease progression|0|||
155666644|NCT02750514|561874989|FG001|Track 5|Disease progression|0|||
155666645|NCT02750514|561874990|FG002|Track 5|Disease progression|0|||
155666646|NCT02750514|561874991|FG003|Track 5|Disease progression|0|||
155666647|NCT02750514|561874992|FG004|Track 5|Disease progression|34|||
155666648|NCT02750514|561874988|FG000|Track 5|Adverse event unrelated to study drug|0|||
155666649|NCT02750514|561874989|FG001|Track 5|Adverse event unrelated to study drug|0|||
155666650|NCT02750514|561874990|FG002|Track 5|Adverse event unrelated to study drug|0|||
155666651|NCT02750514|561874991|FG003|Track 5|Adverse event unrelated to study drug|0|||
155666652|NCT02750514|561874992|FG004|Track 5|Adverse event unrelated to study drug|2|||
155666653|NCT02750514|561874988|FG000|Track 5|Study drug toxicity|0|||
155666654|NCT02750514|561874989|FG001|Track 5|Study drug toxicity|0|||
155666655|NCT02750514|561874990|FG002|Track 5|Study drug toxicity|0|||
155666656|NCT02750514|561874991|FG003|Track 5|Study drug toxicity|0|||
155666657|NCT02750514|561874992|FG004|Track 5|Study drug toxicity|2|||
155666658|NCT02750514|561874988|FG000|Track 5|Participant request to discontinue|0|||
155666659|NCT02750514|561874989|FG001|Track 5|Participant request to discontinue|0|||
155666660|NCT02750514|561874990|FG002|Track 5|Participant request to discontinue|0|||
155666661|NCT02750514|561874991|FG003|Track 5|Participant request to discontinue|0|||
155666662|NCT02750514|561874992|FG004|Track 5|Participant request to discontinue|3|||
155666663|NCT02750514|561874988|FG000|Track 5|Other reasons|0|||
155666664|NCT02750514|561874989|FG001|Track 5|Other reasons|0|||
155666665|NCT02750514|561874990|FG002|Track 5|Other reasons|0|||
155666666|NCT02750514|561874991|FG003|Track 5|Other reasons|0|||
155587259|NCT03263936|561578118|FG001|Overall Study|Adverse Event|1|||
155587260|NCT03263936|561578119|FG002|Overall Study|Adverse Event|0|||
155587261|NCT03263936|561578117|FG000|Overall Study|Death|0|||
155666667|NCT02750514|561874992|FG004|Track 5|Other reasons|2|||
155666668|NCT01882465|561874993|FG000|Period 1|Lens Discomfort|0|||
155666669|NCT01882465|561874994|FG001|Period 1|Lens Discomfort|0|||
155666670|NCT01882465|561874995|FG002|Period 1|Lens Discomfort|0|||
155666671|NCT01882465|561874996|FG003|Period 1|Lens Discomfort|1|||
155587262|NCT03263936|561578118|FG001|Overall Study|Death|1|||
155587263|NCT03263936|561578119|FG002|Overall Study|Death|0|||
155587264|NCT01540487|561578120|FG000|Overall Study|Protocol Violation|1|||
155587265|NCT01540487|561578121|FG001|Overall Study|Protocol Violation|0|||
155666672|NCT01882465|561874997|FG004|Period 1|Lens Discomfort|0|||
155666673|NCT01882465|561874998|FG005|Period 1|Lens Discomfort|0|||
155666674|NCT01882465|561874999|FG006|Period 1|Lens Discomfort|0|||
155666675|NCT01882465|561874993|FG000|Period 1|Withdrawal by Subject|0|||
155666676|NCT01882465|561874994|FG001|Period 1|Withdrawal by Subject|0|||
155666677|NCT01882465|561874995|FG002|Period 1|Withdrawal by Subject|0|||
155666678|NCT01882465|561874996|FG003|Period 1|Withdrawal by Subject|0|||
155666679|NCT01882465|561874997|FG004|Period 1|Withdrawal by Subject|0|||
155666680|NCT01882465|561874998|FG005|Period 1|Withdrawal by Subject|0|||
155666681|NCT01882465|561874999|FG006|Period 1|Withdrawal by Subject|1|||
155666682|NCT01882465|561874993|FG000|Period 2|Protocol Violation|0|||
155666683|NCT01882465|561874994|FG001|Period 2|Protocol Violation|0|||
155666684|NCT01882465|561874995|FG002|Period 2|Protocol Violation|0|||
155666685|NCT01882465|561874996|FG003|Period 2|Protocol Violation|0|||
155666686|NCT01882465|561874997|FG004|Period 2|Protocol Violation|1|||
155666687|NCT01882465|561874998|FG005|Period 2|Protocol Violation|0|||
155666688|NCT01882465|561874999|FG006|Period 2|Protocol Violation|0|||
155666689|NCT00532844|561875005|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
155666690|NCT00532844|561875006|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
155666691|NCT00532844|561875005|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
155666692|NCT00532844|561875006|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
155666693|NCT00532844|561875005|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
155666694|NCT00532844|561875006|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
155666695|NCT00532844|561875005|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
155666696|NCT00532844|561875006|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
155666697|NCT00532844|561875005|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
155666698|NCT00532844|561875006|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
155666699|NCT03894891|561875007|FG000|Overall Study|Withdrawal by Subject|1|||
155666700|NCT03894891|561875007|FG000|Overall Study|Completed protocol treatment per protocol|5|||
155666701|NCT04389866|561875008|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
155666702|NCT04389866|561875009|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
155666703|NCT01644643|561875016|FG000|Overall Study|Death|1|||
155666704|NCT01644643|561875017|FG001|Overall Study|Death|0|||
155666705|NCT01644643|561875018|FG002|Overall Study|Death|3|||
155666706|NCT01644643|561875019|FG003|Overall Study|Death|3|||
155666707|NCT01644643|561875016|FG000|Overall Study|Lost to Follow-up|0|||
155666708|NCT01644643|561875017|FG001|Overall Study|Lost to Follow-up|0|||
155666709|NCT01644643|561875018|FG002|Overall Study|Lost to Follow-up|0|||
155587266|NCT03503370|561578122|FG000|Overall Study|Death|3|||
155587267|NCT03503370|561578123|FG001|Overall Study|Death|1|||
155587268|NCT04545489|561578124|FG000|Overall Study|Withdrawal by Subject|12|||
155587269|NCT04545489|561578125|FG001|Overall Study|Withdrawal by Subject|4|||
155587270|NCT04545489|561578124|FG000|Overall Study|Lost to Follow-up|17|||
155587271|NCT04545489|561578125|FG001|Overall Study|Lost to Follow-up|18|||
155587272|NCT04545489|561578124|FG000|Overall Study|12month BP not collected|4|||
155587273|NCT04545489|561578125|FG001|Overall Study|12month BP not collected|4|||
155587274|NCT00457002|561578126|FG000|Overall Study|Death|40|||
155587275|NCT00457002|561578127|FG001|Overall Study|Death|47|||
155587276|NCT00457002|561578126|FG000|Overall Study|Adverse Event|284|||
155587277|NCT00457002|561578127|FG001|Overall Study|Adverse Event|260|||
155587278|NCT00457002|561578126|FG000|Overall Study|Withdrawal by Subject|299|||
155587279|NCT00457002|561578127|FG001|Overall Study|Withdrawal by Subject|271|||
155587280|NCT00457002|561578126|FG000|Overall Study|Lost to Follow-up|72|||
155587281|NCT00457002|561578127|FG001|Overall Study|Lost to Follow-up|71|||
155587282|NCT00457002|561578126|FG000|Overall Study|Poor/Non-compliance|46|||
155587283|NCT00457002|561578127|FG001|Overall Study|Poor/Non-compliance|33|||
155587284|NCT00457002|561578126|FG000|Overall Study|No longer met criteria|41|||
155587285|NCT00457002|561578127|FG001|Overall Study|No longer met criteria|37|||
155666710|NCT01644643|561875019|FG003|Overall Study|Lost to Follow-up|4|||
155666711|NCT01644643|561875016|FG000|Overall Study|Withdrawal by Subject|1|||
155666712|NCT01644643|561875017|FG001|Overall Study|Withdrawal by Subject|0|||
155666713|NCT01644643|561875018|FG002|Overall Study|Withdrawal by Subject|2|||
155666714|NCT01644643|561875019|FG003|Overall Study|Withdrawal by Subject|1|||
155666715|NCT01644643|561875016|FG000|Overall Study|Other Eligibility criteria|0|||
155666716|NCT01644643|561875017|FG001|Overall Study|Other Eligibility criteria|0|||
155666717|NCT01644643|561875018|FG002|Overall Study|Other Eligibility criteria|0|||
155666718|NCT01644643|561875019|FG003|Overall Study|Other Eligibility criteria|2|||
155666719|NCT02756403|561875020|FG000|Overall Study|Unable to swallow medication|0|||
155666720|NCT02756403|561875021|FG001|Overall Study|Unable to swallow medication|1|||
155666721|NCT02756403|561875022|FG002|Overall Study|Unable to swallow medication|1|||
155666722|NCT02756403|561875023|FG003|Overall Study|Unable to swallow medication|1|||
155666723|NCT02756403|561875020|FG000|Overall Study|Did not complete Procedure|0|||
155666724|NCT02756403|561875021|FG001|Overall Study|Did not complete Procedure|1|||
155666725|NCT02756403|561875022|FG002|Overall Study|Did not complete Procedure|0|||
155666726|NCT02756403|561875023|FG003|Overall Study|Did not complete Procedure|0|||
155666727|NCT02756403|561875020|FG000|Overall Study|Changed Mind About Procedure|0|||
155666728|NCT02756403|561875021|FG001|Overall Study|Changed Mind About Procedure|0|||
155666729|NCT02756403|561875022|FG002|Overall Study|Changed Mind About Procedure|1|||
155666730|NCT02756403|561875023|FG003|Overall Study|Changed Mind About Procedure|0|||
155666731|NCT02756403|561875020|FG000|Overall Study|Protocol Violation|0|||
155666732|NCT02756403|561875021|FG001|Overall Study|Protocol Violation|1|||
155666733|NCT02756403|561875022|FG002|Overall Study|Protocol Violation|0|||
155666734|NCT02756403|561875023|FG003|Overall Study|Protocol Violation|1|||
155666735|NCT01824290|561875024|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
155666736|NCT01824290|561875025|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
155666737|NCT01824290|561875026|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
155666738|NCT01824290|561875027|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
155666739|NCT01824290|561875024|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
155666740|NCT01824290|561875025|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
155666741|NCT01824290|561875026|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
155666742|NCT01824290|561875027|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
155666743|NCT01824290|561875024|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
155666744|NCT01824290|561875025|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
155666745|NCT01824290|561875026|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
155666746|NCT01824290|561875027|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
155666747|NCT01824290|561875024|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
155666748|NCT01824290|561875025|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
155666749|NCT01824290|561875026|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
155666750|NCT01824290|561875027|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
155666751|NCT01824290|561875024|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
155666752|NCT01824290|561875025|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
155587286|NCT00457002|561578126|FG000|Overall Study|Administrative reason by Sponsor|1|||
155587287|NCT00457002|561578127|FG001|Overall Study|Administrative reason by Sponsor|0|||
155587288|NCT00457002|561578126|FG000|Overall Study|non-specified|29|||
155587289|NCT00457002|561578127|FG001|Overall Study|non-specified|38|||
155587290|NCT00457002|561578126|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
155587291|NCT00457002|561578127|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
155587292|NCT01623310|561578128|FG000|Overall Study|Adverse Event|21|||
155587293|NCT01623310|561578128|FG000|Overall Study|Lost to Follow-up|18|||
155587294|NCT01623310|561578128|FG000|Overall Study|Lack of Efficacy|6|||
155587295|NCT01623310|561578128|FG000|Overall Study|Protocol Violation|6|||
155587296|NCT01623310|561578128|FG000|Overall Study|Withdrawal by Subject|25|||
155587297|NCT01623310|561578128|FG000|Overall Study|Became potentially child-bearing|1|||
155587298|NCT01623310|561578128|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
155587299|NCT01623310|561578128|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
155587300|NCT00454246|561578129|FG000|Overall Study|Adverse Event|2|||
155587301|NCT00454246|561578130|FG001|Overall Study|Adverse Event|2|||
155587302|NCT00454246|561578131|FG002|Overall Study|Adverse Event|0|||
155587303|NCT00454246|561578129|FG000|Overall Study|Violation of selection criteria at entry|6|||
155587304|NCT00454246|561578130|FG001|Overall Study|Violation of selection criteria at entry|0|||
155587305|NCT00454246|561578131|FG002|Overall Study|Violation of selection criteria at entry|0|||
155587306|NCT00454246|561578129|FG000|Overall Study|Protocol Violation|1|||
155587307|NCT00454246|561578130|FG001|Overall Study|Protocol Violation|0|||
155587308|NCT00454246|561578131|FG002|Overall Study|Protocol Violation|0|||
155587309|NCT00454246|561578129|FG000|Overall Study|Refused Treatment|1|||
155587310|NCT00454246|561578130|FG001|Overall Study|Refused Treatment|1|||
155587311|NCT00454246|561578131|FG002|Overall Study|Refused Treatment|0|||
155587312|NCT00454246|561578129|FG000|Overall Study|Failure to return|1|||
155587313|NCT00454246|561578130|FG001|Overall Study|Failure to return|0|||
155587314|NCT00454246|561578131|FG002|Overall Study|Failure to return|0|||
155587315|NCT00454246|561578129|FG000|Overall Study|Early termination of study|62|||
155587316|NCT00454246|561578130|FG001|Overall Study|Early termination of study|26|||
155587317|NCT00454246|561578131|FG002|Overall Study|Early termination of study|9|||
155587318|NCT02058537|561578133|FG000|Overall Study|Withdrawal by Subject|1|||
155587319|NCT00651261|561578144|FG000|Overall Study|Adverse Event|32|||
155587320|NCT00651261|561578145|FG001|Overall Study|Adverse Event|22|||
155587321|NCT00651261|561578144|FG000|Overall Study|Death|18|||
155587322|NCT00651261|561578145|FG001|Overall Study|Death|18|||
155587323|NCT00651261|561578144|FG000|Overall Study|Withdrawal by Subject|22|||
155587324|NCT00651261|561578145|FG001|Overall Study|Withdrawal by Subject|40|||
155587325|NCT00651261|561578144|FG000|Overall Study|Induction failure|24|||
155587326|NCT00651261|561578145|FG001|Overall Study|Induction failure|35|||
155587327|NCT00651261|561578144|FG000|Overall Study|Disease progression|58|||
155587328|NCT00651261|561578145|FG001|Overall Study|Disease progression|58|||
155587329|NCT00651261|561578144|FG000|Overall Study|Alternative therapy|109|||
155587330|NCT00651261|561578145|FG001|Overall Study|Alternative therapy|107|||
155587331|NCT00651261|561578144|FG000|Overall Study|Other disease or participant decisions|23|||
155587332|NCT00651261|561578145|FG001|Overall Study|Other disease or participant decisions|23|||
155587333|NCT00651261|561578144|FG000|Overall Study|Never treated|5|||
155587334|NCT00651261|561578145|FG001|Overall Study|Never treated|3|||
155587335|NCT02633293|561578146|FG000|Overall Study|Death|56|||
155587336|NCT02633293|561578146|FG000|Overall Study|Progressive Disease|12|||
155587337|NCT02633293|561578146|FG000|Overall Study|Adverse Event|29|||
155587338|NCT02633293|561578146|FG000|Overall Study|Withdrawal by Subject|41|||
155587339|NCT02633293|561578146|FG000|Overall Study|Protocol Violation|1|||
155587340|NCT02633293|561578146|FG000|Overall Study|Lost to Follow-up|1|||
155587341|NCT02633293|561578146|FG000|Overall Study|Study Terminated by Sponsor|24|||
155587342|NCT02633293|561578146|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
155587343|NCT02633293|561578146|FG000|Overall Study|Lung Transplant|5|||
155587344|NCT02633293|561578146|FG000|Overall Study|Lack of Efficacy|2|||
155587345|NCT02633293|561578146|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
155587346|NCT00808210|561578147|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
155587347|NCT00808210|561578148|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
155587348|NCT00808210|561578147|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
155587349|NCT00808210|561578148|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
155587350|NCT00808210|561578147|FG000|Double-Blind TX Period|Adverse Event|0|||
155587351|NCT00808210|561578148|FG001|Double-Blind TX Period|Adverse Event|1|||
155587352|NCT00808210|561578147|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
155587353|NCT00808210|561578148|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
155587354|NCT00808210|561578147|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
155587355|NCT00808210|561578148|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
155587356|NCT00808210|561578147|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
155587357|NCT00808210|561578148|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
155587358|NCT02044302|561578149|FG000|Overall Study|study terminated|2|||
155587359|NCT02044302|561578150|FG001|Overall Study|study terminated|0|||
155587360|NCT01790984|561578152|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
155587361|NCT01790984|561578153|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
155587362|NCT01790984|561578154|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
155587363|NCT01790984|561578155|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
155587364|NCT00558467|561578158|FG000|Overall Study|Adverse Event|1|||
155587365|NCT00558467|561578159|FG001|Overall Study|Adverse Event|2|||
155587366|NCT00558467|561578158|FG000|Overall Study|Lack of Efficacy|0|||
155587367|NCT00558467|561578159|FG001|Overall Study|Lack of Efficacy|1|||
155587368|NCT00558467|561578158|FG000|Overall Study|Patient moving out of state|0|||
155587369|NCT00558467|561578159|FG001|Overall Study|Patient moving out of state|1|||
155587370|NCT00507455|561578160|FG000|Overall Study|Adverse Event|3|||
155587371|NCT00507455|561578161|FG001|Overall Study|Adverse Event|3|||
155587372|NCT00507455|561578162|FG002|Overall Study|Adverse Event|6|||
155587373|NCT00507455|561578160|FG000|Overall Study|Withdrawal by Subject|2|||
155587374|NCT00507455|561578161|FG001|Overall Study|Withdrawal by Subject|1|||
155587375|NCT00507455|561578162|FG002|Overall Study|Withdrawal by Subject|2|||
155587376|NCT00507455|561578160|FG000|Overall Study|Protocol Violation|4|||
155587377|NCT00507455|561578161|FG001|Overall Study|Protocol Violation|1|||
155587378|NCT00507455|561578162|FG002|Overall Study|Protocol Violation|1|||
155587379|NCT00507455|561578160|FG000|Overall Study|Lost to Follow-up|2|||
155587380|NCT00507455|561578161|FG001|Overall Study|Lost to Follow-up|0|||
155587381|NCT00507455|561578162|FG002|Overall Study|Lost to Follow-up|2|||
155587382|NCT00507455|561578160|FG000|Overall Study|Lack of Efficacy|0|||
155587383|NCT00507455|561578161|FG001|Overall Study|Lack of Efficacy|1|||
155587384|NCT00507455|561578162|FG002|Overall Study|Lack of Efficacy|0|||
155587385|NCT00507455|561578160|FG000|Overall Study|Other - miscellaneous reason|1|||
155587386|NCT00507455|561578161|FG001|Overall Study|Other - miscellaneous reason|0|||
155587387|NCT00507455|561578162|FG002|Overall Study|Other - miscellaneous reason|1|||
155587388|NCT00931255|561578163|FG000|Overall Study|Follow up biopsy not done|2|||
155587389|NCT00931255|561578164|FG001|Overall Study|Follow up biopsy not done|3|||
155587390|NCT01609296|561578174|FG000|Overall Study|Death|253|||
155587391|NCT01609296|561578174|FG000|Overall Study|Withdrawal by Subject|151|||
155587392|NCT01609296|561578174|FG000|Overall Study|Lost to Follow-up|21|||
155587393|NCT01609296|561578174|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
155587394|NCT01609296|561578174|FG000|Overall Study|missed visit but known to be alive|28|||
155587395|NCT00546377|561578177|FG000|Overall Study|Deemed ineligible|1|||
155587396|NCT00546377|561578177|FG000|Overall Study|Adverse Event|6|||
155587397|NCT01684423|561578178|FG000|Overall Study|Withdrawal by Subject|0|||
155587398|NCT01684423|561578179|FG001|Overall Study|Withdrawal by Subject|0|||
155587399|NCT01684423|561578180|FG002|Overall Study|Withdrawal by Subject|1|||
155587400|NCT01684423|561578181|FG003|Overall Study|Withdrawal by Subject|0|||
155587401|NCT01684423|561578182|FG004|Overall Study|Withdrawal by Subject|0|||
155587402|NCT01741688|561578184|FG000|Overall Study|Lack of insurance coverage|2|||
155587403|NCT01741688|561578184|FG000|Overall Study|Withdrawal by Subject|1|||
155587404|NCT00463047|561578188|FG000|Titration Period 1|Adverse Event|10|||
155587405|NCT00463047|561578189|FG001|Titration Period 1|Adverse Event|8|||
155587406|NCT00463047|561578188|FG000|Titration Period 1|Lack of Efficacy|10|||
155587407|NCT00463047|561578189|FG001|Titration Period 1|Lack of Efficacy|4|||
155587408|NCT00463047|561578188|FG000|Titration Period 1|Lost to Follow-up|2|||
155587409|NCT00463047|561578189|FG001|Titration Period 1|Lost to Follow-up|0|||
155587410|NCT00463047|561578188|FG000|Titration Period 1|Non-compliance with study medication|3|||
155587411|NCT00463047|561578189|FG001|Titration Period 1|Non-compliance with study medication|5|||
155587412|NCT00463047|561578188|FG000|Titration Period 1|Protocol Violation|5|||
155587413|NCT00463047|561578189|FG001|Titration Period 1|Protocol Violation|5|||
155587414|NCT00463047|561578188|FG000|Titration Period 1|Withdrawal by Subject|3|||
155587415|NCT00463047|561578189|FG001|Titration Period 1|Withdrawal by Subject|5|||
155587416|NCT00463047|561578188|FG000|Titration Period 1|Non-compliance procedures|4|||
155587417|NCT00463047|561578189|FG001|Titration Period 1|Non-compliance procedures|10|||
155587418|NCT00463047|561578188|FG000|Titration Period 1|Other|0|||
155587419|NCT00463047|561578189|FG001|Titration Period 1|Other|2|||
155587420|NCT00463047|561578188|FG000|Titration Period 2|Adverse Event|9|||
155587421|NCT00463047|561578189|FG001|Titration Period 2|Adverse Event|9|||
155587422|NCT00463047|561578188|FG000|Titration Period 2|Lack of Efficacy|6|||
155587423|NCT00463047|561578189|FG001|Titration Period 2|Lack of Efficacy|4|||
155587424|NCT00463047|561578188|FG000|Titration Period 2|Withdrawal by Subject|1|||
155587425|NCT00463047|561578189|FG001|Titration Period 2|Withdrawal by Subject|0|||
155587426|NCT00463047|561578188|FG000|Titration Period 2|Protocol Violation|2|||
155587427|NCT00463047|561578189|FG001|Titration Period 2|Protocol Violation|3|||
155587428|NCT00463047|561578188|FG000|Titration Period 2|Lost to Follow-up|1|||
155587429|NCT00463047|561578189|FG001|Titration Period 2|Lost to Follow-up|2|||
155587430|NCT00463047|561578188|FG000|Titration Period 2|Non-compliance study medication|4|||
155587431|NCT00463047|561578189|FG001|Titration Period 2|Non-compliance study medication|2|||
155587432|NCT00463047|561578188|FG000|Titration Period 2|Non-compliance procedures|4|||
155587433|NCT00463047|561578189|FG001|Titration Period 2|Non-compliance procedures|1|||
155587434|NCT00463047|561578188|FG000|Titration Period 2|Other|3|||
155587435|NCT00463047|561578189|FG001|Titration Period 2|Other|2|||
155587436|NCT00463047|561578188|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
155587437|NCT00463047|561578189|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
155587438|NCT00463047|561578188|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
155587439|NCT00463047|561578189|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
155587440|NCT00463047|561578188|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
155587441|NCT00463047|561578189|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
155587442|NCT00463047|561578188|FG000|Double-Blind Treatment Period 1|Other|1|||
155587443|NCT00463047|561578189|FG001|Double-Blind Treatment Period 1|Other|0|||
155587444|NCT00463047|561578188|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
155587445|NCT00463047|561578189|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
155587446|NCT00463047|561578188|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
155587447|NCT00463047|561578189|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
155587448|NCT00463047|561578188|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
155587449|NCT00463047|561578189|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
155587450|NCT03674112|561578190|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
155587451|NCT03674112|561578191|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
155587452|NCT03674112|561578190|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
155587453|NCT03674112|561578191|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
155587454|NCT03674112|561578190|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
155587455|NCT03674112|561578191|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
155587456|NCT03674112|561578190|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
155587457|NCT03674112|561578191|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
155587458|NCT03674112|561578190|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
155587459|NCT03674112|561578191|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
155587460|NCT03674112|561578190|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
155587461|NCT03674112|561578191|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
155587462|NCT03674112|561578190|FG000|Follow-Up Period (≥3 Years)|Death|2|||
155587463|NCT03674112|561578191|FG001|Follow-Up Period (≥3 Years)|Death|0|||
155587464|NCT03674112|561578190|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
155587465|NCT03674112|561578191|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
155587466|NCT02220764|561578195|FG000|Overall Study|Lost to Follow-up|3|||
155587467|NCT02220764|561578196|FG001|Overall Study|Lost to Follow-up|1|||
155587468|NCT02220764|561578195|FG000|Overall Study|Death|1|||
155587469|NCT02220764|561578196|FG001|Overall Study|Death|0|||
155587470|NCT03020992|561578197|FG000|Overall Study|Adverse Event|5|||
155587471|NCT03020992|561578197|FG000|Overall Study|Withdrawal by Subject|1|||
155587472|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
155587473|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
155587474|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
155587475|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
155587476|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Pregnancy|0|||
155587477|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Pregnancy|1|||
155587478|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
155587479|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
155587480|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
155587481|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
155587482|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
155587483|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
155587484|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Other|3|||
155587485|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Other|0|||
155587486|NCT01006122|561578198|FG000|First Double-blind Intervention Period|Adverse Event|0|||
155587487|NCT01006122|561578199|FG001|First Double-blind Intervention Period|Adverse Event|4|||
155587488|NCT01006122|561578198|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
155587489|NCT01006122|561578199|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
155587490|NCT01006122|561578198|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
155587491|NCT01006122|561578199|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
155587492|NCT01006122|561578198|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
155587493|NCT01006122|561578199|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
155587494|NCT01006122|561578198|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155587495|NCT01006122|561578199|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
155587496|NCT01006122|561578198|FG000|Second Double-blind Intervention Period|Death|0|||
155587497|NCT01006122|561578199|FG001|Second Double-blind Intervention Period|Death|1|||
155587498|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
155587499|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
155587500|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
155587501|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
155587502|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
155587503|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
155587504|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
155587505|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
155587506|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
155587507|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
155587508|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
155587509|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
155587510|NCT03493854|561578200|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
155587511|NCT03493854|561578201|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
155587512|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
155587513|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
155587514|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
155587515|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
155587516|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
155587517|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
155587518|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
155587519|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
155587520|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
155587521|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
155587522|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
155587523|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
155587524|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
155587525|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
155587526|NCT03493854|561578200|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
155587527|NCT03493854|561578201|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
155587528|NCT03493854|561578200|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
155587529|NCT03493854|561578201|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
155587530|NCT03493854|561578200|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
155587531|NCT03493854|561578201|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
155587532|NCT03493854|561578200|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
155587533|NCT03493854|561578201|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
155587534|NCT00410813|561578202|FG000|Overall Study|Adverse Event|6|||
155587535|NCT00410813|561578203|FG001|Overall Study|Adverse Event|11|||
155587536|NCT00410813|561578202|FG000|Overall Study|Progression|32|||
155587537|NCT00410813|561578203|FG001|Overall Study|Progression|21|||
155587538|NCT00410813|561578202|FG000|Overall Study|Not protocol specified|3|||
155587539|NCT00410813|561578203|FG001|Overall Study|Not protocol specified|4|||
155587540|NCT00410813|561578202|FG000|Overall Study|Ineligible|2|||
155587541|NCT00410813|561578203|FG001|Overall Study|Ineligible|4|||
155587542|NCT00410813|561578202|FG000|Overall Study|Death|0|||
155587543|NCT00410813|561578203|FG001|Overall Study|Death|2|||
155587544|NCT02268916|561578222|FG000|Overall Study|Lost to Follow-up|1|||
155587545|NCT02268916|561578223|FG001|Overall Study|Lost to Follow-up|1|||
155587546|NCT02268916|561578222|FG000|Overall Study|Withdrawal by Subject|6|||
155587547|NCT02268916|561578223|FG001|Overall Study|Withdrawal by Subject|5|||
155587548|NCT02268916|561578222|FG000|Overall Study|Participant did not have diabetes|1|||
155587549|NCT02268916|561578223|FG001|Overall Study|Participant did not have diabetes|0|||
155587550|NCT02268916|561578222|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
155587551|NCT02268916|561578223|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
155587552|NCT03926117|561578224|FG000|Overall Study|Unclassified|1|||
155587553|NCT03926117|561578225|FG001|Overall Study|Unclassified|4|||
155587554|NCT03926117|561578226|FG002|Overall Study|Unclassified|1|||
155587555|NCT03926117|561578227|FG003|Overall Study|Unclassified|4|||
155587556|NCT03926117|561578224|FG000|Overall Study|Withdrawal by Subject|3|||
155587557|NCT03926117|561578225|FG001|Overall Study|Withdrawal by Subject|0|||
155587558|NCT03926117|561578226|FG002|Overall Study|Withdrawal by Subject|1|||
155587559|NCT03926117|561578227|FG003|Overall Study|Withdrawal by Subject|1|||
155587560|NCT03926117|561578224|FG000|Overall Study|Lost to Follow-up|0|||
155587561|NCT03926117|561578225|FG001|Overall Study|Lost to Follow-up|2|||
155587562|NCT03926117|561578226|FG002|Overall Study|Lost to Follow-up|1|||
155587563|NCT03926117|561578227|FG003|Overall Study|Lost to Follow-up|0|||
155587564|NCT03926117|561578224|FG000|Overall Study|Adverse Event|1|||
155587565|NCT03926117|561578225|FG001|Overall Study|Adverse Event|2|||
155587566|NCT03926117|561578226|FG002|Overall Study|Adverse Event|3|||
155587567|NCT03926117|561578227|FG003|Overall Study|Adverse Event|1|||
155587568|NCT03926117|561578224|FG000|Overall Study|Randomized but not treated|1|||
155587569|NCT03926117|561578225|FG001|Overall Study|Randomized but not treated|1|||
155587570|NCT03926117|561578226|FG002|Overall Study|Randomized but not treated|0|||
155587571|NCT03926117|561578227|FG003|Overall Study|Randomized but not treated|1|||
155587572|NCT04526288|561578231|FG000|Overall Study|Disease Progression|1|||
155587573|NCT04526288|561578232|FG001|Overall Study|Disease Progression|0|||
155587574|NCT00594165|561578235|FG000|Overall Study|Major protocol violation|1|||
155587575|NCT00594165|561578235|FG000|Overall Study|Lack of Efficacy|12|||
155587576|NCT00594165|561578235|FG000|Overall Study|Adverse Event|52|||
155587577|NCT00594165|561578235|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
155587578|NCT00594165|561578235|FG000|Overall Study|Subject withdrew consent|27|||
155587579|NCT00594165|561578235|FG000|Overall Study|Study ended per sponsor|102|||
155587580|NCT00594165|561578235|FG000|Overall Study|Lost to Follow-up|4|||
155587581|NCT00594165|561578235|FG000|Overall Study|Other: PI discretion|5|||
155587582|NCT00594165|561578235|FG000|Overall Study|Other: Subject moving|3|||
155587583|NCT00594165|561578235|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
155587584|NCT00594165|561578235|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
155587585|NCT00594165|561578235|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
155587586|NCT00594165|561578235|FG000|Overall Study|Other: Site terminated participation|2|||
155587587|NCT05236764|561578236|FG000|Overall Study|In follow up (ongoing)|1|||
155587588|NCT05236764|561578236|FG000|Overall Study|Taken off study - secondary graft failure|1|||
155587589|NCT05236764|561578236|FG000|Overall Study|Death|1|||
155587590|NCT02203721|561578238|FG000|Overall Study|Lost to Follow-up|1|||
155587591|NCT02203721|561578239|FG001|Overall Study|Lost to Follow-up|0|||
155587592|NCT02203721|561578238|FG000|Overall Study|Death|0|||
155587593|NCT02203721|561578239|FG001|Overall Study|Death|2|||
155587594|NCT02203721|561578238|FG000|Overall Study|Illness|0|||
155587595|NCT02203721|561578239|FG001|Overall Study|Illness|1|||
155587596|NCT00703157|561578240|FG000|Overall Study|Lost to Follow-up|0|||
155587597|NCT00703157|561578241|FG001|Overall Study|Lost to Follow-up|1|||
155587598|NCT00703157|561578240|FG000|Overall Study|source data permanently lost/ other|4|||
155587599|NCT00703157|561578241|FG001|Overall Study|source data permanently lost/ other|1|||
155587600|NCT00347009|561578242|FG000|Overall Study|Death|1|||
155587601|NCT00347009|561578242|FG000|Overall Study|Adverse Event|6|||
155587602|NCT00347009|561578242|FG000|Overall Study|Withdrawal by Subject|3|||
155587603|NCT00347009|561578242|FG000|Overall Study|Physician Decision|5|||
155587604|NCT00347009|561578242|FG000|Overall Study|Lost to Follow-up|4|||
155587605|NCT00347009|561578242|FG000|Overall Study|Protocol Violation|2|||
155587606|NCT00347009|561578242|FG000|Overall Study|Adverse Laboratory Experience|1|||
155587607|NCT00347009|561578242|FG000|Overall Study|Insufficient Viral Suppression|3|||
155587608|NCT00347009|561578242|FG000|Overall Study|Increased ALT/HBV DNA|1|||
155587609|NCT00347009|561578242|FG000|Overall Study|Serious Adverse Event|1|||
155587610|NCT02907177|561578245|FG000|Overall Study|Death|0|||
155587611|NCT02907177|561578246|FG001|Overall Study|Death|1|||
155587612|NCT02907177|561578245|FG000|Overall Study|Physician Decision|3|||
155587613|NCT02907177|561578246|FG001|Overall Study|Physician Decision|3|||
155587614|NCT02907177|561578245|FG000|Overall Study|Withdrawal by Subject|15|||
155587615|NCT02907177|561578246|FG001|Overall Study|Withdrawal by Subject|7|||
155587616|NCT02907177|561578245|FG000|Overall Study|Sponsor's Decision|50|||
155587617|NCT02907177|561578246|FG001|Overall Study|Sponsor's Decision|57|||
155587618|NCT03482635|561578247|FG000|Overall Study|Lack of Efficacy|0|||
155587619|NCT03482635|561578248|FG001|Overall Study|Lack of Efficacy|0|||
155587620|NCT03482635|561578249|FG002|Overall Study|Lack of Efficacy|1|||
155587621|NCT03482635|561578250|FG003|Overall Study|Lack of Efficacy|3|||
155587622|NCT03482635|561578247|FG000|Overall Study|Adverse Event|2|||
155587623|NCT03482635|561578248|FG001|Overall Study|Adverse Event|2|||
155587624|NCT03482635|561578249|FG002|Overall Study|Adverse Event|0|||
155587625|NCT03482635|561578250|FG003|Overall Study|Adverse Event|3|||
155587626|NCT03482635|561578247|FG000|Overall Study|Withdrawal by Subject|2|||
155587627|NCT03482635|561578248|FG001|Overall Study|Withdrawal by Subject|1|||
155587628|NCT03482635|561578249|FG002|Overall Study|Withdrawal by Subject|0|||
155587629|NCT03482635|561578250|FG003|Overall Study|Withdrawal by Subject|1|||
155587630|NCT03482635|561578247|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
155587631|NCT03482635|561578248|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
155587632|NCT03482635|561578249|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
155587633|NCT03482635|561578250|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
155587634|NCT03482635|561578247|FG000|Overall Study|Not treated|0|||
155587635|NCT03482635|561578248|FG001|Overall Study|Not treated|0|||
155587636|NCT03482635|561578249|FG002|Overall Study|Not treated|0|||
155587637|NCT03482635|561578250|FG003|Overall Study|Not treated|1|||
155587638|NCT04639219|561578251|FG000|Overall Study|Withdrawal by Subject|8|||
155587639|NCT04639219|561578251|FG000|Overall Study|Lost to Follow-up|6|||
155587640|NCT04639219|561578251|FG000|Overall Study|Death|55|||
155587641|NCT00669669|561578258|FG000|Overall Study|To late to start treatment|1|||
155587642|NCT03103152|561578260|FG000|Overall Study|Physician Decision|5|||
155587643|NCT03103152|561578261|FG001|Overall Study|Physician Decision|2|||
155587644|NCT03103152|561578262|FG002|Overall Study|Physician Decision|6|||
155587645|NCT03103152|561578263|FG003|Overall Study|Physician Decision|3|||
155587646|NCT03103152|561578264|FG004|Overall Study|Physician Decision|3|||
155587647|NCT03103152|561578265|FG005|Overall Study|Physician Decision|1|||
155587648|NCT03103152|561578260|FG000|Overall Study|Protocol Violation|2|||
155587649|NCT03103152|561578261|FG001|Overall Study|Protocol Violation|2|||
155587650|NCT03103152|561578262|FG002|Overall Study|Protocol Violation|1|||
155587651|NCT03103152|561578263|FG003|Overall Study|Protocol Violation|2|||
155587652|NCT03103152|561578264|FG004|Overall Study|Protocol Violation|1|||
155587653|NCT03103152|561578265|FG005|Overall Study|Protocol Violation|1|||
155587654|NCT03103152|561578260|FG000|Overall Study|Inter-current illness|0|||
155587655|NCT03103152|561578261|FG001|Overall Study|Inter-current illness|0|||
155587656|NCT03103152|561578262|FG002|Overall Study|Inter-current illness|1|||
155587657|NCT03103152|561578263|FG003|Overall Study|Inter-current illness|0|||
155587658|NCT03103152|561578264|FG004|Overall Study|Inter-current illness|0|||
155587659|NCT03103152|561578265|FG005|Overall Study|Inter-current illness|0|||
155587660|NCT03103152|561578260|FG000|Overall Study|Death|0|||
155587661|NCT03103152|561578261|FG001|Overall Study|Death|1|||
155587662|NCT03103152|561578262|FG002|Overall Study|Death|0|||
155587663|NCT03103152|561578263|FG003|Overall Study|Death|0|||
155587664|NCT03103152|561578264|FG004|Overall Study|Death|0|||
155587665|NCT03103152|561578265|FG005|Overall Study|Death|0|||
155587666|NCT03103152|561578260|FG000|Overall Study|Adverse Event|0|||
155587667|NCT03103152|561578261|FG001|Overall Study|Adverse Event|0|||
155587668|NCT03103152|561578262|FG002|Overall Study|Adverse Event|1|||
155587669|NCT03103152|561578263|FG003|Overall Study|Adverse Event|0|||
155587670|NCT03103152|561578264|FG004|Overall Study|Adverse Event|0|||
155587671|NCT03103152|561578265|FG005|Overall Study|Adverse Event|1|||
155587672|NCT03103152|561578260|FG000|Overall Study|Withdrawal by Subject|1|||
155587673|NCT03103152|561578261|FG001|Overall Study|Withdrawal by Subject|0|||
155587674|NCT03103152|561578262|FG002|Overall Study|Withdrawal by Subject|1|||
155587675|NCT03103152|561578263|FG003|Overall Study|Withdrawal by Subject|1|||
155587676|NCT03103152|561578264|FG004|Overall Study|Withdrawal by Subject|1|||
155587677|NCT03103152|561578265|FG005|Overall Study|Withdrawal by Subject|1|||
155587678|NCT03103152|561578260|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
155587679|NCT03103152|561578261|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
155587680|NCT03103152|561578262|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
155587681|NCT03103152|561578263|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
155587682|NCT03103152|561578264|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
155587683|NCT03103152|561578265|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
155587684|NCT03103152|561578260|FG000|Overall Study|Unacceptable side effects|0|||
155587685|NCT03103152|561578261|FG001|Overall Study|Unacceptable side effects|0|||
155587686|NCT03103152|561578262|FG002|Overall Study|Unacceptable side effects|0|||
155587687|NCT03103152|561578263|FG003|Overall Study|Unacceptable side effects|0|||
155587688|NCT03103152|561578264|FG004|Overall Study|Unacceptable side effects|0|||
155587689|NCT03103152|561578265|FG005|Overall Study|Unacceptable side effects|1|||
155587690|NCT03103152|561578260|FG000|Overall Study|Lost to Follow-up|0|||
155587691|NCT03103152|561578261|FG001|Overall Study|Lost to Follow-up|1|||
155587692|NCT03103152|561578262|FG002|Overall Study|Lost to Follow-up|0|||
155587693|NCT03103152|561578263|FG003|Overall Study|Lost to Follow-up|1|||
155587694|NCT03103152|561578264|FG004|Overall Study|Lost to Follow-up|0|||
155587695|NCT03103152|561578265|FG005|Overall Study|Lost to Follow-up|1|||
155587696|NCT03103152|561578260|FG000|Overall Study|Testicular pain|0|||
155587697|NCT03103152|561578261|FG001|Overall Study|Testicular pain|0|||
155587698|NCT03103152|561578262|FG002|Overall Study|Testicular pain|0|||
155587699|NCT03103152|561578263|FG003|Overall Study|Testicular pain|1|||
155587700|NCT03103152|561578264|FG004|Overall Study|Testicular pain|0|||
155587701|NCT03103152|561578265|FG005|Overall Study|Testicular pain|0|||
155587702|NCT03474965|561578266|FG000|Overall Study|Pregnancy|1|||
155587703|NCT03474965|561578267|FG001|Overall Study|Pregnancy|0|||
155587704|NCT03474965|561578268|FG002|Overall Study|Pregnancy|0|||
155587705|NCT03474965|561578269|FG003|Overall Study|Pregnancy|0|||
155587706|NCT03474965|561578266|FG000|Overall Study|Lost to Follow-up|0|||
155587707|NCT03474965|561578267|FG001|Overall Study|Lost to Follow-up|0|||
155587708|NCT03474965|561578268|FG002|Overall Study|Lost to Follow-up|1|||
155587709|NCT03474965|561578269|FG003|Overall Study|Lost to Follow-up|0|||
155587710|NCT03474965|561578266|FG000|Overall Study|Death|1|||
155587711|NCT03474965|561578267|FG001|Overall Study|Death|0|||
155587712|NCT03474965|561578268|FG002|Overall Study|Death|0|||
155587713|NCT03474965|561578269|FG003|Overall Study|Death|0|||
155587714|NCT03474965|561578266|FG000|Overall Study|Adverse Event|1|||
155587715|NCT03474965|561578267|FG001|Overall Study|Adverse Event|0|||
155587716|NCT03474965|561578268|FG002|Overall Study|Adverse Event|0|||
155587717|NCT03474965|561578269|FG003|Overall Study|Adverse Event|1|||
155587718|NCT03474965|561578266|FG000|Overall Study|Physician Decision|3|||
155587719|NCT03474965|561578267|FG001|Overall Study|Physician Decision|1|||
155587720|NCT03474965|561578268|FG002|Overall Study|Physician Decision|2|||
155587721|NCT03474965|561578269|FG003|Overall Study|Physician Decision|0|||
155587722|NCT03474965|561578266|FG000|Overall Study|Participant Decision|7|||
155587723|NCT03474965|561578267|FG001|Overall Study|Participant Decision|0|||
155587724|NCT03474965|561578268|FG002|Overall Study|Participant Decision|1|||
155587725|NCT03474965|561578269|FG003|Overall Study|Participant Decision|0|||
155587726|NCT03474965|561578266|FG000|Overall Study|Guardian Decision|4|||
155587727|NCT03474965|561578267|FG001|Overall Study|Guardian Decision|2|||
155587728|NCT03474965|561578268|FG002|Overall Study|Guardian Decision|7|||
155587729|NCT03474965|561578269|FG003|Overall Study|Guardian Decision|2|||
155587730|NCT03100903|561579810|FG000|Overall Study|Withdrawal by Subject|0|||
155587731|NCT03100903|561579811|FG001|Overall Study|Withdrawal by Subject|0|||
155587732|NCT03100903|561579812|FG002|Overall Study|Withdrawal by Subject|1|||
155587733|NCT04659993|561579813|FG000|Overall Study|Withdrawal by Subject|2|||
155587734|NCT04659993|561579813|FG000|Overall Study|Lost to Follow-up|2|||
155587735|NCT00754234|561579816|FG000|Overall Study|Withdrawal by Subject|3|||
155587736|NCT03483961|561579817|FG000|Overall Study|Lost to Follow-up|7|||
155587737|NCT03483961|561579818|FG001|Overall Study|Lost to Follow-up|6|||
155587738|NCT03483961|561579819|FG002|Overall Study|Lost to Follow-up|6|||
155587739|NCT03483961|561579820|FG003|Overall Study|Lost to Follow-up|6|||
155587740|NCT03483961|561579821|FG004|Overall Study|Lost to Follow-up|6|||
155587741|NCT03483961|561579822|FG005|Overall Study|Lost to Follow-up|4|||
155587742|NCT03483961|561579823|FG006|Overall Study|Lost to Follow-up|4|||
155587743|NCT03483961|561579824|FG007|Overall Study|Lost to Follow-up|11|||
155587744|NCT03483961|561579825|FG008|Overall Study|Lost to Follow-up|1|||
155587745|NCT03483961|561579826|FG009|Overall Study|Lost to Follow-up|0|||
155587746|NCT03483961|561579817|FG000|Overall Study|Withdrawal by Subject|3|||
155587747|NCT03483961|561579818|FG001|Overall Study|Withdrawal by Subject|4|||
155587748|NCT03483961|561579819|FG002|Overall Study|Withdrawal by Subject|5|||
155587749|NCT03483961|561579820|FG003|Overall Study|Withdrawal by Subject|3|||
155587750|NCT03483961|561579821|FG004|Overall Study|Withdrawal by Subject|4|||
155587751|NCT03483961|561579822|FG005|Overall Study|Withdrawal by Subject|2|||
155587752|NCT03483961|561579823|FG006|Overall Study|Withdrawal by Subject|1|||
155587753|NCT03483961|561579824|FG007|Overall Study|Withdrawal by Subject|2|||
155587754|NCT03483961|561579825|FG008|Overall Study|Withdrawal by Subject|1|||
155587755|NCT03483961|561579826|FG009|Overall Study|Withdrawal by Subject|0|||
155587756|NCT03483961|561579817|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
155587757|NCT03483961|561579818|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587758|NCT03483961|561579819|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587759|NCT03483961|561579820|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587760|NCT03483961|561579821|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587761|NCT03483961|561579822|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587762|NCT03483961|561579823|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587763|NCT03483961|561579824|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587764|NCT03483961|561579825|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587765|NCT03483961|561579826|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155587766|NCT03483961|561579817|FG000|Overall Study|Adverse Event|0|||
155587767|NCT03483961|561579818|FG001|Overall Study|Adverse Event|0|||
155587768|NCT03483961|561579819|FG002|Overall Study|Adverse Event|1|||
155587769|NCT03483961|561579820|FG003|Overall Study|Adverse Event|0|||
155587770|NCT03483961|561579821|FG004|Overall Study|Adverse Event|0|||
155587771|NCT03483961|561579822|FG005|Overall Study|Adverse Event|0|||
155587772|NCT03483961|561579823|FG006|Overall Study|Adverse Event|0|||
155587773|NCT03483961|561579824|FG007|Overall Study|Adverse Event|0|||
155587774|NCT03483961|561579825|FG008|Overall Study|Adverse Event|0|||
155587775|NCT03483961|561579826|FG009|Overall Study|Adverse Event|0|||
155587776|NCT04003636|561579827|FG000|Overall Study|Death|409|||
155587777|NCT04003636|561579828|FG001|Overall Study|Death|443|||
155587778|NCT04003636|561579827|FG000|Overall Study|Lost to Follow-up|0|||
155587779|NCT04003636|561579828|FG001|Overall Study|Lost to Follow-up|1|||
155587780|NCT04003636|561579827|FG000|Overall Study|Withdrawal by Subject|5|||
155587781|NCT04003636|561579828|FG001|Overall Study|Withdrawal by Subject|2|||
155587782|NCT04003636|561579827|FG000|Overall Study|Participant On-going|119|||
155587783|NCT04003636|561579828|FG001|Overall Study|Participant On-going|90|||
155587784|NCT03048747|561579829|FG000|Overall Study|Adverse Event|2|||
155587785|NCT03048747|561579829|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
155587786|NCT03048747|561579829|FG000|Overall Study|Physician Decision|1|||
155587787|NCT00298272|561579830|FG000|Double-blind Phase|Adverse Event|2|||
155587788|NCT00298272|561579831|FG001|Double-blind Phase|Adverse Event|0|||
155587789|NCT00298272|561579830|FG000|Double-blind Phase|Failure to Return|2|||
155587790|NCT00298272|561579831|FG001|Double-blind Phase|Failure to Return|0|||
155587791|NCT00298272|561579830|FG000|Double-blind Phase|Protocol Violation|2|||
155587792|NCT00298272|561579831|FG001|Double-blind Phase|Protocol Violation|0|||
155587793|NCT00298272|561579830|FG000|Double-blind Phase|Withdrawal by Subject|2|||
155587794|NCT00298272|561579831|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155587795|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Adverse Event|1|||
155587796|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Adverse Event|2|||
155587797|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
155587798|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
155587799|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Failure to Return|1|||
155587800|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Failure to Return|0|||
155587801|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
155587802|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
155587803|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
155587804|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
155587805|NCT00298272|561579830|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
155587806|NCT00298272|561579831|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
155587807|NCT00298272|561579830|FG000|Safety Follow-up Phase|Failure to Return|1|||
155587808|NCT00298272|561579831|FG001|Safety Follow-up Phase|Failure to Return|1|||
155587809|NCT00298272|561579830|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
155587810|NCT00298272|561579831|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
155587811|NCT00298272|561579830|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
155587812|NCT00298272|561579831|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
155587813|NCT00915018|561579832|FG000|Overall Study|Death|75|||
155587814|NCT00915018|561579833|FG001|Overall Study|Death|70|||
155587815|NCT00915018|561579832|FG000|Overall Study|Lost to Follow-up|10|||
155587816|NCT00915018|561579833|FG001|Overall Study|Lost to Follow-up|5|||
155587817|NCT00915018|561579832|FG000|Overall Study|Withdrawal by Subject|38|||
155587818|NCT00915018|561579833|FG001|Overall Study|Withdrawal by Subject|27|||
155587819|NCT00915018|561579832|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
155587820|NCT00915018|561579833|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
155587821|NCT05326529|561579834|FG000|Overall Study|Lack of Efficacy|0|||
155587822|NCT05326529|561579835|FG001|Overall Study|Lack of Efficacy|1|||
155587823|NCT05326529|561579836|FG002|Overall Study|Lack of Efficacy|0|||
155587824|NCT05326529|561579834|FG000|Overall Study|Physician Decision|0|||
155587825|NCT05326529|561579835|FG001|Overall Study|Physician Decision|0|||
155587826|NCT05326529|561579836|FG002|Overall Study|Physician Decision|2|||
155587827|NCT00734162|561579837|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
155587828|NCT00734162|561579838|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
155587829|NCT00734162|561579839|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
155587830|NCT00734162|561579840|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
155587831|NCT00734162|561579837|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155587832|NCT00734162|561579838|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155587833|NCT00734162|561579839|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155587834|NCT00734162|561579840|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
155587835|NCT00734162|561579837|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
155587836|NCT00734162|561579838|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155587837|NCT00734162|561579839|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155587838|NCT00734162|561579840|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155587839|NCT00734162|561579837|FG000|Open-Label Phase|Withdrew Consent|1|||
155587840|NCT00734162|561579838|FG001|Open-Label Phase|Withdrew Consent|0|||
155587841|NCT00734162|561579839|FG002|Open-Label Phase|Withdrew Consent|1|||
155587842|NCT00734162|561579840|FG003|Open-Label Phase|Withdrew Consent|1|||
155587843|NCT00734162|561579837|FG000|Open-Label Phase|Lost to Follow-up|1|||
155587844|NCT00734162|561579838|FG001|Open-Label Phase|Lost to Follow-up|2|||
155587845|NCT00734162|561579839|FG002|Open-Label Phase|Lost to Follow-up|0|||
155587846|NCT00734162|561579840|FG003|Open-Label Phase|Lost to Follow-up|1|||
155587847|NCT00734162|561579837|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155587848|NCT00734162|561579838|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155587849|NCT00734162|561579839|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155587850|NCT00734162|561579840|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
155587851|NCT00566020|561579841|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
155587852|NCT00566020|561579842|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
155587853|NCT00566020|561579841|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
155587854|NCT00566020|561579842|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
155587855|NCT00566020|561579841|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
155587856|NCT00566020|561579842|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
155587857|NCT00566020|561579841|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
155587858|NCT00566020|561579842|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
155666753|NCT01824290|561875026|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
155587859|NCT00566020|561579841|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
155587860|NCT00566020|561579842|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
155587861|NCT00566020|561579841|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
155587862|NCT00566020|561579842|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
155587863|NCT02609607|561579843|FG000|Overall Study|Lost to Follow-up|0|||
155587864|NCT02609607|561579844|FG001|Overall Study|Lost to Follow-up|1|||
155587865|NCT00687271|561579845|FG000|Overall Study|Adverse Event|1|||
155587866|NCT00687271|561579846|FG001|Overall Study|Adverse Event|3|||
155587867|NCT00687271|561579847|FG002|Overall Study|Adverse Event|1|||
155587868|NCT00687271|561579848|FG003|Overall Study|Adverse Event|0|||
155587869|NCT00687271|561579845|FG000|Overall Study|Lost to Follow-up|0|||
155587870|NCT00687271|561579846|FG001|Overall Study|Lost to Follow-up|1|||
155587871|NCT00687271|561579847|FG002|Overall Study|Lost to Follow-up|0|||
155587872|NCT00687271|561579848|FG003|Overall Study|Lost to Follow-up|0|||
155587873|NCT00687271|561579845|FG000|Overall Study|Protocol Violation|2|||
155587874|NCT00687271|561579846|FG001|Overall Study|Protocol Violation|1|||
155587875|NCT00687271|561579847|FG002|Overall Study|Protocol Violation|1|||
155587876|NCT00687271|561579848|FG003|Overall Study|Protocol Violation|0|||
155587877|NCT00687271|561579845|FG000|Overall Study|Withdrawal by Subject|0|||
155587878|NCT00687271|561579846|FG001|Overall Study|Withdrawal by Subject|1|||
155587879|NCT00687271|561579847|FG002|Overall Study|Withdrawal by Subject|3|||
155587880|NCT00687271|561579848|FG003|Overall Study|Withdrawal by Subject|0|||
155587881|NCT00778817|561579855|FG000|Overall Study|Adverse Event|2|||
155587882|NCT00778817|561579855|FG000|Overall Study|Withdrawal by Subject|2|||
155587883|NCT03150719|561579856|FG000|Overall Study|Adverse Event|0|||
155587884|NCT03150719|561579857|FG001|Overall Study|Adverse Event|1|||
155587885|NCT03150719|561579856|FG000|Overall Study|Death|0|||
155587886|NCT03150719|561579857|FG001|Overall Study|Death|1|||
155587887|NCT03150719|561579856|FG000|Overall Study|Other|1|||
155587888|NCT03150719|561579857|FG001|Overall Study|Other|0|||
155587889|NCT01372995|561579862|FG000|Overall Study|Spouse withdrew participant from study|0|||
155587890|NCT01372995|561579863|FG001|Overall Study|Spouse withdrew participant from study|1|||
155587891|NCT01372995|561579864|FG002|Overall Study|Spouse withdrew participant from study|0|||
155587892|NCT01372995|561579862|FG000|Overall Study|Physician Decision|0|||
155587893|NCT01372995|561579863|FG001|Overall Study|Physician Decision|0|||
155587894|NCT01372995|561579864|FG002|Overall Study|Physician Decision|1|||
155587895|NCT02914613|561579865|FG000|Overall Study|Withdrawal by Subject|1|||
155587896|NCT02914613|561579866|FG001|Overall Study|Withdrawal by Subject|2|||
155587897|NCT02914613|561579865|FG000|Overall Study|Adverse Event|1|||
155587898|NCT02914613|561579866|FG001|Overall Study|Adverse Event|0|||
155587899|NCT01964222|561579869|FG000|Overall Study|Lost to Follow-up|7|||
155587900|NCT01964222|561579870|FG001|Overall Study|Lost to Follow-up|5|||
155587901|NCT01964222|561579869|FG000|Overall Study|Withdrawal by Subject|6|||
155587902|NCT01964222|561579870|FG001|Overall Study|Withdrawal by Subject|6|||
155587903|NCT01964222|561579869|FG000|Overall Study|Screening Failure|2|||
155587904|NCT01964222|561579870|FG001|Overall Study|Screening Failure|0|||
155587905|NCT03850496|561579881|FG000|Overall Study|Withdrawal by Subject|1|||
155587906|NCT03850496|561579882|FG001|Overall Study|Withdrawal by Subject|0|||
155587907|NCT03850496|561579883|FG002|Overall Study|Withdrawal by Subject|0|||
155587908|NCT03850496|561579881|FG000|Overall Study|Lost to Follow-up|0|||
155587909|NCT03850496|561579882|FG001|Overall Study|Lost to Follow-up|1|||
155587910|NCT03850496|561579883|FG002|Overall Study|Lost to Follow-up|4|||
155587911|NCT00869999|561579890|FG000|Overall Study|Withdrawal by Subject|1|||
155587912|NCT00869999|561579890|FG000|Overall Study|removed prior to starting therapy|1|||
155587913|NCT03363776|561579893|FG000|Overall Study|Progressive disease|2|||
155587914|NCT03363776|561579894|FG001|Overall Study|Progressive disease|3|||
155587915|NCT03363776|561579895|FG002|Overall Study|Progressive disease|1|||
155587916|NCT03363776|561579893|FG000|Overall Study|Study drug toxicity|0|||
155587917|NCT03363776|561579894|FG001|Overall Study|Study drug toxicity|0|||
155587918|NCT03363776|561579895|FG002|Overall Study|Study drug toxicity|1|||
155587919|NCT03363776|561579893|FG000|Overall Study|Death|1|||
155587920|NCT03363776|561579894|FG001|Overall Study|Death|0|||
155587921|NCT03363776|561579895|FG002|Overall Study|Death|0|||
155587922|NCT04157348|561579896|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
155587923|NCT04157348|561579897|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
155587924|NCT04157348|561579896|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155587925|NCT04157348|561579897|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155587926|NCT04157348|561579896|FG000|Double-blind Treatment Period|Adverse Event|0|||
155587927|NCT04157348|561579897|FG001|Double-blind Treatment Period|Adverse Event|1|||
155587928|NCT04157348|561579896|FG000|Open-label Extension Period|Adverse Event|1|||
155587929|NCT04157348|561579897|FG001|Open-label Extension Period|Adverse Event|1|||
155587930|NCT04157348|561579896|FG000|Open-label Extension Period|Death|0|||
155587931|NCT04157348|561579897|FG001|Open-label Extension Period|Death|1|||
155587932|NCT04157348|561579896|FG000|Open-label Extension Period|Lack of Efficacy|2|||
155587933|NCT04157348|561579897|FG001|Open-label Extension Period|Lack of Efficacy|2|||
155587934|NCT04157348|561579896|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
155587935|NCT04157348|561579897|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155587936|NCT04157348|561579896|FG000|Open-label Extension Period|Ongoing|60|||
155587937|NCT04157348|561579897|FG001|Open-label Extension Period|Ongoing|57|||
155587938|NCT04157348|561579896|FG000|Open-label Extension Period|other reasons|1|||
155587939|NCT04157348|561579897|FG001|Open-label Extension Period|other reasons|1|||
155587940|NCT02527434|561579898|FG000|Overall Study|Lost to Follow-up|2|||
155587941|NCT02527434|561579899|FG001|Overall Study|Lost to Follow-up|2|||
155587942|NCT02527434|561579900|FG002|Overall Study|Lost to Follow-up|0|||
155587943|NCT02527434|561579898|FG000|Overall Study|Death|19|||
155587944|NCT02527434|561579899|FG001|Overall Study|Death|6|||
155587945|NCT02527434|561579900|FG002|Overall Study|Death|17|||
155587946|NCT02527434|561579898|FG000|Overall Study|Withdrawal by Subject|5|||
155587947|NCT02527434|561579899|FG001|Overall Study|Withdrawal by Subject|3|||
155587948|NCT02527434|561579900|FG002|Overall Study|Withdrawal by Subject|3|||
155587949|NCT02527434|561579898|FG000|Overall Study|Reason Not Specified|1|||
155587950|NCT02527434|561579899|FG001|Overall Study|Reason Not Specified|0|||
155587951|NCT02527434|561579900|FG002|Overall Study|Reason Not Specified|0|||
155587952|NCT02527434|561579898|FG000|Overall Study|Site closure|1|||
155587953|NCT02527434|561579899|FG001|Overall Study|Site closure|0|||
155587954|NCT02527434|561579900|FG002|Overall Study|Site closure|0|||
155587955|NCT02861807|561579901|FG000|Overall Study|Lost to Follow-up|7|||
155587956|NCT02861807|561579902|FG001|Overall Study|Lost to Follow-up|6|||
155587957|NCT02861807|561579901|FG000|Overall Study|Withdrawal by Subject|5|||
155587958|NCT02861807|561579902|FG001|Overall Study|Withdrawal by Subject|8|||
155587959|NCT00568061|561579905|FG000|Overall Study|Inclusion / exclusion criteria|5|||
155587960|NCT00568061|561579906|FG001|Overall Study|Inclusion / exclusion criteria|1|||
155587961|NCT00568061|561579905|FG000|Overall Study|Adverse Event|0|||
155587962|NCT00568061|561579906|FG001|Overall Study|Adverse Event|1|||
155587963|NCT05027451|561579907|FG000|Overall Study|Lost to Follow-up|1|||
155587964|NCT05027451|561579908|FG001|Overall Study|Lost to Follow-up|1|||
155587965|NCT02693002|561579910|FG000|Overall Study|Withdrawal by Subject|1|||
155587966|NCT02693002|561579911|FG001|Overall Study|Withdrawal by Subject|0|||
155587967|NCT01422889|561579915|FG000|Overall Study|No Data Entered for Study Stent|9|||
155587968|NCT02748356|561579920|FG000|Overall Study|Withdrawal by Subject|1|||
155587969|NCT01732458|561579921|FG000|Overall Study|Lost to Follow-up|0|||
155587970|NCT01732458|561579922|FG001|Overall Study|Lost to Follow-up|2|||
155587971|NCT01732458|561579923|FG002|Overall Study|Lost to Follow-up|0|||
155587972|NCT01732458|561579924|FG003|Overall Study|Lost to Follow-up|0|||
155587973|NCT01732458|561579921|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155587974|NCT01732458|561579922|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155587975|NCT01732458|561579923|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155587976|NCT01732458|561579924|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155587977|NCT01732458|561579921|FG000|Overall Study|Physician Decision|1|||
155587978|NCT01732458|561579922|FG001|Overall Study|Physician Decision|2|||
155587979|NCT01732458|561579923|FG002|Overall Study|Physician Decision|2|||
155587980|NCT01732458|561579924|FG003|Overall Study|Physician Decision|0|||
155587981|NCT01732458|561579921|FG000|Overall Study|Protocol Violation|2|||
155587982|NCT01732458|561579922|FG001|Overall Study|Protocol Violation|0|||
155587983|NCT01732458|561579923|FG002|Overall Study|Protocol Violation|0|||
155587984|NCT01732458|561579924|FG003|Overall Study|Protocol Violation|2|||
155587985|NCT01732458|561579921|FG000|Overall Study|Screen Failure|0|||
155587986|NCT01732458|561579922|FG001|Overall Study|Screen Failure|1|||
155587987|NCT01732458|561579923|FG002|Overall Study|Screen Failure|0|||
155587988|NCT01732458|561579924|FG003|Overall Study|Screen Failure|0|||
155587989|NCT05107492|561579926|FG000|Overall Study|Lost to Follow-up|1|||
155587990|NCT05107492|561579927|FG001|Overall Study|Lost to Follow-up|0|||
155587991|NCT04331067|561579928|FG000|Overall Study|Adverse Event|1|||
155587992|NCT04331067|561579929|FG001|Overall Study|Adverse Event|3|||
155587993|NCT04331067|561579930|FG002|Overall Study|Adverse Event|1|||
155587994|NCT04331067|561579928|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
155587995|NCT04331067|561579929|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
155587996|NCT04331067|561579930|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
155587997|NCT02522884|561579931|FG000|Overall Study|Withdrawal by Subject|6|||
155587998|NCT02522884|561579931|FG000|Overall Study|Death|3|||
155587999|NCT02522884|561579931|FG000|Overall Study|Missed 12-month Follow-up|9|||
155588000|NCT04495751|561579932|FG000|Overall Study|Withdrawal by Subject|1|||
155588001|NCT04495751|561579933|FG001|Overall Study|Withdrawal by Subject|0|||
155588002|NCT04495751|561579932|FG000|Overall Study|Lost to Follow-up|1|||
155588003|NCT04495751|561579933|FG001|Overall Study|Lost to Follow-up|0|||
155588004|NCT03289754|561579934|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
155588005|NCT04873934|561579935|FG000|Overall Study|Adverse Event|0|||
155588006|NCT04873934|561579936|FG001|Overall Study|Adverse Event|1|||
155588007|NCT04873934|561579935|FG000|Overall Study|Death|0|||
155588008|NCT04873934|561579936|FG001|Overall Study|Death|2|||
155588009|NCT04873934|561579935|FG000|Overall Study|Lost to Follow-up|13|||
155588010|NCT04873934|561579936|FG001|Overall Study|Lost to Follow-up|9|||
155588011|NCT04873934|561579935|FG000|Overall Study|Physician Decision|1|||
155588012|NCT04873934|561579936|FG001|Overall Study|Physician Decision|1|||
155588013|NCT04873934|561579935|FG000|Overall Study|Protocol deviation|2|||
155588014|NCT04873934|561579936|FG001|Overall Study|Protocol deviation|1|||
155588015|NCT04873934|561579935|FG000|Overall Study|Subject decision|1|||
155588016|NCT04873934|561579936|FG001|Overall Study|Subject decision|8|||
155588017|NCT04873934|561579935|FG000|Overall Study|Withdrew consent|0|||
155588018|NCT04873934|561579936|FG001|Overall Study|Withdrew consent|4|||
155588019|NCT04873934|561579935|FG000|Overall Study|Missing|1|||
155588020|NCT04873934|561579936|FG001|Overall Study|Missing|0|||
155588021|NCT00314327|561579942|FG000|Overall Study|Withdrawal by Subject|1|||
155588022|NCT02134015|561579943|FG000|Overall Study|Protocol Violation|0|||
155588023|NCT02134015|561579944|FG001|Overall Study|Protocol Violation|1|||
155588024|NCT02134015|561579943|FG000|Overall Study|Death|2|||
155588025|NCT02134015|561579944|FG001|Overall Study|Death|1|||
155588026|NCT02134015|561579943|FG000|Overall Study|Reason not provided|1|||
155588027|NCT02134015|561579944|FG001|Overall Study|Reason not provided|2|||
155588028|NCT02134015|561579943|FG000|Overall Study|Clinical progression|14|||
155588029|NCT02134015|561579944|FG001|Overall Study|Clinical progression|7|||
155588030|NCT02134015|561579943|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
155588031|NCT02134015|561579944|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
155588032|NCT02134015|561579943|FG000|Overall Study|Study terminated by sponsor|2|||
155588033|NCT02134015|561579944|FG001|Overall Study|Study terminated by sponsor|3|||
155588034|NCT02134015|561579943|FG000|Overall Study|Adverse Event|9|||
155588035|NCT02134015|561579944|FG001|Overall Study|Adverse Event|10|||
155588036|NCT02134015|561579943|FG000|Overall Study|Withdrawal by Subject|3|||
155588037|NCT02134015|561579944|FG001|Overall Study|Withdrawal by Subject|7|||
155588038|NCT03868930|561581598|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
155588039|NCT03868930|561581599|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
155588040|NCT03868930|561581598|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
155588041|NCT03868930|561581599|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
155588042|NCT03868930|561581598|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
155588043|NCT03868930|561581599|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
155588044|NCT03868930|561581598|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
155588045|NCT03868930|561581599|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
155588046|NCT03868930|561581598|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
155588047|NCT03868930|561581599|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
155588048|NCT02151851|561581602|FG000|Overall Study|Lack of Efficacy|67|||
155588049|NCT02151851|561581603|FG001|Overall Study|Lack of Efficacy|94|||
155588050|NCT02151851|561581602|FG000|Overall Study|Protocol Violation|0|||
155588051|NCT02151851|561581603|FG001|Overall Study|Protocol Violation|1|||
155588052|NCT02151851|561581602|FG000|Overall Study|Withdrawal by Subject|2|||
155588053|NCT02151851|561581603|FG001|Overall Study|Withdrawal by Subject|5|||
155588054|NCT02151851|561581602|FG000|Overall Study|Medical impairment|1|||
155588055|NCT02151851|561581603|FG001|Overall Study|Medical impairment|0|||
155588056|NCT02151851|561581602|FG000|Overall Study|Low compliance to study visits|0|||
155588057|NCT02151851|561581603|FG001|Overall Study|Low compliance to study visits|1|||
155588058|NCT02151851|561581602|FG000|Overall Study|Subject entered into study in error|0|||
155588059|NCT02151851|561581603|FG001|Overall Study|Subject entered into study in error|1|||
155588060|NCT02151851|561581602|FG000|Overall Study|Adverse Event|6|||
155588061|NCT02151851|561581603|FG001|Overall Study|Adverse Event|28|||
155588062|NCT02640950|561581604|FG000|Overall Study|Adverse Event|1|||
155588063|NCT02640950|561581604|FG000|Overall Study|Withdrawal by Subject|1|||
155588064|NCT00652626|561581605|FG000|Initial Treatment Phase|Adverse Event|0|||
155588065|NCT00652626|561581606|FG001|Initial Treatment Phase|Adverse Event|0|||
155588066|NCT00652626|561581607|FG002|Initial Treatment Phase|Adverse Event|0|||
155588067|NCT00652626|561581608|FG003|Initial Treatment Phase|Adverse Event|0|||
155588068|NCT00652626|561581609|FG004|Initial Treatment Phase|Adverse Event|1|||
155588069|NCT00652626|561581610|FG005|Initial Treatment Phase|Adverse Event|0|||
155588070|NCT00652626|561581611|FG006|Initial Treatment Phase|Adverse Event|0|||
155588071|NCT00652626|561581605|FG000|Initial Treatment Phase|Protocol Violation|0|||
155588072|NCT00652626|561581606|FG001|Initial Treatment Phase|Protocol Violation|0|||
155588073|NCT00652626|561581607|FG002|Initial Treatment Phase|Protocol Violation|0|||
155588074|NCT00652626|561581608|FG003|Initial Treatment Phase|Protocol Violation|1|||
155588075|NCT00652626|561581609|FG004|Initial Treatment Phase|Protocol Violation|0|||
155588076|NCT00652626|561581610|FG005|Initial Treatment Phase|Protocol Violation|0|||
155588077|NCT00652626|561581611|FG006|Initial Treatment Phase|Protocol Violation|0|||
155588078|NCT00652626|561581605|FG000|Initial Treatment Phase|Physician Decision|0|||
155588079|NCT00652626|561581606|FG001|Initial Treatment Phase|Physician Decision|0|||
155588080|NCT00652626|561581607|FG002|Initial Treatment Phase|Physician Decision|0|||
155588081|NCT00652626|561581608|FG003|Initial Treatment Phase|Physician Decision|0|||
155588082|NCT00652626|561581609|FG004|Initial Treatment Phase|Physician Decision|1|||
155588083|NCT00652626|561581610|FG005|Initial Treatment Phase|Physician Decision|0|||
155588084|NCT00652626|561581611|FG006|Initial Treatment Phase|Physician Decision|0|||
155588085|NCT00652626|561581605|FG000|Initial Treatment Phase|Sponsor Request|0|||
155588086|NCT00652626|561581606|FG001|Initial Treatment Phase|Sponsor Request|0|||
155588087|NCT00652626|561581607|FG002|Initial Treatment Phase|Sponsor Request|1|||
155588088|NCT00652626|561581608|FG003|Initial Treatment Phase|Sponsor Request|0|||
155588089|NCT00652626|561581609|FG004|Initial Treatment Phase|Sponsor Request|0|||
155588090|NCT00652626|561581610|FG005|Initial Treatment Phase|Sponsor Request|0|||
155588091|NCT00652626|561581611|FG006|Initial Treatment Phase|Sponsor Request|0|||
155588092|NCT00652626|561581605|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
155588093|NCT00652626|561581606|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
155588094|NCT00652626|561581607|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
155588095|NCT00652626|561581608|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
155588096|NCT00652626|561581609|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
155588097|NCT00652626|561581610|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
155588098|NCT00652626|561581611|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
155588099|NCT00652626|561581605|FG000|Extension Phase|Withdrawal by Subject|0|||
155588100|NCT00652626|561581606|FG001|Extension Phase|Withdrawal by Subject|0|||
155588101|NCT00652626|561581607|FG002|Extension Phase|Withdrawal by Subject|0|||
155588102|NCT00652626|561581608|FG003|Extension Phase|Withdrawal by Subject|0|||
155588103|NCT00652626|561581609|FG004|Extension Phase|Withdrawal by Subject|0|||
155588104|NCT00652626|561581610|FG005|Extension Phase|Withdrawal by Subject|2|||
155588105|NCT00652626|561581611|FG006|Extension Phase|Withdrawal by Subject|0|||
155588106|NCT00652626|561581605|FG000|Extension Phase|Adverse Event|0|||
155588107|NCT00652626|561581606|FG001|Extension Phase|Adverse Event|0|||
155588108|NCT00652626|561581607|FG002|Extension Phase|Adverse Event|0|||
155588109|NCT00652626|561581608|FG003|Extension Phase|Adverse Event|0|||
155588110|NCT00652626|561581609|FG004|Extension Phase|Adverse Event|0|||
155588111|NCT00652626|561581610|FG005|Extension Phase|Adverse Event|2|||
155588112|NCT00652626|561581611|FG006|Extension Phase|Adverse Event|1|||
155588113|NCT00652626|561581605|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588114|NCT00652626|561581606|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588115|NCT00652626|561581607|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588116|NCT00652626|561581608|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588117|NCT00652626|561581609|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588118|NCT00652626|561581610|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
155588119|NCT00652626|561581611|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155588120|NCT00652626|561581605|FG000|Extension Phase|Physician Decision|0|||
155588121|NCT00652626|561581606|FG001|Extension Phase|Physician Decision|0|||
155588122|NCT00652626|561581607|FG002|Extension Phase|Physician Decision|0|||
155588123|NCT00652626|561581608|FG003|Extension Phase|Physician Decision|0|||
155588124|NCT00652626|561581609|FG004|Extension Phase|Physician Decision|0|||
155588125|NCT00652626|561581610|FG005|Extension Phase|Physician Decision|1|||
155588126|NCT00652626|561581611|FG006|Extension Phase|Physician Decision|1|||
155588127|NCT00652626|561581605|FG000|Extension Phase|Death|0|||
155588128|NCT00652626|561581606|FG001|Extension Phase|Death|0|||
155588129|NCT00652626|561581607|FG002|Extension Phase|Death|0|||
155588130|NCT00652626|561581608|FG003|Extension Phase|Death|0|||
155588131|NCT00652626|561581609|FG004|Extension Phase|Death|0|||
155588132|NCT00652626|561581610|FG005|Extension Phase|Death|1|||
155588133|NCT00652626|561581611|FG006|Extension Phase|Death|1|||
155588134|NCT00356603|561581614|FG000|Overall Study|Other|6|||
155588135|NCT00356603|561581615|FG001|Overall Study|Other|3|||
155588136|NCT00932373|561581616|FG000|Overall Study|Progressive disease|3|||
155588137|NCT00932373|561581617|FG001|Overall Study|Progressive disease|1|||
155588138|NCT00932373|561581618|FG002|Overall Study|Progressive disease|0|||
155588139|NCT00932373|561581619|FG003|Overall Study|Progressive disease|0|||
155588140|NCT00932373|561581620|FG004|Overall Study|Progressive disease|10|||
155588141|NCT00932373|561581621|FG005|Overall Study|Progressive disease|1|||
155588142|NCT00932373|561581622|FG006|Overall Study|Progressive disease|0|||
155588143|NCT00932373|561581623|FG007|Overall Study|Progressive disease|2|||
155588144|NCT00932373|561581624|FG008|Overall Study|Progressive disease|1|||
155588145|NCT00932373|561581625|FG009|Overall Study|Progressive disease|9|||
155588146|NCT00932373|561581626|FG010|Overall Study|Progressive disease|2|||
155588147|NCT00932373|561581616|FG000|Overall Study|Adverse Event|0|||
155588148|NCT00932373|561581617|FG001|Overall Study|Adverse Event|0|||
155588149|NCT00932373|561581618|FG002|Overall Study|Adverse Event|0|||
155588150|NCT00932373|561581619|FG003|Overall Study|Adverse Event|0|||
155588151|NCT00932373|561581620|FG004|Overall Study|Adverse Event|2|||
155588152|NCT00932373|561581621|FG005|Overall Study|Adverse Event|1|||
155588153|NCT00932373|561581622|FG006|Overall Study|Adverse Event|0|||
155588154|NCT00932373|561581623|FG007|Overall Study|Adverse Event|1|||
155588155|NCT00932373|561581624|FG008|Overall Study|Adverse Event|0|||
155588156|NCT00932373|561581625|FG009|Overall Study|Adverse Event|2|||
155588157|NCT00932373|561581626|FG010|Overall Study|Adverse Event|1|||
155588158|NCT00932373|561581616|FG000|Overall Study|Physician Decision|0|||
155588159|NCT00932373|561581617|FG001|Overall Study|Physician Decision|0|||
155588160|NCT00932373|561581618|FG002|Overall Study|Physician Decision|1|||
155588161|NCT00932373|561581619|FG003|Overall Study|Physician Decision|0|||
155588162|NCT00932373|561581620|FG004|Overall Study|Physician Decision|2|||
155588163|NCT00932373|561581621|FG005|Overall Study|Physician Decision|0|||
155588164|NCT00932373|561581622|FG006|Overall Study|Physician Decision|0|||
155588165|NCT00932373|561581623|FG007|Overall Study|Physician Decision|0|||
155588166|NCT00932373|561581624|FG008|Overall Study|Physician Decision|0|||
155588167|NCT00932373|561581625|FG009|Overall Study|Physician Decision|1|||
155588168|NCT00932373|561581626|FG010|Overall Study|Physician Decision|0|||
155588169|NCT00932373|561581616|FG000|Overall Study|Dose limiting toxicity|0|||
155588170|NCT00932373|561581617|FG001|Overall Study|Dose limiting toxicity|0|||
155588171|NCT00932373|561581618|FG002|Overall Study|Dose limiting toxicity|0|||
155588172|NCT00932373|561581619|FG003|Overall Study|Dose limiting toxicity|0|||
155588173|NCT00932373|561581620|FG004|Overall Study|Dose limiting toxicity|0|||
155588174|NCT00932373|561581621|FG005|Overall Study|Dose limiting toxicity|1|||
155588175|NCT00932373|561581622|FG006|Overall Study|Dose limiting toxicity|0|||
155588176|NCT00932373|561581623|FG007|Overall Study|Dose limiting toxicity|0|||
155588177|NCT00932373|561581624|FG008|Overall Study|Dose limiting toxicity|0|||
155588178|NCT00932373|561581625|FG009|Overall Study|Dose limiting toxicity|0|||
155588179|NCT00932373|561581626|FG010|Overall Study|Dose limiting toxicity|0|||
155588180|NCT00932373|561581616|FG000|Overall Study|Withdrawal by Subject|0|||
155588181|NCT00932373|561581617|FG001|Overall Study|Withdrawal by Subject|0|||
155588182|NCT00932373|561581618|FG002|Overall Study|Withdrawal by Subject|0|||
155588183|NCT00932373|561581619|FG003|Overall Study|Withdrawal by Subject|0|||
155588184|NCT00932373|561581620|FG004|Overall Study|Withdrawal by Subject|0|||
155588185|NCT00932373|561581621|FG005|Overall Study|Withdrawal by Subject|0|||
155588186|NCT00932373|561581622|FG006|Overall Study|Withdrawal by Subject|0|||
155588187|NCT00932373|561581623|FG007|Overall Study|Withdrawal by Subject|0|||
155588188|NCT00932373|561581624|FG008|Overall Study|Withdrawal by Subject|1|||
155588189|NCT00932373|561581625|FG009|Overall Study|Withdrawal by Subject|0|||
155588190|NCT00932373|561581626|FG010|Overall Study|Withdrawal by Subject|0|||
155588191|NCT00932373|561581616|FG000|Overall Study|Clinical progression|0|||
155588192|NCT00932373|561581617|FG001|Overall Study|Clinical progression|0|||
155588193|NCT00932373|561581618|FG002|Overall Study|Clinical progression|0|||
155588194|NCT00932373|561581619|FG003|Overall Study|Clinical progression|0|||
155588195|NCT00932373|561581620|FG004|Overall Study|Clinical progression|0|||
155588196|NCT00932373|561581621|FG005|Overall Study|Clinical progression|0|||
155588197|NCT00932373|561581622|FG006|Overall Study|Clinical progression|1|||
155588198|NCT00932373|561581623|FG007|Overall Study|Clinical progression|0|||
155588199|NCT00932373|561581624|FG008|Overall Study|Clinical progression|0|||
155588200|NCT00932373|561581625|FG009|Overall Study|Clinical progression|0|||
155588201|NCT00932373|561581626|FG010|Overall Study|Clinical progression|0|||
155588202|NCT00932373|561581616|FG000|Overall Study|Lack of Efficacy|0|||
155588203|NCT00932373|561581617|FG001|Overall Study|Lack of Efficacy|0|||
155588204|NCT00932373|561581618|FG002|Overall Study|Lack of Efficacy|0|||
155588205|NCT00932373|561581619|FG003|Overall Study|Lack of Efficacy|0|||
155588206|NCT00932373|561581620|FG004|Overall Study|Lack of Efficacy|0|||
155588207|NCT00932373|561581621|FG005|Overall Study|Lack of Efficacy|0|||
155588208|NCT00932373|561581622|FG006|Overall Study|Lack of Efficacy|0|||
155588209|NCT00932373|561581623|FG007|Overall Study|Lack of Efficacy|0|||
155588210|NCT00932373|561581624|FG008|Overall Study|Lack of Efficacy|0|||
155588211|NCT00932373|561581625|FG009|Overall Study|Lack of Efficacy|1|||
155588212|NCT00932373|561581626|FG010|Overall Study|Lack of Efficacy|0|||
155588213|NCT04134767|561581629|FG000|Overall Study|Death|0|||
155588214|NCT04134767|561581630|FG001|Overall Study|Death|1|||
155588215|NCT04134767|561581629|FG000|Overall Study|Removed for harassing staff|0|||
155588216|NCT04134767|561581630|FG001|Overall Study|Removed for harassing staff|1|||
155588217|NCT04134767|561581629|FG000|Overall Study|Lost to Follow-up|44|||
155588218|NCT04134767|561581630|FG001|Overall Study|Lost to Follow-up|40|||
155588219|NCT02582242|561581631|FG000|Overall Study|Adverse Event|4|||
155588220|NCT02582242|561581632|FG001|Overall Study|Adverse Event|3|||
155588221|NCT02582242|561581631|FG000|Overall Study|Protocol Violation|3|||
155588222|NCT02582242|561581632|FG001|Overall Study|Protocol Violation|1|||
155588223|NCT02582242|561581631|FG000|Overall Study|Lost to Follow-up|0|||
155588224|NCT02582242|561581632|FG001|Overall Study|Lost to Follow-up|1|||
155588225|NCT02582242|561581631|FG000|Overall Study|Withdrawal by Subject|11|||
155588226|NCT02582242|561581632|FG001|Overall Study|Withdrawal by Subject|11|||
155588227|NCT02582242|561581631|FG000|Overall Study|Unclassified|2|||
155588228|NCT02582242|561581632|FG001|Overall Study|Unclassified|1|||
155588229|NCT00638404|561581633|FG000|Overall Study|Physician Decision|8|||
155588230|NCT00638404|561581634|FG001|Overall Study|Physician Decision|0|||
155588231|NCT02101736|561581638|FG000|Overall Study|Protocol Violation|3|||
155588232|NCT02101736|561581639|FG001|Overall Study|Protocol Violation|0|||
155588233|NCT02101736|561581638|FG000|Overall Study|Withdrawal by Subject|1|||
155588234|NCT02101736|561581639|FG001|Overall Study|Withdrawal by Subject|1|||
155588235|NCT02282631|561581640|FG000|Overall Study|Lost to Follow-up|2|||
155588236|NCT02282631|561581641|FG001|Overall Study|Lost to Follow-up|0|||
155588237|NCT00459290|561581642|FG000|Overall Study|Adverse Event|3|||
155588238|NCT00459290|561581642|FG000|Overall Study|Ineligible|2|||
155588239|NCT01841762|561581643|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
155588240|NCT01841762|561581643|FG000|Treatment Period|Adverse Event|16|||
155588241|NCT01841762|561581643|FG000|Treatment Period|Death|1|||
155588242|NCT01841762|561581643|FG000|Treatment Period|Withdrawal by Subject|7|||
155588243|NCT01841762|561581643|FG000|Treatment Period|Lost to Follow-up|1|||
155588244|NCT01841762|561581643|FG000|Treatment Period|Physician Decision|2|||
155588245|NCT01841762|561581643|FG000|Treatment Period|Other, including non-compliance|5|||
155588246|NCT01841762|561581643|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
155588247|NCT01841762|561581643|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
155588248|NCT01841762|561581643|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
155588249|NCT01841762|561581643|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
155588250|NCT05483686|561581644|FG000|Overall Study|Lost to Follow-up|5|||
155588251|NCT05483686|561581645|FG001|Overall Study|Lost to Follow-up|7|||
155588252|NCT05780983|561581646|FG000|Overall Study|Withdrawal by Subject|1|||
155588253|NCT01017874|561581647|FG000|Overall Study|Withdrawal by Subject|23|||
155588254|NCT01017874|561581648|FG001|Overall Study|Withdrawal by Subject|20|||
155588255|NCT01017874|561581647|FG000|Overall Study|Sponsor decision|3|||
155588256|NCT01017874|561581648|FG001|Overall Study|Sponsor decision|1|||
155588257|NCT01017874|561581647|FG000|Overall Study|Lost to Follow-up|3|||
155588258|NCT01017874|561581648|FG001|Overall Study|Lost to Follow-up|2|||
155588259|NCT01017874|561581647|FG000|Overall Study|Physician Decision|1|||
155588260|NCT01017874|561581648|FG001|Overall Study|Physician Decision|3|||
155588261|NCT02509507|561581649|FG000|Overall Study|Death|21|||
155588262|NCT02509507|561581650|FG001|Overall Study|Death|3|||
155588263|NCT02509507|561581651|FG002|Overall Study|Death|22|||
155588264|NCT02509507|561581652|FG003|Overall Study|Death|14|||
155588265|NCT02509507|561581653|FG004|Overall Study|Death|8|||
155588266|NCT02509507|561581654|FG005|Overall Study|Death|12|||
155588267|NCT02509507|561581655|FG006|Overall Study|Death|5|||
155588268|NCT02509507|561581656|FG007|Overall Study|Death|4|||
155588269|NCT02509507|561581657|FG008|Overall Study|Death|8|||
155588270|NCT02509507|561581649|FG000|Overall Study|Lost to Follow-up|0|||
155588271|NCT02509507|561581650|FG001|Overall Study|Lost to Follow-up|1|||
155588272|NCT02509507|561581651|FG002|Overall Study|Lost to Follow-up|0|||
155588273|NCT02509507|561581652|FG003|Overall Study|Lost to Follow-up|0|||
155588274|NCT02509507|561581653|FG004|Overall Study|Lost to Follow-up|0|||
155588275|NCT02509507|561581654|FG005|Overall Study|Lost to Follow-up|2|||
155588276|NCT02509507|561581655|FG006|Overall Study|Lost to Follow-up|0|||
155588277|NCT02509507|561581656|FG007|Overall Study|Lost to Follow-up|0|||
155588278|NCT02509507|561581657|FG008|Overall Study|Lost to Follow-up|0|||
155588279|NCT02509507|561581649|FG000|Overall Study|Withdrawal by Subject|2|||
155588280|NCT02509507|561581650|FG001|Overall Study|Withdrawal by Subject|0|||
155588281|NCT02509507|561581651|FG002|Overall Study|Withdrawal by Subject|1|||
155588282|NCT02509507|561581652|FG003|Overall Study|Withdrawal by Subject|4|||
155588283|NCT02509507|561581653|FG004|Overall Study|Withdrawal by Subject|1|||
155588284|NCT02509507|561581654|FG005|Overall Study|Withdrawal by Subject|3|||
155588285|NCT02509507|561581655|FG006|Overall Study|Withdrawal by Subject|4|||
155588286|NCT02509507|561581656|FG007|Overall Study|Withdrawal by Subject|0|||
155588287|NCT02509507|561581657|FG008|Overall Study|Withdrawal by Subject|1|||
155588288|NCT01954056|561581658|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
155588289|NCT01954056|561581659|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
155588290|NCT03337113|561581671|FG000|Overall Study|Adverse Event|1|||
155588291|NCT03337113|561581672|FG001|Overall Study|Adverse Event|1|||
155666754|NCT01824290|561875027|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
155666755|NCT01824290|561875024|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
155588292|NCT03337113|561581673|FG002|Overall Study|Adverse Event|0|||
155588293|NCT03337113|561581674|FG003|Overall Study|Adverse Event|1|||
155588294|NCT03337113|561581671|FG000|Overall Study|Physician Decision|0|||
155588295|NCT03337113|561581672|FG001|Overall Study|Physician Decision|2|||
155588296|NCT03337113|561581673|FG002|Overall Study|Physician Decision|0|||
155588297|NCT03337113|561581674|FG003|Overall Study|Physician Decision|1|||
155588298|NCT03337113|561581671|FG000|Overall Study|Withdrawal by Subject|0|||
155588299|NCT03337113|561581672|FG001|Overall Study|Withdrawal by Subject|0|||
155588300|NCT03337113|561581673|FG002|Overall Study|Withdrawal by Subject|1|||
155588301|NCT03337113|561581674|FG003|Overall Study|Withdrawal by Subject|0|||
155588302|NCT06110494|561581684|FG000|Overall Study|Protocol Violation|2|||
155588303|NCT06110494|561581685|FG001|Overall Study|Protocol Violation|0|||
155588304|NCT06110494|561581686|FG002|Overall Study|Protocol Violation|1|||
155588305|NCT06110494|561581684|FG000|Overall Study|Dixon's test for outlier analysis|1|||
155588306|NCT06110494|561581685|FG001|Overall Study|Dixon's test for outlier analysis|1|||
155588307|NCT06110494|561581686|FG002|Overall Study|Dixon's test for outlier analysis|0|||
155588308|NCT00105079|561581687|FG000|Overall Study|Adverse Event|5|||
155588309|NCT00105079|561581688|FG001|Overall Study|Adverse Event|12|||
155588310|NCT00105079|561581687|FG000|Overall Study|Death|3|||
155588311|NCT00105079|561581688|FG001|Overall Study|Death|1|||
155588312|NCT00105079|561581687|FG000|Overall Study|Lost to Follow-up|12|||
155588313|NCT00105079|561581688|FG001|Overall Study|Lost to Follow-up|12|||
155588314|NCT00105079|561581687|FG000|Overall Study|Lack of Efficacy|9|||
155588315|NCT00105079|561581688|FG001|Overall Study|Lack of Efficacy|3|||
155588316|NCT00105079|561581687|FG000|Overall Study|Refused treatment|6|||
155588317|NCT00105079|561581688|FG001|Overall Study|Refused treatment|4|||
155588318|NCT00105079|561581687|FG000|Overall Study|Violation of selection criteria at entry|0|||
155588319|NCT00105079|561581688|FG001|Overall Study|Violation of selection criteria at entry|2|||
155588320|NCT00105079|561581687|FG000|Overall Study|Protocol Violation|1|||
155588321|NCT00105079|561581688|FG001|Overall Study|Protocol Violation|0|||
155588322|NCT00105079|561581687|FG000|Overall Study|Other|3|||
155588323|NCT00105079|561581688|FG001|Overall Study|Other|1|||
155588324|NCT01464593|561581691|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
155588325|NCT01297517|561581692|FG000|Overall Study|Adverse Event|21|||
155588326|NCT01297517|561581693|FG001|Overall Study|Adverse Event|7|||
155588327|NCT01297517|561581694|FG002|Overall Study|Adverse Event|16|||
155588328|NCT01297517|561581692|FG000|Overall Study|Lost to Follow-up|1|||
155588329|NCT01297517|561581693|FG001|Overall Study|Lost to Follow-up|0|||
155588330|NCT01297517|561581694|FG002|Overall Study|Lost to Follow-up|1|||
155588331|NCT01297517|561581692|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
155588332|NCT01297517|561581693|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
155588333|NCT01297517|561581694|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
155588334|NCT01297517|561581692|FG000|Overall Study|Noncompliance|1|||
155588335|NCT01297517|561581693|FG001|Overall Study|Noncompliance|0|||
155588336|NCT01297517|561581694|FG002|Overall Study|Noncompliance|0|||
155588337|NCT01297517|561581692|FG000|Overall Study|Protocol Violation|1|||
155588338|NCT01297517|561581693|FG001|Overall Study|Protocol Violation|1|||
155588339|NCT01297517|561581694|FG002|Overall Study|Protocol Violation|1|||
155588340|NCT01297517|561581692|FG000|Overall Study|Inadequate Control of IOP|1|||
155588341|NCT01297517|561581693|FG001|Overall Study|Inadequate Control of IOP|1|||
155588342|NCT01297517|561581694|FG002|Overall Study|Inadequate Control of IOP|2|||
155588343|NCT00386360|561581697|FG000|Overall Study|Adverse Event|4|||
155588344|NCT00386360|561581698|FG001|Overall Study|Adverse Event|2|||
155588345|NCT00386360|561581697|FG000|Overall Study|Physician Decision|2|||
155588346|NCT00386360|561581698|FG001|Overall Study|Physician Decision|2|||
155588347|NCT00386360|561581697|FG000|Overall Study|Lost to Follow-up|0|||
155588348|NCT00386360|561581698|FG001|Overall Study|Lost to Follow-up|2|||
155588349|NCT00386360|561581697|FG000|Overall Study|Protocol Violation|0|||
155588350|NCT00386360|561581698|FG001|Overall Study|Protocol Violation|3|||
155588351|NCT00386360|561581697|FG000|Overall Study|Withdrawal by Subject|3|||
155588352|NCT00386360|561581698|FG001|Overall Study|Withdrawal by Subject|6|||
155588353|NCT00386360|561581697|FG000|Overall Study|Did not take any study medication|0|||
155588354|NCT00386360|561581698|FG001|Overall Study|Did not take any study medication|2|||
155588355|NCT01163851|561581699|FG000|Overall Study|Site Closure|0|||
155588356|NCT01163851|561581700|FG001|Overall Study|Site Closure|1|||
155588357|NCT01163851|561581699|FG000|Overall Study|Enrolled but not treated|1|||
155588358|NCT01163851|561581700|FG001|Overall Study|Enrolled but not treated|0|||
155588359|NCT00789373|561581701|FG000|Induction|Adverse Event|64|||
155588360|NCT00789373|561581702|FG001|Induction|Adverse Event|0|||
155588361|NCT00789373|561581703|FG002|Induction|Adverse Event|0|||
155588362|NCT00789373|561581701|FG000|Induction|Death Due to study disease|24|||
155588363|NCT00789373|561581702|FG001|Induction|Death Due to study disease|0|||
155588364|NCT00789373|561581703|FG002|Induction|Death Due to study disease|0|||
155588365|NCT00789373|561581701|FG000|Induction|Death due to adverse event|19|||
155588366|NCT00789373|561581702|FG001|Induction|Death due to adverse event|0|||
155588367|NCT00789373|561581703|FG002|Induction|Death due to adverse event|0|||
155588368|NCT00789373|561581701|FG000|Induction|Death due to toxicity|11|||
155588369|NCT00789373|561581702|FG001|Induction|Death due to toxicity|0|||
155588370|NCT00789373|561581703|FG002|Induction|Death due to toxicity|0|||
155588371|NCT00789373|561581701|FG000|Induction|Death due to procedure|1|||
155588372|NCT00789373|561581702|FG001|Induction|Death due to procedure|0|||
155588373|NCT00789373|561581703|FG002|Induction|Death due to procedure|0|||
155588374|NCT00789373|561581701|FG000|Induction|Investigator decision|7|||
155588375|NCT00789373|561581702|FG001|Induction|Investigator decision|0|||
155588376|NCT00789373|561581703|FG002|Induction|Investigator decision|0|||
155588377|NCT00789373|561581701|FG000|Induction|Protocol entry criteria not met|9|||
155588378|NCT00789373|561581702|FG001|Induction|Protocol entry criteria not met|0|||
155588379|NCT00789373|561581703|FG002|Induction|Protocol entry criteria not met|0|||
155588380|NCT00789373|561581701|FG000|Induction|Lost to Follow-up|6|||
155588381|NCT00789373|561581702|FG001|Induction|Lost to Follow-up|0|||
155588382|NCT00789373|561581703|FG002|Induction|Lost to Follow-up|0|||
155588383|NCT00789373|561581701|FG000|Induction|Protocol Violation|1|||
155588384|NCT00789373|561581702|FG001|Induction|Protocol Violation|0|||
155588385|NCT00789373|561581703|FG002|Induction|Protocol Violation|0|||
155588386|NCT00789373|561581701|FG000|Induction|Progressive Disease|220|||
155588387|NCT00789373|561581702|FG001|Induction|Progressive Disease|0|||
155588388|NCT00789373|561581703|FG002|Induction|Progressive Disease|0|||
155588389|NCT00789373|561581701|FG000|Induction|Withdrawal by Subject|37|||
155588390|NCT00789373|561581702|FG001|Induction|Withdrawal by Subject|0|||
155588391|NCT00789373|561581703|FG002|Induction|Withdrawal by Subject|0|||
155588392|NCT00789373|561581701|FG000|Maintenance|Adverse Event|0|||
155588393|NCT00789373|561581702|FG001|Maintenance|Adverse Event|65|||
155588394|NCT00789373|561581703|FG002|Maintenance|Adverse Event|12|||
155588395|NCT00789373|561581701|FG000|Maintenance|Death due to study disease|0|||
155588396|NCT00789373|561581702|FG001|Maintenance|Death due to study disease|3|||
155588397|NCT00789373|561581703|FG002|Maintenance|Death due to study disease|1|||
155588398|NCT00789373|561581701|FG000|Maintenance|Death due to adverse event|0|||
155588399|NCT00789373|561581702|FG001|Maintenance|Death due to adverse event|4|||
155588400|NCT00789373|561581703|FG002|Maintenance|Death due to adverse event|1|||
155588401|NCT00789373|561581701|FG000|Maintenance|Death due to toxicity|0|||
155588402|NCT00789373|561581702|FG001|Maintenance|Death due to toxicity|1|||
155588403|NCT00789373|561581703|FG002|Maintenance|Death due to toxicity|2|||
155588404|NCT00789373|561581701|FG000|Maintenance|Investigator Decision|0|||
155588405|NCT00789373|561581702|FG001|Maintenance|Investigator Decision|4|||
155588406|NCT00789373|561581703|FG002|Maintenance|Investigator Decision|2|||
155588407|NCT00789373|561581701|FG000|Maintenance|Protocol entry criteria not met|0|||
155588408|NCT00789373|561581702|FG001|Maintenance|Protocol entry criteria not met|2|||
155588409|NCT00789373|561581703|FG002|Maintenance|Protocol entry criteria not met|0|||
155588410|NCT00789373|561581701|FG000|Maintenance|Lost to Follow-up|0|||
155588411|NCT00789373|561581702|FG001|Maintenance|Lost to Follow-up|2|||
155588412|NCT00789373|561581703|FG002|Maintenance|Lost to Follow-up|0|||
155588413|NCT00789373|561581701|FG000|Maintenance|Progressive Disease|0|||
155588414|NCT00789373|561581702|FG001|Maintenance|Progressive Disease|253|||
155588415|NCT00789373|561581703|FG002|Maintenance|Progressive Disease|152|||
155588416|NCT00789373|561581701|FG000|Maintenance|Withdrawal by Subject|0|||
155588417|NCT00789373|561581702|FG001|Maintenance|Withdrawal by Subject|21|||
155588418|NCT00789373|561581703|FG002|Maintenance|Withdrawal by Subject|8|||
155588419|NCT00789373|561581701|FG000|Maintenance|Sponsor Decision|0|||
155588420|NCT00789373|561581702|FG001|Maintenance|Sponsor Decision|0|||
155588421|NCT00789373|561581703|FG002|Maintenance|Sponsor Decision|2|||
155588422|NCT00789373|561581701|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
155588423|NCT00789373|561581702|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
155588424|NCT00789373|561581703|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
155588425|NCT04938180|561581707|FG000|Overall Study|Adverse Event|1|||
155588426|NCT05343364|561581710|FG000|Overall Study|Miscellaneous|0|||
155588427|NCT05343364|561581711|FG001|Overall Study|Miscellaneous|1|||
155588428|NCT01753570|561581712|FG000|Overall Study|Adverse Event|1|||
155588429|NCT01753570|561581713|FG001|Overall Study|Adverse Event|0|||
155588430|NCT01753570|561581714|FG002|Overall Study|Adverse Event|1|||
155588431|NCT01753570|561581712|FG000|Overall Study|Physician Decision|0|||
155588432|NCT01753570|561581713|FG001|Overall Study|Physician Decision|1|||
155588433|NCT01753570|561581714|FG002|Overall Study|Physician Decision|0|||
155588434|NCT01753570|561581712|FG000|Overall Study|Withdrawal by Subject|1|||
155588435|NCT01753570|561581713|FG001|Overall Study|Withdrawal by Subject|4|||
155588436|NCT01753570|561581714|FG002|Overall Study|Withdrawal by Subject|0|||
155588437|NCT01791894|561581715|FG000|Overall Study|Adverse Event|1|||
155588438|NCT05870371|561581716|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
155588439|NCT05870371|561581717|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
155588440|NCT02062450|561581725|FG000|Overall Study|No follow-up visit|124|||
155588441|NCT02589639|561581728|FG000|Overall Study|Lost to Follow-up|1|||
155588442|NCT02589639|561581729|FG001|Overall Study|Lost to Follow-up|0|||
155588443|NCT02589639|561581730|FG002|Overall Study|Lost to Follow-up|0|||
155588444|NCT02589639|561581728|FG000|Overall Study|Protocol Violation|1|||
155588445|NCT02589639|561581729|FG001|Overall Study|Protocol Violation|0|||
155588446|NCT02589639|561581730|FG002|Overall Study|Protocol Violation|0|||
155588447|NCT02589639|561581728|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
155588448|NCT02589639|561581729|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
155588449|NCT02589639|561581730|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
155588450|NCT02589639|561581728|FG000|Overall Study|Adverse Event|4|||
155588451|NCT02589639|561581729|FG001|Overall Study|Adverse Event|5|||
155588452|NCT02589639|561581730|FG002|Overall Study|Adverse Event|3|||
155588453|NCT02589639|561581728|FG000|Overall Study|Other reason than specified above|1|||
155588454|NCT02589639|561581729|FG001|Overall Study|Other reason than specified above|2|||
155588455|NCT02589639|561581730|FG002|Overall Study|Other reason than specified above|1|||
155588456|NCT02589639|561581728|FG000|Overall Study|Not Treated|0|||
155588457|NCT02589639|561581729|FG001|Overall Study|Not Treated|3|||
155588458|NCT02589639|561581730|FG002|Overall Study|Not Treated|0|||
155588459|NCT00708461|561581731|FG000|Overall Study|Lost to Follow-up|18|||
155588460|NCT00708461|561581732|FG001|Overall Study|Lost to Follow-up|11|||
155588461|NCT00708461|561581731|FG000|Overall Study|Withdrawal by Subject|8|||
155588462|NCT00708461|561581732|FG001|Overall Study|Withdrawal by Subject|9|||
155588463|NCT00708461|561581731|FG000|Overall Study|left workforce|115|||
155588464|NCT00708461|561581732|FG001|Overall Study|left workforce|180|||
155588465|NCT03584854|561581733|FG000|Overall Study|Primary outcome not measured|1|||
155588466|NCT03584854|561581734|FG001|Overall Study|Primary outcome not measured|2|||
155588467|NCT02968173|561581735|FG000|Overall Study|Withdrawal by Subject|1|||
155588468|NCT00153179|561581742|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
155588469|NCT00153179|561581743|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
155588470|NCT00153179|561581744|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
155588471|NCT00153179|561581745|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
155588472|NCT01408303|561581746|FG000|Overall Study|Adverse Event|3|||
155588473|NCT01408303|561581747|FG001|Overall Study|Adverse Event|7|||
155588474|NCT01408303|561581748|FG002|Overall Study|Adverse Event|2|||
155588475|NCT01408303|561581746|FG000|Overall Study|Lost to Follow-up|0|||
155588476|NCT01408303|561581747|FG001|Overall Study|Lost to Follow-up|1|||
155588477|NCT01408303|561581748|FG002|Overall Study|Lost to Follow-up|2|||
155588478|NCT01408303|561581746|FG000|Overall Study|Withdrawal by Subject|2|||
155588479|NCT01408303|561581747|FG001|Overall Study|Withdrawal by Subject|3|||
155588480|NCT01408303|561581748|FG002|Overall Study|Withdrawal by Subject|1|||
155588481|NCT01408303|561581746|FG000|Overall Study|Protocol Violation|0|||
155588482|NCT01408303|561581747|FG001|Overall Study|Protocol Violation|1|||
155588483|NCT01408303|561581748|FG002|Overall Study|Protocol Violation|0|||
155588484|NCT01408303|561581746|FG000|Overall Study|Noncompliance|1|||
155588485|NCT01408303|561581747|FG001|Overall Study|Noncompliance|0|||
155588486|NCT01408303|561581748|FG002|Overall Study|Noncompliance|1|||
155588487|NCT01207687|561581749|FG000|Overall Study|Adverse Event|1|||
155588488|NCT01207687|561581749|FG000|Overall Study|Withdrawal by Subject|1|||
155588489|NCT01801865|561581750|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
155588490|NCT01801865|561581750|FG000|Overall Study|Physician Decision|7|||
155588491|NCT03867201|561581753|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
155588492|NCT03867201|561581754|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
155588493|NCT03867201|561581753|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
155588494|NCT03867201|561581754|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
155588495|NCT03867201|561581753|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
155588496|NCT03867201|561581754|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
155588497|NCT03867201|561581753|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
155588498|NCT03867201|561581754|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
155588499|NCT03867201|561581753|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
155588500|NCT03867201|561581754|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
155588501|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Adverse Event|5|||
155588502|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Adverse Event|11|||
155588503|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
155588504|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
155588505|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Physician Decision|6|||
155588506|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Physician Decision|3|||
155588507|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Pregnancy|2|||
155588508|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Pregnancy|2|||
155588509|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
155588510|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
155588511|NCT03867201|561581753|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
155588512|NCT03867201|561581754|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
155588513|NCT03867201|561581753|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
155588514|NCT03867201|561581754|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
155588515|NCT03867201|561581753|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
155588516|NCT03867201|561581754|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
155588517|NCT05763875|561581759|FG000|Overall Study|Subject decision|5|||
155588518|NCT05763875|561581760|FG001|Overall Study|Subject decision|2|||
155588519|NCT05763875|561581761|FG002|Overall Study|Subject decision|1|||
155588520|NCT05763875|561581759|FG000|Overall Study|Lost to Follow-up|4|||
155588521|NCT05763875|561581760|FG001|Overall Study|Lost to Follow-up|1|||
155588522|NCT05763875|561581761|FG002|Overall Study|Lost to Follow-up|2|||
155588523|NCT05763875|561581759|FG000|Overall Study|Adverse Event|1|||
155588524|NCT05763875|561581760|FG001|Overall Study|Adverse Event|0|||
155588525|NCT05763875|561581761|FG002|Overall Study|Adverse Event|0|||
155588526|NCT01481766|561583617|FG000|4 months|Lost to Follow-up|3|||
155588527|NCT01481766|561583618|FG001|4 months|Lost to Follow-up|2|||
155588528|NCT01481766|561583619|FG002|4 months|Lost to Follow-up|1|||
155588529|NCT01481766|561583620|FG003|4 months|Lost to Follow-up|5|||
155588530|NCT01481766|561583617|FG000|12 months|Lost to Follow-up|7|||
155588531|NCT01481766|561583618|FG001|12 months|Lost to Follow-up|8|||
155588532|NCT01481766|561583619|FG002|12 months|Lost to Follow-up|5|||
155588533|NCT01481766|561583620|FG003|12 months|Lost to Follow-up|3|||
155588534|NCT00347958|561583621|FG000|Overall Study|Adverse Event|1|||
155588535|NCT00347958|561583621|FG000|Overall Study|Protocol Violation|2|||
155588536|NCT00347958|561583621|FG000|Overall Study|Withdrawal by Subject|1|||
155588537|NCT02159053|561583624|FG000|Overall Study|Death|2|||
155588538|NCT02159053|561583625|FG001|Overall Study|Death|0|||
155588539|NCT02159053|561583626|FG002|Overall Study|Death|1|||
155588540|NCT02159053|561583624|FG000|Overall Study|Physician Decision|0|||
155588541|NCT02159053|561583625|FG001|Overall Study|Physician Decision|1|||
155588542|NCT02159053|561583626|FG002|Overall Study|Physician Decision|1|||
155588543|NCT02159053|561583624|FG000|Overall Study|Lack of Efficacy|3|||
155588544|NCT02159053|561583625|FG001|Overall Study|Lack of Efficacy|4|||
155588545|NCT02159053|561583626|FG002|Overall Study|Lack of Efficacy|7|||
155588546|NCT02159053|561583624|FG000|Overall Study|Adverse Event|7|||
155588547|NCT02159053|561583625|FG001|Overall Study|Adverse Event|6|||
155588548|NCT02159053|561583626|FG002|Overall Study|Adverse Event|5|||
155588549|NCT02159053|561583624|FG000|Overall Study|Participants/guardian decision|8|||
155588550|NCT02159053|561583625|FG001|Overall Study|Participants/guardian decision|10|||
155588551|NCT02159053|561583626|FG002|Overall Study|Participants/guardian decision|6|||
155588552|NCT01262287|561583627|FG000|Overall Study|Lost to Follow-up|2|||
155588553|NCT01262287|561583628|FG001|Overall Study|Lost to Follow-up|1|||
155588554|NCT02492984|561583629|FG000|Overall Study|Adverse Event|1|||
155588555|NCT02492984|561583630|FG001|Overall Study|Adverse Event|0|||
155588556|NCT02492984|561583629|FG000|Overall Study|Protocol Violation|1|||
155588557|NCT02492984|561583630|FG001|Overall Study|Protocol Violation|0|||
155588558|NCT02492984|561583629|FG000|Overall Study|Withdrawal by Subject|1|||
155588559|NCT02492984|561583630|FG001|Overall Study|Withdrawal by Subject|0|||
155588560|NCT02453334|561583631|FG000|Overall Study|Death|15|||
155588561|NCT02453334|561583632|FG001|Overall Study|Death|13|||
155588562|NCT02453334|561583631|FG000|Overall Study|Adverse Event|2|||
155588563|NCT02453334|561583632|FG001|Overall Study|Adverse Event|1|||
155588564|NCT02453334|561583631|FG000|Overall Study|Lost to Follow-up|5|||
155588565|NCT02453334|561583632|FG001|Overall Study|Lost to Follow-up|9|||
155588566|NCT02453334|561583631|FG000|Overall Study|Physician Decision|1|||
155588567|NCT02453334|561583632|FG001|Overall Study|Physician Decision|0|||
155588568|NCT02453334|561583631|FG000|Overall Study|Withdrawal by Subject|17|||
155588569|NCT02453334|561583632|FG001|Overall Study|Withdrawal by Subject|13|||
155588570|NCT02453334|561583631|FG000|Overall Study|Other reason|1|||
155588571|NCT02453334|561583632|FG001|Overall Study|Other reason|4|||
155588572|NCT06152224|561583639|FG000|Overall Study|Withdrawal by Subject|1|||
155588573|NCT06152224|561583640|FG001|Overall Study|Withdrawal by Subject|0|||
155588574|NCT06152224|561583639|FG000|Overall Study|Lost to Follow-up|0|||
155588575|NCT06152224|561583640|FG001|Overall Study|Lost to Follow-up|1|||
155588576|NCT06152224|561583639|FG000|Overall Study|On Follow Up|18|||
155588577|NCT06152224|561583640|FG001|Overall Study|On Follow Up|18|||
155588578|NCT06028438|561583641|FG000|Overall Study|Adverse Event|3|||
155588579|NCT06028438|561583642|FG001|Overall Study|Adverse Event|9|||
155588580|NCT06028438|561583641|FG000|Overall Study|Lack of Efficacy|1|||
155588581|NCT06028438|561583642|FG001|Overall Study|Lack of Efficacy|1|||
155588582|NCT06028438|561583641|FG000|Overall Study|Lost to Follow-up|1|||
155588583|NCT06028438|561583642|FG001|Overall Study|Lost to Follow-up|0|||
155588584|NCT06028438|561583641|FG000|Overall Study|Withdrawal by Subject|1|||
155588585|NCT06028438|561583642|FG001|Overall Study|Withdrawal by Subject|0|||
155588586|NCT06028438|561583641|FG000|Overall Study|Other|3|||
155588587|NCT06028438|561583642|FG001|Overall Study|Other|3|||
155588588|NCT05625802|561583643|FG000|Overall Study|Lost to Follow-up|1|||
155588589|NCT05625802|561583644|FG001|Overall Study|Lost to Follow-up|0|||
155588590|NCT00628212|561583647|FG000|Overall Study|Adverse Event|2|||
155588591|NCT00628212|561583648|FG001|Overall Study|Adverse Event|0|||
155588592|NCT00628212|561583649|FG002|Overall Study|Adverse Event|1|||
155588593|NCT00628212|561583650|FG003|Overall Study|Adverse Event|2|||
155588594|NCT00628212|561583647|FG000|Overall Study|Physician Decision|1|||
155588595|NCT00628212|561583648|FG001|Overall Study|Physician Decision|1|||
155588596|NCT00628212|561583649|FG002|Overall Study|Physician Decision|2|||
155588597|NCT00628212|561583650|FG003|Overall Study|Physician Decision|3|||
155588598|NCT02490371|561583651|FG000|Overall Study|Lost to Follow-up|1|||
155588599|NCT02490371|561583652|FG001|Overall Study|Lost to Follow-up|1|||
155588600|NCT01073605|561583655|FG000|Overall Study|Ongoing at Cutoff Date|1|||
155588601|NCT01073605|561583656|FG001|Overall Study|Ongoing at Cutoff Date|1|||
155588602|NCT01073605|561583657|FG002|Overall Study|Ongoing at Cutoff Date|0|||
155588603|NCT01073605|561583655|FG000|Overall Study|Adverse Event|2|||
155588604|NCT01073605|561583656|FG001|Overall Study|Adverse Event|1|||
155588605|NCT01073605|561583657|FG002|Overall Study|Adverse Event|0|||
155588606|NCT01073605|561583655|FG000|Overall Study|Lost to Follow-up|3|||
155588607|NCT01073605|561583656|FG001|Overall Study|Lost to Follow-up|4|||
155588608|NCT01073605|561583657|FG002|Overall Study|Lost to Follow-up|9|||
155588609|NCT01073605|561583655|FG000|Overall Study|Other|25|||
155588610|NCT01073605|561583656|FG001|Overall Study|Other|21|||
155588611|NCT01073605|561583657|FG002|Overall Study|Other|29|||
155588612|NCT01073605|561583655|FG000|Overall Study|Withdrawal by Subject|31|||
155588613|NCT01073605|561583656|FG001|Overall Study|Withdrawal by Subject|39|||
155588614|NCT01073605|561583657|FG002|Overall Study|Withdrawal by Subject|22|||
155588615|NCT01073605|561583655|FG000|Overall Study|Randomized But Not Treated|0|||
155588616|NCT01073605|561583656|FG001|Overall Study|Randomized But Not Treated|1|||
155588617|NCT01073605|561583657|FG002|Overall Study|Randomized But Not Treated|1|||
155588618|NCT03491462|561583658|FG000|Overall Study|Lost to Follow-up|2|||
155588619|NCT03491462|561583659|FG001|Overall Study|Lost to Follow-up|0|||
155588620|NCT03491462|561583658|FG000|Overall Study|Adverse Event|11|||
155588621|NCT03491462|561583659|FG001|Overall Study|Adverse Event|1|||
155588622|NCT03491462|561583658|FG000|Overall Study|Physician Decision|3|||
155588623|NCT03491462|561583659|FG001|Overall Study|Physician Decision|0|||
155588624|NCT03491462|561583658|FG000|Overall Study|Withdrawal by Subject|22|||
155588625|NCT03491462|561583659|FG001|Overall Study|Withdrawal by Subject|15|||
155588626|NCT03018080|561583660|FG000|Overall Study|Death|12|||
155588627|NCT03018080|561583661|FG001|Overall Study|Death|19|||
155588628|NCT00740792|561583662|FG000|Overall Study|Adverse Event|3|||
155588629|NCT00740792|561583663|FG001|Overall Study|Adverse Event|1|||
155588630|NCT00740792|561583664|FG002|Overall Study|Adverse Event|1|||
155588631|NCT00740792|561583665|FG003|Overall Study|Adverse Event|3|||
155588632|NCT00740792|561583662|FG000|Overall Study|Lack of Efficacy|1|||
155588633|NCT00740792|561583663|FG001|Overall Study|Lack of Efficacy|1|||
155588634|NCT00740792|561583664|FG002|Overall Study|Lack of Efficacy|0|||
155588635|NCT00740792|561583665|FG003|Overall Study|Lack of Efficacy|3|||
155588636|NCT00740792|561583662|FG000|Overall Study|Lost to Follow-up|2|||
155588637|NCT00740792|561583663|FG001|Overall Study|Lost to Follow-up|1|||
155588638|NCT00740792|561583664|FG002|Overall Study|Lost to Follow-up|0|||
155588639|NCT00740792|561583665|FG003|Overall Study|Lost to Follow-up|0|||
155588640|NCT00740792|561583662|FG000|Overall Study|Protocol Violation|0|||
155588641|NCT00740792|561583663|FG001|Overall Study|Protocol Violation|1|||
155588642|NCT00740792|561583664|FG002|Overall Study|Protocol Violation|0|||
155588643|NCT00740792|561583665|FG003|Overall Study|Protocol Violation|2|||
155588644|NCT00740792|561583662|FG000|Overall Study|Withdrawal by Subject|1|||
155588645|NCT00740792|561583663|FG001|Overall Study|Withdrawal by Subject|1|||
155588646|NCT00740792|561583664|FG002|Overall Study|Withdrawal by Subject|0|||
155588647|NCT00740792|561583665|FG003|Overall Study|Withdrawal by Subject|0|||
155588648|NCT00740792|561583662|FG000|Overall Study|administrative|3|||
155588649|NCT00740792|561583663|FG001|Overall Study|administrative|3|||
155588650|NCT00740792|561583664|FG002|Overall Study|administrative|8|||
155588651|NCT00740792|561583665|FG003|Overall Study|administrative|2|||
155588652|NCT01019694|561583672|FG000|Overall Study|Adverse Event|12|||
155588653|NCT01019694|561583673|FG001|Overall Study|Adverse Event|16|||
155588654|NCT01019694|561583674|FG002|Overall Study|Adverse Event|19|||
155588655|NCT01019694|561583672|FG000|Overall Study|Protocol Violation|2|||
155588656|NCT01019694|561583673|FG001|Overall Study|Protocol Violation|6|||
155588657|NCT01019694|561583674|FG002|Overall Study|Protocol Violation|4|||
155588658|NCT01019694|561583672|FG000|Overall Study|Lost to Follow-up|5|||
155588659|NCT01019694|561583673|FG001|Overall Study|Lost to Follow-up|3|||
155588660|NCT01019694|561583674|FG002|Overall Study|Lost to Follow-up|3|||
155588661|NCT01019694|561583672|FG000|Overall Study|Withdrawal by Subject|4|||
155588662|NCT01019694|561583673|FG001|Overall Study|Withdrawal by Subject|6|||
155588663|NCT01019694|561583674|FG002|Overall Study|Withdrawal by Subject|12|||
155588664|NCT01019694|561583672|FG000|Overall Study|Not treated|0|||
155588665|NCT01019694|561583673|FG001|Overall Study|Not treated|2|||
155588666|NCT01019694|561583674|FG002|Overall Study|Not treated|3|||
155588667|NCT01019694|561583672|FG000|Overall Study|Other reason (not specified)|1|||
155588668|NCT01019694|561583673|FG001|Overall Study|Other reason (not specified)|5|||
155588669|NCT01019694|561583674|FG002|Overall Study|Other reason (not specified)|6|||
155588670|NCT00026494|561583677|FG000|Overall Study|Withdrawal by Subject|1|||
155588671|NCT00026494|561583678|FG001|Overall Study|Withdrawal by Subject|0|||
155588672|NCT00026494|561583679|FG002|Overall Study|Withdrawal by Subject|1|||
155588673|NCT00026494|561583680|FG003|Overall Study|Withdrawal by Subject|0|||
155588674|NCT00026494|561583677|FG000|Overall Study|Patient non-compliance|1|||
155588675|NCT00026494|561583678|FG001|Overall Study|Patient non-compliance|0|||
155588676|NCT00026494|561583679|FG002|Overall Study|Patient non-compliance|0|||
155588677|NCT00026494|561583680|FG003|Overall Study|Patient non-compliance|0|||
155588678|NCT00026494|561583677|FG000|Overall Study|Patient not treated|0|||
155588679|NCT00026494|561583678|FG001|Overall Study|Patient not treated|0|||
155588680|NCT00026494|561583679|FG002|Overall Study|Patient not treated|2|||
155588681|NCT00026494|561583680|FG003|Overall Study|Patient not treated|0|||
155588682|NCT00026494|561583677|FG000|Overall Study|Clinical progression|0|||
155588683|NCT00026494|561583678|FG001|Overall Study|Clinical progression|0|||
155588684|NCT00026494|561583679|FG002|Overall Study|Clinical progression|3|||
155588685|NCT00026494|561583680|FG003|Overall Study|Clinical progression|0|||
155588686|NCT00441129|561583681|FG000|Overall Study|Withdrawal by Subject|6|||
155588687|NCT00441129|561583682|FG001|Overall Study|Withdrawal by Subject|14|||
155588688|NCT01455597|561583683|FG000|Overall Study|Adverse Event|7|||
155588689|NCT01455597|561583684|FG001|Overall Study|Adverse Event|0|||
155588690|NCT01455597|561583685|FG002|Overall Study|Adverse Event|5|||
155588691|NCT01455597|561583686|FG003|Overall Study|Adverse Event|1|||
155588692|NCT01455597|561583683|FG000|Overall Study|Lack of Efficacy|0|||
155588693|NCT01455597|561583684|FG001|Overall Study|Lack of Efficacy|1|||
155588694|NCT01455597|561583685|FG002|Overall Study|Lack of Efficacy|2|||
155588695|NCT01455597|561583686|FG003|Overall Study|Lack of Efficacy|0|||
155588696|NCT01455597|561583683|FG000|Overall Study|Lost to Follow-up|3|||
155588697|NCT01455597|561583684|FG001|Overall Study|Lost to Follow-up|0|||
155588698|NCT01455597|561583685|FG002|Overall Study|Lost to Follow-up|2|||
155588699|NCT01455597|561583686|FG003|Overall Study|Lost to Follow-up|1|||
155588700|NCT01455597|561583683|FG000|Overall Study|Withdrew Consent|6|||
155588701|NCT01455597|561583684|FG001|Overall Study|Withdrew Consent|5|||
155588702|NCT01455597|561583685|FG002|Overall Study|Withdrew Consent|8|||
155588703|NCT01455597|561583686|FG003|Overall Study|Withdrew Consent|5|||
155588704|NCT01455597|561583683|FG000|Overall Study|Reason not Specified|1|||
155588705|NCT01455597|561583684|FG001|Overall Study|Reason not Specified|2|||
155588706|NCT01455597|561583685|FG002|Overall Study|Reason not Specified|3|||
155588707|NCT01455597|561583686|FG003|Overall Study|Reason not Specified|3|||
155588708|NCT01737710|561583690|FG000|Overall Study|Lost to Follow-up|0|||
155588709|NCT01737710|561583691|FG001|Overall Study|Lost to Follow-up|2|||
155588710|NCT01737710|561583692|FG002|Overall Study|Lost to Follow-up|2|||
155588711|NCT01737710|561583693|FG003|Overall Study|Lost to Follow-up|0|||
155588712|NCT01737710|561583694|FG004|Overall Study|Lost to Follow-up|0|||
155588713|NCT01737710|561583690|FG000|Overall Study|Withdrawal by Subject|1|||
155588714|NCT01737710|561583691|FG001|Overall Study|Withdrawal by Subject|1|||
155588715|NCT01737710|561583692|FG002|Overall Study|Withdrawal by Subject|1|||
155588716|NCT01737710|561583693|FG003|Overall Study|Withdrawal by Subject|0|||
155588717|NCT01737710|561583694|FG004|Overall Study|Withdrawal by Subject|0|||
155588718|NCT01737710|561583690|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
155588719|NCT01737710|561583691|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
155588720|NCT01737710|561583692|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
155588721|NCT01737710|561583693|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
155588722|NCT01737710|561583694|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
155588723|NCT03412734|561583696|FG000|Overall Study|Incorrect labeling of samples|2|||
155588724|NCT03412734|561583697|FG001|Overall Study|Incorrect labeling of samples|0|||
155588725|NCT03412734|561583696|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
155588726|NCT03412734|561583697|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
155588727|NCT00423332|561583698|FG000|Overall Study|Adverse Event|6|||
155588728|NCT00423332|561583699|FG001|Overall Study|Adverse Event|2|||
155588729|NCT00423332|561583698|FG000|Overall Study|Withdrawal by Subject|1|||
155588730|NCT00423332|561583699|FG001|Overall Study|Withdrawal by Subject|0|||
155588731|NCT00423332|561583698|FG000|Overall Study|Condition under investigation worsened|1|||
155588732|NCT00423332|561583699|FG001|Overall Study|Condition under investigation worsened|1|||
155588733|NCT00423332|561583698|FG000|Overall Study|Progressive at Week 6|0|||
155588734|NCT00423332|561583699|FG001|Overall Study|Progressive at Week 6|1|||
155588735|NCT00423332|561583698|FG000|Overall Study|Unblinded before 12 weeks|1|||
155588736|NCT00423332|561583699|FG001|Overall Study|Unblinded before 12 weeks|3|||
155588737|NCT02035202|561583702|FG000|Overall Study|Lost to Follow-up|8|||
155588738|NCT02035202|561583703|FG001|Overall Study|Lost to Follow-up|16|||
155588739|NCT02035202|561583704|FG002|Overall Study|Lost to Follow-up|2|||
155588740|NCT03777436|561583705|FG000|Placebo-controlled Phase|Adverse Event|8|||
155588741|NCT03777436|561583706|FG001|Placebo-controlled Phase|Adverse Event|10|||
155588742|NCT03777436|561583707|FG002|Placebo-controlled Phase|Adverse Event|0|||
155588743|NCT03777436|561583705|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
155588744|NCT03777436|561583706|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
155588745|NCT03777436|561583707|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
155588746|NCT03777436|561583705|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
155588747|NCT03777436|561583706|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
155588748|NCT03777436|561583707|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155588749|NCT03777436|561583705|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
155588750|NCT03777436|561583706|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
155588751|NCT03777436|561583707|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
155588752|NCT03777436|561583705|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
155588753|NCT03777436|561583706|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
155588754|NCT03777436|561583707|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155588755|NCT03777436|561583705|FG000|Placebo-controlled Phase|Physician Decision|0|||
155588756|NCT03777436|561583706|FG001|Placebo-controlled Phase|Physician Decision|1|||
155588757|NCT03777436|561583707|FG002|Placebo-controlled Phase|Physician Decision|0|||
155588758|NCT03777436|561583705|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
155588759|NCT03777436|561583706|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
155588760|NCT03777436|561583707|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
155588761|NCT03777436|561583705|FG000|Apremilast Extension Phase|Adverse Event|0|||
155588762|NCT03777436|561583706|FG001|Apremilast Extension Phase|Adverse Event|0|||
155588763|NCT03777436|561583707|FG002|Apremilast Extension Phase|Adverse Event|6|||
155588764|NCT03777436|561583705|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155588765|NCT03777436|561583706|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155588766|NCT03777436|561583707|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
155588767|NCT03777436|561583705|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155588768|NCT03777436|561583706|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155588769|NCT03777436|561583707|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
155588770|NCT03777436|561583705|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155588771|NCT03777436|561583706|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155588772|NCT03777436|561583707|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
155588773|NCT03777436|561583705|FG000|Apremilast Extension Phase|Miscellaneous|0|||
155588774|NCT03777436|561583706|FG001|Apremilast Extension Phase|Miscellaneous|0|||
155588775|NCT03777436|561583707|FG002|Apremilast Extension Phase|Miscellaneous|1|||
155588776|NCT00685399|561583710|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155588777|NCT00685399|561583711|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155588778|NCT00685399|561583712|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155588779|NCT00685399|561583713|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155588780|NCT00685399|561583714|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155588781|NCT00685399|561583715|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155588782|NCT00685399|561583716|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155588783|NCT00685399|561583717|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155588784|NCT00685399|561583710|FG000|Treatment Period 1|Protocol Violation|1|||
155588785|NCT00685399|561583711|FG001|Treatment Period 1|Protocol Violation|0|||
155588786|NCT00685399|561583712|FG002|Treatment Period 1|Protocol Violation|0|||
155588787|NCT00685399|561583713|FG003|Treatment Period 1|Protocol Violation|0|||
155588788|NCT00685399|561583714|FG004|Treatment Period 1|Protocol Violation|0|||
155588789|NCT00685399|561583715|FG005|Treatment Period 1|Protocol Violation|0|||
155588790|NCT00685399|561583716|FG006|Treatment Period 1|Protocol Violation|0|||
155588791|NCT00685399|561583717|FG007|Treatment Period 1|Protocol Violation|0|||
155588792|NCT00685399|561583710|FG000|Treatment Period 1|Administrative|2|||
155588793|NCT00685399|561583711|FG001|Treatment Period 1|Administrative|0|||
155588794|NCT00685399|561583712|FG002|Treatment Period 1|Administrative|0|||
155588795|NCT00685399|561583713|FG003|Treatment Period 1|Administrative|0|||
155588796|NCT00685399|561583714|FG004|Treatment Period 1|Administrative|0|||
155588797|NCT00685399|561583715|FG005|Treatment Period 1|Administrative|0|||
155588798|NCT00685399|561583716|FG006|Treatment Period 1|Administrative|0|||
155588799|NCT00685399|561583717|FG007|Treatment Period 1|Administrative|0|||
155588800|NCT00685399|561583710|FG000|Treatment Period 1|Lack of Efficacy|1|||
155588801|NCT00685399|561583711|FG001|Treatment Period 1|Lack of Efficacy|0|||
155588802|NCT00685399|561583712|FG002|Treatment Period 1|Lack of Efficacy|0|||
155588803|NCT00685399|561583713|FG003|Treatment Period 1|Lack of Efficacy|0|||
155588804|NCT00685399|561583714|FG004|Treatment Period 1|Lack of Efficacy|0|||
155588805|NCT00685399|561583715|FG005|Treatment Period 1|Lack of Efficacy|0|||
155588806|NCT00685399|561583716|FG006|Treatment Period 1|Lack of Efficacy|0|||
155588807|NCT00685399|561583717|FG007|Treatment Period 1|Lack of Efficacy|0|||
155588808|NCT00685399|561583710|FG000|Treatment Period 2|Administrative Problems|0|||
155588809|NCT00685399|561583711|FG001|Treatment Period 2|Administrative Problems|2|||
155588810|NCT00685399|561583712|FG002|Treatment Period 2|Administrative Problems|1|||
155588811|NCT00685399|561583713|FG003|Treatment Period 2|Administrative Problems|0|||
155588812|NCT00685399|561583714|FG004|Treatment Period 2|Administrative Problems|0|||
155588813|NCT00685399|561583715|FG005|Treatment Period 2|Administrative Problems|0|||
155588814|NCT00685399|561583716|FG006|Treatment Period 2|Administrative Problems|0|||
155588815|NCT00685399|561583717|FG007|Treatment Period 2|Administrative Problems|0|||
155588816|NCT00685399|561583710|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155588817|NCT00685399|561583711|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155588818|NCT00685399|561583712|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155588819|NCT00685399|561583713|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155588820|NCT00685399|561583714|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155588821|NCT00685399|561583715|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155588822|NCT00685399|561583716|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155588823|NCT00685399|561583717|FG007|Treatment Period 2|Withdrawal by Subject|2|||
155588824|NCT00685399|561583710|FG000|Treatment Period 2|Adverse Event|0|||
155588825|NCT00685399|561583711|FG001|Treatment Period 2|Adverse Event|0|||
155588826|NCT00685399|561583712|FG002|Treatment Period 2|Adverse Event|0|||
155588827|NCT00685399|561583713|FG003|Treatment Period 2|Adverse Event|0|||
155588828|NCT00685399|561583714|FG004|Treatment Period 2|Adverse Event|0|||
155588829|NCT00685399|561583715|FG005|Treatment Period 2|Adverse Event|1|||
155588830|NCT00685399|561583716|FG006|Treatment Period 2|Adverse Event|0|||
155588831|NCT00685399|561583717|FG007|Treatment Period 2|Adverse Event|0|||
155588832|NCT00685399|561583710|FG000|Treatment Period 2|Lack of Efficacy|0|||
155588833|NCT00685399|561583711|FG001|Treatment Period 2|Lack of Efficacy|10|||
155588834|NCT00685399|561583712|FG002|Treatment Period 2|Lack of Efficacy|2|||
155588835|NCT00685399|561583713|FG003|Treatment Period 2|Lack of Efficacy|0|||
155588836|NCT00685399|561583714|FG004|Treatment Period 2|Lack of Efficacy|0|||
155588837|NCT00685399|561583715|FG005|Treatment Period 2|Lack of Efficacy|1|||
155588838|NCT00685399|561583716|FG006|Treatment Period 2|Lack of Efficacy|0|||
155588839|NCT00685399|561583717|FG007|Treatment Period 2|Lack of Efficacy|0|||
155588840|NCT00685399|561583710|FG000|Extension|Administrative Issues|0|||
155588841|NCT00685399|561583711|FG001|Extension|Administrative Issues|0|||
155588842|NCT00685399|561583712|FG002|Extension|Administrative Issues|0|||
155588843|NCT00685399|561583713|FG003|Extension|Administrative Issues|1|||
155588844|NCT00685399|561583714|FG004|Extension|Administrative Issues|0|||
155588845|NCT00685399|561583715|FG005|Extension|Administrative Issues|0|||
155588846|NCT00685399|561583716|FG006|Extension|Administrative Issues|0|||
155588847|NCT00685399|561583717|FG007|Extension|Administrative Issues|0|||
155588848|NCT00685399|561583710|FG000|Extension|Withdrawal by Subject|0|||
155588849|NCT00685399|561583711|FG001|Extension|Withdrawal by Subject|0|||
155588850|NCT00685399|561583712|FG002|Extension|Withdrawal by Subject|0|||
155588851|NCT00685399|561583713|FG003|Extension|Withdrawal by Subject|1|||
155588852|NCT00685399|561583714|FG004|Extension|Withdrawal by Subject|0|||
155588853|NCT00685399|561583715|FG005|Extension|Withdrawal by Subject|0|||
155588854|NCT00685399|561583716|FG006|Extension|Withdrawal by Subject|0|||
155588855|NCT00685399|561583717|FG007|Extension|Withdrawal by Subject|0|||
155588856|NCT00685399|561583710|FG000|Extension|Protocol Violation|0|||
155588857|NCT00685399|561583711|FG001|Extension|Protocol Violation|0|||
155588858|NCT00685399|561583712|FG002|Extension|Protocol Violation|0|||
155588859|NCT00685399|561583713|FG003|Extension|Protocol Violation|1|||
155588860|NCT00685399|561583714|FG004|Extension|Protocol Violation|0|||
155588861|NCT00685399|561583715|FG005|Extension|Protocol Violation|0|||
155588862|NCT00685399|561583716|FG006|Extension|Protocol Violation|0|||
155588863|NCT00685399|561583717|FG007|Extension|Protocol Violation|0|||
155588864|NCT00685399|561583710|FG000|Extension|Lack of Efficacy|0|||
155588865|NCT00685399|561583711|FG001|Extension|Lack of Efficacy|0|||
155588866|NCT00685399|561583712|FG002|Extension|Lack of Efficacy|0|||
155588867|NCT00685399|561583713|FG003|Extension|Lack of Efficacy|2|||
155588868|NCT00685399|561583714|FG004|Extension|Lack of Efficacy|0|||
155588869|NCT00685399|561583715|FG005|Extension|Lack of Efficacy|0|||
155588870|NCT00685399|561583716|FG006|Extension|Lack of Efficacy|0|||
155588871|NCT00685399|561583717|FG007|Extension|Lack of Efficacy|0|||
155588872|NCT00685399|561583710|FG000|Extension|Adverse Event|0|||
155588873|NCT00685399|561583711|FG001|Extension|Adverse Event|0|||
155588874|NCT00685399|561583712|FG002|Extension|Adverse Event|0|||
155588875|NCT00685399|561583713|FG003|Extension|Adverse Event|2|||
155588876|NCT00685399|561583714|FG004|Extension|Adverse Event|0|||
155588877|NCT00685399|561583715|FG005|Extension|Adverse Event|0|||
155588878|NCT00685399|561583716|FG006|Extension|Adverse Event|0|||
155588879|NCT00685399|561583717|FG007|Extension|Adverse Event|0|||
155588880|NCT00758485|561583718|FG000|Overall Study|Lost to Follow-up|0|||
155588881|NCT00758485|561583719|FG001|Overall Study|Lost to Follow-up|1|||
155588882|NCT00758485|561583718|FG000|Overall Study|Not Treated|1|||
155588883|NCT00758485|561583719|FG001|Overall Study|Not Treated|2|||
155588884|NCT00656292|561583720|FG000|Overall Study|Withdrawal by Subject|2|||
155588885|NCT00656292|561583721|FG001|Overall Study|Withdrawal by Subject|3|||
155588886|NCT00656292|561583720|FG000|Overall Study|Screen failure|1|||
155588887|NCT00656292|561583721|FG001|Overall Study|Screen failure|2|||
155588888|NCT00921557|561583722|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
155588889|NCT00921557|561583723|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
155588890|NCT00921557|561583724|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
155588891|NCT00921557|561583722|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
155588892|NCT00921557|561583723|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
155588893|NCT00921557|561583724|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
155588894|NCT00921557|561583722|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
155588895|NCT00921557|561583723|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
155588896|NCT00921557|561583724|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
155588897|NCT00921557|561583722|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
155588898|NCT00921557|561583723|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
155588899|NCT00921557|561583724|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
155588900|NCT00921557|561583722|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
155588901|NCT00921557|561583723|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
155588902|NCT00921557|561583724|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
155588903|NCT03259425|561583725|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
155588904|NCT00812981|561583731|FG000|Overall Study|Other|0|||
155588905|NCT00812981|561583732|FG001|Overall Study|Other|1|||
155588906|NCT04666259|561583735|FG000|Treatment Phase|Physician Decision|9|||
155588907|NCT04666259|561583736|FG001|Treatment Phase|Physician Decision|3|||
155588908|NCT04666259|561583737|FG002|Treatment Phase|Physician Decision|3|||
155588909|NCT04666259|561583735|FG000|Treatment Phase|Adverse Event|3|||
155588910|NCT04666259|561583736|FG001|Treatment Phase|Adverse Event|1|||
155588911|NCT04666259|561583737|FG002|Treatment Phase|Adverse Event|0|||
155588912|NCT04666259|561583735|FG000|Treatment Phase|Subject decision|1|||
155588913|NCT04666259|561583736|FG001|Treatment Phase|Subject decision|2|||
155588914|NCT04666259|561583737|FG002|Treatment Phase|Subject decision|0|||
155588915|NCT04666259|561583735|FG000|Treatment Phase|Progressive disease|0|||
155588916|NCT04666259|561583736|FG001|Treatment Phase|Progressive disease|1|||
155588917|NCT04666259|561583737|FG002|Treatment Phase|Progressive disease|0|||
155588918|NCT04666259|561583735|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
155588919|NCT04666259|561583736|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
155588920|NCT04666259|561583737|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
155588921|NCT04666259|561583735|FG000|Safety Follow-up Phase|Physician Decision|2|||
155588922|NCT04666259|561583736|FG001|Safety Follow-up Phase|Physician Decision|0|||
155588923|NCT04666259|561583737|FG002|Safety Follow-up Phase|Physician Decision|0|||
155588924|NCT04666259|561583735|FG000|Safety Follow-up Phase|Subject decision|1|||
155588925|NCT04666259|561583736|FG001|Safety Follow-up Phase|Subject decision|0|||
155588926|NCT04666259|561583737|FG002|Safety Follow-up Phase|Subject decision|0|||
155588927|NCT04666259|561583735|FG000|Safety Follow-up Phase|Death|0|||
155588928|NCT04666259|561583736|FG001|Safety Follow-up Phase|Death|1|||
155588929|NCT04666259|561583737|FG002|Safety Follow-up Phase|Death|0|||
155588930|NCT04178122|561583738|FG000|Overall Study|Withdrawal by Subject|1|||
155588931|NCT04178122|561583739|FG001|Overall Study|Withdrawal by Subject|1|||
155588932|NCT04178122|561583738|FG000|Overall Study|Death|2|||
155588933|NCT04178122|561583739|FG001|Overall Study|Death|0|||
155588934|NCT04178122|561583738|FG000|Overall Study|Did not complete testing|3|||
155588935|NCT04178122|561583739|FG001|Overall Study|Did not complete testing|13|||
155588936|NCT02684097|561583740|FG000|Overall Study|Lack of Efficacy|13|||
155588937|NCT02684097|561583741|FG001|Overall Study|Lack of Efficacy|6|||
155588938|NCT00462709|561583742|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
155588939|NCT00462709|561583742|FG000|Overall Study|Lost to Follow-up|10|||
155588940|NCT00462709|561583742|FG000|Overall Study|Withdrawal by Subject|8|||
155588941|NCT00462709|561583742|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
155588942|NCT00462709|561583742|FG000|Overall Study|Death|2|||
155588943|NCT00462709|561583742|FG000|Overall Study|Logistical reasons|2|||
155588944|NCT00462709|561583742|FG000|Overall Study|Physician Decision|1|||
155588945|NCT00462709|561583742|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
155588946|NCT00425750|561583743|FG000|Overall Study|Death|1|||
155588947|NCT00425750|561583743|FG000|Overall Study|Withdrawal by Subject|3|||
155588948|NCT00425750|561583743|FG000|Overall Study|Adverse Event|3|||
155588949|NCT00425750|561583743|FG000|Overall Study|Progression of disease|18|||
155588950|NCT04339062|561583744|FG000|Overall Study|Death|0|||
155588951|NCT04339062|561583745|FG001|Overall Study|Death|1|||
155588952|NCT01197534|561583746|FG000|Overall Study|Not reported|16|||
155588953|NCT01197534|561583747|FG001|Overall Study|Not reported|10|||
155588954|NCT01197534|561583748|FG002|Overall Study|Not reported|16|||
155588955|NCT01197534|561583746|FG000|Overall Study|Enrolment in long term extension|57|||
155588956|NCT01197534|561583747|FG001|Overall Study|Enrolment in long term extension|66|||
155588957|NCT01197534|561583748|FG002|Overall Study|Enrolment in long term extension|119|||
155588958|NCT01197534|561583746|FG000|Overall Study|Severe non-compliance to protocol|3|||
155588959|NCT01197534|561583747|FG001|Overall Study|Severe non-compliance to protocol|4|||
155588960|NCT01197534|561583748|FG002|Overall Study|Severe non-compliance to protocol|1|||
155588961|NCT01197534|561583746|FG000|Overall Study|Lack of therapeutic response|9|||
155588962|NCT01197534|561583747|FG001|Overall Study|Lack of therapeutic response|4|||
155588963|NCT01197534|561583748|FG002|Overall Study|Lack of therapeutic response|9|||
155588964|NCT01197534|561583746|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
155588965|NCT01197534|561583747|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
155588966|NCT01197534|561583748|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
155588967|NCT01197534|561583746|FG000|Overall Study|Lost to Follow-up|1|||
155588968|NCT01197534|561583747|FG001|Overall Study|Lost to Follow-up|4|||
155588969|NCT01197534|561583748|FG002|Overall Study|Lost to Follow-up|2|||
155588970|NCT01197534|561583746|FG000|Overall Study|Adverse Event|35|||
155588971|NCT01197534|561583747|FG001|Overall Study|Adverse Event|36|||
155588972|NCT01197534|561583748|FG002|Overall Study|Adverse Event|24|||
155588973|NCT01276756|561583751|FG000|Overall Study|Lost to Follow-up|2|||
155588974|NCT01276756|561583752|FG001|Overall Study|Lost to Follow-up|0|||
155588975|NCT01276756|561583751|FG000|Overall Study|Adverse Event|3|||
155588976|NCT01276756|561583752|FG001|Overall Study|Adverse Event|2|||
155588977|NCT02630251|561583757|FG000|Overall Study|Physician Decision|0|||
155588978|NCT02630251|561583758|FG001|Overall Study|Physician Decision|0|||
155588979|NCT02630251|561583759|FG002|Overall Study|Physician Decision|1|||
155588980|NCT02630251|561583760|FG003|Overall Study|Physician Decision|0|||
155588981|NCT04586244|561583763|FG000|Overall Study|Lost to Follow-up|1|||
155588982|NCT04586244|561583764|FG001|Overall Study|Lost to Follow-up|0|||
155588983|NCT04586244|561583765|FG002|Overall Study|Lost to Follow-up|0|||
155588984|NCT04586244|561583766|FG003|Overall Study|Lost to Follow-up|1|||
155588985|NCT04586244|561583767|FG004|Overall Study|Lost to Follow-up|0|||
155588986|NCT04586244|561583763|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155588987|NCT04586244|561583764|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
155588988|NCT04586244|561583765|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155588989|NCT04586244|561583766|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155588990|NCT04586244|561583767|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155588991|NCT02670525|561583768|FG000|Overall Study|Death|94|||
155588992|NCT02670525|561583769|FG001|Overall Study|Death|14|||
155588993|NCT02670525|561583768|FG000|Overall Study|Lost to Follow-up|4|||
155588994|NCT02670525|561583769|FG001|Overall Study|Lost to Follow-up|1|||
155588995|NCT02670525|561583768|FG000|Overall Study|Subject withdrew consent|1|||
155588996|NCT02670525|561583769|FG001|Overall Study|Subject withdrew consent|0|||
155588997|NCT02670525|561583768|FG000|Overall Study|Unknown, data entry delayed|123|||
155588998|NCT02670525|561583769|FG001|Overall Study|Unknown, data entry delayed|78|||
155588999|NCT02505217|561583770|FG000|Overall Study|Withdrawal by Subject|1|||
155589000|NCT02505217|561583771|FG001|Overall Study|Withdrawal by Subject|2|||
155589001|NCT00634036|561583774|FG000|Overall Study|Lost to Follow-up|1|||
155589002|NCT00634036|561583775|FG001|Overall Study|Lost to Follow-up|1|||
155589003|NCT00634036|561583774|FG000|Overall Study|Withdrawal by Subject|1|||
155589004|NCT00634036|561583775|FG001|Overall Study|Withdrawal by Subject|1|||
155589005|NCT03517540|561583776|FG000|Overall Study|Protocol Violation|2|||
155589006|NCT03517540|561583777|FG001|Overall Study|Protocol Violation|0|||
155589007|NCT03517540|561583778|FG002|Overall Study|Protocol Violation|0|||
155589008|NCT03517540|561583779|FG003|Overall Study|Protocol Violation|1|||
155589009|NCT03517540|561583776|FG000|Overall Study|Adverse Event|9|||
155589010|NCT03517540|561583777|FG001|Overall Study|Adverse Event|3|||
155589011|NCT03517540|561583778|FG002|Overall Study|Adverse Event|8|||
155589012|NCT03517540|561583779|FG003|Overall Study|Adverse Event|1|||
155589013|NCT03517540|561583776|FG000|Overall Study|Withdrawal by Subject|3|||
155589014|NCT03517540|561583777|FG001|Overall Study|Withdrawal by Subject|4|||
155589015|NCT03517540|561583778|FG002|Overall Study|Withdrawal by Subject|1|||
155589016|NCT03517540|561583779|FG003|Overall Study|Withdrawal by Subject|3|||
155589017|NCT03896022|561583780|FG000|Overall Study|Withdrawal by Subject|1|||
155589018|NCT03896022|561583781|FG001|Overall Study|Withdrawal by Subject|0|||
155589019|NCT03896022|561583782|FG002|Overall Study|Withdrawal by Subject|0|||
155589020|NCT03896022|561583780|FG000|Overall Study|Did not have procedure|3|||
155589021|NCT03896022|561583781|FG001|Overall Study|Did not have procedure|0|||
155589022|NCT03896022|561583782|FG002|Overall Study|Did not have procedure|0|||
155589023|NCT00615550|561583787|FG000|Overall Study|Lost to Follow-up|6|||
155589024|NCT00615550|561583788|FG001|Overall Study|Lost to Follow-up|1|||
155589025|NCT06868654|561583789|FG000|Overall Study|Death|4|||
155589026|NCT06868654|561583790|FG001|Overall Study|Death|14|||
155589027|NCT06868654|561583789|FG000|Overall Study|Lost to Follow-up|0|||
155589028|NCT06868654|561583790|FG001|Overall Study|Lost to Follow-up|1|||
155589029|NCT06868654|561583789|FG000|Overall Study|Withdrawal by Subject|5|||
155589030|NCT06868654|561583790|FG001|Overall Study|Withdrawal by Subject|3|||
155589031|NCT06868654|561583789|FG000|Overall Study|Physician Decision|0|||
155589032|NCT06868654|561583790|FG001|Overall Study|Physician Decision|1|||
155589033|NCT06868654|561583789|FG000|Overall Study|Ongoing|23|||
155589034|NCT06868654|561583790|FG001|Overall Study|Ongoing|21|||
155589035|NCT01777282|561583791|FG000|Overall Study|Persistent Hyperglycemia|0|||
155589036|NCT01777282|561583792|FG001|Overall Study|Persistent Hyperglycemia|0|||
155589037|NCT01777282|561583793|FG002|Overall Study|Persistent Hyperglycemia|1|||
155589038|NCT01777282|561583794|FG003|Overall Study|Persistent Hyperglycemia|0|||
155589039|NCT01777282|561583795|FG004|Overall Study|Persistent Hyperglycemia|0|||
155589040|NCT01777282|561583791|FG000|Overall Study|New Antidiabetic Medication|0|||
155589041|NCT01777282|561583792|FG001|Overall Study|New Antidiabetic Medication|0|||
155589042|NCT01777282|561583793|FG002|Overall Study|New Antidiabetic Medication|1|||
155589043|NCT01777282|561583794|FG003|Overall Study|New Antidiabetic Medication|0|||
155589044|NCT01777282|561583795|FG004|Overall Study|New Antidiabetic Medication|0|||
155589045|NCT01777282|561583791|FG000|Overall Study|Adverse Event|4|||
155589046|NCT01777282|561583792|FG001|Overall Study|Adverse Event|4|||
155589047|NCT01777282|561583793|FG002|Overall Study|Adverse Event|2|||
155589048|NCT01777282|561583794|FG003|Overall Study|Adverse Event|1|||
155589049|NCT01777282|561583795|FG004|Overall Study|Adverse Event|3|||
155589050|NCT01777282|561583791|FG000|Overall Study|Withdrawal by Subject|4|||
155589051|NCT01777282|561583792|FG001|Overall Study|Withdrawal by Subject|0|||
155589052|NCT01777282|561583793|FG002|Overall Study|Withdrawal by Subject|0|||
155589053|NCT01777282|561583794|FG003|Overall Study|Withdrawal by Subject|1|||
155589054|NCT01777282|561583795|FG004|Overall Study|Withdrawal by Subject|2|||
155589055|NCT01777282|561583791|FG000|Overall Study|Protocol Violation|2|||
155589056|NCT01777282|561583792|FG001|Overall Study|Protocol Violation|0|||
155589057|NCT01777282|561583793|FG002|Overall Study|Protocol Violation|1|||
155589058|NCT01777282|561583794|FG003|Overall Study|Protocol Violation|0|||
155589059|NCT01777282|561583795|FG004|Overall Study|Protocol Violation|2|||
155589060|NCT01777282|561583791|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
155589061|NCT01777282|561583792|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155589062|NCT01777282|561583793|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
155589063|NCT01777282|561583794|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155589064|NCT01777282|561583795|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155589065|NCT04015518|561583796|FG000|Overall Study|Adverse Event|6|||
155589066|NCT04015518|561583797|FG001|Overall Study|Adverse Event|1|||
155589067|NCT04015518|561583798|FG002|Overall Study|Adverse Event|1|||
155589068|NCT04015518|561583799|FG003|Overall Study|Adverse Event|3|||
155589069|NCT04015518|561583800|FG004|Overall Study|Adverse Event|3|||
155589070|NCT04015518|561583796|FG000|Overall Study|Lack of Efficacy|1|||
155589071|NCT04015518|561583797|FG001|Overall Study|Lack of Efficacy|0|||
155589072|NCT04015518|561583798|FG002|Overall Study|Lack of Efficacy|1|||
155589073|NCT04015518|561583799|FG003|Overall Study|Lack of Efficacy|0|||
155589074|NCT04015518|561583800|FG004|Overall Study|Lack of Efficacy|4|||
155589075|NCT04015518|561583796|FG000|Overall Study|Lost to Follow-up|0|||
155589076|NCT04015518|561583797|FG001|Overall Study|Lost to Follow-up|0|||
155589077|NCT04015518|561583798|FG002|Overall Study|Lost to Follow-up|0|||
155589078|NCT04015518|561583799|FG003|Overall Study|Lost to Follow-up|0|||
155589079|NCT04015518|561583800|FG004|Overall Study|Lost to Follow-up|1|||
155589080|NCT04015518|561583796|FG000|Overall Study|Withdrawal by Subject|0|||
155589081|NCT04015518|561583797|FG001|Overall Study|Withdrawal by Subject|1|||
155589082|NCT04015518|561583798|FG002|Overall Study|Withdrawal by Subject|0|||
155589083|NCT04015518|561583799|FG003|Overall Study|Withdrawal by Subject|1|||
155589084|NCT04015518|561583800|FG004|Overall Study|Withdrawal by Subject|1|||
155589085|NCT04015518|561583796|FG000|Overall Study|Patient did not come for consecutive visits|0|||
155589086|NCT04015518|561583797|FG001|Overall Study|Patient did not come for consecutive visits|1|||
155589087|NCT04015518|561583798|FG002|Overall Study|Patient did not come for consecutive visits|0|||
155589088|NCT04015518|561583799|FG003|Overall Study|Patient did not come for consecutive visits|0|||
155589089|NCT04015518|561583800|FG004|Overall Study|Patient did not come for consecutive visits|0|||
155589090|NCT04015518|561583796|FG000|Overall Study|not willing to travel due to Covid-19|0|||
155589091|NCT04015518|561583797|FG001|Overall Study|not willing to travel due to Covid-19|0|||
155589092|NCT04015518|561583798|FG002|Overall Study|not willing to travel due to Covid-19|1|||
155589093|NCT04015518|561583799|FG003|Overall Study|not willing to travel due to Covid-19|0|||
155589094|NCT04015518|561583800|FG004|Overall Study|not willing to travel due to Covid-19|0|||
155589095|NCT04015518|561583796|FG000|Overall Study|Patient wants to discontinue treatment|0|||
155589096|NCT04015518|561583797|FG001|Overall Study|Patient wants to discontinue treatment|0|||
155589097|NCT04015518|561583798|FG002|Overall Study|Patient wants to discontinue treatment|0|||
155589098|NCT04015518|561583799|FG003|Overall Study|Patient wants to discontinue treatment|1|||
155589099|NCT04015518|561583800|FG004|Overall Study|Patient wants to discontinue treatment|0|||
155589100|NCT04015518|561583796|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
155589101|NCT04015518|561583797|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
155589102|NCT04015518|561583798|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
155589103|NCT04015518|561583799|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
155589104|NCT04015518|561583800|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
155589105|NCT04015518|561583796|FG000|Overall Study|Pregnancy|0|||
155589106|NCT04015518|561583797|FG001|Overall Study|Pregnancy|0|||
155589107|NCT04015518|561583798|FG002|Overall Study|Pregnancy|0|||
155589108|NCT04015518|561583799|FG003|Overall Study|Pregnancy|0|||
155589109|NCT04015518|561583800|FG004|Overall Study|Pregnancy|1|||
155589110|NCT04015518|561583796|FG000|Overall Study|Personal reasons|1|||
155589111|NCT04015518|561583797|FG001|Overall Study|Personal reasons|0|||
155589112|NCT04015518|561583798|FG002|Overall Study|Personal reasons|0|||
155589113|NCT04015518|561583799|FG003|Overall Study|Personal reasons|0|||
155589114|NCT04015518|561583800|FG004|Overall Study|Personal reasons|1|||
155589115|NCT04015518|561583796|FG000|Overall Study|Withdrew consent|1|||
155589116|NCT04015518|561583797|FG001|Overall Study|Withdrew consent|0|||
155589117|NCT04015518|561583798|FG002|Overall Study|Withdrew consent|0|||
155589118|NCT04015518|561583799|FG003|Overall Study|Withdrew consent|0|||
155589119|NCT04015518|561583800|FG004|Overall Study|Withdrew consent|0|||
155589120|NCT04015518|561583796|FG000|Overall Study|Prostate carcinoma|1|||
155589121|NCT04015518|561583797|FG001|Overall Study|Prostate carcinoma|0|||
155589122|NCT04015518|561583798|FG002|Overall Study|Prostate carcinoma|0|||
155589123|NCT04015518|561583799|FG003|Overall Study|Prostate carcinoma|0|||
155589124|NCT04015518|561583800|FG004|Overall Study|Prostate carcinoma|0|||
155589125|NCT04015518|561583796|FG000|Overall Study|Could not keep appointments due to work|1|||
155589126|NCT04015518|561583797|FG001|Overall Study|Could not keep appointments due to work|0|||
155589127|NCT04015518|561583798|FG002|Overall Study|Could not keep appointments due to work|0|||
155589128|NCT04015518|561583799|FG003|Overall Study|Could not keep appointments due to work|0|||
155589129|NCT04015518|561583800|FG004|Overall Study|Could not keep appointments due to work|0|||
155589130|NCT00550745|561583801|FG000|Overall Study|Death|20|||
155589131|NCT00550745|561583802|FG001|Overall Study|Death|16|||
155589132|NCT00550745|561583801|FG000|Overall Study|Lost to Follow-up|45|||
155589133|NCT00550745|561583802|FG001|Overall Study|Lost to Follow-up|30|||
155589134|NCT00550745|561583801|FG000|Overall Study|Physician Decision|0|||
155589135|NCT00550745|561583802|FG001|Overall Study|Physician Decision|2|||
155589136|NCT00550745|561583801|FG000|Overall Study|Protocol Violation|4|||
155589137|NCT00550745|561583802|FG001|Overall Study|Protocol Violation|2|||
155589138|NCT00550745|561583801|FG000|Overall Study|Withdrawal by Subject|17|||
155589139|NCT00550745|561583802|FG001|Overall Study|Withdrawal by Subject|10|||
155589140|NCT00550745|561583801|FG000|Overall Study|Screen failure|1|||
155589141|NCT00550745|561583802|FG001|Overall Study|Screen failure|0|||
155589142|NCT00764660|561583803|FG000|Overall Study|Adverse Event|6|||
155589143|NCT00764660|561583804|FG001|Overall Study|Adverse Event|3|||
155589144|NCT00764660|561583803|FG000|Overall Study|Lost to Follow-up|3|||
155589145|NCT00764660|561583804|FG001|Overall Study|Lost to Follow-up|4|||
155589146|NCT00764660|561583803|FG000|Overall Study|Withdrawal by Subject|7|||
155589147|NCT00764660|561583804|FG001|Overall Study|Withdrawal by Subject|3|||
155589148|NCT00764660|561583803|FG000|Overall Study|Noncompliance With Protocol|5|||
155589149|NCT00764660|561583804|FG001|Overall Study|Noncompliance With Protocol|1|||
155589150|NCT00764660|561583803|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155589151|NCT00764660|561583804|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155589152|NCT02186873|561585468|FG000|Overall Study|Adverse Event|1|||
155589153|NCT02186873|561585469|FG001|Overall Study|Adverse Event|3|||
155589154|NCT02186873|561585468|FG000|Overall Study|Lack of Efficacy|0|||
155589155|NCT02186873|561585469|FG001|Overall Study|Lack of Efficacy|1|||
155589156|NCT02186873|561585468|FG000|Overall Study|Lost to Follow-up|1|||
155589157|NCT02186873|561585469|FG001|Overall Study|Lost to Follow-up|2|||
155589158|NCT02186873|561585468|FG000|Overall Study|Withdrawal by Subject|7|||
155589159|NCT02186873|561585469|FG001|Overall Study|Withdrawal by Subject|2|||
155589160|NCT03694002|561585470|FG000|Overall Study|Progression|4|||
155589161|NCT03694002|561585471|FG001|Overall Study|Progression|2|||
155589162|NCT03694002|561585470|FG000|Overall Study|Adverse Event|2|||
155589163|NCT03694002|561585471|FG001|Overall Study|Adverse Event|0|||
155589164|NCT03694002|561585470|FG000|Overall Study|Other not protocol specified|1|||
155589165|NCT03694002|561585471|FG001|Overall Study|Other not protocol specified|0|||
155589166|NCT03694002|561585470|FG000|Overall Study|Ineligible|0|||
155589167|NCT03694002|561585471|FG001|Overall Study|Ineligible|1|||
155589168|NCT03694002|561585470|FG000|Overall Study|Withdrew consent before starting treatment|0|||
155589169|NCT03694002|561585471|FG001|Overall Study|Withdrew consent before starting treatment|3|||
155589170|NCT00596687|561585472|FG000|Overall Study|< 24 hours of insulin treatment|8|||
155589171|NCT00596687|561585473|FG001|Overall Study|< 24 hours of insulin treatment|6|||
155589172|NCT00596687|561585472|FG000|Overall Study|continuous insulin infusion during TPN|2|||
155589173|NCT00596687|561585473|FG001|Overall Study|continuous insulin infusion during TPN|1|||
155589174|NCT00596687|561585472|FG000|Overall Study|Withdrawal by Subject|3|||
155589175|NCT00596687|561585473|FG001|Overall Study|Withdrawal by Subject|1|||
155589176|NCT00596687|561585472|FG000|Overall Study|cancelled surgery|1|||
155589177|NCT00596687|561585473|FG001|Overall Study|cancelled surgery|1|||
155589178|NCT06098339|561585474|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
155589179|NCT06098339|561585475|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
155589180|NCT06098339|561585474|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
155589181|NCT06098339|561585475|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
155589182|NCT00300885|561585476|FG000|Treatment|Adverse Event|134|||
155589183|NCT00300885|561585477|FG001|Treatment|Adverse Event|82|||
155589184|NCT00300885|561585476|FG000|Treatment|Death|20|||
155589185|NCT00300885|561585477|FG001|Treatment|Death|7|||
155589186|NCT00300885|561585476|FG000|Treatment|Lack of Efficacy|1|||
155589187|NCT00300885|561585477|FG001|Treatment|Lack of Efficacy|1|||
155589188|NCT00300885|561585476|FG000|Treatment|Lost to Follow-up|3|||
155589189|NCT00300885|561585477|FG001|Treatment|Lost to Follow-up|2|||
155589190|NCT00300885|561585476|FG000|Treatment|Physician Decision|4|||
155589191|NCT00300885|561585477|FG001|Treatment|Physician Decision|5|||
155589192|NCT00300885|561585476|FG000|Treatment|Protocol Violation|11|||
155589193|NCT00300885|561585477|FG001|Treatment|Protocol Violation|11|||
155589194|NCT00300885|561585476|FG000|Treatment|Withdrawal by Subject|26|||
155589195|NCT00300885|561585477|FG001|Treatment|Withdrawal by Subject|23|||
155589196|NCT00300885|561585476|FG000|Treatment|Disease progression|171|||
155589197|NCT00300885|561585477|FG001|Treatment|Disease progression|238|||
155589198|NCT00300885|561585476|FG000|Treatment|Random code broken (subject died)|0|||
155589199|NCT00300885|561585477|FG001|Treatment|Random code broken (subject died)|1|||
155589200|NCT00300885|561585476|FG000|Treatment|Non-compliant with study medication|3|||
155589201|NCT00300885|561585477|FG001|Treatment|Non-compliant with study medication|4|||
155589202|NCT00300885|561585476|FG000|Follow-up|Death|141|||
155589203|NCT00300885|561585477|FG001|Follow-up|Death|163|||
155589204|NCT00300885|561585476|FG000|Follow-up|Lost to Follow-up|11|||
155589205|NCT00300885|561585477|FG001|Follow-up|Lost to Follow-up|7|||
155589206|NCT00300885|561585476|FG000|Follow-up|Withdrawal by Subject|26|||
155589207|NCT00300885|561585477|FG001|Follow-up|Withdrawal by Subject|25|||
155589208|NCT01637922|561585478|FG000|Overall Study|Adverse Event|0|||
155589209|NCT01637922|561585479|FG001|Overall Study|Adverse Event|1|||
155589210|NCT01637922|561585478|FG000|Overall Study|Protocol Violation|0|||
155589211|NCT01637922|561585479|FG001|Overall Study|Protocol Violation|1|||
155589212|NCT01637922|561585478|FG000|Overall Study|Withdrawal by Subject|0|||
155589213|NCT01637922|561585479|FG001|Overall Study|Withdrawal by Subject|3|||
155589214|NCT01637922|561585478|FG000|Overall Study|Lost to Follow-up|2|||
155589215|NCT01637922|561585479|FG001|Overall Study|Lost to Follow-up|0|||
155589216|NCT01515865|561585480|FG000|Part A (Open-label)|Other|3|||
155589217|NCT01515865|561585481|FG001|Part A (Open-label)|Other|0|||
155589218|NCT01515865|561585482|FG002|Part A (Open-label)|Other|0|||
155589219|NCT01515865|561585480|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
155589220|NCT01515865|561585481|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
155589221|NCT01515865|561585482|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
155589222|NCT01515865|561585480|FG000|Part B (Open-label)|Other|1|||
155589223|NCT01515865|561585481|FG001|Part B (Open-label)|Other|0|||
155589224|NCT01515865|561585482|FG002|Part B (Open-label)|Other|0|||
155589225|NCT03981900|561585483|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
155589226|NCT03981900|561585483|FG000|Overall Study|Adverse Event|5|||
155589227|NCT03981900|561585483|FG000|Overall Study|Protocol Violation|1|||
155589228|NCT03981900|561585483|FG000|Overall Study|Withdrawal by Subject|7|||
155589229|NCT03981900|561585483|FG000|Overall Study|Lost to Follow-up|46|||
155589230|NCT03981900|561585483|FG000|Overall Study|Decision of the researcher|3|||
155589231|NCT03981900|561585483|FG000|Overall Study|Death|3|||
155589232|NCT03981900|561585483|FG000|Overall Study|Other|5|||
155589233|NCT02510664|561585501|FG000|Overall Study|Transferred Care|9|||
155589234|NCT02510664|561585502|FG001|Overall Study|Transferred Care|9|||
155589235|NCT02510664|561585503|FG002|Overall Study|Transferred Care|0|||
155589236|NCT02510664|561585501|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
155589237|NCT02510664|561585502|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
155589238|NCT02510664|561585503|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
155589239|NCT02510664|561585501|FG000|Overall Study|Time Constraints|1|||
155589240|NCT02510664|561585502|FG001|Overall Study|Time Constraints|1|||
155589241|NCT02510664|561585503|FG002|Overall Study|Time Constraints|0|||
155589242|NCT04090060|561585504|FG000|Overall Study|Lost to Follow-up|76|||
155589243|NCT04090060|561585505|FG001|Overall Study|Lost to Follow-up|77|||
155589244|NCT02176655|561585506|FG000|Overall Study|Subjects did not treat|6|||
155589245|NCT01718535|561585514|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
155589246|NCT01718535|561585515|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
155589247|NCT01718535|561585516|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
155589248|NCT01718535|561585517|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
155589249|NCT01718535|561585518|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
155589250|NCT01718535|561585519|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
155589251|NCT01718535|561585520|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
155589252|NCT01718535|561585521|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
155589253|NCT01718535|561585522|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
155589254|NCT01718535|561585523|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
155589255|NCT04747886|561585524|FG000|Overall Study|Withdrawal by Subject|1|||
155589256|NCT04747886|561585525|FG001|Overall Study|Withdrawal by Subject|4|||
155589257|NCT00179660|561585534|FG000|Overall Study|Adverse Event|7|||
155589258|NCT00179660|561585534|FG000|Overall Study|Lack of therapeutic effect|28|||
155589259|NCT00179660|561585534|FG000|Overall Study|Withdrawal by Subject|2|||
155589260|NCT00179660|561585534|FG000|Overall Study|Lost to Follow-up|1|||
155589261|NCT00179660|561585534|FG000|Overall Study|Death|3|||
155589262|NCT00179660|561585534|FG000|Overall Study|Other - Unspecified|9|||
155589263|NCT04478695|561585535|FG000|Overall Study|Death|1|||
155589264|NCT04478695|561585536|FG001|Overall Study|Death|0|||
155589265|NCT00644917|561585537|FG000|Overall Study|Withdrawal by Subject|2|||
155589266|NCT00402688|561585538|FG000|Overall Study|Adverse Event|12|||
155589267|NCT00402688|561585539|FG001|Overall Study|Adverse Event|9|||
155589268|NCT00402688|561585540|FG002|Overall Study|Adverse Event|3|||
155589269|NCT00402688|561585538|FG000|Overall Study|Withdrawal by Subject|3|||
155589270|NCT00402688|561585539|FG001|Overall Study|Withdrawal by Subject|1|||
155589271|NCT00402688|561585540|FG002|Overall Study|Withdrawal by Subject|1|||
155589272|NCT00402688|561585538|FG000|Overall Study|Physician Decision|0|||
155589273|NCT00402688|561585539|FG001|Overall Study|Physician Decision|0|||
155589274|NCT00402688|561585540|FG002|Overall Study|Physician Decision|1|||
155589275|NCT00402688|561585538|FG000|Overall Study|Lack of Efficacy|4|||
155589276|NCT00402688|561585539|FG001|Overall Study|Lack of Efficacy|4|||
155589277|NCT00402688|561585540|FG002|Overall Study|Lack of Efficacy|5|||
155589278|NCT00402688|561585538|FG000|Overall Study|Protocol Violation|1|||
155589279|NCT00402688|561585539|FG001|Overall Study|Protocol Violation|1|||
155589280|NCT00402688|561585540|FG002|Overall Study|Protocol Violation|1|||
155589281|NCT00402688|561585538|FG000|Overall Study|Lost to Follow-up|1|||
155589282|NCT00402688|561585539|FG001|Overall Study|Lost to Follow-up|0|||
155589283|NCT00402688|561585540|FG002|Overall Study|Lost to Follow-up|2|||
155589284|NCT00402688|561585538|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
155589285|NCT00402688|561585539|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
155589286|NCT00402688|561585540|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
155589287|NCT00402688|561585538|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
155589288|NCT00402688|561585539|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
155589289|NCT00402688|561585540|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
155589290|NCT00402688|561585538|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
155589291|NCT00402688|561585539|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
155589292|NCT00402688|561585540|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
155589293|NCT02097238|561585562|FG000|Overall Study|Death|1|||
155589294|NCT02097238|561585562|FG000|Overall Study|Physician Decision|1|||
155589295|NCT02097238|561585562|FG000|Overall Study|Progressive Disease|17|||
155589296|NCT01282372|561585564|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
155589297|NCT01282372|561585564|FG000|Overall Study|Lost to Follow-up|23|||
155589298|NCT01282372|561585564|FG000|Overall Study|Withdrawal by Subject|11|||
155589299|NCT01282372|561585564|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
155589300|NCT01282372|561585564|FG000|Overall Study|Death|1|||
155589301|NCT01282372|561585564|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
155589302|NCT01282372|561585564|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
155589303|NCT01282372|561585564|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
155589304|NCT01282372|561585564|FG000|Overall Study|Adverse Event|12|||
155589305|NCT02993250|561585565|FG000|Overall Study|Lost to Follow-up|0|||
155589306|NCT02993250|561585566|FG001|Overall Study|Lost to Follow-up|1|||
155589307|NCT00356148|561585569|FG000|Overall Study|Reoperation within 30 days|2|||
155589308|NCT00356148|561585570|FG001|Overall Study|Reoperation within 30 days|1|||
155589309|NCT02737930|561585572|FG000|Overall Study|Withdrawal by Subject|0|||
155589310|NCT02737930|561585573|FG001|Overall Study|Withdrawal by Subject|1|||
155589311|NCT04481789|561585574|FG000|Period 1|Withdrawal by Subject|1|||
155589312|NCT04481789|561585575|FG001|Period 1|Withdrawal by Subject|0|||
155589313|NCT04481789|561585576|FG002|Period 1|Withdrawal by Subject|0|||
155589314|NCT04481789|561585577|FG003|Period 1|Withdrawal by Subject|0|||
155589315|NCT04481789|561585578|FG004|Period 1|Withdrawal by Subject|0|||
155589316|NCT04481789|561585579|FG005|Period 1|Withdrawal by Subject|0|||
155589317|NCT03124407|561585584|FG000|Overall Study|Lost to Follow-up|1|||
155589318|NCT03124407|561585585|FG001|Overall Study|Lost to Follow-up|0|||
155589319|NCT03124407|561585586|FG002|Overall Study|Lost to Follow-up|0|||
155589320|NCT03124407|561585587|FG003|Overall Study|Lost to Follow-up|0|||
155589321|NCT03124407|561585584|FG000|Overall Study|Adverse Event|0|||
155589322|NCT03124407|561585585|FG001|Overall Study|Adverse Event|0|||
155589323|NCT03124407|561585586|FG002|Overall Study|Adverse Event|1|||
155589324|NCT03124407|561585587|FG003|Overall Study|Adverse Event|0|||
155589325|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
155589326|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155589327|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155589328|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155589329|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155589330|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155589331|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
155589332|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
155589333|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155589334|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155589335|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155589336|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155589337|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
155589338|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
155589339|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589340|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589341|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589342|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589343|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155589344|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155589345|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589346|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589347|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589348|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589349|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
155589350|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
155589351|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155589352|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155589353|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155589354|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155589355|NCT02105987|561585591|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155589356|NCT02105987|561585592|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
155589357|NCT02105987|561585593|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155589358|NCT02105987|561585594|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155589359|NCT02105987|561585595|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155589360|NCT02105987|561585596|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155589361|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155589362|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155589363|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
155589364|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
155589365|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155589366|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155589367|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155589368|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155589369|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
155589370|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
155589371|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155589372|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155589373|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589374|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589375|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
155589376|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
155589377|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589378|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155589379|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589380|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589381|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
155589382|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155589383|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589384|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155589385|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155589386|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155589387|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
155589388|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155589389|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155589390|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155589391|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155589392|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155589393|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155589394|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
155589395|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155589396|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155589397|NCT02105987|561585591|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155589398|NCT02105987|561585592|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155589399|NCT02105987|561585593|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
155589400|NCT02105987|561585594|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155589401|NCT02105987|561585595|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155589402|NCT02105987|561585596|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155589403|NCT02105987|561585591|FG000|Continuation Phase|Protocol Violation|0|||
155589404|NCT02105987|561585592|FG001|Continuation Phase|Protocol Violation|0|||
155589405|NCT02105987|561585593|FG002|Continuation Phase|Protocol Violation|0|||
155589406|NCT02105987|561585594|FG003|Continuation Phase|Protocol Violation|0|||
155589407|NCT02105987|561585595|FG004|Continuation Phase|Protocol Violation|1|||
155589408|NCT02105987|561585596|FG005|Continuation Phase|Protocol Violation|0|||
155589409|NCT00984542|561585609|FG000|Overall Study|disease progression|19|||
155589410|NCT00984542|561585609|FG000|Overall Study|toxicity|7|||
155589411|NCT00984542|561585609|FG000|Overall Study|Death|7|||
155589412|NCT00984542|561585609|FG000|Overall Study|complicating disease|3|||
155589413|NCT00984542|561585609|FG000|Overall Study|Withdrawal by Subject|3|||
155589414|NCT00984542|561585609|FG000|Overall Study|clinical deterioration|2|||
155589415|NCT02097745|561585614|FG000|Overall Study|Adverse Event|25|||
155589416|NCT02097745|561585614|FG000|Overall Study|Death|16|||
155589417|NCT02097745|561585614|FG000|Overall Study|Failure to Return|14|||
155589418|NCT02097745|561585614|FG000|Overall Study|Administrative/Other|27|||
155589419|NCT02097745|561585614|FG000|Overall Study|Reason Not Specified|96|||
155589420|NCT02064816|561585615|FG000|Overall Study|Adverse Event|3|||
155589421|NCT02064816|561585616|FG001|Overall Study|Adverse Event|2|||
155589422|NCT02064816|561585615|FG000|Overall Study|Withdrawal by Subject|2|||
155589423|NCT02064816|561585616|FG001|Overall Study|Withdrawal by Subject|1|||
155589424|NCT02064816|561585615|FG000|Overall Study|Lost to Follow-up|2|||
155589425|NCT02064816|561585616|FG001|Overall Study|Lost to Follow-up|1|||
155589426|NCT02064816|561585615|FG000|Overall Study|Therapeutic failure|0|||
155589427|NCT02064816|561585616|FG001|Overall Study|Therapeutic failure|1|||
155589428|NCT02064816|561585615|FG000|Overall Study|Other|1|||
155589429|NCT02064816|561585616|FG001|Overall Study|Other|3|||
155589430|NCT01757184|561585619|FG000|Double-blind Period|Adverse Event|1|||
155589431|NCT01757184|561585620|FG001|Double-blind Period|Adverse Event|0|||
155589432|NCT01757184|561585621|FG002|Double-blind Period|Adverse Event|0|||
155589433|NCT01757184|561585622|FG003|Double-blind Period|Adverse Event|0|||
155589434|NCT01757184|561585619|FG000|Open-label Period|Lost to Follow-up|0|||
155589435|NCT01757184|561585620|FG001|Open-label Period|Lost to Follow-up|0|||
155589436|NCT01757184|561585621|FG002|Open-label Period|Lost to Follow-up|2|||
155589437|NCT01757184|561585622|FG003|Open-label Period|Lost to Follow-up|0|||
155589438|NCT01757184|561585619|FG000|Open-label Period|Withdrawal by Subject|0|||
155589439|NCT01757184|561585620|FG001|Open-label Period|Withdrawal by Subject|0|||
155589440|NCT01757184|561585621|FG002|Open-label Period|Withdrawal by Subject|1|||
155589441|NCT01757184|561585622|FG003|Open-label Period|Withdrawal by Subject|1|||
155589442|NCT01757184|561585619|FG000|Open-label Period|Discontinued by Sponsor|0|||
155589443|NCT01757184|561585620|FG001|Open-label Period|Discontinued by Sponsor|0|||
155589444|NCT01757184|561585621|FG002|Open-label Period|Discontinued by Sponsor|1|||
155589445|NCT01757184|561585622|FG003|Open-label Period|Discontinued by Sponsor|2|||
155589446|NCT04468347|561585625|FG000|Overall Study|Withdrawal by Subject|0|||
155589447|NCT04468347|561585626|FG001|Overall Study|Withdrawal by Subject|1|||
155589448|NCT04468347|561585627|FG002|Overall Study|Withdrawal by Subject|3|||
155589449|NCT04468347|561585628|FG003|Overall Study|Withdrawal by Subject|3|||
155589450|NCT04468347|561585625|FG000|Overall Study|Lost to Follow-up|0|||
155589451|NCT04468347|561585626|FG001|Overall Study|Lost to Follow-up|0|||
155589452|NCT04468347|561585627|FG002|Overall Study|Lost to Follow-up|1|||
155589453|NCT04468347|561585628|FG003|Overall Study|Lost to Follow-up|1|||
155589454|NCT04468347|561585625|FG000|Overall Study|Physician Decision|1|||
155589455|NCT04468347|561585626|FG001|Overall Study|Physician Decision|0|||
155589456|NCT04468347|561585627|FG002|Overall Study|Physician Decision|2|||
155589457|NCT04468347|561585628|FG003|Overall Study|Physician Decision|0|||
155589458|NCT04468347|561585625|FG000|Overall Study|Protocol Violation|1|||
155589459|NCT04468347|561585626|FG001|Overall Study|Protocol Violation|0|||
155589460|NCT04468347|561585627|FG002|Overall Study|Protocol Violation|0|||
155589461|NCT04468347|561585628|FG003|Overall Study|Protocol Violation|0|||
155589462|NCT03515811|561585629|FG000|Overall Study|Lost to Follow-up|2|||
155589463|NCT03515811|561585630|FG001|Overall Study|Lost to Follow-up|1|||
155589464|NCT03515811|561585629|FG000|Overall Study|Protocol Violation|1|||
155589465|NCT03515811|561585630|FG001|Overall Study|Protocol Violation|1|||
155589466|NCT03515811|561585629|FG000|Overall Study|Death|1|||
155589467|NCT03515811|561585630|FG001|Overall Study|Death|1|||
155589468|NCT03515811|561585629|FG000|Overall Study|Withdrawal by Subject|0|||
155589469|NCT03515811|561585630|FG001|Overall Study|Withdrawal by Subject|2|||
155589470|NCT03515811|561585629|FG000|Overall Study|Technical Problems|1|||
155589471|NCT03515811|561585630|FG001|Overall Study|Technical Problems|0|||
155589472|NCT03515811|561585629|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
155589473|NCT03515811|561585630|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
155589474|NCT03515811|561585629|FG000|Overall Study|COVID-19|0|||
155589475|NCT03515811|561585630|FG001|Overall Study|COVID-19|1|||
155589476|NCT00237458|561585631|FG000|Overall Study|Lack of Efficacy|1|||
155589477|NCT00237458|561585631|FG000|Overall Study|Adverse Event|1|||
155589478|NCT00237458|561585631|FG000|Overall Study|Withdrawal by Subject|1|||
155589479|NCT03218826|561585632|FG000|Overall Study|Non-compliance with protocol|1|||
155589480|NCT03218826|561585633|FG001|Overall Study|Non-compliance with protocol|0|||
155589481|NCT03218826|561585634|FG002|Overall Study|Non-compliance with protocol|2|||
155589482|NCT03218826|561585635|FG003|Overall Study|Non-compliance with protocol|1|||
155589483|NCT03218826|561585636|FG004|Overall Study|Non-compliance with protocol|1|||
155589484|NCT05868577|561585637|FG000|Overall Study|Lost to Follow-up|5|||
155589485|NCT05868577|561585638|FG001|Overall Study|Lost to Follow-up|5|||
155589486|NCT03564119|561585639|FG000|Overall Study|Adverse Event|4|||
155589487|NCT03564119|561585640|FG001|Overall Study|Adverse Event|0|||
155589488|NCT03564119|561585639|FG000|Overall Study|Lost to Follow-up|1|||
155589489|NCT03564119|561585640|FG001|Overall Study|Lost to Follow-up|4|||
155589490|NCT03564119|561585639|FG000|Overall Study|Protocol Violation|1|||
155589491|NCT03564119|561585640|FG001|Overall Study|Protocol Violation|0|||
155589492|NCT03564119|561585639|FG000|Overall Study|Withdrawal by Subject|9|||
155589493|NCT03564119|561585640|FG001|Overall Study|Withdrawal by Subject|4|||
155589494|NCT03564119|561585639|FG000|Overall Study|Other Than Specified|0|||
155589495|NCT03564119|561585640|FG001|Overall Study|Other Than Specified|1|||
155589496|NCT02644668|561585643|FG000|Overall Study|Adverse Event|2|||
155589497|NCT02644668|561585644|FG001|Overall Study|Adverse Event|0|||
155589498|NCT02644668|561585645|FG002|Overall Study|Adverse Event|1|||
155589499|NCT02644668|561585643|FG000|Overall Study|Protocol Violation|0|||
155589500|NCT02644668|561585644|FG001|Overall Study|Protocol Violation|0|||
155589501|NCT02644668|561585645|FG002|Overall Study|Protocol Violation|1|||
155589502|NCT02644668|561585643|FG000|Overall Study|Withdrawal by Subject|0|||
155589503|NCT02644668|561585644|FG001|Overall Study|Withdrawal by Subject|0|||
155589504|NCT02644668|561585645|FG002|Overall Study|Withdrawal by Subject|1|||
155589505|NCT00961350|561585646|FG000|Overall Study|Adverse Event|18|||
155589506|NCT00961350|561585647|FG001|Overall Study|Adverse Event|33|||
155589507|NCT00961350|561585646|FG000|Overall Study|Withdrawal by Subject|10|||
155589508|NCT00961350|561585647|FG001|Overall Study|Withdrawal by Subject|10|||
155589509|NCT00961350|561585646|FG000|Overall Study|Lost to Follow-up|3|||
155589510|NCT00961350|561585647|FG001|Overall Study|Lost to Follow-up|3|||
155589511|NCT00961350|561585646|FG000|Overall Study|Misc|16|||
155589512|NCT00961350|561585647|FG001|Overall Study|Misc|21|||
155589513|NCT01500382|561585650|FG000|Washout Period|Study site went out of business|0|||
155589514|NCT01500382|561585651|FG001|Washout Period|Study site went out of business|0|||
155589515|NCT01500382|561585652|FG002|Washout Period|Study site went out of business|1|||
155589516|NCT01500382|561585653|FG003|Washout Period|Study site went out of business|0|||
155589517|NCT01131455|561585654|FG000|Overall Study|Death of PI|6|||
155589518|NCT01131455|561585655|FG001|Overall Study|Death of PI|4|||
155589519|NCT01131455|561585656|FG002|Overall Study|Death of PI|0|||
155589520|NCT01760655|561587130|FG000|Overall Study|Death|18|||
155589521|NCT01760655|561587130|FG000|Overall Study|Physician Decision|1|||
155589522|NCT03056638|561587135|FG000|Overall Study|Death|1|||
155589523|NCT03056638|561587136|FG001|Overall Study|Death|0|||
155589524|NCT02530125|561587137|FG000|Completed Treatment|Early termination of study|1|||
155589525|NCT02530125|561587137|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
155589526|NCT00468481|561587138|FG000|Overall Study|Adverse Event|13|||
155589527|NCT00468481|561587139|FG001|Overall Study|Adverse Event|3|||
155589528|NCT00468481|561587138|FG000|Overall Study|Lost to Follow-up|25|||
155589529|NCT00468481|561587139|FG001|Overall Study|Lost to Follow-up|8|||
155589530|NCT00468481|561587138|FG000|Overall Study|Pregnancy|2|||
155589531|NCT00468481|561587139|FG001|Overall Study|Pregnancy|0|||
155589532|NCT00468481|561587138|FG000|Overall Study|Protocol Violation|18|||
155589533|NCT00468481|561587139|FG001|Overall Study|Protocol Violation|8|||
155589534|NCT00468481|561587138|FG000|Overall Study|Withdrawal by Subject|12|||
155589535|NCT00468481|561587139|FG001|Overall Study|Withdrawal by Subject|3|||
155589536|NCT00468481|561587138|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
155589537|NCT00468481|561587139|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
155589538|NCT00468481|561587138|FG000|Overall Study|Prohibited Medication|1|||
155589539|NCT00468481|561587139|FG001|Overall Study|Prohibited Medication|1|||
155589540|NCT00468481|561587138|FG000|Overall Study|Egg Donor|1|||
155589541|NCT00468481|561587139|FG001|Overall Study|Egg Donor|0|||
155589542|NCT00468481|561587138|FG000|Overall Study|Moved out of area|4|||
155589543|NCT00468481|561587139|FG001|Overall Study|Moved out of area|1|||
155589544|NCT00468481|561587138|FG000|Overall Study|Non-Compliance|5|||
155589545|NCT00468481|561587139|FG001|Overall Study|Non-Compliance|0|||
155589546|NCT00468481|561587138|FG000|Overall Study|Other|6|||
155589547|NCT00468481|561587139|FG001|Overall Study|Other|0|||
155589548|NCT00728468|561587141|FG000|Overall Study|Enrolled but not treated|1|||
155589549|NCT00728468|561587141|FG000|Overall Study|Death|1|||
155589550|NCT00728468|561587141|FG000|Overall Study|Protocol Violation|4|||
155589551|NCT00728468|561587141|FG000|Overall Study|Objective progression or relapse|9|||
155589552|NCT00728468|561587141|FG000|Overall Study|Study terminated by sponsor|1|||
155589553|NCT01568034|561587142|FG000|Overall Study|Withdrawal by Subject|1|||
155589554|NCT01568034|561587143|FG001|Overall Study|Withdrawal by Subject|0|||
155589555|NCT01568034|561587144|FG002|Overall Study|Withdrawal by Subject|0|||
155589556|NCT01568034|561587145|FG003|Overall Study|Withdrawal by Subject|0|||
155589557|NCT03831113|561587146|FG000|Overall Study|Withdrawal by Subject|0|||
155589558|NCT03831113|561587147|FG001|Overall Study|Withdrawal by Subject|2|||
155589559|NCT03831113|561587146|FG000|Overall Study|Protocol Violation|0|||
155589560|NCT03831113|561587147|FG001|Overall Study|Protocol Violation|9|||
155589561|NCT02498444|561587151|FG000|Overall Study|Withdrawal by Subject|3|||
155589562|NCT02498444|561587152|FG001|Overall Study|Withdrawal by Subject|0|||
155589563|NCT02498444|561587151|FG000|Overall Study|Physician Decision|1|||
155589564|NCT02498444|561587152|FG001|Overall Study|Physician Decision|0|||
155589565|NCT03656692|561587153|FG000|Overall Study|Worsening of disease activity|2|||
155589566|NCT03656692|561587153|FG000|Overall Study|Physician Decision|1|||
155589567|NCT02693106|561587154|FG000|Overall Study|No time|3|||
155589568|NCT01164579|561587158|FG000|Overall Study|Lack of Efficacy|0|||
155589569|NCT01164579|561587159|FG001|Overall Study|Lack of Efficacy|0|||
155589570|NCT01164579|561587160|FG002|Overall Study|Lack of Efficacy|6|||
155589571|NCT01164579|561587158|FG000|Overall Study|Lost to Follow-up|1|||
155589572|NCT01164579|561587159|FG001|Overall Study|Lost to Follow-up|1|||
155589573|NCT01164579|561587160|FG002|Overall Study|Lost to Follow-up|0|||
155589574|NCT01164579|561587158|FG000|Overall Study|Withdrawal by Subject|2|||
155589575|NCT01164579|561587159|FG001|Overall Study|Withdrawal by Subject|5|||
155589576|NCT01164579|561587160|FG002|Overall Study|Withdrawal by Subject|3|||
155589577|NCT01164579|561587158|FG000|Overall Study|Protocol Violation|0|||
155589578|NCT01164579|561587159|FG001|Overall Study|Protocol Violation|1|||
155589579|NCT01164579|561587160|FG002|Overall Study|Protocol Violation|2|||
155589580|NCT01164579|561587158|FG000|Overall Study|Adverse Event|4|||
155589581|NCT01164579|561587159|FG001|Overall Study|Adverse Event|2|||
155589582|NCT01164579|561587160|FG002|Overall Study|Adverse Event|5|||
155589583|NCT01164579|561587158|FG000|Overall Study|Reason not specified|1|||
155589584|NCT01164579|561587159|FG001|Overall Study|Reason not specified|0|||
155589585|NCT01164579|561587160|FG002|Overall Study|Reason not specified|0|||
155589586|NCT02476578|561587168|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
155589587|NCT02476578|561587169|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
155589588|NCT02476578|561587168|FG000|Overall Study|Lost to Follow-up|6|||
155589589|NCT02476578|561587169|FG001|Overall Study|Lost to Follow-up|13|||
155589590|NCT00927862|561587170|FG000|Overall Study|Missing data needed for endpt analyses|27|||
155589591|NCT00927862|561587171|FG001|Overall Study|Missing data needed for endpt analyses|45|||
155589592|NCT04157296|561587172|FG000|Overall Study|Withdrawal by Subject|0|||
155589593|NCT04157296|561587173|FG001|Overall Study|Withdrawal by Subject|1|||
155589594|NCT04157296|561587172|FG000|Overall Study|Did not obtain second fMRI.|0|||
155589595|NCT04157296|561587173|FG001|Overall Study|Did not obtain second fMRI.|1|||
155589596|NCT04157296|561587172|FG000|Overall Study|MRI failed/no second fMRI|0|||
155589597|NCT04157296|561587173|FG001|Overall Study|MRI failed/no second fMRI|1|||
155589598|NCT02088905|561587176|FG000|Overall Study|Withdrawal by Subject|5|||
155589599|NCT02088905|561587177|FG001|Overall Study|Withdrawal by Subject|1|||
155589600|NCT01562782|561587178|FG000|Overall Study|Withdrawal by Subject|3|||
155589601|NCT01562782|561587179|FG001|Overall Study|Withdrawal by Subject|3|||
155589602|NCT01562782|561587178|FG000|Overall Study|screen failure|1|||
155589603|NCT01562782|561587179|FG001|Overall Study|screen failure|2|||
155589604|NCT02308540|561587180|FG000|Overall Study|Lost to Follow-up|0|||
155589605|NCT02308540|561587181|FG001|Overall Study|Lost to Follow-up|0|||
155589606|NCT02308540|561587182|FG002|Overall Study|Lost to Follow-up|0|||
155589607|NCT02308540|561587183|FG003|Overall Study|Lost to Follow-up|0|||
155589608|NCT02308540|561587184|FG004|Overall Study|Lost to Follow-up|0|||
155589609|NCT02308540|561587185|FG005|Overall Study|Lost to Follow-up|1|||
155589610|NCT01091662|561587186|FG000|Overall Study|Adverse Event|1|||
155589611|NCT01091662|561587187|FG001|Overall Study|Adverse Event|9|||
155589612|NCT01091662|561587186|FG000|Overall Study|Physician Decision|1|||
155589613|NCT01091662|561587187|FG001|Overall Study|Physician Decision|1|||
155589614|NCT01091662|561587186|FG000|Overall Study|Withdrawal by Subject|7|||
155589615|NCT01091662|561587187|FG001|Overall Study|Withdrawal by Subject|6|||
155589616|NCT01091662|561587186|FG000|Overall Study|met exit criteria|7|||
155589617|NCT01091662|561587187|FG001|Overall Study|met exit criteria|13|||
155589618|NCT01091662|561587186|FG000|Overall Study|met exclusion criteria|1|||
155589619|NCT01091662|561587187|FG001|Overall Study|met exclusion criteria|0|||
155589620|NCT01091662|561587186|FG000|Overall Study|Lost to Follow-up|0|||
155589621|NCT01091662|561587187|FG001|Overall Study|Lost to Follow-up|1|||
155589622|NCT01091662|561587186|FG000|Overall Study|Pregnancy|0|||
155589623|NCT01091662|561587187|FG001|Overall Study|Pregnancy|1|||
155589624|NCT01091662|561587186|FG000|Overall Study|Protocol Violation|0|||
155589625|NCT01091662|561587187|FG001|Overall Study|Protocol Violation|2|||
155589626|NCT01091662|561587186|FG000|Overall Study|unable to swallow capsule|0|||
155589627|NCT01091662|561587187|FG001|Overall Study|unable to swallow capsule|1|||
155589628|NCT04109391|561587188|FG000|Overall Study|Adverse Event|2|||
155589629|NCT04109391|561587189|FG001|Overall Study|Adverse Event|2|||
155589630|NCT04109391|561587190|FG002|Overall Study|Adverse Event|0|||
155589631|NCT04109391|561587188|FG000|Overall Study|Withdrawal by Subject|2|||
155589632|NCT04109391|561587189|FG001|Overall Study|Withdrawal by Subject|0|||
155589633|NCT04109391|561587190|FG002|Overall Study|Withdrawal by Subject|0|||
155589634|NCT04109391|561587188|FG000|Overall Study|Pregnancy|1|||
155589635|NCT04109391|561587189|FG001|Overall Study|Pregnancy|0|||
155589636|NCT04109391|561587190|FG002|Overall Study|Pregnancy|0|||
155589637|NCT04109391|561587188|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
155589638|NCT04109391|561587189|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
155589639|NCT04109391|561587190|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
155589640|NCT04109391|561587188|FG000|Overall Study|Lost to Follow-up|0|||
155589641|NCT04109391|561587189|FG001|Overall Study|Lost to Follow-up|0|||
155589642|NCT04109391|561587190|FG002|Overall Study|Lost to Follow-up|1|||
155589643|NCT04109391|561587188|FG000|Overall Study|Lack of Efficacy|2|||
155589644|NCT04109391|561587189|FG001|Overall Study|Lack of Efficacy|2|||
155589645|NCT04109391|561587190|FG002|Overall Study|Lack of Efficacy|3|||
155589646|NCT00443079|561587193|FG000|Overall Study|Lost to Follow-up|0|||
155589647|NCT00443079|561587194|FG001|Overall Study|Lost to Follow-up|1|||
155589648|NCT02649439|561587195|FG000|Overall Study|Switched to alternative treatment|6|||
155589649|NCT02649439|561587196|FG001|Overall Study|Switched to alternative treatment|4|||
155589650|NCT02649439|561587195|FG000|Overall Study|Patient decision|1|||
155589651|NCT02649439|561587196|FG001|Overall Study|Patient decision|0|||
155589652|NCT02649439|561587195|FG000|Overall Study|Patient going out of country|1|||
155589653|NCT02649439|561587196|FG001|Overall Study|Patient going out of country|0|||
155589654|NCT02649439|561587195|FG000|Overall Study|To start finasteride|1|||
155589655|NCT02649439|561587196|FG001|Overall Study|To start finasteride|0|||
155589656|NCT02649439|561587195|FG000|Overall Study|Physician Decision|1|||
155589657|NCT02649439|561587196|FG001|Overall Study|Physician Decision|0|||
155589658|NCT02649439|561587195|FG000|Overall Study|Disease progression on study|12|||
155589659|NCT02649439|561587196|FG001|Overall Study|Disease progression on study|13|||
155589660|NCT02649439|561587195|FG000|Overall Study|Refused further treatment|1|||
155589661|NCT02649439|561587196|FG001|Overall Study|Refused further treatment|0|||
155589662|NCT02649439|561587195|FG000|Overall Study|Refused further follow up|2|||
155589663|NCT02649439|561587196|FG001|Overall Study|Refused further follow up|7|||
155589664|NCT02649439|561587195|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
155589665|NCT02649439|561587196|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
155589666|NCT02649439|561587195|FG000|Overall Study|No treatment, per protocol|1|||
155589667|NCT02649439|561587196|FG001|Overall Study|No treatment, per protocol|0|||
155589668|NCT02649439|561587195|FG000|Overall Study|PSA DT makes ineligible|0|||
155589669|NCT02649439|561587196|FG001|Overall Study|PSA DT makes ineligible|1|||
155589670|NCT02649439|561587195|FG000|Overall Study|Rising PSA No Mets|0|||
155589671|NCT02649439|561587196|FG001|Overall Study|Rising PSA No Mets|1|||
155589672|NCT02649439|561587195|FG000|Overall Study|Rising PSA|0|||
155589673|NCT02649439|561587196|FG001|Overall Study|Rising PSA|1|||
155589674|NCT02649439|561587195|FG000|Overall Study|Signed follow up protocol|0|||
155589675|NCT02649439|561587196|FG001|Overall Study|Signed follow up protocol|1|||
155589676|NCT01106911|561587199|FG000|Overall Study|Physician Decision|2|||
155589677|NCT01106911|561587199|FG000|Overall Study|deemed ineligible after screening|3|||
155589678|NCT01814696|561587207|FG000|Overall Study|Withdrawal by Subject|1|||
155589679|NCT01814696|561587208|FG001|Overall Study|Withdrawal by Subject|0|||
155589680|NCT01814696|561587207|FG000|Overall Study|Randomized to wrong group|1|||
155589681|NCT01814696|561587208|FG001|Overall Study|Randomized to wrong group|0|||
155589682|NCT00713258|561587210|FG000|Overall Study|Adverse Event|2|||
155589683|NCT00713258|561587211|FG001|Overall Study|Adverse Event|4|||
155589684|NCT00713258|561587210|FG000|Overall Study|Non-Compliance|2|||
155589685|NCT00713258|561587211|FG001|Overall Study|Non-Compliance|1|||
155589686|NCT00713258|561587210|FG000|Overall Study|Other|1|||
155589687|NCT00713258|561587211|FG001|Overall Study|Other|1|||
155589688|NCT02484456|561587214|FG000|Washout Period|Withdrawal by Subject|0|||
155589689|NCT02484456|561587215|FG001|Washout Period|Withdrawal by Subject|1|||
155589690|NCT02484456|561587214|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
155589691|NCT02484456|561587215|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
155589692|NCT02484456|561587214|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
155589693|NCT02484456|561587215|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
155589694|NCT02484456|561587214|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
155589695|NCT02484456|561587215|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
155589696|NCT00708214|561587216|FG000|Overall Study|Other Adverse Event|3|||
155589697|NCT00708214|561587217|FG001|Overall Study|Other Adverse Event|6|||
155589698|NCT00708214|561587218|FG002|Overall Study|Other Adverse Event|2|||
155589699|NCT00708214|561587216|FG000|Overall Study|Other|0|||
155589700|NCT00708214|561587217|FG001|Overall Study|Other|1|||
155589701|NCT00708214|561587218|FG002|Overall Study|Other|1|||
155589702|NCT00708214|561587216|FG000|Overall Study|Progressive Disease|4|||
155589703|NCT00708214|561587217|FG001|Overall Study|Progressive Disease|6|||
155589704|NCT00708214|561587218|FG002|Overall Study|Progressive Disease|5|||
155589705|NCT02199795|561587219|FG000|Overall Study|no longer met inclusion criteria|1|||
155589706|NCT02199795|561587220|FG001|Overall Study|no longer met inclusion criteria|0|||
155589707|NCT02199795|561587219|FG000|Overall Study|withdrew due to shoulder pain|1|||
155589708|NCT02199795|561587220|FG001|Overall Study|withdrew due to shoulder pain|0|||
155589709|NCT02677922|561587229|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
155589710|NCT02677922|561587230|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
155589711|NCT02677922|561587231|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
155589712|NCT02677922|561587232|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
155589713|NCT02677922|561587233|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
155589714|NCT02677922|561587234|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
155589715|NCT02677922|561587229|FG000|Treatment Period|Adverse Event|0|||
155589716|NCT02677922|561587230|FG001|Treatment Period|Adverse Event|0|||
155589717|NCT02677922|561587231|FG002|Treatment Period|Adverse Event|1|||
155589718|NCT02677922|561587232|FG003|Treatment Period|Adverse Event|3|||
155589719|NCT02677922|561587233|FG004|Treatment Period|Adverse Event|5|||
155589720|NCT02677922|561587234|FG005|Treatment Period|Adverse Event|2|||
155589721|NCT02677922|561587229|FG000|Treatment Period|Progressive Disease|1|||
155589722|NCT02677922|561587230|FG001|Treatment Period|Progressive Disease|1|||
155589723|NCT02677922|561587231|FG002|Treatment Period|Progressive Disease|0|||
155589724|NCT02677922|561587232|FG003|Treatment Period|Progressive Disease|0|||
155589725|NCT02677922|561587233|FG004|Treatment Period|Progressive Disease|8|||
155589726|NCT02677922|561587234|FG005|Treatment Period|Progressive Disease|7|||
155589727|NCT02677922|561587229|FG000|Treatment Period|Lack of Efficacy|0|||
155589728|NCT02677922|561587230|FG001|Treatment Period|Lack of Efficacy|0|||
155589729|NCT02677922|561587231|FG002|Treatment Period|Lack of Efficacy|0|||
155589730|NCT02677922|561587232|FG003|Treatment Period|Lack of Efficacy|1|||
155589731|NCT02677922|561587233|FG004|Treatment Period|Lack of Efficacy|1|||
155589732|NCT02677922|561587234|FG005|Treatment Period|Lack of Efficacy|6|||
155589733|NCT02677922|561587229|FG000|Treatment Period|Withdrawal by Subject|0|||
155589734|NCT02677922|561587230|FG001|Treatment Period|Withdrawal by Subject|0|||
155589735|NCT02677922|561587231|FG002|Treatment Period|Withdrawal by Subject|1|||
155589736|NCT02677922|561587232|FG003|Treatment Period|Withdrawal by Subject|3|||
155589737|NCT02677922|561587233|FG004|Treatment Period|Withdrawal by Subject|5|||
155589738|NCT02677922|561587234|FG005|Treatment Period|Withdrawal by Subject|5|||
155589739|NCT02677922|561587229|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
155589740|NCT02677922|561587230|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
155589741|NCT02677922|561587231|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
155589742|NCT02677922|561587232|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
155589743|NCT02677922|561587233|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
155589744|NCT02677922|561587234|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
155589745|NCT02677922|561587229|FG000|Treatment Period|Disease Relapse|0|||
155589746|NCT02677922|561587230|FG001|Treatment Period|Disease Relapse|0|||
155589747|NCT02677922|561587231|FG002|Treatment Period|Disease Relapse|0|||
155589748|NCT02677922|561587232|FG003|Treatment Period|Disease Relapse|3|||
155589749|NCT02677922|561587233|FG004|Treatment Period|Disease Relapse|6|||
155589750|NCT02677922|561587234|FG005|Treatment Period|Disease Relapse|1|||
155589751|NCT02677922|561587229|FG000|Treatment Period|Allogeneic HSCT|1|||
155589752|NCT02677922|561587230|FG001|Treatment Period|Allogeneic HSCT|0|||
155589753|NCT02677922|561587231|FG002|Treatment Period|Allogeneic HSCT|0|||
155589754|NCT02677922|561587232|FG003|Treatment Period|Allogeneic HSCT|1|||
155589755|NCT02677922|561587233|FG004|Treatment Period|Allogeneic HSCT|4|||
155589756|NCT02677922|561587234|FG005|Treatment Period|Allogeneic HSCT|1|||
155589757|NCT02677922|561587229|FG000|Treatment Period|Other Reasons|0|||
155589758|NCT02677922|561587230|FG001|Treatment Period|Other Reasons|0|||
155589759|NCT02677922|561587231|FG002|Treatment Period|Other Reasons|0|||
155589760|NCT02677922|561587232|FG003|Treatment Period|Other Reasons|1|||
155589761|NCT02677922|561587233|FG004|Treatment Period|Other Reasons|3|||
155589762|NCT02677922|561587234|FG005|Treatment Period|Other Reasons|5|||
155589763|NCT02677922|561587229|FG000|Treatment Period|Death|0|||
155589764|NCT02677922|561587230|FG001|Treatment Period|Death|0|||
155589765|NCT02677922|561587231|FG002|Treatment Period|Death|0|||
155589766|NCT02677922|561587232|FG003|Treatment Period|Death|0|||
155589767|NCT02677922|561587233|FG004|Treatment Period|Death|12|||
155589768|NCT02677922|561587234|FG005|Treatment Period|Death|1|||
155589769|NCT02677922|561587229|FG000|Treatment Period|Non-compliance with Study Drug|0|||
155589770|NCT02677922|561587230|FG001|Treatment Period|Non-compliance with Study Drug|0|||
155589771|NCT02677922|561587231|FG002|Treatment Period|Non-compliance with Study Drug|0|||
155589772|NCT02677922|561587232|FG003|Treatment Period|Non-compliance with Study Drug|0|||
155589773|NCT02677922|561587233|FG004|Treatment Period|Non-compliance with Study Drug|1|||
155589774|NCT02677922|561587234|FG005|Treatment Period|Non-compliance with Study Drug|0|||
155589775|NCT02677922|561587229|FG000|Treatment Period|Physician Decision|0|||
155589776|NCT02677922|561587230|FG001|Treatment Period|Physician Decision|0|||
155589777|NCT02677922|561587231|FG002|Treatment Period|Physician Decision|0|||
155589778|NCT02677922|561587232|FG003|Treatment Period|Physician Decision|0|||
155589779|NCT02677922|561587233|FG004|Treatment Period|Physician Decision|0|||
155589780|NCT02677922|561587234|FG005|Treatment Period|Physician Decision|1|||
155589781|NCT02677922|561587229|FG000|Treatment Period|Symptomatic Deterioration|0|||
155589782|NCT02677922|561587230|FG001|Treatment Period|Symptomatic Deterioration|0|||
155589783|NCT02677922|561587231|FG002|Treatment Period|Symptomatic Deterioration|0|||
155589784|NCT02677922|561587232|FG003|Treatment Period|Symptomatic Deterioration|0|||
155589785|NCT02677922|561587233|FG004|Treatment Period|Symptomatic Deterioration|1|||
155589786|NCT02677922|561587234|FG005|Treatment Period|Symptomatic Deterioration|0|||
155589787|NCT05708976|561587237|FG000|Overall Study|Withdrawal by Subject|0|||
155589788|NCT05708976|561587238|FG001|Overall Study|Withdrawal by Subject|1|||
155589789|NCT01303172|561587239|FG000|Overall Study|Physician Decision|9|||
155589790|NCT01303172|561587240|FG001|Overall Study|Physician Decision|6|||
155589791|NCT01303172|561587239|FG000|Overall Study|Adverse Event|5|||
155589792|NCT01303172|561587240|FG001|Overall Study|Adverse Event|2|||
155589793|NCT01303172|561587239|FG000|Overall Study|Withdrawal by Subject|4|||
155589794|NCT01303172|561587240|FG001|Overall Study|Withdrawal by Subject|2|||
155589795|NCT01303172|561587239|FG000|Overall Study|Death|20|||
155589796|NCT01303172|561587240|FG001|Overall Study|Death|7|||
155589797|NCT01303172|561587239|FG000|Overall Study|Lack of Efficacy|25|||
155589798|NCT01303172|561587240|FG001|Overall Study|Lack of Efficacy|17|||
155589799|NCT02099110|561587246|FG000|Overall Study|Protocol Violation|2|||
155589800|NCT02099110|561587247|FG001|Overall Study|Protocol Violation|1|||
155589801|NCT02099110|561587248|FG002|Overall Study|Protocol Violation|0|||
155589802|NCT02099110|561587249|FG003|Overall Study|Protocol Violation|3|||
155589803|NCT02099110|561587250|FG004|Overall Study|Protocol Violation|1|||
155589804|NCT02099110|561587246|FG000|Overall Study|Participant moved|1|||
155589805|NCT02099110|561587247|FG001|Overall Study|Participant moved|1|||
155589806|NCT02099110|561587248|FG002|Overall Study|Participant moved|1|||
155589807|NCT02099110|561587249|FG003|Overall Study|Participant moved|0|||
155589808|NCT02099110|561587250|FG004|Overall Study|Participant moved|2|||
155589809|NCT02099110|561587246|FG000|Overall Study|Withdrawal by Subject|7|||
155589810|NCT02099110|561587247|FG001|Overall Study|Withdrawal by Subject|11|||
155589811|NCT02099110|561587248|FG002|Overall Study|Withdrawal by Subject|13|||
155589812|NCT02099110|561587249|FG003|Overall Study|Withdrawal by Subject|9|||
155589813|NCT02099110|561587250|FG004|Overall Study|Withdrawal by Subject|13|||
155589814|NCT02099110|561587246|FG000|Overall Study|Adverse Event|3|||
155589815|NCT02099110|561587247|FG001|Overall Study|Adverse Event|5|||
155589816|NCT02099110|561587248|FG002|Overall Study|Adverse Event|2|||
155589817|NCT02099110|561587249|FG003|Overall Study|Adverse Event|3|||
155589818|NCT02099110|561587250|FG004|Overall Study|Adverse Event|2|||
155589819|NCT02099110|561587246|FG000|Overall Study|Lost to Follow-up|6|||
155589820|NCT02099110|561587247|FG001|Overall Study|Lost to Follow-up|12|||
155589821|NCT02099110|561587248|FG002|Overall Study|Lost to Follow-up|11|||
155589822|NCT02099110|561587249|FG003|Overall Study|Lost to Follow-up|5|||
155589823|NCT02099110|561587250|FG004|Overall Study|Lost to Follow-up|6|||
155589824|NCT02099110|561587246|FG000|Overall Study|Death|0|||
155589825|NCT02099110|561587247|FG001|Overall Study|Death|1|||
155589826|NCT02099110|561587248|FG002|Overall Study|Death|0|||
155589827|NCT02099110|561587249|FG003|Overall Study|Death|0|||
155589828|NCT02099110|561587250|FG004|Overall Study|Death|0|||
155589829|NCT02099110|561587246|FG000|Overall Study|Screen failure|0|||
155589830|NCT02099110|561587247|FG001|Overall Study|Screen failure|0|||
155589831|NCT02099110|561587248|FG002|Overall Study|Screen failure|0|||
155589832|NCT02099110|561587249|FG003|Overall Study|Screen failure|0|||
155589833|NCT02099110|561587250|FG004|Overall Study|Screen failure|1|||
155589834|NCT02099110|561587246|FG000|Overall Study|Non-compliance with study drug|2|||
155589835|NCT02099110|561587247|FG001|Overall Study|Non-compliance with study drug|0|||
155589836|NCT02099110|561587248|FG002|Overall Study|Non-compliance with study drug|0|||
155589837|NCT02099110|561587249|FG003|Overall Study|Non-compliance with study drug|0|||
155589838|NCT02099110|561587250|FG004|Overall Study|Non-compliance with study drug|1|||
155589839|NCT02099110|561587246|FG000|Overall Study|Physician Decision|3|||
155589840|NCT02099110|561587247|FG001|Overall Study|Physician Decision|0|||
155589841|NCT02099110|561587248|FG002|Overall Study|Physician Decision|1|||
155589842|NCT02099110|561587249|FG003|Overall Study|Physician Decision|2|||
155589843|NCT02099110|561587250|FG004|Overall Study|Physician Decision|1|||
155589844|NCT03627546|561587255|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
155589845|NCT03627546|561587256|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
155589846|NCT03627546|561587257|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
155589847|NCT03627546|561587255|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
155589848|NCT03627546|561587256|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
155589849|NCT03627546|561587257|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
155589850|NCT01537042|561587260|FG000|Overall Study|Adverse Event|0|||
155589851|NCT01537042|561587261|FG001|Overall Study|Adverse Event|2|||
155589852|NCT01537042|561587260|FG000|Overall Study|Lack of Efficacy|0|||
155589853|NCT01537042|561587261|FG001|Overall Study|Lack of Efficacy|1|||
155589854|NCT01537042|561587260|FG000|Overall Study|Protocol Violation|0|||
155589855|NCT01537042|561587261|FG001|Overall Study|Protocol Violation|1|||
155589856|NCT01537042|561587260|FG000|Overall Study|Other|0|||
155589857|NCT01537042|561587261|FG001|Overall Study|Other|1|||
155589858|NCT02741076|561587262|FG000|Overall Study|Adverse Event|0|||
155589859|NCT02741076|561587263|FG001|Overall Study|Adverse Event|1|||
155589860|NCT02741076|561587264|FG002|Overall Study|Adverse Event|1|||
155589861|NCT02741076|561587265|FG003|Overall Study|Adverse Event|0|||
155589862|NCT02741076|561587262|FG000|Overall Study|Lack of Efficacy|1|||
155589863|NCT02741076|561587263|FG001|Overall Study|Lack of Efficacy|0|||
155589864|NCT02741076|561587264|FG002|Overall Study|Lack of Efficacy|0|||
155589865|NCT02741076|561587265|FG003|Overall Study|Lack of Efficacy|0|||
155589866|NCT02741076|561587262|FG000|Overall Study|Withdrawal by Subject|0|||
155589867|NCT02741076|561587263|FG001|Overall Study|Withdrawal by Subject|1|||
155589868|NCT02741076|561587264|FG002|Overall Study|Withdrawal by Subject|0|||
155589869|NCT02741076|561587265|FG003|Overall Study|Withdrawal by Subject|0|||
155589870|NCT02741076|561587262|FG000|Overall Study|Sponsor Request|2|||
155589871|NCT02741076|561587263|FG001|Overall Study|Sponsor Request|3|||
155589872|NCT02741076|561587264|FG002|Overall Study|Sponsor Request|0|||
155589873|NCT02741076|561587265|FG003|Overall Study|Sponsor Request|1|||
155589874|NCT02741076|561587262|FG000|Overall Study|No additional information available|0|||
155589875|NCT02741076|561587263|FG001|Overall Study|No additional information available|0|||
155589876|NCT02741076|561587264|FG002|Overall Study|No additional information available|1|||
155589877|NCT02741076|561587265|FG003|Overall Study|No additional information available|1|||
155589878|NCT01779440|561587266|FG000|Overall Study|Withdrawal by Subject|3|||
155589879|NCT01779440|561587267|FG001|Overall Study|Withdrawal by Subject|5|||
155589880|NCT02965573|561587269|FG000|Overall Study|Lack of Efficacy|1|||
155589881|NCT02965573|561587270|FG001|Overall Study|Lack of Efficacy|0|||
155589882|NCT00086619|561587271|FG000|Overall Study|Withdrawal by Subject|6|||
155589883|NCT00086619|561587272|FG001|Overall Study|Withdrawal by Subject|6|||
155589884|NCT00086619|561587271|FG000|Overall Study|Adverse Event|8|||
155589885|NCT00086619|561587272|FG001|Overall Study|Adverse Event|10|||
155589886|NCT00086619|561587271|FG000|Overall Study|Protocol Violation|1|||
155589887|NCT00086619|561587272|FG001|Overall Study|Protocol Violation|1|||
155589888|NCT01209520|561587273|FG000|Overall Study|Withdrawal by Subject|3|||
155589889|NCT03291431|561587275|FG000|Overall Study|Protocol Violation|2|||
155589890|NCT03291431|561587276|FG001|Overall Study|Protocol Violation|1|||
155589891|NCT03291431|561587275|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
155589892|NCT03291431|561587276|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
155589893|NCT03291431|561587275|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
155589894|NCT03291431|561587276|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
155589895|NCT02448537|561588639|FG000|Overall Study|Withdrawal by Subject|1|||
155589896|NCT02448537|561588640|FG001|Overall Study|Withdrawal by Subject|1|||
155589897|NCT02448537|561588641|FG002|Overall Study|Withdrawal by Subject|1|||
155589898|NCT04725812|561588642|FG000|Overall Study|Withdrawal by Subject|1|||
155589899|NCT00839800|561588644|FG000|Overall Study|Adverse Event|8|||
155589900|NCT00839800|561588645|FG001|Overall Study|Adverse Event|12|||
155589901|NCT00839800|561588644|FG000|Overall Study|Lost to Follow-up|31|||
155589902|NCT00839800|561588645|FG001|Overall Study|Lost to Follow-up|26|||
155589903|NCT00839800|561588644|FG000|Overall Study|Withdrawal by Subject|28|||
155589904|NCT00839800|561588645|FG001|Overall Study|Withdrawal by Subject|34|||
155589905|NCT00839800|561588644|FG000|Overall Study|Incorrect Enrolment|3|||
155589906|NCT00839800|561588645|FG001|Overall Study|Incorrect Enrolment|3|||
155589907|NCT00839800|561588644|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
155589908|NCT00839800|561588645|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
155589909|NCT00839800|561588644|FG000|Overall Study|Safety Reasons|2|||
155589910|NCT00839800|561588645|FG001|Overall Study|Safety Reasons|1|||
155589911|NCT00839800|561588644|FG000|Overall Study|Other|8|||
155589912|NCT00839800|561588645|FG001|Overall Study|Other|14|||
155589913|NCT00839800|561588644|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
155589914|NCT00839800|561588645|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
155589915|NCT02801617|561588646|FG000|Overall Study|Protocol Violation|2|||
155589916|NCT02801617|561588647|FG001|Overall Study|Protocol Violation|6|||
155589917|NCT00912743|561588654|FG000|Overall Study|Adverse Event|3|||
155589918|NCT00912743|561588655|FG001|Overall Study|Adverse Event|1|||
155589919|NCT00912743|561588654|FG000|Overall Study|Lack of Efficacy|9|||
155589920|NCT00912743|561588655|FG001|Overall Study|Lack of Efficacy|18|||
155589921|NCT00912743|561588654|FG000|Overall Study|Toxicity|0|||
155589922|NCT00912743|561588655|FG001|Overall Study|Toxicity|1|||
155589923|NCT00912743|561588654|FG000|Overall Study|End of treatment form was not collected|1|||
155589924|NCT00912743|561588655|FG001|Overall Study|End of treatment form was not collected|0|||
155589925|NCT01136356|561588656|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
155589926|NCT01136356|561588657|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
155589927|NCT01136356|561588656|FG000|First 18-day Withdrawal|Physician Decision|1|||
155589928|NCT01136356|561588657|FG001|First 18-day Withdrawal|Physician Decision|0|||
155589929|NCT01136356|561588656|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
155589930|NCT01136356|561588657|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
155589931|NCT00178685|561588658|FG000|Overall Study|Death|3|||
155589932|NCT00178685|561588659|FG001|Overall Study|Death|3|||
155589933|NCT00178685|561588660|FG002|Overall Study|Death|6|||
155589934|NCT00178685|561588658|FG000|Overall Study|Lost to Follow-up|100|||
155589935|NCT00178685|561588659|FG001|Overall Study|Lost to Follow-up|187|||
155589936|NCT00178685|561588660|FG002|Overall Study|Lost to Follow-up|183|||
155589937|NCT00178685|561588658|FG000|Overall Study|Withdrawal by Subject|8|||
155589938|NCT00178685|561588659|FG001|Overall Study|Withdrawal by Subject|14|||
155589939|NCT00178685|561588660|FG002|Overall Study|Withdrawal by Subject|7|||
155589940|NCT00820248|561588661|FG000|Overall Study|No treated|4|||
155589941|NCT00820248|561588662|FG001|Overall Study|No treated|1|||
155589942|NCT02237196|561588663|FG000|Overall Study|Adverse Event|0|||
155589943|NCT02237196|561588664|FG001|Overall Study|Adverse Event|1|||
155589944|NCT02237196|561588665|FG002|Overall Study|Adverse Event|1|||
155589945|NCT02237196|561588666|FG003|Overall Study|Adverse Event|0|||
155589946|NCT02237196|561588663|FG000|Overall Study|Lost to Follow-up|4|||
155589947|NCT02237196|561588664|FG001|Overall Study|Lost to Follow-up|2|||
155589948|NCT02237196|561588665|FG002|Overall Study|Lost to Follow-up|4|||
155589949|NCT02237196|561588666|FG003|Overall Study|Lost to Follow-up|6|||
155589950|NCT02237196|561588663|FG000|Overall Study|Physician Decision|2|||
155589951|NCT02237196|561588664|FG001|Overall Study|Physician Decision|0|||
155589952|NCT02237196|561588665|FG002|Overall Study|Physician Decision|0|||
155589953|NCT02237196|561588666|FG003|Overall Study|Physician Decision|1|||
155589954|NCT02237196|561588663|FG000|Overall Study|Pregnancy|0|||
155589955|NCT02237196|561588664|FG001|Overall Study|Pregnancy|0|||
155589956|NCT02237196|561588665|FG002|Overall Study|Pregnancy|1|||
155589957|NCT02237196|561588666|FG003|Overall Study|Pregnancy|1|||
155589958|NCT02237196|561588663|FG000|Overall Study|Withdrawal by Subject|1|||
155589959|NCT02237196|561588664|FG001|Overall Study|Withdrawal by Subject|1|||
155589960|NCT02237196|561588665|FG002|Overall Study|Withdrawal by Subject|4|||
155589961|NCT02237196|561588666|FG003|Overall Study|Withdrawal by Subject|1|||
155589962|NCT02237196|561588663|FG000|Overall Study|Site Error|1|||
155589963|NCT02237196|561588664|FG001|Overall Study|Site Error|2|||
155589964|NCT02237196|561588665|FG002|Overall Study|Site Error|0|||
155589965|NCT02237196|561588666|FG003|Overall Study|Site Error|2|||
155589966|NCT01057810|561588667|FG000|Overall Study|Disease progression|156|||
155589967|NCT01057810|561588668|FG001|Overall Study|Disease progression|197|||
155589968|NCT01057810|561588667|FG000|Overall Study|Study drug toxicity|5|||
155589969|NCT01057810|561588668|FG001|Overall Study|Study drug toxicity|114|||
155589970|NCT01057810|561588667|FG000|Overall Study|Adverse event unrelated to study drug|13|||
155589971|NCT01057810|561588668|FG001|Overall Study|Adverse event unrelated to study drug|29|||
155589972|NCT01057810|561588667|FG000|Overall Study|Withdrawal by Subject|10|||
155589973|NCT01057810|561588668|FG001|Overall Study|Withdrawal by Subject|25|||
155589974|NCT01057810|561588667|FG000|Overall Study|Death|2|||
155589975|NCT01057810|561588668|FG001|Overall Study|Death|12|||
155589976|NCT01057810|561588667|FG000|Overall Study|Maximum clinical benefit|5|||
155589977|NCT01057810|561588668|FG001|Overall Study|Maximum clinical benefit|5|||
155589978|NCT01057810|561588667|FG000|Overall Study|Poor/non-compliance|0|||
155589979|NCT01057810|561588668|FG001|Overall Study|Poor/non-compliance|1|||
155589980|NCT01057810|561588667|FG000|Overall Study|No longer met study criteria|0|||
155589981|NCT01057810|561588668|FG001|Overall Study|No longer met study criteria|1|||
155589982|NCT01057810|561588667|FG000|Overall Study|Other|7|||
155589983|NCT01057810|561588668|FG001|Overall Study|Other|14|||
155589984|NCT00267969|561588669|FG000|Controlled Period|Adverse Event|6|||
155589985|NCT00267969|561588670|FG001|Controlled Period|Adverse Event|0|||
155589986|NCT00267969|561588671|FG002|Controlled Period|Adverse Event|2|||
155589987|NCT00267969|561588672|FG003|Controlled Period|Adverse Event|0|||
155589988|NCT00267969|561588673|FG004|Controlled Period|Adverse Event|0|||
155589989|NCT00267969|561588674|FG005|Controlled Period|Adverse Event|0|||
155589990|NCT00267969|561588675|FG006|Controlled Period|Adverse Event|0|||
155589991|NCT00267969|561588669|FG000|Controlled Period|Lack of Efficacy|3|||
155589992|NCT00267969|561588670|FG001|Controlled Period|Lack of Efficacy|0|||
155589993|NCT00267969|561588671|FG002|Controlled Period|Lack of Efficacy|1|||
155589994|NCT00267969|561588672|FG003|Controlled Period|Lack of Efficacy|0|||
155589995|NCT00267969|561588673|FG004|Controlled Period|Lack of Efficacy|0|||
155589996|NCT00267969|561588674|FG005|Controlled Period|Lack of Efficacy|0|||
155589997|NCT00267969|561588675|FG006|Controlled Period|Lack of Efficacy|0|||
155589998|NCT00267969|561588669|FG000|Controlled Period|Lost to Follow-up|1|||
155589999|NCT00267969|561588670|FG001|Controlled Period|Lost to Follow-up|0|||
155590000|NCT00267969|561588671|FG002|Controlled Period|Lost to Follow-up|1|||
155590001|NCT00267969|561588672|FG003|Controlled Period|Lost to Follow-up|0|||
155590002|NCT00267969|561588673|FG004|Controlled Period|Lost to Follow-up|0|||
155590003|NCT00267969|561588674|FG005|Controlled Period|Lost to Follow-up|0|||
155590004|NCT00267969|561588675|FG006|Controlled Period|Lost to Follow-up|0|||
155590005|NCT00267969|561588669|FG000|Controlled Period|Randomized but not treated|0|||
155590006|NCT00267969|561588670|FG001|Controlled Period|Randomized but not treated|0|||
155590007|NCT00267969|561588671|FG002|Controlled Period|Randomized but not treated|1|||
155590008|NCT00267969|561588672|FG003|Controlled Period|Randomized but not treated|0|||
155590009|NCT00267969|561588673|FG004|Controlled Period|Randomized but not treated|0|||
155590010|NCT00267969|561588674|FG005|Controlled Period|Randomized but not treated|0|||
155590011|NCT00267969|561588675|FG006|Controlled Period|Randomized but not treated|0|||
155590012|NCT00267969|561588669|FG000|Controlled Period|Other|2|||
155590013|NCT00267969|561588670|FG001|Controlled Period|Other|1|||
155590014|NCT00267969|561588671|FG002|Controlled Period|Other|6|||
155590015|NCT00267969|561588672|FG003|Controlled Period|Other|0|||
155590016|NCT00267969|561588673|FG004|Controlled Period|Other|0|||
155590017|NCT00267969|561588674|FG005|Controlled Period|Other|0|||
155590018|NCT00267969|561588675|FG006|Controlled Period|Other|0|||
155590019|NCT00267969|561588669|FG000|After Controlled Period|Adverse Event|0|||
155590020|NCT00267969|561588670|FG001|After Controlled Period|Adverse Event|0|||
155590021|NCT00267969|561588671|FG002|After Controlled Period|Adverse Event|0|||
155590022|NCT00267969|561588672|FG003|After Controlled Period|Adverse Event|7|||
155590023|NCT00267969|561588673|FG004|After Controlled Period|Adverse Event|8|||
155590024|NCT00267969|561588674|FG005|After Controlled Period|Adverse Event|23|||
155590025|NCT00267969|561588675|FG006|After Controlled Period|Adverse Event|21|||
155590026|NCT00267969|561588669|FG000|After Controlled Period|Death|0|||
155590027|NCT00267969|561588670|FG001|After Controlled Period|Death|0|||
155590028|NCT00267969|561588671|FG002|After Controlled Period|Death|0|||
155590029|NCT00267969|561588672|FG003|After Controlled Period|Death|1|||
155590030|NCT00267969|561588673|FG004|After Controlled Period|Death|2|||
155590031|NCT00267969|561588674|FG005|After Controlled Period|Death|0|||
155590032|NCT00267969|561588675|FG006|After Controlled Period|Death|1|||
155590033|NCT00267969|561588669|FG000|After Controlled Period|Lack of Efficacy|0|||
155590034|NCT00267969|561588670|FG001|After Controlled Period|Lack of Efficacy|0|||
155590035|NCT00267969|561588671|FG002|After Controlled Period|Lack of Efficacy|0|||
155590036|NCT00267969|561588672|FG003|After Controlled Period|Lack of Efficacy|10|||
155590037|NCT00267969|561588673|FG004|After Controlled Period|Lack of Efficacy|6|||
155590038|NCT00267969|561588674|FG005|After Controlled Period|Lack of Efficacy|28|||
155590039|NCT00267969|561588675|FG006|After Controlled Period|Lack of Efficacy|15|||
155590040|NCT00267969|561588669|FG000|After Controlled Period|Lost to Follow-up|0|||
155590041|NCT00267969|561588670|FG001|After Controlled Period|Lost to Follow-up|0|||
155590042|NCT00267969|561588671|FG002|After Controlled Period|Lost to Follow-up|0|||
155590043|NCT00267969|561588672|FG003|After Controlled Period|Lost to Follow-up|5|||
155590044|NCT00267969|561588673|FG004|After Controlled Period|Lost to Follow-up|8|||
155590045|NCT00267969|561588674|FG005|After Controlled Period|Lost to Follow-up|9|||
155590046|NCT00267969|561588675|FG006|After Controlled Period|Lost to Follow-up|10|||
155590047|NCT00267969|561588669|FG000|After Controlled Period|Other|0|||
155590048|NCT00267969|561588670|FG001|After Controlled Period|Other|0|||
155590049|NCT00267969|561588671|FG002|After Controlled Period|Other|0|||
155590050|NCT00267969|561588672|FG003|After Controlled Period|Other|13|||
155590051|NCT00267969|561588673|FG004|After Controlled Period|Other|11|||
155590052|NCT00267969|561588674|FG005|After Controlled Period|Other|22|||
155590053|NCT00267969|561588675|FG006|After Controlled Period|Other|25|||
155590054|NCT00862823|561588676|FG000|First Intervention|Withdrawal by Subject|1|||
155590055|NCT00862823|561588677|FG001|First Intervention|Withdrawal by Subject|1|||
155590056|NCT00887315|561588678|FG000|Overall Study|Study termination|7|||
155590057|NCT00887315|561588679|FG001|Overall Study|Study termination|4|||
155590058|NCT00619892|561588684|FG000|Overall Study|Adverse Event|3|||
155590059|NCT00619892|561588685|FG001|Overall Study|Adverse Event|0|||
155590060|NCT00619892|561588684|FG000|Overall Study|Lost to Follow-up|0|||
155590061|NCT00619892|561588685|FG001|Overall Study|Lost to Follow-up|1|||
155590062|NCT00619892|561588684|FG000|Overall Study|Intercurrent illness|0|||
155590063|NCT00619892|561588685|FG001|Overall Study|Intercurrent illness|1|||
155590064|NCT02049814|561588693|FG000|Overall Study|Reason not Specified|4|||
155590065|NCT02049814|561588694|FG001|Overall Study|Reason not Specified|3|||
155590066|NCT02049814|561588693|FG000|Overall Study|Pregnancy|1|||
155590067|NCT02049814|561588694|FG001|Overall Study|Pregnancy|0|||
155590068|NCT02049814|561588693|FG000|Overall Study|Lost to Follow-up|2|||
155590069|NCT02049814|561588694|FG001|Overall Study|Lost to Follow-up|3|||
155590070|NCT02049814|561588693|FG000|Overall Study|Serious Protocol Violation|5|||
155590071|NCT02049814|561588694|FG001|Overall Study|Serious Protocol Violation|7|||
155590072|NCT02049814|561588693|FG000|Overall Study|Study Termination|0|||
155590073|NCT02049814|561588694|FG001|Overall Study|Study Termination|1|||
155590074|NCT02049814|561588693|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
155590075|NCT02049814|561588694|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
155590076|NCT02049814|561588693|FG000|Overall Study|Voluntary withdrawal|9|||
155590077|NCT02049814|561588694|FG001|Overall Study|Voluntary withdrawal|8|||
155590078|NCT03852264|561588697|FG000|Third Research Visit|Lost to Follow-up|1|||
155590079|NCT03852264|561588698|FG001|Third Research Visit|Lost to Follow-up|0|||
155590080|NCT02477826|561588719|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
155590081|NCT02477826|561588720|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
155590082|NCT02477826|561588721|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
155590083|NCT02477826|561588722|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
155590084|NCT02477826|561588723|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
155590085|NCT02477826|561588724|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
155590086|NCT02477826|561588725|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
155590087|NCT02477826|561588726|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
155590088|NCT02477826|561588727|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
155590089|NCT02477826|561588728|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
155590090|NCT02477826|561588719|FG000|Pre-Treatment|Other reasons|4|||
155590091|NCT02477826|561588720|FG001|Pre-Treatment|Other reasons|1|||
155590092|NCT02477826|561588721|FG002|Pre-Treatment|Other reasons|4|||
155590093|NCT02477826|561588722|FG003|Pre-Treatment|Other reasons|1|||
155590094|NCT02477826|561588723|FG004|Pre-Treatment|Other reasons|4|||
155590095|NCT02477826|561588724|FG005|Pre-Treatment|Other reasons|2|||
155590096|NCT02477826|561588725|FG006|Pre-Treatment|Other reasons|0|||
155590097|NCT02477826|561588726|FG007|Pre-Treatment|Other reasons|0|||
155590098|NCT02477826|561588727|FG008|Pre-Treatment|Other reasons|0|||
155590099|NCT02477826|561588728|FG009|Pre-Treatment|Other reasons|0|||
155590100|NCT02477826|561588719|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
155590101|NCT02477826|561588720|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
155590102|NCT02477826|561588721|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
155590103|NCT02477826|561588722|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
155590104|NCT02477826|561588723|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
155590105|NCT02477826|561588724|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
155590106|NCT02477826|561588725|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
155590107|NCT02477826|561588726|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
155590108|NCT02477826|561588727|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
155590109|NCT02477826|561588728|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
155590110|NCT02477826|561588719|FG000|Pre-Treatment|Subject withdrew consent|0|||
155590111|NCT02477826|561588720|FG001|Pre-Treatment|Subject withdrew consent|0|||
155590112|NCT02477826|561588721|FG002|Pre-Treatment|Subject withdrew consent|3|||
155590113|NCT02477826|561588722|FG003|Pre-Treatment|Subject withdrew consent|0|||
155590114|NCT02477826|561588723|FG004|Pre-Treatment|Subject withdrew consent|0|||
155590115|NCT02477826|561588724|FG005|Pre-Treatment|Subject withdrew consent|1|||
155590116|NCT02477826|561588725|FG006|Pre-Treatment|Subject withdrew consent|0|||
155590117|NCT02477826|561588726|FG007|Pre-Treatment|Subject withdrew consent|1|||
155590118|NCT02477826|561588727|FG008|Pre-Treatment|Subject withdrew consent|0|||
155590119|NCT02477826|561588728|FG009|Pre-Treatment|Subject withdrew consent|3|||
155590120|NCT02477826|561588719|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590121|NCT02477826|561588720|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
155590122|NCT02477826|561588721|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590123|NCT02477826|561588722|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590124|NCT02477826|561588723|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590125|NCT02477826|561588724|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590126|NCT02477826|561588725|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590127|NCT02477826|561588726|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590128|NCT02477826|561588727|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
155590129|NCT02477826|561588728|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
155590130|NCT02477826|561588719|FG000|Pre-Treatment|Death|0|||
155590131|NCT02477826|561588720|FG001|Pre-Treatment|Death|0|||
155590132|NCT02477826|561588721|FG002|Pre-Treatment|Death|0|||
155590133|NCT02477826|561588722|FG003|Pre-Treatment|Death|0|||
155590134|NCT02477826|561588723|FG004|Pre-Treatment|Death|0|||
155590135|NCT02477826|561588724|FG005|Pre-Treatment|Death|0|||
155590136|NCT02477826|561588725|FG006|Pre-Treatment|Death|1|||
155590137|NCT02477826|561588726|FG007|Pre-Treatment|Death|0|||
155590138|NCT02477826|561588727|FG008|Pre-Treatment|Death|0|||
155590139|NCT02477826|561588728|FG009|Pre-Treatment|Death|0|||
155590140|NCT02477826|561588719|FG000|Treatment Period|Not reported|8|||
155590141|NCT02477826|561588720|FG001|Treatment Period|Not reported|6|||
155590142|NCT02477826|561588721|FG002|Treatment Period|Not reported|4|||
155590143|NCT02477826|561588722|FG003|Treatment Period|Not reported|4|||
155590144|NCT02477826|561588723|FG004|Treatment Period|Not reported|2|||
155590145|NCT02477826|561588724|FG005|Treatment Period|Not reported|1|||
155590146|NCT02477826|561588725|FG006|Treatment Period|Not reported|14|||
155590147|NCT02477826|561588726|FG007|Treatment Period|Not reported|8|||
155590148|NCT02477826|561588727|FG008|Treatment Period|Not reported|5|||
155590149|NCT02477826|561588728|FG009|Treatment Period|Not reported|2|||
155590150|NCT02477826|561588719|FG000|Treatment Period|Other reasons|5|||
155590151|NCT02477826|561588720|FG001|Treatment Period|Other reasons|6|||
155590152|NCT02477826|561588721|FG002|Treatment Period|Other reasons|12|||
155590153|NCT02477826|561588722|FG003|Treatment Period|Other reasons|7|||
155590154|NCT02477826|561588723|FG004|Treatment Period|Other reasons|5|||
155590155|NCT02477826|561588724|FG005|Treatment Period|Other reasons|1|||
155590156|NCT02477826|561588725|FG006|Treatment Period|Other reasons|8|||
155590157|NCT02477826|561588726|FG007|Treatment Period|Other reasons|8|||
155590158|NCT02477826|561588727|FG008|Treatment Period|Other reasons|21|||
155590159|NCT02477826|561588728|FG009|Treatment Period|Other reasons|1|||
155590160|NCT02477826|561588719|FG000|Treatment Period|Administrative reason by sponsor|0|||
155590161|NCT02477826|561588720|FG001|Treatment Period|Administrative reason by sponsor|3|||
155590162|NCT02477826|561588721|FG002|Treatment Period|Administrative reason by sponsor|0|||
155590163|NCT02477826|561588722|FG003|Treatment Period|Administrative reason by sponsor|0|||
155590164|NCT02477826|561588723|FG004|Treatment Period|Administrative reason by sponsor|0|||
155590165|NCT02477826|561588724|FG005|Treatment Period|Administrative reason by sponsor|0|||
155590166|NCT02477826|561588725|FG006|Treatment Period|Administrative reason by sponsor|0|||
155590167|NCT02477826|561588726|FG007|Treatment Period|Administrative reason by sponsor|0|||
155590168|NCT02477826|561588727|FG008|Treatment Period|Administrative reason by sponsor|0|||
155590169|NCT02477826|561588728|FG009|Treatment Period|Administrative reason by sponsor|0|||
155590170|NCT02477826|561588719|FG000|Treatment Period|Participant meet no longer study criteria|1|||
155590171|NCT02477826|561588720|FG001|Treatment Period|Participant meet no longer study criteria|1|||
155590172|NCT02477826|561588721|FG002|Treatment Period|Participant meet no longer study criteria|0|||
155590173|NCT02477826|561588722|FG003|Treatment Period|Participant meet no longer study criteria|0|||
155590174|NCT02477826|561588723|FG004|Treatment Period|Participant meet no longer study criteria|1|||
155590175|NCT02477826|561588724|FG005|Treatment Period|Participant meet no longer study criteria|1|||
155590176|NCT02477826|561588725|FG006|Treatment Period|Participant meet no longer study criteria|0|||
155590177|NCT02477826|561588726|FG007|Treatment Period|Participant meet no longer study criteria|1|||
155590178|NCT02477826|561588727|FG008|Treatment Period|Participant meet no longer study criteria|0|||
155590179|NCT02477826|561588728|FG009|Treatment Period|Participant meet no longer study criteria|0|||
155590180|NCT02477826|561588719|FG000|Treatment Period|Poor/Non Compliance|1|||
155590181|NCT02477826|561588720|FG001|Treatment Period|Poor/Non Compliance|0|||
155590182|NCT02477826|561588721|FG002|Treatment Period|Poor/Non Compliance|2|||
155590183|NCT02477826|561588722|FG003|Treatment Period|Poor/Non Compliance|0|||
155590184|NCT02477826|561588723|FG004|Treatment Period|Poor/Non Compliance|0|||
155590185|NCT02477826|561588724|FG005|Treatment Period|Poor/Non Compliance|1|||
155590186|NCT02477826|561588725|FG006|Treatment Period|Poor/Non Compliance|1|||
155590187|NCT02477826|561588726|FG007|Treatment Period|Poor/Non Compliance|0|||
155590188|NCT02477826|561588727|FG008|Treatment Period|Poor/Non Compliance|0|||
155590189|NCT02477826|561588728|FG009|Treatment Period|Poor/Non Compliance|1|||
155590190|NCT02477826|561588719|FG000|Treatment Period|Maximum Clinical Benefit|3|||
155590191|NCT02477826|561588720|FG001|Treatment Period|Maximum Clinical Benefit|3|||
155590192|NCT02477826|561588721|FG002|Treatment Period|Maximum Clinical Benefit|1|||
155590193|NCT02477826|561588722|FG003|Treatment Period|Maximum Clinical Benefit|1|||
155590194|NCT02477826|561588723|FG004|Treatment Period|Maximum Clinical Benefit|3|||
155590195|NCT02477826|561588724|FG005|Treatment Period|Maximum Clinical Benefit|0|||
155590196|NCT02477826|561588725|FG006|Treatment Period|Maximum Clinical Benefit|3|||
155590197|NCT02477826|561588726|FG007|Treatment Period|Maximum Clinical Benefit|2|||
155590198|NCT02477826|561588727|FG008|Treatment Period|Maximum Clinical Benefit|2|||
155590199|NCT02477826|561588728|FG009|Treatment Period|Maximum Clinical Benefit|2|||
155590200|NCT02477826|561588719|FG000|Treatment Period|Lost to Follow-up|0|||
155590201|NCT02477826|561588720|FG001|Treatment Period|Lost to Follow-up|0|||
155590202|NCT02477826|561588721|FG002|Treatment Period|Lost to Follow-up|1|||
155590203|NCT02477826|561588722|FG003|Treatment Period|Lost to Follow-up|1|||
155590204|NCT02477826|561588723|FG004|Treatment Period|Lost to Follow-up|0|||
155590205|NCT02477826|561588724|FG005|Treatment Period|Lost to Follow-up|0|||
155590206|NCT02477826|561588725|FG006|Treatment Period|Lost to Follow-up|2|||
155590207|NCT02477826|561588726|FG007|Treatment Period|Lost to Follow-up|2|||
155590208|NCT02477826|561588727|FG008|Treatment Period|Lost to Follow-up|0|||
155590209|NCT02477826|561588728|FG009|Treatment Period|Lost to Follow-up|0|||
155590210|NCT02477826|561588719|FG000|Treatment Period|Participant withdrew Consent|5|||
155590211|NCT02477826|561588720|FG001|Treatment Period|Participant withdrew Consent|5|||
155590212|NCT02477826|561588721|FG002|Treatment Period|Participant withdrew Consent|3|||
155590213|NCT02477826|561588722|FG003|Treatment Period|Participant withdrew Consent|3|||
155590214|NCT02477826|561588723|FG004|Treatment Period|Participant withdrew Consent|1|||
155590215|NCT02477826|561588724|FG005|Treatment Period|Participant withdrew Consent|3|||
155590216|NCT02477826|561588725|FG006|Treatment Period|Participant withdrew Consent|3|||
155590217|NCT02477826|561588726|FG007|Treatment Period|Participant withdrew Consent|3|||
155590218|NCT02477826|561588727|FG008|Treatment Period|Participant withdrew Consent|2|||
155590219|NCT02477826|561588728|FG009|Treatment Period|Participant withdrew Consent|3|||
155590220|NCT02477826|561588719|FG000|Treatment Period|Participant request to discontinue treatment|5|||
155590221|NCT02477826|561588720|FG001|Treatment Period|Participant request to discontinue treatment|3|||
155590222|NCT02477826|561588721|FG002|Treatment Period|Participant request to discontinue treatment|15|||
155590223|NCT02477826|561588722|FG003|Treatment Period|Participant request to discontinue treatment|5|||
155590224|NCT02477826|561588723|FG004|Treatment Period|Participant request to discontinue treatment|3|||
155590225|NCT02477826|561588724|FG005|Treatment Period|Participant request to discontinue treatment|6|||
155590226|NCT02477826|561588725|FG006|Treatment Period|Participant request to discontinue treatment|13|||
155590227|NCT02477826|561588726|FG007|Treatment Period|Participant request to discontinue treatment|15|||
155590228|NCT02477826|561588727|FG008|Treatment Period|Participant request to discontinue treatment|4|||
155590229|NCT02477826|561588728|FG009|Treatment Period|Participant request to discontinue treatment|18|||
155590230|NCT02477826|561588719|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
155590231|NCT02477826|561588720|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
155590232|NCT02477826|561588721|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
155590233|NCT02477826|561588722|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
155590234|NCT02477826|561588723|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
155590235|NCT02477826|561588724|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
155590236|NCT02477826|561588725|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
155590237|NCT02477826|561588726|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
155590238|NCT02477826|561588727|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
155590239|NCT02477826|561588728|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
155590240|NCT02477826|561588719|FG000|Treatment Period|Death|4|||
155590241|NCT02477826|561588720|FG001|Treatment Period|Death|7|||
155590242|NCT02477826|561588721|FG002|Treatment Period|Death|0|||
155590243|NCT02477826|561588722|FG003|Treatment Period|Death|0|||
155590244|NCT02477826|561588723|FG004|Treatment Period|Death|1|||
155590245|NCT02477826|561588724|FG005|Treatment Period|Death|2|||
155590246|NCT02477826|561588725|FG006|Treatment Period|Death|6|||
155590247|NCT02477826|561588726|FG007|Treatment Period|Death|5|||
155590248|NCT02477826|561588727|FG008|Treatment Period|Death|9|||
155590249|NCT02477826|561588728|FG009|Treatment Period|Death|0|||
155590250|NCT02477826|561588719|FG000|Treatment Period|Study Drug Toxicity|79|||
155590251|NCT02477826|561588720|FG001|Treatment Period|Study Drug Toxicity|51|||
155590252|NCT02477826|561588721|FG002|Treatment Period|Study Drug Toxicity|31|||
155590253|NCT02477826|561588722|FG003|Treatment Period|Study Drug Toxicity|39|||
155590254|NCT02477826|561588723|FG004|Treatment Period|Study Drug Toxicity|12|||
155590255|NCT02477826|561588724|FG005|Treatment Period|Study Drug Toxicity|25|||
155590256|NCT02477826|561588725|FG006|Treatment Period|Study Drug Toxicity|52|||
155590257|NCT02477826|561588726|FG007|Treatment Period|Study Drug Toxicity|30|||
155590258|NCT02477826|561588727|FG008|Treatment Period|Study Drug Toxicity|20|||
155590259|NCT02477826|561588728|FG009|Treatment Period|Study Drug Toxicity|9|||
155590260|NCT02477826|561588719|FG000|Treatment Period|Disease progression|212|||
155590261|NCT02477826|561588720|FG001|Treatment Period|Disease progression|240|||
155590262|NCT02477826|561588721|FG002|Treatment Period|Disease progression|202|||
155590263|NCT02477826|561588722|FG003|Treatment Period|Disease progression|93|||
155590264|NCT02477826|561588723|FG004|Treatment Period|Disease progression|113|||
155590265|NCT02477826|561588724|FG005|Treatment Period|Disease progression|96|||
155590266|NCT02477826|561588725|FG006|Treatment Period|Disease progression|208|||
155590267|NCT02477826|561588726|FG007|Treatment Period|Disease progression|195|||
155590268|NCT02477826|561588727|FG008|Treatment Period|Disease progression|59|||
155590269|NCT02477826|561588728|FG009|Treatment Period|Disease progression|46|||
155590270|NCT02477826|561588719|FG000|Treatment Period|Pregnancy|0|||
155590271|NCT02477826|561588720|FG001|Treatment Period|Pregnancy|0|||
155590272|NCT02477826|561588721|FG002|Treatment Period|Pregnancy|0|||
155590273|NCT02477826|561588722|FG003|Treatment Period|Pregnancy|0|||
155590274|NCT02477826|561588723|FG004|Treatment Period|Pregnancy|0|||
155590275|NCT02477826|561588724|FG005|Treatment Period|Pregnancy|0|||
155590276|NCT02477826|561588725|FG006|Treatment Period|Pregnancy|0|||
155590277|NCT02477826|561588726|FG007|Treatment Period|Pregnancy|0|||
155590278|NCT02477826|561588727|FG008|Treatment Period|Pregnancy|0|||
155590279|NCT02477826|561588728|FG009|Treatment Period|Pregnancy|1|||
155590280|NCT02477826|561588719|FG000|Treatment Period|Other|0|||
155590281|NCT02477826|561588720|FG001|Treatment Period|Other|0|||
155590282|NCT02477826|561588721|FG002|Treatment Period|Other|0|||
155590283|NCT02477826|561588722|FG003|Treatment Period|Other|0|||
155590284|NCT02477826|561588723|FG004|Treatment Period|Other|0|||
155590285|NCT02477826|561588724|FG005|Treatment Period|Other|0|||
155590286|NCT02477826|561588725|FG006|Treatment Period|Other|0|||
155590287|NCT02477826|561588726|FG007|Treatment Period|Other|0|||
155590288|NCT02477826|561588727|FG008|Treatment Period|Other|0|||
155590289|NCT02477826|561588728|FG009|Treatment Period|Other|1|||
155590290|NCT00183885|561588731|FG000|Overall Study|Adverse Event|11|||
155590291|NCT00183885|561588731|FG000|Overall Study|Death|1|||
155590292|NCT00183885|561588731|FG000|Overall Study|Lost to Follow-up|3|||
155590293|NCT00183885|561588731|FG000|Overall Study|Physician Decision|6|||
155590294|NCT00183885|561588731|FG000|Overall Study|Withdrawal by Subject|5|||
155590295|NCT00183885|561588731|FG000|Overall Study|Switched to alternative treatment|8|||
155590296|NCT00183885|561588731|FG000|Overall Study|Treatment delayed too long|4|||
155590297|NCT00183885|561588731|FG000|Overall Study|Developed second malignancy|1|||
155590298|NCT05310071|561588745|FG000|Overall Study|Death|0|||
155590299|NCT05310071|561588746|FG001|Overall Study|Death|3|||
155590300|NCT05310071|561588745|FG000|Overall Study|Adverse Event|4|||
155590301|NCT05310071|561588746|FG001|Overall Study|Adverse Event|31|||
155590302|NCT05310071|561588745|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
155590303|NCT05310071|561588746|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
155590304|NCT05310071|561588745|FG000|Overall Study|Protocol Deviation|2|||
155590305|NCT05310071|561588746|FG001|Overall Study|Protocol Deviation|0|||
155590306|NCT05310071|561588745|FG000|Overall Study|Randomized by Mistake|0|||
155590307|NCT05310071|561588746|FG001|Overall Study|Randomized by Mistake|1|||
155590308|NCT05310071|561588745|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
155590309|NCT05310071|561588746|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155590310|NCT05310071|561588745|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
155590311|NCT05310071|561588746|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155590312|NCT05310071|561588745|FG000|Overall Study|Site Terminated by Sponsor|0|||
155590313|NCT05310071|561588746|FG001|Overall Study|Site Terminated by Sponsor|2|||
155590314|NCT05310071|561588745|FG000|Overall Study|Study Terminated by Sponsor|282|||
155590315|NCT05310071|561588746|FG001|Overall Study|Study Terminated by Sponsor|559|||
155590316|NCT05310071|561588745|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
155590317|NCT05310071|561588746|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
155590318|NCT05310071|561588745|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
155590319|NCT05310071|561588746|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
155590320|NCT05310071|561588745|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
155590321|NCT05310071|561588746|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
155590322|NCT05310071|561588745|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
155590323|NCT05310071|561588746|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
155590324|NCT05310071|561588745|FG000|Overall Study|Withdrawal by Participant - Other|25|||
155590325|NCT05310071|561588746|FG001|Overall Study|Withdrawal by Participant - Other|30|||
155590326|NCT05310071|561588745|FG000|Overall Study|Lost to Follow-up|2|||
155590327|NCT05310071|561588746|FG001|Overall Study|Lost to Follow-up|4|||
155590328|NCT05310071|561588745|FG000|Overall Study|Reason Not Specified|1|||
155590329|NCT05310071|561588746|FG001|Overall Study|Reason Not Specified|3|||
155590330|NCT02418949|561588747|FG000|Overall Study|Withdrawal by Subject|1|||
155590331|NCT02418949|561588748|FG001|Overall Study|Withdrawal by Subject|0|||
155590332|NCT02418949|561588749|FG002|Overall Study|Withdrawal by Subject|1|||
155590333|NCT02418949|561588750|FG003|Overall Study|Withdrawal by Subject|1|||
155590334|NCT02418949|561588747|FG000|Overall Study|Lost to Follow-up|1|||
155590335|NCT02418949|561588748|FG001|Overall Study|Lost to Follow-up|0|||
155590336|NCT02418949|561588749|FG002|Overall Study|Lost to Follow-up|1|||
155590337|NCT02418949|561588750|FG003|Overall Study|Lost to Follow-up|0|||
155590338|NCT02418949|561588747|FG000|Overall Study|Physician Decision|1|||
155590339|NCT02418949|561588748|FG001|Overall Study|Physician Decision|1|||
155590340|NCT02418949|561588749|FG002|Overall Study|Physician Decision|1|||
155590341|NCT02418949|561588750|FG003|Overall Study|Physician Decision|0|||
155590342|NCT00014495|561588751|FG000|Overall Study|Death|0|||
155590343|NCT00014495|561588752|FG001|Overall Study|Death|0|||
155590344|NCT00014495|561588753|FG002|Overall Study|Death|1|||
155590345|NCT00014495|561588754|FG003|Overall Study|Death|0|||
155590346|NCT00014495|561588751|FG000|Overall Study|Clinical deterioration|0|||
155590347|NCT00014495|561588752|FG001|Overall Study|Clinical deterioration|0|||
155590348|NCT00014495|561588753|FG002|Overall Study|Clinical deterioration|0|||
155590349|NCT00014495|561588754|FG003|Overall Study|Clinical deterioration|1|||
155590350|NCT00828568|561588755|FG000|Randomized|Withdrawal by Subject|1|||
155590351|NCT00828568|561588756|FG001|Randomized|Withdrawal by Subject|0|||
155590352|NCT00828568|561588757|FG002|Randomized|Withdrawal by Subject|2|||
155590353|NCT00828568|561588755|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
155590354|NCT00828568|561588756|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
155590355|NCT00828568|561588757|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
155590356|NCT00828568|561588755|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
155590357|NCT00828568|561588756|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
155590358|NCT00828568|561588757|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
155590359|NCT00828568|561588755|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
155590360|NCT00828568|561588756|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
155590361|NCT00828568|561588757|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
155590362|NCT00828568|561588755|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
155590363|NCT00828568|561588756|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
155590364|NCT00828568|561588757|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
155590365|NCT00403481|561588792|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
155590366|NCT00403481|561588792|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
155590367|NCT00403481|561588792|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
155590368|NCT00403481|561588792|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
155590369|NCT00403481|561588792|FG000|Olm 40 mg|Adverse Event|2|||
155590370|NCT00403481|561588792|FG000|Olm 40 mg|Protocol Violation|1|||
155590371|NCT00403481|561588792|FG000|Olm 40 mg|Withdrawal by Subject|1|||
155590372|NCT00403481|561588792|FG000|Olm 40 mg|Other|1|||
155590373|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
155590374|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
155590375|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
155590376|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
155590377|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
155590378|NCT00403481|561588792|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
155590379|NCT00396656|561588793|FG000|First Treatment Period|Withdrawal by Subject|0|||
155590380|NCT00396656|561588794|FG001|First Treatment Period|Withdrawal by Subject|2|||
155590381|NCT00396656|561588793|FG000|Second Treatment Period|Adverse Event|0|||
155590382|NCT00396656|561588794|FG001|Second Treatment Period|Adverse Event|1|||
155590383|NCT02091089|561588795|FG000|Overall Study|Lost to Follow-up|2|||
155590384|NCT02929589|561588797|FG000|Overall Study|Withdrawal by Subject|1|||
155590385|NCT02929589|561588798|FG001|Overall Study|Withdrawal by Subject|0|||
155590386|NCT02929589|561588799|FG002|Overall Study|Withdrawal by Subject|0|||
155590387|NCT02929589|561588800|FG003|Overall Study|Withdrawal by Subject|0|||
155590388|NCT02929589|561588797|FG000|Overall Study|Physician Decision|2|||
155590389|NCT02929589|561588798|FG001|Overall Study|Physician Decision|0|||
155590390|NCT02929589|561588799|FG002|Overall Study|Physician Decision|0|||
155590391|NCT02929589|561588800|FG003|Overall Study|Physician Decision|0|||
155590392|NCT02343939|561588803|FG000|Overall Study|Death|0|||
155590393|NCT02343939|561588804|FG001|Overall Study|Death|15|||
155590394|NCT02343939|561588805|FG002|Overall Study|Death|4|||
155590395|NCT02343939|561588806|FG003|Overall Study|Death|2|||
155590396|NCT02343939|561588807|FG004|Overall Study|Death|5|||
155590397|NCT02343939|561588808|FG005|Overall Study|Death|11|||
155590398|NCT02343939|561588809|FG006|Overall Study|Death|8|||
155590399|NCT02343939|561588810|FG007|Overall Study|Death|22|||
155590400|NCT02343939|561588811|FG008|Overall Study|Death|1|||
155590401|NCT02343939|561588803|FG000|Overall Study|Study terminated by sponsor|0|||
155590402|NCT02343939|561588804|FG001|Overall Study|Study terminated by sponsor|27|||
155590403|NCT02343939|561588805|FG002|Overall Study|Study terminated by sponsor|0|||
155590404|NCT02343939|561588806|FG003|Overall Study|Study terminated by sponsor|1|||
155590405|NCT02343939|561588807|FG004|Overall Study|Study terminated by sponsor|1|||
155590406|NCT02343939|561588808|FG005|Overall Study|Study terminated by sponsor|5|||
155590407|NCT02343939|561588809|FG006|Overall Study|Study terminated by sponsor|3|||
155590408|NCT02343939|561588810|FG007|Overall Study|Study terminated by sponsor|4|||
155590409|NCT02343939|561588811|FG008|Overall Study|Study terminated by sponsor|0|||
155590410|NCT02343939|561588803|FG000|Overall Study|Withdrew consent|3|||
155590411|NCT02343939|561588804|FG001|Overall Study|Withdrew consent|6|||
155590412|NCT02343939|561588805|FG002|Overall Study|Withdrew consent|1|||
155590413|NCT02343939|561588806|FG003|Overall Study|Withdrew consent|2|||
155590414|NCT02343939|561588807|FG004|Overall Study|Withdrew consent|2|||
155590415|NCT02343939|561588808|FG005|Overall Study|Withdrew consent|0|||
155590416|NCT02343939|561588809|FG006|Overall Study|Withdrew consent|0|||
155590417|NCT02343939|561588810|FG007|Overall Study|Withdrew consent|8|||
155590418|NCT02343939|561588811|FG008|Overall Study|Withdrew consent|6|||
155590419|NCT02343939|561588803|FG000|Overall Study|Treatment failure|0|||
155590420|NCT02343939|561588804|FG001|Overall Study|Treatment failure|0|||
155590421|NCT02343939|561588805|FG002|Overall Study|Treatment failure|0|||
155590422|NCT02343939|561588806|FG003|Overall Study|Treatment failure|0|||
155590423|NCT02343939|561588807|FG004|Overall Study|Treatment failure|0|||
155590424|NCT02343939|561588808|FG005|Overall Study|Treatment failure|0|||
155590425|NCT02343939|561588809|FG006|Overall Study|Treatment failure|2|||
155590426|NCT02343939|561588810|FG007|Overall Study|Treatment failure|1|||
155590427|NCT02343939|561588811|FG008|Overall Study|Treatment failure|0|||
155590428|NCT02343939|561588803|FG000|Overall Study|Investigator's discretion|0|||
155590429|NCT02343939|561588804|FG001|Overall Study|Investigator's discretion|0|||
155590430|NCT02343939|561588805|FG002|Overall Study|Investigator's discretion|0|||
155590431|NCT02343939|561588806|FG003|Overall Study|Investigator's discretion|1|||
155590432|NCT02343939|561588807|FG004|Overall Study|Investigator's discretion|0|||
155590433|NCT02343939|561588808|FG005|Overall Study|Investigator's discretion|0|||
155590434|NCT02343939|561588809|FG006|Overall Study|Investigator's discretion|1|||
155590435|NCT02343939|561588810|FG007|Overall Study|Investigator's discretion|0|||
155590436|NCT02343939|561588811|FG008|Overall Study|Investigator's discretion|0|||
155590437|NCT02343939|561588803|FG000|Overall Study|Adverse Event|0|||
155590438|NCT02343939|561588804|FG001|Overall Study|Adverse Event|0|||
155590439|NCT02343939|561588805|FG002|Overall Study|Adverse Event|0|||
155590440|NCT02343939|561588806|FG003|Overall Study|Adverse Event|0|||
155590441|NCT02343939|561588807|FG004|Overall Study|Adverse Event|0|||
155590442|NCT02343939|561588808|FG005|Overall Study|Adverse Event|1|||
155590443|NCT02343939|561588809|FG006|Overall Study|Adverse Event|0|||
155590444|NCT02343939|561588810|FG007|Overall Study|Adverse Event|0|||
155590445|NCT02343939|561588811|FG008|Overall Study|Adverse Event|0|||
155590446|NCT02343939|561588803|FG000|Overall Study|Never Treated With ENTO|0|||
155590447|NCT02343939|561588804|FG001|Overall Study|Never Treated With ENTO|0|||
155590448|NCT02343939|561588805|FG002|Overall Study|Never Treated With ENTO|0|||
155590449|NCT02343939|561588806|FG003|Overall Study|Never Treated With ENTO|0|||
155590450|NCT02343939|561588807|FG004|Overall Study|Never Treated With ENTO|0|||
155590451|NCT02343939|561588808|FG005|Overall Study|Never Treated With ENTO|0|||
155590452|NCT02343939|561588809|FG006|Overall Study|Never Treated With ENTO|1|||
155590453|NCT02343939|561588810|FG007|Overall Study|Never Treated With ENTO|2|||
155590454|NCT02343939|561588811|FG008|Overall Study|Never Treated With ENTO|0|||
155590455|NCT00460811|561588814|FG000|Overall Study|Adverse Event|4|||
155590456|NCT00460811|561588815|FG001|Overall Study|Adverse Event|6|||
155590457|NCT00460811|561588816|FG002|Overall Study|Adverse Event|3|||
155590458|NCT00460811|561588817|FG003|Overall Study|Adverse Event|10|||
155590459|NCT00460811|561588818|FG004|Overall Study|Adverse Event|2|||
155590460|NCT00460811|561588814|FG000|Overall Study|Noncompliance|1|||
155590461|NCT00460811|561588815|FG001|Overall Study|Noncompliance|0|||
155590462|NCT00460811|561588816|FG002|Overall Study|Noncompliance|0|||
155590463|NCT00460811|561588817|FG003|Overall Study|Noncompliance|2|||
155590464|NCT00460811|561588818|FG004|Overall Study|Noncompliance|1|||
155590465|NCT00460811|561588814|FG000|Overall Study|Withdrawal by Subject|7|||
155590466|NCT00460811|561588815|FG001|Overall Study|Withdrawal by Subject|7|||
155590467|NCT00460811|561588816|FG002|Overall Study|Withdrawal by Subject|6|||
155590468|NCT00460811|561588817|FG003|Overall Study|Withdrawal by Subject|3|||
155590469|NCT00460811|561588818|FG004|Overall Study|Withdrawal by Subject|11|||
155590470|NCT00460811|561588814|FG000|Overall Study|Physician Decision|1|||
155590471|NCT00460811|561588815|FG001|Overall Study|Physician Decision|0|||
155590472|NCT00460811|561588816|FG002|Overall Study|Physician Decision|0|||
155590473|NCT00460811|561588817|FG003|Overall Study|Physician Decision|0|||
155590474|NCT00460811|561588818|FG004|Overall Study|Physician Decision|0|||
155590475|NCT00460811|561588814|FG000|Overall Study|Lost to Follow-up|3|||
155590476|NCT00460811|561588815|FG001|Overall Study|Lost to Follow-up|2|||
155590477|NCT00460811|561588816|FG002|Overall Study|Lost to Follow-up|5|||
155590478|NCT00460811|561588817|FG003|Overall Study|Lost to Follow-up|3|||
155590479|NCT00460811|561588818|FG004|Overall Study|Lost to Follow-up|6|||
155590480|NCT02821754|561588819|FG000|Overall Study|Procedure not required prior to amendment change|13|||
155590481|NCT02821754|561588820|FG001|Overall Study|Procedure not required prior to amendment change|11|||
155590482|NCT02821754|561588821|FG002|Overall Study|Procedure not required prior to amendment change|0|||
155590483|NCT02821754|561588819|FG000|Overall Study|Participant's Clinical status|2|||
155590484|NCT02821754|561588820|FG001|Overall Study|Participant's Clinical status|0|||
155590485|NCT02821754|561588821|FG002|Overall Study|Participant's Clinical status|0|||
155590486|NCT02821754|561588819|FG000|Overall Study|Participant removed for noncompliance|1|||
155590487|NCT02821754|561588820|FG001|Overall Study|Participant removed for noncompliance|0|||
155590488|NCT02821754|561588821|FG002|Overall Study|Participant removed for noncompliance|0|||
155590489|NCT02821754|561588819|FG000|Overall Study|Drug not available.|0|||
155590490|NCT02821754|561588820|FG001|Overall Study|Drug not available.|0|||
155590491|NCT02821754|561588821|FG002|Overall Study|Drug not available.|1|||
155590492|NCT02821754|561588819|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
155590493|NCT02821754|561588820|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
155590494|NCT02821754|561588821|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
155590495|NCT00994461|561588826|FG000|Overall Study|Adverse Event|2|||
155590496|NCT00994461|561588827|FG001|Overall Study|Adverse Event|1|||
155590497|NCT00994461|561588828|FG002|Overall Study|Adverse Event|0|||
155590498|NCT02977572|561588829|FG000|Overall Study|Exclusion criterion|2|||
155590499|NCT02977572|561588830|FG001|Overall Study|Exclusion criterion|2|||
155590500|NCT01166438|561588833|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
155590501|NCT01166438|561588834|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
155590502|NCT01166438|561588833|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
155590503|NCT01166438|561588834|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
155590504|NCT01166438|561588833|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
155590505|NCT01166438|561588834|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
155590506|NCT01166438|561588833|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
155590507|NCT01166438|561588834|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
155590508|NCT01166438|561588833|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
155590509|NCT01166438|561588834|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
155590510|NCT01166438|561588833|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
155590511|NCT01166438|561588834|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
155590512|NCT00454363|561588841|FG000|Overall Study|Adverse Event|1|||
155590513|NCT00454363|561588842|FG001|Overall Study|Adverse Event|2|||
155590514|NCT00454363|561588841|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
155590515|NCT00454363|561588842|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
155590516|NCT01863667|561588844|FG000|Overall Study|Adverse Event|1|||
155590517|NCT01863667|561588845|FG001|Overall Study|Adverse Event|0|||
155590518|NCT01863667|561588844|FG000|Overall Study|Study terminated by Sponsor|30|||
155590519|NCT01863667|561588845|FG001|Overall Study|Study terminated by Sponsor|30|||
155590520|NCT01863667|561588844|FG000|Overall Study|Withdrawal by Subject|2|||
155590521|NCT01863667|561588845|FG001|Overall Study|Withdrawal by Subject|2|||
155590522|NCT02837731|561588847|FG000|Allocation|Admitted to General Floor|3|||
155590523|NCT02837731|561588848|FG001|Allocation|Admitted to General Floor|4|||
155590524|NCT02837731|561588847|FG000|Allocation|Immediate surgery/withdrew|2|||
155590525|NCT02837731|561588848|FG001|Allocation|Immediate surgery/withdrew|0|||
155590526|NCT02837731|561588847|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
155590527|NCT02837731|561588848|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
155590528|NCT02837731|561588847|FG000|Allocation|Withdrawal by Subject|2|||
155590529|NCT02837731|561588848|FG001|Allocation|Withdrawal by Subject|0|||
155590530|NCT02837731|561588847|FG000|Allocation|Device not available|1|||
155590531|NCT02837731|561588848|FG001|Allocation|Device not available|0|||
155590532|NCT02837731|561588847|FG000|Allocation|Protocol not implemented|7|||
155590533|NCT02837731|561588848|FG001|Allocation|Protocol not implemented|0|||
155590534|NCT02837731|561588847|FG000|Allocation|Moribund/Do not resuscitate|2|||
155590535|NCT02837731|561588848|FG001|Allocation|Moribund/Do not resuscitate|0|||
155590536|NCT02837731|561588847|FG000|Allocation|Did not meet sepsis criteria|1|||
155590537|NCT02837731|561588848|FG001|Allocation|Did not meet sepsis criteria|2|||
155590538|NCT02837731|561588847|FG000|Allocation|Known aortic abnormalities|0|||
155590539|NCT02837731|561588848|FG001|Allocation|Known aortic abnormalities|1|||
155590540|NCT00315458|561588849|FG000|Overall Study|Administrative|0|||
155590541|NCT00315458|561588850|FG001|Overall Study|Administrative|3|||
155590542|NCT00315458|561588851|FG002|Overall Study|Administrative|8|||
155590543|NCT00315458|561588852|FG003|Overall Study|Administrative|21|||
155590544|NCT00315458|561588849|FG000|Overall Study|Adverse Event|2|||
155590545|NCT00315458|561588850|FG001|Overall Study|Adverse Event|4|||
155590546|NCT00315458|561588851|FG002|Overall Study|Adverse Event|23|||
155590547|NCT00315458|561588852|FG003|Overall Study|Adverse Event|3|||
155590548|NCT00315458|561588849|FG000|Overall Study|Lost to Follow-up|1|||
155590549|NCT00315458|561588850|FG001|Overall Study|Lost to Follow-up|2|||
155590550|NCT00315458|561588851|FG002|Overall Study|Lost to Follow-up|0|||
155590551|NCT00315458|561588852|FG003|Overall Study|Lost to Follow-up|2|||
155590552|NCT00315458|561588849|FG000|Overall Study|Withdrawal by Subject|0|||
155590553|NCT00315458|561588850|FG001|Overall Study|Withdrawal by Subject|3|||
155590554|NCT00315458|561588851|FG002|Overall Study|Withdrawal by Subject|0|||
155590555|NCT00315458|561588852|FG003|Overall Study|Withdrawal by Subject|2|||
155590556|NCT00315458|561588849|FG000|Overall Study|Lack of Efficacy|0|||
155590557|NCT00315458|561588850|FG001|Overall Study|Lack of Efficacy|0|||
155590558|NCT00315458|561588851|FG002|Overall Study|Lack of Efficacy|20|||
155590559|NCT00315458|561588852|FG003|Overall Study|Lack of Efficacy|1|||
155590560|NCT00315458|561588849|FG000|Overall Study|Did not qualify|0|||
155590561|NCT00315458|561588850|FG001|Overall Study|Did not qualify|0|||
155590562|NCT00315458|561588851|FG002|Overall Study|Did not qualify|1|||
155590563|NCT00315458|561588852|FG003|Overall Study|Did not qualify|0|||
155590564|NCT00523848|561588854|FG000|Overall Study|Adverse Event|11|||
155590565|NCT00523848|561588854|FG000|Overall Study|Withdrawal by Subject|2|||
155590566|NCT00523848|561588854|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
155590567|NCT00523848|561588854|FG000|Overall Study|Disease Progression|5|||
155590568|NCT00523848|561588854|FG000|Overall Study|Other, unspecified|4|||
155590569|NCT00489918|561588856|FG000|Overall Study|Withdrawal by Subject|2|||
155590570|NCT00489918|561588857|FG001|Overall Study|Withdrawal by Subject|1|||
155590571|NCT00489918|561588858|FG002|Overall Study|Withdrawal by Subject|1|||
155590572|NCT00489918|561588859|FG003|Overall Study|Withdrawal by Subject|0|||
155590573|NCT00489918|561588860|FG004|Overall Study|Withdrawal by Subject|1|||
155590574|NCT00489918|561588856|FG000|Overall Study|Adverse Event|0|||
155590575|NCT00489918|561588857|FG001|Overall Study|Adverse Event|1|||
155590576|NCT00489918|561588858|FG002|Overall Study|Adverse Event|1|||
155590577|NCT00489918|561588859|FG003|Overall Study|Adverse Event|0|||
155590578|NCT00489918|561588860|FG004|Overall Study|Adverse Event|0|||
155590579|NCT00489918|561588856|FG000|Overall Study|Lost to Follow-up|0|||
155590580|NCT00489918|561588857|FG001|Overall Study|Lost to Follow-up|0|||
155590581|NCT00489918|561588858|FG002|Overall Study|Lost to Follow-up|1|||
155590582|NCT00489918|561588859|FG003|Overall Study|Lost to Follow-up|1|||
155590583|NCT00489918|561588860|FG004|Overall Study|Lost to Follow-up|0|||
155590584|NCT00489918|561588856|FG000|Overall Study|Physician Decision|0|||
155590585|NCT00489918|561588857|FG001|Overall Study|Physician Decision|0|||
155590586|NCT00489918|561588858|FG002|Overall Study|Physician Decision|1|||
155590587|NCT00489918|561588859|FG003|Overall Study|Physician Decision|0|||
155590588|NCT00489918|561588860|FG004|Overall Study|Physician Decision|0|||
155590589|NCT02748213|561588861|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
155590590|NCT02748213|561588862|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
155590591|NCT02748213|561588861|FG000|Overall Study|Abnormal Laboratory Test|1|||
155590592|NCT02748213|561588862|FG001|Overall Study|Abnormal Laboratory Test|0|||
155590593|NCT02748213|561588861|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
155590594|NCT02748213|561588862|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
155590595|NCT02748213|561588861|FG000|Overall Study|Death|5|||
155590596|NCT02748213|561588862|FG001|Overall Study|Death|3|||
155590597|NCT02748213|561588861|FG000|Overall Study|Insufficient Therapeutic Response|56|||
155590598|NCT02748213|561588862|FG001|Overall Study|Insufficient Therapeutic Response|57|||
155590599|NCT02748213|561588861|FG000|Overall Study|Violation of Selection Criteria|2|||
155590600|NCT02748213|561588862|FG001|Overall Study|Violation of Selection Criteria|0|||
155590601|NCT02748213|561588861|FG000|Overall Study|Protocol Violation|6|||
155590602|NCT02748213|561588862|FG001|Overall Study|Protocol Violation|4|||
155590603|NCT02748213|561588861|FG000|Overall Study|Refused Treatment*|6|||
155590604|NCT02748213|561588862|FG001|Overall Study|Refused Treatment*|6|||
155590605|NCT02748213|561588861|FG000|Overall Study|Failure to Return|1|||
155590606|NCT02748213|561588862|FG001|Overall Study|Failure to Return|0|||
155590607|NCT02748213|561588861|FG000|Overall Study|Other|30|||
155590608|NCT02748213|561588862|FG001|Overall Study|Other|29|||
155590609|NCT00068393|561590374|FG000|Overall Study|Adverse Event|2|||
155590610|NCT00068393|561590374|FG000|Overall Study|Death|3|||
155590611|NCT00068393|561590374|FG000|Overall Study|Withdrawal by Subject|3|||
155590612|NCT00068393|561590374|FG000|Overall Study|Alternative treatment|1|||
155590613|NCT00068393|561590374|FG000|Overall Study|Quality of life worsening|1|||
155590614|NCT01190410|561590379|FG000|Overall Study|Adverse Event|0|||
155590615|NCT01190410|561590380|FG001|Overall Study|Adverse Event|3|||
155590616|NCT01190410|561590379|FG000|Overall Study|Lack of Efficacy|0|||
155590617|NCT01190410|561590380|FG001|Overall Study|Lack of Efficacy|2|||
155590618|NCT01190410|561590379|FG000|Overall Study|Withdrawal by Subject|0|||
155590619|NCT01190410|561590380|FG001|Overall Study|Withdrawal by Subject|2|||
155590620|NCT01190410|561590379|FG000|Overall Study|Administrative decision|1|||
155590621|NCT01190410|561590380|FG001|Overall Study|Administrative decision|0|||
155590622|NCT01190410|561590379|FG000|Overall Study|PI discretion|0|||
155590623|NCT01190410|561590380|FG001|Overall Study|PI discretion|2|||
155590624|NCT01399047|561590381|FG000|Overall Study|Withdrawal by Subject|0|||
155590625|NCT01399047|561590382|FG001|Overall Study|Withdrawal by Subject|1|||
155590626|NCT03300505|561590402|FG000|Overall Study|Death|0|||
155590627|NCT03300505|561590403|FG001|Overall Study|Death|1|||
155590628|NCT03300505|561590404|FG002|Overall Study|Death|0|||
155590629|NCT03300505|561590402|FG000|Overall Study|Withdrawal by Subject|0|||
155590630|NCT03300505|561590403|FG001|Overall Study|Withdrawal by Subject|1|||
155590631|NCT03300505|561590404|FG002|Overall Study|Withdrawal by Subject|1|||
155590632|NCT03300505|561590402|FG000|Overall Study|Sponsor Termination|0|||
155590633|NCT03300505|561590403|FG001|Overall Study|Sponsor Termination|1|||
155590634|NCT03300505|561590404|FG002|Overall Study|Sponsor Termination|0|||
155590635|NCT03300505|561590402|FG000|Overall Study|Adverse Event|0|||
155590636|NCT03300505|561590403|FG001|Overall Study|Adverse Event|0|||
155590637|NCT03300505|561590404|FG002|Overall Study|Adverse Event|2|||
155590638|NCT05119595|561590405|FG000|Overall Study|Death|1|||
155590639|NCT05119595|561590405|FG000|Overall Study|Lost to Follow-up|7|||
155590640|NCT01806961|561590406|FG000|Overall Study|sponsor decision|16|||
155590641|NCT01108341|561590409|FG000|Overall Study|Death|2|||
155590642|NCT01108341|561590409|FG000|Overall Study|Withdrawal by Subject|1|||
155590643|NCT01108341|561590409|FG000|Overall Study|Lost to Follow-up|1|||
155590644|NCT01108341|561590409|FG000|Overall Study|Other|1|||
155590645|NCT03467217|561590414|FG000|Overall Study|Trial stopped early|5|||
155590646|NCT03467217|561590415|FG001|Overall Study|Trial stopped early|2|||
155590647|NCT03467217|561590414|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
155590648|NCT03467217|561590415|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
155590649|NCT03467217|561590414|FG000|Overall Study|Lost to Follow-up|0|||
155590650|NCT03467217|561590415|FG001|Overall Study|Lost to Follow-up|2|||
155590651|NCT00769067|561590416|FG000|Overall Study|Death|89|||
155590652|NCT00769067|561590417|FG001|Overall Study|Death|86|||
155590653|NCT00769067|561590416|FG000|Overall Study|Lost to Follow-up|3|||
155590654|NCT00769067|561590417|FG001|Overall Study|Lost to Follow-up|1|||
155590655|NCT00769067|561590416|FG000|Overall Study|Study terminated by sponsor|1|||
155590656|NCT00769067|561590417|FG001|Overall Study|Study terminated by sponsor|3|||
155590657|NCT00769067|561590416|FG000|Overall Study|Other|1|||
155590658|NCT00769067|561590417|FG001|Overall Study|Other|3|||
155590659|NCT00769067|561590416|FG000|Overall Study|Withdrawal by Subject|0|||
155590660|NCT00769067|561590417|FG001|Overall Study|Withdrawal by Subject|1|||
155590661|NCT01270464|561590418|FG000|Overall Study|Protocol Violation|4|||
155590662|NCT01270464|561590419|FG001|Overall Study|Protocol Violation|3|||
155590663|NCT01270464|561590420|FG002|Overall Study|Protocol Violation|2|||
155590664|NCT01270464|561590418|FG000|Overall Study|Lack of Efficacy|2|||
155590665|NCT01270464|561590419|FG001|Overall Study|Lack of Efficacy|3|||
155590666|NCT01270464|561590420|FG002|Overall Study|Lack of Efficacy|1|||
155590667|NCT01270464|561590418|FG000|Overall Study|Adverse Event|9|||
155590668|NCT01270464|561590419|FG001|Overall Study|Adverse Event|1|||
155590669|NCT01270464|561590420|FG002|Overall Study|Adverse Event|7|||
155590670|NCT01270464|561590418|FG000|Overall Study|Withdrawal by Subject|2|||
155590671|NCT01270464|561590419|FG001|Overall Study|Withdrawal by Subject|1|||
155590672|NCT01270464|561590420|FG002|Overall Study|Withdrawal by Subject|4|||
155590673|NCT01270464|561590418|FG000|Overall Study|Lost to Follow-up|2|||
155590674|NCT01270464|561590419|FG001|Overall Study|Lost to Follow-up|3|||
155590675|NCT01270464|561590420|FG002|Overall Study|Lost to Follow-up|1|||
155590676|NCT01270464|561590418|FG000|Overall Study|Other|1|||
155590677|NCT01270464|561590419|FG001|Overall Study|Other|1|||
155590678|NCT01270464|561590420|FG002|Overall Study|Other|3|||
155590679|NCT03528369|561590421|FG000|Overall Study|Withdrawal by Subject|2|||
155590680|NCT03528369|561590422|FG001|Overall Study|Withdrawal by Subject|0|||
155590681|NCT03528369|561590423|FG002|Overall Study|Withdrawal by Subject|0|||
155590682|NCT03528369|561590421|FG000|Overall Study|Lost to Follow-up|1|||
155590683|NCT03528369|561590422|FG001|Overall Study|Lost to Follow-up|0|||
155590684|NCT03528369|561590423|FG002|Overall Study|Lost to Follow-up|0|||
155590685|NCT03528369|561590421|FG000|Overall Study|Adverse Event|0|||
155590686|NCT03528369|561590422|FG001|Overall Study|Adverse Event|1|||
155590687|NCT03528369|561590423|FG002|Overall Study|Adverse Event|0|||
155590688|NCT05656534|561590424|FG000|Overall Study|Withdrawal by Subject|1|||
155590689|NCT05656534|561590425|FG001|Overall Study|Withdrawal by Subject|1|||
155590690|NCT05656534|561590426|FG002|Overall Study|Withdrawal by Subject|0|||
155590691|NCT05656534|561590427|FG003|Overall Study|Withdrawal by Subject|0|||
155590692|NCT05656534|561590424|FG000|Overall Study|Physician Decision|1|||
155590693|NCT05656534|561590425|FG001|Overall Study|Physician Decision|1|||
155590694|NCT05656534|561590426|FG002|Overall Study|Physician Decision|0|||
155590695|NCT05656534|561590427|FG003|Overall Study|Physician Decision|0|||
155590696|NCT00302328|561590428|FG000|Overall Study|Physician Decision|0|||
155590697|NCT00302328|561590429|FG001|Overall Study|Physician Decision|1|||
155590698|NCT00302328|561590430|FG002|Overall Study|Physician Decision|0|||
155590699|NCT01288937|561590431|FG000|Overall Study|Adverse Event|1|||
155590700|NCT01288937|561590432|FG001|Overall Study|Adverse Event|0|||
155590701|NCT01750697|561590436|FG000|Overall Study|Transferred Back to Local Hospital|1|||
155590702|NCT01750697|561590436|FG000|Overall Study|Physician and Family Decision|1|||
155590703|NCT01750697|561590436|FG000|Overall Study|Transferred to Adult Services|5|||
155590704|NCT01750697|561590436|FG000|Overall Study|Physician Decision|1|||
155590705|NCT01750697|561590436|FG000|Overall Study|Withdrawal by Subject|1|||
155590706|NCT00857896|561590439|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
155590707|NCT01431716|561590441|FG000|Overall Study|Withdrawal of consent|1|||
155590708|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
155590709|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
155590710|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
155590711|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
155590712|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
155590713|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
155590714|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
155590715|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
155590716|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
155590717|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
155590718|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
155590719|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
155590720|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
155590721|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
155590722|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155590723|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155590724|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155590725|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155590726|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
155590727|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
155590728|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
155590729|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
155590730|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
155590731|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
155590732|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
155590733|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
155590734|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
155590735|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
155590736|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
155590737|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
155590738|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
155590739|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
155590740|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155590741|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155590742|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155590743|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155590744|NCT02016105|561590442|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
155590745|NCT02016105|561590443|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
155590746|NCT02016105|561590444|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155590747|NCT02016105|561590445|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155590748|NCT02016105|561590446|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155590749|NCT02016105|561590447|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155590750|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
155590751|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
155590752|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
155590753|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
155590754|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
155590755|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
155590756|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
155590757|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
155590758|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
155590759|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
155590760|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
155590761|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
155590762|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
155590763|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
155590764|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
155590765|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
155590766|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
155590767|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
155590768|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Death|0|||
155590769|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Death|0|||
155590770|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Death|0|||
155590771|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Death|0|||
155590772|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Death|0|||
155590773|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Death|1|||
155590774|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
155590775|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
155590776|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
155590777|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
155590778|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
155590779|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
155590780|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
155590781|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
155590782|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
155590783|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
155590784|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
155590785|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
155590786|NCT02016105|561590442|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155590787|NCT02016105|561590443|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155590788|NCT02016105|561590444|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
155590789|NCT02016105|561590445|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155590790|NCT02016105|561590446|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155590791|NCT02016105|561590447|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
155590792|NCT02016105|561590442|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
155590793|NCT02016105|561590443|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
155590794|NCT02016105|561590444|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
155590795|NCT02016105|561590445|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
155590796|NCT02016105|561590446|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
155590797|NCT02016105|561590447|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
155590798|NCT02016105|561590442|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
155590799|NCT02016105|561590443|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
155590800|NCT02016105|561590444|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
155590801|NCT02016105|561590445|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
155590802|NCT02016105|561590446|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
155590803|NCT02016105|561590447|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
155590804|NCT02016105|561590442|FG000|EXTENSION PERIOD|Adverse Event|0|||
155590805|NCT02016105|561590443|FG001|EXTENSION PERIOD|Adverse Event|0|||
155590806|NCT02016105|561590444|FG002|EXTENSION PERIOD|Adverse Event|2|||
155590807|NCT02016105|561590445|FG003|EXTENSION PERIOD|Adverse Event|0|||
155590808|NCT02016105|561590446|FG004|EXTENSION PERIOD|Adverse Event|1|||
155590809|NCT02016105|561590447|FG005|EXTENSION PERIOD|Adverse Event|0|||
155590810|NCT02016105|561590442|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
155590811|NCT02016105|561590443|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
155590812|NCT02016105|561590444|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
155590813|NCT02016105|561590445|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
155590814|NCT02016105|561590446|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
155590815|NCT02016105|561590447|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
155590816|NCT02016105|561590442|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
155590817|NCT02016105|561590443|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
155590818|NCT02016105|561590444|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
155590819|NCT02016105|561590445|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
155590820|NCT02016105|561590446|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
155590821|NCT02016105|561590447|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
155590822|NCT02016105|561590442|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
155590823|NCT02016105|561590443|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
155590824|NCT02016105|561590444|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
155590825|NCT02016105|561590445|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
155590826|NCT02016105|561590446|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
155590827|NCT02016105|561590447|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
155590828|NCT01908829|561590451|FG000|Overall Study|Adverse Event|13|||
155590829|NCT01908829|561590452|FG001|Overall Study|Adverse Event|11|||
155590830|NCT01908829|561590453|FG002|Overall Study|Adverse Event|13|||
155590831|NCT01908829|561590451|FG000|Overall Study|Lost to Follow-up|4|||
155590832|NCT01908829|561590452|FG001|Overall Study|Lost to Follow-up|2|||
155590833|NCT01908829|561590453|FG002|Overall Study|Lost to Follow-up|1|||
155590834|NCT01908829|561590451|FG000|Overall Study|Randomized no double-blind drug received|1|||
155590835|NCT01908829|561590452|FG001|Overall Study|Randomized no double-blind drug received|0|||
155590836|NCT01908829|561590453|FG002|Overall Study|Randomized no double-blind drug received|1|||
155590837|NCT01908829|561590451|FG000|Overall Study|Discontinued (no EoT page)|2|||
155590838|NCT01908829|561590452|FG001|Overall Study|Discontinued (no EoT page)|0|||
155590839|NCT01908829|561590453|FG002|Overall Study|Discontinued (no EoT page)|0|||
155590840|NCT01908829|561590451|FG000|Overall Study|Miscellaneous|0|||
155590841|NCT01908829|561590452|FG001|Overall Study|Miscellaneous|2|||
155590842|NCT01908829|561590453|FG002|Overall Study|Miscellaneous|0|||
155590843|NCT01908829|561590451|FG000|Overall Study|Protocol Violation|2|||
155590844|NCT01908829|561590452|FG001|Overall Study|Protocol Violation|2|||
155590845|NCT01908829|561590453|FG002|Overall Study|Protocol Violation|0|||
155590846|NCT01908829|561590451|FG000|Overall Study|Lack of Efficacy|1|||
155590847|NCT01908829|561590452|FG001|Overall Study|Lack of Efficacy|3|||
155590848|NCT01908829|561590453|FG002|Overall Study|Lack of Efficacy|2|||
155590849|NCT01908829|561590451|FG000|Overall Study|Withdrawal by Subject|26|||
155590850|NCT01908829|561590452|FG001|Overall Study|Withdrawal by Subject|29|||
155590851|NCT01908829|561590453|FG002|Overall Study|Withdrawal by Subject|22|||
155590852|NCT02865499|561590454|FG000|Baseline|Adverse Event|1|||
155590853|NCT02865499|561590454|FG000|Baseline|Withdrawal by Subject|1|||
155590854|NCT02792192|561590455|FG000|Overall Study|Death|1|||
155590855|NCT02792192|561590456|FG001|Overall Study|Death|0|||
155590856|NCT02792192|561590457|FG002|Overall Study|Death|0|||
155590857|NCT02792192|561590458|FG003|Overall Study|Death|0|||
155590858|NCT02792192|561590455|FG000|Overall Study|Informed Consent Withdrawn|4|||
155590859|NCT02792192|561590456|FG001|Overall Study|Informed Consent Withdrawn|0|||
155590860|NCT02792192|561590457|FG002|Overall Study|Informed Consent Withdrawn|0|||
155590861|NCT02792192|561590458|FG003|Overall Study|Informed Consent Withdrawn|0|||
155590862|NCT02792192|561590455|FG000|Overall Study|Physician Decision|1|||
155590863|NCT02792192|561590456|FG001|Overall Study|Physician Decision|0|||
155590864|NCT02792192|561590457|FG002|Overall Study|Physician Decision|0|||
155590865|NCT02792192|561590458|FG003|Overall Study|Physician Decision|0|||
155590866|NCT02792192|561590455|FG000|Overall Study|Progressive Disease|0|||
155590867|NCT02792192|561590456|FG001|Overall Study|Progressive Disease|1|||
155590868|NCT02792192|561590457|FG002|Overall Study|Progressive Disease|0|||
155590869|NCT02792192|561590458|FG003|Overall Study|Progressive Disease|0|||
155590870|NCT02792192|561590455|FG000|Overall Study|Study Terminated By Sponsor|6|||
155590871|NCT02792192|561590456|FG001|Overall Study|Study Terminated By Sponsor|10|||
155590872|NCT02792192|561590457|FG002|Overall Study|Study Terminated By Sponsor|0|||
155590873|NCT02792192|561590458|FG003|Overall Study|Study Terminated By Sponsor|0|||
155590874|NCT02320058|561590459|FG000|Overall Study|Death|25|||
155590875|NCT02320058|561590460|FG001|Overall Study|Death|10|||
155666756|NCT01824290|561875025|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
155666757|NCT01824290|561875026|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
155590876|NCT02320058|561590459|FG000|Overall Study|Lost to Follow-up|4|||
155590877|NCT02320058|561590460|FG001|Overall Study|Lost to Follow-up|0|||
155590878|NCT02320058|561590459|FG000|Overall Study|Other reasons|4|||
155590879|NCT02320058|561590460|FG001|Overall Study|Other reasons|1|||
155590880|NCT02320058|561590459|FG000|Overall Study|Withdrawal by Subject|8|||
155590881|NCT02320058|561590460|FG001|Overall Study|Withdrawal by Subject|2|||
155590882|NCT02320058|561590459|FG000|Overall Study|Not reported|1|||
155590883|NCT02320058|561590460|FG001|Overall Study|Not reported|0|||
155590884|NCT01339923|561590461|FG000|Overall Study|Adverse Event|1|||
155590885|NCT01339923|561590462|FG001|Overall Study|Adverse Event|1|||
155590886|NCT01339923|561590463|FG002|Overall Study|Adverse Event|1|||
155590887|NCT01339923|561590464|FG003|Overall Study|Adverse Event|0|||
155590888|NCT01339923|561590465|FG004|Overall Study|Adverse Event|0|||
155590889|NCT01339923|561590466|FG005|Overall Study|Adverse Event|0|||
155590890|NCT01339923|561590467|FG006|Overall Study|Adverse Event|1|||
155590891|NCT01339923|561590461|FG000|Overall Study|Inappropriate Enrollment|1|||
155590892|NCT01339923|561590462|FG001|Overall Study|Inappropriate Enrollment|0|||
155590893|NCT01339923|561590463|FG002|Overall Study|Inappropriate Enrollment|0|||
155590894|NCT01339923|561590464|FG003|Overall Study|Inappropriate Enrollment|0|||
155590895|NCT01339923|561590465|FG004|Overall Study|Inappropriate Enrollment|0|||
155590896|NCT01339923|561590466|FG005|Overall Study|Inappropriate Enrollment|1|||
155590897|NCT01339923|561590467|FG006|Overall Study|Inappropriate Enrollment|0|||
155590898|NCT01339923|561590461|FG000|Overall Study|Lost to Follow-up|4|||
155590899|NCT01339923|561590462|FG001|Overall Study|Lost to Follow-up|4|||
155590900|NCT01339923|561590463|FG002|Overall Study|Lost to Follow-up|0|||
155590901|NCT01339923|561590464|FG003|Overall Study|Lost to Follow-up|3|||
155590902|NCT01339923|561590465|FG004|Overall Study|Lost to Follow-up|1|||
155590903|NCT01339923|561590466|FG005|Overall Study|Lost to Follow-up|1|||
155590904|NCT01339923|561590467|FG006|Overall Study|Lost to Follow-up|5|||
155590905|NCT01339923|561590461|FG000|Overall Study|Protocol Violation|0|||
155590906|NCT01339923|561590462|FG001|Overall Study|Protocol Violation|0|||
155590907|NCT01339923|561590463|FG002|Overall Study|Protocol Violation|0|||
155590908|NCT01339923|561590464|FG003|Overall Study|Protocol Violation|0|||
155590909|NCT01339923|561590465|FG004|Overall Study|Protocol Violation|0|||
155590910|NCT01339923|561590466|FG005|Overall Study|Protocol Violation|3|||
155590911|NCT01339923|561590467|FG006|Overall Study|Protocol Violation|1|||
155590912|NCT01339923|561590461|FG000|Overall Study|Unable to Classify|1|||
155590913|NCT01339923|561590462|FG001|Overall Study|Unable to Classify|0|||
155590914|NCT01339923|561590463|FG002|Overall Study|Unable to Classify|1|||
155590915|NCT01339923|561590464|FG003|Overall Study|Unable to Classify|0|||
155590916|NCT01339923|561590465|FG004|Overall Study|Unable to Classify|0|||
155590917|NCT01339923|561590466|FG005|Overall Study|Unable to Classify|1|||
155590918|NCT01339923|561590467|FG006|Overall Study|Unable to Classify|5|||
155590919|NCT01339923|561590461|FG000|Overall Study|Withdrawal by Subject|7|||
155590920|NCT01339923|561590462|FG001|Overall Study|Withdrawal by Subject|11|||
155590921|NCT01339923|561590463|FG002|Overall Study|Withdrawal by Subject|6|||
155590922|NCT01339923|561590464|FG003|Overall Study|Withdrawal by Subject|1|||
155590923|NCT01339923|561590465|FG004|Overall Study|Withdrawal by Subject|4|||
155590924|NCT01339923|561590466|FG005|Overall Study|Withdrawal by Subject|3|||
155590925|NCT01339923|561590467|FG006|Overall Study|Withdrawal by Subject|2|||
155590926|NCT01430403|561590468|FG000|Overall Study|Lost to Follow-up|5|||
155590927|NCT01430403|561590469|FG001|Overall Study|Lost to Follow-up|5|||
155590928|NCT01430403|561590470|FG002|Overall Study|Lost to Follow-up|3|||
155590929|NCT01430403|561590468|FG000|Overall Study|Physician Decision|1|||
155590930|NCT01430403|561590469|FG001|Overall Study|Physician Decision|0|||
155590931|NCT01430403|561590470|FG002|Overall Study|Physician Decision|0|||
155590932|NCT01430403|561590468|FG000|Overall Study|Protocol Violation|2|||
155590933|NCT01430403|561590469|FG001|Overall Study|Protocol Violation|3|||
155590934|NCT01430403|561590470|FG002|Overall Study|Protocol Violation|2|||
155590935|NCT01430403|561590468|FG000|Overall Study|Withdrawal by Subject|9|||
155590936|NCT01430403|561590469|FG001|Overall Study|Withdrawal by Subject|1|||
155666758|NCT01824290|561875027|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
155666759|NCT00800982|561875028|FG000|Overall Study|Lost to Follow-up|1|||
155666760|NCT00800982|561875029|FG001|Overall Study|Lost to Follow-up|2|||
155666761|NCT00800982|561875028|FG000|Overall Study|Withdrawal by Subject|0|||
155666762|NCT00800982|561875029|FG001|Overall Study|Withdrawal by Subject|1|||
155666763|NCT00800982|561875028|FG000|Overall Study|Patient moved out of state|1|||
155666764|NCT00800982|561875029|FG001|Overall Study|Patient moved out of state|0|||
155666765|NCT00527618|561875030|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
155666766|NCT00527618|561875031|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
155590937|NCT01430403|561590470|FG002|Overall Study|Withdrawal by Subject|3|||
155590938|NCT01075256|561590474|FG000|Overall Study|Withdrawal by Subject|1|||
155590939|NCT01075256|561590475|FG001|Overall Study|Withdrawal by Subject|0|||
155590940|NCT01075256|561590476|FG002|Overall Study|Withdrawal by Subject|0|||
155590941|NCT03502070|561590477|FG000|Overall Study|Withdrawal by Subject|1|||
155590942|NCT03502070|561590477|FG000|Overall Study|Screen Failure|1|||
155590943|NCT00591565|561590486|FG000|Overall Study|lost follow up, withdrawn|5|||
155590944|NCT03850483|561590489|FG000|Treatment for Stage 1|Adverse Event|1|||
155666767|NCT00527618|561875030|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
155590945|NCT03850483|561590490|FG001|Treatment for Stage 1|Adverse Event|1|||
155590946|NCT03850483|561590491|FG002|Treatment for Stage 1|Adverse Event|3|||
155590947|NCT03850483|561590492|FG003|Treatment for Stage 1|Adverse Event|0|||
155590948|NCT03850483|561590493|FG004|Treatment for Stage 1|Adverse Event|2|||
155590949|NCT03850483|561590494|FG005|Treatment for Stage 1|Adverse Event|0|||
155590950|NCT03850483|561590495|FG006|Treatment for Stage 1|Adverse Event|2|||
155590951|NCT03850483|561590496|FG007|Treatment for Stage 1|Adverse Event|2|||
155590952|NCT03850483|561590497|FG008|Treatment for Stage 1|Adverse Event|0|||
155590953|NCT03850483|561590498|FG009|Treatment for Stage 1|Adverse Event|0|||
155590954|NCT03850483|561590489|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
155590955|NCT03850483|561590490|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
155590956|NCT03850483|561590491|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
155590957|NCT03850483|561590492|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
155590958|NCT03850483|561590493|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
155590959|NCT03850483|561590494|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
155590960|NCT03850483|561590495|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
155590961|NCT03850483|561590496|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
155590962|NCT03850483|561590497|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
155590963|NCT03850483|561590498|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
155590964|NCT03850483|561590489|FG000|Treatment for Stage 1|Protocol Violation|1|||
155590965|NCT03850483|561590490|FG001|Treatment for Stage 1|Protocol Violation|0|||
155590966|NCT03850483|561590491|FG002|Treatment for Stage 1|Protocol Violation|0|||
155590967|NCT03850483|561590492|FG003|Treatment for Stage 1|Protocol Violation|0|||
155590968|NCT03850483|561590493|FG004|Treatment for Stage 1|Protocol Violation|0|||
155590969|NCT03850483|561590494|FG005|Treatment for Stage 1|Protocol Violation|0|||
155590970|NCT03850483|561590495|FG006|Treatment for Stage 1|Protocol Violation|1|||
155590971|NCT03850483|561590496|FG007|Treatment for Stage 1|Protocol Violation|0|||
155590972|NCT03850483|561590497|FG008|Treatment for Stage 1|Protocol Violation|0|||
155590973|NCT03850483|561590498|FG009|Treatment for Stage 1|Protocol Violation|0|||
155590974|NCT03850483|561590489|FG000|Treatment for Stage 1|Physician Decision|0|||
155590975|NCT03850483|561590490|FG001|Treatment for Stage 1|Physician Decision|0|||
155590976|NCT03850483|561590491|FG002|Treatment for Stage 1|Physician Decision|0|||
155590977|NCT03850483|561590492|FG003|Treatment for Stage 1|Physician Decision|0|||
155590978|NCT03850483|561590493|FG004|Treatment for Stage 1|Physician Decision|0|||
155590979|NCT03850483|561590494|FG005|Treatment for Stage 1|Physician Decision|1|||
155590980|NCT03850483|561590495|FG006|Treatment for Stage 1|Physician Decision|0|||
155590981|NCT03850483|561590496|FG007|Treatment for Stage 1|Physician Decision|0|||
155590982|NCT03850483|561590497|FG008|Treatment for Stage 1|Physician Decision|0|||
155590983|NCT03850483|561590498|FG009|Treatment for Stage 1|Physician Decision|0|||
155590984|NCT03850483|561590489|FG000|Treatment for Stage 1|Other|0|||
155590985|NCT03850483|561590490|FG001|Treatment for Stage 1|Other|0|||
155590986|NCT03850483|561590491|FG002|Treatment for Stage 1|Other|0|||
155590987|NCT03850483|561590492|FG003|Treatment for Stage 1|Other|0|||
155590988|NCT03850483|561590493|FG004|Treatment for Stage 1|Other|2|||
155590989|NCT03850483|561590494|FG005|Treatment for Stage 1|Other|1|||
155590990|NCT03850483|561590495|FG006|Treatment for Stage 1|Other|0|||
155590991|NCT03850483|561590496|FG007|Treatment for Stage 1|Other|0|||
155590992|NCT03850483|561590497|FG008|Treatment for Stage 1|Other|0|||
155590993|NCT03850483|561590498|FG009|Treatment for Stage 1|Other|0|||
155590994|NCT03850483|561590489|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155590995|NCT03850483|561590490|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155590996|NCT03850483|561590491|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
155590997|NCT03850483|561590492|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155590998|NCT03850483|561590493|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155590999|NCT03850483|561590494|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155591000|NCT03850483|561590495|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155591001|NCT03850483|561590496|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155591002|NCT03850483|561590497|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155591003|NCT03850483|561590498|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155591004|NCT03850483|561590489|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591005|NCT03850483|561590490|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591006|NCT03850483|561590491|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591007|NCT03850483|561590492|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591008|NCT03850483|561590493|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591009|NCT03850483|561590494|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
155591010|NCT03850483|561590495|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591011|NCT03850483|561590496|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591012|NCT03850483|561590497|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591013|NCT03850483|561590498|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155591014|NCT03850483|561590489|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
155591015|NCT03850483|561590490|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
155591016|NCT03850483|561590491|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
155591017|NCT03850483|561590492|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
155591018|NCT03850483|561590493|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
155591019|NCT03850483|561590494|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
155591020|NCT03850483|561590495|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
155591021|NCT03850483|561590496|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
155591022|NCT03850483|561590497|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
155591023|NCT03850483|561590498|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
155591024|NCT03850483|561590489|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
155591025|NCT03850483|561590490|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
155591026|NCT03850483|561590491|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
155591027|NCT03850483|561590492|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
155591028|NCT03850483|561590493|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
155591029|NCT03850483|561590494|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
155591030|NCT03850483|561590495|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
155591031|NCT03850483|561590496|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
155591032|NCT03850483|561590497|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
155591033|NCT03850483|561590498|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
155591034|NCT03850483|561590489|FG000|Treatment for Stage 1|Death|0|||
155591035|NCT03850483|561590490|FG001|Treatment for Stage 1|Death|0|||
155591036|NCT03850483|561590491|FG002|Treatment for Stage 1|Death|0|||
155591037|NCT03850483|561590492|FG003|Treatment for Stage 1|Death|0|||
155591038|NCT03850483|561590493|FG004|Treatment for Stage 1|Death|0|||
155591039|NCT03850483|561590494|FG005|Treatment for Stage 1|Death|1|||
155591040|NCT03850483|561590495|FG006|Treatment for Stage 1|Death|0|||
155591041|NCT03850483|561590496|FG007|Treatment for Stage 1|Death|0|||
155591042|NCT03850483|561590497|FG008|Treatment for Stage 1|Death|0|||
155591043|NCT03850483|561590498|FG009|Treatment for Stage 1|Death|0|||
155591044|NCT03850483|561590489|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
155591045|NCT03850483|561590490|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
155591046|NCT03850483|561590491|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
155591047|NCT03850483|561590492|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
155591048|NCT03850483|561590493|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
155591049|NCT03850483|561590494|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
155591050|NCT03850483|561590495|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
155591051|NCT03850483|561590496|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
155591052|NCT03850483|561590497|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
155591053|NCT03850483|561590498|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
155591054|NCT03850483|561590489|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
155591055|NCT03850483|561590490|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
155591056|NCT03850483|561590491|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
155591057|NCT03850483|561590492|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
155591058|NCT03850483|561590493|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
155591059|NCT03850483|561590494|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
155591060|NCT03850483|561590495|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
155591061|NCT03850483|561590496|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
155591062|NCT03850483|561590497|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
155591063|NCT03850483|561590498|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
155591064|NCT03850483|561590489|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591065|NCT03850483|561590490|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591066|NCT03850483|561590491|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591067|NCT03850483|561590492|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591068|NCT03850483|561590493|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591069|NCT03850483|561590494|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591070|NCT03850483|561590495|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
155591071|NCT03850483|561590496|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
155591072|NCT03850483|561590497|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591073|NCT03850483|561590498|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
155591074|NCT03850483|561590489|FG000|Follow-up for Stage 1|Physician Decision|0|||
155591075|NCT03850483|561590490|FG001|Follow-up for Stage 1|Physician Decision|0|||
155591076|NCT03850483|561590491|FG002|Follow-up for Stage 1|Physician Decision|0|||
155591077|NCT03850483|561590492|FG003|Follow-up for Stage 1|Physician Decision|0|||
155591078|NCT03850483|561590493|FG004|Follow-up for Stage 1|Physician Decision|1|||
155591079|NCT03850483|561590494|FG005|Follow-up for Stage 1|Physician Decision|0|||
155591080|NCT03850483|561590495|FG006|Follow-up for Stage 1|Physician Decision|1|||
155591081|NCT03850483|561590496|FG007|Follow-up for Stage 1|Physician Decision|0|||
155591082|NCT03850483|561590497|FG008|Follow-up for Stage 1|Physician Decision|0|||
155591083|NCT03850483|561590498|FG009|Follow-up for Stage 1|Physician Decision|0|||
155591084|NCT03850483|561590489|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
155591085|NCT03850483|561590490|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
155591086|NCT03850483|561590491|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
155591087|NCT03850483|561590492|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
155591088|NCT03850483|561590493|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
155591089|NCT03850483|561590494|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
155591090|NCT03850483|561590495|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
155666768|NCT00527618|561875031|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
155666769|NCT00527618|561875030|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
155666770|NCT00527618|561875031|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
155666771|NCT00527618|561875030|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
155666772|NCT00527618|561875031|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
155666773|NCT00527618|561875030|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
155666774|NCT00527618|561875031|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
155666775|NCT00527618|561875030|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
155666776|NCT00527618|561875031|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
155666777|NCT02240121|561875032|FG000|Overall Study|Protocol Violation|1|||
155666778|NCT02240121|561875033|FG001|Overall Study|Protocol Violation|2|||
155666779|NCT02240121|561875032|FG000|Overall Study|Physician Decision|0|||
155666780|NCT02240121|561875033|FG001|Overall Study|Physician Decision|1|||
155666781|NCT02240121|561875032|FG000|Overall Study|Change in protocol interpretation|1|||
155666782|NCT02240121|561875033|FG001|Overall Study|Change in protocol interpretation|0|||
155666783|NCT02240121|561875032|FG000|Overall Study|Lack of Efficacy|2|||
155666784|NCT02240121|561875033|FG001|Overall Study|Lack of Efficacy|3|||
155666785|NCT02240121|561875032|FG000|Overall Study|Site closed|1|||
155666786|NCT02240121|561875033|FG001|Overall Study|Site closed|1|||
155666787|NCT02240121|561875032|FG000|Overall Study|Pregnancy|1|||
155666788|NCT02240121|561875033|FG001|Overall Study|Pregnancy|0|||
155666789|NCT02240121|561875032|FG000|Overall Study|Adverse Event|2|||
155666790|NCT02240121|561875033|FG001|Overall Study|Adverse Event|4|||
155666791|NCT02240121|561875032|FG000|Overall Study|Withdrawal by Subject|6|||
155666792|NCT02240121|561875033|FG001|Overall Study|Withdrawal by Subject|2|||
155666793|NCT02240121|561875032|FG000|Overall Study|Lost to Follow-up|3|||
155666794|NCT02240121|561875033|FG001|Overall Study|Lost to Follow-up|4|||
155666795|NCT02240121|561875032|FG000|Overall Study|Other than specified|1|||
155666796|NCT02240121|561875033|FG001|Overall Study|Other than specified|3|||
155666797|NCT00846846|561875034|FG000|Overall Study|Death|56|||
155666798|NCT00846846|561875034|FG000|Overall Study|Withdrawal by Subject|19|||
155666799|NCT02103062|561875039|FG000|Overall Study|Adverse Event|1|||
155666800|NCT02103062|561875040|FG001|Overall Study|Adverse Event|2|||
155666801|NCT02103062|561875039|FG000|Overall Study|Progressive Disease|17|||
155666802|NCT02103062|561875040|FG001|Overall Study|Progressive Disease|20|||
155666803|NCT02103062|561875039|FG000|Overall Study|Death|0|||
155666804|NCT02103062|561875040|FG001|Overall Study|Death|1|||
155666805|NCT00959907|561875042|FG000|Overall Study|Protocol Violation|0|||
155666806|NCT00959907|561875043|FG001|Overall Study|Protocol Violation|1|||
155666807|NCT00959907|561875042|FG000|Overall Study|Adverse Event|1|||
155666808|NCT00959907|561875043|FG001|Overall Study|Adverse Event|0|||
155666809|NCT00959907|561875042|FG000|Overall Study|Withdrawal by Subject|2|||
155666810|NCT00959907|561875043|FG001|Overall Study|Withdrawal by Subject|0|||
155666811|NCT03958331|561875044|FG000|Overall Study|Withdrawal by Subject|3|||
155666812|NCT03958331|561875045|FG001|Overall Study|Withdrawal by Subject|1|||
155666813|NCT03958331|561875046|FG002|Overall Study|Withdrawal by Subject|5|||
155666814|NCT03958331|561875044|FG000|Overall Study|Weaned from medicine|2|||
155666815|NCT03958331|561875045|FG001|Overall Study|Weaned from medicine|0|||
155666816|NCT03958331|561875046|FG002|Overall Study|Weaned from medicine|0|||
155666817|NCT03958331|561875044|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
155666818|NCT03958331|561875045|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
155666819|NCT03958331|561875046|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
155666820|NCT01991483|561875047|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
155666821|NCT01991483|561875048|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
155666822|NCT01991483|561875049|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
155666823|NCT01991483|561875050|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
155666824|NCT01991483|561875047|FG000|Dose Level 600 mg|Physician Decision|0|||
155666825|NCT01991483|561875048|FG001|Dose Level 600 mg|Physician Decision|0|||
155666826|NCT01991483|561875049|FG002|Dose Level 600 mg|Physician Decision|1|||
155666827|NCT01991483|561875050|FG003|Dose Level 600 mg|Physician Decision|0|||
155666828|NCT01991483|561875047|FG000|Dose Level 1000 mg|Protocol Violation|0|||
155666829|NCT01991483|561875048|FG001|Dose Level 1000 mg|Protocol Violation|0|||
155666830|NCT01991483|561875049|FG002|Dose Level 1000 mg|Protocol Violation|0|||
155666831|NCT01991483|561875050|FG003|Dose Level 1000 mg|Protocol Violation|1|||
155666832|NCT02030821|561875053|FG000|Overall Study|Physician Decision|2|||
155666833|NCT02030821|561875054|FG001|Overall Study|Physician Decision|2|||
155666834|NCT02030821|561875055|FG002|Overall Study|Physician Decision|5|||
155666835|NCT02030821|561875056|FG003|Overall Study|Physician Decision|2|||
155666836|NCT01634152|561875068|FG000|Overall Study|Adverse Event|2|||
155666837|NCT01634152|561875069|FG001|Overall Study|Adverse Event|0|||
155666838|NCT01634152|561875070|FG002|Overall Study|Adverse Event|2|||
155666839|NCT01634152|561875068|FG000|Overall Study|Consent withdrawn not due to AE|1|||
155666840|NCT01634152|561875069|FG001|Overall Study|Consent withdrawn not due to AE|0|||
155666841|NCT01634152|561875070|FG002|Overall Study|Consent withdrawn not due to AE|1|||
155666842|NCT01634152|561875068|FG000|Overall Study|Not treated|0|||
155666843|NCT01634152|561875069|FG001|Overall Study|Not treated|1|||
155591091|NCT03850483|561590496|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
155591092|NCT03850483|561590497|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
155591093|NCT03850483|561590498|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
155591094|NCT03850483|561590489|FG000|Follow-up for Stage 1|Adverse Event|0|||
155591095|NCT03850483|561590490|FG001|Follow-up for Stage 1|Adverse Event|0|||
155591096|NCT03850483|561590491|FG002|Follow-up for Stage 1|Adverse Event|1|||
155591097|NCT03850483|561590492|FG003|Follow-up for Stage 1|Adverse Event|0|||
155591098|NCT03850483|561590493|FG004|Follow-up for Stage 1|Adverse Event|0|||
155591099|NCT03850483|561590494|FG005|Follow-up for Stage 1|Adverse Event|1|||
155591100|NCT03850483|561590495|FG006|Follow-up for Stage 1|Adverse Event|0|||
155591101|NCT03850483|561590496|FG007|Follow-up for Stage 1|Adverse Event|0|||
155591102|NCT03850483|561590497|FG008|Follow-up for Stage 1|Adverse Event|0|||
155591103|NCT03850483|561590498|FG009|Follow-up for Stage 1|Adverse Event|0|||
155591104|NCT03850483|561590489|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591105|NCT03850483|561590490|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
155591106|NCT03850483|561590491|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591107|NCT03850483|561590492|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591108|NCT03850483|561590493|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
155591109|NCT03850483|561590494|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
155591110|NCT03850483|561590495|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591111|NCT03850483|561590496|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591112|NCT03850483|561590497|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591113|NCT03850483|561590498|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155591114|NCT03850483|561590489|FG000|Follow-up for Stage 1|Other|0|||
155591115|NCT03850483|561590490|FG001|Follow-up for Stage 1|Other|2|||
155591116|NCT03850483|561590491|FG002|Follow-up for Stage 1|Other|0|||
155591117|NCT03850483|561590492|FG003|Follow-up for Stage 1|Other|2|||
155591118|NCT03850483|561590493|FG004|Follow-up for Stage 1|Other|0|||
155591119|NCT03850483|561590494|FG005|Follow-up for Stage 1|Other|1|||
155591120|NCT03850483|561590495|FG006|Follow-up for Stage 1|Other|0|||
155591121|NCT03850483|561590496|FG007|Follow-up for Stage 1|Other|0|||
155591122|NCT03850483|561590497|FG008|Follow-up for Stage 1|Other|0|||
155591123|NCT03850483|561590498|FG009|Follow-up for Stage 1|Other|0|||
155591124|NCT03850483|561590489|FG000|Treatment for Stage 2|Adverse Event|0|||
155591125|NCT03850483|561590490|FG001|Treatment for Stage 2|Adverse Event|0|||
155591126|NCT03850483|561590491|FG002|Treatment for Stage 2|Adverse Event|0|||
155591127|NCT03850483|561590492|FG003|Treatment for Stage 2|Adverse Event|0|||
155591128|NCT03850483|561590493|FG004|Treatment for Stage 2|Adverse Event|0|||
155591129|NCT03850483|561590494|FG005|Treatment for Stage 2|Adverse Event|0|||
155591130|NCT03850483|561590495|FG006|Treatment for Stage 2|Adverse Event|0|||
155591131|NCT03850483|561590496|FG007|Treatment for Stage 2|Adverse Event|0|||
155591132|NCT03850483|561590497|FG008|Treatment for Stage 2|Adverse Event|0|||
155591133|NCT03850483|561590498|FG009|Treatment for Stage 2|Adverse Event|1|||
155591134|NCT03850483|561590489|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
155591135|NCT03850483|561590490|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
155591136|NCT03850483|561590491|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
155591137|NCT03850483|561590492|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
155591138|NCT03850483|561590493|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
155591139|NCT03850483|561590494|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
155591140|NCT03850483|561590495|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
155591141|NCT03850483|561590496|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
155591142|NCT03850483|561590497|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
155591143|NCT03850483|561590498|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
155591144|NCT03850483|561590489|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
155591145|NCT03850483|561590490|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
155591146|NCT03850483|561590491|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
155591147|NCT03850483|561590492|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
155591148|NCT03850483|561590493|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
155591149|NCT03850483|561590494|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
155591150|NCT03850483|561590495|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
155591151|NCT03850483|561590496|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
155591152|NCT03850483|561590497|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
155591153|NCT03850483|561590498|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
155591154|NCT03850483|561590489|FG000|Treatment for Stage 2|Physician Decision|0|||
155591155|NCT03850483|561590490|FG001|Treatment for Stage 2|Physician Decision|0|||
155591156|NCT03850483|561590491|FG002|Treatment for Stage 2|Physician Decision|0|||
155591157|NCT03850483|561590492|FG003|Treatment for Stage 2|Physician Decision|0|||
155591158|NCT03850483|561590493|FG004|Treatment for Stage 2|Physician Decision|0|||
155591159|NCT03850483|561590494|FG005|Treatment for Stage 2|Physician Decision|0|||
155591160|NCT03850483|561590495|FG006|Treatment for Stage 2|Physician Decision|0|||
155591161|NCT03850483|561590496|FG007|Treatment for Stage 2|Physician Decision|0|||
155591162|NCT03850483|561590497|FG008|Treatment for Stage 2|Physician Decision|0|||
155591163|NCT03850483|561590498|FG009|Treatment for Stage 2|Physician Decision|1|||
155591164|NCT03850483|561590489|FG000|Treatment for Stage 2|Protocol Violation|0|||
155591165|NCT03850483|561590490|FG001|Treatment for Stage 2|Protocol Violation|0|||
155591166|NCT03850483|561590491|FG002|Treatment for Stage 2|Protocol Violation|0|||
155591167|NCT03850483|561590492|FG003|Treatment for Stage 2|Protocol Violation|0|||
155591168|NCT03850483|561590493|FG004|Treatment for Stage 2|Protocol Violation|0|||
155591169|NCT03850483|561590494|FG005|Treatment for Stage 2|Protocol Violation|0|||
155591170|NCT03850483|561590495|FG006|Treatment for Stage 2|Protocol Violation|0|||
155591171|NCT03850483|561590496|FG007|Treatment for Stage 2|Protocol Violation|0|||
155591172|NCT03850483|561590497|FG008|Treatment for Stage 2|Protocol Violation|1|||
155591173|NCT03850483|561590498|FG009|Treatment for Stage 2|Protocol Violation|0|||
155591174|NCT03850483|561590489|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
155591175|NCT03850483|561590490|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
155591176|NCT03850483|561590491|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
155591177|NCT03850483|561590492|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
155591178|NCT03850483|561590493|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
155591179|NCT03850483|561590494|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
155591180|NCT03850483|561590495|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
155591181|NCT03850483|561590496|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
155591182|NCT03850483|561590497|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
155591183|NCT03850483|561590498|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
155591184|NCT03850483|561590489|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591185|NCT03850483|561590490|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591186|NCT03850483|561590491|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591187|NCT03850483|561590492|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591188|NCT03850483|561590493|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591189|NCT03850483|561590494|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591190|NCT03850483|561590495|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591191|NCT03850483|561590496|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591192|NCT03850483|561590497|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155591193|NCT03850483|561590498|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
155591194|NCT03850483|561590489|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
155591195|NCT03850483|561590490|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
155591196|NCT03850483|561590491|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
155591197|NCT03850483|561590492|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
155591198|NCT03850483|561590493|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
155591199|NCT03850483|561590494|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
155591200|NCT03850483|561590495|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
155591201|NCT03850483|561590496|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
155591202|NCT03850483|561590497|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
155591203|NCT03850483|561590498|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
155591204|NCT03850483|561590489|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
155591205|NCT03850483|561590490|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
155591206|NCT03850483|561590491|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
155591207|NCT03850483|561590492|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
155591208|NCT03850483|561590493|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
155591209|NCT03850483|561590494|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
155591210|NCT03850483|561590495|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
155591211|NCT03850483|561590496|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
155591212|NCT03850483|561590497|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
155591213|NCT03850483|561590498|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
155591214|NCT03850483|561590489|FG000|Follow-up For Stage 2|Other|0|||
155591215|NCT03850483|561590490|FG001|Follow-up For Stage 2|Other|0|||
155591216|NCT03850483|561590491|FG002|Follow-up For Stage 2|Other|0|||
155591217|NCT03850483|561590492|FG003|Follow-up For Stage 2|Other|0|||
155591218|NCT03850483|561590493|FG004|Follow-up For Stage 2|Other|0|||
155591219|NCT03850483|561590494|FG005|Follow-up For Stage 2|Other|0|||
155591220|NCT03850483|561590495|FG006|Follow-up For Stage 2|Other|0|||
155591221|NCT03850483|561590496|FG007|Follow-up For Stage 2|Other|0|||
155591222|NCT03850483|561590497|FG008|Follow-up For Stage 2|Other|0|||
155591223|NCT03850483|561590498|FG009|Follow-up For Stage 2|Other|1|||
155591224|NCT03232931|561592085|FG000|Overall Study|Physician Decision|1|||
155591225|NCT03232931|561592086|FG001|Overall Study|Physician Decision|1|||
155591226|NCT03232931|561592085|FG000|Overall Study|Withdrawal by Subject|6|||
155591227|NCT03232931|561592086|FG001|Overall Study|Withdrawal by Subject|0|||
155591228|NCT03232931|561592085|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
155591229|NCT03232931|561592086|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
155591230|NCT03232931|561592085|FG000|Overall Study|Parent did not record voice|1|||
155591231|NCT03232931|561592086|FG001|Overall Study|Parent did not record voice|2|||
155591232|NCT03232931|561592085|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
155591233|NCT03232931|561592086|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
155666844|NCT01634152|561875070|FG002|Overall Study|Not treated|0|||
155591234|NCT04925557|561592087|FG000|Overall Study|Study closed|5|||
155666845|NCT01634152|561875068|FG000|Overall Study|Other reason not defined above|1|||
155666846|NCT01634152|561875069|FG001|Overall Study|Other reason not defined above|0|||
155666847|NCT01634152|561875070|FG002|Overall Study|Other reason not defined above|1|||
155666848|NCT01900665|561875072|FG000|Placebo Controlled Period|Death|9|||
155666849|NCT01900665|561875073|FG001|Placebo Controlled Period|Death|16|||
155666850|NCT01900665|561875072|FG000|Placebo Controlled Period|Adverse Event|48|||
155666851|NCT01900665|561875073|FG001|Placebo Controlled Period|Adverse Event|39|||
155666852|NCT01900665|561875072|FG000|Placebo Controlled Period|Protocol Violation|1|||
155666853|NCT01900665|561875073|FG001|Placebo Controlled Period|Protocol Violation|7|||
155666854|NCT01900665|561875072|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
155666855|NCT01900665|561875073|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
155666856|NCT01900665|561875072|FG000|Placebo Controlled Period|Physician Decision|11|||
155666857|NCT01900665|561875073|FG001|Placebo Controlled Period|Physician Decision|7|||
155666858|NCT01900665|561875072|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
155666859|NCT01900665|561875073|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
155666860|NCT01900665|561875072|FG000|Placebo Controlled Period|Caregiver Decision|33|||
155666861|NCT01900665|561875073|FG001|Placebo Controlled Period|Caregiver Decision|41|||
155666862|NCT01900665|561875072|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
155666863|NCT01900665|561875073|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
155666864|NCT01900665|561875072|FG000|Open Label Period|Adverse Event|16|||
155591235|NCT04925557|561592088|FG001|Overall Study|Study closed|3|||
155591236|NCT05488470|561592089|FG000|Overall Study|Physician Decision|2|||
155591237|NCT05488470|561592089|FG000|Overall Study|Withdrawal by Subject|1|||
155591238|NCT05488470|561592089|FG000|Overall Study|Death|1|||
155591239|NCT01283334|561592090|FG000|Overall Study|Withdrawal by Subject|1|||
155591240|NCT01283334|561592090|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
155591241|NCT01283334|561592090|FG000|Overall Study|Adverse Event|4|||
155591242|NCT01283334|561592090|FG000|Overall Study|Physician Decision|1|||
155591243|NCT04981470|561592093|FG000|Overall Study|Device failure in all 4 patients|4|||
155591244|NCT04402138|561592094|FG000|Overall Study|Progressive Disease|2|||
155591245|NCT04402138|561592094|FG000|Overall Study|Adverse Event|1|||
155591246|NCT00784238|561592095|FG000|Overall Study|Adverse Event|14|||
155591247|NCT00784238|561592095|FG000|Overall Study|Death|2|||
155591248|NCT00784238|561592095|FG000|Overall Study|Lack of Efficacy|33|||
155591249|NCT00784238|561592095|FG000|Overall Study|Lost to Follow-up|29|||
155591250|NCT00784238|561592095|FG000|Overall Study|Pregnancy|1|||
155591251|NCT00784238|561592095|FG000|Overall Study|Withdrawal by Subject|26|||
155591252|NCT00784238|561592095|FG000|Overall Study|Other|14|||
155591253|NCT04390503|561592097|FG000|Overall Study|Physician Decision|2|||
155591254|NCT04390503|561592098|FG001|Overall Study|Physician Decision|1|||
155591255|NCT04390503|561592097|FG000|Overall Study|Adverse Event|1|||
155591256|NCT04390503|561592098|FG001|Overall Study|Adverse Event|0|||
155591257|NCT00078767|561592099|FG000|Overall Study|Withdrawal by Subject|1|||
155591258|NCT00078767|561592100|FG001|Overall Study|Withdrawal by Subject|1|||
155591259|NCT03508726|561592101|FG000|Overall Study|Withdrawal by Subject|0|||
155591260|NCT03508726|561592102|FG001|Overall Study|Withdrawal by Subject|1|||
155591261|NCT01068730|561592103|FG000|Period 3|Personal reason|1|||
155591262|NCT01068730|561592104|FG001|Period 3|Personal reason|0|||
155591263|NCT01068730|561592105|FG002|Period 3|Personal reason|0|||
155591264|NCT01068730|561592106|FG003|Period 3|Personal reason|0|||
155591265|NCT01068730|561592103|FG000|Period 4|Family emergency|0|||
155591266|NCT01068730|561592104|FG001|Period 4|Family emergency|1|||
155591267|NCT01068730|561592105|FG002|Period 4|Family emergency|0|||
155591268|NCT01068730|561592106|FG003|Period 4|Family emergency|0|||
155591269|NCT03233529|561592114|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
155591270|NCT03233529|561592114|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
155591271|NCT03260244|561592115|FG000|Overall Study|Death|19|||
155591272|NCT03260244|561592115|FG000|Overall Study|Lost to Follow-up|60|||
155591273|NCT03260244|561592115|FG000|Overall Study|Withdrawal by Subject|48|||
155591274|NCT03260244|561592115|FG000|Overall Study|Procedure Not Performed|21|||
155591275|NCT03260244|561592115|FG000|Overall Study|Enrollment Criteria Not Met|31|||
155591276|NCT03260244|561592115|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
155591277|NCT03260244|561592115|FG000|Overall Study|Subject Noncompliance|6|||
155591278|NCT03260244|561592115|FG000|Overall Study|No inducible Arrhythmia|2|||
155591279|NCT03260244|561592115|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
155591280|NCT03260244|561592115|FG000|Overall Study|Screen Failure|2|||
155591281|NCT03260244|561592115|FG000|Overall Study|Treated Off Label|69|||
155591282|NCT03260244|561592115|FG000|Overall Study|No Radiofrequency Ablation|14|||
155666865|NCT01900665|561875073|FG001|Open Label Period|Adverse Event|20|||
155591283|NCT01177293|561592116|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
155666866|NCT01900665|561875072|FG000|Open Label Period|Death|5|||
155666867|NCT01900665|561875073|FG001|Open Label Period|Death|6|||
155591284|NCT01177293|561592117|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
155591285|NCT00594100|561592120|FG000|Procedure|Technical Failure|9|||
155591286|NCT00594100|561592120|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
155591287|NCT00594100|561592120|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
155666868|NCT01900665|561875072|FG000|Open Label Period|Lost to Follow-up|1|||
155666869|NCT01900665|561875073|FG001|Open Label Period|Lost to Follow-up|1|||
155666870|NCT01900665|561875072|FG000|Open Label Period|Parent/Caregiver Decision|33|||
155666871|NCT01900665|561875073|FG001|Open Label Period|Parent/Caregiver Decision|34|||
155666872|NCT01900665|561875072|FG000|Open Label Period|Physician Decision|4|||
155666873|NCT01900665|561875073|FG001|Open Label Period|Physician Decision|4|||
155666874|NCT01900665|561875072|FG000|Open Label Period|Protocol Violation|0|||
155666875|NCT01900665|561875073|FG001|Open Label Period|Protocol Violation|1|||
155666876|NCT01900665|561875072|FG000|Open Label Period|Sponsor Decision|802|||
155666877|NCT01900665|561875073|FG001|Open Label Period|Sponsor Decision|765|||
155666878|NCT01900665|561875072|FG000|Open Label Period|Withdrawal by Subject|20|||
155666879|NCT01900665|561875073|FG001|Open Label Period|Withdrawal by Subject|28|||
155666880|NCT04046939|561875074|FG000|Primary Assessment Period|Adverse Event|1|||
155666881|NCT04046939|561875075|FG001|Primary Assessment Period|Adverse Event|0|||
155666882|NCT04046939|561875076|FG002|Primary Assessment Period|Adverse Event|0|||
155666883|NCT04046939|561875077|FG003|Primary Assessment Period|Adverse Event|0|||
155666884|NCT04046939|561875074|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
155666885|NCT04046939|561875075|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
155666886|NCT04046939|561875076|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
155666887|NCT04046939|561875077|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
155666888|NCT04046939|561875074|FG000|Primary Assessment Period|Physician Decision|0|||
155666889|NCT04046939|561875075|FG001|Primary Assessment Period|Physician Decision|0|||
155666890|NCT04046939|561875076|FG002|Primary Assessment Period|Physician Decision|1|||
155666891|NCT04046939|561875077|FG003|Primary Assessment Period|Physician Decision|0|||
155666892|NCT04046939|561875074|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
155666893|NCT04046939|561875075|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
155666894|NCT04046939|561875076|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
155666895|NCT04046939|561875077|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
155666896|NCT01897532|561875078|FG000|Discontinuation From Treatment|Not Treated|7|||
155666897|NCT01897532|561875079|FG001|Discontinuation From Treatment|Not Treated|5|||
155666898|NCT01897532|561875078|FG000|Discontinuation From Treatment|Other reason than specified|196|||
155666899|NCT01897532|561875079|FG001|Discontinuation From Treatment|Other reason than specified|176|||
155666900|NCT01897532|561875078|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
155666901|NCT01897532|561875079|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
155666902|NCT01897532|561875078|FG000|Discontinuation From Treatment|Non compliance|24|||
155666903|NCT01897532|561875079|FG001|Discontinuation From Treatment|Non compliance|15|||
155666904|NCT01897532|561875078|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
155666905|NCT01897532|561875079|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
155666906|NCT01897532|561875078|FG000|Discontinuation From Trial|Not Treated|7|||
155666907|NCT01897532|561875079|FG001|Discontinuation From Trial|Not Treated|5|||
155666908|NCT01897532|561875078|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
155666909|NCT01897532|561875079|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
155666910|NCT00953706|561875086|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
155666911|NCT00953706|561875087|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
155666912|NCT00953706|561875088|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
155666913|NCT00953706|561875089|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
155591288|NCT00594100|561592120|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
155591289|NCT02875613|561592125|FG000|Overall Study|Withdrawal by Subject|1|||
155591290|NCT02875613|561592125|FG000|Overall Study|Screen Failure|1|||
155591291|NCT02347774|561592126|FG000|Study Participation|Lost to Follow-up|3|||
155591292|NCT02347774|561592127|FG001|Study Participation|Lost to Follow-up|6|||
155591293|NCT02347774|561592128|FG002|Study Participation|Lost to Follow-up|2|||
155591294|NCT02347774|561592126|FG000|Study Participation|Withdrawal by Subject|8|||
155591295|NCT02347774|561592127|FG001|Study Participation|Withdrawal by Subject|9|||
155591296|NCT02347774|561592128|FG002|Study Participation|Withdrawal by Subject|15|||
155591297|NCT02347774|561592126|FG000|Study Participation|Adverse Event|1|||
155591298|NCT02347774|561592127|FG001|Study Participation|Adverse Event|4|||
155591299|NCT02347774|561592128|FG002|Study Participation|Adverse Event|6|||
155591300|NCT02347774|561592126|FG000|Study Participation|withdrew consent|1|||
155591301|NCT02347774|561592127|FG001|Study Participation|withdrew consent|1|||
155591302|NCT02347774|561592128|FG002|Study Participation|withdrew consent|1|||
155591303|NCT02347774|561592126|FG000|Study Participation|Met Prolonged QT criteria|1|||
155591304|NCT02347774|561592127|FG001|Study Participation|Met Prolonged QT criteria|0|||
155591305|NCT02347774|561592128|FG002|Study Participation|Met Prolonged QT criteria|0|||
155591306|NCT02347774|561592126|FG000|Study Participation|non-compliance with study drug|0|||
155591307|NCT02347774|561592127|FG001|Study Participation|non-compliance with study drug|1|||
155591308|NCT02347774|561592128|FG002|Study Participation|non-compliance with study drug|0|||
155591309|NCT02347774|561592126|FG000|Study Participation|incarceration|1|||
155591310|NCT02347774|561592127|FG001|Study Participation|incarceration|0|||
155591311|NCT02347774|561592128|FG002|Study Participation|incarceration|0|||
155591312|NCT02347774|561592126|FG000|Study Participation|randomized in error|0|||
155591313|NCT02347774|561592127|FG001|Study Participation|randomized in error|0|||
155591314|NCT02347774|561592128|FG002|Study Participation|randomized in error|1|||
155591315|NCT02347774|561592126|FG000|On Study Treatment|Adverse Event|9|||
155591316|NCT02347774|561592127|FG001|On Study Treatment|Adverse Event|15|||
155591317|NCT02347774|561592128|FG002|On Study Treatment|Adverse Event|19|||
155591318|NCT02347774|561592126|FG000|On Study Treatment|Lack of Efficacy|3|||
155591319|NCT02347774|561592127|FG001|On Study Treatment|Lack of Efficacy|0|||
155591320|NCT02347774|561592128|FG002|On Study Treatment|Lack of Efficacy|2|||
155591321|NCT02347774|561592126|FG000|On Study Treatment|non-complicance with study medication|0|||
155591322|NCT02347774|561592127|FG001|On Study Treatment|non-complicance with study medication|2|||
155591323|NCT02347774|561592128|FG002|On Study Treatment|non-complicance with study medication|0|||
155591324|NCT02347774|561592126|FG000|On Study Treatment|Protocol Violation|0|||
155591325|NCT02347774|561592127|FG001|On Study Treatment|Protocol Violation|0|||
155591326|NCT02347774|561592128|FG002|On Study Treatment|Protocol Violation|1|||
155591327|NCT02347774|561592126|FG000|On Study Treatment|withdrew consent|9|||
155591328|NCT02347774|561592127|FG001|On Study Treatment|withdrew consent|8|||
155591329|NCT02347774|561592128|FG002|On Study Treatment|withdrew consent|12|||
155591330|NCT02347774|561592126|FG000|On Study Treatment|Lost to Follow-up|2|||
155591331|NCT02347774|561592127|FG001|On Study Treatment|Lost to Follow-up|6|||
155591332|NCT02347774|561592128|FG002|On Study Treatment|Lost to Follow-up|1|||
155591333|NCT02347774|561592126|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
155591334|NCT02347774|561592127|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
155591335|NCT02347774|561592128|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
155591336|NCT02347774|561592126|FG000|On Study Treatment|ranomized in error|0|||
155591337|NCT02347774|561592127|FG001|On Study Treatment|ranomized in error|0|||
155591338|NCT02347774|561592128|FG002|On Study Treatment|ranomized in error|1|||
155591339|NCT04112043|561592130|FG000|Overall Study|Withdrawal by Subject|1|||
155591340|NCT04112043|561592131|FG001|Overall Study|Withdrawal by Subject|1|||
155591341|NCT04112043|561592132|FG002|Overall Study|Withdrawal by Subject|1|||
155591342|NCT04112043|561592130|FG000|Overall Study|Taking NR supplement|1|||
155591343|NCT04112043|561592131|FG001|Overall Study|Taking NR supplement|0|||
155591344|NCT04112043|561592132|FG002|Overall Study|Taking NR supplement|0|||
155591345|NCT04112043|561592130|FG000|Overall Study|Adverse Event|0|||
155591346|NCT04112043|561592131|FG001|Overall Study|Adverse Event|1|||
155591347|NCT04112043|561592132|FG002|Overall Study|Adverse Event|0|||
155591348|NCT02285166|561592135|FG000|Overall Study|Case Report Forms Uncollected|564|||
155591349|NCT02285166|561592135|FG000|Overall Study|Protocol Deviation|402|||
155591350|NCT00384839|561592140|FG000|Overall Study|Adverse Event|4|||
155591351|NCT00384839|561592140|FG000|Overall Study|Investigator Request|1|||
155591352|NCT00384839|561592140|FG000|Overall Study|Patient Request|1|||
155591353|NCT00384839|561592140|FG000|Overall Study|Ineligible|2|||
155591354|NCT01421225|561592143|FG000|Overall Study|Withdrawal by Subject|0|||
155591355|NCT01421225|561592144|FG001|Overall Study|Withdrawal by Subject|1|||
155591356|NCT02714595|561592145|FG000|Overall Study|Lost to Follow-up|1|||
155591357|NCT02714595|561592146|FG001|Overall Study|Lost to Follow-up|0|||
155591358|NCT02714595|561592145|FG000|Overall Study|Withdrawal by Subject|1|||
155591359|NCT02714595|561592146|FG001|Overall Study|Withdrawal by Subject|2|||
155666914|NCT00953706|561875086|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
155666915|NCT00953706|561875087|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
155666916|NCT00953706|561875088|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
155666917|NCT00953706|561875089|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
155666918|NCT00953706|561875086|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155666919|NCT00953706|561875087|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
155666920|NCT00953706|561875088|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155666921|NCT00953706|561875089|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155666922|NCT00953706|561875086|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155666923|NCT00953706|561875087|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
155666924|NCT00953706|561875088|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155666925|NCT00953706|561875089|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155666926|NCT00953706|561875086|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155666927|NCT00953706|561875087|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
155666928|NCT00953706|561875088|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155666929|NCT00953706|561875089|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155666930|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155666931|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155666932|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155666933|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
155666934|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
155666935|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
155666936|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
155666937|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
155666938|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155666939|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155666940|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155666941|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
155666942|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
155666943|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
155666944|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
155666945|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
155666946|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
155666947|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
155666948|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
155666949|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
155666950|NCT00953706|561875086|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
155666951|NCT00953706|561875087|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
155666952|NCT00953706|561875088|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
155666953|NCT00953706|561875089|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
155666954|NCT02549989|561876512|FG000|Overall Study|Adverse Event|4|||
155666955|NCT02549989|561876512|FG000|Overall Study|Death|1|||
155666956|NCT02549989|561876512|FG000|Overall Study|Lack of Efficacy|19|||
155666957|NCT02549989|561876512|FG000|Overall Study|Withdrawal by Subject|3|||
155666958|NCT01713582|561876516|FG000|Overall Study|Disease progression|3|||
155666959|NCT01713582|561876517|FG001|Overall Study|Disease progression|3|||
155666960|NCT01713582|561876518|FG002|Overall Study|Disease progression|3|||
155666961|NCT01713582|561876519|FG003|Overall Study|Disease progression|2|||
155666962|NCT01713582|561876520|FG004|Overall Study|Disease progression|3|||
155666963|NCT01713582|561876521|FG005|Overall Study|Disease progression|3|||
155666964|NCT01713582|561876522|FG006|Overall Study|Disease progression|3|||
155666965|NCT01713582|561876523|FG007|Overall Study|Disease progression|3|||
155666966|NCT01713582|561876524|FG008|Overall Study|Disease progression|3|||
155666967|NCT01713582|561876525|FG009|Overall Study|Disease progression|11|||
155666968|NCT01713582|561876526|FG010|Overall Study|Disease progression|10|||
155666969|NCT01713582|561876527|FG011|Overall Study|Disease progression|5|||
155666970|NCT01713582|561876528|FG012|Overall Study|Disease progression|3|||
155666971|NCT01713582|561876529|FG013|Overall Study|Disease progression|3|||
155666972|NCT01713582|561876530|FG014|Overall Study|Disease progression|6|||
155666973|NCT01713582|561876531|FG015|Overall Study|Disease progression|6|||
155666974|NCT01713582|561876532|FG016|Overall Study|Disease progression|5|||
155666975|NCT01713582|561876533|FG017|Overall Study|Disease progression|2|||
155666976|NCT01713582|561876534|FG018|Overall Study|Disease progression|3|||
155666977|NCT01713582|561876535|FG019|Overall Study|Disease progression|5|||
155666978|NCT01713582|561876536|FG020|Overall Study|Disease progression|15|||
155666979|NCT01713582|561876516|FG000|Overall Study|Death|0|||
155666980|NCT01713582|561876517|FG001|Overall Study|Death|0|||
155666981|NCT01713582|561876518|FG002|Overall Study|Death|0|||
155666982|NCT01713582|561876519|FG003|Overall Study|Death|1|||
155666983|NCT01713582|561876520|FG004|Overall Study|Death|1|||
155666984|NCT01713582|561876521|FG005|Overall Study|Death|3|||
155666985|NCT01713582|561876522|FG006|Overall Study|Death|3|||
155666986|NCT01713582|561876523|FG007|Overall Study|Death|2|||
155666987|NCT01713582|561876524|FG008|Overall Study|Death|3|||
155666988|NCT01713582|561876525|FG009|Overall Study|Death|4|||
155666989|NCT01713582|561876526|FG010|Overall Study|Death|3|||
155666990|NCT01713582|561876527|FG011|Overall Study|Death|0|||
155666991|NCT01713582|561876528|FG012|Overall Study|Death|0|||
155666992|NCT01713582|561876529|FG013|Overall Study|Death|0|||
155666993|NCT01713582|561876530|FG014|Overall Study|Death|0|||
155666994|NCT01713582|561876531|FG015|Overall Study|Death|0|||
155666995|NCT01713582|561876532|FG016|Overall Study|Death|0|||
155666996|NCT01713582|561876533|FG017|Overall Study|Death|0|||
155666997|NCT01713582|561876534|FG018|Overall Study|Death|0|||
155666998|NCT01713582|561876535|FG019|Overall Study|Death|0|||
155666999|NCT01713582|561876536|FG020|Overall Study|Death|0|||
155667000|NCT01713582|561876516|FG000|Overall Study|Adverse event-related|0|||
155667001|NCT01713582|561876517|FG001|Overall Study|Adverse event-related|0|||
155667002|NCT01713582|561876518|FG002|Overall Study|Adverse event-related|0|||
155667003|NCT01713582|561876519|FG003|Overall Study|Adverse event-related|0|||
155667004|NCT01713582|561876520|FG004|Overall Study|Adverse event-related|0|||
155667005|NCT01713582|561876521|FG005|Overall Study|Adverse event-related|0|||
155667006|NCT01713582|561876522|FG006|Overall Study|Adverse event-related|0|||
155667007|NCT01713582|561876523|FG007|Overall Study|Adverse event-related|0|||
155667008|NCT01713582|561876524|FG008|Overall Study|Adverse event-related|0|||
155667009|NCT01713582|561876525|FG009|Overall Study|Adverse event-related|1|||
155667010|NCT01713582|561876526|FG010|Overall Study|Adverse event-related|1|||
155667011|NCT01713582|561876527|FG011|Overall Study|Adverse event-related|0|||
155667012|NCT01713582|561876528|FG012|Overall Study|Adverse event-related|0|||
155667013|NCT01713582|561876529|FG013|Overall Study|Adverse event-related|0|||
155667014|NCT01713582|561876530|FG014|Overall Study|Adverse event-related|0|||
155667015|NCT01713582|561876531|FG015|Overall Study|Adverse event-related|0|||
155667016|NCT01713582|561876532|FG016|Overall Study|Adverse event-related|0|||
155667017|NCT01713582|561876533|FG017|Overall Study|Adverse event-related|0|||
155667018|NCT01713582|561876534|FG018|Overall Study|Adverse event-related|1|||
155667019|NCT01713582|561876535|FG019|Overall Study|Adverse event-related|0|||
155667020|NCT01713582|561876536|FG020|Overall Study|Adverse event-related|0|||
155667021|NCT01713582|561876516|FG000|Overall Study|Adverse event-unrelated|0|||
155667022|NCT01713582|561876517|FG001|Overall Study|Adverse event-unrelated|0|||
155667023|NCT01713582|561876518|FG002|Overall Study|Adverse event-unrelated|0|||
155667024|NCT01713582|561876519|FG003|Overall Study|Adverse event-unrelated|0|||
155667025|NCT01713582|561876520|FG004|Overall Study|Adverse event-unrelated|0|||
155667026|NCT01713582|561876521|FG005|Overall Study|Adverse event-unrelated|1|||
155667027|NCT01713582|561876522|FG006|Overall Study|Adverse event-unrelated|1|||
155667028|NCT01713582|561876523|FG007|Overall Study|Adverse event-unrelated|1|||
155667029|NCT01713582|561876524|FG008|Overall Study|Adverse event-unrelated|0|||
155667030|NCT01713582|561876525|FG009|Overall Study|Adverse event-unrelated|0|||
155667031|NCT01713582|561876526|FG010|Overall Study|Adverse event-unrelated|0|||
155667032|NCT01713582|561876527|FG011|Overall Study|Adverse event-unrelated|0|||
155667033|NCT01713582|561876528|FG012|Overall Study|Adverse event-unrelated|0|||
155667034|NCT01713582|561876529|FG013|Overall Study|Adverse event-unrelated|1|||
155667035|NCT01713582|561876530|FG014|Overall Study|Adverse event-unrelated|1|||
155667036|NCT01713582|561876531|FG015|Overall Study|Adverse event-unrelated|0|||
155667037|NCT01713582|561876532|FG016|Overall Study|Adverse event-unrelated|0|||
155667038|NCT01713582|561876533|FG017|Overall Study|Adverse event-unrelated|0|||
155667039|NCT01713582|561876534|FG018|Overall Study|Adverse event-unrelated|0|||
155667040|NCT01713582|561876535|FG019|Overall Study|Adverse event-unrelated|0|||
155667041|NCT01713582|561876536|FG020|Overall Study|Adverse event-unrelated|0|||
155667042|NCT01713582|561876516|FG000|Overall Study|Withdrawal of consent|0|||
155667043|NCT01713582|561876517|FG001|Overall Study|Withdrawal of consent|0|||
155667044|NCT01713582|561876518|FG002|Overall Study|Withdrawal of consent|1|||
155667045|NCT01713582|561876519|FG003|Overall Study|Withdrawal of consent|0|||
155667046|NCT01713582|561876520|FG004|Overall Study|Withdrawal of consent|0|||
155667047|NCT01713582|561876521|FG005|Overall Study|Withdrawal of consent|1|||
155667048|NCT01713582|561876522|FG006|Overall Study|Withdrawal of consent|0|||
155667049|NCT01713582|561876523|FG007|Overall Study|Withdrawal of consent|0|||
155667050|NCT01713582|561876524|FG008|Overall Study|Withdrawal of consent|0|||
155667051|NCT01713582|561876525|FG009|Overall Study|Withdrawal of consent|1|||
155667052|NCT01713582|561876526|FG010|Overall Study|Withdrawal of consent|0|||
155667053|NCT01713582|561876527|FG011|Overall Study|Withdrawal of consent|0|||
155667054|NCT01713582|561876528|FG012|Overall Study|Withdrawal of consent|0|||
155667055|NCT01713582|561876529|FG013|Overall Study|Withdrawal of consent|0|||
155667056|NCT01713582|561876530|FG014|Overall Study|Withdrawal of consent|0|||
155667057|NCT01713582|561876531|FG015|Overall Study|Withdrawal of consent|0|||
155667058|NCT01713582|561876532|FG016|Overall Study|Withdrawal of consent|0|||
155667059|NCT01713582|561876533|FG017|Overall Study|Withdrawal of consent|0|||
155667060|NCT01713582|561876534|FG018|Overall Study|Withdrawal of consent|1|||
155667061|NCT01713582|561876535|FG019|Overall Study|Withdrawal of consent|0|||
155667062|NCT01713582|561876536|FG020|Overall Study|Withdrawal of consent|0|||
155667063|NCT01713582|561876516|FG000|Overall Study|Lack of Efficacy|0|||
155667064|NCT01713582|561876517|FG001|Overall Study|Lack of Efficacy|0|||
155667065|NCT01713582|561876518|FG002|Overall Study|Lack of Efficacy|0|||
155667066|NCT01713582|561876519|FG003|Overall Study|Lack of Efficacy|0|||
155667067|NCT01713582|561876520|FG004|Overall Study|Lack of Efficacy|0|||
155667068|NCT01713582|561876521|FG005|Overall Study|Lack of Efficacy|0|||
155667069|NCT01713582|561876522|FG006|Overall Study|Lack of Efficacy|0|||
155667070|NCT01713582|561876523|FG007|Overall Study|Lack of Efficacy|0|||
155667071|NCT01713582|561876524|FG008|Overall Study|Lack of Efficacy|0|||
155667072|NCT01713582|561876525|FG009|Overall Study|Lack of Efficacy|1|||
155667073|NCT01713582|561876526|FG010|Overall Study|Lack of Efficacy|2|||
155667074|NCT01713582|561876527|FG011|Overall Study|Lack of Efficacy|0|||
155667075|NCT01713582|561876528|FG012|Overall Study|Lack of Efficacy|0|||
155667076|NCT01713582|561876529|FG013|Overall Study|Lack of Efficacy|0|||
155667077|NCT01713582|561876530|FG014|Overall Study|Lack of Efficacy|0|||
155667078|NCT01713582|561876531|FG015|Overall Study|Lack of Efficacy|0|||
155667079|NCT01713582|561876532|FG016|Overall Study|Lack of Efficacy|0|||
155667080|NCT01713582|561876533|FG017|Overall Study|Lack of Efficacy|0|||
155667081|NCT01713582|561876534|FG018|Overall Study|Lack of Efficacy|0|||
155667082|NCT01713582|561876535|FG019|Overall Study|Lack of Efficacy|0|||
155667083|NCT01713582|561876536|FG020|Overall Study|Lack of Efficacy|0|||
155667084|NCT01713582|561876516|FG000|Overall Study|Withdrawal by Subject|0|||
155667085|NCT01713582|561876517|FG001|Overall Study|Withdrawal by Subject|0|||
155667086|NCT01713582|561876518|FG002|Overall Study|Withdrawal by Subject|0|||
155667087|NCT01713582|561876519|FG003|Overall Study|Withdrawal by Subject|0|||
155667088|NCT01713582|561876520|FG004|Overall Study|Withdrawal by Subject|0|||
155667089|NCT01713582|561876521|FG005|Overall Study|Withdrawal by Subject|0|||
155667090|NCT01713582|561876522|FG006|Overall Study|Withdrawal by Subject|0|||
155667091|NCT01713582|561876523|FG007|Overall Study|Withdrawal by Subject|0|||
155667092|NCT01713582|561876524|FG008|Overall Study|Withdrawal by Subject|0|||
155667093|NCT01713582|561876525|FG009|Overall Study|Withdrawal by Subject|0|||
155667094|NCT01713582|561876526|FG010|Overall Study|Withdrawal by Subject|0|||
155667095|NCT01713582|561876527|FG011|Overall Study|Withdrawal by Subject|0|||
155667096|NCT01713582|561876528|FG012|Overall Study|Withdrawal by Subject|0|||
155667097|NCT01713582|561876529|FG013|Overall Study|Withdrawal by Subject|0|||
155667098|NCT01713582|561876530|FG014|Overall Study|Withdrawal by Subject|0|||
155667099|NCT01713582|561876531|FG015|Overall Study|Withdrawal by Subject|0|||
155667100|NCT01713582|561876532|FG016|Overall Study|Withdrawal by Subject|0|||
155667101|NCT01713582|561876533|FG017|Overall Study|Withdrawal by Subject|1|||
155667102|NCT01713582|561876534|FG018|Overall Study|Withdrawal by Subject|0|||
155667103|NCT01713582|561876535|FG019|Overall Study|Withdrawal by Subject|0|||
155667104|NCT01713582|561876536|FG020|Overall Study|Withdrawal by Subject|0|||
155667105|NCT01713582|561876516|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
155667106|NCT01713582|561876517|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
155667107|NCT01713582|561876518|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
155667108|NCT01713582|561876519|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
155667109|NCT01713582|561876520|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
155667110|NCT01713582|561876521|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
155667111|NCT01713582|561876522|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
155667112|NCT01713582|561876523|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
155667113|NCT01713582|561876524|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
155667114|NCT01713582|561876525|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
155667115|NCT01713582|561876526|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
155667116|NCT01713582|561876527|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
155667117|NCT01713582|561876528|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
155667118|NCT01713582|561876529|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
155667119|NCT01713582|561876530|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
155667120|NCT01713582|561876531|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
155667121|NCT01713582|561876532|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
155667122|NCT01713582|561876533|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
155667123|NCT01713582|561876534|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
155667124|NCT01713582|561876535|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
155667125|NCT01713582|561876536|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
155667126|NCT01713582|561876516|FG000|Overall Study|Disease progression and adverse event|0|||
155667127|NCT01713582|561876517|FG001|Overall Study|Disease progression and adverse event|0|||
155667128|NCT01713582|561876518|FG002|Overall Study|Disease progression and adverse event|0|||
155667129|NCT01713582|561876519|FG003|Overall Study|Disease progression and adverse event|0|||
155667130|NCT01713582|561876520|FG004|Overall Study|Disease progression and adverse event|0|||
155667131|NCT01713582|561876521|FG005|Overall Study|Disease progression and adverse event|0|||
155667132|NCT01713582|561876522|FG006|Overall Study|Disease progression and adverse event|0|||
155667133|NCT01713582|561876523|FG007|Overall Study|Disease progression and adverse event|0|||
155667134|NCT01713582|561876524|FG008|Overall Study|Disease progression and adverse event|0|||
155667135|NCT01713582|561876525|FG009|Overall Study|Disease progression and adverse event|0|||
155667136|NCT01713582|561876526|FG010|Overall Study|Disease progression and adverse event|0|||
155667137|NCT01713582|561876527|FG011|Overall Study|Disease progression and adverse event|0|||
155667138|NCT01713582|561876528|FG012|Overall Study|Disease progression and adverse event|0|||
155667139|NCT01713582|561876529|FG013|Overall Study|Disease progression and adverse event|0|||
155667140|NCT01713582|561876530|FG014|Overall Study|Disease progression and adverse event|0|||
155667141|NCT01713582|561876531|FG015|Overall Study|Disease progression and adverse event|0|||
155667142|NCT01713582|561876532|FG016|Overall Study|Disease progression and adverse event|1|||
155667143|NCT01713582|561876533|FG017|Overall Study|Disease progression and adverse event|0|||
155667144|NCT01713582|561876534|FG018|Overall Study|Disease progression and adverse event|0|||
155667145|NCT01713582|561876535|FG019|Overall Study|Disease progression and adverse event|0|||
155667146|NCT01713582|561876536|FG020|Overall Study|Disease progression and adverse event|0|||
155667147|NCT04776161|561876537|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
155667148|NCT04776161|561876538|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
155667149|NCT04776161|561876539|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
155667150|NCT04776161|561876537|FG000|Overall Study|Withdrawal by Subject|1|||
155667151|NCT04776161|561876538|FG001|Overall Study|Withdrawal by Subject|0|||
155667152|NCT04776161|561876539|FG002|Overall Study|Withdrawal by Subject|1|||
155667153|NCT04776161|561876537|FG000|Overall Study|Adverse Event|0|||
155667154|NCT04776161|561876538|FG001|Overall Study|Adverse Event|1|||
155667155|NCT04776161|561876539|FG002|Overall Study|Adverse Event|1|||
155667156|NCT00342628|561876540|FG000|Overall Study|Withdrawal by Subject|19|||
155667157|NCT00342628|561876541|FG001|Overall Study|Withdrawal by Subject|19|||
155667158|NCT00342628|561876542|FG002|Overall Study|Withdrawal by Subject|18|||
155667159|NCT00342628|561876540|FG000|Overall Study|Death|1|||
155667160|NCT00342628|561876541|FG001|Overall Study|Death|1|||
155667161|NCT00342628|561876542|FG002|Overall Study|Death|0|||
155667162|NCT00342628|561876540|FG000|Overall Study|moved residence|0|||
155667163|NCT00342628|561876541|FG001|Overall Study|moved residence|1|||
155667164|NCT00342628|561876542|FG002|Overall Study|moved residence|1|||
155667165|NCT03846427|561876543|FG000|Overall Study|Death|13|||
155667166|NCT03846427|561876543|FG000|Overall Study|Withdrawal by Subject|3|||
155667167|NCT03846427|561876543|FG000|Overall Study|Physician Decision|1|||
155667168|NCT01334554|561876544|FG000|Overall Study|Adverse Event|4|||
155667169|NCT01334554|561876545|FG001|Overall Study|Adverse Event|2|||
155667170|NCT02393859|561876547|FG000|Overall Study|Decision by Sponsor|2|||
155667171|NCT02393859|561876548|FG001|Overall Study|Decision by Sponsor|4|||
155667172|NCT02393859|561876547|FG000|Overall Study|Withdrawal by Subject|11|||
155667173|NCT02393859|561876548|FG001|Overall Study|Withdrawal by Subject|6|||
155667174|NCT02393859|561876547|FG000|Overall Study|Death|27|||
155667175|NCT02393859|561876548|FG001|Overall Study|Death|10|||
155667176|NCT02393859|561876547|FG000|Overall Study|Lost to Follow-up|1|||
155667177|NCT02393859|561876548|FG001|Overall Study|Lost to Follow-up|1|||
155667178|NCT00954447|561876549|FG000|Overall Study|Adverse Event|33|||
155667179|NCT00954447|561876550|FG001|Overall Study|Adverse Event|25|||
155667180|NCT00954447|561876549|FG000|Overall Study|Lack of Efficacy|17|||
155667181|NCT00954447|561876550|FG001|Overall Study|Lack of Efficacy|3|||
155667182|NCT00954447|561876549|FG000|Overall Study|Protocol Violation|5|||
155667183|NCT00954447|561876550|FG001|Overall Study|Protocol Violation|7|||
155667184|NCT00954447|561876549|FG000|Overall Study|Lost to Follow-up|8|||
155667185|NCT00954447|561876550|FG001|Overall Study|Lost to Follow-up|14|||
155667186|NCT00954447|561876549|FG000|Overall Study|Withdrawal by Subject|26|||
155667187|NCT00954447|561876550|FG001|Overall Study|Withdrawal by Subject|21|||
155667188|NCT00954447|561876549|FG000|Overall Study|Other|21|||
155667189|NCT00954447|561876550|FG001|Overall Study|Other|18|||
155667190|NCT04971967|561876553|FG000|Overall Study|Lost to Follow-up|6|||
155667191|NCT04971967|561876554|FG001|Overall Study|Lost to Follow-up|7|||
155667192|NCT00682929|561876559|FG000|Overall Study|Adverse Event|4|||
155667193|NCT00682929|561876560|FG001|Overall Study|Adverse Event|1|||
155667194|NCT00682929|561876561|FG002|Overall Study|Adverse Event|1|||
155667195|NCT00682929|561876559|FG000|Overall Study|Withdrawal by Subject|1|||
155667196|NCT00682929|561876560|FG001|Overall Study|Withdrawal by Subject|2|||
155667197|NCT00682929|561876561|FG002|Overall Study|Withdrawal by Subject|1|||
155667198|NCT00682929|561876559|FG000|Overall Study|dosing compliance < 80%|0|||
155667199|NCT00682929|561876560|FG001|Overall Study|dosing compliance < 80%|2|||
155667200|NCT00682929|561876561|FG002|Overall Study|dosing compliance < 80%|0|||
155667201|NCT00682929|561876559|FG000|Overall Study|lag in DEA renewal|1|||
155667202|NCT00682929|561876560|FG001|Overall Study|lag in DEA renewal|0|||
155667203|NCT00682929|561876561|FG002|Overall Study|lag in DEA renewal|0|||
155667204|NCT00938912|561876562|FG000|Overall Study|Withdrawal by Subject|28|||
155667205|NCT00938912|561876562|FG000|Overall Study|Lost to Follow-up|4|||
155667206|NCT00938912|561876562|FG000|Overall Study|Lack of Efficacy|43|||
155667207|NCT00938912|561876562|FG000|Overall Study|Adverse event, non-fatal|24|||
155667208|NCT00938912|561876562|FG000|Overall Study|Adverse event, fatal|1|||
155667209|NCT00938912|561876562|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
155667210|NCT00938912|561876562|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
155667211|NCT00938912|561876562|FG000|Overall Study|Participant needed prohibit medication|1|||
155667212|NCT00938912|561876562|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
155667213|NCT00938912|561876562|FG000|Overall Study|Did not meet Eligibility criteria|1|||
155667214|NCT00938912|561876562|FG000|Overall Study|Participant relocated not related to AE|1|||
155667215|NCT00938912|561876562|FG000|Overall Study|Participant moved to another city|1|||
155667216|NCT00938912|561876562|FG000|Overall Study|Participant experienced break through seizures|1|||
155667217|NCT00938912|561876562|FG000|Overall Study|No longer wished to participate in the study|1|||
155667218|NCT00938912|561876562|FG000|Overall Study|Protocol Deviation|2|||
155667219|NCT01772550|561876565|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
155667220|NCT01772550|561876566|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
155667221|NCT01772550|561876567|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
155667222|NCT01772550|561876565|FG000|Overall Study|Adverse Event|0|||
155667223|NCT01772550|561876566|FG001|Overall Study|Adverse Event|0|||
155667224|NCT01772550|561876567|FG002|Overall Study|Adverse Event|1|||
155667225|NCT00559104|561876568|FG000|Overall Study|Lack of Efficacy|9|||
155667226|NCT00559104|561876569|FG001|Overall Study|Lack of Efficacy|0|||
155667227|NCT04723355|561876570|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
155667228|NCT04723355|561876570|FG000|Overall Study|Errors in the informed consent form|2|||
155667229|NCT03374358|561876571|FG000|Overall Study|Withdrawal by Subject|0|||
155667230|NCT03374358|561876572|FG001|Overall Study|Withdrawal by Subject|2|||
155667231|NCT01127633|561876573|FG000|Overall Study|Adverse Event|74|||
155667232|NCT01127633|561876574|FG001|Overall Study|Adverse Event|73|||
155667233|NCT01127633|561876573|FG000|Overall Study|Death|40|||
155667234|NCT01127633|561876574|FG001|Overall Study|Death|43|||
155667235|NCT01127633|561876573|FG000|Overall Study|Lost to Follow-up|4|||
155667236|NCT01127633|561876574|FG001|Overall Study|Lost to Follow-up|0|||
155667237|NCT01127633|561876573|FG000|Overall Study|Parent/Caregiver Decision|246|||
155667238|NCT01127633|561876574|FG001|Overall Study|Parent/Caregiver Decision|228|||
155667239|NCT01127633|561876573|FG000|Overall Study|Physician Decision|60|||
155667240|NCT01127633|561876574|FG001|Overall Study|Physician Decision|45|||
155667241|NCT01127633|561876573|FG000|Overall Study|Withdrawal by Subject|57|||
155667242|NCT01127633|561876574|FG001|Overall Study|Withdrawal by Subject|72|||
155667243|NCT01127633|561876573|FG000|Overall Study|Sponsor Decision|163|||
155667244|NCT01127633|561876574|FG001|Overall Study|Sponsor Decision|195|||
155667245|NCT01127633|561876573|FG000|Overall Study|Protocol Violation|8|||
155667246|NCT01127633|561876574|FG001|Overall Study|Protocol Violation|16|||
155667247|NCT01127633|561876573|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
155667248|NCT01127633|561876574|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
155667249|NCT01127633|561876573|FG000|Overall Study|Not treated|1|||
155667250|NCT01127633|561876574|FG001|Overall Study|Not treated|0|||
155667251|NCT00399568|561876576|FG000|Overall Study|Adverse Event|1|||
155667252|NCT00399568|561876577|FG001|Overall Study|Adverse Event|2|||
155667253|NCT00399568|561876576|FG000|Overall Study|Withdrawal by Subject|7|||
155667254|NCT00399568|561876577|FG001|Overall Study|Withdrawal by Subject|3|||
155667255|NCT00399568|561876576|FG000|Overall Study|Protocol non-compliance|2|||
155667256|NCT00399568|561876577|FG001|Overall Study|Protocol non-compliance|2|||
155667257|NCT00399568|561876576|FG000|Overall Study|Lost to Follow-up|2|||
155667258|NCT00399568|561876577|FG001|Overall Study|Lost to Follow-up|2|||
155667259|NCT00420381|561876583|FG000|Overall Study|Protocol Violation|1|||
155591360|NCT02714595|561592145|FG000|Overall Study|Lack of Efficacy|0|||
155591361|NCT02714595|561592146|FG001|Overall Study|Lack of Efficacy|1|||
155591362|NCT02714595|561592145|FG000|Overall Study|Death|30|||
155591363|NCT02714595|561592146|FG001|Overall Study|Death|9|||
155591364|NCT02714595|561592145|FG000|Overall Study|Other-Miscellaneous|0|||
155591365|NCT02714595|561592146|FG001|Overall Study|Other-Miscellaneous|1|||
155591366|NCT01322490|561592147|FG000|Treatment Period|Adverse Event|12|||
155591367|NCT01322490|561592148|FG001|Treatment Period|Adverse Event|18|||
155591368|NCT01322490|561592149|FG002|Treatment Period|Adverse Event|15|||
155591369|NCT01322490|561592147|FG000|Treatment Period|Death|5|||
155591370|NCT01322490|561592148|FG001|Treatment Period|Death|7|||
155591371|NCT01322490|561592149|FG002|Treatment Period|Death|3|||
155591372|NCT01322490|561592147|FG000|Treatment Period|Lack of Efficacy|89|||
155591373|NCT01322490|561592148|FG001|Treatment Period|Lack of Efficacy|100|||
155591374|NCT01322490|561592149|FG002|Treatment Period|Lack of Efficacy|112|||
155591375|NCT01322490|561592147|FG000|Treatment Period|Physician Decision|0|||
155591376|NCT01322490|561592148|FG001|Treatment Period|Physician Decision|2|||
155591377|NCT01322490|561592149|FG002|Treatment Period|Physician Decision|1|||
155591378|NCT01322490|561592147|FG000|Treatment Period|Protocol Violation|7|||
155591379|NCT01322490|561592148|FG001|Treatment Period|Protocol Violation|5|||
155591380|NCT01322490|561592149|FG002|Treatment Period|Protocol Violation|4|||
155591381|NCT01322490|561592147|FG000|Treatment Period|Withdrawal by Subject|14|||
155591382|NCT01322490|561592148|FG001|Treatment Period|Withdrawal by Subject|16|||
155591383|NCT01322490|561592149|FG002|Treatment Period|Withdrawal by Subject|11|||
155591384|NCT01322490|561592147|FG000|Treatment Period|Non-compliance with study drug|0|||
155591385|NCT01322490|561592148|FG001|Treatment Period|Non-compliance with study drug|0|||
155591386|NCT01322490|561592149|FG002|Treatment Period|Non-compliance with study drug|1|||
155591387|NCT01322490|561592147|FG000|Treatment Period|Other per report|2|||
155591388|NCT01322490|561592148|FG001|Treatment Period|Other per report|2|||
155591389|NCT01322490|561592149|FG002|Treatment Period|Other per report|1|||
155591390|NCT01322490|561592147|FG000|Treatment Period|Randomized but Not Treated|3|||
155591391|NCT01322490|561592148|FG001|Treatment Period|Randomized but Not Treated|3|||
155591392|NCT01322490|561592149|FG002|Treatment Period|Randomized but Not Treated|5|||
155591393|NCT01322490|561592147|FG000|Long Term Follow-up Period|Death|235|||
155591394|NCT01322490|561592148|FG001|Long Term Follow-up Period|Death|239|||
155591395|NCT01322490|561592149|FG002|Long Term Follow-up Period|Death|236|||
155591396|NCT01322490|561592147|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
155591397|NCT01322490|561592148|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
155591398|NCT01322490|561592149|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
155591399|NCT01322490|561592147|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
155591400|NCT01322490|561592148|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
155591401|NCT01322490|561592149|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
155591402|NCT01322490|561592147|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
155591403|NCT01322490|561592148|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
155591404|NCT01322490|561592149|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
155591405|NCT01322490|561592147|FG000|Long Term Follow-up Period|Other per report|3|||
155591406|NCT01322490|561592148|FG001|Long Term Follow-up Period|Other per report|2|||
155591407|NCT01322490|561592149|FG002|Long Term Follow-up Period|Other per report|2|||
155591408|NCT01322490|561592147|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
155591409|NCT01322490|561592148|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
155591410|NCT01322490|561592149|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
155591411|NCT02257489|561592150|FG000|Overall Study|Withdrawal by Subject|0|||
155591412|NCT02257489|561592151|FG001|Overall Study|Withdrawal by Subject|0|||
155591413|NCT02257489|561592152|FG002|Overall Study|Withdrawal by Subject|0|||
155591414|NCT02257489|561592153|FG003|Overall Study|Withdrawal by Subject|1|||
155591415|NCT02257489|561592154|FG004|Overall Study|Withdrawal by Subject|0|||
155591416|NCT02257489|561592155|FG005|Overall Study|Withdrawal by Subject|0|||
155591417|NCT02257489|561592156|FG006|Overall Study|Withdrawal by Subject|0|||
155591418|NCT02257489|561592157|FG007|Overall Study|Withdrawal by Subject|0|||
155591419|NCT02257489|561592158|FG008|Overall Study|Withdrawal by Subject|0|||
155591420|NCT01896128|561592159|FG000|Overall Study|Withdrawal by Subject|3|||
155591421|NCT01896128|561592160|FG001|Overall Study|Withdrawal by Subject|3|||
155591422|NCT01996254|561592164|FG000|Overall Study|Change in Eligibility|0|||
155591423|NCT01996254|561592165|FG001|Overall Study|Change in Eligibility|2|||
155591424|NCT01996254|561592166|FG002|Overall Study|Change in Eligibility|0|||
155591425|NCT01996254|561592164|FG000|Overall Study|Withdrawal by Subject|0|||
155591426|NCT01996254|561592165|FG001|Overall Study|Withdrawal by Subject|3|||
155591427|NCT01996254|561592166|FG002|Overall Study|Withdrawal by Subject|4|||
155591428|NCT01996254|561592164|FG000|Overall Study|Lost to Follow-up|1|||
155591429|NCT01996254|561592165|FG001|Overall Study|Lost to Follow-up|0|||
155591430|NCT01996254|561592166|FG002|Overall Study|Lost to Follow-up|4|||
155591431|NCT02411396|561592170|FG000|Overall Study|Lost to Follow-up|31|||
155591432|NCT02411396|561592170|FG000|Overall Study|Death|10|||
155591433|NCT02071706|561592175|FG000|Overall Study|Adverse Event|1|||
155591434|NCT02071706|561592175|FG000|Overall Study|Withdrawal by Subject|2|||
155591435|NCT02247440|561592178|FG000|Overall Study|Withdrawal by Subject|1|||
155591436|NCT02247440|561592178|FG000|Overall Study|Lack of Efficacy|3|||
155591437|NCT00661609|561592179|FG000|Overall Study|Adverse Event|4|||
155591438|NCT00661609|561592179|FG000|Overall Study|Death|20|||
155591439|NCT00661609|561592179|FG000|Overall Study|Withdrawal by Subject|2|||
155591440|NCT00661609|561592179|FG000|Overall Study|PI Decision|1|||
155591441|NCT00661609|561592179|FG000|Overall Study|Survival follow up stage discontinued|11|||
155591442|NCT00661609|561592179|FG000|Overall Study|Disease progression|3|||
155591443|NCT00637000|561592180|FG000|Overall Study|Withdrawal by Subject|4|||
155667260|NCT03432494|561876596|FG000|Overall Study|Death|1|||
155667261|NCT03432494|561876596|FG000|Overall Study|Noncompliance|1|||
155667262|NCT00775268|561876597|FG000|Baseline|Drug not synthesize dose|1|||
155667263|NCT00775268|561876598|FG001|Baseline|Drug not synthesize dose|0|||
155667264|NCT00775268|561876597|FG000|Baseline|Not treated-ineligible per CT|0|||
155667265|NCT00775268|561876598|FG001|Baseline|Not treated-ineligible per CT|1|||
155667266|NCT00775268|561876597|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
155667267|NCT00775268|561876598|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
155667268|NCT00775268|561876597|FG000|After Completion|Participant missed scan appointment|1|||
155667269|NCT00775268|561876598|FG001|After Completion|Participant missed scan appointment|0|||
155667270|NCT00592631|561876599|FG000|Overall Study|Lost to Follow-up|0|||
155667271|NCT00592631|561876600|FG001|Overall Study|Lost to Follow-up|2|||
155667272|NCT01244035|561876601|FG000|Part 1: Period 1|Adverse Event|0|||
155667273|NCT01244035|561876602|FG001|Part 1: Period 1|Adverse Event|0|||
155667274|NCT01244035|561876603|FG002|Part 1: Period 1|Adverse Event|0|||
155667275|NCT01244035|561876604|FG003|Part 1: Period 1|Adverse Event|0|||
155667276|NCT01244035|561876605|FG004|Part 1: Period 1|Adverse Event|0|||
155667277|NCT01244035|561876606|FG005|Part 1: Period 1|Adverse Event|1|||
155667278|NCT01244035|561876601|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
155667279|NCT01244035|561876602|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
155667280|NCT01244035|561876603|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
155667281|NCT01244035|561876604|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
155667282|NCT01244035|561876605|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
155667283|NCT01244035|561876606|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
155667284|NCT01244035|561876601|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155667285|NCT01244035|561876602|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
155667286|NCT01244035|561876603|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
155667287|NCT01244035|561876604|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
155667288|NCT01244035|561876605|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155667289|NCT01244035|561876606|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155667290|NCT01244035|561876601|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155667291|NCT01244035|561876602|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155667292|NCT01244035|561876603|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
155667293|NCT01244035|561876604|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155667294|NCT01244035|561876605|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155667295|NCT01244035|561876606|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155667296|NCT01244035|561876601|FG000|Part 1: Period 3|Adverse Event|0|||
155667297|NCT01244035|561876602|FG001|Part 1: Period 3|Adverse Event|0|||
155667298|NCT01244035|561876603|FG002|Part 1: Period 3|Adverse Event|0|||
155667299|NCT01244035|561876604|FG003|Part 1: Period 3|Adverse Event|0|||
155667300|NCT01244035|561876605|FG004|Part 1: Period 3|Adverse Event|0|||
155667301|NCT01244035|561876606|FG005|Part 1: Period 3|Adverse Event|1|||
155667302|NCT01244035|561876601|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
155667303|NCT01244035|561876602|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
155667304|NCT01244035|561876603|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
155667305|NCT01244035|561876604|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
155667306|NCT01244035|561876605|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
155667307|NCT01244035|561876606|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
155667308|NCT01244035|561876601|FG000|Part 1: Period 3|Protocol Deviation|0|||
155667309|NCT01244035|561876602|FG001|Part 1: Period 3|Protocol Deviation|1|||
155667310|NCT01244035|561876603|FG002|Part 1: Period 3|Protocol Deviation|0|||
155667311|NCT01244035|561876604|FG003|Part 1: Period 3|Protocol Deviation|0|||
155667312|NCT01244035|561876605|FG004|Part 1: Period 3|Protocol Deviation|0|||
155667313|NCT01244035|561876606|FG005|Part 1: Period 3|Protocol Deviation|0|||
155667314|NCT00374595|561876607|FG000|Overall Study|Death|23|||
155667315|NCT00374595|561876607|FG000|Overall Study|Withdrawal by Subject|39|||
155667316|NCT00374595|561876607|FG000|Overall Study|Lost to Follow-up|3|||
155667317|NCT00374595|561876607|FG000|Overall Study|too much time commitment|1|||
155667318|NCT00374595|561876607|FG000|Overall Study|transfer care to other clinical site|1|||
155667319|NCT00374595|561876607|FG000|Overall Study|relocation|3|||
155667320|NCT03745768|561876609|FG000|Overall Study|discontinued study|2|||
155667321|NCT03745768|561876610|FG001|Overall Study|discontinued study|0|||
155667322|NCT00443118|561876611|FG000|Overall Study|unknown primary outcome|3|||
155667323|NCT00443118|561876612|FG001|Overall Study|unknown primary outcome|1|||
155667324|NCT00443118|561876613|FG002|Overall Study|unknown primary outcome|0|||
155667325|NCT00443118|561876611|FG000|Overall Study|Withdrawal by Subject|1|||
155667326|NCT00443118|561876612|FG001|Overall Study|Withdrawal by Subject|0|||
155667327|NCT00443118|561876613|FG002|Overall Study|Withdrawal by Subject|0|||
155667328|NCT00400517|561876621|FG000|Overall Study|Withdrawal by Subject|1|||
155667329|NCT00400517|561876621|FG000|Overall Study|Physician Decision|1|||
155667330|NCT01106157|561876622|FG000|Overall Study|Withdrawal by Subject|1|||
155667331|NCT01106157|561876623|FG001|Overall Study|Withdrawal by Subject|0|||
155667332|NCT02298868|561876627|FG000|Overall Study|Adverse Event|1|||
155667333|NCT02298868|561876627|FG000|Overall Study|Death|1|||
155667334|NCT02298868|561876627|FG000|Overall Study|Patient underwent transplant|1|||
155667335|NCT01194245|561876628|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
155667336|NCT01194245|561876629|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155667337|NCT01194245|561876630|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155667338|NCT01194245|561876631|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155667339|NCT01194245|561876632|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155667340|NCT01194245|561876628|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
155667341|NCT01194245|561876629|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155667342|NCT01194245|561876630|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155667343|NCT01194245|561876631|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155667344|NCT01194245|561876632|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155667345|NCT01194245|561876628|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
155667346|NCT01194245|561876629|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155667347|NCT01194245|561876630|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155667348|NCT01194245|561876631|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155667349|NCT01194245|561876632|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155667350|NCT01194245|561876628|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
155667351|NCT01194245|561876629|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155667352|NCT01194245|561876630|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155667353|NCT01194245|561876631|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155591444|NCT00637000|561592181|FG001|Overall Study|Withdrawal by Subject|3|||
155591445|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
155591446|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
155591447|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
155591448|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
155591449|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
155591450|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
155591451|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
155591452|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
155591453|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
155591454|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
155591455|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
155591456|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
155591457|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
155591458|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
155591459|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
155591460|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
155591461|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
155591462|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
155591463|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
155591464|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
155591465|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
155591466|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
155591467|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
155591468|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
155591469|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
155591470|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
155591471|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
155591472|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
155591473|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155591474|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155591475|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
155591476|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
155591477|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
155591478|NCT00839527|561592182|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
155591479|NCT00839527|561592183|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
155591480|NCT00839527|561592184|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
155591481|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155591482|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
155591483|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155591484|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
155591485|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
155591486|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
155591487|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
155591488|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
155591489|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
155591490|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
155591491|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
155591492|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
155591493|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
155591494|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
155591495|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155591496|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
155591497|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
155591498|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
155591499|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
155591500|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
155591501|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
155667354|NCT01194245|561876632|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155591502|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
155591503|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
155591504|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
155591505|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
155591506|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
155591507|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
155591508|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
155591509|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
155591510|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
155591511|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
155591512|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
155591513|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
155591514|NCT00839527|561592182|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
155591515|NCT00839527|561592183|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
155667355|NCT01194245|561876628|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155667356|NCT01194245|561876629|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155667357|NCT01194245|561876630|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155667358|NCT01194245|561876631|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155591516|NCT00839527|561592184|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
155591517|NCT00562302|561592185|FG000|Overall Study|Lost to Follow-up|3|||
155591518|NCT00562302|561592186|FG001|Overall Study|Lost to Follow-up|3|||
155591519|NCT00562302|561592185|FG000|Overall Study|Adverse Event|0|||
155591520|NCT00562302|561592186|FG001|Overall Study|Adverse Event|6|||
155591521|NCT00562302|561592185|FG000|Overall Study|Non-compliance|1|||
155591522|NCT00562302|561592186|FG001|Overall Study|Non-compliance|2|||
155591523|NCT00562302|561592185|FG000|Overall Study|Withdrawal by Subject|7|||
155591524|NCT00562302|561592186|FG001|Overall Study|Withdrawal by Subject|8|||
155591525|NCT00562302|561592185|FG000|Overall Study|Death|1|||
155591526|NCT00562302|561592186|FG001|Overall Study|Death|2|||
155591527|NCT00562302|561592185|FG000|Overall Study|Lung resection prior to study completion|7|||
155591528|NCT00562302|561592186|FG001|Overall Study|Lung resection prior to study completion|7|||
155591529|NCT00562302|561592185|FG000|Overall Study|Not stated|1|||
155591530|NCT00562302|561592186|FG001|Overall Study|Not stated|4|||
155591531|NCT01855243|561592187|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
155591532|NCT01855243|561592188|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
155591533|NCT01855243|561592189|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
155591534|NCT03615144|561592190|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
155591535|NCT03615144|561592191|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
155591536|NCT01860040|561592194|FG000|Overall Study|Withdrawal by Subject|1|||
155591537|NCT01860040|561592195|FG001|Overall Study|Withdrawal by Subject|0|||
155591538|NCT01931995|561592196|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
155591539|NCT01931995|561592197|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
155591540|NCT01931995|561592196|FG000|First Intervention (1 Day)|Physician Decision|1|||
155591541|NCT01931995|561592197|FG001|First Intervention (1 Day)|Physician Decision|1|||
155591542|NCT01931995|561592196|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
155591543|NCT01931995|561592197|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
155591544|NCT00679289|561592198|FG000|Overall Study|Progressive disease|4|||
155591545|NCT00679289|561592199|FG001|Overall Study|Progressive disease|5|||
155591546|NCT00679289|561592200|FG002|Overall Study|Progressive disease|18|||
155591547|NCT00679289|561592198|FG000|Overall Study|Withdrawal by Subject|0|||
155591548|NCT00679289|561592199|FG001|Overall Study|Withdrawal by Subject|1|||
155591549|NCT00679289|561592200|FG002|Overall Study|Withdrawal by Subject|1|||
155591550|NCT00679289|561592198|FG000|Overall Study|Adverse Event|0|||
155591551|NCT00679289|561592199|FG001|Overall Study|Adverse Event|0|||
155591552|NCT00679289|561592200|FG002|Overall Study|Adverse Event|3|||
155591553|NCT00679289|561592198|FG000|Overall Study|Physician Decision|1|||
155591554|NCT00679289|561592199|FG001|Overall Study|Physician Decision|0|||
155591555|NCT00679289|561592200|FG002|Overall Study|Physician Decision|1|||
155591556|NCT00937040|561592201|FG000|Overall Study|Adverse Event|5|||
155591557|NCT00937040|561592202|FG001|Overall Study|Adverse Event|8|||
155591558|NCT00937040|561592201|FG000|Overall Study|Lost to Follow-up|12|||
155591559|NCT00937040|561592202|FG001|Overall Study|Lost to Follow-up|12|||
155591560|NCT00937040|561592201|FG000|Overall Study|Protocol Violation|3|||
155591561|NCT00937040|561592202|FG001|Overall Study|Protocol Violation|0|||
155591562|NCT00937040|561592201|FG000|Overall Study|Withdrawal by Subject|13|||
155591563|NCT00937040|561592202|FG001|Overall Study|Withdrawal by Subject|7|||
155591564|NCT00937040|561592201|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
155591565|NCT00937040|561592202|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
155591566|NCT00937040|561592201|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
155591567|NCT00937040|561592202|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
155591568|NCT00554515|561592205|FG000|Overall Study|Withdrawal by Subject|3|||
155591569|NCT00554515|561592205|FG000|Overall Study|Disease progression|52|||
155591570|NCT00554515|561592205|FG000|Overall Study|Physician Decision|18|||
155591571|NCT00554515|561592205|FG000|Overall Study|Withdrawal by Subject|11|||
155591572|NCT00554515|561592205|FG000|Overall Study|Adverse Event|9|||
155591573|NCT00554515|561592205|FG000|Overall Study|Death|2|||
155591574|NCT00554515|561592205|FG000|Overall Study|Achieved Stable Disease|7|||
155591575|NCT00554515|561592205|FG000|Overall Study|Other|1|||
155591576|NCT00554515|561592205|FG000|Overall Study|Misc|15|||
155591577|NCT02477332|561592208|FG000|Overall Study|Adverse Event|0|||
155591578|NCT02477332|561592209|FG001|Overall Study|Adverse Event|1|||
155591579|NCT02477332|561592210|FG002|Overall Study|Adverse Event|1|||
155591580|NCT02477332|561592211|FG003|Overall Study|Adverse Event|2|||
155591581|NCT02477332|561592212|FG004|Overall Study|Adverse Event|1|||
155591582|NCT02477332|561592213|FG005|Overall Study|Adverse Event|2|||
155591583|NCT02477332|561592208|FG000|Overall Study|Lack of Efficacy|1|||
155591584|NCT02477332|561592209|FG001|Overall Study|Lack of Efficacy|2|||
155591585|NCT02477332|561592210|FG002|Overall Study|Lack of Efficacy|1|||
155591586|NCT02477332|561592211|FG003|Overall Study|Lack of Efficacy|2|||
155591587|NCT02477332|561592212|FG004|Overall Study|Lack of Efficacy|1|||
155591588|NCT02477332|561592213|FG005|Overall Study|Lack of Efficacy|1|||
155591589|NCT02477332|561592208|FG000|Overall Study|Non-compliance with study treatment|0|||
155591590|NCT02477332|561592209|FG001|Overall Study|Non-compliance with study treatment|1|||
155591591|NCT02477332|561592210|FG002|Overall Study|Non-compliance with study treatment|2|||
155591592|NCT02477332|561592211|FG003|Overall Study|Non-compliance with study treatment|0|||
155591593|NCT02477332|561592212|FG004|Overall Study|Non-compliance with study treatment|0|||
155591594|NCT02477332|561592213|FG005|Overall Study|Non-compliance with study treatment|0|||
155591595|NCT02477332|561592208|FG000|Overall Study|Pregnancy|0|||
155591596|NCT02477332|561592209|FG001|Overall Study|Pregnancy|0|||
155591597|NCT02477332|561592210|FG002|Overall Study|Pregnancy|0|||
155591598|NCT02477332|561592211|FG003|Overall Study|Pregnancy|1|||
155591599|NCT02477332|561592212|FG004|Overall Study|Pregnancy|0|||
155591600|NCT02477332|561592213|FG005|Overall Study|Pregnancy|0|||
155591601|NCT02477332|561592208|FG000|Overall Study|Protocol Violation|2|||
155591602|NCT02477332|561592209|FG001|Overall Study|Protocol Violation|0|||
155591603|NCT02477332|561592210|FG002|Overall Study|Protocol Violation|3|||
155591604|NCT02477332|561592211|FG003|Overall Study|Protocol Violation|3|||
155591605|NCT02477332|561592212|FG004|Overall Study|Protocol Violation|1|||
155591606|NCT02477332|561592213|FG005|Overall Study|Protocol Violation|1|||
155591607|NCT02477332|561592208|FG000|Overall Study|Technical problems|0|||
155591608|NCT02477332|561592209|FG001|Overall Study|Technical problems|0|||
155591609|NCT02477332|561592210|FG002|Overall Study|Technical problems|1|||
155591610|NCT02477332|561592211|FG003|Overall Study|Technical problems|0|||
155591611|NCT02477332|561592212|FG004|Overall Study|Technical problems|0|||
155591612|NCT02477332|561592213|FG005|Overall Study|Technical problems|0|||
155591613|NCT02477332|561592208|FG000|Overall Study|Lost to Follow-up|0|||
155591614|NCT02477332|561592209|FG001|Overall Study|Lost to Follow-up|0|||
155591615|NCT02477332|561592210|FG002|Overall Study|Lost to Follow-up|2|||
155591616|NCT02477332|561592211|FG003|Overall Study|Lost to Follow-up|0|||
155591617|NCT02477332|561592212|FG004|Overall Study|Lost to Follow-up|0|||
155591618|NCT02477332|561592213|FG005|Overall Study|Lost to Follow-up|0|||
155591619|NCT02477332|561592208|FG000|Overall Study|Physician Decision|0|||
155591620|NCT02477332|561592209|FG001|Overall Study|Physician Decision|0|||
155591621|NCT02477332|561592210|FG002|Overall Study|Physician Decision|1|||
155591622|NCT02477332|561592211|FG003|Overall Study|Physician Decision|3|||
155591623|NCT02477332|561592212|FG004|Overall Study|Physician Decision|0|||
155591624|NCT02477332|561592213|FG005|Overall Study|Physician Decision|1|||
155591625|NCT02477332|561592208|FG000|Overall Study|Withdrawal by Subject|0|||
155591626|NCT02477332|561592209|FG001|Overall Study|Withdrawal by Subject|3|||
155591627|NCT02477332|561592210|FG002|Overall Study|Withdrawal by Subject|1|||
155591628|NCT02477332|561592211|FG003|Overall Study|Withdrawal by Subject|2|||
155591629|NCT02477332|561592212|FG004|Overall Study|Withdrawal by Subject|1|||
155591630|NCT02477332|561592213|FG005|Overall Study|Withdrawal by Subject|0|||
155591631|NCT04657198|561592214|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
155591632|NCT04657198|561592215|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
155591633|NCT04657198|561592216|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
155591634|NCT03793842|561592217|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
155591635|NCT03793842|561592218|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
155591636|NCT03793842|561592217|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
155591637|NCT03793842|561592218|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
155591638|NCT02549287|561592219|FG000|Overall Study|Lost to Follow-up|65|||
155591639|NCT02549287|561592220|FG001|Overall Study|Lost to Follow-up|26|||
155591640|NCT02549287|561592219|FG000|Overall Study|Withdrawal by Subject|15|||
155591641|NCT02549287|561592220|FG001|Overall Study|Withdrawal by Subject|6|||
155591642|NCT03340454|561592221|FG000|Overall Study|Lost to Follow-up|0|||
155591643|NCT03340454|561592222|FG001|Overall Study|Lost to Follow-up|4|||
155591644|NCT02568189|561592228|FG000|Overall Study|Protocol Violation|0|||
155591645|NCT02568189|561592229|FG001|Overall Study|Protocol Violation|0|||
155591646|NCT02568189|561592230|FG002|Overall Study|Protocol Violation|19|||
155591647|NCT02568189|561592231|FG003|Overall Study|Protocol Violation|18|||
155591648|NCT01052480|561592232|FG000|Overall Study|Lost to Follow-up|3|||
155591649|NCT01052480|561592233|FG001|Overall Study|Lost to Follow-up|3|||
155591650|NCT01052480|561592232|FG000|Overall Study|Protocol Violation|1|||
155591651|NCT01052480|561592233|FG001|Overall Study|Protocol Violation|0|||
155591652|NCT01052480|561592232|FG000|Overall Study|Withdrawal by Subject|3|||
155591653|NCT01052480|561592233|FG001|Overall Study|Withdrawal by Subject|7|||
155591654|NCT01052480|561592232|FG000|Overall Study|Physician Decision|0|||
155591655|NCT01052480|561592233|FG001|Overall Study|Physician Decision|2|||
155591656|NCT01052480|561592232|FG000|Overall Study|Death|1|||
155591657|NCT01052480|561592233|FG001|Overall Study|Death|5|||
155591658|NCT03806933|561593824|FG000|Main Period|Physician Decision|0|||
155591659|NCT03806933|561593825|FG001|Main Period|Physician Decision|0|||
155591660|NCT03806933|561593826|FG002|Main Period|Physician Decision|0|||
155591661|NCT03806933|561593827|FG003|Main Period|Physician Decision|1|||
155591662|NCT03806933|561593824|FG000|Main Period|Pregnancy|0|||
155591663|NCT03806933|561593825|FG001|Main Period|Pregnancy|0|||
155591664|NCT03806933|561593826|FG002|Main Period|Pregnancy|1|||
155591665|NCT03806933|561593827|FG003|Main Period|Pregnancy|0|||
155667359|NCT01194245|561876632|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155591666|NCT03806933|561593824|FG000|Main Period|Withdrawal by Subject|2|||
155591667|NCT03806933|561593825|FG001|Main Period|Withdrawal by Subject|1|||
155591668|NCT03806933|561593826|FG002|Main Period|Withdrawal by Subject|1|||
155591669|NCT03806933|561593827|FG003|Main Period|Withdrawal by Subject|2|||
155591670|NCT03806933|561593824|FG000|Main Period|Lost to Follow-up|2|||
155591671|NCT03806933|561593825|FG001|Main Period|Lost to Follow-up|2|||
155591672|NCT03806933|561593826|FG002|Main Period|Lost to Follow-up|0|||
155591673|NCT03806933|561593827|FG003|Main Period|Lost to Follow-up|0|||
155591674|NCT03806933|561593824|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155591675|NCT03806933|561593825|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155591676|NCT03806933|561593826|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155591677|NCT03806933|561593827|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
155591678|NCT02028767|561593828|FG000|Treatment Period 2|Non compliant with protocol|1|||
155591679|NCT02028767|561593829|FG001|Treatment Period 2|Non compliant with protocol|0|||
155591680|NCT02028767|561593828|FG000|Treatment Period 2|Reason other than those specified above|1|||
155591681|NCT02028767|561593829|FG001|Treatment Period 2|Reason other than those specified above|0|||
155591682|NCT04606394|561593832|FG000|Overall Study|Withdrawal by Subject|3|||
155591683|NCT04606394|561593832|FG000|Overall Study|Exclusion criteria screen failure|12|||
155591684|NCT00954941|561593833|FG000|Overall Study|Received treatment at home|1|||
155591685|NCT00954941|561593834|FG001|Overall Study|Received treatment at home|0|||
155591686|NCT00954941|561593833|FG000|Overall Study|Withdrawal by Subject|1|||
155591687|NCT00954941|561593834|FG001|Overall Study|Withdrawal by Subject|0|||
155591688|NCT00954941|561593833|FG000|Overall Study|Insurance Denial|2|||
155591689|NCT00954941|561593834|FG001|Overall Study|Insurance Denial|2|||
155591690|NCT00954941|561593833|FG000|Overall Study|Physician Decision|2|||
155591691|NCT00954941|561593834|FG001|Overall Study|Physician Decision|2|||
155591692|NCT00954941|561593833|FG000|Overall Study|Ineligible|2|||
155591693|NCT00954941|561593834|FG001|Overall Study|Ineligible|2|||
155591694|NCT00954941|561593833|FG000|Overall Study|Adverse Event|0|||
155591695|NCT00954941|561593834|FG001|Overall Study|Adverse Event|1|||
155591696|NCT01053663|561593835|FG000|Overall Study|Death|2|||
155591697|NCT01053663|561593835|FG000|Overall Study|Lost to Follow-up|1|||
155591698|NCT01053663|561593835|FG000|Overall Study|Poor IV Access|1|||
155591699|NCT01053663|561593835|FG000|Overall Study|Transferred to Another Hospital|1|||
155591700|NCT01053663|561593835|FG000|Overall Study|Negative Influenza Diagnosis|1|||
155591701|NCT02920008|561593836|FG000|Overall Study|Death|117|||
155591702|NCT02920008|561593837|FG001|Overall Study|Death|127|||
155591703|NCT02920008|561593836|FG000|Overall Study|Withdrawal by Subject|3|||
155591704|NCT02920008|561593837|FG001|Overall Study|Withdrawal by Subject|6|||
155591705|NCT02920008|561593836|FG000|Overall Study|Lost to Follow-up|0|||
155591706|NCT02920008|561593837|FG001|Overall Study|Lost to Follow-up|1|||
155591707|NCT01862250|561593838|FG000|Overall Study|Adverse Event|4|||
155591708|NCT00090493|561593841|FG000|Overall Study|Physician Decision|2|||
155591709|NCT01769508|561593844|FG000|Overall Study|Death|3|||
155591710|NCT01769508|561593844|FG000|Overall Study|Withdrawal by Subject|1|||
155591711|NCT01769508|561593844|FG000|Overall Study|Adverse Event|1|||
155591712|NCT01769508|561593844|FG000|Overall Study|Lost to Follow-up|1|||
155591713|NCT02751450|561593845|FG000|Overall Study|Adverse Event|1|||
155591714|NCT02751450|561593846|FG001|Overall Study|Adverse Event|0|||
155591715|NCT02587598|561593847|FG000|Overall Study|Death|4|||
155591716|NCT02587598|561593848|FG001|Overall Study|Death|8|||
155591717|NCT02587598|561593849|FG002|Overall Study|Death|4|||
155591718|NCT02587598|561593850|FG003|Overall Study|Death|16|||
155591719|NCT02587598|561593851|FG004|Overall Study|Death|9|||
155591720|NCT02587598|561593852|FG005|Overall Study|Death|4|||
155591721|NCT02587598|561593853|FG006|Overall Study|Death|6|||
155591722|NCT02587598|561593854|FG007|Overall Study|Death|7|||
155591723|NCT02587598|561593855|FG008|Overall Study|Death|9|||
155591724|NCT02587598|561593856|FG009|Overall Study|Death|1|||
155591725|NCT02587598|561593857|FG010|Overall Study|Death|3|||
155591726|NCT02587598|561593847|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155591727|NCT02587598|561593848|FG001|Overall Study|Study Terminated by the Sponsor|1|||
155591728|NCT02587598|561593849|FG002|Overall Study|Study Terminated by the Sponsor|0|||
155591729|NCT02587598|561593850|FG003|Overall Study|Study Terminated by the Sponsor|3|||
155591730|NCT02587598|561593851|FG004|Overall Study|Study Terminated by the Sponsor|0|||
155591731|NCT02587598|561593852|FG005|Overall Study|Study Terminated by the Sponsor|1|||
155667360|NCT01194245|561876628|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155591732|NCT02587598|561593853|FG006|Overall Study|Study Terminated by the Sponsor|0|||
155591733|NCT02587598|561593854|FG007|Overall Study|Study Terminated by the Sponsor|0|||
155591734|NCT02587598|561593855|FG008|Overall Study|Study Terminated by the Sponsor|0|||
155591735|NCT02587598|561593856|FG009|Overall Study|Study Terminated by the Sponsor|1|||
155591736|NCT02587598|561593857|FG010|Overall Study|Study Terminated by the Sponsor|6|||
155591737|NCT02587598|561593847|FG000|Overall Study|Reason for study withdrawal not specified|0|||
155591738|NCT02587598|561593848|FG001|Overall Study|Reason for study withdrawal not specified|1|||
155591739|NCT02587598|561593849|FG002|Overall Study|Reason for study withdrawal not specified|0|||
155591740|NCT02587598|561593850|FG003|Overall Study|Reason for study withdrawal not specified|0|||
155591741|NCT02587598|561593851|FG004|Overall Study|Reason for study withdrawal not specified|0|||
155667361|NCT01194245|561876629|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155667362|NCT01194245|561876630|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155667363|NCT01194245|561876631|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155667364|NCT01194245|561876632|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155667365|NCT03962855|561876633|FG000|Overall Study|Death|0|||
155667366|NCT03962855|561876634|FG001|Overall Study|Death|1|||
155667367|NCT03962855|561876633|FG000|Overall Study|Lost to Follow-up|0|||
155667368|NCT03962855|561876634|FG001|Overall Study|Lost to Follow-up|1|||
155667369|NCT03962855|561876633|FG000|Overall Study|Adverse Event|0|||
155667370|NCT03962855|561876634|FG001|Overall Study|Adverse Event|1|||
155667371|NCT03962855|561876633|FG000|Overall Study|Physician Decision|0|||
155667372|NCT03962855|561876634|FG001|Overall Study|Physician Decision|2|||
155667373|NCT03326063|561876635|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
155667374|NCT03326063|561876636|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
155667375|NCT00881894|561876639|FG000|Overall Study|Consent withdrawn|0|||
155667376|NCT00881894|561876640|FG001|Overall Study|Consent withdrawn|1|||
155667377|NCT00881894|561876639|FG000|Overall Study|Other reasons for premature termination|1|||
155667378|NCT00881894|561876640|FG001|Overall Study|Other reasons for premature termination|2|||
155667379|NCT01253369|561876641|FG000|Overall Study|Adverse Event|4|||
155667380|NCT01253369|561876641|FG000|Overall Study|Withdrawal by Subject|2|||
155667381|NCT01253369|561876641|FG000|Overall Study|Death|1|||
155667382|NCT01253369|561876641|FG000|Overall Study|Progressive disease|23|||
155667383|NCT01253369|561876641|FG000|Overall Study|Not Evaluable|3|||
155667384|NCT01932788|561876643|FG000|Overall Study|Protocol Violation|18|||
155667385|NCT01932788|561876644|FG001|Overall Study|Protocol Violation|0|||
155667386|NCT01932788|561876643|FG000|Overall Study|Lost to Follow-up|18|||
155667387|NCT01932788|561876644|FG001|Overall Study|Lost to Follow-up|46|||
155667388|NCT01932788|561876643|FG000|Overall Study|Lack of Efficacy|2|||
155667389|NCT01932788|561876644|FG001|Overall Study|Lack of Efficacy|0|||
155667390|NCT01932788|561876643|FG000|Overall Study|Withdrawal by Subject|0|||
155667391|NCT01932788|561876644|FG001|Overall Study|Withdrawal by Subject|5|||
155667392|NCT00543985|561876647|FG000|Overall Study|Withdrawal by Subject|4|||
155667393|NCT04749914|561876648|FG000|Period 1|Adverse Event|1|||
155667394|NCT04749914|561876649|FG001|Period 1|Adverse Event|0|||
155667395|NCT04749914|561876650|FG002|Period 1|Adverse Event|0|||
155667396|NCT04749914|561876651|FG003|Period 1|Adverse Event|0|||
155667397|NCT04749914|561876648|FG000|Period 1|Withdrawal by Subject|1|||
155667398|NCT04749914|561876649|FG001|Period 1|Withdrawal by Subject|0|||
155667399|NCT04749914|561876650|FG002|Period 1|Withdrawal by Subject|1|||
155667400|NCT04749914|561876651|FG003|Period 1|Withdrawal by Subject|0|||
155667401|NCT01214837|561876653|FG000|Overall Study|Death|0|||
155667402|NCT01214837|561876654|FG001|Overall Study|Death|0|||
155667403|NCT01214837|561876655|FG002|Overall Study|Death|1|||
155667404|NCT01214837|561876653|FG000|Overall Study|Adverse Event|1|||
155667405|NCT01214837|561876654|FG001|Overall Study|Adverse Event|2|||
155667406|NCT01214837|561876655|FG002|Overall Study|Adverse Event|1|||
155667407|NCT01214837|561876653|FG000|Overall Study|Withdrawal by Subject|27|||
155667408|NCT01214837|561876654|FG001|Overall Study|Withdrawal by Subject|36|||
155667409|NCT01214837|561876655|FG002|Overall Study|Withdrawal by Subject|28|||
155667410|NCT01214837|561876653|FG000|Overall Study|Lost to Follow-up|20|||
155667411|NCT01214837|561876654|FG001|Overall Study|Lost to Follow-up|15|||
155667412|NCT01214837|561876655|FG002|Overall Study|Lost to Follow-up|21|||
155667413|NCT01214837|561876653|FG000|Overall Study|Inappropriate Enrolment|0|||
155667414|NCT01214837|561876654|FG001|Overall Study|Inappropriate Enrolment|1|||
155667415|NCT01214837|561876655|FG002|Overall Study|Inappropriate Enrolment|2|||
155667416|NCT01214837|561876653|FG000|Overall Study|Administrative Reason|2|||
155667417|NCT01214837|561876654|FG001|Overall Study|Administrative Reason|6|||
155667418|NCT01214837|561876655|FG002|Overall Study|Administrative Reason|4|||
155667419|NCT01214837|561876653|FG000|Overall Study|Protocol Violation|3|||
155667420|NCT01214837|561876654|FG001|Overall Study|Protocol Violation|1|||
155667421|NCT01214837|561876655|FG002|Overall Study|Protocol Violation|5|||
155667422|NCT01214837|561876653|FG000|Overall Study|Unable to Classify|1|||
155667423|NCT01214837|561876654|FG001|Overall Study|Unable to Classify|3|||
155667424|NCT01214837|561876655|FG002|Overall Study|Unable to Classify|0|||
155667425|NCT05414175|561876656|FG000|Overall Study|Withdrawal by Subject|1|||
155591742|NCT02587598|561593852|FG005|Overall Study|Reason for study withdrawal not specified|0|||
155591743|NCT02587598|561593853|FG006|Overall Study|Reason for study withdrawal not specified|0|||
155591744|NCT02587598|561593854|FG007|Overall Study|Reason for study withdrawal not specified|0|||
155591745|NCT02587598|561593855|FG008|Overall Study|Reason for study withdrawal not specified|0|||
155591746|NCT02587598|561593856|FG009|Overall Study|Reason for study withdrawal not specified|0|||
155591747|NCT02587598|561593857|FG010|Overall Study|Reason for study withdrawal not specified|0|||
155591748|NCT02587598|561593847|FG000|Overall Study|Withdrawal by Subject|0|||
155591749|NCT02587598|561593848|FG001|Overall Study|Withdrawal by Subject|1|||
155591750|NCT02587598|561593849|FG002|Overall Study|Withdrawal by Subject|0|||
155591751|NCT02587598|561593850|FG003|Overall Study|Withdrawal by Subject|2|||
155591752|NCT02587598|561593851|FG004|Overall Study|Withdrawal by Subject|3|||
155591753|NCT02587598|561593852|FG005|Overall Study|Withdrawal by Subject|1|||
155591754|NCT02587598|561593853|FG006|Overall Study|Withdrawal by Subject|0|||
155591755|NCT02587598|561593854|FG007|Overall Study|Withdrawal by Subject|0|||
155591756|NCT02587598|561593855|FG008|Overall Study|Withdrawal by Subject|0|||
155591757|NCT02587598|561593856|FG009|Overall Study|Withdrawal by Subject|1|||
155591758|NCT02587598|561593857|FG010|Overall Study|Withdrawal by Subject|2|||
155591759|NCT02587598|561593847|FG000|Overall Study|Physician Decision|0|||
155591760|NCT02587598|561593848|FG001|Overall Study|Physician Decision|0|||
155591761|NCT02587598|561593849|FG002|Overall Study|Physician Decision|0|||
155591762|NCT02587598|561593850|FG003|Overall Study|Physician Decision|0|||
155591763|NCT02587598|561593851|FG004|Overall Study|Physician Decision|0|||
155591764|NCT02587598|561593852|FG005|Overall Study|Physician Decision|0|||
155591765|NCT02587598|561593853|FG006|Overall Study|Physician Decision|0|||
155591766|NCT02587598|561593854|FG007|Overall Study|Physician Decision|0|||
155591767|NCT02587598|561593855|FG008|Overall Study|Physician Decision|0|||
155591768|NCT02587598|561593856|FG009|Overall Study|Physician Decision|0|||
155591769|NCT02587598|561593857|FG010|Overall Study|Physician Decision|3|||
155591770|NCT01704651|561593858|FG000|Overall Study|Pre-op withdrawal by subject|1|||
155591771|NCT01704651|561593859|FG001|Overall Study|Pre-op withdrawal by subject|1|||
155591772|NCT01704651|561593858|FG000|Overall Study|Pre-op change in treatment plan|1|||
155591773|NCT01704651|561593859|FG001|Overall Study|Pre-op change in treatment plan|4|||
155591774|NCT01704651|561593858|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
155591775|NCT01704651|561593859|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
155591776|NCT01704651|561593858|FG000|Overall Study|Post-op did not have laparotomy|2|||
155591777|NCT01704651|561593859|FG001|Overall Study|Post-op did not have laparotomy|1|||
155591778|NCT00791661|561593860|FG000|7 Day Wash-out|Adverse Event|0|||
155591779|NCT00791661|561593861|FG001|7 Day Wash-out|Adverse Event|0|||
155591780|NCT00791661|561593862|FG002|7 Day Wash-out|Adverse Event|1|||
155591781|NCT00791661|561593860|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
155591782|NCT00791661|561593861|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
155591783|NCT00791661|561593862|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
155591784|NCT00634803|561593865|FG000|Overall Study|Lost to Follow-up|6|||
155591785|NCT00634803|561593866|FG001|Overall Study|Lost to Follow-up|7|||
155591786|NCT00634803|561593867|FG002|Overall Study|Lost to Follow-up|7|||
155591787|NCT00427921|561593871|FG000|Overall Study|Adverse Event|26|||
155591788|NCT00427921|561593871|FG000|Overall Study|Withdrawal by Subject|4|||
155591789|NCT00427921|561593871|FG000|Overall Study|Lost to Follow-up|2|||
155591790|NCT00427921|561593871|FG000|Overall Study|Other reason not specified|10|||
155591791|NCT00427921|561593871|FG000|Overall Study|Adverse Event + Hospitalization|1|||
155591792|NCT00427921|561593871|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
155591793|NCT00427921|561593871|FG000|Overall Study|Adverse Event + No Response|1|||
155591794|NCT00427921|561593871|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
155591795|NCT00427921|561593871|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
155591796|NCT00427921|561593871|FG000|Overall Study|Adverse Event + Lost Response|1|||
155591797|NCT00427921|561593871|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
155591798|NCT00427921|561593871|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
155591799|NCT00900159|561593872|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
155591800|NCT00900159|561593873|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
155591801|NCT00520533|561593874|FG000|Overall Study|Death|1|||
155591802|NCT00520533|561593874|FG000|Overall Study|Suspension of the study for safety reasons|1|||
155591803|NCT00520533|561593874|FG000|Overall Study|Withdrawal by Subject|1|||
155591804|NCT00520533|561593874|FG000|Overall Study|Physician Decision|1|||
155591805|NCT02593097|561593882|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
155591806|NCT02593097|561593883|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
155591807|NCT02593097|561593882|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155591808|NCT02593097|561593883|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155591809|NCT02593097|561593882|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
155591810|NCT02593097|561593883|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
155591811|NCT02593097|561593882|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
155591812|NCT02593097|561593883|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
155591813|NCT02593097|561593882|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
155591814|NCT02593097|561593883|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
155591815|NCT02858583|561593884|FG000|Overall Study|Declined consent|1|||
155591816|NCT02858583|561593885|FG001|Overall Study|Declined consent|1|||
155591817|NCT03759587|561593886|FG000|Overall Study|Adverse Event|5|||
155591818|NCT03759587|561593886|FG000|Overall Study|Progressive Disease|10|||
155591819|NCT03759587|561593886|FG000|Overall Study|Site Terminated by Sponsor|3|||
155591820|NCT03759587|561593886|FG000|Overall Study|Withdrawal by Subject|1|||
155591821|NCT01218087|561593889|FG000|Overall Study|Death|2|||
155591822|NCT01218087|561593890|FG001|Overall Study|Death|1|||
155591823|NCT01218087|561593889|FG000|Overall Study|Withdrawal by Subject|5|||
155591824|NCT01218087|561593890|FG001|Overall Study|Withdrawal by Subject|0|||
155591825|NCT01218087|561593889|FG000|Overall Study|Transferred|8|||
155591826|NCT01218087|561593890|FG001|Overall Study|Transferred|5|||
155591827|NCT03170362|561593891|FG000|Overall Study|Death|2|||
155591828|NCT03170362|561593892|FG001|Overall Study|Death|2|||
155591829|NCT03170362|561593891|FG000|Overall Study|Withdrawal by Subject|23|||
155591830|NCT03170362|561593892|FG001|Overall Study|Withdrawal by Subject|22|||
155591831|NCT03170362|561593891|FG000|Overall Study|Lost to Follow-up|187|||
155591832|NCT03170362|561593892|FG001|Overall Study|Lost to Follow-up|167|||
155591833|NCT04615403|561593893|FG000|Overall Study|Death|1|||
155591834|NCT00552396|561593894|FG000|Overall Study|protocol withdrawal criteria|3|||
155591835|NCT00552396|561593895|FG001|Overall Study|protocol withdrawal criteria|3|||
155591836|NCT00552396|561593896|FG002|Overall Study|protocol withdrawal criteria|3|||
155591837|NCT00552396|561593897|FG003|Overall Study|protocol withdrawal criteria|6|||
155591838|NCT00552396|561593898|FG004|Overall Study|protocol withdrawal criteria|3|||
155591839|NCT00552396|561593899|FG005|Overall Study|protocol withdrawal criteria|3|||
155591840|NCT00552396|561593900|FG006|Overall Study|protocol withdrawal criteria|9|||
155591841|NCT00665431|561593901|FG000|Overall Study|Adverse Event|16|||
155591842|NCT00665431|561593902|FG001|Overall Study|Adverse Event|22|||
155591843|NCT00665431|561593903|FG002|Overall Study|Adverse Event|6|||
155591844|NCT00665431|561593901|FG000|Overall Study|Withdrawal by Subject|17|||
155591845|NCT00665431|561593902|FG001|Overall Study|Withdrawal by Subject|25|||
155591846|NCT00665431|561593903|FG002|Overall Study|Withdrawal by Subject|15|||
155591847|NCT00665431|561593901|FG000|Overall Study|Lost to Follow-up|3|||
155591848|NCT00665431|561593902|FG001|Overall Study|Lost to Follow-up|3|||
155591849|NCT00665431|561593903|FG002|Overall Study|Lost to Follow-up|1|||
155591850|NCT00665431|561593901|FG000|Overall Study|Other|4|||
155591851|NCT00665431|561593902|FG001|Overall Study|Other|7|||
155591852|NCT00665431|561593903|FG002|Overall Study|Other|2|||
155591853|NCT00529373|561593904|FG000|Base Study|Adverse Event|525|||
155591854|NCT00529373|561593905|FG001|Base Study|Adverse Event|470|||
155591855|NCT00529373|561593904|FG000|Base Study|Lack of Efficacy|16|||
155591856|NCT00529373|561593905|FG001|Base Study|Lack of Efficacy|75|||
155591857|NCT00529373|561593904|FG000|Base Study|Lost to Follow-up|221|||
155591858|NCT00529373|561593905|FG001|Base Study|Lost to Follow-up|208|||
155591859|NCT00529373|561593904|FG000|Base Study|Other Protocol Specified Criteria|19|||
155591860|NCT00529373|561593905|FG001|Base Study|Other Protocol Specified Criteria|20|||
155591861|NCT00529373|561593904|FG000|Base Study|Physician Decision|60|||
155591862|NCT00529373|561593905|FG001|Base Study|Physician Decision|52|||
155591863|NCT00529373|561593904|FG000|Base Study|Protocol Violation|48|||
155591864|NCT00529373|561593905|FG001|Base Study|Protocol Violation|38|||
155591865|NCT00529373|561593904|FG000|Base Study|Withdrawal by Subject|1062|||
155591866|NCT00529373|561593905|FG001|Base Study|Withdrawal by Subject|967|||
155591867|NCT00529373|561593904|FG000|Base Study|Did not continue into Extension|1795|||
155591868|NCT00529373|561593905|FG001|Base Study|Did not continue into Extension|2238|||
155591869|NCT00529373|561593904|FG000|First Extension Study|Adverse Event|162|||
155591870|NCT00529373|561593905|FG001|First Extension Study|Adverse Event|142|||
155591871|NCT00529373|561593904|FG000|First Extension Study|Lack of Efficacy|65|||
155591872|NCT00529373|561593905|FG001|First Extension Study|Lack of Efficacy|427|||
155591873|NCT00529373|561593904|FG000|First Extension Study|Lost to Follow-up|41|||
155591874|NCT00529373|561593905|FG001|First Extension Study|Lost to Follow-up|37|||
155591875|NCT00529373|561593904|FG000|First Extension Study|Other|27|||
155591876|NCT00529373|561593905|FG001|First Extension Study|Other|47|||
155591877|NCT00529373|561593904|FG000|First Extension Study|Physician Decision|50|||
155591878|NCT00529373|561593905|FG001|First Extension Study|Physician Decision|45|||
155591879|NCT00529373|561593904|FG000|First Extension Study|Protocol Violation|16|||
155591880|NCT00529373|561593905|FG001|First Extension Study|Protocol Violation|13|||
155591881|NCT00529373|561593904|FG000|First Extension Study|Withdrawal by Subject|296|||
155591882|NCT00529373|561593905|FG001|First Extension Study|Withdrawal by Subject|287|||
155591883|NCT00529373|561593904|FG000|First Extension Study|Disposition record non-existing|0|||
155591884|NCT00529373|561593905|FG001|First Extension Study|Disposition record non-existing|1|||
155591885|NCT00529373|561593904|FG000|First Extension Study|Discontinued after 5 years completion|208|||
155667426|NCT05414175|561876656|FG000|Overall Study|Other Reasons|1|||
155591886|NCT00529373|561593905|FG001|First Extension Study|Discontinued after 5 years completion|346|||
155591887|NCT00529373|561593904|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
155591888|NCT00529373|561593905|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
155591889|NCT00529373|561593904|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
155591890|NCT00529373|561593905|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
155591891|NCT00529373|561593904|FG000|Second Extension Study|Adverse Event|101|||
155591892|NCT00529373|561593905|FG001|Second Extension Study|Adverse Event|51|||
155591893|NCT00529373|561593904|FG000|Second Extension Study|Lack of Efficacy|7|||
155591894|NCT00529373|561593905|FG001|Second Extension Study|Lack of Efficacy|15|||
155591895|NCT00529373|561593904|FG000|Second Extension Study|Lost to Follow-up|18|||
155591896|NCT00529373|561593905|FG001|Second Extension Study|Lost to Follow-up|12|||
155591897|NCT00529373|561593904|FG000|Second Extension Study|Other|7|||
155591898|NCT00529373|561593905|FG001|Second Extension Study|Other|12|||
155591899|NCT00529373|561593904|FG000|Second Extension Study|Physician Decision|63|||
155591900|NCT00529373|561593905|FG001|Second Extension Study|Physician Decision|26|||
155591901|NCT00529373|561593904|FG000|Second Extension Study|Protocol Violation|2|||
155591902|NCT00529373|561593905|FG001|Second Extension Study|Protocol Violation|1|||
155591903|NCT00529373|561593904|FG000|Second Extension Study|Withdrawal by Subject|97|||
155591904|NCT00529373|561593905|FG001|Second Extension Study|Withdrawal by Subject|75|||
155591905|NCT00529373|561593904|FG000|Second Extension Study|Status Missing|5|||
155591906|NCT00529373|561593905|FG001|Second Extension Study|Status Missing|5|||
155591907|NCT01074268|561593906|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
155591908|NCT01074268|561593907|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
155591909|NCT01074268|561593906|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
155591910|NCT01074268|561593907|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
155591911|NCT01074268|561593906|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
155591912|NCT01074268|561593907|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
155591913|NCT01074268|561593906|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
155591914|NCT01074268|561593907|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
155591915|NCT01074268|561593906|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
155591916|NCT01074268|561593907|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
155591917|NCT01074268|561593906|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
155591918|NCT01074268|561593907|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
155591919|NCT01074268|561593906|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
155591920|NCT01074268|561593907|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
155591921|NCT01074268|561593906|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
155591922|NCT01074268|561593907|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
155591923|NCT01074268|561593906|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
155591924|NCT01074268|561593907|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
155591925|NCT01578239|561593908|FG000|Treatment Period|Progressive Disease|19|||
155591926|NCT01578239|561593909|FG001|Treatment Period|Progressive Disease|64|||
155591927|NCT01578239|561593908|FG000|Treatment Period|Physician Decision|17|||
155591928|NCT01578239|561593909|FG001|Treatment Period|Physician Decision|17|||
155591929|NCT01578239|561593908|FG000|Treatment Period|Adverse Event|13|||
155591930|NCT01578239|561593909|FG001|Treatment Period|Adverse Event|10|||
155591931|NCT01578239|561593908|FG000|Treatment Period|Non-compliance|2|||
155591932|NCT01578239|561593909|FG001|Treatment Period|Non-compliance|0|||
155591933|NCT01578239|561593908|FG000|Treatment Period|Withdrawal by Subject|10|||
155591934|NCT01578239|561593909|FG001|Treatment Period|Withdrawal by Subject|9|||
155591935|NCT01578239|561593908|FG000|Treatment Period|Other|6|||
155591936|NCT01578239|561593909|FG001|Treatment Period|Other|1|||
155591937|NCT01578239|561593908|FG000|Long-term Follow-Up Period|Death|69|||
155591938|NCT01578239|561593909|FG001|Long-term Follow-Up Period|Death|64|||
155591939|NCT01578239|561593908|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
155591940|NCT01578239|561593909|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
155591941|NCT01578239|561593908|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
155591942|NCT01578239|561593909|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
155591943|NCT01578239|561593908|FG000|Long-term Follow-Up Period|Other|2|||
155591944|NCT01578239|561593909|FG001|Long-term Follow-Up Period|Other|2|||
155591945|NCT02347813|561593912|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
155591946|NCT02347813|561593913|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
155591947|NCT02347813|561593912|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
155591948|NCT02347813|561593913|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
155591949|NCT01119859|561593916|FG000|Overall Study|Adverse Event|9|||
155591950|NCT01119859|561593917|FG001|Overall Study|Adverse Event|10|||
155591951|NCT01119859|561593916|FG000|Overall Study|Death|2|||
155591952|NCT01119859|561593917|FG001|Overall Study|Death|0|||
155591953|NCT01119859|561593916|FG000|Overall Study|Insufficient therapeutic response|7|||
155591954|NCT01119859|561593917|FG001|Overall Study|Insufficient therapeutic response|14|||
155591955|NCT01119859|561593916|FG000|Overall Study|Refused treatment|3|||
155591956|NCT01119859|561593917|FG001|Overall Study|Refused treatment|6|||
155591957|NCT01119859|561593916|FG000|Overall Study|Failure to return|3|||
155591958|NCT01119859|561593917|FG001|Overall Study|Failure to return|0|||
155591959|NCT00603473|561593918|FG000|Overall Study|Adverse Event|4|||
155591960|NCT00603473|561593918|FG000|Overall Study|Lack of Efficacy|4|||
155591961|NCT00603473|561593918|FG000|Overall Study|Protocol Violation|1|||
155591962|NCT01134939|561593922|FG000|Overall Study|Adverse Event|9|||
155591963|NCT01134939|561593923|FG001|Overall Study|Adverse Event|3|||
155591964|NCT01134939|561593924|FG002|Overall Study|Adverse Event|4|||
155591965|NCT01134939|561593925|FG003|Overall Study|Adverse Event|5|||
155591966|NCT01134939|561593926|FG004|Overall Study|Adverse Event|5|||
155591967|NCT01134939|561593927|FG005|Overall Study|Adverse Event|5|||
155591968|NCT01134939|561593928|FG006|Overall Study|Adverse Event|1|||
155591969|NCT01134939|561593929|FG007|Overall Study|Adverse Event|0|||
155591970|NCT01134939|561593922|FG000|Overall Study|Lack of Efficacy|2|||
155591971|NCT01134939|561593923|FG001|Overall Study|Lack of Efficacy|5|||
155591972|NCT01134939|561593924|FG002|Overall Study|Lack of Efficacy|1|||
155591973|NCT01134939|561593925|FG003|Overall Study|Lack of Efficacy|0|||
155591974|NCT01134939|561593926|FG004|Overall Study|Lack of Efficacy|3|||
155591975|NCT01134939|561593927|FG005|Overall Study|Lack of Efficacy|0|||
155591976|NCT01134939|561593928|FG006|Overall Study|Lack of Efficacy|1|||
155591977|NCT01134939|561593929|FG007|Overall Study|Lack of Efficacy|0|||
155591978|NCT01134939|561593922|FG000|Overall Study|Lost to Follow-up|2|||
155591979|NCT01134939|561593923|FG001|Overall Study|Lost to Follow-up|3|||
155591980|NCT01134939|561593924|FG002|Overall Study|Lost to Follow-up|0|||
155591981|NCT01134939|561593925|FG003|Overall Study|Lost to Follow-up|1|||
155591982|NCT01134939|561593926|FG004|Overall Study|Lost to Follow-up|2|||
155591983|NCT01134939|561593927|FG005|Overall Study|Lost to Follow-up|1|||
155591984|NCT01134939|561593928|FG006|Overall Study|Lost to Follow-up|0|||
155591985|NCT01134939|561593929|FG007|Overall Study|Lost to Follow-up|0|||
155591986|NCT01134939|561593922|FG000|Overall Study|Death|0|||
155591987|NCT01134939|561593923|FG001|Overall Study|Death|1|||
155591988|NCT01134939|561593924|FG002|Overall Study|Death|0|||
155591989|NCT01134939|561593925|FG003|Overall Study|Death|0|||
155591990|NCT01134939|561593926|FG004|Overall Study|Death|0|||
155591991|NCT01134939|561593927|FG005|Overall Study|Death|0|||
155591992|NCT01134939|561593928|FG006|Overall Study|Death|0|||
155591993|NCT01134939|561593929|FG007|Overall Study|Death|0|||
155591994|NCT01134939|561593922|FG000|Overall Study|Termination page not available|4|||
155591995|NCT01134939|561593923|FG001|Overall Study|Termination page not available|6|||
155591996|NCT01134939|561593924|FG002|Overall Study|Termination page not available|5|||
155591997|NCT01134939|561593925|FG003|Overall Study|Termination page not available|8|||
155591998|NCT01134939|561593926|FG004|Overall Study|Termination page not available|0|||
155591999|NCT01134939|561593927|FG005|Overall Study|Termination page not available|3|||
155592000|NCT01134939|561593928|FG006|Overall Study|Termination page not available|7|||
155592001|NCT01134939|561593929|FG007|Overall Study|Termination page not available|0|||
155592002|NCT00733421|561593930|FG000|Overall Study|Withdrawal by Subject|1|||
155592003|NCT00733421|561593931|FG001|Overall Study|Withdrawal by Subject|1|||
155592004|NCT03817229|561593932|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
155592005|NCT03817229|561593933|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
155592006|NCT03817229|561593934|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
155592007|NCT03817229|561593935|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
155592008|NCT03817229|561593932|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155592009|NCT03817229|561593933|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
155592010|NCT03817229|561593934|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155592011|NCT03817229|561593935|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155592012|NCT03817229|561593932|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
155592013|NCT03817229|561593933|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
155592014|NCT03817229|561593934|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
155592015|NCT03817229|561593935|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
155592016|NCT03817229|561593932|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
155592017|NCT03817229|561593933|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
155592018|NCT03817229|561593934|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
155592019|NCT03817229|561593935|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
155592020|NCT03817229|561593932|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155592021|NCT03817229|561593933|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155592022|NCT03817229|561593934|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155592023|NCT03817229|561593935|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
155592024|NCT03817229|561593932|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
155592025|NCT03817229|561593933|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
155592026|NCT03817229|561593934|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
155592027|NCT03817229|561593935|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
155592028|NCT03817229|561593932|FG000|Post-Intervention|Withdrawal by Subject|6|||
155592029|NCT03817229|561593933|FG001|Post-Intervention|Withdrawal by Subject|0|||
155592030|NCT03817229|561593934|FG002|Post-Intervention|Withdrawal by Subject|2|||
155592031|NCT03817229|561593935|FG003|Post-Intervention|Withdrawal by Subject|2|||
155592032|NCT03817229|561593932|FG000|Post-Intervention|Withdrawal by Study Team|3|||
155592033|NCT03817229|561593933|FG001|Post-Intervention|Withdrawal by Study Team|1|||
155592034|NCT03817229|561593934|FG002|Post-Intervention|Withdrawal by Study Team|1|||
155592035|NCT03817229|561593935|FG003|Post-Intervention|Withdrawal by Study Team|4|||
155592036|NCT03817229|561593932|FG000|Post-Intervention|Weaned from medication|3|||
155592037|NCT03817229|561593933|FG001|Post-Intervention|Weaned from medication|0|||
155592038|NCT03817229|561593934|FG002|Post-Intervention|Weaned from medication|2|||
155592039|NCT03817229|561593935|FG003|Post-Intervention|Weaned from medication|1|||
155592040|NCT03817229|561593932|FG000|Post-Intervention|Transferred care to another institution|1|||
155592041|NCT03817229|561593933|FG001|Post-Intervention|Transferred care to another institution|0|||
155592042|NCT03817229|561593934|FG002|Post-Intervention|Transferred care to another institution|0|||
155592043|NCT03817229|561593935|FG003|Post-Intervention|Transferred care to another institution|0|||
155592044|NCT03817229|561593932|FG000|Post-Intervention|Change in parental guardianship|0|||
155592045|NCT03817229|561593933|FG001|Post-Intervention|Change in parental guardianship|0|||
155592046|NCT03817229|561593934|FG002|Post-Intervention|Change in parental guardianship|1|||
155592047|NCT03817229|561593935|FG003|Post-Intervention|Change in parental guardianship|0|||
155592048|NCT03817229|561593932|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
155592049|NCT03817229|561593933|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
155592050|NCT03817229|561593934|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
155592051|NCT03817229|561593935|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
155592052|NCT03817229|561593932|FG000|Follow-up 1|Withdrawal by Subject|1|||
155592053|NCT03817229|561593933|FG001|Follow-up 1|Withdrawal by Subject|2|||
155592054|NCT03817229|561593934|FG002|Follow-up 1|Withdrawal by Subject|0|||
155592055|NCT03817229|561593935|FG003|Follow-up 1|Withdrawal by Subject|0|||
155592056|NCT03817229|561593932|FG000|Follow-up 1|Withdrawal by Study Team|3|||
155592057|NCT03817229|561593933|FG001|Follow-up 1|Withdrawal by Study Team|1|||
155592058|NCT03817229|561593934|FG002|Follow-up 1|Withdrawal by Study Team|0|||
155592059|NCT03817229|561593935|FG003|Follow-up 1|Withdrawal by Study Team|0|||
155592060|NCT03817229|561593932|FG000|Follow-up 1|Wean from medication|3|||
155592061|NCT03817229|561593933|FG001|Follow-up 1|Wean from medication|4|||
155592062|NCT03817229|561593934|FG002|Follow-up 1|Wean from medication|0|||
155592063|NCT03817229|561593935|FG003|Follow-up 1|Wean from medication|1|||
155592064|NCT03817229|561593932|FG000|Follow-up 1|Transferred care to another hospital|1|||
155592065|NCT03817229|561593933|FG001|Follow-up 1|Transferred care to another hospital|0|||
155592066|NCT03817229|561593934|FG002|Follow-up 1|Transferred care to another hospital|0|||
155592067|NCT03817229|561593935|FG003|Follow-up 1|Transferred care to another hospital|0|||
155592068|NCT03817229|561593932|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
155592069|NCT03817229|561593933|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
155592070|NCT03817229|561593934|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
155592071|NCT03817229|561593935|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
155592072|NCT03817229|561593932|FG000|Follow-up 2|Withdrawal by Subject|2|||
155592073|NCT03817229|561593933|FG001|Follow-up 2|Withdrawal by Subject|0|||
155592074|NCT03817229|561593934|FG002|Follow-up 2|Withdrawal by Subject|1|||
155592075|NCT03817229|561593935|FG003|Follow-up 2|Withdrawal by Subject|1|||
155592076|NCT03817229|561593932|FG000|Follow-up 2|Withdrawal by Study Team|2|||
155592077|NCT03817229|561593933|FG001|Follow-up 2|Withdrawal by Study Team|0|||
155592078|NCT03817229|561593934|FG002|Follow-up 2|Withdrawal by Study Team|1|||
155592079|NCT03817229|561593935|FG003|Follow-up 2|Withdrawal by Study Team|0|||
155592080|NCT03817229|561593932|FG000|Follow-up 2|Wean from medication|1|||
155592081|NCT03817229|561593933|FG001|Follow-up 2|Wean from medication|0|||
155592082|NCT03817229|561593934|FG002|Follow-up 2|Wean from medication|0|||
155592083|NCT03817229|561593935|FG003|Follow-up 2|Wean from medication|0|||
155592084|NCT03817229|561593932|FG000|Follow-up 2|Transferred care|0|||
155592085|NCT03817229|561593933|FG001|Follow-up 2|Transferred care|0|||
155592086|NCT03817229|561593934|FG002|Follow-up 2|Transferred care|1|||
155592087|NCT03817229|561593935|FG003|Follow-up 2|Transferred care|0|||
155592088|NCT04185220|561593936|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
155592089|NCT04185220|561593937|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
155592090|NCT04185220|561593936|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
155667427|NCT00027560|561876657|FG000|Overall Study|Withdrawal by Subject|1|||
155592091|NCT04185220|561593937|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
155592092|NCT01031680|561593938|FG000|Overall Study|Adverse Event|8|||
155592093|NCT01031680|561593939|FG001|Overall Study|Adverse Event|3|||
155592094|NCT01031680|561593938|FG000|Overall Study|Lost to Follow-up|2|||
155592095|NCT01031680|561593939|FG001|Overall Study|Lost to Follow-up|10|||
155592096|NCT01031680|561593938|FG000|Overall Study|Withdrawal by Subject|12|||
155592097|NCT01031680|561593939|FG001|Overall Study|Withdrawal by Subject|16|||
155592098|NCT01031680|561593938|FG000|Overall Study|Death|2|||
155592099|NCT01031680|561593939|FG001|Overall Study|Death|1|||
155592100|NCT01031680|561593938|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
155592101|NCT01031680|561593939|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
155592102|NCT01031680|561593938|FG000|Overall Study|Poor/Non-compliance|5|||
155592103|NCT01031680|561593939|FG001|Overall Study|Poor/Non-compliance|6|||
155592104|NCT01031680|561593938|FG000|Overall Study|Safety|1|||
155592105|NCT01031680|561593939|FG001|Overall Study|Safety|0|||
155592106|NCT01031680|561593938|FG000|Overall Study|Incorrect Enrolment|1|||
155592107|NCT01031680|561593939|FG001|Overall Study|Incorrect Enrolment|2|||
155592108|NCT01031680|561593938|FG000|Overall Study|Administrative Reason by Sponsor|0|||
155592109|NCT01031680|561593939|FG001|Overall Study|Administrative Reason by Sponsor|1|||
155592110|NCT01031680|561593938|FG000|Overall Study|Various|0|||
155592111|NCT01031680|561593939|FG001|Overall Study|Various|2|||
155592112|NCT01029782|561593942|FG000|Overall Study|Lost to Follow-up|2|||
155592113|NCT01029782|561593943|FG001|Overall Study|Lost to Follow-up|2|||
155592114|NCT01029782|561593942|FG000|Overall Study|Diagnosis changed|1|||
155592115|NCT01029782|561593943|FG001|Overall Study|Diagnosis changed|1|||
155592116|NCT01029782|561593942|FG000|Overall Study|Adverse Event|0|||
155592117|NCT01029782|561593943|FG001|Overall Study|Adverse Event|1|||
155592118|NCT01029782|561593942|FG000|Overall Study|Physician Decision|0|||
155592119|NCT01029782|561593943|FG001|Overall Study|Physician Decision|1|||
155592120|NCT01029782|561593942|FG000|Overall Study|Protocol Violation|0|||
155592121|NCT01029782|561593943|FG001|Overall Study|Protocol Violation|2|||
155592122|NCT01029782|561593942|FG000|Overall Study|Withdrawal by Subject|0|||
155592123|NCT01029782|561593943|FG001|Overall Study|Withdrawal by Subject|1|||
155592124|NCT00757042|561593950|FG000|Overall Study|Lost to Follow-up|0|||
155592125|NCT00757042|561593951|FG001|Overall Study|Lost to Follow-up|0|||
155592126|NCT00757042|561593952|FG002|Overall Study|Lost to Follow-up|0|||
155592127|NCT00757042|561593953|FG003|Overall Study|Lost to Follow-up|0|||
155592128|NCT00757042|561593954|FG004|Overall Study|Lost to Follow-up|0|||
155592129|NCT00757042|561593955|FG005|Overall Study|Lost to Follow-up|0|||
155592130|NCT00757042|561593956|FG006|Overall Study|Lost to Follow-up|0|||
155592131|NCT00757042|561593957|FG007|Overall Study|Lost to Follow-up|0|||
155592132|NCT00757042|561593958|FG008|Overall Study|Lost to Follow-up|1|||
155592133|NCT00757042|561593959|FG009|Overall Study|Lost to Follow-up|0|||
155592134|NCT00757042|561593960|FG010|Overall Study|Lost to Follow-up|0|||
155592135|NCT00757042|561593950|FG000|Overall Study|Ineligibility Determined|0|||
155592136|NCT00757042|561593951|FG001|Overall Study|Ineligibility Determined|0|||
155592137|NCT00757042|561593952|FG002|Overall Study|Ineligibility Determined|0|||
155592138|NCT00757042|561593953|FG003|Overall Study|Ineligibility Determined|0|||
155592139|NCT00757042|561593954|FG004|Overall Study|Ineligibility Determined|0|||
155592140|NCT00757042|561593955|FG005|Overall Study|Ineligibility Determined|0|||
155592141|NCT00757042|561593956|FG006|Overall Study|Ineligibility Determined|0|||
155592142|NCT00757042|561593957|FG007|Overall Study|Ineligibility Determined|0|||
155592143|NCT00757042|561593958|FG008|Overall Study|Ineligibility Determined|0|||
155592144|NCT00757042|561593959|FG009|Overall Study|Ineligibility Determined|0|||
155592145|NCT00757042|561593960|FG010|Overall Study|Ineligibility Determined|1|||
155592146|NCT00757042|561593950|FG000|Overall Study|Withdrawal by Subject|0|||
155592147|NCT00757042|561593951|FG001|Overall Study|Withdrawal by Subject|0|||
155592148|NCT00757042|561593952|FG002|Overall Study|Withdrawal by Subject|0|||
155592149|NCT00757042|561593953|FG003|Overall Study|Withdrawal by Subject|0|||
155592150|NCT00757042|561593954|FG004|Overall Study|Withdrawal by Subject|0|||
155592151|NCT00757042|561593955|FG005|Overall Study|Withdrawal by Subject|0|||
155592152|NCT00757042|561593956|FG006|Overall Study|Withdrawal by Subject|0|||
155592153|NCT00757042|561593957|FG007|Overall Study|Withdrawal by Subject|0|||
155592154|NCT00757042|561593958|FG008|Overall Study|Withdrawal by Subject|0|||
155592155|NCT00757042|561593959|FG009|Overall Study|Withdrawal by Subject|1|||
155592156|NCT00757042|561593960|FG010|Overall Study|Withdrawal by Subject|0|||
155667428|NCT03559270|561876659|FG000|Overall Study|Adverse Event|6|||
155592157|NCT03319732|561593961|FG000|Overall Study|Adverse Event|40|||
155592158|NCT03319732|561593961|FG000|Overall Study|Withdrawal by Subject|50|||
155592159|NCT03319732|561593961|FG000|Overall Study|MS relapse|10|||
155592160|NCT03319732|561593961|FG000|Overall Study|reason not specified|5|||
155667429|NCT03559270|561876660|FG001|Overall Study|Adverse Event|5|||
155592161|NCT02729051|561593967|FG000|Overall Study|Adverse Event|21|||
155592162|NCT02729051|561593968|FG001|Overall Study|Adverse Event|11|||
155592163|NCT02729051|561593967|FG000|Overall Study|Lack of Efficacy|1|||
155592164|NCT02729051|561593968|FG001|Overall Study|Lack of Efficacy|1|||
155592165|NCT02729051|561593967|FG000|Overall Study|Lost to Follow-up|1|||
155592166|NCT02729051|561593968|FG001|Overall Study|Lost to Follow-up|2|||
155592167|NCT02729051|561593967|FG000|Overall Study|Physician Decision|1|||
155592168|NCT02729051|561593968|FG001|Overall Study|Physician Decision|1|||
155592169|NCT02729051|561593967|FG000|Overall Study|Withdrawal by Subject|6|||
155592170|NCT02729051|561593968|FG001|Overall Study|Withdrawal by Subject|17|||
155592171|NCT02702388|561593969|FG000|Overall Study|Disease Progression|18|||
155592172|NCT02702388|561593970|FG001|Overall Study|Disease Progression|25|||
155592173|NCT02702388|561593969|FG000|Overall Study|Withdrawal by Subject|9|||
155592174|NCT02702388|561593970|FG001|Overall Study|Withdrawal by Subject|7|||
155592175|NCT02702388|561593969|FG000|Overall Study|Adverse Event|11|||
155592176|NCT02702388|561593970|FG001|Overall Study|Adverse Event|15|||
155592177|NCT02702388|561593969|FG000|Overall Study|Other|2|||
155592178|NCT02702388|561593970|FG001|Overall Study|Other|4|||
155592179|NCT03652636|561595497|FG000|Overall Study|Withdrawal by Subject|7|||
155592180|NCT01736397|561595500|FG000|Overall Study|Lack of Efficacy|1|||
155592181|NCT01736397|561595501|FG001|Overall Study|Lack of Efficacy|11|||
155592182|NCT01736397|561595500|FG000|Overall Study|Withdrawal by Subject|6|||
155592183|NCT01736397|561595501|FG001|Overall Study|Withdrawal by Subject|5|||
155592184|NCT01736397|561595500|FG000|Overall Study|Lost to Follow-up|0|||
155592185|NCT01736397|561595501|FG001|Overall Study|Lost to Follow-up|1|||
155592186|NCT01736397|561595500|FG000|Overall Study|Adverse Event|6|||
155592187|NCT01736397|561595501|FG001|Overall Study|Adverse Event|3|||
155592188|NCT01736397|561595500|FG000|Overall Study|Not stated|1|||
155592189|NCT01736397|561595501|FG001|Overall Study|Not stated|4|||
155592190|NCT05088603|561595502|FG000|Overall Study|Protocol Violation|6|||
155592191|NCT05088603|561595503|FG001|Overall Study|Protocol Violation|1|||
155592192|NCT01868438|561595504|FG000|First Intervention|Withdrawal by Subject|5|||
155592193|NCT01868438|561595505|FG001|First Intervention|Withdrawal by Subject|1|||
155592194|NCT01868438|561595504|FG000|First Intervention|Lost to Follow-up|2|||
155592195|NCT01868438|561595505|FG001|First Intervention|Lost to Follow-up|3|||
155592196|NCT01868438|561595504|FG000|First Intervention|Meeting the non-redosing criteria|0|||
155592197|NCT01868438|561595505|FG001|First Intervention|Meeting the non-redosing criteria|1|||
155592198|NCT01868438|561595504|FG000|Second Intervention|Adverse Event|3|||
155592199|NCT01868438|561595505|FG001|Second Intervention|Adverse Event|3|||
155592200|NCT03555565|561595508|FG000|Overall Study|Case Report Forms Uncollected|2|||
155592201|NCT03555565|561595508|FG000|Overall Study|Protocol Deviation|13|||
155592202|NCT00076752|561595511|FG000|Overall Study|Death|2|||
155592203|NCT00076752|561595511|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
155592204|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
155592205|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
155592206|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
155592207|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
155592208|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
155592209|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
155592210|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
155592211|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
155592212|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Death|0|||
155592213|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Death|1|||
155592214|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
155592215|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
155592216|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
155592217|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
155592218|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
155592219|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
155592220|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
155592221|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
155592222|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
155592223|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
155592224|NCT00394836|561595512|FG000|Teatment or Follow-up Phase|Non compliance|0|||
155592225|NCT00394836|561595513|FG001|Teatment or Follow-up Phase|Non compliance|1|||
155592226|NCT00394836|561595512|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
155592227|NCT00394836|561595513|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
155592228|NCT00394836|561595512|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
155667430|NCT03559270|561876661|FG002|Overall Study|Adverse Event|3|||
155667431|NCT03559270|561876662|FG003|Overall Study|Adverse Event|0|||
155592229|NCT00394836|561595513|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
155592230|NCT00394836|561595512|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
155592231|NCT00394836|561595513|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
155592232|NCT00394836|561595512|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
155592233|NCT00394836|561595513|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
155592234|NCT01560234|561595514|FG000|Overall Study|Lost to Follow-up|3|||
155592235|NCT01560234|561595515|FG001|Overall Study|Lost to Follow-up|0|||
155592236|NCT01560234|561595516|FG002|Overall Study|Lost to Follow-up|1|||
155592237|NCT01560234|561595517|FG003|Overall Study|Lost to Follow-up|0|||
155592238|NCT01560234|561595518|FG004|Overall Study|Lost to Follow-up|0|||
155592239|NCT01560234|561595519|FG005|Overall Study|Lost to Follow-up|2|||
155592240|NCT01560234|561595520|FG006|Overall Study|Lost to Follow-up|0|||
155592241|NCT01560234|561595521|FG007|Overall Study|Lost to Follow-up|2|||
155592242|NCT01284348|561595522|FG000|Overall Study|Death|1|||
155592243|NCT01284348|561595523|FG001|Overall Study|Death|1|||
155592244|NCT01284348|561595522|FG000|Overall Study|Withdrew consent|0|||
155592245|NCT01284348|561595523|FG001|Overall Study|Withdrew consent|1|||
155592246|NCT01284348|561595522|FG000|Overall Study|Status not recorded|9|||
155592247|NCT01284348|561595523|FG001|Overall Study|Status not recorded|10|||
155592248|NCT00892151|561595524|FG000|Overall Study|Protocol Violation|1|||
155592249|NCT04075682|561595527|FG000|Overall Study|Lost to Follow-up|5|||
155592250|NCT04075682|561595528|FG001|Overall Study|Lost to Follow-up|5|||
155592251|NCT04075682|561595529|FG002|Overall Study|Lost to Follow-up|2|||
155592252|NCT04075682|561595530|FG003|Overall Study|Lost to Follow-up|2|||
155592253|NCT04075682|561595527|FG000|Overall Study|Withdrawal by Subject|1|||
155592254|NCT04075682|561595528|FG001|Overall Study|Withdrawal by Subject|0|||
155592255|NCT04075682|561595529|FG002|Overall Study|Withdrawal by Subject|1|||
155592256|NCT04075682|561595530|FG003|Overall Study|Withdrawal by Subject|0|||
155592257|NCT04075682|561595527|FG000|Overall Study|Protocol Violation|0|||
155592258|NCT04075682|561595528|FG001|Overall Study|Protocol Violation|1|||
155592259|NCT04075682|561595529|FG002|Overall Study|Protocol Violation|1|||
155592260|NCT04075682|561595530|FG003|Overall Study|Protocol Violation|0|||
155592261|NCT04075682|561595527|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
155592262|NCT04075682|561595528|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
155592263|NCT04075682|561595529|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
155592264|NCT04075682|561595530|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
155592265|NCT04075682|561595527|FG000|Overall Study|Lost study phone the first day of study participation|0|||
155592266|NCT04075682|561595528|FG001|Overall Study|Lost study phone the first day of study participation|1|||
155592267|NCT04075682|561595529|FG002|Overall Study|Lost study phone the first day of study participation|0|||
155592268|NCT04075682|561595530|FG003|Overall Study|Lost study phone the first day of study participation|0|||
155592269|NCT01222520|561595533|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
155592270|NCT01222520|561595534|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
155592271|NCT01222520|561595533|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
155592272|NCT01222520|561595534|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
155592273|NCT01222520|561595533|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
155592274|NCT01222520|561595534|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
155592275|NCT01222520|561595533|FG000|Double-blind Period|Adverse Event|0|||
155592276|NCT01222520|561595534|FG001|Double-blind Period|Adverse Event|1|||
155592277|NCT01222520|561595533|FG000|Double-blind Period|Lack of Efficacy|0|||
155592278|NCT01222520|561595534|FG001|Double-blind Period|Lack of Efficacy|1|||
155592279|NCT01222520|561595533|FG000|Double-blind Period|Study medication stolen|1|||
155592280|NCT01222520|561595534|FG001|Double-blind Period|Study medication stolen|0|||
155592281|NCT03423173|561595539|FG000|Overall Study|Randomized but not vaccinated|1|||
155592282|NCT03423173|561595540|FG001|Overall Study|Randomized but not vaccinated|0|||
155592283|NCT03423173|561595541|FG002|Overall Study|Randomized but not vaccinated|2|||
155667432|NCT03559270|561876659|FG000|Overall Study|Lack of Efficacy|34|||
155667433|NCT03559270|561876660|FG001|Overall Study|Lack of Efficacy|52|||
155592284|NCT03423173|561595542|FG003|Overall Study|Randomized but not vaccinated|1|||
155592285|NCT03423173|561595539|FG000|Overall Study|Adverse Event|1|||
155592286|NCT03423173|561595540|FG001|Overall Study|Adverse Event|1|||
155592287|NCT03423173|561595541|FG002|Overall Study|Adverse Event|1|||
155592288|NCT03423173|561595542|FG003|Overall Study|Adverse Event|1|||
155592289|NCT03423173|561595539|FG000|Overall Study|Lost to Follow-up|10|||
155592290|NCT03423173|561595540|FG001|Overall Study|Lost to Follow-up|19|||
155592291|NCT03423173|561595541|FG002|Overall Study|Lost to Follow-up|17|||
155592292|NCT03423173|561595542|FG003|Overall Study|Lost to Follow-up|22|||
155592293|NCT03423173|561595539|FG000|Overall Study|Withdrawal of consent|4|||
155592294|NCT03423173|561595540|FG001|Overall Study|Withdrawal of consent|10|||
155592295|NCT03423173|561595541|FG002|Overall Study|Withdrawal of consent|4|||
155592296|NCT03423173|561595542|FG003|Overall Study|Withdrawal of consent|5|||
155592297|NCT03423173|561595539|FG000|Overall Study|Death|1|||
155592298|NCT03423173|561595540|FG001|Overall Study|Death|0|||
155592299|NCT03423173|561595541|FG002|Overall Study|Death|0|||
155592300|NCT03423173|561595542|FG003|Overall Study|Death|0|||
155592301|NCT03423173|561595539|FG000|Overall Study|Reason not Specified|2|||
155592302|NCT03423173|561595540|FG001|Overall Study|Reason not Specified|5|||
155592303|NCT03423173|561595541|FG002|Overall Study|Reason not Specified|3|||
155592304|NCT03423173|561595542|FG003|Overall Study|Reason not Specified|1|||
155592305|NCT03348930|561595543|FG000|Washout (1 Week)|Lost to Follow-up|1|||
155592306|NCT03348930|561595544|FG001|Washout (1 Week)|Lost to Follow-up|1|||
155592307|NCT03533114|561595545|FG000|Overall|Adverse Event|16|||
155592308|NCT03533114|561595546|FG001|Overall|Adverse Event|11|||
155592309|NCT03533114|561595545|FG000|Overall|Consent Withdrawal by Participant|7|||
155592310|NCT03533114|561595546|FG001|Overall|Consent Withdrawal by Participant|6|||
155592311|NCT03533114|561595545|FG000|Overall|Lack of Efficacy|5|||
155592312|NCT03533114|561595546|FG001|Overall|Lack of Efficacy|3|||
155667434|NCT03559270|561876661|FG002|Overall Study|Lack of Efficacy|37|||
155667435|NCT03559270|561876662|FG003|Overall Study|Lack of Efficacy|2|||
155667436|NCT03559270|561876659|FG000|Overall Study|Death|0|||
155667437|NCT03559270|561876660|FG001|Overall Study|Death|2|||
155667438|NCT03559270|561876661|FG002|Overall Study|Death|0|||
155667439|NCT03559270|561876662|FG003|Overall Study|Death|0|||
155667440|NCT03559270|561876659|FG000|Overall Study|Lost to Follow-up|16|||
155667441|NCT03559270|561876660|FG001|Overall Study|Lost to Follow-up|4|||
155667442|NCT03559270|561876661|FG002|Overall Study|Lost to Follow-up|12|||
155667443|NCT03559270|561876662|FG003|Overall Study|Lost to Follow-up|3|||
155667444|NCT03559270|561876659|FG000|Overall Study|Sponsor Decision|38|||
155667445|NCT03559270|561876660|FG001|Overall Study|Sponsor Decision|31|||
155667446|NCT03559270|561876661|FG002|Overall Study|Sponsor Decision|35|||
155667447|NCT03559270|561876662|FG003|Overall Study|Sponsor Decision|18|||
155667448|NCT03559270|561876659|FG000|Overall Study|Withdrawal by Subject|19|||
155667449|NCT03559270|561876660|FG001|Overall Study|Withdrawal by Subject|21|||
155667450|NCT03559270|561876661|FG002|Overall Study|Withdrawal by Subject|18|||
155667451|NCT03559270|561876662|FG003|Overall Study|Withdrawal by Subject|7|||
155667452|NCT03559270|561876659|FG000|Overall Study|Physician Decision|3|||
155667453|NCT03559270|561876660|FG001|Overall Study|Physician Decision|2|||
155667454|NCT03559270|561876661|FG002|Overall Study|Physician Decision|1|||
155667455|NCT03559270|561876662|FG003|Overall Study|Physician Decision|0|||
155667456|NCT03559270|561876659|FG000|Overall Study|Pregnancy|0|||
155667457|NCT03559270|561876660|FG001|Overall Study|Pregnancy|1|||
155667458|NCT03559270|561876661|FG002|Overall Study|Pregnancy|0|||
155667459|NCT03559270|561876662|FG003|Overall Study|Pregnancy|0|||
155667460|NCT03559270|561876659|FG000|Overall Study|Protocol Violation|1|||
155667461|NCT03559270|561876660|FG001|Overall Study|Protocol Violation|0|||
155667462|NCT03559270|561876661|FG002|Overall Study|Protocol Violation|2|||
155667463|NCT03559270|561876662|FG003|Overall Study|Protocol Violation|0|||
155667464|NCT04790279|561878392|FG000|Overall Study|Did not meet medication start criteria|27|||
155667465|NCT04790279|561878393|FG001|Overall Study|Did not meet medication start criteria|15|||
155667466|NCT04790279|561878392|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
155667467|NCT04790279|561878393|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
155667468|NCT04790279|561878392|FG000|Overall Study|Protocol Violation|8|||
155667469|NCT04790279|561878393|FG001|Overall Study|Protocol Violation|3|||
155667470|NCT04790279|561878392|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
155592313|NCT03533114|561595545|FG000|Overall|Lost to Follow-up|1|||
155667471|NCT04790279|561878393|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
155667472|NCT00810277|561878395|FG000|Overall Study|Adverse Event|1|||
155667473|NCT00678288|561878402|FG000|Overall Study|Adverse Event|0|||
155592314|NCT03533114|561595546|FG001|Overall|Lost to Follow-up|1|||
155592315|NCT03533114|561595545|FG000|Overall|Physician Decision|0|||
155592316|NCT03533114|561595546|FG001|Overall|Physician Decision|2|||
155592317|NCT03533114|561595545|FG000|Overall|Protocol deviation|1|||
155592318|NCT03533114|561595546|FG001|Overall|Protocol deviation|1|||
155667474|NCT00678288|561878403|FG001|Overall Study|Adverse Event|2|||
155667475|NCT00678288|561878402|FG000|Overall Study|Withdrawal by Subject|1|||
155592319|NCT03533114|561595545|FG000|Overall|Failure to meet randomization criteria|1|||
155592320|NCT03533114|561595546|FG001|Overall|Failure to meet randomization criteria|2|||
155592321|NCT03533114|561595545|FG000|Overall|Non-Compliance with study drug|0|||
155592322|NCT03533114|561595546|FG001|Overall|Non-Compliance with study drug|1|||
155592323|NCT03533114|561595545|FG000|Overall|Other|0|||
155592324|NCT03533114|561595546|FG001|Overall|Other|1|||
155592325|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Adverse Event|11|||
155592326|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Adverse Event|8|||
155592327|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
155592328|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
155592329|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
155592330|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
155592331|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
155592332|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
155592333|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
155592334|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
155592335|NCT03533114|561595545|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
155592336|NCT03533114|561595546|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
155592337|NCT03533114|561595545|FG000|Stable Dose|Adverse Event|0|||
155592338|NCT03533114|561595546|FG001|Stable Dose|Adverse Event|2|||
155592339|NCT03533114|561595545|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
155592340|NCT03533114|561595546|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
155592341|NCT03533114|561595545|FG000|Stable Dose|Lack of Efficacy|1|||
155592342|NCT03533114|561595546|FG001|Stable Dose|Lack of Efficacy|0|||
155592343|NCT03533114|561595545|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
155592344|NCT03533114|561595546|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
155592345|NCT03533114|561595545|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
155592346|NCT03533114|561595546|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
155592347|NCT03533114|561595545|FG000|Open-Label Safety Extension|Adverse Event|3|||
155592348|NCT03533114|561595546|FG001|Open-Label Safety Extension|Adverse Event|0|||
155592349|NCT03533114|561595545|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
155592350|NCT03533114|561595546|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
155592351|NCT03533114|561595545|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
155592352|NCT03533114|561595546|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
155592353|NCT03533114|561595545|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
155592354|NCT03533114|561595546|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
155592355|NCT03533114|561595545|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
155592356|NCT03533114|561595546|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
155592357|NCT01062113|561595547|FG000|Overall Study|Adverse Event|1|||
155592358|NCT01062113|561595548|FG001|Overall Study|Adverse Event|0|||
155592359|NCT01062113|561595549|FG002|Overall Study|Adverse Event|0|||
155592360|NCT01062113|561595547|FG000|Overall Study|Lack of Efficacy|38|||
155592361|NCT01062113|561595548|FG001|Overall Study|Lack of Efficacy|22|||
155592362|NCT01062113|561595549|FG002|Overall Study|Lack of Efficacy|31|||
155592363|NCT01062113|561595547|FG000|Overall Study|Withdrawal by Subject|1|||
155592364|NCT01062113|561595548|FG001|Overall Study|Withdrawal by Subject|0|||
155592365|NCT01062113|561595549|FG002|Overall Study|Withdrawal by Subject|0|||
155592366|NCT02295020|561595561|FG000|Overall Study|Adverse Event|0|||
155592367|NCT02295020|561595562|FG001|Overall Study|Adverse Event|1|||
155592368|NCT02295020|561595561|FG000|Overall Study|Withdrawal by Subject|3|||
155592369|NCT02295020|561595562|FG001|Overall Study|Withdrawal by Subject|2|||
155592370|NCT01290679|561595563|FG000|Overall Study|Adverse Event|2|||
155667476|NCT00678288|561878403|FG001|Overall Study|Withdrawal by Subject|1|||
155667477|NCT00678288|561878402|FG000|Overall Study|Study terminated by the sponsor|2|||
155667478|NCT00678288|561878403|FG001|Overall Study|Study terminated by the sponsor|0|||
155667479|NCT00678288|561878402|FG000|Overall Study|Not compliant with study medication|0|||
155667480|NCT00678288|561878403|FG001|Overall Study|Not compliant with study medication|1|||
155667481|NCT00678288|561878402|FG000|Overall Study|Switch to commercial drug|0|||
155667482|NCT00678288|561878403|FG001|Overall Study|Switch to commercial drug|1|||
155667483|NCT00678288|561878402|FG000|Overall Study|Reason not reported|1|||
155667484|NCT00678288|561878403|FG001|Overall Study|Reason not reported|0|||
155667485|NCT00678288|561878402|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
155667486|NCT00678288|561878403|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
155667487|NCT04472650|561878414|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
155667488|NCT04472650|561878415|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
155667489|NCT02628444|561878418|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
155667490|NCT02628444|561878419|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667491|NCT02628444|561878420|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667492|NCT02628444|561878421|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667493|NCT02628444|561878422|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667494|NCT02628444|561878423|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667495|NCT02628444|561878424|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667496|NCT02628444|561878425|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667497|NCT02628444|561878426|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155667498|NCT02628444|561878418|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667499|NCT02628444|561878419|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
155667500|NCT02628444|561878420|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
155667501|NCT02628444|561878421|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667502|NCT02628444|561878422|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667503|NCT02628444|561878423|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667504|NCT02628444|561878424|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667505|NCT02628444|561878425|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667506|NCT02628444|561878426|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155667507|NCT02628444|561878418|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
155667508|NCT02628444|561878419|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
155667509|NCT02628444|561878420|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
155667510|NCT02628444|561878421|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667511|NCT02628444|561878422|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667512|NCT02628444|561878423|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667513|NCT02628444|561878424|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667514|NCT02628444|561878425|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667515|NCT02628444|561878426|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667516|NCT02628444|561878418|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
155667517|NCT02628444|561878419|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
155667518|NCT02628444|561878420|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
155667519|NCT02628444|561878421|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667520|NCT02628444|561878422|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667521|NCT02628444|561878423|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667522|NCT02628444|561878424|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667523|NCT02628444|561878425|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667524|NCT02628444|561878426|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155667525|NCT02628444|561878418|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
155667526|NCT02628444|561878419|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
155667527|NCT02628444|561878420|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
155667528|NCT02628444|561878421|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155667529|NCT02628444|561878422|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155667530|NCT02628444|561878423|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155667531|NCT02628444|561878424|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155592371|NCT01290679|561595564|FG001|Overall Study|Adverse Event|0|||
155592372|NCT01290679|561595563|FG000|Overall Study|Lost to Follow-up|8|||
155592373|NCT01290679|561595564|FG001|Overall Study|Lost to Follow-up|10|||
155592374|NCT01290679|561595563|FG000|Overall Study|Protocol Violation|0|||
155592375|NCT01290679|561595564|FG001|Overall Study|Protocol Violation|1|||
155592376|NCT01290679|561595563|FG000|Overall Study|Withdrawal by Subject|6|||
155592377|NCT01290679|561595564|FG001|Overall Study|Withdrawal by Subject|5|||
155592378|NCT01290679|561595563|FG000|Overall Study|Subject Entered Another Trial|0|||
155592379|NCT01290679|561595564|FG001|Overall Study|Subject Entered Another Trial|5|||
155592380|NCT04791319|561595565|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
155592381|NCT04791319|561595566|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
155592382|NCT04791319|561595567|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
155592383|NCT04791319|561595568|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
155592384|NCT04791319|561595569|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592385|NCT04791319|561595570|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592386|NCT04791319|561595571|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592387|NCT04791319|561595572|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592388|NCT04791319|561595573|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592389|NCT04791319|561595574|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592390|NCT04791319|561595575|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155592391|NCT04791319|561595565|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
155592392|NCT04791319|561595566|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592393|NCT04791319|561595567|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
155592394|NCT04791319|561595568|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
155592395|NCT04791319|561595569|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592396|NCT04791319|561595570|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592397|NCT04791319|561595571|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592398|NCT04791319|561595572|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592399|NCT04791319|561595573|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592400|NCT04791319|561595574|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592401|NCT04791319|561595575|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155592402|NCT04791319|561595565|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
155592403|NCT04791319|561595566|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
155592404|NCT04791319|561595567|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
155592405|NCT04791319|561595568|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
155592406|NCT04791319|561595569|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592407|NCT04791319|561595570|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592408|NCT04791319|561595571|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592409|NCT04791319|561595572|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592410|NCT04791319|561595573|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592411|NCT04791319|561595574|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592412|NCT04791319|561595575|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155592413|NCT04791319|561595565|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
155592414|NCT04791319|561595566|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
155592415|NCT04791319|561595567|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
155592416|NCT04791319|561595568|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
155592417|NCT04791319|561595569|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592418|NCT04791319|561595570|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592419|NCT04791319|561595571|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592420|NCT04791319|561595572|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592421|NCT04791319|561595573|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592422|NCT04791319|561595574|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592423|NCT04791319|561595575|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155592424|NCT04791319|561595565|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592425|NCT04791319|561595566|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592426|NCT04791319|561595567|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592427|NCT04791319|561595568|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
155592428|NCT04791319|561595569|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592429|NCT04791319|561595570|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592430|NCT04791319|561595571|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592431|NCT04791319|561595572|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592432|NCT04791319|561595573|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592433|NCT04791319|561595574|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592434|NCT04791319|561595575|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155592435|NCT04791319|561595565|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592436|NCT04791319|561595566|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592437|NCT04791319|561595567|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592438|NCT04791319|561595568|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592439|NCT04791319|561595569|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
155592440|NCT04791319|561595570|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
155592441|NCT04791319|561595571|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
155592442|NCT04791319|561595572|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592443|NCT04791319|561595573|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592444|NCT04791319|561595574|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155592445|NCT04791319|561595575|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
155592446|NCT04791319|561595565|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592447|NCT04791319|561595566|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592448|NCT04791319|561595567|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592449|NCT04791319|561595568|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592450|NCT04791319|561595569|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592451|NCT04791319|561595570|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592452|NCT04791319|561595571|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592453|NCT04791319|561595572|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592454|NCT04791319|561595573|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592455|NCT04791319|561595574|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
155592456|NCT04791319|561595575|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155592457|NCT04791319|561595565|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155592458|NCT04791319|561595566|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155592459|NCT04791319|561595567|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155592460|NCT04791319|561595568|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155592461|NCT04791319|561595569|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
155592462|NCT04791319|561595570|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
155592463|NCT04791319|561595571|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
155592464|NCT04791319|561595572|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155592465|NCT04791319|561595573|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
155592466|NCT04791319|561595574|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
155592467|NCT04791319|561595575|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
155592468|NCT04791319|561595565|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155592469|NCT04791319|561595566|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155592470|NCT04791319|561595567|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155592471|NCT04791319|561595568|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155592472|NCT04791319|561595569|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
155592473|NCT04791319|561595570|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
155592474|NCT04791319|561595571|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
155592475|NCT04791319|561595572|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
155592476|NCT04791319|561595573|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
155592477|NCT04791319|561595574|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
155592478|NCT04791319|561595575|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
155592479|NCT00766636|561595582|FG000|Overall Study|Withdrawal by Subject|1|||
155592480|NCT00766636|561595583|FG001|Overall Study|Withdrawal by Subject|1|||
155592481|NCT00766636|561595582|FG000|Overall Study|Incomplete Treatment|0|||
155592482|NCT00766636|561595583|FG001|Overall Study|Incomplete Treatment|1|||
155592483|NCT00766636|561595582|FG000|Overall Study|Adverse Event|1|||
155592484|NCT00766636|561595583|FG001|Overall Study|Adverse Event|0|||
155592485|NCT00766636|561595582|FG000|Overall Study|Disease Progression|1|||
155592486|NCT00766636|561595583|FG001|Overall Study|Disease Progression|0|||
155592487|NCT04087720|561595588|FG000|Overall Study|Withdrawal by Subject|2|||
155592488|NCT04087720|561595588|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
155592489|NCT00478777|561595591|FG000|Overall Study|Adverse Event|29|||
155592490|NCT00478777|561595591|FG000|Overall Study|Lack of Efficacy|23|||
155592491|NCT00478777|561595591|FG000|Overall Study|Withdrawal by Subject|4|||
155592492|NCT00478777|561595591|FG000|Overall Study|Death|3|||
155592493|NCT00478777|561595591|FG000|Overall Study|Protocol Violation|3|||
155592494|NCT00478777|561595591|FG000|Overall Study|Lost to Follow-up|3|||
155592495|NCT00478777|561595591|FG000|Overall Study|Physician Decision|1|||
155592496|NCT00478777|561595591|FG000|Overall Study|Intolerance of therapy|1|||
155592497|NCT00478777|561595591|FG000|Overall Study|Lack of compliance|1|||
155592498|NCT00478777|561595591|FG000|Overall Study|Lymphocytes infusion|1|||
155592499|NCT00478777|561595591|FG000|Overall Study|End of therapy|2|||
155592500|NCT00478777|561595591|FG000|Overall Study|Not treated with lenalidomide|6|||
155592501|NCT01377922|561595597|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
155592502|NCT01377922|561595598|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
155592503|NCT02553499|561595601|FG000|Overall Study|Adverse Event|0|||
155592504|NCT02553499|561595602|FG001|Overall Study|Adverse Event|0|||
155592505|NCT02553499|561595603|FG002|Overall Study|Adverse Event|0|||
155592506|NCT02553499|561595604|FG003|Overall Study|Adverse Event|0|||
155592507|NCT02553499|561595605|FG004|Overall Study|Adverse Event|0|||
155592508|NCT02553499|561595606|FG005|Overall Study|Adverse Event|0|||
155592509|NCT02553499|561595607|FG006|Overall Study|Adverse Event|1|||
155592510|NCT02553499|561595608|FG007|Overall Study|Adverse Event|1|||
155592511|NCT02553499|561595609|FG008|Overall Study|Adverse Event|0|||
155592512|NCT02553499|561595610|FG009|Overall Study|Adverse Event|0|||
155592513|NCT02553499|561595611|FG010|Overall Study|Adverse Event|0|||
155592514|NCT02553499|561595612|FG011|Overall Study|Adverse Event|0|||
155592515|NCT02553499|561595613|FG012|Overall Study|Adverse Event|0|||
155592516|NCT02553499|561595614|FG013|Overall Study|Adverse Event|1|||
155592517|NCT02553499|561595601|FG000|Overall Study|Death|0|||
155592518|NCT02553499|561595602|FG001|Overall Study|Death|1|||
155592519|NCT02553499|561595603|FG002|Overall Study|Death|1|||
155592520|NCT02553499|561595604|FG003|Overall Study|Death|0|||
155592521|NCT02553499|561595605|FG004|Overall Study|Death|1|||
155592522|NCT02553499|561595606|FG005|Overall Study|Death|2|||
155592523|NCT02553499|561595607|FG006|Overall Study|Death|0|||
155592524|NCT02553499|561595608|FG007|Overall Study|Death|0|||
155592525|NCT02553499|561595609|FG008|Overall Study|Death|0|||
155592526|NCT02553499|561595610|FG009|Overall Study|Death|0|||
155592527|NCT02553499|561595611|FG010|Overall Study|Death|1|||
155592528|NCT02553499|561595612|FG011|Overall Study|Death|0|||
155592529|NCT02553499|561595613|FG012|Overall Study|Death|0|||
155592530|NCT02553499|561595614|FG013|Overall Study|Death|0|||
155592531|NCT02553499|561595601|FG000|Overall Study|Lost to Follow-up|0|||
155592532|NCT02553499|561595602|FG001|Overall Study|Lost to Follow-up|0|||
155592533|NCT02553499|561595603|FG002|Overall Study|Lost to Follow-up|0|||
155592534|NCT02553499|561595604|FG003|Overall Study|Lost to Follow-up|0|||
155592535|NCT02553499|561595605|FG004|Overall Study|Lost to Follow-up|0|||
155592536|NCT02553499|561595606|FG005|Overall Study|Lost to Follow-up|0|||
155592537|NCT02553499|561595607|FG006|Overall Study|Lost to Follow-up|1|||
155592538|NCT02553499|561595608|FG007|Overall Study|Lost to Follow-up|0|||
155592539|NCT02553499|561595609|FG008|Overall Study|Lost to Follow-up|0|||
155592540|NCT02553499|561595610|FG009|Overall Study|Lost to Follow-up|0|||
155592541|NCT02553499|561595611|FG010|Overall Study|Lost to Follow-up|0|||
155592542|NCT02553499|561595612|FG011|Overall Study|Lost to Follow-up|0|||
155592543|NCT02553499|561595613|FG012|Overall Study|Lost to Follow-up|0|||
155592544|NCT02553499|561595614|FG013|Overall Study|Lost to Follow-up|0|||
155592545|NCT02553499|561595601|FG000|Overall Study|Physician Decision|0|||
155592546|NCT02553499|561595602|FG001|Overall Study|Physician Decision|1|||
155592547|NCT02553499|561595603|FG002|Overall Study|Physician Decision|1|||
155592548|NCT02553499|561595604|FG003|Overall Study|Physician Decision|0|||
155592549|NCT02553499|561595605|FG004|Overall Study|Physician Decision|1|||
155592550|NCT02553499|561595606|FG005|Overall Study|Physician Decision|0|||
155592551|NCT02553499|561595607|FG006|Overall Study|Physician Decision|0|||
155592552|NCT02553499|561595608|FG007|Overall Study|Physician Decision|1|||
155592553|NCT02553499|561595609|FG008|Overall Study|Physician Decision|1|||
155592554|NCT02553499|561595610|FG009|Overall Study|Physician Decision|2|||
155592555|NCT02553499|561595611|FG010|Overall Study|Physician Decision|1|||
155592556|NCT02553499|561595612|FG011|Overall Study|Physician Decision|3|||
155592557|NCT02553499|561595613|FG012|Overall Study|Physician Decision|1|||
155592558|NCT02553499|561595614|FG013|Overall Study|Physician Decision|0|||
155592559|NCT02553499|561595601|FG000|Overall Study|Progressive Disease|0|||
155592560|NCT02553499|561595602|FG001|Overall Study|Progressive Disease|0|||
155592561|NCT02553499|561595603|FG002|Overall Study|Progressive Disease|0|||
155592562|NCT02553499|561595604|FG003|Overall Study|Progressive Disease|2|||
155592563|NCT02553499|561595605|FG004|Overall Study|Progressive Disease|1|||
155592564|NCT02553499|561595606|FG005|Overall Study|Progressive Disease|1|||
155592565|NCT02553499|561595607|FG006|Overall Study|Progressive Disease|1|||
155592566|NCT02553499|561595608|FG007|Overall Study|Progressive Disease|0|||
155592567|NCT02553499|561595609|FG008|Overall Study|Progressive Disease|0|||
155592568|NCT02553499|561595610|FG009|Overall Study|Progressive Disease|1|||
155592569|NCT02553499|561595611|FG010|Overall Study|Progressive Disease|0|||
155592570|NCT02553499|561595612|FG011|Overall Study|Progressive Disease|0|||
155592571|NCT02553499|561595613|FG012|Overall Study|Progressive Disease|2|||
155592572|NCT02553499|561595614|FG013|Overall Study|Progressive Disease|1|||
155592573|NCT02553499|561595601|FG000|Overall Study|Study Terminated by Sponsor|0|||
155592574|NCT02553499|561595602|FG001|Overall Study|Study Terminated by Sponsor|0|||
155592575|NCT02553499|561595603|FG002|Overall Study|Study Terminated by Sponsor|0|||
155592576|NCT02553499|561595604|FG003|Overall Study|Study Terminated by Sponsor|0|||
155592577|NCT02553499|561595605|FG004|Overall Study|Study Terminated by Sponsor|0|||
155592578|NCT02553499|561595606|FG005|Overall Study|Study Terminated by Sponsor|0|||
155592579|NCT02553499|561595607|FG006|Overall Study|Study Terminated by Sponsor|0|||
155592580|NCT02553499|561595608|FG007|Overall Study|Study Terminated by Sponsor|0|||
155592581|NCT02553499|561595609|FG008|Overall Study|Study Terminated by Sponsor|1|||
155592582|NCT02553499|561595610|FG009|Overall Study|Study Terminated by Sponsor|0|||
155592583|NCT02553499|561595611|FG010|Overall Study|Study Terminated by Sponsor|0|||
155592584|NCT02553499|561595612|FG011|Overall Study|Study Terminated by Sponsor|0|||
155592585|NCT02553499|561595613|FG012|Overall Study|Study Terminated by Sponsor|0|||
155592586|NCT02553499|561595614|FG013|Overall Study|Study Terminated by Sponsor|0|||
155592587|NCT02553499|561595601|FG000|Overall Study|Withdrawal by Subject|2|||
155592588|NCT02553499|561595602|FG001|Overall Study|Withdrawal by Subject|0|||
155592589|NCT02553499|561595603|FG002|Overall Study|Withdrawal by Subject|0|||
155667532|NCT02628444|561878425|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155667533|NCT02628444|561878426|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155667534|NCT02628444|561878418|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667535|NCT02628444|561878419|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667536|NCT02628444|561878420|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667537|NCT02628444|561878421|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
155667538|NCT02628444|561878422|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667539|NCT02628444|561878423|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667540|NCT02628444|561878424|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667541|NCT02628444|561878425|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667542|NCT02628444|561878426|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155667543|NCT02628444|561878418|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155667544|NCT02628444|561878419|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155667545|NCT02628444|561878420|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155667546|NCT02628444|561878421|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155667547|NCT02628444|561878422|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155667548|NCT02628444|561878423|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155667549|NCT02628444|561878424|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
155667550|NCT02628444|561878425|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
155667551|NCT02628444|561878426|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
155667552|NCT02628444|561878418|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667553|NCT02628444|561878419|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667554|NCT02628444|561878420|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
155667555|NCT02628444|561878421|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
155667556|NCT02628444|561878422|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
155667557|NCT02628444|561878423|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
155667558|NCT02628444|561878424|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
155667559|NCT02628444|561878425|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
155667560|NCT02628444|561878426|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
155667561|NCT02628444|561878418|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155667562|NCT02628444|561878419|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155667563|NCT02628444|561878420|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155667564|NCT02628444|561878421|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155667565|NCT02628444|561878422|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
155667566|NCT02628444|561878423|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155667567|NCT02628444|561878424|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155592590|NCT02553499|561595604|FG003|Overall Study|Withdrawal by Subject|0|||
155592591|NCT02553499|561595605|FG004|Overall Study|Withdrawal by Subject|0|||
155592592|NCT02553499|561595606|FG005|Overall Study|Withdrawal by Subject|0|||
155592593|NCT02553499|561595607|FG006|Overall Study|Withdrawal by Subject|0|||
155592594|NCT02553499|561595608|FG007|Overall Study|Withdrawal by Subject|1|||
155592595|NCT02553499|561595609|FG008|Overall Study|Withdrawal by Subject|1|||
155592596|NCT02553499|561595610|FG009|Overall Study|Withdrawal by Subject|0|||
155592597|NCT02553499|561595611|FG010|Overall Study|Withdrawal by Subject|1|||
155592598|NCT02553499|561595612|FG011|Overall Study|Withdrawal by Subject|0|||
155592599|NCT02553499|561595613|FG012|Overall Study|Withdrawal by Subject|0|||
155592600|NCT02553499|561595614|FG013|Overall Study|Withdrawal by Subject|0|||
155592601|NCT01582178|561595615|FG000|Overall Study|Physician Decision|6|||
155592602|NCT01582178|561595616|FG001|Overall Study|Physician Decision|5|||
155592603|NCT01726270|561595619|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
155592604|NCT01726270|561595619|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
155592605|NCT01726270|561595619|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
155592606|NCT01726270|561595619|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
155592607|NCT01726270|561595619|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
155592608|NCT01726270|561595619|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
155592609|NCT01323387|561595620|FG000|Overall Study|Withdrawal by Subject|41|||
155592610|NCT01323387|561595620|FG000|Overall Study|Radiographic Data Unavailable|1|||
155592611|NCT01323387|561595620|FG000|Overall Study|Revision|14|||
155592612|NCT01323387|561595620|FG000|Overall Study|Protocol Violation|12|||
155592613|NCT01323387|561595620|FG000|Overall Study|Randomized but Never Treated|16|||
155592614|NCT01464164|561595622|FG000|Overall Study|Screen failure|0|||
155592615|NCT01464164|561595623|FG001|Overall Study|Screen failure|1|||
155592616|NCT01464164|561595624|FG002|Overall Study|Screen failure|2|||
155592617|NCT01464164|561595625|FG003|Overall Study|Screen failure|0|||
155592618|NCT01464164|561595626|FG004|Overall Study|Screen failure|0|||
155592619|NCT01464164|561595627|FG005|Overall Study|Screen failure|0|||
155592620|NCT01464164|561595628|FG006|Overall Study|Screen failure|0|||
155592621|NCT01464164|561595622|FG000|Overall Study|Physician Decision|0|||
155592622|NCT01464164|561595623|FG001|Overall Study|Physician Decision|1|||
155592623|NCT01464164|561595624|FG002|Overall Study|Physician Decision|0|||
155592624|NCT01464164|561595625|FG003|Overall Study|Physician Decision|0|||
155592625|NCT01464164|561595626|FG004|Overall Study|Physician Decision|0|||
155592626|NCT01464164|561595627|FG005|Overall Study|Physician Decision|0|||
155592627|NCT01464164|561595628|FG006|Overall Study|Physician Decision|2|||
155592628|NCT01972438|561595629|FG000|Baseline-Month 3 Crossover Period|Death|1|||
155592629|NCT01972438|561595630|FG001|Baseline-Month 3 Crossover Period|Death|0|||
155592630|NCT01972438|561595629|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
155592631|NCT01972438|561595630|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
155592632|NCT01972438|561595629|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
155592633|NCT01972438|561595630|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
155592634|NCT01972438|561595629|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
155592635|NCT01972438|561595630|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
155592636|NCT01972438|561595629|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
155592637|NCT01972438|561595630|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
155592638|NCT01972438|561595629|FG000|Months 6-12 Study Period|Death|1|||
155592639|NCT01972438|561595630|FG001|Months 6-12 Study Period|Death|0|||
155592640|NCT01972438|561595629|FG000|Months 6-12 Study Period|Early Study Closure|2|||
155592641|NCT01972438|561595630|FG001|Months 6-12 Study Period|Early Study Closure|2|||
155592642|NCT01972438|561595629|FG000|Post Month 12 Study Period|Early Study Closure|3|||
155592643|NCT01972438|561595630|FG001|Post Month 12 Study Period|Early Study Closure|4|||
155592644|NCT02887183|561595631|FG000|Overall Study|Adverse Event|44|||
155592645|NCT02887183|561595631|FG000|Overall Study|Death|30|||
155592646|NCT02887183|561595631|FG000|Overall Study|Pregnancy|1|||
155592647|NCT02887183|561595631|FG000|Overall Study|Protocol Violation|6|||
155592648|NCT02887183|561595631|FG000|Overall Study|Technical Problems|2|||
155592649|NCT02887183|561595631|FG000|Overall Study|Lost to Follow-up|13|||
155592650|NCT02887183|561595631|FG000|Overall Study|Physician Decision|10|||
155592651|NCT02887183|561595631|FG000|Overall Study|Withdrawal by Subject|35|||
155592652|NCT01186692|561595634|FG000|Overall Study|Not Catheterized|11|||
155592653|NCT01186692|561595634|FG000|Overall Study|Futher testing contraindicated implant|19|||
155667568|NCT02628444|561878425|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
155667569|NCT02628444|561878426|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
155667570|NCT02628444|561878418|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155667571|NCT02628444|561878419|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155667572|NCT02628444|561878420|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155667573|NCT02628444|561878421|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155667574|NCT02628444|561878422|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155667575|NCT02628444|561878423|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
155667576|NCT02628444|561878424|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
155667577|NCT02628444|561878425|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155667578|NCT02628444|561878426|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
155667579|NCT01333722|561878429|FG000|Overall Study|Lack of Efficacy|0|||
155667580|NCT01333722|561878430|FG001|Overall Study|Lack of Efficacy|2|||
155667581|NCT01333722|561878429|FG000|Overall Study|Withdrawal by Subject|0|||
155667582|NCT01333722|561878430|FG001|Overall Study|Withdrawal by Subject|1|||
155667583|NCT00784368|561878431|FG000|Overall Study|Physician Decision|0|||
155667584|NCT00784368|561878432|FG001|Overall Study|Physician Decision|0|||
155667585|NCT00784368|561878433|FG002|Overall Study|Physician Decision|6|||
155667586|NCT00784368|561878431|FG000|Overall Study|Lack of Efficacy|2|||
155667587|NCT00784368|561878432|FG001|Overall Study|Lack of Efficacy|0|||
155667588|NCT00784368|561878433|FG002|Overall Study|Lack of Efficacy|1|||
155667589|NCT00784368|561878431|FG000|Overall Study|Adverse Event|6|||
155667590|NCT00784368|561878432|FG001|Overall Study|Adverse Event|9|||
155667591|NCT00784368|561878433|FG002|Overall Study|Adverse Event|2|||
155667592|NCT00784368|561878431|FG000|Overall Study|Diagnosis of fever|0|||
155667593|NCT00784368|561878432|FG001|Overall Study|Diagnosis of fever|0|||
155667594|NCT00784368|561878433|FG002|Overall Study|Diagnosis of fever|1|||
155667595|NCT00784368|561878431|FG000|Overall Study|Worsening of complications|0|||
155667596|NCT00784368|561878432|FG001|Overall Study|Worsening of complications|0|||
155667597|NCT00784368|561878433|FG002|Overall Study|Worsening of complications|1|||
155667598|NCT00784368|561878431|FG000|Overall Study|Worsening of symptoms|0|||
155667599|NCT00784368|561878432|FG001|Overall Study|Worsening of symptoms|1|||
155667600|NCT00784368|561878433|FG002|Overall Study|Worsening of symptoms|0|||
155667601|NCT00784368|561878431|FG000|Overall Study|Withdrawal of informed consent|0|||
155667602|NCT00784368|561878432|FG001|Overall Study|Withdrawal of informed consent|1|||
155667603|NCT00784368|561878433|FG002|Overall Study|Withdrawal of informed consent|0|||
155667604|NCT02079909|561878434|FG000|Overall Study|Adverse Event|23|||
155667605|NCT02079909|561878435|FG001|Overall Study|Adverse Event|23|||
155667606|NCT02079909|561878436|FG002|Overall Study|Adverse Event|7|||
155667607|NCT02079909|561878434|FG000|Overall Study|Withdrawal by Subject|9|||
155667608|NCT02079909|561878435|FG001|Overall Study|Withdrawal by Subject|17|||
155667609|NCT02079909|561878436|FG002|Overall Study|Withdrawal by Subject|4|||
155667610|NCT02079909|561878434|FG000|Overall Study|Lost to Follow-up|2|||
155667611|NCT02079909|561878435|FG001|Overall Study|Lost to Follow-up|3|||
155667612|NCT02079909|561878436|FG002|Overall Study|Lost to Follow-up|1|||
155667613|NCT02079909|561878434|FG000|Overall Study|Death|2|||
155667614|NCT02079909|561878435|FG001|Overall Study|Death|2|||
155667615|NCT02079909|561878436|FG002|Overall Study|Death|0|||
155667616|NCT02079909|561878434|FG000|Overall Study|Lack of Efficacy|0|||
155667617|NCT02079909|561878435|FG001|Overall Study|Lack of Efficacy|0|||
155667618|NCT02079909|561878436|FG002|Overall Study|Lack of Efficacy|1|||
155667619|NCT02079909|561878434|FG000|Overall Study|Protocol Violation|0|||
155667620|NCT02079909|561878435|FG001|Overall Study|Protocol Violation|1|||
155667621|NCT02079909|561878436|FG002|Overall Study|Protocol Violation|1|||
155667622|NCT02079909|561878434|FG000|Overall Study|Physician Decision|0|||
155667623|NCT02079909|561878435|FG001|Overall Study|Physician Decision|1|||
155667624|NCT02079909|561878436|FG002|Overall Study|Physician Decision|1|||
155667625|NCT02079909|561878434|FG000|Overall Study|Relocation etc.|2|||
155667626|NCT02079909|561878435|FG001|Overall Study|Relocation etc.|2|||
155667627|NCT02079909|561878436|FG002|Overall Study|Relocation etc.|3|||
155667628|NCT00720356|561878441|FG000|Registration to Study|Determined to have methylated MGMT|67|||
155667629|NCT00720356|561878441|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
155667630|NCT00720356|561878441|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
155667631|NCT00720356|561878441|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
155667632|NCT00720356|561878441|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
155667633|NCT00720356|561878441|FG000|Follow up Until Death|Withdrawal by Subject|1|||
155667634|NCT00720356|561878441|FG000|Follow up Until Death|Alive at last data collection|4|||
155667635|NCT02237001|561878444|FG000|Overall Study|Lost to Follow-up|2|||
155667636|NCT02237001|561878444|FG000|Overall Study|Withdrawal by Subject|1|||
155667637|NCT02237001|561878444|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
155667638|NCT02237001|561878444|FG000|Overall Study|Re-operation|4|||
155667639|NCT02237001|561878444|FG000|Overall Study|Incarceration|1|||
155667640|NCT04551898|561878446|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
155667641|NCT04551898|561878447|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
155667642|NCT04551898|561878448|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
155592654|NCT01186692|561595634|FG000|Overall Study|Adverse Event|2|||
155592655|NCT02195869|561595635|FG000|Overall Study|cGVHD Progression|5|||
155592656|NCT02195869|561595635|FG000|Overall Study|Malignancy Progression/relapse|2|||
155592657|NCT02195869|561595635|FG000|Overall Study|Adverse Event|15|||
155592658|NCT02195869|561595635|FG000|Overall Study|Withdrawal by Subject|7|||
155592659|NCT02195869|561595635|FG000|Overall Study|Physician Decision|4|||
155592660|NCT02195869|561595635|FG000|Overall Study|Study Terminated by Sponsor|7|||
155592661|NCT02195869|561595635|FG000|Overall Study|Noncompliance with study drug|2|||
155592662|NCT02654977|561595636|FG000|Overall Study|Death|1|||
155592663|NCT02654977|561595636|FG000|Overall Study|Lost to Follow-up|1|||
155592664|NCT02654977|561595636|FG000|Overall Study|Adverse Event|1|||
155592665|NCT02654977|561595636|FG000|Overall Study|Withdrawal by Subject|1|||
155592666|NCT02654977|561595636|FG000|Overall Study|Lack of Efficacy|3|||
155592667|NCT01921101|561595638|FG000|Overall Study|Death|16|||
155592668|NCT01921101|561595639|FG001|Overall Study|Death|6|||
155592669|NCT01266291|561595640|FG000|Overall Study|Adverse Event|1|||
155592670|NCT03225105|561595642|FG000|Overall Study|Withdrawal by Subject|1|||
155592671|NCT03225105|561595643|FG001|Overall Study|Withdrawal by Subject|0|||
155592672|NCT03225105|561595644|FG002|Overall Study|Withdrawal by Subject|0|||
155592673|NCT03225105|561595645|FG003|Overall Study|Withdrawal by Subject|0|||
155592674|NCT03225105|561595642|FG000|Overall Study|Death|0|||
155592675|NCT03225105|561595643|FG001|Overall Study|Death|4|||
155592676|NCT03225105|561595644|FG002|Overall Study|Death|2|||
155592677|NCT03225105|561595645|FG003|Overall Study|Death|0|||
155592678|NCT03225105|561595642|FG000|Overall Study|Study termination per Sponsor Decision|2|||
155592679|NCT03225105|561595643|FG001|Overall Study|Study termination per Sponsor Decision|0|||
155592680|NCT03225105|561595644|FG002|Overall Study|Study termination per Sponsor Decision|3|||
155592681|NCT03225105|561595645|FG003|Overall Study|Study termination per Sponsor Decision|3|||
155592682|NCT00679029|561597104|FG000|Overall Study|Adverse Event|3|||
155592683|NCT00679029|561597104|FG000|Overall Study|Withdrawal by Subject|1|||
155592684|NCT00679029|561597104|FG000|Overall Study|Lost to Follow-up|1|||
155592685|NCT00160706|561597107|FG000|Overall Study|Adverse Event|53|||
155592686|NCT00160706|561597107|FG000|Overall Study|Adverse Event and Other Reason|105|||
155592687|NCT00160706|561597107|FG000|Overall Study|Protocol Violation|3|||
155592688|NCT00160706|561597107|FG000|Overall Study|Withdrawal by Subject|41|||
155592689|NCT00160706|561597107|FG000|Overall Study|Withdrawal by Subject and Other|12|||
155592690|NCT00160706|561597107|FG000|Overall Study|Physician Decision|10|||
155592691|NCT00160706|561597107|FG000|Overall Study|Physician Decision and Other|3|||
155592692|NCT00160706|561597107|FG000|Overall Study|Lost to Follow-up|4|||
155592693|NCT00160706|561597107|FG000|Overall Study|Lost to Follow-up and Other|1|||
155592694|NCT00160706|561597107|FG000|Overall Study|Lack of Efficacy|42|||
155592695|NCT00160706|561597107|FG000|Overall Study|Lack of Efficacy and Other|1|||
155592696|NCT00160706|561597107|FG000|Overall Study|Other Reason|11|||
155592697|NCT02162719|561597108|FG000|Overall Study|Death|41|||
155592698|NCT02162719|561597109|FG001|Overall Study|Death|46|||
155592699|NCT02162719|561597108|FG000|Overall Study|Lost to Follow-up|1|||
155592700|NCT02162719|561597109|FG001|Overall Study|Lost to Follow-up|3|||
155592701|NCT02162719|561597108|FG000|Overall Study|Disease Progression|2|||
155592702|NCT02162719|561597109|FG001|Overall Study|Disease Progression|1|||
155592703|NCT02162719|561597108|FG000|Overall Study|Withdrawal by Subject|8|||
155592704|NCT02162719|561597109|FG001|Overall Study|Withdrawal by Subject|2|||
155592705|NCT02162719|561597108|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
155592706|NCT02162719|561597109|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
155592707|NCT03214380|561597110|FG000|Lead-in|Adverse Event|3|||
155592708|NCT03214380|561597111|FG001|Lead-in|Adverse Event|0|||
155592709|NCT03214380|561597112|FG002|Lead-in|Adverse Event|0|||
155592710|NCT03214380|561597113|FG003|Lead-in|Adverse Event|1|||
155592711|NCT03214380|561597114|FG004|Lead-in|Adverse Event|0|||
155592712|NCT03214380|561597115|FG005|Lead-in|Adverse Event|0|||
155592713|NCT03214380|561597110|FG000|Lead-in|Lost to Follow-up|4|||
155592714|NCT03214380|561597111|FG001|Lead-in|Lost to Follow-up|0|||
155592715|NCT03214380|561597112|FG002|Lead-in|Lost to Follow-up|0|||
155592716|NCT03214380|561597113|FG003|Lead-in|Lost to Follow-up|1|||
155667643|NCT04551898|561878449|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
155667644|NCT04551898|561878446|FG000|Overall Study|Withdrawal by Subject|5|||
155667645|NCT04551898|561878447|FG001|Overall Study|Withdrawal by Subject|1|||
155667646|NCT04551898|561878448|FG002|Overall Study|Withdrawal by Subject|2|||
155667647|NCT04551898|561878449|FG003|Overall Study|Withdrawal by Subject|2|||
155667648|NCT04551898|561878446|FG000|Overall Study|Lost to Follow-up|2|||
155667649|NCT04551898|561878447|FG001|Overall Study|Lost to Follow-up|1|||
155667650|NCT04551898|561878448|FG002|Overall Study|Lost to Follow-up|2|||
155667651|NCT04551898|561878449|FG003|Overall Study|Lost to Follow-up|2|||
155667652|NCT04551898|561878446|FG000|Overall Study|Death|1|||
155667653|NCT04551898|561878447|FG001|Overall Study|Death|0|||
155667654|NCT04551898|561878448|FG002|Overall Study|Death|0|||
155667655|NCT04551898|561878449|FG003|Overall Study|Death|0|||
155667656|NCT04551898|561878446|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155667657|NCT04551898|561878447|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155667658|NCT04551898|561878448|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
155667659|NCT04551898|561878449|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155667660|NCT03427814|561878450|FG000|Overall Study|Withdrawal by Subject|4|||
155667661|NCT03427814|561878451|FG001|Overall Study|Withdrawal by Subject|4|||
155667662|NCT03427814|561878450|FG000|Overall Study|Lost to Follow-up|0|||
155667663|NCT03427814|561878451|FG001|Overall Study|Lost to Follow-up|2|||
155667664|NCT03427814|561878450|FG000|Overall Study|Death|42|||
155667665|NCT03427814|561878451|FG001|Overall Study|Death|31|||
155667666|NCT03427814|561878450|FG000|Overall Study|Sponsor's Decision|1|||
155667667|NCT03427814|561878451|FG001|Overall Study|Sponsor's Decision|0|||
155667668|NCT03427814|561878450|FG000|Overall Study|Investigator's Decision|1|||
155667669|NCT03427814|561878451|FG001|Overall Study|Investigator's Decision|2|||
155667670|NCT03427814|561878450|FG000|Overall Study|Disease progression|1|||
155667671|NCT03427814|561878451|FG001|Overall Study|Disease progression|0|||
155667672|NCT03427814|561878450|FG000|Overall Study|Treatment Completed|0|||
155667673|NCT03427814|561878451|FG001|Overall Study|Treatment Completed|1|||
155667674|NCT03427814|561878450|FG000|Overall Study|Sponsor's Decision to End study|21|||
155667675|NCT03427814|561878451|FG001|Overall Study|Sponsor's Decision to End study|25|||
155667676|NCT03427814|561878450|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
155667677|NCT03427814|561878451|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
155667678|NCT01979614|561878452|FG000|Overall Study|Adverse Event|1|||
155667679|NCT01979614|561878453|FG001|Overall Study|Adverse Event|1|||
155667680|NCT00488514|561878454|FG000|Overall Study|Adverse Event|41|||
155667681|NCT00488514|561878454|FG000|Overall Study|Lost to Follow-up|44|||
155667682|NCT00488514|561878454|FG000|Overall Study|Protocol Violation|32|||
155667683|NCT00488514|561878454|FG000|Overall Study|Withdrawal by Subject|106|||
155667684|NCT00488514|561878454|FG000|Overall Study|Lack of Efficacy|28|||
155667685|NCT00488514|561878454|FG000|Overall Study|Did not meet criteria for treatment|30|||
155667686|NCT00488514|561878454|FG000|Overall Study|Postive drug screen|1|||
155667687|NCT00488514|561878454|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
155667688|NCT00488514|561878454|FG000|Overall Study|Investigator decision|1|||
155667689|NCT00488514|561878454|FG000|Overall Study|Participant had too few migraines|5|||
155667690|NCT00488514|561878454|FG000|Overall Study|Increase in number of migraines|2|||
155667691|NCT00488514|561878454|FG000|Overall Study|Increased use of concomitant medication|1|||
155667692|NCT00628446|561878455|FG000|Overall Study|Lost to Follow-up|3|||
155667693|NCT00628446|561878455|FG000|Overall Study|Withdrawal by Subject|1|||
155667694|NCT00628446|561878455|FG000|Overall Study|Protocol Violation|3|||
155667695|NCT00756275|561878456|FG000|Overall Study|Lost to Follow-up|25|||
155667696|NCT00756275|561878457|FG001|Overall Study|Lost to Follow-up|21|||
155667697|NCT00756275|561878456|FG000|Overall Study|Withdrawal by Subject|4|||
155667698|NCT00756275|561878457|FG001|Overall Study|Withdrawal by Subject|7|||
155667699|NCT01475721|561878465|FG000|Overall Study|Death|3|||
155667700|NCT01475721|561878466|FG001|Overall Study|Death|6|||
155667701|NCT01475721|561878465|FG000|Overall Study|Withdrawal by Subject|8|||
155667702|NCT01475721|561878466|FG001|Overall Study|Withdrawal by Subject|8|||
155667703|NCT00803738|561878467|FG000|Overall Study|Adverse Event|3|||
155667704|NCT00803738|561878468|FG001|Overall Study|Adverse Event|5|||
155667705|NCT00803738|561878467|FG000|Overall Study|Lost to Follow-up|4|||
155667706|NCT00803738|561878468|FG001|Overall Study|Lost to Follow-up|4|||
155667707|NCT00803738|561878467|FG000|Overall Study|Protocol Violation|18|||
155667708|NCT00803738|561878468|FG001|Overall Study|Protocol Violation|10|||
155667709|NCT00803738|561878467|FG000|Overall Study|Withdrawal by Subject|1|||
155667710|NCT00803738|561878468|FG001|Overall Study|Withdrawal by Subject|4|||
155667711|NCT00803738|561878467|FG000|Overall Study|Lack of Efficacy|10|||
155667712|NCT00803738|561878468|FG001|Overall Study|Lack of Efficacy|16|||
155667713|NCT00803738|561878467|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
155667714|NCT00803738|561878468|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
155667715|NCT00803738|561878467|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
155667716|NCT00803738|561878468|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
155667717|NCT01048242|561878469|FG000|Overall Study|See study flow chart|4|||
155667718|NCT01048242|561878470|FG001|Overall Study|See study flow chart|2|||
155667719|NCT02364037|561878471|FG000|Overall Study|Withdrawal by Subject|7|||
155667720|NCT02364037|561878472|FG001|Overall Study|Withdrawal by Subject|4|||
155667721|NCT02364037|561878471|FG000|Overall Study|Lost to Follow-up|37|||
155667722|NCT02364037|561878472|FG001|Overall Study|Lost to Follow-up|49|||
155667723|NCT01453036|561878473|FG000|Overall Study|Lost to Follow-up|26|||
155667724|NCT01453036|561878474|FG001|Overall Study|Lost to Follow-up|115|||
155667725|NCT01453036|561878475|FG002|Overall Study|Lost to Follow-up|31|||
155667726|NCT01815424|561878477|FG000|Week 0 to 16|Adverse Event|1|||
155667727|NCT01815424|561878478|FG001|Week 0 to 16|Adverse Event|3|||
155667728|NCT01815424|561878479|FG002|Week 0 to 16|Adverse Event|3|||
155667729|NCT01815424|561878480|FG003|Week 0 to 16|Adverse Event|0|||
155667730|NCT01815424|561878481|FG004|Week 0 to 16|Adverse Event|0|||
155667731|NCT01815424|561878477|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
155667732|NCT01815424|561878478|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155667733|NCT01815424|561878479|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155667734|NCT01815424|561878480|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155667735|NCT01815424|561878481|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155667736|NCT01815424|561878477|FG000|Week 0 to 16|Lost to Follow-up|0|||
155667737|NCT01815424|561878478|FG001|Week 0 to 16|Lost to Follow-up|1|||
155667738|NCT01815424|561878479|FG002|Week 0 to 16|Lost to Follow-up|0|||
155667739|NCT01815424|561878480|FG003|Week 0 to 16|Lost to Follow-up|0|||
155667740|NCT01815424|561878481|FG004|Week 0 to 16|Lost to Follow-up|0|||
155667741|NCT01815424|561878477|FG000|Week 0 to 16|Withdrawal by Subject|0|||
155667742|NCT01815424|561878478|FG001|Week 0 to 16|Withdrawal by Subject|0|||
155667743|NCT01815424|561878479|FG002|Week 0 to 16|Withdrawal by Subject|1|||
155667744|NCT01815424|561878480|FG003|Week 0 to 16|Withdrawal by Subject|0|||
155667745|NCT01815424|561878481|FG004|Week 0 to 16|Withdrawal by Subject|0|||
155667746|NCT01815424|561878477|FG000|Week 0 to 16|Other|1|||
155667747|NCT01815424|561878478|FG001|Week 0 to 16|Other|0|||
155667748|NCT01815424|561878479|FG002|Week 0 to 16|Other|3|||
155667749|NCT01815424|561878480|FG003|Week 0 to 16|Other|0|||
155667750|NCT01815424|561878481|FG004|Week 0 to 16|Other|0|||
155667751|NCT01815424|561878477|FG000|Week 0 to 16|Protocol Violation|1|||
155667752|NCT01815424|561878478|FG001|Week 0 to 16|Protocol Violation|0|||
155667753|NCT01815424|561878479|FG002|Week 0 to 16|Protocol Violation|0|||
155667754|NCT01815424|561878480|FG003|Week 0 to 16|Protocol Violation|0|||
155667755|NCT01815424|561878481|FG004|Week 0 to 16|Protocol Violation|0|||
155667756|NCT01815424|561878477|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
155667757|NCT01815424|561878478|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
155667758|NCT01815424|561878479|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
155667759|NCT01815424|561878480|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
155667760|NCT01815424|561878481|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
155667761|NCT01815424|561878477|FG000|Week 16 to 52|Other|0|||
155667762|NCT01815424|561878478|FG001|Week 16 to 52|Other|1|||
155667763|NCT01815424|561878479|FG002|Week 16 to 52|Other|0|||
155667764|NCT01815424|561878480|FG003|Week 16 to 52|Other|0|||
155667765|NCT01815424|561878481|FG004|Week 16 to 52|Other|0|||
155667766|NCT01815424|561878477|FG000|Week 16 to 52|Adverse Event|0|||
155667767|NCT01815424|561878478|FG001|Week 16 to 52|Adverse Event|0|||
155667768|NCT01815424|561878479|FG002|Week 16 to 52|Adverse Event|0|||
155667769|NCT01815424|561878480|FG003|Week 16 to 52|Adverse Event|0|||
155667770|NCT01815424|561878481|FG004|Week 16 to 52|Adverse Event|1|||
155667771|NCT01815424|561878477|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
155667772|NCT01815424|561878478|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
155667773|NCT01815424|561878479|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
155667774|NCT01815424|561878480|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
155667775|NCT01815424|561878481|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
155667776|NCT01815424|561878477|FG000|Week 16 to 52|Lost to Follow-up|0|||
155667777|NCT01815424|561878478|FG001|Week 16 to 52|Lost to Follow-up|2|||
155667778|NCT01815424|561878479|FG002|Week 16 to 52|Lost to Follow-up|0|||
155667779|NCT01815424|561878480|FG003|Week 16 to 52|Lost to Follow-up|2|||
155667780|NCT01815424|561878481|FG004|Week 16 to 52|Lost to Follow-up|1|||
155667781|NCT01815424|561878477|FG000|Week 16 to 52|Withdrawal by Subject|1|||
155667782|NCT01815424|561878478|FG001|Week 16 to 52|Withdrawal by Subject|2|||
155667783|NCT01815424|561878479|FG002|Week 16 to 52|Withdrawal by Subject|0|||
155667784|NCT01815424|561878480|FG003|Week 16 to 52|Withdrawal by Subject|0|||
155667785|NCT01815424|561878481|FG004|Week 16 to 52|Withdrawal by Subject|0|||
155667786|NCT04072835|561878482|FG000|Overall Study|Overall trial ended|603|||
155667787|NCT04072835|561878482|FG000|Overall Study|Ablation|97|||
155592717|NCT03214380|561597114|FG004|Lead-in|Lost to Follow-up|0|||
155592718|NCT03214380|561597115|FG005|Lead-in|Lost to Follow-up|0|||
155592719|NCT03214380|561597110|FG000|Lead-in|Eligibility Criteria|3|||
155592720|NCT03214380|561597111|FG001|Lead-in|Eligibility Criteria|0|||
155592721|NCT03214380|561597112|FG002|Lead-in|Eligibility Criteria|0|||
155592722|NCT03214380|561597113|FG003|Lead-in|Eligibility Criteria|0|||
155592723|NCT03214380|561597114|FG004|Lead-in|Eligibility Criteria|0|||
155592724|NCT03214380|561597115|FG005|Lead-in|Eligibility Criteria|0|||
155592725|NCT03214380|561597110|FG000|Lead-in|Physician Decision|6|||
155592726|NCT03214380|561597111|FG001|Lead-in|Physician Decision|0|||
155592727|NCT03214380|561597112|FG002|Lead-in|Physician Decision|0|||
155592728|NCT03214380|561597113|FG003|Lead-in|Physician Decision|0|||
155592729|NCT03214380|561597114|FG004|Lead-in|Physician Decision|0|||
155592730|NCT03214380|561597115|FG005|Lead-in|Physician Decision|0|||
155592731|NCT03214380|561597110|FG000|Lead-in|Protocol Deviation|7|||
155592732|NCT03214380|561597111|FG001|Lead-in|Protocol Deviation|0|||
155592733|NCT03214380|561597112|FG002|Lead-in|Protocol Deviation|0|||
155592734|NCT03214380|561597113|FG003|Lead-in|Protocol Deviation|3|||
155592735|NCT03214380|561597114|FG004|Lead-in|Protocol Deviation|0|||
155592736|NCT03214380|561597115|FG005|Lead-in|Protocol Deviation|0|||
155592737|NCT03214380|561597110|FG000|Lead-in|Withdrawal by Subject|41|||
155592738|NCT03214380|561597111|FG001|Lead-in|Withdrawal by Subject|0|||
155592739|NCT03214380|561597112|FG002|Lead-in|Withdrawal by Subject|0|||
155592740|NCT03214380|561597113|FG003|Lead-in|Withdrawal by Subject|14|||
155592741|NCT03214380|561597114|FG004|Lead-in|Withdrawal by Subject|0|||
155592742|NCT03214380|561597115|FG005|Lead-in|Withdrawal by Subject|0|||
155592743|NCT03214380|561597110|FG000|Lead-in|Family Emergency|1|||
155592744|NCT03214380|561597111|FG001|Lead-in|Family Emergency|0|||
155592745|NCT03214380|561597112|FG002|Lead-in|Family Emergency|0|||
155592746|NCT03214380|561597113|FG003|Lead-in|Family Emergency|0|||
155592747|NCT03214380|561597114|FG004|Lead-in|Family Emergency|0|||
155592748|NCT03214380|561597115|FG005|Lead-in|Family Emergency|0|||
155592749|NCT03214380|561597110|FG000|Lead-in|Natural Disaster|9|||
155592750|NCT03214380|561597111|FG001|Lead-in|Natural Disaster|0|||
155592751|NCT03214380|561597112|FG002|Lead-in|Natural Disaster|0|||
155592752|NCT03214380|561597113|FG003|Lead-in|Natural Disaster|0|||
155592753|NCT03214380|561597114|FG004|Lead-in|Natural Disaster|0|||
155592754|NCT03214380|561597115|FG005|Lead-in|Natural Disaster|0|||
155592755|NCT03214380|561597110|FG000|Lead-in|Non Compliance|1|||
155592756|NCT03214380|561597111|FG001|Lead-in|Non Compliance|0|||
155592757|NCT03214380|561597112|FG002|Lead-in|Non Compliance|0|||
155592758|NCT03214380|561597113|FG003|Lead-in|Non Compliance|0|||
155592759|NCT03214380|561597114|FG004|Lead-in|Non Compliance|0|||
155592760|NCT03214380|561597115|FG005|Lead-in|Non Compliance|0|||
155592761|NCT03214380|561597110|FG000|Lead-in|Participant Schedule|2|||
155592762|NCT03214380|561597111|FG001|Lead-in|Participant Schedule|0|||
155592763|NCT03214380|561597112|FG002|Lead-in|Participant Schedule|0|||
155592764|NCT03214380|561597113|FG003|Lead-in|Participant Schedule|0|||
155592765|NCT03214380|561597114|FG004|Lead-in|Participant Schedule|0|||
155592766|NCT03214380|561597115|FG005|Lead-in|Participant Schedule|0|||
155592767|NCT03214380|561597110|FG000|Treatment Period|Adverse Event|0|||
155592768|NCT03214380|561597111|FG001|Treatment Period|Adverse Event|1|||
155592769|NCT03214380|561597112|FG002|Treatment Period|Adverse Event|1|||
155592770|NCT03214380|561597113|FG003|Treatment Period|Adverse Event|0|||
155592771|NCT03214380|561597114|FG004|Treatment Period|Adverse Event|1|||
155592772|NCT03214380|561597115|FG005|Treatment Period|Adverse Event|0|||
155592773|NCT03214380|561597110|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
155592774|NCT03214380|561597111|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
155592775|NCT03214380|561597112|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
155592776|NCT03214380|561597113|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
155592777|NCT03214380|561597114|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
155592778|NCT03214380|561597115|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
155592779|NCT03214380|561597110|FG000|Treatment Period|Withdrawal by Subject|0|||
155592780|NCT03214380|561597111|FG001|Treatment Period|Withdrawal by Subject|10|||
155592781|NCT03214380|561597112|FG002|Treatment Period|Withdrawal by Subject|8|||
155592782|NCT03214380|561597113|FG003|Treatment Period|Withdrawal by Subject|0|||
155592783|NCT03214380|561597114|FG004|Treatment Period|Withdrawal by Subject|7|||
155592784|NCT03214380|561597115|FG005|Treatment Period|Withdrawal by Subject|11|||
155592785|NCT03214380|561597110|FG000|Treatment Period|Death|0|||
155592786|NCT03214380|561597111|FG001|Treatment Period|Death|1|||
155592787|NCT03214380|561597112|FG002|Treatment Period|Death|2|||
155592788|NCT03214380|561597113|FG003|Treatment Period|Death|0|||
155592789|NCT03214380|561597114|FG004|Treatment Period|Death|0|||
155592790|NCT03214380|561597115|FG005|Treatment Period|Death|0|||
155592791|NCT03214380|561597110|FG000|Treatment Period|Lost to Follow-up|0|||
155592792|NCT03214380|561597111|FG001|Treatment Period|Lost to Follow-up|6|||
155592793|NCT03214380|561597112|FG002|Treatment Period|Lost to Follow-up|3|||
155592794|NCT03214380|561597113|FG003|Treatment Period|Lost to Follow-up|0|||
155592795|NCT03214380|561597114|FG004|Treatment Period|Lost to Follow-up|0|||
155592796|NCT03214380|561597115|FG005|Treatment Period|Lost to Follow-up|0|||
155592797|NCT03214380|561597110|FG000|Treatment Period|Participant schedule|0|||
155592798|NCT03214380|561597111|FG001|Treatment Period|Participant schedule|0|||
155592799|NCT03214380|561597112|FG002|Treatment Period|Participant schedule|1|||
155592800|NCT03214380|561597113|FG003|Treatment Period|Participant schedule|0|||
155592801|NCT03214380|561597114|FG004|Treatment Period|Participant schedule|0|||
155592802|NCT03214380|561597115|FG005|Treatment Period|Participant schedule|0|||
155592803|NCT03214380|561597110|FG000|Treatment Period|Treatment Interruption|0|||
155592804|NCT03214380|561597111|FG001|Treatment Period|Treatment Interruption|0|||
155592805|NCT03214380|561597112|FG002|Treatment Period|Treatment Interruption|1|||
155592806|NCT03214380|561597113|FG003|Treatment Period|Treatment Interruption|0|||
155592807|NCT03214380|561597114|FG004|Treatment Period|Treatment Interruption|0|||
155592808|NCT03214380|561597115|FG005|Treatment Period|Treatment Interruption|0|||
155592809|NCT01905553|561597119|FG000|Period 2|Adverse Event|1|||
155592810|NCT01905553|561597120|FG001|Period 2|Adverse Event|0|||
155592811|NCT03692325|561597124|FG000|Overall Study|Adverse Event|2|||
155592812|NCT03692325|561597124|FG000|Overall Study|Progression/Recurrence|2|||
155592813|NCT02817516|561597125|FG000|Overall Study|Other|0|||
155592814|NCT02817516|561597126|FG001|Overall Study|Other|0|||
155592815|NCT02817516|561597127|FG002|Overall Study|Other|1|||
155592816|NCT02817516|561597128|FG003|Overall Study|Other|0|||
155592817|NCT01920958|561597130|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
155592818|NCT00610155|561597131|FG000|Period 1|Withdrawal by Subject|0|||
155592819|NCT00610155|561597132|FG001|Period 1|Withdrawal by Subject|0|||
155592820|NCT00610155|561597133|FG002|Period 1|Withdrawal by Subject|1|||
155592821|NCT00610155|561597134|FG003|Period 1|Withdrawal by Subject|0|||
155592822|NCT00610155|561597135|FG004|Period 1|Withdrawal by Subject|0|||
155592823|NCT00610155|561597136|FG005|Period 1|Withdrawal by Subject|0|||
155592824|NCT00610155|561597131|FG000|Period 3|Adverse Event|1|||
155592825|NCT00610155|561597132|FG001|Period 3|Adverse Event|0|||
155592826|NCT00610155|561597133|FG002|Period 3|Adverse Event|0|||
155592827|NCT00610155|561597134|FG003|Period 3|Adverse Event|0|||
155592828|NCT00610155|561597135|FG004|Period 3|Adverse Event|0|||
155592829|NCT00610155|561597136|FG005|Period 3|Adverse Event|0|||
155592830|NCT00379080|561597141|FG000|Overall Study|Withdrawal by Subject|0|||
155592831|NCT00379080|561597142|FG001|Overall Study|Withdrawal by Subject|4|||
155592832|NCT00379080|561597143|FG002|Overall Study|Withdrawal by Subject|0|||
155592833|NCT01089608|561597144|FG000|Overall Study|Adverse Event|0|||
155592834|NCT01089608|561597145|FG001|Overall Study|Adverse Event|4|||
155592835|NCT01089608|561597144|FG000|Overall Study|Lost to Follow-up|0|||
155592836|NCT01089608|561597145|FG001|Overall Study|Lost to Follow-up|2|||
155592837|NCT04292912|561597146|FG000|Overall Study|Physician Decision|1|||
155592838|NCT04292912|561597146|FG000|Overall Study|Protocol Violation|6|||
155592839|NCT00955955|561597147|FG000|Overall Study|Lost to Follow-up|2|||
155592840|NCT00955955|561597148|FG001|Overall Study|Lost to Follow-up|0|||
155592841|NCT00955955|561597149|FG002|Overall Study|Lost to Follow-up|0|||
155592842|NCT03575793|561597150|FG000|Overall Study|Withdrawal by Subject|0|||
155592843|NCT03575793|561597151|FG001|Overall Study|Withdrawal by Subject|1|||
155592844|NCT03575793|561597150|FG000|Overall Study|Never Treated|0|||
155592845|NCT03575793|561597151|FG001|Overall Study|Never Treated|2|||
155592846|NCT01250873|561597152|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
155592847|NCT01250873|561597152|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
155592848|NCT01127451|561597156|FG000|Overall Study|Other|2|||
155592849|NCT01127451|561597157|FG001|Overall Study|Other|1|||
155592850|NCT01127451|561597156|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
155592851|NCT01127451|561597157|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
155592852|NCT01127451|561597156|FG000|Overall Study|Death|22|||
155592853|NCT01127451|561597157|FG001|Overall Study|Death|17|||
155592854|NCT01127451|561597156|FG000|Overall Study|Lost to Follow-up|3|||
155592855|NCT01127451|561597157|FG001|Overall Study|Lost to Follow-up|0|||
155592856|NCT01127451|561597156|FG000|Overall Study|Administrative Reason by Sponsor|2|||
155592857|NCT01127451|561597157|FG001|Overall Study|Administrative Reason by Sponsor|2|||
155667788|NCT04072835|561878482|FG000|Overall Study|Withdrawal of consent|66|||
155667789|NCT04072835|561878482|FG000|Overall Study|Physician Decision|50|||
155667790|NCT04072835|561878482|FG000|Overall Study|Lost to Follow-up|39|||
155592858|NCT02429778|561597159|FG000|Overall Study|Lost to Follow-up|2|||
155592859|NCT02429778|561597160|FG001|Overall Study|Lost to Follow-up|0|||
155592860|NCT02429778|561597159|FG000|Overall Study|Withdrawal by Subject|5|||
155592861|NCT02429778|561597160|FG001|Overall Study|Withdrawal by Subject|0|||
155592862|NCT03521115|561597161|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
155592863|NCT03521115|561597162|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
155592864|NCT03521115|561597161|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
155592865|NCT03521115|561597162|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
155592866|NCT03063086|561597163|FG000|Overall Study|technical problems|1|||
155592867|NCT03063086|561597164|FG001|Overall Study|technical problems|0|||
155592868|NCT03063086|561597165|FG002|Overall Study|technical problems|0|||
155592869|NCT03063086|561597166|FG003|Overall Study|technical problems|0|||
155592870|NCT03063086|561597167|FG004|Overall Study|technical problems|0|||
155667791|NCT04072835|561878482|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
155667792|NCT04072835|561878482|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
155667793|NCT04072835|561878482|FG000|Overall Study|Adverse Event|25|||
155667794|NCT04072835|561878482|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
155667795|NCT04072835|561878482|FG000|Overall Study|Death|11|||
155667796|NCT04072835|561878482|FG000|Overall Study|Participant felt the drug did not work|8|||
155667797|NCT04072835|561878482|FG000|Overall Study|Participant tolerability|5|||
155667798|NCT04072835|561878482|FG000|Overall Study|Missing|5|||
155667799|NCT04072835|561878482|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
155667800|NCT04072835|561878482|FG000|Overall Study|Pregnancy|3|||
155667801|NCT00856323|561878483|FG000|Overall Study|Withdrawal by Subject|2|||
155667802|NCT01119443|561878487|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
155667803|NCT01119443|561878488|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
155667804|NCT02329743|561878489|FG000|Overall Study|Adverse Event|1|||
155667805|NCT02329743|561878490|FG001|Overall Study|Adverse Event|1|||
155667806|NCT02329743|561878491|FG002|Overall Study|Adverse Event|3|||
155667807|NCT02329743|561878489|FG000|Overall Study|Lost to Follow-up|1|||
155667808|NCT02329743|561878490|FG001|Overall Study|Lost to Follow-up|0|||
155667809|NCT02329743|561878491|FG002|Overall Study|Lost to Follow-up|1|||
155667810|NCT02329743|561878489|FG000|Overall Study|Withdrawal by Subject|4|||
155667811|NCT02329743|561878490|FG001|Overall Study|Withdrawal by Subject|4|||
155667812|NCT02329743|561878491|FG002|Overall Study|Withdrawal by Subject|1|||
155667813|NCT02329743|561878489|FG000|Overall Study|Other|0|||
155667814|NCT02329743|561878490|FG001|Overall Study|Other|2|||
155667815|NCT02329743|561878491|FG002|Overall Study|Other|3|||
155667816|NCT01428219|561878492|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
155667817|NCT00825994|561878493|FG000|Overall Study|Withdrawal by Subject|2|||
155667818|NCT00825994|561878493|FG000|Overall Study|Lost to Follow-up|1|||
155667819|NCT00825994|561878493|FG000|Overall Study|Protocol Violation|1|||
155667820|NCT00825994|561878493|FG000|Overall Study|Placebo Responder at V2|1|||
155667821|NCT01833494|561878497|FG000|Overall Study|Adverse Event|24|||
155667822|NCT01833494|561878497|FG000|Overall Study|Physician Decision|6|||
155667823|NCT01833494|561878497|FG000|Overall Study|Withdrawal by Subject|6|||
155667824|NCT01833494|561878497|FG000|Overall Study|Decrease in serum phosphorus|4|||
155667825|NCT01833494|561878497|FG000|Overall Study|Decrease in serum calcium|4|||
155667826|NCT01833494|561878497|FG000|Overall Study|Increase in serum ferritin|1|||
155667827|NCT01694433|561878502|FG000|Overall Study|Adverse Event|7|||
155667828|NCT01694433|561878503|FG001|Overall Study|Adverse Event|0|||
155667829|NCT01694433|561878502|FG000|Overall Study|Physician Decision|1|||
155667830|NCT01694433|561878503|FG001|Overall Study|Physician Decision|0|||
155667831|NCT01694433|561878502|FG000|Overall Study|Withdrawal by Subject|3|||
155667832|NCT01694433|561878503|FG001|Overall Study|Withdrawal by Subject|4|||
155667833|NCT04571060|561878508|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
155667834|NCT04571060|561878509|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
155667835|NCT04571060|561878508|FG000|Overall Study|Never treated migraine|47|||
155667836|NCT04571060|561878509|FG001|Overall Study|Never treated migraine|36|||
155667837|NCT04571060|561878508|FG000|Overall Study|Protocol Violation|4|||
155667838|NCT04571060|561878509|FG001|Overall Study|Protocol Violation|2|||
155667839|NCT04571060|561878508|FG000|Overall Study|Withdrawal by Subject|6|||
155667840|NCT04571060|561878509|FG001|Overall Study|Withdrawal by Subject|2|||
155667841|NCT04571060|561878508|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
155667842|NCT04571060|561878509|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
155667843|NCT01220401|561878514|FG000|Overall Study|Withdrawal by Subject|2|||
155667844|NCT01220401|561878514|FG000|Overall Study|Protocol Violation|1|||
155667845|NCT01853462|561878517|FG000|Overall Study|Withdrawal by Subject|1|||
155667846|NCT01853462|561878518|FG001|Overall Study|Withdrawal by Subject|1|||
155667847|NCT03386435|561878519|FG000|Overall Study|Protocol Violation|5|||
155667848|NCT03386435|561878520|FG001|Overall Study|Protocol Violation|7|||
155667849|NCT04068922|561878521|FG000|Overall Study|Lost to Follow-up|5|||
155667850|NCT04068922|561878521|FG000|Overall Study|Withdrawal by Subject|7|||
155667851|NCT04068922|561878521|FG000|Overall Study|Adverse Event|1|||
155667852|NCT00625586|561878522|FG000|Overall Study|Adverse Event|1|||
155667853|NCT00625586|561878522|FG000|Overall Study|Progressive disease|1|||
155667854|NCT03192137|561878525|FG000|Overall Study|Adverse Event|10|||
155592871|NCT03063086|561597168|FG005|Overall Study|technical problems|0|||
155592872|NCT03063086|561597163|FG000|Overall Study|Adverse Event|1|||
155592873|NCT03063086|561597164|FG001|Overall Study|Adverse Event|1|||
155592874|NCT03063086|561597165|FG002|Overall Study|Adverse Event|1|||
155592875|NCT03063086|561597166|FG003|Overall Study|Adverse Event|1|||
155592876|NCT03063086|561597167|FG004|Overall Study|Adverse Event|0|||
155592877|NCT03063086|561597168|FG005|Overall Study|Adverse Event|0|||
155592878|NCT03063086|561597163|FG000|Overall Study|subject/guardian decision|1|||
155592879|NCT03063086|561597164|FG001|Overall Study|subject/guardian decision|0|||
155592880|NCT03063086|561597165|FG002|Overall Study|subject/guardian decision|0|||
155592881|NCT03063086|561597166|FG003|Overall Study|subject/guardian decision|0|||
155592882|NCT03063086|561597167|FG004|Overall Study|subject/guardian decision|0|||
155592883|NCT03063086|561597168|FG005|Overall Study|subject/guardian decision|0|||
155592884|NCT03063086|561597163|FG000|Overall Study|Non-compliance with study treatment|0|||
155592885|NCT03063086|561597164|FG001|Overall Study|Non-compliance with study treatment|0|||
155592886|NCT03063086|561597165|FG002|Overall Study|Non-compliance with study treatment|0|||
155592887|NCT03063086|561597166|FG003|Overall Study|Non-compliance with study treatment|1|||
155592888|NCT03063086|561597167|FG004|Overall Study|Non-compliance with study treatment|0|||
155592889|NCT03063086|561597168|FG005|Overall Study|Non-compliance with study treatment|1|||
155592890|NCT03063086|561597163|FG000|Overall Study|Physician Decision|0|||
155592891|NCT03063086|561597164|FG001|Overall Study|Physician Decision|0|||
155592892|NCT03063086|561597165|FG002|Overall Study|Physician Decision|0|||
155592893|NCT03063086|561597166|FG003|Overall Study|Physician Decision|1|||
155592894|NCT03063086|561597167|FG004|Overall Study|Physician Decision|0|||
155592895|NCT03063086|561597168|FG005|Overall Study|Physician Decision|0|||
155592896|NCT01598090|561597169|FG000|Treatment Period|Poor/non-compliance|0|||
155592897|NCT01598090|561597170|FG001|Treatment Period|Poor/non-compliance|2|||
155592898|NCT01598090|561597171|FG002|Treatment Period|Poor/non-compliance|0|||
155592899|NCT01598090|561597169|FG000|Treatment Period|No longer meet study criteria|0|||
155592900|NCT01598090|561597170|FG001|Treatment Period|No longer meet study criteria|1|||
155592901|NCT01598090|561597171|FG002|Treatment Period|No longer meet study criteria|0|||
155592902|NCT01598090|561597169|FG000|Treatment Period|Lack of Efficacy|5|||
155592903|NCT01598090|561597170|FG001|Treatment Period|Lack of Efficacy|14|||
155592904|NCT01598090|561597171|FG002|Treatment Period|Lack of Efficacy|6|||
155592905|NCT01598090|561597169|FG000|Treatment Period|Adverse Event|2|||
155592906|NCT01598090|561597170|FG001|Treatment Period|Adverse Event|33|||
155592907|NCT01598090|561597171|FG002|Treatment Period|Adverse Event|17|||
155592908|NCT01598090|561597169|FG000|Treatment Period|Other reasons|0|||
155592909|NCT01598090|561597170|FG001|Treatment Period|Other reasons|4|||
155592910|NCT01598090|561597171|FG002|Treatment Period|Other reasons|1|||
155592911|NCT01598090|561597169|FG000|Treatment Period|Withdrawal by Subject|3|||
155592912|NCT01598090|561597170|FG001|Treatment Period|Withdrawal by Subject|13|||
155592913|NCT01598090|561597171|FG002|Treatment Period|Withdrawal by Subject|10|||
155592914|NCT01598090|561597169|FG000|Treatment Period|Lost to Follow-up|1|||
155592915|NCT01598090|561597170|FG001|Treatment Period|Lost to Follow-up|5|||
155592916|NCT01598090|561597171|FG002|Treatment Period|Lost to Follow-up|1|||
155592917|NCT01598090|561597169|FG000|Follow-up Period|Death|0|||
155592918|NCT01598090|561597170|FG001|Follow-up Period|Death|1|||
155592919|NCT01598090|561597171|FG002|Follow-up Period|Death|0|||
155592920|NCT01598090|561597169|FG000|Follow-up Period|No longer required per protocol|1|||
155592921|NCT01598090|561597170|FG001|Follow-up Period|No longer required per protocol|3|||
155592922|NCT01598090|561597171|FG002|Follow-up Period|No longer required per protocol|2|||
155592923|NCT01598090|561597169|FG000|Follow-up Period|Not reported|0|||
155592924|NCT01598090|561597170|FG001|Follow-up Period|Not reported|10|||
155592925|NCT01598090|561597171|FG002|Follow-up Period|Not reported|4|||
155592926|NCT01598090|561597169|FG000|Follow-up Period|Withdrawal by Subject|0|||
155592927|NCT01598090|561597170|FG001|Follow-up Period|Withdrawal by Subject|3|||
155592928|NCT01598090|561597171|FG002|Follow-up Period|Withdrawal by Subject|2|||
155592929|NCT01598090|561597169|FG000|Follow-up Period|Other reasons|2|||
155592930|NCT01598090|561597170|FG001|Follow-up Period|Other reasons|8|||
155592931|NCT01598090|561597171|FG002|Follow-up Period|Other reasons|8|||
155667855|NCT03192137|561878526|FG001|Overall Study|Adverse Event|11|||
155667856|NCT03192137|561878525|FG000|Overall Study|Physician Decision|1|||
155667857|NCT03192137|561878526|FG001|Overall Study|Physician Decision|0|||
155667858|NCT03192137|561878525|FG000|Overall Study|Lack of Efficacy|20|||
155667859|NCT03192137|561878526|FG001|Overall Study|Lack of Efficacy|37|||
155667860|NCT03192137|561878525|FG000|Overall Study|Withdrawal by Subject|3|||
155667861|NCT03192137|561878526|FG001|Overall Study|Withdrawal by Subject|3|||
155667862|NCT03192137|561878525|FG000|Overall Study|Protocol Violation|4|||
155667863|NCT03192137|561878526|FG001|Overall Study|Protocol Violation|3|||
155667864|NCT03192137|561878525|FG000|Overall Study|Surgery Cancelled|4|||
155667865|NCT03192137|561878526|FG001|Overall Study|Surgery Cancelled|1|||
155667866|NCT03192137|561878525|FG000|Overall Study|Other - Various Administrative Reasons|8|||
155667867|NCT03192137|561878526|FG001|Overall Study|Other - Various Administrative Reasons|3|||
155667868|NCT01261975|561878532|FG000|Overall Study|Surgical complication|1|||
155667869|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
155667870|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155667871|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155667872|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155667873|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155667874|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155667875|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
155667876|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
155667877|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
155667878|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
155667879|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
155667880|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
155667881|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
155667882|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155667883|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155667884|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155667885|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155667886|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155667887|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
155667888|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
155667889|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
155667890|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
155667891|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
155667892|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
155667893|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
155667894|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
155667895|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155667896|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155667897|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155667898|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155667899|NCT00716274|561878534|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155667900|NCT00716274|561878535|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
155667901|NCT00716274|561878536|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155667902|NCT00716274|561878537|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155667903|NCT00716274|561878538|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155667904|NCT00716274|561878539|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155667905|NCT00716274|561878534|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155667906|NCT00716274|561878535|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155667907|NCT00716274|561878536|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
155667908|NCT00716274|561878537|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155667909|NCT00716274|561878538|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155667910|NCT00716274|561878539|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155667911|NCT00716274|561878534|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
155667912|NCT00716274|561878535|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
155667913|NCT00716274|561878536|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
155592932|NCT01598090|561597169|FG000|Follow-up Period|Lost to Follow-up|2|||
155592933|NCT01598090|561597170|FG001|Follow-up Period|Lost to Follow-up|10|||
155592934|NCT01598090|561597171|FG002|Follow-up Period|Lost to Follow-up|12|||
155592935|NCT00355147|561597176|FG000|Overall Study|Lost to Follow-up|10|||
155592936|NCT00355147|561597177|FG001|Overall Study|Lost to Follow-up|8|||
155592937|NCT00355147|561597176|FG000|Overall Study|Withdrawal by Subject|8|||
155592938|NCT00355147|561597177|FG001|Overall Study|Withdrawal by Subject|12|||
155592939|NCT03557931|561597184|FG000|Overall Study|Adverse Event|4|||
155592940|NCT03557931|561597185|FG001|Overall Study|Adverse Event|6|||
155592941|NCT03557931|561597186|FG002|Overall Study|Adverse Event|1|||
155592942|NCT03557931|561597184|FG000|Overall Study|Lost to Follow-up|4|||
155667914|NCT00716274|561878537|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
155667915|NCT00716274|561878538|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
155667916|NCT00716274|561878539|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
155667917|NCT00716274|561878534|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155667918|NCT00716274|561878535|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155667919|NCT00716274|561878536|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155667920|NCT00716274|561878537|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
155667921|NCT00716274|561878538|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
155667922|NCT00716274|561878539|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155667923|NCT00716274|561878534|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
155667924|NCT00716274|561878535|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
155667925|NCT00716274|561878536|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
155667926|NCT00716274|561878537|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
155667927|NCT00716274|561878538|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
155667928|NCT00716274|561878539|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
155667929|NCT01171677|561878540|FG000|Overall Study|Withdrawal by Subject|0|||
155667930|NCT01171677|561878541|FG001|Overall Study|Withdrawal by Subject|3|||
155667931|NCT01171677|561878540|FG000|Overall Study|Adverse Event|1|||
155667932|NCT01171677|561878541|FG001|Overall Study|Adverse Event|0|||
155667933|NCT01171677|561878540|FG000|Overall Study|completed <70% IntenSati classes|5|||
155667934|NCT01171677|561878541|FG001|Overall Study|completed <70% IntenSati classes|0|||
155667935|NCT02015039|561878552|FG000|Overall Study|Not eligible|0|||
155667936|NCT02015039|561878553|FG001|Overall Study|Not eligible|1|||
155667937|NCT00403130|561878557|FG000|2 Years From Start of Treatment|Not Eligible|3|||
155667938|NCT00403130|561878557|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
155667939|NCT00403130|561878557|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
155667940|NCT00403130|561878557|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
155667941|NCT01404234|561878558|FG000|Overall Study|Withdrawal by Subject|2|||
155667942|NCT02670473|561878559|FG000|Overall Study|Withdrawal by Subject|1|||
155667943|NCT00456755|561880532|FG000|Overall Study|Lost to Follow-up|2|||
155667944|NCT00456755|561880533|FG001|Overall Study|Lost to Follow-up|1|||
155667945|NCT03073525|561880537|FG000|Overall Study|Withdrawal by Subject|0|||
155667946|NCT03073525|561880538|FG001|Overall Study|Withdrawal by Subject|0|||
155667947|NCT03073525|561880539|FG002|Overall Study|Withdrawal by Subject|3|||
155667948|NCT02477527|561880540|FG000|Overall Study|Lost to Follow-up|2|||
155667949|NCT02477527|561880540|FG000|Overall Study|Withdrawal by Subject|1|||
155667950|NCT02477527|561880540|FG000|Overall Study|Screen Failure|3|||
155667951|NCT01976299|561880541|FG000|Overall Study|Withdrawal by Subject|3|||
155667952|NCT01976299|561880542|FG001|Overall Study|Withdrawal by Subject|1|||
155667953|NCT01976299|561880541|FG000|Overall Study|Death|4|||
155667954|NCT01976299|561880542|FG001|Overall Study|Death|2|||
155667955|NCT01976299|561880541|FG000|Overall Study|Lost to Follow-up|7|||
155667956|NCT01976299|561880542|FG001|Overall Study|Lost to Follow-up|1|||
155667957|NCT01976299|561880541|FG000|Overall Study|See clarification above in comments|9|||
155667958|NCT01976299|561880542|FG001|Overall Study|See clarification above in comments|2|||
155667959|NCT03692403|561880543|FG000|Overall Study|Withdrawal by Subject|1|||
155667960|NCT03692403|561880544|FG001|Overall Study|Withdrawal by Subject|0|||
155667961|NCT03692403|561880545|FG002|Overall Study|Withdrawal by Subject|1|||
155667962|NCT03692403|561880546|FG003|Overall Study|Withdrawal by Subject|0|||
155667963|NCT03692403|561880543|FG000|Overall Study|Adverse Event|0|||
155667964|NCT03692403|561880544|FG001|Overall Study|Adverse Event|0|||
155667965|NCT03692403|561880545|FG002|Overall Study|Adverse Event|0|||
155667966|NCT03692403|561880546|FG003|Overall Study|Adverse Event|1|||
155667967|NCT03692403|561880543|FG000|Overall Study|Pregnancy|0|||
155667968|NCT03692403|561880544|FG001|Overall Study|Pregnancy|1|||
155667969|NCT03692403|561880545|FG002|Overall Study|Pregnancy|0|||
155667970|NCT03692403|561880546|FG003|Overall Study|Pregnancy|0|||
155667971|NCT03692403|561880543|FG000|Overall Study|Other|0|||
155667972|NCT03692403|561880544|FG001|Overall Study|Other|0|||
155667973|NCT03692403|561880545|FG002|Overall Study|Other|1|||
155667974|NCT03692403|561880546|FG003|Overall Study|Other|0|||
155667975|NCT04567524|561880547|FG000|Overall Study|Adverse Event|1|||
155667976|NCT04567524|561880548|FG001|Overall Study|Adverse Event|1|||
155667977|NCT04567524|561880549|FG002|Overall Study|Adverse Event|0|||
155667978|NCT04567524|561880550|FG003|Overall Study|Adverse Event|0|||
155667979|NCT04567524|561880547|FG000|Overall Study|Withdrawal by Subject|2|||
155667980|NCT04567524|561880548|FG001|Overall Study|Withdrawal by Subject|0|||
155667981|NCT04567524|561880549|FG002|Overall Study|Withdrawal by Subject|0|||
155667982|NCT04567524|561880550|FG003|Overall Study|Withdrawal by Subject|1|||
155667983|NCT02848092|561880552|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
155667984|NCT02848092|561880553|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
155667985|NCT02848092|561880552|FG000|1-month Post-training Follow-up|Adverse Event|2|||
155667986|NCT02848092|561880553|FG001|1-month Post-training Follow-up|Adverse Event|1|||
155592943|NCT03557931|561597185|FG001|Overall Study|Lost to Follow-up|4|||
155592944|NCT03557931|561597186|FG002|Overall Study|Lost to Follow-up|1|||
155592945|NCT03557931|561597184|FG000|Overall Study|Protocol Violation|1|||
155592946|NCT03557931|561597185|FG001|Overall Study|Protocol Violation|4|||
155592947|NCT03557931|561597186|FG002|Overall Study|Protocol Violation|1|||
155592948|NCT03557931|561597184|FG000|Overall Study|Withdrawal by Subject|14|||
155592949|NCT03557931|561597185|FG001|Overall Study|Withdrawal by Subject|0|||
155592950|NCT03557931|561597186|FG002|Overall Study|Withdrawal by Subject|7|||
155592951|NCT03557931|561597184|FG000|Overall Study|Miscellaneous|8|||
155592952|NCT03557931|561597185|FG001|Overall Study|Miscellaneous|5|||
155592953|NCT03557931|561597186|FG002|Overall Study|Miscellaneous|3|||
155592954|NCT02394340|561597187|FG000|Overall Study|Failed drug screen test|1|||
155592955|NCT02394340|561597187|FG000|Overall Study|Adverse Event|1|||
155592956|NCT03605862|561597190|FG000|Overall Study|Withdrawal by Subject|12|||
155592957|NCT03605862|561597191|FG001|Overall Study|Withdrawal by Subject|9|||
155592958|NCT03605862|561597190|FG000|Overall Study|Adverse Event|2|||
155592959|NCT03605862|561597191|FG001|Overall Study|Adverse Event|1|||
155592960|NCT03605862|561597190|FG000|Overall Study|Physician Decision|3|||
155592961|NCT03605862|561597191|FG001|Overall Study|Physician Decision|1|||
155592962|NCT03605862|561597190|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
155592963|NCT03605862|561597191|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
155592964|NCT00364923|561597192|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
155592965|NCT00364923|561597192|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
155592966|NCT01355575|561597200|FG000|Overall Study|Withdrawal by Subject|2|||
155592967|NCT00765336|561597203|FG000|Overall Study|Protocol Violation|4|||
155592968|NCT00765336|561597204|FG001|Overall Study|Protocol Violation|2|||
155592969|NCT00765336|561597203|FG000|Overall Study|Withdrawal by Subject|6|||
155592970|NCT00765336|561597204|FG001|Overall Study|Withdrawal by Subject|4|||
155592971|NCT00765336|561597203|FG000|Overall Study|Lost to Follow-up|7|||
155592972|NCT00765336|561597204|FG001|Overall Study|Lost to Follow-up|9|||
155592973|NCT00765336|561597203|FG000|Overall Study|Adverse Event|2|||
155592974|NCT00765336|561597204|FG001|Overall Study|Adverse Event|1|||
155592975|NCT00570063|561597207|FG000|Overall Study|Adverse Event|4|||
155592976|NCT00570063|561597208|FG001|Overall Study|Adverse Event|1|||
155592977|NCT00570063|561597207|FG000|Overall Study|Lack of Efficacy|0|||
155592978|NCT00570063|561597208|FG001|Overall Study|Lack of Efficacy|1|||
155592979|NCT00570063|561597207|FG000|Overall Study|Withdrawal by Subject|4|||
155592980|NCT00570063|561597208|FG001|Overall Study|Withdrawal by Subject|3|||
155592981|NCT00570063|561597207|FG000|Overall Study|Sponsor's Decision|7|||
155592982|NCT00570063|561597208|FG001|Overall Study|Sponsor's Decision|3|||
155592983|NCT00697463|561597209|FG000|Overall Study|Withdrawal by Subject|1|||
155592984|NCT03307252|561597210|FG000|Part 2, Period 1|Treatment not received|0|||
155592985|NCT03307252|561597211|FG001|Part 2, Period 1|Treatment not received|0|||
155592986|NCT03307252|561597212|FG002|Part 2, Period 1|Treatment not received|0|||
155592987|NCT03307252|561597213|FG003|Part 2, Period 1|Treatment not received|0|||
155592988|NCT03307252|561597214|FG004|Part 2, Period 1|Treatment not received|0|||
155592989|NCT03307252|561597215|FG005|Part 2, Period 1|Treatment not received|1|||
155592990|NCT03307252|561597216|FG006|Part 2, Period 1|Treatment not received|0|||
155592991|NCT03307252|561597217|FG007|Part 2, Period 1|Treatment not received|0|||
155592992|NCT03307252|561597218|FG008|Part 2, Period 1|Treatment not received|0|||
155592993|NCT03307252|561597219|FG009|Part 2, Period 1|Treatment not received|0|||
155592994|NCT03307252|561597220|FG010|Part 2, Period 1|Treatment not received|0|||
155592995|NCT03307252|561597210|FG000|Part 2, Period 3|Other than listed|0|||
155592996|NCT03307252|561597211|FG001|Part 2, Period 3|Other than listed|0|||
155592997|NCT03307252|561597212|FG002|Part 2, Period 3|Other than listed|0|||
155592998|NCT03307252|561597213|FG003|Part 2, Period 3|Other than listed|0|||
155592999|NCT03307252|561597214|FG004|Part 2, Period 3|Other than listed|1|||
155593000|NCT03307252|561597215|FG005|Part 2, Period 3|Other than listed|0|||
155593001|NCT03307252|561597216|FG006|Part 2, Period 3|Other than listed|0|||
155593002|NCT03307252|561597217|FG007|Part 2, Period 3|Other than listed|0|||
155593003|NCT03307252|561597218|FG008|Part 2, Period 3|Other than listed|0|||
155593004|NCT03307252|561597219|FG009|Part 2, Period 3|Other than listed|0|||
155593005|NCT03307252|561597220|FG010|Part 2, Period 3|Other than listed|0|||
155593006|NCT03307252|561597210|FG000|Part 2, Period 4|Other than listed|0|||
155593007|NCT03307252|561597211|FG001|Part 2, Period 4|Other than listed|0|||
155593008|NCT03307252|561597212|FG002|Part 2, Period 4|Other than listed|0|||
155593009|NCT03307252|561597213|FG003|Part 2, Period 4|Other than listed|0|||
155593010|NCT03307252|561597214|FG004|Part 2, Period 4|Other than listed|0|||
155593011|NCT03307252|561597215|FG005|Part 2, Period 4|Other than listed|0|||
155593012|NCT03307252|561597216|FG006|Part 2, Period 4|Other than listed|1|||
155593013|NCT03307252|561597217|FG007|Part 2, Period 4|Other than listed|0|||
155593014|NCT03307252|561597218|FG008|Part 2, Period 4|Other than listed|0|||
155593015|NCT03307252|561597219|FG009|Part 2, Period 4|Other than listed|0|||
155593016|NCT03307252|561597220|FG010|Part 2, Period 4|Other than listed|0|||
155593017|NCT03307252|561597210|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593018|NCT03307252|561597211|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593019|NCT03307252|561597212|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593020|NCT03307252|561597213|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593021|NCT03307252|561597214|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593022|NCT03307252|561597215|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593023|NCT03307252|561597216|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593024|NCT03307252|561597217|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593025|NCT03307252|561597218|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593026|NCT03307252|561597219|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155593027|NCT03307252|561597220|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
155593028|NCT01554527|561597221|FG000|Overall Study|Withdrawal by Subject|1|||
155593029|NCT01554527|561597222|FG001|Overall Study|Withdrawal by Subject|0|||
155593030|NCT01554527|561597223|FG002|Overall Study|Withdrawal by Subject|3|||
155593031|NCT01554527|561597221|FG000|Overall Study|Lost to Follow-up|0|||
155667987|NCT02848092|561880552|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
155667988|NCT02848092|561880553|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
155667989|NCT02848092|561880552|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
155667990|NCT02848092|561880553|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
155667991|NCT02848092|561880552|FG000|1-month Post-training Follow-up|fatigue|0|||
155667992|NCT02848092|561880553|FG001|1-month Post-training Follow-up|fatigue|1|||
155667993|NCT02848092|561880552|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
155667994|NCT02848092|561880553|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
155667995|NCT02848092|561880552|FG000|6-month Post-training Follow-up|Adverse Event|1|||
155667996|NCT02848092|561880553|FG001|6-month Post-training Follow-up|Adverse Event|1|||
155667997|NCT02848092|561880552|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
155667998|NCT02848092|561880553|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
155667999|NCT02848092|561880552|FG000|6-month Post-training Follow-up|frustrated with task|1|||
155668000|NCT02848092|561880553|FG001|6-month Post-training Follow-up|frustrated with task|0|||
155668001|NCT02848092|561880552|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
155668002|NCT02848092|561880553|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
155668003|NCT02848092|561880552|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
155668004|NCT02848092|561880553|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
155668005|NCT01639469|561880555|FG000|Overall Study|Death|4|||
155668006|NCT01639469|561880556|FG001|Overall Study|Death|2|||
155668007|NCT01639469|561880555|FG000|Overall Study|Lost to Follow-up|1|||
155668008|NCT01639469|561880556|FG001|Overall Study|Lost to Follow-up|1|||
155668009|NCT01147393|561880563|FG000|Dose Level 1|Dose limiting Toxicity|2|||
155593032|NCT01554527|561597222|FG001|Overall Study|Lost to Follow-up|0|||
155593033|NCT01554527|561597223|FG002|Overall Study|Lost to Follow-up|4|||
155593034|NCT01554527|561597221|FG000|Overall Study|Physician Decision|0|||
155593035|NCT01554527|561597222|FG001|Overall Study|Physician Decision|0|||
155593036|NCT01554527|561597223|FG002|Overall Study|Physician Decision|1|||
155593037|NCT02157376|561597224|FG000|Overall Study|Death|10|||
155593038|NCT02157376|561597225|FG001|Overall Study|Death|4|||
155593039|NCT02157376|561597224|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155593040|NCT02157376|561597225|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155593041|NCT02157376|561597224|FG000|Overall Study|Withdrawal by Subject|3|||
155593042|NCT02157376|561597225|FG001|Overall Study|Withdrawal by Subject|8|||
155593043|NCT02157376|561597224|FG000|Overall Study|Not treated|8|||
155593044|NCT02157376|561597225|FG001|Overall Study|Not treated|3|||
155593045|NCT02157376|561597224|FG000|Overall Study|Investigator's misjudgement|1|||
155593046|NCT02157376|561597225|FG001|Overall Study|Investigator's misjudgement|2|||
155593047|NCT04200651|561597228|FG000|Overall Study|Moved to another country during follow-up|2|||
155593048|NCT04200651|561597229|FG001|Overall Study|Moved to another country during follow-up|2|||
155593049|NCT04200651|561597228|FG000|Overall Study|Lost to Follow-up|1|||
155593050|NCT04200651|561597229|FG001|Overall Study|Lost to Follow-up|3|||
155593051|NCT02547220|561597233|FG000|Overall Study|Withdrawal by Subject|1|||
155593052|NCT02547220|561597234|FG001|Overall Study|Withdrawal by Subject|0|||
155593053|NCT02547220|561597233|FG000|Overall Study|Study terminated by sponsor|18|||
155593054|NCT02547220|561597234|FG001|Overall Study|Study terminated by sponsor|20|||
155593055|NCT02981082|561597240|FG000|Overall Study|Withdrawal by Subject|2|||
155593056|NCT02981082|561597241|FG001|Overall Study|Withdrawal by Subject|0|||
155593057|NCT02981082|561597240|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
155593058|NCT02981082|561597241|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
155593059|NCT02981082|561597240|FG000|Overall Study|Adverse Event|0|||
155593060|NCT02981082|561597241|FG001|Overall Study|Adverse Event|1|||
155593061|NCT00596817|561597242|FG000|Open-label Period|Adverse Event|0|||
155593062|NCT00596817|561597243|FG001|Open-label Period|Adverse Event|49|||
155593063|NCT00596817|561597242|FG000|Open-label Period|Lack of Efficacy|0|||
155593064|NCT00596817|561597243|FG001|Open-label Period|Lack of Efficacy|33|||
155593065|NCT00596817|561597242|FG000|Open-label Period|Other Reasons|0|||
155593066|NCT00596817|561597243|FG001|Open-label Period|Other Reasons|65|||
155593067|NCT00596817|561597242|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
155593068|NCT00596817|561597243|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
155593069|NCT00596817|561597242|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
155593070|NCT00596817|561597243|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
155593071|NCT00596817|561597242|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
155593072|NCT00596817|561597243|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
155593073|NCT00596817|561597242|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
155593074|NCT00596817|561597243|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
155593075|NCT00596817|561597242|FG000|Double-blind Period|Adverse Event|5|||
155593076|NCT00596817|561597243|FG001|Double-blind Period|Adverse Event|16|||
155593077|NCT00596817|561597242|FG000|Double-blind Period|Lack of Efficacy|52|||
155593078|NCT00596817|561597243|FG001|Double-blind Period|Lack of Efficacy|28|||
155593079|NCT00596817|561597242|FG000|Double-blind Period|Non-compliance With Study Product|3|||
155593080|NCT00596817|561597243|FG001|Double-blind Period|Non-compliance With Study Product|4|||
155593081|NCT00596817|561597242|FG000|Double-blind Period|Protocol Violation|11|||
155593082|NCT00596817|561597243|FG001|Double-blind Period|Protocol Violation|8|||
155593083|NCT00596817|561597242|FG000|Double-blind Period|Withdrawal of Consent|7|||
155593084|NCT00596817|561597243|FG001|Double-blind Period|Withdrawal of Consent|3|||
155593085|NCT00596817|561597242|FG000|Double-blind Period|Lost to Follow-up|0|||
155593086|NCT00596817|561597243|FG001|Double-blind Period|Lost to Follow-up|2|||
155593087|NCT00596817|561597242|FG000|Double-blind Period|Other Reasons|10|||
155593088|NCT00596817|561597243|FG001|Double-blind Period|Other Reasons|18|||
155593089|NCT04250350|561598580|FG000|Overall Study|Withdrawal by Subject|13|||
155593090|NCT04250350|561598580|FG000|Overall Study|Lost to Follow-up|8|||
155593091|NCT04250350|561598580|FG000|Overall Study|Adverse Event|5|||
155593092|NCT04250350|561598580|FG000|Overall Study|Lack of Efficacy|4|||
155593093|NCT04250350|561598580|FG000|Overall Study|Physician Decision|1|||
155593094|NCT04250350|561598580|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
155593095|NCT00378508|561598585|FG000|Overall Study|Withdrawal by Subject|1|||
155593096|NCT00378508|561598586|FG001|Overall Study|Withdrawal by Subject|3|||
155593097|NCT00378508|561598585|FG000|Overall Study|Lost to Follow-up|1|||
155593098|NCT00378508|561598586|FG001|Overall Study|Lost to Follow-up|0|||
155593099|NCT00956592|561598589|FG000|Overall Study|Protocol Violation|1|||
155593100|NCT00956592|561598590|FG001|Overall Study|Protocol Violation|3|||
155593101|NCT03192306|561598591|FG000|Overall Study|Did not treat cold sore during study|149|||
155593102|NCT03192306|561598592|FG001|Overall Study|Did not treat cold sore during study|143|||
155593103|NCT03192306|561598591|FG000|Overall Study|Withdrawal by Subject|1|||
155593104|NCT03192306|561598592|FG001|Overall Study|Withdrawal by Subject|1|||
155593105|NCT03192306|561598591|FG000|Overall Study|Lost to Follow-up|1|||
155593106|NCT03192306|561598592|FG001|Overall Study|Lost to Follow-up|0|||
155593107|NCT03192306|561598591|FG000|Overall Study|Protocol Violation|1|||
155593108|NCT03192306|561598592|FG001|Overall Study|Protocol Violation|1|||
155593109|NCT00083759|561598600|FG000|Overall Study|Adverse Event|5|||
155593110|NCT00083759|561598601|FG001|Overall Study|Adverse Event|3|||
155593111|NCT00083759|561598600|FG000|Overall Study|Lost to Follow-up|1|||
155593112|NCT00083759|561598601|FG001|Overall Study|Lost to Follow-up|0|||
155593113|NCT00083759|561598600|FG000|Overall Study|Death|1|||
155593114|NCT00083759|561598601|FG001|Overall Study|Death|1|||
155668010|NCT01147393|561880563|FG000|Dose Level -1|Dose Limited Toxicity|1|||
155668011|NCT00856635|561880572|FG000|Overall Study|Lost to Follow-up|2|||
155668012|NCT00856635|561880573|FG001|Overall Study|Lost to Follow-up|5|||
155668013|NCT00856635|561880572|FG000|Overall Study|Pregnancy|1|||
155668014|NCT00856635|561880573|FG001|Overall Study|Pregnancy|0|||
155668015|NCT00856635|561880572|FG000|Overall Study|Withdrawal by Subject|3|||
155668016|NCT00856635|561880573|FG001|Overall Study|Withdrawal by Subject|1|||
155668017|NCT00856635|561880572|FG000|Overall Study|Serious Adverse Event|1|||
155668018|NCT00856635|561880573|FG001|Overall Study|Serious Adverse Event|0|||
155668019|NCT00856635|561880572|FG000|Overall Study|Other|1|||
155668020|NCT00856635|561880573|FG001|Overall Study|Other|0|||
155668021|NCT00856635|561880572|FG000|Overall Study|Discontinued at Randomization|2|||
155668022|NCT00856635|561880573|FG001|Overall Study|Discontinued at Randomization|2|||
155668023|NCT02383862|561880574|FG000|3 Month Follow up|Lost to Follow-up|23|||
155668024|NCT02383862|561880575|FG001|3 Month Follow up|Lost to Follow-up|21|||
155668025|NCT01665911|561880576|FG000|Overall Study|Protocol Violation|4|||
155668026|NCT01665911|561880576|FG000|Overall Study|Withdrawal by Subject|1|||
155668027|NCT01665911|561880576|FG000|Overall Study|Adverse Event|1|||
155668028|NCT00506779|561880577|FG000|Overall Study|Withdrawal by Subject|1|||
155668029|NCT00506779|561880578|FG001|Overall Study|Withdrawal by Subject|0|||
155668030|NCT00506779|561880579|FG002|Overall Study|Withdrawal by Subject|1|||
155668031|NCT00506779|561880580|FG003|Overall Study|Withdrawal by Subject|0|||
155668032|NCT00506779|561880577|FG000|Overall Study|Adverse Event|0|||
155668033|NCT00506779|561880578|FG001|Overall Study|Adverse Event|1|||
155668034|NCT00506779|561880579|FG002|Overall Study|Adverse Event|1|||
155668035|NCT00506779|561880580|FG003|Overall Study|Adverse Event|1|||
155668036|NCT03198767|561880581|FG000|Overall Study|Protocol Violation|0|||
155668037|NCT03198767|561880582|FG001|Overall Study|Protocol Violation|0|||
155668038|NCT03198767|561880583|FG002|Overall Study|Protocol Violation|0|||
155668039|NCT03198767|561880584|FG003|Overall Study|Protocol Violation|6|||
155668040|NCT03198767|561880585|FG004|Overall Study|Protocol Violation|0|||
155668041|NCT03198767|561880586|FG005|Overall Study|Protocol Violation|0|||
155668042|NCT03198767|561880587|FG006|Overall Study|Protocol Violation|0|||
155668043|NCT02820844|561880588|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
155668044|NCT02820844|561880589|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
155668045|NCT02820844|561880590|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155668046|NCT02820844|561880591|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155668047|NCT02820844|561880592|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155668048|NCT02820844|561880593|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155668049|NCT02820844|561880588|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
155668050|NCT02820844|561880589|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
155668051|NCT02820844|561880590|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155668052|NCT02820844|561880591|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155668053|NCT02820844|561880592|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155668054|NCT02820844|561880593|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155668055|NCT02820844|561880588|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155668056|NCT02820844|561880589|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
155668057|NCT02820844|561880590|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155668058|NCT02820844|561880591|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155668059|NCT02820844|561880592|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155668060|NCT02820844|561880593|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155668061|NCT02820844|561880588|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
155668062|NCT02820844|561880589|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
155668063|NCT02820844|561880590|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155668064|NCT02820844|561880591|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155668065|NCT02820844|561880592|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155668066|NCT02820844|561880593|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155668067|NCT02820844|561880588|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
155668068|NCT02820844|561880589|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155668069|NCT02820844|561880590|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155668070|NCT02820844|561880591|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155668071|NCT02820844|561880592|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155668072|NCT02820844|561880593|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155668073|NCT02820844|561880588|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155668074|NCT02820844|561880589|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155668075|NCT02820844|561880590|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
155668076|NCT02820844|561880591|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
155668077|NCT02820844|561880592|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155668078|NCT02820844|561880593|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155668079|NCT02820844|561880588|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155668080|NCT02820844|561880589|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155668081|NCT02820844|561880590|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
155593115|NCT00083759|561598600|FG000|Overall Study|Inadequate Therapeutic Response|32|||
155593116|NCT00083759|561598601|FG001|Overall Study|Inadequate Therapeutic Response|35|||
155593117|NCT00083759|561598600|FG000|Overall Study|Subject Withdrew Consent|2|||
155593118|NCT00083759|561598601|FG001|Overall Study|Subject Withdrew Consent|2|||
155593119|NCT00083759|561598600|FG000|Overall Study|Non-Compliance|1|||
155593120|NCT00083759|561598601|FG001|Overall Study|Non-Compliance|0|||
155593121|NCT00083759|561598600|FG000|Overall Study|Sponsor's Discretion|28|||
155593122|NCT00083759|561598601|FG001|Overall Study|Sponsor's Discretion|29|||
155593123|NCT00083759|561598600|FG000|Overall Study|Other|14|||
155593124|NCT00083759|561598601|FG001|Overall Study|Other|13|||
155593125|NCT00280397|561598604|FG000|Overall Study|Adverse Event|1|||
155593126|NCT01028014|561598612|FG000|Overall Study|Lost to Follow-up|1|||
155593127|NCT01028014|561598613|FG001|Overall Study|Lost to Follow-up|2|||
155593128|NCT01028014|561598614|FG002|Overall Study|Lost to Follow-up|0|||
155593129|NCT01028014|561598615|FG003|Overall Study|Lost to Follow-up|1|||
155593130|NCT01028014|561598616|FG004|Overall Study|Lost to Follow-up|1|||
155593131|NCT01028014|561598617|FG005|Overall Study|Lost to Follow-up|2|||
155593132|NCT05338502|561598618|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
155593133|NCT05338502|561598619|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
155593134|NCT05338502|561598620|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
155593135|NCT05338502|561598618|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
155593136|NCT05338502|561598619|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
155593137|NCT05338502|561598620|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
155593138|NCT00729157|561598628|FG000|Overall Study|Withdrawal by Subject|1|||
155593139|NCT01683266|561598629|FG000|Overall Study|Adverse Event|5|||
155593140|NCT01683266|561598630|FG001|Overall Study|Adverse Event|4|||
155593141|NCT01683266|561598629|FG000|Overall Study|Lack of Efficacy|5|||
155593142|NCT01683266|561598630|FG001|Overall Study|Lack of Efficacy|2|||
155593143|NCT01683266|561598629|FG000|Overall Study|Protocol Violation|13|||
155593144|NCT01683266|561598630|FG001|Overall Study|Protocol Violation|6|||
155593145|NCT01683266|561598629|FG000|Overall Study|Personal Reason|17|||
155593146|NCT01683266|561598630|FG001|Overall Study|Personal Reason|25|||
155593147|NCT01683266|561598629|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
155593148|NCT01683266|561598630|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
155593149|NCT01683266|561598629|FG000|Overall Study|Lost to Follow-up|5|||
155593150|NCT01683266|561598630|FG001|Overall Study|Lost to Follow-up|0|||
155593151|NCT01683266|561598629|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
155593152|NCT01683266|561598630|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
155593153|NCT01683266|561598629|FG000|Overall Study|Nonserious Hypoglycemia|0|||
155593154|NCT01683266|561598630|FG001|Overall Study|Nonserious Hypoglycemia|3|||
155593155|NCT01683266|561598629|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155593156|NCT01683266|561598630|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155593157|NCT01683266|561598629|FG000|Overall Study|Possibly Hypoglycemia|1|||
155593158|NCT01683266|561598630|FG001|Overall Study|Possibly Hypoglycemia|0|||
155593159|NCT01683266|561598629|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
155593160|NCT01683266|561598630|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
155593161|NCT02217410|561598633|FG000|Overall Study|Graft Loss|0|||
155593162|NCT02217410|561598634|FG001|Overall Study|Graft Loss|0|||
155593163|NCT02217410|561598635|FG002|Overall Study|Graft Loss|2|||
155593164|NCT02217410|561598633|FG000|Overall Study|Withdrawal by Subject|0|||
155593165|NCT02217410|561598634|FG001|Overall Study|Withdrawal by Subject|0|||
155593166|NCT02217410|561598635|FG002|Overall Study|Withdrawal by Subject|2|||
155593167|NCT02217410|561598633|FG000|Overall Study|Lost to Follow-up|0|||
155593168|NCT02217410|561598634|FG001|Overall Study|Lost to Follow-up|0|||
155593169|NCT02217410|561598635|FG002|Overall Study|Lost to Follow-up|1|||
155593170|NCT02217410|561598633|FG000|Overall Study|Lack of Efficacy|0|||
155593171|NCT02217410|561598634|FG001|Overall Study|Lack of Efficacy|1|||
155593172|NCT02217410|561598635|FG002|Overall Study|Lack of Efficacy|0|||
155593173|NCT02217410|561598633|FG000|Overall Study|Physician Decision|1|||
155593174|NCT02217410|561598634|FG001|Overall Study|Physician Decision|3|||
155593175|NCT02217410|561598635|FG002|Overall Study|Physician Decision|0|||
155593176|NCT01940887|561598643|FG000|Year 1|Protocol Violation|0|||
155593177|NCT01940887|561598644|FG001|Year 1|Protocol Violation|1|||
155668082|NCT02820844|561880591|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155668083|NCT02820844|561880592|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155668084|NCT02820844|561880593|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155668085|NCT02820844|561880588|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668086|NCT02820844|561880589|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668087|NCT02820844|561880590|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
155668088|NCT02820844|561880591|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
155668089|NCT02820844|561880592|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668090|NCT02820844|561880593|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668091|NCT02820844|561880588|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155668092|NCT02820844|561880589|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155668093|NCT02820844|561880590|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155668094|NCT02820844|561880591|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155668095|NCT02820844|561880592|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
155668096|NCT02820844|561880593|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155668097|NCT02820844|561880588|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668098|NCT02820844|561880589|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668099|NCT02820844|561880590|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668100|NCT02820844|561880591|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668101|NCT02820844|561880592|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155668102|NCT02820844|561880593|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
155668103|NCT02954887|561880594|FG000|Overall Study|Withdrawal by Subject|3|||
155668104|NCT02954887|561880594|FG000|Overall Study|Lack of Efficacy|3|||
155668105|NCT02954887|561880594|FG000|Overall Study|Other|1|||
155668106|NCT00920556|561880595|FG000|Overall Study|Adverse Event|16|||
155668107|NCT00920556|561880595|FG000|Overall Study|Physician Decision|7|||
155668108|NCT00920556|561880595|FG000|Overall Study|Withdrawal by Subject|1|||
155668109|NCT03637491|561880596|FG000|Overall Study|Death|9|||
155668110|NCT03637491|561880597|FG001|Overall Study|Death|9|||
155668111|NCT03637491|561880598|FG002|Overall Study|Death|5|||
155668112|NCT03637491|561880599|FG003|Overall Study|Death|3|||
155668113|NCT03637491|561880596|FG000|Overall Study|Lost to Follow-up|0|||
155668114|NCT03637491|561880597|FG001|Overall Study|Lost to Follow-up|1|||
155668115|NCT03637491|561880598|FG002|Overall Study|Lost to Follow-up|0|||
155668116|NCT03637491|561880599|FG003|Overall Study|Lost to Follow-up|1|||
155668117|NCT03637491|561880596|FG000|Overall Study|Study Terminated By Sponsor|0|||
155668118|NCT03637491|561880597|FG001|Overall Study|Study Terminated By Sponsor|2|||
155668119|NCT03637491|561880598|FG002|Overall Study|Study Terminated By Sponsor|1|||
155668120|NCT03637491|561880599|FG003|Overall Study|Study Terminated By Sponsor|0|||
155668121|NCT03637491|561880596|FG000|Overall Study|Withdrawal by Subject|1|||
155668122|NCT03637491|561880597|FG001|Overall Study|Withdrawal by Subject|0|||
155668123|NCT03637491|561880598|FG002|Overall Study|Withdrawal by Subject|1|||
155668124|NCT03637491|561880599|FG003|Overall Study|Withdrawal by Subject|2|||
155668125|NCT01151020|561880602|FG000|Overall Study|Death|25|||
155668126|NCT01151020|561880602|FG000|Overall Study|Conversion to open repair|1|||
155668127|NCT01151020|561880602|FG000|Overall Study|Lost to Follow-up|4|||
155668128|NCT01151020|561880602|FG000|Overall Study|Withdrawal by Subject|22|||
155668129|NCT01151020|561880602|FG000|Overall Study|Patients did not receive the device|2|||
155668130|NCT04419467|561880603|FG000|Overall Study|Not treated with IP|0|||
155668131|NCT04419467|561880604|FG001|Overall Study|Not treated with IP|0|||
155668132|NCT04419467|561880605|FG002|Overall Study|Not treated with IP|2|||
155668133|NCT04419467|561880603|FG000|Overall Study|Adverse Event|0|||
155668134|NCT04419467|561880604|FG001|Overall Study|Adverse Event|2|||
155668135|NCT04419467|561880605|FG002|Overall Study|Adverse Event|0|||
155668136|NCT04419467|561880603|FG000|Overall Study|Death|1|||
155668137|NCT04419467|561880604|FG001|Overall Study|Death|0|||
155593178|NCT01940887|561598643|FG000|Year 1|Physician Decision|7|||
155593179|NCT01940887|561598644|FG001|Year 1|Physician Decision|3|||
155593180|NCT01940887|561598643|FG000|Year 1|Death|5|||
155593181|NCT01940887|561598644|FG001|Year 1|Death|3|||
155593182|NCT01940887|561598643|FG000|Year 1|Adverse Event|7|||
155593183|NCT01940887|561598644|FG001|Year 1|Adverse Event|6|||
155593184|NCT01940887|561598643|FG000|Year 1|Withdrawal by Subject|18|||
155593185|NCT01940887|561598644|FG001|Year 1|Withdrawal by Subject|9|||
155593186|NCT01940887|561598643|FG000|Year 1|Lost to Follow-up|2|||
155593187|NCT01940887|561598644|FG001|Year 1|Lost to Follow-up|1|||
155593188|NCT01940887|561598643|FG000|Year 2|Physician Decision|8|||
155668138|NCT04419467|561880605|FG002|Overall Study|Death|0|||
155593189|NCT01940887|561598644|FG001|Year 2|Physician Decision|1|||
155593190|NCT01940887|561598643|FG000|Year 2|Death|0|||
155593191|NCT01940887|561598644|FG001|Year 2|Death|2|||
155593192|NCT01940887|561598643|FG000|Year 2|Sponsor Decision, early termination|192|||
155593193|NCT01940887|561598644|FG001|Year 2|Sponsor Decision, early termination|203|||
155593194|NCT01940887|561598643|FG000|Year 2|Adverse Event|8|||
155593195|NCT01940887|561598644|FG001|Year 2|Adverse Event|2|||
155593196|NCT01940887|561598643|FG000|Year 2|Withdrawal by Subject|8|||
155593197|NCT01940887|561598644|FG001|Year 2|Withdrawal by Subject|8|||
155593198|NCT01940887|561598643|FG000|Year 2|Lost to Follow-up|1|||
155593199|NCT01940887|561598644|FG001|Year 2|Lost to Follow-up|6|||
155593200|NCT00090220|561598645|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
155593201|NCT00090220|561598646|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
155593202|NCT00090220|561598647|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155593203|NCT00090220|561598648|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155593204|NCT00090220|561598649|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155593205|NCT00090220|561598650|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155593206|NCT00090220|561598645|FG000|Base Study Vaccination Period|Adverse Event|6|||
155593207|NCT00090220|561598646|FG001|Base Study Vaccination Period|Adverse Event|1|||
155593208|NCT00090220|561598647|FG002|Base Study Vaccination Period|Adverse Event|0|||
155593209|NCT00090220|561598648|FG003|Base Study Vaccination Period|Adverse Event|0|||
155593210|NCT00090220|561598649|FG004|Base Study Vaccination Period|Adverse Event|0|||
155593211|NCT00090220|561598650|FG005|Base Study Vaccination Period|Adverse Event|0|||
155593212|NCT00090220|561598645|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
155593213|NCT00090220|561598646|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
155593214|NCT00090220|561598647|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
155593215|NCT00090220|561598648|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
155593216|NCT00090220|561598649|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155593217|NCT00090220|561598650|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
155593218|NCT00090220|561598645|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
155593219|NCT00090220|561598646|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
155593220|NCT00090220|561598647|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
155593221|NCT00090220|561598648|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
155593222|NCT00090220|561598649|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155593223|NCT00090220|561598650|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
155593224|NCT00090220|561598645|FG000|Base Study Vaccination Period|Patient Moved|6|||
155593225|NCT00090220|561598646|FG001|Base Study Vaccination Period|Patient Moved|2|||
155593226|NCT00090220|561598647|FG002|Base Study Vaccination Period|Patient Moved|0|||
155593227|NCT00090220|561598648|FG003|Base Study Vaccination Period|Patient Moved|0|||
155593228|NCT00090220|561598649|FG004|Base Study Vaccination Period|Patient Moved|0|||
155593229|NCT00090220|561598650|FG005|Base Study Vaccination Period|Patient Moved|0|||
155593230|NCT00090220|561598645|FG000|Base Study Vaccination Period|Other|4|||
155593231|NCT00090220|561598646|FG001|Base Study Vaccination Period|Other|4|||
155593232|NCT00090220|561598647|FG002|Base Study Vaccination Period|Other|0|||
155593233|NCT00090220|561598648|FG003|Base Study Vaccination Period|Other|0|||
155593234|NCT00090220|561598649|FG004|Base Study Vaccination Period|Other|0|||
155593235|NCT00090220|561598650|FG005|Base Study Vaccination Period|Other|0|||
155593236|NCT00090220|561598645|FG000|Base Study Follow-up Period|Adverse Event|6|||
155593237|NCT00090220|561598646|FG001|Base Study Follow-up Period|Adverse Event|1|||
155593238|NCT00090220|561598647|FG002|Base Study Follow-up Period|Adverse Event|0|||
155593239|NCT00090220|561598648|FG003|Base Study Follow-up Period|Adverse Event|0|||
155593240|NCT00090220|561598649|FG004|Base Study Follow-up Period|Adverse Event|0|||
155593241|NCT00090220|561598650|FG005|Base Study Follow-up Period|Adverse Event|0|||
155593242|NCT00090220|561598645|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
155593243|NCT00090220|561598646|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
155593244|NCT00090220|561598647|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
155593245|NCT00090220|561598648|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
155593246|NCT00090220|561598649|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
155593247|NCT00090220|561598650|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
155593248|NCT00090220|561598645|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
155593249|NCT00090220|561598646|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
155593250|NCT00090220|561598647|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
155593251|NCT00090220|561598648|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
155593252|NCT00090220|561598649|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
155593253|NCT00090220|561598650|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
155593254|NCT00090220|561598645|FG000|Base Study Follow-up Period|Patient Moved|20|||
155593255|NCT00090220|561598646|FG001|Base Study Follow-up Period|Patient Moved|28|||
155593256|NCT00090220|561598647|FG002|Base Study Follow-up Period|Patient Moved|0|||
155593257|NCT00090220|561598648|FG003|Base Study Follow-up Period|Patient Moved|0|||
155593258|NCT00090220|561598649|FG004|Base Study Follow-up Period|Patient Moved|0|||
155593259|NCT00090220|561598650|FG005|Base Study Follow-up Period|Patient Moved|0|||
155593260|NCT00090220|561598645|FG000|Base Study Follow-up Period|Other|19|||
155593261|NCT00090220|561598646|FG001|Base Study Follow-up Period|Other|21|||
155593262|NCT00090220|561598647|FG002|Base Study Follow-up Period|Other|0|||
155593263|NCT00090220|561598648|FG003|Base Study Follow-up Period|Other|0|||
155593264|NCT00090220|561598649|FG004|Base Study Follow-up Period|Other|0|||
155593265|NCT00090220|561598650|FG005|Base Study Follow-up Period|Other|0|||
155593266|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Adverse Event|0|||
155593267|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Adverse Event|0|||
155593268|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Adverse Event|4|||
155593269|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Adverse Event|0|||
155668139|NCT04419467|561880603|FG000|Overall Study|Lost to Follow-up|0|||
155668140|NCT04419467|561880604|FG001|Overall Study|Lost to Follow-up|1|||
155668141|NCT04419467|561880605|FG002|Overall Study|Lost to Follow-up|2|||
155668142|NCT04419467|561880603|FG000|Overall Study|Withdrawal by Subject|0|||
155668143|NCT04419467|561880604|FG001|Overall Study|Withdrawal by Subject|0|||
155668144|NCT04419467|561880605|FG002|Overall Study|Withdrawal by Subject|4|||
155668145|NCT04419467|561880603|FG000|Overall Study|Pandemic related|0|||
155668146|NCT04419467|561880604|FG001|Overall Study|Pandemic related|0|||
155668147|NCT04419467|561880605|FG002|Overall Study|Pandemic related|1|||
155668148|NCT04419467|561880603|FG000|Overall Study|Reason not known|1|||
155668149|NCT04419467|561880604|FG001|Overall Study|Reason not known|0|||
155668150|NCT04419467|561880605|FG002|Overall Study|Reason not known|0|||
155668151|NCT00003631|561880609|FG000|Overall Study|Patient not treated|1|||
155668152|NCT00003631|561880610|FG001|Overall Study|Patient not treated|0|||
155668153|NCT00003631|561880611|FG002|Overall Study|Patient not treated|1|||
155668154|NCT00003631|561880609|FG000|Overall Study|Protocol Violation|1|||
155668155|NCT00003631|561880610|FG001|Overall Study|Protocol Violation|0|||
155668156|NCT00003631|561880611|FG002|Overall Study|Protocol Violation|0|||
155668157|NCT00003631|561880609|FG000|Overall Study|Adverse Event|1|||
155668158|NCT00003631|561880610|FG001|Overall Study|Adverse Event|1|||
155668159|NCT00003631|561880611|FG002|Overall Study|Adverse Event|5|||
155668160|NCT00003631|561880609|FG000|Overall Study|Death|0|||
155668161|NCT00003631|561880610|FG001|Overall Study|Death|0|||
155668162|NCT00003631|561880611|FG002|Overall Study|Death|1|||
155668163|NCT00003631|561880609|FG000|Overall Study|Evaluable for toxicity only|0|||
155668164|NCT00003631|561880610|FG001|Overall Study|Evaluable for toxicity only|0|||
155668165|NCT00003631|561880611|FG002|Overall Study|Evaluable for toxicity only|2|||
155668166|NCT00600067|561880612|FG000|Overall Study|Adverse Event|0|||
155668167|NCT00600067|561880613|FG001|Overall Study|Adverse Event|1|||
155668168|NCT00600067|561880612|FG000|Overall Study|Lost to Follow-up|2|||
155668169|NCT00600067|561880613|FG001|Overall Study|Lost to Follow-up|3|||
155668170|NCT00600067|561880612|FG000|Overall Study|protocol non-compliance|0|||
155668171|NCT00600067|561880613|FG001|Overall Study|protocol non-compliance|3|||
155668172|NCT00600067|561880612|FG000|Overall Study|Lack of Efficacy|1|||
155668173|NCT00600067|561880613|FG001|Overall Study|Lack of Efficacy|0|||
155668174|NCT03943290|561880625|FG000|Overall Study|Sponsor Terminated Study|6|||
155668175|NCT03943290|561880626|FG001|Overall Study|Sponsor Terminated Study|1|||
155668176|NCT03943290|561880627|FG002|Overall Study|Sponsor Terminated Study|11|||
155668177|NCT03943290|561880628|FG003|Overall Study|Sponsor Terminated Study|6|||
155668178|NCT03943290|561880629|FG004|Overall Study|Sponsor Terminated Study|7|||
155668179|NCT03943290|561880630|FG005|Overall Study|Sponsor Terminated Study|6|||
155668180|NCT03943290|561880631|FG006|Overall Study|Sponsor Terminated Study|6|||
155668181|NCT03943290|561880632|FG007|Overall Study|Sponsor Terminated Study|7|||
155668182|NCT03943290|561880633|FG008|Overall Study|Sponsor Terminated Study|8|||
155668183|NCT03943290|561880625|FG000|Overall Study|Lost to Follow-up|1|||
155668184|NCT03943290|561880626|FG001|Overall Study|Lost to Follow-up|0|||
155668185|NCT03943290|561880627|FG002|Overall Study|Lost to Follow-up|1|||
155668186|NCT03943290|561880628|FG003|Overall Study|Lost to Follow-up|0|||
155668187|NCT03943290|561880629|FG004|Overall Study|Lost to Follow-up|0|||
155668188|NCT03943290|561880630|FG005|Overall Study|Lost to Follow-up|0|||
155668189|NCT03943290|561880631|FG006|Overall Study|Lost to Follow-up|0|||
155668190|NCT03943290|561880632|FG007|Overall Study|Lost to Follow-up|1|||
155668191|NCT03943290|561880633|FG008|Overall Study|Lost to Follow-up|0|||
155668192|NCT03943290|561880625|FG000|Overall Study|Withdrawal by Subject|0|||
155668193|NCT03943290|561880626|FG001|Overall Study|Withdrawal by Subject|0|||
155668194|NCT03943290|561880627|FG002|Overall Study|Withdrawal by Subject|1|||
155668195|NCT03943290|561880628|FG003|Overall Study|Withdrawal by Subject|0|||
155668196|NCT03943290|561880629|FG004|Overall Study|Withdrawal by Subject|0|||
155668197|NCT03943290|561880630|FG005|Overall Study|Withdrawal by Subject|0|||
155668198|NCT03943290|561880631|FG006|Overall Study|Withdrawal by Subject|0|||
155668199|NCT03943290|561880632|FG007|Overall Study|Withdrawal by Subject|0|||
155668200|NCT03943290|561880633|FG008|Overall Study|Withdrawal by Subject|0|||
155668201|NCT04819113|561880634|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155668202|NCT04819113|561880634|FG000|Overall Study|Lost to Follow-up|1|||
155668203|NCT04819113|561880634|FG000|Overall Study|Withdrawn before vaccination|2|||
155668204|NCT00437268|561880635|FG000|Overall Study|Adverse Event|1|||
155668205|NCT00437268|561880636|FG001|Overall Study|Adverse Event|1|||
155668206|NCT00437268|561880635|FG000|Overall Study|Withdrawal by Subject|2|||
155668207|NCT00437268|561880636|FG001|Overall Study|Withdrawal by Subject|2|||
155668208|NCT00437268|561880635|FG000|Overall Study|Progressive disease|9|||
155668209|NCT00437268|561880636|FG001|Overall Study|Progressive disease|9|||
155668210|NCT00437268|561880635|FG000|Overall Study|Physician Decision|1|||
155668211|NCT00437268|561880636|FG001|Overall Study|Physician Decision|0|||
155668212|NCT00437268|561880635|FG000|Overall Study|Death|0|||
155668213|NCT00437268|561880636|FG001|Overall Study|Death|1|||
155668214|NCT00444925|561880641|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
155668215|NCT00444925|561880642|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
155668216|NCT00444925|561880643|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
155593270|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Adverse Event|0|||
155593271|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Adverse Event|0|||
155593272|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
155593273|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
155593274|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
155593275|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
155593276|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
155593277|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
155593278|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Moved|0|||
155593279|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Moved|0|||
155593280|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Moved|2|||
155593281|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Moved|1|||
155593282|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Moved|0|||
155593283|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Moved|0|||
155593284|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155593285|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155593286|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
155593287|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155593288|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155593289|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155593290|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
155593291|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
155593292|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
155593293|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
155593294|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
155593295|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
155593296|NCT00090220|561598645|FG000|Extension 1 (EXT1)|Other reason|0|||
155593297|NCT00090220|561598646|FG001|Extension 1 (EXT1)|Other reason|0|||
155593298|NCT00090220|561598647|FG002|Extension 1 (EXT1)|Other reason|2|||
155593299|NCT00090220|561598648|FG003|Extension 1 (EXT1)|Other reason|0|||
155593300|NCT00090220|561598649|FG004|Extension 1 (EXT1)|Other reason|0|||
155593301|NCT00090220|561598650|FG005|Extension 1 (EXT1)|Other reason|0|||
155593302|NCT00090220|561598645|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155593303|NCT00090220|561598646|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155593304|NCT00090220|561598647|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155593305|NCT00090220|561598648|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155593306|NCT00090220|561598649|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
155593307|NCT00090220|561598650|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
155593308|NCT00090220|561598645|FG000|Long-term Follow-up (EXT2)|Death|0|||
155593309|NCT00090220|561598646|FG001|Long-term Follow-up (EXT2)|Death|0|||
155593310|NCT00090220|561598647|FG002|Long-term Follow-up (EXT2)|Death|0|||
155593311|NCT00090220|561598648|FG003|Long-term Follow-up (EXT2)|Death|0|||
155593312|NCT00090220|561598649|FG004|Long-term Follow-up (EXT2)|Death|1|||
155593313|NCT00090220|561598650|FG005|Long-term Follow-up (EXT2)|Death|1|||
155593314|NCT00090220|561598645|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155593315|NCT00090220|561598646|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155593316|NCT00090220|561598647|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155593317|NCT00090220|561598648|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155593318|NCT00090220|561598649|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
155593319|NCT00090220|561598650|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
155593320|NCT00090220|561598645|FG000|Long-term Follow-up (EXT2)|Other|0|||
155593321|NCT00090220|561598646|FG001|Long-term Follow-up (EXT2)|Other|0|||
155593322|NCT00090220|561598647|FG002|Long-term Follow-up (EXT2)|Other|0|||
155593323|NCT00090220|561598648|FG003|Long-term Follow-up (EXT2)|Other|0|||
155593324|NCT00090220|561598649|FG004|Long-term Follow-up (EXT2)|Other|1|||
155593325|NCT00090220|561598650|FG005|Long-term Follow-up (EXT2)|Other|0|||
155593326|NCT02475265|561598651|FG000|Overall Study|Physician Decision|1|||
155593327|NCT02475265|561598651|FG000|Overall Study|Withdrawal by Subject|2|||
155593328|NCT03499899|561598652|FG000|Overall Study|Adverse Event|2|||
155593329|NCT03499899|561598653|FG001|Overall Study|Adverse Event|3|||
155593330|NCT03499899|561598654|FG002|Overall Study|Adverse Event|3|||
155593331|NCT03499899|561598652|FG000|Overall Study|Death|0|||
155593332|NCT03499899|561598653|FG001|Overall Study|Death|0|||
155593333|NCT03499899|561598654|FG002|Overall Study|Death|1|||
155593334|NCT03499899|561598652|FG000|Overall Study|Physician Decision|3|||
155593335|NCT03499899|561598653|FG001|Overall Study|Physician Decision|6|||
155593336|NCT03499899|561598654|FG002|Overall Study|Physician Decision|6|||
155593337|NCT03499899|561598652|FG000|Overall Study|Progressive disease|15|||
155593338|NCT03499899|561598653|FG001|Overall Study|Progressive disease|23|||
155593339|NCT03499899|561598654|FG002|Overall Study|Progressive disease|23|||
155593340|NCT03499899|561598652|FG000|Overall Study|Patient decision|0|||
155593341|NCT03499899|561598653|FG001|Overall Study|Patient decision|1|||
155593342|NCT03499899|561598654|FG002|Overall Study|Patient decision|1|||
155593343|NCT03499899|561598652|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
155593344|NCT03499899|561598653|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
155593345|NCT03499899|561598654|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
155593346|NCT03655470|561598659|FG000|Overall Study|Lost to Follow-up|6|||
155593347|NCT03655470|561598660|FG001|Overall Study|Lost to Follow-up|7|||
155668217|NCT00444925|561880641|FG000|Double-blind Treatment Period|Death|2|||
155668218|NCT00444925|561880642|FG001|Double-blind Treatment Period|Death|0|||
155593348|NCT04590586|561598661|FG000|Overall Study|Death|7|||
155593349|NCT04590586|561598662|FG001|Overall Study|Death|1|||
155593350|NCT04590586|561598663|FG002|Overall Study|Death|37|||
155593351|NCT04590586|561598664|FG003|Overall Study|Death|34|||
155593352|NCT04590586|561598665|FG004|Overall Study|Death|19|||
155593353|NCT04590586|561598666|FG005|Overall Study|Death|3|||
155593354|NCT04590586|561598661|FG000|Overall Study|Lost to Follow-up|3|||
155593355|NCT04590586|561598662|FG001|Overall Study|Lost to Follow-up|0|||
155593356|NCT04590586|561598663|FG002|Overall Study|Lost to Follow-up|11|||
155593357|NCT04590586|561598664|FG003|Overall Study|Lost to Follow-up|11|||
155668219|NCT00444925|561880643|FG002|Double-blind Treatment Period|Death|0|||
155668220|NCT00444925|561880641|FG000|Double-blind Treatment Period|Adverse Event|6|||
155668221|NCT00444925|561880642|FG001|Double-blind Treatment Period|Adverse Event|28|||
155668222|NCT00444925|561880643|FG002|Double-blind Treatment Period|Adverse Event|44|||
155668223|NCT00444925|561880641|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
155668224|NCT00444925|561880642|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
155668225|NCT00444925|561880643|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
155668226|NCT00444925|561880641|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
155668227|NCT00444925|561880642|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
155668228|NCT00444925|561880643|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155668229|NCT00444925|561880641|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
155668230|NCT00444925|561880642|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
155668231|NCT00444925|561880643|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
155668232|NCT00444925|561880641|FG000|Double-blind Treatment Period|Other|7|||
155668233|NCT00444925|561880642|FG001|Double-blind Treatment Period|Other|7|||
155668234|NCT00444925|561880643|FG002|Double-blind Treatment Period|Other|12|||
155668235|NCT00833027|561880644|FG000|Overall Study|Adverse Event|33|||
155668236|NCT00833027|561880644|FG000|Overall Study|Death|1|||
155668237|NCT00833027|561880644|FG000|Overall Study|Lack of Efficacy|12|||
155668238|NCT00833027|561880644|FG000|Overall Study|Lost to Follow-up|24|||
155668239|NCT00833027|561880644|FG000|Overall Study|Protocol Violation|115|||
155668240|NCT00833027|561880644|FG000|Overall Study|Withdrawal by Subject|16|||
155668241|NCT00833027|561880644|FG000|Overall Study|Missing|10|||
155668242|NCT01342094|561880647|FG000|Overall Study|Adverse Event|5|||
155668243|NCT01342094|561880648|FG001|Overall Study|Adverse Event|0|||
155668244|NCT01342094|561880647|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155668245|NCT01342094|561880648|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155668246|NCT01342094|561880647|FG000|Overall Study|Withdrawal by Subject|0|||
155668247|NCT01342094|561880648|FG001|Overall Study|Withdrawal by Subject|2|||
155668248|NCT02806414|561880649|FG000|Overall Study|Lost to Follow-up|2|||
155668249|NCT05653700|561880654|FG000|Overall Study|Non Responders|9|||
155668250|NCT05653700|561880655|FG001|Overall Study|Non Responders|0|||
155668251|NCT01085214|561880658|FG000|Overall Study|Alternate treatment required|1|||
155668252|NCT01152437|561880672|FG000|Overall Study|Other Adverse Event|8|||
155593358|NCT04590586|561598665|FG004|Overall Study|Lost to Follow-up|6|||
155668253|NCT01152437|561880673|FG001|Overall Study|Other Adverse Event|1|||
155593359|NCT04590586|561598666|FG005|Overall Study|Lost to Follow-up|0|||
155593360|NCT04590586|561598661|FG000|Overall Study|Withdrawal by Subject|0|||
155593361|NCT04590586|561598662|FG001|Overall Study|Withdrawal by Subject|0|||
155593362|NCT04590586|561598663|FG002|Overall Study|Withdrawal by Subject|6|||
155593363|NCT04590586|561598664|FG003|Overall Study|Withdrawal by Subject|0|||
155593364|NCT04590586|561598665|FG004|Overall Study|Withdrawal by Subject|3|||
155593365|NCT04590586|561598666|FG005|Overall Study|Withdrawal by Subject|0|||
155593366|NCT04590586|561598661|FG000|Overall Study|Other|3|||
155593367|NCT04590586|561598662|FG001|Overall Study|Other|0|||
155593368|NCT04590586|561598663|FG002|Overall Study|Other|1|||
155593369|NCT04590586|561598664|FG003|Overall Study|Other|1|||
155593370|NCT04590586|561598665|FG004|Overall Study|Other|2|||
155593371|NCT04590586|561598666|FG005|Overall Study|Other|1|||
155593372|NCT01893281|561598667|FG000|Overall Study|Adverse Event|1|||
155593373|NCT01893281|561598667|FG000|Overall Study|Protocol Violation|1|||
155593374|NCT01893281|561598667|FG000|Overall Study|Withdrawal by Subject|1|||
155593375|NCT05481125|561598670|FG000|Overall Study|Adverse Event|1|||
155593376|NCT05481125|561598671|FG001|Overall Study|Adverse Event|0|||
155593377|NCT05481125|561598670|FG000|Overall Study|Lost to Follow-up|0|||
155593378|NCT05481125|561598671|FG001|Overall Study|Lost to Follow-up|1|||
155593379|NCT05481125|561598670|FG000|Overall Study|Withdrawal by Subject|0|||
155593380|NCT05481125|561598671|FG001|Overall Study|Withdrawal by Subject|1|||
155593381|NCT02244463|561598672|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
155593382|NCT02244463|561598673|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155593383|NCT02244463|561598674|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155593384|NCT02244463|561598675|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155593385|NCT02244463|561598676|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155593386|NCT02244463|561598677|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155593387|NCT02244463|561598672|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
155593388|NCT02244463|561598673|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
155593389|NCT02244463|561598674|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
155593390|NCT02244463|561598675|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
155593391|NCT02244463|561598676|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
155593392|NCT02244463|561598677|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
155593393|NCT02244463|561598672|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155593394|NCT02244463|561598673|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
155593395|NCT02244463|561598674|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155593396|NCT02244463|561598675|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155593397|NCT02244463|561598676|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155593398|NCT02244463|561598677|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155593399|NCT02244463|561598672|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155593400|NCT02244463|561598673|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155593401|NCT02244463|561598674|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
155593402|NCT02244463|561598675|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155593403|NCT02244463|561598676|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155593404|NCT02244463|561598677|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155593405|NCT02244463|561598672|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155593406|NCT02244463|561598673|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155593407|NCT02244463|561598674|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155593408|NCT02244463|561598675|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
155593409|NCT02244463|561598676|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155593410|NCT02244463|561598677|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155593411|NCT02244463|561598672|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155593412|NCT02244463|561598673|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155593413|NCT02244463|561598674|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155593414|NCT02244463|561598675|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
155593415|NCT02244463|561598676|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155593416|NCT02244463|561598677|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155593417|NCT02244463|561598672|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155593418|NCT02244463|561598673|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155593419|NCT02244463|561598674|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155593420|NCT02244463|561598675|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
155593421|NCT02244463|561598676|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155593422|NCT02244463|561598677|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155593423|NCT02244463|561598672|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155668254|NCT01152437|561880674|FG002|Overall Study|Other Adverse Event|7|||
155668255|NCT01152437|561880672|FG000|Overall Study|Not treated|0|||
155593424|NCT02244463|561598673|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155593425|NCT02244463|561598674|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155593426|NCT02244463|561598675|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
155668256|NCT01152437|561880673|FG001|Overall Study|Not treated|1|||
155593427|NCT02244463|561598676|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155593428|NCT02244463|561598677|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155593429|NCT02244463|561598672|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155593430|NCT02244463|561598673|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155593431|NCT02244463|561598674|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155593432|NCT02244463|561598675|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
155593433|NCT02244463|561598676|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155593434|NCT02244463|561598677|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155593435|NCT02244463|561598672|FG000|Period 5: Phase II|Disease Progression|0|||
155593436|NCT02244463|561598673|FG001|Period 5: Phase II|Disease Progression|0|||
155593437|NCT02244463|561598674|FG002|Period 5: Phase II|Disease Progression|0|||
155593438|NCT02244463|561598675|FG003|Period 5: Phase II|Disease Progression|0|||
155593439|NCT02244463|561598676|FG004|Period 5: Phase II|Disease Progression|10|||
155593440|NCT02244463|561598677|FG005|Period 5: Phase II|Disease Progression|11|||
155593441|NCT02244463|561598672|FG000|Period 5: Phase II|Physician Decision|0|||
155593442|NCT02244463|561598673|FG001|Period 5: Phase II|Physician Decision|0|||
155593443|NCT02244463|561598674|FG002|Period 5: Phase II|Physician Decision|0|||
155593444|NCT02244463|561598675|FG003|Period 5: Phase II|Physician Decision|0|||
155593445|NCT02244463|561598676|FG004|Period 5: Phase II|Physician Decision|3|||
155593446|NCT02244463|561598677|FG005|Period 5: Phase II|Physician Decision|2|||
155593447|NCT02244463|561598672|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
155593448|NCT02244463|561598673|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
155593449|NCT02244463|561598674|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
155593450|NCT02244463|561598675|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
155593451|NCT02244463|561598676|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
155593452|NCT02244463|561598677|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
155593453|NCT02244463|561598672|FG000|Period 5: Phase II|Intercurrent Illness|0|||
155593454|NCT02244463|561598673|FG001|Period 5: Phase II|Intercurrent Illness|0|||
155593455|NCT02244463|561598674|FG002|Period 5: Phase II|Intercurrent Illness|0|||
155593456|NCT02244463|561598675|FG003|Period 5: Phase II|Intercurrent Illness|0|||
155593457|NCT02244463|561598676|FG004|Period 5: Phase II|Intercurrent Illness|2|||
155593458|NCT02244463|561598677|FG005|Period 5: Phase II|Intercurrent Illness|0|||
155593459|NCT02244463|561598672|FG000|Period 5: Phase II|Adverse Event|0|||
155593460|NCT02244463|561598673|FG001|Period 5: Phase II|Adverse Event|0|||
155593461|NCT02244463|561598674|FG002|Period 5: Phase II|Adverse Event|0|||
155593462|NCT02244463|561598675|FG003|Period 5: Phase II|Adverse Event|0|||
155593463|NCT02244463|561598676|FG004|Period 5: Phase II|Adverse Event|0|||
155593464|NCT02244463|561598677|FG005|Period 5: Phase II|Adverse Event|2|||
155593465|NCT02244463|561598672|FG000|Period 5: Phase II|Still On treatment|0|||
155593466|NCT02244463|561598673|FG001|Period 5: Phase II|Still On treatment|0|||
155593467|NCT02244463|561598674|FG002|Period 5: Phase II|Still On treatment|0|||
155593468|NCT02244463|561598675|FG003|Period 5: Phase II|Still On treatment|0|||
155593469|NCT02244463|561598676|FG004|Period 5: Phase II|Still On treatment|0|||
155593470|NCT02244463|561598677|FG005|Period 5: Phase II|Still On treatment|3|||
155593471|NCT03702010|561598680|FG000|Follow-up (30days)|Lack of Efficacy|2|||
155593472|NCT03702010|561598681|FG001|Follow-up (30days)|Lack of Efficacy|2|||
155593473|NCT03474731|561598688|FG000|Overall Study|Withdrawal by Subject|36|||
155593474|NCT03474731|561598689|FG001|Overall Study|Withdrawal by Subject|29|||
155593475|NCT03474731|561598690|FG002|Overall Study|Withdrawal by Subject|11|||
155593476|NCT03474731|561598691|FG003|Overall Study|Withdrawal by Subject|27|||
155593477|NCT03474731|561598688|FG000|Overall Study|COVID|0|||
155593478|NCT03474731|561598689|FG001|Overall Study|COVID|23|||
155593479|NCT03474731|561598690|FG002|Overall Study|COVID|0|||
155593480|NCT03474731|561598691|FG003|Overall Study|COVID|0|||
155593481|NCT03474731|561598688|FG000|Overall Study|Participant moved from area|1|||
155593482|NCT03474731|561598689|FG001|Overall Study|Participant moved from area|0|||
155593483|NCT03474731|561598690|FG002|Overall Study|Participant moved from area|0|||
155593484|NCT03474731|561598691|FG003|Overall Study|Participant moved from area|0|||
155593485|NCT03474731|561598688|FG000|Overall Study|Lost to Follow-up|11|||
155593486|NCT03474731|561598689|FG001|Overall Study|Lost to Follow-up|3|||
155593487|NCT03474731|561598690|FG002|Overall Study|Lost to Follow-up|18|||
155593488|NCT03474731|561598691|FG003|Overall Study|Lost to Follow-up|17|||
155593489|NCT03474731|561598688|FG000|Overall Study|Death|0|||
155593490|NCT03474731|561598689|FG001|Overall Study|Death|1|||
155593491|NCT03474731|561598690|FG002|Overall Study|Death|0|||
155593492|NCT03474731|561598691|FG003|Overall Study|Death|0|||
155593493|NCT03474731|561598688|FG000|Overall Study|Participant Removed|0|||
155593494|NCT03474731|561598689|FG001|Overall Study|Participant Removed|0|||
155668257|NCT01152437|561880674|FG002|Overall Study|Not treated|2|||
155668258|NCT01152437|561880672|FG000|Overall Study|Progressive disease|27|||
155668259|NCT01152437|561880673|FG001|Overall Study|Progressive disease|13|||
155668260|NCT01152437|561880674|FG002|Overall Study|Progressive disease|32|||
155668261|NCT01152437|561880672|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
155668262|NCT01152437|561880673|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
155668263|NCT01152437|561880674|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
155668264|NCT01985022|561880675|FG000|Overall Study|Lost to Follow-up|0|||
155668265|NCT01985022|561880676|FG001|Overall Study|Lost to Follow-up|1|||
155668266|NCT01985022|561880675|FG000|Overall Study|Protocol Violation|0|||
155668267|NCT01985022|561880676|FG001|Overall Study|Protocol Violation|1|||
155668268|NCT01985022|561880675|FG000|Overall Study|Withdrawal by Subject|4|||
155668269|NCT01985022|561880676|FG001|Overall Study|Withdrawal by Subject|1|||
155668270|NCT00806260|561880680|FG000|Period 1 (1 Day)|Adverse Event|0|||
155668271|NCT00806260|561880681|FG001|Period 1 (1 Day)|Adverse Event|0|||
155668272|NCT00806260|561880682|FG002|Period 1 (1 Day)|Adverse Event|0|||
155668273|NCT00806260|561880683|FG003|Period 1 (1 Day)|Adverse Event|0|||
155668274|NCT00806260|561880684|FG004|Period 1 (1 Day)|Adverse Event|3|||
155668275|NCT00806260|561880685|FG005|Period 1 (1 Day)|Adverse Event|0|||
155668276|NCT00806260|561880680|FG000|Period 2|Adverse Event|0|||
155668277|NCT00806260|561880681|FG001|Period 2|Adverse Event|0|||
155593495|NCT03474731|561598690|FG002|Overall Study|Participant Removed|0|||
155593496|NCT03474731|561598691|FG003|Overall Study|Participant Removed|1|||
155593497|NCT00675428|561598693|FG000|Overall Study|Disease Progression|2|||
155593498|NCT00675428|561598694|FG001|Overall Study|Disease Progression|2|||
155593499|NCT00675428|561598693|FG000|Overall Study|No Disease Response After Cycle 6|0|||
155593500|NCT00675428|561598694|FG001|Overall Study|No Disease Response After Cycle 6|1|||
155593501|NCT00675428|561598693|FG000|Overall Study|Physician Decision|1|||
155593502|NCT00675428|561598694|FG001|Overall Study|Physician Decision|0|||
155593503|NCT00886743|561598696|FG000|Overall Study|Adverse Event|3|||
155593504|NCT00886743|561598696|FG000|Overall Study|Other|1|||
155593505|NCT04105218|561598697|FG000|Overall Study|Withdrawal by Subject|3|||
155593506|NCT04105218|561598698|FG001|Overall Study|Withdrawal by Subject|2|||
155593507|NCT04105218|561598697|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
155593508|NCT04105218|561598698|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
155593509|NCT04105218|561598697|FG000|Overall Study|Failed screening tests|2|||
155593510|NCT04105218|561598698|FG001|Overall Study|Failed screening tests|1|||
155593511|NCT00582608|561598705|FG000|Overall Study|Not Treated|7|||
155593512|NCT00582608|561598705|FG000|Overall Study|Patient Ineligible|1|||
155593513|NCT00582608|561598705|FG000|Overall Study|Lack of accrual|4|||
155593514|NCT00550043|561598709|FG000|Overall Study|Adverse Event|0|||
155593515|NCT00550043|561598710|FG001|Overall Study|Adverse Event|0|||
155593516|NCT00550043|561598711|FG002|Overall Study|Adverse Event|0|||
155593517|NCT00550043|561598712|FG003|Overall Study|Adverse Event|1|||
155593518|NCT00550043|561598713|FG004|Overall Study|Adverse Event|1|||
155593519|NCT00550043|561598709|FG000|Overall Study|Subject Withdrew Consent|0|||
155593520|NCT00550043|561598710|FG001|Overall Study|Subject Withdrew Consent|2|||
155593521|NCT00550043|561598711|FG002|Overall Study|Subject Withdrew Consent|1|||
155593522|NCT00550043|561598712|FG003|Overall Study|Subject Withdrew Consent|0|||
155593523|NCT00550043|561598713|FG004|Overall Study|Subject Withdrew Consent|0|||
155593524|NCT00550043|561598709|FG000|Overall Study|Other Reasons- Unspecified|0|||
155593525|NCT00550043|561598710|FG001|Overall Study|Other Reasons- Unspecified|1|||
155593526|NCT00550043|561598711|FG002|Overall Study|Other Reasons- Unspecified|0|||
155593527|NCT00550043|561598712|FG003|Overall Study|Other Reasons- Unspecified|1|||
155593528|NCT00550043|561598713|FG004|Overall Study|Other Reasons- Unspecified|0|||
155593529|NCT00789698|561598714|FG000|Overall Study|Lack of Efficacy|10|||
155593530|NCT00789698|561598715|FG001|Overall Study|Lack of Efficacy|4|||
155593531|NCT00789698|561598716|FG002|Overall Study|Lack of Efficacy|5|||
155593532|NCT00789698|561598717|FG003|Overall Study|Lack of Efficacy|18|||
155593533|NCT00789698|561598714|FG000|Overall Study|Adverse Event|5|||
155593534|NCT00789698|561598715|FG001|Overall Study|Adverse Event|5|||
155593535|NCT00789698|561598716|FG002|Overall Study|Adverse Event|3|||
155593536|NCT00789698|561598717|FG003|Overall Study|Adverse Event|4|||
155593537|NCT00789698|561598714|FG000|Overall Study|Lost to Follow-up|5|||
155593538|NCT00789698|561598715|FG001|Overall Study|Lost to Follow-up|5|||
155593539|NCT00789698|561598716|FG002|Overall Study|Lost to Follow-up|2|||
155593540|NCT00789698|561598717|FG003|Overall Study|Lost to Follow-up|9|||
155593541|NCT00789698|561598714|FG000|Overall Study|Protocol Violation|6|||
155593542|NCT00789698|561598715|FG001|Overall Study|Protocol Violation|1|||
155593543|NCT00789698|561598716|FG002|Overall Study|Protocol Violation|2|||
155593544|NCT00789698|561598717|FG003|Overall Study|Protocol Violation|1|||
155593545|NCT00789698|561598714|FG000|Overall Study|Withdrawal by Subject|14|||
155668278|NCT00806260|561880682|FG002|Period 2|Adverse Event|0|||
155668279|NCT00806260|561880683|FG003|Period 2|Adverse Event|1|||
155593546|NCT00789698|561598715|FG001|Overall Study|Withdrawal by Subject|15|||
155593547|NCT00789698|561598716|FG002|Overall Study|Withdrawal by Subject|12|||
155668280|NCT00806260|561880684|FG004|Period 2|Adverse Event|0|||
155668281|NCT00806260|561880685|FG005|Period 2|Adverse Event|0|||
155668282|NCT00806260|561880680|FG000|Period 2|Protocol Violation|1|||
155593548|NCT00789698|561598717|FG003|Overall Study|Withdrawal by Subject|19|||
155593549|NCT00789698|561598714|FG000|Overall Study|Administrative|0|||
155593550|NCT00789698|561598715|FG001|Overall Study|Administrative|3|||
155593551|NCT00789698|561598716|FG002|Overall Study|Administrative|3|||
155593552|NCT00789698|561598717|FG003|Overall Study|Administrative|1|||
155593553|NCT01870973|561598718|FG000|Overall Study|Lost to Follow-up|10|||
155593554|NCT01870973|561598719|FG001|Overall Study|Lost to Follow-up|3|||
155593555|NCT01314872|561598720|FG000|Treatment Period 1|Protocol Violation|2|||
155593556|NCT01314872|561598721|FG001|Treatment Period 1|Protocol Violation|1|||
155593557|NCT01314872|561598722|FG002|Treatment Period 1|Protocol Violation|1|||
155593558|NCT01314872|561598723|FG003|Treatment Period 1|Protocol Violation|0|||
155593559|NCT01314872|561598724|FG004|Treatment Period 1|Protocol Violation|1|||
155593560|NCT01314872|561598725|FG005|Treatment Period 1|Protocol Violation|0|||
155593561|NCT01314872|561598726|FG006|Treatment Period 1|Protocol Violation|0|||
155593562|NCT01314872|561598727|FG007|Treatment Period 1|Protocol Violation|0|||
155593563|NCT01314872|561598728|FG008|Treatment Period 1|Protocol Violation|0|||
155593564|NCT01314872|561598729|FG009|Treatment Period 1|Protocol Violation|1|||
155593565|NCT01314872|561598730|FG010|Treatment Period 1|Protocol Violation|1|||
155593566|NCT01314872|561598731|FG011|Treatment Period 1|Protocol Violation|0|||
155593567|NCT01314872|561598732|FG012|Treatment Period 1|Protocol Violation|0|||
155593568|NCT01314872|561598733|FG013|Treatment Period 1|Protocol Violation|0|||
155593569|NCT01314872|561598734|FG014|Treatment Period 1|Protocol Violation|0|||
155593570|NCT01314872|561598720|FG000|Treatment Period 1|Physician Decision|0|||
155593571|NCT01314872|561598721|FG001|Treatment Period 1|Physician Decision|1|||
155593572|NCT01314872|561598722|FG002|Treatment Period 1|Physician Decision|0|||
155593573|NCT01314872|561598723|FG003|Treatment Period 1|Physician Decision|1|||
155593574|NCT01314872|561598724|FG004|Treatment Period 1|Physician Decision|0|||
155593575|NCT01314872|561598725|FG005|Treatment Period 1|Physician Decision|0|||
155593576|NCT01314872|561598726|FG006|Treatment Period 1|Physician Decision|0|||
155593577|NCT01314872|561598727|FG007|Treatment Period 1|Physician Decision|0|||
155593578|NCT01314872|561598728|FG008|Treatment Period 1|Physician Decision|0|||
155593579|NCT01314872|561598729|FG009|Treatment Period 1|Physician Decision|1|||
155593580|NCT01314872|561598730|FG010|Treatment Period 1|Physician Decision|0|||
155593581|NCT01314872|561598731|FG011|Treatment Period 1|Physician Decision|0|||
155593582|NCT01314872|561598732|FG012|Treatment Period 1|Physician Decision|0|||
155593583|NCT01314872|561598733|FG013|Treatment Period 1|Physician Decision|0|||
155593584|NCT01314872|561598734|FG014|Treatment Period 1|Physician Decision|0|||
155593585|NCT01314872|561598720|FG000|Treatment Period 1|Lack of Efficacy|1|||
155593586|NCT01314872|561598721|FG001|Treatment Period 1|Lack of Efficacy|0|||
155593587|NCT01314872|561598722|FG002|Treatment Period 1|Lack of Efficacy|0|||
155593588|NCT01314872|561598723|FG003|Treatment Period 1|Lack of Efficacy|0|||
155593589|NCT01314872|561598724|FG004|Treatment Period 1|Lack of Efficacy|0|||
155593590|NCT01314872|561598725|FG005|Treatment Period 1|Lack of Efficacy|1|||
155593591|NCT01314872|561598726|FG006|Treatment Period 1|Lack of Efficacy|0|||
155593592|NCT01314872|561598727|FG007|Treatment Period 1|Lack of Efficacy|2|||
155593593|NCT01314872|561598728|FG008|Treatment Period 1|Lack of Efficacy|0|||
155593594|NCT01314872|561598729|FG009|Treatment Period 1|Lack of Efficacy|0|||
155593595|NCT01314872|561598730|FG010|Treatment Period 1|Lack of Efficacy|0|||
155593596|NCT01314872|561598731|FG011|Treatment Period 1|Lack of Efficacy|0|||
155593597|NCT01314872|561598732|FG012|Treatment Period 1|Lack of Efficacy|0|||
155668283|NCT00806260|561880681|FG001|Period 2|Protocol Violation|0|||
155668284|NCT00806260|561880682|FG002|Period 2|Protocol Violation|1|||
155668285|NCT00806260|561880683|FG003|Period 2|Protocol Violation|0|||
155668286|NCT00806260|561880684|FG004|Period 2|Protocol Violation|0|||
155668287|NCT00806260|561880685|FG005|Period 2|Protocol Violation|0|||
155668288|NCT00806260|561880680|FG000|Period 2|Need to take concomitant medication|1|||
155668289|NCT00806260|561880681|FG001|Period 2|Need to take concomitant medication|0|||
155668290|NCT00806260|561880682|FG002|Period 2|Need to take concomitant medication|0|||
155668291|NCT00806260|561880683|FG003|Period 2|Need to take concomitant medication|0|||
155668292|NCT00806260|561880684|FG004|Period 2|Need to take concomitant medication|0|||
155668293|NCT00806260|561880685|FG005|Period 2|Need to take concomitant medication|0|||
155668294|NCT00806260|561880680|FG000|Period 2|sponsor request|0|||
155668295|NCT00806260|561880681|FG001|Period 2|sponsor request|0|||
155668296|NCT00806260|561880682|FG002|Period 2|sponsor request|1|||
155668297|NCT00806260|561880683|FG003|Period 2|sponsor request|1|||
155668298|NCT00806260|561880684|FG004|Period 2|sponsor request|0|||
155668299|NCT00806260|561880685|FG005|Period 2|sponsor request|0|||
155668300|NCT00806260|561880680|FG000|Period 3|Protocol Violation|0|||
155668301|NCT00806260|561880681|FG001|Period 3|Protocol Violation|1|||
155668302|NCT00806260|561880682|FG002|Period 3|Protocol Violation|1|||
155668303|NCT00806260|561880683|FG003|Period 3|Protocol Violation|0|||
155668304|NCT00806260|561880684|FG004|Period 3|Protocol Violation|0|||
155593598|NCT01314872|561598733|FG013|Treatment Period 1|Lack of Efficacy|0|||
155593599|NCT01314872|561598734|FG014|Treatment Period 1|Lack of Efficacy|0|||
155593600|NCT01314872|561598720|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
155593601|NCT01314872|561598721|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
155593602|NCT01314872|561598722|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
155593603|NCT01314872|561598723|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
155593604|NCT01314872|561598724|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
155593605|NCT01314872|561598725|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
155593606|NCT01314872|561598726|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
155593607|NCT01314872|561598727|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
155593608|NCT01314872|561598728|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
155593609|NCT01314872|561598729|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
155593610|NCT01314872|561598730|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
155593611|NCT01314872|561598731|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
155593612|NCT01314872|561598732|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
155593613|NCT01314872|561598733|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
155593614|NCT01314872|561598734|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
155593615|NCT01314872|561598720|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155593616|NCT01314872|561598721|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155593617|NCT01314872|561598722|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155593618|NCT01314872|561598723|FG003|Treatment Period 1|Withdrawal by Subject|2|||
155593619|NCT01314872|561598724|FG004|Treatment Period 1|Withdrawal by Subject|3|||
155593620|NCT01314872|561598725|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155593621|NCT01314872|561598726|FG006|Treatment Period 1|Withdrawal by Subject|3|||
155593622|NCT01314872|561598727|FG007|Treatment Period 1|Withdrawal by Subject|2|||
155593623|NCT01314872|561598728|FG008|Treatment Period 1|Withdrawal by Subject|2|||
155593624|NCT01314872|561598729|FG009|Treatment Period 1|Withdrawal by Subject|2|||
155593625|NCT01314872|561598730|FG010|Treatment Period 1|Withdrawal by Subject|1|||
155593626|NCT01314872|561598731|FG011|Treatment Period 1|Withdrawal by Subject|0|||
155593627|NCT01314872|561598732|FG012|Treatment Period 1|Withdrawal by Subject|0|||
155593628|NCT01314872|561598733|FG013|Treatment Period 1|Withdrawal by Subject|0|||
155593629|NCT01314872|561598734|FG014|Treatment Period 1|Withdrawal by Subject|0|||
155593630|NCT01314872|561598720|FG000|Treatment Period 1|Lost to Follow-up|0|||
155593631|NCT01314872|561598721|FG001|Treatment Period 1|Lost to Follow-up|1|||
155593632|NCT01314872|561598722|FG002|Treatment Period 1|Lost to Follow-up|2|||
155593633|NCT01314872|561598723|FG003|Treatment Period 1|Lost to Follow-up|2|||
155593634|NCT01314872|561598724|FG004|Treatment Period 1|Lost to Follow-up|1|||
155593635|NCT01314872|561598725|FG005|Treatment Period 1|Lost to Follow-up|1|||
155593636|NCT01314872|561598726|FG006|Treatment Period 1|Lost to Follow-up|1|||
155593637|NCT01314872|561598727|FG007|Treatment Period 1|Lost to Follow-up|1|||
155593638|NCT01314872|561598728|FG008|Treatment Period 1|Lost to Follow-up|1|||
155593639|NCT01314872|561598729|FG009|Treatment Period 1|Lost to Follow-up|0|||
155593640|NCT01314872|561598730|FG010|Treatment Period 1|Lost to Follow-up|0|||
155593641|NCT01314872|561598731|FG011|Treatment Period 1|Lost to Follow-up|0|||
155593642|NCT01314872|561598732|FG012|Treatment Period 1|Lost to Follow-up|0|||
155593643|NCT01314872|561598733|FG013|Treatment Period 1|Lost to Follow-up|0|||
155593644|NCT01314872|561598734|FG014|Treatment Period 1|Lost to Follow-up|0|||
155593645|NCT01314872|561598720|FG000|Period 2|Protocol Violation|0|||
155593646|NCT01314872|561598721|FG001|Period 2|Protocol Violation|0|||
155593647|NCT01314872|561598722|FG002|Period 2|Protocol Violation|0|||
155593648|NCT01314872|561598723|FG003|Period 2|Protocol Violation|0|||
155593649|NCT01314872|561598724|FG004|Period 2|Protocol Violation|0|||
155593650|NCT01314872|561598725|FG005|Period 2|Protocol Violation|0|||
155593651|NCT01314872|561598726|FG006|Period 2|Protocol Violation|0|||
155593652|NCT01314872|561598727|FG007|Period 2|Protocol Violation|0|||
155593653|NCT01314872|561598728|FG008|Period 2|Protocol Violation|0|||
155593654|NCT01314872|561598729|FG009|Period 2|Protocol Violation|0|||
155593655|NCT01314872|561598730|FG010|Period 2|Protocol Violation|0|||
155593656|NCT01314872|561598731|FG011|Period 2|Protocol Violation|3|||
155593657|NCT01314872|561598732|FG012|Period 2|Protocol Violation|3|||
155593658|NCT01314872|561598733|FG013|Period 2|Protocol Violation|2|||
155593659|NCT01314872|561598734|FG014|Period 2|Protocol Violation|0|||
155593660|NCT01314872|561598720|FG000|Period 2|Non-compliance with study drug|0|||
155593661|NCT01314872|561598721|FG001|Period 2|Non-compliance with study drug|0|||
155593662|NCT01314872|561598722|FG002|Period 2|Non-compliance with study drug|0|||
155593663|NCT01314872|561598723|FG003|Period 2|Non-compliance with study drug|0|||
155593664|NCT01314872|561598724|FG004|Period 2|Non-compliance with study drug|0|||
155593665|NCT01314872|561598725|FG005|Period 2|Non-compliance with study drug|0|||
155593666|NCT01314872|561598726|FG006|Period 2|Non-compliance with study drug|0|||
155593667|NCT01314872|561598727|FG007|Period 2|Non-compliance with study drug|0|||
155593668|NCT01314872|561598728|FG008|Period 2|Non-compliance with study drug|0|||
155668305|NCT00806260|561880685|FG005|Period 3|Protocol Violation|0|||
155668306|NCT00806260|561880680|FG000|Period 3|Pregnancy|1|||
155668307|NCT00806260|561880681|FG001|Period 3|Pregnancy|0|||
155668308|NCT00806260|561880682|FG002|Period 3|Pregnancy|0|||
155668309|NCT00806260|561880683|FG003|Period 3|Pregnancy|0|||
155668310|NCT00806260|561880684|FG004|Period 3|Pregnancy|0|||
155668311|NCT00806260|561880685|FG005|Period 3|Pregnancy|0|||
155668312|NCT01074931|561880686|FG000|Overall Study|Economic reasons|1|||
155668313|NCT01074931|561880686|FG000|Overall Study|Death|5|||
155668314|NCT05223673|561880687|FG000|Overall Study|Protocol Violation|1|||
155668315|NCT05223673|561880687|FG000|Overall Study|Study termination|6|||
155668316|NCT01088906|561880688|FG000|Overall Study|Inclusion error|1|||
155668317|NCT01088906|561880688|FG000|Overall Study|Did not receive study treatment|3|||
155668318|NCT01088906|561880688|FG000|Overall Study|Missing data|1|||
155668319|NCT00457626|561880689|FG000|Overall Study|Adverse Event|3|||
155668320|NCT00457626|561880689|FG000|Overall Study|Administrative Problems|2|||
155668321|NCT00457626|561880689|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
155668322|NCT00532129|561882147|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
155668323|NCT00532129|561882147|FG000|Treatment Period|Physician Decision|15|||
155668324|NCT00532129|561882147|FG000|Treatment Period|Disease progression|3|||
155668325|NCT00532129|561882147|FG000|Treatment Period|Protocol Violation|1|||
155668326|NCT00532129|561882147|FG000|Treatment Period|Other|5|||
155668327|NCT00532129|561882147|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
155668328|NCT00532129|561882147|FG000|Follow-up Period|Disease progression|57|||
155668329|NCT00532129|561882147|FG000|Follow-up Period|Lost to Follow-up|1|||
155668330|NCT00532129|561882147|FG000|Follow-up Period|Other|6|||
155668331|NCT03145064|561882148|FG000|Overall Study|Death|24|||
155668332|NCT03145064|561882148|FG000|Overall Study|Lost to Follow-up|3|||
155668333|NCT03145064|561882148|FG000|Overall Study|Withdrawal by Subject|6|||
155668334|NCT03145064|561882148|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
155668335|NCT03145064|561882148|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
155668336|NCT00661830|561882149|FG000|Overall Study|Death|37|||
155668337|NCT00661830|561882150|FG001|Overall Study|Death|33|||
155668338|NCT00661830|561882149|FG000|Overall Study|Lost to Follow-up|1|||
155668339|NCT00661830|561882150|FG001|Overall Study|Lost to Follow-up|3|||
155668340|NCT00661830|561882149|FG000|Overall Study|Withdrawal by Subject|1|||
155668341|NCT00661830|561882150|FG001|Overall Study|Withdrawal by Subject|1|||
155668342|NCT00661830|561882149|FG000|Overall Study|Other reason|1|||
155668343|NCT00661830|561882150|FG001|Overall Study|Other reason|5|||
155668344|NCT00551031|561882154|FG000|Overall Study|Adverse Event|0|||
155668345|NCT00551031|561882155|FG001|Overall Study|Adverse Event|1|||
155668346|NCT00551031|561882156|FG002|Overall Study|Adverse Event|0|||
155668347|NCT00551031|561882157|FG003|Overall Study|Adverse Event|0|||
155668348|NCT00551031|561882158|FG004|Overall Study|Adverse Event|0|||
155668349|NCT00551031|561882154|FG000|Overall Study|Protocol Violation|1|||
155668350|NCT00551031|561882155|FG001|Overall Study|Protocol Violation|1|||
155668351|NCT00551031|561882156|FG002|Overall Study|Protocol Violation|0|||
155668352|NCT00551031|561882157|FG003|Overall Study|Protocol Violation|0|||
155668353|NCT00551031|561882158|FG004|Overall Study|Protocol Violation|0|||
155668354|NCT00551031|561882154|FG000|Overall Study|Lost to Follow-up|0|||
155668355|NCT00551031|561882155|FG001|Overall Study|Lost to Follow-up|1|||
155668356|NCT00551031|561882156|FG002|Overall Study|Lost to Follow-up|0|||
155668357|NCT00551031|561882157|FG003|Overall Study|Lost to Follow-up|1|||
155668358|NCT00551031|561882158|FG004|Overall Study|Lost to Follow-up|1|||
155668359|NCT00551031|561882154|FG000|Overall Study|Withdrawal by Subject|0|||
155668360|NCT00551031|561882155|FG001|Overall Study|Withdrawal by Subject|4|||
155668361|NCT00551031|561882156|FG002|Overall Study|Withdrawal by Subject|1|||
155668362|NCT00551031|561882157|FG003|Overall Study|Withdrawal by Subject|2|||
155668363|NCT00551031|561882158|FG004|Overall Study|Withdrawal by Subject|0|||
155668364|NCT00551031|561882154|FG000|Overall Study|Serious Adverse Event|0|||
155668365|NCT00551031|561882155|FG001|Overall Study|Serious Adverse Event|2|||
155668366|NCT00551031|561882156|FG002|Overall Study|Serious Adverse Event|1|||
155668367|NCT00551031|561882157|FG003|Overall Study|Serious Adverse Event|0|||
155668368|NCT00551031|561882158|FG004|Overall Study|Serious Adverse Event|0|||
155668369|NCT00551031|561882154|FG000|Overall Study|Did not receive vaccine|1|||
155668370|NCT00551031|561882155|FG001|Overall Study|Did not receive vaccine|2|||
155668371|NCT00551031|561882156|FG002|Overall Study|Did not receive vaccine|0|||
155668372|NCT00551031|561882157|FG003|Overall Study|Did not receive vaccine|0|||
155668373|NCT00551031|561882158|FG004|Overall Study|Did not receive vaccine|0|||
155668374|NCT01650831|561882162|FG000|Overall Study|Screen failure|1|||
155668375|NCT02964273|561882163|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
155668376|NCT02964273|561882164|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155668377|NCT02964273|561882165|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155668378|NCT02964273|561882166|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155668379|NCT02964273|561882163|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155668380|NCT02964273|561882164|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
155668381|NCT02964273|561882165|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155668382|NCT02964273|561882166|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155668383|NCT02964273|561882163|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
155668384|NCT02964273|561882164|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
155668385|NCT02964273|561882165|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
155668386|NCT02964273|561882166|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
155668387|NCT02964273|561882163|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155668388|NCT02964273|561882164|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155668389|NCT02964273|561882165|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155668390|NCT02964273|561882166|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
155668391|NCT02964273|561882163|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
155668392|NCT02964273|561882164|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
155668393|NCT02964273|561882165|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
155668394|NCT02964273|561882166|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
155668395|NCT02964273|561882163|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
155668396|NCT02964273|561882164|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
155668397|NCT02964273|561882165|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
155668398|NCT02964273|561882166|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
155668399|NCT01336712|561882168|FG000|Overall Study|Death|2|||
155668400|NCT01336712|561882168|FG000|Overall Study|Lack of Efficacy|1|||
155668401|NCT03462758|561882170|FG000|Overall Study|Chose no or other method of contraception|20|||
155668402|NCT03462758|561882171|FG001|Overall Study|Chose no or other method of contraception|23|||
155668403|NCT03462758|561882170|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
155668404|NCT03462758|561882171|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
155668405|NCT03462758|561882170|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
155668406|NCT03462758|561882171|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
155668407|NCT03462758|561882170|FG000|Overall Study|Medical contraindication|2|||
155668408|NCT03462758|561882171|FG001|Overall Study|Medical contraindication|2|||
155668409|NCT03462758|561882170|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
155668410|NCT03462758|561882171|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
155668411|NCT00413660|561882172|FG000|Up To Week 12|Adverse Event|1|||
155668412|NCT00413660|561882173|FG001|Up To Week 12|Adverse Event|3|||
155668413|NCT00413660|561882174|FG002|Up To Week 12|Adverse Event|1|||
155668414|NCT00413660|561882175|FG003|Up To Week 12|Adverse Event|4|||
155668415|NCT00413660|561882176|FG004|Up To Week 12|Adverse Event|6|||
155668416|NCT00413660|561882177|FG005|Up To Week 12|Adverse Event|4|||
155668417|NCT00413660|561882178|FG006|Up To Week 12|Adverse Event|1|||
155668418|NCT00413660|561882179|FG007|Up To Week 12|Adverse Event|0|||
155668419|NCT00413660|561882180|FG008|Up To Week 12|Adverse Event|0|||
155668420|NCT00413660|561882181|FG009|Up To Week 12|Adverse Event|0|||
155668421|NCT00413660|561882182|FG010|Up To Week 12|Adverse Event|0|||
155668422|NCT00413660|561882172|FG000|Up To Week 12|Lack of Efficacy|2|||
155668423|NCT00413660|561882173|FG001|Up To Week 12|Lack of Efficacy|0|||
155668424|NCT00413660|561882174|FG002|Up To Week 12|Lack of Efficacy|0|||
155668425|NCT00413660|561882175|FG003|Up To Week 12|Lack of Efficacy|0|||
155668426|NCT00413660|561882176|FG004|Up To Week 12|Lack of Efficacy|0|||
155668427|NCT00413660|561882177|FG005|Up To Week 12|Lack of Efficacy|0|||
155668428|NCT00413660|561882178|FG006|Up To Week 12|Lack of Efficacy|5|||
155668429|NCT00413660|561882179|FG007|Up To Week 12|Lack of Efficacy|0|||
155668430|NCT00413660|561882180|FG008|Up To Week 12|Lack of Efficacy|0|||
155668431|NCT00413660|561882181|FG009|Up To Week 12|Lack of Efficacy|0|||
155668432|NCT00413660|561882182|FG010|Up To Week 12|Lack of Efficacy|0|||
155668433|NCT00413660|561882172|FG000|Up To Week 12|Lost to Follow-up|0|||
155668434|NCT00413660|561882173|FG001|Up To Week 12|Lost to Follow-up|1|||
155668435|NCT00413660|561882174|FG002|Up To Week 12|Lost to Follow-up|0|||
155668436|NCT00413660|561882175|FG003|Up To Week 12|Lost to Follow-up|0|||
155668437|NCT00413660|561882176|FG004|Up To Week 12|Lost to Follow-up|1|||
155668438|NCT00413660|561882177|FG005|Up To Week 12|Lost to Follow-up|0|||
155668439|NCT00413660|561882178|FG006|Up To Week 12|Lost to Follow-up|0|||
155668440|NCT00413660|561882179|FG007|Up To Week 12|Lost to Follow-up|0|||
155668441|NCT00413660|561882180|FG008|Up To Week 12|Lost to Follow-up|0|||
155668442|NCT00413660|561882181|FG009|Up To Week 12|Lost to Follow-up|0|||
155668443|NCT00413660|561882182|FG010|Up To Week 12|Lost to Follow-up|0|||
155668444|NCT00413660|561882172|FG000|Up To Week 12|Withdrawal by Subject|0|||
155668445|NCT00413660|561882173|FG001|Up To Week 12|Withdrawal by Subject|2|||
155668446|NCT00413660|561882174|FG002|Up To Week 12|Withdrawal by Subject|0|||
155668447|NCT00413660|561882175|FG003|Up To Week 12|Withdrawal by Subject|2|||
155668448|NCT00413660|561882176|FG004|Up To Week 12|Withdrawal by Subject|0|||
155668449|NCT00413660|561882177|FG005|Up To Week 12|Withdrawal by Subject|2|||
155668450|NCT00413660|561882178|FG006|Up To Week 12|Withdrawal by Subject|2|||
155668451|NCT00413660|561882179|FG007|Up To Week 12|Withdrawal by Subject|0|||
155668452|NCT00413660|561882180|FG008|Up To Week 12|Withdrawal by Subject|0|||
155668453|NCT00413660|561882181|FG009|Up To Week 12|Withdrawal by Subject|0|||
155668454|NCT00413660|561882182|FG010|Up To Week 12|Withdrawal by Subject|0|||
155668455|NCT00413660|561882172|FG000|Up To Week 12|Randomized, Not Treated|1|||
155593669|NCT01314872|561598729|FG009|Period 2|Non-compliance with study drug|0|||
155593670|NCT01314872|561598730|FG010|Period 2|Non-compliance with study drug|0|||
155593671|NCT01314872|561598731|FG011|Period 2|Non-compliance with study drug|3|||
155593672|NCT01314872|561598732|FG012|Period 2|Non-compliance with study drug|3|||
155593673|NCT01314872|561598733|FG013|Period 2|Non-compliance with study drug|1|||
155593674|NCT01314872|561598734|FG014|Period 2|Non-compliance with study drug|2|||
155593675|NCT01314872|561598720|FG000|Period 2|Lack of Efficacy|0|||
155593676|NCT01314872|561598721|FG001|Period 2|Lack of Efficacy|0|||
155593677|NCT01314872|561598722|FG002|Period 2|Lack of Efficacy|0|||
155593678|NCT01314872|561598723|FG003|Period 2|Lack of Efficacy|0|||
155593679|NCT01314872|561598724|FG004|Period 2|Lack of Efficacy|0|||
155593680|NCT01314872|561598725|FG005|Period 2|Lack of Efficacy|0|||
155593681|NCT01314872|561598726|FG006|Period 2|Lack of Efficacy|0|||
155593682|NCT01314872|561598727|FG007|Period 2|Lack of Efficacy|0|||
155593683|NCT01314872|561598728|FG008|Period 2|Lack of Efficacy|0|||
155668456|NCT00413660|561882173|FG001|Up To Week 12|Randomized, Not Treated|0|||
155593684|NCT01314872|561598729|FG009|Period 2|Lack of Efficacy|0|||
155593685|NCT01314872|561598730|FG010|Period 2|Lack of Efficacy|0|||
155593686|NCT01314872|561598731|FG011|Period 2|Lack of Efficacy|7|||
155593687|NCT01314872|561598732|FG012|Period 2|Lack of Efficacy|12|||
155593688|NCT01314872|561598733|FG013|Period 2|Lack of Efficacy|9|||
155593689|NCT01314872|561598734|FG014|Period 2|Lack of Efficacy|2|||
155668457|NCT00413660|561882174|FG002|Up To Week 12|Randomized, Not Treated|0|||
155668458|NCT00413660|561882175|FG003|Up To Week 12|Randomized, Not Treated|1|||
155668459|NCT00413660|561882176|FG004|Up To Week 12|Randomized, Not Treated|0|||
155668460|NCT00413660|561882177|FG005|Up To Week 12|Randomized, Not Treated|0|||
155668461|NCT00413660|561882178|FG006|Up To Week 12|Randomized, Not Treated|0|||
155668462|NCT00413660|561882179|FG007|Up To Week 12|Randomized, Not Treated|0|||
155668463|NCT00413660|561882180|FG008|Up To Week 12|Randomized, Not Treated|0|||
155668464|NCT00413660|561882181|FG009|Up To Week 12|Randomized, Not Treated|0|||
155668465|NCT00413660|561882182|FG010|Up To Week 12|Randomized, Not Treated|0|||
155668466|NCT00413660|561882172|FG000|Up To Week 12|Other|3|||
155668467|NCT00413660|561882173|FG001|Up To Week 12|Other|1|||
155668468|NCT00413660|561882174|FG002|Up To Week 12|Other|6|||
155668469|NCT00413660|561882175|FG003|Up To Week 12|Other|1|||
155668470|NCT00413660|561882176|FG004|Up To Week 12|Other|2|||
155668471|NCT00413660|561882177|FG005|Up To Week 12|Other|4|||
155668472|NCT00413660|561882178|FG006|Up To Week 12|Other|3|||
155668473|NCT00413660|561882179|FG007|Up To Week 12|Other|0|||
155668474|NCT00413660|561882180|FG008|Up To Week 12|Other|0|||
155668475|NCT00413660|561882181|FG009|Up To Week 12|Other|0|||
155668476|NCT00413660|561882182|FG010|Up To Week 12|Other|0|||
155668477|NCT00413660|561882172|FG000|Post Week 12|Adverse Event|2|||
155668478|NCT00413660|561882173|FG001|Post Week 12|Adverse Event|0|||
155668479|NCT00413660|561882174|FG002|Post Week 12|Adverse Event|2|||
155668480|NCT00413660|561882175|FG003|Post Week 12|Adverse Event|1|||
155668481|NCT00413660|561882176|FG004|Post Week 12|Adverse Event|4|||
155668482|NCT00413660|561882177|FG005|Post Week 12|Adverse Event|2|||
155668483|NCT00413660|561882178|FG006|Post Week 12|Adverse Event|2|||
155668484|NCT00413660|561882179|FG007|Post Week 12|Adverse Event|0|||
155668485|NCT00413660|561882180|FG008|Post Week 12|Adverse Event|0|||
155668486|NCT00413660|561882181|FG009|Post Week 12|Adverse Event|0|||
155668487|NCT00413660|561882182|FG010|Post Week 12|Adverse Event|0|||
155668488|NCT00413660|561882172|FG000|Post Week 12|Lack of Efficacy|0|||
155668489|NCT00413660|561882173|FG001|Post Week 12|Lack of Efficacy|0|||
155668490|NCT00413660|561882174|FG002|Post Week 12|Lack of Efficacy|1|||
155668491|NCT00413660|561882175|FG003|Post Week 12|Lack of Efficacy|0|||
155668492|NCT00413660|561882176|FG004|Post Week 12|Lack of Efficacy|0|||
155668493|NCT00413660|561882177|FG005|Post Week 12|Lack of Efficacy|0|||
155668494|NCT00413660|561882178|FG006|Post Week 12|Lack of Efficacy|0|||
155668495|NCT00413660|561882179|FG007|Post Week 12|Lack of Efficacy|0|||
155668496|NCT00413660|561882180|FG008|Post Week 12|Lack of Efficacy|0|||
155668497|NCT00413660|561882181|FG009|Post Week 12|Lack of Efficacy|1|||
155668498|NCT00413660|561882182|FG010|Post Week 12|Lack of Efficacy|0|||
155668499|NCT00413660|561882172|FG000|Post Week 12|Lost to Follow-up|0|||
155668500|NCT00413660|561882173|FG001|Post Week 12|Lost to Follow-up|1|||
155668501|NCT00413660|561882174|FG002|Post Week 12|Lost to Follow-up|1|||
155668502|NCT00413660|561882175|FG003|Post Week 12|Lost to Follow-up|0|||
155668503|NCT00413660|561882176|FG004|Post Week 12|Lost to Follow-up|0|||
155668504|NCT00413660|561882177|FG005|Post Week 12|Lost to Follow-up|0|||
155668505|NCT00413660|561882178|FG006|Post Week 12|Lost to Follow-up|0|||
155668506|NCT00413660|561882179|FG007|Post Week 12|Lost to Follow-up|0|||
155668507|NCT00413660|561882180|FG008|Post Week 12|Lost to Follow-up|0|||
155668508|NCT00413660|561882181|FG009|Post Week 12|Lost to Follow-up|0|||
155668509|NCT00413660|561882182|FG010|Post Week 12|Lost to Follow-up|0|||
155668510|NCT00413660|561882172|FG000|Post Week 12|Withdrawal by Subject|0|||
155668511|NCT00413660|561882173|FG001|Post Week 12|Withdrawal by Subject|1|||
155668512|NCT00413660|561882174|FG002|Post Week 12|Withdrawal by Subject|1|||
155668513|NCT00413660|561882175|FG003|Post Week 12|Withdrawal by Subject|0|||
155668514|NCT00413660|561882176|FG004|Post Week 12|Withdrawal by Subject|1|||
155668515|NCT00413660|561882177|FG005|Post Week 12|Withdrawal by Subject|0|||
155668516|NCT00413660|561882178|FG006|Post Week 12|Withdrawal by Subject|0|||
155668517|NCT00413660|561882179|FG007|Post Week 12|Withdrawal by Subject|0|||
155668518|NCT00413660|561882180|FG008|Post Week 12|Withdrawal by Subject|0|||
155668519|NCT00413660|561882181|FG009|Post Week 12|Withdrawal by Subject|0|||
155668520|NCT00413660|561882182|FG010|Post Week 12|Withdrawal by Subject|1|||
155668521|NCT00413660|561882172|FG000|Post Week 12|Other|1|||
155668522|NCT00413660|561882173|FG001|Post Week 12|Other|2|||
155668523|NCT00413660|561882174|FG002|Post Week 12|Other|3|||
155668524|NCT00413660|561882175|FG003|Post Week 12|Other|0|||
155668525|NCT00413660|561882176|FG004|Post Week 12|Other|1|||
155668526|NCT00413660|561882177|FG005|Post Week 12|Other|1|||
155668527|NCT00413660|561882178|FG006|Post Week 12|Other|1|||
155668528|NCT00413660|561882179|FG007|Post Week 12|Other|0|||
155668529|NCT00413660|561882180|FG008|Post Week 12|Other|0|||
155668530|NCT00413660|561882181|FG009|Post Week 12|Other|0|||
155668531|NCT00413660|561882182|FG010|Post Week 12|Other|0|||
155668532|NCT01791517|561882183|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
155668533|NCT01791517|561882184|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
155668534|NCT01791517|561882185|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
155668535|NCT01791517|561882186|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
155668536|NCT01791517|561882187|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
155668537|NCT01791517|561882188|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
155668538|NCT01791517|561882189|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
155668539|NCT01791517|561882190|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
155668540|NCT01791517|561882191|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
155668541|NCT01791517|561882192|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
155668542|NCT01791517|561882193|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
155668543|NCT01791517|561882194|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
155668544|NCT01791517|561882183|FG000|Phase I: Period 1|Adverse Event|0|||
155668545|NCT01791517|561882184|FG001|Phase I: Period 1|Adverse Event|0|||
155668546|NCT01791517|561882185|FG002|Phase I: Period 1|Adverse Event|1|||
155668547|NCT01791517|561882186|FG003|Phase I: Period 1|Adverse Event|1|||
155668548|NCT01791517|561882187|FG004|Phase I: Period 1|Adverse Event|0|||
155668549|NCT01791517|561882188|FG005|Phase I: Period 1|Adverse Event|0|||
155668550|NCT01791517|561882189|FG006|Phase I: Period 1|Adverse Event|0|||
155668551|NCT01791517|561882190|FG007|Phase I: Period 1|Adverse Event|0|||
155668552|NCT01791517|561882191|FG008|Phase I: Period 1|Adverse Event|0|||
155668553|NCT01791517|561882192|FG009|Phase I: Period 1|Adverse Event|0|||
155668554|NCT01791517|561882193|FG010|Phase I: Period 1|Adverse Event|0|||
155668555|NCT01791517|561882194|FG011|Phase I: Period 1|Adverse Event|0|||
155668556|NCT01791517|561882183|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
155668557|NCT01791517|561882184|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668558|NCT01791517|561882185|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668559|NCT01791517|561882186|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668560|NCT01791517|561882187|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668561|NCT01791517|561882188|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668562|NCT01791517|561882189|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668563|NCT01791517|561882190|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668564|NCT01791517|561882191|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668565|NCT01791517|561882192|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668566|NCT01791517|561882193|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668567|NCT01791517|561882194|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155668568|NCT01791517|561882183|FG000|Phase I: Period 1|Protocol Violation|0|||
155668569|NCT01791517|561882184|FG001|Phase I: Period 1|Protocol Violation|1|||
155668570|NCT01791517|561882185|FG002|Phase I: Period 1|Protocol Violation|0|||
155668571|NCT01791517|561882186|FG003|Phase I: Period 1|Protocol Violation|0|||
155668572|NCT01791517|561882187|FG004|Phase I: Period 1|Protocol Violation|0|||
155668573|NCT01791517|561882188|FG005|Phase I: Period 1|Protocol Violation|0|||
155668574|NCT01791517|561882189|FG006|Phase I: Period 1|Protocol Violation|0|||
155668575|NCT01791517|561882190|FG007|Phase I: Period 1|Protocol Violation|0|||
155668576|NCT01791517|561882191|FG008|Phase I: Period 1|Protocol Violation|0|||
155668577|NCT01791517|561882192|FG009|Phase I: Period 1|Protocol Violation|0|||
155668578|NCT01791517|561882193|FG010|Phase I: Period 1|Protocol Violation|0|||
155668579|NCT01791517|561882194|FG011|Phase I: Period 1|Protocol Violation|0|||
155668580|NCT01791517|561882183|FG000|Phase I: Period 1|Lost to Follow-up|0|||
155668581|NCT01791517|561882184|FG001|Phase I: Period 1|Lost to Follow-up|0|||
155668582|NCT01791517|561882185|FG002|Phase I: Period 1|Lost to Follow-up|0|||
155668583|NCT01791517|561882186|FG003|Phase I: Period 1|Lost to Follow-up|1|||
155668584|NCT01791517|561882187|FG004|Phase I: Period 1|Lost to Follow-up|0|||
155668585|NCT01791517|561882188|FG005|Phase I: Period 1|Lost to Follow-up|0|||
155668586|NCT01791517|561882189|FG006|Phase I: Period 1|Lost to Follow-up|1|||
155668587|NCT01791517|561882190|FG007|Phase I: Period 1|Lost to Follow-up|0|||
155668588|NCT01791517|561882191|FG008|Phase I: Period 1|Lost to Follow-up|1|||
155668589|NCT01791517|561882192|FG009|Phase I: Period 1|Lost to Follow-up|1|||
155668590|NCT01791517|561882193|FG010|Phase I: Period 1|Lost to Follow-up|0|||
155668591|NCT01791517|561882194|FG011|Phase I: Period 1|Lost to Follow-up|0|||
155668592|NCT01791517|561882183|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668593|NCT01791517|561882184|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668594|NCT01791517|561882185|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668595|NCT01791517|561882186|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668596|NCT01791517|561882187|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668597|NCT01791517|561882188|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668598|NCT01791517|561882189|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668599|NCT01791517|561882190|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668600|NCT01791517|561882191|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668601|NCT01791517|561882192|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668602|NCT01791517|561882193|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
155668603|NCT01791517|561882194|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
155668604|NCT01791517|561882183|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
155668605|NCT01791517|561882184|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668606|NCT01791517|561882185|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668607|NCT01791517|561882186|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668608|NCT01791517|561882187|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668609|NCT01791517|561882188|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668610|NCT01791517|561882189|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668611|NCT01791517|561882190|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668612|NCT01791517|561882191|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668613|NCT01791517|561882192|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668614|NCT01791517|561882193|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668615|NCT01791517|561882194|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155668616|NCT01791517|561882183|FG000|Phase I: Period 2|Protocol Violation|0|||
155668617|NCT01791517|561882184|FG001|Phase I: Period 2|Protocol Violation|0|||
155668618|NCT01791517|561882185|FG002|Phase I: Period 2|Protocol Violation|0|||
155668619|NCT01791517|561882186|FG003|Phase I: Period 2|Protocol Violation|1|||
155668620|NCT01791517|561882187|FG004|Phase I: Period 2|Protocol Violation|0|||
155668621|NCT01791517|561882188|FG005|Phase I: Period 2|Protocol Violation|0|||
155668622|NCT01791517|561882189|FG006|Phase I: Period 2|Protocol Violation|0|||
155668623|NCT01791517|561882190|FG007|Phase I: Period 2|Protocol Violation|0|||
155668624|NCT01791517|561882191|FG008|Phase I: Period 2|Protocol Violation|0|||
155668625|NCT01791517|561882192|FG009|Phase I: Period 2|Protocol Violation|0|||
155668626|NCT01791517|561882193|FG010|Phase I: Period 2|Protocol Violation|0|||
155668627|NCT01791517|561882194|FG011|Phase I: Period 2|Protocol Violation|0|||
155668628|NCT01791517|561882183|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
155668629|NCT01791517|561882184|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
155668630|NCT01791517|561882185|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
155668631|NCT01791517|561882186|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
155668632|NCT01791517|561882187|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
155668633|NCT01791517|561882188|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
155668634|NCT01791517|561882189|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
155668635|NCT01791517|561882190|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
155668636|NCT01791517|561882191|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
155668637|NCT01791517|561882192|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
155668638|NCT01791517|561882193|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
155593690|NCT01314872|561598720|FG000|Period 2|Pregnancy|0|||
155593691|NCT01314872|561598721|FG001|Period 2|Pregnancy|0|||
155593692|NCT01314872|561598722|FG002|Period 2|Pregnancy|0|||
155593693|NCT01314872|561598723|FG003|Period 2|Pregnancy|0|||
155593694|NCT01314872|561598724|FG004|Period 2|Pregnancy|0|||
155593695|NCT01314872|561598725|FG005|Period 2|Pregnancy|0|||
155593696|NCT01314872|561598726|FG006|Period 2|Pregnancy|0|||
155593697|NCT01314872|561598727|FG007|Period 2|Pregnancy|0|||
155593698|NCT01314872|561598728|FG008|Period 2|Pregnancy|0|||
155593699|NCT01314872|561598729|FG009|Period 2|Pregnancy|0|||
155593700|NCT01314872|561598730|FG010|Period 2|Pregnancy|0|||
155593701|NCT01314872|561598731|FG011|Period 2|Pregnancy|0|||
155593702|NCT01314872|561598732|FG012|Period 2|Pregnancy|0|||
155593703|NCT01314872|561598733|FG013|Period 2|Pregnancy|0|||
155593704|NCT01314872|561598734|FG014|Period 2|Pregnancy|1|||
155593705|NCT01314872|561598720|FG000|Period 2|Study terminated by Sponsor|0|||
155593706|NCT01314872|561598721|FG001|Period 2|Study terminated by Sponsor|0|||
155593707|NCT01314872|561598722|FG002|Period 2|Study terminated by Sponsor|0|||
155593708|NCT01314872|561598723|FG003|Period 2|Study terminated by Sponsor|0|||
155593709|NCT01314872|561598724|FG004|Period 2|Study terminated by Sponsor|0|||
155593710|NCT01314872|561598725|FG005|Period 2|Study terminated by Sponsor|0|||
155593711|NCT01314872|561598726|FG006|Period 2|Study terminated by Sponsor|0|||
155593712|NCT01314872|561598727|FG007|Period 2|Study terminated by Sponsor|0|||
155593713|NCT01314872|561598728|FG008|Period 2|Study terminated by Sponsor|0|||
155593714|NCT01314872|561598729|FG009|Period 2|Study terminated by Sponsor|0|||
155593715|NCT01314872|561598730|FG010|Period 2|Study terminated by Sponsor|0|||
155593716|NCT01314872|561598731|FG011|Period 2|Study terminated by Sponsor|2|||
155593717|NCT01314872|561598732|FG012|Period 2|Study terminated by Sponsor|2|||
155593718|NCT01314872|561598733|FG013|Period 2|Study terminated by Sponsor|3|||
155593719|NCT01314872|561598734|FG014|Period 2|Study terminated by Sponsor|0|||
155593720|NCT01314872|561598720|FG000|Period 2|Adverse event, non-fatal|0|||
155593721|NCT01314872|561598721|FG001|Period 2|Adverse event, non-fatal|0|||
155593722|NCT01314872|561598722|FG002|Period 2|Adverse event, non-fatal|0|||
155593723|NCT01314872|561598723|FG003|Period 2|Adverse event, non-fatal|0|||
155593724|NCT01314872|561598724|FG004|Period 2|Adverse event, non-fatal|0|||
155593725|NCT01314872|561598725|FG005|Period 2|Adverse event, non-fatal|0|||
155593726|NCT01314872|561598726|FG006|Period 2|Adverse event, non-fatal|0|||
155593727|NCT01314872|561598727|FG007|Period 2|Adverse event, non-fatal|0|||
155593728|NCT01314872|561598728|FG008|Period 2|Adverse event, non-fatal|0|||
155593729|NCT01314872|561598729|FG009|Period 2|Adverse event, non-fatal|0|||
155593730|NCT01314872|561598730|FG010|Period 2|Adverse event, non-fatal|0|||
155593731|NCT01314872|561598731|FG011|Period 2|Adverse event, non-fatal|13|||
155593732|NCT01314872|561598732|FG012|Period 2|Adverse event, non-fatal|16|||
155593733|NCT01314872|561598733|FG013|Period 2|Adverse event, non-fatal|24|||
155593734|NCT01314872|561598734|FG014|Period 2|Adverse event, non-fatal|9|||
155593735|NCT01314872|561598720|FG000|Period 2|Withdrawal by Subject|0|||
155593736|NCT01314872|561598721|FG001|Period 2|Withdrawal by Subject|0|||
155593737|NCT01314872|561598722|FG002|Period 2|Withdrawal by Subject|0|||
155593738|NCT01314872|561598723|FG003|Period 2|Withdrawal by Subject|0|||
155593739|NCT01314872|561598724|FG004|Period 2|Withdrawal by Subject|0|||
155593740|NCT01314872|561598725|FG005|Period 2|Withdrawal by Subject|0|||
155593741|NCT01314872|561598726|FG006|Period 2|Withdrawal by Subject|0|||
155593742|NCT01314872|561598727|FG007|Period 2|Withdrawal by Subject|0|||
155593743|NCT01314872|561598728|FG008|Period 2|Withdrawal by Subject|0|||
155593744|NCT01314872|561598729|FG009|Period 2|Withdrawal by Subject|0|||
155593745|NCT01314872|561598730|FG010|Period 2|Withdrawal by Subject|0|||
155593746|NCT01314872|561598731|FG011|Period 2|Withdrawal by Subject|14|||
155593747|NCT01314872|561598732|FG012|Period 2|Withdrawal by Subject|17|||
155593748|NCT01314872|561598733|FG013|Period 2|Withdrawal by Subject|12|||
155593749|NCT01314872|561598734|FG014|Period 2|Withdrawal by Subject|4|||
155593750|NCT01314872|561598720|FG000|Period 2|Lost to Follow-up|0|||
155593751|NCT01314872|561598721|FG001|Period 2|Lost to Follow-up|0|||
155593752|NCT01314872|561598722|FG002|Period 2|Lost to Follow-up|0|||
155593753|NCT01314872|561598723|FG003|Period 2|Lost to Follow-up|0|||
155593754|NCT01314872|561598724|FG004|Period 2|Lost to Follow-up|0|||
155593755|NCT01314872|561598725|FG005|Period 2|Lost to Follow-up|0|||
155593756|NCT01314872|561598726|FG006|Period 2|Lost to Follow-up|0|||
155593757|NCT01314872|561598727|FG007|Period 2|Lost to Follow-up|0|||
155593758|NCT01314872|561598728|FG008|Period 2|Lost to Follow-up|0|||
155593759|NCT01314872|561598729|FG009|Period 2|Lost to Follow-up|0|||
155593760|NCT01314872|561598730|FG010|Period 2|Lost to Follow-up|0|||
155593761|NCT01314872|561598731|FG011|Period 2|Lost to Follow-up|6|||
155593762|NCT01314872|561598732|FG012|Period 2|Lost to Follow-up|7|||
155593763|NCT01314872|561598733|FG013|Period 2|Lost to Follow-up|2|||
155593764|NCT01314872|561598734|FG014|Period 2|Lost to Follow-up|6|||
155593765|NCT00199797|561600689|FG000|Overall Study|Progressive Disease|1|||
155593766|NCT00199797|561600689|FG000|Overall Study|Adverse Event|1|||
155593767|NCT00199797|561600689|FG000|Overall Study|Physician Decision|1|||
155593768|NCT00504725|561600690|FG000|Overall Study|Protocol Violation|1|||
155593769|NCT00504725|561600691|FG001|Overall Study|Protocol Violation|0|||
155593770|NCT01435018|561600692|FG000|Overall Study|Death|37|||
155593771|NCT01435018|561600693|FG001|Overall Study|Death|18|||
155593772|NCT01435018|561600694|FG002|Overall Study|Death|25|||
155593773|NCT01435018|561600692|FG000|Overall Study|Site is closing|4|||
155593774|NCT01435018|561600693|FG001|Overall Study|Site is closing|9|||
155593775|NCT01435018|561600694|FG002|Overall Study|Site is closing|7|||
155593776|NCT01435018|561600692|FG000|Overall Study|Withdrew consent|0|||
155593777|NCT01435018|561600693|FG001|Overall Study|Withdrew consent|3|||
155593778|NCT01435018|561600694|FG002|Overall Study|Withdrew consent|1|||
155593779|NCT01435018|561600692|FG000|Overall Study|Not willing to adhere to requirements|0|||
155593780|NCT01435018|561600693|FG001|Overall Study|Not willing to adhere to requirements|2|||
155593781|NCT01435018|561600694|FG002|Overall Study|Not willing to adhere to requirements|3|||
155593782|NCT01435018|561600692|FG000|Overall Study|Not able to get to clinic|2|||
155593783|NCT01435018|561600693|FG001|Overall Study|Not able to get to clinic|0|||
155593784|NCT01435018|561600694|FG002|Overall Study|Not able to get to clinic|2|||
155593785|NCT01435018|561600692|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155593786|NCT01435018|561600693|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155593787|NCT01435018|561600694|FG002|Overall Study|Severe debilitation, unable to continue|1|||
155593788|NCT01435018|561600692|FG000|Overall Study|Unable to contact participant/parent|1|||
155593789|NCT01435018|561600693|FG001|Overall Study|Unable to contact participant/parent|1|||
155593790|NCT01435018|561600694|FG002|Overall Study|Unable to contact participant/parent|1|||
155593791|NCT01435018|561600692|FG000|Overall Study|Enrollment Violation|0|||
155593792|NCT01435018|561600693|FG001|Overall Study|Enrollment Violation|1|||
155593793|NCT01435018|561600694|FG002|Overall Study|Enrollment Violation|0|||
155593794|NCT01435018|561600692|FG000|Overall Study|Never started chemotherapy|3|||
155593795|NCT01435018|561600693|FG001|Overall Study|Never started chemotherapy|0|||
155593796|NCT01435018|561600694|FG002|Overall Study|Never started chemotherapy|1|||
155593797|NCT03205761|561600695|FG000|Overall Study|Withdrawal by Subject|1|||
155593798|NCT03205761|561600695|FG000|Overall Study|Progressive Disease|10|||
155593799|NCT00636194|561600696|FG000|Overall Study|Study related symptoms and complaints|1|||
155593800|NCT00636194|561600697|FG001|Overall Study|Study related symptoms and complaints|0|||
155593801|NCT00636194|561600696|FG000|Overall Study|Protocol Violation|2|||
155593802|NCT00636194|561600697|FG001|Overall Study|Protocol Violation|0|||
155593803|NCT00972816|561600699|FG000|Overall Study|Adverse Event|0|||
155593804|NCT00972816|561600700|FG001|Overall Study|Adverse Event|0|||
155593805|NCT00972816|561600701|FG002|Overall Study|Adverse Event|1|||
155593806|NCT00972816|561600702|FG003|Overall Study|Adverse Event|0|||
155593807|NCT00972816|561600703|FG004|Overall Study|Adverse Event|0|||
155593808|NCT00972816|561600704|FG005|Overall Study|Adverse Event|0|||
155593809|NCT00972816|561600705|FG006|Overall Study|Adverse Event|0|||
155593810|NCT00972816|561600706|FG007|Overall Study|Adverse Event|0|||
155593811|NCT00972816|561600699|FG000|Overall Study|Withdrawal by Subject|4|||
155593812|NCT00972816|561600700|FG001|Overall Study|Withdrawal by Subject|2|||
155593813|NCT00972816|561600701|FG002|Overall Study|Withdrawal by Subject|1|||
155593814|NCT00972816|561600702|FG003|Overall Study|Withdrawal by Subject|3|||
155593815|NCT00972816|561600703|FG004|Overall Study|Withdrawal by Subject|0|||
155593816|NCT00972816|561600704|FG005|Overall Study|Withdrawal by Subject|1|||
155593817|NCT00972816|561600705|FG006|Overall Study|Withdrawal by Subject|1|||
155593818|NCT00972816|561600706|FG007|Overall Study|Withdrawal by Subject|2|||
155593819|NCT00972816|561600699|FG000|Overall Study|Lost to Follow-up|11|||
155593820|NCT00972816|561600700|FG001|Overall Study|Lost to Follow-up|9|||
155593821|NCT00972816|561600701|FG002|Overall Study|Lost to Follow-up|7|||
155593822|NCT00972816|561600702|FG003|Overall Study|Lost to Follow-up|5|||
155593823|NCT00972816|561600703|FG004|Overall Study|Lost to Follow-up|11|||
155593824|NCT00972816|561600704|FG005|Overall Study|Lost to Follow-up|10|||
155593825|NCT00972816|561600705|FG006|Overall Study|Lost to Follow-up|7|||
155593826|NCT00972816|561600706|FG007|Overall Study|Lost to Follow-up|7|||
155593827|NCT00972816|561600699|FG000|Overall Study|Inappropriate enrolment|0|||
155593828|NCT00972816|561600700|FG001|Overall Study|Inappropriate enrolment|0|||
155593829|NCT00972816|561600701|FG002|Overall Study|Inappropriate enrolment|0|||
155593830|NCT00972816|561600702|FG003|Overall Study|Inappropriate enrolment|0|||
155593831|NCT00972816|561600703|FG004|Overall Study|Inappropriate enrolment|0|||
155593832|NCT00972816|561600704|FG005|Overall Study|Inappropriate enrolment|0|||
155593833|NCT00972816|561600705|FG006|Overall Study|Inappropriate enrolment|2|||
155593834|NCT00972816|561600706|FG007|Overall Study|Inappropriate enrolment|0|||
155593835|NCT00972816|561600699|FG000|Overall Study|Unable to classify|2|||
155593836|NCT00972816|561600700|FG001|Overall Study|Unable to classify|0|||
155593837|NCT00972816|561600701|FG002|Overall Study|Unable to classify|0|||
155593838|NCT00972816|561600702|FG003|Overall Study|Unable to classify|0|||
155593839|NCT00972816|561600703|FG004|Overall Study|Unable to classify|1|||
155593840|NCT00972816|561600704|FG005|Overall Study|Unable to classify|0|||
155593841|NCT00972816|561600705|FG006|Overall Study|Unable to classify|0|||
155593842|NCT00972816|561600706|FG007|Overall Study|Unable to classify|0|||
155593843|NCT02163226|561600707|FG000|Overall Study|Death|2|||
155593844|NCT02163226|561600708|FG001|Overall Study|Death|1|||
155593845|NCT02163226|561600707|FG000|Overall Study|Withdrawal by Subject|5|||
155593846|NCT02163226|561600708|FG001|Overall Study|Withdrawal by Subject|2|||
155593847|NCT02163226|561600707|FG000|Overall Study|Returned home, local radiotherapy|3|||
155593848|NCT02163226|561600708|FG001|Overall Study|Returned home, local radiotherapy|0|||
155593849|NCT02163226|561600707|FG000|Overall Study|Repeat imaging showed no disease|2|||
155593850|NCT02163226|561600708|FG001|Overall Study|Repeat imaging showed no disease|0|||
155593851|NCT02163226|561600707|FG000|Overall Study|Incomplete radiotherapy|3|||
155593852|NCT02163226|561600708|FG001|Overall Study|Incomplete radiotherapy|0|||
155593853|NCT02163226|561600707|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
155593854|NCT02163226|561600708|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
155593855|NCT02163226|561600707|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
155593856|NCT02163226|561600708|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
155593857|NCT02163226|561600707|FG000|Overall Study|ineligible|0|||
155593858|NCT02163226|561600708|FG001|Overall Study|ineligible|3|||
155593859|NCT00593684|561600711|FG000|Overall Study|Death|2|||
155593860|NCT00593684|561600712|FG001|Overall Study|Death|1|||
155593861|NCT03625466|561600713|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
155593862|NCT03625466|561600714|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
155593863|NCT03625466|561600715|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
155593864|NCT03625466|561600713|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155593865|NCT03625466|561600714|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155593866|NCT03625466|561600715|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155593867|NCT03625466|561600713|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155593868|NCT03625466|561600714|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155593869|NCT03625466|561600715|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155593870|NCT05318092|561600716|FG000|Overall Study|Lost to Follow-up|3|||
155593871|NCT05318092|561600716|FG000|Overall Study|Withdrawal by Subject|1|||
155593872|NCT00664859|561600718|FG000|Overall Study|Adverse Event|2|||
155593873|NCT00664859|561600719|FG001|Overall Study|Adverse Event|1|||
155593874|NCT00664859|561600720|FG002|Overall Study|Adverse Event|3|||
155593875|NCT00664859|561600718|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
155593876|NCT00664859|561600719|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
155593877|NCT00664859|561600720|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
155593878|NCT00664859|561600718|FG000|Overall Study|Noncompliance with protocol|1|||
155593879|NCT00664859|561600719|FG001|Overall Study|Noncompliance with protocol|0|||
155593880|NCT00664859|561600720|FG002|Overall Study|Noncompliance with protocol|4|||
155593881|NCT00664859|561600718|FG000|Overall Study|Laboratory abnormality|2|||
155593882|NCT00664859|561600719|FG001|Overall Study|Laboratory abnormality|1|||
155593883|NCT00664859|561600720|FG002|Overall Study|Laboratory abnormality|4|||
155593884|NCT00664859|561600718|FG000|Overall Study|Withdrawal by Subject|4|||
155593885|NCT00664859|561600719|FG001|Overall Study|Withdrawal by Subject|1|||
155593886|NCT00664859|561600720|FG002|Overall Study|Withdrawal by Subject|3|||
155593887|NCT00664859|561600718|FG000|Overall Study|Lost to Follow-up|2|||
155593888|NCT00664859|561600719|FG001|Overall Study|Lost to Follow-up|2|||
155593889|NCT00664859|561600720|FG002|Overall Study|Lost to Follow-up|1|||
155593890|NCT00664859|561600718|FG000|Overall Study|Other|0|||
155593891|NCT00664859|561600719|FG001|Overall Study|Other|1|||
155593892|NCT00664859|561600720|FG002|Overall Study|Other|2|||
155593893|NCT00748189|561600721|FG000|Overall Study|Death|99|||
155593894|NCT00748189|561600722|FG001|Overall Study|Death|84|||
155593895|NCT00748189|561600721|FG000|Overall Study|Withdrawal by Subject|23|||
155593896|NCT00748189|561600722|FG001|Overall Study|Withdrawal by Subject|29|||
155593897|NCT00748189|561600721|FG000|Overall Study|Physician Decision|16|||
155593898|NCT00748189|561600722|FG001|Overall Study|Physician Decision|5|||
155593899|NCT00748189|561600721|FG000|Overall Study|Lost to Follow-up|8|||
155593900|NCT00748189|561600722|FG001|Overall Study|Lost to Follow-up|15|||
155593901|NCT00748189|561600721|FG000|Overall Study|Study terminated by Sponsor|70|||
155593902|NCT00748189|561600722|FG001|Overall Study|Study terminated by Sponsor|79|||
155593903|NCT04481191|561600729|FG000|Overall Study|Withdrawn by parent/guardian|15|||
155593904|NCT04481191|561600730|FG001|Overall Study|Withdrawn by parent/guardian|10|||
155593905|NCT00546117|561600735|FG000|Overall Study|Withdrawal by Subject|3|||
155593906|NCT00546117|561600736|FG001|Overall Study|Withdrawal by Subject|0|||
155668639|NCT01791517|561882194|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
155668640|NCT01791517|561882183|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668641|NCT01791517|561882184|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668642|NCT01791517|561882185|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668643|NCT01791517|561882186|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668644|NCT01791517|561882187|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668645|NCT01791517|561882188|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668646|NCT01791517|561882189|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668647|NCT01791517|561882190|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668648|NCT01791517|561882191|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668649|NCT01791517|561882192|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668650|NCT01791517|561882193|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
155668651|NCT01791517|561882194|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155668652|NCT01791517|561882183|FG000|Phase I: Period 2|Lens Discomfort|0|||
155668653|NCT01791517|561882184|FG001|Phase I: Period 2|Lens Discomfort|0|||
155668654|NCT01791517|561882185|FG002|Phase I: Period 2|Lens Discomfort|0|||
155668655|NCT01791517|561882186|FG003|Phase I: Period 2|Lens Discomfort|0|||
155668656|NCT01791517|561882187|FG004|Phase I: Period 2|Lens Discomfort|0|||
155668657|NCT01791517|561882188|FG005|Phase I: Period 2|Lens Discomfort|1|||
155668658|NCT01791517|561882189|FG006|Phase I: Period 2|Lens Discomfort|0|||
155668659|NCT01791517|561882190|FG007|Phase I: Period 2|Lens Discomfort|0|||
155668660|NCT01791517|561882191|FG008|Phase I: Period 2|Lens Discomfort|0|||
155668661|NCT01791517|561882192|FG009|Phase I: Period 2|Lens Discomfort|0|||
155668662|NCT01791517|561882193|FG010|Phase I: Period 2|Lens Discomfort|0|||
155668663|NCT01791517|561882194|FG011|Phase I: Period 2|Lens Discomfort|0|||
155668664|NCT01791517|561882183|FG000|Phase I: Period 2|Lost to Follow-up|0|||
155668665|NCT01791517|561882184|FG001|Phase I: Period 2|Lost to Follow-up|3|||
155668666|NCT01791517|561882185|FG002|Phase I: Period 2|Lost to Follow-up|2|||
155668667|NCT01791517|561882186|FG003|Phase I: Period 2|Lost to Follow-up|0|||
155668668|NCT01791517|561882187|FG004|Phase I: Period 2|Lost to Follow-up|0|||
155668669|NCT01791517|561882188|FG005|Phase I: Period 2|Lost to Follow-up|0|||
155668670|NCT01791517|561882189|FG006|Phase I: Period 2|Lost to Follow-up|0|||
155668671|NCT01791517|561882190|FG007|Phase I: Period 2|Lost to Follow-up|0|||
155668672|NCT01791517|561882191|FG008|Phase I: Period 2|Lost to Follow-up|0|||
155668673|NCT01791517|561882192|FG009|Phase I: Period 2|Lost to Follow-up|0|||
155668674|NCT01791517|561882193|FG010|Phase I: Period 2|Lost to Follow-up|0|||
155668675|NCT01791517|561882194|FG011|Phase I: Period 2|Lost to Follow-up|0|||
155668676|NCT01791517|561882183|FG000|Phase I: Period 3|Lens Discomfort|0|||
155668677|NCT01791517|561882184|FG001|Phase I: Period 3|Lens Discomfort|0|||
155668678|NCT01791517|561882185|FG002|Phase I: Period 3|Lens Discomfort|0|||
155668679|NCT01791517|561882186|FG003|Phase I: Period 3|Lens Discomfort|0|||
155668680|NCT01791517|561882187|FG004|Phase I: Period 3|Lens Discomfort|0|||
155668681|NCT01791517|561882188|FG005|Phase I: Period 3|Lens Discomfort|0|||
155668682|NCT01791517|561882189|FG006|Phase I: Period 3|Lens Discomfort|0|||
155668683|NCT01791517|561882190|FG007|Phase I: Period 3|Lens Discomfort|0|||
155668684|NCT01791517|561882191|FG008|Phase I: Period 3|Lens Discomfort|0|||
155668685|NCT01791517|561882192|FG009|Phase I: Period 3|Lens Discomfort|0|||
155668686|NCT01791517|561882193|FG010|Phase I: Period 3|Lens Discomfort|0|||
155668687|NCT01791517|561882194|FG011|Phase I: Period 3|Lens Discomfort|1|||
155668688|NCT01791517|561882183|FG000|Phase I: Period 3|Lost to Follow-up|0|||
155668689|NCT01791517|561882184|FG001|Phase I: Period 3|Lost to Follow-up|1|||
155668690|NCT01791517|561882185|FG002|Phase I: Period 3|Lost to Follow-up|0|||
155668691|NCT01791517|561882186|FG003|Phase I: Period 3|Lost to Follow-up|0|||
155668692|NCT01791517|561882187|FG004|Phase I: Period 3|Lost to Follow-up|1|||
155668693|NCT01791517|561882188|FG005|Phase I: Period 3|Lost to Follow-up|0|||
155668694|NCT01791517|561882189|FG006|Phase I: Period 3|Lost to Follow-up|0|||
155668695|NCT01791517|561882190|FG007|Phase I: Period 3|Lost to Follow-up|0|||
155668696|NCT01791517|561882191|FG008|Phase I: Period 3|Lost to Follow-up|0|||
155668697|NCT01791517|561882192|FG009|Phase I: Period 3|Lost to Follow-up|0|||
155668698|NCT01791517|561882193|FG010|Phase I: Period 3|Lost to Follow-up|0|||
155668699|NCT01791517|561882194|FG011|Phase I: Period 3|Lost to Follow-up|0|||
155668700|NCT01791517|561882183|FG000|Phase I: Period 3|Adverse Event|0|||
155668701|NCT01791517|561882184|FG001|Phase I: Period 3|Adverse Event|0|||
155668702|NCT01791517|561882185|FG002|Phase I: Period 3|Adverse Event|0|||
155668703|NCT01791517|561882186|FG003|Phase I: Period 3|Adverse Event|1|||
155668704|NCT01791517|561882187|FG004|Phase I: Period 3|Adverse Event|0|||
155668705|NCT01791517|561882188|FG005|Phase I: Period 3|Adverse Event|0|||
155668706|NCT01791517|561882189|FG006|Phase I: Period 3|Adverse Event|0|||
155668707|NCT01791517|561882190|FG007|Phase I: Period 3|Adverse Event|0|||
155668708|NCT01791517|561882191|FG008|Phase I: Period 3|Adverse Event|0|||
155668709|NCT01791517|561882192|FG009|Phase I: Period 3|Adverse Event|0|||
155668710|NCT01791517|561882193|FG010|Phase I: Period 3|Adverse Event|0|||
155668711|NCT01791517|561882194|FG011|Phase I: Period 3|Adverse Event|0|||
155668712|NCT01791517|561882183|FG000|Phase II|Lost to Follow-up|1|||
155668713|NCT01791517|561882184|FG001|Phase II|Lost to Follow-up|0|||
155668714|NCT01791517|561882185|FG002|Phase II|Lost to Follow-up|1|||
155668715|NCT01791517|561882186|FG003|Phase II|Lost to Follow-up|0|||
155668716|NCT01791517|561882187|FG004|Phase II|Lost to Follow-up|1|||
155668717|NCT01791517|561882188|FG005|Phase II|Lost to Follow-up|2|||
155668718|NCT01791517|561882189|FG006|Phase II|Lost to Follow-up|0|||
155668719|NCT01791517|561882190|FG007|Phase II|Lost to Follow-up|1|||
155668720|NCT01791517|561882191|FG008|Phase II|Lost to Follow-up|1|||
155668721|NCT01791517|561882192|FG009|Phase II|Lost to Follow-up|1|||
155668722|NCT01791517|561882193|FG010|Phase II|Lost to Follow-up|0|||
155668723|NCT01791517|561882194|FG011|Phase II|Lost to Follow-up|0|||
155668724|NCT01791517|561882183|FG000|Phase II|Withdrawal by Subject|1|||
155668725|NCT01791517|561882184|FG001|Phase II|Withdrawal by Subject|0|||
155668726|NCT01791517|561882185|FG002|Phase II|Withdrawal by Subject|0|||
155668727|NCT01791517|561882186|FG003|Phase II|Withdrawal by Subject|0|||
155668728|NCT01791517|561882187|FG004|Phase II|Withdrawal by Subject|0|||
155668729|NCT01791517|561882188|FG005|Phase II|Withdrawal by Subject|2|||
155668730|NCT01791517|561882189|FG006|Phase II|Withdrawal by Subject|0|||
155668731|NCT01791517|561882190|FG007|Phase II|Withdrawal by Subject|1|||
155668732|NCT01791517|561882191|FG008|Phase II|Withdrawal by Subject|0|||
155668733|NCT01791517|561882192|FG009|Phase II|Withdrawal by Subject|0|||
155668734|NCT01791517|561882193|FG010|Phase II|Withdrawal by Subject|1|||
155668735|NCT01791517|561882194|FG011|Phase II|Withdrawal by Subject|0|||
155668736|NCT01791517|561882183|FG000|Phase II|Lack of Efficacy|0|||
155668737|NCT01791517|561882184|FG001|Phase II|Lack of Efficacy|0|||
155668738|NCT01791517|561882185|FG002|Phase II|Lack of Efficacy|0|||
155668739|NCT01791517|561882186|FG003|Phase II|Lack of Efficacy|0|||
155593907|NCT00546117|561600735|FG000|Overall Study|Inability to schedule follow-up visit|1|||
155593908|NCT00546117|561600736|FG001|Overall Study|Inability to schedule follow-up visit|0|||
155593909|NCT04984278|561600742|FG000|Period 1|Withdrawal by Subject|1|||
155593910|NCT04984278|561600743|FG001|Period 1|Withdrawal by Subject|0|||
155593911|NCT04984278|561600742|FG000|Period 1|Other|0|||
155593912|NCT04984278|561600743|FG001|Period 1|Other|1|||
155593913|NCT04984278|561600742|FG000|Period 2|Adverse Event|1|||
155593914|NCT04984278|561600743|FG001|Period 2|Adverse Event|0|||
155593915|NCT04984278|561600742|FG000|Period 2|Other|0|||
155593916|NCT04984278|561600743|FG001|Period 2|Other|1|||
155593917|NCT04696055|561600744|FG000|Overall Study|Adverse Event|10|||
155593918|NCT04696055|561600745|FG001|Overall Study|Adverse Event|2|||
155593919|NCT04696055|561600744|FG000|Overall Study|Death|4|||
155593920|NCT04696055|561600745|FG001|Overall Study|Death|0|||
155593921|NCT04696055|561600744|FG000|Overall Study|Other|7|||
155593922|NCT04696055|561600745|FG001|Overall Study|Other|2|||
155593923|NCT04696055|561600744|FG000|Overall Study|Physician Decision|3|||
155593924|NCT04696055|561600745|FG001|Overall Study|Physician Decision|0|||
155593925|NCT04696055|561600744|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
155593926|NCT04696055|561600745|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
155593927|NCT04696055|561600744|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
155593928|NCT04696055|561600745|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
155593929|NCT04696055|561600744|FG000|Overall Study|Subject Decision|1|||
155593930|NCT04696055|561600745|FG001|Overall Study|Subject Decision|2|||
155593931|NCT03969901|561600746|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155593932|NCT03969901|561600747|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155593933|NCT03969901|561600748|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155593934|NCT03969901|561600749|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155593935|NCT03969901|561600750|FG004|Overall Study|Withdrawal by parent/guardian|1|||
155593936|NCT03969901|561600751|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155593937|NCT03969901|561600752|FG006|Overall Study|Withdrawal by parent/guardian|0|||
155593938|NCT03969901|561600753|FG007|Overall Study|Withdrawal by parent/guardian|1|||
155593939|NCT03969901|561600754|FG008|Overall Study|Withdrawal by parent/guardian|1|||
155593940|NCT03969901|561600755|FG009|Overall Study|Withdrawal by parent/guardian|0|||
155593941|NCT00348595|561600756|FG000|Overall Study|Adverse Event|5|||
155593942|NCT00348595|561600757|FG001|Overall Study|Adverse Event|8|||
155593943|NCT02589626|561600760|FG000|Overall Study|Other than the reason specified|1|||
155593944|NCT02589626|561600761|FG001|Overall Study|Other than the reason specified|0|||
155593945|NCT02589626|561600760|FG000|Overall Study|Withdrawal by Subject|1|||
155593946|NCT02589626|561600761|FG001|Overall Study|Withdrawal by Subject|1|||
155593947|NCT02589626|561600760|FG000|Overall Study|Adverse Event|1|||
155593948|NCT02589626|561600761|FG001|Overall Study|Adverse Event|1|||
155593949|NCT03645395|561600762|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
155593950|NCT03645395|561600763|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
155593951|NCT03645395|561600764|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
155593952|NCT03645395|561600765|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
155593953|NCT03645395|561600762|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
155593954|NCT03645395|561600763|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
155593955|NCT03645395|561600764|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
155593956|NCT03645395|561600765|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
155593957|NCT03645395|561600762|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155593958|NCT03645395|561600763|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155593959|NCT03645395|561600764|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
155593960|NCT03645395|561600765|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155593961|NCT03645395|561600762|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
155593962|NCT03645395|561600763|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
155593963|NCT03645395|561600764|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
155593964|NCT03645395|561600765|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
155593965|NCT02564900|561600766|FG000|Dose Escalation|Progressive disease per RECIST|2|||
155593966|NCT02564900|561600767|FG001|Dose Escalation|Progressive disease per RECIST|3|||
155593967|NCT02564900|561600768|FG002|Dose Escalation|Progressive disease per RECIST|3|||
155593968|NCT02564900|561600769|FG003|Dose Escalation|Progressive disease per RECIST|3|||
155593969|NCT02564900|561600770|FG004|Dose Escalation|Progressive disease per RECIST|3|||
155593970|NCT02564900|561600771|FG005|Dose Escalation|Progressive disease per RECIST|1|||
155593971|NCT02564900|561600772|FG006|Dose Escalation|Progressive disease per RECIST|0|||
155593972|NCT02564900|561600773|FG007|Dose Escalation|Progressive disease per RECIST|0|||
155593973|NCT02564900|561600774|FG008|Dose Escalation|Progressive disease per RECIST|0|||
155593974|NCT02564900|561600775|FG009|Dose Escalation|Progressive disease per RECIST|0|||
155593975|NCT02564900|561600776|FG010|Dose Escalation|Progressive disease per RECIST|0|||
155668740|NCT01791517|561882187|FG004|Phase II|Lack of Efficacy|1|||
155668741|NCT01791517|561882188|FG005|Phase II|Lack of Efficacy|0|||
155668742|NCT01791517|561882189|FG006|Phase II|Lack of Efficacy|0|||
155668743|NCT01791517|561882190|FG007|Phase II|Lack of Efficacy|0|||
155668744|NCT01791517|561882191|FG008|Phase II|Lack of Efficacy|0|||
155668745|NCT01791517|561882192|FG009|Phase II|Lack of Efficacy|0|||
155668746|NCT01791517|561882193|FG010|Phase II|Lack of Efficacy|0|||
155668747|NCT01791517|561882194|FG011|Phase II|Lack of Efficacy|0|||
155668748|NCT01791517|561882183|FG000|Phase II|Adverse Event|0|||
155668749|NCT01791517|561882184|FG001|Phase II|Adverse Event|0|||
155668750|NCT01791517|561882185|FG002|Phase II|Adverse Event|0|||
155668751|NCT01791517|561882186|FG003|Phase II|Adverse Event|0|||
155668752|NCT01791517|561882187|FG004|Phase II|Adverse Event|0|||
155668753|NCT01791517|561882188|FG005|Phase II|Adverse Event|0|||
155668754|NCT01791517|561882189|FG006|Phase II|Adverse Event|2|||
155668755|NCT01791517|561882190|FG007|Phase II|Adverse Event|1|||
155668756|NCT01791517|561882191|FG008|Phase II|Adverse Event|0|||
155668757|NCT01791517|561882192|FG009|Phase II|Adverse Event|1|||
155668758|NCT01791517|561882193|FG010|Phase II|Adverse Event|0|||
155668759|NCT01791517|561882194|FG011|Phase II|Adverse Event|0|||
155668760|NCT01791517|561882183|FG000|Phase II|Lens Handling Difficulties|0|||
155668761|NCT01791517|561882184|FG001|Phase II|Lens Handling Difficulties|0|||
155668762|NCT01791517|561882185|FG002|Phase II|Lens Handling Difficulties|0|||
155668763|NCT01791517|561882186|FG003|Phase II|Lens Handling Difficulties|0|||
155668764|NCT01791517|561882187|FG004|Phase II|Lens Handling Difficulties|0|||
155668765|NCT01791517|561882188|FG005|Phase II|Lens Handling Difficulties|0|||
155668766|NCT01791517|561882189|FG006|Phase II|Lens Handling Difficulties|0|||
155668767|NCT01791517|561882190|FG007|Phase II|Lens Handling Difficulties|0|||
155668768|NCT01791517|561882191|FG008|Phase II|Lens Handling Difficulties|1|||
155668769|NCT01791517|561882192|FG009|Phase II|Lens Handling Difficulties|0|||
155668770|NCT01791517|561882193|FG010|Phase II|Lens Handling Difficulties|0|||
155668771|NCT01791517|561882194|FG011|Phase II|Lens Handling Difficulties|0|||
155668772|NCT01791517|561882183|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
155668773|NCT01791517|561882184|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
155668774|NCT01791517|561882185|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
155668775|NCT01791517|561882186|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
155668776|NCT01791517|561882187|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
155668777|NCT01791517|561882188|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
155668778|NCT01791517|561882189|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
155668779|NCT01791517|561882190|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
155593976|NCT02564900|561600777|FG011|Dose Escalation|Progressive disease per RECIST|0|||
155593977|NCT02564900|561600778|FG012|Dose Escalation|Progressive disease per RECIST|0|||
155593978|NCT02564900|561600779|FG013|Dose Escalation|Progressive disease per RECIST|0|||
155593979|NCT02564900|561600780|FG014|Dose Escalation|Progressive disease per RECIST|0|||
155593980|NCT02564900|561600766|FG000|Dose Escalation|Ongoing|1|||
155593981|NCT02564900|561600767|FG001|Dose Escalation|Ongoing|0|||
155593982|NCT02564900|561600768|FG002|Dose Escalation|Ongoing|0|||
155593983|NCT02564900|561600769|FG003|Dose Escalation|Ongoing|2|||
155593984|NCT02564900|561600770|FG004|Dose Escalation|Ongoing|2|||
155593985|NCT02564900|561600771|FG005|Dose Escalation|Ongoing|2|||
155593986|NCT02564900|561600772|FG006|Dose Escalation|Ongoing|0|||
155593987|NCT02564900|561600773|FG007|Dose Escalation|Ongoing|0|||
155593988|NCT02564900|561600774|FG008|Dose Escalation|Ongoing|0|||
155593989|NCT02564900|561600775|FG009|Dose Escalation|Ongoing|0|||
155593990|NCT02564900|561600776|FG010|Dose Escalation|Ongoing|0|||
155593991|NCT02564900|561600777|FG011|Dose Escalation|Ongoing|0|||
155593992|NCT02564900|561600778|FG012|Dose Escalation|Ongoing|0|||
155593993|NCT02564900|561600779|FG013|Dose Escalation|Ongoing|0|||
155593994|NCT02564900|561600780|FG014|Dose Escalation|Ongoing|0|||
155593995|NCT02564900|561600766|FG000|Dose Escalation|Adverse Event|0|||
155593996|NCT02564900|561600767|FG001|Dose Escalation|Adverse Event|0|||
155593997|NCT02564900|561600768|FG002|Dose Escalation|Adverse Event|0|||
155593998|NCT02564900|561600769|FG003|Dose Escalation|Adverse Event|1|||
155593999|NCT02564900|561600770|FG004|Dose Escalation|Adverse Event|1|||
155594000|NCT02564900|561600771|FG005|Dose Escalation|Adverse Event|3|||
155594001|NCT02564900|561600772|FG006|Dose Escalation|Adverse Event|0|||
155594002|NCT02564900|561600773|FG007|Dose Escalation|Adverse Event|0|||
155594003|NCT02564900|561600774|FG008|Dose Escalation|Adverse Event|0|||
155594004|NCT02564900|561600775|FG009|Dose Escalation|Adverse Event|0|||
155594005|NCT02564900|561600776|FG010|Dose Escalation|Adverse Event|0|||
155668780|NCT01791517|561882191|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
155594006|NCT02564900|561600777|FG011|Dose Escalation|Adverse Event|0|||
155668781|NCT01791517|561882192|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
155668782|NCT01791517|561882193|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
155668783|NCT01791517|561882194|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
155668784|NCT01791517|561882183|FG000|Phase II|Pre-Existing Ocular Issue|0|||
155668785|NCT01791517|561882184|FG001|Phase II|Pre-Existing Ocular Issue|0|||
155668786|NCT01791517|561882185|FG002|Phase II|Pre-Existing Ocular Issue|0|||
155668787|NCT01791517|561882186|FG003|Phase II|Pre-Existing Ocular Issue|0|||
155594007|NCT02564900|561600778|FG012|Dose Escalation|Adverse Event|0|||
155594008|NCT02564900|561600779|FG013|Dose Escalation|Adverse Event|0|||
155594009|NCT02564900|561600780|FG014|Dose Escalation|Adverse Event|0|||
155594010|NCT02564900|561600766|FG000|Dose Expansion|Progressive disease per RECIST|0|||
155594011|NCT02564900|561600767|FG001|Dose Expansion|Progressive disease per RECIST|0|||
155594012|NCT02564900|561600768|FG002|Dose Expansion|Progressive disease per RECIST|0|||
155594013|NCT02564900|561600769|FG003|Dose Expansion|Progressive disease per RECIST|0|||
155594014|NCT02564900|561600770|FG004|Dose Expansion|Progressive disease per RECIST|0|||
155594015|NCT02564900|561600771|FG005|Dose Expansion|Progressive disease per RECIST|0|||
155594016|NCT02564900|561600772|FG006|Dose Expansion|Progressive disease per RECIST|19|||
155594017|NCT02564900|561600773|FG007|Dose Expansion|Progressive disease per RECIST|17|||
155594018|NCT02564900|561600774|FG008|Dose Expansion|Progressive disease per RECIST|8|||
155594019|NCT02564900|561600775|FG009|Dose Expansion|Progressive disease per RECIST|16|||
155594020|NCT02564900|561600776|FG010|Dose Expansion|Progressive disease per RECIST|13|||
155594021|NCT02564900|561600777|FG011|Dose Expansion|Progressive disease per RECIST|19|||
155594022|NCT02564900|561600778|FG012|Dose Expansion|Progressive disease per RECIST|10|||
155594023|NCT02564900|561600779|FG013|Dose Expansion|Progressive disease per RECIST|13|||
155594024|NCT02564900|561600780|FG014|Dose Expansion|Progressive disease per RECIST|11|||
155594025|NCT02564900|561600766|FG000|Dose Expansion|Clinical progression|0|||
155594026|NCT02564900|561600767|FG001|Dose Expansion|Clinical progression|0|||
155594027|NCT02564900|561600768|FG002|Dose Expansion|Clinical progression|0|||
155594028|NCT02564900|561600769|FG003|Dose Expansion|Clinical progression|0|||
155594029|NCT02564900|561600770|FG004|Dose Expansion|Clinical progression|0|||
155594030|NCT02564900|561600771|FG005|Dose Expansion|Clinical progression|0|||
155594031|NCT02564900|561600772|FG006|Dose Expansion|Clinical progression|5|||
155594032|NCT02564900|561600773|FG007|Dose Expansion|Clinical progression|12|||
155594033|NCT02564900|561600774|FG008|Dose Expansion|Clinical progression|0|||
155594034|NCT02564900|561600775|FG009|Dose Expansion|Clinical progression|3|||
155594035|NCT02564900|561600776|FG010|Dose Expansion|Clinical progression|2|||
155594036|NCT02564900|561600777|FG011|Dose Expansion|Clinical progression|0|||
155594037|NCT02564900|561600778|FG012|Dose Expansion|Clinical progression|1|||
155594038|NCT02564900|561600779|FG013|Dose Expansion|Clinical progression|3|||
155594039|NCT02564900|561600780|FG014|Dose Expansion|Clinical progression|1|||
155594040|NCT02564900|561600766|FG000|Dose Expansion|Adverse Event|0|||
155594041|NCT02564900|561600767|FG001|Dose Expansion|Adverse Event|0|||
155594042|NCT02564900|561600768|FG002|Dose Expansion|Adverse Event|0|||
155594043|NCT02564900|561600769|FG003|Dose Expansion|Adverse Event|0|||
155594044|NCT02564900|561600770|FG004|Dose Expansion|Adverse Event|0|||
155594045|NCT02564900|561600771|FG005|Dose Expansion|Adverse Event|0|||
155594046|NCT02564900|561600772|FG006|Dose Expansion|Adverse Event|9|||
155594047|NCT02564900|561600773|FG007|Dose Expansion|Adverse Event|22|||
155594048|NCT02564900|561600774|FG008|Dose Expansion|Adverse Event|0|||
155594049|NCT02564900|561600775|FG009|Dose Expansion|Adverse Event|11|||
155594050|NCT02564900|561600776|FG010|Dose Expansion|Adverse Event|0|||
155594051|NCT02564900|561600777|FG011|Dose Expansion|Adverse Event|5|||
155594052|NCT02564900|561600778|FG012|Dose Expansion|Adverse Event|2|||
155594053|NCT02564900|561600779|FG013|Dose Expansion|Adverse Event|2|||
155594054|NCT02564900|561600780|FG014|Dose Expansion|Adverse Event|1|||
155594055|NCT02564900|561600766|FG000|Dose Expansion|Ongoing|0|||
155594056|NCT02564900|561600767|FG001|Dose Expansion|Ongoing|0|||
155594057|NCT02564900|561600768|FG002|Dose Expansion|Ongoing|0|||
155594058|NCT02564900|561600769|FG003|Dose Expansion|Ongoing|0|||
155594059|NCT02564900|561600770|FG004|Dose Expansion|Ongoing|0|||
155594060|NCT02564900|561600771|FG005|Dose Expansion|Ongoing|0|||
155594061|NCT02564900|561600772|FG006|Dose Expansion|Ongoing|9|||
155594062|NCT02564900|561600773|FG007|Dose Expansion|Ongoing|10|||
155594063|NCT02564900|561600774|FG008|Dose Expansion|Ongoing|11|||
155594064|NCT02564900|561600775|FG009|Dose Expansion|Ongoing|3|||
155594065|NCT02564900|561600776|FG010|Dose Expansion|Ongoing|0|||
155594066|NCT02564900|561600777|FG011|Dose Expansion|Ongoing|0|||
155594067|NCT02564900|561600778|FG012|Dose Expansion|Ongoing|4|||
155594068|NCT02564900|561600779|FG013|Dose Expansion|Ongoing|0|||
155594069|NCT02564900|561600780|FG014|Dose Expansion|Ongoing|6|||
155594070|NCT02564900|561600766|FG000|Dose Expansion|Death|0|||
155594071|NCT02564900|561600767|FG001|Dose Expansion|Death|0|||
155594072|NCT02564900|561600768|FG002|Dose Expansion|Death|0|||
155594073|NCT02564900|561600769|FG003|Dose Expansion|Death|0|||
155594074|NCT02564900|561600770|FG004|Dose Expansion|Death|0|||
155594075|NCT02564900|561600771|FG005|Dose Expansion|Death|0|||
155594076|NCT02564900|561600772|FG006|Dose Expansion|Death|1|||
155594077|NCT02564900|561600773|FG007|Dose Expansion|Death|0|||
155594078|NCT02564900|561600774|FG008|Dose Expansion|Death|0|||
155594079|NCT02564900|561600775|FG009|Dose Expansion|Death|0|||
155594080|NCT02564900|561600776|FG010|Dose Expansion|Death|1|||
155594081|NCT02564900|561600777|FG011|Dose Expansion|Death|0|||
155594082|NCT02564900|561600778|FG012|Dose Expansion|Death|1|||
155594083|NCT02564900|561600779|FG013|Dose Expansion|Death|1|||
155594084|NCT02564900|561600780|FG014|Dose Expansion|Death|0|||
155594085|NCT02564900|561600766|FG000|Dose Expansion|Withdrawal by Subject|0|||
155594086|NCT02564900|561600767|FG001|Dose Expansion|Withdrawal by Subject|0|||
155668788|NCT01791517|561882187|FG004|Phase II|Pre-Existing Ocular Issue|0|||
155668789|NCT01791517|561882188|FG005|Phase II|Pre-Existing Ocular Issue|0|||
155668790|NCT01791517|561882189|FG006|Phase II|Pre-Existing Ocular Issue|0|||
155668791|NCT01791517|561882190|FG007|Phase II|Pre-Existing Ocular Issue|0|||
155668792|NCT01791517|561882191|FG008|Phase II|Pre-Existing Ocular Issue|0|||
155668793|NCT01791517|561882192|FG009|Phase II|Pre-Existing Ocular Issue|0|||
155668794|NCT01791517|561882193|FG010|Phase II|Pre-Existing Ocular Issue|0|||
155668795|NCT01791517|561882194|FG011|Phase II|Pre-Existing Ocular Issue|1|||
155668796|NCT03230318|561882196|FG000|Overall Study|Radiographic disease progression|72|||
155668797|NCT03230318|561882197|FG001|Overall Study|Radiographic disease progression|19|||
155668798|NCT03230318|561882196|FG000|Overall Study|Clinical progression|17|||
155668799|NCT03230318|561882197|FG001|Overall Study|Clinical progression|7|||
155668800|NCT03230318|561882196|FG000|Overall Study|Adverse Event|5|||
155668801|NCT03230318|561882197|FG001|Overall Study|Adverse Event|3|||
155668802|NCT03230318|561882196|FG000|Overall Study|Physician Decision|2|||
155668803|NCT03230318|561882197|FG001|Overall Study|Physician Decision|3|||
155668804|NCT03230318|561882196|FG000|Overall Study|Death|3|||
155668805|NCT03230318|561882197|FG001|Overall Study|Death|2|||
155668806|NCT03230318|561882196|FG000|Overall Study|Lost to Follow-up|1|||
155668807|NCT03230318|561882197|FG001|Overall Study|Lost to Follow-up|0|||
155668808|NCT03230318|561882196|FG000|Overall Study|Withdrawal by Subject|1|||
155668809|NCT03230318|561882197|FG001|Overall Study|Withdrawal by Subject|3|||
155668810|NCT03230318|561882196|FG000|Overall Study|Other|3|||
155668811|NCT03230318|561882197|FG001|Overall Study|Other|7|||
155668812|NCT02141672|561882198|FG000|Overall Study|Adverse Event|0|||
155668813|NCT02141672|561882199|FG001|Overall Study|Adverse Event|1|||
155668814|NCT02141672|561882200|FG002|Overall Study|Adverse Event|0|||
155668815|NCT02141672|561882198|FG000|Overall Study|Death|10|||
155668816|NCT02141672|561882199|FG001|Overall Study|Death|2|||
155668817|NCT02141672|561882200|FG002|Overall Study|Death|1|||
155668818|NCT02141672|561882198|FG000|Overall Study|Lack of Efficacy|0|||
155668819|NCT02141672|561882199|FG001|Overall Study|Lack of Efficacy|0|||
155668820|NCT02141672|561882200|FG002|Overall Study|Lack of Efficacy|2|||
155668821|NCT02141672|561882198|FG000|Overall Study|Lost to Follow-up|1|||
155668822|NCT02141672|561882199|FG001|Overall Study|Lost to Follow-up|1|||
155668823|NCT02141672|561882200|FG002|Overall Study|Lost to Follow-up|3|||
155668824|NCT02141672|561882198|FG000|Overall Study|Physician Decision|1|||
155668825|NCT02141672|561882199|FG001|Overall Study|Physician Decision|2|||
155668826|NCT02141672|561882200|FG002|Overall Study|Physician Decision|5|||
155668827|NCT02141672|561882198|FG000|Overall Study|Protocol Violation|0|||
155668828|NCT02141672|561882199|FG001|Overall Study|Protocol Violation|0|||
155668829|NCT02141672|561882200|FG002|Overall Study|Protocol Violation|1|||
155668830|NCT02141672|561882198|FG000|Overall Study|Withdrawal by Subject|3|||
155668831|NCT02141672|561882199|FG001|Overall Study|Withdrawal by Subject|2|||
155668832|NCT02141672|561882200|FG002|Overall Study|Withdrawal by Subject|5|||
155668833|NCT02141672|561882198|FG000|Overall Study|refused to follow-up|1|||
155668834|NCT02141672|561882199|FG001|Overall Study|refused to follow-up|0|||
155668835|NCT02141672|561882200|FG002|Overall Study|refused to follow-up|1|||
155668836|NCT00075764|561882201|FG000|Overall Study|Adverse Event|5|||
155668837|NCT00075764|561882202|FG001|Overall Study|Adverse Event|12|||
155668838|NCT00075764|561882201|FG000|Overall Study|Death|4|||
155668839|NCT00075764|561882202|FG001|Overall Study|Death|8|||
155668840|NCT00075764|561882201|FG000|Overall Study|Withdrawal by Subject|28|||
155668841|NCT00075764|561882202|FG001|Overall Study|Withdrawal by Subject|18|||
155668842|NCT00075764|561882201|FG000|Overall Study|Progression|269|||
155668843|NCT00075764|561882202|FG001|Overall Study|Progression|274|||
155668844|NCT00075764|561882201|FG000|Overall Study|Still on treatment|8|||
155668845|NCT00075764|561882202|FG001|Overall Study|Still on treatment|15|||
155668846|NCT00075764|561882201|FG000|Overall Study|Delinquent|4|||
155668847|NCT00075764|561882202|FG001|Overall Study|Delinquent|2|||
155668848|NCT00075764|561882201|FG000|Overall Study|Not protocol specified|27|||
155668849|NCT00075764|561882202|FG001|Overall Study|Not protocol specified|19|||
155668850|NCT00075764|561882201|FG000|Overall Study|Under review|0|||
155668851|NCT00075764|561882202|FG001|Overall Study|Under review|1|||
155668852|NCT02817594|561882206|FG000|Overall Study|Withdrawal by Subject|1|||
155668853|NCT02817594|561882206|FG000|Overall Study|Other|1|||
155668854|NCT02817594|561882206|FG000|Overall Study|Did Not Receive Treatment|1|||
155668855|NCT02010593|561882207|FG000|Overall Study|Lost to Follow-up|1|||
155668856|NCT02010593|561882208|FG001|Overall Study|Lost to Follow-up|0|||
155668857|NCT02010593|561882207|FG000|Overall Study|Physician Decision|1|||
155668858|NCT02010593|561882208|FG001|Overall Study|Physician Decision|0|||
155668859|NCT02010593|561882207|FG000|Overall Study|Unable to adhere to visit schedule|0|||
155668860|NCT02010593|561882208|FG001|Overall Study|Unable to adhere to visit schedule|2|||
155668861|NCT01773967|561882209|FG000|Overall Study|Lost to Follow-up|15|||
155668862|NCT01773967|561882210|FG001|Overall Study|Lost to Follow-up|13|||
155668863|NCT00739310|561882215|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
155668864|NCT00739310|561882215|FG000|Overall Study|Withdrawal by Subject|1|||
155668865|NCT00739310|561882215|FG000|Overall Study|Lost to Follow-up|2|||
155668866|NCT01492088|561882216|FG000|Overall Study|Withdrawal by Patient|0|||
155594087|NCT02564900|561600768|FG002|Dose Expansion|Withdrawal by Subject|0|||
155594088|NCT02564900|561600769|FG003|Dose Expansion|Withdrawal by Subject|0|||
155594089|NCT02564900|561600770|FG004|Dose Expansion|Withdrawal by Subject|0|||
155594090|NCT02564900|561600771|FG005|Dose Expansion|Withdrawal by Subject|0|||
155594091|NCT02564900|561600772|FG006|Dose Expansion|Withdrawal by Subject|4|||
155594092|NCT02564900|561600773|FG007|Dose Expansion|Withdrawal by Subject|0|||
155594093|NCT02564900|561600774|FG008|Dose Expansion|Withdrawal by Subject|0|||
155594094|NCT02564900|561600775|FG009|Dose Expansion|Withdrawal by Subject|0|||
155594095|NCT02564900|561600776|FG010|Dose Expansion|Withdrawal by Subject|1|||
155594096|NCT02564900|561600777|FG011|Dose Expansion|Withdrawal by Subject|0|||
155594097|NCT02564900|561600778|FG012|Dose Expansion|Withdrawal by Subject|0|||
155594098|NCT02564900|561600779|FG013|Dose Expansion|Withdrawal by Subject|1|||
155594099|NCT02564900|561600780|FG014|Dose Expansion|Withdrawal by Subject|1|||
155594100|NCT02564900|561600766|FG000|Dose Expansion|Other|0|||
155594101|NCT02564900|561600767|FG001|Dose Expansion|Other|0|||
155668867|NCT01492088|561882217|FG001|Overall Study|Withdrawal by Patient|2|||
155668868|NCT01492088|561882218|FG002|Overall Study|Withdrawal by Patient|0|||
155668869|NCT01492088|561882216|FG000|Overall Study|Death|1|||
155668870|NCT01492088|561882217|FG001|Overall Study|Death|6|||
155668871|NCT01492088|561882218|FG002|Overall Study|Death|2|||
155668872|NCT01492088|561882216|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
155668873|NCT01492088|561882217|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
155668874|NCT01492088|561882218|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
155668875|NCT01492088|561882216|FG000|Overall Study|Alive at Last Follow-up|0|||
155668876|NCT01492088|561882217|FG001|Overall Study|Alive at Last Follow-up|6|||
155668877|NCT01492088|561882218|FG002|Overall Study|Alive at Last Follow-up|11|||
155668878|NCT02803203|561882219|FG000|Overall Study|Adverse Event|4|||
155668879|NCT02803203|561882219|FG000|Overall Study|Death|4|||
155668880|NCT02803203|561882219|FG000|Overall Study|Progressive disease|29|||
155668881|NCT02803203|561882219|FG000|Overall Study|Withdrawal by Subject|8|||
155668882|NCT02803203|561882219|FG000|Overall Study|Complete resection of target disease|2|||
155668883|NCT02803203|561882219|FG000|Overall Study|Switched to commercial Osi|1|||
155668884|NCT02803203|561882219|FG000|Overall Study|Participant moved away|1|||
155668885|NCT00590967|561882220|FG000|Overall Study|Withdrawal by Subject|1|||
155668886|NCT00590967|561882221|FG001|Overall Study|Withdrawal by Subject|1|||
155668887|NCT00590967|561882220|FG000|Overall Study|Ineligible|1|||
155668888|NCT00590967|561882221|FG001|Overall Study|Ineligible|0|||
155668889|NCT00590967|561882220|FG000|Overall Study|Poor performance status|0|||
155668890|NCT00590967|561882221|FG001|Overall Study|Poor performance status|1|||
155668891|NCT00590967|561882220|FG000|Overall Study|Non-compliant|0|||
155668892|NCT00590967|561882221|FG001|Overall Study|Non-compliant|2|||
155668893|NCT00590967|561882220|FG000|Overall Study|Did not sign consent form|0|||
155668894|NCT00590967|561882221|FG001|Overall Study|Did not sign consent form|1|||
155668895|NCT00590967|561882220|FG000|Overall Study|Did not receive chemo per protocol|1|||
155668896|NCT00590967|561882221|FG001|Overall Study|Did not receive chemo per protocol|0|||
155668897|NCT01881789|561882222|FG000|Overall Study|Withdrawal by Subject|0|||
155668898|NCT01881789|561882223|FG001|Overall Study|Withdrawal by Subject|2|||
155668899|NCT01881789|561882224|FG002|Overall Study|Withdrawal by Subject|1|||
155668900|NCT01881789|561882225|FG003|Overall Study|Withdrawal by Subject|0|||
155668901|NCT01881789|561882226|FG004|Overall Study|Withdrawal by Subject|1|||
155668902|NCT01881789|561882227|FG005|Overall Study|Withdrawal by Subject|1|||
155668903|NCT01881789|561882222|FG000|Overall Study|Study Terminated by Sponsor|0|||
155668904|NCT01881789|561882223|FG001|Overall Study|Study Terminated by Sponsor|0|||
155668905|NCT01881789|561882224|FG002|Overall Study|Study Terminated by Sponsor|0|||
155668906|NCT01881789|561882225|FG003|Overall Study|Study Terminated by Sponsor|0|||
155668907|NCT01881789|561882226|FG004|Overall Study|Study Terminated by Sponsor|0|||
155668908|NCT01881789|561882227|FG005|Overall Study|Study Terminated by Sponsor|1|||
155668909|NCT01881789|561882222|FG000|Overall Study|Other|3|||
155668910|NCT01881789|561882223|FG001|Overall Study|Other|5|||
155668911|NCT01881789|561882224|FG002|Overall Study|Other|2|||
155668912|NCT01881789|561882225|FG003|Overall Study|Other|3|||
155668913|NCT01881789|561882226|FG004|Overall Study|Other|1|||
155668914|NCT01881789|561882227|FG005|Overall Study|Other|1|||
155668915|NCT01887717|561882228|FG000|Overall Study|Withdrawal by Subject|1|||
155668916|NCT01887717|561882229|FG001|Overall Study|Withdrawal by Subject|7|||
155668917|NCT01887717|561882228|FG000|Overall Study|Physician Decision|0|||
155668918|NCT01887717|561882229|FG001|Overall Study|Physician Decision|2|||
155668919|NCT01887717|561882228|FG000|Overall Study|Administrative reasons|5|||
155668920|NCT01887717|561882229|FG001|Overall Study|Administrative reasons|2|||
155594102|NCT02564900|561600768|FG002|Dose Expansion|Other|0|||
155594103|NCT02564900|561600769|FG003|Dose Expansion|Other|0|||
155594104|NCT02564900|561600770|FG004|Dose Expansion|Other|0|||
155594105|NCT02564900|561600771|FG005|Dose Expansion|Other|0|||
155594106|NCT02564900|561600772|FG006|Dose Expansion|Other|1|||
155668921|NCT01299389|561882230|FG000|Double-blind|Adverse Event|45|||
155668922|NCT01299389|561882231|FG001|Double-blind|Adverse Event|27|||
155668923|NCT01299389|561882232|FG002|Double-blind|Adverse Event|0|||
155668924|NCT01299389|561882233|FG003|Double-blind|Adverse Event|0|||
155668925|NCT01299389|561882230|FG000|Double-blind|Lack of Efficacy|45|||
155668926|NCT01299389|561882231|FG001|Double-blind|Lack of Efficacy|21|||
155668927|NCT01299389|561882232|FG002|Double-blind|Lack of Efficacy|0|||
155668928|NCT01299389|561882233|FG003|Double-blind|Lack of Efficacy|0|||
155668929|NCT01299389|561882230|FG000|Double-blind|Lost to Follow-up|2|||
155668930|NCT01299389|561882231|FG001|Double-blind|Lost to Follow-up|1|||
155668931|NCT01299389|561882232|FG002|Double-blind|Lost to Follow-up|0|||
155668932|NCT01299389|561882233|FG003|Double-blind|Lost to Follow-up|0|||
155668933|NCT01299389|561882230|FG000|Double-blind|Withdrawal by Subject|16|||
155668934|NCT01299389|561882231|FG001|Double-blind|Withdrawal by Subject|13|||
155668935|NCT01299389|561882232|FG002|Double-blind|Withdrawal by Subject|0|||
155668936|NCT01299389|561882233|FG003|Double-blind|Withdrawal by Subject|0|||
155668937|NCT01299389|561882230|FG000|Double-blind|Other|1|||
155668938|NCT01299389|561882231|FG001|Double-blind|Other|1|||
155668939|NCT01299389|561882232|FG002|Double-blind|Other|0|||
155668940|NCT01299389|561882233|FG003|Double-blind|Other|0|||
155668941|NCT01299389|561882230|FG000|Double-blind|"fail to meet study population criteria"|0|||
155668942|NCT01299389|561882231|FG001|Double-blind|"fail to meet study population criteria"|1|||
155668943|NCT01299389|561882232|FG002|Double-blind|"fail to meet study population criteria"|0|||
155668944|NCT01299389|561882233|FG003|Double-blind|"fail to meet study population criteria"|0|||
155668945|NCT01299389|561882230|FG000|Post-observational|Other|0|||
155668946|NCT01299389|561882231|FG001|Post-observational|Other|0|||
155668947|NCT01299389|561882232|FG002|Post-observational|Other|12|||
155668948|NCT01299389|561882233|FG003|Post-observational|Other|6|||
155668949|NCT00889707|561882235|FG000|Overall Study|Adverse Event|1|||
155668950|NCT00889707|561882236|FG001|Overall Study|Adverse Event|0|||
155668951|NCT00889707|561882235|FG000|Overall Study|Withdrawal by Subject|4|||
155668952|NCT00889707|561882236|FG001|Overall Study|Withdrawal by Subject|3|||
155668953|NCT00889707|561882235|FG000|Overall Study|Lost to Follow-up|0|||
155668954|NCT00889707|561882236|FG001|Overall Study|Lost to Follow-up|2|||
155668955|NCT00889707|561882235|FG000|Overall Study|Lack of Efficacy|2|||
155668956|NCT00889707|561882236|FG001|Overall Study|Lack of Efficacy|5|||
155668957|NCT02185534|561882238|FG000|First Period|Withdrawal by Subject|0|||
155668958|NCT02185534|561882239|FG001|First Period|Withdrawal by Subject|0|||
155668959|NCT02185534|561882240|FG002|First Period|Withdrawal by Subject|0|||
155668960|NCT02185534|561882241|FG003|First Period|Withdrawal by Subject|1|||
155668961|NCT02185534|561882242|FG004|First Period|Withdrawal by Subject|0|||
155668962|NCT02185534|561882243|FG005|First Period|Withdrawal by Subject|0|||
155668963|NCT02185534|561882238|FG000|First Washout Period|Withdrawal by Subject|1|||
155668964|NCT02185534|561882239|FG001|First Washout Period|Withdrawal by Subject|0|||
155668965|NCT02185534|561882240|FG002|First Washout Period|Withdrawal by Subject|0|||
155668966|NCT02185534|561882241|FG003|First Washout Period|Withdrawal by Subject|0|||
155668967|NCT02185534|561882242|FG004|First Washout Period|Withdrawal by Subject|1|||
155668968|NCT02185534|561882243|FG005|First Washout Period|Withdrawal by Subject|0|||
155668969|NCT02185534|561882238|FG000|First Washout Period|Protocol Violation|0|||
155668970|NCT02185534|561882239|FG001|First Washout Period|Protocol Violation|0|||
155668971|NCT02185534|561882240|FG002|First Washout Period|Protocol Violation|0|||
155668972|NCT02185534|561882241|FG003|First Washout Period|Protocol Violation|0|||
155668973|NCT02185534|561882242|FG004|First Washout Period|Protocol Violation|0|||
155668974|NCT02185534|561882243|FG005|First Washout Period|Protocol Violation|1|||
155668975|NCT01635998|561882244|FG000|Overall Study|Death|1|||
155668976|NCT01635998|561882245|FG001|Overall Study|Death|1|||
155668977|NCT01635998|561882244|FG000|Overall Study|Lost to Follow-up|2|||
155668978|NCT01635998|561882245|FG001|Overall Study|Lost to Follow-up|1|||
155668979|NCT01635998|561882244|FG000|Overall Study|Withdrawal by Subject|1|||
155668980|NCT01635998|561882245|FG001|Overall Study|Withdrawal by Subject|5|||
155668981|NCT04179305|561882251|FG000|Overall Study|Death|1|||
155668982|NCT04179305|561882252|FG001|Overall Study|Death|1|||
155668983|NCT04179305|561882253|FG002|Overall Study|Death|0|||
155668984|NCT04179305|561882254|FG003|Overall Study|Death|0|||
155668985|NCT04179305|561882251|FG000|Overall Study|Lost to Follow-up|1|||
155668986|NCT04179305|561882252|FG001|Overall Study|Lost to Follow-up|1|||
155668987|NCT04179305|561882253|FG002|Overall Study|Lost to Follow-up|0|||
155668988|NCT04179305|561882254|FG003|Overall Study|Lost to Follow-up|0|||
155668989|NCT04179305|561882251|FG000|Overall Study|Withdrawal by Subject|0|||
155668990|NCT04179305|561882252|FG001|Overall Study|Withdrawal by Subject|1|||
155668991|NCT04179305|561882253|FG002|Overall Study|Withdrawal by Subject|0|||
155668992|NCT04179305|561882254|FG003|Overall Study|Withdrawal by Subject|0|||
155668993|NCT04179305|561882251|FG000|Overall Study|Did not have scan|1|||
155594107|NCT02564900|561600773|FG007|Dose Expansion|Other|0|||
155594108|NCT02564900|561600774|FG008|Dose Expansion|Other|1|||
155594109|NCT02564900|561600775|FG009|Dose Expansion|Other|0|||
155594110|NCT02564900|561600776|FG010|Dose Expansion|Other|0|||
155594111|NCT02564900|561600777|FG011|Dose Expansion|Other|0|||
155594112|NCT02564900|561600778|FG012|Dose Expansion|Other|0|||
155594113|NCT02564900|561600779|FG013|Dose Expansion|Other|0|||
155594114|NCT02564900|561600780|FG014|Dose Expansion|Other|1|||
155594115|NCT02564900|561600766|FG000|Dose Expansion|Did not receive treatment|0|||
155594116|NCT02564900|561600767|FG001|Dose Expansion|Did not receive treatment|0|||
155594117|NCT02564900|561600768|FG002|Dose Expansion|Did not receive treatment|0|||
155594118|NCT02564900|561600769|FG003|Dose Expansion|Did not receive treatment|0|||
155594119|NCT02564900|561600770|FG004|Dose Expansion|Did not receive treatment|0|||
155594120|NCT02564900|561600771|FG005|Dose Expansion|Did not receive treatment|0|||
155594121|NCT02564900|561600772|FG006|Dose Expansion|Did not receive treatment|1|||
155594122|NCT02564900|561600773|FG007|Dose Expansion|Did not receive treatment|1|||
155594123|NCT02564900|561600774|FG008|Dose Expansion|Did not receive treatment|0|||
155594124|NCT02564900|561600775|FG009|Dose Expansion|Did not receive treatment|0|||
155594125|NCT02564900|561600776|FG010|Dose Expansion|Did not receive treatment|0|||
155594126|NCT02564900|561600777|FG011|Dose Expansion|Did not receive treatment|0|||
155594127|NCT02564900|561600778|FG012|Dose Expansion|Did not receive treatment|0|||
155594128|NCT02564900|561600779|FG013|Dose Expansion|Did not receive treatment|0|||
155594129|NCT02564900|561600780|FG014|Dose Expansion|Did not receive treatment|1|||
155594130|NCT01289639|561600782|FG000|Overall Study|Lost to Follow-up|1|||
155594131|NCT01289639|561600783|FG001|Overall Study|Lost to Follow-up|0|||
155594132|NCT01289639|561600784|FG002|Overall Study|Lost to Follow-up|0|||
155594133|NCT02780713|561600785|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155594134|NCT02780713|561600786|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155594135|NCT02780713|561600787|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
155594136|NCT02780713|561600788|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155594137|NCT02780713|561600789|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155594138|NCT01931475|561600790|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
155594139|NCT01931475|561600791|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
155594140|NCT01931475|561600790|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
155594141|NCT01931475|561600791|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
155594142|NCT01931475|561600790|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
155594143|NCT01931475|561600791|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
155594144|NCT01931475|561600790|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
155594145|NCT01931475|561600791|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
155594146|NCT01931475|561600790|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
155594147|NCT01931475|561600791|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
155594148|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
155594149|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
155594150|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
155594151|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
155594152|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
155594153|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
155594154|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
155594155|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
155594156|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
155594157|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
155594158|NCT01931475|561600790|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
155594159|NCT01931475|561600791|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
155594160|NCT02423343|561600794|FG000|Overall Study|Withdrawal by Subject|0|||
155594161|NCT02423343|561600795|FG001|Overall Study|Withdrawal by Subject|1|||
155594162|NCT02423343|561600796|FG002|Overall Study|Withdrawal by Subject|0|||
155594163|NCT02423343|561600797|FG003|Overall Study|Withdrawal by Subject|0|||
155594164|NCT02423343|561600798|FG004|Overall Study|Withdrawal by Subject|0|||
155594165|NCT02423343|561600799|FG005|Overall Study|Withdrawal by Subject|0|||
155594166|NCT02423343|561600794|FG000|Overall Study|Progressive Disease|0|||
155594167|NCT02423343|561600795|FG001|Overall Study|Progressive Disease|0|||
155594168|NCT02423343|561600796|FG002|Overall Study|Progressive Disease|0|||
155594169|NCT02423343|561600797|FG003|Overall Study|Progressive Disease|0|||
155594170|NCT02423343|561600798|FG004|Overall Study|Progressive Disease|2|||
155594171|NCT02423343|561600799|FG005|Overall Study|Progressive Disease|0|||
155594172|NCT02423343|561600794|FG000|Overall Study|Adverse Event|0|||
155594173|NCT02423343|561600795|FG001|Overall Study|Adverse Event|0|||
155594174|NCT02423343|561600796|FG002|Overall Study|Adverse Event|0|||
155594175|NCT02423343|561600797|FG003|Overall Study|Adverse Event|0|||
155594176|NCT02423343|561600798|FG004|Overall Study|Adverse Event|2|||
155594177|NCT02423343|561600799|FG005|Overall Study|Adverse Event|0|||
155594178|NCT02423343|561600794|FG000|Overall Study|Death|0|||
155594179|NCT02423343|561600795|FG001|Overall Study|Death|0|||
155594180|NCT02423343|561600796|FG002|Overall Study|Death|0|||
155594181|NCT02423343|561600797|FG003|Overall Study|Death|0|||
155594182|NCT02423343|561600798|FG004|Overall Study|Death|1|||
155594183|NCT02423343|561600799|FG005|Overall Study|Death|0|||
155594184|NCT02111577|561600800|FG000|Overall Study|Protocol Violation|2|||
155594185|NCT02111577|561600801|FG001|Overall Study|Protocol Violation|0|||
155594186|NCT02111577|561600800|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
155594187|NCT02111577|561600801|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
155594188|NCT02111577|561600800|FG000|Overall Study|Failure to produce study treatment|6|||
155594189|NCT02111577|561600801|FG001|Overall Study|Failure to produce study treatment|0|||
155594190|NCT02111577|561600800|FG000|Overall Study|Death|518|||
155594191|NCT02111577|561600801|FG001|Overall Study|Death|254|||
155594192|NCT02111577|561600800|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
155594193|NCT02111577|561600801|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
155594194|NCT02111577|561600800|FG000|Overall Study|Adverse Event|1|||
155594195|NCT02111577|561600801|FG001|Overall Study|Adverse Event|1|||
155594196|NCT02111577|561600800|FG000|Overall Study|Withdrawal by Subject|51|||
155594197|NCT02111577|561600801|FG001|Overall Study|Withdrawal by Subject|23|||
155594198|NCT02111577|561600800|FG000|Overall Study|Disease progression|0|||
155594199|NCT02111577|561600801|FG001|Overall Study|Disease progression|1|||
155594200|NCT02111577|561600800|FG000|Overall Study|Lost to Follow-up|19|||
155594201|NCT02111577|561600801|FG001|Overall Study|Lost to Follow-up|10|||
155594202|NCT04967885|561600802|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
155594203|NCT04967885|561600803|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
155594204|NCT04967885|561600802|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
155594205|NCT04967885|561600803|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
155594206|NCT04967885|561600802|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
155594207|NCT04967885|561600803|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
155594208|NCT04967885|561600802|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
155594209|NCT04967885|561600803|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
155594210|NCT04967885|561600802|FG000|EMI-II Intervention|Lost to Follow-up|14|||
155594211|NCT04967885|561600803|FG001|EMI-II Intervention|Lost to Follow-up|10|||
155594212|NCT00654875|561600804|FG000|Overall Study|Adverse Event|5|||
155594213|NCT00654875|561600805|FG001|Overall Study|Adverse Event|5|||
155594214|NCT00654875|561600804|FG000|Overall Study|Withdrawal by Subject|4|||
155594215|NCT00654875|561600805|FG001|Overall Study|Withdrawal by Subject|4|||
155594216|NCT00654875|561600804|FG000|Overall Study|Protocol Violation|3|||
155594217|NCT00654875|561600805|FG001|Overall Study|Protocol Violation|3|||
155594218|NCT00654875|561600804|FG000|Overall Study|Lack of Efficacy|2|||
155594219|NCT00654875|561600805|FG001|Overall Study|Lack of Efficacy|2|||
155594220|NCT00654875|561600804|FG000|Overall Study|Lost to Follow-up|1|||
155594221|NCT00654875|561600805|FG001|Overall Study|Lost to Follow-up|3|||
155594222|NCT00654875|561600804|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155594223|NCT00654875|561600805|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155594224|NCT00654875|561600804|FG000|Overall Study|Administrative Problems|1|||
155594225|NCT00654875|561600805|FG001|Overall Study|Administrative Problems|0|||
155594226|NCT01011465|561600806|FG000|Overall Study|Withdrawal by Subject|2|||
155594227|NCT01011465|561600807|FG001|Overall Study|Withdrawal by Subject|1|||
155594228|NCT01011465|561600808|FG002|Overall Study|Withdrawal by Subject|0|||
155594229|NCT01011465|561600809|FG003|Overall Study|Withdrawal by Subject|0|||
155594230|NCT01011465|561600810|FG004|Overall Study|Withdrawal by Subject|1|||
155594231|NCT01011465|561600811|FG005|Overall Study|Withdrawal by Subject|0|||
155594232|NCT01011465|561600812|FG006|Overall Study|Withdrawal by Subject|1|||
155594233|NCT01011465|561600813|FG007|Overall Study|Withdrawal by Subject|0|||
155594234|NCT02042950|561600816|FG000|Overall Study|Progressive Disease|4|||
155594235|NCT00723008|561600817|FG000|Enrollment|Lost to Follow-up|1|||
155594236|NCT00723008|561600818|FG001|Enrollment|Lost to Follow-up|0|||
155594237|NCT00723008|561600817|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
155594238|NCT00723008|561600818|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
155594239|NCT00723008|561600817|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
155594240|NCT00723008|561600818|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
155594241|NCT00723008|561600817|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
155594242|NCT00723008|561600818|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
155594243|NCT00723008|561600817|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
155594244|NCT00723008|561600818|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
155594245|NCT00723008|561600817|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
155594246|NCT00723008|561600818|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
155594247|NCT01014988|561600822|FG000|Overall Study|Adverse Event|20|||
155594248|NCT01014988|561600823|FG001|Overall Study|Adverse Event|0|||
155594249|NCT01014988|561600824|FG002|Overall Study|Adverse Event|1|||
155594250|NCT01014988|561600825|FG003|Overall Study|Adverse Event|0|||
155594251|NCT01014988|561600826|FG004|Overall Study|Adverse Event|1|||
155594252|NCT01014988|561600827|FG005|Overall Study|Adverse Event|3|||
155594253|NCT01014988|561600822|FG000|Overall Study|Lost to Follow-up|1|||
155594254|NCT01014988|561600823|FG001|Overall Study|Lost to Follow-up|0|||
155594255|NCT01014988|561600824|FG002|Overall Study|Lost to Follow-up|1|||
155594256|NCT01014988|561600825|FG003|Overall Study|Lost to Follow-up|0|||
155594257|NCT01014988|561600826|FG004|Overall Study|Lost to Follow-up|0|||
155668994|NCT04179305|561882252|FG001|Overall Study|Did not have scan|0|||
155594258|NCT01014988|561600827|FG005|Overall Study|Lost to Follow-up|0|||
155594259|NCT01014988|561600822|FG000|Overall Study|Physician Decision|1|||
155594260|NCT01014988|561600823|FG001|Overall Study|Physician Decision|0|||
155594261|NCT01014988|561600824|FG002|Overall Study|Physician Decision|0|||
155594262|NCT01014988|561600825|FG003|Overall Study|Physician Decision|0|||
155594263|NCT01014988|561600826|FG004|Overall Study|Physician Decision|0|||
155594264|NCT01014988|561600827|FG005|Overall Study|Physician Decision|0|||
155594265|NCT01014988|561600822|FG000|Overall Study|Withdrawal by Subject|1|||
155594266|NCT01014988|561600823|FG001|Overall Study|Withdrawal by Subject|0|||
155594267|NCT01014988|561600824|FG002|Overall Study|Withdrawal by Subject|0|||
155594268|NCT01014988|561600825|FG003|Overall Study|Withdrawal by Subject|0|||
155594269|NCT01014988|561600826|FG004|Overall Study|Withdrawal by Subject|0|||
155594270|NCT01014988|561600827|FG005|Overall Study|Withdrawal by Subject|0|||
155594271|NCT01254318|561600828|FG000|Overall Study|Lost to Follow-up|5|||
155594272|NCT01254318|561600828|FG000|Overall Study|Death|47|||
155594273|NCT01137110|561600835|FG000|Overall Study|Protocol Violation|1|||
155594274|NCT01137110|561600836|FG001|Overall Study|Protocol Violation|0|||
155594275|NCT03482453|561600844|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594276|NCT03482453|561600845|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594277|NCT03482453|561600846|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594278|NCT03482453|561600847|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594279|NCT03482453|561600848|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594280|NCT03482453|561600849|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594281|NCT03482453|561600850|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594282|NCT03482453|561600851|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594283|NCT03482453|561600852|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594284|NCT03482453|561600853|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594285|NCT03482453|561600854|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
155594286|NCT03482453|561600855|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155594287|NCT03478644|561600858|FG000|Phase 2|Withdrawal by Subject|2|||
155594288|NCT03478644|561600859|FG001|Phase 2|Withdrawal by Subject|1|||
155594289|NCT03478644|561600858|FG000|Phase 2|Lost to Follow-up|1|||
155594290|NCT03478644|561600859|FG001|Phase 2|Lost to Follow-up|0|||
155594291|NCT00767455|561600860|FG000|Overall Study|Investigator error|19|||
155594292|NCT03634033|561602841|FG000|Overall Study|Did not have a post-assessment|384|||
155594293|NCT03634033|561602842|FG001|Overall Study|Did not have a post-assessment|291|||
155594294|NCT03634033|561602843|FG002|Overall Study|Did not have a post-assessment|114|||
155594295|NCT03634033|561602844|FG003|Overall Study|Did not have a post-assessment|161|||
155594296|NCT03634033|561602845|FG004|Overall Study|Did not have a post-assessment|5|||
155594297|NCT03634033|561602846|FG005|Overall Study|Did not have a post-assessment|0|||
155594298|NCT03634033|561602847|FG006|Overall Study|Did not have a post-assessment|0|||
155594299|NCT03634033|561602841|FG000|Overall Study|Death|0|||
155594300|NCT03634033|561602842|FG001|Overall Study|Death|0|||
155594301|NCT03634033|561602843|FG002|Overall Study|Death|0|||
155594302|NCT03634033|561602844|FG003|Overall Study|Death|0|||
155594303|NCT03634033|561602845|FG004|Overall Study|Death|0|||
155594304|NCT03634033|561602846|FG005|Overall Study|Death|7|||
155594305|NCT03634033|561602847|FG006|Overall Study|Death|7|||
155594306|NCT03634033|561602841|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155594307|NCT03634033|561602842|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155594308|NCT03634033|561602843|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155594309|NCT03634033|561602844|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155594310|NCT03634033|561602845|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155594311|NCT03634033|561602846|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
155594312|NCT03634033|561602847|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
155594313|NCT03634033|561602841|FG000|Overall Study|Lost to Follow-up|0|||
155594314|NCT03634033|561602842|FG001|Overall Study|Lost to Follow-up|0|||
155594315|NCT03634033|561602843|FG002|Overall Study|Lost to Follow-up|0|||
155594316|NCT03634033|561602844|FG003|Overall Study|Lost to Follow-up|0|||
155594317|NCT03634033|561602845|FG004|Overall Study|Lost to Follow-up|0|||
155594318|NCT03634033|561602846|FG005|Overall Study|Lost to Follow-up|1|||
155594319|NCT03634033|561602847|FG006|Overall Study|Lost to Follow-up|2|||
155594320|NCT03634033|561602841|FG000|Overall Study|Withdrawal by Subject|0|||
155594321|NCT03634033|561602842|FG001|Overall Study|Withdrawal by Subject|0|||
155594322|NCT03634033|561602843|FG002|Overall Study|Withdrawal by Subject|0|||
155594323|NCT03634033|561602844|FG003|Overall Study|Withdrawal by Subject|0|||
155594324|NCT03634033|561602845|FG004|Overall Study|Withdrawal by Subject|0|||
155594325|NCT03634033|561602846|FG005|Overall Study|Withdrawal by Subject|0|||
155594326|NCT03634033|561602847|FG006|Overall Study|Withdrawal by Subject|1|||
155594327|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
155594328|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
155594329|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
155594330|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
155594331|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Death|0|||
155594332|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Death|0|||
155594333|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Death|1|||
155594334|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Death|0|||
155594335|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
155594336|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155594337|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155594338|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155594339|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
155594340|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155594341|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
155594342|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
155594343|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
155594344|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
155594345|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
155594346|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
155594347|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
155594348|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
155594349|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
155594350|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
155594351|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
155594352|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
155594353|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
155594354|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
155594355|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
155594356|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
155594357|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
155594358|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
155594359|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155594360|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
155594361|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155594362|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155594363|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
155594364|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
155594365|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
155594366|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
155594367|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
155594368|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
155594369|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
155594370|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
155594371|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Other|8|||
155594372|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Other|14|||
155594373|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Other|8|||
155594374|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Other|23|||
155594375|NCT01106677|561602849|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
155594376|NCT01106677|561602850|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
155594377|NCT01106677|561602851|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
155594378|NCT01106677|561602852|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
155594379|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155594380|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155594381|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
155594382|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
155594383|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Death|0|||
155594384|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Death|0|||
155594385|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Death|0|||
155594386|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Death|1|||
155594387|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
155594388|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
155594389|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
155594390|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
155594391|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155594392|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155594393|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155594394|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155594395|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155594396|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
155594397|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155594398|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
155594399|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155594400|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155594401|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155594402|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155594403|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155594404|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
155594405|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
155594406|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155594407|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
155668995|NCT04179305|561882253|FG002|Overall Study|Did not have scan|0|||
155668996|NCT04179305|561882254|FG003|Overall Study|Did not have scan|0|||
155668997|NCT04179305|561882251|FG000|Overall Study|In hospice care|3|||
155668998|NCT04179305|561882252|FG001|Overall Study|In hospice care|0|||
155668999|NCT04179305|561882253|FG002|Overall Study|In hospice care|0|||
155669000|NCT04179305|561882254|FG003|Overall Study|In hospice care|0|||
155669001|NCT00326599|561882255|FG000|Overall Study|Withdrawal by Subject|1|||
155669002|NCT00326599|561882256|FG001|Overall Study|Withdrawal by Subject|0|||
155669003|NCT00326599|561882257|FG002|Overall Study|Withdrawal by Subject|5|||
155669004|NCT00326599|561882258|FG003|Overall Study|Withdrawal by Subject|2|||
155669005|NCT00326599|561882255|FG000|Overall Study|Adverse Event|1|||
155669006|NCT00326599|561882256|FG001|Overall Study|Adverse Event|0|||
155669007|NCT00326599|561882257|FG002|Overall Study|Adverse Event|32|||
155669008|NCT00326599|561882258|FG003|Overall Study|Adverse Event|3|||
155669009|NCT00326599|561882255|FG000|Overall Study|Disease Progression|3|||
155669010|NCT00326599|561882256|FG001|Overall Study|Disease Progression|1|||
155669011|NCT00326599|561882257|FG002|Overall Study|Disease Progression|13|||
155669012|NCT00326599|561882258|FG003|Overall Study|Disease Progression|11|||
155669013|NCT00326599|561882255|FG000|Overall Study|Alternate Treatment|1|||
155669014|NCT00326599|561882256|FG001|Overall Study|Alternate Treatment|0|||
155669015|NCT00326599|561882257|FG002|Overall Study|Alternate Treatment|0|||
155669016|NCT00326599|561882258|FG003|Overall Study|Alternate Treatment|0|||
155669017|NCT00326599|561882255|FG000|Overall Study|Death|0|||
155669018|NCT00326599|561882256|FG001|Overall Study|Death|0|||
155669019|NCT00326599|561882257|FG002|Overall Study|Death|1|||
155669020|NCT00326599|561882258|FG003|Overall Study|Death|2|||
155669021|NCT00326599|561882255|FG000|Overall Study|Other Unspecified Reason|0|||
155669022|NCT00326599|561882256|FG001|Overall Study|Other Unspecified Reason|0|||
155669023|NCT00326599|561882257|FG002|Overall Study|Other Unspecified Reason|2|||
155669024|NCT00326599|561882258|FG003|Overall Study|Other Unspecified Reason|1|||
155669025|NCT00657267|561882270|FG000|Overall Study|Progressive disease|45|||
155669026|NCT00657267|561882270|FG000|Overall Study|Adverse Event|9|||
155669027|NCT02737501|561882271|FG000|Randomized Phase|Died|41|||
155669028|NCT02737501|561882272|FG001|Randomized Phase|Died|29|||
155669029|NCT02737501|561882273|FG002|Randomized Phase|Died|0|||
155669030|NCT02737501|561882271|FG000|Randomized Phase|Withdrawal by Subject|16|||
155669031|NCT02737501|561882272|FG001|Randomized Phase|Withdrawal by Subject|6|||
155669032|NCT02737501|561882273|FG002|Randomized Phase|Withdrawal by Subject|0|||
155669033|NCT02737501|561882271|FG000|Randomized Phase|Lost to Follow-up|0|||
155669034|NCT02737501|561882272|FG001|Randomized Phase|Lost to Follow-up|1|||
155669035|NCT02737501|561882273|FG002|Randomized Phase|Lost to Follow-up|0|||
155669036|NCT02737501|561882271|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
155669037|NCT02737501|561882272|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
155669038|NCT02737501|561882273|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
155669039|NCT02737501|561882271|FG000|Randomized Phase|Reason not Specified|1|||
155669040|NCT02737501|561882272|FG001|Randomized Phase|Reason not Specified|1|||
155669041|NCT02737501|561882273|FG002|Randomized Phase|Reason not Specified|0|||
155669042|NCT02737501|561882271|FG000|Randomized Phase|Never Treated|1|||
155669043|NCT02737501|561882272|FG001|Randomized Phase|Never Treated|1|||
155669044|NCT02737501|561882273|FG002|Randomized Phase|Never Treated|0|||
155669045|NCT02737501|561882271|FG000|Crossover Phase|Died|0|||
155669046|NCT02737501|561882272|FG001|Crossover Phase|Died|0|||
155669047|NCT02737501|561882273|FG002|Crossover Phase|Died|22|||
155669048|NCT02737501|561882271|FG000|Crossover Phase|Withdrew Consent|0|||
155669049|NCT02737501|561882272|FG001|Crossover Phase|Withdrew Consent|0|||
155669050|NCT02737501|561882273|FG002|Crossover Phase|Withdrew Consent|9|||
155669051|NCT02737501|561882271|FG000|Crossover Phase|Physician Decision|0|||
155669052|NCT02737501|561882272|FG001|Crossover Phase|Physician Decision|0|||
155669053|NCT02737501|561882273|FG002|Crossover Phase|Physician Decision|1|||
155669054|NCT02737501|561882271|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
155669055|NCT02737501|561882272|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
155669056|NCT02737501|561882273|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
155669057|NCT01070979|561882276|FG000|Overall Study|Adverse Event|2|||
155669058|NCT01070979|561882277|FG001|Overall Study|Adverse Event|3|||
155669059|NCT01070979|561882278|FG002|Overall Study|Adverse Event|3|||
155669060|NCT01070979|561882276|FG000|Overall Study|Lost to Follow-up|2|||
155669061|NCT01070979|561882277|FG001|Overall Study|Lost to Follow-up|1|||
155669062|NCT01070979|561882278|FG002|Overall Study|Lost to Follow-up|1|||
155669063|NCT01070979|561882276|FG000|Overall Study|Protocol Violation|0|||
155669064|NCT01070979|561882277|FG001|Overall Study|Protocol Violation|2|||
155669065|NCT01070979|561882278|FG002|Overall Study|Protocol Violation|6|||
155669066|NCT01070979|561882276|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
155669067|NCT01070979|561882277|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
155669068|NCT01070979|561882278|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
155669069|NCT01070979|561882276|FG000|Overall Study|Withdrawal by Subject|3|||
155669070|NCT01070979|561882277|FG001|Overall Study|Withdrawal by Subject|1|||
155669071|NCT01070979|561882278|FG002|Overall Study|Withdrawal by Subject|1|||
155669072|NCT01070979|561882276|FG000|Overall Study|No study drug taken|0|||
155669073|NCT01070979|561882277|FG001|Overall Study|No study drug taken|1|||
155669074|NCT01070979|561882278|FG002|Overall Study|No study drug taken|0|||
155669075|NCT00142792|561882279|FG000|Overall Study|Death|0|||
155669076|NCT00142792|561882280|FG001|Overall Study|Death|0|||
155669077|NCT00142792|561882281|FG002|Overall Study|Death|1|||
155669078|NCT00142792|561882279|FG000|Overall Study|Withdrawal by Subject|3|||
155669079|NCT00142792|561882280|FG001|Overall Study|Withdrawal by Subject|2|||
155669080|NCT00142792|561882281|FG002|Overall Study|Withdrawal by Subject|3|||
155669081|NCT00142792|561882279|FG000|Overall Study|Lost to Follow-up|8|||
155669082|NCT00142792|561882280|FG001|Overall Study|Lost to Follow-up|11|||
155669083|NCT00142792|561882281|FG002|Overall Study|Lost to Follow-up|7|||
155669084|NCT00142792|561882279|FG000|Overall Study|No category|1|||
155669085|NCT00142792|561882280|FG001|Overall Study|No category|2|||
155669086|NCT00142792|561882281|FG002|Overall Study|No category|1|||
155669087|NCT03069716|561882282|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
155669088|NCT03069716|561882283|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
155669089|NCT03069716|561882284|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
155669090|NCT03069716|561882282|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
155669091|NCT03069716|561882283|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
155669092|NCT03069716|561882284|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
155669093|NCT03069716|561882282|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
155669094|NCT03069716|561882283|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
155669095|NCT03069716|561882284|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
155669096|NCT03069716|561882282|FG000|Randomized Treatment|Withdrawal by Subject|0|||
155669097|NCT03069716|561882283|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155669098|NCT03069716|561882284|FG002|Randomized Treatment|Withdrawal by Subject|0|||
155669099|NCT01673126|561882285|FG000|Overall Study|change of diagnosis|4|||
155669100|NCT01673126|561882286|FG001|Overall Study|change of diagnosis|3|||
155669101|NCT00237042|561882289|FG000|Treatment|Became ineligible post-randomization|0|||
155669102|NCT00237042|561882290|FG001|Treatment|Became ineligible post-randomization|1|||
155669103|NCT00237042|561882291|FG002|Treatment|Became ineligible post-randomization|16|||
155669104|NCT00237042|561882289|FG000|Treatment|Moved out of state|1|||
155669105|NCT00237042|561882290|FG001|Treatment|Moved out of state|1|||
155669106|NCT00237042|561882291|FG002|Treatment|Moved out of state|1|||
155669107|NCT00237042|561882289|FG000|Treatment|Completed no treatment|5|||
155669108|NCT00237042|561882290|FG001|Treatment|Completed no treatment|5|||
155669109|NCT00237042|561882291|FG002|Treatment|Completed no treatment|21|||
155669110|NCT00237042|561882289|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
155669111|NCT00237042|561882290|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
155669112|NCT00237042|561882291|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
155669113|NCT00237042|561882289|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
155669114|NCT00237042|561882290|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
155669115|NCT00237042|561882291|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
155669116|NCT01913327|561882294|FG000|Overall Study|Withdrawal by Subject|0|||
155669117|NCT01913327|561882295|FG001|Overall Study|Withdrawal by Subject|1|||
155669118|NCT03132467|561882296|FG000|Overall Study|Adverse Event|2|||
155669119|NCT03132467|561882296|FG000|Overall Study|Withdrawal by Subject|2|||
155669120|NCT00841776|561883548|FG000|Overall Study|Lack of Efficacy|0|||
155669121|NCT00841776|561883549|FG001|Overall Study|Lack of Efficacy|1|||
155669122|NCT00841776|561883548|FG000|Overall Study|Lost to Follow-up|2|||
155669123|NCT00841776|561883549|FG001|Overall Study|Lost to Follow-up|1|||
155669124|NCT00841776|561883548|FG000|Overall Study|Withdrawal by Subject|0|||
155669125|NCT00841776|561883549|FG001|Overall Study|Withdrawal by Subject|1|||
155669126|NCT04245449|561883550|FG000|Overall Study|COVID shutdown|7|||
155669127|NCT00355368|561883553|FG000|Overall Study|Protocol Violation|8|||
155669128|NCT00355368|561883554|FG001|Overall Study|Protocol Violation|7|||
155669129|NCT00355368|561883553|FG000|Overall Study|cardiac arrest prior to intubation|2|||
155669130|NCT00355368|561883554|FG001|Overall Study|cardiac arrest prior to intubation|2|||
155669131|NCT01349673|561883555|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
155669132|NCT01349673|561883555|FG000|Overall Study|No Longer Qualified For Study|1|||
155669133|NCT01349673|561883555|FG000|Overall Study|Site Closure|10|||
155669134|NCT01349673|561883555|FG000|Overall Study|Withdrawal by Subject|21|||
155669135|NCT01349673|561883555|FG000|Overall Study|Lost to Follow-up|6|||
155669136|NCT01349673|561883555|FG000|Overall Study|Adverse Event|17|||
155669137|NCT01349673|561883555|FG000|Overall Study|Study Terminated By Sponsor|50|||
155669138|NCT01349673|561883555|FG000|Overall Study|Lack of Efficacy|8|||
155669139|NCT00347932|561883558|FG000|Overall Study|Adverse Event|4|||
155669140|NCT00347932|561883559|FG001|Overall Study|Adverse Event|5|||
155669141|NCT00347932|561883558|FG000|Overall Study|Lack of Efficacy|3|||
155669142|NCT00347932|561883559|FG001|Overall Study|Lack of Efficacy|14|||
155669143|NCT00347932|561883558|FG000|Overall Study|Lost to Follow-up|10|||
155669144|NCT00347932|561883559|FG001|Overall Study|Lost to Follow-up|9|||
155669145|NCT00347932|561883558|FG000|Overall Study|Withdrawal by Subject|10|||
155669146|NCT00347932|561883559|FG001|Overall Study|Withdrawal by Subject|16|||
155669147|NCT00347932|561883558|FG000|Overall Study|Did not meet inclusion criteria|4|||
155669148|NCT00347932|561883559|FG001|Overall Study|Did not meet inclusion criteria|8|||
155669149|NCT00589797|561883569|FG000|Overall Study|Death|1|||
155669150|NCT00589797|561883570|FG001|Overall Study|Death|0|||
155669151|NCT00589797|561883569|FG000|Overall Study|Lost to Follow-up|12|||
155669152|NCT00589797|561883570|FG001|Overall Study|Lost to Follow-up|9|||
155669153|NCT00589797|561883569|FG000|Overall Study|Physician Decision|8|||
155669154|NCT00589797|561883570|FG001|Overall Study|Physician Decision|3|||
155669155|NCT00589797|561883569|FG000|Overall Study|Withdrawal by Subject|6|||
155669156|NCT00589797|561883570|FG001|Overall Study|Withdrawal by Subject|5|||
155669157|NCT00589797|561883569|FG000|Overall Study|Non-Randomized Training Subjects|46|||
155669158|NCT00589797|561883570|FG001|Overall Study|Non-Randomized Training Subjects|6|||
155669159|NCT04011735|561883575|FG000|Overall Study|Withdrawal by Subject|1|||
155669160|NCT04011735|561883576|FG001|Overall Study|Withdrawal by Subject|0|||
155669161|NCT04011735|561883577|FG002|Overall Study|Withdrawal by Subject|1|||
155669162|NCT04011735|561883575|FG000|Overall Study|Met exclusion criteria after study entry|0|||
155669163|NCT04011735|561883576|FG001|Overall Study|Met exclusion criteria after study entry|1|||
155669164|NCT04011735|561883577|FG002|Overall Study|Met exclusion criteria after study entry|0|||
155669165|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
155669166|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
155669167|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
155669168|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
155669169|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
155669170|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
155669171|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
155669172|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
155669173|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
155669174|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
155669175|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
155669176|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
155669177|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
155669178|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
155669179|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
155669180|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
155669181|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
155669182|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
155669183|NCT02831855|561883578|FG000|Open Label Phase (24 Weeks)|Other|4|||
155669184|NCT02831855|561883579|FG001|Open Label Phase (24 Weeks)|Other|0|||
155669185|NCT02831855|561883580|FG002|Open Label Phase (24 Weeks)|Other|0|||
155669186|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
155669187|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
155669188|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
155669189|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Death|0|||
155669190|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Death|0|||
155669191|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Death|2|||
155669192|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
155669193|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
155669194|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
155669195|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
155669196|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
155669197|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
155669198|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
155669199|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
155669200|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
155669201|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Other|0|||
155669202|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Other|2|||
155669203|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Other|5|||
155669204|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
155669205|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
155669206|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
155669207|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
155669208|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
155669209|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
155669210|NCT02831855|561883578|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
155669211|NCT02831855|561883579|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
155669212|NCT02831855|561883580|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
155669213|NCT02688192|561883582|FG000|Overall Study|Lost to Follow-up|11|||
155669214|NCT02688192|561883583|FG001|Overall Study|Lost to Follow-up|5|||
155669215|NCT02688192|561883582|FG000|Overall Study|Physician Decision|1|||
155669216|NCT02688192|561883583|FG001|Overall Study|Physician Decision|0|||
155669217|NCT01459666|561883588|FG000|Overall Study|PI left institution|5|||
155669218|NCT01459666|561883589|FG001|Overall Study|PI left institution|4|||
155669219|NCT01061385|561883591|FG000|Overall Study|Lost to Follow-up|1|||
155669220|NCT01061385|561883592|FG001|Overall Study|Lost to Follow-up|0|||
155669221|NCT01061385|561883591|FG000|Overall Study|subject decision not related to AE|0|||
155669222|NCT01061385|561883592|FG001|Overall Study|subject decision not related to AE|1|||
155669223|NCT00533429|561883593|FG000|Overall Study|Adverse Event|3|||
155669224|NCT00533429|561883594|FG001|Overall Study|Adverse Event|1|||
155669225|NCT00533429|561883593|FG000|Overall Study|Death|1|||
155669226|NCT00533429|561883594|FG001|Overall Study|Death|0|||
155669227|NCT00533429|561883593|FG000|Overall Study|Withdrawal by Subject|2|||
155669228|NCT00533429|561883594|FG001|Overall Study|Withdrawal by Subject|0|||
155669229|NCT00533429|561883593|FG000|Overall Study|Progressive Disease|12|||
155669230|NCT00533429|561883594|FG001|Overall Study|Progressive Disease|13|||
155669231|NCT00533429|561883593|FG000|Overall Study|Symptomatic deterioration|1|||
155669232|NCT00533429|561883594|FG001|Overall Study|Symptomatic deterioration|2|||
155669233|NCT02379052|561883601|FG000|Overall Study|Protocol Violation|0|||
155669234|NCT02379052|561883602|FG001|Overall Study|Protocol Violation|1|||
155669235|NCT02379052|561883601|FG000|Overall Study|Adverse Event|0|||
155669236|NCT02379052|561883602|FG001|Overall Study|Adverse Event|1|||
155669237|NCT02379052|561883601|FG000|Overall Study|Physician Decision|1|||
155669238|NCT02379052|561883602|FG001|Overall Study|Physician Decision|1|||
155669239|NCT02379052|561883601|FG000|Overall Study|Withdrawal by Subject|2|||
155669240|NCT02379052|561883602|FG001|Overall Study|Withdrawal by Subject|0|||
155669241|NCT02379052|561883601|FG000|Overall Study|Lost to Follow-up|2|||
155669242|NCT02379052|561883602|FG001|Overall Study|Lost to Follow-up|1|||
155669243|NCT02379052|561883601|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
155669244|NCT02379052|561883602|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
155669245|NCT02379052|561883601|FG000|Overall Study|Subject was Incarcerated|0|||
155669246|NCT02379052|561883602|FG001|Overall Study|Subject was Incarcerated|1|||
155669247|NCT00127855|561883603|FG000|Primary Vaccination Course|Adverse Event|0|||
155669248|NCT00127855|561883604|FG001|Primary Vaccination Course|Adverse Event|0|||
155669249|NCT00127855|561883605|FG002|Primary Vaccination Course|Adverse Event|1|||
155669250|NCT00127855|561883606|FG003|Primary Vaccination Course|Adverse Event|0|||
155669251|NCT00127855|561883607|FG004|Primary Vaccination Course|Adverse Event|0|||
155669252|NCT00127855|561883603|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
155669253|NCT00127855|561883604|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
155669254|NCT00127855|561883605|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
155669255|NCT00127855|561883606|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
155669256|NCT00127855|561883607|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
155669257|NCT00127855|561883603|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
155669258|NCT00127855|561883604|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
155669259|NCT00127855|561883605|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
155669260|NCT00127855|561883606|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
155669261|NCT00127855|561883607|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
155669262|NCT00127855|561883603|FG000|Primary Vaccination Course|Other|0|||
155669263|NCT00127855|561883604|FG001|Primary Vaccination Course|Other|0|||
155669264|NCT00127855|561883605|FG002|Primary Vaccination Course|Other|0|||
155669265|NCT00127855|561883606|FG003|Primary Vaccination Course|Other|0|||
155669266|NCT00127855|561883607|FG004|Primary Vaccination Course|Other|1|||
155669267|NCT02343302|561883608|FG000|Overall Study|Physician Decision|1|||
155669268|NCT02343302|561883609|FG001|Overall Study|Physician Decision|1|||
155669269|NCT02655887|561883612|FG000|Overall Study|Lost to Follow-up|3|||
155669270|NCT02655887|561883612|FG000|Overall Study|Death|4|||
155669271|NCT02655887|561883612|FG000|Overall Study|Withdrawal by Subject|3|||
155669272|NCT02655887|561883612|FG000|Overall Study|Missed 12-month follow-up visit|4|||
155669273|NCT02834819|561883613|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
155669274|NCT02834819|561883614|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
155669275|NCT04245709|561883615|FG000|Overall Study|Adverse Event|13|||
155669276|NCT04245709|561883615|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
155669277|NCT02041299|561883623|FG000|Overall Study|Adverse Event|9|||
155669278|NCT02041299|561883624|FG001|Overall Study|Adverse Event|3|||
155669279|NCT02041299|561883623|FG000|Overall Study|Lost to Follow-up|4|||
155669280|NCT02041299|561883624|FG001|Overall Study|Lost to Follow-up|1|||
155669281|NCT02041299|561883623|FG000|Overall Study|Physician Decision|1|||
155594408|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
155594409|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
155594410|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
155594411|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155594412|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155594413|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155594414|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155594415|NCT01106677|561602849|FG000|Extension Period: Week 26 to Week 52|Other|6|||
155594416|NCT01106677|561602850|FG001|Extension Period: Week 26 to Week 52|Other|5|||
155594417|NCT01106677|561602851|FG002|Extension Period: Week 26 to Week 52|Other|8|||
155594418|NCT01106677|561602852|FG003|Extension Period: Week 26 to Week 52|Other|5|||
155594419|NCT03937908|561602853|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
155594420|NCT03937908|561602854|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
155594421|NCT03875092|561602855|FG000|Overall Study|Adverse Event|2|||
155594422|NCT03875092|561602856|FG001|Overall Study|Adverse Event|5|||
155594423|NCT03875092|561602855|FG000|Overall Study|Death|44|||
155594424|NCT03875092|561602856|FG001|Overall Study|Death|51|||
155594425|NCT03875092|561602855|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
155594426|NCT03875092|561602856|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
155594427|NCT04114357|561602857|FG000|Baseline-Randomization|Adverse Event|2|||
155594428|NCT04114357|561602858|FG001|Baseline-Randomization|Adverse Event|1|||
155594429|NCT04114357|561602857|FG000|Baseline-Randomization|Lost to Follow-up|1|||
155594430|NCT04114357|561602858|FG001|Baseline-Randomization|Lost to Follow-up|1|||
155594431|NCT04114357|561602857|FG000|Cross-over|Adverse Event|0|||
155594432|NCT04114357|561602858|FG001|Cross-over|Adverse Event|1|||
155594433|NCT03693612|561602862|FG000|Overall Study|Lost to Follow-up|0|||
155594434|NCT03693612|561602863|FG001|Overall Study|Lost to Follow-up|0|||
155594435|NCT03693612|561602864|FG002|Overall Study|Lost to Follow-up|0|||
155594436|NCT03693612|561602865|FG003|Overall Study|Lost to Follow-up|0|||
155594437|NCT03693612|561602866|FG004|Overall Study|Lost to Follow-up|1|||
155594438|NCT03693612|561602867|FG005|Overall Study|Lost to Follow-up|0|||
155594439|NCT03693612|561602868|FG006|Overall Study|Lost to Follow-up|0|||
155594440|NCT03693612|561602862|FG000|Overall Study|Withdrawal by Subject|0|||
155594441|NCT03693612|561602863|FG001|Overall Study|Withdrawal by Subject|0|||
155594442|NCT03693612|561602864|FG002|Overall Study|Withdrawal by Subject|1|||
155594443|NCT03693612|561602865|FG003|Overall Study|Withdrawal by Subject|0|||
155594444|NCT03693612|561602866|FG004|Overall Study|Withdrawal by Subject|2|||
155594445|NCT03693612|561602867|FG005|Overall Study|Withdrawal by Subject|0|||
155594446|NCT03693612|561602868|FG006|Overall Study|Withdrawal by Subject|0|||
155594447|NCT03693612|561602862|FG000|Overall Study|Study Terminated by Sponsor|0|||
155594448|NCT03693612|561602863|FG001|Overall Study|Study Terminated by Sponsor|1|||
155594449|NCT03693612|561602864|FG002|Overall Study|Study Terminated by Sponsor|0|||
155594450|NCT03693612|561602865|FG003|Overall Study|Study Terminated by Sponsor|0|||
155594451|NCT03693612|561602866|FG004|Overall Study|Study Terminated by Sponsor|3|||
155594452|NCT03693612|561602867|FG005|Overall Study|Study Terminated by Sponsor|0|||
155594453|NCT03693612|561602868|FG006|Overall Study|Study Terminated by Sponsor|0|||
155594454|NCT00809471|561602870|FG000|Overall Study|Protocol non-compliance|15|||
155594455|NCT00809471|561602871|FG001|Overall Study|Protocol non-compliance|15|||
155594456|NCT00809471|561602872|FG002|Overall Study|Protocol non-compliance|6|||
155594457|NCT00809471|561602870|FG000|Overall Study|Lost to Follow-up|4|||
155594458|NCT00809471|561602871|FG001|Overall Study|Lost to Follow-up|2|||
155594459|NCT00809471|561602872|FG002|Overall Study|Lost to Follow-up|9|||
155594460|NCT00809471|561602870|FG000|Overall Study|Adverse Event|0|||
155594461|NCT00809471|561602871|FG001|Overall Study|Adverse Event|2|||
155594462|NCT00809471|561602872|FG002|Overall Study|Adverse Event|2|||
155594463|NCT00809471|561602870|FG000|Overall Study|Requirement for restricted medication|1|||
155594464|NCT00809471|561602871|FG001|Overall Study|Requirement for restricted medication|1|||
155594465|NCT00809471|561602872|FG002|Overall Study|Requirement for restricted medication|0|||
155594466|NCT01669174|561602882|FG000|Overall Study|Subject withdrew consent|2|||
155594467|NCT01669174|561602883|FG001|Overall Study|Subject withdrew consent|2|||
155594468|NCT01669174|561602882|FG000|Overall Study|Lost to Follow-up|1|||
155594469|NCT01669174|561602883|FG001|Overall Study|Lost to Follow-up|0|||
155594470|NCT01669174|561602882|FG000|Overall Study|Adverse Event|2|||
155594471|NCT01669174|561602883|FG001|Overall Study|Adverse Event|2|||
155594472|NCT01669174|561602882|FG000|Overall Study|Administrative problems|1|||
155594473|NCT01669174|561602883|FG001|Overall Study|Administrative problems|2|||
155594474|NCT01953601|561602887|FG000|Part 1 (Base Study)|Adverse Event|24|||
155594475|NCT01953601|561602888|FG001|Part 1 (Base Study)|Adverse Event|37|||
155594476|NCT01953601|561602889|FG002|Part 1 (Base Study)|Adverse Event|15|||
155594477|NCT01953601|561602887|FG000|Part 1 (Base Study)|Death|2|||
155594478|NCT01953601|561602888|FG001|Part 1 (Base Study)|Death|0|||
155594479|NCT01953601|561602889|FG002|Part 1 (Base Study)|Death|3|||
155594480|NCT01953601|561602887|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
155594481|NCT01953601|561602888|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
155594482|NCT01953601|561602889|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
155594483|NCT01953601|561602887|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
155594484|NCT01953601|561602888|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
155594485|NCT01953601|561602889|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
155594486|NCT01953601|561602887|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
155594487|NCT01953601|561602888|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
155594488|NCT01953601|561602889|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
155594489|NCT01953601|561602887|FG000|Part 1 (Base Study)|Physician Decision|3|||
155594490|NCT01953601|561602888|FG001|Part 1 (Base Study)|Physician Decision|7|||
155594491|NCT01953601|561602889|FG002|Part 1 (Base Study)|Physician Decision|4|||
155594492|NCT01953601|561602887|FG000|Part 1 (Base Study)|Screen failure|1|||
155594493|NCT01953601|561602888|FG001|Part 1 (Base Study)|Screen failure|0|||
155594494|NCT01953601|561602889|FG002|Part 1 (Base Study)|Screen failure|1|||
155594495|NCT01953601|561602887|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
155594496|NCT01953601|561602888|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
155594497|NCT01953601|561602889|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
155594498|NCT01953601|561602887|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
155594499|NCT01953601|561602888|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
155594500|NCT01953601|561602889|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
155594501|NCT01953601|561602887|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
155594502|NCT01953601|561602888|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
155594503|NCT01953601|561602889|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
155594504|NCT01953601|561602887|FG000|Part 1 (Base Study)|Subject moved|2|||
155594505|NCT01953601|561602888|FG001|Part 1 (Base Study)|Subject moved|2|||
155594506|NCT01953601|561602889|FG002|Part 1 (Base Study)|Subject moved|1|||
155594507|NCT01953601|561602887|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
155594508|NCT01953601|561602888|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
155594509|NCT01953601|561602889|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
155594510|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Adverse Event|1|||
155594511|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Adverse Event|1|||
155594512|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Adverse Event|10|||
155594513|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Death|0|||
155594514|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Death|3|||
155594515|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Death|0|||
155594516|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
155594517|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
155594518|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
155594519|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
155594520|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
155594521|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
155594522|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Physician Decision|2|||
155594523|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Physician Decision|0|||
155594524|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Physician Decision|2|||
155594525|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
155594526|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
155594527|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
155594528|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
155594529|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
155594530|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
155594531|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
155594532|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
155594533|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
155594534|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Subject moved|0|||
155594535|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Subject moved|0|||
155594536|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Subject moved|1|||
155594537|NCT01953601|561602887|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
155594538|NCT01953601|561602888|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
155594539|NCT01953601|561602889|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
155594540|NCT04310397|561602896|FG000|Overall Study|Lack of Efficacy|3|||
155594541|NCT04310397|561602896|FG000|Overall Study|Withdrawal by Subject|1|||
155594542|NCT00723255|561602899|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
155594543|NCT00723255|561602899|FG000|Overall Study|Ineligible: Second primary|1|||
155594544|NCT00723255|561602899|FG000|Overall Study|Ineligible: Wrong Primary|2|||
155594545|NCT00614523|561602900|FG000|Overall Study|Adverse Event|4|||
155594546|NCT00614523|561602901|FG001|Overall Study|Adverse Event|20|||
155594547|NCT00614523|561602900|FG000|Overall Study|Death|5|||
155594548|NCT00614523|561602901|FG001|Overall Study|Death|8|||
155594549|NCT00614523|561602900|FG000|Overall Study|Lack of Efficacy|9|||
155594550|NCT00614523|561602901|FG001|Overall Study|Lack of Efficacy|11|||
155594551|NCT00614523|561602900|FG000|Overall Study|Lost to Follow-up|0|||
155594552|NCT00614523|561602901|FG001|Overall Study|Lost to Follow-up|1|||
155594553|NCT00614523|561602900|FG000|Overall Study|Protocol Violation|3|||
155594554|NCT00614523|561602901|FG001|Overall Study|Protocol Violation|2|||
155594555|NCT00614523|561602900|FG000|Overall Study|Withdrawal by Subject|12|||
155594556|NCT00614523|561602901|FG001|Overall Study|Withdrawal by Subject|22|||
155594557|NCT00614523|561602900|FG000|Overall Study|Other|6|||
155594558|NCT00614523|561602901|FG001|Overall Study|Other|11|||
155594559|NCT00614523|561602900|FG000|Overall Study|Ineligibility Determined|1|||
155594560|NCT00614523|561602901|FG001|Overall Study|Ineligibility Determined|2|||
155594561|NCT00614523|561602900|FG000|Overall Study|Disease Progression|0|||
155594562|NCT00614523|561602901|FG001|Overall Study|Disease Progression|8|||
155594563|NCT00614523|561602900|FG000|Overall Study|Administrative Decision|23|||
155594564|NCT00614523|561602901|FG001|Overall Study|Administrative Decision|46|||
155594565|NCT03962790|561602904|FG000|Period 1|Adverse Event|0|||
155594566|NCT03962790|561602905|FG001|Period 1|Adverse Event|1|||
155594567|NCT03962790|561602904|FG000|Period 1|Failed to meet all eligibility criteria|1|||
155594568|NCT03962790|561602905|FG001|Period 1|Failed to meet all eligibility criteria|1|||
155594569|NCT03962790|561602904|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
155594570|NCT03962790|561602905|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
155594571|NCT03962790|561602904|FG000|Period 1|Withdrawal by Subject|1|||
155594572|NCT03962790|561602905|FG001|Period 1|Withdrawal by Subject|0|||
155594573|NCT03854370|561602915|FG000|Overall Study|samples not collected|1|||
155594574|NCT03854370|561602916|FG001|Overall Study|samples not collected|1|||
155594575|NCT03854370|561602917|FG002|Overall Study|samples not collected|1|||
155594576|NCT03854370|561602918|FG003|Overall Study|samples not collected|1|||
155594577|NCT00452673|561602922|FG000|Dose Escalation Period|Disease Progression|6|||
155594578|NCT00452673|561602923|FG001|Dose Escalation Period|Disease Progression|6|||
155594579|NCT00452673|561602924|FG002|Dose Escalation Period|Disease Progression|2|||
155594580|NCT00452673|561602925|FG003|Dose Escalation Period|Disease Progression|6|||
155594581|NCT00452673|561602926|FG004|Dose Escalation Period|Disease Progression|0|||
155594582|NCT00452673|561602922|FG000|Dose Escalation Period|study drug toxicity|1|||
155594583|NCT00452673|561602923|FG001|Dose Escalation Period|study drug toxicity|3|||
155594584|NCT00452673|561602924|FG002|Dose Escalation Period|study drug toxicity|3|||
155594585|NCT00452673|561602925|FG003|Dose Escalation Period|study drug toxicity|1|||
155594586|NCT00452673|561602926|FG004|Dose Escalation Period|study drug toxicity|0|||
155594587|NCT00452673|561602922|FG000|Dose Escalation Period|Other|0|||
155594588|NCT00452673|561602923|FG001|Dose Escalation Period|Other|0|||
155594589|NCT00452673|561602924|FG002|Dose Escalation Period|Other|1|||
155594590|NCT00452673|561602925|FG003|Dose Escalation Period|Other|0|||
155594591|NCT00452673|561602926|FG004|Dose Escalation Period|Other|0|||
155594592|NCT00452673|561602922|FG000|Dose Escalation Period|Adverse Event|0|||
155594593|NCT00452673|561602923|FG001|Dose Escalation Period|Adverse Event|0|||
155594594|NCT00452673|561602924|FG002|Dose Escalation Period|Adverse Event|0|||
155594595|NCT00452673|561602925|FG003|Dose Escalation Period|Adverse Event|1|||
155594596|NCT00452673|561602926|FG004|Dose Escalation Period|Adverse Event|0|||
155594597|NCT00452673|561602922|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
155594598|NCT00452673|561602923|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
155594599|NCT00452673|561602924|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
155594600|NCT00452673|561602925|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
155594601|NCT00452673|561602926|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
155594602|NCT00452673|561602922|FG000|Dose Expansion Period|Disease Progression|0|||
155594603|NCT00452673|561602923|FG001|Dose Expansion Period|Disease Progression|0|||
155594604|NCT00452673|561602924|FG002|Dose Expansion Period|Disease Progression|0|||
155594605|NCT00452673|561602925|FG003|Dose Expansion Period|Disease Progression|0|||
155594606|NCT00452673|561602926|FG004|Dose Expansion Period|Disease Progression|19|||
155594607|NCT00452673|561602922|FG000|Dose Expansion Period|Other|0|||
155594608|NCT00452673|561602923|FG001|Dose Expansion Period|Other|0|||
155594609|NCT00452673|561602924|FG002|Dose Expansion Period|Other|0|||
155594610|NCT00452673|561602925|FG003|Dose Expansion Period|Other|0|||
155594611|NCT00452673|561602926|FG004|Dose Expansion Period|Other|2|||
155594612|NCT02656290|561602927|FG000|Overall Study|Lost to Follow-up|1|||
155594613|NCT02656290|561602927|FG000|Overall Study|Reintervention|3|||
155594614|NCT01608087|561602930|FG000|Overall Study|Lost to Follow-up|0|||
155594615|NCT01608087|561602931|FG001|Overall Study|Lost to Follow-up|1|||
155594616|NCT01608087|561602932|FG002|Overall Study|Lost to Follow-up|0|||
155594617|NCT01608087|561602930|FG000|Overall Study|Other Reason|0|||
155594618|NCT01608087|561602931|FG001|Overall Study|Other Reason|1|||
155594619|NCT01608087|561602932|FG002|Overall Study|Other Reason|0|||
155594620|NCT00401544|561602935|FG000|Overall Study|Adverse Event|5|||
155594621|NCT00401544|561602936|FG001|Overall Study|Adverse Event|1|||
155594622|NCT00401544|561602937|FG002|Overall Study|Adverse Event|1|||
155594623|NCT00401544|561602938|FG003|Overall Study|Adverse Event|1|||
155594624|NCT00401544|561602935|FG000|Overall Study|Death|3|||
155594625|NCT00401544|561602936|FG001|Overall Study|Death|6|||
155594626|NCT00401544|561602937|FG002|Overall Study|Death|2|||
155594627|NCT00401544|561602938|FG003|Overall Study|Death|5|||
155594628|NCT00401544|561602935|FG000|Overall Study|Lost to Follow-up|2|||
155594629|NCT00401544|561602936|FG001|Overall Study|Lost to Follow-up|0|||
155594630|NCT00401544|561602937|FG002|Overall Study|Lost to Follow-up|1|||
155594631|NCT00401544|561602938|FG003|Overall Study|Lost to Follow-up|1|||
155594632|NCT00401544|561602935|FG000|Overall Study|Withdrawal by Subject|7|||
155594633|NCT00401544|561602936|FG001|Overall Study|Withdrawal by Subject|6|||
155594634|NCT00401544|561602937|FG002|Overall Study|Withdrawal by Subject|6|||
155594635|NCT00401544|561602938|FG003|Overall Study|Withdrawal by Subject|5|||
155594636|NCT00401544|561602935|FG000|Overall Study|Physician Decision|1|||
155594637|NCT00401544|561602936|FG001|Overall Study|Physician Decision|3|||
155594638|NCT00401544|561602937|FG002|Overall Study|Physician Decision|0|||
155594639|NCT00401544|561602938|FG003|Overall Study|Physician Decision|0|||
155594640|NCT00401544|561602935|FG000|Overall Study|Ineligibility determined|0|||
155594641|NCT00401544|561602936|FG001|Overall Study|Ineligibility determined|1|||
155594642|NCT00401544|561602937|FG002|Overall Study|Ineligibility determined|0|||
155594643|NCT00401544|561602938|FG003|Overall Study|Ineligibility determined|2|||
155594644|NCT00401544|561602935|FG000|Overall Study|Disease progression|0|||
155594645|NCT00401544|561602936|FG001|Overall Study|Disease progression|1|||
155594646|NCT00401544|561602937|FG002|Overall Study|Disease progression|0|||
155594647|NCT00401544|561602938|FG003|Overall Study|Disease progression|0|||
155594648|NCT00401544|561602935|FG000|Overall Study|Other|0|||
155594649|NCT00401544|561602936|FG001|Overall Study|Other|0|||
155594650|NCT00401544|561602937|FG002|Overall Study|Other|2|||
155594651|NCT00401544|561602938|FG003|Overall Study|Other|2|||
155594652|NCT04411810|561602939|FG000|Overall Study|Screen failure|1|||
155594653|NCT04411810|561602939|FG000|Overall Study|Withdrawal by Subject|1|||
155594654|NCT03991299|561602942|FG000|Overall Study|Study closed, sponsor decision|3|||
155594655|NCT03991299|561602942|FG000|Overall Study|Withdrawal by Subject|1|||
155594656|NCT04304235|561602943|FG000|Overall Study|incomplete triage data|0|||
155594657|NCT04304235|561602944|FG001|Overall Study|incomplete triage data|69|||
155594658|NCT04304235|561602945|FG002|Overall Study|incomplete triage data|0|||
155594659|NCT04304235|561602946|FG003|Overall Study|incomplete triage data|0|||
155594660|NCT04304235|561602947|FG004|Overall Study|incomplete triage data|289|||
155594661|NCT04304235|561602948|FG005|Overall Study|incomplete triage data|123|||
155594662|NCT04304235|561602949|FG006|Overall Study|incomplete triage data|65|||
155594663|NCT02278939|561602950|FG000|Overall Study|lack of time|1|||
155594664|NCT02278939|561602951|FG001|Overall Study|lack of time|0|||
155594665|NCT02278939|561602950|FG000|Overall Study|Lost to Follow-up|1|||
155594666|NCT02278939|561602951|FG001|Overall Study|Lost to Follow-up|1|||
155594667|NCT02278939|561602950|FG000|Overall Study|death in family|1|||
155594668|NCT02278939|561602951|FG001|Overall Study|death in family|0|||
155594669|NCT02278939|561602950|FG000|Overall Study|family emergency unable to commit|2|||
155594670|NCT02278939|561602951|FG001|Overall Study|family emergency unable to commit|0|||
155594671|NCT00930774|561602952|FG000|Overall Study|Withdrawal by Subject|1|||
155594672|NCT00930774|561602953|FG001|Overall Study|Withdrawal by Subject|9|||
155594673|NCT00930774|561602954|FG002|Overall Study|Withdrawal by Subject|2|||
155594674|NCT00930774|561602955|FG003|Overall Study|Withdrawal by Subject|0|||
155594675|NCT03200704|561602956|FG000|Overall Study|Withdrawal by Subject|1|||
155594676|NCT00425061|561602957|FG000|Overall Study|Adverse Event|1|||
155594677|NCT00425061|561602958|FG001|Overall Study|Adverse Event|0|||
155594678|NCT00425061|561602959|FG002|Overall Study|Adverse Event|0|||
155594679|NCT00425061|561602960|FG003|Overall Study|Adverse Event|2|||
155594680|NCT00425061|561602961|FG004|Overall Study|Adverse Event|2|||
155594681|NCT00425061|561602962|FG005|Overall Study|Adverse Event|0|||
155594682|NCT00425061|561602963|FG006|Overall Study|Adverse Event|0|||
155594683|NCT00425061|561602957|FG000|Overall Study|Lost to Follow-up|0|||
155594684|NCT00425061|561602958|FG001|Overall Study|Lost to Follow-up|1|||
155594685|NCT00425061|561602959|FG002|Overall Study|Lost to Follow-up|0|||
155594686|NCT00425061|561602960|FG003|Overall Study|Lost to Follow-up|0|||
155594687|NCT00425061|561602961|FG004|Overall Study|Lost to Follow-up|0|||
155594688|NCT00425061|561602962|FG005|Overall Study|Lost to Follow-up|0|||
155594689|NCT00425061|561602963|FG006|Overall Study|Lost to Follow-up|0|||
155594690|NCT00425061|561602957|FG000|Overall Study|Protocol Violation|1|||
155594691|NCT00425061|561602958|FG001|Overall Study|Protocol Violation|0|||
155594692|NCT00425061|561602959|FG002|Overall Study|Protocol Violation|0|||
155594693|NCT00425061|561602960|FG003|Overall Study|Protocol Violation|0|||
155594694|NCT00425061|561602961|FG004|Overall Study|Protocol Violation|0|||
155594695|NCT00425061|561602962|FG005|Overall Study|Protocol Violation|0|||
155594696|NCT00425061|561602963|FG006|Overall Study|Protocol Violation|0|||
155594697|NCT00425061|561602957|FG000|Overall Study|Withdrawal by Subject|0|||
155594698|NCT00425061|561602958|FG001|Overall Study|Withdrawal by Subject|1|||
155594699|NCT00425061|561602959|FG002|Overall Study|Withdrawal by Subject|0|||
155594700|NCT00425061|561602960|FG003|Overall Study|Withdrawal by Subject|0|||
155594701|NCT00425061|561602961|FG004|Overall Study|Withdrawal by Subject|1|||
155594702|NCT00425061|561602962|FG005|Overall Study|Withdrawal by Subject|0|||
155594703|NCT00425061|561602963|FG006|Overall Study|Withdrawal by Subject|3|||
155594704|NCT00425061|561602957|FG000|Overall Study|Sponsor's request|0|||
155594705|NCT00425061|561602958|FG001|Overall Study|Sponsor's request|0|||
155594706|NCT00425061|561602959|FG002|Overall Study|Sponsor's request|0|||
155594707|NCT00425061|561602960|FG003|Overall Study|Sponsor's request|0|||
155594708|NCT00425061|561602961|FG004|Overall Study|Sponsor's request|19|||
155594709|NCT00425061|561602962|FG005|Overall Study|Sponsor's request|4|||
155594710|NCT00425061|561602963|FG006|Overall Study|Sponsor's request|15|||
155594711|NCT00425061|561602957|FG000|Overall Study|Physician Decision|0|||
155594712|NCT00425061|561602958|FG001|Overall Study|Physician Decision|0|||
155594713|NCT00425061|561602959|FG002|Overall Study|Physician Decision|0|||
155594714|NCT00425061|561602960|FG003|Overall Study|Physician Decision|0|||
155594715|NCT00425061|561602961|FG004|Overall Study|Physician Decision|1|||
155594716|NCT00425061|561602962|FG005|Overall Study|Physician Decision|0|||
155594717|NCT00425061|561602963|FG006|Overall Study|Physician Decision|0|||
155594718|NCT00425061|561602957|FG000|Overall Study|Other|0|||
155594719|NCT00425061|561602958|FG001|Overall Study|Other|0|||
155594720|NCT00425061|561602959|FG002|Overall Study|Other|0|||
155594721|NCT00425061|561602960|FG003|Overall Study|Other|0|||
155594722|NCT00425061|561602961|FG004|Overall Study|Other|3|||
155594723|NCT00425061|561602962|FG005|Overall Study|Other|0|||
155594724|NCT00425061|561602963|FG006|Overall Study|Other|1|||
155594725|NCT03436693|561602964|FG000|Overall Study|Adverse Event|22|||
155594726|NCT03436693|561602965|FG001|Overall Study|Adverse Event|10|||
155594727|NCT03436693|561602964|FG000|Overall Study|Physician Decision|3|||
155594728|NCT03436693|561602965|FG001|Overall Study|Physician Decision|3|||
155594729|NCT03436693|561602964|FG000|Overall Study|Withdrawal by Subject|4|||
155594730|NCT03436693|561602965|FG001|Overall Study|Withdrawal by Subject|13|||
155594731|NCT03436693|561602964|FG000|Overall Study|Progressive Disease|1|||
155594732|NCT03436693|561602965|FG001|Overall Study|Progressive Disease|1|||
155594733|NCT00626821|561602968|FG000|Overall Study|Adverse Event|44|||
155594734|NCT00626821|561602968|FG000|Overall Study|Protocol Violation|33|||
155594735|NCT00626821|561602968|FG000|Overall Study|Withdrawal by Subject|10|||
155594736|NCT00626821|561602968|FG000|Overall Study|Physician Decision|9|||
155594737|NCT00626821|561602968|FG000|Overall Study|Product dysfunction|21|||
155594738|NCT00626821|561602968|FG000|Overall Study|other/unknown reason|104|||
155594739|NCT01471340|561602969|FG000|Overall Study|Death|5|||
155594740|NCT01471340|561602970|FG001|Overall Study|Death|4|||
155594741|NCT01471340|561602969|FG000|Overall Study|Lost to Follow-up|0|||
155594742|NCT01471340|561602970|FG001|Overall Study|Lost to Follow-up|1|||
155594743|NCT01471340|561602969|FG000|Overall Study|Investigational site closure|0|||
155594744|NCT01471340|561602970|FG001|Overall Study|Investigational site closure|1|||
155594745|NCT01471340|561602969|FG000|Overall Study|Invalid informed consent|1|||
155594746|NCT01471340|561602970|FG001|Overall Study|Invalid informed consent|0|||
155594747|NCT01981954|561602971|FG000|Titration Period|Protocol Deviation|1|||
155594748|NCT01981954|561602971|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
155594749|NCT01609543|561602980|FG000|Overall Study|Disease Progression|28|||
155594750|NCT01609543|561602980|FG000|Overall Study|Adverse Event|5|||
155594751|NCT01609543|561602980|FG000|Overall Study|Withdrawal by Subject|1|||
155594752|NCT01609543|561602980|FG000|Overall Study|Protocol Violation|1|||
155594753|NCT01609543|561602980|FG000|Overall Study|Death|7|||
155594754|NCT02294396|561602982|FG000|Overall Study|Adverse Event|26|||
155594755|NCT02294396|561602983|FG001|Overall Study|Adverse Event|25|||
155594756|NCT02294396|561602984|FG002|Overall Study|Adverse Event|21|||
155594757|NCT02294396|561602985|FG003|Overall Study|Adverse Event|24|||
155594758|NCT02294396|561602982|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
155594759|NCT02294396|561602983|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
155594760|NCT02294396|561602984|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
155594761|NCT02294396|561602985|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
155594762|NCT02294396|561602982|FG000|Overall Study|Withdrawal by Subject|8|||
155594763|NCT02294396|561602983|FG001|Overall Study|Withdrawal by Subject|6|||
155594764|NCT02294396|561602984|FG002|Overall Study|Withdrawal by Subject|6|||
155594765|NCT02294396|561602985|FG003|Overall Study|Withdrawal by Subject|8|||
155594766|NCT02294396|561602982|FG000|Overall Study|Lost to Follow-up|0|||
155594767|NCT02294396|561602983|FG001|Overall Study|Lost to Follow-up|0|||
155594768|NCT02294396|561602984|FG002|Overall Study|Lost to Follow-up|1|||
155594769|NCT02294396|561602985|FG003|Overall Study|Lost to Follow-up|1|||
155594770|NCT02294396|561602982|FG000|Overall Study|Protocol Deviation|3|||
155594771|NCT02294396|561602983|FG001|Overall Study|Protocol Deviation|2|||
155594772|NCT02294396|561602984|FG002|Overall Study|Protocol Deviation|2|||
155594773|NCT02294396|561602985|FG003|Overall Study|Protocol Deviation|1|||
155594774|NCT02294396|561602982|FG000|Overall Study|Miscellaneous|2|||
155594775|NCT02294396|561602983|FG001|Overall Study|Miscellaneous|0|||
155594776|NCT02294396|561602984|FG002|Overall Study|Miscellaneous|5|||
155594777|NCT02294396|561602985|FG003|Overall Study|Miscellaneous|2|||
155594778|NCT02120833|561602986|FG000|Overall Study|Adverse Event|1|||
155594779|NCT02120833|561602987|FG001|Overall Study|Adverse Event|0|||
155594780|NCT02120833|561602986|FG000|Overall Study|Withdrawal by Subject|2|||
155594781|NCT02120833|561602987|FG001|Overall Study|Withdrawal by Subject|0|||
155594782|NCT02120833|561602986|FG000|Overall Study|Lost to Follow-up|1|||
155594783|NCT02120833|561602987|FG001|Overall Study|Lost to Follow-up|1|||
155594784|NCT02438826|561602988|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
155594785|NCT02438826|561602989|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
155594786|NCT02438826|561602990|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155594787|NCT02438826|561602991|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155594788|NCT02438826|561602988|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
155594789|NCT02438826|561602989|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155594790|NCT02438826|561602990|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155594791|NCT02438826|561602991|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155594792|NCT02438826|561602988|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
155594793|NCT02438826|561602989|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
155594794|NCT02438826|561602990|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155594795|NCT02438826|561602991|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155594796|NCT02438826|561602988|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
155594797|NCT02438826|561602989|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
155594798|NCT02438826|561602990|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155594799|NCT02438826|561602991|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
155594800|NCT02438826|561602988|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
155594801|NCT02438826|561602989|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
155594802|NCT02438826|561602990|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
155594803|NCT02438826|561602991|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
155594804|NCT02438826|561602988|FG000|Open-Label Treatment Phase|Adverse Event|11|||
155594805|NCT02438826|561602989|FG001|Open-Label Treatment Phase|Adverse Event|6|||
155594806|NCT02438826|561602990|FG002|Open-Label Treatment Phase|Adverse Event|0|||
155594807|NCT02438826|561602991|FG003|Open-Label Treatment Phase|Adverse Event|0|||
155594808|NCT02438826|561602988|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
155594809|NCT02438826|561602989|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
155594810|NCT02438826|561602990|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
155594811|NCT02438826|561602991|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
155594812|NCT02438826|561602988|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
155594813|NCT02438826|561602989|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
155594814|NCT02438826|561602990|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
155594815|NCT02438826|561602991|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
155594816|NCT02438826|561602988|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
155594817|NCT02438826|561602989|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
155594818|NCT02438826|561602990|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
155594819|NCT02438826|561602991|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
155594820|NCT02438826|561602988|FG000|Post-Treatment Phase|Adverse Event|3|||
155594821|NCT02438826|561602989|FG001|Post-Treatment Phase|Adverse Event|0|||
155594822|NCT02438826|561602990|FG002|Post-Treatment Phase|Adverse Event|0|||
155594823|NCT02438826|561602991|FG003|Post-Treatment Phase|Adverse Event|0|||
155594824|NCT02438826|561602988|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
155594825|NCT02438826|561602989|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
155594826|NCT02438826|561602990|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
155594827|NCT02438826|561602991|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
155594828|NCT02438826|561602988|FG000|Post-Treatment Phase|Physician Decision|1|||
155594829|NCT02438826|561602989|FG001|Post-Treatment Phase|Physician Decision|0|||
155594830|NCT02438826|561602990|FG002|Post-Treatment Phase|Physician Decision|0|||
155594831|NCT02438826|561602991|FG003|Post-Treatment Phase|Physician Decision|0|||
155594832|NCT02438826|561602988|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
155594833|NCT02438826|561602989|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
155594834|NCT02438826|561602990|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
155594835|NCT02438826|561602991|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
155594836|NCT04152837|561602997|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
155594837|NCT04152837|561602997|FG000|Maintenance Period|Adverse Event|1|||
155594838|NCT04152837|561602997|FG000|Maintenance Period|Withdrawal by Subject|1|||
155594839|NCT04152837|561602997|FG000|Maintenance Period|Sponsor Termination of Study|2|||
155594840|NCT00586820|561602998|FG000|Overall Study|Unsuccessful PCI|1|||
155594841|NCT00586820|561602999|FG001|Overall Study|Unsuccessful PCI|0|||
155594842|NCT02073929|561603000|FG000|Overall Study|Lost to Follow-up|2|||
155594843|NCT02073929|561603001|FG001|Overall Study|Lost to Follow-up|1|||
155594844|NCT02073929|561603000|FG000|Overall Study|Adverse Event|2|||
155594845|NCT02073929|561603001|FG001|Overall Study|Adverse Event|1|||
155594846|NCT02073929|561603000|FG000|Overall Study|Withdrawal by Subject|0|||
155594847|NCT02073929|561603001|FG001|Overall Study|Withdrawal by Subject|1|||
155594848|NCT01483027|561603002|FG000|Overall Study|Administrative Reasons|2|||
155594849|NCT01483027|561603003|FG001|Overall Study|Administrative Reasons|1|||
155594850|NCT01483027|561603002|FG000|Overall Study|Withdrawal by Subject|21|||
155594851|NCT01483027|561603003|FG001|Overall Study|Withdrawal by Subject|32|||
155594852|NCT01483027|561603002|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
155594853|NCT01483027|561603003|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
155594854|NCT01483027|561603002|FG000|Overall Study|Lost to Follow-up|1|||
155594855|NCT01483027|561603003|FG001|Overall Study|Lost to Follow-up|1|||
155594856|NCT01483027|561603002|FG000|Overall Study|Adverse Event|0|||
155594857|NCT01483027|561603003|FG001|Overall Study|Adverse Event|1|||
155594858|NCT01483027|561603002|FG000|Overall Study|Withdrawal by Subject|0|||
155594859|NCT01483027|561603003|FG001|Overall Study|Withdrawal by Subject|1|||
155594860|NCT02504827|561603006|FG000|Overall Study|Could not produce sputum|1|||
155594861|NCT00686829|561603007|FG000|Overall Study|Adverse Event|5|||
155594862|NCT00686829|561603007|FG000|Overall Study|Lack of Efficacy|6|||
155594863|NCT00686829|561603007|FG000|Overall Study|Lost to Follow-up|4|||
155594864|NCT00686829|561603007|FG000|Overall Study|Withdrawal by Subject|14|||
155594865|NCT00686829|561603007|FG000|Overall Study|Protocol Violation|3|||
155594866|NCT00686829|561603007|FG000|Overall Study|Sponsor discontinued VCV|47|||
155594867|NCT01732640|561603009|FG000|Overall Study|Adverse Event|0|||
155594868|NCT01732640|561603010|FG001|Overall Study|Adverse Event|1|||
155594869|NCT01732640|561603009|FG000|Overall Study|Death|0|||
155594870|NCT01732640|561603010|FG001|Overall Study|Death|1|||
155594871|NCT03070002|561603013|FG000|Follow up for 2 Years|Death|1|||
155594872|NCT00712543|561603016|FG000|Day 8-14|Lost to Follow-up|0|||
155594873|NCT00712543|561603017|FG001|Day 8-14|Lost to Follow-up|2|||
155594874|NCT06366087|561606079|FG000|Overall Study|Withdrawal by Subject|0|||
155594875|NCT06366087|561606080|FG001|Overall Study|Withdrawal by Subject|1|||
155594876|NCT01397786|561606083|FG000|Phase A|Lost to Follow-up|0|||
155594877|NCT01397786|561606084|FG001|Phase A|Lost to Follow-up|0|||
155594878|NCT01397786|561606085|FG002|Phase A|Lost to Follow-up|6|||
155594879|NCT01397786|561606083|FG000|Phase A|Adverse Event|0|||
155594880|NCT01397786|561606084|FG001|Phase A|Adverse Event|0|||
155594881|NCT01397786|561606085|FG002|Phase A|Adverse Event|8|||
155594882|NCT01397786|561606083|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
155594883|NCT01397786|561606084|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
155594884|NCT01397786|561606085|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
155594885|NCT01397786|561606083|FG000|Phase A|Physician Decision|0|||
155594886|NCT01397786|561606084|FG001|Phase A|Physician Decision|0|||
155594887|NCT01397786|561606085|FG002|Phase A|Physician Decision|1|||
155594888|NCT01397786|561606083|FG000|Phase A|Withdrawal by Subject|0|||
155594889|NCT01397786|561606084|FG001|Phase A|Withdrawal by Subject|0|||
155594890|NCT01397786|561606085|FG002|Phase A|Withdrawal by Subject|5|||
155594891|NCT01397786|561606083|FG000|Phase A|Lack of Efficacy|0|||
155594892|NCT01397786|561606084|FG001|Phase A|Lack of Efficacy|0|||
155594893|NCT01397786|561606085|FG002|Phase A|Lack of Efficacy|1|||
155594894|NCT01397786|561606083|FG000|Phase B|Lost to Follow-up|22|||
155594895|NCT01397786|561606084|FG001|Phase B|Lost to Follow-up|12|||
155594896|NCT01397786|561606085|FG002|Phase B|Lost to Follow-up|22|||
155594897|NCT01397786|561606083|FG000|Phase B|Adverse Event|109|||
155594898|NCT01397786|561606084|FG001|Phase B|Adverse Event|23|||
155594899|NCT01397786|561606085|FG002|Phase B|Adverse Event|27|||
155594900|NCT01397786|561606083|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
155594901|NCT01397786|561606084|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
155594902|NCT01397786|561606085|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
155594903|NCT01397786|561606083|FG000|Phase B|Physician Decision|9|||
155594904|NCT01397786|561606084|FG001|Phase B|Physician Decision|1|||
155594905|NCT01397786|561606085|FG002|Phase B|Physician Decision|3|||
155594906|NCT01397786|561606083|FG000|Phase B|Withdrawal by Subject|102|||
155594907|NCT01397786|561606084|FG001|Phase B|Withdrawal by Subject|45|||
155594908|NCT01397786|561606085|FG002|Phase B|Withdrawal by Subject|30|||
155594909|NCT01397786|561606083|FG000|Phase B|Protocol Deviation|1|||
155594910|NCT01397786|561606084|FG001|Phase B|Protocol Deviation|2|||
155594911|NCT01397786|561606085|FG002|Phase B|Protocol Deviation|4|||
155594912|NCT01397786|561606083|FG000|Phase B|Lack of Efficacy|22|||
155594913|NCT01397786|561606084|FG001|Phase B|Lack of Efficacy|7|||
155594914|NCT01397786|561606085|FG002|Phase B|Lack of Efficacy|14|||
155594915|NCT02836236|561606092|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
155594916|NCT02836236|561606093|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
155594917|NCT02836236|561606094|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
155594918|NCT02836236|561606095|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
155594919|NCT02836236|561606092|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
155594920|NCT02836236|561606093|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
155594921|NCT02836236|561606094|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155594922|NCT02836236|561606095|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155594923|NCT02836236|561606092|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155594924|NCT02836236|561606093|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
155594925|NCT02836236|561606094|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155594926|NCT02836236|561606095|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155594927|NCT02836236|561606092|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
155594928|NCT02836236|561606093|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155594929|NCT02836236|561606094|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155594930|NCT02836236|561606095|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155594931|NCT02836236|561606092|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155594932|NCT02836236|561606093|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155594933|NCT02836236|561606094|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
155594934|NCT02836236|561606095|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
155594935|NCT02836236|561606092|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155594936|NCT02836236|561606093|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155594937|NCT02836236|561606094|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
155594938|NCT02836236|561606095|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
155594939|NCT02836236|561606092|FG000|Open-Label TAF Treatment Phase|Death|0|||
155594940|NCT02836236|561606093|FG001|Open-Label TAF Treatment Phase|Death|0|||
155594941|NCT02836236|561606094|FG002|Open-Label TAF Treatment Phase|Death|1|||
155594942|NCT02836236|561606095|FG003|Open-Label TAF Treatment Phase|Death|1|||
155594943|NCT02836236|561606092|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155594944|NCT02836236|561606093|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155594945|NCT02836236|561606094|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
155594946|NCT02836236|561606095|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155594947|NCT00831311|561606096|FG000|Overall Study|Definitive Contraindication|3|||
155594948|NCT00831311|561606097|FG001|Overall Study|Definitive Contraindication|3|||
155594949|NCT00831311|561606096|FG000|Overall Study|Lost to Follow-up|3|||
155594950|NCT00831311|561606097|FG001|Overall Study|Lost to Follow-up|0|||
155594951|NCT00831311|561606096|FG000|Overall Study|Physician Decision|0|||
155594952|NCT00831311|561606097|FG001|Overall Study|Physician Decision|1|||
155594953|NCT00831311|561606096|FG000|Overall Study|Withdrawal by Subject|6|||
155594954|NCT00831311|561606097|FG001|Overall Study|Withdrawal by Subject|4|||
155594955|NCT01300338|561606104|FG000|Overall Study|Lost to Follow-up|5|||
155594956|NCT01300338|561606105|FG001|Overall Study|Lost to Follow-up|0|||
155594957|NCT02461524|561606109|FG000|Overall Study|Death|16|||
155594958|NCT02461524|561606109|FG000|Overall Study|Withdrawal by Subject|4|||
155594959|NCT02461524|561606109|FG000|Overall Study|Device Explanted|5|||
155594960|NCT02461524|561606109|FG000|Overall Study|Missed Visit|6|||
155594961|NCT01943851|561606111|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594962|NCT01943851|561606112|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594963|NCT01943851|561606113|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594964|NCT01943851|561606114|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155669282|NCT02041299|561883624|FG001|Overall Study|Physician Decision|1|||
155669283|NCT02041299|561883623|FG000|Overall Study|Withdrawal by Subject|13|||
155669284|NCT02041299|561883624|FG001|Overall Study|Withdrawal by Subject|7|||
155669285|NCT02041299|561883623|FG000|Overall Study|Protocol Violation|11|||
155669286|NCT02041299|561883624|FG001|Overall Study|Protocol Violation|4|||
155669287|NCT02041299|561883623|FG000|Overall Study|Termination of the study|7|||
155669288|NCT02041299|561883624|FG001|Overall Study|Termination of the study|3|||
155669289|NCT02041299|561883623|FG000|Overall Study|Required bone marrow transplant|0|||
155669290|NCT02041299|561883624|FG001|Overall Study|Required bone marrow transplant|1|||
155669291|NCT02041299|561883623|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
155594965|NCT01943851|561606115|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594966|NCT01943851|561606116|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594967|NCT01943851|561606117|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155594968|NCT01943851|561606118|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155594969|NCT01943851|561606119|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155594970|NCT01943851|561606120|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594971|NCT01943851|561606121|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594972|NCT01943851|561606122|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594973|NCT01943851|561606123|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594974|NCT01943851|561606124|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594975|NCT01943851|561606125|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594976|NCT01943851|561606126|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155669292|NCT02041299|561883624|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
155669293|NCT02389465|561883625|FG000|Overall Study|Lost to Follow-up|1|||
155669294|NCT02389465|561883626|FG001|Overall Study|Lost to Follow-up|3|||
155669295|NCT02389465|561883627|FG002|Overall Study|Lost to Follow-up|3|||
155594977|NCT01943851|561606127|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594978|NCT01943851|561606128|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155594979|NCT01943851|561606111|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594980|NCT01943851|561606112|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594981|NCT01943851|561606113|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594982|NCT01943851|561606114|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594983|NCT01943851|561606115|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
155594984|NCT01943851|561606116|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594985|NCT01943851|561606117|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594986|NCT01943851|561606118|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
155594987|NCT01943851|561606119|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594988|NCT01943851|561606120|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594989|NCT01943851|561606121|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594990|NCT01943851|561606122|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594991|NCT01943851|561606123|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594992|NCT01943851|561606124|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594993|NCT01943851|561606125|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594994|NCT01943851|561606126|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155594995|NCT01943851|561606127|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155669296|NCT02389465|561883628|FG003|Overall Study|Lost to Follow-up|0|||
155669297|NCT02389465|561883625|FG000|Overall Study|Physician Decision|0|||
155669298|NCT02389465|561883626|FG001|Overall Study|Physician Decision|0|||
155669299|NCT02389465|561883627|FG002|Overall Study|Physician Decision|0|||
155669300|NCT02389465|561883628|FG003|Overall Study|Physician Decision|1|||
155669301|NCT02389465|561883625|FG000|Overall Study|Withdrawal by Subject|0|||
155669302|NCT02389465|561883626|FG001|Overall Study|Withdrawal by Subject|1|||
155669303|NCT02389465|561883627|FG002|Overall Study|Withdrawal by Subject|2|||
155669304|NCT02389465|561883628|FG003|Overall Study|Withdrawal by Subject|2|||
155669305|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155669306|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155669307|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155669308|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
155669309|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
155669310|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
155669311|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
155669312|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
155669313|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
155669314|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
155669315|NCT01925768|561883629|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
155669316|NCT01925768|561883630|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
155669317|NCT01925768|561883629|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
155669318|NCT01925768|561883630|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
155669319|NCT01925768|561883629|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
155669320|NCT01925768|561883630|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
155669321|NCT01925768|561883629|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
155669322|NCT01925768|561883630|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
155669323|NCT01925768|561883629|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
155669324|NCT01925768|561883630|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
155669325|NCT01925768|561883629|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
155669326|NCT01925768|561883630|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
155669327|NCT04339413|561883631|FG000|Overall Study|Reason Not Specified|2|||
155669328|NCT04339413|561883632|FG001|Overall Study|Reason Not Specified|7|||
155669329|NCT04339413|561883631|FG000|Overall Study|Study Terminated by Sponsor|30|||
155594996|NCT01943851|561606128|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155669330|NCT04339413|561883632|FG001|Overall Study|Study Terminated by Sponsor|33|||
155669331|NCT04339413|561883631|FG000|Overall Study|Progressive Disease|9|||
155669332|NCT04339413|561883632|FG001|Overall Study|Progressive Disease|6|||
155669333|NCT04339413|561883631|FG000|Overall Study|Withdrawal by Subject|9|||
155669334|NCT04339413|561883632|FG001|Overall Study|Withdrawal by Subject|10|||
155669335|NCT04339413|561883631|FG000|Overall Study|Physician Decision|3|||
155669336|NCT04339413|561883632|FG001|Overall Study|Physician Decision|1|||
155669337|NCT04339413|561883631|FG000|Overall Study|Death|2|||
155669338|NCT04339413|561883632|FG001|Overall Study|Death|0|||
155669339|NCT04339413|561883631|FG000|Overall Study|Adverse Event|3|||
155594997|NCT01943851|561606111|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155594998|NCT01943851|561606112|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155669340|NCT04339413|561883632|FG001|Overall Study|Adverse Event|0|||
155669341|NCT00087698|561883638|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
155669342|NCT00087698|561883638|FG000|Overall Study|Death from Other Causes|3|||
155669343|NCT00087698|561883638|FG000|Overall Study|Adverse Event|4|||
155669344|NCT00087698|561883638|FG000|Overall Study|Withdrawal by Subject|4|||
155669345|NCT00087698|561883638|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
155669346|NCT00087698|561883638|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
155669347|NCT00087698|561883638|FG000|Overall Study|Clinical Relapse|1|||
155669348|NCT00087698|561883638|FG000|Overall Study|Death from Study Disease|2|||
155669349|NCT00087698|561883638|FG000|Overall Study|Death from Study Drug Toxicity|2|||
155669350|NCT00087698|561883638|FG000|Overall Study|Protocol Violation|1|||
155669351|NCT01737762|561883641|FG000|Overall Study|Adverse Event|2|||
155669352|NCT01737762|561883642|FG001|Overall Study|Adverse Event|2|||
155669353|NCT01737762|561883641|FG000|Overall Study|Lost to Follow-up|1|||
155669354|NCT01737762|561883642|FG001|Overall Study|Lost to Follow-up|0|||
155669355|NCT01737762|561883641|FG000|Overall Study|Withdrawal by Subject|2|||
155669356|NCT01737762|561883642|FG001|Overall Study|Withdrawal by Subject|2|||
155669357|NCT01737762|561883641|FG000|Overall Study|Progressive disease|1|||
155669358|NCT01737762|561883642|FG001|Overall Study|Progressive disease|2|||
155669359|NCT01737762|561883641|FG000|Overall Study|Physician Decision|1|||
155669360|NCT01737762|561883642|FG001|Overall Study|Physician Decision|1|||
155669361|NCT01737762|561883641|FG000|Overall Study|Moved from area|2|||
155669362|NCT01737762|561883642|FG001|Overall Study|Moved from area|1|||
155669363|NCT01737762|561883641|FG000|Overall Study|Trial termination|11|||
155669364|NCT01737762|561883642|FG001|Overall Study|Trial termination|9|||
155594999|NCT01943851|561606113|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595000|NCT01943851|561606114|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595001|NCT01943851|561606115|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595002|NCT01943851|561606116|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595003|NCT01943851|561606117|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595004|NCT01943851|561606118|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595005|NCT01943851|561606119|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595006|NCT01943851|561606120|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595007|NCT01943851|561606121|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595008|NCT01943851|561606122|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595009|NCT01943851|561606123|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595010|NCT01943851|561606124|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
155595011|NCT01943851|561606125|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595012|NCT01943851|561606126|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595013|NCT01943851|561606127|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595014|NCT01943851|561606128|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155595015|NCT01943851|561606111|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595016|NCT01943851|561606112|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595017|NCT01943851|561606113|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595018|NCT01943851|561606114|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595019|NCT01943851|561606115|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595020|NCT01943851|561606116|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595021|NCT01943851|561606117|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595022|NCT01943851|561606118|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595023|NCT01943851|561606119|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595024|NCT01943851|561606120|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595025|NCT01943851|561606121|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595026|NCT01943851|561606122|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595027|NCT01943851|561606123|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595028|NCT01943851|561606124|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595029|NCT01943851|561606125|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595030|NCT01943851|561606126|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
155595031|NCT01943851|561606127|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595032|NCT01943851|561606128|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155595033|NCT01943851|561606111|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155669365|NCT01964378|561883643|FG000|Overall Study|Disc. due to death before first dosing|0|||
155669366|NCT01964378|561883644|FG001|Overall Study|Disc. due to death before first dosing|1|||
155669367|NCT01964378|561883643|FG000|Overall Study|Disc. due to AE before first dosing|1|||
155669368|NCT01964378|561883644|FG001|Overall Study|Disc. due to AE before first dosing|0|||
155669369|NCT01964378|561883643|FG000|Overall Study|Death|3|||
155669370|NCT01964378|561883644|FG001|Overall Study|Death|2|||
155669371|NCT01964378|561883643|FG000|Overall Study|Adverse Event|12|||
155669372|NCT01964378|561883644|FG001|Overall Study|Adverse Event|5|||
155669373|NCT01964378|561883643|FG000|Overall Study|Lack of Efficacy|0|||
155669374|NCT01964378|561883644|FG001|Overall Study|Lack of Efficacy|1|||
155669375|NCT01964378|561883643|FG000|Overall Study|Protocol Violation|0|||
155669376|NCT01964378|561883644|FG001|Overall Study|Protocol Violation|1|||
155669377|NCT01964378|561883643|FG000|Overall Study|Lost to Follow-up|0|||
155669378|NCT01964378|561883644|FG001|Overall Study|Lost to Follow-up|1|||
155669379|NCT01964378|561883643|FG000|Overall Study|Withdrawal by Subject|7|||
155669380|NCT01964378|561883644|FG001|Overall Study|Withdrawal by Subject|5|||
155669381|NCT01964378|561883643|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
155669382|NCT01964378|561883644|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
155669383|NCT01964378|561883643|FG000|Overall Study|Other|1|||
155669384|NCT01964378|561883644|FG001|Overall Study|Other|2|||
155669385|NCT03542266|561883645|FG000|Treatment Phase|Withdrawal by Subject|1|||
155669386|NCT03542266|561883645|FG000|Treatment Phase|Adverse Event|1|||
155669387|NCT03542266|561883645|FG000|Treatment Phase|PD|1|||
155669388|NCT02012218|561883651|FG000|Overall Study|Withdrawal by Subject|1|||
155669389|NCT02012218|561883652|FG001|Overall Study|Withdrawal by Subject|0|||
155669390|NCT02012218|561883653|FG002|Overall Study|Withdrawal by Subject|1|||
155669391|NCT02012218|561883654|FG003|Overall Study|Withdrawal by Subject|1|||
155669392|NCT02012218|561883655|FG004|Overall Study|Withdrawal by Subject|1|||
155669393|NCT02012218|561883651|FG000|Overall Study|Adverse Event|1|||
155669394|NCT02012218|561883652|FG001|Overall Study|Adverse Event|0|||
155669395|NCT02012218|561883653|FG002|Overall Study|Adverse Event|0|||
155669396|NCT02012218|561883654|FG003|Overall Study|Adverse Event|1|||
155669397|NCT02012218|561883655|FG004|Overall Study|Adverse Event|0|||
155669398|NCT02012218|561883651|FG000|Overall Study|Lost to Follow-up|0|||
155669399|NCT02012218|561883652|FG001|Overall Study|Lost to Follow-up|1|||
155669400|NCT02012218|561883653|FG002|Overall Study|Lost to Follow-up|1|||
155669401|NCT02012218|561883654|FG003|Overall Study|Lost to Follow-up|0|||
155669402|NCT02012218|561883655|FG004|Overall Study|Lost to Follow-up|0|||
155669403|NCT02012218|561883651|FG000|Overall Study|Protocol Specified|1|||
155669404|NCT02012218|561883652|FG001|Overall Study|Protocol Specified|0|||
155669405|NCT02012218|561883653|FG002|Overall Study|Protocol Specified|0|||
155669406|NCT02012218|561883654|FG003|Overall Study|Protocol Specified|0|||
155669407|NCT02012218|561883655|FG004|Overall Study|Protocol Specified|0|||
155669408|NCT02012218|561883651|FG000|Overall Study|Protocol Deviation|1|||
155669409|NCT02012218|561883652|FG001|Overall Study|Protocol Deviation|0|||
155595034|NCT01943851|561606112|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595035|NCT01943851|561606113|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595036|NCT01943851|561606114|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595037|NCT01943851|561606115|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595038|NCT01943851|561606116|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595039|NCT01943851|561606117|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595040|NCT01943851|561606118|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595041|NCT01943851|561606119|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595042|NCT01943851|561606120|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595043|NCT01943851|561606121|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595044|NCT01943851|561606122|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595045|NCT01943851|561606123|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595046|NCT01943851|561606124|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595047|NCT01943851|561606125|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155595048|NCT01943851|561606126|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
155595049|NCT01943851|561606127|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
155595050|NCT01943851|561606128|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
155595051|NCT00381238|561606133|FG000|Overall Study|Adverse Event|3|||
155669410|NCT02012218|561883653|FG002|Overall Study|Protocol Deviation|0|||
155669411|NCT02012218|561883654|FG003|Overall Study|Protocol Deviation|0|||
155669412|NCT02012218|561883655|FG004|Overall Study|Protocol Deviation|0|||
155669413|NCT04417257|561883656|FG000|Pilot Phase 2|Adverse Event|2|||
155669414|NCT04417257|561883657|FG001|Pilot Phase 2|Adverse Event|0|||
155595052|NCT00381238|561606133|FG000|Overall Study|Protocol Violation|1|||
155595053|NCT00381238|561606133|FG000|Overall Study|Withdrawal by Subject|4|||
155595054|NCT00381238|561606133|FG000|Overall Study|Lack of Efficacy|2|||
155669415|NCT04417257|561883656|FG000|Pilot Phase 2|Death|14|||
155669416|NCT04417257|561883657|FG001|Pilot Phase 2|Death|11|||
155669417|NCT04417257|561883656|FG000|Pilot Phase 2|Lost to Follow-up|3|||
155669418|NCT04417257|561883657|FG001|Pilot Phase 2|Lost to Follow-up|5|||
155669419|NCT04417257|561883656|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
155669420|NCT04417257|561883657|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
155669421|NCT04417257|561883656|FG000|Pilot Phase 2|Hepatic impairment|1|||
155595055|NCT00381238|561606133|FG000|Overall Study|Withdrew by physician|1|||
155595056|NCT00381238|561606133|FG000|Overall Study|Disease progression|1|||
155595057|NCT00843037|561606137|FG000|Overall Study|Lost to Follow-up|1|||
155595058|NCT03535194|561606138|FG000|Induction Period|Adverse Event|2|||
155595059|NCT03535194|561606139|FG001|Induction Period|Adverse Event|2|||
155595060|NCT03535194|561606140|FG002|Induction Period|Adverse Event|1|||
155595061|NCT03535194|561606141|FG003|Induction Period|Adverse Event|3|||
155595062|NCT03535194|561606142|FG004|Induction Period|Adverse Event|0|||
155595063|NCT03535194|561606138|FG000|Induction Period|Death|0|||
155595064|NCT03535194|561606139|FG001|Induction Period|Death|1|||
155595065|NCT03535194|561606140|FG002|Induction Period|Death|0|||
155595066|NCT03535194|561606141|FG003|Induction Period|Death|0|||
155595067|NCT03535194|561606142|FG004|Induction Period|Death|0|||
155595068|NCT03535194|561606138|FG000|Induction Period|Lack of Efficacy|1|||
155595069|NCT03535194|561606139|FG001|Induction Period|Lack of Efficacy|3|||
155595070|NCT03535194|561606140|FG002|Induction Period|Lack of Efficacy|2|||
155595071|NCT03535194|561606141|FG003|Induction Period|Lack of Efficacy|2|||
155595072|NCT03535194|561606142|FG004|Induction Period|Lack of Efficacy|0|||
155595073|NCT03535194|561606138|FG000|Induction Period|Lost to Follow-up|3|||
155595074|NCT03535194|561606139|FG001|Induction Period|Lost to Follow-up|5|||
155595075|NCT03535194|561606140|FG002|Induction Period|Lost to Follow-up|2|||
155595076|NCT03535194|561606141|FG003|Induction Period|Lost to Follow-up|3|||
155595077|NCT03535194|561606142|FG004|Induction Period|Lost to Follow-up|0|||
155595078|NCT03535194|561606138|FG000|Induction Period|Physician Decision|1|||
155595079|NCT03535194|561606139|FG001|Induction Period|Physician Decision|1|||
155595080|NCT03535194|561606140|FG002|Induction Period|Physician Decision|0|||
155595081|NCT03535194|561606141|FG003|Induction Period|Physician Decision|0|||
155595082|NCT03535194|561606142|FG004|Induction Period|Physician Decision|0|||
155595083|NCT03535194|561606138|FG000|Induction Period|Protocol Violation|1|||
155595084|NCT03535194|561606139|FG001|Induction Period|Protocol Violation|0|||
155595085|NCT03535194|561606140|FG002|Induction Period|Protocol Violation|0|||
155595086|NCT03535194|561606141|FG003|Induction Period|Protocol Violation|1|||
155595087|NCT03535194|561606142|FG004|Induction Period|Protocol Violation|0|||
155595088|NCT03535194|561606138|FG000|Induction Period|Screen Failure|0|||
155595089|NCT03535194|561606139|FG001|Induction Period|Screen Failure|1|||
155595090|NCT03535194|561606140|FG002|Induction Period|Screen Failure|0|||
155595091|NCT03535194|561606141|FG003|Induction Period|Screen Failure|0|||
155595092|NCT03535194|561606142|FG004|Induction Period|Screen Failure|0|||
155595093|NCT03535194|561606138|FG000|Induction Period|Withdrawal by Subject|3|||
155595094|NCT03535194|561606139|FG001|Induction Period|Withdrawal by Subject|4|||
155595095|NCT03535194|561606140|FG002|Induction Period|Withdrawal by Subject|3|||
155595096|NCT03535194|561606141|FG003|Induction Period|Withdrawal by Subject|2|||
155595097|NCT03535194|561606142|FG004|Induction Period|Withdrawal by Subject|0|||
155595098|NCT03535194|561606138|FG000|Maintenance Period|Adverse Event|6|||
155595099|NCT03535194|561606139|FG001|Maintenance Period|Adverse Event|5|||
155595100|NCT03535194|561606140|FG002|Maintenance Period|Adverse Event|1|||
155595101|NCT03535194|561606141|FG003|Maintenance Period|Adverse Event|11|||
155669422|NCT04417257|561883657|FG001|Pilot Phase 2|Hepatic impairment|0|||
155595102|NCT03535194|561606142|FG004|Maintenance Period|Adverse Event|4|||
155595103|NCT03535194|561606138|FG000|Maintenance Period|Lack of Efficacy|3|||
155595104|NCT03535194|561606139|FG001|Maintenance Period|Lack of Efficacy|2|||
155595105|NCT03535194|561606140|FG002|Maintenance Period|Lack of Efficacy|5|||
155595106|NCT03535194|561606141|FG003|Maintenance Period|Lack of Efficacy|9|||
155595107|NCT03535194|561606142|FG004|Maintenance Period|Lack of Efficacy|0|||
155595108|NCT03535194|561606138|FG000|Maintenance Period|Lost to Follow-up|4|||
155595109|NCT03535194|561606139|FG001|Maintenance Period|Lost to Follow-up|2|||
155595110|NCT03535194|561606140|FG002|Maintenance Period|Lost to Follow-up|1|||
155595111|NCT03535194|561606141|FG003|Maintenance Period|Lost to Follow-up|5|||
155595112|NCT03535194|561606142|FG004|Maintenance Period|Lost to Follow-up|2|||
155595113|NCT03535194|561606138|FG000|Maintenance Period|Other|1|||
155595114|NCT03535194|561606139|FG001|Maintenance Period|Other|2|||
155595115|NCT03535194|561606140|FG002|Maintenance Period|Other|0|||
155595116|NCT03535194|561606141|FG003|Maintenance Period|Other|0|||
155595117|NCT03535194|561606142|FG004|Maintenance Period|Other|0|||
155595118|NCT03535194|561606138|FG000|Maintenance Period|Physician Decision|1|||
155595119|NCT03535194|561606139|FG001|Maintenance Period|Physician Decision|2|||
155595120|NCT03535194|561606140|FG002|Maintenance Period|Physician Decision|0|||
155595121|NCT03535194|561606141|FG003|Maintenance Period|Physician Decision|2|||
155595122|NCT03535194|561606142|FG004|Maintenance Period|Physician Decision|0|||
155595123|NCT03535194|561606138|FG000|Maintenance Period|Pregnancy|0|||
155595124|NCT03535194|561606139|FG001|Maintenance Period|Pregnancy|0|||
155595125|NCT03535194|561606140|FG002|Maintenance Period|Pregnancy|0|||
155595126|NCT03535194|561606141|FG003|Maintenance Period|Pregnancy|2|||
155595127|NCT03535194|561606142|FG004|Maintenance Period|Pregnancy|0|||
155595128|NCT03535194|561606138|FG000|Maintenance Period|Protocol Violation|0|||
155595129|NCT03535194|561606139|FG001|Maintenance Period|Protocol Violation|1|||
155595130|NCT03535194|561606140|FG002|Maintenance Period|Protocol Violation|0|||
155595131|NCT03535194|561606141|FG003|Maintenance Period|Protocol Violation|0|||
155595132|NCT03535194|561606142|FG004|Maintenance Period|Protocol Violation|0|||
155595133|NCT03535194|561606138|FG000|Maintenance Period|Withdrawal by Subject|7|||
155595134|NCT03535194|561606139|FG001|Maintenance Period|Withdrawal by Subject|2|||
155595135|NCT03535194|561606140|FG002|Maintenance Period|Withdrawal by Subject|1|||
155595136|NCT03535194|561606141|FG003|Maintenance Period|Withdrawal by Subject|8|||
155595137|NCT03535194|561606142|FG004|Maintenance Period|Withdrawal by Subject|0|||
155595138|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Adverse Event|4|||
155595139|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Adverse Event|5|||
155595140|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Adverse Event|1|||
155595141|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Adverse Event|8|||
155595142|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Adverse Event|0|||
155595143|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
155595144|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
155595145|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
155595146|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
155595147|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
155595148|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
155595149|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
155595150|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
155595151|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
155595152|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
155595153|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Other|1|||
155595154|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Other|0|||
155595155|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Other|0|||
155595156|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Other|5|||
155595157|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Other|0|||
155595158|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Physician Decision|0|||
155595159|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Physician Decision|2|||
155595160|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Physician Decision|1|||
155595161|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Physician Decision|1|||
155595162|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Physician Decision|0|||
155669423|NCT04417257|561883656|FG000|Pilot Phase 2|Unblinding|1|||
155669424|NCT04417257|561883657|FG001|Pilot Phase 2|Unblinding|0|||
155669425|NCT04417257|561883656|FG000|Pilot Phase 2|All other|0|||
155669426|NCT04417257|561883657|FG001|Pilot Phase 2|All other|2|||
155669427|NCT04417257|561883656|FG000|Phase 3 Extension|Death|3|||
155669428|NCT04417257|561883657|FG001|Phase 3 Extension|Death|1|||
155669429|NCT04417257|561883656|FG000|Phase 3 Extension|Lost to Follow-up|4|||
155669430|NCT04417257|561883657|FG001|Phase 3 Extension|Lost to Follow-up|2|||
155595163|NCT03535194|561606138|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
155595164|NCT03535194|561606139|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
155595165|NCT03535194|561606140|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
155595166|NCT03535194|561606141|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
155595167|NCT03535194|561606142|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155595168|NCT04429555|561606151|FG000|Overall Study|Death|0|||
155595169|NCT04429555|561606152|FG001|Overall Study|Death|2|||
155595170|NCT04429555|561606151|FG000|Overall Study|Other|2|||
155595171|NCT04429555|561606152|FG001|Overall Study|Other|0|||
155595172|NCT02703272|561606153|FG000|Overall Study|Death|4|||
155669431|NCT04417257|561883656|FG000|Phase 3 Extension|Patient withdrawal|2|||
155669432|NCT04417257|561883657|FG001|Phase 3 Extension|Patient withdrawal|2|||
155669433|NCT04417257|561883656|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
155669434|NCT04417257|561883657|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
155595173|NCT02703272|561606154|FG001|Overall Study|Death|9|||
155595174|NCT02703272|561606155|FG002|Overall Study|Death|19|||
155595175|NCT02703272|561606156|FG003|Overall Study|Death|10|||
155595176|NCT02703272|561606153|FG000|Overall Study|Withdrawal by Subject|0|||
155669435|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Death|2|||
155669436|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
155669437|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
155669438|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Physician Decision|1|||
155669439|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
155595177|NCT02703272|561606154|FG001|Overall Study|Withdrawal by Subject|0|||
155595178|NCT02703272|561606155|FG002|Overall Study|Withdrawal by Subject|4|||
155595179|NCT02703272|561606156|FG003|Overall Study|Withdrawal by Subject|2|||
155595180|NCT02703272|561606153|FG000|Overall Study|Study Terminated by Sponsor|6|||
155595181|NCT02703272|561606154|FG001|Overall Study|Study Terminated by Sponsor|1|||
155595182|NCT02703272|561606155|FG002|Overall Study|Study Terminated by Sponsor|12|||
155595183|NCT02703272|561606156|FG003|Overall Study|Study Terminated by Sponsor|4|||
155595184|NCT02703272|561606153|FG000|Overall Study|Other|1|||
155595185|NCT02703272|561606154|FG001|Overall Study|Other|0|||
155595186|NCT02703272|561606155|FG002|Overall Study|Other|0|||
155595187|NCT02703272|561606156|FG003|Overall Study|Other|0|||
155595188|NCT04470544|561606159|FG000|Overall Study|Withdrawal by Subject|4|||
155595189|NCT04470544|561606160|FG001|Overall Study|Withdrawal by Subject|6|||
155595190|NCT01680861|561606161|FG000|Early Post-transplant Period|Protocol Violation|1|||
155595191|NCT01680861|561606162|FG001|Early Post-transplant Period|Protocol Violation|1|||
155595192|NCT05835011|561606165|FG000|Overall Study|Study Terminated by the Sponsor|1|||
155595193|NCT05835011|561606165|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
155669440|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
155669441|NCT00786422|561883659|FG000|Rivaroxaban Treatment|Adverse Event|2|||
155669442|NCT00786422|561883659|FG000|Follow-up Period|Death|1|||
155669443|NCT00786422|561883659|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
155669444|NCT03484429|561883660|FG000|Overall Study|Withdrawal by Subject|1|||
155669445|NCT03484429|561883661|FG001|Overall Study|Withdrawal by Subject|0|||
155669446|NCT03484429|561883660|FG000|Overall Study|Adverse Event|2|||
155669447|NCT03484429|561883661|FG001|Overall Study|Adverse Event|0|||
155669448|NCT04466384|561883662|FG000|First Phase|Protocol Violation|1|||
155669449|NCT04466384|561883663|FG001|First Phase|Protocol Violation|0|||
155669450|NCT04466384|561883662|FG000|First Phase|Missing data|1|||
155669451|NCT04466384|561883663|FG001|First Phase|Missing data|0|||
155669452|NCT04466384|561883662|FG000|Cross Over Phase|Physician Decision|1|||
155669453|NCT04466384|561883663|FG001|Cross Over Phase|Physician Decision|0|||
155669454|NCT04466384|561883662|FG000|Cross Over Phase|Withdrawal by Subject|0|||
155669455|NCT04466384|561883663|FG001|Cross Over Phase|Withdrawal by Subject|1|||
155669456|NCT00714948|561883666|FG000|Overall Study|Adverse Event|2|||
155669457|NCT02454530|561883673|FG000|Overall Study|Other|8|||
155595194|NCT04720911|561606166|FG000|Overall Study|Withdrawal by Subject|0|||
155595195|NCT04720911|561606167|FG001|Overall Study|Withdrawal by Subject|1|||
155669458|NCT02454530|561883674|FG001|Overall Study|Other|13|||
155669459|NCT02454530|561883673|FG000|Overall Study|Missing information|56|||
155595196|NCT04720911|561606168|FG002|Overall Study|Withdrawal by Subject|0|||
155595197|NCT00941863|561606170|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
155595198|NCT00941863|561606171|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
155669460|NCT02454530|561883674|FG001|Overall Study|Missing information|69|||
155669461|NCT02454530|561883673|FG000|Overall Study|Death|2|||
155669462|NCT02454530|561883674|FG001|Overall Study|Death|41|||
155669463|NCT02454530|561883673|FG000|Overall Study|Lost to Follow-up|4|||
155669464|NCT02454530|561883674|FG001|Overall Study|Lost to Follow-up|4|||
155669465|NCT00326001|561883675|FG000|Overall Study|Adverse Event|4|||
155669466|NCT00326001|561883676|FG001|Overall Study|Adverse Event|5|||
155669467|NCT00326001|561883675|FG000|Overall Study|Physician Decision|3|||
155669468|NCT00326001|561883676|FG001|Overall Study|Physician Decision|3|||
155669469|NCT04267926|561884918|FG000|Overall Study|abnormal labs. No longer eligible|0|||
155669470|NCT04267926|561884919|FG001|Overall Study|abnormal labs. No longer eligible|0|||
155669471|NCT04267926|561884920|FG002|Overall Study|abnormal labs. No longer eligible|1|||
155669472|NCT04267926|561884918|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
155669473|NCT04267926|561884919|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
155669474|NCT04267926|561884920|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
155669475|NCT03718325|561884921|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
155669476|NCT03718325|561884922|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
155595199|NCT00941863|561606172|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
155595200|NCT00941863|561606173|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
155669477|NCT03718325|561884923|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
155669478|NCT03718325|561884921|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
155669479|NCT03718325|561884922|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
155669480|NCT03718325|561884923|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
155669481|NCT00972023|561884928|FG000|Overall Study|Withdrawal by Subject|1|||
155669482|NCT03052608|561884930|FG000|Treatment Phase|Adverse Event|10|||
155669483|NCT03052608|561884931|FG001|Treatment Phase|Adverse Event|12|||
155595201|NCT00941863|561606174|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
155595202|NCT00941863|561606170|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
155595203|NCT00941863|561606171|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
155595204|NCT00941863|561606172|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
155595205|NCT00941863|561606173|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
155595206|NCT00941863|561606174|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
155595207|NCT00941863|561606170|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155595208|NCT00941863|561606171|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155595209|NCT00941863|561606172|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
155595210|NCT00941863|561606173|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155595211|NCT00941863|561606174|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
155595212|NCT00941863|561606170|FG000|Until Primary Completion Date (PCD)|Death|0|||
155595213|NCT00941863|561606171|FG001|Until Primary Completion Date (PCD)|Death|0|||
155595214|NCT00941863|561606172|FG002|Until Primary Completion Date (PCD)|Death|1|||
155595215|NCT00941863|561606173|FG003|Until Primary Completion Date (PCD)|Death|2|||
155595216|NCT00941863|561606174|FG004|Until Primary Completion Date (PCD)|Death|7|||
155595217|NCT00941863|561606170|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
155595218|NCT00941863|561606171|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
155595219|NCT00941863|561606172|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
155595220|NCT00941863|561606173|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
155595221|NCT00941863|561606174|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
155595222|NCT00941863|561606170|FG000|Continued After PCD|Withdrawal by Subject|0|||
155669484|NCT03052608|561884930|FG000|Treatment Phase|Death|6|||
155669485|NCT03052608|561884931|FG001|Treatment Phase|Death|4|||
155669486|NCT03052608|561884930|FG000|Treatment Phase|Withdrawal by Subject|4|||
155669487|NCT03052608|561884931|FG001|Treatment Phase|Withdrawal by Subject|12|||
155669488|NCT03052608|561884930|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
155669489|NCT03052608|561884931|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
155669490|NCT03052608|561884930|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
155669491|NCT03052608|561884931|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
155669492|NCT03052608|561884930|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
155669493|NCT03052608|561884931|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
155669494|NCT03052608|561884930|FG000|Treatment Phase|Ongoing|103|||
155669495|NCT03052608|561884931|FG001|Treatment Phase|Ongoing|31|||
155669496|NCT03052608|561884930|FG000|Long-Term Follow-up Phase|Death|23|||
155669497|NCT03052608|561884931|FG001|Long-Term Follow-up Phase|Death|28|||
155669498|NCT03052608|561884930|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
155669499|NCT03052608|561884931|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
155669500|NCT03052608|561884930|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
155669501|NCT03052608|561884931|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
155669502|NCT03052608|561884930|FG000|Long-Term Follow-up Phase|Ongoing|122|||
155669503|NCT03052608|561884931|FG001|Long-Term Follow-up Phase|Ongoing|99|||
155669504|NCT02595879|561884933|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
155669505|NCT02595879|561884934|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
155669506|NCT01396187|561884935|FG000|Overall Study|Adverse Event|0|||
155669507|NCT01396187|561884936|FG001|Overall Study|Adverse Event|1|||
155669508|NCT01396187|561884937|FG002|Overall Study|Adverse Event|0|||
155669509|NCT01396187|561884938|FG003|Overall Study|Adverse Event|0|||
155669510|NCT01396187|561884939|FG004|Overall Study|Adverse Event|0|||
155669511|NCT01396187|561884935|FG000|Overall Study|Withdrawal by Subject|0|||
155669512|NCT01396187|561884936|FG001|Overall Study|Withdrawal by Subject|1|||
155669513|NCT01396187|561884937|FG002|Overall Study|Withdrawal by Subject|1|||
155669514|NCT01396187|561884938|FG003|Overall Study|Withdrawal by Subject|0|||
155669515|NCT01396187|561884939|FG004|Overall Study|Withdrawal by Subject|0|||
155669516|NCT01396187|561884935|FG000|Overall Study|Other|1|||
155669517|NCT01396187|561884936|FG001|Overall Study|Other|1|||
155669518|NCT01396187|561884937|FG002|Overall Study|Other|0|||
155669519|NCT01396187|561884938|FG003|Overall Study|Other|0|||
155669520|NCT01396187|561884939|FG004|Overall Study|Other|1|||
155669521|NCT01898286|561884940|FG000|Overall Study|Withdrawal by Subject|1|||
155669522|NCT01898286|561884940|FG000|Overall Study|Protocol Violation|1|||
155669523|NCT01898286|561884940|FG000|Overall Study|Lost to Follow-up|1|||
155669524|NCT05554146|561884941|FG000|Overall Study|Adverse Event|0|||
155669525|NCT05554146|561884942|FG001|Overall Study|Adverse Event|1|||
155669526|NCT05554146|561884943|FG002|Overall Study|Adverse Event|0|||
155669527|NCT05554146|561884944|FG003|Overall Study|Adverse Event|0|||
155669528|NCT05554146|561884941|FG000|Overall Study|Protocol Violation|0|||
155669529|NCT05554146|561884942|FG001|Overall Study|Protocol Violation|1|||
155669530|NCT05554146|561884943|FG002|Overall Study|Protocol Violation|0|||
155669531|NCT05554146|561884944|FG003|Overall Study|Protocol Violation|0|||
155669532|NCT05554146|561884941|FG000|Overall Study|No longer interested in participating|0|||
155669533|NCT05554146|561884942|FG001|Overall Study|No longer interested in participating|0|||
155669534|NCT05554146|561884943|FG002|Overall Study|No longer interested in participating|1|||
155669535|NCT05554146|561884944|FG003|Overall Study|No longer interested in participating|0|||
155669536|NCT05554146|561884941|FG000|Overall Study|Lost to Follow-up|1|||
155669537|NCT05554146|561884942|FG001|Overall Study|Lost to Follow-up|0|||
155669538|NCT05554146|561884943|FG002|Overall Study|Lost to Follow-up|0|||
155669539|NCT05554146|561884944|FG003|Overall Study|Lost to Follow-up|0|||
155669540|NCT00620373|561884945|FG000|Overall Study|Unverified cancer status|33|||
155669541|NCT01408277|561884946|FG000|Overall Study|Adverse Event|3|||
155669542|NCT01408277|561884947|FG001|Overall Study|Adverse Event|4|||
155669543|NCT01408277|561884946|FG000|Overall Study|Lost to Follow-up|1|||
155669544|NCT01408277|561884947|FG001|Overall Study|Lost to Follow-up|0|||
155669545|NCT01408277|561884946|FG000|Overall Study|Withdrawal by Subject|2|||
155669546|NCT01408277|561884947|FG001|Overall Study|Withdrawal by Subject|0|||
155669547|NCT01408277|561884946|FG000|Overall Study|Protocol Violation|2|||
155669548|NCT01408277|561884947|FG001|Overall Study|Protocol Violation|0|||
155669549|NCT01645735|561884952|FG000|Overall Study|Physician Decision|2|||
155669550|NCT01645735|561884953|FG001|Overall Study|Physician Decision|0|||
155669551|NCT01645735|561884952|FG000|Overall Study|Withdrawal by Subject|1|||
155669552|NCT01645735|561884953|FG001|Overall Study|Withdrawal by Subject|0|||
155669553|NCT01645735|561884952|FG000|Overall Study|Protocol Violation|1|||
155669554|NCT01645735|561884953|FG001|Overall Study|Protocol Violation|0|||
155669555|NCT01645735|561884952|FG000|Overall Study|Adverse Event|0|||
155669556|NCT01645735|561884953|FG001|Overall Study|Adverse Event|1|||
155669557|NCT00041470|561884962|FG000|Overall Study|Loss of Funding|38|||
155669558|NCT03465722|561884965|FG000|Overall Study|Withdrawal by Subject|21|||
155669559|NCT03465722|561884966|FG001|Overall Study|Withdrawal by Subject|14|||
155669560|NCT03465722|561884965|FG000|Overall Study|Death|89|||
155669561|NCT03465722|561884966|FG001|Overall Study|Death|87|||
155669562|NCT03465722|561884965|FG000|Overall Study|Lost to Follow-up|5|||
155669563|NCT03465722|561884966|FG001|Overall Study|Lost to Follow-up|3|||
155669564|NCT03465722|561884965|FG000|Overall Study|Administrative/Other|33|||
155595223|NCT00941863|561606171|FG001|Continued After PCD|Withdrawal by Subject|0|||
155595224|NCT00941863|561606172|FG002|Continued After PCD|Withdrawal by Subject|0|||
155669565|NCT03465722|561884966|FG001|Overall Study|Administrative/Other|32|||
155669566|NCT03465722|561884965|FG000|Overall Study|Not treated|1|||
155669567|NCT03465722|561884966|FG001|Overall Study|Not treated|2|||
155669568|NCT03465722|561884965|FG000|Overall Study|Sponsor decision|91|||
155669569|NCT03465722|561884966|FG001|Overall Study|Sponsor decision|98|||
155669570|NCT02948582|561884969|FG000|Washout Period 1|Adverse Event|0|||
155669571|NCT02948582|561884970|FG001|Washout Period 1|Adverse Event|2|||
155669572|NCT02948582|561884971|FG002|Washout Period 1|Adverse Event|0|||
155669573|NCT02948582|561884972|FG003|Washout Period 1|Adverse Event|0|||
155669574|NCT02948582|561884973|FG004|Washout Period 1|Adverse Event|0|||
155669575|NCT02948582|561884974|FG005|Washout Period 1|Adverse Event|0|||
155669576|NCT02948582|561884969|FG000|Washout Period 1|Protocol Violation|0|||
155669577|NCT02948582|561884970|FG001|Washout Period 1|Protocol Violation|0|||
155669578|NCT02948582|561884971|FG002|Washout Period 1|Protocol Violation|0|||
155669579|NCT02948582|561884972|FG003|Washout Period 1|Protocol Violation|0|||
155669580|NCT02948582|561884973|FG004|Washout Period 1|Protocol Violation|0|||
155669581|NCT02948582|561884974|FG005|Washout Period 1|Protocol Violation|1|||
155669582|NCT02948582|561884969|FG000|Washout Period 2|Adverse Event|0|||
155669583|NCT02948582|561884970|FG001|Washout Period 2|Adverse Event|1|||
155669584|NCT02948582|561884971|FG002|Washout Period 2|Adverse Event|0|||
155669585|NCT02948582|561884972|FG003|Washout Period 2|Adverse Event|0|||
155669586|NCT02948582|561884973|FG004|Washout Period 2|Adverse Event|0|||
155669587|NCT02948582|561884974|FG005|Washout Period 2|Adverse Event|0|||
155669588|NCT02948582|561884969|FG000|Washout Period 2|personal reasons|0|||
155669589|NCT02948582|561884970|FG001|Washout Period 2|personal reasons|0|||
155669590|NCT02948582|561884971|FG002|Washout Period 2|personal reasons|0|||
155669591|NCT02948582|561884972|FG003|Washout Period 2|personal reasons|1|||
155669592|NCT02948582|561884973|FG004|Washout Period 2|personal reasons|0|||
155669593|NCT02948582|561884974|FG005|Washout Period 2|personal reasons|0|||
155669594|NCT02948582|561884969|FG000|Washout Period 4|Adverse Event|1|||
155595225|NCT00941863|561606173|FG003|Continued After PCD|Withdrawal by Subject|0|||
155595226|NCT00941863|561606174|FG004|Continued After PCD|Withdrawal by Subject|1|||
155595227|NCT00941863|561606170|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
155595228|NCT00941863|561606171|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
155595229|NCT00941863|561606172|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
155595230|NCT00941863|561606173|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
155595231|NCT00941863|561606174|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
155595232|NCT02048826|561606180|FG000|Overall Study|Withdrawal by Subject|1|||
155595233|NCT02048826|561606181|FG001|Overall Study|Withdrawal by Subject|0|||
155595234|NCT02218736|561606191|FG000|Overall Study|Withdrawal by Subject|10|||
155595235|NCT02218736|561606192|FG001|Overall Study|Withdrawal by Subject|9|||
155595236|NCT02218736|561606191|FG000|Overall Study|Protocol Violation|2|||
155595237|NCT02218736|561606192|FG001|Overall Study|Protocol Violation|0|||
155595238|NCT03452488|561606193|FG000|Overall Study|Adverse Event|4|||
155595239|NCT03452488|561606194|FG001|Overall Study|Adverse Event|6|||
155595240|NCT03452488|561606195|FG002|Overall Study|Adverse Event|1|||
155595241|NCT03452488|561606193|FG000|Overall Study|Death|0|||
155669595|NCT02948582|561884970|FG001|Washout Period 4|Adverse Event|0|||
155669596|NCT02948582|561884971|FG002|Washout Period 4|Adverse Event|1|||
155669597|NCT02948582|561884972|FG003|Washout Period 4|Adverse Event|0|||
155669598|NCT02948582|561884973|FG004|Washout Period 4|Adverse Event|0|||
155669599|NCT02948582|561884974|FG005|Washout Period 4|Adverse Event|0|||
155669600|NCT00955474|561884980|FG000|Overall Study|Physician Decision|7|||
155669601|NCT00955474|561884981|FG001|Overall Study|Physician Decision|5|||
155669602|NCT02382991|561884983|FG000|Overall Study|Adverse Event|1|||
155669603|NCT02382991|561884984|FG001|Overall Study|Adverse Event|2|||
155669604|NCT02382991|561884983|FG000|Overall Study|Lost to Follow-up|1|||
155669605|NCT02382991|561884984|FG001|Overall Study|Lost to Follow-up|0|||
155669606|NCT02382991|561884983|FG000|Overall Study|Withdrawal by Subject|0|||
155669607|NCT02382991|561884984|FG001|Overall Study|Withdrawal by Subject|1|||
155669608|NCT04570384|561884991|FG000|Overall Study|Adverse Event|2|||
155669609|NCT04570384|561884992|FG001|Overall Study|Adverse Event|1|||
155669610|NCT04570384|561884991|FG000|Overall Study|Death|2|||
155669611|NCT04570384|561884992|FG001|Overall Study|Death|5|||
155669612|NCT04570384|561884991|FG000|Overall Study|Lost to Follow-up|1|||
155669613|NCT04570384|561884992|FG001|Overall Study|Lost to Follow-up|0|||
155669614|NCT04570384|561884991|FG000|Overall Study|Other|1|||
155669615|NCT04570384|561884992|FG001|Overall Study|Other|0|||
155669616|NCT04570384|561884991|FG000|Overall Study|Protocol Violation|0|||
155669617|NCT04570384|561884992|FG001|Overall Study|Protocol Violation|1|||
155669618|NCT04570384|561884991|FG000|Overall Study|Sponsor Decision|1|||
155595242|NCT03452488|561606194|FG001|Overall Study|Death|0|||
155595243|NCT03452488|561606195|FG002|Overall Study|Death|1|||
155595244|NCT03452488|561606193|FG000|Overall Study|Lost to Follow-up|1|||
155595245|NCT03452488|561606194|FG001|Overall Study|Lost to Follow-up|2|||
155595246|NCT03452488|561606195|FG002|Overall Study|Lost to Follow-up|0|||
155595247|NCT03452488|561606193|FG000|Overall Study|PI Decision|1|||
155595248|NCT03452488|561606194|FG001|Overall Study|PI Decision|0|||
155595249|NCT03452488|561606195|FG002|Overall Study|PI Decision|0|||
155595250|NCT03452488|561606193|FG000|Overall Study|Withdrew consent|4|||
155595251|NCT03452488|561606194|FG001|Overall Study|Withdrew consent|2|||
155595252|NCT03452488|561606195|FG002|Overall Study|Withdrew consent|2|||
155595253|NCT03452488|561606193|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
155595254|NCT03452488|561606194|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
155595255|NCT03452488|561606195|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
155595256|NCT03452488|561606193|FG000|Overall Study|Other|0|||
155595257|NCT03452488|561606194|FG001|Overall Study|Other|2|||
155595258|NCT03452488|561606195|FG002|Overall Study|Other|2|||
155595259|NCT04016779|561606198|FG000|Overall Study|Adverse Event|9|||
155595260|NCT04016779|561606199|FG001|Overall Study|Adverse Event|17|||
155595261|NCT04016779|561606198|FG000|Overall Study|Lack of Efficacy|4|||
155595262|NCT04016779|561606199|FG001|Overall Study|Lack of Efficacy|1|||
155595263|NCT04016779|561606198|FG000|Overall Study|Lost to Follow-up|5|||
155595264|NCT04016779|561606199|FG001|Overall Study|Lost to Follow-up|14|||
155595265|NCT04016779|561606198|FG000|Overall Study|Physician Decision|1|||
155595266|NCT04016779|561606199|FG001|Overall Study|Physician Decision|3|||
155595267|NCT04016779|561606198|FG000|Overall Study|Withdrawal by Subject|6|||
155595268|NCT04016779|561606199|FG001|Overall Study|Withdrawal by Subject|8|||
155595269|NCT04016779|561606198|FG000|Overall Study|Non-compliance with Study Drug|2|||
155595270|NCT04016779|561606199|FG001|Overall Study|Non-compliance with Study Drug|3|||
155595271|NCT04016779|561606198|FG000|Overall Study|Other, Multiple categories|17|||
155595272|NCT04016779|561606199|FG001|Overall Study|Other, Multiple categories|17|||
155595273|NCT00623935|561606200|FG000|Overall Study|Death|1|||
155595274|NCT00623935|561606200|FG000|Overall Study|Patient Declined Transplant|1|||
155595275|NCT00747474|561606201|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595276|NCT00747474|561606202|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595277|NCT00747474|561606203|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595278|NCT00747474|561606204|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595279|NCT00747474|561606205|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595280|NCT00747474|561606206|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595281|NCT00747474|561606207|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595282|NCT00747474|561606208|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
155595283|NCT00747474|561606209|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595284|NCT00747474|561606210|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595285|NCT00747474|561606211|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595286|NCT00747474|561606212|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155595287|NCT02829723|561606214|FG000|Overall Study|Adverse Event|0|||
155595288|NCT02829723|561606215|FG001|Overall Study|Adverse Event|0|||
155595289|NCT02829723|561606216|FG002|Overall Study|Adverse Event|1|||
155595290|NCT02829723|561606217|FG003|Overall Study|Adverse Event|1|||
155595291|NCT02829723|561606218|FG004|Overall Study|Adverse Event|0|||
155595292|NCT02829723|561606219|FG005|Overall Study|Adverse Event|0|||
155595293|NCT02829723|561606220|FG006|Overall Study|Adverse Event|0|||
155595294|NCT02829723|561606221|FG007|Overall Study|Adverse Event|1|||
155595295|NCT02829723|561606222|FG008|Overall Study|Adverse Event|0|||
155595296|NCT02829723|561606223|FG009|Overall Study|Adverse Event|0|||
155595297|NCT02829723|561606224|FG010|Overall Study|Adverse Event|0|||
155595298|NCT02829723|561606225|FG011|Overall Study|Adverse Event|0|||
155595299|NCT02829723|561606226|FG012|Overall Study|Adverse Event|0|||
155595300|NCT02829723|561606227|FG013|Overall Study|Adverse Event|0|||
155595301|NCT02829723|561606228|FG014|Overall Study|Adverse Event|1|||
155595302|NCT02829723|561606229|FG015|Overall Study|Adverse Event|1|||
155595303|NCT02829723|561606230|FG016|Overall Study|Adverse Event|1|||
155595304|NCT02829723|561606231|FG017|Overall Study|Adverse Event|2|||
155595305|NCT02829723|561606232|FG018|Overall Study|Adverse Event|1|||
155595306|NCT02829723|561606233|FG019|Overall Study|Adverse Event|1|||
155595307|NCT02829723|561606234|FG020|Overall Study|Adverse Event|3|||
155595308|NCT02829723|561606235|FG021|Overall Study|Adverse Event|0|||
155595309|NCT02829723|561606236|FG022|Overall Study|Adverse Event|0|||
155595310|NCT02829723|561606237|FG023|Overall Study|Adverse Event|1|||
155595311|NCT02829723|561606238|FG024|Overall Study|Adverse Event|1|||
155595312|NCT02829723|561606239|FG025|Overall Study|Adverse Event|3|||
155595313|NCT02829723|561606240|FG026|Overall Study|Adverse Event|5|||
155595314|NCT02829723|561606214|FG000|Overall Study|Death|1|||
155595315|NCT02829723|561606215|FG001|Overall Study|Death|0|||
155595316|NCT02829723|561606216|FG002|Overall Study|Death|1|||
155595317|NCT02829723|561606217|FG003|Overall Study|Death|1|||
155595318|NCT02829723|561606218|FG004|Overall Study|Death|0|||
155595319|NCT02829723|561606219|FG005|Overall Study|Death|0|||
155595320|NCT02829723|561606220|FG006|Overall Study|Death|2|||
155595321|NCT02829723|561606221|FG007|Overall Study|Death|0|||
155595322|NCT02829723|561606222|FG008|Overall Study|Death|1|||
155595323|NCT02829723|561606223|FG009|Overall Study|Death|0|||
155595324|NCT02829723|561606224|FG010|Overall Study|Death|0|||
155595325|NCT02829723|561606225|FG011|Overall Study|Death|0|||
155595326|NCT02829723|561606226|FG012|Overall Study|Death|2|||
155595327|NCT02829723|561606227|FG013|Overall Study|Death|1|||
155595328|NCT02829723|561606228|FG014|Overall Study|Death|0|||
155595329|NCT02829723|561606229|FG015|Overall Study|Death|0|||
155595330|NCT02829723|561606230|FG016|Overall Study|Death|0|||
155595331|NCT02829723|561606231|FG017|Overall Study|Death|0|||
155595332|NCT02829723|561606232|FG018|Overall Study|Death|0|||
155595333|NCT02829723|561606233|FG019|Overall Study|Death|0|||
155595334|NCT02829723|561606234|FG020|Overall Study|Death|0|||
155595335|NCT02829723|561606235|FG021|Overall Study|Death|2|||
155595336|NCT02829723|561606236|FG022|Overall Study|Death|0|||
155595337|NCT02829723|561606237|FG023|Overall Study|Death|0|||
155595338|NCT02829723|561606238|FG024|Overall Study|Death|0|||
155595339|NCT02829723|561606239|FG025|Overall Study|Death|1|||
155595340|NCT02829723|561606240|FG026|Overall Study|Death|2|||
155595341|NCT02829723|561606214|FG000|Overall Study|Physician Decision|0|||
155595342|NCT02829723|561606215|FG001|Overall Study|Physician Decision|0|||
155595343|NCT02829723|561606216|FG002|Overall Study|Physician Decision|0|||
155595344|NCT02829723|561606217|FG003|Overall Study|Physician Decision|0|||
155595345|NCT02829723|561606218|FG004|Overall Study|Physician Decision|0|||
155595346|NCT02829723|561606219|FG005|Overall Study|Physician Decision|0|||
155595347|NCT02829723|561606220|FG006|Overall Study|Physician Decision|0|||
155595348|NCT02829723|561606221|FG007|Overall Study|Physician Decision|0|||
155595349|NCT02829723|561606222|FG008|Overall Study|Physician Decision|0|||
155595350|NCT02829723|561606223|FG009|Overall Study|Physician Decision|1|||
155595351|NCT02829723|561606224|FG010|Overall Study|Physician Decision|1|||
155595352|NCT02829723|561606225|FG011|Overall Study|Physician Decision|0|||
155595353|NCT02829723|561606226|FG012|Overall Study|Physician Decision|0|||
155595354|NCT02829723|561606227|FG013|Overall Study|Physician Decision|1|||
155595355|NCT02829723|561606228|FG014|Overall Study|Physician Decision|0|||
155595356|NCT02829723|561606229|FG015|Overall Study|Physician Decision|0|||
155595357|NCT02829723|561606230|FG016|Overall Study|Physician Decision|2|||
155595358|NCT02829723|561606231|FG017|Overall Study|Physician Decision|0|||
155595359|NCT02829723|561606232|FG018|Overall Study|Physician Decision|0|||
155595360|NCT02829723|561606233|FG019|Overall Study|Physician Decision|0|||
155595361|NCT02829723|561606234|FG020|Overall Study|Physician Decision|0|||
155595362|NCT02829723|561606235|FG021|Overall Study|Physician Decision|0|||
155595363|NCT02829723|561606236|FG022|Overall Study|Physician Decision|1|||
155595364|NCT02829723|561606237|FG023|Overall Study|Physician Decision|1|||
155595365|NCT02829723|561606238|FG024|Overall Study|Physician Decision|1|||
155595366|NCT02829723|561606239|FG025|Overall Study|Physician Decision|1|||
155595367|NCT02829723|561606240|FG026|Overall Study|Physician Decision|3|||
155595368|NCT02829723|561606214|FG000|Overall Study|Progressive disease|4|||
155595369|NCT02829723|561606215|FG001|Overall Study|Progressive disease|6|||
155595370|NCT02829723|561606216|FG002|Overall Study|Progressive disease|3|||
155595371|NCT02829723|561606217|FG003|Overall Study|Progressive disease|3|||
155595372|NCT02829723|561606218|FG004|Overall Study|Progressive disease|3|||
155595373|NCT02829723|561606219|FG005|Overall Study|Progressive disease|5|||
155595374|NCT02829723|561606220|FG006|Overall Study|Progressive disease|4|||
155595375|NCT02829723|561606221|FG007|Overall Study|Progressive disease|6|||
155595376|NCT02829723|561606222|FG008|Overall Study|Progressive disease|8|||
155595377|NCT02829723|561606223|FG009|Overall Study|Progressive disease|4|||
155595378|NCT02829723|561606224|FG010|Overall Study|Progressive disease|9|||
155595379|NCT02829723|561606225|FG011|Overall Study|Progressive disease|0|||
155595380|NCT02829723|561606226|FG012|Overall Study|Progressive disease|3|||
155595381|NCT02829723|561606227|FG013|Overall Study|Progressive disease|4|||
155595382|NCT02829723|561606228|FG014|Overall Study|Progressive disease|2|||
155595383|NCT02829723|561606229|FG015|Overall Study|Progressive disease|4|||
155595384|NCT02829723|561606230|FG016|Overall Study|Progressive disease|5|||
155595385|NCT02829723|561606231|FG017|Overall Study|Progressive disease|3|||
155595386|NCT02829723|561606232|FG018|Overall Study|Progressive disease|4|||
155595387|NCT02829723|561606233|FG019|Overall Study|Progressive disease|4|||
155595388|NCT02829723|561606234|FG020|Overall Study|Progressive disease|7|||
155595389|NCT02829723|561606235|FG021|Overall Study|Progressive disease|6|||
155669619|NCT04570384|561884992|FG001|Overall Study|Sponsor Decision|0|||
155595390|NCT02829723|561606236|FG022|Overall Study|Progressive disease|3|||
155595391|NCT02829723|561606237|FG023|Overall Study|Progressive disease|3|||
155595392|NCT02829723|561606238|FG024|Overall Study|Progressive disease|3|||
155595393|NCT02829723|561606239|FG025|Overall Study|Progressive disease|16|||
155595394|NCT02829723|561606240|FG026|Overall Study|Progressive disease|10|||
155595395|NCT02829723|561606214|FG000|Overall Study|Subject/guardian decision|0|||
155595396|NCT02829723|561606215|FG001|Overall Study|Subject/guardian decision|1|||
155595397|NCT02829723|561606216|FG002|Overall Study|Subject/guardian decision|0|||
155595398|NCT02829723|561606217|FG003|Overall Study|Subject/guardian decision|1|||
155595399|NCT02829723|561606218|FG004|Overall Study|Subject/guardian decision|0|||
155595400|NCT02829723|561606219|FG005|Overall Study|Subject/guardian decision|0|||
155595401|NCT02829723|561606220|FG006|Overall Study|Subject/guardian decision|0|||
155595402|NCT02829723|561606221|FG007|Overall Study|Subject/guardian decision|1|||
155595403|NCT02829723|561606222|FG008|Overall Study|Subject/guardian decision|0|||
155595404|NCT02829723|561606223|FG009|Overall Study|Subject/guardian decision|0|||
155595405|NCT02829723|561606224|FG010|Overall Study|Subject/guardian decision|0|||
155595406|NCT02829723|561606225|FG011|Overall Study|Subject/guardian decision|0|||
155595407|NCT02829723|561606226|FG012|Overall Study|Subject/guardian decision|0|||
155595408|NCT02829723|561606227|FG013|Overall Study|Subject/guardian decision|0|||
155595409|NCT02829723|561606228|FG014|Overall Study|Subject/guardian decision|1|||
155595410|NCT02829723|561606229|FG015|Overall Study|Subject/guardian decision|0|||
155595411|NCT02829723|561606230|FG016|Overall Study|Subject/guardian decision|1|||
155595412|NCT02829723|561606231|FG017|Overall Study|Subject/guardian decision|0|||
155595413|NCT02829723|561606232|FG018|Overall Study|Subject/guardian decision|1|||
155595414|NCT02829723|561606233|FG019|Overall Study|Subject/guardian decision|0|||
155595415|NCT02829723|561606234|FG020|Overall Study|Subject/guardian decision|1|||
155595416|NCT02829723|561606235|FG021|Overall Study|Subject/guardian decision|0|||
155595417|NCT02829723|561606236|FG022|Overall Study|Subject/guardian decision|0|||
155595418|NCT02829723|561606237|FG023|Overall Study|Subject/guardian decision|1|||
155595419|NCT02829723|561606238|FG024|Overall Study|Subject/guardian decision|0|||
155595420|NCT02829723|561606239|FG025|Overall Study|Subject/guardian decision|1|||
155595421|NCT02829723|561606240|FG026|Overall Study|Subject/guardian decision|1|||
155595422|NCT02829723|561606214|FG000|Overall Study|Study terminated by sponsor|0|||
155595423|NCT02829723|561606215|FG001|Overall Study|Study terminated by sponsor|0|||
155595424|NCT02829723|561606216|FG002|Overall Study|Study terminated by sponsor|0|||
155595425|NCT02829723|561606217|FG003|Overall Study|Study terminated by sponsor|0|||
155595426|NCT02829723|561606218|FG004|Overall Study|Study terminated by sponsor|0|||
155595427|NCT02829723|561606219|FG005|Overall Study|Study terminated by sponsor|0|||
155595428|NCT02829723|561606220|FG006|Overall Study|Study terminated by sponsor|0|||
155595429|NCT02829723|561606221|FG007|Overall Study|Study terminated by sponsor|0|||
155595430|NCT02829723|561606222|FG008|Overall Study|Study terminated by sponsor|0|||
155595431|NCT02829723|561606223|FG009|Overall Study|Study terminated by sponsor|0|||
155595432|NCT02829723|561606224|FG010|Overall Study|Study terminated by sponsor|0|||
155595433|NCT02829723|561606225|FG011|Overall Study|Study terminated by sponsor|0|||
155595434|NCT02829723|561606226|FG012|Overall Study|Study terminated by sponsor|0|||
155595435|NCT02829723|561606227|FG013|Overall Study|Study terminated by sponsor|0|||
155595436|NCT02829723|561606228|FG014|Overall Study|Study terminated by sponsor|0|||
155595437|NCT02829723|561606229|FG015|Overall Study|Study terminated by sponsor|0|||
155595438|NCT02829723|561606230|FG016|Overall Study|Study terminated by sponsor|0|||
155595439|NCT02829723|561606231|FG017|Overall Study|Study terminated by sponsor|0|||
155595440|NCT02829723|561606232|FG018|Overall Study|Study terminated by sponsor|0|||
155595441|NCT02829723|561606233|FG019|Overall Study|Study terminated by sponsor|0|||
155595442|NCT02829723|561606234|FG020|Overall Study|Study terminated by sponsor|0|||
155595443|NCT02829723|561606235|FG021|Overall Study|Study terminated by sponsor|1|||
155595444|NCT02829723|561606236|FG022|Overall Study|Study terminated by sponsor|0|||
155595445|NCT02829723|561606237|FG023|Overall Study|Study terminated by sponsor|0|||
155595446|NCT02829723|561606238|FG024|Overall Study|Study terminated by sponsor|0|||
155595447|NCT02829723|561606239|FG025|Overall Study|Study terminated by sponsor|0|||
155595448|NCT02829723|561606240|FG026|Overall Study|Study terminated by sponsor|0|||
155595449|NCT03514485|561606241|FG000|Overall Study|Lost to Follow-up|5|||
155595450|NCT03514485|561606242|FG001|Overall Study|Lost to Follow-up|3|||
155595451|NCT03514485|561606243|FG002|Overall Study|Lost to Follow-up|2|||
155595452|NCT03514485|561606244|FG003|Overall Study|Lost to Follow-up|0|||
155595453|NCT03514485|561606245|FG004|Overall Study|Lost to Follow-up|1|||
155595454|NCT03514485|561606246|FG005|Overall Study|Lost to Follow-up|4|||
155595455|NCT03514485|561606241|FG000|Overall Study|Withdrawal by Subject|0|||
155595456|NCT03514485|561606242|FG001|Overall Study|Withdrawal by Subject|1|||
155595457|NCT03514485|561606243|FG002|Overall Study|Withdrawal by Subject|3|||
155595458|NCT03514485|561606244|FG003|Overall Study|Withdrawal by Subject|1|||
155595459|NCT03514485|561606245|FG004|Overall Study|Withdrawal by Subject|2|||
155595460|NCT03514485|561606246|FG005|Overall Study|Withdrawal by Subject|1|||
155595461|NCT03075891|561606247|FG000|Overall Study|Withdrawal by Subject|3|||
155595462|NCT03075891|561606248|FG001|Overall Study|Withdrawal by Subject|6|||
155595463|NCT03075891|561606247|FG000|Overall Study|Lost to Follow-up|1|||
155595464|NCT03075891|561606248|FG001|Overall Study|Lost to Follow-up|0|||
155595465|NCT03075891|561606247|FG000|Overall Study|Pregnancy|3|||
155595466|NCT03075891|561606248|FG001|Overall Study|Pregnancy|1|||
155595467|NCT03075891|561606247|FG000|Overall Study|visits not performed (no time)|1|||
155595468|NCT03075891|561606248|FG001|Overall Study|visits not performed (no time)|0|||
155595469|NCT03075891|561606247|FG000|Overall Study|Drug abuse relapse issue|0|||
155595470|NCT03075891|561606248|FG001|Overall Study|Drug abuse relapse issue|1|||
155595471|NCT03075891|561606247|FG000|Overall Study|Participant requiring study withdrawal|0|||
155595472|NCT03075891|561606248|FG001|Overall Study|Participant requiring study withdrawal|1|||
155595473|NCT03075891|561606247|FG000|Overall Study|Adverse event, non-fatal|1|||
155595474|NCT03075891|561606248|FG001|Overall Study|Adverse event, non-fatal|4|||
155595475|NCT00179673|561606252|FG000|Overall Study|Adverse Event|7|||
155595476|NCT00179673|561606252|FG000|Overall Study|Lack of Efficacy|15|||
155595477|NCT00179673|561606252|FG000|Overall Study|Withdrawal by Subject|3|||
155595478|NCT00179673|561606252|FG000|Overall Study|Death|4|||
155595479|NCT00179673|561606252|FG000|Overall Study|Other Observations and options|14|||
155595480|NCT00492648|561606253|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
155595481|NCT00492648|561606254|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
155595482|NCT00282113|561606255|FG000|Overall Study|Removed at parents request|1|||
155595483|NCT00282113|561606256|FG001|Overall Study|Removed at parents request|0|||
155595484|NCT00282113|561606257|FG002|Overall Study|Removed at parents request|0|||
155595485|NCT02387957|561606258|FG000|Overall Study|The study was discontinued|21|||
155595486|NCT02387957|561606259|FG001|Overall Study|The study was discontinued|21|||
155595487|NCT02387957|561606260|FG002|Overall Study|The study was discontinued|20|||
155595488|NCT02887248|561606261|FG000|Overall Study|Withdrawal by Subject|1|||
155595489|NCT02887248|561606261|FG000|Overall Study|Adverse Event|1|||
155595490|NCT02887248|561606261|FG000|Overall Study|Progressive Disease|1|||
155595491|NCT01500187|561606264|FG000|Overall Study|Lost to Follow-up|6|||
155595492|NCT01500187|561606265|FG001|Overall Study|Lost to Follow-up|0|||
155595493|NCT04740827|561606282|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
155595494|NCT04740827|561606283|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
155595495|NCT04740827|561606282|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
155595496|NCT04740827|561606283|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
155595497|NCT04740827|561606282|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
155595498|NCT04740827|561606283|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
155595499|NCT04740827|561606282|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
155595500|NCT04740827|561606283|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
155595501|NCT04740827|561606282|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
155595502|NCT04740827|561606283|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
155595503|NCT04740827|561606282|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
155595504|NCT04740827|561606283|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
155595505|NCT02147158|561606284|FG000|Treatment Course 1|Adverse Event|1|||
155595506|NCT02147158|561606285|FG001|Treatment Course 1|Adverse Event|4|||
155595507|NCT02147158|561606286|FG002|Treatment Course 1|Adverse Event|3|||
155595508|NCT02147158|561606287|FG003|Treatment Course 1|Adverse Event|4|||
155595509|NCT02147158|561606288|FG004|Treatment Course 1|Adverse Event|1|||
155595510|NCT02147158|561606289|FG005|Treatment Course 1|Adverse Event|2|||
155595511|NCT02147158|561606284|FG000|Treatment Course 1|Lost to Follow-up|2|||
155595512|NCT02147158|561606285|FG001|Treatment Course 1|Lost to Follow-up|4|||
155595513|NCT02147158|561606286|FG002|Treatment Course 1|Lost to Follow-up|3|||
155595514|NCT02147158|561606287|FG003|Treatment Course 1|Lost to Follow-up|3|||
155595515|NCT02147158|561606288|FG004|Treatment Course 1|Lost to Follow-up|2|||
155595516|NCT02147158|561606289|FG005|Treatment Course 1|Lost to Follow-up|4|||
155595517|NCT02147158|561606284|FG000|Treatment Course 1|Protocol Violation|0|||
155595518|NCT02147158|561606285|FG001|Treatment Course 1|Protocol Violation|0|||
155595519|NCT02147158|561606286|FG002|Treatment Course 1|Protocol Violation|1|||
155595520|NCT02147158|561606287|FG003|Treatment Course 1|Protocol Violation|1|||
155595521|NCT02147158|561606288|FG004|Treatment Course 1|Protocol Violation|0|||
155595522|NCT02147158|561606289|FG005|Treatment Course 1|Protocol Violation|0|||
155669620|NCT04570384|561884991|FG000|Overall Study|Withdrawal by Subject|4|||
155669621|NCT04570384|561884992|FG001|Overall Study|Withdrawal by Subject|2|||
155669622|NCT02573948|561884993|FG000|Longitudinal Cohort|Death|9|||
155669623|NCT02573948|561884993|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
155669624|NCT02573948|561884993|FG000|Longitudinal Cohort|Incarcerated|25|||
155595523|NCT02147158|561606284|FG000|Treatment Course 1|Withdrawal of Consent|1|||
155595524|NCT02147158|561606285|FG001|Treatment Course 1|Withdrawal of Consent|1|||
155595525|NCT02147158|561606286|FG002|Treatment Course 1|Withdrawal of Consent|1|||
155595526|NCT02147158|561606287|FG003|Treatment Course 1|Withdrawal of Consent|5|||
155595527|NCT02147158|561606288|FG004|Treatment Course 1|Withdrawal of Consent|3|||
155595528|NCT02147158|561606289|FG005|Treatment Course 1|Withdrawal of Consent|2|||
155595529|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Adverse Event|1|||
155595530|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Adverse Event|0|||
155595531|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Adverse Event|0|||
155595532|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Adverse Event|1|||
155669625|NCT03654274|561884998|FG000|Overall Study|Adverse Event|19|||
155669626|NCT03654274|561884999|FG001|Overall Study|Adverse Event|23|||
155595533|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Adverse Event|0|||
155595534|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Adverse Event|0|||
155669627|NCT03654274|561885000|FG002|Overall Study|Adverse Event|24|||
155595535|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
155595536|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
155595537|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
155595538|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
155595539|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
155595540|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
155595541|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
155595542|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
155595543|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
155595544|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
155595545|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
155595546|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
155595547|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
155595548|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
155595549|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
155595550|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
155595551|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
155595552|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
155595553|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
155595554|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
155595555|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
155595556|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
155595557|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
155595558|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
155595559|NCT02147158|561606284|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
155595560|NCT02147158|561606285|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155595561|NCT02147158|561606286|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
155595562|NCT02147158|561606287|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
155595563|NCT02147158|561606288|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155595564|NCT02147158|561606289|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155595565|NCT02147158|561606284|FG000|Treatment Course 2|Adverse Event|0|||
155595566|NCT02147158|561606285|FG001|Treatment Course 2|Adverse Event|4|||
155595567|NCT02147158|561606286|FG002|Treatment Course 2|Adverse Event|2|||
155595568|NCT02147158|561606287|FG003|Treatment Course 2|Adverse Event|1|||
155595569|NCT02147158|561606288|FG004|Treatment Course 2|Adverse Event|0|||
155595570|NCT02147158|561606289|FG005|Treatment Course 2|Adverse Event|1|||
155595571|NCT02147158|561606284|FG000|Treatment Course 2|Withdrawal of Consent|0|||
155595572|NCT02147158|561606285|FG001|Treatment Course 2|Withdrawal of Consent|1|||
155595573|NCT02147158|561606286|FG002|Treatment Course 2|Withdrawal of Consent|2|||
155595574|NCT02147158|561606287|FG003|Treatment Course 2|Withdrawal of Consent|3|||
155595575|NCT02147158|561606288|FG004|Treatment Course 2|Withdrawal of Consent|0|||
155595576|NCT02147158|561606289|FG005|Treatment Course 2|Withdrawal of Consent|0|||
155595577|NCT02147158|561606284|FG000|Treatment Course 2|Lost to Follow-up|1|||
155669628|NCT03654274|561884998|FG000|Overall Study|Protocol Deviation|0|||
155669629|NCT03654274|561884999|FG001|Overall Study|Protocol Deviation|2|||
155669630|NCT03654274|561885000|FG002|Overall Study|Protocol Deviation|0|||
155669631|NCT03654274|561884998|FG000|Overall Study|Lost to Follow-up|8|||
155669632|NCT03654274|561884999|FG001|Overall Study|Lost to Follow-up|6|||
155669633|NCT03654274|561885000|FG002|Overall Study|Lost to Follow-up|5|||
155669634|NCT03654274|561884998|FG000|Overall Study|Withdrawal by Subject|46|||
155669635|NCT03654274|561884999|FG001|Overall Study|Withdrawal by Subject|25|||
155669636|NCT03654274|561885000|FG002|Overall Study|Withdrawal by Subject|33|||
155669637|NCT03654274|561884998|FG000|Overall Study|Lack of Efficacy|4|||
155669638|NCT03654274|561884999|FG001|Overall Study|Lack of Efficacy|5|||
155669639|NCT03654274|561885000|FG002|Overall Study|Lack of Efficacy|7|||
155669640|NCT03654274|561884998|FG000|Overall Study|Pregnancy|2|||
155669641|NCT03654274|561884999|FG001|Overall Study|Pregnancy|2|||
155669642|NCT03654274|561885000|FG002|Overall Study|Pregnancy|1|||
155669643|NCT03654274|561884998|FG000|Overall Study|Other|27|||
155669644|NCT03654274|561884999|FG001|Overall Study|Other|29|||
155669645|NCT03654274|561885000|FG002|Overall Study|Other|32|||
155669646|NCT03654274|561884998|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
155669647|NCT03654274|561884999|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
155669648|NCT03654274|561885000|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
155669649|NCT01265992|561885001|FG000|Overall Study|Lost to Follow-up|1|||
155669650|NCT01265992|561885001|FG000|Overall Study|Withdrawal by Subject|1|||
155669651|NCT01265992|561885001|FG000|Overall Study|Adverse Event|1|||
155669652|NCT01265992|561885001|FG000|Overall Study|Administrative reasons|2|||
155669653|NCT01265992|561885001|FG000|Overall Study|Stopped treatment|3|||
155669654|NCT01265992|561885001|FG000|Overall Study|Did not receive treatment|1|||
155669655|NCT01102491|561885002|FG000|Overall Study|Protocol Violation|11|||
155669656|NCT01102491|561885003|FG001|Overall Study|Protocol Violation|12|||
155669657|NCT01837680|561885004|FG000|Overall Study|Lost to Follow-up|2|||
155669658|NCT01837680|561885005|FG001|Overall Study|Lost to Follow-up|2|||
155669659|NCT01837680|561885004|FG000|Overall Study|lack of insurance|0|||
155669660|NCT01837680|561885005|FG001|Overall Study|lack of insurance|2|||
155669661|NCT01837680|561885004|FG000|Overall Study|allergic reaction|6|||
155669662|NCT01837680|561885005|FG001|Overall Study|allergic reaction|0|||
155669663|NCT01837680|561885004|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
155669664|NCT01837680|561885005|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
155669665|NCT05005273|561885006|FG000|Overall Study|Study Terminated|1|||
155669666|NCT05005273|561885007|FG001|Overall Study|Study Terminated|0|||
155669667|NCT03265145|561885008|FG000|Overall Study|Protocol Violation|2|||
155669668|NCT03265145|561885009|FG001|Overall Study|Protocol Violation|0|||
155669669|NCT03265145|561885008|FG000|Overall Study|Adverse Event|1|||
155669670|NCT03265145|561885009|FG001|Overall Study|Adverse Event|0|||
155669671|NCT03265145|561885008|FG000|Overall Study|Withdrawal by Subject|23|||
155669672|NCT03265145|561885009|FG001|Overall Study|Withdrawal by Subject|19|||
155669673|NCT03265145|561885008|FG000|Overall Study|Death|12|||
155669674|NCT03265145|561885009|FG001|Overall Study|Death|12|||
155669675|NCT03265145|561885008|FG000|Overall Study|Lost to Follow-up|13|||
155669676|NCT03265145|561885009|FG001|Overall Study|Lost to Follow-up|9|||
155669677|NCT03265145|561885008|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
155669678|NCT03265145|561885009|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
155669679|NCT03265145|561885008|FG000|Overall Study|Switched back to previous medication|1|||
155669680|NCT03265145|561885009|FG001|Overall Study|Switched back to previous medication|0|||
155669681|NCT03265145|561885008|FG000|Overall Study|Did not want to take medication|1|||
155669682|NCT03265145|561885009|FG001|Overall Study|Did not want to take medication|0|||
155669683|NCT03265145|561885008|FG000|Overall Study|Subject could not afford medication|0|||
155669684|NCT03265145|561885009|FG001|Overall Study|Subject could not afford medication|1|||
155669685|NCT03265145|561885008|FG000|Overall Study|Site closed|2|||
155669686|NCT03265145|561885009|FG001|Overall Study|Site closed|3|||
155669687|NCT03265145|561885008|FG000|Overall Study|Incorrectly randomized|16|||
155669688|NCT03265145|561885009|FG001|Overall Study|Incorrectly randomized|6|||
155669689|NCT03265145|561885008|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
155669690|NCT03265145|561885009|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
155669691|NCT03265145|561885008|FG000|Overall Study|Physician Decision|0|||
155669692|NCT03265145|561885009|FG001|Overall Study|Physician Decision|3|||
155669693|NCT03265145|561885008|FG000|Overall Study|Subject transferred to another facility|0|||
155669694|NCT03265145|561885009|FG001|Overall Study|Subject transferred to another facility|1|||
155669695|NCT04409834|561885010|FG000|Overall Study|Death|55|||
155669696|NCT04409834|561885011|FG001|Overall Study|Death|62|||
155669697|NCT02137070|561885012|FG000|Overall Study|Adverse Event|12|||
155669698|NCT02137070|561885013|FG001|Overall Study|Adverse Event|3|||
155669699|NCT02137070|561885012|FG000|Overall Study|Death|2|||
155669700|NCT02137070|561885013|FG001|Overall Study|Death|0|||
155669701|NCT02137070|561885012|FG000|Overall Study|Lost to Follow-up|24|||
155669702|NCT02137070|561885013|FG001|Overall Study|Lost to Follow-up|9|||
155669703|NCT02137070|561885012|FG000|Overall Study|Physician Decision|0|||
155595578|NCT02147158|561606285|FG001|Treatment Course 2|Lost to Follow-up|0|||
155595579|NCT02147158|561606286|FG002|Treatment Course 2|Lost to Follow-up|1|||
155595580|NCT02147158|561606287|FG003|Treatment Course 2|Lost to Follow-up|1|||
155595581|NCT02147158|561606288|FG004|Treatment Course 2|Lost to Follow-up|0|||
155595582|NCT02147158|561606289|FG005|Treatment Course 2|Lost to Follow-up|1|||
155595583|NCT02147158|561606284|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
155595584|NCT02147158|561606285|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
155595585|NCT02147158|561606286|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
155595586|NCT02147158|561606287|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
155595587|NCT02147158|561606288|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
155595588|NCT02147158|561606289|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
155595589|NCT02147158|561606284|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
155595590|NCT02147158|561606285|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
155595591|NCT02147158|561606286|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
155595592|NCT02147158|561606287|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
155595593|NCT02147158|561606288|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
155595594|NCT02147158|561606289|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
155595595|NCT02147158|561606284|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
155595596|NCT02147158|561606285|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
155595597|NCT02147158|561606286|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
155595598|NCT02147158|561606287|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
155595599|NCT02147158|561606288|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
155595600|NCT02147158|561606289|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
155595601|NCT02147158|561606284|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
155595602|NCT02147158|561606285|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
155595603|NCT02147158|561606286|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
155595604|NCT02147158|561606287|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
155595605|NCT02147158|561606288|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
155595606|NCT02147158|561606289|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
155595607|NCT02147158|561606284|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
155595608|NCT02147158|561606285|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
155595609|NCT02147158|561606286|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
155595610|NCT02147158|561606287|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
155595611|NCT02147158|561606288|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
155595612|NCT02147158|561606289|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
155595613|NCT00940823|561606290|FG000|Overall Study|Death|8|||
155595614|NCT00940823|561606291|FG001|Overall Study|Death|12|||
155595615|NCT00940823|561606290|FG000|Overall Study|Lost to Follow-up|27|||
155595616|NCT00940823|561606291|FG001|Overall Study|Lost to Follow-up|20|||
155595617|NCT04520997|561606294|FG000|Overall Study|Lost to Follow-up|1|||
155595618|NCT04520997|561606295|FG001|Overall Study|Lost to Follow-up|1|||
155595619|NCT04520997|561606294|FG000|Overall Study|Withdrawal by Subject|1|||
155595620|NCT04520997|561606295|FG001|Overall Study|Withdrawal by Subject|0|||
155595621|NCT04520997|561606294|FG000|Overall Study|Not Treated|0|||
155595622|NCT04520997|561606295|FG001|Overall Study|Not Treated|1|||
155595623|NCT03689374|561606296|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
155595624|NCT03689374|561606297|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
155595625|NCT03689374|561606298|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
155595626|NCT03689374|561606296|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
155595627|NCT03689374|561606297|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
155595628|NCT03689374|561606298|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
155595629|NCT03689374|561606296|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
155595630|NCT03689374|561606297|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
155595631|NCT03689374|561606298|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
155595632|NCT03689374|561606296|FG000|Treatment Period (Week 0 to 52)|Death|0|||
155595633|NCT03689374|561606297|FG001|Treatment Period (Week 0 to 52)|Death|11|||
155595634|NCT03689374|561606298|FG002|Treatment Period (Week 0 to 52)|Death|1|||
155595635|NCT00860249|561608227|FG000|Overall Study|trial was terminated prior to completion|21|||
155595636|NCT00860249|561608228|FG001|Overall Study|trial was terminated prior to completion|18|||
155595637|NCT00860249|561608229|FG002|Overall Study|trial was terminated prior to completion|21|||
155595638|NCT00743288|561608230|FG000|Overall Study|Adverse Event|1|||
155595639|NCT00743288|561608231|FG001|Overall Study|Adverse Event|1|||
155595640|NCT00743288|561608232|FG002|Overall Study|Adverse Event|2|||
155595641|NCT00743288|561608233|FG003|Overall Study|Adverse Event|2|||
155595642|NCT00743288|561608234|FG004|Overall Study|Adverse Event|1|||
155595643|NCT00743288|561608235|FG005|Overall Study|Adverse Event|1|||
155595644|NCT00743288|561608236|FG006|Overall Study|Adverse Event|2|||
155595645|NCT00743288|561608230|FG000|Overall Study|Withdrawal by Subject|0|||
155595646|NCT00743288|561608231|FG001|Overall Study|Withdrawal by Subject|0|||
155595647|NCT00743288|561608232|FG002|Overall Study|Withdrawal by Subject|1|||
155595648|NCT00743288|561608233|FG003|Overall Study|Withdrawal by Subject|0|||
155595649|NCT00743288|561608234|FG004|Overall Study|Withdrawal by Subject|0|||
155595650|NCT00743288|561608235|FG005|Overall Study|Withdrawal by Subject|1|||
155595651|NCT00743288|561608236|FG006|Overall Study|Withdrawal by Subject|1|||
155595652|NCT00743288|561608230|FG000|Overall Study|Progressive disease (PD)|2|||
155595653|NCT00743288|561608231|FG001|Overall Study|Progressive disease (PD)|0|||
155595654|NCT00743288|561608232|FG002|Overall Study|Progressive disease (PD)|1|||
155595655|NCT00743288|561608233|FG003|Overall Study|Progressive disease (PD)|4|||
155595656|NCT00743288|561608234|FG004|Overall Study|Progressive disease (PD)|5|||
155595657|NCT00743288|561608235|FG005|Overall Study|Progressive disease (PD)|3|||
155595658|NCT00743288|561608236|FG006|Overall Study|Progressive disease (PD)|6|||
155595659|NCT00743288|561608230|FG000|Overall Study|Worsening of condition (Not PD)|0|||
155595660|NCT00743288|561608231|FG001|Overall Study|Worsening of condition (Not PD)|2|||
155595661|NCT00743288|561608232|FG002|Overall Study|Worsening of condition (Not PD)|1|||
155595662|NCT00743288|561608233|FG003|Overall Study|Worsening of condition (Not PD)|1|||
155595663|NCT00743288|561608234|FG004|Overall Study|Worsening of condition (Not PD)|0|||
155595664|NCT00743288|561608235|FG005|Overall Study|Worsening of condition (Not PD)|0|||
155595665|NCT00743288|561608236|FG006|Overall Study|Worsening of condition (Not PD)|0|||
155595666|NCT00519428|561608237|FG000|Overall Study|Adverse Event|5|||
155595667|NCT00519428|561608238|FG001|Overall Study|Adverse Event|2|||
155595668|NCT00519428|561608239|FG002|Overall Study|Adverse Event|10|||
155595669|NCT00519428|561608237|FG000|Overall Study|Lost to Follow-up|7|||
155595670|NCT00519428|561608238|FG001|Overall Study|Lost to Follow-up|7|||
155595671|NCT00519428|561608239|FG002|Overall Study|Lost to Follow-up|6|||
155595672|NCT00519428|561608237|FG000|Overall Study|Withdrawal by Subject|8|||
155595673|NCT00519428|561608238|FG001|Overall Study|Withdrawal by Subject|3|||
155595674|NCT00519428|561608239|FG002|Overall Study|Withdrawal by Subject|7|||
155595675|NCT00519428|561608237|FG000|Overall Study|unstated|1|||
155595676|NCT00519428|561608238|FG001|Overall Study|unstated|3|||
155595677|NCT00519428|561608239|FG002|Overall Study|unstated|2|||
155595678|NCT00688701|561608240|FG000|Overall Study|Adverse Event|1|||
155595679|NCT00688701|561608241|FG001|Overall Study|Adverse Event|0|||
155595680|NCT00688701|561608242|FG002|Overall Study|Adverse Event|5|||
155595681|NCT00688701|561608243|FG003|Overall Study|Adverse Event|3|||
155595682|NCT00688701|561608240|FG000|Overall Study|Lack of Efficacy|0|||
155595683|NCT00688701|561608241|FG001|Overall Study|Lack of Efficacy|1|||
155595684|NCT00688701|561608242|FG002|Overall Study|Lack of Efficacy|0|||
155595685|NCT00688701|561608243|FG003|Overall Study|Lack of Efficacy|0|||
155595686|NCT00688701|561608240|FG000|Overall Study|Withdrawal by Subject|3|||
155595687|NCT00688701|561608241|FG001|Overall Study|Withdrawal by Subject|3|||
155595688|NCT00688701|561608242|FG002|Overall Study|Withdrawal by Subject|4|||
155595689|NCT00688701|561608243|FG003|Overall Study|Withdrawal by Subject|8|||
155595690|NCT00688701|561608240|FG000|Overall Study|Poor compliance to protocol|0|||
155595691|NCT00688701|561608241|FG001|Overall Study|Poor compliance to protocol|1|||
155595692|NCT00688701|561608242|FG002|Overall Study|Poor compliance to protocol|1|||
155595693|NCT00688701|561608243|FG003|Overall Study|Poor compliance to protocol|0|||
155595694|NCT01275755|561608253|FG000|Double-blind Treatment Period|Adverse Event|0|||
155595695|NCT01275755|561608254|FG001|Double-blind Treatment Period|Adverse Event|2|||
155595696|NCT01275755|561608253|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155595697|NCT01275755|561608254|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155595698|NCT01275755|561608253|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155595699|NCT01275755|561608254|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155595700|NCT01275755|561608253|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
155595701|NCT01275755|561608254|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
155595702|NCT04420585|561608257|FG000|Overall Study|Adverse Event|1|||
155595703|NCT04420585|561608257|FG000|Overall Study|Never initiated medication|2|||
155595704|NCT00477750|561608259|FG000|Overall Study|Currently Receiving Treatment|11|||
155595705|NCT00601172|561608260|FG000|Overall Study|Adverse Event|43|||
155595706|NCT00601172|561608261|FG001|Overall Study|Adverse Event|32|||
155595707|NCT00601172|561608260|FG000|Overall Study|Lack of Efficacy|11|||
155595708|NCT00601172|561608261|FG001|Overall Study|Lack of Efficacy|12|||
155595709|NCT00601172|561608260|FG000|Overall Study|Protocol Violation|2|||
155595710|NCT00601172|561608261|FG001|Overall Study|Protocol Violation|5|||
155595711|NCT00601172|561608260|FG000|Overall Study|Lost to Follow-up|4|||
155595712|NCT00601172|561608261|FG001|Overall Study|Lost to Follow-up|3|||
155595713|NCT00601172|561608260|FG000|Overall Study|Physician Decision|27|||
155595714|NCT00601172|561608261|FG001|Overall Study|Physician Decision|28|||
155595715|NCT00601172|561608260|FG000|Overall Study|Withdrawal by Subject|35|||
155595716|NCT00601172|561608261|FG001|Overall Study|Withdrawal by Subject|27|||
155595717|NCT00601172|561608260|FG000|Overall Study|Did not meet continuation criteria|19|||
155595718|NCT00601172|561608261|FG001|Overall Study|Did not meet continuation criteria|20|||
155595719|NCT04434469|561608262|FG000|Overall Study|Death|2|||
155595720|NCT04434469|561608263|FG001|Overall Study|Death|3|||
155595721|NCT04434469|561608264|FG002|Overall Study|Death|2|||
155595722|NCT04434469|561608265|FG003|Overall Study|Death|2|||
155595723|NCT04434469|561608266|FG004|Overall Study|Death|2|||
155595724|NCT04434469|561608267|FG005|Overall Study|Death|0|||
155595725|NCT04434469|561608262|FG000|Overall Study|Lost to Follow-up|0|||
155595726|NCT04434469|561608263|FG001|Overall Study|Lost to Follow-up|0|||
155595727|NCT04434469|561608264|FG002|Overall Study|Lost to Follow-up|0|||
155595728|NCT04434469|561608265|FG003|Overall Study|Lost to Follow-up|1|||
155595729|NCT04434469|561608266|FG004|Overall Study|Lost to Follow-up|1|||
155595730|NCT04434469|561608267|FG005|Overall Study|Lost to Follow-up|0|||
155595731|NCT04434469|561608262|FG000|Overall Study|Study terminated by sponsor|1|||
155595732|NCT04434469|561608263|FG001|Overall Study|Study terminated by sponsor|1|||
155595733|NCT04434469|561608264|FG002|Overall Study|Study terminated by sponsor|1|||
155595734|NCT04434469|561608265|FG003|Overall Study|Study terminated by sponsor|2|||
155595735|NCT04434469|561608266|FG004|Overall Study|Study terminated by sponsor|3|||
155595736|NCT04434469|561608267|FG005|Overall Study|Study terminated by sponsor|3|||
155595737|NCT04434469|561608262|FG000|Overall Study|Withdrawal by Subject|0|||
155595738|NCT04434469|561608263|FG001|Overall Study|Withdrawal by Subject|0|||
155595739|NCT04434469|561608264|FG002|Overall Study|Withdrawal by Subject|1|||
155595740|NCT04434469|561608265|FG003|Overall Study|Withdrawal by Subject|0|||
155595741|NCT04434469|561608266|FG004|Overall Study|Withdrawal by Subject|0|||
155595742|NCT04434469|561608267|FG005|Overall Study|Withdrawal by Subject|0|||
155595743|NCT00712881|561608272|FG000|Overall Study|Adverse Event|3|||
155595744|NCT00712881|561608273|FG001|Overall Study|Adverse Event|3|||
155595745|NCT00712881|561608272|FG000|Overall Study|Withdrawal by Subject|1|||
155595746|NCT00712881|561608273|FG001|Overall Study|Withdrawal by Subject|1|||
155595747|NCT00712881|561608272|FG000|Overall Study|Disease Progression|2|||
155595748|NCT00712881|561608273|FG001|Overall Study|Disease Progression|1|||
155595749|NCT00712881|561608272|FG000|Overall Study|Lost to Follow-up|1|||
155595750|NCT00712881|561608273|FG001|Overall Study|Lost to Follow-up|1|||
155595751|NCT00712881|561608272|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
155595752|NCT00712881|561608273|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
155595753|NCT00712881|561608272|FG000|Overall Study|Protocol Violation|1|||
155595754|NCT00712881|561608273|FG001|Overall Study|Protocol Violation|1|||
155595755|NCT00712881|561608272|FG000|Overall Study|Randomized but not treated|1|||
155595756|NCT00712881|561608273|FG001|Overall Study|Randomized but not treated|0|||
155595757|NCT00537316|561608274|FG000|Part 1|Adverse Event|7|||
155595758|NCT00537316|561608275|FG001|Part 1|Adverse Event|11|||
155595759|NCT00537316|561608276|FG002|Part 1|Adverse Event|8|||
155595760|NCT00537316|561608277|FG003|Part 1|Adverse Event|0|||
155595761|NCT00537316|561608278|FG004|Part 1|Adverse Event|0|||
155595762|NCT00537316|561608279|FG005|Part 1|Adverse Event|0|||
155595763|NCT00537316|561608280|FG006|Part 1|Adverse Event|0|||
155595764|NCT00537316|561608274|FG000|Part 1|Protocol defined clinical event|1|||
155595765|NCT00537316|561608275|FG001|Part 1|Protocol defined clinical event|0|||
155595766|NCT00537316|561608276|FG002|Part 1|Protocol defined clinical event|0|||
155595767|NCT00537316|561608277|FG003|Part 1|Protocol defined clinical event|0|||
155595768|NCT00537316|561608278|FG004|Part 1|Protocol defined clinical event|0|||
155595769|NCT00537316|561608279|FG005|Part 1|Protocol defined clinical event|0|||
155595770|NCT00537316|561608280|FG006|Part 1|Protocol defined clinical event|0|||
155595771|NCT00537316|561608274|FG000|Part 1|Lost to Follow-up|1|||
155595772|NCT00537316|561608275|FG001|Part 1|Lost to Follow-up|0|||
155595773|NCT00537316|561608276|FG002|Part 1|Lost to Follow-up|0|||
155595774|NCT00537316|561608277|FG003|Part 1|Lost to Follow-up|0|||
155595775|NCT00537316|561608278|FG004|Part 1|Lost to Follow-up|0|||
155595776|NCT00537316|561608279|FG005|Part 1|Lost to Follow-up|0|||
155595777|NCT00537316|561608280|FG006|Part 1|Lost to Follow-up|0|||
155595778|NCT00537316|561608274|FG000|Part 1|Withdrawal by Subject|3|||
155595779|NCT00537316|561608275|FG001|Part 1|Withdrawal by Subject|8|||
155595780|NCT00537316|561608276|FG002|Part 1|Withdrawal by Subject|4|||
155595781|NCT00537316|561608277|FG003|Part 1|Withdrawal by Subject|0|||
155595782|NCT00537316|561608278|FG004|Part 1|Withdrawal by Subject|0|||
155595783|NCT00537316|561608279|FG005|Part 1|Withdrawal by Subject|0|||
155595784|NCT00537316|561608280|FG006|Part 1|Withdrawal by Subject|0|||
155595785|NCT00537316|561608274|FG000|Part 1|Protocol Violation|1|||
155595786|NCT00537316|561608275|FG001|Part 1|Protocol Violation|5|||
155595787|NCT00537316|561608276|FG002|Part 1|Protocol Violation|1|||
155595788|NCT00537316|561608277|FG003|Part 1|Protocol Violation|0|||
155595789|NCT00537316|561608278|FG004|Part 1|Protocol Violation|0|||
155595790|NCT00537316|561608279|FG005|Part 1|Protocol Violation|0|||
155595791|NCT00537316|561608280|FG006|Part 1|Protocol Violation|0|||
155595792|NCT00537316|561608274|FG000|Part 1|Did not meet protocol eligibility|1|||
155669704|NCT02137070|561885013|FG001|Overall Study|Physician Decision|1|||
155669705|NCT02137070|561885012|FG000|Overall Study|Protocol Violation|18|||
155669706|NCT02137070|561885013|FG001|Overall Study|Protocol Violation|4|||
155595793|NCT00537316|561608275|FG001|Part 1|Did not meet protocol eligibility|3|||
155595794|NCT00537316|561608276|FG002|Part 1|Did not meet protocol eligibility|2|||
155595795|NCT00537316|561608277|FG003|Part 1|Did not meet protocol eligibility|0|||
155595796|NCT00537316|561608278|FG004|Part 1|Did not meet protocol eligibility|0|||
155595797|NCT00537316|561608279|FG005|Part 1|Did not meet protocol eligibility|0|||
155595798|NCT00537316|561608280|FG006|Part 1|Did not meet protocol eligibility|0|||
155595799|NCT00537316|561608274|FG000|Part 1|Administrative|0|||
155595800|NCT00537316|561608275|FG001|Part 1|Administrative|0|||
155595801|NCT00537316|561608276|FG002|Part 1|Administrative|2|||
155595802|NCT00537316|561608277|FG003|Part 1|Administrative|0|||
155595803|NCT00537316|561608278|FG004|Part 1|Administrative|0|||
155595804|NCT00537316|561608279|FG005|Part 1|Administrative|0|||
155595805|NCT00537316|561608280|FG006|Part 1|Administrative|0|||
155595806|NCT00537316|561608274|FG000|Part 2|Never entered follow-up|0|||
155595807|NCT00537316|561608275|FG001|Part 2|Never entered follow-up|0|||
155595808|NCT00537316|561608276|FG002|Part 2|Never entered follow-up|0|||
155595809|NCT00537316|561608277|FG003|Part 2|Never entered follow-up|0|||
155595810|NCT00537316|561608278|FG004|Part 2|Never entered follow-up|0|||
155595811|NCT00537316|561608279|FG005|Part 2|Never entered follow-up|0|||
155595812|NCT00537316|561608280|FG006|Part 2|Never entered follow-up|1|||
155595813|NCT00537316|561608274|FG000|Part 2|Adverse Event|4|||
155595814|NCT00537316|561608275|FG001|Part 2|Adverse Event|0|||
155595815|NCT00537316|561608276|FG002|Part 2|Adverse Event|2|||
155595816|NCT00537316|561608277|FG003|Part 2|Adverse Event|0|||
155595817|NCT00537316|561608278|FG004|Part 2|Adverse Event|0|||
155595818|NCT00537316|561608279|FG005|Part 2|Adverse Event|0|||
155595819|NCT00537316|561608280|FG006|Part 2|Adverse Event|0|||
155595820|NCT00537316|561608274|FG000|Part 2|Lost to Follow-up|1|||
155595821|NCT00537316|561608275|FG001|Part 2|Lost to Follow-up|0|||
155595822|NCT00537316|561608276|FG002|Part 2|Lost to Follow-up|2|||
155595823|NCT00537316|561608277|FG003|Part 2|Lost to Follow-up|0|||
155595824|NCT00537316|561608278|FG004|Part 2|Lost to Follow-up|0|||
155595825|NCT00537316|561608279|FG005|Part 2|Lost to Follow-up|0|||
155595826|NCT00537316|561608280|FG006|Part 2|Lost to Follow-up|0|||
155595827|NCT00537316|561608274|FG000|Part 2|Withdrawal by Subject|5|||
155595828|NCT00537316|561608275|FG001|Part 2|Withdrawal by Subject|1|||
155595829|NCT00537316|561608276|FG002|Part 2|Withdrawal by Subject|4|||
155595830|NCT00537316|561608277|FG003|Part 2|Withdrawal by Subject|0|||
155595831|NCT00537316|561608278|FG004|Part 2|Withdrawal by Subject|0|||
155595832|NCT00537316|561608279|FG005|Part 2|Withdrawal by Subject|0|||
155595833|NCT00537316|561608280|FG006|Part 2|Withdrawal by Subject|0|||
155669707|NCT02137070|561885012|FG000|Overall Study|Withdrawal by Subject|18|||
155669708|NCT02137070|561885013|FG001|Overall Study|Withdrawal by Subject|1|||
155669709|NCT02151786|561885014|FG000|Overall Study|Unavailability of Case Report Form|26|||
155669710|NCT02151786|561885014|FG000|Overall Study|Outside the Contract Period|1|||
155669711|NCT02151786|561885014|FG000|Overall Study|Randomized, not Treated|1|||
155669712|NCT02151786|561885014|FG000|Overall Study|Unavailability of Information|8|||
155669713|NCT02112656|561885018|FG000|Overall Study|Death|78|||
155669714|NCT02112656|561885019|FG001|Overall Study|Death|82|||
155669715|NCT02112656|561885018|FG000|Overall Study|Withdrawal by Subject|9|||
155669716|NCT02112656|561885019|FG001|Overall Study|Withdrawal by Subject|11|||
155669717|NCT02112656|561885018|FG000|Overall Study|Lost to Follow-up|2|||
155669718|NCT02112656|561885019|FG001|Overall Study|Lost to Follow-up|4|||
155669719|NCT02112656|561885018|FG000|Overall Study|Noncompliance|1|||
155669720|NCT02112656|561885019|FG001|Overall Study|Noncompliance|2|||
155669721|NCT03761056|561885020|FG000|Overall Study|Death|8|||
155669722|NCT03761056|561885020|FG000|Overall Study|Enrolled but never treated|2|||
155669723|NCT03761056|561885020|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
155669724|NCT03761056|561885020|FG000|Overall Study|Investigator decision|1|||
155669725|NCT01365455|561885026|FG000|Induction Period|Adverse Event|5|||
155669726|NCT01365455|561885027|FG001|Induction Period|Adverse Event|3|||
155669727|NCT01365455|561885028|FG002|Induction Period|Adverse Event|4|||
155669728|NCT01365455|561885029|FG003|Induction Period|Adverse Event|0|||
155669729|NCT01365455|561885030|FG004|Induction Period|Adverse Event|0|||
155669730|NCT01365455|561885026|FG000|Induction Period|Lack of Efficacy|1|||
155669731|NCT01365455|561885027|FG001|Induction Period|Lack of Efficacy|1|||
155669732|NCT01365455|561885028|FG002|Induction Period|Lack of Efficacy|0|||
155669733|NCT01365455|561885029|FG003|Induction Period|Lack of Efficacy|0|||
155669734|NCT01365455|561885030|FG004|Induction Period|Lack of Efficacy|0|||
155669735|NCT01365455|561885026|FG000|Induction Period|Pregnancy|0|||
155669736|NCT01365455|561885027|FG001|Induction Period|Pregnancy|1|||
155669737|NCT01365455|561885028|FG002|Induction Period|Pregnancy|0|||
155669738|NCT01365455|561885029|FG003|Induction Period|Pregnancy|0|||
155595834|NCT00537316|561608274|FG000|Part 2|Administrative|16|||
155669739|NCT01365455|561885030|FG004|Induction Period|Pregnancy|0|||
155669740|NCT01365455|561885026|FG000|Induction Period|Protocol deviation|0|||
155669741|NCT01365455|561885027|FG001|Induction Period|Protocol deviation|1|||
155669742|NCT01365455|561885028|FG002|Induction Period|Protocol deviation|1|||
155669743|NCT01365455|561885029|FG003|Induction Period|Protocol deviation|0|||
155669744|NCT01365455|561885030|FG004|Induction Period|Protocol deviation|0|||
155669745|NCT01365455|561885026|FG000|Induction Period|Subject/guardian decision|9|||
155595835|NCT00537316|561608275|FG001|Part 2|Administrative|8|||
155595836|NCT00537316|561608276|FG002|Part 2|Administrative|24|||
155595837|NCT00537316|561608277|FG003|Part 2|Administrative|3|||
155595838|NCT00537316|561608278|FG004|Part 2|Administrative|1|||
155595839|NCT00537316|561608279|FG005|Part 2|Administrative|4|||
155595840|NCT00537316|561608280|FG006|Part 2|Administrative|1|||
155669746|NCT01365455|561885027|FG001|Induction Period|Subject/guardian decision|1|||
155669747|NCT01365455|561885028|FG002|Induction Period|Subject/guardian decision|8|||
155595841|NCT02651155|561608281|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155595842|NCT02651155|561608282|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155595843|NCT02651155|561608281|FG000|Overall Study|Voluntary Withdrawal|5|||
155595844|NCT02651155|561608282|FG001|Overall Study|Voluntary Withdrawal|0|||
155595845|NCT01867710|561608283|FG000|Overall Study|Death|25|||
155595846|NCT01867710|561608284|FG001|Overall Study|Death|15|||
155595847|NCT01867710|561608285|FG002|Overall Study|Death|27|||
155595848|NCT01867710|561608286|FG003|Overall Study|Death|20|||
155595849|NCT01867710|561608283|FG000|Overall Study|Lost to Follow-up|3|||
155595850|NCT01867710|561608284|FG001|Overall Study|Lost to Follow-up|4|||
155595851|NCT01867710|561608285|FG002|Overall Study|Lost to Follow-up|3|||
155595852|NCT01867710|561608286|FG003|Overall Study|Lost to Follow-up|2|||
155595853|NCT01867710|561608283|FG000|Overall Study|Withdrawal of consent|2|||
155595854|NCT01867710|561608284|FG001|Overall Study|Withdrawal of consent|5|||
155595855|NCT01867710|561608285|FG002|Overall Study|Withdrawal of consent|1|||
155595856|NCT01867710|561608286|FG003|Overall Study|Withdrawal of consent|2|||
155595857|NCT01867710|561608283|FG000|Overall Study|Study Terminated by Sponsor|9|||
155595858|NCT01867710|561608284|FG001|Overall Study|Study Terminated by Sponsor|13|||
155595859|NCT01867710|561608285|FG002|Overall Study|Study Terminated by Sponsor|8|||
155595860|NCT01867710|561608286|FG003|Overall Study|Study Terminated by Sponsor|16|||
155595861|NCT01867710|561608283|FG000|Overall Study|Biochemical progression|0|||
155595862|NCT01867710|561608284|FG001|Overall Study|Biochemical progression|1|||
155595863|NCT01867710|561608285|FG002|Overall Study|Biochemical progression|0|||
155595864|NCT01867710|561608286|FG003|Overall Study|Biochemical progression|0|||
155595865|NCT01867710|561608283|FG000|Overall Study|Clinical progression|0|||
155595866|NCT01867710|561608284|FG001|Overall Study|Clinical progression|0|||
155595867|NCT01867710|561608285|FG002|Overall Study|Clinical progression|1|||
155595868|NCT01867710|561608286|FG003|Overall Study|Clinical progression|0|||
155595869|NCT01867710|561608283|FG000|Overall Study|Disease progression|1|||
155595870|NCT01867710|561608284|FG001|Overall Study|Disease progression|0|||
155595871|NCT01867710|561608285|FG002|Overall Study|Disease progression|0|||
155595872|NCT01867710|561608286|FG003|Overall Study|Disease progression|0|||
155595873|NCT01867710|561608283|FG000|Overall Study|Patient decision|0|||
155595874|NCT01867710|561608284|FG001|Overall Study|Patient decision|0|||
155595875|NCT01867710|561608285|FG002|Overall Study|Patient decision|0|||
155595876|NCT01867710|561608286|FG003|Overall Study|Patient decision|1|||
155595877|NCT01867710|561608283|FG000|Overall Study|Patient to follow subsequent treatment|0|||
155595878|NCT01867710|561608284|FG001|Overall Study|Patient to follow subsequent treatment|1|||
155595879|NCT01867710|561608285|FG002|Overall Study|Patient to follow subsequent treatment|0|||
155595880|NCT01867710|561608286|FG003|Overall Study|Patient to follow subsequent treatment|0|||
155669748|NCT01365455|561885029|FG003|Induction Period|Subject/guardian decision|0|||
155669749|NCT01365455|561885030|FG004|Induction Period|Subject/guardian decision|0|||
155669750|NCT01365455|561885026|FG000|Induction Period|Lost to Follow-up|0|||
155669751|NCT01365455|561885027|FG001|Induction Period|Lost to Follow-up|0|||
155669752|NCT01365455|561885028|FG002|Induction Period|Lost to Follow-up|3|||
155669753|NCT01365455|561885029|FG003|Induction Period|Lost to Follow-up|0|||
155669754|NCT01365455|561885030|FG004|Induction Period|Lost to Follow-up|0|||
155669755|NCT01365455|561885026|FG000|Maintenance Period|Adverse Event|12|||
155669756|NCT01365455|561885027|FG001|Maintenance Period|Adverse Event|5|||
155669757|NCT01365455|561885028|FG002|Maintenance Period|Adverse Event|1|||
155669758|NCT01365455|561885029|FG003|Maintenance Period|Adverse Event|2|||
155669759|NCT01365455|561885030|FG004|Maintenance Period|Adverse Event|4|||
155669760|NCT01365455|561885026|FG000|Maintenance Period|Lack of Efficacy|10|||
155669761|NCT01365455|561885027|FG001|Maintenance Period|Lack of Efficacy|2|||
155669762|NCT01365455|561885028|FG002|Maintenance Period|Lack of Efficacy|0|||
155669763|NCT01365455|561885029|FG003|Maintenance Period|Lack of Efficacy|2|||
155669764|NCT01365455|561885030|FG004|Maintenance Period|Lack of Efficacy|2|||
155669765|NCT01365455|561885026|FG000|Maintenance Period|Lost to Follow-up|2|||
155669766|NCT01365455|561885027|FG001|Maintenance Period|Lost to Follow-up|4|||
155669767|NCT01365455|561885028|FG002|Maintenance Period|Lost to Follow-up|0|||
155669768|NCT01365455|561885029|FG003|Maintenance Period|Lost to Follow-up|0|||
155669769|NCT01365455|561885030|FG004|Maintenance Period|Lost to Follow-up|3|||
155669770|NCT01365455|561885026|FG000|Maintenance Period|Non-compliance with study treatment|0|||
155669771|NCT01365455|561885027|FG001|Maintenance Period|Non-compliance with study treatment|0|||
155669772|NCT01365455|561885028|FG002|Maintenance Period|Non-compliance with study treatment|0|||
155669773|NCT01365455|561885029|FG003|Maintenance Period|Non-compliance with study treatment|1|||
155669774|NCT01365455|561885030|FG004|Maintenance Period|Non-compliance with study treatment|0|||
155669775|NCT01365455|561885026|FG000|Maintenance Period|Physician Decision|0|||
155669776|NCT01365455|561885027|FG001|Maintenance Period|Physician Decision|1|||
155669777|NCT01365455|561885028|FG002|Maintenance Period|Physician Decision|0|||
155669778|NCT01365455|561885029|FG003|Maintenance Period|Physician Decision|0|||
155595881|NCT01867710|561608283|FG000|Overall Study|Progressive disease|1|||
155595882|NCT01867710|561608284|FG001|Overall Study|Progressive disease|0|||
155595883|NCT01867710|561608285|FG002|Overall Study|Progressive disease|0|||
155595884|NCT01867710|561608286|FG003|Overall Study|Progressive disease|0|||
155595885|NCT01867710|561608283|FG000|Overall Study|Protocol Violation|0|||
155595886|NCT01867710|561608284|FG001|Overall Study|Protocol Violation|0|||
155595887|NCT01867710|561608285|FG002|Overall Study|Protocol Violation|0|||
155595888|NCT01867710|561608286|FG003|Overall Study|Protocol Violation|1|||
155595889|NCT01867710|561608283|FG000|Overall Study|PSA-progression|0|||
155595890|NCT01867710|561608284|FG001|Overall Study|PSA-progression|1|||
155595891|NCT01867710|561608285|FG002|Overall Study|PSA-progression|0|||
155595892|NCT01867710|561608286|FG003|Overall Study|PSA-progression|0|||
155595893|NCT01867710|561608283|FG000|Overall Study|Study medication no longer effective|0|||
155595894|NCT01867710|561608284|FG001|Overall Study|Study medication no longer effective|1|||
155595895|NCT01867710|561608285|FG002|Overall Study|Study medication no longer effective|0|||
155595896|NCT01867710|561608286|FG003|Overall Study|Study medication no longer effective|0|||
155595897|NCT00526669|561608287|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
155595898|NCT00526669|561608288|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
155595899|NCT00526669|561608287|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
155595900|NCT00526669|561608288|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
155595901|NCT00526669|561608287|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
155595902|NCT00526669|561608288|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
155595903|NCT00526669|561608287|FG000|Combined Treatment Phase|Death|0|||
155595904|NCT00526669|561608288|FG001|Combined Treatment Phase|Death|2|||
155595905|NCT03315286|561608291|FG000|Overall Study|Lost to Follow-up|0|||
155595906|NCT03315286|561608292|FG001|Overall Study|Lost to Follow-up|3|||
155595907|NCT03315286|561608291|FG000|Overall Study|Withdrawal by Subject|1|||
155595908|NCT03315286|561608292|FG001|Overall Study|Withdrawal by Subject|0|||
155595909|NCT03315286|561608291|FG000|Overall Study|Protocol Violation|0|||
155595910|NCT03315286|561608292|FG001|Overall Study|Protocol Violation|1|||
155595911|NCT02828124|561608293|FG000|Overall Study|Disease Progression|1|||
155595912|NCT02828124|561608294|FG001|Overall Study|Disease Progression|2|||
155595913|NCT02828124|561608295|FG002|Overall Study|Disease Progression|1|||
155595914|NCT02828124|561608296|FG003|Overall Study|Disease Progression|4|||
155595915|NCT02828124|561608293|FG000|Overall Study|AE Unrelated to Study Drug|0|||
155595916|NCT02828124|561608294|FG001|Overall Study|AE Unrelated to Study Drug|0|||
155595917|NCT02828124|561608295|FG002|Overall Study|AE Unrelated to Study Drug|0|||
155595918|NCT02828124|561608296|FG003|Overall Study|AE Unrelated to Study Drug|1|||
155595919|NCT02828124|561608293|FG000|Overall Study|Subject Withdrew Consent|0|||
155595920|NCT02828124|561608294|FG001|Overall Study|Subject Withdrew Consent|0|||
155595921|NCT02828124|561608295|FG002|Overall Study|Subject Withdrew Consent|0|||
155595922|NCT02828124|561608296|FG003|Overall Study|Subject Withdrew Consent|1|||
155595923|NCT02989649|561608297|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
155595924|NCT02989649|561608297|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
155595925|NCT02989649|561608297|FG000|Overall Study|Lost For Observation During Study|3|||
155595926|NCT02989649|561608297|FG000|Overall Study|Reason Not Specified|13|||
155595927|NCT00330343|561608298|FG000|Overall Study|Lost to Follow-up|5|||
155595928|NCT00256854|561608299|FG000|Overall Study|Withdrawal by Subject|2|||
155595929|NCT00256854|561608300|FG001|Overall Study|Withdrawal by Subject|3|||
155595930|NCT00256854|561608301|FG002|Overall Study|Withdrawal by Subject|0|||
155595931|NCT00256854|561608302|FG003|Overall Study|Withdrawal by Subject|0|||
155595932|NCT00256854|561608303|FG004|Overall Study|Withdrawal by Subject|0|||
155595933|NCT00256854|561608304|FG005|Overall Study|Withdrawal by Subject|0|||
155595934|NCT00256854|561608299|FG000|Overall Study|Lack of Efficacy|1|||
155595935|NCT00256854|561608300|FG001|Overall Study|Lack of Efficacy|0|||
155595936|NCT00256854|561608301|FG002|Overall Study|Lack of Efficacy|0|||
155595937|NCT00256854|561608302|FG003|Overall Study|Lack of Efficacy|0|||
155595938|NCT00256854|561608303|FG004|Overall Study|Lack of Efficacy|0|||
155595939|NCT00256854|561608304|FG005|Overall Study|Lack of Efficacy|0|||
155595940|NCT00256854|561608299|FG000|Overall Study|Protocol Violation|0|||
155595941|NCT00256854|561608300|FG001|Overall Study|Protocol Violation|1|||
155595942|NCT00256854|561608301|FG002|Overall Study|Protocol Violation|1|||
155595943|NCT00256854|561608302|FG003|Overall Study|Protocol Violation|1|||
155595944|NCT00256854|561608303|FG004|Overall Study|Protocol Violation|0|||
155595945|NCT00256854|561608304|FG005|Overall Study|Protocol Violation|0|||
155595946|NCT00256854|561608299|FG000|Overall Study|Adverse Event|0|||
155595947|NCT00256854|561608300|FG001|Overall Study|Adverse Event|0|||
155595948|NCT00256854|561608301|FG002|Overall Study|Adverse Event|2|||
155595949|NCT00256854|561608302|FG003|Overall Study|Adverse Event|2|||
155595950|NCT00256854|561608303|FG004|Overall Study|Adverse Event|0|||
155595951|NCT00256854|561608304|FG005|Overall Study|Adverse Event|1|||
155595952|NCT00256854|561608299|FG000|Overall Study|Not compliant with the study drug|0|||
155595953|NCT00256854|561608300|FG001|Overall Study|Not compliant with the study drug|0|||
155595954|NCT00256854|561608301|FG002|Overall Study|Not compliant with the study drug|0|||
155595955|NCT00256854|561608302|FG003|Overall Study|Not compliant with the study drug|0|||
155595956|NCT00256854|561608303|FG004|Overall Study|Not compliant with the study drug|1|||
155595957|NCT00256854|561608304|FG005|Overall Study|Not compliant with the study drug|0|||
155595958|NCT06586788|561608305|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
155595959|NCT03990571|561608306|FG000|Overall Study|Withdrawal by Subject|1|||
155595960|NCT03990571|561608306|FG000|Overall Study|Insurance Issues|3|||
155595961|NCT03990571|561608306|FG000|Overall Study|Covid Restrictions|2|||
155595962|NCT03047720|561608309|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
155595963|NCT03047720|561608310|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
155595964|NCT01475851|561608311|FG000|Overall Study|Protocol defined stopping criteria|1|||
155595965|NCT01475851|561608312|FG001|Overall Study|Protocol defined stopping criteria|0|||
155595966|NCT04603482|561608313|FG000|Overall Study|Lost to Follow-up|15|||
155595967|NCT04603482|561608314|FG001|Overall Study|Lost to Follow-up|15|||
155595968|NCT04603482|561608315|FG002|Overall Study|Lost to Follow-up|15|||
155595969|NCT00732758|561608316|FG000|Overall Study|Lost to Follow-up|8|||
155595970|NCT00732758|561608317|FG001|Overall Study|Lost to Follow-up|16|||
155595971|NCT00373958|561608318|FG000|Infant Series|Withdrawal by Subject|13|||
155595972|NCT00373958|561608319|FG001|Infant Series|Withdrawal by Subject|15|||
155595973|NCT00373958|561608318|FG000|Infant Series|Failed to return|8|||
155595974|NCT00373958|561608319|FG001|Infant Series|Failed to return|13|||
155595975|NCT00373958|561608318|FG000|Infant Series|Lost to Follow-up|6|||
155595976|NCT00373958|561608319|FG001|Infant Series|Lost to Follow-up|5|||
155595977|NCT00373958|561608318|FG000|Infant Series|Protocol Violation|3|||
155595978|NCT00373958|561608319|FG001|Infant Series|Protocol Violation|7|||
155595979|NCT00373958|561608318|FG000|Infant Series|Lost Kaiser coverage|4|||
155595980|NCT00373958|561608319|FG001|Infant Series|Lost Kaiser coverage|0|||
155595981|NCT00373958|561608318|FG000|Infant Series|Child relocated|1|||
155595982|NCT00373958|561608319|FG001|Infant Series|Child relocated|0|||
155595983|NCT00373958|561608318|FG000|Infant Series|Consent was not received|1|||
155595984|NCT00373958|561608319|FG001|Infant Series|Consent was not received|0|||
155595985|NCT00373958|561608318|FG000|Infant Series|Adverse Event|3|||
155595986|NCT00373958|561608319|FG001|Infant Series|Adverse Event|1|||
155595987|NCT00373958|561608318|FG000|Infant Series|Physician Decision|1|||
155595988|NCT00373958|561608319|FG001|Infant Series|Physician Decision|1|||
155595989|NCT00373958|561608318|FG000|Toddler Dose|Lost to Follow-up|5|||
155595990|NCT00373958|561608319|FG001|Toddler Dose|Lost to Follow-up|8|||
155595991|NCT00373958|561608318|FG000|Toddler Dose|Withdrawal by Subject|2|||
155595992|NCT00373958|561608319|FG001|Toddler Dose|Withdrawal by Subject|2|||
155595993|NCT00373958|561608318|FG000|Toddler Dose|Failed to return|1|||
155595994|NCT00373958|561608319|FG001|Toddler Dose|Failed to return|2|||
155595995|NCT00373958|561608318|FG000|Toddler Dose|Protocol Violation|0|||
155595996|NCT00373958|561608319|FG001|Toddler Dose|Protocol Violation|1|||
155595997|NCT00373958|561608318|FG000|Toddler Dose|Withdrawn after infant series|22|||
155595998|NCT00373958|561608319|FG001|Toddler Dose|Withdrawn after infant series|25|||
155595999|NCT03382834|561608322|FG000|Step 1|Lost to Follow-up|0|||
155596000|NCT03382834|561608323|FG001|Step 1|Lost to Follow-up|1|||
155596001|NCT03382834|561608322|FG000|Step 2|Death|1|||
155596002|NCT03382834|561608323|FG001|Step 2|Death|0|||
155596003|NCT03382834|561608322|FG000|Step 2|Lost to Follow-up|2|||
155596004|NCT03382834|561608323|FG001|Step 2|Lost to Follow-up|2|||
155596005|NCT03382834|561608322|FG000|Step 2|Site Terminated by Sponsor|1|||
155596006|NCT03382834|561608323|FG001|Step 2|Site Terminated by Sponsor|0|||
155596007|NCT02949843|561608324|FG000|Overall Study|Withdrawal by Subject|0|||
155596008|NCT02949843|561608325|FG001|Overall Study|Withdrawal by Subject|1|||
155596009|NCT02949843|561608326|FG002|Overall Study|Withdrawal by Subject|1|||
155596010|NCT03613649|561608327|FG000|Second Treatment|Lost to Follow-up|0|||
155596011|NCT03613649|561608328|FG001|Second Treatment|Lost to Follow-up|0|||
155596012|NCT03613649|561608329|FG002|Second Treatment|Lost to Follow-up|1|||
155596013|NCT03613649|561608330|FG003|Second Treatment|Lost to Follow-up|0|||
155596014|NCT03613649|561608331|FG004|Second Treatment|Lost to Follow-up|0|||
155596015|NCT03613649|561608332|FG005|Second Treatment|Lost to Follow-up|0|||
155596016|NCT03613649|561608333|FG006|Second Treatment|Lost to Follow-up|0|||
155596017|NCT03613649|561608334|FG007|Second Treatment|Lost to Follow-up|0|||
155596018|NCT03613649|561608335|FG008|Second Treatment|Lost to Follow-up|0|||
155596019|NCT03613649|561608336|FG009|Second Treatment|Lost to Follow-up|0|||
155596020|NCT03613649|561608337|FG010|Second Treatment|Lost to Follow-up|0|||
155596021|NCT03613649|561608338|FG011|Second Treatment|Lost to Follow-up|0|||
155596022|NCT03613649|561608327|FG000|Second Treatment|Withdrawal by Subject|0|||
155596023|NCT03613649|561608328|FG001|Second Treatment|Withdrawal by Subject|0|||
155596024|NCT03613649|561608329|FG002|Second Treatment|Withdrawal by Subject|0|||
155596025|NCT03613649|561608330|FG003|Second Treatment|Withdrawal by Subject|0|||
155596026|NCT03613649|561608331|FG004|Second Treatment|Withdrawal by Subject|1|||
155596027|NCT03613649|561608332|FG005|Second Treatment|Withdrawal by Subject|0|||
155596028|NCT03613649|561608333|FG006|Second Treatment|Withdrawal by Subject|0|||
155596029|NCT03613649|561608334|FG007|Second Treatment|Withdrawal by Subject|0|||
155596030|NCT03613649|561608335|FG008|Second Treatment|Withdrawal by Subject|0|||
155596031|NCT03613649|561608336|FG009|Second Treatment|Withdrawal by Subject|0|||
155596032|NCT03613649|561608337|FG010|Second Treatment|Withdrawal by Subject|0|||
155596033|NCT03613649|561608338|FG011|Second Treatment|Withdrawal by Subject|0|||
155596034|NCT03613649|561608327|FG000|Third Treatment|Lost to Follow-up|0|||
155596035|NCT03613649|561608328|FG001|Third Treatment|Lost to Follow-up|0|||
155596036|NCT03613649|561608329|FG002|Third Treatment|Lost to Follow-up|0|||
155596037|NCT03613649|561608330|FG003|Third Treatment|Lost to Follow-up|0|||
155596038|NCT03613649|561608331|FG004|Third Treatment|Lost to Follow-up|1|||
155596039|NCT03613649|561608332|FG005|Third Treatment|Lost to Follow-up|0|||
155596040|NCT03613649|561608333|FG006|Third Treatment|Lost to Follow-up|0|||
155596041|NCT03613649|561608334|FG007|Third Treatment|Lost to Follow-up|0|||
155596042|NCT03613649|561608335|FG008|Third Treatment|Lost to Follow-up|0|||
155596043|NCT03613649|561608336|FG009|Third Treatment|Lost to Follow-up|0|||
155596044|NCT03613649|561608337|FG010|Third Treatment|Lost to Follow-up|0|||
155596045|NCT03613649|561608338|FG011|Third Treatment|Lost to Follow-up|1|||
155596046|NCT03613649|561608327|FG000|Third Treatment|Protocol Violation|0|||
155596047|NCT03613649|561608328|FG001|Third Treatment|Protocol Violation|0|||
155596048|NCT03613649|561608329|FG002|Third Treatment|Protocol Violation|0|||
155596049|NCT03613649|561608330|FG003|Third Treatment|Protocol Violation|0|||
155596050|NCT03613649|561608331|FG004|Third Treatment|Protocol Violation|0|||
155596051|NCT03613649|561608332|FG005|Third Treatment|Protocol Violation|0|||
155596052|NCT03613649|561608333|FG006|Third Treatment|Protocol Violation|1|||
155596053|NCT03613649|561608334|FG007|Third Treatment|Protocol Violation|0|||
155596054|NCT03613649|561608335|FG008|Third Treatment|Protocol Violation|0|||
155596055|NCT03613649|561608336|FG009|Third Treatment|Protocol Violation|0|||
155596056|NCT03613649|561608337|FG010|Third Treatment|Protocol Violation|0|||
155596057|NCT03613649|561608338|FG011|Third Treatment|Protocol Violation|1|||
155596058|NCT03613649|561608327|FG000|Fourth Treatment|Protocol Violation|1|||
155596059|NCT03613649|561608328|FG001|Fourth Treatment|Protocol Violation|0|||
155596060|NCT03613649|561608329|FG002|Fourth Treatment|Protocol Violation|0|||
155596061|NCT03613649|561608330|FG003|Fourth Treatment|Protocol Violation|0|||
155596062|NCT03613649|561608331|FG004|Fourth Treatment|Protocol Violation|1|||
155596063|NCT03613649|561608332|FG005|Fourth Treatment|Protocol Violation|0|||
155596064|NCT03613649|561608333|FG006|Fourth Treatment|Protocol Violation|0|||
155596065|NCT03613649|561608334|FG007|Fourth Treatment|Protocol Violation|0|||
155596066|NCT03613649|561608335|FG008|Fourth Treatment|Protocol Violation|0|||
155596067|NCT03613649|561608336|FG009|Fourth Treatment|Protocol Violation|0|||
155596068|NCT03613649|561608337|FG010|Fourth Treatment|Protocol Violation|0|||
155596069|NCT03613649|561608338|FG011|Fourth Treatment|Protocol Violation|0|||
155596070|NCT03613649|561608327|FG000|Fourth Treatment|Physician Decision|0|||
155596071|NCT03613649|561608328|FG001|Fourth Treatment|Physician Decision|0|||
155596072|NCT03613649|561608329|FG002|Fourth Treatment|Physician Decision|0|||
155596073|NCT03613649|561608330|FG003|Fourth Treatment|Physician Decision|0|||
155596074|NCT03613649|561608331|FG004|Fourth Treatment|Physician Decision|0|||
155596075|NCT03613649|561608332|FG005|Fourth Treatment|Physician Decision|0|||
155596076|NCT03613649|561608333|FG006|Fourth Treatment|Physician Decision|1|||
155596077|NCT03613649|561608334|FG007|Fourth Treatment|Physician Decision|0|||
155596078|NCT03613649|561608335|FG008|Fourth Treatment|Physician Decision|0|||
155596079|NCT03613649|561608336|FG009|Fourth Treatment|Physician Decision|0|||
155596080|NCT03613649|561608337|FG010|Fourth Treatment|Physician Decision|0|||
155596081|NCT03613649|561608338|FG011|Fourth Treatment|Physician Decision|0|||
155596082|NCT02693171|561608339|FG000|Overall Study|Adverse Event|1|||
155596083|NCT02693171|561608339|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
155596084|NCT00319592|561608341|FG000|Overall Study|Protocol Violation|1|||
155596085|NCT00319592|561608342|FG001|Overall Study|Protocol Violation|0|||
155596086|NCT00319592|561608341|FG000|Overall Study|Physician Decision|0|||
155596087|NCT00319592|561608342|FG001|Overall Study|Physician Decision|1|||
155596088|NCT03429244|561608343|FG000|Overall Study|Withdrawal by Subject|2|||
155596089|NCT03429244|561608344|FG001|Overall Study|Withdrawal by Subject|1|||
155596090|NCT03429244|561608345|FG002|Overall Study|Withdrawal by Subject|1|||
155596091|NCT00750139|561608348|FG000|Overall Study|Adverse Event|1|||
155596092|NCT00750139|561608349|FG001|Overall Study|Adverse Event|2|||
155596093|NCT00750139|561608350|FG002|Overall Study|Adverse Event|0|||
155596094|NCT00750139|561608351|FG003|Overall Study|Adverse Event|1|||
155596095|NCT00750139|561608348|FG000|Overall Study|Lost to Follow-up|17|||
155596096|NCT00750139|561608349|FG001|Overall Study|Lost to Follow-up|12|||
155596097|NCT00750139|561608350|FG002|Overall Study|Lost to Follow-up|15|||
155596098|NCT00750139|561608351|FG003|Overall Study|Lost to Follow-up|6|||
155596099|NCT00750139|561608348|FG000|Overall Study|Withdrawal by Subject|3|||
155596100|NCT00750139|561608349|FG001|Overall Study|Withdrawal by Subject|2|||
155596101|NCT00750139|561608350|FG002|Overall Study|Withdrawal by Subject|6|||
155596102|NCT00750139|561608351|FG003|Overall Study|Withdrawal by Subject|2|||
155596103|NCT00750139|561608348|FG000|Overall Study|Physician Decision|1|||
155596104|NCT00750139|561608349|FG001|Overall Study|Physician Decision|1|||
155596105|NCT00750139|561608350|FG002|Overall Study|Physician Decision|0|||
155596106|NCT00750139|561608351|FG003|Overall Study|Physician Decision|0|||
155596107|NCT00750139|561608348|FG000|Overall Study|Non-compliance|1|||
155596108|NCT00750139|561608349|FG001|Overall Study|Non-compliance|0|||
155596109|NCT00750139|561608350|FG002|Overall Study|Non-compliance|1|||
155596110|NCT00750139|561608351|FG003|Overall Study|Non-compliance|3|||
155596111|NCT00750139|561608348|FG000|Overall Study|Termination by sponsor|4|||
155596112|NCT00750139|561608349|FG001|Overall Study|Termination by sponsor|0|||
155596113|NCT00750139|561608350|FG002|Overall Study|Termination by sponsor|0|||
155596114|NCT00750139|561608351|FG003|Overall Study|Termination by sponsor|1|||
155596115|NCT00750139|561608348|FG000|Overall Study|Non-specific|62|||
155596116|NCT00750139|561608349|FG001|Overall Study|Non-specific|42|||
155596117|NCT00750139|561608350|FG002|Overall Study|Non-specific|79|||
155596118|NCT00750139|561608351|FG003|Overall Study|Non-specific|33|||
155596119|NCT00658775|561608352|FG000|Overall Study|Adverse Event|4|||
155596120|NCT00658775|561608353|FG001|Overall Study|Adverse Event|6|||
155596121|NCT00658775|561608352|FG000|Overall Study|Lost to Follow-up|17|||
155596122|NCT00658775|561608353|FG001|Overall Study|Lost to Follow-up|18|||
155596123|NCT00658775|561608352|FG000|Overall Study|Withdrawal by Subject|6|||
155596124|NCT00658775|561608353|FG001|Overall Study|Withdrawal by Subject|4|||
155596125|NCT00658775|561608352|FG000|Overall Study|Withdrawal of consent|8|||
155596126|NCT00658775|561608353|FG001|Overall Study|Withdrawal of consent|7|||
155596127|NCT00658775|561608352|FG000|Overall Study|Other|7|||
155596128|NCT00658775|561608353|FG001|Overall Study|Other|8|||
155596129|NCT01992653|561608356|FG000|Overall Study|Death|0|||
155596130|NCT01992653|561608357|FG001|Overall Study|Death|0|||
155596131|NCT01992653|561608358|FG002|Overall Study|Death|1|||
155596132|NCT01992653|561608359|FG003|Overall Study|Death|0|||
155596133|NCT01992653|561608360|FG004|Overall Study|Death|1|||
155596134|NCT01992653|561608361|FG005|Overall Study|Death|0|||
155596135|NCT01992653|561608362|FG006|Overall Study|Death|4|||
155596136|NCT01992653|561608363|FG007|Overall Study|Death|2|||
155596137|NCT01992653|561608356|FG000|Overall Study|Lost to Follow-up|0|||
155596138|NCT01992653|561608357|FG001|Overall Study|Lost to Follow-up|0|||
155596139|NCT01992653|561608358|FG002|Overall Study|Lost to Follow-up|0|||
155596140|NCT01992653|561608359|FG003|Overall Study|Lost to Follow-up|0|||
155596141|NCT01992653|561608360|FG004|Overall Study|Lost to Follow-up|0|||
155596142|NCT01992653|561608361|FG005|Overall Study|Lost to Follow-up|0|||
155596143|NCT01992653|561608362|FG006|Overall Study|Lost to Follow-up|0|||
155596144|NCT01992653|561608363|FG007|Overall Study|Lost to Follow-up|1|||
155596145|NCT01992653|561608356|FG000|Overall Study|Study Completed|0|||
155596146|NCT01992653|561608357|FG001|Overall Study|Study Completed|0|||
155596147|NCT01992653|561608358|FG002|Overall Study|Study Completed|0|||
155596148|NCT01992653|561608359|FG003|Overall Study|Study Completed|0|||
155596149|NCT01992653|561608360|FG004|Overall Study|Study Completed|0|||
155596150|NCT01992653|561608361|FG005|Overall Study|Study Completed|0|||
155596151|NCT01992653|561608362|FG006|Overall Study|Study Completed|0|||
155596152|NCT01992653|561608363|FG007|Overall Study|Study Completed|1|||
155596153|NCT01992653|561608356|FG000|Overall Study|Disease Progression|0|||
155596154|NCT01992653|561608357|FG001|Overall Study|Disease Progression|0|||
155596155|NCT01992653|561608358|FG002|Overall Study|Disease Progression|0|||
155596156|NCT01992653|561608359|FG003|Overall Study|Disease Progression|0|||
155596157|NCT01992653|561608360|FG004|Overall Study|Disease Progression|0|||
155596158|NCT01992653|561608361|FG005|Overall Study|Disease Progression|0|||
155596159|NCT01992653|561608362|FG006|Overall Study|Disease Progression|4|||
155596160|NCT01992653|561608363|FG007|Overall Study|Disease Progression|0|||
155596161|NCT01435460|561608364|FG000|Overall Study|Adverse Event|2|||
155596162|NCT01435460|561608365|FG001|Overall Study|Adverse Event|1|||
155596163|NCT01435460|561608364|FG000|Overall Study|Lost to Follow-up|6|||
155596164|NCT01435460|561608365|FG001|Overall Study|Lost to Follow-up|1|||
155596165|NCT01435460|561608364|FG000|Overall Study|Withdrawal by Subject|1|||
155596166|NCT01435460|561608365|FG001|Overall Study|Withdrawal by Subject|3|||
155596167|NCT01435460|561608364|FG000|Overall Study|Protocol Violation|0|||
155596168|NCT01435460|561608365|FG001|Overall Study|Protocol Violation|1|||
155596169|NCT01435460|561608364|FG000|Overall Study|Did not meet eligibility criteria|2|||
155596170|NCT01435460|561608365|FG001|Overall Study|Did not meet eligibility criteria|0|||
155596171|NCT01706939|561608366|FG000|Pre Randomization|Screen Failure|1|||
155596172|NCT01706939|561608367|FG001|Pre Randomization|Screen Failure|0|||
155596173|NCT01706939|561608368|FG002|Pre Randomization|Screen Failure|0|||
155596174|NCT01706939|561608366|FG000|Pre Randomization|Ineligible for Randomization|1|||
155596175|NCT01706939|561608367|FG001|Pre Randomization|Ineligible for Randomization|0|||
155596176|NCT01706939|561608368|FG002|Pre Randomization|Ineligible for Randomization|0|||
155596177|NCT01706939|561608366|FG000|Pre Randomization|Withdrawal by Subject|1|||
155596178|NCT01706939|561608367|FG001|Pre Randomization|Withdrawal by Subject|0|||
155596179|NCT01706939|561608368|FG002|Pre Randomization|Withdrawal by Subject|0|||
155596180|NCT01706939|561608366|FG000|Randomization|Insufficient QoL survey compliance|0|||
155596181|NCT01706939|561608367|FG001|Randomization|Insufficient QoL survey compliance|1|||
155596182|NCT01706939|561608368|FG002|Randomization|Insufficient QoL survey compliance|1|||
155596183|NCT01706939|561608366|FG000|Randomization|Progression of disease|0|||
155596184|NCT01706939|561608367|FG001|Randomization|Progression of disease|2|||
155596185|NCT01706939|561608368|FG002|Randomization|Progression of disease|1|||
155596186|NCT01046903|561608369|FG000|Overall Study|Lost to Follow-up|16|||
155596187|NCT01046903|561608369|FG000|Overall Study|Adverse Event|4|||
155596188|NCT01046903|561608369|FG000|Overall Study|Withdrawal by Subject|3|||
155596189|NCT01046903|561608369|FG000|Overall Study|Other|5|||
155596190|NCT04013672|561608373|FG000|Overall Study|Withdrawal by Subject|3|||
155596191|NCT04013672|561608374|FG001|Overall Study|Withdrawal by Subject|0|||
155596192|NCT04013672|561608373|FG000|Overall Study|Death|1|||
155596193|NCT04013672|561608374|FG001|Overall Study|Death|0|||
155596194|NCT04013672|561608373|FG000|Overall Study|Physician Decision|5|||
155596195|NCT04013672|561608374|FG001|Overall Study|Physician Decision|0|||
155596196|NCT03887442|561608375|FG000|Overall Study|Adverse Event|1|||
155596197|NCT03887442|561608376|FG001|Overall Study|Adverse Event|0|||
155596198|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
155596199|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
155596200|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
155596201|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
155596202|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155596203|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155596204|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
155596205|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155596206|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
155596207|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155596208|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155596209|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155596210|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
155596211|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
155596212|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
155596213|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
155596214|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155596215|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
155596216|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155596217|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155596218|NCT00556933|561608377|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155596219|NCT00556933|561608378|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
155596220|NCT00556933|561608379|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155596221|NCT00556933|561608380|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155596222|NCT00556933|561608377|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
155596223|NCT00556933|561608378|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
155596224|NCT00556933|561608379|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
155596225|NCT00556933|561608380|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
155596226|NCT00556933|561608377|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
155596227|NCT00556933|561608378|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
155596228|NCT00556933|561608379|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
155596229|NCT00556933|561608380|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
155596230|NCT00556933|561608377|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
155596231|NCT00556933|561608378|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
155596232|NCT00556933|561608379|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
155596233|NCT00556933|561608380|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
155596234|NCT00556933|561608377|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
155596235|NCT00556933|561608378|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
155596236|NCT00556933|561608379|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
155596237|NCT00556933|561608380|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
155596238|NCT00556933|561608377|FG000|CNI Withdrawal vs. Minimization|Death|0|||
155596239|NCT00556933|561608378|FG001|CNI Withdrawal vs. Minimization|Death|0|||
155596240|NCT00556933|561608379|FG002|CNI Withdrawal vs. Minimization|Death|0|||
155596241|NCT00556933|561608380|FG003|CNI Withdrawal vs. Minimization|Death|1|||
155596242|NCT04463251|561608385|FG000|Overall Study|Death|1|||
155596243|NCT04463251|561608386|FG001|Overall Study|Death|0|||
155596244|NCT04463251|561608387|FG002|Overall Study|Death|1|||
155596245|NCT04463251|561608385|FG000|Overall Study|Adverse Event|0|||
155596246|NCT04463251|561608386|FG001|Overall Study|Adverse Event|1|||
155596247|NCT04463251|561608387|FG002|Overall Study|Adverse Event|0|||
155596248|NCT04463251|561608385|FG000|Overall Study|Lost to Follow-up|0|||
155596249|NCT04463251|561608386|FG001|Overall Study|Lost to Follow-up|1|||
155596250|NCT04463251|561608387|FG002|Overall Study|Lost to Follow-up|0|||
155596251|NCT04463251|561608385|FG000|Overall Study|Withdrawal by Subject|0|||
155596252|NCT04463251|561608386|FG001|Overall Study|Withdrawal by Subject|2|||
155596253|NCT04463251|561608387|FG002|Overall Study|Withdrawal by Subject|2|||
155596254|NCT01628198|561608389|FG000|Overall Study|Lost to Follow-up|7|||
155596255|NCT01628198|561608389|FG000|Overall Study|Withdrawal by Subject|10|||
155596256|NCT01628198|561608389|FG000|Overall Study|Screen failure|1|||
155596257|NCT01743560|561608390|FG000|Overall Study|Disease progression|26|||
155669779|NCT01365455|561885030|FG004|Maintenance Period|Physician Decision|1|||
155596258|NCT01743560|561608390|FG000|Overall Study|Adverse Event|8|||
155596259|NCT01743560|561608390|FG000|Overall Study|Death|3|||
155596260|NCT01743560|561608390|FG000|Overall Study|Withdrawal by Subject|2|||
155596261|NCT01743560|561608390|FG000|Overall Study|Protocol Violation|1|||
155596262|NCT01743560|561608390|FG000|Overall Study|>1 dose of study drug|3|||
155596263|NCT01827267|561608396|FG000|Overall Study|Did not receive study drug|1|||
155596264|NCT01827267|561608397|FG001|Overall Study|Did not receive study drug|1|||
155596265|NCT01827267|561608396|FG000|Overall Study|Physician Decision|1|||
155596266|NCT01827267|561608397|FG001|Overall Study|Physician Decision|0|||
155596267|NCT01827267|561608396|FG000|Overall Study|Disease Progression|1|||
155596268|NCT01827267|561608397|FG001|Overall Study|Disease Progression|1|||
155596269|NCT01827267|561608396|FG000|Overall Study|Sponsor Discontinued Study|2|||
155596270|NCT01827267|561608397|FG001|Overall Study|Sponsor Discontinued Study|8|||
155596271|NCT01827267|561608396|FG000|Overall Study|Still on study|0|||
155596272|NCT01827267|561608397|FG001|Overall Study|Still on study|2|||
155596273|NCT05367973|561608398|FG000|Overall Study|Adverse Event|0|||
155596274|NCT05367973|561608399|FG001|Overall Study|Adverse Event|2|||
155596275|NCT04999163|561608400|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
155596276|NCT04999163|561608401|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
155596277|NCT04999163|561608400|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
155596278|NCT04999163|561608401|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
155596279|NCT04999163|561608400|FG000|Overall Study|Withdrawal by Subject|1|||
155596280|NCT04999163|561608401|FG001|Overall Study|Withdrawal by Subject|0|||
155596281|NCT01346189|561610442|FG000|Overall Study|Withdrawal by Subject|7|||
155596282|NCT01346189|561610443|FG001|Overall Study|Withdrawal by Subject|5|||
155596283|NCT01346189|561610444|FG002|Overall Study|Withdrawal by Subject|3|||
155596284|NCT01346189|561610445|FG003|Overall Study|Withdrawal by Subject|5|||
155596285|NCT01346189|561610442|FG000|Overall Study|Physician Decision|4|||
155596286|NCT01346189|561610443|FG001|Overall Study|Physician Decision|0|||
155596287|NCT01346189|561610444|FG002|Overall Study|Physician Decision|0|||
155596288|NCT01346189|561610445|FG003|Overall Study|Physician Decision|0|||
155596289|NCT01346189|561610442|FG000|Overall Study|Moved|3|||
155596290|NCT01346189|561610443|FG001|Overall Study|Moved|0|||
155596291|NCT01346189|561610444|FG002|Overall Study|Moved|4|||
155596292|NCT01346189|561610445|FG003|Overall Study|Moved|0|||
155596293|NCT01346189|561610442|FG000|Overall Study|Other|2|||
155596294|NCT01346189|561610443|FG001|Overall Study|Other|4|||
155596295|NCT01346189|561610444|FG002|Overall Study|Other|7|||
155596296|NCT01346189|561610445|FG003|Overall Study|Other|3|||
155596297|NCT01346189|561610442|FG000|Overall Study|Death|0|||
155596298|NCT01346189|561610443|FG001|Overall Study|Death|3|||
155596299|NCT01346189|561610444|FG002|Overall Study|Death|0|||
155596300|NCT01346189|561610445|FG003|Overall Study|Death|0|||
155596301|NCT01346189|561610442|FG000|Overall Study|Non-health system primary care physician|0|||
155596302|NCT01346189|561610443|FG001|Overall Study|Non-health system primary care physician|5|||
155596303|NCT01346189|561610444|FG002|Overall Study|Non-health system primary care physician|0|||
155596304|NCT01346189|561610445|FG003|Overall Study|Non-health system primary care physician|0|||
155596305|NCT01346189|561610442|FG000|Overall Study|Travel|0|||
155596306|NCT01346189|561610443|FG001|Overall Study|Travel|0|||
155596307|NCT01346189|561610444|FG002|Overall Study|Travel|0|||
155596308|NCT01346189|561610445|FG003|Overall Study|Travel|3|||
155596309|NCT00900757|561610446|FG000|Overall Study|screen failure|19|||
155596310|NCT05113979|561610449|FG000|Overall Study|Death|2|||
155596311|NCT05113979|561610449|FG000|Overall Study|Lost to Follow-up|1|||
155596312|NCT00976820|561610450|FG000|Overall Study|Lost to Follow-up|5|||
155596313|NCT00976820|561610451|FG001|Overall Study|Lost to Follow-up|16|||
155596314|NCT00976820|561610452|FG002|Overall Study|Lost to Follow-up|2|||
155596315|NCT00976820|561610453|FG003|Overall Study|Lost to Follow-up|3|||
155596316|NCT00976820|561610450|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
155596317|NCT00976820|561610451|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
155596318|NCT00976820|561610452|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
155596319|NCT00976820|561610453|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
155596320|NCT00976820|561610450|FG000|Overall Study|Withdrawal by Subject|2|||
155596321|NCT00976820|561610451|FG001|Overall Study|Withdrawal by Subject|4|||
155596322|NCT00976820|561610452|FG002|Overall Study|Withdrawal by Subject|1|||
155596323|NCT00976820|561610453|FG003|Overall Study|Withdrawal by Subject|4|||
155596324|NCT00968981|561610454|FG000|Overall Study|Adverse Event|2|||
155596325|NCT00968981|561610455|FG001|Overall Study|Adverse Event|0|||
155596326|NCT00968981|561610456|FG002|Overall Study|Adverse Event|0|||
155596327|NCT00968981|561610454|FG000|Overall Study|Disease Progression|14|||
155596328|NCT00968981|561610455|FG001|Overall Study|Disease Progression|16|||
155669780|NCT01365455|561885026|FG000|Maintenance Period|Pregnancy|0|||
155669781|NCT01365455|561885027|FG001|Maintenance Period|Pregnancy|4|||
155596329|NCT00968981|561610456|FG002|Overall Study|Disease Progression|13|||
155596330|NCT00968981|561610454|FG000|Overall Study|Lost to Follow-up|0|||
155596331|NCT00968981|561610455|FG001|Overall Study|Lost to Follow-up|0|||
155596332|NCT00968981|561610456|FG002|Overall Study|Lost to Follow-up|1|||
155596333|NCT00968981|561610454|FG000|Overall Study|Physician Decision|5|||
155596334|NCT00968981|561610455|FG001|Overall Study|Physician Decision|3|||
155596335|NCT00968981|561610456|FG002|Overall Study|Physician Decision|5|||
155596336|NCT00968981|561610454|FG000|Overall Study|Withdrawal by Subject|1|||
155596337|NCT00968981|561610455|FG001|Overall Study|Withdrawal by Subject|3|||
155596338|NCT00968981|561610456|FG002|Overall Study|Withdrawal by Subject|3|||
155596339|NCT01489254|561610457|FG000|Double-blind Part|Adverse Event|7|||
155596340|NCT01489254|561610458|FG001|Double-blind Part|Adverse Event|2|||
155596341|NCT01489254|561610459|FG002|Double-blind Part|Adverse Event|2|||
155596342|NCT01489254|561610460|FG003|Double-blind Part|Adverse Event|0|||
155596343|NCT01489254|561610457|FG000|Double-blind Part|Pregnancy|1|||
155596344|NCT01489254|561610458|FG001|Double-blind Part|Pregnancy|3|||
155596345|NCT01489254|561610459|FG002|Double-blind Part|Pregnancy|0|||
155596346|NCT01489254|561610460|FG003|Double-blind Part|Pregnancy|0|||
155596347|NCT01489254|561610457|FG000|Double-blind Part|Withdrawal by Subject|12|||
155596348|NCT01489254|561610458|FG001|Double-blind Part|Withdrawal by Subject|20|||
155596349|NCT01489254|561610459|FG002|Double-blind Part|Withdrawal by Subject|1|||
155596350|NCT01489254|561610460|FG003|Double-blind Part|Withdrawal by Subject|0|||
155596351|NCT01489254|561610457|FG000|Double-blind Part|Lost to Follow-up|1|||
155596352|NCT01489254|561610458|FG001|Double-blind Part|Lost to Follow-up|2|||
155596353|NCT01489254|561610459|FG002|Double-blind Part|Lost to Follow-up|0|||
155596354|NCT01489254|561610460|FG003|Double-blind Part|Lost to Follow-up|0|||
155596355|NCT01489254|561610457|FG000|Double-blind Part|Other reasons for not completing study|4|||
155596356|NCT01489254|561610458|FG001|Double-blind Part|Other reasons for not completing study|6|||
155596357|NCT01489254|561610459|FG002|Double-blind Part|Other reasons for not completing study|0|||
155596358|NCT01489254|561610460|FG003|Double-blind Part|Other reasons for not completing study|0|||
155596359|NCT01489254|561610457|FG000|Open-label Extension Part|Adverse Event|0|||
155596360|NCT01489254|561610458|FG001|Open-label Extension Part|Adverse Event|0|||
155596361|NCT01489254|561610459|FG002|Open-label Extension Part|Adverse Event|0|||
155596362|NCT01489254|561610460|FG003|Open-label Extension Part|Adverse Event|10|||
155596363|NCT01489254|561610457|FG000|Open-label Extension Part|Pregnancy|0|||
155596364|NCT01489254|561610458|FG001|Open-label Extension Part|Pregnancy|0|||
155596365|NCT01489254|561610459|FG002|Open-label Extension Part|Pregnancy|0|||
155596366|NCT01489254|561610460|FG003|Open-label Extension Part|Pregnancy|3|||
155596367|NCT01489254|561610457|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
155596368|NCT01489254|561610458|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
155596369|NCT01489254|561610459|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
155596370|NCT01489254|561610460|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
155596371|NCT01489254|561610457|FG000|Open-label Extension Part|Protocol Violation|0|||
155596372|NCT01489254|561610458|FG001|Open-label Extension Part|Protocol Violation|0|||
155596373|NCT01489254|561610459|FG002|Open-label Extension Part|Protocol Violation|0|||
155596374|NCT01489254|561610460|FG003|Open-label Extension Part|Protocol Violation|1|||
155596375|NCT01489254|561610457|FG000|Open-label Extension Part|Lost to Follow-up|0|||
155596376|NCT01489254|561610458|FG001|Open-label Extension Part|Lost to Follow-up|0|||
155596377|NCT01489254|561610459|FG002|Open-label Extension Part|Lost to Follow-up|0|||
155596378|NCT01489254|561610460|FG003|Open-label Extension Part|Lost to Follow-up|9|||
155596379|NCT01489254|561610457|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
155596380|NCT01489254|561610458|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
155596381|NCT01489254|561610459|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
155596382|NCT01489254|561610460|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
155596383|NCT00281632|561610461|FG000|Overall Study|Adverse Event|7|||
155596384|NCT00281632|561610461|FG000|Overall Study|Withdrawal by Subject|2|||
155596385|NCT00281632|561610461|FG000|Overall Study|Disease Progression|22|||
155596386|NCT00281632|561610461|FG000|Overall Study|Death|1|||
155596387|NCT00281632|561610461|FG000|Overall Study|Physician Decision|1|||
155596388|NCT00281632|561610461|FG000|Overall Study|Ongoing|3|||
155596389|NCT02691936|561610467|FG000|Overall Study|Withdrawal by Subject|2|||
155596390|NCT02691936|561610468|FG001|Overall Study|Withdrawal by Subject|5|||
155669782|NCT01365455|561885028|FG002|Maintenance Period|Pregnancy|0|||
155596391|NCT01878084|561610469|FG000|Overall Study|Physician Decision|2|||
155596392|NCT00749684|561610470|FG000|Overall Study|Death|1|||
155596393|NCT00749684|561610470|FG000|Overall Study|Adverse Event|27|||
155596394|NCT00749684|561610470|FG000|Overall Study|Participant's Wish|10|||
155596395|NCT00749684|561610470|FG000|Overall Study|Not Documented|1|||
155596396|NCT00749684|561610470|FG000|Overall Study|Progressive Desease|31|||
155596397|NCT00749684|561610470|FG000|Overall Study|Therapy according to protocol + AE|2|||
155596398|NCT00749684|561610470|FG000|Overall Study|AE+discontinuation on participants wish|1|||
155596399|NCT00749684|561610470|FG000|Overall Study|Missing|9|||
155596400|NCT03696108|561610471|FG000|Overall Study|Physician Decision|1|||
155596401|NCT03696108|561610472|FG001|Overall Study|Physician Decision|0|||
155596402|NCT03696108|561610471|FG000|Overall Study|Withdrawal by Subject|3|||
155596403|NCT03696108|561610472|FG001|Overall Study|Withdrawal by Subject|6|||
155596404|NCT03891862|561610474|FG000|Open-label Period|Adverse Event|2|||
155596405|NCT03891862|561610475|FG001|Open-label Period|Adverse Event|0|||
155596406|NCT03891862|561610476|FG002|Open-label Period|Adverse Event|0|||
155596407|NCT03891862|561610474|FG000|Open-label Period|Protocol Violation|5|||
155596408|NCT03891862|561610475|FG001|Open-label Period|Protocol Violation|0|||
155596409|NCT03891862|561610476|FG002|Open-label Period|Protocol Violation|0|||
155596410|NCT03891862|561610474|FG000|Open-label Period|Withdrawal by Subject|6|||
155596411|NCT03891862|561610475|FG001|Open-label Period|Withdrawal by Subject|0|||
155596412|NCT03891862|561610476|FG002|Open-label Period|Withdrawal by Subject|0|||
155596413|NCT03891862|561610474|FG000|Open-label Period|Death|1|||
155596414|NCT03891862|561610475|FG001|Open-label Period|Death|0|||
155596415|NCT03891862|561610476|FG002|Open-label Period|Death|0|||
155596416|NCT03891862|561610474|FG000|Open-label Period|Lost to Follow-up|2|||
155596417|NCT03891862|561610475|FG001|Open-label Period|Lost to Follow-up|0|||
155596418|NCT03891862|561610476|FG002|Open-label Period|Lost to Follow-up|0|||
155596419|NCT03891862|561610474|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
155596420|NCT03891862|561610475|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
155596421|NCT03891862|561610476|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
155596422|NCT03891862|561610474|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
155596423|NCT03891862|561610475|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
155596424|NCT03891862|561610476|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
155596425|NCT03891862|561610474|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
155596426|NCT03891862|561610475|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
155596427|NCT03891862|561610476|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
155596428|NCT03891862|561610474|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
155596429|NCT03891862|561610475|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
155596430|NCT03891862|561610476|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
155596431|NCT01053962|561610477|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155596432|NCT01053962|561610478|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155596433|NCT01053962|561610479|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155596434|NCT01053962|561610480|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
155596435|NCT01053962|561610481|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
155596436|NCT01053962|561610477|FG000|Pretreatment Period|Venipuncture Failure|0|||
155596437|NCT01053962|561610478|FG001|Pretreatment Period|Venipuncture Failure|0|||
155596438|NCT01053962|561610479|FG002|Pretreatment Period|Venipuncture Failure|1|||
155596439|NCT01053962|561610480|FG003|Pretreatment Period|Venipuncture Failure|0|||
155596440|NCT01053962|561610481|FG004|Pretreatment Period|Venipuncture Failure|0|||
155596441|NCT01053962|561610477|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155596442|NCT01053962|561610478|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
155596443|NCT01053962|561610479|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155596444|NCT01053962|561610480|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155596445|NCT01053962|561610481|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155596446|NCT01053962|561610477|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155596447|NCT01053962|561610478|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155596448|NCT01053962|561610479|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155596449|NCT01053962|561610480|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
155596450|NCT01053962|561610481|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155596451|NCT01053962|561610477|FG000|Treatment Period|Lack of Efficacy|0|||
155596452|NCT01053962|561610478|FG001|Treatment Period|Lack of Efficacy|0|||
155596453|NCT01053962|561610479|FG002|Treatment Period|Lack of Efficacy|0|||
155596454|NCT01053962|561610480|FG003|Treatment Period|Lack of Efficacy|0|||
155596455|NCT01053962|561610481|FG004|Treatment Period|Lack of Efficacy|1|||
155596456|NCT01053962|561610477|FG000|Treatment Period|Adverse Event|0|||
155596457|NCT01053962|561610478|FG001|Treatment Period|Adverse Event|0|||
155596458|NCT01053962|561610479|FG002|Treatment Period|Adverse Event|0|||
155596459|NCT01053962|561610480|FG003|Treatment Period|Adverse Event|0|||
155596460|NCT01053962|561610481|FG004|Treatment Period|Adverse Event|1|||
155596461|NCT01053962|561610477|FG000|Treatment Period|Withdrawal by Subject|0|||
155596462|NCT01053962|561610478|FG001|Treatment Period|Withdrawal by Subject|0|||
155596463|NCT01053962|561610479|FG002|Treatment Period|Withdrawal by Subject|0|||
155596464|NCT01053962|561610480|FG003|Treatment Period|Withdrawal by Subject|0|||
155596465|NCT01053962|561610481|FG004|Treatment Period|Withdrawal by Subject|1|||
155596466|NCT01053962|561610477|FG000|Treatment Period|Noncompliance with protocol|1|||
155596467|NCT01053962|561610478|FG001|Treatment Period|Noncompliance with protocol|0|||
155596468|NCT01053962|561610479|FG002|Treatment Period|Noncompliance with protocol|0|||
155596469|NCT01053962|561610480|FG003|Treatment Period|Noncompliance with protocol|0|||
155596470|NCT01053962|561610481|FG004|Treatment Period|Noncompliance with protocol|0|||
155596471|NCT04143594|561610482|FG000|Overall Study|Withdrew consent|3|||
155596472|NCT04143594|561610483|FG001|Overall Study|Withdrew consent|10|||
155596473|NCT04143594|561610484|FG002|Overall Study|Withdrew consent|3|||
155596474|NCT04143594|561610485|FG003|Overall Study|Withdrew consent|1|||
155596475|NCT04143594|561610482|FG000|Overall Study|Lost to Follow-up|3|||
155596476|NCT04143594|561610483|FG001|Overall Study|Lost to Follow-up|5|||
155596477|NCT04143594|561610484|FG002|Overall Study|Lost to Follow-up|11|||
155596478|NCT04143594|561610485|FG003|Overall Study|Lost to Follow-up|0|||
155596479|NCT04143594|561610482|FG000|Overall Study|Investigator's discretion|2|||
155596480|NCT04143594|561610483|FG001|Overall Study|Investigator's discretion|2|||
155596481|NCT04143594|561610484|FG002|Overall Study|Investigator's discretion|0|||
155596482|NCT04143594|561610485|FG003|Overall Study|Investigator's discretion|0|||
155596483|NCT04143594|561610482|FG000|Overall Study|Randomized but never treated|0|||
155596484|NCT04143594|561610483|FG001|Overall Study|Randomized but never treated|0|||
155596485|NCT04143594|561610484|FG002|Overall Study|Randomized but never treated|0|||
155596486|NCT04143594|561610485|FG003|Overall Study|Randomized but never treated|1|||
155596487|NCT04143594|561610482|FG000|Overall Study|Death|1|||
155596488|NCT04143594|561610483|FG001|Overall Study|Death|0|||
155596489|NCT04143594|561610484|FG002|Overall Study|Death|1|||
155596490|NCT04143594|561610485|FG003|Overall Study|Death|0|||
155596491|NCT04143594|561610482|FG000|Overall Study|Adverse Event|1|||
155596492|NCT04143594|561610483|FG001|Overall Study|Adverse Event|0|||
155596493|NCT04143594|561610484|FG002|Overall Study|Adverse Event|0|||
155596494|NCT04143594|561610485|FG003|Overall Study|Adverse Event|0|||
155596495|NCT04143594|561610482|FG000|Overall Study|Pregnancy|0|||
155596496|NCT04143594|561610483|FG001|Overall Study|Pregnancy|0|||
155596497|NCT04143594|561610484|FG002|Overall Study|Pregnancy|1|||
155596498|NCT04143594|561610485|FG003|Overall Study|Pregnancy|0|||
155596499|NCT04143594|561610482|FG000|Overall Study|Lack of Efficacy|1|||
155596500|NCT04143594|561610483|FG001|Overall Study|Lack of Efficacy|1|||
155596501|NCT04143594|561610484|FG002|Overall Study|Lack of Efficacy|0|||
155596502|NCT04143594|561610485|FG003|Overall Study|Lack of Efficacy|0|||
155596503|NCT03089697|561610486|FG000|Overall Study|Adverse Event|1|||
155596504|NCT03089697|561610487|FG001|Overall Study|Adverse Event|2|||
155596505|NCT03089697|561610486|FG000|Overall Study|Withdrawal by Subject|1|||
155596506|NCT03089697|561610487|FG001|Overall Study|Withdrawal by Subject|0|||
155596507|NCT00638443|561610488|FG000|First Intervention|Adverse Event|2|||
155596508|NCT00638443|561610489|FG001|First Intervention|Adverse Event|1|||
155596509|NCT01044290|561610490|FG000|Follow-up 1|Death|3|||
155596510|NCT01044290|561610491|FG001|Follow-up 1|Death|3|||
155596511|NCT01044290|561610492|FG002|Follow-up 1|Death|1|||
155596512|NCT01044290|561610490|FG000|Follow-up 1|Withdrawal by Subject|2|||
155596513|NCT01044290|561610491|FG001|Follow-up 1|Withdrawal by Subject|2|||
155596514|NCT01044290|561610492|FG002|Follow-up 1|Withdrawal by Subject|0|||
155596515|NCT01044290|561610490|FG000|Follow-Up 2|Death|0|||
155596516|NCT01044290|561610491|FG001|Follow-Up 2|Death|1|||
155596517|NCT01044290|561610492|FG002|Follow-Up 2|Death|1|||
155596518|NCT01044290|561610490|FG000|Follow-Up 2|Withdrawal by Subject|0|||
155596519|NCT01044290|561610491|FG001|Follow-Up 2|Withdrawal by Subject|1|||
155596520|NCT01044290|561610492|FG002|Follow-Up 2|Withdrawal by Subject|1|||
155596521|NCT01646021|561610495|FG000|Overall Study|Death|77|||
155596522|NCT01646021|561610496|FG001|Overall Study|Death|83|||
155596523|NCT01646021|561610495|FG000|Overall Study|Study Terminated by Sponsor|50|||
155596524|NCT01646021|561610496|FG001|Overall Study|Study Terminated by Sponsor|41|||
155596525|NCT01646021|561610495|FG000|Overall Study|Lost to Follow-up|2|||
155596526|NCT01646021|561610496|FG001|Overall Study|Lost to Follow-up|2|||
155596527|NCT01646021|561610495|FG000|Overall Study|Withdrawal by Subject|10|||
155596528|NCT01646021|561610496|FG001|Overall Study|Withdrawal by Subject|15|||
155596529|NCT01967706|561610499|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155596530|NCT01967706|561610500|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155596531|NCT01967706|561610501|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155596532|NCT01967706|561610502|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155596533|NCT00614120|561610506|FG000|Overall Study|Adverse Event|9|||
155596534|NCT00614120|561610507|FG001|Overall Study|Adverse Event|22|||
155596535|NCT00614120|561610508|FG002|Overall Study|Adverse Event|30|||
155596536|NCT00614120|561610509|FG003|Overall Study|Adverse Event|3|||
155596537|NCT00614120|561610506|FG000|Overall Study|Lack of Efficacy|3|||
155596538|NCT00614120|561610507|FG001|Overall Study|Lack of Efficacy|3|||
155596539|NCT00614120|561610508|FG002|Overall Study|Lack of Efficacy|2|||
155596540|NCT00614120|561610509|FG003|Overall Study|Lack of Efficacy|2|||
155596541|NCT00614120|561610506|FG000|Overall Study|Protocol Violation|2|||
155596542|NCT00614120|561610507|FG001|Overall Study|Protocol Violation|5|||
155596543|NCT00614120|561610508|FG002|Overall Study|Protocol Violation|3|||
155596544|NCT00614120|561610509|FG003|Overall Study|Protocol Violation|1|||
155596545|NCT00614120|561610506|FG000|Overall Study|Withdrawal criteria|1|||
155596546|NCT00614120|561610507|FG001|Overall Study|Withdrawal criteria|0|||
155596547|NCT00614120|561610508|FG002|Overall Study|Withdrawal criteria|0|||
155596548|NCT00614120|561610509|FG003|Overall Study|Withdrawal criteria|0|||
155596549|NCT00614120|561610506|FG000|Overall Study|Withdrawal by Subject|9|||
155596550|NCT00614120|561610507|FG001|Overall Study|Withdrawal by Subject|10|||
155596551|NCT00614120|561610508|FG002|Overall Study|Withdrawal by Subject|16|||
155596552|NCT00614120|561610509|FG003|Overall Study|Withdrawal by Subject|3|||
155596553|NCT00614120|561610506|FG000|Overall Study|Did not meet trial criteria|0|||
155596554|NCT00614120|561610507|FG001|Overall Study|Did not meet trial criteria|1|||
155596555|NCT00614120|561610508|FG002|Overall Study|Did not meet trial criteria|1|||
155596556|NCT00614120|561610509|FG003|Overall Study|Did not meet trial criteria|1|||
155596557|NCT00614120|561610506|FG000|Overall Study|hCG positive (not pregnant)|0|||
155596558|NCT00614120|561610507|FG001|Overall Study|hCG positive (not pregnant)|0|||
155596559|NCT00614120|561610508|FG002|Overall Study|hCG positive (not pregnant)|1|||
155596560|NCT00614120|561610509|FG003|Overall Study|hCG positive (not pregnant)|0|||
155596561|NCT00614120|561610506|FG000|Overall Study|Hypoglycaemia|0|||
155596562|NCT00614120|561610507|FG001|Overall Study|Hypoglycaemia|0|||
155596563|NCT00614120|561610508|FG002|Overall Study|Hypoglycaemia|0|||
155596564|NCT00614120|561610509|FG003|Overall Study|Hypoglycaemia|1|||
155596565|NCT00614120|561610506|FG000|Overall Study|Lack of trial product|3|||
155669783|NCT01365455|561885029|FG003|Maintenance Period|Pregnancy|0|||
155669784|NCT01365455|561885030|FG004|Maintenance Period|Pregnancy|2|||
155596566|NCT00614120|561610507|FG001|Overall Study|Lack of trial product|3|||
155669785|NCT01365455|561885026|FG000|Maintenance Period|Protocol deviation|1|||
155669786|NCT01365455|561885027|FG001|Maintenance Period|Protocol deviation|1|||
155669787|NCT01365455|561885028|FG002|Maintenance Period|Protocol deviation|0|||
155669788|NCT01365455|561885029|FG003|Maintenance Period|Protocol deviation|0|||
155669789|NCT01365455|561885030|FG004|Maintenance Period|Protocol deviation|0|||
155669790|NCT01365455|561885026|FG000|Maintenance Period|Subject/guardian decision|4|||
155669791|NCT01365455|561885027|FG001|Maintenance Period|Subject/guardian decision|6|||
155669792|NCT01365455|561885028|FG002|Maintenance Period|Subject/guardian decision|2|||
155669793|NCT01365455|561885029|FG003|Maintenance Period|Subject/guardian decision|4|||
155669794|NCT01365455|561885030|FG004|Maintenance Period|Subject/guardian decision|1|||
155669795|NCT03965403|561885031|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
155669796|NCT01897727|561886498|FG000|Overall Study|Exclusion: central sleep apnea|0|||
155669797|NCT01897727|561886499|FG001|Overall Study|Exclusion: central sleep apnea|1|||
155669798|NCT01273038|561886504|FG000|Second Intervention (14 Days)|Adverse Event|0|||
155669799|NCT01273038|561886505|FG001|Second Intervention (14 Days)|Adverse Event|1|||
155669800|NCT01273038|561886504|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155669801|NCT01273038|561886505|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155669802|NCT02197572|561886506|FG000|Overall Study|Progressive Disease|28|||
155669803|NCT02197572|561886506|FG000|Overall Study|Withdrawal by Subject|9|||
155596567|NCT00614120|561610508|FG002|Overall Study|Lack of trial product|2|||
155596568|NCT00614120|561610509|FG003|Overall Study|Lack of trial product|0|||
155596569|NCT00614120|561610506|FG000|Overall Study|Late syphilis, latent|1|||
155596570|NCT00614120|561610507|FG001|Overall Study|Late syphilis, latent|0|||
155596571|NCT00614120|561610508|FG002|Overall Study|Late syphilis, latent|0|||
155596572|NCT00614120|561610509|FG003|Overall Study|Late syphilis, latent|0|||
155596573|NCT00614120|561610506|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
155596574|NCT00614120|561610507|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
155596575|NCT00614120|561610508|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
155669804|NCT02197572|561886506|FG000|Overall Study|Adverse Event|3|||
155669805|NCT02197572|561886506|FG000|Overall Study|Reason Not Specified|4|||
155596576|NCT00614120|561610509|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
155596577|NCT00614120|561610506|FG000|Overall Study|Lost to Follow-up|1|||
155596578|NCT00614120|561610507|FG001|Overall Study|Lost to Follow-up|2|||
155596579|NCT00614120|561610508|FG002|Overall Study|Lost to Follow-up|3|||
155596580|NCT00614120|561610509|FG003|Overall Study|Lost to Follow-up|4|||
155596581|NCT05129137|561610511|FG000|Second Period|Adverse Event|1|||
155596582|NCT05129137|561610512|FG001|Second Period|Adverse Event|0|||
155596583|NCT05129137|561610513|FG002|Second Period|Adverse Event|0|||
155596584|NCT05129137|561610514|FG003|Second Period|Adverse Event|0|||
155596585|NCT05129137|561610511|FG000|Second Period|Protocol Violation|0|||
155596586|NCT05129137|561610512|FG001|Second Period|Protocol Violation|0|||
155596587|NCT05129137|561610513|FG002|Second Period|Protocol Violation|0|||
155596588|NCT05129137|561610514|FG003|Second Period|Protocol Violation|1|||
155596589|NCT05129137|561610511|FG000|Third Period|Protocol Violation|0|||
155596590|NCT05129137|561610512|FG001|Third Period|Protocol Violation|0|||
155596591|NCT05129137|561610513|FG002|Third Period|Protocol Violation|0|||
155596592|NCT05129137|561610514|FG003|Third Period|Protocol Violation|1|||
155596593|NCT05129137|561610511|FG000|Forth Period|Protocol Violation|0|||
155596594|NCT05129137|561610512|FG001|Forth Period|Protocol Violation|1|||
155596595|NCT05129137|561610513|FG002|Forth Period|Protocol Violation|0|||
155596596|NCT05129137|561610514|FG003|Forth Period|Protocol Violation|0|||
155596597|NCT05129137|561610511|FG000|Forth Period|Withdrawal by Subject|0|||
155596598|NCT05129137|561610512|FG001|Forth Period|Withdrawal by Subject|0|||
155596599|NCT05129137|561610513|FG002|Forth Period|Withdrawal by Subject|1|||
155596600|NCT05129137|561610514|FG003|Forth Period|Withdrawal by Subject|0|||
155596601|NCT01552915|561610525|FG000|Overall Study|Adverse Event|3|||
155596602|NCT01552915|561610526|FG001|Overall Study|Adverse Event|14|||
155596603|NCT01552915|561610527|FG002|Overall Study|Adverse Event|3|||
155596604|NCT01552915|561610525|FG000|Overall Study|Lost to Follow-up|4|||
155596605|NCT01552915|561610526|FG001|Overall Study|Lost to Follow-up|6|||
155596606|NCT01552915|561610527|FG002|Overall Study|Lost to Follow-up|5|||
155596607|NCT01552915|561610525|FG000|Overall Study|Withdrawal by Subject|6|||
155596608|NCT01552915|561610526|FG001|Overall Study|Withdrawal by Subject|4|||
155596609|NCT01552915|561610527|FG002|Overall Study|Withdrawal by Subject|5|||
155596610|NCT01552915|561610525|FG000|Overall Study|Protocol Violation|0|||
155596611|NCT01552915|561610526|FG001|Overall Study|Protocol Violation|4|||
155596612|NCT01552915|561610527|FG002|Overall Study|Protocol Violation|4|||
155596613|NCT01552915|561610525|FG000|Overall Study|Lack of Efficacy|8|||
155596614|NCT01552915|561610526|FG001|Overall Study|Lack of Efficacy|1|||
155596615|NCT01552915|561610527|FG002|Overall Study|Lack of Efficacy|4|||
155596616|NCT01552915|561610525|FG000|Overall Study|Other|2|||
155596617|NCT01552915|561610526|FG001|Overall Study|Other|0|||
155596618|NCT01552915|561610527|FG002|Overall Study|Other|6|||
155596619|NCT00979420|561610528|FG000|Overall Study|Adverse Event|1|||
155596620|NCT00979420|561610529|FG001|Overall Study|Adverse Event|0|||
155596621|NCT00979420|561610530|FG002|Overall Study|Adverse Event|0|||
155596622|NCT00979420|561610531|FG003|Overall Study|Adverse Event|0|||
155596623|NCT00979420|561610528|FG000|Overall Study|Lack of Efficacy|3|||
155596624|NCT00979420|561610529|FG001|Overall Study|Lack of Efficacy|0|||
155596625|NCT00979420|561610530|FG002|Overall Study|Lack of Efficacy|1|||
155596626|NCT00979420|561610531|FG003|Overall Study|Lack of Efficacy|1|||
155596627|NCT00979420|561610528|FG000|Overall Study|Other reasons not related to Viramune|3|||
155596628|NCT00979420|561610529|FG001|Overall Study|Other reasons not related to Viramune|0|||
155596629|NCT00979420|561610530|FG002|Overall Study|Other reasons not related to Viramune|0|||
155596630|NCT00979420|561610531|FG003|Overall Study|Other reasons not related to Viramune|1|||
155596631|NCT01054196|561610532|FG000|Overall Study|Physician Decision|0|||
155596632|NCT01054196|561610533|FG001|Overall Study|Physician Decision|0|||
155596633|NCT01054196|561610534|FG002|Overall Study|Physician Decision|0|||
155596634|NCT01054196|561610535|FG003|Overall Study|Physician Decision|1|||
155596635|NCT01054196|561610536|FG004|Overall Study|Physician Decision|0|||
155596636|NCT01054196|561610537|FG005|Overall Study|Physician Decision|0|||
155596637|NCT01054196|561610538|FG006|Overall Study|Physician Decision|1|||
155596638|NCT01820572|561610549|FG000|Randomization|Not Treated|2|||
155596639|NCT01820572|561610550|FG001|Randomization|Not Treated|1|||
155596640|NCT01820572|561610549|FG000|Treatment Period|Adverse Event|12|||
155596641|NCT01820572|561610550|FG001|Treatment Period|Adverse Event|7|||
155596642|NCT01820572|561610549|FG000|Treatment Period|Death|3|||
155596643|NCT01820572|561610550|FG001|Treatment Period|Death|3|||
155596644|NCT01820572|561610549|FG000|Treatment Period|Lack of Efficacy|1|||
155596645|NCT01820572|561610550|FG001|Treatment Period|Lack of Efficacy|0|||
155596646|NCT01820572|561610549|FG000|Treatment Period|poor/non compliance|0|||
155596647|NCT01820572|561610550|FG001|Treatment Period|poor/non compliance|3|||
155596648|NCT01820572|561610549|FG000|Treatment Period|request to discontinue|6|||
155596649|NCT01820572|561610550|FG001|Treatment Period|request to discontinue|11|||
155596650|NCT01820572|561610549|FG000|Treatment Period|No longer meets study criteria|3|||
155596651|NCT01820572|561610550|FG001|Treatment Period|No longer meets study criteria|10|||
155596652|NCT01820572|561610549|FG000|Treatment Period|withdrew consent|1|||
155596653|NCT01820572|561610550|FG001|Treatment Period|withdrew consent|2|||
155596654|NCT00595517|561610551|FG000|Overall Study|Adverse Event|6|||
155596655|NCT00595517|561610551|FG000|Overall Study|Withdrawal by Subject|4|||
155596656|NCT00595517|561610551|FG000|Overall Study|Protocol Violation|2|||
155596657|NCT00595517|561610551|FG000|Overall Study|Recurrence of ulcer|5|||
155596658|NCT00595517|561610551|FG000|Overall Study|usage of prohibited treatment|1|||
155596659|NCT00595517|561610551|FG000|Overall Study|No intention to attend regularly|1|||
155596660|NCT01167881|561610552|FG000|Overall Study|Adverse Event|47|||
155596661|NCT01167881|561610553|FG001|Overall Study|Adverse Event|51|||
155596662|NCT01167881|561610552|FG000|Overall Study|Lack of Efficacy|4|||
155596663|NCT01167881|561610553|FG001|Overall Study|Lack of Efficacy|7|||
155596664|NCT01167881|561610552|FG000|Overall Study|Non compliant with protocol|9|||
155596665|NCT01167881|561610553|FG001|Overall Study|Non compliant with protocol|18|||
155596666|NCT01167881|561610552|FG000|Overall Study|Lost to Follow-up|19|||
155596667|NCT01167881|561610553|FG001|Overall Study|Lost to Follow-up|20|||
155596668|NCT01167881|561610552|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
155596669|NCT01167881|561610553|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
155596670|NCT01167881|561610552|FG000|Overall Study|Not treated|4|||
155596671|NCT01167881|561610553|FG001|Overall Study|Not treated|0|||
155596672|NCT01167881|561610552|FG000|Overall Study|Other not defined above|31|||
155596673|NCT01167881|561610553|FG001|Overall Study|Other not defined above|55|||
155596674|NCT02107859|561610554|FG000|Overall Study|Withdrawal by Subject|14|||
155596675|NCT02107859|561610554|FG000|Overall Study|Adverse Event|3|||
155596676|NCT02107859|561610554|FG000|Overall Study|Study closure|41|||
155596677|NCT02107859|561610554|FG000|Overall Study|Other than specified|3|||
155596678|NCT00977314|561610555|FG000|Overall Study|Withdrawal by Subject|1|||
155596679|NCT00977314|561610556|FG001|Overall Study|Withdrawal by Subject|0|||
155596680|NCT00977314|561610555|FG000|Overall Study|Physician Decision|1|||
155596681|NCT00977314|561610556|FG001|Overall Study|Physician Decision|0|||
155596682|NCT01343277|561610557|FG000|Overall Study|Other|3|||
155596683|NCT01343277|561610558|FG001|Overall Study|Other|3|||
155596684|NCT01343277|561610557|FG000|Overall Study|Withdrawal by Subject|18|||
155596685|NCT01343277|561610558|FG001|Overall Study|Withdrawal by Subject|13|||
155596686|NCT01343277|561610557|FG000|Overall Study|Physician Decision|1|||
155596687|NCT01343277|561610558|FG001|Overall Study|Physician Decision|2|||
155596688|NCT01343277|561610557|FG000|Overall Study|Death|10|||
155596689|NCT01343277|561610558|FG001|Overall Study|Death|1|||
155596690|NCT01343277|561610557|FG000|Overall Study|Adverse Event|67|||
155596691|NCT01343277|561610558|FG001|Overall Study|Adverse Event|13|||
155596692|NCT01343277|561610557|FG000|Overall Study|Disease progression|270|||
155596693|NCT01343277|561610558|FG001|Overall Study|Disease progression|138|||
155596694|NCT01343277|561610557|FG000|Overall Study|Randomized not treated|6|||
155596695|NCT01343277|561610558|FG001|Overall Study|Randomized not treated|21|||
155596696|NCT01343277|561610557|FG000|Overall Study|Treatment ongoing|8|||
155596697|NCT01343277|561610558|FG001|Overall Study|Treatment ongoing|2|||
155596698|NCT01343277|561610557|FG000|Overall Study|Subsequent anticancer therapy|1|||
155596699|NCT01343277|561610558|FG001|Overall Study|Subsequent anticancer therapy|0|||
155596700|NCT01894100|561610561|FG000|Overall Study|Lost to Follow-up|0|||
155596701|NCT01894100|561610562|FG001|Overall Study|Lost to Follow-up|1|||
155596702|NCT01894100|561610561|FG000|Overall Study|Withdrawal by Subject|3|||
155596703|NCT01894100|561610562|FG001|Overall Study|Withdrawal by Subject|0|||
155596704|NCT00135512|561610565|FG000|Overall Study|Adverse Event|56|||
155596705|NCT00135512|561610565|FG000|Overall Study|Lack of Efficacy|25|||
155596706|NCT00135512|561610565|FG000|Overall Study|Other|42|||
155596707|NCT01094301|561610566|FG000|Trial Stage|Withdrawal by Subject|1|||
155596708|NCT01094301|561610566|FG000|Implant Stage|Adverse Event|1|||
155596709|NCT01094301|561610566|FG000|Implant Stage|Protocol Violation|1|||
155596710|NCT01094301|561610566|FG000|Implant Stage|Withdrawal by Subject|2|||
155596711|NCT01094301|561610566|FG000|Implant Stage|No return of pain|4|||
155596712|NCT04439214|561610570|FG000|Overall Study|Adverse Event|13|||
155596713|NCT04439214|561610570|FG000|Overall Study|Disease progression|16|||
155596714|NCT04439214|561610570|FG000|Overall Study|Death|1|||
155596715|NCT04439214|561610570|FG000|Overall Study|Withdrawal by Subject|2|||
155596716|NCT04439214|561610570|FG000|Overall Study|Declining health|1|||
155596717|NCT04439214|561610570|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
155596718|NCT04439214|561610570|FG000|Overall Study|Ineligible|5|||
155596719|NCT02235077|561610571|FG000|Overall Study|Death|5|||
155596720|NCT02235077|561610572|FG001|Overall Study|Death|7|||
155596721|NCT02235077|561610571|FG000|Overall Study|Lost to Follow-up|5|||
155596722|NCT02235077|561610572|FG001|Overall Study|Lost to Follow-up|6|||
155596723|NCT02235077|561610571|FG000|Overall Study|Withdrawal by Subject|8|||
155596724|NCT02235077|561610572|FG001|Overall Study|Withdrawal by Subject|5|||
155596725|NCT02235077|561610571|FG000|Overall Study|Physician Decision|0|||
155596726|NCT02235077|561610572|FG001|Overall Study|Physician Decision|1|||
155596727|NCT03852628|561610573|FG000|Overall Study|Lost to Follow-up|7|||
155596728|NCT03852628|561610574|FG001|Overall Study|Lost to Follow-up|6|||
155596729|NCT03852628|561610573|FG000|Overall Study|Lack of Efficacy|6|||
155596730|NCT03852628|561610574|FG001|Overall Study|Lack of Efficacy|6|||
155596731|NCT02964208|561610575|FG000|Overall Study|Death|103|||
155596732|NCT02964208|561610575|FG000|Overall Study|Withdrawal by Subject|6|||
155596733|NCT02964208|561610575|FG000|Overall Study|Lost to Follow-up|6|||
155596734|NCT02964208|561610575|FG000|Overall Study|Unsuccessful Procedure|5|||
155596735|NCT02964208|561610575|FG000|Overall Study|Device Explant|1|||
155596736|NCT02964208|561610575|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
155596737|NCT00430573|561610578|FG000|Overall Study|Withdrawal by Subject|5|||
155596738|NCT01668173|561610583|FG000|Overall Study|Adverse Event|3|||
155596739|NCT01668173|561610583|FG000|Overall Study|Trial suspension|4|||
155596740|NCT05020665|561610584|FG000|Overall Study|Study terminated by Sponsor|5|||
155596741|NCT05020665|561610585|FG001|Overall Study|Study terminated by Sponsor|4|||
155596742|NCT05020665|561610584|FG000|Overall Study|Death|2|||
155596743|NCT05020665|561610585|FG001|Overall Study|Death|1|||
155596744|NCT05020665|561610584|FG000|Overall Study|Physician Decision|0|||
155596745|NCT05020665|561610585|FG001|Overall Study|Physician Decision|1|||
155596746|NCT05020665|561610584|FG000|Overall Study|Withdrawal by Subject|0|||
155596747|NCT05020665|561610585|FG001|Overall Study|Withdrawal by Subject|1|||
155596748|NCT05020665|561610584|FG000|Overall Study|Reason not specified|1|||
155596749|NCT05020665|561610585|FG001|Overall Study|Reason not specified|0|||
155596750|NCT00101166|561610586|FG000|Overall Study|progressive disease|10|||
155596751|NCT01868022|561610587|FG000|Overall Study|Withdrawal by Subject|0|||
155596752|NCT01868022|561610588|FG001|Overall Study|Withdrawal by Subject|0|||
155596753|NCT01868022|561610589|FG002|Overall Study|Withdrawal by Subject|1|||
155596754|NCT01868022|561610590|FG003|Overall Study|Withdrawal by Subject|1|||
155596755|NCT01868022|561610591|FG004|Overall Study|Withdrawal by Subject|0|||
155596756|NCT01868022|561610592|FG005|Overall Study|Withdrawal by Subject|0|||
155596757|NCT01868022|561610593|FG006|Overall Study|Withdrawal by Subject|0|||
155596758|NCT01868022|561610594|FG007|Overall Study|Withdrawal by Subject|1|||
155596759|NCT01868022|561610595|FG008|Overall Study|Withdrawal by Subject|0|||
155596760|NCT01868022|561610587|FG000|Overall Study|Adverse Event|0|||
155596761|NCT01868022|561610588|FG001|Overall Study|Adverse Event|0|||
155596762|NCT01868022|561610589|FG002|Overall Study|Adverse Event|0|||
155596763|NCT01868022|561610590|FG003|Overall Study|Adverse Event|0|||
155596764|NCT01868022|561610591|FG004|Overall Study|Adverse Event|2|||
155596765|NCT01868022|561610592|FG005|Overall Study|Adverse Event|0|||
155596766|NCT01868022|561610593|FG006|Overall Study|Adverse Event|0|||
155596767|NCT01868022|561610594|FG007|Overall Study|Adverse Event|2|||
155596768|NCT01868022|561610595|FG008|Overall Study|Adverse Event|2|||
155596769|NCT01868022|561610587|FG000|Overall Study|Physician Decision|0|||
155596770|NCT01868022|561610588|FG001|Overall Study|Physician Decision|0|||
155596771|NCT01868022|561610589|FG002|Overall Study|Physician Decision|0|||
155596772|NCT01868022|561610590|FG003|Overall Study|Physician Decision|0|||
155596773|NCT01868022|561610591|FG004|Overall Study|Physician Decision|0|||
155596774|NCT01868022|561610592|FG005|Overall Study|Physician Decision|1|||
155596775|NCT01868022|561610593|FG006|Overall Study|Physician Decision|0|||
155596776|NCT01868022|561610594|FG007|Overall Study|Physician Decision|2|||
155596777|NCT01868022|561610595|FG008|Overall Study|Physician Decision|0|||
155596778|NCT01868022|561610587|FG000|Overall Study|Study closed/terminated|0|||
155596779|NCT01868022|561610588|FG001|Overall Study|Study closed/terminated|0|||
155596780|NCT01868022|561610589|FG002|Overall Study|Study closed/terminated|0|||
155596781|NCT01868022|561610590|FG003|Overall Study|Study closed/terminated|0|||
155596782|NCT01868022|561610591|FG004|Overall Study|Study closed/terminated|0|||
155596783|NCT01868022|561610592|FG005|Overall Study|Study closed/terminated|0|||
155596784|NCT01868022|561610593|FG006|Overall Study|Study closed/terminated|0|||
155596785|NCT01868022|561610594|FG007|Overall Study|Study closed/terminated|1|||
155596786|NCT01868022|561610595|FG008|Overall Study|Study closed/terminated|0|||
155596787|NCT01868022|561610587|FG000|Overall Study|Ongoing|0|||
155596788|NCT01868022|561610588|FG001|Overall Study|Ongoing|0|||
155596789|NCT01868022|561610589|FG002|Overall Study|Ongoing|0|||
155596790|NCT01868022|561610590|FG003|Overall Study|Ongoing|0|||
155596791|NCT01868022|561610591|FG004|Overall Study|Ongoing|0|||
155596792|NCT01868022|561610592|FG005|Overall Study|Ongoing|0|||
155596793|NCT01868022|561610593|FG006|Overall Study|Ongoing|0|||
155596794|NCT01868022|561610594|FG007|Overall Study|Ongoing|3|||
155596795|NCT01868022|561610595|FG008|Overall Study|Ongoing|0|||
155596796|NCT00746564|561610596|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
155596797|NCT03386994|561610600|FG000|Overall Study|Lung transplant|1|||
155596798|NCT03386994|561610600|FG000|Overall Study|Adverse Event|14|||
155596799|NCT03386994|561610600|FG000|Overall Study|Lost to Follow-up|4|||
155596800|NCT03386994|561610600|FG000|Overall Study|Withdrawal by Subject|3|||
155596801|NCT03386994|561610600|FG000|Overall Study|Death|16|||
155596802|NCT00877487|561610601|FG000|Open-label Treatment Phase|Adverse Event|1|||
155596803|NCT00877487|561610602|FG001|Open-label Treatment Phase|Adverse Event|0|||
155596804|NCT00877487|561610601|FG000|Open-label Treatment Phase|Protocol Violation|3|||
155596805|NCT00877487|561610602|FG001|Open-label Treatment Phase|Protocol Violation|0|||
155596806|NCT00877487|561610601|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
155596807|NCT00877487|561610602|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
155596808|NCT00877487|561610601|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
155596809|NCT00877487|561610602|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
155596810|NCT00877487|561610601|FG000|Open-label Treatment Phase|Out of country for business|1|||
155596811|NCT00877487|561610602|FG001|Open-label Treatment Phase|Out of country for business|0|||
155596812|NCT00877487|561610601|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
155596813|NCT00877487|561610602|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
155596814|NCT00877487|561610601|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
155596815|NCT00877487|561610602|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
155596816|NCT00877487|561610601|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
155596817|NCT00877487|561610602|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
155596818|NCT00877487|561610601|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
155596819|NCT00877487|561610602|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
155596820|NCT03033602|561610607|FG000|Overall Study|Withdrawal by Subject|11|||
155596821|NCT03033602|561610608|FG001|Overall Study|Withdrawal by Subject|21|||
155596822|NCT03033602|561610607|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
155596823|NCT03033602|561610608|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
155596824|NCT03425396|561610609|FG000|Overall Study|Lost to Follow-up|2|||
155596825|NCT03425396|561610610|FG001|Overall Study|Lost to Follow-up|5|||
155596826|NCT03425396|561610611|FG002|Overall Study|Lost to Follow-up|2|||
155596827|NCT03425396|561610612|FG003|Overall Study|Lost to Follow-up|0|||
155596828|NCT03425396|561610613|FG004|Overall Study|Lost to Follow-up|0|||
155596829|NCT03425396|561610609|FG000|Overall Study|Withdrawal by Subject|0|||
155596830|NCT03425396|561610610|FG001|Overall Study|Withdrawal by Subject|1|||
155596831|NCT03425396|561610611|FG002|Overall Study|Withdrawal by Subject|0|||
155596832|NCT03425396|561610612|FG003|Overall Study|Withdrawal by Subject|1|||
155596833|NCT03425396|561610613|FG004|Overall Study|Withdrawal by Subject|0|||
155596834|NCT03425396|561610609|FG000|Overall Study|Other|0|||
155596835|NCT03425396|561610610|FG001|Overall Study|Other|1|||
155596836|NCT03425396|561610611|FG002|Overall Study|Other|1|||
155596837|NCT03425396|561610612|FG003|Overall Study|Other|0|||
155596838|NCT03425396|561610613|FG004|Overall Study|Other|1|||
155596839|NCT01441765|561610614|FG000|Overall Study|Death|1|||
155596840|NCT01441765|561610615|FG001|Overall Study|Death|0|||
155596841|NCT01758731|561610616|FG000|Overall Study|Physician Decision|1|||
155596842|NCT04445714|561610617|FG000|Overall Study|Discontinuation of the study|14|||
155596843|NCT04445714|561610617|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
155596844|NCT04445714|561610617|FG000|Overall Study|Withdrawal of Informed Consent|8|||
155596845|NCT02122887|561610623|FG000|Overall Study|Withdrawal by Subject|20|||
155596846|NCT02122887|561610624|FG001|Overall Study|Withdrawal by Subject|2|||
155596847|NCT01082211|561610625|FG000|Overall Study|Protocol Violation|4|||
155596848|NCT01082211|561610625|FG000|Overall Study|No protocol treatment received|3|||
155596849|NCT03725761|561610626|FG000|Overall Study|still on study|1|||
155596850|NCT00784550|561612170|FG000|Overall Study|Adverse Event|12|||
155596851|NCT00784550|561612171|FG001|Overall Study|Adverse Event|10|||
155596852|NCT00784550|561612170|FG000|Overall Study|Lack of Efficacy|0|||
155596853|NCT00784550|561612171|FG001|Overall Study|Lack of Efficacy|1|||
155596854|NCT00784550|561612170|FG000|Overall Study|Protocol Violation|10|||
155596855|NCT00784550|561612171|FG001|Overall Study|Protocol Violation|10|||
155596856|NCT00784550|561612170|FG000|Overall Study|Lost to Follow-up|8|||
155596857|NCT00784550|561612171|FG001|Overall Study|Lost to Follow-up|5|||
155596858|NCT00784550|561612170|FG000|Overall Study|Physician Decision|2|||
155596859|NCT00784550|561612171|FG001|Overall Study|Physician Decision|3|||
155596860|NCT00784550|561612170|FG000|Overall Study|Withdrawal by Subject|4|||
155596861|NCT00784550|561612171|FG001|Overall Study|Withdrawal by Subject|13|||
155596862|NCT05903924|561612172|FG000|Overall Study|Lost to Follow-up|1|||
155596863|NCT05903924|561612173|FG001|Overall Study|Lost to Follow-up|0|||
155596864|NCT05903924|561612174|FG002|Overall Study|Lost to Follow-up|0|||
155596865|NCT00174967|561612175|FG000|Overall Study|Adverse Event|1|||
155596866|NCT00174967|561612176|FG001|Overall Study|Adverse Event|2|||
155596867|NCT00174967|561612177|FG002|Overall Study|Adverse Event|2|||
155596868|NCT00174967|561612178|FG003|Overall Study|Adverse Event|1|||
155596869|NCT00174967|561612175|FG000|Overall Study|Gout Flare|0|||
155596870|NCT00174967|561612176|FG001|Overall Study|Gout Flare|0|||
155596871|NCT00174967|561612177|FG002|Overall Study|Gout Flare|0|||
155596872|NCT00174967|561612178|FG003|Overall Study|Gout Flare|1|||
155596873|NCT00174967|561612175|FG000|Overall Study|Other|0|||
155596874|NCT00174967|561612176|FG001|Overall Study|Other|1|||
155596875|NCT00174967|561612177|FG002|Overall Study|Other|0|||
155596876|NCT00174967|561612178|FG003|Overall Study|Other|0|||
155596877|NCT03558152|561612179|FG000|Overall Study|Adverse Event|0|||
155596878|NCT03558152|561612180|FG001|Overall Study|Adverse Event|0|||
155596879|NCT03558152|561612181|FG002|Overall Study|Adverse Event|1|||
155596880|NCT03558152|561612182|FG003|Overall Study|Adverse Event|1|||
155596881|NCT03558152|561612183|FG004|Overall Study|Adverse Event|2|||
155596882|NCT03558152|561612184|FG005|Overall Study|Adverse Event|1|||
155596883|NCT03558152|561612185|FG006|Overall Study|Adverse Event|1|||
155596884|NCT03558152|561612186|FG007|Overall Study|Adverse Event|0|||
155596885|NCT03558152|561612179|FG000|Overall Study|Death|0|||
155596886|NCT03558152|561612180|FG001|Overall Study|Death|0|||
155596887|NCT03558152|561612181|FG002|Overall Study|Death|0|||
155596888|NCT03558152|561612182|FG003|Overall Study|Death|0|||
155596889|NCT03558152|561612183|FG004|Overall Study|Death|1|||
155596890|NCT03558152|561612184|FG005|Overall Study|Death|0|||
155596891|NCT03558152|561612185|FG006|Overall Study|Death|0|||
155596892|NCT03558152|561612186|FG007|Overall Study|Death|0|||
155596893|NCT03558152|561612179|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
155596894|NCT03558152|561612180|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596895|NCT03558152|561612181|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596896|NCT03558152|561612182|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596897|NCT03558152|561612183|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596898|NCT03558152|561612184|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596899|NCT03558152|561612185|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596900|NCT03558152|561612186|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155596901|NCT03558152|561612179|FG000|Overall Study|Miscalculation in mmcs|0|||
155596902|NCT03558152|561612180|FG001|Overall Study|Miscalculation in mmcs|0|||
155596903|NCT03558152|561612181|FG002|Overall Study|Miscalculation in mmcs|0|||
155596904|NCT03558152|561612182|FG003|Overall Study|Miscalculation in mmcs|0|||
155596905|NCT03558152|561612183|FG004|Overall Study|Miscalculation in mmcs|0|||
155596906|NCT03558152|561612184|FG005|Overall Study|Miscalculation in mmcs|0|||
155596907|NCT03558152|561612185|FG006|Overall Study|Miscalculation in mmcs|1|||
155596908|NCT03558152|561612186|FG007|Overall Study|Miscalculation in mmcs|0|||
155596909|NCT03558152|561612179|FG000|Overall Study|Mistake in calculation|0|||
155596910|NCT03558152|561612180|FG001|Overall Study|Mistake in calculation|0|||
155596911|NCT03558152|561612181|FG002|Overall Study|Mistake in calculation|0|||
155596912|NCT03558152|561612182|FG003|Overall Study|Mistake in calculation|1|||
155596913|NCT03558152|561612183|FG004|Overall Study|Mistake in calculation|0|||
155596914|NCT03558152|561612184|FG005|Overall Study|Mistake in calculation|0|||
155596915|NCT03558152|561612185|FG006|Overall Study|Mistake in calculation|0|||
155596916|NCT03558152|561612186|FG007|Overall Study|Mistake in calculation|0|||
155596917|NCT03558152|561612179|FG000|Overall Study|Mistake in evaluation of disease status|0|||
155596918|NCT03558152|561612180|FG001|Overall Study|Mistake in evaluation of disease status|0|||
155596919|NCT03558152|561612181|FG002|Overall Study|Mistake in evaluation of disease status|0|||
155596920|NCT03558152|561612182|FG003|Overall Study|Mistake in evaluation of disease status|0|||
155596921|NCT03558152|561612183|FG004|Overall Study|Mistake in evaluation of disease status|0|||
155596922|NCT03558152|561612184|FG005|Overall Study|Mistake in evaluation of disease status|0|||
155596923|NCT03558152|561612185|FG006|Overall Study|Mistake in evaluation of disease status|0|||
155596924|NCT03558152|561612186|FG007|Overall Study|Mistake in evaluation of disease status|1|||
155596925|NCT03558152|561612179|FG000|Overall Study|Physician Decision|0|||
155596926|NCT03558152|561612180|FG001|Overall Study|Physician Decision|0|||
155596927|NCT03558152|561612181|FG002|Overall Study|Physician Decision|0|||
155596928|NCT03558152|561612182|FG003|Overall Study|Physician Decision|0|||
155596929|NCT03558152|561612183|FG004|Overall Study|Physician Decision|0|||
155596930|NCT03558152|561612184|FG005|Overall Study|Physician Decision|0|||
155596931|NCT03558152|561612185|FG006|Overall Study|Physician Decision|1|||
155596932|NCT03558152|561612186|FG007|Overall Study|Physician Decision|0|||
155596933|NCT03558152|561612179|FG000|Overall Study|Withdrawal by Subject|2|||
155596934|NCT03558152|561612180|FG001|Overall Study|Withdrawal by Subject|3|||
155596935|NCT03558152|561612181|FG002|Overall Study|Withdrawal by Subject|2|||
155596936|NCT03558152|561612182|FG003|Overall Study|Withdrawal by Subject|1|||
155596937|NCT03558152|561612183|FG004|Overall Study|Withdrawal by Subject|1|||
155596938|NCT03558152|561612184|FG005|Overall Study|Withdrawal by Subject|1|||
155596939|NCT03558152|561612185|FG006|Overall Study|Withdrawal by Subject|3|||
155596940|NCT03558152|561612186|FG007|Overall Study|Withdrawal by Subject|2|||
155596941|NCT03558152|561612179|FG000|Overall Study|Lack of Efficacy|11|||
155596942|NCT03558152|561612180|FG001|Overall Study|Lack of Efficacy|11|||
155596943|NCT03558152|561612181|FG002|Overall Study|Lack of Efficacy|10|||
155596944|NCT03558152|561612182|FG003|Overall Study|Lack of Efficacy|11|||
155596945|NCT03558152|561612183|FG004|Overall Study|Lack of Efficacy|14|||
155596946|NCT03558152|561612184|FG005|Overall Study|Lack of Efficacy|12|||
155596947|NCT03558152|561612185|FG006|Overall Study|Lack of Efficacy|14|||
155596948|NCT03558152|561612186|FG007|Overall Study|Lack of Efficacy|13|||
155596949|NCT03558152|561612179|FG000|Overall Study|Protocol Violation|1|||
155596950|NCT03558152|561612180|FG001|Overall Study|Protocol Violation|1|||
155596951|NCT03558152|561612181|FG002|Overall Study|Protocol Violation|0|||
155596952|NCT03558152|561612182|FG003|Overall Study|Protocol Violation|1|||
155596953|NCT03558152|561612183|FG004|Overall Study|Protocol Violation|1|||
155596954|NCT03558152|561612184|FG005|Overall Study|Protocol Violation|0|||
155596955|NCT03558152|561612185|FG006|Overall Study|Protocol Violation|2|||
155596956|NCT03558152|561612186|FG007|Overall Study|Protocol Violation|0|||
155596957|NCT04166591|561612187|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155596958|NCT04166591|561612188|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155669806|NCT01306643|561886507|FG000|Overall Study|Adverse Event|5|||
155596959|NCT04166591|561612189|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155596960|NCT04166591|561612190|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155596961|NCT04166591|561612187|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155669807|NCT01306643|561886507|FG000|Overall Study|Disease Progression|7|||
155669808|NCT01306643|561886507|FG000|Overall Study|Other: Change in Eligibility Status|1|||
155596962|NCT04166591|561612188|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155669809|NCT01465386|561886508|FG000|Overall Study|Lack of Efficacy|3|||
155669810|NCT01465386|561886508|FG000|Overall Study|Adverse Event|1|||
155596963|NCT04166591|561612189|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155596964|NCT04166591|561612190|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155596965|NCT03960021|561612191|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
155596966|NCT01936181|561612195|FG000|Randomised, Double-blind|Adverse Event|27|||
155596967|NCT01936181|561612196|FG001|Randomised, Double-blind|Adverse Event|21|||
155596968|NCT01936181|561612197|FG002|Randomised, Double-blind|Adverse Event|0|||
155596969|NCT01936181|561612198|FG003|Randomised, Double-blind|Adverse Event|0|||
155596970|NCT01936181|561612195|FG000|Randomised, Double-blind|Protocol Violation|1|||
155596971|NCT01936181|561612196|FG001|Randomised, Double-blind|Protocol Violation|5|||
155596972|NCT01936181|561612197|FG002|Randomised, Double-blind|Protocol Violation|0|||
155596973|NCT01936181|561612198|FG003|Randomised, Double-blind|Protocol Violation|0|||
155596974|NCT01936181|561612195|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
155596975|NCT01936181|561612196|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
155596976|NCT01936181|561612197|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
155596977|NCT01936181|561612198|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
155596978|NCT01936181|561612195|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
155596979|NCT01936181|561612196|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
155596980|NCT01936181|561612197|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
155596981|NCT01936181|561612198|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
155596982|NCT01936181|561612195|FG000|Randomised, Double-blind|Pregnancy|0|||
155596983|NCT01936181|561612196|FG001|Randomised, Double-blind|Pregnancy|1|||
155596984|NCT01936181|561612197|FG002|Randomised, Double-blind|Pregnancy|0|||
155596985|NCT01936181|561612198|FG003|Randomised, Double-blind|Pregnancy|0|||
155596986|NCT01936181|561612195|FG000|Randomised, Double-blind|Physician Decision|4|||
155596987|NCT01936181|561612196|FG001|Randomised, Double-blind|Physician Decision|4|||
155596988|NCT01936181|561612197|FG002|Randomised, Double-blind|Physician Decision|0|||
155596989|NCT01936181|561612198|FG003|Randomised, Double-blind|Physician Decision|0|||
155596990|NCT01936181|561612195|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
155596991|NCT01936181|561612196|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
155596992|NCT01936181|561612197|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
155596993|NCT01936181|561612198|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
155596994|NCT01936181|561612195|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
155596995|NCT01936181|561612196|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
155596996|NCT01936181|561612197|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
155596997|NCT01936181|561612198|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
155596998|NCT01936181|561612195|FG000|Transition-extension|Adverse Event|3|||
155596999|NCT01936181|561612196|FG001|Transition-extension|Adverse Event|0|||
155597000|NCT01936181|561612197|FG002|Transition-extension|Adverse Event|3|||
155597001|NCT01936181|561612198|FG003|Transition-extension|Adverse Event|1|||
155597002|NCT01936181|561612195|FG000|Transition-extension|Lost to Follow-up|3|||
155597003|NCT01936181|561612196|FG001|Transition-extension|Lost to Follow-up|0|||
155597004|NCT01936181|561612197|FG002|Transition-extension|Lost to Follow-up|1|||
155597005|NCT01936181|561612198|FG003|Transition-extension|Lost to Follow-up|2|||
155597006|NCT01936181|561612195|FG000|Transition-extension|Physician Decision|2|||
155597007|NCT01936181|561612196|FG001|Transition-extension|Physician Decision|0|||
155597008|NCT01936181|561612197|FG002|Transition-extension|Physician Decision|0|||
155597009|NCT01936181|561612198|FG003|Transition-extension|Physician Decision|1|||
155597010|NCT01936181|561612195|FG000|Transition-extension|Withdrawal by Subject|7|||
155597011|NCT01936181|561612196|FG001|Transition-extension|Withdrawal by Subject|0|||
155597012|NCT01936181|561612197|FG002|Transition-extension|Withdrawal by Subject|2|||
155597013|NCT01936181|561612198|FG003|Transition-extension|Withdrawal by Subject|1|||
155597014|NCT02086448|561612201|FG000|Overall Study|Withdrawal by Subject|1|||
155597015|NCT02086448|561612202|FG001|Overall Study|Withdrawal by Subject|0|||
155597016|NCT02086448|561612203|FG002|Overall Study|Withdrawal by Subject|0|||
155597017|NCT02086448|561612204|FG003|Overall Study|Withdrawal by Subject|2|||
155597018|NCT01730534|561612208|FG000|Overall Study|Withdrawal by Subject|97|||
155597019|NCT01730534|561612209|FG001|Overall Study|Withdrawal by Subject|127|||
155597020|NCT01730534|561612208|FG000|Overall Study|Lost to Follow-up|12|||
155597021|NCT01730534|561612209|FG001|Overall Study|Lost to Follow-up|18|||
155597022|NCT02980341|561612210|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155597023|NCT02980341|561612211|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155597024|NCT02980341|561612212|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
155597025|NCT02980341|561612213|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
155597026|NCT02980341|561612214|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155597027|NCT02980341|561612215|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155597028|NCT02980341|561612216|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155597029|NCT02980341|561612217|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155669811|NCT02479880|561886511|FG000|Overall Study|Study Terminated by Sponsor|13|||
155669812|NCT02479880|561886512|FG001|Overall Study|Study Terminated by Sponsor|12|||
155669813|NCT02479880|561886511|FG000|Overall Study|Pregnancy|0|||
155669814|NCT02479880|561886512|FG001|Overall Study|Pregnancy|1|||
155669815|NCT01279044|561886513|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
155669816|NCT01279044|561886514|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
155669817|NCT01279044|561886515|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
155669818|NCT01279044|561886513|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
155669819|NCT01279044|561886514|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
155669820|NCT01279044|561886515|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
155669821|NCT01279044|561886513|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
155669822|NCT01279044|561886514|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
155669823|NCT01279044|561886515|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
155669824|NCT02840253|561886518|FG000|Overall Study|Unsuccessful block|4|||
155669825|NCT03801928|561886521|FG000|Overall Study|Adverse Event|1|||
155669826|NCT03801928|561886522|FG001|Overall Study|Adverse Event|0|||
155669827|NCT03801928|561886523|FG002|Overall Study|Adverse Event|1|||
155669828|NCT03801928|561886524|FG003|Overall Study|Adverse Event|2|||
155669829|NCT03801928|561886525|FG004|Overall Study|Adverse Event|0|||
155669830|NCT03801928|561886526|FG005|Overall Study|Adverse Event|2|||
155669831|NCT03801928|561886521|FG000|Overall Study|Lack of Efficacy|0|||
155669832|NCT03801928|561886522|FG001|Overall Study|Lack of Efficacy|0|||
155669833|NCT03801928|561886523|FG002|Overall Study|Lack of Efficacy|1|||
155669834|NCT03801928|561886524|FG003|Overall Study|Lack of Efficacy|0|||
155669835|NCT03801928|561886525|FG004|Overall Study|Lack of Efficacy|0|||
155669836|NCT03801928|561886526|FG005|Overall Study|Lack of Efficacy|0|||
155669837|NCT03801928|561886521|FG000|Overall Study|Lost to Follow-up|5|||
155669838|NCT03801928|561886522|FG001|Overall Study|Lost to Follow-up|1|||
155669839|NCT03801928|561886523|FG002|Overall Study|Lost to Follow-up|1|||
155669840|NCT03801928|561886524|FG003|Overall Study|Lost to Follow-up|4|||
155669841|NCT03801928|561886525|FG004|Overall Study|Lost to Follow-up|4|||
155669842|NCT03801928|561886526|FG005|Overall Study|Lost to Follow-up|2|||
155669843|NCT03801928|561886521|FG000|Overall Study|Withdrawal by Subject|0|||
155669844|NCT03801928|561886522|FG001|Overall Study|Withdrawal by Subject|0|||
155669845|NCT03801928|561886523|FG002|Overall Study|Withdrawal by Subject|2|||
155669846|NCT03801928|561886524|FG003|Overall Study|Withdrawal by Subject|1|||
155669847|NCT03801928|561886525|FG004|Overall Study|Withdrawal by Subject|0|||
155669848|NCT03801928|561886526|FG005|Overall Study|Withdrawal by Subject|0|||
155669849|NCT03801928|561886521|FG000|Overall Study|Other|0|||
155669850|NCT03801928|561886522|FG001|Overall Study|Other|2|||
155669851|NCT03801928|561886523|FG002|Overall Study|Other|0|||
155669852|NCT03801928|561886524|FG003|Overall Study|Other|1|||
155669853|NCT03801928|561886525|FG004|Overall Study|Other|0|||
155669854|NCT03801928|561886526|FG005|Overall Study|Other|1|||
155669855|NCT03688919|561886527|FG000|Overall Study|Lost to Follow-up|2|||
155669856|NCT03688919|561886528|FG001|Overall Study|Lost to Follow-up|1|||
155597030|NCT02980341|561612218|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155597031|NCT02980341|561612219|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155597032|NCT02980341|561612220|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155597033|NCT02980341|561612210|FG000|Dose Escalation|Clinical progression|0|||
155597034|NCT02980341|561612211|FG001|Dose Escalation|Clinical progression|0|||
155597035|NCT02980341|561612212|FG002|Dose Escalation|Clinical progression|2|||
155597036|NCT02980341|561612213|FG003|Dose Escalation|Clinical progression|1|||
155597037|NCT02980341|561612214|FG004|Dose Escalation|Clinical progression|0|||
155597038|NCT02980341|561612215|FG005|Dose Escalation|Clinical progression|0|||
155597039|NCT02980341|561612216|FG006|Dose Escalation|Clinical progression|0|||
155597040|NCT02980341|561612217|FG007|Dose Escalation|Clinical progression|0|||
155597041|NCT02980341|561612218|FG008|Dose Escalation|Clinical progression|0|||
155597042|NCT02980341|561612219|FG009|Dose Escalation|Clinical progression|0|||
155597043|NCT02980341|561612220|FG010|Dose Escalation|Clinical progression|0|||
155597044|NCT02980341|561612210|FG000|Dose Escalation|Adverse Event|0|||
155597045|NCT02980341|561612211|FG001|Dose Escalation|Adverse Event|0|||
155597046|NCT02980341|561612212|FG002|Dose Escalation|Adverse Event|1|||
155597047|NCT02980341|561612213|FG003|Dose Escalation|Adverse Event|2|||
155669857|NCT03688919|561886527|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
155669858|NCT03688919|561886528|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
155597048|NCT02980341|561612214|FG004|Dose Escalation|Adverse Event|2|||
155597049|NCT02980341|561612215|FG005|Dose Escalation|Adverse Event|0|||
155597050|NCT02980341|561612216|FG006|Dose Escalation|Adverse Event|0|||
155597051|NCT02980341|561612217|FG007|Dose Escalation|Adverse Event|0|||
155669859|NCT00564733|561886529|FG000|Overall Study|Withdrawal by Subject|4|||
155669860|NCT00564733|561886529|FG000|Overall Study|Ineligible|5|||
155669861|NCT01484496|561886532|FG000|Period 1|Protocol Violation|3|||
155669862|NCT01484496|561886533|FG001|Period 1|Protocol Violation|4|||
155669863|NCT01484496|561886534|FG002|Period 1|Protocol Violation|0|||
155669864|NCT01484496|561886535|FG003|Period 1|Protocol Violation|0|||
155669865|NCT01484496|561886532|FG000|Period 1|Physician Decision|5|||
155669866|NCT01484496|561886533|FG001|Period 1|Physician Decision|1|||
155669867|NCT01484496|561886534|FG002|Period 1|Physician Decision|0|||
155669868|NCT01484496|561886535|FG003|Period 1|Physician Decision|0|||
155669869|NCT01484496|561886532|FG000|Period 1|Lack of Efficacy|10|||
155669870|NCT01484496|561886533|FG001|Period 1|Lack of Efficacy|15|||
155669871|NCT01484496|561886534|FG002|Period 1|Lack of Efficacy|0|||
155669872|NCT01484496|561886535|FG003|Period 1|Lack of Efficacy|0|||
155669873|NCT01484496|561886532|FG000|Period 1|Adverse Event|25|||
155669874|NCT01484496|561886533|FG001|Period 1|Adverse Event|40|||
155669875|NCT01484496|561886534|FG002|Period 1|Adverse Event|0|||
155669876|NCT01484496|561886535|FG003|Period 1|Adverse Event|0|||
155669877|NCT01484496|561886532|FG000|Period 1|Withdrawal by Subject|15|||
155669878|NCT01484496|561886533|FG001|Period 1|Withdrawal by Subject|12|||
155669879|NCT01484496|561886534|FG002|Period 1|Withdrawal by Subject|0|||
155669880|NCT01484496|561886535|FG003|Period 1|Withdrawal by Subject|0|||
155669881|NCT01484496|561886532|FG000|Period 1|Lost to Follow-up|2|||
155669882|NCT01484496|561886533|FG001|Period 1|Lost to Follow-up|6|||
155669883|NCT01484496|561886534|FG002|Period 1|Lost to Follow-up|0|||
155669884|NCT01484496|561886535|FG003|Period 1|Lost to Follow-up|0|||
155669885|NCT01484496|561886532|FG000|Period 1|Positive Pregnancy|1|||
155669886|NCT01484496|561886533|FG001|Period 1|Positive Pregnancy|6|||
155669887|NCT01484496|561886534|FG002|Period 1|Positive Pregnancy|0|||
155669888|NCT01484496|561886535|FG003|Period 1|Positive Pregnancy|0|||
155669889|NCT01484496|561886532|FG000|Period 1|Treatment Failure|3|||
155669890|NCT01484496|561886533|FG001|Period 1|Treatment Failure|6|||
155669891|NCT01484496|561886534|FG002|Period 1|Treatment Failure|0|||
155669892|NCT01484496|561886535|FG003|Period 1|Treatment Failure|0|||
155669893|NCT01484496|561886532|FG000|Period 1|Lack of Compliance|2|||
155669894|NCT01484496|561886533|FG001|Period 1|Lack of Compliance|1|||
155669895|NCT01484496|561886534|FG002|Period 1|Lack of Compliance|0|||
155669896|NCT01484496|561886535|FG003|Period 1|Lack of Compliance|0|||
155669897|NCT01484496|561886532|FG000|Period 1|Unable to Visit Site|0|||
155669898|NCT01484496|561886533|FG001|Period 1|Unable to Visit Site|2|||
155669899|NCT01484496|561886534|FG002|Period 1|Unable to Visit Site|0|||
155669900|NCT01484496|561886535|FG003|Period 1|Unable to Visit Site|0|||
155669901|NCT01484496|561886532|FG000|Period 2|Lack of Efficacy|0|||
155669902|NCT01484496|561886533|FG001|Period 2|Lack of Efficacy|0|||
155669903|NCT01484496|561886534|FG002|Period 2|Lack of Efficacy|1|||
155669904|NCT01484496|561886535|FG003|Period 2|Lack of Efficacy|3|||
155669905|NCT01484496|561886532|FG000|Period 2|Adverse Event|0|||
155669906|NCT01484496|561886533|FG001|Period 2|Adverse Event|0|||
155669907|NCT01484496|561886534|FG002|Period 2|Adverse Event|5|||
155669908|NCT01484496|561886535|FG003|Period 2|Adverse Event|13|||
155669909|NCT01484496|561886532|FG000|Period 2|Other|0|||
155669910|NCT01484496|561886533|FG001|Period 2|Other|0|||
155669911|NCT01484496|561886534|FG002|Period 2|Other|9|||
155669912|NCT01484496|561886535|FG003|Period 2|Other|6|||
155597052|NCT02980341|561612218|FG008|Dose Escalation|Adverse Event|0|||
155597053|NCT02980341|561612219|FG009|Dose Escalation|Adverse Event|0|||
155597054|NCT02980341|561612220|FG010|Dose Escalation|Adverse Event|0|||
155597055|NCT02980341|561612210|FG000|Dose Escalation|Withdrawal by Subject|0|||
155597056|NCT02980341|561612211|FG001|Dose Escalation|Withdrawal by Subject|0|||
155597057|NCT02980341|561612212|FG002|Dose Escalation|Withdrawal by Subject|1|||
155597058|NCT02980341|561612213|FG003|Dose Escalation|Withdrawal by Subject|0|||
155597059|NCT02980341|561612214|FG004|Dose Escalation|Withdrawal by Subject|0|||
155597060|NCT02980341|561612215|FG005|Dose Escalation|Withdrawal by Subject|0|||
155597061|NCT02980341|561612216|FG006|Dose Escalation|Withdrawal by Subject|0|||
155597062|NCT02980341|561612217|FG007|Dose Escalation|Withdrawal by Subject|0|||
155597063|NCT02980341|561612218|FG008|Dose Escalation|Withdrawal by Subject|0|||
155669913|NCT01456130|561886536|FG000|Overall Study|Adverse Event|4|||
155669914|NCT01456130|561886536|FG000|Overall Study|Voluntary Withdrawal|1|||
155669915|NCT01456130|561886536|FG000|Overall Study|Lack of Efficacy|4|||
155669916|NCT01456130|561886536|FG000|Overall Study|Other|1|||
155669917|NCT03369665|561886539|FG000|Overall Study|Adverse Event|3|||
155669918|NCT03369665|561886539|FG000|Overall Study|Lost to Follow-up|7|||
155669919|NCT03369665|561886539|FG000|Overall Study|Withdrawal by Subject|15|||
155669920|NCT03369665|561886539|FG000|Overall Study|Progression Disease|2|||
155669921|NCT03369665|561886539|FG000|Overall Study|Not classified|3|||
155669922|NCT02168101|561886540|FG000|Overall Study|Death|2|||
155669923|NCT02168101|561886541|FG001|Overall Study|Death|2|||
155597064|NCT02980341|561612219|FG009|Dose Escalation|Withdrawal by Subject|0|||
155669924|NCT02168101|561886542|FG002|Overall Study|Death|1|||
155669925|NCT01135459|561886546|FG000|Overall Study|Adverse Event|8|||
155669926|NCT01135459|561886547|FG001|Overall Study|Adverse Event|10|||
155669927|NCT01135459|561886546|FG000|Overall Study|Lack of Efficacy|3|||
155669928|NCT01135459|561886547|FG001|Overall Study|Lack of Efficacy|1|||
155669929|NCT01135459|561886546|FG000|Overall Study|Withdrawal by Subject|2|||
155669930|NCT01135459|561886547|FG001|Overall Study|Withdrawal by Subject|3|||
155597065|NCT02980341|561612220|FG010|Dose Escalation|Withdrawal by Subject|0|||
155597066|NCT02980341|561612210|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597067|NCT02980341|561612211|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597068|NCT02980341|561612212|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597069|NCT02980341|561612213|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
155597070|NCT02980341|561612214|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597071|NCT02980341|561612215|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597072|NCT02980341|561612216|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597073|NCT02980341|561612217|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597074|NCT02980341|561612218|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597075|NCT02980341|561612219|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597076|NCT02980341|561612220|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
155597077|NCT02980341|561612210|FG000|Dose Escalation|Due to investigator's decision|0|||
155597078|NCT02980341|561612211|FG001|Dose Escalation|Due to investigator's decision|0|||
155597079|NCT02980341|561612212|FG002|Dose Escalation|Due to investigator's decision|0|||
155597080|NCT02980341|561612213|FG003|Dose Escalation|Due to investigator's decision|0|||
155597081|NCT02980341|561612214|FG004|Dose Escalation|Due to investigator's decision|1|||
155597082|NCT02980341|561612215|FG005|Dose Escalation|Due to investigator's decision|0|||
155597083|NCT02980341|561612216|FG006|Dose Escalation|Due to investigator's decision|0|||
155597084|NCT02980341|561612217|FG007|Dose Escalation|Due to investigator's decision|0|||
155597085|NCT02980341|561612218|FG008|Dose Escalation|Due to investigator's decision|0|||
155597086|NCT02980341|561612219|FG009|Dose Escalation|Due to investigator's decision|0|||
155597087|NCT02980341|561612220|FG010|Dose Escalation|Due to investigator's decision|0|||
155597088|NCT02980341|561612210|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597089|NCT02980341|561612211|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597090|NCT02980341|561612212|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597091|NCT02980341|561612213|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597092|NCT02980341|561612214|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597093|NCT02980341|561612215|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
155597094|NCT02980341|561612216|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
155597095|NCT02980341|561612217|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597096|NCT02980341|561612218|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597097|NCT02980341|561612219|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597098|NCT02980341|561612220|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
155597099|NCT02980341|561612210|FG000|Dose Finding|Adverse Event|0|||
155597100|NCT02980341|561612211|FG001|Dose Finding|Adverse Event|0|||
155597101|NCT02980341|561612212|FG002|Dose Finding|Adverse Event|0|||
155597102|NCT02980341|561612213|FG003|Dose Finding|Adverse Event|0|||
155597103|NCT02980341|561612214|FG004|Dose Finding|Adverse Event|0|||
155597104|NCT02980341|561612215|FG005|Dose Finding|Adverse Event|3|||
155597105|NCT02980341|561612216|FG006|Dose Finding|Adverse Event|0|||
155597106|NCT02980341|561612217|FG007|Dose Finding|Adverse Event|0|||
155597107|NCT02980341|561612218|FG008|Dose Finding|Adverse Event|0|||
155597108|NCT02980341|561612219|FG009|Dose Finding|Adverse Event|0|||
155597109|NCT02980341|561612220|FG010|Dose Finding|Adverse Event|0|||
155597110|NCT02980341|561612210|FG000|Dose Finding|Withdrawal by Subject|0|||
155597111|NCT02980341|561612211|FG001|Dose Finding|Withdrawal by Subject|0|||
155597112|NCT02980341|561612212|FG002|Dose Finding|Withdrawal by Subject|0|||
155597113|NCT02980341|561612213|FG003|Dose Finding|Withdrawal by Subject|0|||
155597114|NCT02980341|561612214|FG004|Dose Finding|Withdrawal by Subject|0|||
155597115|NCT02980341|561612215|FG005|Dose Finding|Withdrawal by Subject|1|||
155597116|NCT02980341|561612216|FG006|Dose Finding|Withdrawal by Subject|1|||
155597117|NCT02980341|561612217|FG007|Dose Finding|Withdrawal by Subject|0|||
155597118|NCT02980341|561612218|FG008|Dose Finding|Withdrawal by Subject|0|||
155597119|NCT02980341|561612219|FG009|Dose Finding|Withdrawal by Subject|0|||
155597120|NCT02980341|561612220|FG010|Dose Finding|Withdrawal by Subject|0|||
155597121|NCT02980341|561612210|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597122|NCT02980341|561612211|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597123|NCT02980341|561612212|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597124|NCT02980341|561612213|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597125|NCT02980341|561612214|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597126|NCT02980341|561612215|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597127|NCT02980341|561612216|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155597128|NCT02980341|561612217|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
155597129|NCT02980341|561612218|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
155597130|NCT02980341|561612219|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
155597131|NCT02980341|561612220|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
155597132|NCT02980341|561612210|FG000|Dose Expansion|Clinical progression|0|||
155597133|NCT02980341|561612211|FG001|Dose Expansion|Clinical progression|0|||
155597134|NCT02980341|561612212|FG002|Dose Expansion|Clinical progression|0|||
155597135|NCT02980341|561612213|FG003|Dose Expansion|Clinical progression|0|||
155597136|NCT02980341|561612214|FG004|Dose Expansion|Clinical progression|0|||
155597137|NCT02980341|561612215|FG005|Dose Expansion|Clinical progression|0|||
155597138|NCT02980341|561612216|FG006|Dose Expansion|Clinical progression|0|||
155597139|NCT02980341|561612217|FG007|Dose Expansion|Clinical progression|4|||
155597140|NCT02980341|561612218|FG008|Dose Expansion|Clinical progression|3|||
155597141|NCT02980341|561612219|FG009|Dose Expansion|Clinical progression|1|||
155597142|NCT02980341|561612220|FG010|Dose Expansion|Clinical progression|4|||
155597143|NCT02980341|561612210|FG000|Dose Expansion|Adverse Event|0|||
155597144|NCT02980341|561612211|FG001|Dose Expansion|Adverse Event|0|||
155597145|NCT02980341|561612212|FG002|Dose Expansion|Adverse Event|0|||
155597146|NCT02980341|561612213|FG003|Dose Expansion|Adverse Event|0|||
155597147|NCT02980341|561612214|FG004|Dose Expansion|Adverse Event|0|||
155597148|NCT02980341|561612215|FG005|Dose Expansion|Adverse Event|0|||
155597149|NCT02980341|561612216|FG006|Dose Expansion|Adverse Event|0|||
155597150|NCT02980341|561612217|FG007|Dose Expansion|Adverse Event|3|||
155597151|NCT02980341|561612218|FG008|Dose Expansion|Adverse Event|0|||
155597152|NCT02980341|561612219|FG009|Dose Expansion|Adverse Event|1|||
155597153|NCT02980341|561612220|FG010|Dose Expansion|Adverse Event|3|||
155597154|NCT02980341|561612210|FG000|Dose Expansion|Death|0|||
155597155|NCT02980341|561612211|FG001|Dose Expansion|Death|0|||
155597156|NCT02980341|561612212|FG002|Dose Expansion|Death|0|||
155597157|NCT02980341|561612213|FG003|Dose Expansion|Death|0|||
155597158|NCT02980341|561612214|FG004|Dose Expansion|Death|0|||
155597159|NCT02980341|561612215|FG005|Dose Expansion|Death|0|||
155597160|NCT02980341|561612216|FG006|Dose Expansion|Death|0|||
155597161|NCT02980341|561612217|FG007|Dose Expansion|Death|0|||
155597162|NCT02980341|561612218|FG008|Dose Expansion|Death|2|||
155597163|NCT02980341|561612219|FG009|Dose Expansion|Death|1|||
155597164|NCT02980341|561612220|FG010|Dose Expansion|Death|0|||
155597165|NCT02980341|561612210|FG000|Dose Expansion|Withdrawal by Subject|0|||
155597166|NCT02980341|561612211|FG001|Dose Expansion|Withdrawal by Subject|0|||
155597167|NCT02980341|561612212|FG002|Dose Expansion|Withdrawal by Subject|0|||
155597168|NCT02980341|561612213|FG003|Dose Expansion|Withdrawal by Subject|0|||
155597169|NCT02980341|561612214|FG004|Dose Expansion|Withdrawal by Subject|0|||
155597170|NCT02980341|561612215|FG005|Dose Expansion|Withdrawal by Subject|0|||
155597171|NCT02980341|561612216|FG006|Dose Expansion|Withdrawal by Subject|0|||
155597172|NCT02980341|561612217|FG007|Dose Expansion|Withdrawal by Subject|2|||
155597173|NCT02980341|561612218|FG008|Dose Expansion|Withdrawal by Subject|0|||
155597174|NCT02980341|561612219|FG009|Dose Expansion|Withdrawal by Subject|1|||
155597175|NCT02980341|561612220|FG010|Dose Expansion|Withdrawal by Subject|0|||
155597176|NCT02980341|561612210|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597177|NCT02980341|561612211|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597178|NCT02980341|561612212|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597179|NCT02980341|561612213|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597180|NCT02980341|561612214|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597181|NCT02980341|561612215|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597182|NCT02980341|561612216|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597183|NCT02980341|561612217|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
155597184|NCT02980341|561612218|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597185|NCT02980341|561612219|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597186|NCT02980341|561612220|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155597187|NCT02980341|561612210|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597188|NCT02980341|561612211|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597189|NCT02980341|561612212|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597190|NCT02980341|561612213|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597191|NCT02980341|561612214|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597192|NCT02980341|561612215|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597193|NCT02980341|561612216|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597194|NCT02980341|561612217|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597195|NCT02980341|561612218|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
155597196|NCT02980341|561612219|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597197|NCT02980341|561612220|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155597198|NCT02980341|561612210|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597199|NCT02980341|561612211|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597200|NCT02980341|561612212|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597201|NCT02980341|561612213|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597202|NCT02980341|561612214|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597203|NCT02980341|561612215|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597204|NCT02980341|561612216|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597205|NCT02980341|561612217|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597206|NCT02980341|561612218|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
155597207|NCT02980341|561612219|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597208|NCT02980341|561612220|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155597209|NCT02980341|561612210|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597210|NCT02980341|561612211|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597211|NCT02980341|561612212|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597212|NCT02980341|561612213|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597213|NCT02980341|561612214|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597214|NCT02980341|561612215|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597215|NCT02980341|561612216|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597216|NCT02980341|561612217|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597217|NCT02980341|561612218|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597218|NCT02980341|561612219|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155597219|NCT02980341|561612220|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
155597220|NCT02004886|561612221|FG000|Overall Study|Adverse Event|0|||
155597221|NCT02004886|561612222|FG001|Overall Study|Adverse Event|1|||
155597222|NCT02004886|561612223|FG002|Overall Study|Adverse Event|0|||
155597223|NCT02004886|561612224|FG003|Overall Study|Adverse Event|0|||
155597224|NCT02004886|561612221|FG000|Overall Study|Unable to attend future visits|1|||
155597225|NCT02004886|561612222|FG001|Overall Study|Unable to attend future visits|0|||
155597226|NCT02004886|561612223|FG002|Overall Study|Unable to attend future visits|0|||
155597227|NCT02004886|561612224|FG003|Overall Study|Unable to attend future visits|0|||
155597228|NCT01895608|561612226|FG000|Overall Study|change in health status|0|||
155597229|NCT01895608|561612227|FG001|Overall Study|change in health status|1|||
155597230|NCT01895608|561612228|FG002|Overall Study|change in health status|1|||
155597231|NCT01895608|561612229|FG003|Overall Study|change in health status|0|||
155597232|NCT01895608|561612226|FG000|Overall Study|Withdrawal by Subject|0|||
155597233|NCT01895608|561612227|FG001|Overall Study|Withdrawal by Subject|0|||
155597234|NCT01895608|561612228|FG002|Overall Study|Withdrawal by Subject|2|||
155597235|NCT01895608|561612229|FG003|Overall Study|Withdrawal by Subject|0|||
155597236|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
155597237|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
155597238|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
155597239|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
155597240|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
155597241|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
155597242|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
155597243|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
155597244|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
155597245|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
155597246|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Death|1|||
155597247|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Death|0|||
155597248|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
155597249|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
155597250|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
155597251|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
155597252|NCT01876784|561612230|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
155597253|NCT01876784|561612231|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
155597254|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
155597255|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
155597256|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Adverse Event|2|||
155597257|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Adverse Event|6|||
155597258|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
155597259|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
155597260|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Progressive disease|4|||
155597261|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Progressive disease|35|||
155597262|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
155607039|NCT01897571|561649620|FG007|Overall Study|Enrolled in rollover study|9|||
155597263|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
155597264|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
155597265|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
155597266|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Death|0|||
155597267|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Death|1|||
155597268|NCT01876784|561612230|FG000|Open-label Period (31 Months)|Other than specified above|9|||
155597269|NCT01876784|561612231|FG001|Open-label Period (31 Months)|Other than specified above|18|||
155597270|NCT03505593|561612232|FG000|Overall Study|Withdrawal by Subject|1|||
155597271|NCT03505593|561612232|FG000|Overall Study|Died before procedure|1|||
155597272|NCT03505593|561612232|FG000|Overall Study|Anatomical abnormality|1|||
155597273|NCT03505593|561612232|FG000|Overall Study|Unable to pass through esophagus|1|||
155597274|NCT03505593|561612232|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
155597275|NCT01194531|561612233|FG000|Overall Study|Withdrawal by Subject|1|||
155597276|NCT01194531|561612234|FG001|Overall Study|Withdrawal by Subject|0|||
155597277|NCT01194531|561612233|FG000|Overall Study|Protocol Violation|4|||
155597278|NCT01194531|561612234|FG001|Overall Study|Protocol Violation|1|||
155597279|NCT01194531|561612233|FG000|Overall Study|Physician Decision|0|||
155597280|NCT01194531|561612234|FG001|Overall Study|Physician Decision|2|||
155597281|NCT02822573|561612235|FG000|Overall Study|Lost to Follow-up|5|||
155597282|NCT02822573|561612236|FG001|Overall Study|Lost to Follow-up|3|||
155597283|NCT02822573|561612235|FG000|Overall Study|Physician Decision|1|||
155597284|NCT02822573|561612236|FG001|Overall Study|Physician Decision|1|||
155597285|NCT02822573|561612235|FG000|Overall Study|Withdrawal by Subject|9|||
155597286|NCT02822573|561612236|FG001|Overall Study|Withdrawal by Subject|5|||
155597287|NCT02822573|561612235|FG000|Overall Study|Protocol Violation|6|||
155597288|NCT02822573|561612236|FG001|Overall Study|Protocol Violation|4|||
155597289|NCT02822573|561612235|FG000|Overall Study|Too sick or ill|2|||
155597290|NCT02822573|561612236|FG001|Overall Study|Too sick or ill|1|||
155597291|NCT02822573|561612235|FG000|Overall Study|Disease Progression|1|||
155597292|NCT02822573|561612236|FG001|Overall Study|Disease Progression|1|||
155597293|NCT02822573|561612235|FG000|Overall Study|No reason given|6|||
155597294|NCT02822573|561612236|FG001|Overall Study|No reason given|4|||
155597295|NCT05239494|561612237|FG000|Overall Study|Lost to Follow-up|1|||
155597296|NCT02892422|561612240|FG000|Overall Study|Enrolled not treated|4|||
155597297|NCT02892422|561612240|FG000|Overall Study|Adverse Event|38|||
155597298|NCT02892422|561612240|FG000|Overall Study|Lack of Efficacy|32|||
155597299|NCT02892422|561612240|FG000|Overall Study|Non-compliance with study drug|11|||
155597300|NCT02892422|561612240|FG000|Overall Study|Protocol Violation|4|||
155597301|NCT02892422|561612240|FG000|Overall Study|Withdrawal by Subject|56|||
155597302|NCT02892422|561612240|FG000|Overall Study|Lost to Follow-up|5|||
155597303|NCT02892422|561612240|FG000|Overall Study|sponsor information 16159A results|21|||
155597304|NCT02892422|561612240|FG000|Overall Study|withdrawal of consent|13|||
155597305|NCT02892422|561612240|FG000|Overall Study|exclusion criteria met|3|||
155597306|NCT02892422|561612240|FG000|Overall Study|moving elsewhere|4|||
155597307|NCT02892422|561612240|FG000|Overall Study|non-compliance|10|||
155597308|NCT02892422|561612240|FG000|Overall Study|patient legally incapable|1|||
155597309|NCT02892422|561612240|FG000|Overall Study|patient decision|7|||
155597310|NCT02892422|561612240|FG000|Overall Study|Investigator decision|1|||
155597311|NCT02855359|561612243|FG000|Overall Study|Death|2|||
155597312|NCT02855359|561612244|FG001|Overall Study|Death|2|||
155597313|NCT02855359|561612245|FG002|Overall Study|Death|0|||
155597314|NCT02855359|561612246|FG003|Overall Study|Death|0|||
155597315|NCT02855359|561612243|FG000|Overall Study|Study Termination by Sponsor|9|||
155597316|NCT02855359|561612244|FG001|Overall Study|Study Termination by Sponsor|11|||
155597317|NCT02855359|561612245|FG002|Overall Study|Study Termination by Sponsor|0|||
155597318|NCT02855359|561612246|FG003|Overall Study|Study Termination by Sponsor|0|||
155597319|NCT01023256|561612247|FG000|Overall Study|Protocol Violation|2|||
155597320|NCT01023256|561612248|FG001|Overall Study|Protocol Violation|3|||
155597321|NCT01023256|561612249|FG002|Overall Study|Protocol Violation|0|||
155597322|NCT01023256|561612250|FG003|Overall Study|Protocol Violation|0|||
155597323|NCT01023256|561612247|FG000|Overall Study|Randomized but not treated|1|||
155597324|NCT01023256|561612248|FG001|Overall Study|Randomized but not treated|0|||
155597325|NCT01023256|561612249|FG002|Overall Study|Randomized but not treated|1|||
155597326|NCT01023256|561612250|FG003|Overall Study|Randomized but not treated|0|||
155597327|NCT01023256|561612247|FG000|Overall Study|Other|1|||
155597328|NCT01023256|561612248|FG001|Overall Study|Other|0|||
155597329|NCT01023256|561612249|FG002|Overall Study|Other|0|||
155597330|NCT01023256|561612250|FG003|Overall Study|Other|2|||
155669931|NCT01135459|561886546|FG000|Overall Study|Protocol Violation|5|||
155669932|NCT01135459|561886547|FG001|Overall Study|Protocol Violation|3|||
155669933|NCT01135459|561886546|FG000|Overall Study|Lost to Follow-up|2|||
155669934|NCT01135459|561886547|FG001|Overall Study|Lost to Follow-up|1|||
155669935|NCT01135459|561886546|FG000|Overall Study|Non-compliance to study procedures|0|||
155669936|NCT01135459|561886547|FG001|Overall Study|Non-compliance to study procedures|1|||
155669937|NCT01135459|561886546|FG000|Overall Study|Other than specified|1|||
155597331|NCT01023256|561612247|FG000|Overall Study|Adverse Event|0|||
155597332|NCT01023256|561612248|FG001|Overall Study|Adverse Event|0|||
155597333|NCT01023256|561612249|FG002|Overall Study|Adverse Event|0|||
155597334|NCT01023256|561612250|FG003|Overall Study|Adverse Event|1|||
155597335|NCT01023256|561612247|FG000|Overall Study|Withdrawal by Subject|0|||
155597336|NCT01023256|561612248|FG001|Overall Study|Withdrawal by Subject|0|||
155597337|NCT01023256|561612249|FG002|Overall Study|Withdrawal by Subject|0|||
155669938|NCT01135459|561886547|FG001|Overall Study|Other than specified|1|||
155669939|NCT02236572|561886549|FG000|Overall Study|Withdrawal by Subject|1|||
155669940|NCT02236572|561886549|FG000|Overall Study|Protocol Violation|1|||
155669941|NCT02236572|561886549|FG000|Overall Study|Lost to Follow-up|1|||
155669942|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
155669943|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
155669944|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
155669945|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
155669946|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
155669947|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
155669948|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
155669949|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
155669950|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
155669951|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
155669952|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
155669953|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
155669954|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
155669955|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
155669956|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
155669957|NCT01057693|561886550|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
155669958|NCT01057693|561886551|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
155669959|NCT01057693|561886552|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
155669960|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
155669961|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
155669962|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
155669963|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
155669964|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
155669965|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
155669966|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
155669967|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
155669968|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
155669969|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
155669970|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
155669971|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
155669972|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
155669973|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
155669974|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
155669975|NCT01057693|561886550|FG000|Between Single-Blind and Double-Blind|Other|6|||
155669976|NCT01057693|561886551|FG001|Between Single-Blind and Double-Blind|Other|0|||
155669977|NCT01057693|561886552|FG002|Between Single-Blind and Double-Blind|Other|0|||
155669978|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
155669979|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
155669980|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
155669981|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
155669982|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
155669983|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
155669984|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
155669985|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
155597338|NCT01023256|561612250|FG003|Overall Study|Withdrawal by Subject|2|||
155597339|NCT00725608|561612253|FG000|Overall Study|Lost to Follow-up|60|||
155597340|NCT00725608|561612253|FG000|Overall Study|Adverse Event|14|||
155597341|NCT00725608|561612253|FG000|Overall Study|Individual reasons|86|||
155669986|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
155669987|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
155669988|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
155669989|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
155597342|NCT00725608|561612253|FG000|Overall Study|Other|7|||
155597343|NCT01154088|561612254|FG000|Overall Study|Lost to Follow-up|4|||
155597344|NCT01154088|561612255|FG001|Overall Study|Lost to Follow-up|6|||
155597345|NCT01154088|561612256|FG002|Overall Study|Lost to Follow-up|7|||
155597346|NCT01084668|561612257|FG000|Overall Study|Lack of Efficacy|5|||
155597347|NCT01084668|561612257|FG000|Overall Study|Withdrawal by Subject|2|||
155597348|NCT01084668|561612257|FG000|Overall Study|Pregnancy|1|||
155597349|NCT01084668|561612257|FG000|Overall Study|Non-compliance|1|||
155597350|NCT02447497|561612258|FG000|Overall Study|Did not meet treatment day baseline.|6|||
155597351|NCT02447497|561612259|FG001|Overall Study|Did not meet treatment day baseline.|5|||
155597352|NCT02447497|561612260|FG002|Overall Study|Did not meet treatment day baseline.|2|||
155597353|NCT02447497|561612261|FG003|Overall Study|Did not meet treatment day baseline.|2|||
155597354|NCT02447497|561612258|FG000|Overall Study|Dressing was compromised|0|||
155597355|NCT02447497|561612259|FG001|Overall Study|Dressing was compromised|1|||
155597356|NCT02447497|561612260|FG002|Overall Study|Dressing was compromised|0|||
155597357|NCT02447497|561612261|FG003|Overall Study|Dressing was compromised|0|||
155597358|NCT00985959|561612262|FG000|Overall Study|Adverse Event|0|||
155597359|NCT00985959|561612263|FG001|Overall Study|Adverse Event|0|||
155597360|NCT00985959|561612264|FG002|Overall Study|Adverse Event|19|||
155597361|NCT00985959|561612262|FG000|Overall Study|Withdrawal by Subject|0|||
155597362|NCT00985959|561612263|FG001|Overall Study|Withdrawal by Subject|0|||
155597363|NCT00985959|561612264|FG002|Overall Study|Withdrawal by Subject|8|||
155597364|NCT00985959|561612262|FG000|Overall Study|Progressive disease|1|||
155597365|NCT00985959|561612263|FG001|Overall Study|Progressive disease|2|||
155597366|NCT00985959|561612264|FG002|Overall Study|Progressive disease|8|||
155597367|NCT00985959|561612262|FG000|Overall Study|Unrecovered toxicity|0|||
155597368|NCT00985959|561612263|FG001|Overall Study|Unrecovered toxicity|0|||
155597369|NCT00985959|561612264|FG002|Overall Study|Unrecovered toxicity|7|||
155597370|NCT00985959|561612262|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
155597371|NCT00985959|561612263|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
155597372|NCT00985959|561612264|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
155597373|NCT00985959|561612262|FG000|Overall Study|Complete response observed over 2 cycles|0|||
155597374|NCT00985959|561612263|FG001|Overall Study|Complete response observed over 2 cycles|1|||
155597375|NCT00985959|561612264|FG002|Overall Study|Complete response observed over 2 cycles|4|||
155597376|NCT00985959|561612262|FG000|Overall Study|Other|0|||
155597377|NCT00985959|561612263|FG001|Overall Study|Other|0|||
155597378|NCT00985959|561612264|FG002|Overall Study|Other|11|||
155597379|NCT01295827|561612277|FG000|Overall Study|Adverse Event|1|||
155597380|NCT01295827|561612278|FG001|Overall Study|Adverse Event|2|||
155597381|NCT01295827|561612279|FG002|Overall Study|Adverse Event|2|||
155597382|NCT01295827|561612280|FG003|Overall Study|Adverse Event|1|||
155597383|NCT01295827|561612281|FG004|Overall Study|Adverse Event|1|||
155597384|NCT01295827|561612282|FG005|Overall Study|Adverse Event|4|||
155597385|NCT01295827|561612283|FG006|Overall Study|Adverse Event|15|||
155597386|NCT01295827|561612284|FG007|Overall Study|Adverse Event|49|||
155597387|NCT01295827|561612285|FG008|Overall Study|Adverse Event|22|||
155597388|NCT01295827|561612286|FG009|Overall Study|Adverse Event|7|||
155597389|NCT01295827|561612287|FG010|Overall Study|Adverse Event|50|||
155597390|NCT01295827|561612288|FG011|Overall Study|Adverse Event|21|||
155597391|NCT01295827|561612289|FG012|Overall Study|Adverse Event|0|||
155597392|NCT01295827|561612290|FG013|Overall Study|Adverse Event|0|||
155597393|NCT01295827|561612291|FG014|Overall Study|Adverse Event|0|||
155597394|NCT01295827|561612277|FG000|Overall Study|Lost to Follow-up|0|||
155597395|NCT01295827|561612278|FG001|Overall Study|Lost to Follow-up|0|||
155597396|NCT01295827|561612279|FG002|Overall Study|Lost to Follow-up|3|||
155597397|NCT01295827|561612280|FG003|Overall Study|Lost to Follow-up|0|||
155597398|NCT01295827|561612281|FG004|Overall Study|Lost to Follow-up|1|||
155597399|NCT01295827|561612282|FG005|Overall Study|Lost to Follow-up|0|||
155597400|NCT01295827|561612283|FG006|Overall Study|Lost to Follow-up|4|||
155597401|NCT01295827|561612284|FG007|Overall Study|Lost to Follow-up|8|||
155597402|NCT01295827|561612285|FG008|Overall Study|Lost to Follow-up|7|||
155597403|NCT01295827|561612286|FG009|Overall Study|Lost to Follow-up|4|||
155597404|NCT01295827|561612287|FG010|Overall Study|Lost to Follow-up|7|||
155597405|NCT01295827|561612288|FG011|Overall Study|Lost to Follow-up|3|||
155597406|NCT01295827|561612289|FG012|Overall Study|Lost to Follow-up|0|||
155597407|NCT01295827|561612290|FG013|Overall Study|Lost to Follow-up|0|||
155597408|NCT01295827|561612291|FG014|Overall Study|Lost to Follow-up|0|||
155597409|NCT01295827|561612277|FG000|Overall Study|Not Reported|0|||
155597410|NCT01295827|561612278|FG001|Overall Study|Not Reported|0|||
155597411|NCT01295827|561612279|FG002|Overall Study|Not Reported|0|||
155597412|NCT01295827|561612280|FG003|Overall Study|Not Reported|1|||
155597413|NCT01295827|561612281|FG004|Overall Study|Not Reported|0|||
155597414|NCT01295827|561612282|FG005|Overall Study|Not Reported|0|||
155597415|NCT01295827|561612283|FG006|Overall Study|Not Reported|24|||
155597416|NCT01295827|561612284|FG007|Overall Study|Not Reported|58|||
155597417|NCT01295827|561612285|FG008|Overall Study|Not Reported|41|||
155597418|NCT01295827|561612286|FG009|Overall Study|Not Reported|2|||
155597419|NCT01295827|561612287|FG010|Overall Study|Not Reported|23|||
155597420|NCT01295827|561612288|FG011|Overall Study|Not Reported|13|||
155597421|NCT01295827|561612289|FG012|Overall Study|Not Reported|0|||
155597422|NCT01295827|561612290|FG013|Overall Study|Not Reported|0|||
155597423|NCT01295827|561612291|FG014|Overall Study|Not Reported|0|||
155597424|NCT01295827|561612277|FG000|Overall Study|Progressive Disease|2|||
155597425|NCT01295827|561612278|FG001|Overall Study|Progressive Disease|1|||
155597426|NCT01295827|561612279|FG002|Overall Study|Progressive Disease|5|||
155597427|NCT01295827|561612280|FG003|Overall Study|Progressive Disease|2|||
155597428|NCT01295827|561612281|FG004|Overall Study|Progressive Disease|0|||
155597429|NCT01295827|561612282|FG005|Overall Study|Progressive Disease|1|||
155597430|NCT01295827|561612283|FG006|Overall Study|Progressive Disease|87|||
155597431|NCT01295827|561612284|FG007|Overall Study|Progressive Disease|144|||
155597432|NCT01295827|561612285|FG008|Overall Study|Progressive Disease|85|||
155597433|NCT01295827|561612286|FG009|Overall Study|Progressive Disease|40|||
155597434|NCT01295827|561612287|FG010|Overall Study|Progressive Disease|175|||
155597435|NCT01295827|561612288|FG011|Overall Study|Progressive Disease|136|||
155597436|NCT01295827|561612289|FG012|Overall Study|Progressive Disease|0|||
155597437|NCT01295827|561612290|FG013|Overall Study|Progressive Disease|0|||
155597438|NCT01295827|561612291|FG014|Overall Study|Progressive Disease|0|||
155597439|NCT01295827|561612277|FG000|Overall Study|Screen Failure|0|||
155597440|NCT01295827|561612278|FG001|Overall Study|Screen Failure|0|||
155597441|NCT01295827|561612279|FG002|Overall Study|Screen Failure|0|||
155597442|NCT01295827|561612280|FG003|Overall Study|Screen Failure|0|||
155597443|NCT01295827|561612281|FG004|Overall Study|Screen Failure|0|||
155597444|NCT01295827|561612282|FG005|Overall Study|Screen Failure|0|||
155597445|NCT01295827|561612283|FG006|Overall Study|Screen Failure|2|||
155597446|NCT01295827|561612284|FG007|Overall Study|Screen Failure|2|||
155597447|NCT01295827|561612285|FG008|Overall Study|Screen Failure|2|||
155597448|NCT01295827|561612286|FG009|Overall Study|Screen Failure|0|||
155597449|NCT01295827|561612287|FG010|Overall Study|Screen Failure|1|||
155597450|NCT01295827|561612288|FG011|Overall Study|Screen Failure|0|||
155597451|NCT01295827|561612289|FG012|Overall Study|Screen Failure|0|||
155597452|NCT01295827|561612290|FG013|Overall Study|Screen Failure|0|||
155597453|NCT01295827|561612291|FG014|Overall Study|Screen Failure|0|||
155597454|NCT01295827|561612277|FG000|Overall Study|Withdrawal by Subject|1|||
155597455|NCT01295827|561612278|FG001|Overall Study|Withdrawal by Subject|0|||
155597456|NCT01295827|561612279|FG002|Overall Study|Withdrawal by Subject|2|||
155597457|NCT01295827|561612280|FG003|Overall Study|Withdrawal by Subject|0|||
155597458|NCT01295827|561612281|FG004|Overall Study|Withdrawal by Subject|0|||
155597459|NCT01295827|561612282|FG005|Overall Study|Withdrawal by Subject|1|||
155597460|NCT01295827|561612283|FG006|Overall Study|Withdrawal by Subject|13|||
155597461|NCT01295827|561612284|FG007|Overall Study|Withdrawal by Subject|35|||
155597462|NCT01295827|561612285|FG008|Overall Study|Withdrawal by Subject|11|||
155597463|NCT01295827|561612286|FG009|Overall Study|Withdrawal by Subject|2|||
155597464|NCT01295827|561612287|FG010|Overall Study|Withdrawal by Subject|18|||
155597465|NCT01295827|561612288|FG011|Overall Study|Withdrawal by Subject|13|||
155597466|NCT01295827|561612289|FG012|Overall Study|Withdrawal by Subject|0|||
155597467|NCT01295827|561612290|FG013|Overall Study|Withdrawal by Subject|0|||
155597468|NCT01295827|561612291|FG014|Overall Study|Withdrawal by Subject|0|||
155597469|NCT01295827|561612277|FG000|Overall Study|Other|0|||
155597470|NCT01295827|561612278|FG001|Overall Study|Other|0|||
155597471|NCT01295827|561612279|FG002|Overall Study|Other|0|||
155597472|NCT01295827|561612280|FG003|Overall Study|Other|0|||
155597473|NCT01295827|561612281|FG004|Overall Study|Other|0|||
155597474|NCT01295827|561612282|FG005|Overall Study|Other|0|||
155597475|NCT01295827|561612283|FG006|Overall Study|Other|1|||
155597476|NCT01295827|561612284|FG007|Overall Study|Other|1|||
155597477|NCT01295827|561612285|FG008|Overall Study|Other|1|||
155597478|NCT01295827|561612286|FG009|Overall Study|Other|0|||
155597479|NCT01295827|561612287|FG010|Overall Study|Other|2|||
155597480|NCT01295827|561612288|FG011|Overall Study|Other|0|||
155597481|NCT01295827|561612289|FG012|Overall Study|Other|0|||
155597482|NCT01295827|561612290|FG013|Overall Study|Other|0|||
155597483|NCT01295827|561612291|FG014|Overall Study|Other|0|||
155597484|NCT00022698|561612292|FG000|Overall Study|Adverse Event|5|||
155597485|NCT00022698|561612293|FG001|Overall Study|Adverse Event|9|||
155597486|NCT00022698|561612292|FG000|Overall Study|Death|0|||
155597487|NCT00022698|561612293|FG001|Overall Study|Death|2|||
155597488|NCT00022698|561612292|FG000|Overall Study|Failure to return|0|||
155597489|NCT00022698|561612293|FG001|Overall Study|Failure to return|1|||
155597490|NCT00022698|561612292|FG000|Overall Study|Refused treatment|0|||
155597491|NCT00022698|561612293|FG001|Overall Study|Refused treatment|2|||
155597492|NCT00022698|561612292|FG000|Overall Study|Insufficient therapeutic response|2|||
155597493|NCT00022698|561612293|FG001|Overall Study|Insufficient therapeutic response|14|||
155597494|NCT00022698|561612292|FG000|Overall Study|Administrative /other|1|||
155597495|NCT00022698|561612293|FG001|Overall Study|Administrative /other|7|||
155597496|NCT01217476|561612298|FG000|Overall Study|Adverse Event|6|||
155597497|NCT01217476|561612299|FG001|Overall Study|Adverse Event|1|||
155597498|NCT01217476|561612298|FG000|Overall Study|Physician Decision|0|||
155597499|NCT01217476|561612299|FG001|Overall Study|Physician Decision|1|||
155597500|NCT01217476|561612298|FG000|Overall Study|Withdrawal by Subject|3|||
155597501|NCT01217476|561612299|FG001|Overall Study|Withdrawal by Subject|3|||
155597502|NCT01217476|561612298|FG000|Overall Study|Surgery on the Target Limb|0|||
155597503|NCT01217476|561612299|FG001|Overall Study|Surgery on the Target Limb|2|||
155597504|NCT01217476|561612298|FG000|Overall Study|Protocol Deviation|1|||
155597505|NCT01217476|561612299|FG001|Overall Study|Protocol Deviation|0|||
155597506|NCT01217476|561612298|FG000|Overall Study|Other|2|||
155597507|NCT01217476|561612299|FG001|Overall Study|Other|0|||
155597508|NCT00813813|561612302|FG000|Overall Study|Withdrawal by Subject|1|||
155597509|NCT00813813|561612303|FG001|Overall Study|Withdrawal by Subject|1|||
155597510|NCT00813813|561612302|FG000|Overall Study|Lost to Follow-up|2|||
155597511|NCT00813813|561612303|FG001|Overall Study|Lost to Follow-up|7|||
155597512|NCT00813813|561612302|FG000|Overall Study|Other|0|||
155597513|NCT00813813|561612303|FG001|Overall Study|Other|1|||
155597514|NCT00986921|561612304|FG000|Overall Study|Physician Decision|1|||
155597515|NCT00986921|561612305|FG001|Overall Study|Physician Decision|0|||
155597516|NCT02396420|561612308|FG000|Overall Study|Death|1|||
155597517|NCT01273623|561612314|FG000|Overall Study|did not meet IVUS criteria|29|||
155597518|NCT01493284|561612315|FG000|Overall Study|Death|29|||
155597519|NCT01493284|561612315|FG000|Overall Study|Withdrawal by Subject|32|||
155597520|NCT00325156|561612318|FG000|Overall Study|Protocol Violation|8|||
155597521|NCT00325156|561612318|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
155597522|NCT00325156|561612318|FG000|Overall Study|Migrated/moved from study area|12|||
155597523|NCT00325156|561612318|FG000|Overall Study|Adverse event, non-fatal|3|||
155597524|NCT00325156|561612318|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
155597525|NCT00325156|561612318|FG000|Overall Study|Other|1|||
155597526|NCT00325156|561612318|FG000|Overall Study|Withdrawal by Subject|31|||
155597527|NCT03489707|561612319|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
155597528|NCT03489707|561612320|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
155597529|NCT03489707|561612319|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
155597530|NCT03489707|561612320|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
155597531|NCT03030989|561614411|FG000|Overall Study|Fever|2|||
155597532|NCT03030989|561614412|FG001|Overall Study|Fever|2|||
155597533|NCT03030989|561614411|FG000|Overall Study|Rash|2|||
155597534|NCT03030989|561614412|FG001|Overall Study|Rash|1|||
155597535|NCT03030989|561614411|FG000|Overall Study|Fatigue/Overwhelmed|1|||
155597536|NCT03030989|561614412|FG001|Overall Study|Fatigue/Overwhelmed|5|||
155597537|NCT03030989|561614411|FG000|Overall Study|Positive Blood Cultures|2|||
155597538|NCT03030989|561614412|FG001|Overall Study|Positive Blood Cultures|1|||
155597539|NCT03030989|561614411|FG000|Overall Study|Line Removed|0|||
155597540|NCT03030989|561614412|FG001|Overall Study|Line Removed|2|||
155597541|NCT03030989|561614411|FG000|Overall Study|No longer interested|5|||
155597542|NCT03030989|561614412|FG001|Overall Study|No longer interested|3|||
155597543|NCT02730377|561614413|FG000|Overall Study|Other|5|||
155597544|NCT02730377|561614414|FG001|Overall Study|Other|4|||
155597545|NCT02730377|561614413|FG000|Overall Study|Death|1|||
155597546|NCT02730377|561614414|FG001|Overall Study|Death|8|||
155597547|NCT02730377|561614413|FG000|Overall Study|Inadequate glycaemic control|368|||
155597548|NCT02730377|561614414|FG001|Overall Study|Inadequate glycaemic control|473|||
155597549|NCT02730377|561614413|FG000|Overall Study|Adverse Event|79|||
155597550|NCT02730377|561614414|FG001|Overall Study|Adverse Event|41|||
155597551|NCT02730377|561614413|FG000|Overall Study|Protocol Violation|23|||
155597552|NCT02730377|561614414|FG001|Overall Study|Protocol Violation|30|||
155597553|NCT02730377|561614413|FG000|Overall Study|Lack of Efficacy|4|||
155597554|NCT02730377|561614414|FG001|Overall Study|Lack of Efficacy|13|||
155597555|NCT02730377|561614413|FG000|Overall Study|Pregnancy|0|||
155597556|NCT02730377|561614414|FG001|Overall Study|Pregnancy|1|||
155597557|NCT02730377|561614413|FG000|Overall Study|Withdrawal by Subject|45|||
155597558|NCT02730377|561614414|FG001|Overall Study|Withdrawal by Subject|42|||
155597559|NCT02730377|561614413|FG000|Overall Study|Lost to Follow-up|25|||
155597560|NCT02730377|561614414|FG001|Overall Study|Lost to Follow-up|21|||
155597561|NCT03917472|561614415|FG000|Overall Study|Physician Decision|4|||
155597562|NCT03917472|561614416|FG001|Overall Study|Physician Decision|0|||
155669990|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
155669991|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
155669992|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
155669993|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
155669994|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
155669995|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
155669996|NCT01057693|561886550|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
155669997|NCT01057693|561886551|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
155669998|NCT01057693|561886552|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
155669999|NCT02959463|561886553|FG000|Overall Study|Adverse Event|1|||
155670000|NCT02959463|561886554|FG001|Overall Study|Adverse Event|1|||
155670001|NCT02959463|561886553|FG000|Overall Study|Death|1|||
155670002|NCT02959463|561886554|FG001|Overall Study|Death|0|||
155670003|NCT02959463|561886553|FG000|Overall Study|Withdrawal by Subject|1|||
155670004|NCT02959463|561886554|FG001|Overall Study|Withdrawal by Subject|0|||
155670005|NCT02413996|561886555|FG000|Overall Study|not comfortable with the intervention|9|||
155670006|NCT02413996|561886556|FG001|Overall Study|not comfortable with the intervention|2|||
155670007|NCT00709319|561886557|FG000|Overall Study|Death|4|||
155670008|NCT00709319|561886557|FG000|Overall Study|Withdrawal by Subject|2|||
155670009|NCT00579553|561886561|FG000|Overall Study|Lost to Follow-up|16|||
155670010|NCT00579553|561886562|FG001|Overall Study|Lost to Follow-up|13|||
155670011|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
155670012|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
155670013|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
155670014|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
155670015|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
155670016|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
155670017|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
155670018|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
155670019|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
155670020|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
155670021|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
155670022|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
155670023|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
155670024|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
155670025|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
155670026|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
155670027|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
155670028|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
155670029|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
155670030|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
155670031|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
155670032|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
155670033|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
155670034|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
155670035|NCT01672879|561886563|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
155670036|NCT01672879|561886564|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
155597563|NCT03917472|561614415|FG000|Overall Study|Adverse Event|3|||
155597564|NCT03917472|561614416|FG001|Overall Study|Adverse Event|1|||
155597565|NCT03917472|561614415|FG000|Overall Study|Death|7|||
155597566|NCT03917472|561614416|FG001|Overall Study|Death|5|||
155597567|NCT03917472|561614415|FG000|Overall Study|Withdrawal by Subject|11|||
155597568|NCT03917472|561614416|FG001|Overall Study|Withdrawal by Subject|4|||
155597569|NCT03917472|561614415|FG000|Overall Study|Lost to Follow-up|10|||
155597570|NCT03917472|561614416|FG001|Overall Study|Lost to Follow-up|5|||
155597571|NCT02706886|561614417|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
155597572|NCT02706886|561614418|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
155597573|NCT02706886|561614419|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
155597574|NCT02706886|561614420|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
155597575|NCT02706886|561614421|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
155597576|NCT02706886|561614422|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
155597577|NCT02706886|561614423|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
155597578|NCT02706886|561614424|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
155597579|NCT02706886|561614425|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
155597580|NCT01154296|561614426|FG000|Randomization and Intervention|Decided to decline|1|||
155597581|NCT01154296|561614427|FG001|Randomization and Intervention|Decided to decline|1|||
155670037|NCT01672879|561886565|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
155670038|NCT01672879|561886563|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
155670039|NCT01672879|561886564|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
155670040|NCT01672879|561886565|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
155670041|NCT01672879|561886563|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
155597582|NCT01154296|561614426|FG000|Randomization and Intervention|Declined by staff|1|||
155597583|NCT01154296|561614427|FG001|Randomization and Intervention|Declined by staff|0|||
155597584|NCT01154296|561614426|FG000|Randomization and Intervention|Did not return|1|||
155597585|NCT01154296|561614427|FG001|Randomization and Intervention|Did not return|0|||
155597586|NCT01154296|561614426|FG000|Randomization and Intervention|Left before test|0|||
155597587|NCT01154296|561614427|FG001|Randomization and Intervention|Left before test|1|||
155597588|NCT01154296|561614426|FG000|Randomization and Intervention|Left clinic early|2|||
155597589|NCT01154296|561614427|FG001|Randomization and Intervention|Left clinic early|0|||
155597590|NCT01154296|561614426|FG000|6-month Follow-up|Lost contact|269|||
155597591|NCT01154296|561614427|FG001|6-month Follow-up|Lost contact|275|||
155597592|NCT01154296|561614426|FG000|6-month Follow-up|Incarcerated|37|||
155597593|NCT01154296|561614427|FG001|6-month Follow-up|Incarcerated|32|||
155597594|NCT01154296|561614426|FG000|6-month Follow-up|Withdrew consent|14|||
155597595|NCT01154296|561614427|FG001|6-month Follow-up|Withdrew consent|15|||
155597596|NCT01154296|561614426|FG000|6-month Follow-up|Death|3|||
155597597|NCT01154296|561614427|FG001|6-month Follow-up|Death|2|||
155597598|NCT01154296|561614426|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
155597599|NCT01154296|561614427|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
155597600|NCT02203851|561614428|FG000|Overall Study|Lost to Follow-up|4|||
155597601|NCT02203851|561614428|FG000|Overall Study|Withdrawal by Subject|6|||
155597602|NCT02203851|561614428|FG000|Overall Study|Other|1|||
155597603|NCT04934189|561614429|FG000|Overall Study|Lost to Follow-up|4|||
155597604|NCT04934189|561614429|FG000|Overall Study|Withdrawal by Subject|17|||
155597605|NCT03320850|561614432|FG000|Overall Study|Lost to Follow-up|0|||
155597606|NCT03320850|561614433|FG001|Overall Study|Lost to Follow-up|0|||
155597607|NCT03320850|561614434|FG002|Overall Study|Lost to Follow-up|0|||
155597608|NCT03320850|561614435|FG003|Overall Study|Lost to Follow-up|0|||
155597609|NCT03320850|561614436|FG004|Overall Study|Lost to Follow-up|1|||
155597610|NCT03320850|561614437|FG005|Overall Study|Lost to Follow-up|2|||
155597611|NCT03320850|561614438|FG006|Overall Study|Lost to Follow-up|2|||
155597612|NCT03320850|561614439|FG007|Overall Study|Lost to Follow-up|0|||
155597613|NCT03320850|561614440|FG008|Overall Study|Lost to Follow-up|6|||
155597614|NCT03320850|561614441|FG009|Overall Study|Lost to Follow-up|4|||
155597615|NCT03320850|561614432|FG000|Overall Study|Withdrawal by Subject|0|||
155597616|NCT03320850|561614433|FG001|Overall Study|Withdrawal by Subject|0|||
155597617|NCT03320850|561614434|FG002|Overall Study|Withdrawal by Subject|0|||
155597618|NCT03320850|561614435|FG003|Overall Study|Withdrawal by Subject|0|||
155597619|NCT03320850|561614436|FG004|Overall Study|Withdrawal by Subject|1|||
155597620|NCT03320850|561614437|FG005|Overall Study|Withdrawal by Subject|2|||
155597621|NCT03320850|561614438|FG006|Overall Study|Withdrawal by Subject|4|||
155597622|NCT03320850|561614439|FG007|Overall Study|Withdrawal by Subject|5|||
155597623|NCT03320850|561614440|FG008|Overall Study|Withdrawal by Subject|2|||
155597624|NCT03320850|561614441|FG009|Overall Study|Withdrawal by Subject|1|||
155597625|NCT03320850|561614432|FG000|Overall Study|Lack of Efficacy|0|||
155597626|NCT03320850|561614433|FG001|Overall Study|Lack of Efficacy|0|||
155597627|NCT03320850|561614434|FG002|Overall Study|Lack of Efficacy|0|||
155597628|NCT03320850|561614435|FG003|Overall Study|Lack of Efficacy|1|||
155597629|NCT03320850|561614436|FG004|Overall Study|Lack of Efficacy|0|||
155597630|NCT03320850|561614437|FG005|Overall Study|Lack of Efficacy|1|||
155597631|NCT03320850|561614438|FG006|Overall Study|Lack of Efficacy|0|||
155597632|NCT03320850|561614439|FG007|Overall Study|Lack of Efficacy|2|||
155597633|NCT03320850|561614440|FG008|Overall Study|Lack of Efficacy|0|||
155597634|NCT03320850|561614441|FG009|Overall Study|Lack of Efficacy|3|||
155597635|NCT03320850|561614432|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155597636|NCT03320850|561614433|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155597637|NCT03320850|561614434|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155597638|NCT03320850|561614435|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
155597639|NCT03320850|561614436|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
155597640|NCT03320850|561614437|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
155597641|NCT03320850|561614438|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
155597642|NCT03320850|561614439|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
155597643|NCT03320850|561614440|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
155597644|NCT03320850|561614441|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
155597645|NCT03320850|561614432|FG000|Overall Study|Adverse Event|0|||
155597646|NCT03320850|561614433|FG001|Overall Study|Adverse Event|0|||
155597647|NCT03320850|561614434|FG002|Overall Study|Adverse Event|0|||
155597648|NCT03320850|561614435|FG003|Overall Study|Adverse Event|0|||
155597649|NCT03320850|561614436|FG004|Overall Study|Adverse Event|0|||
155597650|NCT03320850|561614437|FG005|Overall Study|Adverse Event|2|||
155597651|NCT03320850|561614438|FG006|Overall Study|Adverse Event|1|||
155597652|NCT03320850|561614439|FG007|Overall Study|Adverse Event|0|||
155597653|NCT03320850|561614440|FG008|Overall Study|Adverse Event|2|||
155597654|NCT03320850|561614441|FG009|Overall Study|Adverse Event|0|||
155597655|NCT03320850|561614432|FG000|Overall Study|Reason Not Specified|0|||
155597656|NCT03320850|561614433|FG001|Overall Study|Reason Not Specified|0|||
155597657|NCT03320850|561614434|FG002|Overall Study|Reason Not Specified|0|||
155597658|NCT03320850|561614435|FG003|Overall Study|Reason Not Specified|0|||
155597659|NCT03320850|561614436|FG004|Overall Study|Reason Not Specified|0|||
155597660|NCT03320850|561614437|FG005|Overall Study|Reason Not Specified|1|||
155597661|NCT03320850|561614438|FG006|Overall Study|Reason Not Specified|0|||
155597662|NCT03320850|561614439|FG007|Overall Study|Reason Not Specified|0|||
155597663|NCT03320850|561614440|FG008|Overall Study|Reason Not Specified|0|||
155597664|NCT03320850|561614441|FG009|Overall Study|Reason Not Specified|1|||
155597665|NCT01871402|561614451|FG000|Overall Study|Lost to Follow-up|1|||
155597666|NCT01871402|561614452|FG001|Overall Study|Lost to Follow-up|0|||
155597667|NCT01871402|561614451|FG000|Overall Study|Withdrawal by Subject|0|||
155597668|NCT01871402|561614452|FG001|Overall Study|Withdrawal by Subject|2|||
155597669|NCT01871402|561614451|FG000|Overall Study|Non-compliance|0|||
155597670|NCT01871402|561614452|FG001|Overall Study|Non-compliance|1|||
155597671|NCT04594941|561614453|FG000|Overall Study|Other|0|||
155597672|NCT04594941|561614454|FG001|Overall Study|Other|3|||
155597673|NCT04594941|561614455|FG002|Overall Study|Other|1|||
155597674|NCT04594941|561614456|FG003|Overall Study|Other|0|||
155597675|NCT00231114|561614457|FG000|Randomized|Withdrawal by Subject|6|||
155597676|NCT00231114|561614458|FG001|Randomized|Withdrawal by Subject|3|||
155597677|NCT00231114|561614457|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
155597678|NCT00231114|561614458|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
155597679|NCT00231114|561614457|FG000|Post-Treatment Period|Lost to Follow-up|6|||
155597680|NCT00231114|561614458|FG001|Post-Treatment Period|Lost to Follow-up|1|||
155597681|NCT00231114|561614457|FG000|Post-Treatment Period|Physician Decision|1|||
155597682|NCT00231114|561614458|FG001|Post-Treatment Period|Physician Decision|0|||
155597683|NCT00231114|561614457|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
155597684|NCT00231114|561614458|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
155597685|NCT02031640|561614460|FG000|Screening Period|Adverse Event|1|||
155597686|NCT02031640|561614461|FG001|Screening Period|Adverse Event|0|||
155597687|NCT02031640|561614462|FG002|Screening Period|Adverse Event|0|||
155597688|NCT02031640|561614463|FG003|Screening Period|Adverse Event|0|||
155597689|NCT02031640|561614464|FG004|Screening Period|Adverse Event|0|||
155597690|NCT02031640|561614465|FG005|Screening Period|Adverse Event|0|||
155597691|NCT02031640|561614460|FG000|Screening Period|Withdrawal by Subject|29|||
155597692|NCT02031640|561614461|FG001|Screening Period|Withdrawal by Subject|0|||
155597693|NCT02031640|561614462|FG002|Screening Period|Withdrawal by Subject|0|||
155597694|NCT02031640|561614463|FG003|Screening Period|Withdrawal by Subject|0|||
155597695|NCT02031640|561614464|FG004|Screening Period|Withdrawal by Subject|0|||
155597696|NCT02031640|561614465|FG005|Screening Period|Withdrawal by Subject|0|||
155597697|NCT02031640|561614460|FG000|Screening Period|Inclusion criteria not met|312|||
155597698|NCT02031640|561614461|FG001|Screening Period|Inclusion criteria not met|0|||
155597699|NCT02031640|561614462|FG002|Screening Period|Inclusion criteria not met|0|||
155597700|NCT02031640|561614463|FG003|Screening Period|Inclusion criteria not met|0|||
155597701|NCT02031640|561614464|FG004|Screening Period|Inclusion criteria not met|0|||
155597702|NCT02031640|561614465|FG005|Screening Period|Inclusion criteria not met|0|||
155597703|NCT02031640|561614460|FG000|Screening Period|Exclusion criteria met|30|||
155597704|NCT02031640|561614461|FG001|Screening Period|Exclusion criteria met|0|||
155597705|NCT02031640|561614462|FG002|Screening Period|Exclusion criteria met|0|||
155597706|NCT02031640|561614463|FG003|Screening Period|Exclusion criteria met|0|||
155597707|NCT02031640|561614464|FG004|Screening Period|Exclusion criteria met|0|||
155597708|NCT02031640|561614465|FG005|Screening Period|Exclusion criteria met|0|||
155597709|NCT02031640|561614460|FG000|Screening Period|Lost to Follow-up|14|||
155597710|NCT02031640|561614461|FG001|Screening Period|Lost to Follow-up|0|||
155597711|NCT02031640|561614462|FG002|Screening Period|Lost to Follow-up|0|||
155597712|NCT02031640|561614463|FG003|Screening Period|Lost to Follow-up|0|||
155597713|NCT02031640|561614464|FG004|Screening Period|Lost to Follow-up|0|||
155597714|NCT02031640|561614465|FG005|Screening Period|Lost to Follow-up|0|||
155597715|NCT02031640|561614460|FG000|Screening Period|Enrollment closed|26|||
155597716|NCT02031640|561614461|FG001|Screening Period|Enrollment closed|0|||
155597717|NCT02031640|561614462|FG002|Screening Period|Enrollment closed|0|||
155597718|NCT02031640|561614463|FG003|Screening Period|Enrollment closed|0|||
155597719|NCT02031640|561614464|FG004|Screening Period|Enrollment closed|0|||
155597720|NCT02031640|561614465|FG005|Screening Period|Enrollment closed|0|||
155597721|NCT02031640|561614460|FG000|Run-In Period|Adverse Event|4|||
155597722|NCT02031640|561614461|FG001|Run-In Period|Adverse Event|0|||
155597723|NCT02031640|561614462|FG002|Run-In Period|Adverse Event|0|||
155597724|NCT02031640|561614463|FG003|Run-In Period|Adverse Event|0|||
155597725|NCT02031640|561614464|FG004|Run-In Period|Adverse Event|0|||
155597726|NCT02031640|561614465|FG005|Run-In Period|Adverse Event|0|||
155597727|NCT02031640|561614460|FG000|Run-In Period|Withdrawal by Subject|17|||
155597728|NCT02031640|561614461|FG001|Run-In Period|Withdrawal by Subject|0|||
155597729|NCT02031640|561614462|FG002|Run-In Period|Withdrawal by Subject|0|||
155597730|NCT02031640|561614463|FG003|Run-In Period|Withdrawal by Subject|0|||
155597731|NCT02031640|561614464|FG004|Run-In Period|Withdrawal by Subject|0|||
155597732|NCT02031640|561614465|FG005|Run-In Period|Withdrawal by Subject|0|||
155597733|NCT02031640|561614460|FG000|Run-In Period|Inclusion criteria not met|38|||
155597734|NCT02031640|561614461|FG001|Run-In Period|Inclusion criteria not met|0|||
155597735|NCT02031640|561614462|FG002|Run-In Period|Inclusion criteria not met|0|||
155597736|NCT02031640|561614463|FG003|Run-In Period|Inclusion criteria not met|0|||
155597737|NCT02031640|561614464|FG004|Run-In Period|Inclusion criteria not met|0|||
155597738|NCT02031640|561614465|FG005|Run-In Period|Inclusion criteria not met|0|||
155597739|NCT02031640|561614460|FG000|Run-In Period|Exclusion criteria met|8|||
155597740|NCT02031640|561614461|FG001|Run-In Period|Exclusion criteria met|0|||
155597741|NCT02031640|561614462|FG002|Run-In Period|Exclusion criteria met|0|||
155597742|NCT02031640|561614463|FG003|Run-In Period|Exclusion criteria met|0|||
155597743|NCT02031640|561614464|FG004|Run-In Period|Exclusion criteria met|0|||
155597744|NCT02031640|561614465|FG005|Run-In Period|Exclusion criteria met|0|||
155597745|NCT02031640|561614460|FG000|Run-In Period|Randomization criteria not met|85|||
155597746|NCT02031640|561614461|FG001|Run-In Period|Randomization criteria not met|0|||
155597747|NCT02031640|561614462|FG002|Run-In Period|Randomization criteria not met|0|||
155597748|NCT02031640|561614463|FG003|Run-In Period|Randomization criteria not met|0|||
155597749|NCT02031640|561614464|FG004|Run-In Period|Randomization criteria not met|0|||
155597750|NCT02031640|561614465|FG005|Run-In Period|Randomization criteria not met|0|||
155597751|NCT02031640|561614460|FG000|Run-In Period|Various administrative reasons|17|||
155597752|NCT02031640|561614461|FG001|Run-In Period|Various administrative reasons|0|||
155597753|NCT02031640|561614462|FG002|Run-In Period|Various administrative reasons|0|||
155597754|NCT02031640|561614463|FG003|Run-In Period|Various administrative reasons|0|||
155597755|NCT02031640|561614464|FG004|Run-In Period|Various administrative reasons|0|||
155597756|NCT02031640|561614465|FG005|Run-In Period|Various administrative reasons|0|||
155597757|NCT02031640|561614460|FG000|Double-blind Treatment Period|Protocol deviation|0|||
155597758|NCT02031640|561614461|FG001|Double-blind Treatment Period|Protocol deviation|2|||
155597759|NCT02031640|561614462|FG002|Double-blind Treatment Period|Protocol deviation|0|||
155597760|NCT02031640|561614463|FG003|Double-blind Treatment Period|Protocol deviation|1|||
155597761|NCT02031640|561614464|FG004|Double-blind Treatment Period|Protocol deviation|3|||
155597762|NCT02031640|561614465|FG005|Double-blind Treatment Period|Protocol deviation|1|||
155597763|NCT02031640|561614460|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155597764|NCT02031640|561614461|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
155597765|NCT02031640|561614462|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
155597766|NCT02031640|561614463|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
155597767|NCT02031640|561614464|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
155597768|NCT02031640|561614465|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
155597769|NCT02031640|561614460|FG000|Double-blind Treatment Period|Non-compliance|0|||
155597770|NCT02031640|561614461|FG001|Double-blind Treatment Period|Non-compliance|1|||
155597771|NCT02031640|561614462|FG002|Double-blind Treatment Period|Non-compliance|0|||
155597772|NCT02031640|561614463|FG003|Double-blind Treatment Period|Non-compliance|1|||
155597773|NCT02031640|561614464|FG004|Double-blind Treatment Period|Non-compliance|1|||
155597774|NCT02031640|561614465|FG005|Double-blind Treatment Period|Non-compliance|0|||
155597775|NCT02031640|561614460|FG000|Double-blind Treatment Period|Adverse Event|0|||
155597776|NCT02031640|561614461|FG001|Double-blind Treatment Period|Adverse Event|0|||
155597777|NCT02031640|561614462|FG002|Double-blind Treatment Period|Adverse Event|0|||
155597778|NCT02031640|561614463|FG003|Double-blind Treatment Period|Adverse Event|2|||
155597779|NCT02031640|561614464|FG004|Double-blind Treatment Period|Adverse Event|0|||
155597780|NCT02031640|561614465|FG005|Double-blind Treatment Period|Adverse Event|0|||
155597781|NCT02031640|561614460|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155597782|NCT02031640|561614461|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155597783|NCT02031640|561614462|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
155597784|NCT02031640|561614463|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
155597785|NCT02031640|561614464|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
155597786|NCT02031640|561614465|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
155597787|NCT02031640|561614460|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155597788|NCT02031640|561614461|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
155597789|NCT02031640|561614462|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155597790|NCT02031640|561614463|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155597791|NCT02031640|561614464|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
155597792|NCT02031640|561614465|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
155597793|NCT02005692|561614468|FG000|Overall Study|Protocol Violation|1|||
155597794|NCT02005692|561614468|FG000|Overall Study|Withdrawal by Subject|1|||
155597795|NCT02005692|561614468|FG000|Overall Study|Discharged earlier than anticipated|5|||
155597796|NCT01194999|561614469|FG000|Overall Study|Lost to Follow-up|17|||
155597797|NCT01895270|561614470|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
155597798|NCT01895270|561614471|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
155597799|NCT01895270|561614470|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
155670042|NCT01672879|561886564|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
155670043|NCT01672879|561886565|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
155670044|NCT01672879|561886563|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
155670045|NCT01672879|561886564|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
155670046|NCT01672879|561886565|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
155670047|NCT01672879|561886563|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
155670048|NCT01672879|561886564|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
155670049|NCT01672879|561886565|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
155670050|NCT04860869|561886566|FG000|Overall Study|Withdrawal by Subject|1|||
155670051|NCT04860869|561886567|FG001|Overall Study|Withdrawal by Subject|0|||
155670052|NCT02651116|561886570|FG000|Overall Study|Adverse Event|0|||
155670053|NCT02651116|561886571|FG001|Overall Study|Adverse Event|1|||
155670054|NCT02651116|561886570|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
155670055|NCT02651116|561886571|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
155670056|NCT01775553|561886572|FG000|Overall Study|Adverse Event|1|||
155670057|NCT01775553|561886572|FG000|Overall Study|Disease Progression|12|||
155670058|NCT04834726|561886575|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
155670059|NCT04834726|561886576|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
155670060|NCT04834726|561886577|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
155670061|NCT04834726|561886578|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
155670062|NCT04834726|561886579|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
155721145|NCT02587221|562077762|FG000|Overall Study|Other Reason or Unspecified|2|||
155597800|NCT01895270|561614471|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
155597801|NCT01895270|561614470|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
155597802|NCT01895270|561614471|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
155597803|NCT01895270|561614470|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
155597804|NCT01895270|561614471|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
155597805|NCT01895270|561614470|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
155597806|NCT01895270|561614471|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
155597807|NCT01895270|561614470|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
155597808|NCT01895270|561614471|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
155597809|NCT01895270|561614470|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
155597810|NCT01895270|561614471|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
155597811|NCT02091375|561614474|FG000|Overall Study|Adverse Event|8|||
155597812|NCT02091375|561614475|FG001|Overall Study|Adverse Event|1|||
155597813|NCT02091375|561614474|FG000|Overall Study|Lost to Follow-up|0|||
155597814|NCT02091375|561614475|FG001|Overall Study|Lost to Follow-up|1|||
155597815|NCT02091375|561614474|FG000|Overall Study|Withdrawal by Subject|0|||
155597816|NCT02091375|561614475|FG001|Overall Study|Withdrawal by Subject|1|||
155597817|NCT02091375|561614474|FG000|Overall Study|Withdrawn by the investigator|1|||
155597818|NCT02091375|561614475|FG001|Overall Study|Withdrawn by the investigator|0|||
155597819|NCT02682823|561614477|FG000|Overall Study|Withdrawal by Subject|0|||
155597820|NCT02682823|561614478|FG001|Overall Study|Withdrawal by Subject|0|||
155597821|NCT02682823|561614479|FG002|Overall Study|Withdrawal by Subject|1|||
155597822|NCT02682823|561614480|FG003|Overall Study|Withdrawal by Subject|0|||
155597823|NCT02682823|561614481|FG004|Overall Study|Withdrawal by Subject|1|||
155597824|NCT02682823|561614477|FG000|Overall Study|Protocol Deviation|0|||
155597825|NCT02682823|561614478|FG001|Overall Study|Protocol Deviation|1|||
155597826|NCT02682823|561614479|FG002|Overall Study|Protocol Deviation|0|||
155597827|NCT02682823|561614480|FG003|Overall Study|Protocol Deviation|0|||
155597828|NCT02682823|561614481|FG004|Overall Study|Protocol Deviation|0|||
155597829|NCT02682823|561614477|FG000|Overall Study|Adverse Event|0|||
155597830|NCT02682823|561614478|FG001|Overall Study|Adverse Event|0|||
155597831|NCT02682823|561614479|FG002|Overall Study|Adverse Event|0|||
155597832|NCT02682823|561614480|FG003|Overall Study|Adverse Event|1|||
155597833|NCT02682823|561614481|FG004|Overall Study|Adverse Event|0|||
155597834|NCT05896527|561614482|FG000|Overall Study|Withdrawal by Subject|11|||
155597835|NCT05896527|561614483|FG001|Overall Study|Withdrawal by Subject|10|||
155597836|NCT05896527|561614484|FG002|Overall Study|Withdrawal by Subject|4|||
155597837|NCT05896527|561614485|FG003|Overall Study|Withdrawal by Subject|3|||
155597838|NCT05896527|561614486|FG004|Overall Study|Withdrawal by Subject|2|||
155597839|NCT05896527|561614482|FG000|Overall Study|Lost to Follow-up|0|||
155597840|NCT05896527|561614483|FG001|Overall Study|Lost to Follow-up|2|||
155597841|NCT05896527|561614484|FG002|Overall Study|Lost to Follow-up|2|||
155597842|NCT05896527|561614485|FG003|Overall Study|Lost to Follow-up|2|||
155597843|NCT05896527|561614486|FG004|Overall Study|Lost to Follow-up|1|||
155597844|NCT05896527|561614482|FG000|Overall Study|Significant protocol noncompliance|0|||
155597845|NCT05896527|561614483|FG001|Overall Study|Significant protocol noncompliance|1|||
155597846|NCT05896527|561614484|FG002|Overall Study|Significant protocol noncompliance|0|||
155597847|NCT05896527|561614485|FG003|Overall Study|Significant protocol noncompliance|0|||
155597848|NCT05896527|561614486|FG004|Overall Study|Significant protocol noncompliance|0|||
155670063|NCT04834726|561886580|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
155670064|NCT04834726|561886581|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
155670065|NCT04834726|561886582|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
155670066|NCT04834726|561886583|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
155670067|NCT03810014|561886584|FG000|Overall Study|Pregnancy|2|||
155670068|NCT03810014|561886585|FG001|Overall Study|Pregnancy|2|||
155670069|NCT03810014|561886586|FG002|Overall Study|Pregnancy|0|||
155670070|NCT03810014|561886587|FG003|Overall Study|Pregnancy|2|||
155670071|NCT03606486|561886591|FG000|Overall Study|Unable to collect sample|5|||
155670072|NCT00442416|561886597|FG000|Overall Study|Adverse Event|4|||
155670073|NCT00442416|561886598|FG001|Overall Study|Adverse Event|1|||
155670074|NCT00442416|561886597|FG000|Overall Study|Death|1|||
155670075|NCT00442416|561886598|FG001|Overall Study|Death|0|||
155670076|NCT00442416|561886597|FG000|Overall Study|Lack of Efficacy|2|||
155670077|NCT00442416|561886598|FG001|Overall Study|Lack of Efficacy|0|||
155670078|NCT00442416|561886597|FG000|Overall Study|Protocol Violation|2|||
155670079|NCT00442416|561886598|FG001|Overall Study|Protocol Violation|3|||
155670080|NCT00442416|561886597|FG000|Overall Study|Withdrew consent|1|||
155670081|NCT00442416|561886598|FG001|Overall Study|Withdrew consent|2|||
155670082|NCT00442416|561886597|FG000|Overall Study|Administrative/Other|27|||
155670083|NCT00442416|561886598|FG001|Overall Study|Administrative/Other|33|||
155670084|NCT02148263|561886608|FG000|Overall Study|Withdrawal by Subject|3|||
155670085|NCT02148263|561886609|FG001|Overall Study|Withdrawal by Subject|2|||
155670086|NCT00503425|561886610|FG000|Overall Study|Participant files lost|6|||
155670087|NCT00503425|561886610|FG000|Overall Study|Adverse Event|5|||
155670088|NCT00503425|561886610|FG000|Overall Study|Lack of Efficacy|25|||
155670089|NCT00503425|561886610|FG000|Overall Study|Withdrawal by Subject|8|||
155670090|NCT00503425|561886610|FG000|Overall Study|Lost to Follow-up|3|||
155670091|NCT00503425|561886610|FG000|Overall Study|Death|3|||
155670092|NCT00503425|561886610|FG000|Overall Study|Missing Data/Unknown|4|||
155670093|NCT00003869|561886611|FG000|Overall Study|Adverse Event|14|||
155670094|NCT00003869|561886612|FG001|Overall Study|Adverse Event|3|||
155670095|NCT00003869|561886611|FG000|Overall Study|Withdrawal by Subject|21|||
155670096|NCT00003869|561886612|FG001|Overall Study|Withdrawal by Subject|3|||
155670097|NCT00003869|561886611|FG000|Overall Study|Death|1|||
155670098|NCT00003869|561886612|FG001|Overall Study|Death|2|||
155670099|NCT00003869|561886611|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
155670100|NCT00003869|561886612|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
155670101|NCT03364231|561886613|FG000|Overall Study|Adverse Event|1|||
155670102|NCT03364231|561886614|FG001|Overall Study|Adverse Event|4|||
155670103|NCT03364231|561886613|FG000|Overall Study|Death|1|||
155670104|NCT03364231|561886614|FG001|Overall Study|Death|0|||
155670105|NCT03364231|561886613|FG000|Overall Study|Investigator Decision|2|||
155670106|NCT03364231|561886614|FG001|Overall Study|Investigator Decision|2|||
155670107|NCT03364231|561886613|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
155670108|NCT03364231|561886614|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
155670109|NCT03364231|561886613|FG000|Overall Study|Withdrawal of Subject Consent|1|||
155670110|NCT03364231|561886614|FG001|Overall Study|Withdrawal of Subject Consent|0|||
155670111|NCT03364231|561886613|FG000|Overall Study|Reason Not Specified|1|||
155670112|NCT03364231|561886614|FG001|Overall Study|Reason Not Specified|0|||
155670113|NCT03364231|561886613|FG000|Overall Study|Disease Progression|0|||
155670114|NCT03364231|561886614|FG001|Overall Study|Disease Progression|6|||
155670115|NCT02534883|561886621|FG000|Overall Study|Early Termination|8|||
155670116|NCT02534883|561886622|FG001|Overall Study|Early Termination|3|||
155670117|NCT00886769|561886623|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155670118|NCT00886769|561886624|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
155670119|NCT03328832|561886625|FG000|Overall Study|Lost to Follow-up|0|||
155670120|NCT03328832|561886626|FG001|Overall Study|Lost to Follow-up|1|||
155670121|NCT00414076|561886627|FG000|Overall Study|Progression|1|||
155670122|NCT00414076|561886628|FG001|Overall Study|Progression|2|||
155670123|NCT00414076|561886627|FG000|Overall Study|Withdrawal by Subject|1|||
155670124|NCT00414076|561886628|FG001|Overall Study|Withdrawal by Subject|3|||
155670125|NCT00414076|561886627|FG000|Overall Study|Adverse Event|1|||
155670126|NCT00414076|561886628|FG001|Overall Study|Adverse Event|0|||
155670127|NCT00778336|561886631|FG000|Index Procedure-Discharge|Death|6|||
155670128|NCT00778336|561886632|FG001|Index Procedure-Discharge|Death|3|||
155670129|NCT00778336|561886633|FG002|Index Procedure-Discharge|Death|2|||
155670130|NCT00778336|561886634|FG003|Index Procedure-Discharge|Death|0|||
155670131|NCT00778336|561886631|FG000|3 Month Follow Up|Lost to Follow-up|15|||
155670132|NCT00778336|561886632|FG001|3 Month Follow Up|Lost to Follow-up|20|||
155670133|NCT00778336|561886633|FG002|3 Month Follow Up|Lost to Follow-up|3|||
155670134|NCT00778336|561886634|FG003|3 Month Follow Up|Lost to Follow-up|0|||
155670135|NCT00778336|561886631|FG000|3 Month Follow Up|Death|8|||
155670136|NCT00778336|561886632|FG001|3 Month Follow Up|Death|3|||
155670137|NCT00778336|561886633|FG002|3 Month Follow Up|Death|2|||
155670138|NCT00778336|561886634|FG003|3 Month Follow Up|Death|0|||
155670139|NCT00049257|561886635|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
155597849|NCT05896527|561614482|FG000|Overall Study|Eligibility criteria not met|1|||
155597850|NCT05896527|561614483|FG001|Overall Study|Eligibility criteria not met|0|||
155597851|NCT05896527|561614484|FG002|Overall Study|Eligibility criteria not met|0|||
155597852|NCT05896527|561614485|FG003|Overall Study|Eligibility criteria not met|0|||
155597853|NCT05896527|561614486|FG004|Overall Study|Eligibility criteria not met|0|||
155597854|NCT05896527|561614482|FG000|Overall Study|Sponsor's decision|0|||
155597855|NCT05896527|561614483|FG001|Overall Study|Sponsor's decision|0|||
155597856|NCT05896527|561614484|FG002|Overall Study|Sponsor's decision|0|||
155597857|NCT05896527|561614485|FG003|Overall Study|Sponsor's decision|1|||
155597858|NCT05896527|561614486|FG004|Overall Study|Sponsor's decision|0|||
155597859|NCT05896527|561614482|FG000|Overall Study|Investigator's decision|0|||
155597860|NCT05896527|561614483|FG001|Overall Study|Investigator's decision|1|||
155597861|NCT05896527|561614484|FG002|Overall Study|Investigator's decision|0|||
155597862|NCT05896527|561614485|FG003|Overall Study|Investigator's decision|0|||
155597863|NCT05896527|561614486|FG004|Overall Study|Investigator's decision|0|||
155597864|NCT05896527|561614482|FG000|Overall Study|Pregnancy of his partner|0|||
155597865|NCT05896527|561614483|FG001|Overall Study|Pregnancy of his partner|0|||
155597866|NCT05896527|561614484|FG002|Overall Study|Pregnancy of his partner|0|||
155597867|NCT05896527|561614485|FG003|Overall Study|Pregnancy of his partner|1|||
155597868|NCT05896527|561614486|FG004|Overall Study|Pregnancy of his partner|0|||
155597869|NCT01279070|561614488|FG000|Overall Study|Withdrawal by Subject|2|||
155597870|NCT01279070|561614489|FG001|Overall Study|Withdrawal by Subject|3|||
155597871|NCT01279070|561614488|FG000|Overall Study|Acute exacerbation|3|||
155597872|NCT01279070|561614489|FG001|Overall Study|Acute exacerbation|1|||
155597873|NCT03781583|561614490|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
155597874|NCT03781583|561614491|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
155597875|NCT03781583|561614492|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
155597876|NCT03781583|561614493|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
155597877|NCT03781583|561614490|FG000|Overall Study|Technology did not work for that person in that environment|1|||
155597878|NCT03781583|561614491|FG001|Overall Study|Technology did not work for that person in that environment|0|||
155597879|NCT03781583|561614492|FG002|Overall Study|Technology did not work for that person in that environment|0|||
155597880|NCT03781583|561614493|FG003|Overall Study|Technology did not work for that person in that environment|0|||
155597881|NCT03781583|561614490|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
155597882|NCT03781583|561614491|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
155597883|NCT03781583|561614492|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
155597884|NCT03781583|561614493|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
155597885|NCT03781583|561614490|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155597886|NCT03781583|561614491|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
155597887|NCT03781583|561614492|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155597888|NCT03781583|561614493|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155597889|NCT02222545|561614494|FG000|Overall Study|Adverse Event|1|||
155597890|NCT02222545|561614495|FG001|Overall Study|Adverse Event|0|||
155597891|NCT02222545|561614496|FG002|Overall Study|Adverse Event|2|||
155597892|NCT02222545|561614494|FG000|Overall Study|Death|0|||
155597893|NCT02222545|561614495|FG001|Overall Study|Death|0|||
155597894|NCT02222545|561614496|FG002|Overall Study|Death|9|||
155597895|NCT02222545|561614494|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
155597896|NCT02222545|561614495|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
155597897|NCT02222545|561614496|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
155597898|NCT02222545|561614494|FG000|Overall Study|Withdrawal by Subject|0|||
155597899|NCT02222545|561614495|FG001|Overall Study|Withdrawal by Subject|0|||
155597900|NCT02222545|561614496|FG002|Overall Study|Withdrawal by Subject|3|||
155597901|NCT02222545|561614494|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
155597902|NCT02222545|561614495|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
155597903|NCT02222545|561614496|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
155597904|NCT01938430|561614497|FG000|Overall Study|Randomized but Not Treated|0|||
155597905|NCT01938430|561614498|FG001|Overall Study|Randomized but Not Treated|0|||
155597906|NCT01938430|561614499|FG002|Overall Study|Randomized but Not Treated|0|||
155597907|NCT01938430|561614500|FG003|Overall Study|Randomized but Not Treated|0|||
155597908|NCT01938430|561614501|FG004|Overall Study|Randomized but Not Treated|0|||
155597909|NCT01938430|561614502|FG005|Overall Study|Randomized but Not Treated|0|||
155597910|NCT01938430|561614503|FG006|Overall Study|Randomized but Not Treated|0|||
155597911|NCT01938430|561614504|FG007|Overall Study|Randomized but Not Treated|0|||
155597912|NCT01938430|561614505|FG008|Overall Study|Randomized but Not Treated|0|||
155597913|NCT01938430|561614506|FG009|Overall Study|Randomized but Not Treated|0|||
155670140|NCT00049257|561886635|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
155670141|NCT00049257|561886635|FG000|Carboplatin, Paclitaxel|Death|2|||
155597914|NCT01938430|561614507|FG010|Overall Study|Randomized but Not Treated|1|||
155597915|NCT01938430|561614508|FG011|Overall Study|Randomized but Not Treated|0|||
155597916|NCT01938430|561614509|FG012|Overall Study|Randomized but Not Treated|0|||
155597917|NCT01938430|561614510|FG013|Overall Study|Randomized but Not Treated|1|||
155597918|NCT01938430|561614497|FG000|Overall Study|Adverse Event|0|||
155597919|NCT01938430|561614498|FG001|Overall Study|Adverse Event|0|||
155597920|NCT01938430|561614499|FG002|Overall Study|Adverse Event|0|||
155597921|NCT01938430|561614500|FG003|Overall Study|Adverse Event|0|||
155597922|NCT01938430|561614501|FG004|Overall Study|Adverse Event|0|||
155597923|NCT01938430|561614502|FG005|Overall Study|Adverse Event|0|||
155597924|NCT01938430|561614503|FG006|Overall Study|Adverse Event|1|||
155597925|NCT01938430|561614504|FG007|Overall Study|Adverse Event|0|||
155597926|NCT01938430|561614505|FG008|Overall Study|Adverse Event|0|||
155597927|NCT01938430|561614506|FG009|Overall Study|Adverse Event|0|||
155597928|NCT01938430|561614507|FG010|Overall Study|Adverse Event|0|||
155597929|NCT01938430|561614508|FG011|Overall Study|Adverse Event|0|||
155597930|NCT01938430|561614509|FG012|Overall Study|Adverse Event|0|||
155597931|NCT01938430|561614510|FG013|Overall Study|Adverse Event|0|||
155597932|NCT01938430|561614497|FG000|Overall Study|Death|1|||
155597933|NCT01938430|561614498|FG001|Overall Study|Death|2|||
155597934|NCT01938430|561614499|FG002|Overall Study|Death|2|||
155597935|NCT01938430|561614500|FG003|Overall Study|Death|1|||
155597936|NCT01938430|561614501|FG004|Overall Study|Death|0|||
155597937|NCT01938430|561614502|FG005|Overall Study|Death|0|||
155597938|NCT01938430|561614503|FG006|Overall Study|Death|1|||
155597939|NCT01938430|561614504|FG007|Overall Study|Death|1|||
155597940|NCT01938430|561614505|FG008|Overall Study|Death|2|||
155597941|NCT01938430|561614506|FG009|Overall Study|Death|3|||
155597942|NCT01938430|561614507|FG010|Overall Study|Death|0|||
155597943|NCT01938430|561614508|FG011|Overall Study|Death|0|||
155597944|NCT01938430|561614509|FG012|Overall Study|Death|0|||
155597945|NCT01938430|561614510|FG013|Overall Study|Death|0|||
155597946|NCT01938430|561614497|FG000|Overall Study|Investigator's Discretion|0|||
155597947|NCT01938430|561614498|FG001|Overall Study|Investigator's Discretion|0|||
155597948|NCT01938430|561614499|FG002|Overall Study|Investigator's Discretion|1|||
155597949|NCT01938430|561614500|FG003|Overall Study|Investigator's Discretion|0|||
155597950|NCT01938430|561614501|FG004|Overall Study|Investigator's Discretion|0|||
155597951|NCT01938430|561614502|FG005|Overall Study|Investigator's Discretion|0|||
155597952|NCT01938430|561614503|FG006|Overall Study|Investigator's Discretion|0|||
155597953|NCT01938430|561614504|FG007|Overall Study|Investigator's Discretion|0|||
155597954|NCT01938430|561614505|FG008|Overall Study|Investigator's Discretion|0|||
155597955|NCT01938430|561614506|FG009|Overall Study|Investigator's Discretion|0|||
155597956|NCT01938430|561614507|FG010|Overall Study|Investigator's Discretion|0|||
155597957|NCT01938430|561614508|FG011|Overall Study|Investigator's Discretion|0|||
155597958|NCT01938430|561614509|FG012|Overall Study|Investigator's Discretion|0|||
155597959|NCT01938430|561614510|FG013|Overall Study|Investigator's Discretion|0|||
155597960|NCT01938430|561614497|FG000|Overall Study|Lack of Efficacy|3|||
155597961|NCT01938430|561614498|FG001|Overall Study|Lack of Efficacy|1|||
155597962|NCT01938430|561614499|FG002|Overall Study|Lack of Efficacy|1|||
155597963|NCT01938430|561614500|FG003|Overall Study|Lack of Efficacy|1|||
155597964|NCT01938430|561614501|FG004|Overall Study|Lack of Efficacy|0|||
155597965|NCT01938430|561614502|FG005|Overall Study|Lack of Efficacy|0|||
155597966|NCT01938430|561614503|FG006|Overall Study|Lack of Efficacy|0|||
155597967|NCT01938430|561614504|FG007|Overall Study|Lack of Efficacy|0|||
155597968|NCT01938430|561614505|FG008|Overall Study|Lack of Efficacy|1|||
155597969|NCT01938430|561614506|FG009|Overall Study|Lack of Efficacy|0|||
155597970|NCT01938430|561614507|FG010|Overall Study|Lack of Efficacy|2|||
155597971|NCT01938430|561614508|FG011|Overall Study|Lack of Efficacy|1|||
155597972|NCT01938430|561614509|FG012|Overall Study|Lack of Efficacy|0|||
155597973|NCT01938430|561614510|FG013|Overall Study|Lack of Efficacy|0|||
155597974|NCT01938430|561614497|FG000|Overall Study|Lost to Follow-up|0|||
155597975|NCT01938430|561614498|FG001|Overall Study|Lost to Follow-up|0|||
155597976|NCT01938430|561614499|FG002|Overall Study|Lost to Follow-up|1|||
155597977|NCT01938430|561614500|FG003|Overall Study|Lost to Follow-up|0|||
155597978|NCT01938430|561614501|FG004|Overall Study|Lost to Follow-up|0|||
155597979|NCT01938430|561614502|FG005|Overall Study|Lost to Follow-up|1|||
155597980|NCT01938430|561614503|FG006|Overall Study|Lost to Follow-up|0|||
155597981|NCT01938430|561614504|FG007|Overall Study|Lost to Follow-up|0|||
155597982|NCT01938430|561614505|FG008|Overall Study|Lost to Follow-up|0|||
155597983|NCT01938430|561614506|FG009|Overall Study|Lost to Follow-up|0|||
155597984|NCT01938430|561614507|FG010|Overall Study|Lost to Follow-up|0|||
155597985|NCT01938430|561614508|FG011|Overall Study|Lost to Follow-up|0|||
155597986|NCT01938430|561614509|FG012|Overall Study|Lost to Follow-up|0|||
155597987|NCT01938430|561614510|FG013|Overall Study|Lost to Follow-up|0|||
155597988|NCT01938430|561614497|FG000|Overall Study|Withdrew Consent|0|||
155597989|NCT01938430|561614498|FG001|Overall Study|Withdrew Consent|0|||
155597990|NCT01938430|561614499|FG002|Overall Study|Withdrew Consent|0|||
155597991|NCT01938430|561614500|FG003|Overall Study|Withdrew Consent|0|||
155597992|NCT01938430|561614501|FG004|Overall Study|Withdrew Consent|0|||
155597993|NCT01938430|561614502|FG005|Overall Study|Withdrew Consent|0|||
155597994|NCT01938430|561614503|FG006|Overall Study|Withdrew Consent|0|||
155597995|NCT01938430|561614504|FG007|Overall Study|Withdrew Consent|0|||
155597996|NCT01938430|561614505|FG008|Overall Study|Withdrew Consent|1|||
155597997|NCT01938430|561614506|FG009|Overall Study|Withdrew Consent|0|||
155597998|NCT01938430|561614507|FG010|Overall Study|Withdrew Consent|0|||
155597999|NCT01938430|561614508|FG011|Overall Study|Withdrew Consent|0|||
155598000|NCT01938430|561614509|FG012|Overall Study|Withdrew Consent|0|||
155598001|NCT01938430|561614510|FG013|Overall Study|Withdrew Consent|0|||
155598002|NCT04533412|561614511|FG000|Overall Study|Withdrawal by Subject|1|||
155598003|NCT04533412|561614512|FG001|Overall Study|Withdrawal by Subject|1|||
155598004|NCT04533412|561614511|FG000|Overall Study|Lost to Follow-up|1|||
155598005|NCT04533412|561614512|FG001|Overall Study|Lost to Follow-up|4|||
155598006|NCT03261674|561614515|FG000|Overall Study|Lost to Follow-up|6|||
155598007|NCT03261674|561614516|FG001|Overall Study|Lost to Follow-up|7|||
155598008|NCT03261674|561614515|FG000|Overall Study|Protocol Violation|1|||
155598009|NCT03261674|561614516|FG001|Overall Study|Protocol Violation|4|||
155598010|NCT03261674|561614515|FG000|Overall Study|Withdrawal by Subject|1|||
155598011|NCT03261674|561614516|FG001|Overall Study|Withdrawal by Subject|4|||
155598012|NCT03261674|561614515|FG000|Overall Study|Physician Decision|1|||
155598013|NCT03261674|561614516|FG001|Overall Study|Physician Decision|0|||
155598014|NCT02353442|561614519|FG000|Overall Study|Withdrawal by Subject|3|||
155598015|NCT02353442|561614520|FG001|Overall Study|Withdrawal by Subject|4|||
155598016|NCT00782184|561614533|FG000|Overall Study|Adverse Event|1|||
155598017|NCT00782184|561614534|FG001|Overall Study|Adverse Event|2|||
155598018|NCT00782184|561614533|FG000|Overall Study|Protocol Violation|0|||
155670142|NCT00049257|561886635|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
155670143|NCT04721158|561886636|FG000|Overall Study|Lost to Follow-up|4|||
155670144|NCT04721158|561886636|FG000|Overall Study|Device did not connect|1|||
155670145|NCT02708680|561886637|FG000|Overall Study|Withdrawal by Subject|4|||
155670146|NCT02708680|561886638|FG001|Overall Study|Withdrawal by Subject|12|||
155670147|NCT02708680|561886639|FG002|Overall Study|Withdrawal by Subject|12|||
155670148|NCT02708680|561886637|FG000|Overall Study|Death|4|||
155670149|NCT02708680|561886638|FG001|Overall Study|Death|19|||
155670150|NCT02708680|561886639|FG002|Overall Study|Death|21|||
155670151|NCT02708680|561886637|FG000|Overall Study|Lost to Follow-up|0|||
155670152|NCT02708680|561886638|FG001|Overall Study|Lost to Follow-up|3|||
155670153|NCT02708680|561886639|FG002|Overall Study|Lost to Follow-up|3|||
155670154|NCT02708680|561886637|FG000|Overall Study|Study Terminated By Sponsor|0|||
155670155|NCT02708680|561886638|FG001|Overall Study|Study Terminated By Sponsor|5|||
155670156|NCT02708680|561886639|FG002|Overall Study|Study Terminated By Sponsor|4|||
155670157|NCT02708680|561886637|FG000|Overall Study|Other than Specified|0|||
155670158|NCT02708680|561886638|FG001|Overall Study|Other than Specified|0|||
155670159|NCT02708680|561886639|FG002|Overall Study|Other than Specified|1|||
155670160|NCT02708680|561886637|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
155670161|NCT02708680|561886638|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
155670162|NCT02708680|561886639|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
155670163|NCT04162470|561886640|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
155670164|NCT03929913|561886643|FG000|Overall Study|Death|4|||
155670165|NCT03929913|561886643|FG000|Overall Study|Lost to Follow-up|1|||
155598019|NCT00782184|561614534|FG001|Overall Study|Protocol Violation|1|||
155670166|NCT03929913|561886643|FG000|Overall Study|Failed Procedure|2|||
155670167|NCT03919929|561886644|FG000|Overall Study|Withdrawal by Subject|0|||
155670168|NCT03919929|561886645|FG001|Overall Study|Withdrawal by Subject|4|||
155598020|NCT00782184|561614533|FG000|Overall Study|Withdrawal by Subject|3|||
155598021|NCT00782184|561614534|FG001|Overall Study|Withdrawal by Subject|2|||
155598022|NCT00890084|561614535|FG000|Overall Study|Adverse Event|16|||
155598023|NCT00890084|561614535|FG000|Overall Study|Lost to Follow-up|126|||
155598024|NCT02738879|561614536|FG000|Overall Study|Adverse Event|1|||
155598025|NCT02738879|561614537|FG001|Overall Study|Adverse Event|1|||
155598026|NCT02738879|561614536|FG000|Overall Study|Death|0|||
155598027|NCT02738879|561614537|FG001|Overall Study|Death|2|||
155598028|NCT02738879|561614536|FG000|Overall Study|Lost to Follow-up|1|||
155598029|NCT02738879|561614537|FG001|Overall Study|Lost to Follow-up|5|||
155598030|NCT02738879|561614536|FG000|Overall Study|Protocol Violation|1|||
155598031|NCT02738879|561614537|FG001|Overall Study|Protocol Violation|3|||
155598032|NCT02738879|561614536|FG000|Overall Study|Physician Decision|3|||
155598033|NCT02738879|561614537|FG001|Overall Study|Physician Decision|4|||
155598034|NCT02738879|561614536|FG000|Overall Study|Pregnancy|0|||
155598035|NCT02738879|561614537|FG001|Overall Study|Pregnancy|1|||
155598036|NCT02738879|561614536|FG000|Overall Study|Screen Failure|1|||
155598037|NCT02738879|561614537|FG001|Overall Study|Screen Failure|2|||
155598038|NCT02738879|561614536|FG000|Overall Study|Site Discontinued Study Participation|1|||
155598039|NCT02738879|561614537|FG001|Overall Study|Site Discontinued Study Participation|0|||
155598040|NCT02738879|561614536|FG000|Overall Study|Withdrawal by Subject|5|||
155598041|NCT02738879|561614537|FG001|Overall Study|Withdrawal by Subject|7|||
155598042|NCT01438294|561614538|FG000|Overall Study|Lost to Follow-up|3|||
155598043|NCT01438294|561614539|FG001|Overall Study|Lost to Follow-up|7|||
155598044|NCT01075646|561614542|FG000|Overall Study|Lost to Follow-up|4|||
155598045|NCT01075646|561614543|FG001|Overall Study|Lost to Follow-up|3|||
155598046|NCT01075646|561614544|FG002|Overall Study|Lost to Follow-up|1|||
155598047|NCT01075646|561614545|FG003|Overall Study|Lost to Follow-up|2|||
155598048|NCT01647516|561614549|FG000|Induction Period (IP)|Physician Decision|2|||
155598049|NCT01647516|561614550|FG001|Induction Period (IP)|Physician Decision|0|||
155598050|NCT01647516|561614551|FG002|Induction Period (IP)|Physician Decision|0|||
155598051|NCT01647516|561614552|FG003|Induction Period (IP)|Physician Decision|0|||
155598052|NCT01647516|561614553|FG004|Induction Period (IP)|Physician Decision|0|||
155598053|NCT01647516|561614554|FG005|Induction Period (IP)|Physician Decision|0|||
155598054|NCT01647516|561614549|FG000|Induction Period (IP)|Adverse Event|1|||
155598055|NCT01647516|561614550|FG001|Induction Period (IP)|Adverse Event|2|||
155598056|NCT01647516|561614551|FG002|Induction Period (IP)|Adverse Event|0|||
155598057|NCT01647516|561614552|FG003|Induction Period (IP)|Adverse Event|0|||
155598058|NCT01647516|561614553|FG004|Induction Period (IP)|Adverse Event|0|||
155598059|NCT01647516|561614554|FG005|Induction Period (IP)|Adverse Event|0|||
155598060|NCT01647516|561614549|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
155598061|NCT01647516|561614550|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
155598062|NCT01647516|561614551|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
155598063|NCT01647516|561614552|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
155598064|NCT01647516|561614553|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
155598065|NCT01647516|561614554|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
155598066|NCT01647516|561614549|FG000|Induction Period (IP)|Participant Choice|0|||
155598067|NCT01647516|561614550|FG001|Induction Period (IP)|Participant Choice|0|||
155598068|NCT01647516|561614551|FG002|Induction Period (IP)|Participant Choice|1|||
155598069|NCT01647516|561614552|FG003|Induction Period (IP)|Participant Choice|0|||
155598070|NCT01647516|561614553|FG004|Induction Period (IP)|Participant Choice|0|||
155598071|NCT01647516|561614554|FG005|Induction Period (IP)|Participant Choice|0|||
155598072|NCT01647516|561614549|FG000|Induction Period (IP)|Lack of Efficacy|1|||
155598073|NCT01647516|561614550|FG001|Induction Period (IP)|Lack of Efficacy|0|||
155598074|NCT01647516|561614551|FG002|Induction Period (IP)|Lack of Efficacy|0|||
155598075|NCT01647516|561614552|FG003|Induction Period (IP)|Lack of Efficacy|0|||
155598076|NCT01647516|561614553|FG004|Induction Period (IP)|Lack of Efficacy|0|||
155598077|NCT01647516|561614554|FG005|Induction Period (IP)|Lack of Efficacy|0|||
155598078|NCT01647516|561614549|FG000|Induction Period (IP)|No study drug received|1|||
155598079|NCT01647516|561614550|FG001|Induction Period (IP)|No study drug received|1|||
155598080|NCT01647516|561614551|FG002|Induction Period (IP)|No study drug received|0|||
155598081|NCT01647516|561614552|FG003|Induction Period (IP)|No study drug received|0|||
155598082|NCT01647516|561614553|FG004|Induction Period (IP)|No study drug received|0|||
155598083|NCT01647516|561614554|FG005|Induction Period (IP)|No study drug received|0|||
155598084|NCT01647516|561614549|FG000|Maintenance Period (MP)|Adverse Event|2|||
155598085|NCT01647516|561614550|FG001|Maintenance Period (MP)|Adverse Event|1|||
155598086|NCT01647516|561614551|FG002|Maintenance Period (MP)|Adverse Event|0|||
155598087|NCT01647516|561614552|FG003|Maintenance Period (MP)|Adverse Event|0|||
155598088|NCT01647516|561614553|FG004|Maintenance Period (MP)|Adverse Event|0|||
155598089|NCT01647516|561614554|FG005|Maintenance Period (MP)|Adverse Event|0|||
155598090|NCT01647516|561614549|FG000|Maintenance Period (MP)|Non-compliance|1|||
155598091|NCT01647516|561614550|FG001|Maintenance Period (MP)|Non-compliance|0|||
155598092|NCT01647516|561614551|FG002|Maintenance Period (MP)|Non-compliance|0|||
155598093|NCT01647516|561614552|FG003|Maintenance Period (MP)|Non-compliance|0|||
155598094|NCT01647516|561614553|FG004|Maintenance Period (MP)|Non-compliance|0|||
155598095|NCT01647516|561614554|FG005|Maintenance Period (MP)|Non-compliance|0|||
155598096|NCT01647516|561614549|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
155670169|NCT03919929|561886644|FG000|Overall Study|Screen Failure|0|||
155670170|NCT03919929|561886645|FG001|Overall Study|Screen Failure|5|||
155670171|NCT03941483|561886646|FG000|Overall Study|Miscellaneous|2|||
155670172|NCT03941483|561886647|FG001|Overall Study|Miscellaneous|3|||
155670173|NCT03941483|561886648|FG002|Overall Study|Miscellaneous|0|||
155598097|NCT01647516|561614550|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
155598098|NCT01647516|561614551|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
155598099|NCT01647516|561614552|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
155598100|NCT01647516|561614553|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
155598101|NCT01647516|561614554|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
155598102|NCT01647516|561614549|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
155598103|NCT01647516|561614550|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
155598104|NCT01647516|561614551|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
155598105|NCT01647516|561614552|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
155598106|NCT01647516|561614553|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
155598107|NCT01647516|561614554|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
155598108|NCT01647516|561614549|FG000|Open-Label Period|Adverse Event|0|||
155598109|NCT01647516|561614550|FG001|Open-Label Period|Adverse Event|0|||
155598110|NCT01647516|561614551|FG002|Open-Label Period|Adverse Event|0|||
155598111|NCT01647516|561614552|FG003|Open-Label Period|Adverse Event|5|||
155598112|NCT01647516|561614553|FG004|Open-Label Period|Adverse Event|6|||
155598113|NCT01647516|561614554|FG005|Open-Label Period|Adverse Event|3|||
155598114|NCT01647516|561614549|FG000|Open-Label Period|Pregnancy|0|||
155598115|NCT01647516|561614550|FG001|Open-Label Period|Pregnancy|0|||
155598116|NCT01647516|561614551|FG002|Open-Label Period|Pregnancy|0|||
155598117|NCT01647516|561614552|FG003|Open-Label Period|Pregnancy|0|||
155598118|NCT01647516|561614553|FG004|Open-Label Period|Pregnancy|0|||
155598119|NCT01647516|561614554|FG005|Open-Label Period|Pregnancy|1|||
155598120|NCT01647516|561614549|FG000|Open-Label Period|Non-compliance|0|||
155598121|NCT01647516|561614550|FG001|Open-Label Period|Non-compliance|0|||
155598122|NCT01647516|561614551|FG002|Open-Label Period|Non-compliance|0|||
155598123|NCT01647516|561614552|FG003|Open-Label Period|Non-compliance|1|||
155598124|NCT01647516|561614553|FG004|Open-Label Period|Non-compliance|0|||
155598125|NCT01647516|561614554|FG005|Open-Label Period|Non-compliance|1|||
155598126|NCT01647516|561614549|FG000|Open-Label Period|Physician Decision|0|||
155598127|NCT01647516|561614550|FG001|Open-Label Period|Physician Decision|0|||
155598128|NCT01647516|561614551|FG002|Open-Label Period|Physician Decision|0|||
155598129|NCT01647516|561614552|FG003|Open-Label Period|Physician Decision|1|||
155598130|NCT01647516|561614553|FG004|Open-Label Period|Physician Decision|1|||
155598131|NCT01647516|561614554|FG005|Open-Label Period|Physician Decision|0|||
155598132|NCT01647516|561614549|FG000|Open-Label Period|Withdrawal by Subject|0|||
155598133|NCT01647516|561614550|FG001|Open-Label Period|Withdrawal by Subject|0|||
155598134|NCT01647516|561614551|FG002|Open-Label Period|Withdrawal by Subject|0|||
155598135|NCT01647516|561614552|FG003|Open-Label Period|Withdrawal by Subject|9|||
155598136|NCT01647516|561614553|FG004|Open-Label Period|Withdrawal by Subject|11|||
155598137|NCT01647516|561614554|FG005|Open-Label Period|Withdrawal by Subject|6|||
155598138|NCT01647516|561614549|FG000|Open-Label Period|Lost to Follow-up|0|||
155598139|NCT01647516|561614550|FG001|Open-Label Period|Lost to Follow-up|0|||
155598140|NCT01647516|561614551|FG002|Open-Label Period|Lost to Follow-up|0|||
155598141|NCT01647516|561614552|FG003|Open-Label Period|Lost to Follow-up|1|||
155598142|NCT01647516|561614553|FG004|Open-Label Period|Lost to Follow-up|0|||
155598143|NCT01647516|561614554|FG005|Open-Label Period|Lost to Follow-up|1|||
155598144|NCT01647516|561614549|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155598145|NCT01647516|561614550|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155598146|NCT01647516|561614551|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155598147|NCT01647516|561614552|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
155598148|NCT01647516|561614553|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
155598149|NCT01647516|561614554|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
155598150|NCT01647516|561614549|FG000|Open-Label Period|Lack of Efficacy|0|||
155598151|NCT01647516|561614550|FG001|Open-Label Period|Lack of Efficacy|0|||
155598152|NCT01647516|561614551|FG002|Open-Label Period|Lack of Efficacy|0|||
155598153|NCT01647516|561614552|FG003|Open-Label Period|Lack of Efficacy|7|||
155598154|NCT01647516|561614553|FG004|Open-Label Period|Lack of Efficacy|9|||
155598155|NCT01647516|561614554|FG005|Open-Label Period|Lack of Efficacy|10|||
155598156|NCT01647516|561614549|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155598157|NCT01647516|561614550|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155598158|NCT01647516|561614551|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155598159|NCT01647516|561614552|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
155598160|NCT01647516|561614553|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
155598161|NCT01647516|561614554|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
155598162|NCT01647516|561614549|FG000|Open-Label Period|No completion / discontinuation visit|0|||
155598163|NCT01647516|561614550|FG001|Open-Label Period|No completion / discontinuation visit|0|||
155598164|NCT01647516|561614551|FG002|Open-Label Period|No completion / discontinuation visit|0|||
155598165|NCT01647516|561614552|FG003|Open-Label Period|No completion / discontinuation visit|0|||
155598166|NCT01647516|561614553|FG004|Open-Label Period|No completion / discontinuation visit|2|||
155598167|NCT01647516|561614554|FG005|Open-Label Period|No completion / discontinuation visit|1|||
155598168|NCT04964544|561614557|FG000|Overall Study|Screen failure or other uncategorised|10|||
155598169|NCT04964544|561614557|FG000|Overall Study|Physician Decision|4|||
155670174|NCT03941483|561886646|FG000|Overall Study|Study Terminated by Sponsor|1|||
155670175|NCT03941483|561886647|FG001|Overall Study|Study Terminated by Sponsor|0|||
155670176|NCT03941483|561886648|FG002|Overall Study|Study Terminated by Sponsor|0|||
155670177|NCT03941483|561886646|FG000|Overall Study|Withdrawal by Subject|1|||
155670178|NCT03941483|561886647|FG001|Overall Study|Withdrawal by Subject|4|||
155670179|NCT03941483|561886648|FG002|Overall Study|Withdrawal by Subject|1|||
155670180|NCT03941483|561886646|FG000|Overall Study|Lost to Follow-up|2|||
155670181|NCT03941483|561886647|FG001|Overall Study|Lost to Follow-up|1|||
155670182|NCT03941483|561886648|FG002|Overall Study|Lost to Follow-up|8|||
155670183|NCT03941483|561886646|FG000|Overall Study|Death|3|||
155670184|NCT03941483|561886647|FG001|Overall Study|Death|2|||
155670185|NCT03941483|561886648|FG002|Overall Study|Death|6|||
155670186|NCT04749745|561886649|FG000|Overall Study|Withdrawal by Subject|1|||
155670187|NCT04749745|561886650|FG001|Overall Study|Withdrawal by Subject|0|||
155670188|NCT01234480|561887986|FG000|Overall Study|Pregnancy|88|||
155670189|NCT01234480|561887986|FG000|Overall Study|>36/Normal History|50|||
155670190|NCT01234480|561887986|FG000|Overall Study|Age|3|||
155670191|NCT01234480|561887986|FG000|Overall Study|HPV Vaccine History|28|||
155670192|NCT01234480|561887986|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
155670193|NCT01234480|561887986|FG000|Overall Study|Hysterectomy|2|||
155670194|NCT01234480|561887986|FG000|Overall Study|Hysterectomy post enrollment|1|||
155670195|NCT01234480|561887986|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
155670196|NCT01234480|561887986|FG000|Overall Study|Informed Consent Form Violation|30|||
155670197|NCT01234480|561887986|FG000|Overall Study|Incorrect Visit|3|||
155670198|NCT01234480|561887986|FG000|Overall Study|No Florida Lab License|20|||
155670199|NCT01234480|561887986|FG000|Overall Study|Out of Window|42|||
155670200|NCT01234480|561887986|FG000|Overall Study|Sample Processing/Storage|92|||
155670201|NCT01234480|561887986|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
155670202|NCT01234480|561887986|FG000|Overall Study|Site/Subject non-compliance|44|||
155670203|NCT01234480|561887986|FG000|Overall Study|Missing Sample|9|||
155670204|NCT00617084|561887987|FG000|Overall Study|Withdrawal by Subject|5|||
155670205|NCT00617084|561887988|FG001|Overall Study|Withdrawal by Subject|7|||
155670206|NCT00617084|561887987|FG000|Overall Study|Missed 12 Months visit|16|||
155670207|NCT00617084|561887988|FG001|Overall Study|Missed 12 Months visit|19|||
155670208|NCT03370419|561887989|FG000|Overall Study|Lost to Follow-up|16|||
155670209|NCT01693250|561887994|FG000|Overall Study|Lost to Follow-up|2|||
155670210|NCT01693250|561887995|FG001|Overall Study|Lost to Follow-up|2|||
155670211|NCT01147965|561887996|FG000|Overall Study|Progressive Disease|3|||
155670212|NCT01147965|561887997|FG001|Overall Study|Progressive Disease|3|||
155670213|NCT01147965|561887998|FG002|Overall Study|Progressive Disease|5|||
155670214|NCT01147965|561887999|FG003|Overall Study|Progressive Disease|9|||
155670215|NCT01147965|561888000|FG004|Overall Study|Progressive Disease|5|||
155670216|NCT01147965|561888001|FG005|Overall Study|Progressive Disease|5|||
155670217|NCT01147965|561887996|FG000|Overall Study|Death|0|||
155670218|NCT01147965|561887997|FG001|Overall Study|Death|0|||
155670219|NCT01147965|561887998|FG002|Overall Study|Death|1|||
155670220|NCT01147965|561887999|FG003|Overall Study|Death|1|||
155670221|NCT01147965|561888000|FG004|Overall Study|Death|0|||
155670222|NCT01147965|561888001|FG005|Overall Study|Death|2|||
155670223|NCT01147965|561887996|FG000|Overall Study|Withdrawal by Subject|0|||
155670224|NCT01147965|561887997|FG001|Overall Study|Withdrawal by Subject|0|||
155670225|NCT01147965|561887998|FG002|Overall Study|Withdrawal by Subject|1|||
155670226|NCT01147965|561887999|FG003|Overall Study|Withdrawal by Subject|1|||
155670227|NCT01147965|561888000|FG004|Overall Study|Withdrawal by Subject|0|||
155670228|NCT01147965|561888001|FG005|Overall Study|Withdrawal by Subject|0|||
155670229|NCT01147965|561887996|FG000|Overall Study|Administration Of Alternative Therapy|0|||
155670230|NCT01147965|561887997|FG001|Overall Study|Administration Of Alternative Therapy|0|||
155670231|NCT01147965|561887998|FG002|Overall Study|Administration Of Alternative Therapy|0|||
155670232|NCT01147965|561887999|FG003|Overall Study|Administration Of Alternative Therapy|0|||
155670233|NCT01147965|561888000|FG004|Overall Study|Administration Of Alternative Therapy|0|||
155670234|NCT01147965|561888001|FG005|Overall Study|Administration Of Alternative Therapy|1|||
155670235|NCT01147965|561887996|FG000|Overall Study|Other|0|||
155670236|NCT01147965|561887997|FG001|Overall Study|Other|0|||
155670237|NCT01147965|561887998|FG002|Overall Study|Other|0|||
155670238|NCT01147965|561887999|FG003|Overall Study|Other|3|||
155670239|NCT01147965|561888000|FG004|Overall Study|Other|1|||
155670240|NCT01147965|561888001|FG005|Overall Study|Other|0|||
155670241|NCT02257242|561888002|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
155670242|NCT02257242|561888003|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670243|NCT02257242|561888004|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670244|NCT02257242|561888005|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155598170|NCT04964544|561614557|FG000|Overall Study|Lost to Follow-up|9|||
155598171|NCT04964544|561614557|FG000|Overall Study|Withdrawal by Subject|18|||
155598172|NCT04964544|561614557|FG000|Overall Study|Death|1|||
155598173|NCT01613222|561614560|FG000|Overall Study|Physician Decision|1|||
155598174|NCT01613222|561614560|FG000|Overall Study|Unable to place arterial line|1|||
155598175|NCT01613222|561614560|FG000|Overall Study|Reused disposable sensors|10|||
155598176|NCT03155178|561614565|FG000|Overall Study|Did not meet treatment day baseline|7|||
155598177|NCT03155178|561614566|FG001|Overall Study|Did not meet treatment day baseline|7|||
155598178|NCT03155178|561614567|FG002|Overall Study|Did not meet treatment day baseline|7|||
155598179|NCT03155178|561614568|FG003|Overall Study|Did not meet treatment day baseline|7|||
155598180|NCT02833844|561614569|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155598181|NCT02833844|561614570|FG001|Double-Blind Period|Withdrawal by Subject|3|||
155598182|NCT02833844|561614569|FG000|Double-Blind Period|Protocol Violation|0|||
155598183|NCT02833844|561614570|FG001|Double-Blind Period|Protocol Violation|4|||
155598184|NCT02833844|561614569|FG000|Open-Label Period|Death|0|||
155598185|NCT02833844|561614570|FG001|Open-Label Period|Death|2|||
155598186|NCT02833844|561614569|FG000|Open-Label Period|Lost to Follow-up|1|||
155598187|NCT02833844|561614570|FG001|Open-Label Period|Lost to Follow-up|0|||
155598188|NCT02833844|561614569|FG000|Open-Label Period|Withdrawal by Subject|1|||
155598189|NCT02833844|561614570|FG001|Open-Label Period|Withdrawal by Subject|0|||
155598190|NCT00308087|561614571|FG000|Overall Study|Progressive Disease|19|||
155598191|NCT00308087|561614572|FG001|Overall Study|Progressive Disease|21|||
155598192|NCT00308087|561614571|FG000|Overall Study|Study Closure|11|||
155598193|NCT00308087|561614572|FG001|Overall Study|Study Closure|12|||
155598194|NCT00308087|561614571|FG000|Overall Study|Withdrawal by Subject|2|||
155598195|NCT00308087|561614572|FG001|Overall Study|Withdrawal by Subject|1|||
155598196|NCT00308087|561614571|FG000|Overall Study|Other|4|||
155598197|NCT00308087|561614572|FG001|Overall Study|Other|3|||
155598198|NCT04323306|561614573|FG000|Overall Study|Physician Decision|1|||
155598199|NCT04323306|561614574|FG001|Overall Study|Physician Decision|0|||
155598200|NCT04323306|561614575|FG002|Overall Study|Physician Decision|0|||
155598201|NCT04323306|561614576|FG003|Overall Study|Physician Decision|0|||
155598202|NCT04323306|561614577|FG004|Overall Study|Physician Decision|0|||
155598203|NCT04323306|561614578|FG005|Overall Study|Physician Decision|0|||
155598204|NCT04323306|561614579|FG006|Overall Study|Physician Decision|0|||
155598205|NCT04323306|561614580|FG007|Overall Study|Physician Decision|0|||
155598206|NCT04323306|561614581|FG008|Overall Study|Physician Decision|0|||
155598207|NCT04323306|561614573|FG000|Overall Study|Withdrawal by Subject|0|||
155598208|NCT04323306|561614574|FG001|Overall Study|Withdrawal by Subject|0|||
155598209|NCT04323306|561614575|FG002|Overall Study|Withdrawal by Subject|0|||
155670245|NCT02257242|561888006|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670246|NCT02257242|561888007|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670247|NCT02257242|561888008|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670248|NCT02257242|561888009|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670249|NCT02257242|561888010|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155670250|NCT02522429|561888013|FG000|Overall Study|Lost to Follow-up|8|||
155670251|NCT02522429|561888013|FG000|Overall Study|Adverse Event|2|||
155670252|NCT02522429|561888013|FG000|Overall Study|Death|1|||
155670253|NCT02522429|561888013|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
155670254|NCT00600106|561888014|FG000|Overall Study|Withdrawal by Subject|1|||
155670255|NCT00600106|561888015|FG001|Overall Study|Withdrawal by Subject|1|||
155670256|NCT04667949|561888016|FG000|Overall Study|Adverse Event|0|||
155670257|NCT04667949|561888017|FG001|Overall Study|Adverse Event|2|||
155670258|NCT04667949|561888016|FG000|Overall Study|Lost to Follow-up|0|||
155670259|NCT04667949|561888017|FG001|Overall Study|Lost to Follow-up|1|||
155670260|NCT04667949|561888016|FG000|Overall Study|Physician Decision|0|||
155670261|NCT04667949|561888017|FG001|Overall Study|Physician Decision|2|||
155670262|NCT04667949|561888016|FG000|Overall Study|Subject decision|1|||
155670263|NCT04667949|561888017|FG001|Overall Study|Subject decision|7|||
155670264|NCT03783962|561888019|FG000|Overall Study|Lost to Follow-up|3|||
155670265|NCT03783962|561888020|FG001|Overall Study|Lost to Follow-up|6|||
155670266|NCT03783962|561888019|FG000|Overall Study|Protocol Violation|0|||
155670267|NCT03783962|561888020|FG001|Overall Study|Protocol Violation|1|||
155670268|NCT02763059|561888023|FG000|Overall Study|Lost to Follow-up|4|||
155670269|NCT02763059|561888024|FG001|Overall Study|Lost to Follow-up|1|||
155670270|NCT02763059|561888025|FG002|Overall Study|Lost to Follow-up|6|||
155670271|NCT02763059|561888023|FG000|Overall Study|Withdrawal by Subject|1|||
155670272|NCT02763059|561888024|FG001|Overall Study|Withdrawal by Subject|0|||
155670273|NCT02763059|561888025|FG002|Overall Study|Withdrawal by Subject|3|||
155670274|NCT02370368|561888026|FG000|Overall Study|Adverse Event|1|||
155670275|NCT02370368|561888027|FG001|Overall Study|Adverse Event|2|||
155670276|NCT02370368|561888026|FG000|Overall Study|Withdrawal by Subject|5|||
155670277|NCT02370368|561888027|FG001|Overall Study|Withdrawal by Subject|4|||
155670278|NCT01724216|561888028|FG000|Overall Study|Scan was not completed|1|||
155670279|NCT04423939|561888029|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
155670280|NCT04423939|561888030|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
155670281|NCT04423939|561888029|FG000|Overall Study|Death|3|||
155670282|NCT04423939|561888030|FG001|Overall Study|Death|0|||
155670283|NCT04423939|561888029|FG000|Overall Study|Withdrawal by Subject|3|||
155670284|NCT04423939|561888030|FG001|Overall Study|Withdrawal by Subject|0|||
155670285|NCT04423939|561888029|FG000|Overall Study|Caregiver to patient who died|0|||
155670286|NCT04423939|561888030|FG001|Overall Study|Caregiver to patient who died|3|||
155670287|NCT04423939|561888029|FG000|Overall Study|Caregiver to patient who withdrew|0|||
155670288|NCT04423939|561888030|FG001|Overall Study|Caregiver to patient who withdrew|3|||
155670289|NCT04024436|561888031|FG000|Overall Study|Death|10|||
155670290|NCT04024436|561888032|FG001|Overall Study|Death|14|||
155670291|NCT04024436|561888033|FG002|Overall Study|Death|2|||
155670292|NCT04024436|561888034|FG003|Overall Study|Death|7|||
155670293|NCT04024436|561888031|FG000|Overall Study|Loss to follow up|1|||
155670294|NCT04024436|561888032|FG001|Overall Study|Loss to follow up|0|||
155670295|NCT04024436|561888033|FG002|Overall Study|Loss to follow up|0|||
155670296|NCT04024436|561888034|FG003|Overall Study|Loss to follow up|1|||
155670297|NCT04024436|561888031|FG000|Overall Study|Withdrawal of consent|2|||
155670298|NCT04024436|561888032|FG001|Overall Study|Withdrawal of consent|0|||
155670299|NCT04024436|561888033|FG002|Overall Study|Withdrawal of consent|0|||
155670300|NCT04024436|561888034|FG003|Overall Study|Withdrawal of consent|1|||
155670301|NCT04024436|561888031|FG000|Overall Study|Study termination by sponsor|4|||
155670302|NCT04024436|561888032|FG001|Overall Study|Study termination by sponsor|6|||
155670303|NCT04024436|561888033|FG002|Overall Study|Study termination by sponsor|2|||
155670304|NCT04024436|561888034|FG003|Overall Study|Study termination by sponsor|11|||
155670305|NCT04024436|561888031|FG000|Overall Study|Reason Not Specified|0|||
155670306|NCT04024436|561888032|FG001|Overall Study|Reason Not Specified|1|||
155670307|NCT04024436|561888033|FG002|Overall Study|Reason Not Specified|0|||
155670308|NCT04024436|561888034|FG003|Overall Study|Reason Not Specified|2|||
155670309|NCT01169337|561888035|FG000|Overall Study|Lack of Efficacy|5|||
155670310|NCT01169337|561888036|FG001|Overall Study|Lack of Efficacy|7|||
155670311|NCT01169337|561888037|FG002|Overall Study|Lack of Efficacy|0|||
155670312|NCT01169337|561888035|FG000|Overall Study|Adverse Event|12|||
155670313|NCT01169337|561888036|FG001|Overall Study|Adverse Event|18|||
155598210|NCT04323306|561614576|FG003|Overall Study|Withdrawal by Subject|0|||
155598211|NCT04323306|561614577|FG004|Overall Study|Withdrawal by Subject|0|||
155598212|NCT04323306|561614578|FG005|Overall Study|Withdrawal by Subject|1|||
155598213|NCT04323306|561614579|FG006|Overall Study|Withdrawal by Subject|3|||
155598214|NCT04323306|561614580|FG007|Overall Study|Withdrawal by Subject|0|||
155598215|NCT04323306|561614581|FG008|Overall Study|Withdrawal by Subject|1|||
155598216|NCT00089778|561614583|FG000|Overall Study|Protocol Violation|0|||
155598217|NCT00089778|561614584|FG001|Overall Study|Protocol Violation|0|||
155598218|NCT00089778|561614585|FG002|Overall Study|Protocol Violation|1|||
155598219|NCT04712019|561614586|FG000|Overall Study|Withdrawal by Subject|2|||
155598220|NCT04712019|561614587|FG001|Overall Study|Withdrawal by Subject|2|||
155598221|NCT04712019|561614586|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
155598222|NCT04712019|561614587|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
155598223|NCT04240457|561614598|FG000|Overall Study|Lost to Follow-up|5|||
155598224|NCT04240457|561614599|FG001|Overall Study|Lost to Follow-up|1|||
155598225|NCT02858180|561614600|FG000|Overall Study|Lost to Follow-up|0|||
155598226|NCT02858180|561614601|FG001|Overall Study|Lost to Follow-up|2|||
155598227|NCT00844480|561614602|FG000|Overall Study|Withdrawal by Subject|2|||
155598228|NCT00844480|561614603|FG001|Overall Study|Withdrawal by Subject|3|||
155598229|NCT01516008|561614610|FG000|Overall Study|Adverse Event|0|||
155598230|NCT01516008|561614611|FG001|Overall Study|Adverse Event|2|||
155598231|NCT01516008|561614612|FG002|Overall Study|Adverse Event|7|||
155598232|NCT01516008|561614610|FG000|Overall Study|Lack of Efficacy|44|||
155598233|NCT01516008|561614611|FG001|Overall Study|Lack of Efficacy|14|||
155598234|NCT01516008|561614612|FG002|Overall Study|Lack of Efficacy|10|||
155598235|NCT01516008|561614610|FG000|Overall Study|Protocol Violation|1|||
155598236|NCT01516008|561614611|FG001|Overall Study|Protocol Violation|0|||
155598237|NCT01516008|561614612|FG002|Overall Study|Protocol Violation|0|||
155598238|NCT01516008|561614610|FG000|Overall Study|Reason not specified|0|||
155598239|NCT01516008|561614611|FG001|Overall Study|Reason not specified|0|||
155598240|NCT01516008|561614612|FG002|Overall Study|Reason not specified|1|||
155598241|NCT02805660|561614613|FG000|Overall Study|Death|5|||
155598242|NCT02805660|561614614|FG001|Overall Study|Death|2|||
155598243|NCT02805660|561614615|FG002|Overall Study|Death|9|||
155598244|NCT02805660|561614616|FG003|Overall Study|Death|5|||
155598245|NCT02805660|561614617|FG004|Overall Study|Death|0|||
155598246|NCT02805660|561614618|FG005|Overall Study|Death|14|||
155598247|NCT02805660|561614619|FG006|Overall Study|Death|12|||
155598248|NCT02805660|561614613|FG000|Overall Study|Lost to Follow-up|0|||
155598249|NCT02805660|561614614|FG001|Overall Study|Lost to Follow-up|1|||
155598250|NCT02805660|561614615|FG002|Overall Study|Lost to Follow-up|1|||
155598251|NCT02805660|561614616|FG003|Overall Study|Lost to Follow-up|2|||
155598252|NCT02805660|561614617|FG004|Overall Study|Lost to Follow-up|0|||
155598253|NCT02805660|561614618|FG005|Overall Study|Lost to Follow-up|0|||
155598254|NCT02805660|561614619|FG006|Overall Study|Lost to Follow-up|0|||
155598255|NCT02805660|561614613|FG000|Overall Study|Withdrawal by Subject|0|||
155598256|NCT02805660|561614614|FG001|Overall Study|Withdrawal by Subject|0|||
155598257|NCT02805660|561614615|FG002|Overall Study|Withdrawal by Subject|0|||
155598258|NCT02805660|561614616|FG003|Overall Study|Withdrawal by Subject|3|||
155598259|NCT02805660|561614617|FG004|Overall Study|Withdrawal by Subject|1|||
155598260|NCT02805660|561614618|FG005|Overall Study|Withdrawal by Subject|0|||
155598261|NCT02805660|561614619|FG006|Overall Study|Withdrawal by Subject|2|||
155598262|NCT02805660|561614613|FG000|Overall Study|Study terminated by Sponsor|0|||
155598263|NCT02805660|561614614|FG001|Overall Study|Study terminated by Sponsor|0|||
155598264|NCT02805660|561614615|FG002|Overall Study|Study terminated by Sponsor|1|||
155598265|NCT02805660|561614616|FG003|Overall Study|Study terminated by Sponsor|4|||
155598266|NCT02805660|561614617|FG004|Overall Study|Study terminated by Sponsor|2|||
155598267|NCT02805660|561614618|FG005|Overall Study|Study terminated by Sponsor|3|||
155598268|NCT02805660|561614619|FG006|Overall Study|Study terminated by Sponsor|1|||
155598269|NCT02805660|561614613|FG000|Overall Study|Miscellaneous|0|||
155598270|NCT02805660|561614614|FG001|Overall Study|Miscellaneous|1|||
155598271|NCT02805660|561614615|FG002|Overall Study|Miscellaneous|0|||
155598272|NCT02805660|561614616|FG003|Overall Study|Miscellaneous|4|||
155598273|NCT02805660|561614617|FG004|Overall Study|Miscellaneous|0|||
155598274|NCT02805660|561614618|FG005|Overall Study|Miscellaneous|6|||
155598275|NCT02805660|561614619|FG006|Overall Study|Miscellaneous|4|||
155598276|NCT02572076|561614621|FG000|Overall Study|Protocol Violation|1|||
155670314|NCT01169337|561888037|FG002|Overall Study|Adverse Event|0|||
155670315|NCT01169337|561888035|FG000|Overall Study|Death|2|||
155598277|NCT04064411|561614622|FG000|Overall Study|Adverse Event|29|||
155598278|NCT04064411|561614623|FG001|Overall Study|Adverse Event|19|||
155598279|NCT04064411|561614622|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
155598280|NCT04064411|561614623|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
155598281|NCT04064411|561614622|FG000|Overall Study|Protocol Deviation|0|||
155598282|NCT04064411|561614623|FG001|Overall Study|Protocol Deviation|2|||
155598283|NCT04064411|561614622|FG000|Overall Study|Withdrawal by Subject|25|||
155598284|NCT04064411|561614623|FG001|Overall Study|Withdrawal by Subject|29|||
155598285|NCT04064411|561614622|FG000|Overall Study|Lost to Follow-up|5|||
155598286|NCT04064411|561614623|FG001|Overall Study|Lost to Follow-up|2|||
155598287|NCT04064411|561614622|FG000|Overall Study|Other than Specified|4|||
155598288|NCT04064411|561614623|FG001|Overall Study|Other than Specified|1|||
155598289|NCT04064411|561614622|FG000|Overall Study|Death|1|||
155598290|NCT04064411|561614623|FG001|Overall Study|Death|0|||
155598291|NCT03512210|561614626|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
155598292|NCT03512210|561614626|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
155670316|NCT01169337|561888036|FG001|Overall Study|Death|0|||
155670317|NCT01169337|561888037|FG002|Overall Study|Death|0|||
155670318|NCT01169337|561888035|FG000|Overall Study|Withdrawal by Subject|11|||
155670319|NCT01169337|561888036|FG001|Overall Study|Withdrawal by Subject|11|||
155670320|NCT01169337|561888037|FG002|Overall Study|Withdrawal by Subject|6|||
155670321|NCT01169337|561888035|FG000|Overall Study|Noncompliance|2|||
155670322|NCT01169337|561888036|FG001|Overall Study|Noncompliance|0|||
155670323|NCT01169337|561888037|FG002|Overall Study|Noncompliance|0|||
155670324|NCT01169337|561888035|FG000|Overall Study|Other complicating disease|1|||
155670325|NCT01169337|561888036|FG001|Overall Study|Other complicating disease|1|||
155670326|NCT01169337|561888037|FG002|Overall Study|Other complicating disease|0|||
155670327|NCT01169337|561888035|FG000|Overall Study|Physician Decision|1|||
155670328|NCT01169337|561888036|FG001|Overall Study|Physician Decision|5|||
155670329|NCT01169337|561888037|FG002|Overall Study|Physician Decision|0|||
155670330|NCT01169337|561888035|FG000|Overall Study|Alternative therapy|0|||
155670331|NCT01169337|561888036|FG001|Overall Study|Alternative therapy|2|||
155670332|NCT01169337|561888037|FG002|Overall Study|Alternative therapy|0|||
155670333|NCT01169337|561888035|FG000|Overall Study|Changed hospital|0|||
155670334|NCT01169337|561888036|FG001|Overall Study|Changed hospital|1|||
155670335|NCT01169337|561888037|FG002|Overall Study|Changed hospital|0|||
155670336|NCT01169337|561888035|FG000|Overall Study|Never started treatment|0|||
155670337|NCT01169337|561888036|FG001|Overall Study|Never started treatment|2|||
155670338|NCT01169337|561888037|FG002|Overall Study|Never started treatment|0|||
155670339|NCT01169337|561888035|FG000|Overall Study|Reason not reported|1|||
155670340|NCT01169337|561888036|FG001|Overall Study|Reason not reported|0|||
155670341|NCT01169337|561888037|FG002|Overall Study|Reason not reported|0|||
155670342|NCT01169337|561888035|FG000|Overall Study|Continuing lenalidomide|9|||
155670343|NCT01169337|561888036|FG001|Overall Study|Continuing lenalidomide|43|||
155670344|NCT01169337|561888037|FG002|Overall Study|Continuing lenalidomide|0|||
155670345|NCT01134614|561888038|FG000|Overall Study|Still on treatment as of March 2013|21|||
155670346|NCT01134614|561888039|FG001|Overall Study|Still on treatment as of March 2013|13|||
155670347|NCT01134614|561888038|FG000|Overall Study|Progressive disease|60|||
155670348|NCT01134614|561888039|FG001|Overall Study|Progressive disease|54|||
155670349|NCT01134614|561888038|FG000|Overall Study|Adverse Event|26|||
155670350|NCT01134614|561888039|FG001|Overall Study|Adverse Event|39|||
155670351|NCT01134614|561888038|FG000|Overall Study|Death|5|||
155670352|NCT01134614|561888039|FG001|Overall Study|Death|8|||
155670353|NCT01134614|561888038|FG000|Overall Study|Withdrawal by Subject|3|||
155670354|NCT01134614|561888039|FG001|Overall Study|Withdrawal by Subject|2|||
155670355|NCT01134614|561888038|FG000|Overall Study|Alternative therapy|2|||
155670356|NCT01134614|561888039|FG001|Overall Study|Alternative therapy|0|||
155670357|NCT01134614|561888038|FG000|Overall Study|Complicating disease|2|||
155670358|NCT01134614|561888039|FG001|Overall Study|Complicating disease|1|||
155670359|NCT01134614|561888038|FG000|Overall Study|Physician's decision|0|||
155670360|NCT01134614|561888039|FG001|Overall Study|Physician's decision|1|||
155670361|NCT01134614|561888038|FG000|Overall Study|Never started treatment|4|||
155670362|NCT01134614|561888039|FG001|Overall Study|Never started treatment|1|||
155670363|NCT01134614|561888038|FG000|Overall Study|Pt received tx not allowed on study|0|||
155670364|NCT01134614|561888039|FG001|Overall Study|Pt received tx not allowed on study|1|||
155670365|NCT01134614|561888038|FG000|Overall Study|Symptomatic deterioration|0|||
155670366|NCT01134614|561888039|FG001|Overall Study|Symptomatic deterioration|1|||
155670367|NCT01134614|561888038|FG000|Overall Study|Patient in hospice care|0|||
155670368|NCT01134614|561888039|FG001|Overall Study|Patient in hospice care|1|||
155670369|NCT00540592|561888040|FG000|Overall Study|Adverse Event|0|||
155670370|NCT00540592|561888041|FG001|Overall Study|Adverse Event|1|||
155670371|NCT00540592|561888042|FG002|Overall Study|Adverse Event|0|||
155670372|NCT00540592|561888043|FG003|Overall Study|Adverse Event|0|||
155670373|NCT00540592|561888044|FG004|Overall Study|Adverse Event|1|||
155670374|NCT00540592|561888045|FG005|Overall Study|Adverse Event|0|||
155670375|NCT00540592|561888046|FG006|Overall Study|Adverse Event|0|||
155670376|NCT00540592|561888047|FG007|Overall Study|Adverse Event|1|||
155670377|NCT00540592|561888048|FG008|Overall Study|Adverse Event|1|||
155670378|NCT00540592|561888049|FG009|Overall Study|Adverse Event|2|||
155670379|NCT00540592|561888040|FG000|Overall Study|Lost to Follow-up|2|||
155670380|NCT00540592|561888041|FG001|Overall Study|Lost to Follow-up|0|||
155670381|NCT00540592|561888042|FG002|Overall Study|Lost to Follow-up|0|||
155670382|NCT00540592|561888043|FG003|Overall Study|Lost to Follow-up|0|||
155670383|NCT00540592|561888044|FG004|Overall Study|Lost to Follow-up|0|||
155670384|NCT00540592|561888045|FG005|Overall Study|Lost to Follow-up|0|||
155670385|NCT00540592|561888046|FG006|Overall Study|Lost to Follow-up|0|||
155670386|NCT00540592|561888047|FG007|Overall Study|Lost to Follow-up|0|||
155670387|NCT00540592|561888048|FG008|Overall Study|Lost to Follow-up|0|||
155670388|NCT00540592|561888049|FG009|Overall Study|Lost to Follow-up|0|||
155670389|NCT00540592|561888040|FG000|Overall Study|Withdrawal by Subject|0|||
155670390|NCT00540592|561888041|FG001|Overall Study|Withdrawal by Subject|0|||
155670391|NCT00540592|561888042|FG002|Overall Study|Withdrawal by Subject|1|||
155670392|NCT00540592|561888043|FG003|Overall Study|Withdrawal by Subject|1|||
155598293|NCT03512210|561614626|FG000|Step 2:Post-MINMON|Death|2|||
155598294|NCT03512210|561614626|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
155598295|NCT03512210|561614626|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
155598296|NCT01286168|561616506|FG000|Overall Study|Withdrawal by Subject|1|||
155598297|NCT01286168|561616506|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
155598298|NCT01424514|561616507|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
155598299|NCT01424514|561616508|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
155598300|NCT01424514|561616507|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
155598301|NCT01424514|561616508|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
155598302|NCT02653170|561616511|FG000|Overall Study|Withdrawal by Subject|3|||
155598303|NCT02653170|561616512|FG001|Overall Study|Withdrawal by Subject|8|||
155598304|NCT02653170|561616513|FG002|Overall Study|Withdrawal by Subject|3|||
155598305|NCT02653170|561616511|FG000|Overall Study|withdrawn by study team|2|||
155598306|NCT02653170|561616512|FG001|Overall Study|withdrawn by study team|4|||
155598307|NCT02653170|561616513|FG002|Overall Study|withdrawn by study team|5|||
155598308|NCT02653170|561616511|FG000|Overall Study|Lost to Follow-up|12|||
155598309|NCT02653170|561616512|FG001|Overall Study|Lost to Follow-up|4|||
155598310|NCT02653170|561616513|FG002|Overall Study|Lost to Follow-up|10|||
155598311|NCT02002533|561616514|FG000|Overall Study|Withdrawal by Subject|6|||
155598312|NCT02002533|561616515|FG001|Overall Study|Withdrawal by Subject|13|||
155598313|NCT02002533|561616514|FG000|Overall Study|Protocol Violation|0|||
155598314|NCT02002533|561616515|FG001|Overall Study|Protocol Violation|1|||
155598315|NCT02002533|561616514|FG000|Overall Study|Adverse Event|0|||
155598316|NCT02002533|561616515|FG001|Overall Study|Adverse Event|3|||
155598317|NCT02002533|561616514|FG000|Overall Study|Lost to Follow-up|0|||
155598318|NCT02002533|561616515|FG001|Overall Study|Lost to Follow-up|1|||
155598319|NCT01482065|561616518|FG000|Overall Study|Withdrawal by Subject|0|||
155598320|NCT01482065|561616519|FG001|Overall Study|Withdrawal by Subject|1|||
155598321|NCT01942486|561616520|FG000|Overall Study|Lost to Follow-up|27|||
155598322|NCT03728426|561616521|FG000|Overall Study|Death|3|||
155598323|NCT02424630|561616524|FG000|Overall Study|No rotator cuff tear|1|||
155598324|NCT02424630|561616525|FG001|Overall Study|No rotator cuff tear|2|||
155598325|NCT02424630|561616524|FG000|Overall Study|Open procedure|0|||
155598326|NCT02424630|561616525|FG001|Overall Study|Open procedure|1|||
155598327|NCT01741792|561616526|FG000|Overall Study|Death|6|||
155598328|NCT01741792|561616527|FG001|Overall Study|Death|1|||
155598329|NCT01741792|561616528|FG002|Overall Study|Death|12|||
155598330|NCT05139303|561616529|FG000|Overall Study|Lost to Follow-up|3|||
155598331|NCT05139303|561616530|FG001|Overall Study|Lost to Follow-up|0|||
155598332|NCT05139303|561616529|FG000|Overall Study|Adverse Event|1|||
155598333|NCT05139303|561616530|FG001|Overall Study|Adverse Event|0|||
155598334|NCT01676896|561616532|FG000|Overall Study|Withdrawal by Subject|12|||
155598335|NCT01676896|561616533|FG001|Overall Study|Withdrawal by Subject|7|||
155598336|NCT01676896|561616534|FG002|Overall Study|Withdrawal by Subject|19|||
155598337|NCT03614078|561616535|FG000|Overall Study|Withdrawal by Subject|2|||
155598338|NCT03614078|561616536|FG001|Overall Study|Withdrawal by Subject|2|||
155598339|NCT03614078|561616537|FG002|Overall Study|Withdrawal by Subject|3|||
155598340|NCT03614078|561616535|FG000|Overall Study|Participant Did Not Return for Visit|0|||
155598341|NCT03614078|561616536|FG001|Overall Study|Participant Did Not Return for Visit|1|||
155598342|NCT03614078|561616537|FG002|Overall Study|Participant Did Not Return for Visit|0|||
155598343|NCT03614078|561616535|FG000|Overall Study|High Neutrophils|0|||
155598344|NCT03614078|561616536|FG001|Overall Study|High Neutrophils|0|||
155598345|NCT03614078|561616537|FG002|Overall Study|High Neutrophils|2|||
155598346|NCT03614078|561616535|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
155598347|NCT03614078|561616536|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
155598348|NCT03614078|561616537|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
155598349|NCT03614078|561616535|FG000|Overall Study|Exacerbation of Psoriasis|0|||
155598350|NCT03614078|561616536|FG001|Overall Study|Exacerbation of Psoriasis|1|||
155598351|NCT03614078|561616537|FG002|Overall Study|Exacerbation of Psoriasis|0|||
155598352|NCT03614078|561616535|FG000|Overall Study|Adverse Event|0|||
155598353|NCT03614078|561616536|FG001|Overall Study|Adverse Event|2|||
155598354|NCT03614078|561616537|FG002|Overall Study|Adverse Event|0|||
155598355|NCT03614078|561616535|FG000|Overall Study|Dizziness and Rash|0|||
155598356|NCT03614078|561616536|FG001|Overall Study|Dizziness and Rash|1|||
155598357|NCT03614078|561616537|FG002|Overall Study|Dizziness and Rash|0|||
155598358|NCT03729570|561616542|FG000|Overall Study|Lost to Follow-up|16|||
155598359|NCT03729570|561616543|FG001|Overall Study|Lost to Follow-up|20|||
155598360|NCT03729570|561616542|FG000|Overall Study|Seroconversion|5|||
155598361|NCT03729570|561616543|FG001|Overall Study|Seroconversion|0|||
155598362|NCT03729570|561616542|FG000|Overall Study|Moved out of the city|1|||
155598363|NCT03729570|561616543|FG001|Overall Study|Moved out of the city|0|||
155598364|NCT03729570|561616542|FG000|Overall Study|Time Conflict|1|||
155598365|NCT03729570|561616543|FG001|Overall Study|Time Conflict|0|||
155598366|NCT03729570|561616542|FG000|Overall Study|Time Commitment|2|||
155598367|NCT03729570|561616543|FG001|Overall Study|Time Commitment|0|||
155598368|NCT03729570|561616542|FG000|Overall Study|Bad Experience|0|||
155598369|NCT03729570|561616543|FG001|Overall Study|Bad Experience|1|||
155598370|NCT03729570|561616542|FG000|Overall Study|No reason provided|2|||
155598371|NCT03729570|561616543|FG001|Overall Study|No reason provided|1|||
155598372|NCT03729570|561616542|FG000|Overall Study|Family Conflict|0|||
155598373|NCT03729570|561616543|FG001|Overall Study|Family Conflict|1|||
155598374|NCT03729570|561616542|FG000|Overall Study|Did not want to continue taking medications|0|||
155598375|NCT03729570|561616543|FG001|Overall Study|Did not want to continue taking medications|1|||
155598376|NCT03729570|561616542|FG000|Overall Study|Found another PrEP provider|1|||
155598377|NCT03729570|561616543|FG001|Overall Study|Found another PrEP provider|0|||
155598378|NCT03729570|561616542|FG000|Overall Study|Did not enjoy being in the control group|0|||
155598379|NCT03729570|561616543|FG001|Overall Study|Did not enjoy being in the control group|1|||
155598380|NCT01867294|561616548|FG000|Overall Study|Withdrawal by Subject|1|||
155598381|NCT01867294|561616549|FG001|Overall Study|Withdrawal by Subject|1|||
155598382|NCT01867294|561616550|FG002|Overall Study|Withdrawal by Subject|0|||
155598383|NCT01867294|561616551|FG003|Overall Study|Withdrawal by Subject|0|||
155598384|NCT00631410|561616552|FG000|Overall Study|Adverse Event|1|||
155598385|NCT00631410|561616553|FG001|Overall Study|Adverse Event|3|||
155598386|NCT00631410|561616552|FG000|Overall Study|Objective Progression or Relapse|4|||
155598387|NCT00631410|561616553|FG001|Overall Study|Objective Progression or Relapse|3|||
155598388|NCT00631410|561616552|FG000|Overall Study|Surgery|1|||
155598389|NCT00631410|561616553|FG001|Overall Study|Surgery|0|||
155598390|NCT01322035|561616555|FG000|Overall Study|Lost to Follow-up|8|||
155598391|NCT01322035|561616556|FG001|Overall Study|Lost to Follow-up|3|||
155598392|NCT00727844|561616557|FG000|Initial Randomization|Physician Decision|2|||
155670393|NCT00540592|561888044|FG004|Overall Study|Withdrawal by Subject|0|||
155670394|NCT00540592|561888045|FG005|Overall Study|Withdrawal by Subject|0|||
155670395|NCT00540592|561888046|FG006|Overall Study|Withdrawal by Subject|0|||
155670396|NCT00540592|561888047|FG007|Overall Study|Withdrawal by Subject|0|||
155670397|NCT00540592|561888048|FG008|Overall Study|Withdrawal by Subject|0|||
155670398|NCT00540592|561888049|FG009|Overall Study|Withdrawal by Subject|0|||
155670399|NCT04908683|561888051|FG000|Overall Study|Failure to meet continuation criteria|34|||
155670400|NCT04908683|561888052|FG001|Overall Study|Failure to meet continuation criteria|22|||
155670401|NCT04908683|561888051|FG000|Overall Study|Initiated prohibited medication|3|||
155670402|NCT04908683|561888052|FG001|Overall Study|Initiated prohibited medication|0|||
155670403|NCT04908683|561888051|FG000|Overall Study|Randomized by mistake|1|||
155670404|NCT04908683|561888052|FG001|Overall Study|Randomized by mistake|0|||
155670405|NCT04908683|561888051|FG000|Overall Study|Lost to Follow-up|679|||
155670406|NCT04908683|561888052|FG001|Overall Study|Lost to Follow-up|341|||
155670407|NCT04908683|561888051|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
155670408|NCT04908683|561888052|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
155670409|NCT04908683|561888051|FG000|Overall Study|Physician Decision|44|||
155670410|NCT04908683|561888052|FG001|Overall Study|Physician Decision|35|||
155670411|NCT04908683|561888051|FG000|Overall Study|Technical problems|12|||
155670412|NCT04908683|561888052|FG001|Overall Study|Technical problems|9|||
155670413|NCT04908683|561888051|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
155670414|NCT04908683|561888052|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
155670415|NCT04908683|561888051|FG000|Overall Study|Protocol Violation|2|||
155670416|NCT04908683|561888052|FG001|Overall Study|Protocol Violation|0|||
155670417|NCT04908683|561888051|FG000|Overall Study|Withdrawal by Subject|1188|||
155670418|NCT04908683|561888052|FG001|Overall Study|Withdrawal by Subject|570|||
155670419|NCT04908683|561888051|FG000|Overall Study|Site Closure by Sponsor|6|||
155670420|NCT04908683|561888052|FG001|Overall Study|Site Closure by Sponsor|3|||
155670421|NCT04908683|561888051|FG000|Overall Study|Adverse Event|21|||
155670422|NCT04908683|561888052|FG001|Overall Study|Adverse Event|11|||
155670423|NCT04908683|561888051|FG000|Overall Study|Death|101|||
155670424|NCT04908683|561888052|FG001|Overall Study|Death|61|||
155670425|NCT04908683|561888051|FG000|Overall Study|Sponsor's decision|14398|||
155670426|NCT04908683|561888052|FG001|Overall Study|Sponsor's decision|7205|||
155670427|NCT04908683|561888051|FG000|Overall Study|Other|92|||
155670428|NCT04908683|561888052|FG001|Overall Study|Other|50|||
155670429|NCT04908683|561888051|FG000|Overall Study|Randomized not vaccinated|108|||
155598393|NCT00727844|561616558|FG001|Initial Randomization|Physician Decision|0|||
155670430|NCT04908683|561888052|FG001|Overall Study|Randomized not vaccinated|52|||
155598394|NCT00727844|561616559|FG002|Initial Randomization|Physician Decision|0|||
155598395|NCT00727844|561616560|FG003|Initial Randomization|Physician Decision|0|||
155598396|NCT04569968|561616561|FG000|Overall Study|Lost to Follow-up|2|||
155598397|NCT04569968|561616562|FG001|Overall Study|Lost to Follow-up|5|||
155598398|NCT04569968|561616561|FG000|Overall Study|Story of head and/or neck surgery|2|||
155598399|NCT04569968|561616562|FG001|Overall Study|Story of head and/or neck surgery|2|||
155598400|NCT04569968|561616561|FG000|Overall Study|Time of stroke onset|8|||
155598401|NCT04569968|561616562|FG001|Overall Study|Time of stroke onset|7|||
155598402|NCT04569968|561616561|FG000|Overall Study|Type of strokr|12|||
155598403|NCT04569968|561616562|FG001|Overall Study|Type of strokr|8|||
155598404|NCT04569968|561616561|FG000|Overall Study|Cooperation|8|||
155598405|NCT04569968|561616562|FG001|Overall Study|Cooperation|8|||
155598406|NCT04569968|561616561|FG000|Overall Study|Age interval|17|||
155670431|NCT05507567|561888053|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
155670432|NCT05507567|561888054|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
155670433|NCT05507567|561888055|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
155670434|NCT05507567|561888053|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
155670435|NCT05507567|561888054|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
155598407|NCT04569968|561616562|FG001|Overall Study|Age interval|6|||
155670436|NCT05507567|561888055|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
155670437|NCT05507567|561888053|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
155670438|NCT05507567|561888054|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
155670439|NCT05507567|561888055|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
155670440|NCT05507567|561888053|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
155670441|NCT05507567|561888054|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
155670442|NCT05507567|561888055|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
155670443|NCT01722994|561888058|FG000|Overall Study|Missing data|25|||
155670444|NCT01722994|561888059|FG001|Overall Study|Missing data|17|||
155670445|NCT01206140|561888060|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
155670446|NCT01206140|561888061|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
155670447|NCT01803880|561888062|FG000|Overall Study|Adverse Event|1|||
155670448|NCT01803880|561888063|FG001|Overall Study|Adverse Event|0|||
155670449|NCT01803880|561888064|FG002|Overall Study|Adverse Event|0|||
155670450|NCT01803880|561888062|FG000|Overall Study|Withdrawal by Subject|1|||
155670451|NCT01803880|561888063|FG001|Overall Study|Withdrawal by Subject|1|||
155670452|NCT01803880|561888064|FG002|Overall Study|Withdrawal by Subject|4|||
155670453|NCT01803880|561888062|FG000|Overall Study|Physician Decision|0|||
155670454|NCT01803880|561888063|FG001|Overall Study|Physician Decision|0|||
155670455|NCT01803880|561888064|FG002|Overall Study|Physician Decision|1|||
155670456|NCT01803880|561888062|FG000|Overall Study|Unable to return for follow-up visits|0|||
155670457|NCT01803880|561888063|FG001|Overall Study|Unable to return for follow-up visits|1|||
155670458|NCT01803880|561888064|FG002|Overall Study|Unable to return for follow-up visits|2|||
155670459|NCT01803880|561888062|FG000|Overall Study|Lost to Follow-up|1|||
155670460|NCT01803880|561888063|FG001|Overall Study|Lost to Follow-up|2|||
155670461|NCT01803880|561888064|FG002|Overall Study|Lost to Follow-up|3|||
155670462|NCT01803880|561888062|FG000|Overall Study|Protocol Violation|1|||
155670463|NCT01803880|561888063|FG001|Overall Study|Protocol Violation|0|||
155670464|NCT01803880|561888064|FG002|Overall Study|Protocol Violation|0|||
155670465|NCT01803880|561888062|FG000|Overall Study|Early study termination|0|||
155670466|NCT01803880|561888063|FG001|Overall Study|Early study termination|6|||
155670467|NCT01803880|561888064|FG002|Overall Study|Early study termination|5|||
155670468|NCT01803880|561888062|FG000|Overall Study|Incomplete data entry by sites|2|||
155670469|NCT01803880|561888063|FG001|Overall Study|Incomplete data entry by sites|0|||
155670470|NCT01803880|561888064|FG002|Overall Study|Incomplete data entry by sites|0|||
155670471|NCT01766037|561888065|FG000|Overall Study|Adverse Event|1|||
155670472|NCT01766037|561888066|FG001|Overall Study|Adverse Event|0|||
155670473|NCT01766037|561888065|FG000|Overall Study|Lack of Efficacy|1|||
155670474|NCT01766037|561888066|FG001|Overall Study|Lack of Efficacy|0|||
155670475|NCT01766037|561888065|FG000|Overall Study|Lost to Follow-up|0|||
155670476|NCT01766037|561888066|FG001|Overall Study|Lost to Follow-up|10|||
155670477|NCT01766037|561888065|FG000|Overall Study|Physician Decision|0|||
155670478|NCT01766037|561888066|FG001|Overall Study|Physician Decision|1|||
155670479|NCT01766037|561888065|FG000|Overall Study|Withdrawal by Subject|18|||
155670480|NCT01766037|561888066|FG001|Overall Study|Withdrawal by Subject|16|||
155670481|NCT01766037|561888065|FG000|Overall Study|Moved from area|5|||
155670482|NCT01766037|561888066|FG001|Overall Study|Moved from area|0|||
155670483|NCT01766037|561888065|FG000|Overall Study|medical - unrelated|1|||
155670484|NCT01766037|561888066|FG001|Overall Study|medical - unrelated|2|||
155670485|NCT01766037|561888065|FG000|Overall Study|nausea / discomfort|3|||
155670486|NCT01766037|561888066|FG001|Overall Study|nausea / discomfort|0|||
155670487|NCT05226598|561888068|FG000|Overall Study|Death|186|||
155670488|NCT05226598|561888069|FG001|Overall Study|Death|191|||
155670489|NCT05226598|561888068|FG000|Overall Study|Withdrawal by Subject|6|||
155670490|NCT05226598|561888069|FG001|Overall Study|Withdrawal by Subject|6|||
155670491|NCT05226598|561888068|FG000|Overall Study|Ongoing|174|||
155670492|NCT05226598|561888069|FG001|Overall Study|Ongoing|176|||
155670493|NCT00090779|561888070|FG000|Step 1|Withdrawal by Subject|4|||
155670494|NCT00090779|561888071|FG001|Step 1|Withdrawal by Subject|2|||
155670495|NCT00090779|561888070|FG000|Step 1|Lost to Follow-up|3|||
155670496|NCT00090779|561888071|FG001|Step 1|Lost to Follow-up|2|||
155670497|NCT00090779|561888070|FG000|Step 1|Death|0|||
155670498|NCT00090779|561888071|FG001|Step 1|Death|2|||
155670499|NCT00090779|561888070|FG000|Step 1|Physician Decision|1|||
155670500|NCT00090779|561888071|FG001|Step 1|Physician Decision|0|||
155670501|NCT00090779|561888070|FG000|Step 1|Pregnancy|1|||
155670502|NCT00090779|561888071|FG001|Step 1|Pregnancy|0|||
155670503|NCT00090779|561888070|FG000|Step 1|Non-compliance to study requirements|0|||
155670504|NCT00090779|561888071|FG001|Step 1|Non-compliance to study requirements|1|||
155670505|NCT00090779|561888070|FG000|Step 1|Subject relocated|2|||
155670506|NCT00090779|561888071|FG001|Step 1|Subject relocated|8|||
155670507|NCT00090779|561888070|FG000|Step 2|Off study per study closure|6|||
155670508|NCT00090779|561888071|FG001|Step 2|Off study per study closure|16|||
155670509|NCT00090779|561888070|FG000|Step 2|Subject relocated|0|||
155670510|NCT00090779|561888071|FG001|Step 2|Subject relocated|1|||
155670511|NCT00090779|561888070|FG000|Step 2|Non-compliance to study requirements|0|||
155670512|NCT00090779|561888071|FG001|Step 2|Non-compliance to study requirements|1|||
155598408|NCT04569968|561616561|FG000|Overall Study|Denial of participation to the study|0|||
155598409|NCT04569968|561616562|FG001|Overall Study|Denial of participation to the study|3|||
155598410|NCT04569968|561616561|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
155598411|NCT04569968|561616562|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
155598412|NCT04569968|561616561|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
155598413|NCT04569968|561616562|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
155598414|NCT04569968|561616561|FG000|Overall Study|Quarantine|1|||
155598415|NCT04569968|561616562|FG001|Overall Study|Quarantine|0|||
155598416|NCT04569968|561616561|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
155598417|NCT04569968|561616562|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
155598418|NCT04569968|561616561|FG000|Overall Study|Repetitive stroke|8|||
155598419|NCT04569968|561616562|FG001|Overall Study|Repetitive stroke|0|||
155598420|NCT04569968|561616561|FG000|Overall Study|Insufficient mastication|1|||
155598421|NCT04569968|561616562|FG001|Overall Study|Insufficient mastication|0|||
155598422|NCT04569968|561616561|FG000|Overall Study|Infection|1|||
155598423|NCT04569968|561616562|FG001|Overall Study|Infection|0|||
155598424|NCT03843632|561616578|FG000|Overall Study|Withdrawal by Subject|1|||
155598425|NCT03843632|561616579|FG001|Overall Study|Withdrawal by Subject|0|||
155598426|NCT03843632|561616580|FG002|Overall Study|Withdrawal by Subject|0|||
155598427|NCT03843632|561616581|FG003|Overall Study|Withdrawal by Subject|0|||
155598428|NCT03085238|561616582|FG000|Overall Study|Adverse Event|2|||
155598429|NCT03085238|561616582|FG000|Overall Study|Death|2|||
155598430|NCT01931956|561616586|FG000|Overall Study|Death|42|||
155598431|NCT01931956|561616587|FG001|Overall Study|Death|7|||
155598432|NCT01931956|561616588|FG002|Overall Study|Death|379|||
155598433|NCT01931956|561616589|FG003|Overall Study|Death|96|||
155598434|NCT01931956|561616586|FG000|Overall Study|Withdrawal by Subject|5|||
155598435|NCT01931956|561616587|FG001|Overall Study|Withdrawal by Subject|0|||
155598436|NCT01931956|561616588|FG002|Overall Study|Withdrawal by Subject|70|||
155598437|NCT01931956|561616589|FG003|Overall Study|Withdrawal by Subject|30|||
155598438|NCT01931956|561616586|FG000|Overall Study|Lost to Follow-up|2|||
155598439|NCT01931956|561616587|FG001|Overall Study|Lost to Follow-up|0|||
155598440|NCT01931956|561616588|FG002|Overall Study|Lost to Follow-up|11|||
155670513|NCT00090779|561888070|FG000|Step 3|Initiation of ART and off extended study|3|||
155670514|NCT00090779|561888071|FG001|Step 3|Initiation of ART and off extended study|2|||
155670515|NCT00090779|561888070|FG000|Step 3|Off extended study due to study closure|4|||
155670516|NCT00090779|561888071|FG001|Step 3|Off extended study due to study closure|3|||
155670517|NCT03951766|561888074|FG000|Treatment Phase|Lost to Follow-up|1|||
155670518|NCT03951766|561888074|FG000|Follow-up Phase|Lost to Follow-up|10|||
155670519|NCT01162473|561888079|FG000|Overall Study|Adverse Event|2|||
155670520|NCT01162473|561888080|FG001|Overall Study|Adverse Event|1|||
155670521|NCT01162473|561888079|FG000|Overall Study|Withdrawal by Subject|0|||
155670522|NCT01162473|561888080|FG001|Overall Study|Withdrawal by Subject|4|||
155670523|NCT01144416|561888081|FG000|Intervention Period|Adverse Event|5|||
155670524|NCT01144416|561888082|FG001|Intervention Period|Adverse Event|6|||
155670525|NCT01144416|561888081|FG000|Intervention Period|Insufficient ovarian response|11|||
155670526|NCT01144416|561888082|FG001|Intervention Period|Insufficient ovarian response|17|||
155670527|NCT01144416|561888081|FG000|Intervention Period|Risk of OHSS|0|||
155670528|NCT01144416|561888082|FG001|Intervention Period|Risk of OHSS|1|||
155670529|NCT01144416|561888081|FG000|Intervention Period|Too high ovarian response|4|||
155670530|NCT01144416|561888082|FG001|Intervention Period|Too high ovarian response|2|||
155670531|NCT01144416|561888081|FG000|Intervention Period|No/too few/bad oocytes|7|||
155670532|NCT01144416|561888082|FG001|Intervention Period|No/too few/bad oocytes|5|||
155670533|NCT01144416|561888081|FG000|Intervention Period|No or abnormal fertilization|25|||
155670534|NCT01144416|561888082|FG001|Intervention Period|No or abnormal fertilization|10|||
155670535|NCT01144416|561888081|FG000|Intervention Period|No/too few/bad quality embryos|3|||
155670536|NCT01144416|561888082|FG001|Intervention Period|No/too few/bad quality embryos|3|||
155670537|NCT01144416|561888081|FG000|Intervention Period|Other|7|||
155670538|NCT01144416|561888082|FG001|Intervention Period|Other|5|||
155598441|NCT01931956|561616589|FG003|Overall Study|Lost to Follow-up|7|||
155598442|NCT01931956|561616586|FG000|Overall Study|Expected|2|||
155670539|NCT00132301|561888086|FG000|Overall Study|Death|7|||
155598443|NCT01931956|561616587|FG001|Overall Study|Expected|0|||
155598444|NCT01931956|561616588|FG002|Overall Study|Expected|6|||
155598445|NCT01931956|561616589|FG003|Overall Study|Expected|0|||
155670540|NCT00132301|561888087|FG001|Overall Study|Death|6|||
155598446|NCT01931956|561616586|FG000|Overall Study|Not due|0|||
155598447|NCT01931956|561616587|FG001|Overall Study|Not due|0|||
155598448|NCT01931956|561616588|FG002|Overall Study|Not due|21|||
155598449|NCT01931956|561616589|FG003|Overall Study|Not due|0|||
155670541|NCT00132301|561888086|FG000|Overall Study|Withdrawal by Subject|5|||
155670542|NCT00132301|561888087|FG001|Overall Study|Withdrawal by Subject|2|||
155670543|NCT00132301|561888086|FG000|Overall Study|Physician Decision|1|||
155598450|NCT02847494|561616590|FG000|Overall Study|Lost to Follow-up|8|||
155670544|NCT00132301|561888087|FG001|Overall Study|Physician Decision|1|||
155670545|NCT00132301|561888086|FG000|Overall Study|Lost to Follow-up|5|||
155670546|NCT00132301|561888087|FG001|Overall Study|Lost to Follow-up|3|||
155670547|NCT00132301|561888086|FG000|Overall Study|Other|1|||
155670548|NCT00132301|561888087|FG001|Overall Study|Other|1|||
155670549|NCT00132301|561888086|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
155670550|NCT00132301|561888087|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
155670551|NCT00996658|561888088|FG000|Overall Study|Adverse Event|2|||
155670552|NCT00996658|561888089|FG001|Overall Study|Adverse Event|5|||
155670553|NCT00996658|561888088|FG000|Overall Study|Protocol Violation|0|||
155670554|NCT00996658|561888089|FG001|Overall Study|Protocol Violation|1|||
155670555|NCT00996658|561888088|FG000|Overall Study|Lost to Follow-up|2|||
155670556|NCT00996658|561888089|FG001|Overall Study|Lost to Follow-up|5|||
155670557|NCT00996658|561888088|FG000|Overall Study|Non-compliance issues|3|||
155670558|NCT00996658|561888089|FG001|Overall Study|Non-compliance issues|3|||
155670559|NCT00996658|561888088|FG000|Overall Study|Other|9|||
155670560|NCT00996658|561888089|FG001|Overall Study|Other|7|||
155670561|NCT02685826|561888094|FG000|Overall Study|Adverse Event|2|||
155670562|NCT02685826|561888095|FG001|Overall Study|Adverse Event|0|||
155670563|NCT02685826|561888096|FG002|Overall Study|Adverse Event|1|||
155670564|NCT02685826|561888094|FG000|Overall Study|Progressive Disease|2|||
155670565|NCT02685826|561888095|FG001|Overall Study|Progressive Disease|1|||
155670566|NCT02685826|561888096|FG002|Overall Study|Progressive Disease|0|||
155670567|NCT02685826|561888094|FG000|Overall Study|Withdrawal by Subject|2|||
155670568|NCT02685826|561888095|FG001|Overall Study|Withdrawal by Subject|0|||
155670569|NCT02685826|561888096|FG002|Overall Study|Withdrawal by Subject|0|||
155670570|NCT02685826|561888094|FG000|Overall Study|Full Clinical Hold by FDA|19|||
155670571|NCT02685826|561888095|FG001|Overall Study|Full Clinical Hold by FDA|9|||
155670572|NCT02685826|561888096|FG002|Overall Study|Full Clinical Hold by FDA|20|||
155670573|NCT03154476|561888097|FG000|Overall Study|Lost to Follow-up|4|||
155670574|NCT03154476|561888098|FG001|Overall Study|Lost to Follow-up|4|||
155670575|NCT01444430|561888100|FG000|Overall Study|Withdrawal by Subject|53|||
155670576|NCT01444430|561888101|FG001|Overall Study|Withdrawal by Subject|72|||
155670577|NCT01444430|561888100|FG000|Overall Study|Death|6|||
155670578|NCT01444430|561888101|FG001|Overall Study|Death|8|||
155670579|NCT01444430|561888100|FG000|Overall Study|Lost to Follow-up|2|||
155670580|NCT01444430|561888101|FG001|Overall Study|Lost to Follow-up|0|||
155670581|NCT01444430|561888100|FG000|Overall Study|CRF termination module not completed.|0|||
155670582|NCT01444430|561888101|FG001|Overall Study|CRF termination module not completed.|1|||
155670583|NCT03640325|561889498|FG000|Overall Study|Withdrawal by Subject|4|||
155670584|NCT03640325|561889499|FG001|Overall Study|Withdrawal by Subject|1|||
155670585|NCT03640325|561889500|FG002|Overall Study|Withdrawal by Subject|0|||
155670586|NCT03640325|561889498|FG000|Overall Study|Lost to Follow-up|4|||
155670587|NCT03640325|561889499|FG001|Overall Study|Lost to Follow-up|5|||
155670588|NCT03640325|561889500|FG002|Overall Study|Lost to Follow-up|21|||
155670589|NCT03640325|561889498|FG000|Overall Study|Death|5|||
155670590|NCT03640325|561889499|FG001|Overall Study|Death|5|||
155670591|NCT03640325|561889500|FG002|Overall Study|Death|0|||
155670592|NCT03493451|561889501|FG000|Overall Study|Death|11|||
155670593|NCT03493451|561889502|FG001|Overall Study|Death|26|||
155598451|NCT02847494|561616591|FG001|Overall Study|Lost to Follow-up|5|||
155598452|NCT02294175|561616592|FG000|Overall Study|Withdrawal by Subject|1|||
155598453|NCT02294175|561616593|FG001|Overall Study|Withdrawal by Subject|2|||
155598454|NCT02294175|561616592|FG000|Overall Study|pt taking excluded medication|3|||
155598455|NCT02294175|561616593|FG001|Overall Study|pt taking excluded medication|1|||
155598456|NCT02294175|561616592|FG000|Overall Study|Protocol Violation|1|||
155598457|NCT02294175|561616593|FG001|Overall Study|Protocol Violation|0|||
155598458|NCT02294175|561616592|FG000|Overall Study|Lost to Follow-up|0|||
155598459|NCT02294175|561616593|FG001|Overall Study|Lost to Follow-up|1|||
155598460|NCT02294175|561616592|FG000|Overall Study|wound healed|0|||
155598461|NCT02294175|561616593|FG001|Overall Study|wound healed|2|||
155598462|NCT01901653|561616594|FG000|Overall Study|Death|2|||
155598463|NCT01901653|561616595|FG001|Overall Study|Death|1|||
155598464|NCT01901653|561616596|FG002|Overall Study|Death|8|||
155598465|NCT01901653|561616597|FG003|Overall Study|Death|3|||
155598466|NCT01901653|561616598|FG004|Overall Study|Death|2|||
155598467|NCT01901653|561616599|FG005|Overall Study|Death|2|||
155598468|NCT01901653|561616600|FG006|Overall Study|Death|6|||
155598469|NCT01901653|561616601|FG007|Overall Study|Death|9|||
155598470|NCT01901653|561616602|FG008|Overall Study|Death|1|||
155598471|NCT01901653|561616603|FG009|Overall Study|Death|16|||
155598472|NCT01901653|561616604|FG010|Overall Study|Death|2|||
155598473|NCT01901653|561616605|FG011|Overall Study|Death|15|||
155670594|NCT03493451|561889503|FG002|Overall Study|Death|3|||
155670595|NCT03493451|561889501|FG000|Overall Study|Lost to Follow-up|1|||
155670596|NCT03493451|561889502|FG001|Overall Study|Lost to Follow-up|4|||
155670597|NCT03493451|561889503|FG002|Overall Study|Lost to Follow-up|1|||
155670598|NCT03493451|561889501|FG000|Overall Study|Withdrawal by Subject|1|||
155670599|NCT03493451|561889502|FG001|Overall Study|Withdrawal by Subject|1|||
155670600|NCT03493451|561889503|FG002|Overall Study|Withdrawal by Subject|2|||
155670601|NCT03493451|561889501|FG000|Overall Study|Progressive Disease|1|||
155670602|NCT03493451|561889502|FG001|Overall Study|Progressive Disease|0|||
155598474|NCT01901653|561616606|FG012|Overall Study|Death|4|||
155598475|NCT01901653|561616594|FG000|Overall Study|Lost to Follow-up|1|||
155598476|NCT01901653|561616595|FG001|Overall Study|Lost to Follow-up|0|||
155598477|NCT01901653|561616596|FG002|Overall Study|Lost to Follow-up|2|||
155598478|NCT01901653|561616597|FG003|Overall Study|Lost to Follow-up|0|||
155598479|NCT01901653|561616598|FG004|Overall Study|Lost to Follow-up|0|||
155598480|NCT01901653|561616599|FG005|Overall Study|Lost to Follow-up|1|||
155598481|NCT01901653|561616600|FG006|Overall Study|Lost to Follow-up|0|||
155598482|NCT01901653|561616601|FG007|Overall Study|Lost to Follow-up|1|||
155598483|NCT01901653|561616602|FG008|Overall Study|Lost to Follow-up|0|||
155598484|NCT01901653|561616603|FG009|Overall Study|Lost to Follow-up|0|||
155598485|NCT01901653|561616604|FG010|Overall Study|Lost to Follow-up|0|||
155598486|NCT01901653|561616605|FG011|Overall Study|Lost to Follow-up|0|||
155598487|NCT01901653|561616606|FG012|Overall Study|Lost to Follow-up|0|||
155598488|NCT01901653|561616594|FG000|Overall Study|Withdrawal by Subject|0|||
155598489|NCT01901653|561616595|FG001|Overall Study|Withdrawal by Subject|0|||
155598490|NCT01901653|561616596|FG002|Overall Study|Withdrawal by Subject|0|||
155598491|NCT01901653|561616597|FG003|Overall Study|Withdrawal by Subject|0|||
155598492|NCT01901653|561616598|FG004|Overall Study|Withdrawal by Subject|0|||
155598493|NCT01901653|561616599|FG005|Overall Study|Withdrawal by Subject|0|||
155598494|NCT01901653|561616600|FG006|Overall Study|Withdrawal by Subject|1|||
155598495|NCT01901653|561616601|FG007|Overall Study|Withdrawal by Subject|0|||
155598496|NCT01901653|561616602|FG008|Overall Study|Withdrawal by Subject|0|||
155598497|NCT01901653|561616603|FG009|Overall Study|Withdrawal by Subject|0|||
155598498|NCT01901653|561616604|FG010|Overall Study|Withdrawal by Subject|0|||
155598499|NCT01901653|561616605|FG011|Overall Study|Withdrawal by Subject|0|||
155598500|NCT01901653|561616606|FG012|Overall Study|Withdrawal by Subject|0|||
155598501|NCT01901653|561616594|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
155598502|NCT01901653|561616595|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
155598503|NCT01901653|561616596|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
155598504|NCT01901653|561616597|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
155598505|NCT01901653|561616598|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
155598506|NCT01901653|561616599|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
155598507|NCT01901653|561616600|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
155598508|NCT01901653|561616601|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
155598509|NCT01901653|561616602|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
155598510|NCT01901653|561616603|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
155598511|NCT01901653|561616604|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
155598512|NCT01901653|561616605|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
155598513|NCT01901653|561616606|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
155598514|NCT02548351|561616607|FG000|Overall Study|Withdrawal by Subject|149|||
155598515|NCT02548351|561616608|FG001|Overall Study|Withdrawal by Subject|154|||
155598516|NCT02548351|561616609|FG002|Overall Study|Withdrawal by Subject|152|||
155598517|NCT02548351|561616607|FG000|Overall Study|Death|11|||
155598518|NCT02548351|561616608|FG001|Overall Study|Death|15|||
155598519|NCT02548351|561616609|FG002|Overall Study|Death|12|||
155598520|NCT02548351|561616607|FG000|Overall Study|Adverse Event|22|||
155598521|NCT02548351|561616608|FG001|Overall Study|Adverse Event|56|||
155598522|NCT02548351|561616609|FG002|Overall Study|Adverse Event|36|||
155598523|NCT02548351|561616607|FG000|Overall Study|Study Terminated by Sponsor|549|||
155598524|NCT02548351|561616608|FG001|Overall Study|Study Terminated by Sponsor|509|||
155598525|NCT02548351|561616609|FG002|Overall Study|Study Terminated by Sponsor|528|||
155598526|NCT02548351|561616607|FG000|Overall Study|Site Closure|14|||
155598527|NCT02548351|561616608|FG001|Overall Study|Site Closure|5|||
155598528|NCT02548351|561616609|FG002|Overall Study|Site Closure|7|||
155598529|NCT02548351|561616607|FG000|Overall Study|Non-compliance with Study Drug|4|||
155598530|NCT02548351|561616608|FG001|Overall Study|Non-compliance with Study Drug|2|||
155598531|NCT02548351|561616609|FG002|Overall Study|Non-compliance with Study Drug|0|||
155598532|NCT02548351|561616607|FG000|Overall Study|Protocol Violation|2|||
155598533|NCT02548351|561616608|FG001|Overall Study|Protocol Violation|1|||
155598534|NCT02548351|561616609|FG002|Overall Study|Protocol Violation|2|||
155598535|NCT02548351|561616607|FG000|Overall Study|Physician Decision|11|||
155598536|NCT02548351|561616608|FG001|Overall Study|Physician Decision|18|||
155598537|NCT02548351|561616609|FG002|Overall Study|Physician Decision|11|||
155598538|NCT02548351|561616607|FG000|Overall Study|Lost to Follow-up|43|||
155598539|NCT02548351|561616608|FG001|Overall Study|Lost to Follow-up|50|||
155598540|NCT02548351|561616609|FG002|Overall Study|Lost to Follow-up|57|||
155598541|NCT02548351|561616607|FG000|Overall Study|Other|19|||
155598542|NCT02548351|561616608|FG001|Overall Study|Other|16|||
155598543|NCT02548351|561616609|FG002|Overall Study|Other|20|||
155598544|NCT02548351|561616607|FG000|Overall Study|Missing|1|||
155598545|NCT02548351|561616608|FG001|Overall Study|Missing|1|||
155598546|NCT02548351|561616609|FG002|Overall Study|Missing|0|||
155598547|NCT03226769|561616615|FG000|Overall Study|Withdrawal by Subject|0|||
155598548|NCT03226769|561616616|FG001|Overall Study|Withdrawal by Subject|1|||
155598549|NCT02640677|561616617|FG000|Overall Study|Lost to Follow-up|1|||
155598550|NCT02640677|561616617|FG000|Overall Study|Withdrawal by Subject|1|||
155670603|NCT03493451|561889503|FG002|Overall Study|Progressive Disease|0|||
155670604|NCT03493451|561889501|FG000|Overall Study|Transferred to long term extension study|8|||
155670605|NCT03493451|561889502|FG001|Overall Study|Transferred to long term extension study|13|||
155670606|NCT03493451|561889503|FG002|Overall Study|Transferred to long term extension study|5|||
155670607|NCT01566149|561889506|FG000|Overall Study|Adverse Event|0|||
155670608|NCT01566149|561889507|FG001|Overall Study|Adverse Event|1|||
155670609|NCT01566149|561889506|FG000|Overall Study|Non-compliance with study medication|2|||
155670610|NCT01566149|561889507|FG001|Overall Study|Non-compliance with study medication|0|||
155670611|NCT01566149|561889506|FG000|Overall Study|Protocol Violation|0|||
155670612|NCT01566149|561889507|FG001|Overall Study|Protocol Violation|1|||
155670613|NCT01566149|561889506|FG000|Overall Study|Withdrawal by Subject|1|||
155670614|NCT01566149|561889507|FG001|Overall Study|Withdrawal by Subject|0|||
155670615|NCT03687957|561889512|FG000|Overall Study|Withdrawal by Subject|0|||
155670616|NCT03687957|561889513|FG001|Overall Study|Withdrawal by Subject|0|||
155670617|NCT03687957|561889514|FG002|Overall Study|Withdrawal by Subject|0|||
155670618|NCT03687957|561889515|FG003|Overall Study|Withdrawal by Subject|2|||
155670619|NCT03687957|561889516|FG004|Overall Study|Withdrawal by Subject|0|||
155670620|NCT03687957|561889517|FG005|Overall Study|Withdrawal by Subject|0|||
155670621|NCT03687957|561889518|FG006|Overall Study|Withdrawal by Subject|3|||
155670622|NCT03687957|561889519|FG007|Overall Study|Withdrawal by Subject|1|||
155670623|NCT03687957|561889520|FG008|Overall Study|Withdrawal by Subject|1|||
155670624|NCT03687957|561889521|FG009|Overall Study|Withdrawal by Subject|0|||
155670625|NCT03687957|561889512|FG000|Overall Study|Disease progression|0|||
155670626|NCT03687957|561889513|FG001|Overall Study|Disease progression|1|||
155670627|NCT03687957|561889514|FG002|Overall Study|Disease progression|1|||
155670628|NCT03687957|561889515|FG003|Overall Study|Disease progression|2|||
155670629|NCT03687957|561889516|FG004|Overall Study|Disease progression|2|||
155670630|NCT03687957|561889517|FG005|Overall Study|Disease progression|0|||
155670631|NCT03687957|561889518|FG006|Overall Study|Disease progression|2|||
155670632|NCT03687957|561889519|FG007|Overall Study|Disease progression|1|||
155670633|NCT03687957|561889520|FG008|Overall Study|Disease progression|0|||
155598551|NCT04553471|561616618|FG000|Overall Study|Did not start treatment on protocol|3|||
155598552|NCT04553471|561616618|FG000|Overall Study|Death|1|||
155598553|NCT02778074|561616620|FG000|Overall Study|Lost to Follow-up|7|||
155598554|NCT02778074|561616621|FG001|Overall Study|Lost to Follow-up|10|||
155598555|NCT01684943|561616624|FG000|Overall Study|Inadequate Venous Access|3|||
155598556|NCT01684943|561616625|FG001|Overall Study|Inadequate Venous Access|0|||
155598557|NCT01684943|561616626|FG002|Overall Study|Inadequate Venous Access|0|||
155598558|NCT01684943|561616624|FG000|Overall Study|Principal Investigator Determination|1|||
155598559|NCT01684943|561616625|FG001|Overall Study|Principal Investigator Determination|0|||
155598560|NCT01684943|561616626|FG002|Overall Study|Principal Investigator Determination|0|||
155598561|NCT01684943|561616624|FG000|Overall Study|Excluded from Analysis|1|||
155598562|NCT01684943|561616625|FG001|Overall Study|Excluded from Analysis|1|||
155598563|NCT01684943|561616626|FG002|Overall Study|Excluded from Analysis|1|||
155598564|NCT01684943|561616624|FG000|Overall Study|Lost to Follow-up|3|||
155598565|NCT01684943|561616625|FG001|Overall Study|Lost to Follow-up|0|||
155598566|NCT01684943|561616626|FG002|Overall Study|Lost to Follow-up|0|||
155598567|NCT01684943|561616624|FG000|Overall Study|Planning Pregnancy|1|||
155598568|NCT01684943|561616625|FG001|Overall Study|Planning Pregnancy|0|||
155598569|NCT01684943|561616626|FG002|Overall Study|Planning Pregnancy|0|||
155598570|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
155598571|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
155598572|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
155598573|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155598574|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155598575|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155598576|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155598577|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155670634|NCT03687957|561889521|FG009|Overall Study|Disease progression|0|||
155670635|NCT03687957|561889512|FG000|Overall Study|Physician Decision|0|||
155670636|NCT03687957|561889513|FG001|Overall Study|Physician Decision|0|||
155670637|NCT03687957|561889514|FG002|Overall Study|Physician Decision|0|||
155670638|NCT03687957|561889515|FG003|Overall Study|Physician Decision|2|||
155670639|NCT03687957|561889516|FG004|Overall Study|Physician Decision|1|||
155598578|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
155598579|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
155598580|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155670640|NCT03687957|561889517|FG005|Overall Study|Physician Decision|0|||
155670641|NCT03687957|561889518|FG006|Overall Study|Physician Decision|1|||
155670642|NCT03687957|561889519|FG007|Overall Study|Physician Decision|0|||
155670643|NCT03687957|561889520|FG008|Overall Study|Physician Decision|0|||
155598581|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155598582|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155598583|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155598584|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
155598585|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
155598586|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155598587|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155598588|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155598589|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155598590|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155598591|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598592|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
155598593|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598594|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598595|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598596|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598597|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155598598|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
155598599|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155598600|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
155598601|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155598602|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155598603|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155598604|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155598605|NCT03395184|561616629|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
155598606|NCT03395184|561616630|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
155598607|NCT03395184|561616631|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
155598608|NCT03395184|561616632|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
155598609|NCT03395184|561616633|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
155598610|NCT03395184|561616634|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
155598611|NCT03395184|561616635|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
155598612|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
155598613|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
155598614|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
155598615|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
155598616|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
155598617|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
155598618|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
155598619|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155598620|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155598621|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155598622|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
155598623|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
155598624|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
155598625|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
155598626|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598627|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598628|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598629|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598630|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
155598631|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598632|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155598633|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155598634|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155598635|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155598636|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
155598637|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
155598638|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
155598639|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
155598640|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155598641|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155598642|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155598643|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
155598644|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155598645|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
155598646|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155598647|NCT03395184|561616629|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155598648|NCT03395184|561616630|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155598649|NCT03395184|561616631|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155598650|NCT03395184|561616632|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
155598651|NCT03395184|561616633|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
155598652|NCT03395184|561616634|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
155598653|NCT03395184|561616635|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
155598654|NCT01817582|561616644|FG000|Overall Study|Withdrawal by Subject|0|||
155598655|NCT01817582|561616645|FG001|Overall Study|Withdrawal by Subject|1|||
155598656|NCT01817582|561616646|FG002|Overall Study|Withdrawal by Subject|0|||
155598657|NCT01817582|561616644|FG000|Overall Study|Participant revealed masked treatment|1|||
155598658|NCT01817582|561616645|FG001|Overall Study|Participant revealed masked treatment|0|||
155598659|NCT01817582|561616646|FG002|Overall Study|Participant revealed masked treatment|0|||
155598660|NCT01817582|561616644|FG000|Overall Study|Randomized but exclusion criteria met|1|||
155598661|NCT01817582|561616645|FG001|Overall Study|Randomized but exclusion criteria met|0|||
155598662|NCT01817582|561616646|FG002|Overall Study|Randomized but exclusion criteria met|0|||
155598663|NCT03053063|561616647|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
155598664|NCT03053063|561616648|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
155598665|NCT03053063|561616649|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
155598666|NCT03053063|561616650|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
155598667|NCT03053063|561616647|FG000|Randomized Phase|Withdrew consent|8|||
155598668|NCT03053063|561616648|FG001|Randomized Phase|Withdrew consent|11|||
155598669|NCT03053063|561616649|FG002|Randomized Phase|Withdrew consent|5|||
155598670|NCT03053063|561616650|FG003|Randomized Phase|Withdrew consent|0|||
155598671|NCT03053063|561616647|FG000|Randomized Phase|Investigator's Discretion|8|||
155598672|NCT03053063|561616648|FG001|Randomized Phase|Investigator's Discretion|6|||
155598673|NCT03053063|561616649|FG002|Randomized Phase|Investigator's Discretion|2|||
155598674|NCT03053063|561616650|FG003|Randomized Phase|Investigator's Discretion|0|||
155598675|NCT03053063|561616647|FG000|Randomized Phase|Lost to Follow-up|3|||
155598676|NCT03053063|561616648|FG001|Randomized Phase|Lost to Follow-up|5|||
155598677|NCT03053063|561616649|FG002|Randomized Phase|Lost to Follow-up|1|||
155670644|NCT03687957|561889521|FG009|Overall Study|Physician Decision|0|||
155670645|NCT03687957|561889512|FG000|Overall Study|New malignancy|0|||
155670646|NCT03687957|561889513|FG001|Overall Study|New malignancy|0|||
155670647|NCT03687957|561889514|FG002|Overall Study|New malignancy|0|||
155670648|NCT03687957|561889515|FG003|Overall Study|New malignancy|0|||
155670649|NCT03687957|561889516|FG004|Overall Study|New malignancy|1|||
155670650|NCT03687957|561889517|FG005|Overall Study|New malignancy|0|||
155670651|NCT03687957|561889518|FG006|Overall Study|New malignancy|0|||
155670652|NCT03687957|561889519|FG007|Overall Study|New malignancy|0|||
155670653|NCT03687957|561889520|FG008|Overall Study|New malignancy|0|||
155670654|NCT03687957|561889521|FG009|Overall Study|New malignancy|0|||
155670655|NCT03687957|561889512|FG000|Overall Study|Adverse Event|0|||
155670656|NCT03687957|561889513|FG001|Overall Study|Adverse Event|0|||
155670657|NCT03687957|561889514|FG002|Overall Study|Adverse Event|0|||
155670658|NCT03687957|561889515|FG003|Overall Study|Adverse Event|0|||
155670659|NCT03687957|561889516|FG004|Overall Study|Adverse Event|0|||
155670660|NCT03687957|561889517|FG005|Overall Study|Adverse Event|2|||
155670661|NCT03687957|561889518|FG006|Overall Study|Adverse Event|0|||
155670662|NCT03687957|561889519|FG007|Overall Study|Adverse Event|3|||
155670663|NCT03687957|561889520|FG008|Overall Study|Adverse Event|0|||
155670664|NCT03687957|561889521|FG009|Overall Study|Adverse Event|0|||
155670665|NCT03687957|561889512|FG000|Overall Study|Patient went on hospice|0|||
155670666|NCT03687957|561889513|FG001|Overall Study|Patient went on hospice|0|||
155670667|NCT03687957|561889514|FG002|Overall Study|Patient went on hospice|0|||
155670668|NCT03687957|561889515|FG003|Overall Study|Patient went on hospice|0|||
155670669|NCT03687957|561889516|FG004|Overall Study|Patient went on hospice|0|||
155670670|NCT03687957|561889517|FG005|Overall Study|Patient went on hospice|0|||
155670671|NCT03687957|561889518|FG006|Overall Study|Patient went on hospice|1|||
155670672|NCT03687957|561889519|FG007|Overall Study|Patient went on hospice|0|||
155670673|NCT03687957|561889520|FG008|Overall Study|Patient went on hospice|0|||
155670674|NCT03687957|561889521|FG009|Overall Study|Patient went on hospice|0|||
155670675|NCT03687957|561889512|FG000|Overall Study|Death|0|||
155670676|NCT03687957|561889513|FG001|Overall Study|Death|0|||
155670677|NCT03687957|561889514|FG002|Overall Study|Death|0|||
155598678|NCT03053063|561616650|FG003|Randomized Phase|Lost to Follow-up|0|||
155598679|NCT03053063|561616647|FG000|Randomized Phase|Adverse Event|0|||
155598680|NCT03053063|561616648|FG001|Randomized Phase|Adverse Event|1|||
155598681|NCT03053063|561616649|FG002|Randomized Phase|Adverse Event|0|||
155670678|NCT03687957|561889515|FG003|Overall Study|Death|0|||
155598682|NCT03053063|561616650|FG003|Randomized Phase|Adverse Event|0|||
155670679|NCT03687957|561889516|FG004|Overall Study|Death|0|||
155670680|NCT03687957|561889517|FG005|Overall Study|Death|0|||
155670681|NCT03687957|561889518|FG006|Overall Study|Death|0|||
155598683|NCT03053063|561616647|FG000|Randomized Phase|Randomized but Never Treated|1|||
155670682|NCT03687957|561889519|FG007|Overall Study|Death|1|||
155670683|NCT03687957|561889520|FG008|Overall Study|Death|0|||
155670684|NCT03687957|561889521|FG009|Overall Study|Death|0|||
155670685|NCT03276728|561889522|FG000|Overall Study|Lost to Follow-up|0|||
155670686|NCT03276728|561889523|FG001|Overall Study|Lost to Follow-up|0|||
155670687|NCT03276728|561889524|FG002|Overall Study|Lost to Follow-up|2|||
155670688|NCT03276728|561889525|FG003|Overall Study|Lost to Follow-up|2|||
155670689|NCT03276728|561889526|FG004|Overall Study|Lost to Follow-up|0|||
155670690|NCT03276728|561889527|FG005|Overall Study|Lost to Follow-up|0|||
155670691|NCT03276728|561889528|FG006|Overall Study|Lost to Follow-up|0|||
155670692|NCT03276728|561889529|FG007|Overall Study|Lost to Follow-up|0|||
155670693|NCT03276728|561889522|FG000|Overall Study|Withdrawal by Subject|0|||
155670694|NCT03276728|561889523|FG001|Overall Study|Withdrawal by Subject|0|||
155670695|NCT03276728|561889524|FG002|Overall Study|Withdrawal by Subject|0|||
155670696|NCT03276728|561889525|FG003|Overall Study|Withdrawal by Subject|3|||
155670697|NCT03276728|561889526|FG004|Overall Study|Withdrawal by Subject|0|||
155670698|NCT03276728|561889527|FG005|Overall Study|Withdrawal by Subject|0|||
155670699|NCT03276728|561889528|FG006|Overall Study|Withdrawal by Subject|0|||
155670700|NCT03276728|561889529|FG007|Overall Study|Withdrawal by Subject|0|||
155670701|NCT03276728|561889522|FG000|Overall Study|Decision by sponsor|0|||
155670702|NCT03276728|561889523|FG001|Overall Study|Decision by sponsor|0|||
155670703|NCT03276728|561889524|FG002|Overall Study|Decision by sponsor|0|||
155670704|NCT03276728|561889525|FG003|Overall Study|Decision by sponsor|0|||
155670705|NCT03276728|561889526|FG004|Overall Study|Decision by sponsor|1|||
155670706|NCT03276728|561889527|FG005|Overall Study|Decision by sponsor|0|||
155670707|NCT03276728|561889528|FG006|Overall Study|Decision by sponsor|2|||
155670708|NCT03276728|561889529|FG007|Overall Study|Decision by sponsor|1|||
155670709|NCT02213926|561889532|FG000|Overall Study|Death|59|||
155670710|NCT02213926|561889532|FG000|Overall Study|Withdrawal by Subject|10|||
155670711|NCT02213926|561889532|FG000|Overall Study|study terminated by sponsor|51|||
155670712|NCT02213926|561889532|FG000|Overall Study|Lost to Follow-up|3|||
155670713|NCT02213926|561889532|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
155670714|NCT01188551|561889533|FG000|Overall Study|Pharmacy issues|1|||
155670715|NCT01188551|561889534|FG001|Overall Study|Pharmacy issues|0|||
155670716|NCT01188551|561889535|FG002|Overall Study|Pharmacy issues|0|||
155670717|NCT01188551|561889536|FG003|Overall Study|Pharmacy issues|0|||
155670718|NCT03458325|561889544|FG000|Overall Study|Withdrawal by Subject|1|||
155670719|NCT02630693|561889549|FG000|Overall Study|No receive treatment|0|||
155670720|NCT02630693|561889550|FG001|Overall Study|No receive treatment|1|||
155670721|NCT00175916|561889551|FG000|Overall Study|Death|19|||
155670722|NCT00175916|561889551|FG000|Overall Study|Adverse Event|81|||
155670723|NCT00175916|561889551|FG000|Overall Study|Lack of Efficacy|354|||
155670724|NCT00175916|561889551|FG000|Overall Study|Lost to Follow-up|17|||
155670725|NCT00175916|561889551|FG000|Overall Study|Subject Choice|98|||
155670726|NCT00175916|561889551|FG000|Overall Study|Lack of compliance|8|||
155670727|NCT00175916|561889551|FG000|Overall Study|Patient cannot record seizures|1|||
155670728|NCT00175916|561889551|FG000|Overall Study|Sponsor decision|17|||
155670729|NCT00175916|561889551|FG000|Overall Study|Vigabatrin intake|1|||
155670730|NCT00175916|561889551|FG000|Overall Study|Suicidal behaviour|1|||
155670731|NCT00175916|561889551|FG000|Overall Study|Withdrawal by Subject|1|||
155670732|NCT00175916|561889551|FG000|Overall Study|Seizure - free|4|||
155670733|NCT00175916|561889551|FG000|Overall Study|Administrative reason|1|||
155670734|NCT00175916|561889551|FG000|Overall Study|Pregnancy|1|||
155670735|NCT00175916|561889551|FG000|Overall Study|Patient's request|2|||
155670736|NCT00175916|561889551|FG000|Overall Study|Treating physiciant's choice|1|||
155670737|NCT00175916|561889551|FG000|Overall Study|Moved overseas|1|||
155670738|NCT00175916|561889551|FG000|Overall Study|Loss of job and economic burden|1|||
155670739|NCT00175916|561889551|FG000|Overall Study|Site was closed|9|||
155670740|NCT00175916|561889551|FG000|Overall Study|Patient went to prison|1|||
155670741|NCT00310375|561889552|FG000|Primary Reporting Phase|Adverse Event|28|||
155670742|NCT00310375|561889553|FG001|Primary Reporting Phase|Adverse Event|22|||
155670743|NCT00310375|561889554|FG002|Primary Reporting Phase|Adverse Event|0|||
155670744|NCT00310375|561889552|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
155670745|NCT00310375|561889553|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
155670746|NCT00310375|561889554|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
155670747|NCT00310375|561889552|FG000|Primary Reporting Phase|Pregnancy|2|||
155670748|NCT00310375|561889553|FG001|Primary Reporting Phase|Pregnancy|2|||
155670749|NCT00310375|561889554|FG002|Primary Reporting Phase|Pregnancy|0|||
155670750|NCT00310375|561889552|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
155670751|NCT00310375|561889553|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
155670752|NCT00310375|561889554|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
155670753|NCT00310375|561889552|FG000|Primary Reporting Phase|Protocol Violation|8|||
155670754|NCT00310375|561889553|FG001|Primary Reporting Phase|Protocol Violation|5|||
155670755|NCT00310375|561889554|FG002|Primary Reporting Phase|Protocol Violation|0|||
155670756|NCT00310375|561889552|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
155670757|NCT00310375|561889553|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
155670758|NCT00310375|561889554|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
155670759|NCT00310375|561889552|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
155670760|NCT00310375|561889553|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
155670761|NCT00310375|561889554|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
155670762|NCT00310375|561889552|FG000|Primary Reporting Phase|Physician Decision|5|||
155670763|NCT00310375|561889553|FG001|Primary Reporting Phase|Physician Decision|3|||
155670764|NCT00310375|561889554|FG002|Primary Reporting Phase|Physician Decision|0|||
155670765|NCT00310375|561889552|FG000|Primary Reporting Phase|Request of the sponsor|2|||
155670766|NCT00310375|561889553|FG001|Primary Reporting Phase|Request of the sponsor|2|||
155670767|NCT00310375|561889554|FG002|Primary Reporting Phase|Request of the sponsor|0|||
155670768|NCT00310375|561889552|FG000|Primary Reporting Phase|Failed to return|1|||
155670769|NCT00310375|561889553|FG001|Primary Reporting Phase|Failed to return|3|||
155670770|NCT00310375|561889554|FG002|Primary Reporting Phase|Failed to return|0|||
155670771|NCT00310375|561889552|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
155670772|NCT00310375|561889553|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
155670773|NCT00310375|561889554|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
155670774|NCT00310375|561889552|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
155670775|NCT00310375|561889553|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
155670776|NCT00310375|561889554|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
155670777|NCT00310375|561889552|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
155670778|NCT00310375|561889553|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
155670779|NCT00310375|561889554|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
155670780|NCT00310375|561889552|FG000|Primary Reporting Phase|Site closure|3|||
155670781|NCT00310375|561889553|FG001|Primary Reporting Phase|Site closure|0|||
155670782|NCT00310375|561889554|FG002|Primary Reporting Phase|Site closure|0|||
155670783|NCT00310375|561889552|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
155670784|NCT00310375|561889553|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
155670785|NCT00310375|561889554|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
155670786|NCT00310375|561889552|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
155670787|NCT00310375|561889553|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
155670788|NCT00310375|561889554|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
155670789|NCT00310375|561889552|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
155670790|NCT00310375|561889553|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
155670791|NCT00310375|561889554|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
155670792|NCT00310375|561889552|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
155670793|NCT00310375|561889553|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
155670794|NCT00310375|561889554|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
155670795|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
155670796|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
155670797|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670798|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670799|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670800|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670801|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670802|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670803|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670804|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155670805|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
155670806|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
155670807|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670808|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670809|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670810|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670811|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670812|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670813|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670814|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155670815|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
155670816|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670817|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670818|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670819|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670820|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670821|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670822|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670823|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670824|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155670825|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
155670826|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
155670827|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670828|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670829|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670830|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670831|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670832|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670833|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670834|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155670835|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670836|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
155670837|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670838|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670839|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670840|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670841|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670842|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670843|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670844|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155670845|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
155670846|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
155670847|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670848|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670849|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670850|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670851|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670852|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670853|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670854|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155670855|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
155670856|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
155670857|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670858|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670859|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670860|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670861|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670862|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670863|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670864|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155670865|NCT01194219|561889557|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
155670866|NCT01194219|561889558|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
155670867|NCT01194219|561889559|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670868|NCT01194219|561889560|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670869|NCT01194219|561889561|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670870|NCT01194219|561889562|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670871|NCT01194219|561889563|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670872|NCT01194219|561889564|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670873|NCT01194219|561889565|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670874|NCT01194219|561889566|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155670875|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670876|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670877|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
155670878|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
155670879|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670880|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670881|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670882|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670883|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670884|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
155670885|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670886|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670887|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
155670888|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
155670889|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670890|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670891|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670892|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670893|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670894|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155670895|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670896|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670897|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
155670898|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
155670899|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670900|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670901|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670902|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670903|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670904|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155670905|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670906|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670907|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
155670908|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
155670909|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670910|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670911|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670912|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670913|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670914|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155670915|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670916|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670917|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
155670918|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670919|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670920|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670921|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670922|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670923|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670924|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155670925|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670926|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670927|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670928|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
155670929|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670930|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670931|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670932|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670933|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670934|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155670935|NCT01194219|561889557|FG000|Maintenance Phase Weeks16-32|Other|0|||
155670936|NCT01194219|561889558|FG001|Maintenance Phase Weeks16-32|Other|0|||
155670937|NCT01194219|561889559|FG002|Maintenance Phase Weeks16-32|Other|2|||
155670938|NCT01194219|561889560|FG003|Maintenance Phase Weeks16-32|Other|1|||
155670939|NCT01194219|561889561|FG004|Maintenance Phase Weeks16-32|Other|0|||
155670940|NCT01194219|561889562|FG005|Maintenance Phase Weeks16-32|Other|0|||
155670941|NCT01194219|561889563|FG006|Maintenance Phase Weeks16-32|Other|0|||
155670942|NCT01194219|561889564|FG007|Maintenance Phase Weeks16-32|Other|0|||
155670943|NCT01194219|561889565|FG008|Maintenance Phase Weeks16-32|Other|0|||
155670944|NCT01194219|561889566|FG009|Maintenance Phase Weeks16-32|Other|0|||
155670945|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670946|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670947|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670948|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670949|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670950|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
155670951|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
155670952|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
155670953|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670954|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155670955|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670956|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670957|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670958|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670959|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
155670960|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
155670961|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
155670962|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
155670963|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670964|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155670965|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670966|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670967|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670968|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670969|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
155670970|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670971|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
155670972|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670973|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670974|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155670975|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670976|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670977|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670978|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670979|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
155670980|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670981|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
155670982|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
155670983|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670984|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155670985|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670986|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670987|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670988|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670989|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
155670990|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
155670991|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
155670992|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670993|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670994|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155670995|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155670996|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155670997|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155670998|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155670999|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155671000|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155671001|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155671002|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
155671003|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155671004|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155671005|NCT01194219|561889557|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671006|NCT01194219|561889558|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671007|NCT01194219|561889559|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671008|NCT01194219|561889560|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671009|NCT01194219|561889561|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671010|NCT01194219|561889562|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671011|NCT01194219|561889563|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
155671012|NCT01194219|561889564|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671013|NCT01194219|561889565|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671014|NCT01194219|561889566|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155671015|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671016|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671017|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671018|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671019|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671020|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671021|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671022|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155671023|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
155671024|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
155671025|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671026|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671027|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671028|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671029|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671030|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671031|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671032|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155671033|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
155671034|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
155671035|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671036|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671037|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671038|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671039|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671040|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671041|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671042|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155671043|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
155671044|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
155671045|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671046|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671047|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671048|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671049|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671050|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671051|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671052|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155671053|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
155671054|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
155671055|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
155671056|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
155671057|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
155671058|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
155671059|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
155671060|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
155671061|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
155671062|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
155671063|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
155671064|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
155671065|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671066|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671067|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671068|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671069|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671070|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671071|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671072|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155671073|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
155671074|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
155671075|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671076|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671077|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671078|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671079|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671080|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671081|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671082|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671083|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
155671084|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155671085|NCT01194219|561889557|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671086|NCT01194219|561889558|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671087|NCT01194219|561889559|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671088|NCT01194219|561889560|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671089|NCT01194219|561889561|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671090|NCT01194219|561889562|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671091|NCT01194219|561889563|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671092|NCT01194219|561889564|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155671093|NCT01194219|561889565|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
155671094|NCT01194219|561889566|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
155671095|NCT05338710|561889567|FG000|Overall Study|Withdrawal by Subject|3|||
155671096|NCT01081951|561889568|FG000|Overall Study|Death|54|||
155671097|NCT01081951|561889569|FG001|Overall Study|Death|47|||
155671098|NCT01081951|561889568|FG000|Overall Study|Withdrawal by Subject|2|||
155671099|NCT01081951|561889569|FG001|Overall Study|Withdrawal by Subject|6|||
155671100|NCT01081951|561889568|FG000|Overall Study|Allocated treatment but did not take it|0|||
155671101|NCT01081951|561889569|FG001|Overall Study|Allocated treatment but did not take it|1|||
155671102|NCT01081951|561889568|FG000|Overall Study|Lost to Follow-up|0|||
155671103|NCT01081951|561889569|FG001|Overall Study|Lost to Follow-up|1|||
155671104|NCT05384834|561889578|FG000|Overall Study|Lost to Follow-up|43|||
155671105|NCT05384834|561889578|FG000|Overall Study|Withdrawal by Subject|5|||
155671106|NCT01871545|561889579|FG000|Overall Study|Death|2|||
155671107|NCT01871545|561889580|FG001|Overall Study|Death|0|||
155671108|NCT01871545|561889579|FG000|Overall Study|Lack of Efficacy|11|||
155671109|NCT01871545|561889580|FG001|Overall Study|Lack of Efficacy|2|||
155671110|NCT01871545|561889579|FG000|Overall Study|Physician Decision|4|||
155671111|NCT01871545|561889580|FG001|Overall Study|Physician Decision|0|||
155671112|NCT01871545|561889579|FG000|Overall Study|Withdrawal by Subject|0|||
155671113|NCT01871545|561889580|FG001|Overall Study|Withdrawal by Subject|1|||
155671114|NCT05710640|561889583|FG000|Overall Study|Physician Decision|0|||
155671115|NCT05710640|561889584|FG001|Overall Study|Physician Decision|1|||
155671116|NCT05710640|561889583|FG000|Overall Study|Withdrawal by Subject|1|||
155671117|NCT05710640|561889584|FG001|Overall Study|Withdrawal by Subject|0|||
155671118|NCT05710640|561889583|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
155671119|NCT05710640|561889584|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
155671120|NCT04188509|561889585|FG000|Overall Study|Adverse Event|2|||
155671121|NCT04188509|561889585|FG000|Overall Study|Lost to Follow-up|1|||
155671122|NCT04188509|561889585|FG000|Overall Study|Withdrawal of Consent|1|||
155671123|NCT04188509|561889585|FG000|Overall Study|Discretion of Investigator|1|||
155671124|NCT04188509|561889585|FG000|Overall Study|Noncompliance|3|||
155671125|NCT04188509|561889585|FG000|Overall Study|Sponsor Decision|127|||
155671126|NCT04188509|561889585|FG000|Overall Study|Other|2|||
155671127|NCT04158375|561889586|FG000|Overall Study|Withdrawal by Subject|0|||
155671128|NCT04158375|561889587|FG001|Overall Study|Withdrawal by Subject|3|||
155671129|NCT04158375|561889588|FG002|Overall Study|Withdrawal by Subject|0|||
155671130|NCT04847843|561889589|FG000|Overall Study|Scheduling Conflicts|6|||
155671131|NCT04847843|561889590|FG001|Overall Study|Scheduling Conflicts|9|||
155671132|NCT04847843|561889589|FG000|Overall Study|Withdrawal by Subject|1|||
155671133|NCT04847843|561889590|FG001|Overall Study|Withdrawal by Subject|0|||
155671134|NCT04847843|561889589|FG000|Overall Study|Lost to Follow-up|1|||
155671135|NCT04847843|561889590|FG001|Overall Study|Lost to Follow-up|1|||
155671136|NCT04847843|561889589|FG000|Overall Study|Pregnancy|0|||
155671137|NCT04847843|561889590|FG001|Overall Study|Pregnancy|2|||
155671138|NCT04847843|561889589|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
155671139|NCT04847843|561889590|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
155598684|NCT03053063|561616648|FG001|Randomized Phase|Randomized but Never Treated|3|||
155598685|NCT03053063|561616649|FG002|Randomized Phase|Randomized but Never Treated|2|||
155598686|NCT03053063|561616650|FG003|Randomized Phase|Randomized but Never Treated|0|||
155598687|NCT03053063|561616647|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
155598688|NCT03053063|561616648|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
155598689|NCT03053063|561616649|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
155598690|NCT03053063|561616650|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
155598691|NCT03053063|561616647|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
155598692|NCT03053063|561616648|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
155598693|NCT03053063|561616649|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
155598694|NCT03053063|561616650|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
155598695|NCT03053063|561616647|FG000|Open-Label Phase|Death|0|||
155598696|NCT03053063|561616648|FG001|Open-Label Phase|Death|0|||
155598697|NCT03053063|561616649|FG002|Open-Label Phase|Death|0|||
155598698|NCT03053063|561616650|FG003|Open-Label Phase|Death|2|||
155598699|NCT03053063|561616647|FG000|Open-Label Phase|Investigator's discretion|0|||
155598700|NCT03053063|561616648|FG001|Open-Label Phase|Investigator's discretion|0|||
155598701|NCT03053063|561616649|FG002|Open-Label Phase|Investigator's discretion|0|||
155598702|NCT03053063|561616650|FG003|Open-Label Phase|Investigator's discretion|2|||
155598703|NCT02600845|561616651|FG000|Overall Study|Reason Not Specified|3|||
155598704|NCT02600845|561616651|FG000|Overall Study|Non-compliance with Study Procedures|10|||
155598705|NCT02600845|561616651|FG000|Overall Study|Consent Withdrawal|5|||
155598706|NCT00356135|561616654|FG000|Overall Study|Protocol Violation|1|||
155598707|NCT00356135|561616655|FG001|Overall Study|Protocol Violation|0|||
155598708|NCT00356135|561616656|FG002|Overall Study|Protocol Violation|0|||
155598709|NCT00356135|561616654|FG000|Overall Study|Adverse Event|1|||
155598710|NCT00356135|561616655|FG001|Overall Study|Adverse Event|0|||
155598711|NCT00356135|561616656|FG002|Overall Study|Adverse Event|0|||
155598712|NCT00356135|561616654|FG000|Overall Study|Lost to Follow-up|0|||
155598713|NCT00356135|561616655|FG001|Overall Study|Lost to Follow-up|0|||
155598714|NCT00356135|561616656|FG002|Overall Study|Lost to Follow-up|1|||
155598715|NCT00356135|561616654|FG000|Overall Study|Physician Decision|1|||
155598716|NCT00356135|561616655|FG001|Overall Study|Physician Decision|1|||
155598717|NCT00356135|561616656|FG002|Overall Study|Physician Decision|1|||
155598718|NCT00356135|561616654|FG000|Overall Study|Subject non-compliance|1|||
155598719|NCT00356135|561616655|FG001|Overall Study|Subject non-compliance|1|||
155598720|NCT00356135|561616656|FG002|Overall Study|Subject non-compliance|3|||
155598721|NCT03963232|561616657|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155598722|NCT03963232|561616658|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
155598723|NCT03963232|561616657|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
155598724|NCT03963232|561616658|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155598725|NCT03963232|561616657|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
155598726|NCT03963232|561616658|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155598727|NCT03963232|561616657|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
155598728|NCT03963232|561616658|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155598729|NCT03963232|561616657|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
155598730|NCT03963232|561616658|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
155598731|NCT03963232|561616657|FG000|Open-Label Treatment Phase|Adverse Event|1|||
155598732|NCT03963232|561616658|FG001|Open-Label Treatment Phase|Adverse Event|2|||
155598733|NCT03963232|561616657|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
155598734|NCT03963232|561616658|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
155598735|NCT03963232|561616657|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
155598736|NCT03963232|561616658|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
155598737|NCT03963232|561616657|FG000|Open-Label Treatment Phase|Pregnancy|1|||
155598738|NCT03963232|561616658|FG001|Open-Label Treatment Phase|Pregnancy|0|||
155598739|NCT03963232|561616657|FG000|Follow-up Phase|Withdrawal by Subject|7|||
155598740|NCT03963232|561616658|FG001|Follow-up Phase|Withdrawal by Subject|5|||
155598741|NCT03963232|561616657|FG000|Follow-up Phase|Protocol Violation|0|||
155598742|NCT03963232|561616658|FG001|Follow-up Phase|Protocol Violation|2|||
155598743|NCT03963232|561616657|FG000|Follow-up Phase|Adverse Event|0|||
155598744|NCT03963232|561616658|FG001|Follow-up Phase|Adverse Event|1|||
155598745|NCT03963232|561616657|FG000|Follow-up Phase|Lost to Follow-up|0|||
155598746|NCT03963232|561616658|FG001|Follow-up Phase|Lost to Follow-up|1|||
155598747|NCT03617770|561616659|FG000|Overall Study|Lost to Follow-up|1|||
155598748|NCT03617770|561616660|FG001|Overall Study|Lost to Follow-up|0|||
155598749|NCT01672710|561616661|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
155598750|NCT01672710|561616662|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
155598751|NCT01672710|561616661|FG000|3 Month Follow up|Lost to Follow-up|2|||
155598752|NCT01672710|561616662|FG001|3 Month Follow up|Lost to Follow-up|3|||
155598753|NCT01672710|561616661|FG000|3 Month Follow up|follow up due after termination date|4|||
155598754|NCT01672710|561616662|FG001|3 Month Follow up|follow up due after termination date|1|||
155598755|NCT05033262|561616668|FG000|Overall Study|Lost to Follow-up|1|||
155598756|NCT05033262|561616669|FG001|Overall Study|Lost to Follow-up|0|||
155598757|NCT05033262|561616670|FG002|Overall Study|Lost to Follow-up|0|||
155598758|NCT05033262|561616671|FG003|Overall Study|Lost to Follow-up|1|||
155598759|NCT05270395|561616672|FG000|Overall Study|Lost to Follow-up|2|||
155598760|NCT05270395|561616673|FG001|Overall Study|Lost to Follow-up|2|||
155598761|NCT05270395|561616672|FG000|Overall Study|Death|1|||
155598762|NCT05270395|561616673|FG001|Overall Study|Death|2|||
155598763|NCT05270395|561616672|FG000|Overall Study|Study Team Withdrew|1|||
155598764|NCT05270395|561616673|FG001|Overall Study|Study Team Withdrew|0|||
155598765|NCT03055494|561618986|FG000|Overall Study|Lost to Follow-up|6|||
155598766|NCT03055494|561618987|FG001|Overall Study|Lost to Follow-up|0|||
155598767|NCT03055494|561618986|FG000|Overall Study|Physician Decision|2|||
155598768|NCT03055494|561618987|FG001|Overall Study|Physician Decision|0|||
155598769|NCT03055494|561618986|FG000|Overall Study|Withdrawal by Subject|1|||
155598770|NCT03055494|561618987|FG001|Overall Study|Withdrawal by Subject|0|||
155598771|NCT03055494|561618986|FG000|Overall Study|Adverse Event|0|||
155598772|NCT03055494|561618987|FG001|Overall Study|Adverse Event|1|||
155598773|NCT03055494|561618986|FG000|Overall Study|Non-compliance with study treatment|1|||
155598774|NCT03055494|561618987|FG001|Overall Study|Non-compliance with study treatment|0|||
155598775|NCT03197467|561618988|FG000|Overall Study|Withdrawal by Subject|1|||
155598776|NCT03666533|561618989|FG000|Overall Study|Lost to Follow-up|2|||
155598777|NCT03666533|561618990|FG001|Overall Study|Lost to Follow-up|2|||
155598778|NCT02017717|561618991|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598779|NCT02017717|561618992|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598780|NCT02017717|561618993|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598781|NCT02017717|561618994|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598782|NCT02017717|561618995|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598783|NCT02017717|561618996|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598784|NCT02017717|561618997|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598785|NCT02017717|561618998|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
155598786|NCT02017717|561618999|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155598787|NCT02017717|561618991|FG000|Before Treatment Period|Participant request to stop therapy|0|||
155598788|NCT02017717|561618992|FG001|Before Treatment Period|Participant request to stop therapy|0|||
155598789|NCT02017717|561618993|FG002|Before Treatment Period|Participant request to stop therapy|0|||
155598790|NCT02017717|561618994|FG003|Before Treatment Period|Participant request to stop therapy|0|||
155598791|NCT02017717|561618995|FG004|Before Treatment Period|Participant request to stop therapy|0|||
155598792|NCT02017717|561618996|FG005|Before Treatment Period|Participant request to stop therapy|0|||
155671140|NCT02734004|561889591|FG000|Overall Study|Death|36|||
155671141|NCT02734004|561889592|FG001|Overall Study|Death|24|||
155671142|NCT02734004|561889593|FG002|Overall Study|Death|26|||
155671143|NCT02734004|561889594|FG003|Overall Study|Death|35|||
155671144|NCT02734004|561889595|FG004|Overall Study|Death|13|||
155671145|NCT02734004|561889596|FG005|Overall Study|Death|17|||
155671146|NCT02734004|561889597|FG006|Overall Study|Death|20|||
155671147|NCT02734004|561889591|FG000|Overall Study|Lost to Follow-up|1|||
155671148|NCT02734004|561889592|FG001|Overall Study|Lost to Follow-up|1|||
155671149|NCT02734004|561889593|FG002|Overall Study|Lost to Follow-up|0|||
155671150|NCT02734004|561889594|FG003|Overall Study|Lost to Follow-up|0|||
155671151|NCT02734004|561889595|FG004|Overall Study|Lost to Follow-up|1|||
155671152|NCT02734004|561889596|FG005|Overall Study|Lost to Follow-up|0|||
155671153|NCT02734004|561889597|FG006|Overall Study|Lost to Follow-up|0|||
155671154|NCT02734004|561889591|FG000|Overall Study|Withdrawal by Subject|3|||
155671155|NCT02734004|561889592|FG001|Overall Study|Withdrawal by Subject|1|||
155671156|NCT02734004|561889593|FG002|Overall Study|Withdrawal by Subject|1|||
155671157|NCT02734004|561889594|FG003|Overall Study|Withdrawal by Subject|1|||
155671158|NCT02734004|561889595|FG004|Overall Study|Withdrawal by Subject|3|||
155671159|NCT02734004|561889596|FG005|Overall Study|Withdrawal by Subject|0|||
155671160|NCT02734004|561889597|FG006|Overall Study|Withdrawal by Subject|2|||
155671161|NCT02734004|561889591|FG000|Overall Study|Other|0|||
155671162|NCT02734004|561889592|FG001|Overall Study|Other|8|||
155671163|NCT02734004|561889593|FG002|Overall Study|Other|7|||
155671164|NCT02734004|561889594|FG003|Overall Study|Other|4|||
155671165|NCT02734004|561889595|FG004|Overall Study|Other|34|||
155671166|NCT02734004|561889596|FG005|Overall Study|Other|14|||
155671167|NCT02734004|561889597|FG006|Overall Study|Other|10|||
155671168|NCT01282866|561889604|FG000|Overall Study|Adverse Event|1|||
155671169|NCT01541865|561889606|FG000|Overall Study|Lost to Follow-up|11|||
155671170|NCT01541865|561889606|FG000|Overall Study|Withdrawal by Subject|9|||
155671171|NCT01541865|561889606|FG000|Overall Study|Adverse Event|1|||
155671172|NCT01541865|561889606|FG000|Overall Study|Protocol Violation|1|||
155671173|NCT00049322|561889607|FG000|Overall Study|disease burden|0|||
155671174|NCT00049322|561889608|FG001|Overall Study|disease burden|3|||
155671175|NCT00049322|561889607|FG000|Overall Study|Adverse Event|1|||
155671176|NCT00049322|561889608|FG001|Overall Study|Adverse Event|0|||
155671177|NCT00049322|561889607|FG000|Overall Study|refused angio|0|||
155671178|NCT00049322|561889608|FG001|Overall Study|refused angio|3|||
155671179|NCT00124072|561889609|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
155671180|NCT00124072|561889610|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
155671181|NCT00124072|561889611|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
155671182|NCT00124072|561889612|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
155671183|NCT00124072|561889609|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
155671184|NCT00124072|561889610|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
155671185|NCT00124072|561889611|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
155671186|NCT00124072|561889612|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
155671187|NCT00124072|561889609|FG000|Overall Study|Death|499|||
155671188|NCT00124072|561889610|FG001|Overall Study|Death|484|||
155671189|NCT00124072|561889611|FG002|Overall Study|Death|471|||
155671190|NCT00124072|561889612|FG003|Overall Study|Death|480|||
155671191|NCT04872569|561889615|FG000|Overall Study|Withdrawal by Subject|2|||
155671192|NCT01890265|561889622|FG000|Overall Study|Other (Unspecified reason)|0|||
155671193|NCT01890265|561889623|FG001|Overall Study|Other (Unspecified reason)|1|||
155671194|NCT01890265|561889624|FG002|Overall Study|Other (Unspecified reason)|0|||
155671195|NCT01890265|561889625|FG003|Overall Study|Other (Unspecified reason)|0|||
155671196|NCT01890265|561889626|FG004|Overall Study|Other (Unspecified reason)|0|||
155671197|NCT01890265|561889627|FG005|Overall Study|Other (Unspecified reason)|0|||
155671198|NCT01890265|561889622|FG000|Overall Study|Progressive disease|6|||
155671199|NCT01890265|561889623|FG001|Overall Study|Progressive disease|6|||
155671200|NCT01890265|561889624|FG002|Overall Study|Progressive disease|0|||
155671201|NCT01890265|561889625|FG003|Overall Study|Progressive disease|0|||
155671202|NCT01890265|561889626|FG004|Overall Study|Progressive disease|0|||
155671203|NCT01890265|561889627|FG005|Overall Study|Progressive disease|0|||
155671204|NCT01890265|561889622|FG000|Overall Study|Adverse Event|2|||
155671205|NCT01890265|561889623|FG001|Overall Study|Adverse Event|1|||
155671206|NCT01890265|561889624|FG002|Overall Study|Adverse Event|0|||
155671207|NCT01890265|561889625|FG003|Overall Study|Adverse Event|0|||
155671208|NCT01890265|561889626|FG004|Overall Study|Adverse Event|0|||
155671209|NCT01890265|561889627|FG005|Overall Study|Adverse Event|0|||
155671210|NCT01890265|561889622|FG000|Overall Study|Death|2|||
155671211|NCT01890265|561889623|FG001|Overall Study|Death|3|||
155671212|NCT01890265|561889624|FG002|Overall Study|Death|1|||
155671213|NCT01890265|561889625|FG003|Overall Study|Death|0|||
155671214|NCT01890265|561889626|FG004|Overall Study|Death|0|||
155671215|NCT01890265|561889627|FG005|Overall Study|Death|0|||
155671216|NCT01890265|561889622|FG000|Overall Study|Withdrawal by Subject|0|||
155671217|NCT01890265|561889623|FG001|Overall Study|Withdrawal by Subject|2|||
155671218|NCT01890265|561889624|FG002|Overall Study|Withdrawal by Subject|3|||
155671219|NCT01890265|561889625|FG003|Overall Study|Withdrawal by Subject|0|||
155671220|NCT01890265|561889626|FG004|Overall Study|Withdrawal by Subject|2|||
155671221|NCT01890265|561889627|FG005|Overall Study|Withdrawal by Subject|0|||
155671222|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
155671223|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
155671224|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155671225|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155671226|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155671227|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
155671228|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
155671229|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155671230|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155671231|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155671232|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
155671233|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
155671234|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
155671235|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
155671236|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
155671237|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155671238|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
155671239|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155671240|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155671241|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155671242|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
155671243|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
155671244|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155671245|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155671246|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155671247|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155671248|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
155671249|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155671250|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155671251|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155671252|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
155671253|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155671254|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155671255|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155671256|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155671257|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
155671258|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155671259|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155671260|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155671261|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155671262|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
155671263|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155671264|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155671265|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155671266|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155671267|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155671268|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
155671269|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155671270|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155671271|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155671272|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
155671273|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155671274|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155671275|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155671276|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155671277|NCT04951622|561889628|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155671278|NCT04951622|561889629|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
155671279|NCT04951622|561889630|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155671280|NCT04951622|561889631|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155671281|NCT04951622|561889632|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155671282|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155671283|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155671284|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
155671285|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155671286|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
155671287|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155671288|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155671289|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155671290|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
155671291|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
155671292|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
155671293|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
155671294|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
155671295|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
155671296|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
155671297|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155671298|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155671299|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
155671300|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
155671301|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155671302|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155671303|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155671304|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
155671305|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155671306|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155671307|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155671308|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155671309|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
155671310|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
155671311|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155671312|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
155671313|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
155671314|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
155671315|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
155671316|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
155671317|NCT04951622|561889628|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155671318|NCT04951622|561889629|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155671319|NCT04951622|561889630|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155671320|NCT04951622|561889631|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155671321|NCT04951622|561889632|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
155671322|NCT03517436|561889635|FG000|Overall Study|Death|3|||
155671323|NCT03517436|561889635|FG000|Overall Study|Withdrawal by Subject|4|||
155671324|NCT03517436|561889635|FG000|Overall Study|Did not receive study valve.|1|||
155671325|NCT04271540|561889636|FG000|Overall Study|Lost to Follow-up|1|||
155671326|NCT04271540|561889636|FG000|Overall Study|Screen Fail|5|||
155671327|NCT04587869|561889639|FG000|Overall Study|Death|1|||
155671328|NCT04587869|561889640|FG001|Overall Study|Death|0|||
155671329|NCT04587869|561889639|FG000|Overall Study|Lost to Follow-up|27|||
155671330|NCT04587869|561889640|FG001|Overall Study|Lost to Follow-up|34|||
155671331|NCT04587869|561889639|FG000|Overall Study|Grant Termination|13|||
155671332|NCT04587869|561889640|FG001|Overall Study|Grant Termination|25|||
155671333|NCT04587869|561889639|FG000|Overall Study|too busy|2|||
155671334|NCT04587869|561889640|FG001|Overall Study|too busy|0|||
155671335|NCT04587869|561889639|FG000|Overall Study|Withdrawal by Subject|2|||
155671336|NCT04587869|561889640|FG001|Overall Study|Withdrawal by Subject|2|||
155671337|NCT04587869|561889639|FG000|Overall Study|Other|1|||
155671338|NCT04587869|561889640|FG001|Overall Study|Other|0|||
155671339|NCT02268383|561889643|FG000|Overall Study|Death|12|||
155671340|NCT02268383|561889643|FG000|Overall Study|Lost to Follow-up|2|||
155671341|NCT02268383|561889643|FG000|Overall Study|Withdrawal by Subject|9|||
155671342|NCT02268383|561889643|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
155671343|NCT02268383|561889643|FG000|Overall Study|Protocol deviation|3|||
155671344|NCT02268383|561889643|FG000|Overall Study|Sponsor decision|22|||
155671345|NCT02268383|561889643|FG000|Overall Study|Not reported|12|||
155671346|NCT00943761|561889644|FG000|Overall Study|Lost to Follow-up|2|||
155671347|NCT00943761|561889645|FG001|Overall Study|Lost to Follow-up|0|||
155671348|NCT00943761|561889644|FG000|Overall Study|Withdrawal by Subject|2|||
155671349|NCT00943761|561889645|FG001|Overall Study|Withdrawal by Subject|1|||
155671350|NCT01342926|561889648|FG000|Overall Study|Adverse Event|5|||
155671351|NCT01342926|561889649|FG001|Overall Study|Adverse Event|8|||
155671352|NCT01342926|561889650|FG002|Overall Study|Adverse Event|10|||
155671353|NCT01342926|561889651|FG003|Overall Study|Adverse Event|7|||
155671354|NCT01342926|561889648|FG000|Overall Study|Lost to Follow-up|0|||
155671355|NCT01342926|561889649|FG001|Overall Study|Lost to Follow-up|1|||
155598793|NCT02017717|561618997|FG006|Before Treatment Period|Participant request to stop therapy|0|||
155598794|NCT02017717|561618998|FG007|Before Treatment Period|Participant request to stop therapy|0|||
155598795|NCT02017717|561618999|FG008|Before Treatment Period|Participant request to stop therapy|5|||
155598796|NCT02017717|561618991|FG000|Before Treatment Period|Participant withdrew consent|0|||
155598797|NCT02017717|561618992|FG001|Before Treatment Period|Participant withdrew consent|0|||
155598798|NCT02017717|561618993|FG002|Before Treatment Period|Participant withdrew consent|0|||
155598799|NCT02017717|561618994|FG003|Before Treatment Period|Participant withdrew consent|0|||
155598800|NCT02017717|561618995|FG004|Before Treatment Period|Participant withdrew consent|0|||
155598801|NCT02017717|561618996|FG005|Before Treatment Period|Participant withdrew consent|0|||
155598802|NCT02017717|561618997|FG006|Before Treatment Period|Participant withdrew consent|2|||
155598803|NCT02017717|561618998|FG007|Before Treatment Period|Participant withdrew consent|0|||
155598804|NCT02017717|561618999|FG008|Before Treatment Period|Participant withdrew consent|11|||
155598805|NCT02017717|561618991|FG000|Before Treatment Period|Lost to Follow-up|0|||
155598806|NCT02017717|561618992|FG001|Before Treatment Period|Lost to Follow-up|0|||
155598807|NCT02017717|561618993|FG002|Before Treatment Period|Lost to Follow-up|0|||
155598808|NCT02017717|561618994|FG003|Before Treatment Period|Lost to Follow-up|0|||
155598809|NCT02017717|561618995|FG004|Before Treatment Period|Lost to Follow-up|0|||
155598810|NCT02017717|561618996|FG005|Before Treatment Period|Lost to Follow-up|0|||
155598811|NCT02017717|561618997|FG006|Before Treatment Period|Lost to Follow-up|0|||
155598812|NCT02017717|561618998|FG007|Before Treatment Period|Lost to Follow-up|0|||
155598813|NCT02017717|561618999|FG008|Before Treatment Period|Lost to Follow-up|1|||
155598814|NCT02017717|561618991|FG000|Before Treatment Period|Participant no longer met criteria|0|||
155598815|NCT02017717|561618992|FG001|Before Treatment Period|Participant no longer met criteria|0|||
155598816|NCT02017717|561618993|FG002|Before Treatment Period|Participant no longer met criteria|0|||
155598817|NCT02017717|561618994|FG003|Before Treatment Period|Participant no longer met criteria|0|||
155598818|NCT02017717|561618995|FG004|Before Treatment Period|Participant no longer met criteria|0|||
155598819|NCT02017717|561618996|FG005|Before Treatment Period|Participant no longer met criteria|1|||
155598820|NCT02017717|561618997|FG006|Before Treatment Period|Participant no longer met criteria|0|||
155598821|NCT02017717|561618998|FG007|Before Treatment Period|Participant no longer met criteria|1|||
155598822|NCT02017717|561618999|FG008|Before Treatment Period|Participant no longer met criteria|2|||
155598823|NCT02017717|561618991|FG000|Before Treatment Period|other reason|0|||
155671356|NCT01342926|561889650|FG002|Overall Study|Lost to Follow-up|1|||
155671357|NCT01342926|561889651|FG003|Overall Study|Lost to Follow-up|0|||
155671358|NCT01342926|561889648|FG000|Overall Study|Investigator Discretion|2|||
155671359|NCT01342926|561889649|FG001|Overall Study|Investigator Discretion|2|||
155598824|NCT02017717|561618992|FG001|Before Treatment Period|other reason|0|||
155598825|NCT02017717|561618993|FG002|Before Treatment Period|other reason|0|||
155598826|NCT02017717|561618994|FG003|Before Treatment Period|other reason|0|||
155598827|NCT02017717|561618995|FG004|Before Treatment Period|other reason|0|||
155598828|NCT02017717|561618996|FG005|Before Treatment Period|other reason|0|||
155598829|NCT02017717|561618997|FG006|Before Treatment Period|other reason|0|||
155598830|NCT02017717|561618998|FG007|Before Treatment Period|other reason|0|||
155598831|NCT02017717|561618999|FG008|Before Treatment Period|other reason|1|||
155598832|NCT02017717|561618991|FG000|Treatment Period|Disease progression|7|||
155598833|NCT02017717|561618992|FG001|Treatment Period|Disease progression|9|||
155598834|NCT02017717|561618993|FG002|Treatment Period|Disease progression|12|||
155598835|NCT02017717|561618994|FG003|Treatment Period|Disease progression|20|||
155598836|NCT02017717|561618995|FG004|Treatment Period|Disease progression|26|||
155598837|NCT02017717|561618996|FG005|Treatment Period|Disease progression|16|||
155598838|NCT02017717|561618997|FG006|Treatment Period|Disease progression|22|||
155598839|NCT02017717|561618998|FG007|Treatment Period|Disease progression|165|||
155598840|NCT02017717|561618999|FG008|Treatment Period|Disease progression|135|||
155598841|NCT02017717|561618991|FG000|Treatment Period|Study drug toxicity|3|||
155598842|NCT02017717|561618992|FG001|Treatment Period|Study drug toxicity|0|||
155598843|NCT02017717|561618993|FG002|Treatment Period|Study drug toxicity|1|||
155598844|NCT02017717|561618994|FG003|Treatment Period|Study drug toxicity|4|||
155598845|NCT02017717|561618995|FG004|Treatment Period|Study drug toxicity|4|||
155598846|NCT02017717|561618996|FG005|Treatment Period|Study drug toxicity|5|||
155598847|NCT02017717|561618997|FG006|Treatment Period|Study drug toxicity|3|||
155598848|NCT02017717|561618998|FG007|Treatment Period|Study drug toxicity|7|||
155598849|NCT02017717|561618999|FG008|Treatment Period|Study drug toxicity|11|||
155598850|NCT02017717|561618991|FG000|Treatment Period|Death|0|||
155598851|NCT02017717|561618992|FG001|Treatment Period|Death|0|||
155598852|NCT02017717|561618993|FG002|Treatment Period|Death|1|||
155598853|NCT02017717|561618994|FG003|Treatment Period|Death|0|||
155598854|NCT02017717|561618995|FG004|Treatment Period|Death|0|||
155598855|NCT02017717|561618996|FG005|Treatment Period|Death|2|||
155598856|NCT02017717|561618997|FG006|Treatment Period|Death|0|||
155598857|NCT02017717|561618998|FG007|Treatment Period|Death|0|||
155598858|NCT02017717|561618999|FG008|Treatment Period|Death|0|||
155598859|NCT02017717|561618991|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
155598860|NCT02017717|561618992|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
155598861|NCT02017717|561618993|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
155598862|NCT02017717|561618994|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
155598863|NCT02017717|561618995|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
155598864|NCT02017717|561618996|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
155598865|NCT02017717|561618997|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
155598866|NCT02017717|561618998|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
155598867|NCT02017717|561618999|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
155598868|NCT02017717|561618991|FG000|Treatment Period|Participant request to stop therapy|0|||
155598869|NCT02017717|561618992|FG001|Treatment Period|Participant request to stop therapy|0|||
155598870|NCT02017717|561618993|FG002|Treatment Period|Participant request to stop therapy|3|||
155598871|NCT02017717|561618994|FG003|Treatment Period|Participant request to stop therapy|6|||
155598872|NCT02017717|561618995|FG004|Treatment Period|Participant request to stop therapy|0|||
155598873|NCT02017717|561618996|FG005|Treatment Period|Participant request to stop therapy|2|||
155598874|NCT02017717|561618997|FG006|Treatment Period|Participant request to stop therapy|1|||
155598875|NCT02017717|561618998|FG007|Treatment Period|Participant request to stop therapy|4|||
155598876|NCT02017717|561618999|FG008|Treatment Period|Participant request to stop therapy|7|||
155598877|NCT02017717|561618991|FG000|Treatment Period|Participant withdrew consent|0|||
155598878|NCT02017717|561618992|FG001|Treatment Period|Participant withdrew consent|0|||
155598879|NCT02017717|561618993|FG002|Treatment Period|Participant withdrew consent|1|||
155598880|NCT02017717|561618994|FG003|Treatment Period|Participant withdrew consent|0|||
155598881|NCT02017717|561618995|FG004|Treatment Period|Participant withdrew consent|0|||
155598882|NCT02017717|561618996|FG005|Treatment Period|Participant withdrew consent|2|||
155598883|NCT02017717|561618997|FG006|Treatment Period|Participant withdrew consent|0|||
155598884|NCT02017717|561618998|FG007|Treatment Period|Participant withdrew consent|1|||
155598885|NCT02017717|561618999|FG008|Treatment Period|Participant withdrew consent|4|||
155598886|NCT02017717|561618991|FG000|Treatment Period|Participant no longer met criteria|0|||
155598887|NCT02017717|561618992|FG001|Treatment Period|Participant no longer met criteria|0|||
155598888|NCT02017717|561618993|FG002|Treatment Period|Participant no longer met criteria|0|||
155598889|NCT02017717|561618994|FG003|Treatment Period|Participant no longer met criteria|0|||
155598890|NCT02017717|561618995|FG004|Treatment Period|Participant no longer met criteria|0|||
155598891|NCT02017717|561618996|FG005|Treatment Period|Participant no longer met criteria|0|||
155598892|NCT02017717|561618997|FG006|Treatment Period|Participant no longer met criteria|0|||
155598893|NCT02017717|561618998|FG007|Treatment Period|Participant no longer met criteria|0|||
155598894|NCT02017717|561618999|FG008|Treatment Period|Participant no longer met criteria|1|||
155598895|NCT02017717|561618991|FG000|Treatment Period|Other reasons|0|||
155598896|NCT02017717|561618992|FG001|Treatment Period|Other reasons|0|||
155598897|NCT02017717|561618993|FG002|Treatment Period|Other reasons|0|||
155598898|NCT02017717|561618994|FG003|Treatment Period|Other reasons|1|||
155598899|NCT02017717|561618995|FG004|Treatment Period|Other reasons|0|||
155598900|NCT02017717|561618996|FG005|Treatment Period|Other reasons|1|||
155671360|NCT01342926|561889650|FG002|Overall Study|Investigator Discretion|0|||
155671361|NCT01342926|561889651|FG003|Overall Study|Investigator Discretion|0|||
155671362|NCT01342926|561889648|FG000|Overall Study|Withdrawal by Subject|2|||
155671363|NCT01342926|561889649|FG001|Overall Study|Withdrawal by Subject|4|||
155671364|NCT01342926|561889650|FG002|Overall Study|Withdrawal by Subject|3|||
155671365|NCT01342926|561889651|FG003|Overall Study|Withdrawal by Subject|5|||
155671366|NCT03382912|561889652|FG000|Overall Study|Physician Decision|0|||
155671367|NCT03382912|561889653|FG001|Overall Study|Physician Decision|1|||
155671368|NCT03382912|561889652|FG000|Overall Study|Sponsor Decision|6|||
155671369|NCT03382912|561889653|FG001|Overall Study|Sponsor Decision|6|||
155671370|NCT03382912|561889652|FG000|Overall Study|Withdrawal by Subject|0|||
155671371|NCT03382912|561889653|FG001|Overall Study|Withdrawal by Subject|5|||
155671372|NCT01402869|561889654|FG000|Overall Study|Required Tooth Extraction|0|||
155671373|NCT01402869|561889655|FG001|Overall Study|Required Tooth Extraction|0|||
155671374|NCT01402869|561889656|FG002|Overall Study|Required Tooth Extraction|1|||
155671375|NCT01544348|561889657|FG000|Overall Study|Lost to Follow-up|1|||
155671376|NCT01544348|561889658|FG001|Overall Study|Lost to Follow-up|0|||
155671377|NCT01544348|561889659|FG002|Overall Study|Lost to Follow-up|0|||
155671378|NCT01544348|561889660|FG003|Overall Study|Lost to Follow-up|0|||
155671379|NCT01544348|561889661|FG004|Overall Study|Lost to Follow-up|0|||
155671380|NCT01544348|561889662|FG005|Overall Study|Lost to Follow-up|0|||
155671381|NCT01544348|561889663|FG006|Overall Study|Lost to Follow-up|1|||
155671382|NCT01544348|561889664|FG007|Overall Study|Lost to Follow-up|0|||
155671383|NCT01544348|561889657|FG000|Overall Study|Withdrawal by Subject|1|||
155671384|NCT01544348|561889658|FG001|Overall Study|Withdrawal by Subject|0|||
155671385|NCT01544348|561889659|FG002|Overall Study|Withdrawal by Subject|0|||
155671386|NCT01544348|561889660|FG003|Overall Study|Withdrawal by Subject|0|||
155671387|NCT01544348|561889661|FG004|Overall Study|Withdrawal by Subject|1|||
155671388|NCT01544348|561889662|FG005|Overall Study|Withdrawal by Subject|2|||
155671389|NCT01544348|561889663|FG006|Overall Study|Withdrawal by Subject|1|||
155671390|NCT01544348|561889664|FG007|Overall Study|Withdrawal by Subject|0|||
155671391|NCT01544348|561889657|FG000|Overall Study|Physician Decision|0|||
155671392|NCT01544348|561889658|FG001|Overall Study|Physician Decision|0|||
155671393|NCT01544348|561889659|FG002|Overall Study|Physician Decision|0|||
155671394|NCT01544348|561889660|FG003|Overall Study|Physician Decision|0|||
155671395|NCT01544348|561889661|FG004|Overall Study|Physician Decision|0|||
155671396|NCT01544348|561889662|FG005|Overall Study|Physician Decision|1|||
155671397|NCT01544348|561889663|FG006|Overall Study|Physician Decision|0|||
155671398|NCT01544348|561889664|FG007|Overall Study|Physician Decision|0|||
155671399|NCT00642707|561889665|FG000|Overall Study|Adverse Event|0|||
155671400|NCT00642707|561889666|FG001|Overall Study|Adverse Event|0|||
155671401|NCT00642707|561889667|FG002|Overall Study|Adverse Event|0|||
155671402|NCT00642707|561889668|FG003|Overall Study|Adverse Event|2|||
155671403|NCT00642707|561889665|FG000|Overall Study|Withdrawal by Subject|1|||
155671404|NCT00642707|561889666|FG001|Overall Study|Withdrawal by Subject|0|||
155671405|NCT00642707|561889667|FG002|Overall Study|Withdrawal by Subject|0|||
155671406|NCT00642707|561889668|FG003|Overall Study|Withdrawal by Subject|0|||
155671407|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
155671408|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
155671409|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
155671410|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671411|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671412|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671413|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671414|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671415|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671416|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671417|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671418|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671419|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671420|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671421|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671422|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155671423|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155671424|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155671425|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671426|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671427|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671428|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671429|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671430|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671431|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671432|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671433|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671434|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155598901|NCT02017717|561618997|FG006|Treatment Period|Other reasons|1|||
155598902|NCT02017717|561618998|FG007|Treatment Period|Other reasons|1|||
155598903|NCT02017717|561618999|FG008|Treatment Period|Other reasons|1|||
155598904|NCT02017717|561618991|FG000|Treatment Period|Maximum clinical benefit|0|||
155598905|NCT02017717|561618992|FG001|Treatment Period|Maximum clinical benefit|0|||
155598906|NCT02017717|561618993|FG002|Treatment Period|Maximum clinical benefit|0|||
155598907|NCT02017717|561618994|FG003|Treatment Period|Maximum clinical benefit|0|||
155598908|NCT02017717|561618995|FG004|Treatment Period|Maximum clinical benefit|0|||
155598909|NCT02017717|561618996|FG005|Treatment Period|Maximum clinical benefit|0|||
155598910|NCT02017717|561618997|FG006|Treatment Period|Maximum clinical benefit|0|||
155598911|NCT02017717|561618998|FG007|Treatment Period|Maximum clinical benefit|0|||
155598912|NCT02017717|561618999|FG008|Treatment Period|Maximum clinical benefit|1|||
155598913|NCT02017717|561618991|FG000|Treatment Period|Not reported|0|||
155598914|NCT02017717|561618992|FG001|Treatment Period|Not reported|1|||
155598915|NCT02017717|561618993|FG002|Treatment Period|Not reported|0|||
155598916|NCT02017717|561618994|FG003|Treatment Period|Not reported|0|||
155598917|NCT02017717|561618995|FG004|Treatment Period|Not reported|0|||
155598918|NCT02017717|561618996|FG005|Treatment Period|Not reported|0|||
155598919|NCT02017717|561618997|FG006|Treatment Period|Not reported|0|||
155598920|NCT02017717|561618998|FG007|Treatment Period|Not reported|0|||
155598921|NCT02017717|561618999|FG008|Treatment Period|Not reported|0|||
155598922|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
155598923|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
155598924|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
155598925|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
155598926|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
155598927|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
155598928|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
155598929|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
155598930|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
155598931|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
155598932|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
155598933|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
155598934|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
155598935|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
155598936|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
155598937|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
155598938|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
155598939|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
155598940|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
155598941|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
155598942|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
155598943|NCT04488419|561619001|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
155598944|NCT04488419|561619002|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
155598945|NCT04488419|561619003|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
155598946|NCT04488419|561619001|FG000|Primary Analysis Population|Adverse Event|6|||
155598947|NCT04488419|561619002|FG001|Primary Analysis Population|Adverse Event|9|||
155598948|NCT04488419|561619003|FG002|Primary Analysis Population|Adverse Event|0|||
155598949|NCT04488419|561619001|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
155598950|NCT04488419|561619002|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
155598951|NCT04488419|561619003|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
155598952|NCT04488419|561619001|FG000|Primary Analysis Population|Protocol Violation|1|||
155598953|NCT04488419|561619002|FG001|Primary Analysis Population|Protocol Violation|1|||
155598954|NCT04488419|561619003|FG002|Primary Analysis Population|Protocol Violation|0|||
155598955|NCT04488419|561619001|FG000|Primary Analysis Population|Undetermined|7|||
155598956|NCT04488419|561619002|FG001|Primary Analysis Population|Undetermined|3|||
155598957|NCT04488419|561619003|FG002|Primary Analysis Population|Undetermined|0|||
155598958|NCT04488419|561619001|FG000|Primary Analysis Population|>1 Reason|2|||
155598959|NCT04488419|561619002|FG001|Primary Analysis Population|>1 Reason|4|||
155598960|NCT04488419|561619003|FG002|Primary Analysis Population|>1 Reason|0|||
155598961|NCT04743804|561619008|FG000|Overall Study|Other|1|||
155598962|NCT04743804|561619009|FG001|Overall Study|Other|0|||
155598963|NCT04743804|561619008|FG000|Overall Study|Withdrawal by Subject|0|||
155598964|NCT04743804|561619009|FG001|Overall Study|Withdrawal by Subject|1|||
155598965|NCT04743804|561619008|FG000|Overall Study|Study Terminated by Sponsor|1|||
155598966|NCT04743804|561619009|FG001|Overall Study|Study Terminated by Sponsor|4|||
155598967|NCT04743804|561619008|FG000|Overall Study|Physician Decision|0|||
155671435|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671436|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671437|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671438|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155671439|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671440|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671441|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671442|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
155671443|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671444|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671445|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671446|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671447|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671448|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671449|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671450|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671451|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671452|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671453|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671454|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155671455|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671456|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671457|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
155671458|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671459|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671460|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671461|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671462|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671463|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671464|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671465|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671466|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671467|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671468|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671469|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671470|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155671471|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671472|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671473|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671474|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
155671475|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671476|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671477|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671478|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671479|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671480|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671481|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671482|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671483|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671484|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671485|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671486|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155671487|NCT02891226|561889669|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671488|NCT02891226|561889670|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671489|NCT02891226|561889671|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671490|NCT02891226|561889672|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
155671491|NCT02891226|561889673|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671492|NCT02891226|561889674|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671493|NCT02891226|561889675|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671494|NCT02891226|561889676|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671495|NCT02891226|561889677|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671496|NCT02891226|561889678|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671497|NCT02891226|561889679|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155598968|NCT04743804|561619009|FG001|Overall Study|Physician Decision|1|||
155598969|NCT04743804|561619008|FG000|Overall Study|Death|3|||
155598970|NCT04743804|561619009|FG001|Overall Study|Death|0|||
155598971|NCT04338269|561619010|FG000|Overall Study|Death|86|||
155598972|NCT04338269|561619011|FG001|Overall Study|Death|89|||
155598973|NCT04338269|561619010|FG000|Overall Study|Lost to Follow-up|1|||
155598974|NCT04338269|561619011|FG001|Overall Study|Lost to Follow-up|2|||
155598975|NCT04338269|561619010|FG000|Overall Study|Physician Decision|1|||
155598976|NCT04338269|561619011|FG001|Overall Study|Physician Decision|0|||
155598977|NCT04338269|561619010|FG000|Overall Study|Withdrawal by Subject|14|||
155598978|NCT04338269|561619011|FG001|Overall Study|Withdrawal by Subject|11|||
155598979|NCT00970632|561619012|FG000|Overall Study|Adverse Event|2|||
155598980|NCT00970632|561619013|FG001|Overall Study|Adverse Event|2|||
155598981|NCT00970632|561619014|FG002|Overall Study|Adverse Event|1|||
155598982|NCT00970632|561619012|FG000|Overall Study|Lack of Efficacy|3|||
155598983|NCT00970632|561619013|FG001|Overall Study|Lack of Efficacy|0|||
155598984|NCT00970632|561619014|FG002|Overall Study|Lack of Efficacy|0|||
155598985|NCT00970632|561619012|FG000|Overall Study|Lost to Follow-up|3|||
155598986|NCT00970632|561619013|FG001|Overall Study|Lost to Follow-up|0|||
155598987|NCT00970632|561619014|FG002|Overall Study|Lost to Follow-up|2|||
155598988|NCT00970632|561619012|FG000|Overall Study|Protocol Violation|8|||
155598989|NCT00970632|561619013|FG001|Overall Study|Protocol Violation|5|||
155598990|NCT00970632|561619014|FG002|Overall Study|Protocol Violation|8|||
155598991|NCT00970632|561619012|FG000|Overall Study|Withdrawal by Subject|7|||
155598992|NCT00970632|561619013|FG001|Overall Study|Withdrawal by Subject|6|||
155598993|NCT00970632|561619014|FG002|Overall Study|Withdrawal by Subject|4|||
155598994|NCT00970632|561619012|FG000|Overall Study|Entry criteria not met|0|||
155598995|NCT00970632|561619013|FG001|Overall Study|Entry criteria not met|2|||
155598996|NCT00970632|561619014|FG002|Overall Study|Entry criteria not met|2|||
155598997|NCT00970632|561619012|FG000|Overall Study|Sponsor decision|1|||
155598998|NCT00970632|561619013|FG001|Overall Study|Sponsor decision|0|||
155598999|NCT00970632|561619014|FG002|Overall Study|Sponsor decision|1|||
155599000|NCT02487771|561619019|FG000|Overall Study|Lost to Follow-up|2|||
155599001|NCT02487771|561619020|FG001|Overall Study|Lost to Follow-up|3|||
155599002|NCT02487771|561619019|FG000|Overall Study|Moved out of area|5|||
155599003|NCT02487771|561619020|FG001|Overall Study|Moved out of area|6|||
155599004|NCT02487771|561619019|FG000|Overall Study|Withdrawal by Subject|3|||
155599005|NCT02487771|561619020|FG001|Overall Study|Withdrawal by Subject|5|||
155599006|NCT03408444|561619027|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
155599007|NCT03408444|561619028|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155599008|NCT03408444|561619029|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155599009|NCT03408444|561619030|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155599010|NCT03408444|561619027|FG000|Overall Study|Lens Discomfort|0|||
155599011|NCT03408444|561619028|FG001|Overall Study|Lens Discomfort|1|||
155599012|NCT03408444|561619029|FG002|Overall Study|Lens Discomfort|0|||
155599013|NCT03408444|561619030|FG003|Overall Study|Lens Discomfort|0|||
155599014|NCT03408444|561619027|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155599015|NCT03408444|561619028|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155599016|NCT03408444|561619029|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155599017|NCT03408444|561619030|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155599018|NCT03408444|561619027|FG000|Overall Study|Withdrawal by Subject|0|||
155599019|NCT03408444|561619028|FG001|Overall Study|Withdrawal by Subject|2|||
155599020|NCT03408444|561619029|FG002|Overall Study|Withdrawal by Subject|3|||
155599021|NCT03408444|561619030|FG003|Overall Study|Withdrawal by Subject|0|||
155599022|NCT03408444|561619027|FG000|Overall Study|Lost to Follow-up|0|||
155599023|NCT03408444|561619028|FG001|Overall Study|Lost to Follow-up|0|||
155599024|NCT03408444|561619029|FG002|Overall Study|Lost to Follow-up|1|||
155599025|NCT03408444|561619030|FG003|Overall Study|Lost to Follow-up|0|||
155599026|NCT03408444|561619027|FG000|Overall Study|Adverse Event|0|||
155599027|NCT03408444|561619028|FG001|Overall Study|Adverse Event|0|||
155599028|NCT03408444|561619029|FG002|Overall Study|Adverse Event|0|||
155599029|NCT03408444|561619030|FG003|Overall Study|Adverse Event|1|||
155599030|NCT03408444|561619027|FG000|Overall Study|Lens Handling Difficulties|0|||
155599031|NCT03408444|561619028|FG001|Overall Study|Lens Handling Difficulties|0|||
155599032|NCT03408444|561619029|FG002|Overall Study|Lens Handling Difficulties|1|||
155599033|NCT03408444|561619030|FG003|Overall Study|Lens Handling Difficulties|0|||
155599034|NCT03408444|561619027|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155599035|NCT03408444|561619028|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155599036|NCT03408444|561619029|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155599037|NCT03408444|561619030|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
155671498|NCT02891226|561889680|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671499|NCT02891226|561889681|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671500|NCT02891226|561889682|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671501|NCT02891226|561889683|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671502|NCT02891226|561889684|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155671503|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671504|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671505|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671506|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671507|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671508|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671509|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
155671510|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
155671511|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
155671512|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
155671513|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671514|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671515|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671516|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671517|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671518|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155671519|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671520|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671521|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671522|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671523|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671524|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
155671525|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671526|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671527|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671528|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
155671529|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671530|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671531|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671532|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671533|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671534|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155671535|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671536|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671537|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671538|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671539|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671540|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671541|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
155671542|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
155671543|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
155671544|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
155671545|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671546|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671547|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671548|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671549|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671550|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155671551|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671552|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671553|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671554|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671555|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
155671556|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671557|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671558|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671559|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671560|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671561|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671562|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671563|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671564|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671565|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155671566|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155599038|NCT03875482|561619031|FG000|Overall Study|Adverse Event|0|||
155599039|NCT03875482|561619032|FG001|Overall Study|Adverse Event|1|||
155599040|NCT03875482|561619031|FG000|Overall Study|Withdrew consent|5|||
155599041|NCT03875482|561619032|FG001|Overall Study|Withdrew consent|6|||
155599042|NCT03875482|561619031|FG000|Overall Study|Lost to Follow-up|8|||
155599043|NCT03875482|561619032|FG001|Overall Study|Lost to Follow-up|2|||
155599044|NCT03875482|561619031|FG000|Overall Study|Lack of Efficacy|0|||
155599045|NCT03875482|561619032|FG001|Overall Study|Lack of Efficacy|11|||
155599046|NCT00507819|561619035|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
155599047|NCT00507819|561619036|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
155599048|NCT04507256|561619041|FG000|Overall Study|Withdrawal by Subject|1|||
155599049|NCT04507256|561619042|FG001|Overall Study|Withdrawal by Subject|0|||
155599050|NCT04507256|561619043|FG002|Overall Study|Withdrawal by Subject|0|||
155599051|NCT04507256|561619044|FG003|Overall Study|Withdrawal by Subject|1|||
155599052|NCT04507256|561619045|FG004|Overall Study|Withdrawal by Subject|0|||
155599053|NCT04507256|561619046|FG005|Overall Study|Withdrawal by Subject|0|||
155599054|NCT02256982|561619049|FG000|Overall Study|Disease Progression|0|||
155599055|NCT02256982|561619050|FG001|Overall Study|Disease Progression|1|||
155599056|NCT02777970|561619051|FG000|Overall Study|Lost to Follow-up|0|||
155599057|NCT02777970|561619052|FG001|Overall Study|Lost to Follow-up|1|||
155599058|NCT02777970|561619053|FG002|Overall Study|Lost to Follow-up|0|||
155599059|NCT02777970|561619051|FG000|Overall Study|Protocol Violation|1|||
155599060|NCT02777970|561619052|FG001|Overall Study|Protocol Violation|0|||
155599061|NCT02777970|561619053|FG002|Overall Study|Protocol Violation|0|||
155599062|NCT02347891|561619054|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
155599063|NCT02347891|561619055|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
155599064|NCT02347891|561619054|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
155599065|NCT02347891|561619055|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
155599066|NCT02541669|561619061|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155599067|NCT02541669|561619062|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155599068|NCT02541669|561619063|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155599069|NCT02541669|561619064|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155599070|NCT02541669|561619065|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155599071|NCT04739722|561619066|FG000|Overall Study|Lost to Follow-up|5301|||
155599072|NCT04739722|561619066|FG000|Overall Study|Withdrawal by Subject|42|||
155599073|NCT04739722|561619066|FG000|Overall Study|Non Average-risk|1157|||
155599074|NCT00834639|561619067|FG000|Second Intervention|Physician Decision|0|||
155599075|NCT00834639|561619068|FG001|Second Intervention|Physician Decision|2|||
155599076|NCT01869699|561619069|FG000|Overall Study|Withdrawal by Subject|1|||
155599077|NCT01869699|561619070|FG001|Overall Study|Withdrawal by Subject|0|||
155599078|NCT01083186|561619071|FG000|Overall Study|Lost to Follow-up|48|||
155599079|NCT01083186|561619071|FG000|Overall Study|Consent Withdrawal|7|||
155599080|NCT01083186|561619071|FG000|Overall Study|Death|3|||
155599081|NCT01083186|561619071|FG000|Overall Study|Adverse Event|3|||
155599082|NCT01083186|561619071|FG000|Overall Study|Lack of Efficacy|2|||
155599083|NCT01083186|561619071|FG000|Overall Study|Hemodialysis Initiation|28|||
155599084|NCT01083186|561619071|FG000|Overall Study|Administrative Reasons|2|||
155599085|NCT01083186|561619071|FG000|Overall Study|Non-compliance to Study Treatment|1|||
155599086|NCT03419598|561619078|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
155599087|NCT00380081|561619079|FG000|Overall Study|Withdrawal by Subject|0|||
155599088|NCT00380081|561619080|FG001|Overall Study|Withdrawal by Subject|0|||
155599089|NCT00380081|561619081|FG002|Overall Study|Withdrawal by Subject|0|||
155599090|NCT00380081|561619082|FG003|Overall Study|Withdrawal by Subject|0|||
155599091|NCT00380081|561619083|FG004|Overall Study|Withdrawal by Subject|1|||
155599092|NCT00380081|561619084|FG005|Overall Study|Withdrawal by Subject|0|||
155599093|NCT00380081|561619079|FG000|Overall Study|Family Emergency|0|||
155599094|NCT00380081|561619080|FG001|Overall Study|Family Emergency|0|||
155599095|NCT00380081|561619081|FG002|Overall Study|Family Emergency|0|||
155599096|NCT00380081|561619082|FG003|Overall Study|Family Emergency|0|||
155599097|NCT00380081|561619083|FG004|Overall Study|Family Emergency|0|||
155671567|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671568|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671569|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671570|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671571|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671572|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671573|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
155671574|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671575|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671576|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671577|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671578|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671579|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671580|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671581|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671582|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155671583|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671584|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671585|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671586|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671587|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671588|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671589|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671590|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155671591|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155671592|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155671593|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671594|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671595|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671596|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671597|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671598|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155671599|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671600|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671601|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671602|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671603|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671604|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671605|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671606|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
155671607|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671608|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671609|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671610|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671611|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671612|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671613|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671614|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155671615|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671616|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671617|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671618|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671619|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671620|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671621|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671622|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671623|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
155671624|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671625|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671626|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671627|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671628|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671629|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671630|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155671631|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671632|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671633|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671634|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671635|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671636|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671637|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671638|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671639|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671640|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
155671641|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671642|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671643|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671644|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671645|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671646|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155671647|NCT02891226|561889669|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671648|NCT02891226|561889670|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671649|NCT02891226|561889671|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671650|NCT02891226|561889672|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671651|NCT02891226|561889673|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671652|NCT02891226|561889674|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671653|NCT02891226|561889675|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671654|NCT02891226|561889676|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671655|NCT02891226|561889677|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671656|NCT02891226|561889678|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
155671657|NCT02891226|561889679|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671658|NCT02891226|561889680|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671659|NCT02891226|561889681|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671660|NCT02891226|561889682|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671661|NCT02891226|561889683|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671662|NCT02891226|561889684|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155671663|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671664|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671665|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671666|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671667|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671668|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671669|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671670|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671671|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671672|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671673|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
155671674|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671675|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671676|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671677|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671678|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155671679|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671680|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671681|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671682|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671683|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671684|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671685|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671686|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671687|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671688|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671689|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
155671690|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671691|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671692|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671693|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671694|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155671695|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671696|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671697|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671698|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671699|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671700|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671701|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671702|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671703|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671704|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671705|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
155671706|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671707|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671708|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671709|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671710|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155671711|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671712|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671713|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671714|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671715|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671716|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671717|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671718|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671719|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671720|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671721|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
155671722|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671723|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671724|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671725|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671726|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155671727|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671728|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671729|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671730|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671731|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671732|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671733|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671734|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671735|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671736|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671737|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
155671738|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671739|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671740|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671741|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671742|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155671743|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671744|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671745|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671746|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671747|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671748|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671749|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671750|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671751|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671752|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671753|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
155671754|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671755|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671756|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671757|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671758|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155671759|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671760|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671761|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671762|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671763|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671764|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671765|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671766|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671767|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671768|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671769|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
155671770|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671771|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671772|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671773|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671774|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155671775|NCT02891226|561889669|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671776|NCT02891226|561889670|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671777|NCT02891226|561889671|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671778|NCT02891226|561889672|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671779|NCT02891226|561889673|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671780|NCT02891226|561889674|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671781|NCT02891226|561889675|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671782|NCT02891226|561889676|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671783|NCT02891226|561889677|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671784|NCT02891226|561889678|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671785|NCT02891226|561889679|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
155671786|NCT02891226|561889680|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671787|NCT02891226|561889681|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671788|NCT02891226|561889682|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671789|NCT02891226|561889683|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671790|NCT02891226|561889684|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155671791|NCT02891226|561889669|FG000|Follow-up Period|Withdrawal by Subject|0|||
155671792|NCT02891226|561889670|FG001|Follow-up Period|Withdrawal by Subject|0|||
155671793|NCT02891226|561889671|FG002|Follow-up Period|Withdrawal by Subject|0|||
155671794|NCT02891226|561889672|FG003|Follow-up Period|Withdrawal by Subject|0|||
155671795|NCT02891226|561889673|FG004|Follow-up Period|Withdrawal by Subject|0|||
155671796|NCT02891226|561889674|FG005|Follow-up Period|Withdrawal by Subject|0|||
155671797|NCT02891226|561889675|FG006|Follow-up Period|Withdrawal by Subject|0|||
155671798|NCT02891226|561889676|FG007|Follow-up Period|Withdrawal by Subject|0|||
155671799|NCT02891226|561889677|FG008|Follow-up Period|Withdrawal by Subject|0|||
155671800|NCT02891226|561889678|FG009|Follow-up Period|Withdrawal by Subject|0|||
155671801|NCT02891226|561889679|FG010|Follow-up Period|Withdrawal by Subject|0|||
155671802|NCT02891226|561889680|FG011|Follow-up Period|Withdrawal by Subject|1|||
155671803|NCT02891226|561889681|FG012|Follow-up Period|Withdrawal by Subject|0|||
155671804|NCT02891226|561889682|FG013|Follow-up Period|Withdrawal by Subject|0|||
155671805|NCT02891226|561889683|FG014|Follow-up Period|Withdrawal by Subject|1|||
155671806|NCT02891226|561889684|FG015|Follow-up Period|Withdrawal by Subject|1|||
155671807|NCT01445847|561889685|FG000|Overall Study|Protocol Violation|13|||
155671808|NCT01445847|561889686|FG001|Overall Study|Protocol Violation|14|||
155671809|NCT01445847|561889685|FG000|Overall Study|Missed Data|1|||
155671810|NCT01445847|561889686|FG001|Overall Study|Missed Data|0|||
155671811|NCT00707993|561889687|FG000|Overall Study|Adverse Event|16|||
155671812|NCT00707993|561889688|FG001|Overall Study|Adverse Event|20|||
155671813|NCT00707993|561889687|FG000|Overall Study|Protocol Violation|4|||
155671814|NCT00707993|561889688|FG001|Overall Study|Protocol Violation|7|||
155671815|NCT00707993|561889687|FG000|Overall Study|Lost to Follow-up|0|||
155671816|NCT00707993|561889688|FG001|Overall Study|Lost to Follow-up|4|||
155671817|NCT00707993|561889687|FG000|Overall Study|Withdrawal by Subject|12|||
155671818|NCT00707993|561889688|FG001|Overall Study|Withdrawal by Subject|16|||
155671819|NCT00707993|561889687|FG000|Overall Study|Hyperglycemic Rescue|55|||
155671820|NCT00707993|561889688|FG001|Overall Study|Hyperglycemic Rescue|47|||
155671821|NCT00707993|561889687|FG000|Overall Study|Other|2|||
155671822|NCT00707993|561889688|FG001|Overall Study|Other|0|||
155671823|NCT03008070|561889689|FG000|Overall Study|Adverse Event|3|||
155671824|NCT03008070|561889690|FG001|Overall Study|Adverse Event|3|||
155671825|NCT03008070|561889691|FG002|Overall Study|Adverse Event|3|||
155671826|NCT03008070|561889689|FG000|Overall Study|Lost to Follow-up|1|||
155671827|NCT03008070|561889690|FG001|Overall Study|Lost to Follow-up|1|||
155671828|NCT03008070|561889691|FG002|Overall Study|Lost to Follow-up|0|||
155671829|NCT03008070|561889689|FG000|Overall Study|Non compliance|0|||
155671830|NCT03008070|561889690|FG001|Overall Study|Non compliance|1|||
155671831|NCT03008070|561889691|FG002|Overall Study|Non compliance|1|||
155671832|NCT03008070|561889689|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
155671833|NCT03008070|561889690|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
155671834|NCT03008070|561889691|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
155671835|NCT03008070|561889689|FG000|Overall Study|Withdrawal by Subject|2|||
155671836|NCT03008070|561889690|FG001|Overall Study|Withdrawal by Subject|0|||
155671837|NCT03008070|561889691|FG002|Overall Study|Withdrawal by Subject|1|||
155671838|NCT03008070|561889689|FG000|Overall Study|Use of prohibited drug|0|||
155671839|NCT03008070|561889690|FG001|Overall Study|Use of prohibited drug|0|||
155671840|NCT03008070|561889691|FG002|Overall Study|Use of prohibited drug|2|||
155671841|NCT03960684|561889692|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
155671842|NCT03533660|561889693|FG000|Overall Study|Withdrawal by Subject|2|||
155671843|NCT03533660|561889694|FG001|Overall Study|Withdrawal by Subject|2|||
155671844|NCT03533660|561889693|FG000|Overall Study|Death|2|||
155671845|NCT03533660|561889694|FG001|Overall Study|Death|4|||
155671846|NCT03533660|561889693|FG000|Overall Study|Adverse Event|0|||
155671847|NCT03533660|561889694|FG001|Overall Study|Adverse Event|2|||
155671848|NCT03816176|561889695|FG000|Overall Study|Miscellaneous|5|||
155671849|NCT03816176|561889695|FG000|Overall Study|Lack of Efficacy|4|||
155671850|NCT03816176|561889695|FG000|Overall Study|Adverse Event|3|||
155671851|NCT01142388|561891654|FG000|Overall Study|Lack of Efficacy|21|||
155671852|NCT01142388|561891655|FG001|Overall Study|Lack of Efficacy|31|||
155671853|NCT01142388|561891654|FG000|Overall Study|Adverse Event|9|||
155671854|NCT01142388|561891655|FG001|Overall Study|Adverse Event|5|||
155671855|NCT01142388|561891654|FG000|Overall Study|Death|3|||
155671856|NCT01142388|561891655|FG001|Overall Study|Death|2|||
155671857|NCT01142388|561891654|FG000|Overall Study|Withdrawal by Subject|5|||
155599098|NCT00380081|561619084|FG005|Overall Study|Family Emergency|1|||
155599099|NCT00459706|561619085|FG000|Overall Study|Adverse Event|19|||
155599100|NCT00459706|561619086|FG001|Overall Study|Adverse Event|13|||
155599101|NCT00459706|561619085|FG000|Overall Study|Withdrawal by Subject|1|||
155599102|NCT00459706|561619086|FG001|Overall Study|Withdrawal by Subject|6|||
155599103|NCT00459706|561619085|FG000|Overall Study|Physician Decision|2|||
155599104|NCT00459706|561619086|FG001|Overall Study|Physician Decision|0|||
155599105|NCT00459706|561619085|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
155599106|NCT00459706|561619086|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155599107|NCT00459706|561619085|FG000|Overall Study|Protocol Violation|2|||
155599108|NCT00459706|561619086|FG001|Overall Study|Protocol Violation|1|||
155599109|NCT00459706|561619085|FG000|Overall Study|Failed to Return|1|||
155599110|NCT00459706|561619086|FG001|Overall Study|Failed to Return|0|||
155599111|NCT00459706|561619085|FG000|Overall Study|Other|0|||
155599112|NCT00459706|561619086|FG001|Overall Study|Other|1|||
155599113|NCT00189306|561619087|FG000|Treatment Period|Withdrawal by Subject|2|||
155599114|NCT00189306|561619087|FG000|Treatment Period|Adverse Event|2|||
155599115|NCT00189306|561619087|FG000|Treatment Period|Protocol Violation|1|||
155599116|NCT00189306|561619087|FG000|Posttreatment Period|Death|1|||
155599117|NCT00189306|561619087|FG000|Posttreatment Period|Withdrawal by Subject|2|||
155599118|NCT00189306|561619087|FG000|Posttreatment Period|Noncompliance|1|||
155599119|NCT00189306|561619087|FG000|Posttreatment Period|Target lesion excised|1|||
155599120|NCT00189306|561619087|FG000|Posttreatment Period|Protocol Violation|1|||
155599121|NCT00189306|561619087|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
155599122|NCT00189306|561619087|FG000|Posttreatment Period|Local skin reaction/sign|1|||
155599123|NCT00189306|561619087|FG000|Long-Term Follow-up|Adverse Event|2|||
155599124|NCT00189306|561619087|FG000|Long-Term Follow-up|Death|4|||
155599125|NCT00189306|561619087|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
155599126|NCT00189306|561619087|FG000|Long-Term Follow-up|Intercurrent disease|2|||
155599127|NCT00189306|561619087|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
155599128|NCT00189306|561619087|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
155599129|NCT02017912|561619088|FG000|Overall Study|Withdrawal by Subject|2|||
155599130|NCT02017912|561619089|FG001|Overall Study|Withdrawal by Subject|1|||
155599131|NCT02017912|561619088|FG000|Overall Study|miscellaneous|1|||
155599132|NCT02017912|561619089|FG001|Overall Study|miscellaneous|1|||
155599133|NCT03640481|561619090|FG000|Overall Study|Death|14|||
155599134|NCT03640481|561619091|FG001|Overall Study|Death|14|||
155599135|NCT03640481|561619092|FG002|Overall Study|Death|0|||
155599136|NCT03640481|561619093|FG003|Overall Study|Death|0|||
155599137|NCT03640481|561619090|FG000|Overall Study|Lost to Follow-up|2|||
155599138|NCT03640481|561619091|FG001|Overall Study|Lost to Follow-up|0|||
155599139|NCT03640481|561619092|FG002|Overall Study|Lost to Follow-up|0|||
155599140|NCT03640481|561619093|FG003|Overall Study|Lost to Follow-up|0|||
155599141|NCT03640481|561619090|FG000|Overall Study|Site terminated by sponsor|1|||
155599142|NCT03640481|561619091|FG001|Overall Study|Site terminated by sponsor|3|||
155599143|NCT03640481|561619092|FG002|Overall Study|Site terminated by sponsor|0|||
155599144|NCT03640481|561619093|FG003|Overall Study|Site terminated by sponsor|0|||
155599145|NCT03640481|561619090|FG000|Overall Study|Study terminated by sponsor|29|||
155599146|NCT03640481|561619091|FG001|Overall Study|Study terminated by sponsor|42|||
155599147|NCT03640481|561619092|FG002|Overall Study|Study terminated by sponsor|1|||
155599148|NCT03640481|561619093|FG003|Overall Study|Study terminated by sponsor|0|||
155599149|NCT03640481|561619090|FG000|Overall Study|Withdrawal by Subject|5|||
155599150|NCT03640481|561619091|FG001|Overall Study|Withdrawal by Subject|4|||
155599151|NCT03640481|561619092|FG002|Overall Study|Withdrawal by Subject|0|||
155599152|NCT03640481|561619093|FG003|Overall Study|Withdrawal by Subject|1|||
155599153|NCT03640481|561619090|FG000|Overall Study|Other|26|||
155599154|NCT03640481|561619091|FG001|Overall Study|Other|12|||
155599155|NCT03640481|561619092|FG002|Overall Study|Other|1|||
155599156|NCT03640481|561619093|FG003|Overall Study|Other|0|||
155671858|NCT01142388|561891655|FG001|Overall Study|Withdrawal by Subject|3|||
155599157|NCT03640481|561619090|FG000|Overall Study|Randomized, but not treated|1|||
155599158|NCT03640481|561619091|FG001|Overall Study|Randomized, but not treated|3|||
155599159|NCT03640481|561619092|FG002|Overall Study|Randomized, but not treated|0|||
155599160|NCT03640481|561619093|FG003|Overall Study|Randomized, but not treated|0|||
155599161|NCT00535847|561619094|FG000|Overall Study|Adverse Event|5|||
155599162|NCT00535847|561619095|FG001|Overall Study|Adverse Event|3|||
155599163|NCT00535847|561619096|FG002|Overall Study|Adverse Event|2|||
155599164|NCT00535847|561619094|FG000|Overall Study|Non compliance|1|||
155599165|NCT00535847|561619095|FG001|Overall Study|Non compliance|1|||
155599166|NCT00535847|561619096|FG002|Overall Study|Non compliance|0|||
155599167|NCT00535847|561619094|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
155599168|NCT00535847|561619095|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
155599169|NCT00535847|561619096|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
155599170|NCT03197870|561619105|FG000|Overall Study|Adverse Event|9|||
155599171|NCT03197870|561619106|FG001|Overall Study|Adverse Event|4|||
155599172|NCT03197870|561619107|FG002|Overall Study|Adverse Event|6|||
155599173|NCT03197870|561619105|FG000|Overall Study|Withdrawal by Subject|2|||
155599174|NCT03197870|561619106|FG001|Overall Study|Withdrawal by Subject|3|||
155599175|NCT03197870|561619107|FG002|Overall Study|Withdrawal by Subject|0|||
155599176|NCT03197870|561619105|FG000|Overall Study|Lost to Follow-up|2|||
155599177|NCT03197870|561619106|FG001|Overall Study|Lost to Follow-up|2|||
155599178|NCT03197870|561619107|FG002|Overall Study|Lost to Follow-up|0|||
155599179|NCT03197870|561619105|FG000|Overall Study|data not available|1|||
155599180|NCT03197870|561619106|FG001|Overall Study|data not available|1|||
155599181|NCT03197870|561619107|FG002|Overall Study|data not available|0|||
155599182|NCT01618019|561619108|FG000|Overall Study|Withdrawal by Subject|14|||
155599183|NCT01618019|561619109|FG001|Overall Study|Withdrawal by Subject|14|||
155599184|NCT01508130|561619113|FG000|Overall Study|Adverse Event|81|||
155599185|NCT01508130|561619114|FG001|Overall Study|Adverse Event|28|||
155599186|NCT01508130|561619113|FG000|Overall Study|Death|3|||
155671859|NCT01142388|561891654|FG000|Overall Study|Alternative therapy|1|||
155599187|NCT01508130|561619114|FG001|Overall Study|Death|1|||
155599188|NCT01508130|561619113|FG000|Overall Study|Protocol Violation|2|||
155599189|NCT01508130|561619114|FG001|Overall Study|Protocol Violation|0|||
155599190|NCT01508130|561619113|FG000|Overall Study|Lost to Follow-up|25|||
155599191|NCT01508130|561619114|FG001|Overall Study|Lost to Follow-up|2|||
155671860|NCT01142388|561891655|FG001|Overall Study|Alternative therapy|0|||
155671861|NCT01142388|561891654|FG000|Overall Study|Other complications|0|||
155671862|NCT01142388|561891655|FG001|Overall Study|Other complications|2|||
155671863|NCT01142388|561891654|FG000|Overall Study|Other|1|||
155671864|NCT01142388|561891655|FG001|Overall Study|Other|1|||
155671865|NCT01142388|561891654|FG000|Overall Study|Never started therapy|7|||
155671866|NCT01142388|561891655|FG001|Overall Study|Never started therapy|3|||
155671867|NCT05265728|561891661|FG000|Overall Study|Adverse Event|1|||
155671868|NCT05265728|561891661|FG000|Overall Study|Study Terminated by Sponsor|5|||
155671869|NCT05265728|561891661|FG000|Overall Study|Withdrawal by Subject|2|||
155671870|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
155671871|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
155671872|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
155671873|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
155671874|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
155671875|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
155671876|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
155671877|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
155671878|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
155671879|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
155671880|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
155671881|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
155671882|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
155671883|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
155671884|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
155671885|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
155671886|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
155671887|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
155671888|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
155671889|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
155671890|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
155671891|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
155671892|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
155671893|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
155671894|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Other|6|||
155671895|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Other|0|||
155671896|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Other|0|||
155671897|NCT05615220|561891662|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
155671898|NCT05615220|561891663|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
155671899|NCT05615220|561891664|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
155671900|NCT05615220|561891662|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
155671901|NCT05615220|561891663|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
155671902|NCT05615220|561891664|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
155671903|NCT05615220|561891662|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
155671904|NCT05615220|561891663|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
155671905|NCT05615220|561891664|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
155671906|NCT05615220|561891662|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
155671907|NCT05615220|561891663|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
155671908|NCT05615220|561891664|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
155671909|NCT05615220|561891662|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
155671910|NCT05615220|561891663|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
155671911|NCT05615220|561891664|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
155671912|NCT05615220|561891662|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
155671913|NCT05615220|561891663|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
155671914|NCT05615220|561891664|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
155671915|NCT00703963|561891669|FG000|Overall Study|Withdrawal by Subject|7|||
155671916|NCT00703963|561891670|FG001|Overall Study|Withdrawal by Subject|13|||
155671917|NCT00703963|561891669|FG000|Overall Study|Physician Decision|0|||
155671918|NCT00703963|561891670|FG001|Overall Study|Physician Decision|1|||
155671919|NCT03994211|561891677|FG000|Core Phase|Adverse Event|0|||
155671920|NCT03994211|561891678|FG001|Core Phase|Adverse Event|1|||
155671921|NCT03994211|561891679|FG002|Core Phase|Adverse Event|0|||
155671922|NCT03994211|561891677|FG000|Extension Phase|Adverse Event|0|||
155671923|NCT03994211|561891678|FG001|Extension Phase|Adverse Event|0|||
155671924|NCT03994211|561891679|FG002|Extension Phase|Adverse Event|1|||
155671925|NCT03994211|561891677|FG000|Extension Phase|Physician Decision|0|||
155671926|NCT03994211|561891678|FG001|Extension Phase|Physician Decision|0|||
155671927|NCT03994211|561891679|FG002|Extension Phase|Physician Decision|1|||
155671928|NCT03994211|561891677|FG000|Extension Phase|Progressive Disease|0|||
155671929|NCT03994211|561891678|FG001|Extension Phase|Progressive Disease|0|||
155671930|NCT03994211|561891679|FG002|Extension Phase|Progressive Disease|20|||
155671931|NCT03994211|561891677|FG000|Extension Phase|Withdrawal by Subject|0|||
155671932|NCT03994211|561891678|FG001|Extension Phase|Withdrawal by Subject|0|||
155671933|NCT03994211|561891679|FG002|Extension Phase|Withdrawal by Subject|2|||
155671934|NCT02528942|561891680|FG000|Overall Study|Did not meet imaging criteria|9|||
155671935|NCT02528942|561891680|FG000|Overall Study|Lost to Follow-up|25|||
155671936|NCT00881530|561891681|FG000|Overall Study|Adverse Event|5|||
155671937|NCT00881530|561891682|FG001|Overall Study|Adverse Event|1|||
155671938|NCT00881530|561891683|FG002|Overall Study|Adverse Event|1|||
155671939|NCT00881530|561891684|FG003|Overall Study|Adverse Event|4|||
155671940|NCT00881530|561891685|FG004|Overall Study|Adverse Event|10|||
155671941|NCT00881530|561891686|FG005|Overall Study|Adverse Event|2|||
155671942|NCT00881530|561891681|FG000|Overall Study|Lack of Efficacy|1|||
155671943|NCT00881530|561891682|FG001|Overall Study|Lack of Efficacy|0|||
155671944|NCT00881530|561891683|FG002|Overall Study|Lack of Efficacy|0|||
155671945|NCT00881530|561891684|FG003|Overall Study|Lack of Efficacy|0|||
155671946|NCT00881530|561891685|FG004|Overall Study|Lack of Efficacy|1|||
155671947|NCT00881530|561891686|FG005|Overall Study|Lack of Efficacy|1|||
155671948|NCT00881530|561891681|FG000|Overall Study|Not compliant with the protocol|0|||
155671949|NCT00881530|561891682|FG001|Overall Study|Not compliant with the protocol|0|||
155671950|NCT00881530|561891683|FG002|Overall Study|Not compliant with the protocol|0|||
155671951|NCT00881530|561891684|FG003|Overall Study|Not compliant with the protocol|0|||
155671952|NCT00881530|561891685|FG004|Overall Study|Not compliant with the protocol|2|||
155671953|NCT00881530|561891686|FG005|Overall Study|Not compliant with the protocol|0|||
155671954|NCT00881530|561891681|FG000|Overall Study|Lost to Follow-up|0|||
155671955|NCT00881530|561891682|FG001|Overall Study|Lost to Follow-up|1|||
155671956|NCT00881530|561891683|FG002|Overall Study|Lost to Follow-up|1|||
155671957|NCT00881530|561891684|FG003|Overall Study|Lost to Follow-up|3|||
155671958|NCT00881530|561891685|FG004|Overall Study|Lost to Follow-up|1|||
155671959|NCT00881530|561891686|FG005|Overall Study|Lost to Follow-up|0|||
155671960|NCT00881530|561891681|FG000|Overall Study|Refused to continue medication|7|||
155671961|NCT00881530|561891682|FG001|Overall Study|Refused to continue medication|2|||
155671962|NCT00881530|561891683|FG002|Overall Study|Refused to continue medication|1|||
155671963|NCT00881530|561891684|FG003|Overall Study|Refused to continue medication|2|||
155671964|NCT00881530|561891685|FG004|Overall Study|Refused to continue medication|0|||
155671965|NCT00881530|561891686|FG005|Overall Study|Refused to continue medication|0|||
155671966|NCT00881530|561891681|FG000|Overall Study|Other reason not defined above|1|||
155671967|NCT00881530|561891682|FG001|Overall Study|Other reason not defined above|1|||
155671968|NCT00881530|561891683|FG002|Overall Study|Other reason not defined above|2|||
155671969|NCT00881530|561891684|FG003|Overall Study|Other reason not defined above|0|||
155671970|NCT00881530|561891685|FG004|Overall Study|Other reason not defined above|0|||
155671971|NCT00881530|561891686|FG005|Overall Study|Other reason not defined above|2|||
155671972|NCT03900728|561891687|FG000|Overall Study|No text responses|0|||
155671973|NCT03900728|561891688|FG001|Overall Study|No text responses|0|||
155599192|NCT01508130|561619113|FG000|Overall Study|Withdrawal by Subject|3|||
155599193|NCT01508130|561619114|FG001|Overall Study|Withdrawal by Subject|3|||
155599194|NCT01508130|561619113|FG000|Overall Study|Subject's substantial non-compliance|25|||
155599195|NCT01508130|561619114|FG001|Overall Study|Subject's substantial non-compliance|9|||
155599196|NCT01508130|561619113|FG000|Overall Study|Insufficient therapeutic response|74|||
155599197|NCT01508130|561619114|FG001|Overall Study|Insufficient therapeutic response|23|||
155599198|NCT01508130|561619113|FG000|Overall Study|Administrative|14|||
155671974|NCT03900728|561891689|FG002|Overall Study|No text responses|4|||
155671975|NCT00763256|561891691|FG000|Overall Study|Didn't return for appointments|7|||
155671976|NCT00763256|561891692|FG001|Overall Study|Didn't return for appointments|10|||
155671977|NCT01272037|561891696|FG000|Overall Study|Death|25|||
155671978|NCT01272037|561891697|FG001|Overall Study|Death|28|||
155671979|NCT01272037|561891696|FG000|Overall Study|Adverse Event|12|||
155671980|NCT01272037|561891697|FG001|Overall Study|Adverse Event|7|||
155671981|NCT01272037|561891696|FG000|Overall Study|Withdrawal by Subject|175|||
155671982|NCT01272037|561891697|FG001|Overall Study|Withdrawal by Subject|93|||
155671983|NCT01272037|561891696|FG000|Overall Study|Disease progression|70|||
155671984|NCT01272037|561891697|FG001|Overall Study|Disease progression|111|||
155671985|NCT01272037|561891696|FG000|Overall Study|Other reason|42|||
155671986|NCT01272037|561891697|FG001|Overall Study|Other reason|41|||
155671987|NCT01272037|561891696|FG000|Overall Study|Delinquent data|24|||
155671988|NCT01272037|561891697|FG001|Overall Study|Delinquent data|19|||
155671989|NCT01272037|561891696|FG000|Overall Study|Reason under review|33|||
155671990|NCT01272037|561891697|FG001|Overall Study|Reason under review|29|||
155671991|NCT01272037|561891696|FG000|Overall Study|On treatment|626|||
155671992|NCT01272037|561891697|FG001|Overall Study|On treatment|632|||
155671993|NCT01393899|561891700|FG000|Overall Study|Study terminated by sponsor|1|||
155671994|NCT01393899|561891701|FG001|Overall Study|Study terminated by sponsor|0|||
155671995|NCT01393899|561891702|FG002|Overall Study|Study terminated by sponsor|1|||
155671996|NCT01393899|561891700|FG000|Overall Study|Other|1|||
155671997|NCT01393899|561891701|FG001|Overall Study|Other|0|||
155671998|NCT01393899|561891702|FG002|Overall Study|Other|0|||
155671999|NCT01393899|561891700|FG000|Overall Study|Withdrawal by Subject|2|||
155672000|NCT01393899|561891701|FG001|Overall Study|Withdrawal by Subject|2|||
155672001|NCT01393899|561891702|FG002|Overall Study|Withdrawal by Subject|1|||
155672002|NCT01393899|561891700|FG000|Overall Study|Lost to Follow-up|0|||
155672003|NCT01393899|561891701|FG001|Overall Study|Lost to Follow-up|0|||
155672004|NCT01393899|561891702|FG002|Overall Study|Lost to Follow-up|1|||
155672005|NCT01393899|561891700|FG000|Overall Study|Does not meet entrance criteria|1|||
155672006|NCT01393899|561891701|FG001|Overall Study|Does not meet entrance criteria|0|||
155672007|NCT01393899|561891702|FG002|Overall Study|Does not meet entrance criteria|1|||
155672008|NCT01393899|561891700|FG000|Overall Study|Lack of Efficacy|26|||
155672009|NCT01393899|561891701|FG001|Overall Study|Lack of Efficacy|21|||
155672010|NCT01393899|561891702|FG002|Overall Study|Lack of Efficacy|16|||
155672011|NCT01393899|561891700|FG000|Overall Study|Adverse Event|1|||
155672012|NCT01393899|561891701|FG001|Overall Study|Adverse Event|5|||
155672013|NCT01393899|561891702|FG002|Overall Study|Adverse Event|3|||
155672014|NCT02503085|561891703|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
155672015|NCT02503085|561891704|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
155672016|NCT02503085|561891705|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
155672017|NCT02503085|561891706|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
155672018|NCT02720523|561891710|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
155672019|NCT02720523|561891711|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
155672020|NCT02720523|561891712|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
155599199|NCT01508130|561619114|FG001|Overall Study|Administrative|3|||
155599200|NCT01680159|561619115|FG000|Screening Period|Not meet criteria for dose-up period|7|||
155672021|NCT02720523|561891713|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
155672022|NCT02720523|561891714|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
155672023|NCT02720523|561891715|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
155672024|NCT02720523|561891716|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
155672025|NCT02720523|561891710|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
155672026|NCT02720523|561891711|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672027|NCT02720523|561891712|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672028|NCT02720523|561891713|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672029|NCT02720523|561891714|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672030|NCT02720523|561891715|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672031|NCT02720523|561891716|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155672032|NCT02720523|561891710|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
155672033|NCT02720523|561891711|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672034|NCT02720523|561891712|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672035|NCT02720523|561891713|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672036|NCT02720523|561891714|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672037|NCT02720523|561891715|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672038|NCT02720523|561891716|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155672039|NCT02720523|561891710|FG000|Period 1: Placebo-controlled Period|Other|0|||
155672040|NCT02720523|561891711|FG001|Period 1: Placebo-controlled Period|Other|0|||
155672041|NCT02720523|561891712|FG002|Period 1: Placebo-controlled Period|Other|1|||
155672042|NCT02720523|561891713|FG003|Period 1: Placebo-controlled Period|Other|1|||
155672043|NCT02720523|561891714|FG004|Period 1: Placebo-controlled Period|Other|0|||
155672044|NCT02720523|561891715|FG005|Period 1: Placebo-controlled Period|Other|0|||
155672045|NCT02720523|561891716|FG006|Period 1: Placebo-controlled Period|Other|0|||
155672046|NCT02720523|561891710|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
155672047|NCT02720523|561891711|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
155672048|NCT02720523|561891712|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
155672049|NCT02720523|561891713|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
155672050|NCT02720523|561891714|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
155672051|NCT02720523|561891715|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
155672052|NCT02720523|561891716|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
155672053|NCT02720523|561891710|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
155672054|NCT02720523|561891711|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
155672055|NCT02720523|561891712|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
155672056|NCT02720523|561891713|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
155672057|NCT02720523|561891714|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
155672058|NCT02720523|561891715|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
155672059|NCT02720523|561891716|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
155672060|NCT02720523|561891710|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155672061|NCT02720523|561891711|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155672062|NCT02720523|561891712|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155672063|NCT02720523|561891713|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155672064|NCT02720523|561891714|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
155672065|NCT02720523|561891715|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
155672066|NCT02720523|561891716|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
155672067|NCT02720523|561891710|FG000|Period 2: Long-term Extension Period|Other|0|||
155672068|NCT02720523|561891711|FG001|Period 2: Long-term Extension Period|Other|0|||
155672069|NCT02720523|561891712|FG002|Period 2: Long-term Extension Period|Other|0|||
155672070|NCT02720523|561891713|FG003|Period 2: Long-term Extension Period|Other|0|||
155672071|NCT02720523|561891714|FG004|Period 2: Long-term Extension Period|Other|2|||
155672072|NCT02720523|561891715|FG005|Period 2: Long-term Extension Period|Other|0|||
155672073|NCT02720523|561891716|FG006|Period 2: Long-term Extension Period|Other|3|||
155672074|NCT04585269|561891720|FG000|Intervention|Withdrawal by Subject|9|||
155672075|NCT04585269|561891721|FG001|Intervention|Withdrawal by Subject|0|||
155672076|NCT04585269|561891720|FG000|Intervention|Unable to schedule|15|||
155672077|NCT04585269|561891721|FG001|Intervention|Unable to schedule|0|||
155672078|NCT04585269|561891720|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
155672079|NCT04585269|561891721|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
155672080|NCT04585269|561891720|FG000|FU Time 2 (3 months)|Death|2|||
155672081|NCT04585269|561891721|FG001|FU Time 2 (3 months)|Death|2|||
155672082|NCT04585269|561891720|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
155672083|NCT04585269|561891721|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
155672084|NCT04585269|561891720|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
155672085|NCT04585269|561891721|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
155672086|NCT04585269|561891720|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
155672087|NCT04585269|561891721|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
155672088|NCT04585269|561891720|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
155672089|NCT04585269|561891721|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
155672090|NCT04585269|561891720|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
155672091|NCT04585269|561891721|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
155672092|NCT03670355|561891724|FG000|Overall Study|Adverse Event|1|||
155672093|NCT03670355|561891725|FG001|Overall Study|Adverse Event|0|||
155672094|NCT03670355|561891724|FG000|Overall Study|Unable to comply with study procedures|0|||
155672095|NCT03670355|561891725|FG001|Overall Study|Unable to comply with study procedures|1|||
155672096|NCT03670355|561891724|FG000|Overall Study|Participant refused|0|||
155672097|NCT03670355|561891725|FG001|Overall Study|Participant refused|1|||
155672098|NCT03307785|561891726|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
155672099|NCT03307785|561891727|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672100|NCT03307785|561891728|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672101|NCT03307785|561891729|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672102|NCT03307785|561891730|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672103|NCT03307785|561891731|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672104|NCT03307785|561891732|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672105|NCT03307785|561891733|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672106|NCT03307785|561891734|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672107|NCT03307785|561891735|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672108|NCT03307785|561891736|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672109|NCT03307785|561891737|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672110|NCT03307785|561891738|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155672111|NCT03307785|561891726|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
155672112|NCT03307785|561891727|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
155672113|NCT03307785|561891728|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672114|NCT03307785|561891729|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672115|NCT03307785|561891730|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672116|NCT03307785|561891731|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672117|NCT03307785|561891732|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672118|NCT03307785|561891733|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672119|NCT03307785|561891734|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672120|NCT03307785|561891735|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672121|NCT03307785|561891736|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672122|NCT03307785|561891737|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672123|NCT03307785|561891738|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155672124|NCT03307785|561891726|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
155672125|NCT03307785|561891727|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
155672126|NCT03307785|561891728|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672127|NCT03307785|561891729|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672128|NCT03307785|561891730|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672129|NCT03307785|561891731|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672130|NCT03307785|561891732|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672131|NCT03307785|561891733|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672132|NCT03307785|561891734|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672133|NCT03307785|561891735|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672134|NCT03307785|561891736|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672135|NCT03307785|561891737|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672136|NCT03307785|561891738|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
155672137|NCT03307785|561891726|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
155672138|NCT03307785|561891727|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
155672139|NCT03307785|561891728|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672140|NCT03307785|561891729|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672141|NCT03307785|561891730|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672142|NCT03307785|561891731|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672143|NCT03307785|561891732|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672144|NCT03307785|561891733|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672145|NCT03307785|561891734|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672146|NCT03307785|561891735|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672147|NCT03307785|561891736|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672148|NCT03307785|561891737|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672149|NCT03307785|561891738|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155672150|NCT03307785|561891726|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672151|NCT03307785|561891727|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672152|NCT03307785|561891728|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
155672153|NCT03307785|561891729|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672154|NCT03307785|561891730|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672155|NCT03307785|561891731|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672156|NCT03307785|561891732|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672157|NCT03307785|561891733|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672158|NCT03307785|561891734|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672159|NCT03307785|561891735|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672160|NCT03307785|561891736|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672161|NCT03307785|561891737|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672162|NCT03307785|561891738|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155672163|NCT03307785|561891726|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672164|NCT03307785|561891727|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672165|NCT03307785|561891728|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
155672166|NCT03307785|561891729|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672167|NCT03307785|561891730|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672168|NCT03307785|561891731|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672169|NCT03307785|561891732|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672170|NCT03307785|561891733|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672171|NCT03307785|561891734|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672172|NCT03307785|561891735|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672173|NCT03307785|561891736|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672174|NCT03307785|561891737|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672175|NCT03307785|561891738|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
155672176|NCT03307785|561891726|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672177|NCT03307785|561891727|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672178|NCT03307785|561891728|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
155672179|NCT03307785|561891729|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672180|NCT03307785|561891730|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672181|NCT03307785|561891731|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672182|NCT03307785|561891732|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672183|NCT03307785|561891733|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672184|NCT03307785|561891734|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672185|NCT03307785|561891735|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672186|NCT03307785|561891736|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672187|NCT03307785|561891737|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672188|NCT03307785|561891738|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155672189|NCT03307785|561891726|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672190|NCT03307785|561891727|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672191|NCT03307785|561891728|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
155672192|NCT03307785|561891729|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672193|NCT03307785|561891730|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672194|NCT03307785|561891731|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672195|NCT03307785|561891732|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672196|NCT03307785|561891733|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672197|NCT03307785|561891734|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672198|NCT03307785|561891735|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672199|NCT03307785|561891736|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672200|NCT03307785|561891737|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672201|NCT03307785|561891738|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155672202|NCT03307785|561891726|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672203|NCT03307785|561891727|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672204|NCT03307785|561891728|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
155672205|NCT03307785|561891729|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672206|NCT03307785|561891730|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672207|NCT03307785|561891731|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672208|NCT03307785|561891732|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672209|NCT03307785|561891733|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672210|NCT03307785|561891734|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672211|NCT03307785|561891735|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672212|NCT03307785|561891736|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672213|NCT03307785|561891737|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672214|NCT03307785|561891738|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155672215|NCT03307785|561891726|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672216|NCT03307785|561891727|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672217|NCT03307785|561891728|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672218|NCT03307785|561891729|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
155672219|NCT03307785|561891730|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
155672220|NCT03307785|561891731|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672221|NCT03307785|561891732|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672222|NCT03307785|561891733|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672223|NCT03307785|561891734|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672224|NCT03307785|561891735|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672225|NCT03307785|561891736|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672226|NCT03307785|561891737|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672227|NCT03307785|561891738|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155672228|NCT03307785|561891726|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672229|NCT03307785|561891727|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672230|NCT03307785|561891728|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672231|NCT03307785|561891729|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
155672232|NCT03307785|561891730|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
155672233|NCT03307785|561891731|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672234|NCT03307785|561891732|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672235|NCT03307785|561891733|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672236|NCT03307785|561891734|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672237|NCT03307785|561891735|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672238|NCT03307785|561891736|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672239|NCT03307785|561891737|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672240|NCT03307785|561891738|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
155672241|NCT03307785|561891726|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672242|NCT03307785|561891727|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672243|NCT03307785|561891728|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672244|NCT03307785|561891729|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
155672245|NCT03307785|561891730|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672246|NCT03307785|561891731|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672247|NCT03307785|561891732|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672248|NCT03307785|561891733|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672249|NCT03307785|561891734|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672250|NCT03307785|561891735|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672251|NCT03307785|561891736|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672252|NCT03307785|561891737|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672253|NCT03307785|561891738|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155672254|NCT03307785|561891726|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672255|NCT03307785|561891727|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672256|NCT03307785|561891728|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672257|NCT03307785|561891729|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672258|NCT03307785|561891730|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
155672259|NCT03307785|561891731|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672260|NCT03307785|561891732|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672261|NCT03307785|561891733|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672262|NCT03307785|561891734|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672263|NCT03307785|561891735|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672264|NCT03307785|561891736|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672265|NCT03307785|561891737|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672266|NCT03307785|561891738|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155672267|NCT03307785|561891726|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672268|NCT03307785|561891727|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672269|NCT03307785|561891728|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672270|NCT03307785|561891729|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672271|NCT03307785|561891730|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672272|NCT03307785|561891731|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
155672273|NCT03307785|561891732|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672274|NCT03307785|561891733|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672275|NCT03307785|561891734|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672276|NCT03307785|561891735|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672277|NCT03307785|561891736|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672278|NCT03307785|561891737|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672279|NCT03307785|561891738|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155672280|NCT03307785|561891726|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672281|NCT03307785|561891727|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672282|NCT03307785|561891728|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672283|NCT03307785|561891729|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672284|NCT03307785|561891730|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672285|NCT03307785|561891731|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
155672286|NCT03307785|561891732|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672287|NCT03307785|561891733|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672288|NCT03307785|561891734|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672289|NCT03307785|561891735|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672290|NCT03307785|561891736|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672291|NCT03307785|561891737|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672292|NCT03307785|561891738|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155672293|NCT03307785|561891726|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672294|NCT03307785|561891727|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672295|NCT03307785|561891728|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672296|NCT03307785|561891729|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672297|NCT03307785|561891730|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672298|NCT03307785|561891731|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
155672299|NCT03307785|561891732|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672300|NCT03307785|561891733|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672301|NCT03307785|561891734|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672302|NCT03307785|561891735|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155599201|NCT01680159|561619115|FG000|Increased Dose Period|Adverse Event|6|||
155599202|NCT01680159|561619115|FG000|Increased Dose Period|Withdrawal by Subject|2|||
155599203|NCT02783729|561619119|FG000|Overall Study|Lack of Efficacy|1|||
155599204|NCT02783729|561619120|FG001|Overall Study|Lack of Efficacy|0|||
155672303|NCT03307785|561891736|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672304|NCT03307785|561891737|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672305|NCT03307785|561891738|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155672306|NCT03307785|561891726|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672307|NCT03307785|561891727|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672308|NCT03307785|561891728|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672309|NCT03307785|561891729|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155599205|NCT02783729|561619121|FG002|Overall Study|Lack of Efficacy|0|||
155599206|NCT02783729|561619122|FG003|Overall Study|Lack of Efficacy|0|||
155599207|NCT02783729|561619119|FG000|Overall Study|Adverse Event|2|||
155599208|NCT02783729|561619120|FG001|Overall Study|Adverse Event|6|||
155599209|NCT02783729|561619121|FG002|Overall Study|Adverse Event|2|||
155599210|NCT02783729|561619122|FG003|Overall Study|Adverse Event|3|||
155599211|NCT02783729|561619119|FG000|Overall Study|Other|1|||
155599212|NCT02783729|561619120|FG001|Overall Study|Other|6|||
155599213|NCT02783729|561619121|FG002|Overall Study|Other|2|||
155599214|NCT02783729|561619122|FG003|Overall Study|Other|3|||
155599215|NCT02783729|561619119|FG000|Overall Study|Withdrawal by Subject|2|||
155599216|NCT02783729|561619120|FG001|Overall Study|Withdrawal by Subject|3|||
155599217|NCT02783729|561619121|FG002|Overall Study|Withdrawal by Subject|1|||
155599218|NCT02783729|561619122|FG003|Overall Study|Withdrawal by Subject|2|||
155599219|NCT02783729|561619119|FG000|Overall Study|Participant's choice|2|||
155599220|NCT02783729|561619120|FG001|Overall Study|Participant's choice|1|||
155599221|NCT02783729|561619121|FG002|Overall Study|Participant's choice|2|||
155599222|NCT02783729|561619122|FG003|Overall Study|Participant's choice|1|||
155599223|NCT02783729|561619119|FG000|Overall Study|Lost to Follow-up|2|||
155599224|NCT02783729|561619120|FG001|Overall Study|Lost to Follow-up|1|||
155599225|NCT02783729|561619121|FG002|Overall Study|Lost to Follow-up|1|||
155599226|NCT02783729|561619122|FG003|Overall Study|Lost to Follow-up|0|||
155599227|NCT02288091|561619124|FG000|Overall Study|Lost to Follow-up|1|||
155599228|NCT02288091|561619124|FG000|Overall Study|Screen fail|7|||
155599229|NCT03403751|561619125|FG000|Overall Study|Death|5|||
155599230|NCT03403751|561619126|FG001|Overall Study|Death|6|||
155599231|NCT03403751|561619125|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
155599232|NCT03403751|561619126|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
155599233|NCT00387010|561619130|FG000|Dose Titration Period|Adverse Event|12|||
155672310|NCT03307785|561891730|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672311|NCT03307785|561891731|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
155672312|NCT03307785|561891732|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672313|NCT03307785|561891733|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672314|NCT03307785|561891734|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672315|NCT03307785|561891735|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672316|NCT03307785|561891736|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672317|NCT03307785|561891737|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672318|NCT03307785|561891738|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155672319|NCT03307785|561891726|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672320|NCT03307785|561891727|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672321|NCT03307785|561891728|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672322|NCT03307785|561891729|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672323|NCT03307785|561891730|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672324|NCT03307785|561891731|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
155672325|NCT03307785|561891732|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672326|NCT03307785|561891733|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672327|NCT03307785|561891734|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672328|NCT03307785|561891735|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672329|NCT03307785|561891736|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672330|NCT03307785|561891737|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672331|NCT03307785|561891738|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155672332|NCT03307785|561891726|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672333|NCT03307785|561891727|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672334|NCT03307785|561891728|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672335|NCT03307785|561891729|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672336|NCT03307785|561891730|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672337|NCT03307785|561891731|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672338|NCT03307785|561891732|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
155672339|NCT03307785|561891733|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672340|NCT03307785|561891734|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672341|NCT03307785|561891735|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672342|NCT03307785|561891736|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672343|NCT03307785|561891737|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672344|NCT03307785|561891738|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
155672345|NCT03307785|561891726|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672346|NCT03307785|561891727|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672347|NCT03307785|561891728|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672348|NCT03307785|561891729|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672349|NCT03307785|561891730|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672350|NCT03307785|561891731|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672351|NCT03307785|561891732|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
155672352|NCT03307785|561891733|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672353|NCT03307785|561891734|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672354|NCT03307785|561891735|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672355|NCT03307785|561891736|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672356|NCT03307785|561891737|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672357|NCT03307785|561891738|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155672358|NCT03307785|561891726|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672359|NCT03307785|561891727|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672360|NCT03307785|561891728|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672361|NCT03307785|561891729|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672362|NCT03307785|561891730|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672363|NCT03307785|561891731|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672364|NCT03307785|561891732|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672365|NCT03307785|561891733|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
155672366|NCT03307785|561891734|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672367|NCT03307785|561891735|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672368|NCT03307785|561891736|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672369|NCT03307785|561891737|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672370|NCT03307785|561891738|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155672371|NCT03307785|561891726|FG000|PACT Phase: Up to 19 Months|Death|0|||
155672372|NCT03307785|561891727|FG001|PACT Phase: Up to 19 Months|Death|0|||
155672373|NCT03307785|561891728|FG002|PACT Phase: Up to 19 Months|Death|0|||
155672374|NCT03307785|561891729|FG003|PACT Phase: Up to 19 Months|Death|0|||
155672375|NCT03307785|561891730|FG004|PACT Phase: Up to 19 Months|Death|0|||
155672376|NCT03307785|561891731|FG005|PACT Phase: Up to 19 Months|Death|0|||
155672377|NCT03307785|561891732|FG006|PACT Phase: Up to 19 Months|Death|0|||
155672378|NCT03307785|561891733|FG007|PACT Phase: Up to 19 Months|Death|0|||
155672379|NCT03307785|561891734|FG008|PACT Phase: Up to 19 Months|Death|0|||
155672380|NCT03307785|561891735|FG009|PACT Phase: Up to 19 Months|Death|0|||
155672381|NCT03307785|561891736|FG010|PACT Phase: Up to 19 Months|Death|0|||
155672382|NCT03307785|561891737|FG011|PACT Phase: Up to 19 Months|Death|0|||
155672383|NCT03307785|561891738|FG012|PACT Phase: Up to 19 Months|Death|1|||
155672384|NCT03146663|561891739|FG000|Overall Study|Did not receive study treatment|1|||
155672385|NCT03146663|561891740|FG001|Overall Study|Did not receive study treatment|1|||
155672386|NCT03666988|561891741|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
155672387|NCT03666988|561891742|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
155672388|NCT03666988|561891743|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
155672389|NCT03666988|561891744|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
155672390|NCT03666988|561891745|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
155672391|NCT03666988|561891746|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
155672392|NCT03666988|561891741|FG000|Part 1 (Up to 28 Months)|Other|0|||
155672393|NCT03666988|561891742|FG001|Part 1 (Up to 28 Months)|Other|1|||
155672394|NCT03666988|561891743|FG002|Part 1 (Up to 28 Months)|Other|1|||
155672395|NCT03666988|561891744|FG003|Part 1 (Up to 28 Months)|Other|0|||
155672396|NCT03666988|561891745|FG004|Part 1 (Up to 28 Months)|Other|0|||
155672397|NCT03666988|561891746|FG005|Part 1 (Up to 28 Months)|Other|0|||
155672398|NCT03666988|561891741|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
155672399|NCT03666988|561891742|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
155672400|NCT03666988|561891743|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
155672401|NCT03666988|561891744|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
155672402|NCT03666988|561891745|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
155672403|NCT03666988|561891746|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
155672404|NCT03666988|561891741|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
155672405|NCT03666988|561891742|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
155672406|NCT03666988|561891743|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
155672407|NCT03666988|561891744|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
155672408|NCT03666988|561891745|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
155672409|NCT03666988|561891746|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
155672410|NCT03666988|561891741|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
155672411|NCT03666988|561891742|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155672412|NCT03666988|561891743|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155672413|NCT03666988|561891744|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155672414|NCT03666988|561891745|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155672415|NCT03666988|561891746|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155672416|NCT05526521|561891752|FG000|Overall Study|Withdrawal by Subject|0|||
155672417|NCT05526521|561891753|FG001|Overall Study|Withdrawal by Subject|1|||
155672418|NCT05526521|561891754|FG002|Overall Study|Withdrawal by Subject|0|||
155672419|NCT05526521|561891755|FG003|Overall Study|Withdrawal by Subject|0|||
155672420|NCT00436436|561891761|FG000|Overall Study|Progression|4|||
155672421|NCT00436436|561891761|FG000|Overall Study|Adverse Event|2|||
155672422|NCT00436436|561891761|FG000|Overall Study|Death|6|||
155672423|NCT03381287|561891766|FG000|Overall Study|Withdrawal by Subject|0|||
155672424|NCT03381287|561891767|FG001|Overall Study|Withdrawal by Subject|1|||
155672425|NCT03381287|561891768|FG002|Overall Study|Withdrawal by Subject|0|||
155672426|NCT03381287|561891769|FG003|Overall Study|Withdrawal by Subject|0|||
155672427|NCT03381287|561891766|FG000|Overall Study|Adverse Event|0|||
155672428|NCT03381287|561891767|FG001|Overall Study|Adverse Event|0|||
155672429|NCT03381287|561891768|FG002|Overall Study|Adverse Event|0|||
155672430|NCT03381287|561891769|FG003|Overall Study|Adverse Event|1|||
155672431|NCT03381287|561891766|FG000|Overall Study|Physician Decision|0|||
155672432|NCT03381287|561891767|FG001|Overall Study|Physician Decision|0|||
155672433|NCT03381287|561891768|FG002|Overall Study|Physician Decision|0|||
155672434|NCT03381287|561891769|FG003|Overall Study|Physician Decision|1|||
155672435|NCT00325130|561891803|FG000|Overall Study|Lost to Follow-up|6|||
155672436|NCT00325130|561891804|FG001|Overall Study|Lost to Follow-up|14|||
155672437|NCT00325130|561891803|FG000|Overall Study|Withdrawal by Subject|12|||
155672438|NCT00325130|561891804|FG001|Overall Study|Withdrawal by Subject|14|||
155672439|NCT00325130|561891803|FG000|Overall Study|Protocol Deviation|0|||
155672440|NCT00325130|561891804|FG001|Overall Study|Protocol Deviation|1|||
155672441|NCT00325130|561891803|FG000|Overall Study|Moved|0|||
155672442|NCT00325130|561891804|FG001|Overall Study|Moved|1|||
155672443|NCT00325130|561891803|FG000|Overall Study|Patient Discontinued for Other|1|||
155672444|NCT00325130|561891804|FG001|Overall Study|Patient Discontinued for Other|0|||
155672445|NCT01671956|561891807|FG000|Overall Study|Disease progression|0|||
155672446|NCT01671956|561891808|FG001|Overall Study|Disease progression|1|||
155672447|NCT01671956|561891807|FG000|Overall Study|Withdrawal by Subject|1|||
155672448|NCT01671956|561891808|FG001|Overall Study|Withdrawal by Subject|1|||
155672449|NCT01671956|561891807|FG000|Overall Study|Adverse Event|1|||
155672450|NCT01671956|561891808|FG001|Overall Study|Adverse Event|0|||
155672451|NCT04266912|561891814|FG000|Overall Study|Withdrawal by Subject|1|||
155672452|NCT04266912|561891815|FG001|Overall Study|Withdrawal by Subject|0|||
155672453|NCT04266912|561891816|FG002|Overall Study|Withdrawal by Subject|0|||
155672454|NCT04266912|561891817|FG003|Overall Study|Withdrawal by Subject|0|||
155672455|NCT04266912|561891814|FG000|Overall Study|Progression|6|||
155672456|NCT04266912|561891815|FG001|Overall Study|Progression|6|||
155672457|NCT04266912|561891816|FG002|Overall Study|Progression|0|||
155672458|NCT04266912|561891817|FG003|Overall Study|Progression|10|||
155672459|NCT03581292|561891824|FG000|Overall Study|Physician Decision|9|||
155672460|NCT03581292|561891825|FG001|Overall Study|Physician Decision|5|||
155672461|NCT03581292|561891824|FG000|Overall Study|Withdrawal by Subject|3|||
155672462|NCT03581292|561891825|FG001|Overall Study|Withdrawal by Subject|0|||
155672463|NCT03581292|561891824|FG000|Overall Study|Withdrawal before Therapy Start|1|||
155672464|NCT03581292|561891825|FG001|Overall Study|Withdrawal before Therapy Start|0|||
155672465|NCT07214935|561891831|FG000|Overall Study|Adverse Event|1|||
155672466|NCT07214935|561891832|FG001|Overall Study|Adverse Event|1|||
155672467|NCT07214935|561891833|FG002|Overall Study|Adverse Event|1|||
155672468|NCT07214935|561891834|FG003|Overall Study|Adverse Event|0|||
155672469|NCT07214935|561891831|FG000|Overall Study|Lost to Follow-up|0|||
155672470|NCT07214935|561891832|FG001|Overall Study|Lost to Follow-up|1|||
155672471|NCT07214935|561891833|FG002|Overall Study|Lost to Follow-up|0|||
155672472|NCT07214935|561891834|FG003|Overall Study|Lost to Follow-up|0|||
155672473|NCT07214935|561891831|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
155672474|NCT07214935|561891832|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155672475|NCT07214935|561891833|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155672476|NCT07214935|561891834|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155672477|NCT07214935|561891831|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
155672478|NCT07214935|561891832|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
155672479|NCT07214935|561891833|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
155672480|NCT07214935|561891834|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
155672481|NCT05823974|561894098|FG000|Overall Study|Lost to Follow-up|0|||
155672482|NCT05823974|561894099|FG001|Overall Study|Lost to Follow-up|3|||
155672483|NCT05823974|561894100|FG002|Overall Study|Lost to Follow-up|1|||
155672484|NCT05823974|561894101|FG003|Overall Study|Lost to Follow-up|0|||
155672485|NCT05823974|561894102|FG004|Overall Study|Lost to Follow-up|1|||
155672486|NCT05823974|561894103|FG005|Overall Study|Lost to Follow-up|0|||
155672487|NCT05823974|561894104|FG006|Overall Study|Lost to Follow-up|1|||
155672488|NCT05823974|561894105|FG007|Overall Study|Lost to Follow-up|0|||
155672489|NCT05823974|561894106|FG008|Overall Study|Lost to Follow-up|0|||
155672490|NCT05823974|561894107|FG009|Overall Study|Lost to Follow-up|1|||
155672491|NCT05823974|561894108|FG010|Overall Study|Lost to Follow-up|1|||
155672492|NCT05823974|561894109|FG011|Overall Study|Lost to Follow-up|0|||
155672493|NCT05823974|561894110|FG012|Overall Study|Lost to Follow-up|1|||
155672494|NCT05823974|561894111|FG013|Overall Study|Lost to Follow-up|2|||
155672495|NCT05823974|561894112|FG014|Overall Study|Lost to Follow-up|1|||
155672496|NCT05823974|561894113|FG015|Overall Study|Lost to Follow-up|1|||
155672497|NCT05823974|561894114|FG016|Overall Study|Lost to Follow-up|1|||
155672498|NCT05823974|561894115|FG017|Overall Study|Lost to Follow-up|0|||
155672499|NCT05823974|561894116|FG018|Overall Study|Lost to Follow-up|0|||
155672500|NCT05823974|561894117|FG019|Overall Study|Lost to Follow-up|2|||
155672501|NCT05823974|561894118|FG020|Overall Study|Lost to Follow-up|0|||
155672502|NCT05823974|561894098|FG000|Overall Study|Physician Decision|0|||
155672503|NCT05823974|561894099|FG001|Overall Study|Physician Decision|0|||
155672504|NCT05823974|561894100|FG002|Overall Study|Physician Decision|0|||
155672505|NCT05823974|561894101|FG003|Overall Study|Physician Decision|0|||
155672506|NCT05823974|561894102|FG004|Overall Study|Physician Decision|0|||
155672507|NCT05823974|561894103|FG005|Overall Study|Physician Decision|0|||
155672508|NCT05823974|561894104|FG006|Overall Study|Physician Decision|0|||
155672509|NCT05823974|561894105|FG007|Overall Study|Physician Decision|0|||
155672510|NCT05823974|561894106|FG008|Overall Study|Physician Decision|0|||
155672511|NCT05823974|561894107|FG009|Overall Study|Physician Decision|0|||
155672512|NCT05823974|561894108|FG010|Overall Study|Physician Decision|0|||
155672513|NCT05823974|561894109|FG011|Overall Study|Physician Decision|0|||
155672514|NCT05823974|561894110|FG012|Overall Study|Physician Decision|0|||
155672515|NCT05823974|561894111|FG013|Overall Study|Physician Decision|0|||
155672516|NCT05823974|561894112|FG014|Overall Study|Physician Decision|0|||
155672517|NCT05823974|561894113|FG015|Overall Study|Physician Decision|1|||
155672518|NCT05823974|561894114|FG016|Overall Study|Physician Decision|0|||
155672519|NCT05823974|561894115|FG017|Overall Study|Physician Decision|1|||
155672520|NCT05823974|561894116|FG018|Overall Study|Physician Decision|1|||
155672521|NCT05823974|561894117|FG019|Overall Study|Physician Decision|0|||
155672522|NCT05823974|561894118|FG020|Overall Study|Physician Decision|0|||
155672523|NCT05823974|561894098|FG000|Overall Study|Withdrawal by Subject|1|||
155672524|NCT05823974|561894099|FG001|Overall Study|Withdrawal by Subject|1|||
155672525|NCT05823974|561894100|FG002|Overall Study|Withdrawal by Subject|2|||
155672526|NCT05823974|561894101|FG003|Overall Study|Withdrawal by Subject|0|||
155672527|NCT05823974|561894102|FG004|Overall Study|Withdrawal by Subject|2|||
155672528|NCT05823974|561894103|FG005|Overall Study|Withdrawal by Subject|3|||
155672529|NCT05823974|561894104|FG006|Overall Study|Withdrawal by Subject|1|||
155672530|NCT05823974|561894105|FG007|Overall Study|Withdrawal by Subject|1|||
155672531|NCT05823974|561894106|FG008|Overall Study|Withdrawal by Subject|2|||
155672532|NCT05823974|561894107|FG009|Overall Study|Withdrawal by Subject|1|||
155672533|NCT05823974|561894108|FG010|Overall Study|Withdrawal by Subject|1|||
155672534|NCT05823974|561894109|FG011|Overall Study|Withdrawal by Subject|0|||
155672535|NCT05823974|561894110|FG012|Overall Study|Withdrawal by Subject|0|||
155672536|NCT05823974|561894111|FG013|Overall Study|Withdrawal by Subject|1|||
155672537|NCT05823974|561894112|FG014|Overall Study|Withdrawal by Subject|1|||
155672538|NCT05823974|561894113|FG015|Overall Study|Withdrawal by Subject|3|||
155672539|NCT05823974|561894114|FG016|Overall Study|Withdrawal by Subject|0|||
155672540|NCT05823974|561894115|FG017|Overall Study|Withdrawal by Subject|2|||
155672541|NCT05823974|561894116|FG018|Overall Study|Withdrawal by Subject|2|||
155672542|NCT05823974|561894117|FG019|Overall Study|Withdrawal by Subject|0|||
155672543|NCT05823974|561894118|FG020|Overall Study|Withdrawal by Subject|1|||
155672544|NCT05823974|561894098|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672545|NCT05823974|561894099|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672546|NCT05823974|561894100|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155672547|NCT05823974|561894101|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672548|NCT05823974|561894102|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672549|NCT05823974|561894103|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672550|NCT05823974|561894104|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672551|NCT05823974|561894105|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672552|NCT05823974|561894106|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672553|NCT05823974|561894107|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672554|NCT05823974|561894108|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672555|NCT05823974|561894109|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672556|NCT05823974|561894110|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672557|NCT05823974|561894111|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672558|NCT05823974|561894112|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155672559|NCT05823974|561894113|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672560|NCT05823974|561894114|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672561|NCT05823974|561894115|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672562|NCT05823974|561894116|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672563|NCT05823974|561894117|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672564|NCT05823974|561894118|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155672565|NCT05823974|561894098|FG000|Overall Study|Other|0|||
155672566|NCT05823974|561894099|FG001|Overall Study|Other|1|||
155672567|NCT05823974|561894100|FG002|Overall Study|Other|1|||
155672568|NCT05823974|561894101|FG003|Overall Study|Other|1|||
155672569|NCT05823974|561894102|FG004|Overall Study|Other|0|||
155672570|NCT05823974|561894103|FG005|Overall Study|Other|1|||
155672571|NCT05823974|561894104|FG006|Overall Study|Other|1|||
155672572|NCT05823974|561894105|FG007|Overall Study|Other|1|||
155672573|NCT05823974|561894106|FG008|Overall Study|Other|1|||
155672574|NCT05823974|561894107|FG009|Overall Study|Other|0|||
155672575|NCT05823974|561894108|FG010|Overall Study|Other|0|||
155672576|NCT05823974|561894109|FG011|Overall Study|Other|0|||
155672577|NCT05823974|561894110|FG012|Overall Study|Other|2|||
155672578|NCT05823974|561894111|FG013|Overall Study|Other|1|||
155672579|NCT05823974|561894112|FG014|Overall Study|Other|0|||
155672580|NCT05823974|561894113|FG015|Overall Study|Other|1|||
155672581|NCT05823974|561894114|FG016|Overall Study|Other|0|||
155672582|NCT05823974|561894115|FG017|Overall Study|Other|0|||
155672583|NCT05823974|561894116|FG018|Overall Study|Other|0|||
155672584|NCT05823974|561894117|FG019|Overall Study|Other|0|||
155672585|NCT05823974|561894118|FG020|Overall Study|Other|0|||
155672586|NCT02744612|561894119|FG000|Overall Study|Withdrawal by Subject|0|||
155672587|NCT02744612|561894120|FG001|Overall Study|Withdrawal by Subject|2|||
155672588|NCT00316706|561894121|FG000|Overall Study|Lost to Follow-up|38|||
155672589|NCT00316706|561894122|FG001|Overall Study|Lost to Follow-up|48|||
155672590|NCT00283803|561894124|FG000|Overall Study|Physician Decision|9|||
155672591|NCT00283803|561894124|FG000|Overall Study|Withdrawal by Subject|4|||
155672592|NCT01127607|561894125|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
155672593|NCT01127607|561894126|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
155672594|NCT01127607|561894125|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
155672595|NCT01127607|561894126|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
155672596|NCT02220855|561894127|FG000|Overall Study|Adverse Event|8|||
155672597|NCT02220855|561894127|FG000|Overall Study|Disease Progression|5|||
155672598|NCT02220855|561894127|FG000|Overall Study|Withdrawal by Subject|1|||
155672599|NCT03419897|561894128|FG000|Overall Study|Death|180|||
155672600|NCT03419897|561894128|FG000|Overall Study|Lost to Follow-up|1|||
155672601|NCT03419897|561894128|FG000|Overall Study|Withdrawal by Subject|6|||
155672602|NCT03419897|561894128|FG000|Overall Study|Sponsor Decision|61|||
155672603|NCT03419897|561894128|FG000|Overall Study|Physician Decision|1|||
155672604|NCT05730725|561894131|FG000|Overall Study|Withdrawal by Subject|3|||
155672605|NCT05730725|561894132|FG001|Overall Study|Withdrawal by Subject|0|||
155672606|NCT05730725|561894133|FG002|Overall Study|Withdrawal by Subject|0|||
155672607|NCT05730725|561894134|FG003|Overall Study|Withdrawal by Subject|1|||
155672608|NCT05730725|561894131|FG000|Overall Study|Not Reported|1|||
155672609|NCT05730725|561894132|FG001|Overall Study|Not Reported|1|||
155672610|NCT05730725|561894133|FG002|Overall Study|Not Reported|1|||
155672611|NCT05730725|561894134|FG003|Overall Study|Not Reported|1|||
155672612|NCT01133756|561894136|FG000|Overall Study|Adverse Event|1|||
155672613|NCT01133756|561894137|FG001|Overall Study|Adverse Event|2|||
155672614|NCT01133756|561894138|FG002|Overall Study|Adverse Event|1|||
155672615|NCT01133756|561894136|FG000|Overall Study|Investigator Decision|1|||
155672616|NCT01133756|561894137|FG001|Overall Study|Investigator Decision|0|||
155672617|NCT01133756|561894138|FG002|Overall Study|Investigator Decision|0|||
155672618|NCT01133756|561894136|FG000|Overall Study|Withdrawal by Subject|0|||
155672619|NCT01133756|561894137|FG001|Overall Study|Withdrawal by Subject|1|||
155672620|NCT01133756|561894138|FG002|Overall Study|Withdrawal by Subject|0|||
155672621|NCT01133756|561894136|FG000|Overall Study|Progression of Disease|0|||
155672622|NCT01133756|561894137|FG001|Overall Study|Progression of Disease|0|||
155672623|NCT01133756|561894138|FG002|Overall Study|Progression of Disease|1|||
155672624|NCT01945216|561894144|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
155672625|NCT01945216|561894144|FG000|Overall Study|Protocol Violation|42|||
155672626|NCT01945216|561894144|FG000|Overall Study|CRF not assured by investigators|5|||
155672627|NCT03941873|561894151|FG000|Overall Study|Death|0|||
155672628|NCT03941873|561894152|FG001|Overall Study|Death|12|||
155672629|NCT03941873|561894153|FG002|Overall Study|Death|2|||
155672630|NCT03941873|561894154|FG003|Overall Study|Death|53|||
155672631|NCT03941873|561894151|FG000|Overall Study|Withdrawal by Subject|1|||
155672632|NCT03941873|561894152|FG001|Overall Study|Withdrawal by Subject|1|||
155672633|NCT03941873|561894153|FG002|Overall Study|Withdrawal by Subject|0|||
155672634|NCT03941873|561894154|FG003|Overall Study|Withdrawal by Subject|5|||
155672635|NCT03941873|561894151|FG000|Overall Study|Lost to Follow-up|1|||
155672636|NCT03941873|561894152|FG001|Overall Study|Lost to Follow-up|2|||
155672637|NCT03941873|561894153|FG002|Overall Study|Lost to Follow-up|0|||
155672638|NCT03941873|561894154|FG003|Overall Study|Lost to Follow-up|0|||
155672639|NCT03941873|561894151|FG000|Overall Study|Sponsor Decision|0|||
155672640|NCT03941873|561894152|FG001|Overall Study|Sponsor Decision|6|||
155672641|NCT03941873|561894153|FG002|Overall Study|Sponsor Decision|0|||
155672642|NCT03941873|561894154|FG003|Overall Study|Sponsor Decision|15|||
155672643|NCT02982772|561894160|FG000|Intervention|Lost to Follow-up|19|||
155672644|NCT02982772|561894161|FG001|Intervention|Lost to Follow-up|13|||
155672645|NCT02982772|561894160|FG000|1M Follow-Up|Lost to Follow-up|21|||
155672646|NCT02982772|561894161|FG001|1M Follow-Up|Lost to Follow-up|18|||
155672647|NCT02982772|561894160|FG000|3M Follow-Up|Lost to Follow-up|17|||
155672648|NCT02982772|561894161|FG001|3M Follow-Up|Lost to Follow-up|11|||
155672649|NCT02982772|561894160|FG000|6M Follow-Up|Lost to Follow-up|11|||
155672650|NCT02982772|561894161|FG001|6M Follow-Up|Lost to Follow-up|9|||
155672651|NCT02982772|561894160|FG000|12M Follow-Up|Lost to Follow-up|11|||
155672652|NCT02982772|561894161|FG001|12M Follow-Up|Lost to Follow-up|5|||
155672653|NCT02974140|561894162|FG000|Overall Study|Adverse Event|2|||
155672654|NCT02974140|561894162|FG000|Overall Study|Lost to Follow-up|1|||
155672655|NCT02974140|561894162|FG000|Overall Study|Study Terminated by Sponsor|36|||
155672656|NCT01905943|561894163|FG000|Overall Study|Withdrawal of consent|90|||
155672657|NCT01905943|561894163|FG000|Overall Study|Lost to Follow-up|16|||
155672658|NCT01905943|561894163|FG000|Overall Study|Investigator discretion|7|||
155672659|NCT01905943|561894163|FG000|Overall Study|Death|186|||
155672660|NCT01905943|561894163|FG000|Overall Study|Adverse Event|3|||
155672661|NCT01905943|561894163|FG000|Overall Study|Other|12|||
155672662|NCT01238991|561894166|FG000|Overall Study|Adverse Event|1|||
155672663|NCT01238991|561894167|FG001|Overall Study|Adverse Event|0|||
155672664|NCT01238991|561894168|FG002|Overall Study|Adverse Event|3|||
155672665|NCT01238991|561894169|FG003|Overall Study|Adverse Event|1|||
155672666|NCT01238991|561894170|FG004|Overall Study|Adverse Event|1|||
155672667|NCT01238991|561894171|FG005|Overall Study|Adverse Event|0|||
155672668|NCT01238991|561894172|FG006|Overall Study|Adverse Event|1|||
155672669|NCT01238991|561894173|FG007|Overall Study|Adverse Event|1|||
155672670|NCT01238991|561894174|FG008|Overall Study|Adverse Event|0|||
155672671|NCT01238991|561894175|FG009|Overall Study|Adverse Event|0|||
155672672|NCT01238991|561894166|FG000|Overall Study|Death|0|||
155672673|NCT01238991|561894167|FG001|Overall Study|Death|0|||
155672674|NCT01238991|561894168|FG002|Overall Study|Death|0|||
155672675|NCT01238991|561894169|FG003|Overall Study|Death|1|||
155672676|NCT01238991|561894170|FG004|Overall Study|Death|0|||
155672677|NCT01238991|561894171|FG005|Overall Study|Death|0|||
155672678|NCT01238991|561894172|FG006|Overall Study|Death|0|||
155672679|NCT01238991|561894173|FG007|Overall Study|Death|0|||
155672680|NCT01238991|561894174|FG008|Overall Study|Death|0|||
155672681|NCT01238991|561894175|FG009|Overall Study|Death|0|||
155672682|NCT01238991|561894166|FG000|Overall Study|Lack of Efficacy|0|||
155672683|NCT01238991|561894167|FG001|Overall Study|Lack of Efficacy|0|||
155672684|NCT01238991|561894168|FG002|Overall Study|Lack of Efficacy|1|||
155672685|NCT01238991|561894169|FG003|Overall Study|Lack of Efficacy|0|||
155672686|NCT01238991|561894170|FG004|Overall Study|Lack of Efficacy|0|||
155672687|NCT01238991|561894171|FG005|Overall Study|Lack of Efficacy|0|||
155672688|NCT01238991|561894172|FG006|Overall Study|Lack of Efficacy|0|||
155672689|NCT01238991|561894173|FG007|Overall Study|Lack of Efficacy|0|||
155672690|NCT01238991|561894174|FG008|Overall Study|Lack of Efficacy|1|||
155672691|NCT01238991|561894175|FG009|Overall Study|Lack of Efficacy|0|||
155672692|NCT01238991|561894166|FG000|Overall Study|Withdrawal by Subject|0|||
155672693|NCT01238991|561894167|FG001|Overall Study|Withdrawal by Subject|0|||
155672694|NCT01238991|561894168|FG002|Overall Study|Withdrawal by Subject|1|||
155672695|NCT01238991|561894169|FG003|Overall Study|Withdrawal by Subject|0|||
155672696|NCT01238991|561894170|FG004|Overall Study|Withdrawal by Subject|0|||
155672697|NCT01238991|561894171|FG005|Overall Study|Withdrawal by Subject|0|||
155672698|NCT01238991|561894172|FG006|Overall Study|Withdrawal by Subject|0|||
155672699|NCT01238991|561894173|FG007|Overall Study|Withdrawal by Subject|0|||
155672700|NCT01238991|561894174|FG008|Overall Study|Withdrawal by Subject|0|||
155672701|NCT01238991|561894175|FG009|Overall Study|Withdrawal by Subject|0|||
155672702|NCT01238991|561894166|FG000|Overall Study|Study Terminated by Sponsor|0|||
155672703|NCT01238991|561894167|FG001|Overall Study|Study Terminated by Sponsor|0|||
155672704|NCT01238991|561894168|FG002|Overall Study|Study Terminated by Sponsor|0|||
155672705|NCT01238991|561894169|FG003|Overall Study|Study Terminated by Sponsor|0|||
155672706|NCT01238991|561894170|FG004|Overall Study|Study Terminated by Sponsor|1|||
155672707|NCT01238991|561894171|FG005|Overall Study|Study Terminated by Sponsor|0|||
155672708|NCT01238991|561894172|FG006|Overall Study|Study Terminated by Sponsor|7|||
155672709|NCT01238991|561894173|FG007|Overall Study|Study Terminated by Sponsor|4|||
155672710|NCT01238991|561894174|FG008|Overall Study|Study Terminated by Sponsor|2|||
155672711|NCT01238991|561894175|FG009|Overall Study|Study Terminated by Sponsor|2|||
155672712|NCT01238991|561894166|FG000|Overall Study|Caregiver's request|0|||
155672713|NCT01238991|561894167|FG001|Overall Study|Caregiver's request|0|||
155672714|NCT01238991|561894168|FG002|Overall Study|Caregiver's request|0|||
155672715|NCT01238991|561894169|FG003|Overall Study|Caregiver's request|0|||
155672716|NCT01238991|561894170|FG004|Overall Study|Caregiver's request|0|||
155672717|NCT01238991|561894171|FG005|Overall Study|Caregiver's request|0|||
155672718|NCT01238991|561894172|FG006|Overall Study|Caregiver's request|0|||
155672719|NCT01238991|561894173|FG007|Overall Study|Caregiver's request|0|||
155672720|NCT01238991|561894174|FG008|Overall Study|Caregiver's request|1|||
155672721|NCT01238991|561894175|FG009|Overall Study|Caregiver's request|0|||
155672722|NCT01238991|561894166|FG000|Overall Study|Admission to a nursing home|1|||
155672723|NCT01238991|561894167|FG001|Overall Study|Admission to a nursing home|0|||
155672724|NCT01238991|561894168|FG002|Overall Study|Admission to a nursing home|1|||
155672725|NCT01238991|561894169|FG003|Overall Study|Admission to a nursing home|0|||
155672726|NCT01238991|561894170|FG004|Overall Study|Admission to a nursing home|0|||
155672727|NCT01238991|561894171|FG005|Overall Study|Admission to a nursing home|0|||
155672728|NCT01238991|561894172|FG006|Overall Study|Admission to a nursing home|0|||
155672729|NCT01238991|561894173|FG007|Overall Study|Admission to a nursing home|0|||
155672730|NCT01238991|561894174|FG008|Overall Study|Admission to a nursing home|0|||
155672731|NCT01238991|561894175|FG009|Overall Study|Admission to a nursing home|0|||
155672732|NCT02574078|561894179|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672733|NCT02574078|561894180|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672734|NCT02574078|561894181|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672735|NCT02574078|561894182|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672736|NCT02574078|561894183|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672737|NCT02574078|561894184|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155672738|NCT02574078|561894185|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
155672739|NCT02574078|561894186|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672740|NCT02574078|561894187|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155672741|NCT02574078|561894188|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672742|NCT02574078|561894189|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672743|NCT02574078|561894190|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672744|NCT02574078|561894191|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155672745|NCT02574078|561894179|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
155672746|NCT02574078|561894180|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155672747|NCT02574078|561894181|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
155672748|NCT02574078|561894182|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
155672749|NCT02574078|561894183|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
155672750|NCT02574078|561894184|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
155672751|NCT02574078|561894185|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
155672752|NCT02574078|561894186|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
155672753|NCT02574078|561894187|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
155672754|NCT02574078|561894188|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
155672755|NCT02574078|561894189|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
155672756|NCT02574078|561894190|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
155672757|NCT02574078|561894191|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
155672758|NCT02574078|561894179|FG000|Pre-Treatment Period|Other reasons|0|||
155672759|NCT02574078|561894180|FG001|Pre-Treatment Period|Other reasons|0|||
155672760|NCT02574078|561894181|FG002|Pre-Treatment Period|Other reasons|0|||
155672761|NCT02574078|561894182|FG003|Pre-Treatment Period|Other reasons|0|||
155672762|NCT02574078|561894183|FG004|Pre-Treatment Period|Other reasons|0|||
155672763|NCT02574078|561894184|FG005|Pre-Treatment Period|Other reasons|0|||
155672764|NCT02574078|561894185|FG006|Pre-Treatment Period|Other reasons|2|||
155672765|NCT02574078|561894186|FG007|Pre-Treatment Period|Other reasons|0|||
155672766|NCT02574078|561894187|FG008|Pre-Treatment Period|Other reasons|0|||
155672767|NCT02574078|561894188|FG009|Pre-Treatment Period|Other reasons|0|||
155672768|NCT02574078|561894189|FG010|Pre-Treatment Period|Other reasons|2|||
155672769|NCT02574078|561894190|FG011|Pre-Treatment Period|Other reasons|0|||
155672770|NCT02574078|561894191|FG012|Pre-Treatment Period|Other reasons|0|||
155672771|NCT02574078|561894179|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
155672772|NCT02574078|561894180|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
155672773|NCT02574078|561894181|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
155672774|NCT02574078|561894182|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
155672775|NCT02574078|561894183|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
155672776|NCT02574078|561894184|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
155672777|NCT02574078|561894185|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
155672778|NCT02574078|561894186|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
155672779|NCT02574078|561894187|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
155672780|NCT02574078|561894188|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
155672781|NCT02574078|561894189|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
155672782|NCT02574078|561894190|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
155672783|NCT02574078|561894191|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
155672784|NCT02574078|561894179|FG000|Treatment Period|Disease progression|6|||
155672785|NCT02574078|561894180|FG001|Treatment Period|Disease progression|4|||
155672786|NCT02574078|561894181|FG002|Treatment Period|Disease progression|7|||
155672787|NCT02574078|561894182|FG003|Treatment Period|Disease progression|18|||
155672788|NCT02574078|561894183|FG004|Treatment Period|Disease progression|16|||
155672789|NCT02574078|561894184|FG005|Treatment Period|Disease progression|26|||
155672790|NCT02574078|561894185|FG006|Treatment Period|Disease progression|5|||
155672791|NCT02574078|561894186|FG007|Treatment Period|Disease progression|9|||
155672792|NCT02574078|561894187|FG008|Treatment Period|Disease progression|8|||
155672793|NCT02574078|561894188|FG009|Treatment Period|Disease progression|5|||
155672794|NCT02574078|561894189|FG010|Treatment Period|Disease progression|20|||
155672795|NCT02574078|561894190|FG011|Treatment Period|Disease progression|29|||
155672796|NCT02574078|561894191|FG012|Treatment Period|Disease progression|2|||
155672797|NCT02574078|561894179|FG000|Treatment Period|Study drug toxicity|1|||
155672798|NCT02574078|561894180|FG001|Treatment Period|Study drug toxicity|1|||
155672799|NCT02574078|561894181|FG002|Treatment Period|Study drug toxicity|0|||
155672800|NCT02574078|561894182|FG003|Treatment Period|Study drug toxicity|5|||
155672801|NCT02574078|561894183|FG004|Treatment Period|Study drug toxicity|3|||
155672802|NCT02574078|561894184|FG005|Treatment Period|Study drug toxicity|1|||
155672803|NCT02574078|561894185|FG006|Treatment Period|Study drug toxicity|2|||
155672804|NCT02574078|561894186|FG007|Treatment Period|Study drug toxicity|0|||
155672805|NCT02574078|561894187|FG008|Treatment Period|Study drug toxicity|2|||
155672806|NCT02574078|561894188|FG009|Treatment Period|Study drug toxicity|1|||
155672807|NCT02574078|561894189|FG010|Treatment Period|Study drug toxicity|16|||
155672808|NCT02574078|561894190|FG011|Treatment Period|Study drug toxicity|2|||
155672809|NCT02574078|561894191|FG012|Treatment Period|Study drug toxicity|4|||
155672810|NCT02574078|561894179|FG000|Treatment Period|Death|2|||
155672811|NCT02574078|561894180|FG001|Treatment Period|Death|0|||
155672812|NCT02574078|561894181|FG002|Treatment Period|Death|0|||
155672813|NCT02574078|561894182|FG003|Treatment Period|Death|0|||
155672814|NCT02574078|561894183|FG004|Treatment Period|Death|1|||
155672815|NCT02574078|561894184|FG005|Treatment Period|Death|1|||
155672816|NCT02574078|561894185|FG006|Treatment Period|Death|1|||
155672817|NCT02574078|561894186|FG007|Treatment Period|Death|1|||
155672818|NCT02574078|561894187|FG008|Treatment Period|Death|7|||
155672819|NCT02574078|561894188|FG009|Treatment Period|Death|1|||
155672820|NCT02574078|561894189|FG010|Treatment Period|Death|0|||
155672821|NCT02574078|561894190|FG011|Treatment Period|Death|2|||
155672822|NCT02574078|561894191|FG012|Treatment Period|Death|1|||
155672823|NCT02574078|561894179|FG000|Treatment Period|Adverse event unrelated to drug|0|||
155672824|NCT02574078|561894180|FG001|Treatment Period|Adverse event unrelated to drug|0|||
155672825|NCT02574078|561894181|FG002|Treatment Period|Adverse event unrelated to drug|1|||
155672826|NCT02574078|561894182|FG003|Treatment Period|Adverse event unrelated to drug|0|||
155672827|NCT02574078|561894183|FG004|Treatment Period|Adverse event unrelated to drug|2|||
155672828|NCT02574078|561894184|FG005|Treatment Period|Adverse event unrelated to drug|3|||
155672829|NCT02574078|561894185|FG006|Treatment Period|Adverse event unrelated to drug|0|||
155672830|NCT02574078|561894186|FG007|Treatment Period|Adverse event unrelated to drug|0|||
155672831|NCT02574078|561894187|FG008|Treatment Period|Adverse event unrelated to drug|1|||
155672832|NCT02574078|561894188|FG009|Treatment Period|Adverse event unrelated to drug|2|||
155672833|NCT02574078|561894189|FG010|Treatment Period|Adverse event unrelated to drug|4|||
155672834|NCT02574078|561894190|FG011|Treatment Period|Adverse event unrelated to drug|1|||
155672835|NCT02574078|561894191|FG012|Treatment Period|Adverse event unrelated to drug|0|||
155672836|NCT02574078|561894179|FG000|Treatment Period|Administrative reason by Sponsor|0|||
155672837|NCT02574078|561894180|FG001|Treatment Period|Administrative reason by Sponsor|1|||
155672838|NCT02574078|561894181|FG002|Treatment Period|Administrative reason by Sponsor|0|||
155672839|NCT02574078|561894182|FG003|Treatment Period|Administrative reason by Sponsor|0|||
155672840|NCT02574078|561894183|FG004|Treatment Period|Administrative reason by Sponsor|0|||
155672841|NCT02574078|561894184|FG005|Treatment Period|Administrative reason by Sponsor|0|||
155672842|NCT02574078|561894185|FG006|Treatment Period|Administrative reason by Sponsor|1|||
155672843|NCT02574078|561894186|FG007|Treatment Period|Administrative reason by Sponsor|0|||
155672844|NCT02574078|561894187|FG008|Treatment Period|Administrative reason by Sponsor|0|||
155672845|NCT02574078|561894188|FG009|Treatment Period|Administrative reason by Sponsor|0|||
155672846|NCT02574078|561894189|FG010|Treatment Period|Administrative reason by Sponsor|0|||
155672847|NCT02574078|561894190|FG011|Treatment Period|Administrative reason by Sponsor|0|||
155672848|NCT02574078|561894191|FG012|Treatment Period|Administrative reason by Sponsor|3|||
155672849|NCT02574078|561894179|FG000|Treatment Period|Other reasons|1|||
155672850|NCT02574078|561894180|FG001|Treatment Period|Other reasons|0|||
155672851|NCT02574078|561894181|FG002|Treatment Period|Other reasons|1|||
155672852|NCT02574078|561894182|FG003|Treatment Period|Other reasons|3|||
155672853|NCT02574078|561894183|FG004|Treatment Period|Other reasons|3|||
155672854|NCT02574078|561894184|FG005|Treatment Period|Other reasons|1|||
155672855|NCT02574078|561894185|FG006|Treatment Period|Other reasons|2|||
155672856|NCT02574078|561894186|FG007|Treatment Period|Other reasons|1|||
155672857|NCT02574078|561894187|FG008|Treatment Period|Other reasons|3|||
155672858|NCT02574078|561894188|FG009|Treatment Period|Other reasons|1|||
155672859|NCT02574078|561894189|FG010|Treatment Period|Other reasons|1|||
155672860|NCT02574078|561894190|FG011|Treatment Period|Other reasons|3|||
155672861|NCT02574078|561894191|FG012|Treatment Period|Other reasons|1|||
155672862|NCT02574078|561894179|FG000|Treatment Period|Participant request to stop drug|0|||
155672863|NCT02574078|561894180|FG001|Treatment Period|Participant request to stop drug|0|||
155672864|NCT02574078|561894181|FG002|Treatment Period|Participant request to stop drug|0|||
155672865|NCT02574078|561894182|FG003|Treatment Period|Participant request to stop drug|2|||
155672866|NCT02574078|561894183|FG004|Treatment Period|Participant request to stop drug|4|||
155672867|NCT02574078|561894184|FG005|Treatment Period|Participant request to stop drug|0|||
155672868|NCT02574078|561894185|FG006|Treatment Period|Participant request to stop drug|1|||
155672869|NCT02574078|561894186|FG007|Treatment Period|Participant request to stop drug|0|||
155672870|NCT02574078|561894187|FG008|Treatment Period|Participant request to stop drug|3|||
155672871|NCT02574078|561894188|FG009|Treatment Period|Participant request to stop drug|2|||
155672872|NCT02574078|561894189|FG010|Treatment Period|Participant request to stop drug|2|||
155672873|NCT02574078|561894190|FG011|Treatment Period|Participant request to stop drug|4|||
155672874|NCT02574078|561894191|FG012|Treatment Period|Participant request to stop drug|1|||
155672875|NCT02574078|561894179|FG000|Treatment Period|Participant withdrew consent|0|||
155672876|NCT02574078|561894180|FG001|Treatment Period|Participant withdrew consent|0|||
155672877|NCT02574078|561894181|FG002|Treatment Period|Participant withdrew consent|0|||
155672878|NCT02574078|561894182|FG003|Treatment Period|Participant withdrew consent|0|||
155672879|NCT02574078|561894183|FG004|Treatment Period|Participant withdrew consent|1|||
155672880|NCT02574078|561894184|FG005|Treatment Period|Participant withdrew consent|1|||
155672881|NCT02574078|561894185|FG006|Treatment Period|Participant withdrew consent|0|||
155672882|NCT02574078|561894186|FG007|Treatment Period|Participant withdrew consent|1|||
155672883|NCT02574078|561894187|FG008|Treatment Period|Participant withdrew consent|0|||
155672884|NCT02574078|561894188|FG009|Treatment Period|Participant withdrew consent|2|||
155672885|NCT02574078|561894189|FG010|Treatment Period|Participant withdrew consent|1|||
155672886|NCT02574078|561894190|FG011|Treatment Period|Participant withdrew consent|4|||
155672887|NCT02574078|561894191|FG012|Treatment Period|Participant withdrew consent|1|||
155672888|NCT02574078|561894179|FG000|Treatment Period|Participant no longer meets criteria|0|||
155672889|NCT02574078|561894180|FG001|Treatment Period|Participant no longer meets criteria|0|||
155672890|NCT02574078|561894181|FG002|Treatment Period|Participant no longer meets criteria|0|||
155672891|NCT02574078|561894182|FG003|Treatment Period|Participant no longer meets criteria|0|||
155672892|NCT02574078|561894183|FG004|Treatment Period|Participant no longer meets criteria|1|||
155672893|NCT02574078|561894184|FG005|Treatment Period|Participant no longer meets criteria|0|||
155672894|NCT02574078|561894185|FG006|Treatment Period|Participant no longer meets criteria|0|||
155672895|NCT02574078|561894186|FG007|Treatment Period|Participant no longer meets criteria|0|||
155672896|NCT02574078|561894187|FG008|Treatment Period|Participant no longer meets criteria|0|||
155672897|NCT02574078|561894188|FG009|Treatment Period|Participant no longer meets criteria|1|||
155672898|NCT02574078|561894189|FG010|Treatment Period|Participant no longer meets criteria|1|||
155672899|NCT02574078|561894190|FG011|Treatment Period|Participant no longer meets criteria|1|||
155672900|NCT02574078|561894191|FG012|Treatment Period|Participant no longer meets criteria|0|||
155672901|NCT02574078|561894179|FG000|Treatment Period|Lost to Follow-up|0|||
155672902|NCT02574078|561894180|FG001|Treatment Period|Lost to Follow-up|0|||
155672903|NCT02574078|561894181|FG002|Treatment Period|Lost to Follow-up|0|||
155672904|NCT02574078|561894182|FG003|Treatment Period|Lost to Follow-up|0|||
155672905|NCT02574078|561894183|FG004|Treatment Period|Lost to Follow-up|0|||
155672906|NCT02574078|561894184|FG005|Treatment Period|Lost to Follow-up|0|||
155672907|NCT02574078|561894185|FG006|Treatment Period|Lost to Follow-up|0|||
155672908|NCT02574078|561894186|FG007|Treatment Period|Lost to Follow-up|0|||
155672909|NCT02574078|561894187|FG008|Treatment Period|Lost to Follow-up|0|||
155672910|NCT02574078|561894188|FG009|Treatment Period|Lost to Follow-up|1|||
155672911|NCT02574078|561894189|FG010|Treatment Period|Lost to Follow-up|0|||
155672912|NCT02574078|561894190|FG011|Treatment Period|Lost to Follow-up|1|||
155672913|NCT02574078|561894191|FG012|Treatment Period|Lost to Follow-up|0|||
155672914|NCT02574078|561894179|FG000|Treatment Period|Maximum clinical benefit|0|||
155672915|NCT02574078|561894180|FG001|Treatment Period|Maximum clinical benefit|0|||
155672916|NCT02574078|561894181|FG002|Treatment Period|Maximum clinical benefit|0|||
155672917|NCT02574078|561894182|FG003|Treatment Period|Maximum clinical benefit|0|||
155672918|NCT02574078|561894183|FG004|Treatment Period|Maximum clinical benefit|0|||
155672919|NCT02574078|561894184|FG005|Treatment Period|Maximum clinical benefit|0|||
155672920|NCT02574078|561894185|FG006|Treatment Period|Maximum clinical benefit|0|||
155672921|NCT02574078|561894186|FG007|Treatment Period|Maximum clinical benefit|0|||
155672922|NCT02574078|561894187|FG008|Treatment Period|Maximum clinical benefit|0|||
155672923|NCT02574078|561894188|FG009|Treatment Period|Maximum clinical benefit|1|||
155672924|NCT02574078|561894189|FG010|Treatment Period|Maximum clinical benefit|0|||
155672925|NCT02574078|561894190|FG011|Treatment Period|Maximum clinical benefit|0|||
155672926|NCT02574078|561894191|FG012|Treatment Period|Maximum clinical benefit|0|||
155672927|NCT02222688|561894192|FG000|Overall Study|Withdrawal by Subject|0|||
155672928|NCT02222688|561894193|FG001|Overall Study|Withdrawal by Subject|0|||
155672929|NCT02222688|561894194|FG002|Overall Study|Withdrawal by Subject|0|||
155672930|NCT02222688|561894195|FG003|Overall Study|Withdrawal by Subject|2|||
155672931|NCT02222688|561894196|FG004|Overall Study|Withdrawal by Subject|1|||
155672932|NCT02222688|561894197|FG005|Overall Study|Withdrawal by Subject|0|||
155672933|NCT02222688|561894198|FG006|Overall Study|Withdrawal by Subject|1|||
155672934|NCT02222688|561894192|FG000|Overall Study|Disease progression|1|||
155672935|NCT02222688|561894193|FG001|Overall Study|Disease progression|0|||
155672936|NCT02222688|561894194|FG002|Overall Study|Disease progression|0|||
155672937|NCT02222688|561894195|FG003|Overall Study|Disease progression|0|||
155672938|NCT02222688|561894196|FG004|Overall Study|Disease progression|0|||
155672939|NCT02222688|561894197|FG005|Overall Study|Disease progression|0|||
155672940|NCT02222688|561894198|FG006|Overall Study|Disease progression|0|||
155672941|NCT02297815|561894203|FG000|Overall Study|Lost to Follow-up|236|||
155672942|NCT02297815|561894204|FG001|Overall Study|Lost to Follow-up|140|||
155672943|NCT00293813|561894209|FG000|Overall Study|Physician Decision|0|||
155672944|NCT00293813|561894210|FG001|Overall Study|Physician Decision|1|||
155672945|NCT00293813|561894211|FG002|Overall Study|Physician Decision|0|||
155672946|NCT00293813|561894209|FG000|Overall Study|Adverse Event|3|||
155672947|NCT00293813|561894210|FG001|Overall Study|Adverse Event|1|||
155672948|NCT00293813|561894211|FG002|Overall Study|Adverse Event|1|||
155672949|NCT00293813|561894209|FG000|Overall Study|Withdrawal by Subject|7|||
155672950|NCT00293813|561894210|FG001|Overall Study|Withdrawal by Subject|4|||
155672951|NCT00293813|561894211|FG002|Overall Study|Withdrawal by Subject|4|||
155672952|NCT00293813|561894209|FG000|Overall Study|Lost to Follow-up|3|||
155672953|NCT00293813|561894210|FG001|Overall Study|Lost to Follow-up|2|||
155672954|NCT00293813|561894211|FG002|Overall Study|Lost to Follow-up|3|||
155672955|NCT00293813|561894209|FG000|Overall Study|Noncompliance|0|||
155672956|NCT00293813|561894210|FG001|Overall Study|Noncompliance|1|||
155672957|NCT00293813|561894211|FG002|Overall Study|Noncompliance|0|||
155672958|NCT00460655|561894212|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
155672959|NCT00460655|561894213|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155672960|NCT00460655|561894214|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155672961|NCT00460655|561894215|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155672962|NCT00460655|561894212|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
155672963|NCT00460655|561894213|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155672964|NCT00460655|561894214|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155672965|NCT00460655|561894215|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155672966|NCT00460655|561894212|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
155672967|NCT00460655|561894213|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
155672968|NCT00460655|561894214|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
155672969|NCT00460655|561894215|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
155672970|NCT00460655|561894212|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155672971|NCT00460655|561894213|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155672972|NCT00460655|561894214|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
155672973|NCT00460655|561894215|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
155672974|NCT00460655|561894212|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155672975|NCT00460655|561894213|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155672976|NCT00460655|561894214|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
155672977|NCT00460655|561894215|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
155672978|NCT00460655|561894212|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155672979|NCT00460655|561894213|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155672980|NCT00460655|561894214|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155672981|NCT00460655|561894215|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
155672982|NCT03650413|561894216|FG000|Overall Study|Adverse Event|1|||
155672983|NCT03650413|561894216|FG000|Overall Study|Lack of Efficacy|17|||
155672984|NCT03650413|561894216|FG000|Overall Study|Other|9|||
155672985|NCT03650413|561894216|FG000|Overall Study|Physician Decision|2|||
155672986|NCT03650413|561894216|FG000|Overall Study|Study Terminated By Sponsor|16|||
155672987|NCT03650413|561894216|FG000|Overall Study|Withdrawal by Subject|16|||
155672988|NCT02553928|561894217|FG000|Overall Study|Adverse Event|2|||
155672989|NCT02553928|561894218|FG001|Overall Study|Adverse Event|1|||
155672990|NCT02553928|561894217|FG000|Overall Study|Lost to Follow-up|0|||
155672991|NCT02553928|561894218|FG001|Overall Study|Lost to Follow-up|1|||
155672992|NCT02553928|561894217|FG000|Overall Study|Administrative reason(s)|0|||
155672993|NCT02553928|561894218|FG001|Overall Study|Administrative reason(s)|1|||
155672994|NCT00910910|561894219|FG000|Overall Study|Adverse Event|63|||
155672995|NCT00910910|561894220|FG001|Overall Study|Adverse Event|35|||
155672996|NCT00910910|561894219|FG000|Overall Study|PD without histologic change|27|||
155672997|NCT00910910|561894220|FG001|Overall Study|PD without histologic change|23|||
155672998|NCT00910910|561894219|FG000|Overall Study|PD with histologic change|0|||
155672999|NCT00910910|561894220|FG001|Overall Study|PD with histologic change|2|||
155673000|NCT00910910|561894219|FG000|Overall Study|Withdrawal by Subject|7|||
155673001|NCT00910910|561894220|FG001|Overall Study|Withdrawal by Subject|5|||
155673002|NCT00910910|561894219|FG000|Overall Study|Lost to Follow-up|2|||
155673003|NCT00910910|561894220|FG001|Overall Study|Lost to Follow-up|2|||
155673004|NCT00910910|561894219|FG000|Overall Study|Death|9|||
155673005|NCT00910910|561894220|FG001|Overall Study|Death|3|||
155673006|NCT00910910|561894219|FG000|Overall Study|Protocol Violation|2|||
155673007|NCT00910910|561894220|FG001|Overall Study|Protocol Violation|2|||
155673008|NCT00910910|561894219|FG000|Overall Study|Completed 13 cycles of treatment|0|||
155673009|NCT00910910|561894220|FG001|Overall Study|Completed 13 cycles of treatment|118|||
155673010|NCT00910910|561894219|FG000|Overall Study|Other|114|||
155673011|NCT00910910|561894220|FG001|Overall Study|Other|32|||
155673012|NCT00910910|561894219|FG000|Overall Study|Untreated before cycle 1|1|||
155673013|NCT00910910|561894220|FG001|Overall Study|Untreated before cycle 1|2|||
155673014|NCT01973231|561894221|FG000|Overall Study|Protocol Violation|1|||
155673015|NCT01973231|561894222|FG001|Overall Study|Protocol Violation|1|||
155673016|NCT01973231|561894221|FG000|Overall Study|Lost to Follow-up|1|||
155673017|NCT01973231|561894222|FG001|Overall Study|Lost to Follow-up|1|||
155673018|NCT01973231|561894221|FG000|Overall Study|unclassified|2|||
155673019|NCT01973231|561894222|FG001|Overall Study|unclassified|1|||
155673020|NCT01973231|561894221|FG000|Overall Study|Withdrawal by Subject|7|||
155673021|NCT01973231|561894222|FG001|Overall Study|Withdrawal by Subject|9|||
155673022|NCT01485796|561894223|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
155673023|NCT01485796|561894223|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
155673024|NCT01485796|561894223|FG000|Period 2: Epoch 2|Adverse Event|3|||
155673025|NCT01485796|561894223|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
155673026|NCT01485796|561894223|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
155673027|NCT01485796|561894223|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
155673028|NCT01485796|561894223|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
155673029|NCT01485796|561894223|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
155673030|NCT04830215|561894224|FG000|Overall Study|Adverse Event|6|||
155673031|NCT04830215|561894224|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
155673032|NCT04830215|561894224|FG000|Overall Study|Withdrawal by Subject|3|||
155673033|NCT04830215|561894224|FG000|Overall Study|Protocol Deviation|1|||
155673034|NCT00770562|561894230|FG000|Overall Study|Did not take treatment|1|||
155673035|NCT00770562|561894231|FG001|Overall Study|Did not take treatment|1|||
155673036|NCT01643408|561894232|FG000|Overall Study|Adverse Event|12|||
155673037|NCT01643408|561894232|FG000|Overall Study|Other|2|||
155673038|NCT00292045|561894236|FG000|Core Study (Through Week 13)|Adverse Event|1|||
155673039|NCT00292045|561894236|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
155673040|NCT00606411|561894237|FG000|Overall Study|Adverse Event|1|||
155673041|NCT00606411|561894238|FG001|Overall Study|Adverse Event|2|||
155673042|NCT00606411|561894237|FG000|Overall Study|Lack of Adherence|1|||
155673043|NCT00606411|561894238|FG001|Overall Study|Lack of Adherence|1|||
155673044|NCT00606411|561894237|FG000|Overall Study|Lack of Efficacy|1|||
155673045|NCT00606411|561894238|FG001|Overall Study|Lack of Efficacy|1|||
155673046|NCT00606411|561894237|FG000|Overall Study|Withdrawal by Subject|2|||
155673047|NCT00606411|561894238|FG001|Overall Study|Withdrawal by Subject|0|||
155673048|NCT00606411|561894237|FG000|Overall Study|Lost to Follow-up|1|||
155673049|NCT00606411|561894238|FG001|Overall Study|Lost to Follow-up|2|||
155673050|NCT00606411|561894237|FG000|Overall Study|Move out of state|0|||
155673051|NCT00606411|561894238|FG001|Overall Study|Move out of state|1|||
155673052|NCT04503551|561894239|FG000|Overall Study|Withdrawal by Subject|5|||
155673053|NCT04503551|561894240|FG001|Overall Study|Withdrawal by Subject|3|||
155673054|NCT04503551|561894239|FG000|Overall Study|Physician Decision|1|||
155673055|NCT04503551|561894240|FG001|Overall Study|Physician Decision|0|||
155673056|NCT04503551|561894239|FG000|Overall Study|Death|0|||
155673057|NCT04503551|561894240|FG001|Overall Study|Death|1|||
155673058|NCT04503551|561894239|FG000|Overall Study|Lost to Follow-up|1|||
155673059|NCT04503551|561894240|FG001|Overall Study|Lost to Follow-up|2|||
155673060|NCT04503551|561894239|FG000|Overall Study|Ongoing at Week 52|99|||
155673061|NCT04503551|561894240|FG001|Overall Study|Ongoing at Week 52|62|||
155673062|NCT03726658|561894241|FG000|Overall Study|Lost to Follow-up|0|||
155673063|NCT03726658|561894242|FG001|Overall Study|Lost to Follow-up|0|||
155673064|NCT03726658|561894243|FG002|Overall Study|Lost to Follow-up|2|||
155673065|NCT03726658|561894244|FG003|Overall Study|Lost to Follow-up|0|||
155673066|NCT03726658|561894245|FG004|Overall Study|Lost to Follow-up|0|||
155673067|NCT03726658|561894246|FG005|Overall Study|Lost to Follow-up|1|||
155673068|NCT03726658|561894247|FG006|Overall Study|Lost to Follow-up|1|||
155673069|NCT03726658|561894241|FG000|Overall Study|Withdrawal by Subject|1|||
155673070|NCT03726658|561894242|FG001|Overall Study|Withdrawal by Subject|0|||
155673071|NCT03726658|561894243|FG002|Overall Study|Withdrawal by Subject|0|||
155673072|NCT03726658|561894244|FG003|Overall Study|Withdrawal by Subject|0|||
155673073|NCT03726658|561894245|FG004|Overall Study|Withdrawal by Subject|6|||
155673074|NCT03726658|561894246|FG005|Overall Study|Withdrawal by Subject|4|||
155673075|NCT03726658|561894247|FG006|Overall Study|Withdrawal by Subject|2|||
155673076|NCT03726658|561894241|FG000|Overall Study|Pregnancy|0|||
155673077|NCT03726658|561894242|FG001|Overall Study|Pregnancy|0|||
155673078|NCT03726658|561894243|FG002|Overall Study|Pregnancy|0|||
155673079|NCT03726658|561894244|FG003|Overall Study|Pregnancy|0|||
155673080|NCT03726658|561894245|FG004|Overall Study|Pregnancy|0|||
155673081|NCT03726658|561894246|FG005|Overall Study|Pregnancy|0|||
155673082|NCT03726658|561894247|FG006|Overall Study|Pregnancy|1|||
155673083|NCT03726658|561894241|FG000|Overall Study|Not Reported|0|||
155673084|NCT03726658|561894242|FG001|Overall Study|Not Reported|0|||
155673085|NCT03726658|561894243|FG002|Overall Study|Not Reported|0|||
155673086|NCT03726658|561894244|FG003|Overall Study|Not Reported|0|||
155673087|NCT03726658|561894245|FG004|Overall Study|Not Reported|0|||
155673088|NCT03726658|561894246|FG005|Overall Study|Not Reported|0|||
155673089|NCT03726658|561894247|FG006|Overall Study|Not Reported|1|||
155673090|NCT00412958|561894248|FG000|Overall Study|Withdrawal by Subject|3|||
155673091|NCT00412958|561894249|FG001|Overall Study|Withdrawal by Subject|0|||
155673092|NCT00412958|561894250|FG002|Overall Study|Withdrawal by Subject|0|||
155673093|NCT00412958|561894251|FG003|Overall Study|Withdrawal by Subject|1|||
155673094|NCT00412958|561894248|FG000|Overall Study|Adverse Event|0|||
155673095|NCT00412958|561894249|FG001|Overall Study|Adverse Event|1|||
155673096|NCT00412958|561894250|FG002|Overall Study|Adverse Event|0|||
155673097|NCT00412958|561894251|FG003|Overall Study|Adverse Event|0|||
155673098|NCT00412958|561894248|FG000|Overall Study|Lost to Follow-up|0|||
155673099|NCT00412958|561894249|FG001|Overall Study|Lost to Follow-up|1|||
155673100|NCT00412958|561894250|FG002|Overall Study|Lost to Follow-up|0|||
155673101|NCT00412958|561894251|FG003|Overall Study|Lost to Follow-up|0|||
155673102|NCT00412958|561894248|FG000|Overall Study|Death|0|||
155673103|NCT00412958|561894249|FG001|Overall Study|Death|1|||
155673104|NCT00412958|561894250|FG002|Overall Study|Death|0|||
155673105|NCT00412958|561894251|FG003|Overall Study|Death|0|||
155673106|NCT00412958|561894248|FG000|Overall Study|Transport issue|0|||
155673107|NCT00412958|561894249|FG001|Overall Study|Transport issue|1|||
155673108|NCT00412958|561894250|FG002|Overall Study|Transport issue|0|||
155673109|NCT00412958|561894251|FG003|Overall Study|Transport issue|0|||
155673110|NCT01318135|561894252|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
155673111|NCT01318135|561894253|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673112|NCT01318135|561894254|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673113|NCT01318135|561894255|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673114|NCT01318135|561894256|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673115|NCT01318135|561894257|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673116|NCT01318135|561894258|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673117|NCT01318135|561894259|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155673118|NCT01318135|561894252|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
155673119|NCT01318135|561894253|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673120|NCT01318135|561894254|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673121|NCT01318135|561894255|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673122|NCT01318135|561894256|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673123|NCT01318135|561894257|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673124|NCT01318135|561894258|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673125|NCT01318135|561894259|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155673126|NCT01318135|561894252|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
155673127|NCT01318135|561894253|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
155673128|NCT01318135|561894254|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
155673129|NCT01318135|561894255|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
155673130|NCT01318135|561894256|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
155673131|NCT01318135|561894257|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
155673132|NCT01318135|561894258|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
155673133|NCT01318135|561894259|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
155673134|NCT01318135|561894252|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
155673135|NCT01318135|561894253|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
155673136|NCT01318135|561894254|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
155673137|NCT01318135|561894255|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
155673138|NCT01318135|561894256|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
155673139|NCT01318135|561894257|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
155673140|NCT01318135|561894258|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
155673141|NCT01318135|561894259|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
155673142|NCT01318135|561894252|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155673143|NCT01318135|561894253|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155673144|NCT01318135|561894254|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155673145|NCT01318135|561894255|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155673146|NCT01318135|561894256|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155673147|NCT01318135|561894257|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155673148|NCT01318135|561894258|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155673149|NCT01318135|561894259|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155673150|NCT01318135|561894252|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
155673151|NCT01318135|561894253|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
155673152|NCT01318135|561894254|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155673153|NCT01318135|561894255|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
155673154|NCT01318135|561894256|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155673155|NCT01318135|561894257|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155673156|NCT01318135|561894258|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155673157|NCT01318135|561894259|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155673158|NCT01318135|561894252|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673159|NCT01318135|561894253|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673160|NCT01318135|561894254|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673161|NCT01318135|561894255|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673162|NCT01318135|561894256|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673163|NCT01318135|561894257|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673164|NCT01318135|561894258|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155673165|NCT01318135|561894259|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
155673166|NCT01523743|561894263|FG000|Period 1|Adverse Event|1|||
155673167|NCT01523743|561894264|FG001|Period 1|Adverse Event|0|||
155673168|NCT01523743|561894263|FG000|Period 1|Withdrawal by Subject|6|||
155673169|NCT01523743|561894264|FG001|Period 1|Withdrawal by Subject|2|||
155673170|NCT01523743|561894263|FG000|Period 1|Lost to Follow-up|1|||
155673171|NCT01523743|561894264|FG001|Period 1|Lost to Follow-up|0|||
155673172|NCT01523743|561894263|FG000|Period 1|Lack of Efficacy|1|||
155673173|NCT01523743|561894264|FG001|Period 1|Lack of Efficacy|0|||
155673174|NCT01523743|561894263|FG000|Period 1|Felt unable to empty bladder|1|||
155673175|NCT01523743|561894264|FG001|Period 1|Felt unable to empty bladder|0|||
155673176|NCT01523743|561894263|FG000|Period 2|Withdrawal by Subject|0|||
155673177|NCT01523743|561894264|FG001|Period 2|Withdrawal by Subject|2|||
155673178|NCT01523743|561894263|FG000|Period 2|Adverse Event|1|||
155673179|NCT01523743|561894264|FG001|Period 2|Adverse Event|0|||
155673180|NCT02569476|561894265|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
155673181|NCT02569476|561894265|FG000|Overall Study|Death|33|||
155673182|NCT02569476|561894265|FG000|Overall Study|Withdrawal by Subject|9|||
155673183|NCT02569476|561894265|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
155673184|NCT02569476|561894265|FG000|Overall Study|Palliative care|1|||
155673185|NCT02569476|561894265|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
155673186|NCT02569476|561894265|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
155673187|NCT01071954|561894266|FG000|Overall Study|Noncompliance|4|||
155673188|NCT01071954|561894266|FG000|Overall Study|Adverse Event|1|||
155673189|NCT01071954|561894266|FG000|Overall Study|Withdrawal by Subject|11|||
155673190|NCT01071954|561894266|FG000|Overall Study|Requirement for Alternative Therapy|5|||
155673191|NCT01071954|561894266|FG000|Overall Study|Administrative Decision|5|||
155673192|NCT01071954|561894266|FG000|Overall Study|Protocol Specified Criteria|1|||
155673193|NCT01152788|561894267|FG000|Overall Study|Withdrawal by Subject|0|||
155673194|NCT01152788|561894268|FG001|Overall Study|Withdrawal by Subject|3|||
155673195|NCT01152788|561894267|FG000|Overall Study|No treatment|0|||
155673196|NCT01152788|561894268|FG001|Overall Study|No treatment|1|||
155673197|NCT01434654|561894270|FG000|Overall Study|Withdrawal by Subject|1|||
155673198|NCT01434654|561894271|FG001|Overall Study|Withdrawal by Subject|0|||
155673199|NCT01434654|561894270|FG000|Overall Study|Lost to Follow-up|1|||
155673200|NCT01434654|561894271|FG001|Overall Study|Lost to Follow-up|0|||
155673201|NCT03782064|561894274|FG000|Overall Study|Lack of Efficacy|2|||
155673202|NCT03782064|561894274|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
155673203|NCT00363142|561894275|FG000|Overall Study|Adverse Event|2|||
155673204|NCT00363142|561894276|FG001|Overall Study|Adverse Event|0|||
155673205|NCT00363142|561894275|FG000|Overall Study|Lack of Efficacy|0|||
155673206|NCT00363142|561894276|FG001|Overall Study|Lack of Efficacy|1|||
155673207|NCT00363142|561894275|FG000|Overall Study|Lost to Follow-up|1|||
155673208|NCT00363142|561894276|FG001|Overall Study|Lost to Follow-up|0|||
155673209|NCT00363142|561894275|FG000|Overall Study|Non-compliance|1|||
155673210|NCT00363142|561894276|FG001|Overall Study|Non-compliance|1|||
155673211|NCT00363142|561894275|FG000|Overall Study|Withdrawal by Subject|3|||
155673212|NCT00363142|561894276|FG001|Overall Study|Withdrawal by Subject|1|||
155673213|NCT02625220|561894278|FG000|Overall Study|Adverse Event|2|||
155673214|NCT02625220|561894278|FG000|Overall Study|Lost to Follow-up|2|||
155673215|NCT02625220|561894278|FG000|Overall Study|Protocol Violation|1|||
155673216|NCT02625220|561894278|FG000|Overall Study|Study discontinued at site|2|||
155673217|NCT01140867|561894279|FG000|Overall Study|Adverse Event|22|||
155673218|NCT01140867|561894279|FG000|Overall Study|Lack of Efficacy|3|||
155673219|NCT01140867|561894279|FG000|Overall Study|Lost to Follow-up|2|||
155673220|NCT01140867|561894279|FG000|Overall Study|Withdrawal by Subject|1|||
155673221|NCT01140867|561894279|FG000|Overall Study|Protocol Violation|1|||
155673222|NCT01140867|561894279|FG000|Overall Study|Uncooperative patient|2|||
155673223|NCT01140867|561894279|FG000|Overall Study|Medication Noncompliance|2|||
155673224|NCT01926444|561894280|FG000|Overall Study|Colonoscopy not performed|0|||
155673225|NCT01926444|561894281|FG001|Overall Study|Colonoscopy not performed|0|||
155673226|NCT01926444|561894282|FG002|Overall Study|Colonoscopy not performed|4|||
155673227|NCT01926444|561894283|FG003|Overall Study|Colonoscopy not performed|2|||
155673228|NCT00995436|561894286|FG000|Overall Study|Withdrawal by Subject|2|||
155673229|NCT00995436|561894287|FG001|Overall Study|Withdrawal by Subject|5|||
155673230|NCT00995436|561894288|FG002|Overall Study|Withdrawal by Subject|0|||
155673231|NCT03035864|561894290|FG000|Treatment Period|Adverse Event|1|||
155673232|NCT03035864|561894291|FG001|Treatment Period|Adverse Event|0|||
155673233|NCT03035864|561894290|FG000|Treatment Period|Other|3|||
155673234|NCT03035864|561894291|FG001|Treatment Period|Other|1|||
155673235|NCT03035864|561894290|FG000|Follow-up Period|Adverse Event|1|||
155673236|NCT03035864|561894291|FG001|Follow-up Period|Adverse Event|0|||
155673237|NCT03035864|561894290|FG000|Follow-up Period|Lost to Follow-up|6|||
155673238|NCT03035864|561894291|FG001|Follow-up Period|Lost to Follow-up|2|||
155673239|NCT03035864|561894290|FG000|Follow-up Period|Physician Decision|1|||
155673240|NCT03035864|561894291|FG001|Follow-up Period|Physician Decision|0|||
155673241|NCT03035864|561894290|FG000|Follow-up Period|Other|3|||
155673242|NCT03035864|561894291|FG001|Follow-up Period|Other|2|||
155673243|NCT02842086|561894296|FG000|Overall Study|Randomized but Never Treated|6|||
155673244|NCT02842086|561894297|FG001|Overall Study|Randomized but Never Treated|6|||
155673245|NCT02842086|561894296|FG000|Overall Study|Still in Double-Blind Phase|7|||
155673246|NCT02842086|561894297|FG001|Overall Study|Still in Double-Blind Phase|3|||
155673247|NCT02842086|561894296|FG000|Overall Study|Adverse Event|18|||
155673248|NCT02842086|561894297|FG001|Overall Study|Adverse Event|20|||
155673249|NCT02842086|561894296|FG000|Overall Study|Death|3|||
155673250|NCT02842086|561894297|FG001|Overall Study|Death|3|||
155673251|NCT02842086|561894296|FG000|Overall Study|Investigator's Discretion|9|||
155673252|NCT02842086|561894297|FG001|Overall Study|Investigator's Discretion|13|||
155673253|NCT02842086|561894296|FG000|Overall Study|Non-Compliance with Study Drug|9|||
155673254|NCT02842086|561894297|FG001|Overall Study|Non-Compliance with Study Drug|8|||
155673255|NCT02842086|561894296|FG000|Overall Study|Protocol Violation|8|||
155673256|NCT02842086|561894297|FG001|Overall Study|Protocol Violation|4|||
155673257|NCT02842086|561894296|FG000|Overall Study|Withdrew Consent|205|||
155673258|NCT02842086|561894297|FG001|Overall Study|Withdrew Consent|194|||
155673259|NCT02842086|561894296|FG000|Overall Study|Lost to Follow-up|274|||
155673260|NCT02842086|561894297|FG001|Overall Study|Lost to Follow-up|236|||
155673261|NCT02842086|561894296|FG000|Overall Study|HIV-1 Infection|5|||
155673262|NCT02842086|561894297|FG001|Overall Study|HIV-1 Infection|6|||
155673263|NCT05935878|561895504|FG000|Overall Study|Death|1|||
155673264|NCT05935878|561895505|FG001|Overall Study|Death|2|||
155673265|NCT05935878|561895504|FG000|Overall Study|Withdrawal by Subject|5|||
155673266|NCT05935878|561895505|FG001|Overall Study|Withdrawal by Subject|5|||
155673267|NCT05935878|561895504|FG000|Overall Study|Revision of implant|1|||
155673268|NCT05935878|561895505|FG001|Overall Study|Revision of implant|1|||
155673269|NCT05935878|561895504|FG000|Overall Study|Mobile bearing dislocation|0|||
155673270|NCT05935878|561895505|FG001|Overall Study|Mobile bearing dislocation|1|||
155673271|NCT00662831|561895519|FG000|Overall Study|Death|4|||
155673272|NCT00662831|561895520|FG001|Overall Study|Death|1|||
155673273|NCT00662831|561895519|FG000|Overall Study|Lack of Efficacy|6|||
155673274|NCT00662831|561895520|FG001|Overall Study|Lack of Efficacy|6|||
155673275|NCT00662831|561895519|FG000|Overall Study|Lost to Follow-up|1|||
155673276|NCT00662831|561895520|FG001|Overall Study|Lost to Follow-up|0|||
155673277|NCT00662831|561895519|FG000|Overall Study|Withdrawal by Subject|2|||
155673278|NCT00662831|561895520|FG001|Overall Study|Withdrawal by Subject|1|||
155673279|NCT00662831|561895519|FG000|Overall Study|Other|62|||
155673280|NCT00662831|561895520|FG001|Overall Study|Other|31|||
155673281|NCT00662831|561895519|FG000|Overall Study|Protocol Violation|8|||
155673282|NCT00662831|561895520|FG001|Overall Study|Protocol Violation|4|||
155673283|NCT00662831|561895519|FG000|Overall Study|Adverse Event|23|||
155673284|NCT00662831|561895520|FG001|Overall Study|Adverse Event|16|||
155673285|NCT00294671|561895521|FG000|Overall Study|Lack of Efficacy|11|||
155673286|NCT00294671|561895522|FG001|Overall Study|Lack of Efficacy|23|||
155673287|NCT00294671|561895521|FG000|Overall Study|Liver transplant|7|||
155673288|NCT00294671|561895522|FG001|Overall Study|Liver transplant|9|||
155673289|NCT00294671|561895521|FG000|Overall Study|Drug related adverse event (AE)|4|||
155673290|NCT00294671|561895522|FG001|Overall Study|Drug related adverse event (AE)|2|||
155673291|NCT00294671|561895521|FG000|Overall Study|Non-drug related AE|3|||
155673292|NCT00294671|561895522|FG001|Overall Study|Non-drug related AE|2|||
155673293|NCT00294671|561895521|FG000|Overall Study|Lost to Follow-up|1|||
155673294|NCT00294671|561895522|FG001|Overall Study|Lost to Follow-up|3|||
155673295|NCT00294671|561895521|FG000|Overall Study|Non-compliance|1|||
155673296|NCT00294671|561895522|FG001|Overall Study|Non-compliance|0|||
155673297|NCT00294671|561895521|FG000|Overall Study|Death|0|||
155673298|NCT00294671|561895522|FG001|Overall Study|Death|1|||
155673299|NCT01061723|561895526|FG000|Overall Study|Adverse Event|0|||
155673300|NCT01061723|561895527|FG001|Overall Study|Adverse Event|2|||
155673301|NCT01061723|561895528|FG002|Overall Study|Adverse Event|5|||
155673302|NCT01061723|561895529|FG003|Overall Study|Adverse Event|5|||
155673303|NCT01061723|561895530|FG004|Overall Study|Adverse Event|2|||
155673304|NCT01061723|561895531|FG005|Overall Study|Adverse Event|6|||
155673305|NCT01061723|561895526|FG000|Overall Study|Lack of Efficacy|2|||
155673306|NCT01061723|561895527|FG001|Overall Study|Lack of Efficacy|3|||
155673307|NCT01061723|561895528|FG002|Overall Study|Lack of Efficacy|4|||
155673308|NCT01061723|561895529|FG003|Overall Study|Lack of Efficacy|2|||
155673309|NCT01061723|561895530|FG004|Overall Study|Lack of Efficacy|1|||
155673310|NCT01061723|561895531|FG005|Overall Study|Lack of Efficacy|1|||
155673311|NCT01061723|561895526|FG000|Overall Study|Randomized but not treated|0|||
155673312|NCT01061723|561895527|FG001|Overall Study|Randomized but not treated|0|||
155673313|NCT01061723|561895528|FG002|Overall Study|Randomized but not treated|0|||
155673314|NCT01061723|561895529|FG003|Overall Study|Randomized but not treated|0|||
155673315|NCT01061723|561895530|FG004|Overall Study|Randomized but not treated|0|||
155673316|NCT01061723|561895531|FG005|Overall Study|Randomized but not treated|1|||
155673317|NCT01061723|561895526|FG000|Overall Study|Other than specified above|2|||
155673318|NCT01061723|561895527|FG001|Overall Study|Other than specified above|1|||
155673319|NCT01061723|561895528|FG002|Overall Study|Other than specified above|1|||
155673320|NCT01061723|561895529|FG003|Overall Study|Other than specified above|1|||
155673321|NCT01061723|561895530|FG004|Overall Study|Other than specified above|0|||
155673322|NCT01061723|561895531|FG005|Overall Study|Other than specified above|1|||
155673323|NCT01734785|561895532|FG000|Open-Label Period|Adverse Event|0|||
155673324|NCT01734785|561895533|FG001|Open-Label Period|Adverse Event|0|||
155673325|NCT01734785|561895534|FG002|Open-Label Period|Adverse Event|0|||
155673326|NCT01734785|561895535|FG003|Open-Label Period|Adverse Event|9|||
155673327|NCT01734785|561895532|FG000|Open-Label Period|Lack of Efficacy|0|||
155673328|NCT01734785|561895533|FG001|Open-Label Period|Lack of Efficacy|0|||
155673329|NCT01734785|561895534|FG002|Open-Label Period|Lack of Efficacy|0|||
155673330|NCT01734785|561895535|FG003|Open-Label Period|Lack of Efficacy|1|||
155673331|NCT01734785|561895532|FG000|Open-Label Period|Protocol Violation|0|||
155673332|NCT01734785|561895533|FG001|Open-Label Period|Protocol Violation|0|||
155673333|NCT01734785|561895534|FG002|Open-Label Period|Protocol Violation|0|||
155673334|NCT01734785|561895535|FG003|Open-Label Period|Protocol Violation|13|||
155673335|NCT01734785|561895532|FG000|Open-Label Period|Lost to Follow-up|0|||
155673336|NCT01734785|561895533|FG001|Open-Label Period|Lost to Follow-up|0|||
155673337|NCT01734785|561895534|FG002|Open-Label Period|Lost to Follow-up|0|||
155673338|NCT01734785|561895535|FG003|Open-Label Period|Lost to Follow-up|14|||
155673339|NCT01734785|561895532|FG000|Open-Label Period|Withdrawal by Subject|0|||
155673340|NCT01734785|561895533|FG001|Open-Label Period|Withdrawal by Subject|0|||
155673341|NCT01734785|561895534|FG002|Open-Label Period|Withdrawal by Subject|0|||
155673342|NCT01734785|561895535|FG003|Open-Label Period|Withdrawal by Subject|12|||
155673343|NCT01734785|561895532|FG000|Open-Label Period|Other Reasons|0|||
155673344|NCT01734785|561895533|FG001|Open-Label Period|Other Reasons|0|||
155673345|NCT01734785|561895534|FG002|Open-Label Period|Other Reasons|0|||
155673346|NCT01734785|561895535|FG003|Open-Label Period|Other Reasons|224|||
155673347|NCT01734785|561895532|FG000|Double-Blind Period|Adverse Event|0|||
155673348|NCT01734785|561895533|FG001|Double-Blind Period|Adverse Event|3|||
155673349|NCT01734785|561895534|FG002|Double-Blind Period|Adverse Event|2|||
155673350|NCT01734785|561895535|FG003|Double-Blind Period|Adverse Event|0|||
155673351|NCT01734785|561895532|FG000|Double-Blind Period|Lack of Efficacy|0|||
155673352|NCT01734785|561895533|FG001|Double-Blind Period|Lack of Efficacy|1|||
155673353|NCT01734785|561895534|FG002|Double-Blind Period|Lack of Efficacy|0|||
155673354|NCT01734785|561895535|FG003|Double-Blind Period|Lack of Efficacy|0|||
155673355|NCT01734785|561895532|FG000|Double-Blind Period|Protocol Violation|0|||
155673356|NCT01734785|561895533|FG001|Double-Blind Period|Protocol Violation|1|||
155673357|NCT01734785|561895534|FG002|Double-Blind Period|Protocol Violation|1|||
155673358|NCT01734785|561895535|FG003|Double-Blind Period|Protocol Violation|0|||
155673359|NCT01734785|561895532|FG000|Double-Blind Period|Lost to Follow-up|2|||
155673360|NCT01734785|561895533|FG001|Double-Blind Period|Lost to Follow-up|4|||
155673361|NCT01734785|561895534|FG002|Double-Blind Period|Lost to Follow-up|2|||
155673362|NCT01734785|561895535|FG003|Double-Blind Period|Lost to Follow-up|0|||
155673363|NCT01734785|561895532|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155673364|NCT01734785|561895533|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155673365|NCT01734785|561895534|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155673366|NCT01734785|561895535|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155673367|NCT01734785|561895532|FG000|Double-Blind Period|Not treated|1|||
155673368|NCT01734785|561895533|FG001|Double-Blind Period|Not treated|0|||
155673369|NCT01734785|561895534|FG002|Double-Blind Period|Not treated|0|||
155673370|NCT01734785|561895535|FG003|Double-Blind Period|Not treated|0|||
155673371|NCT02397915|561895536|FG000|Period 1|Protocol Violation|0|||
155673372|NCT02397915|561895537|FG001|Period 1|Protocol Violation|1|||
155673373|NCT02397915|561895538|FG002|Period 1|Protocol Violation|0|||
155673374|NCT02397915|561895539|FG003|Period 1|Protocol Violation|0|||
155673375|NCT02397915|561895536|FG000|Period 1|Physician Decision|1|||
155673376|NCT02397915|561895537|FG001|Period 1|Physician Decision|0|||
155673377|NCT02397915|561895538|FG002|Period 1|Physician Decision|0|||
155673378|NCT02397915|561895539|FG003|Period 1|Physician Decision|0|||
155673379|NCT00368745|561895540|FG000|Double-blind Treatment Period|Adverse Event|6|||
155673380|NCT00368745|561895541|FG001|Double-blind Treatment Period|Adverse Event|6|||
155673381|NCT00368745|561895540|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
155673382|NCT00368745|561895541|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
155673383|NCT00368745|561895540|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155673384|NCT00368745|561895541|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155673385|NCT00368745|561895540|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
155673386|NCT00368745|561895541|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
155673387|NCT00368745|561895540|FG000|Double-blind Treatment Period|Other|7|||
155673388|NCT00368745|561895541|FG001|Double-blind Treatment Period|Other|6|||
155673389|NCT03292874|561895542|FG000|Overall Study|Due to pandemic|5|||
155673390|NCT01961297|561895548|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
155673391|NCT01961297|561895549|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
155673392|NCT02482298|561895550|FG000|Overall Study|Withdrawal by Subject|2|||
155673393|NCT02482298|561895551|FG001|Overall Study|Withdrawal by Subject|1|||
155673394|NCT02482298|561895552|FG002|Overall Study|Withdrawal by Subject|2|||
155673395|NCT02482298|561895550|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
155673396|NCT02482298|561895551|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
155673397|NCT02482298|561895552|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
155673398|NCT02482298|561895550|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
155673399|NCT02482298|561895551|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
155673400|NCT02482298|561895552|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
155673401|NCT02482298|561895550|FG000|Overall Study|Lost to Follow-up|0|||
155673402|NCT02482298|561895551|FG001|Overall Study|Lost to Follow-up|1|||
155673403|NCT02482298|561895552|FG002|Overall Study|Lost to Follow-up|0|||
155673404|NCT03053440|561895557|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
155673405|NCT03053440|561895558|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
155673406|NCT03053440|561895557|FG000|Overall Study|Death|18|||
155673407|NCT03053440|561895558|FG001|Overall Study|Death|14|||
155673408|NCT03053440|561895557|FG000|Overall Study|Withdrawal by Subject|9|||
155673409|NCT03053440|561895558|FG001|Overall Study|Withdrawal by Subject|8|||
155673410|NCT03053440|561895557|FG000|Overall Study|Lost to Follow-up|1|||
155673411|NCT03053440|561895558|FG001|Overall Study|Lost to Follow-up|0|||
155673412|NCT03053440|561895557|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
155673413|NCT03053440|561895558|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
155673414|NCT03053440|561895557|FG000|Overall Study|Physician Decision|2|||
155673415|NCT03053440|561895558|FG001|Overall Study|Physician Decision|1|||
155673416|NCT03053440|561895557|FG000|Overall Study|Participant Randomized but died before dosing|1|||
155673417|NCT03053440|561895558|FG001|Overall Study|Participant Randomized but died before dosing|0|||
155673418|NCT01582009|561895559|FG000|Overall Study|Withdrawal by Subject|1|||
155673419|NCT01582009|561895559|FG000|Overall Study|Physician Decision|1|||
155673420|NCT05002985|561895560|FG000|Overall Study|Withdrawal by Subject|1|||
155673421|NCT02705105|561895561|FG000|Treatment|Objective Disease Progression|1|||
155673422|NCT02705105|561895562|FG001|Treatment|Objective Disease Progression|50|||
155673423|NCT02705105|561895561|FG000|Treatment|Withdrawal by Subject|3|||
155673424|NCT02705105|561895562|FG001|Treatment|Withdrawal by Subject|5|||
155673425|NCT02705105|561895561|FG000|Treatment|Adverse Event|0|||
155673426|NCT02705105|561895562|FG001|Treatment|Adverse Event|17|||
155673427|NCT02705105|561895561|FG000|Treatment|Clinical Disease Progression|0|||
155673428|NCT02705105|561895562|FG001|Treatment|Clinical Disease Progression|32|||
155673429|NCT02705105|561895561|FG000|Treatment|Physician Decision|0|||
155673430|NCT02705105|561895562|FG001|Treatment|Physician Decision|3|||
155673431|NCT02705105|561895561|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
155673432|NCT02705105|561895562|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
155673433|NCT02705105|561895561|FG000|Follow-Up|Death|3|||
155673434|NCT02705105|561895562|FG001|Follow-Up|Death|68|||
155673435|NCT02705105|561895561|FG000|Follow-Up|Withdrawal by Subject|1|||
155673436|NCT02705105|561895562|FG001|Follow-Up|Withdrawal by Subject|14|||
155673437|NCT02705105|561895561|FG000|Follow-Up|Study Terminated|0|||
155673438|NCT02705105|561895562|FG001|Follow-Up|Study Terminated|26|||
155673439|NCT02705105|561895561|FG000|Follow-Up|Discontinued per Amendment 3|0|||
155673440|NCT02705105|561895562|FG001|Follow-Up|Discontinued per Amendment 3|2|||
155673441|NCT00485758|561895565|FG000|Overall Study|Adverse Event|102|||
155673442|NCT00485758|561895566|FG001|Overall Study|Adverse Event|31|||
155673443|NCT00485758|561895565|FG000|Overall Study|Death|0|||
155673444|NCT00485758|561895566|FG001|Overall Study|Death|1|||
155673445|NCT00485758|561895565|FG000|Overall Study|Lost to Follow-up|5|||
155673446|NCT00485758|561895566|FG001|Overall Study|Lost to Follow-up|1|||
155673447|NCT00485758|561895565|FG000|Overall Study|Physician Decision|3|||
155673448|NCT00485758|561895566|FG001|Overall Study|Physician Decision|3|||
155673449|NCT00485758|561895565|FG000|Overall Study|Protocol Violation|11|||
155673450|NCT00485758|561895566|FG001|Overall Study|Protocol Violation|2|||
155673451|NCT00485758|561895565|FG000|Overall Study|Withdrawal by Subject|32|||
155673452|NCT00485758|561895566|FG001|Overall Study|Withdrawal by Subject|27|||
155673453|NCT00485758|561895565|FG000|Overall Study|Study Terminated by Sponsor|3|||
155673454|NCT00485758|561895566|FG001|Overall Study|Study Terminated by Sponsor|0|||
155673455|NCT04556591|561895567|FG000|Overall Study|Lost to Follow-up|1|||
155673456|NCT04556591|561895568|FG001|Overall Study|Lost to Follow-up|0|||
155673457|NCT04556591|561895567|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
155673458|NCT04556591|561895568|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
155673459|NCT03332173|561895569|FG000|Overall Study|Death|7|||
155673460|NCT03332173|561895569|FG000|Overall Study|Withdrawal by Subject|6|||
155673461|NCT03332173|561895569|FG000|Overall Study|Lost to Follow-up|2|||
155673462|NCT03332173|561895569|FG000|Overall Study|Transferred to long-term extension study|29|||
155673463|NCT00211172|561895570|FG000|Overall Study|Died or lost health plan eligibility|39|||
155673464|NCT00211172|561895571|FG001|Overall Study|Died or lost health plan eligibility|32|||
155673465|NCT04474197|561895572|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155673466|NCT04474197|561895573|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
155673467|NCT04474197|561895574|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155673468|NCT04474197|561895575|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155673469|NCT00624468|561895577|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
155673470|NCT00624468|561895578|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
155673471|NCT00624468|561895579|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
155673472|NCT00624468|561895580|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
155673473|NCT00624468|561895577|FG000|Double-blind Period|Withdrew Prematurely|1|||
155673474|NCT00624468|561895578|FG001|Double-blind Period|Withdrew Prematurely|1|||
155673475|NCT00624468|561895579|FG002|Double-blind Period|Withdrew Prematurely|0|||
155673476|NCT00624468|561895580|FG003|Double-blind Period|Withdrew Prematurely|0|||
155673477|NCT00624468|561895577|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
155673478|NCT00624468|561895578|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
155673479|NCT00624468|561895579|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
155673480|NCT00624468|561895580|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
155673481|NCT00624468|561895577|FG000|Safety Follow-up (SFU) Period|Other|0|||
155673482|NCT00624468|561895578|FG001|Safety Follow-up (SFU) Period|Other|0|||
155673483|NCT00624468|561895579|FG002|Safety Follow-up (SFU) Period|Other|1|||
155673484|NCT00624468|561895580|FG003|Safety Follow-up (SFU) Period|Other|1|||
155673485|NCT03072043|561895589|FG000|Overall Study|Death|0|||
155673486|NCT03072043|561895590|FG001|Overall Study|Death|0|||
155673487|NCT03072043|561895591|FG002|Overall Study|Death|3|||
155673488|NCT03072043|561895589|FG000|Overall Study|Adverse Event|0|||
155673489|NCT03072043|561895590|FG001|Overall Study|Adverse Event|0|||
155673490|NCT03072043|561895591|FG002|Overall Study|Adverse Event|2|||
155673491|NCT03072043|561895589|FG000|Overall Study|Withdrawal by Subject|0|||
155673492|NCT03072043|561895590|FG001|Overall Study|Withdrawal by Subject|0|||
155673493|NCT03072043|561895591|FG002|Overall Study|Withdrawal by Subject|4|||
155673494|NCT01340664|561895592|FG000|Overall Study|Adverse Event|0|||
155673495|NCT01340664|561895593|FG001|Overall Study|Adverse Event|1|||
155673496|NCT01340664|561895594|FG002|Overall Study|Adverse Event|7|||
155673497|NCT01340664|561895592|FG000|Overall Study|Lost to Follow-up|2|||
155673498|NCT01340664|561895593|FG001|Overall Study|Lost to Follow-up|0|||
155673499|NCT01340664|561895594|FG002|Overall Study|Lost to Follow-up|2|||
155673500|NCT01340664|561895592|FG000|Overall Study|Withdrawal by Subject|2|||
155673501|NCT01340664|561895593|FG001|Overall Study|Withdrawal by Subject|4|||
155673502|NCT01340664|561895594|FG002|Overall Study|Withdrawal by Subject|0|||
155673503|NCT01340664|561895592|FG000|Overall Study|Glycemic withdrawal criteria|2|||
155673504|NCT01340664|561895593|FG001|Overall Study|Glycemic withdrawal criteria|0|||
155673505|NCT01340664|561895594|FG002|Overall Study|Glycemic withdrawal criteria|0|||
155673506|NCT01340664|561895592|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
155673507|NCT01340664|561895593|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
155673508|NCT01340664|561895594|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
155673509|NCT01340664|561895592|FG000|Overall Study|Other|1|||
155673510|NCT01340664|561895593|FG001|Overall Study|Other|2|||
155673511|NCT01340664|561895594|FG002|Overall Study|Other|2|||
155673512|NCT02923531|561895595|FG000|Overall Study|Adverse Event|4|||
155673513|NCT02923531|561895595|FG000|Overall Study|Clinical Deterioration|1|||
155673514|NCT02923531|561895595|FG000|Overall Study|Disease Progression|3|||
155673515|NCT02923531|561895595|FG000|Overall Study|Study Termination|1|||
155673516|NCT01823198|561895597|FG000|Overall Study|Physician Decision|0|||
155673517|NCT01823198|561895598|FG001|Overall Study|Physician Decision|1|||
155673518|NCT01823198|561895599|FG002|Overall Study|Physician Decision|0|||
155673519|NCT01823198|561895600|FG003|Overall Study|Physician Decision|0|||
155673520|NCT01823198|561895601|FG004|Overall Study|Physician Decision|0|||
155673521|NCT01823198|561895602|FG005|Overall Study|Physician Decision|3|||
155673522|NCT01823198|561895603|FG006|Overall Study|Physician Decision|3|||
155673523|NCT05588440|561895611|FG000|Overall Study|Sponsor Decision|2|||
155673524|NCT05588440|561895612|FG001|Overall Study|Sponsor Decision|0|||
155673525|NCT05588440|561895613|FG002|Overall Study|Sponsor Decision|1|||
155673526|NCT05588440|561895611|FG000|Overall Study|Death|1|||
155673527|NCT05588440|561895612|FG001|Overall Study|Death|1|||
155599234|NCT00387010|561619130|FG000|Dose Titration Period|Lack of Efficacy|5|||
155599235|NCT00387010|561619130|FG000|Dose Titration Period|Withdrawal by Subject|3|||
155599236|NCT00387010|561619130|FG000|Dose Titration Period|Protocol Violation|1|||
155599237|NCT00387010|561619130|FG000|Dose Titration Period|Lost to Follow-up|2|||
155599238|NCT00387010|561619130|FG000|Dose Titration Period|Noncompliance with study medication|8|||
155599239|NCT00387010|561619130|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
155599240|NCT00387010|561619130|FG000|Treatment Period|Adverse Event|4|||
155599241|NCT00387010|561619130|FG000|Treatment Period|Withdrawal by Subject|1|||
155599242|NCT00387010|561619130|FG000|Treatment Period|Noncompliance with study medication|2|||
155599243|NCT00387010|561619130|FG000|Treatment Period|Noncompliance with study procedures|3|||
155599244|NCT00387010|561619130|FG000|Treatment Period|Participant reported study drug stolen|1|||
155599245|NCT00520481|561619136|FG000|Overall Study|Adverse Event|4|||
155599246|NCT00520481|561619137|FG001|Overall Study|Adverse Event|1|||
155599247|NCT00520481|561619136|FG000|Overall Study|Withdrawal by Subject|3|||
155599248|NCT00520481|561619137|FG001|Overall Study|Withdrawal by Subject|0|||
155599249|NCT00471718|561619142|FG000|Overall Study|Adverse Event|3|||
155599250|NCT00471718|561619142|FG000|Overall Study|other complicating disease|1|||
155599251|NCT00471718|561619142|FG000|Overall Study|disease progression|22|||
155599252|NCT00471718|561619142|FG000|Overall Study|Withdrawal by Subject|1|||
155599253|NCT02841280|561619143|FG000|Overall Study|Adverse Event|2|||
155599254|NCT02841280|561619144|FG001|Overall Study|Adverse Event|1|||
155599255|NCT02841280|561619143|FG000|Overall Study|Death|1|||
155599256|NCT02841280|561619144|FG001|Overall Study|Death|0|||
155599257|NCT02841280|561619143|FG000|Overall Study|Lost to Follow-up|2|||
155599258|NCT02841280|561619144|FG001|Overall Study|Lost to Follow-up|2|||
155599259|NCT02841280|561619143|FG000|Overall Study|Withdrawal by Subject|7|||
155599260|NCT02841280|561619144|FG001|Overall Study|Withdrawal by Subject|3|||
155599261|NCT02841280|561619143|FG000|Overall Study|Stop Point: BP above threshold|2|||
155599262|NCT02841280|561619144|FG001|Overall Study|Stop Point: BP above threshold|0|||
155599263|NCT00957268|561619145|FG000|Overall Study|Voluntary Withdrawal|0|||
155599264|NCT00957268|561619146|FG001|Overall Study|Voluntary Withdrawal|0|||
155599265|NCT00957268|561619147|FG002|Overall Study|Voluntary Withdrawal|1|||
155599266|NCT00957268|561619148|FG003|Overall Study|Voluntary Withdrawal|0|||
155599267|NCT00957268|561619149|FG004|Overall Study|Voluntary Withdrawal|0|||
155599268|NCT01340027|561619151|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
155599269|NCT01340027|561619152|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
155599270|NCT01340027|561619153|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
155599271|NCT01340027|561619154|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
155599272|NCT01340027|561619155|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
155599273|NCT01340027|561619156|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
155599274|NCT01340027|561619157|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
155599275|NCT01340027|561619158|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
155599276|NCT01340027|561619159|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
155599277|NCT01340027|561619160|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
155599278|NCT01340027|561619161|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
155599279|NCT01340027|561619162|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
155673528|NCT05588440|561895613|FG002|Overall Study|Death|1|||
155673529|NCT05588440|561895611|FG000|Overall Study|Screen Fail|0|||
155673530|NCT05588440|561895612|FG001|Overall Study|Screen Fail|1|||
155673531|NCT05588440|561895613|FG002|Overall Study|Screen Fail|1|||
155673532|NCT05588440|561895611|FG000|Overall Study|Withdrawal by Subject|0|||
155673533|NCT05588440|561895612|FG001|Overall Study|Withdrawal by Subject|0|||
155673534|NCT05588440|561895613|FG002|Overall Study|Withdrawal by Subject|1|||
155673535|NCT00100802|561895618|FG000|Overall Study|Adverse Event|9|||
155673536|NCT00100802|561895618|FG000|Overall Study|Death|1|||
155673537|NCT00100802|561895618|FG000|Overall Study|Lack of Efficacy|47|||
155673538|NCT00100802|561895618|FG000|Overall Study|Physician Decision|5|||
155673539|NCT00100802|561895618|FG000|Overall Study|Protocol Violation|1|||
155673540|NCT00100802|561895618|FG000|Overall Study|Withdrawal by Subject|5|||
155673541|NCT00100802|561895618|FG000|Overall Study|Ineligible|12|||
155673542|NCT02709720|561895619|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
155673543|NCT02709720|561895619|FG000|Overall Study|Protocol Violation|1|||
155673544|NCT02709720|561895619|FG000|Overall Study|Not take study medication|1|||
155673545|NCT00928187|561895630|FG000|Overall Study|Death|1|||
155673546|NCT00928187|561895631|FG001|Overall Study|Death|2|||
155673547|NCT00928187|561895632|FG002|Overall Study|Death|3|||
155673548|NCT00928187|561895630|FG000|Overall Study|Lost to Follow-up|1|||
155673549|NCT00928187|561895631|FG001|Overall Study|Lost to Follow-up|2|||
155673550|NCT00928187|561895632|FG002|Overall Study|Lost to Follow-up|1|||
155673551|NCT00928187|561895630|FG000|Overall Study|Withdrawal by Subject|0|||
155673552|NCT00928187|561895631|FG001|Overall Study|Withdrawal by Subject|1|||
155673553|NCT00928187|561895632|FG002|Overall Study|Withdrawal by Subject|1|||
155673554|NCT00928187|561895630|FG000|Overall Study|Protocol Violation|0|||
155673555|NCT00928187|561895631|FG001|Overall Study|Protocol Violation|1|||
155673556|NCT00928187|561895632|FG002|Overall Study|Protocol Violation|0|||
155673557|NCT02524145|561895633|FG000|Overall Study|Withdrawal by Subject|2|||
155673558|NCT02524145|561895634|FG001|Overall Study|Withdrawal by Subject|2|||
155673559|NCT02524145|561895635|FG002|Overall Study|Withdrawal by Subject|3|||
155673560|NCT00735553|561896899|FG000|Overall Study|Study prematurely terminated|77|||
155673561|NCT05069597|561896900|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155673562|NCT05069597|561896901|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155673563|NCT02707965|561896903|FG000|Overall Study|Withdrawal by Subject|0|||
155673564|NCT02707965|561896904|FG001|Overall Study|Withdrawal by Subject|0|||
155673565|NCT02707965|561896905|FG002|Overall Study|Withdrawal by Subject|1|||
155673566|NCT02707965|561896906|FG003|Overall Study|Withdrawal by Subject|0|||
155673567|NCT02707965|561896907|FG004|Overall Study|Withdrawal by Subject|0|||
155673568|NCT02707965|561896908|FG005|Overall Study|Withdrawal by Subject|0|||
155673569|NCT02707965|561896909|FG006|Overall Study|Withdrawal by Subject|0|||
155673570|NCT02707965|561896910|FG007|Overall Study|Withdrawal by Subject|2|||
155673571|NCT02707965|561896911|FG008|Overall Study|Withdrawal by Subject|0|||
155673572|NCT02707965|561896912|FG009|Overall Study|Withdrawal by Subject|0|||
155673573|NCT02707965|561896913|FG010|Overall Study|Withdrawal by Subject|0|||
155673574|NCT02707965|561896914|FG011|Overall Study|Withdrawal by Subject|0|||
155673575|NCT02707965|561896915|FG012|Overall Study|Withdrawal by Subject|0|||
155673576|NCT02707965|561896916|FG013|Overall Study|Withdrawal by Subject|0|||
155673577|NCT02707965|561896917|FG014|Overall Study|Withdrawal by Subject|0|||
155673578|NCT02707965|561896918|FG015|Overall Study|Withdrawal by Subject|0|||
155673579|NCT02707965|561896903|FG000|Overall Study|PI decisions|0|||
155673580|NCT02707965|561896904|FG001|Overall Study|PI decisions|0|||
155673581|NCT02707965|561896905|FG002|Overall Study|PI decisions|0|||
155673582|NCT02707965|561896906|FG003|Overall Study|PI decisions|0|||
155673583|NCT02707965|561896907|FG004|Overall Study|PI decisions|0|||
155673584|NCT02707965|561896908|FG005|Overall Study|PI decisions|0|||
155673585|NCT02707965|561896909|FG006|Overall Study|PI decisions|0|||
155673586|NCT02707965|561896910|FG007|Overall Study|PI decisions|0|||
155673587|NCT02707965|561896911|FG008|Overall Study|PI decisions|0|||
155673588|NCT02707965|561896912|FG009|Overall Study|PI decisions|0|||
155673589|NCT02707965|561896913|FG010|Overall Study|PI decisions|0|||
155673590|NCT02707965|561896914|FG011|Overall Study|PI decisions|0|||
155673591|NCT02707965|561896915|FG012|Overall Study|PI decisions|0|||
155673592|NCT02707965|561896916|FG013|Overall Study|PI decisions|0|||
155673593|NCT02707965|561896917|FG014|Overall Study|PI decisions|2|||
155673594|NCT02707965|561896918|FG015|Overall Study|PI decisions|0|||
155673595|NCT02707965|561896903|FG000|Overall Study|Protocol deviation|1|||
155673596|NCT02707965|561896904|FG001|Overall Study|Protocol deviation|1|||
155673597|NCT02707965|561896905|FG002|Overall Study|Protocol deviation|0|||
155673598|NCT02707965|561896906|FG003|Overall Study|Protocol deviation|0|||
155673599|NCT02707965|561896907|FG004|Overall Study|Protocol deviation|0|||
155673600|NCT02707965|561896908|FG005|Overall Study|Protocol deviation|0|||
155673601|NCT02707965|561896909|FG006|Overall Study|Protocol deviation|0|||
155673602|NCT02707965|561896910|FG007|Overall Study|Protocol deviation|1|||
155673603|NCT02707965|561896911|FG008|Overall Study|Protocol deviation|0|||
155673604|NCT02707965|561896912|FG009|Overall Study|Protocol deviation|0|||
155673605|NCT02707965|561896913|FG010|Overall Study|Protocol deviation|0|||
155673606|NCT02707965|561896914|FG011|Overall Study|Protocol deviation|0|||
155673607|NCT02707965|561896915|FG012|Overall Study|Protocol deviation|0|||
155673608|NCT02707965|561896916|FG013|Overall Study|Protocol deviation|0|||
155673609|NCT02707965|561896917|FG014|Overall Study|Protocol deviation|0|||
155673610|NCT02707965|561896918|FG015|Overall Study|Protocol deviation|0|||
155673611|NCT00131352|561896919|FG000|Initial Treatment Period|Adverse Event|1|||
155673612|NCT00131352|561896920|FG001|Initial Treatment Period|Adverse Event|3|||
155673613|NCT00131352|561896919|FG000|Initial Treatment Period|Non-compliant|1|||
155673614|NCT00131352|561896920|FG001|Initial Treatment Period|Non-compliant|2|||
155673615|NCT00131352|561896919|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155673616|NCT00131352|561896920|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
155673617|NCT00131352|561896919|FG000|Initial Treatment Period|Lack of Efficacy|6|||
155673618|NCT00131352|561896920|FG001|Initial Treatment Period|Lack of Efficacy|4|||
155673619|NCT00131352|561896919|FG000|Initial Treatment Period|Other|0|||
155673620|NCT00131352|561896920|FG001|Initial Treatment Period|Other|2|||
155673621|NCT00131352|561896919|FG000|Repeat Treatment Period|Adverse Event|1|||
155673622|NCT00131352|561896920|FG001|Repeat Treatment Period|Adverse Event|0|||
155673623|NCT00131352|561896919|FG000|Repeat Treatment Period|Other|1|||
155673624|NCT00131352|561896920|FG001|Repeat Treatment Period|Other|0|||
155673625|NCT02526212|561896928|FG000|Overall Study|Incarceration|1|||
155673626|NCT02526212|561896929|FG001|Overall Study|Incarceration|0|||
155673627|NCT02526212|561896928|FG000|Overall Study|Lost to Follow-up|1|||
155673628|NCT02526212|561896929|FG001|Overall Study|Lost to Follow-up|0|||
155673629|NCT02526212|561896928|FG000|Overall Study|Death|0|||
155673630|NCT02526212|561896929|FG001|Overall Study|Death|1|||
155673631|NCT02096952|561896936|FG000|Overall Study|Adverse Event|1|||
155673632|NCT00635349|561896938|FG000|Overall Study|Other|8|||
155673633|NCT00635349|561896939|FG001|Overall Study|Other|6|||
155673634|NCT00635349|561896938|FG000|Overall Study|Protocol Violation|18|||
155673635|NCT00635349|561896939|FG001|Overall Study|Protocol Violation|22|||
155673636|NCT00635349|561896938|FG000|Overall Study|Withdrawal by Subject|3|||
155673637|NCT00635349|561896939|FG001|Overall Study|Withdrawal by Subject|8|||
155673638|NCT00635349|561896938|FG000|Overall Study|Lost to Follow-up|4|||
155673639|NCT00635349|561896939|FG001|Overall Study|Lost to Follow-up|3|||
155673640|NCT00635349|561896938|FG000|Overall Study|Adverse Event|11|||
155673641|NCT00635349|561896939|FG001|Overall Study|Adverse Event|9|||
155673642|NCT02446769|561896942|FG000|Screening Period|Screen Failure|11|||
155673643|NCT02446769|561896943|FG001|Screening Period|Screen Failure|0|||
155673644|NCT02446769|561896944|FG002|Screening Period|Screen Failure|0|||
155673645|NCT02446769|561896942|FG000|Study Period|Randomized in Error|0|||
155673646|NCT02446769|561896943|FG001|Study Period|Randomized in Error|2|||
155673647|NCT02446769|561896944|FG002|Study Period|Randomized in Error|0|||
155673648|NCT04482439|561896945|FG000|Overall Study|Lost to Follow-up|1|||
155673649|NCT04482439|561896945|FG000|Overall Study|Unrelated illness|1|||
155673650|NCT00645840|561896946|FG000|Overall Study|Protocol Violation|3|||
155673651|NCT00402324|561896947|FG000|Overall Study|Lost to Follow-up|11|||
155673652|NCT00402324|561896948|FG001|Overall Study|Lost to Follow-up|11|||
155673653|NCT00402324|561896947|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
155673654|NCT00402324|561896948|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
155673655|NCT00402324|561896947|FG000|Overall Study|Protocol Violation|8|||
155673656|NCT00402324|561896948|FG001|Overall Study|Protocol Violation|7|||
155673657|NCT00402324|561896947|FG000|Overall Study|Withdrawal by Subject|5|||
155673658|NCT00402324|561896948|FG001|Overall Study|Withdrawal by Subject|2|||
155673659|NCT00402324|561896947|FG000|Overall Study|Physician Decision|2|||
155673660|NCT00402324|561896948|FG001|Overall Study|Physician Decision|4|||
155673661|NCT00402324|561896947|FG000|Overall Study|Sponsor Decision|4|||
155673662|NCT00402324|561896948|FG001|Overall Study|Sponsor Decision|5|||
155673663|NCT00402324|561896947|FG000|Overall Study|Lack of Efficacy|1|||
155673664|NCT00402324|561896948|FG001|Overall Study|Lack of Efficacy|4|||
155673665|NCT00402324|561896947|FG000|Overall Study|Adverse Event|6|||
155673666|NCT00402324|561896948|FG001|Overall Study|Adverse Event|4|||
155673667|NCT00402324|561896947|FG000|Overall Study|Death|1|||
155673668|NCT00402324|561896948|FG001|Overall Study|Death|0|||
155673669|NCT01277822|561896949|FG000|Overall Study|Adverse Event|2|||
155673670|NCT01277822|561896950|FG001|Overall Study|Adverse Event|1|||
155673671|NCT01277822|561896949|FG000|Overall Study|Withdrawal by Subject|6|||
155673672|NCT01277822|561896950|FG001|Overall Study|Withdrawal by Subject|7|||
155673673|NCT01277822|561896949|FG000|Overall Study|Physician Decision|1|||
155673674|NCT01277822|561896950|FG001|Overall Study|Physician Decision|1|||
155673675|NCT01277822|561896949|FG000|Overall Study|Protocol Violation|1|||
155673676|NCT01277822|561896950|FG001|Overall Study|Protocol Violation|0|||
155673677|NCT01277822|561896949|FG000|Overall Study|Lost to Follow-up|2|||
155673678|NCT01277822|561896950|FG001|Overall Study|Lost to Follow-up|1|||
155673679|NCT01277822|561896949|FG000|Overall Study|Contraindicated medication used|2|||
155673680|NCT01277822|561896950|FG001|Overall Study|Contraindicated medication used|1|||
155673681|NCT01277822|561896949|FG000|Overall Study|Participant moved|1|||
155673682|NCT01277822|561896950|FG001|Overall Study|Participant moved|0|||
155673683|NCT00997984|561896951|FG000|Overall Study|Adverse Event|1|||
155673684|NCT00997984|561896952|FG001|Overall Study|Adverse Event|8|||
155673685|NCT00997984|561896953|FG002|Overall Study|Adverse Event|8|||
155673686|NCT00997984|561896951|FG000|Overall Study|Protocol Violation|1|||
155673687|NCT00997984|561896952|FG001|Overall Study|Protocol Violation|3|||
155673688|NCT00997984|561896953|FG002|Overall Study|Protocol Violation|0|||
155673689|NCT00997984|561896951|FG000|Overall Study|Withdrawal by Subject|6|||
155673690|NCT00997984|561896952|FG001|Overall Study|Withdrawal by Subject|9|||
155673691|NCT00997984|561896953|FG002|Overall Study|Withdrawal by Subject|5|||
155673692|NCT00997984|561896951|FG000|Overall Study|Lost to Follow-up|8|||
155673693|NCT00997984|561896952|FG001|Overall Study|Lost to Follow-up|5|||
155673694|NCT00997984|561896953|FG002|Overall Study|Lost to Follow-up|4|||
155673695|NCT00997984|561896951|FG000|Overall Study|Lack of Efficacy|20|||
155673696|NCT00997984|561896952|FG001|Overall Study|Lack of Efficacy|6|||
155673697|NCT00997984|561896953|FG002|Overall Study|Lack of Efficacy|3|||
155673698|NCT00997984|561896951|FG000|Overall Study|Met exclusion criteria|1|||
155673699|NCT00997984|561896952|FG001|Overall Study|Met exclusion criteria|0|||
155673700|NCT00997984|561896953|FG002|Overall Study|Met exclusion criteria|0|||
155673701|NCT00997984|561896951|FG000|Overall Study|non-compliance|0|||
155673702|NCT00997984|561896952|FG001|Overall Study|non-compliance|2|||
155673703|NCT00997984|561896953|FG002|Overall Study|non-compliance|3|||
155673704|NCT00997984|561896951|FG000|Overall Study|Wrong medication dispensed|0|||
155673705|NCT00997984|561896952|FG001|Overall Study|Wrong medication dispensed|1|||
155673706|NCT00997984|561896953|FG002|Overall Study|Wrong medication dispensed|0|||
155673707|NCT00997984|561896951|FG000|Overall Study|Suicidal ideation|0|||
155673708|NCT00997984|561896952|FG001|Overall Study|Suicidal ideation|0|||
155673709|NCT00997984|561896953|FG002|Overall Study|Suicidal ideation|1|||
155673710|NCT00997984|561896951|FG000|Overall Study|Work schedule|0|||
155673711|NCT00997984|561896952|FG001|Overall Study|Work schedule|0|||
155673712|NCT00997984|561896953|FG002|Overall Study|Work schedule|2|||
155673713|NCT01232127|561896954|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
155673714|NCT01232127|561896955|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
155673715|NCT01232127|561896956|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
155673716|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
155673717|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
155673718|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
155673719|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
155673720|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
155673721|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
155673722|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
155673723|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
155673724|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
155673725|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
155673726|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155673727|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155673728|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
155673729|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
155673730|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
155673731|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
155673732|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155673733|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155673734|NCT03162796|561896962|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
155673735|NCT03162796|561896963|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
155673736|NCT03162796|561896964|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
155673737|NCT03162796|561896962|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
155673738|NCT03162796|561896963|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
155673739|NCT03162796|561896964|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
155673740|NCT03162796|561896962|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
155673741|NCT03162796|561896963|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
155673742|NCT03162796|561896964|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
155673743|NCT03162796|561896962|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
155673744|NCT03162796|561896963|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
155673745|NCT03162796|561896964|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
155673746|NCT03162796|561896962|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
155673747|NCT03162796|561896963|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
155673748|NCT03162796|561896964|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
155673749|NCT02725476|561896966|FG000|Overall Study|Physician Decision|2|||
155673750|NCT02725476|561896967|FG001|Overall Study|Physician Decision|0|||
155673751|NCT02725476|561896966|FG000|Overall Study|Adverse Event|1|||
155673752|NCT02725476|561896967|FG001|Overall Study|Adverse Event|1|||
155673753|NCT00289289|561896968|FG000|Overall Study|Withdrawal by Subject|5|||
155673754|NCT00289289|561896969|FG001|Overall Study|Withdrawal by Subject|3|||
155673755|NCT00289289|561896970|FG002|Overall Study|Withdrawal by Subject|15|||
155673756|NCT00289289|561896968|FG000|Overall Study|Lost to Follow-up|1|||
155673757|NCT00289289|561896969|FG001|Overall Study|Lost to Follow-up|0|||
155673758|NCT00289289|561896970|FG002|Overall Study|Lost to Follow-up|1|||
155673759|NCT00289289|561896968|FG000|Overall Study|Death|4|||
155673760|NCT00289289|561896969|FG001|Overall Study|Death|2|||
155673761|NCT00289289|561896970|FG002|Overall Study|Death|5|||
155673762|NCT00289289|561896968|FG000|Overall Study|No implant attempted|0|||
155673763|NCT00289289|561896969|FG001|Overall Study|No implant attempted|0|||
155673764|NCT00289289|561896970|FG002|Overall Study|No implant attempted|1|||
155673765|NCT00289289|561896968|FG000|Overall Study|Physician Decision|1|||
155673766|NCT00289289|561896969|FG001|Overall Study|Physician Decision|0|||
155673767|NCT00289289|561896970|FG002|Overall Study|Physician Decision|6|||
155673768|NCT00289289|561896968|FG000|Overall Study|Non-study device implanted|2|||
155673769|NCT00289289|561896969|FG001|Overall Study|Non-study device implanted|1|||
155673770|NCT00289289|561896970|FG002|Overall Study|Non-study device implanted|3|||
155673771|NCT00289289|561896968|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
155673772|NCT00289289|561896969|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
155673773|NCT00289289|561896970|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
155673774|NCT00289289|561896968|FG000|Overall Study|Other Exit Reason|6|||
155673775|NCT00289289|561896969|FG001|Overall Study|Other Exit Reason|4|||
155673776|NCT00289289|561896970|FG002|Overall Study|Other Exit Reason|12|||
155673777|NCT00407602|561896971|FG000|Overall Study|Death - unrelated to device|1|||
155673778|NCT00407602|561896971|FG000|Overall Study|Device explanted|5|||
155673779|NCT00407602|561896971|FG000|Overall Study|Withdrawal by Subject|1|||
155673780|NCT00577707|561896972|FG000|Overall Study|Withdrawal by Subject|3|||
155673781|NCT01154452|561896979|FG000|Phase Ib|Not Treated|1|||
155673782|NCT01154452|561896980|FG001|Phase Ib|Not Treated|0|||
155673783|NCT01154452|561896981|FG002|Phase Ib|Not Treated|0|||
155673784|NCT01154452|561896982|FG003|Phase Ib|Not Treated|0|||
155673785|NCT01154452|561896979|FG000|Phase Ib|Adverse Event|2|||
155673786|NCT01154452|561896980|FG001|Phase Ib|Adverse Event|1|||
155673787|NCT01154452|561896981|FG002|Phase Ib|Adverse Event|0|||
155673788|NCT01154452|561896982|FG003|Phase Ib|Adverse Event|0|||
155673789|NCT01154452|561896979|FG000|Phase II|Withdrawal by Subject|0|||
155673790|NCT01154452|561896980|FG001|Phase II|Withdrawal by Subject|0|||
155673791|NCT01154452|561896981|FG002|Phase II|Withdrawal by Subject|1|||
155673792|NCT01154452|561896982|FG003|Phase II|Withdrawal by Subject|2|||
155673793|NCT01154452|561896979|FG000|Phase II|Adverse Event|0|||
155673794|NCT01154452|561896980|FG001|Phase II|Adverse Event|0|||
155673795|NCT01154452|561896981|FG002|Phase II|Adverse Event|4|||
155673796|NCT01154452|561896982|FG003|Phase II|Adverse Event|4|||
155673797|NCT00130039|561896983|FG000|Overall Study|Withdrawal by Subject|15|||
155673798|NCT00130039|561896984|FG001|Overall Study|Withdrawal by Subject|11|||
155673799|NCT00130039|561896983|FG000|Overall Study|Lost to Follow-up|3|||
155673800|NCT00130039|561896984|FG001|Overall Study|Lost to Follow-up|1|||
155673801|NCT00130039|561896983|FG000|Overall Study|Adverse Event|4|||
155673802|NCT00130039|561896984|FG001|Overall Study|Adverse Event|2|||
155673803|NCT00130039|561896983|FG000|Overall Study|Physician Decision|3|||
155673804|NCT00130039|561896984|FG001|Overall Study|Physician Decision|0|||
155673805|NCT00130039|561896983|FG000|Overall Study|clinical events without follow up MRI|5|||
155673806|NCT00130039|561896984|FG001|Overall Study|clinical events without follow up MRI|4|||
155673807|NCT03706430|561896985|FG000|Overall Study|No A-Line placed|5|||
155673808|NCT03706430|561896985|FG000|Overall Study|Subject had gel nail polish|1|||
155673809|NCT03706430|561896985|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
155673810|NCT03706430|561896985|FG000|Overall Study|Cancelled Case|6|||
155673811|NCT03706430|561896985|FG000|Overall Study|Physician Decision|2|||
155673812|NCT00145626|561896986|FG000|Overall Study|Did not have NK infusions|2|||
155673813|NCT00145626|561896986|FG000|Overall Study|Turned 2 years old before treatment|1|||
155673814|NCT00145626|561896986|FG000|Overall Study|Death|1|||
155673815|NCT00145626|561896986|FG000|Overall Study|Withdrawal by Subject|1|||
155673816|NCT01392573|561896987|FG000|Overall Study|Adverse Event|1|||
155673817|NCT01392573|561896988|FG001|Overall Study|Adverse Event|3|||
155673818|NCT01392573|561896987|FG000|Overall Study|Lack of Efficacy|1|||
155673819|NCT01392573|561896988|FG001|Overall Study|Lack of Efficacy|2|||
155673820|NCT01392573|561896987|FG000|Overall Study|Protocol Violation|0|||
155673821|NCT01392573|561896988|FG001|Overall Study|Protocol Violation|2|||
155673822|NCT01392573|561896987|FG000|Overall Study|Withdrawal Criteria|13|||
155673823|NCT01392573|561896988|FG001|Overall Study|Withdrawal Criteria|15|||
155673824|NCT01392573|561896987|FG000|Overall Study|Site closure|8|||
155673825|NCT01392573|561896988|FG001|Overall Study|Site closure|7|||
155673826|NCT01392573|561896987|FG000|Overall Study|Unclassified|9|||
155673827|NCT01392573|561896988|FG001|Overall Study|Unclassified|6|||
155673828|NCT01198574|561896991|FG000|Overall Study|Resigned from schools|4|||
155673829|NCT01198574|561896992|FG001|Overall Study|Resigned from schools|1|||
155673830|NCT01198574|561896993|FG002|Overall Study|Resigned from schools|1|||
155673831|NCT01198574|561896994|FG003|Overall Study|Resigned from schools|4|||
155673832|NCT00200967|561896995|FG000|First Treatment Period|Withdrawal by Subject|5|||
155673833|NCT00200967|561896996|FG001|First Treatment Period|Withdrawal by Subject|1|||
155673834|NCT00200967|561896995|FG000|First Treatment Period|Pregnancy|1|||
155673835|NCT00200967|561896996|FG001|First Treatment Period|Pregnancy|0|||
155673836|NCT00200967|561896995|FG000|Wash-out Period|Lost to Follow-up|0|||
155673837|NCT00200967|561896996|FG001|Wash-out Period|Lost to Follow-up|1|||
155673838|NCT00200967|561896995|FG000|Second Treatment Period|Withdrawal by Subject|1|||
155673839|NCT00200967|561896996|FG001|Second Treatment Period|Withdrawal by Subject|2|||
155673840|NCT00200967|561896995|FG000|Run-out Period|Lost to Follow-up|1|||
155673841|NCT00200967|561896996|FG001|Run-out Period|Lost to Follow-up|0|||
155673842|NCT00980460|561896997|FG000|Overall Study|Death|0|||
155673843|NCT00980460|561896998|FG001|Overall Study|Death|0|||
155673844|NCT00980460|561896999|FG002|Overall Study|Death|1|||
155673845|NCT00980460|561897000|FG003|Overall Study|Death|2|||
155673846|NCT00980460|561897001|FG004|Overall Study|Death|1|||
155673847|NCT00980460|561896997|FG000|Overall Study|Lack of Efficacy|0|||
155673848|NCT00980460|561896998|FG001|Overall Study|Lack of Efficacy|0|||
155673849|NCT00980460|561896999|FG002|Overall Study|Lack of Efficacy|10|||
155673850|NCT00980460|561897000|FG003|Overall Study|Lack of Efficacy|6|||
155673851|NCT00980460|561897001|FG004|Overall Study|Lack of Efficacy|8|||
155673852|NCT00980460|561896997|FG000|Overall Study|Lost to Follow-up|0|||
155673853|NCT00980460|561896998|FG001|Overall Study|Lost to Follow-up|0|||
155673854|NCT00980460|561896999|FG002|Overall Study|Lost to Follow-up|0|||
155673855|NCT00980460|561897000|FG003|Overall Study|Lost to Follow-up|1|||
155673856|NCT00980460|561897001|FG004|Overall Study|Lost to Follow-up|0|||
155673857|NCT00980460|561896997|FG000|Overall Study|Physician Decision|0|||
155673858|NCT00980460|561896998|FG001|Overall Study|Physician Decision|0|||
155673859|NCT00980460|561896999|FG002|Overall Study|Physician Decision|11|||
155673860|NCT00980460|561897000|FG003|Overall Study|Physician Decision|5|||
155673861|NCT00980460|561897001|FG004|Overall Study|Physician Decision|3|||
155673862|NCT00980460|561896997|FG000|Overall Study|Withdrawal by Subject|0|||
155599280|NCT01340027|561619151|FG000|Overall Study|Adverse Event|0|||
155599281|NCT01340027|561619152|FG001|Overall Study|Adverse Event|1|||
155599282|NCT01340027|561619153|FG002|Overall Study|Adverse Event|2|||
155599283|NCT01340027|561619154|FG003|Overall Study|Adverse Event|0|||
155599284|NCT01340027|561619155|FG004|Overall Study|Adverse Event|1|||
155599285|NCT01340027|561619156|FG005|Overall Study|Adverse Event|2|||
155599286|NCT01340027|561619157|FG006|Overall Study|Adverse Event|2|||
155599287|NCT01340027|561619158|FG007|Overall Study|Adverse Event|1|||
155599288|NCT01340027|561619159|FG008|Overall Study|Adverse Event|4|||
155599289|NCT01340027|561619160|FG009|Overall Study|Adverse Event|1|||
155599290|NCT01340027|561619161|FG010|Overall Study|Adverse Event|1|||
155599291|NCT01340027|561619162|FG011|Overall Study|Adverse Event|3|||
155599292|NCT01340027|561619151|FG000|Overall Study|Lack of Efficacy|0|||
155599293|NCT01340027|561619152|FG001|Overall Study|Lack of Efficacy|0|||
155599294|NCT01340027|561619153|FG002|Overall Study|Lack of Efficacy|0|||
155599295|NCT01340027|561619154|FG003|Overall Study|Lack of Efficacy|0|||
155599296|NCT01340027|561619155|FG004|Overall Study|Lack of Efficacy|0|||
155599297|NCT01340027|561619156|FG005|Overall Study|Lack of Efficacy|0|||
155599298|NCT01340027|561619157|FG006|Overall Study|Lack of Efficacy|1|||
155599299|NCT01340027|561619158|FG007|Overall Study|Lack of Efficacy|1|||
155599300|NCT01340027|561619159|FG008|Overall Study|Lack of Efficacy|1|||
155599301|NCT01340027|561619160|FG009|Overall Study|Lack of Efficacy|0|||
155599302|NCT01340027|561619161|FG010|Overall Study|Lack of Efficacy|0|||
155599303|NCT01340027|561619162|FG011|Overall Study|Lack of Efficacy|0|||
155599304|NCT01340027|561619151|FG000|Overall Study|Lost to Follow-up|0|||
155599305|NCT01340027|561619152|FG001|Overall Study|Lost to Follow-up|1|||
155599306|NCT01340027|561619153|FG002|Overall Study|Lost to Follow-up|0|||
155599307|NCT01340027|561619154|FG003|Overall Study|Lost to Follow-up|0|||
155599308|NCT01340027|561619155|FG004|Overall Study|Lost to Follow-up|0|||
155599309|NCT01340027|561619156|FG005|Overall Study|Lost to Follow-up|0|||
155599310|NCT01340027|561619157|FG006|Overall Study|Lost to Follow-up|1|||
155599311|NCT01340027|561619158|FG007|Overall Study|Lost to Follow-up|0|||
155599312|NCT01340027|561619159|FG008|Overall Study|Lost to Follow-up|0|||
155599313|NCT01340027|561619160|FG009|Overall Study|Lost to Follow-up|1|||
155599314|NCT01340027|561619161|FG010|Overall Study|Lost to Follow-up|0|||
155599315|NCT01340027|561619162|FG011|Overall Study|Lost to Follow-up|0|||
155599316|NCT01340027|561619151|FG000|Overall Study|Protocol Violation|1|||
155599317|NCT01340027|561619152|FG001|Overall Study|Protocol Violation|2|||
155673863|NCT00980460|561896998|FG001|Overall Study|Withdrawal by Subject|0|||
155673864|NCT00980460|561896999|FG002|Overall Study|Withdrawal by Subject|1|||
155673865|NCT00980460|561897000|FG003|Overall Study|Withdrawal by Subject|0|||
155599318|NCT01340027|561619153|FG002|Overall Study|Protocol Violation|0|||
155599319|NCT01340027|561619154|FG003|Overall Study|Protocol Violation|0|||
155599320|NCT01340027|561619155|FG004|Overall Study|Protocol Violation|6|||
155673866|NCT00980460|561897001|FG004|Overall Study|Withdrawal by Subject|0|||
155673867|NCT00980460|561896997|FG000|Overall Study|Ineligible|0|||
155673868|NCT00980460|561896998|FG001|Overall Study|Ineligible|2|||
155673869|NCT00980460|561896999|FG002|Overall Study|Ineligible|3|||
155673870|NCT00980460|561897000|FG003|Overall Study|Ineligible|1|||
155673871|NCT00980460|561897001|FG004|Overall Study|Ineligible|4|||
155673872|NCT00980460|561896997|FG000|Overall Study|Refusal of further therapy|0|||
155673873|NCT00980460|561896998|FG001|Overall Study|Refusal of further therapy|2|||
155673874|NCT00980460|561896999|FG002|Overall Study|Refusal of further therapy|3|||
155673875|NCT00980460|561897000|FG003|Overall Study|Refusal of further therapy|2|||
155673876|NCT00980460|561897001|FG004|Overall Study|Refusal of further therapy|0|||
155673877|NCT00980460|561896997|FG000|Overall Study|No therapy within 42 days of resection|0|||
155673878|NCT00980460|561896998|FG001|Overall Study|No therapy within 42 days of resection|0|||
155673879|NCT00980460|561896999|FG002|Overall Study|No therapy within 42 days of resection|3|||
155673880|NCT00980460|561897000|FG003|Overall Study|No therapy within 42 days of resection|1|||
155673881|NCT00980460|561897001|FG004|Overall Study|No therapy within 42 days of resection|0|||
155673882|NCT00980460|561896997|FG000|Overall Study|No transplant by protocol timepoints|0|||
155673883|NCT00980460|561896998|FG001|Overall Study|No transplant by protocol timepoints|0|||
155673884|NCT00980460|561896999|FG002|Overall Study|No transplant by protocol timepoints|3|||
155673885|NCT00980460|561897000|FG003|Overall Study|No transplant by protocol timepoints|0|||
155673886|NCT00980460|561897001|FG004|Overall Study|No transplant by protocol timepoints|0|||
155673887|NCT05696444|561897002|FG000|Treatment|Physician Decision|0|||
155673888|NCT05696444|561897003|FG001|Treatment|Physician Decision|1|||
155673889|NCT05696444|561897004|FG002|Treatment|Physician Decision|0|||
155673890|NCT05696444|561897002|FG000|30 Days|Death|1|||
155673891|NCT05696444|561897003|FG001|30 Days|Death|1|||
155673892|NCT05696444|561897004|FG002|30 Days|Death|0|||
155673893|NCT05696444|561897002|FG000|30 Days|Missed Visit|1|||
155673894|NCT05696444|561897003|FG001|30 Days|Missed Visit|1|||
155673895|NCT05696444|561897004|FG002|30 Days|Missed Visit|1|||
155673896|NCT05200572|561897005|FG000|Overall Study|Withdrawal by Subject|14|||
155673897|NCT03744910|561898836|FG000|Overall Study|Withdrew Consent|1|||
155673898|NCT03744910|561898837|FG001|Overall Study|Withdrew Consent|8|||
155673899|NCT03744910|561898836|FG000|Overall Study|Physician Decision|5|||
155673900|NCT03744910|561898837|FG001|Overall Study|Physician Decision|4|||
155673901|NCT03744910|561898836|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
155673902|NCT03744910|561898837|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
155673903|NCT03744910|561898836|FG000|Overall Study|Lost to Follow-up|0|||
155673904|NCT03744910|561898837|FG001|Overall Study|Lost to Follow-up|1|||
155673905|NCT03744910|561898836|FG000|Overall Study|Other-unspecified|4|||
155673906|NCT03744910|561898837|FG001|Overall Study|Other-unspecified|1|||
155673907|NCT03280303|561898838|FG000|Overall Study|Death|505|||
155673908|NCT03280303|561898838|FG000|Overall Study|Study terminated by sponsor|383|||
155673909|NCT03280303|561898838|FG000|Overall Study|Other|148|||
155673910|NCT03280303|561898838|FG000|Overall Study|No longer willing to participate in study|101|||
155673911|NCT03280303|561898838|FG000|Overall Study|Lost to follow up|39|||
155673912|NCT03280303|561898838|FG000|Overall Study|Adverse Event|20|||
155673913|NCT00948857|561898839|FG000|Overall Study|Lost to Follow-up|1|||
155673914|NCT00948857|561898840|FG001|Overall Study|Lost to Follow-up|0|||
155599321|NCT01340027|561619156|FG005|Overall Study|Protocol Violation|0|||
155599322|NCT01340027|561619157|FG006|Overall Study|Protocol Violation|0|||
155599323|NCT01340027|561619158|FG007|Overall Study|Protocol Violation|1|||
155599324|NCT01340027|561619159|FG008|Overall Study|Protocol Violation|2|||
155599325|NCT01340027|561619160|FG009|Overall Study|Protocol Violation|2|||
155599326|NCT01340027|561619161|FG010|Overall Study|Protocol Violation|0|||
155599327|NCT01340027|561619162|FG011|Overall Study|Protocol Violation|0|||
155599328|NCT01340027|561619151|FG000|Overall Study|Withdrawal by Subject|4|||
155599329|NCT01340027|561619152|FG001|Overall Study|Withdrawal by Subject|3|||
155599330|NCT01340027|561619153|FG002|Overall Study|Withdrawal by Subject|1|||
155599331|NCT01340027|561619154|FG003|Overall Study|Withdrawal by Subject|3|||
155599332|NCT01340027|561619155|FG004|Overall Study|Withdrawal by Subject|3|||
155599333|NCT01340027|561619156|FG005|Overall Study|Withdrawal by Subject|2|||
155599334|NCT01340027|561619157|FG006|Overall Study|Withdrawal by Subject|3|||
155599335|NCT01340027|561619158|FG007|Overall Study|Withdrawal by Subject|4|||
155599336|NCT01340027|561619159|FG008|Overall Study|Withdrawal by Subject|1|||
155599337|NCT01340027|561619160|FG009|Overall Study|Withdrawal by Subject|2|||
155599338|NCT01340027|561619161|FG010|Overall Study|Withdrawal by Subject|0|||
155599339|NCT01340027|561619162|FG011|Overall Study|Withdrawal by Subject|1|||
155599340|NCT01340027|561619151|FG000|Overall Study|Miscellaneous|0|||
155599341|NCT01340027|561619152|FG001|Overall Study|Miscellaneous|0|||
155599342|NCT01340027|561619153|FG002|Overall Study|Miscellaneous|0|||
155599343|NCT01340027|561619154|FG003|Overall Study|Miscellaneous|1|||
155599344|NCT01340027|561619155|FG004|Overall Study|Miscellaneous|0|||
155599345|NCT01340027|561619156|FG005|Overall Study|Miscellaneous|0|||
155599346|NCT01340027|561619157|FG006|Overall Study|Miscellaneous|0|||
155599347|NCT01340027|561619158|FG007|Overall Study|Miscellaneous|0|||
155599348|NCT01340027|561619159|FG008|Overall Study|Miscellaneous|0|||
155599349|NCT01340027|561619160|FG009|Overall Study|Miscellaneous|0|||
155599350|NCT01340027|561619161|FG010|Overall Study|Miscellaneous|1|||
155599351|NCT01340027|561619162|FG011|Overall Study|Miscellaneous|0|||
155599352|NCT00833482|561619163|FG000|Days 11-20|Adverse Event|0|||
155599353|NCT00833482|561619164|FG001|Days 11-20|Adverse Event|2|||
155599354|NCT00833482|561619165|FG002|Days 11-20|Adverse Event|0|||
155599355|NCT00833482|561619166|FG003|Days 11-20|Adverse Event|0|||
155599356|NCT00833482|561619167|FG004|Days 11-20|Adverse Event|0|||
155599357|NCT00833482|561619168|FG005|Days 11-20|Adverse Event|0|||
155599358|NCT00833482|561619163|FG000|Days 11-20|Withdrawal by Subject|0|||
155599359|NCT00833482|561619164|FG001|Days 11-20|Withdrawal by Subject|1|||
155599360|NCT00833482|561619165|FG002|Days 11-20|Withdrawal by Subject|0|||
155599361|NCT00833482|561619166|FG003|Days 11-20|Withdrawal by Subject|0|||
155599362|NCT00833482|561619167|FG004|Days 11-20|Withdrawal by Subject|0|||
155599363|NCT00833482|561619168|FG005|Days 11-20|Withdrawal by Subject|0|||
155599364|NCT00833482|561619163|FG000|Days 21-30|Adverse Event|0|||
155599365|NCT00833482|561619164|FG001|Days 21-30|Adverse Event|0|||
155599366|NCT00833482|561619165|FG002|Days 21-30|Adverse Event|1|||
155599367|NCT00833482|561619166|FG003|Days 21-30|Adverse Event|0|||
155599368|NCT00833482|561619167|FG004|Days 21-30|Adverse Event|0|||
155599369|NCT00833482|561619168|FG005|Days 21-30|Adverse Event|0|||
155599370|NCT00833482|561619163|FG000|Days 21-30|Withdrawal by Subject|0|||
155599371|NCT00833482|561619164|FG001|Days 21-30|Withdrawal by Subject|0|||
155599372|NCT00833482|561619165|FG002|Days 21-30|Withdrawal by Subject|0|||
155599373|NCT00833482|561619166|FG003|Days 21-30|Withdrawal by Subject|0|||
155599374|NCT00833482|561619167|FG004|Days 21-30|Withdrawal by Subject|1|||
155599375|NCT00833482|561619168|FG005|Days 21-30|Withdrawal by Subject|0|||
155599376|NCT02496091|561619169|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155599377|NCT02234596|561619173|FG000|Overall Study|Participant not treated|2|||
155599378|NCT02759055|561620453|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
155599379|NCT02759055|561620454|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
155599380|NCT02515994|561620455|FG000|Overall Study|Protocol Violation|3|||
155599381|NCT02515994|561620456|FG001|Overall Study|Protocol Violation|5|||
155599382|NCT02515994|561620455|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
155599383|NCT02515994|561620456|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
155599384|NCT02515994|561620455|FG000|Overall Study|Adverse Event|3|||
155599385|NCT02515994|561620456|FG001|Overall Study|Adverse Event|1|||
155599386|NCT02515994|561620455|FG000|Overall Study|Withdrawal by Subject|2|||
155599387|NCT02515994|561620456|FG001|Overall Study|Withdrawal by Subject|0|||
155599388|NCT04045132|561620459|FG000|Overall Study|Lost to Follow-up|3|||
155599389|NCT04045132|561620460|FG001|Overall Study|Lost to Follow-up|6|||
155599390|NCT04598451|561620461|FG000|Overall Study|Adverse Event|3|||
155599391|NCT04598451|561620462|FG001|Overall Study|Adverse Event|2|||
155599392|NCT04598451|561620461|FG000|Overall Study|Withdrawal by Subject|3|||
155599393|NCT04598451|561620462|FG001|Overall Study|Withdrawal by Subject|7|||
155599394|NCT04598451|561620461|FG000|Overall Study|Lost to Follow-up|2|||
155599395|NCT04598451|561620462|FG001|Overall Study|Lost to Follow-up|0|||
155599396|NCT04598451|561620461|FG000|Overall Study|Physician Decision|4|||
155599397|NCT04598451|561620462|FG001|Overall Study|Physician Decision|1|||
155599398|NCT04598451|561620461|FG000|Overall Study|Requires Prohibited Medication|1|||
155599399|NCT04598451|561620462|FG001|Overall Study|Requires Prohibited Medication|0|||
155599400|NCT04598451|561620461|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
155599401|NCT04598451|561620462|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
155599402|NCT01632150|561620465|FG000|Overall Study|Disease progression|27|||
155599403|NCT01632150|561620465|FG000|Overall Study|Study drug toxicity|1|||
155599404|NCT01632150|561620465|FG000|Overall Study|Unrelated adverse event|7|||
155599405|NCT01632150|561620465|FG000|Overall Study|Withdrawal by Subject|2|||
155599406|NCT01632150|561620465|FG000|Overall Study|Patient underwent autologous transplant|1|||
155599407|NCT01632150|561620465|FG000|Overall Study|Moved to compassionate program|2|||
155599408|NCT01473394|561620468|FG000|Overall Study|Adverse Event|13|||
155599409|NCT01473394|561620469|FG001|Overall Study|Adverse Event|16|||
155599410|NCT01473394|561620468|FG000|Overall Study|Insufficient Therapeutic Response|4|||
155599411|NCT01473394|561620469|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155599412|NCT01473394|561620468|FG000|Overall Study|Protocol Violation|7|||
155599413|NCT01473394|561620469|FG001|Overall Study|Protocol Violation|5|||
155599414|NCT01473394|561620468|FG000|Overall Study|Withdrew Consent|12|||
155599415|NCT01473394|561620469|FG001|Overall Study|Withdrew Consent|10|||
155599416|NCT01473394|561620468|FG000|Overall Study|Lost to Follow-up|9|||
155599417|NCT01473394|561620469|FG001|Overall Study|Lost to Follow-up|11|||
155599418|NCT03391232|561620470|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
155599419|NCT03391232|561620471|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
155599420|NCT03391232|561620470|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
155673915|NCT03430843|561898841|FG000|Overall Study|Death|233|||
155673916|NCT03430843|561898842|FG001|Overall Study|Death|233|||
155673917|NCT03430843|561898841|FG000|Overall Study|Sponsor Decision|17|||
155673918|NCT03430843|561898842|FG001|Overall Study|Sponsor Decision|6|||
155673919|NCT03430843|561898841|FG000|Overall Study|Withdrawal by Subject|5|||
155673920|NCT03430843|561898842|FG001|Overall Study|Withdrawal by Subject|14|||
155673921|NCT03430843|561898841|FG000|Overall Study|Lost to Follow-up|1|||
155673922|NCT03430843|561898842|FG001|Overall Study|Lost to Follow-up|3|||
155673923|NCT05360966|561898847|FG000|Overall Study|Adverse Event|5|||
155673924|NCT05360966|561898848|FG001|Overall Study|Adverse Event|5|||
155673925|NCT05360966|561898847|FG000|Overall Study|Withdrawal of Consent|5|||
155673926|NCT05360966|561898848|FG001|Overall Study|Withdrawal of Consent|3|||
155673927|NCT05360966|561898847|FG000|Overall Study|Noncompliance|2|||
155673928|NCT05360966|561898848|FG001|Overall Study|Noncompliance|1|||
155673929|NCT05360966|561898847|FG000|Overall Study|Lost to Follow-up|2|||
155673930|NCT05360966|561898848|FG001|Overall Study|Lost to Follow-up|3|||
155673931|NCT05360966|561898847|FG000|Overall Study|Protocol Deviation|2|||
155673932|NCT05360966|561898848|FG001|Overall Study|Protocol Deviation|1|||
155673933|NCT05360966|561898847|FG000|Overall Study|As specified in the Clinical Study Report|1|||
155673934|NCT05360966|561898848|FG001|Overall Study|As specified in the Clinical Study Report|3|||
155673935|NCT05396014|561898849|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
155673936|NCT05396014|561898850|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673937|NCT05396014|561898851|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673938|NCT05396014|561898852|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673939|NCT05396014|561898853|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673940|NCT05396014|561898854|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673941|NCT05396014|561898855|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673942|NCT05396014|561898856|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673943|NCT05396014|561898857|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673944|NCT05396014|561898858|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673945|NCT05396014|561898859|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673946|NCT05396014|561898860|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673947|NCT05396014|561898861|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673948|NCT05396014|561898862|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
155673949|NCT05396014|561898863|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673950|NCT05396014|561898864|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673951|NCT05396014|561898865|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673952|NCT05396014|561898866|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673953|NCT05396014|561898867|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673954|NCT05396014|561898868|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673955|NCT05396014|561898869|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673956|NCT05396014|561898870|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673957|NCT05396014|561898871|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673958|NCT05396014|561898872|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673959|NCT05396014|561898873|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673960|NCT05396014|561898874|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673961|NCT05396014|561898875|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
155673962|NCT05396014|561898876|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673963|NCT05396014|561898877|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673964|NCT05396014|561898878|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673965|NCT05396014|561898879|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673966|NCT05396014|561898880|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673967|NCT05396014|561898881|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673968|NCT05396014|561898882|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673969|NCT05396014|561898883|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673970|NCT05396014|561898884|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673971|NCT05396014|561898885|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673972|NCT05396014|561898886|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673973|NCT05396014|561898887|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673974|NCT05396014|561898888|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
155673975|NCT05396014|561898889|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673976|NCT05396014|561898890|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673977|NCT05396014|561898891|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155673978|NCT05396014|561898849|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
155673979|NCT05396014|561898850|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673980|NCT05396014|561898851|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673981|NCT05396014|561898852|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673982|NCT05396014|561898853|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673983|NCT05396014|561898854|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673984|NCT05396014|561898855|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673985|NCT05396014|561898856|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673986|NCT05396014|561898857|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673987|NCT05396014|561898858|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673988|NCT05396014|561898859|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673989|NCT05396014|561898860|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673990|NCT05396014|561898861|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673991|NCT05396014|561898862|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
155673992|NCT05396014|561898863|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673993|NCT05396014|561898864|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673994|NCT05396014|561898865|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673995|NCT05396014|561898866|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673996|NCT05396014|561898867|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673997|NCT05396014|561898868|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673998|NCT05396014|561898869|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155673999|NCT05396014|561898870|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674000|NCT05396014|561898871|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674001|NCT05396014|561898872|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674002|NCT05396014|561898873|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674003|NCT05396014|561898874|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674004|NCT05396014|561898875|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
155674005|NCT05396014|561898876|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674006|NCT05396014|561898877|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674007|NCT05396014|561898878|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674008|NCT05396014|561898879|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674009|NCT05396014|561898880|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674010|NCT05396014|561898881|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674011|NCT05396014|561898882|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674012|NCT05396014|561898883|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674013|NCT05396014|561898884|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674014|NCT05396014|561898885|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674015|NCT05396014|561898886|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674016|NCT05396014|561898887|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674017|NCT05396014|561898888|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
155674018|NCT05396014|561898889|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674019|NCT05396014|561898890|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674020|NCT05396014|561898891|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155674021|NCT05396014|561898849|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155674022|NCT05396014|561898850|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674023|NCT05396014|561898851|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674024|NCT05396014|561898852|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674025|NCT05396014|561898853|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674026|NCT05396014|561898854|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674027|NCT05396014|561898855|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674028|NCT05396014|561898856|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674029|NCT05396014|561898857|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674030|NCT05396014|561898858|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674031|NCT05396014|561898859|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674032|NCT05396014|561898860|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674033|NCT05396014|561898861|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674034|NCT05396014|561898862|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155674035|NCT05396014|561898863|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674036|NCT05396014|561898864|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674037|NCT05396014|561898865|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674038|NCT05396014|561898866|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674039|NCT05396014|561898867|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674040|NCT05396014|561898868|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674041|NCT05396014|561898869|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674042|NCT05396014|561898870|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674043|NCT05396014|561898871|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674044|NCT05396014|561898872|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674045|NCT05396014|561898873|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674046|NCT05396014|561898874|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674047|NCT05396014|561898875|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155674048|NCT05396014|561898876|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674049|NCT05396014|561898877|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674050|NCT05396014|561898878|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674051|NCT05396014|561898879|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674052|NCT05396014|561898880|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674053|NCT05396014|561898881|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674054|NCT05396014|561898882|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674055|NCT05396014|561898883|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674056|NCT05396014|561898884|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674057|NCT05396014|561898885|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674058|NCT05396014|561898886|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674059|NCT05396014|561898887|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674060|NCT05396014|561898888|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
155674061|NCT05396014|561898889|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674062|NCT05396014|561898890|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674063|NCT05396014|561898891|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155674064|NCT05396014|561898849|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674065|NCT05396014|561898850|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674066|NCT05396014|561898851|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674067|NCT05396014|561898852|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674068|NCT05396014|561898853|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674069|NCT05396014|561898854|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674070|NCT05396014|561898855|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674071|NCT05396014|561898856|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674072|NCT05396014|561898857|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674073|NCT05396014|561898858|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674074|NCT05396014|561898859|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674075|NCT05396014|561898860|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674076|NCT05396014|561898861|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674077|NCT05396014|561898862|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674078|NCT05396014|561898863|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674079|NCT05396014|561898864|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674080|NCT05396014|561898865|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674081|NCT05396014|561898866|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674082|NCT05396014|561898867|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674083|NCT05396014|561898868|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674084|NCT05396014|561898869|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674085|NCT05396014|561898870|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674086|NCT05396014|561898871|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674087|NCT05396014|561898872|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674088|NCT05396014|561898873|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674089|NCT05396014|561898874|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674090|NCT05396014|561898875|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
155674091|NCT05396014|561898876|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674092|NCT05396014|561898877|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674093|NCT05396014|561898878|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674094|NCT05396014|561898879|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674095|NCT05396014|561898880|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674096|NCT05396014|561898881|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674097|NCT05396014|561898882|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674098|NCT05396014|561898883|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674099|NCT05396014|561898884|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674100|NCT05396014|561898885|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674101|NCT05396014|561898886|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674102|NCT05396014|561898887|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674103|NCT05396014|561898888|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
155674104|NCT05396014|561898889|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674105|NCT05396014|561898890|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674106|NCT05396014|561898891|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155674107|NCT05396014|561898849|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674108|NCT05396014|561898850|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674109|NCT05396014|561898851|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674110|NCT05396014|561898852|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674111|NCT05396014|561898853|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674112|NCT05396014|561898854|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674113|NCT05396014|561898855|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674114|NCT05396014|561898856|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674115|NCT05396014|561898857|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674116|NCT05396014|561898858|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674117|NCT05396014|561898859|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674118|NCT05396014|561898860|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674119|NCT05396014|561898861|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674120|NCT05396014|561898862|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674121|NCT05396014|561898863|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674122|NCT05396014|561898864|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674123|NCT05396014|561898865|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674124|NCT05396014|561898866|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674125|NCT05396014|561898867|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674126|NCT05396014|561898868|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674127|NCT05396014|561898869|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674128|NCT05396014|561898870|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674129|NCT05396014|561898871|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674130|NCT05396014|561898872|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674131|NCT05396014|561898873|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674132|NCT05396014|561898874|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674133|NCT05396014|561898875|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
155674134|NCT05396014|561898876|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674135|NCT05396014|561898877|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674136|NCT05396014|561898878|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674137|NCT05396014|561898879|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674138|NCT05396014|561898880|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674139|NCT05396014|561898881|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674140|NCT05396014|561898882|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674141|NCT05396014|561898883|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674142|NCT05396014|561898884|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674143|NCT05396014|561898885|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674144|NCT05396014|561898886|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674145|NCT05396014|561898887|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674146|NCT05396014|561898888|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674147|NCT05396014|561898889|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674148|NCT05396014|561898890|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674149|NCT05396014|561898891|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155674150|NCT05396014|561898849|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674151|NCT05396014|561898850|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674152|NCT05396014|561898851|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674153|NCT05396014|561898852|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674154|NCT05396014|561898853|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674155|NCT05396014|561898854|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674156|NCT05396014|561898855|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674157|NCT05396014|561898856|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674158|NCT05396014|561898857|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674159|NCT05396014|561898858|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674160|NCT05396014|561898859|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674161|NCT05396014|561898860|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674162|NCT05396014|561898861|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674163|NCT05396014|561898862|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
155674164|NCT05396014|561898863|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674165|NCT05396014|561898864|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674166|NCT05396014|561898865|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674167|NCT05396014|561898866|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674168|NCT05396014|561898867|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674169|NCT05396014|561898868|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674170|NCT05396014|561898869|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674171|NCT05396014|561898870|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674172|NCT05396014|561898871|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674173|NCT05396014|561898872|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674174|NCT05396014|561898873|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674175|NCT05396014|561898874|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674176|NCT05396014|561898875|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674177|NCT05396014|561898876|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674178|NCT05396014|561898877|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674179|NCT05396014|561898878|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674180|NCT05396014|561898879|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674181|NCT05396014|561898880|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674182|NCT05396014|561898881|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674183|NCT05396014|561898882|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674184|NCT05396014|561898883|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674185|NCT05396014|561898884|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674186|NCT05396014|561898885|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674187|NCT05396014|561898886|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674188|NCT05396014|561898887|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674189|NCT05396014|561898888|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674190|NCT05396014|561898889|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674191|NCT05396014|561898890|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674192|NCT05396014|561898891|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155674193|NCT05396014|561898849|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
155674194|NCT05396014|561898850|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674195|NCT05396014|561898851|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674196|NCT05396014|561898852|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674197|NCT05396014|561898853|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674198|NCT05396014|561898854|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674199|NCT05396014|561898855|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674200|NCT05396014|561898856|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674201|NCT05396014|561898857|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674202|NCT05396014|561898858|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674203|NCT05396014|561898859|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674204|NCT05396014|561898860|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674205|NCT05396014|561898861|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674206|NCT05396014|561898862|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
155674207|NCT05396014|561898863|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674208|NCT05396014|561898864|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674209|NCT05396014|561898865|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674210|NCT05396014|561898866|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674211|NCT05396014|561898867|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674212|NCT05396014|561898868|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674213|NCT05396014|561898869|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674214|NCT05396014|561898870|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674215|NCT05396014|561898871|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674216|NCT05396014|561898872|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674217|NCT05396014|561898873|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674218|NCT05396014|561898874|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674219|NCT05396014|561898875|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674220|NCT05396014|561898876|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674221|NCT05396014|561898877|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674222|NCT05396014|561898878|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674223|NCT05396014|561898879|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674224|NCT05396014|561898880|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674225|NCT05396014|561898881|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674226|NCT05396014|561898882|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674227|NCT05396014|561898883|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674228|NCT05396014|561898884|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674229|NCT05396014|561898885|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674230|NCT05396014|561898886|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674231|NCT05396014|561898887|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674232|NCT05396014|561898888|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
155674233|NCT05396014|561898889|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674234|NCT05396014|561898890|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674235|NCT05396014|561898891|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155674236|NCT05396014|561898849|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
155674237|NCT05396014|561898850|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674238|NCT05396014|561898851|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674239|NCT05396014|561898852|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674240|NCT05396014|561898853|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674241|NCT05396014|561898854|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674242|NCT05396014|561898855|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674243|NCT05396014|561898856|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674244|NCT05396014|561898857|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674245|NCT05396014|561898858|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674246|NCT05396014|561898859|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674247|NCT05396014|561898860|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674248|NCT05396014|561898861|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674249|NCT05396014|561898862|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674250|NCT05396014|561898863|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674251|NCT05396014|561898864|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674252|NCT05396014|561898865|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674253|NCT05396014|561898866|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674254|NCT05396014|561898867|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674255|NCT05396014|561898868|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674256|NCT05396014|561898869|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674257|NCT05396014|561898870|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674258|NCT05396014|561898871|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674259|NCT05396014|561898872|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674260|NCT05396014|561898873|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674261|NCT05396014|561898874|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674262|NCT05396014|561898875|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
155674263|NCT05396014|561898876|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674264|NCT05396014|561898877|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674265|NCT05396014|561898878|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674266|NCT05396014|561898879|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674267|NCT05396014|561898880|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674268|NCT05396014|561898881|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674269|NCT05396014|561898882|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674270|NCT05396014|561898883|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674271|NCT05396014|561898884|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674272|NCT05396014|561898885|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674273|NCT05396014|561898886|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674274|NCT05396014|561898887|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674275|NCT05396014|561898888|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674276|NCT05396014|561898889|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674277|NCT05396014|561898890|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674278|NCT05396014|561898891|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155674279|NCT05396014|561898849|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674280|NCT05396014|561898850|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674281|NCT05396014|561898851|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674282|NCT05396014|561898852|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674283|NCT05396014|561898853|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674284|NCT05396014|561898854|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674285|NCT05396014|561898855|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674286|NCT05396014|561898856|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674287|NCT05396014|561898857|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674288|NCT05396014|561898858|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674289|NCT05396014|561898859|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674290|NCT05396014|561898860|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674291|NCT05396014|561898861|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674292|NCT05396014|561898862|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
155674293|NCT05396014|561898863|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674294|NCT05396014|561898864|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674295|NCT05396014|561898865|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674296|NCT05396014|561898866|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674297|NCT05396014|561898867|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674298|NCT05396014|561898868|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674299|NCT05396014|561898869|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674300|NCT05396014|561898870|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674301|NCT05396014|561898871|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674302|NCT05396014|561898872|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674303|NCT05396014|561898873|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674304|NCT05396014|561898874|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674305|NCT05396014|561898875|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674306|NCT05396014|561898876|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674307|NCT05396014|561898877|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674308|NCT05396014|561898878|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674309|NCT05396014|561898879|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674310|NCT05396014|561898880|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674311|NCT05396014|561898881|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674312|NCT05396014|561898882|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674313|NCT05396014|561898883|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674314|NCT05396014|561898884|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674315|NCT05396014|561898885|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674316|NCT05396014|561898886|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674317|NCT05396014|561898887|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674318|NCT05396014|561898888|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674319|NCT05396014|561898889|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674320|NCT05396014|561898890|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674321|NCT05396014|561898891|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155674322|NCT05396014|561898849|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674323|NCT05396014|561898850|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674324|NCT05396014|561898851|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674325|NCT05396014|561898852|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155674326|NCT05396014|561898853|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674327|NCT05396014|561898854|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674328|NCT05396014|561898855|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674329|NCT05396014|561898856|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674330|NCT05396014|561898857|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155674331|NCT05396014|561898858|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674332|NCT05396014|561898859|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674333|NCT05396014|561898860|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674334|NCT05396014|561898861|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674335|NCT05396014|561898862|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674336|NCT05396014|561898863|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674337|NCT05396014|561898864|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674338|NCT05396014|561898865|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674339|NCT05396014|561898866|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674340|NCT05396014|561898867|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674341|NCT05396014|561898868|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674342|NCT05396014|561898869|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674343|NCT05396014|561898870|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674344|NCT05396014|561898871|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674345|NCT05396014|561898872|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674346|NCT05396014|561898873|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674347|NCT05396014|561898874|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155674348|NCT05396014|561898875|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674349|NCT05396014|561898876|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674350|NCT05396014|561898877|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674351|NCT05396014|561898878|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674352|NCT05396014|561898879|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674353|NCT05396014|561898880|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674354|NCT05396014|561898881|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674355|NCT05396014|561898882|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674356|NCT05396014|561898883|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674357|NCT05396014|561898884|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674358|NCT05396014|561898885|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674359|NCT05396014|561898886|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674360|NCT05396014|561898887|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674361|NCT05396014|561898888|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155674362|NCT05396014|561898889|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
155674363|NCT05396014|561898890|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155674364|NCT05396014|561898891|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155674365|NCT05396014|561898849|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674366|NCT05396014|561898850|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674367|NCT05396014|561898851|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674368|NCT05396014|561898852|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674369|NCT05396014|561898853|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674370|NCT05396014|561898854|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674371|NCT05396014|561898855|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674372|NCT05396014|561898856|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674373|NCT05396014|561898857|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155674374|NCT05396014|561898858|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674375|NCT05396014|561898859|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674376|NCT05396014|561898860|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674377|NCT05396014|561898861|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674378|NCT05396014|561898862|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674379|NCT05396014|561898863|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674380|NCT05396014|561898864|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674381|NCT05396014|561898865|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674382|NCT05396014|561898866|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674383|NCT05396014|561898867|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674384|NCT05396014|561898868|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674385|NCT05396014|561898869|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674386|NCT05396014|561898870|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674387|NCT05396014|561898871|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155674388|NCT05396014|561898872|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674389|NCT05396014|561898873|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674390|NCT05396014|561898874|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674391|NCT05396014|561898875|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674392|NCT05396014|561898876|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674393|NCT05396014|561898877|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674394|NCT05396014|561898878|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674395|NCT05396014|561898879|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674396|NCT05396014|561898880|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674397|NCT05396014|561898881|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674398|NCT05396014|561898882|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674399|NCT05396014|561898883|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674400|NCT05396014|561898884|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155674401|NCT05396014|561898885|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674402|NCT05396014|561898886|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674403|NCT05396014|561898887|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674404|NCT05396014|561898888|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155674405|NCT05396014|561898889|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674406|NCT05396014|561898890|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
155674407|NCT05396014|561898891|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155674408|NCT05396014|561898849|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674409|NCT05396014|561898850|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674410|NCT05396014|561898851|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674411|NCT05396014|561898852|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674412|NCT05396014|561898853|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674413|NCT05396014|561898854|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674414|NCT05396014|561898855|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674415|NCT05396014|561898856|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674416|NCT05396014|561898857|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674417|NCT05396014|561898858|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674418|NCT05396014|561898859|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674419|NCT05396014|561898860|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674420|NCT05396014|561898861|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674421|NCT05396014|561898862|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155674422|NCT05396014|561898863|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674423|NCT05396014|561898864|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674424|NCT05396014|561898865|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674425|NCT05396014|561898866|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674426|NCT05396014|561898867|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674427|NCT05396014|561898868|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674428|NCT05396014|561898869|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674429|NCT05396014|561898870|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674430|NCT05396014|561898871|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674431|NCT05396014|561898872|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674432|NCT05396014|561898873|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674433|NCT05396014|561898874|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674434|NCT05396014|561898875|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155674435|NCT05396014|561898876|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674436|NCT05396014|561898877|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674437|NCT05396014|561898878|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674438|NCT05396014|561898879|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674439|NCT05396014|561898880|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674440|NCT05396014|561898881|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674441|NCT05396014|561898882|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674442|NCT05396014|561898883|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155674443|NCT05396014|561898884|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674444|NCT05396014|561898885|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674445|NCT05396014|561898886|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674446|NCT05396014|561898887|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674447|NCT05396014|561898888|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674448|NCT05396014|561898889|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674449|NCT05396014|561898890|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155674450|NCT05396014|561898891|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155674451|NCT05396014|561898849|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674452|NCT05396014|561898850|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674453|NCT05396014|561898851|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674454|NCT05396014|561898852|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674455|NCT05396014|561898853|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674456|NCT05396014|561898854|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674457|NCT05396014|561898855|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674458|NCT05396014|561898856|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674459|NCT05396014|561898857|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674460|NCT05396014|561898858|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674461|NCT05396014|561898859|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674462|NCT05396014|561898860|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674463|NCT05396014|561898861|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674464|NCT05396014|561898862|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674465|NCT05396014|561898863|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674466|NCT05396014|561898864|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674467|NCT05396014|561898865|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674468|NCT05396014|561898866|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674469|NCT05396014|561898867|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674470|NCT05396014|561898868|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674471|NCT05396014|561898869|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674472|NCT05396014|561898870|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674473|NCT05396014|561898871|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674474|NCT05396014|561898872|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674475|NCT05396014|561898873|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674476|NCT05396014|561898874|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674477|NCT05396014|561898875|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
155674478|NCT05396014|561898876|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674479|NCT05396014|561898877|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674480|NCT05396014|561898878|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674481|NCT05396014|561898879|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674482|NCT05396014|561898880|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674483|NCT05396014|561898881|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674484|NCT05396014|561898882|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674485|NCT05396014|561898883|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674486|NCT05396014|561898884|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674487|NCT05396014|561898885|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674488|NCT05396014|561898886|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674489|NCT05396014|561898887|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674490|NCT05396014|561898888|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674491|NCT05396014|561898889|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674492|NCT05396014|561898890|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674493|NCT05396014|561898891|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155674494|NCT04439539|561898892|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
155674495|NCT04439539|561898893|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
155674496|NCT04439539|561898894|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
155674497|NCT04439539|561898892|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
155674498|NCT04439539|561898893|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
155674499|NCT04439539|561898894|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
155674500|NCT04439539|561898892|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
155674501|NCT04439539|561898893|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
155674502|NCT04439539|561898894|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
155674503|NCT05258890|561898896|FG000|Overall Study|Patient withdrawal|6|||
155674504|NCT05258890|561898897|FG001|Overall Study|Patient withdrawal|7|||
155674505|NCT05258890|561898896|FG000|Overall Study|Patient lost to follow-up|10|||
155674506|NCT05258890|561898897|FG001|Overall Study|Patient lost to follow-up|3|||
155674507|NCT05258890|561898896|FG000|Overall Study|Social network member withdrawal|1|||
155674508|NCT05258890|561898897|FG001|Overall Study|Social network member withdrawal|0|||
155674509|NCT05258890|561898896|FG000|Overall Study|Social network member lost to follow-up|5|||
155674510|NCT05258890|561898897|FG001|Overall Study|Social network member lost to follow-up|0|||
155674511|NCT05959447|561898904|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
155674512|NCT05959447|561898905|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
155674513|NCT05959447|561898904|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
155674514|NCT05959447|561898905|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
155674515|NCT05959447|561898904|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
155674516|NCT05959447|561898905|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
155674517|NCT05959447|561898904|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
155674518|NCT05959447|561898905|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
155674519|NCT02013778|561898913|FG000|Overall Study|Death|4|||
155674520|NCT02013778|561898913|FG000|Overall Study|Withdrawal by Subject|1|||
155674521|NCT02013778|561898913|FG000|Overall Study|Physician Decision|1|||
155674522|NCT02013778|561898913|FG000|Overall Study|Adverse Event|1|||
155674523|NCT00861757|561898914|FG000|Overall Study|Adverse Event|1|||
155674524|NCT00861757|561898915|FG001|Overall Study|Adverse Event|5|||
155674525|NCT00861757|561898916|FG002|Overall Study|Adverse Event|7|||
155674526|NCT00861757|561898917|FG003|Overall Study|Adverse Event|2|||
155674527|NCT00861757|561898914|FG000|Overall Study|Entry Criteria Not Met|1|||
155674528|NCT00861757|561898915|FG001|Overall Study|Entry Criteria Not Met|2|||
155674529|NCT00861757|561898916|FG002|Overall Study|Entry Criteria Not Met|1|||
155674530|NCT00861757|561898917|FG003|Overall Study|Entry Criteria Not Met|1|||
155674531|NCT00861757|561898914|FG000|Overall Study|Lack of Efficacy|3|||
155674532|NCT00861757|561898915|FG001|Overall Study|Lack of Efficacy|1|||
155674533|NCT00861757|561898916|FG002|Overall Study|Lack of Efficacy|0|||
155674534|NCT00861757|561898917|FG003|Overall Study|Lack of Efficacy|1|||
155674535|NCT00861757|561898914|FG000|Overall Study|Lost to Follow-up|1|||
155674536|NCT00861757|561898915|FG001|Overall Study|Lost to Follow-up|0|||
155674537|NCT00861757|561898916|FG002|Overall Study|Lost to Follow-up|1|||
155674538|NCT00861757|561898917|FG003|Overall Study|Lost to Follow-up|1|||
155674539|NCT00861757|561898914|FG000|Overall Study|Physician Decision|0|||
155674540|NCT00861757|561898915|FG001|Overall Study|Physician Decision|0|||
155674541|NCT00861757|561898916|FG002|Overall Study|Physician Decision|0|||
155674542|NCT00861757|561898917|FG003|Overall Study|Physician Decision|1|||
155674543|NCT00861757|561898914|FG000|Overall Study|Protocol Violation|2|||
155674544|NCT00861757|561898915|FG001|Overall Study|Protocol Violation|2|||
155674545|NCT00861757|561898916|FG002|Overall Study|Protocol Violation|4|||
155674546|NCT00861757|561898917|FG003|Overall Study|Protocol Violation|1|||
155674547|NCT00861757|561898914|FG000|Overall Study|Withdrawal by Subject|1|||
155674548|NCT00861757|561898915|FG001|Overall Study|Withdrawal by Subject|5|||
155674549|NCT00861757|561898916|FG002|Overall Study|Withdrawal by Subject|5|||
155674550|NCT00861757|561898917|FG003|Overall Study|Withdrawal by Subject|2|||
155674551|NCT00391053|561898926|FG000|Overall Study|Serious Adverse Events|1|||
155674552|NCT00391053|561898927|FG001|Overall Study|Serious Adverse Events|0|||
155674553|NCT00391053|561898928|FG002|Overall Study|Serious Adverse Events|1|||
155674554|NCT00391053|561898929|FG003|Overall Study|Serious Adverse Events|4|||
155674555|NCT00391053|561898926|FG000|Overall Study|Protocol Violation|2|||
155674556|NCT00391053|561898927|FG001|Overall Study|Protocol Violation|0|||
155674557|NCT00391053|561898928|FG002|Overall Study|Protocol Violation|0|||
155674558|NCT00391053|561898929|FG003|Overall Study|Protocol Violation|0|||
155674559|NCT00391053|561898926|FG000|Overall Study|Lost to Follow-up|1|||
155674560|NCT00391053|561898927|FG001|Overall Study|Lost to Follow-up|0|||
155674561|NCT00391053|561898928|FG002|Overall Study|Lost to Follow-up|0|||
155674562|NCT00391053|561898929|FG003|Overall Study|Lost to Follow-up|5|||
155674563|NCT00391053|561898926|FG000|Overall Study|Withdrawal by Subject|5|||
155674564|NCT00391053|561898927|FG001|Overall Study|Withdrawal by Subject|1|||
155674565|NCT00391053|561898928|FG002|Overall Study|Withdrawal by Subject|1|||
155674566|NCT00391053|561898929|FG003|Overall Study|Withdrawal by Subject|1|||
155674567|NCT02140970|561898930|FG000|Overall Study|Lost to Follow-up|1|||
155674568|NCT02140970|561898931|FG001|Overall Study|Lost to Follow-up|2|||
155674569|NCT02140970|561898930|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
155674570|NCT02140970|561898931|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
155674571|NCT02140970|561898930|FG000|Overall Study|Did not meet inclusion criteria|0|||
155674572|NCT02140970|561898931|FG001|Overall Study|Did not meet inclusion criteria|1|||
155674573|NCT00603941|561898935|FG000|Overall Study|Disease progression|6|||
155674574|NCT00603941|561898936|FG001|Overall Study|Disease progression|7|||
155674575|NCT00603941|561898937|FG002|Overall Study|Disease progression|1|||
155674576|NCT00603941|561898935|FG000|Overall Study|Adverse Event|1|||
155674577|NCT00603941|561898936|FG001|Overall Study|Adverse Event|0|||
155674578|NCT00603941|561898937|FG002|Overall Study|Adverse Event|1|||
155674579|NCT00603941|561898935|FG000|Overall Study|Physician Decision|0|||
155674580|NCT00603941|561898936|FG001|Overall Study|Physician Decision|1|||
155674581|NCT00603941|561898937|FG002|Overall Study|Physician Decision|0|||
155674582|NCT00603941|561898935|FG000|Overall Study|Withdrawal by Subject|0|||
155674583|NCT00603941|561898936|FG001|Overall Study|Withdrawal by Subject|2|||
155674584|NCT00603941|561898937|FG002|Overall Study|Withdrawal by Subject|0|||
155674585|NCT03592771|561898938|FG000|Overall Study|Adverse Event|2|||
155674586|NCT03592771|561898939|FG001|Overall Study|Adverse Event|0|||
155674587|NCT03592771|561898940|FG002|Overall Study|Adverse Event|1|||
155674588|NCT03592771|561898938|FG000|Overall Study|Death|0|||
155674589|NCT03592771|561898939|FG001|Overall Study|Death|1|||
155674590|NCT03592771|561898940|FG002|Overall Study|Death|1|||
155674591|NCT03592771|561898938|FG000|Overall Study|Lost to Follow-up|5|||
155674592|NCT03592771|561898939|FG001|Overall Study|Lost to Follow-up|11|||
155674593|NCT03592771|561898940|FG002|Overall Study|Lost to Follow-up|15|||
155674594|NCT03592771|561898938|FG000|Overall Study|Withdrawal by Subject|0|||
155674595|NCT03592771|561898939|FG001|Overall Study|Withdrawal by Subject|2|||
155674596|NCT03592771|561898940|FG002|Overall Study|Withdrawal by Subject|0|||
155674597|NCT00135330|561898941|FG000|Overall Study|Adverse Event|2|||
155674598|NCT00135330|561898942|FG001|Overall Study|Adverse Event|5|||
155674599|NCT00135330|561898943|FG002|Overall Study|Adverse Event|1|||
155674600|NCT00135330|561898941|FG000|Overall Study|Lost to Follow-up|0|||
155674601|NCT00135330|561898942|FG001|Overall Study|Lost to Follow-up|2|||
155674602|NCT00135330|561898943|FG002|Overall Study|Lost to Follow-up|3|||
155674603|NCT00135330|561898941|FG000|Overall Study|Physician Decision|1|||
155674604|NCT00135330|561898942|FG001|Overall Study|Physician Decision|1|||
155674605|NCT00135330|561898943|FG002|Overall Study|Physician Decision|0|||
155674606|NCT00135330|561898941|FG000|Overall Study|Protocol Violation|4|||
155674607|NCT00135330|561898942|FG001|Overall Study|Protocol Violation|3|||
155674608|NCT00135330|561898943|FG002|Overall Study|Protocol Violation|3|||
155674609|NCT00135330|561898941|FG000|Overall Study|Patient Decision|5|||
155674610|NCT00135330|561898942|FG001|Overall Study|Patient Decision|1|||
155674611|NCT00135330|561898943|FG002|Overall Study|Patient Decision|4|||
155674612|NCT00135330|561898941|FG000|Overall Study|Sponsor Decision|0|||
155674613|NCT00135330|561898942|FG001|Overall Study|Sponsor Decision|1|||
155674614|NCT00135330|561898943|FG002|Overall Study|Sponsor Decision|0|||
155674615|NCT02253433|561898947|FG000|Overall Study|Unable to Contact|9|||
155674616|NCT02253433|561898948|FG001|Overall Study|Unable to Contact|16|||
155674617|NCT02253433|561898947|FG000|Overall Study|Death|1|||
155674618|NCT02253433|561898948|FG001|Overall Study|Death|1|||
155674619|NCT02253433|561898947|FG000|Overall Study|No Longer Interested|3|||
155674620|NCT02253433|561898948|FG001|Overall Study|No Longer Interested|15|||
155674621|NCT02253433|561898947|FG000|Overall Study|Out of Study Area|2|||
155674622|NCT02253433|561898948|FG001|Overall Study|Out of Study Area|7|||
155674623|NCT02253433|561898947|FG000|Overall Study|Uncomfortable with home visitors|0|||
155674624|NCT02253433|561898948|FG001|Overall Study|Uncomfortable with home visitors|3|||
155674625|NCT02253433|561898947|FG000|Overall Study|Unstable Housing/Homeless|0|||
155674626|NCT02253433|561898948|FG001|Overall Study|Unstable Housing/Homeless|7|||
155674627|NCT02253433|561898947|FG000|Overall Study|Too Busy|0|||
155674628|NCT02253433|561898948|FG001|Overall Study|Too Busy|4|||
155674629|NCT02253433|561898947|FG000|Overall Study|Medical or Other Concerns|1|||
155674630|NCT02253433|561898948|FG001|Overall Study|Medical or Other Concerns|2|||
155674631|NCT02229825|561898951|FG000|Overall Study|Personal Reasons|0|||
155674632|NCT02229825|561898952|FG001|Overall Study|Personal Reasons|1|||
155674633|NCT02229825|561898951|FG000|Overall Study|Refused continuing medication|7|||
155674634|NCT02229825|561898952|FG001|Overall Study|Refused continuing medication|6|||
155674635|NCT02229825|561898951|FG000|Overall Study|Lost to Follow-up|1|||
155674636|NCT02229825|561898952|FG001|Overall Study|Lost to Follow-up|2|||
155674637|NCT02229825|561898951|FG000|Overall Study|Protocol Violation|1|||
155674638|NCT02229825|561898952|FG001|Overall Study|Protocol Violation|1|||
155674639|NCT02229825|561898951|FG000|Overall Study|Lack of Efficacy|4|||
155674640|NCT02229825|561898952|FG001|Overall Study|Lack of Efficacy|10|||
155674641|NCT02229825|561898951|FG000|Overall Study|Adverse Event|11|||
155674642|NCT02229825|561898952|FG001|Overall Study|Adverse Event|9|||
155674643|NCT02229825|561898951|FG000|Overall Study|Not treated|0|||
155674644|NCT02229825|561898952|FG001|Overall Study|Not treated|1|||
155674645|NCT01532921|561898953|FG000|Overall Study|Death|3|||
155674646|NCT01532921|561898953|FG000|Overall Study|Withdrawal by Subject|2|||
155674647|NCT01532921|561898953|FG000|Overall Study|Lost to Follow-up|3|||
155674648|NCT01532921|561898953|FG000|Overall Study|Physician Decision|7|||
155674649|NCT01532921|561898953|FG000|Overall Study|Device was explanted during procedure|1|||
155674650|NCT01390298|561898954|FG000|Overall Study|Death|1|||
155674651|NCT01390298|561898954|FG000|Overall Study|long term ICU admission|1|||
155674652|NCT01390298|561898954|FG000|Overall Study|Withdrawal by Subject|14|||
155674653|NCT01390298|561898954|FG000|Overall Study|Lost to Follow-up|7|||
155674654|NCT01390298|561898954|FG000|Overall Study|Surgery cancelled|1|||
155674655|NCT02443337|561898955|FG000|Overall Study|Adverse Event|0|||
155674656|NCT02443337|561898956|FG001|Overall Study|Adverse Event|1|||
155674657|NCT02443337|561898955|FG000|Overall Study|Clinical Progressive Disease|3|||
155674658|NCT02443337|561898956|FG001|Overall Study|Clinical Progressive Disease|0|||
155674659|NCT02443337|561898955|FG000|Overall Study|Withdrawal by Subject|2|||
155674660|NCT02443337|561898956|FG001|Overall Study|Withdrawal by Subject|1|||
155674661|NCT00040742|561898957|FG000|Overall Study|Death|0|||
155674662|NCT00040742|561898958|FG001|Overall Study|Death|0|||
155674663|NCT00040742|561898959|FG002|Overall Study|Death|1|||
155674664|NCT00040742|561898960|FG003|Overall Study|Death|0|||
155674665|NCT00040742|561898957|FG000|Overall Study|Adverse Event|15|||
155674666|NCT00040742|561898958|FG001|Overall Study|Adverse Event|16|||
155674667|NCT00040742|561898959|FG002|Overall Study|Adverse Event|21|||
155674668|NCT00040742|561898960|FG003|Overall Study|Adverse Event|9|||
155674669|NCT00040742|561898957|FG000|Overall Study|Withdrawal by Subject|7|||
155674670|NCT00040742|561898958|FG001|Overall Study|Withdrawal by Subject|15|||
155674671|NCT00040742|561898959|FG002|Overall Study|Withdrawal by Subject|10|||
155674672|NCT00040742|561898960|FG003|Overall Study|Withdrawal by Subject|13|||
155674673|NCT00040742|561898957|FG000|Overall Study|Chemotoxicity|4|||
155674674|NCT00040742|561898958|FG001|Overall Study|Chemotoxicity|3|||
155674675|NCT00040742|561898959|FG002|Overall Study|Chemotoxicity|5|||
155674676|NCT00040742|561898960|FG003|Overall Study|Chemotoxicity|2|||
155674677|NCT00040742|561898957|FG000|Overall Study|Incomplete Forms|6|||
155674678|NCT00040742|561898958|FG001|Overall Study|Incomplete Forms|10|||
155674679|NCT00040742|561898959|FG002|Overall Study|Incomplete Forms|4|||
155674680|NCT00040742|561898960|FG003|Overall Study|Incomplete Forms|5|||
155674681|NCT00040742|561898957|FG000|Overall Study|Other medical|7|||
155674682|NCT00040742|561898958|FG001|Overall Study|Other medical|5|||
155674683|NCT00040742|561898959|FG002|Overall Study|Other medical|5|||
155674684|NCT00040742|561898960|FG003|Overall Study|Other medical|5|||
155674685|NCT02997865|561898962|FG000|Overall Study|Death|2|||
155674686|NCT02997865|561898963|FG001|Overall Study|Death|1|||
155674687|NCT02997865|561898962|FG000|Overall Study|Lost to Follow-up|6|||
155674688|NCT02997865|561898963|FG001|Overall Study|Lost to Follow-up|3|||
155674689|NCT02997865|561898962|FG000|Overall Study|Withdrawal by Subject|5|||
155674690|NCT02997865|561898963|FG001|Overall Study|Withdrawal by Subject|0|||
155674691|NCT01119066|561898964|FG000|Overall Study|Withdrawal by Subject|4|||
155674692|NCT01119066|561898965|FG001|Overall Study|Withdrawal by Subject|6|||
155674693|NCT01119066|561898966|FG002|Overall Study|Withdrawal by Subject|0|||
155674694|NCT01119066|561898967|FG003|Overall Study|Withdrawal by Subject|0|||
155674695|NCT01119066|561898964|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
155674696|NCT01119066|561898965|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
155674697|NCT01119066|561898966|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
155674698|NCT01119066|561898967|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
155674699|NCT01119066|561898964|FG000|Overall Study|Relapse identified before transplant|1|||
155674700|NCT01119066|561898965|FG001|Overall Study|Relapse identified before transplant|0|||
155674701|NCT01119066|561898966|FG002|Overall Study|Relapse identified before transplant|0|||
155674702|NCT01119066|561898967|FG003|Overall Study|Relapse identified before transplant|0|||
155674703|NCT01119066|561898964|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
155674704|NCT01119066|561898965|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
155674705|NCT01119066|561898966|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
155674706|NCT01119066|561898967|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
155674707|NCT01119066|561898964|FG000|Overall Study|Relapse identified before transplant|0|||
155674708|NCT01119066|561898965|FG001|Overall Study|Relapse identified before transplant|4|||
155674709|NCT01119066|561898966|FG002|Overall Study|Relapse identified before transplant|0|||
155674710|NCT01119066|561898967|FG003|Overall Study|Relapse identified before transplant|0|||
155674711|NCT02243371|561898974|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
155674712|NCT02243371|561898975|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
155674713|NCT02243371|561898974|FG000|Overall Study|Death (unrelated)|2|||
155674714|NCT02243371|561898975|FG001|Overall Study|Death (unrelated)|4|||
155674715|NCT02243371|561898974|FG000|Overall Study|Adverse Event (unrelated)|0|||
155674716|NCT02243371|561898975|FG001|Overall Study|Adverse Event (unrelated)|1|||
155674717|NCT02243371|561898974|FG000|Overall Study|Lack of Clinical Benefit|0|||
155674718|NCT02243371|561898975|FG001|Overall Study|Lack of Clinical Benefit|1|||
155674719|NCT02243371|561898974|FG000|Overall Study|Withdrawal by Subject|0|||
155674720|NCT02243371|561898975|FG001|Overall Study|Withdrawal by Subject|2|||
155674721|NCT02441101|561898976|FG000|Overall Study|Withdrawal by Subject|1|||
155674722|NCT02441101|561898977|FG001|Overall Study|Withdrawal by Subject|0|||
155674723|NCT02441101|561898976|FG000|Overall Study|Lost to Follow-up|1|||
155674724|NCT02441101|561898977|FG001|Overall Study|Lost to Follow-up|0|||
155674725|NCT02441101|561898976|FG000|Overall Study|PI relocated and study terminated|1|||
155674726|NCT02441101|561898977|FG001|Overall Study|PI relocated and study terminated|0|||
155674727|NCT00271856|561898980|FG000|Overall Study|Withdrawal by Subject|1|||
155674728|NCT00271856|561898981|FG001|Overall Study|Withdrawal by Subject|7|||
155674729|NCT00271856|561898980|FG000|Overall Study|Lost to Follow-up|10|||
155674730|NCT00271856|561898981|FG001|Overall Study|Lost to Follow-up|11|||
155674731|NCT03012828|561898982|FG000|Overall Study|Lost to Follow-up|1|||
155674732|NCT03012828|561898983|FG001|Overall Study|Lost to Follow-up|0|||
155674733|NCT03012828|561898984|FG002|Overall Study|Lost to Follow-up|1|||
155674734|NCT03012828|561898985|FG003|Overall Study|Lost to Follow-up|0|||
155674735|NCT03012828|561898986|FG004|Overall Study|Lost to Follow-up|1|||
155674736|NCT03012828|561898987|FG005|Overall Study|Lost to Follow-up|0|||
155674737|NCT03012828|561898982|FG000|Overall Study|Withdrawal by Subject|0|||
155674738|NCT03012828|561898983|FG001|Overall Study|Withdrawal by Subject|0|||
155674739|NCT03012828|561898984|FG002|Overall Study|Withdrawal by Subject|1|||
155674740|NCT03012828|561898985|FG003|Overall Study|Withdrawal by Subject|0|||
155674741|NCT03012828|561898986|FG004|Overall Study|Withdrawal by Subject|0|||
155674742|NCT03012828|561898987|FG005|Overall Study|Withdrawal by Subject|1|||
155674743|NCT03012828|561898982|FG000|Overall Study|Non-compliance with protocol|0|||
155674744|NCT03012828|561898983|FG001|Overall Study|Non-compliance with protocol|0|||
155674745|NCT03012828|561898984|FG002|Overall Study|Non-compliance with protocol|0|||
155674746|NCT03012828|561898985|FG003|Overall Study|Non-compliance with protocol|0|||
155674747|NCT03012828|561898986|FG004|Overall Study|Non-compliance with protocol|1|||
155674748|NCT03012828|561898987|FG005|Overall Study|Non-compliance with protocol|0|||
155674749|NCT03012828|561898982|FG000|Overall Study|Delay to last visit would delay DBL|0|||
155674750|NCT03012828|561898983|FG001|Overall Study|Delay to last visit would delay DBL|0|||
155674751|NCT03012828|561898984|FG002|Overall Study|Delay to last visit would delay DBL|0|||
155674752|NCT03012828|561898985|FG003|Overall Study|Delay to last visit would delay DBL|0|||
155674753|NCT03012828|561898986|FG004|Overall Study|Delay to last visit would delay DBL|0|||
155674754|NCT03012828|561898987|FG005|Overall Study|Delay to last visit would delay DBL|1|||
155674755|NCT04599803|561898988|FG000|Overall Study|Withdrawal by Subject|5|||
155674756|NCT04599803|561898988|FG000|Overall Study|Lost to Follow-up|26|||
155674757|NCT02544750|561898989|FG000|Overall Study|Physician Decision|3|||
155674758|NCT02544750|561898990|FG001|Overall Study|Physician Decision|1|||
155674759|NCT02544750|561898989|FG000|Overall Study|Other reasons|69|||
155674760|NCT02544750|561898990|FG001|Overall Study|Other reasons|39|||
155674761|NCT02544750|561898989|FG000|Overall Study|Met withdrawal criteria|2|||
155674762|NCT02544750|561898990|FG001|Overall Study|Met withdrawal criteria|2|||
155674763|NCT02544750|561898989|FG000|Overall Study|Transition To Commercial Product|1|||
155674764|NCT02544750|561898990|FG001|Overall Study|Transition To Commercial Product|0|||
155674765|NCT02544750|561898989|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
155674766|NCT02544750|561898990|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
155674767|NCT02544750|561898989|FG000|Overall Study|Adverse Event|8|||
155674768|NCT02544750|561898990|FG001|Overall Study|Adverse Event|10|||
155674769|NCT02544750|561898989|FG000|Overall Study|Withdrawal by Subject|10|||
155674770|NCT02544750|561898990|FG001|Overall Study|Withdrawal by Subject|4|||
155674771|NCT02544750|561898989|FG000|Overall Study|Lost to Follow-up|1|||
155674772|NCT02544750|561898990|FG001|Overall Study|Lost to Follow-up|0|||
155674773|NCT02366923|561898991|FG000|Overall Study|Withdrawal by Subject|1|||
155674774|NCT02366923|561898991|FG000|Overall Study|Positive Slit Lamp Findings|2|||
155674775|NCT02366923|561898991|FG000|Overall Study|High Astigmatism|3|||
155674776|NCT04677543|561898992|FG000|Overall Study|Withdrawal by Subject|4|||
155674777|NCT04677543|561898993|FG001|Overall Study|Withdrawal by Subject|1|||
155674778|NCT04677543|561898992|FG000|Overall Study|Physician Decision|0|||
155674779|NCT04677543|561898993|FG001|Overall Study|Physician Decision|1|||
155674780|NCT04677543|561898992|FG000|Overall Study|Adverse Event|0|||
155674781|NCT04677543|561898993|FG001|Overall Study|Adverse Event|1|||
155674782|NCT02520388|561898996|FG000|Overall Study|Physician Decision|1|||
155674783|NCT02520388|561898997|FG001|Overall Study|Physician Decision|0|||
155674784|NCT02520388|561898996|FG000|Overall Study|Subject or parent/guardian request|0|||
155674785|NCT02520388|561898997|FG001|Overall Study|Subject or parent/guardian request|6|||
155674786|NCT02520388|561898996|FG000|Overall Study|Adverse Event|1|||
155674787|NCT02520388|561898997|FG001|Overall Study|Adverse Event|4|||
155674788|NCT02520388|561898996|FG000|Overall Study|Lost to Follow-up|3|||
155674789|NCT02520388|561898997|FG001|Overall Study|Lost to Follow-up|2|||
155674790|NCT02520388|561898996|FG000|Overall Study|Other (reason not defined)|4|||
155674791|NCT02520388|561898997|FG001|Overall Study|Other (reason not defined)|4|||
155674792|NCT01437111|561898998|FG000|Overall Study|Adverse Event|2|||
155674793|NCT01437111|561898998|FG000|Overall Study|Withdrawal by Subject|4|||
155674794|NCT01437111|561898998|FG000|Overall Study|Not reported|5|||
155674795|NCT01437111|561898998|FG000|Overall Study|Physician Decision|1|||
155674796|NCT01437111|561898998|FG000|Overall Study|Lost to Follow-up|5|||
155674797|NCT01437111|561898998|FG000|Overall Study|Protocol Violation|1|||
155674798|NCT02623205|561898999|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
155674799|NCT02623205|561899000|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
155674800|NCT02342288|561899001|FG000|Overall Study|no protocol anesthesiologist available|3|||
155674801|NCT02342288|561899002|FG001|Overall Study|no protocol anesthesiologist available|2|||
155674802|NCT02342288|561899001|FG000|Overall Study|anesthesia leak in system|1|||
155674803|NCT02342288|561899002|FG001|Overall Study|anesthesia leak in system|0|||
155674804|NCT02342288|561899001|FG000|Overall Study|Withdrawal by Subject|1|||
155674805|NCT02342288|561899002|FG001|Overall Study|Withdrawal by Subject|0|||
155674806|NCT02342288|561899001|FG000|Overall Study|coordinator contaminated with blood|0|||
155674807|NCT02342288|561899002|FG001|Overall Study|coordinator contaminated with blood|1|||
155674808|NCT02342288|561899001|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
155674809|NCT02342288|561899002|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
155674810|NCT02342288|561899001|FG000|Overall Study|coordinator not available|0|||
155674811|NCT02342288|561899002|FG001|Overall Study|coordinator not available|2|||
155674812|NCT02375373|561899004|FG000|Overall Study|Withdrawal by Subject|11|||
155674813|NCT01445613|561899006|FG000|30-day Follow-up|Withdrawal by Subject|6|||
155674814|NCT01445613|561899006|FG000|30-day Follow-up|Physician Decision|3|||
155674815|NCT01445613|561899006|FG000|30-day Follow-up|Missed visit|23|||
155674816|NCT01445613|561899006|FG000|30-day Follow-up|Death|3|||
155674817|NCT01445613|561899006|FG000|1-year Follow-up|Withdrawal by Subject|12|||
155674818|NCT01445613|561899006|FG000|1-year Follow-up|Missed visit|29|||
155674819|NCT01445613|561899006|FG000|1-year Follow-up|Lost to Follow-up|2|||
155674820|NCT01445613|561899006|FG000|1-year Follow-up|Death|30|||
155674821|NCT01445613|561899006|FG000|1-year Follow-up|Physician Decision|2|||
155674822|NCT01445613|561899006|FG000|1-year Follow-up|Received a non-study stent|2|||
155674823|NCT03711370|561899007|FG000|Overall Study|Lost to Follow-up|16|||
155674824|NCT03711370|561899008|FG001|Overall Study|Lost to Follow-up|10|||
155674825|NCT03711370|561899007|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
155674826|NCT03711370|561899008|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
155674827|NCT01169701|561899009|FG000|Overall Study|Lost to Follow-up|1|||
155674828|NCT01169701|561899010|FG001|Overall Study|Lost to Follow-up|1|||
155674829|NCT01169701|561899009|FG000|Overall Study|Withdrawal by Subject|1|||
155674830|NCT01169701|561899010|FG001|Overall Study|Withdrawal by Subject|3|||
155674831|NCT01169701|561899009|FG000|Overall Study|Adverse Event|1|||
155674832|NCT01169701|561899010|FG001|Overall Study|Adverse Event|2|||
155674833|NCT01169701|561899009|FG000|Overall Study|Exclusion criteria|2|||
155674834|NCT01169701|561899010|FG001|Overall Study|Exclusion criteria|0|||
155674835|NCT01169701|561899009|FG000|Overall Study|Death|0|||
155674836|NCT01169701|561899010|FG001|Overall Study|Death|1|||
155674837|NCT01169701|561899009|FG000|Overall Study|Administrative problems|0|||
155674838|NCT01169701|561899010|FG001|Overall Study|Administrative problems|1|||
155674839|NCT01169701|561899009|FG000|Overall Study|Serious adverse event|0|||
155674840|NCT01169701|561899010|FG001|Overall Study|Serious adverse event|1|||
155674841|NCT01169701|561899009|FG000|Overall Study|Sponsor decision|0|||
155674842|NCT01169701|561899010|FG001|Overall Study|Sponsor decision|1|||
155674843|NCT04188834|561899011|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
155674844|NCT00553436|561899012|FG000|Overall Study|Conversion to another procedure|1|||
155674845|NCT02455336|561899015|FG000|Overall Study|Withdrawal by Subject|0|||
155674846|NCT02455336|561899016|FG001|Overall Study|Withdrawal by Subject|2|||
155674847|NCT02455336|561899015|FG000|Overall Study|Adverse Event|3|||
155674848|NCT02455336|561899016|FG001|Overall Study|Adverse Event|0|||
155674849|NCT02455336|561899015|FG000|Overall Study|Non-responder to treatment|2|||
155674850|NCT02455336|561899016|FG001|Overall Study|Non-responder to treatment|0|||
155674851|NCT00391430|561899017|FG000|Overall Study|Withdrawal by Subject|3|||
155674852|NCT00391430|561899018|FG001|Overall Study|Withdrawal by Subject|0|||
155674853|NCT00391430|561899019|FG002|Overall Study|Withdrawal by Subject|12|||
155674854|NCT03299244|561899020|FG000|Overall Study|Withdrawal by Subject|34|||
155674855|NCT03299244|561899021|FG001|Overall Study|Withdrawal by Subject|29|||
155674856|NCT03299244|561899020|FG000|Overall Study|Decision by Sponsor|4|||
155674857|NCT03299244|561899021|FG001|Overall Study|Decision by Sponsor|5|||
155674858|NCT03299244|561899020|FG000|Overall Study|Death|9|||
155674859|NCT03299244|561899021|FG001|Overall Study|Death|4|||
155674860|NCT02517398|561899025|FG000|Overall Study|Death|2|||
155674861|NCT02517398|561899026|FG001|Overall Study|Death|3|||
155674862|NCT02517398|561899027|FG002|Overall Study|Death|4|||
155674863|NCT02517398|561899028|FG003|Overall Study|Death|2|||
155674864|NCT02517398|561899029|FG004|Overall Study|Death|3|||
155674865|NCT02517398|561899030|FG005|Overall Study|Death|8|||
155674866|NCT02517398|561899031|FG006|Overall Study|Death|3|||
155674867|NCT02517398|561899032|FG007|Overall Study|Death|2|||
155674868|NCT02517398|561899033|FG008|Overall Study|Death|6|||
155674869|NCT02517398|561899034|FG009|Overall Study|Death|24|||
155674870|NCT02517398|561899035|FG010|Overall Study|Death|53|||
155674871|NCT02517398|561899036|FG011|Overall Study|Death|25|||
155674872|NCT02517398|561899037|FG012|Overall Study|Death|73|||
155674873|NCT02517398|561899038|FG013|Overall Study|Death|29|||
155674874|NCT02517398|561899039|FG014|Overall Study|Death|26|||
155674875|NCT02517398|561899040|FG015|Overall Study|Death|23|||
155674876|NCT02517398|561899041|FG016|Overall Study|Death|26|||
155674877|NCT02517398|561899042|FG017|Overall Study|Death|25|||
155674878|NCT02517398|561899043|FG018|Overall Study|Death|22|||
155674879|NCT02517398|561899044|FG019|Overall Study|Death|7|||
155674880|NCT02517398|561899045|FG020|Overall Study|Death|26|||
155674881|NCT02517398|561899046|FG021|Overall Study|Death|30|||
155674882|NCT02517398|561899047|FG022|Overall Study|Death|20|||
155674883|NCT02517398|561899025|FG000|Overall Study|Other|0|||
155674884|NCT02517398|561899026|FG001|Overall Study|Other|0|||
155674885|NCT02517398|561899027|FG002|Overall Study|Other|0|||
155674886|NCT02517398|561899028|FG003|Overall Study|Other|1|||
155674887|NCT02517398|561899029|FG004|Overall Study|Other|0|||
155674888|NCT02517398|561899030|FG005|Overall Study|Other|0|||
155674889|NCT02517398|561899031|FG006|Overall Study|Other|0|||
155674890|NCT02517398|561899032|FG007|Overall Study|Other|0|||
155674891|NCT02517398|561899033|FG008|Overall Study|Other|0|||
155674892|NCT02517398|561899034|FG009|Overall Study|Other|1|||
155674893|NCT02517398|561899035|FG010|Overall Study|Other|0|||
155674894|NCT02517398|561899036|FG011|Overall Study|Other|0|||
155674895|NCT02517398|561899037|FG012|Overall Study|Other|0|||
155674896|NCT02517398|561899038|FG013|Overall Study|Other|1|||
155674897|NCT02517398|561899039|FG014|Overall Study|Other|0|||
155674898|NCT02517398|561899040|FG015|Overall Study|Other|1|||
155674899|NCT02517398|561899041|FG016|Overall Study|Other|1|||
155674900|NCT02517398|561899042|FG017|Overall Study|Other|0|||
155674901|NCT02517398|561899043|FG018|Overall Study|Other|0|||
155674902|NCT02517398|561899044|FG019|Overall Study|Other|1|||
155674903|NCT02517398|561899045|FG020|Overall Study|Other|0|||
155674904|NCT02517398|561899046|FG021|Overall Study|Other|0|||
155674905|NCT02517398|561899047|FG022|Overall Study|Other|0|||
155674906|NCT02517398|561899025|FG000|Overall Study|Lost to Follow-up|0|||
155674907|NCT02517398|561899026|FG001|Overall Study|Lost to Follow-up|0|||
155674908|NCT02517398|561899027|FG002|Overall Study|Lost to Follow-up|0|||
155674909|NCT02517398|561899028|FG003|Overall Study|Lost to Follow-up|0|||
155674910|NCT02517398|561899029|FG004|Overall Study|Lost to Follow-up|0|||
155674911|NCT02517398|561899030|FG005|Overall Study|Lost to Follow-up|0|||
155674912|NCT02517398|561899031|FG006|Overall Study|Lost to Follow-up|0|||
155674913|NCT02517398|561899032|FG007|Overall Study|Lost to Follow-up|0|||
155674914|NCT02517398|561899033|FG008|Overall Study|Lost to Follow-up|0|||
155674915|NCT02517398|561899034|FG009|Overall Study|Lost to Follow-up|1|||
155674916|NCT02517398|561899035|FG010|Overall Study|Lost to Follow-up|0|||
155674917|NCT02517398|561899036|FG011|Overall Study|Lost to Follow-up|2|||
155674918|NCT02517398|561899037|FG012|Overall Study|Lost to Follow-up|2|||
155674919|NCT02517398|561899038|FG013|Overall Study|Lost to Follow-up|0|||
155674920|NCT02517398|561899039|FG014|Overall Study|Lost to Follow-up|1|||
155674921|NCT02517398|561899040|FG015|Overall Study|Lost to Follow-up|1|||
155674922|NCT02517398|561899041|FG016|Overall Study|Lost to Follow-up|0|||
155674923|NCT02517398|561899042|FG017|Overall Study|Lost to Follow-up|3|||
155674924|NCT02517398|561899043|FG018|Overall Study|Lost to Follow-up|1|||
155674925|NCT02517398|561899044|FG019|Overall Study|Lost to Follow-up|0|||
155674926|NCT02517398|561899045|FG020|Overall Study|Lost to Follow-up|1|||
155674927|NCT02517398|561899046|FG021|Overall Study|Lost to Follow-up|0|||
155674928|NCT02517398|561899047|FG022|Overall Study|Lost to Follow-up|2|||
155674929|NCT02517398|561899025|FG000|Overall Study|Withdrew Consent|0|||
155674930|NCT02517398|561899026|FG001|Overall Study|Withdrew Consent|0|||
155674931|NCT02517398|561899027|FG002|Overall Study|Withdrew Consent|0|||
155674932|NCT02517398|561899028|FG003|Overall Study|Withdrew Consent|0|||
155674933|NCT02517398|561899029|FG004|Overall Study|Withdrew Consent|0|||
155674934|NCT02517398|561899030|FG005|Overall Study|Withdrew Consent|0|||
155674935|NCT02517398|561899031|FG006|Overall Study|Withdrew Consent|1|||
155674936|NCT02517398|561899032|FG007|Overall Study|Withdrew Consent|0|||
155674937|NCT02517398|561899033|FG008|Overall Study|Withdrew Consent|0|||
155674938|NCT02517398|561899034|FG009|Overall Study|Withdrew Consent|2|||
155674939|NCT02517398|561899035|FG010|Overall Study|Withdrew Consent|7|||
155674940|NCT02517398|561899036|FG011|Overall Study|Withdrew Consent|1|||
155674941|NCT02517398|561899037|FG012|Overall Study|Withdrew Consent|5|||
155674942|NCT02517398|561899038|FG013|Overall Study|Withdrew Consent|4|||
155674943|NCT02517398|561899039|FG014|Overall Study|Withdrew Consent|2|||
155674944|NCT02517398|561899040|FG015|Overall Study|Withdrew Consent|5|||
155674945|NCT02517398|561899041|FG016|Overall Study|Withdrew Consent|4|||
155674946|NCT02517398|561899042|FG017|Overall Study|Withdrew Consent|2|||
155674947|NCT02517398|561899043|FG018|Overall Study|Withdrew Consent|3|||
155674948|NCT02517398|561899044|FG019|Overall Study|Withdrew Consent|2|||
155674949|NCT02517398|561899045|FG020|Overall Study|Withdrew Consent|9|||
155674950|NCT02517398|561899046|FG021|Overall Study|Withdrew Consent|3|||
155674951|NCT02517398|561899047|FG022|Overall Study|Withdrew Consent|1|||
155674952|NCT00958360|561900532|FG000|Overall Study|Withdrawal by Subject|3|||
155674953|NCT00958360|561900533|FG001|Overall Study|Withdrawal by Subject|1|||
155674954|NCT00958360|561900532|FG000|Overall Study|Death|6|||
155674955|NCT00958360|561900533|FG001|Overall Study|Death|7|||
155674956|NCT00958360|561900532|FG000|Overall Study|Physician Decision|2|||
155674957|NCT00958360|561900533|FG001|Overall Study|Physician Decision|1|||
155674958|NCT00958360|561900532|FG000|Overall Study|Lost to Follow-up|0|||
155674959|NCT00958360|561900533|FG001|Overall Study|Lost to Follow-up|1|||
155674960|NCT03015363|561900534|FG000|Overall Study|Physician Decision|14|||
155674961|NCT03015363|561900534|FG000|Overall Study|Withdrawal by Subject|3|||
155674962|NCT03107052|561900535|FG000|Overall Study|Adverse Event|6|||
155674963|NCT03107052|561900536|FG001|Overall Study|Adverse Event|1|||
155674964|NCT03107052|561900537|FG002|Overall Study|Adverse Event|2|||
155674965|NCT03107052|561900535|FG000|Overall Study|Withdrawal by Subject|9|||
155674966|NCT03107052|561900536|FG001|Overall Study|Withdrawal by Subject|5|||
155674967|NCT03107052|561900537|FG002|Overall Study|Withdrawal by Subject|8|||
155674968|NCT03107052|561900535|FG000|Overall Study|Protocol Violation|6|||
155674969|NCT03107052|561900536|FG001|Overall Study|Protocol Violation|0|||
155674970|NCT03107052|561900537|FG002|Overall Study|Protocol Violation|3|||
155674971|NCT03107052|561900535|FG000|Overall Study|Lost to Follow-up|4|||
155674972|NCT03107052|561900536|FG001|Overall Study|Lost to Follow-up|0|||
155674973|NCT03107052|561900537|FG002|Overall Study|Lost to Follow-up|1|||
155674974|NCT03107052|561900535|FG000|Overall Study|Lack of Efficacy|23|||
155674975|NCT03107052|561900536|FG001|Overall Study|Lack of Efficacy|7|||
155674976|NCT03107052|561900537|FG002|Overall Study|Lack of Efficacy|4|||
155674977|NCT03107052|561900535|FG000|Overall Study|Other than specified|4|||
155674978|NCT03107052|561900536|FG001|Overall Study|Other than specified|2|||
155674979|NCT03107052|561900537|FG002|Overall Study|Other than specified|0|||
155674980|NCT03107052|561900535|FG000|Overall Study|Study terminated due to futility|67|||
155674981|NCT03107052|561900536|FG001|Overall Study|Study terminated due to futility|31|||
155674982|NCT03107052|561900537|FG002|Overall Study|Study terminated due to futility|23|||
155674983|NCT00500357|561900538|FG000|Overall Study|Death|1|||
155674984|NCT02263326|561900539|FG000|Overall Study|Lost to Follow-up|1|||
155674985|NCT02263326|561900540|FG001|Overall Study|Lost to Follow-up|1|||
155674986|NCT00078806|561900541|FG000|Part 1A|Adverse Event|2|||
155674987|NCT00078806|561900542|FG001|Part 1A|Adverse Event|0|||
155674988|NCT00078806|561900543|FG002|Part 1A|Adverse Event|0|||
155674989|NCT00078806|561900544|FG003|Part 1A|Adverse Event|0|||
155674990|NCT00078806|561900541|FG000|Part 1A|Lack of Efficacy|7|||
155674991|NCT00078806|561900542|FG001|Part 1A|Lack of Efficacy|0|||
155674992|NCT00078806|561900543|FG002|Part 1A|Lack of Efficacy|0|||
155674993|NCT00078806|561900544|FG003|Part 1A|Lack of Efficacy|0|||
155674994|NCT00078806|561900541|FG000|Part 1A|Other|1|||
155674995|NCT00078806|561900542|FG001|Part 1A|Other|0|||
155674996|NCT00078806|561900543|FG002|Part 1A|Other|0|||
155674997|NCT00078806|561900544|FG003|Part 1A|Other|0|||
155674998|NCT00078806|561900541|FG000|Part 1B|Adverse Event|1|||
155674999|NCT00078806|561900542|FG001|Part 1B|Adverse Event|0|||
155675000|NCT00078806|561900543|FG002|Part 1B|Adverse Event|0|||
155675001|NCT00078806|561900544|FG003|Part 1B|Adverse Event|0|||
155675002|NCT00078806|561900541|FG000|Part 1B|Lack of Efficacy|7|||
155675003|NCT00078806|561900542|FG001|Part 1B|Lack of Efficacy|0|||
155675004|NCT00078806|561900543|FG002|Part 1B|Lack of Efficacy|0|||
155675005|NCT00078806|561900544|FG003|Part 1B|Lack of Efficacy|0|||
155675006|NCT00078806|561900541|FG000|Part 2|Adverse Event|0|||
155675007|NCT00078806|561900542|FG001|Part 2|Adverse Event|1|||
155675008|NCT00078806|561900543|FG002|Part 2|Adverse Event|0|||
155675009|NCT00078806|561900544|FG003|Part 2|Adverse Event|0|||
155675010|NCT01893411|561900547|FG000|Overall Study|Protocol Violation|1|||
155675011|NCT01893411|561900548|FG001|Overall Study|Protocol Violation|0|||
155675012|NCT01893411|561900549|FG002|Overall Study|Protocol Violation|0|||
155675013|NCT01893411|561900547|FG000|Overall Study|Physician Decision|1|||
155675014|NCT01893411|561900548|FG001|Overall Study|Physician Decision|1|||
155675015|NCT01893411|561900549|FG002|Overall Study|Physician Decision|2|||
155675016|NCT01893411|561900547|FG000|Overall Study|Lack of Efficacy|2|||
155675017|NCT01893411|561900548|FG001|Overall Study|Lack of Efficacy|1|||
155675018|NCT01893411|561900549|FG002|Overall Study|Lack of Efficacy|0|||
155675019|NCT01893411|561900547|FG000|Overall Study|Other|3|||
155675020|NCT01893411|561900548|FG001|Overall Study|Other|1|||
155675021|NCT01893411|561900549|FG002|Overall Study|Other|3|||
155675022|NCT01893411|561900547|FG000|Overall Study|Adverse Event|1|||
155675023|NCT01893411|561900548|FG001|Overall Study|Adverse Event|0|||
155675024|NCT01893411|561900549|FG002|Overall Study|Adverse Event|0|||
155675025|NCT01893411|561900547|FG000|Overall Study|Withdrawal by Subject|7|||
155675026|NCT01893411|561900548|FG001|Overall Study|Withdrawal by Subject|4|||
155675027|NCT01893411|561900549|FG002|Overall Study|Withdrawal by Subject|3|||
155675028|NCT01893411|561900547|FG000|Overall Study|Lost to Follow-up|2|||
155675029|NCT01893411|561900548|FG001|Overall Study|Lost to Follow-up|0|||
155675030|NCT01893411|561900549|FG002|Overall Study|Lost to Follow-up|1|||
155675031|NCT00566982|561900550|FG000|Overall Study|Adverse Event|6|||
155675032|NCT00566982|561900551|FG001|Overall Study|Adverse Event|48|||
155675033|NCT00566982|561900550|FG000|Overall Study|Withdrawal by Subject|1|||
155675034|NCT00566982|561900551|FG001|Overall Study|Withdrawal by Subject|14|||
155675035|NCT00566982|561900550|FG000|Overall Study|Protocol Violation|1|||
155675036|NCT00566982|561900551|FG001|Overall Study|Protocol Violation|4|||
155675037|NCT00566982|561900550|FG000|Overall Study|Lost to Follow-up|0|||
155675038|NCT00566982|561900551|FG001|Overall Study|Lost to Follow-up|1|||
155675039|NCT00566982|561900550|FG000|Overall Study|Other-family problems & doctor's request|0|||
155675040|NCT00566982|561900551|FG001|Overall Study|Other-family problems & doctor's request|2|||
155675041|NCT00161616|561900552|FG000|Overall Study|Withdrawal by Subject|6|||
155675042|NCT00161616|561900553|FG001|Overall Study|Withdrawal by Subject|5|||
155675043|NCT00161616|561900552|FG000|Overall Study|Physician Decision|1|||
155675044|NCT00161616|561900553|FG001|Overall Study|Physician Decision|0|||
155675045|NCT00161616|561900552|FG000|Overall Study|Death|1|||
155675046|NCT00161616|561900553|FG001|Overall Study|Death|1|||
155675047|NCT00161616|561900552|FG000|Overall Study|Lost to Follow-up|17|||
155675048|NCT00161616|561900553|FG001|Overall Study|Lost to Follow-up|13|||
155675049|NCT00161616|561900552|FG000|Overall Study|Protocol deviation|1|||
155675050|NCT00161616|561900553|FG001|Overall Study|Protocol deviation|0|||
155675051|NCT02719691|561900554|FG000|Overall Study|Physician Decision|0|||
155675052|NCT02719691|561900555|FG001|Overall Study|Physician Decision|0|||
155675053|NCT02719691|561900556|FG002|Overall Study|Physician Decision|1|||
155675054|NCT02719691|561900557|FG003|Overall Study|Physician Decision|0|||
155675055|NCT02719691|561900558|FG004|Overall Study|Physician Decision|0|||
155675056|NCT02719691|561900559|FG005|Overall Study|Physician Decision|0|||
155675057|NCT02719691|561900560|FG006|Overall Study|Physician Decision|0|||
155675058|NCT02719691|561900554|FG000|Overall Study|Withdrawal by Subject|0|||
155675059|NCT02719691|561900555|FG001|Overall Study|Withdrawal by Subject|0|||
155675060|NCT02719691|561900556|FG002|Overall Study|Withdrawal by Subject|0|||
155675061|NCT02719691|561900557|FG003|Overall Study|Withdrawal by Subject|0|||
155675062|NCT02719691|561900558|FG004|Overall Study|Withdrawal by Subject|0|||
155675063|NCT02719691|561900559|FG005|Overall Study|Withdrawal by Subject|1|||
155675064|NCT02719691|561900560|FG006|Overall Study|Withdrawal by Subject|0|||
155675065|NCT02141633|561900563|FG000|Overall Study|Physician Decision|1|||
155675066|NCT02141633|561900564|FG001|Overall Study|Physician Decision|0|||
155675067|NCT02403817|561900565|FG000|Overall Study|Withdrawal by Subject|5|||
155675068|NCT02403817|561900566|FG001|Overall Study|Withdrawal by Subject|0|||
155675069|NCT00473889|561900569|FG000|Overall Study|Did not receive study medication|1|||
155675070|NCT00473889|561900570|FG001|Overall Study|Did not receive study medication|4|||
155675071|NCT00473889|561900569|FG000|Overall Study|Adverse Event|30|||
155675072|NCT00473889|561900570|FG001|Overall Study|Adverse Event|17|||
155675073|NCT00473889|561900569|FG000|Overall Study|Protocol Violation|4|||
155675074|NCT00473889|561900570|FG001|Overall Study|Protocol Violation|2|||
155675075|NCT00473889|561900569|FG000|Overall Study|Lack of Efficacy|28|||
155675076|NCT00473889|561900570|FG001|Overall Study|Lack of Efficacy|29|||
155675077|NCT00473889|561900569|FG000|Overall Study|Lost to Follow-up|2|||
155675078|NCT00473889|561900570|FG001|Overall Study|Lost to Follow-up|1|||
155675079|NCT00473889|561900569|FG000|Overall Study|Physician Decision|10|||
155675080|NCT00473889|561900570|FG001|Overall Study|Physician Decision|5|||
155675081|NCT00473889|561900569|FG000|Overall Study|Trial Terminated|3|||
155675082|NCT00473889|561900570|FG001|Overall Study|Trial Terminated|6|||
155675083|NCT00473889|561900569|FG000|Overall Study|Withdrawal by Subject|5|||
155675084|NCT00473889|561900570|FG001|Overall Study|Withdrawal by Subject|0|||
155675085|NCT01498692|561900574|FG000|Overall Study|Death|4|||
155675086|NCT01498692|561900574|FG000|Overall Study|Withdrawal by Subject|1|||
155675087|NCT01498692|561900574|FG000|Overall Study|Missed 12-month visit|3|||
155675088|NCT01947283|561900575|FG000|Overall Study|Death|1|||
155675089|NCT01947283|561900576|FG001|Overall Study|Death|1|||
155675090|NCT01947283|561900577|FG002|Overall Study|Death|1|||
155675091|NCT01947283|561900578|FG003|Overall Study|Death|0|||
155675092|NCT01947283|561900579|FG004|Overall Study|Death|0|||
155675093|NCT01947283|561900580|FG005|Overall Study|Death|0|||
155675094|NCT01947283|561900581|FG006|Overall Study|Death|0|||
155675095|NCT01947283|561900575|FG000|Overall Study|Lost to Follow-up|4|||
155675096|NCT01947283|561900576|FG001|Overall Study|Lost to Follow-up|6|||
155675097|NCT01947283|561900577|FG002|Overall Study|Lost to Follow-up|5|||
155675098|NCT01947283|561900578|FG003|Overall Study|Lost to Follow-up|5|||
155675099|NCT01947283|561900579|FG004|Overall Study|Lost to Follow-up|0|||
155675100|NCT01947283|561900580|FG005|Overall Study|Lost to Follow-up|2|||
155675101|NCT01947283|561900581|FG006|Overall Study|Lost to Follow-up|5|||
155675102|NCT01947283|561900575|FG000|Overall Study|Withdrawal by Subject|10|||
155675103|NCT01947283|561900576|FG001|Overall Study|Withdrawal by Subject|8|||
155675104|NCT01947283|561900577|FG002|Overall Study|Withdrawal by Subject|4|||
155675105|NCT01947283|561900578|FG003|Overall Study|Withdrawal by Subject|1|||
155675106|NCT01947283|561900579|FG004|Overall Study|Withdrawal by Subject|0|||
155675107|NCT01947283|561900580|FG005|Overall Study|Withdrawal by Subject|0|||
155675108|NCT01947283|561900581|FG006|Overall Study|Withdrawal by Subject|2|||
155675109|NCT01947283|561900575|FG000|Overall Study|No Clinical Recording|12|||
155675110|NCT01947283|561900576|FG001|Overall Study|No Clinical Recording|6|||
155675111|NCT01947283|561900577|FG002|Overall Study|No Clinical Recording|8|||
155675112|NCT01947283|561900578|FG003|Overall Study|No Clinical Recording|10|||
155675113|NCT01947283|561900579|FG004|Overall Study|No Clinical Recording|0|||
155675114|NCT01947283|561900580|FG005|Overall Study|No Clinical Recording|0|||
155675115|NCT01947283|561900581|FG006|Overall Study|No Clinical Recording|0|||
155675116|NCT01947283|561900575|FG000|Overall Study|Non-coding Clinical Recording language|0|||
155675117|NCT01947283|561900576|FG001|Overall Study|Non-coding Clinical Recording language|0|||
155675118|NCT01947283|561900577|FG002|Overall Study|Non-coding Clinical Recording language|0|||
155675119|NCT01947283|561900578|FG003|Overall Study|Non-coding Clinical Recording language|1|||
155675120|NCT01947283|561900579|FG004|Overall Study|Non-coding Clinical Recording language|0|||
155675121|NCT01947283|561900580|FG005|Overall Study|Non-coding Clinical Recording language|0|||
155675122|NCT01947283|561900581|FG006|Overall Study|Non-coding Clinical Recording language|0|||
155675123|NCT01947283|561900575|FG000|Overall Study|Missing Follow-up Assessment|2|||
155675124|NCT01947283|561900576|FG001|Overall Study|Missing Follow-up Assessment|2|||
155675125|NCT01947283|561900577|FG002|Overall Study|Missing Follow-up Assessment|3|||
155675126|NCT01947283|561900578|FG003|Overall Study|Missing Follow-up Assessment|0|||
155675127|NCT01947283|561900579|FG004|Overall Study|Missing Follow-up Assessment|0|||
155675128|NCT01947283|561900580|FG005|Overall Study|Missing Follow-up Assessment|2|||
155675129|NCT01947283|561900581|FG006|Overall Study|Missing Follow-up Assessment|0|||
155675130|NCT01947283|561900575|FG000|Overall Study|No patients were enrolled in study|0|||
155675131|NCT01947283|561900576|FG001|Overall Study|No patients were enrolled in study|0|||
155675132|NCT01947283|561900577|FG002|Overall Study|No patients were enrolled in study|0|||
155675133|NCT01947283|561900578|FG003|Overall Study|No patients were enrolled in study|0|||
155675134|NCT01947283|561900579|FG004|Overall Study|No patients were enrolled in study|0|||
155675135|NCT01947283|561900580|FG005|Overall Study|No patients were enrolled in study|3|||
155675136|NCT01947283|561900581|FG006|Overall Study|No patients were enrolled in study|1|||
155675137|NCT04729972|561900582|FG000|Overall Study|Adverse Event|1|||
155675138|NCT00430989|561900583|FG000|Overall Study|Lost to Follow-up|2|||
155675139|NCT00430989|561900584|FG001|Overall Study|Lost to Follow-up|3|||
155675140|NCT00430989|561900583|FG000|Overall Study|Withdrawal by Subject|15|||
155599421|NCT03391232|561620471|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
155599422|NCT02091960|561620472|FG000|Overall Study|Death|7|||
155599423|NCT02091960|561620472|FG000|Overall Study|Withdrawal by Subject|1|||
155599424|NCT02091960|561620472|FG000|Overall Study|Miscellaneous Reasons|37|||
155675141|NCT00430989|561900584|FG001|Overall Study|Withdrawal by Subject|14|||
155675142|NCT00430989|561900583|FG000|Overall Study|Protocol Violation|30|||
155675143|NCT00430989|561900584|FG001|Overall Study|Protocol Violation|37|||
155675144|NCT00430989|561900583|FG000|Overall Study|Not eligible|13|||
155675145|NCT00430989|561900584|FG001|Overall Study|Not eligible|6|||
155675146|NCT03782259|561900585|FG000|Overall Study|Lost to Follow-up|1|||
155675147|NCT03782259|561900586|FG001|Overall Study|Lost to Follow-up|1|||
155675148|NCT03782259|561900585|FG000|Overall Study|Moved out of state|0|||
155675149|NCT03782259|561900586|FG001|Overall Study|Moved out of state|2|||
155675150|NCT03782259|561900585|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
155675151|NCT03782259|561900586|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
155675152|NCT03782259|561900585|FG000|Overall Study|Subject discontinued intervention|1|||
155675153|NCT03782259|561900586|FG001|Overall Study|Subject discontinued intervention|0|||
155599425|NCT02637895|561620486|FG000|Overall Study|Lost to Follow-up|4|||
155599426|NCT02637895|561620487|FG001|Overall Study|Lost to Follow-up|0|||
155599427|NCT02637895|561620486|FG000|Overall Study|Protocol Violation|0|||
155599428|NCT02637895|561620487|FG001|Overall Study|Protocol Violation|1|||
155599429|NCT02637895|561620486|FG000|Overall Study|Lack of Efficacy|1|||
155599430|NCT02637895|561620487|FG001|Overall Study|Lack of Efficacy|0|||
155599431|NCT02637895|561620486|FG000|Overall Study|Withdrawal by Subject|1|||
155599432|NCT02637895|561620487|FG001|Overall Study|Withdrawal by Subject|1|||
155599433|NCT02637895|561620486|FG000|Overall Study|Abnormal baseline lab|0|||
155599434|NCT02637895|561620487|FG001|Overall Study|Abnormal baseline lab|1|||
155599435|NCT01995175|561620490|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
155599436|NCT01995175|561620490|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
155599437|NCT01995175|561620490|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
155599438|NCT01995175|561620490|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
155599439|NCT01995175|561620490|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
155599440|NCT01995175|561620490|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
155599441|NCT01995175|561620490|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
155599442|NCT01995175|561620490|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
155599443|NCT01995175|561620490|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
155599444|NCT00984061|561620491|FG000|Clarithromycin Alone|Protocol Violation|1|||
155599445|NCT00761280|561620492|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
155599446|NCT00761280|561620493|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
155599447|NCT00761280|561620492|FG000|Randomization to First Dose|Sponsor decision|1|||
155599448|NCT00761280|561620493|FG001|Randomization to First Dose|Sponsor decision|0|||
155599449|NCT00761280|561620492|FG000|Randomization to First Dose|Other|1|||
155599450|NCT00761280|561620493|FG001|Randomization to First Dose|Other|0|||
155599451|NCT00761280|561620492|FG000|First Dose to End of Study|End of trial|5|||
155599452|NCT00761280|561620493|FG001|First Dose to End of Study|End of trial|5|||
155599453|NCT00761280|561620492|FG000|First Dose to End of Study|Progressive disease|5|||
155599454|NCT00761280|561620493|FG001|First Dose to End of Study|Progressive disease|3|||
155599455|NCT00761280|561620492|FG000|First Dose to End of Study|Sponsor decision|1|||
155599456|NCT00761280|561620493|FG001|First Dose to End of Study|Sponsor decision|2|||
155599457|NCT00761280|561620492|FG000|First Dose to End of Study|Death|1|||
155599458|NCT00761280|561620493|FG001|First Dose to End of Study|Death|0|||
155599459|NCT00761280|561620492|FG000|First Dose to End of Study|Lost to Follow-up|0|||
155599460|NCT00761280|561620493|FG001|First Dose to End of Study|Lost to Follow-up|1|||
155599461|NCT04777201|561620497|FG000|Main Study|Withdrawal by Subject|19|||
155599462|NCT04777201|561620498|FG001|Main Study|Withdrawal by Subject|27|||
155599463|NCT04777201|561620499|FG002|Main Study|Withdrawal by Subject|0|||
155599464|NCT04777201|561620497|FG000|Main Study|Death|13|||
155599465|NCT04777201|561620498|FG001|Main Study|Death|27|||
155599466|NCT04777201|561620499|FG002|Main Study|Death|0|||
155599467|NCT04777201|561620497|FG000|Main Study|Subject missed the safety follow-up visit|9|||
155599468|NCT04777201|561620498|FG001|Main Study|Subject missed the safety follow-up visit|10|||
155599469|NCT04777201|561620499|FG002|Main Study|Subject missed the safety follow-up visit|0|||
155599470|NCT04777201|561620497|FG000|Main Study|Physician Decision|8|||
155599471|NCT04777201|561620498|FG001|Main Study|Physician Decision|10|||
155599472|NCT04777201|561620499|FG002|Main Study|Physician Decision|0|||
155599473|NCT04777201|561620497|FG000|Main Study|Adverse Event|8|||
155599474|NCT04777201|561620498|FG001|Main Study|Adverse Event|8|||
155599475|NCT04777201|561620499|FG002|Main Study|Adverse Event|0|||
155599476|NCT04777201|561620497|FG000|Main Study|Lost to Follow-up|9|||
155599477|NCT04777201|561620498|FG001|Main Study|Lost to Follow-up|4|||
155599478|NCT04777201|561620499|FG002|Main Study|Lost to Follow-up|0|||
155599479|NCT04777201|561620497|FG000|Main Study|Reason not specified|3|||
155599480|NCT04777201|561620498|FG001|Main Study|Reason not specified|3|||
155599481|NCT04777201|561620499|FG002|Main Study|Reason not specified|0|||
155599482|NCT04777201|561620497|FG000|Main Study|Lack of Efficacy|1|||
155599483|NCT04777201|561620498|FG001|Main Study|Lack of Efficacy|1|||
155599484|NCT04777201|561620499|FG002|Main Study|Lack of Efficacy|0|||
155599485|NCT04777201|561620497|FG000|Main Study|Protocol Violation|1|||
155599486|NCT04777201|561620498|FG001|Main Study|Protocol Violation|0|||
155599487|NCT04777201|561620499|FG002|Main Study|Protocol Violation|0|||
155599488|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
155599489|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
155599490|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
155599491|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
155599492|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
155599493|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
155599494|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
155599495|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
155599496|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
155599497|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
155599498|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
155599499|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
155599500|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
155599501|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
155599502|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
155599503|NCT04777201|561620497|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
155599504|NCT04777201|561620498|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
155599505|NCT04777201|561620499|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
155599506|NCT02045862|561620500|FG000|Overall Study|Death|0|||
155599507|NCT02045862|561620501|FG001|Overall Study|Death|0|||
155599508|NCT02045862|561620502|FG002|Overall Study|Death|1|||
155599509|NCT02045862|561620500|FG000|Overall Study|Miscellaneous|5|||
155599510|NCT02045862|561620501|FG001|Overall Study|Miscellaneous|0|||
155599511|NCT02045862|561620502|FG002|Overall Study|Miscellaneous|8|||
155599512|NCT02045862|561620500|FG000|Overall Study|Withdrawal by Patient|18|||
155599513|NCT02045862|561620501|FG001|Overall Study|Withdrawal by Patient|27|||
155599514|NCT02045862|561620502|FG002|Overall Study|Withdrawal by Patient|57|||
155599515|NCT02045862|561620500|FG000|Overall Study|Protocol Violation|0|||
155599516|NCT02045862|561620501|FG001|Overall Study|Protocol Violation|0|||
155599517|NCT02045862|561620502|FG002|Overall Study|Protocol Violation|6|||
155599518|NCT02045862|561620500|FG000|Overall Study|Lack of Efficacy|8|||
155599519|NCT02045862|561620501|FG001|Overall Study|Lack of Efficacy|4|||
155599520|NCT02045862|561620502|FG002|Overall Study|Lack of Efficacy|13|||
155599521|NCT02045862|561620500|FG000|Overall Study|Randomized but not Received Study Drug|0|||
155599522|NCT02045862|561620501|FG001|Overall Study|Randomized but not Received Study Drug|2|||
155599523|NCT02045862|561620502|FG002|Overall Study|Randomized but not Received Study Drug|8|||
155599524|NCT02045862|561620500|FG000|Overall Study|Adverse Event|7|||
155599525|NCT02045862|561620501|FG001|Overall Study|Adverse Event|5|||
155599526|NCT02045862|561620502|FG002|Overall Study|Adverse Event|27|||
155599527|NCT02045862|561620500|FG000|Overall Study|Lost to Follow-up|1|||
155599528|NCT02045862|561620501|FG001|Overall Study|Lost to Follow-up|2|||
155599529|NCT02045862|561620502|FG002|Overall Study|Lost to Follow-up|6|||
155599530|NCT02691013|561620505|FG000|Overall Study|Withdrawal by Subject|3|||
155675154|NCT00590122|561900587|FG000|Overall Study|swallowed oral dissolving dose|1|||
155675155|NCT00590122|561900588|FG001|Overall Study|swallowed oral dissolving dose|0|||
155599531|NCT02691013|561620506|FG001|Overall Study|Withdrawal by Subject|0|||
155599532|NCT02111785|561620508|FG000|Overall Study|Death|0|||
155599533|NCT02111785|561620509|FG001|Overall Study|Death|1|||
155599534|NCT02111785|561620510|FG002|Overall Study|Death|0|||
155599535|NCT02111785|561620511|FG003|Overall Study|Death|0|||
155599536|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Adverse Event|6|||
155599537|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Adverse Event|14|||
155599538|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Death|3|||
155599539|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Death|1|||
155599540|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
155599541|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
155599542|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
155599543|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
155599544|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
155599545|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
155599546|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
155599547|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
155599548|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
155599549|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
155599550|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Physician Decision|2|||
155599551|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Physician Decision|4|||
155599552|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Pregnancy|2|||
155599553|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Pregnancy|1|||
155599554|NCT02275780|561620512|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
155599555|NCT02275780|561620513|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
155599556|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
155599557|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
155599558|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
155599559|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
155599560|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
155599561|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
155599562|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
155599563|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
155599564|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
155599565|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
155599566|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
155599567|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
155599568|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
155599569|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
155599570|NCT02275780|561620512|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
155599571|NCT02275780|561620513|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
155599572|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
155599573|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
155599574|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
155599575|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
155599576|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
155599577|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
155599578|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
155599579|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
155599580|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
155599581|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
155599582|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
155599583|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
155599584|NCT02275780|561620512|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
155599585|NCT02275780|561620513|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
155599586|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
155599587|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
155599588|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
155599589|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
155599590|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
155599591|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
155599592|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
155599593|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
155599594|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
155675156|NCT03050450|561900589|FG000|Overall Study|Physician Decision|1|||
155675157|NCT03050450|561900590|FG001|Overall Study|Physician Decision|0|||
155675158|NCT03050450|561900591|FG002|Overall Study|Physician Decision|0|||
155675159|NCT03050450|561900592|FG003|Overall Study|Physician Decision|0|||
155675160|NCT03050450|561900593|FG004|Overall Study|Physician Decision|0|||
155675161|NCT01642901|561900594|FG000|12-month Follow-up|Withdrawal by Subject|1|||
155675162|NCT01642901|561900595|FG001|12-month Follow-up|Withdrawal by Subject|0|||
155675163|NCT00984165|561900602|FG000|Overall Study|Death on study|2|||
155675164|NCT00984165|561900603|FG001|Overall Study|Death on study|0|||
155675165|NCT00984165|561900604|FG002|Overall Study|Death on study|0|||
155675166|NCT00984165|561900605|FG003|Overall Study|Death on study|0|||
155675167|NCT00984165|561900602|FG000|Overall Study|Disease progression on study|5|||
155675168|NCT00984165|561900603|FG001|Overall Study|Disease progression on study|1|||
155675169|NCT00984165|561900604|FG002|Overall Study|Disease progression on study|0|||
155675170|NCT00984165|561900605|FG003|Overall Study|Disease progression on study|0|||
155675171|NCT00984165|561900602|FG000|Overall Study|Death of recipient|0|||
155675172|NCT00984165|561900603|FG001|Overall Study|Death of recipient|0|||
155675173|NCT00984165|561900604|FG002|Overall Study|Death of recipient|0|||
155675174|NCT00984165|561900605|FG003|Overall Study|Death of recipient|1|||
155675175|NCT00984165|561900602|FG000|Overall Study|New protocol|0|||
155675176|NCT00984165|561900603|FG001|Overall Study|New protocol|0|||
155675177|NCT00984165|561900604|FG002|Overall Study|New protocol|0|||
155675178|NCT00984165|561900605|FG003|Overall Study|New protocol|1|||
155675179|NCT00984165|561900602|FG000|Overall Study|P+/donor pair removed from protocol|0|||
155675180|NCT00984165|561900603|FG001|Overall Study|P+/donor pair removed from protocol|0|||
155675181|NCT00984165|561900604|FG002|Overall Study|P+/donor pair removed from protocol|0|||
155675182|NCT00984165|561900605|FG003|Overall Study|P+/donor pair removed from protocol|1|||
155675183|NCT00984165|561900602|FG000|Overall Study|removed with a pair recipient|0|||
155675184|NCT00984165|561900603|FG001|Overall Study|removed with a pair recipient|0|||
155675185|NCT00984165|561900604|FG002|Overall Study|removed with a pair recipient|0|||
155675186|NCT00984165|561900605|FG003|Overall Study|removed with a pair recipient|1|||
155675187|NCT00700622|561900607|FG000|Overall Study|Adverse Event|4|||
155675188|NCT00700622|561900608|FG001|Overall Study|Adverse Event|0|||
155675189|NCT00700622|561900607|FG000|Overall Study|Lost to Follow-up|0|||
155675190|NCT00700622|561900608|FG001|Overall Study|Lost to Follow-up|1|||
155675191|NCT00700622|561900607|FG000|Overall Study|Physician Decision|2|||
155675192|NCT00700622|561900608|FG001|Overall Study|Physician Decision|1|||
155675193|NCT00700622|561900607|FG000|Overall Study|Protocol Violation|0|||
155675194|NCT00700622|561900608|FG001|Overall Study|Protocol Violation|1|||
155675195|NCT00700622|561900607|FG000|Overall Study|Withdrawal by Subject|4|||
155675196|NCT00700622|561900608|FG001|Overall Study|Withdrawal by Subject|1|||
155675197|NCT00700622|561900607|FG000|Overall Study|Other|3|||
155675198|NCT00700622|561900608|FG001|Overall Study|Other|1|||
155675199|NCT00383331|561900609|FG000|Overall Study|Protocol Violation|0|||
155675200|NCT00383331|561900610|FG001|Overall Study|Protocol Violation|1|||
155675201|NCT01309997|561900611|FG000|Overall Study|Adverse Event|1|||
155675202|NCT01309997|561900612|FG001|Overall Study|Adverse Event|0|||
155675203|NCT01309997|561900611|FG000|Overall Study|Death|1|||
155675204|NCT01309997|561900612|FG001|Overall Study|Death|3|||
155675205|NCT01309997|561900611|FG000|Overall Study|Lack of Efficacy|2|||
155675206|NCT01309997|561900612|FG001|Overall Study|Lack of Efficacy|2|||
155675207|NCT01309997|561900611|FG000|Overall Study|Withdrawal by Subject|1|||
155675208|NCT01309997|561900612|FG001|Overall Study|Withdrawal by Subject|1|||
155599595|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
155599596|NCT02275780|561620512|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
155599597|NCT02275780|561620513|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
155599598|NCT01899742|561620518|FG000|Overall Study|Adverse Event|5|||
155599599|NCT01899742|561620519|FG001|Overall Study|Adverse Event|4|||
155599600|NCT01899742|561620518|FG000|Overall Study|Lack of Efficacy|1|||
155599601|NCT01899742|561620519|FG001|Overall Study|Lack of Efficacy|5|||
155599602|NCT01899742|561620518|FG000|Overall Study|Protocol Violation|2|||
155599603|NCT01899742|561620519|FG001|Overall Study|Protocol Violation|2|||
155599604|NCT01899742|561620518|FG000|Overall Study|Withdrawal by Subject|9|||
155599605|NCT01899742|561620519|FG001|Overall Study|Withdrawal by Subject|5|||
155599606|NCT02662764|561620520|FG000|Overall Study|Adverse Event|6|||
155599607|NCT02662764|561620520|FG000|Overall Study|Lack of Efficacy|8|||
155599608|NCT02662764|561620520|FG000|Overall Study|Protocol Violation|1|||
155599609|NCT02662764|561620520|FG000|Overall Study|Withdrawal by Subject|5|||
155599610|NCT02662764|561620520|FG000|Overall Study|Device failure|4|||
155599611|NCT02662764|561620520|FG000|Overall Study|Patient changed treatment|1|||
155675209|NCT00282087|561900613|FG000|Overall Study|Death|1|||
155675210|NCT03520920|561900614|FG000|Overall Study|Death|13|||
155675211|NCT03520920|561900615|FG001|Overall Study|Death|1|||
155675212|NCT03520920|561900616|FG002|Overall Study|Death|0|||
155675213|NCT03520920|561900614|FG000|Overall Study|Withdrawal by Subject|2|||
155675214|NCT03520920|561900615|FG001|Overall Study|Withdrawal by Subject|1|||
155675215|NCT03520920|561900616|FG002|Overall Study|Withdrawal by Subject|0|||
155675216|NCT03520920|561900614|FG000|Overall Study|Study Terminated by the Sponsor|5|||
155675217|NCT03520920|561900615|FG001|Overall Study|Study Terminated by the Sponsor|14|||
155675218|NCT03520920|561900616|FG002|Overall Study|Study Terminated by the Sponsor|5|||
155675219|NCT00372619|561900617|FG000|Overall Study|Ineligible|0|||
155675220|NCT00372619|561900618|FG001|Overall Study|Ineligible|0|||
155675221|NCT00372619|561900619|FG002|Overall Study|Ineligible|0|||
155675222|NCT00372619|561900620|FG003|Overall Study|Ineligible|0|||
155675223|NCT00372619|561900621|FG004|Overall Study|Ineligible|0|||
155675224|NCT00372619|561900622|FG005|Overall Study|Ineligible|2|||
155675225|NCT00372619|561900623|FG006|Overall Study|Ineligible|0|||
155675226|NCT00372619|561900617|FG000|Overall Study|Inevaluable|0|||
155675227|NCT00372619|561900618|FG001|Overall Study|Inevaluable|0|||
155675228|NCT00372619|561900619|FG002|Overall Study|Inevaluable|0|||
155675229|NCT00372619|561900620|FG003|Overall Study|Inevaluable|0|||
155675230|NCT00372619|561900621|FG004|Overall Study|Inevaluable|0|||
155675231|NCT00372619|561900622|FG005|Overall Study|Inevaluable|1|||
155675232|NCT00372619|561900623|FG006|Overall Study|Inevaluable|0|||
155675233|NCT00066222|561900624|FG000|Overall Study|No protocol treatment received|1|||
155675234|NCT00405392|561900625|FG000|Overall Study|Adverse Event|15|||
155675235|NCT00405392|561900626|FG001|Overall Study|Adverse Event|14|||
155675236|NCT00405392|561900625|FG000|Overall Study|Did not meet Eligibility criteria|7|||
155675237|NCT00405392|561900626|FG001|Overall Study|Did not meet Eligibility criteria|2|||
155675238|NCT00405392|561900625|FG000|Overall Study|Withdrawal by Subject|4|||
155675239|NCT00405392|561900626|FG001|Overall Study|Withdrawal by Subject|3|||
155675240|NCT00405392|561900625|FG000|Overall Study|Lost to Follow-up|1|||
155675241|NCT00405392|561900626|FG001|Overall Study|Lost to Follow-up|2|||
155675242|NCT00405392|561900625|FG000|Overall Study|Data missing|2|||
155675243|NCT00405392|561900626|FG001|Overall Study|Data missing|0|||
155675244|NCT00405392|561900625|FG000|Overall Study|Non-compliance|0|||
155675245|NCT00405392|561900626|FG001|Overall Study|Non-compliance|1|||
155675246|NCT00405392|561900625|FG000|Overall Study|Other|1|||
155675247|NCT00405392|561900626|FG001|Overall Study|Other|5|||
155675248|NCT00988052|561900640|FG000|Overall Study|Missing|1|||
155675249|NCT00988052|561900641|FG001|Overall Study|Missing|0|||
155675250|NCT00988052|561900640|FG000|Overall Study|Teva requested subject withdrawal|3|||
155675251|NCT00988052|561900641|FG001|Overall Study|Teva requested subject withdrawal|1|||
155675252|NCT00988052|561900640|FG000|Overall Study|Death|1|||
155675253|NCT00988052|561900641|FG001|Overall Study|Death|3|||
155675254|NCT00988052|561900640|FG000|Overall Study|Protocol Violation|6|||
155675255|NCT00988052|561900641|FG001|Overall Study|Protocol Violation|5|||
155675256|NCT00988052|561900640|FG000|Overall Study|Pregnancy|6|||
155675257|NCT00988052|561900641|FG001|Overall Study|Pregnancy|6|||
155675258|NCT00988052|561900640|FG000|Overall Study|Lack of Efficacy|8|||
155675259|NCT00988052|561900641|FG001|Overall Study|Lack of Efficacy|7|||
155675260|NCT00988052|561900640|FG000|Overall Study|Lost to Follow-up|6|||
155675261|NCT00988052|561900641|FG001|Overall Study|Lost to Follow-up|11|||
155675262|NCT00988052|561900640|FG000|Overall Study|Physician Decision|27|||
155675263|NCT00988052|561900641|FG001|Overall Study|Physician Decision|28|||
155675264|NCT00988052|561900640|FG000|Overall Study|Adverse Event|35|||
155675265|NCT00988052|561900641|FG001|Overall Study|Adverse Event|28|||
155675266|NCT00988052|561900640|FG000|Overall Study|Withdrawal by Subject|90|||
155675267|NCT00988052|561900641|FG001|Overall Study|Withdrawal by Subject|91|||
155675268|NCT00988052|561900640|FG000|Overall Study|Study terminated by sponsor|240|||
155675269|NCT00988052|561900641|FG001|Overall Study|Study terminated by sponsor|236|||
155675270|NCT00295646|561900642|FG000|Overall Study|Protocol Violation|18|||
155675271|NCT00295646|561900643|FG001|Overall Study|Protocol Violation|20|||
155675272|NCT00295646|561900644|FG002|Overall Study|Protocol Violation|20|||
155675273|NCT00295646|561900645|FG003|Overall Study|Protocol Violation|18|||
155675274|NCT00295646|561900642|FG000|Overall Study|Withdrawal by Subject|8|||
155675275|NCT00295646|561900643|FG001|Overall Study|Withdrawal by Subject|9|||
155675276|NCT00295646|561900644|FG002|Overall Study|Withdrawal by Subject|11|||
155675277|NCT00295646|561900645|FG003|Overall Study|Withdrawal by Subject|14|||
155675278|NCT00295646|561900642|FG000|Overall Study|Lost to Follow-up|0|||
155675279|NCT00295646|561900643|FG001|Overall Study|Lost to Follow-up|5|||
155675280|NCT00295646|561900644|FG002|Overall Study|Lost to Follow-up|1|||
155675281|NCT00295646|561900645|FG003|Overall Study|Lost to Follow-up|5|||
155675282|NCT00295646|561900642|FG000|Overall Study|Death|9|||
155675283|NCT00295646|561900643|FG001|Overall Study|Death|7|||
155675284|NCT00295646|561900644|FG002|Overall Study|Death|18|||
155675285|NCT00295646|561900645|FG003|Overall Study|Death|8|||
155675286|NCT01509846|561900647|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155675287|NCT01509846|561900648|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155675288|NCT01509846|561900649|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
155675289|NCT01509846|561900650|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155675290|NCT01509846|561900651|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155675291|NCT01509846|561900647|FG000|Received Vaccination 2|Illness|0|||
155675292|NCT01509846|561900648|FG001|Received Vaccination 2|Illness|0|||
155675293|NCT01509846|561900649|FG002|Received Vaccination 2|Illness|0|||
155675294|NCT01509846|561900650|FG003|Received Vaccination 2|Illness|0|||
155675295|NCT01509846|561900651|FG004|Received Vaccination 2|Illness|1|||
155675296|NCT01509846|561900647|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
155675297|NCT01509846|561900648|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
155675298|NCT01509846|561900649|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
155675299|NCT01509846|561900650|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
155675300|NCT01509846|561900651|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
155675301|NCT01509846|561900647|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
155675302|NCT01509846|561900648|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
155675303|NCT01509846|561900649|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
155675304|NCT01509846|561900650|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
155675305|NCT01509846|561900651|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
155675306|NCT01509846|561900647|FG000|Received Vaccination 3|Pregnancy|0|||
155675307|NCT01509846|561900648|FG001|Received Vaccination 3|Pregnancy|0|||
155675308|NCT01509846|561900649|FG002|Received Vaccination 3|Pregnancy|0|||
155675309|NCT01509846|561900650|FG003|Received Vaccination 3|Pregnancy|1|||
155675310|NCT01509846|561900651|FG004|Received Vaccination 3|Pregnancy|0|||
155675311|NCT01509846|561900647|FG000|Received Vaccination 3|Lost to Follow-up|0|||
155675312|NCT01509846|561900648|FG001|Received Vaccination 3|Lost to Follow-up|0|||
155675313|NCT01509846|561900649|FG002|Received Vaccination 3|Lost to Follow-up|1|||
155675314|NCT01509846|561900650|FG003|Received Vaccination 3|Lost to Follow-up|0|||
155675315|NCT01509846|561900651|FG004|Received Vaccination 3|Lost to Follow-up|0|||
155675316|NCT01637584|561900653|FG000|Overall Study|Withdrawal by Subject|1|||
155675317|NCT01637584|561900654|FG001|Overall Study|Withdrawal by Subject|3|||
155675318|NCT04396795|561900655|FG000|Month 1|Lost to Follow-up|2|||
155675319|NCT04396795|561900656|FG001|Month 1|Lost to Follow-up|3|||
155675320|NCT04396795|561900655|FG000|Month 3|Lost to Follow-up|1|||
155675321|NCT04396795|561900656|FG001|Month 3|Lost to Follow-up|3|||
155675322|NCT04396795|561900655|FG000|Month 6|Lost to Follow-up|3|||
155675323|NCT04396795|561900656|FG001|Month 6|Lost to Follow-up|3|||
155675324|NCT02484443|561900657|FG000|Overall Study|Lack of Efficacy|28|||
155675325|NCT02484443|561900657|FG000|Overall Study|Physician Decision|2|||
155675326|NCT02484443|561900657|FG000|Overall Study|Ineligible|2|||
155675327|NCT01970241|561900658|FG000|Overall Study|Withdrawal by Subject|2|||
155675328|NCT01970241|561900659|FG001|Overall Study|Withdrawal by Subject|0|||
155675329|NCT01970241|561900658|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
155675330|NCT01970241|561900659|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
155675331|NCT03472495|561900660|FG000|Overall Study|Treatment no longer indicated|1|||
155675332|NCT03472495|561900661|FG001|Overall Study|Treatment no longer indicated|2|||
155675333|NCT03472495|561900660|FG000|Overall Study|Physician Decision|0|||
155675334|NCT03472495|561900661|FG001|Overall Study|Physician Decision|2|||
155675335|NCT02595866|561900662|FG000|Overall Study|Adverse Event|2|||
155675336|NCT02595866|561900663|FG001|Overall Study|Adverse Event|5|||
155675337|NCT02595866|561900662|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
155675338|NCT02595866|561900663|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
155675339|NCT02595866|561900662|FG000|Overall Study|Death|0|||
155675340|NCT02595866|561900663|FG001|Overall Study|Death|1|||
155675341|NCT02595866|561900662|FG000|Overall Study|Incarceration|1|||
155675342|NCT02595866|561900663|FG001|Overall Study|Incarceration|0|||
155675343|NCT02595866|561900662|FG000|Overall Study|Lack of Efficacy|17|||
155675344|NCT02595866|561900663|FG001|Overall Study|Lack of Efficacy|7|||
155675345|NCT02595866|561900662|FG000|Overall Study|Physician Decision|4|||
155675346|NCT02595866|561900663|FG001|Overall Study|Physician Decision|3|||
155675347|NCT02595866|561900662|FG000|Overall Study|Switched to Alternative Treatment|1|||
155675348|NCT02595866|561900663|FG001|Overall Study|Switched to Alternative Treatment|0|||
155675349|NCT02595866|561900662|FG000|Overall Study|Study Terminated|0|||
155675350|NCT02595866|561900663|FG001|Overall Study|Study Terminated|4|||
155675351|NCT02595866|561900662|FG000|Overall Study|Withdrawal by Subject|6|||
155675352|NCT02595866|561900663|FG001|Overall Study|Withdrawal by Subject|1|||
155675353|NCT02689206|561900665|FG000|Overall Study|Adverse Event|0|||
155675354|NCT02689206|561900666|FG001|Overall Study|Adverse Event|0|||
155675355|NCT02689206|561900667|FG002|Overall Study|Adverse Event|1|||
155675356|NCT02689206|561900668|FG003|Overall Study|Adverse Event|0|||
155675357|NCT02689206|561900669|FG004|Overall Study|Adverse Event|2|||
155675358|NCT02689206|561900665|FG000|Overall Study|Protocol Violation|1|||
155675359|NCT02689206|561900666|FG001|Overall Study|Protocol Violation|0|||
155675360|NCT02689206|561900667|FG002|Overall Study|Protocol Violation|0|||
155675361|NCT02689206|561900668|FG003|Overall Study|Protocol Violation|1|||
155675362|NCT02689206|561900669|FG004|Overall Study|Protocol Violation|2|||
155675363|NCT02689206|561900665|FG000|Overall Study|Other: Reached stopping criteria|0|||
155675364|NCT02689206|561900666|FG001|Overall Study|Other: Reached stopping criteria|1|||
155675365|NCT02689206|561900667|FG002|Overall Study|Other: Reached stopping criteria|2|||
155675366|NCT02689206|561900668|FG003|Overall Study|Other: Reached stopping criteria|3|||
155675367|NCT02689206|561900669|FG004|Overall Study|Other: Reached stopping criteria|4|||
155675368|NCT02689206|561900665|FG000|Overall Study|Physician Decision|1|||
155675369|NCT02689206|561900666|FG001|Overall Study|Physician Decision|0|||
155675370|NCT02689206|561900667|FG002|Overall Study|Physician Decision|0|||
155675371|NCT02689206|561900668|FG003|Overall Study|Physician Decision|0|||
155675372|NCT02689206|561900669|FG004|Overall Study|Physician Decision|0|||
155675373|NCT02689206|561900665|FG000|Overall Study|Withdrawal by Subject|1|||
155675374|NCT02689206|561900666|FG001|Overall Study|Withdrawal by Subject|0|||
155675375|NCT02689206|561900667|FG002|Overall Study|Withdrawal by Subject|1|||
155675376|NCT02689206|561900668|FG003|Overall Study|Withdrawal by Subject|0|||
155675377|NCT02689206|561900669|FG004|Overall Study|Withdrawal by Subject|0|||
155675378|NCT02131311|561900671|FG000|Overall Study|Adverse Event|2|||
155675379|NCT02131311|561900671|FG000|Overall Study|Protocol Violation|1|||
155675380|NCT02131311|561900671|FG000|Overall Study|Lost to Follow-up|1|||
155675381|NCT01479764|561900672|FG000|Randomized|Adverse Event|1|||
155675382|NCT01479764|561900673|FG001|Randomized|Adverse Event|1|||
155675383|NCT01479764|561900672|FG000|Randomized|Withdrawal by Subject|1|||
155675384|NCT01479764|561900673|FG001|Randomized|Withdrawal by Subject|0|||
155675385|NCT01479764|561900672|FG000|Treated|Lost to Follow-up|0|||
155675386|NCT01479764|561900673|FG001|Treated|Lost to Follow-up|2|||
155675387|NCT03082677|561900674|FG000|Overall Study|Not Treated|2|||
155675388|NCT00255723|561900679|FG000|Overall Study|Adverse Event|1|||
155675389|NCT00255723|561900680|FG001|Overall Study|Adverse Event|1|||
155675390|NCT00255723|561900679|FG000|Overall Study|Death|0|||
155675391|NCT00255723|561900680|FG001|Overall Study|Death|1|||
155675392|NCT00255723|561900679|FG000|Overall Study|Response Data Not Available|1|||
155675393|NCT00255723|561900680|FG001|Overall Study|Response Data Not Available|0|||
155675394|NCT00431444|561900681|FG000|Overall Study|Protocol Violation|1|||
155675395|NCT00431444|561900682|FG001|Overall Study|Protocol Violation|4|||
155675396|NCT00431444|561900681|FG000|Overall Study|Adverse Event|2|||
155675397|NCT00431444|561900682|FG001|Overall Study|Adverse Event|1|||
155675398|NCT00431444|561900681|FG000|Overall Study|Withdrawal by Subject|1|||
155675399|NCT00431444|561900682|FG001|Overall Study|Withdrawal by Subject|1|||
155675400|NCT00431444|561900681|FG000|Overall Study|Lost to Follow-up|1|||
155675401|NCT00431444|561900682|FG001|Overall Study|Lost to Follow-up|0|||
155675402|NCT00431444|561900681|FG000|Overall Study|Administrative Problems|0|||
155675403|NCT00431444|561900682|FG001|Overall Study|Administrative Problems|1|||
155675404|NCT03497039|561900686|FG000|Overall Study|Withdrawal by Subject|1|||
155675405|NCT03497039|561900687|FG001|Overall Study|Withdrawal by Subject|0|||
155675406|NCT03497039|561900686|FG000|Overall Study|Protocol Violation|0|||
155675407|NCT03497039|561900687|FG001|Overall Study|Protocol Violation|1|||
155675408|NCT03554018|561900689|FG000|Overall Study|Lost to Follow-up|3|||
155675409|NCT03554018|561900690|FG001|Overall Study|Lost to Follow-up|7|||
155675410|NCT02131662|561900691|FG000|Overall Study|Protocol Violation|1|||
155675411|NCT02131662|561900692|FG001|Overall Study|Protocol Violation|0|||
155675412|NCT02131662|561900693|FG002|Overall Study|Protocol Violation|0|||
155675413|NCT02131662|561900694|FG003|Overall Study|Protocol Violation|0|||
155675414|NCT02131662|561900695|FG004|Overall Study|Protocol Violation|0|||
155675415|NCT02131662|561900691|FG000|Overall Study|Other|2|||
155675416|NCT02131662|561900692|FG001|Overall Study|Other|4|||
155675417|NCT02131662|561900693|FG002|Overall Study|Other|3|||
155675418|NCT02131662|561900694|FG003|Overall Study|Other|3|||
155675419|NCT02131662|561900695|FG004|Overall Study|Other|4|||
155675420|NCT02131662|561900691|FG000|Overall Study|Adverse Event|0|||
155675421|NCT02131662|561900692|FG001|Overall Study|Adverse Event|1|||
155675422|NCT02131662|561900693|FG002|Overall Study|Adverse Event|1|||
155675423|NCT02131662|561900694|FG003|Overall Study|Adverse Event|1|||
155675424|NCT02131662|561900695|FG004|Overall Study|Adverse Event|3|||
155675425|NCT02131662|561900691|FG000|Overall Study|Pregnancy|0|||
155675426|NCT02131662|561900692|FG001|Overall Study|Pregnancy|1|||
155675427|NCT02131662|561900693|FG002|Overall Study|Pregnancy|0|||
155675428|NCT02131662|561900694|FG003|Overall Study|Pregnancy|1|||
155675429|NCT02131662|561900695|FG004|Overall Study|Pregnancy|0|||
155675430|NCT02131662|561900691|FG000|Overall Study|Wish for pregnancy|0|||
155675431|NCT02131662|561900692|FG001|Overall Study|Wish for pregnancy|0|||
155675432|NCT02131662|561900693|FG002|Overall Study|Wish for pregnancy|0|||
155675433|NCT02131662|561900694|FG003|Overall Study|Wish for pregnancy|0|||
155675434|NCT02131662|561900695|FG004|Overall Study|Wish for pregnancy|1|||
155675435|NCT02131662|561900691|FG000|Overall Study|Lack of Efficacy|1|||
155675436|NCT02131662|561900692|FG001|Overall Study|Lack of Efficacy|0|||
155675437|NCT02131662|561900693|FG002|Overall Study|Lack of Efficacy|0|||
155675438|NCT02131662|561900694|FG003|Overall Study|Lack of Efficacy|0|||
155675439|NCT02131662|561900695|FG004|Overall Study|Lack of Efficacy|1|||
155675440|NCT02131662|561900691|FG000|Overall Study|Withdrawal by Subject|1|||
155675441|NCT02131662|561900692|FG001|Overall Study|Withdrawal by Subject|5|||
155675442|NCT02131662|561900693|FG002|Overall Study|Withdrawal by Subject|1|||
155675443|NCT02131662|561900694|FG003|Overall Study|Withdrawal by Subject|5|||
155675444|NCT02131662|561900695|FG004|Overall Study|Withdrawal by Subject|6|||
155675445|NCT02131662|561900691|FG000|Overall Study|Lost to Follow-up|1|||
155675446|NCT02131662|561900692|FG001|Overall Study|Lost to Follow-up|3|||
155675447|NCT02131662|561900693|FG002|Overall Study|Lost to Follow-up|0|||
155675448|NCT02131662|561900694|FG003|Overall Study|Lost to Follow-up|9|||
155675449|NCT02131662|561900695|FG004|Overall Study|Lost to Follow-up|0|||
155675450|NCT02131662|561900691|FG000|Overall Study|Not treated|2|||
155675451|NCT02131662|561900692|FG001|Overall Study|Not treated|0|||
155675452|NCT02131662|561900693|FG002|Overall Study|Not treated|2|||
155675453|NCT02131662|561900694|FG003|Overall Study|Not treated|2|||
155675454|NCT02131662|561900695|FG004|Overall Study|Not treated|3|||
155675455|NCT01928433|561900697|FG000|Overall Study|Adverse Event|5|||
155675456|NCT01928433|561900698|FG001|Overall Study|Adverse Event|2|||
155675457|NCT01928433|561900699|FG002|Overall Study|Adverse Event|5|||
155675458|NCT01928433|561900697|FG000|Overall Study|Protocol Violation|0|||
155675459|NCT01928433|561900698|FG001|Overall Study|Protocol Violation|0|||
155675460|NCT01928433|561900699|FG002|Overall Study|Protocol Violation|2|||
155675461|NCT01928433|561900697|FG000|Overall Study|Lack of Efficacy|5|||
155675462|NCT01928433|561900698|FG001|Overall Study|Lack of Efficacy|4|||
155675463|NCT01928433|561900699|FG002|Overall Study|Lack of Efficacy|4|||
155675464|NCT01928433|561900697|FG000|Overall Study|Withdrawal by Subject|0|||
155675465|NCT01928433|561900698|FG001|Overall Study|Withdrawal by Subject|4|||
155675466|NCT01928433|561900699|FG002|Overall Study|Withdrawal by Subject|0|||
155675467|NCT01928433|561900697|FG000|Overall Study|Negative screening urine culture|7|||
155675468|NCT01928433|561900698|FG001|Overall Study|Negative screening urine culture|6|||
155675469|NCT01928433|561900699|FG002|Overall Study|Negative screening urine culture|10|||
155675470|NCT01928433|561900697|FG000|Overall Study|Lost to Follow-up|0|||
155675471|NCT01928433|561900698|FG001|Overall Study|Lost to Follow-up|2|||
155675472|NCT01928433|561900699|FG002|Overall Study|Lost to Follow-up|3|||
155675473|NCT01928433|561900697|FG000|Overall Study|Other reasons|3|||
155675474|NCT01928433|561900698|FG001|Overall Study|Other reasons|3|||
155675475|NCT01928433|561900699|FG002|Overall Study|Other reasons|4|||
155675476|NCT01740687|561900700|FG000|Overall Study|Lost to Follow-up|11|||
155675477|NCT01740687|561900700|FG000|Overall Study|Withdrawal by Subject|2|||
155675478|NCT01740687|561900700|FG000|Overall Study|other reason|22|||
155675479|NCT01740687|561900700|FG000|Overall Study|treatment not received|2|||
155675480|NCT00854724|561902226|FG000|First Intervention|Withdrawal by Subject|1|||
155675481|NCT00854724|561902227|FG001|First Intervention|Withdrawal by Subject|1|||
155675482|NCT00854724|561902226|FG000|Washout|Protocol Violation|1|||
155675483|NCT00854724|561902227|FG001|Washout|Protocol Violation|0|||
155675484|NCT00854724|561902226|FG000|Washout|Withdrawal by Subject|0|||
155675485|NCT00854724|561902227|FG001|Washout|Withdrawal by Subject|1|||
155675486|NCT00854724|561902226|FG000|Second Intervention|Protocol Violation|1|||
155675487|NCT00854724|561902227|FG001|Second Intervention|Protocol Violation|0|||
155675488|NCT00854724|561902226|FG000|Second Intervention|Physician Decision|0|||
155675489|NCT00854724|561902227|FG001|Second Intervention|Physician Decision|1|||
155675490|NCT00933608|561902229|FG000|Overall Study|Adverse Event|4|||
155675491|NCT00933608|561902230|FG001|Overall Study|Adverse Event|2|||
155675492|NCT00933608|561902229|FG000|Overall Study|Physician Decision|1|||
155675493|NCT00933608|561902230|FG001|Overall Study|Physician Decision|0|||
155675494|NCT00336284|561902235|FG000|Overall Study|Death|52|||
155675495|NCT00336284|561902236|FG001|Overall Study|Death|26|||
155675496|NCT00336284|561902235|FG000|Overall Study|Lost to Follow-up|82|||
155675497|NCT00336284|561902236|FG001|Overall Study|Lost to Follow-up|61|||
155675498|NCT00336284|561902235|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
155675499|NCT00336284|561902236|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
155675500|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
155675501|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
155675502|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
155675503|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
155675504|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
155675505|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
155675506|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
155675507|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
155675508|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
155675509|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
155675510|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
155675511|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
155675512|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
155675513|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
155675514|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
155675515|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
155675516|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
155675517|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
155675518|NCT03308968|561902239|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
155675519|NCT03308968|561902240|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
155675520|NCT03308968|561902241|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
155675521|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
155675522|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
155675523|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
155675524|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
155675525|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
155599612|NCT02662764|561620520|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
155599613|NCT00759785|561620525|FG000|Overall Study|Participant sample not evaluable|11|||
155599614|NCT00759785|561620526|FG001|Overall Study|Participant sample not evaluable|2|||
155599615|NCT00759785|561620525|FG000|Overall Study|Participant sample lost|0|||
155599616|NCT00759785|561620526|FG001|Overall Study|Participant sample lost|1|||
155599617|NCT00759785|561620525|FG000|Overall Study|Protocol Violation|1|||
155599618|NCT00759785|561620526|FG001|Overall Study|Protocol Violation|0|||
155599619|NCT00759785|561620525|FG000|Overall Study|Physician Decision|0|||
155599620|NCT00759785|561620526|FG001|Overall Study|Physician Decision|1|||
155599621|NCT00759785|561620525|FG000|Overall Study|Withdrawal by Subject|0|||
155599622|NCT00759785|561620526|FG001|Overall Study|Withdrawal by Subject|1|||
155599623|NCT00177307|561620527|FG000|Overall Study|Withdrawal by Subject|1|||
155599624|NCT02677038|561620528|FG000|Overall Study|Physician Decision|1|||
155599625|NCT02677038|561620528|FG000|Overall Study|Withdrawal by Subject|1|||
155599626|NCT05178641|561620538|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
155599627|NCT05178641|561620539|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
155599628|NCT05178641|561620538|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
155599629|NCT05178641|561620539|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
155599630|NCT00278148|561620544|FG000|Phase II - Expansion Phase|Disease progression|0|||
155599631|NCT00278148|561620545|FG001|Phase II - Expansion Phase|Disease progression|0|||
155599632|NCT00278148|561620546|FG002|Phase II - Expansion Phase|Disease progression|4|||
155599633|NCT00278148|561620544|FG000|Phase II - Expansion Phase|Adverse Event|0|||
155599634|NCT00278148|561620545|FG001|Phase II - Expansion Phase|Adverse Event|0|||
155599635|NCT00278148|561620546|FG002|Phase II - Expansion Phase|Adverse Event|2|||
155599636|NCT01546168|561620549|FG000|Overall Study|Lost to Follow-up|1|||
155599637|NCT01546168|561620550|FG001|Overall Study|Lost to Follow-up|0|||
155599638|NCT01546168|561620549|FG000|Overall Study|Withdrawal by Subject|1|||
155599639|NCT01546168|561620550|FG001|Overall Study|Withdrawal by Subject|0|||
155599640|NCT01546168|561620549|FG000|Overall Study|ineligible after signing consent|2|||
155599641|NCT01546168|561620550|FG001|Overall Study|ineligible after signing consent|0|||
155599642|NCT02850016|561620553|FG000|Overall Study|Withdrawal by Subject|1|||
155599643|NCT02850016|561620554|FG001|Overall Study|Withdrawal by Subject|2|||
155599644|NCT00070018|561620555|FG000|Overall Study|Adverse Event|2|||
155599645|NCT00070018|561620555|FG000|Overall Study|Lack of Efficacy|1|||
155599646|NCT00070018|561620555|FG000|Overall Study|Withdrawal by Subject|1|||
155599647|NCT04442269|561620558|FG000|Overall Study|Adverse Event|1|||
155599648|NCT04442269|561620559|FG001|Overall Study|Adverse Event|0|||
155599649|NCT04442269|561620558|FG000|Overall Study|Death|0|||
155599650|NCT04442269|561620559|FG001|Overall Study|Death|1|||
155599651|NCT04442269|561620558|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
155599652|NCT04442269|561620559|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
155599653|NCT04442269|561620558|FG000|Overall Study|Lost to Follow-up|1|||
155599654|NCT04442269|561620559|FG001|Overall Study|Lost to Follow-up|0|||
155599655|NCT04442269|561620558|FG000|Overall Study|Withdrawal by Subject|3|||
155599656|NCT04442269|561620559|FG001|Overall Study|Withdrawal by Subject|2|||
155599657|NCT04442269|561620558|FG000|Overall Study|Protocol Deviation|0|||
155599658|NCT04442269|561620559|FG001|Overall Study|Protocol Deviation|1|||
155599659|NCT04442269|561620558|FG000|Overall Study|Travel Limitations|1|||
155599660|NCT04442269|561620559|FG001|Overall Study|Travel Limitations|1|||
155599661|NCT03802565|561620560|FG000|Overall Study|Adverse Event|0|||
155599662|NCT03802565|561620561|FG001|Overall Study|Adverse Event|1|||
155599663|NCT03802565|561620562|FG002|Overall Study|Adverse Event|2|||
155599664|NCT03802565|561620563|FG003|Overall Study|Adverse Event|1|||
155599665|NCT03802565|561620564|FG004|Overall Study|Adverse Event|1|||
155599666|NCT03802565|561620560|FG000|Overall Study|Withdrawal by Subject|2|||
155599667|NCT03802565|561620561|FG001|Overall Study|Withdrawal by Subject|2|||
155599668|NCT03802565|561620562|FG002|Overall Study|Withdrawal by Subject|2|||
155599669|NCT03802565|561620563|FG003|Overall Study|Withdrawal by Subject|0|||
155599670|NCT03802565|561620564|FG004|Overall Study|Withdrawal by Subject|1|||
155599671|NCT03802565|561620560|FG000|Overall Study|Protocol Violation|2|||
155599672|NCT03802565|561620561|FG001|Overall Study|Protocol Violation|1|||
155599673|NCT03802565|561620562|FG002|Overall Study|Protocol Violation|4|||
155599674|NCT03802565|561620563|FG003|Overall Study|Protocol Violation|5|||
155599675|NCT03802565|561620564|FG004|Overall Study|Protocol Violation|1|||
155599676|NCT03802565|561620560|FG000|Overall Study|Lost to Follow-up|0|||
155599677|NCT03802565|561620561|FG001|Overall Study|Lost to Follow-up|0|||
155599678|NCT03802565|561620562|FG002|Overall Study|Lost to Follow-up|1|||
155599679|NCT03802565|561620563|FG003|Overall Study|Lost to Follow-up|0|||
155599680|NCT03802565|561620564|FG004|Overall Study|Lost to Follow-up|0|||
155599681|NCT03802565|561620560|FG000|Overall Study|Subjects Related to Each Other|1|||
155599682|NCT03802565|561620561|FG001|Overall Study|Subjects Related to Each Other|0|||
155599683|NCT03802565|561620562|FG002|Overall Study|Subjects Related to Each Other|0|||
155599684|NCT03802565|561620563|FG003|Overall Study|Subjects Related to Each Other|2|||
155599685|NCT03802565|561620564|FG004|Overall Study|Subjects Related to Each Other|1|||
155599686|NCT03802565|561620560|FG000|Overall Study|Elevated Enzymes|0|||
155675526|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
155675527|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
155675528|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
155675529|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
155675530|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
155675531|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
155675532|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
155675533|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
155675534|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
155675535|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
155675536|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
155675537|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
155675538|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
155675539|NCT03308968|561902239|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
155675540|NCT03308968|561902240|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
155675541|NCT03308968|561902241|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
155675542|NCT01521923|561902245|FG000|Overall Study|AE, serious fatal|1|||
155675543|NCT01521923|561902246|FG001|Overall Study|AE, serious fatal|0|||
155675544|NCT01521923|561902247|FG002|Overall Study|AE, serious fatal|0|||
155675545|NCT01521923|561902248|FG003|Overall Study|AE, serious fatal|0|||
155675546|NCT01521923|561902245|FG000|Overall Study|SAE, non-fatal|0|||
155675547|NCT01521923|561902246|FG001|Overall Study|SAE, non-fatal|2|||
155675548|NCT01521923|561902247|FG002|Overall Study|SAE, non-fatal|2|||
155675549|NCT01521923|561902248|FG003|Overall Study|SAE, non-fatal|0|||
155599687|NCT03802565|561620561|FG001|Overall Study|Elevated Enzymes|0|||
155599688|NCT03802565|561620562|FG002|Overall Study|Elevated Enzymes|0|||
155599689|NCT03802565|561620563|FG003|Overall Study|Elevated Enzymes|0|||
155599690|NCT03802565|561620564|FG004|Overall Study|Elevated Enzymes|2|||
155599691|NCT00430352|561620568|FG000|Overall Study|Disease progression|58|||
155599692|NCT00430352|561620568|FG000|Overall Study|Withdrawal by Subject|11|||
155599693|NCT00430352|561620568|FG000|Overall Study|Adverse Event|16|||
155599694|NCT00430352|561620568|FG000|Overall Study|Death|5|||
155599695|NCT00430352|561620568|FG000|Overall Study|Other|48|||
155599696|NCT03099694|561620569|FG000|Overall Study|Withdrawal by Subject|11|||
155599697|NCT03099694|561620570|FG001|Overall Study|Withdrawal by Subject|13|||
155599698|NCT03099694|561620569|FG000|Overall Study|Lost to Follow-up|9|||
155599699|NCT03099694|561620570|FG001|Overall Study|Lost to Follow-up|5|||
155599700|NCT04326439|561620571|FG000|Overall Study|Withdrawal by Subject|1|||
155599701|NCT04326439|561620572|FG001|Overall Study|Withdrawal by Subject|0|||
155599702|NCT04326439|561620571|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
155599703|NCT04326439|561620572|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
155599704|NCT04326439|561620571|FG000|Overall Study|Relapse after Induction 2|0|||
155599705|NCT04326439|561620572|FG001|Overall Study|Relapse after Induction 2|1|||
155599706|NCT04326439|561620571|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
155599707|NCT04326439|561620572|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
155599708|NCT01446237|561620573|FG000|Overall Study|Adverse Event|1|||
155599709|NCT01446237|561620573|FG000|Overall Study|Lost to Follow-up|2|||
155599710|NCT01446237|561620573|FG000|Overall Study|Withdrawal by Subject|7|||
155599711|NCT01744184|561620588|FG000|Overall Study|Adverse Event|1|||
155599712|NCT01744184|561620589|FG001|Overall Study|Adverse Event|0|||
155599713|NCT01744184|561620588|FG000|Overall Study|Withdrawal by Subject|0|||
155599714|NCT01744184|561620589|FG001|Overall Study|Withdrawal by Subject|1|||
155599715|NCT00072280|561620590|FG000|Treatment|Found ineligible|1|||
155599716|NCT00072280|561620591|FG001|Treatment|Found ineligible|2|||
155599717|NCT00072280|561620590|FG000|Follow-up|Early termination of study|2|||
155599718|NCT00072280|561620591|FG001|Follow-up|Early termination of study|2|||
155599719|NCT00197002|561622402|FG000|Overall Study|Adverse Event|0|||
155599720|NCT00197002|561622403|FG001|Overall Study|Adverse Event|1|||
155599721|NCT00197002|561622404|FG002|Overall Study|Adverse Event|0|||
155599722|NCT00197002|561622402|FG000|Overall Study|Protocol Violation|1|||
155599723|NCT00197002|561622403|FG001|Overall Study|Protocol Violation|0|||
155599724|NCT00197002|561622404|FG002|Overall Study|Protocol Violation|2|||
155599725|NCT00197002|561622402|FG000|Overall Study|Withdrawal by Subject|9|||
155599726|NCT00197002|561622403|FG001|Overall Study|Withdrawal by Subject|5|||
155599727|NCT00197002|561622404|FG002|Overall Study|Withdrawal by Subject|7|||
155599728|NCT00197002|561622402|FG000|Overall Study|Migrated/moved from study area|3|||
155599729|NCT00197002|561622403|FG001|Overall Study|Migrated/moved from study area|5|||
155675550|NCT01521923|561902245|FG000|Overall Study|AE, non-serious, non-fatal|1|||
155675551|NCT01521923|561902246|FG001|Overall Study|AE, non-serious, non-fatal|3|||
155599730|NCT00197002|561622404|FG002|Overall Study|Migrated/moved from study area|1|||
155599731|NCT00197002|561622402|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
155599732|NCT00197002|561622403|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
155599733|NCT00197002|561622404|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
155599734|NCT00197002|561622402|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
155599735|NCT00197002|561622403|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
155599736|NCT00197002|561622404|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
155599737|NCT00197002|561622402|FG000|Overall Study|Others|3|||
155599738|NCT00197002|561622403|FG001|Overall Study|Others|1|||
155599739|NCT00197002|561622404|FG002|Overall Study|Others|1|||
155599740|NCT05072106|561622407|FG000|Overall Study|Progressive disease|3|||
155599741|NCT05072106|561622408|FG001|Overall Study|Progressive disease|3|||
155599742|NCT05072106|561622407|FG000|Overall Study|Compassionate use|3|||
155599743|NCT05072106|561622408|FG001|Overall Study|Compassionate use|1|||
155599744|NCT05072106|561622407|FG000|Overall Study|Withdrawal by Subject|1|||
155599745|NCT05072106|561622408|FG001|Overall Study|Withdrawal by Subject|0|||
155599746|NCT03839459|561622409|FG000|Overall Study|Withdrawal by Subject|2|||
155599747|NCT03839459|561622409|FG000|Overall Study|progression of disease|3|||
155599748|NCT04240886|561622410|FG000|Treatment Phase|Death|4|||
155599749|NCT04240886|561622410|FG000|Treatment Phase|Discontinuation by Subject|1|||
155599750|NCT04240886|561622410|FG000|Treatment Phase|Adverse Event|5|||
155599751|NCT04240886|561622410|FG000|Follow-up Phase|Withdrawal by Subject|1|||
155599752|NCT04240886|561622410|FG000|Follow-up Phase|Discontinuation by Subject|1|||
155599753|NCT04240886|561622410|FG000|Follow-up Phase|Death|2|||
155599754|NCT04161079|561622415|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
155599755|NCT04327661|561622418|FG000|Overall Study|Withdrawal by Subject|1|||
155599756|NCT04327661|561622419|FG001|Overall Study|Withdrawal by Subject|0|||
155599757|NCT04327661|561622420|FG002|Overall Study|Withdrawal by Subject|0|||
155599758|NCT01054300|561622427|FG000|Period 1|Adverse Event|1|||
155599759|NCT01054300|561622428|FG001|Period 1|Adverse Event|0|||
155599760|NCT01054300|561622429|FG002|Period 1|Adverse Event|0|||
155599761|NCT01054300|561622430|FG003|Period 1|Adverse Event|0|||
155599762|NCT01054300|561622427|FG000|Period 2|Withdrawal by Subject|0|||
155599763|NCT01054300|561622428|FG001|Period 2|Withdrawal by Subject|0|||
155599764|NCT01054300|561622429|FG002|Period 2|Withdrawal by Subject|1|||
155599765|NCT01054300|561622430|FG003|Period 2|Withdrawal by Subject|0|||
155599766|NCT00738881|561622434|FG000|Overall Study|Withdrawal by Subject|0|||
155599767|NCT00738881|561622435|FG001|Overall Study|Withdrawal by Subject|2|||
155599768|NCT03671564|561622439|FG000|Overall Study|Progressive Disease|3|||
155599769|NCT03671564|561622440|FG001|Overall Study|Progressive Disease|5|||
155599770|NCT03671564|561622441|FG002|Overall Study|Progressive Disease|3|||
155599771|NCT03671564|561622439|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
155599772|NCT03671564|561622440|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
155599773|NCT03671564|561622441|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
155599774|NCT03671564|561622439|FG000|Overall Study|Withdrawal by Subject|1|||
155599775|NCT03671564|561622440|FG001|Overall Study|Withdrawal by Subject|1|||
155599776|NCT03671564|561622441|FG002|Overall Study|Withdrawal by Subject|0|||
155599777|NCT01282164|561622442|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
155599778|NCT01282164|561622443|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
155599779|NCT04521621|561622444|FG000|Overall Study|Death|17|||
155599780|NCT04521621|561622445|FG001|Overall Study|Death|8|||
155599781|NCT04521621|561622446|FG002|Overall Study|Death|8|||
155599782|NCT04521621|561622447|FG003|Overall Study|Death|5|||
155599783|NCT04521621|561622448|FG004|Overall Study|Death|2|||
155599784|NCT04521621|561622449|FG005|Overall Study|Death|7|||
155599785|NCT04521621|561622450|FG006|Overall Study|Death|0|||
155599786|NCT04521621|561622451|FG007|Overall Study|Death|0|||
155599787|NCT04521621|561622444|FG000|Overall Study|Study Terminated by Sponsor|4|||
155599788|NCT04521621|561622445|FG001|Overall Study|Study Terminated by Sponsor|6|||
155599789|NCT04521621|561622446|FG002|Overall Study|Study Terminated by Sponsor|8|||
155599790|NCT04521621|561622447|FG003|Overall Study|Study Terminated by Sponsor|0|||
155599791|NCT04521621|561622448|FG004|Overall Study|Study Terminated by Sponsor|1|||
155599792|NCT04521621|561622449|FG005|Overall Study|Study Terminated by Sponsor|7|||
155599793|NCT04521621|561622450|FG006|Overall Study|Study Terminated by Sponsor|0|||
155599794|NCT04521621|561622451|FG007|Overall Study|Study Terminated by Sponsor|0|||
155599795|NCT04521621|561622444|FG000|Overall Study|Withdrawal by Subject|0|||
155599796|NCT04521621|561622445|FG001|Overall Study|Withdrawal by Subject|0|||
155599797|NCT04521621|561622446|FG002|Overall Study|Withdrawal by Subject|1|||
155599798|NCT04521621|561622447|FG003|Overall Study|Withdrawal by Subject|1|||
155599799|NCT04521621|561622448|FG004|Overall Study|Withdrawal by Subject|0|||
155599800|NCT04521621|561622449|FG005|Overall Study|Withdrawal by Subject|0|||
155599801|NCT04521621|561622450|FG006|Overall Study|Withdrawal by Subject|0|||
155599802|NCT04521621|561622451|FG007|Overall Study|Withdrawal by Subject|0|||
155599803|NCT04521621|561622444|FG000|Overall Study|Allocated in error without study intervention|1|||
155599804|NCT04521621|561622445|FG001|Overall Study|Allocated in error without study intervention|0|||
155599805|NCT04521621|561622446|FG002|Overall Study|Allocated in error without study intervention|0|||
155599806|NCT04521621|561622447|FG003|Overall Study|Allocated in error without study intervention|0|||
155599807|NCT04521621|561622448|FG004|Overall Study|Allocated in error without study intervention|0|||
155599808|NCT04521621|561622449|FG005|Overall Study|Allocated in error without study intervention|0|||
155599809|NCT04521621|561622450|FG006|Overall Study|Allocated in error without study intervention|0|||
155599810|NCT04521621|561622451|FG007|Overall Study|Allocated in error without study intervention|0|||
155675552|NCT01521923|561902247|FG002|Overall Study|AE, non-serious, non-fatal|6|||
155675553|NCT01521923|561902248|FG003|Overall Study|AE, non-serious, non-fatal|2|||
155675554|NCT01521923|561902245|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155675555|NCT01521923|561902246|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155675556|NCT01521923|561902247|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155675557|NCT01521923|561902248|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
155675558|NCT01521923|561902245|FG000|Overall Study|Lack of Efficacy|1|||
155675559|NCT01521923|561902246|FG001|Overall Study|Lack of Efficacy|1|||
155675560|NCT01521923|561902247|FG002|Overall Study|Lack of Efficacy|0|||
155675561|NCT01521923|561902248|FG003|Overall Study|Lack of Efficacy|0|||
155675562|NCT01521923|561902245|FG000|Overall Study|Protocol Violation|0|||
155675563|NCT01521923|561902246|FG001|Overall Study|Protocol Violation|0|||
155675564|NCT01521923|561902247|FG002|Overall Study|Protocol Violation|1|||
155675565|NCT01521923|561902248|FG003|Overall Study|Protocol Violation|0|||
155675566|NCT01521923|561902245|FG000|Overall Study|Lost to Follow-up|1|||
155675567|NCT01521923|561902246|FG001|Overall Study|Lost to Follow-up|0|||
155675568|NCT01521923|561902247|FG002|Overall Study|Lost to Follow-up|2|||
155675569|NCT01521923|561902248|FG003|Overall Study|Lost to Follow-up|1|||
155675570|NCT01521923|561902245|FG000|Overall Study|Withdrawal by Subject|1|||
155675571|NCT01521923|561902246|FG001|Overall Study|Withdrawal by Subject|1|||
155675572|NCT01521923|561902247|FG002|Overall Study|Withdrawal by Subject|1|||
155675573|NCT01521923|561902248|FG003|Overall Study|Withdrawal by Subject|2|||
155675574|NCT01521923|561902245|FG000|Overall Study|Other|2|||
155675575|NCT01521923|561902246|FG001|Overall Study|Other|1|||
155675576|NCT01521923|561902247|FG002|Overall Study|Other|3|||
155675577|NCT01521923|561902248|FG003|Overall Study|Other|6|||
155675578|NCT01521923|561902245|FG000|Overall Study|AE, captured in Period 1|0|||
155675579|NCT01521923|561902246|FG001|Overall Study|AE, captured in Period 1|1|||
155675580|NCT01521923|561902247|FG002|Overall Study|AE, captured in Period 1|0|||
155675581|NCT01521923|561902248|FG003|Overall Study|AE, captured in Period 1|1|||
155675582|NCT03037476|561902249|FG000|Overall Study|Lost to Follow-up|63|||
155675583|NCT03037476|561902250|FG001|Overall Study|Lost to Follow-up|46|||
155675584|NCT04908384|561902256|FG000|Overall Study|Lost to Follow-up|4|||
155675585|NCT04908384|561902257|FG001|Overall Study|Lost to Follow-up|4|||
155675586|NCT04908384|561902258|FG002|Overall Study|Lost to Follow-up|0|||
155675587|NCT04908384|561902259|FG003|Overall Study|Lost to Follow-up|0|||
155675588|NCT00833469|561902260|FG000|Overall Study|Withdrawal by Subject|1|||
155675589|NCT00833469|561902260|FG000|Overall Study|Lost to Follow-up|1|||
155675590|NCT01208324|561902261|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
155675591|NCT01208324|561902262|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
155675592|NCT01208324|561902263|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
155675593|NCT01208324|561902264|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
155675594|NCT02943070|561902265|FG000|Overall Study|Physician Decision|1|||
155675595|NCT02943070|561902265|FG000|Overall Study|Adverse Event|2|||
155675596|NCT02943070|561902265|FG000|Overall Study|Death|2|||
155675597|NCT02943070|561902265|FG000|Overall Study|Withdrawal by Subject|3|||
155675598|NCT02943070|561902265|FG000|Overall Study|Lost to Follow-up|4|||
155675599|NCT02943070|561902265|FG000|Overall Study|Retreatment or TURP|13|||
155675600|NCT02943070|561902265|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
155675601|NCT01701362|561902266|FG000|Overall Study|Adverse events not related to study drug|1|||
155675602|NCT01701362|561902267|FG001|Overall Study|Adverse events not related to study drug|6|||
155675603|NCT01701362|561902266|FG000|Overall Study|Adverse events related to study drug|12|||
155675604|NCT01701362|561902267|FG001|Overall Study|Adverse events related to study drug|10|||
155675605|NCT01701362|561902266|FG000|Overall Study|Protocol Violation|5|||
155675606|NCT01701362|561902267|FG001|Overall Study|Protocol Violation|3|||
155675607|NCT01701362|561902266|FG000|Overall Study|No longer willing to participate|8|||
155675608|NCT01701362|561902267|FG001|Overall Study|No longer willing to participate|14|||
155675609|NCT01701362|561902266|FG000|Overall Study|Lost to Follow-up|6|||
155675610|NCT01701362|561902267|FG001|Overall Study|Lost to Follow-up|9|||
155675611|NCT01701362|561902266|FG000|Overall Study|Insufficient clinical response|6|||
155675612|NCT01701362|561902267|FG001|Overall Study|Insufficient clinical response|6|||
155675613|NCT01701362|561902266|FG000|Overall Study|Death|0|||
155675614|NCT01701362|561902267|FG001|Overall Study|Death|1|||
155675615|NCT01701362|561902266|FG000|Overall Study|Randomized but not treated|1|||
155675616|NCT01701362|561902267|FG001|Overall Study|Randomized but not treated|2|||
155675617|NCT01701362|561902266|FG000|Overall Study|Reasons other than those mentioned above|3|||
155675618|NCT01701362|561902267|FG001|Overall Study|Reasons other than those mentioned above|5|||
155675619|NCT00570778|561902268|FG000|Overall Study|Protocol deviation|2|||
155675620|NCT00570778|561902269|FG001|Overall Study|Protocol deviation|1|||
155675621|NCT00570778|561902270|FG002|Overall Study|Protocol deviation|2|||
155675622|NCT00570778|561902271|FG003|Overall Study|Protocol deviation|2|||
155675623|NCT00570778|561902268|FG000|Overall Study|Adverse Event|0|||
155675624|NCT00570778|561902269|FG001|Overall Study|Adverse Event|1|||
155675625|NCT00570778|561902270|FG002|Overall Study|Adverse Event|4|||
155675626|NCT00570778|561902271|FG003|Overall Study|Adverse Event|1|||
155675627|NCT00570778|561902268|FG000|Overall Study|Subject withdrew consent|0|||
155675628|NCT00570778|561902269|FG001|Overall Study|Subject withdrew consent|1|||
155675629|NCT00570778|561902270|FG002|Overall Study|Subject withdrew consent|0|||
155675630|NCT00570778|561902271|FG003|Overall Study|Subject withdrew consent|1|||
155675631|NCT00570778|561902268|FG000|Overall Study|Abnormal test procedure|1|||
155675632|NCT00570778|561902269|FG001|Overall Study|Abnormal test procedure|0|||
155675633|NCT00570778|561902270|FG002|Overall Study|Abnormal test procedure|0|||
155675634|NCT00570778|561902271|FG003|Overall Study|Abnormal test procedure|0|||
155675635|NCT00570778|561902268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155675636|NCT00570778|561902269|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155675637|NCT00570778|561902270|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155675638|NCT00570778|561902271|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155675639|NCT00570778|561902268|FG000|Overall Study|Lost to Follow-up|0|||
155675640|NCT00570778|561902269|FG001|Overall Study|Lost to Follow-up|0|||
155675641|NCT00570778|561902270|FG002|Overall Study|Lost to Follow-up|1|||
155675642|NCT00570778|561902271|FG003|Overall Study|Lost to Follow-up|0|||
155675643|NCT00570778|561902268|FG000|Overall Study|Subject no longer requires study drug|0|||
155675644|NCT00570778|561902269|FG001|Overall Study|Subject no longer requires study drug|1|||
155675645|NCT00570778|561902270|FG002|Overall Study|Subject no longer requires study drug|0|||
155675646|NCT00570778|561902271|FG003|Overall Study|Subject no longer requires study drug|0|||
155675647|NCT00249808|561902274|FG000|Overall Study|Other|27|||
155675648|NCT00249808|561902274|FG000|Overall Study|Protocol Violation|3|||
155675649|NCT00249808|561902274|FG000|Overall Study|Lost to Follow-up|8|||
155675650|NCT00249808|561902274|FG000|Overall Study|Adverse Event|81|||
155675651|NCT00249808|561902274|FG000|Overall Study|Lack of Efficacy|52|||
155675652|NCT00249808|561902274|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
155675653|NCT00711594|561902275|FG000|Overall Study|Progressive disease|2|||
155675654|NCT00711594|561902276|FG001|Overall Study|Progressive disease|2|||
155675655|NCT00711594|561902277|FG002|Overall Study|Progressive disease|6|||
155675656|NCT00711594|561902278|FG003|Overall Study|Progressive disease|44|||
155675657|NCT00711594|561902275|FG000|Overall Study|Other Adverse Event|1|||
155675658|NCT00711594|561902276|FG001|Overall Study|Other Adverse Event|0|||
155675659|NCT00711594|561902277|FG002|Overall Study|Other Adverse Event|0|||
155675660|NCT00711594|561902278|FG003|Overall Study|Other Adverse Event|16|||
155675661|NCT00711594|561902275|FG000|Overall Study|Withdrawal by Subject|0|||
155675662|NCT00711594|561902276|FG001|Overall Study|Withdrawal by Subject|1|||
155675663|NCT00711594|561902277|FG002|Overall Study|Withdrawal by Subject|0|||
155675664|NCT00711594|561902278|FG003|Overall Study|Withdrawal by Subject|2|||
155675665|NCT00443872|561902279|FG000|Overall Study|Protocol Violation|7|||
155675666|NCT00443872|561902279|FG000|Overall Study|Lost to Follow-up|2|||
155675667|NCT00443872|561902279|FG000|Overall Study|Adverse Event|8|||
155675668|NCT02789345|561902280|FG000|Overall Study|Adverse Event|0|||
155675669|NCT02789345|561902281|FG001|Overall Study|Adverse Event|0|||
155675670|NCT02789345|561902282|FG002|Overall Study|Adverse Event|1|||
155675671|NCT02789345|561902280|FG000|Overall Study|Death|0|||
155675672|NCT02789345|561902281|FG001|Overall Study|Death|0|||
155675673|NCT02789345|561902282|FG002|Overall Study|Death|1|||
155675674|NCT02789345|561902280|FG000|Overall Study|Physician Decision|2|||
155675675|NCT02789345|561902281|FG001|Overall Study|Physician Decision|0|||
155675676|NCT02789345|561902282|FG002|Overall Study|Physician Decision|1|||
155675677|NCT02789345|561902280|FG000|Overall Study|Progressive Disease|1|||
155675678|NCT02789345|561902281|FG001|Overall Study|Progressive Disease|3|||
155675679|NCT02789345|561902282|FG002|Overall Study|Progressive Disease|14|||
155675680|NCT02836717|561902296|FG000|Test Phase|Lack of Efficacy|14|||
155675681|NCT02836717|561902297|FG001|Test Phase|Lack of Efficacy|8|||
155675682|NCT02836717|561902298|FG002|Test Phase|Lack of Efficacy|0|||
155675683|NCT02836717|561902296|FG000|Study Phase|Adverse Event|2|||
155675684|NCT02836717|561902297|FG001|Study Phase|Adverse Event|0|||
155675685|NCT02836717|561902298|FG002|Study Phase|Adverse Event|0|||
155675686|NCT02836717|561902296|FG000|Study Phase|Lack of Efficacy|8|||
155675687|NCT02836717|561902297|FG001|Study Phase|Lack of Efficacy|6|||
155675688|NCT02836717|561902298|FG002|Study Phase|Lack of Efficacy|1|||
155675689|NCT02836717|561902296|FG000|Study Phase|Withdrawal by Subject|1|||
155675690|NCT02836717|561902297|FG001|Study Phase|Withdrawal by Subject|0|||
155675691|NCT02836717|561902298|FG002|Study Phase|Withdrawal by Subject|0|||
155675692|NCT02836717|561902296|FG000|Study Phase|Death|1|||
155675693|NCT02836717|561902297|FG001|Study Phase|Death|0|||
155675694|NCT02836717|561902298|FG002|Study Phase|Death|0|||
155675695|NCT02836717|561902296|FG000|Study Phase|abdominal surgeries|2|||
155675696|NCT02836717|561902297|FG001|Study Phase|abdominal surgeries|1|||
155675697|NCT02836717|561902298|FG002|Study Phase|abdominal surgeries|0|||
155675698|NCT03226249|561902299|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
155675699|NCT03226249|561902299|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
155675700|NCT03226249|561902299|FG000|Survival Follow-up|Patients still in follow-up.|30|||
155675701|NCT00588237|561902302|FG000|Overall Study|Evaluable for toxicity only|3|||
155675702|NCT00588237|561902302|FG000|Overall Study|Patien not treated|1|||
155675703|NCT00441142|561902314|FG000|Overall Study|Adverse Event|2|||
155675704|NCT00441142|561902315|FG001|Overall Study|Adverse Event|3|||
155675705|NCT00441142|561902316|FG002|Overall Study|Adverse Event|3|||
155675706|NCT00441142|561902317|FG003|Overall Study|Adverse Event|22|||
155675707|NCT00441142|561902314|FG000|Overall Study|Lack of Efficacy|3|||
155675708|NCT00441142|561902315|FG001|Overall Study|Lack of Efficacy|3|||
155675709|NCT00441142|561902316|FG002|Overall Study|Lack of Efficacy|17|||
155675710|NCT00441142|561902317|FG003|Overall Study|Lack of Efficacy|32|||
155675711|NCT00441142|561902314|FG000|Overall Study|Withdrawal by Subject|0|||
155675712|NCT00441142|561902315|FG001|Overall Study|Withdrawal by Subject|0|||
155675713|NCT00441142|561902316|FG002|Overall Study|Withdrawal by Subject|2|||
155675714|NCT00441142|561902317|FG003|Overall Study|Withdrawal by Subject|10|||
155675715|NCT00441142|561902314|FG000|Overall Study|Patient still receiving active study tx|1|||
155675716|NCT00441142|561902315|FG001|Overall Study|Patient still receiving active study tx|0|||
155675717|NCT00441142|561902316|FG002|Overall Study|Patient still receiving active study tx|0|||
155675718|NCT00441142|561902317|FG003|Overall Study|Patient still receiving active study tx|2|||
155675719|NCT00441142|561902314|FG000|Overall Study|Physician Decision|0|||
155675720|NCT00441142|561902315|FG001|Overall Study|Physician Decision|1|||
155675721|NCT00441142|561902316|FG002|Overall Study|Physician Decision|0|||
155675722|NCT00441142|561902317|FG003|Overall Study|Physician Decision|1|||
155675723|NCT00441142|561902314|FG000|Overall Study|Death|0|||
155675724|NCT00441142|561902315|FG001|Overall Study|Death|0|||
155675725|NCT00441142|561902316|FG002|Overall Study|Death|0|||
155675726|NCT00441142|561902317|FG003|Overall Study|Death|1|||
155675727|NCT01524224|561902320|FG000|Overall Study|Progressive Disease|1|||
155675728|NCT01524224|561902321|FG001|Overall Study|Progressive Disease|0|||
155675729|NCT01524224|561902322|FG002|Overall Study|Progressive Disease|2|||
155675730|NCT01524224|561902323|FG003|Overall Study|Progressive Disease|1|||
155675731|NCT01524224|561902324|FG004|Overall Study|Progressive Disease|2|||
155675732|NCT01524224|561902325|FG005|Overall Study|Progressive Disease|1|||
155675733|NCT01524224|561902326|FG006|Overall Study|Progressive Disease|1|||
155675734|NCT01524224|561902327|FG007|Overall Study|Progressive Disease|5|||
155675735|NCT01524224|561902320|FG000|Overall Study|Withdrawal by Subject|2|||
155675736|NCT01524224|561902321|FG001|Overall Study|Withdrawal by Subject|0|||
155675737|NCT01524224|561902322|FG002|Overall Study|Withdrawal by Subject|0|||
155675738|NCT01524224|561902323|FG003|Overall Study|Withdrawal by Subject|0|||
155675739|NCT01524224|561902324|FG004|Overall Study|Withdrawal by Subject|0|||
155675740|NCT01524224|561902325|FG005|Overall Study|Withdrawal by Subject|0|||
155675741|NCT01524224|561902326|FG006|Overall Study|Withdrawal by Subject|2|||
155675742|NCT01524224|561902327|FG007|Overall Study|Withdrawal by Subject|0|||
155675743|NCT01524224|561902320|FG000|Overall Study|Adverse Event|0|||
155675744|NCT01524224|561902321|FG001|Overall Study|Adverse Event|1|||
155675745|NCT01524224|561902322|FG002|Overall Study|Adverse Event|0|||
155599811|NCT05845567|561622454|FG000|Overall Study|Withdrawal by Subject|1|||
155599812|NCT01968707|561622457|FG000|Overall Study|Did not meet treatment day baseline|49|||
155599813|NCT01968707|561622458|FG001|Overall Study|Did not meet treatment day baseline|12|||
155599814|NCT01968707|561622459|FG002|Overall Study|Did not meet treatment day baseline|41|||
155599815|NCT01968707|561622460|FG003|Overall Study|Did not meet treatment day baseline|44|||
155599816|NCT01968707|561622461|FG004|Overall Study|Did not meet treatment day baseline|36|||
155599817|NCT01968707|561622462|FG005|Overall Study|Did not meet treatment day baseline|11|||
155599818|NCT01968707|561622463|FG006|Overall Study|Did not meet treatment day baseline|34|||
155599819|NCT01968707|561622464|FG007|Overall Study|Did not meet treatment day baseline|35|||
155599820|NCT01104246|561622469|FG000|Overall Study|Withdrawal by Subject|1|||
155599821|NCT01104246|561622469|FG000|Overall Study|did not meet inclusion criteria|4|||
155599822|NCT02062944|561622476|FG000|Overall Study|Lost to Follow-up|1|||
155599823|NCT02062944|561622476|FG000|Overall Study|New hemotological disorder identified|1|||
155599824|NCT02062944|561622476|FG000|Overall Study|Uncontrolled Hypertension|1|||
155599825|NCT02062944|561622476|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
155599826|NCT02035748|561622477|FG000|Overall Study|Adverse Event|5|||
155599827|NCT02035748|561622477|FG000|Overall Study|Death|3|||
155599828|NCT02035748|561622477|FG000|Overall Study|Lost to Follow-up|2|||
155599829|NCT02035748|561622477|FG000|Overall Study|Physician Decision|3|||
155599830|NCT02035748|561622477|FG000|Overall Study|Withdrawal by Subject|6|||
155599831|NCT02035748|561622477|FG000|Overall Study|Progressive Disease|1|||
155599832|NCT02083185|561622478|FG000|Overall Study|Lost to Follow-up|0|||
155599833|NCT02083185|561622479|FG001|Overall Study|Lost to Follow-up|3|||
155599834|NCT02083185|561622480|FG002|Overall Study|Lost to Follow-up|0|||
155599835|NCT02083185|561622478|FG000|Overall Study|Withdrawal by Subject|9|||
155599836|NCT02083185|561622479|FG001|Overall Study|Withdrawal by Subject|15|||
155599837|NCT02083185|561622480|FG002|Overall Study|Withdrawal by Subject|1|||
155675746|NCT01524224|561902323|FG003|Overall Study|Adverse Event|0|||
155675747|NCT01524224|561902324|FG004|Overall Study|Adverse Event|0|||
155675748|NCT01524224|561902325|FG005|Overall Study|Adverse Event|1|||
155675749|NCT01524224|561902326|FG006|Overall Study|Adverse Event|0|||
155675750|NCT01524224|561902327|FG007|Overall Study|Adverse Event|0|||
155675751|NCT01524224|561902320|FG000|Overall Study|Physician Decision|0|||
155675752|NCT01524224|561902321|FG001|Overall Study|Physician Decision|0|||
155675753|NCT01524224|561902322|FG002|Overall Study|Physician Decision|0|||
155675754|NCT01524224|561902323|FG003|Overall Study|Physician Decision|1|||
155675755|NCT01524224|561902324|FG004|Overall Study|Physician Decision|1|||
155675756|NCT01524224|561902325|FG005|Overall Study|Physician Decision|0|||
155675757|NCT01524224|561902326|FG006|Overall Study|Physician Decision|0|||
155675758|NCT01524224|561902327|FG007|Overall Study|Physician Decision|1|||
155675759|NCT01524224|561902320|FG000|Overall Study|Sponsor Decision|0|||
155675760|NCT01524224|561902321|FG001|Overall Study|Sponsor Decision|0|||
155675761|NCT01524224|561902322|FG002|Overall Study|Sponsor Decision|0|||
155675762|NCT01524224|561902323|FG003|Overall Study|Sponsor Decision|0|||
155675763|NCT01524224|561902324|FG004|Overall Study|Sponsor Decision|1|||
155675764|NCT01524224|561902325|FG005|Overall Study|Sponsor Decision|0|||
155675765|NCT01524224|561902326|FG006|Overall Study|Sponsor Decision|0|||
155675766|NCT01524224|561902327|FG007|Overall Study|Sponsor Decision|0|||
155675767|NCT04283656|561902330|FG000|Overall Study|Adverse Event|1|||
155675768|NCT04283656|561902331|FG001|Overall Study|Adverse Event|0|||
155675769|NCT04283656|561902330|FG000|Overall Study|Lost to Follow-up|0|||
155675770|NCT04283656|561902331|FG001|Overall Study|Lost to Follow-up|1|||
155675771|NCT00803361|561902332|FG000|Overall Study|Adverse Event|13|||
155675772|NCT00803361|561902333|FG001|Overall Study|Adverse Event|3|||
155675773|NCT00803361|561902332|FG000|Overall Study|Lack of Efficacy|4|||
155675774|NCT00803361|561902333|FG001|Overall Study|Lack of Efficacy|13|||
155675775|NCT00803361|561902332|FG000|Overall Study|Lost to Follow-up|1|||
155675776|NCT00803361|561902333|FG001|Overall Study|Lost to Follow-up|2|||
155675777|NCT00803361|561902332|FG000|Overall Study|Physician Decision|1|||
155675778|NCT00803361|561902333|FG001|Overall Study|Physician Decision|0|||
155675779|NCT00803361|561902332|FG000|Overall Study|Protocol Violation|2|||
155675780|NCT00803361|561902333|FG001|Overall Study|Protocol Violation|4|||
155675781|NCT00803361|561902332|FG000|Overall Study|Withdrawal by Subject|5|||
155675782|NCT00803361|561902333|FG001|Overall Study|Withdrawal by Subject|6|||
155675783|NCT04445519|561902334|FG000|Overall Study|Due to adaptive design|3|||
155675784|NCT04445519|561902335|FG001|Overall Study|Due to adaptive design|0|||
155675785|NCT04445519|561902336|FG002|Overall Study|Due to adaptive design|0|||
155675786|NCT04445519|561902334|FG000|Overall Study|Lost to Follow-up|0|||
155675787|NCT04445519|561902335|FG001|Overall Study|Lost to Follow-up|1|||
155675788|NCT04445519|561902336|FG002|Overall Study|Lost to Follow-up|4|||
155675789|NCT04445519|561902334|FG000|Overall Study|Sponsor or IRB Decision|0|||
155675790|NCT04445519|561902335|FG001|Overall Study|Sponsor or IRB Decision|1|||
155675791|NCT04445519|561902336|FG002|Overall Study|Sponsor or IRB Decision|2|||
155675792|NCT04445519|561902334|FG000|Overall Study|Withdrawal by Subject|0|||
155675793|NCT04445519|561902335|FG001|Overall Study|Withdrawal by Subject|3|||
155675794|NCT04445519|561902336|FG002|Overall Study|Withdrawal by Subject|3|||
155675795|NCT04445519|561902334|FG000|Overall Study|Adverse Event|0|||
155675796|NCT04445519|561902335|FG001|Overall Study|Adverse Event|8|||
155675797|NCT04445519|561902336|FG002|Overall Study|Adverse Event|6|||
155675798|NCT04445519|561902334|FG000|Overall Study|Other Reason|0|||
155675799|NCT04445519|561902335|FG001|Overall Study|Other Reason|1|||
155675800|NCT04445519|561902336|FG002|Overall Study|Other Reason|1|||
155675801|NCT04445519|561902334|FG000|Overall Study|Protocol Violation|0|||
155599838|NCT02083185|561622478|FG000|Overall Study|Death|2|||
155599839|NCT02083185|561622479|FG001|Overall Study|Death|2|||
155599840|NCT02083185|561622480|FG002|Overall Study|Death|1|||
155599841|NCT02083185|561622478|FG000|Overall Study|Reason not Specified|9|||
155599842|NCT02083185|561622479|FG001|Overall Study|Reason not Specified|6|||
155599843|NCT02083185|561622480|FG002|Overall Study|Reason not Specified|5|||
155599844|NCT02083185|561622478|FG000|Overall Study|Study Terminated by Sponsor|0|||
155599845|NCT02083185|561622479|FG001|Overall Study|Study Terminated by Sponsor|1|||
155599846|NCT02083185|561622480|FG002|Overall Study|Study Terminated by Sponsor|0|||
155599847|NCT02083185|561622478|FG000|Overall Study|Did not Receive Study Drug|0|||
155599848|NCT02083185|561622479|FG001|Overall Study|Did not Receive Study Drug|2|||
155599849|NCT02083185|561622480|FG002|Overall Study|Did not Receive Study Drug|0|||
155599850|NCT01740128|561622481|FG000|Overall Study|Pregnancy|0|||
155599851|NCT01740128|561622482|FG001|Overall Study|Pregnancy|1|||
155599852|NCT01740128|561622481|FG000|Overall Study|Protocol Violation|1|||
155599853|NCT01740128|561622482|FG001|Overall Study|Protocol Violation|2|||
155675802|NCT04445519|561902335|FG001|Overall Study|Protocol Violation|0|||
155675803|NCT04445519|561902336|FG002|Overall Study|Protocol Violation|1|||
155599854|NCT01740128|561622481|FG000|Overall Study|Lost to Follow-up|2|||
155675804|NCT02858440|561902341|FG000|Overall Study|Lost to Follow-up|3|||
155675805|NCT02858440|561902341|FG000|Overall Study|Protocol Violation|2|||
155675806|NCT02858440|561902341|FG000|Overall Study|Consent withdrawal|3|||
155675807|NCT02858440|561902341|FG000|Overall Study|Migrated/moved from study area|4|||
155675808|NCT04660552|561902342|FG000|Overall Study|Withdrawal by Subject|3|||
155675809|NCT04660552|561902343|FG001|Overall Study|Withdrawal by Subject|1|||
155675810|NCT00470262|561902344|FG000|Overall Study|Withdrawal by Subject|2|||
155675811|NCT00470262|561902345|FG001|Overall Study|Withdrawal by Subject|0|||
155675812|NCT00191945|561902346|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
155675813|NCT00191945|561902347|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
155675814|NCT00191945|561902346|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
155675815|NCT00191945|561902347|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
155675816|NCT00191945|561902346|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
155675817|NCT00191945|561902347|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
155675818|NCT00191945|561902346|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
155675819|NCT00191945|561902347|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
155675820|NCT00429182|561902348|FG000|Overall Study|Not evaluable, Disease Progression|2|||
155675821|NCT00429182|561902348|FG000|Overall Study|Not eligible|5|||
155675822|NCT01451749|561902350|FG000|Overall Study|Protocol Violation|14|||
155675823|NCT01451749|561902351|FG001|Overall Study|Protocol Violation|7|||
155675824|NCT01451749|561902350|FG000|Overall Study|Lost to Follow-up|15|||
155675825|NCT01451749|561902351|FG001|Overall Study|Lost to Follow-up|5|||
155675826|NCT01451749|561902350|FG000|Overall Study|Meet the exclusion criteria,and|1|||
155675827|NCT01451749|561902351|FG001|Overall Study|Meet the exclusion criteria,and|1|||
155675828|NCT01451749|561902350|FG000|Overall Study|Adverse Event|2|||
155675829|NCT01451749|561902351|FG001|Overall Study|Adverse Event|0|||
155675830|NCT01451749|561902350|FG000|Overall Study|Withdrawal by Subject|0|||
155675831|NCT01451749|561902351|FG001|Overall Study|Withdrawal by Subject|1|||
155675832|NCT00972517|561902352|FG000|Overall Study|Adverse Event|0|||
155675833|NCT00972517|561902353|FG001|Overall Study|Adverse Event|0|||
155675834|NCT00972517|561902354|FG002|Overall Study|Adverse Event|0|||
155675835|NCT00972517|561902355|FG003|Overall Study|Adverse Event|1|||
155675836|NCT00972517|561902356|FG004|Overall Study|Adverse Event|0|||
155675837|NCT00972517|561902357|FG005|Overall Study|Adverse Event|0|||
155675838|NCT00972517|561902352|FG000|Overall Study|Withdrawal by Subject|0|||
155675839|NCT00972517|561902353|FG001|Overall Study|Withdrawal by Subject|1|||
155675840|NCT00972517|561902354|FG002|Overall Study|Withdrawal by Subject|0|||
155675841|NCT00972517|561902355|FG003|Overall Study|Withdrawal by Subject|2|||
155675842|NCT00972517|561902356|FG004|Overall Study|Withdrawal by Subject|1|||
155675843|NCT00972517|561902357|FG005|Overall Study|Withdrawal by Subject|0|||
155675844|NCT02311881|561902358|FG000|Overall Study|Did not meet the study criteria|2|||
155675845|NCT02311881|561902359|FG001|Overall Study|Did not meet the study criteria|2|||
155675846|NCT02311881|561902360|FG002|Overall Study|Did not meet the study criteria|0|||
155675847|NCT02311881|561902358|FG000|Overall Study|Adverse Event|7|||
155675848|NCT02311881|561902359|FG001|Overall Study|Adverse Event|15|||
155675849|NCT02311881|561902360|FG002|Overall Study|Adverse Event|8|||
155675850|NCT02311881|561902358|FG000|Overall Study|Lost to Follow-up|3|||
155675851|NCT02311881|561902359|FG001|Overall Study|Lost to Follow-up|3|||
155675852|NCT02311881|561902360|FG002|Overall Study|Lost to Follow-up|2|||
155675853|NCT02311881|561902358|FG000|Overall Study|Protocol Violation|1|||
155675854|NCT02311881|561902359|FG001|Overall Study|Protocol Violation|2|||
155675855|NCT02311881|561902360|FG002|Overall Study|Protocol Violation|3|||
155675856|NCT02311881|561902358|FG000|Overall Study|Withdrawal of consent|14|||
155675857|NCT02311881|561902359|FG001|Overall Study|Withdrawal of consent|16|||
155675858|NCT02311881|561902360|FG002|Overall Study|Withdrawal of consent|17|||
155675859|NCT02311881|561902358|FG000|Overall Study|Other|0|||
155675860|NCT02311881|561902359|FG001|Overall Study|Other|0|||
155675861|NCT02311881|561902360|FG002|Overall Study|Other|1|||
155675862|NCT02311881|561902358|FG000|Overall Study|Lack of Efficacy|1|||
155675863|NCT02311881|561902359|FG001|Overall Study|Lack of Efficacy|2|||
155675864|NCT02311881|561902360|FG002|Overall Study|Lack of Efficacy|0|||
155675865|NCT02311881|561902358|FG000|Overall Study|Subject has border line pregnancy test|1|||
155675866|NCT02311881|561902359|FG001|Overall Study|Subject has border line pregnancy test|0|||
155675867|NCT02311881|561902360|FG002|Overall Study|Subject has border line pregnancy test|0|||
155675868|NCT02311881|561902358|FG000|Overall Study|Withdrawal by Subject|3|||
155675869|NCT02311881|561902359|FG001|Overall Study|Withdrawal by Subject|1|||
155675870|NCT02311881|561902360|FG002|Overall Study|Withdrawal by Subject|4|||
155675871|NCT02311881|561902358|FG000|Overall Study|Sponsor Decision|1|||
155675872|NCT02311881|561902359|FG001|Overall Study|Sponsor Decision|1|||
155675873|NCT02311881|561902360|FG002|Overall Study|Sponsor Decision|1|||
155675874|NCT02311881|561902358|FG000|Overall Study|Protocol Deviation|1|||
155675875|NCT02311881|561902359|FG001|Overall Study|Protocol Deviation|0|||
155675876|NCT02311881|561902360|FG002|Overall Study|Protocol Deviation|0|||
155675877|NCT02311881|561902358|FG000|Overall Study|Non-Compliance|1|||
155675878|NCT02311881|561902359|FG001|Overall Study|Non-Compliance|0|||
155675879|NCT02311881|561902360|FG002|Overall Study|Non-Compliance|2|||
155675880|NCT02311881|561902358|FG000|Overall Study|Physician Decision|0|||
155675881|NCT02311881|561902359|FG001|Overall Study|Physician Decision|0|||
155675882|NCT02311881|561902360|FG002|Overall Study|Physician Decision|1|||
155675883|NCT02311881|561902358|FG000|Overall Study|Medical Monitor Discretion|0|||
155675884|NCT02311881|561902359|FG001|Overall Study|Medical Monitor Discretion|0|||
155675885|NCT02311881|561902360|FG002|Overall Study|Medical Monitor Discretion|1|||
155675886|NCT02311881|561902358|FG000|Overall Study|Participant taking another medication|0|||
155675887|NCT02311881|561902359|FG001|Overall Study|Participant taking another medication|0|||
155675888|NCT02311881|561902360|FG002|Overall Study|Participant taking another medication|1|||
155675889|NCT02311881|561902358|FG000|Overall Study|Serious Adverse Event|0|||
155675890|NCT02311881|561902359|FG001|Overall Study|Serious Adverse Event|1|||
155675891|NCT02311881|561902360|FG002|Overall Study|Serious Adverse Event|0|||
155675892|NCT00556439|561902365|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
155675893|NCT00556439|561902366|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
155675894|NCT00556439|561902367|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
155675895|NCT00556439|561902368|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
155675896|NCT00556439|561902365|FG000|Study Entry to Week 12|Physician Decision|1|||
155675897|NCT00556439|561902366|FG001|Study Entry to Week 12|Physician Decision|0|||
155675898|NCT00556439|561902367|FG002|Study Entry to Week 12|Physician Decision|0|||
155675899|NCT00556439|561902368|FG003|Study Entry to Week 12|Physician Decision|0|||
155675900|NCT00556439|561902365|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
155675901|NCT00556439|561902366|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
155675902|NCT00556439|561902367|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
155675903|NCT00556439|561902368|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
155675904|NCT00556439|561902365|FG000|Study Entry to Week 12|Recurrent infection|1|||
155675905|NCT00556439|561902366|FG001|Study Entry to Week 12|Recurrent infection|0|||
155675906|NCT00556439|561902367|FG002|Study Entry to Week 12|Recurrent infection|0|||
155675907|NCT00556439|561902368|FG003|Study Entry to Week 12|Recurrent infection|0|||
155675908|NCT00556439|561902365|FG000|Study Entry to Week 12|Malignancy|0|||
155675909|NCT00556439|561902366|FG001|Study Entry to Week 12|Malignancy|0|||
155675910|NCT00556439|561902367|FG002|Study Entry to Week 12|Malignancy|1|||
155675911|NCT00556439|561902368|FG003|Study Entry to Week 12|Malignancy|0|||
155675912|NCT00556439|561902365|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
155675913|NCT00556439|561902366|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
155675914|NCT00556439|561902367|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
155675915|NCT00556439|561902368|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
155675916|NCT00556439|561902365|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
155675917|NCT00556439|561902366|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
155675918|NCT00556439|561902367|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
155675919|NCT00556439|561902368|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
155675920|NCT00556439|561902365|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
155675921|NCT00556439|561902366|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
155675922|NCT00556439|561902367|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
155675923|NCT00556439|561902368|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
155675924|NCT00556439|561902365|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
155675925|NCT00556439|561902366|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
155675926|NCT00556439|561902367|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
155675927|NCT00556439|561902368|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
155675928|NCT02100423|561902369|FG000|Overall Study|Death|1|||
155675929|NCT02100423|561902369|FG000|Overall Study|Withdrawal by Subject|3|||
155675930|NCT02100423|561902369|FG000|Overall Study|Adverse Event|1|||
155675931|NCT02100423|561902369|FG000|Overall Study|Physician Decision|1|||
155675932|NCT02949024|561902370|FG000|Overall Study|Withdrawal by Subject|0|||
155675933|NCT02949024|561902371|FG001|Overall Study|Withdrawal by Subject|1|||
155675934|NCT01014767|561904176|FG000|Overall Study|PI left institution, data unavailable|12|||
155675935|NCT01014767|561904177|FG001|Overall Study|PI left institution, data unavailable|1|||
155675936|NCT01014767|561904178|FG002|Overall Study|PI left institution, data unavailable|4|||
155675937|NCT01014767|561904179|FG003|Overall Study|PI left institution, data unavailable|1|||
155675938|NCT01709110|561904180|FG000|Overall Study|Adverse Event|56|||
155675939|NCT01709110|561904181|FG001|Overall Study|Adverse Event|48|||
155675940|NCT01709110|561904180|FG000|Overall Study|Death|14|||
155675941|NCT01709110|561904181|FG001|Overall Study|Death|6|||
155675942|NCT01709110|561904180|FG000|Overall Study|Lost to Follow-up|7|||
155675943|NCT01709110|561904181|FG001|Overall Study|Lost to Follow-up|5|||
155675944|NCT01709110|561904180|FG000|Overall Study|Protocol Violation|4|||
155675945|NCT01709110|561904181|FG001|Overall Study|Protocol Violation|6|||
155675946|NCT01709110|561904180|FG000|Overall Study|Withdrawal by Subject|96|||
155675947|NCT01709110|561904181|FG001|Overall Study|Withdrawal by Subject|89|||
155675948|NCT01709110|561904180|FG000|Overall Study|Physician Decision|4|||
155675949|NCT01709110|561904181|FG001|Overall Study|Physician Decision|10|||
155675950|NCT01709110|561904180|FG000|Overall Study|Sponsor Decision|2|||
155675951|NCT01709110|561904181|FG001|Overall Study|Sponsor Decision|2|||
155675952|NCT01709110|561904180|FG000|Overall Study|Lack of Efficacy|1|||
155675953|NCT01709110|561904181|FG001|Overall Study|Lack of Efficacy|1|||
155675954|NCT01709110|561904180|FG000|Overall Study|Caregiver Decision|1|||
155675955|NCT01709110|561904181|FG001|Overall Study|Caregiver Decision|1|||
155675956|NCT04123093|561904185|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
155675957|NCT04123093|561904186|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
155675958|NCT04123093|561904185|FG000|Phase 2|Physician Decision|0|||
155675959|NCT04123093|561904186|FG001|Phase 2|Physician Decision|1|||
155675960|NCT04123093|561904185|FG000|Phase 2|Withdrawal by Subject|0|||
155675961|NCT04123093|561904186|FG001|Phase 2|Withdrawal by Subject|1|||
155675962|NCT01164891|561904191|FG000|Overall Study|Disease Progression|5|||
155675963|NCT01164891|561904191|FG000|Overall Study|Adverse Event|1|||
155675964|NCT00338286|561904192|FG000|Overall Study|Withdrawal by Subject|50|||
155675965|NCT00338286|561904193|FG001|Overall Study|Withdrawal by Subject|54|||
155675966|NCT00338286|561904192|FG000|Overall Study|Lost to Follow-up|80|||
155675967|NCT00338286|561904193|FG001|Overall Study|Lost to Follow-up|66|||
155675968|NCT00338286|561904192|FG000|Overall Study|Other|103|||
155675969|NCT00338286|561904193|FG001|Overall Study|Other|93|||
155675970|NCT01265563|561904194|FG000|Overall Study|Withdrawal by Subject|0|||
155675971|NCT01265563|561904195|FG001|Overall Study|Withdrawal by Subject|1|||
155675972|NCT01265563|561904196|FG002|Overall Study|Withdrawal by Subject|1|||
155675973|NCT01265563|561904197|FG003|Overall Study|Withdrawal by Subject|0|||
155675974|NCT01265563|561904198|FG004|Overall Study|Withdrawal by Subject|2|||
155675975|NCT01703091|561904199|FG000|Overall Study|Adverse Event|5|||
155675976|NCT01703091|561904200|FG001|Overall Study|Adverse Event|3|||
155675977|NCT01703091|561904199|FG000|Overall Study|Physician Decision|2|||
155675978|NCT01703091|561904200|FG001|Overall Study|Physician Decision|1|||
155675979|NCT01703091|561904199|FG000|Overall Study|Withdrawal by Subject|1|||
155675980|NCT01703091|561904200|FG001|Overall Study|Withdrawal by Subject|0|||
155675981|NCT01703091|561904199|FG000|Overall Study|Sponsor Decision|1|||
155675982|NCT01703091|561904200|FG001|Overall Study|Sponsor Decision|0|||
155675983|NCT00022763|561904211|FG000|Overall Study|Adverse Event|1|||
155675984|NCT00022763|561904212|FG001|Overall Study|Adverse Event|2|||
155675985|NCT00022763|561904211|FG000|Overall Study|Injection Site Reactions|0|||
155675986|NCT00022763|561904212|FG001|Overall Study|Injection Site Reactions|2|||
155675987|NCT00022763|561904211|FG000|Overall Study|Death|0|||
155675988|NCT00022763|561904212|FG001|Overall Study|Death|1|||
155675989|NCT00022763|561904211|FG000|Overall Study|Lost to Follow-up|0|||
155675990|NCT00022763|561904212|FG001|Overall Study|Lost to Follow-up|3|||
155675991|NCT00022763|561904211|FG000|Overall Study|Withdrawal by Subject|4|||
155675992|NCT00022763|561904212|FG001|Overall Study|Withdrawal by Subject|7|||
155675993|NCT00022763|561904211|FG000|Overall Study|Insufficient Therapy|1|||
155675994|NCT00022763|561904212|FG001|Overall Study|Insufficient Therapy|0|||
155675995|NCT00022763|561904211|FG000|Overall Study|Admin|3|||
155675996|NCT00022763|561904212|FG001|Overall Study|Admin|2|||
155675997|NCT04908865|561904213|FG000|Overall Study|Adverse Event|2|||
155675998|NCT04908865|561904213|FG000|Overall Study|Lack of Efficacy|5|||
155599855|NCT01740128|561622482|FG001|Overall Study|Lost to Follow-up|2|||
155599856|NCT01740128|561622481|FG000|Overall Study|Withdrawal by Subject|1|||
155599857|NCT01740128|561622482|FG001|Overall Study|Withdrawal by Subject|0|||
155599858|NCT01740128|561622481|FG000|Overall Study|Insufficient protocol compliance|2|||
155599859|NCT01740128|561622482|FG001|Overall Study|Insufficient protocol compliance|2|||
155599860|NCT02474589|561622483|FG000|Overall Study|Adverse Event|6|||
155599861|NCT02474589|561622484|FG001|Overall Study|Adverse Event|2|||
155599862|NCT02474589|561622483|FG000|Overall Study|Lost to Follow-up|6|||
155599863|NCT02474589|561622484|FG001|Overall Study|Lost to Follow-up|1|||
155599864|NCT02474589|561622483|FG000|Overall Study|Protocol Violation|4|||
155599865|NCT02474589|561622484|FG001|Overall Study|Protocol Violation|1|||
155599866|NCT02474589|561622483|FG000|Overall Study|Withdrawal by Subject|4|||
155599867|NCT02474589|561622484|FG001|Overall Study|Withdrawal by Subject|0|||
155599868|NCT02474589|561622483|FG000|Overall Study|Inability to complete study procedures|5|||
155599869|NCT02474589|561622484|FG001|Overall Study|Inability to complete study procedures|1|||
155599870|NCT02231879|561622485|FG000|Overall Study|Adverse Event|2|||
155599871|NCT02231879|561622486|FG001|Overall Study|Adverse Event|1|||
155599872|NCT02231879|561622485|FG000|Overall Study|Lack of Efficacy|0|||
155599873|NCT02231879|561622486|FG001|Overall Study|Lack of Efficacy|1|||
155599874|NCT05007041|561622487|FG000|Overall Study|Missing Diary Entries|0|||
155599875|NCT05007041|561622488|FG001|Overall Study|Missing Diary Entries|1|||
155599876|NCT00705718|561622489|FG000|Overall Study|Death|6|||
155599877|NCT00705718|561622490|FG001|Overall Study|Death|6|||
155599878|NCT00705718|561622489|FG000|Overall Study|Not due for Visit|0|||
155599879|NCT00705718|561622490|FG001|Overall Study|Not due for Visit|12|||
155599880|NCT00705718|561622489|FG000|Overall Study|Follow up not done|1|||
155599881|NCT00705718|561622490|FG001|Overall Study|Follow up not done|4|||
155599882|NCT00423189|561622492|FG000|Overall Study|Death|0|||
155599883|NCT00423189|561622493|FG001|Overall Study|Death|1|||
155599884|NCT00423189|561622494|FG002|Overall Study|Death|0|||
155599885|NCT01459718|561622501|FG000|Overall Study|Physician Decision|1|||
155599886|NCT01459718|561622501|FG000|Overall Study|Lost to Follow-up|1|||
155599887|NCT01459718|561622501|FG000|Overall Study|Adverse Event|1|||
155599888|NCT02939716|561622504|FG000|Overall Study|scanner failure|0|||
155599889|NCT02939716|561622505|FG001|Overall Study|scanner failure|0|||
155599890|NCT02939716|561622506|FG002|Overall Study|scanner failure|0|||
155599891|NCT02939716|561622507|FG003|Overall Study|scanner failure|1|||
155599892|NCT02939716|561622508|FG004|Overall Study|scanner failure|1|||
155599893|NCT02939716|561622509|FG005|Overall Study|scanner failure|1|||
155599894|NCT00976209|561622510|FG000|Treatment Period 1|Protocol Violation|1|||
155599895|NCT00976209|561622511|FG001|Treatment Period 1|Protocol Violation|0|||
155599896|NCT00976209|561622510|FG000|Treatment Period 1|Lost to Follow-up|2|||
155599897|NCT00976209|561622511|FG001|Treatment Period 1|Lost to Follow-up|0|||
155599898|NCT00976209|561622510|FG000|Treatment Period 1|Other|0|||
155599899|NCT00976209|561622511|FG001|Treatment Period 1|Other|1|||
155599900|NCT00976209|561622510|FG000|Wash-out Period|Adverse Event|1|||
155599901|NCT00976209|561622511|FG001|Wash-out Period|Adverse Event|2|||
155599902|NCT00976209|561622510|FG000|Wash-out Period|Lost to Follow-up|1|||
155599903|NCT00976209|561622511|FG001|Wash-out Period|Lost to Follow-up|0|||
155599904|NCT00976209|561622510|FG000|Wash-out Period|Protocol Violation|1|||
155599905|NCT00976209|561622511|FG001|Wash-out Period|Protocol Violation|0|||
155599906|NCT00976209|561622510|FG000|Wash-out Period|Other|1|||
155599907|NCT00976209|561622511|FG001|Wash-out Period|Other|0|||
155599908|NCT00976209|561622510|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155599909|NCT00976209|561622511|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155599910|NCT00976209|561622510|FG000|Treatment Period 2|Lost to Follow-up|0|||
155599911|NCT00976209|561622511|FG001|Treatment Period 2|Lost to Follow-up|1|||
155599912|NCT00574249|561622512|FG000|Overall Study|Adverse Event|6|||
155599913|NCT00574249|561622513|FG001|Overall Study|Adverse Event|18|||
155599914|NCT00574249|561622512|FG000|Overall Study|Lack of Efficacy|5|||
155599915|NCT00574249|561622513|FG001|Overall Study|Lack of Efficacy|3|||
155599916|NCT00574249|561622512|FG000|Overall Study|Lost to Follow-up|4|||
155599917|NCT00574249|561622513|FG001|Overall Study|Lost to Follow-up|3|||
155599918|NCT00574249|561622512|FG000|Overall Study|Protocol Violation|5|||
155599919|NCT00574249|561622513|FG001|Overall Study|Protocol Violation|2|||
155599920|NCT00574249|561622512|FG000|Overall Study|History of carcinoma|1|||
155599921|NCT00574249|561622513|FG001|Overall Study|History of carcinoma|0|||
155599922|NCT00574249|561622512|FG000|Overall Study|Withdrawal by Subject|3|||
155599923|NCT00574249|561622513|FG001|Overall Study|Withdrawal by Subject|0|||
155599924|NCT00574249|561622512|FG000|Overall Study|Physician Decision|1|||
155675999|NCT04908865|561904213|FG000|Overall Study|Lost to Follow-up|1|||
155676000|NCT02550288|561904214|FG000|Overall Study|Adverse Event|0|||
155676001|NCT02550288|561904215|FG001|Overall Study|Adverse Event|1|||
155676002|NCT02550288|561904216|FG002|Overall Study|Adverse Event|0|||
155676003|NCT02550288|561904217|FG003|Overall Study|Adverse Event|0|||
155676004|NCT02550288|561904218|FG004|Overall Study|Adverse Event|0|||
155676005|NCT02550288|561904214|FG000|Overall Study|Physician Decision|0|||
155676006|NCT02550288|561904215|FG001|Overall Study|Physician Decision|0|||
155676007|NCT02550288|561904216|FG002|Overall Study|Physician Decision|0|||
155676008|NCT02550288|561904217|FG003|Overall Study|Physician Decision|1|||
155676009|NCT02550288|561904218|FG004|Overall Study|Physician Decision|0|||
155676010|NCT02550288|561904214|FG000|Overall Study|Protocol Violation|2|||
155676011|NCT02550288|561904215|FG001|Overall Study|Protocol Violation|2|||
155676012|NCT02550288|561904216|FG002|Overall Study|Protocol Violation|1|||
155676013|NCT02550288|561904217|FG003|Overall Study|Protocol Violation|0|||
155676014|NCT02550288|561904218|FG004|Overall Study|Protocol Violation|3|||
155676015|NCT02550288|561904214|FG000|Overall Study|Participant moved|0|||
155676016|NCT02550288|561904215|FG001|Overall Study|Participant moved|0|||
155676017|NCT02550288|561904216|FG002|Overall Study|Participant moved|0|||
155676018|NCT02550288|561904217|FG003|Overall Study|Participant moved|1|||
155676019|NCT02550288|561904218|FG004|Overall Study|Participant moved|0|||
155676020|NCT02550288|561904214|FG000|Overall Study|Withdrawal by Subject|0|||
155676021|NCT02550288|561904215|FG001|Overall Study|Withdrawal by Subject|0|||
155676022|NCT02550288|561904216|FG002|Overall Study|Withdrawal by Subject|0|||
155676023|NCT02550288|561904217|FG003|Overall Study|Withdrawal by Subject|1|||
155676024|NCT02550288|561904218|FG004|Overall Study|Withdrawal by Subject|0|||
155676025|NCT05312697|561904219|FG000|Overall Study|Sponsor Terminated Trial|2|||
155676026|NCT05420961|561904220|FG000|Overall Study|Withdrawal by Subject|2|||
155676027|NCT05420961|561904221|FG001|Overall Study|Withdrawal by Subject|1|||
155676028|NCT05420961|561904222|FG002|Overall Study|Withdrawal by Subject|1|||
155676029|NCT05420961|561904223|FG003|Overall Study|Withdrawal by Subject|0|||
155676030|NCT05420961|561904224|FG004|Overall Study|Withdrawal by Subject|0|||
155676031|NCT05420961|561904220|FG000|Overall Study|Lost to Follow-up|0|||
155676032|NCT05420961|561904221|FG001|Overall Study|Lost to Follow-up|0|||
155676033|NCT05420961|561904222|FG002|Overall Study|Lost to Follow-up|1|||
155676034|NCT05420961|561904223|FG003|Overall Study|Lost to Follow-up|0|||
155676035|NCT05420961|561904224|FG004|Overall Study|Lost to Follow-up|0|||
155676036|NCT05420961|561904220|FG000|Overall Study|Randomized by mistake without study treatment|0|||
155676037|NCT05420961|561904221|FG001|Overall Study|Randomized by mistake without study treatment|0|||
155676038|NCT05420961|561904222|FG002|Overall Study|Randomized by mistake without study treatment|1|||
155676039|NCT05420961|561904223|FG003|Overall Study|Randomized by mistake without study treatment|0|||
155676040|NCT05420961|561904224|FG004|Overall Study|Randomized by mistake without study treatment|1|||
155676041|NCT00783835|561904225|FG000|Overall Study|Adverse Event|3|||
155676042|NCT00783835|561904225|FG000|Overall Study|Medical Criteria|1|||
155676043|NCT00783835|561904225|FG000|Overall Study|Withdrawal by Subject|2|||
155676044|NCT00783835|561904225|FG000|Overall Study|Lost to Follow-up|1|||
155676045|NCT00783835|561904225|FG000|Overall Study|Participant not Adherent|3|||
155676046|NCT01945996|561904226|FG000|Overall Study|Lost to Follow-up|3|||
155676047|NCT01945996|561904227|FG001|Overall Study|Lost to Follow-up|5|||
155676048|NCT03248167|561904228|FG000|Overall Study|Withdrawal by Subject|2|||
155676049|NCT03248167|561904229|FG001|Overall Study|Withdrawal by Subject|2|||
155676050|NCT03248167|561904228|FG000|Overall Study|Physician Decision|0|||
155676051|NCT03248167|561904229|FG001|Overall Study|Physician Decision|1|||
155676052|NCT03248167|561904228|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
155676053|NCT03248167|561904229|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
155676054|NCT03248167|561904228|FG000|Overall Study|Lost to Follow-up|1|||
155676055|NCT03248167|561904229|FG001|Overall Study|Lost to Follow-up|0|||
155676056|NCT02122146|561904230|FG000|Part 1: Dose Escalation|Death|0|||
155676057|NCT02122146|561904231|FG001|Part 1: Dose Escalation|Death|1|||
155676058|NCT02122146|561904232|FG002|Part 1: Dose Escalation|Death|1|||
155676059|NCT02122146|561904233|FG003|Part 1: Dose Escalation|Death|0|||
155676060|NCT02122146|561904234|FG004|Part 1: Dose Escalation|Death|0|||
155676061|NCT02122146|561904235|FG005|Part 1: Dose Escalation|Death|0|||
155676062|NCT02122146|561904236|FG006|Part 1: Dose Escalation|Death|0|||
155676063|NCT02122146|561904237|FG007|Part 1: Dose Escalation|Death|0|||
155599925|NCT00574249|561622513|FG001|Overall Study|Physician Decision|0|||
155599926|NCT00574249|561622512|FG000|Overall Study|Pregnancy|1|||
155599927|NCT00574249|561622513|FG001|Overall Study|Pregnancy|0|||
155599928|NCT00574249|561622512|FG000|Overall Study|Excluded by company|0|||
155599929|NCT00574249|561622513|FG001|Overall Study|Excluded by company|1|||
155599930|NCT00574249|561622512|FG000|Overall Study|PPD test taken twice|0|||
155599931|NCT00574249|561622513|FG001|Overall Study|PPD test taken twice|1|||
155599932|NCT01542034|561622517|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
155599933|NCT01542034|561622518|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
155599934|NCT01542034|561622517|FG000|Overall Study|Administrative decision|0|||
155599935|NCT01542034|561622518|FG001|Overall Study|Administrative decision|3|||
155599936|NCT01542034|561622517|FG000|Overall Study|Subject Noncompliance|1|||
155599937|NCT01542034|561622518|FG001|Overall Study|Subject Noncompliance|0|||
155599938|NCT01542034|561622517|FG000|Overall Study|Adverse Event|2|||
155599939|NCT01542034|561622518|FG001|Overall Study|Adverse Event|2|||
155599940|NCT01542034|561622517|FG000|Overall Study|Lost to Follow-up|7|||
155599941|NCT01542034|561622518|FG001|Overall Study|Lost to Follow-up|6|||
155599942|NCT01546571|561622519|FG000|Overall Study|Adverse Event|1|||
155599943|NCT01546571|561622520|FG001|Overall Study|Adverse Event|0|||
155599944|NCT01546571|561622521|FG002|Overall Study|Adverse Event|0|||
155599945|NCT01546571|561622522|FG003|Overall Study|Adverse Event|1|||
155599946|NCT01546571|561622523|FG004|Overall Study|Adverse Event|0|||
155599947|NCT01546571|561622519|FG000|Overall Study|assigned placebo in Part A|0|||
155599948|NCT01546571|561622520|FG001|Overall Study|assigned placebo in Part A|0|||
155599949|NCT01546571|561622521|FG002|Overall Study|assigned placebo in Part A|22|||
155599950|NCT01546571|561622522|FG003|Overall Study|assigned placebo in Part A|0|||
155599951|NCT01546571|561622523|FG004|Overall Study|assigned placebo in Part A|0|||
155599952|NCT01546571|561622519|FG000|Overall Study|Death|0|||
155599953|NCT01546571|561622520|FG001|Overall Study|Death|1|||
155599954|NCT01546571|561622521|FG002|Overall Study|Death|0|||
155599955|NCT01546571|561622522|FG003|Overall Study|Death|0|||
155599956|NCT01546571|561622523|FG004|Overall Study|Death|0|||
155599957|NCT01546571|561622519|FG000|Overall Study|Lost to Follow-up|0|||
155599958|NCT01546571|561622520|FG001|Overall Study|Lost to Follow-up|0|||
155599959|NCT01546571|561622521|FG002|Overall Study|Lost to Follow-up|2|||
155599960|NCT01546571|561622522|FG003|Overall Study|Lost to Follow-up|2|||
155599961|NCT01546571|561622523|FG004|Overall Study|Lost to Follow-up|3|||
155599962|NCT01546571|561622519|FG000|Overall Study|Pregnancy|0|||
155599963|NCT01546571|561622520|FG001|Overall Study|Pregnancy|0|||
155599964|NCT01546571|561622521|FG002|Overall Study|Pregnancy|0|||
155599965|NCT01546571|561622522|FG003|Overall Study|Pregnancy|1|||
155599966|NCT01546571|561622523|FG004|Overall Study|Pregnancy|0|||
155599967|NCT01546571|561622519|FG000|Overall Study|Disease Progression|20|||
155599968|NCT01546571|561622520|FG001|Overall Study|Disease Progression|18|||
155599969|NCT01546571|561622521|FG002|Overall Study|Disease Progression|15|||
155599970|NCT01546571|561622522|FG003|Overall Study|Disease Progression|73|||
155599971|NCT01546571|561622523|FG004|Overall Study|Disease Progression|37|||
155599972|NCT01546571|561622519|FG000|Overall Study|Withdrawal by Subject|1|||
155599973|NCT01546571|561622520|FG001|Overall Study|Withdrawal by Subject|2|||
155599974|NCT01546571|561622521|FG002|Overall Study|Withdrawal by Subject|4|||
155599975|NCT01546571|561622522|FG003|Overall Study|Withdrawal by Subject|9|||
155599976|NCT01546571|561622523|FG004|Overall Study|Withdrawal by Subject|2|||
155599977|NCT01546571|561622519|FG000|Overall Study|Intercurrent Illness|1|||
155599978|NCT01546571|561622520|FG001|Overall Study|Intercurrent Illness|2|||
155599979|NCT01546571|561622521|FG002|Overall Study|Intercurrent Illness|0|||
155599980|NCT01546571|561622522|FG003|Overall Study|Intercurrent Illness|0|||
155599981|NCT01546571|561622523|FG004|Overall Study|Intercurrent Illness|0|||
155599982|NCT01546571|561622519|FG000|Overall Study|Other Cancers|0|||
155599983|NCT01546571|561622520|FG001|Overall Study|Other Cancers|0|||
155599984|NCT01546571|561622521|FG002|Overall Study|Other Cancers|0|||
155599985|NCT01546571|561622522|FG003|Overall Study|Other Cancers|3|||
155599986|NCT01546571|561622523|FG004|Overall Study|Other Cancers|1|||
155599987|NCT01546571|561622519|FG000|Overall Study|Other|0|||
155599988|NCT01546571|561622520|FG001|Overall Study|Other|0|||
155599989|NCT01546571|561622521|FG002|Overall Study|Other|3|||
155599990|NCT01546571|561622522|FG003|Overall Study|Other|0|||
155599991|NCT01546571|561622523|FG004|Overall Study|Other|0|||
155599992|NCT01880086|561622529|FG000|Overall Study|Lost to Follow-up|1|||
155599993|NCT01880086|561622530|FG001|Overall Study|Lost to Follow-up|1|||
155599994|NCT04021121|561622535|FG000|Overall Study|Death|3|||
155599995|NCT04021121|561622536|FG001|Overall Study|Death|3|||
155599996|NCT04021121|561622537|FG002|Overall Study|Death|5|||
155599997|NCT04021121|561622538|FG003|Overall Study|Death|4|||
155599998|NCT00978250|561622539|FG000|Overall Study|Late determination of ineligibility|0|||
155599999|NCT00978250|561622540|FG001|Overall Study|Late determination of ineligibility|1|||
155600000|NCT00978250|561622541|FG002|Overall Study|Late determination of ineligibility|0|||
155600001|NCT00978250|561622542|FG003|Overall Study|Late determination of ineligibility|1|||
155600002|NCT02029989|561622548|FG000|Overall Study|Withdrawal by Subject|1|||
155600003|NCT02029989|561622549|FG001|Overall Study|Withdrawal by Subject|0|||
155600004|NCT02029989|561622548|FG000|Overall Study|Withdrawal: Fear of needles|1|||
155600005|NCT02029989|561622549|FG001|Overall Study|Withdrawal: Fear of needles|0|||
155600006|NCT02029989|561622548|FG000|Overall Study|Change of location|2|||
155600007|NCT02029989|561622549|FG001|Overall Study|Change of location|3|||
155600008|NCT02029989|561622548|FG000|Overall Study|Physician Decision|2|||
155600009|NCT02029989|561622549|FG001|Overall Study|Physician Decision|0|||
155600010|NCT02029989|561622548|FG000|Overall Study|Lost to Follow-up|9|||
155600011|NCT02029989|561622549|FG001|Overall Study|Lost to Follow-up|7|||
155600012|NCT02029989|561622548|FG000|Overall Study|Death|0|||
155600013|NCT02029989|561622549|FG001|Overall Study|Death|1|||
155600014|NCT02029989|561622548|FG000|Overall Study|Protocol Violation|1|||
155600015|NCT02029989|561622549|FG001|Overall Study|Protocol Violation|0|||
155600016|NCT05036668|561622550|FG000|Overall Study|lost to follow Up|0|||
155600017|NCT05036668|561622551|FG001|Overall Study|lost to follow Up|0|||
155600018|NCT05036668|561622552|FG002|Overall Study|lost to follow Up|1|||
155600019|NCT04601103|561622553|FG000|Overall Study|Needed crown & cleaning|0|||
155600020|NCT04601103|561622554|FG001|Overall Study|Needed crown & cleaning|0|||
155600021|NCT04601103|561622555|FG002|Overall Study|Needed crown & cleaning|1|||
155600022|NCT04601103|561622553|FG000|Overall Study|study was terminated|18|||
155600023|NCT04601103|561622554|FG001|Overall Study|study was terminated|18|||
155600024|NCT04601103|561622555|FG002|Overall Study|study was terminated|16|||
155600025|NCT00381043|561622560|FG000|Overall Study|Lost to Follow-up|8|||
155600026|NCT00381043|561622561|FG001|Overall Study|Lost to Follow-up|6|||
155600027|NCT00381043|561622560|FG000|Overall Study|Withdrawal by Subject|3|||
155600028|NCT00381043|561622561|FG001|Overall Study|Withdrawal by Subject|1|||
155600029|NCT00381043|561622560|FG000|Overall Study|wanted more care|0|||
155600030|NCT00381043|561622561|FG001|Overall Study|wanted more care|1|||
155600031|NCT00381043|561622560|FG000|Overall Study|incarcerated|1|||
155600032|NCT00381043|561622561|FG001|Overall Study|incarcerated|0|||
155600033|NCT02880865|561622562|FG000|Overall Study|Adverse Event|1|||
155600034|NCT02880865|561622563|FG001|Overall Study|Adverse Event|0|||
155600035|NCT02880865|561622562|FG000|Overall Study|Withdrawal by Subject|0|||
155600036|NCT02880865|561622563|FG001|Overall Study|Withdrawal by Subject|2|||
155600037|NCT02880865|561622562|FG000|Overall Study|Physician Decision|0|||
155600038|NCT02880865|561622563|FG001|Overall Study|Physician Decision|1|||
155600039|NCT00125242|561622567|FG000|Overall Study|did not qualify|7|||
155600040|NCT00125242|561622568|FG001|Overall Study|did not qualify|2|||
155600041|NCT01664949|561622569|FG000|Overall Study|Adverse Event|11|||
155600042|NCT01664949|561622570|FG001|Overall Study|Adverse Event|12|||
155600043|NCT01664949|561622569|FG000|Overall Study|Lack of Efficacy|1|||
155600044|NCT01664949|561622570|FG001|Overall Study|Lack of Efficacy|1|||
155600045|NCT01664949|561622569|FG000|Overall Study|Lost to Follow-up|1|||
155600046|NCT01664949|561622570|FG001|Overall Study|Lost to Follow-up|2|||
155600047|NCT01664949|561622569|FG000|Overall Study|Personal Reasons|3|||
155600048|NCT01664949|561622570|FG001|Overall Study|Personal Reasons|4|||
155600049|NCT01664949|561622569|FG000|Overall Study|Protocol Violation|5|||
155600050|NCT01664949|561622570|FG001|Overall Study|Protocol Violation|5|||
155600051|NCT01664949|561622569|FG000|Overall Study|Other Miscellaneous Reasons|3|||
155600052|NCT01664949|561622570|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155600053|NCT02727777|561622572|FG000|Overall Study|Screen Failure|2|||
155600054|NCT02727777|561622573|FG001|Overall Study|Screen Failure|0|||
155600055|NCT02727777|561622574|FG002|Overall Study|Screen Failure|0|||
155600056|NCT02727777|561622572|FG000|Overall Study|Progressive disease|2|||
155600057|NCT02727777|561622573|FG001|Overall Study|Progressive disease|0|||
155600058|NCT02727777|561622574|FG002|Overall Study|Progressive disease|0|||
155600059|NCT01738503|561622575|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
155600060|NCT01738503|561622576|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600061|NCT01738503|561622577|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600062|NCT01738503|561622578|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600063|NCT01738503|561622579|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600064|NCT01738503|561622580|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600065|NCT01738503|561622581|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
155600066|NCT01738503|561622575|FG000|Treatment Period|Adverse Event|0|||
155600067|NCT01738503|561622576|FG001|Treatment Period|Adverse Event|1|||
155600068|NCT01738503|561622577|FG002|Treatment Period|Adverse Event|0|||
155600069|NCT01738503|561622578|FG003|Treatment Period|Adverse Event|1|||
155600070|NCT01738503|561622579|FG004|Treatment Period|Adverse Event|2|||
155600071|NCT01738503|561622580|FG005|Treatment Period|Adverse Event|2|||
155600072|NCT01738503|561622581|FG006|Treatment Period|Adverse Event|2|||
155600073|NCT01738503|561622575|FG000|Treatment Period|Lost to Follow-up|0|||
155600074|NCT01738503|561622576|FG001|Treatment Period|Lost to Follow-up|0|||
155600075|NCT01738503|561622577|FG002|Treatment Period|Lost to Follow-up|3|||
155600076|NCT01738503|561622578|FG003|Treatment Period|Lost to Follow-up|4|||
155600077|NCT01738503|561622579|FG004|Treatment Period|Lost to Follow-up|1|||
155600078|NCT01738503|561622580|FG005|Treatment Period|Lost to Follow-up|1|||
155600079|NCT01738503|561622581|FG006|Treatment Period|Lost to Follow-up|5|||
155600080|NCT01738503|561622575|FG000|Treatment Period|Withdrawal by Subject|0|||
155600081|NCT01738503|561622576|FG001|Treatment Period|Withdrawal by Subject|1|||
155600082|NCT01738503|561622577|FG002|Treatment Period|Withdrawal by Subject|0|||
155600083|NCT01738503|561622578|FG003|Treatment Period|Withdrawal by Subject|1|||
155600084|NCT01738503|561622579|FG004|Treatment Period|Withdrawal by Subject|1|||
155600085|NCT01738503|561622580|FG005|Treatment Period|Withdrawal by Subject|1|||
155600086|NCT01738503|561622581|FG006|Treatment Period|Withdrawal by Subject|1|||
155600087|NCT01738503|561622575|FG000|Treatment Period|Protocol Violation|0|||
155600088|NCT01738503|561622576|FG001|Treatment Period|Protocol Violation|3|||
155600089|NCT01738503|561622577|FG002|Treatment Period|Protocol Violation|1|||
155600090|NCT01738503|561622578|FG003|Treatment Period|Protocol Violation|0|||
155600091|NCT01738503|561622579|FG004|Treatment Period|Protocol Violation|4|||
155600092|NCT01738503|561622580|FG005|Treatment Period|Protocol Violation|2|||
155600093|NCT01738503|561622581|FG006|Treatment Period|Protocol Violation|0|||
155600094|NCT01738503|561622575|FG000|Treatment Period|Other|0|||
155600095|NCT01738503|561622576|FG001|Treatment Period|Other|0|||
155600096|NCT01738503|561622577|FG002|Treatment Period|Other|1|||
155600097|NCT01738503|561622578|FG003|Treatment Period|Other|0|||
155600098|NCT01738503|561622579|FG004|Treatment Period|Other|0|||
155600099|NCT01738503|561622580|FG005|Treatment Period|Other|0|||
155600100|NCT01738503|561622581|FG006|Treatment Period|Other|0|||
155600101|NCT01738503|561622575|FG000|PET Imaging Sub-study|Adverse Event|0|||
155600102|NCT01738503|561622576|FG001|PET Imaging Sub-study|Adverse Event|0|||
155600103|NCT01738503|561622577|FG002|PET Imaging Sub-study|Adverse Event|0|||
155600104|NCT01738503|561622578|FG003|PET Imaging Sub-study|Adverse Event|0|||
155600105|NCT01738503|561622579|FG004|PET Imaging Sub-study|Adverse Event|0|||
155600106|NCT01738503|561622580|FG005|PET Imaging Sub-study|Adverse Event|1|||
155600107|NCT01738503|561622581|FG006|PET Imaging Sub-study|Adverse Event|0|||
155600108|NCT01738503|561622575|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155600109|NCT01738503|561622576|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155600110|NCT01738503|561622577|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155600111|NCT01738503|561622578|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155600112|NCT01738503|561622579|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155600113|NCT01738503|561622580|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
155600114|NCT01738503|561622581|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
155600115|NCT04687072|561622582|FG000|Overall Study|Adverse Event|2|||
155600116|NCT04687072|561622583|FG001|Overall Study|Adverse Event|0|||
155600117|NCT04687072|561622582|FG000|Overall Study|Death|1|||
155600118|NCT04687072|561622583|FG001|Overall Study|Death|0|||
155600119|NCT04687072|561622582|FG000|Overall Study|Lack of Efficacy|2|||
155600120|NCT04687072|561622583|FG001|Overall Study|Lack of Efficacy|1|||
155600121|NCT04687072|561622582|FG000|Overall Study|Physician Decision|1|||
155600122|NCT04687072|561622583|FG001|Overall Study|Physician Decision|0|||
155600123|NCT04687072|561622582|FG000|Overall Study|Pregnancy|1|||
155600124|NCT04687072|561622583|FG001|Overall Study|Pregnancy|0|||
155600125|NCT04687072|561622582|FG000|Overall Study|Requires Prohibited Medication|2|||
155600126|NCT04687072|561622583|FG001|Overall Study|Requires Prohibited Medication|0|||
155600127|NCT04687072|561622582|FG000|Overall Study|Withdrawal of Consent|11|||
155600128|NCT04687072|561622583|FG001|Overall Study|Withdrawal of Consent|6|||
155600129|NCT04687072|561622582|FG000|Overall Study|Miscellaneous|4|||
155600130|NCT04687072|561622583|FG001|Overall Study|Miscellaneous|1|||
155600131|NCT02272842|561622584|FG000|Overall Study|Lost to Follow-up|8|||
155600132|NCT02272842|561622585|FG001|Overall Study|Lost to Follow-up|8|||
155600133|NCT02272842|561622584|FG000|Overall Study|Withdrawal by Subject|8|||
155600134|NCT02272842|561622585|FG001|Overall Study|Withdrawal by Subject|2|||
155600135|NCT05376241|561624669|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
155600136|NCT05376241|561624669|FG000|Overall Study|103 did not complete the survey|103|||
155600137|NCT05376241|561624669|FG000|Overall Study|17 failed 2 attention check questions|17|||
155600138|NCT03036098|561624670|FG000|Pre-Treatment|Other Reasons|1|||
155600139|NCT03036098|561624671|FG001|Pre-Treatment|Other Reasons|2|||
155600140|NCT03036098|561624672|FG002|Pre-Treatment|Other Reasons|0|||
155600141|NCT03036098|561624673|FG003|Pre-Treatment|Other Reasons|5|||
155600142|NCT03036098|561624670|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
155600143|NCT03036098|561624671|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
155600144|NCT03036098|561624672|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
155600145|NCT03036098|561624673|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
155600146|NCT03036098|561624670|FG000|Pre-Treatment|Withdrawal by Subject|1|||
155600147|NCT03036098|561624671|FG001|Pre-Treatment|Withdrawal by Subject|14|||
155600148|NCT03036098|561624672|FG002|Pre-Treatment|Withdrawal by Subject|0|||
155600149|NCT03036098|561624673|FG003|Pre-Treatment|Withdrawal by Subject|5|||
155600150|NCT03036098|561624670|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
155676064|NCT02122146|561904230|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
155600151|NCT03036098|561624671|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
155600152|NCT03036098|561624672|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
155600153|NCT03036098|561624673|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
155600154|NCT03036098|561624670|FG000|Treatment|Disease Progression|130|||
155600155|NCT03036098|561624671|FG001|Treatment|Disease Progression|77|||
155600156|NCT03036098|561624672|FG002|Treatment|Disease Progression|168|||
155600157|NCT03036098|561624673|FG003|Treatment|Disease Progression|50|||
155600158|NCT03036098|561624670|FG000|Treatment|Study Drug Toxicity|95|||
155600159|NCT03036098|561624671|FG001|Treatment|Study Drug Toxicity|45|||
155600160|NCT03036098|561624672|FG002|Treatment|Study Drug Toxicity|26|||
155676065|NCT02122146|561904231|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155676066|NCT02122146|561904232|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
155676067|NCT02122146|561904233|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
155676068|NCT02122146|561904234|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
155676069|NCT02122146|561904235|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
155676070|NCT02122146|561904236|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
155676071|NCT02122146|561904237|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
155676072|NCT02122146|561904230|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676073|NCT02122146|561904231|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676074|NCT02122146|561904232|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676075|NCT02122146|561904233|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155676076|NCT02122146|561904234|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676077|NCT02122146|561904235|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676078|NCT02122146|561904236|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155600161|NCT03036098|561624673|FG003|Treatment|Study Drug Toxicity|22|||
155600162|NCT03036098|561624670|FG000|Treatment|Death|9|||
155600163|NCT03036098|561624671|FG001|Treatment|Death|3|||
155600164|NCT03036098|561624672|FG002|Treatment|Death|1|||
155600165|NCT03036098|561624673|FG003|Treatment|Death|2|||
155600166|NCT03036098|561624670|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
155600167|NCT03036098|561624671|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
155600168|NCT03036098|561624672|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
155600169|NCT03036098|561624673|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
155600170|NCT03036098|561624670|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
155600171|NCT03036098|561624671|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
155600172|NCT03036098|561624672|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
155600173|NCT03036098|561624673|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
155600174|NCT03036098|561624670|FG000|Treatment|Withdrawal by Subject|2|||
155600175|NCT03036098|561624671|FG001|Treatment|Withdrawal by Subject|9|||
155600176|NCT03036098|561624672|FG002|Treatment|Withdrawal by Subject|2|||
155600177|NCT03036098|561624673|FG003|Treatment|Withdrawal by Subject|4|||
155600178|NCT03036098|561624670|FG000|Treatment|Maximum Clinical Benefit|6|||
155600179|NCT03036098|561624671|FG001|Treatment|Maximum Clinical Benefit|1|||
155600180|NCT03036098|561624672|FG002|Treatment|Maximum Clinical Benefit|6|||
155600181|NCT03036098|561624673|FG003|Treatment|Maximum Clinical Benefit|10|||
155600182|NCT03036098|561624670|FG000|Treatment|Poor/Non Compliance|1|||
155600183|NCT03036098|561624671|FG001|Treatment|Poor/Non Compliance|2|||
155600184|NCT03036098|561624672|FG002|Treatment|Poor/Non Compliance|0|||
155600185|NCT03036098|561624673|FG003|Treatment|Poor/Non Compliance|1|||
155600186|NCT03036098|561624670|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
155600187|NCT03036098|561624671|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
155600188|NCT03036098|561624672|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
155600189|NCT03036098|561624673|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
155600190|NCT03036098|561624670|FG000|Treatment|Administrative Reason by Sponsor|1|||
155600191|NCT03036098|561624671|FG001|Treatment|Administrative Reason by Sponsor|0|||
155600192|NCT03036098|561624672|FG002|Treatment|Administrative Reason by Sponsor|2|||
155600193|NCT03036098|561624673|FG003|Treatment|Administrative Reason by Sponsor|1|||
155600194|NCT03036098|561624670|FG000|Treatment|Other Reasons|31|||
155600195|NCT03036098|561624671|FG001|Treatment|Other Reasons|5|||
155600196|NCT03036098|561624672|FG002|Treatment|Other Reasons|21|||
155600197|NCT03036098|561624673|FG003|Treatment|Other Reasons|8|||
155600198|NCT03036098|561624670|FG000|Treatment|Ongoing Treatment|0|||
155600199|NCT03036098|561624671|FG001|Treatment|Ongoing Treatment|0|||
155600200|NCT03036098|561624672|FG002|Treatment|Ongoing Treatment|23|||
155600201|NCT03036098|561624673|FG003|Treatment|Ongoing Treatment|0|||
155600202|NCT01632904|561624676|FG000|Overall Study|Adverse Event|4|||
155600203|NCT01632904|561624677|FG001|Overall Study|Adverse Event|1|||
155600204|NCT01632904|561624676|FG000|Overall Study|Physician Decision|0|||
155600205|NCT01632904|561624677|FG001|Overall Study|Physician Decision|1|||
155600206|NCT01632904|561624676|FG000|Overall Study|Subject decision|3|||
155600207|NCT01632904|561624677|FG001|Overall Study|Subject decision|2|||
155600208|NCT01632904|561624676|FG000|Overall Study|Disease Progression|0|||
155600209|NCT01632904|561624677|FG001|Overall Study|Disease Progression|1|||
155600210|NCT01632904|561624676|FG000|Overall Study|Reason for discontinuation not available|0|||
155600211|NCT01632904|561624677|FG001|Overall Study|Reason for discontinuation not available|1|||
155676079|NCT02122146|561904237|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155676080|NCT02122146|561904230|FG000|Part 1: Dose Escalation|Other|1|||
155676081|NCT02122146|561904231|FG001|Part 1: Dose Escalation|Other|0|||
155676082|NCT02122146|561904232|FG002|Part 1: Dose Escalation|Other|0|||
155676083|NCT02122146|561904233|FG003|Part 1: Dose Escalation|Other|0|||
155676084|NCT02122146|561904234|FG004|Part 1: Dose Escalation|Other|0|||
155676085|NCT02122146|561904235|FG005|Part 1: Dose Escalation|Other|1|||
155676086|NCT02122146|561904236|FG006|Part 1: Dose Escalation|Other|1|||
155676087|NCT02122146|561904237|FG007|Part 1: Dose Escalation|Other|2|||
155676088|NCT00992056|561904242|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
155676089|NCT00992056|561904243|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
155676090|NCT00992056|561904242|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
155676091|NCT00992056|561904243|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
155676092|NCT01001767|561904246|FG000|Overall Study|no baseline study performed|1|||
155676093|NCT01001767|561904247|FG001|Overall Study|no baseline study performed|0|||
155676094|NCT01001767|561904246|FG000|Overall Study|Protocol Violation|1|||
155676095|NCT01001767|561904247|FG001|Overall Study|Protocol Violation|0|||
155676096|NCT01001767|561904246|FG000|Overall Study|Lost to Follow-up|1|||
155676097|NCT01001767|561904247|FG001|Overall Study|Lost to Follow-up|0|||
155676098|NCT01001767|561904246|FG000|Overall Study|Physician Decision|1|||
155676099|NCT01001767|561904247|FG001|Overall Study|Physician Decision|0|||
155676100|NCT02584452|561904248|FG000|Overall Study|Physician Decision|1|||
155676101|NCT02584452|561904249|FG001|Overall Study|Physician Decision|1|||
155676102|NCT02584452|561904248|FG000|Overall Study|Lost to Follow-up|1|||
155676103|NCT02584452|561904249|FG001|Overall Study|Lost to Follow-up|1|||
155676104|NCT01107392|561904250|FG000|Overall Study|Adverse Event|2|||
155676105|NCT01107392|561904251|FG001|Overall Study|Adverse Event|0|||
155676106|NCT01107392|561904250|FG000|Overall Study|Personal Reasons|2|||
155676107|NCT01107392|561904251|FG001|Overall Study|Personal Reasons|3|||
155676108|NCT01107392|561904250|FG000|Overall Study|Administrative decision|1|||
155676109|NCT01107392|561904251|FG001|Overall Study|Administrative decision|0|||
155676110|NCT00851552|561904252|FG000|Overall Study|Death|2|||
155676111|NCT00851552|561904252|FG000|Overall Study|Adverse Event|1|||
155676112|NCT00851552|561904252|FG000|Overall Study|Disease Progression|4|||
155676113|NCT00177294|561904253|FG000|Overall Study|Withdrawal by Subject|7|||
155676114|NCT00177294|561904254|FG001|Overall Study|Withdrawal by Subject|5|||
155676115|NCT02998671|561904255|FG000|Period 1|Study Terminated By Sponsor|2|||
155676116|NCT02998671|561904256|FG001|Period 1|Study Terminated By Sponsor|1|||
155676117|NCT02998671|561904257|FG002|Period 1|Study Terminated By Sponsor|0|||
155676118|NCT02998671|561904258|FG003|Period 1|Study Terminated By Sponsor|0|||
155676119|NCT02998671|561904259|FG004|Period 1|Study Terminated By Sponsor|1|||
155676120|NCT02998671|561904255|FG000|Period 1|Withdrawal by Subject|1|||
155676121|NCT02998671|561904256|FG001|Period 1|Withdrawal by Subject|2|||
155676122|NCT02998671|561904257|FG002|Period 1|Withdrawal by Subject|0|||
155676123|NCT02998671|561904258|FG003|Period 1|Withdrawal by Subject|0|||
155676124|NCT02998671|561904259|FG004|Period 1|Withdrawal by Subject|2|||
155676125|NCT02998671|561904255|FG000|Period 1|Pregnancy|1|||
155676126|NCT02998671|561904256|FG001|Period 1|Pregnancy|0|||
155676127|NCT02998671|561904257|FG002|Period 1|Pregnancy|0|||
155676128|NCT02998671|561904258|FG003|Period 1|Pregnancy|0|||
155676129|NCT02998671|561904259|FG004|Period 1|Pregnancy|0|||
155676130|NCT02998671|561904255|FG000|Period 1|Adverse Event|0|||
155676131|NCT02998671|561904256|FG001|Period 1|Adverse Event|0|||
155676132|NCT02998671|561904257|FG002|Period 1|Adverse Event|0|||
155676133|NCT02998671|561904258|FG003|Period 1|Adverse Event|0|||
155676134|NCT02998671|561904259|FG004|Period 1|Adverse Event|1|||
155676135|NCT02998671|561904255|FG000|Period 2|Adverse Event|0|||
155676136|NCT02998671|561904256|FG001|Period 2|Adverse Event|1|||
155676137|NCT02998671|561904257|FG002|Period 2|Adverse Event|0|||
155676138|NCT02998671|561904258|FG003|Period 2|Adverse Event|0|||
155676139|NCT02998671|561904259|FG004|Period 2|Adverse Event|0|||
155676140|NCT02998671|561904255|FG000|Period 2|Study Terminated By Sponsor|3|||
155676141|NCT02998671|561904256|FG001|Period 2|Study Terminated By Sponsor|5|||
155676142|NCT02998671|561904257|FG002|Period 2|Study Terminated By Sponsor|1|||
155676143|NCT02998671|561904258|FG003|Period 2|Study Terminated By Sponsor|3|||
155676144|NCT02998671|561904259|FG004|Period 2|Study Terminated By Sponsor|0|||
155676145|NCT02998671|561904255|FG000|Period 2|Withdrawal by Subject|0|||
155676146|NCT02998671|561904256|FG001|Period 2|Withdrawal by Subject|1|||
155676147|NCT02998671|561904257|FG002|Period 2|Withdrawal by Subject|0|||
155676148|NCT02998671|561904258|FG003|Period 2|Withdrawal by Subject|0|||
155676149|NCT02998671|561904259|FG004|Period 2|Withdrawal by Subject|0|||
155676150|NCT02998671|561904255|FG000|Period 2|Lost to Follow-up|0|||
155676151|NCT02998671|561904256|FG001|Period 2|Lost to Follow-up|0|||
155676152|NCT02998671|561904257|FG002|Period 2|Lost to Follow-up|0|||
155676153|NCT02998671|561904258|FG003|Period 2|Lost to Follow-up|1|||
155676154|NCT02998671|561904259|FG004|Period 2|Lost to Follow-up|0|||
155676155|NCT02038946|561904261|FG000|Overall Study|Death|5|||
155676156|NCT02038946|561904261|FG000|Overall Study|Withdrawal by Subject|3|||
155676157|NCT02038946|561904261|FG000|Overall Study|Lost to Follow-up|2|||
155676158|NCT02038946|561904261|FG000|Overall Study|Other reasons|2|||
155676159|NCT01558596|561904264|FG000|Overall Study|Withdrawal by Subject|1|||
155676160|NCT01558596|561904265|FG001|Overall Study|Withdrawal by Subject|0|||
155676161|NCT01558596|561904264|FG000|Overall Study|surgery elsewhere or cancelled|1|||
155676162|NCT01558596|561904265|FG001|Overall Study|surgery elsewhere or cancelled|1|||
155676163|NCT01558596|561904264|FG000|Overall Study|Protocol Violation|1|||
155676164|NCT01558596|561904265|FG001|Overall Study|Protocol Violation|0|||
155676165|NCT02473471|561904266|FG000|Overall Study|poor oral hygiene|2|||
155676166|NCT02473471|561904266|FG000|Overall Study|Lost to Follow-up|1|||
155676167|NCT02063984|561904271|FG000|Overall Study|Lost to Follow-up|6|||
155676168|NCT02063984|561904272|FG001|Overall Study|Lost to Follow-up|5|||
155676169|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
155676170|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
155676171|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
155676172|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
155676173|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
155676174|NCT01536561|561904277|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
155676175|NCT01030952|561904278|FG000|Overall Study|Protocol Violation|0|||
155676176|NCT01030952|561904279|FG001|Overall Study|Protocol Violation|1|||
155676177|NCT01030952|561904278|FG000|Overall Study|Informed consent withdrawal|1|||
155676178|NCT01030952|561904279|FG001|Overall Study|Informed consent withdrawal|0|||
155676179|NCT01030952|561904278|FG000|Overall Study|Lost to Follow-up|0|||
155676180|NCT01030952|561904279|FG001|Overall Study|Lost to Follow-up|1|||
155676181|NCT01030952|561904278|FG000|Overall Study|Unexplained|1|||
155676182|NCT01030952|561904279|FG001|Overall Study|Unexplained|1|||
155676183|NCT02467192|561904280|FG000|Overall Study|Death|1|||
155676184|NCT02467192|561904280|FG000|Overall Study|revealed to have pneumonia before|2|||
155676185|NCT00958347|561904281|FG000|Overall Study|Death|43|||
155676186|NCT00958347|561904281|FG000|Overall Study|Withdrawal by Subject|23|||
155676187|NCT00958347|561904281|FG000|Overall Study|Lost to Follow-up|15|||
155676188|NCT00958347|561904281|FG000|Overall Study|revision/removal|10|||
155676189|NCT00958347|561904281|FG000|Overall Study|study termination|135|||
155676190|NCT01603043|561904282|FG000|Overall Study|Study Futility|7|||
155676191|NCT01603043|561904283|FG001|Overall Study|Study Futility|3|||
155676192|NCT02146131|561904303|FG000|Overall Study|Physician Decision|61|||
155676193|NCT02146131|561904304|FG001|Overall Study|Physician Decision|56|||
155676194|NCT02567799|561904305|FG000|Concurrent Chemoradiotherapy|Death|1|||
155676195|NCT02567799|561904306|FG001|Concurrent Chemoradiotherapy|Death|0|||
155676196|NCT02567799|561904307|FG002|Concurrent Chemoradiotherapy|Death|0|||
155676197|NCT02567799|561904305|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
155676198|NCT02567799|561904306|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
155676199|NCT02567799|561904307|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
155676200|NCT02567799|561904305|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
155676201|NCT02567799|561904306|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
155676202|NCT02567799|561904307|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
155676203|NCT02567799|561904305|FG000|Follow-up|Death|1|||
155676204|NCT02567799|561904306|FG001|Follow-up|Death|0|||
155676205|NCT02567799|561904307|FG002|Follow-up|Death|1|||
155676206|NCT02567799|561904305|FG000|Follow-up|Progressive Disease|1|||
155676207|NCT02567799|561904306|FG001|Follow-up|Progressive Disease|1|||
155676208|NCT02567799|561904307|FG002|Follow-up|Progressive Disease|3|||
155676209|NCT00861692|561904312|FG000|Overall Study|Death|6|||
155676210|NCT02218697|561904315|FG000|Overall Study|Adverse Event|0|||
155676211|NCT02218697|561904316|FG001|Overall Study|Adverse Event|2|||
155676212|NCT02218697|561904315|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
155676213|NCT02218697|561904316|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
155676214|NCT02218697|561904315|FG000|Overall Study|Withdrawal by Subject|2|||
155676215|NCT02218697|561904316|FG001|Overall Study|Withdrawal by Subject|3|||
155676216|NCT02142803|561904317|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155676217|NCT02142803|561904318|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155676218|NCT02142803|561904319|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155676219|NCT02142803|561904320|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
155676220|NCT05111002|561904321|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
155676221|NCT05111002|561904322|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
155676222|NCT05111002|561904321|FG000|Secondary Outcome|Lost to Follow-up|1|||
155676223|NCT05111002|561904322|FG001|Secondary Outcome|Lost to Follow-up|0|||
155676224|NCT02712996|561904323|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
155676225|NCT02712996|561904324|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
155676226|NCT01016132|561904328|FG000|Overall Study|Discomfort|1|||
155676227|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Adverse Event|21|||
155676228|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Adverse Event|34|||
155676229|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Adverse Event|14|||
155676230|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Adverse Event|17|||
155676231|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Adverse Event|0|||
155676232|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
155676233|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
155676234|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
155676235|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
155676236|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
155676237|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
155676238|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
155676239|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
155676240|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
155676241|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
155676242|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Physician Decision|2|||
155676243|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Physician Decision|4|||
155676244|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Physician Decision|4|||
155676245|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Physician Decision|4|||
155676246|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Physician Decision|0|||
155676247|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
155676248|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
155676249|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
155676250|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
155676251|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
155676252|NCT00451958|561904331|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
155676253|NCT00451958|561904332|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
155676254|NCT00451958|561904333|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
155676255|NCT00451958|561904334|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
155676256|NCT00451958|561904335|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
155676257|NCT01027650|561904338|FG000|Overall Study|Personal Reasons|0|||
155676258|NCT01027650|561904339|FG001|Overall Study|Personal Reasons|0|||
155676259|NCT01027650|561904340|FG002|Overall Study|Personal Reasons|0|||
155676260|NCT01027650|561904341|FG003|Overall Study|Personal Reasons|0|||
155676261|NCT01027650|561904342|FG004|Overall Study|Personal Reasons|2|||
155676262|NCT01027650|561904343|FG005|Overall Study|Personal Reasons|1|||
155676263|NCT01027650|561904344|FG006|Overall Study|Personal Reasons|0|||
155676264|NCT01027650|561904345|FG007|Overall Study|Personal Reasons|0|||
155676265|NCT01027650|561904338|FG000|Overall Study|Lost to Follow-up|0|||
155676266|NCT01027650|561904339|FG001|Overall Study|Lost to Follow-up|0|||
155676267|NCT01027650|561904340|FG002|Overall Study|Lost to Follow-up|0|||
155676268|NCT01027650|561904341|FG003|Overall Study|Lost to Follow-up|0|||
155676269|NCT01027650|561904342|FG004|Overall Study|Lost to Follow-up|0|||
155676270|NCT01027650|561904343|FG005|Overall Study|Lost to Follow-up|0|||
155676271|NCT01027650|561904344|FG006|Overall Study|Lost to Follow-up|1|||
155676272|NCT01027650|561904345|FG007|Overall Study|Lost to Follow-up|0|||
155676273|NCT01027650|561904338|FG000|Overall Study|Lack of Efficacy|0|||
155676274|NCT01027650|561904339|FG001|Overall Study|Lack of Efficacy|0|||
155676275|NCT01027650|561904340|FG002|Overall Study|Lack of Efficacy|0|||
155676276|NCT01027650|561904341|FG003|Overall Study|Lack of Efficacy|0|||
155676277|NCT01027650|561904342|FG004|Overall Study|Lack of Efficacy|0|||
155676278|NCT01027650|561904343|FG005|Overall Study|Lack of Efficacy|1|||
155676279|NCT01027650|561904344|FG006|Overall Study|Lack of Efficacy|0|||
155676280|NCT01027650|561904345|FG007|Overall Study|Lack of Efficacy|0|||
155676281|NCT01082081|561904346|FG000|Overall Study|Lost to Follow-up|0|||
155676282|NCT01082081|561904347|FG001|Overall Study|Lost to Follow-up|0|||
155676283|NCT01082081|561904348|FG002|Overall Study|Lost to Follow-up|1|||
155676284|NCT01082081|561904346|FG000|Overall Study|Withdrawal by Subject|0|||
155676285|NCT01082081|561904347|FG001|Overall Study|Withdrawal by Subject|0|||
155676286|NCT01082081|561904348|FG002|Overall Study|Withdrawal by Subject|1|||
155676287|NCT01082081|561904346|FG000|Overall Study|Other Reason|0|||
155676288|NCT01082081|561904347|FG001|Overall Study|Other Reason|1|||
155676289|NCT01082081|561904348|FG002|Overall Study|Other Reason|0|||
155676290|NCT02175277|561904349|FG000|Overall Study|Protocol-specified Criteria|1|||
155676291|NCT00670930|561904350|FG000|Overall Study|Adminstrative Problem|0|||
155676292|NCT00670930|561904351|FG001|Overall Study|Adminstrative Problem|1|||
155676293|NCT00670930|561904350|FG000|Overall Study|Lost to Follow-up|1|||
155676294|NCT00670930|561904351|FG001|Overall Study|Lost to Follow-up|0|||
155676295|NCT01042158|561904352|FG000|Overall Study|Physician Decision|1|||
155676296|NCT02201329|561906239|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
155600212|NCT01944670|561624678|FG000|Overall Study|Lost to Follow-up|2|||
155600213|NCT03339726|561624680|FG000|Overall Study|Withdrawal by Subject|1|||
155600214|NCT03339726|561624681|FG001|Overall Study|Withdrawal by Subject|0|||
155600215|NCT03339726|561624682|FG002|Overall Study|Withdrawal by Subject|0|||
155600216|NCT03339726|561624680|FG000|Overall Study|Lost to Follow-up|0|||
155600217|NCT03339726|561624681|FG001|Overall Study|Lost to Follow-up|1|||
155600218|NCT03339726|561624682|FG002|Overall Study|Lost to Follow-up|0|||
155600219|NCT04542499|561624688|FG000|Overall Study|Adverse Event|23|||
155600220|NCT04542499|561624689|FG001|Overall Study|Adverse Event|43|||
155600221|NCT04542499|561624688|FG000|Overall Study|Lack of Efficacy|5|||
155600222|NCT04542499|561624689|FG001|Overall Study|Lack of Efficacy|2|||
155600223|NCT04542499|561624688|FG000|Overall Study|Lost to Follow-up|3|||
155676297|NCT02201329|561906239|FG000|Overall Study|Withdrawal by Subject|2|||
155676298|NCT01534351|561906240|FG000|Overall Study|Study Terminated Early|1|||
155676299|NCT01534351|561906241|FG001|Overall Study|Study Terminated Early|0|||
155676300|NCT01534351|561906242|FG002|Overall Study|Study Terminated Early|0|||
155676301|NCT02702609|561906243|FG000|Overall Study|Lost to Follow-up|8|||
155676302|NCT02702609|561906244|FG001|Overall Study|Lost to Follow-up|4|||
155676303|NCT02702609|561906243|FG000|Overall Study|Physician Decision|1|||
155676304|NCT02702609|561906244|FG001|Overall Study|Physician Decision|0|||
155676305|NCT02674464|561906245|FG000|Overall Study|Death|10|||
155676306|NCT02674464|561906246|FG001|Overall Study|Death|21|||
155676307|NCT02674464|561906245|FG000|Overall Study|Withdrawal by Subject|24|||
155676308|NCT02674464|561906246|FG001|Overall Study|Withdrawal by Subject|44|||
155676309|NCT02674464|561906245|FG000|Overall Study|Lost to Follow-up|97|||
155676310|NCT02674464|561906246|FG001|Overall Study|Lost to Follow-up|92|||
155676311|NCT02674464|561906245|FG000|Overall Study|Outside survey window|6|||
155676312|NCT02674464|561906246|FG001|Overall Study|Outside survey window|3|||
155676313|NCT04153981|561906247|FG000|Overall Study|Death|1|||
155676314|NCT04153981|561906247|FG000|Overall Study|Withdrawal by Subject|24|||
155676315|NCT04153981|561906247|FG000|Overall Study|Lost to Follow-up|1|||
155676316|NCT04153981|561906247|FG000|Overall Study|Physician Decision|1|||
155676317|NCT04153981|561906247|FG000|Overall Study|Due to Unavailable Glucometer|1|||
155676318|NCT04153981|561906247|FG000|Overall Study|Covid 19|52|||
155676319|NCT04153981|561906247|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
155676320|NCT04153981|561906247|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
155676321|NCT01262638|561906248|FG000|Overall Study|Adverse Event|3|||
155676322|NCT01262638|561906249|FG001|Overall Study|Adverse Event|4|||
155676323|NCT01262638|561906250|FG002|Overall Study|Adverse Event|3|||
155676324|NCT01262638|561906251|FG003|Overall Study|Adverse Event|4|||
155676325|NCT01262638|561906248|FG000|Overall Study|Protocol Violation|1|||
155676326|NCT01262638|561906249|FG001|Overall Study|Protocol Violation|0|||
155676327|NCT01262638|561906250|FG002|Overall Study|Protocol Violation|0|||
155676328|NCT01262638|561906251|FG003|Overall Study|Protocol Violation|1|||
155676329|NCT01262638|561906248|FG000|Overall Study|Withdrawal by Subject|2|||
155676330|NCT01262638|561906249|FG001|Overall Study|Withdrawal by Subject|1|||
155676331|NCT01262638|561906250|FG002|Overall Study|Withdrawal by Subject|0|||
155676332|NCT01262638|561906251|FG003|Overall Study|Withdrawal by Subject|1|||
155676333|NCT01262638|561906248|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155676334|NCT01262638|561906249|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155676335|NCT01262638|561906250|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
155676336|NCT01262638|561906251|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155676337|NCT01262638|561906248|FG000|Overall Study|Lost to Follow-up|1|||
155676338|NCT01262638|561906249|FG001|Overall Study|Lost to Follow-up|1|||
155676339|NCT01262638|561906250|FG002|Overall Study|Lost to Follow-up|1|||
155676340|NCT01262638|561906251|FG003|Overall Study|Lost to Follow-up|1|||
155676341|NCT01262638|561906248|FG000|Overall Study|Participant Went Out of Town|0|||
155676342|NCT01262638|561906249|FG001|Overall Study|Participant Went Out of Town|0|||
155676343|NCT01262638|561906250|FG002|Overall Study|Participant Went Out of Town|1|||
155676344|NCT01262638|561906251|FG003|Overall Study|Participant Went Out of Town|0|||
155676345|NCT01369199|561906254|FG000|Overall Study|Withdrawal by Subject|1|||
155676346|NCT01369199|561906254|FG000|Overall Study|Lost to Follow-up|2|||
155676347|NCT01066104|561906255|FG000|Overall Study|Adverse Event|1|||
155676348|NCT01066104|561906256|FG001|Overall Study|Adverse Event|1|||
155676349|NCT01066104|561906255|FG000|Overall Study|Protocol Violation|1|||
155676350|NCT01066104|561906256|FG001|Overall Study|Protocol Violation|0|||
155676351|NCT01667133|561906257|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
155676352|NCT01667133|561906258|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
155676353|NCT01667133|561906259|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
155676354|NCT01667133|561906260|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
155676355|NCT01667133|561906261|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
155676356|NCT01667133|561906262|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
155676357|NCT01667133|561906263|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
155676358|NCT01667133|561906264|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
155676359|NCT01667133|561906265|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
155676360|NCT01667133|561906266|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
155676361|NCT01667133|561906267|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
155676362|NCT01667133|561906268|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
155676363|NCT01667133|561906257|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676364|NCT01667133|561906258|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676365|NCT01667133|561906259|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
155676366|NCT01667133|561906260|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676367|NCT01667133|561906261|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676368|NCT01667133|561906262|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676369|NCT01667133|561906263|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676370|NCT01667133|561906264|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676371|NCT01667133|561906265|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676372|NCT01667133|561906266|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676373|NCT01667133|561906267|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676374|NCT01667133|561906268|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155676375|NCT01667133|561906257|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
155676376|NCT01667133|561906258|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
155676377|NCT01667133|561906259|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
155676378|NCT01667133|561906260|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
155676379|NCT01667133|561906261|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
155676380|NCT01667133|561906262|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
155676381|NCT01667133|561906263|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
155676382|NCT01667133|561906264|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
155676383|NCT01667133|561906265|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
155676384|NCT01667133|561906266|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
155676385|NCT01667133|561906267|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
155676386|NCT01667133|561906268|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
155676387|NCT01667133|561906257|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676388|NCT01667133|561906258|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676389|NCT01667133|561906259|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676390|NCT01667133|561906260|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
155676391|NCT01667133|561906261|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676392|NCT01667133|561906262|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676393|NCT01667133|561906263|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676394|NCT01667133|561906264|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676395|NCT01667133|561906265|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676396|NCT01667133|561906266|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676397|NCT01667133|561906267|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676398|NCT01667133|561906268|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155676399|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
155676400|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
155676401|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
155676402|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
155676403|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
155676404|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
155676405|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
155676406|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
155676407|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
155676408|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
155676409|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
155676410|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
155676411|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676412|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676413|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676414|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676415|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676416|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676417|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676418|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676419|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676420|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
155676421|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676422|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155676423|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
155676424|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
155676425|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
155676426|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
155676427|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
155676428|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
155676429|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
155676430|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
155676431|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
155676432|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
155676433|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
155676434|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
155676435|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676436|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676437|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676438|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676439|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676440|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676441|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676442|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676443|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676444|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
155676445|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676446|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155676447|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Death|0|||
155676448|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Death|0|||
155676449|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Death|0|||
155676450|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Death|0|||
155676451|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Death|0|||
155676452|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Death|0|||
155676453|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Death|0|||
155676454|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Death|0|||
155676455|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Death|0|||
155676456|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Death|1|||
155676457|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Death|0|||
155676458|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Death|0|||
155676459|NCT01667133|561906257|FG000|Phase 2: Dose-expansion|Other|0|||
155676460|NCT01667133|561906258|FG001|Phase 2: Dose-expansion|Other|0|||
155676461|NCT01667133|561906259|FG002|Phase 2: Dose-expansion|Other|0|||
155676462|NCT01667133|561906260|FG003|Phase 2: Dose-expansion|Other|0|||
155676463|NCT01667133|561906261|FG004|Phase 2: Dose-expansion|Other|0|||
155676464|NCT01667133|561906262|FG005|Phase 2: Dose-expansion|Other|0|||
155676465|NCT01667133|561906263|FG006|Phase 2: Dose-expansion|Other|0|||
155676466|NCT01667133|561906264|FG007|Phase 2: Dose-expansion|Other|0|||
155676467|NCT01667133|561906265|FG008|Phase 2: Dose-expansion|Other|0|||
155676468|NCT01667133|561906266|FG009|Phase 2: Dose-expansion|Other|0|||
155676469|NCT01667133|561906267|FG010|Phase 2: Dose-expansion|Other|0|||
155676470|NCT01667133|561906268|FG011|Phase 2: Dose-expansion|Other|1|||
155676471|NCT01916824|561906271|FG000|Overall Study|Lost to Follow-up|3|||
155676472|NCT01916824|561906272|FG001|Overall Study|Lost to Follow-up|6|||
155676473|NCT01916824|561906271|FG000|Overall Study|Physician Decision|2|||
155676474|NCT01916824|561906272|FG001|Overall Study|Physician Decision|0|||
155676475|NCT01916824|561906271|FG000|Overall Study|Withdrawal by Subject|2|||
155676476|NCT01916824|561906272|FG001|Overall Study|Withdrawal by Subject|3|||
155676477|NCT00771927|561906275|FG000|Overall Study|Adverse Event|100|||
155676478|NCT00771927|561906276|FG001|Overall Study|Adverse Event|105|||
155676479|NCT00771927|561906275|FG000|Overall Study|Lack of Efficacy|70|||
155676480|NCT00771927|561906276|FG001|Overall Study|Lack of Efficacy|42|||
155676481|NCT00771927|561906275|FG000|Overall Study|Lost to Follow-up|46|||
155676482|NCT00771927|561906276|FG001|Overall Study|Lost to Follow-up|46|||
155676483|NCT00771927|561906275|FG000|Overall Study|Withdrawal by Subject|16|||
155676484|NCT00771927|561906276|FG001|Overall Study|Withdrawal by Subject|17|||
155676485|NCT00771927|561906275|FG000|Overall Study|Other reason|23|||
155676486|NCT00771927|561906276|FG001|Overall Study|Other reason|27|||
155676487|NCT03835481|561906277|FG000|Double-blind Period|Other not stated below|0|||
155676488|NCT03835481|561906278|FG001|Double-blind Period|Other not stated below|0|||
155676489|NCT03835481|561906279|FG002|Double-blind Period|Other not stated below|0|||
155676490|NCT03835481|561906280|FG003|Double-blind Period|Other not stated below|1|||
155676491|NCT03835481|561906281|FG004|Double-blind Period|Other not stated below|1|||
155676492|NCT03835481|561906277|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
155676493|NCT03835481|561906278|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
155676494|NCT03835481|561906279|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
155676495|NCT03835481|561906280|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
155676496|NCT03835481|561906281|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
155676497|NCT03835481|561906277|FG000|Double-blind Period|Withdrawal by Subject|0|||
155676498|NCT03835481|561906278|FG001|Double-blind Period|Withdrawal by Subject|0|||
155676499|NCT03835481|561906279|FG002|Double-blind Period|Withdrawal by Subject|1|||
155676500|NCT03835481|561906280|FG003|Double-blind Period|Withdrawal by Subject|0|||
155676501|NCT03835481|561906281|FG004|Double-blind Period|Withdrawal by Subject|5|||
155676502|NCT03835481|561906277|FG000|Double-blind Period|Lost to Follow-up|0|||
155676503|NCT03835481|561906278|FG001|Double-blind Period|Lost to Follow-up|0|||
155676504|NCT03835481|561906279|FG002|Double-blind Period|Lost to Follow-up|0|||
155676505|NCT03835481|561906280|FG003|Double-blind Period|Lost to Follow-up|1|||
155676506|NCT03835481|561906281|FG004|Double-blind Period|Lost to Follow-up|0|||
155676507|NCT03835481|561906277|FG000|Double-blind Period|Protocol Violation|0|||
155676508|NCT03835481|561906278|FG001|Double-blind Period|Protocol Violation|2|||
155676509|NCT03835481|561906279|FG002|Double-blind Period|Protocol Violation|0|||
155676510|NCT03835481|561906280|FG003|Double-blind Period|Protocol Violation|1|||
155676511|NCT03835481|561906281|FG004|Double-blind Period|Protocol Violation|0|||
155676512|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
155676513|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
155676514|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
155676515|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
155676516|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
155676517|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
155676518|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
155676519|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
155676520|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
155676521|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
155676522|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155676523|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155676524|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
155676525|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
155676526|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155676527|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
155676528|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
155676529|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
155676530|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
155676531|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
155676532|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155676533|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155676534|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155676535|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
155676536|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155676537|NCT03835481|561906277|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
155676538|NCT03835481|561906278|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
155676539|NCT03835481|561906279|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
155676540|NCT03835481|561906280|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
155676541|NCT03835481|561906281|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
155600224|NCT04542499|561624689|FG001|Overall Study|Lost to Follow-up|4|||
155600225|NCT04542499|561624688|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
155600226|NCT04542499|561624689|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
155600227|NCT04542499|561624688|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155676542|NCT00976716|561906288|FG000|Overall Study|Adverse Event|1|||
155600228|NCT04542499|561624689|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155600229|NCT04542499|561624688|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155600230|NCT04542499|561624689|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155600231|NCT04542499|561624688|FG000|Overall Study|Physician Decision|0|||
155600232|NCT04542499|561624689|FG001|Overall Study|Physician Decision|1|||
155600233|NCT04542499|561624688|FG000|Overall Study|Site Terminated by Sponsor|3|||
155600234|NCT04542499|561624689|FG001|Overall Study|Site Terminated by Sponsor|5|||
155600235|NCT04542499|561624688|FG000|Overall Study|Withdrawal by Subject|12|||
155600236|NCT04542499|561624689|FG001|Overall Study|Withdrawal by Subject|33|||
155600237|NCT04542499|561624688|FG000|Overall Study|Other|2|||
155600238|NCT04542499|561624689|FG001|Overall Study|Other|2|||
155600239|NCT04035434|561624695|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600240|NCT04035434|561624696|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600241|NCT04035434|561624697|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600242|NCT04035434|561624698|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
155600243|NCT04035434|561624699|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600244|NCT04035434|561624700|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600245|NCT04035434|561624701|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600246|NCT04035434|561624702|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600247|NCT04035434|561624703|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600248|NCT04035434|561624704|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600249|NCT04035434|561624705|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600250|NCT04035434|561624706|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600251|NCT04035434|561624707|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600252|NCT04035434|561624695|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155600253|NCT04035434|561624696|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155600254|NCT04035434|561624697|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
155600255|NCT04035434|561624698|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155600256|NCT04035434|561624699|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
155600257|NCT04035434|561624700|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155600258|NCT04035434|561624701|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
155600259|NCT04035434|561624702|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155600260|NCT04035434|561624703|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155600261|NCT04035434|561624704|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
155600262|NCT04035434|561624705|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155600263|NCT04035434|561624706|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
155600264|NCT04035434|561624707|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155600265|NCT04035434|561624695|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600266|NCT04035434|561624696|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155600267|NCT04035434|561624697|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155600268|NCT04035434|561624698|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600269|NCT04035434|561624699|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155600270|NCT04035434|561624700|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155600271|NCT04035434|561624701|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600272|NCT04035434|561624702|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600273|NCT04035434|561624703|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155600274|NCT04035434|561624704|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155600275|NCT04035434|561624705|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600276|NCT04035434|561624706|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155600277|NCT04035434|561624707|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
155600278|NCT04035434|561624695|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600279|NCT04035434|561624696|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600280|NCT04035434|561624697|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600281|NCT04035434|561624698|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
155600282|NCT04035434|561624699|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600283|NCT04035434|561624700|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600284|NCT04035434|561624701|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600285|NCT04035434|561624702|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600286|NCT04035434|561624703|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600287|NCT04035434|561624704|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600288|NCT04035434|561624705|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600289|NCT04035434|561624706|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600290|NCT04035434|561624707|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155600291|NCT04035434|561624695|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600292|NCT04035434|561624696|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600293|NCT04035434|561624697|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600294|NCT04035434|561624698|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600295|NCT04035434|561624699|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600296|NCT04035434|561624700|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
155600297|NCT04035434|561624701|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
155600298|NCT04035434|561624702|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600299|NCT04035434|561624703|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600300|NCT04035434|561624704|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600301|NCT04035434|561624705|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600302|NCT04035434|561624706|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600303|NCT04035434|561624707|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155600304|NCT04035434|561624695|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600305|NCT04035434|561624696|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600306|NCT04035434|561624697|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600307|NCT04035434|561624698|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600308|NCT04035434|561624699|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600309|NCT04035434|561624700|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600310|NCT04035434|561624701|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155600311|NCT04035434|561624702|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600312|NCT04035434|561624703|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600313|NCT04035434|561624704|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600314|NCT04035434|561624705|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600315|NCT04035434|561624706|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600316|NCT04035434|561624707|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155600317|NCT04035434|561624695|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600318|NCT04035434|561624696|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600319|NCT04035434|561624697|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600320|NCT04035434|561624698|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600321|NCT04035434|561624699|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600322|NCT04035434|561624700|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
155600323|NCT04035434|561624701|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
155600324|NCT04035434|561624702|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600325|NCT04035434|561624703|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600326|NCT04035434|561624704|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600327|NCT04035434|561624705|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600328|NCT04035434|561624706|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600329|NCT04035434|561624707|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155600330|NCT02879994|561624709|FG000|Overall Study|off treatment early|7|||
155600331|NCT02879994|561624709|FG000|Overall Study|Adverse Event|2|||
155600332|NCT02879994|561624709|FG000|Overall Study|Death|2|||
155600333|NCT02143791|561624710|FG000|Enrolled|Withdrawal by Subject|4|||
155600334|NCT02143791|561624710|FG000|Trial Stimulation|Lack of Efficacy|21|||
155600335|NCT02143791|561624710|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
155600336|NCT02143791|561624710|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
155600337|NCT02143791|561624710|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
155600338|NCT02143791|561624710|FG000|Any Programming (3-6 Months)|Missing Data|1|||
155600339|NCT02143791|561624710|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
155600340|NCT04984681|561624716|FG000|Overall Study|Lost to Follow-up|3|||
155600341|NCT04984681|561624717|FG001|Overall Study|Lost to Follow-up|1|||
155600342|NCT01214252|561624718|FG000|Overall Study|Not eligible per protocol|82|||
155600343|NCT00552032|561624720|FG000|Overall Study|Withdrawal by Subject|2|||
155600344|NCT00552032|561624721|FG001|Overall Study|Withdrawal by Subject|2|||
155600345|NCT00552032|561624720|FG000|Overall Study|Protocol Violation|7|||
155600346|NCT00552032|561624721|FG001|Overall Study|Protocol Violation|12|||
155600347|NCT00552032|561624720|FG000|Overall Study|Lost to Follow-up|8|||
155600348|NCT00552032|561624721|FG001|Overall Study|Lost to Follow-up|5|||
155600349|NCT01258075|561624724|FG000|Overall Study|Adverse Event|8|||
155600350|NCT01258075|561624725|FG001|Overall Study|Adverse Event|3|||
155600351|NCT01258075|561624724|FG000|Overall Study|Lost to Follow-up|11|||
155600352|NCT01258075|561624725|FG001|Overall Study|Lost to Follow-up|6|||
155600353|NCT01258075|561624724|FG000|Overall Study|Withdrawal by Subject|10|||
155600354|NCT01258075|561624725|FG001|Overall Study|Withdrawal by Subject|7|||
155600355|NCT01258075|561624724|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
155600356|NCT01258075|561624725|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
155600357|NCT01258075|561624724|FG000|Overall Study|Other|12|||
155600358|NCT01258075|561624725|FG001|Overall Study|Other|5|||
155600359|NCT02612610|561624726|FG000|Overall Study|Withdrawal by Subject|1|||
155600360|NCT02612610|561624727|FG001|Overall Study|Withdrawal by Subject|1|||
155600361|NCT02612610|561624728|FG002|Overall Study|Withdrawal by Subject|0|||
155600362|NCT02612610|561624729|FG003|Overall Study|Withdrawal by Subject|2|||
155600363|NCT02612610|561624726|FG000|Overall Study|Adverse Event|2|||
155600364|NCT02612610|561624727|FG001|Overall Study|Adverse Event|2|||
155600365|NCT02612610|561624728|FG002|Overall Study|Adverse Event|3|||
155600366|NCT02612610|561624729|FG003|Overall Study|Adverse Event|10|||
155600367|NCT02612610|561624726|FG000|Overall Study|Lost to Follow-up|0|||
155600368|NCT02612610|561624727|FG001|Overall Study|Lost to Follow-up|1|||
155600369|NCT02612610|561624728|FG002|Overall Study|Lost to Follow-up|0|||
155600370|NCT02612610|561624729|FG003|Overall Study|Lost to Follow-up|0|||
155600371|NCT02612610|561624726|FG000|Overall Study|Protocol Violation|0|||
155600372|NCT02612610|561624727|FG001|Overall Study|Protocol Violation|1|||
155600373|NCT02612610|561624728|FG002|Overall Study|Protocol Violation|1|||
155600374|NCT02612610|561624729|FG003|Overall Study|Protocol Violation|0|||
155600375|NCT02612610|561624726|FG000|Overall Study|Lack of Efficacy|1|||
155600376|NCT02612610|561624727|FG001|Overall Study|Lack of Efficacy|2|||
155600377|NCT02612610|561624728|FG002|Overall Study|Lack of Efficacy|0|||
155600378|NCT02612610|561624729|FG003|Overall Study|Lack of Efficacy|1|||
155600379|NCT02612610|561624726|FG000|Overall Study|Physician Decision|0|||
155600380|NCT02612610|561624727|FG001|Overall Study|Physician Decision|1|||
155600381|NCT02612610|561624728|FG002|Overall Study|Physician Decision|0|||
155600382|NCT02612610|561624729|FG003|Overall Study|Physician Decision|0|||
155600383|NCT02612610|561624726|FG000|Overall Study|Noncompliance|1|||
155600384|NCT02612610|561624727|FG001|Overall Study|Noncompliance|0|||
155600385|NCT02612610|561624728|FG002|Overall Study|Noncompliance|0|||
155600386|NCT02612610|561624729|FG003|Overall Study|Noncompliance|0|||
155600387|NCT02612610|561624726|FG000|Overall Study|Cough Improvement|0|||
155600388|NCT02612610|561624727|FG001|Overall Study|Cough Improvement|0|||
155600389|NCT02612610|561624728|FG002|Overall Study|Cough Improvement|1|||
155600390|NCT02612610|561624729|FG003|Overall Study|Cough Improvement|0|||
155600391|NCT00478699|561624734|FG000|Overall Study|Inclusion Error|1|||
155600392|NCT00478699|561624735|FG001|Overall Study|Inclusion Error|7|||
155600393|NCT00478699|561624734|FG000|Overall Study|Not receive study treatment|6|||
155600394|NCT00478699|561624735|FG001|Overall Study|Not receive study treatment|30|||
155600395|NCT01252563|561624737|FG000|Overall Study|Contract Deviation|41|||
155600396|NCT01252563|561624737|FG000|Overall Study|Centralized Registration Deviation|30|||
155600397|NCT01252563|561624737|FG000|Overall Study|Lost to Follow-up|161|||
155600398|NCT01252563|561624737|FG000|Overall Study|No visit after first day of treatment|194|||
155600399|NCT01252563|561624737|FG000|Overall Study|No drug administration|6|||
155600400|NCT01866657|561624738|FG000|Overall Study|Surgery canceled|2|||
155600401|NCT01866657|561624739|FG001|Overall Study|Surgery canceled|0|||
155600402|NCT05174949|561624741|FG000|Overall Study|Physician Decision|1|||
155600403|NCT05174949|561624742|FG001|Overall Study|Physician Decision|2|||
155600404|NCT05174949|561624743|FG002|Overall Study|Physician Decision|0|||
155600405|NCT05174949|561624744|FG003|Overall Study|Physician Decision|1|||
155600406|NCT05174949|561624745|FG004|Overall Study|Physician Decision|0|||
155600407|NCT05174949|561624746|FG005|Overall Study|Physician Decision|0|||
155600408|NCT05174949|561624741|FG000|Overall Study|Withdrawal by Subject|0|||
155600409|NCT05174949|561624742|FG001|Overall Study|Withdrawal by Subject|1|||
155600410|NCT05174949|561624743|FG002|Overall Study|Withdrawal by Subject|0|||
155600411|NCT05174949|561624744|FG003|Overall Study|Withdrawal by Subject|0|||
155600412|NCT05174949|561624745|FG004|Overall Study|Withdrawal by Subject|0|||
155600413|NCT05174949|561624746|FG005|Overall Study|Withdrawal by Subject|0|||
155600414|NCT05174949|561624741|FG000|Overall Study|Lost to Follow-up|0|||
155600415|NCT05174949|561624742|FG001|Overall Study|Lost to Follow-up|0|||
155600416|NCT05174949|561624743|FG002|Overall Study|Lost to Follow-up|0|||
155600417|NCT05174949|561624744|FG003|Overall Study|Lost to Follow-up|1|||
155600418|NCT05174949|561624745|FG004|Overall Study|Lost to Follow-up|0|||
155600419|NCT05174949|561624746|FG005|Overall Study|Lost to Follow-up|0|||
155600420|NCT02951533|561624747|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
155600421|NCT02951533|561624748|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
155600422|NCT02951533|561624749|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
155600423|NCT02951533|561624747|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
155600424|NCT02951533|561624748|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
155600425|NCT02951533|561624749|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
155676543|NCT04222699|561906289|FG000|Overall Study|Lost to Follow-up|2|||
155676544|NCT01814046|561906298|FG000|Drug Administration|Death due to complications of RSV|1|||
155676545|NCT01814046|561906299|FG001|Drug Administration|Death due to complications of RSV|0|||
155676546|NCT01814046|561906300|FG002|Drug Administration|Death due to complications of RSV|0|||
155676547|NCT00564902|561906301|FG000|Overall Study|Withdrawal by Subject|0|||
155676548|NCT00564902|561906302|FG001|Overall Study|Withdrawal by Subject|3|||
155676549|NCT00564902|561906303|FG002|Overall Study|Withdrawal by Subject|4|||
155676550|NCT00564902|561906301|FG000|Overall Study|Death|1|||
155676551|NCT00564902|561906302|FG001|Overall Study|Death|1|||
155676552|NCT00564902|561906303|FG002|Overall Study|Death|0|||
155676553|NCT04552288|561906306|FG000|Overall Study|Death|3|||
155676554|NCT04552288|561906306|FG000|Overall Study|Lost to Follow-up|6|||
155676555|NCT04552288|561906306|FG000|Overall Study|Physician Decision|3|||
155676556|NCT04552288|561906306|FG000|Overall Study|Protocol Violation|9|||
155676557|NCT04552288|561906306|FG000|Overall Study|Withdrawal by Subject|6|||
155676558|NCT04552288|561906306|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
155676559|NCT03089047|561906307|FG000|Overall Study|Lost to Follow-up|1|||
155676560|NCT03089047|561906308|FG001|Overall Study|Lost to Follow-up|0|||
155676561|NCT03599518|561906309|FG000|Overall Study|Clinical progression|0|||
155676562|NCT03599518|561906310|FG001|Overall Study|Clinical progression|0|||
155676563|NCT03599518|561906311|FG002|Overall Study|Clinical progression|0|||
155676564|NCT03599518|561906312|FG003|Overall Study|Clinical progression|0|||
155676565|NCT03599518|561906313|FG004|Overall Study|Clinical progression|1|||
155676566|NCT03599518|561906309|FG000|Overall Study|Adverse Event|0|||
155676567|NCT03599518|561906310|FG001|Overall Study|Adverse Event|0|||
155676568|NCT03599518|561906311|FG002|Overall Study|Adverse Event|0|||
155676569|NCT03599518|561906312|FG003|Overall Study|Adverse Event|0|||
155676570|NCT03599518|561906313|FG004|Overall Study|Adverse Event|1|||
155676571|NCT03599518|561906309|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
155676572|NCT03599518|561906310|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
155676573|NCT03599518|561906311|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
155676574|NCT03599518|561906312|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
155676575|NCT03599518|561906313|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
155676576|NCT03599518|561906309|FG000|Overall Study|Participant withdrawal from study treatment|0|||
155676577|NCT03599518|561906310|FG001|Overall Study|Participant withdrawal from study treatment|0|||
155676578|NCT03599518|561906311|FG002|Overall Study|Participant withdrawal from study treatment|1|||
155676579|NCT03599518|561906312|FG003|Overall Study|Participant withdrawal from study treatment|0|||
155676580|NCT03599518|561906313|FG004|Overall Study|Participant withdrawal from study treatment|0|||
155676581|NCT03583359|561906314|FG000|Overall Study|Withdrawal by Subject|15|||
155676582|NCT03583359|561906315|FG001|Overall Study|Withdrawal by Subject|6|||
155676583|NCT03583359|561906314|FG000|Overall Study|Lost to Follow-up|12|||
155676584|NCT03583359|561906315|FG001|Overall Study|Lost to Follow-up|3|||
155676585|NCT03583359|561906314|FG000|Overall Study|Adverse Event|0|||
155676586|NCT03583359|561906315|FG001|Overall Study|Adverse Event|1|||
155676587|NCT03583359|561906314|FG000|Overall Study|Protocol Violation|0|||
155676588|NCT03583359|561906315|FG001|Overall Study|Protocol Violation|1|||
155676589|NCT03583359|561906314|FG000|Overall Study|Other|2|||
155676590|NCT03583359|561906315|FG001|Overall Study|Other|1|||
155676591|NCT01831466|561906323|FG000|Overall Study|Protocol Violation|1|||
155676592|NCT01831466|561906324|FG001|Overall Study|Protocol Violation|1|||
155676593|NCT01831466|561906325|FG002|Overall Study|Protocol Violation|2|||
155676594|NCT01831466|561906326|FG003|Overall Study|Protocol Violation|0|||
155676595|NCT01831466|561906327|FG004|Overall Study|Protocol Violation|0|||
155676596|NCT01831466|561906328|FG005|Overall Study|Protocol Violation|1|||
155676597|NCT01831466|561906329|FG006|Overall Study|Protocol Violation|0|||
155676598|NCT01831466|561906330|FG007|Overall Study|Protocol Violation|0|||
155676599|NCT01831466|561906331|FG008|Overall Study|Protocol Violation|0|||
155676600|NCT01831466|561906332|FG009|Overall Study|Protocol Violation|0|||
155676601|NCT01831466|561906333|FG010|Overall Study|Protocol Violation|0|||
155676602|NCT01831466|561906334|FG011|Overall Study|Protocol Violation|0|||
155676603|NCT01831466|561906323|FG000|Overall Study|Other|2|||
155676604|NCT01831466|561906324|FG001|Overall Study|Other|3|||
155676605|NCT01831466|561906325|FG002|Overall Study|Other|2|||
155676606|NCT01831466|561906326|FG003|Overall Study|Other|2|||
155676607|NCT01831466|561906327|FG004|Overall Study|Other|2|||
155676608|NCT01831466|561906328|FG005|Overall Study|Other|1|||
155676609|NCT01831466|561906329|FG006|Overall Study|Other|0|||
155676610|NCT01831466|561906330|FG007|Overall Study|Other|0|||
155676611|NCT01831466|561906331|FG008|Overall Study|Other|0|||
155676612|NCT01831466|561906332|FG009|Overall Study|Other|0|||
155676613|NCT01831466|561906333|FG010|Overall Study|Other|0|||
155676614|NCT01831466|561906334|FG011|Overall Study|Other|0|||
155676615|NCT01831466|561906323|FG000|Overall Study|Non-compliance with study treatment|2|||
155676616|NCT01831466|561906324|FG001|Overall Study|Non-compliance with study treatment|1|||
155676617|NCT01831466|561906325|FG002|Overall Study|Non-compliance with study treatment|1|||
155676618|NCT01831466|561906326|FG003|Overall Study|Non-compliance with study treatment|0|||
155676619|NCT01831466|561906327|FG004|Overall Study|Non-compliance with study treatment|0|||
155676620|NCT01831466|561906328|FG005|Overall Study|Non-compliance with study treatment|1|||
155676621|NCT01831466|561906329|FG006|Overall Study|Non-compliance with study treatment|0|||
155676622|NCT01831466|561906330|FG007|Overall Study|Non-compliance with study treatment|0|||
155676623|NCT01831466|561906331|FG008|Overall Study|Non-compliance with study treatment|0|||
155676624|NCT01831466|561906332|FG009|Overall Study|Non-compliance with study treatment|0|||
155676625|NCT01831466|561906333|FG010|Overall Study|Non-compliance with study treatment|0|||
155676626|NCT01831466|561906334|FG011|Overall Study|Non-compliance with study treatment|0|||
155676627|NCT01831466|561906323|FG000|Overall Study|Death|0|||
155676628|NCT01831466|561906324|FG001|Overall Study|Death|1|||
155676629|NCT01831466|561906325|FG002|Overall Study|Death|0|||
155676630|NCT01831466|561906326|FG003|Overall Study|Death|0|||
155676631|NCT01831466|561906327|FG004|Overall Study|Death|0|||
155676632|NCT01831466|561906328|FG005|Overall Study|Death|0|||
155676633|NCT01831466|561906329|FG006|Overall Study|Death|0|||
155676634|NCT01831466|561906330|FG007|Overall Study|Death|0|||
155676635|NCT01831466|561906331|FG008|Overall Study|Death|0|||
155676636|NCT01831466|561906332|FG009|Overall Study|Death|0|||
155676637|NCT01831466|561906333|FG010|Overall Study|Death|0|||
155676638|NCT01831466|561906334|FG011|Overall Study|Death|0|||
155676639|NCT01831466|561906323|FG000|Overall Study|Withdrawal by Subject|6|||
155676640|NCT01831466|561906324|FG001|Overall Study|Withdrawal by Subject|3|||
155676641|NCT01831466|561906325|FG002|Overall Study|Withdrawal by Subject|3|||
155676642|NCT01831466|561906326|FG003|Overall Study|Withdrawal by Subject|3|||
155676643|NCT01831466|561906327|FG004|Overall Study|Withdrawal by Subject|3|||
155676644|NCT01831466|561906328|FG005|Overall Study|Withdrawal by Subject|5|||
155676645|NCT01831466|561906329|FG006|Overall Study|Withdrawal by Subject|0|||
155676646|NCT01831466|561906330|FG007|Overall Study|Withdrawal by Subject|0|||
155676647|NCT01831466|561906331|FG008|Overall Study|Withdrawal by Subject|0|||
155676648|NCT01831466|561906332|FG009|Overall Study|Withdrawal by Subject|1|||
155676649|NCT01831466|561906333|FG010|Overall Study|Withdrawal by Subject|0|||
155676650|NCT01831466|561906334|FG011|Overall Study|Withdrawal by Subject|1|||
155676651|NCT01831466|561906323|FG000|Overall Study|Lost to Follow-up|0|||
155676652|NCT01831466|561906324|FG001|Overall Study|Lost to Follow-up|1|||
155676653|NCT01831466|561906325|FG002|Overall Study|Lost to Follow-up|4|||
155676654|NCT01831466|561906326|FG003|Overall Study|Lost to Follow-up|2|||
155676655|NCT01831466|561906327|FG004|Overall Study|Lost to Follow-up|0|||
155676656|NCT01831466|561906328|FG005|Overall Study|Lost to Follow-up|3|||
155676657|NCT01831466|561906329|FG006|Overall Study|Lost to Follow-up|0|||
155676658|NCT01831466|561906330|FG007|Overall Study|Lost to Follow-up|0|||
155676659|NCT01831466|561906331|FG008|Overall Study|Lost to Follow-up|0|||
155676660|NCT01831466|561906332|FG009|Overall Study|Lost to Follow-up|1|||
155676661|NCT01831466|561906333|FG010|Overall Study|Lost to Follow-up|0|||
155676662|NCT01831466|561906334|FG011|Overall Study|Lost to Follow-up|1|||
155676663|NCT01831466|561906323|FG000|Overall Study|Lack of Efficacy|5|||
155676664|NCT01831466|561906324|FG001|Overall Study|Lack of Efficacy|8|||
155676665|NCT01831466|561906325|FG002|Overall Study|Lack of Efficacy|7|||
155676666|NCT01831466|561906326|FG003|Overall Study|Lack of Efficacy|6|||
155676667|NCT01831466|561906327|FG004|Overall Study|Lack of Efficacy|9|||
155676668|NCT01831466|561906328|FG005|Overall Study|Lack of Efficacy|8|||
155676669|NCT01831466|561906329|FG006|Overall Study|Lack of Efficacy|1|||
155676670|NCT01831466|561906330|FG007|Overall Study|Lack of Efficacy|1|||
155676671|NCT01831466|561906331|FG008|Overall Study|Lack of Efficacy|2|||
155676672|NCT01831466|561906332|FG009|Overall Study|Lack of Efficacy|2|||
155676673|NCT01831466|561906333|FG010|Overall Study|Lack of Efficacy|2|||
155676674|NCT01831466|561906334|FG011|Overall Study|Lack of Efficacy|0|||
155676675|NCT01831466|561906323|FG000|Overall Study|Adverse Event|0|||
155676676|NCT01831466|561906324|FG001|Overall Study|Adverse Event|0|||
155676677|NCT01831466|561906325|FG002|Overall Study|Adverse Event|4|||
155676678|NCT01831466|561906326|FG003|Overall Study|Adverse Event|6|||
155676679|NCT01831466|561906327|FG004|Overall Study|Adverse Event|3|||
155676680|NCT01831466|561906328|FG005|Overall Study|Adverse Event|7|||
155676681|NCT01831466|561906329|FG006|Overall Study|Adverse Event|0|||
155676682|NCT01831466|561906330|FG007|Overall Study|Adverse Event|1|||
155676683|NCT01831466|561906331|FG008|Overall Study|Adverse Event|1|||
155676684|NCT01831466|561906332|FG009|Overall Study|Adverse Event|1|||
155676685|NCT01831466|561906333|FG010|Overall Study|Adverse Event|0|||
155676686|NCT01831466|561906334|FG011|Overall Study|Adverse Event|2|||
155676687|NCT03335150|561906338|FG000|Overall Study|Withdrawal by Subject|10|||
155676688|NCT03335150|561906339|FG001|Overall Study|Withdrawal by Subject|4|||
155676689|NCT03335150|561906338|FG000|Overall Study|Adverse Event|0|||
155676690|NCT03335150|561906339|FG001|Overall Study|Adverse Event|1|||
155676691|NCT04380753|561906346|FG000|Overall Study|Participants continuing study|4|||
155676692|NCT04380753|561906346|FG000|Overall Study|Death|2|||
155676693|NCT00809926|561906347|FG000|Overall Study|Adverse Event|18|||
155676694|NCT00809926|561906348|FG001|Overall Study|Adverse Event|10|||
155676695|NCT00809926|561906347|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155676696|NCT00809926|561906348|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155676697|NCT00809926|561906347|FG000|Overall Study|Patient withdrew consent|8|||
155676698|NCT00809926|561906348|FG001|Overall Study|Patient withdrew consent|6|||
155676699|NCT00809926|561906347|FG000|Overall Study|Lost to Follow-up|2|||
155676700|NCT00809926|561906348|FG001|Overall Study|Lost to Follow-up|1|||
155676701|NCT00809926|561906347|FG000|Overall Study|Administrative Problems|0|||
155676702|NCT00809926|561906348|FG001|Overall Study|Administrative Problems|1|||
155676703|NCT00809926|561906347|FG000|Overall Study|Protocol deviation|0|||
155676704|NCT00809926|561906348|FG001|Overall Study|Protocol deviation|2|||
155676705|NCT04776720|561906366|FG000|Overall Study|COVID Related|4|||
155676706|NCT04776720|561906367|FG001|Overall Study|COVID Related|2|||
155676707|NCT04776720|561906366|FG000|Overall Study|Adverse Event|2|||
155676708|NCT04776720|561906367|FG001|Overall Study|Adverse Event|0|||
155676709|NCT04776720|561906366|FG000|Overall Study|Serious Adverse Event|0|||
155600426|NCT02951533|561624747|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
155600427|NCT02951533|561624748|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
155600428|NCT02951533|561624749|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
155600429|NCT02951533|561624747|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
155600430|NCT02951533|561624748|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
155600431|NCT02951533|561624749|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
155600432|NCT02951533|561624747|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
155600433|NCT02951533|561624748|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
155600434|NCT02951533|561624749|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
155600435|NCT02951533|561624747|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
155600436|NCT02951533|561624748|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
155600437|NCT02951533|561624749|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
155600438|NCT02951533|561624747|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
155600439|NCT02951533|561624748|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
155600440|NCT02951533|561624749|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
155600441|NCT02951533|561624747|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
155600442|NCT02951533|561624748|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
155600443|NCT02951533|561624749|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
155600444|NCT02951533|561624747|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
155676710|NCT04776720|561906367|FG001|Overall Study|Serious Adverse Event|1|||
155676711|NCT04776720|561906366|FG000|Overall Study|Too Busy|3|||
155676712|NCT04776720|561906367|FG001|Overall Study|Too Busy|1|||
155676713|NCT04776720|561906366|FG000|Overall Study|Lost to Follow-up|1|||
155676714|NCT04776720|561906367|FG001|Overall Study|Lost to Follow-up|2|||
155676715|NCT04776720|561906366|FG000|Overall Study|Family|2|||
155676716|NCT04776720|561906367|FG001|Overall Study|Family|2|||
155676717|NCT04776720|561906366|FG000|Overall Study|No remote technology access|0|||
155676718|NCT04776720|561906367|FG001|Overall Study|No remote technology access|1|||
155676719|NCT04776720|561906366|FG000|Overall Study|Withdrawal by Subject|1|||
155676720|NCT04776720|561906367|FG001|Overall Study|Withdrawal by Subject|0|||
155676721|NCT04776720|561906366|FG000|Overall Study|Cannot tolerate intervention|1|||
155676722|NCT04776720|561906367|FG001|Overall Study|Cannot tolerate intervention|0|||
155676723|NCT04776720|561906366|FG000|Overall Study|Incomplete outcome data|6|||
155676724|NCT04776720|561906367|FG001|Overall Study|Incomplete outcome data|1|||
155676725|NCT05356910|561906370|FG000|Overall Study|Lost to Follow-up|10|||
155676726|NCT05356910|561906371|FG001|Overall Study|Lost to Follow-up|19|||
155676727|NCT05356910|561906372|FG002|Overall Study|Lost to Follow-up|0|||
155600445|NCT02951533|561624748|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
155600446|NCT02951533|561624749|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
155600447|NCT02951533|561624747|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
155600448|NCT02951533|561624748|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
155600449|NCT02951533|561624749|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
155600450|NCT02951533|561624747|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
155600451|NCT02951533|561624748|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
155600452|NCT02951533|561624749|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
155600453|NCT04351373|561624750|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
155600454|NCT01123941|561624756|FG000|Overall Study|Lost to Follow-up|2|||
155600455|NCT01123941|561624757|FG001|Overall Study|Lost to Follow-up|1|||
155600456|NCT05083923|561624759|FG000|Overall Study|Adverse Event|2|||
155600457|NCT05083923|561624760|FG001|Overall Study|Adverse Event|0|||
155600458|NCT05083923|561624759|FG000|Overall Study|Lack of Efficacy|1|||
155600459|NCT05083923|561624760|FG001|Overall Study|Lack of Efficacy|3|||
155600460|NCT05083923|561624759|FG000|Overall Study|Withdrawal by Subject|2|||
155600461|NCT05083923|561624760|FG001|Overall Study|Withdrawal by Subject|6|||
155600462|NCT05083923|561624759|FG000|Overall Study|Reason Not Specified|0|||
155600463|NCT05083923|561624760|FG001|Overall Study|Reason Not Specified|1|||
155600464|NCT01537068|561624765|FG000|Overall Study|Lost to Follow-up|2|||
155600465|NCT01537068|561624766|FG001|Overall Study|Lost to Follow-up|1|||
155600466|NCT01537068|561624765|FG000|Overall Study|Adverse Event|0|||
155600467|NCT01537068|561624766|FG001|Overall Study|Adverse Event|1|||
155600468|NCT01537068|561624765|FG000|Overall Study|Withdrawal by Subject|1|||
155600469|NCT01537068|561624766|FG001|Overall Study|Withdrawal by Subject|1|||
155600470|NCT01537068|561624765|FG000|Overall Study|Lack of Efficacy|1|||
155600471|NCT01537068|561624766|FG001|Overall Study|Lack of Efficacy|0|||
155600472|NCT06011161|561624767|FG000|Overall Study|Withdrawal by Subject|2|||
155600473|NCT06011161|561624767|FG000|Overall Study|Lost to Follow-up|5|||
155600474|NCT02291601|561624770|FG000|Abdomen|Did not qualify|333|||
155600475|NCT02291601|561624771|FG001|Abdomen|Did not qualify|54|||
155600476|NCT02291601|561624772|FG002|Abdomen|Did not qualify|339|||
155600477|NCT02291601|561624770|FG000|Groin|Did not qualify|183|||
155600478|NCT02291601|561624771|FG001|Groin|Did not qualify|30|||
155600479|NCT02291601|561624772|FG002|Groin|Did not qualify|177|||
155600480|NCT01597375|561624774|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
155600481|NCT01597375|561624775|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
155600482|NCT01597375|561624774|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
155600483|NCT01597375|561624775|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
155600484|NCT01597375|561624774|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155600485|NCT01597375|561624775|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155600486|NCT01597375|561624774|FG000|Washout (2 Weeks)|Adverse Event|1|||
155600487|NCT01597375|561624775|FG001|Washout (2 Weeks)|Adverse Event|0|||
155600488|NCT01597375|561624774|FG000|Second Intervention|Failed to react at both Aspirin|1|||
155600489|NCT01597375|561624775|FG001|Second Intervention|Failed to react at both Aspirin|1|||
155676728|NCT05356910|561906373|FG003|Overall Study|Lost to Follow-up|0|||
155600490|NCT01190267|561624778|FG000|Overall Study|Adverse Event|10|||
155600491|NCT01190267|561624779|FG001|Overall Study|Adverse Event|0|||
155600492|NCT01190267|561624778|FG000|Overall Study|Treatment Failure|8|||
155600493|NCT01190267|561624779|FG001|Overall Study|Treatment Failure|2|||
155600494|NCT01190267|561624778|FG000|Overall Study|Lost to Follow-up|2|||
155600495|NCT01190267|561624779|FG001|Overall Study|Lost to Follow-up|0|||
155600496|NCT01190267|561624778|FG000|Overall Study|Withdrawal by Subject|13|||
155600497|NCT01190267|561624779|FG001|Overall Study|Withdrawal by Subject|1|||
155676729|NCT05356910|561906370|FG000|Overall Study|Withdrawal by Subject|4|||
155676730|NCT05356910|561906371|FG001|Overall Study|Withdrawal by Subject|2|||
155676731|NCT05356910|561906372|FG002|Overall Study|Withdrawal by Subject|0|||
155676732|NCT05356910|561906373|FG003|Overall Study|Withdrawal by Subject|0|||
155676733|NCT03306433|561906377|FG000|Overall Study|Lost to Follow-up|3|||
155676734|NCT03306433|561906377|FG000|Overall Study|Patient did not have teeth extracted|1|||
155676735|NCT03306433|561906377|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
155676736|NCT00819156|561906378|FG000|Overall Study|Adverse Event|1|||
155676737|NCT00819156|561906379|FG001|Overall Study|Adverse Event|4|||
155676738|NCT00819156|561906380|FG002|Overall Study|Adverse Event|2|||
155676739|NCT00819156|561906381|FG003|Overall Study|Adverse Event|1|||
155676740|NCT00819156|561906382|FG004|Overall Study|Adverse Event|2|||
155676741|NCT00819156|561906383|FG005|Overall Study|Adverse Event|3|||
155676742|NCT00819156|561906378|FG000|Overall Study|Withdrawal by Subject|0|||
155676743|NCT00819156|561906379|FG001|Overall Study|Withdrawal by Subject|3|||
155676744|NCT00819156|561906380|FG002|Overall Study|Withdrawal by Subject|2|||
155676745|NCT00819156|561906381|FG003|Overall Study|Withdrawal by Subject|0|||
155676746|NCT00819156|561906382|FG004|Overall Study|Withdrawal by Subject|1|||
155676747|NCT00819156|561906383|FG005|Overall Study|Withdrawal by Subject|0|||
155676748|NCT00819156|561906378|FG000|Overall Study|Protocol Violation|1|||
155676749|NCT00819156|561906379|FG001|Overall Study|Protocol Violation|0|||
155676750|NCT00819156|561906380|FG002|Overall Study|Protocol Violation|1|||
155676751|NCT00819156|561906381|FG003|Overall Study|Protocol Violation|0|||
155676752|NCT00819156|561906382|FG004|Overall Study|Protocol Violation|0|||
155676753|NCT00819156|561906383|FG005|Overall Study|Protocol Violation|1|||
155676754|NCT00819156|561906378|FG000|Overall Study|Lost to Follow-up|0|||
155676755|NCT00819156|561906379|FG001|Overall Study|Lost to Follow-up|1|||
155676756|NCT00819156|561906380|FG002|Overall Study|Lost to Follow-up|0|||
155676757|NCT00819156|561906381|FG003|Overall Study|Lost to Follow-up|0|||
155676758|NCT00819156|561906382|FG004|Overall Study|Lost to Follow-up|0|||
155676759|NCT00819156|561906383|FG005|Overall Study|Lost to Follow-up|2|||
155676760|NCT00819156|561906378|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
155676761|NCT00819156|561906379|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
155676762|NCT00819156|561906380|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155676763|NCT00819156|561906381|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155676764|NCT00819156|561906382|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155676765|NCT00819156|561906383|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
155676766|NCT00819156|561906378|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
155676767|NCT00819156|561906379|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155676768|NCT00819156|561906380|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155676769|NCT00819156|561906381|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155676770|NCT00819156|561906382|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
155676771|NCT00819156|561906383|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155676772|NCT00819156|561906378|FG000|Overall Study|Prostate-specific antigen progression|0|||
155676773|NCT00819156|561906379|FG001|Overall Study|Prostate-specific antigen progression|0|||
155676774|NCT00819156|561906380|FG002|Overall Study|Prostate-specific antigen progression|0|||
155676775|NCT00819156|561906381|FG003|Overall Study|Prostate-specific antigen progression|0|||
155676776|NCT00819156|561906382|FG004|Overall Study|Prostate-specific antigen progression|1|||
155676777|NCT00819156|561906383|FG005|Overall Study|Prostate-specific antigen progression|0|||
155676778|NCT00790582|561906384|FG000|Overall Study|Death|14|||
155676779|NCT00790582|561906385|FG001|Overall Study|Death|32|||
155676780|NCT00790582|561906384|FG000|Overall Study|Physician Decision|7|||
155676781|NCT00790582|561906385|FG001|Overall Study|Physician Decision|1|||
155676782|NCT00790582|561906384|FG000|Overall Study|Lost to Follow-up|3|||
155676783|NCT00790582|561906385|FG001|Overall Study|Lost to Follow-up|3|||
155676784|NCT00790582|561906384|FG000|Overall Study|Withdrawal by Subject|7|||
155676785|NCT00790582|561906385|FG001|Overall Study|Withdrawal by Subject|51|||
155676786|NCT00803595|561906386|FG000|Overall Study|Adverse Event|3|||
155676787|NCT00803595|561906387|FG001|Overall Study|Adverse Event|4|||
155676788|NCT00803595|561906388|FG002|Overall Study|Adverse Event|1|||
155676789|NCT00803595|561906386|FG000|Overall Study|Protocol Violation|7|||
155676790|NCT00803595|561906387|FG001|Overall Study|Protocol Violation|2|||
155676791|NCT00803595|561906388|FG002|Overall Study|Protocol Violation|12|||
155676792|NCT00803595|561906386|FG000|Overall Study|Withdrawal by Subject|5|||
155676793|NCT00803595|561906387|FG001|Overall Study|Withdrawal by Subject|2|||
155676794|NCT00803595|561906388|FG002|Overall Study|Withdrawal by Subject|3|||
155676795|NCT00703846|561906390|FG000|Overall Study|Adverse Event|8|||
155676796|NCT00703846|561906390|FG000|Overall Study|Lost to Follow-up|55|||
155676797|NCT00703846|561906390|FG000|Overall Study|Lack of Efficacy|15|||
155676798|NCT00703846|561906390|FG000|Overall Study|Noncompliance with Study Treatment|2|||
155676799|NCT00703846|561906390|FG000|Overall Study|Withdrawal by Subject|40|||
155676800|NCT00703846|561906390|FG000|Overall Study|Death|1|||
155676801|NCT00703846|561906390|FG000|Overall Study|Other|14|||
155676802|NCT00703846|561906390|FG000|Overall Study|Did Not Receive Study Drug|2|||
155676803|NCT04601532|561906391|FG000|Overall Study|Lost to Follow-up|1|||
155676804|NCT04601532|561906392|FG001|Overall Study|Lost to Follow-up|2|||
155676805|NCT04601532|561906391|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
155676806|NCT04601532|561906392|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
155676807|NCT02195700|561906393|FG000|Overall Study|Protocol Violation|0|||
155676808|NCT02195700|561906394|FG001|Overall Study|Protocol Violation|2|||
155676809|NCT02195700|561906393|FG000|Overall Study|Noncompliance|1|||
155676810|NCT02195700|561906394|FG001|Overall Study|Noncompliance|0|||
155676811|NCT02195700|561906393|FG000|Overall Study|Adverse Event|1|||
155676812|NCT02195700|561906394|FG001|Overall Study|Adverse Event|2|||
155676813|NCT02195700|561906393|FG000|Overall Study|Withdrawal by Subject|3|||
155676814|NCT02195700|561906394|FG001|Overall Study|Withdrawal by Subject|2|||
155676815|NCT02195700|561906393|FG000|Overall Study|Lost to Follow-up|1|||
155676816|NCT02195700|561906394|FG001|Overall Study|Lost to Follow-up|1|||
155676817|NCT01352221|561906395|FG000|Double-blind Phase|Adverse Event|6|||
155676818|NCT01352221|561906396|FG001|Double-blind Phase|Adverse Event|4|||
155676819|NCT01352221|561906397|FG002|Double-blind Phase|Adverse Event|0|||
155676820|NCT01352221|561906398|FG003|Double-blind Phase|Adverse Event|0|||
155676821|NCT01352221|561906395|FG000|Double-blind Phase|Withdrawal by Subject|3|||
155676822|NCT01352221|561906396|FG001|Double-blind Phase|Withdrawal by Subject|5|||
155676823|NCT01352221|561906397|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155676824|NCT01352221|561906398|FG003|Double-blind Phase|Withdrawal by Subject|0|||
155676825|NCT01352221|561906395|FG000|Double-blind Phase|Lost to Follow-up|0|||
155676826|NCT01352221|561906396|FG001|Double-blind Phase|Lost to Follow-up|1|||
155676827|NCT01352221|561906397|FG002|Double-blind Phase|Lost to Follow-up|0|||
155676828|NCT01352221|561906398|FG003|Double-blind Phase|Lost to Follow-up|0|||
155676829|NCT01352221|561906395|FG000|Double-blind Phase|Protocol Violation|0|||
155676830|NCT01352221|561906396|FG001|Double-blind Phase|Protocol Violation|1|||
155676831|NCT01352221|561906397|FG002|Double-blind Phase|Protocol Violation|0|||
155676832|NCT01352221|561906398|FG003|Double-blind Phase|Protocol Violation|0|||
155676833|NCT01352221|561906395|FG000|Open-label Phase|Physician Decision|0|||
155676834|NCT01352221|561906396|FG001|Open-label Phase|Physician Decision|0|||
155676835|NCT01352221|561906397|FG002|Open-label Phase|Physician Decision|2|||
155676836|NCT01352221|561906398|FG003|Open-label Phase|Physician Decision|1|||
155676837|NCT01352221|561906395|FG000|Open-label Phase|Pregnancy|0|||
155676838|NCT01352221|561906396|FG001|Open-label Phase|Pregnancy|0|||
155676839|NCT01352221|561906397|FG002|Open-label Phase|Pregnancy|1|||
155676840|NCT01352221|561906398|FG003|Open-label Phase|Pregnancy|0|||
155676841|NCT01352221|561906395|FG000|Open-label Phase|Adverse Event|0|||
155676842|NCT01352221|561906396|FG001|Open-label Phase|Adverse Event|0|||
155676843|NCT01352221|561906397|FG002|Open-label Phase|Adverse Event|8|||
155676844|NCT01352221|561906398|FG003|Open-label Phase|Adverse Event|4|||
155676845|NCT01352221|561906395|FG000|Open-label Phase|Withdrawal by Subject|0|||
155676846|NCT01352221|561906396|FG001|Open-label Phase|Withdrawal by Subject|0|||
155676847|NCT01352221|561906397|FG002|Open-label Phase|Withdrawal by Subject|1|||
155676848|NCT01352221|561906398|FG003|Open-label Phase|Withdrawal by Subject|6|||
155676849|NCT01352221|561906395|FG000|Open-label Phase|Worsening of IBD|0|||
155676850|NCT01352221|561906396|FG001|Open-label Phase|Worsening of IBD|0|||
155676851|NCT01352221|561906397|FG002|Open-label Phase|Worsening of IBD|1|||
155676852|NCT01352221|561906398|FG003|Open-label Phase|Worsening of IBD|0|||
155676853|NCT02566785|561906399|FG000|Overall Study|Lost to Follow-up|0|||
155676854|NCT02566785|561906400|FG001|Overall Study|Lost to Follow-up|2|||
155676855|NCT02566785|561906399|FG000|Overall Study|Worsening condition|1|||
155676856|NCT02566785|561906400|FG001|Overall Study|Worsening condition|1|||
155676857|NCT01597908|561906401|FG000|Randomized Phase|Death|217|||
155676858|NCT01597908|561906402|FG001|Randomized Phase|Death|238|||
155676859|NCT01597908|561906403|FG002|Randomized Phase|Death|0|||
155676860|NCT01597908|561906401|FG000|Randomized Phase|Sponsor Decision|93|||
155676861|NCT01597908|561906402|FG001|Randomized Phase|Sponsor Decision|39|||
155676862|NCT01597908|561906403|FG002|Randomized Phase|Sponsor Decision|0|||
155676863|NCT01597908|561906401|FG000|Randomized Phase|Lost to Follow-up|9|||
155676864|NCT01597908|561906402|FG001|Randomized Phase|Lost to Follow-up|16|||
155676865|NCT01597908|561906403|FG002|Randomized Phase|Lost to Follow-up|0|||
155676866|NCT01597908|561906401|FG000|Randomized Phase|Physician Decision|6|||
155676867|NCT01597908|561906402|FG001|Randomized Phase|Physician Decision|3|||
155676868|NCT01597908|561906403|FG002|Randomized Phase|Physician Decision|0|||
155676869|NCT01597908|561906401|FG000|Randomized Phase|Withdrawal by Subject|26|||
155676870|NCT01597908|561906402|FG001|Randomized Phase|Withdrawal by Subject|22|||
155676871|NCT01597908|561906403|FG002|Randomized Phase|Withdrawal by Subject|0|||
155676872|NCT01597908|561906401|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
155676873|NCT01597908|561906402|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
155676874|NCT01597908|561906403|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
155676875|NCT01597908|561906401|FG000|Crossover Phase|Death|0|||
155676876|NCT01597908|561906402|FG001|Crossover Phase|Death|0|||
155676877|NCT01597908|561906403|FG002|Crossover Phase|Death|11|||
155676878|NCT01597908|561906401|FG000|Crossover Phase|Withdrawal by Subject|0|||
155676879|NCT01597908|561906402|FG001|Crossover Phase|Withdrawal by Subject|0|||
155676880|NCT01597908|561906403|FG002|Crossover Phase|Withdrawal by Subject|3|||
155676881|NCT01597908|561906401|FG000|Crossover Phase|Sponsor Decision|0|||
155676882|NCT01597908|561906402|FG001|Crossover Phase|Sponsor Decision|0|||
155676883|NCT01597908|561906403|FG002|Crossover Phase|Sponsor Decision|20|||
155676884|NCT00281099|561906406|FG000|Overall Study|Death|46|||
155676885|NCT00281099|561906407|FG001|Overall Study|Death|57|||
155676886|NCT00281099|561906406|FG000|Overall Study|Lost to Follow-up|10|||
155676887|NCT00281099|561906407|FG001|Overall Study|Lost to Follow-up|19|||
155676888|NCT00281099|561906406|FG000|Overall Study|Withdrawal by Subject|65|||
155676889|NCT00281099|561906407|FG001|Overall Study|Withdrawal by Subject|70|||
155676890|NCT00281099|561906406|FG000|Overall Study|Physician Decision|79|||
155676891|NCT00281099|561906407|FG001|Overall Study|Physician Decision|72|||
155676892|NCT00281099|561906406|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
155676893|NCT00281099|561906407|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
155676894|NCT00837161|561906408|FG000|Overall Study|refused hysterectomy|2|||
155676895|NCT02931838|561906409|FG000|Overall Study|Reason not provided by investigator|1|||
155676896|NCT02931838|561906410|FG001|Overall Study|Reason not provided by investigator|0|||
155676897|NCT02931838|561906411|FG002|Overall Study|Reason not provided by investigator|1|||
155676898|NCT02931838|561906412|FG003|Overall Study|Reason not provided by investigator|0|||
155676899|NCT02931838|561906413|FG004|Overall Study|Reason not provided by investigator|0|||
155676900|NCT02931838|561906414|FG005|Overall Study|Reason not provided by investigator|0|||
155676901|NCT02931838|561906409|FG000|Overall Study|Poor/non-compliance|0|||
155676902|NCT02931838|561906410|FG001|Overall Study|Poor/non-compliance|0|||
155676903|NCT02931838|561906411|FG002|Overall Study|Poor/non-compliance|1|||
155676904|NCT02931838|561906412|FG003|Overall Study|Poor/non-compliance|0|||
155676905|NCT02931838|561906413|FG004|Overall Study|Poor/non-compliance|0|||
155676906|NCT02931838|561906414|FG005|Overall Study|Poor/non-compliance|0|||
155676907|NCT02931838|561906409|FG000|Overall Study|Lack of Efficacy|5|||
155676908|NCT02931838|561906410|FG001|Overall Study|Lack of Efficacy|4|||
155676909|NCT02931838|561906411|FG002|Overall Study|Lack of Efficacy|0|||
155676910|NCT02931838|561906412|FG003|Overall Study|Lack of Efficacy|0|||
155676911|NCT02931838|561906413|FG004|Overall Study|Lack of Efficacy|0|||
155676912|NCT02931838|561906414|FG005|Overall Study|Lack of Efficacy|1|||
155676913|NCT02931838|561906409|FG000|Overall Study|Lost to Follow-up|1|||
155676914|NCT02931838|561906410|FG001|Overall Study|Lost to Follow-up|0|||
155676915|NCT02931838|561906411|FG002|Overall Study|Lost to Follow-up|1|||
155676916|NCT02931838|561906412|FG003|Overall Study|Lost to Follow-up|1|||
155676917|NCT02931838|561906413|FG004|Overall Study|Lost to Follow-up|2|||
155676918|NCT02931838|561906414|FG005|Overall Study|Lost to Follow-up|0|||
155676919|NCT02931838|561906409|FG000|Overall Study|Subject request to discontinue treatment|4|||
155676920|NCT02931838|561906410|FG001|Overall Study|Subject request to discontinue treatment|3|||
155676921|NCT02931838|561906411|FG002|Overall Study|Subject request to discontinue treatment|3|||
155676922|NCT02931838|561906412|FG003|Overall Study|Subject request to discontinue treatment|0|||
155676923|NCT02931838|561906413|FG004|Overall Study|Subject request to discontinue treatment|1|||
155676924|NCT02931838|561906414|FG005|Overall Study|Subject request to discontinue treatment|0|||
155676925|NCT02931838|561906409|FG000|Overall Study|Withdrawal by Subject|1|||
155676926|NCT02931838|561906410|FG001|Overall Study|Withdrawal by Subject|2|||
155676927|NCT02931838|561906411|FG002|Overall Study|Withdrawal by Subject|0|||
155676928|NCT02931838|561906412|FG003|Overall Study|Withdrawal by Subject|1|||
155676929|NCT02931838|561906413|FG004|Overall Study|Withdrawal by Subject|0|||
155676930|NCT02931838|561906414|FG005|Overall Study|Withdrawal by Subject|0|||
155676931|NCT02931838|561906409|FG000|Overall Study|Adverse Event|2|||
155676932|NCT02931838|561906410|FG001|Overall Study|Adverse Event|1|||
155676933|NCT02931838|561906411|FG002|Overall Study|Adverse Event|2|||
155676934|NCT02931838|561906412|FG003|Overall Study|Adverse Event|1|||
155676935|NCT02931838|561906413|FG004|Overall Study|Adverse Event|3|||
155676936|NCT02931838|561906414|FG005|Overall Study|Adverse Event|1|||
155676937|NCT00104728|561906415|FG000|Overall Study|screen failures|19|||
155676938|NCT01963767|561906416|FG000|Overall Study|Withdrawal by Subject|4|||
155676939|NCT01963767|561906417|FG001|Overall Study|Withdrawal by Subject|2|||
155676940|NCT01963767|561906416|FG000|Overall Study|Adverse Event|2|||
155676941|NCT01963767|561906417|FG001|Overall Study|Adverse Event|0|||
155676942|NCT02709577|561906418|FG000|Overall Study|non-accommodating anatomy|0|||
155676943|NCT02709577|561906419|FG001|Overall Study|non-accommodating anatomy|1|||
155676944|NCT02709577|561906420|FG002|Overall Study|non-accommodating anatomy|0|||
155676945|NCT02709577|561906421|FG003|Overall Study|non-accommodating anatomy|0|||
155676946|NCT02709577|561906418|FG000|Overall Study|procedural complication|0|||
155676947|NCT02709577|561906419|FG001|Overall Study|procedural complication|1|||
155676948|NCT02709577|561906420|FG002|Overall Study|procedural complication|0|||
155676949|NCT02709577|561906421|FG003|Overall Study|procedural complication|0|||
155676950|NCT02709577|561906418|FG000|Overall Study|Withdrawal by Subject|2|||
155676951|NCT02709577|561906419|FG001|Overall Study|Withdrawal by Subject|3|||
155676952|NCT02709577|561906420|FG002|Overall Study|Withdrawal by Subject|2|||
155676953|NCT02709577|561906421|FG003|Overall Study|Withdrawal by Subject|0|||
155676954|NCT03823287|561906422|FG000|Overall Study|Withdrawal by Subject|25|||
155676955|NCT03823287|561906423|FG001|Overall Study|Withdrawal by Subject|17|||
155676956|NCT03823287|561906422|FG000|Overall Study|Death|13|||
155676957|NCT03823287|561906423|FG001|Overall Study|Death|7|||
155676958|NCT03823287|561906422|FG000|Overall Study|Lost to Follow-up|7|||
155676959|NCT03823287|561906423|FG001|Overall Study|Lost to Follow-up|8|||
155676960|NCT03823287|561906422|FG000|Overall Study|Adverse Event|6|||
155676961|NCT03823287|561906423|FG001|Overall Study|Adverse Event|8|||
155676962|NCT03823287|561906422|FG000|Overall Study|Physician Decision|5|||
155676963|NCT03823287|561906423|FG001|Overall Study|Physician Decision|2|||
155676964|NCT03823287|561906422|FG000|Overall Study|Lack of Efficacy|2|||
155676965|NCT03823287|561906423|FG001|Overall Study|Lack of Efficacy|0|||
155676966|NCT03823287|561906422|FG000|Overall Study|Other|2|||
155676967|NCT03823287|561906423|FG001|Overall Study|Other|4|||
155676968|NCT01059864|561906424|FG000|Open-Label Run-In Phase|Adverse Event|7|||
155676969|NCT01059864|561906425|FG001|Open-Label Run-In Phase|Adverse Event|0|||
155676970|NCT01059864|561906426|FG002|Open-Label Run-In Phase|Adverse Event|0|||
155676971|NCT01059864|561906424|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
155676972|NCT01059864|561906425|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
155676973|NCT01059864|561906426|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
155676974|NCT01059864|561906424|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
155676975|NCT01059864|561906425|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
155676976|NCT01059864|561906426|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
155676977|NCT01059864|561906424|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
155676978|NCT01059864|561906425|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
155676979|NCT01059864|561906426|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
155676980|NCT01059864|561906424|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
155676981|NCT01059864|561906425|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
155676982|NCT01059864|561906426|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
155676983|NCT01059864|561906424|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155676984|NCT01059864|561906425|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155676985|NCT01059864|561906426|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
155676986|NCT02712983|561908307|FG000|Treatment Phase|Adverse Event|3|||
155676987|NCT02712983|561908308|FG001|Treatment Phase|Adverse Event|1|||
155676988|NCT02712983|561908309|FG002|Treatment Phase|Adverse Event|1|||
155676989|NCT02712983|561908310|FG003|Treatment Phase|Adverse Event|4|||
155676990|NCT02712983|561908311|FG004|Treatment Phase|Adverse Event|3|||
155676991|NCT02712983|561908312|FG005|Treatment Phase|Adverse Event|0|||
155676992|NCT02712983|561908313|FG006|Treatment Phase|Adverse Event|6|||
155676993|NCT02712983|561908314|FG007|Treatment Phase|Adverse Event|6|||
155676994|NCT02712983|561908315|FG008|Treatment Phase|Adverse Event|1|||
155676995|NCT02712983|561908307|FG000|Treatment Phase|Protocol Deviation|0|||
155676996|NCT02712983|561908308|FG001|Treatment Phase|Protocol Deviation|0|||
155676997|NCT02712983|561908309|FG002|Treatment Phase|Protocol Deviation|0|||
155676998|NCT02712983|561908310|FG003|Treatment Phase|Protocol Deviation|2|||
155676999|NCT02712983|561908311|FG004|Treatment Phase|Protocol Deviation|0|||
155677000|NCT02712983|561908312|FG005|Treatment Phase|Protocol Deviation|0|||
155677001|NCT02712983|561908313|FG006|Treatment Phase|Protocol Deviation|1|||
155677002|NCT02712983|561908314|FG007|Treatment Phase|Protocol Deviation|0|||
155677003|NCT02712983|561908315|FG008|Treatment Phase|Protocol Deviation|0|||
155677004|NCT02712983|561908307|FG000|Treatment Phase|Technical Problems|0|||
155677005|NCT02712983|561908308|FG001|Treatment Phase|Technical Problems|0|||
155677006|NCT02712983|561908309|FG002|Treatment Phase|Technical Problems|0|||
155677007|NCT02712983|561908310|FG003|Treatment Phase|Technical Problems|0|||
155677008|NCT02712983|561908311|FG004|Treatment Phase|Technical Problems|0|||
155600498|NCT01190267|561624778|FG000|Overall Study|Protocol Violation|8|||
155600499|NCT01190267|561624779|FG001|Overall Study|Protocol Violation|1|||
155600500|NCT04017832|561624780|FG000|Overall Study|Withdrawal by Subject|13|||
155600501|NCT04017832|561624781|FG001|Overall Study|Withdrawal by Subject|12|||
155600502|NCT04017832|561624782|FG002|Overall Study|Withdrawal by Subject|21|||
155600503|NCT04017832|561624783|FG003|Overall Study|Withdrawal by Subject|7|||
155600504|NCT04017832|561624780|FG000|Overall Study|Lost to Follow-up|0|||
155600505|NCT04017832|561624781|FG001|Overall Study|Lost to Follow-up|3|||
155600506|NCT04017832|561624782|FG002|Overall Study|Lost to Follow-up|3|||
155600507|NCT04017832|561624783|FG003|Overall Study|Lost to Follow-up|1|||
155600508|NCT04017832|561624780|FG000|Overall Study|Physician Decision|1|||
155600509|NCT04017832|561624781|FG001|Overall Study|Physician Decision|1|||
155600510|NCT04017832|561624782|FG002|Overall Study|Physician Decision|1|||
155600511|NCT04017832|561624783|FG003|Overall Study|Physician Decision|1|||
155600512|NCT04017832|561624780|FG000|Overall Study|Death|2|||
155600513|NCT04017832|561624781|FG001|Overall Study|Death|2|||
155600514|NCT04017832|561624782|FG002|Overall Study|Death|1|||
155600515|NCT04017832|561624783|FG003|Overall Study|Death|0|||
155600516|NCT02375555|561624793|FG000|Induction Period|Adverse Event|7|||
155600517|NCT02375555|561624793|FG000|Induction Period|Withdrawal by Subject|2|||
155600518|NCT02375555|561624793|FG000|Induction Period|Other|1|||
155600519|NCT02375555|561624793|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
155600520|NCT02375555|561624793|FG000|Maintenance Period|Adverse Event|2|||
155600521|NCT02375555|561624793|FG000|Maintenance Period|Withdrawal by Subject|4|||
155600522|NCT02375555|561624793|FG000|Maintenance Period|Death|1|||
155677009|NCT02712983|561908312|FG005|Treatment Phase|Technical Problems|0|||
155677010|NCT02712983|561908313|FG006|Treatment Phase|Technical Problems|1|||
155677011|NCT02712983|561908314|FG007|Treatment Phase|Technical Problems|0|||
155677012|NCT02712983|561908315|FG008|Treatment Phase|Technical Problems|0|||
155677013|NCT02712983|561908307|FG000|Treatment Phase|Physician Decision|0|||
155677014|NCT02712983|561908308|FG001|Treatment Phase|Physician Decision|0|||
155677015|NCT02712983|561908309|FG002|Treatment Phase|Physician Decision|0|||
155677016|NCT02712983|561908310|FG003|Treatment Phase|Physician Decision|0|||
155677017|NCT02712983|561908311|FG004|Treatment Phase|Physician Decision|0|||
155677018|NCT02712983|561908312|FG005|Treatment Phase|Physician Decision|0|||
155677019|NCT02712983|561908313|FG006|Treatment Phase|Physician Decision|0|||
155677020|NCT02712983|561908314|FG007|Treatment Phase|Physician Decision|1|||
155677021|NCT02712983|561908315|FG008|Treatment Phase|Physician Decision|1|||
155677022|NCT02712983|561908307|FG000|Treatment Phase|Subject Decision|2|||
155677023|NCT02712983|561908308|FG001|Treatment Phase|Subject Decision|0|||
155677024|NCT02712983|561908309|FG002|Treatment Phase|Subject Decision|0|||
155677025|NCT02712983|561908310|FG003|Treatment Phase|Subject Decision|2|||
155677026|NCT02712983|561908311|FG004|Treatment Phase|Subject Decision|1|||
155677027|NCT02712983|561908312|FG005|Treatment Phase|Subject Decision|0|||
155677028|NCT02712983|561908313|FG006|Treatment Phase|Subject Decision|1|||
155677029|NCT02712983|561908314|FG007|Treatment Phase|Subject Decision|2|||
155677030|NCT02712983|561908315|FG008|Treatment Phase|Subject Decision|0|||
155677031|NCT02712983|561908307|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677032|NCT02712983|561908308|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155677033|NCT02712983|561908309|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677034|NCT02712983|561908310|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677035|NCT02712983|561908311|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677036|NCT02712983|561908312|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677037|NCT02712983|561908313|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155677038|NCT02712983|561908314|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155677039|NCT02712983|561908315|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155677040|NCT02712983|561908307|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677041|NCT02712983|561908308|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677042|NCT02712983|561908309|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677043|NCT02712983|561908310|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
155677044|NCT02712983|561908311|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677045|NCT02712983|561908312|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677046|NCT02712983|561908313|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677047|NCT02712983|561908314|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677048|NCT02712983|561908315|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155677049|NCT02712983|561908307|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155677050|NCT02712983|561908308|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155677051|NCT02712983|561908309|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155677052|NCT02712983|561908310|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155677053|NCT02712983|561908311|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
155677054|NCT02712983|561908312|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
155677055|NCT02712983|561908313|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
155677056|NCT02712983|561908314|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
155677057|NCT02712983|561908315|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155677058|NCT00064259|561908316|FG000|Overall Study|Adverse Event|1|||
155677059|NCT00064259|561908317|FG001|Overall Study|Adverse Event|0|||
155677060|NCT00064259|561908318|FG002|Overall Study|Adverse Event|0|||
155677061|NCT00064259|561908319|FG003|Overall Study|Adverse Event|1|||
155677062|NCT01132651|561908322|FG000|Overall Study|Lost to Follow-up|1|||
155677063|NCT01132651|561908323|FG001|Overall Study|Lost to Follow-up|1|||
155677064|NCT03062280|561908334|FG000|Overall Study|Adverse Event|1|||
155677065|NCT03062280|561908334|FG000|Overall Study|Death|1|||
155677066|NCT03062280|561908334|FG000|Overall Study|Fertility Treatment|2|||
155677067|NCT03062280|561908334|FG000|Overall Study|Physician Decision|2|||
155677068|NCT03062280|561908334|FG000|Overall Study|Pregnancy|5|||
155677069|NCT03062280|561908334|FG000|Overall Study|Withdrawal by Subject|11|||
155677070|NCT00814580|561908335|FG000|Overall Study|Adverse Event|6|||
155677071|NCT00814580|561908336|FG001|Overall Study|Adverse Event|15|||
155677072|NCT00814580|561908335|FG000|Overall Study|Lack of Efficacy|18|||
155677073|NCT00814580|561908336|FG001|Overall Study|Lack of Efficacy|25|||
155677074|NCT00814580|561908335|FG000|Overall Study|Protocol Violation|2|||
155677075|NCT00814580|561908336|FG001|Overall Study|Protocol Violation|0|||
155677076|NCT00814580|561908335|FG000|Overall Study|Withdrawal by Subject|2|||
155677077|NCT00814580|561908336|FG001|Overall Study|Withdrawal by Subject|2|||
155677078|NCT00814580|561908335|FG000|Overall Study|Other|1|||
155677079|NCT00814580|561908336|FG001|Overall Study|Other|3|||
155677080|NCT00814580|561908335|FG000|Overall Study|Did Not Take Drug|2|||
155677081|NCT00814580|561908336|FG001|Overall Study|Did Not Take Drug|2|||
155677082|NCT02547038|561908337|FG000|Overall Study|Lost to Follow-up|3|||
155677083|NCT02547038|561908338|FG001|Overall Study|Lost to Follow-up|2|||
155677084|NCT00516893|561908339|FG000|Overall Study|Lost to Follow-up|4|||
155677085|NCT00516893|561908339|FG000|Overall Study|Adverse Event|3|||
155677086|NCT00516893|561908339|FG000|Overall Study|Withdrawal by Subject|2|||
155677087|NCT00516893|561908339|FG000|Overall Study|Noncompliance|2|||
155677088|NCT00516893|561908339|FG000|Overall Study|Death|1|||
155677089|NCT00516893|561908339|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
155677090|NCT00516893|561908339|FG000|Overall Study|Relocated|1|||
155677091|NCT00516893|561908339|FG000|Overall Study|Pregnancy|1|||
155677092|NCT00516893|561908339|FG000|Overall Study|Received Medication From Another Study|1|||
155677093|NCT01340625|561908342|FG000|First Intervention|Adverse Event|1|||
155677094|NCT01340625|561908343|FG001|First Intervention|Adverse Event|0|||
155677095|NCT01340625|561908342|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
155677096|NCT01340625|561908343|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
155677097|NCT01519791|561908344|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
155677098|NCT01519791|561908345|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
155677099|NCT01519791|561908344|FG000|Overall Study|Protocol Violation|6|||
155677100|NCT01519791|561908345|FG001|Overall Study|Protocol Violation|19|||
155677101|NCT01519791|561908344|FG000|Overall Study|Other Reason|87|||
155677102|NCT01519791|561908345|FG001|Overall Study|Other Reason|222|||
155677103|NCT01519791|561908344|FG000|Overall Study|subjects randomized in error|2|||
155677104|NCT01519791|561908345|FG001|Overall Study|subjects randomized in error|0|||
155677105|NCT01519791|561908344|FG000|Overall Study|Lack of Efficacy|16|||
155677106|NCT01519791|561908345|FG001|Overall Study|Lack of Efficacy|20|||
155677107|NCT01519791|561908344|FG000|Overall Study|SAE, non-fatal|6|||
155677108|NCT01519791|561908345|FG001|Overall Study|SAE, non-fatal|22|||
155677109|NCT01519791|561908344|FG000|Overall Study|AE, serious fatal|0|||
155677110|NCT01519791|561908345|FG001|Overall Study|AE, serious fatal|1|||
155677111|NCT01519791|561908344|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
155677112|NCT01519791|561908345|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
155677113|NCT01519791|561908344|FG000|Overall Study|AE, non-serious non-fatal|12|||
155677114|NCT01519791|561908345|FG001|Overall Study|AE, non-serious non-fatal|31|||
155677115|NCT01519791|561908344|FG000|Overall Study|Withdrawal by Subject|15|||
155677116|NCT01519791|561908345|FG001|Overall Study|Withdrawal by Subject|37|||
155677117|NCT01519791|561908344|FG000|Overall Study|Lost to Follow-up|6|||
155677118|NCT01519791|561908345|FG001|Overall Study|Lost to Follow-up|14|||
155677119|NCT00623233|561908346|FG000|Overall Study|Adverse Event|10|||
155677120|NCT00623233|561908346|FG000|Overall Study|Physician Decision|10|||
155677121|NCT00623233|561908346|FG000|Overall Study|Lost to Follow-up|1|||
155677122|NCT00623233|561908346|FG000|Overall Study|Withdrawal by Subject|3|||
155677123|NCT00559845|561908347|FG000|Overall Study|Withdrew Consent|1|||
155677124|NCT00559845|561908347|FG000|Overall Study|Disease Progression|1|||
155677125|NCT00559845|561908347|FG000|Overall Study|Adverse Event|3|||
155677126|NCT00559845|561908347|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
155677127|NCT00559845|561908347|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
155677128|NCT00459875|561908348|FG000|Overall Study|Ineligible participant|1|||
155677129|NCT00459875|561908348|FG000|Overall Study|Adverse Event|2|||
155677130|NCT03206970|561908351|FG000|Overall Study|Death|21|||
155677131|NCT03206970|561908351|FG000|Overall Study|Withdrawal by Subject|13|||
155677132|NCT03206970|561908351|FG000|Overall Study|Lost to Follow-up|3|||
155677133|NCT03206970|561908351|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
155677134|NCT03654040|561908352|FG000|Overall Study|Death|1|||
155677135|NCT03654040|561908353|FG001|Overall Study|Death|0|||
155677136|NCT03654040|561908352|FG000|Overall Study|Withdrawal by Subject|1|||
155677137|NCT03654040|561908353|FG001|Overall Study|Withdrawal by Subject|0|||
155677138|NCT03654040|561908352|FG000|Overall Study|Study terminated by sponsor|8|||
155677139|NCT03654040|561908353|FG001|Overall Study|Study terminated by sponsor|2|||
155677140|NCT03654040|561908352|FG000|Overall Study|Failure to initiate study therapy|2|||
155677141|NCT03654040|561908353|FG001|Overall Study|Failure to initiate study therapy|0|||
155677142|NCT03654040|561908352|FG000|Overall Study|Transplanted at another center|2|||
155677143|NCT03654040|561908353|FG001|Overall Study|Transplanted at another center|0|||
155677144|NCT03654040|561908352|FG000|Overall Study|Failure to meet eligibility criteria|14|||
155677145|NCT03654040|561908353|FG001|Overall Study|Failure to meet eligibility criteria|2|||
155677146|NCT03654040|561908352|FG000|Overall Study|No longer transplant candidate|1|||
155677147|NCT03654040|561908353|FG001|Overall Study|No longer transplant candidate|0|||
155677148|NCT03654040|561908352|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
155677149|NCT03654040|561908353|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
155677150|NCT03654040|561908352|FG000|Overall Study|Recipient ineligible|0|||
155677151|NCT03654040|561908353|FG001|Overall Study|Recipient ineligible|2|||
155677152|NCT03654040|561908352|FG000|Overall Study|Received deceased liver|0|||
155677153|NCT03654040|561908353|FG001|Overall Study|Received deceased liver|1|||
155677154|NCT03645421|561908354|FG000|Overall Study|Adverse Event|0|||
155677155|NCT03645421|561908355|FG001|Overall Study|Adverse Event|0|||
155677156|NCT03645421|561908356|FG002|Overall Study|Adverse Event|4|||
155677157|NCT03645421|561908357|FG003|Overall Study|Adverse Event|1|||
155677158|NCT03645421|561908354|FG000|Overall Study|Withdrawal by patient|0|||
155677159|NCT03645421|561908355|FG001|Overall Study|Withdrawal by patient|0|||
155677160|NCT03645421|561908356|FG002|Overall Study|Withdrawal by patient|0|||
155677161|NCT03645421|561908357|FG003|Overall Study|Withdrawal by patient|3|||
155677162|NCT03645421|561908354|FG000|Overall Study|Study specific withdrawal criteria|0|||
155677163|NCT03645421|561908355|FG001|Overall Study|Study specific withdrawal criteria|0|||
155677164|NCT03645421|561908356|FG002|Overall Study|Study specific withdrawal criteria|1|||
155677165|NCT03645421|561908357|FG003|Overall Study|Study specific withdrawal criteria|0|||
155677166|NCT03379259|561908358|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
155677167|NCT03379259|561908359|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
155677168|NCT03379259|561908360|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
155677169|NCT03379259|561908361|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
155677170|NCT03379259|561908362|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
155677171|NCT03379259|561908363|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
155677172|NCT03379259|561908358|FG000|Overall Study|Death|0|||
155677173|NCT03379259|561908359|FG001|Overall Study|Death|1|||
155677174|NCT03379259|561908360|FG002|Overall Study|Death|2|||
155677175|NCT03379259|561908361|FG003|Overall Study|Death|1|||
155677176|NCT03379259|561908362|FG004|Overall Study|Death|4|||
155677177|NCT03379259|561908363|FG005|Overall Study|Death|2|||
155677178|NCT03379259|561908358|FG000|Overall Study|Withdrawal by Subject|0|||
155677179|NCT03379259|561908359|FG001|Overall Study|Withdrawal by Subject|0|||
155677180|NCT03379259|561908360|FG002|Overall Study|Withdrawal by Subject|1|||
155677181|NCT03379259|561908361|FG003|Overall Study|Withdrawal by Subject|0|||
155677182|NCT03379259|561908362|FG004|Overall Study|Withdrawal by Subject|2|||
155677183|NCT03379259|561908363|FG005|Overall Study|Withdrawal by Subject|0|||
155677184|NCT03379259|561908358|FG000|Overall Study|Study terminated by sponsor|0|||
155677185|NCT03379259|561908359|FG001|Overall Study|Study terminated by sponsor|0|||
155677186|NCT03379259|561908360|FG002|Overall Study|Study terminated by sponsor|0|||
155677187|NCT03379259|561908361|FG003|Overall Study|Study terminated by sponsor|1|||
155677188|NCT03379259|561908362|FG004|Overall Study|Study terminated by sponsor|1|||
155677189|NCT03379259|561908363|FG005|Overall Study|Study terminated by sponsor|4|||
155677190|NCT03379259|561908358|FG000|Overall Study|Disease progression|0|||
155677191|NCT03379259|561908359|FG001|Overall Study|Disease progression|0|||
155677192|NCT03379259|561908360|FG002|Overall Study|Disease progression|0|||
155677193|NCT03379259|561908361|FG003|Overall Study|Disease progression|1|||
155677194|NCT03379259|561908362|FG004|Overall Study|Disease progression|0|||
155677195|NCT03379259|561908363|FG005|Overall Study|Disease progression|1|||
155677196|NCT03379259|561908358|FG000|Overall Study|Lost to Follow-up|0|||
155677197|NCT03379259|561908359|FG001|Overall Study|Lost to Follow-up|0|||
155677198|NCT03379259|561908360|FG002|Overall Study|Lost to Follow-up|0|||
155677199|NCT03379259|561908361|FG003|Overall Study|Lost to Follow-up|0|||
155600523|NCT02375555|561624793|FG000|Maintenance Period|Disease Progression|5|||
155600524|NCT02375555|561624793|FG000|Maintenance Period|Patient Non-compliance|1|||
155600525|NCT02375555|561624793|FG000|Maintenance Period|Still on maintenance|16|||
155600526|NCT02091986|561624794|FG000|Overall Study|7 rand in error 1 patient decision|2|||
155600527|NCT02091986|561624795|FG001|Overall Study|7 rand in error 1 patient decision|3|||
155600528|NCT02091986|561624796|FG002|Overall Study|7 rand in error 1 patient decision|3|||
155600529|NCT02091986|561624794|FG000|Overall Study|Lost to Follow-up|1|||
155600530|NCT02091986|561624795|FG001|Overall Study|Lost to Follow-up|0|||
155600531|NCT02091986|561624796|FG002|Overall Study|Lost to Follow-up|0|||
155600532|NCT02091986|561624794|FG000|Overall Study|Withdrawal by Subject|4|||
155600533|NCT02091986|561624795|FG001|Overall Study|Withdrawal by Subject|8|||
155600534|NCT02091986|561624796|FG002|Overall Study|Withdrawal by Subject|3|||
155600535|NCT02091986|561624794|FG000|Overall Study|Adverse Event|0|||
155600536|NCT02091986|561624795|FG001|Overall Study|Adverse Event|0|||
155600537|NCT02091986|561624796|FG002|Overall Study|Adverse Event|2|||
155600538|NCT00915876|561624799|FG000|Overall Study|Adverse Event|0|||
155600539|NCT00915876|561624800|FG001|Overall Study|Adverse Event|1|||
155600540|NCT03626363|561624803|FG000|Overall Study|Protocol Violation|4|||
155600541|NCT03626363|561624804|FG001|Overall Study|Protocol Violation|0|||
155600542|NCT03626363|561624803|FG000|Overall Study|Lost to Follow-up|5|||
155600543|NCT03626363|561624804|FG001|Overall Study|Lost to Follow-up|7|||
155600544|NCT01970475|561624805|FG000|Overall Study|Withdrawal by Subject|11|||
155600545|NCT01970475|561624806|FG001|Overall Study|Withdrawal by Subject|6|||
155600546|NCT01970475|561624805|FG000|Overall Study|Adverse Event|7|||
155600547|NCT01970475|561624806|FG001|Overall Study|Adverse Event|3|||
155600548|NCT01970475|561624805|FG000|Overall Study|Lost to Follow-up|2|||
155600549|NCT01970475|561624806|FG001|Overall Study|Lost to Follow-up|2|||
155600550|NCT01970475|561624805|FG000|Overall Study|Protocol Violation|1|||
155600551|NCT01970475|561624806|FG001|Overall Study|Protocol Violation|0|||
155600552|NCT00960986|561624807|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
155600553|NCT00960986|561624808|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
155600554|NCT00960986|561624809|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
155600555|NCT00960986|561624810|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
155600556|NCT00960986|561624807|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
155600557|NCT00960986|561624808|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
155600558|NCT00960986|561624809|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
155600559|NCT00960986|561624810|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
155600560|NCT00960986|561624807|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
155600561|NCT00960986|561624808|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
155600562|NCT00960986|561624809|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
155600563|NCT00960986|561624810|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
155600564|NCT00960986|561624807|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155600565|NCT00960986|561624808|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
155600566|NCT00960986|561624809|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155600567|NCT00960986|561624810|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155600568|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
155600569|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
155600570|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
155600571|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
155600572|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Death|0|||
155600573|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Death|0|||
155600574|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Death|1|||
155600575|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Death|0|||
155600576|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155600577|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155600578|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
155600579|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155600580|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
155600581|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
155600582|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
155600583|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
155600584|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155600585|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155600586|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
155600587|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155600588|NCT00960986|561624807|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
155600589|NCT00960986|561624808|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
155600590|NCT00960986|561624809|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
155600591|NCT00960986|561624810|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
155600592|NCT01984892|561624811|FG000|Overall Study|Progressive disease|7|||
155600593|NCT04464720|561624812|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
155600594|NCT03495154|561624819|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
155600595|NCT03495154|561624819|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
155600596|NCT03495154|561624819|FG000|Overall Study|Screen Failures During Surgery|6|||
155600597|NCT03495154|561624819|FG000|Overall Study|Death|2|||
155600598|NCT03495154|561624819|FG000|Overall Study|Lost to Follow-up|16|||
155600599|NCT03495154|561624819|FG000|Overall Study|Withdrawal by Subject|2|||
155600600|NCT03495154|561624819|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
155600601|NCT01294696|561624828|FG000|Overall Study|Screening failures|7|||
155600602|NCT01294696|561624828|FG000|Overall Study|Protocol Violation|8|||
155600603|NCT01294696|561624828|FG000|Overall Study|Missing BPI Response|7|||
155600604|NCT01294696|561624828|FG000|Overall Study|Site closure|52|||
155600605|NCT02276053|561626165|FG000|Overall Study|Death|2|||
155600606|NCT02276053|561626165|FG000|Overall Study|Adverse Event|5|||
155600607|NCT02276053|561626165|FG000|Overall Study|Lack of Efficacy|2|||
155600608|NCT02276053|561626165|FG000|Overall Study|Withdrawal by Subject|1|||
155600609|NCT02276053|561626165|FG000|Overall Study|Patient does not meet selection criteria|3|||
155600610|NCT02276053|561626165|FG000|Overall Study|Patient needs to increase baseline AED|1|||
155600611|NCT01004406|561626168|FG000|Overall Study|Withdrawal by Subject|2|||
155600612|NCT01004406|561626169|FG001|Overall Study|Withdrawal by Subject|0|||
155600613|NCT01004406|561626168|FG000|Overall Study|Lost to Follow-up|1|||
155600614|NCT01004406|561626169|FG001|Overall Study|Lost to Follow-up|0|||
155600615|NCT02907593|561626172|FG000|Overall Study|Withdrawal by Subject|0|||
155600616|NCT02907593|561626173|FG001|Overall Study|Withdrawal by Subject|0|||
155600617|NCT02907593|561626174|FG002|Overall Study|Withdrawal by Subject|1|||
155600618|NCT02907593|561626175|FG003|Overall Study|Withdrawal by Subject|0|||
155600619|NCT04488497|561626181|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
155600620|NCT04488497|561626182|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
155600621|NCT04488497|561626181|FG000|Intervention|Physician Decision|2|||
155600622|NCT04488497|561626182|FG001|Intervention|Physician Decision|1|||
155600623|NCT04488497|561626181|FG000|Intervention|Withdrawal by Subject|5|||
155600624|NCT04488497|561626182|FG001|Intervention|Withdrawal by Subject|6|||
155600625|NCT04488497|561626181|FG000|Intervention|Lost to Follow-up|2|||
155600626|NCT04488497|561626182|FG001|Intervention|Lost to Follow-up|0|||
155600627|NCT04488497|561626181|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
155600628|NCT04488497|561626182|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
155600629|NCT04488497|561626181|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
155600630|NCT04488497|561626182|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
155600631|NCT04322539|561626183|FG000|Overall Study|Adverse Event|2|||
155600632|NCT04322539|561626184|FG001|Overall Study|Adverse Event|0|||
155600633|NCT04322539|561626183|FG000|Overall Study|Death|411|||
155600634|NCT04322539|561626184|FG001|Overall Study|Death|203|||
155600635|NCT04322539|561626183|FG000|Overall Study|Lost to Follow-up|3|||
155600636|NCT04322539|561626184|FG001|Overall Study|Lost to Follow-up|1|||
155600637|NCT04322539|561626183|FG000|Overall Study|Withdrawal of consent|14|||
155600638|NCT04322539|561626184|FG001|Overall Study|Withdrawal of consent|8|||
155600639|NCT04322539|561626183|FG000|Overall Study|Radiological Disease Progression|6|||
155600640|NCT04322539|561626184|FG001|Overall Study|Radiological Disease Progression|0|||
155600641|NCT04322539|561626183|FG000|Overall Study|Sponsor Decision|19|||
155600642|NCT04322539|561626184|FG001|Overall Study|Sponsor Decision|14|||
155600643|NCT04322539|561626183|FG000|Overall Study|Other|6|||
155600644|NCT04322539|561626184|FG001|Overall Study|Other|4|||
155600645|NCT04063657|561626189|FG000|Overall Study|Lost to Follow-up|1|||
155600646|NCT04063657|561626190|FG001|Overall Study|Lost to Follow-up|0|||
155600647|NCT03409107|561626191|FG000|Overall Study|Withdrawal by Subject|4|||
155600648|NCT03409107|561626192|FG001|Overall Study|Withdrawal by Subject|2|||
155600649|NCT03409107|561626191|FG000|Overall Study|Physician Decision|1|||
155600650|NCT03409107|561626192|FG001|Overall Study|Physician Decision|0|||
155600651|NCT03409107|561626191|FG000|Overall Study|Lost to Follow-up|7|||
155600652|NCT03409107|561626192|FG001|Overall Study|Lost to Follow-up|2|||
155600653|NCT03409107|561626191|FG000|Overall Study|Adverse Event|5|||
155600654|NCT03409107|561626192|FG001|Overall Study|Adverse Event|3|||
155600655|NCT01185509|561626193|FG000|Overall Study|Progression/Relapse|9|||
155600656|NCT01185509|561626194|FG001|Overall Study|Progression/Relapse|15|||
155600657|NCT01185509|561626193|FG000|Overall Study|Physician Decision|2|||
155600658|NCT01185509|561626194|FG001|Overall Study|Physician Decision|2|||
155600659|NCT01185509|561626193|FG000|Overall Study|Withdrawal by Subject|0|||
155600660|NCT01185509|561626194|FG001|Overall Study|Withdrawal by Subject|1|||
155600661|NCT01185509|561626193|FG000|Overall Study|Death|0|||
155600662|NCT01185509|561626194|FG001|Overall Study|Death|1|||
155600663|NCT01185509|561626193|FG000|Overall Study|Intercurrent Illness|0|||
155600664|NCT01185509|561626194|FG001|Overall Study|Intercurrent Illness|1|||
155600665|NCT00916344|561626195|FG000|Overall Study|Death|2|||
155600666|NCT00916344|561626195|FG000|Overall Study|ICD upgrade|1|||
155600667|NCT00916344|561626195|FG000|Overall Study|Drop-out|5|||
155600668|NCT01088243|561626203|FG000|Overall Study|Adverse Event|1|||
155600669|NCT01088243|561626204|FG001|Overall Study|Adverse Event|0|||
155600670|NCT02122770|561626205|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
155600671|NCT02122770|561626206|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155600672|NCT02122770|561626207|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
155600673|NCT02122770|561626208|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
155600674|NCT02122770|561626209|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155600675|NCT02122770|561626210|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155600676|NCT02122770|561626205|FG000|Part A: Drug-drug Interaction 2|Other|0|||
155600677|NCT02122770|561626206|FG001|Part A: Drug-drug Interaction 2|Other|0|||
155600678|NCT02122770|561626207|FG002|Part A: Drug-drug Interaction 2|Other|1|||
155600679|NCT02122770|561626208|FG003|Part A: Drug-drug Interaction 2|Other|0|||
155600680|NCT02122770|561626209|FG004|Part A: Drug-drug Interaction 2|Other|0|||
155600681|NCT02122770|561626210|FG005|Part A: Drug-drug Interaction 2|Other|0|||
155600682|NCT02122770|561626205|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155600683|NCT02122770|561626206|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
155600684|NCT02122770|561626207|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155600685|NCT02122770|561626208|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155600686|NCT02122770|561626209|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155600687|NCT02122770|561626210|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155600688|NCT02122770|561626205|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
155600689|NCT02122770|561626206|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
155600690|NCT02122770|561626207|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155677200|NCT03379259|561908362|FG004|Overall Study|Lost to Follow-up|1|||
155677201|NCT03379259|561908363|FG005|Overall Study|Lost to Follow-up|0|||
155677202|NCT03379259|561908358|FG000|Overall Study|Deteriorating condition|0|||
155677203|NCT03379259|561908359|FG001|Overall Study|Deteriorating condition|0|||
155677204|NCT03379259|561908360|FG002|Overall Study|Deteriorating condition|0|||
155677205|NCT03379259|561908361|FG003|Overall Study|Deteriorating condition|0|||
155677206|NCT03379259|561908362|FG004|Overall Study|Deteriorating condition|1|||
155677207|NCT03379259|561908363|FG005|Overall Study|Deteriorating condition|0|||
155677208|NCT03850093|561908365|FG000|Overall Study|Withdrawal by Subject|1|||
155677209|NCT03850093|561908366|FG001|Overall Study|Withdrawal by Subject|0|||
155677210|NCT03850093|561908367|FG002|Overall Study|Withdrawal by Subject|2|||
155677211|NCT00224120|561908369|FG000|Overall Study|Adverse Event|10|||
155677212|NCT00224120|561908370|FG001|Overall Study|Adverse Event|4|||
155677213|NCT00224120|561908369|FG000|Overall Study|Protocol Violation|1|||
155677214|NCT00224120|561908370|FG001|Overall Study|Protocol Violation|0|||
155677215|NCT00224120|561908369|FG000|Overall Study|Withdrawal by Subject|5|||
155677216|NCT00224120|561908370|FG001|Overall Study|Withdrawal by Subject|10|||
155677217|NCT00224120|561908369|FG000|Overall Study|Lack of Efficacy|0|||
155677218|NCT00224120|561908370|FG001|Overall Study|Lack of Efficacy|2|||
155677219|NCT00224120|561908369|FG000|Overall Study|Lost to Follow-up|2|||
155677220|NCT00224120|561908370|FG001|Overall Study|Lost to Follow-up|3|||
155677221|NCT00224120|561908369|FG000|Overall Study|Other|4|||
155677222|NCT00224120|561908370|FG001|Overall Study|Other|5|||
155677223|NCT00104416|561908373|FG000|Double-Blind Phase|Adverse Event|2|||
155677224|NCT00104416|561908374|FG001|Double-Blind Phase|Adverse Event|1|||
155677225|NCT00104416|561908375|FG002|Double-Blind Phase|Adverse Event|0|||
155677226|NCT00104416|561908376|FG003|Double-Blind Phase|Adverse Event|0|||
155677227|NCT00104416|561908377|FG004|Double-Blind Phase|Adverse Event|0|||
155677228|NCT00104416|561908373|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155677229|NCT00104416|561908374|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155677230|NCT00104416|561908375|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155677231|NCT00104416|561908376|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155677232|NCT00104416|561908377|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155677233|NCT00104416|561908373|FG000|Double-Blind Phase|Protocol Violation|0|||
155677234|NCT00104416|561908374|FG001|Double-Blind Phase|Protocol Violation|1|||
155677235|NCT00104416|561908375|FG002|Double-Blind Phase|Protocol Violation|0|||
155677236|NCT00104416|561908376|FG003|Double-Blind Phase|Protocol Violation|0|||
155677237|NCT00104416|561908377|FG004|Double-Blind Phase|Protocol Violation|0|||
155677238|NCT00104416|561908373|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155677239|NCT00104416|561908374|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
155677240|NCT00104416|561908375|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155677241|NCT00104416|561908376|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155677242|NCT00104416|561908377|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155677243|NCT00104416|561908373|FG000|Double-Blind Phase|Pregnancy|1|||
155677244|NCT00104416|561908374|FG001|Double-Blind Phase|Pregnancy|0|||
155677245|NCT00104416|561908375|FG002|Double-Blind Phase|Pregnancy|0|||
155677246|NCT00104416|561908376|FG003|Double-Blind Phase|Pregnancy|0|||
155677247|NCT00104416|561908377|FG004|Double-Blind Phase|Pregnancy|0|||
155677248|NCT00104416|561908373|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
155677249|NCT00104416|561908374|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
155677250|NCT00104416|561908375|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
155677251|NCT00104416|561908376|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
155677252|NCT00104416|561908377|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
155677253|NCT00104416|561908373|FG000|Continuation Phase|Adverse Event|0|||
155677254|NCT00104416|561908374|FG001|Continuation Phase|Adverse Event|0|||
155677255|NCT00104416|561908375|FG002|Continuation Phase|Adverse Event|2|||
155677256|NCT00104416|561908376|FG003|Continuation Phase|Adverse Event|0|||
155677257|NCT00104416|561908377|FG004|Continuation Phase|Adverse Event|2|||
155677258|NCT00104416|561908373|FG000|Continuation Phase|Lost to Follow-up|0|||
155677259|NCT00104416|561908374|FG001|Continuation Phase|Lost to Follow-up|0|||
155677260|NCT00104416|561908375|FG002|Continuation Phase|Lost to Follow-up|1|||
155677261|NCT00104416|561908376|FG003|Continuation Phase|Lost to Follow-up|0|||
155677262|NCT00104416|561908377|FG004|Continuation Phase|Lost to Follow-up|1|||
155677263|NCT00104416|561908373|FG000|Continuation Phase|Withdrawal by Subject|0|||
155677264|NCT00104416|561908374|FG001|Continuation Phase|Withdrawal by Subject|0|||
155677265|NCT00104416|561908375|FG002|Continuation Phase|Withdrawal by Subject|2|||
155677266|NCT00104416|561908376|FG003|Continuation Phase|Withdrawal by Subject|1|||
155677267|NCT00104416|561908377|FG004|Continuation Phase|Withdrawal by Subject|1|||
155677268|NCT00104416|561908373|FG000|Continuation Phase|Pregnancy|0|||
155677269|NCT00104416|561908374|FG001|Continuation Phase|Pregnancy|0|||
155677270|NCT00104416|561908375|FG002|Continuation Phase|Pregnancy|1|||
155677271|NCT00104416|561908376|FG003|Continuation Phase|Pregnancy|1|||
155677272|NCT00104416|561908377|FG004|Continuation Phase|Pregnancy|0|||
155677273|NCT00104416|561908373|FG000|Continuation Phase|Non-compliance|0|||
155677274|NCT00104416|561908374|FG001|Continuation Phase|Non-compliance|0|||
155677275|NCT00104416|561908375|FG002|Continuation Phase|Non-compliance|0|||
155677276|NCT00104416|561908376|FG003|Continuation Phase|Non-compliance|0|||
155677277|NCT00104416|561908377|FG004|Continuation Phase|Non-compliance|1|||
155677278|NCT00438360|561908378|FG000|Overall Study|Adverse Event|6|||
155677279|NCT00438360|561908379|FG001|Overall Study|Adverse Event|1|||
155677280|NCT00438360|561908378|FG000|Overall Study|Lack of Efficacy|42|||
155677281|NCT00438360|561908379|FG001|Overall Study|Lack of Efficacy|27|||
155677282|NCT00438360|561908378|FG000|Overall Study|Other|24|||
155677283|NCT00438360|561908379|FG001|Overall Study|Other|15|||
155677284|NCT03462641|561908384|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
155677285|NCT03462641|561908385|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
155677286|NCT03462641|561908384|FG000|Visit 2|Withdrawal by Subject|0|||
155677287|NCT03462641|561908385|FG001|Visit 2|Withdrawal by Subject|1|||
155677288|NCT01804049|561908386|FG000|Overall Study|Adverse Event|2|||
155677289|NCT01804049|561908387|FG001|Overall Study|Adverse Event|10|||
155677290|NCT01804049|561908386|FG000|Overall Study|Lost to Follow-up|2|||
155677291|NCT01804049|561908387|FG001|Overall Study|Lost to Follow-up|1|||
155677292|NCT01804049|561908386|FG000|Overall Study|Decreased interest/personal|4|||
155677293|NCT01804049|561908387|FG001|Overall Study|Decreased interest/personal|5|||
155677294|NCT01804049|561908386|FG000|Overall Study|Other health concerns|2|||
155677295|NCT01804049|561908387|FG001|Overall Study|Other health concerns|7|||
155677296|NCT01804049|561908386|FG000|Overall Study|Moved out of area|0|||
155677297|NCT01804049|561908387|FG001|Overall Study|Moved out of area|7|||
155677298|NCT01804049|561908386|FG000|Overall Study|other MD recommended|1|||
155677299|NCT01804049|561908387|FG001|Overall Study|other MD recommended|1|||
155677300|NCT01804049|561908386|FG000|Overall Study|Enrollment in dual studies|0|||
155677301|NCT01804049|561908387|FG001|Overall Study|Enrollment in dual studies|1|||
155677302|NCT00070109|561908388|FG000|Overall Study|Death|1|||
155677303|NCT00070109|561908389|FG001|Overall Study|Death|1|||
155677304|NCT00070109|561908390|FG002|Overall Study|Death|0|||
155677305|NCT00070109|561908391|FG003|Overall Study|Death|0|||
155677306|NCT00070109|561908392|FG004|Overall Study|Death|1|||
155677307|NCT00070109|561908388|FG000|Overall Study|Lack of Efficacy|6|||
155677308|NCT00070109|561908389|FG001|Overall Study|Lack of Efficacy|4|||
155677309|NCT00070109|561908390|FG002|Overall Study|Lack of Efficacy|5|||
155677310|NCT00070109|561908391|FG003|Overall Study|Lack of Efficacy|15|||
155677311|NCT00070109|561908392|FG004|Overall Study|Lack of Efficacy|5|||
155677312|NCT00070109|561908388|FG000|Overall Study|Physician Decision|1|||
155677313|NCT00070109|561908389|FG001|Overall Study|Physician Decision|0|||
155677314|NCT00070109|561908390|FG002|Overall Study|Physician Decision|0|||
155677315|NCT00070109|561908391|FG003|Overall Study|Physician Decision|0|||
155677316|NCT00070109|561908392|FG004|Overall Study|Physician Decision|0|||
155677317|NCT00070109|561908388|FG000|Overall Study|Withdrawal by Subject|0|||
155677318|NCT00070109|561908389|FG001|Overall Study|Withdrawal by Subject|1|||
155677319|NCT00070109|561908390|FG002|Overall Study|Withdrawal by Subject|1|||
155677320|NCT00070109|561908391|FG003|Overall Study|Withdrawal by Subject|0|||
155677321|NCT00070109|561908392|FG004|Overall Study|Withdrawal by Subject|0|||
155677322|NCT00070109|561908388|FG000|Overall Study|Adverse Event|0|||
155677323|NCT00070109|561908389|FG001|Overall Study|Adverse Event|0|||
155677324|NCT00070109|561908390|FG002|Overall Study|Adverse Event|2|||
155677325|NCT00070109|561908391|FG003|Overall Study|Adverse Event|4|||
155677326|NCT00070109|561908392|FG004|Overall Study|Adverse Event|2|||
155677327|NCT00070109|561908388|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
155677328|NCT00070109|561908389|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
155677329|NCT00070109|561908390|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
155677330|NCT00070109|561908391|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
155677331|NCT00070109|561908392|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
155677332|NCT01147250|561908395|FG000|Overall Study|Lost to Follow-up|14|||
155677333|NCT01147250|561908396|FG001|Overall Study|Lost to Follow-up|11|||
155677334|NCT01147250|561908395|FG000|Overall Study|Withdrawal by Subject|83|||
155677335|NCT01147250|561908396|FG001|Overall Study|Withdrawal by Subject|88|||
155677336|NCT01147250|561908395|FG000|Overall Study|Site termination by sponsor|13|||
155677337|NCT01147250|561908396|FG001|Overall Study|Site termination by sponsor|5|||
155677338|NCT01147250|561908395|FG000|Overall Study|Other than specified|0|||
155677339|NCT01147250|561908396|FG001|Overall Study|Other than specified|1|||
155677340|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155677341|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
155677342|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155677343|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155677344|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155600691|NCT02122770|561626208|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
155600692|NCT02122770|561626209|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155600693|NCT02122770|561626210|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155600694|NCT02122770|561626205|FG000|Part B: Standard of Care|Adverse Event|0|||
155600695|NCT02122770|561626206|FG001|Part B: Standard of Care|Adverse Event|0|||
155600696|NCT02122770|561626207|FG002|Part B: Standard of Care|Adverse Event|0|||
155600697|NCT02122770|561626208|FG003|Part B: Standard of Care|Adverse Event|0|||
155600698|NCT02122770|561626209|FG004|Part B: Standard of Care|Adverse Event|4|||
155600699|NCT02122770|561626210|FG005|Part B: Standard of Care|Adverse Event|1|||
155600700|NCT02122770|561626205|FG000|Part B: Standard of Care|Other|0|||
155600701|NCT02122770|561626206|FG001|Part B: Standard of Care|Other|0|||
155600702|NCT02122770|561626207|FG002|Part B: Standard of Care|Other|0|||
155600703|NCT02122770|561626208|FG003|Part B: Standard of Care|Other|0|||
155600704|NCT02122770|561626209|FG004|Part B: Standard of Care|Other|0|||
155600705|NCT02122770|561626210|FG005|Part B: Standard of Care|Other|2|||
155600706|NCT02122770|561626205|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
155600707|NCT02122770|561626206|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
155600708|NCT02122770|561626207|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
155600709|NCT02122770|561626208|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
155600710|NCT02122770|561626209|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
155600711|NCT02122770|561626210|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
155600712|NCT02122770|561626205|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
155600713|NCT02122770|561626206|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
155600714|NCT02122770|561626207|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
155600715|NCT02122770|561626208|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
155600716|NCT02122770|561626209|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
155600717|NCT02122770|561626210|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
155600718|NCT02122770|561626205|FG000|Part B: Standard of Care|Progressive Disease|0|||
155600719|NCT02122770|561626206|FG001|Part B: Standard of Care|Progressive Disease|0|||
155600720|NCT02122770|561626207|FG002|Part B: Standard of Care|Progressive Disease|0|||
155600721|NCT02122770|561626208|FG003|Part B: Standard of Care|Progressive Disease|0|||
155600722|NCT02122770|561626209|FG004|Part B: Standard of Care|Progressive Disease|10|||
155600723|NCT02122770|561626210|FG005|Part B: Standard of Care|Progressive Disease|8|||
155600724|NCT01041976|561626211|FG000|Overall Study|Withdrawal by Subject|3|||
155600725|NCT01041976|561626212|FG001|Overall Study|Withdrawal by Subject|0|||
155600726|NCT01041976|561626211|FG000|Overall Study|Incarceration|2|||
155600727|NCT01041976|561626212|FG001|Overall Study|Incarceration|0|||
155600728|NCT01041976|561626211|FG000|Overall Study|Death|0|||
155600729|NCT01041976|561626212|FG001|Overall Study|Death|4|||
155600730|NCT02658734|561626213|FG000|Overall Study|Adverse Event|2|||
155600731|NCT02658734|561626213|FG000|Overall Study|Death|4|||
155600732|NCT02658734|561626213|FG000|Overall Study|Lost to Follow-up|7|||
155600733|NCT02658734|561626213|FG000|Overall Study|Withdrawal of Consent|16|||
155600734|NCT02658734|561626213|FG000|Overall Study|Disease Progression|28|||
155600735|NCT02370667|561626229|FG000|Overall Study|Lost to Follow-up|0|||
155600736|NCT02370667|561626230|FG001|Overall Study|Lost to Follow-up|1|||
155600737|NCT02370667|561626231|FG002|Overall Study|Lost to Follow-up|0|||
155600738|NCT03536949|561626232|FG000|Overall Study|Adverse Event|4|||
155600739|NCT03536949|561626233|FG001|Overall Study|Adverse Event|0|||
155600740|NCT03536949|561626232|FG000|Overall Study|Lost to Follow-up|2|||
155600741|NCT03536949|561626233|FG001|Overall Study|Lost to Follow-up|1|||
155600742|NCT03536949|561626232|FG000|Overall Study|Withdrawal by Subject|6|||
155600743|NCT03536949|561626233|FG001|Overall Study|Withdrawal by Subject|0|||
155600744|NCT03536949|561626232|FG000|Overall Study|Non-compliance|2|||
155600745|NCT03536949|561626233|FG001|Overall Study|Non-compliance|1|||
155600746|NCT02954653|561626235|FG000|Overall Study|Death|3|||
155600747|NCT02954653|561626236|FG001|Overall Study|Death|1|||
155600748|NCT02954653|561626237|FG002|Overall Study|Death|0|||
155600749|NCT02954653|561626238|FG003|Overall Study|Death|0|||
155600750|NCT02954653|561626239|FG004|Overall Study|Death|0|||
155600751|NCT02954653|561626240|FG005|Overall Study|Death|0|||
155600752|NCT02954653|561626241|FG006|Overall Study|Death|0|||
155600753|NCT02954653|561626242|FG007|Overall Study|Death|0|||
155600754|NCT02954653|561626243|FG008|Overall Study|Death|0|||
155600755|NCT02954653|561626235|FG000|Overall Study|Randomized but did not receive treatment|1|||
155600756|NCT02954653|561626236|FG001|Overall Study|Randomized but did not receive treatment|0|||
155600757|NCT02954653|561626237|FG002|Overall Study|Randomized but did not receive treatment|0|||
155600758|NCT02954653|561626238|FG003|Overall Study|Randomized but did not receive treatment|0|||
155600759|NCT02954653|561626239|FG004|Overall Study|Randomized but did not receive treatment|0|||
155600760|NCT02954653|561626240|FG005|Overall Study|Randomized but did not receive treatment|0|||
155600761|NCT02954653|561626241|FG006|Overall Study|Randomized but did not receive treatment|0|||
155600762|NCT02954653|561626242|FG007|Overall Study|Randomized but did not receive treatment|0|||
155600763|NCT02954653|561626243|FG008|Overall Study|Randomized but did not receive treatment|0|||
155600764|NCT02954653|561626235|FG000|Overall Study|Started another anti-cancer therapy|0|||
155600765|NCT02954653|561626236|FG001|Overall Study|Started another anti-cancer therapy|1|||
155677345|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155677346|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
155677347|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
155677348|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155677349|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155677350|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155677351|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155677352|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
155677353|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
155677354|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155677355|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155677356|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155677357|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155677358|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
155677359|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
155677360|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155677361|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155677362|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155677363|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155677364|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155677365|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
155677366|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155677367|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155677368|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155677369|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155677370|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
155677371|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
155677372|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155677373|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155677374|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155677375|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155677376|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155677377|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
155677378|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155677379|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155677380|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155677381|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155677382|NCT03985943|561908401|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155677383|NCT03985943|561908402|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
155677384|NCT03985943|561908403|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155677385|NCT03985943|561908404|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155677386|NCT03985943|561908405|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155677387|NCT03985943|561908406|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155677388|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155677389|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155677390|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
155677391|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155677392|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
155677393|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
155677394|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155677395|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155677396|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
155677397|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155677398|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
155677399|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
155677400|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
155677401|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
155677402|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
155677403|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
155677404|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
155677405|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
155677406|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155677407|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155677408|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155677409|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155677410|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155677411|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155677412|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155677413|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155677414|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
155677415|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155677416|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
155677417|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155677418|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
155677419|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
155677420|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
155677421|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
155677422|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
155677423|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
155677424|NCT03985943|561908401|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
155677425|NCT03985943|561908402|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
155677426|NCT03985943|561908403|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
155677427|NCT03985943|561908404|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
155677428|NCT03985943|561908405|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
155677429|NCT03985943|561908406|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
155677430|NCT00716482|561908407|FG000|Overall Study|Lost to Follow-up|6|||
155677431|NCT00716482|561908407|FG000|Overall Study|Inadequate acquisition or analysis|50|||
155677432|NCT00716482|561908407|FG000|Overall Study|no pathology obtained|10|||
155677433|NCT00716482|561908407|FG000|Overall Study|technical/machine error|28|||
155677434|NCT00716482|561908407|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
155677435|NCT03248531|561908408|FG000|Overall Study|Adverse Event|0|||
155677436|NCT03248531|561908409|FG001|Overall Study|Adverse Event|0|||
155677437|NCT03248531|561908410|FG002|Overall Study|Adverse Event|1|||
155677438|NCT03248531|561908408|FG000|Overall Study|Lost to Follow-up|1|||
155677439|NCT03248531|561908409|FG001|Overall Study|Lost to Follow-up|0|||
155677440|NCT03248531|561908410|FG002|Overall Study|Lost to Follow-up|5|||
155677441|NCT03248531|561908408|FG000|Overall Study|Withdrawal by Subject|3|||
155677442|NCT03248531|561908409|FG001|Overall Study|Withdrawal by Subject|3|||
155677443|NCT03248531|561908410|FG002|Overall Study|Withdrawal by Subject|2|||
155677444|NCT03248531|561908408|FG000|Overall Study|Sponsor Request|0|||
155677445|NCT03248531|561908409|FG001|Overall Study|Sponsor Request|2|||
155677446|NCT03248531|561908410|FG002|Overall Study|Sponsor Request|0|||
155677447|NCT04075513|561908413|FG000|Overall Study|Withdrawal by Subject|2|||
155677448|NCT04075513|561908414|FG001|Overall Study|Withdrawal by Subject|2|||
155677449|NCT04075513|561908413|FG000|Overall Study|Lack of Efficacy|1|||
155677450|NCT04075513|561908414|FG001|Overall Study|Lack of Efficacy|0|||
155677451|NCT04075513|561908413|FG000|Overall Study|Lost to Follow-up|4|||
155677452|NCT04075513|561908414|FG001|Overall Study|Lost to Follow-up|2|||
155677453|NCT04075513|561908413|FG000|Overall Study|Switch to insulin pump|1|||
155677454|NCT04075513|561908414|FG001|Overall Study|Switch to insulin pump|0|||
155677455|NCT03249909|561908415|FG000|Overall Study|Withdrawal by Subject|3|||
155677456|NCT03249909|561908416|FG001|Overall Study|Withdrawal by Subject|0|||
155677457|NCT03249909|561908417|FG002|Overall Study|Withdrawal by Subject|0|||
155677458|NCT03249909|561908415|FG000|Overall Study|Adverse Event|3|||
155677459|NCT03249909|561908416|FG001|Overall Study|Adverse Event|0|||
155677460|NCT03249909|561908417|FG002|Overall Study|Adverse Event|0|||
155677461|NCT03249909|561908415|FG000|Overall Study|Lost to Follow-up|0|||
155677462|NCT03249909|561908416|FG001|Overall Study|Lost to Follow-up|1|||
155677463|NCT03249909|561908417|FG002|Overall Study|Lost to Follow-up|0|||
155677464|NCT05411822|561908420|FG000|Overall Study|Withdrawal by Subject|2|||
155677465|NCT05411822|561908421|FG001|Overall Study|Withdrawal by Subject|1|||
155677466|NCT01071252|561908422|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
155677467|NCT01071252|561908423|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
155677468|NCT01071252|561908424|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
155677469|NCT01071252|561908425|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
155677470|NCT01071252|561908426|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
155677471|NCT01071252|561908422|FG000|Overall Study|Withdrawal by Subject|8|||
155677472|NCT01071252|561908423|FG001|Overall Study|Withdrawal by Subject|2|||
155677473|NCT01071252|561908424|FG002|Overall Study|Withdrawal by Subject|1|||
155677474|NCT01071252|561908425|FG003|Overall Study|Withdrawal by Subject|2|||
155677475|NCT01071252|561908426|FG004|Overall Study|Withdrawal by Subject|3|||
155677476|NCT01071252|561908422|FG000|Overall Study|administrative problems|1|||
155677477|NCT01071252|561908423|FG001|Overall Study|administrative problems|1|||
155677478|NCT01071252|561908424|FG002|Overall Study|administrative problems|0|||
155677479|NCT01071252|561908425|FG003|Overall Study|administrative problems|2|||
155677480|NCT01071252|561908426|FG004|Overall Study|administrative problems|1|||
155677481|NCT01071252|561908422|FG000|Overall Study|Lost to Follow-up|1|||
155677482|NCT01071252|561908423|FG001|Overall Study|Lost to Follow-up|0|||
155677483|NCT01071252|561908424|FG002|Overall Study|Lost to Follow-up|1|||
155677484|NCT01071252|561908425|FG003|Overall Study|Lost to Follow-up|2|||
155677485|NCT01071252|561908426|FG004|Overall Study|Lost to Follow-up|0|||
155677486|NCT01071252|561908422|FG000|Overall Study|Adverse Event|1|||
155677487|NCT01071252|561908423|FG001|Overall Study|Adverse Event|1|||
155677488|NCT01071252|561908424|FG002|Overall Study|Adverse Event|0|||
155677489|NCT01071252|561908425|FG003|Overall Study|Adverse Event|1|||
155677490|NCT01071252|561908426|FG004|Overall Study|Adverse Event|0|||
155677491|NCT01071252|561908422|FG000|Overall Study|Death|0|||
155677492|NCT01071252|561908423|FG001|Overall Study|Death|0|||
155677493|NCT01071252|561908424|FG002|Overall Study|Death|0|||
155677494|NCT01071252|561908425|FG003|Overall Study|Death|0|||
155677495|NCT01071252|561908426|FG004|Overall Study|Death|1|||
155677496|NCT02125838|561908427|FG000|Overall Study|Lost to Follow-up|4|||
155677497|NCT02125838|561908428|FG001|Overall Study|Lost to Follow-up|4|||
155677498|NCT00787839|561908429|FG000|Overall Study|Failure to have the OGTT was most common|404|||
155677499|NCT03902392|561908430|FG000|Overall Study|Lost to Follow-up|7|||
155677500|NCT03902392|561908431|FG001|Overall Study|Lost to Follow-up|7|||
155677501|NCT00244725|561908436|FG000|Overall Study|Lost to Follow-up|3|||
155677502|NCT00244725|561908437|FG001|Overall Study|Lost to Follow-up|4|||
155677503|NCT00244725|561908438|FG002|Overall Study|Lost to Follow-up|9|||
155677504|NCT00244725|561908439|FG003|Overall Study|Lost to Follow-up|2|||
155677505|NCT00244725|561908436|FG000|Overall Study|Withdrawal by Subject|9|||
155677506|NCT00244725|561908437|FG001|Overall Study|Withdrawal by Subject|7|||
155677507|NCT00244725|561908438|FG002|Overall Study|Withdrawal by Subject|7|||
155677508|NCT00244725|561908439|FG003|Overall Study|Withdrawal by Subject|8|||
155677509|NCT00244725|561908436|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
155677510|NCT00244725|561908437|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
155677511|NCT00244725|561908438|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
155677512|NCT00244725|561908439|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
155677513|NCT00244725|561908436|FG000|Overall Study|Physician Decision|3|||
155677514|NCT00244725|561908437|FG001|Overall Study|Physician Decision|0|||
155677515|NCT00244725|561908438|FG002|Overall Study|Physician Decision|1|||
155677516|NCT00244725|561908439|FG003|Overall Study|Physician Decision|2|||
155677517|NCT00244725|561908436|FG000|Overall Study|Adverse Events|3|||
155677518|NCT00244725|561908437|FG001|Overall Study|Adverse Events|1|||
155677519|NCT00244725|561908438|FG002|Overall Study|Adverse Events|4|||
155677520|NCT00244725|561908439|FG003|Overall Study|Adverse Events|4|||
155677521|NCT00244725|561908436|FG000|Overall Study|Withdrwal by participant|1|||
155677522|NCT00244725|561908437|FG001|Overall Study|Withdrwal by participant|0|||
155677523|NCT00244725|561908438|FG002|Overall Study|Withdrwal by participant|0|||
155677524|NCT00244725|561908439|FG003|Overall Study|Withdrwal by participant|1|||
155677525|NCT00244725|561908436|FG000|Overall Study|Liver function test abnormality|2|||
155677526|NCT00244725|561908437|FG001|Overall Study|Liver function test abnormality|0|||
155677527|NCT00244725|561908438|FG002|Overall Study|Liver function test abnormality|0|||
155677528|NCT00244725|561908439|FG003|Overall Study|Liver function test abnormality|1|||
155677529|NCT00244725|561908436|FG000|Overall Study|Sponsor withdrew the participant|1|||
155677530|NCT00244725|561908437|FG001|Overall Study|Sponsor withdrew the participant|0|||
155677531|NCT00244725|561908438|FG002|Overall Study|Sponsor withdrew the participant|0|||
155677532|NCT00244725|561908439|FG003|Overall Study|Sponsor withdrew the participant|1|||
155677533|NCT00244725|561908436|FG000|Overall Study|Mediciation Error|0|||
155677534|NCT00244725|561908437|FG001|Overall Study|Mediciation Error|1|||
155677535|NCT00244725|561908438|FG002|Overall Study|Mediciation Error|0|||
155677536|NCT00244725|561908439|FG003|Overall Study|Mediciation Error|0|||
155677537|NCT00244725|561908436|FG000|Overall Study|Rehab Refused to allow participantion|0|||
155677538|NCT00244725|561908437|FG001|Overall Study|Rehab Refused to allow participantion|1|||
155677539|NCT00244725|561908438|FG002|Overall Study|Rehab Refused to allow participantion|0|||
155677540|NCT00244725|561908439|FG003|Overall Study|Rehab Refused to allow participantion|0|||
155677541|NCT00244725|561908436|FG000|Overall Study|Headache|0|||
155677542|NCT00244725|561908437|FG001|Overall Study|Headache|1|||
155677543|NCT00244725|561908438|FG002|Overall Study|Headache|0|||
155677544|NCT00244725|561908439|FG003|Overall Study|Headache|0|||
155677545|NCT00244725|561908436|FG000|Overall Study|Received prohibited medication|0|||
155677546|NCT00244725|561908437|FG001|Overall Study|Received prohibited medication|1|||
155677547|NCT00244725|561908438|FG002|Overall Study|Received prohibited medication|0|||
155677548|NCT00244725|561908439|FG003|Overall Study|Received prohibited medication|1|||
155677549|NCT00244725|561908436|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155677550|NCT00244725|561908437|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
155677551|NCT00244725|561908438|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155677552|NCT00244725|561908439|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155677553|NCT00244725|561908436|FG000|Overall Study|Administrative reason|0|||
155677554|NCT00244725|561908437|FG001|Overall Study|Administrative reason|0|||
155677555|NCT00244725|561908438|FG002|Overall Study|Administrative reason|1|||
155677556|NCT00244725|561908439|FG003|Overall Study|Administrative reason|0|||
155677557|NCT00244725|561908436|FG000|Overall Study|Vomit|0|||
155677558|NCT00244725|561908437|FG001|Overall Study|Vomit|0|||
155677559|NCT00244725|561908438|FG002|Overall Study|Vomit|1|||
155677560|NCT00244725|561908439|FG003|Overall Study|Vomit|0|||
155677561|NCT00244725|561908436|FG000|Overall Study|Failed to follow-up|0|||
155677562|NCT00244725|561908437|FG001|Overall Study|Failed to follow-up|0|||
155677563|NCT00244725|561908438|FG002|Overall Study|Failed to follow-up|1|||
155677564|NCT00244725|561908439|FG003|Overall Study|Failed to follow-up|1|||
155677565|NCT00335738|561908440|FG000|Overall Study|Physician Decision|6|||
155677566|NCT00335738|561908441|FG001|Overall Study|Physician Decision|0|||
155677567|NCT00335738|561908440|FG000|Overall Study|Withdrawal by Subject|2|||
155677568|NCT00335738|561908441|FG001|Overall Study|Withdrawal by Subject|0|||
155677569|NCT00335738|561908440|FG000|Overall Study|Ineligible|3|||
155677570|NCT00335738|561908441|FG001|Overall Study|Ineligible|4|||
155677571|NCT01104545|561908442|FG000|Overall Study|Adverse Event|0|||
155677572|NCT01104545|561908443|FG001|Overall Study|Adverse Event|1|||
155677573|NCT01104545|561908444|FG002|Overall Study|Adverse Event|2|||
155677574|NCT04532294|561908445|FG000|Overall Study|Withdrawal by Subject|0|||
155677575|NCT04532294|561908446|FG001|Overall Study|Withdrawal by Subject|0|||
155677576|NCT04532294|561908447|FG002|Overall Study|Withdrawal by Subject|1|||
155677577|NCT04532294|561908445|FG000|Overall Study|Participants Not Dosed|0|||
155677578|NCT04532294|561908446|FG001|Overall Study|Participants Not Dosed|0|||
155677579|NCT04532294|561908447|FG002|Overall Study|Participants Not Dosed|2|||
155677580|NCT00375505|561908448|FG000|Overall Study|Adverse Event|1|||
155677581|NCT00375505|561908449|FG001|Overall Study|Adverse Event|2|||
155677582|NCT02798315|561908450|FG000|Overall Study|Failure to return|1|||
155677583|NCT00005947|561908451|FG000|Overall Study|Death|54|||
155677584|NCT00005947|561908452|FG001|Overall Study|Death|40|||
155677585|NCT00005947|561908451|FG000|Overall Study|Patient Refused to Continue|2|||
155677586|NCT00005947|561908452|FG001|Overall Study|Patient Refused to Continue|1|||
155677587|NCT00005947|561908451|FG000|Overall Study|Site Closure|1|||
155677588|NCT00005947|561908452|FG001|Overall Study|Site Closure|0|||
155677589|NCT01575808|561908454|FG000|Overall Study|Death|2|||
155677590|NCT01575808|561908455|FG001|Overall Study|Death|0|||
155677591|NCT01575808|561908454|FG000|Overall Study|Withdrawal by Subject|1|||
155677592|NCT01575808|561908455|FG001|Overall Study|Withdrawal by Subject|0|||
155677593|NCT03159468|561908456|FG000|Overall Study|Withdrawal by Subject|0|||
155677594|NCT03159468|561908457|FG001|Overall Study|Withdrawal by Subject|0|||
155677595|NCT03159468|561908458|FG002|Overall Study|Withdrawal by Subject|3|||
155677596|NCT03159468|561908459|FG003|Overall Study|Withdrawal by Subject|0|||
155677597|NCT03159468|561908460|FG004|Overall Study|Withdrawal by Subject|0|||
155677598|NCT03159468|561908461|FG005|Overall Study|Withdrawal by Subject|0|||
155677599|NCT00912782|561908462|FG000|Overall Study|Death|2|||
155677600|NCT00912782|561908463|FG001|Overall Study|Death|1|||
155677601|NCT00912782|561908462|FG000|Overall Study|Lost to Follow-up|0|||
155677602|NCT00912782|561908463|FG001|Overall Study|Lost to Follow-up|1|||
155677603|NCT00912782|561908462|FG000|Overall Study|Did not receive vascular access type|1|||
155677604|NCT00912782|561908463|FG001|Overall Study|Did not receive vascular access type|2|||
155677605|NCT00912782|561908462|FG000|Overall Study|Relocated before study completion|0|||
155677606|NCT00912782|561908463|FG001|Overall Study|Relocated before study completion|1|||
155677607|NCT02482428|561910101|FG000|Overall Study|Lost to Follow-up|4|||
155677608|NCT02482428|561910102|FG001|Overall Study|Lost to Follow-up|9|||
155677609|NCT02482428|561910103|FG002|Overall Study|Lost to Follow-up|1|||
155677610|NCT02482428|561910104|FG003|Overall Study|Lost to Follow-up|2|||
155677611|NCT02482428|561910105|FG004|Overall Study|Lost to Follow-up|4|||
155677612|NCT02482428|561910101|FG000|Overall Study|Physician Decision|0|||
155677613|NCT02482428|561910102|FG001|Overall Study|Physician Decision|0|||
155677614|NCT02482428|561910103|FG002|Overall Study|Physician Decision|0|||
155677615|NCT02482428|561910104|FG003|Overall Study|Physician Decision|0|||
155677616|NCT02482428|561910105|FG004|Overall Study|Physician Decision|1|||
155677617|NCT02482428|561910101|FG000|Overall Study|protocol deviation|1|||
155677618|NCT02482428|561910102|FG001|Overall Study|protocol deviation|1|||
155677619|NCT02482428|561910103|FG002|Overall Study|protocol deviation|0|||
155677620|NCT02482428|561910104|FG003|Overall Study|protocol deviation|0|||
155677621|NCT02482428|561910105|FG004|Overall Study|protocol deviation|0|||
155677622|NCT02482428|561910101|FG000|Overall Study|subject/guardian decision|4|||
155677623|NCT02482428|561910102|FG001|Overall Study|subject/guardian decision|2|||
155677624|NCT02482428|561910103|FG002|Overall Study|subject/guardian decision|0|||
155677625|NCT02482428|561910104|FG003|Overall Study|subject/guardian decision|0|||
155600766|NCT02954653|561626237|FG002|Overall Study|Started another anti-cancer therapy|0|||
155600767|NCT02954653|561626238|FG003|Overall Study|Started another anti-cancer therapy|0|||
155600768|NCT02954653|561626239|FG004|Overall Study|Started another anti-cancer therapy|0|||
155677626|NCT02482428|561910105|FG004|Overall Study|subject/guardian decision|2|||
155677627|NCT00809835|561910108|FG000|Overall Study|Lost to Follow-up|7|||
155677628|NCT00809835|561910109|FG001|Overall Study|Lost to Follow-up|6|||
155677629|NCT00809835|561910110|FG002|Overall Study|Lost to Follow-up|10|||
155677630|NCT00809835|561910111|FG003|Overall Study|Lost to Follow-up|2|||
155677631|NCT00809835|561910108|FG000|Overall Study|Withdrawal by Subject|1|||
155677632|NCT00809835|561910109|FG001|Overall Study|Withdrawal by Subject|1|||
155677633|NCT00809835|561910110|FG002|Overall Study|Withdrawal by Subject|1|||
155677634|NCT00809835|561910111|FG003|Overall Study|Withdrawal by Subject|0|||
155677635|NCT05160415|561910112|FG000|Overall Study|Withdrawal by Subject|3|||
155677636|NCT00576628|561910113|FG000|Overall Study|Adverse Event|11|||
155677637|NCT00576628|561910113|FG000|Overall Study|Death|2|||
155677638|NCT00576628|561910113|FG000|Overall Study|Failure to return|1|||
155677639|NCT00576628|561910113|FG000|Overall Study|Refused Treatment|8|||
155677640|NCT00576628|561910113|FG000|Overall Study|Pregnancy|1|||
155677641|NCT00576628|561910113|FG000|Overall Study|RBC transfusion|1|||
155677642|NCT00576628|561910113|FG000|Overall Study|Progression of Kidney Disease|1|||
155677643|NCT00576628|561910113|FG000|Overall Study|Progression of Renal Failure|1|||
155677644|NCT00576628|561910113|FG000|Overall Study|The patient move into other town|1|||
155677645|NCT00576628|561910113|FG000|Overall Study|Transplantation|1|||
155677646|NCT00576628|561910113|FG000|Overall Study|Dialysis|15|||
155677647|NCT02516982|561910120|FG000|Overall Study|Called in to antenatal appointment|32|||
155677648|NCT02516982|561910121|FG001|Overall Study|Called in to antenatal appointment|35|||
155677649|NCT02516982|561910122|FG002|Overall Study|Called in to antenatal appointment|0|||
155677650|NCT02516982|561910123|FG003|Overall Study|Called in to antenatal appointment|0|||
155677651|NCT02516982|561910120|FG000|Overall Study|Withdrawal by Subject|0|||
155677652|NCT02516982|561910121|FG001|Overall Study|Withdrawal by Subject|0|||
155677653|NCT02516982|561910122|FG002|Overall Study|Withdrawal by Subject|1|||
155677654|NCT02516982|561910123|FG003|Overall Study|Withdrawal by Subject|2|||
155677655|NCT02516982|561910120|FG000|Overall Study|Protocol Violation|0|||
155677656|NCT02516982|561910121|FG001|Overall Study|Protocol Violation|0|||
155677657|NCT02516982|561910122|FG002|Overall Study|Protocol Violation|1|||
155677658|NCT02516982|561910123|FG003|Overall Study|Protocol Violation|1|||
155677659|NCT02516982|561910120|FG000|Overall Study|Did not install the app|0|||
155677660|NCT02516982|561910121|FG001|Overall Study|Did not install the app|0|||
155677661|NCT02516982|561910122|FG002|Overall Study|Did not install the app|46|||
155677662|NCT02516982|561910123|FG003|Overall Study|Did not install the app|47|||
155677663|NCT01951586|561910128|FG000|Overall Study|Death|61|||
155677664|NCT01951586|561910129|FG001|Overall Study|Death|120|||
155677665|NCT01951586|561910128|FG000|Overall Study|Withdrawal by Subject|8|||
155677666|NCT01951586|561910129|FG001|Overall Study|Withdrawal by Subject|17|||
155677667|NCT01951586|561910128|FG000|Overall Study|Lost to Follow-up|0|||
155677668|NCT01951586|561910129|FG001|Overall Study|Lost to Follow-up|1|||
155677669|NCT01951586|561910128|FG000|Overall Study|Sponsor Decision|9|||
155677670|NCT01951586|561910129|FG001|Overall Study|Sponsor Decision|10|||
155677671|NCT02120781|561910132|FG000|Overall Study|Physician Decision|2|||
155677672|NCT02120781|561910133|FG001|Overall Study|Physician Decision|0|||
155677673|NCT02120781|561910132|FG000|Overall Study|Completion not documented|2|||
155677674|NCT02120781|561910133|FG001|Overall Study|Completion not documented|1|||
155677675|NCT03195660|561910134|FG000|Overall Study|The study was terminated|2|||
155677676|NCT00375427|561910135|FG000|Overall Study|Adverse Event|21|||
155677677|NCT00375427|561910136|FG001|Overall Study|Adverse Event|27|||
155677678|NCT00375427|561910135|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155677679|NCT00375427|561910136|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155677680|NCT00375427|561910135|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155677681|NCT00375427|561910136|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155677682|NCT00375427|561910135|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155677683|NCT00375427|561910136|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155677684|NCT00375427|561910135|FG000|Overall Study|Patient no longer requires study drug|3|||
155677685|NCT00375427|561910136|FG001|Overall Study|Patient no longer requires study drug|7|||
155677686|NCT00375427|561910135|FG000|Overall Study|Protocol Violation|10|||
155677687|NCT00375427|561910136|FG001|Overall Study|Protocol Violation|8|||
155677688|NCT00375427|561910135|FG000|Overall Study|Withdrawal by Subject|9|||
155677689|NCT00375427|561910136|FG001|Overall Study|Withdrawal by Subject|13|||
155677690|NCT00375427|561910135|FG000|Overall Study|Lost to Follow-up|1|||
155677691|NCT00375427|561910136|FG001|Overall Study|Lost to Follow-up|1|||
155677692|NCT00375427|561910135|FG000|Overall Study|Administrative reasons|0|||
155677693|NCT00375427|561910136|FG001|Overall Study|Administrative reasons|1|||
155677694|NCT00375427|561910135|FG000|Overall Study|Death|11|||
155677695|NCT00375427|561910136|FG001|Overall Study|Death|10|||
155677696|NCT03286543|561910141|FG000|Consented|Screen failure before randomization|2|||
155677697|NCT03286543|561910142|FG001|Consented|Screen failure before randomization|0|||
155677698|NCT03286543|561910143|FG002|Consented|Screen failure before randomization|0|||
155677699|NCT03286543|561910141|FG000|Consented|Screen failure before enrollment|4|||
155677700|NCT03286543|561910142|FG001|Consented|Screen failure before enrollment|0|||
155677701|NCT03286543|561910143|FG002|Consented|Screen failure before enrollment|0|||
155677702|NCT03286543|561910141|FG000|Consented|TKA cancelled after enrollment|1|||
155677703|NCT03286543|561910142|FG001|Consented|TKA cancelled after enrollment|0|||
155677704|NCT03286543|561910143|FG002|Consented|TKA cancelled after enrollment|0|||
155677705|NCT03286543|561910141|FG000|Consented|Withdrawn from study|12|||
155677706|NCT03286543|561910142|FG001|Consented|Withdrawn from study|0|||
155677707|NCT03286543|561910143|FG002|Consented|Withdrawn from study|0|||
155677708|NCT03286543|561910141|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
155677709|NCT03286543|561910142|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
155677710|NCT03286543|561910143|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
155677711|NCT03286543|561910141|FG000|Study Enrollment|Withdrawn from study|0|||
155677712|NCT03286543|561910142|FG001|Study Enrollment|Withdrawn from study|6|||
155677713|NCT03286543|561910143|FG002|Study Enrollment|Withdrawn from study|6|||
155677714|NCT05332392|561910144|FG000|Overall Study|Did not meet inclusion criteria|25|||
155677715|NCT05332392|561910144|FG000|Overall Study|Principal Investigator's decision|17|||
155677716|NCT05332392|561910144|FG000|Overall Study|Adverse Event|1|||
155677717|NCT05332392|561910144|FG000|Overall Study|Subject's decision|1|||
155677718|NCT01268046|561910145|FG000|Overall Study|Withdrawal by Subject|1|||
155677719|NCT01268046|561910146|FG001|Overall Study|Withdrawal by Subject|0|||
155677720|NCT01268046|561910147|FG002|Overall Study|Withdrawal by Subject|0|||
155677721|NCT01268046|561910148|FG003|Overall Study|Withdrawal by Subject|1|||
155677722|NCT01268046|561910145|FG000|Overall Study|Lost to Follow-up|0|||
155677723|NCT01268046|561910146|FG001|Overall Study|Lost to Follow-up|0|||
155677724|NCT01268046|561910147|FG002|Overall Study|Lost to Follow-up|1|||
155677725|NCT01268046|561910148|FG003|Overall Study|Lost to Follow-up|0|||
155677726|NCT03636893|561910149|FG000|Overall Study|Death|0|||
155677727|NCT03636893|561910150|FG001|Overall Study|Death|1|||
155677728|NCT03636893|561910149|FG000|Overall Study|Protocol Violation|0|||
155677729|NCT03636893|561910150|FG001|Overall Study|Protocol Violation|3|||
155600769|NCT02954653|561626240|FG005|Overall Study|Started another anti-cancer therapy|0|||
155600770|NCT02954653|561626241|FG006|Overall Study|Started another anti-cancer therapy|0|||
155600771|NCT02954653|561626242|FG007|Overall Study|Started another anti-cancer therapy|0|||
155600772|NCT02954653|561626243|FG008|Overall Study|Started another anti-cancer therapy|0|||
155600773|NCT02954653|561626235|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
155600774|NCT02954653|561626236|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
155600775|NCT02954653|561626237|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
155600776|NCT02954653|561626238|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
155600777|NCT02954653|561626239|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
155600778|NCT02954653|561626240|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
155600779|NCT02954653|561626241|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
155600780|NCT02954653|561626242|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
155600781|NCT02954653|561626243|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
155600782|NCT03054064|561626244|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
155600783|NCT03054064|561626244|FG000|Overall Study|Investigator Decision|2|||
155600784|NCT03054064|561626244|FG000|Overall Study|Bladder Issue|1|||
155600785|NCT03054064|561626244|FG000|Overall Study|High Blood Pressure|1|||
155600786|NCT03054064|561626244|FG000|Overall Study|Change in Status|1|||
155600787|NCT04329091|561626245|FG000|Overall Study|Physician Decision|5|||
155600788|NCT03787303|561626248|FG000|Overall Study|Death|1|||
155600789|NCT03787303|561626248|FG000|Overall Study|Premature Termination of Study|1|||
155600790|NCT00785213|561626253|FG000|Quinine Sulfate Alone|Adverse Event|4|||
155600791|NCT00785213|561626253|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
155600792|NCT01500213|561626254|FG000|Overall Study|Adverse Event|35|||
155600793|NCT01500213|561626255|FG001|Overall Study|Adverse Event|35|||
155600794|NCT01500213|561626254|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
155600795|NCT01500213|561626255|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
155600796|NCT01500213|561626254|FG000|Overall Study|Withdrawal by Subject|28|||
155600797|NCT01500213|561626255|FG001|Overall Study|Withdrawal by Subject|37|||
155600798|NCT01500213|561626254|FG000|Overall Study|Death|7|||
155600799|NCT01500213|561626255|FG001|Overall Study|Death|3|||
155600800|NCT01500213|561626254|FG000|Overall Study|Disease Progression|13|||
155600801|NCT01500213|561626255|FG001|Overall Study|Disease Progression|21|||
155600802|NCT01500213|561626254|FG000|Overall Study|Protocol Violation|19|||
155677730|NCT03636893|561910149|FG000|Overall Study|Withdrawal by Subject|1|||
155600803|NCT01500213|561626255|FG001|Overall Study|Protocol Violation|19|||
155600804|NCT01500213|561626254|FG000|Overall Study|Physician Decision|12|||
155600805|NCT01500213|561626255|FG001|Overall Study|Physician Decision|10|||
155600806|NCT01500213|561626254|FG000|Overall Study|Lack of Efficacy|9|||
155600807|NCT01500213|561626255|FG001|Overall Study|Lack of Efficacy|7|||
155600808|NCT01500213|561626254|FG000|Overall Study|Lost to Follow-up|3|||
155600809|NCT01500213|561626255|FG001|Overall Study|Lost to Follow-up|6|||
155600810|NCT01500213|561626254|FG000|Overall Study|Other Reasons|7|||
155600811|NCT01500213|561626255|FG001|Overall Study|Other Reasons|5|||
155600812|NCT02386345|561626256|FG000|Overall Study|Not treated|14|||
155600813|NCT02386345|561626256|FG000|Overall Study|Lost to Follow-up|1|||
155600814|NCT02386345|561626256|FG000|Overall Study|Adverse Event|5|||
155600815|NCT02386345|561626256|FG000|Overall Study|Repeat Procedure|10|||
155600816|NCT02386345|561626256|FG000|Overall Study|Did not complete 12-month follow-up|72|||
155600817|NCT01043705|561626259|FG000|Overall Study|Death|28|||
155600818|NCT01043705|561626260|FG001|Overall Study|Death|60|||
155600819|NCT01043705|561626261|FG002|Overall Study|Death|26|||
155600820|NCT01043705|561626259|FG000|Overall Study|Lost to Follow-up|27|||
155600821|NCT01043705|561626260|FG001|Overall Study|Lost to Follow-up|12|||
155600822|NCT01043705|561626261|FG002|Overall Study|Lost to Follow-up|0|||
155600823|NCT01043705|561626259|FG000|Overall Study|Multiple Reasons|4|||
155600824|NCT01043705|561626260|FG001|Overall Study|Multiple Reasons|7|||
155600825|NCT01043705|561626261|FG002|Overall Study|Multiple Reasons|0|||
155600826|NCT01043705|561626259|FG000|Overall Study|Protocol Violation|2|||
155600827|NCT01043705|561626260|FG001|Overall Study|Protocol Violation|1|||
155600828|NCT01043705|561626261|FG002|Overall Study|Protocol Violation|0|||
155600829|NCT01043705|561626259|FG000|Overall Study|Withdrawal by Subject|8|||
155600830|NCT01043705|561626260|FG001|Overall Study|Withdrawal by Subject|6|||
155600831|NCT01043705|561626261|FG002|Overall Study|Withdrawal by Subject|0|||
155600832|NCT01043705|561626259|FG000|Overall Study|Site Closure|8|||
155600833|NCT01043705|561626260|FG001|Overall Study|Site Closure|0|||
155600834|NCT01043705|561626261|FG002|Overall Study|Site Closure|0|||
155600835|NCT01043705|561626259|FG000|Overall Study|Subsequent Procedure|9|||
155600836|NCT01043705|561626260|FG001|Overall Study|Subsequent Procedure|24|||
155600837|NCT01043705|561626261|FG002|Overall Study|Subsequent Procedure|29|||
155600838|NCT01043705|561626259|FG000|Overall Study|Adverse Event|0|||
155600839|NCT01043705|561626260|FG001|Overall Study|Adverse Event|2|||
155600840|NCT01043705|561626261|FG002|Overall Study|Adverse Event|0|||
155600841|NCT01043705|561626259|FG000|Overall Study|Screen Fail|21|||
155600842|NCT01043705|561626260|FG001|Overall Study|Screen Fail|0|||
155600843|NCT01043705|561626261|FG002|Overall Study|Screen Fail|0|||
155600844|NCT01043705|561626259|FG000|Overall Study|Other|0|||
155600845|NCT01043705|561626260|FG001|Overall Study|Other|19|||
155600846|NCT01043705|561626261|FG002|Overall Study|Other|25|||
155600847|NCT02003963|561626263|FG000|Overall Study|Lost to Follow-up|2|||
155600848|NCT02003963|561626264|FG001|Overall Study|Lost to Follow-up|1|||
155600849|NCT00581542|561626265|FG000|Overall Study|they met an exclusion criteria|2|||
155600850|NCT00581542|561626266|FG001|Overall Study|they met an exclusion criteria|2|||
155600851|NCT00581542|561626265|FG000|Overall Study|Lost to Follow-up|9|||
155600852|NCT00581542|561626266|FG001|Overall Study|Lost to Follow-up|21|||
155600853|NCT01801280|561626267|FG000|Period 1|Withdrawal by Subject|0|||
155600854|NCT01801280|561626268|FG001|Period 1|Withdrawal by Subject|1|||
155600855|NCT01801280|561626269|FG002|Period 1|Withdrawal by Subject|0|||
155600856|NCT01801280|561626270|FG003|Period 1|Withdrawal by Subject|0|||
155600857|NCT01801280|561626267|FG000|Period 2|Withdrawal by Subject|1|||
155600858|NCT01801280|561626268|FG001|Period 2|Withdrawal by Subject|0|||
155600859|NCT01801280|561626269|FG002|Period 2|Withdrawal by Subject|0|||
155600860|NCT01801280|561626270|FG003|Period 2|Withdrawal by Subject|0|||
155600861|NCT01801280|561626267|FG000|Period 4|Protocol Violation|0|||
155600862|NCT01801280|561626268|FG001|Period 4|Protocol Violation|0|||
155600863|NCT01801280|561626269|FG002|Period 4|Protocol Violation|1|||
155677731|NCT03636893|561910150|FG001|Overall Study|Withdrawal by Subject|2|||
155677732|NCT03636893|561910149|FG000|Overall Study|Refusal to surgery|4|||
155600864|NCT01801280|561626270|FG003|Period 4|Protocol Violation|0|||
155600865|NCT00176644|561626271|FG000|Overall Study|Withdrawal by Subject|1|||
155600866|NCT05020366|561626272|FG000|Overall Study|Lost to Follow-up|2|||
155600867|NCT05020366|561626273|FG001|Overall Study|Lost to Follow-up|0|||
155600868|NCT05020366|561626272|FG000|Overall Study|Withdrawal by Subject|2|||
155600869|NCT05020366|561626273|FG001|Overall Study|Withdrawal by Subject|0|||
155600870|NCT03045276|561626284|FG000|Intervention Phase|Withdrawal by Subject|7|||
155600871|NCT03045276|561626285|FG001|Intervention Phase|Withdrawal by Subject|2|||
155677733|NCT03636893|561910150|FG001|Overall Study|Refusal to surgery|3|||
155600872|NCT03045276|561626286|FG002|Intervention Phase|Withdrawal by Subject|3|||
155600873|NCT03045276|561626287|FG003|Intervention Phase|Withdrawal by Subject|7|||
155600874|NCT03045276|561626284|FG000|Intervention Phase|Developed exclusionary criteria|3|||
155677734|NCT03636893|561910149|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
155677735|NCT03636893|561910150|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
155677736|NCT03636893|561910149|FG000|Overall Study|Adverse Event|1|||
155677737|NCT03636893|561910150|FG001|Overall Study|Adverse Event|1|||
155677738|NCT02314156|561910151|FG000|Overall Study|Adverse Event|1|||
155677739|NCT02314156|561910152|FG001|Overall Study|Adverse Event|0|||
155677740|NCT02314156|561910151|FG000|Overall Study|Withdrawal by Subject|1|||
155677741|NCT02314156|561910152|FG001|Overall Study|Withdrawal by Subject|0|||
155677742|NCT00758069|561910153|FG000|Overall Study|Lack of Efficacy|0|||
155677743|NCT00758069|561910154|FG001|Overall Study|Lack of Efficacy|0|||
155677744|NCT00758069|561910155|FG002|Overall Study|Lack of Efficacy|1|||
155677745|NCT00758069|561910153|FG000|Overall Study|Incorrect Study Drug|1|||
155677746|NCT00758069|561910154|FG001|Overall Study|Incorrect Study Drug|0|||
155677747|NCT00758069|561910155|FG002|Overall Study|Incorrect Study Drug|0|||
155677748|NCT04560816|561910156|FG000|Overall Study|Withdrawal by Subject|1|||
155677749|NCT04560816|561910157|FG001|Overall Study|Withdrawal by Subject|1|||
155677750|NCT04560816|561910158|FG002|Overall Study|Withdrawal by Subject|1|||
155677751|NCT04560816|561910159|FG003|Overall Study|Withdrawal by Subject|0|||
155677752|NCT04560816|561910160|FG004|Overall Study|Withdrawal by Subject|3|||
155677753|NCT04560816|561910161|FG005|Overall Study|Withdrawal by Subject|0|||
155677754|NCT04560816|561910156|FG000|Overall Study|Lost to Follow-up|1|||
155677755|NCT04560816|561910157|FG001|Overall Study|Lost to Follow-up|0|||
155677756|NCT04560816|561910158|FG002|Overall Study|Lost to Follow-up|0|||
155677757|NCT04560816|561910159|FG003|Overall Study|Lost to Follow-up|0|||
155677758|NCT04560816|561910160|FG004|Overall Study|Lost to Follow-up|0|||
155677759|NCT04560816|561910161|FG005|Overall Study|Lost to Follow-up|0|||
155677760|NCT04560816|561910156|FG000|Overall Study|Protocol Violation|1|||
155677761|NCT04560816|561910157|FG001|Overall Study|Protocol Violation|0|||
155677762|NCT04560816|561910158|FG002|Overall Study|Protocol Violation|0|||
155677763|NCT04560816|561910159|FG003|Overall Study|Protocol Violation|0|||
155677764|NCT04560816|561910160|FG004|Overall Study|Protocol Violation|0|||
155677765|NCT04560816|561910161|FG005|Overall Study|Protocol Violation|0|||
155677766|NCT02277691|561910162|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
155677767|NCT02277691|561910162|FG000|Overall Study|Voluntary Withdrawal|7|||
155677768|NCT02277691|561910162|FG000|Overall Study|Lack of Efficacy|5|||
155677769|NCT02277691|561910162|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
155677770|NCT02846389|561910163|FG000|Overall Study|Withdrawal by Subject|1|||
155677771|NCT02846389|561910164|FG001|Overall Study|Withdrawal by Subject|1|||
155677772|NCT03818607|561910167|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
155677773|NCT03818607|561910168|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
155677774|NCT03818607|561910167|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
155677775|NCT03818607|561910168|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
155677776|NCT03818607|561910167|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
155677777|NCT03818607|561910168|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
155677778|NCT05286658|561910170|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
155677779|NCT05286658|561910170|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
155677780|NCT00842153|561910171|FG000|Overall Study|Adverse Event|0|||
155677781|NCT00842153|561910172|FG001|Overall Study|Adverse Event|1|||
155677782|NCT00842153|561910171|FG000|Overall Study|Lost to Follow-up|1|||
155677783|NCT00842153|561910172|FG001|Overall Study|Lost to Follow-up|2|||
155677784|NCT03517371|561910173|FG000|Overall Study|Adverse Event|8|||
155677785|NCT03517371|561910174|FG001|Overall Study|Adverse Event|9|||
155677786|NCT03517371|561910173|FG000|Overall Study|Lost to Follow-up|1|||
155677787|NCT03517371|561910174|FG001|Overall Study|Lost to Follow-up|2|||
155677788|NCT03517371|561910173|FG000|Overall Study|Withdrawal by Subject|4|||
155677789|NCT03517371|561910174|FG001|Overall Study|Withdrawal by Subject|4|||
155677790|NCT03517371|561910173|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
155677791|NCT03517371|561910174|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
155677792|NCT03517371|561910173|FG000|Overall Study|COVID restrictions|2|||
155677793|NCT03517371|561910174|FG001|Overall Study|COVID restrictions|0|||
155677794|NCT03517371|561910173|FG000|Overall Study|Receiving DBS Surgery|0|||
155677795|NCT03517371|561910174|FG001|Overall Study|Receiving DBS Surgery|1|||
155677796|NCT01345929|561910176|FG000|Overall Study|Withdrawal by Subject|9|||
155677797|NCT01345929|561910177|FG001|Overall Study|Withdrawal by Subject|8|||
155677798|NCT01345929|561910176|FG000|Overall Study|Lost to Follow-up|9|||
155677799|NCT01345929|561910177|FG001|Overall Study|Lost to Follow-up|9|||
155677800|NCT01345929|561910176|FG000|Overall Study|Adverse Event|0|||
155677801|NCT01345929|561910177|FG001|Overall Study|Adverse Event|1|||
155677802|NCT01345929|561910176|FG000|Overall Study|Didn't meet eligibility criteria|2|||
155677803|NCT01345929|561910177|FG001|Overall Study|Didn't meet eligibility criteria|0|||
155677804|NCT01345929|561910176|FG000|Overall Study|40,000 CFU/ML|1|||
155677805|NCT01345929|561910177|FG001|Overall Study|40,000 CFU/ML|0|||
155677806|NCT01345929|561910176|FG000|Overall Study|Patient withdrawal|0|||
155677807|NCT01345929|561910177|FG001|Overall Study|Patient withdrawal|1|||
155677808|NCT02819297|561910178|FG000|Overall Study|Withdrawal by Subject|25|||
155677809|NCT02819297|561910179|FG001|Overall Study|Withdrawal by Subject|13|||
155677810|NCT02819297|561910178|FG000|Overall Study|Lost to Follow-up|12|||
155677811|NCT02819297|561910179|FG001|Overall Study|Lost to Follow-up|14|||
155677812|NCT02819297|561910178|FG000|Overall Study|Adverse Event|12|||
155677813|NCT02819297|561910179|FG001|Overall Study|Adverse Event|10|||
155677814|NCT02819297|561910178|FG000|Overall Study|Physician Decision|5|||
155677815|NCT02819297|561910179|FG001|Overall Study|Physician Decision|5|||
155677816|NCT02819297|561910178|FG000|Overall Study|Lack of Efficacy|5|||
155677817|NCT02819297|561910179|FG001|Overall Study|Lack of Efficacy|8|||
155677818|NCT02819297|561910178|FG000|Overall Study|Protocol Violation|1|||
155677819|NCT02819297|561910179|FG001|Overall Study|Protocol Violation|2|||
155677820|NCT01670279|561910180|FG000|Overall Study|Adverse Event|0|||
155677821|NCT01670279|561910181|FG001|Overall Study|Adverse Event|1|||
155677822|NCT01670279|561910182|FG002|Overall Study|Adverse Event|0|||
155677823|NCT01670279|561910183|FG003|Overall Study|Adverse Event|0|||
155677824|NCT01670279|561910180|FG000|Overall Study|Physician Decision|0|||
155677825|NCT01670279|561910181|FG001|Overall Study|Physician Decision|1|||
155677826|NCT01670279|561910182|FG002|Overall Study|Physician Decision|0|||
155677827|NCT01670279|561910183|FG003|Overall Study|Physician Decision|0|||
155677828|NCT01670279|561910180|FG000|Overall Study|Participant met withdrawal criteria|0|||
155677829|NCT01670279|561910181|FG001|Overall Study|Participant met withdrawal criteria|0|||
155677830|NCT01670279|561910182|FG002|Overall Study|Participant met withdrawal criteria|0|||
155677831|NCT01670279|561910183|FG003|Overall Study|Participant met withdrawal criteria|1|||
155677832|NCT01901614|561910186|FG000|Overall Study|Adverse Event|0|||
155677833|NCT01901614|561910187|FG001|Overall Study|Adverse Event|1|||
155677834|NCT01901614|561910186|FG000|Overall Study|Lost to Follow-up|1|||
155677835|NCT01901614|561910187|FG001|Overall Study|Lost to Follow-up|0|||
155677836|NCT01901614|561910186|FG000|Overall Study|Screen Fail|1|||
155677837|NCT01901614|561910187|FG001|Overall Study|Screen Fail|0|||
155677838|NCT03629223|561910188|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
155677839|NCT03629223|561910189|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
155677840|NCT03629223|561910190|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
155677841|NCT03629223|561910191|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
155677842|NCT03629223|561910192|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
155677843|NCT03629223|561910193|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
155677844|NCT03629223|561910188|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155677845|NCT03629223|561910189|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155677846|NCT03629223|561910190|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155677847|NCT03629223|561910191|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
155677848|NCT03629223|561910192|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155677849|NCT03629223|561910193|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155677850|NCT03629223|561910188|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155677851|NCT03629223|561910189|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
155677852|NCT03629223|561910190|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155677853|NCT03629223|561910191|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155677854|NCT03629223|561910192|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155677855|NCT03629223|561910193|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155677856|NCT03629223|561910188|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155677857|NCT03629223|561910189|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
155677858|NCT03629223|561910190|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155677859|NCT03629223|561910191|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155677860|NCT03629223|561910192|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155677861|NCT03629223|561910193|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155677862|NCT03629223|561910188|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
155677863|NCT03629223|561910189|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155677864|NCT03629223|561910190|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155677865|NCT03629223|561910191|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155677866|NCT03629223|561910192|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155677867|NCT03629223|561910193|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155677868|NCT01555073|561910194|FG000|Overall Study|Lost to Follow-up|1|||
155677869|NCT01555073|561910195|FG001|Overall Study|Lost to Follow-up|2|||
155677870|NCT01555073|561910196|FG002|Overall Study|Lost to Follow-up|0|||
155677871|NCT01555073|561910197|FG003|Overall Study|Lost to Follow-up|5|||
155677872|NCT02027311|561910198|FG000|Overall Study|Protocol Violation|3|||
155677873|NCT02027311|561910199|FG001|Overall Study|Protocol Violation|2|||
155677874|NCT03928418|561910200|FG000|Overall Study|Lost to Follow-up|5|||
155677875|NCT03928418|561910201|FG001|Overall Study|Lost to Follow-up|3|||
155677876|NCT03928418|561910202|FG002|Overall Study|Lost to Follow-up|5|||
155677877|NCT03928418|561910200|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
155677878|NCT03928418|561910201|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
155600875|NCT03045276|561626285|FG001|Intervention Phase|Developed exclusionary criteria|3|||
155600876|NCT03045276|561626286|FG002|Intervention Phase|Developed exclusionary criteria|0|||
155600877|NCT03045276|561626287|FG003|Intervention Phase|Developed exclusionary criteria|0|||
155600878|NCT03045276|561626284|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
155600879|NCT03045276|561626285|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
155600880|NCT03045276|561626286|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
155600881|NCT03045276|561626287|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
155600882|NCT03045276|561626284|FG000|Follow-Up Phase|Lost to Follow-up|0|||
155600883|NCT03045276|561626285|FG001|Follow-Up Phase|Lost to Follow-up|1|||
155600884|NCT03045276|561626286|FG002|Follow-Up Phase|Lost to Follow-up|0|||
155600885|NCT03045276|561626287|FG003|Follow-Up Phase|Lost to Follow-up|1|||
155600886|NCT03045276|561626284|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
155600887|NCT03045276|561626285|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
155600888|NCT03045276|561626286|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
155600889|NCT03045276|561626287|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
155600890|NCT03003494|561626296|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
155600891|NCT00794040|561626297|FG000|Overall Study|Withdrawal by Subject|3|||
155600892|NCT00794040|561626298|FG001|Overall Study|Withdrawal by Subject|4|||
155600893|NCT00794040|561626297|FG000|Overall Study|Physician Decision|0|||
155600894|NCT00794040|561626298|FG001|Overall Study|Physician Decision|1|||
155600895|NCT04696354|561626299|FG000|Overall Study|Study termination|6|||
155600896|NCT04696354|561626300|FG001|Overall Study|Study termination|6|||
155600897|NCT03005327|561626301|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155600898|NCT03005327|561626302|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155600899|NCT03005327|561626303|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
155600900|NCT03005327|561626304|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155600901|NCT03005327|561626301|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155600902|NCT03005327|561626302|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155677879|NCT03928418|561910202|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
155600903|NCT03005327|561626303|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155600904|NCT03005327|561626304|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155600905|NCT01263782|561626306|FG000|Overall Study|Death|0|||
155600906|NCT01263782|561626307|FG001|Overall Study|Death|0|||
155600907|NCT01263782|561626308|FG002|Overall Study|Death|1|||
155600908|NCT01263782|561626309|FG003|Overall Study|Death|0|||
155600909|NCT01263782|561626306|FG000|Overall Study|Progressive disease|0|||
155600910|NCT01263782|561626307|FG001|Overall Study|Progressive disease|0|||
155600911|NCT01263782|561626308|FG002|Overall Study|Progressive disease|0|||
155600912|NCT01263782|561626309|FG003|Overall Study|Progressive disease|1|||
155600913|NCT01263782|561626306|FG000|Overall Study|Too early|0|||
155600914|NCT01263782|561626307|FG001|Overall Study|Too early|0|||
155600915|NCT01263782|561626308|FG002|Overall Study|Too early|1|||
155600916|NCT01263782|561626309|FG003|Overall Study|Too early|0|||
155600917|NCT01263782|561626306|FG000|Overall Study|Inevaluable|0|||
155600918|NCT01263782|561626307|FG001|Overall Study|Inevaluable|0|||
155600919|NCT01263782|561626308|FG002|Overall Study|Inevaluable|1|||
155600920|NCT01263782|561626309|FG003|Overall Study|Inevaluable|0|||
155600921|NCT04545567|561626313|FG000|Overall Study|tested positive for SARS-co-V2|1|||
155600922|NCT04545567|561626314|FG001|Overall Study|tested positive for SARS-co-V2|1|||
155600923|NCT04545567|561626313|FG000|Overall Study|Withdrawal by Subject|0|||
155600924|NCT04545567|561626314|FG001|Overall Study|Withdrawal by Subject|1|||
155600925|NCT02000882|561628300|FG000|Overall Study|Adverse Event|3|||
155600926|NCT02000882|561628300|FG000|Overall Study|Physician Decision|2|||
155600927|NCT02000882|561628300|FG000|Overall Study|Withdrawal by Subject|1|||
155600928|NCT02417961|561628304|FG000|Overall Study|Adverse Event|1|||
155600929|NCT02417961|561628304|FG000|Overall Study|Lost to Follow-up|1|||
155600930|NCT02417961|561628304|FG000|Overall Study|Withdrawal by Subject|2|||
155600931|NCT01390428|561628305|FG000|Overall Study|Elective Surgery|0|||
155600932|NCT01390428|561628306|FG001|Overall Study|Elective Surgery|0|||
155600933|NCT01390428|561628307|FG002|Overall Study|Elective Surgery|0|||
155600934|NCT01390428|561628308|FG003|Overall Study|Elective Surgery|0|||
155600935|NCT01390428|561628309|FG004|Overall Study|Elective Surgery|1|||
155600936|NCT01390428|561628310|FG005|Overall Study|Elective Surgery|0|||
155600937|NCT01390428|561628305|FG000|Overall Study|Withdrawal by Subject|0|||
155600938|NCT01390428|561628306|FG001|Overall Study|Withdrawal by Subject|0|||
155600939|NCT01390428|561628307|FG002|Overall Study|Withdrawal by Subject|1|||
155600940|NCT01390428|561628308|FG003|Overall Study|Withdrawal by Subject|0|||
155600941|NCT01390428|561628309|FG004|Overall Study|Withdrawal by Subject|0|||
155600942|NCT01390428|561628310|FG005|Overall Study|Withdrawal by Subject|0|||
155600943|NCT05079750|561628311|FG000|Overall Study|Lost to Follow-up|0|||
155600944|NCT05079750|561628312|FG001|Overall Study|Lost to Follow-up|0|||
155600945|NCT05079750|561628313|FG002|Overall Study|Lost to Follow-up|1|||
155600946|NCT05091346|561628316|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
155600947|NCT05091346|561628317|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
155600948|NCT05091346|561628318|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
155600949|NCT05091346|561628319|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
155600950|NCT05091346|561628320|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
155600951|NCT05091346|561628316|FG000|Overall Study|Death|6|||
155600952|NCT05091346|561628317|FG001|Overall Study|Death|5|||
155600953|NCT05091346|561628318|FG002|Overall Study|Death|8|||
155600954|NCT05091346|561628319|FG003|Overall Study|Death|16|||
155600955|NCT05091346|561628320|FG004|Overall Study|Death|26|||
155600956|NCT05091346|561628316|FG000|Overall Study|Lost to Follow-up|0|||
155600957|NCT05091346|561628317|FG001|Overall Study|Lost to Follow-up|0|||
155600958|NCT05091346|561628318|FG002|Overall Study|Lost to Follow-up|0|||
155600959|NCT05091346|561628319|FG003|Overall Study|Lost to Follow-up|1|||
155600960|NCT05091346|561628320|FG004|Overall Study|Lost to Follow-up|0|||
155600961|NCT05091346|561628316|FG000|Overall Study|Withdrawal by Subject|0|||
155600962|NCT05091346|561628317|FG001|Overall Study|Withdrawal by Subject|1|||
155600963|NCT05091346|561628318|FG002|Overall Study|Withdrawal by Subject|2|||
155600964|NCT05091346|561628319|FG003|Overall Study|Withdrawal by Subject|2|||
155600965|NCT05091346|561628320|FG004|Overall Study|Withdrawal by Subject|1|||
155600966|NCT05897827|561628321|FG000|Overall Study|Lost to Follow-up|33|||
155600967|NCT05897827|561628322|FG001|Overall Study|Lost to Follow-up|14|||
155600968|NCT05897827|561628321|FG000|Overall Study|Withdrawal by Subject|1|||
155600969|NCT05897827|561628322|FG001|Overall Study|Withdrawal by Subject|1|||
155600970|NCT03569293|561628323|FG000|Overall Study|Adverse Event|4|||
155600971|NCT03569293|561628324|FG001|Overall Study|Adverse Event|1|||
155600972|NCT03569293|561628325|FG002|Overall Study|Adverse Event|5|||
155600973|NCT03569293|561628326|FG003|Overall Study|Adverse Event|1|||
155600974|NCT03569293|561628327|FG004|Overall Study|Adverse Event|0|||
155600975|NCT03569293|561628328|FG005|Overall Study|Adverse Event|0|||
155600976|NCT03569293|561628323|FG000|Overall Study|Withdrawal by Subject|16|||
155600977|NCT03569293|561628324|FG001|Overall Study|Withdrawal by Subject|2|||
155600978|NCT03569293|561628325|FG002|Overall Study|Withdrawal by Subject|4|||
155600979|NCT03569293|561628326|FG003|Overall Study|Withdrawal by Subject|1|||
155600980|NCT03569293|561628327|FG004|Overall Study|Withdrawal by Subject|0|||
155600981|NCT03569293|561628328|FG005|Overall Study|Withdrawal by Subject|0|||
155600982|NCT03569293|561628323|FG000|Overall Study|Lost to Follow-up|1|||
155600983|NCT03569293|561628324|FG001|Overall Study|Lost to Follow-up|3|||
155600984|NCT03569293|561628325|FG002|Overall Study|Lost to Follow-up|1|||
155600985|NCT03569293|561628326|FG003|Overall Study|Lost to Follow-up|1|||
155600986|NCT03569293|561628327|FG004|Overall Study|Lost to Follow-up|0|||
155600987|NCT03569293|561628328|FG005|Overall Study|Lost to Follow-up|0|||
155600988|NCT03569293|561628323|FG000|Overall Study|Other|8|||
155600989|NCT03569293|561628324|FG001|Overall Study|Other|2|||
155600990|NCT03569293|561628325|FG002|Overall Study|Other|1|||
155600991|NCT03569293|561628326|FG003|Overall Study|Other|1|||
155600992|NCT03569293|561628327|FG004|Overall Study|Other|0|||
155600993|NCT03569293|561628328|FG005|Overall Study|Other|0|||
155600994|NCT03569293|561628323|FG000|Overall Study|Ongoing at Time of Analysis|8|||
155600995|NCT03569293|561628324|FG001|Overall Study|Ongoing at Time of Analysis|1|||
155600996|NCT03569293|561628325|FG002|Overall Study|Ongoing at Time of Analysis|3|||
155600997|NCT03569293|561628326|FG003|Overall Study|Ongoing at Time of Analysis|0|||
155600998|NCT03569293|561628327|FG004|Overall Study|Ongoing at Time of Analysis|0|||
155600999|NCT03569293|561628328|FG005|Overall Study|Ongoing at Time of Analysis|0|||
155601000|NCT02059434|561628342|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
155601001|NCT02059434|561628343|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
155601002|NCT02059434|561628344|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
155601003|NCT02059434|561628345|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
155601004|NCT02059434|561628346|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
155601005|NCT02059434|561628347|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
155601006|NCT02059434|561628348|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
155601007|NCT02059434|561628349|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
155601008|NCT02059434|561628350|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
155601009|NCT02059434|561628342|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
155601010|NCT02059434|561628343|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
155601011|NCT02059434|561628344|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
155601012|NCT02059434|561628345|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
155601013|NCT02059434|561628346|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
155601014|NCT02059434|561628347|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
155601015|NCT02059434|561628348|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
155601016|NCT02059434|561628349|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
155601017|NCT02059434|561628350|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
155601018|NCT02059434|561628342|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
155601019|NCT02059434|561628343|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
155601020|NCT02059434|561628344|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
155601021|NCT02059434|561628345|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
155601022|NCT02059434|561628346|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
155601023|NCT02059434|561628347|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
155601024|NCT02059434|561628348|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
155601025|NCT02059434|561628349|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
155601026|NCT02059434|561628350|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
155601027|NCT02059434|561628342|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
155601028|NCT02059434|561628343|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
155601029|NCT02059434|561628344|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
155601030|NCT02059434|561628345|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
155601031|NCT02059434|561628346|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
155601032|NCT02059434|561628347|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
155601033|NCT02059434|561628348|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
155601034|NCT02059434|561628349|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
155601035|NCT02059434|561628350|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
155601036|NCT02059434|561628342|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601037|NCT02059434|561628343|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601038|NCT02059434|561628344|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601039|NCT02059434|561628345|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601040|NCT02059434|561628346|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601041|NCT02059434|561628347|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601042|NCT02059434|561628348|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601043|NCT02059434|561628349|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155601044|NCT02059434|561628350|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
155601045|NCT02928770|561628351|FG000|Overall Study|Withdrawal by Subject|2|||
155601046|NCT03201874|561628352|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
155601047|NCT03201874|561628353|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
155601048|NCT03201874|561628352|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
155601049|NCT03201874|561628353|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
155601050|NCT05128773|561628364|FG000|Overall Study|Sponsor decision to terminate study|3|||
155601051|NCT04250714|561628365|FG000|Overall Study|Treatment - withdrawal by subject|14|||
155601052|NCT04250714|561628365|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
155601053|NCT04250714|561628365|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
155601054|NCT04250714|561628365|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
155601055|NCT04250714|561628365|FG000|Overall Study|Treatment - Death|1|||
155601056|NCT04250714|561628365|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
155601057|NCT04250714|561628365|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
155601058|NCT04250714|561628365|FG000|Overall Study|Attempt|2|||
155601059|NCT04250714|561628365|FG000|Overall Study|Intent|7|||
155601060|NCT04697056|561628366|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
155601061|NCT04697056|561628367|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
155601062|NCT03617861|561628368|FG000|Second Intervention (1 Day)|Adverse Event|0|||
155601063|NCT03617861|561628369|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155601064|NCT03617861|561628370|FG002|Second Intervention (1 Day)|Adverse Event|1|||
155601065|NCT03617861|561628371|FG003|Second Intervention (1 Day)|Adverse Event|0|||
155601066|NCT00345878|561628372|FG000|Overall Study|Adverse Event|1|||
155601067|NCT00345878|561628373|FG001|Overall Study|Adverse Event|0|||
155601068|NCT00345878|561628372|FG000|Overall Study|Lost to Follow-up|2|||
155601069|NCT00345878|561628373|FG001|Overall Study|Lost to Follow-up|1|||
155601070|NCT00345878|561628372|FG000|Overall Study|Other|1|||
155601071|NCT00345878|561628373|FG001|Overall Study|Other|0|||
155601072|NCT00308750|561628374|FG000|Overall Study|Adverse Event|9|||
155601073|NCT00308750|561628375|FG001|Overall Study|Adverse Event|9|||
155601074|NCT00308750|561628376|FG002|Overall Study|Adverse Event|13|||
155601075|NCT00308750|561628374|FG000|Overall Study|Withdrawal by Subject|6|||
155601076|NCT00308750|561628375|FG001|Overall Study|Withdrawal by Subject|2|||
155601077|NCT00308750|561628376|FG002|Overall Study|Withdrawal by Subject|3|||
155601078|NCT00308750|561628374|FG000|Overall Study|Physician Decision|3|||
155601079|NCT00308750|561628375|FG001|Overall Study|Physician Decision|4|||
155601080|NCT00308750|561628376|FG002|Overall Study|Physician Decision|3|||
155601081|NCT00308750|561628374|FG000|Overall Study|Sponsor Decision|1|||
155601082|NCT00308750|561628375|FG001|Overall Study|Sponsor Decision|0|||
155601083|NCT00308750|561628376|FG002|Overall Study|Sponsor Decision|0|||
155601084|NCT00308750|561628374|FG000|Overall Study|Disease Progression|47|||
155601085|NCT00308750|561628375|FG001|Overall Study|Disease Progression|24|||
155601086|NCT00308750|561628376|FG002|Overall Study|Disease Progression|28|||
155601087|NCT00308750|561628374|FG000|Overall Study|Unrelated Complication|3|||
155601088|NCT00308750|561628375|FG001|Overall Study|Unrelated Complication|0|||
155601089|NCT00308750|561628376|FG002|Overall Study|Unrelated Complication|1|||
155601090|NCT00308750|561628374|FG000|Overall Study|Death|1|||
155601091|NCT00308750|561628375|FG001|Overall Study|Death|0|||
155601092|NCT00308750|561628376|FG002|Overall Study|Death|1|||
155601093|NCT00308750|561628374|FG000|Overall Study|Protocol Violation|1|||
155601094|NCT00308750|561628375|FG001|Overall Study|Protocol Violation|0|||
155601095|NCT00308750|561628376|FG002|Overall Study|Protocol Violation|0|||
155601096|NCT00308750|561628374|FG000|Overall Study|New Primary Disease Identified|1|||
155601097|NCT00308750|561628375|FG001|Overall Study|New Primary Disease Identified|1|||
155601098|NCT00308750|561628376|FG002|Overall Study|New Primary Disease Identified|0|||
155677880|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
155677881|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
155677882|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
155677883|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
155677884|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Death|58|||
155677885|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Death|65|||
155677886|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Adverse Event|28|||
155677887|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Adverse Event|40|||
155677888|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Disease Progression|22|||
155677889|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Disease Progression|35|||
155677890|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Other|25|||
155677891|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Other|33|||
155677892|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
155677893|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
155677894|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Noncompliance|8|||
155677895|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Noncompliance|8|||
155677896|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
155677897|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
155677898|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
155677899|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
155677900|NCT00286091|561910212|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
155677901|NCT00286091|561910213|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
155677902|NCT00286091|561910212|FG000|Open-label Treatment Phase|Physician Decision|24|||
155677903|NCT00286091|561910213|FG001|Open-label Treatment Phase|Physician Decision|21|||
155677904|NCT00286091|561910212|FG000|Open-label Treatment Phase|Adverse Event|5|||
155677905|NCT00286091|561910213|FG001|Open-label Treatment Phase|Adverse Event|16|||
155677906|NCT00286091|561910212|FG000|Open-label Treatment Phase|Other|11|||
155677907|NCT00286091|561910213|FG001|Open-label Treatment Phase|Other|11|||
155677908|NCT00286091|561910212|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
155677909|NCT00286091|561910213|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
155677910|NCT00286091|561910212|FG000|Open-label Treatment Phase|Death|10|||
155677911|NCT00286091|561910213|FG001|Open-label Treatment Phase|Death|7|||
155677912|NCT00286091|561910212|FG000|Open-label Treatment Phase|Disease Progression|9|||
155677913|NCT00286091|561910213|FG001|Open-label Treatment Phase|Disease Progression|3|||
155677914|NCT00286091|561910212|FG000|Open-label Treatment Phase|Noncompliance|3|||
155677915|NCT00286091|561910213|FG001|Open-label Treatment Phase|Noncompliance|1|||
155677916|NCT00286091|561910212|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
155677917|NCT00286091|561910213|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
155677918|NCT00286091|561910212|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
155677919|NCT00286091|561910213|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
155677920|NCT00286091|561910212|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
155677921|NCT00286091|561910213|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
155677922|NCT02936869|561910214|FG000|Overall Study|Lost to Follow-up|1|||
155677923|NCT02936869|561910215|FG001|Overall Study|Lost to Follow-up|3|||
155677924|NCT02936869|561910214|FG000|Overall Study|Death|0|||
155677925|NCT02936869|561910215|FG001|Overall Study|Death|1|||
155677926|NCT02936869|561910214|FG000|Overall Study|Legal Case|0|||
155677927|NCT02936869|561910215|FG001|Overall Study|Legal Case|1|||
155677928|NCT02936869|561910214|FG000|Overall Study|Protocol Violation|1|||
155677929|NCT02936869|561910215|FG001|Overall Study|Protocol Violation|0|||
155677930|NCT03799952|561910216|FG000|Overall Study|Program was too easy, discontinued|1|||
155677931|NCT03799952|561910217|FG001|Overall Study|Program was too easy, discontinued|0|||
155677932|NCT03799952|561910216|FG000|Overall Study|Lost to Follow-up|0|||
155677933|NCT03799952|561910217|FG001|Overall Study|Lost to Follow-up|2|||
155677934|NCT04004221|561910224|FG000|Overall Study|Death|89|||
155677935|NCT04004221|561910224|FG000|Overall Study|Withdrawal by Subject|5|||
155677936|NCT04004221|561910224|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
155677937|NCT04004221|561910224|FG000|Overall Study|Sponsor Decision|9|||
155677938|NCT04004221|561910224|FG000|Overall Study|Participant refused to enter LTE|1|||
155677939|NCT03423238|561910225|FG000|Overall Study|Lost to Follow-up|1|||
155677940|NCT03423238|561910226|FG001|Overall Study|Lost to Follow-up|0|||
155677941|NCT03423238|561910225|FG000|Overall Study|Withdrawal by Subject|1|||
155677942|NCT03423238|561910226|FG001|Overall Study|Withdrawal by Subject|0|||
155677943|NCT02036580|561910230|FG000|Overall Study|Withdrawal by Subject|0|||
155677944|NCT02036580|561910231|FG001|Overall Study|Withdrawal by Subject|1|||
155677945|NCT02036580|561910232|FG002|Overall Study|Withdrawal by Subject|0|||
155677946|NCT02036580|561910230|FG000|Overall Study|Adverse Event|1|||
155677947|NCT02036580|561910231|FG001|Overall Study|Adverse Event|0|||
155677948|NCT02036580|561910232|FG002|Overall Study|Adverse Event|0|||
155677949|NCT00506454|561910233|FG000|Overall Study|Withdrawal by Subject|1|||
155677950|NCT00506454|561910234|FG001|Overall Study|Withdrawal by Subject|1|||
155677951|NCT00260832|561910235|FG000|Overall Study|Adverse Event|26|||
155677952|NCT00260832|561910236|FG001|Overall Study|Adverse Event|19|||
155677953|NCT00260832|561910235|FG000|Overall Study|Progression|116|||
155677954|NCT00260832|561910236|FG001|Overall Study|Progression|96|||
155677955|NCT00260832|561910235|FG000|Overall Study|Withdrawal by Subject|15|||
155677956|NCT00260832|561910236|FG001|Overall Study|Withdrawal by Subject|17|||
155677957|NCT00260832|561910235|FG000|Overall Study|Physician Decision|15|||
155677958|NCT00260832|561910236|FG001|Overall Study|Physician Decision|9|||
155677959|NCT00260832|561910235|FG000|Overall Study|Death|43|||
155677960|NCT00260832|561910236|FG001|Overall Study|Death|62|||
155677961|NCT00260832|561910235|FG000|Overall Study|Other|10|||
155677962|NCT00260832|561910236|FG001|Overall Study|Other|7|||
155677963|NCT00260832|561910235|FG000|Overall Study|Protocol Violation|3|||
155677964|NCT00260832|561910236|FG001|Overall Study|Protocol Violation|1|||
155677965|NCT00902850|561910237|FG000|Overall Study|Physician Decision|2|||
155677966|NCT00902850|561910238|FG001|Overall Study|Physician Decision|2|||
155677967|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
155677968|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
155677969|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155677970|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155677971|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155677972|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155677973|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155677974|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155677975|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677976|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677977|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677978|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677979|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677980|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155677981|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155677982|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
155677983|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
155677984|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155677985|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155677986|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155677987|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155677988|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155677989|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155677990|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155677991|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155677992|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155677993|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155677994|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155677995|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
155677996|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155677997|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155677998|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155677999|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155678000|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155678001|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155678002|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678003|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
155678004|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678005|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678006|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678007|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678008|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155678009|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
155678010|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
155678011|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
155678012|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155678013|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155678014|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155678015|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155678016|NCT03745638|561910239|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
155678017|NCT03745638|561910240|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
155678018|NCT03745638|561910241|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155678019|NCT03745638|561910242|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155678020|NCT03745638|561910243|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155678021|NCT03745638|561910244|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155678022|NCT03745638|561910245|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155678023|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155678024|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155678025|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155678026|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155678027|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155678028|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
155678029|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
155678030|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155678031|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155678032|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155678033|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155678034|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155678035|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155678036|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155678037|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155678038|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155678039|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155678040|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
155678041|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
155678042|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
155678043|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
155678044|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155678045|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155678046|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155678047|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155678048|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
155678049|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
155678050|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155678051|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678052|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678053|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678054|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678055|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678056|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
155678057|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155678058|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155678059|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155678060|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155678061|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
155678062|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
155678063|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
155678064|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
155678065|NCT03745638|561910239|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155678066|NCT03745638|561910240|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155678067|NCT03745638|561910241|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155678068|NCT03745638|561910242|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155678069|NCT03745638|561910243|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155678070|NCT03745638|561910244|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
155678071|NCT03745638|561910245|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
155678072|NCT02993822|561910253|FG000|Overall Study|Lack of Efficacy|1|||
155678073|NCT02993822|561910254|FG001|Overall Study|Lack of Efficacy|1|||
155678074|NCT02993822|561910255|FG002|Overall Study|Lack of Efficacy|0|||
155678075|NCT02993822|561910256|FG003|Overall Study|Lack of Efficacy|0|||
155678076|NCT02993822|561910253|FG000|Overall Study|Protocol Violation|1|||
155678077|NCT02993822|561910254|FG001|Overall Study|Protocol Violation|0|||
155678078|NCT02993822|561910255|FG002|Overall Study|Protocol Violation|0|||
155678079|NCT02993822|561910256|FG003|Overall Study|Protocol Violation|0|||
155678080|NCT02993822|561910253|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
155678081|NCT02993822|561910254|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
155678082|NCT02993822|561910255|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
155678083|NCT02993822|561910256|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
155678084|NCT02993822|561910253|FG000|Overall Study|Adverse Event|3|||
155678085|NCT02993822|561910254|FG001|Overall Study|Adverse Event|1|||
155678086|NCT02993822|561910255|FG002|Overall Study|Adverse Event|7|||
155678087|NCT02993822|561910256|FG003|Overall Study|Adverse Event|0|||
155678088|NCT02993822|561910253|FG000|Overall Study|Withdrawal by Subject|4|||
155678089|NCT02993822|561910254|FG001|Overall Study|Withdrawal by Subject|2|||
155678090|NCT02993822|561910255|FG002|Overall Study|Withdrawal by Subject|2|||
155678091|NCT02993822|561910256|FG003|Overall Study|Withdrawal by Subject|3|||
155678092|NCT02993822|561910253|FG000|Overall Study|Lost to Follow-up|1|||
155678093|NCT02993822|561910254|FG001|Overall Study|Lost to Follow-up|0|||
155678094|NCT02993822|561910255|FG002|Overall Study|Lost to Follow-up|1|||
155678095|NCT02993822|561910256|FG003|Overall Study|Lost to Follow-up|0|||
155678096|NCT01221753|561910260|FG000|Overall Study|Adverse Event|1|||
155678097|NCT01854775|561910261|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
155678098|NCT01854775|561910262|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
155678099|NCT01854775|561910263|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
155678100|NCT01854775|561910261|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
155678101|NCT01854775|561910262|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
155678102|NCT01854775|561910263|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
155678103|NCT01854775|561910261|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
155678104|NCT01854775|561910262|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
155678105|NCT01854775|561910263|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
155678106|NCT01854775|561910261|FG000|Extension Phase|Pregnancy|3|||
155678107|NCT01854775|561910262|FG001|Extension Phase|Pregnancy|0|||
155678108|NCT01854775|561910263|FG002|Extension Phase|Pregnancy|0|||
155678109|NCT01854775|561910261|FG000|Extension Phase|Investigator's Discretion|1|||
155678110|NCT01854775|561910262|FG001|Extension Phase|Investigator's Discretion|0|||
155678111|NCT01854775|561910263|FG002|Extension Phase|Investigator's Discretion|0|||
155678112|NCT01854775|561910261|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
155678113|NCT01854775|561910262|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
155678114|NCT01854775|561910263|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
155678115|NCT01854775|561910261|FG000|Extension Phase|Lost to Follow-up|2|||
155678116|NCT01854775|561910262|FG001|Extension Phase|Lost to Follow-up|0|||
155678117|NCT01854775|561910263|FG002|Extension Phase|Lost to Follow-up|0|||
155678118|NCT01854775|561910261|FG000|Extension Phase|Still on Study|32|||
155678119|NCT01854775|561910262|FG001|Extension Phase|Still on Study|47|||
155678120|NCT01854775|561910263|FG002|Extension Phase|Still on Study|18|||
155678121|NCT03135431|561910270|FG000|Overall Study|Study Surgeon not available|2|||
155678122|NCT03135431|561910271|FG001|Overall Study|Study Surgeon not available|0|||
155678123|NCT02597452|561910272|FG000|Overall Study|testing incomplete|30|||
155678124|NCT01659996|561910273|FG000|Overall Study|Protocol Violation|3|||
155678125|NCT01659996|561910274|FG001|Overall Study|Protocol Violation|3|||
155678126|NCT01659996|561910275|FG002|Overall Study|Protocol Violation|3|||
155678127|NCT01659996|561910273|FG000|Overall Study|Lost to Follow-up|1|||
155678128|NCT01659996|561910274|FG001|Overall Study|Lost to Follow-up|3|||
155678129|NCT01659996|561910275|FG002|Overall Study|Lost to Follow-up|2|||
155678130|NCT01659996|561910273|FG000|Overall Study|Adverse Event|0|||
155678131|NCT01659996|561910274|FG001|Overall Study|Adverse Event|0|||
155678132|NCT01659996|561910275|FG002|Overall Study|Adverse Event|1|||
155678133|NCT01659996|561910273|FG000|Overall Study|Withdrawal by Subject|4|||
155678134|NCT01659996|561910274|FG001|Overall Study|Withdrawal by Subject|1|||
155678135|NCT01659996|561910275|FG002|Overall Study|Withdrawal by Subject|5|||
155678136|NCT02701764|561910276|FG000|Overall Study|Lost to Follow-up|0|||
155678137|NCT02701764|561910277|FG001|Overall Study|Lost to Follow-up|1|||
155678138|NCT01170273|561910282|FG000|Overall Study|Lost to Follow-up|6|||
155678139|NCT01170273|561910283|FG001|Overall Study|Lost to Follow-up|8|||
155678140|NCT01170273|561910282|FG000|Overall Study|Protocol Violation|1|||
155678141|NCT01170273|561910283|FG001|Overall Study|Protocol Violation|0|||
155678142|NCT01170273|561910282|FG000|Overall Study|Death|1|||
155678143|NCT01170273|561910283|FG001|Overall Study|Death|0|||
155678144|NCT01170273|561910282|FG000|Overall Study|Adverse Event|0|||
155678145|NCT01170273|561910283|FG001|Overall Study|Adverse Event|1|||
155678146|NCT00875485|561911900|FG000|Challenge Dose Epoch|Pregnancy|1|||
155678147|NCT00875485|561911901|FG001|Challenge Dose Epoch|Pregnancy|0|||
155678148|NCT02908685|561911902|FG000|Part 1 OLE|Withdrawal by Subject|0|||
155678149|NCT02908685|561911903|FG001|Part 1 OLE|Withdrawal by Subject|0|||
155678150|NCT02908685|561911904|FG002|Part 1 OLE|Withdrawal by Subject|0|||
155678151|NCT02908685|561911905|FG003|Part 1 OLE|Withdrawal by Subject|0|||
155678152|NCT02908685|561911906|FG004|Part 1 OLE|Withdrawal by Subject|0|||
155678153|NCT02908685|561911907|FG005|Part 1 OLE|Withdrawal by Subject|0|||
155678154|NCT02908685|561911908|FG006|Part 1 OLE|Withdrawal by Subject|0|||
155678155|NCT02908685|561911909|FG007|Part 1 OLE|Withdrawal by Subject|0|||
155678156|NCT02908685|561911910|FG008|Part 1 OLE|Withdrawal by Subject|0|||
155678157|NCT02908685|561911911|FG009|Part 1 OLE|Withdrawal by Subject|0|||
155678158|NCT02908685|561911912|FG010|Part 1 OLE|Withdrawal by Subject|2|||
155678159|NCT02908685|561911913|FG011|Part 1 OLE|Withdrawal by Subject|1|||
155678160|NCT02908685|561911914|FG012|Part 1 OLE|Withdrawal by Subject|0|||
155678161|NCT02908685|561911915|FG013|Part 1 OLE|Withdrawal by Subject|0|||
155678162|NCT02908685|561911902|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678163|NCT02908685|561911903|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678164|NCT02908685|561911904|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678165|NCT02908685|561911905|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678166|NCT02908685|561911906|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678167|NCT02908685|561911907|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678168|NCT02908685|561911908|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678169|NCT02908685|561911909|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155601099|NCT01358578|561628377|FG000|Induction Period|Adverse Event|2|||
155601100|NCT01358578|561628378|FG001|Induction Period|Adverse Event|4|||
155601101|NCT01358578|561628379|FG002|Induction Period|Adverse Event|2|||
155601102|NCT01358578|561628380|FG003|Induction Period|Adverse Event|6|||
155601103|NCT01358578|561628381|FG004|Induction Period|Adverse Event|0|||
155601104|NCT01358578|561628382|FG005|Induction Period|Adverse Event|0|||
155601105|NCT01358578|561628377|FG000|Induction Period|Lack of Efficacy|0|||
155601106|NCT01358578|561628378|FG001|Induction Period|Lack of Efficacy|0|||
155601107|NCT01358578|561628379|FG002|Induction Period|Lack of Efficacy|9|||
155601108|NCT01358578|561628380|FG003|Induction Period|Lack of Efficacy|1|||
155601109|NCT01358578|561628381|FG004|Induction Period|Lack of Efficacy|0|||
155601110|NCT01358578|561628382|FG005|Induction Period|Lack of Efficacy|0|||
155601111|NCT01358578|561628377|FG000|Induction Period|Lost to Follow-up|0|||
155601112|NCT01358578|561628378|FG001|Induction Period|Lost to Follow-up|0|||
155601113|NCT01358578|561628379|FG002|Induction Period|Lost to Follow-up|1|||
155601114|NCT01358578|561628380|FG003|Induction Period|Lost to Follow-up|4|||
155601115|NCT01358578|561628381|FG004|Induction Period|Lost to Follow-up|0|||
155601116|NCT01358578|561628382|FG005|Induction Period|Lost to Follow-up|0|||
155601117|NCT01358578|561628377|FG000|Induction Period|Physician Decision|2|||
155601118|NCT01358578|561628378|FG001|Induction Period|Physician Decision|1|||
155601119|NCT01358578|561628379|FG002|Induction Period|Physician Decision|2|||
155601120|NCT01358578|561628380|FG003|Induction Period|Physician Decision|0|||
155601121|NCT01358578|561628381|FG004|Induction Period|Physician Decision|0|||
155601122|NCT01358578|561628382|FG005|Induction Period|Physician Decision|0|||
155601123|NCT01358578|561628377|FG000|Induction Period|Protocol Deviation|3|||
155601124|NCT01358578|561628378|FG001|Induction Period|Protocol Deviation|5|||
155601125|NCT01358578|561628379|FG002|Induction Period|Protocol Deviation|0|||
155601126|NCT01358578|561628380|FG003|Induction Period|Protocol Deviation|3|||
155678170|NCT02908685|561911910|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678171|NCT02908685|561911911|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678172|NCT02908685|561911912|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678173|NCT02908685|561911913|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155678174|NCT02908685|561911914|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
155601127|NCT01358578|561628381|FG004|Induction Period|Protocol Deviation|0|||
155601128|NCT01358578|561628382|FG005|Induction Period|Protocol Deviation|0|||
155601129|NCT01358578|561628377|FG000|Induction Period|technical problems|0|||
155601130|NCT01358578|561628378|FG001|Induction Period|technical problems|0|||
155601131|NCT01358578|561628379|FG002|Induction Period|technical problems|1|||
155601132|NCT01358578|561628380|FG003|Induction Period|technical problems|1|||
155601133|NCT01358578|561628381|FG004|Induction Period|technical problems|0|||
155601134|NCT01358578|561628382|FG005|Induction Period|technical problems|0|||
155601135|NCT01358578|561628377|FG000|Induction Period|Withdrawal by Subject|5|||
155601136|NCT01358578|561628378|FG001|Induction Period|Withdrawal by Subject|5|||
155601137|NCT01358578|561628379|FG002|Induction Period|Withdrawal by Subject|10|||
155601138|NCT01358578|561628380|FG003|Induction Period|Withdrawal by Subject|6|||
155601139|NCT01358578|561628381|FG004|Induction Period|Withdrawal by Subject|0|||
155601140|NCT01358578|561628382|FG005|Induction Period|Withdrawal by Subject|0|||
155601141|NCT01358578|561628377|FG000|Maintenance Period|Adverse Event|2|||
155601142|NCT01358578|561628378|FG001|Maintenance Period|Adverse Event|7|||
155601143|NCT01358578|561628379|FG002|Maintenance Period|Adverse Event|0|||
155601144|NCT01358578|561628380|FG003|Maintenance Period|Adverse Event|6|||
155601145|NCT01358578|561628381|FG004|Maintenance Period|Adverse Event|4|||
155601146|NCT01358578|561628382|FG005|Maintenance Period|Adverse Event|3|||
155601147|NCT01358578|561628377|FG000|Maintenance Period|Lack of Efficacy|10|||
155601148|NCT01358578|561628378|FG001|Maintenance Period|Lack of Efficacy|2|||
155601149|NCT01358578|561628379|FG002|Maintenance Period|Lack of Efficacy|0|||
155601150|NCT01358578|561628380|FG003|Maintenance Period|Lack of Efficacy|11|||
155601151|NCT01358578|561628381|FG004|Maintenance Period|Lack of Efficacy|3|||
155601152|NCT01358578|561628382|FG005|Maintenance Period|Lack of Efficacy|0|||
155601153|NCT01358578|561628377|FG000|Maintenance Period|Lost to Follow-up|4|||
155601154|NCT01358578|561628378|FG001|Maintenance Period|Lost to Follow-up|0|||
155601155|NCT01358578|561628379|FG002|Maintenance Period|Lost to Follow-up|0|||
155601156|NCT01358578|561628380|FG003|Maintenance Period|Lost to Follow-up|5|||
155678175|NCT02908685|561911915|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
155678176|NCT02908685|561911902|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678177|NCT02908685|561911903|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678178|NCT02908685|561911904|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678179|NCT02908685|561911905|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678180|NCT02908685|561911906|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678181|NCT02908685|561911907|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678182|NCT02908685|561911908|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678183|NCT02908685|561911909|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678184|NCT02908685|561911910|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678185|NCT02908685|561911911|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155601157|NCT01358578|561628381|FG004|Maintenance Period|Lost to Follow-up|1|||
155601158|NCT01358578|561628382|FG005|Maintenance Period|Lost to Follow-up|1|||
155601159|NCT01358578|561628377|FG000|Maintenance Period|Non-compliance with study treatment|3|||
155601160|NCT01358578|561628378|FG001|Maintenance Period|Non-compliance with study treatment|1|||
155601161|NCT01358578|561628379|FG002|Maintenance Period|Non-compliance with study treatment|0|||
155601162|NCT01358578|561628380|FG003|Maintenance Period|Non-compliance with study treatment|2|||
155601163|NCT01358578|561628381|FG004|Maintenance Period|Non-compliance with study treatment|1|||
155601164|NCT01358578|561628382|FG005|Maintenance Period|Non-compliance with study treatment|2|||
155678186|NCT02908685|561911912|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678187|NCT02908685|561911913|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678188|NCT02908685|561911914|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
155678189|NCT02908685|561911915|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155678190|NCT02908685|561911902|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678191|NCT02908685|561911903|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678192|NCT02908685|561911904|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678193|NCT02908685|561911905|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678194|NCT02908685|561911906|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678195|NCT02908685|561911907|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678196|NCT02908685|561911908|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678197|NCT02908685|561911909|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678198|NCT02908685|561911910|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678199|NCT02908685|561911911|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678200|NCT02908685|561911912|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678201|NCT02908685|561911913|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678202|NCT02908685|561911914|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
155678203|NCT02908685|561911915|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155678204|NCT02908685|561911902|FG000|Part 2 OLE: > Month 24|Death|0|||
155601165|NCT01358578|561628377|FG000|Maintenance Period|Physician Decision|0|||
155601166|NCT01358578|561628378|FG001|Maintenance Period|Physician Decision|1|||
155601167|NCT01358578|561628379|FG002|Maintenance Period|Physician Decision|0|||
155601168|NCT01358578|561628380|FG003|Maintenance Period|Physician Decision|1|||
155678205|NCT02908685|561911903|FG001|Part 2 OLE: > Month 24|Death|0|||
155678206|NCT02908685|561911904|FG002|Part 2 OLE: > Month 24|Death|0|||
155678207|NCT02908685|561911905|FG003|Part 2 OLE: > Month 24|Death|0|||
155678208|NCT02908685|561911906|FG004|Part 2 OLE: > Month 24|Death|0|||
155678209|NCT02908685|561911907|FG005|Part 2 OLE: > Month 24|Death|0|||
155678210|NCT02908685|561911908|FG006|Part 2 OLE: > Month 24|Death|0|||
155678211|NCT02908685|561911909|FG007|Part 2 OLE: > Month 24|Death|0|||
155678212|NCT02908685|561911910|FG008|Part 2 OLE: > Month 24|Death|0|||
155678213|NCT02908685|561911911|FG009|Part 2 OLE: > Month 24|Death|0|||
155678214|NCT02908685|561911912|FG010|Part 2 OLE: > Month 24|Death|0|||
155678215|NCT02908685|561911913|FG011|Part 2 OLE: > Month 24|Death|0|||
155678216|NCT02908685|561911914|FG012|Part 2 OLE: > Month 24|Death|1|||
155678217|NCT02908685|561911915|FG013|Part 2 OLE: > Month 24|Death|0|||
155678218|NCT02908685|561911902|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
155678219|NCT02908685|561911903|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
155678220|NCT02908685|561911904|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
155678221|NCT02908685|561911905|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
155678222|NCT02908685|561911906|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
155678223|NCT02908685|561911907|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
155678224|NCT02908685|561911908|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
155678225|NCT02908685|561911909|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
155678226|NCT02908685|561911910|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
155678227|NCT02908685|561911911|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
155678228|NCT02908685|561911912|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
155678229|NCT02908685|561911913|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
155678230|NCT02908685|561911914|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
155678231|NCT02908685|561911915|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
155678232|NCT02908685|561911902|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678233|NCT02908685|561911903|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678234|NCT02908685|561911904|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678235|NCT02908685|561911905|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678236|NCT02908685|561911906|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678237|NCT02908685|561911907|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678238|NCT02908685|561911908|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678239|NCT02908685|561911909|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678240|NCT02908685|561911910|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678241|NCT02908685|561911911|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678242|NCT02908685|561911912|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678243|NCT02908685|561911913|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155678244|NCT02908685|561911914|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
155678245|NCT02908685|561911915|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
155678246|NCT02954406|561911916|FG000|Overall Study|Adverse Event|0|||
155678247|NCT02954406|561911917|FG001|Overall Study|Adverse Event|1|||
155601169|NCT01358578|561628381|FG004|Maintenance Period|Physician Decision|0|||
155601170|NCT01358578|561628382|FG005|Maintenance Period|Physician Decision|0|||
155601171|NCT01358578|561628377|FG000|Maintenance Period|Pregnancy|1|||
155601172|NCT01358578|561628378|FG001|Maintenance Period|Pregnancy|0|||
155601173|NCT01358578|561628379|FG002|Maintenance Period|Pregnancy|0|||
155601174|NCT01358578|561628380|FG003|Maintenance Period|Pregnancy|0|||
155601175|NCT01358578|561628381|FG004|Maintenance Period|Pregnancy|0|||
155601176|NCT01358578|561628382|FG005|Maintenance Period|Pregnancy|0|||
155601177|NCT01358578|561628377|FG000|Maintenance Period|Protocol deviation|7|||
155601178|NCT01358578|561628378|FG001|Maintenance Period|Protocol deviation|4|||
155678248|NCT02954406|561911918|FG002|Overall Study|Adverse Event|0|||
155678249|NCT02954406|561911919|FG003|Overall Study|Adverse Event|0|||
155678250|NCT02954406|561911920|FG004|Overall Study|Adverse Event|1|||
155601179|NCT01358578|561628379|FG002|Maintenance Period|Protocol deviation|0|||
155601180|NCT01358578|561628380|FG003|Maintenance Period|Protocol deviation|2|||
155601181|NCT01358578|561628381|FG004|Maintenance Period|Protocol deviation|2|||
155601182|NCT01358578|561628382|FG005|Maintenance Period|Protocol deviation|2|||
155601183|NCT01358578|561628377|FG000|Maintenance Period|Withdrawal by Subject|12|||
155601184|NCT01358578|561628378|FG001|Maintenance Period|Withdrawal by Subject|7|||
155601185|NCT01358578|561628379|FG002|Maintenance Period|Withdrawal by Subject|2|||
155678251|NCT02954406|561911921|FG005|Overall Study|Adverse Event|0|||
155678252|NCT02954406|561911922|FG006|Overall Study|Adverse Event|0|||
155601186|NCT01358578|561628380|FG003|Maintenance Period|Withdrawal by Subject|15|||
155601187|NCT01358578|561628381|FG004|Maintenance Period|Withdrawal by Subject|6|||
155601188|NCT01358578|561628382|FG005|Maintenance Period|Withdrawal by Subject|3|||
155601189|NCT01358578|561628377|FG000|Follow-up Period|Adverse Event|1|||
155678253|NCT02954406|561911923|FG007|Overall Study|Adverse Event|0|||
155678254|NCT02954406|561911924|FG008|Overall Study|Adverse Event|1|||
155678255|NCT02954406|561911925|FG009|Overall Study|Adverse Event|1|||
155678256|NCT02954406|561911926|FG010|Overall Study|Adverse Event|0|||
155678257|NCT02954406|561911916|FG000|Overall Study|Progressive Disease|3|||
155678258|NCT02954406|561911917|FG001|Overall Study|Progressive Disease|4|||
155678259|NCT02954406|561911918|FG002|Overall Study|Progressive Disease|3|||
155678260|NCT02954406|561911919|FG003|Overall Study|Progressive Disease|4|||
155678261|NCT02954406|561911920|FG004|Overall Study|Progressive Disease|3|||
155678262|NCT02954406|561911921|FG005|Overall Study|Progressive Disease|3|||
155678263|NCT02954406|561911922|FG006|Overall Study|Progressive Disease|2|||
155678264|NCT02954406|561911923|FG007|Overall Study|Progressive Disease|2|||
155678265|NCT02954406|561911924|FG008|Overall Study|Progressive Disease|1|||
155678266|NCT02954406|561911925|FG009|Overall Study|Progressive Disease|1|||
155678267|NCT02954406|561911926|FG010|Overall Study|Progressive Disease|0|||
155678268|NCT02954406|561911916|FG000|Overall Study|Symptomatic Deterioration|0|||
155678269|NCT02954406|561911917|FG001|Overall Study|Symptomatic Deterioration|1|||
155678270|NCT02954406|561911918|FG002|Overall Study|Symptomatic Deterioration|0|||
155678271|NCT02954406|561911919|FG003|Overall Study|Symptomatic Deterioration|0|||
155678272|NCT02954406|561911920|FG004|Overall Study|Symptomatic Deterioration|0|||
155678273|NCT02954406|561911921|FG005|Overall Study|Symptomatic Deterioration|0|||
155678274|NCT02954406|561911922|FG006|Overall Study|Symptomatic Deterioration|0|||
155678275|NCT02954406|561911923|FG007|Overall Study|Symptomatic Deterioration|0|||
155601190|NCT01358578|561628378|FG001|Follow-up Period|Adverse Event|1|||
155601191|NCT01358578|561628379|FG002|Follow-up Period|Adverse Event|0|||
155601192|NCT01358578|561628380|FG003|Follow-up Period|Adverse Event|0|||
155601193|NCT01358578|561628381|FG004|Follow-up Period|Adverse Event|0|||
155601194|NCT01358578|561628382|FG005|Follow-up Period|Adverse Event|0|||
155601195|NCT01358578|561628377|FG000|Follow-up Period|Lack of Efficacy|3|||
155601196|NCT01358578|561628378|FG001|Follow-up Period|Lack of Efficacy|0|||
155601197|NCT01358578|561628379|FG002|Follow-up Period|Lack of Efficacy|4|||
155601198|NCT01358578|561628380|FG003|Follow-up Period|Lack of Efficacy|1|||
155601199|NCT01358578|561628381|FG004|Follow-up Period|Lack of Efficacy|0|||
155601200|NCT01358578|561628382|FG005|Follow-up Period|Lack of Efficacy|0|||
155601201|NCT01358578|561628377|FG000|Follow-up Period|Lost to Follow-up|0|||
155601202|NCT01358578|561628378|FG001|Follow-up Period|Lost to Follow-up|1|||
155601203|NCT01358578|561628379|FG002|Follow-up Period|Lost to Follow-up|0|||
155601204|NCT01358578|561628380|FG003|Follow-up Period|Lost to Follow-up|4|||
155601205|NCT01358578|561628381|FG004|Follow-up Period|Lost to Follow-up|0|||
155601206|NCT01358578|561628382|FG005|Follow-up Period|Lost to Follow-up|0|||
155601207|NCT01358578|561628377|FG000|Follow-up Period|non- compliance with study treatment|1|||
155601208|NCT01358578|561628378|FG001|Follow-up Period|non- compliance with study treatment|0|||
155601209|NCT01358578|561628379|FG002|Follow-up Period|non- compliance with study treatment|0|||
155601210|NCT01358578|561628380|FG003|Follow-up Period|non- compliance with study treatment|0|||
155601211|NCT01358578|561628381|FG004|Follow-up Period|non- compliance with study treatment|0|||
155601212|NCT01358578|561628382|FG005|Follow-up Period|non- compliance with study treatment|0|||
155601213|NCT01358578|561628377|FG000|Follow-up Period|Pregnancy|1|||
155601214|NCT01358578|561628378|FG001|Follow-up Period|Pregnancy|0|||
155601215|NCT01358578|561628379|FG002|Follow-up Period|Pregnancy|0|||
155601216|NCT01358578|561628380|FG003|Follow-up Period|Pregnancy|0|||
155678276|NCT02954406|561911924|FG008|Overall Study|Symptomatic Deterioration|0|||
155678277|NCT02954406|561911925|FG009|Overall Study|Symptomatic Deterioration|0|||
155678278|NCT02954406|561911926|FG010|Overall Study|Symptomatic Deterioration|0|||
155678279|NCT02954406|561911916|FG000|Overall Study|Death|0|||
155678280|NCT02954406|561911917|FG001|Overall Study|Death|0|||
155678281|NCT02954406|561911918|FG002|Overall Study|Death|0|||
155678282|NCT02954406|561911919|FG003|Overall Study|Death|0|||
155678283|NCT02954406|561911920|FG004|Overall Study|Death|1|||
155678284|NCT02954406|561911921|FG005|Overall Study|Death|0|||
155678285|NCT02954406|561911922|FG006|Overall Study|Death|0|||
155678286|NCT02954406|561911923|FG007|Overall Study|Death|0|||
155678287|NCT02954406|561911924|FG008|Overall Study|Death|1|||
155678288|NCT02954406|561911925|FG009|Overall Study|Death|1|||
155601217|NCT01358578|561628381|FG004|Follow-up Period|Pregnancy|0|||
155601218|NCT01358578|561628382|FG005|Follow-up Period|Pregnancy|0|||
155678289|NCT02954406|561911926|FG010|Overall Study|Death|0|||
155678290|NCT02954406|561911916|FG000|Overall Study|Reason Not Specified|0|||
155678291|NCT02954406|561911917|FG001|Overall Study|Reason Not Specified|0|||
155678292|NCT02954406|561911918|FG002|Overall Study|Reason Not Specified|3|||
155601219|NCT01358578|561628377|FG000|Follow-up Period|Withdrawal by Subject|3|||
155601220|NCT01358578|561628378|FG001|Follow-up Period|Withdrawal by Subject|3|||
155601221|NCT01358578|561628379|FG002|Follow-up Period|Withdrawal by Subject|1|||
155601222|NCT01358578|561628380|FG003|Follow-up Period|Withdrawal by Subject|12|||
155678293|NCT02954406|561911919|FG003|Overall Study|Reason Not Specified|2|||
155678294|NCT02954406|561911920|FG004|Overall Study|Reason Not Specified|2|||
155678295|NCT02954406|561911921|FG005|Overall Study|Reason Not Specified|0|||
155678296|NCT02954406|561911922|FG006|Overall Study|Reason Not Specified|1|||
155678297|NCT02954406|561911923|FG007|Overall Study|Reason Not Specified|0|||
155678298|NCT02954406|561911924|FG008|Overall Study|Reason Not Specified|1|||
155678299|NCT02954406|561911925|FG009|Overall Study|Reason Not Specified|0|||
155678300|NCT02954406|561911926|FG010|Overall Study|Reason Not Specified|0|||
155678301|NCT00782171|561911927|FG000|Overall Study|Lost to Follow-up|2|||
155678302|NCT00782171|561911928|FG001|Overall Study|Lost to Follow-up|2|||
155678303|NCT00782171|561911927|FG000|Overall Study|Withdrawal by Subject|2|||
155678304|NCT00782171|561911928|FG001|Overall Study|Withdrawal by Subject|1|||
155678305|NCT00782171|561911927|FG000|Overall Study|complications|3|||
155678306|NCT00782171|561911928|FG001|Overall Study|complications|1|||
155678307|NCT00782171|561911927|FG000|Overall Study|others|7|||
155601223|NCT01358578|561628381|FG004|Follow-up Period|Withdrawal by Subject|0|||
155601224|NCT01358578|561628382|FG005|Follow-up Period|Withdrawal by Subject|0|||
155601225|NCT01358578|561628377|FG000|Follow-up Period|Physician Decision|1|||
155601226|NCT01358578|561628378|FG001|Follow-up Period|Physician Decision|1|||
155601227|NCT01358578|561628379|FG002|Follow-up Period|Physician Decision|0|||
155601228|NCT01358578|561628380|FG003|Follow-up Period|Physician Decision|2|||
155601229|NCT01358578|561628381|FG004|Follow-up Period|Physician Decision|0|||
155601230|NCT01358578|561628382|FG005|Follow-up Period|Physician Decision|0|||
155601231|NCT01643798|561628383|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
155601232|NCT01643798|561628384|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
155601233|NCT03605849|561628385|FG000|Overall Study|Adverse Event|20|||
155601234|NCT03605849|561628386|FG001|Overall Study|Adverse Event|21|||
155601235|NCT03605849|561628387|FG002|Overall Study|Adverse Event|29|||
155601236|NCT03605849|561628388|FG003|Overall Study|Adverse Event|11|||
155601237|NCT03605849|561628385|FG000|Overall Study|Lack of Efficacy|4|||
155601238|NCT03605849|561628386|FG001|Overall Study|Lack of Efficacy|7|||
155601239|NCT03605849|561628387|FG002|Overall Study|Lack of Efficacy|9|||
155601240|NCT03605849|561628388|FG003|Overall Study|Lack of Efficacy|2|||
155601241|NCT03605849|561628385|FG000|Overall Study|Lost to Follow-up|8|||
155601242|NCT03605849|561628386|FG001|Overall Study|Lost to Follow-up|8|||
155601243|NCT03605849|561628387|FG002|Overall Study|Lost to Follow-up|14|||
155601244|NCT03605849|561628388|FG003|Overall Study|Lost to Follow-up|11|||
155601245|NCT03605849|561628385|FG000|Overall Study|Non-compliance With IMP|6|||
155601246|NCT03605849|561628386|FG001|Overall Study|Non-compliance With IMP|5|||
155601247|NCT03605849|561628387|FG002|Overall Study|Non-compliance With IMP|2|||
155601248|NCT03605849|561628388|FG003|Overall Study|Non-compliance With IMP|1|||
155601249|NCT03605849|561628385|FG000|Overall Study|Protocol Deviation|1|||
155601250|NCT03605849|561628386|FG001|Overall Study|Protocol Deviation|2|||
155678308|NCT00782171|561911928|FG001|Overall Study|others|9|||
155678309|NCT00782171|561911927|FG000|Overall Study|not eligible|8|||
155678310|NCT00782171|561911928|FG001|Overall Study|not eligible|6|||
155678311|NCT01691014|561911929|FG000|Overall Study|Premature Termination|1|||
155678312|NCT01691014|561911930|FG001|Overall Study|Premature Termination|6|||
155678313|NCT01691014|561911931|FG002|Overall Study|Premature Termination|0|||
155678314|NCT01691014|561911932|FG003|Overall Study|Premature Termination|3|||
155678315|NCT01691014|561911929|FG000|Overall Study|Other|0|||
155678316|NCT01691014|561911930|FG001|Overall Study|Other|0|||
155678317|NCT01691014|561911931|FG002|Overall Study|Other|2|||
155678318|NCT01691014|561911932|FG003|Overall Study|Other|0|||
155678319|NCT01691014|561911929|FG000|Overall Study|Withdrawal by Subject|0|||
155678320|NCT01691014|561911930|FG001|Overall Study|Withdrawal by Subject|1|||
155678321|NCT01691014|561911931|FG002|Overall Study|Withdrawal by Subject|1|||
155678322|NCT01691014|561911932|FG003|Overall Study|Withdrawal by Subject|1|||
155678323|NCT01691014|561911929|FG000|Overall Study|Adverse Event|0|||
155678324|NCT01691014|561911930|FG001|Overall Study|Adverse Event|5|||
155678325|NCT01691014|561911931|FG002|Overall Study|Adverse Event|1|||
155601251|NCT03605849|561628387|FG002|Overall Study|Protocol Deviation|1|||
155601252|NCT03605849|561628388|FG003|Overall Study|Protocol Deviation|3|||
155601253|NCT03605849|561628385|FG000|Overall Study|Withdrawal by Subject|33|||
155678326|NCT01691014|561911932|FG003|Overall Study|Adverse Event|1|||
155678327|NCT01691014|561911929|FG000|Overall Study|Lack of Efficacy|2|||
155678328|NCT01691014|561911930|FG001|Overall Study|Lack of Efficacy|3|||
155678329|NCT01691014|561911931|FG002|Overall Study|Lack of Efficacy|7|||
155601254|NCT03605849|561628386|FG001|Overall Study|Withdrawal by Subject|28|||
155601255|NCT03605849|561628387|FG002|Overall Study|Withdrawal by Subject|30|||
155601256|NCT03605849|561628388|FG003|Overall Study|Withdrawal by Subject|28|||
155601257|NCT03605849|561628385|FG000|Overall Study|Site Terminated by Sponsor|0|||
155678330|NCT01691014|561911932|FG003|Overall Study|Lack of Efficacy|0|||
155678331|NCT05897242|561911935|FG000|Overall Study|Lost to Follow-up|6|||
155678332|NCT05897242|561911936|FG001|Overall Study|Lost to Follow-up|1|||
155678333|NCT05897242|561911935|FG000|Overall Study|Incomplete|1|||
155601258|NCT03605849|561628386|FG001|Overall Study|Site Terminated by Sponsor|0|||
155678334|NCT05897242|561911936|FG001|Overall Study|Incomplete|0|||
155601259|NCT03605849|561628387|FG002|Overall Study|Site Terminated by Sponsor|0|||
155601260|NCT03605849|561628388|FG003|Overall Study|Site Terminated by Sponsor|1|||
155601261|NCT03605849|561628385|FG000|Overall Study|Physician Decision|2|||
155601262|NCT03605849|561628386|FG001|Overall Study|Physician Decision|1|||
155601263|NCT03605849|561628387|FG002|Overall Study|Physician Decision|2|||
155601264|NCT03605849|561628388|FG003|Overall Study|Physician Decision|1|||
155601265|NCT03605849|561628385|FG000|Overall Study|Enrolled, but not Treated|2|||
155601266|NCT03605849|561628386|FG001|Overall Study|Enrolled, but not Treated|2|||
155601267|NCT03605849|561628387|FG002|Overall Study|Enrolled, but not Treated|3|||
155601268|NCT03605849|561628388|FG003|Overall Study|Enrolled, but not Treated|2|||
155601269|NCT03605849|561628385|FG000|Overall Study|Other (COVID-19 Related)|0|||
155601270|NCT03605849|561628386|FG001|Overall Study|Other (COVID-19 Related)|1|||
155601271|NCT03605849|561628387|FG002|Overall Study|Other (COVID-19 Related)|1|||
155601272|NCT03605849|561628388|FG003|Overall Study|Other (COVID-19 Related)|0|||
155601273|NCT03605849|561628385|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
155601274|NCT03605849|561628386|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
155601275|NCT03605849|561628387|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
155601276|NCT03605849|561628388|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
155601277|NCT02045732|561628393|FG000|Overall Study|At the discretion of the investigator|1|||
155601278|NCT02045732|561628394|FG001|Overall Study|At the discretion of the investigator|1|||
155601279|NCT05014815|561628395|FG000|Overall Study|Death|63|||
155601280|NCT05014815|561628396|FG001|Overall Study|Death|70|||
155601281|NCT05014815|561628395|FG000|Overall Study|Withdrawal by Subject|10|||
155601282|NCT05014815|561628396|FG001|Overall Study|Withdrawal by Subject|10|||
155601283|NCT05014815|561628395|FG000|Overall Study|Lost to Follow-up|4|||
155601284|NCT05014815|561628396|FG001|Overall Study|Lost to Follow-up|2|||
155601285|NCT05014815|561628395|FG000|Overall Study|Physician Decision|2|||
155601286|NCT05014815|561628396|FG001|Overall Study|Physician Decision|4|||
155601287|NCT06303167|561628407|FG000|Overall Study|Ineligible|1|||
155601288|NCT06303167|561628407|FG000|Overall Study|Never start protocol therapy|2|||
155601289|NCT06303167|561628407|FG000|Overall Study|Disease progression|16|||
155601290|NCT01877551|561628408|FG000|Overall Study|Physician Decision|0|||
155601291|NCT01877551|561628409|FG001|Overall Study|Physician Decision|1|||
155601292|NCT02659514|561628410|FG000|Overall Study|Adverse Event|3|||
155601293|NCT02659514|561628411|FG001|Overall Study|Adverse Event|12|||
155601294|NCT02659514|561628410|FG000|Overall Study|Disease Progression|23|||
155601295|NCT02659514|561628411|FG001|Overall Study|Disease Progression|13|||
155601296|NCT02659514|561628410|FG000|Overall Study|Withdrawal by Subject|0|||
155601297|NCT02659514|561628411|FG001|Overall Study|Withdrawal by Subject|4|||
155601298|NCT02659514|561628410|FG000|Overall Study|Lost to Follow-up|0|||
155601299|NCT02659514|561628411|FG001|Overall Study|Lost to Follow-up|1|||
155601300|NCT02659514|561628410|FG000|Overall Study|Death|6|||
155601301|NCT02659514|561628411|FG001|Overall Study|Death|1|||
155601302|NCT02659514|561628410|FG000|Overall Study|Reason Unspecified|0|||
155601303|NCT02659514|561628411|FG001|Overall Study|Reason Unspecified|3|||
155601304|NCT00348790|561628412|FG000|Completed Treatment|Withdrawal by Subject|4|||
155601305|NCT00348790|561628412|FG000|Completed Treatment|Disease progression|14|||
155601306|NCT00348790|561628412|FG000|Completed Treatment|Adverse Event|4|||
155601307|NCT00348790|561628412|FG000|Completed Treatment|Required surgery|2|||
155601308|NCT00348790|561628412|FG000|Completed Treatment|Unable to travel to study site|1|||
155601309|NCT03687372|561628416|FG000|Overall Study|Lost to Follow-up|12|||
155601310|NCT03687372|561628417|FG001|Overall Study|Lost to Follow-up|21|||
155601311|NCT03687372|561628416|FG000|Overall Study|Withdrawal by Subject|4|||
155601312|NCT03687372|561628417|FG001|Overall Study|Withdrawal by Subject|17|||
155601313|NCT03687372|561628416|FG000|Overall Study|Investigator Decision|1|||
155601314|NCT03687372|561628417|FG001|Overall Study|Investigator Decision|1|||
155601315|NCT03602391|561628420|FG000|Overall Study|COVID-19|7|||
155601316|NCT03602391|561628421|FG001|Overall Study|COVID-19|6|||
155601317|NCT00108485|561628423|FG000|Overall Study|Withdrawal by Subject|3|||
155601318|NCT00108485|561628424|FG001|Overall Study|Withdrawal by Subject|0|||
155601319|NCT00108485|561628423|FG000|Overall Study|Lost to Follow-up|0|||
155601320|NCT00108485|561628424|FG001|Overall Study|Lost to Follow-up|2|||
155601321|NCT00878969|561628426|FG000|Overall Study|Physician Decision|5|||
155601322|NCT00878969|561628427|FG001|Overall Study|Physician Decision|3|||
155601323|NCT00878969|561628428|FG002|Overall Study|Physician Decision|2|||
155601324|NCT00878969|561628426|FG000|Overall Study|Withdrawal by Subject|1|||
155601325|NCT00878969|561628427|FG001|Overall Study|Withdrawal by Subject|6|||
155601326|NCT00878969|561628428|FG002|Overall Study|Withdrawal by Subject|3|||
155601327|NCT00878969|561628426|FG000|Overall Study|kidney transplant|2|||
155678335|NCT05897242|561911935|FG000|Overall Study|Withdrawal by Subject|1|||
155601328|NCT00878969|561628427|FG001|Overall Study|kidney transplant|3|||
155601329|NCT00878969|561628428|FG002|Overall Study|kidney transplant|2|||
155601330|NCT00878969|561628426|FG000|Overall Study|Adverse Event|3|||
155678336|NCT05897242|561911936|FG001|Overall Study|Withdrawal by Subject|0|||
155601331|NCT00878969|561628427|FG001|Overall Study|Adverse Event|1|||
155601332|NCT00878969|561628428|FG002|Overall Study|Adverse Event|2|||
155601333|NCT00878969|561628426|FG000|Overall Study|Lost to Follow-up|2|||
155601334|NCT00878969|561628427|FG001|Overall Study|Lost to Follow-up|1|||
155601335|NCT00878969|561628428|FG002|Overall Study|Lost to Follow-up|0|||
155601336|NCT00878969|561628426|FG000|Overall Study|Protocol Violation|2|||
155601337|NCT00878969|561628427|FG001|Overall Study|Protocol Violation|0|||
155601338|NCT00878969|561628428|FG002|Overall Study|Protocol Violation|0|||
155601339|NCT00878969|561628426|FG000|Overall Study|Death|0|||
155601340|NCT00878969|561628427|FG001|Overall Study|Death|0|||
155601341|NCT00878969|561628428|FG002|Overall Study|Death|2|||
155601342|NCT00878969|561628426|FG000|Overall Study|Pregnancy|0|||
155601343|NCT00878969|561628427|FG001|Overall Study|Pregnancy|1|||
155601344|NCT00878969|561628428|FG002|Overall Study|Pregnancy|0|||
155601345|NCT00655733|561628429|FG000|Overall Study|Lost to Follow-up|2|||
155601346|NCT00655733|561628430|FG001|Overall Study|Lost to Follow-up|2|||
155601347|NCT00655733|561628429|FG000|Overall Study|Adverse Event|2|||
155601348|NCT00655733|561628430|FG001|Overall Study|Adverse Event|2|||
155601349|NCT00655733|561628429|FG000|Overall Study|Withdrawal by Subject|3|||
155601350|NCT00655733|561628430|FG001|Overall Study|Withdrawal by Subject|3|||
155601351|NCT00655733|561628429|FG000|Overall Study|Physician Decision|0|||
155601352|NCT00655733|561628430|FG001|Overall Study|Physician Decision|1|||
155601353|NCT04495816|561628438|FG000|Overall Study|Lost to Follow-up|10|||
155601354|NCT04495816|561628439|FG001|Overall Study|Lost to Follow-up|4|||
155601355|NCT04495816|561628438|FG000|Overall Study|Withdrawal by Subject|3|||
155601356|NCT04495816|561628439|FG001|Overall Study|Withdrawal by Subject|5|||
155601357|NCT01826370|561628444|FG000|Overall Study|Protocol Violation|6|||
155601358|NCT01826370|561628444|FG000|Overall Study|Lost to Follow-up|12|||
155601359|NCT01826370|561628444|FG000|Overall Study|Other reason not defined above|2|||
155601360|NCT04489381|561628445|FG000|Overall Study|Lost to Follow-up|2|||
155601361|NCT04489381|561628446|FG001|Overall Study|Lost to Follow-up|3|||
155601362|NCT04489381|561628445|FG000|Overall Study|Withdrawal by Subject|1|||
155601363|NCT04489381|561628446|FG001|Overall Study|Withdrawal by Subject|0|||
155601364|NCT03199612|561628449|FG000|Overall Study|Adverse Event|1|||
155601365|NCT03199612|561628450|FG001|Overall Study|Adverse Event|0|||
155601366|NCT03973918|561628455|FG000|Overall Study|Adverse Event|0|||
155601367|NCT03973918|561628456|FG001|Overall Study|Adverse Event|0|||
155601368|NCT03973918|561628457|FG002|Overall Study|Adverse Event|0|||
155601369|NCT03973918|561628458|FG003|Overall Study|Adverse Event|1|||
155601370|NCT03973918|561628455|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155601371|NCT03973918|561628456|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
155601372|NCT03973918|561628457|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155601373|NCT03973918|561628458|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155601374|NCT04050124|561628461|FG000|Overall Study|Death|1|||
155601375|NCT04050124|561628462|FG001|Overall Study|Death|0|||
155601376|NCT00347919|561628469|FG000|Overall Study|Lost to Follow-up|11|||
155601377|NCT00347919|561628470|FG001|Overall Study|Lost to Follow-up|13|||
155601378|NCT00347919|561628471|FG002|Overall Study|Lost to Follow-up|0|||
155601379|NCT00347919|561628469|FG000|Overall Study|Withdrawal by Subject|6|||
155601380|NCT00347919|561628470|FG001|Overall Study|Withdrawal by Subject|8|||
155601381|NCT00347919|561628471|FG002|Overall Study|Withdrawal by Subject|0|||
155601382|NCT00347919|561628469|FG000|Overall Study|Physician Decision|1|||
155601383|NCT00347919|561628470|FG001|Overall Study|Physician Decision|1|||
155601384|NCT00347919|561628471|FG002|Overall Study|Physician Decision|0|||
155601385|NCT00347919|561628469|FG000|Overall Study|Sponsor terminated study|15|||
155601386|NCT00347919|561628470|FG001|Overall Study|Sponsor terminated study|10|||
155601387|NCT00347919|561628471|FG002|Overall Study|Sponsor terminated study|16|||
155601388|NCT00347919|561628469|FG000|Overall Study|Death|35|||
155601389|NCT00347919|561628470|FG001|Overall Study|Death|42|||
155601390|NCT00347919|561628471|FG002|Overall Study|Death|19|||
155601391|NCT00347919|561628469|FG000|Overall Study|Par. Started Other Treatment|1|||
155601392|NCT00347919|561628470|FG001|Overall Study|Par. Started Other Treatment|1|||
155601393|NCT00347919|561628471|FG002|Overall Study|Par. Started Other Treatment|1|||
155678337|NCT03522246|561911937|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
155678338|NCT03522246|561911938|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
155678339|NCT03522246|561911939|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
155678340|NCT03522246|561911940|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
155601394|NCT00347919|561628469|FG000|Overall Study|Missing|2|||
155601395|NCT00347919|561628470|FG001|Overall Study|Missing|1|||
155601396|NCT00347919|561628471|FG002|Overall Study|Missing|2|||
155601397|NCT01419080|561628472|FG000|Overall Study|Withdrawal by Subject|75|||
155601398|NCT01419080|561628472|FG000|Overall Study|Death|30|||
155601399|NCT01419080|561628472|FG000|Overall Study|Lost to Follow-up|23|||
155601400|NCT01419080|561628472|FG000|Overall Study|Too Ill|3|||
155601401|NCT02419612|561628474|FG000|Short-term Treatment Period|Adverse Event|1|||
155601402|NCT02419612|561628475|FG001|Short-term Treatment Period|Adverse Event|1|||
155601403|NCT02419612|561628474|FG000|Short-term Treatment Period|Death|0|||
155678341|NCT03522246|561911941|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
155601404|NCT02419612|561628475|FG001|Short-term Treatment Period|Death|2|||
155678342|NCT02249091|561911942|FG000|Overall Study|Lack of Efficacy|8|||
155678343|NCT02249091|561911943|FG001|Overall Study|Lack of Efficacy|3|||
155678344|NCT02249091|561911942|FG000|Overall Study|Physician Decision|4|||
155678345|NCT02249091|561911943|FG001|Overall Study|Physician Decision|1|||
155678346|NCT02249091|561911942|FG000|Overall Study|Withdrawal by Subject|2|||
155601405|NCT02419612|561628474|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
155601406|NCT02419612|561628475|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
155601407|NCT02419612|561628474|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
155601408|NCT02419612|561628475|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
155601409|NCT02419612|561628474|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
155601410|NCT02419612|561628475|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
155601411|NCT02419612|561628474|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
155601412|NCT02419612|561628475|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
155601413|NCT02419612|561628474|FG000|Short-term Treatment Period|Worsening of liver function|0|||
155601414|NCT02419612|561628475|FG001|Short-term Treatment Period|Worsening of liver function|1|||
155678347|NCT02249091|561911943|FG001|Overall Study|Withdrawal by Subject|2|||
155678348|NCT02249091|561911942|FG000|Overall Study|Death|3|||
155678349|NCT02249091|561911943|FG001|Overall Study|Death|4|||
155678350|NCT02249091|561911942|FG000|Overall Study|Adverse Event|1|||
155678351|NCT02249091|561911943|FG001|Overall Study|Adverse Event|0|||
155678352|NCT02249091|561911942|FG000|Overall Study|Stable disease with following SCT|0|||
155678353|NCT02249091|561911943|FG001|Overall Study|Stable disease with following SCT|1|||
155678354|NCT02249091|561911942|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
155678355|NCT02249091|561911943|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
155678356|NCT02249091|561911942|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
155678357|NCT02249091|561911943|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
155678358|NCT02249091|561911942|FG000|Overall Study|Refractory AML|1|||
155678359|NCT02249091|561911943|FG001|Overall Study|Refractory AML|1|||
155678360|NCT02684617|561911944|FG000|Overall Study|Adverse Event|1|||
155678361|NCT02684617|561911945|FG001|Overall Study|Adverse Event|0|||
155678362|NCT02684617|561911946|FG002|Overall Study|Adverse Event|1|||
155678363|NCT02684617|561911944|FG000|Overall Study|Death|8|||
155678364|NCT02684617|561911945|FG001|Overall Study|Death|16|||
155678365|NCT02684617|561911946|FG002|Overall Study|Death|28|||
155678366|NCT02684617|561911944|FG000|Overall Study|Withdrawal by Subject|2|||
155678367|NCT02684617|561911945|FG001|Overall Study|Withdrawal by Subject|0|||
155678368|NCT02684617|561911946|FG002|Overall Study|Withdrawal by Subject|4|||
155678369|NCT02684617|561911944|FG000|Overall Study|Screen Failure|1|||
155678370|NCT02684617|561911945|FG001|Overall Study|Screen Failure|0|||
155678371|NCT02684617|561911946|FG002|Overall Study|Screen Failure|2|||
155678372|NCT02684617|561911944|FG000|Overall Study|Study Terminated by Sponsor|6|||
155678373|NCT02684617|561911945|FG001|Overall Study|Study Terminated by Sponsor|1|||
155678374|NCT02684617|561911946|FG002|Overall Study|Study Terminated by Sponsor|5|||
155678375|NCT02141399|561911947|FG000|Overall Study|Adverse Event|158|||
155678376|NCT02141399|561911947|FG000|Overall Study|Lack of Efficacy|62|||
155678377|NCT02141399|561911947|FG000|Overall Study|Lost to Follow-up|151|||
155678378|NCT02141399|561911947|FG000|Overall Study|Non-compliance with study drug|18|||
155678379|NCT02141399|561911947|FG000|Overall Study|Other|45|||
155678380|NCT02141399|561911947|FG000|Overall Study|Physician Decision|17|||
155678381|NCT02141399|561911947|FG000|Overall Study|Pregnancy|3|||
155678382|NCT02141399|561911947|FG000|Overall Study|Protocol Violation|38|||
155678383|NCT02141399|561911947|FG000|Overall Study|Withdrawal by Subject|238|||
155678384|NCT02141399|561911947|FG000|Overall Study|Failure to meet eligibility criteria|14|||
155678385|NCT05730335|561911948|FG000|Overall Study|Lost to Follow-up|8|||
155678386|NCT05730335|561911948|FG000|Overall Study|Withdrawal by Subject|6|||
155678387|NCT00615719|561911949|FG000|Overall Study|Physician Decision|5|||
155678388|NCT02300558|561911950|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
155678389|NCT02300558|561911950|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
155678390|NCT02300558|561911950|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
155678391|NCT02300558|561911950|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
155678392|NCT01471028|561911951|FG000|VTI-208|Adverse Event|39|||
155678393|NCT01471028|561911952|FG001|VTI-208|Adverse Event|41|||
155678394|NCT01471028|561911951|FG000|VTI-208|Withdrawal by Subject|0|||
155678395|NCT01471028|561911952|FG001|VTI-208|Withdrawal by Subject|2|||
155678396|NCT01471028|561911951|FG000|VTI-208|Lost to Follow-up|1|||
155678397|NCT01471028|561911952|FG001|VTI-208|Lost to Follow-up|1|||
155678398|NCT01471028|561911951|FG000|VTI-208E|Death|7|||
155678399|NCT01471028|561911952|FG001|VTI-208E|Death|10|||
155678400|NCT01471028|561911951|FG000|VTI-208E|Withdrawal by Subject|1|||
155678401|NCT01471028|561911952|FG001|VTI-208E|Withdrawal by Subject|0|||
155678402|NCT01471028|561911951|FG000|VTI-208E|Lost to Follow-up|0|||
155678403|NCT01471028|561911952|FG001|VTI-208E|Lost to Follow-up|2|||
155678404|NCT02318368|561911953|FG000|Overall Study|Withdrawal by Subject|2|||
155678405|NCT02318368|561911954|FG001|Overall Study|Withdrawal by Subject|0|||
155678406|NCT02318368|561911953|FG000|Overall Study|Study terminated by the sponsor|5|||
155678407|NCT02318368|561911954|FG001|Overall Study|Study terminated by the sponsor|2|||
155678408|NCT02318368|561911953|FG000|Overall Study|Death|0|||
155678409|NCT02318368|561911954|FG001|Overall Study|Death|1|||
155601415|NCT02419612|561628474|FG000|Short-term Treatment Period|Subject moved out of state|0|||
155601416|NCT02419612|561628475|FG001|Short-term Treatment Period|Subject moved out of state|1|||
155601417|NCT02419612|561628474|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
155601418|NCT02419612|561628475|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
155601419|NCT02419612|561628474|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
155601420|NCT02419612|561628475|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
155601421|NCT02419612|561628474|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
155601422|NCT02419612|561628475|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
155601423|NCT02419612|561628474|FG000|Long-term Treatment Period|Death|0|||
155601424|NCT02419612|561628475|FG001|Long-term Treatment Period|Death|1|||
155601425|NCT02419612|561628474|FG000|Long-term Treatment Period|Adverse Event|0|||
155601426|NCT02419612|561628475|FG001|Long-term Treatment Period|Adverse Event|5|||
155601427|NCT02419612|561628474|FG000|Long-term Treatment Period|Other|4|||
155601428|NCT02419612|561628475|FG001|Long-term Treatment Period|Other|4|||
155601429|NCT02419612|561628474|FG000|Long-term Treatment Period|Subject Decision|2|||
155601430|NCT02419612|561628475|FG001|Long-term Treatment Period|Subject Decision|4|||
155601431|NCT02419612|561628474|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
155601432|NCT02419612|561628475|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
155601433|NCT00533702|561628476|FG000|Overall Study|Withdrawal by Subject|3|||
155601434|NCT00533702|561628477|FG001|Overall Study|Withdrawal by Subject|1|||
155601435|NCT00533702|561628476|FG000|Overall Study|Found ineligible after randomization|2|||
155601436|NCT00533702|561628477|FG001|Overall Study|Found ineligible after randomization|1|||
155601437|NCT01095978|561628478|FG000|Overall Study|Did not take Klacid SR|2|||
155601438|NCT01095978|561628478|FG000|Overall Study|Adverse Event|1|||
155601439|NCT00965341|561628481|FG000|Overall Study|Withdrew consent|1|||
155601440|NCT00965341|561628482|FG001|Overall Study|Withdrew consent|5|||
155601441|NCT00965341|561628481|FG000|Overall Study|Lost to Follow-up|1|||
155601442|NCT00965341|561628482|FG001|Overall Study|Lost to Follow-up|0|||
155601443|NCT00965341|561628481|FG000|Overall Study|Transportation issues|4|||
155601444|NCT00965341|561628482|FG001|Overall Study|Transportation issues|3|||
155601445|NCT01077739|561628488|FG000|Overall Study|Premature withdrawal|1|||
155601446|NCT01077739|561628489|FG001|Overall Study|Premature withdrawal|3|||
155601447|NCT01077739|561628488|FG000|Overall Study|Withdrawal by Subject|1|||
155601448|NCT01077739|561628489|FG001|Overall Study|Withdrawal by Subject|0|||
155678410|NCT00935493|561911955|FG000|Overall Study|Lost to Follow-up|1|||
155678411|NCT00935493|561911956|FG001|Overall Study|Lost to Follow-up|1|||
155678412|NCT00935493|561911957|FG002|Overall Study|Lost to Follow-up|1|||
155678413|NCT00935493|561911955|FG000|Overall Study|Treatment Discontinued|0|||
155678414|NCT00935493|561911956|FG001|Overall Study|Treatment Discontinued|1|||
155601449|NCT01077739|561628488|FG000|Overall Study|Death|0|||
155601450|NCT01077739|561628489|FG001|Overall Study|Death|3|||
155601451|NCT01077739|561628488|FG000|Overall Study|Unacceptable toxicity|1|||
155601452|NCT01077739|561628489|FG001|Overall Study|Unacceptable toxicity|2|||
155601453|NCT01077739|561628488|FG000|Overall Study|Other|2|||
155601454|NCT01077739|561628489|FG001|Overall Study|Other|2|||
155601455|NCT00877071|561628490|FG000|Overall Study|disease progression|2|||
155601456|NCT04413552|561628491|FG000|Overall Study|Adverse Event|0|||
155601457|NCT04413552|561628492|FG001|Overall Study|Adverse Event|0|||
155601458|NCT04413552|561628493|FG002|Overall Study|Adverse Event|0|||
155601459|NCT04413552|561628494|FG003|Overall Study|Adverse Event|0|||
155601460|NCT04413552|561628495|FG004|Overall Study|Adverse Event|0|||
155601461|NCT04413552|561628496|FG005|Overall Study|Adverse Event|0|||
155601462|NCT04413552|561628497|FG006|Overall Study|Adverse Event|1|||
155601463|NCT04413552|561628498|FG007|Overall Study|Adverse Event|0|||
155601464|NCT04413552|561628499|FG008|Overall Study|Adverse Event|0|||
155601465|NCT04413552|561628500|FG009|Overall Study|Adverse Event|0|||
155601466|NCT05723328|561628501|FG000|Overall Study|Investigator's Decision|5|||
155601467|NCT05723328|561628502|FG001|Overall Study|Investigator's Decision|2|||
155601468|NCT01794793|561628504|FG000|Treatment Period|Withdrawal by Subject|24|||
155678415|NCT00935493|561911957|FG002|Overall Study|Treatment Discontinued|0|||
155678416|NCT02091362|561911964|FG000|Period 1|Protocol Violation|1|||
155678417|NCT02091362|561911965|FG001|Period 1|Protocol Violation|0|||
155678418|NCT02091362|561911964|FG000|Period 1|Withdrawal by Subject|2|||
155678419|NCT02091362|561911965|FG001|Period 1|Withdrawal by Subject|3|||
155601469|NCT01794793|561628504|FG000|Treatment Period|Lack of Efficacy|22|||
155601470|NCT01794793|561628504|FG000|Treatment Period|Adverse Event|17|||
155601471|NCT01794793|561628504|FG000|Treatment Period|Physician Decision|14|||
155601472|NCT01794793|561628504|FG000|Treatment Period|Lost to Follow-up|7|||
155601473|NCT01794793|561628504|FG000|Treatment Period|Death|6|||
155601474|NCT01794793|561628504|FG000|Treatment Period|Protocol Violation|5|||
155601475|NCT01794793|561628504|FG000|Treatment Period|administrative problem|3|||
155601476|NCT01794793|561628504|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
155601477|NCT01794793|561628504|FG000|Post-treatment Follow-up|Adverse Event|8|||
155601478|NCT01794793|561628504|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
155601479|NCT01794793|561628504|FG000|Post-treatment Follow-up|administrative problem|5|||
155601480|NCT01794793|561628504|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
155601481|NCT01794793|561628504|FG000|Post-treatment Follow-up|Protocol Violation|3|||
155601482|NCT04852679|561628505|FG000|Main Intervention Period|Withdrawal by Subject|3|||
155601483|NCT04852679|561628505|FG000|Main Intervention Period|Adverse Event|1|||
155601484|NCT04852679|561628505|FG000|Main Intervention Period|Progressive Disease|16|||
155601485|NCT04852679|561628505|FG000|Main Intervention Period|Refused study visit|1|||
155601486|NCT04852679|561628505|FG000|Independent Injection Period|Missed study visit|1|||
155601487|NCT01752634|561630313|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155601488|NCT01752634|561630314|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155601489|NCT01752634|561630315|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155601490|NCT01752634|561630316|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
155601491|NCT01752634|561630317|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
155601492|NCT01752634|561630318|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
155601493|NCT01752634|561630313|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155601494|NCT01752634|561630314|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
155601495|NCT01752634|561630315|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155601496|NCT01752634|561630316|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155601497|NCT01752634|561630317|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155601498|NCT01752634|561630318|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155601499|NCT01752634|561630313|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
155601500|NCT01752634|561630314|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
155601501|NCT01752634|561630315|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155601502|NCT01752634|561630316|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155601503|NCT01752634|561630317|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155601504|NCT01752634|561630318|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
155601505|NCT01752634|561630313|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
155601506|NCT01752634|561630314|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155601507|NCT01752634|561630315|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
155601508|NCT01752634|561630316|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155601509|NCT01752634|561630317|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155601510|NCT01752634|561630318|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
155601511|NCT01752634|561630313|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
155601512|NCT01752634|561630314|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
155601513|NCT01752634|561630315|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
155601514|NCT01752634|561630316|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
155601515|NCT01752634|561630317|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
155601516|NCT01752634|561630318|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
155601517|NCT01752634|561630313|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
155601518|NCT01752634|561630314|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
155601519|NCT01752634|561630315|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
155601520|NCT01752634|561630316|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
155601521|NCT01752634|561630317|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
155601522|NCT01752634|561630318|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
155601523|NCT01752634|561630313|FG000|Week 24 to Week 260|Physician Decision|1|||
155601524|NCT01752634|561630314|FG001|Week 24 to Week 260|Physician Decision|2|||
155601525|NCT01752634|561630315|FG002|Week 24 to Week 260|Physician Decision|4|||
155601526|NCT01752634|561630316|FG003|Week 24 to Week 260|Physician Decision|2|||
155601527|NCT01752634|561630317|FG004|Week 24 to Week 260|Physician Decision|1|||
155601528|NCT01752634|561630318|FG005|Week 24 to Week 260|Physician Decision|0|||
155601529|NCT01752634|561630313|FG000|Week 24 to Week 260|Death|0|||
155601530|NCT01752634|561630314|FG001|Week 24 to Week 260|Death|1|||
155601531|NCT01752634|561630315|FG002|Week 24 to Week 260|Death|0|||
155601532|NCT01752634|561630316|FG003|Week 24 to Week 260|Death|0|||
155601533|NCT01752634|561630317|FG004|Week 24 to Week 260|Death|0|||
155601534|NCT01752634|561630318|FG005|Week 24 to Week 260|Death|0|||
155601535|NCT01752634|561630313|FG000|Week 24 to Week 260|Pregnancy|0|||
155601536|NCT01752634|561630314|FG001|Week 24 to Week 260|Pregnancy|0|||
155601537|NCT01752634|561630315|FG002|Week 24 to Week 260|Pregnancy|1|||
155601538|NCT01752634|561630316|FG003|Week 24 to Week 260|Pregnancy|0|||
155601539|NCT01752634|561630317|FG004|Week 24 to Week 260|Pregnancy|0|||
155601540|NCT01752634|561630318|FG005|Week 24 to Week 260|Pregnancy|0|||
155601541|NCT01752634|561630313|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
155601542|NCT01752634|561630314|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
155601543|NCT01752634|561630315|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
155601544|NCT01752634|561630316|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
155601545|NCT01752634|561630317|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
155601546|NCT01752634|561630318|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
155601547|NCT01752634|561630313|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
155601548|NCT01752634|561630314|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
155601549|NCT01752634|561630315|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
155601550|NCT01752634|561630316|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
155601551|NCT01752634|561630317|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
155601552|NCT01752634|561630318|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
155601553|NCT01752634|561630313|FG000|Week 24 to Week 260|Adverse Event|4|||
155601554|NCT01752634|561630314|FG001|Week 24 to Week 260|Adverse Event|8|||
155601555|NCT01752634|561630315|FG002|Week 24 to Week 260|Adverse Event|8|||
155601556|NCT01752634|561630316|FG003|Week 24 to Week 260|Adverse Event|4|||
155601557|NCT01752634|561630317|FG004|Week 24 to Week 260|Adverse Event|2|||
155601558|NCT01752634|561630318|FG005|Week 24 to Week 260|Adverse Event|0|||
155601559|NCT05562934|561630319|FG000|Overall Study|Adverse Event|0|||
155601560|NCT05562934|561630320|FG001|Overall Study|Adverse Event|2|||
155601561|NCT05562934|561630321|FG002|Overall Study|Adverse Event|0|||
155601562|NCT05562934|561630322|FG003|Overall Study|Adverse Event|0|||
155601563|NCT05562934|561630323|FG004|Overall Study|Adverse Event|2|||
155601564|NCT05562934|561630319|FG000|Overall Study|Lost to Follow-up|0|||
155601565|NCT05562934|561630320|FG001|Overall Study|Lost to Follow-up|0|||
155601566|NCT05562934|561630321|FG002|Overall Study|Lost to Follow-up|0|||
155601567|NCT05562934|561630322|FG003|Overall Study|Lost to Follow-up|0|||
155601568|NCT05562934|561630323|FG004|Overall Study|Lost to Follow-up|1|||
155601569|NCT05562934|561630319|FG000|Overall Study|Protocol Violation|0|||
155601570|NCT05562934|561630320|FG001|Overall Study|Protocol Violation|0|||
155601571|NCT05562934|561630321|FG002|Overall Study|Protocol Violation|0|||
155601572|NCT05562934|561630322|FG003|Overall Study|Protocol Violation|1|||
155601573|NCT05562934|561630323|FG004|Overall Study|Protocol Violation|1|||
155601574|NCT05562934|561630319|FG000|Overall Study|Withdrawal by Subject|0|||
155601575|NCT05562934|561630320|FG001|Overall Study|Withdrawal by Subject|0|||
155601576|NCT05562934|561630321|FG002|Overall Study|Withdrawal by Subject|1|||
155601577|NCT05562934|561630322|FG003|Overall Study|Withdrawal by Subject|1|||
155601578|NCT05562934|561630323|FG004|Overall Study|Withdrawal by Subject|0|||
155601579|NCT01702532|561630326|FG000|Overall Study|Adverse Event|0|||
155601580|NCT01702532|561630327|FG001|Overall Study|Adverse Event|1|||
155601581|NCT00623597|561630328|FG000|Overall Study|Failed to return|1|||
155601582|NCT00623597|561630329|FG001|Overall Study|Failed to return|0|||
155601583|NCT01451164|561630330|FG000|Overall Study|Adverse Event|19|||
155601584|NCT01451164|561630331|FG001|Overall Study|Adverse Event|12|||
155601585|NCT01451164|561630332|FG002|Overall Study|Adverse Event|18|||
155601586|NCT01451164|561630333|FG003|Overall Study|Adverse Event|21|||
155601587|NCT01451164|561630330|FG000|Overall Study|Withdrawal Criteria|1|||
155601588|NCT01451164|561630331|FG001|Overall Study|Withdrawal Criteria|1|||
155601589|NCT01451164|561630332|FG002|Overall Study|Withdrawal Criteria|1|||
155601590|NCT01451164|561630333|FG003|Overall Study|Withdrawal Criteria|1|||
155601591|NCT01451164|561630330|FG000|Overall Study|Physician Decision|2|||
155601592|NCT01451164|561630331|FG001|Overall Study|Physician Decision|0|||
155601593|NCT01451164|561630332|FG002|Overall Study|Physician Decision|1|||
155601594|NCT01451164|561630333|FG003|Overall Study|Physician Decision|0|||
155601595|NCT01451164|561630330|FG000|Overall Study|Withdrawal by Subject|14|||
155601596|NCT01451164|561630331|FG001|Overall Study|Withdrawal by Subject|11|||
155678420|NCT02091362|561911964|FG000|Period 1|Lost to Follow-up|0|||
155678421|NCT02091362|561911965|FG001|Period 1|Lost to Follow-up|1|||
155601597|NCT01451164|561630332|FG002|Overall Study|Withdrawal by Subject|16|||
155601598|NCT01451164|561630333|FG003|Overall Study|Withdrawal by Subject|17|||
155601599|NCT01451164|561630330|FG000|Overall Study|Protocol Violation|0|||
155601600|NCT01451164|561630331|FG001|Overall Study|Protocol Violation|1|||
155601601|NCT01451164|561630332|FG002|Overall Study|Protocol Violation|0|||
155601602|NCT01451164|561630333|FG003|Overall Study|Protocol Violation|0|||
155601603|NCT01451164|561630330|FG000|Overall Study|Lack of Efficacy|7|||
155601604|NCT01451164|561630331|FG001|Overall Study|Lack of Efficacy|9|||
155601605|NCT01451164|561630332|FG002|Overall Study|Lack of Efficacy|9|||
155601606|NCT01451164|561630333|FG003|Overall Study|Lack of Efficacy|7|||
155678422|NCT02091362|561911964|FG000|Period 1|Adverse Event|2|||
155601607|NCT01846221|561630334|FG000|Overall Study|Catheter Failure|2|||
155601608|NCT01846221|561630335|FG001|Overall Study|Catheter Failure|0|||
155601609|NCT01846221|561630334|FG000|Overall Study|Age Exclusion|1|||
155601610|NCT01846221|561630335|FG001|Overall Study|Age Exclusion|0|||
155601611|NCT04599933|561630336|FG000|Overall Study|Adverse Event|4|||
155601612|NCT04599933|561630337|FG001|Overall Study|Adverse Event|1|||
155601613|NCT04599933|561630336|FG000|Overall Study|Withdrawal by Subject|4|||
155601614|NCT04599933|561630337|FG001|Overall Study|Withdrawal by Subject|2|||
155601615|NCT04599933|561630336|FG000|Overall Study|Lost to Follow-up|0|||
155601616|NCT04599933|561630337|FG001|Overall Study|Lost to Follow-up|1|||
155601617|NCT04599933|561630336|FG000|Overall Study|Physician Decision|0|||
155601618|NCT04599933|561630337|FG001|Overall Study|Physician Decision|1|||
155601619|NCT04599933|561630336|FG000|Overall Study|Screen Failure|1|||
155601620|NCT04599933|561630337|FG001|Overall Study|Screen Failure|2|||
155601621|NCT02963558|561630345|FG000|Overall Study|Withdrawn by investigator|1|||
155601622|NCT02963558|561630346|FG001|Overall Study|Withdrawn by investigator|0|||
155601623|NCT02963558|561630345|FG000|Overall Study|Withdrawal by Subject|0|||
155601624|NCT02963558|561630346|FG001|Overall Study|Withdrawal by Subject|1|||
155601625|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Adverse Event|0|||
155601626|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Adverse Event|1|||
155601627|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Adverse Event|0|||
155601628|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Adverse Event|0|||
155601629|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Adverse Event|0|||
155601630|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Adverse Event|0|||
155601631|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Death|0|||
155601632|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Death|0|||
155601633|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Death|1|||
155678423|NCT02091362|561911965|FG001|Period 1|Adverse Event|0|||
155678424|NCT02091362|561911964|FG000|Wash-out|Lost to Follow-up|1|||
155678425|NCT02091362|561911965|FG001|Wash-out|Lost to Follow-up|1|||
155678426|NCT02091362|561911964|FG000|Wash-out|Withdrawal by Subject|0|||
155601634|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Death|0|||
155601635|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Death|0|||
155601636|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Death|0|||
155601637|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
155601638|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
155601639|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
155601640|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
155601641|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
155601642|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
155601643|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155601644|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155601645|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
155601646|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155601647|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155601648|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155601649|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155601650|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155601651|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155601652|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
155601653|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155601654|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155601655|NCT03226678|561630351|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
155601656|NCT03226678|561630352|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
155601657|NCT03226678|561630353|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155601658|NCT03226678|561630354|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155601659|NCT03226678|561630355|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155601660|NCT03226678|561630356|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155601661|NCT03226678|561630351|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155601662|NCT03226678|561630352|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155601663|NCT03226678|561630353|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155601664|NCT03226678|561630354|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155601665|NCT03226678|561630355|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
155601666|NCT03226678|561630356|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
155601667|NCT03226678|561630351|FG000|Part B (Long-Term Extension Phase)|Death|0|||
155601668|NCT03226678|561630352|FG001|Part B (Long-Term Extension Phase)|Death|0|||
155678427|NCT02091362|561911965|FG001|Wash-out|Withdrawal by Subject|2|||
155678428|NCT02091362|561911964|FG000|Period 2|Adverse Event|1|||
155601669|NCT03226678|561630353|FG002|Part B (Long-Term Extension Phase)|Death|0|||
155601670|NCT03226678|561630354|FG003|Part B (Long-Term Extension Phase)|Death|0|||
155601671|NCT03226678|561630355|FG004|Part B (Long-Term Extension Phase)|Death|0|||
155601672|NCT03226678|561630356|FG005|Part B (Long-Term Extension Phase)|Death|1|||
155678429|NCT02091362|561911965|FG001|Period 2|Adverse Event|0|||
155678430|NCT02091362|561911964|FG000|Period 2|Lost to Follow-up|0|||
155601673|NCT03226678|561630351|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155601674|NCT03226678|561630352|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155601675|NCT03226678|561630353|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155601676|NCT03226678|561630354|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155601677|NCT03226678|561630355|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155601678|NCT03226678|561630356|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
155601679|NCT03226678|561630351|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155601680|NCT03226678|561630352|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155601681|NCT03226678|561630353|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155601682|NCT03226678|561630354|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155601683|NCT03226678|561630355|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
155601684|NCT03226678|561630356|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
155601685|NCT03226678|561630351|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155601686|NCT03226678|561630352|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155601687|NCT03226678|561630353|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155601688|NCT03226678|561630354|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155601689|NCT03226678|561630355|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155601690|NCT03226678|561630356|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
155601691|NCT01371877|561630357|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
155601692|NCT01371877|561630358|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
155601693|NCT03427268|561630359|FG000|Overall Study|Progressive disease|25|||
155601694|NCT03427268|561630359|FG000|Overall Study|Never treated|2|||
155601695|NCT03427268|561630359|FG000|Overall Study|Compassionate use|1|||
155601696|NCT03427268|561630359|FG000|Overall Study|Withdrawal by Subject|1|||
155601697|NCT03427268|561630359|FG000|Overall Study|Adverse Event|3|||
155601698|NCT04186806|561630367|FG000|Period 1: 7 Days|Adverse Event|1|||
155601699|NCT04186806|561630368|FG001|Period 1: 7 Days|Adverse Event|0|||
155601700|NCT01701193|561630369|FG000|Overall Study|Withdrawal by Subject|2|||
155601701|NCT01701193|561630370|FG001|Overall Study|Withdrawal by Subject|2|||
155601702|NCT01701193|561630371|FG002|Overall Study|Withdrawal by Subject|1|||
155601703|NCT01701193|561630372|FG003|Overall Study|Withdrawal by Subject|2|||
155601704|NCT01701193|561630369|FG000|Overall Study|Adverse Event|1|||
155601705|NCT01701193|561630370|FG001|Overall Study|Adverse Event|0|||
155601706|NCT01701193|561630371|FG002|Overall Study|Adverse Event|0|||
155601707|NCT01701193|561630372|FG003|Overall Study|Adverse Event|0|||
155601708|NCT02720744|561630373|FG000|Overall Study|Protocol Violation|0|||
155601709|NCT02720744|561630374|FG001|Overall Study|Protocol Violation|2|||
155601710|NCT02720744|561630373|FG000|Overall Study|Pregnancy|2|||
155601711|NCT02720744|561630374|FG001|Overall Study|Pregnancy|0|||
155601712|NCT02720744|561630373|FG000|Overall Study|Lack of Efficacy|2|||
155601713|NCT02720744|561630374|FG001|Overall Study|Lack of Efficacy|8|||
155601714|NCT02720744|561630373|FG000|Overall Study|Adverse Event|21|||
155601715|NCT02720744|561630374|FG001|Overall Study|Adverse Event|3|||
155601716|NCT02720744|561630373|FG000|Overall Study|Withdrawal by Subject|11|||
155601717|NCT02720744|561630374|FG001|Overall Study|Withdrawal by Subject|11|||
155601718|NCT02720744|561630373|FG000|Overall Study|Lost to follow up|2|||
155601719|NCT02720744|561630374|FG001|Overall Study|Lost to follow up|0|||
155601720|NCT02720744|561630373|FG000|Overall Study|Non Compliance with Investigational Product|0|||
155601721|NCT02720744|561630374|FG001|Overall Study|Non Compliance with Investigational Product|1|||
155601722|NCT02720744|561630373|FG000|Overall Study|Excluded Concomitant Medication|0|||
155601723|NCT02720744|561630374|FG001|Overall Study|Excluded Concomitant Medication|1|||
155601724|NCT01482962|561630375|FG000|Overall Study|Progressive Disease|65|||
155601725|NCT01482962|561630376|FG001|Overall Study|Progressive Disease|53|||
155601726|NCT01482962|561630375|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
155601727|NCT01482962|561630376|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
155601728|NCT01482962|561630375|FG000|Overall Study|Adverse Event|18|||
155601729|NCT01482962|561630376|FG001|Overall Study|Adverse Event|22|||
155601730|NCT01482962|561630375|FG000|Overall Study|Withdrawal by Participant|8|||
155601731|NCT01482962|561630376|FG001|Overall Study|Withdrawal by Participant|13|||
155601732|NCT01482962|561630375|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
155601733|NCT01482962|561630376|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
155601734|NCT01482962|561630375|FG000|Overall Study|Other Reason|1|||
155601735|NCT01482962|561630376|FG001|Overall Study|Other Reason|5|||
155601736|NCT01482962|561630375|FG000|Overall Study|Study Terminated by Sponsor|5|||
155601737|NCT01482962|561630376|FG001|Overall Study|Study Terminated by Sponsor|2|||
155601738|NCT01482962|561630375|FG000|Overall Study|Did not Receive Study Drug|1|||
155601739|NCT01482962|561630376|FG001|Overall Study|Did not Receive Study Drug|6|||
155601740|NCT02407457|561630377|FG000|1 Month|Death|3|||
155601741|NCT02407457|561630378|FG001|1 Month|Death|0|||
155601742|NCT02407457|561630377|FG000|1 Month|Lost to Follow-up|1|||
155601743|NCT02407457|561630378|FG001|1 Month|Lost to Follow-up|1|||
155601744|NCT02407457|561630377|FG000|1 Month|missed visit|2|||
155601745|NCT02407457|561630378|FG001|1 Month|missed visit|5|||
155601746|NCT02407457|561630377|FG000|6-Month|Death|2|||
155601747|NCT02407457|561630378|FG001|6-Month|Death|8|||
155601748|NCT02407457|561630377|FG000|6-Month|Lost to Follow-up|2|||
155601749|NCT02407457|561630378|FG001|6-Month|Lost to Follow-up|2|||
155601750|NCT02407457|561630377|FG000|6-Month|missed visit|16|||
155601751|NCT02407457|561630378|FG001|6-Month|missed visit|14|||
155601752|NCT02407457|561630377|FG000|6-Month|Open Repair|0|||
155601753|NCT02407457|561630378|FG001|6-Month|Open Repair|1|||
155601754|NCT02407457|561630377|FG000|1 Year|Death|6|||
155601755|NCT02407457|561630378|FG001|1 Year|Death|11|||
155601756|NCT02407457|561630377|FG000|1 Year|Lost to Follow-up|3|||
155601757|NCT02407457|561630378|FG001|1 Year|Lost to Follow-up|2|||
155601758|NCT02407457|561630377|FG000|1 Year|Missed Visit|24|||
155601759|NCT02407457|561630378|FG001|1 Year|Missed Visit|14|||
155601760|NCT02407457|561630377|FG000|1 Year|Open Repair|0|||
155601761|NCT02407457|561630378|FG001|1 Year|Open Repair|1|||
155601762|NCT02407457|561630377|FG000|2-year|Death|14|||
155601763|NCT02407457|561630378|FG001|2-year|Death|8|||
155601764|NCT02407457|561630377|FG000|2-year|Lost to Follow-up|7|||
155601765|NCT02407457|561630378|FG001|2-year|Lost to Follow-up|10|||
155601766|NCT02407457|561630377|FG000|2-year|Missed Visit|13|||
155601767|NCT02407457|561630378|FG001|2-year|Missed Visit|15|||
155601768|NCT02407457|561630377|FG000|2-year|Open Repair|0|||
155601769|NCT02407457|561630378|FG001|2-year|Open Repair|2|||
155601770|NCT02407457|561630377|FG000|3-year|Death|11|||
155601771|NCT02407457|561630378|FG001|3-year|Death|10|||
155601772|NCT02407457|561630377|FG000|3-year|Lost to Follow-up|9|||
155601773|NCT02407457|561630378|FG001|3-year|Lost to Follow-up|10|||
155601774|NCT02407457|561630377|FG000|3-year|Missed Visit|19|||
155601775|NCT02407457|561630378|FG001|3-year|Missed Visit|16|||
155601776|NCT02407457|561630377|FG000|4-year|Death|18|||
155601777|NCT02407457|561630378|FG001|4-year|Death|10|||
155601778|NCT02407457|561630377|FG000|4-year|Lost to Follow-up|10|||
155601779|NCT02407457|561630378|FG001|4-year|Lost to Follow-up|12|||
155601780|NCT02407457|561630377|FG000|4-year|Missed Visit|18|||
155601781|NCT02407457|561630378|FG001|4-year|Missed Visit|16|||
155601782|NCT02407457|561630377|FG000|5-year|Death|10|||
155601783|NCT02407457|561630378|FG001|5-year|Death|3|||
155601784|NCT02407457|561630377|FG000|5-year|Lost to Follow-up|22|||
155601785|NCT02407457|561630378|FG001|5-year|Lost to Follow-up|13|||
155601786|NCT02407457|561630377|FG000|5-year|Missed Visit|9|||
155601787|NCT02407457|561630378|FG001|5-year|Missed Visit|1|||
155601788|NCT06137703|561630379|FG000|Overall Study|Other|0|||
155601789|NCT06137703|561630380|FG001|Overall Study|Other|1|||
155601790|NCT06137703|561630381|FG002|Overall Study|Other|0|||
155601791|NCT06137703|561630382|FG003|Overall Study|Other|0|||
155601792|NCT06137703|561630379|FG000|Overall Study|Adverse Event|0|||
155601793|NCT06137703|561630380|FG001|Overall Study|Adverse Event|0|||
155601794|NCT06137703|561630381|FG002|Overall Study|Adverse Event|1|||
155601795|NCT06137703|561630382|FG003|Overall Study|Adverse Event|0|||
155601796|NCT01801358|561630385|FG000|Overall Study|Adverse Event|0|||
155601797|NCT01801358|561630386|FG001|Overall Study|Adverse Event|2|||
155601798|NCT01801358|561630387|FG002|Overall Study|Adverse Event|1|||
155601799|NCT01801358|561630388|FG003|Overall Study|Adverse Event|0|||
155601800|NCT01801358|561630389|FG004|Overall Study|Adverse Event|0|||
155601801|NCT01801358|561630390|FG005|Overall Study|Adverse Event|1|||
155601802|NCT01801358|561630385|FG000|Overall Study|Physician Decision|0|||
155601803|NCT01801358|561630386|FG001|Overall Study|Physician Decision|0|||
155601804|NCT01801358|561630387|FG002|Overall Study|Physician Decision|1|||
155601805|NCT01801358|561630388|FG003|Overall Study|Physician Decision|0|||
155601806|NCT01801358|561630389|FG004|Overall Study|Physician Decision|0|||
155601807|NCT01801358|561630390|FG005|Overall Study|Physician Decision|0|||
155601808|NCT01801358|561630385|FG000|Overall Study|Progressive Disease|6|||
155601809|NCT01801358|561630386|FG001|Overall Study|Progressive Disease|4|||
155601810|NCT01801358|561630387|FG002|Overall Study|Progressive Disease|4|||
155601811|NCT01801358|561630388|FG003|Overall Study|Progressive Disease|5|||
155601812|NCT01801358|561630389|FG004|Overall Study|Progressive Disease|6|||
155601813|NCT01801358|561630390|FG005|Overall Study|Progressive Disease|5|||
155601814|NCT01801358|561630385|FG000|Overall Study|Withdrawal by Subject|0|||
155601815|NCT01801358|561630386|FG001|Overall Study|Withdrawal by Subject|0|||
155601816|NCT01801358|561630387|FG002|Overall Study|Withdrawal by Subject|0|||
155601817|NCT01801358|561630388|FG003|Overall Study|Withdrawal by Subject|1|||
155601818|NCT01801358|561630389|FG004|Overall Study|Withdrawal by Subject|0|||
155601819|NCT01801358|561630390|FG005|Overall Study|Withdrawal by Subject|2|||
155601820|NCT01210495|561630393|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
155601821|NCT01210495|561630394|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
155601822|NCT01210495|561630395|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
155601823|NCT01210495|561630396|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
155601824|NCT01210495|561630393|FG000|Overall Study|Death|14|||
155601825|NCT01210495|561630394|FG001|Overall Study|Death|7|||
155601826|NCT01210495|561630395|FG002|Overall Study|Death|112|||
155601827|NCT01210495|561630396|FG003|Overall Study|Death|54|||
155601828|NCT01210495|561630393|FG000|Overall Study|Study Terminated by Sponsor|0|||
155601829|NCT01210495|561630394|FG001|Overall Study|Study Terminated by Sponsor|0|||
155601830|NCT01210495|561630395|FG002|Overall Study|Study Terminated by Sponsor|4|||
155601831|NCT01210495|561630396|FG003|Overall Study|Study Terminated by Sponsor|11|||
155601832|NCT01210495|561630393|FG000|Overall Study|Lost to Follow-up|0|||
155601833|NCT01210495|561630394|FG001|Overall Study|Lost to Follow-up|0|||
155601834|NCT01210495|561630395|FG002|Overall Study|Lost to Follow-up|1|||
155601835|NCT01210495|561630396|FG003|Overall Study|Lost to Follow-up|1|||
155601836|NCT01210495|561630393|FG000|Overall Study|Other unspecified|0|||
155601837|NCT01210495|561630394|FG001|Overall Study|Other unspecified|0|||
155601838|NCT01210495|561630395|FG002|Overall Study|Other unspecified|6|||
155601839|NCT01210495|561630396|FG003|Overall Study|Other unspecified|0|||
155601840|NCT01384019|561630399|FG000|Overall Study|Withdrawal by Subject|3|||
155601841|NCT01384019|561630400|FG001|Overall Study|Withdrawal by Subject|0|||
155601842|NCT01384019|561630399|FG000|Overall Study|Death|1|||
155601843|NCT01384019|561630400|FG001|Overall Study|Death|0|||
155601844|NCT01384019|561630399|FG000|Overall Study|MRI refusal|6|||
155601845|NCT01384019|561630400|FG001|Overall Study|MRI refusal|6|||
155601846|NCT04416737|561630401|FG000|Week 1 (First Injection)|Physician Decision|0|||
155601847|NCT04416737|561630402|FG001|Week 1 (First Injection)|Physician Decision|1|||
155601848|NCT03332628|561630403|FG000|Overall Study|Physician Decision|2|||
155601849|NCT01472757|561630409|FG000|Overall Study|Withdrawal by Subject|1|||
155601850|NCT01472757|561630410|FG001|Overall Study|Withdrawal by Subject|2|||
155601851|NCT01472757|561630411|FG002|Overall Study|Withdrawal by Subject|2|||
155601852|NCT01472757|561630412|FG003|Overall Study|Withdrawal by Subject|0|||
155601853|NCT01472757|561630409|FG000|Overall Study|Asthma exacerbation|4|||
155601854|NCT01472757|561630410|FG001|Overall Study|Asthma exacerbation|1|||
155601855|NCT01472757|561630411|FG002|Overall Study|Asthma exacerbation|2|||
155601856|NCT01472757|561630412|FG003|Overall Study|Asthma exacerbation|1|||
155601857|NCT01472757|561630409|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
155601858|NCT01472757|561630410|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
155601859|NCT01472757|561630411|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
155601860|NCT01472757|561630412|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
155601861|NCT01472757|561630409|FG000|Overall Study|Protocol Violation|3|||
155601862|NCT01472757|561630410|FG001|Overall Study|Protocol Violation|2|||
155601863|NCT01472757|561630411|FG002|Overall Study|Protocol Violation|4|||
155601864|NCT01472757|561630412|FG003|Overall Study|Protocol Violation|4|||
155601865|NCT01472757|561630409|FG000|Overall Study|Other reasons|1|||
155601866|NCT01472757|561630410|FG001|Overall Study|Other reasons|0|||
155601867|NCT01472757|561630411|FG002|Overall Study|Other reasons|2|||
155601868|NCT01472757|561630412|FG003|Overall Study|Other reasons|2|||
155601869|NCT01549041|561630417|FG000|Overall Study|Lack of Efficacy|2|||
155601870|NCT01549041|561630418|FG001|Overall Study|Lack of Efficacy|4|||
155601871|NCT01549041|561630417|FG000|Overall Study|Adverse Event|0|||
155601872|NCT01549041|561630418|FG001|Overall Study|Adverse Event|4|||
155601873|NCT02543892|561630419|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
155601874|NCT02543892|561630420|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155601875|NCT02543892|561630421|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
155601876|NCT02543892|561630422|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155601877|NCT02543892|561630423|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155601878|NCT02543892|561630424|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
155601879|NCT02543892|561630425|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
155601880|NCT02543892|561630426|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
155601881|NCT02543892|561630419|FG000|Received Vaccination 2|Physician Decision|0|||
155601882|NCT02543892|561630420|FG001|Received Vaccination 2|Physician Decision|0|||
155601883|NCT02543892|561630421|FG002|Received Vaccination 2|Physician Decision|0|||
155601884|NCT02543892|561630422|FG003|Received Vaccination 2|Physician Decision|0|||
155601885|NCT02543892|561630423|FG004|Received Vaccination 2|Physician Decision|0|||
155601886|NCT02543892|561630424|FG005|Received Vaccination 2|Physician Decision|1|||
155601887|NCT02543892|561630425|FG006|Received Vaccination 2|Physician Decision|0|||
155601888|NCT02543892|561630426|FG007|Received Vaccination 2|Physician Decision|0|||
155601889|NCT02543892|561630419|FG000|Received Vaccination 2|Adverse Event|0|||
155601890|NCT02543892|561630420|FG001|Received Vaccination 2|Adverse Event|1|||
155601891|NCT02543892|561630421|FG002|Received Vaccination 2|Adverse Event|0|||
155601892|NCT02543892|561630422|FG003|Received Vaccination 2|Adverse Event|0|||
155601893|NCT02543892|561630423|FG004|Received Vaccination 2|Adverse Event|0|||
155601894|NCT02543892|561630424|FG005|Received Vaccination 2|Adverse Event|0|||
155601895|NCT02543892|561630425|FG006|Received Vaccination 2|Adverse Event|0|||
155601896|NCT02543892|561630426|FG007|Received Vaccination 2|Adverse Event|0|||
155601897|NCT02543892|561630419|FG000|Had Immunology Data|Withdrawal by Subject|0|||
155601898|NCT02543892|561630420|FG001|Had Immunology Data|Withdrawal by Subject|0|||
155601899|NCT02543892|561630421|FG002|Had Immunology Data|Withdrawal by Subject|0|||
155601900|NCT02543892|561630422|FG003|Had Immunology Data|Withdrawal by Subject|0|||
155601901|NCT02543892|561630423|FG004|Had Immunology Data|Withdrawal by Subject|0|||
155601902|NCT02543892|561630424|FG005|Had Immunology Data|Withdrawal by Subject|0|||
155601903|NCT02543892|561630425|FG006|Had Immunology Data|Withdrawal by Subject|1|||
155601904|NCT02543892|561630426|FG007|Had Immunology Data|Withdrawal by Subject|0|||
155601905|NCT01199822|561630427|FG000|Overall Study|Investigator discontinued therapy|0|||
155601906|NCT01199822|561630428|FG001|Overall Study|Investigator discontinued therapy|1|||
155601907|NCT01199822|561630429|FG002|Overall Study|Investigator discontinued therapy|0|||
155601908|NCT04027075|561630430|FG000|Overall Study|Lost to Follow-up|41|||
155601909|NCT04027075|561630431|FG001|Overall Study|Lost to Follow-up|22|||
155601910|NCT00526331|561630432|FG000|Overall Study|Sponsor Termination|55|||
155601911|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
155601912|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
155601913|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
155601914|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
155601915|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Death|1|||
155601916|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Death|1|||
155601917|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
155601918|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
155601919|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
155601920|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
155601921|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
155601922|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
155601923|NCT00033657|561630434|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
155601924|NCT00033657|561630435|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
155601925|NCT00033657|561630434|FG000|Surgical Resection|not complete resection|0|||
155601926|NCT00033657|561630435|FG001|Surgical Resection|not complete resection|3|||
155601927|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
155601928|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
155601929|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
155601930|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
155601931|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|Death|2|||
155601932|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|Death|1|||
155601933|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
155601934|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
155601935|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
155601936|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
155601937|NCT00033657|561630434|FG000|Adjuvant Chemotherapy|Other|0|||
155601938|NCT00033657|561630435|FG001|Adjuvant Chemotherapy|Other|2|||
155601939|NCT01259375|561630436|FG000|Overall Study|Adverse Event|1|||
155601940|NCT00628095|561630437|FG000|Overall Study|Adverse Event|5|||
155601941|NCT00628095|561630438|FG001|Overall Study|Adverse Event|3|||
155601942|NCT00628095|561630437|FG000|Overall Study|Lack of Efficacy|0|||
155601943|NCT00628095|561630438|FG001|Overall Study|Lack of Efficacy|3|||
155601944|NCT00628095|561630437|FG000|Overall Study|Withdrawal by Subject|2|||
155601945|NCT00628095|561630438|FG001|Overall Study|Withdrawal by Subject|0|||
155601946|NCT00628095|561630437|FG000|Overall Study|Other|0|||
155601947|NCT00628095|561630438|FG001|Overall Study|Other|1|||
155601948|NCT03932331|561630441|FG000|Overall Study|Death|0|||
155601949|NCT03932331|561630442|FG001|Overall Study|Death|7|||
155601950|NCT03932331|561630443|FG002|Overall Study|Death|2|||
155601951|NCT03932331|561630441|FG000|Overall Study|Withdrawal by Subject|0|||
155601952|NCT03932331|561630442|FG001|Overall Study|Withdrawal by Subject|3|||
155601953|NCT03932331|561630443|FG002|Overall Study|Withdrawal by Subject|0|||
155601954|NCT03932331|561630441|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
155601955|NCT03932331|561630442|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
155601956|NCT03932331|561630443|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
155601957|NCT03932331|561630441|FG000|Overall Study|Progressive disease|3|||
155601958|NCT03932331|561630442|FG001|Overall Study|Progressive disease|0|||
155601959|NCT03932331|561630443|FG002|Overall Study|Progressive disease|0|||
155601960|NCT03932331|561630441|FG000|Overall Study|Lung infection|1|||
155601961|NCT03932331|561630442|FG001|Overall Study|Lung infection|0|||
155601962|NCT03932331|561630443|FG002|Overall Study|Lung infection|0|||
155601963|NCT03932331|561630441|FG000|Overall Study|Other|0|||
155601964|NCT03932331|561630442|FG001|Overall Study|Other|0|||
155601965|NCT03932331|561630443|FG002|Overall Study|Other|58|||
155601966|NCT03379753|561630444|FG000|Overall Study|Withdrawal by Subject|2|||
155601967|NCT03379753|561630445|FG001|Overall Study|Withdrawal by Subject|1|||
155601968|NCT03379753|561630444|FG000|Overall Study|not having correct procedure|1|||
155601969|NCT03379753|561630445|FG001|Overall Study|not having correct procedure|2|||
155601970|NCT03379753|561630444|FG000|Overall Study|No primary outcome|12|||
155601971|NCT03379753|561630445|FG001|Overall Study|No primary outcome|22|||
155601972|NCT02225366|561630452|FG000|Overall Study|Lack of Efficacy|1|||
155601973|NCT02225366|561630453|FG001|Overall Study|Lack of Efficacy|0|||
155601974|NCT00742508|561630454|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
155601975|NCT00742508|561630455|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
155601976|NCT00742508|561630454|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
155601977|NCT00742508|561630455|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
155601978|NCT00742508|561630454|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
155601979|NCT00742508|561630455|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
155601980|NCT00742508|561630454|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
155601981|NCT00742508|561630455|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
155601982|NCT00742508|561630454|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
155601983|NCT00742508|561630455|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
155601984|NCT03619902|561630458|FG000|Overall Study|Termination of Study by Investigator|1|||
155601985|NCT03619902|561630458|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
155601986|NCT04450407|561630459|FG000|Overall Study|Withdrawal by Subject|10|||
155601987|NCT04450407|561630460|FG001|Overall Study|Withdrawal by Subject|1|||
155601988|NCT04450407|561630461|FG002|Overall Study|Withdrawal by Subject|4|||
155601989|NCT04450407|561630459|FG000|Overall Study|Adverse Event|0|||
155601990|NCT04450407|561630460|FG001|Overall Study|Adverse Event|0|||
155601991|NCT04450407|561630461|FG002|Overall Study|Adverse Event|1|||
155601992|NCT04450407|561630459|FG000|Overall Study|Lost to Follow-up|1|||
155601993|NCT04450407|561630460|FG001|Overall Study|Lost to Follow-up|0|||
155601994|NCT04450407|561630461|FG002|Overall Study|Lost to Follow-up|0|||
155601995|NCT04450407|561630459|FG000|Overall Study|Physician Decision|0|||
155601996|NCT04450407|561630460|FG001|Overall Study|Physician Decision|0|||
155601997|NCT04450407|561630461|FG002|Overall Study|Physician Decision|1|||
155601998|NCT04450407|561630459|FG000|Overall Study|Pregnancy|1|||
155601999|NCT04450407|561630460|FG001|Overall Study|Pregnancy|0|||
155602000|NCT04450407|561630461|FG002|Overall Study|Pregnancy|0|||
155602001|NCT04450407|561630459|FG000|Overall Study|Protocol Violation|2|||
155602002|NCT04450407|561630460|FG001|Overall Study|Protocol Violation|0|||
155602003|NCT04450407|561630461|FG002|Overall Study|Protocol Violation|0|||
155602004|NCT04450407|561630459|FG000|Overall Study|Investigational site terminated by sponsor|3|||
155602005|NCT04450407|561630460|FG001|Overall Study|Investigational site terminated by sponsor|0|||
155602006|NCT04450407|561630461|FG002|Overall Study|Investigational site terminated by sponsor|2|||
155602007|NCT02537431|561630463|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
155602008|NCT03197324|561630473|FG000|Overall Study|Adverse Event|0|||
155602009|NCT03197324|561630474|FG001|Overall Study|Adverse Event|1|||
155602010|NCT00102531|561630475|FG000|Overall Study|Adverse Event|0|||
155602011|NCT00102531|561630476|FG001|Overall Study|Adverse Event|1|||
155602012|NCT00102531|561630475|FG000|Overall Study|Disease Progression|5|||
155602013|NCT00102531|561630476|FG001|Overall Study|Disease Progression|9|||
155602014|NCT00102531|561630475|FG000|Overall Study|Physician Decision|0|||
155602015|NCT00102531|561630476|FG001|Overall Study|Physician Decision|1|||
155602016|NCT00710684|561630480|FG000|Overall Study|Adverse Event|11|||
155602017|NCT00710684|561630481|FG001|Overall Study|Adverse Event|19|||
155602018|NCT00710684|561630482|FG002|Overall Study|Adverse Event|16|||
155602019|NCT00710684|561630480|FG000|Overall Study|Lack of Efficacy|4|||
155602020|NCT00710684|561630481|FG001|Overall Study|Lack of Efficacy|3|||
155602021|NCT00710684|561630482|FG002|Overall Study|Lack of Efficacy|5|||
155602022|NCT00710684|561630480|FG000|Overall Study|Protocol Violation|5|||
155602023|NCT00710684|561630481|FG001|Overall Study|Protocol Violation|5|||
155602024|NCT00710684|561630482|FG002|Overall Study|Protocol Violation|5|||
155602025|NCT00710684|561630480|FG000|Overall Study|Lost to Follow-up|4|||
155602026|NCT00710684|561630481|FG001|Overall Study|Lost to Follow-up|6|||
155602027|NCT00710684|561630482|FG002|Overall Study|Lost to Follow-up|7|||
155602028|NCT00710684|561630480|FG000|Overall Study|Physician Decision|0|||
155602029|NCT00710684|561630481|FG001|Overall Study|Physician Decision|2|||
155602030|NCT00710684|561630482|FG002|Overall Study|Physician Decision|4|||
155602031|NCT00710684|561630480|FG000|Overall Study|Withdrawal by Subject|24|||
155602032|NCT00710684|561630481|FG001|Overall Study|Withdrawal by Subject|18|||
155602033|NCT00710684|561630482|FG002|Overall Study|Withdrawal by Subject|11|||
155602034|NCT00710684|561630480|FG000|Overall Study|Missing|1|||
155602035|NCT00710684|561630481|FG001|Overall Study|Missing|0|||
155602036|NCT00710684|561630482|FG002|Overall Study|Missing|0|||
155602037|NCT00710684|561630480|FG000|Overall Study|Did not continue after week 24|25|||
155602038|NCT00710684|561630481|FG001|Overall Study|Did not continue after week 24|21|||
155602039|NCT00710684|561630482|FG002|Overall Study|Did not continue after week 24|16|||
155602040|NCT04778059|561630483|FG000|Overall Study|Death|2|||
155602041|NCT04778059|561630484|FG001|Overall Study|Death|2|||
155602042|NCT04778059|561630485|FG002|Overall Study|Death|1|||
155602043|NCT04778059|561630486|FG003|Overall Study|Death|1|||
155602044|NCT04778059|561630487|FG004|Overall Study|Death|1|||
155602045|NCT04778059|561630483|FG000|Overall Study|Lost to Follow-up|0|||
155602046|NCT04778059|561630484|FG001|Overall Study|Lost to Follow-up|0|||
155602047|NCT04778059|561630485|FG002|Overall Study|Lost to Follow-up|0|||
155602048|NCT04778059|561630486|FG003|Overall Study|Lost to Follow-up|0|||
155602049|NCT04778059|561630487|FG004|Overall Study|Lost to Follow-up|1|||
155602050|NCT04778059|561630483|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
155602051|NCT04778059|561630484|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
155602052|NCT04778059|561630485|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
155602053|NCT04778059|561630486|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
155602054|NCT04778059|561630487|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
155602055|NCT02832375|561630488|FG000|Overall Study|Lost to Follow-up|1|||
155602056|NCT02832375|561630489|FG001|Overall Study|Lost to Follow-up|0|||
155602057|NCT02832375|561630488|FG000|Overall Study|Withdrawal of Consent|1|||
155602058|NCT02832375|561630489|FG001|Overall Study|Withdrawal of Consent|0|||
155602059|NCT00514904|561630490|FG000|Overall Study|Withdrawal by Subject|3|||
155602060|NCT00514904|561630491|FG001|Overall Study|Withdrawal by Subject|2|||
155602061|NCT00514904|561630490|FG000|Overall Study|Lost to Follow-up|21|||
155602062|NCT00514904|561630491|FG001|Overall Study|Lost to Follow-up|3|||
155602063|NCT00084318|561630492|FG000|Overall Study|Withdrawal by Subject|5|||
155602064|NCT00084318|561630493|FG001|Overall Study|Withdrawal by Subject|2|||
155602065|NCT00084318|561630492|FG000|Overall Study|Protocol Violation|15|||
155602066|NCT00084318|561630493|FG001|Overall Study|Protocol Violation|11|||
155602067|NCT00084318|561630492|FG000|Overall Study|No protocol treatment|2|||
155602068|NCT00084318|561630493|FG001|Overall Study|No protocol treatment|0|||
155602069|NCT04676412|561632075|FG000|Overall Study|Death|28|||
155602070|NCT04676412|561632076|FG001|Overall Study|Death|31|||
155602071|NCT04676412|561632075|FG000|Overall Study|Lost to Follow-up|1|||
155602072|NCT04676412|561632076|FG001|Overall Study|Lost to Follow-up|2|||
155602073|NCT04676412|561632075|FG000|Overall Study|Sponsor Decision|20|||
155602074|NCT04676412|561632076|FG001|Overall Study|Sponsor Decision|23|||
155602075|NCT04676412|561632075|FG000|Overall Study|Withdrawal by Subject|0|||
155602076|NCT04676412|561632076|FG001|Overall Study|Withdrawal by Subject|2|||
155602077|NCT05741346|561632077|FG000|Overall Study|Withdrawn due to termination of study|28|||
155602078|NCT04439357|561632081|FG000|Overall Study|Disease Progression|4|||
155602079|NCT05906836|561632084|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
155602080|NCT05906836|561632084|FG000|Overall Study|Lost to Follow-up|1|||
155602081|NCT01458951|561632097|FG000|Overall Study|Other|1|||
155602082|NCT01458951|561632098|FG001|Overall Study|Other|0|||
155602083|NCT01458951|561632099|FG002|Overall Study|Other|0|||
155602084|NCT01458951|561632097|FG000|Overall Study|Protocol Violation|5|||
155602085|NCT01458951|561632098|FG001|Overall Study|Protocol Violation|1|||
155602086|NCT01458951|561632099|FG002|Overall Study|Protocol Violation|0|||
155602087|NCT01458951|561632097|FG000|Overall Study|Withdrawal by Subject|2|||
155602088|NCT01458951|561632098|FG001|Overall Study|Withdrawal by Subject|0|||
155602089|NCT01458951|561632099|FG002|Overall Study|Withdrawal by Subject|2|||
155602090|NCT01458951|561632097|FG000|Overall Study|Adverse Event|7|||
155602091|NCT01458951|561632098|FG001|Overall Study|Adverse Event|0|||
155602092|NCT01458951|561632099|FG002|Overall Study|Adverse Event|2|||
155602093|NCT01458951|561632097|FG000|Overall Study|Insufficient Clinical Response|17|||
155602094|NCT01458951|561632098|FG001|Overall Study|Insufficient Clinical Response|0|||
155602095|NCT01458951|561632099|FG002|Overall Study|Insufficient Clinical Response|11|||
155602096|NCT01668966|561632104|FG000|Overall Study|Withdrawal by Subject|1|||
155602097|NCT01668966|561632104|FG000|Overall Study|Death|1|||
155602098|NCT01668966|561632104|FG000|Overall Study|Not treated|2|||
155602099|NCT04392167|561632105|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
155602100|NCT01573767|561632107|FG000|Overall Study|Adverse Event|0|||
155602101|NCT01573767|561632108|FG001|Overall Study|Adverse Event|1|||
155602102|NCT01573767|561632109|FG002|Overall Study|Adverse Event|0|||
155602103|NCT01573767|561632110|FG003|Overall Study|Adverse Event|1|||
155602104|NCT01573767|561632107|FG000|Overall Study|Lack of Efficacy|18|||
155602105|NCT01573767|561632108|FG001|Overall Study|Lack of Efficacy|15|||
155602106|NCT01573767|561632109|FG002|Overall Study|Lack of Efficacy|12|||
155602107|NCT01573767|561632110|FG003|Overall Study|Lack of Efficacy|17|||
155602108|NCT01573767|561632107|FG000|Overall Study|Protocol Violation|3|||
155602109|NCT01573767|561632108|FG001|Overall Study|Protocol Violation|1|||
155602110|NCT01573767|561632109|FG002|Overall Study|Protocol Violation|1|||
155602111|NCT01573767|561632110|FG003|Overall Study|Protocol Violation|3|||
155602112|NCT01573767|561632107|FG000|Overall Study|Lost to Follow-up|0|||
155602113|NCT01573767|561632108|FG001|Overall Study|Lost to Follow-up|1|||
155602114|NCT01573767|561632109|FG002|Overall Study|Lost to Follow-up|1|||
155602115|NCT01573767|561632110|FG003|Overall Study|Lost to Follow-up|1|||
155602116|NCT01573767|561632107|FG000|Overall Study|Physician Decision|1|||
155602117|NCT01573767|561632108|FG001|Overall Study|Physician Decision|2|||
155602118|NCT01573767|561632109|FG002|Overall Study|Physician Decision|0|||
155602119|NCT01573767|561632110|FG003|Overall Study|Physician Decision|2|||
155602120|NCT01573767|561632107|FG000|Overall Study|Withdrawal by Subject|0|||
155602121|NCT01573767|561632108|FG001|Overall Study|Withdrawal by Subject|1|||
155602122|NCT01573767|561632109|FG002|Overall Study|Withdrawal by Subject|0|||
155602123|NCT01573767|561632110|FG003|Overall Study|Withdrawal by Subject|0|||
155602124|NCT02339155|561632111|FG000|Overall Study|Adverse Event|0|||
155602125|NCT02339155|561632112|FG001|Overall Study|Adverse Event|6|||
155602126|NCT02339155|561632111|FG000|Overall Study|Death|1|||
155602127|NCT02339155|561632112|FG001|Overall Study|Death|1|||
155602128|NCT02339155|561632111|FG000|Overall Study|Lost to Follow-up|8|||
155602129|NCT02339155|561632112|FG001|Overall Study|Lost to Follow-up|9|||
155602130|NCT02339155|561632111|FG000|Overall Study|Physician Decision|2|||
155602131|NCT02339155|561632112|FG001|Overall Study|Physician Decision|1|||
155602132|NCT02339155|561632111|FG000|Overall Study|Withdrawal by Subject|4|||
155602133|NCT02339155|561632112|FG001|Overall Study|Withdrawal by Subject|4|||
155602134|NCT05932225|561632117|FG000|Overall Study|Lost to Follow-up|0|||
155602135|NCT05932225|561632118|FG001|Overall Study|Lost to Follow-up|1|||
155602136|NCT05932225|561632119|FG002|Overall Study|Lost to Follow-up|0|||
155602137|NCT05932225|561632117|FG000|Overall Study|Withdrawal by Subject|1|||
155602138|NCT05932225|561632118|FG001|Overall Study|Withdrawal by Subject|0|||
155602139|NCT05932225|561632119|FG002|Overall Study|Withdrawal by Subject|0|||
155602140|NCT05932225|561632117|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
155602141|NCT05932225|561632118|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
155602142|NCT05932225|561632119|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
155602143|NCT01911780|561632120|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
155602144|NCT01911780|561632121|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
155602145|NCT01911780|561632120|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
155602146|NCT01911780|561632121|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
155602147|NCT01911780|561632120|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
155602148|NCT01911780|561632121|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
155602149|NCT01911780|561632120|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
155602150|NCT01911780|561632121|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
155602151|NCT01911780|561632120|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
155602152|NCT01911780|561632121|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
155602153|NCT01911780|561632120|FG000|Extension Period (52 Weeks)|Personal reason|1|||
155602154|NCT01911780|561632121|FG001|Extension Period (52 Weeks)|Personal reason|1|||
155602155|NCT04247880|561632122|FG000|Overall Study|Lost to Follow-up|24|||
155602156|NCT04247880|561632123|FG001|Overall Study|Lost to Follow-up|17|||
155602157|NCT04247880|561632122|FG000|Overall Study|Withdrawal by Subject|3|||
155602158|NCT04247880|561632123|FG001|Overall Study|Withdrawal by Subject|0|||
155602159|NCT04076059|561632126|FG000|Double Blind Phase|Progressive disease|22|||
155602160|NCT04076059|561632127|FG001|Double Blind Phase|Progressive disease|26|||
155602161|NCT04076059|561632128|FG002|Double Blind Phase|Progressive disease|0|||
155602162|NCT04076059|561632126|FG000|Double Blind Phase|Withdrawal by Subject|4|||
155602163|NCT04076059|561632127|FG001|Double Blind Phase|Withdrawal by Subject|11|||
155602164|NCT04076059|561632128|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155602165|NCT04076059|561632126|FG000|Double Blind Phase|Death|1|||
155602166|NCT04076059|561632127|FG001|Double Blind Phase|Death|1|||
155602167|NCT04076059|561632128|FG002|Double Blind Phase|Death|0|||
155602168|NCT04076059|561632126|FG000|Double Blind Phase|Lost to Follow-up|1|||
155602169|NCT04076059|561632127|FG001|Double Blind Phase|Lost to Follow-up|0|||
155602170|NCT04076059|561632128|FG002|Double Blind Phase|Lost to Follow-up|0|||
155602171|NCT04076059|561632126|FG000|Double Blind Phase|Adverse Event|5|||
155602172|NCT04076059|561632127|FG001|Double Blind Phase|Adverse Event|1|||
155602173|NCT04076059|561632128|FG002|Double Blind Phase|Adverse Event|0|||
155602174|NCT04076059|561632126|FG000|Double Blind Phase|Ongoing Participants|82|||
155602175|NCT04076059|561632127|FG001|Double Blind Phase|Ongoing Participants|18|||
155602176|NCT04076059|561632128|FG002|Double Blind Phase|Ongoing Participants|0|||
155602177|NCT04076059|561632126|FG000|Double Blind Phase|Miscellaneous|3|||
155602178|NCT04076059|561632127|FG001|Double Blind Phase|Miscellaneous|1|||
155602179|NCT04076059|561632128|FG002|Double Blind Phase|Miscellaneous|0|||
155602180|NCT04076059|561632126|FG000|Double Blind Phase|Protocol Deviation|1|||
155602181|NCT04076059|561632127|FG001|Double Blind Phase|Protocol Deviation|1|||
155602182|NCT04076059|561632128|FG002|Double Blind Phase|Protocol Deviation|0|||
155602183|NCT04076059|561632126|FG000|Double Blind Phase|Did not take study drug|1|||
155602184|NCT04076059|561632127|FG001|Double Blind Phase|Did not take study drug|1|||
155602185|NCT04076059|561632128|FG002|Double Blind Phase|Did not take study drug|0|||
155602186|NCT04076059|561632126|FG000|Open Label Phase|Progressive disease|0|||
155602187|NCT04076059|561632127|FG001|Open Label Phase|Progressive disease|0|||
155602188|NCT04076059|561632128|FG002|Open Label Phase|Progressive disease|7|||
155602189|NCT04076059|561632126|FG000|Open Label Phase|Withdrawal by Subject|0|||
155602190|NCT04076059|561632127|FG001|Open Label Phase|Withdrawal by Subject|0|||
155602191|NCT04076059|561632128|FG002|Open Label Phase|Withdrawal by Subject|3|||
155602192|NCT04076059|561632126|FG000|Open Label Phase|Death|0|||
155602193|NCT04076059|561632127|FG001|Open Label Phase|Death|0|||
155602194|NCT04076059|561632128|FG002|Open Label Phase|Death|2|||
155602195|NCT04076059|561632126|FG000|Open Label Phase|Ongoing Participants|0|||
155602196|NCT04076059|561632127|FG001|Open Label Phase|Ongoing Participants|0|||
155602197|NCT04076059|561632128|FG002|Open Label Phase|Ongoing Participants|11|||
155602198|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Death|117|||
155602199|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Death|197|||
155678431|NCT02091362|561911965|FG001|Period 2|Lost to Follow-up|1|||
155678432|NCT02091362|561911964|FG000|Period 2|Withdrawal by Subject|1|||
155678433|NCT02091362|561911965|FG001|Period 2|Withdrawal by Subject|1|||
155602200|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
155602201|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
155602202|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
155602203|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
155602204|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
155602205|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
155602206|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
155602207|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
155602208|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
155602209|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
155602210|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
155602211|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
155602212|NCT02677896|561632129|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
155602213|NCT02677896|561632130|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
155602214|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
155602215|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
155602216|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
155602217|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
155602218|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
155602219|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
155602220|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
155602221|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
155602222|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
155602223|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
155602224|NCT02677896|561632129|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
155602225|NCT02677896|561632130|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
155602226|NCT00741091|561632137|FG000|Overall Study|Death|13|||
155602227|NCT00741091|561632137|FG000|Overall Study|Lost to Follow-up|16|||
155602228|NCT00741091|561632137|FG000|Overall Study|Withdrawal by Subject|6|||
155602229|NCT00741091|561632137|FG000|Overall Study|Missed Visit|22|||
155602230|NCT01527487|561632138|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
155602231|NCT01527487|561632139|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
155602232|NCT01527487|561632138|FG000|Overall Study|Disease Progression|4|||
155602233|NCT01527487|561632139|FG001|Overall Study|Disease Progression|1|||
155602234|NCT01527487|561632138|FG000|Overall Study|Adverse Event|1|||
155602235|NCT01527487|561632139|FG001|Overall Study|Adverse Event|1|||
155602236|NCT01527487|561632138|FG000|Overall Study|Death|0|||
155602237|NCT01527487|561632139|FG001|Overall Study|Death|1|||
155602238|NCT00767039|561632140|FG000|Overall Study|Death|5|||
155602239|NCT00767039|561632141|FG001|Overall Study|Death|2|||
155602240|NCT02505334|561632145|FG000|Main Treatment Period|Adverse Event|3|||
155602241|NCT02505334|561632146|FG001|Main Treatment Period|Adverse Event|3|||
155602242|NCT02505334|561632145|FG000|Main Treatment Period|Lack of Efficacy|7|||
155602243|NCT02505334|561632146|FG001|Main Treatment Period|Lack of Efficacy|17|||
155602244|NCT02505334|561632145|FG000|Main Treatment Period|Protocol Violation|0|||
155602245|NCT02505334|561632146|FG001|Main Treatment Period|Protocol Violation|1|||
155602246|NCT02505334|561632145|FG000|Main Treatment Period|Withdrawal by Subject|1|||
155602247|NCT02505334|561632146|FG001|Main Treatment Period|Withdrawal by Subject|8|||
155602248|NCT02505334|561632145|FG000|Main Treatment Period|Unclassified|4|||
155602249|NCT02505334|561632146|FG001|Main Treatment Period|Unclassified|10|||
155602250|NCT02505334|561632145|FG000|Extension Treatment Period|Adverse Event|5|||
155602251|NCT02505334|561632146|FG001|Extension Treatment Period|Adverse Event|0|||
155602252|NCT02505334|561632145|FG000|Extension Treatment Period|Lack of Efficacy|4|||
155602253|NCT02505334|561632146|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155602254|NCT02505334|561632145|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
155602255|NCT02505334|561632146|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155602256|NCT02505334|561632145|FG000|Extension Treatment Period|Unclassified|3|||
155602257|NCT02505334|561632146|FG001|Extension Treatment Period|Unclassified|0|||
155602258|NCT00597506|561632147|FG000|Overall Study|Subject is being followed for survival|1|||
155602259|NCT00081731|561632152|FG000|Overall Study|scientific integrity issue|8|||
155602260|NCT00081731|561632153|FG001|Overall Study|scientific integrity issue|8|||
155678434|NCT00690430|561911966|FG000|Core Phase|Abnormal Laboratory value|0|||
155678435|NCT00690430|561911967|FG001|Core Phase|Abnormal Laboratory value|1|||
155678436|NCT00690430|561911968|FG002|Core Phase|Abnormal Laboratory value|0|||
155602261|NCT01629823|561632154|FG000|Trial Period|Missed visit|11|||
155602262|NCT01629823|561632155|FG001|Trial Period|Missed visit|9|||
155602263|NCT01629823|561632156|FG002|Trial Period|Missed visit|8|||
155678437|NCT00690430|561911966|FG000|Core Phase|Adverse Event|5|||
155678438|NCT00690430|561911967|FG001|Core Phase|Adverse Event|1|||
155678439|NCT00690430|561911968|FG002|Core Phase|Adverse Event|0|||
155678440|NCT00690430|561911966|FG000|Core Phase|Death|0|||
155678441|NCT00690430|561911967|FG001|Core Phase|Death|2|||
155678442|NCT00690430|561911968|FG002|Core Phase|Death|0|||
155678443|NCT00690430|561911966|FG000|Core Phase|Protocol Violation|1|||
155678444|NCT00690430|561911967|FG001|Core Phase|Protocol Violation|0|||
155678445|NCT00690430|561911968|FG002|Core Phase|Protocol Violation|0|||
155678446|NCT00690430|561911966|FG000|Core Phase|Withdrawal by Subject|3|||
155678447|NCT00690430|561911967|FG001|Core Phase|Withdrawal by Subject|3|||
155678448|NCT00690430|561911968|FG002|Core Phase|Withdrawal by Subject|0|||
155678449|NCT00690430|561911966|FG000|Core Phase|Subject no longer requires study drug|1|||
155678450|NCT00690430|561911967|FG001|Core Phase|Subject no longer requires study drug|0|||
155678451|NCT00690430|561911968|FG002|Core Phase|Subject no longer requires study drug|0|||
155678452|NCT00690430|561911966|FG000|Core Phase|Lack of Efficacy|8|||
155678453|NCT00690430|561911967|FG001|Core Phase|Lack of Efficacy|10|||
155678454|NCT00690430|561911968|FG002|Core Phase|Lack of Efficacy|0|||
155678455|NCT00690430|561911966|FG000|Core Phase|Administrative Problems|0|||
155678456|NCT00690430|561911967|FG001|Core Phase|Administrative Problems|1|||
155678457|NCT00690430|561911968|FG002|Core Phase|Administrative Problems|0|||
155678458|NCT00690430|561911966|FG000|Core Phase|Early Termination|0|||
155678459|NCT00690430|561911967|FG001|Core Phase|Early Termination|5|||
155678460|NCT00690430|561911968|FG002|Core Phase|Early Termination|0|||
155678461|NCT00690430|561911966|FG000|Extension Phase|Lack of Efficacy|3|||
155678462|NCT00690430|561911967|FG001|Extension Phase|Lack of Efficacy|1|||
155678463|NCT00690430|561911968|FG002|Extension Phase|Lack of Efficacy|4|||
155678464|NCT00690430|561911966|FG000|Extension Phase|Abnormal Lab Values|1|||
155678465|NCT00690430|561911967|FG001|Extension Phase|Abnormal Lab Values|0|||
155678466|NCT00690430|561911968|FG002|Extension Phase|Abnormal Lab Values|0|||
155678467|NCT00690430|561911966|FG000|Extension Phase|Abnormal test procedure results|1|||
155678468|NCT00690430|561911967|FG001|Extension Phase|Abnormal test procedure results|0|||
155678469|NCT00690430|561911968|FG002|Extension Phase|Abnormal test procedure results|0|||
155678470|NCT00690430|561911966|FG000|Extension Phase|Administrative Problems|0|||
155678471|NCT00690430|561911967|FG001|Extension Phase|Administrative Problems|1|||
155602264|NCT01629823|561632154|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155602265|NCT01629823|561632155|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155602266|NCT01629823|561632156|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155602267|NCT01629823|561632154|FG000|Trial Period|Pregnancy|1|||
155602268|NCT01629823|561632155|FG001|Trial Period|Pregnancy|0|||
155602269|NCT01629823|561632156|FG002|Trial Period|Pregnancy|0|||
155602270|NCT01629823|561632154|FG000|Trial Period|Adverse Event|0|||
155678472|NCT00690430|561911968|FG002|Extension Phase|Administrative Problems|1|||
155678473|NCT00690430|561911966|FG000|Extension Phase|Adverse Event|2|||
155678474|NCT00690430|561911967|FG001|Extension Phase|Adverse Event|1|||
155678475|NCT00690430|561911968|FG002|Extension Phase|Adverse Event|2|||
155678476|NCT00690430|561911966|FG000|Extension Phase|Death|1|||
155678477|NCT00690430|561911967|FG001|Extension Phase|Death|1|||
155602271|NCT01629823|561632155|FG001|Trial Period|Adverse Event|1|||
155602272|NCT01629823|561632156|FG002|Trial Period|Adverse Event|0|||
155602273|NCT01629823|561632154|FG000|Trial Period|Out-of-window visit|0|||
155602274|NCT01629823|561632155|FG001|Trial Period|Out-of-window visit|2|||
155602275|NCT01629823|561632156|FG002|Trial Period|Out-of-window visit|0|||
155602276|NCT01629823|561632154|FG000|Trial Period|Failed to hold medication|0|||
155602277|NCT01629823|561632155|FG001|Trial Period|Failed to hold medication|0|||
155602278|NCT01629823|561632156|FG002|Trial Period|Failed to hold medication|1|||
155602279|NCT01629823|561632154|FG000|Washout Period|Safety|2|||
155602280|NCT01629823|561632155|FG001|Washout Period|Safety|5|||
155602281|NCT01629823|561632156|FG002|Washout Period|Safety|0|||
155602282|NCT01629823|561632154|FG000|Washout Period|Pregnancy|1|||
155602283|NCT01629823|561632155|FG001|Washout Period|Pregnancy|0|||
155602284|NCT01629823|561632156|FG002|Washout Period|Pregnancy|0|||
155602285|NCT01629823|561632154|FG000|Washout Period|Protocol Violation|0|||
155602286|NCT01629823|561632155|FG001|Washout Period|Protocol Violation|1|||
155678478|NCT00690430|561911968|FG002|Extension Phase|Death|1|||
155678479|NCT00690430|561911966|FG000|Extension Phase|Withdrawal by Subject|0|||
155678480|NCT00690430|561911967|FG001|Extension Phase|Withdrawal by Subject|0|||
155602287|NCT01629823|561632156|FG002|Washout Period|Protocol Violation|0|||
155602288|NCT00525902|561632158|FG000|Overall Study|Lack of Efficacy|1|||
155602289|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
155678481|NCT00690430|561911968|FG002|Extension Phase|Withdrawal by Subject|2|||
155678482|NCT00690430|561911966|FG000|Extension Phase|Early Termination|10|||
155678483|NCT00690430|561911967|FG001|Extension Phase|Early Termination|1|||
155602290|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
155602291|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
155602292|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
155602293|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
155602294|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
155602295|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
155602296|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
155602297|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
155678484|NCT00690430|561911968|FG002|Extension Phase|Early Termination|3|||
155678485|NCT02565147|561911969|FG000|Overall Study|Withdrawal by Subject|5|||
155678486|NCT02565147|561911970|FG001|Overall Study|Withdrawal by Subject|1|||
155678487|NCT02565147|561911969|FG000|Overall Study|Lost to Follow-up|0|||
155678488|NCT02565147|561911970|FG001|Overall Study|Lost to Follow-up|1|||
155678489|NCT02565147|561911969|FG000|Overall Study|Death|1|||
155678490|NCT02565147|561911970|FG001|Overall Study|Death|1|||
155678491|NCT03098433|561911974|FG000|Overall Study|Withdrawal by Subject|10|||
155678492|NCT04470050|561911975|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155678493|NCT04470050|561911976|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155678494|NCT04470050|561911977|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155678495|NCT04470050|561911978|FG003|Double-blind Treatment Phase|Adverse Event|1|||
155678496|NCT04470050|561911979|FG004|Double-blind Treatment Phase|Adverse Event|0|||
155678497|NCT04470050|561911980|FG005|Double-blind Treatment Phase|Adverse Event|0|||
155678498|NCT04470050|561911981|FG006|Double-blind Treatment Phase|Adverse Event|0|||
155678499|NCT04470050|561911975|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155678500|NCT04470050|561911976|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
155678501|NCT04470050|561911977|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
155678502|NCT04470050|561911978|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
155678503|NCT04470050|561911979|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
155678504|NCT04470050|561911980|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
155602298|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
155602299|NCT00455520|561632159|FG000|Open Label Tapentadol Extended Release|All other|33|||
155602300|NCT00455520|561632160|FG001|Open Label Tapentadol Extended Release|All other|0|||
155602301|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
155602302|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
155602303|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
155602304|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
155602305|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
155678505|NCT04470050|561911981|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
155678506|NCT04470050|561911975|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
155678507|NCT04470050|561911976|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155678508|NCT04470050|561911977|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
155678509|NCT04470050|561911978|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155678510|NCT04470050|561911979|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
155678511|NCT04470050|561911980|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
155678512|NCT04470050|561911981|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
155678513|NCT03640507|561911982|FG000|Overall Study|Withdrawal by Subject|0|||
155678514|NCT03640507|561911983|FG001|Overall Study|Withdrawal by Subject|0|||
155678515|NCT03640507|561911984|FG002|Overall Study|Withdrawal by Subject|1|||
155602306|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
155602307|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
155602308|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
155678516|NCT01270880|561911985|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
155678517|NCT00395486|561911990|FG000|Overall Study|Adverse Event|1|||
155678518|NCT00395486|561911991|FG001|Overall Study|Adverse Event|2|||
155678519|NCT00395486|561911990|FG000|Overall Study|Withdrawal by Subject|5|||
155678520|NCT00395486|561911991|FG001|Overall Study|Withdrawal by Subject|2|||
155678521|NCT00395486|561911990|FG000|Overall Study|Lost to Follow-up|0|||
155678522|NCT00395486|561911991|FG001|Overall Study|Lost to Follow-up|1|||
155602309|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
155602310|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
155602311|NCT00455520|561632159|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
155602312|NCT00455520|561632160|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
155602313|NCT03448939|561632163|FG000|Overall Study|Adverse Event|5|||
155602314|NCT03448939|561632164|FG001|Overall Study|Adverse Event|1|||
155602315|NCT03448939|561632163|FG000|Overall Study|Lost to Follow-up|6|||
155602316|NCT03448939|561632164|FG001|Overall Study|Lost to Follow-up|6|||
155602317|NCT03448939|561632163|FG000|Overall Study|Pregnancy|1|||
155602318|NCT03448939|561632164|FG001|Overall Study|Pregnancy|1|||
155602319|NCT03448939|561632163|FG000|Overall Study|Withdrawal by Subject|9|||
155602320|NCT03448939|561632164|FG001|Overall Study|Withdrawal by Subject|3|||
155602321|NCT00986986|561632165|FG000|Overall Study|Lost to Follow-up|0|||
155602322|NCT00986986|561632166|FG001|Overall Study|Lost to Follow-up|1|||
155602323|NCT03235115|561632169|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155678523|NCT01939977|561911993|FG000|Overall Study|Adverse Event|4|||
155678524|NCT01939977|561911994|FG001|Overall Study|Adverse Event|3|||
155678525|NCT01939977|561911993|FG000|Overall Study|Lack of Efficacy|3|||
155678526|NCT01939977|561911994|FG001|Overall Study|Lack of Efficacy|0|||
155678527|NCT01939977|561911993|FG000|Overall Study|Physician Decision|1|||
155678528|NCT01939977|561911994|FG001|Overall Study|Physician Decision|1|||
155678529|NCT01939977|561911993|FG000|Overall Study|Withdrawal by Subject|0|||
155678530|NCT01939977|561911994|FG001|Overall Study|Withdrawal by Subject|2|||
155678531|NCT01939977|561911993|FG000|Overall Study|Did not meet inclusion criteria|1|||
155678532|NCT01939977|561911994|FG001|Overall Study|Did not meet inclusion criteria|0|||
155678533|NCT01939977|561911993|FG000|Overall Study|Did not receive study medication|0|||
155678534|NCT01939977|561911994|FG001|Overall Study|Did not receive study medication|1|||
155678535|NCT03213938|561911997|FG000|Overall Study|Lost to Follow-up|4|||
155678536|NCT03213938|561911998|FG001|Overall Study|Lost to Follow-up|3|||
155678537|NCT03213938|561911997|FG000|Overall Study|Lack of Efficacy|1|||
155678538|NCT03213938|561911998|FG001|Overall Study|Lack of Efficacy|0|||
155678539|NCT03213938|561911997|FG000|Overall Study|Decline to participate|5|||
155602324|NCT03235115|561632170|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155602325|NCT03235115|561632171|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155602326|NCT03235115|561632172|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155602327|NCT03235115|561632173|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155602328|NCT03235115|561632174|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
155602329|NCT00656851|561632175|FG000|Overall Study|Withdrawal by Subject|0|||
155602330|NCT00656851|561632176|FG001|Overall Study|Withdrawal by Subject|4|||
155602331|NCT03782298|561632181|FG000|Overall Study|Protocol Deviation|4|||
155602332|NCT02431806|561632182|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
155602333|NCT02431806|561632183|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
155602334|NCT02431806|561632184|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
155602335|NCT02431806|561632185|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
155602336|NCT02431806|561632182|FG000|Double-blind Treatment Period|Adverse Event|4|||
155602337|NCT02431806|561632183|FG001|Double-blind Treatment Period|Adverse Event|7|||
155602338|NCT02431806|561632184|FG002|Double-blind Treatment Period|Adverse Event|11|||
155602339|NCT02431806|561632185|FG003|Double-blind Treatment Period|Adverse Event|7|||
155602340|NCT02431806|561632182|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
155602341|NCT02431806|561632183|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155602342|NCT02431806|561632184|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
155602343|NCT02431806|561632185|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
155602344|NCT02431806|561632182|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
155602345|NCT02431806|561632183|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
155602346|NCT02431806|561632184|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
155602347|NCT02431806|561632185|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
155602348|NCT02431806|561632182|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
155602349|NCT02431806|561632183|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
155602350|NCT02431806|561632184|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155678540|NCT03213938|561911998|FG001|Overall Study|Decline to participate|4|||
155602351|NCT02431806|561632185|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
155678541|NCT03213938|561911997|FG000|Overall Study|Without reason|4|||
155678542|NCT03213938|561911998|FG001|Overall Study|Without reason|5|||
155602352|NCT02431806|561632182|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
155602353|NCT02431806|561632183|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
155602354|NCT02431806|561632184|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
155602355|NCT02431806|561632185|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
155602356|NCT02431806|561632182|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
155602357|NCT02431806|561632183|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
155602358|NCT02431806|561632184|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
155602359|NCT02431806|561632185|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
155602360|NCT02484651|561632186|FG000|Overall Study|Patients' data files were corrupted.|1|||
155602361|NCT02484651|561632187|FG001|Overall Study|Patients' data files were corrupted.|1|||
155602362|NCT02484651|561632186|FG000|Overall Study|BIS monitoring failed.|1|||
155602363|NCT02484651|561632187|FG001|Overall Study|BIS monitoring failed.|1|||
155602364|NCT02484651|561632186|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
155602365|NCT02484651|561632187|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
155602366|NCT05238025|561632188|FG000|Overall Study|Adverse Event|2|||
155602367|NCT05238025|561632189|FG001|Overall Study|Adverse Event|2|||
155602368|NCT05238025|561632188|FG000|Overall Study|Lost to Follow-up|334|||
155602369|NCT05238025|561632189|FG001|Overall Study|Lost to Follow-up|339|||
155602370|NCT05238025|561632188|FG000|Overall Study|Withdrawal by Subject|203|||
155602371|NCT05238025|561632189|FG001|Overall Study|Withdrawal by Subject|222|||
155602372|NCT05238025|561632188|FG000|Overall Study|Physician Decision|20|||
155602373|NCT05238025|561632189|FG001|Overall Study|Physician Decision|8|||
155602374|NCT05238025|561632188|FG000|Overall Study|Protocol Violation|6|||
155602375|NCT05238025|561632189|FG001|Overall Study|Protocol Violation|2|||
155602376|NCT05238025|561632188|FG000|Overall Study|Death|38|||
155602377|NCT05238025|561632189|FG001|Overall Study|Death|32|||
155602378|NCT05238025|561632188|FG000|Overall Study|Study terminated by Sponsor|6358|||
155602379|NCT05238025|561632189|FG001|Overall Study|Study terminated by Sponsor|6358|||
155602380|NCT05238025|561632188|FG000|Overall Study|Other Reason|669|||
155602381|NCT05238025|561632189|FG001|Overall Study|Other Reason|690|||
155602382|NCT02278120|561632192|FG000|Treatment Period|Progressive disease|234|||
155602383|NCT02278120|561632193|FG001|Treatment Period|Progressive disease|260|||
155602384|NCT02278120|561632192|FG000|Treatment Period|Subject/guardian decision|23|||
155602385|NCT02278120|561632193|FG001|Treatment Period|Subject/guardian decision|20|||
155602386|NCT02278120|561632192|FG000|Treatment Period|Adverse Event|16|||
155602387|NCT02278120|561632193|FG001|Treatment Period|Adverse Event|14|||
155602388|NCT02278120|561632192|FG000|Treatment Period|Physician Decision|14|||
155602389|NCT02278120|561632193|FG001|Treatment Period|Physician Decision|27|||
155602390|NCT02278120|561632192|FG000|Treatment Period|Death|3|||
155602391|NCT02278120|561632193|FG001|Treatment Period|Death|3|||
155602392|NCT02278120|561632192|FG000|Treatment Period|Lost to Follow-up|2|||
155602393|NCT02278120|561632193|FG001|Treatment Period|Lost to Follow-up|0|||
155602394|NCT02278120|561632192|FG000|Treatment Period|Protocol deviation|0|||
155602395|NCT02278120|561632193|FG001|Treatment Period|Protocol deviation|2|||
155602396|NCT02278120|561632192|FG000|Treatment Period|Study terminated as per protocol|43|||
155602397|NCT02278120|561632193|FG001|Treatment Period|Study terminated as per protocol|11|||
155602398|NCT02278120|561632192|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155602399|NCT02278120|561632193|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155602400|NCT02278120|561632192|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155602401|NCT02278120|561632193|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155602402|NCT02278120|561632192|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
155602403|NCT02278120|561632193|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
155602404|NCT02278120|561632192|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
155602405|NCT02278120|561632193|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
155602406|NCT02278120|561632192|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155602407|NCT02278120|561632193|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155602408|NCT01317797|561632194|FG000|Overall Study|Other|0|||
155602409|NCT01317797|561632195|FG001|Overall Study|Other|1|||
155602410|NCT01317797|561632196|FG002|Overall Study|Other|0|||
155602411|NCT01317797|561632194|FG000|Overall Study|Withdrawal of Patient|0|||
155602412|NCT01317797|561632195|FG001|Overall Study|Withdrawal of Patient|0|||
155602413|NCT01317797|561632196|FG002|Overall Study|Withdrawal of Patient|1|||
155602414|NCT03026530|561632200|FG000|Overall Study|Lost to Follow-up|19|||
155602415|NCT03026530|561632201|FG001|Overall Study|Lost to Follow-up|24|||
155602416|NCT03026530|561632200|FG000|Overall Study|Protocol Violation|2|||
155602417|NCT03026530|561632201|FG001|Overall Study|Protocol Violation|5|||
155602418|NCT00954512|561632203|FG000|Overall Study|Withdrawal by Subject|0|||
155602419|NCT00954512|561632204|FG001|Overall Study|Withdrawal by Subject|0|||
155602420|NCT00954512|561632205|FG002|Overall Study|Withdrawal by Subject|0|||
155602421|NCT00954512|561632206|FG003|Overall Study|Withdrawal by Subject|0|||
155602422|NCT00954512|561632207|FG004|Overall Study|Withdrawal by Subject|0|||
155602423|NCT00954512|561632208|FG005|Overall Study|Withdrawal by Subject|1|||
155602424|NCT00954512|561632203|FG000|Overall Study|Adverse Event|0|||
155602425|NCT00954512|561632204|FG001|Overall Study|Adverse Event|0|||
155602426|NCT00954512|561632205|FG002|Overall Study|Adverse Event|0|||
155602427|NCT00954512|561632206|FG003|Overall Study|Adverse Event|0|||
155602428|NCT00954512|561632207|FG004|Overall Study|Adverse Event|1|||
155602429|NCT00954512|561632208|FG005|Overall Study|Adverse Event|2|||
155602430|NCT00954512|561632203|FG000|Overall Study|Physician Decision|0|||
155602431|NCT00954512|561632204|FG001|Overall Study|Physician Decision|1|||
155602432|NCT00954512|561632205|FG002|Overall Study|Physician Decision|0|||
155602433|NCT00954512|561632206|FG003|Overall Study|Physician Decision|1|||
155678543|NCT02443116|561912000|FG000|Part 1|Adverse Event|2|||
155678544|NCT02443116|561912001|FG001|Part 1|Adverse Event|3|||
155678545|NCT02443116|561912002|FG002|Part 1|Adverse Event|0|||
155678546|NCT02443116|561912003|FG003|Part 1|Adverse Event|0|||
155678547|NCT02443116|561912004|FG004|Part 1|Adverse Event|0|||
155678548|NCT02443116|561912005|FG005|Part 1|Adverse Event|0|||
155678549|NCT02443116|561912006|FG006|Part 1|Adverse Event|0|||
155678550|NCT02443116|561912007|FG007|Part 1|Adverse Event|0|||
155678551|NCT02443116|561912008|FG008|Part 1|Adverse Event|0|||
155678552|NCT02443116|561912000|FG000|Part 1|Withdrew informed consent|0|||
155678553|NCT02443116|561912001|FG001|Part 1|Withdrew informed consent|1|||
155678554|NCT02443116|561912002|FG002|Part 1|Withdrew informed consent|0|||
155678555|NCT02443116|561912003|FG003|Part 1|Withdrew informed consent|0|||
155678556|NCT02443116|561912004|FG004|Part 1|Withdrew informed consent|0|||
155678557|NCT02443116|561912005|FG005|Part 1|Withdrew informed consent|0|||
155678558|NCT02443116|561912006|FG006|Part 1|Withdrew informed consent|0|||
155678559|NCT02443116|561912007|FG007|Part 1|Withdrew informed consent|0|||
155678560|NCT02443116|561912008|FG008|Part 1|Withdrew informed consent|0|||
155678561|NCT02443116|561912000|FG000|Part 1|Lost to Follow-up|0|||
155678562|NCT02443116|561912001|FG001|Part 1|Lost to Follow-up|0|||
155678563|NCT02443116|561912002|FG002|Part 1|Lost to Follow-up|2|||
155678564|NCT02443116|561912003|FG003|Part 1|Lost to Follow-up|0|||
155678565|NCT02443116|561912004|FG004|Part 1|Lost to Follow-up|0|||
155678566|NCT02443116|561912005|FG005|Part 1|Lost to Follow-up|0|||
155678567|NCT02443116|561912006|FG006|Part 1|Lost to Follow-up|0|||
155678568|NCT02443116|561912007|FG007|Part 1|Lost to Follow-up|0|||
155678569|NCT02443116|561912008|FG008|Part 1|Lost to Follow-up|0|||
155678570|NCT02443116|561912000|FG000|Part 1|Participant moved out of state|0|||
155678571|NCT02443116|561912001|FG001|Part 1|Participant moved out of state|0|||
155678572|NCT02443116|561912002|FG002|Part 1|Participant moved out of state|1|||
155678573|NCT02443116|561912003|FG003|Part 1|Participant moved out of state|0|||
155678574|NCT02443116|561912004|FG004|Part 1|Participant moved out of state|0|||
155678575|NCT02443116|561912005|FG005|Part 1|Participant moved out of state|0|||
155678576|NCT02443116|561912006|FG006|Part 1|Participant moved out of state|0|||
155678577|NCT02443116|561912007|FG007|Part 1|Participant moved out of state|0|||
155678578|NCT02443116|561912008|FG008|Part 1|Participant moved out of state|0|||
155678579|NCT02443116|561912000|FG000|Part 1|Participant enrolled in another clinical trial|0|||
155678580|NCT02443116|561912001|FG001|Part 1|Participant enrolled in another clinical trial|0|||
155678581|NCT02443116|561912002|FG002|Part 1|Participant enrolled in another clinical trial|1|||
155678582|NCT02443116|561912003|FG003|Part 1|Participant enrolled in another clinical trial|0|||
155678583|NCT02443116|561912004|FG004|Part 1|Participant enrolled in another clinical trial|0|||
155678584|NCT02443116|561912005|FG005|Part 1|Participant enrolled in another clinical trial|0|||
155678585|NCT02443116|561912006|FG006|Part 1|Participant enrolled in another clinical trial|0|||
155678586|NCT02443116|561912007|FG007|Part 1|Participant enrolled in another clinical trial|0|||
155678587|NCT02443116|561912008|FG008|Part 1|Participant enrolled in another clinical trial|0|||
155678588|NCT02443116|561912000|FG000|Part 2|Adverse Event|0|||
155678589|NCT02443116|561912001|FG001|Part 2|Adverse Event|0|||
155678590|NCT02443116|561912002|FG002|Part 2|Adverse Event|0|||
155678591|NCT02443116|561912003|FG003|Part 2|Adverse Event|0|||
155678592|NCT02443116|561912004|FG004|Part 2|Adverse Event|1|||
155678593|NCT02443116|561912005|FG005|Part 2|Adverse Event|1|||
155678594|NCT02443116|561912006|FG006|Part 2|Adverse Event|2|||
155678595|NCT02443116|561912007|FG007|Part 2|Adverse Event|0|||
155678596|NCT02443116|561912008|FG008|Part 2|Adverse Event|0|||
155678597|NCT02443116|561912000|FG000|Part 2|Withdrew informed consent|0|||
155602434|NCT00954512|561632207|FG004|Overall Study|Physician Decision|0|||
155602435|NCT00954512|561632208|FG005|Overall Study|Physician Decision|0|||
155602436|NCT00954512|561632203|FG000|Overall Study|Symptomatic Deterioration|0|||
155678598|NCT02443116|561912001|FG001|Part 2|Withdrew informed consent|0|||
155678599|NCT02443116|561912002|FG002|Part 2|Withdrew informed consent|0|||
155678600|NCT02443116|561912003|FG003|Part 2|Withdrew informed consent|0|||
155602437|NCT00954512|561632204|FG001|Overall Study|Symptomatic Deterioration|1|||
155602438|NCT00954512|561632205|FG002|Overall Study|Symptomatic Deterioration|0|||
155602439|NCT00954512|561632206|FG003|Overall Study|Symptomatic Deterioration|0|||
155678601|NCT02443116|561912004|FG004|Part 2|Withdrew informed consent|0|||
155678602|NCT02443116|561912005|FG005|Part 2|Withdrew informed consent|1|||
155678603|NCT02443116|561912006|FG006|Part 2|Withdrew informed consent|1|||
155678604|NCT02443116|561912007|FG007|Part 2|Withdrew informed consent|0|||
155678605|NCT02443116|561912008|FG008|Part 2|Withdrew informed consent|0|||
155678606|NCT02443116|561912000|FG000|Part 2|Inability to comply with protocol|0|||
155678607|NCT02443116|561912001|FG001|Part 2|Inability to comply with protocol|0|||
155678608|NCT02443116|561912002|FG002|Part 2|Inability to comply with protocol|0|||
155678609|NCT02443116|561912003|FG003|Part 2|Inability to comply with protocol|1|||
155678610|NCT02443116|561912004|FG004|Part 2|Inability to comply with protocol|0|||
155678611|NCT02443116|561912005|FG005|Part 2|Inability to comply with protocol|0|||
155678612|NCT02443116|561912006|FG006|Part 2|Inability to comply with protocol|0|||
155678613|NCT02443116|561912007|FG007|Part 2|Inability to comply with protocol|0|||
155678614|NCT02443116|561912008|FG008|Part 2|Inability to comply with protocol|0|||
155678615|NCT02443116|561912000|FG000|Part 2|Lost to Follow-up|0|||
155678616|NCT02443116|561912001|FG001|Part 2|Lost to Follow-up|0|||
155678617|NCT02443116|561912002|FG002|Part 2|Lost to Follow-up|0|||
155678618|NCT02443116|561912003|FG003|Part 2|Lost to Follow-up|1|||
155678619|NCT02443116|561912004|FG004|Part 2|Lost to Follow-up|0|||
155678620|NCT02443116|561912005|FG005|Part 2|Lost to Follow-up|0|||
155678621|NCT02443116|561912006|FG006|Part 2|Lost to Follow-up|0|||
155678622|NCT02443116|561912007|FG007|Part 2|Lost to Follow-up|0|||
155678623|NCT02443116|561912008|FG008|Part 2|Lost to Follow-up|0|||
155678624|NCT02443116|561912000|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678625|NCT02443116|561912001|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678626|NCT02443116|561912002|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678627|NCT02443116|561912003|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678628|NCT02443116|561912004|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678629|NCT02443116|561912005|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
155678630|NCT02443116|561912006|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678631|NCT02443116|561912007|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678632|NCT02443116|561912008|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155678633|NCT02443116|561912000|FG000|Part 3|Adverse Event|0|||
155678634|NCT02443116|561912001|FG001|Part 3|Adverse Event|0|||
155678635|NCT02443116|561912002|FG002|Part 3|Adverse Event|0|||
155678636|NCT02443116|561912003|FG003|Part 3|Adverse Event|0|||
155678637|NCT02443116|561912004|FG004|Part 3|Adverse Event|0|||
155678638|NCT02443116|561912005|FG005|Part 3|Adverse Event|0|||
155678639|NCT02443116|561912006|FG006|Part 3|Adverse Event|0|||
155678640|NCT02443116|561912007|FG007|Part 3|Adverse Event|0|||
155678641|NCT02443116|561912008|FG008|Part 3|Adverse Event|1|||
155678642|NCT02443116|561912000|FG000|Part 3|Withdrew informed consent|0|||
155678643|NCT02443116|561912001|FG001|Part 3|Withdrew informed consent|0|||
155678644|NCT02443116|561912002|FG002|Part 3|Withdrew informed consent|0|||
155678645|NCT02443116|561912003|FG003|Part 3|Withdrew informed consent|0|||
155678646|NCT02443116|561912004|FG004|Part 3|Withdrew informed consent|0|||
155678647|NCT02443116|561912005|FG005|Part 3|Withdrew informed consent|0|||
155678648|NCT02443116|561912006|FG006|Part 3|Withdrew informed consent|0|||
155678649|NCT02443116|561912007|FG007|Part 3|Withdrew informed consent|3|||
155678650|NCT02443116|561912008|FG008|Part 3|Withdrew informed consent|2|||
155678651|NCT02443116|561912000|FG000|Part 3|Lost to Follow-up|0|||
155678652|NCT02443116|561912001|FG001|Part 3|Lost to Follow-up|0|||
155678653|NCT02443116|561912002|FG002|Part 3|Lost to Follow-up|0|||
155678654|NCT02443116|561912003|FG003|Part 3|Lost to Follow-up|0|||
155678655|NCT02443116|561912004|FG004|Part 3|Lost to Follow-up|0|||
155678656|NCT02443116|561912005|FG005|Part 3|Lost to Follow-up|0|||
155678657|NCT02443116|561912006|FG006|Part 3|Lost to Follow-up|0|||
155678658|NCT02443116|561912007|FG007|Part 3|Lost to Follow-up|1|||
155678659|NCT02443116|561912008|FG008|Part 3|Lost to Follow-up|2|||
155678660|NCT01917929|561912009|FG000|Overall Study|Death|8|||
155678661|NCT01917929|561912009|FG000|Overall Study|Lost to Follow-up|19|||
155678662|NCT01917929|561912009|FG000|Overall Study|Withdrawal by Subject|33|||
155678663|NCT01917929|561912009|FG000|Overall Study|Adverse Event|6|||
155678664|NCT01917929|561912009|FG000|Overall Study|Investigative Site Terminated|35|||
155678665|NCT01917929|561912009|FG000|Overall Study|Censored because study device not implanted|6|||
155678666|NCT01917929|561912009|FG000|Overall Study|Censored because surgery not performed|3|||
155678667|NCT01917929|561912009|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
155678668|NCT01917929|561912009|FG000|Overall Study|Sponsor terminated study|175|||
155678669|NCT04295759|561912010|FG000|Overall Study|Lack of Efficacy|9|||
155678670|NCT04295759|561912010|FG000|Overall Study|Death|1|||
155678671|NCT04295759|561912010|FG000|Overall Study|Withdrawal by Subject|2|||
155678672|NCT04295759|561912010|FG000|Overall Study|Deemed ineligible|1|||
155678673|NCT01696981|561912011|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
155678674|NCT01696981|561912012|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
155678675|NCT01696981|561912011|FG000|Overall Study|Died Before Randomization|3|||
155678676|NCT01696981|561912012|FG001|Overall Study|Died Before Randomization|8|||
155678677|NCT01696981|561912011|FG000|Overall Study|Died Before ASU (Control)|278|||
155678678|NCT01696981|561912012|FG001|Overall Study|Died Before ASU (Control)|0|||
155678679|NCT01696981|561912011|FG000|Overall Study|Refused ASU (Control)|920|||
155678680|NCT01696981|561912012|FG001|Overall Study|Refused ASU (Control)|0|||
155678681|NCT01696981|561912011|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
155602440|NCT00954512|561632207|FG004|Overall Study|Symptomatic Deterioration|2|||
155602441|NCT00954512|561632208|FG005|Overall Study|Symptomatic Deterioration|0|||
155602442|NCT00954512|561632203|FG000|Overall Study|Progression of Disease|2|||
155602443|NCT00954512|561632204|FG001|Overall Study|Progression of Disease|1|||
155602444|NCT00954512|561632205|FG002|Overall Study|Progression of Disease|0|||
155602445|NCT00954512|561632206|FG003|Overall Study|Progression of Disease|1|||
155602446|NCT00954512|561632207|FG004|Overall Study|Progression of Disease|1|||
155602447|NCT00954512|561632208|FG005|Overall Study|Progression of Disease|1|||
155602448|NCT04814368|561632209|FG000|Overall Study|Study Terminated by Sponsor|0|||
155678682|NCT01696981|561912012|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
155678683|NCT00465972|561912015|FG000|Overall Study|Withdrawal by Subject|2|||
155678684|NCT00465972|561912016|FG001|Overall Study|Withdrawal by Subject|1|||
155678685|NCT02097719|561912017|FG000|Overall Study|Subject Withdrew Consent|1|||
155678686|NCT02097719|561912018|FG001|Overall Study|Subject Withdrew Consent|0|||
155678687|NCT02097719|561912017|FG000|Overall Study|Lost to Follow-up|0|||
155678688|NCT02097719|561912018|FG001|Overall Study|Lost to Follow-up|1|||
155678689|NCT02097719|561912017|FG000|Overall Study|Adverse Event|2|||
155678690|NCT02097719|561912018|FG001|Overall Study|Adverse Event|0|||
155678691|NCT03292640|561912019|FG000|Overall Study|Withdrawal by Subject|17|||
155678692|NCT03292640|561912020|FG001|Overall Study|Withdrawal by Subject|16|||
155678693|NCT03292640|561912019|FG000|Overall Study|Adverse Event|20|||
155678694|NCT03292640|561912020|FG001|Overall Study|Adverse Event|2|||
155678695|NCT03292640|561912019|FG000|Overall Study|Lost to Follow-up|24|||
155678696|NCT03292640|561912020|FG001|Overall Study|Lost to Follow-up|24|||
155678697|NCT01108731|561912022|FG000|Overall Study|Withdrawal by Subject|1|||
155678698|NCT01108731|561912023|FG001|Overall Study|Withdrawal by Subject|1|||
155678699|NCT01108731|561912022|FG000|Overall Study|Adverse Event|3|||
155678700|NCT01108731|561912023|FG001|Overall Study|Adverse Event|3|||
155678701|NCT00984594|561912025|FG000|Overall Study|Lost to Follow-up|1|||
155678702|NCT00984594|561912026|FG001|Overall Study|Lost to Follow-up|0|||
155678703|NCT00984594|561912025|FG000|Overall Study|Withdrawal by Subject|0|||
155678704|NCT00984594|561912026|FG001|Overall Study|Withdrawal by Subject|1|||
155678705|NCT00851890|561912027|FG000|Overall Study|Lost to Follow-up|0|||
155678706|NCT00851890|561912028|FG001|Overall Study|Lost to Follow-up|1|||
155678707|NCT00851890|561912029|FG002|Overall Study|Lost to Follow-up|0|||
155678708|NCT00851890|561912030|FG003|Overall Study|Lost to Follow-up|1|||
155678709|NCT01063062|561912031|FG000|Overall Study|Patient withdrew consent|0|||
155678710|NCT01063062|561912032|FG001|Overall Study|Patient withdrew consent|1|||
155678711|NCT01063062|561912031|FG000|Overall Study|Adverse Event|2|||
155678712|NCT01063062|561912032|FG001|Overall Study|Adverse Event|4|||
155678713|NCT01063062|561912031|FG000|Overall Study|Protocol Violation|5|||
155678714|NCT01063062|561912032|FG001|Overall Study|Protocol Violation|4|||
155678715|NCT01063062|561912031|FG000|Overall Study|Investigator's request|1|||
155678716|NCT01063062|561912032|FG001|Overall Study|Investigator's request|0|||
155678717|NCT01063062|561912031|FG000|Overall Study|Lost to Follow-up|0|||
155678718|NCT01063062|561912032|FG001|Overall Study|Lost to Follow-up|2|||
155678719|NCT01063062|561912031|FG000|Overall Study|Miscellaneous reason|0|||
155678720|NCT01063062|561912032|FG001|Overall Study|Miscellaneous reason|1|||
155678721|NCT02015481|561912033|FG000|Overall Study|Death|1|||
155678722|NCT03122145|561912037|FG000|Overall Study|Concurrent respiratory disease|3|||
155678723|NCT03122145|561912038|FG001|Overall Study|Concurrent respiratory disease|0|||
155678724|NCT02016716|561912043|FG000|Overall Study|Withdrawal by Subject|5|||
155678725|NCT02016716|561912044|FG001|Overall Study|Withdrawal by Subject|5|||
155678726|NCT02016716|561912045|FG002|Overall Study|Withdrawal by Subject|5|||
155678727|NCT02016716|561912043|FG000|Overall Study|Protocol-specified Criteria|0|||
155678728|NCT02016716|561912044|FG001|Overall Study|Protocol-specified Criteria|1|||
155678729|NCT02016716|561912045|FG002|Overall Study|Protocol-specified Criteria|0|||
155602449|NCT04814368|561632210|FG001|Overall Study|Study Terminated by Sponsor|3|||
155678730|NCT02016716|561912043|FG000|Overall Study|Lost to Follow-up|1|||
155678731|NCT02016716|561912044|FG001|Overall Study|Lost to Follow-up|2|||
155678732|NCT02016716|561912045|FG002|Overall Study|Lost to Follow-up|1|||
155678733|NCT00079391|561912046|FG000|Overall Study|Withdrawal by Subject|1|||
155678734|NCT03206918|561912047|FG000|Overall Study|Death|11|||
155678735|NCT03206918|561912047|FG000|Overall Study|Withdrawal by Subject|5|||
155678736|NCT03206918|561912047|FG000|Overall Study|Study terminated by sponsor|12|||
155678737|NCT03206918|561912047|FG000|Overall Study|Lost to Follow-up|3|||
155678738|NCT03206918|561912047|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
155678739|NCT03479541|561912050|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
155678740|NCT03479541|561912051|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
155678741|NCT03479541|561912052|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
155678742|NCT03479541|561912053|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
155678743|NCT03479541|561912050|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
155678744|NCT03479541|561912051|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
155602450|NCT04814368|561632211|FG002|Overall Study|Study Terminated by Sponsor|0|||
155602451|NCT04814368|561632212|FG003|Overall Study|Study Terminated by Sponsor|2|||
155602452|NCT04814368|561632209|FG000|Overall Study|Subject Decision|1|||
155602453|NCT04814368|561632210|FG001|Overall Study|Subject Decision|2|||
155602454|NCT04814368|561632211|FG002|Overall Study|Subject Decision|0|||
155602455|NCT04814368|561632212|FG003|Overall Study|Subject Decision|0|||
155602456|NCT04216589|561632214|FG000|Overall Study|Withdrawal by Subject|2|||
155602457|NCT04216589|561632214|FG000|Overall Study|Protocol Violation|1|||
155602458|NCT04216589|561632214|FG000|Overall Study|Incarceration|1|||
155602459|NCT03721835|561632215|FG000|Overall Study|Participant not able to return|1|||
155602460|NCT03721835|561632215|FG000|Overall Study|Lost to Follow-up|1|||
155602461|NCT03721835|561632215|FG000|Overall Study|Revision of the components of the study device|2|||
155602462|NCT03721835|561632215|FG000|Overall Study|Sponsor terminated study|6|||
155602463|NCT03721835|561632215|FG000|Overall Study|Death|1|||
155602464|NCT03721835|561632215|FG000|Overall Study|Sponsor decision|1|||
155602465|NCT02100670|561632219|FG000|Overall Study|Adverse Event|10|||
155602466|NCT02100670|561632220|FG001|Overall Study|Adverse Event|3|||
155602467|NCT02100670|561632221|FG002|Overall Study|Adverse Event|3|||
155602468|NCT02100670|561632222|FG003|Overall Study|Adverse Event|0|||
155602469|NCT02100670|561632219|FG000|Overall Study|Lost to Follow-up|1|||
155602470|NCT02100670|561632220|FG001|Overall Study|Lost to Follow-up|0|||
155602471|NCT02100670|561632221|FG002|Overall Study|Lost to Follow-up|0|||
155602472|NCT02100670|561632222|FG003|Overall Study|Lost to Follow-up|0|||
155602473|NCT02100670|561632219|FG000|Overall Study|Protocol Violation|0|||
155602474|NCT02100670|561632220|FG001|Overall Study|Protocol Violation|1|||
155602475|NCT02100670|561632221|FG002|Overall Study|Protocol Violation|0|||
155602476|NCT02100670|561632222|FG003|Overall Study|Protocol Violation|1|||
155602477|NCT02100670|561632219|FG000|Overall Study|Withdrawal of Consent|0|||
155602478|NCT02100670|561632220|FG001|Overall Study|Withdrawal of Consent|1|||
155602479|NCT02100670|561632221|FG002|Overall Study|Withdrawal of Consent|1|||
155602480|NCT02100670|561632222|FG003|Overall Study|Withdrawal of Consent|0|||
155602481|NCT02100670|561632219|FG000|Overall Study|No swelling no pain|1|||
155602482|NCT02100670|561632220|FG001|Overall Study|No swelling no pain|0|||
155602483|NCT02100670|561632221|FG002|Overall Study|No swelling no pain|0|||
155602484|NCT02100670|561632222|FG003|Overall Study|No swelling no pain|0|||
155602485|NCT02100670|561632219|FG000|Overall Study|Poor Efficacy|0|||
155602486|NCT02100670|561632220|FG001|Overall Study|Poor Efficacy|1|||
155602487|NCT02100670|561632221|FG002|Overall Study|Poor Efficacy|0|||
155602488|NCT02100670|561632222|FG003|Overall Study|Poor Efficacy|0|||
155602489|NCT02100670|561632219|FG000|Overall Study|Physician Decision|0|||
155602490|NCT02100670|561632220|FG001|Overall Study|Physician Decision|1|||
155602491|NCT02100670|561632221|FG002|Overall Study|Physician Decision|0|||
155602492|NCT02100670|561632222|FG003|Overall Study|Physician Decision|0|||
155602493|NCT02100670|561632219|FG000|Overall Study|Withdrawal by Subject|1|||
155602494|NCT02100670|561632220|FG001|Overall Study|Withdrawal by Subject|0|||
155602495|NCT02100670|561632221|FG002|Overall Study|Withdrawal by Subject|0|||
155602496|NCT02100670|561632222|FG003|Overall Study|Withdrawal by Subject|0|||
155602497|NCT01892085|561633658|FG000|Overall Study|Death|4|||
155602498|NCT01892085|561633659|FG001|Overall Study|Death|1|||
155602499|NCT01892085|561633660|FG002|Overall Study|Death|3|||
155602500|NCT01892085|561633658|FG000|Overall Study|Withdrawal by Subject|2|||
155602501|NCT01892085|561633659|FG001|Overall Study|Withdrawal by Subject|0|||
155602502|NCT01892085|561633660|FG002|Overall Study|Withdrawal by Subject|2|||
155602503|NCT00503997|561633662|FG000|Overall Study|disease progression|1|||
155602504|NCT00503997|561633662|FG000|Overall Study|Adverse Event|5|||
155602505|NCT00503997|561633662|FG000|Overall Study|Death|1|||
155602506|NCT00503997|561633662|FG000|Overall Study|Withdrawal by Subject|1|||
155602507|NCT01195844|561633663|FG000|Overall Study|Fecal sample not collected|40|||
155602508|NCT00087126|561633664|FG000|Overall Study|Ineligible - second primary|1|||
155602509|NCT00087126|561633664|FG000|Overall Study|Never treated|1|||
155602510|NCT00435487|561633669|FG000|Overall Study|Death|3|||
155602511|NCT00435487|561633670|FG001|Overall Study|Death|4|||
155602512|NCT00435487|561633669|FG000|Overall Study|Adverse Event|0|||
155602513|NCT00435487|561633670|FG001|Overall Study|Adverse Event|3|||
155602514|NCT00435487|561633669|FG000|Overall Study|Lost to Follow-up|2|||
155602515|NCT00435487|561633670|FG001|Overall Study|Lost to Follow-up|2|||
155602516|NCT00435487|561633669|FG000|Overall Study|Other|5|||
155602517|NCT00435487|561633670|FG001|Overall Study|Other|2|||
155602518|NCT00435487|561633669|FG000|Overall Study|Withdrawal by Subject|2|||
155602519|NCT00435487|561633670|FG001|Overall Study|Withdrawal by Subject|1|||
155602520|NCT00435487|561633669|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
155602521|NCT00435487|561633670|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
155602522|NCT00435487|561633669|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
155602523|NCT00435487|561633670|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
155602524|NCT00835679|561633672|FG000|Overall Study|Withdrawal by Subject|1|||
155602525|NCT00835679|561633673|FG001|Overall Study|Withdrawal by Subject|0|||
155602526|NCT00835679|561633674|FG002|Overall Study|Withdrawal by Subject|0|||
155602527|NCT00835679|561633675|FG003|Overall Study|Withdrawal by Subject|0|||
155602528|NCT00955968|561633679|FG000|Overall Study|Death|2|||
155602529|NCT00955968|561633680|FG001|Overall Study|Death|4|||
155602530|NCT00955968|561633679|FG000|Overall Study|Withdrawal by Subject|35|||
155602531|NCT00955968|561633680|FG001|Overall Study|Withdrawal by Subject|31|||
155602532|NCT00955968|561633679|FG000|Overall Study|Lost to Follow-up|45|||
155602533|NCT00955968|561633680|FG001|Overall Study|Lost to Follow-up|39|||
155602534|NCT00955968|561633679|FG000|Overall Study|Site closed|55|||
155602535|NCT00955968|561633680|FG001|Overall Study|Site closed|52|||
155602536|NCT05020899|561633682|FG000|8 Week Follow-up|Lost to Follow-up|3|||
155602537|NCT05020899|561633683|FG001|8 Week Follow-up|Lost to Follow-up|6|||
155602538|NCT05020899|561633682|FG000|12 Week Follow-up|Lost to Follow-up|1|||
155602539|NCT05020899|561633683|FG001|12 Week Follow-up|Lost to Follow-up|0|||
155602540|NCT05020899|561633682|FG000|12 Week Follow-up|Death|0|||
155602541|NCT05020899|561633683|FG001|12 Week Follow-up|Death|1|||
155602542|NCT01068626|561633686|FG000|Overall Study|Adverse Event|3|||
155602543|NCT01068626|561633687|FG001|Overall Study|Adverse Event|0|||
155602544|NCT01068626|561633686|FG000|Overall Study|Withdrawal by Subject|0|||
155602545|NCT01068626|561633687|FG001|Overall Study|Withdrawal by Subject|2|||
155602546|NCT01785849|561633688|FG000|Overall Study|Death|7|||
155602547|NCT01785849|561633689|FG001|Overall Study|Death|9|||
155602548|NCT01785849|561633688|FG000|Overall Study|Protocol Specified Criteria|29|||
155602549|NCT01785849|561633689|FG001|Overall Study|Protocol Specified Criteria|1|||
155602550|NCT01785849|561633688|FG000|Overall Study|Withdrawal by Subject|15|||
155602551|NCT01785849|561633689|FG001|Overall Study|Withdrawal by Subject|12|||
155602552|NCT01785849|561633688|FG000|Overall Study|Sponsor Decision|0|||
155602553|NCT01785849|561633689|FG001|Overall Study|Sponsor Decision|1|||
155602554|NCT01785849|561633688|FG000|Overall Study|Lost to Follow-up|10|||
155602555|NCT01785849|561633689|FG001|Overall Study|Lost to Follow-up|11|||
155602556|NCT01032239|561633690|FG000|Overall Study|Lost to Follow-up|3|||
155602557|NCT01032239|561633691|FG001|Overall Study|Lost to Follow-up|2|||
155602558|NCT01032239|561633690|FG000|Overall Study|Withdrawal by Subject|2|||
155602559|NCT01032239|561633691|FG001|Overall Study|Withdrawal by Subject|3|||
155602560|NCT01032239|561633690|FG000|Overall Study|Death|1|||
155602561|NCT01032239|561633691|FG001|Overall Study|Death|0|||
155602562|NCT01032239|561633690|FG000|Overall Study|Protocol Violation|1|||
155602563|NCT01032239|561633691|FG001|Overall Study|Protocol Violation|0|||
155602564|NCT00204477|561633692|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
155602565|NCT00204477|561633693|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
155602566|NCT00204477|561633692|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
155602567|NCT00204477|561633693|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
155602568|NCT01940900|561633694|FG000|Overall Study|Physician Decision|4|||
155602569|NCT01940900|561633695|FG001|Overall Study|Physician Decision|0|||
155602570|NCT01940900|561633694|FG000|Overall Study|Adverse Event|10|||
155602571|NCT01940900|561633695|FG001|Overall Study|Adverse Event|15|||
155602572|NCT01940900|561633694|FG000|Overall Study|Withdrawal by Subject|11|||
155602573|NCT01940900|561633695|FG001|Overall Study|Withdrawal by Subject|15|||
155602574|NCT01940900|561633694|FG000|Overall Study|Lost to Follow-up|1|||
155602575|NCT01940900|561633695|FG001|Overall Study|Lost to Follow-up|0|||
155602576|NCT01940900|561633694|FG000|Overall Study|Sponsor Decision|1|||
155602577|NCT01940900|561633695|FG001|Overall Study|Sponsor Decision|0|||
155602578|NCT01940900|561633694|FG000|Overall Study|subject non-compliance|1|||
155602579|NCT01940900|561633695|FG001|Overall Study|subject non-compliance|1|||
155602580|NCT01940900|561633694|FG000|Overall Study|other|1|||
155602581|NCT01940900|561633695|FG001|Overall Study|other|0|||
155602582|NCT04713592|561633698|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155602583|NCT04713592|561633699|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
155602584|NCT04713592|561633700|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155602585|NCT04713592|561633701|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155602586|NCT04713592|561633698|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
155602587|NCT04713592|561633699|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
155602588|NCT04713592|561633700|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
155602589|NCT04713592|561633701|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
155602590|NCT04713592|561633698|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
155602591|NCT04713592|561633699|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
155602592|NCT04713592|561633700|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
155602593|NCT04713592|561633701|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
155602594|NCT04713592|561633698|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155602595|NCT04713592|561633699|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155602596|NCT04713592|561633700|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
155602597|NCT04713592|561633701|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
155602598|NCT04713592|561633698|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
155602599|NCT04713592|561633699|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
155602600|NCT04713592|561633700|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
155602601|NCT04713592|561633701|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
155602602|NCT04713592|561633698|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155602603|NCT04713592|561633699|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155602604|NCT04713592|561633700|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155602605|NCT04713592|561633701|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155602606|NCT04713592|561633698|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
155602607|NCT04713592|561633699|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
155602608|NCT04713592|561633700|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
155602609|NCT04713592|561633701|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
155602610|NCT01382225|561633704|FG000|Overall Study|Adverse Event|3|||
155602611|NCT01382225|561633705|FG001|Overall Study|Adverse Event|2|||
155602612|NCT01382225|561633704|FG000|Overall Study|Protocol Violation|2|||
155602613|NCT01382225|561633705|FG001|Overall Study|Protocol Violation|1|||
155602614|NCT01382225|561633704|FG000|Overall Study|Subject Withdrew Consent|5|||
155602615|NCT01382225|561633705|FG001|Overall Study|Subject Withdrew Consent|2|||
155602616|NCT01382225|561633704|FG000|Overall Study|Other|4|||
155602617|NCT01382225|561633705|FG001|Overall Study|Other|2|||
155602618|NCT01797081|561633708|FG000|Overall Study|Adverse Event|1|||
155602619|NCT01797081|561633709|FG001|Overall Study|Adverse Event|0|||
155602620|NCT01797081|561633710|FG002|Overall Study|Adverse Event|1|||
155602621|NCT01797081|561633711|FG003|Overall Study|Adverse Event|0|||
155602622|NCT01797081|561633708|FG000|Overall Study|Pregnancy|1|||
155602623|NCT01797081|561633709|FG001|Overall Study|Pregnancy|0|||
155602624|NCT01797081|561633710|FG002|Overall Study|Pregnancy|0|||
155602625|NCT01797081|561633711|FG003|Overall Study|Pregnancy|0|||
155602626|NCT01797081|561633708|FG000|Overall Study|Personal Reasons|12|||
155602627|NCT01797081|561633709|FG001|Overall Study|Personal Reasons|4|||
155602628|NCT01797081|561633710|FG002|Overall Study|Personal Reasons|4|||
155602629|NCT01797081|561633711|FG003|Overall Study|Personal Reasons|8|||
155602630|NCT01797081|561633708|FG000|Overall Study|Protocol Violation|0|||
155602631|NCT01797081|561633709|FG001|Overall Study|Protocol Violation|0|||
155602632|NCT01797081|561633710|FG002|Overall Study|Protocol Violation|0|||
155602633|NCT01797081|561633711|FG003|Overall Study|Protocol Violation|1|||
155602634|NCT05513703|561633718|FG000|Overall Study|Death|4|||
155602635|NCT05513703|561633718|FG000|Overall Study|Study terminated by sponsor|5|||
155602636|NCT01793688|561633720|FG000|Overall Study|Protocol Violation|2|||
155602637|NCT01698879|561633723|FG000|Overall Study|Withdrawal by Subject|1|||
155602638|NCT01698879|561633724|FG001|Overall Study|Withdrawal by Subject|0|||
155602639|NCT01698879|561633725|FG002|Overall Study|Withdrawal by Subject|0|||
155602640|NCT00150800|561633726|FG000|Overall Study|Adverse Event|89|||
155602641|NCT00150800|561633726|FG000|Overall Study|Death|18|||
155602642|NCT00150800|561633726|FG000|Overall Study|Lack of Efficacy|166|||
155602643|NCT00150800|561633726|FG000|Overall Study|Lost to Follow-up|58|||
155602644|NCT00150800|561633726|FG000|Overall Study|Subject's choice|90|||
155602645|NCT00150800|561633726|FG000|Overall Study|No compliance|18|||
155602646|NCT00150800|561633726|FG000|Overall Study|IP misshandling|1|||
155602647|NCT00150800|561633726|FG000|Overall Study|Site closure|24|||
155602648|NCT00150800|561633726|FG000|Overall Study|Protocol non-adherence|2|||
155602649|NCT00150800|561633726|FG000|Overall Study|Nobody to accompany patient|1|||
155602650|NCT00150800|561633726|FG000|Overall Study|Distance too long for patient|1|||
155602651|NCT00150800|561633726|FG000|Overall Study|Neurosurgery|2|||
155602652|NCT00150800|561633726|FG000|Overall Study|BRV monotherapy|1|||
155602653|NCT00150800|561633726|FG000|Overall Study|Visit refusal|3|||
155602654|NCT00150800|561633726|FG000|Overall Study|Sponsor's request|2|||
155602655|NCT00150800|561633726|FG000|Overall Study|Generalized Epilepsy|1|||
155602656|NCT00150800|561633726|FG000|Overall Study|Moved from area/country|8|||
155602657|NCT00150800|561633726|FG000|Overall Study|PI retiring|2|||
155602658|NCT00150800|561633726|FG000|Overall Study|PI leaving site|2|||
155602659|NCT00150800|561633726|FG000|Overall Study|Patient insurance|1|||
155602660|NCT00150800|561633726|FG000|Overall Study|Surgical intervention|4|||
155602661|NCT00150800|561633726|FG000|Overall Study|Pregnancy planned|1|||
155602662|NCT00150800|561633726|FG000|Overall Study|PI discontinuation request|1|||
155602663|NCT04972968|561633727|FG000|Overall Study|Adverse Event|3|||
155602664|NCT04972968|561633728|FG001|Overall Study|Adverse Event|1|||
155678745|NCT03479541|561912052|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
155678746|NCT03479541|561912053|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
155678747|NCT03479541|561912050|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
155678748|NCT03479541|561912051|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
155602665|NCT04972968|561633729|FG002|Overall Study|Adverse Event|1|||
155602666|NCT04972968|561633730|FG003|Overall Study|Adverse Event|7|||
155602667|NCT04972968|561633727|FG000|Overall Study|Lack of Efficacy|2|||
155602668|NCT04972968|561633728|FG001|Overall Study|Lack of Efficacy|1|||
155602669|NCT04972968|561633729|FG002|Overall Study|Lack of Efficacy|0|||
155602670|NCT04972968|561633730|FG003|Overall Study|Lack of Efficacy|0|||
155602671|NCT04972968|561633727|FG000|Overall Study|Withdrawal by Subject|7|||
155602672|NCT04972968|561633728|FG001|Overall Study|Withdrawal by Subject|4|||
155602673|NCT04972968|561633729|FG002|Overall Study|Withdrawal by Subject|3|||
155602674|NCT04972968|561633730|FG003|Overall Study|Withdrawal by Subject|2|||
155602675|NCT04972968|561633727|FG000|Overall Study|Study Terminated by Sponsor|25|||
155602676|NCT04972968|561633728|FG001|Overall Study|Study Terminated by Sponsor|28|||
155602677|NCT04972968|561633729|FG002|Overall Study|Study Terminated by Sponsor|32|||
155602678|NCT04972968|561633730|FG003|Overall Study|Study Terminated by Sponsor|27|||
155602679|NCT04972968|561633727|FG000|Overall Study|Other|1|||
155602680|NCT04972968|561633728|FG001|Overall Study|Other|0|||
155602681|NCT04972968|561633729|FG002|Overall Study|Other|1|||
155602682|NCT04972968|561633730|FG003|Overall Study|Other|1|||
155602683|NCT03649178|561633731|FG000|Overall Study|Adverse Event|1|||
155602684|NCT03649178|561633732|FG001|Overall Study|Adverse Event|2|||
155602685|NCT03649178|561633731|FG000|Overall Study|Withdrawal by Subject|0|||
155602686|NCT03649178|561633732|FG001|Overall Study|Withdrawal by Subject|2|||
155602687|NCT03649178|561633731|FG000|Overall Study|COVID regulation required halt in protocol|1|||
155602688|NCT03649178|561633732|FG001|Overall Study|COVID regulation required halt in protocol|0|||
155602689|NCT03814720|561633744|FG000|Overall Study|Lost to Follow-up|0|||
155602690|NCT03814720|561633745|FG001|Overall Study|Lost to Follow-up|1|||
155602691|NCT03814720|561633746|FG002|Overall Study|Lost to Follow-up|0|||
155602692|NCT03814720|561633747|FG003|Overall Study|Lost to Follow-up|0|||
155602693|NCT03814720|561633748|FG004|Overall Study|Lost to Follow-up|0|||
155602694|NCT02135107|561633755|FG000|Treatment Period|Withdrawal by Subject|11|||
155602695|NCT02135107|561633756|FG001|Treatment Period|Withdrawal by Subject|0|||
155602696|NCT02135107|561633757|FG002|Treatment Period|Withdrawal by Subject|0|||
155602697|NCT02135107|561633758|FG003|Treatment Period|Withdrawal by Subject|0|||
155602698|NCT02135107|561633755|FG000|Treatment Period|Adverse Event|5|||
155602699|NCT02135107|561633756|FG001|Treatment Period|Adverse Event|2|||
155602700|NCT02135107|561633757|FG002|Treatment Period|Adverse Event|0|||
155602701|NCT02135107|561633758|FG003|Treatment Period|Adverse Event|0|||
155602702|NCT02135107|561633755|FG000|Treatment Period|Pregnancy|1|||
155602703|NCT02135107|561633756|FG001|Treatment Period|Pregnancy|0|||
155602704|NCT02135107|561633757|FG002|Treatment Period|Pregnancy|0|||
155602705|NCT02135107|561633758|FG003|Treatment Period|Pregnancy|0|||
155602706|NCT02135107|561633755|FG000|Treatment Period|Other|115|||
155602707|NCT02135107|561633756|FG001|Treatment Period|Other|24|||
155602708|NCT02135107|561633757|FG002|Treatment Period|Other|0|||
155602709|NCT02135107|561633758|FG003|Treatment Period|Other|0|||
155602710|NCT02135107|561633755|FG000|Maintenance Therapy Period|Adverse Event|0|||
155602711|NCT02135107|561633756|FG001|Maintenance Therapy Period|Adverse Event|0|||
155602712|NCT02135107|561633757|FG002|Maintenance Therapy Period|Adverse Event|3|||
155602713|NCT02135107|561633758|FG003|Maintenance Therapy Period|Adverse Event|7|||
155602714|NCT02135107|561633755|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
155602715|NCT02135107|561633756|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
155602716|NCT02135107|561633757|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
155602717|NCT02135107|561633758|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
155602718|NCT02135107|561633755|FG000|Maintenance Therapy Period|Pregnancy|0|||
155602719|NCT02135107|561633756|FG001|Maintenance Therapy Period|Pregnancy|0|||
155602720|NCT02135107|561633757|FG002|Maintenance Therapy Period|Pregnancy|0|||
155602721|NCT02135107|561633758|FG003|Maintenance Therapy Period|Pregnancy|1|||
155602722|NCT02135107|561633755|FG000|Maintenance Therapy Period|Other|0|||
155602723|NCT02135107|561633756|FG001|Maintenance Therapy Period|Other|0|||
155602724|NCT02135107|561633757|FG002|Maintenance Therapy Period|Other|7|||
155602725|NCT02135107|561633758|FG003|Maintenance Therapy Period|Other|8|||
155602726|NCT00474045|561633759|FG000|Overall Study|Adverse Event|18|||
155602727|NCT00474045|561633760|FG001|Overall Study|Adverse Event|8|||
155602728|NCT00474045|561633759|FG000|Overall Study|Unclassified|1|||
155602729|NCT00474045|561633760|FG001|Overall Study|Unclassified|3|||
155602730|NCT00474045|561633759|FG000|Overall Study|Lack of Efficacy|0|||
155602731|NCT00474045|561633760|FG001|Overall Study|Lack of Efficacy|9|||
155602732|NCT00474045|561633759|FG000|Overall Study|Lost to Follow-up|1|||
155602733|NCT00474045|561633760|FG001|Overall Study|Lost to Follow-up|1|||
155602734|NCT00474045|561633759|FG000|Overall Study|Protocol Violation|10|||
155602735|NCT00474045|561633760|FG001|Overall Study|Protocol Violation|12|||
155602736|NCT00474045|561633759|FG000|Overall Study|Withdrawal by Subject|16|||
155602737|NCT00474045|561633760|FG001|Overall Study|Withdrawal by Subject|18|||
155602738|NCT00474045|561633759|FG000|Overall Study|Withdrawal criteria|60|||
155602739|NCT00474045|561633760|FG001|Overall Study|Withdrawal criteria|50|||
155602740|NCT02009397|561633761|FG000|Overall Study|Protocol Violation|6|||
155602741|NCT02009397|561633761|FG000|Overall Study|Death|8|||
155602742|NCT02009397|561633761|FG000|Overall Study|Lost to Follow-up|6|||
155602743|NCT00191282|561633765|FG000|Overall Study|Adverse Event|5|||
155602744|NCT00191282|561633766|FG001|Overall Study|Adverse Event|6|||
155602745|NCT00191282|561633765|FG000|Overall Study|Death|51|||
155602746|NCT00191282|561633766|FG001|Overall Study|Death|51|||
155602747|NCT00191282|561633765|FG000|Overall Study|Lack of Efficacy|11|||
155602748|NCT00191282|561633766|FG001|Overall Study|Lack of Efficacy|6|||
155602749|NCT00191282|561633765|FG000|Overall Study|Noncompliance|14|||
155602750|NCT00191282|561633766|FG001|Overall Study|Noncompliance|17|||
155602751|NCT00191282|561633765|FG000|Overall Study|Patient moved|11|||
155602752|NCT00191282|561633766|FG001|Overall Study|Patient moved|14|||
155602753|NCT00191282|561633765|FG000|Overall Study|Withdrawal by Subject|59|||
155602754|NCT00191282|561633766|FG001|Overall Study|Withdrawal by Subject|44|||
155602755|NCT00191282|561633765|FG000|Overall Study|Physician Decision|18|||
155602756|NCT00191282|561633766|FG001|Overall Study|Physician Decision|15|||
155678749|NCT03479541|561912052|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
155678750|NCT03479541|561912053|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
155678751|NCT03479541|561912050|FG000|Home Monitoring|Lost to Follow-up|0|||
155678752|NCT03479541|561912051|FG001|Home Monitoring|Lost to Follow-up|0|||
155602757|NCT00191282|561633765|FG000|Overall Study|Protocol entry criteria not met|14|||
155602758|NCT00191282|561633766|FG001|Overall Study|Protocol entry criteria not met|9|||
155602759|NCT00191282|561633765|FG000|Overall Study|Protocol Violation|9|||
155602760|NCT00191282|561633766|FG001|Overall Study|Protocol Violation|12|||
155602761|NCT00191282|561633765|FG000|Overall Study|Severity of outcome|2|||
155602762|NCT00191282|561633766|FG001|Overall Study|Severity of outcome|5|||
155602763|NCT00191282|561633765|FG000|Overall Study|Sponsor's decision|2|||
155602764|NCT00191282|561633766|FG001|Overall Study|Sponsor's decision|2|||
155602765|NCT00191282|561633765|FG000|Overall Study|Lost to Follow-up|24|||
155602766|NCT00191282|561633766|FG001|Overall Study|Lost to Follow-up|31|||
155602767|NCT04756154|561633767|FG000|Overall Study|Did not meet treatment day baseline|30|||
155602768|NCT04756154|561633768|FG001|Overall Study|Did not meet treatment day baseline|28|||
155602769|NCT04756154|561633769|FG002|Overall Study|Did not meet treatment day baseline|7|||
155602770|NCT04756154|561633767|FG000|Overall Study|Did not return for final sample collection|1|||
155602771|NCT04756154|561633768|FG001|Overall Study|Did not return for final sample collection|1|||
155678753|NCT03479541|561912052|FG002|Home Monitoring|Lost to Follow-up|8|||
155678754|NCT03479541|561912053|FG003|Home Monitoring|Lost to Follow-up|12|||
155602772|NCT04756154|561633769|FG002|Overall Study|Did not return for final sample collection|0|||
155602773|NCT03430895|561633775|FG000|Overall Study|Not Treated|2|||
155602774|NCT00138073|561633777|FG000|Overall Study|lack of resources|55|||
155602775|NCT03301740|561633778|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
155602776|NCT03301740|561633779|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
155602777|NCT03301740|561633778|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
155602778|NCT03301740|561633779|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
155602779|NCT01173055|561633783|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
155602780|NCT01173055|561633784|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
155602781|NCT01173055|561633783|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
155602782|NCT01173055|561633784|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
155602783|NCT04253782|561633786|FG000|Overall Study|Death|2|||
155602784|NCT04253782|561633787|FG001|Overall Study|Death|0|||
155602785|NCT01306045|561633792|FG000|Met General Eligibility Criteria|Screen failures|193|||
155602786|NCT01306045|561633793|FG001|Met General Eligibility Criteria|Screen failures|11|||
155602787|NCT01306045|561633794|FG002|Met General Eligibility Criteria|Screen failures|8|||
155678755|NCT03479541|561912050|FG000|Home Monitoring|Withdrawal by Subject|0|||
155678756|NCT03479541|561912051|FG001|Home Monitoring|Withdrawal by Subject|0|||
155678757|NCT03479541|561912052|FG002|Home Monitoring|Withdrawal by Subject|17|||
155678758|NCT03479541|561912053|FG003|Home Monitoring|Withdrawal by Subject|30|||
155678759|NCT03479541|561912050|FG000|Home Monitoring|Early Termination - PI Decision|0|||
155678760|NCT03479541|561912051|FG001|Home Monitoring|Early Termination - PI Decision|0|||
155602788|NCT05685732|561633795|FG000|Overall Study|Withdrawal by Subject|2|||
155602789|NCT05685732|561633796|FG001|Overall Study|Withdrawal by Subject|0|||
155602790|NCT05685732|561633797|FG002|Overall Study|Withdrawal by Subject|2|||
155602791|NCT05685732|561633798|FG003|Overall Study|Withdrawal by Subject|3|||
155602792|NCT05685732|561633795|FG000|Overall Study|Protocol Violation|1|||
155602793|NCT05685732|561633796|FG001|Overall Study|Protocol Violation|2|||
155602794|NCT05685732|561633797|FG002|Overall Study|Protocol Violation|4|||
155602795|NCT05685732|561633798|FG003|Overall Study|Protocol Violation|1|||
155602796|NCT05685732|561633795|FG000|Overall Study|Lost to Follow-up|5|||
155602797|NCT05685732|561633796|FG001|Overall Study|Lost to Follow-up|1|||
155602798|NCT05685732|561633797|FG002|Overall Study|Lost to Follow-up|3|||
155602799|NCT05685732|561633798|FG003|Overall Study|Lost to Follow-up|1|||
155602800|NCT05685732|561633795|FG000|Overall Study|Adverse Event|2|||
155602801|NCT05685732|561633796|FG001|Overall Study|Adverse Event|1|||
155602802|NCT05685732|561633797|FG002|Overall Study|Adverse Event|0|||
155602803|NCT05685732|561633798|FG003|Overall Study|Adverse Event|0|||
155602804|NCT05685732|561633795|FG000|Overall Study|Physician Decision|1|||
155602805|NCT05685732|561633796|FG001|Overall Study|Physician Decision|0|||
155602806|NCT05685732|561633797|FG002|Overall Study|Physician Decision|0|||
155602807|NCT05685732|561633798|FG003|Overall Study|Physician Decision|0|||
155602808|NCT02640404|561633799|FG000|Overall Study|Protocol Violation|1|||
155602809|NCT02640404|561633800|FG001|Overall Study|Protocol Violation|0|||
155602810|NCT02640404|561633799|FG000|Overall Study|Withdrawal by Subject|1|||
155602811|NCT02640404|561633800|FG001|Overall Study|Withdrawal by Subject|0|||
155602812|NCT04908202|561633801|FG000|Pre-Treatment Period|OTHER REASONS|3|||
155602813|NCT04908202|561633802|FG001|Pre-Treatment Period|OTHER REASONS|1|||
155602814|NCT04908202|561633803|FG002|Pre-Treatment Period|OTHER REASONS|0|||
155602815|NCT04908202|561633804|FG003|Pre-Treatment Period|OTHER REASONS|0|||
155602816|NCT04908202|561633801|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
155602817|NCT04908202|561633802|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602818|NCT04908202|561633803|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602819|NCT04908202|561633804|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602820|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
155602821|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
155602822|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155602823|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155602824|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
155602825|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
155678761|NCT03479541|561912052|FG002|Home Monitoring|Early Termination - PI Decision|4|||
155602826|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
155602827|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
155678762|NCT03479541|561912053|FG003|Home Monitoring|Early Termination - PI Decision|6|||
155602828|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155602829|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
155602830|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155602831|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155602832|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
155602833|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
155602834|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602835|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602836|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155602837|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
155602838|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155602839|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155602840|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155602841|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155602842|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155602843|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155602844|NCT04908202|561633801|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
155602845|NCT04908202|561633802|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
155602846|NCT04908202|561633803|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
155602847|NCT04908202|561633804|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
155602848|NCT04908202|561633801|FG000|Active Treatment Period|OTHER REASONS|0|||
155602849|NCT04908202|561633802|FG001|Active Treatment Period|OTHER REASONS|0|||
155602850|NCT04908202|561633803|FG002|Active Treatment Period|OTHER REASONS|1|||
155602851|NCT04908202|561633804|FG003|Active Treatment Period|OTHER REASONS|3|||
155602852|NCT04908202|561633801|FG000|Active Treatment Period|Lack of Efficacy|0|||
155602853|NCT04908202|561633802|FG001|Active Treatment Period|Lack of Efficacy|0|||
155602854|NCT04908202|561633803|FG002|Active Treatment Period|Lack of Efficacy|4|||
155602855|NCT04908202|561633804|FG003|Active Treatment Period|Lack of Efficacy|5|||
155602856|NCT04908202|561633801|FG000|Active Treatment Period|Adverse Event|0|||
155602857|NCT04908202|561633802|FG001|Active Treatment Period|Adverse Event|0|||
155602858|NCT04908202|561633803|FG002|Active Treatment Period|Adverse Event|5|||
155602859|NCT04908202|561633804|FG003|Active Treatment Period|Adverse Event|8|||
155602860|NCT04908202|561633801|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155602861|NCT04908202|561633802|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155602862|NCT04908202|561633803|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155602863|NCT04908202|561633804|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155602864|NCT04908202|561633801|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602865|NCT04908202|561633802|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155602866|NCT04908202|561633803|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
155602867|NCT04908202|561633804|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
155602868|NCT04908202|561633801|FG000|Active Treatment Period|Lost to Follow-up|0|||
155602869|NCT04908202|561633802|FG001|Active Treatment Period|Lost to Follow-up|0|||
155602870|NCT04908202|561633803|FG002|Active Treatment Period|Lost to Follow-up|2|||
155602871|NCT04908202|561633804|FG003|Active Treatment Period|Lost to Follow-up|2|||
155602872|NCT04908202|561633801|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155602873|NCT04908202|561633802|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155602874|NCT04908202|561633803|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
155602875|NCT04908202|561633804|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155602876|NCT04908202|561633801|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155602877|NCT04908202|561633802|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155602878|NCT04908202|561633803|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155602879|NCT04908202|561633804|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155602880|NCT04908202|561633801|FG000|Active Treatment Period|ONGOING Treatment|0|||
155602881|NCT04908202|561633802|FG001|Active Treatment Period|ONGOING Treatment|0|||
155602882|NCT04908202|561633803|FG002|Active Treatment Period|ONGOING Treatment|117|||
155602883|NCT04908202|561633804|FG003|Active Treatment Period|ONGOING Treatment|114|||
155602884|NCT05397171|561633805|FG000|Overall Study|Death|2|||
155602885|NCT05397171|561633806|FG001|Overall Study|Death|3|||
155602886|NCT05397171|561633807|FG002|Overall Study|Death|3|||
155602887|NCT05397171|561633805|FG000|Overall Study|Study Terminated By Sponsor|1|||
155602888|NCT05397171|561633806|FG001|Overall Study|Study Terminated By Sponsor|2|||
155602889|NCT05397171|561633807|FG002|Overall Study|Study Terminated By Sponsor|3|||
155602890|NCT05397171|561633805|FG000|Overall Study|Withdrawal by Subject|0|||
155602891|NCT05397171|561633806|FG001|Overall Study|Withdrawal by Subject|1|||
155602892|NCT05397171|561633807|FG002|Overall Study|Withdrawal by Subject|1|||
155602893|NCT03117881|561635384|FG000|Baseline|Withdrawal by Subject|21|||
155602894|NCT03117881|561635385|FG001|Baseline|Withdrawal by Subject|10|||
155602895|NCT03117881|561635386|FG002|Baseline|Withdrawal by Subject|0|||
155602896|NCT03117881|561635384|FG000|Baseline|Lost to Follow-up|22|||
155602897|NCT03117881|561635385|FG001|Baseline|Lost to Follow-up|25|||
155602898|NCT03117881|561635386|FG002|Baseline|Lost to Follow-up|0|||
155602899|NCT03117881|561635384|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
155602900|NCT03117881|561635385|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
155602901|NCT03117881|561635386|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
155602902|NCT03117881|561635384|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
155602903|NCT03117881|561635385|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
155602904|NCT03117881|561635386|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
155602905|NCT03117881|561635384|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
155602906|NCT03117881|561635385|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
155602907|NCT03117881|561635386|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
155602908|NCT03117881|561635384|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
155602909|NCT03117881|561635385|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
155602910|NCT03117881|561635386|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
155602911|NCT03117881|561635384|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
155602912|NCT03117881|561635385|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
155602913|NCT03117881|561635386|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
155602914|NCT03117881|561635384|FG000|6-Month Follow-Up|Did not complete test|53|||
155602915|NCT03117881|561635385|FG001|6-Month Follow-Up|Did not complete test|25|||
155602916|NCT03117881|561635386|FG002|6-Month Follow-Up|Did not complete test|7|||
155602917|NCT03117881|561635384|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
155602918|NCT03117881|561635385|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
155602919|NCT03117881|561635386|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
155602920|NCT03117881|561635384|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
155602921|NCT03117881|561635385|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
155602922|NCT03117881|561635386|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
155602923|NCT03117881|561635384|FG000|12-Month Follow-Up|Did not complete test|40|||
155602924|NCT03117881|561635385|FG001|12-Month Follow-Up|Did not complete test|0|||
155602925|NCT03117881|561635386|FG002|12-Month Follow-Up|Did not complete test|0|||
155602926|NCT01027897|561635387|FG000|Overall Study|Protocol Violation|1|||
155602927|NCT01027897|561635387|FG000|Overall Study|Withdrawal by Subject|1|||
155602928|NCT01661933|561635388|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
155602929|NCT01661933|561635388|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
155602930|NCT03385304|561635389|FG000|Overall Study|Death|19|||
155602931|NCT03385304|561635390|FG001|Overall Study|Death|7|||
155602932|NCT03385304|561635389|FG000|Overall Study|Lost to Follow-up|17|||
155602933|NCT03385304|561635390|FG001|Overall Study|Lost to Follow-up|14|||
155602934|NCT03385304|561635389|FG000|Overall Study|Withdrawal by Subject|3|||
155602935|NCT03385304|561635390|FG001|Overall Study|Withdrawal by Subject|2|||
155602936|NCT03385304|561635389|FG000|Overall Study|Incarceration|2|||
155602937|NCT03385304|561635390|FG001|Overall Study|Incarceration|3|||
155602938|NCT01097421|561635391|FG000|Overall Study|Adverse Event|8|||
155602939|NCT01097421|561635391|FG000|Overall Study|Protocol Violation|2|||
155602940|NCT01097421|561635391|FG000|Overall Study|Lost to Follow-up|1|||
155602941|NCT01097421|561635391|FG000|Overall Study|Withdrawal by Subject|3|||
155602942|NCT01120249|561635392|FG000|Overall Study|No protocol treatment received|21|||
155602943|NCT01120249|561635393|FG001|Overall Study|No protocol treatment received|15|||
155602944|NCT01120249|561635392|FG000|Overall Study|Disease recurrence|107|||
155602945|NCT01120249|561635393|FG001|Overall Study|Disease recurrence|57|||
155602946|NCT01120249|561635392|FG000|Overall Study|Death|1|||
155602947|NCT01120249|561635393|FG001|Overall Study|Death|0|||
155602948|NCT01120249|561635392|FG000|Overall Study|Adverse Event|40|||
155602949|NCT01120249|561635393|FG001|Overall Study|Adverse Event|276|||
155602950|NCT01120249|561635392|FG000|Overall Study|Participant refusal|34|||
155602951|NCT01120249|561635393|FG001|Overall Study|Participant refusal|42|||
155602952|NCT01120249|561635392|FG000|Overall Study|Other reasons, not protocol specified|29|||
155602953|NCT01120249|561635393|FG001|Overall Study|Other reasons, not protocol specified|22|||
155602954|NCT02052596|561635394|FG000|Active Phase|Adverse Event|3|||
155602955|NCT02052596|561635395|FG001|Active Phase|Adverse Event|2|||
155602956|NCT02052596|561635394|FG000|Active Phase|Lost to Follow-up|8|||
155602957|NCT02052596|561635395|FG001|Active Phase|Lost to Follow-up|11|||
155602958|NCT02052596|561635394|FG000|Active Phase|Protocol Violation|1|||
155602959|NCT02052596|561635395|FG001|Active Phase|Protocol Violation|2|||
155602960|NCT02052596|561635394|FG000|Active Phase|Withdrawal by Subject|3|||
155602961|NCT02052596|561635395|FG001|Active Phase|Withdrawal by Subject|4|||
155602962|NCT02052596|561635394|FG000|Active Phase|Enrolled in error|1|||
155602963|NCT02052596|561635395|FG001|Active Phase|Enrolled in error|0|||
155602964|NCT02052596|561635394|FG000|Active Phase|Lost due to Crohn's disease|0|||
155602965|NCT02052596|561635395|FG001|Active Phase|Lost due to Crohn's disease|1|||
155602966|NCT02052596|561635394|FG000|Safety Phase|Adverse Event|6|||
155602967|NCT02052596|561635395|FG001|Safety Phase|Adverse Event|3|||
155602968|NCT02052596|561635394|FG000|Safety Phase|Lost to Follow-up|11|||
155602969|NCT02052596|561635395|FG001|Safety Phase|Lost to Follow-up|18|||
155602970|NCT02052596|561635394|FG000|Safety Phase|Protocol Violation|1|||
155602971|NCT02052596|561635395|FG001|Safety Phase|Protocol Violation|2|||
155678763|NCT03108521|561912054|FG000|Overall Study|Lost to Follow-up|3|||
155678764|NCT03108521|561912055|FG001|Overall Study|Lost to Follow-up|0|||
155678765|NCT03108521|561912054|FG000|Overall Study|Lack of Efficacy|2|||
155678766|NCT03108521|561912055|FG001|Overall Study|Lack of Efficacy|0|||
155678767|NCT03108521|561912054|FG000|Overall Study|Physician Decision|4|||
155678768|NCT03108521|561912055|FG001|Overall Study|Physician Decision|0|||
155678769|NCT03108521|561912054|FG000|Overall Study|Adverse Event|3|||
155678770|NCT03108521|561912055|FG001|Overall Study|Adverse Event|0|||
155678771|NCT06899737|561912061|FG000|Overall Study|Lost to Follow-up|19|||
155678772|NCT06899737|561912062|FG001|Overall Study|Lost to Follow-up|7|||
155678773|NCT03110029|561912064|FG000|Overall Study|Withdrawal by Subject|1|||
155678774|NCT03110029|561912065|FG001|Overall Study|Withdrawal by Subject|1|||
155678775|NCT03281629|561912067|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
155678776|NCT03281629|561912068|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
155678777|NCT03281629|561912067|FG000|Overall Study|Death|0|||
155678778|NCT03281629|561912068|FG001|Overall Study|Death|1|||
155678779|NCT03281629|561912067|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
155678780|NCT03281629|561912068|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
155678781|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
155678782|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
155678783|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
155678784|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
155678785|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
155678786|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
155678787|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
155678788|NCT01673854|561912073|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
155678789|NCT01673854|561912073|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
155678790|NCT01673854|561912073|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
155678791|NCT01673854|561912073|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
155678792|NCT01673854|561912073|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
155678793|NCT00334737|561912074|FG000|Hospital Phase|Death|1|||
155678794|NCT00334737|561912075|FG001|Hospital Phase|Death|2|||
155678795|NCT00334737|561912076|FG002|Hospital Phase|Death|3|||
155678796|NCT00334737|561912074|FG000|Hospital Phase|Withdrawal by Subject|0|||
155678797|NCT00334737|561912075|FG001|Hospital Phase|Withdrawal by Subject|0|||
155678798|NCT00334737|561912076|FG002|Hospital Phase|Withdrawal by Subject|1|||
155678799|NCT00334737|561912074|FG000|Hospital Phase|Did not receive study drug|1|||
155678800|NCT00334737|561912075|FG001|Hospital Phase|Did not receive study drug|0|||
155678801|NCT00334737|561912076|FG002|Hospital Phase|Did not receive study drug|0|||
155678802|NCT00334737|561912074|FG000|Follow up Phase|Lost to Follow-up|5|||
155678803|NCT00334737|561912075|FG001|Follow up Phase|Lost to Follow-up|3|||
155678804|NCT00334737|561912076|FG002|Follow up Phase|Lost to Follow-up|6|||
155678805|NCT02316353|561912077|FG000|Overall Study|Pregnancy|1|||
155678806|NCT02316353|561912078|FG001|Overall Study|Pregnancy|3|||
155678807|NCT02316353|561912077|FG000|Overall Study|Adverse Event|1|||
155678808|NCT02316353|561912078|FG001|Overall Study|Adverse Event|3|||
155678809|NCT02316353|561912077|FG000|Overall Study|Withdrawal by Subject|6|||
155678810|NCT02316353|561912078|FG001|Overall Study|Withdrawal by Subject|2|||
155678811|NCT00375674|561912079|FG000|Overall Study|Other|26|||
155678812|NCT00375674|561912080|FG001|Overall Study|Other|18|||
155678813|NCT00375674|561912079|FG000|Overall Study|Death|67|||
155678814|NCT00375674|561912080|FG001|Overall Study|Death|76|||
155678815|NCT00375674|561912079|FG000|Overall Study|Participants refused further follow-up|31|||
155678816|NCT00375674|561912080|FG001|Overall Study|Participants refused further follow-up|30|||
155678817|NCT00375674|561912079|FG000|Overall Study|Lost to Follow-up|17|||
155678818|NCT00375674|561912080|FG001|Overall Study|Lost to Follow-up|15|||
155678819|NCT00375674|561912079|FG000|Overall Study|Enrolled but not treated|3|||
155678820|NCT00375674|561912080|FG001|Overall Study|Enrolled but not treated|2|||
155678821|NCT01271010|561914318|FG000|Overall Study|Reason not specified|11|||
155678822|NCT01271010|561914318|FG000|Overall Study|Start of new CLL therapy|1|||
155678823|NCT01271010|561914318|FG000|Overall Study|Protocol Violation|1|||
155678824|NCT01271010|561914318|FG000|Overall Study|Death|2|||
155678825|NCT01271010|561914318|FG000|Overall Study|Progression and relapse of disease|1|||
155678826|NCT01271010|561914318|FG000|Overall Study|Withdrawal by Subject|18|||
155678827|NCT01271010|561914318|FG000|Overall Study|Disease progression|27|||
155678828|NCT01631747|561914319|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
155678829|NCT01631747|561914320|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
155678830|NCT01631747|561914319|FG000|Live Birth|Pregnancy Termination|1|||
155678831|NCT01631747|561914320|FG001|Live Birth|Pregnancy Termination|0|||
155678832|NCT01631747|561914319|FG000|Live Birth|MIscarriage|2|||
155678833|NCT01631747|561914320|FG001|Live Birth|MIscarriage|0|||
155678834|NCT01631747|561914319|FG000|Live Birth|Stillbirth|1|||
155678835|NCT01631747|561914320|FG001|Live Birth|Stillbirth|1|||
155678836|NCT01631747|561914319|FG000|One Year Infant Outcomes|Patient Refused|13|||
155678837|NCT01631747|561914320|FG001|One Year Infant Outcomes|Patient Refused|9|||
155678838|NCT01456195|561914321|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155678839|NCT01456195|561914322|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
155678840|NCT01456195|561914323|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155678841|NCT01456195|561914321|FG000|Overall Study|Lost to Follow-up|3|||
155678842|NCT01456195|561914322|FG001|Overall Study|Lost to Follow-up|1|||
155678843|NCT01456195|561914323|FG002|Overall Study|Lost to Follow-up|3|||
155678844|NCT01456195|561914321|FG000|Overall Study|Voluntary Withdrawal|5|||
155678845|NCT01456195|561914322|FG001|Overall Study|Voluntary Withdrawal|3|||
155678846|NCT01456195|561914323|FG002|Overall Study|Voluntary Withdrawal|7|||
155678847|NCT01456195|561914321|FG000|Overall Study|Lack of Efficacy|0|||
155678848|NCT01456195|561914322|FG001|Overall Study|Lack of Efficacy|1|||
155678849|NCT01456195|561914323|FG002|Overall Study|Lack of Efficacy|0|||
155678850|NCT01456195|561914321|FG000|Overall Study|Other Reasons|2|||
155678851|NCT01456195|561914322|FG001|Overall Study|Other Reasons|1|||
155678852|NCT01456195|561914323|FG002|Overall Study|Other Reasons|3|||
155678853|NCT02109432|561914324|FG000|Overall Study|Withdrawal by Subject|1|||
155678854|NCT03372551|561914331|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
155678855|NCT03372551|561914332|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
155678856|NCT04683029|561914341|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
155678857|NCT04683029|561914342|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155678858|NCT04683029|561914343|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155678859|NCT04683029|561914344|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155678860|NCT04683029|561914341|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155678861|NCT04683029|561914342|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155678862|NCT04683029|561914343|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155678863|NCT04683029|561914344|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
155678864|NCT04683029|561914341|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155678865|NCT04683029|561914342|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155678866|NCT04683029|561914343|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
155678867|NCT04683029|561914344|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155678868|NCT04299308|561914345|FG000|Overall Study|Withdrawal by Subject|1|||
155678869|NCT04299308|561914346|FG001|Overall Study|Withdrawal by Subject|0|||
155678870|NCT04299308|561914345|FG000|Overall Study|issue with PET image (1)|1|||
155678871|NCT04299308|561914346|FG001|Overall Study|issue with PET image (1)|0|||
155678872|NCT02920528|561914349|FG000|Overall Study|Incomplete Data|1|||
155678873|NCT02920528|561914350|FG001|Overall Study|Incomplete Data|1|||
155678874|NCT02920528|561914351|FG002|Overall Study|Incomplete Data|1|||
155678875|NCT02920528|561914349|FG000|Overall Study|Adverse Event|0|||
155678876|NCT02920528|561914350|FG001|Overall Study|Adverse Event|0|||
155678877|NCT02920528|561914351|FG002|Overall Study|Adverse Event|3|||
155678878|NCT02920528|561914349|FG000|Overall Study|Did not meet inclusion criteria|2|||
155678879|NCT02920528|561914350|FG001|Overall Study|Did not meet inclusion criteria|0|||
155678880|NCT02920528|561914351|FG002|Overall Study|Did not meet inclusion criteria|1|||
155678881|NCT00066703|561914352|FG000|Overall Study|Adverse Event|80|||
155678882|NCT00066703|561914353|FG001|Overall Study|Adverse Event|111|||
155678883|NCT00066703|561914352|FG000|Overall Study|Death|3|||
155678884|NCT00066703|561914353|FG001|Overall Study|Death|0|||
155678885|NCT00066703|561914352|FG000|Overall Study|Lack of Efficacy|114|||
155678886|NCT00066703|561914353|FG001|Overall Study|Lack of Efficacy|69|||
155678887|NCT00066703|561914352|FG000|Overall Study|Lost to Follow-up|31|||
155678888|NCT00066703|561914353|FG001|Overall Study|Lost to Follow-up|28|||
155678889|NCT00066703|561914352|FG000|Overall Study|Withdrawal by Subject|38|||
155678890|NCT00066703|561914353|FG001|Overall Study|Withdrawal by Subject|63|||
155678891|NCT00066703|561914352|FG000|Overall Study|Treatment ongoing|346|||
155678892|NCT00066703|561914353|FG001|Overall Study|Treatment ongoing|311|||
155678893|NCT05924165|561914356|FG000|Overall Study|Physician Decision|2|||
155678894|NCT05924165|561914357|FG001|Overall Study|Physician Decision|3|||
155678895|NCT01681186|561914358|FG000|Washout Period From Second Intervention|Adverse Event|0|||
155678896|NCT01681186|561914359|FG001|Washout Period From Second Intervention|Adverse Event|0|||
155678897|NCT01681186|561914360|FG002|Washout Period From Second Intervention|Adverse Event|0|||
155678898|NCT01681186|561914361|FG003|Washout Period From Second Intervention|Adverse Event|0|||
155678899|NCT01681186|561914362|FG004|Washout Period From Second Intervention|Adverse Event|0|||
155678900|NCT01681186|561914363|FG005|Washout Period From Second Intervention|Adverse Event|0|||
155678901|NCT01681186|561914364|FG006|Washout Period From Second Intervention|Adverse Event|1|||
155678902|NCT01681186|561914365|FG007|Washout Period From Second Intervention|Adverse Event|0|||
155678903|NCT01681186|561914358|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
155678904|NCT01681186|561914359|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
155678905|NCT01681186|561914360|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
155678906|NCT01681186|561914361|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
155678907|NCT01681186|561914362|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
155678908|NCT01681186|561914363|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
155678909|NCT01681186|561914364|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
155678910|NCT01681186|561914365|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
155678911|NCT01681186|561914358|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678912|NCT01681186|561914359|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678913|NCT01681186|561914360|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678914|NCT01681186|561914361|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678915|NCT01681186|561914362|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678916|NCT01681186|561914363|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678917|NCT01681186|561914364|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
155678918|NCT01681186|561914365|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
155678919|NCT01681186|561914358|FG000|Fourth Intervention|Protocol Violation|0|||
155678920|NCT01681186|561914359|FG001|Fourth Intervention|Protocol Violation|0|||
155678921|NCT01681186|561914360|FG002|Fourth Intervention|Protocol Violation|0|||
155678922|NCT01681186|561914361|FG003|Fourth Intervention|Protocol Violation|0|||
155678923|NCT01681186|561914362|FG004|Fourth Intervention|Protocol Violation|0|||
155678924|NCT01681186|561914363|FG005|Fourth Intervention|Protocol Violation|0|||
155678925|NCT01681186|561914364|FG006|Fourth Intervention|Protocol Violation|0|||
155678926|NCT01681186|561914365|FG007|Fourth Intervention|Protocol Violation|1|||
155678927|NCT00301262|561914372|FG000|Double Blind Phase (DB)|Adverse Event|1|||
155678928|NCT00301262|561914373|FG001|Double Blind Phase (DB)|Adverse Event|0|||
155678929|NCT00301262|561914372|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
155678930|NCT00301262|561914373|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
155678931|NCT00301262|561914372|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
155678932|NCT00301262|561914373|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
155678933|NCT00301262|561914372|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
155678934|NCT00301262|561914373|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
155678935|NCT00301262|561914372|FG000|Double Blind Phase (DB)|Other|1|||
155678936|NCT00301262|561914373|FG001|Double Blind Phase (DB)|Other|4|||
155678937|NCT00301262|561914372|FG000|Open Label Phase (OL)|Adverse Event|1|||
155678938|NCT00301262|561914373|FG001|Open Label Phase (OL)|Adverse Event|0|||
155678939|NCT00301262|561914372|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
155678940|NCT00301262|561914373|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
155678941|NCT00301262|561914372|FG000|Open Label Phase (OL)|Other|2|||
155678942|NCT00301262|561914373|FG001|Open Label Phase (OL)|Other|0|||
155678943|NCT03530995|561914377|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
155678944|NCT03530995|561914378|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
155678945|NCT03530995|561914377|FG000|Part 1 Period 3|Protocol Violation|1|||
155678946|NCT03530995|561914378|FG001|Part 1 Period 3|Protocol Violation|0|||
155678947|NCT03530995|561914377|FG000|Part 1 Period 4|Physician Decision|1|||
155678948|NCT03530995|561914378|FG001|Part 1 Period 4|Physician Decision|0|||
155678949|NCT03530995|561914377|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
155678950|NCT03530995|561914378|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
155678951|NCT04308239|561914384|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
155678952|NCT04308239|561914385|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
155678953|NCT04308239|561914384|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
155678954|NCT04308239|561914385|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
155678955|NCT04308239|561914384|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
155678956|NCT04308239|561914385|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
155678957|NCT04308239|561914384|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
155678958|NCT04308239|561914385|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
155678959|NCT01443364|561914386|FG000|Overall Study|Lack of Efficacy|14|||
155678960|NCT01443364|561914386|FG000|Overall Study|Lost to Follow-up|3|||
155678961|NCT01443364|561914386|FG000|Overall Study|Withdrawal by Subject|5|||
155678962|NCT01443364|561914386|FG000|Overall Study|Other Reason|4|||
155678963|NCT01443364|561914386|FG000|Overall Study|SAE, non-fatal|6|||
155678964|NCT01443364|561914386|FG000|Overall Study|AE, non-serious non-fatal|8|||
155678965|NCT01443364|561914386|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155678966|NCT01986231|561914391|FG000|Overall Study|Adverse Event|1|||
155678967|NCT04848220|561914392|FG000|Overall Study|Unable to proceed to study procedure|0|||
155678968|NCT04848220|561914393|FG001|Overall Study|Unable to proceed to study procedure|1|||
155678969|NCT04848220|561914394|FG002|Overall Study|Unable to proceed to study procedure|0|||
155678970|NCT04848220|561914392|FG000|Overall Study|Fractional flow not significant|0|||
155678971|NCT04848220|561914393|FG001|Overall Study|Fractional flow not significant|1|||
155678972|NCT04848220|561914394|FG002|Overall Study|Fractional flow not significant|0|||
155678973|NCT02150057|561914406|FG000|Overall Study|Lost to Follow-up|6|||
155678974|NCT02150057|561914407|FG001|Overall Study|Lost to Follow-up|4|||
155678975|NCT00489424|561914408|FG000|Overall Study|Adverse Event|3|||
155678976|NCT00489424|561914409|FG001|Overall Study|Adverse Event|3|||
155678977|NCT00489424|561914410|FG002|Overall Study|Adverse Event|4|||
155678978|NCT00489424|561914408|FG000|Overall Study|Lack of Efficacy|1|||
155678979|NCT00489424|561914409|FG001|Overall Study|Lack of Efficacy|0|||
155678980|NCT00489424|561914410|FG002|Overall Study|Lack of Efficacy|0|||
155678981|NCT00489424|561914408|FG000|Overall Study|Administrative problems|0|||
155678982|NCT00489424|561914409|FG001|Overall Study|Administrative problems|2|||
155678983|NCT00489424|561914410|FG002|Overall Study|Administrative problems|1|||
155678984|NCT05791565|561914411|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
155678985|NCT05791565|561914412|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
155678986|NCT01558115|561914413|FG000|Overall Study|Withdrawal by Subject|3|||
155678987|NCT01558115|561914413|FG000|Overall Study|Study closed due to poor enrollment|4|||
155678988|NCT01436656|561914414|FG000|Dose Escalation|Death|1|||
155678989|NCT01436656|561914415|FG001|Dose Escalation|Death|3|||
155678990|NCT01436656|561914416|FG002|Dose Escalation|Death|1|||
155678991|NCT01436656|561914417|FG003|Dose Escalation|Death|0|||
155678992|NCT01436656|561914418|FG004|Dose Escalation|Death|2|||
155678993|NCT01436656|561914419|FG005|Dose Escalation|Death|1|||
155678994|NCT01436656|561914420|FG006|Dose Escalation|Death|1|||
155678995|NCT01436656|561914421|FG007|Dose Escalation|Death|1|||
155678996|NCT01436656|561914422|FG008|Dose Escalation|Death|1|||
155678997|NCT01436656|561914423|FG009|Dose Escalation|Death|0|||
155678998|NCT01436656|561914424|FG010|Dose Escalation|Death|0|||
155678999|NCT01436656|561914425|FG011|Dose Escalation|Death|0|||
155679000|NCT01436656|561914426|FG012|Dose Escalation|Death|0|||
155679001|NCT01436656|561914427|FG013|Dose Escalation|Death|0|||
155679002|NCT01436656|561914428|FG014|Dose Escalation|Death|0|||
155679003|NCT01436656|561914429|FG015|Dose Escalation|Death|0|||
155679004|NCT01436656|561914430|FG016|Dose Escalation|Death|0|||
155679005|NCT01436656|561914431|FG017|Dose Escalation|Death|0|||
155679006|NCT01436656|561914414|FG000|Dose Escalation|Protocol Violation|0|||
155679007|NCT01436656|561914415|FG001|Dose Escalation|Protocol Violation|0|||
155679008|NCT01436656|561914416|FG002|Dose Escalation|Protocol Violation|0|||
155679009|NCT01436656|561914417|FG003|Dose Escalation|Protocol Violation|0|||
155679010|NCT01436656|561914418|FG004|Dose Escalation|Protocol Violation|0|||
155679011|NCT01436656|561914419|FG005|Dose Escalation|Protocol Violation|1|||
155679012|NCT01436656|561914420|FG006|Dose Escalation|Protocol Violation|0|||
155679013|NCT01436656|561914421|FG007|Dose Escalation|Protocol Violation|0|||
155679014|NCT01436656|561914422|FG008|Dose Escalation|Protocol Violation|0|||
155679015|NCT01436656|561914423|FG009|Dose Escalation|Protocol Violation|0|||
155679016|NCT01436656|561914424|FG010|Dose Escalation|Protocol Violation|0|||
155679017|NCT01436656|561914425|FG011|Dose Escalation|Protocol Violation|0|||
155679018|NCT01436656|561914426|FG012|Dose Escalation|Protocol Violation|0|||
155679019|NCT01436656|561914427|FG013|Dose Escalation|Protocol Violation|0|||
155679020|NCT01436656|561914428|FG014|Dose Escalation|Protocol Violation|0|||
155679021|NCT01436656|561914429|FG015|Dose Escalation|Protocol Violation|0|||
155679022|NCT01436656|561914430|FG016|Dose Escalation|Protocol Violation|0|||
155679023|NCT01436656|561914431|FG017|Dose Escalation|Protocol Violation|0|||
155679024|NCT01436656|561914414|FG000|Dose Escalation|Withdrawal by Subject|0|||
155602972|NCT02052596|561635394|FG000|Safety Phase|Withdrawal by Subject|8|||
155602973|NCT02052596|561635395|FG001|Safety Phase|Withdrawal by Subject|11|||
155602974|NCT02052596|561635394|FG000|Safety Phase|Enrolled in error|1|||
155602975|NCT02052596|561635395|FG001|Safety Phase|Enrolled in error|0|||
155602976|NCT02052596|561635394|FG000|Safety Phase|Lost due to Crohn's disease|0|||
155602977|NCT02052596|561635395|FG001|Safety Phase|Lost due to Crohn's disease|1|||
155602978|NCT00558896|561635396|FG000|Overall Study|Adverse Event|1|||
155602979|NCT00558896|561635397|FG001|Overall Study|Adverse Event|1|||
155602980|NCT00558896|561635398|FG002|Overall Study|Adverse Event|1|||
155602981|NCT00558896|561635399|FG003|Overall Study|Adverse Event|3|||
155602982|NCT00558896|561635400|FG004|Overall Study|Adverse Event|4|||
155602983|NCT00558896|561635401|FG005|Overall Study|Adverse Event|10|||
155602984|NCT00558896|561635402|FG006|Overall Study|Adverse Event|3|||
155602985|NCT00558896|561635396|FG000|Overall Study|Death|3|||
155602986|NCT00558896|561635397|FG001|Overall Study|Death|0|||
155602987|NCT00558896|561635398|FG002|Overall Study|Death|2|||
155602988|NCT00558896|561635399|FG003|Overall Study|Death|3|||
155602989|NCT00558896|561635400|FG004|Overall Study|Death|2|||
155602990|NCT00558896|561635401|FG005|Overall Study|Death|2|||
155602991|NCT00558896|561635402|FG006|Overall Study|Death|6|||
155602992|NCT00558896|561635396|FG000|Overall Study|Withdrawal by Subject|2|||
155602993|NCT00558896|561635397|FG001|Overall Study|Withdrawal by Subject|1|||
155602994|NCT00558896|561635398|FG002|Overall Study|Withdrawal by Subject|1|||
155602995|NCT00558896|561635399|FG003|Overall Study|Withdrawal by Subject|1|||
155602996|NCT00558896|561635400|FG004|Overall Study|Withdrawal by Subject|1|||
155602997|NCT00558896|561635401|FG005|Overall Study|Withdrawal by Subject|5|||
155602998|NCT00558896|561635402|FG006|Overall Study|Withdrawal by Subject|5|||
155602999|NCT00558896|561635396|FG000|Overall Study|Alternative Treatment|2|||
155603000|NCT00558896|561635397|FG001|Overall Study|Alternative Treatment|2|||
155603001|NCT00558896|561635398|FG002|Overall Study|Alternative Treatment|0|||
155603002|NCT00558896|561635399|FG003|Overall Study|Alternative Treatment|2|||
155603003|NCT00558896|561635400|FG004|Overall Study|Alternative Treatment|6|||
155603004|NCT00558896|561635401|FG005|Overall Study|Alternative Treatment|7|||
155603005|NCT00558896|561635402|FG006|Overall Study|Alternative Treatment|1|||
155603006|NCT00558896|561635396|FG000|Overall Study|Physician discretion|3|||
155603007|NCT00558896|561635397|FG001|Overall Study|Physician discretion|2|||
155603008|NCT00558896|561635398|FG002|Overall Study|Physician discretion|1|||
155603009|NCT00558896|561635399|FG003|Overall Study|Physician discretion|2|||
155679025|NCT01436656|561914415|FG001|Dose Escalation|Withdrawal by Subject|0|||
155679026|NCT01436656|561914416|FG002|Dose Escalation|Withdrawal by Subject|0|||
155679027|NCT01436656|561914417|FG003|Dose Escalation|Withdrawal by Subject|0|||
155679028|NCT01436656|561914418|FG004|Dose Escalation|Withdrawal by Subject|1|||
155679029|NCT01436656|561914419|FG005|Dose Escalation|Withdrawal by Subject|0|||
155679030|NCT01436656|561914420|FG006|Dose Escalation|Withdrawal by Subject|0|||
155679031|NCT01436656|561914421|FG007|Dose Escalation|Withdrawal by Subject|2|||
155679032|NCT01436656|561914422|FG008|Dose Escalation|Withdrawal by Subject|0|||
155603010|NCT00558896|561635400|FG004|Overall Study|Physician discretion|1|||
155603011|NCT00558896|561635401|FG005|Overall Study|Physician discretion|3|||
155603012|NCT00558896|561635402|FG006|Overall Study|Physician discretion|3|||
155603013|NCT00558896|561635396|FG000|Overall Study|Continues on treatment|10|||
155679033|NCT01436656|561914423|FG009|Dose Escalation|Withdrawal by Subject|1|||
155679034|NCT01436656|561914424|FG010|Dose Escalation|Withdrawal by Subject|1|||
155679035|NCT01436656|561914425|FG011|Dose Escalation|Withdrawal by Subject|0|||
155679036|NCT01436656|561914426|FG012|Dose Escalation|Withdrawal by Subject|0|||
155679037|NCT01436656|561914427|FG013|Dose Escalation|Withdrawal by Subject|0|||
155679038|NCT01436656|561914428|FG014|Dose Escalation|Withdrawal by Subject|0|||
155679039|NCT01436656|561914429|FG015|Dose Escalation|Withdrawal by Subject|0|||
155679040|NCT01436656|561914430|FG016|Dose Escalation|Withdrawal by Subject|0|||
155679041|NCT01436656|561914431|FG017|Dose Escalation|Withdrawal by Subject|0|||
155679042|NCT01436656|561914414|FG000|Dose Escalation|Administrative problems|0|||
155679043|NCT01436656|561914415|FG001|Dose Escalation|Administrative problems|1|||
155679044|NCT01436656|561914416|FG002|Dose Escalation|Administrative problems|0|||
155679045|NCT01436656|561914417|FG003|Dose Escalation|Administrative problems|0|||
155679046|NCT01436656|561914418|FG004|Dose Escalation|Administrative problems|0|||
155679047|NCT01436656|561914419|FG005|Dose Escalation|Administrative problems|0|||
155679048|NCT01436656|561914420|FG006|Dose Escalation|Administrative problems|0|||
155679049|NCT01436656|561914421|FG007|Dose Escalation|Administrative problems|0|||
155679050|NCT01436656|561914422|FG008|Dose Escalation|Administrative problems|0|||
155679051|NCT01436656|561914423|FG009|Dose Escalation|Administrative problems|0|||
155679052|NCT01436656|561914424|FG010|Dose Escalation|Administrative problems|0|||
155679053|NCT01436656|561914425|FG011|Dose Escalation|Administrative problems|0|||
155679054|NCT01436656|561914426|FG012|Dose Escalation|Administrative problems|0|||
155679055|NCT01436656|561914427|FG013|Dose Escalation|Administrative problems|0|||
155679056|NCT01436656|561914428|FG014|Dose Escalation|Administrative problems|0|||
155679057|NCT01436656|561914429|FG015|Dose Escalation|Administrative problems|0|||
155679058|NCT01436656|561914430|FG016|Dose Escalation|Administrative problems|0|||
155679059|NCT01436656|561914431|FG017|Dose Escalation|Administrative problems|0|||
155679060|NCT01436656|561914414|FG000|Dose Escalation|Lost to Follow-up|1|||
155679061|NCT01436656|561914415|FG001|Dose Escalation|Lost to Follow-up|0|||
155679062|NCT01436656|561914416|FG002|Dose Escalation|Lost to Follow-up|0|||
155679063|NCT01436656|561914417|FG003|Dose Escalation|Lost to Follow-up|0|||
155679064|NCT01436656|561914418|FG004|Dose Escalation|Lost to Follow-up|1|||
155679065|NCT01436656|561914419|FG005|Dose Escalation|Lost to Follow-up|0|||
155679066|NCT01436656|561914420|FG006|Dose Escalation|Lost to Follow-up|0|||
155679067|NCT01436656|561914421|FG007|Dose Escalation|Lost to Follow-up|0|||
155679068|NCT01436656|561914422|FG008|Dose Escalation|Lost to Follow-up|0|||
155679069|NCT01436656|561914423|FG009|Dose Escalation|Lost to Follow-up|0|||
155679070|NCT01436656|561914424|FG010|Dose Escalation|Lost to Follow-up|0|||
155679071|NCT01436656|561914425|FG011|Dose Escalation|Lost to Follow-up|0|||
155679072|NCT01436656|561914426|FG012|Dose Escalation|Lost to Follow-up|0|||
155679073|NCT01436656|561914427|FG013|Dose Escalation|Lost to Follow-up|0|||
155679074|NCT01436656|561914428|FG014|Dose Escalation|Lost to Follow-up|0|||
155679075|NCT01436656|561914429|FG015|Dose Escalation|Lost to Follow-up|0|||
155679076|NCT01436656|561914430|FG016|Dose Escalation|Lost to Follow-up|0|||
155679077|NCT01436656|561914431|FG017|Dose Escalation|Lost to Follow-up|0|||
155679078|NCT01436656|561914414|FG000|Dose Escalation|New anti-cancer therapy|1|||
155679079|NCT01436656|561914415|FG001|Dose Escalation|New anti-cancer therapy|0|||
155679080|NCT01436656|561914416|FG002|Dose Escalation|New anti-cancer therapy|0|||
155679081|NCT01436656|561914417|FG003|Dose Escalation|New anti-cancer therapy|0|||
155679082|NCT01436656|561914418|FG004|Dose Escalation|New anti-cancer therapy|0|||
155679083|NCT01436656|561914419|FG005|Dose Escalation|New anti-cancer therapy|0|||
155679084|NCT01436656|561914420|FG006|Dose Escalation|New anti-cancer therapy|0|||
155679085|NCT01436656|561914421|FG007|Dose Escalation|New anti-cancer therapy|0|||
155679086|NCT01436656|561914422|FG008|Dose Escalation|New anti-cancer therapy|1|||
155679087|NCT01436656|561914423|FG009|Dose Escalation|New anti-cancer therapy|1|||
155679088|NCT01436656|561914424|FG010|Dose Escalation|New anti-cancer therapy|0|||
155679089|NCT01436656|561914425|FG011|Dose Escalation|New anti-cancer therapy|0|||
155679090|NCT01436656|561914426|FG012|Dose Escalation|New anti-cancer therapy|0|||
155679091|NCT01436656|561914427|FG013|Dose Escalation|New anti-cancer therapy|0|||
155679092|NCT01436656|561914428|FG014|Dose Escalation|New anti-cancer therapy|0|||
155679093|NCT01436656|561914429|FG015|Dose Escalation|New anti-cancer therapy|0|||
155679094|NCT01436656|561914430|FG016|Dose Escalation|New anti-cancer therapy|0|||
155679095|NCT01436656|561914431|FG017|Dose Escalation|New anti-cancer therapy|0|||
155679096|NCT01436656|561914414|FG000|Dose Expansion|Adverse Event|0|||
155679097|NCT01436656|561914415|FG001|Dose Expansion|Adverse Event|0|||
155679098|NCT01436656|561914416|FG002|Dose Expansion|Adverse Event|0|||
155679099|NCT01436656|561914417|FG003|Dose Expansion|Adverse Event|0|||
155679100|NCT01436656|561914418|FG004|Dose Expansion|Adverse Event|0|||
155679101|NCT01436656|561914419|FG005|Dose Expansion|Adverse Event|0|||
155679102|NCT01436656|561914420|FG006|Dose Expansion|Adverse Event|0|||
155679103|NCT01436656|561914421|FG007|Dose Expansion|Adverse Event|0|||
155679104|NCT01436656|561914422|FG008|Dose Expansion|Adverse Event|0|||
155679105|NCT01436656|561914423|FG009|Dose Expansion|Adverse Event|0|||
155679106|NCT01436656|561914424|FG010|Dose Expansion|Adverse Event|0|||
155679107|NCT01436656|561914425|FG011|Dose Expansion|Adverse Event|1|||
155679108|NCT01436656|561914426|FG012|Dose Expansion|Adverse Event|0|||
155679109|NCT01436656|561914427|FG013|Dose Expansion|Adverse Event|0|||
155679110|NCT01436656|561914428|FG014|Dose Expansion|Adverse Event|0|||
155679111|NCT01436656|561914429|FG015|Dose Expansion|Adverse Event|0|||
155679112|NCT01436656|561914430|FG016|Dose Expansion|Adverse Event|0|||
155679113|NCT01436656|561914431|FG017|Dose Expansion|Adverse Event|0|||
155679114|NCT01436656|561914414|FG000|Dose Expansion|Withdrawal by Subject|0|||
155679115|NCT01436656|561914415|FG001|Dose Expansion|Withdrawal by Subject|0|||
155679116|NCT01436656|561914416|FG002|Dose Expansion|Withdrawal by Subject|0|||
155679117|NCT01436656|561914417|FG003|Dose Expansion|Withdrawal by Subject|0|||
155679118|NCT01436656|561914418|FG004|Dose Expansion|Withdrawal by Subject|0|||
155679119|NCT01436656|561914419|FG005|Dose Expansion|Withdrawal by Subject|0|||
155679120|NCT01436656|561914420|FG006|Dose Expansion|Withdrawal by Subject|0|||
155679121|NCT01436656|561914421|FG007|Dose Expansion|Withdrawal by Subject|0|||
155679122|NCT01436656|561914422|FG008|Dose Expansion|Withdrawal by Subject|0|||
155679123|NCT01436656|561914423|FG009|Dose Expansion|Withdrawal by Subject|0|||
155679124|NCT01436656|561914424|FG010|Dose Expansion|Withdrawal by Subject|0|||
155679125|NCT01436656|561914425|FG011|Dose Expansion|Withdrawal by Subject|1|||
155679126|NCT01436656|561914426|FG012|Dose Expansion|Withdrawal by Subject|3|||
155679127|NCT01436656|561914427|FG013|Dose Expansion|Withdrawal by Subject|1|||
155679128|NCT01436656|561914428|FG014|Dose Expansion|Withdrawal by Subject|2|||
155679129|NCT01436656|561914429|FG015|Dose Expansion|Withdrawal by Subject|0|||
155679130|NCT01436656|561914430|FG016|Dose Expansion|Withdrawal by Subject|1|||
155679131|NCT01436656|561914431|FG017|Dose Expansion|Withdrawal by Subject|1|||
155679132|NCT01436656|561914414|FG000|Dose Expansion|Death|0|||
155679133|NCT01436656|561914415|FG001|Dose Expansion|Death|0|||
155679134|NCT01436656|561914416|FG002|Dose Expansion|Death|0|||
155679135|NCT01436656|561914417|FG003|Dose Expansion|Death|0|||
155679136|NCT01436656|561914418|FG004|Dose Expansion|Death|0|||
155679137|NCT01436656|561914419|FG005|Dose Expansion|Death|0|||
155679138|NCT01436656|561914420|FG006|Dose Expansion|Death|0|||
155679139|NCT01436656|561914421|FG007|Dose Expansion|Death|0|||
155679140|NCT01436656|561914422|FG008|Dose Expansion|Death|0|||
155679141|NCT01436656|561914423|FG009|Dose Expansion|Death|0|||
155679142|NCT01436656|561914424|FG010|Dose Expansion|Death|0|||
155679143|NCT01436656|561914425|FG011|Dose Expansion|Death|0|||
155679144|NCT01436656|561914426|FG012|Dose Expansion|Death|1|||
155679145|NCT01436656|561914427|FG013|Dose Expansion|Death|0|||
155679146|NCT01436656|561914428|FG014|Dose Expansion|Death|3|||
155679147|NCT01436656|561914429|FG015|Dose Expansion|Death|0|||
155679148|NCT01436656|561914430|FG016|Dose Expansion|Death|3|||
155679149|NCT01436656|561914431|FG017|Dose Expansion|Death|3|||
155679150|NCT01436656|561914414|FG000|Dose Expansion|Lost to Follow-up|0|||
155679151|NCT01436656|561914415|FG001|Dose Expansion|Lost to Follow-up|0|||
155679152|NCT01436656|561914416|FG002|Dose Expansion|Lost to Follow-up|0|||
155679153|NCT01436656|561914417|FG003|Dose Expansion|Lost to Follow-up|0|||
155679154|NCT01436656|561914418|FG004|Dose Expansion|Lost to Follow-up|0|||
155679155|NCT01436656|561914419|FG005|Dose Expansion|Lost to Follow-up|0|||
155679156|NCT01436656|561914420|FG006|Dose Expansion|Lost to Follow-up|0|||
155679157|NCT01436656|561914421|FG007|Dose Expansion|Lost to Follow-up|0|||
155679158|NCT01436656|561914422|FG008|Dose Expansion|Lost to Follow-up|0|||
155679159|NCT01436656|561914423|FG009|Dose Expansion|Lost to Follow-up|0|||
155679160|NCT01436656|561914424|FG010|Dose Expansion|Lost to Follow-up|0|||
155679161|NCT01436656|561914425|FG011|Dose Expansion|Lost to Follow-up|0|||
155679162|NCT01436656|561914426|FG012|Dose Expansion|Lost to Follow-up|0|||
155679163|NCT01436656|561914427|FG013|Dose Expansion|Lost to Follow-up|0|||
155679164|NCT01436656|561914428|FG014|Dose Expansion|Lost to Follow-up|0|||
155679165|NCT01436656|561914429|FG015|Dose Expansion|Lost to Follow-up|0|||
155679166|NCT01436656|561914430|FG016|Dose Expansion|Lost to Follow-up|0|||
155679167|NCT01436656|561914431|FG017|Dose Expansion|Lost to Follow-up|3|||
155679168|NCT01436656|561914414|FG000|Dose Expansion|Disease progression|0|||
155679169|NCT01436656|561914415|FG001|Dose Expansion|Disease progression|0|||
155679170|NCT01436656|561914416|FG002|Dose Expansion|Disease progression|0|||
155679171|NCT01436656|561914417|FG003|Dose Expansion|Disease progression|0|||
155679172|NCT01436656|561914418|FG004|Dose Expansion|Disease progression|0|||
155679173|NCT01436656|561914419|FG005|Dose Expansion|Disease progression|0|||
155679174|NCT01436656|561914420|FG006|Dose Expansion|Disease progression|0|||
155679175|NCT01436656|561914421|FG007|Dose Expansion|Disease progression|0|||
155679176|NCT01436656|561914422|FG008|Dose Expansion|Disease progression|0|||
155679177|NCT01436656|561914423|FG009|Dose Expansion|Disease progression|0|||
155679178|NCT01436656|561914424|FG010|Dose Expansion|Disease progression|0|||
155679179|NCT01436656|561914425|FG011|Dose Expansion|Disease progression|3|||
155679180|NCT01436656|561914426|FG012|Dose Expansion|Disease progression|1|||
155679181|NCT01436656|561914427|FG013|Dose Expansion|Disease progression|0|||
155679182|NCT01436656|561914428|FG014|Dose Expansion|Disease progression|1|||
155679183|NCT01436656|561914429|FG015|Dose Expansion|Disease progression|0|||
155679184|NCT01436656|561914430|FG016|Dose Expansion|Disease progression|0|||
155679185|NCT01436656|561914431|FG017|Dose Expansion|Disease progression|1|||
155679186|NCT01436656|561914414|FG000|Dose Expansion|New cancer therapy|0|||
155679187|NCT01436656|561914415|FG001|Dose Expansion|New cancer therapy|0|||
155679188|NCT01436656|561914416|FG002|Dose Expansion|New cancer therapy|0|||
155679189|NCT01436656|561914417|FG003|Dose Expansion|New cancer therapy|0|||
155679190|NCT01436656|561914418|FG004|Dose Expansion|New cancer therapy|0|||
155679191|NCT01436656|561914419|FG005|Dose Expansion|New cancer therapy|0|||
155679192|NCT01436656|561914420|FG006|Dose Expansion|New cancer therapy|0|||
155679193|NCT01436656|561914421|FG007|Dose Expansion|New cancer therapy|0|||
155679194|NCT01436656|561914422|FG008|Dose Expansion|New cancer therapy|0|||
155679195|NCT01436656|561914423|FG009|Dose Expansion|New cancer therapy|0|||
155679196|NCT01436656|561914424|FG010|Dose Expansion|New cancer therapy|0|||
155679197|NCT01436656|561914425|FG011|Dose Expansion|New cancer therapy|1|||
155679198|NCT01436656|561914426|FG012|Dose Expansion|New cancer therapy|1|||
155679199|NCT01436656|561914427|FG013|Dose Expansion|New cancer therapy|0|||
155679200|NCT01436656|561914428|FG014|Dose Expansion|New cancer therapy|2|||
155679201|NCT01436656|561914429|FG015|Dose Expansion|New cancer therapy|0|||
155679202|NCT01436656|561914430|FG016|Dose Expansion|New cancer therapy|0|||
155679203|NCT01436656|561914431|FG017|Dose Expansion|New cancer therapy|0|||
155679204|NCT01696994|561914432|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
155679205|NCT01696994|561914433|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
155679206|NCT01696994|561914432|FG000|Overall Study|Died Before Randomization|1|||
155679207|NCT01696994|561914433|FG001|Overall Study|Died Before Randomization|2|||
155679208|NCT01696994|561914432|FG000|Overall Study|Died Before ASU (Control)|73|||
155679209|NCT01696994|561914433|FG001|Overall Study|Died Before ASU (Control)|0|||
155679210|NCT01696994|561914432|FG000|Overall Study|No Ovaries at Baseline|4807|||
155679211|NCT01696994|561914433|FG001|Overall Study|No Ovaries at Baseline|4851|||
155679212|NCT01696994|561914432|FG000|Overall Study|Refused ASU (Control)|311|||
155679213|NCT01696994|561914433|FG001|Overall Study|Refused ASU (Control)|0|||
155679214|NCT01696994|561914432|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
155679215|NCT01696994|561914433|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
155679216|NCT02388165|561914436|FG000|Overall Study|Study terminated by sponsor|5|||
155679217|NCT02388165|561914437|FG001|Overall Study|Study terminated by sponsor|5|||
155679218|NCT02388165|561914436|FG000|Overall Study|Other|11|||
155679219|NCT02388165|561914437|FG001|Overall Study|Other|13|||
155679220|NCT02388165|561914436|FG000|Overall Study|No longer meet eligibility criteria|40|||
155679221|NCT02388165|561914437|FG001|Overall Study|No longer meet eligibility criteria|43|||
155679222|NCT02388165|561914436|FG000|Overall Study|Withdrawal of consent|31|||
155679223|NCT02388165|561914437|FG001|Overall Study|Withdrawal of consent|32|||
155679224|NCT02388165|561914436|FG000|Overall Study|Lost to Follow-up|19|||
155679225|NCT02388165|561914437|FG001|Overall Study|Lost to Follow-up|20|||
155679226|NCT02388165|561914436|FG000|Overall Study|Death|13|||
155679227|NCT02388165|561914437|FG001|Overall Study|Death|10|||
155679228|NCT02388165|561914436|FG000|Overall Study|Adverse Event|3|||
155679229|NCT02388165|561914437|FG001|Overall Study|Adverse Event|5|||
155679230|NCT02388165|561914436|FG000|Overall Study|Did not meet entrance criteria|5|||
155679231|NCT02388165|561914437|FG001|Overall Study|Did not meet entrance criteria|2|||
155679232|NCT00705250|561914438|FG000|Overall Study|Withdrawal by Subject|1|||
155679233|NCT00705250|561914438|FG000|Overall Study|Patient died in car accident|1|||
155679234|NCT00880269|561914439|FG000|Overall Study|Protocol Violation|1|||
155679235|NCT00880269|561914440|FG001|Overall Study|Protocol Violation|0|||
155679236|NCT00880269|561914439|FG000|Overall Study|Disease Progression|13|||
155679237|NCT00880269|561914440|FG001|Overall Study|Disease Progression|11|||
155679238|NCT00880269|561914439|FG000|Overall Study|New Cancer Therapy|1|||
155679239|NCT00880269|561914440|FG001|Overall Study|New Cancer Therapy|0|||
155679240|NCT00880269|561914439|FG000|Overall Study|Death|4|||
155679241|NCT00880269|561914440|FG001|Overall Study|Death|2|||
155679242|NCT00880269|561914439|FG000|Overall Study|Lost to Follow-up|0|||
155679243|NCT00880269|561914440|FG001|Overall Study|Lost to Follow-up|1|||
155679244|NCT00880269|561914439|FG000|Overall Study|Withdrawal by Subject|3|||
155679245|NCT00880269|561914440|FG001|Overall Study|Withdrawal by Subject|4|||
155679246|NCT00880269|561914439|FG000|Overall Study|Adverse Event|10|||
155679247|NCT00880269|561914440|FG001|Overall Study|Adverse Event|9|||
155679248|NCT01406938|561914441|FG000|Induction Period|Subject/guardian decision|6|||
155679249|NCT01406938|561914442|FG001|Induction Period|Subject/guardian decision|8|||
155679250|NCT01406938|561914443|FG002|Induction Period|Subject/guardian decision|0|||
155679251|NCT01406938|561914444|FG003|Induction Period|Subject/guardian decision|0|||
155679252|NCT01406938|561914445|FG004|Induction Period|Subject/guardian decision|0|||
155679253|NCT01406938|561914446|FG005|Induction Period|Subject/guardian decision|0|||
155679254|NCT01406938|561914441|FG000|Induction Period|Protocol deviation|1|||
155679255|NCT01406938|561914442|FG001|Induction Period|Protocol deviation|0|||
155679256|NCT01406938|561914443|FG002|Induction Period|Protocol deviation|0|||
155679257|NCT01406938|561914444|FG003|Induction Period|Protocol deviation|0|||
155679258|NCT01406938|561914445|FG004|Induction Period|Protocol deviation|0|||
155679259|NCT01406938|561914446|FG005|Induction Period|Protocol deviation|0|||
155679260|NCT01406938|561914441|FG000|Induction Period|Adverse Event|8|||
155679261|NCT01406938|561914442|FG001|Induction Period|Adverse Event|9|||
155679262|NCT01406938|561914443|FG002|Induction Period|Adverse Event|0|||
155679263|NCT01406938|561914444|FG003|Induction Period|Adverse Event|0|||
155679264|NCT01406938|561914445|FG004|Induction Period|Adverse Event|0|||
155679265|NCT01406938|561914446|FG005|Induction Period|Adverse Event|0|||
155679266|NCT01406938|561914441|FG000|Induction Period|Lack of Efficacy|1|||
155679267|NCT01406938|561914442|FG001|Induction Period|Lack of Efficacy|0|||
155679268|NCT01406938|561914443|FG002|Induction Period|Lack of Efficacy|0|||
155679269|NCT01406938|561914444|FG003|Induction Period|Lack of Efficacy|0|||
155679270|NCT01406938|561914445|FG004|Induction Period|Lack of Efficacy|0|||
155679271|NCT01406938|561914446|FG005|Induction Period|Lack of Efficacy|0|||
155679272|NCT01406938|561914441|FG000|Induction Period|Lost to Follow-up|2|||
155679273|NCT01406938|561914442|FG001|Induction Period|Lost to Follow-up|3|||
155679274|NCT01406938|561914443|FG002|Induction Period|Lost to Follow-up|0|||
155679275|NCT01406938|561914444|FG003|Induction Period|Lost to Follow-up|0|||
155679276|NCT01406938|561914445|FG004|Induction Period|Lost to Follow-up|0|||
155679277|NCT01406938|561914446|FG005|Induction Period|Lost to Follow-up|0|||
155679278|NCT01406938|561914441|FG000|Maintenance Period|Adverse Event|0|||
155679279|NCT01406938|561914442|FG001|Maintenance Period|Adverse Event|0|||
155679280|NCT01406938|561914443|FG002|Maintenance Period|Adverse Event|2|||
155679281|NCT01406938|561914444|FG003|Maintenance Period|Adverse Event|8|||
155679282|NCT01406938|561914445|FG004|Maintenance Period|Adverse Event|4|||
155679283|NCT01406938|561914446|FG005|Maintenance Period|Adverse Event|2|||
155679284|NCT01406938|561914441|FG000|Maintenance Period|Death|0|||
155679285|NCT01406938|561914442|FG001|Maintenance Period|Death|0|||
155679286|NCT01406938|561914443|FG002|Maintenance Period|Death|0|||
155679287|NCT01406938|561914444|FG003|Maintenance Period|Death|0|||
155679288|NCT01406938|561914445|FG004|Maintenance Period|Death|1|||
155679289|NCT01406938|561914446|FG005|Maintenance Period|Death|0|||
155679290|NCT01406938|561914441|FG000|Maintenance Period|Subject/guardian decision|0|||
155679291|NCT01406938|561914442|FG001|Maintenance Period|Subject/guardian decision|0|||
155679292|NCT01406938|561914443|FG002|Maintenance Period|Subject/guardian decision|11|||
155679293|NCT01406938|561914444|FG003|Maintenance Period|Subject/guardian decision|7|||
155679294|NCT01406938|561914445|FG004|Maintenance Period|Subject/guardian decision|10|||
155679295|NCT01406938|561914446|FG005|Maintenance Period|Subject/guardian decision|7|||
155679296|NCT01406938|561914441|FG000|Maintenance Period|Protocol Violation|0|||
155679297|NCT01406938|561914442|FG001|Maintenance Period|Protocol Violation|0|||
155679298|NCT01406938|561914443|FG002|Maintenance Period|Protocol Violation|2|||
155679299|NCT01406938|561914444|FG003|Maintenance Period|Protocol Violation|2|||
155679300|NCT01406938|561914445|FG004|Maintenance Period|Protocol Violation|2|||
155679301|NCT01406938|561914446|FG005|Maintenance Period|Protocol Violation|2|||
155679302|NCT01406938|561914441|FG000|Maintenance Period|Pregnancy|0|||
155679303|NCT01406938|561914442|FG001|Maintenance Period|Pregnancy|0|||
155679304|NCT01406938|561914443|FG002|Maintenance Period|Pregnancy|0|||
155679305|NCT01406938|561914444|FG003|Maintenance Period|Pregnancy|0|||
155679306|NCT01406938|561914445|FG004|Maintenance Period|Pregnancy|1|||
155679307|NCT01406938|561914446|FG005|Maintenance Period|Pregnancy|0|||
155679308|NCT01406938|561914441|FG000|Maintenance Period|Lost to Follow-up|0|||
155679309|NCT01406938|561914442|FG001|Maintenance Period|Lost to Follow-up|0|||
155679310|NCT01406938|561914443|FG002|Maintenance Period|Lost to Follow-up|0|||
155679311|NCT01406938|561914444|FG003|Maintenance Period|Lost to Follow-up|0|||
155679312|NCT01406938|561914445|FG004|Maintenance Period|Lost to Follow-up|4|||
155679313|NCT01406938|561914446|FG005|Maintenance Period|Lost to Follow-up|0|||
155679314|NCT01406938|561914441|FG000|Maintenance Period|Lack of Efficacy|0|||
155679315|NCT01406938|561914442|FG001|Maintenance Period|Lack of Efficacy|0|||
155679316|NCT01406938|561914443|FG002|Maintenance Period|Lack of Efficacy|2|||
155679317|NCT01406938|561914444|FG003|Maintenance Period|Lack of Efficacy|1|||
155679318|NCT01406938|561914445|FG004|Maintenance Period|Lack of Efficacy|3|||
155679319|NCT01406938|561914446|FG005|Maintenance Period|Lack of Efficacy|5|||
155679320|NCT01406938|561914441|FG000|Follow up|Lack of Efficacy|3|||
155679321|NCT01406938|561914442|FG001|Follow up|Lack of Efficacy|2|||
155679322|NCT01406938|561914443|FG002|Follow up|Lack of Efficacy|1|||
155679323|NCT01406938|561914444|FG003|Follow up|Lack of Efficacy|0|||
155679324|NCT01406938|561914445|FG004|Follow up|Lack of Efficacy|0|||
155679325|NCT01406938|561914446|FG005|Follow up|Lack of Efficacy|0|||
155679326|NCT01406938|561914441|FG000|Follow up|Patient/guardian decision|4|||
155679327|NCT01406938|561914442|FG001|Follow up|Patient/guardian decision|2|||
155679328|NCT01406938|561914443|FG002|Follow up|Patient/guardian decision|4|||
155679329|NCT01406938|561914444|FG003|Follow up|Patient/guardian decision|2|||
155679330|NCT01406938|561914445|FG004|Follow up|Patient/guardian decision|4|||
155679331|NCT01406938|561914446|FG005|Follow up|Patient/guardian decision|1|||
155679332|NCT01406938|561914441|FG000|Follow up|Protocol Violation|0|||
155679333|NCT01406938|561914442|FG001|Follow up|Protocol Violation|0|||
155679334|NCT01406938|561914443|FG002|Follow up|Protocol Violation|1|||
155679335|NCT01406938|561914444|FG003|Follow up|Protocol Violation|0|||
155679336|NCT01406938|561914445|FG004|Follow up|Protocol Violation|0|||
155679337|NCT01406938|561914446|FG005|Follow up|Protocol Violation|0|||
155679338|NCT01406938|561914441|FG000|Follow up|Physician Decision|0|||
155679339|NCT01406938|561914442|FG001|Follow up|Physician Decision|0|||
155679340|NCT01406938|561914443|FG002|Follow up|Physician Decision|2|||
155679341|NCT01406938|561914444|FG003|Follow up|Physician Decision|0|||
155679342|NCT01406938|561914445|FG004|Follow up|Physician Decision|3|||
155679343|NCT01406938|561914446|FG005|Follow up|Physician Decision|1|||
155679344|NCT01406938|561914441|FG000|Follow up|Lost to Follow-up|1|||
155679345|NCT01406938|561914442|FG001|Follow up|Lost to Follow-up|1|||
155679346|NCT01406938|561914443|FG002|Follow up|Lost to Follow-up|0|||
155679347|NCT01406938|561914444|FG003|Follow up|Lost to Follow-up|1|||
155679348|NCT01406938|561914445|FG004|Follow up|Lost to Follow-up|2|||
155679349|NCT01406938|561914446|FG005|Follow up|Lost to Follow-up|1|||
155679350|NCT00962741|561914451|FG000|Overall Study|Failed to return|3|||
155679351|NCT00962741|561914451|FG000|Overall Study|Lost to Follow-up|2|||
155679352|NCT00962741|561914451|FG000|Overall Study|Withdrawal by Subject|1|||
155679353|NCT00962741|561914451|FG000|Overall Study|Lack of Efficacy|1|||
155679354|NCT00962741|561914451|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
155679355|NCT00316225|561914452|FG000|Overall Study|Adverse Event|2|||
155679356|NCT00316225|561914452|FG000|Overall Study|Physician Decision|3|||
155679357|NCT00316225|561914452|FG000|Overall Study|Progressive Disease|15|||
155679358|NCT00316225|561914452|FG000|Overall Study|Withdrawal by Subject|3|||
155679359|NCT00316225|561914452|FG000|Overall Study|Death|2|||
155679360|NCT01814878|561914454|FG000|Overall Study|Adverse Event|16|||
155679361|NCT01814878|561914455|FG001|Overall Study|Adverse Event|5|||
155679362|NCT01814878|561914454|FG000|Overall Study|Withdrawal by Subject|20|||
155679363|NCT01814878|561914455|FG001|Overall Study|Withdrawal by Subject|16|||
155679364|NCT01814878|561914454|FG000|Overall Study|Protocol Violation|5|||
155679365|NCT01814878|561914455|FG001|Overall Study|Protocol Violation|5|||
155679366|NCT01814878|561914454|FG000|Overall Study|Physician Decision|3|||
155679367|NCT01814878|561914455|FG001|Overall Study|Physician Decision|1|||
155679368|NCT01814878|561914454|FG000|Overall Study|Screening failure (drop-out)|0|||
155679369|NCT01814878|561914455|FG001|Overall Study|Screening failure (drop-out)|3|||
155679370|NCT01814878|561914454|FG000|Overall Study|Other|2|||
155679371|NCT01814878|561914455|FG001|Overall Study|Other|0|||
155679372|NCT01545934|561914456|FG000|Overall Study|Withdrawal by Subject|4|||
155679373|NCT01545934|561914457|FG001|Overall Study|Withdrawal by Subject|3|||
155679374|NCT01545934|561914456|FG000|Overall Study|Lost to Follow-up|1|||
155679375|NCT01545934|561914457|FG001|Overall Study|Lost to Follow-up|0|||
155679376|NCT03654404|561914458|FG000|Overall Study|Death|1|||
155679377|NCT03654404|561914458|FG000|Overall Study|Lost to Follow-up|2|||
155679378|NCT03654404|561914458|FG000|Overall Study|Withdrawal by Subject|5|||
155679379|NCT02003638|561914465|FG000|Overall Study|Withdrawal by Subject|1|||
155679380|NCT02003638|561914466|FG001|Overall Study|Withdrawal by Subject|0|||
155679381|NCT00654745|561914469|FG000|Overall Study|Adverse Event|12|||
155679382|NCT00654745|561914469|FG000|Overall Study|Lost to Follow-up|7|||
155679383|NCT00654745|561914469|FG000|Overall Study|Protocol Violation|11|||
155679384|NCT00654745|561914469|FG000|Overall Study|Withdrawal by Subject|10|||
155679385|NCT00654745|561914469|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
155679386|NCT04551963|561914470|FG000|Overall Study|Physician Decision|1|||
155679387|NCT04551963|561914471|FG001|Overall Study|Physician Decision|1|||
155679388|NCT04551963|561914470|FG000|Overall Study|Death|1|||
155679389|NCT04551963|561914471|FG001|Overall Study|Death|0|||
155679390|NCT00748618|561914472|FG000|Overall Study|Adverse Event|1|||
155679391|NCT00748618|561914473|FG001|Overall Study|Adverse Event|0|||
155679392|NCT00466947|561914474|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
155679393|NCT00466947|561914475|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
155679394|NCT00466947|561914474|FG000|Study End Analysis Period|Adverse Event|35|||
155679395|NCT00466947|561914475|FG001|Study End Analysis Period|Adverse Event|43|||
155679396|NCT00466947|561914474|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
155679397|NCT00466947|561914475|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
155679398|NCT00466947|561914474|FG000|Study End Analysis Period|Physician Decision|29|||
155679399|NCT00466947|561914475|FG001|Study End Analysis Period|Physician Decision|29|||
155679400|NCT00466947|561914474|FG000|Study End Analysis Period|Protocol Violation|9|||
155679401|NCT00466947|561914475|FG001|Study End Analysis Period|Protocol Violation|17|||
155679402|NCT00466947|561914474|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
155679403|NCT00466947|561914475|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
155679404|NCT00466947|561914474|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
155679405|NCT00466947|561914475|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
155679406|NCT00466947|561914474|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
155679407|NCT00466947|561914475|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
155679408|NCT00466947|561914474|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
155679409|NCT00466947|561914475|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
155679410|NCT00878254|561914476|FG000|Overall Study|Physician Decision|1|||
155679411|NCT00878254|561914476|FG000|Overall Study|Death|1|||
155679412|NCT00878254|561914476|FG000|Overall Study|Withdrawal by Subject|1|||
155679413|NCT01977729|561914480|FG000|Overall Study|Study terminated|1|||
155679414|NCT00606034|561914487|FG000|Overall Study|incarceration|1|||
155679415|NCT00765037|561914489|FG000|Overall Study|Lost to Follow-up|5|||
155679416|NCT00765037|561914489|FG000|Overall Study|Adverse Event|1|||
155679417|NCT00964002|561914490|FG000|Overall Study|Protocol Violation|8|||
155679418|NCT03596047|561916420|FG000|Overall Study|Withdrawal by Subject|7|||
155679419|NCT03596047|561916421|FG001|Overall Study|Withdrawal by Subject|4|||
155679420|NCT03596047|561916420|FG000|Overall Study|Lost to Follow-up|0|||
155679421|NCT03596047|561916421|FG001|Overall Study|Lost to Follow-up|2|||
155679422|NCT01696968|561916422|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
155679423|NCT01696968|561916423|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
155679424|NCT01696968|561916422|FG000|Overall Study|Died Before Randomization|3|||
155679425|NCT01696968|561916423|FG001|Overall Study|Died Before Randomization|8|||
155679426|NCT01696968|561916422|FG000|Overall Study|Died Before ASU (Control)|278|||
155679427|NCT01696968|561916423|FG001|Overall Study|Died Before ASU (Control)|0|||
155679428|NCT01696968|561916422|FG000|Overall Study|Refused ASU (Control)|920|||
155679429|NCT01696968|561916423|FG001|Overall Study|Refused ASU (Control)|0|||
155679430|NCT01696968|561916422|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
155679431|NCT01696968|561916423|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
155679432|NCT03727646|561916424|FG000|Overall Study|Adverse Event|1|||
155679433|NCT03727646|561916425|FG001|Overall Study|Adverse Event|0|||
155679434|NCT04753658|561916426|FG000|Overall Study|Progressive disease|7|||
155679435|NCT04753658|561916426|FG000|Overall Study|Other|7|||
155679436|NCT04753658|561916426|FG000|Overall Study|Adverse Event|1|||
155679437|NCT02582814|561916433|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155679438|NCT02582814|561916434|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155679439|NCT02582814|561916433|FG000|Overall Study|Withdrawal by Subject|4|||
155679440|NCT02582814|561916434|FG001|Overall Study|Withdrawal by Subject|3|||
155679441|NCT02582814|561916433|FG000|Overall Study|Adverse Event|4|||
155679442|NCT02582814|561916434|FG001|Overall Study|Adverse Event|4|||
155679443|NCT00306293|561916435|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
155679444|NCT00306293|561916436|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
155679445|NCT00306293|561916435|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
155679446|NCT00306293|561916436|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
155679447|NCT00306293|561916435|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
155679448|NCT00306293|561916436|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
155679449|NCT00306293|561916435|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
155679450|NCT00306293|561916436|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
155679451|NCT00306293|561916435|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
155679452|NCT00306293|561916436|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
155679453|NCT00306293|561916435|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
155679454|NCT00306293|561916436|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
155679455|NCT00306293|561916435|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
155679456|NCT00306293|561916436|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
155679457|NCT00306293|561916435|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
155679458|NCT00306293|561916436|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
155679459|NCT00176488|561916437|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
155679460|NCT02650804|561916438|FG000|Overall Study|Adverse Event|3|||
155679461|NCT02650804|561916439|FG001|Overall Study|Adverse Event|2|||
155679462|NCT02650804|561916438|FG000|Overall Study|Death|1|||
155679463|NCT02650804|561916439|FG001|Overall Study|Death|2|||
155679464|NCT02650804|561916438|FG000|Overall Study|Progressive Disease|7|||
155679465|NCT02650804|561916439|FG001|Overall Study|Progressive Disease|10|||
155679466|NCT02650804|561916438|FG000|Overall Study|Physician Decision|0|||
155679467|NCT02650804|561916439|FG001|Overall Study|Physician Decision|2|||
155679468|NCT02650804|561916438|FG000|Overall Study|Withdrawal by Subject|1|||
155679469|NCT02650804|561916439|FG001|Overall Study|Withdrawal by Subject|4|||
155679470|NCT02650804|561916438|FG000|Overall Study|Symptomatic deterioration|5|||
155679471|NCT02650804|561916439|FG001|Overall Study|Symptomatic deterioration|7|||
155679472|NCT02650804|561916438|FG000|Overall Study|Protocol Violation|0|||
155679473|NCT02650804|561916439|FG001|Overall Study|Protocol Violation|1|||
155679474|NCT02557100|561916451|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
155679475|NCT02557100|561916452|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
155679476|NCT02557100|561916453|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
155679477|NCT02557100|561916451|FG000|Single Blind Treatment Period|Death|0|||
155679478|NCT02557100|561916452|FG001|Single Blind Treatment Period|Death|1|||
155679479|NCT02557100|561916453|FG002|Single Blind Treatment Period|Death|0|||
155679480|NCT02557100|561916451|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
155679481|NCT02557100|561916452|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
155679482|NCT02557100|561916453|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
155679483|NCT02557100|561916451|FG000|Single Blind Treatment Period|Adverse Event|0|||
155679484|NCT02557100|561916452|FG001|Single Blind Treatment Period|Adverse Event|1|||
155679485|NCT02557100|561916453|FG002|Single Blind Treatment Period|Adverse Event|0|||
155679486|NCT02557100|561916451|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
155679487|NCT02557100|561916452|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
155679488|NCT02557100|561916453|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
155679489|NCT02557100|561916451|FG000|Cumulative Abatacept Period|Other Reasons|0|||
155679490|NCT02557100|561916452|FG001|Cumulative Abatacept Period|Other Reasons|0|||
155679491|NCT02557100|561916453|FG002|Cumulative Abatacept Period|Other Reasons|1|||
155679492|NCT02557100|561916451|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
155679493|NCT02557100|561916452|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
155679494|NCT02557100|561916453|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
155679495|NCT02557100|561916451|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
155679496|NCT02557100|561916452|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
155679497|NCT02557100|561916453|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
155679498|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
155679499|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
155679500|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
155679501|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
155679502|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
155679503|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
155679504|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
155679505|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
155679506|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
155679507|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
155679508|NCT00510718|561916456|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
155679509|NCT00510718|561916457|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
155679510|NCT04644276|561916458|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
155679511|NCT04644276|561916459|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
155679512|NCT04644276|561916460|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
155679513|NCT01576146|561916461|FG000|Extension Period 1|Adverse Event|2|||
155679514|NCT01576146|561916461|FG000|Extension Period 1|Death|2|||
155679515|NCT01576146|561916461|FG000|Extension Period 1|Physician Decision|2|||
155679516|NCT01576146|561916461|FG000|Extension Period 1|Withdrawal by Subject|1|||
155679517|NCT01576146|561916461|FG000|Extension Period 1|Lost to Follow-up|1|||
155679518|NCT01576146|561916461|FG000|Extension Period 1|Parathyroidectomy|1|||
155679519|NCT01576146|561916461|FG000|Extension Period 1|Renal Transplant|1|||
155679520|NCT01576146|561916461|FG000|Extension Period 2|Sponsor Decision|13|||
155679521|NCT01576146|561916461|FG000|Extension Period 2|Death|1|||
155679522|NCT01576146|561916461|FG000|Extension Period 2|Adverse Event|1|||
155679523|NCT01576146|561916461|FG000|Extension Period 2|Renal Transplant|1|||
155679524|NCT01576146|561916461|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
155679525|NCT01811485|561916463|FG000|Overall Study|Adverse Event|1|||
155679526|NCT01811485|561916464|FG001|Overall Study|Adverse Event|3|||
155679527|NCT01811485|561916465|FG002|Overall Study|Adverse Event|2|||
155679528|NCT01811485|561916463|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155679529|NCT01811485|561916464|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155679530|NCT01811485|561916465|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
155679531|NCT01811485|561916463|FG000|Overall Study|Administrative problems|1|||
155679532|NCT01811485|561916464|FG001|Overall Study|Administrative problems|0|||
155679533|NCT01811485|561916465|FG002|Overall Study|Administrative problems|0|||
155679534|NCT01811485|561916463|FG000|Overall Study|Protocol Deviation|0|||
155679535|NCT01811485|561916464|FG001|Overall Study|Protocol Deviation|1|||
155679536|NCT01811485|561916465|FG002|Overall Study|Protocol Deviation|0|||
155679537|NCT03299881|561916466|FG000|Overall Study|Study Termination|17|||
155679538|NCT03299881|561916467|FG001|Overall Study|Study Termination|13|||
155679539|NCT02974855|561916468|FG000|Overall Study|Adverse Event|0|||
155679540|NCT02974855|561916469|FG001|Overall Study|Adverse Event|1|||
155679541|NCT02974855|561916470|FG002|Overall Study|Adverse Event|0|||
155679542|NCT02974855|561916471|FG003|Overall Study|Adverse Event|1|||
155679543|NCT01474772|561916472|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
155679544|NCT01474772|561916473|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
155679545|NCT01474772|561916472|FG000|Period 1|AE not Related to Study Drug|1|||
155679546|NCT01474772|561916473|FG001|Period 1|AE not Related to Study Drug|0|||
155679547|NCT01474772|561916472|FG000|Period 1|Withdrawal by Subject|3|||
155679548|NCT01474772|561916473|FG001|Period 1|Withdrawal by Subject|1|||
155679549|NCT01474772|561916472|FG000|Period 1|Lost to Follow-up|1|||
155679550|NCT01474772|561916473|FG001|Period 1|Lost to Follow-up|0|||
155679551|NCT01474772|561916472|FG000|Period 1|Reason not Specified|1|||
155679552|NCT01474772|561916473|FG001|Period 1|Reason not Specified|1|||
155679553|NCT01474772|561916472|FG000|Washout|AE not Related to Study Drug|2|||
155679554|NCT01474772|561916473|FG001|Washout|AE not Related to Study Drug|0|||
155679555|NCT01474772|561916472|FG000|Washout|Withdrawal by Subject|1|||
155679556|NCT01474772|561916473|FG001|Washout|Withdrawal by Subject|0|||
155679557|NCT01474772|561916472|FG000|Washout|Lost to Follow-up|0|||
155679558|NCT01474772|561916473|FG001|Washout|Lost to Follow-up|1|||
155679559|NCT01474772|561916472|FG000|Washout|Reason not Specified|0|||
155679560|NCT01474772|561916473|FG001|Washout|Reason not Specified|1|||
155679561|NCT01474772|561916472|FG000|Period 2|Death|0|||
155679562|NCT01474772|561916473|FG001|Period 2|Death|1|||
155679563|NCT01474772|561916472|FG000|Period 2|AE Related to Study Drug|0|||
155679564|NCT01474772|561916473|FG001|Period 2|AE Related to Study Drug|1|||
155679565|NCT01474772|561916472|FG000|Period 2|AE not Related to Study Drug|4|||
155679566|NCT01474772|561916473|FG001|Period 2|AE not Related to Study Drug|1|||
155679567|NCT01474772|561916472|FG000|Period 2|Lack of Efficacy|1|||
155679568|NCT01474772|561916473|FG001|Period 2|Lack of Efficacy|0|||
155679569|NCT01474772|561916472|FG000|Period 2|Withdrawal by Subject|3|||
155679570|NCT01474772|561916473|FG001|Period 2|Withdrawal by Subject|4|||
155679571|NCT01474772|561916472|FG000|Period 2|Lost to Follow-up|1|||
155679572|NCT01474772|561916473|FG001|Period 2|Lost to Follow-up|1|||
155679573|NCT01474772|561916472|FG000|Period 2|Reason not Specified|0|||
155679574|NCT01474772|561916473|FG001|Period 2|Reason not Specified|2|||
155679575|NCT01474772|561916472|FG000|Follow-up|AE not Related to Study Drug|0|||
155679576|NCT01474772|561916473|FG001|Follow-up|AE not Related to Study Drug|1|||
155679577|NCT00633074|561916474|FG000|Overall Study|Adverse Event|1|||
155679578|NCT00633074|561916475|FG001|Overall Study|Adverse Event|0|||
155679579|NCT01995526|561916476|FG000|Overall Study|Physician Decision|1|||
155679580|NCT03367403|561916480|FG000|Overall Study|Adverse Event|20|||
155679581|NCT03367403|561916481|FG001|Overall Study|Adverse Event|6|||
155679582|NCT03367403|561916482|FG002|Overall Study|Adverse Event|2|||
155679583|NCT03367403|561916480|FG000|Overall Study|Withdrawal by Subject|12|||
155679584|NCT03367403|561916481|FG001|Overall Study|Withdrawal by Subject|13|||
155679585|NCT03367403|561916482|FG002|Overall Study|Withdrawal by Subject|1|||
155679586|NCT03367403|561916480|FG000|Overall Study|Death|1|||
155679587|NCT03367403|561916481|FG001|Overall Study|Death|2|||
155679588|NCT03367403|561916482|FG002|Overall Study|Death|0|||
155679589|NCT03367403|561916480|FG000|Overall Study|Physician Decision|0|||
155679590|NCT03367403|561916481|FG001|Overall Study|Physician Decision|1|||
155679591|NCT03367403|561916482|FG002|Overall Study|Physician Decision|0|||
155679592|NCT03367403|561916480|FG000|Overall Study|Protocol Violation|1|||
155679593|NCT03367403|561916481|FG001|Overall Study|Protocol Violation|1|||
155679594|NCT03367403|561916482|FG002|Overall Study|Protocol Violation|0|||
155679595|NCT03367403|561916480|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
155679596|NCT03367403|561916481|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
155679597|NCT03367403|561916482|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
155679598|NCT03367403|561916480|FG000|Overall Study|COVID-19|3|||
155679599|NCT03367403|561916481|FG001|Overall Study|COVID-19|6|||
155679600|NCT03367403|561916482|FG002|Overall Study|COVID-19|0|||
155679601|NCT03367403|561916480|FG000|Overall Study|Abuse of Alcohol Intake|0|||
155679602|NCT03367403|561916481|FG001|Overall Study|Abuse of Alcohol Intake|1|||
155679603|NCT03367403|561916482|FG002|Overall Study|Abuse of Alcohol Intake|0|||
155679604|NCT03367403|561916480|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
155679605|NCT03367403|561916481|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
155679606|NCT03367403|561916482|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
155679607|NCT00194077|561916483|FG000|Overall Study|Lack of Efficacy|22|||
155679608|NCT00194077|561916484|FG001|Overall Study|Lack of Efficacy|29|||
155679609|NCT00194077|561916483|FG000|Overall Study|Study nonadherence|1|||
155679610|NCT00194077|561916484|FG001|Overall Study|Study nonadherence|0|||
155679611|NCT00194077|561916483|FG000|Overall Study|Withdrawal by Subject|1|||
155679612|NCT00194077|561916484|FG001|Overall Study|Withdrawal by Subject|1|||
155679613|NCT03470194|561916485|FG000|Overall Study|Lost to Follow-up|11|||
155679614|NCT03470194|561916486|FG001|Overall Study|Lost to Follow-up|17|||
155679615|NCT01822899|561916487|FG000|Overall Study|Adverse Event|6|||
155679616|NCT01822899|561916488|FG001|Overall Study|Adverse Event|5|||
155679617|NCT01822899|561916487|FG000|Overall Study|Lack of Efficacy|6|||
155679618|NCT01822899|561916488|FG001|Overall Study|Lack of Efficacy|3|||
155679619|NCT01822899|561916487|FG000|Overall Study|Protocol Violation|6|||
155679620|NCT01822899|561916488|FG001|Overall Study|Protocol Violation|3|||
155679621|NCT01822899|561916487|FG000|Overall Study|Lost to Follow-up|1|||
155679622|NCT01822899|561916488|FG001|Overall Study|Lost to Follow-up|0|||
155679623|NCT01822899|561916487|FG000|Overall Study|Withdrawal by Subject|5|||
155679624|NCT01822899|561916488|FG001|Overall Study|Withdrawal by Subject|7|||
155679625|NCT00759876|561916490|FG000|Overall Study|Sponsor terminated study early|36|||
155679626|NCT01450696|561916492|FG000|Overall Study|Never Treated|1|||
155679627|NCT01450696|561916493|FG001|Overall Study|Never Treated|1|||
155679628|NCT01450696|561916492|FG000|Overall Study|Death|77|||
155679629|NCT01450696|561916493|FG001|Overall Study|Death|84|||
155679630|NCT01450696|561916492|FG000|Overall Study|Lost to Follow-up|3|||
155679631|NCT01450696|561916493|FG001|Overall Study|Lost to Follow-up|3|||
155679632|NCT01450696|561916492|FG000|Overall Study|Non-Compliance|1|||
155679633|NCT01450696|561916493|FG001|Overall Study|Non-Compliance|0|||
155679634|NCT01450696|561916492|FG000|Overall Study|Withdrawal by Subject|13|||
155679635|NCT01450696|561916493|FG001|Overall Study|Withdrawal by Subject|2|||
155679636|NCT01450696|561916492|FG000|Overall Study|Study Terminated by Sponsor|53|||
155679637|NCT01450696|561916493|FG001|Overall Study|Study Terminated by Sponsor|58|||
155679638|NCT02321319|561916495|FG000|Overall Study|Product discontinued|5|||
155679639|NCT02570152|561916498|FG000|Overall Study|Protocol Violation|2|||
155679640|NCT02570152|561916498|FG000|Overall Study|Migrated/moved from study area|13|||
155679641|NCT00853242|561916499|FG000|Overall Study|Adverse Event|0|||
155679642|NCT00853242|561916500|FG001|Overall Study|Adverse Event|1|||
155679643|NCT00853242|561916501|FG002|Overall Study|Adverse Event|1|||
155679644|NCT00853242|561916502|FG003|Overall Study|Adverse Event|0|||
155679645|NCT00853242|561916503|FG004|Overall Study|Adverse Event|3|||
155679646|NCT00853242|561916504|FG005|Overall Study|Adverse Event|1|||
155679647|NCT00853242|561916505|FG006|Overall Study|Adverse Event|1|||
155679648|NCT00853242|561916499|FG000|Overall Study|Noncompliant|0|||
155679649|NCT00853242|561916500|FG001|Overall Study|Noncompliant|0|||
155679650|NCT00853242|561916501|FG002|Overall Study|Noncompliant|0|||
155679651|NCT00853242|561916502|FG003|Overall Study|Noncompliant|0|||
155679652|NCT00853242|561916503|FG004|Overall Study|Noncompliant|1|||
155679653|NCT00853242|561916504|FG005|Overall Study|Noncompliant|0|||
155679654|NCT00853242|561916505|FG006|Overall Study|Noncompliant|0|||
155679655|NCT00853242|561916499|FG000|Overall Study|Withdrawal by Subject|1|||
155679656|NCT00853242|561916500|FG001|Overall Study|Withdrawal by Subject|2|||
155679657|NCT00853242|561916501|FG002|Overall Study|Withdrawal by Subject|0|||
155679658|NCT00853242|561916502|FG003|Overall Study|Withdrawal by Subject|4|||
155679659|NCT00853242|561916503|FG004|Overall Study|Withdrawal by Subject|0|||
155679660|NCT00853242|561916504|FG005|Overall Study|Withdrawal by Subject|0|||
155679661|NCT00853242|561916505|FG006|Overall Study|Withdrawal by Subject|2|||
155679662|NCT00853242|561916499|FG000|Overall Study|Other|2|||
155679663|NCT00853242|561916500|FG001|Overall Study|Other|0|||
155679664|NCT00853242|561916501|FG002|Overall Study|Other|2|||
155679665|NCT00853242|561916502|FG003|Overall Study|Other|0|||
155679666|NCT00853242|561916503|FG004|Overall Study|Other|0|||
155679667|NCT00853242|561916504|FG005|Overall Study|Other|1|||
155679668|NCT00853242|561916505|FG006|Overall Study|Other|2|||
155679669|NCT03497975|561916506|FG000|Overall Study|Withdrew Consent|34|||
155679670|NCT03497975|561916507|FG001|Overall Study|Withdrew Consent|35|||
155679671|NCT03497975|561916506|FG000|Overall Study|Lost to Follow-up|7|||
155679672|NCT03497975|561916507|FG001|Overall Study|Lost to Follow-up|7|||
155679673|NCT03497975|561916506|FG000|Overall Study|Physician Decision|4|||
155679674|NCT03497975|561916507|FG001|Overall Study|Physician Decision|5|||
155679675|NCT03497975|561916506|FG000|Overall Study|Discontinued|42|||
155679676|NCT03497975|561916507|FG001|Overall Study|Discontinued|39|||
155679677|NCT03497975|561916506|FG000|Overall Study|Reason Not Specified|15|||
155679678|NCT03497975|561916507|FG001|Overall Study|Reason Not Specified|14|||
155679679|NCT02516098|561916508|FG000|Period 1|Protocol Violation|1|||
155679680|NCT02516098|561916509|FG001|Period 1|Protocol Violation|0|||
155679681|NCT02516098|561916508|FG000|Washout After Period 1|Adverse Event|0|||
155679682|NCT02516098|561916509|FG001|Washout After Period 1|Adverse Event|1|||
155679683|NCT02516098|561916508|FG000|Period 2|Withdrawal by Subject|0|||
155679684|NCT02516098|561916509|FG001|Period 2|Withdrawal by Subject|1|||
155679685|NCT01355679|561916511|FG000|Overall Study|benign tumor types found at biopsy|2|||
155679686|NCT02466425|561916515|FG000|Overall Study|Adverse Event|3|||
155679687|NCT02466425|561916516|FG001|Overall Study|Adverse Event|11|||
155679688|NCT02466425|561916515|FG000|Overall Study|Lack of Efficacy|4|||
155679689|NCT02466425|561916516|FG001|Overall Study|Lack of Efficacy|1|||
155679690|NCT02466425|561916515|FG000|Overall Study|Lost to Follow-up|3|||
155679691|NCT02466425|561916516|FG001|Overall Study|Lost to Follow-up|0|||
155679692|NCT02466425|561916515|FG000|Overall Study|Protocol Violation|1|||
155679693|NCT02466425|561916516|FG001|Overall Study|Protocol Violation|0|||
155679694|NCT02466425|561916515|FG000|Overall Study|Withdrawal by Subject|0|||
155679695|NCT02466425|561916516|FG001|Overall Study|Withdrawal by Subject|1|||
155679696|NCT02466425|561916515|FG000|Overall Study|Other|1|||
155679697|NCT02466425|561916516|FG001|Overall Study|Other|3|||
155679698|NCT02466425|561916515|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155679699|NCT02466425|561916516|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155679700|NCT00582712|561916517|FG000|Overall Study|Adverse Event|1|||
155679701|NCT00582712|561916517|FG000|Overall Study|Lack of Efficacy|1|||
155679702|NCT00582712|561916517|FG000|Overall Study|Withdrawal by Subject|1|||
155679703|NCT00582712|561916517|FG000|Overall Study|Complicating disease requiring treatment|1|||
155679704|NCT05141175|561916524|FG000|Overall Study|Withdrawal by Subject|1|||
155679705|NCT01813058|561916531|FG000|Overall Study|Withdrawal by Subject|5|||
155679706|NCT01813058|561916532|FG001|Overall Study|Withdrawal by Subject|4|||
155679707|NCT03585764|561916533|FG000|Overall Study|Death|3|||
155679708|NCT03585764|561916534|FG001|Overall Study|Death|2|||
155679709|NCT03585764|561916535|FG002|Overall Study|Death|3|||
155679710|NCT03585764|561916536|FG003|Overall Study|Death|0|||
155679711|NCT03585764|561916533|FG000|Overall Study|Lost to Follow-up|0|||
155679712|NCT03585764|561916534|FG001|Overall Study|Lost to Follow-up|1|||
155679713|NCT03585764|561916535|FG002|Overall Study|Lost to Follow-up|0|||
155679714|NCT03585764|561916536|FG003|Overall Study|Lost to Follow-up|0|||
155679715|NCT03585764|561916533|FG000|Overall Study|Physician Decision|0|||
155679716|NCT03585764|561916534|FG001|Overall Study|Physician Decision|0|||
155679717|NCT03585764|561916535|FG002|Overall Study|Physician Decision|2|||
155679718|NCT03585764|561916536|FG003|Overall Study|Physician Decision|0|||
155679719|NCT01581021|561916538|FG000|Overall Study|Lost to Follow-up|4|||
155679720|NCT01581021|561916539|FG001|Overall Study|Lost to Follow-up|6|||
155679721|NCT01581021|561916538|FG000|Overall Study|More than 2 hooks in thoracic|3|||
155679722|NCT01581021|561916539|FG001|Overall Study|More than 2 hooks in thoracic|0|||
155679723|NCT01581021|561916538|FG000|Overall Study|Neuromuscular|2|||
155679724|NCT01581021|561916539|FG001|Overall Study|Neuromuscular|1|||
155679725|NCT01581021|561916538|FG000|Overall Study|Not Randomized|1|||
155679726|NCT01581021|561916539|FG001|Overall Study|Not Randomized|2|||
155679727|NCT01581021|561916538|FG000|Overall Study|Lenke 6 Classification|0|||
155679728|NCT01581021|561916539|FG001|Overall Study|Lenke 6 Classification|1|||
155679729|NCT01581021|561916538|FG000|Overall Study|Lack of Efficacy|0|||
155679730|NCT01581021|561916539|FG001|Overall Study|Lack of Efficacy|1|||
155679731|NCT03604172|561916540|FG000|Overall Study|Lost to Follow-up|1|||
155679732|NCT03604172|561916541|FG001|Overall Study|Lost to Follow-up|2|||
155679733|NCT02676895|561916542|FG000|Overall Study|Administrative reason|1|||
155679734|NCT02676895|561916543|FG001|Overall Study|Administrative reason|0|||
155679735|NCT02676895|561916544|FG002|Overall Study|Administrative reason|0|||
155679736|NCT02676895|561916542|FG000|Overall Study|Protocol Violation|1|||
155679737|NCT02676895|561916543|FG001|Overall Study|Protocol Violation|0|||
155679738|NCT02676895|561916544|FG002|Overall Study|Protocol Violation|0|||
155679739|NCT02676895|561916542|FG000|Overall Study|Adverse Event|0|||
155679740|NCT02676895|561916543|FG001|Overall Study|Adverse Event|3|||
155679741|NCT02676895|561916544|FG002|Overall Study|Adverse Event|1|||
155679742|NCT02676895|561916542|FG000|Overall Study|Lost to Follow-up|0|||
155679743|NCT02676895|561916543|FG001|Overall Study|Lost to Follow-up|0|||
155679744|NCT02676895|561916544|FG002|Overall Study|Lost to Follow-up|1|||
155679745|NCT02676895|561916542|FG000|Overall Study|Withdrawal by Subject|0|||
155679746|NCT02676895|561916543|FG001|Overall Study|Withdrawal by Subject|0|||
155679747|NCT02676895|561916544|FG002|Overall Study|Withdrawal by Subject|1|||
155679748|NCT00054327|561916545|FG000|Overall Study|Engraftment failure|1|||
155679749|NCT00054327|561916546|FG001|Overall Study|Engraftment failure|0|||
155679750|NCT00054327|561916547|FG002|Overall Study|Engraftment failure|0|||
155679751|NCT00054327|561916548|FG003|Overall Study|Engraftment failure|0|||
155679752|NCT00054327|561916549|FG004|Overall Study|Engraftment failure|0|||
155679753|NCT00054327|561916550|FG005|Overall Study|Engraftment failure|0|||
155679754|NCT03028129|561916556|FG000|Overall Study|Adverse Event|13|||
155679755|NCT03028129|561916557|FG001|Overall Study|Adverse Event|2|||
155679756|NCT03028129|561916556|FG000|Overall Study|Lost to Follow-up|50|||
155679757|NCT03028129|561916557|FG001|Overall Study|Lost to Follow-up|38|||
155679758|NCT03028129|561916556|FG000|Overall Study|Physician Decision|0|||
155679759|NCT03028129|561916557|FG001|Overall Study|Physician Decision|1|||
155679760|NCT03028129|561916556|FG000|Overall Study|Protocol Violation|1|||
155679761|NCT03028129|561916557|FG001|Overall Study|Protocol Violation|1|||
155679762|NCT03028129|561916556|FG000|Overall Study|Withdrawal by Subject|62|||
155679763|NCT03028129|561916557|FG001|Overall Study|Withdrawal by Subject|45|||
155679764|NCT00923351|561916558|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
155679765|NCT00923351|561916559|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
155679766|NCT00923351|561916560|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
155679767|NCT00182078|561916561|FG000|Overall Study|Withdrawal by Subject|1|||
155679768|NCT00182078|561916562|FG001|Overall Study|Withdrawal by Subject|0|||
155679769|NCT01076205|561916563|FG000|Overall Study|Adverse Drug Reaction|299|||
155679770|NCT01076205|561916563|FG000|Overall Study|Lack of Effectiveness|1423|||
155679771|NCT01076205|561916563|FG000|Overall Study|Other Reason|1075|||
155679772|NCT01076205|561916563|FG000|Overall Study|Unknown Reason|71|||
155679773|NCT01076205|561916563|FG000|Overall Study|Lost to Follow-up|3151|||
155679774|NCT00361231|561916564|FG000|Overall Study|Physician Decision|3|||
155679775|NCT00361231|561916564|FG000|Overall Study|Symptomatic deterioration|5|||
155679776|NCT00361231|561916564|FG000|Overall Study|Radiographic disease progression|16|||
155679777|NCT00361231|561916564|FG000|Overall Study|Withdrawal by Subject|4|||
155679778|NCT00361231|561916564|FG000|Overall Study|Adverse Event|6|||
155679779|NCT01732510|561916565|FG000|Overall Study|Adverse Event|0|||
155679780|NCT01732510|561916566|FG001|Overall Study|Adverse Event|1|||
155679781|NCT01732510|561916567|FG002|Overall Study|Adverse Event|1|||
155679782|NCT01732510|561916568|FG003|Overall Study|Adverse Event|0|||
155679783|NCT01732510|561916569|FG004|Overall Study|Adverse Event|0|||
155679784|NCT01732510|561916570|FG005|Overall Study|Adverse Event|0|||
155679785|NCT01732510|561916571|FG006|Overall Study|Adverse Event|1|||
155679786|NCT01732510|561916565|FG000|Overall Study|Protocol Violation|0|||
155679787|NCT01732510|561916566|FG001|Overall Study|Protocol Violation|0|||
155679788|NCT01732510|561916567|FG002|Overall Study|Protocol Violation|0|||
155679789|NCT01732510|561916568|FG003|Overall Study|Protocol Violation|1|||
155679790|NCT01732510|561916569|FG004|Overall Study|Protocol Violation|0|||
155679791|NCT01732510|561916570|FG005|Overall Study|Protocol Violation|0|||
155679792|NCT01732510|561916571|FG006|Overall Study|Protocol Violation|0|||
155679793|NCT01732510|561916565|FG000|Overall Study|Withdrawal by Subject|1|||
155679794|NCT01732510|561916566|FG001|Overall Study|Withdrawal by Subject|3|||
155679795|NCT01732510|561916567|FG002|Overall Study|Withdrawal by Subject|2|||
155679796|NCT01732510|561916568|FG003|Overall Study|Withdrawal by Subject|1|||
155679797|NCT01732510|561916569|FG004|Overall Study|Withdrawal by Subject|5|||
155679798|NCT01732510|561916570|FG005|Overall Study|Withdrawal by Subject|0|||
155679799|NCT01732510|561916571|FG006|Overall Study|Withdrawal by Subject|1|||
155679800|NCT01732510|561916565|FG000|Overall Study|Lost to Follow-up|0|||
155679801|NCT01732510|561916566|FG001|Overall Study|Lost to Follow-up|0|||
155679802|NCT01732510|561916567|FG002|Overall Study|Lost to Follow-up|1|||
155679803|NCT01732510|561916568|FG003|Overall Study|Lost to Follow-up|1|||
155679804|NCT01732510|561916569|FG004|Overall Study|Lost to Follow-up|0|||
155679805|NCT01732510|561916570|FG005|Overall Study|Lost to Follow-up|1|||
155679806|NCT01732510|561916571|FG006|Overall Study|Lost to Follow-up|0|||
155679807|NCT01732510|561916565|FG000|Overall Study|Physician Decision|0|||
155679808|NCT01732510|561916566|FG001|Overall Study|Physician Decision|1|||
155679809|NCT01732510|561916567|FG002|Overall Study|Physician Decision|0|||
155679810|NCT01732510|561916568|FG003|Overall Study|Physician Decision|0|||
155679811|NCT01732510|561916569|FG004|Overall Study|Physician Decision|0|||
155679812|NCT01732510|561916570|FG005|Overall Study|Physician Decision|0|||
155679813|NCT01732510|561916571|FG006|Overall Study|Physician Decision|0|||
155679814|NCT01732510|561916565|FG000|Overall Study|Pregnancy|0|||
155679815|NCT01732510|561916566|FG001|Overall Study|Pregnancy|0|||
155679816|NCT01732510|561916567|FG002|Overall Study|Pregnancy|0|||
155679817|NCT01732510|561916568|FG003|Overall Study|Pregnancy|1|||
155679818|NCT01732510|561916569|FG004|Overall Study|Pregnancy|0|||
155679819|NCT01732510|561916570|FG005|Overall Study|Pregnancy|0|||
155679820|NCT01732510|561916571|FG006|Overall Study|Pregnancy|0|||
155679821|NCT01732510|561916565|FG000|Overall Study|Study Terminated By Sponsor|0|||
155679822|NCT01732510|561916566|FG001|Overall Study|Study Terminated By Sponsor|0|||
155679823|NCT01732510|561916567|FG002|Overall Study|Study Terminated By Sponsor|0|||
155679824|NCT01732510|561916568|FG003|Overall Study|Study Terminated By Sponsor|1|||
155679825|NCT01732510|561916569|FG004|Overall Study|Study Terminated By Sponsor|0|||
155679826|NCT01732510|561916570|FG005|Overall Study|Study Terminated By Sponsor|12|||
155679827|NCT01732510|561916571|FG006|Overall Study|Study Terminated By Sponsor|6|||
155679828|NCT01262560|561916573|FG000|Overall Study|Protocol Violation|0|||
155679829|NCT01262560|561916574|FG001|Overall Study|Protocol Violation|1|||
155679830|NCT01262560|561916575|FG002|Overall Study|Protocol Violation|2|||
155679831|NCT01932372|561916580|FG000|Overall Study|Not meeting eligibility criteria|33|||
155679832|NCT01932372|561916581|FG001|Overall Study|Not meeting eligibility criteria|179|||
155679833|NCT03594747|561916582|FG000|Overall Study|Death|78|||
155679834|NCT03594747|561916583|FG001|Overall Study|Death|86|||
155679835|NCT03594747|561916584|FG002|Overall Study|Death|87|||
155679836|NCT03594747|561916582|FG000|Overall Study|Withdrawal by Subject|5|||
155679837|NCT03594747|561916583|FG001|Overall Study|Withdrawal by Subject|2|||
155679838|NCT03594747|561916584|FG002|Overall Study|Withdrawal by Subject|11|||
155679839|NCT03594747|561916582|FG000|Overall Study|Lost to Follow-up|4|||
155679840|NCT03594747|561916583|FG001|Overall Study|Lost to Follow-up|1|||
155679841|NCT03594747|561916584|FG002|Overall Study|Lost to Follow-up|1|||
155679842|NCT03594747|561916582|FG000|Overall Study|Physician Decision|0|||
155679843|NCT03594747|561916583|FG001|Overall Study|Physician Decision|1|||
155679844|NCT03594747|561916584|FG002|Overall Study|Physician Decision|0|||
155679845|NCT03594747|561916582|FG000|Overall Study|Sponsor decision|23|||
155679846|NCT03594747|561916583|FG001|Overall Study|Sponsor decision|17|||
155679847|NCT03594747|561916584|FG002|Overall Study|Sponsor decision|16|||
155679848|NCT03594747|561916582|FG000|Overall Study|Did not meet inclusion criteria|0|||
155679849|NCT03594747|561916583|FG001|Overall Study|Did not meet inclusion criteria|0|||
155679850|NCT03594747|561916584|FG002|Overall Study|Did not meet inclusion criteria|1|||
155679851|NCT03594747|561916582|FG000|Overall Study|Transfer to long term extension study|10|||
155679852|NCT03594747|561916583|FG001|Overall Study|Transfer to long term extension study|12|||
155679853|NCT03594747|561916584|FG002|Overall Study|Transfer to long term extension study|5|||
155679854|NCT00349349|561916585|FG000|Overall Study|Adverse Event|5|||
155679855|NCT00349349|561916586|FG001|Overall Study|Adverse Event|6|||
155679856|NCT00349349|561916587|FG002|Overall Study|Adverse Event|2|||
155679857|NCT00349349|561916585|FG000|Overall Study|Withdrawal by Subject|5|||
155679858|NCT00349349|561916586|FG001|Overall Study|Withdrawal by Subject|2|||
155679859|NCT00349349|561916587|FG002|Overall Study|Withdrawal by Subject|1|||
155679860|NCT00349349|561916585|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
155679861|NCT00349349|561916586|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
155679862|NCT00349349|561916587|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
155679863|NCT00349349|561916585|FG000|Overall Study|Death|13|||
155679864|NCT00349349|561916586|FG001|Overall Study|Death|10|||
155679865|NCT00349349|561916587|FG002|Overall Study|Death|1|||
155679866|NCT00349349|561916585|FG000|Overall Study|Other Treatment Selected|2|||
155679867|NCT00349349|561916586|FG001|Overall Study|Other Treatment Selected|0|||
155679868|NCT00349349|561916587|FG002|Overall Study|Other Treatment Selected|0|||
155679869|NCT00349349|561916585|FG000|Overall Study|Participant Reduced General Condition|0|||
155679870|NCT00349349|561916586|FG001|Overall Study|Participant Reduced General Condition|1|||
155679871|NCT00349349|561916587|FG002|Overall Study|Participant Reduced General Condition|0|||
155679872|NCT00349349|561916585|FG000|Overall Study|Physician Decision|1|||
155679873|NCT00349349|561916586|FG001|Overall Study|Physician Decision|2|||
155679874|NCT00349349|561916587|FG002|Overall Study|Physician Decision|1|||
155679875|NCT00349349|561916585|FG000|Overall Study|No Response|0|||
155679876|NCT00349349|561916586|FG001|Overall Study|No Response|3|||
155679877|NCT00349349|561916587|FG002|Overall Study|No Response|0|||
155679878|NCT00349349|561916585|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
155679879|NCT00349349|561916586|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
155679880|NCT00349349|561916587|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
155679881|NCT02242435|561918830|FG000|Overall Study|Lost to Follow-up|3|||
155679882|NCT02242435|561918831|FG001|Overall Study|Lost to Follow-up|4|||
155679883|NCT02242435|561918830|FG000|Overall Study|Adverse Event|3|||
155679884|NCT02242435|561918831|FG001|Overall Study|Adverse Event|2|||
155679885|NCT02242435|561918830|FG000|Overall Study|Withdrawal by Subject|13|||
155679886|NCT02242435|561918831|FG001|Overall Study|Withdrawal by Subject|8|||
155679887|NCT02242435|561918830|FG000|Overall Study|Death|0|||
155679888|NCT02242435|561918831|FG001|Overall Study|Death|1|||
155679889|NCT02242435|561918830|FG000|Overall Study|Protocol Violation|1|||
155679890|NCT02242435|561918831|FG001|Overall Study|Protocol Violation|0|||
155679891|NCT02242435|561918830|FG000|Overall Study|Physician Decision|0|||
155679892|NCT02242435|561918831|FG001|Overall Study|Physician Decision|1|||
155679893|NCT01667224|561918834|FG000|Overall Study|Withdrawal by Subject|3|||
155679894|NCT01667224|561918835|FG001|Overall Study|Withdrawal by Subject|1|||
155679895|NCT01667224|561918834|FG000|Overall Study|Protocol Violation|1|||
155679896|NCT01667224|561918835|FG001|Overall Study|Protocol Violation|1|||
155679897|NCT02752633|561918836|FG000|Overall Study|Withdrawal by Subject|1|||
155679898|NCT01843673|561918837|FG000|Overall Study|Lack of Efficacy|2|||
155679899|NCT01843673|561918837|FG000|Overall Study|Withdrawal by Subject|4|||
155679900|NCT03275246|561918838|FG000|Overall Study|Protocol Violation|5|||
155679901|NCT03275246|561918838|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
155679902|NCT00433966|561918841|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
155679903|NCT00433966|561918842|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
155679904|NCT00433966|561918843|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
155679905|NCT00433966|561918844|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
155679906|NCT00433966|561918841|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
155679907|NCT00433966|561918842|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
155679908|NCT00433966|561918843|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
155679909|NCT00433966|561918844|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
155679910|NCT00433966|561918841|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
155679911|NCT00433966|561918842|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
155679912|NCT00433966|561918843|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
155679913|NCT00433966|561918844|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
155679914|NCT00433966|561918841|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
155679915|NCT00433966|561918842|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
155679916|NCT00433966|561918843|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
155679917|NCT00433966|561918844|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
155679918|NCT00433966|561918841|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
155679919|NCT00433966|561918842|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
155679920|NCT00433966|561918843|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
155679921|NCT00433966|561918844|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
155679922|NCT05059301|561918845|FG000|Overall Study|Adverse Event|0|||
155679923|NCT05059301|561918846|FG001|Overall Study|Adverse Event|2|||
155679924|NCT05059301|561918847|FG002|Overall Study|Adverse Event|2|||
155679925|NCT05059301|561918845|FG000|Overall Study|Lost to Follow-up|2|||
155679926|NCT05059301|561918846|FG001|Overall Study|Lost to Follow-up|3|||
155679927|NCT05059301|561918847|FG002|Overall Study|Lost to Follow-up|3|||
155679928|NCT04952597|561918849|FG000|Overall Study|Death|12|||
155679929|NCT04952597|561918850|FG001|Overall Study|Death|13|||
155679930|NCT04952597|561918851|FG002|Overall Study|Death|14|||
155679931|NCT04952597|561918849|FG000|Overall Study|Withdrawal by Subject|1|||
155679932|NCT04952597|561918850|FG001|Overall Study|Withdrawal by Subject|0|||
155679933|NCT04952597|561918851|FG002|Overall Study|Withdrawal by Subject|3|||
155679934|NCT04952597|561918849|FG000|Overall Study|Lost to Follow-up|0|||
155679935|NCT04952597|561918850|FG001|Overall Study|Lost to Follow-up|1|||
155679936|NCT04952597|561918851|FG002|Overall Study|Lost to Follow-up|1|||
155679937|NCT01296711|561918852|FG000|Overall Study|Adverse Event|3|||
155679938|NCT01296711|561918853|FG001|Overall Study|Adverse Event|1|||
155679939|NCT01296711|561918854|FG002|Overall Study|Adverse Event|4|||
155679940|NCT01296711|561918855|FG003|Overall Study|Adverse Event|3|||
155679941|NCT01296711|561918856|FG004|Overall Study|Adverse Event|1|||
155679942|NCT01296711|561918857|FG005|Overall Study|Adverse Event|6|||
155679943|NCT01296711|561918858|FG006|Overall Study|Adverse Event|11|||
155679944|NCT01296711|561918859|FG007|Overall Study|Adverse Event|3|||
155679945|NCT01296711|561918852|FG000|Overall Study|Lack of Efficacy|1|||
155679946|NCT01296711|561918853|FG001|Overall Study|Lack of Efficacy|4|||
155679947|NCT01296711|561918854|FG002|Overall Study|Lack of Efficacy|1|||
155679948|NCT01296711|561918855|FG003|Overall Study|Lack of Efficacy|1|||
155679949|NCT01296711|561918856|FG004|Overall Study|Lack of Efficacy|1|||
155679950|NCT01296711|561918857|FG005|Overall Study|Lack of Efficacy|0|||
155679951|NCT01296711|561918858|FG006|Overall Study|Lack of Efficacy|2|||
155679952|NCT01296711|561918859|FG007|Overall Study|Lack of Efficacy|3|||
155679953|NCT01296711|561918852|FG000|Overall Study|Lost to Follow-up|0|||
155679954|NCT01296711|561918853|FG001|Overall Study|Lost to Follow-up|0|||
155679955|NCT01296711|561918854|FG002|Overall Study|Lost to Follow-up|1|||
155679956|NCT01296711|561918855|FG003|Overall Study|Lost to Follow-up|1|||
155679957|NCT01296711|561918856|FG004|Overall Study|Lost to Follow-up|2|||
155679958|NCT01296711|561918857|FG005|Overall Study|Lost to Follow-up|0|||
155679959|NCT01296711|561918858|FG006|Overall Study|Lost to Follow-up|4|||
155679960|NCT01296711|561918859|FG007|Overall Study|Lost to Follow-up|2|||
155679961|NCT01296711|561918852|FG000|Overall Study|Protocol Violation|0|||
155679962|NCT01296711|561918853|FG001|Overall Study|Protocol Violation|0|||
155679963|NCT01296711|561918854|FG002|Overall Study|Protocol Violation|0|||
155679964|NCT01296711|561918855|FG003|Overall Study|Protocol Violation|1|||
155679965|NCT01296711|561918856|FG004|Overall Study|Protocol Violation|1|||
155679966|NCT01296711|561918857|FG005|Overall Study|Protocol Violation|0|||
155679967|NCT01296711|561918858|FG006|Overall Study|Protocol Violation|0|||
155679968|NCT01296711|561918859|FG007|Overall Study|Protocol Violation|0|||
155679969|NCT01296711|561918852|FG000|Overall Study|Withdrawal by Subject|4|||
155679970|NCT01296711|561918853|FG001|Overall Study|Withdrawal by Subject|2|||
155679971|NCT01296711|561918854|FG002|Overall Study|Withdrawal by Subject|2|||
155679972|NCT01296711|561918855|FG003|Overall Study|Withdrawal by Subject|1|||
155679973|NCT01296711|561918856|FG004|Overall Study|Withdrawal by Subject|1|||
155679974|NCT01296711|561918857|FG005|Overall Study|Withdrawal by Subject|1|||
155679975|NCT01296711|561918858|FG006|Overall Study|Withdrawal by Subject|2|||
155679976|NCT01296711|561918859|FG007|Overall Study|Withdrawal by Subject|1|||
155679977|NCT01296711|561918852|FG000|Overall Study|Study termination|8|||
155679978|NCT01296711|561918853|FG001|Overall Study|Study termination|1|||
155679979|NCT01296711|561918854|FG002|Overall Study|Study termination|5|||
155679980|NCT01296711|561918855|FG003|Overall Study|Study termination|4|||
155679981|NCT01296711|561918856|FG004|Overall Study|Study termination|4|||
155679982|NCT01296711|561918857|FG005|Overall Study|Study termination|4|||
155679983|NCT01296711|561918858|FG006|Overall Study|Study termination|8|||
155679984|NCT01296711|561918859|FG007|Overall Study|Study termination|10|||
155679985|NCT01296711|561918852|FG000|Overall Study|Continued elevated liver enzymes|0|||
155679986|NCT01296711|561918853|FG001|Overall Study|Continued elevated liver enzymes|0|||
155679987|NCT01296711|561918854|FG002|Overall Study|Continued elevated liver enzymes|0|||
155679988|NCT01296711|561918855|FG003|Overall Study|Continued elevated liver enzymes|1|||
155679989|NCT01296711|561918856|FG004|Overall Study|Continued elevated liver enzymes|0|||
155679990|NCT01296711|561918857|FG005|Overall Study|Continued elevated liver enzymes|0|||
155679991|NCT01296711|561918858|FG006|Overall Study|Continued elevated liver enzymes|0|||
155679992|NCT01296711|561918859|FG007|Overall Study|Continued elevated liver enzymes|0|||
155679993|NCT01296711|561918852|FG000|Overall Study|Methotrexate discontinued|0|||
155603014|NCT00558896|561635397|FG001|Overall Study|Continues on treatment|1|||
155603015|NCT00558896|561635398|FG002|Overall Study|Continues on treatment|0|||
155603016|NCT00558896|561635399|FG003|Overall Study|Continues on treatment|1|||
155603017|NCT00558896|561635400|FG004|Overall Study|Continues on treatment|9|||
155603018|NCT00558896|561635401|FG005|Overall Study|Continues on treatment|25|||
155603019|NCT00558896|561635402|FG006|Overall Study|Continues on treatment|6|||
155603020|NCT00250458|561635406|FG000|Overall Study|Lost to Follow-up|4|||
155603021|NCT00250458|561635407|FG001|Overall Study|Lost to Follow-up|2|||
155603022|NCT00250458|561635406|FG000|Overall Study|Protocol Violation|0|||
155603023|NCT00250458|561635407|FG001|Overall Study|Protocol Violation|1|||
155603024|NCT00250458|561635406|FG000|Overall Study|Withdrawal by Subject|4|||
155603025|NCT00250458|561635407|FG001|Overall Study|Withdrawal by Subject|2|||
155603026|NCT00250458|561635406|FG000|Overall Study|Lack of Migraine Attack|20|||
155603027|NCT00250458|561635407|FG001|Overall Study|Lack of Migraine Attack|9|||
155603028|NCT00250458|561635406|FG000|Overall Study|Qualifying migraine but did not treat|3|||
155603029|NCT00250458|561635407|FG001|Overall Study|Qualifying migraine but did not treat|3|||
155603030|NCT00250458|561635406|FG000|Overall Study|Other|1|||
155603031|NCT00250458|561635407|FG001|Overall Study|Other|0|||
155603032|NCT00723190|561635410|FG000|Overall Study|Withdrawal by Subject|45|||
155603033|NCT00723190|561635410|FG000|Overall Study|Lost to Follow-up|37|||
155603034|NCT00723190|561635410|FG000|Overall Study|Adverse Event|18|||
155603035|NCT00723190|561635410|FG000|Overall Study|Lack of Efficacy|16|||
155603036|NCT00723190|561635410|FG000|Overall Study|Protocol Violation|15|||
155603037|NCT00723190|561635410|FG000|Overall Study|Other-Premature Discontinuation|9|||
155603038|NCT00723190|561635410|FG000|Overall Study|Other-Not included in safety population|2|||
155603039|NCT00480493|561635417|FG000|Overall Study|moved|2|||
155603040|NCT00480493|561635418|FG001|Overall Study|moved|7|||
155603041|NCT03747302|561635419|FG000|Overall Study|Withdrawal by Subject|1|||
155603042|NCT03747302|561635420|FG001|Overall Study|Withdrawal by Subject|2|||
155603043|NCT03769675|561635421|FG000|Overall Study|Lost to Follow-up|1|||
155603044|NCT02844907|561635424|FG000|With Dexamethasone|No IV access|1|||
155603045|NCT02772276|561635425|FG000|Overall Study|Lost to Follow-up|0|||
155603046|NCT02772276|561635426|FG001|Overall Study|Lost to Follow-up|0|||
155603047|NCT02772276|561635427|FG002|Overall Study|Lost to Follow-up|0|||
155603048|NCT02772276|561635428|FG003|Overall Study|Lost to Follow-up|0|||
155603049|NCT02772276|561635429|FG004|Overall Study|Lost to Follow-up|0|||
155603050|NCT02772276|561635430|FG005|Overall Study|Lost to Follow-up|0|||
155603051|NCT02772276|561635431|FG006|Overall Study|Lost to Follow-up|1|||
155603052|NCT02772276|561635432|FG007|Overall Study|Lost to Follow-up|0|||
155603053|NCT02772276|561635433|FG008|Overall Study|Lost to Follow-up|0|||
155603054|NCT02772276|561635434|FG009|Overall Study|Lost to Follow-up|0|||
155603055|NCT02772276|561635435|FG010|Overall Study|Lost to Follow-up|0|||
155603056|NCT02772276|561635436|FG011|Overall Study|Lost to Follow-up|0|||
155603057|NCT02772276|561635437|FG012|Overall Study|Lost to Follow-up|0|||
155603058|NCT02772276|561635425|FG000|Overall Study|Withdrew consent|0|||
155603059|NCT02772276|561635426|FG001|Overall Study|Withdrew consent|0|||
155603060|NCT02772276|561635427|FG002|Overall Study|Withdrew consent|0|||
155603061|NCT02772276|561635428|FG003|Overall Study|Withdrew consent|0|||
155603062|NCT02772276|561635429|FG004|Overall Study|Withdrew consent|0|||
155603063|NCT02772276|561635430|FG005|Overall Study|Withdrew consent|0|||
155603064|NCT02772276|561635431|FG006|Overall Study|Withdrew consent|0|||
155603065|NCT02772276|561635432|FG007|Overall Study|Withdrew consent|1|||
155603066|NCT02772276|561635433|FG008|Overall Study|Withdrew consent|0|||
155603067|NCT02772276|561635434|FG009|Overall Study|Withdrew consent|0|||
155603068|NCT02772276|561635435|FG010|Overall Study|Withdrew consent|0|||
155603069|NCT02772276|561635436|FG011|Overall Study|Withdrew consent|0|||
155603070|NCT02772276|561635437|FG012|Overall Study|Withdrew consent|0|||
155603071|NCT00738062|561635438|FG000|Open Label Treatment|Lack of Efficacy|5|||
155603072|NCT00738062|561635439|FG001|Open Label Treatment|Lack of Efficacy|0|||
155603073|NCT00738062|561635440|FG002|Open Label Treatment|Lack of Efficacy|0|||
155679994|NCT01296711|561918853|FG001|Overall Study|Methotrexate discontinued|0|||
155679995|NCT01296711|561918854|FG002|Overall Study|Methotrexate discontinued|0|||
155679996|NCT01296711|561918855|FG003|Overall Study|Methotrexate discontinued|1|||
155679997|NCT01296711|561918856|FG004|Overall Study|Methotrexate discontinued|0|||
155679998|NCT01296711|561918857|FG005|Overall Study|Methotrexate discontinued|0|||
155679999|NCT01296711|561918858|FG006|Overall Study|Methotrexate discontinued|0|||
155680000|NCT01296711|561918859|FG007|Overall Study|Methotrexate discontinued|0|||
155680001|NCT01296711|561918852|FG000|Overall Study|Investigator discretion|0|||
155680002|NCT01296711|561918853|FG001|Overall Study|Investigator discretion|0|||
155680003|NCT01296711|561918854|FG002|Overall Study|Investigator discretion|0|||
155680004|NCT01296711|561918855|FG003|Overall Study|Investigator discretion|0|||
155680005|NCT01296711|561918856|FG004|Overall Study|Investigator discretion|0|||
155680006|NCT01296711|561918857|FG005|Overall Study|Investigator discretion|0|||
155680007|NCT01296711|561918858|FG006|Overall Study|Investigator discretion|1|||
155680008|NCT01296711|561918859|FG007|Overall Study|Investigator discretion|0|||
155680009|NCT01296711|561918852|FG000|Overall Study|Other|0|||
155680010|NCT01296711|561918853|FG001|Overall Study|Other|0|||
155680011|NCT01296711|561918854|FG002|Overall Study|Other|0|||
155680012|NCT01296711|561918855|FG003|Overall Study|Other|0|||
155680013|NCT01296711|561918856|FG004|Overall Study|Other|0|||
155680014|NCT01296711|561918857|FG005|Overall Study|Other|0|||
155680015|NCT01296711|561918858|FG006|Overall Study|Other|1|||
155680016|NCT01296711|561918859|FG007|Overall Study|Other|0|||
155680017|NCT01296711|561918852|FG000|Overall Study|Required restricted steroid injections|0|||
155680018|NCT01296711|561918853|FG001|Overall Study|Required restricted steroid injections|0|||
155680019|NCT01296711|561918854|FG002|Overall Study|Required restricted steroid injections|0|||
155680020|NCT01296711|561918855|FG003|Overall Study|Required restricted steroid injections|0|||
155680021|NCT01296711|561918856|FG004|Overall Study|Required restricted steroid injections|0|||
155680022|NCT01296711|561918857|FG005|Overall Study|Required restricted steroid injections|0|||
155680023|NCT01296711|561918858|FG006|Overall Study|Required restricted steroid injections|1|||
155680024|NCT01296711|561918859|FG007|Overall Study|Required restricted steroid injections|0|||
155680025|NCT01296711|561918852|FG000|Overall Study|Ongoing missed appointments|0|||
155680026|NCT01296711|561918853|FG001|Overall Study|Ongoing missed appointments|0|||
155680027|NCT01296711|561918854|FG002|Overall Study|Ongoing missed appointments|0|||
155680028|NCT01296711|561918855|FG003|Overall Study|Ongoing missed appointments|0|||
155680029|NCT01296711|561918856|FG004|Overall Study|Ongoing missed appointments|0|||
155680030|NCT01296711|561918857|FG005|Overall Study|Ongoing missed appointments|0|||
155680031|NCT01296711|561918858|FG006|Overall Study|Ongoing missed appointments|1|||
155680032|NCT01296711|561918859|FG007|Overall Study|Ongoing missed appointments|0|||
155680033|NCT01296711|561918852|FG000|Overall Study|Failure to comply with visits|0|||
155680034|NCT01296711|561918853|FG001|Overall Study|Failure to comply with visits|0|||
155680035|NCT01296711|561918854|FG002|Overall Study|Failure to comply with visits|0|||
155680036|NCT01296711|561918855|FG003|Overall Study|Failure to comply with visits|0|||
155680037|NCT01296711|561918856|FG004|Overall Study|Failure to comply with visits|0|||
155680038|NCT01296711|561918857|FG005|Overall Study|Failure to comply with visits|0|||
155680039|NCT01296711|561918858|FG006|Overall Study|Failure to comply with visits|0|||
155680040|NCT01296711|561918859|FG007|Overall Study|Failure to comply with visits|1|||
155680041|NCT01296711|561918852|FG000|Overall Study|Patient decision due to transport|0|||
155680042|NCT01296711|561918853|FG001|Overall Study|Patient decision due to transport|0|||
155680043|NCT01296711|561918854|FG002|Overall Study|Patient decision due to transport|0|||
155680044|NCT01296711|561918855|FG003|Overall Study|Patient decision due to transport|0|||
155680045|NCT01296711|561918856|FG004|Overall Study|Patient decision due to transport|0|||
155680046|NCT01296711|561918857|FG005|Overall Study|Patient decision due to transport|0|||
155680047|NCT01296711|561918858|FG006|Overall Study|Patient decision due to transport|0|||
155680048|NCT01296711|561918859|FG007|Overall Study|Patient decision due to transport|1|||
155680049|NCT00923975|561918867|FG000|Overall Study|Did not meet inclusion criteria|1|||
155680050|NCT01005316|561918870|FG000|Overall Study|Adverse Event|0|||
155680051|NCT01005316|561918871|FG001|Overall Study|Adverse Event|0|||
155680052|NCT01005316|561918872|FG002|Overall Study|Adverse Event|0|||
155680053|NCT01005316|561918873|FG003|Overall Study|Adverse Event|1|||
155680054|NCT01005316|561918870|FG000|Overall Study|Death|20|||
155680055|NCT01005316|561918871|FG001|Overall Study|Death|5|||
155680056|NCT01005316|561918872|FG002|Overall Study|Death|1|||
155680057|NCT01005316|561918873|FG003|Overall Study|Death|15|||
155680058|NCT01005316|561918870|FG000|Overall Study|Study Termination|5|||
155680059|NCT01005316|561918871|FG001|Overall Study|Study Termination|63|||
155680060|NCT01005316|561918872|FG002|Overall Study|Study Termination|9|||
155680061|NCT01005316|561918873|FG003|Overall Study|Study Termination|85|||
155680062|NCT01005316|561918870|FG000|Overall Study|Lost to Follow-up|1|||
155680063|NCT01005316|561918871|FG001|Overall Study|Lost to Follow-up|3|||
155680064|NCT01005316|561918872|FG002|Overall Study|Lost to Follow-up|0|||
155680065|NCT01005316|561918873|FG003|Overall Study|Lost to Follow-up|2|||
155680066|NCT01005316|561918870|FG000|Overall Study|Physician Decision|6|||
155680067|NCT01005316|561918871|FG001|Overall Study|Physician Decision|0|||
155680068|NCT01005316|561918872|FG002|Overall Study|Physician Decision|0|||
155680069|NCT01005316|561918873|FG003|Overall Study|Physician Decision|0|||
155603074|NCT00738062|561635438|FG000|Open Label Treatment|Adverse Event|11|||
155603075|NCT00738062|561635439|FG001|Open Label Treatment|Adverse Event|0|||
155603076|NCT00738062|561635440|FG002|Open Label Treatment|Adverse Event|0|||
155603077|NCT00738062|561635438|FG000|Open Label Treatment|Protocol Violation|2|||
155603078|NCT00738062|561635439|FG001|Open Label Treatment|Protocol Violation|0|||
155603079|NCT00738062|561635440|FG002|Open Label Treatment|Protocol Violation|0|||
155603080|NCT00738062|561635438|FG000|Open Label Treatment|Withdrawal by Subject|9|||
155603081|NCT00738062|561635439|FG001|Open Label Treatment|Withdrawal by Subject|0|||
155603082|NCT00738062|561635440|FG002|Open Label Treatment|Withdrawal by Subject|0|||
155603083|NCT00738062|561635438|FG000|Open Label Treatment|Investigator Decision|1|||
155603084|NCT00738062|561635439|FG001|Open Label Treatment|Investigator Decision|0|||
155603085|NCT00738062|561635440|FG002|Open Label Treatment|Investigator Decision|0|||
155603086|NCT00738062|561635438|FG000|Open-Label Extension|Adverse Event|5|||
155603087|NCT00738062|561635439|FG001|Open-Label Extension|Adverse Event|0|||
155603088|NCT00738062|561635440|FG002|Open-Label Extension|Adverse Event|0|||
155603089|NCT00738062|561635438|FG000|Open-Label Extension|Physician Decision|1|||
155603090|NCT00738062|561635439|FG001|Open-Label Extension|Physician Decision|0|||
155603091|NCT00738062|561635440|FG002|Open-Label Extension|Physician Decision|0|||
155603092|NCT00738062|561635438|FG000|Open-Label Extension|Lack of Efficacy|2|||
155603093|NCT00738062|561635439|FG001|Open-Label Extension|Lack of Efficacy|0|||
155603094|NCT00738062|561635440|FG002|Open-Label Extension|Lack of Efficacy|0|||
155603095|NCT00738062|561635438|FG000|Open-Label Extension|Withdrawal by Subject|6|||
155603096|NCT00738062|561635439|FG001|Open-Label Extension|Withdrawal by Subject|0|||
155603097|NCT00738062|561635440|FG002|Open-Label Extension|Withdrawal by Subject|0|||
155603098|NCT00738062|561635438|FG000|Open-Label Extension|Protocol Violation|1|||
155603099|NCT00738062|561635439|FG001|Open-Label Extension|Protocol Violation|0|||
155603100|NCT00738062|561635440|FG002|Open-Label Extension|Protocol Violation|0|||
155603101|NCT00738062|561635438|FG000|Open-Label Extension|Study Terminated|2|||
155603102|NCT00738062|561635439|FG001|Open-Label Extension|Study Terminated|0|||
155603103|NCT00738062|561635440|FG002|Open-Label Extension|Study Terminated|0|||
155603104|NCT00550862|561635441|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
155603105|NCT00550862|561635442|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
155603106|NCT00550862|561635443|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
155603107|NCT00550862|561635444|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
155603108|NCT00550862|561635445|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
155603109|NCT00550862|561635441|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
155603110|NCT00550862|561635442|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155603111|NCT00550862|561635443|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
155603112|NCT00550862|561635444|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155603113|NCT00550862|561635445|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155603114|NCT00550862|561635441|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155603115|NCT00550862|561635442|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155603116|NCT00550862|561635443|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
155603117|NCT00550862|561635444|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155603118|NCT00550862|561635445|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155603119|NCT00550862|561635441|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155603120|NCT00550862|561635442|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155603121|NCT00550862|561635443|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
155603122|NCT00550862|561635444|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155603123|NCT00550862|561635445|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155603124|NCT00550862|561635441|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155603125|NCT00550862|561635442|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
155603126|NCT00550862|561635443|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155603127|NCT00550862|561635444|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155680070|NCT01005316|561918870|FG000|Overall Study|Sponsor Decision|6|||
155680071|NCT01005316|561918871|FG001|Overall Study|Sponsor Decision|3|||
155680072|NCT01005316|561918872|FG002|Overall Study|Sponsor Decision|0|||
155680073|NCT01005316|561918873|FG003|Overall Study|Sponsor Decision|0|||
155680074|NCT01005316|561918870|FG000|Overall Study|Withdrawal by Subject|1|||
155680075|NCT01005316|561918871|FG001|Overall Study|Withdrawal by Subject|1|||
155680076|NCT01005316|561918872|FG002|Overall Study|Withdrawal by Subject|0|||
155680077|NCT01005316|561918873|FG003|Overall Study|Withdrawal by Subject|2|||
155680078|NCT01005316|561918870|FG000|Overall Study|Consented to Another Study|2|||
155680079|NCT01005316|561918871|FG001|Overall Study|Consented to Another Study|0|||
155680080|NCT01005316|561918872|FG002|Overall Study|Consented to Another Study|0|||
155680081|NCT01005316|561918873|FG003|Overall Study|Consented to Another Study|0|||
155680082|NCT01005316|561918870|FG000|Overall Study|Delisted|8|||
155680083|NCT01005316|561918871|FG001|Overall Study|Delisted|0|||
155680084|NCT01005316|561918872|FG002|Overall Study|Delisted|0|||
155680085|NCT01005316|561918873|FG003|Overall Study|Delisted|0|||
155680086|NCT01005316|561918870|FG000|Overall Study|Transferred Care|1|||
155680087|NCT01005316|561918871|FG001|Overall Study|Transferred Care|0|||
155680088|NCT01005316|561918872|FG002|Overall Study|Transferred Care|1|||
155680089|NCT01005316|561918873|FG003|Overall Study|Transferred Care|3|||
155680090|NCT01005316|561918870|FG000|Overall Study|Retransplanted|0|||
155680091|NCT01005316|561918871|FG001|Overall Study|Retransplanted|1|||
155680092|NCT01005316|561918872|FG002|Overall Study|Retransplanted|0|||
155680093|NCT01005316|561918873|FG003|Overall Study|Retransplanted|0|||
155680094|NCT00632827|561918876|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
155680095|NCT00632827|561918876|FG000|Overall Study|Death|2|||
155680096|NCT00632827|561918876|FG000|Overall Study|Adverse Event|5|||
155680097|NCT00632827|561918876|FG000|Overall Study|Lost to Follow-up|1|||
155680098|NCT01035463|561918877|FG000|Overall Study|Adverse Event|0|||
155680099|NCT01035463|561918878|FG001|Overall Study|Adverse Event|0|||
155680100|NCT01035463|561918879|FG002|Overall Study|Adverse Event|4|||
155680101|NCT01035463|561918880|FG003|Overall Study|Adverse Event|1|||
155680102|NCT01035463|561918881|FG004|Overall Study|Adverse Event|5|||
155680103|NCT01035463|561918882|FG005|Overall Study|Adverse Event|7|||
155680104|NCT01035463|561918877|FG000|Overall Study|Withdrawal by Subject|0|||
155603128|NCT00550862|561635445|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155603129|NCT00550862|561635441|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155603130|NCT00550862|561635442|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155603131|NCT00550862|561635443|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155603132|NCT00550862|561635444|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155603133|NCT00550862|561635445|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
155603134|NCT00550862|561635441|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155603135|NCT00550862|561635442|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155603136|NCT00550862|561635443|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155603137|NCT00550862|561635444|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155603138|NCT00550862|561635445|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
155603139|NCT00550862|561635441|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155603140|NCT00550862|561635442|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155603141|NCT00550862|561635443|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155603142|NCT00550862|561635444|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155603143|NCT00550862|561635445|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
155603144|NCT00550862|561635441|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
155603145|NCT00550862|561635442|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
155603146|NCT00550862|561635443|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
155603147|NCT00550862|561635444|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
155603148|NCT00550862|561635445|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
155603149|NCT00550862|561635441|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155603150|NCT00550862|561635442|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155603151|NCT00550862|561635443|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155603152|NCT00550862|561635444|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155603153|NCT00550862|561635445|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
155603154|NCT02248974|561635449|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
155603155|NCT02248974|561635450|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
155603156|NCT02248974|561635449|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
155603157|NCT02248974|561635450|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
155603158|NCT02248974|561635449|FG000|1-Day Follow-Up|Enrolled in another study|1|||
155603159|NCT02248974|561635450|FG001|1-Day Follow-Up|Enrolled in another study|0|||
155603160|NCT02248974|561635449|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
155603161|NCT02248974|561635450|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
155603162|NCT02248974|561635449|FG000|1-Week Follow-Up|Enrolled in another study|1|||
155603163|NCT02248974|561635450|FG001|1-Week Follow-Up|Enrolled in another study|1|||
155603164|NCT02248974|561635449|FG000|1-Week Follow-Up|Transferred to another facility|1|||
155603165|NCT02248974|561635450|FG001|1-Week Follow-Up|Transferred to another facility|0|||
155603166|NCT02248974|561635449|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
155603167|NCT02248974|561635450|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
155603168|NCT02248974|561635449|FG000|1-Week Follow-Up|Death|1|||
155603169|NCT02248974|561635450|FG001|1-Week Follow-Up|Death|1|||
155603170|NCT02248974|561635449|FG000|1-Week Follow-Up|Excluded because of age|0|||
155603171|NCT02248974|561635450|FG001|1-Week Follow-Up|Excluded because of age|1|||
155603172|NCT02248974|561635449|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
155603173|NCT02248974|561635450|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
155603174|NCT02248974|561635449|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
155603175|NCT02248974|561635450|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
155603176|NCT02248974|561635449|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
155603177|NCT02248974|561635450|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
155603178|NCT02248974|561635449|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
155603179|NCT02248974|561635450|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
155603180|NCT02248974|561635449|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
155603181|NCT02248974|561635450|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
155603182|NCT03488225|561635451|FG000|Overall Study|Off Protocol Therapy|2|||
155603183|NCT03488225|561635451|FG000|Overall Study|Stem Cell Transplant|2|||
155603184|NCT04093492|561635452|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
155603185|NCT04093492|561635453|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
155603186|NCT04093492|561635454|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
155603187|NCT04093492|561635455|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
155603188|NCT04093492|561635452|FG000|25 Weeks Gestational Age (GA)|No response|5|||
155603189|NCT04093492|561635453|FG001|25 Weeks Gestational Age (GA)|No response|5|||
155603190|NCT04093492|561635454|FG002|25 Weeks Gestational Age (GA)|No response|5|||
155603191|NCT04093492|561635455|FG003|25 Weeks Gestational Age (GA)|No response|2|||
155603192|NCT04093492|561635452|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155680105|NCT01035463|561918878|FG001|Overall Study|Withdrawal by Subject|2|||
155680106|NCT01035463|561918879|FG002|Overall Study|Withdrawal by Subject|1|||
155680107|NCT01035463|561918880|FG003|Overall Study|Withdrawal by Subject|0|||
155680108|NCT01035463|561918881|FG004|Overall Study|Withdrawal by Subject|1|||
155680109|NCT01035463|561918882|FG005|Overall Study|Withdrawal by Subject|4|||
155680110|NCT01035463|561918877|FG000|Overall Study|Disease progression|0|||
155680111|NCT01035463|561918878|FG001|Overall Study|Disease progression|0|||
155680112|NCT01035463|561918879|FG002|Overall Study|Disease progression|0|||
155680113|NCT01035463|561918880|FG003|Overall Study|Disease progression|0|||
155680114|NCT01035463|561918881|FG004|Overall Study|Disease progression|0|||
155680115|NCT01035463|561918882|FG005|Overall Study|Disease progression|3|||
155680116|NCT01035463|561918877|FG000|Overall Study|Other Malignancy|0|||
155680117|NCT01035463|561918878|FG001|Overall Study|Other Malignancy|0|||
155680118|NCT01035463|561918879|FG002|Overall Study|Other Malignancy|0|||
155680119|NCT01035463|561918880|FG003|Overall Study|Other Malignancy|0|||
155680120|NCT01035463|561918881|FG004|Overall Study|Other Malignancy|0|||
155680121|NCT01035463|561918882|FG005|Overall Study|Other Malignancy|2|||
155680122|NCT01035463|561918877|FG000|Overall Study|Other|0|||
155680123|NCT01035463|561918878|FG001|Overall Study|Other|0|||
155680124|NCT01035463|561918879|FG002|Overall Study|Other|0|||
155680125|NCT01035463|561918880|FG003|Overall Study|Other|1|||
155680126|NCT01035463|561918881|FG004|Overall Study|Other|0|||
155680127|NCT01035463|561918882|FG005|Overall Study|Other|2|||
155680128|NCT01734395|561918885|FG000|Overall Study|Other|65|||
155680129|NCT01734395|561918885|FG000|Overall Study|Lost to Follow-up|287|||
155680130|NCT01734395|561918885|FG000|Overall Study|Lack of Efficacy|5|||
155680131|NCT01734395|561918885|FG000|Overall Study|Adverse Event|40|||
155680132|NCT01734395|561918885|FG000|Overall Study|Withdrawal by Subject|10|||
155680133|NCT01734395|561918885|FG000|Overall Study|Missing the reasons for not completed|3|||
155680134|NCT01092780|561918886|FG000|Washout Period 1|Adverse Event|0|||
155680135|NCT01092780|561918887|FG001|Washout Period 1|Adverse Event|1|||
155680136|NCT01092780|561918888|FG002|Washout Period 1|Adverse Event|0|||
155680137|NCT01092780|561918889|FG003|Washout Period 1|Adverse Event|0|||
155680138|NCT01092780|561918886|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
155680139|NCT01092780|561918887|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
155680140|NCT01092780|561918888|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
155680141|NCT01092780|561918889|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
155680142|NCT01092780|561918886|FG000|Washout Period 2|Adverse Event|0|||
155680143|NCT01092780|561918887|FG001|Washout Period 2|Adverse Event|1|||
155680144|NCT01092780|561918888|FG002|Washout Period 2|Adverse Event|1|||
155680145|NCT01092780|561918889|FG003|Washout Period 2|Adverse Event|0|||
155680146|NCT04026009|561918890|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155680147|NCT04026009|561918891|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155680148|NCT04026009|561918892|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155680149|NCT04026009|561918893|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155680150|NCT04026009|561918894|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155680151|NCT04026009|561918890|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
155680152|NCT04026009|561918891|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
155680153|NCT04026009|561918892|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
155680154|NCT04026009|561918893|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
155680155|NCT04026009|561918894|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
155680156|NCT02957747|561918900|FG000|Overall Study|Withdrawal by Subject|0|||
155680157|NCT02957747|561918901|FG001|Overall Study|Withdrawal by Subject|3|||
155680158|NCT02957747|561918900|FG000|Overall Study|Lost to Follow-up|10|||
155680159|NCT02957747|561918901|FG001|Overall Study|Lost to Follow-up|5|||
155680160|NCT01177553|561918902|FG000|Overall Study|babies not yet 6 months of age|1|||
155680161|NCT01177553|561918903|FG001|Overall Study|babies not yet 6 months of age|0|||
155680162|NCT00610857|561918905|FG000|Overall Study|Not evaluable for response|2|||
155680163|NCT00888329|561918906|FG000|Overall Study|Physician Decision|6|||
155680164|NCT00888329|561918907|FG001|Overall Study|Physician Decision|9|||
155680165|NCT00002540|561918908|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
155680166|NCT00002540|561918909|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
155680167|NCT00002540|561918908|FG000|Overall Study|Died Before Randomization|2|||
155680168|NCT00002540|561918909|FG001|Overall Study|Died Before Randomization|6|||
155680169|NCT00002540|561918908|FG000|Overall Study|Died Before ASU (Control)|202|||
155680170|NCT00002540|561918909|FG001|Overall Study|Died Before ASU (Control)|0|||
155680171|NCT00002540|561918908|FG000|Overall Study|Refused ASU (Control)|597|||
155680172|NCT00002540|561918909|FG001|Overall Study|Refused ASU (Control)|0|||
155680173|NCT00002540|561918908|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
155680174|NCT00002540|561918909|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
155680175|NCT04826094|561918910|FG000|Overall Study|Lost to Follow-up|2|||
155680176|NCT04826094|561918911|FG001|Overall Study|Lost to Follow-up|1|||
155680177|NCT04826094|561918912|FG002|Overall Study|Lost to Follow-up|0|||
155680178|NCT04826094|561918913|FG003|Overall Study|Lost to Follow-up|0|||
155680179|NCT04826094|561918914|FG004|Overall Study|Lost to Follow-up|1|||
155680180|NCT04826094|561918915|FG005|Overall Study|Lost to Follow-up|3|||
155680181|NCT04826094|561918916|FG006|Overall Study|Lost to Follow-up|1|||
155680182|NCT04826094|561918917|FG007|Overall Study|Lost to Follow-up|1|||
155680183|NCT04826094|561918910|FG000|Overall Study|Participant withdrew consent|1|||
155680184|NCT04826094|561918911|FG001|Overall Study|Participant withdrew consent|0|||
155680185|NCT04826094|561918912|FG002|Overall Study|Participant withdrew consent|0|||
155680186|NCT04826094|561918913|FG003|Overall Study|Participant withdrew consent|1|||
155680187|NCT04826094|561918914|FG004|Overall Study|Participant withdrew consent|1|||
155680188|NCT04826094|561918915|FG005|Overall Study|Participant withdrew consent|1|||
155680189|NCT04826094|561918916|FG006|Overall Study|Participant withdrew consent|0|||
155680190|NCT04826094|561918917|FG007|Overall Study|Participant withdrew consent|1|||
155680191|NCT04826094|561918910|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
155680192|NCT04826094|561918911|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
155680193|NCT04826094|561918912|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
155680194|NCT04826094|561918913|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
155680195|NCT04826094|561918914|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
155680196|NCT04826094|561918915|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
155680197|NCT04826094|561918916|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
155680198|NCT04826094|561918917|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
155680199|NCT04826094|561918910|FG000|Overall Study|Withdrawn by Investigator|0|||
155680200|NCT04826094|561918911|FG001|Overall Study|Withdrawn by Investigator|0|||
155680201|NCT04826094|561918912|FG002|Overall Study|Withdrawn by Investigator|0|||
155680202|NCT04826094|561918913|FG003|Overall Study|Withdrawn by Investigator|0|||
155680203|NCT04826094|561918914|FG004|Overall Study|Withdrawn by Investigator|0|||
155680204|NCT04826094|561918915|FG005|Overall Study|Withdrawn by Investigator|1|||
155680205|NCT04826094|561918916|FG006|Overall Study|Withdrawn by Investigator|0|||
155680206|NCT04826094|561918917|FG007|Overall Study|Withdrawn by Investigator|1|||
155680207|NCT04826094|561918910|FG000|Overall Study|Other: Moved from area|1|||
155680208|NCT04826094|561918911|FG001|Overall Study|Other: Moved from area|1|||
155680209|NCT04826094|561918912|FG002|Overall Study|Other: Moved from area|1|||
155680210|NCT04826094|561918913|FG003|Overall Study|Other: Moved from area|0|||
155680211|NCT04826094|561918914|FG004|Overall Study|Other: Moved from area|0|||
155680212|NCT04826094|561918915|FG005|Overall Study|Other: Moved from area|0|||
155680213|NCT04826094|561918916|FG006|Overall Study|Other: Moved from area|0|||
155680214|NCT04826094|561918917|FG007|Overall Study|Other: Moved from area|0|||
155680215|NCT04826094|561918910|FG000|Overall Study|Other: Declined|0|||
155680216|NCT04826094|561918911|FG001|Overall Study|Other: Declined|0|||
155680217|NCT04826094|561918912|FG002|Overall Study|Other: Declined|0|||
155680218|NCT04826094|561918913|FG003|Overall Study|Other: Declined|0|||
155680219|NCT04826094|561918914|FG004|Overall Study|Other: Declined|1|||
155680220|NCT04826094|561918915|FG005|Overall Study|Other: Declined|0|||
155680221|NCT04826094|561918916|FG006|Overall Study|Other: Declined|0|||
155680222|NCT04826094|561918917|FG007|Overall Study|Other: Declined|0|||
155680223|NCT04826094|561918910|FG000|Overall Study|Other: Vaccine not administered|0|||
155680224|NCT04826094|561918911|FG001|Overall Study|Other: Vaccine not administered|0|||
155680225|NCT04826094|561918912|FG002|Overall Study|Other: Vaccine not administered|1|||
155680226|NCT04826094|561918913|FG003|Overall Study|Other: Vaccine not administered|0|||
155680227|NCT04826094|561918914|FG004|Overall Study|Other: Vaccine not administered|0|||
155680228|NCT04826094|561918915|FG005|Overall Study|Other: Vaccine not administered|1|||
155680229|NCT04826094|561918916|FG006|Overall Study|Other: Vaccine not administered|1|||
155680230|NCT04826094|561918917|FG007|Overall Study|Other: Vaccine not administered|3|||
155680231|NCT02151903|561918918|FG000|Overall Study|Withdrawal by Subject|1|||
155680232|NCT02151903|561918919|FG001|Overall Study|Withdrawal by Subject|0|||
155680233|NCT02151903|561918918|FG000|Overall Study|Progressive disease|2|||
155680234|NCT02151903|561918919|FG001|Overall Study|Progressive disease|1|||
155680235|NCT00778375|561918920|FG000|Overall Study|Ineligible|3|||
155680236|NCT01421303|561918921|FG000|Overall Study|Lost to Follow-up|13|||
155680237|NCT01421303|561918921|FG000|Overall Study|Non compliance with study procedure|1|||
155680238|NCT01421303|561918921|FG000|Overall Study|Other|7|||
155680239|NCT01421303|561918921|FG000|Overall Study|Withdrawal by Subject|1|||
155680240|NCT06003777|561918922|FG000|Period 1|Adverse Event|0|||
155680241|NCT06003777|561918923|FG001|Period 1|Adverse Event|0|||
155680242|NCT06003777|561918924|FG002|Period 1|Adverse Event|1|||
155680243|NCT06003777|561918925|FG003|Period 1|Adverse Event|0|||
155680244|NCT06003777|561918926|FG004|Period 1|Adverse Event|0|||
155680245|NCT06003777|561918927|FG005|Period 1|Adverse Event|0|||
155680246|NCT06003777|561918928|FG006|Period 1|Adverse Event|0|||
155680247|NCT06003777|561918929|FG007|Period 1|Adverse Event|0|||
155680248|NCT06003777|561918930|FG008|Period 1|Adverse Event|0|||
155680249|NCT06003777|561918931|FG009|Period 1|Adverse Event|0|||
155680250|NCT06003777|561918932|FG010|Period 1|Adverse Event|0|||
155680251|NCT06003777|561918933|FG011|Period 1|Adverse Event|0|||
155680252|NCT06003777|561918922|FG000|Period 1|Withdrawal by Subject|0|||
155680253|NCT06003777|561918923|FG001|Period 1|Withdrawal by Subject|0|||
155680254|NCT06003777|561918924|FG002|Period 1|Withdrawal by Subject|0|||
155680255|NCT06003777|561918925|FG003|Period 1|Withdrawal by Subject|0|||
155680256|NCT06003777|561918926|FG004|Period 1|Withdrawal by Subject|1|||
155680257|NCT06003777|561918927|FG005|Period 1|Withdrawal by Subject|0|||
155680258|NCT06003777|561918928|FG006|Period 1|Withdrawal by Subject|0|||
155680259|NCT06003777|561918929|FG007|Period 1|Withdrawal by Subject|0|||
155680260|NCT06003777|561918930|FG008|Period 1|Withdrawal by Subject|0|||
155680261|NCT06003777|561918931|FG009|Period 1|Withdrawal by Subject|0|||
155680262|NCT06003777|561918932|FG010|Period 1|Withdrawal by Subject|0|||
155680263|NCT06003777|561918933|FG011|Period 1|Withdrawal by Subject|0|||
155680264|NCT06003777|561918922|FG000|Period 2|Withdrawal by Subject|0|||
155680265|NCT06003777|561918923|FG001|Period 2|Withdrawal by Subject|0|||
155680266|NCT06003777|561918924|FG002|Period 2|Withdrawal by Subject|0|||
155680267|NCT06003777|561918925|FG003|Period 2|Withdrawal by Subject|0|||
155680268|NCT06003777|561918926|FG004|Period 2|Withdrawal by Subject|0|||
155680269|NCT06003777|561918927|FG005|Period 2|Withdrawal by Subject|0|||
155680270|NCT06003777|561918928|FG006|Period 2|Withdrawal by Subject|0|||
155680271|NCT06003777|561918929|FG007|Period 2|Withdrawal by Subject|0|||
155680272|NCT06003777|561918930|FG008|Period 2|Withdrawal by Subject|1|||
155680273|NCT06003777|561918931|FG009|Period 2|Withdrawal by Subject|0|||
155680274|NCT06003777|561918932|FG010|Period 2|Withdrawal by Subject|0|||
155680275|NCT06003777|561918933|FG011|Period 2|Withdrawal by Subject|0|||
155680276|NCT06003777|561918922|FG000|Period 3|Adverse Event|0|||
155680277|NCT06003777|561918923|FG001|Period 3|Adverse Event|0|||
155680278|NCT06003777|561918924|FG002|Period 3|Adverse Event|0|||
155680279|NCT06003777|561918925|FG003|Period 3|Adverse Event|0|||
155680280|NCT06003777|561918926|FG004|Period 3|Adverse Event|0|||
155680281|NCT06003777|561918927|FG005|Period 3|Adverse Event|0|||
155680282|NCT06003777|561918928|FG006|Period 3|Adverse Event|1|||
155680283|NCT06003777|561918929|FG007|Period 3|Adverse Event|0|||
155680284|NCT06003777|561918930|FG008|Period 3|Adverse Event|0|||
155680285|NCT06003777|561918931|FG009|Period 3|Adverse Event|0|||
155680286|NCT06003777|561918932|FG010|Period 3|Adverse Event|0|||
155680287|NCT06003777|561918933|FG011|Period 3|Adverse Event|0|||
155680288|NCT06003777|561918922|FG000|Period 4|No longer met eligibility criteria|0|||
155680289|NCT06003777|561918923|FG001|Period 4|No longer met eligibility criteria|0|||
155680290|NCT06003777|561918924|FG002|Period 4|No longer met eligibility criteria|1|||
155680291|NCT06003777|561918925|FG003|Period 4|No longer met eligibility criteria|0|||
155680292|NCT06003777|561918926|FG004|Period 4|No longer met eligibility criteria|0|||
155680293|NCT06003777|561918927|FG005|Period 4|No longer met eligibility criteria|0|||
155680294|NCT06003777|561918928|FG006|Period 4|No longer met eligibility criteria|0|||
155680295|NCT06003777|561918929|FG007|Period 4|No longer met eligibility criteria|0|||
155680296|NCT06003777|561918930|FG008|Period 4|No longer met eligibility criteria|0|||
155680297|NCT06003777|561918931|FG009|Period 4|No longer met eligibility criteria|0|||
155680298|NCT06003777|561918932|FG010|Period 4|No longer met eligibility criteria|0|||
155680299|NCT06003777|561918933|FG011|Period 4|No longer met eligibility criteria|0|||
155680300|NCT06003777|561918922|FG000|Period 4|Withdrawal by Subject|0|||
155680301|NCT06003777|561918923|FG001|Period 4|Withdrawal by Subject|1|||
155680302|NCT06003777|561918924|FG002|Period 4|Withdrawal by Subject|0|||
155680303|NCT06003777|561918925|FG003|Period 4|Withdrawal by Subject|0|||
155680304|NCT06003777|561918926|FG004|Period 4|Withdrawal by Subject|0|||
155680305|NCT06003777|561918927|FG005|Period 4|Withdrawal by Subject|0|||
155680306|NCT06003777|561918928|FG006|Period 4|Withdrawal by Subject|0|||
155680307|NCT06003777|561918929|FG007|Period 4|Withdrawal by Subject|0|||
155680308|NCT06003777|561918930|FG008|Period 4|Withdrawal by Subject|0|||
155680309|NCT06003777|561918931|FG009|Period 4|Withdrawal by Subject|0|||
155680310|NCT06003777|561918932|FG010|Period 4|Withdrawal by Subject|0|||
155680311|NCT06003777|561918933|FG011|Period 4|Withdrawal by Subject|0|||
155680312|NCT05319600|561918934|FG000|Overall Study|Withdrawal by Subject|1|||
155680313|NCT05319600|561918935|FG001|Overall Study|Withdrawal by Subject|0|||
155680314|NCT05319600|561918934|FG000|Overall Study|Lost to Follow-up|0|||
155680315|NCT05319600|561918935|FG001|Overall Study|Lost to Follow-up|4|||
155680316|NCT00904670|561918936|FG000|Open Label Phase|Withdrawal by Subject|2|||
155680317|NCT00904670|561918937|FG001|Open Label Phase|Withdrawal by Subject|0|||
155680318|NCT00904670|561918936|FG000|Open Label Phase|Adverse Event|2|||
155680319|NCT00904670|561918937|FG001|Open Label Phase|Adverse Event|0|||
155680320|NCT00904670|561918936|FG000|Open Label Phase|Lack of Efficacy|1|||
155680321|NCT00904670|561918937|FG001|Open Label Phase|Lack of Efficacy|0|||
155680322|NCT00904670|561918936|FG000|Open Label Phase|Lost to Follow-up|1|||
155680323|NCT00904670|561918937|FG001|Open Label Phase|Lost to Follow-up|0|||
155680324|NCT02120300|561918942|FG000|Overall Study|Enrolled but Never Treated|2|||
155680325|NCT02120300|561918943|FG001|Overall Study|Enrolled but Never Treated|0|||
155680326|NCT02120300|561918944|FG002|Overall Study|Enrolled but Never Treated|0|||
155680327|NCT02120300|561918945|FG003|Overall Study|Enrolled but Never Treated|0|||
155680328|NCT02120300|561918942|FG000|Overall Study|Lack of Efficacy|0|||
155680329|NCT02120300|561918943|FG001|Overall Study|Lack of Efficacy|0|||
155680330|NCT02120300|561918944|FG002|Overall Study|Lack of Efficacy|0|||
155680331|NCT02120300|561918945|FG003|Overall Study|Lack of Efficacy|1|||
155680332|NCT02120300|561918942|FG000|Overall Study|Lost to Follow-up|1|||
155680333|NCT02120300|561918943|FG001|Overall Study|Lost to Follow-up|0|||
155680334|NCT02120300|561918944|FG002|Overall Study|Lost to Follow-up|0|||
155680335|NCT02120300|561918945|FG003|Overall Study|Lost to Follow-up|0|||
155680336|NCT01721486|561918952|FG000|Overall Study|Protocol Violation|1|||
155680337|NCT01721486|561918953|FG001|Overall Study|Protocol Violation|0|||
155680338|NCT01721486|561918952|FG000|Overall Study|Physician Decision|0|||
155680339|NCT01721486|561918953|FG001|Overall Study|Physician Decision|1|||
155680340|NCT00613327|561918954|FG000|Overall Study|Adverse Event|38|||
155680341|NCT00613327|561918954|FG000|Overall Study|Lost to Follow-up|8|||
155680342|NCT00613327|561918954|FG000|Overall Study|Withdrawal by Subject|6|||
155680343|NCT00613327|561918954|FG000|Overall Study|Protocol Violation|2|||
155680344|NCT00613327|561918954|FG000|Overall Study|Other|47|||
155680345|NCT01814397|561918955|FG000|Overall Study|Adverse Event|7|||
155680346|NCT01814397|561918955|FG000|Overall Study|Withdrawal by Subject|7|||
155680347|NCT00313144|561918956|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
155680348|NCT00313144|561918956|FG000|Overall Study|Death|7|||
155680349|NCT00313144|561918956|FG000|Overall Study|Lost to Follow-up|5|||
155680350|NCT00313144|561918956|FG000|Overall Study|Withdrawal by Subject|4|||
155680351|NCT00313144|561918956|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
155680352|NCT00313144|561918956|FG000|Overall Study|Physician Decision|4|||
155680353|NCT00313144|561918956|FG000|Overall Study|Adverse event - transient|5|||
155680354|NCT00313144|561918956|FG000|Overall Study|Liver transplant|1|||
155680355|NCT00313144|561918956|FG000|Overall Study|Insurance (homecare provider) change|1|||
155680356|NCT00313144|561918956|FG000|Overall Study|Change to different product|1|||
155680357|NCT00313144|561918956|FG000|Overall Study|Due to termination of the study|66|||
155680358|NCT04154293|561918959|FG000|Overall Study|Withdrawal by Subject|2|||
155680359|NCT04154293|561918960|FG001|Overall Study|Withdrawal by Subject|3|||
155680360|NCT04154293|561918961|FG002|Overall Study|Withdrawal by Subject|1|||
155680361|NCT04154293|561918959|FG000|Overall Study|Physician Decision|0|||
155680362|NCT04154293|561918960|FG001|Overall Study|Physician Decision|0|||
155680363|NCT04154293|561918961|FG002|Overall Study|Physician Decision|1|||
155680364|NCT04731298|561918962|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
155680365|NCT04731298|561918963|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
155680366|NCT01208961|561918964|FG000|High-Fat Period III|Protocol Violation|1|||
155680367|NCT01208961|561918965|FG001|High-Fat Period III|Protocol Violation|0|||
155680368|NCT03403361|561918974|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
155680369|NCT02487654|561918975|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
155680370|NCT02487654|561918976|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
155680371|NCT02487654|561918975|FG000|Overall Study|Withdrawal by Subject|3|||
155680372|NCT02487654|561918976|FG001|Overall Study|Withdrawal by Subject|7|||
155680373|NCT04238481|561918977|FG000|Overall Study|Miscellaneous|0|||
155680374|NCT04238481|561918978|FG001|Overall Study|Miscellaneous|1|||
155680375|NCT04238481|561918979|FG002|Overall Study|Miscellaneous|0|||
155680376|NCT04238481|561918980|FG003|Overall Study|Miscellaneous|0|||
155680377|NCT02152371|561918981|FG000|Overall Study|Adverse Event|6|||
155680378|NCT02152371|561918982|FG001|Overall Study|Adverse Event|2|||
155680379|NCT02152371|561918981|FG000|Overall Study|Withdrawal by Subject|3|||
155680380|NCT02152371|561918982|FG001|Overall Study|Withdrawal by Subject|7|||
155680381|NCT02152371|561918981|FG000|Overall Study|Protocol Violation|2|||
155680382|NCT02152371|561918982|FG001|Overall Study|Protocol Violation|3|||
155680383|NCT02152371|561918981|FG000|Overall Study|Lost to Follow-up|1|||
155680384|NCT02152371|561918982|FG001|Overall Study|Lost to Follow-up|0|||
155680385|NCT02152371|561918981|FG000|Overall Study|Lack of Efficacy|0|||
155680386|NCT02152371|561918982|FG001|Overall Study|Lack of Efficacy|1|||
155680387|NCT02152371|561918981|FG000|Overall Study|Physician Decision|0|||
155680388|NCT02152371|561918982|FG001|Overall Study|Physician Decision|2|||
155680389|NCT02152371|561918981|FG000|Overall Study|Reason Not Given|0|||
155680390|NCT02152371|561918982|FG001|Overall Study|Reason Not Given|1|||
155680391|NCT00350870|561918983|FG000|Overall Study|Withdrawal by Subject|21|||
155680392|NCT00350870|561918984|FG001|Overall Study|Withdrawal by Subject|17|||
155680393|NCT00350870|561918985|FG002|Overall Study|Withdrawal by Subject|15|||
155680394|NCT00350870|561918986|FG003|Overall Study|Withdrawal by Subject|14|||
155680395|NCT00350870|561918983|FG000|Overall Study|Physician Decision|1|||
155680396|NCT00350870|561918984|FG001|Overall Study|Physician Decision|0|||
155680397|NCT00350870|561918985|FG002|Overall Study|Physician Decision|1|||
155680398|NCT00350870|561918986|FG003|Overall Study|Physician Decision|1|||
155680399|NCT00349921|561918987|FG000|First Spinal Injection|Physician Decision|1|||
155680400|NCT00349921|561918988|FG001|First Spinal Injection|Physician Decision|0|||
155680401|NCT00349921|561918989|FG002|First Spinal Injection|Physician Decision|0|||
155680402|NCT00349921|561918990|FG003|First Spinal Injection|Physician Decision|0|||
155680403|NCT00349921|561918987|FG000|First Spinal Injection|Adverse Event|0|||
155680404|NCT00349921|561918988|FG001|First Spinal Injection|Adverse Event|0|||
155680405|NCT00349921|561918989|FG002|First Spinal Injection|Adverse Event|1|||
155680406|NCT00349921|561918990|FG003|First Spinal Injection|Adverse Event|0|||
155680407|NCT05285644|561918995|FG000|Overall Study|Adverse Event|3|||
155680408|NCT05285644|561918996|FG001|Overall Study|Adverse Event|3|||
155680409|NCT05285644|561918995|FG000|Overall Study|Withdrawal of Consent|2|||
155680410|NCT05285644|561918996|FG001|Overall Study|Withdrawal of Consent|5|||
155680411|NCT05285644|561918995|FG000|Overall Study|Noncompliance|0|||
155680412|NCT05285644|561918996|FG001|Overall Study|Noncompliance|4|||
155680413|NCT05285644|561918995|FG000|Overall Study|Lost to Follow-up|4|||
155680414|NCT05285644|561918996|FG001|Overall Study|Lost to Follow-up|6|||
155680415|NCT05285644|561918995|FG000|Overall Study|Disallowed Concurrent Medication|1|||
155680416|NCT05285644|561918996|FG001|Overall Study|Disallowed Concurrent Medication|1|||
155680417|NCT05285644|561918995|FG000|Overall Study|Investigator Decision|2|||
155680418|NCT05285644|561918996|FG001|Overall Study|Investigator Decision|0|||
155680419|NCT05285644|561918995|FG000|Overall Study|Protocol Deviation|1|||
155680420|NCT05285644|561918996|FG001|Overall Study|Protocol Deviation|0|||
155680421|NCT05285644|561918995|FG000|Overall Study|As specified in the Clinical Study Report|7|||
155680422|NCT05285644|561918996|FG001|Overall Study|As specified in the Clinical Study Report|3|||
155680423|NCT04382586|561919000|FG000|Overall Study|Death|3|||
155680424|NCT04382586|561919001|FG001|Overall Study|Death|4|||
155680425|NCT04382586|561919000|FG000|Overall Study|Lost to Follow-up|11|||
155680426|NCT04382586|561919001|FG001|Overall Study|Lost to Follow-up|8|||
155680427|NCT04382586|561919000|FG000|Overall Study|Withdrawal by Subject|3|||
155680428|NCT04382586|561919001|FG001|Overall Study|Withdrawal by Subject|1|||
155680429|NCT04382586|561919000|FG000|Overall Study|Physician Decision|0|||
155680430|NCT04382586|561919001|FG001|Overall Study|Physician Decision|3|||
155680431|NCT02265536|561919009|FG000|Overall Study|Adverse Event|1|||
155680432|NCT02265536|561919010|FG001|Overall Study|Adverse Event|0|||
155680433|NCT02265536|561919011|FG002|Overall Study|Adverse Event|0|||
155680434|NCT02265536|561919012|FG003|Overall Study|Adverse Event|0|||
155680435|NCT02265536|561919013|FG004|Overall Study|Adverse Event|1|||
155680436|NCT02265536|561919014|FG005|Overall Study|Adverse Event|0|||
155680437|NCT02265536|561919009|FG000|Overall Study|Physician Decision|0|||
155680438|NCT02265536|561919010|FG001|Overall Study|Physician Decision|0|||
155680439|NCT02265536|561919011|FG002|Overall Study|Physician Decision|0|||
155680440|NCT02265536|561919012|FG003|Overall Study|Physician Decision|0|||
155680441|NCT02265536|561919013|FG004|Overall Study|Physician Decision|2|||
155680442|NCT02265536|561919014|FG005|Overall Study|Physician Decision|0|||
155680443|NCT02265536|561919009|FG000|Overall Study|Withdrawal by Subject|0|||
155680444|NCT02265536|561919010|FG001|Overall Study|Withdrawal by Subject|3|||
155680445|NCT02265536|561919011|FG002|Overall Study|Withdrawal by Subject|0|||
155680446|NCT02265536|561919012|FG003|Overall Study|Withdrawal by Subject|0|||
155680447|NCT02265536|561919013|FG004|Overall Study|Withdrawal by Subject|0|||
155680448|NCT02265536|561919014|FG005|Overall Study|Withdrawal by Subject|0|||
155680449|NCT02470585|561919017|FG000|Overall Study|Death|224|||
155680450|NCT02470585|561919018|FG001|Overall Study|Death|227|||
155680451|NCT02470585|561919019|FG002|Overall Study|Death|199|||
155680452|NCT02470585|561919017|FG000|Overall Study|Withdrew consent|21|||
155680453|NCT02470585|561919018|FG001|Overall Study|Withdrew consent|22|||
155680454|NCT02470585|561919019|FG002|Overall Study|Withdrew consent|31|||
155680455|NCT02470585|561919017|FG000|Overall Study|Lost to Follow-up|8|||
155680456|NCT02470585|561919018|FG001|Overall Study|Lost to Follow-up|15|||
155680457|NCT02470585|561919019|FG002|Overall Study|Lost to Follow-up|13|||
155680458|NCT02470585|561919017|FG000|Overall Study|Sponsor discontinued study|117|||
155680459|NCT02470585|561919018|FG001|Overall Study|Sponsor discontinued study|110|||
155680460|NCT02470585|561919019|FG002|Overall Study|Sponsor discontinued study|122|||
155680461|NCT02470585|561919017|FG000|Overall Study|Other, not specified|5|||
155680462|NCT02470585|561919018|FG001|Overall Study|Other, not specified|7|||
155680463|NCT02470585|561919019|FG002|Overall Study|Other, not specified|14|||
155680464|NCT02470585|561919017|FG000|Overall Study|Missing due to site non-compliance|0|||
155680465|NCT02470585|561919018|FG001|Overall Study|Missing due to site non-compliance|2|||
155680466|NCT02470585|561919019|FG002|Overall Study|Missing due to site non-compliance|3|||
155680467|NCT03028415|561919020|FG000|Overall Study|Lost to Follow-up|6|||
155680468|NCT03028415|561919021|FG001|Overall Study|Lost to Follow-up|3|||
155680469|NCT03028415|561919020|FG000|Overall Study|Withdrawal by Subject|1|||
155680470|NCT03028415|561919021|FG001|Overall Study|Withdrawal by Subject|0|||
155680471|NCT03028415|561919020|FG000|Overall Study|Discontinued due to COVID-19|1|||
155680472|NCT03028415|561919021|FG001|Overall Study|Discontinued due to COVID-19|0|||
155680473|NCT02907216|561919022|FG000|Overall Study|No benefit to be obtained by continuing|0|||
155680474|NCT02907216|561919023|FG001|Overall Study|No benefit to be obtained by continuing|1|||
155680475|NCT02907216|561919022|FG000|Overall Study|Withdrawal by Subject|1|||
155680476|NCT02907216|561919023|FG001|Overall Study|Withdrawal by Subject|0|||
155680477|NCT02095873|561919025|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155680478|NCT02095873|561919026|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155680479|NCT02095873|561919025|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155680480|NCT02095873|561919026|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155680481|NCT02095873|561919025|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
155680482|NCT02095873|561919026|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
155680483|NCT03763656|561919029|FG000|Overall Study|Physician Decision|1|||
155680484|NCT03763656|561919029|FG000|Overall Study|Protocol Violation|1|||
155680485|NCT03763656|561919029|FG000|Overall Study|Withdrawal by Subject|7|||
155680486|NCT00107900|561919033|FG000|Overall Study|Adverse Event|3|||
155680487|NCT00107900|561919034|FG001|Overall Study|Adverse Event|2|||
155680488|NCT00107900|561919035|FG002|Overall Study|Adverse Event|10|||
155680489|NCT00107900|561919036|FG003|Overall Study|Adverse Event|3|||
155680490|NCT00107900|561919037|FG004|Overall Study|Adverse Event|5|||
155680491|NCT00107900|561919038|FG005|Overall Study|Adverse Event|3|||
155680492|NCT00107900|561919033|FG000|Overall Study|Death|0|||
155680493|NCT00107900|561919034|FG001|Overall Study|Death|0|||
155680494|NCT00107900|561919035|FG002|Overall Study|Death|0|||
155680495|NCT00107900|561919036|FG003|Overall Study|Death|0|||
155680496|NCT00107900|561919037|FG004|Overall Study|Death|1|||
155680497|NCT00107900|561919038|FG005|Overall Study|Death|0|||
155680498|NCT00107900|561919033|FG000|Overall Study|Lost to Follow-up|4|||
155680499|NCT00107900|561919034|FG001|Overall Study|Lost to Follow-up|1|||
155680500|NCT00107900|561919035|FG002|Overall Study|Lost to Follow-up|3|||
155680501|NCT00107900|561919036|FG003|Overall Study|Lost to Follow-up|2|||
155680502|NCT00107900|561919037|FG004|Overall Study|Lost to Follow-up|5|||
155680503|NCT00107900|561919038|FG005|Overall Study|Lost to Follow-up|5|||
155680504|NCT00107900|561919033|FG000|Overall Study|Protocol Violation|1|||
155680505|NCT00107900|561919034|FG001|Overall Study|Protocol Violation|0|||
155680506|NCT00107900|561919035|FG002|Overall Study|Protocol Violation|5|||
155680507|NCT00107900|561919036|FG003|Overall Study|Protocol Violation|5|||
155680508|NCT00107900|561919037|FG004|Overall Study|Protocol Violation|7|||
155680509|NCT00107900|561919038|FG005|Overall Study|Protocol Violation|0|||
155680510|NCT00107900|561919033|FG000|Overall Study|Withdrawal by Subject|1|||
155680511|NCT00107900|561919034|FG001|Overall Study|Withdrawal by Subject|0|||
155680512|NCT00107900|561919035|FG002|Overall Study|Withdrawal by Subject|5|||
155680513|NCT00107900|561919036|FG003|Overall Study|Withdrawal by Subject|0|||
155680514|NCT00107900|561919037|FG004|Overall Study|Withdrawal by Subject|1|||
155680515|NCT00107900|561919038|FG005|Overall Study|Withdrawal by Subject|1|||
155680516|NCT00107900|561919033|FG000|Overall Study|Administrative Reasons|1|||
155680517|NCT00107900|561919034|FG001|Overall Study|Administrative Reasons|0|||
155680518|NCT00107900|561919035|FG002|Overall Study|Administrative Reasons|2|||
155680519|NCT00107900|561919036|FG003|Overall Study|Administrative Reasons|2|||
155680520|NCT00107900|561919037|FG004|Overall Study|Administrative Reasons|2|||
155680521|NCT00107900|561919038|FG005|Overall Study|Administrative Reasons|0|||
155680522|NCT02640625|561921636|FG000|Overall Study|Adverse Event|1|||
155680523|NCT00197145|561921637|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
155680524|NCT00197145|561921638|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
155680525|NCT00197145|561921637|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
155680526|NCT00197145|561921638|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
155680527|NCT00197145|561921637|FG000|Period 1: Randomized Treatment Phase|Other|2|||
155680528|NCT00197145|561921638|FG001|Period 1: Randomized Treatment Phase|Other|2|||
155680529|NCT00197145|561921637|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
155680530|NCT00197145|561921638|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
155680531|NCT00197145|561921637|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
155680532|NCT00197145|561921638|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
155680533|NCT00197145|561921637|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
155680534|NCT00197145|561921638|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
155680535|NCT00197145|561921637|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
155680536|NCT00197145|561921638|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
155680537|NCT00197145|561921637|FG000|Period 2 : Open Label Phase|Other|1|||
155680538|NCT00197145|561921638|FG001|Period 2 : Open Label Phase|Other|0|||
155680539|NCT02370537|561921639|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
155680540|NCT02370537|561921640|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
155680541|NCT02370537|561921641|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
155680542|NCT02370537|561921639|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
155680543|NCT02370537|561921640|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
155680544|NCT02370537|561921641|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
155680545|NCT02370537|561921639|FG000|Part B|Not randomised to receive treatment|1|||
155680546|NCT02370537|561921640|FG001|Part B|Not randomised to receive treatment|2|||
155680547|NCT02370537|561921641|FG002|Part B|Not randomised to receive treatment|259|||
155680548|NCT02370537|561921639|FG000|Part B|Withdrawal by Subject|0|||
155680549|NCT02370537|561921640|FG001|Part B|Withdrawal by Subject|1|||
155680550|NCT02370537|561921641|FG002|Part B|Withdrawal by Subject|0|||
155680551|NCT03100539|561921646|FG000|Overall Study|Lost to Follow-up|60|||
155680552|NCT03100539|561921647|FG001|Overall Study|Lost to Follow-up|54|||
155680553|NCT03100539|561921648|FG002|Overall Study|Lost to Follow-up|17|||
155680554|NCT03100539|561921646|FG000|Overall Study|Uncollected|8|||
155680555|NCT03100539|561921647|FG001|Overall Study|Uncollected|8|||
155680556|NCT03100539|561921648|FG002|Overall Study|Uncollected|0|||
155680557|NCT03100539|561921646|FG000|Overall Study|Ally Health|0|||
155680558|NCT03100539|561921647|FG001|Overall Study|Ally Health|0|||
155680559|NCT03100539|561921648|FG002|Overall Study|Ally Health|3|||
155680560|NCT03100539|561921646|FG000|Overall Study|Disinterest|0|||
155680561|NCT03100539|561921647|FG001|Overall Study|Disinterest|0|||
155680562|NCT03100539|561921648|FG002|Overall Study|Disinterest|22|||
155680563|NCT03100539|561921646|FG000|Overall Study|Veteran Health|0|||
155680564|NCT03100539|561921647|FG001|Overall Study|Veteran Health|0|||
155680565|NCT03100539|561921648|FG002|Overall Study|Veteran Health|8|||
155680566|NCT03100539|561921646|FG000|Overall Study|Moved|0|||
155680567|NCT03100539|561921647|FG001|Overall Study|Moved|0|||
155680568|NCT03100539|561921648|FG002|Overall Study|Moved|1|||
155680569|NCT03100539|561921646|FG000|Overall Study|Scheduling Conflicts|0|||
155680570|NCT03100539|561921647|FG001|Overall Study|Scheduling Conflicts|0|||
155680571|NCT03100539|561921648|FG002|Overall Study|Scheduling Conflicts|12|||
155680572|NCT05659719|561921652|FG000|Overall Study|At sponsor's request|0|||
155680573|NCT05659719|561921653|FG001|Overall Study|At sponsor's request|0|||
155680574|NCT05659719|561921654|FG002|Overall Study|At sponsor's request|0|||
155680575|NCT05659719|561921655|FG003|Overall Study|At sponsor's request|95|||
155680576|NCT05659719|561921652|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
155680577|NCT05659719|561921653|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
155680578|NCT05659719|561921654|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
155680579|NCT05659719|561921655|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
155680580|NCT05659719|561921652|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
155680581|NCT05659719|561921653|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
155680582|NCT05659719|561921654|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
155680583|NCT05659719|561921655|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
155680584|NCT05659719|561921652|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155680585|NCT05659719|561921653|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155680586|NCT05659719|561921654|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155680587|NCT05659719|561921655|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
155680588|NCT05659719|561921652|FG000|Overall Study|Lost to Follow-up|0|||
155680589|NCT05659719|561921653|FG001|Overall Study|Lost to Follow-up|0|||
155680590|NCT05659719|561921654|FG002|Overall Study|Lost to Follow-up|0|||
155680591|NCT05659719|561921655|FG003|Overall Study|Lost to Follow-up|2|||
155680592|NCT05659719|561921652|FG000|Overall Study|Moved to another observational study|0|||
155680593|NCT05659719|561921653|FG001|Overall Study|Moved to another observational study|0|||
155603193|NCT04093492|561635453|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155603194|NCT04093492|561635454|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155603195|NCT04093492|561635455|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
155603196|NCT04093492|561635452|FG000|30 Weeks GA|Delivered before assessment|1|||
155603197|NCT04093492|561635453|FG001|30 Weeks GA|Delivered before assessment|2|||
155603198|NCT04093492|561635454|FG002|30 Weeks GA|Delivered before assessment|0|||
155603199|NCT04093492|561635455|FG003|30 Weeks GA|Delivered before assessment|0|||
155603200|NCT04093492|561635452|FG000|30 Weeks GA|No response|7|||
155603201|NCT04093492|561635453|FG001|30 Weeks GA|No response|5|||
155603202|NCT04093492|561635454|FG002|30 Weeks GA|No response|5|||
155603203|NCT04093492|561635455|FG003|30 Weeks GA|No response|2|||
155603204|NCT04093492|561635452|FG000|30 Weeks GA|Lost to Follow-up|0|||
155603205|NCT04093492|561635453|FG001|30 Weeks GA|Lost to Follow-up|1|||
155603206|NCT04093492|561635454|FG002|30 Weeks GA|Lost to Follow-up|0|||
155603207|NCT04093492|561635455|FG003|30 Weeks GA|Lost to Follow-up|0|||
155603208|NCT04093492|561635452|FG000|34 Weeks GA|Delivered before assessment|6|||
155603209|NCT04093492|561635453|FG001|34 Weeks GA|Delivered before assessment|3|||
155603210|NCT04093492|561635454|FG002|34 Weeks GA|Delivered before assessment|0|||
155603211|NCT04093492|561635455|FG003|34 Weeks GA|Delivered before assessment|0|||
155603212|NCT04093492|561635452|FG000|34 Weeks GA|No response|0|||
155603213|NCT04093492|561635453|FG001|34 Weeks GA|No response|7|||
155603214|NCT04093492|561635454|FG002|34 Weeks GA|No response|5|||
155603215|NCT04093492|561635455|FG003|34 Weeks GA|No response|3|||
155603216|NCT04093492|561635452|FG000|34 Weeks GA|Lost to Follow-up|0|||
155603217|NCT04093492|561635453|FG001|34 Weeks GA|Lost to Follow-up|1|||
155603218|NCT04093492|561635454|FG002|34 Weeks GA|Lost to Follow-up|0|||
155603219|NCT04093492|561635455|FG003|34 Weeks GA|Lost to Follow-up|0|||
155603220|NCT02945254|561635462|FG000|Overall Study|Lost to Follow-up|1|||
155603221|NCT02945254|561635463|FG001|Overall Study|Lost to Follow-up|0|||
155603222|NCT02945254|561635462|FG000|Overall Study|Withdrawal by Subject|1|||
155603223|NCT02945254|561635463|FG001|Overall Study|Withdrawal by Subject|0|||
155603224|NCT01711619|561635464|FG000|Overall Study|Early study termination|10|||
155603225|NCT01711619|561635465|FG001|Overall Study|Early study termination|14|||
155603226|NCT01711619|561635464|FG000|Overall Study|Withdrawal by Subject|3|||
155603227|NCT01711619|561635465|FG001|Overall Study|Withdrawal by Subject|7|||
155603228|NCT01711619|561635464|FG000|Overall Study|Protocol Violation|2|||
155603229|NCT01711619|561635465|FG001|Overall Study|Protocol Violation|3|||
155603230|NCT01711619|561635464|FG000|Overall Study|Adverse Event|2|||
155603231|NCT01711619|561635465|FG001|Overall Study|Adverse Event|0|||
155603232|NCT01711619|561635464|FG000|Overall Study|Lost to Follow-up|1|||
155603233|NCT01711619|561635465|FG001|Overall Study|Lost to Follow-up|0|||
155603234|NCT00783224|561635466|FG000|Overall Study|Adverse Event|0|||
155603235|NCT00783224|561635467|FG001|Overall Study|Adverse Event|0|||
155603236|NCT00783224|561635468|FG002|Overall Study|Adverse Event|1|||
155603237|NCT00783224|561635469|FG003|Overall Study|Adverse Event|0|||
155603238|NCT00783224|561635466|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
155603239|NCT00783224|561635467|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
155603240|NCT00783224|561635468|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
155603241|NCT00783224|561635469|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
155603242|NCT00783224|561635466|FG000|Overall Study|Inappropriate as a study subject|0|||
155603243|NCT00783224|561635467|FG001|Overall Study|Inappropriate as a study subject|0|||
155603244|NCT00783224|561635468|FG002|Overall Study|Inappropriate as a study subject|0|||
155603245|NCT00783224|561635469|FG003|Overall Study|Inappropriate as a study subject|1|||
155603246|NCT04631107|561635470|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
155603247|NCT04631107|561635470|FG000|Second Intervention (1 Night)|Adverse Event|1|||
155603248|NCT04631107|561635470|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
155603249|NCT04631107|561635470|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
155603250|NCT01432275|561635474|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
155603251|NCT01432275|561635475|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
155603252|NCT01432275|561635474|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
155603253|NCT01432275|561635475|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
155603254|NCT01432275|561635474|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
155603255|NCT01432275|561635475|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
155603256|NCT01432275|561635474|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
155603257|NCT01432275|561635475|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
155603258|NCT01432275|561635474|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
155603259|NCT01432275|561635475|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
155603260|NCT01432275|561635474|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
155603261|NCT01432275|561635475|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
155603262|NCT01432275|561635474|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
155680594|NCT05659719|561921654|FG002|Overall Study|Moved to another observational study|0|||
155680595|NCT05659719|561921655|FG003|Overall Study|Moved to another observational study|1|||
155680596|NCT05659719|561921652|FG000|Overall Study|The child was enrolled in an interventional study|0|||
155680597|NCT05659719|561921653|FG001|Overall Study|The child was enrolled in an interventional study|0|||
155680598|NCT05659719|561921654|FG002|Overall Study|The child was enrolled in an interventional study|0|||
155680599|NCT05659719|561921655|FG003|Overall Study|The child was enrolled in an interventional study|55|||
155680600|NCT05659719|561921652|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155680601|NCT05659719|561921653|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155680602|NCT05659719|561921654|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155680603|NCT05659719|561921655|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
155680604|NCT05659719|561921652|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155680605|NCT05659719|561921653|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155680606|NCT05659719|561921654|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155680607|NCT05659719|561921655|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
155680608|NCT02290691|561921656|FG000|Overall Study|Noncompliance|0|||
155680609|NCT02290691|561921657|FG001|Overall Study|Noncompliance|1|||
155680610|NCT02290691|561921656|FG000|Overall Study|Withdrawal by Subject|1|||
155680611|NCT02290691|561921657|FG001|Overall Study|Withdrawal by Subject|1|||
155680612|NCT02290691|561921656|FG000|Overall Study|Lost to Follow-up|7|||
155680613|NCT02290691|561921657|FG001|Overall Study|Lost to Follow-up|7|||
155680614|NCT00185380|561921661|FG000|Overall Study|Adverse Event|41|||
155680615|NCT00185380|561921662|FG001|Overall Study|Adverse Event|43|||
155680616|NCT00185380|561921663|FG002|Overall Study|Adverse Event|48|||
155680617|NCT00185380|561921661|FG000|Overall Study|Lost to Follow-up|0|||
155680618|NCT00185380|561921662|FG001|Overall Study|Lost to Follow-up|4|||
155680619|NCT00185380|561921663|FG002|Overall Study|Lost to Follow-up|3|||
155680620|NCT00185380|561921661|FG000|Overall Study|Pregnancy|1|||
155680621|NCT00185380|561921662|FG001|Overall Study|Pregnancy|4|||
155680622|NCT00185380|561921663|FG002|Overall Study|Pregnancy|0|||
155680623|NCT00185380|561921661|FG000|Overall Study|Protocol Violation|2|||
155680624|NCT00185380|561921662|FG001|Overall Study|Protocol Violation|2|||
155680625|NCT00185380|561921663|FG002|Overall Study|Protocol Violation|1|||
155680626|NCT00185380|561921661|FG000|Overall Study|Withdrawal by Subject|1|||
155680627|NCT00185380|561921662|FG001|Overall Study|Withdrawal by Subject|2|||
155680628|NCT00185380|561921663|FG002|Overall Study|Withdrawal by Subject|0|||
155680629|NCT00185380|561921661|FG000|Overall Study|Failed insertion|1|||
155680630|NCT00185380|561921662|FG001|Overall Study|Failed insertion|1|||
155680631|NCT00185380|561921663|FG002|Overall Study|Failed insertion|2|||
155680632|NCT00185380|561921661|FG000|Overall Study|Planned pregnancy|9|||
155680633|NCT00185380|561921662|FG001|Overall Study|Planned pregnancy|12|||
155680634|NCT00185380|561921663|FG002|Overall Study|Planned pregnancy|12|||
155680635|NCT00185380|561921661|FG000|Overall Study|No need for contraception|3|||
155680636|NCT00185380|561921662|FG001|Overall Study|No need for contraception|3|||
155680637|NCT00185380|561921663|FG002|Overall Study|No need for contraception|3|||
155680638|NCT00185380|561921661|FG000|Overall Study|Could not attend visits|2|||
155680639|NCT00185380|561921662|FG001|Overall Study|Could not attend visits|0|||
155680640|NCT00185380|561921663|FG002|Overall Study|Could not attend visits|4|||
155680641|NCT00185380|561921661|FG000|Overall Study|personal reason|6|||
155680642|NCT00185380|561921662|FG001|Overall Study|personal reason|1|||
155680643|NCT00185380|561921663|FG002|Overall Study|personal reason|1|||
155680644|NCT00978380|561921664|FG000|Overall Study|Protocol Violation|2|||
155680645|NCT00978380|561921664|FG000|Overall Study|Withdrawal criteria|9|||
155680646|NCT00978380|561921664|FG000|Overall Study|Unclassified|8|||
155680647|NCT02199314|561921665|FG000|Overall Study|Withdrawal by Subject|6|||
155680648|NCT02199314|561921665|FG000|Overall Study|Physician Decision|10|||
155680649|NCT01110330|561921670|FG000|Overall Study|Adverse Event|0|||
155680650|NCT01110330|561921671|FG001|Overall Study|Adverse Event|4|||
155680651|NCT01110330|561921672|FG002|Overall Study|Adverse Event|3|||
155680652|NCT01110330|561921670|FG000|Overall Study|Lack of Efficacy|3|||
155680653|NCT01110330|561921671|FG001|Overall Study|Lack of Efficacy|1|||
155680654|NCT01110330|561921672|FG002|Overall Study|Lack of Efficacy|1|||
155680655|NCT01110330|561921670|FG000|Overall Study|Lost to Follow-up|9|||
155680656|NCT01110330|561921671|FG001|Overall Study|Lost to Follow-up|10|||
155680657|NCT01110330|561921672|FG002|Overall Study|Lost to Follow-up|15|||
155680658|NCT01110330|561921670|FG000|Overall Study|Physician Decision|0|||
155680659|NCT01110330|561921671|FG001|Overall Study|Physician Decision|1|||
155680660|NCT01110330|561921672|FG002|Overall Study|Physician Decision|0|||
155680661|NCT01110330|561921670|FG000|Overall Study|Protocol Violation|2|||
155680662|NCT01110330|561921671|FG001|Overall Study|Protocol Violation|0|||
155680663|NCT01110330|561921672|FG002|Overall Study|Protocol Violation|4|||
155680664|NCT01110330|561921670|FG000|Overall Study|Withdrawal by Subject|0|||
155680665|NCT01110330|561921671|FG001|Overall Study|Withdrawal by Subject|6|||
155680666|NCT01110330|561921672|FG002|Overall Study|Withdrawal by Subject|2|||
155680667|NCT01110330|561921670|FG000|Overall Study|Other|1|||
155680668|NCT01110330|561921671|FG001|Overall Study|Other|1|||
155680669|NCT01110330|561921672|FG002|Overall Study|Other|1|||
155680670|NCT01089413|561921679|FG000|Overall Study|Lost to Follow-up|1|||
155680671|NCT01089413|561921679|FG000|Overall Study|Progressive Disease|93|||
155680672|NCT01089413|561921679|FG000|Overall Study|Participant Withdrew Consent|1|||
155680673|NCT01089413|561921679|FG000|Overall Study|Unacceptable Toxicity|12|||
155680674|NCT01089413|561921679|FG000|Overall Study|Death|10|||
155680675|NCT01089413|561921679|FG000|Overall Study|Metastasectomy|13|||
155680676|NCT01089413|561921679|FG000|Overall Study|Other|71|||
155680677|NCT02513485|561921680|FG000|Overall Study|Adverse Event|1|||
155680678|NCT02513485|561921681|FG001|Overall Study|Adverse Event|0|||
155680679|NCT00394251|561921689|FG000|Overall Study|Adverse Event|7|||
155680680|NCT00394251|561921690|FG001|Overall Study|Adverse Event|5|||
155680681|NCT00394251|561921689|FG000|Overall Study|Unacceptable Toxicity|20|||
155680682|NCT00394251|561921690|FG001|Overall Study|Unacceptable Toxicity|18|||
155680683|NCT00394251|561921689|FG000|Overall Study|Physician Decision|1|||
155680684|NCT00394251|561921690|FG001|Overall Study|Physician Decision|1|||
155680685|NCT00394251|561921689|FG000|Overall Study|Protocol Violation|0|||
155680686|NCT00394251|561921690|FG001|Overall Study|Protocol Violation|1|||
155680687|NCT00394251|561921689|FG000|Overall Study|Withdrawal by Subject|7|||
155680688|NCT00394251|561921690|FG001|Overall Study|Withdrawal by Subject|11|||
155680689|NCT00394251|561921689|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
155680690|NCT00394251|561921690|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
155680691|NCT03350035|561921691|FG000|Overall Study|Lack of Efficacy|2|||
155680692|NCT03350035|561921692|FG001|Overall Study|Lack of Efficacy|0|||
155680693|NCT03350035|561921693|FG002|Overall Study|Lack of Efficacy|0|||
155680694|NCT03350035|561921691|FG000|Overall Study|Subject discharged to hospice|0|||
155680695|NCT03350035|561921692|FG001|Overall Study|Subject discharged to hospice|0|||
155680696|NCT03350035|561921693|FG002|Overall Study|Subject discharged to hospice|1|||
155680697|NCT01610557|561921694|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155680698|NCT01610557|561921695|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
155680699|NCT01610557|561921696|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155680700|NCT01610557|561921697|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155680701|NCT01610557|561921698|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155680702|NCT01610557|561921694|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155680703|NCT01610557|561921695|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155680704|NCT01610557|561921696|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155680705|NCT01610557|561921697|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155680706|NCT01610557|561921698|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
155680707|NCT03215758|561921704|FG000|Overall Study|Technical Problems|1|||
155680708|NCT03215758|561921705|FG001|Overall Study|Technical Problems|0|||
155680709|NCT03215758|561921704|FG000|Overall Study|Protocol deviation|0|||
155680710|NCT03215758|561921705|FG001|Overall Study|Protocol deviation|1|||
155680711|NCT03215758|561921704|FG000|Overall Study|Physician Decision|0|||
155680712|NCT03215758|561921705|FG001|Overall Study|Physician Decision|1|||
155680713|NCT03215758|561921704|FG000|Overall Study|Death|0|||
155680714|NCT03215758|561921705|FG001|Overall Study|Death|1|||
155680715|NCT03215758|561921704|FG000|Overall Study|Adverse Event|1|||
155680716|NCT03215758|561921705|FG001|Overall Study|Adverse Event|2|||
155680717|NCT03215758|561921704|FG000|Overall Study|Subject/Guardian Decision|3|||
155680718|NCT03215758|561921705|FG001|Overall Study|Subject/Guardian Decision|3|||
155680719|NCT04115748|561921706|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
155680720|NCT04115748|561921707|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
155680721|NCT04115748|561921708|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
155680722|NCT04115748|561921709|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
155680723|NCT04115748|561921710|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680724|NCT04115748|561921711|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680725|NCT04115748|561921712|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680726|NCT04115748|561921713|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680727|NCT04115748|561921714|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680728|NCT04115748|561921715|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155680729|NCT04115748|561921706|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680730|NCT04115748|561921707|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680731|NCT04115748|561921708|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680732|NCT04115748|561921709|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
155680733|NCT04115748|561921710|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680734|NCT04115748|561921711|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680735|NCT04115748|561921712|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680736|NCT04115748|561921713|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680737|NCT04115748|561921714|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680738|NCT04115748|561921715|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155680739|NCT04115748|561921706|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155680740|NCT04115748|561921707|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155680741|NCT04115748|561921708|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155680742|NCT04115748|561921709|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155680743|NCT04115748|561921710|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
155680744|NCT04115748|561921711|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
155680745|NCT04115748|561921712|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155680746|NCT04115748|561921713|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155680747|NCT04115748|561921714|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155680748|NCT04115748|561921715|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
155680749|NCT04115748|561921706|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680750|NCT04115748|561921707|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680751|NCT04115748|561921708|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680752|NCT04115748|561921709|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680753|NCT04115748|561921710|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680754|NCT04115748|561921711|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680755|NCT04115748|561921712|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680756|NCT04115748|561921713|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680757|NCT04115748|561921714|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
155680758|NCT04115748|561921715|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155680759|NCT00713349|561921716|FG000|Overall Study|Protocol Violation|1|||
155680760|NCT01200407|561921717|FG000|Overall Study|Lost to Follow-up|56|||
155680761|NCT01200407|561921717|FG000|Overall Study|Adverse Event|3|||
155680762|NCT01200407|561921717|FG000|Overall Study|Withdrawal by Subject|4|||
155680763|NCT01200407|561921717|FG000|Overall Study|Other|19|||
155680764|NCT00365105|561921718|FG000|Overall Study|Protocol Violation|5|||
155680765|NCT00365105|561921719|FG001|Overall Study|Protocol Violation|8|||
155680766|NCT06004895|561921720|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
155680767|NCT06004895|561921720|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
155680768|NCT00425698|561921721|FG000|Overall Study|Adverse Event|3|||
155680769|NCT00425698|561921722|FG001|Overall Study|Adverse Event|1|||
155680770|NCT00425698|561921721|FG000|Overall Study|Withdrawal by Subject|0|||
155680771|NCT00425698|561921722|FG001|Overall Study|Withdrawal by Subject|1|||
155680772|NCT01328535|561921723|FG000|Overall Study|Ineligible|1|||
155680773|NCT01257230|561921724|FG000|Overall Study|Not Treated|0|||
155680774|NCT01257230|561921725|FG001|Overall Study|Not Treated|0|||
155680775|NCT01257230|561921726|FG002|Overall Study|Not Treated|1|||
155680776|NCT01257230|561921724|FG000|Overall Study|Adverse Event|2|||
155680777|NCT01257230|561921725|FG001|Overall Study|Adverse Event|0|||
155680778|NCT01257230|561921726|FG002|Overall Study|Adverse Event|0|||
155680779|NCT01257230|561921724|FG000|Overall Study|Lack of Efficacy|0|||
155680780|NCT01257230|561921725|FG001|Overall Study|Lack of Efficacy|1|||
155680781|NCT01257230|561921726|FG002|Overall Study|Lack of Efficacy|0|||
155680782|NCT01257230|561921724|FG000|Overall Study|Protocol Violation|3|||
155680783|NCT01257230|561921725|FG001|Overall Study|Protocol Violation|0|||
155680784|NCT01257230|561921726|FG002|Overall Study|Protocol Violation|1|||
155680785|NCT01257230|561921724|FG000|Overall Study|Withdrawal by Subject|0|||
155680786|NCT01257230|561921725|FG001|Overall Study|Withdrawal by Subject|4|||
155680787|NCT01257230|561921726|FG002|Overall Study|Withdrawal by Subject|1|||
155680788|NCT01257230|561921724|FG000|Overall Study|Other reason not defined above|1|||
155680789|NCT01257230|561921725|FG001|Overall Study|Other reason not defined above|5|||
155680790|NCT01257230|561921726|FG002|Overall Study|Other reason not defined above|3|||
155680791|NCT01205061|561921734|FG000|Overall Study|Adverse Event|4|||
155680792|NCT01205061|561921734|FG000|Overall Study|Withdrawal by Subject|11|||
155680793|NCT01205061|561921734|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
155680794|NCT01205061|561921734|FG000|Overall Study|Lost to Follow-up|9|||
155680795|NCT01205061|561921734|FG000|Overall Study|Other|1|||
155680796|NCT01988662|561921739|FG000|Overall Study|Subject/guardian decision|1|||
155680797|NCT01988662|561921740|FG001|Overall Study|Subject/guardian decision|1|||
155680798|NCT01988662|561921739|FG000|Overall Study|Adverse Event|3|||
155680799|NCT01988662|561921740|FG001|Overall Study|Adverse Event|1|||
155680800|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
155680801|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
155680802|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
155680803|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
155680804|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155680805|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155680806|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155680807|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155680808|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
155680809|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
155680810|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
155680811|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
155680812|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
155680813|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
155680814|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
155680815|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
155680816|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
155680817|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680818|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680819|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680820|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680821|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680822|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680823|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680824|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680825|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680826|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680827|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680828|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680829|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155680830|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
155680831|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
155680832|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
155680833|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
155680834|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
155680835|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
155680836|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
155680837|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
155680838|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
155680839|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
155680840|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
155680841|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
155680842|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
155680843|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
155680844|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
155680845|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
155680846|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
155680847|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
155680848|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
155680849|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
155680850|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
155680851|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
155680852|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
155680853|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
155680854|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
155680855|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
155680856|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
155680857|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
155680858|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
155680859|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
155680860|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
155680861|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155680862|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
155680863|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
155680864|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680865|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680866|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680867|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680868|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680869|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680870|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680871|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680872|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680873|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680874|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155680875|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
155680876|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
155680877|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
155680878|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
155680879|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680880|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680881|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680882|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680883|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680884|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680885|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680886|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680887|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680888|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680889|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155680890|NCT03831191|561921742|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680891|NCT03831191|561921743|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680892|NCT03831191|561921744|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680893|NCT03831191|561921745|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
155680894|NCT03831191|561921746|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680895|NCT03831191|561921747|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680896|NCT03831191|561921748|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680897|NCT03831191|561921749|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680898|NCT03831191|561921750|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680899|NCT03831191|561921751|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680900|NCT03831191|561921752|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680901|NCT03831191|561921753|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680902|NCT03831191|561921754|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680903|NCT03831191|561921755|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680904|NCT03831191|561921756|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
155680905|NCT03831191|561921742|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155680906|NCT03831191|561921743|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155680907|NCT03831191|561921744|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155680908|NCT03831191|561921745|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155680909|NCT03831191|561921746|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155680910|NCT03831191|561921747|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
155680911|NCT03831191|561921748|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
155680912|NCT03831191|561921749|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155680913|NCT03831191|561921750|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
155680914|NCT03831191|561921751|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155680915|NCT03831191|561921752|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155680916|NCT03831191|561921753|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
155680917|NCT03831191|561921754|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155680918|NCT03831191|561921755|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155680919|NCT03831191|561921756|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
155680920|NCT03831191|561921742|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680921|NCT03831191|561921743|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680922|NCT03831191|561921744|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680923|NCT03831191|561921745|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680924|NCT03831191|561921746|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680925|NCT03831191|561921747|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680926|NCT03831191|561921748|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680927|NCT03831191|561921749|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680928|NCT03831191|561921750|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680929|NCT03831191|561921751|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680930|NCT03831191|561921752|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680931|NCT03831191|561921753|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680932|NCT03831191|561921754|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680933|NCT03831191|561921755|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155680934|NCT03831191|561921756|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155680935|NCT03831191|561921742|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680936|NCT03831191|561921743|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680937|NCT03831191|561921744|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680938|NCT03831191|561921745|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680939|NCT03831191|561921746|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680940|NCT03831191|561921747|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680941|NCT03831191|561921748|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680942|NCT03831191|561921749|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680943|NCT03831191|561921750|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680944|NCT03831191|561921751|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680945|NCT03831191|561921752|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680946|NCT03831191|561921753|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680947|NCT03831191|561921754|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155603263|NCT01432275|561635475|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
155603264|NCT01432275|561635474|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
155603265|NCT01432275|561635475|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
155603266|NCT01432275|561635474|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
155603267|NCT01432275|561635475|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
155603268|NCT00096993|561635478|FG000|Overall Study|Death|1|||
155603269|NCT00096993|561635479|FG001|Overall Study|Death|0|||
155603270|NCT00096993|561635478|FG000|Overall Study|Disease progression|56|||
155603271|NCT00096993|561635479|FG001|Overall Study|Disease progression|53|||
155603272|NCT00096993|561635478|FG000|Overall Study|Adverse Event|2|||
155603273|NCT00096993|561635479|FG001|Overall Study|Adverse Event|8|||
155603274|NCT00096993|561635478|FG000|Overall Study|Subject's decision|3|||
155603275|NCT00096993|561635479|FG001|Overall Study|Subject's decision|1|||
155603276|NCT00096993|561635478|FG000|Overall Study|Physician Decision|2|||
155603277|NCT00096993|561635479|FG001|Overall Study|Physician Decision|1|||
155603278|NCT00096993|561635478|FG000|Overall Study|Non-compliance|0|||
155603279|NCT00096993|561635479|FG001|Overall Study|Non-compliance|1|||
155603280|NCT00096993|561635478|FG000|Overall Study|Other unspecified|1|||
155603281|NCT00096993|561635479|FG001|Overall Study|Other unspecified|1|||
155603282|NCT01440569|561635483|FG000|Main Study|Enrolled but not treated|1|||
155603283|NCT01440569|561635484|FG001|Main Study|Enrolled but not treated|0|||
155603284|NCT01440569|561635483|FG000|Main Study|Adverse Event|9|||
155603285|NCT01440569|561635484|FG001|Main Study|Adverse Event|0|||
155603286|NCT01440569|561635483|FG000|Main Study|Pregnancy|1|||
155603287|NCT01440569|561635484|FG001|Main Study|Pregnancy|0|||
155603288|NCT01440569|561635483|FG000|Main Study|Investigator's Discretion|1|||
155603289|NCT01440569|561635484|FG001|Main Study|Investigator's Discretion|1|||
155603290|NCT01440569|561635483|FG000|Main Study|Withdrew Consent|7|||
155603291|NCT01440569|561635484|FG001|Main Study|Withdrew Consent|1|||
155603292|NCT01440569|561635483|FG000|Main Study|Lost to Follow-up|13|||
155603293|NCT01440569|561635484|FG001|Main Study|Lost to Follow-up|2|||
155603294|NCT01440569|561635483|FG000|Main Study|Subject Non-Compliance|3|||
155603295|NCT01440569|561635484|FG001|Main Study|Subject Non-Compliance|0|||
155603296|NCT01440569|561635483|FG000|Main Study|Protocol Violation|1|||
155603297|NCT01440569|561635484|FG001|Main Study|Protocol Violation|0|||
155603298|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Adverse Event|3|||
155603299|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Adverse Event|0|||
155603300|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Pregnancy|1|||
155603301|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Pregnancy|0|||
155603302|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
155603303|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
155603304|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
155603305|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
155603306|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
155603307|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
155603308|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
155603309|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
155603310|NCT01440569|561635483|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
155603311|NCT01440569|561635484|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
155603312|NCT01438814|561635486|FG000|Overall Study|Adverse Event|3|||
155603313|NCT01438814|561635487|FG001|Overall Study|Adverse Event|3|||
155603314|NCT01438814|561635486|FG000|Overall Study|Protocol Violation|1|||
155603315|NCT01438814|561635487|FG001|Overall Study|Protocol Violation|2|||
155603316|NCT01438814|561635486|FG000|Overall Study|Lost to Follow-up|4|||
155603317|NCT01438814|561635487|FG001|Overall Study|Lost to Follow-up|3|||
155603318|NCT01438814|561635486|FG000|Overall Study|Withdrawal by Subject|4|||
155603319|NCT01438814|561635487|FG001|Overall Study|Withdrawal by Subject|2|||
155603320|NCT01438814|561635486|FG000|Overall Study|Other|2|||
155603321|NCT01438814|561635487|FG001|Overall Study|Other|4|||
155603322|NCT02584959|561635488|FG000|Period 1|Withdrawn from study|3|||
155603323|NCT02584959|561635489|FG001|Period 1|Withdrawn from study|4|||
155603324|NCT02584959|561635490|FG002|Period 1|Withdrawn from study|0|||
155603325|NCT02584959|561635488|FG000|Period 2|Withdrawn from study|6|||
155603326|NCT02584959|561635489|FG001|Period 2|Withdrawn from study|1|||
155603327|NCT02584959|561635490|FG002|Period 2|Withdrawn from study|2|||
155603328|NCT00195494|561635493|FG000|Year 1|Adverse Event|0|||
155603329|NCT00195494|561635494|FG001|Year 1|Adverse Event|0|||
155603330|NCT00195494|561635495|FG002|Year 1|Adverse Event|0|||
155603331|NCT00195494|561635496|FG003|Year 1|Adverse Event|0|||
155603332|NCT00195494|561635497|FG004|Year 1|Adverse Event|34|||
155603333|NCT00195494|561635498|FG005|Year 1|Adverse Event|27|||
155603334|NCT00195494|561635493|FG000|Year 1|System Toxicity|0|||
155603335|NCT00195494|561635494|FG001|Year 1|System Toxicity|0|||
155603336|NCT00195494|561635495|FG002|Year 1|System Toxicity|0|||
155603337|NCT00195494|561635496|FG003|Year 1|System Toxicity|0|||
155603338|NCT00195494|561635497|FG004|Year 1|System Toxicity|0|||
155603339|NCT00195494|561635498|FG005|Year 1|System Toxicity|1|||
155603340|NCT00195494|561635493|FG000|Year 1|Lack of Efficacy|0|||
155603341|NCT00195494|561635494|FG001|Year 1|Lack of Efficacy|0|||
155603342|NCT00195494|561635495|FG002|Year 1|Lack of Efficacy|0|||
155680948|NCT03831191|561921755|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155680949|NCT03831191|561921756|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
155680950|NCT03748706|561921757|FG000|Overall Study|Lost to Follow-up|1|||
155680951|NCT00695955|561921760|FG000|Cohort 1|Adverse Event|26|||
155680952|NCT00695955|561921760|FG000|Cohort 1|Protocol Violation|2|||
155680953|NCT00695955|561921760|FG000|Cohort 1|Lost to Follow-up|30|||
155680954|NCT00695955|561921760|FG000|Cohort 1|Withdrawal by Subject|25|||
155680955|NCT00695955|561921760|FG000|Cohort 1|Lack of Efficacy|3|||
155680956|NCT00695955|561921760|FG000|Cohort 1|Other|16|||
155680957|NCT00695955|561921760|FG000|Cohort 2|Adverse Event|24|||
155680958|NCT00695955|561921760|FG000|Cohort 2|Protocol Violation|5|||
155680959|NCT00695955|561921760|FG000|Cohort 2|Lost to Follow-up|38|||
155680960|NCT00695955|561921760|FG000|Cohort 2|Withdrawal by Subject|28|||
155680961|NCT00695955|561921760|FG000|Cohort 2|Lack of Efficacy|4|||
155680962|NCT00695955|561921760|FG000|Cohort 2|Other|5|||
155680963|NCT03655054|561921763|FG000|Overall Study|Lost to Follow-up|1|||
155680964|NCT01626118|561921764|FG000|Overall Study|Lack of Efficacy|1|||
155680965|NCT01626118|561921765|FG001|Overall Study|Lack of Efficacy|0|||
155680966|NCT01626118|561921766|FG002|Overall Study|Lack of Efficacy|1|||
155680967|NCT01626118|561921767|FG003|Overall Study|Lack of Efficacy|3|||
155680968|NCT01626118|561921764|FG000|Overall Study|Lost to Follow-up|1|||
155680969|NCT01626118|561921765|FG001|Overall Study|Lost to Follow-up|0|||
155680970|NCT01626118|561921766|FG002|Overall Study|Lost to Follow-up|0|||
155680971|NCT01626118|561921767|FG003|Overall Study|Lost to Follow-up|0|||
155680972|NCT01626118|561921764|FG000|Overall Study|Adverse Event|0|||
155680973|NCT01626118|561921765|FG001|Overall Study|Adverse Event|1|||
155680974|NCT01626118|561921766|FG002|Overall Study|Adverse Event|1|||
155680975|NCT01626118|561921767|FG003|Overall Study|Adverse Event|0|||
155680976|NCT01626118|561921764|FG000|Overall Study|Investigator Decision|0|||
155680977|NCT01626118|561921765|FG001|Overall Study|Investigator Decision|1|||
155680978|NCT01626118|561921766|FG002|Overall Study|Investigator Decision|0|||
155680979|NCT01626118|561921767|FG003|Overall Study|Investigator Decision|0|||
155680980|NCT03931382|561921769|FG000|Overall Study|Equipment malfunction|2|||
155680981|NCT03931382|561921770|FG001|Overall Study|Equipment malfunction|0|||
155680982|NCT03931382|561921771|FG002|Overall Study|Equipment malfunction|2|||
155680983|NCT03931382|561921769|FG000|Overall Study|Withdrawal by Subject|0|||
155680984|NCT03931382|561921770|FG001|Overall Study|Withdrawal by Subject|1|||
155680985|NCT03931382|561921771|FG002|Overall Study|Withdrawal by Subject|0|||
155680986|NCT01864148|561921773|FG000|Overall Study|Other|2|||
155680987|NCT01864148|561921774|FG001|Overall Study|Other|1|||
155680988|NCT01864148|561921775|FG002|Overall Study|Other|1|||
155680989|NCT01864148|561921776|FG003|Overall Study|Other|3|||
155680990|NCT01864148|561921777|FG004|Overall Study|Other|1|||
155680991|NCT01864148|561921773|FG000|Overall Study|Death|0|||
155680992|NCT01864148|561921774|FG001|Overall Study|Death|0|||
155680993|NCT01864148|561921775|FG002|Overall Study|Death|0|||
155680994|NCT01864148|561921776|FG003|Overall Study|Death|1|||
155680995|NCT01864148|561921777|FG004|Overall Study|Death|0|||
155680996|NCT01864148|561921773|FG000|Overall Study|Investigator Decision|5|||
155680997|NCT01864148|561921774|FG001|Overall Study|Investigator Decision|0|||
155680998|NCT01864148|561921775|FG002|Overall Study|Investigator Decision|0|||
155680999|NCT01864148|561921776|FG003|Overall Study|Investigator Decision|4|||
155681000|NCT01864148|561921777|FG004|Overall Study|Investigator Decision|6|||
155681001|NCT01864148|561921773|FG000|Overall Study|Withdrawal by Subject|9|||
155681002|NCT01864148|561921774|FG001|Overall Study|Withdrawal by Subject|2|||
155681003|NCT01864148|561921775|FG002|Overall Study|Withdrawal by Subject|6|||
155681004|NCT01864148|561921776|FG003|Overall Study|Withdrawal by Subject|8|||
155681005|NCT01864148|561921777|FG004|Overall Study|Withdrawal by Subject|8|||
155681006|NCT01864148|561921773|FG000|Overall Study|Lost to Follow-up|0|||
155681007|NCT01864148|561921774|FG001|Overall Study|Lost to Follow-up|0|||
155681008|NCT01864148|561921775|FG002|Overall Study|Lost to Follow-up|0|||
155681009|NCT01864148|561921776|FG003|Overall Study|Lost to Follow-up|2|||
155681010|NCT01864148|561921777|FG004|Overall Study|Lost to Follow-up|1|||
155681011|NCT01864148|561921773|FG000|Overall Study|Adverse Event|4|||
155681012|NCT01864148|561921774|FG001|Overall Study|Adverse Event|2|||
155681013|NCT01864148|561921775|FG002|Overall Study|Adverse Event|4|||
155681014|NCT01864148|561921776|FG003|Overall Study|Adverse Event|7|||
155681015|NCT01864148|561921777|FG004|Overall Study|Adverse Event|7|||
155681016|NCT01864148|561921773|FG000|Overall Study|Not Dosed|0|||
155681017|NCT01864148|561921774|FG001|Overall Study|Not Dosed|0|||
155681018|NCT01864148|561921775|FG002|Overall Study|Not Dosed|0|||
155681019|NCT01864148|561921776|FG003|Overall Study|Not Dosed|1|||
155681020|NCT01864148|561921777|FG004|Overall Study|Not Dosed|0|||
155681021|NCT01500252|561921782|FG000|Overall Study|Death|4|||
155681022|NCT01500252|561921783|FG001|Overall Study|Death|2|||
155681023|NCT01500252|561921782|FG000|Overall Study|Lost to Follow-up|5|||
155681024|NCT01500252|561921783|FG001|Overall Study|Lost to Follow-up|4|||
155681025|NCT03490292|561921784|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
155681026|NCT03490292|561921785|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
155681027|NCT03490292|561921784|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
155681028|NCT03490292|561921785|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
155681029|NCT03490292|561921784|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
155681030|NCT03490292|561921785|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
155681031|NCT03490292|561921784|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
155681032|NCT03490292|561921785|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
155681033|NCT03490292|561921784|FG000|1 Year Follow Up Post Last Dose|Death|1|||
155681034|NCT03490292|561921785|FG001|1 Year Follow Up Post Last Dose|Death|1|||
155681035|NCT01106651|561921786|FG000|Overall Study|Adverse Event|17|||
155681036|NCT01106651|561921787|FG001|Overall Study|Adverse Event|9|||
155681037|NCT01106651|561921788|FG002|Overall Study|Adverse Event|23|||
155681038|NCT01106651|561921786|FG000|Overall Study|Lost to Follow-up|8|||
155681039|NCT01106651|561921787|FG001|Overall Study|Lost to Follow-up|2|||
155681040|NCT01106651|561921788|FG002|Overall Study|Lost to Follow-up|6|||
155681041|NCT01106651|561921786|FG000|Overall Study|Physician Decision|4|||
155681042|NCT01106651|561921787|FG001|Overall Study|Physician Decision|3|||
155681043|NCT01106651|561921788|FG002|Overall Study|Physician Decision|1|||
155681044|NCT01106651|561921786|FG000|Overall Study|Protocol Violation|1|||
155681045|NCT01106651|561921787|FG001|Overall Study|Protocol Violation|2|||
155681046|NCT01106651|561921788|FG002|Overall Study|Protocol Violation|1|||
155681047|NCT01106651|561921786|FG000|Overall Study|Withdrawal by Subject|14|||
155681048|NCT01106651|561921787|FG001|Overall Study|Withdrawal by Subject|7|||
155681049|NCT01106651|561921788|FG002|Overall Study|Withdrawal by Subject|4|||
155681050|NCT01106651|561921786|FG000|Overall Study|Noncompliance with study drug|1|||
155681051|NCT01106651|561921787|FG001|Overall Study|Noncompliance with study drug|0|||
155681052|NCT01106651|561921788|FG002|Overall Study|Noncompliance with study drug|2|||
155681053|NCT01106651|561921786|FG000|Overall Study|Other|34|||
155681054|NCT01106651|561921787|FG001|Overall Study|Other|31|||
155681055|NCT01106651|561921788|FG002|Overall Study|Other|21|||
155681056|NCT01106651|561921786|FG000|Overall Study|Death|0|||
155681057|NCT01106651|561921787|FG001|Overall Study|Death|3|||
155681058|NCT01106651|561921788|FG002|Overall Study|Death|0|||
155681059|NCT00673231|561921793|FG000|Overall Study|Withdrawal by Subject|14|||
155681060|NCT00673231|561921794|FG001|Overall Study|Withdrawal by Subject|10|||
155681061|NCT00673231|561921795|FG002|Overall Study|Withdrawal by Subject|8|||
155681062|NCT00673231|561921796|FG003|Overall Study|Withdrawal by Subject|6|||
155681063|NCT00673231|561921793|FG000|Overall Study|Adverse Event|6|||
155681064|NCT00673231|561921794|FG001|Overall Study|Adverse Event|5|||
155681065|NCT00673231|561921795|FG002|Overall Study|Adverse Event|9|||
155681066|NCT00673231|561921796|FG003|Overall Study|Adverse Event|6|||
155681067|NCT00673231|561921793|FG000|Overall Study|Lost to Follow-up|1|||
155681068|NCT00673231|561921794|FG001|Overall Study|Lost to Follow-up|2|||
155681069|NCT00673231|561921795|FG002|Overall Study|Lost to Follow-up|1|||
155681070|NCT00673231|561921796|FG003|Overall Study|Lost to Follow-up|2|||
155681071|NCT00673231|561921793|FG000|Overall Study|Death|0|||
155681072|NCT00673231|561921794|FG001|Overall Study|Death|0|||
155681073|NCT00673231|561921795|FG002|Overall Study|Death|1|||
155681074|NCT00673231|561921796|FG003|Overall Study|Death|0|||
155681075|NCT00673231|561921793|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
155681076|NCT00673231|561921794|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
155681077|NCT00673231|561921795|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
155681078|NCT00673231|561921796|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
155681079|NCT02952313|561921797|FG000|Primary Endpoint|Lost to Follow-up|4|||
155681080|NCT02952313|561921797|FG000|Primary Endpoint|Withdrawal by Subject|1|||
155681081|NCT02952313|561921797|FG000|Primary Endpoint|Lack of Efficacy|1|||
155681082|NCT02952313|561921797|FG000|Primary Endpoint|Missed visit|1|||
155681083|NCT02952313|561921797|FG000|Long-term Follow-up|Lost to Follow-up|12|||
155681084|NCT02952313|561921797|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
155681085|NCT02952313|561921797|FG000|Long-term Follow-up|Lack of Efficacy|6|||
155681086|NCT02952313|561921797|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
155681087|NCT02952313|561921797|FG000|Long-term Follow-up|Physician Decision|1|||
155681088|NCT02952313|561921797|FG000|Long-term Follow-up|Death|1|||
155681089|NCT02791516|561921802|FG000|Overall Study|Withdrawal by Subject|1|||
155681090|NCT02791516|561921803|FG001|Overall Study|Withdrawal by Subject|1|||
155681091|NCT02524275|561921804|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
155681092|NCT00511433|561923673|FG000|Overall Study|Adverse Event|5|||
155681093|NCT00511433|561923674|FG001|Overall Study|Adverse Event|0|||
155681094|NCT00511433|561923673|FG000|Overall Study|Other Reason|1|||
155681095|NCT00511433|561923674|FG001|Overall Study|Other Reason|1|||
155681096|NCT03764631|561923680|FG000|Overall Study|Personal Reasons|3|||
155681097|NCT03764631|561923681|FG001|Overall Study|Personal Reasons|2|||
155681098|NCT03764631|561923680|FG000|Overall Study|Switching Therapy|3|||
155681099|NCT03764631|561923681|FG001|Overall Study|Switching Therapy|3|||
155681100|NCT03764631|561923680|FG000|Overall Study|Adverse Event|0|||
155681101|NCT03764631|561923681|FG001|Overall Study|Adverse Event|1|||
155681102|NCT03764631|561923680|FG000|Overall Study|Lost to Follow-up|33|||
155681103|NCT03764631|561923681|FG001|Overall Study|Lost to Follow-up|41|||
155681104|NCT03764631|561923680|FG000|Overall Study|No data as study site was closed|2|||
155681105|NCT03764631|561923681|FG001|Overall Study|No data as study site was closed|6|||
155681106|NCT01289353|561923682|FG000|Overall Study|Lost to Follow-up|2|||
155681107|NCT01549886|561923683|FG000|Overall Study|Sponsor's decision|2|||
155681108|NCT01549886|561923684|FG001|Overall Study|Sponsor's decision|3|||
155681109|NCT01466660|561923692|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
155681110|NCT01466660|561923693|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
155681111|NCT01466660|561923692|FG000|Overall Study|Worsening of underlying cancer disease|5|||
155681112|NCT01466660|561923693|FG001|Overall Study|Worsening of underlying cancer disease|2|||
155681113|NCT01466660|561923692|FG000|Overall Study|Other adverse event|19|||
155681114|NCT01466660|561923693|FG001|Overall Study|Other adverse event|18|||
155681115|NCT01466660|561923692|FG000|Overall Study|Protocol Violation|2|||
155681116|NCT01466660|561923693|FG001|Overall Study|Protocol Violation|1|||
155681117|NCT01466660|561923692|FG000|Overall Study|Refused continuation of trial medication|4|||
155681118|NCT01466660|561923693|FG001|Overall Study|Refused continuation of trial medication|3|||
155681119|NCT01466660|561923692|FG000|Overall Study|Other reason not defined above|10|||
155681120|NCT01466660|561923693|FG001|Overall Study|Other reason not defined above|8|||
155681121|NCT03576066|561923694|FG000|Overall Study|Noncompliance with study drug|0|||
155681122|NCT03576066|561923695|FG001|Overall Study|Noncompliance with study drug|1|||
155681123|NCT01126268|561923698|FG000|Overall Study|Adverse Event|1|||
155681124|NCT03425006|561923699|FG000|Overall Study|Withdrawal by Subject|1|||
155681125|NCT03425006|561923699|FG000|Overall Study|Physician Decision|1|||
155681126|NCT03425006|561923699|FG000|Overall Study|Death|1|||
155681127|NCT03070171|561923707|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
155681128|NCT03070171|561923708|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
155681129|NCT03070171|561923707|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
155681130|NCT03070171|561923708|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
155681131|NCT03768089|561923712|FG000|Part A|Lost to Follow-up|0|||
155681132|NCT03768089|561923713|FG001|Part A|Lost to Follow-up|0|||
155681133|NCT03768089|561923714|FG002|Part A|Lost to Follow-up|0|||
155681134|NCT03768089|561923715|FG003|Part A|Lost to Follow-up|0|||
155681135|NCT03768089|561923716|FG004|Part A|Lost to Follow-up|1|||
155681136|NCT03768089|561923717|FG005|Part A|Lost to Follow-up|0|||
155681137|NCT03768089|561923718|FG006|Part A|Lost to Follow-up|0|||
155681138|NCT03768089|561923719|FG007|Part A|Lost to Follow-up|0|||
155681139|NCT03768089|561923720|FG008|Part A|Lost to Follow-up|0|||
155681140|NCT03768089|561923721|FG009|Part A|Lost to Follow-up|0|||
155681141|NCT03768089|561923722|FG010|Part A|Lost to Follow-up|0|||
155681142|NCT03768089|561923723|FG011|Part A|Lost to Follow-up|0|||
155681143|NCT03768089|561923724|FG012|Part A|Lost to Follow-up|0|||
155681144|NCT03768089|561923725|FG013|Part A|Lost to Follow-up|0|||
155681145|NCT03768089|561923726|FG014|Part A|Lost to Follow-up|0|||
155681146|NCT03768089|561923727|FG015|Part A|Lost to Follow-up|0|||
155681147|NCT03768089|561923728|FG016|Part A|Lost to Follow-up|0|||
155681148|NCT03768089|561923729|FG017|Part A|Lost to Follow-up|0|||
155681149|NCT03768089|561923712|FG000|Part C|Randomized, Never Dosed|0|||
155681150|NCT03768089|561923713|FG001|Part C|Randomized, Never Dosed|0|||
155681151|NCT03768089|561923714|FG002|Part C|Randomized, Never Dosed|0|||
155681152|NCT03768089|561923715|FG003|Part C|Randomized, Never Dosed|0|||
155681153|NCT03768089|561923716|FG004|Part C|Randomized, Never Dosed|0|||
155681154|NCT03768089|561923717|FG005|Part C|Randomized, Never Dosed|0|||
155681155|NCT03768089|561923718|FG006|Part C|Randomized, Never Dosed|0|||
155681156|NCT03768089|561923719|FG007|Part C|Randomized, Never Dosed|0|||
155681157|NCT03768089|561923720|FG008|Part C|Randomized, Never Dosed|0|||
155681158|NCT03768089|561923721|FG009|Part C|Randomized, Never Dosed|0|||
155681159|NCT03768089|561923722|FG010|Part C|Randomized, Never Dosed|0|||
155681160|NCT03768089|561923723|FG011|Part C|Randomized, Never Dosed|0|||
155681161|NCT03768089|561923724|FG012|Part C|Randomized, Never Dosed|0|||
155681162|NCT03768089|561923725|FG013|Part C|Randomized, Never Dosed|0|||
155681163|NCT03768089|561923726|FG014|Part C|Randomized, Never Dosed|1|||
155681164|NCT03768089|561923727|FG015|Part C|Randomized, Never Dosed|0|||
155681165|NCT03768089|561923728|FG016|Part C|Randomized, Never Dosed|0|||
155681166|NCT03768089|561923729|FG017|Part C|Randomized, Never Dosed|0|||
155681167|NCT00712725|561923730|FG000|Overall Study|Adverse Event|1|||
155681168|NCT00712725|561923731|FG001|Overall Study|Adverse Event|0|||
155681169|NCT00712725|561923732|FG002|Overall Study|Adverse Event|0|||
155681170|NCT00712725|561923733|FG003|Overall Study|Adverse Event|1|||
155681171|NCT00712725|561923734|FG004|Overall Study|Adverse Event|0|||
155681172|NCT00712725|561923735|FG005|Overall Study|Adverse Event|0|||
155681173|NCT00712725|561923736|FG006|Overall Study|Adverse Event|0|||
155681174|NCT00712725|561923737|FG007|Overall Study|Adverse Event|0|||
155681175|NCT00712725|561923730|FG000|Overall Study|Lost to Follow-up|3|||
155681176|NCT00712725|561923731|FG001|Overall Study|Lost to Follow-up|2|||
155681177|NCT00712725|561923732|FG002|Overall Study|Lost to Follow-up|1|||
155681178|NCT00712725|561923733|FG003|Overall Study|Lost to Follow-up|1|||
155681179|NCT00712725|561923734|FG004|Overall Study|Lost to Follow-up|2|||
155681180|NCT00712725|561923735|FG005|Overall Study|Lost to Follow-up|2|||
155681181|NCT00712725|561923736|FG006|Overall Study|Lost to Follow-up|3|||
155681182|NCT00712725|561923737|FG007|Overall Study|Lost to Follow-up|1|||
155681183|NCT00712725|561923730|FG000|Overall Study|Physician Decision|2|||
155681184|NCT00712725|561923731|FG001|Overall Study|Physician Decision|0|||
155681185|NCT00712725|561923732|FG002|Overall Study|Physician Decision|0|||
155681186|NCT00712725|561923733|FG003|Overall Study|Physician Decision|0|||
155681187|NCT00712725|561923734|FG004|Overall Study|Physician Decision|1|||
155681188|NCT00712725|561923735|FG005|Overall Study|Physician Decision|0|||
155681189|NCT00712725|561923736|FG006|Overall Study|Physician Decision|2|||
155681190|NCT00712725|561923737|FG007|Overall Study|Physician Decision|0|||
155681191|NCT00712725|561923730|FG000|Overall Study|Pregnancy|0|||
155681192|NCT00712725|561923731|FG001|Overall Study|Pregnancy|1|||
155681193|NCT00712725|561923732|FG002|Overall Study|Pregnancy|0|||
155681194|NCT00712725|561923733|FG003|Overall Study|Pregnancy|0|||
155681195|NCT00712725|561923734|FG004|Overall Study|Pregnancy|1|||
155681196|NCT00712725|561923735|FG005|Overall Study|Pregnancy|0|||
155681197|NCT00712725|561923736|FG006|Overall Study|Pregnancy|2|||
155681198|NCT00712725|561923737|FG007|Overall Study|Pregnancy|0|||
155681199|NCT00712725|561923730|FG000|Overall Study|Protocol Violation|2|||
155681200|NCT00712725|561923731|FG001|Overall Study|Protocol Violation|0|||
155681201|NCT00712725|561923732|FG002|Overall Study|Protocol Violation|1|||
155681202|NCT00712725|561923733|FG003|Overall Study|Protocol Violation|3|||
155681203|NCT00712725|561923734|FG004|Overall Study|Protocol Violation|2|||
155681204|NCT00712725|561923735|FG005|Overall Study|Protocol Violation|0|||
155681205|NCT00712725|561923736|FG006|Overall Study|Protocol Violation|1|||
155681206|NCT00712725|561923737|FG007|Overall Study|Protocol Violation|1|||
155681207|NCT00712725|561923730|FG000|Overall Study|Withdrawal by Subject|2|||
155681208|NCT00712725|561923731|FG001|Overall Study|Withdrawal by Subject|1|||
155681209|NCT00712725|561923732|FG002|Overall Study|Withdrawal by Subject|1|||
155681210|NCT00712725|561923733|FG003|Overall Study|Withdrawal by Subject|2|||
155681211|NCT00712725|561923734|FG004|Overall Study|Withdrawal by Subject|1|||
155681212|NCT00712725|561923735|FG005|Overall Study|Withdrawal by Subject|1|||
155681213|NCT00712725|561923736|FG006|Overall Study|Withdrawal by Subject|1|||
155681214|NCT00712725|561923737|FG007|Overall Study|Withdrawal by Subject|2|||
155681215|NCT00712725|561923730|FG000|Overall Study|Lack of Qualifying Event|16|||
155681216|NCT00712725|561923731|FG001|Overall Study|Lack of Qualifying Event|2|||
155681217|NCT00712725|561923732|FG002|Overall Study|Lack of Qualifying Event|6|||
155681218|NCT00712725|561923733|FG003|Overall Study|Lack of Qualifying Event|8|||
155681219|NCT00712725|561923734|FG004|Overall Study|Lack of Qualifying Event|11|||
155681220|NCT00712725|561923735|FG005|Overall Study|Lack of Qualifying Event|13|||
155681221|NCT00712725|561923736|FG006|Overall Study|Lack of Qualifying Event|11|||
155681222|NCT00712725|561923737|FG007|Overall Study|Lack of Qualifying Event|6|||
155681223|NCT00712725|561923730|FG000|Overall Study|Protocol Specified Criteria|3|||
155681224|NCT00712725|561923731|FG001|Overall Study|Protocol Specified Criteria|0|||
155681225|NCT00712725|561923732|FG002|Overall Study|Protocol Specified Criteria|1|||
155681226|NCT00712725|561923733|FG003|Overall Study|Protocol Specified Criteria|2|||
155681227|NCT00712725|561923734|FG004|Overall Study|Protocol Specified Criteria|1|||
155681228|NCT00712725|561923735|FG005|Overall Study|Protocol Specified Criteria|0|||
155681229|NCT00712725|561923736|FG006|Overall Study|Protocol Specified Criteria|2|||
155681230|NCT00712725|561923737|FG007|Overall Study|Protocol Specified Criteria|1|||
155681231|NCT01901289|561923738|FG000|Overall Study|Death|32|||
155681232|NCT01901289|561923738|FG000|Overall Study|Lost to Follow-up|16|||
155681233|NCT01901289|561923738|FG000|Overall Study|Withdrawal by Subject|35|||
155681234|NCT01901289|561923738|FG000|Overall Study|Other type of endpoint met|2|||
155681235|NCT00889603|561923739|FG000|Overall Study|Adverse Event|7|||
155681236|NCT00889603|561923739|FG000|Overall Study|Death|3|||
155681237|NCT00889603|561923739|FG000|Overall Study|Lost to Follow-up|19|||
155681238|NCT00889603|561923739|FG000|Overall Study|No longer willing to participant in stud|4|||
155681239|NCT00889603|561923739|FG000|Overall Study|Other|4|||
155681240|NCT03525600|561923740|FG000|Overall Study|Adverse Event|9|||
155681241|NCT03525600|561923741|FG001|Overall Study|Adverse Event|6|||
155681242|NCT03525600|561923742|FG002|Overall Study|Adverse Event|5|||
155681243|NCT03525600|561923743|FG003|Overall Study|Adverse Event|3|||
155681244|NCT03525600|561923740|FG000|Overall Study|Lost to Follow-up|2|||
155681245|NCT03525600|561923741|FG001|Overall Study|Lost to Follow-up|4|||
155681246|NCT03525600|561923742|FG002|Overall Study|Lost to Follow-up|4|||
155681247|NCT03525600|561923743|FG003|Overall Study|Lost to Follow-up|0|||
155681248|NCT03525600|561923740|FG000|Overall Study|Physician Decision|1|||
155681249|NCT03525600|561923741|FG001|Overall Study|Physician Decision|0|||
155681250|NCT03525600|561923742|FG002|Overall Study|Physician Decision|2|||
155681251|NCT03525600|561923743|FG003|Overall Study|Physician Decision|0|||
155681252|NCT03525600|561923740|FG000|Overall Study|Consent withdrawal|36|||
155681253|NCT03525600|561923741|FG001|Overall Study|Consent withdrawal|20|||
155681254|NCT03525600|561923742|FG002|Overall Study|Consent withdrawal|6|||
155681255|NCT03525600|561923743|FG003|Overall Study|Consent withdrawal|13|||
155681256|NCT03525600|561923740|FG000|Overall Study|Death|7|||
155681257|NCT03525600|561923741|FG001|Overall Study|Death|6|||
155681258|NCT03525600|561923742|FG002|Overall Study|Death|4|||
155681259|NCT03525600|561923743|FG003|Overall Study|Death|3|||
155681260|NCT03525600|561923740|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
155681261|NCT03525600|561923741|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
155681262|NCT03525600|561923742|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
155603343|NCT00195494|561635496|FG003|Year 1|Lack of Efficacy|0|||
155603344|NCT00195494|561635497|FG004|Year 1|Lack of Efficacy|24|||
155603345|NCT00195494|561635498|FG005|Year 1|Lack of Efficacy|9|||
155603346|NCT00195494|561635493|FG000|Year 1|Compliance|0|||
155603347|NCT00195494|561635494|FG001|Year 1|Compliance|0|||
155603348|NCT00195494|561635495|FG002|Year 1|Compliance|0|||
155603349|NCT00195494|561635496|FG003|Year 1|Compliance|0|||
155603350|NCT00195494|561635497|FG004|Year 1|Compliance|5|||
155603351|NCT00195494|561635498|FG005|Year 1|Compliance|1|||
155603352|NCT00195494|561635493|FG000|Year 1|Lost to Follow-up|0|||
155603353|NCT00195494|561635494|FG001|Year 1|Lost to Follow-up|0|||
155603354|NCT00195494|561635495|FG002|Year 1|Lost to Follow-up|0|||
155603355|NCT00195494|561635496|FG003|Year 1|Lost to Follow-up|0|||
155603356|NCT00195494|561635497|FG004|Year 1|Lost to Follow-up|1|||
155603357|NCT00195494|561635498|FG005|Year 1|Lost to Follow-up|0|||
155603358|NCT00195494|561635493|FG000|Year 1|Missed >4 consecutive doses|0|||
155603359|NCT00195494|561635494|FG001|Year 1|Missed >4 consecutive doses|0|||
155603360|NCT00195494|561635495|FG002|Year 1|Missed >4 consecutive doses|0|||
155603361|NCT00195494|561635496|FG003|Year 1|Missed >4 consecutive doses|0|||
155603362|NCT00195494|561635497|FG004|Year 1|Missed >4 consecutive doses|3|||
155603363|NCT00195494|561635498|FG005|Year 1|Missed >4 consecutive doses|2|||
155603364|NCT00195494|561635493|FG000|Year 1|Protocol deviation|0|||
155603365|NCT00195494|561635494|FG001|Year 1|Protocol deviation|0|||
155603366|NCT00195494|561635495|FG002|Year 1|Protocol deviation|0|||
155603367|NCT00195494|561635496|FG003|Year 1|Protocol deviation|0|||
155603368|NCT00195494|561635497|FG004|Year 1|Protocol deviation|2|||
155603369|NCT00195494|561635498|FG005|Year 1|Protocol deviation|3|||
155603370|NCT00195494|561635493|FG000|Year 1|Physician Decision|0|||
155603371|NCT00195494|561635494|FG001|Year 1|Physician Decision|0|||
155603372|NCT00195494|561635495|FG002|Year 1|Physician Decision|0|||
155603373|NCT00195494|561635496|FG003|Year 1|Physician Decision|0|||
155603374|NCT00195494|561635497|FG004|Year 1|Physician Decision|1|||
155603375|NCT00195494|561635498|FG005|Year 1|Physician Decision|0|||
155603376|NCT00195494|561635493|FG000|Year 1|Withdrawal by Subject|0|||
155603377|NCT00195494|561635494|FG001|Year 1|Withdrawal by Subject|0|||
155603378|NCT00195494|561635495|FG002|Year 1|Withdrawal by Subject|0|||
155603379|NCT00195494|561635496|FG003|Year 1|Withdrawal by Subject|0|||
155603380|NCT00195494|561635497|FG004|Year 1|Withdrawal by Subject|8|||
155603381|NCT00195494|561635498|FG005|Year 1|Withdrawal by Subject|9|||
155603382|NCT00195494|561635493|FG000|Year 1|Protocol Violation|0|||
155603383|NCT00195494|561635494|FG001|Year 1|Protocol Violation|0|||
155603384|NCT00195494|561635495|FG002|Year 1|Protocol Violation|0|||
155603385|NCT00195494|561635496|FG003|Year 1|Protocol Violation|0|||
155603386|NCT00195494|561635497|FG004|Year 1|Protocol Violation|1|||
155603387|NCT00195494|561635498|FG005|Year 1|Protocol Violation|1|||
155603388|NCT00195494|561635493|FG000|Year 2|Adverse Event|3|||
155603389|NCT00195494|561635494|FG001|Year 2|Adverse Event|7|||
155603390|NCT00195494|561635495|FG002|Year 2|Adverse Event|5|||
155603391|NCT00195494|561635496|FG003|Year 2|Adverse Event|9|||
155603392|NCT00195494|561635497|FG004|Year 2|Adverse Event|0|||
155603393|NCT00195494|561635498|FG005|Year 2|Adverse Event|0|||
155603394|NCT00195494|561635493|FG000|Year 2|Lack of Efficacy|0|||
155603395|NCT00195494|561635494|FG001|Year 2|Lack of Efficacy|1|||
155603396|NCT00195494|561635495|FG002|Year 2|Lack of Efficacy|7|||
155603397|NCT00195494|561635496|FG003|Year 2|Lack of Efficacy|7|||
155603398|NCT00195494|561635497|FG004|Year 2|Lack of Efficacy|0|||
155603399|NCT00195494|561635498|FG005|Year 2|Lack of Efficacy|0|||
155603400|NCT00195494|561635493|FG000|Year 2|Compliance|1|||
155603401|NCT00195494|561635494|FG001|Year 2|Compliance|0|||
155603402|NCT00195494|561635495|FG002|Year 2|Compliance|0|||
155603403|NCT00195494|561635496|FG003|Year 2|Compliance|2|||
155603404|NCT00195494|561635497|FG004|Year 2|Compliance|0|||
155603405|NCT00195494|561635498|FG005|Year 2|Compliance|0|||
155603406|NCT00195494|561635493|FG000|Year 2|Lost to Follow-up|0|||
155603407|NCT00195494|561635494|FG001|Year 2|Lost to Follow-up|0|||
155603408|NCT00195494|561635495|FG002|Year 2|Lost to Follow-up|1|||
155603409|NCT00195494|561635496|FG003|Year 2|Lost to Follow-up|1|||
155603410|NCT00195494|561635497|FG004|Year 2|Lost to Follow-up|0|||
155603411|NCT00195494|561635498|FG005|Year 2|Lost to Follow-up|0|||
155603412|NCT00195494|561635493|FG000|Year 2|Missed >4 consecutive doses|1|||
155603413|NCT00195494|561635494|FG001|Year 2|Missed >4 consecutive doses|1|||
155603414|NCT00195494|561635495|FG002|Year 2|Missed >4 consecutive doses|1|||
155603415|NCT00195494|561635496|FG003|Year 2|Missed >4 consecutive doses|0|||
155603416|NCT00195494|561635497|FG004|Year 2|Missed >4 consecutive doses|0|||
155603417|NCT00195494|561635498|FG005|Year 2|Missed >4 consecutive doses|0|||
155603418|NCT00195494|561635493|FG000|Year 2|Protocol deviation|0|||
155603419|NCT00195494|561635494|FG001|Year 2|Protocol deviation|1|||
155603420|NCT00195494|561635495|FG002|Year 2|Protocol deviation|0|||
155603421|NCT00195494|561635496|FG003|Year 2|Protocol deviation|0|||
155603422|NCT00195494|561635497|FG004|Year 2|Protocol deviation|0|||
155603423|NCT00195494|561635498|FG005|Year 2|Protocol deviation|0|||
155681263|NCT03525600|561923743|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
155681264|NCT03525600|561923740|FG000|Overall Study|Other|0|||
155681265|NCT03525600|561923741|FG001|Overall Study|Other|1|||
155681266|NCT03525600|561923742|FG002|Overall Study|Other|0|||
155681267|NCT03525600|561923743|FG003|Overall Study|Other|0|||
155681268|NCT00344318|561923744|FG000|Overall Study|Adverse Event|0|||
155681269|NCT00344318|561923745|FG001|Overall Study|Adverse Event|3|||
155681270|NCT00344318|561923746|FG002|Overall Study|Adverse Event|0|||
155681271|NCT00344318|561923747|FG003|Overall Study|Adverse Event|1|||
155681272|NCT00344318|561923744|FG000|Overall Study|Withdrawal by Subject|2|||
155681273|NCT00344318|561923745|FG001|Overall Study|Withdrawal by Subject|2|||
155681274|NCT00344318|561923746|FG002|Overall Study|Withdrawal by Subject|0|||
155681275|NCT00344318|561923747|FG003|Overall Study|Withdrawal by Subject|2|||
155681276|NCT00344318|561923744|FG000|Overall Study|Lost to Follow-up|2|||
155681277|NCT00344318|561923745|FG001|Overall Study|Lost to Follow-up|0|||
155681278|NCT00344318|561923746|FG002|Overall Study|Lost to Follow-up|1|||
155681279|NCT00344318|561923747|FG003|Overall Study|Lost to Follow-up|0|||
155681280|NCT00700882|561923753|FG000|Overall Study|Never received treatment|6|||
155681281|NCT00700882|561923753|FG000|Overall Study|Ineligible|2|||
155681282|NCT00700882|561923753|FG000|Overall Study|No KIT mutation|51|||
155681283|NCT01606176|561923758|FG000|Overall Study|Adverse Event|2|||
155681284|NCT01606176|561923759|FG001|Overall Study|Adverse Event|3|||
155681285|NCT01606176|561923758|FG000|Overall Study|Disease progression|1|||
155681286|NCT01606176|561923759|FG001|Overall Study|Disease progression|0|||
155681287|NCT01606176|561923758|FG000|Overall Study|Withdrawal by Subject|1|||
155681288|NCT01606176|561923759|FG001|Overall Study|Withdrawal by Subject|0|||
155681289|NCT01832493|561923760|FG000|Overall Study|Physician Decision|2|||
155681290|NCT01832493|561923760|FG000|Overall Study|Protocol Violation|4|||
155681291|NCT01832493|561923760|FG000|Overall Study|Unable to place LV lead|2|||
155681292|NCT00290771|561923769|FG000|Overall Study|Disease progression|95|||
155681293|NCT00290771|561923770|FG001|Overall Study|Disease progression|73|||
155681294|NCT00290771|561923769|FG000|Overall Study|Death|11|||
155681295|NCT00290771|561923770|FG001|Overall Study|Death|10|||
155681296|NCT00290771|561923769|FG000|Overall Study|Adverse Event|12|||
155681297|NCT00290771|561923770|FG001|Overall Study|Adverse Event|6|||
155681298|NCT00290771|561923769|FG000|Overall Study|Withdrawal by Subject|5|||
155681299|NCT00290771|561923770|FG001|Overall Study|Withdrawal by Subject|6|||
155681300|NCT00290771|561923769|FG000|Overall Study|Administrative problems|2|||
155681301|NCT00290771|561923770|FG001|Overall Study|Administrative problems|1|||
155681302|NCT00290771|561923769|FG000|Overall Study|Protocol Violation|2|||
155681303|NCT00290771|561923770|FG001|Overall Study|Protocol Violation|0|||
155681304|NCT00290771|561923769|FG000|Overall Study|Lost to Follow-up|0|||
155681305|NCT00290771|561923770|FG001|Overall Study|Lost to Follow-up|1|||
155681306|NCT03703817|561923771|FG000|Overall Study|Not meeting eligibility criteria|7|||
155681307|NCT03703817|561923772|FG001|Overall Study|Not meeting eligibility criteria|4|||
155681308|NCT02247011|561923773|FG000|Overall Study|Poor quality of radiological results|125|||
155681309|NCT05145322|561923774|FG000|Overall Study|Lost to Follow-up|4|||
155681310|NCT05145322|561923775|FG001|Overall Study|Lost to Follow-up|5|||
155681311|NCT06359028|561923776|FG000|Overall Study|Adverse Event|1|||
155681312|NCT06359028|561923777|FG001|Overall Study|Adverse Event|0|||
155681313|NCT06359028|561923776|FG000|Overall Study|Withdrawal by Subject|1|||
155681314|NCT06359028|561923777|FG001|Overall Study|Withdrawal by Subject|0|||
155681315|NCT00792740|561923778|FG000|Overall Study|Disease Worsening|3|||
155681316|NCT00792740|561923779|FG001|Overall Study|Disease Worsening|2|||
155681317|NCT00792740|561923778|FG000|Overall Study|Personal Reason|1|||
155681318|NCT00792740|561923779|FG001|Overall Study|Personal Reason|0|||
155681319|NCT00792740|561923778|FG000|Overall Study|Adverse Event|1|||
155681320|NCT00792740|561923779|FG001|Overall Study|Adverse Event|3|||
155681321|NCT00792740|561923778|FG000|Overall Study|Patient's withdrawal of consent|0|||
155681322|NCT00792740|561923779|FG001|Overall Study|Patient's withdrawal of consent|1|||
155681323|NCT00792740|561923778|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
155681324|NCT00792740|561923779|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
155681325|NCT00792740|561923778|FG000|Overall Study|Other reasons|0|||
155681326|NCT00792740|561923779|FG001|Overall Study|Other reasons|1|||
155681327|NCT02485639|561923780|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
155681328|NCT02485639|561923780|FG000|Overall Study|Early termination|4|||
155681329|NCT02485639|561923780|FG000|Overall Study|Withdrawal by Subject|4|||
155681330|NCT01439971|561923781|FG000|Overall Study|Required number in cohort dosed|0|||
155681331|NCT01439971|561923782|FG001|Overall Study|Required number in cohort dosed|1|||
155681332|NCT01439971|561923783|FG002|Overall Study|Required number in cohort dosed|2|||
155681333|NCT01439971|561923784|FG003|Overall Study|Required number in cohort dosed|0|||
155681334|NCT01439971|561923785|FG004|Overall Study|Required number in cohort dosed|1|||
155681335|NCT02628600|561923786|FG000|Overall Study|Death|2|||
155681336|NCT02628600|561923787|FG001|Overall Study|Death|1|||
155681337|NCT02628600|561923786|FG000|Overall Study|Adverse Event|3|||
155681338|NCT02628600|561923787|FG001|Overall Study|Adverse Event|20|||
155681339|NCT02628600|561923786|FG000|Overall Study|Protocol Violation|0|||
155681340|NCT02628600|561923787|FG001|Overall Study|Protocol Violation|1|||
155681341|NCT02628600|561923786|FG000|Overall Study|Lack of Efficacy|2|||
155681342|NCT02628600|561923787|FG001|Overall Study|Lack of Efficacy|0|||
155681343|NCT02628600|561923786|FG000|Overall Study|Withdrawal by Subject|13|||
155681344|NCT02628600|561923787|FG001|Overall Study|Withdrawal by Subject|8|||
155681345|NCT02628600|561923786|FG000|Overall Study|Lost to Follow-up|1|||
155681346|NCT02628600|561923787|FG001|Overall Study|Lost to Follow-up|0|||
155681347|NCT02628600|561923786|FG000|Overall Study|Physician Decision|2|||
155681348|NCT02628600|561923787|FG001|Overall Study|Physician Decision|2|||
155681349|NCT02628600|561923786|FG000|Overall Study|Other not specified|1|||
155681350|NCT02628600|561923787|FG001|Overall Study|Other not specified|0|||
155681351|NCT04283994|561923789|FG000|Overall Study|Death|11|||
155681352|NCT04283994|561923790|FG001|Overall Study|Death|20|||
155681353|NCT04283994|561923791|FG002|Overall Study|Death|11|||
155681354|NCT04283994|561923792|FG003|Overall Study|Death|0|||
155681355|NCT04283994|561923793|FG004|Overall Study|Death|0|||
155681356|NCT04283994|561923794|FG005|Overall Study|Death|0|||
155681357|NCT04283994|561923795|FG006|Overall Study|Death|0|||
155681358|NCT04283994|561923789|FG000|Overall Study|Withdrawal by Subject|16|||
155681359|NCT04283994|561923790|FG001|Overall Study|Withdrawal by Subject|4|||
155681360|NCT04283994|561923791|FG002|Overall Study|Withdrawal by Subject|6|||
155681361|NCT04283994|561923792|FG003|Overall Study|Withdrawal by Subject|1|||
155681362|NCT04283994|561923793|FG004|Overall Study|Withdrawal by Subject|0|||
155681363|NCT04283994|561923794|FG005|Overall Study|Withdrawal by Subject|1|||
155681364|NCT04283994|561923795|FG006|Overall Study|Withdrawal by Subject|0|||
155681365|NCT00583752|561923796|FG000|Overall Study|Lost to Follow-up|5|||
155681366|NCT00583752|561923797|FG001|Overall Study|Lost to Follow-up|5|||
155681367|NCT00830375|561923800|FG000|Overall Study|Lost to Follow-up|1|||
155681368|NCT01700959|561923801|FG000|Overall Study|Adverse Event|0|||
155681369|NCT01700959|561923802|FG001|Overall Study|Adverse Event|1|||
155681370|NCT01700959|561923803|FG002|Overall Study|Adverse Event|1|||
155681371|NCT01700959|561923804|FG003|Overall Study|Adverse Event|2|||
155681372|NCT01700959|561923805|FG004|Overall Study|Adverse Event|0|||
155681373|NCT01700959|561923806|FG005|Overall Study|Adverse Event|2|||
155681374|NCT01700959|561923801|FG000|Overall Study|Withdrawal by Subject|15|||
155681375|NCT01700959|561923802|FG001|Overall Study|Withdrawal by Subject|9|||
155681376|NCT01700959|561923803|FG002|Overall Study|Withdrawal by Subject|12|||
155681377|NCT01700959|561923804|FG003|Overall Study|Withdrawal by Subject|11|||
155681378|NCT01700959|561923805|FG004|Overall Study|Withdrawal by Subject|8|||
155681379|NCT01700959|561923806|FG005|Overall Study|Withdrawal by Subject|12|||
155681380|NCT01700959|561923801|FG000|Overall Study|Ineligible|2|||
155681381|NCT01700959|561923802|FG001|Overall Study|Ineligible|1|||
155681382|NCT01700959|561923803|FG002|Overall Study|Ineligible|2|||
155681383|NCT01700959|561923804|FG003|Overall Study|Ineligible|0|||
155681384|NCT01700959|561923805|FG004|Overall Study|Ineligible|0|||
155681385|NCT01700959|561923806|FG005|Overall Study|Ineligible|1|||
155681386|NCT01700959|561923801|FG000|Overall Study|Noncompliant|9|||
155681387|NCT01700959|561923802|FG001|Overall Study|Noncompliant|9|||
155681388|NCT01700959|561923803|FG002|Overall Study|Noncompliant|17|||
155681389|NCT01700959|561923804|FG003|Overall Study|Noncompliant|18|||
155681390|NCT01700959|561923805|FG004|Overall Study|Noncompliant|15|||
155681391|NCT01700959|561923806|FG005|Overall Study|Noncompliant|9|||
155681392|NCT01700959|561923801|FG000|Overall Study|Side effects|1|||
155681393|NCT01700959|561923802|FG001|Overall Study|Side effects|4|||
155681394|NCT01700959|561923803|FG002|Overall Study|Side effects|8|||
155681395|NCT01700959|561923804|FG003|Overall Study|Side effects|4|||
155681396|NCT01700959|561923805|FG004|Overall Study|Side effects|4|||
155681397|NCT01700959|561923806|FG005|Overall Study|Side effects|1|||
155603424|NCT00195494|561635493|FG000|Year 2|Physician Decision|1|||
155603425|NCT00195494|561635494|FG001|Year 2|Physician Decision|1|||
155603426|NCT00195494|561635495|FG002|Year 2|Physician Decision|0|||
155603427|NCT00195494|561635496|FG003|Year 2|Physician Decision|0|||
155603428|NCT00195494|561635497|FG004|Year 2|Physician Decision|0|||
155603429|NCT00195494|561635498|FG005|Year 2|Physician Decision|0|||
155603430|NCT00195494|561635493|FG000|Year 2|Withdrawal by Subject|1|||
155603431|NCT00195494|561635494|FG001|Year 2|Withdrawal by Subject|5|||
155603432|NCT00195494|561635495|FG002|Year 2|Withdrawal by Subject|4|||
155603433|NCT00195494|561635496|FG003|Year 2|Withdrawal by Subject|3|||
155603434|NCT00195494|561635497|FG004|Year 2|Withdrawal by Subject|0|||
155603435|NCT00195494|561635498|FG005|Year 2|Withdrawal by Subject|0|||
155603436|NCT00195494|561635493|FG000|Year 2|System toxicity|0|||
155603437|NCT00195494|561635494|FG001|Year 2|System toxicity|0|||
155603438|NCT00195494|561635495|FG002|Year 2|System toxicity|0|||
155603439|NCT00195494|561635496|FG003|Year 2|System toxicity|1|||
155603440|NCT00195494|561635497|FG004|Year 2|System toxicity|0|||
155681398|NCT02867813|561925608|FG000|Overall Study|Withdrawal by Subject|57|||
155603441|NCT00195494|561635498|FG005|Year 2|System toxicity|0|||
155603442|NCT00513357|561635499|FG000|Overall Study|did not receive allocated placebo|2|||
155681399|NCT02867813|561925609|FG001|Overall Study|Withdrawal by Subject|56|||
155681400|NCT02867813|561925608|FG000|Overall Study|Decision by Sponsor|7|||
155681401|NCT02867813|561925609|FG001|Overall Study|Decision by Sponsor|7|||
155681402|NCT02867813|561925608|FG000|Overall Study|Lost to Follow-up|91|||
155681403|NCT02867813|561925609|FG001|Overall Study|Lost to Follow-up|78|||
155681404|NCT02867813|561925608|FG000|Overall Study|Missing|2|||
155681405|NCT02867813|561925609|FG001|Overall Study|Missing|1|||
155681406|NCT02867813|561925608|FG000|Overall Study|Death|294|||
155681407|NCT02867813|561925609|FG001|Overall Study|Death|268|||
155681408|NCT02013206|561925610|FG000|Overall Study|Progressive disease (PD)|14|||
155681409|NCT02013206|561925611|FG001|Overall Study|Progressive disease (PD)|17|||
155681410|NCT02013206|561925610|FG000|Overall Study|Symptomatic deterioration|3|||
155681411|NCT02013206|561925611|FG001|Overall Study|Symptomatic deterioration|1|||
155681412|NCT02013206|561925610|FG000|Overall Study|Adverse Event|1|||
155681413|NCT02013206|561925611|FG001|Overall Study|Adverse Event|0|||
155681414|NCT02013206|561925610|FG000|Overall Study|Patient refusal|2|||
155681415|NCT02013206|561925611|FG001|Overall Study|Patient refusal|0|||
155681416|NCT02013206|561925610|FG000|Overall Study|Patient non-compliance|1|||
155681417|NCT02013206|561925611|FG001|Overall Study|Patient non-compliance|0|||
155681418|NCT02013206|561925610|FG000|Overall Study|Death|1|||
155681419|NCT02013206|561925611|FG001|Overall Study|Death|2|||
155681420|NCT02013206|561925610|FG000|Overall Study|Other reasons off treatment|5|||
155681421|NCT02013206|561925611|FG001|Overall Study|Other reasons off treatment|2|||
155681422|NCT01952665|561925614|FG000|Overall Study|Physician Decision|3|||
155681423|NCT01952665|561925615|FG001|Overall Study|Physician Decision|2|||
155681424|NCT01952665|561925614|FG000|Overall Study|Lost to Follow-up|1|||
155681425|NCT01952665|561925615|FG001|Overall Study|Lost to Follow-up|2|||
155681426|NCT01952665|561925614|FG000|Overall Study|Adverse Event|2|||
155681427|NCT01952665|561925615|FG001|Overall Study|Adverse Event|1|||
155681428|NCT01952665|561925614|FG000|Overall Study|Protocol Violation|0|||
155681429|NCT01952665|561925615|FG001|Overall Study|Protocol Violation|1|||
155681430|NCT01537081|561925617|FG000|Overall Study|Adverse Event|5|||
155681431|NCT01537081|561925618|FG001|Overall Study|Adverse Event|2|||
155681432|NCT01537081|561925619|FG002|Overall Study|Adverse Event|2|||
155681433|NCT01537081|561925617|FG000|Overall Study|Lack of Efficacy|2|||
155681434|NCT01537081|561925618|FG001|Overall Study|Lack of Efficacy|1|||
155681435|NCT01537081|561925619|FG002|Overall Study|Lack of Efficacy|0|||
155681436|NCT01537081|561925617|FG000|Overall Study|Lost to Follow-up|17|||
155681437|NCT01537081|561925618|FG001|Overall Study|Lost to Follow-up|15|||
155681438|NCT01537081|561925619|FG002|Overall Study|Lost to Follow-up|9|||
155681439|NCT01537081|561925617|FG000|Overall Study|Protocol Violation|3|||
155681440|NCT01537081|561925618|FG001|Overall Study|Protocol Violation|2|||
155681441|NCT01537081|561925619|FG002|Overall Study|Protocol Violation|2|||
155681442|NCT01537081|561925617|FG000|Overall Study|Withdrawal by Subject|6|||
155681443|NCT01537081|561925618|FG001|Overall Study|Withdrawal by Subject|11|||
155681444|NCT01537081|561925619|FG002|Overall Study|Withdrawal by Subject|3|||
155681445|NCT01537081|561925617|FG000|Overall Study|Physician Decision|5|||
155681446|NCT01537081|561925618|FG001|Overall Study|Physician Decision|6|||
155681447|NCT01537081|561925619|FG002|Overall Study|Physician Decision|0|||
155681448|NCT01537081|561925617|FG000|Overall Study|Sponsor decision|0|||
155681449|NCT01537081|561925618|FG001|Overall Study|Sponsor decision|1|||
155681450|NCT01537081|561925619|FG002|Overall Study|Sponsor decision|0|||
155681451|NCT01537081|561925617|FG000|Overall Study|Assigned but never dosed|1|||
155681452|NCT01537081|561925618|FG001|Overall Study|Assigned but never dosed|0|||
155681453|NCT01537081|561925619|FG002|Overall Study|Assigned but never dosed|0|||
155681454|NCT00882583|561925624|FG000|Overall Study|Physician Decision|1|||
155681455|NCT00882583|561925625|FG001|Overall Study|Physician Decision|0|||
155681456|NCT00882583|561925624|FG000|Overall Study|Adverse Event|0|||
155681457|NCT00882583|561925625|FG001|Overall Study|Adverse Event|1|||
155681458|NCT02596958|561925632|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
155681459|NCT02596958|561925632|FG000|Overall Study|Cancer Progression|441|||
155681460|NCT02596958|561925632|FG000|Overall Study|Death From Cancer|112|||
155681461|NCT02596958|561925632|FG000|Overall Study|Death From Other Cause|33|||
155681462|NCT02596958|561925632|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
155681463|NCT02596958|561925632|FG000|Overall Study|Administrative Reasons/Other|231|||
155681464|NCT02596958|561925632|FG000|Overall Study|Lost to Follow-up|33|||
155681465|NCT02596958|561925632|FG000|Overall Study|Missing|32|||
155681466|NCT02596958|561925632|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
155681467|NCT01559259|561925633|FG000|Overall Study|Withdrawal by Subject|0|||
155681468|NCT01559259|561925634|FG001|Overall Study|Withdrawal by Subject|0|||
155681469|NCT01559259|561925635|FG002|Overall Study|Withdrawal by Subject|0|||
155681470|NCT01559259|561925636|FG003|Overall Study|Withdrawal by Subject|1|||
155681471|NCT01559259|561925637|FG004|Overall Study|Withdrawal by Subject|0|||
155681472|NCT01559259|561925633|FG000|Overall Study|Adverse Event|0|||
155681473|NCT01559259|561925634|FG001|Overall Study|Adverse Event|1|||
155681474|NCT01559259|561925635|FG002|Overall Study|Adverse Event|1|||
155681475|NCT01559259|561925636|FG003|Overall Study|Adverse Event|0|||
155681476|NCT01559259|561925637|FG004|Overall Study|Adverse Event|0|||
155681477|NCT01995669|561925638|FG000|Overall Study|Progression|2|||
155681478|NCT01995669|561925639|FG001|Overall Study|Progression|1|||
155681479|NCT01995669|561925640|FG002|Overall Study|Progression|1|||
155681480|NCT01995669|561925641|FG003|Overall Study|Progression|13|||
155681481|NCT01995669|561925638|FG000|Overall Study|Adverse Event|0|||
155681482|NCT01995669|561925639|FG001|Overall Study|Adverse Event|0|||
155681483|NCT01995669|561925640|FG002|Overall Study|Adverse Event|0|||
155681484|NCT01995669|561925641|FG003|Overall Study|Adverse Event|3|||
155681485|NCT01995669|561925638|FG000|Overall Study|Death|0|||
155681486|NCT01995669|561925639|FG001|Overall Study|Death|0|||
155681487|NCT01995669|561925640|FG002|Overall Study|Death|0|||
155681488|NCT01995669|561925641|FG003|Overall Study|Death|6|||
155681489|NCT01995669|561925638|FG000|Overall Study|Withdrawal by Subject|0|||
155681490|NCT01995669|561925639|FG001|Overall Study|Withdrawal by Subject|0|||
155681491|NCT01995669|561925640|FG002|Overall Study|Withdrawal by Subject|0|||
155681492|NCT01995669|561925641|FG003|Overall Study|Withdrawal by Subject|6|||
155681493|NCT01995669|561925638|FG000|Overall Study|Insurance Expired|0|||
155681494|NCT01995669|561925639|FG001|Overall Study|Insurance Expired|0|||
155681495|NCT01995669|561925640|FG002|Overall Study|Insurance Expired|0|||
155681496|NCT01995669|561925641|FG003|Overall Study|Insurance Expired|1|||
155681497|NCT05425732|561925642|FG000|Overall Study|Death|4|||
155681498|NCT05425732|561925643|FG001|Overall Study|Death|2|||
155681499|NCT05425732|561925644|FG002|Overall Study|Death|0|||
155681500|NCT05425732|561925645|FG003|Overall Study|Death|0|||
155681501|NCT05425732|561925642|FG000|Overall Study|Lost to Follow-up|10|||
155681502|NCT05425732|561925643|FG001|Overall Study|Lost to Follow-up|15|||
155681503|NCT05425732|561925644|FG002|Overall Study|Lost to Follow-up|5|||
155681504|NCT05425732|561925645|FG003|Overall Study|Lost to Follow-up|3|||
155681505|NCT05425732|561925642|FG000|Overall Study|Physician Decision|0|||
155681506|NCT05425732|561925643|FG001|Overall Study|Physician Decision|2|||
155681507|NCT05425732|561925644|FG002|Overall Study|Physician Decision|0|||
155681508|NCT05425732|561925645|FG003|Overall Study|Physician Decision|0|||
155681509|NCT05425732|561925642|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155681510|NCT05425732|561925643|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155681511|NCT05425732|561925644|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155681512|NCT05425732|561925645|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155681513|NCT05425732|561925642|FG000|Overall Study|Withdrawal by Subject|4|||
155681514|NCT05425732|561925643|FG001|Overall Study|Withdrawal by Subject|8|||
155681515|NCT05425732|561925644|FG002|Overall Study|Withdrawal by Subject|1|||
155681516|NCT05425732|561925645|FG003|Overall Study|Withdrawal by Subject|1|||
155681517|NCT05425732|561925642|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
155681518|NCT05425732|561925643|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155681519|NCT05425732|561925644|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155681520|NCT05425732|561925645|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155681521|NCT00327015|561925649|FG000|Overall Study|Lack of Efficacy|18|||
155681522|NCT00327015|561925650|FG001|Overall Study|Lack of Efficacy|18|||
155681523|NCT00327015|561925651|FG002|Overall Study|Lack of Efficacy|35|||
155681524|NCT00327015|561925652|FG003|Overall Study|Lack of Efficacy|29|||
155681525|NCT00327015|561925649|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
155681526|NCT00327015|561925650|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
155681527|NCT00327015|561925651|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
155681528|NCT00327015|561925652|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
155681529|NCT00327015|561925649|FG000|Overall Study|Lost to Follow-up|22|||
155681530|NCT00327015|561925650|FG001|Overall Study|Lost to Follow-up|23|||
155681531|NCT00327015|561925651|FG002|Overall Study|Lost to Follow-up|29|||
155681532|NCT00327015|561925652|FG003|Overall Study|Lost to Follow-up|22|||
155681533|NCT00327015|561925649|FG000|Overall Study|Adverse Event|14|||
155681534|NCT00327015|561925650|FG001|Overall Study|Adverse Event|10|||
155681535|NCT00327015|561925651|FG002|Overall Study|Adverse Event|14|||
155681536|NCT00327015|561925652|FG003|Overall Study|Adverse Event|14|||
155681537|NCT00327015|561925649|FG000|Overall Study|Subject no longer meets study criteria|4|||
155681538|NCT00327015|561925650|FG001|Overall Study|Subject no longer meets study criteria|2|||
155681539|NCT00327015|561925651|FG002|Overall Study|Subject no longer meets study criteria|8|||
155681540|NCT00327015|561925652|FG003|Overall Study|Subject no longer meets study criteria|7|||
155681541|NCT00327015|561925649|FG000|Overall Study|Poor/Noncompliance|11|||
155681542|NCT00327015|561925650|FG001|Overall Study|Poor/Noncompliance|8|||
155681543|NCT00327015|561925651|FG002|Overall Study|Poor/Noncompliance|4|||
155681544|NCT00327015|561925652|FG003|Overall Study|Poor/Noncompliance|5|||
155681545|NCT00327015|561925649|FG000|Overall Study|Physician Decision|0|||
155681546|NCT00327015|561925650|FG001|Overall Study|Physician Decision|1|||
155681547|NCT00327015|561925651|FG002|Overall Study|Physician Decision|3|||
155681548|NCT00327015|561925652|FG003|Overall Study|Physician Decision|2|||
155681549|NCT00327015|561925649|FG000|Overall Study|Death|1|||
155681550|NCT00327015|561925650|FG001|Overall Study|Death|2|||
155681551|NCT00327015|561925651|FG002|Overall Study|Death|2|||
155681552|NCT00327015|561925652|FG003|Overall Study|Death|3|||
155681553|NCT00327015|561925649|FG000|Overall Study|Pregnancy|0|||
155681554|NCT00327015|561925650|FG001|Overall Study|Pregnancy|2|||
155681555|NCT00327015|561925651|FG002|Overall Study|Pregnancy|1|||
155681556|NCT00327015|561925652|FG003|Overall Study|Pregnancy|1|||
155681557|NCT00327015|561925649|FG000|Overall Study|Administrative Reason by Sponsor|1|||
155681558|NCT00327015|561925650|FG001|Overall Study|Administrative Reason by Sponsor|2|||
155681559|NCT00327015|561925651|FG002|Overall Study|Administrative Reason by Sponsor|2|||
155681560|NCT00327015|561925652|FG003|Overall Study|Administrative Reason by Sponsor|1|||
155681561|NCT04569136|561925653|FG000|Overall Study|Lost to Follow-up|2|||
155681562|NCT04569136|561925654|FG001|Overall Study|Lost to Follow-up|0|||
155681563|NCT04569136|561925655|FG002|Overall Study|Lost to Follow-up|1|||
155681564|NCT00129701|561925656|FG000|Overall Study|Withdrawal by Subject|33|||
155681565|NCT00244933|561925675|FG000|Overall Study|Not response evaluable|2|||
155681566|NCT05129449|561925678|FG000|Overall Study|Protocol Violation|1|||
155681567|NCT00656058|561925683|FG000|Overall Study|Withdrawal by Subject|2|||
155681568|NCT00656058|561925683|FG000|Overall Study|Withdrawal by Subject|4|||
155681569|NCT00616018|561925686|FG000|Overall Study|Protocol Violation|3|||
155681570|NCT03718884|561925687|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
155681571|NCT03718884|561925688|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
155681572|NCT03718884|561925687|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
155681573|NCT03718884|561925688|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
155681574|NCT01818258|561925690|FG000|Overall Study|Death|3|||
155681575|NCT01818258|561925691|FG001|Overall Study|Death|0|||
155681576|NCT01818258|561925690|FG000|Overall Study|Withdrawal by Subject|0|||
155681577|NCT01818258|561925691|FG001|Overall Study|Withdrawal by Subject|1|||
155681578|NCT01818258|561925690|FG000|Overall Study|Lost to Follow-up|0|||
155681579|NCT01818258|561925691|FG001|Overall Study|Lost to Follow-up|1|||
155681580|NCT01818258|561925690|FG000|Overall Study|Unable to Travel to Clinic|0|||
155681581|NCT01818258|561925691|FG001|Overall Study|Unable to Travel to Clinic|1|||
155681582|NCT02099344|561925692|FG000|Overall Study|Physician Decision|1|||
155681583|NCT02099344|561925693|FG001|Overall Study|Physician Decision|0|||
155681584|NCT00404755|561925696|FG000|Phase I (Bupropion)|Adverse Event|3|||
155681585|NCT00404755|561925696|FG000|Phase I (Bupropion)|Other|1|||
155681586|NCT00404755|561925696|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
155681587|NCT02839720|561925697|FG000|Overall Study|Adverse Event|2|||
155681588|NCT02839720|561925697|FG000|Overall Study|Non-compliance|2|||
155681589|NCT02839720|561925697|FG000|Overall Study|Intercurrent Illness|1|||
155681590|NCT02839720|561925697|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
155681591|NCT04700540|561925698|FG000|Overall Study|Withdrawal by Subject|12|||
155681592|NCT04700540|561925699|FG001|Overall Study|Withdrawal by Subject|8|||
155681593|NCT04700540|561925698|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
155681594|NCT04700540|561925699|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
155681595|NCT03194568|561925700|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
155681596|NCT05248997|561925705|FG000|Overall Study|Lost to Follow-up|1|||
155681597|NCT05248997|561925706|FG001|Overall Study|Lost to Follow-up|1|||
155681598|NCT05248997|561925705|FG000|Overall Study|Randomized but not treated|32|||
155681599|NCT05248997|561925706|FG001|Overall Study|Randomized but not treated|25|||
155681600|NCT03515551|561925707|FG000|Overall Study|Death|4|||
155681601|NCT03515551|561925708|FG001|Overall Study|Death|1|||
155681602|NCT03515551|561925709|FG002|Overall Study|Death|2|||
155681603|NCT03515551|561925710|FG003|Overall Study|Death|2|||
155681604|NCT03515551|561925711|FG004|Overall Study|Death|2|||
155681605|NCT03515551|561925712|FG005|Overall Study|Death|4|||
155681606|NCT03515551|561925713|FG006|Overall Study|Death|1|||
155681607|NCT03515551|561925707|FG000|Overall Study|Lost to Follow-up|0|||
155681608|NCT03515551|561925708|FG001|Overall Study|Lost to Follow-up|0|||
155681609|NCT03515551|561925709|FG002|Overall Study|Lost to Follow-up|1|||
155681610|NCT03515551|561925710|FG003|Overall Study|Lost to Follow-up|0|||
155681611|NCT03515551|561925711|FG004|Overall Study|Lost to Follow-up|0|||
155681612|NCT03515551|561925712|FG005|Overall Study|Lost to Follow-up|0|||
155681613|NCT03515551|561925713|FG006|Overall Study|Lost to Follow-up|0|||
155681614|NCT03515551|561925707|FG000|Overall Study|Withdrawal by Subject|0|||
155681615|NCT03515551|561925708|FG001|Overall Study|Withdrawal by Subject|1|||
155681616|NCT03515551|561925709|FG002|Overall Study|Withdrawal by Subject|0|||
155681617|NCT03515551|561925710|FG003|Overall Study|Withdrawal by Subject|0|||
155681618|NCT03515551|561925711|FG004|Overall Study|Withdrawal by Subject|0|||
155681619|NCT03515551|561925712|FG005|Overall Study|Withdrawal by Subject|0|||
155681620|NCT03515551|561925713|FG006|Overall Study|Withdrawal by Subject|1|||
155681621|NCT03515551|561925707|FG000|Overall Study|Study ended by sponsor|0|||
155681622|NCT03515551|561925708|FG001|Overall Study|Study ended by sponsor|0|||
155681623|NCT03515551|561925709|FG002|Overall Study|Study ended by sponsor|2|||
155681624|NCT03515551|561925710|FG003|Overall Study|Study ended by sponsor|1|||
155681625|NCT03515551|561925711|FG004|Overall Study|Study ended by sponsor|3|||
155681626|NCT03515551|561925712|FG005|Overall Study|Study ended by sponsor|0|||
155681627|NCT03515551|561925713|FG006|Overall Study|Study ended by sponsor|3|||
155681628|NCT03515551|561925707|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681629|NCT03515551|561925708|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
155681630|NCT03515551|561925709|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681631|NCT03515551|561925710|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681632|NCT03515551|561925711|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681633|NCT03515551|561925712|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681634|NCT03515551|561925713|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155681635|NCT00920387|561925714|FG000|Stage 1|Adverse Event|1|||
155681636|NCT00920387|561925715|FG001|Stage 1|Adverse Event|0|||
155681637|NCT00920387|561925716|FG002|Stage 1|Adverse Event|0|||
155681638|NCT04470908|561925717|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
155681639|NCT02602275|561925728|FG000|Day 1|Physician Decision|0|||
155681640|NCT02602275|561925729|FG001|Day 1|Physician Decision|1|||
155681641|NCT02241733|561925732|FG000|Overall Study|Lost to Follow-up|9|||
155681642|NCT02241733|561925733|FG001|Overall Study|Lost to Follow-up|4|||
155681643|NCT02241733|561925732|FG000|Overall Study|Physician Decision|6|||
155681644|NCT02241733|561925733|FG001|Overall Study|Physician Decision|2|||
155681645|NCT02241733|561925732|FG000|Overall Study|Withdrawal by Subject|0|||
155681646|NCT02241733|561925733|FG001|Overall Study|Withdrawal by Subject|2|||
155681647|NCT02241733|561925732|FG000|Overall Study|Death|0|||
155681648|NCT02241733|561925733|FG001|Overall Study|Death|2|||
155681649|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
155681650|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
155681651|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
155681652|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
155681653|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
155681654|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
155681655|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
155681656|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
155681657|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
155681658|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
155681659|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
155681660|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
155681661|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
155681662|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
155681663|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
155681664|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
155681665|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
155681666|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
155681667|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
155681668|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
155681669|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
155681670|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
155681671|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
155681672|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
155681673|NCT01866111|561925734|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
155681674|NCT01866111|561925735|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
155681675|NCT01866111|561925736|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
155681676|NCT01866111|561925737|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
155681677|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
155681678|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
155681679|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
155681680|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
155681681|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
155681682|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
155681683|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
155681684|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
155681685|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
155681686|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
155681687|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
155681688|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
155681689|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
155681690|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
155681691|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
155681692|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
155681693|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Death|1|||
155681694|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Death|1|||
155681695|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Death|3|||
155681696|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Death|2|||
155681697|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
155681698|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
155681699|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
155681700|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
155681701|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
155681702|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
155681703|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
155681704|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
155681705|NCT01866111|561925734|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155681706|NCT01866111|561925735|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155681707|NCT01866111|561925736|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
155681708|NCT01866111|561925737|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155681709|NCT04113018|561925740|FG000|Overall Study|Death|2|||
155681710|NCT04113018|561925740|FG000|Overall Study|Lost to Follow-up|1|||
155681711|NCT04113018|561925740|FG000|Overall Study|Still On Study (on study treatment)|24|||
155681712|NCT04113018|561925740|FG000|Overall Study|Still On Study (in follow up)|12|||
155681713|NCT03802630|561925741|FG000|Overall Study|Study terminated by sponsor|130|||
155681714|NCT03802630|561925742|FG001|Overall Study|Study terminated by sponsor|134|||
155681715|NCT03802630|561925741|FG000|Overall Study|Subject decision|16|||
155681716|NCT03802630|561925742|FG001|Overall Study|Subject decision|9|||
155681717|NCT03802630|561925741|FG000|Overall Study|Adverse Event|3|||
155681718|NCT03802630|561925742|FG001|Overall Study|Adverse Event|1|||
155681719|NCT03802630|561925741|FG000|Overall Study|Lost to Follow-up|2|||
155681720|NCT03802630|561925742|FG001|Overall Study|Lost to Follow-up|2|||
155681721|NCT03802630|561925741|FG000|Overall Study|Physician Decision|2|||
155681722|NCT03802630|561925742|FG001|Overall Study|Physician Decision|0|||
155681723|NCT03802630|561925741|FG000|Overall Study|Death|0|||
155681724|NCT03802630|561925742|FG001|Overall Study|Death|2|||
155681725|NCT00157196|561925743|FG000|Overall Study|Ongoing at data cut-off|9|||
155681726|NCT05005013|561925744|FG000|Overall Study|Withdrawal by Subject|5|||
155681727|NCT05005013|561925745|FG001|Overall Study|Withdrawal by Subject|1|||
155681728|NCT05005013|561925744|FG000|Overall Study|Lost to Follow-up|3|||
155681729|NCT05005013|561925745|FG001|Overall Study|Lost to Follow-up|1|||
155681730|NCT05005013|561925744|FG000|Overall Study|Ineligibility|1|||
155681731|NCT05005013|561925745|FG001|Overall Study|Ineligibility|1|||
155681732|NCT06099223|561925746|FG000|Overall Study|Preoperative surveys missed|0|||
155681733|NCT06099223|561925747|FG001|Overall Study|Preoperative surveys missed|1|||
155681734|NCT01252186|561925748|FG000|Overall Study|Adverse Event|9|||
155681735|NCT01252186|561925749|FG001|Overall Study|Adverse Event|6|||
155681736|NCT01252186|561925750|FG002|Overall Study|Adverse Event|8|||
155681737|NCT01252186|561925748|FG000|Overall Study|Withdrawal by Subject|2|||
155681738|NCT01252186|561925749|FG001|Overall Study|Withdrawal by Subject|5|||
155681739|NCT01252186|561925750|FG002|Overall Study|Withdrawal by Subject|2|||
155681740|NCT01252186|561925748|FG000|Overall Study|Physician Decision|0|||
155681741|NCT01252186|561925749|FG001|Overall Study|Physician Decision|0|||
155681742|NCT01252186|561925750|FG002|Overall Study|Physician Decision|1|||
155681743|NCT01252186|561925748|FG000|Overall Study|Non-compliance|0|||
155681744|NCT01252186|561925749|FG001|Overall Study|Non-compliance|3|||
155681745|NCT01252186|561925750|FG002|Overall Study|Non-compliance|4|||
155681746|NCT01252186|561925748|FG000|Overall Study|Protocol Violation|0|||
155681747|NCT01252186|561925749|FG001|Overall Study|Protocol Violation|0|||
155681748|NCT01252186|561925750|FG002|Overall Study|Protocol Violation|1|||
155681749|NCT01252186|561925748|FG000|Overall Study|Pregnancy|2|||
155681750|NCT01252186|561925749|FG001|Overall Study|Pregnancy|2|||
155681751|NCT01252186|561925750|FG002|Overall Study|Pregnancy|0|||
155681752|NCT01252186|561925748|FG000|Overall Study|Sponsor Request|2|||
155681753|NCT01252186|561925749|FG001|Overall Study|Sponsor Request|1|||
155681754|NCT01252186|561925750|FG002|Overall Study|Sponsor Request|0|||
155681755|NCT01252186|561925748|FG000|Overall Study|Lost to Follow-up|10|||
155681756|NCT01252186|561925749|FG001|Overall Study|Lost to Follow-up|10|||
155681757|NCT01252186|561925750|FG002|Overall Study|Lost to Follow-up|11|||
155681758|NCT01252186|561925748|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
155681759|NCT01252186|561925749|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
155681760|NCT01252186|561925750|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
155681761|NCT01221623|561925756|FG000|Overall Study|Withdrawal by Subject|19|||
155681762|NCT01221623|561925757|FG001|Overall Study|Withdrawal by Subject|8|||
155681763|NCT01221623|561925756|FG000|Overall Study|Lost to Follow-up|7|||
155681764|NCT01221623|561925757|FG001|Overall Study|Lost to Follow-up|1|||
155681765|NCT01221623|561925756|FG000|Overall Study|Adverse Event|6|||
155681766|NCT01221623|561925757|FG001|Overall Study|Adverse Event|3|||
155681767|NCT01221623|561925756|FG000|Overall Study|Death|1|||
155681768|NCT01221623|561925757|FG001|Overall Study|Death|0|||
155681769|NCT01221623|561925756|FG000|Overall Study|Other|5|||
155681770|NCT01221623|561925757|FG001|Overall Study|Other|2|||
155681771|NCT00661726|561925758|FG000|Overall Study|Adverse Event|1|||
155681772|NCT02147197|561925759|FG000|Overall Study|Adverse Event|1|||
155681773|NCT02147197|561925760|FG001|Overall Study|Adverse Event|0|||
155681774|NCT02147197|561925761|FG002|Overall Study|Adverse Event|0|||
155681775|NCT02147197|561925759|FG000|Overall Study|Withdrawal of Consent|4|||
155681776|NCT02147197|561925760|FG001|Overall Study|Withdrawal of Consent|3|||
155681777|NCT02147197|561925761|FG002|Overall Study|Withdrawal of Consent|2|||
155681778|NCT02147197|561925759|FG000|Overall Study|Lost to Follow-up|2|||
155681779|NCT02147197|561925760|FG001|Overall Study|Lost to Follow-up|3|||
155681780|NCT02147197|561925761|FG002|Overall Study|Lost to Follow-up|1|||
155681781|NCT02147197|561925759|FG000|Overall Study|Protocol Violation|1|||
155681782|NCT02147197|561925760|FG001|Overall Study|Protocol Violation|0|||
155681783|NCT02147197|561925761|FG002|Overall Study|Protocol Violation|3|||
155681784|NCT02147197|561925759|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155681785|NCT02147197|561925760|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155681786|NCT02147197|561925761|FG002|Overall Study|Other Miscellaneous Reasons|3|||
155681787|NCT04091581|561925763|FG000|Overall Study|Lost to Follow-up|0|||
155681788|NCT04091581|561925764|FG001|Overall Study|Lost to Follow-up|1|||
155681789|NCT03315793|561925765|FG000|Overall Study|Adverse Event|4|||
155681790|NCT03315793|561925766|FG001|Overall Study|Adverse Event|2|||
155681791|NCT03315793|561925765|FG000|Overall Study|Protocol Deviation|1|||
155681792|NCT03315793|561925766|FG001|Overall Study|Protocol Deviation|0|||
155681793|NCT03315793|561925765|FG000|Overall Study|Difficult for regular visit|0|||
155681794|NCT03315793|561925766|FG001|Overall Study|Difficult for regular visit|1|||
155681795|NCT01331837|561925767|FG000|Overall Study|Death|30|||
155681796|NCT01331837|561925768|FG001|Overall Study|Death|34|||
155681797|NCT01331837|561925767|FG000|Overall Study|Lost to Follow-up|3|||
155681798|NCT01331837|561925768|FG001|Overall Study|Lost to Follow-up|1|||
155681799|NCT01331837|561925767|FG000|Overall Study|Info not recorded|10|||
155681800|NCT01331837|561925768|FG001|Overall Study|Info not recorded|16|||
155681801|NCT01331837|561925767|FG000|Overall Study|Withdrawal by Subject|13|||
155681802|NCT01331837|561925768|FG001|Overall Study|Withdrawal by Subject|16|||
155681803|NCT03724981|561927968|FG000|First Device|Protocol Violation|1|||
155681804|NCT03724981|561927969|FG001|First Device|Protocol Violation|1|||
155681805|NCT00790868|561927971|FG000|Overall Study|Withdrawal by Subject|4|||
155681806|NCT00790868|561927972|FG001|Overall Study|Withdrawal by Subject|5|||
155681807|NCT00790868|561927971|FG000|Overall Study|Lost to Follow-up|2|||
155681808|NCT00790868|561927972|FG001|Overall Study|Lost to Follow-up|12|||
155681809|NCT01380535|561927973|FG000|Overall Study|Adverse Event|3|||
155681810|NCT01380535|561927974|FG001|Overall Study|Adverse Event|3|||
155681811|NCT01380535|561927973|FG000|Overall Study|Death|3|||
155681812|NCT01380535|561927974|FG001|Overall Study|Death|0|||
155681813|NCT01380535|561927973|FG000|Overall Study|Study site closed|0|||
155681814|NCT01380535|561927974|FG001|Overall Study|Study site closed|5|||
155681815|NCT01380535|561927973|FG000|Overall Study|Withdrawal by Subject|1|||
155681816|NCT01380535|561927974|FG001|Overall Study|Withdrawal by Subject|2|||
155681817|NCT01380535|561927973|FG000|Overall Study|Protocol Violation|0|||
155681818|NCT01380535|561927974|FG001|Overall Study|Protocol Violation|2|||
155681819|NCT01380535|561927973|FG000|Overall Study|Lack of Efficacy|0|||
155681820|NCT01380535|561927974|FG001|Overall Study|Lack of Efficacy|3|||
155681821|NCT01579565|561927975|FG000|Randomized|Adverse Event|1|||
155681822|NCT01579565|561927976|FG001|Randomized|Adverse Event|3|||
155681823|NCT01579565|561927975|FG000|Randomized|Withdrawal by Subject|3|||
155681824|NCT01579565|561927976|FG001|Randomized|Withdrawal by Subject|0|||
155681825|NCT01579565|561927975|FG000|Randomized|inadequate preoperative pupil dilation|0|||
155681826|NCT01579565|561927976|FG001|Randomized|inadequate preoperative pupil dilation|1|||
155681827|NCT01579565|561927975|FG000|Randomized|prohibited preoperative eating|1|||
155681828|NCT01579565|561927976|FG001|Randomized|prohibited preoperative eating|0|||
155681829|NCT01579565|561927975|FG000|Randomized|prohibited preoperative medication|0|||
155681830|NCT01579565|561927976|FG001|Randomized|prohibited preoperative medication|1|||
155681831|NCT01579565|561927975|FG000|Treated|Physician Decision|0|||
155681832|NCT01579565|561927976|FG001|Treated|Physician Decision|1|||
155681833|NCT01579565|561927975|FG000|Treated|Lost to Follow-up|2|||
155681834|NCT01579565|561927976|FG001|Treated|Lost to Follow-up|1|||
155681835|NCT01579565|561927975|FG000|Treated|declined to return for final visit|0|||
155681836|NCT01579565|561927976|FG001|Treated|declined to return for final visit|1|||
155681837|NCT02791191|561927977|FG000|Overall Study|Adverse Event|2|||
155681838|NCT02791191|561927978|FG001|Overall Study|Adverse Event|4|||
155681839|NCT02791191|561927979|FG002|Overall Study|Adverse Event|5|||
155681840|NCT02791191|561927977|FG000|Overall Study|Lack of Efficacy|0|||
155681841|NCT02791191|561927978|FG001|Overall Study|Lack of Efficacy|1|||
155681842|NCT02791191|561927979|FG002|Overall Study|Lack of Efficacy|0|||
155681843|NCT02791191|561927977|FG000|Overall Study|Study Drug Non-Compliance|0|||
155681844|NCT02791191|561927978|FG001|Overall Study|Study Drug Non-Compliance|2|||
155681845|NCT02791191|561927979|FG002|Overall Study|Study Drug Non-Compliance|0|||
155681846|NCT02791191|561927977|FG000|Overall Study|Site Closed by Sponsor|1|||
155681847|NCT02791191|561927978|FG001|Overall Study|Site Closed by Sponsor|1|||
155681848|NCT02791191|561927979|FG002|Overall Study|Site Closed by Sponsor|3|||
155681849|NCT02791191|561927977|FG000|Overall Study|Progressive Disease|1|||
155681850|NCT02791191|561927978|FG001|Overall Study|Progressive Disease|0|||
155681851|NCT02791191|561927979|FG002|Overall Study|Progressive Disease|0|||
155681852|NCT02791191|561927977|FG000|Overall Study|Study Terminated by Sponsor|29|||
155681853|NCT02791191|561927978|FG001|Overall Study|Study Terminated by Sponsor|101|||
155681854|NCT02791191|561927979|FG002|Overall Study|Study Terminated by Sponsor|109|||
155681855|NCT02791191|561927977|FG000|Overall Study|Withdrawal by Subject|3|||
155681856|NCT02791191|561927978|FG001|Overall Study|Withdrawal by Subject|1|||
155681857|NCT02791191|561927979|FG002|Overall Study|Withdrawal by Subject|3|||
155681858|NCT02791191|561927977|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
155681859|NCT02791191|561927978|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
155681860|NCT02791191|561927979|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
155681861|NCT01448824|561927980|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681862|NCT01448824|561927981|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681863|NCT01448824|561927982|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681864|NCT01448824|561927983|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681865|NCT01448824|561927984|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681866|NCT01448824|561927985|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681867|NCT01448824|561927986|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
155681868|NCT01448824|561927987|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155681869|NCT01448824|561927980|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155681870|NCT01448824|561927981|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155681871|NCT01448824|561927982|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155681872|NCT01448824|561927983|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
155681873|NCT01448824|561927984|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
155681874|NCT01448824|561927985|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
155681875|NCT01448824|561927986|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155681876|NCT01448824|561927987|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155681877|NCT01448824|561927980|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681878|NCT01448824|561927981|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681879|NCT01448824|561927982|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681880|NCT01448824|561927983|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681881|NCT01448824|561927984|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681882|NCT01448824|561927985|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
155681883|NCT01448824|561927986|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681884|NCT01448824|561927987|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155681885|NCT01448824|561927980|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
155681886|NCT01448824|561927981|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
155681887|NCT01448824|561927982|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
155681888|NCT01448824|561927983|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
155681889|NCT01448824|561927984|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
155681890|NCT01448824|561927985|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
155681891|NCT01448824|561927986|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
155681892|NCT01448824|561927987|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
155681893|NCT01448824|561927980|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681894|NCT01448824|561927981|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681895|NCT01448824|561927982|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681896|NCT01448824|561927983|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681897|NCT01448824|561927984|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681898|NCT01448824|561927985|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681899|NCT01448824|561927986|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155681900|NCT01448824|561927987|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
155681901|NCT01448824|561927980|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681902|NCT01448824|561927981|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681903|NCT01448824|561927982|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681904|NCT01448824|561927983|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681905|NCT01448824|561927984|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681906|NCT01448824|561927985|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681907|NCT01448824|561927986|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155681908|NCT01448824|561927987|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
155681909|NCT01448824|561927980|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681910|NCT01448824|561927981|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681911|NCT01448824|561927982|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681912|NCT01448824|561927983|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681913|NCT01448824|561927984|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681914|NCT01448824|561927985|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681915|NCT01448824|561927986|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155681916|NCT01448824|561927987|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
155681917|NCT01448824|561927980|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681918|NCT01448824|561927981|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681919|NCT01448824|561927982|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681920|NCT01448824|561927983|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681921|NCT01448824|561927984|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681922|NCT01448824|561927985|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681923|NCT01448824|561927986|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155681924|NCT01448824|561927987|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
155681925|NCT01463111|561927990|FG000|Overall Study|Withdrawal by Subject|2|||
155681926|NCT01463111|561927990|FG000|Overall Study|Lost to Follow-up|5|||
155681927|NCT01463111|561927990|FG000|Overall Study|Physician Decision|2|||
155681928|NCT02578680|561927991|FG000|Overall Study|Death|329|||
155681929|NCT02578680|561927992|FG001|Overall Study|Death|181|||
155681930|NCT02578680|561927991|FG000|Overall Study|Lost to Follow-up|3|||
155681931|NCT02578680|561927992|FG001|Overall Study|Lost to Follow-up|1|||
155681932|NCT02578680|561927991|FG000|Overall Study|Physician Decision|0|||
155681933|NCT02578680|561927992|FG001|Overall Study|Physician Decision|1|||
155681934|NCT02578680|561927991|FG000|Overall Study|Protocol Violation|1|||
155681935|NCT02578680|561927992|FG001|Overall Study|Protocol Violation|1|||
155681936|NCT02578680|561927991|FG000|Overall Study|Sponsor Decision|64|||
155681937|NCT02578680|561927992|FG001|Overall Study|Sponsor Decision|13|||
155681938|NCT02578680|561927991|FG000|Overall Study|Withdrawal by Subject|13|||
155681939|NCT02578680|561927992|FG001|Overall Study|Withdrawal by Subject|9|||
155681940|NCT00218634|561927995|FG000|Overall Study|Lost to Follow-up|8|||
155681941|NCT00218634|561927996|FG001|Overall Study|Lost to Follow-up|15|||
155681942|NCT00734604|561927997|FG000|Overall Study|Adverse Event|0|||
155681943|NCT00734604|561927998|FG001|Overall Study|Adverse Event|2|||
155681944|NCT00734604|561927999|FG002|Overall Study|Adverse Event|0|||
155681945|NCT00734604|561928000|FG003|Overall Study|Adverse Event|2|||
155681946|NCT00734604|561928001|FG004|Overall Study|Adverse Event|1|||
155681947|NCT00734604|561928002|FG005|Overall Study|Adverse Event|1|||
155681948|NCT00734604|561927997|FG000|Overall Study|Serious Adverse Event|1|||
155681949|NCT00734604|561927998|FG001|Overall Study|Serious Adverse Event|0|||
155681950|NCT00734604|561927999|FG002|Overall Study|Serious Adverse Event|1|||
155681951|NCT00734604|561928000|FG003|Overall Study|Serious Adverse Event|2|||
155681952|NCT00734604|561928001|FG004|Overall Study|Serious Adverse Event|0|||
155681953|NCT00734604|561928002|FG005|Overall Study|Serious Adverse Event|1|||
155681954|NCT00734604|561927997|FG000|Overall Study|Lost to Follow-up|1|||
155681955|NCT00734604|561927998|FG001|Overall Study|Lost to Follow-up|2|||
155681956|NCT00734604|561927999|FG002|Overall Study|Lost to Follow-up|2|||
155681957|NCT00734604|561928000|FG003|Overall Study|Lost to Follow-up|4|||
155681958|NCT00734604|561928001|FG004|Overall Study|Lost to Follow-up|2|||
155681959|NCT00734604|561928002|FG005|Overall Study|Lost to Follow-up|3|||
155681960|NCT00734604|561927997|FG000|Overall Study|Physician Decision|0|||
155681961|NCT00734604|561927998|FG001|Overall Study|Physician Decision|1|||
155681962|NCT00734604|561927999|FG002|Overall Study|Physician Decision|1|||
155681963|NCT00734604|561928000|FG003|Overall Study|Physician Decision|0|||
155681964|NCT00734604|561928001|FG004|Overall Study|Physician Decision|0|||
155681965|NCT00734604|561928002|FG005|Overall Study|Physician Decision|0|||
155681966|NCT00734604|561927997|FG000|Overall Study|Protocol Violation|0|||
155681967|NCT00734604|561927998|FG001|Overall Study|Protocol Violation|2|||
155681968|NCT00734604|561927999|FG002|Overall Study|Protocol Violation|0|||
155681969|NCT00734604|561928000|FG003|Overall Study|Protocol Violation|0|||
155681970|NCT00734604|561928001|FG004|Overall Study|Protocol Violation|1|||
155681971|NCT00734604|561928002|FG005|Overall Study|Protocol Violation|0|||
155681972|NCT00734604|561927997|FG000|Overall Study|Sponsor Decision|1|||
155681973|NCT00734604|561927998|FG001|Overall Study|Sponsor Decision|2|||
155681974|NCT00734604|561927999|FG002|Overall Study|Sponsor Decision|1|||
155681975|NCT00734604|561928000|FG003|Overall Study|Sponsor Decision|0|||
155681976|NCT00734604|561928001|FG004|Overall Study|Sponsor Decision|2|||
155681977|NCT00734604|561928002|FG005|Overall Study|Sponsor Decision|0|||
155681978|NCT00734604|561927997|FG000|Overall Study|Withdrawal by Subject|0|||
155681979|NCT00734604|561927998|FG001|Overall Study|Withdrawal by Subject|2|||
155681980|NCT00734604|561927999|FG002|Overall Study|Withdrawal by Subject|0|||
155681981|NCT00734604|561928000|FG003|Overall Study|Withdrawal by Subject|1|||
155681982|NCT00734604|561928001|FG004|Overall Study|Withdrawal by Subject|2|||
155681983|NCT00734604|561928002|FG005|Overall Study|Withdrawal by Subject|1|||
155681984|NCT00734604|561927997|FG000|Overall Study|Lack of Efficacy|0|||
155681985|NCT00734604|561927998|FG001|Overall Study|Lack of Efficacy|1|||
155681986|NCT00734604|561927999|FG002|Overall Study|Lack of Efficacy|1|||
155681987|NCT00734604|561928000|FG003|Overall Study|Lack of Efficacy|0|||
155681988|NCT00734604|561928001|FG004|Overall Study|Lack of Efficacy|0|||
155681989|NCT00734604|561928002|FG005|Overall Study|Lack of Efficacy|0|||
155681990|NCT02589665|561928003|FG000|Induction Period|Did not receive drug|0|||
155681991|NCT02589665|561928004|FG001|Induction Period|Did not receive drug|0|||
155681992|NCT02589665|561928005|FG002|Induction Period|Did not receive drug|0|||
155681993|NCT02589665|561928006|FG003|Induction Period|Did not receive drug|1|||
155681994|NCT02589665|561928007|FG004|Induction Period|Did not receive drug|0|||
155681995|NCT02589665|561928008|FG005|Induction Period|Did not receive drug|0|||
155681996|NCT02589665|561928009|FG006|Induction Period|Did not receive drug|0|||
155681997|NCT02589665|561928010|FG007|Induction Period|Did not receive drug|0|||
155681998|NCT02589665|561928011|FG008|Induction Period|Did not receive drug|0|||
155681999|NCT02589665|561928012|FG009|Induction Period|Did not receive drug|0|||
155682000|NCT02589665|561928003|FG000|Induction Period|Adverse Event|3|||
155682001|NCT02589665|561928004|FG001|Induction Period|Adverse Event|0|||
155682002|NCT02589665|561928005|FG002|Induction Period|Adverse Event|2|||
155682003|NCT02589665|561928006|FG003|Induction Period|Adverse Event|2|||
155682004|NCT02589665|561928007|FG004|Induction Period|Adverse Event|0|||
155682005|NCT02589665|561928008|FG005|Induction Period|Adverse Event|0|||
155682006|NCT02589665|561928009|FG006|Induction Period|Adverse Event|0|||
155682007|NCT02589665|561928010|FG007|Induction Period|Adverse Event|0|||
155682008|NCT02589665|561928011|FG008|Induction Period|Adverse Event|0|||
155682009|NCT02589665|561928012|FG009|Induction Period|Adverse Event|0|||
155682010|NCT02589665|561928003|FG000|Induction Period|Withdrawal by Subject|0|||
155682011|NCT02589665|561928004|FG001|Induction Period|Withdrawal by Subject|1|||
155682012|NCT02589665|561928005|FG002|Induction Period|Withdrawal by Subject|0|||
155682013|NCT02589665|561928006|FG003|Induction Period|Withdrawal by Subject|1|||
155682014|NCT02589665|561928007|FG004|Induction Period|Withdrawal by Subject|0|||
155682015|NCT02589665|561928008|FG005|Induction Period|Withdrawal by Subject|0|||
155682016|NCT02589665|561928009|FG006|Induction Period|Withdrawal by Subject|0|||
155682017|NCT02589665|561928010|FG007|Induction Period|Withdrawal by Subject|0|||
155682018|NCT02589665|561928011|FG008|Induction Period|Withdrawal by Subject|0|||
155682019|NCT02589665|561928012|FG009|Induction Period|Withdrawal by Subject|0|||
155682020|NCT02589665|561928003|FG000|Induction Period|Protocol Violation|0|||
155682021|NCT02589665|561928004|FG001|Induction Period|Protocol Violation|1|||
155682022|NCT02589665|561928005|FG002|Induction Period|Protocol Violation|0|||
155682023|NCT02589665|561928006|FG003|Induction Period|Protocol Violation|0|||
155682024|NCT02589665|561928007|FG004|Induction Period|Protocol Violation|0|||
155682025|NCT02589665|561928008|FG005|Induction Period|Protocol Violation|0|||
155682026|NCT02589665|561928009|FG006|Induction Period|Protocol Violation|0|||
155682027|NCT02589665|561928010|FG007|Induction Period|Protocol Violation|0|||
155682028|NCT02589665|561928011|FG008|Induction Period|Protocol Violation|0|||
155682029|NCT02589665|561928012|FG009|Induction Period|Protocol Violation|0|||
155682030|NCT02589665|561928003|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682031|NCT02589665|561928004|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682032|NCT02589665|561928005|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682033|NCT02589665|561928006|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682034|NCT02589665|561928007|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
155682035|NCT02589665|561928008|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
155682036|NCT02589665|561928009|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
155682037|NCT02589665|561928010|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682038|NCT02589665|561928011|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682039|NCT02589665|561928012|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682040|NCT02589665|561928003|FG000|Maintenance Period|Withdrawal by Subject|0|||
155682041|NCT02589665|561928004|FG001|Maintenance Period|Withdrawal by Subject|0|||
155682042|NCT02589665|561928005|FG002|Maintenance Period|Withdrawal by Subject|0|||
155682043|NCT02589665|561928006|FG003|Maintenance Period|Withdrawal by Subject|0|||
155682044|NCT02589665|561928007|FG004|Maintenance Period|Withdrawal by Subject|4|||
155682045|NCT02589665|561928008|FG005|Maintenance Period|Withdrawal by Subject|2|||
155682046|NCT02589665|561928009|FG006|Maintenance Period|Withdrawal by Subject|4|||
155682047|NCT02589665|561928010|FG007|Maintenance Period|Withdrawal by Subject|0|||
155682048|NCT02589665|561928011|FG008|Maintenance Period|Withdrawal by Subject|0|||
155682049|NCT02589665|561928012|FG009|Maintenance Period|Withdrawal by Subject|0|||
155682050|NCT02589665|561928003|FG000|Maintenance Period|Lack of Efficacy|0|||
155682051|NCT02589665|561928004|FG001|Maintenance Period|Lack of Efficacy|0|||
155682052|NCT02589665|561928005|FG002|Maintenance Period|Lack of Efficacy|0|||
155682053|NCT02589665|561928006|FG003|Maintenance Period|Lack of Efficacy|0|||
155682054|NCT02589665|561928007|FG004|Maintenance Period|Lack of Efficacy|2|||
155682055|NCT02589665|561928008|FG005|Maintenance Period|Lack of Efficacy|1|||
155682056|NCT02589665|561928009|FG006|Maintenance Period|Lack of Efficacy|0|||
155682057|NCT02589665|561928010|FG007|Maintenance Period|Lack of Efficacy|0|||
155682058|NCT02589665|561928011|FG008|Maintenance Period|Lack of Efficacy|0|||
155682059|NCT02589665|561928012|FG009|Maintenance Period|Lack of Efficacy|0|||
155682060|NCT02589665|561928003|FG000|Maintenance Period|Adverse Event|0|||
155682061|NCT02589665|561928004|FG001|Maintenance Period|Adverse Event|0|||
155682062|NCT02589665|561928005|FG002|Maintenance Period|Adverse Event|0|||
155682063|NCT02589665|561928006|FG003|Maintenance Period|Adverse Event|0|||
155682064|NCT02589665|561928007|FG004|Maintenance Period|Adverse Event|0|||
155682065|NCT02589665|561928008|FG005|Maintenance Period|Adverse Event|0|||
155682066|NCT02589665|561928009|FG006|Maintenance Period|Adverse Event|2|||
155682067|NCT02589665|561928010|FG007|Maintenance Period|Adverse Event|0|||
155682068|NCT02589665|561928011|FG008|Maintenance Period|Adverse Event|0|||
155682069|NCT02589665|561928012|FG009|Maintenance Period|Adverse Event|0|||
155682070|NCT02589665|561928003|FG000|Maintenance Period|Lost to Follow-up|0|||
155682071|NCT02589665|561928004|FG001|Maintenance Period|Lost to Follow-up|0|||
155682072|NCT02589665|561928005|FG002|Maintenance Period|Lost to Follow-up|0|||
155682073|NCT02589665|561928006|FG003|Maintenance Period|Lost to Follow-up|0|||
155682074|NCT02589665|561928007|FG004|Maintenance Period|Lost to Follow-up|0|||
155682075|NCT02589665|561928008|FG005|Maintenance Period|Lost to Follow-up|1|||
155682076|NCT02589665|561928009|FG006|Maintenance Period|Lost to Follow-up|0|||
155682077|NCT02589665|561928010|FG007|Maintenance Period|Lost to Follow-up|0|||
155682078|NCT02589665|561928011|FG008|Maintenance Period|Lost to Follow-up|0|||
155682079|NCT02589665|561928012|FG009|Maintenance Period|Lost to Follow-up|0|||
155682080|NCT02589665|561928003|FG000|Maintenance Period|Physician Decision|0|||
155682081|NCT02589665|561928004|FG001|Maintenance Period|Physician Decision|0|||
155682082|NCT02589665|561928005|FG002|Maintenance Period|Physician Decision|0|||
155682083|NCT02589665|561928006|FG003|Maintenance Period|Physician Decision|0|||
155682084|NCT02589665|561928007|FG004|Maintenance Period|Physician Decision|0|||
155682085|NCT02589665|561928008|FG005|Maintenance Period|Physician Decision|1|||
155682086|NCT02589665|561928009|FG006|Maintenance Period|Physician Decision|0|||
155682087|NCT02589665|561928010|FG007|Maintenance Period|Physician Decision|0|||
155682088|NCT02589665|561928011|FG008|Maintenance Period|Physician Decision|0|||
155682089|NCT02589665|561928012|FG009|Maintenance Period|Physician Decision|0|||
155682090|NCT02589665|561928003|FG000|Maintenance Period|Reason Not Collected|0|||
155682091|NCT02589665|561928004|FG001|Maintenance Period|Reason Not Collected|0|||
155682092|NCT02589665|561928005|FG002|Maintenance Period|Reason Not Collected|0|||
155682093|NCT02589665|561928006|FG003|Maintenance Period|Reason Not Collected|0|||
155682094|NCT02589665|561928007|FG004|Maintenance Period|Reason Not Collected|0|||
155682095|NCT02589665|561928008|FG005|Maintenance Period|Reason Not Collected|1|||
155682096|NCT02589665|561928009|FG006|Maintenance Period|Reason Not Collected|1|||
155682097|NCT02589665|561928010|FG007|Maintenance Period|Reason Not Collected|0|||
155682098|NCT02589665|561928011|FG008|Maintenance Period|Reason Not Collected|0|||
155682099|NCT02589665|561928012|FG009|Maintenance Period|Reason Not Collected|0|||
155682100|NCT02589665|561928003|FG000|Induction Extension Period|Adverse Event|0|||
155682101|NCT02589665|561928004|FG001|Induction Extension Period|Adverse Event|0|||
155682102|NCT02589665|561928005|FG002|Induction Extension Period|Adverse Event|0|||
155682103|NCT02589665|561928006|FG003|Induction Extension Period|Adverse Event|0|||
155682104|NCT02589665|561928007|FG004|Induction Extension Period|Adverse Event|0|||
155682105|NCT02589665|561928008|FG005|Induction Extension Period|Adverse Event|0|||
155682106|NCT02589665|561928009|FG006|Induction Extension Period|Adverse Event|0|||
155682107|NCT02589665|561928010|FG007|Induction Extension Period|Adverse Event|0|||
155682108|NCT02589665|561928011|FG008|Induction Extension Period|Adverse Event|4|||
155682109|NCT02589665|561928012|FG009|Induction Extension Period|Adverse Event|0|||
155682110|NCT02589665|561928003|FG000|Induction Extension Period|Lack of Efficacy|0|||
155682111|NCT02589665|561928004|FG001|Induction Extension Period|Lack of Efficacy|0|||
155682112|NCT02589665|561928005|FG002|Induction Extension Period|Lack of Efficacy|0|||
155682113|NCT02589665|561928006|FG003|Induction Extension Period|Lack of Efficacy|0|||
155682114|NCT02589665|561928007|FG004|Induction Extension Period|Lack of Efficacy|0|||
155682115|NCT02589665|561928008|FG005|Induction Extension Period|Lack of Efficacy|0|||
155682116|NCT02589665|561928009|FG006|Induction Extension Period|Lack of Efficacy|0|||
155682117|NCT02589665|561928010|FG007|Induction Extension Period|Lack of Efficacy|0|||
155682118|NCT02589665|561928011|FG008|Induction Extension Period|Lack of Efficacy|3|||
155682119|NCT02589665|561928012|FG009|Induction Extension Period|Lack of Efficacy|0|||
155682120|NCT02589665|561928003|FG000|Induction Extension Period|Withdrawal by Subject|0|||
155682121|NCT02589665|561928004|FG001|Induction Extension Period|Withdrawal by Subject|0|||
155682122|NCT02589665|561928005|FG002|Induction Extension Period|Withdrawal by Subject|0|||
155682123|NCT02589665|561928006|FG003|Induction Extension Period|Withdrawal by Subject|0|||
155682124|NCT02589665|561928007|FG004|Induction Extension Period|Withdrawal by Subject|0|||
155682125|NCT02589665|561928008|FG005|Induction Extension Period|Withdrawal by Subject|0|||
155682126|NCT02589665|561928009|FG006|Induction Extension Period|Withdrawal by Subject|0|||
155682127|NCT02589665|561928010|FG007|Induction Extension Period|Withdrawal by Subject|2|||
155682128|NCT02589665|561928011|FG008|Induction Extension Period|Withdrawal by Subject|3|||
155682129|NCT02589665|561928012|FG009|Induction Extension Period|Withdrawal by Subject|0|||
155682130|NCT02589665|561928003|FG000|Induction Extension Period|Physician Decision|0|||
155682131|NCT02589665|561928004|FG001|Induction Extension Period|Physician Decision|0|||
155682132|NCT02589665|561928005|FG002|Induction Extension Period|Physician Decision|0|||
155682133|NCT02589665|561928006|FG003|Induction Extension Period|Physician Decision|0|||
155682134|NCT02589665|561928007|FG004|Induction Extension Period|Physician Decision|0|||
155682135|NCT02589665|561928008|FG005|Induction Extension Period|Physician Decision|0|||
155682136|NCT02589665|561928009|FG006|Induction Extension Period|Physician Decision|0|||
155682137|NCT02589665|561928010|FG007|Induction Extension Period|Physician Decision|0|||
155682138|NCT02589665|561928011|FG008|Induction Extension Period|Physician Decision|1|||
155682139|NCT02589665|561928012|FG009|Induction Extension Period|Physician Decision|0|||
155682140|NCT02589665|561928003|FG000|Induction Extension Period|Reason Not Collected|0|||
155682141|NCT02589665|561928004|FG001|Induction Extension Period|Reason Not Collected|0|||
155682142|NCT02589665|561928005|FG002|Induction Extension Period|Reason Not Collected|0|||
155682143|NCT02589665|561928006|FG003|Induction Extension Period|Reason Not Collected|0|||
155682144|NCT02589665|561928007|FG004|Induction Extension Period|Reason Not Collected|0|||
155682145|NCT02589665|561928008|FG005|Induction Extension Period|Reason Not Collected|0|||
155682146|NCT02589665|561928009|FG006|Induction Extension Period|Reason Not Collected|0|||
155682147|NCT02589665|561928010|FG007|Induction Extension Period|Reason Not Collected|0|||
155682148|NCT02589665|561928011|FG008|Induction Extension Period|Reason Not Collected|1|||
155682149|NCT02589665|561928012|FG009|Induction Extension Period|Reason Not Collected|0|||
155682150|NCT02589665|561928003|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682151|NCT02589665|561928004|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682152|NCT02589665|561928005|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682153|NCT02589665|561928006|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682154|NCT02589665|561928007|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682155|NCT02589665|561928008|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682156|NCT02589665|561928009|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682157|NCT02589665|561928010|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682158|NCT02589665|561928011|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155682159|NCT02589665|561928012|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
155682160|NCT02589665|561928003|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
155682161|NCT02589665|561928004|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
155682162|NCT02589665|561928005|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
155682163|NCT02589665|561928006|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
155682164|NCT02589665|561928007|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
155682165|NCT02589665|561928008|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
155682166|NCT02589665|561928009|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
155682167|NCT02589665|561928010|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
155682168|NCT02589665|561928011|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
155682169|NCT02589665|561928012|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
155682170|NCT02589665|561928003|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
155682171|NCT02589665|561928004|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
155682172|NCT02589665|561928005|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
155682173|NCT02589665|561928006|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
155682174|NCT02589665|561928007|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
155682175|NCT02589665|561928008|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
155682176|NCT02589665|561928009|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
155682177|NCT02589665|561928010|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
155682178|NCT02589665|561928011|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
155682179|NCT02589665|561928012|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
155682180|NCT02589665|561928003|FG000|Maintenance Extension Period|Adverse Event|0|||
155682181|NCT02589665|561928004|FG001|Maintenance Extension Period|Adverse Event|0|||
155682182|NCT02589665|561928005|FG002|Maintenance Extension Period|Adverse Event|0|||
155682183|NCT02589665|561928006|FG003|Maintenance Extension Period|Adverse Event|0|||
155682184|NCT02589665|561928007|FG004|Maintenance Extension Period|Adverse Event|0|||
155682185|NCT02589665|561928008|FG005|Maintenance Extension Period|Adverse Event|0|||
155682186|NCT02589665|561928009|FG006|Maintenance Extension Period|Adverse Event|0|||
155682187|NCT02589665|561928010|FG007|Maintenance Extension Period|Adverse Event|0|||
155682188|NCT02589665|561928011|FG008|Maintenance Extension Period|Adverse Event|0|||
155682189|NCT02589665|561928012|FG009|Maintenance Extension Period|Adverse Event|2|||
155682190|NCT02589665|561928003|FG000|Maintenance Extension Period|Non-responder|0|||
155682191|NCT02589665|561928004|FG001|Maintenance Extension Period|Non-responder|0|||
155682192|NCT02589665|561928005|FG002|Maintenance Extension Period|Non-responder|0|||
155682193|NCT02589665|561928006|FG003|Maintenance Extension Period|Non-responder|0|||
155682194|NCT02589665|561928007|FG004|Maintenance Extension Period|Non-responder|0|||
155682195|NCT02589665|561928008|FG005|Maintenance Extension Period|Non-responder|0|||
155682196|NCT02589665|561928009|FG006|Maintenance Extension Period|Non-responder|0|||
155682197|NCT02589665|561928010|FG007|Maintenance Extension Period|Non-responder|0|||
155682198|NCT02589665|561928011|FG008|Maintenance Extension Period|Non-responder|0|||
155682199|NCT02589665|561928012|FG009|Maintenance Extension Period|Non-responder|1|||
155682200|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Adverse Event|76|||
155682201|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Adverse Event|0|||
155682202|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Adverse Event|0|||
155682203|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Death|3|||
155682204|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Death|0|||
155682205|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Death|0|||
155682206|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
155682207|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
155682208|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
155682209|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Physician Decision|9|||
155682210|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Physician Decision|0|||
155682211|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Physician Decision|0|||
155682212|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
155682213|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
155682214|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
155682215|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Disease progression|45|||
155682216|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Disease progression|0|||
155682217|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Disease progression|0|||
155682218|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
155682219|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
155682220|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
155682221|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
155682222|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
155682223|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
155682224|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
155682225|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
155682226|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
155682227|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
155682228|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
155682229|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
155682230|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
155682231|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
155682232|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
155682233|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
155682234|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
155682235|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
155682236|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
155682237|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
155682238|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
155682239|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
155682240|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
155682241|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
155682242|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
155682243|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
155682244|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
155682245|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Promotor request|1|||
155682246|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Promotor request|0|||
155682247|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Promotor request|0|||
155682248|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
155682249|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
155682250|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
155682251|NCT01461928|561928013|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
155682252|NCT01461928|561928014|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
155682253|NCT01461928|561928015|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
155682254|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Death|3|||
155682255|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Death|0|||
155682256|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Death|0|||
155682257|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
155682258|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
155682259|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
155682260|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
155682261|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
155682262|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
155682263|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Diseases progression|91|||
155682264|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Diseases progression|0|||
155682265|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Diseases progression|0|||
155682266|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Adverse Event|70|||
155682267|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Adverse Event|0|||
155682268|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Adverse Event|0|||
155682269|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Physician Decision|9|||
155682270|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Physician Decision|0|||
155682271|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Physician Decision|0|||
155682272|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
155682273|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
155682274|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
155682275|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
155682276|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
155682277|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
155682278|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
155682279|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
155682280|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
155682281|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Not compliant|1|||
155682282|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Not compliant|0|||
155682283|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Not compliant|0|||
155682284|NCT01461928|561928013|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
155682285|NCT01461928|561928014|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
155682286|NCT01461928|561928015|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
155682287|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Adverse Event|0|||
155682288|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Adverse Event|2|||
155682289|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Adverse Event|0|||
155682290|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Death|0|||
155682291|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Death|10|||
155682292|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Death|8|||
155682293|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Physician Decision|0|||
155682294|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Physician Decision|0|||
155682295|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Physician Decision|4|||
155682296|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
155682297|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
155682298|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
155682299|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Moved to another town|0|||
155682300|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Moved to another town|1|||
155682301|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Moved to another town|0|||
155682302|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Disease progression|0|||
155682303|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Disease progression|0|||
155682304|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Disease progression|3|||
155682305|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
155682306|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
155682307|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
155682308|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
155682309|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
155682310|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
155682311|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
155682312|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
155682313|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
155682314|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
155682315|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
155682316|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
155682317|NCT01461928|561928013|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
155682318|NCT01461928|561928014|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
155682319|NCT01461928|561928015|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
155682320|NCT01159171|561928016|FG000|Overall Study|Adverse Event|11|||
155682321|NCT01159171|561928016|FG000|Overall Study|Progression of Disease|28|||
155682322|NCT01159171|561928016|FG000|Overall Study|Protocol Violation|1|||
155682323|NCT01159171|561928016|FG000|Overall Study|Need for Surgery|5|||
155682324|NCT01159171|561928016|FG000|Overall Study|Medical Decision|4|||
155682325|NCT01159171|561928016|FG000|Overall Study|Death|1|||
155682326|NCT01892436|561928019|FG000|Overall Study|Withdrawal by Subject|8|||
155682327|NCT01892436|561928020|FG001|Overall Study|Withdrawal by Subject|15|||
155682328|NCT01892436|561928021|FG002|Overall Study|Withdrawal by Subject|4|||
155682329|NCT01892436|561928022|FG003|Overall Study|Withdrawal by Subject|4|||
155682330|NCT01892436|561928019|FG000|Overall Study|Death|1|||
155682331|NCT01892436|561928020|FG001|Overall Study|Death|1|||
155682332|NCT01892436|561928021|FG002|Overall Study|Death|0|||
155682333|NCT01892436|561928022|FG003|Overall Study|Death|0|||
155682334|NCT01892436|561928019|FG000|Overall Study|Physician Decision|2|||
155682335|NCT01892436|561928020|FG001|Overall Study|Physician Decision|1|||
155682336|NCT01892436|561928021|FG002|Overall Study|Physician Decision|0|||
155682337|NCT01892436|561928022|FG003|Overall Study|Physician Decision|1|||
155682338|NCT01892436|561928019|FG000|Overall Study|Pregnancy|0|||
155682339|NCT01892436|561928020|FG001|Overall Study|Pregnancy|2|||
155682340|NCT01892436|561928021|FG002|Overall Study|Pregnancy|1|||
155682341|NCT01892436|561928022|FG003|Overall Study|Pregnancy|0|||
155682342|NCT01892436|561928019|FG000|Overall Study|Technical problems|2|||
155682343|NCT01892436|561928020|FG001|Overall Study|Technical problems|1|||
155682344|NCT01892436|561928021|FG002|Overall Study|Technical problems|1|||
155682345|NCT01892436|561928022|FG003|Overall Study|Technical problems|1|||
155682346|NCT01892436|561928019|FG000|Overall Study|Lack of Efficacy|1|||
155682347|NCT01892436|561928020|FG001|Overall Study|Lack of Efficacy|2|||
155682348|NCT01892436|561928021|FG002|Overall Study|Lack of Efficacy|2|||
155682349|NCT01892436|561928022|FG003|Overall Study|Lack of Efficacy|2|||
155682350|NCT01892436|561928019|FG000|Overall Study|Lost to Follow-up|1|||
155682351|NCT01892436|561928020|FG001|Overall Study|Lost to Follow-up|1|||
155682352|NCT01892436|561928021|FG002|Overall Study|Lost to Follow-up|1|||
155682353|NCT01892436|561928022|FG003|Overall Study|Lost to Follow-up|3|||
155682354|NCT01892436|561928019|FG000|Overall Study|non-compliance with treatment|1|||
155682355|NCT01892436|561928020|FG001|Overall Study|non-compliance with treatment|0|||
155682356|NCT01892436|561928021|FG002|Overall Study|non-compliance with treatment|0|||
155682357|NCT01892436|561928022|FG003|Overall Study|non-compliance with treatment|0|||
155682358|NCT01892436|561928019|FG000|Overall Study|Adverse Event|7|||
155682359|NCT01892436|561928020|FG001|Overall Study|Adverse Event|6|||
155682360|NCT01892436|561928021|FG002|Overall Study|Adverse Event|2|||
155682361|NCT01892436|561928022|FG003|Overall Study|Adverse Event|3|||
155682362|NCT02923830|561928026|FG000|Overall Study|Physician Decision|13|||
155682363|NCT02923830|561928027|FG001|Overall Study|Physician Decision|15|||
155682364|NCT00837265|561928028|FG000|Pilot Phase|Withdrawal by Subject|0|||
155682365|NCT00837265|561928029|FG001|Pilot Phase|Withdrawal by Subject|2|||
155682366|NCT00837265|561928030|FG002|Pilot Phase|Withdrawal by Subject|3|||
155682367|NCT00837265|561928031|FG003|Pilot Phase|Withdrawal by Subject|2|||
155682368|NCT00837265|561928032|FG004|Pilot Phase|Withdrawal by Subject|0|||
155682369|NCT00837265|561928033|FG005|Pilot Phase|Withdrawal by Subject|0|||
155682370|NCT00837265|561928034|FG006|Pilot Phase|Withdrawal by Subject|0|||
155682371|NCT00837265|561928028|FG000|Pilot Phase|Decision of the investigator|2|||
155682372|NCT00837265|561928029|FG001|Pilot Phase|Decision of the investigator|1|||
155682373|NCT00837265|561928030|FG002|Pilot Phase|Decision of the investigator|0|||
155682374|NCT00837265|561928031|FG003|Pilot Phase|Decision of the investigator|0|||
155682375|NCT00837265|561928032|FG004|Pilot Phase|Decision of the investigator|0|||
155682376|NCT00837265|561928033|FG005|Pilot Phase|Decision of the investigator|0|||
155682377|NCT00837265|561928034|FG006|Pilot Phase|Decision of the investigator|0|||
155682378|NCT00837265|561928028|FG000|Pilot Phase|Adverse Event|1|||
155682379|NCT00837265|561928029|FG001|Pilot Phase|Adverse Event|0|||
155682380|NCT00837265|561928030|FG002|Pilot Phase|Adverse Event|0|||
155682381|NCT00837265|561928031|FG003|Pilot Phase|Adverse Event|0|||
155682382|NCT00837265|561928032|FG004|Pilot Phase|Adverse Event|0|||
155682383|NCT00837265|561928033|FG005|Pilot Phase|Adverse Event|0|||
155682384|NCT00837265|561928034|FG006|Pilot Phase|Adverse Event|0|||
155682385|NCT00837265|561928028|FG000|Pilot Phase|Disease progression|0|||
155682386|NCT00837265|561928029|FG001|Pilot Phase|Disease progression|0|||
155682387|NCT00837265|561928030|FG002|Pilot Phase|Disease progression|0|||
155682388|NCT00837265|561928031|FG003|Pilot Phase|Disease progression|1|||
155682389|NCT00837265|561928032|FG004|Pilot Phase|Disease progression|0|||
155682390|NCT00837265|561928033|FG005|Pilot Phase|Disease progression|0|||
155682391|NCT00837265|561928034|FG006|Pilot Phase|Disease progression|0|||
155682392|NCT00837265|561928028|FG000|Pilot Phase|Participant left the city|0|||
155682393|NCT00837265|561928029|FG001|Pilot Phase|Participant left the city|0|||
155682394|NCT00837265|561928030|FG002|Pilot Phase|Participant left the city|0|||
155682395|NCT00837265|561928031|FG003|Pilot Phase|Participant left the city|1|||
155682396|NCT00837265|561928032|FG004|Pilot Phase|Participant left the city|0|||
155682397|NCT00837265|561928033|FG005|Pilot Phase|Participant left the city|0|||
155682398|NCT00837265|561928034|FG006|Pilot Phase|Participant left the city|0|||
155682399|NCT00837265|561928028|FG000|Main Phase|Withdrawal by Subject|0|||
155682400|NCT00837265|561928029|FG001|Main Phase|Withdrawal by Subject|0|||
155682401|NCT00837265|561928030|FG002|Main Phase|Withdrawal by Subject|0|||
155682402|NCT00837265|561928031|FG003|Main Phase|Withdrawal by Subject|0|||
155682403|NCT00837265|561928032|FG004|Main Phase|Withdrawal by Subject|4|||
155682404|NCT00837265|561928033|FG005|Main Phase|Withdrawal by Subject|2|||
155682405|NCT00837265|561928034|FG006|Main Phase|Withdrawal by Subject|1|||
155682406|NCT00837265|561928028|FG000|Main Phase|Decision of the investigator|0|||
155682407|NCT00837265|561928029|FG001|Main Phase|Decision of the investigator|0|||
155682408|NCT00837265|561928030|FG002|Main Phase|Decision of the investigator|0|||
155682409|NCT00837265|561928031|FG003|Main Phase|Decision of the investigator|0|||
155682410|NCT00837265|561928032|FG004|Main Phase|Decision of the investigator|0|||
155682411|NCT00837265|561928033|FG005|Main Phase|Decision of the investigator|2|||
155682412|NCT00837265|561928034|FG006|Main Phase|Decision of the investigator|1|||
155682413|NCT00837265|561928028|FG000|Main Phase|Adverse Event|0|||
155682414|NCT00837265|561928029|FG001|Main Phase|Adverse Event|0|||
155682415|NCT00837265|561928030|FG002|Main Phase|Adverse Event|0|||
155682416|NCT00837265|561928031|FG003|Main Phase|Adverse Event|0|||
155682417|NCT00837265|561928032|FG004|Main Phase|Adverse Event|0|||
155682418|NCT00837265|561928033|FG005|Main Phase|Adverse Event|1|||
155682419|NCT00837265|561928034|FG006|Main Phase|Adverse Event|0|||
155682420|NCT00837265|561928028|FG000|Main Phase|Death|0|||
155682421|NCT00837265|561928029|FG001|Main Phase|Death|0|||
155682422|NCT00837265|561928030|FG002|Main Phase|Death|0|||
155682423|NCT00837265|561928031|FG003|Main Phase|Death|0|||
155682424|NCT00837265|561928032|FG004|Main Phase|Death|2|||
155682425|NCT00837265|561928033|FG005|Main Phase|Death|0|||
155682426|NCT00837265|561928034|FG006|Main Phase|Death|1|||
155682427|NCT00837265|561928028|FG000|Main Phase|Lost to Follow-up|0|||
155682428|NCT00837265|561928029|FG001|Main Phase|Lost to Follow-up|0|||
155682429|NCT00837265|561928030|FG002|Main Phase|Lost to Follow-up|0|||
155682430|NCT00837265|561928031|FG003|Main Phase|Lost to Follow-up|0|||
155682431|NCT00837265|561928032|FG004|Main Phase|Lost to Follow-up|1|||
155682432|NCT00837265|561928033|FG005|Main Phase|Lost to Follow-up|0|||
155682433|NCT00837265|561928034|FG006|Main Phase|Lost to Follow-up|0|||
155682434|NCT00837265|561928028|FG000|Main Phase|Principal investigator resignation|0|||
155682435|NCT00837265|561928029|FG001|Main Phase|Principal investigator resignation|0|||
155682436|NCT00837265|561928030|FG002|Main Phase|Principal investigator resignation|0|||
155682437|NCT00837265|561928031|FG003|Main Phase|Principal investigator resignation|0|||
155682438|NCT00837265|561928032|FG004|Main Phase|Principal investigator resignation|2|||
155682439|NCT00837265|561928033|FG005|Main Phase|Principal investigator resignation|0|||
155682440|NCT00837265|561928034|FG006|Main Phase|Principal investigator resignation|0|||
155682441|NCT00837265|561928028|FG000|Main Phase|Participant's personal reason|0|||
155603443|NCT00513357|561635500|FG001|Overall Study|did not receive allocated placebo|3|||
155603444|NCT00513357|561635499|FG000|Overall Study|Adverse Event|4|||
155603445|NCT00513357|561635500|FG001|Overall Study|Adverse Event|2|||
155603446|NCT00513357|561635499|FG000|Overall Study|Death|2|||
155603447|NCT00513357|561635500|FG001|Overall Study|Death|0|||
155603448|NCT00513357|561635499|FG000|Overall Study|Withdrawal by Subject|5|||
155603449|NCT00513357|561635500|FG001|Overall Study|Withdrawal by Subject|4|||
155603450|NCT00513357|561635499|FG000|Overall Study|Disease Progression|2|||
155603451|NCT00513357|561635500|FG001|Overall Study|Disease Progression|1|||
155603452|NCT01162122|561635501|FG000|Overall Study|Withdrawal by Subject|52|||
155603453|NCT01162122|561635502|FG001|Overall Study|Withdrawal by Subject|43|||
155603454|NCT01162122|561635501|FG000|Overall Study|Lost to Follow-up|73|||
155603455|NCT01162122|561635502|FG001|Overall Study|Lost to Follow-up|91|||
155603456|NCT01162122|561635501|FG000|Overall Study|Adverse Event|3|||
155603457|NCT01162122|561635502|FG001|Overall Study|Adverse Event|2|||
155603458|NCT01162122|561635501|FG000|Overall Study|Death|51|||
155603459|NCT01162122|561635502|FG001|Overall Study|Death|46|||
155603460|NCT01162122|561635501|FG000|Overall Study|Protocol Violation|2|||
155603461|NCT01162122|561635502|FG001|Overall Study|Protocol Violation|2|||
155603462|NCT01162122|561635501|FG000|Overall Study|Inappropriate enrollment|5|||
155603463|NCT01162122|561635502|FG001|Overall Study|Inappropriate enrollment|4|||
155603464|NCT01162122|561635501|FG000|Overall Study|Administrative reason|1|||
155603465|NCT01162122|561635502|FG001|Overall Study|Administrative reason|1|||
155603466|NCT01162122|561635501|FG000|Overall Study|Unable to classify|3|||
155603467|NCT01162122|561635502|FG001|Overall Study|Unable to classify|7|||
155603468|NCT01162122|561635501|FG000|Overall Study|Missing primary reason|1|||
155603469|NCT01162122|561635502|FG001|Overall Study|Missing primary reason|0|||
155603470|NCT02020512|561635503|FG000|Overall Study|Adverse Event|1|||
155603471|NCT02020512|561635503|FG000|Overall Study|Lost to Follow-up|3|||
155603472|NCT02020512|561635503|FG000|Overall Study|Protocol Violation|4|||
155603473|NCT01966068|561635512|FG000|Overall Study|Withdrawal by Subject|57|||
155603474|NCT01966068|561635512|FG000|Overall Study|Lost to Follow-up|81|||
155603475|NCT00808639|561635513|FG000|Overall Study|Disease progression before surgery.|1|||
155603476|NCT01790828|561635517|FG000|Overall Study|Other|34|||
155603477|NCT03589976|561635519|FG000|Overall Study|Death|5|||
155603478|NCT03589976|561635520|FG001|Overall Study|Death|1|||
155603479|NCT03589976|561635519|FG000|Overall Study|Adverse Event|5|||
155603480|NCT03589976|561635520|FG001|Overall Study|Adverse Event|1|||
155603481|NCT03589976|561635519|FG000|Overall Study|Withdrawal by Subject|4|||
155603482|NCT03589976|561635520|FG001|Overall Study|Withdrawal by Subject|1|||
155603483|NCT03589976|561635519|FG000|Overall Study|Lost to Follow-up|1|||
155603484|NCT03589976|561635520|FG001|Overall Study|Lost to Follow-up|0|||
155603485|NCT03589976|561635519|FG000|Overall Study|Other|4|||
155603486|NCT03589976|561635520|FG001|Overall Study|Other|3|||
155603487|NCT02089334|561635521|FG000|Overall Study|Withdrawal by Subject|0|||
155603488|NCT02089334|561635522|FG001|Overall Study|Withdrawal by Subject|0|||
155603489|NCT02089334|561635523|FG002|Overall Study|Withdrawal by Subject|0|||
155603490|NCT02089334|561635524|FG003|Overall Study|Withdrawal by Subject|2|||
155603491|NCT02089334|561635521|FG000|Overall Study|Adverse Event|0|||
155603492|NCT02089334|561635522|FG001|Overall Study|Adverse Event|0|||
155603493|NCT02089334|561635523|FG002|Overall Study|Adverse Event|0|||
155603494|NCT02089334|561635524|FG003|Overall Study|Adverse Event|2|||
155603495|NCT02089334|561635521|FG000|Overall Study|Progressive disease|0|||
155603496|NCT02089334|561635522|FG001|Overall Study|Progressive disease|0|||
155603497|NCT02089334|561635523|FG002|Overall Study|Progressive disease|0|||
155603498|NCT02089334|561635524|FG003|Overall Study|Progressive disease|2|||
155603499|NCT02089334|561635521|FG000|Overall Study|Physician Decision|0|||
155603500|NCT02089334|561635522|FG001|Overall Study|Physician Decision|0|||
155603501|NCT02089334|561635523|FG002|Overall Study|Physician Decision|1|||
155603502|NCT02089334|561635524|FG003|Overall Study|Physician Decision|1|||
155603503|NCT01645891|561635531|FG000|Overall Study|Adverse Event|6|||
155603504|NCT01645891|561635532|FG001|Overall Study|Adverse Event|10|||
155603505|NCT01645891|561635531|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
155603506|NCT01645891|561635532|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
155603507|NCT01645891|561635531|FG000|Overall Study|Withdrawal by Subject|3|||
155603508|NCT01645891|561635532|FG001|Overall Study|Withdrawal by Subject|3|||
155603509|NCT01645891|561635531|FG000|Overall Study|Protocol Violation|4|||
155603510|NCT01645891|561635532|FG001|Overall Study|Protocol Violation|0|||
155603511|NCT01645891|561635531|FG000|Overall Study|Lost to Follow-up|4|||
155603512|NCT01645891|561635532|FG001|Overall Study|Lost to Follow-up|1|||
155603513|NCT01645891|561635531|FG000|Overall Study|Death|0|||
155603514|NCT01645891|561635532|FG001|Overall Study|Death|2|||
155603515|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
155603516|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
155603517|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
155603518|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
155603519|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
155603520|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
155603521|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
155603522|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
155603523|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
155603524|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
155603525|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
155603526|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
155603527|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
155603528|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
155603529|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
155603530|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
155603531|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
155603532|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
155603533|NCT02294461|561635534|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
155603534|NCT02294461|561635535|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
155603535|NCT02294461|561635536|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
155603536|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
155603537|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
155603538|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
155603539|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
155603540|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
155603541|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
155603542|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
155603543|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
155603544|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
155603545|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
155603546|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
155603547|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
155603548|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
155603549|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
155603550|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
155603551|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
155603552|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
155603553|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
155603554|NCT02294461|561635534|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
155603555|NCT02294461|561635535|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
155603556|NCT02294461|561635536|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
155603557|NCT00549601|561637723|FG000|Randomized|Protocol Violation|0|||
155603558|NCT00549601|561637724|FG001|Randomized|Protocol Violation|0|||
155603559|NCT00549601|561637725|FG002|Randomized|Protocol Violation|1|||
155603560|NCT00549601|561637723|FG000|Randomized|Withdrawal by Subject|0|||
155603561|NCT00549601|561637724|FG001|Randomized|Withdrawal by Subject|1|||
155603562|NCT00549601|561637725|FG002|Randomized|Withdrawal by Subject|1|||
155603563|NCT00549601|561637723|FG000|Received Study Drug|Adverse Event|2|||
155603564|NCT00549601|561637724|FG001|Received Study Drug|Adverse Event|5|||
155603565|NCT00549601|561637725|FG002|Received Study Drug|Adverse Event|1|||
155603566|NCT00549601|561637723|FG000|Received Study Drug|Death|0|||
155603567|NCT00549601|561637724|FG001|Received Study Drug|Death|1|||
155603568|NCT00549601|561637725|FG002|Received Study Drug|Death|0|||
155603569|NCT00549601|561637723|FG000|Received Study Drug|Lost to Follow-up|0|||
155603570|NCT00549601|561637724|FG001|Received Study Drug|Lost to Follow-up|1|||
155603571|NCT00549601|561637725|FG002|Received Study Drug|Lost to Follow-up|1|||
155603572|NCT00549601|561637723|FG000|Received Study Drug|Protocol Violation|3|||
155603573|NCT00549601|561637724|FG001|Received Study Drug|Protocol Violation|4|||
155603574|NCT00549601|561637725|FG002|Received Study Drug|Protocol Violation|1|||
155603575|NCT00549601|561637723|FG000|Received Study Drug|Withdrawal by Subject|2|||
155603576|NCT00549601|561637724|FG001|Received Study Drug|Withdrawal by Subject|0|||
155603577|NCT00549601|561637725|FG002|Received Study Drug|Withdrawal by Subject|1|||
155603578|NCT00908596|561637729|FG000|Overall Study|Other reasons|46|||
155603579|NCT00908596|561637730|FG001|Overall Study|Other reasons|6|||
155603580|NCT00908596|561637731|FG002|Overall Study|Other reasons|2|||
155682442|NCT00837265|561928029|FG001|Main Phase|Participant's personal reason|0|||
155682443|NCT00837265|561928030|FG002|Main Phase|Participant's personal reason|0|||
155682444|NCT00837265|561928031|FG003|Main Phase|Participant's personal reason|0|||
155682445|NCT00837265|561928032|FG004|Main Phase|Participant's personal reason|1|||
155682446|NCT00837265|561928033|FG005|Main Phase|Participant's personal reason|0|||
155682447|NCT00837265|561928034|FG006|Main Phase|Participant's personal reason|0|||
155682448|NCT01751906|561928036|FG000|Overall Study|Lost to Follow-up|151|||
155682449|NCT01751906|561928037|FG001|Overall Study|Lost to Follow-up|68|||
155682450|NCT01751906|561928036|FG000|Overall Study|Withdrawal by Subject|22|||
155682451|NCT01751906|561928037|FG001|Overall Study|Withdrawal by Subject|18|||
155682452|NCT01751906|561928036|FG000|Overall Study|Physician Decision|5|||
155682453|NCT01751906|561928037|FG001|Overall Study|Physician Decision|2|||
155682454|NCT01751906|561928036|FG000|Overall Study|Death|84|||
155682455|NCT01751906|561928037|FG001|Overall Study|Death|43|||
155682456|NCT01751906|561928036|FG000|Overall Study|Denied on premises for follow-up by law|1|||
155682457|NCT01751906|561928037|FG001|Overall Study|Denied on premises for follow-up by law|0|||
155682458|NCT00733291|561928038|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
155682459|NCT00733291|561928039|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155682460|NCT00733291|561928040|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155682461|NCT00733291|561928041|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155682462|NCT02759107|561928048|FG000|Overall Study|Adverse Event|0|||
155682463|NCT02759107|561928049|FG001|Overall Study|Adverse Event|0|||
155682464|NCT02759107|561928050|FG002|Overall Study|Adverse Event|0|||
155682465|NCT02759107|561928051|FG003|Overall Study|Adverse Event|0|||
155682466|NCT02759107|561928052|FG004|Overall Study|Adverse Event|0|||
155682467|NCT02759107|561928053|FG005|Overall Study|Adverse Event|0|||
155682468|NCT02759107|561928054|FG006|Overall Study|Adverse Event|0|||
155682469|NCT02759107|561928055|FG007|Overall Study|Adverse Event|0|||
155682470|NCT02759107|561928056|FG008|Overall Study|Adverse Event|0|||
155682471|NCT02759107|561928057|FG009|Overall Study|Adverse Event|0|||
155682472|NCT02759107|561928058|FG010|Overall Study|Adverse Event|0|||
155682473|NCT02759107|561928059|FG011|Overall Study|Adverse Event|0|||
155682474|NCT02759107|561928060|FG012|Overall Study|Adverse Event|2|||
155682475|NCT02759107|561928061|FG013|Overall Study|Adverse Event|0|||
155682476|NCT02759107|561928062|FG014|Overall Study|Adverse Event|0|||
155682477|NCT02759107|561928063|FG015|Overall Study|Adverse Event|1|||
155682478|NCT02759107|561928064|FG016|Overall Study|Adverse Event|0|||
155682479|NCT02759107|561928065|FG017|Overall Study|Adverse Event|2|||
155682480|NCT02759107|561928048|FG000|Overall Study|Scheduling Conflict|0|||
155682481|NCT02759107|561928049|FG001|Overall Study|Scheduling Conflict|0|||
155682482|NCT02759107|561928050|FG002|Overall Study|Scheduling Conflict|0|||
155682483|NCT02759107|561928051|FG003|Overall Study|Scheduling Conflict|0|||
155682484|NCT02759107|561928052|FG004|Overall Study|Scheduling Conflict|0|||
155682485|NCT02759107|561928053|FG005|Overall Study|Scheduling Conflict|0|||
155682486|NCT02759107|561928054|FG006|Overall Study|Scheduling Conflict|0|||
155682487|NCT02759107|561928055|FG007|Overall Study|Scheduling Conflict|0|||
155682488|NCT02759107|561928056|FG008|Overall Study|Scheduling Conflict|0|||
155682489|NCT02759107|561928057|FG009|Overall Study|Scheduling Conflict|1|||
155682490|NCT02759107|561928058|FG010|Overall Study|Scheduling Conflict|0|||
155682491|NCT02759107|561928059|FG011|Overall Study|Scheduling Conflict|0|||
155682492|NCT02759107|561928060|FG012|Overall Study|Scheduling Conflict|0|||
155682493|NCT02759107|561928061|FG013|Overall Study|Scheduling Conflict|0|||
155682494|NCT02759107|561928062|FG014|Overall Study|Scheduling Conflict|0|||
155682495|NCT02759107|561928063|FG015|Overall Study|Scheduling Conflict|0|||
155682496|NCT02759107|561928064|FG016|Overall Study|Scheduling Conflict|0|||
155682497|NCT02759107|561928065|FG017|Overall Study|Scheduling Conflict|0|||
155682498|NCT00420004|561928074|FG000|Overall Study|Adverse Event|4|||
155682499|NCT00420004|561928075|FG001|Overall Study|Adverse Event|1|||
155682500|NCT00420004|561928076|FG002|Overall Study|Adverse Event|1|||
155682501|NCT00420004|561928074|FG000|Overall Study|Lack of Efficacy|5|||
155682502|NCT00420004|561928075|FG001|Overall Study|Lack of Efficacy|4|||
155682503|NCT00420004|561928076|FG002|Overall Study|Lack of Efficacy|1|||
155682504|NCT00420004|561928074|FG000|Overall Study|Lost to Follow-up|31|||
155682505|NCT00420004|561928075|FG001|Overall Study|Lost to Follow-up|12|||
155682506|NCT00420004|561928076|FG002|Overall Study|Lost to Follow-up|10|||
155682507|NCT00420004|561928074|FG000|Overall Study|Entry Criteria Not Met|0|||
155682508|NCT00420004|561928075|FG001|Overall Study|Entry Criteria Not Met|1|||
155682509|NCT00420004|561928076|FG002|Overall Study|Entry Criteria Not Met|0|||
155682510|NCT00420004|561928074|FG000|Overall Study|Physician Decision|14|||
155682511|NCT00420004|561928075|FG001|Overall Study|Physician Decision|4|||
155682512|NCT00420004|561928076|FG002|Overall Study|Physician Decision|2|||
155682513|NCT00420004|561928074|FG000|Overall Study|Protocol Violation|5|||
155682514|NCT00420004|561928075|FG001|Overall Study|Protocol Violation|4|||
155682515|NCT00420004|561928076|FG002|Overall Study|Protocol Violation|3|||
155682516|NCT00420004|561928074|FG000|Overall Study|Withdrawal by Subject|67|||
155682517|NCT00420004|561928075|FG001|Overall Study|Withdrawal by Subject|42|||
155682518|NCT00420004|561928076|FG002|Overall Study|Withdrawal by Subject|14|||
155682519|NCT00420004|561928074|FG000|Overall Study|Sponsor Decision|3|||
155682520|NCT00420004|561928075|FG001|Overall Study|Sponsor Decision|3|||
155682521|NCT00420004|561928076|FG002|Overall Study|Sponsor Decision|1|||
155682522|NCT00470093|561928077|FG000|Overall Study|Adverse Event|2|||
155682523|NCT00664560|561928078|FG000|Overall Study|Adverse Event|19|||
155682524|NCT00664560|561928079|FG001|Overall Study|Adverse Event|16|||
155682525|NCT00664560|561928080|FG002|Overall Study|Adverse Event|7|||
155682526|NCT00664560|561928078|FG000|Overall Study|Withdrawal by Subject|9|||
155682527|NCT00664560|561928079|FG001|Overall Study|Withdrawal by Subject|13|||
155682528|NCT00664560|561928080|FG002|Overall Study|Withdrawal by Subject|7|||
155682529|NCT00664560|561928078|FG000|Overall Study|Lost to Follow-up|0|||
155682530|NCT00664560|561928079|FG001|Overall Study|Lost to Follow-up|2|||
155682531|NCT00664560|561928080|FG002|Overall Study|Lost to Follow-up|0|||
155682532|NCT00664560|561928078|FG000|Overall Study|Other|11|||
155682533|NCT00664560|561928079|FG001|Overall Study|Other|4|||
155682534|NCT00664560|561928080|FG002|Overall Study|Other|5|||
155682535|NCT00473668|561928083|FG000|Overall Study|Withdrawal by Subject|0|||
155682536|NCT00473668|561928084|FG001|Overall Study|Withdrawal by Subject|2|||
155682537|NCT00473668|561928085|FG002|Overall Study|Withdrawal by Subject|0|||
155682538|NCT00473668|561928083|FG000|Overall Study|Migrated/moved from study area|3|||
155682539|NCT00473668|561928084|FG001|Overall Study|Migrated/moved from study area|2|||
155682540|NCT00473668|561928085|FG002|Overall Study|Migrated/moved from study area|0|||
155682541|NCT00473668|561928083|FG000|Overall Study|Lost to Follow-up|0|||
155682542|NCT00473668|561928084|FG001|Overall Study|Lost to Follow-up|4|||
155682543|NCT00473668|561928085|FG002|Overall Study|Lost to Follow-up|6|||
155682544|NCT00473668|561928083|FG000|Overall Study|Other|2|||
155682545|NCT00473668|561928084|FG001|Overall Study|Other|3|||
155682546|NCT00473668|561928085|FG002|Overall Study|Other|4|||
155682547|NCT02039219|561928086|FG000|Treatment|Withdrawal by Subject|1|||
155682548|NCT02039219|561928087|FG001|Treatment|Withdrawal by Subject|0|||
155682549|NCT02039219|561928086|FG000|Treatment|Adverse Event|0|||
155682550|NCT02039219|561928087|FG001|Treatment|Adverse Event|1|||
155682551|NCT02039219|561928086|FG000|Treatment|Physician Decision|1|||
155682552|NCT02039219|561928087|FG001|Treatment|Physician Decision|0|||
155682553|NCT02039219|561928086|FG000|Treatment|Lost to Follow-up|0|||
155682554|NCT02039219|561928087|FG001|Treatment|Lost to Follow-up|1|||
155682555|NCT02039219|561928086|FG000|Treatment|Protocol Violation|1|||
155682556|NCT02039219|561928087|FG001|Treatment|Protocol Violation|0|||
155682557|NCT02039219|561928086|FG000|Treatment|Death|1|||
155682558|NCT02039219|561928087|FG001|Treatment|Death|0|||
155682559|NCT02039219|561928086|FG000|Follow up|Adverse Event|0|||
155682560|NCT02039219|561928087|FG001|Follow up|Adverse Event|1|||
155682561|NCT02226562|561928093|FG000|Overall Study|Lost to Follow-up|0|||
155682562|NCT02226562|561928094|FG001|Overall Study|Lost to Follow-up|1|||
155682563|NCT00006164|561928095|FG000|Overall Study|Withdrew or lost to follow-up|70|||
155682564|NCT00006164|561928096|FG001|Overall Study|Withdrew or lost to follow-up|81|||
155682565|NCT02750345|561928097|FG000|Intervention 1|Adverse Event|0|||
155682566|NCT02750345|561928098|FG001|Intervention 1|Adverse Event|0|||
155682567|NCT02750345|561928099|FG002|Intervention 1|Adverse Event|0|||
155682568|NCT02750345|561928100|FG003|Intervention 1|Adverse Event|0|||
155682569|NCT02750345|561928101|FG004|Intervention 1|Adverse Event|1|||
155682570|NCT02750345|561928102|FG005|Intervention 1|Adverse Event|0|||
155682571|NCT00223808|561928103|FG000|Overall Study|<5 hrs therapy before discharge|3|||
155682572|NCT00223808|561928104|FG001|Overall Study|<5 hrs therapy before discharge|5|||
155682573|NCT00223808|561928105|FG002|Overall Study|<5 hrs therapy before discharge|5|||
155682574|NCT00191724|561928108|FG000|Overall Study|Adverse Event|0|||
155682575|NCT00191724|561928109|FG001|Overall Study|Adverse Event|0|||
155682576|NCT00191724|561928110|FG002|Overall Study|Adverse Event|1|||
155682577|NCT00191724|561928111|FG003|Overall Study|Adverse Event|0|||
155682578|NCT00191724|561928112|FG004|Overall Study|Adverse Event|0|||
155682579|NCT00191724|561928108|FG000|Overall Study|Lost to Follow-up|1|||
155682580|NCT00191724|561928109|FG001|Overall Study|Lost to Follow-up|1|||
155682581|NCT00191724|561928110|FG002|Overall Study|Lost to Follow-up|0|||
155682582|NCT00191724|561928111|FG003|Overall Study|Lost to Follow-up|2|||
155682583|NCT00191724|561928112|FG004|Overall Study|Lost to Follow-up|3|||
155682584|NCT00191724|561928108|FG000|Overall Study|Withdrawal by Subject|0|||
155682585|NCT00191724|561928109|FG001|Overall Study|Withdrawal by Subject|0|||
155682586|NCT00191724|561928110|FG002|Overall Study|Withdrawal by Subject|0|||
155682587|NCT00191724|561928111|FG003|Overall Study|Withdrawal by Subject|1|||
155682588|NCT00191724|561928112|FG004|Overall Study|Withdrawal by Subject|0|||
155682589|NCT00608023|561928113|FG000|Overall Study|Withdrawal by Subject|8|||
155682590|NCT00608023|561928114|FG001|Overall Study|Withdrawal by Subject|10|||
155682591|NCT00608023|561928115|FG002|Overall Study|Withdrawal by Subject|7|||
155682592|NCT00608023|561928113|FG000|Overall Study|Adverse Event|1|||
155682593|NCT00608023|561928114|FG001|Overall Study|Adverse Event|4|||
155682594|NCT00608023|561928115|FG002|Overall Study|Adverse Event|5|||
155682595|NCT00608023|561928113|FG000|Overall Study|Lost to Follow-up|2|||
155682596|NCT00608023|561928114|FG001|Overall Study|Lost to Follow-up|2|||
155682597|NCT00608023|561928115|FG002|Overall Study|Lost to Follow-up|1|||
155682598|NCT00608023|561928113|FG000|Overall Study|Protocol Violation|1|||
155682599|NCT00608023|561928114|FG001|Overall Study|Protocol Violation|3|||
155682600|NCT00608023|561928115|FG002|Overall Study|Protocol Violation|1|||
155682601|NCT00608023|561928113|FG000|Overall Study|Unknown reason|0|||
155682602|NCT00608023|561928114|FG001|Overall Study|Unknown reason|3|||
155682603|NCT00608023|561928115|FG002|Overall Study|Unknown reason|0|||
155682604|NCT01231321|561928118|FG000|Overall Study|Adverse Event|3|||
155682605|NCT01231321|561928118|FG000|Overall Study|Lack of Efficacy|2|||
155682606|NCT00489736|561928119|FG000|Overall Study|Lack of Efficacy|53|||
155682607|NCT00489736|561928120|FG001|Overall Study|Lack of Efficacy|14|||
155682608|NCT00489736|561928119|FG000|Overall Study|Adverse Event|32|||
155682609|NCT00489736|561928120|FG001|Overall Study|Adverse Event|45|||
155682610|NCT00489736|561928119|FG000|Overall Study|Poor compliance|6|||
155682611|NCT00489736|561928120|FG001|Overall Study|Poor compliance|2|||
155682612|NCT00489736|561928119|FG000|Overall Study|Not coded/ Not pre-specified|5|||
155682613|NCT00489736|561928120|FG001|Overall Study|Not coded/ Not pre-specified|8|||
155682614|NCT04021524|561928121|FG000|Overall Study|Change in surgical intervention|0|||
155682615|NCT04021524|561928122|FG001|Overall Study|Change in surgical intervention|1|||
155682616|NCT06422364|561928123|FG000|Overall Study|Withdrawn due to study closure|0|||
155682617|NCT06422364|561928124|FG001|Overall Study|Withdrawn due to study closure|2|||
155682618|NCT05260073|561928126|FG000|Overall Study|Physician Decision|1|||
155682619|NCT05260073|561928126|FG000|Overall Study|Withdrawal by Subject|6|||
155682620|NCT05260073|561928126|FG000|Overall Study|Lost to Follow-up|14|||
155682621|NCT03458910|561928127|FG000|Overall Study|Withdrawal by Subject|7|||
155682622|NCT03458910|561928128|FG001|Overall Study|Withdrawal by Subject|8|||
155682623|NCT03458910|561928129|FG002|Overall Study|Withdrawal by Subject|6|||
155682624|NCT03458910|561928130|FG003|Overall Study|Withdrawal by Subject|4|||
155682625|NCT03458910|561928127|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
155682626|NCT03458910|561928128|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
155682627|NCT03458910|561928129|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
155682628|NCT03458910|561928130|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
155682629|NCT05275010|561928131|FG000|Overall Study|Reason Not Specified|4|||
155682630|NCT05275010|561928132|FG001|Overall Study|Reason Not Specified|1|||
155682631|NCT05275010|561928131|FG000|Overall Study|Withdrawal by Subject|1|||
155682632|NCT05275010|561928132|FG001|Overall Study|Withdrawal by Subject|0|||
155682633|NCT05275010|561928131|FG000|Overall Study|Lost to Follow-up|0|||
155682634|NCT05275010|561928132|FG001|Overall Study|Lost to Follow-up|1|||
155682635|NCT04484649|561928135|FG000|Overall Study|Lost to Follow-up|2|||
155682636|NCT04484649|561928136|FG001|Overall Study|Lost to Follow-up|1|||
155682637|NCT04484649|561928135|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
155682638|NCT04484649|561928136|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
155682639|NCT01463696|561928137|FG000|Overall Study|Adverse Event|0|||
155682640|NCT01463696|561928138|FG001|Overall Study|Adverse Event|1|||
155682641|NCT01463696|561928139|FG002|Overall Study|Adverse Event|0|||
155682642|NCT01463696|561928140|FG003|Overall Study|Adverse Event|2|||
155682643|NCT01463696|561928141|FG004|Overall Study|Adverse Event|0|||
155682644|NCT01463696|561928142|FG005|Overall Study|Adverse Event|1|||
155682645|NCT01463696|561928143|FG006|Overall Study|Adverse Event|3|||
155682646|NCT01463696|561928144|FG007|Overall Study|Adverse Event|2|||
155682647|NCT01463696|561928137|FG000|Overall Study|Lost to Follow-up|0|||
155682648|NCT01463696|561928138|FG001|Overall Study|Lost to Follow-up|0|||
155682649|NCT01463696|561928139|FG002|Overall Study|Lost to Follow-up|1|||
155682650|NCT01463696|561928140|FG003|Overall Study|Lost to Follow-up|0|||
155682651|NCT01463696|561928141|FG004|Overall Study|Lost to Follow-up|0|||
155682652|NCT01463696|561928142|FG005|Overall Study|Lost to Follow-up|0|||
155682653|NCT01463696|561928143|FG006|Overall Study|Lost to Follow-up|0|||
155682654|NCT01463696|561928144|FG007|Overall Study|Lost to Follow-up|0|||
155682655|NCT01463696|561928137|FG000|Overall Study|Progressive Disease|0|||
155682656|NCT01463696|561928138|FG001|Overall Study|Progressive Disease|1|||
155682657|NCT01463696|561928139|FG002|Overall Study|Progressive Disease|0|||
155682658|NCT01463696|561928140|FG003|Overall Study|Progressive Disease|1|||
155682659|NCT01463696|561928141|FG004|Overall Study|Progressive Disease|0|||
155682660|NCT01463696|561928142|FG005|Overall Study|Progressive Disease|1|||
155682661|NCT01463696|561928143|FG006|Overall Study|Progressive Disease|4|||
155682662|NCT01463696|561928144|FG007|Overall Study|Progressive Disease|2|||
155682663|NCT01463696|561928137|FG000|Overall Study|Withdrawal by Subject|0|||
155682664|NCT01463696|561928138|FG001|Overall Study|Withdrawal by Subject|0|||
155682665|NCT01463696|561928139|FG002|Overall Study|Withdrawal by Subject|0|||
155603581|NCT00908596|561637732|FG003|Overall Study|Other reasons|0|||
155603582|NCT00908596|561637729|FG000|Overall Study|Lost to Follow-up|0|||
155603583|NCT00908596|561637730|FG001|Overall Study|Lost to Follow-up|1|||
155603584|NCT00908596|561637731|FG002|Overall Study|Lost to Follow-up|12|||
155603585|NCT00908596|561637732|FG003|Overall Study|Lost to Follow-up|4|||
155603586|NCT00908596|561637729|FG000|Overall Study|Death|0|||
155603587|NCT00908596|561637730|FG001|Overall Study|Death|5|||
155603588|NCT00908596|561637731|FG002|Overall Study|Death|57|||
155603589|NCT00908596|561637732|FG003|Overall Study|Death|32|||
155603590|NCT00908596|561637729|FG000|Overall Study|Protocol Violation|1|||
155603591|NCT00908596|561637730|FG001|Overall Study|Protocol Violation|0|||
155603592|NCT00908596|561637731|FG002|Overall Study|Protocol Violation|0|||
155603593|NCT00908596|561637732|FG003|Overall Study|Protocol Violation|0|||
155603594|NCT00908596|561637729|FG000|Overall Study|Withdrawal by Subject|0|||
155603595|NCT00908596|561637730|FG001|Overall Study|Withdrawal by Subject|1|||
155603596|NCT00908596|561637731|FG002|Overall Study|Withdrawal by Subject|3|||
155603597|NCT00908596|561637732|FG003|Overall Study|Withdrawal by Subject|1|||
155603598|NCT00224406|561637733|FG000|Overall Study|Re-transplant|0|||
155603599|NCT00224406|561637734|FG001|Overall Study|Re-transplant|2|||
155603600|NCT00224406|561637733|FG000|Overall Study|Death|0|||
155603601|NCT00224406|561637734|FG001|Overall Study|Death|1|||
155603602|NCT00224406|561637733|FG000|Overall Study|Transplant cancelled|0|||
155603603|NCT00224406|561637734|FG001|Overall Study|Transplant cancelled|4|||
155603604|NCT00224406|561637733|FG000|Overall Study|Drug not delivered|2|||
155603605|NCT00224406|561637734|FG001|Overall Study|Drug not delivered|0|||
155603606|NCT00224406|561637733|FG000|Overall Study|Other|4|||
155603607|NCT00224406|561637734|FG001|Overall Study|Other|0|||
155603608|NCT00224406|561637733|FG000|Overall Study|Transplant cancelled|3|||
155603609|NCT00224406|561637734|FG001|Overall Study|Transplant cancelled|0|||
155603610|NCT01556997|561637735|FG000|Overall Study|Adverse Event|10|||
155603611|NCT01556997|561637736|FG001|Overall Study|Adverse Event|12|||
155603612|NCT01556997|561637737|FG002|Overall Study|Adverse Event|12|||
155603613|NCT01556997|561637735|FG000|Overall Study|Lost to Follow-up|6|||
155603614|NCT01556997|561637736|FG001|Overall Study|Lost to Follow-up|6|||
155603615|NCT01556997|561637737|FG002|Overall Study|Lost to Follow-up|4|||
155603616|NCT01556997|561637735|FG000|Overall Study|Physician Decision|1|||
155603617|NCT01556997|561637736|FG001|Overall Study|Physician Decision|1|||
155603618|NCT01556997|561637737|FG002|Overall Study|Physician Decision|1|||
155603619|NCT01556997|561637735|FG000|Overall Study|Withdrawal by Subject|7|||
155603620|NCT01556997|561637736|FG001|Overall Study|Withdrawal by Subject|6|||
155603621|NCT01556997|561637737|FG002|Overall Study|Withdrawal by Subject|8|||
155603622|NCT01556997|561637735|FG000|Overall Study|Other|2|||
155603623|NCT01556997|561637736|FG001|Overall Study|Other|3|||
155603624|NCT01556997|561637737|FG002|Overall Study|Other|7|||
155603625|NCT01250171|561637742|FG000|Overall Study|Administrative reasons|1|||
155603626|NCT01250171|561637743|FG001|Overall Study|Administrative reasons|0|||
155603627|NCT01250171|561637744|FG002|Overall Study|Administrative reasons|0|||
155603628|NCT04550832|561637745|FG000|Overall Study|Adverse Event|0|||
155603629|NCT04550832|561637746|FG001|Overall Study|Adverse Event|0|||
155603630|NCT04550832|561637747|FG002|Overall Study|Adverse Event|2|||
155603631|NCT04550832|561637748|FG003|Overall Study|Adverse Event|0|||
155603632|NCT04550832|561637749|FG004|Overall Study|Adverse Event|1|||
155603633|NCT04823130|561637750|FG000|Overall Study|Withdrawal by Subject|2|||
155603634|NCT04823130|561637751|FG001|Overall Study|Withdrawal by Subject|3|||
155603635|NCT04823130|561637750|FG000|Overall Study|Failure to meet inclusion criteria|6|||
155603636|NCT04823130|561637751|FG001|Overall Study|Failure to meet inclusion criteria|4|||
155603637|NCT04823130|561637750|FG000|Overall Study|Other-unspecified|1|||
155603638|NCT04823130|561637751|FG001|Overall Study|Other-unspecified|0|||
155603639|NCT03315455|561637753|FG000|Overall Study|Ongoing in the Study|13|||
155603640|NCT03315455|561637754|FG001|Overall Study|Ongoing in the Study|24|||
155603641|NCT03315455|561637755|FG002|Overall Study|Ongoing in the Study|17|||
155603642|NCT03315455|561637756|FG003|Overall Study|Ongoing in the Study|15|||
155603643|NCT03315455|561637753|FG000|Overall Study|Withdrawal by Subject|0|||
155682666|NCT01463696|561928140|FG003|Overall Study|Withdrawal by Subject|1|||
155682667|NCT01463696|561928141|FG004|Overall Study|Withdrawal by Subject|1|||
155682668|NCT01463696|561928142|FG005|Overall Study|Withdrawal by Subject|1|||
155682669|NCT01463696|561928143|FG006|Overall Study|Withdrawal by Subject|2|||
155682670|NCT01463696|561928144|FG007|Overall Study|Withdrawal by Subject|0|||
155682671|NCT01463696|561928137|FG000|Overall Study|Not Treated|0|||
155682672|NCT01463696|561928138|FG001|Overall Study|Not Treated|0|||
155682673|NCT01463696|561928139|FG002|Overall Study|Not Treated|0|||
155682674|NCT01463696|561928140|FG003|Overall Study|Not Treated|0|||
155682675|NCT01463696|561928141|FG004|Overall Study|Not Treated|0|||
155682676|NCT01463696|561928142|FG005|Overall Study|Not Treated|0|||
155682677|NCT01463696|561928143|FG006|Overall Study|Not Treated|1|||
155682678|NCT01463696|561928144|FG007|Overall Study|Not Treated|0|||
155682679|NCT00967694|561928147|FG000|Overall Study|Withdrawal by Subject|6|||
155682680|NCT00152477|561928153|FG000|Chemotherapy Period|Adverse Event|9|||
155682681|NCT00152477|561928154|FG001|Chemotherapy Period|Adverse Event|4|||
155682682|NCT00152477|561928155|FG002|Chemotherapy Period|Adverse Event|5|||
155682683|NCT00152477|561928153|FG000|Chemotherapy Period|Death|1|||
155682684|NCT00152477|561928154|FG001|Chemotherapy Period|Death|3|||
155682685|NCT00152477|561928155|FG002|Chemotherapy Period|Death|3|||
155682686|NCT00152477|561928153|FG000|Chemotherapy Period|Lack of Efficacy|4|||
155682687|NCT00152477|561928154|FG001|Chemotherapy Period|Lack of Efficacy|5|||
155682688|NCT00152477|561928155|FG002|Chemotherapy Period|Lack of Efficacy|6|||
155682689|NCT00152477|561928153|FG000|Chemotherapy Period|Lost to Follow-up|1|||
155682690|NCT00152477|561928154|FG001|Chemotherapy Period|Lost to Follow-up|0|||
155682691|NCT00152477|561928155|FG002|Chemotherapy Period|Lost to Follow-up|1|||
155682692|NCT00152477|561928153|FG000|Chemotherapy Period|Protocol Violation|1|||
155682693|NCT00152477|561928154|FG001|Chemotherapy Period|Protocol Violation|1|||
155682694|NCT00152477|561928155|FG002|Chemotherapy Period|Protocol Violation|0|||
155682695|NCT00152477|561928153|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
155682696|NCT00152477|561928154|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
155682697|NCT00152477|561928155|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
155682698|NCT00152477|561928153|FG000|Chemotherapy Period|Progression of Disease|6|||
155682699|NCT00152477|561928154|FG001|Chemotherapy Period|Progression of Disease|8|||
155682700|NCT00152477|561928155|FG002|Chemotherapy Period|Progression of Disease|4|||
155682701|NCT00152477|561928153|FG000|Chemotherapy Period|Investigator decision|0|||
155682702|NCT00152477|561928154|FG001|Chemotherapy Period|Investigator decision|0|||
155682703|NCT00152477|561928155|FG002|Chemotherapy Period|Investigator decision|1|||
155682704|NCT00152477|561928153|FG000|Chemotherapy Period|Patient condition worsened|1|||
155682705|NCT00152477|561928154|FG001|Chemotherapy Period|Patient condition worsened|0|||
155682706|NCT00152477|561928155|FG002|Chemotherapy Period|Patient condition worsened|0|||
155682707|NCT00152477|561928153|FG000|Monotherapy Period|Adverse Event|1|||
155682708|NCT00152477|561928154|FG001|Monotherapy Period|Adverse Event|0|||
155682709|NCT00152477|561928155|FG002|Monotherapy Period|Adverse Event|5|||
155682710|NCT00152477|561928153|FG000|Monotherapy Period|Death|2|||
155682711|NCT00152477|561928154|FG001|Monotherapy Period|Death|0|||
155682712|NCT00152477|561928155|FG002|Monotherapy Period|Death|1|||
155682713|NCT00152477|561928153|FG000|Monotherapy Period|Lack of Efficacy|7|||
155682714|NCT00152477|561928154|FG001|Monotherapy Period|Lack of Efficacy|16|||
155682715|NCT00152477|561928155|FG002|Monotherapy Period|Lack of Efficacy|10|||
155682716|NCT00152477|561928153|FG000|Monotherapy Period|Protocol Violation|0|||
155682717|NCT00152477|561928154|FG001|Monotherapy Period|Protocol Violation|1|||
155682718|NCT00152477|561928155|FG002|Monotherapy Period|Protocol Violation|0|||
155682719|NCT00152477|561928153|FG000|Monotherapy Period|Withdrawal by Subject|0|||
155682720|NCT00152477|561928154|FG001|Monotherapy Period|Withdrawal by Subject|0|||
155682721|NCT00152477|561928155|FG002|Monotherapy Period|Withdrawal by Subject|4|||
155682722|NCT00152477|561928153|FG000|Monotherapy Period|Progression of Disease|5|||
155682723|NCT00152477|561928154|FG001|Monotherapy Period|Progression of Disease|11|||
155682724|NCT00152477|561928155|FG002|Monotherapy Period|Progression of Disease|12|||
155682725|NCT00152477|561928153|FG000|Monotherapy Period|Patient decision|0|||
155682726|NCT00152477|561928154|FG001|Monotherapy Period|Patient decision|1|||
155682727|NCT00152477|561928155|FG002|Monotherapy Period|Patient decision|1|||
155682728|NCT00152477|561928153|FG000|Monotherapy Period|Study personel decision|0|||
155682729|NCT00152477|561928154|FG001|Monotherapy Period|Study personel decision|0|||
155682730|NCT00152477|561928155|FG002|Monotherapy Period|Study personel decision|1|||
155682731|NCT02301546|561928156|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
155682732|NCT02301546|561928157|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
155682733|NCT02301546|561928156|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
155682734|NCT02301546|561928157|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
155682735|NCT02301546|561928156|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
155682736|NCT02301546|561928157|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
155682737|NCT02301546|561928156|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
155682738|NCT02301546|561928157|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
155682739|NCT02301546|561928156|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
155682740|NCT02301546|561928157|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
155682741|NCT02301546|561928156|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
155682742|NCT02301546|561928157|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
155682743|NCT02301546|561928156|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
155682744|NCT02301546|561928157|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
155682745|NCT03905265|561928159|FG000|Overall Study|Withdrawal by Subject|1|||
155682746|NCT03905265|561928160|FG001|Overall Study|Withdrawal by Subject|1|||
155682747|NCT03905265|561928161|FG002|Overall Study|Withdrawal by Subject|0|||
155682748|NCT03905265|561928162|FG003|Overall Study|Withdrawal by Subject|0|||
155682749|NCT01801436|561928165|FG000|Overall Study|Withdrawal by Subject|3|||
155682750|NCT01801436|561928165|FG000|Overall Study|Adverse Event|2|||
155682751|NCT01801436|561928165|FG000|Overall Study|Progressive disease|4|||
155682752|NCT02447250|561928168|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
155682753|NCT02447250|561928168|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
155682754|NCT02447250|561928168|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
155682755|NCT03632993|561928169|FG000|Overall Study|Withdrawal by Subject|1|||
155682756|NCT03632993|561928170|FG001|Overall Study|Withdrawal by Subject|0|||
155682757|NCT03632993|561928171|FG002|Overall Study|Withdrawal by Subject|0|||
155682758|NCT03632993|561928172|FG003|Overall Study|Withdrawal by Subject|0|||
155682759|NCT03632993|561928173|FG004|Overall Study|Withdrawal by Subject|0|||
155682760|NCT03632993|561928174|FG005|Overall Study|Withdrawal by Subject|0|||
155682761|NCT03632993|561928175|FG006|Overall Study|Withdrawal by Subject|0|||
155682762|NCT03632993|561928176|FG007|Overall Study|Withdrawal by Subject|0|||
155682763|NCT03632993|561928177|FG008|Overall Study|Withdrawal by Subject|0|||
155682764|NCT03632993|561928178|FG009|Overall Study|Withdrawal by Subject|1|||
155682765|NCT03632993|561928169|FG000|Overall Study|Protocol Non-compliance|0|||
155682766|NCT03632993|561928170|FG001|Overall Study|Protocol Non-compliance|1|||
155682767|NCT03632993|561928171|FG002|Overall Study|Protocol Non-compliance|0|||
155682768|NCT03632993|561928172|FG003|Overall Study|Protocol Non-compliance|0|||
155682769|NCT03632993|561928173|FG004|Overall Study|Protocol Non-compliance|0|||
155682770|NCT03632993|561928174|FG005|Overall Study|Protocol Non-compliance|0|||
155682771|NCT03632993|561928175|FG006|Overall Study|Protocol Non-compliance|0|||
155682772|NCT03632993|561928176|FG007|Overall Study|Protocol Non-compliance|0|||
155682773|NCT03632993|561928177|FG008|Overall Study|Protocol Non-compliance|0|||
155682774|NCT03632993|561928178|FG009|Overall Study|Protocol Non-compliance|0|||
155682775|NCT03632993|561928169|FG000|Overall Study|Lost to Follow-up|0|||
155682776|NCT03632993|561928170|FG001|Overall Study|Lost to Follow-up|0|||
155682777|NCT03632993|561928171|FG002|Overall Study|Lost to Follow-up|0|||
155682778|NCT03632993|561928172|FG003|Overall Study|Lost to Follow-up|0|||
155682779|NCT03632993|561928173|FG004|Overall Study|Lost to Follow-up|0|||
155682780|NCT03632993|561928174|FG005|Overall Study|Lost to Follow-up|1|||
155682781|NCT03632993|561928175|FG006|Overall Study|Lost to Follow-up|0|||
155682782|NCT03632993|561928176|FG007|Overall Study|Lost to Follow-up|1|||
155682783|NCT03632993|561928177|FG008|Overall Study|Lost to Follow-up|0|||
155682784|NCT03632993|561928178|FG009|Overall Study|Lost to Follow-up|0|||
155682785|NCT03632993|561928169|FG000|Overall Study|Adverse Event|0|||
155682786|NCT03632993|561928170|FG001|Overall Study|Adverse Event|0|||
155682787|NCT03632993|561928171|FG002|Overall Study|Adverse Event|0|||
155682788|NCT03632993|561928172|FG003|Overall Study|Adverse Event|0|||
155682789|NCT03632993|561928173|FG004|Overall Study|Adverse Event|0|||
155682790|NCT03632993|561928174|FG005|Overall Study|Adverse Event|1|||
155682791|NCT03632993|561928175|FG006|Overall Study|Adverse Event|0|||
155682792|NCT03632993|561928176|FG007|Overall Study|Adverse Event|1|||
155682793|NCT03632993|561928177|FG008|Overall Study|Adverse Event|0|||
155682794|NCT03632993|561928178|FG009|Overall Study|Adverse Event|0|||
155682795|NCT03389555|561928179|FG000|Overall Study|Protocol Violation|1|||
155682796|NCT03389555|561928180|FG001|Overall Study|Protocol Violation|3|||
155682797|NCT03389555|561928179|FG000|Overall Study|Death|1|||
155682798|NCT03389555|561928180|FG001|Overall Study|Death|0|||
155682799|NCT00960011|561928181|FG000|Overall Study|Death|5|||
155682800|NCT00960011|561928182|FG001|Overall Study|Death|0|||
155682801|NCT00960011|561928181|FG000|Overall Study|Lost to Follow-up|6|||
155682802|NCT00960011|561928182|FG001|Overall Study|Lost to Follow-up|2|||
155682803|NCT04417218|561928183|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
155682804|NCT04417218|561928184|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
155682805|NCT00873041|561928185|FG000|Core Study|Adverse Event|2|||
155682806|NCT00873041|561928186|FG001|Core Study|Adverse Event|3|||
155682807|NCT00873041|561928187|FG002|Core Study|Adverse Event|1|||
155682808|NCT00873041|561928185|FG000|Core Study|Withdrawal by Subject|1|||
155682809|NCT00873041|561928186|FG001|Core Study|Withdrawal by Subject|2|||
155682810|NCT00873041|561928187|FG002|Core Study|Withdrawal by Subject|2|||
155682811|NCT00873041|561928185|FG000|Core Study|Lost to Follow-up|3|||
155682812|NCT00873041|561928186|FG001|Core Study|Lost to Follow-up|1|||
155682813|NCT00873041|561928187|FG002|Core Study|Lost to Follow-up|0|||
155682814|NCT00873041|561928185|FG000|Core Study|Abnormal laboratory value|0|||
155682815|NCT00873041|561928186|FG001|Core Study|Abnormal laboratory value|0|||
155682816|NCT00873041|561928187|FG002|Core Study|Abnormal laboratory value|1|||
155682817|NCT00873041|561928185|FG000|Core Study|Protocol deviation|1|||
155682818|NCT00873041|561928186|FG001|Core Study|Protocol deviation|0|||
155682819|NCT00873041|561928187|FG002|Core Study|Protocol deviation|1|||
155682820|NCT00873041|561928185|FG000|Extension Study|Adverse Event|1|||
155682821|NCT00873041|561928186|FG001|Extension Study|Adverse Event|0|||
155682822|NCT00873041|561928187|FG002|Extension Study|Adverse Event|1|||
155682823|NCT00873041|561928185|FG000|Extension Study|Administrative reasons|0|||
155682824|NCT00873041|561928186|FG001|Extension Study|Administrative reasons|0|||
155682825|NCT00873041|561928187|FG002|Extension Study|Administrative reasons|1|||
155682826|NCT00758264|561928190|FG000|Active Phase|Withdrawal by Subject|0|||
155682827|NCT00758264|561928191|FG001|Active Phase|Withdrawal by Subject|0|||
155682828|NCT00758264|561928192|FG002|Active Phase|Withdrawal by Subject|1|||
155682829|NCT00758264|561928190|FG000|Active Phase|Lost to Follow-up|1|||
155682830|NCT00758264|561928191|FG001|Active Phase|Lost to Follow-up|0|||
155682831|NCT00758264|561928192|FG002|Active Phase|Lost to Follow-up|0|||
155682832|NCT00758264|561928190|FG000|Active Phase|Other|0|||
155682833|NCT00758264|561928191|FG001|Active Phase|Other|0|||
155682834|NCT00758264|561928192|FG002|Active Phase|Other|4|||
155682835|NCT04154605|561928198|FG000|Overall Study|Procedure Canceled|1|||
155682836|NCT04154605|561928199|FG001|Overall Study|Procedure Canceled|1|||
155682837|NCT04154605|561928198|FG000|Overall Study|Missed follow up|1|||
155682838|NCT04154605|561928199|FG001|Overall Study|Missed follow up|1|||
155682839|NCT04154605|561928198|FG000|Overall Study|Withdrawal by Subject|1|||
155682840|NCT04154605|561928199|FG001|Overall Study|Withdrawal by Subject|0|||
155682841|NCT00675441|561928200|FG000|Overall Study|Withdrawal by Subject|2|||
155682842|NCT00675441|561928200|FG000|Overall Study|Death|1|||
155682843|NCT01740089|561929183|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
155682844|NCT01740089|561929184|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
155682845|NCT01740089|561929185|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
155682846|NCT01740089|561929183|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
155682847|NCT01740089|561929184|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
155682848|NCT01740089|561929185|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
155682849|NCT01740089|561929183|FG000|After 12 Weeks|Lack of Efficacy|3|||
155682850|NCT01740089|561929184|FG001|After 12 Weeks|Lack of Efficacy|1|||
155682851|NCT01740089|561929185|FG002|After 12 Weeks|Lack of Efficacy|4|||
155682852|NCT01740089|561929183|FG000|After 12 Weeks|Adverse Event|2|||
155682853|NCT01740089|561929184|FG001|After 12 Weeks|Adverse Event|0|||
155682854|NCT01740089|561929185|FG002|After 12 Weeks|Adverse Event|5|||
155682855|NCT01740089|561929183|FG000|After 12 Weeks|Protocol Violation|1|||
155682856|NCT01740089|561929184|FG001|After 12 Weeks|Protocol Violation|1|||
155682857|NCT01740089|561929185|FG002|After 12 Weeks|Protocol Violation|1|||
155682858|NCT01740089|561929183|FG000|After 12 Weeks|Withdrawal by Subject|1|||
155682859|NCT01740089|561929184|FG001|After 12 Weeks|Withdrawal by Subject|1|||
155682860|NCT01740089|561929185|FG002|After 12 Weeks|Withdrawal by Subject|1|||
155682861|NCT02526524|561929192|FG000|Overall Study|Withdrawal by Subject|3|||
155682862|NCT02526524|561929193|FG001|Overall Study|Withdrawal by Subject|3|||
155682863|NCT02526524|561929194|FG002|Overall Study|Withdrawal by Subject|6|||
155682864|NCT02526524|561929195|FG003|Overall Study|Withdrawal by Subject|1|||
155682865|NCT02526524|561929196|FG004|Overall Study|Withdrawal by Subject|9|||
155682866|NCT02526524|561929197|FG005|Overall Study|Withdrawal by Subject|5|||
155682867|NCT02526524|561929192|FG000|Overall Study|Adverse Event|3|||
155682868|NCT02526524|561929193|FG001|Overall Study|Adverse Event|2|||
155682869|NCT02526524|561929194|FG002|Overall Study|Adverse Event|4|||
155682870|NCT02526524|561929195|FG003|Overall Study|Adverse Event|2|||
155682871|NCT02526524|561929196|FG004|Overall Study|Adverse Event|6|||
155682872|NCT02526524|561929197|FG005|Overall Study|Adverse Event|8|||
155682873|NCT02526524|561929192|FG000|Overall Study|Lost to Follow-up|2|||
155682874|NCT02526524|561929193|FG001|Overall Study|Lost to Follow-up|3|||
155682875|NCT02526524|561929194|FG002|Overall Study|Lost to Follow-up|8|||
155682876|NCT02526524|561929195|FG003|Overall Study|Lost to Follow-up|1|||
155682877|NCT02526524|561929196|FG004|Overall Study|Lost to Follow-up|2|||
155682878|NCT02526524|561929197|FG005|Overall Study|Lost to Follow-up|5|||
155682879|NCT02526524|561929192|FG000|Overall Study|Protocol Violation|3|||
155682880|NCT02526524|561929193|FG001|Overall Study|Protocol Violation|1|||
155682881|NCT02526524|561929194|FG002|Overall Study|Protocol Violation|5|||
155682882|NCT02526524|561929195|FG003|Overall Study|Protocol Violation|3|||
155682883|NCT02526524|561929196|FG004|Overall Study|Protocol Violation|4|||
155682884|NCT02526524|561929197|FG005|Overall Study|Protocol Violation|3|||
155682885|NCT02526524|561929192|FG000|Overall Study|Loss of Glucose Control|0|||
155682886|NCT02526524|561929193|FG001|Overall Study|Loss of Glucose Control|0|||
155682887|NCT02526524|561929194|FG002|Overall Study|Loss of Glucose Control|3|||
155682888|NCT02526524|561929195|FG003|Overall Study|Loss of Glucose Control|0|||
155682889|NCT02526524|561929196|FG004|Overall Study|Loss of Glucose Control|2|||
155682890|NCT02526524|561929197|FG005|Overall Study|Loss of Glucose Control|0|||
155682891|NCT02526524|561929192|FG000|Overall Study|Physician Decision|0|||
155682892|NCT02526524|561929193|FG001|Overall Study|Physician Decision|0|||
155682893|NCT02526524|561929194|FG002|Overall Study|Physician Decision|0|||
155682894|NCT02526524|561929195|FG003|Overall Study|Physician Decision|0|||
155682895|NCT02526524|561929196|FG004|Overall Study|Physician Decision|1|||
155682896|NCT02526524|561929197|FG005|Overall Study|Physician Decision|0|||
155682897|NCT02526524|561929192|FG000|Overall Study|Sponsor Decision|1|||
155682898|NCT02526524|561929193|FG001|Overall Study|Sponsor Decision|0|||
155682899|NCT02526524|561929194|FG002|Overall Study|Sponsor Decision|0|||
155682900|NCT02526524|561929195|FG003|Overall Study|Sponsor Decision|0|||
155682901|NCT02526524|561929196|FG004|Overall Study|Sponsor Decision|0|||
155682902|NCT02526524|561929197|FG005|Overall Study|Sponsor Decision|0|||
155682903|NCT00591149|561929201|FG000|Overall Study|Adverse Event|4|||
155682904|NCT00591149|561929201|FG000|Overall Study|Withdrawal by Subject|1|||
155682905|NCT00539513|561929202|FG000|Overall Study|Withdrawal by Subject|2|||
155682906|NCT00539513|561929203|FG001|Overall Study|Withdrawal by Subject|1|||
155603644|NCT03315455|561637754|FG001|Overall Study|Withdrawal by Subject|1|||
155603645|NCT03315455|561637755|FG002|Overall Study|Withdrawal by Subject|0|||
155603646|NCT03315455|561637756|FG003|Overall Study|Withdrawal by Subject|0|||
155603647|NCT02304380|561637759|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155603648|NCT02304380|561637760|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155603649|NCT02304380|561637761|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155603650|NCT02304380|561637762|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
155603651|NCT02304380|561637763|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155603652|NCT02304380|561637764|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155603653|NCT00328094|561637765|FG000|Overall Study|Physician Decision|3|||
155603654|NCT00328094|561637766|FG001|Overall Study|Physician Decision|3|||
155603655|NCT00473824|561637767|FG000|Overall Study|Virologic Breakthrough|1|||
155603656|NCT00473824|561637768|FG001|Overall Study|Virologic Breakthrough|0|||
155603657|NCT00473824|561637767|FG000|Overall Study|Adverse Event|1|||
155603658|NCT00473824|561637768|FG001|Overall Study|Adverse Event|0|||
155603659|NCT00473824|561637767|FG000|Overall Study|Death|1|||
155603660|NCT00473824|561637768|FG001|Overall Study|Death|0|||
155603661|NCT00473824|561637767|FG000|Overall Study|Lost to Follow-up|1|||
155603662|NCT00473824|561637768|FG001|Overall Study|Lost to Follow-up|0|||
155603663|NCT00473824|561637767|FG000|Overall Study|Withdrawal by physician|1|||
155603664|NCT00473824|561637768|FG001|Overall Study|Withdrawal by physician|0|||
155603665|NCT01349322|561637769|FG000|Overall Study|Protocol Violation|45|||
155603666|NCT01349322|561637770|FG001|Overall Study|Protocol Violation|47|||
155603667|NCT00985426|561637774|FG000|Overall Study|Adverse Event|0|||
155603668|NCT00985426|561637775|FG001|Overall Study|Adverse Event|1|||
155603669|NCT00985426|561637774|FG000|Overall Study|Subject Non-Compliance|3|||
155603670|NCT00985426|561637775|FG001|Overall Study|Subject Non-Compliance|3|||
155603671|NCT00985426|561637774|FG000|Overall Study|Withdrawal by Subject|12|||
155603672|NCT00985426|561637775|FG001|Overall Study|Withdrawal by Subject|16|||
155603673|NCT00985426|561637774|FG000|Overall Study|Lost to Follow-up|8|||
155603674|NCT00985426|561637775|FG001|Overall Study|Lost to Follow-up|10|||
155603675|NCT00985426|561637774|FG000|Overall Study|Death|7|||
155603676|NCT00985426|561637775|FG001|Overall Study|Death|3|||
155603677|NCT00985426|561637774|FG000|Overall Study|Protocol Violation|2|||
155603678|NCT00985426|561637775|FG001|Overall Study|Protocol Violation|0|||
155603679|NCT00985426|561637774|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
155603680|NCT00985426|561637775|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
155603681|NCT04829331|561637776|FG000|Overall Study|Lost to Follow-up|1|||
155603682|NCT04829331|561637777|FG001|Overall Study|Lost to Follow-up|0|||
155603683|NCT03181503|561637779|FG000|Overall Study|Adverse Event|2|||
155603684|NCT03181503|561637780|FG001|Overall Study|Adverse Event|2|||
155603685|NCT03181503|561637779|FG000|Overall Study|Protocol Violation|1|||
155603686|NCT03181503|561637780|FG001|Overall Study|Protocol Violation|0|||
155603687|NCT03181503|561637779|FG000|Overall Study|Withdrawal by Subject|3|||
155603688|NCT03181503|561637780|FG001|Overall Study|Withdrawal by Subject|0|||
155603689|NCT03181503|561637779|FG000|Overall Study|Lost to Follow-up|1|||
155603690|NCT03181503|561637780|FG001|Overall Study|Lost to Follow-up|1|||
155603691|NCT01404208|561637785|FG000|Overall Study|Discontinued|3|||
155603692|NCT01404208|561637786|FG001|Overall Study|Discontinued|0|||
155603693|NCT02258542|561637789|FG000|Overall Study|eg. not made to the visit|7|||
155603694|NCT02258542|561637790|FG001|Overall Study|eg. not made to the visit|4|||
155603695|NCT02258542|561637791|FG002|Overall Study|eg. not made to the visit|0|||
155603696|NCT02258542|561637792|FG003|Overall Study|eg. not made to the visit|1|||
155603697|NCT02258542|561637789|FG000|Overall Study|study specific discount. criteria|1|||
155603698|NCT02258542|561637790|FG001|Overall Study|study specific discount. criteria|1|||
155603699|NCT02258542|561637791|FG002|Overall Study|study specific discount. criteria|0|||
155603700|NCT02258542|561637792|FG003|Overall Study|study specific discount. criteria|0|||
155603701|NCT02258542|561637789|FG000|Overall Study|Withdrawal by Subject|20|||
155603702|NCT02258542|561637790|FG001|Overall Study|Withdrawal by Subject|20|||
155603703|NCT02258542|561637791|FG002|Overall Study|Withdrawal by Subject|7|||
155603704|NCT02258542|561637792|FG003|Overall Study|Withdrawal by Subject|1|||
155603705|NCT02258542|561637789|FG000|Overall Study|Lost to Follow-up|5|||
155603706|NCT02258542|561637790|FG001|Overall Study|Lost to Follow-up|12|||
155603707|NCT02258542|561637791|FG002|Overall Study|Lost to Follow-up|1|||
155603708|NCT02258542|561637792|FG003|Overall Study|Lost to Follow-up|2|||
155603709|NCT02258542|561637789|FG000|Overall Study|Death|5|||
155603710|NCT02258542|561637790|FG001|Overall Study|Death|4|||
155603711|NCT02258542|561637791|FG002|Overall Study|Death|0|||
155603712|NCT02258542|561637792|FG003|Overall Study|Death|1|||
155603713|NCT02258542|561637789|FG000|Overall Study|Adverse Event|3|||
155603714|NCT02258542|561637790|FG001|Overall Study|Adverse Event|4|||
155603715|NCT02258542|561637791|FG002|Overall Study|Adverse Event|0|||
155603716|NCT02258542|561637792|FG003|Overall Study|Adverse Event|0|||
155603717|NCT02258542|561637789|FG000|Overall Study|Protocol Violation|1|||
155682907|NCT00539513|561929202|FG000|Overall Study|Lost to Follow-up|0|||
155682908|NCT00539513|561929203|FG001|Overall Study|Lost to Follow-up|1|||
155682909|NCT03002818|561929204|FG000|Overall Study|Decision of the investigator|1|||
155682910|NCT01328041|561929205|FG000|Overall Study|Adverse Event|7|||
155682911|NCT01328041|561929205|FG000|Overall Study|Lack of Efficacy|27|||
155682912|NCT01328041|561929205|FG000|Overall Study|Protocol Violation|7|||
155682913|NCT01328041|561929205|FG000|Overall Study|Lost to Follow-up|7|||
155682914|NCT01328041|561929205|FG000|Overall Study|Physician Decision|2|||
155682915|NCT01328041|561929205|FG000|Overall Study|Withdrawal by Subject|7|||
155682916|NCT00711113|561929206|FG000|Overall Study|Lost to Follow-up|9|||
155682917|NCT00711113|561929206|FG000|Overall Study|Implant lost|2|||
155682918|NCT02456636|561929207|FG000|Overall Study|Death|0|||
155682919|NCT02456636|561929208|FG001|Overall Study|Death|3|||
155682920|NCT02456636|561929209|FG002|Overall Study|Death|0|||
155682921|NCT02456636|561929207|FG000|Overall Study|Pregnancy|1|||
155682922|NCT02456636|561929208|FG001|Overall Study|Pregnancy|3|||
155682923|NCT02456636|561929209|FG002|Overall Study|Pregnancy|5|||
155682924|NCT02456636|561929207|FG000|Overall Study|Physician Decision|4|||
155682925|NCT02456636|561929208|FG001|Overall Study|Physician Decision|5|||
155682926|NCT02456636|561929209|FG002|Overall Study|Physician Decision|4|||
155682927|NCT02456636|561929207|FG000|Overall Study|Withdrawal by Subject|13|||
155682928|NCT02456636|561929208|FG001|Overall Study|Withdrawal by Subject|14|||
155682929|NCT02456636|561929209|FG002|Overall Study|Withdrawal by Subject|16|||
155682930|NCT02456636|561929207|FG000|Overall Study|Lost to Follow-up|50|||
155682931|NCT02456636|561929208|FG001|Overall Study|Lost to Follow-up|44|||
155682932|NCT02456636|561929209|FG002|Overall Study|Lost to Follow-up|50|||
155682933|NCT01606787|561929211|FG000|Overall Study|Withdrawal by Subject|4|||
155682934|NCT01606787|561929212|FG001|Overall Study|Withdrawal by Subject|5|||
155682935|NCT01606787|561929211|FG000|Overall Study|Surgery canceled|0|||
155682936|NCT01606787|561929212|FG001|Overall Study|Surgery canceled|2|||
155682937|NCT00313313|561929215|FG000|Overall Study|Lack of Efficacy|14|||
155682938|NCT00313313|561929216|FG001|Overall Study|Lack of Efficacy|9|||
155682939|NCT00313313|561929217|FG002|Overall Study|Lack of Efficacy|20|||
155682940|NCT00313313|561929215|FG000|Overall Study|Withdrawal of consent by subject|18|||
155682941|NCT00313313|561929216|FG001|Overall Study|Withdrawal of consent by subject|17|||
155682942|NCT00313313|561929217|FG002|Overall Study|Withdrawal of consent by subject|31|||
155682943|NCT00313313|561929215|FG000|Overall Study|Lost to Follow-up|10|||
155682944|NCT00313313|561929216|FG001|Overall Study|Lost to Follow-up|7|||
155682945|NCT00313313|561929217|FG002|Overall Study|Lost to Follow-up|9|||
155682946|NCT00313313|561929215|FG000|Overall Study|Adverse Event|15|||
155682947|NCT00313313|561929216|FG001|Overall Study|Adverse Event|16|||
155682948|NCT00313313|561929217|FG002|Overall Study|Adverse Event|12|||
155682949|NCT00313313|561929215|FG000|Overall Study|Physician Decision|2|||
155682950|NCT00313313|561929216|FG001|Overall Study|Physician Decision|6|||
155682951|NCT00313313|561929217|FG002|Overall Study|Physician Decision|4|||
155682952|NCT00313313|561929215|FG000|Overall Study|Poor/Noncompliance|3|||
155682953|NCT00313313|561929216|FG001|Overall Study|Poor/Noncompliance|6|||
155682954|NCT00313313|561929217|FG002|Overall Study|Poor/Noncompliance|2|||
155682955|NCT00313313|561929215|FG000|Overall Study|Pregnancy|1|||
155682956|NCT00313313|561929216|FG001|Overall Study|Pregnancy|2|||
155682957|NCT00313313|561929217|FG002|Overall Study|Pregnancy|0|||
155682958|NCT00313313|561929215|FG000|Overall Study|Death|0|||
155682959|NCT00313313|561929216|FG001|Overall Study|Death|0|||
155682960|NCT00313313|561929217|FG002|Overall Study|Death|2|||
155682961|NCT00313313|561929215|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155682962|NCT00313313|561929216|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
155682963|NCT00313313|561929217|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
155682964|NCT00368836|561929218|FG000|Phase II|Screen Failure|1|||
155682965|NCT00368836|561929218|FG000|Phase II|Withdrawal by Subject|1|||
155682966|NCT00368836|561929218|FG000|Phase II|unable to collect blood and/or breath|17|||
155682967|NCT00368836|561929218|FG000|Phase II|Protocol Violation|2|||
155682968|NCT01082874|561929219|FG000|Overall Study|Lost to Follow-up|10|||
155682969|NCT01082874|561929220|FG001|Overall Study|Lost to Follow-up|10|||
155682970|NCT01082874|561929221|FG002|Overall Study|Lost to Follow-up|6|||
155682971|NCT01082874|561929222|FG003|Overall Study|Lost to Follow-up|10|||
155682972|NCT01082874|561929219|FG000|Overall Study|Withdrawal by Subject|1|||
155682973|NCT01082874|561929220|FG001|Overall Study|Withdrawal by Subject|2|||
155682974|NCT01082874|561929221|FG002|Overall Study|Withdrawal by Subject|5|||
155682975|NCT01082874|561929222|FG003|Overall Study|Withdrawal by Subject|3|||
155682976|NCT01846663|561929225|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
155682977|NCT01846663|561929226|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
155682978|NCT01846663|561929225|FG000|Overall Study|Withdrawal by Subject|1|||
155682979|NCT01846663|561929226|FG001|Overall Study|Withdrawal by Subject|0|||
155682980|NCT01846663|561929225|FG000|Overall Study|Adverse Event|1|||
155682981|NCT01846663|561929226|FG001|Overall Study|Adverse Event|2|||
155682982|NCT03466099|561929240|FG000|Overall Study|Adverse Event|1|||
155682983|NCT03466099|561929241|FG001|Overall Study|Adverse Event|1|||
155682984|NCT03466099|561929242|FG002|Overall Study|Adverse Event|1|||
155682985|NCT03466099|561929240|FG000|Overall Study|Withdrawal by Subject|2|||
155682986|NCT03466099|561929241|FG001|Overall Study|Withdrawal by Subject|3|||
155682987|NCT03466099|561929242|FG002|Overall Study|Withdrawal by Subject|1|||
155682988|NCT03466099|561929240|FG000|Overall Study|Use of rescue medication|8|||
155682989|NCT03466099|561929241|FG001|Overall Study|Use of rescue medication|9|||
155682990|NCT03466099|561929242|FG002|Overall Study|Use of rescue medication|13|||
155682991|NCT03466099|561929240|FG000|Overall Study|Rescued without meeting criteria|4|||
155682992|NCT03466099|561929241|FG001|Overall Study|Rescued without meeting criteria|1|||
155682993|NCT03466099|561929242|FG002|Overall Study|Rescued without meeting criteria|1|||
155682994|NCT03466099|561929240|FG000|Overall Study|Subject compliance|2|||
155682995|NCT03466099|561929241|FG001|Overall Study|Subject compliance|0|||
155682996|NCT03466099|561929242|FG002|Overall Study|Subject compliance|0|||
155682997|NCT03466099|561929240|FG000|Overall Study|Worsening disease|0|||
155682998|NCT03466099|561929241|FG001|Overall Study|Worsening disease|0|||
155682999|NCT03466099|561929242|FG002|Overall Study|Worsening disease|1|||
155683000|NCT00075946|561929245|FG000|Overall Study|Path ineligible: undetermined histology|0|||
155683001|NCT00075946|561929246|FG001|Overall Study|Path ineligible: undetermined histology|0|||
155683002|NCT00075946|561929247|FG002|Overall Study|Path ineligible: undetermined histology|0|||
155683003|NCT00075946|561929248|FG003|Overall Study|Path ineligible: undetermined histology|0|||
155683004|NCT00075946|561929249|FG004|Overall Study|Path ineligible: undetermined histology|6|||
155683005|NCT00075946|561929245|FG000|Overall Study|Did not achieve response after induction|0|||
155683006|NCT00075946|561929246|FG001|Overall Study|Did not achieve response after induction|0|||
155683007|NCT00075946|561929247|FG002|Overall Study|Did not achieve response after induction|0|||
155683008|NCT00075946|561929248|FG003|Overall Study|Did not achieve response after induction|0|||
155683009|NCT00075946|561929249|FG004|Overall Study|Did not achieve response after induction|182|||
155683010|NCT00075946|561929245|FG000|Overall Study|Incorrectly randomized (no response)|5|||
155683011|NCT00075946|561929246|FG001|Overall Study|Incorrectly randomized (no response)|5|||
155683012|NCT00075946|561929247|FG002|Overall Study|Incorrectly randomized (no response)|5|||
155683013|NCT00075946|561929248|FG003|Overall Study|Incorrectly randomized (no response)|1|||
155683014|NCT00075946|561929249|FG004|Overall Study|Incorrectly randomized (no response)|0|||
155683015|NCT00075946|561929245|FG000|Overall Study|Adverse Event|2|||
155683016|NCT00075946|561929246|FG001|Overall Study|Adverse Event|10|||
155683017|NCT00075946|561929247|FG002|Overall Study|Adverse Event|0|||
155683018|NCT00075946|561929248|FG003|Overall Study|Adverse Event|2|||
155683019|NCT00075946|561929249|FG004|Overall Study|Adverse Event|0|||
155683020|NCT00075946|561929245|FG000|Overall Study|Death|0|||
155683021|NCT00075946|561929246|FG001|Overall Study|Death|1|||
155683022|NCT00075946|561929247|FG002|Overall Study|Death|0|||
155683023|NCT00075946|561929248|FG003|Overall Study|Death|0|||
155683024|NCT00075946|561929249|FG004|Overall Study|Death|0|||
155683025|NCT00075946|561929245|FG000|Overall Study|Withdrawal by Subject|23|||
155683026|NCT00075946|561929246|FG001|Overall Study|Withdrawal by Subject|58|||
155683027|NCT00075946|561929247|FG002|Overall Study|Withdrawal by Subject|4|||
155683028|NCT00075946|561929248|FG003|Overall Study|Withdrawal by Subject|9|||
155683029|NCT00075946|561929249|FG004|Overall Study|Withdrawal by Subject|0|||
155683030|NCT00075946|561929245|FG000|Overall Study|Alternative therapy|16|||
155683031|NCT00075946|561929246|FG001|Overall Study|Alternative therapy|2|||
155683032|NCT00075946|561929247|FG002|Overall Study|Alternative therapy|5|||
155683033|NCT00075946|561929248|FG003|Overall Study|Alternative therapy|0|||
155683034|NCT00075946|561929249|FG004|Overall Study|Alternative therapy|0|||
155683035|NCT00075946|561929245|FG000|Overall Study|Other complicating disease|7|||
155683036|NCT00075946|561929246|FG001|Overall Study|Other complicating disease|13|||
155683037|NCT00075946|561929247|FG002|Overall Study|Other complicating disease|1|||
155683038|NCT00075946|561929248|FG003|Overall Study|Other complicating disease|4|||
155683039|NCT00075946|561929249|FG004|Overall Study|Other complicating disease|0|||
155683040|NCT00075946|561929245|FG000|Overall Study|No response to retreatment|23|||
155683041|NCT00075946|561929246|FG001|Overall Study|No response to retreatment|0|||
155683042|NCT00075946|561929247|FG002|Overall Study|No response to retreatment|2|||
155683043|NCT00075946|561929248|FG003|Overall Study|No response to retreatment|0|||
155683044|NCT00075946|561929249|FG004|Overall Study|No response to retreatment|0|||
155683045|NCT00075946|561929245|FG000|Overall Study|Time to progression less than 6 months|15|||
155683046|NCT00075946|561929246|FG001|Overall Study|Time to progression less than 6 months|30|||
155683047|NCT00075946|561929247|FG002|Overall Study|Time to progression less than 6 months|8|||
155683048|NCT00075946|561929248|FG003|Overall Study|Time to progression less than 6 months|3|||
155683049|NCT00075946|561929249|FG004|Overall Study|Time to progression less than 6 months|0|||
155683050|NCT00075946|561929245|FG000|Overall Study|Other|57|||
155683051|NCT00075946|561929246|FG001|Overall Study|Other|32|||
155683052|NCT00075946|561929247|FG002|Overall Study|Other|3|||
155683053|NCT00075946|561929248|FG003|Overall Study|Other|11|||
155683054|NCT00075946|561929249|FG004|Overall Study|Other|0|||
155683055|NCT01923363|561929250|FG000|Overall Study|Protocol Violation|1|||
155683056|NCT02901054|561929253|FG000|Overall Study|Physician Decision|1|||
155683057|NCT02901054|561929253|FG000|Overall Study|Withdrawal by Subject|3|||
155683058|NCT05593913|561929255|FG000|Overall Study|Insufficient image quality|39|||
155683059|NCT01453205|561929256|FG000|Overall Study|Lost to Follow-up|3|||
155683060|NCT01453205|561929257|FG001|Overall Study|Lost to Follow-up|0|||
155683061|NCT01453205|561929258|FG002|Overall Study|Lost to Follow-up|1|||
155683062|NCT01453205|561929256|FG000|Overall Study|Withdrawal by Subject|8|||
155683063|NCT01453205|561929257|FG001|Overall Study|Withdrawal by Subject|3|||
155683064|NCT01453205|561929258|FG002|Overall Study|Withdrawal by Subject|0|||
155683065|NCT01453205|561929256|FG000|Overall Study|Death|24|||
155683066|NCT01453205|561929257|FG001|Overall Study|Death|22|||
155683067|NCT01453205|561929258|FG002|Overall Study|Death|18|||
155683068|NCT01453205|561929256|FG000|Overall Study|Other|45|||
155683069|NCT01453205|561929257|FG001|Overall Study|Other|27|||
155683070|NCT01453205|561929258|FG002|Overall Study|Other|35|||
155683071|NCT01666119|561929259|FG000|Overall Study|Adverse Event|6|||
155683072|NCT01666119|561929259|FG000|Overall Study|Withdrawal by Subject|16|||
155683073|NCT01666119|561929259|FG000|Overall Study|Lost to Follow-up|7|||
155683074|NCT01666119|561929259|FG000|Overall Study|non compliance with study medication, pa|18|||
155683075|NCT01666119|561929259|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
155683076|NCT03255967|561929264|FG000|Overall Study|Adverse Event|26|||
155683077|NCT03255967|561929265|FG001|Overall Study|Adverse Event|30|||
155683078|NCT03255967|561929264|FG000|Overall Study|Withdrawal by Subject|6|||
155683079|NCT03255967|561929265|FG001|Overall Study|Withdrawal by Subject|6|||
155683080|NCT03255967|561929264|FG000|Overall Study|Schedule conflict|6|||
155683081|NCT03255967|561929265|FG001|Overall Study|Schedule conflict|4|||
155683082|NCT03255967|561929264|FG000|Overall Study|POA did not sign consent form|2|||
155683083|NCT03255967|561929265|FG001|Overall Study|POA did not sign consent form|0|||
155683084|NCT00778258|561929271|FG000|Overall Study|Adverse Event|1|||
155683085|NCT00778258|561929272|FG001|Overall Study|Adverse Event|0|||
155683086|NCT00778258|561929273|FG002|Overall Study|Adverse Event|0|||
155683087|NCT00778258|561929274|FG003|Overall Study|Adverse Event|0|||
155683088|NCT00778258|561929275|FG004|Overall Study|Adverse Event|0|||
155683089|NCT00778258|561929276|FG005|Overall Study|Adverse Event|1|||
155683090|NCT00778258|561929277|FG006|Overall Study|Adverse Event|0|||
155683091|NCT00778258|561929278|FG007|Overall Study|Adverse Event|0|||
155683092|NCT00778258|561929279|FG008|Overall Study|Adverse Event|0|||
155683093|NCT00778258|561929271|FG000|Overall Study|Lost to Follow-up|0|||
155683094|NCT00778258|561929272|FG001|Overall Study|Lost to Follow-up|0|||
155683095|NCT00778258|561929273|FG002|Overall Study|Lost to Follow-up|2|||
155683096|NCT00778258|561929274|FG003|Overall Study|Lost to Follow-up|0|||
155683097|NCT00778258|561929275|FG004|Overall Study|Lost to Follow-up|0|||
155683098|NCT00778258|561929276|FG005|Overall Study|Lost to Follow-up|3|||
155683099|NCT00778258|561929277|FG006|Overall Study|Lost to Follow-up|2|||
155683100|NCT00778258|561929278|FG007|Overall Study|Lost to Follow-up|2|||
155683101|NCT00778258|561929279|FG008|Overall Study|Lost to Follow-up|0|||
155683102|NCT00778258|561929271|FG000|Overall Study|Withdrawal by Subject|6|||
155683103|NCT00778258|561929272|FG001|Overall Study|Withdrawal by Subject|2|||
155683104|NCT00778258|561929273|FG002|Overall Study|Withdrawal by Subject|8|||
155683105|NCT00778258|561929274|FG003|Overall Study|Withdrawal by Subject|2|||
155683106|NCT00778258|561929275|FG004|Overall Study|Withdrawal by Subject|0|||
155683107|NCT00778258|561929276|FG005|Overall Study|Withdrawal by Subject|6|||
155683108|NCT00778258|561929277|FG006|Overall Study|Withdrawal by Subject|12|||
155683109|NCT00778258|561929278|FG007|Overall Study|Withdrawal by Subject|12|||
155683110|NCT00778258|561929279|FG008|Overall Study|Withdrawal by Subject|4|||
155683111|NCT00778258|561929271|FG000|Overall Study|New Contraindication|0|||
155683112|NCT00778258|561929272|FG001|Overall Study|New Contraindication|0|||
155683113|NCT00778258|561929273|FG002|Overall Study|New Contraindication|0|||
155683114|NCT00778258|561929274|FG003|Overall Study|New Contraindication|0|||
155683115|NCT00778258|561929275|FG004|Overall Study|New Contraindication|0|||
155683116|NCT00778258|561929276|FG005|Overall Study|New Contraindication|0|||
155683117|NCT00778258|561929277|FG006|Overall Study|New Contraindication|0|||
155683118|NCT00778258|561929278|FG007|Overall Study|New Contraindication|1|||
155683119|NCT00778258|561929279|FG008|Overall Study|New Contraindication|0|||
155683120|NCT00778258|561929271|FG000|Overall Study|Non-compliance|0|||
155683121|NCT00778258|561929272|FG001|Overall Study|Non-compliance|0|||
155683122|NCT00778258|561929273|FG002|Overall Study|Non-compliance|0|||
155683123|NCT00778258|561929274|FG003|Overall Study|Non-compliance|1|||
155683124|NCT00778258|561929275|FG004|Overall Study|Non-compliance|0|||
155683125|NCT00778258|561929276|FG005|Overall Study|Non-compliance|0|||
155683126|NCT00778258|561929277|FG006|Overall Study|Non-compliance|0|||
155683127|NCT00778258|561929278|FG007|Overall Study|Non-compliance|0|||
155683128|NCT00778258|561929279|FG008|Overall Study|Non-compliance|0|||
155683129|NCT00778258|561929271|FG000|Overall Study|Other|0|||
155683130|NCT00778258|561929272|FG001|Overall Study|Other|0|||
155683131|NCT00778258|561929273|FG002|Overall Study|Other|0|||
155683132|NCT00778258|561929274|FG003|Overall Study|Other|0|||
155683133|NCT00778258|561929275|FG004|Overall Study|Other|0|||
155683134|NCT00778258|561929276|FG005|Overall Study|Other|0|||
155683135|NCT00778258|561929277|FG006|Overall Study|Other|1|||
155683136|NCT00778258|561929278|FG007|Overall Study|Other|0|||
155683137|NCT00778258|561929279|FG008|Overall Study|Other|0|||
155683138|NCT00780143|561929280|FG000|Overall Study|Progressive disease|1|||
155683139|NCT00780143|561929280|FG000|Overall Study|Toxicity|1|||
155683140|NCT00780143|561929280|FG000|Overall Study|Adverse Event|1|||
155683141|NCT02644096|561929283|FG000|Overall Study|Withdrawal by Subject|28|||
155683142|NCT02644096|561929284|FG001|Overall Study|Withdrawal by Subject|25|||
155683143|NCT02461290|561929285|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
155683144|NCT02461290|561929285|FG000|Overall Study|Lost to Follow-up|3|||
155683145|NCT00322452|561929286|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155603718|NCT02258542|561637790|FG001|Overall Study|Protocol Violation|2|||
155603719|NCT02258542|561637791|FG002|Overall Study|Protocol Violation|0|||
155603720|NCT02258542|561637792|FG003|Overall Study|Protocol Violation|0|||
155603721|NCT02258542|561637789|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155603722|NCT02258542|561637790|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155603723|NCT02258542|561637791|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155603724|NCT02258542|561637792|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
155603725|NCT01032070|561637793|FG000|Overall Study|Disease progression|13|||
155603726|NCT01032070|561637794|FG001|Overall Study|Disease progression|8|||
155603727|NCT01032070|561637793|FG000|Overall Study|Medical or ethical reasons|0|||
155603728|NCT01032070|561637794|FG001|Overall Study|Medical or ethical reasons|2|||
155603729|NCT01032070|561637793|FG000|Overall Study|Withdrawal by Subject|0|||
155603730|NCT01032070|561637794|FG001|Overall Study|Withdrawal by Subject|2|||
155603731|NCT02554318|561637795|FG000|Overall Study|Withdrawal by Subject|10|||
155603732|NCT02554318|561637796|FG001|Overall Study|Withdrawal by Subject|8|||
155603733|NCT02332239|561637797|FG000|Overall Study|Lost to Follow-up|4|||
155603734|NCT02332239|561637798|FG001|Overall Study|Lost to Follow-up|6|||
155603735|NCT00894790|561637801|FG000|Overall Study|Protocol Violation|0|||
155603736|NCT00894790|561637802|FG001|Overall Study|Protocol Violation|1|||
155603737|NCT00894790|561637801|FG000|Overall Study|Lost to Follow-up|0|||
155603738|NCT00894790|561637802|FG001|Overall Study|Lost to Follow-up|1|||
155603739|NCT00894790|561637801|FG000|Overall Study|Did not meet entrance criteria|1|||
155603740|NCT00894790|561637802|FG001|Overall Study|Did not meet entrance criteria|0|||
155603741|NCT01472965|561637803|FG000|Overall Study|Withdrawal by Subject|1|||
155603742|NCT01472965|561637804|FG001|Overall Study|Withdrawal by Subject|0|||
155603743|NCT00334802|561637807|FG000|Overall Study|Progressive Disease|2|||
155603744|NCT00334802|561637808|FG001|Overall Study|Progressive Disease|24|||
155603745|NCT00334802|561637807|FG000|Overall Study|Toxicity|1|||
155603746|NCT00334802|561637808|FG001|Overall Study|Toxicity|5|||
155603747|NCT00334802|561637807|FG000|Overall Study|Lack of Efficacy|1|||
155603748|NCT00334802|561637808|FG001|Overall Study|Lack of Efficacy|3|||
155603749|NCT00334802|561637807|FG000|Overall Study|Patient Condition Aggrevated|1|||
155603750|NCT00334802|561637808|FG001|Overall Study|Patient Condition Aggrevated|0|||
155603751|NCT00334802|561637807|FG000|Overall Study|Physician Decision|1|||
155603752|NCT00334802|561637808|FG001|Overall Study|Physician Decision|0|||
155603753|NCT00334802|561637807|FG000|Overall Study|Withdrawal by Subject|0|||
155603754|NCT00334802|561637808|FG001|Overall Study|Withdrawal by Subject|4|||
155603755|NCT00334802|561637807|FG000|Overall Study|Adverse Event|0|||
155603756|NCT00334802|561637808|FG001|Overall Study|Adverse Event|3|||
155603757|NCT00334802|561637807|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
155603758|NCT00334802|561637808|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
155683146|NCT00322452|561929287|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155603759|NCT03422159|561637809|FG000|Overall Study|Exclusion due to terminal disease|2|||
155683147|NCT00322452|561929286|FG000|Overall Study|Lost to Follow-up|5|||
155683148|NCT00322452|561929287|FG001|Overall Study|Lost to Follow-up|2|||
155683149|NCT00322452|561929286|FG000|Overall Study|Withdrawal by Subject|19|||
155683150|NCT00322452|561929287|FG001|Overall Study|Withdrawal by Subject|46|||
155683151|NCT00322452|561929286|FG000|Overall Study|Death|223|||
155683152|NCT00322452|561929287|FG001|Overall Study|Death|227|||
155683153|NCT00526656|561929288|FG000|Overall Study|Death|1|||
155683154|NCT00526656|561929288|FG000|Overall Study|Refused surgery|1|||
155683155|NCT02438384|561929289|FG000|Overall Study|Lost to Follow-up|8|||
155683156|NCT02438384|561929290|FG001|Overall Study|Lost to Follow-up|6|||
155683157|NCT02438384|561929291|FG002|Overall Study|Lost to Follow-up|4|||
155683158|NCT01795495|561929293|FG000|Overall Study|Protocol Violation|1|||
155683159|NCT01795495|561929294|FG001|Overall Study|Protocol Violation|0|||
155683160|NCT01795495|561929295|FG002|Overall Study|Protocol Violation|1|||
155683161|NCT01795495|561929293|FG000|Overall Study|Physician Decision|0|||
155683162|NCT01795495|561929294|FG001|Overall Study|Physician Decision|0|||
155683163|NCT01795495|561929295|FG002|Overall Study|Physician Decision|1|||
155683164|NCT04027049|561929296|FG000|Overall Study|Withdrawn by family|1|||
155683165|NCT04027049|561929297|FG001|Overall Study|Withdrawn by family|0|||
155683166|NCT04027049|561929296|FG000|Overall Study|Participant safety|1|||
155683167|NCT04027049|561929297|FG001|Overall Study|Participant safety|0|||
155683168|NCT02650128|561929298|FG000|Overall Study|Death|2|||
155683169|NCT03116828|561931552|FG000|Overall Study|Adverse Event|1|||
155683170|NCT03116828|561931553|FG001|Overall Study|Adverse Event|10|||
155683171|NCT03116828|561931552|FG000|Overall Study|Withdrawal by Subject|4|||
155683172|NCT03116828|561931553|FG001|Overall Study|Withdrawal by Subject|8|||
155683173|NCT03116828|561931552|FG000|Overall Study|OTHER|3|||
155683174|NCT03116828|561931553|FG001|Overall Study|OTHER|3|||
155683175|NCT00983515|561931554|FG000|Ritonavir Alone|liver panel out of range|6|||
155683176|NCT00983515|561931554|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
155683177|NCT05243745|561931555|FG000|Overall Study|Withdrawal by Subject|0|||
155683178|NCT05243745|561931556|FG001|Overall Study|Withdrawal by Subject|0|||
155683179|NCT05243745|561931557|FG002|Overall Study|Withdrawal by Subject|0|||
155683180|NCT05243745|561931558|FG003|Overall Study|Withdrawal by Subject|1|||
155683181|NCT05243745|561931555|FG000|Overall Study|Unable to Attend Visit 6|0|||
155683182|NCT05243745|561931556|FG001|Overall Study|Unable to Attend Visit 6|0|||
155683183|NCT05243745|561931557|FG002|Overall Study|Unable to Attend Visit 6|1|||
155683184|NCT05243745|561931558|FG003|Overall Study|Unable to Attend Visit 6|0|||
155683185|NCT02998203|561931559|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
155683186|NCT02998203|561931560|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
155683187|NCT02998203|561931559|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
155683188|NCT02998203|561931560|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
155683189|NCT04187144|561931563|FG000|Overall Study|Lost to Follow-up|12|||
155683190|NCT04187144|561931564|FG001|Overall Study|Lost to Follow-up|11|||
155683191|NCT04187144|561931563|FG000|Overall Study|Withdrawal by Subject|20|||
155683192|NCT04187144|561931564|FG001|Overall Study|Withdrawal by Subject|18|||
155683193|NCT04187144|561931563|FG000|Overall Study|Adverse Event|19|||
155683194|NCT04187144|561931564|FG001|Overall Study|Adverse Event|4|||
155683195|NCT04187144|561931563|FG000|Overall Study|Physician Decision|5|||
155683196|NCT04187144|561931564|FG001|Overall Study|Physician Decision|3|||
155683197|NCT04187144|561931563|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
155683198|NCT04187144|561931564|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
155683199|NCT04187144|561931563|FG000|Overall Study|Protocol Deviation|1|||
155683200|NCT04187144|561931564|FG001|Overall Study|Protocol Deviation|4|||
155683201|NCT01044745|561931565|FG000|Overall Study|Ineiligible|2|||
155683202|NCT05312632|561931569|FG000|Overall Study|Adverse Event|12|||
155683203|NCT05312632|561931569|FG000|Overall Study|Withdrawal by Subject|10|||
155683204|NCT05312632|561931569|FG000|Overall Study|Lack of Efficacy|4|||
155683205|NCT05312632|561931569|FG000|Overall Study|Non-compliance with study procedures|9|||
155683206|NCT05312632|561931569|FG000|Overall Study|Other|4|||
155683207|NCT02379221|561931571|FG000|Overall Study|Lost to Follow-up|1|||
155683208|NCT02019108|561931572|FG000|Overall Study|Lost to Follow-up|5|||
155683209|NCT02019108|561931573|FG001|Overall Study|Lost to Follow-up|7|||
155683210|NCT00519376|561931576|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683211|NCT00519376|561931577|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683212|NCT00519376|561931578|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683213|NCT00519376|561931579|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683214|NCT00519376|561931580|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683215|NCT00519376|561931581|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683216|NCT00519376|561931582|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683217|NCT00519376|561931583|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683218|NCT00519376|561931584|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683219|NCT00519376|561931585|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683220|NCT00519376|561931586|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683221|NCT00519376|561931587|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683222|NCT00519376|561931588|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
155683223|NCT00519376|561931589|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683224|NCT00519376|561931590|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683225|NCT00519376|561931591|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155683226|NCT00519376|561931576|FG000|Treatment Period 4|Lost to Follow-up|0|||
155683227|NCT00519376|561931577|FG001|Treatment Period 4|Lost to Follow-up|0|||
155683228|NCT00519376|561931578|FG002|Treatment Period 4|Lost to Follow-up|1|||
155683229|NCT00519376|561931579|FG003|Treatment Period 4|Lost to Follow-up|0|||
155683230|NCT00519376|561931580|FG004|Treatment Period 4|Lost to Follow-up|0|||
155683231|NCT00519376|561931581|FG005|Treatment Period 4|Lost to Follow-up|0|||
155683232|NCT00519376|561931582|FG006|Treatment Period 4|Lost to Follow-up|0|||
155683233|NCT00519376|561931583|FG007|Treatment Period 4|Lost to Follow-up|0|||
155683234|NCT00519376|561931584|FG008|Treatment Period 4|Lost to Follow-up|0|||
155683235|NCT00519376|561931585|FG009|Treatment Period 4|Lost to Follow-up|0|||
155683236|NCT00519376|561931586|FG010|Treatment Period 4|Lost to Follow-up|0|||
155683237|NCT00519376|561931587|FG011|Treatment Period 4|Lost to Follow-up|0|||
155683238|NCT00519376|561931588|FG012|Treatment Period 4|Lost to Follow-up|0|||
155683239|NCT00519376|561931589|FG013|Treatment Period 4|Lost to Follow-up|0|||
155683240|NCT00519376|561931590|FG014|Treatment Period 4|Lost to Follow-up|0|||
155683241|NCT00519376|561931591|FG015|Treatment Period 4|Lost to Follow-up|0|||
155683242|NCT02688088|561931595|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155683243|NCT02688088|561931596|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
155683244|NCT02688088|561931597|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155683245|NCT02688088|561931598|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155683246|NCT02688088|561931599|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155683247|NCT02688088|561931595|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155683248|NCT02688088|561931596|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
155683249|NCT02688088|561931597|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155683250|NCT02688088|561931598|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155683251|NCT02688088|561931599|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155683252|NCT02688088|561931595|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155683253|NCT02688088|561931596|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
155683254|NCT02688088|561931597|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155683255|NCT02688088|561931598|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155683256|NCT02688088|561931599|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155683257|NCT02688088|561931595|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155683258|NCT02688088|561931596|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
155683259|NCT02688088|561931597|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155683260|NCT02688088|561931598|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155683261|NCT02688088|561931599|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155683262|NCT02688088|561931595|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155683263|NCT02688088|561931596|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155683264|NCT02688088|561931597|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
155683265|NCT02688088|561931598|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155683266|NCT02688088|561931599|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155683267|NCT02688088|561931595|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155683268|NCT02688088|561931596|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155683269|NCT02688088|561931597|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
155683270|NCT02688088|561931598|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155683271|NCT02688088|561931599|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155683272|NCT02688088|561931595|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155683273|NCT02688088|561931596|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155683274|NCT02688088|561931597|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155683275|NCT02688088|561931598|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
155683276|NCT02688088|561931599|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155683277|NCT02688088|561931595|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155683278|NCT02688088|561931596|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155683279|NCT02688088|561931597|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155683280|NCT02688088|561931598|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
155683281|NCT02688088|561931599|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155683282|NCT02688088|561931595|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155683283|NCT02688088|561931596|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155683284|NCT02688088|561931597|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155683285|NCT02688088|561931598|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155683286|NCT02688088|561931599|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
155683287|NCT03812185|561931606|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
155683288|NCT01681069|561931617|FG000|Overall Study|Withdrawal by Subject|4|||
155683289|NCT01681069|561931618|FG001|Overall Study|Withdrawal by Subject|5|||
155683290|NCT01681069|561931617|FG000|Overall Study|Protocol Violation|1|||
155683291|NCT01681069|561931618|FG001|Overall Study|Protocol Violation|1|||
155683292|NCT01681069|561931617|FG000|Overall Study|Adverse Event|0|||
155683293|NCT01681069|561931618|FG001|Overall Study|Adverse Event|1|||
155683294|NCT03883165|561931620|FG000|Overall Study|Withdrawal by Subject|4|||
155683295|NCT03883165|561931621|FG001|Overall Study|Withdrawal by Subject|3|||
155683296|NCT00245050|561931622|FG000|Overall Study|Adverse Event|3|||
155683297|NCT00245050|561931623|FG001|Overall Study|Adverse Event|2|||
155683298|NCT00730041|561931624|FG000|Overall Study|Lost to Follow-up|0|||
155683299|NCT00730041|561931625|FG001|Overall Study|Lost to Follow-up|2|||
155683300|NCT05526781|561931628|FG000|Overall Study|Lost to Follow-up|1|||
155683301|NCT04085458|561931629|FG000|Overall Study|Other|1|||
155683302|NCT04085458|561931629|FG000|Overall Study|Withdrawal by Subject|2|||
155683303|NCT04085458|561931629|FG000|Overall Study|Adverse Event|2|||
155683304|NCT02743949|561931630|FG000|Overall Study|Adverse Event|0|||
155683305|NCT02743949|561931631|FG001|Overall Study|Adverse Event|0|||
155683306|NCT02743949|561931632|FG002|Overall Study|Adverse Event|2|||
155683307|NCT02743949|561931630|FG000|Overall Study|Significant Protocol Deviation|2|||
155683308|NCT02743949|561931631|FG001|Overall Study|Significant Protocol Deviation|0|||
155683309|NCT02743949|561931632|FG002|Overall Study|Significant Protocol Deviation|1|||
155683310|NCT02743949|561931630|FG000|Overall Study|Voluntary Withdrawal|2|||
155683311|NCT02743949|561931631|FG001|Overall Study|Voluntary Withdrawal|1|||
155683312|NCT02743949|561931632|FG002|Overall Study|Voluntary Withdrawal|0|||
155683313|NCT01921218|561931633|FG000|Overall Study|Death|2|||
155683314|NCT01921218|561931634|FG001|Overall Study|Death|1|||
155683315|NCT01921218|561931633|FG000|Overall Study|Withdrawal by Subject|0|||
155683316|NCT01921218|561931634|FG001|Overall Study|Withdrawal by Subject|2|||
155683317|NCT01921218|561931633|FG000|Overall Study|Kidney transplant|1|||
155683318|NCT01921218|561931634|FG001|Overall Study|Kidney transplant|1|||
155683319|NCT01885208|561931635|FG000|Overall Study|Unclassified|32|||
155683320|NCT01885208|561931636|FG001|Overall Study|Unclassified|38|||
155683321|NCT00920218|561931637|FG000|Overall Study|Serious Adverse Event|2|||
155683322|NCT00920218|561931638|FG001|Overall Study|Serious Adverse Event|0|||
155683323|NCT00920218|561931639|FG002|Overall Study|Serious Adverse Event|2|||
155683324|NCT00920218|561931640|FG003|Overall Study|Serious Adverse Event|1|||
155683325|NCT00920218|561931637|FG000|Overall Study|Withdrawal by Subject|0|||
155683326|NCT00920218|561931638|FG001|Overall Study|Withdrawal by Subject|3|||
155683327|NCT00920218|561931639|FG002|Overall Study|Withdrawal by Subject|2|||
155683328|NCT00920218|561931640|FG003|Overall Study|Withdrawal by Subject|0|||
155683329|NCT00920218|561931637|FG000|Overall Study|Migrated/moved from study area|0|||
155683330|NCT00920218|561931638|FG001|Overall Study|Migrated/moved from study area|0|||
155683331|NCT00920218|561931639|FG002|Overall Study|Migrated/moved from study area|1|||
155683332|NCT00920218|561931640|FG003|Overall Study|Migrated/moved from study area|0|||
155683333|NCT00920218|561931637|FG000|Overall Study|Lost to Follow-up|0|||
155683334|NCT00920218|561931638|FG001|Overall Study|Lost to Follow-up|1|||
155683335|NCT00920218|561931639|FG002|Overall Study|Lost to Follow-up|0|||
155683336|NCT00920218|561931640|FG003|Overall Study|Lost to Follow-up|3|||
155683337|NCT00920218|561931637|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
155683338|NCT00920218|561931638|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
155683339|NCT00920218|561931639|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
155683340|NCT00920218|561931640|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
155683341|NCT00920218|561931637|FG000|Overall Study|Other|0|||
155683342|NCT00920218|561931638|FG001|Overall Study|Other|0|||
155683343|NCT00920218|561931639|FG002|Overall Study|Other|1|||
155683344|NCT00920218|561931640|FG003|Overall Study|Other|0|||
155683345|NCT02449889|561931644|FG000|Overall Study|Adverse Event|1|||
155683346|NCT02449889|561931645|FG001|Overall Study|Adverse Event|2|||
155683347|NCT02449889|561931646|FG002|Overall Study|Adverse Event|0|||
155683348|NCT02449889|561931644|FG000|Overall Study|Protocol Violation|0|||
155683349|NCT02449889|561931645|FG001|Overall Study|Protocol Violation|4|||
155683350|NCT02449889|561931646|FG002|Overall Study|Protocol Violation|1|||
155683351|NCT01973387|561931647|FG000|Overall Study|Adverse Event|14|||
155683352|NCT01973387|561931648|FG001|Overall Study|Adverse Event|4|||
155683353|NCT01973387|561931647|FG000|Overall Study|Withdrawal by Subject|7|||
155683354|NCT01973387|561931648|FG001|Overall Study|Withdrawal by Subject|4|||
155683355|NCT01973387|561931647|FG000|Overall Study|Study terminated by sponsor|63|||
155683356|NCT01973387|561931648|FG001|Overall Study|Study terminated by sponsor|0|||
155683357|NCT01973387|561931647|FG000|Overall Study|Progressive disease or relapse|16|||
155683358|NCT01973387|561931648|FG001|Overall Study|Progressive disease or relapse|5|||
155683359|NCT01973387|561931647|FG000|Overall Study|Death|4|||
155683360|NCT01973387|561931648|FG001|Overall Study|Death|3|||
155683361|NCT01973387|561931647|FG000|Overall Study|Randomized, not treated|2|||
155683362|NCT01973387|561931648|FG001|Overall Study|Randomized, not treated|2|||
155683363|NCT00596154|561931652|FG000|Overall Study|Not Evaluable|2|||
155683364|NCT03888235|561931661|FG000|Overall Study|Lost to Follow-up|1|||
155683365|NCT03888235|561931662|FG001|Overall Study|Lost to Follow-up|1|||
155683366|NCT03888235|561931663|FG002|Overall Study|Lost to Follow-up|0|||
155683367|NCT01054560|561931664|FG000|Overall Study|Death|10|||
155683368|NCT01054560|561931665|FG001|Overall Study|Death|21|||
155683369|NCT01054560|561931664|FG000|Overall Study|Lost to Follow-up|2|||
155683370|NCT01054560|561931665|FG001|Overall Study|Lost to Follow-up|5|||
155683371|NCT01054560|561931664|FG000|Overall Study|Withdrawal by Subject|0|||
155683372|NCT01054560|561931665|FG001|Overall Study|Withdrawal by Subject|2|||
155683373|NCT01054560|561931664|FG000|Overall Study|Physician Decision|1|||
155683374|NCT01054560|561931665|FG001|Overall Study|Physician Decision|0|||
155683375|NCT02135029|561931669|FG000|Overall Study|Adverse Event|2|||
155683376|NCT02135029|561931670|FG001|Overall Study|Adverse Event|2|||
155683377|NCT02135029|561931671|FG002|Overall Study|Adverse Event|2|||
155683378|NCT02135029|561931669|FG000|Overall Study|Lost to Follow-up|0|||
155683379|NCT02135029|561931670|FG001|Overall Study|Lost to Follow-up|1|||
155683380|NCT02135029|561931671|FG002|Overall Study|Lost to Follow-up|0|||
155683381|NCT02135029|561931669|FG000|Overall Study|Withdrawal by Subject|2|||
155683382|NCT02135029|561931670|FG001|Overall Study|Withdrawal by Subject|0|||
155683383|NCT02135029|561931671|FG002|Overall Study|Withdrawal by Subject|1|||
155683384|NCT02135029|561931669|FG000|Overall Study|Other|0|||
155683385|NCT02135029|561931670|FG001|Overall Study|Other|1|||
155683386|NCT02135029|561931671|FG002|Overall Study|Other|0|||
155683387|NCT02135029|561931669|FG000|Overall Study|Death|0|||
155683388|NCT02135029|561931670|FG001|Overall Study|Death|1|||
155683389|NCT02135029|561931671|FG002|Overall Study|Death|0|||
155683390|NCT02210689|561931672|FG000|Overall Study|Withdrawal by Subject|7|||
155683391|NCT02210689|561931673|FG001|Overall Study|Withdrawal by Subject|4|||
155683392|NCT02210689|561931674|FG002|Overall Study|Withdrawal by Subject|2|||
155683393|NCT02210689|561931672|FG000|Overall Study|Adverse Event|0|||
155683394|NCT02210689|561931673|FG001|Overall Study|Adverse Event|1|||
155683395|NCT02210689|561931674|FG002|Overall Study|Adverse Event|0|||
155683396|NCT02210689|561931672|FG000|Overall Study|Protocol Violation|1|||
155683397|NCT02210689|561931673|FG001|Overall Study|Protocol Violation|0|||
155683398|NCT02210689|561931674|FG002|Overall Study|Protocol Violation|0|||
155683399|NCT02210689|561931672|FG000|Overall Study|Lost to Follow-up|11|||
155683400|NCT02210689|561931673|FG001|Overall Study|Lost to Follow-up|9|||
155683401|NCT02210689|561931674|FG002|Overall Study|Lost to Follow-up|5|||
155683402|NCT02210689|561931672|FG000|Overall Study|Pregnancy|0|||
155683403|NCT02210689|561931673|FG001|Overall Study|Pregnancy|1|||
155683404|NCT02210689|561931674|FG002|Overall Study|Pregnancy|0|||
155683405|NCT02210689|561931672|FG000|Overall Study|Lack of Efficacy|0|||
155683406|NCT02210689|561931673|FG001|Overall Study|Lack of Efficacy|1|||
155683407|NCT02210689|561931674|FG002|Overall Study|Lack of Efficacy|5|||
155683408|NCT02210689|561931672|FG000|Overall Study|Prohibited medication|2|||
155683409|NCT02210689|561931673|FG001|Overall Study|Prohibited medication|8|||
155683410|NCT02210689|561931674|FG002|Overall Study|Prohibited medication|1|||
155683411|NCT02210689|561931672|FG000|Overall Study|Negative Nugent score at baseline|6|||
155683412|NCT02210689|561931673|FG001|Overall Study|Negative Nugent score at baseline|2|||
155683413|NCT02210689|561931674|FG002|Overall Study|Negative Nugent score at baseline|2|||
155683414|NCT02210689|561931672|FG000|Overall Study|Other|25|||
155683415|NCT02210689|561931673|FG001|Overall Study|Other|21|||
155683416|NCT02210689|561931674|FG002|Overall Study|Other|8|||
155683417|NCT00866047|561931675|FG000|Treatment Period|Progressive disease|13|||
155683418|NCT00866047|561931675|FG000|Treatment Period|Adverse Event|16|||
155683419|NCT00866047|561931675|FG000|Treatment Period|Physician Decision|14|||
155683420|NCT00866047|561931675|FG000|Treatment Period|Withdrawal by Subject|5|||
155683421|NCT00866047|561931675|FG000|Follow-up Period|Lost to Follow-up|5|||
155683422|NCT05427539|561931676|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155683423|NCT05427539|561931677|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155683424|NCT05427539|561931676|FG000|Period 1|Withdrawal by Subject|1|||
155683425|NCT05427539|561931677|FG001|Period 1|Withdrawal by Subject|0|||
155683426|NCT00223977|561931678|FG000|Overall Study|Adverse Event|7|||
155683427|NCT00223977|561931679|FG001|Overall Study|Adverse Event|10|||
155683428|NCT00223977|561931680|FG002|Overall Study|Adverse Event|0|||
155683429|NCT00223977|561931678|FG000|Overall Study|Protocol Violation|0|||
155683430|NCT00223977|561931679|FG001|Overall Study|Protocol Violation|0|||
155683431|NCT00223977|561931680|FG002|Overall Study|Protocol Violation|1|||
155683432|NCT00223977|561931678|FG000|Overall Study|Withdrawal by Subject|1|||
155683433|NCT00223977|561931679|FG001|Overall Study|Withdrawal by Subject|1|||
155683434|NCT00223977|561931680|FG002|Overall Study|Withdrawal by Subject|2|||
155683435|NCT00223977|561931678|FG000|Overall Study|Other|1|||
155683436|NCT00223977|561931679|FG001|Overall Study|Other|0|||
155683437|NCT00223977|561931680|FG002|Overall Study|Other|0|||
155683438|NCT04376684|561931685|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
155683439|NCT04376684|561931686|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
155683440|NCT04376684|561931687|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
155683441|NCT04376684|561931688|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
155683442|NCT04376684|561931685|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
155683443|NCT04376684|561931686|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
155683444|NCT04376684|561931687|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
155683445|NCT04376684|561931688|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
155683446|NCT04376684|561931685|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
155683447|NCT04376684|561931686|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
155683448|NCT04376684|561931687|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
155683449|NCT04376684|561931688|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
155683450|NCT04376684|561931685|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
155683451|NCT04376684|561931686|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
155683452|NCT04376684|561931687|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
155683453|NCT04376684|561931688|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
155683454|NCT04376684|561931685|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
155683455|NCT04376684|561931686|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
155683456|NCT04376684|561931687|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
155683457|NCT04376684|561931688|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
155683458|NCT04376684|561931685|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
155683459|NCT04376684|561931686|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
155683460|NCT04376684|561931687|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
155683461|NCT04376684|561931688|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
155683462|NCT04376684|561931685|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
155683463|NCT04376684|561931686|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
155683464|NCT04376684|561931687|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
155683465|NCT04376684|561931688|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
155683466|NCT04934800|561931690|FG000|Overall Study|Other|1|||
155683467|NCT04934800|561931690|FG000|Overall Study|Withdrawal by Subject|5|||
155683468|NCT04934800|561931690|FG000|Overall Study|Lack of Efficacy|1|||
155683469|NCT04934800|561931690|FG000|Overall Study|Adverse Event|9|||
155683470|NCT04934800|561931690|FG000|Overall Study|Lost to Follow-up|5|||
155683471|NCT04934800|561931690|FG000|Overall Study|Enrolled but not treated|1|||
155683472|NCT05596734|561931691|FG000|Substudy A|Withdrawal by Subject|1|||
155683473|NCT05596734|561931692|FG001|Substudy A|Withdrawal by Subject|0|||
155683474|NCT05596734|561931693|FG002|Substudy A|Withdrawal by Subject|0|||
155683475|NCT05596734|561931694|FG003|Substudy A|Withdrawal by Subject|0|||
155683476|NCT05596734|561931695|FG004|Substudy A|Withdrawal by Subject|0|||
155683477|NCT05596734|561931696|FG005|Substudy A|Withdrawal by Subject|0|||
155683478|NCT05596734|561931697|FG006|Substudy A|Withdrawal by Subject|1|||
155683479|NCT05596734|561931698|FG007|Substudy A|Withdrawal by Subject|0|||
155683480|NCT05596734|561931699|FG008|Substudy A|Withdrawal by Subject|0|||
155683481|NCT05596734|561931700|FG009|Substudy A|Withdrawal by Subject|0|||
155683482|NCT05596734|561931701|FG010|Substudy A|Withdrawal by Subject|0|||
155683483|NCT05596734|561931702|FG011|Substudy A|Withdrawal by Subject|0|||
155683484|NCT05596734|561931703|FG012|Substudy A|Withdrawal by Subject|0|||
155683485|NCT05596734|561931704|FG013|Substudy A|Withdrawal by Subject|0|||
155683486|NCT05596734|561931705|FG014|Substudy A|Withdrawal by Subject|0|||
155683487|NCT05596734|561931706|FG015|Substudy A|Withdrawal by Subject|0|||
155683488|NCT05596734|561931707|FG016|Substudy A|Withdrawal by Subject|0|||
155683489|NCT05596734|561931708|FG017|Substudy A|Withdrawal by Subject|0|||
155683490|NCT05596734|561931709|FG018|Substudy A|Withdrawal by Subject|0|||
155683491|NCT05596734|561931710|FG019|Substudy A|Withdrawal by Subject|0|||
155683492|NCT05596734|561931711|FG020|Substudy A|Withdrawal by Subject|0|||
155683493|NCT05596734|561931712|FG021|Substudy A|Withdrawal by Subject|0|||
155683494|NCT05596734|561931713|FG022|Substudy A|Withdrawal by Subject|0|||
155683495|NCT05596734|561931714|FG023|Substudy A|Withdrawal by Subject|0|||
155683496|NCT05596734|561931691|FG000|Substudy A|Lost to Follow-up|1|||
155683497|NCT05596734|561931692|FG001|Substudy A|Lost to Follow-up|0|||
155683498|NCT05596734|561931693|FG002|Substudy A|Lost to Follow-up|1|||
155683499|NCT05596734|561931694|FG003|Substudy A|Lost to Follow-up|0|||
155683500|NCT05596734|561931695|FG004|Substudy A|Lost to Follow-up|0|||
155683501|NCT05596734|561931696|FG005|Substudy A|Lost to Follow-up|0|||
155683502|NCT05596734|561931697|FG006|Substudy A|Lost to Follow-up|0|||
155683503|NCT05596734|561931698|FG007|Substudy A|Lost to Follow-up|0|||
155683504|NCT05596734|561931699|FG008|Substudy A|Lost to Follow-up|0|||
155683505|NCT05596734|561931700|FG009|Substudy A|Lost to Follow-up|0|||
155683506|NCT05596734|561931701|FG010|Substudy A|Lost to Follow-up|0|||
155683507|NCT05596734|561931702|FG011|Substudy A|Lost to Follow-up|0|||
155683508|NCT05596734|561931703|FG012|Substudy A|Lost to Follow-up|0|||
155683509|NCT05596734|561931704|FG013|Substudy A|Lost to Follow-up|0|||
155683510|NCT05596734|561931705|FG014|Substudy A|Lost to Follow-up|0|||
155683511|NCT05596734|561931706|FG015|Substudy A|Lost to Follow-up|0|||
155683512|NCT05596734|561931707|FG016|Substudy A|Lost to Follow-up|0|||
155683513|NCT05596734|561931708|FG017|Substudy A|Lost to Follow-up|0|||
155683514|NCT05596734|561931709|FG018|Substudy A|Lost to Follow-up|0|||
155683515|NCT05596734|561931710|FG019|Substudy A|Lost to Follow-up|0|||
155683516|NCT05596734|561931711|FG020|Substudy A|Lost to Follow-up|0|||
155683517|NCT05596734|561931712|FG021|Substudy A|Lost to Follow-up|0|||
155683518|NCT05596734|561931713|FG022|Substudy A|Lost to Follow-up|0|||
155683519|NCT05596734|561931714|FG023|Substudy A|Lost to Follow-up|0|||
155683520|NCT05596734|561931691|FG000|Substudy B|Withdrawal by Subject|0|||
155683521|NCT05596734|561931692|FG001|Substudy B|Withdrawal by Subject|0|||
155683522|NCT05596734|561931693|FG002|Substudy B|Withdrawal by Subject|0|||
155683523|NCT05596734|561931694|FG003|Substudy B|Withdrawal by Subject|0|||
155683524|NCT05596734|561931695|FG004|Substudy B|Withdrawal by Subject|0|||
155683525|NCT05596734|561931696|FG005|Substudy B|Withdrawal by Subject|0|||
155683526|NCT05596734|561931697|FG006|Substudy B|Withdrawal by Subject|0|||
155683527|NCT05596734|561931698|FG007|Substudy B|Withdrawal by Subject|0|||
155683528|NCT05596734|561931699|FG008|Substudy B|Withdrawal by Subject|0|||
155683529|NCT05596734|561931700|FG009|Substudy B|Withdrawal by Subject|0|||
155683530|NCT05596734|561931701|FG010|Substudy B|Withdrawal by Subject|0|||
155683531|NCT05596734|561931702|FG011|Substudy B|Withdrawal by Subject|0|||
155683532|NCT05596734|561931703|FG012|Substudy B|Withdrawal by Subject|1|||
155683533|NCT05596734|561931704|FG013|Substudy B|Withdrawal by Subject|0|||
155683534|NCT05596734|561931705|FG014|Substudy B|Withdrawal by Subject|1|||
155683535|NCT05596734|561931706|FG015|Substudy B|Withdrawal by Subject|2|||
155683536|NCT05596734|561931707|FG016|Substudy B|Withdrawal by Subject|2|||
155683537|NCT05596734|561931708|FG017|Substudy B|Withdrawal by Subject|1|||
155683538|NCT05596734|561931709|FG018|Substudy B|Withdrawal by Subject|2|||
155683539|NCT05596734|561931710|FG019|Substudy B|Withdrawal by Subject|0|||
155683540|NCT05596734|561931711|FG020|Substudy B|Withdrawal by Subject|0|||
155683541|NCT05596734|561931712|FG021|Substudy B|Withdrawal by Subject|0|||
155683542|NCT05596734|561931713|FG022|Substudy B|Withdrawal by Subject|0|||
155683543|NCT05596734|561931714|FG023|Substudy B|Withdrawal by Subject|1|||
155683544|NCT05596734|561931691|FG000|Substudy B|Physician Decision|0|||
155683545|NCT05596734|561931692|FG001|Substudy B|Physician Decision|0|||
155683546|NCT05596734|561931693|FG002|Substudy B|Physician Decision|0|||
155683547|NCT05596734|561931694|FG003|Substudy B|Physician Decision|0|||
155683548|NCT05596734|561931695|FG004|Substudy B|Physician Decision|0|||
155683549|NCT05596734|561931696|FG005|Substudy B|Physician Decision|0|||
155683550|NCT05596734|561931697|FG006|Substudy B|Physician Decision|0|||
155683551|NCT05596734|561931698|FG007|Substudy B|Physician Decision|0|||
155683552|NCT05596734|561931699|FG008|Substudy B|Physician Decision|0|||
155683553|NCT05596734|561931700|FG009|Substudy B|Physician Decision|0|||
155603760|NCT03422159|561637810|FG001|Overall Study|Exclusion due to terminal disease|1|||
155603761|NCT03436199|561637811|FG000|Overall Study|Adverse Event|15|||
155603762|NCT03436199|561637812|FG001|Overall Study|Adverse Event|40|||
155603763|NCT03436199|561637813|FG002|Overall Study|Adverse Event|7|||
155603764|NCT03436199|561637811|FG000|Overall Study|Withdrawal by Subject|4|||
155603765|NCT03436199|561637812|FG001|Overall Study|Withdrawal by Subject|10|||
155603766|NCT03436199|561637813|FG002|Overall Study|Withdrawal by Subject|3|||
155603767|NCT03436199|561637811|FG000|Overall Study|Lost to Follow-up|1|||
155603768|NCT03436199|561637812|FG001|Overall Study|Lost to Follow-up|0|||
155603769|NCT03436199|561637813|FG002|Overall Study|Lost to Follow-up|2|||
155603770|NCT03436199|561637811|FG000|Overall Study|Protocol Violation|1|||
155603771|NCT03436199|561637812|FG001|Overall Study|Protocol Violation|1|||
155603772|NCT03436199|561637813|FG002|Overall Study|Protocol Violation|0|||
155603773|NCT03436199|561637811|FG000|Overall Study|Physician Decision|0|||
155603774|NCT03436199|561637812|FG001|Overall Study|Physician Decision|1|||
155603775|NCT03436199|561637813|FG002|Overall Study|Physician Decision|0|||
155603776|NCT03436199|561637811|FG000|Overall Study|Could not return to clinic|1|||
155603777|NCT03436199|561637812|FG001|Overall Study|Could not return to clinic|0|||
155603778|NCT03436199|561637813|FG002|Overall Study|Could not return to clinic|0|||
155603779|NCT03436199|561637811|FG000|Overall Study|Withdrawn per physician|0|||
155603780|NCT03436199|561637812|FG001|Overall Study|Withdrawn per physician|1|||
155603781|NCT03436199|561637813|FG002|Overall Study|Withdrawn per physician|0|||
155603782|NCT00085098|561637814|FG000|Overall Study|Withdrawal by Subject|0|||
155603783|NCT00085098|561637815|FG001|Overall Study|Withdrawal by Subject|1|||
155603784|NCT00085098|561637814|FG000|Overall Study|Ineligible|1|||
155603785|NCT00085098|561637815|FG001|Overall Study|Ineligible|1|||
155603786|NCT01886781|561637816|FG000|Overall Study|Protocol Violation|5|||
155603787|NCT01886781|561637817|FG001|Overall Study|Protocol Violation|0|||
155603788|NCT01886781|561637816|FG000|Overall Study|Adverse Event|1|||
155603789|NCT01886781|561637817|FG001|Overall Study|Adverse Event|0|||
155603790|NCT01886781|561637816|FG000|Overall Study|Lost to Follow-up|5|||
155603791|NCT01886781|561637817|FG001|Overall Study|Lost to Follow-up|0|||
155603792|NCT01886781|561637816|FG000|Overall Study|Withdrawal by Subject|2|||
155603793|NCT01886781|561637817|FG001|Overall Study|Withdrawal by Subject|1|||
155603794|NCT01886781|561637816|FG000|Overall Study|Worsening of symptoms|1|||
155603795|NCT01886781|561637817|FG001|Overall Study|Worsening of symptoms|1|||
155603796|NCT01935700|561637822|FG000|Overall Study|Withdrawal by Subject|1|||
155603797|NCT01935700|561637823|FG001|Overall Study|Withdrawal by Subject|0|||
155603798|NCT01935700|561637822|FG000|Overall Study|Physician Decision|4|||
155603799|NCT01935700|561637823|FG001|Overall Study|Physician Decision|0|||
155603800|NCT01935128|561637824|FG000|Overall Study|Death|1|||
155603801|NCT01935128|561637824|FG000|Overall Study|Adverse Event|6|||
155603802|NCT00772005|561637826|FG000|Overall Study|Adverse Event|9|||
155603803|NCT00772005|561637827|FG001|Overall Study|Adverse Event|14|||
155603804|NCT00772005|561637828|FG002|Overall Study|Adverse Event|10|||
155603805|NCT00772005|561637829|FG003|Overall Study|Adverse Event|13|||
155603806|NCT00772005|561637826|FG000|Overall Study|Lack of Efficacy|0|||
155603807|NCT00772005|561637827|FG001|Overall Study|Lack of Efficacy|1|||
155603808|NCT00772005|561637828|FG002|Overall Study|Lack of Efficacy|0|||
155603809|NCT00772005|561637829|FG003|Overall Study|Lack of Efficacy|0|||
155603810|NCT00772005|561637826|FG000|Overall Study|Withdrawal by Subject|3|||
155683554|NCT05596734|561931701|FG010|Substudy B|Physician Decision|0|||
155603811|NCT00772005|561637827|FG001|Overall Study|Withdrawal by Subject|7|||
155603812|NCT00772005|561637828|FG002|Overall Study|Withdrawal by Subject|10|||
155603813|NCT00772005|561637829|FG003|Overall Study|Withdrawal by Subject|2|||
155603814|NCT00772005|561637826|FG000|Overall Study|Protocol Violation|2|||
155603815|NCT00772005|561637827|FG001|Overall Study|Protocol Violation|4|||
155603816|NCT00772005|561637828|FG002|Overall Study|Protocol Violation|1|||
155683555|NCT05596734|561931702|FG011|Substudy B|Physician Decision|0|||
155683556|NCT05596734|561931703|FG012|Substudy B|Physician Decision|0|||
155603817|NCT00772005|561637829|FG003|Overall Study|Protocol Violation|6|||
155603818|NCT00772005|561637826|FG000|Overall Study|Lost to Follow-up|7|||
155683557|NCT05596734|561931704|FG013|Substudy B|Physician Decision|0|||
155683558|NCT05596734|561931705|FG014|Substudy B|Physician Decision|0|||
155683559|NCT05596734|561931706|FG015|Substudy B|Physician Decision|1|||
155683560|NCT05596734|561931707|FG016|Substudy B|Physician Decision|0|||
155683561|NCT05596734|561931708|FG017|Substudy B|Physician Decision|0|||
155683562|NCT05596734|561931709|FG018|Substudy B|Physician Decision|0|||
155683563|NCT05596734|561931710|FG019|Substudy B|Physician Decision|0|||
155683564|NCT05596734|561931711|FG020|Substudy B|Physician Decision|0|||
155683565|NCT05596734|561931712|FG021|Substudy B|Physician Decision|0|||
155683566|NCT05596734|561931713|FG022|Substudy B|Physician Decision|0|||
155683567|NCT05596734|561931714|FG023|Substudy B|Physician Decision|0|||
155683568|NCT05596734|561931691|FG000|Substudy B|Lost to Follow-up|0|||
155683569|NCT05596734|561931692|FG001|Substudy B|Lost to Follow-up|0|||
155683570|NCT05596734|561931693|FG002|Substudy B|Lost to Follow-up|0|||
155683571|NCT05596734|561931694|FG003|Substudy B|Lost to Follow-up|0|||
155683572|NCT05596734|561931695|FG004|Substudy B|Lost to Follow-up|0|||
155683573|NCT05596734|561931696|FG005|Substudy B|Lost to Follow-up|0|||
155683574|NCT05596734|561931697|FG006|Substudy B|Lost to Follow-up|0|||
155683575|NCT05596734|561931698|FG007|Substudy B|Lost to Follow-up|0|||
155683576|NCT05596734|561931699|FG008|Substudy B|Lost to Follow-up|0|||
155683577|NCT05596734|561931700|FG009|Substudy B|Lost to Follow-up|0|||
155683578|NCT05596734|561931701|FG010|Substudy B|Lost to Follow-up|0|||
155683579|NCT05596734|561931702|FG011|Substudy B|Lost to Follow-up|0|||
155683580|NCT05596734|561931703|FG012|Substudy B|Lost to Follow-up|1|||
155683581|NCT05596734|561931704|FG013|Substudy B|Lost to Follow-up|0|||
155683582|NCT05596734|561931705|FG014|Substudy B|Lost to Follow-up|1|||
155683583|NCT05596734|561931706|FG015|Substudy B|Lost to Follow-up|1|||
155683584|NCT05596734|561931707|FG016|Substudy B|Lost to Follow-up|0|||
155683585|NCT05596734|561931708|FG017|Substudy B|Lost to Follow-up|0|||
155683586|NCT05596734|561931709|FG018|Substudy B|Lost to Follow-up|0|||
155683587|NCT05596734|561931710|FG019|Substudy B|Lost to Follow-up|0|||
155683588|NCT05596734|561931711|FG020|Substudy B|Lost to Follow-up|0|||
155683589|NCT05596734|561931712|FG021|Substudy B|Lost to Follow-up|0|||
155683590|NCT05596734|561931713|FG022|Substudy B|Lost to Follow-up|0|||
155683591|NCT05596734|561931714|FG023|Substudy B|Lost to Follow-up|0|||
155683592|NCT01974206|561931715|FG000|Overall Study|Did Not Take Study Drug|0|||
155683593|NCT01974206|561931716|FG001|Overall Study|Did Not Take Study Drug|1|||
155683594|NCT01974206|561931715|FG000|Overall Study|Physician Decision|1|||
155683595|NCT01974206|561931716|FG001|Overall Study|Physician Decision|0|||
155683596|NCT01974206|561931715|FG000|Overall Study|Withdrawal by Subject|3|||
155683597|NCT01974206|561931716|FG001|Overall Study|Withdrawal by Subject|0|||
155683598|NCT01974206|561931715|FG000|Overall Study|Lost to Follow-up|1|||
155683599|NCT01974206|561931716|FG001|Overall Study|Lost to Follow-up|0|||
155683600|NCT01974206|561931715|FG000|Overall Study|Death|1|||
155683601|NCT01974206|561931716|FG001|Overall Study|Death|0|||
155683602|NCT02059499|561931720|FG000|Upto Week 20|Lost to Follow-up|2|||
155683603|NCT02059499|561931721|FG001|Upto Week 20|Lost to Follow-up|6|||
155683604|NCT02059499|561931722|FG002|Upto Week 20|Lost to Follow-up|0|||
155683605|NCT02059499|561931720|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
155683606|NCT02059499|561931721|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
155683607|NCT02059499|561931722|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
155683608|NCT02059499|561931720|FG000|Upto Week 20|Withdrawal by Subject|1|||
155683609|NCT02059499|561931721|FG001|Upto Week 20|Withdrawal by Subject|1|||
155683610|NCT02059499|561931722|FG002|Upto Week 20|Withdrawal by Subject|0|||
155683611|NCT02059499|561931720|FG000|Upto Week 20|No treatment per protocol criteria|0|||
155683612|NCT02059499|561931721|FG001|Upto Week 20|No treatment per protocol criteria|0|||
155683613|NCT02059499|561931722|FG002|Upto Week 20|No treatment per protocol criteria|5|||
155683614|NCT02059499|561931720|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
155683615|NCT02059499|561931721|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
155683616|NCT02059499|561931722|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
155683617|NCT02059499|561931720|FG000|Post-week 20|Lost to Follow-up|0|||
155683618|NCT02059499|561931721|FG001|Post-week 20|Lost to Follow-up|2|||
155683619|NCT02059499|561931722|FG002|Post-week 20|Lost to Follow-up|0|||
155683620|NCT02059499|561931720|FG000|Post-week 20|Withdrawal by Subject|0|||
155683621|NCT02059499|561931721|FG001|Post-week 20|Withdrawal by Subject|1|||
155683622|NCT02059499|561931722|FG002|Post-week 20|Withdrawal by Subject|0|||
155683623|NCT02059499|561931720|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
155683624|NCT02059499|561931721|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
155683625|NCT02059499|561931722|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
155683626|NCT04210245|561931723|FG000|Overall Study|Adverse Event|0|||
155683627|NCT04210245|561931724|FG001|Overall Study|Adverse Event|3|||
155683628|NCT04210245|561931725|FG002|Overall Study|Adverse Event|6|||
155683629|NCT04210245|561931726|FG003|Overall Study|Adverse Event|0|||
155683630|NCT04210245|561931723|FG000|Overall Study|Withdrawal by Subject|0|||
155683631|NCT04210245|561931724|FG001|Overall Study|Withdrawal by Subject|1|||
155683632|NCT04210245|561931725|FG002|Overall Study|Withdrawal by Subject|4|||
155683633|NCT04210245|561931726|FG003|Overall Study|Withdrawal by Subject|4|||
155683634|NCT04210245|561931723|FG000|Overall Study|Lost to Follow-up|0|||
155683635|NCT04210245|561931724|FG001|Overall Study|Lost to Follow-up|1|||
155683636|NCT04210245|561931725|FG002|Overall Study|Lost to Follow-up|1|||
155683637|NCT04210245|561931726|FG003|Overall Study|Lost to Follow-up|1|||
155683638|NCT04210245|561931723|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
155683639|NCT04210245|561931724|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
155683640|NCT04210245|561931725|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
155683641|NCT04210245|561931726|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
155683642|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
155683643|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155683644|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155683645|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155683646|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155683647|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155683648|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
155683649|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
155683650|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155683651|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155683652|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155683653|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155683654|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
155683655|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
155683656|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155683657|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155683658|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155683659|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155683660|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
155683661|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
155683662|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155683663|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155683664|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155683665|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155683666|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
155683667|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
155683668|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155683669|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155683670|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155683671|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155683672|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
155683673|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155683674|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155683675|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155683676|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155683677|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155683678|NCT03989349|561931729|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
155683679|NCT03989349|561931730|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
155683680|NCT03989349|561931731|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155683681|NCT03989349|561931732|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155683682|NCT03989349|561931733|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155683683|NCT03989349|561931734|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155683684|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155683685|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155683686|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
155683687|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
155683688|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155683689|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155683690|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155683691|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155683692|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155683693|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
155683694|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155683695|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
155683696|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155683697|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155683698|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
155683699|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
155683700|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
155683701|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
155683702|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155683703|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155683704|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155683705|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155683706|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
155683707|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155683708|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155683709|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155683710|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155683711|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155683712|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155683713|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155683714|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
155683715|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
155683716|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
155683717|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
155683718|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
155683719|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
155683720|NCT03989349|561931729|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155683721|NCT03989349|561931730|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155683722|NCT03989349|561931731|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155683723|NCT03989349|561931732|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155683724|NCT03989349|561931733|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155683725|NCT03989349|561931734|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155683726|NCT02684058|561931737|FG000|Treatment Period|Progressive disease|4|||
155683727|NCT02684058|561931738|FG001|Treatment Period|Progressive disease|10|||
155683728|NCT02684058|561931739|FG002|Treatment Period|Progressive disease|19|||
155683729|NCT02684058|561931737|FG000|Treatment Period|Adverse Event|3|||
155683730|NCT02684058|561931738|FG001|Treatment Period|Adverse Event|8|||
155683731|NCT02684058|561931739|FG002|Treatment Period|Adverse Event|1|||
155683732|NCT02684058|561931737|FG000|Treatment Period|Physician Decision|5|||
155683733|NCT02684058|561931738|FG001|Treatment Period|Physician Decision|1|||
155683734|NCT02684058|561931739|FG002|Treatment Period|Physician Decision|2|||
155683735|NCT02684058|561931737|FG000|Treatment Period|New therapy for study indication|1|||
155683736|NCT02684058|561931738|FG001|Treatment Period|New therapy for study indication|0|||
155683737|NCT02684058|561931739|FG002|Treatment Period|New therapy for study indication|0|||
155683738|NCT02684058|561931737|FG000|Treatment Period|Protocol deviation|0|||
155683739|NCT02684058|561931738|FG001|Treatment Period|Protocol deviation|1|||
155683740|NCT02684058|561931739|FG002|Treatment Period|Protocol deviation|0|||
155683741|NCT02684058|561931737|FG000|Treatment Period|Subject/guardian decision|4|||
155683742|NCT02684058|561931738|FG001|Treatment Period|Subject/guardian decision|3|||
155683743|NCT02684058|561931739|FG002|Treatment Period|Subject/guardian decision|0|||
155683744|NCT02684058|561931737|FG000|Treatment Period|Death|0|||
155683745|NCT02684058|561931738|FG001|Treatment Period|Death|0|||
155683746|NCT02684058|561931739|FG002|Treatment Period|Death|2|||
155683747|NCT02684058|561931737|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155683748|NCT02684058|561931738|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155683749|NCT02684058|561931739|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155683750|NCT02684058|561931737|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
155683751|NCT02684058|561931738|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155683752|NCT02684058|561931739|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
155683753|NCT02684058|561931737|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155683754|NCT02684058|561931738|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155683755|NCT02684058|561931739|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155683756|NCT02684058|561931737|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155683757|NCT02684058|561931738|FG001|Post-treatment Efficacy Follow-up|Death|0|||
155683758|NCT02684058|561931739|FG002|Post-treatment Efficacy Follow-up|Death|3|||
155683759|NCT02684058|561931737|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
155683760|NCT02684058|561931738|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
155683761|NCT02684058|561931739|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
155683762|NCT02684058|561931737|FG000|Post-treatment Survival Follow-up|Death|0|||
155683763|NCT02684058|561931738|FG001|Post-treatment Survival Follow-up|Death|0|||
155683764|NCT02684058|561931739|FG002|Post-treatment Survival Follow-up|Death|7|||
155683765|NCT02684058|561931737|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
155683766|NCT02684058|561931738|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
155683767|NCT02684058|561931739|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
155683768|NCT02684058|561931737|FG000|Crossover Treatment Period|Progressive disease|0|||
155683769|NCT02684058|561931738|FG001|Crossover Treatment Period|Progressive disease|1|||
155683770|NCT02684058|561931739|FG002|Crossover Treatment Period|Progressive disease|0|||
155683771|NCT03219034|561931740|FG000|Overall Study|Lost to Follow-up|9|||
155683772|NCT03219034|561931741|FG001|Overall Study|Lost to Follow-up|13|||
155683773|NCT03219034|561931740|FG000|Overall Study|Additional dental work needed|1|||
155683774|NCT03219034|561931741|FG001|Overall Study|Additional dental work needed|0|||
155683775|NCT03219034|561931740|FG000|Overall Study|UPPP Surgery|1|||
155683776|NCT03219034|561931741|FG001|Overall Study|UPPP Surgery|0|||
155683777|NCT03219034|561931740|FG000|Overall Study|Dental sensitivity|0|||
155683778|NCT03219034|561931741|FG001|Overall Study|Dental sensitivity|1|||
155683779|NCT03219034|561931740|FG000|Overall Study|Death in family|0|||
155683780|NCT03219034|561931741|FG001|Overall Study|Death in family|1|||
155683781|NCT01802580|561931742|FG000|Overall Study|Physician Decision|1|||
155683782|NCT01802580|561931743|FG001|Overall Study|Physician Decision|0|||
155683783|NCT01802580|561931742|FG000|Overall Study|Protocol Violation|2|||
155683784|NCT01802580|561931743|FG001|Overall Study|Protocol Violation|0|||
155683785|NCT01802580|561931742|FG000|Overall Study|Withdrawal by Subject|5|||
155683786|NCT01802580|561931743|FG001|Overall Study|Withdrawal by Subject|6|||
155683787|NCT01802580|561931742|FG000|Overall Study|Other|1|||
155683788|NCT01802580|561931743|FG001|Overall Study|Other|3|||
155683789|NCT01802580|561931742|FG000|Overall Study|Lack of Efficacy|0|||
155683790|NCT01802580|561931743|FG001|Overall Study|Lack of Efficacy|2|||
155683791|NCT01457014|561931745|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
155683792|NCT01457014|561931746|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
155683793|NCT01457014|561931747|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
155683794|NCT01457014|561931748|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
155683795|NCT01457014|561931745|FG000|First Night|Withdrawal by Subject|3|||
155683796|NCT01457014|561931746|FG001|First Night|Withdrawal by Subject|0|||
155683797|NCT01457014|561931747|FG002|First Night|Withdrawal by Subject|0|||
155683798|NCT01457014|561931748|FG003|First Night|Withdrawal by Subject|0|||
155683799|NCT03319953|561931749|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
155683800|NCT03319953|561931750|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155683801|NCT03319953|561931751|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155683802|NCT03319953|561931752|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155683803|NCT03319953|561931749|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
155683804|NCT03319953|561931750|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
155683805|NCT03319953|561931751|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
155683806|NCT03319953|561931752|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
155683807|NCT00789581|561933811|FG000|AC Therapy|Adverse Event|2|||
155683808|NCT00789581|561933812|FG001|AC Therapy|Adverse Event|3|||
155683809|NCT00789581|561933811|FG000|AC Therapy|Withdrawal by Subject|4|||
155683810|NCT00789581|561933812|FG001|AC Therapy|Withdrawal by Subject|7|||
155683811|NCT00789581|561933811|FG000|AC Therapy|Disease recurrence|3|||
155683812|NCT00789581|561933812|FG001|AC Therapy|Disease recurrence|1|||
155683813|NCT00789581|561933811|FG000|AC Therapy|Intercurrent Illness|1|||
155683814|NCT00789581|561933812|FG001|AC Therapy|Intercurrent Illness|0|||
155683815|NCT00789581|561933811|FG000|AC Therapy|Never Treated|1|||
155683816|NCT00789581|561933812|FG001|AC Therapy|Never Treated|4|||
155683817|NCT00789581|561933811|FG000|AC Therapy|Other|0|||
155683818|NCT00789581|561933812|FG001|AC Therapy|Other|2|||
155683819|NCT00789581|561933811|FG000|Adjuvant Therapy|Never treated|2|||
155683820|NCT00789581|561933812|FG001|Adjuvant Therapy|Never treated|2|||
155683821|NCT00789581|561933811|FG000|Adjuvant Therapy|Adverse Event|20|||
155683822|NCT00789581|561933812|FG001|Adjuvant Therapy|Adverse Event|44|||
155683823|NCT00789581|561933811|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
155683824|NCT00789581|561933812|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
155683825|NCT00789581|561933811|FG000|Adjuvant Therapy|Disease recurrence|2|||
155683826|NCT00789581|561933812|FG001|Adjuvant Therapy|Disease recurrence|1|||
155683827|NCT00789581|561933811|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
155683828|NCT00789581|561933812|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
155683829|NCT00789581|561933811|FG000|Adjuvant Therapy|Protocol Violation|1|||
155683830|NCT00789581|561933812|FG001|Adjuvant Therapy|Protocol Violation|1|||
155683831|NCT00789581|561933811|FG000|Adjuvant Therapy|Other|0|||
155683832|NCT00789581|561933812|FG001|Adjuvant Therapy|Other|1|||
155683833|NCT03392883|561933817|FG000|Overall Study|Lost to Follow-up|122|||
155683834|NCT03392883|561933818|FG001|Overall Study|Lost to Follow-up|13|||
155683835|NCT03392883|561933819|FG002|Overall Study|Lost to Follow-up|9|||
155683836|NCT03392883|561933817|FG000|Overall Study|Death|4|||
155683837|NCT03392883|561933818|FG001|Overall Study|Death|0|||
155683838|NCT03392883|561933819|FG002|Overall Study|Death|0|||
155683839|NCT03392883|561933817|FG000|Overall Study|Lack of Efficacy|29|||
155683840|NCT03392883|561933818|FG001|Overall Study|Lack of Efficacy|0|||
155683841|NCT03392883|561933819|FG002|Overall Study|Lack of Efficacy|0|||
155683842|NCT03392883|561933817|FG000|Overall Study|Withdrawal by Subject|180|||
155683843|NCT03392883|561933818|FG001|Overall Study|Withdrawal by Subject|0|||
155683844|NCT03392883|561933819|FG002|Overall Study|Withdrawal by Subject|0|||
155683845|NCT03392883|561933817|FG000|Overall Study|Adverse Event|1|||
155683846|NCT03392883|561933818|FG001|Overall Study|Adverse Event|0|||
155683847|NCT03392883|561933819|FG002|Overall Study|Adverse Event|0|||
155683848|NCT01498575|561933825|FG000|Overall Sample|Withdrawal by Subject|60|||
155683849|NCT01498575|561933826|FG001|Overall Sample|Withdrawal by Subject|14|||
155683850|NCT01498575|561933825|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
155683851|NCT01498575|561933826|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
155683852|NCT01498575|561933825|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
155683853|NCT01498575|561933826|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
155683854|NCT01345591|561933828|FG000|Overall Study|Lost to Follow-up|1|||
155683855|NCT00090142|561933829|FG000|Treatment Period I|Lost to Follow-up|1|||
155683856|NCT00090142|561933830|FG001|Treatment Period I|Lost to Follow-up|2|||
155683857|NCT00090142|561933829|FG000|Treatment Period I|Protocol Violation|2|||
155683858|NCT00090142|561933830|FG001|Treatment Period I|Protocol Violation|0|||
155683859|NCT00090142|561933829|FG000|Treatment Period I|Withdrawal by Subject|2|||
155683860|NCT00090142|561933830|FG001|Treatment Period I|Withdrawal by Subject|0|||
155683861|NCT00090142|561933829|FG000|Treatment Period I|Other|0|||
155683862|NCT00090142|561933830|FG001|Treatment Period I|Other|1|||
155683863|NCT00090142|561933829|FG000|Treatment Period II|Other|1|||
155683864|NCT00090142|561933830|FG001|Treatment Period II|Other|0|||
155683865|NCT02442310|561933831|FG000|Overall Study|Adverse Event|2|||
155683866|NCT02442310|561933831|FG000|Overall Study|Withdrawal by Subject|1|||
155683867|NCT01126437|561933832|FG000|Overall Study|Not treated|11|||
155683868|NCT01126437|561933833|FG001|Overall Study|Not treated|18|||
155683869|NCT01126437|561933834|FG002|Overall Study|Not treated|19|||
155683870|NCT01126437|561933832|FG000|Overall Study|Sites with data irregularities/fraud|6|||
155683871|NCT01126437|561933833|FG001|Overall Study|Sites with data irregularities/fraud|6|||
155683872|NCT01126437|561933834|FG002|Overall Study|Sites with data irregularities/fraud|7|||
155683873|NCT01126437|561933832|FG000|Overall Study|Adverse Event|602|||
155683874|NCT01126437|561933833|FG001|Overall Study|Adverse Event|606|||
155683875|NCT01126437|561933834|FG002|Overall Study|Adverse Event|635|||
155683876|NCT01126437|561933832|FG000|Overall Study|Lack of Efficacy|65|||
155683877|NCT01126437|561933833|FG001|Overall Study|Lack of Efficacy|60|||
155683878|NCT01126437|561933834|FG002|Overall Study|Lack of Efficacy|59|||
155683879|NCT01126437|561933832|FG000|Overall Study|Protocol Violation|64|||
155683880|NCT01126437|561933833|FG001|Overall Study|Protocol Violation|66|||
155683881|NCT01126437|561933834|FG002|Overall Study|Protocol Violation|41|||
155683882|NCT01126437|561933832|FG000|Overall Study|Lost to Follow-up|52|||
155683883|NCT01126437|561933833|FG001|Overall Study|Lost to Follow-up|63|||
155683884|NCT01126437|561933834|FG002|Overall Study|Lost to Follow-up|55|||
155683885|NCT01126437|561933832|FG000|Overall Study|Withdrawal by Subject|331|||
155683886|NCT01126437|561933833|FG001|Overall Study|Withdrawal by Subject|335|||
155683887|NCT01126437|561933834|FG002|Overall Study|Withdrawal by Subject|319|||
155683888|NCT01126437|561933832|FG000|Overall Study|Other reason not specified|210|||
155683889|NCT01126437|561933833|FG001|Overall Study|Other reason not specified|176|||
155683890|NCT01126437|561933834|FG002|Overall Study|Other reason not specified|178|||
155683891|NCT00006046|561933846|FG000|Overall Study|Adverse Event|3|||
155683892|NCT00006046|561933847|FG001|Overall Study|Adverse Event|0|||
155683893|NCT00006046|561933848|FG002|Overall Study|Adverse Event|0|||
155683894|NCT00006046|561933849|FG003|Overall Study|Adverse Event|0|||
155683895|NCT00006046|561933850|FG004|Overall Study|Adverse Event|0|||
155683896|NCT00006046|561933846|FG000|Overall Study|Disease Progression|2|||
155683897|NCT00006046|561933847|FG001|Overall Study|Disease Progression|0|||
155683898|NCT00006046|561933848|FG002|Overall Study|Disease Progression|0|||
155683899|NCT00006046|561933849|FG003|Overall Study|Disease Progression|0|||
155683900|NCT00006046|561933850|FG004|Overall Study|Disease Progression|0|||
155683901|NCT03176472|561933851|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
155683902|NCT03176472|561933852|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
155683903|NCT03176472|561933851|FG000|Double Blind Treatment Period|Adverse Event|0|||
155683904|NCT03176472|561933852|FG001|Double Blind Treatment Period|Adverse Event|5|||
155683905|NCT03176472|561933851|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
155683906|NCT03176472|561933852|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155683907|NCT03176472|561933851|FG000|Double Blind Treatment Period|Physician Decision|0|||
155683908|NCT03176472|561933852|FG001|Double Blind Treatment Period|Physician Decision|1|||
155683909|NCT03176472|561933851|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155683910|NCT03176472|561933852|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155683911|NCT03176472|561933851|FG000|Double Blind Treatment Period|Not Provided|1|||
155683912|NCT03176472|561933852|FG001|Double Blind Treatment Period|Not Provided|0|||
155683913|NCT03176472|561933851|FG000|Open Label Extension|Withdrawal by Subject|3|||
155683914|NCT03176472|561933852|FG001|Open Label Extension|Withdrawal by Subject|4|||
155683915|NCT03176472|561933851|FG000|Open Label Extension|Adverse Event|2|||
155683916|NCT03176472|561933852|FG001|Open Label Extension|Adverse Event|4|||
155683917|NCT03176472|561933851|FG000|Open Label Extension|Lost to Follow-up|1|||
155683918|NCT03176472|561933852|FG001|Open Label Extension|Lost to Follow-up|2|||
155683919|NCT03176472|561933851|FG000|Open Label Extension|Protocol Violation|0|||
155683920|NCT03176472|561933852|FG001|Open Label Extension|Protocol Violation|1|||
155683921|NCT03176472|561933851|FG000|Open Label Extension|Not Provided|2|||
155683922|NCT03176472|561933852|FG001|Open Label Extension|Not Provided|1|||
155683923|NCT03272828|561933853|FG000|Overall Study|Lost to Follow-up|7|||
155683924|NCT03272828|561933854|FG001|Overall Study|Lost to Follow-up|7|||
155683925|NCT03272828|561933853|FG000|Overall Study|Withdrawal by Subject|2|||
155683926|NCT03272828|561933854|FG001|Overall Study|Withdrawal by Subject|0|||
155683927|NCT03272828|561933853|FG000|Overall Study|Deceased|1|||
155683928|NCT03272828|561933854|FG001|Overall Study|Deceased|1|||
155683929|NCT03272828|561933853|FG000|Overall Study|Failed implant|1|||
155683930|NCT03272828|561933854|FG001|Overall Study|Failed implant|2|||
155683931|NCT00847665|561933860|FG000|Overall Study|Withdrawal by Subject|1|||
155683932|NCT00847665|561933861|FG001|Overall Study|Withdrawal by Subject|0|||
155683933|NCT00585546|561933868|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
155683934|NCT00585546|561933868|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
155683935|NCT02851797|561933869|FG000|Overall Study|Withdrawal by Subject|4|||
155683936|NCT02851797|561933870|FG001|Overall Study|Withdrawal by Subject|2|||
155683937|NCT02851797|561933869|FG000|Overall Study|Adverse Event|3|||
155683938|NCT02851797|561933870|FG001|Overall Study|Adverse Event|0|||
155683939|NCT03077438|561933871|FG000|Overall Study|Protocol Violation|3|||
155683940|NCT03077438|561933872|FG001|Overall Study|Protocol Violation|5|||
155683941|NCT03077438|561933871|FG000|Overall Study|Withdrawal by Subject|3|||
155603819|NCT00772005|561637827|FG001|Overall Study|Lost to Follow-up|3|||
155603820|NCT00772005|561637828|FG002|Overall Study|Lost to Follow-up|6|||
155603821|NCT00772005|561637829|FG003|Overall Study|Lost to Follow-up|3|||
155603822|NCT00772005|561637826|FG000|Overall Study|Non-compliance with study procedures|1|||
155603823|NCT00772005|561637827|FG001|Overall Study|Non-compliance with study procedures|1|||
155603824|NCT00772005|561637828|FG002|Overall Study|Non-compliance with study procedures|0|||
155603825|NCT00772005|561637829|FG003|Overall Study|Non-compliance with study procedures|1|||
155603826|NCT00772005|561637826|FG000|Overall Study|Non-compliance with drug administration|3|||
155603827|NCT00772005|561637827|FG001|Overall Study|Non-compliance with drug administration|0|||
155603828|NCT00772005|561637828|FG002|Overall Study|Non-compliance with drug administration|1|||
155603829|NCT00772005|561637829|FG003|Overall Study|Non-compliance with drug administration|1|||
155603830|NCT03887117|561637839|FG000|Overall Study|Discontinued prematurely|0|||
155603831|NCT03887117|561637840|FG001|Overall Study|Discontinued prematurely|1|||
155603832|NCT03887117|561637841|FG002|Overall Study|Discontinued prematurely|1|||
155603833|NCT03887117|561637842|FG003|Overall Study|Discontinued prematurely|2|||
155603834|NCT03301844|561637843|FG000|Overall Study|suspected colon cancer|1|||
155603835|NCT03301844|561637844|FG001|Overall Study|suspected colon cancer|1|||
155603836|NCT05087966|561637845|FG000|Overall Study|Lost to Follow-up|1|||
155603837|NCT05087966|561637845|FG000|Overall Study|Withdrawal by Subject|5|||
155603838|NCT01037127|561637847|FG000|Overall Study|Lost to Follow-up|2|||
155603839|NCT01037127|561637848|FG001|Overall Study|Lost to Follow-up|4|||
155603840|NCT01037127|561637847|FG000|Overall Study|Physician Decision|1|||
155603841|NCT01037127|561637848|FG001|Overall Study|Physician Decision|0|||
155603842|NCT01037127|561637847|FG000|Overall Study|Study Closed Terminated|2|||
155603843|NCT01037127|561637848|FG001|Overall Study|Study Closed Terminated|17|||
155603844|NCT00078949|561639598|FG000|Overall Study|No treated|4|||
155603845|NCT00078949|561639599|FG001|Overall Study|No treated|5|||
155603846|NCT00078949|561639600|FG002|Overall Study|No treated|3|||
155603847|NCT00078949|561639601|FG003|Overall Study|No treated|3|||
155603848|NCT02667626|561639602|FG000|Overall Study|Withdrawal by Subject|0|||
155603849|NCT02667626|561639603|FG001|Overall Study|Withdrawal by Subject|1|||
155603850|NCT02309723|561639604|FG000|Overall Study|Withdrawal by Subject|24|||
155603851|NCT02309723|561639605|FG001|Overall Study|Withdrawal by Subject|23|||
155603852|NCT02309723|561639606|FG002|Overall Study|Withdrawal by Subject|24|||
155603853|NCT02560623|561639607|FG000|Overall Study|Unable to swallow sponge|0|||
155603854|NCT02560623|561639608|FG001|Overall Study|Unable to swallow sponge|1|||
155603855|NCT02560623|561639609|FG002|Overall Study|Unable to swallow sponge|0|||
155603856|NCT02560623|561639610|FG003|Overall Study|Unable to swallow sponge|0|||
155603857|NCT02560623|561639607|FG000|Overall Study|Intervention prior to sponge administration|0|||
155683942|NCT03077438|561933872|FG001|Overall Study|Withdrawal by Subject|6|||
155603858|NCT02560623|561639608|FG001|Overall Study|Intervention prior to sponge administration|1|||
155603859|NCT02560623|561639609|FG002|Overall Study|Intervention prior to sponge administration|0|||
155683943|NCT03077438|561933871|FG000|Overall Study|Lost to Follow-up|6|||
155683944|NCT03077438|561933872|FG001|Overall Study|Lost to Follow-up|3|||
155683945|NCT00813865|561933873|FG000|Overall Study|Failure to Respond|3|||
155683946|NCT00813865|561933873|FG000|Overall Study|Lost to Follow-up|3|||
155683947|NCT00813865|561933873|FG000|Overall Study|Withdrawal by Subject|1|||
155683948|NCT04295681|561933883|FG000|Overall Study|Eligibility error|1|||
155683949|NCT04295681|561933884|FG001|Overall Study|Eligibility error|3|||
155683950|NCT00939029|561933885|FG000|Overall Study|Withdrawal by Subject|3|||
155683951|NCT00939029|561933886|FG001|Overall Study|Withdrawal by Subject|7|||
155683952|NCT00939029|561933885|FG000|Overall Study|Lost to Follow-up|3|||
155683953|NCT00939029|561933886|FG001|Overall Study|Lost to Follow-up|4|||
155683954|NCT00939029|561933885|FG000|Overall Study|Adverse Event|0|||
155683955|NCT00939029|561933886|FG001|Overall Study|Adverse Event|1|||
155683956|NCT04686084|561933888|FG000|Overall Study|Lost to Follow-up|1|||
155683957|NCT01535599|561933889|FG000|Overall Study|Adverse Event|6|||
155683958|NCT01535599|561933890|FG001|Overall Study|Adverse Event|15|||
155683959|NCT01535599|561933889|FG000|Overall Study|Lost to Follow-up|3|||
155683960|NCT01535599|561933890|FG001|Overall Study|Lost to Follow-up|4|||
155683961|NCT01535599|561933889|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
155683962|NCT01535599|561933890|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
155683963|NCT01535599|561933889|FG000|Overall Study|Treatment Failure|33|||
155683964|NCT01535599|561933890|FG001|Overall Study|Treatment Failure|66|||
155683965|NCT01535599|561933889|FG000|Overall Study|BL Culture + for Group A Strep|0|||
155683966|NCT01535599|561933890|FG001|Overall Study|BL Culture + for Group A Strep|1|||
155683967|NCT01535599|561933889|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
155683968|NCT01535599|561933890|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
155683969|NCT01535599|561933889|FG000|Overall Study|Randomized in Error|2|||
155683970|NCT01535599|561933890|FG001|Overall Study|Randomized in Error|4|||
155683971|NCT01535599|561933889|FG000|Overall Study|Did not use product|1|||
155683972|NCT01535599|561933890|FG001|Overall Study|Did not use product|0|||
155683973|NCT01535599|561933889|FG000|Overall Study|Other|1|||
155683974|NCT01535599|561933890|FG001|Overall Study|Other|0|||
155683975|NCT01535599|561933889|FG000|Overall Study|Stopped medication|0|||
155683976|NCT01535599|561933890|FG001|Overall Study|Stopped medication|1|||
155683977|NCT01535599|561933889|FG000|Overall Study|Noncompliance|0|||
155683978|NCT01535599|561933890|FG001|Overall Study|Noncompliance|1|||
155683979|NCT03172325|561933894|FG000|Overall Study|Adverse Event|2|||
155683980|NCT03172325|561933895|FG001|Overall Study|Adverse Event|3|||
155683981|NCT03172325|561933894|FG000|Overall Study|Positive PPD|1|||
155683982|NCT03172325|561933895|FG001|Overall Study|Positive PPD|0|||
155683983|NCT03172325|561933894|FG000|Overall Study|Poor Compliance|1|||
155683984|NCT03172325|561933895|FG001|Overall Study|Poor Compliance|1|||
155683985|NCT03622112|561933911|FG000|Overall Study|Withdrawal by Subject|6|||
155683986|NCT03622112|561933912|FG001|Overall Study|Withdrawal by Subject|2|||
155683987|NCT03622112|561933913|FG002|Overall Study|Withdrawal by Subject|4|||
155683988|NCT03622112|561933914|FG003|Overall Study|Withdrawal by Subject|2|||
155683989|NCT03622112|561933915|FG004|Overall Study|Withdrawal by Subject|1|||
155683990|NCT03622112|561933916|FG005|Overall Study|Withdrawal by Subject|2|||
155683991|NCT03622112|561933917|FG006|Overall Study|Withdrawal by Subject|2|||
155683992|NCT03622112|561933911|FG000|Overall Study|Death|0|||
155683993|NCT03622112|561933912|FG001|Overall Study|Death|0|||
155683994|NCT03622112|561933913|FG002|Overall Study|Death|0|||
155683995|NCT03622112|561933914|FG003|Overall Study|Death|1|||
155683996|NCT03622112|561933915|FG004|Overall Study|Death|0|||
155683997|NCT03622112|561933916|FG005|Overall Study|Death|0|||
155683998|NCT03622112|561933917|FG006|Overall Study|Death|0|||
155683999|NCT03622112|561933911|FG000|Overall Study|Lost to Follow-up|1|||
155684000|NCT03622112|561933912|FG001|Overall Study|Lost to Follow-up|1|||
155684001|NCT03622112|561933913|FG002|Overall Study|Lost to Follow-up|0|||
155684002|NCT03622112|561933914|FG003|Overall Study|Lost to Follow-up|0|||
155684003|NCT03622112|561933915|FG004|Overall Study|Lost to Follow-up|0|||
155684004|NCT03622112|561933916|FG005|Overall Study|Lost to Follow-up|0|||
155684005|NCT03622112|561933917|FG006|Overall Study|Lost to Follow-up|0|||
155684006|NCT03622112|561933911|FG000|Overall Study|Study-specific withdrawal criteria|10|||
155684007|NCT03622112|561933912|FG001|Overall Study|Study-specific withdrawal criteria|8|||
155684008|NCT03622112|561933913|FG002|Overall Study|Study-specific withdrawal criteria|7|||
155684009|NCT03622112|561933914|FG003|Overall Study|Study-specific withdrawal criteria|6|||
155684010|NCT03622112|561933915|FG004|Overall Study|Study-specific withdrawal criteria|4|||
155684011|NCT03622112|561933916|FG005|Overall Study|Study-specific withdrawal criteria|18|||
155684012|NCT03622112|561933917|FG006|Overall Study|Study-specific withdrawal criteria|4|||
155684013|NCT03622112|561933911|FG000|Overall Study|Protocol Violation|2|||
155684014|NCT03622112|561933912|FG001|Overall Study|Protocol Violation|0|||
155684015|NCT03622112|561933913|FG002|Overall Study|Protocol Violation|1|||
155684016|NCT03622112|561933914|FG003|Overall Study|Protocol Violation|1|||
155684017|NCT03622112|561933915|FG004|Overall Study|Protocol Violation|0|||
155684018|NCT03622112|561933916|FG005|Overall Study|Protocol Violation|0|||
155684019|NCT03622112|561933917|FG006|Overall Study|Protocol Violation|0|||
155684020|NCT03622112|561933911|FG000|Overall Study|Adverse Event|6|||
155684021|NCT03622112|561933912|FG001|Overall Study|Adverse Event|8|||
155684022|NCT03622112|561933913|FG002|Overall Study|Adverse Event|4|||
155684023|NCT03622112|561933914|FG003|Overall Study|Adverse Event|11|||
155684024|NCT03622112|561933915|FG004|Overall Study|Adverse Event|4|||
155684025|NCT03622112|561933916|FG005|Overall Study|Adverse Event|20|||
155684026|NCT03622112|561933917|FG006|Overall Study|Adverse Event|2|||
155684027|NCT03622112|561933911|FG000|Overall Study|Reason not specified|0|||
155684028|NCT03622112|561933912|FG001|Overall Study|Reason not specified|1|||
155684029|NCT03622112|561933913|FG002|Overall Study|Reason not specified|0|||
155684030|NCT03622112|561933914|FG003|Overall Study|Reason not specified|1|||
155684031|NCT03622112|561933915|FG004|Overall Study|Reason not specified|1|||
155684032|NCT03622112|561933916|FG005|Overall Study|Reason not specified|2|||
155603860|NCT02560623|561639610|FG003|Overall Study|Intervention prior to sponge administration|0|||
155603861|NCT01125813|561639611|FG000|Overall Study|Death|1|||
155603862|NCT01125813|561639611|FG000|Overall Study|Withdrawal by Subject|1|||
155603863|NCT01125813|561639611|FG000|Overall Study|Screen Failures|4|||
155603864|NCT01143064|561639614|FG000|Overall Study|Death|109|||
155603865|NCT01143064|561639615|FG001|Overall Study|Death|91|||
155603866|NCT01143064|561639614|FG000|Overall Study|Adverse Event|0|||
155603867|NCT01143064|561639615|FG001|Overall Study|Adverse Event|1|||
155603868|NCT01143064|561639614|FG000|Overall Study|Withdrawal by Subject|7|||
155603869|NCT01143064|561639615|FG001|Overall Study|Withdrawal by Subject|5|||
155603870|NCT01143064|561639614|FG000|Overall Study|Lost to Follow-up|17|||
155603871|NCT01143064|561639615|FG001|Overall Study|Lost to Follow-up|14|||
155603872|NCT01143064|561639614|FG000|Overall Study|Physician Decision|0|||
155603873|NCT01143064|561639615|FG001|Overall Study|Physician Decision|4|||
155603874|NCT02453282|561639616|FG000|Overall Study|Death|275|||
155603875|NCT02453282|561639617|FG001|Overall Study|Death|277|||
155603876|NCT02453282|561639618|FG002|Overall Study|Death|296|||
155603877|NCT02453282|561639616|FG000|Overall Study|Lost to Follow-up|1|||
155603878|NCT02453282|561639617|FG001|Overall Study|Lost to Follow-up|0|||
155603879|NCT02453282|561639618|FG002|Overall Study|Lost to Follow-up|2|||
155603880|NCT02453282|561639616|FG000|Overall Study|Withdrawal by Subject|12|||
155603881|NCT02453282|561639617|FG001|Overall Study|Withdrawal by Subject|10|||
155603882|NCT02453282|561639618|FG002|Overall Study|Withdrawal by Subject|11|||
155603883|NCT02453282|561639616|FG000|Overall Study|Participants ongoing at data cut-off|85|||
155603884|NCT02453282|561639617|FG001|Overall Study|Participants ongoing at data cut-off|84|||
155603885|NCT02453282|561639618|FG002|Overall Study|Participants ongoing at data cut-off|62|||
155603886|NCT02453282|561639616|FG000|Overall Study|Other|1|||
155603887|NCT02453282|561639617|FG001|Overall Study|Other|1|||
155603888|NCT02453282|561639618|FG002|Overall Study|Other|1|||
155603889|NCT02327013|561639621|FG000|Overall Study|Adverse Event|4|||
155603890|NCT02327013|561639622|FG001|Overall Study|Adverse Event|4|||
155603891|NCT02327013|561639623|FG002|Overall Study|Adverse Event|3|||
155603892|NCT02327013|561639624|FG003|Overall Study|Adverse Event|0|||
155603893|NCT02327013|561639625|FG004|Overall Study|Adverse Event|1|||
155603894|NCT02327013|561639621|FG000|Overall Study|Lack of Efficacy|2|||
155603895|NCT02327013|561639622|FG001|Overall Study|Lack of Efficacy|0|||
155603896|NCT02327013|561639623|FG002|Overall Study|Lack of Efficacy|5|||
155603897|NCT02327013|561639624|FG003|Overall Study|Lack of Efficacy|0|||
155603898|NCT02327013|561639625|FG004|Overall Study|Lack of Efficacy|1|||
155603899|NCT02327013|561639621|FG000|Overall Study|Non-compliance with IMP|1|||
155603900|NCT02327013|561639622|FG001|Overall Study|Non-compliance with IMP|2|||
155603901|NCT02327013|561639623|FG002|Overall Study|Non-compliance with IMP|7|||
155603902|NCT02327013|561639624|FG003|Overall Study|Non-compliance with IMP|0|||
155603903|NCT02327013|561639625|FG004|Overall Study|Non-compliance with IMP|0|||
155603904|NCT02327013|561639621|FG000|Overall Study|Withdrawal of Consent|1|||
155684033|NCT03622112|561933917|FG006|Overall Study|Reason not specified|1|||
155684034|NCT03305419|561933921|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155603905|NCT02327013|561639622|FG001|Overall Study|Withdrawal of Consent|0|||
155603906|NCT02327013|561639623|FG002|Overall Study|Withdrawal of Consent|3|||
155603907|NCT02327013|561639624|FG003|Overall Study|Withdrawal of Consent|0|||
155603908|NCT02327013|561639625|FG004|Overall Study|Withdrawal of Consent|0|||
155603909|NCT02327013|561639621|FG000|Overall Study|Lost to Follow-up|2|||
155603910|NCT02327013|561639622|FG001|Overall Study|Lost to Follow-up|4|||
155603911|NCT02327013|561639623|FG002|Overall Study|Lost to Follow-up|5|||
155603912|NCT02327013|561639624|FG003|Overall Study|Lost to Follow-up|0|||
155603913|NCT02327013|561639625|FG004|Overall Study|Lost to Follow-up|0|||
155603914|NCT02327013|561639621|FG000|Overall Study|Administrative or other reason(s)|1|||
155603915|NCT02327013|561639622|FG001|Overall Study|Administrative or other reason(s)|5|||
155603916|NCT02327013|561639623|FG002|Overall Study|Administrative or other reason(s)|11|||
155684035|NCT03305419|561933922|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
155603917|NCT02327013|561639624|FG003|Overall Study|Administrative or other reason(s)|1|||
155603918|NCT02327013|561639625|FG004|Overall Study|Administrative or other reason(s)|1|||
155603919|NCT02327013|561639621|FG000|Overall Study|Protocol Violation|0|||
155603920|NCT02327013|561639622|FG001|Overall Study|Protocol Violation|0|||
155603921|NCT02327013|561639623|FG002|Overall Study|Protocol Violation|3|||
155603922|NCT02327013|561639624|FG003|Overall Study|Protocol Violation|0|||
155603923|NCT02327013|561639625|FG004|Overall Study|Protocol Violation|1|||
155603924|NCT02327013|561639621|FG000|Overall Study|Withdrawal before treatment|2|||
155603925|NCT02327013|561639622|FG001|Overall Study|Withdrawal before treatment|1|||
155603926|NCT02327013|561639623|FG002|Overall Study|Withdrawal before treatment|5|||
155603927|NCT02327013|561639624|FG003|Overall Study|Withdrawal before treatment|0|||
155603928|NCT02327013|561639625|FG004|Overall Study|Withdrawal before treatment|0|||
155603929|NCT02380859|561639626|FG000|Overall Study|Withdrawal by Subject|2|||
155603930|NCT02380859|561639627|FG001|Overall Study|Withdrawal by Subject|0|||
155603931|NCT01565668|561639628|FG000|Overall Study|Death|2|||
155603932|NCT01565668|561639629|FG001|Overall Study|Death|1|||
155603933|NCT01565668|561639628|FG000|Overall Study|Lack of Efficacy|4|||
155603934|NCT01565668|561639629|FG001|Overall Study|Lack of Efficacy|2|||
155603935|NCT01565668|561639628|FG000|Overall Study|Participant went on Hospice Care|1|||
155603936|NCT01565668|561639629|FG001|Overall Study|Participant went on Hospice Care|0|||
155603937|NCT01565668|561639628|FG000|Overall Study|Adverse Event|6|||
155603938|NCT01565668|561639629|FG001|Overall Study|Adverse Event|1|||
155603939|NCT01565668|561639628|FG000|Overall Study|Randomized, but never received drug|0|||
155603940|NCT01565668|561639629|FG001|Overall Study|Randomized, but never received drug|2|||
155603941|NCT01565668|561639628|FG000|Overall Study|Progressive disease|13|||
155603942|NCT01565668|561639629|FG001|Overall Study|Progressive disease|14|||
155603943|NCT01565668|561639628|FG000|Overall Study|Withdrawal by Subject|1|||
155603944|NCT01565668|561639629|FG001|Overall Study|Withdrawal by Subject|3|||
155603945|NCT01565668|561639628|FG000|Overall Study|HSCT Transplant|11|||
155603946|NCT01565668|561639629|FG001|Overall Study|HSCT Transplant|15|||
155603947|NCT04258254|561639630|FG000|Overall Study|Withdrawal by Subject|0|||
155603948|NCT04258254|561639631|FG001|Overall Study|Withdrawal by Subject|1|||
155603949|NCT04258254|561639632|FG002|Overall Study|Withdrawal by Subject|0|||
155603950|NCT02255552|561639633|FG000|Overall Study|Participants enrolled into another study|0|||
155603951|NCT02255552|561639634|FG001|Overall Study|Participants enrolled into another study|11|||
155603952|NCT02255552|561639633|FG000|Overall Study|Withdrawal by Subject|1|||
155603953|NCT02255552|561639634|FG001|Overall Study|Withdrawal by Subject|4|||
155603954|NCT01447446|561639635|FG000|Overall Study|Death|6|||
155603955|NCT01447446|561639636|FG001|Overall Study|Death|3|||
155603956|NCT01447446|561639637|FG002|Overall Study|Death|2|||
155603957|NCT01447446|561639638|FG003|Overall Study|Death|1|||
155603958|NCT01447446|561639639|FG004|Overall Study|Death|7|||
155603959|NCT01447446|561639640|FG005|Overall Study|Death|0|||
155603960|NCT01447446|561639635|FG000|Overall Study|Adverse Event|3|||
155603961|NCT01447446|561639636|FG001|Overall Study|Adverse Event|0|||
155603962|NCT01447446|561639637|FG002|Overall Study|Adverse Event|1|||
155603963|NCT01447446|561639638|FG003|Overall Study|Adverse Event|0|||
155603964|NCT01447446|561639639|FG004|Overall Study|Adverse Event|2|||
155603965|NCT01447446|561639640|FG005|Overall Study|Adverse Event|0|||
155603966|NCT01447446|561639635|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
155603967|NCT01447446|561639636|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
155603968|NCT01447446|561639637|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
155603969|NCT01447446|561639638|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
155603970|NCT01447446|561639639|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
155603971|NCT01447446|561639640|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
155603972|NCT01447446|561639635|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
155603973|NCT01447446|561639636|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
155603974|NCT01447446|561639637|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
155603975|NCT01447446|561639638|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
155603976|NCT01447446|561639639|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
155603977|NCT01447446|561639640|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
155603978|NCT01447446|561639635|FG000|Overall Study|Administrative/Other|34|||
155603979|NCT01447446|561639636|FG001|Overall Study|Administrative/Other|9|||
155603980|NCT01447446|561639637|FG002|Overall Study|Administrative/Other|10|||
155603981|NCT01447446|561639638|FG003|Overall Study|Administrative/Other|2|||
155603982|NCT01447446|561639639|FG004|Overall Study|Administrative/Other|33|||
155603983|NCT01447446|561639640|FG005|Overall Study|Administrative/Other|4|||
155603984|NCT01447446|561639635|FG000|Overall Study|SVR12 Assessment|13|||
155603985|NCT01447446|561639636|FG001|Overall Study|SVR12 Assessment|1|||
155603986|NCT01447446|561639637|FG002|Overall Study|SVR12 Assessment|2|||
155603987|NCT01447446|561639638|FG003|Overall Study|SVR12 Assessment|1|||
155603988|NCT01447446|561639639|FG004|Overall Study|SVR12 Assessment|5|||
155603989|NCT01447446|561639640|FG005|Overall Study|SVR12 Assessment|5|||
155603990|NCT01447446|561639635|FG000|Overall Study|New Treatment Started|8|||
155603991|NCT01447446|561639636|FG001|Overall Study|New Treatment Started|2|||
155603992|NCT01447446|561639637|FG002|Overall Study|New Treatment Started|1|||
155603993|NCT01447446|561639638|FG003|Overall Study|New Treatment Started|0|||
155603994|NCT01447446|561639639|FG004|Overall Study|New Treatment Started|2|||
155603995|NCT01447446|561639640|FG005|Overall Study|New Treatment Started|0|||
155603996|NCT01447446|561639635|FG000|Overall Study|Reason not Specified|1|||
155603997|NCT01447446|561639636|FG001|Overall Study|Reason not Specified|1|||
155603998|NCT01447446|561639637|FG002|Overall Study|Reason not Specified|1|||
155603999|NCT01447446|561639638|FG003|Overall Study|Reason not Specified|1|||
155604000|NCT01447446|561639639|FG004|Overall Study|Reason not Specified|1|||
155604001|NCT01447446|561639640|FG005|Overall Study|Reason not Specified|0|||
155604002|NCT05323994|561639643|FG000|Overall Study|Protocol Violation|1|||
155604003|NCT00454818|561639646|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
155604004|NCT00454818|561639647|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155604005|NCT00454818|561639648|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155604006|NCT00454818|561639649|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155604007|NCT00454818|561639650|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155604008|NCT00454818|561639646|FG000|Phase I: Open-label Dose-escalation|Death|0|||
155604009|NCT00454818|561639647|FG001|Phase I: Open-label Dose-escalation|Death|1|||
155604010|NCT00454818|561639648|FG002|Phase I: Open-label Dose-escalation|Death|0|||
155604011|NCT00454818|561639649|FG003|Phase I: Open-label Dose-escalation|Death|0|||
155604012|NCT00454818|561639650|FG004|Phase I: Open-label Dose-escalation|Death|0|||
155604013|NCT00454818|561639646|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155604014|NCT00454818|561639647|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155604015|NCT00454818|561639648|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
155604016|NCT00454818|561639649|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
155604017|NCT00454818|561639650|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155604018|NCT00454818|561639646|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155604019|NCT00454818|561639647|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
155604020|NCT00454818|561639648|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155604021|NCT00454818|561639649|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
155604022|NCT00454818|561639650|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155604023|NCT00454818|561639646|FG000|Phase 2: Randomized Double-blind|Death|0|||
155604024|NCT00454818|561639647|FG001|Phase 2: Randomized Double-blind|Death|1|||
155604025|NCT00454818|561639648|FG002|Phase 2: Randomized Double-blind|Death|0|||
155604026|NCT00454818|561639649|FG003|Phase 2: Randomized Double-blind|Death|0|||
155684036|NCT03305419|561933923|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684037|NCT03305419|561933924|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684038|NCT03305419|561933925|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684039|NCT03305419|561933926|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684040|NCT03305419|561933927|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684041|NCT03305419|561933928|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155684042|NCT03305419|561933921|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
155684043|NCT03305419|561933922|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684044|NCT03305419|561933923|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684045|NCT03305419|561933924|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684046|NCT03305419|561933925|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684047|NCT03305419|561933926|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684048|NCT03305419|561933927|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684049|NCT03305419|561933928|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155684050|NCT03305419|561933921|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
155684051|NCT03305419|561933922|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684052|NCT03305419|561933923|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684053|NCT03305419|561933924|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684054|NCT03305419|561933925|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684055|NCT03305419|561933926|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684056|NCT03305419|561933927|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684057|NCT03305419|561933928|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155684058|NCT03305419|561933921|FG000|Part B (14 Days)|Adverse Event|0|||
155684059|NCT03305419|561933922|FG001|Part B (14 Days)|Adverse Event|0|||
155684060|NCT03305419|561933923|FG002|Part B (14 Days)|Adverse Event|0|||
155684061|NCT03305419|561933924|FG003|Part B (14 Days)|Adverse Event|0|||
155684062|NCT03305419|561933925|FG004|Part B (14 Days)|Adverse Event|1|||
155684063|NCT03305419|561933926|FG005|Part B (14 Days)|Adverse Event|2|||
155684064|NCT03305419|561933927|FG006|Part B (14 Days)|Adverse Event|4|||
155684065|NCT03305419|561933928|FG007|Part B (14 Days)|Adverse Event|0|||
155684066|NCT03305419|561933921|FG000|Part B (14 Days)|Physician Decision|0|||
155684067|NCT03305419|561933922|FG001|Part B (14 Days)|Physician Decision|0|||
155684068|NCT03305419|561933923|FG002|Part B (14 Days)|Physician Decision|0|||
155684069|NCT03305419|561933924|FG003|Part B (14 Days)|Physician Decision|0|||
155684070|NCT03305419|561933925|FG004|Part B (14 Days)|Physician Decision|2|||
155684071|NCT03305419|561933926|FG005|Part B (14 Days)|Physician Decision|8|||
155684072|NCT03305419|561933927|FG006|Part B (14 Days)|Physician Decision|1|||
155684073|NCT03305419|561933928|FG007|Part B (14 Days)|Physician Decision|0|||
155684074|NCT01155466|561933929|FG000|Overall Study|Adverse Event|13|||
155684075|NCT01155466|561933930|FG001|Overall Study|Adverse Event|15|||
155684076|NCT01155466|561933931|FG002|Overall Study|Adverse Event|6|||
155684077|NCT01155466|561933932|FG003|Overall Study|Adverse Event|17|||
155684078|NCT01155466|561933933|FG004|Overall Study|Adverse Event|18|||
155684079|NCT01155466|561933929|FG000|Overall Study|Lost to Follow-up|0|||
155684080|NCT01155466|561933930|FG001|Overall Study|Lost to Follow-up|0|||
155684081|NCT01155466|561933931|FG002|Overall Study|Lost to Follow-up|0|||
155684082|NCT01155466|561933932|FG003|Overall Study|Lost to Follow-up|0|||
155684083|NCT01155466|561933933|FG004|Overall Study|Lost to Follow-up|2|||
155684084|NCT01155466|561933929|FG000|Overall Study|Withdrawal by Subject|7|||
155684085|NCT01155466|561933930|FG001|Overall Study|Withdrawal by Subject|5|||
155684086|NCT01155466|561933931|FG002|Overall Study|Withdrawal by Subject|9|||
155684087|NCT01155466|561933932|FG003|Overall Study|Withdrawal by Subject|4|||
155684088|NCT01155466|561933933|FG004|Overall Study|Withdrawal by Subject|4|||
155684089|NCT01155466|561933929|FG000|Overall Study|Protocol Violation|0|||
155684090|NCT01155466|561933930|FG001|Overall Study|Protocol Violation|0|||
155684091|NCT01155466|561933931|FG002|Overall Study|Protocol Violation|2|||
155684092|NCT01155466|561933932|FG003|Overall Study|Protocol Violation|0|||
155684093|NCT01155466|561933933|FG004|Overall Study|Protocol Violation|1|||
155684094|NCT01155466|561933929|FG000|Overall Study|Administrative|0|||
155684095|NCT01155466|561933930|FG001|Overall Study|Administrative|3|||
155684096|NCT01155466|561933931|FG002|Overall Study|Administrative|0|||
155684097|NCT01155466|561933932|FG003|Overall Study|Administrative|0|||
155684098|NCT01155466|561933933|FG004|Overall Study|Administrative|0|||
155684099|NCT01155466|561933929|FG000|Overall Study|Randomized not treated|2|||
155684100|NCT01155466|561933930|FG001|Overall Study|Randomized not treated|2|||
155684101|NCT01155466|561933931|FG002|Overall Study|Randomized not treated|3|||
155684102|NCT01155466|561933932|FG003|Overall Study|Randomized not treated|0|||
155684103|NCT01155466|561933933|FG004|Overall Study|Randomized not treated|2|||
155684104|NCT02231892|561933936|FG000|Overall Study|Lost to Follow-up|1|||
155684105|NCT02231892|561933937|FG001|Overall Study|Lost to Follow-up|0|||
155684106|NCT02231892|561933938|FG002|Overall Study|Lost to Follow-up|3|||
155684107|NCT02231892|561933936|FG000|Overall Study|Withdrawal by Subject|4|||
155684108|NCT02231892|561933937|FG001|Overall Study|Withdrawal by Subject|3|||
155684109|NCT02231892|561933938|FG002|Overall Study|Withdrawal by Subject|15|||
155684110|NCT02231892|561933936|FG000|Overall Study|Physician Decision|0|||
155684111|NCT02231892|561933937|FG001|Overall Study|Physician Decision|2|||
155684112|NCT02231892|561933938|FG002|Overall Study|Physician Decision|4|||
155684113|NCT02231892|561933936|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
155684114|NCT02231892|561933937|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
155684115|NCT02231892|561933938|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
155684116|NCT02231892|561933936|FG000|Overall Study|Participant motor threshold was >83%|0|||
155684117|NCT02231892|561933937|FG001|Overall Study|Participant motor threshold was >83%|0|||
155684118|NCT02231892|561933938|FG002|Overall Study|Participant motor threshold was >83%|9|||
155684119|NCT02231892|561933936|FG000|Overall Study|Could not find motor threshold|2|||
155684120|NCT02231892|561933937|FG001|Overall Study|Could not find motor threshold|0|||
155684121|NCT02231892|561933938|FG002|Overall Study|Could not find motor threshold|1|||
155684122|NCT02231892|561933936|FG000|Overall Study|Could not find reliable motor hotspot|0|||
155684123|NCT02231892|561933937|FG001|Overall Study|Could not find reliable motor hotspot|0|||
155684124|NCT02231892|561933938|FG002|Overall Study|Could not find reliable motor hotspot|1|||
155684125|NCT03832322|561933939|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
155684126|NCT03832322|561933940|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
155684127|NCT01694121|561933949|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
155684128|NCT01694121|561933950|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
155684129|NCT00744978|561933953|FG000|Period 1|Lost to Follow-up|1|||
155684130|NCT00744978|561933954|FG001|Period 1|Lost to Follow-up|0|||
155684131|NCT00744978|561933953|FG000|Period 1|Withdrawal by Subject|0|||
155684132|NCT00744978|561933954|FG001|Period 1|Withdrawal by Subject|2|||
155684133|NCT00744978|561933953|FG000|Period 1|Other|0|||
155684134|NCT00744978|561933954|FG001|Period 1|Other|2|||
155684135|NCT00744978|561933953|FG000|Period 1|Adverse Event|4|||
155684136|NCT00744978|561933954|FG001|Period 1|Adverse Event|0|||
155684137|NCT00744978|561933953|FG000|Period 1|Randomized but not Treated|1|||
155684138|NCT00744978|561933954|FG001|Period 1|Randomized but not Treated|1|||
155684139|NCT00744978|561933953|FG000|Period 2|Adverse Event|0|||
155684140|NCT00744978|561933954|FG001|Period 2|Adverse Event|1|||
155684141|NCT03773133|561933955|FG000|Overall Study|Screen Failure|8|||
155684142|NCT02928029|561933956|FG000|Overall Study|Withdrawal by Subject|0|||
155684143|NCT02928029|561933957|FG001|Overall Study|Withdrawal by Subject|1|||
155684144|NCT02928029|561933956|FG000|Overall Study|Radiological progression|1|||
155684145|NCT02928029|561933957|FG001|Overall Study|Radiological progression|0|||
155684146|NCT02928029|561933956|FG000|Overall Study|Clinical progression|1|||
155684147|NCT02928029|561933957|FG001|Overall Study|Clinical progression|2|||
155684148|NCT02928029|561933956|FG000|Overall Study|AE not related to clinical progression|1|||
155684149|NCT02928029|561933957|FG001|Overall Study|AE not related to clinical progression|1|||
155684150|NCT00515294|561933958|FG000|Overall Study|Lost to Follow-up|3|||
155684151|NCT00515294|561933959|FG001|Overall Study|Lost to Follow-up|2|||
155684152|NCT00515294|561933960|FG002|Overall Study|Lost to Follow-up|3|||
155684153|NCT00515294|561933961|FG003|Overall Study|Lost to Follow-up|1|||
155684154|NCT00515294|561933958|FG000|Overall Study|Driver simulator problems|1|||
155684155|NCT00515294|561933959|FG001|Overall Study|Driver simulator problems|1|||
155684156|NCT00515294|561933960|FG002|Overall Study|Driver simulator problems|1|||
155684157|NCT00515294|561933961|FG003|Overall Study|Driver simulator problems|3|||
155684158|NCT00515294|561933958|FG000|Overall Study|Caffeine amount inaccurate|5|||
155684159|NCT00515294|561933959|FG001|Overall Study|Caffeine amount inaccurate|0|||
155684160|NCT00515294|561933960|FG002|Overall Study|Caffeine amount inaccurate|7|||
155684161|NCT00515294|561933961|FG003|Overall Study|Caffeine amount inaccurate|0|||
155684162|NCT02359045|561933965|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
155684163|NCT02359045|561933966|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155684164|NCT02359045|561933965|FG000|Overall Study|Lost to Follow-up|1|||
155684165|NCT02359045|561933966|FG001|Overall Study|Lost to Follow-up|1|||
155684166|NCT02359045|561933965|FG000|Overall Study|Adverse Event|0|||
155684167|NCT02359045|561933966|FG001|Overall Study|Adverse Event|1|||
155684168|NCT02979093|561933984|FG000|First Scan Session|Scanning data problems|1|||
155684169|NCT02979093|561933985|FG001|First Scan Session|Scanning data problems|2|||
155684170|NCT02979093|561933986|FG002|First Scan Session|Scanning data problems|2|||
155684171|NCT02979093|561933987|FG003|First Scan Session|Scanning data problems|0|||
155684172|NCT02979093|561933984|FG000|Second Scan Session|Scanning data problems|3|||
155684173|NCT02979093|561933985|FG001|Second Scan Session|Scanning data problems|0|||
155684174|NCT02979093|561933986|FG002|Second Scan Session|Scanning data problems|1|||
155684175|NCT02979093|561933987|FG003|Second Scan Session|Scanning data problems|3|||
155684176|NCT06107803|561933988|FG000|Overall Study|Adverse Event|1|||
155684177|NCT06107803|561933988|FG000|Overall Study|Withdrawal by Subject|2|||
155684178|NCT06107803|561933988|FG000|Overall Study|Protocol Violation|1|||
155684179|NCT03099174|561933989|FG000|Overall Study|Withdrawal by Subject|0|||
155684180|NCT03099174|561933990|FG001|Overall Study|Withdrawal by Subject|0|||
155684181|NCT03099174|561933991|FG002|Overall Study|Withdrawal by Subject|1|||
155684182|NCT03099174|561933992|FG003|Overall Study|Withdrawal by Subject|0|||
155684183|NCT03099174|561933993|FG004|Overall Study|Withdrawal by Subject|2|||
155684184|NCT03099174|561933994|FG005|Overall Study|Withdrawal by Subject|2|||
155684185|NCT03099174|561933995|FG006|Overall Study|Withdrawal by Subject|1|||
155684186|NCT03099174|561933996|FG007|Overall Study|Withdrawal by Subject|4|||
155684187|NCT03099174|561933989|FG000|Overall Study|Adverse Event|0|||
155684188|NCT03099174|561933990|FG001|Overall Study|Adverse Event|1|||
155684189|NCT03099174|561933991|FG002|Overall Study|Adverse Event|1|||
155684190|NCT03099174|561933992|FG003|Overall Study|Adverse Event|2|||
155604027|NCT00454818|561639650|FG004|Phase 2: Randomized Double-blind|Death|1|||
155604028|NCT00454818|561639646|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155604029|NCT00454818|561639647|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155604030|NCT00454818|561639648|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
155604031|NCT00454818|561639649|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155604032|NCT00454818|561639650|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
155604033|NCT00454818|561639646|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155604034|NCT00454818|561639647|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155604035|NCT00454818|561639648|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
155604036|NCT00454818|561639649|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155604037|NCT00454818|561639650|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
155604038|NCT03435224|561639652|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
155604039|NCT04472026|561639655|FG000|Overall Study|Lost to Follow-up|5|||
155604040|NCT03077659|561639656|FG000|Overall Study|Withdrawal by Subject|0|||
155604041|NCT03077659|561639657|FG001|Overall Study|Withdrawal by Subject|0|||
155604042|NCT03077659|561639658|FG002|Overall Study|Withdrawal by Subject|1|||
155604043|NCT01273155|561639670|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
155604044|NCT01273155|561639671|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
155604045|NCT01273155|561639672|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
155604046|NCT01273155|561639673|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
155604047|NCT01273155|561639674|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
155604048|NCT01273155|561639675|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
155604049|NCT01273155|561639676|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
155604050|NCT01273155|561639670|FG000|Overall Study|Change in liver function/no longer eval.|0|||
155604051|NCT01273155|561639671|FG001|Overall Study|Change in liver function/no longer eval.|1|||
155604052|NCT01273155|561639672|FG002|Overall Study|Change in liver function/no longer eval.|0|||
155604053|NCT01273155|561639673|FG003|Overall Study|Change in liver function/no longer eval.|0|||
155604054|NCT01273155|561639674|FG004|Overall Study|Change in liver function/no longer eval.|1|||
155604055|NCT01273155|561639675|FG005|Overall Study|Change in liver function/no longer eval.|0|||
155604056|NCT01273155|561639676|FG006|Overall Study|Change in liver function/no longer eval.|0|||
155604057|NCT01273155|561639670|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
155604058|NCT01273155|561639671|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
155604059|NCT01273155|561639672|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
155604060|NCT01273155|561639673|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
155604061|NCT01273155|561639674|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
155604062|NCT01273155|561639675|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
155604063|NCT01273155|561639676|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
155604064|NCT01273155|561639670|FG000|Overall Study|Died during Cycle 1|0|||
155604065|NCT01273155|561639671|FG001|Overall Study|Died during Cycle 1|0|||
155604066|NCT01273155|561639672|FG002|Overall Study|Died during Cycle 1|1|||
155604067|NCT01273155|561639673|FG003|Overall Study|Died during Cycle 1|1|||
155604068|NCT01273155|561639674|FG004|Overall Study|Died during Cycle 1|0|||
155604069|NCT01273155|561639675|FG005|Overall Study|Died during Cycle 1|2|||
155604070|NCT01273155|561639676|FG006|Overall Study|Died during Cycle 1|2|||
155604071|NCT01273155|561639670|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
155604072|NCT01273155|561639671|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
155604073|NCT01273155|561639672|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
155604074|NCT01273155|561639673|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
155604075|NCT01273155|561639674|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
155604076|NCT01273155|561639675|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
155604077|NCT01273155|561639676|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
155604078|NCT04908475|561639677|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
155604079|NCT04908475|561639678|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155604080|NCT04908475|561639679|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155604081|NCT04908475|561639680|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155604082|NCT04908475|561639681|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155604083|NCT04908475|561639682|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155604084|NCT04908475|561639677|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
155604085|NCT04908475|561639678|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155604086|NCT04908475|561639679|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155604087|NCT04908475|561639680|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155604088|NCT04908475|561639681|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155604089|NCT04908475|561639682|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155604090|NCT04908475|561639677|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
155604091|NCT04908475|561639678|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155604092|NCT04908475|561639679|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155604093|NCT04908475|561639680|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155684191|NCT03099174|561933993|FG004|Overall Study|Adverse Event|5|||
155684192|NCT03099174|561933994|FG005|Overall Study|Adverse Event|3|||
155684193|NCT03099174|561933995|FG006|Overall Study|Adverse Event|6|||
155684194|NCT03099174|561933996|FG007|Overall Study|Adverse Event|4|||
155684195|NCT03099174|561933989|FG000|Overall Study|Other than listed|6|||
155684196|NCT03099174|561933990|FG001|Overall Study|Other than listed|6|||
155684197|NCT03099174|561933991|FG002|Overall Study|Other than listed|5|||
155684198|NCT03099174|561933992|FG003|Overall Study|Other than listed|6|||
155684199|NCT03099174|561933993|FG004|Overall Study|Other than listed|19|||
155684200|NCT03099174|561933994|FG005|Overall Study|Other than listed|10|||
155684201|NCT03099174|561933995|FG006|Overall Study|Other than listed|26|||
155684202|NCT03099174|561933996|FG007|Overall Study|Other than listed|23|||
155684203|NCT04730635|561933997|FG000|Overall Study|Lost to Follow-up|1|||
155684204|NCT04730635|561933998|FG001|Overall Study|Lost to Follow-up|0|||
155684205|NCT04730635|561933997|FG000|Overall Study|Withdrawal by Subject|0|||
155684206|NCT04730635|561933998|FG001|Overall Study|Withdrawal by Subject|1|||
155684207|NCT03070223|561933999|FG000|Overall Study|Lost to Follow-up|34|||
155684208|NCT03070223|561934000|FG001|Overall Study|Lost to Follow-up|27|||
155684209|NCT03070223|561933999|FG000|Overall Study|Withdrawal by Subject|12|||
155684210|NCT03070223|561934000|FG001|Overall Study|Withdrawal by Subject|22|||
155684211|NCT03070223|561933999|FG000|Overall Study|Protocol Violation|0|||
155684212|NCT03070223|561934000|FG001|Overall Study|Protocol Violation|1|||
155684213|NCT00516906|561934001|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
155684214|NCT00516906|561934002|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
155684215|NCT01327053|561934005|FG000|Overall Study|Adverse Event|23|||
155684216|NCT01327053|561934006|FG001|Overall Study|Adverse Event|57|||
155684217|NCT01327053|561934005|FG000|Overall Study|Patient/guardian decision|11|||
155684218|NCT01327053|561934006|FG001|Overall Study|Patient/guardian decision|35|||
155684219|NCT01327053|561934005|FG000|Overall Study|Physician Decision|10|||
155684220|NCT01327053|561934006|FG001|Overall Study|Physician Decision|14|||
155684221|NCT01327053|561934005|FG000|Overall Study|Death|1|||
155684222|NCT01327053|561934006|FG001|Overall Study|Death|5|||
155684223|NCT01327053|561934005|FG000|Overall Study|Lost to Follow-up|2|||
155684224|NCT01327053|561934006|FG001|Overall Study|Lost to Follow-up|4|||
155684225|NCT01327053|561934005|FG000|Overall Study|Non-compliance with study treatment|0|||
155684226|NCT01327053|561934006|FG001|Overall Study|Non-compliance with study treatment|5|||
155684227|NCT01327053|561934005|FG000|Overall Study|Study terminated by Sponsor|1|||
155684228|NCT01327053|561934006|FG001|Overall Study|Study terminated by Sponsor|3|||
155684229|NCT01327053|561934005|FG000|Overall Study|Progressive disease|31|||
155684230|NCT01327053|561934006|FG001|Overall Study|Progressive disease|26|||
155684231|NCT01327053|561934005|FG000|Overall Study|Protocol Violation|0|||
155684232|NCT01327053|561934006|FG001|Overall Study|Protocol Violation|1|||
155684233|NCT01327053|561934005|FG000|Overall Study|Untreated|0|||
155684234|NCT01327053|561934006|FG001|Overall Study|Untreated|1|||
155684235|NCT00721578|561934012|FG000|Overall Study|Death|1|||
155684236|NCT00721578|561934013|FG001|Overall Study|Death|1|||
155684237|NCT00721578|561934012|FG000|Overall Study|Withdrawal by Subject|1|||
155684238|NCT00721578|561934013|FG001|Overall Study|Withdrawal by Subject|1|||
155684239|NCT04621240|561934014|FG000|Overall Study|Withdrawal by Subject|36|||
155684240|NCT00211757|561934016|FG000|Overall Study|Withdrawal by Subject|1|||
155684241|NCT00211757|561934017|FG001|Overall Study|Withdrawal by Subject|1|||
155684242|NCT00211757|561934016|FG000|Overall Study|Lack of Efficacy|0|||
155684243|NCT00211757|561934017|FG001|Overall Study|Lack of Efficacy|1|||
155684244|NCT02226198|561936374|FG000|Lead-in Phase|Protocol Violation|1|||
155684245|NCT02226198|561936375|FG001|Lead-in Phase|Protocol Violation|0|||
155684246|NCT02226198|561936376|FG002|Lead-in Phase|Protocol Violation|0|||
155684247|NCT02226198|561936374|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
155684248|NCT02226198|561936375|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
155684249|NCT02226198|561936376|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
155684250|NCT01440517|561936380|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
155684251|NCT01288612|561936381|FG000|Overall Study|Unable to contact|11|||
155684252|NCT01288612|561936382|FG001|Overall Study|Unable to contact|16|||
155684253|NCT01288612|561936383|FG002|Overall Study|Unable to contact|20|||
155684254|NCT01288612|561936381|FG000|Overall Study|Declined|78|||
155684255|NCT01288612|561936382|FG001|Overall Study|Declined|63|||
155684256|NCT01288612|561936383|FG002|Overall Study|Declined|62|||
155684257|NCT01288612|561936381|FG000|Overall Study|Unable to intubate|0|||
155684258|NCT01288612|561936382|FG001|Overall Study|Unable to intubate|3|||
155684259|NCT01288612|561936383|FG002|Overall Study|Unable to intubate|0|||
155684260|NCT00871923|561936384|FG000|Overall Study|Death|1|||
155684261|NCT00871923|561936384|FG000|Overall Study|Withdrawal by Subject|1|||
155684262|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
155684263|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
155684264|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
155684265|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
155684266|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
155684267|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
155684268|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
155684269|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
155684270|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
155684271|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
155684272|NCT01263015|561936389|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
155684273|NCT01263015|561936390|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
155684274|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
155684275|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
155684276|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
155684277|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
155684278|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
155684279|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
155684280|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
155684281|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
155684282|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
155684283|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
155684284|NCT01263015|561936389|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
155684285|NCT01263015|561936390|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
155684286|NCT05599451|561936391|FG000|Overall Study|Not randomized|11|||
155684287|NCT05599451|561936392|FG001|Overall Study|Not randomized|0|||
155684288|NCT05599451|561936393|FG002|Overall Study|Not randomized|0|||
155684289|NCT05599451|561936394|FG003|Overall Study|Not randomized|0|||
155684290|NCT05599451|561936395|FG004|Overall Study|Not randomized|0|||
155684291|NCT05599451|561936391|FG000|Overall Study|Physician Decision|0|||
155684292|NCT05599451|561936392|FG001|Overall Study|Physician Decision|0|||
155684293|NCT05599451|561936393|FG002|Overall Study|Physician Decision|0|||
155684294|NCT05599451|561936394|FG003|Overall Study|Physician Decision|1|||
155684295|NCT05599451|561936395|FG004|Overall Study|Physician Decision|0|||
155684296|NCT02723006|561936396|FG000|Overall Study|Withdrawal by Subject|0|||
155684297|NCT02723006|561936397|FG001|Overall Study|Withdrawal by Subject|1|||
155684298|NCT02723006|561936398|FG002|Overall Study|Withdrawal by Subject|1|||
155684299|NCT02723006|561936396|FG000|Overall Study|Study Terminated by Sponsor|1|||
155684300|NCT02723006|561936397|FG001|Overall Study|Study Terminated by Sponsor|6|||
155684301|NCT02723006|561936398|FG002|Overall Study|Study Terminated by Sponsor|6|||
155684302|NCT00303446|561936399|FG000|Overall Study|Withdrawal by Subject|2|||
155684303|NCT00303446|561936400|FG001|Overall Study|Withdrawal by Subject|2|||
155684304|NCT00303446|561936399|FG000|Overall Study|Death|0|||
155684305|NCT00303446|561936400|FG001|Overall Study|Death|1|||
155684306|NCT00303446|561936399|FG000|Overall Study|Physician Decision|0|||
155684307|NCT00303446|561936400|FG001|Overall Study|Physician Decision|1|||
155684308|NCT03285958|561936401|FG000|Overall Study|Lost to Follow-up|1|||
155684309|NCT03285958|561936402|FG001|Overall Study|Lost to Follow-up|1|||
155684310|NCT03285958|561936401|FG000|Overall Study|Withdrawal by Subject|1|||
155684311|NCT03285958|561936402|FG001|Overall Study|Withdrawal by Subject|0|||
155684312|NCT03285958|561936401|FG000|Overall Study|Not able to attend required orientation|3|||
155684313|NCT03285958|561936402|FG001|Overall Study|Not able to attend required orientation|0|||
155684314|NCT03842969|561936415|FG000|Overall Study|Participant declined follow-up visit|0|||
155684315|NCT03842969|561936416|FG001|Overall Study|Participant declined follow-up visit|1|||
155684316|NCT03842969|561936417|FG002|Overall Study|Participant declined follow-up visit|0|||
155684317|NCT03842969|561936415|FG000|Overall Study|Sponsor's decision|12|||
155684318|NCT03842969|561936416|FG001|Overall Study|Sponsor's decision|99|||
155684319|NCT03842969|561936417|FG002|Overall Study|Sponsor's decision|61|||
155684320|NCT03842969|561936415|FG000|Overall Study|Pregnancy|0|||
155684321|NCT03842969|561936416|FG001|Overall Study|Pregnancy|0|||
155684322|NCT03842969|561936417|FG002|Overall Study|Pregnancy|1|||
155684323|NCT03842969|561936415|FG000|Overall Study|Death|1|||
155684324|NCT03842969|561936416|FG001|Overall Study|Death|0|||
155684325|NCT03842969|561936417|FG002|Overall Study|Death|1|||
155684326|NCT03842969|561936415|FG000|Overall Study|Withdrawal by Subject|3|||
155684327|NCT03842969|561936416|FG001|Overall Study|Withdrawal by Subject|30|||
155684328|NCT03842969|561936417|FG002|Overall Study|Withdrawal by Subject|18|||
155684329|NCT03842969|561936415|FG000|Overall Study|Protocol Violation|1|||
155684330|NCT03842969|561936416|FG001|Overall Study|Protocol Violation|1|||
155684331|NCT03842969|561936417|FG002|Overall Study|Protocol Violation|0|||
155684332|NCT03842969|561936415|FG000|Overall Study|Physician Decision|0|||
155684333|NCT03842969|561936416|FG001|Overall Study|Physician Decision|3|||
155684334|NCT03842969|561936417|FG002|Overall Study|Physician Decision|0|||
155684335|NCT03842969|561936415|FG000|Overall Study|Lost to Follow-up|0|||
155684336|NCT03842969|561936416|FG001|Overall Study|Lost to Follow-up|2|||
155684337|NCT03842969|561936417|FG002|Overall Study|Lost to Follow-up|0|||
155684338|NCT03842969|561936415|FG000|Overall Study|Adverse Event|0|||
155684339|NCT03842969|561936416|FG001|Overall Study|Adverse Event|2|||
155684340|NCT03842969|561936417|FG002|Overall Study|Adverse Event|0|||
155684341|NCT02264665|561936420|FG000|Overall Study|Other|0|||
155684342|NCT02264665|561936421|FG001|Overall Study|Other|0|||
155684343|NCT02264665|561936422|FG002|Overall Study|Other|3|||
155684344|NCT02264665|561936423|FG003|Overall Study|Other|0|||
155684345|NCT02264665|561936424|FG004|Overall Study|Other|0|||
155684346|NCT02264665|561936425|FG005|Overall Study|Other|0|||
155684347|NCT02264665|561936426|FG006|Overall Study|Other|0|||
155684348|NCT02264665|561936420|FG000|Overall Study|Death|9|||
155684349|NCT02264665|561936421|FG001|Overall Study|Death|8|||
155684350|NCT02264665|561936422|FG002|Overall Study|Death|13|||
155684351|NCT02264665|561936423|FG003|Overall Study|Death|5|||
155684352|NCT02264665|561936424|FG004|Overall Study|Death|0|||
155684353|NCT02264665|561936425|FG005|Overall Study|Death|0|||
155684354|NCT02264665|561936426|FG006|Overall Study|Death|1|||
155684355|NCT02264665|561936420|FG000|Overall Study|Lost to Follow-up|1|||
155684356|NCT02264665|561936421|FG001|Overall Study|Lost to Follow-up|0|||
155684357|NCT02264665|561936422|FG002|Overall Study|Lost to Follow-up|2|||
155684358|NCT02264665|561936423|FG003|Overall Study|Lost to Follow-up|1|||
155684359|NCT02264665|561936424|FG004|Overall Study|Lost to Follow-up|0|||
155684360|NCT02264665|561936425|FG005|Overall Study|Lost to Follow-up|0|||
155684361|NCT02264665|561936426|FG006|Overall Study|Lost to Follow-up|0|||
155684362|NCT02264665|561936420|FG000|Overall Study|Participant decision|0|||
155684363|NCT02264665|561936421|FG001|Overall Study|Participant decision|0|||
155684364|NCT02264665|561936422|FG002|Overall Study|Participant decision|0|||
155684365|NCT02264665|561936423|FG003|Overall Study|Participant decision|1|||
155684366|NCT02264665|561936424|FG004|Overall Study|Participant decision|0|||
155684367|NCT02264665|561936425|FG005|Overall Study|Participant decision|0|||
155684368|NCT02264665|561936426|FG006|Overall Study|Participant decision|0|||
155684369|NCT02264665|561936420|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
155684370|NCT02264665|561936421|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155684371|NCT02264665|561936422|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155684372|NCT02264665|561936423|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155684373|NCT02264665|561936424|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155684374|NCT02264665|561936425|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155684375|NCT02264665|561936426|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155684376|NCT02264665|561936420|FG000|Overall Study|Data Missing|0|||
155684377|NCT02264665|561936421|FG001|Overall Study|Data Missing|0|||
155684378|NCT02264665|561936422|FG002|Overall Study|Data Missing|1|||
155684379|NCT02264665|561936423|FG003|Overall Study|Data Missing|0|||
155684380|NCT02264665|561936424|FG004|Overall Study|Data Missing|0|||
155684381|NCT02264665|561936425|FG005|Overall Study|Data Missing|0|||
155684382|NCT02264665|561936426|FG006|Overall Study|Data Missing|0|||
155684383|NCT01468207|561936427|FG000|Treatment Period 1|Adverse Event|1|||
155684384|NCT01468207|561936428|FG001|Treatment Period 1|Adverse Event|0|||
155684385|NCT01468207|561936429|FG002|Treatment Period 1|Adverse Event|0|||
155684386|NCT01468207|561936430|FG003|Treatment Period 1|Adverse Event|0|||
155684387|NCT01468207|561936431|FG004|Treatment Period 1|Adverse Event|0|||
155684388|NCT01468207|561936432|FG005|Treatment Period 1|Adverse Event|0|||
155684389|NCT01468207|561936427|FG000|Treatment Period 1|Protocol Violation|1|||
155684390|NCT01468207|561936428|FG001|Treatment Period 1|Protocol Violation|1|||
155684391|NCT01468207|561936429|FG002|Treatment Period 1|Protocol Violation|0|||
155684392|NCT01468207|561936430|FG003|Treatment Period 1|Protocol Violation|0|||
155684393|NCT01468207|561936431|FG004|Treatment Period 1|Protocol Violation|0|||
155684394|NCT01468207|561936432|FG005|Treatment Period 1|Protocol Violation|0|||
155684395|NCT01468207|561936427|FG000|Treatment Period 1|Withdrawal by Subject|5|||
155684396|NCT01468207|561936428|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155684397|NCT01468207|561936429|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155684398|NCT01468207|561936430|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155684399|NCT01468207|561936431|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155684400|NCT01468207|561936432|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155684401|NCT01468207|561936427|FG000|Treatment Period 1|Lost to Follow-up|2|||
155684402|NCT01468207|561936428|FG001|Treatment Period 1|Lost to Follow-up|1|||
155684403|NCT01468207|561936429|FG002|Treatment Period 1|Lost to Follow-up|0|||
155684404|NCT01468207|561936430|FG003|Treatment Period 1|Lost to Follow-up|0|||
155684405|NCT01468207|561936431|FG004|Treatment Period 1|Lost to Follow-up|0|||
155684406|NCT01468207|561936432|FG005|Treatment Period 1|Lost to Follow-up|0|||
155684407|NCT01468207|561936427|FG000|Treatment Period 1|Other|0|||
155684408|NCT01468207|561936428|FG001|Treatment Period 1|Other|2|||
155684409|NCT01468207|561936429|FG002|Treatment Period 1|Other|0|||
155684410|NCT01468207|561936430|FG003|Treatment Period 1|Other|0|||
155684411|NCT01468207|561936431|FG004|Treatment Period 1|Other|0|||
155684412|NCT01468207|561936432|FG005|Treatment Period 1|Other|0|||
155684413|NCT01468207|561936427|FG000|Treatment Period 2|Adverse Event|0|||
155684414|NCT01468207|561936428|FG001|Treatment Period 2|Adverse Event|0|||
155684415|NCT01468207|561936429|FG002|Treatment Period 2|Adverse Event|6|||
155684416|NCT01468207|561936430|FG003|Treatment Period 2|Adverse Event|1|||
155684417|NCT01468207|561936431|FG004|Treatment Period 2|Adverse Event|2|||
155684418|NCT01468207|561936432|FG005|Treatment Period 2|Adverse Event|1|||
155684419|NCT01468207|561936427|FG000|Treatment Period 2|Lack of Efficacy|0|||
155684420|NCT01468207|561936428|FG001|Treatment Period 2|Lack of Efficacy|0|||
155684421|NCT01468207|561936429|FG002|Treatment Period 2|Lack of Efficacy|1|||
155684422|NCT01468207|561936430|FG003|Treatment Period 2|Lack of Efficacy|1|||
155684423|NCT01468207|561936431|FG004|Treatment Period 2|Lack of Efficacy|0|||
155684424|NCT01468207|561936432|FG005|Treatment Period 2|Lack of Efficacy|2|||
155684425|NCT01468207|561936427|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155684426|NCT01468207|561936428|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155684427|NCT01468207|561936429|FG002|Treatment Period 2|Withdrawal by Subject|5|||
155684428|NCT01468207|561936430|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155684429|NCT01468207|561936431|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155684430|NCT01468207|561936432|FG005|Treatment Period 2|Withdrawal by Subject|2|||
155684431|NCT01468207|561936427|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
155684432|NCT01468207|561936428|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
155684433|NCT01468207|561936429|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
155684434|NCT01468207|561936430|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
155684435|NCT01468207|561936431|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
155684436|NCT01468207|561936432|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
155684437|NCT01468207|561936427|FG000|Treatment Period 2|Lost to Follow-up|0|||
155684438|NCT01468207|561936428|FG001|Treatment Period 2|Lost to Follow-up|0|||
155684439|NCT01468207|561936429|FG002|Treatment Period 2|Lost to Follow-up|5|||
155684440|NCT01468207|561936430|FG003|Treatment Period 2|Lost to Follow-up|1|||
155684441|NCT01468207|561936431|FG004|Treatment Period 2|Lost to Follow-up|0|||
155684442|NCT01468207|561936432|FG005|Treatment Period 2|Lost to Follow-up|0|||
155684443|NCT01468207|561936427|FG000|Treatment Period 2|Other|0|||
155684444|NCT01468207|561936428|FG001|Treatment Period 2|Other|0|||
155684445|NCT01468207|561936429|FG002|Treatment Period 2|Other|5|||
155684446|NCT01468207|561936430|FG003|Treatment Period 2|Other|1|||
155684447|NCT01468207|561936431|FG004|Treatment Period 2|Other|1|||
155684448|NCT01468207|561936432|FG005|Treatment Period 2|Other|2|||
155684449|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
155684450|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
155684451|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
155684452|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
155684453|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
155684454|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
155684455|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
155684456|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
155684457|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
155684458|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
155684459|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Other|1|||
155684460|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Other|1|||
155684461|NCT02075047|561936433|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
155684462|NCT02075047|561936434|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
155684463|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
155684464|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
155684465|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
155684466|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
155684467|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
155684468|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
155684469|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
155684470|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
155684471|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
155684472|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
155684473|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Other|1|||
155684474|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Other|2|||
155684475|NCT02075047|561936433|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
155684476|NCT02075047|561936434|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
155684477|NCT01229254|561936439|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
155684478|NCT01229254|561936440|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
155684479|NCT01229254|561936441|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
155684480|NCT01229254|561936439|FG000|Overall Study|Adverse Event|4|||
155684481|NCT01229254|561936440|FG001|Overall Study|Adverse Event|5|||
155684482|NCT01229254|561936441|FG002|Overall Study|Adverse Event|3|||
155684483|NCT01229254|561936439|FG000|Overall Study|Lost to Follow-up|3|||
155684484|NCT01229254|561936440|FG001|Overall Study|Lost to Follow-up|0|||
155684485|NCT01229254|561936441|FG002|Overall Study|Lost to Follow-up|1|||
155684486|NCT01229254|561936439|FG000|Overall Study|Physician Decision|0|||
155684487|NCT01229254|561936440|FG001|Overall Study|Physician Decision|3|||
155684488|NCT01229254|561936441|FG002|Overall Study|Physician Decision|0|||
155684489|NCT01229254|561936439|FG000|Overall Study|Protocol Violation|4|||
155684490|NCT01229254|561936440|FG001|Overall Study|Protocol Violation|6|||
155684491|NCT01229254|561936441|FG002|Overall Study|Protocol Violation|5|||
155684492|NCT01229254|561936439|FG000|Overall Study|Withdrawal by Subject|1|||
155684493|NCT01229254|561936440|FG001|Overall Study|Withdrawal by Subject|0|||
155684494|NCT01229254|561936441|FG002|Overall Study|Withdrawal by Subject|1|||
155684495|NCT01229254|561936439|FG000|Overall Study|Non-compliance with Study Drug|0|||
155684496|NCT01229254|561936440|FG001|Overall Study|Non-compliance with Study Drug|1|||
155684497|NCT01229254|561936441|FG002|Overall Study|Non-compliance with Study Drug|1|||
155684498|NCT02186652|561936446|FG000|Overall Study|Lost to Follow-up|2|||
155684499|NCT02186652|561936447|FG001|Overall Study|Lost to Follow-up|0|||
155684500|NCT03770728|561936451|FG000|Overall Study|Adverse Event|1|||
155684501|NCT03770728|561936452|FG001|Overall Study|Adverse Event|0|||
155684502|NCT03770728|561936453|FG002|Overall Study|Adverse Event|1|||
155684503|NCT03770728|561936454|FG003|Overall Study|Adverse Event|0|||
155684504|NCT03770728|561936451|FG000|Overall Study|Poor compliance to protocol|0|||
155684505|NCT03770728|561936452|FG001|Overall Study|Poor compliance to protocol|0|||
155684506|NCT03770728|561936453|FG002|Overall Study|Poor compliance to protocol|1|||
155684507|NCT03770728|561936454|FG003|Overall Study|Poor compliance to protocol|0|||
155684508|NCT03770728|561936451|FG000|Overall Study|Withdrawal by Subject|13|||
155684509|NCT03770728|561936452|FG001|Overall Study|Withdrawal by Subject|8|||
155684510|NCT03770728|561936453|FG002|Overall Study|Withdrawal by Subject|9|||
155684511|NCT03770728|561936454|FG003|Overall Study|Withdrawal by Subject|13|||
155684512|NCT03770728|561936451|FG000|Overall Study|Other than specified|24|||
155684513|NCT03770728|561936452|FG001|Overall Study|Other than specified|23|||
155684514|NCT03770728|561936453|FG002|Overall Study|Other than specified|21|||
155684515|NCT03770728|561936454|FG003|Overall Study|Other than specified|22|||
155684516|NCT00503776|561936455|FG000|Overall Study|Withdrawal by Subject|1|||
155684517|NCT00503776|561936456|FG001|Overall Study|Withdrawal by Subject|0|||
155684518|NCT00503776|561936457|FG002|Overall Study|Withdrawal by Subject|1|||
155684519|NCT00503776|561936458|FG003|Overall Study|Withdrawal by Subject|1|||
155684520|NCT00503776|561936455|FG000|Overall Study|Physician Decision|0|||
155684521|NCT00503776|561936456|FG001|Overall Study|Physician Decision|0|||
155684522|NCT00503776|561936457|FG002|Overall Study|Physician Decision|1|||
155684523|NCT00503776|561936458|FG003|Overall Study|Physician Decision|1|||
155684524|NCT02778555|561936459|FG000|Overall Study|Withdrawal by Subject|55|||
155684525|NCT02778555|561936460|FG001|Overall Study|Withdrawal by Subject|32|||
155684526|NCT02778555|561936461|FG002|Overall Study|Withdrawal by Subject|107|||
155684527|NCT00107315|561936462|FG000|Overall Study|Disease Progression|9|||
155684528|NCT00107315|561936462|FG000|Overall Study|Adverse Event|4|||
155684529|NCT00107315|561936462|FG000|Overall Study|Withdrawal by Subject|2|||
155684530|NCT02509039|561936465|FG000|Overall Study|Adverse Event|0|||
155684531|NCT02509039|561936466|FG001|Overall Study|Adverse Event|1|||
155684532|NCT02509039|561936467|FG002|Overall Study|Adverse Event|1|||
155684533|NCT02509039|561936468|FG003|Overall Study|Adverse Event|1|||
155684534|NCT02509039|561936465|FG000|Overall Study|Withdrawal by Subject|0|||
155684535|NCT02509039|561936466|FG001|Overall Study|Withdrawal by Subject|0|||
155684536|NCT02509039|561936467|FG002|Overall Study|Withdrawal by Subject|1|||
155684537|NCT02509039|561936468|FG003|Overall Study|Withdrawal by Subject|0|||
155684538|NCT02509039|561936465|FG000|Overall Study|Progressive disease|2|||
155684539|NCT02509039|561936466|FG001|Overall Study|Progressive disease|2|||
155684540|NCT02509039|561936467|FG002|Overall Study|Progressive disease|1|||
155684541|NCT02509039|561936468|FG003|Overall Study|Progressive disease|5|||
155684542|NCT02509039|561936465|FG000|Overall Study|Study terminated by Sponsor|1|||
155684543|NCT02509039|561936466|FG001|Overall Study|Study terminated by Sponsor|0|||
155684544|NCT02509039|561936467|FG002|Overall Study|Study terminated by Sponsor|0|||
155684545|NCT02509039|561936468|FG003|Overall Study|Study terminated by Sponsor|0|||
155684546|NCT03943550|561936471|FG000|Overall Study|Adverse Event|0|||
155684547|NCT03943550|561936472|FG001|Overall Study|Adverse Event|0|||
155684548|NCT03943550|561936473|FG002|Overall Study|Adverse Event|1|||
155684549|NCT03943550|561936471|FG000|Overall Study|Lost to Follow-up|0|||
155684550|NCT03943550|561936472|FG001|Overall Study|Lost to Follow-up|0|||
155684551|NCT03943550|561936473|FG002|Overall Study|Lost to Follow-up|1|||
155684552|NCT03943550|561936471|FG000|Overall Study|Progressive Disease|0|||
155684553|NCT03943550|561936472|FG001|Overall Study|Progressive Disease|0|||
155684554|NCT03943550|561936473|FG002|Overall Study|Progressive Disease|2|||
155684555|NCT03943550|561936471|FG000|Overall Study|Participant Moved Out of the Country|0|||
155684556|NCT03943550|561936472|FG001|Overall Study|Participant Moved Out of the Country|1|||
155684557|NCT03943550|561936473|FG002|Overall Study|Participant Moved Out of the Country|0|||
155684558|NCT04659174|561936482|FG000|Overall Study|Sponsor decision to discontinue study|0|||
155684559|NCT04659174|561936483|FG001|Overall Study|Sponsor decision to discontinue study|2|||
155684560|NCT04659174|561936482|FG000|Overall Study|Lost to Follow-up|9|||
155684561|NCT04659174|561936483|FG001|Overall Study|Lost to Follow-up|11|||
155684562|NCT04659174|561936482|FG000|Overall Study|Adverse Event|8|||
155684563|NCT04659174|561936483|FG001|Overall Study|Adverse Event|5|||
155684564|NCT04659174|561936482|FG000|Overall Study|Withdrawal by Subject|17|||
155684565|NCT04659174|561936483|FG001|Overall Study|Withdrawal by Subject|33|||
155684566|NCT04659174|561936482|FG000|Overall Study|Progressive disease|0|||
155684567|NCT04659174|561936483|FG001|Overall Study|Progressive disease|2|||
155684568|NCT04659174|561936482|FG000|Overall Study|Other reasons|0|||
155684569|NCT04659174|561936483|FG001|Overall Study|Other reasons|2|||
155684570|NCT04659174|561936482|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
155684571|NCT04659174|561936483|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
155684572|NCT04659174|561936482|FG000|Overall Study|Alcohol or illegal drug use|0|||
155684573|NCT04659174|561936483|FG001|Overall Study|Alcohol or illegal drug use|3|||
155684574|NCT04659174|561936482|FG000|Overall Study|Violation of entry criteria|1|||
155684575|NCT04659174|561936483|FG001|Overall Study|Violation of entry criteria|0|||
155684576|NCT04659174|561936482|FG000|Overall Study|Death|0|||
155684577|NCT04659174|561936483|FG001|Overall Study|Death|1|||
155684578|NCT03276026|561936486|FG000|Overall Study|Protocol Violation|1|||
155684579|NCT03276026|561936487|FG001|Overall Study|Protocol Violation|0|||
155684580|NCT03650803|561936489|FG000|Overall Study|Lost to Follow-up|6|||
155684581|NCT01534260|561936490|FG000|Overall Study|Adverse Event|1|||
155684582|NCT01534260|561936491|FG001|Overall Study|Adverse Event|8|||
155684583|NCT01534260|561936490|FG000|Overall Study|Death|2|||
155684584|NCT01534260|561936491|FG001|Overall Study|Death|0|||
155684585|NCT01534260|561936490|FG000|Overall Study|Lack of Efficacy|1|||
155684586|NCT01534260|561936491|FG001|Overall Study|Lack of Efficacy|1|||
155684587|NCT01534260|561936490|FG000|Overall Study|Withdrawal by Subject|1|||
155684588|NCT01534260|561936491|FG001|Overall Study|Withdrawal by Subject|3|||
155684589|NCT01534260|561936490|FG000|Overall Study|Disease Progression|8|||
155684590|NCT01534260|561936491|FG001|Overall Study|Disease Progression|6|||
155684591|NCT01534260|561936490|FG000|Overall Study|Physician Decision|3|||
155684592|NCT01534260|561936491|FG001|Overall Study|Physician Decision|1|||
155684593|NCT01534260|561936490|FG000|Overall Study|No treatment, per protocol|0|||
155684594|NCT01534260|561936491|FG001|Overall Study|No treatment, per protocol|1|||
155684595|NCT00503581|561936498|FG000|Overall Study|Study closed|3|||
155684596|NCT00503581|561936499|FG001|Overall Study|Study closed|4|||
155684597|NCT00503581|561936500|FG002|Overall Study|Study closed|2|||
155684598|NCT01301066|561936502|FG000|Overall Study|Lost to Follow-up|5|||
155684599|NCT01301066|561936503|FG001|Overall Study|Lost to Follow-up|11|||
155684600|NCT01301066|561936502|FG000|Overall Study|Protocol Violation|8|||
155684601|NCT01301066|561936503|FG001|Overall Study|Protocol Violation|7|||
155684602|NCT01301066|561936502|FG000|Overall Study|Withdrawal by Subject|4|||
155684603|NCT01301066|561936503|FG001|Overall Study|Withdrawal by Subject|9|||
155684604|NCT01301066|561936502|FG000|Overall Study|Adverse Event|6|||
155684605|NCT01301066|561936503|FG001|Overall Study|Adverse Event|6|||
155684606|NCT01301066|561936502|FG000|Overall Study|Sponsor Decision|2|||
155684607|NCT01301066|561936503|FG001|Overall Study|Sponsor Decision|1|||
155684608|NCT01301066|561936502|FG000|Overall Study|Physician Decision|0|||
155684609|NCT01301066|561936503|FG001|Overall Study|Physician Decision|1|||
155684610|NCT01301066|561936502|FG000|Overall Study|Other|2|||
155684611|NCT01301066|561936503|FG001|Overall Study|Other|0|||
155684612|NCT02118766|561936508|FG000|Overall Study|Adverse Event|7|||
155684613|NCT02118766|561936509|FG001|Overall Study|Adverse Event|2|||
155684614|NCT02118766|561936508|FG000|Overall Study|Withdrawal by Subject|3|||
155684615|NCT02118766|561936509|FG001|Overall Study|Withdrawal by Subject|6|||
155684616|NCT02118766|561936508|FG000|Overall Study|Lost to Follow-up|5|||
155684617|NCT02118766|561936509|FG001|Overall Study|Lost to Follow-up|4|||
155684618|NCT02118766|561936508|FG000|Overall Study|Withdrawal by parent/guardian|12|||
155684619|NCT02118766|561936509|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155684620|NCT02118766|561936508|FG000|Overall Study|Other|3|||
155684621|NCT02118766|561936509|FG001|Overall Study|Other|1|||
155684622|NCT02248649|561936512|FG000|Overall Study|Death|7|||
155684623|NCT02248649|561936513|FG001|Overall Study|Death|11|||
155684624|NCT02248649|561936512|FG000|Overall Study|Lost to Follow-up|14|||
155684625|NCT02248649|561936513|FG001|Overall Study|Lost to Follow-up|10|||
155684626|NCT02438683|561936514|FG000|Overall Study|Adverse Event|1|||
155684627|NCT02438683|561936515|FG001|Overall Study|Adverse Event|0|||
155684628|NCT02438683|561936516|FG002|Overall Study|Adverse Event|0|||
155684629|NCT02438683|561936517|FG003|Overall Study|Adverse Event|0|||
155684630|NCT02438683|561936518|FG004|Overall Study|Adverse Event|0|||
155684631|NCT02438683|561936519|FG005|Overall Study|Adverse Event|0|||
155684632|NCT01202188|561936533|FG000|Overall Study|Protocol deviation|14|||
155684633|NCT01202188|561936534|FG001|Overall Study|Protocol deviation|8|||
155684634|NCT01202188|561936535|FG002|Overall Study|Protocol deviation|12|||
155684635|NCT01202188|561936536|FG003|Overall Study|Protocol deviation|10|||
155684636|NCT01202188|561936537|FG004|Overall Study|Protocol deviation|11|||
155684637|NCT01202188|561936533|FG000|Overall Study|Subject withdrew consent|12|||
155684638|NCT01202188|561936534|FG001|Overall Study|Subject withdrew consent|13|||
155684639|NCT01202188|561936535|FG002|Overall Study|Subject withdrew consent|22|||
155684640|NCT01202188|561936536|FG003|Overall Study|Subject withdrew consent|11|||
155684641|NCT01202188|561936537|FG004|Overall Study|Subject withdrew consent|13|||
155684642|NCT01202188|561936533|FG000|Overall Study|Adverse Event|5|||
155684643|NCT01202188|561936534|FG001|Overall Study|Adverse Event|23|||
155684644|NCT01202188|561936535|FG002|Overall Study|Adverse Event|13|||
155684645|NCT01202188|561936536|FG003|Overall Study|Adverse Event|10|||
155684646|NCT01202188|561936537|FG004|Overall Study|Adverse Event|10|||
155684647|NCT01202188|561936533|FG000|Overall Study|Administrative problems|3|||
155684648|NCT01202188|561936534|FG001|Overall Study|Administrative problems|2|||
155684649|NCT01202188|561936535|FG002|Overall Study|Administrative problems|1|||
155684650|NCT01202188|561936536|FG003|Overall Study|Administrative problems|1|||
155684651|NCT01202188|561936537|FG004|Overall Study|Administrative problems|2|||
155684652|NCT01202188|561936533|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155684653|NCT01202188|561936534|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155684654|NCT01202188|561936535|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155684655|NCT01202188|561936536|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
155684656|NCT01202188|561936537|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
155684657|NCT01202188|561936533|FG000|Overall Study|Lost to Follow-up|1|||
155684658|NCT01202188|561936534|FG001|Overall Study|Lost to Follow-up|1|||
155684659|NCT01202188|561936535|FG002|Overall Study|Lost to Follow-up|0|||
155684660|NCT01202188|561936536|FG003|Overall Study|Lost to Follow-up|4|||
155684661|NCT01202188|561936537|FG004|Overall Study|Lost to Follow-up|1|||
155684662|NCT01202188|561936533|FG000|Overall Study|Death|1|||
155684663|NCT01202188|561936534|FG001|Overall Study|Death|1|||
155684664|NCT01202188|561936535|FG002|Overall Study|Death|1|||
155684665|NCT01202188|561936536|FG003|Overall Study|Death|1|||
155684666|NCT01202188|561936537|FG004|Overall Study|Death|0|||
155684667|NCT01202188|561936533|FG000|Overall Study|Abnormal test procedure result (s)|0|||
155684668|NCT01202188|561936534|FG001|Overall Study|Abnormal test procedure result (s)|0|||
155684669|NCT01202188|561936535|FG002|Overall Study|Abnormal test procedure result (s)|2|||
155684670|NCT01202188|561936536|FG003|Overall Study|Abnormal test procedure result (s)|0|||
155684671|NCT01202188|561936537|FG004|Overall Study|Abnormal test procedure result (s)|0|||
155684672|NCT05032690|561936538|FG000|Period 1|Adverse Event|0|||
155684673|NCT05032690|561936539|FG001|Period 1|Adverse Event|1|||
155684674|NCT05032690|561936540|FG002|Period 1|Adverse Event|0|||
155684675|NCT05032690|561936541|FG003|Period 1|Adverse Event|0|||
155684676|NCT05032690|561936538|FG000|Period 1|Withdrawal by Subject|1|||
155684677|NCT05032690|561936539|FG001|Period 1|Withdrawal by Subject|0|||
155684678|NCT05032690|561936540|FG002|Period 1|Withdrawal by Subject|0|||
155684679|NCT05032690|561936541|FG003|Period 1|Withdrawal by Subject|0|||
155684680|NCT05032690|561936538|FG000|Period 1|No longer meets eligibility criteria|0|||
155684681|NCT05032690|561936539|FG001|Period 1|No longer meets eligibility criteria|1|||
155684682|NCT05032690|561936540|FG002|Period 1|No longer meets eligibility criteria|0|||
155684683|NCT05032690|561936541|FG003|Period 1|No longer meets eligibility criteria|0|||
155684684|NCT05032690|561936538|FG000|Period 2|Adverse Event|1|||
155684685|NCT05032690|561936539|FG001|Period 2|Adverse Event|0|||
155684686|NCT05032690|561936540|FG002|Period 2|Adverse Event|0|||
155684687|NCT05032690|561936541|FG003|Period 2|Adverse Event|0|||
155684688|NCT05032690|561936538|FG000|Period 2|Withdrawal by Subject|0|||
155684689|NCT05032690|561936539|FG001|Period 2|Withdrawal by Subject|1|||
155684690|NCT05032690|561936540|FG002|Period 2|Withdrawal by Subject|0|||
155684691|NCT05032690|561936541|FG003|Period 2|Withdrawal by Subject|0|||
155684692|NCT05032690|561936538|FG000|Period 2|No longer meets eligibility criteria|0|||
155684693|NCT05032690|561936539|FG001|Period 2|No longer meets eligibility criteria|1|||
155684694|NCT05032690|561936540|FG002|Period 2|No longer meets eligibility criteria|0|||
155684695|NCT05032690|561936541|FG003|Period 2|No longer meets eligibility criteria|0|||
155684696|NCT05032690|561936538|FG000|Period 3|Adverse Event|0|||
155684697|NCT05032690|561936539|FG001|Period 3|Adverse Event|1|||
155684698|NCT05032690|561936540|FG002|Period 3|Adverse Event|0|||
155684699|NCT05032690|561936541|FG003|Period 3|Adverse Event|0|||
155684700|NCT00487942|561936542|FG000|Overall Study|Adverse Event|1|||
155684701|NCT00487942|561936543|FG001|Overall Study|Adverse Event|1|||
155684702|NCT00487942|561936544|FG002|Overall Study|Adverse Event|1|||
155684703|NCT00487942|561936545|FG003|Overall Study|Adverse Event|1|||
155684704|NCT00487942|561936542|FG000|Overall Study|Lost to Follow-up|1|||
155684705|NCT00487942|561936543|FG001|Overall Study|Lost to Follow-up|0|||
155684706|NCT00487942|561936544|FG002|Overall Study|Lost to Follow-up|0|||
155684707|NCT00487942|561936545|FG003|Overall Study|Lost to Follow-up|1|||
155684708|NCT00487942|561936542|FG000|Overall Study|Protocol Violation|1|||
155684709|NCT00487942|561936543|FG001|Overall Study|Protocol Violation|1|||
155684710|NCT00487942|561936544|FG002|Overall Study|Protocol Violation|0|||
155684711|NCT00487942|561936545|FG003|Overall Study|Protocol Violation|0|||
155684712|NCT00487942|561936542|FG000|Overall Study|Withdrawal by Subject|0|||
155684713|NCT00487942|561936543|FG001|Overall Study|Withdrawal by Subject|1|||
155684714|NCT00487942|561936544|FG002|Overall Study|Withdrawal by Subject|2|||
155684715|NCT00487942|561936545|FG003|Overall Study|Withdrawal by Subject|0|||
155684716|NCT05151445|561936546|FG000|Overall Study|Withdrawal by Subject|3|||
155684717|NCT02298179|561936550|FG000|Overall Study|Lost to Follow-up|0|||
155684718|NCT02298179|561936551|FG001|Overall Study|Lost to Follow-up|0|||
155684719|NCT02298179|561936552|FG002|Overall Study|Lost to Follow-up|1|||
155684720|NCT02298179|561936553|FG003|Overall Study|Lost to Follow-up|0|||
155684721|NCT02298179|561936554|FG004|Overall Study|Lost to Follow-up|0|||
155684722|NCT02298179|561936555|FG005|Overall Study|Lost to Follow-up|0|||
155684723|NCT02298179|561936556|FG006|Overall Study|Lost to Follow-up|0|||
155684724|NCT02298179|561936557|FG007|Overall Study|Lost to Follow-up|1|||
155684725|NCT02298179|561936558|FG008|Overall Study|Lost to Follow-up|0|||
155684726|NCT02298179|561936559|FG009|Overall Study|Lost to Follow-up|0|||
155684727|NCT02298179|561936560|FG010|Overall Study|Lost to Follow-up|0|||
155684728|NCT02298179|561936561|FG011|Overall Study|Lost to Follow-up|0|||
155684729|NCT01846299|561936564|FG000|Overall Study|Physician Decision|4|||
155684730|NCT01846299|561936565|FG001|Overall Study|Physician Decision|2|||
155684731|NCT01846299|561936564|FG000|Overall Study|Protocol deviation|1|||
155684732|NCT01846299|561936565|FG001|Overall Study|Protocol deviation|0|||
155684733|NCT01846299|561936564|FG000|Overall Study|Death|1|||
155684734|NCT01846299|561936565|FG001|Overall Study|Death|2|||
155684735|NCT01846299|561936564|FG000|Overall Study|Lost to Follow-up|3|||
155684736|NCT01846299|561936565|FG001|Overall Study|Lost to Follow-up|0|||
155684737|NCT01846299|561936564|FG000|Overall Study|Withdrawal by Subject|1|||
155684738|NCT01846299|561936565|FG001|Overall Study|Withdrawal by Subject|6|||
155684739|NCT01846299|561936564|FG000|Overall Study|Adverse Event|2|||
155684740|NCT01846299|561936565|FG001|Overall Study|Adverse Event|0|||
155684741|NCT03559517|561936566|FG000|Overall Study|Withdrawal by Subject|1|||
155684742|NCT03559517|561936567|FG001|Overall Study|Withdrawal by Subject|0|||
155684743|NCT03559517|561936568|FG002|Overall Study|Withdrawal by Subject|0|||
155684744|NCT00082368|561936569|FG000|Overall Study|Not treated-pt had poor IV access|1|||
155684745|NCT01330628|561936570|FG000|Overall Study|Death|2|||
155684746|NCT01330628|561936571|FG001|Overall Study|Death|3|||
155684747|NCT01330628|561936570|FG000|Overall Study|Lost to Follow-up|5|||
155684748|NCT01330628|561936571|FG001|Overall Study|Lost to Follow-up|6|||
155684749|NCT01330628|561936570|FG000|Overall Study|Adverse Event|44|||
155684750|NCT01330628|561936571|FG001|Overall Study|Adverse Event|25|||
155684751|NCT01330628|561936570|FG000|Overall Study|Withdrawn|18|||
155684752|NCT01330628|561936571|FG001|Overall Study|Withdrawn|6|||
155684753|NCT01330628|561936570|FG000|Overall Study|Didn't receive study treatment|1|||
155684754|NCT01330628|561936571|FG001|Overall Study|Didn't receive study treatment|0|||
155684755|NCT00413894|561938210|FG000|Overall Study|Withdrawal by Subject|10|||
155684756|NCT00413894|561938210|FG000|Overall Study|Administrative Reasons|1|||
155684757|NCT00413894|561938210|FG000|Overall Study|Hb <10 grams/deciliter|12|||
155684758|NCT00413894|561938210|FG000|Overall Study|Adverse Event|28|||
155684759|NCT00413894|561938210|FG000|Overall Study|Protocol Violation|11|||
155684760|NCT00413894|561938210|FG000|Overall Study|Other|18|||
155684761|NCT04225676|561938211|FG000|Overall Study|Physician Decision|1|||
155684762|NCT04225676|561938211|FG000|Overall Study|Lack of Efficacy|1|||
155684763|NCT04225676|561938211|FG000|Overall Study|Study terminated by sponsor|3|||
155684764|NCT01942161|561938212|FG000|Overall Study|Adverse Event|1|||
155684765|NCT01942161|561938213|FG001|Overall Study|Adverse Event|2|||
155684766|NCT01942161|561938214|FG002|Overall Study|Adverse Event|5|||
155684767|NCT01942161|561938212|FG000|Overall Study|Physician Decision|3|||
155684768|NCT01942161|561938213|FG001|Overall Study|Physician Decision|1|||
155684769|NCT01942161|561938214|FG002|Overall Study|Physician Decision|0|||
155684770|NCT01942161|561938212|FG000|Overall Study|Protocol Violation|1|||
155684771|NCT01942161|561938213|FG001|Overall Study|Protocol Violation|0|||
155684772|NCT01942161|561938214|FG002|Overall Study|Protocol Violation|0|||
155684773|NCT01942161|561938212|FG000|Overall Study|Withdrawal by Subject|3|||
155684774|NCT01942161|561938213|FG001|Overall Study|Withdrawal by Subject|3|||
155684775|NCT01942161|561938214|FG002|Overall Study|Withdrawal by Subject|1|||
155684776|NCT05289271|561938219|FG000|Overall Study|Mistakenly allocated, untreated|1|||
155684777|NCT05289271|561938220|FG001|Overall Study|Mistakenly allocated, untreated|0|||
155684778|NCT01257568|561938221|FG000|Overall Study|Lost to Follow-up|2|||
155684779|NCT01257568|561938221|FG000|Overall Study|Withdrawal by Subject|6|||
155684780|NCT01257568|561938221|FG000|Overall Study|Terminated|1|||
155684781|NCT01257568|561938221|FG000|Overall Study|Component Revision|24|||
155684782|NCT00132691|561938229|FG000|Overall Study|Lost to Follow-up|5|||
155684783|NCT00132691|561938230|FG001|Overall Study|Lost to Follow-up|8|||
155684784|NCT00132691|561938229|FG000|Overall Study|Missed 2-year visit|4|||
155684785|NCT00132691|561938230|FG001|Overall Study|Missed 2-year visit|4|||
155684786|NCT00132691|561938229|FG000|Overall Study|Death|2|||
155684787|NCT00132691|561938230|FG001|Overall Study|Death|0|||
155684788|NCT03356977|561938231|FG000|Overall Study|Lost to Follow-up|3|||
155684789|NCT03356977|561938231|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155684790|NCT00908115|561938238|FG000|Overall Study|Other|14|||
155684791|NCT01728077|561938239|FG000|Overall Study|Lack of Efficacy|3|||
155684792|NCT01728077|561938240|FG001|Overall Study|Lack of Efficacy|1|||
155684793|NCT01728077|561938239|FG000|Overall Study|Lost to Follow-up|1|||
155684794|NCT01728077|561938240|FG001|Overall Study|Lost to Follow-up|0|||
155684795|NCT01728077|561938239|FG000|Overall Study|Subject choice|2|||
155684796|NCT01728077|561938240|FG001|Overall Study|Subject choice|3|||
155684797|NCT01728077|561938239|FG000|Overall Study|Death|0|||
155684798|NCT01728077|561938240|FG001|Overall Study|Death|1|||
155684799|NCT01728077|561938239|FG000|Overall Study|Patient moving|1|||
155684800|NCT01728077|561938240|FG001|Overall Study|Patient moving|0|||
155684801|NCT01728077|561938239|FG000|Overall Study|Non compliance|1|||
155684802|NCT01728077|561938240|FG001|Overall Study|Non compliance|0|||
155684803|NCT00378599|561938241|FG000|Overall Study|Adverse Event|38|||
155684804|NCT00378599|561938241|FG000|Overall Study|Protocol Violation|2|||
155684805|NCT00378599|561938241|FG000|Overall Study|Treatment failure|7|||
155684806|NCT00378599|561938241|FG000|Overall Study|Withdrawal by Subject|5|||
155684807|NCT00642369|561938242|FG000|Overall Study|Adverse Event|2|||
155684808|NCT00642369|561938243|FG001|Overall Study|Adverse Event|3|||
155684809|NCT00642369|561938242|FG000|Overall Study|Withdrawal by Subject|1|||
155684810|NCT00642369|561938243|FG001|Overall Study|Withdrawal by Subject|0|||
155684811|NCT00642369|561938242|FG000|Overall Study|misdiagnosis|0|||
155684812|NCT00642369|561938243|FG001|Overall Study|misdiagnosis|1|||
155684813|NCT00642369|561938242|FG000|Overall Study|Lack of Efficacy|2|||
155684814|NCT00642369|561938243|FG001|Overall Study|Lack of Efficacy|2|||
155684815|NCT04035564|561938244|FG000|Overall Study|Protocol Violation|1|||
155684816|NCT04035564|561938245|FG001|Overall Study|Protocol Violation|2|||
155684817|NCT04035564|561938244|FG000|Overall Study|No laboratory available|2|||
155684818|NCT04035564|561938245|FG001|Overall Study|No laboratory available|2|||
155684819|NCT04035564|561938244|FG000|Overall Study|Guardian declined consent|1|||
155684820|NCT04035564|561938245|FG001|Overall Study|Guardian declined consent|2|||
155684821|NCT00624585|561938250|FG000|Overall Study|Death|3|||
155684822|NCT00624585|561938250|FG000|Overall Study|Disease Progression|6|||
155684823|NCT00624585|561938250|FG000|Overall Study|Adverse Event|3|||
155684824|NCT04154345|561938255|FG000|Overall Study|Covid-19 pandemic|4|||
155684825|NCT00676520|561938257|FG000|Overall Study|Withdrawal by Subject|163|||
155684826|NCT00676520|561938257|FG000|Overall Study|Lost to Follow-up|162|||
155684827|NCT00676520|561938257|FG000|Overall Study|Death|159|||
155684828|NCT00676520|561938257|FG000|Overall Study|Physician Decision|20|||
155684829|NCT00676520|561938257|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
155684830|NCT00676520|561938257|FG000|Overall Study|Other Reason|18|||
155684831|NCT01425359|561938258|FG000|Overall Study|Randomized but Not Treated|2|||
155684832|NCT01425359|561938259|FG001|Overall Study|Randomized but Not Treated|3|||
155684833|NCT01425359|561938258|FG000|Overall Study|Adverse Event|9|||
155684834|NCT01425359|561938259|FG001|Overall Study|Adverse Event|8|||
155684835|NCT01425359|561938258|FG000|Overall Study|Revascularization|0|||
155684836|NCT01425359|561938259|FG001|Overall Study|Revascularization|1|||
155684837|NCT01425359|561938258|FG000|Overall Study|Death|0|||
155684838|NCT01425359|561938259|FG001|Overall Study|Death|1|||
155684839|NCT01425359|561938258|FG000|Overall Study|Unsatisfactory Response|1|||
155684840|NCT01425359|561938259|FG001|Overall Study|Unsatisfactory Response|0|||
155684841|NCT01425359|561938258|FG000|Overall Study|Protocol Violation|1|||
155684842|NCT01425359|561938259|FG001|Overall Study|Protocol Violation|2|||
155684843|NCT01425359|561938258|FG000|Overall Study|Subject Withdrew Consent|1|||
155684844|NCT01425359|561938259|FG001|Overall Study|Subject Withdrew Consent|2|||
155684845|NCT01425359|561938258|FG000|Overall Study|Investigator's Discretion|2|||
155684846|NCT01425359|561938259|FG001|Overall Study|Investigator's Discretion|0|||
155684847|NCT01425359|561938258|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
155684848|NCT01425359|561938259|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
155684849|NCT04043234|561938264|FG000|Overall Study|Lost to Follow-up|1|||
155684850|NCT04043234|561938264|FG000|Overall Study|Withdrawal by Subject|1|||
155684851|NCT01165320|561938265|FG000|Overall Study|Clinical adverse experience|2|||
155684852|NCT01165320|561938266|FG001|Overall Study|Clinical adverse experience|1|||
155684853|NCT01165320|561938267|FG002|Overall Study|Clinical adverse experience|0|||
155684854|NCT01165320|561938265|FG000|Overall Study|Laboratory adverse experience|1|||
155684855|NCT01165320|561938266|FG001|Overall Study|Laboratory adverse experience|0|||
155684856|NCT01165320|561938267|FG002|Overall Study|Laboratory adverse experience|0|||
155684857|NCT01165320|561938265|FG000|Overall Study|Lack of Efficacy|0|||
155684858|NCT01165320|561938266|FG001|Overall Study|Lack of Efficacy|2|||
155684859|NCT01165320|561938267|FG002|Overall Study|Lack of Efficacy|0|||
155684860|NCT01165320|561938265|FG000|Overall Study|Reason unknown|0|||
155684861|NCT01165320|561938266|FG001|Overall Study|Reason unknown|1|||
155684862|NCT01165320|561938267|FG002|Overall Study|Reason unknown|0|||
155684863|NCT00385944|561938269|FG000|1st Maintenance Dose Period|Physician Decision|1|||
155684864|NCT00385944|561938270|FG001|1st Maintenance Dose Period|Physician Decision|0|||
155684865|NCT00385944|561938271|FG002|1st Maintenance Dose Period|Physician Decision|0|||
155684866|NCT00385944|561938269|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
155684867|NCT00385944|561938270|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
155684868|NCT00385944|561938271|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
155684869|NCT00385944|561938269|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
155684870|NCT00385944|561938270|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
155684871|NCT00385944|561938271|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
155684872|NCT00385944|561938269|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
155684873|NCT00385944|561938270|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
155684874|NCT00385944|561938271|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
155684875|NCT00590824|561938272|FG000|Overall Study|Disease could not be resected|0|||
155684876|NCT00590824|561938273|FG001|Overall Study|Disease could not be resected|2|||
155684877|NCT00590824|561938274|FG002|Overall Study|Disease could not be resected|1|||
155684878|NCT00590824|561938275|FG003|Overall Study|Disease could not be resected|0|||
155684879|NCT00590824|561938272|FG000|Overall Study|Adverse Event|0|||
155684880|NCT00590824|561938273|FG001|Overall Study|Adverse Event|0|||
155684881|NCT00590824|561938274|FG002|Overall Study|Adverse Event|0|||
155684882|NCT00590824|561938275|FG003|Overall Study|Adverse Event|1|||
155684883|NCT01778049|561938277|FG000|Open Label Treatment Period|Adverse Event|5|||
155684884|NCT01778049|561938278|FG001|Open Label Treatment Period|Adverse Event|15|||
155684885|NCT01778049|561938279|FG002|Open Label Treatment Period|Adverse Event|0|||
155684886|NCT01778049|561938280|FG003|Open Label Treatment Period|Adverse Event|0|||
155684887|NCT01778049|561938281|FG004|Open Label Treatment Period|Adverse Event|0|||
155684888|NCT01778049|561938282|FG005|Open Label Treatment Period|Adverse Event|0|||
155684889|NCT01778049|561938277|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
155684890|NCT01778049|561938278|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
155684891|NCT01778049|561938279|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
155684892|NCT01778049|561938280|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
155684893|NCT01778049|561938281|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
155684894|NCT01778049|561938282|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
155684895|NCT01778049|561938277|FG000|Open Label Treatment Period|Protocol Violation|5|||
155684896|NCT01778049|561938278|FG001|Open Label Treatment Period|Protocol Violation|5|||
155684897|NCT01778049|561938279|FG002|Open Label Treatment Period|Protocol Violation|0|||
155684898|NCT01778049|561938280|FG003|Open Label Treatment Period|Protocol Violation|0|||
155684899|NCT01778049|561938281|FG004|Open Label Treatment Period|Protocol Violation|0|||
155684900|NCT01778049|561938282|FG005|Open Label Treatment Period|Protocol Violation|0|||
155684901|NCT01778049|561938277|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
155684902|NCT01778049|561938278|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
155684903|NCT01778049|561938279|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
155684904|NCT01778049|561938280|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
155684905|NCT01778049|561938281|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
155684906|NCT01778049|561938282|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
155684907|NCT01778049|561938277|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
155684908|NCT01778049|561938278|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
155684909|NCT01778049|561938279|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
155684910|NCT01778049|561938280|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
155684911|NCT01778049|561938281|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
155684912|NCT01778049|561938282|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
155684913|NCT01778049|561938277|FG000|Open Label Treatment Period|Not treated|2|||
155684914|NCT01778049|561938278|FG001|Open Label Treatment Period|Not treated|1|||
155684915|NCT01778049|561938279|FG002|Open Label Treatment Period|Not treated|0|||
155684916|NCT01778049|561938280|FG003|Open Label Treatment Period|Not treated|0|||
155684917|NCT01778049|561938281|FG004|Open Label Treatment Period|Not treated|0|||
155684918|NCT01778049|561938282|FG005|Open Label Treatment Period|Not treated|0|||
155684919|NCT01778049|561938277|FG000|Open Label Treatment Period|Other reason not defined above|77|||
155684920|NCT01778049|561938278|FG001|Open Label Treatment Period|Other reason not defined above|94|||
155684921|NCT01778049|561938279|FG002|Open Label Treatment Period|Other reason not defined above|0|||
155684922|NCT01778049|561938280|FG003|Open Label Treatment Period|Other reason not defined above|0|||
155684923|NCT01778049|561938281|FG004|Open Label Treatment Period|Other reason not defined above|0|||
155684924|NCT01778049|561938282|FG005|Open Label Treatment Period|Other reason not defined above|0|||
155684925|NCT01778049|561938277|FG000|Double Blind Treatment Period|Adverse Event|0|||
155684926|NCT01778049|561938278|FG001|Double Blind Treatment Period|Adverse Event|0|||
155684927|NCT01778049|561938279|FG002|Double Blind Treatment Period|Adverse Event|4|||
155684928|NCT01778049|561938280|FG003|Double Blind Treatment Period|Adverse Event|5|||
155684929|NCT01778049|561938281|FG004|Double Blind Treatment Period|Adverse Event|3|||
155684930|NCT01778049|561938282|FG005|Double Blind Treatment Period|Adverse Event|2|||
155684931|NCT01778049|561938277|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
155684932|NCT01778049|561938278|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155684933|NCT01778049|561938279|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155684934|NCT01778049|561938280|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155684935|NCT01778049|561938281|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
155684936|NCT01778049|561938282|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
155684937|NCT01778049|561938277|FG000|Double Blind Treatment Period|Protocol Violation|0|||
155684938|NCT01778049|561938278|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155684939|NCT01778049|561938279|FG002|Double Blind Treatment Period|Protocol Violation|2|||
155684940|NCT01778049|561938280|FG003|Double Blind Treatment Period|Protocol Violation|0|||
155684941|NCT01778049|561938281|FG004|Double Blind Treatment Period|Protocol Violation|0|||
155684942|NCT01778049|561938282|FG005|Double Blind Treatment Period|Protocol Violation|0|||
155684943|NCT01778049|561938277|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155684944|NCT01778049|561938278|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155684945|NCT01778049|561938279|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
155604094|NCT04908475|561639681|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155604095|NCT04908475|561639682|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155604096|NCT04908475|561639677|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155604097|NCT04908475|561639678|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
155604098|NCT04908475|561639679|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
155604099|NCT04908475|561639680|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
155604100|NCT04908475|561639681|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155604101|NCT04908475|561639682|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155604102|NCT04908475|561639677|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
155604103|NCT04908475|561639678|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
155604104|NCT04908475|561639679|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
155604105|NCT04908475|561639680|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
155604106|NCT04908475|561639681|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
155604107|NCT04908475|561639682|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
155604108|NCT04908475|561639677|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
155604109|NCT04908475|561639678|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
155604110|NCT04908475|561639679|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
155604111|NCT04908475|561639680|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
155604112|NCT04908475|561639681|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
155604113|NCT04908475|561639682|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
155604114|NCT01739764|561639683|FG000|Overall Study|Adverse Event|0|||
155604115|NCT01739764|561639684|FG001|Overall Study|Adverse Event|3|||
155604116|NCT01739764|561639685|FG002|Overall Study|Adverse Event|4|||
155604117|NCT01739764|561639683|FG000|Overall Study|Death|4|||
155604118|NCT01739764|561639684|FG001|Overall Study|Death|6|||
155604119|NCT01739764|561639685|FG002|Overall Study|Death|38|||
155604120|NCT01739764|561639683|FG000|Overall Study|Lost to Follow-up|0|||
155604121|NCT01739764|561639684|FG001|Overall Study|Lost to Follow-up|0|||
155604122|NCT01739764|561639685|FG002|Overall Study|Lost to Follow-up|5|||
155604123|NCT01739764|561639683|FG000|Overall Study|Non-Compliance|0|||
155604124|NCT01739764|561639684|FG001|Overall Study|Non-Compliance|0|||
155604125|NCT01739764|561639685|FG002|Overall Study|Non-Compliance|1|||
155604126|NCT01739764|561639683|FG000|Overall Study|Multiple Reasons|3|||
155604127|NCT01739764|561639684|FG001|Overall Study|Multiple Reasons|2|||
155604128|NCT01739764|561639685|FG002|Overall Study|Multiple Reasons|3|||
155604129|NCT01739764|561639683|FG000|Overall Study|Physician Decision|2|||
155604130|NCT01739764|561639684|FG001|Overall Study|Physician Decision|2|||
155604131|NCT01739764|561639685|FG002|Overall Study|Physician Decision|4|||
155604132|NCT01739764|561639683|FG000|Overall Study|Progressive Disease|3|||
155604133|NCT01739764|561639684|FG001|Overall Study|Progressive Disease|5|||
155604134|NCT01739764|561639685|FG002|Overall Study|Progressive Disease|16|||
155604135|NCT01739764|561639683|FG000|Overall Study|Protocol Violation|0|||
155604136|NCT01739764|561639684|FG001|Overall Study|Protocol Violation|0|||
155604137|NCT01739764|561639685|FG002|Overall Study|Protocol Violation|2|||
155604138|NCT01739764|561639683|FG000|Overall Study|Study Terminated by Sponsor|8|||
155604139|NCT01739764|561639684|FG001|Overall Study|Study Terminated by Sponsor|13|||
155604140|NCT01739764|561639685|FG002|Overall Study|Study Terminated by Sponsor|26|||
155604141|NCT01739764|561639683|FG000|Overall Study|Withdrawal by Subject|6|||
155604142|NCT01739764|561639684|FG001|Overall Study|Withdrawal by Subject|5|||
155604143|NCT01739764|561639685|FG002|Overall Study|Withdrawal by Subject|27|||
155604144|NCT00404924|561639686|FG000|Overall Study|Adverse Event|75|||
155604145|NCT00404924|561639687|FG001|Overall Study|Adverse Event|16|||
155604146|NCT00404924|561639686|FG000|Overall Study|Condition under investigation worsened|475|||
155604147|NCT00404924|561639687|FG001|Overall Study|Condition under investigation worsened|264|||
155604148|NCT00404924|561639686|FG000|Overall Study|Lost to Follow-up|1|||
155604149|NCT00404924|561639687|FG001|Overall Study|Lost to Follow-up|1|||
155604150|NCT00404924|561639686|FG000|Overall Study|Withdrawal by Subject|26|||
155604151|NCT00404924|561639687|FG001|Overall Study|Withdrawal by Subject|13|||
155604152|NCT00404924|561639686|FG000|Overall Study|Other|25|||
155604153|NCT00404924|561639687|FG001|Overall Study|Other|11|||
155604154|NCT00404924|561639686|FG000|Overall Study|Randomised but not received treatment|1|||
155604155|NCT00404924|561639687|FG001|Overall Study|Randomised but not received treatment|1|||
155604156|NCT00926536|561639692|FG000|Overall Study|Physician Decision|1|||
155604157|NCT00926536|561639693|FG001|Overall Study|Physician Decision|2|||
155604158|NCT01267201|561639694|FG000|First Intervention Period|Withdrawal by Subject|1|||
155604159|NCT01267201|561639695|FG001|First Intervention Period|Withdrawal by Subject|0|||
155604160|NCT01267201|561639696|FG002|First Intervention Period|Withdrawal by Subject|0|||
155604161|NCT01267201|561639697|FG003|First Intervention Period|Withdrawal by Subject|0|||
155604162|NCT01267201|561639698|FG004|First Intervention Period|Withdrawal by Subject|0|||
155604163|NCT01267201|561639699|FG005|First Intervention Period|Withdrawal by Subject|0|||
155604164|NCT01267201|561639694|FG000|Second Intervention Period|Withdrawal by Subject|0|||
155604165|NCT01267201|561639695|FG001|Second Intervention Period|Withdrawal by Subject|1|||
155604166|NCT01267201|561639696|FG002|Second Intervention Period|Withdrawal by Subject|0|||
155604167|NCT01267201|561639697|FG003|Second Intervention Period|Withdrawal by Subject|0|||
155604168|NCT01267201|561639698|FG004|Second Intervention Period|Withdrawal by Subject|0|||
155604169|NCT01267201|561639699|FG005|Second Intervention Period|Withdrawal by Subject|0|||
155604170|NCT00483704|561639700|FG000|Randomization|Withdrawal by Subject|19|||
155604171|NCT00483704|561639701|FG001|Randomization|Withdrawal by Subject|28|||
155604172|NCT00483704|561639702|FG002|Randomization|Withdrawal by Subject|18|||
155604173|NCT00483704|561639700|FG000|Randomization|Protocol Violation|14|||
155604174|NCT00483704|561639701|FG001|Randomization|Protocol Violation|25|||
155604175|NCT00483704|561639702|FG002|Randomization|Protocol Violation|22|||
155604176|NCT00483704|561639700|FG000|Randomization|Lost to Follow-up|14|||
155604177|NCT00483704|561639701|FG001|Randomization|Lost to Follow-up|14|||
155604178|NCT00483704|561639702|FG002|Randomization|Lost to Follow-up|19|||
155604179|NCT00483704|561639700|FG000|Randomization|Pregnancy|1|||
155604180|NCT00483704|561639701|FG001|Randomization|Pregnancy|0|||
155604181|NCT00483704|561639702|FG002|Randomization|Pregnancy|0|||
155604182|NCT00483704|561639700|FG000|Randomization|Physician Decision|2|||
155604183|NCT00483704|561639701|FG001|Randomization|Physician Decision|4|||
155604184|NCT00483704|561639702|FG002|Randomization|Physician Decision|0|||
155604185|NCT00483704|561639700|FG000|Randomization|Progressive disease|0|||
155604186|NCT00483704|561639701|FG001|Randomization|Progressive disease|0|||
155604187|NCT00483704|561639702|FG002|Randomization|Progressive disease|1|||
155604188|NCT00483704|561639700|FG000|Randomization|Lack of qualifying migraines|21|||
155604189|NCT00483704|561639701|FG001|Randomization|Lack of qualifying migraines|25|||
155604190|NCT00483704|561639702|FG002|Randomization|Lack of qualifying migraines|31|||
155604191|NCT00483704|561639700|FG000|Treatment|Lack of qualifying migraines|101|||
155604192|NCT00483704|561639701|FG001|Treatment|Lack of qualifying migraines|99|||
155604193|NCT00483704|561639702|FG002|Treatment|Lack of qualifying migraines|116|||
155604194|NCT00483704|561639700|FG000|Treatment|Adverse Event|3|||
155604195|NCT00483704|561639701|FG001|Treatment|Adverse Event|5|||
155604196|NCT00483704|561639702|FG002|Treatment|Adverse Event|4|||
155604197|NCT00483704|561639700|FG000|Treatment|Withdrawal by Subject|16|||
155604198|NCT00483704|561639701|FG001|Treatment|Withdrawal by Subject|12|||
155604199|NCT00483704|561639702|FG002|Treatment|Withdrawal by Subject|21|||
155604200|NCT00483704|561639700|FG000|Treatment|Protocol Violation|6|||
155604201|NCT00483704|561639701|FG001|Treatment|Protocol Violation|3|||
155604202|NCT00483704|561639702|FG002|Treatment|Protocol Violation|5|||
155604203|NCT00483704|561639700|FG000|Treatment|Lost to Follow-up|2|||
155604204|NCT00483704|561639701|FG001|Treatment|Lost to Follow-up|7|||
155604205|NCT00483704|561639702|FG002|Treatment|Lost to Follow-up|5|||
155604206|NCT00483704|561639700|FG000|Treatment|Lack of Efficacy|1|||
155604207|NCT00483704|561639701|FG001|Treatment|Lack of Efficacy|1|||
155604208|NCT00483704|561639702|FG002|Treatment|Lack of Efficacy|1|||
155604209|NCT00483704|561639700|FG000|Treatment|Pregnancy|0|||
155604210|NCT00483704|561639701|FG001|Treatment|Pregnancy|1|||
155604211|NCT00483704|561639702|FG002|Treatment|Pregnancy|0|||
155604212|NCT00483704|561639700|FG000|Treatment|Physician Decision|0|||
155604213|NCT00483704|561639701|FG001|Treatment|Physician Decision|1|||
155604214|NCT00483704|561639702|FG002|Treatment|Physician Decision|4|||
155604215|NCT00819780|561639703|FG000|Overall Study|Did not receive study drug|3|||
155604216|NCT00819780|561639704|FG001|Overall Study|Did not receive study drug|4|||
155684946|NCT01778049|561938280|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
155604217|NCT00819780|561639703|FG000|Overall Study|Still in treatment|25|||
155604218|NCT00819780|561639704|FG001|Overall Study|Still in treatment|17|||
155604219|NCT03912428|561639705|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155604220|NCT03912428|561639706|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
155684947|NCT01778049|561938281|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
155604221|NCT03912428|561639707|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155604222|NCT03912428|561639708|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155604223|NCT03912428|561639705|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
155604224|NCT03912428|561639706|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
155604225|NCT03912428|561639707|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
155604226|NCT03912428|561639708|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
155604227|NCT03912428|561639705|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155604228|NCT03912428|561639706|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155604229|NCT03912428|561639707|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155604230|NCT03912428|561639708|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
155604231|NCT02637713|561639710|FG000|Overall Study|Screen Failure|2|||
155604232|NCT02847182|561639711|FG000|Overall Study|Withdrawal by Subject|0|||
155604233|NCT02847182|561639712|FG001|Overall Study|Withdrawal by Subject|1|||
155604234|NCT02345889|561639713|FG000|Overall Study|Inadequate Bowel Prep|17|||
155604235|NCT02345889|561639714|FG001|Overall Study|Inadequate Bowel Prep|16|||
155604236|NCT02345889|561639715|FG002|Overall Study|Inadequate Bowel Prep|18|||
155604237|NCT02345889|561639716|FG003|Overall Study|Inadequate Bowel Prep|14|||
155604238|NCT02345889|561639713|FG000|Overall Study|Polyposis identified during procedure|1|||
155604239|NCT02345889|561639714|FG001|Overall Study|Polyposis identified during procedure|1|||
155604240|NCT02345889|561639715|FG002|Overall Study|Polyposis identified during procedure|0|||
155604241|NCT02345889|561639716|FG003|Overall Study|Polyposis identified during procedure|1|||
155604242|NCT02345889|561639713|FG000|Overall Study|Recognized ineligible post-randomization|1|||
155604243|NCT02345889|561639714|FG001|Overall Study|Recognized ineligible post-randomization|0|||
155604244|NCT02345889|561639715|FG002|Overall Study|Recognized ineligible post-randomization|2|||
155604245|NCT02345889|561639716|FG003|Overall Study|Recognized ineligible post-randomization|1|||
155604246|NCT02345889|561639713|FG000|Overall Study|Ulcerative Colitis identified|1|||
155604247|NCT02345889|561639714|FG001|Overall Study|Ulcerative Colitis identified|0|||
155604248|NCT02345889|561639715|FG002|Overall Study|Ulcerative Colitis identified|0|||
155604249|NCT02345889|561639716|FG003|Overall Study|Ulcerative Colitis identified|0|||
155604250|NCT02345889|561639713|FG000|Overall Study|Cecum not intubated|1|||
155604251|NCT02345889|561639714|FG001|Overall Study|Cecum not intubated|0|||
155604252|NCT02345889|561639715|FG002|Overall Study|Cecum not intubated|0|||
155604253|NCT02345889|561639716|FG003|Overall Study|Cecum not intubated|0|||
155604254|NCT04325698|561639717|FG000|Overall Study|Study Terminated By Sponsor|1|||
155604255|NCT04325698|561639718|FG001|Overall Study|Study Terminated By Sponsor|1|||
155604256|NCT04325698|561639717|FG000|Overall Study|Withdrawal by Subject|0|||
155604257|NCT04325698|561639718|FG001|Overall Study|Withdrawal by Subject|2|||
155604258|NCT00962091|561639719|FG000|Overall Study|Withdrawal by Subject|1|||
155604259|NCT00962091|561639720|FG001|Overall Study|Withdrawal by Subject|2|||
155604260|NCT00962091|561639721|FG002|Overall Study|Withdrawal by Subject|1|||
155604261|NCT00962091|561639722|FG003|Overall Study|Withdrawal by Subject|1|||
155604262|NCT00962091|561639723|FG004|Overall Study|Withdrawal by Subject|0|||
155604263|NCT00962091|561639724|FG005|Overall Study|Withdrawal by Subject|1|||
155604264|NCT00962091|561639725|FG006|Overall Study|Withdrawal by Subject|0|||
155604265|NCT00962091|561639719|FG000|Overall Study|Adverse Event|0|||
155604266|NCT00962091|561639720|FG001|Overall Study|Adverse Event|0|||
155604267|NCT00962091|561639721|FG002|Overall Study|Adverse Event|0|||
155604268|NCT00962091|561639722|FG003|Overall Study|Adverse Event|0|||
155604269|NCT00962091|561639723|FG004|Overall Study|Adverse Event|0|||
155604270|NCT00962091|561639724|FG005|Overall Study|Adverse Event|0|||
155604271|NCT00962091|561639725|FG006|Overall Study|Adverse Event|1|||
155604272|NCT02044874|561639731|FG000|Overall Study|Adverse Event|5|||
155604273|NCT02044874|561639732|FG001|Overall Study|Adverse Event|6|||
155604274|NCT02044874|561639733|FG002|Overall Study|Adverse Event|6|||
155604275|NCT02044874|561639731|FG000|Overall Study|Withdrawal by Subject|8|||
155604276|NCT02044874|561639732|FG001|Overall Study|Withdrawal by Subject|16|||
155604277|NCT02044874|561639733|FG002|Overall Study|Withdrawal by Subject|23|||
155604278|NCT02044874|561639731|FG000|Overall Study|Physician Decision|0|||
155604279|NCT02044874|561639732|FG001|Overall Study|Physician Decision|2|||
155604280|NCT02044874|561639733|FG002|Overall Study|Physician Decision|1|||
155604281|NCT02044874|561639731|FG000|Overall Study|Lost to Follow-up|10|||
155604282|NCT02044874|561639732|FG001|Overall Study|Lost to Follow-up|27|||
155604283|NCT02044874|561639733|FG002|Overall Study|Lost to Follow-up|21|||
155604284|NCT02044874|561639731|FG000|Overall Study|Sponsor Decision|0|||
155604285|NCT02044874|561639732|FG001|Overall Study|Sponsor Decision|1|||
155604286|NCT02044874|561639733|FG002|Overall Study|Sponsor Decision|1|||
155604287|NCT02044874|561639731|FG000|Overall Study|Other|7|||
155604288|NCT02044874|561639732|FG001|Overall Study|Other|3|||
155604289|NCT02044874|561639733|FG002|Overall Study|Other|8|||
155604290|NCT02889835|561639734|FG000|Overall Study|Lost to Follow-up|13|||
155604291|NCT02889835|561639735|FG001|Overall Study|Lost to Follow-up|13|||
155604292|NCT02889835|561639736|FG002|Overall Study|Lost to Follow-up|13|||
155604293|NCT02889835|561639734|FG000|Overall Study|Withdrawal by Subject|2|||
155604294|NCT02889835|561639735|FG001|Overall Study|Withdrawal by Subject|2|||
155604295|NCT02889835|561639736|FG002|Overall Study|Withdrawal by Subject|2|||
155604296|NCT02889835|561639734|FG000|Overall Study|Protocol Violation|1|||
155604297|NCT02889835|561639735|FG001|Overall Study|Protocol Violation|1|||
155604298|NCT02889835|561639736|FG002|Overall Study|Protocol Violation|1|||
155604299|NCT02889835|561639734|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
155604300|NCT02889835|561639735|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
155604301|NCT02889835|561639736|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
155604302|NCT02889835|561639734|FG000|Overall Study|Death|1|||
155604303|NCT02889835|561639735|FG001|Overall Study|Death|1|||
155604304|NCT02889835|561639736|FG002|Overall Study|Death|1|||
155604305|NCT05072964|561639737|FG000|Overall Study|Withdrawal by Subject|4|||
155604306|NCT05072964|561639737|FG000|Overall Study|Death|1|||
155604307|NCT02342548|561639738|FG000|Overall Study|Adverse Event|12|||
155604308|NCT02342548|561639739|FG001|Overall Study|Adverse Event|17|||
155604309|NCT02342548|561639740|FG002|Overall Study|Adverse Event|13|||
155604310|NCT02342548|561639738|FG000|Overall Study|Lost to Follow-up|0|||
155604311|NCT02342548|561639739|FG001|Overall Study|Lost to Follow-up|1|||
155604312|NCT02342548|561639740|FG002|Overall Study|Lost to Follow-up|0|||
155604313|NCT02342548|561639738|FG000|Overall Study|Study terminated by sponsor|20|||
155604314|NCT02342548|561639739|FG001|Overall Study|Study terminated by sponsor|39|||
155604315|NCT02342548|561639740|FG002|Overall Study|Study terminated by sponsor|25|||
155604316|NCT02342548|561639738|FG000|Overall Study|Protocol Violation|0|||
155604317|NCT02342548|561639739|FG001|Overall Study|Protocol Violation|1|||
155604318|NCT02342548|561639740|FG002|Overall Study|Protocol Violation|0|||
155604319|NCT02342548|561639738|FG000|Overall Study|Withdrawal by Subject|1|||
155604320|NCT02342548|561639739|FG001|Overall Study|Withdrawal by Subject|3|||
155604321|NCT02342548|561639740|FG002|Overall Study|Withdrawal by Subject|4|||
155604322|NCT02342548|561639738|FG000|Overall Study|Other|1|||
155604323|NCT02342548|561639739|FG001|Overall Study|Other|1|||
155604324|NCT02342548|561639740|FG002|Overall Study|Other|1|||
155604325|NCT02987972|561639741|FG000|Overall Study|Adverse Event|1|||
155604326|NCT02987972|561639742|FG001|Overall Study|Adverse Event|1|||
155604327|NCT02987972|561639743|FG002|Overall Study|Adverse Event|0|||
155604328|NCT02987972|561639741|FG000|Overall Study|Death|1|||
155604329|NCT02987972|561639742|FG001|Overall Study|Death|0|||
155604330|NCT02987972|561639743|FG002|Overall Study|Death|0|||
155604331|NCT02987972|561639741|FG000|Overall Study|Lack of Efficacy|9|||
155604332|NCT02987972|561639742|FG001|Overall Study|Lack of Efficacy|12|||
155604333|NCT02987972|561639743|FG002|Overall Study|Lack of Efficacy|12|||
155604334|NCT02987972|561639741|FG000|Overall Study|Lost to Follow-up|7|||
155604335|NCT02987972|561639742|FG001|Overall Study|Lost to Follow-up|8|||
155604336|NCT02987972|561639743|FG002|Overall Study|Lost to Follow-up|4|||
155604337|NCT02987972|561639741|FG000|Overall Study|Physician Decision|1|||
155604338|NCT02987972|561639742|FG001|Overall Study|Physician Decision|6|||
155604339|NCT02987972|561639743|FG002|Overall Study|Physician Decision|0|||
155604340|NCT02987972|561639741|FG000|Overall Study|Protocol Violation|2|||
155604341|NCT02987972|561639742|FG001|Overall Study|Protocol Violation|1|||
155604342|NCT02987972|561639743|FG002|Overall Study|Protocol Violation|5|||
155604343|NCT02987972|561639741|FG000|Overall Study|Withdrawal by Subject|22|||
155604344|NCT02987972|561639742|FG001|Overall Study|Withdrawal by Subject|17|||
155604345|NCT02987972|561639743|FG002|Overall Study|Withdrawal by Subject|21|||
155604346|NCT01047332|561639746|FG000|Overall Study|SEMS Obstruction|11|||
155604347|NCT01047332|561639747|FG001|Overall Study|SEMS Obstruction|20|||
155604348|NCT01047332|561639746|FG000|Overall Study|Died Unobstructed|38|||
155604349|NCT01047332|561639747|FG001|Overall Study|Died Unobstructed|41|||
155604350|NCT01047332|561639746|FG000|Overall Study|Lost to Follow-up|8|||
155604351|NCT01047332|561639747|FG001|Overall Study|Lost to Follow-up|3|||
155604352|NCT00787917|561639753|FG000|Blinded Treatment|Adverse Event|1|||
155604353|NCT00787917|561639754|FG001|Blinded Treatment|Adverse Event|0|||
155604354|NCT00787917|561639753|FG000|Blinded Treatment|Lack of Efficacy|1|||
155604355|NCT00787917|561639754|FG001|Blinded Treatment|Lack of Efficacy|0|||
155604356|NCT00787917|561639753|FG000|Blinded Treatment|Administrative problems|3|||
155604357|NCT00787917|561639754|FG001|Blinded Treatment|Administrative problems|2|||
155604358|NCT00787917|561639753|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
155604359|NCT00787917|561639754|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
155604360|NCT00787917|561639753|FG000|Open Label|Administrative problems|3|||
155604361|NCT00787917|561639754|FG001|Open Label|Administrative problems|0|||
155604362|NCT03521817|561639755|FG000|Overall Study|Protocol Violation|0|||
155604363|NCT03521817|561639756|FG001|Overall Study|Protocol Violation|1|||
155604364|NCT02172040|561639759|FG000|Overall Study|Adverse Event|0|||
155604365|NCT02172040|561639760|FG001|Overall Study|Adverse Event|2|||
155604366|NCT02172040|561639761|FG002|Overall Study|Adverse Event|0|||
155604367|NCT02172040|561639762|FG003|Overall Study|Adverse Event|0|||
155604368|NCT02172040|561639759|FG000|Overall Study|Protocol Violation|0|||
155604369|NCT02172040|561639760|FG001|Overall Study|Protocol Violation|1|||
155604370|NCT02172040|561639761|FG002|Overall Study|Protocol Violation|0|||
155604371|NCT02172040|561639762|FG003|Overall Study|Protocol Violation|0|||
155604372|NCT02172040|561639759|FG000|Overall Study|Withdrawal by Subject|0|||
155604373|NCT02172040|561639760|FG001|Overall Study|Withdrawal by Subject|0|||
155604374|NCT02172040|561639761|FG002|Overall Study|Withdrawal by Subject|1|||
155604375|NCT02172040|561639762|FG003|Overall Study|Withdrawal by Subject|0|||
155604376|NCT02172040|561639759|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
155604377|NCT02172040|561639760|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
155604378|NCT02172040|561639761|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
155604379|NCT02172040|561639762|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
155604380|NCT02172040|561639759|FG000|Overall Study|Family emergency abroad|0|||
155604381|NCT02172040|561639760|FG001|Overall Study|Family emergency abroad|0|||
155604382|NCT02172040|561639761|FG002|Overall Study|Family emergency abroad|0|||
155604383|NCT02172040|561639762|FG003|Overall Study|Family emergency abroad|1|||
155604384|NCT00778102|561639767|FG000|Overall Study|Adverse Event|8|||
155604385|NCT00778102|561639768|FG001|Overall Study|Adverse Event|5|||
155604386|NCT00778102|561639767|FG000|Overall Study|Death|1|||
155604387|NCT00778102|561639768|FG001|Overall Study|Death|1|||
155604388|NCT00778102|561639767|FG000|Overall Study|Lost to Follow-up|1|||
155604389|NCT00778102|561639768|FG001|Overall Study|Lost to Follow-up|0|||
155604390|NCT00778102|561639767|FG000|Overall Study|Violation of Selection Criteria|1|||
155604391|NCT00778102|561639768|FG001|Overall Study|Violation of Selection Criteria|1|||
155604392|NCT00778102|561639767|FG000|Overall Study|Protocol Violation|0|||
155604393|NCT00778102|561639768|FG001|Overall Study|Protocol Violation|1|||
155604394|NCT00778102|561639767|FG000|Overall Study|Refused Treatment|2|||
155604395|NCT00778102|561639768|FG001|Overall Study|Refused Treatment|3|||
155604396|NCT00778102|561639767|FG000|Overall Study|Withdrawal by Subject|1|||
155604397|NCT00778102|561639768|FG001|Overall Study|Withdrawal by Subject|1|||
155604398|NCT00778102|561639767|FG000|Overall Study|Administrative Reason|7|||
155604399|NCT00778102|561639768|FG001|Overall Study|Administrative Reason|10|||
155604400|NCT01328548|561639769|FG000|Overall Study|Death|3|||
155604401|NCT01328548|561639770|FG001|Overall Study|Death|0|||
155604402|NCT01328548|561639769|FG000|Overall Study|Protocol Violation|1|||
155604403|NCT01328548|561639770|FG001|Overall Study|Protocol Violation|0|||
155604404|NCT02824562|561641268|FG000|Overall Study|Lost to Follow-up|3|||
155604405|NCT02824562|561641269|FG001|Overall Study|Lost to Follow-up|4|||
155604406|NCT02824562|561641268|FG000|Overall Study|Death|0|||
155604407|NCT02824562|561641269|FG001|Overall Study|Death|1|||
155604408|NCT03334422|561641270|FG000|Overall Study|Adverse Event|1|||
155604409|NCT03334422|561641271|FG001|Overall Study|Adverse Event|3|||
155604410|NCT03334422|561641272|FG002|Overall Study|Adverse Event|2|||
155604411|NCT03334422|561641273|FG003|Overall Study|Adverse Event|2|||
155604412|NCT03334422|561641270|FG000|Overall Study|Lack of Efficacy|10|||
155604413|NCT03334422|561641271|FG001|Overall Study|Lack of Efficacy|2|||
155604414|NCT03334422|561641272|FG002|Overall Study|Lack of Efficacy|7|||
155604415|NCT03334422|561641273|FG003|Overall Study|Lack of Efficacy|3|||
155604416|NCT03334422|561641270|FG000|Overall Study|Withdrawal by Subject|8|||
155604417|NCT03334422|561641271|FG001|Overall Study|Withdrawal by Subject|3|||
155604418|NCT03334422|561641272|FG002|Overall Study|Withdrawal by Subject|1|||
155604419|NCT03334422|561641273|FG003|Overall Study|Withdrawal by Subject|0|||
155604420|NCT03334422|561641270|FG000|Overall Study|Lost to Follow-up|0|||
155604421|NCT03334422|561641271|FG001|Overall Study|Lost to Follow-up|0|||
155604422|NCT03334422|561641272|FG002|Overall Study|Lost to Follow-up|0|||
155604423|NCT03334422|561641273|FG003|Overall Study|Lost to Follow-up|1|||
155604424|NCT03334422|561641270|FG000|Overall Study|Inability to obtain laboratory samples|0|||
155604425|NCT03334422|561641271|FG001|Overall Study|Inability to obtain laboratory samples|1|||
155604426|NCT03334422|561641272|FG002|Overall Study|Inability to obtain laboratory samples|0|||
155604427|NCT03334422|561641273|FG003|Overall Study|Inability to obtain laboratory samples|0|||
155604428|NCT03334422|561641270|FG000|Overall Study|Pregnancy|0|||
155604429|NCT03334422|561641271|FG001|Overall Study|Pregnancy|1|||
155604430|NCT03334422|561641272|FG002|Overall Study|Pregnancy|0|||
155604431|NCT03334422|561641273|FG003|Overall Study|Pregnancy|0|||
155604432|NCT01313221|561641274|FG000|Overall Study|Protocol Violation|0|||
155604433|NCT01313221|561641275|FG001|Overall Study|Protocol Violation|1|||
155604434|NCT01313221|561641276|FG002|Overall Study|Protocol Violation|1|||
155604435|NCT01313221|561641274|FG000|Overall Study|Non-compliance|3|||
155604436|NCT01313221|561641275|FG001|Overall Study|Non-compliance|0|||
155604437|NCT01313221|561641276|FG002|Overall Study|Non-compliance|2|||
155604438|NCT01313221|561641274|FG000|Overall Study|Withdrawal by Subject|2|||
155604439|NCT01313221|561641275|FG001|Overall Study|Withdrawal by Subject|3|||
155604440|NCT01313221|561641276|FG002|Overall Study|Withdrawal by Subject|5|||
155604441|NCT01313221|561641274|FG000|Overall Study|Requirement for alternative therapy|0|||
155604442|NCT01313221|561641275|FG001|Overall Study|Requirement for alternative therapy|1|||
155604443|NCT01313221|561641276|FG002|Overall Study|Requirement for alternative therapy|1|||
155604444|NCT01313221|561641274|FG000|Overall Study|Lost to Follow-up|6|||
155604445|NCT01313221|561641275|FG001|Overall Study|Lost to Follow-up|3|||
155604446|NCT01313221|561641276|FG002|Overall Study|Lost to Follow-up|1|||
155604447|NCT01313221|561641274|FG000|Overall Study|Other|1|||
155604448|NCT01313221|561641275|FG001|Overall Study|Other|0|||
155604449|NCT01313221|561641276|FG002|Overall Study|Other|0|||
155604450|NCT01313221|561641274|FG000|Overall Study|Adverse Event|0|||
155604451|NCT01313221|561641275|FG001|Overall Study|Adverse Event|0|||
155604452|NCT01313221|561641276|FG002|Overall Study|Adverse Event|7|||
155604453|NCT01313221|561641274|FG000|Overall Study|Disease progression|0|||
155604454|NCT01313221|561641275|FG001|Overall Study|Disease progression|0|||
155604455|NCT01313221|561641276|FG002|Overall Study|Disease progression|2|||
155604456|NCT01313221|561641274|FG000|Overall Study|Physician Decision|0|||
155604457|NCT01313221|561641275|FG001|Overall Study|Physician Decision|0|||
155604458|NCT01313221|561641276|FG002|Overall Study|Physician Decision|2|||
155604459|NCT01313221|561641274|FG000|Overall Study|Pregnancy|0|||
155604460|NCT01313221|561641275|FG001|Overall Study|Pregnancy|0|||
155604461|NCT01313221|561641276|FG002|Overall Study|Pregnancy|2|||
155604462|NCT05459558|561641281|FG000|Overall Study|Adverse Event|1|||
155604463|NCT05459558|561641282|FG001|Overall Study|Adverse Event|0|||
155604464|NCT05459558|561641283|FG002|Overall Study|Adverse Event|0|||
155604465|NCT05459558|561641281|FG000|Overall Study|Scheduling issue|0|||
155604466|NCT05459558|561641282|FG001|Overall Study|Scheduling issue|1|||
155604467|NCT05459558|561641283|FG002|Overall Study|Scheduling issue|3|||
155604468|NCT05459558|561641281|FG000|Overall Study|Withdrawal by Subject|0|||
155604469|NCT05459558|561641282|FG001|Overall Study|Withdrawal by Subject|0|||
155604470|NCT05459558|561641283|FG002|Overall Study|Withdrawal by Subject|2|||
155604471|NCT01887288|561641284|FG000|Overall Study|The study was terminated and the PI has|16|||
155604472|NCT01092637|561641285|FG000|Overall Study|Death|47|||
155604473|NCT01092637|561641286|FG001|Overall Study|Death|49|||
155604474|NCT02921750|561641287|FG000|Overall Study|Adverse Event|1|||
155604475|NCT02921750|561641288|FG001|Overall Study|Adverse Event|2|||
155604476|NCT02921750|561641287|FG000|Overall Study|Withdrawal by Subject|1|||
155604477|NCT02921750|561641288|FG001|Overall Study|Withdrawal by Subject|1|||
155604478|NCT02921750|561641287|FG000|Overall Study|Lost to Follow-up|3|||
155604479|NCT02921750|561641288|FG001|Overall Study|Lost to Follow-up|3|||
155604480|NCT02921750|561641287|FG000|Overall Study|Wound healed|3|||
155604481|NCT02921750|561641288|FG001|Overall Study|Wound healed|3|||
155604482|NCT02921750|561641287|FG000|Overall Study|Serious Adverse Event|1|||
155604483|NCT02921750|561641288|FG001|Overall Study|Serious Adverse Event|2|||
155604484|NCT03309696|561641293|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
155604485|NCT03309696|561641294|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
155604486|NCT03309696|561641295|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
155604487|NCT03309696|561641296|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
155604488|NCT04643964|561641297|FG000|Overall Study|Lost to Follow-up|55|||
155604489|NCT04643964|561641298|FG001|Overall Study|Lost to Follow-up|59|||
155604490|NCT04643964|561641299|FG002|Overall Study|Lost to Follow-up|54|||
155604491|NCT04643964|561641300|FG003|Overall Study|Lost to Follow-up|129|||
155604492|NCT04643964|561641301|FG004|Overall Study|Lost to Follow-up|48|||
155604493|NCT04643964|561641297|FG000|Overall Study|Failed attention check|1|||
155604494|NCT04643964|561641298|FG001|Overall Study|Failed attention check|8|||
155604495|NCT04643964|561641299|FG002|Overall Study|Failed attention check|2|||
155604496|NCT04643964|561641300|FG003|Overall Study|Failed attention check|14|||
155604497|NCT04643964|561641301|FG004|Overall Study|Failed attention check|11|||
155604498|NCT02638129|561641302|FG000|Overall Study|Study terminated|28|||
155604499|NCT02638129|561641303|FG001|Overall Study|Study terminated|30|||
155604500|NCT02949908|561641304|FG000|Overall Study|Study termination|2|||
155604501|NCT02607280|561641308|FG000|Overall Study|Adverse Event|4|||
155604502|NCT02607280|561641309|FG001|Overall Study|Adverse Event|0|||
155604503|NCT02607280|561641308|FG000|Overall Study|Decrease in CrCl <15|0|||
155604504|NCT02607280|561641309|FG001|Overall Study|Decrease in CrCl <15|1|||
155604505|NCT02368210|561641310|FG000|Overall Study|Withdrawal by Subject|1|||
155604506|NCT02368210|561641311|FG001|Overall Study|Withdrawal by Subject|0|||
155604507|NCT02368210|561641310|FG000|Overall Study|Adverse Event|0|||
155604508|NCT02368210|561641311|FG001|Overall Study|Adverse Event|1|||
155604509|NCT00577005|561641312|FG000|Overall Study|Lost to Follow-up|3|||
155604510|NCT00577005|561641313|FG001|Overall Study|Lost to Follow-up|2|||
155604511|NCT00577005|561641312|FG000|Overall Study|Withdrawal by Subject|2|||
155604512|NCT00577005|561641313|FG001|Overall Study|Withdrawal by Subject|1|||
155604513|NCT01004432|561641314|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
155604514|NCT01004432|561641315|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155604515|NCT01004432|561641316|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155604516|NCT01004432|561641317|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155604517|NCT01004432|561641318|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155604518|NCT01004432|561641314|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
155604519|NCT01004432|561641315|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155604520|NCT01004432|561641316|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155604521|NCT01004432|561641317|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155604522|NCT01004432|561641318|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155604523|NCT01004432|561641314|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
155604524|NCT01004432|561641315|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155604525|NCT01004432|561641316|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155604526|NCT01004432|561641317|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155604527|NCT01004432|561641318|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155604528|NCT01004432|561641314|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
155604529|NCT01004432|561641315|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155604530|NCT01004432|561641316|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155604531|NCT01004432|561641317|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155604532|NCT01004432|561641318|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155604533|NCT01004432|561641314|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
155604534|NCT01004432|561641315|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155604535|NCT01004432|561641316|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155604536|NCT01004432|561641317|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155604537|NCT01004432|561641318|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155604538|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
155604539|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
155604540|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
155604541|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
155604542|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
155604543|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
155604544|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
155604545|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
155604546|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
155604547|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
155604548|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
155604549|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
155604550|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
155604551|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
155604552|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
155604553|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155604554|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155604555|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155604556|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
155604557|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155604558|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
155604559|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
155604560|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
155604561|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
155604562|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
155604563|NCT01004432|561641314|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
155604564|NCT01004432|561641315|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
155604565|NCT01004432|561641316|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
155604566|NCT01004432|561641317|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
155604567|NCT01004432|561641318|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
155604568|NCT01004432|561641314|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155604569|NCT01004432|561641315|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155604570|NCT01004432|561641316|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155604571|NCT01004432|561641317|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155604572|NCT01004432|561641318|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
155604573|NCT01004432|561641314|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155604574|NCT01004432|561641315|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155604575|NCT01004432|561641316|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155604576|NCT01004432|561641317|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155604577|NCT01004432|561641318|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
155604578|NCT01004432|561641314|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155604579|NCT01004432|561641315|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155604580|NCT01004432|561641316|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155604581|NCT01004432|561641317|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155604582|NCT01004432|561641318|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
155604583|NCT01004432|561641314|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155604584|NCT01004432|561641315|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155604585|NCT01004432|561641316|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155604586|NCT01004432|561641317|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155604587|NCT01004432|561641318|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
155604588|NCT00590538|561641319|FG000|Overall Study|Study terminated before completed|2|||
155604589|NCT02539134|561641320|FG000|Overall Study|Lost to Follow-up|1|||
155604590|NCT02539134|561641321|FG001|Overall Study|Lost to Follow-up|0|||
155604591|NCT02539134|561641322|FG002|Overall Study|Lost to Follow-up|0|||
155604592|NCT02539134|561641323|FG003|Overall Study|Lost to Follow-up|0|||
155604593|NCT02539134|561641324|FG004|Overall Study|Lost to Follow-up|0|||
155604594|NCT02539134|561641325|FG005|Overall Study|Lost to Follow-up|0|||
155604595|NCT02604550|561641327|FG000|Overall Study|Lost to Follow-up|7|||
155604596|NCT02604550|561641328|FG001|Overall Study|Lost to Follow-up|6|||
155604597|NCT02604550|561641327|FG000|Overall Study|Withdrawal by Subject|0|||
155604598|NCT02604550|561641328|FG001|Overall Study|Withdrawal by Subject|1|||
155604599|NCT02604550|561641327|FG000|Overall Study|Incomplete data using paper journal|18|||
155604600|NCT02604550|561641328|FG001|Overall Study|Incomplete data using paper journal|19|||
155604601|NCT00908076|561641329|FG000|Overall Study|Lack of Efficacy|1|||
155604602|NCT00908076|561641330|FG001|Overall Study|Lack of Efficacy|1|||
155604603|NCT02382796|561641331|FG000|Overall Study|Global deterioration of health status|1|||
155604604|NCT02382796|561641331|FG000|Overall Study|Objective progression or relapse|3|||
155604605|NCT02382796|561641331|FG000|Overall Study|Commercial dacomitinib became available|3|||
155604606|NCT02609724|561641332|FG000|Overall Study|Death|2|||
155604607|NCT02609724|561641333|FG001|Overall Study|Death|0|||
155604608|NCT02609724|561641334|FG002|Overall Study|Death|1|||
155604609|NCT02609724|561641332|FG000|Overall Study|Withdrawal by Subject|1|||
155604610|NCT02609724|561641333|FG001|Overall Study|Withdrawal by Subject|2|||
155604611|NCT02609724|561641334|FG002|Overall Study|Withdrawal by Subject|3|||
155604612|NCT02609724|561641332|FG000|Overall Study|Illness|2|||
155604613|NCT02609724|561641333|FG001|Overall Study|Illness|1|||
155604614|NCT02609724|561641334|FG002|Overall Study|Illness|0|||
155604615|NCT04007107|561641335|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155604616|NCT04007107|561641336|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
155604617|NCT04007107|561641337|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155604618|NCT04007107|561641338|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155604619|NCT04526574|561641339|FG000|Overall Study|Protocol Violation|3|||
155604620|NCT04526574|561641340|FG001|Overall Study|Protocol Violation|1|||
155604621|NCT04526574|561641339|FG000|Overall Study|Withdrawal by Subject|12|||
155604622|NCT04526574|561641340|FG001|Overall Study|Withdrawal by Subject|9|||
155604623|NCT04526574|561641339|FG000|Overall Study|Other|1|||
155604624|NCT04526574|561641340|FG001|Overall Study|Other|2|||
155604625|NCT04526574|561641339|FG000|Overall Study|Adverse Event|1|||
155604626|NCT04526574|561641340|FG001|Overall Study|Adverse Event|1|||
155604627|NCT04526574|561641339|FG000|Overall Study|Death|2|||
155604628|NCT04526574|561641340|FG001|Overall Study|Death|3|||
155604629|NCT04526574|561641339|FG000|Overall Study|Lost to Follow-up|9|||
155604630|NCT04526574|561641340|FG001|Overall Study|Lost to Follow-up|9|||
155604631|NCT04526574|561641339|FG000|Overall Study|No longer meets eligibility criteria|8|||
155604632|NCT04526574|561641340|FG001|Overall Study|No longer meets eligibility criteria|8|||
155604633|NCT04068688|561641341|FG000|Overall Study|Lost to Follow-up|1|||
155604634|NCT04068688|561641342|FG001|Overall Study|Lost to Follow-up|1|||
155604635|NCT04068688|561641343|FG002|Overall Study|Lost to Follow-up|0|||
155604636|NCT04068688|561641344|FG003|Overall Study|Lost to Follow-up|0|||
155604637|NCT04068688|561641345|FG004|Overall Study|Lost to Follow-up|5|||
155604638|NCT04068688|561641346|FG005|Overall Study|Lost to Follow-up|5|||
155604639|NCT04068688|561641347|FG006|Overall Study|Lost to Follow-up|0|||
155604640|NCT04068688|561641348|FG007|Overall Study|Lost to Follow-up|0|||
155604641|NCT04068688|561641349|FG008|Overall Study|Lost to Follow-up|1|||
155604642|NCT04068688|561641350|FG009|Overall Study|Lost to Follow-up|0|||
155604643|NCT04068688|561641341|FG000|Overall Study|Withdrawal by Subject|1|||
155604644|NCT04068688|561641342|FG001|Overall Study|Withdrawal by Subject|1|||
155604645|NCT04068688|561641343|FG002|Overall Study|Withdrawal by Subject|0|||
155604646|NCT04068688|561641344|FG003|Overall Study|Withdrawal by Subject|0|||
155604647|NCT04068688|561641345|FG004|Overall Study|Withdrawal by Subject|0|||
155604648|NCT04068688|561641346|FG005|Overall Study|Withdrawal by Subject|0|||
155604649|NCT04068688|561641347|FG006|Overall Study|Withdrawal by Subject|0|||
155604650|NCT04068688|561641348|FG007|Overall Study|Withdrawal by Subject|0|||
155604651|NCT04068688|561641349|FG008|Overall Study|Withdrawal by Subject|0|||
155684948|NCT01778049|561938282|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
155604652|NCT04068688|561641350|FG009|Overall Study|Withdrawal by Subject|0|||
155604653|NCT04068688|561641341|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
155604654|NCT04068688|561641342|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
155684949|NCT01778049|561938277|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155604655|NCT04068688|561641343|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604656|NCT04068688|561641344|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604657|NCT04068688|561641345|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604658|NCT04068688|561641346|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604659|NCT04068688|561641347|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604660|NCT04068688|561641348|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604661|NCT04068688|561641349|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604662|NCT04068688|561641350|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155604663|NCT04679051|561641351|FG000|Overall Study|felt tired after restricted time in bed|3|||
155604664|NCT04679051|561641352|FG001|Overall Study|felt tired after restricted time in bed|0|||
155604665|NCT04679051|561641351|FG000|Overall Study|discomfort with blood pressure cuff|2|||
155604666|NCT04679051|561641352|FG001|Overall Study|discomfort with blood pressure cuff|0|||
155604667|NCT04679051|561641351|FG000|Overall Study|scheduling conflict|1|||
155604668|NCT04679051|561641352|FG001|Overall Study|scheduling conflict|1|||
155604669|NCT04679051|561641351|FG000|Overall Study|Protocol Violation|0|||
155604670|NCT04679051|561641352|FG001|Overall Study|Protocol Violation|4|||
155604671|NCT00006305|561641353|FG000|Overall Study|Withdrawal by Subject|17|||
155604672|NCT00006305|561641354|FG001|Overall Study|Withdrawal by Subject|10|||
155604673|NCT00006305|561641355|FG002|Overall Study|Withdrawal by Subject|15|||
155604674|NCT00006305|561641356|FG003|Overall Study|Withdrawal by Subject|14|||
155604675|NCT00662558|561641357|FG000|Overall Study|Adverse Event|21|||
155604676|NCT00662558|561641358|FG001|Overall Study|Adverse Event|59|||
155604677|NCT00662558|561641357|FG000|Overall Study|Lack of Efficacy|4|||
155604678|NCT00662558|561641358|FG001|Overall Study|Lack of Efficacy|7|||
155604679|NCT00662558|561641357|FG000|Overall Study|Lost to Follow-up|13|||
155604680|NCT00662558|561641358|FG001|Overall Study|Lost to Follow-up|10|||
155604681|NCT00662558|561641357|FG000|Overall Study|Other|9|||
155604682|NCT00662558|561641358|FG001|Overall Study|Other|14|||
155604683|NCT00662558|561641357|FG000|Overall Study|Withdrawal by Subject|7|||
155604684|NCT00662558|561641358|FG001|Overall Study|Withdrawal by Subject|12|||
155604685|NCT00662558|561641357|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
155604686|NCT00662558|561641358|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
155604687|NCT00329641|561641359|FG000|Overall Study|Did not start treatment|1|||
155604688|NCT00329641|561641359|FG000|Overall Study|Not eligible|1|||
155604689|NCT00329641|561641359|FG000|Overall Study|Adverse Event|3|||
155604690|NCT00329641|561641359|FG000|Overall Study|Other reason, not protocol specified|1|||
155604691|NCT00396877|561641361|FG000|Overall Study|Lost to Follow-up|2|||
155604692|NCT00396877|561641362|FG001|Overall Study|Lost to Follow-up|1|||
155604693|NCT00396877|561641361|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
155604694|NCT00396877|561641362|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
155604695|NCT02631070|561641372|FG000|Overall Study|Withdrawal by Subject|35|||
155604696|NCT02631070|561641373|FG001|Overall Study|Withdrawal by Subject|13|||
155604697|NCT02631070|561641372|FG000|Overall Study|Death|45|||
155604698|NCT02631070|561641373|FG001|Overall Study|Death|24|||
155604699|NCT02631070|561641372|FG000|Overall Study|Lost to Follow-up|5|||
155604700|NCT02631070|561641373|FG001|Overall Study|Lost to Follow-up|1|||
155604701|NCT02631070|561641372|FG000|Overall Study|Transition to rollover protocol|52|||
155604702|NCT02631070|561641373|FG001|Overall Study|Transition to rollover protocol|21|||
155604703|NCT02631070|561641372|FG000|Overall Study|Other reasons|12|||
155604704|NCT02631070|561641373|FG001|Overall Study|Other reasons|5|||
155604705|NCT00980018|561641379|FG000|Overall Study|Adverse Event|8|||
155604706|NCT00980018|561641379|FG000|Overall Study|Patient withdrew consent|3|||
155604707|NCT00980018|561641379|FG000|Overall Study|Lost to Follow-up|1|||
155604708|NCT00551161|561641383|FG000|Overall Study|Withdrawal by Subject|1|||
155604709|NCT00934856|561641384|FG000|Feasibility Part|Progressive disease|4|||
155604710|NCT00934856|561641385|FG001|Feasibility Part|Progressive disease|4|||
155604711|NCT00934856|561641386|FG002|Feasibility Part|Progressive disease|2|||
155604712|NCT00934856|561641387|FG003|Feasibility Part|Progressive disease|3|||
155604713|NCT00934856|561641388|FG004|Feasibility Part|Progressive disease|0|||
155604714|NCT00934856|561641389|FG005|Feasibility Part|Progressive disease|0|||
155604715|NCT00934856|561641384|FG000|Feasibility Part|Physician Decision|0|||
155604716|NCT00934856|561641385|FG001|Feasibility Part|Physician Decision|0|||
155604717|NCT00934856|561641386|FG002|Feasibility Part|Physician Decision|1|||
155604718|NCT00934856|561641387|FG003|Feasibility Part|Physician Decision|0|||
155604719|NCT00934856|561641388|FG004|Feasibility Part|Physician Decision|0|||
155604720|NCT00934856|561641389|FG005|Feasibility Part|Physician Decision|0|||
155604721|NCT00934856|561641384|FG000|Feasibility Part|Adverse Event|1|||
155604722|NCT00934856|561641385|FG001|Feasibility Part|Adverse Event|1|||
155604723|NCT00934856|561641386|FG002|Feasibility Part|Adverse Event|0|||
155604724|NCT00934856|561641387|FG003|Feasibility Part|Adverse Event|1|||
155604725|NCT00934856|561641388|FG004|Feasibility Part|Adverse Event|0|||
155604726|NCT00934856|561641389|FG005|Feasibility Part|Adverse Event|2|||
155604727|NCT00934856|561641384|FG000|Feasibility Part|Withdrawal by Subject|0|||
155604728|NCT00934856|561641385|FG001|Feasibility Part|Withdrawal by Subject|0|||
155604729|NCT00934856|561641386|FG002|Feasibility Part|Withdrawal by Subject|0|||
155604730|NCT00934856|561641387|FG003|Feasibility Part|Withdrawal by Subject|1|||
155604731|NCT00934856|561641388|FG004|Feasibility Part|Withdrawal by Subject|0|||
155604732|NCT00934856|561641389|FG005|Feasibility Part|Withdrawal by Subject|1|||
155604733|NCT00934856|561641384|FG000|Extension Part|Adverse Event|0|||
155604734|NCT00934856|561641385|FG001|Extension Part|Adverse Event|0|||
155604735|NCT00934856|561641386|FG002|Extension Part|Adverse Event|0|||
155604736|NCT00934856|561641387|FG003|Extension Part|Adverse Event|1|||
155604737|NCT00934856|561641388|FG004|Extension Part|Adverse Event|4|||
155604738|NCT00934856|561641389|FG005|Extension Part|Adverse Event|4|||
155604739|NCT00934856|561641384|FG000|Extension Part|Progressive disease|0|||
155604740|NCT00934856|561641385|FG001|Extension Part|Progressive disease|0|||
155604741|NCT00934856|561641386|FG002|Extension Part|Progressive disease|0|||
155604742|NCT00934856|561641387|FG003|Extension Part|Progressive disease|1|||
155604743|NCT00934856|561641388|FG004|Extension Part|Progressive disease|0|||
155604744|NCT00934856|561641389|FG005|Extension Part|Progressive disease|0|||
155604745|NCT00934856|561641384|FG000|Extension Part|Non-compliance with drug|0|||
155604746|NCT00934856|561641385|FG001|Extension Part|Non-compliance with drug|0|||
155604747|NCT00934856|561641386|FG002|Extension Part|Non-compliance with drug|0|||
155604748|NCT00934856|561641387|FG003|Extension Part|Non-compliance with drug|0|||
155604749|NCT00934856|561641388|FG004|Extension Part|Non-compliance with drug|0|||
155604750|NCT00934856|561641389|FG005|Extension Part|Non-compliance with drug|1|||
155604751|NCT01256385|561641390|FG000|Overall Study|Physician Decision|1|||
155604752|NCT01256385|561641391|FG001|Overall Study|Physician Decision|1|||
155604753|NCT01256385|561641390|FG000|Overall Study|Withdrawal by Subject|2|||
155604754|NCT01256385|561641391|FG001|Overall Study|Withdrawal by Subject|2|||
155604755|NCT02326298|561641399|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604756|NCT02326298|561641400|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604757|NCT02326298|561641401|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
155604758|NCT02326298|561641402|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604759|NCT02326298|561641403|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604760|NCT02326298|561641404|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604761|NCT02326298|561641405|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604762|NCT02326298|561641406|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604763|NCT02326298|561641407|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604764|NCT02326298|561641408|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604765|NCT02326298|561641409|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604766|NCT02326298|561641410|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604767|NCT02326298|561641411|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604768|NCT02326298|561641412|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155604769|NCT02326298|561641399|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
155604770|NCT02326298|561641400|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604771|NCT02326298|561641401|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604772|NCT02326298|561641402|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604773|NCT02326298|561641403|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604774|NCT02326298|561641404|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604775|NCT02326298|561641405|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604776|NCT02326298|561641406|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604777|NCT02326298|561641407|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604778|NCT02326298|561641408|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604779|NCT02326298|561641409|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604780|NCT02326298|561641410|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604781|NCT02326298|561641411|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604782|NCT02326298|561641412|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155604783|NCT02326298|561641399|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155604784|NCT02326298|561641400|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155604785|NCT02326298|561641401|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604786|NCT02326298|561641402|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604787|NCT02326298|561641403|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604788|NCT02326298|561641404|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604789|NCT02326298|561641405|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604790|NCT02326298|561641406|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604791|NCT02326298|561641407|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604792|NCT02326298|561641408|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604793|NCT02326298|561641409|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604794|NCT02326298|561641410|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604795|NCT02326298|561641411|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604796|NCT02326298|561641412|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155604797|NCT02326298|561641399|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
155604798|NCT02326298|561641400|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
155604799|NCT02326298|561641401|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604800|NCT02326298|561641402|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604801|NCT02326298|561641403|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604802|NCT02326298|561641404|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604803|NCT02326298|561641405|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604804|NCT02326298|561641406|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604805|NCT02326298|561641407|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604806|NCT02326298|561641408|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604807|NCT02326298|561641409|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604808|NCT02326298|561641410|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604809|NCT02326298|561641411|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604810|NCT02326298|561641412|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155604811|NCT02326298|561641399|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604812|NCT02326298|561641400|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604813|NCT02326298|561641401|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
155604814|NCT02326298|561641402|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604815|NCT02326298|561641403|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604816|NCT02326298|561641404|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604817|NCT02326298|561641405|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604818|NCT02326298|561641406|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604819|NCT02326298|561641407|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604820|NCT02326298|561641408|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604821|NCT02326298|561641409|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604822|NCT02326298|561641410|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604823|NCT02326298|561641411|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604824|NCT02326298|561641412|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155604825|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604826|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604827|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604828|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604829|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604830|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155604831|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
155604832|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155604833|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155604834|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155604835|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604836|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604837|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604838|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155604839|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604840|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604841|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604842|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604843|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604844|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
155604845|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
155604846|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604847|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
155607040|NCT01897571|561649621|FG008|Overall Study|Enrolled in rollover study|7|||
155607041|NCT01897571|561649622|FG009|Overall Study|Enrolled in rollover study|9|||
155604848|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604849|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604850|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604851|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604852|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155604853|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604854|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604855|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604856|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604857|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604858|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
155604859|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604860|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604861|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604862|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604863|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604864|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604865|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604866|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155604867|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604868|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604869|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604870|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604871|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604872|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604873|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
155604874|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604875|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604876|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604877|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604878|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604879|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604880|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155604881|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604882|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604883|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604884|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604885|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604886|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604887|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604888|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
155604889|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604890|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604891|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604892|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604893|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604894|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155604895|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604896|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604897|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604898|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604899|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604900|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604901|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
155604902|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155604903|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604904|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604905|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604906|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604907|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604908|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155604909|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604910|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604911|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604912|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604913|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604914|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604915|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604916|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155604917|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604918|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604919|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604920|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604921|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604922|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155604923|NCT02326298|561641399|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604924|NCT02326298|561641400|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604925|NCT02326298|561641401|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604926|NCT02326298|561641402|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604927|NCT02326298|561641403|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604928|NCT02326298|561641404|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
155604929|NCT02326298|561641405|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604930|NCT02326298|561641406|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604931|NCT02326298|561641407|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604932|NCT02326298|561641408|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604933|NCT02326298|561641409|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604934|NCT02326298|561641410|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604935|NCT02326298|561641411|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604936|NCT02326298|561641412|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155604937|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
155604938|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
155604939|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
155604940|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
155604941|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
155604942|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
155604943|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
155604944|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
155604945|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
155604946|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
155604947|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
155604948|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
155604949|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
155604950|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
155604951|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604952|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604953|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604954|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604955|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604956|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604957|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604958|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604959|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604960|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604961|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604962|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155604963|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155604964|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155604965|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604966|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604967|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604968|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604969|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604970|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604971|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604972|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604973|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604974|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604975|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604976|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155604977|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155604978|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155604979|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604980|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604981|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604982|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604983|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604984|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604985|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604986|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604987|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604988|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604989|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604990|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604991|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155604992|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
155604993|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604994|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604995|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604996|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604997|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604998|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155604999|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155605000|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155605001|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155605002|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155605003|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155605004|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
155605005|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
155605006|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155605007|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605008|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605009|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605010|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605011|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605012|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605013|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605014|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605015|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605016|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605017|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155605018|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
155605019|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
155605020|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155605021|NCT02326298|561641399|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605022|NCT02326298|561641400|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605023|NCT02326298|561641401|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155684950|NCT01778049|561938278|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
155684951|NCT01778049|561938279|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
155684952|NCT01778049|561938280|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
155605024|NCT02326298|561641402|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605025|NCT02326298|561641403|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605026|NCT02326298|561641404|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605027|NCT02326298|561641405|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605028|NCT02326298|561641406|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605029|NCT02326298|561641407|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605030|NCT02326298|561641408|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605031|NCT02326298|561641409|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155605032|NCT02326298|561641410|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
155605033|NCT02326298|561641411|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
155605034|NCT02326298|561641412|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155605035|NCT00073983|561641415|FG000|Overall Study|not evaluable|1|||
155605036|NCT03976323|561641418|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
155605037|NCT03976323|561641419|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155605038|NCT03976323|561641420|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155605039|NCT03976323|561641418|FG000|Induction Phase|Death|80|||
155605040|NCT03976323|561641419|FG001|Induction Phase|Death|0|||
155605041|NCT03976323|561641420|FG002|Induction Phase|Death|0|||
155605042|NCT03976323|561641418|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
155684953|NCT01778049|561938281|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155684954|NCT01778049|561938282|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
155684955|NCT01778049|561938277|FG000|Double Blind Treatment Period|Not treated|0|||
155684956|NCT01778049|561938278|FG001|Double Blind Treatment Period|Not treated|0|||
155684957|NCT01778049|561938279|FG002|Double Blind Treatment Period|Not treated|0|||
155684958|NCT01778049|561938280|FG003|Double Blind Treatment Period|Not treated|2|||
155684959|NCT01778049|561938281|FG004|Double Blind Treatment Period|Not treated|2|||
155684960|NCT01778049|561938282|FG005|Double Blind Treatment Period|Not treated|0|||
155684961|NCT01778049|561938277|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
155684962|NCT01778049|561938278|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
155684963|NCT01778049|561938279|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
155684964|NCT01778049|561938280|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
155684965|NCT01778049|561938281|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
155684966|NCT01778049|561938282|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
155684967|NCT02379988|561938284|FG000|Overall Study|Not eligible|1|||
155684968|NCT03359785|561938289|FG000|Overall Study|Protocol Violation|0|||
155684969|NCT03359785|561938290|FG001|Overall Study|Protocol Violation|1|||
155684970|NCT03359785|561938291|FG002|Overall Study|Protocol Violation|0|||
155684971|NCT03359785|561938292|FG003|Overall Study|Protocol Violation|0|||
155684972|NCT03359785|561938289|FG000|Overall Study|Early study termination due to study pause|0|||
155684973|NCT03359785|561938290|FG001|Overall Study|Early study termination due to study pause|0|||
155684974|NCT03359785|561938291|FG002|Overall Study|Early study termination due to study pause|2|||
155684975|NCT03359785|561938292|FG003|Overall Study|Early study termination due to study pause|0|||
155684976|NCT03359785|561938289|FG000|Overall Study|Withdrawal by Subject|2|||
155684977|NCT03359785|561938290|FG001|Overall Study|Withdrawal by Subject|2|||
155684978|NCT03359785|561938291|FG002|Overall Study|Withdrawal by Subject|0|||
155684979|NCT03359785|561938292|FG003|Overall Study|Withdrawal by Subject|0|||
155684980|NCT01895543|561938293|FG000|Overall Study|Withdrawal by Subject|43|||
155684981|NCT01895543|561938293|FG000|Overall Study|Lost to Follow-up|25|||
155684982|NCT01895543|561938293|FG000|Overall Study|Adverse Event|28|||
155684983|NCT01895543|561938293|FG000|Overall Study|Subject's substantial non-compliance|6|||
155684984|NCT01895543|561938293|FG000|Overall Study|Protocol Violation|1|||
155684985|NCT01895543|561938293|FG000|Overall Study|Physician Decision|2|||
155684986|NCT01895543|561938293|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
155684987|NCT00367744|561938294|FG000|Overall Study|Lost to Follow-up|4|||
155684988|NCT00367744|561938295|FG001|Overall Study|Lost to Follow-up|5|||
155684989|NCT04262882|561938297|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
155684990|NCT04262882|561938298|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
155684991|NCT04262882|561938297|FG000|Overall Study|Lost to Follow-up|1|||
155684992|NCT04262882|561938298|FG001|Overall Study|Lost to Follow-up|0|||
155684993|NCT00443053|561938300|FG000|Overall Study|Adverse Event|2|||
155684994|NCT00443053|561938301|FG001|Overall Study|Adverse Event|1|||
155684995|NCT00443053|561938300|FG000|Overall Study|Withdrawal by Subject|9|||
155605043|NCT03976323|561641419|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
155605044|NCT03976323|561641420|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
155684996|NCT00443053|561938301|FG001|Overall Study|Withdrawal by Subject|18|||
155684997|NCT00443053|561938300|FG000|Overall Study|Lost to Follow-up|4|||
155684998|NCT00443053|561938301|FG001|Overall Study|Lost to Follow-up|5|||
155684999|NCT00443053|561938300|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155685000|NCT00443053|561938301|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155685001|NCT00443053|561938300|FG000|Overall Study|Noncompliance|2|||
155685002|NCT00443053|561938301|FG001|Overall Study|Noncompliance|1|||
155685003|NCT00443053|561938300|FG000|Overall Study|Other|3|||
155685004|NCT00443053|561938301|FG001|Overall Study|Other|4|||
155685005|NCT00443053|561938300|FG000|Overall Study|Physician Decision|0|||
155685006|NCT00443053|561938301|FG001|Overall Study|Physician Decision|4|||
155685007|NCT00541866|561938302|FG000|Overall Study|Adverse Event|3|||
155685008|NCT00541866|561938303|FG001|Overall Study|Adverse Event|0|||
155685009|NCT00541866|561938304|FG002|Overall Study|Adverse Event|0|||
155685010|NCT00541866|561938305|FG003|Overall Study|Adverse Event|0|||
155685011|NCT00541866|561938306|FG004|Overall Study|Adverse Event|0|||
155685012|NCT00541866|561938302|FG000|Overall Study|Death|1|||
155685013|NCT00541866|561938303|FG001|Overall Study|Death|0|||
155685014|NCT00541866|561938304|FG002|Overall Study|Death|0|||
155685015|NCT00541866|561938305|FG003|Overall Study|Death|0|||
155685016|NCT00541866|561938306|FG004|Overall Study|Death|0|||
155685017|NCT00541866|561938302|FG000|Overall Study|Lack of Efficacy|19|||
155685018|NCT00541866|561938303|FG001|Overall Study|Lack of Efficacy|15|||
155685019|NCT00541866|561938304|FG002|Overall Study|Lack of Efficacy|10|||
155685020|NCT00541866|561938305|FG003|Overall Study|Lack of Efficacy|12|||
155685021|NCT00541866|561938306|FG004|Overall Study|Lack of Efficacy|14|||
155685022|NCT00541866|561938302|FG000|Overall Study|Not Reported or Other|11|||
155685023|NCT00541866|561938303|FG001|Overall Study|Not Reported or Other|3|||
155685024|NCT00541866|561938304|FG002|Overall Study|Not Reported or Other|3|||
155685025|NCT00541866|561938305|FG003|Overall Study|Not Reported or Other|3|||
155685026|NCT00541866|561938306|FG004|Overall Study|Not Reported or Other|1|||
155685027|NCT00541866|561938302|FG000|Overall Study|Physician Decision|0|||
155685028|NCT00541866|561938303|FG001|Overall Study|Physician Decision|0|||
155685029|NCT00541866|561938304|FG002|Overall Study|Physician Decision|2|||
155685030|NCT00541866|561938305|FG003|Overall Study|Physician Decision|1|||
155685031|NCT00541866|561938306|FG004|Overall Study|Physician Decision|0|||
155685032|NCT00522418|561938307|FG000|Overall Study|Local IRB Consent Violation|5|||
155685033|NCT00522418|561938308|FG001|Overall Study|Local IRB Consent Violation|5|||
155685034|NCT00522418|561938307|FG000|Overall Study|Early Study Termination|46|||
155685035|NCT00522418|561938308|FG001|Overall Study|Early Study Termination|47|||
155685036|NCT00522418|561938307|FG000|Overall Study|Noncompliance|2|||
155685037|NCT00522418|561938308|FG001|Overall Study|Noncompliance|2|||
155685038|NCT00522418|561938307|FG000|Overall Study|Reason Not Specified|3|||
155685039|NCT00522418|561938308|FG001|Overall Study|Reason Not Specified|1|||
155685040|NCT00522418|561938307|FG000|Overall Study|Consent Withdraw|1|||
155685041|NCT00522418|561938308|FG001|Overall Study|Consent Withdraw|2|||
155685042|NCT00522418|561938307|FG000|Overall Study|Lack of Efficacy|0|||
155685043|NCT00522418|561938308|FG001|Overall Study|Lack of Efficacy|1|||
155685044|NCT00578877|561938309|FG000|Overall Study|Lost to Follow-up|8|||
155685045|NCT00578877|561938310|FG001|Overall Study|Lost to Follow-up|10|||
155685046|NCT00578877|561938309|FG000|Overall Study|early discontinue|61|||
155685047|NCT00578877|561938310|FG001|Overall Study|early discontinue|101|||
155685048|NCT00578877|561938309|FG000|Overall Study|did not provide follow-up data|12|||
155685049|NCT00578877|561938310|FG001|Overall Study|did not provide follow-up data|17|||
155685050|NCT02256384|561938316|FG000|Overall Study|Withdrawal by Subject|12|||
155685051|NCT02256384|561938316|FG000|Overall Study|Equipment not capturing data|2|||
155685052|NCT02136680|561938317|FG000|Overall Study|No Longer Interested|1|||
155685053|NCT02136680|561938318|FG001|Overall Study|No Longer Interested|1|||
155685054|NCT02136680|561938317|FG000|Overall Study|No longer receiving care at clinic|3|||
155685055|NCT02136680|561938318|FG001|Overall Study|No longer receiving care at clinic|5|||
155685056|NCT02136680|561938317|FG000|Overall Study|Moved away|5|||
155685057|NCT02136680|561938318|FG001|Overall Study|Moved away|4|||
155685058|NCT02136680|561938317|FG000|Overall Study|Unable to schedule|17|||
155685059|NCT02136680|561938318|FG001|Overall Study|Unable to schedule|16|||
155685060|NCT02136680|561938317|FG000|Overall Study|Study ended before interview due|6|||
155685061|NCT02136680|561938318|FG001|Overall Study|Study ended before interview due|3|||
155685062|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
155685063|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
155685064|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
155685065|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
155685066|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
155685067|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
155685068|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
155685069|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
155685070|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
155685071|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
155685072|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
155685073|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
155685074|NCT01632241|561938319|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
155685075|NCT01632241|561938320|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
155685076|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
155685077|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
155685078|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
155685079|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
155685080|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
155685081|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
155685082|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
155685083|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
155685084|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
155685085|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
155685086|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
155685087|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
155685088|NCT01632241|561938319|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
155685089|NCT01632241|561938320|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
155685090|NCT01638013|561938321|FG000|Overall Study|Adverse Event|36|||
155685091|NCT01638013|561938322|FG001|Overall Study|Adverse Event|29|||
155685092|NCT01638013|561938323|FG002|Overall Study|Adverse Event|48|||
155685093|NCT01638013|561938321|FG000|Overall Study|Lack of Efficacy|39|||
155685094|NCT01638013|561938322|FG001|Overall Study|Lack of Efficacy|11|||
155685095|NCT01638013|561938323|FG002|Overall Study|Lack of Efficacy|14|||
155685096|NCT01638013|561938321|FG000|Overall Study|Protocol Violation|10|||
155685097|NCT01638013|561938322|FG001|Overall Study|Protocol Violation|7|||
155685098|NCT01638013|561938323|FG002|Overall Study|Protocol Violation|11|||
155685099|NCT01638013|561938321|FG000|Overall Study|Met discontinuation criteria|4|||
155685100|NCT01638013|561938322|FG001|Overall Study|Met discontinuation criteria|0|||
155685101|NCT01638013|561938323|FG002|Overall Study|Met discontinuation criteria|7|||
155685102|NCT01638013|561938321|FG000|Overall Study|Subject Lost to Follow up|1|||
155685103|NCT01638013|561938322|FG001|Overall Study|Subject Lost to Follow up|0|||
155685104|NCT01638013|561938323|FG002|Overall Study|Subject Lost to Follow up|1|||
155685105|NCT01638013|561938321|FG000|Overall Study|Miscellaneous|25|||
155685106|NCT01638013|561938322|FG001|Overall Study|Miscellaneous|19|||
155685107|NCT01638013|561938323|FG002|Overall Study|Miscellaneous|23|||
155685108|NCT01638013|561938321|FG000|Overall Study|Withdrawal of Consent|16|||
155685109|NCT01638013|561938322|FG001|Overall Study|Withdrawal of Consent|12|||
155685110|NCT01638013|561938323|FG002|Overall Study|Withdrawal of Consent|16|||
155685111|NCT01638013|561938321|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
155685112|NCT01638013|561938322|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
155685113|NCT01638013|561938323|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
155685114|NCT02825420|561938330|FG000|Overall Study|Death|30|||
155685115|NCT02825420|561938331|FG001|Overall Study|Death|12|||
155685116|NCT02825420|561938330|FG000|Overall Study|Progressive disease|6|||
155685117|NCT02825420|561938331|FG001|Overall Study|Progressive disease|1|||
155685118|NCT02825420|561938330|FG000|Overall Study|Lost to Follow-up|2|||
155685119|NCT02825420|561938331|FG001|Overall Study|Lost to Follow-up|2|||
155685120|NCT02825420|561938330|FG000|Overall Study|Withdrawal by Subject|1|||
155685121|NCT02825420|561938331|FG001|Overall Study|Withdrawal by Subject|1|||
155685122|NCT02825420|561938330|FG000|Overall Study|Protocol amendment not signed|1|||
155685123|NCT02825420|561938331|FG001|Overall Study|Protocol amendment not signed|1|||
155685124|NCT02825420|561938330|FG000|Overall Study|Physician Decision|1|||
155685125|NCT02825420|561938331|FG001|Overall Study|Physician Decision|0|||
155685126|NCT02825420|561938330|FG000|Overall Study|Did not receive PLD|2|||
155685127|NCT02825420|561938331|FG001|Overall Study|Did not receive PLD|0|||
155685128|NCT00496483|561940056|FG000|Overall Study|Not dosed|9|||
155685129|NCT00496483|561940056|FG000|Overall Study|Adverse Event|2|||
155685130|NCT00496483|561940056|FG000|Overall Study|Lack of Efficacy|1|||
155685131|NCT04258995|561940058|FG000|Overall Study|Lost to Follow-up|1|||
155685132|NCT04258995|561940059|FG001|Overall Study|Lost to Follow-up|1|||
155685133|NCT01962987|561940062|FG000|Overall Study|Adverse Event|4|||
155685134|NCT01962987|561940063|FG001|Overall Study|Adverse Event|4|||
155685135|NCT01962987|561940064|FG002|Overall Study|Adverse Event|0|||
155685136|NCT01962987|561940062|FG000|Overall Study|Lost to Follow-up|0|||
155685137|NCT01962987|561940063|FG001|Overall Study|Lost to Follow-up|0|||
155685138|NCT01962987|561940064|FG002|Overall Study|Lost to Follow-up|1|||
155685139|NCT01962987|561940062|FG000|Overall Study|Non compliance with dosing requirements|4|||
155685140|NCT01962987|561940063|FG001|Overall Study|Non compliance with dosing requirements|2|||
155685141|NCT01962987|561940064|FG002|Overall Study|Non compliance with dosing requirements|0|||
155685142|NCT01962987|561940062|FG000|Overall Study|Miscellaneous|1|||
155685143|NCT01962987|561940063|FG001|Overall Study|Miscellaneous|9|||
155685144|NCT01962987|561940064|FG002|Overall Study|Miscellaneous|2|||
155685145|NCT01962987|561940062|FG000|Overall Study|Restricted medication|5|||
155685146|NCT01962987|561940063|FG001|Overall Study|Restricted medication|1|||
155685147|NCT01962987|561940064|FG002|Overall Study|Restricted medication|1|||
155685148|NCT01962987|561940062|FG000|Overall Study|Serious Adverse Event|1|||
155685149|NCT01962987|561940063|FG001|Overall Study|Serious Adverse Event|0|||
155685150|NCT01962987|561940064|FG002|Overall Study|Serious Adverse Event|0|||
155685151|NCT01962987|561940062|FG000|Overall Study|Withdrawal by Subject|11|||
155685152|NCT01962987|561940063|FG001|Overall Study|Withdrawal by Subject|10|||
155685153|NCT01962987|561940064|FG002|Overall Study|Withdrawal by Subject|6|||
155685154|NCT01962987|561940062|FG000|Overall Study|Randomized in Error|4|||
155685155|NCT01962987|561940063|FG001|Overall Study|Randomized in Error|2|||
155685156|NCT01962987|561940064|FG002|Overall Study|Randomized in Error|2|||
155685157|NCT01967823|561940065|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
155685158|NCT00316693|561940066|FG000|Overall Study|Adverse Event|6|||
155685159|NCT00316693|561940067|FG001|Overall Study|Adverse Event|1|||
155685160|NCT00316693|561940066|FG000|Overall Study|Protocol Violation|1|||
155685161|NCT00316693|561940067|FG001|Overall Study|Protocol Violation|0|||
155685162|NCT00316693|561940066|FG000|Overall Study|Withdrawal by Subject|6|||
155685163|NCT00316693|561940067|FG001|Overall Study|Withdrawal by Subject|6|||
155685164|NCT00316693|561940066|FG000|Overall Study|Lost to Follow-up|26|||
155685165|NCT00316693|561940067|FG001|Overall Study|Lost to Follow-up|34|||
155685166|NCT00316693|561940066|FG000|Overall Study|Other|38|||
155685167|NCT00316693|561940067|FG001|Overall Study|Other|44|||
155685168|NCT03245736|561940070|FG000|Overall Study|Adverse Event|1|||
155685169|NCT03245736|561940070|FG000|Overall Study|Progressive Disease|4|||
155685170|NCT01739933|561940072|FG000|Overall Study|Death|89|||
155685171|NCT01739933|561940073|FG001|Overall Study|Death|86|||
155685172|NCT01739933|561940072|FG000|Overall Study|Withdrawal by Subject|10|||
155685173|NCT01739933|561940073|FG001|Overall Study|Withdrawal by Subject|8|||
155685174|NCT01739933|561940072|FG000|Overall Study|Lost to Follow-up|3|||
155685175|NCT01739933|561940073|FG001|Overall Study|Lost to Follow-up|10|||
155685176|NCT01739933|561940072|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
155605045|NCT03976323|561641418|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155605046|NCT03976323|561641419|FG001|Maintenance Phase|Withdrawal by Subject|9|||
155605047|NCT03976323|561641420|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155605048|NCT03976323|561641418|FG000|Maintenance Phase|Physician Decision|0|||
155605049|NCT03976323|561641419|FG001|Maintenance Phase|Physician Decision|0|||
155605050|NCT03976323|561641420|FG002|Maintenance Phase|Physician Decision|1|||
155605051|NCT03976323|561641418|FG000|Maintenance Phase|Death|0|||
155605052|NCT03976323|561641419|FG001|Maintenance Phase|Death|228|||
155605053|NCT03976323|561641420|FG002|Maintenance Phase|Death|234|||
155605054|NCT03800836|561641421|FG000|Overall Study|Other|2|||
155605055|NCT03800836|561641422|FG001|Overall Study|Other|1|||
155605056|NCT03800836|561641423|FG002|Overall Study|Other|0|||
155605057|NCT03800836|561641424|FG003|Overall Study|Other|2|||
155605058|NCT03800836|561641425|FG004|Overall Study|Other|0|||
155605059|NCT03800836|561641426|FG005|Overall Study|Other|1|||
155605060|NCT03800836|561641421|FG000|Overall Study|Lost to Follow-up|2|||
155605061|NCT03800836|561641422|FG001|Overall Study|Lost to Follow-up|0|||
155605062|NCT03800836|561641423|FG002|Overall Study|Lost to Follow-up|1|||
155605063|NCT03800836|561641424|FG003|Overall Study|Lost to Follow-up|1|||
155605064|NCT03800836|561641425|FG004|Overall Study|Lost to Follow-up|3|||
155605065|NCT03800836|561641426|FG005|Overall Study|Lost to Follow-up|0|||
155605066|NCT03800836|561641421|FG000|Overall Study|Withdrawal by Subject|1|||
155605067|NCT03800836|561641422|FG001|Overall Study|Withdrawal by Subject|0|||
155605068|NCT03800836|561641423|FG002|Overall Study|Withdrawal by Subject|0|||
155605069|NCT03800836|561641424|FG003|Overall Study|Withdrawal by Subject|0|||
155605070|NCT03800836|561641425|FG004|Overall Study|Withdrawal by Subject|0|||
155605071|NCT03800836|561641426|FG005|Overall Study|Withdrawal by Subject|0|||
155605072|NCT03800836|561641421|FG000|Overall Study|Physician Decision|31|||
155605073|NCT03800836|561641422|FG001|Overall Study|Physician Decision|3|||
155605074|NCT03800836|561641423|FG002|Overall Study|Physician Decision|6|||
155605075|NCT03800836|561641424|FG003|Overall Study|Physician Decision|4|||
155605076|NCT03800836|561641425|FG004|Overall Study|Physician Decision|4|||
155605077|NCT03800836|561641426|FG005|Overall Study|Physician Decision|5|||
155605078|NCT03800836|561641421|FG000|Overall Study|Death|34|||
155605079|NCT03800836|561641422|FG001|Overall Study|Death|16|||
155685177|NCT01739933|561940073|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
155685178|NCT00416715|561940076|FG000|Overall Study|Not evaluable for joint aches|7|||
155685179|NCT00416715|561940076|FG000|Overall Study|Vitamin D levels not evaluable|8|||
155605080|NCT03800836|561641423|FG002|Overall Study|Death|5|||
155605081|NCT03800836|561641424|FG003|Overall Study|Death|5|||
155605082|NCT03800836|561641425|FG004|Overall Study|Death|10|||
155605083|NCT03800836|561641426|FG005|Overall Study|Death|0|||
155605084|NCT03800836|561641421|FG000|Overall Study|Symptomatic Deterioration|1|||
155605085|NCT03800836|561641422|FG001|Overall Study|Symptomatic Deterioration|0|||
155605086|NCT03800836|561641423|FG002|Overall Study|Symptomatic Deterioration|1|||
155605087|NCT03800836|561641424|FG003|Overall Study|Symptomatic Deterioration|0|||
155605088|NCT03800836|561641425|FG004|Overall Study|Symptomatic Deterioration|0|||
155685180|NCT03224507|561940089|FG000|Overall Study|Death|3|||
155685181|NCT03224507|561940090|FG001|Overall Study|Death|0|||
155685182|NCT03224507|561940089|FG000|Overall Study|Lack of Efficacy|6|||
155685183|NCT03224507|561940090|FG001|Overall Study|Lack of Efficacy|0|||
155685184|NCT03224507|561940089|FG000|Overall Study|Withdrawal by Subject|6|||
155685185|NCT03224507|561940090|FG001|Overall Study|Withdrawal by Subject|0|||
155685186|NCT01007435|561940091|FG000|Overall Study|Adverse Event|16|||
155685187|NCT01007435|561940092|FG001|Overall Study|Adverse Event|25|||
155685188|NCT01007435|561940093|FG002|Overall Study|Adverse Event|47|||
155685189|NCT01007435|561940094|FG003|Overall Study|Adverse Event|31|||
155685190|NCT01007435|561940091|FG000|Overall Study|Death|2|||
155685191|NCT01007435|561940092|FG001|Overall Study|Death|4|||
155685192|NCT01007435|561940093|FG002|Overall Study|Death|2|||
155685193|NCT01007435|561940094|FG003|Overall Study|Death|1|||
155685194|NCT01007435|561940091|FG000|Overall Study|Insufficient Therapeutic Response|21|||
155685195|NCT01007435|561940092|FG001|Overall Study|Insufficient Therapeutic Response|7|||
155685196|NCT01007435|561940093|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155685197|NCT01007435|561940094|FG003|Overall Study|Insufficient Therapeutic Response|9|||
155685198|NCT01007435|561940091|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
155685199|NCT01007435|561940092|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
155685200|NCT01007435|561940093|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
155685201|NCT01007435|561940094|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
155685202|NCT01007435|561940091|FG000|Overall Study|Other Protocol Violation|2|||
155685203|NCT01007435|561940092|FG001|Overall Study|Other Protocol Violation|0|||
155685204|NCT01007435|561940093|FG002|Overall Study|Other Protocol Violation|1|||
155685205|NCT01007435|561940094|FG003|Overall Study|Other Protocol Violation|0|||
155685206|NCT01007435|561940091|FG000|Overall Study|Refused Treatment|13|||
155685207|NCT01007435|561940092|FG001|Overall Study|Refused Treatment|13|||
155685208|NCT01007435|561940093|FG002|Overall Study|Refused Treatment|5|||
155685209|NCT01007435|561940094|FG003|Overall Study|Refused Treatment|8|||
155685210|NCT01007435|561940091|FG000|Overall Study|Failure to Return|5|||
155685211|NCT01007435|561940092|FG001|Overall Study|Failure to Return|4|||
155685212|NCT01007435|561940093|FG002|Overall Study|Failure to Return|3|||
155685213|NCT01007435|561940094|FG003|Overall Study|Failure to Return|6|||
155685214|NCT01007435|561940091|FG000|Overall Study|Reason not Specified|1|||
155685215|NCT01007435|561940092|FG001|Overall Study|Reason not Specified|1|||
155685216|NCT01007435|561940093|FG002|Overall Study|Reason not Specified|2|||
155685217|NCT01007435|561940094|FG003|Overall Study|Reason not Specified|1|||
155685218|NCT01032291|561940095|FG000|Safety Lead-in|Adverse Event|1|||
155685219|NCT01032291|561940096|FG001|Safety Lead-in|Adverse Event|0|||
155685220|NCT01032291|561940097|FG002|Safety Lead-in|Adverse Event|0|||
155685221|NCT01032291|561940095|FG000|Safety Lead-in|Death|1|||
155685222|NCT01032291|561940096|FG001|Safety Lead-in|Death|0|||
155685223|NCT01032291|561940097|FG002|Safety Lead-in|Death|0|||
155685224|NCT01032291|561940095|FG000|Proof of Concept|Adverse Event|0|||
155685225|NCT01032291|561940096|FG001|Proof of Concept|Adverse Event|5|||
155685226|NCT01032291|561940097|FG002|Proof of Concept|Adverse Event|1|||
155685227|NCT01032291|561940095|FG000|Proof of Concept|Death|0|||
155685228|NCT01032291|561940096|FG001|Proof of Concept|Death|1|||
155685229|NCT01032291|561940097|FG002|Proof of Concept|Death|2|||
155685230|NCT01032291|561940095|FG000|Proof of Concept|Lack of Efficacy|0|||
155685231|NCT01032291|561940096|FG001|Proof of Concept|Lack of Efficacy|1|||
155685232|NCT01032291|561940097|FG002|Proof of Concept|Lack of Efficacy|0|||
155685233|NCT01032291|561940095|FG000|Proof of Concept|Never Received Study Drug|0|||
155685234|NCT01032291|561940096|FG001|Proof of Concept|Never Received Study Drug|1|||
155685235|NCT01032291|561940097|FG002|Proof of Concept|Never Received Study Drug|0|||
155685236|NCT02576535|561940098|FG000|Overall Study|Withdrawal by Subject|2|||
155685237|NCT00347438|561940099|FG000|Overall Study|Withdrawal by Subject|1|||
155685238|NCT00347438|561940099|FG000|Overall Study|Physician Decision|1|||
155685239|NCT02545517|561940100|FG000|Overall Study|Death|2|||
155685240|NCT02545517|561940101|FG001|Overall Study|Death|2|||
155685241|NCT02545517|561940102|FG002|Overall Study|Death|1|||
155685242|NCT02545517|561940100|FG000|Overall Study|Lost to Follow-up|14|||
155685243|NCT02545517|561940101|FG001|Overall Study|Lost to Follow-up|13|||
155685244|NCT02545517|561940102|FG002|Overall Study|Lost to Follow-up|17|||
155685245|NCT02545517|561940100|FG000|Overall Study|Protocol Violation|0|||
155685246|NCT02545517|561940101|FG001|Overall Study|Protocol Violation|1|||
155685247|NCT02545517|561940102|FG002|Overall Study|Protocol Violation|1|||
155685248|NCT02545517|561940100|FG000|Overall Study|Withdrawal by Subject|5|||
155685249|NCT02545517|561940101|FG001|Overall Study|Withdrawal by Subject|8|||
155685250|NCT02545517|561940102|FG002|Overall Study|Withdrawal by Subject|9|||
155685251|NCT02545517|561940100|FG000|Overall Study|Administrative reason|5|||
155685252|NCT02545517|561940101|FG001|Overall Study|Administrative reason|6|||
155685253|NCT02545517|561940102|FG002|Overall Study|Administrative reason|10|||
155685254|NCT02545517|561940100|FG000|Overall Study|Other|2|||
155685255|NCT02545517|561940101|FG001|Overall Study|Other|4|||
155685256|NCT02545517|561940102|FG002|Overall Study|Other|3|||
155685257|NCT01529515|561940103|FG000|TRANSITION PHASE|Adverse Event|16|||
155685258|NCT01529515|561940104|FG001|TRANSITION PHASE|Adverse Event|0|||
155685259|NCT01529515|561940105|FG002|TRANSITION PHASE|Adverse Event|0|||
155685260|NCT01529515|561940106|FG003|TRANSITION PHASE|Adverse Event|0|||
155685261|NCT01529515|561940103|FG000|TRANSITION PHASE|Death|1|||
155605089|NCT03800836|561641426|FG005|Overall Study|Symptomatic Deterioration|0|||
155605090|NCT01709864|561642896|FG000|Overall Study|Physician Decision|0|||
155605091|NCT01709864|561642897|FG001|Overall Study|Physician Decision|1|||
155605092|NCT01709864|561642896|FG000|Overall Study|subject/guardian decision|5|||
155605093|NCT01709864|561642897|FG001|Overall Study|subject/guardian decision|6|||
155605094|NCT01709864|561642896|FG000|Overall Study|Lost to Follow-up|1|||
155605095|NCT01709864|561642897|FG001|Overall Study|Lost to Follow-up|0|||
155605096|NCT01709864|561642896|FG000|Overall Study|non-compliance with study treatment|1|||
155605097|NCT01709864|561642897|FG001|Overall Study|non-compliance with study treatment|1|||
155605098|NCT01709864|561642896|FG000|Overall Study|Adverse Event|0|||
155605099|NCT01709864|561642897|FG001|Overall Study|Adverse Event|2|||
155605100|NCT01709864|561642896|FG000|Overall Study|Death|0|||
155605101|NCT01709864|561642897|FG001|Overall Study|Death|1|||
155605102|NCT01066793|561642898|FG000|Overall Study|Death|4|||
155605103|NCT01066793|561642899|FG001|Overall Study|Death|1|||
155605104|NCT01066793|561642900|FG002|Overall Study|Death|1|||
155605105|NCT01066793|561642901|FG003|Overall Study|Death|0|||
155605106|NCT01066793|561642902|FG004|Overall Study|Death|0|||
155605107|NCT01066793|561642903|FG005|Overall Study|Death|0|||
155605108|NCT01066793|561642898|FG000|Overall Study|Lack of Efficacy|2|||
155605109|NCT01066793|561642899|FG001|Overall Study|Lack of Efficacy|1|||
155605110|NCT01066793|561642900|FG002|Overall Study|Lack of Efficacy|0|||
155605111|NCT01066793|561642901|FG003|Overall Study|Lack of Efficacy|0|||
155605112|NCT01066793|561642902|FG004|Overall Study|Lack of Efficacy|0|||
155605113|NCT01066793|561642903|FG005|Overall Study|Lack of Efficacy|0|||
155605114|NCT01066793|561642898|FG000|Overall Study|Lost to Follow-up|180|||
155605115|NCT01066793|561642899|FG001|Overall Study|Lost to Follow-up|39|||
155605116|NCT01066793|561642900|FG002|Overall Study|Lost to Follow-up|82|||
155605117|NCT01066793|561642901|FG003|Overall Study|Lost to Follow-up|16|||
155605118|NCT01066793|561642902|FG004|Overall Study|Lost to Follow-up|0|||
155605119|NCT01066793|561642903|FG005|Overall Study|Lost to Follow-up|1|||
155605120|NCT01066793|561642898|FG000|Overall Study|Physician Decision|3|||
155605121|NCT01066793|561642899|FG001|Overall Study|Physician Decision|0|||
155605122|NCT01066793|561642900|FG002|Overall Study|Physician Decision|0|||
155605123|NCT01066793|561642901|FG003|Overall Study|Physician Decision|0|||
155605124|NCT01066793|561642902|FG004|Overall Study|Physician Decision|0|||
155605125|NCT01066793|561642903|FG005|Overall Study|Physician Decision|0|||
155605126|NCT01066793|561642898|FG000|Overall Study|Protocol Violation|3|||
155605127|NCT01066793|561642899|FG001|Overall Study|Protocol Violation|2|||
155605128|NCT01066793|561642900|FG002|Overall Study|Protocol Violation|2|||
155605129|NCT01066793|561642901|FG003|Overall Study|Protocol Violation|0|||
155605130|NCT01066793|561642902|FG004|Overall Study|Protocol Violation|0|||
155605131|NCT01066793|561642903|FG005|Overall Study|Protocol Violation|0|||
155605132|NCT01066793|561642898|FG000|Overall Study|Withdrawal by Subject|7|||
155605133|NCT01066793|561642899|FG001|Overall Study|Withdrawal by Subject|4|||
155605134|NCT01066793|561642900|FG002|Overall Study|Withdrawal by Subject|1|||
155605135|NCT01066793|561642901|FG003|Overall Study|Withdrawal by Subject|0|||
155605136|NCT01066793|561642902|FG004|Overall Study|Withdrawal by Subject|0|||
155605137|NCT01066793|561642903|FG005|Overall Study|Withdrawal by Subject|0|||
155605138|NCT01066793|561642898|FG000|Overall Study|Early Termination|3|||
155605139|NCT01066793|561642899|FG001|Overall Study|Early Termination|0|||
155605140|NCT01066793|561642900|FG002|Overall Study|Early Termination|0|||
155605141|NCT01066793|561642901|FG003|Overall Study|Early Termination|0|||
155605142|NCT01066793|561642902|FG004|Overall Study|Early Termination|0|||
155605143|NCT01066793|561642903|FG005|Overall Study|Early Termination|0|||
155605144|NCT01066793|561642898|FG000|Overall Study|Lab test not done|7|||
155605145|NCT01066793|561642899|FG001|Overall Study|Lab test not done|0|||
155605146|NCT01066793|561642900|FG002|Overall Study|Lab test not done|0|||
155605147|NCT01066793|561642901|FG003|Overall Study|Lab test not done|1|||
155605148|NCT01066793|561642902|FG004|Overall Study|Lab test not done|0|||
155605149|NCT01066793|561642903|FG005|Overall Study|Lab test not done|0|||
155605150|NCT01066793|561642898|FG000|Overall Study|Miscellaneous|4|||
155605151|NCT01066793|561642899|FG001|Overall Study|Miscellaneous|5|||
155605152|NCT01066793|561642900|FG002|Overall Study|Miscellaneous|6|||
155605153|NCT01066793|561642901|FG003|Overall Study|Miscellaneous|0|||
155605154|NCT01066793|561642902|FG004|Overall Study|Miscellaneous|0|||
155605155|NCT01066793|561642903|FG005|Overall Study|Miscellaneous|0|||
155605156|NCT01066793|561642898|FG000|Overall Study|Non-responders|104|||
155605157|NCT01066793|561642899|FG001|Overall Study|Non-responders|5|||
155605158|NCT01066793|561642900|FG002|Overall Study|Non-responders|11|||
155605159|NCT01066793|561642901|FG003|Overall Study|Non-responders|25|||
155605160|NCT01066793|561642902|FG004|Overall Study|Non-responders|0|||
155605161|NCT01066793|561642903|FG005|Overall Study|Non-responders|0|||
155605162|NCT01066793|561642898|FG000|Overall Study|Other|15|||
155605163|NCT01066793|561642899|FG001|Overall Study|Other|5|||
155605164|NCT01066793|561642900|FG002|Overall Study|Other|6|||
155605165|NCT01066793|561642901|FG003|Overall Study|Other|2|||
155605166|NCT01066793|561642902|FG004|Overall Study|Other|0|||
155685262|NCT01529515|561940104|FG001|TRANSITION PHASE|Death|0|||
155685263|NCT01529515|561940105|FG002|TRANSITION PHASE|Death|0|||
155685264|NCT01529515|561940106|FG003|TRANSITION PHASE|Death|0|||
155685265|NCT01529515|561940103|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
155685266|NCT01529515|561940104|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
155685267|NCT01529515|561940105|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
155685268|NCT01529515|561940106|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
155685269|NCT01529515|561940103|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
155685270|NCT01529515|561940104|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
155685271|NCT01529515|561940105|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
155685272|NCT01529515|561940106|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
155685273|NCT01529515|561940103|FG000|TRANSITION PHASE|Protocol Violation|4|||
155685274|NCT01529515|561940104|FG001|TRANSITION PHASE|Protocol Violation|0|||
155685275|NCT01529515|561940105|FG002|TRANSITION PHASE|Protocol Violation|0|||
155685276|NCT01529515|561940106|FG003|TRANSITION PHASE|Protocol Violation|0|||
155685277|NCT01529515|561940103|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
155685278|NCT01529515|561940104|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
155685279|NCT01529515|561940105|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
155685280|NCT01529515|561940106|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
155685281|NCT01529515|561940103|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
155685282|NCT01529515|561940104|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
155685283|NCT01529515|561940105|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
155685284|NCT01529515|561940106|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
155685285|NCT01529515|561940103|FG000|TRANSITION PHASE|Other|9|||
155685286|NCT01529515|561940104|FG001|TRANSITION PHASE|Other|0|||
155685287|NCT01529515|561940105|FG002|TRANSITION PHASE|Other|0|||
155685288|NCT01529515|561940106|FG003|TRANSITION PHASE|Other|0|||
155685289|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Adverse Event|0|||
155685290|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Adverse Event|10|||
155685291|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Adverse Event|0|||
155685292|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Adverse Event|0|||
155685293|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
155685294|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
155685295|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
155685296|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
155685297|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
155685298|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
155685299|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
155685300|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
155685301|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
155685302|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
155685303|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
155685304|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
155685305|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155685306|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
155685307|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155685308|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155685309|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
155685310|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
155685311|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
155685312|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
155685313|NCT01529515|561940103|FG000|MAINTENANCE PHASE|Other|0|||
155685314|NCT01529515|561940104|FG001|MAINTENANCE PHASE|Other|10|||
155685315|NCT01529515|561940105|FG002|MAINTENANCE PHASE|Other|0|||
155685316|NCT01529515|561940106|FG003|MAINTENANCE PHASE|Other|0|||
155685317|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
155685318|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
155685319|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
155685320|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
155685321|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
155685322|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
155685323|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
155685324|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
155685325|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
155685326|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
155685327|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
155685328|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
155685329|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
155685330|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
155685331|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
155685332|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
155685333|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
155685334|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
155685335|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
155685336|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
155685337|NCT01529515|561940103|FG000|DOUBLE BLIND PHASE|Other|0|||
155685338|NCT01529515|561940104|FG001|DOUBLE BLIND PHASE|Other|0|||
155685339|NCT01529515|561940105|FG002|DOUBLE BLIND PHASE|Other|9|||
155685340|NCT01529515|561940106|FG003|DOUBLE BLIND PHASE|Other|2|||
155685341|NCT03334851|561940108|FG000|Overall Study|Other|0|||
155685342|NCT03334851|561940109|FG001|Overall Study|Other|0|||
155685343|NCT03334851|561940110|FG002|Overall Study|Other|0|||
155685344|NCT03334851|561940111|FG003|Overall Study|Other|0|||
155685345|NCT03334851|561940112|FG004|Overall Study|Other|0|||
155685346|NCT03334851|561940113|FG005|Overall Study|Other|0|||
155685347|NCT03334851|561940114|FG006|Overall Study|Other|0|||
155685348|NCT03334851|561940115|FG007|Overall Study|Other|1|||
155685349|NCT03334851|561940116|FG008|Overall Study|Other|0|||
155685350|NCT03334851|561940117|FG009|Overall Study|Other|0|||
155685351|NCT03334851|561940118|FG010|Overall Study|Other|0|||
155685352|NCT03334851|561940119|FG011|Overall Study|Other|0|||
155685353|NCT03334851|561940120|FG012|Overall Study|Other|0|||
155685354|NCT03334851|561940108|FG000|Overall Study|Adverse Event|0|||
155685355|NCT03334851|561940109|FG001|Overall Study|Adverse Event|0|||
155685356|NCT03334851|561940110|FG002|Overall Study|Adverse Event|0|||
155685357|NCT03334851|561940111|FG003|Overall Study|Adverse Event|0|||
155685358|NCT03334851|561940112|FG004|Overall Study|Adverse Event|0|||
155685359|NCT03334851|561940113|FG005|Overall Study|Adverse Event|0|||
155685360|NCT03334851|561940114|FG006|Overall Study|Adverse Event|0|||
155685361|NCT03334851|561940115|FG007|Overall Study|Adverse Event|1|||
155685362|NCT03334851|561940116|FG008|Overall Study|Adverse Event|0|||
155685363|NCT03334851|561940117|FG009|Overall Study|Adverse Event|0|||
155685364|NCT03334851|561940118|FG010|Overall Study|Adverse Event|0|||
155685365|NCT03334851|561940119|FG011|Overall Study|Adverse Event|0|||
155685366|NCT03334851|561940120|FG012|Overall Study|Adverse Event|0|||
155685367|NCT03334851|561940108|FG000|Overall Study|Withdrawal by Subject|0|||
155685368|NCT03334851|561940109|FG001|Overall Study|Withdrawal by Subject|0|||
155685369|NCT03334851|561940110|FG002|Overall Study|Withdrawal by Subject|0|||
155685370|NCT03334851|561940111|FG003|Overall Study|Withdrawal by Subject|0|||
155685371|NCT03334851|561940112|FG004|Overall Study|Withdrawal by Subject|0|||
155685372|NCT03334851|561940113|FG005|Overall Study|Withdrawal by Subject|0|||
155685373|NCT03334851|561940114|FG006|Overall Study|Withdrawal by Subject|0|||
155685374|NCT03334851|561940115|FG007|Overall Study|Withdrawal by Subject|0|||
155685375|NCT03334851|561940116|FG008|Overall Study|Withdrawal by Subject|0|||
155685376|NCT03334851|561940117|FG009|Overall Study|Withdrawal by Subject|0|||
155685377|NCT03334851|561940118|FG010|Overall Study|Withdrawal by Subject|1|||
155685378|NCT03334851|561940119|FG011|Overall Study|Withdrawal by Subject|0|||
155685379|NCT03334851|561940120|FG012|Overall Study|Withdrawal by Subject|1|||
155685380|NCT03334851|561940108|FG000|Overall Study|Lost to Follow-up|0|||
155685381|NCT03334851|561940109|FG001|Overall Study|Lost to Follow-up|0|||
155685382|NCT03334851|561940110|FG002|Overall Study|Lost to Follow-up|0|||
155685383|NCT03334851|561940111|FG003|Overall Study|Lost to Follow-up|0|||
155685384|NCT03334851|561940112|FG004|Overall Study|Lost to Follow-up|0|||
155685385|NCT03334851|561940113|FG005|Overall Study|Lost to Follow-up|0|||
155685386|NCT03334851|561940114|FG006|Overall Study|Lost to Follow-up|0|||
155685387|NCT03334851|561940115|FG007|Overall Study|Lost to Follow-up|0|||
155685388|NCT03334851|561940116|FG008|Overall Study|Lost to Follow-up|0|||
155685389|NCT03334851|561940117|FG009|Overall Study|Lost to Follow-up|0|||
155685390|NCT03334851|561940118|FG010|Overall Study|Lost to Follow-up|2|||
155685391|NCT03334851|561940119|FG011|Overall Study|Lost to Follow-up|1|||
155685392|NCT03334851|561940120|FG012|Overall Study|Lost to Follow-up|0|||
155685393|NCT03327220|561940121|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
155685394|NCT03327220|561940122|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
155685395|NCT03327220|561940121|FG000|Overall Study|Investigator Decision|2|||
155685396|NCT03327220|561940122|FG001|Overall Study|Investigator Decision|0|||
155685397|NCT03327220|561940121|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
155685398|NCT03327220|561940122|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
155685399|NCT03327220|561940121|FG000|Overall Study|Fungal infection|1|||
155685400|NCT03327220|561940122|FG001|Overall Study|Fungal infection|0|||
155685401|NCT03327220|561940121|FG000|Overall Study|Discharged to Rehabilitation|0|||
155685402|NCT03327220|561940122|FG001|Overall Study|Discharged to Rehabilitation|1|||
155685403|NCT03327220|561940121|FG000|Overall Study|Missing|1|||
155685404|NCT03327220|561940122|FG001|Overall Study|Missing|0|||
155685405|NCT00523705|561940123|FG000|Overall Study|No time for study.|0|||
155685406|NCT00523705|561940124|FG001|Overall Study|No time for study.|1|||
155685407|NCT00693017|561940125|FG000|Overall Study|Sponsor Decision|2|||
155685408|NCT00693017|561940126|FG001|Overall Study|Sponsor Decision|1|||
155685409|NCT00693017|561940125|FG000|Overall Study|Death|0|||
155685410|NCT00693017|561940126|FG001|Overall Study|Death|1|||
155685411|NCT01691885|561940128|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
155685412|NCT01691885|561940129|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
155685413|NCT01691885|561940128|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
155685414|NCT01691885|561940129|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
155685415|NCT00688324|561940131|FG000|Overall Study|Withdrawal by Subject|2|||
155685416|NCT00688324|561940131|FG000|Overall Study|Physician Decision|5|||
155685417|NCT00688324|561940131|FG000|Overall Study|Lost to Follow-up|1|||
155685418|NCT01562314|561940133|FG000|Overall Study|Adverse Event|10|||
155685419|NCT01562314|561940134|FG001|Overall Study|Adverse Event|5|||
155685420|NCT01562314|561940133|FG000|Overall Study|Met Withdrawal Criteria|3|||
155685421|NCT01562314|561940134|FG001|Overall Study|Met Withdrawal Criteria|2|||
155685422|NCT01562314|561940133|FG000|Overall Study|Withdrawal by Subject|0|||
155685423|NCT01562314|561940134|FG001|Overall Study|Withdrawal by Subject|1|||
155685424|NCT01190475|561940137|FG000|Overall Study|Withdrawal by Subject|0|||
155685425|NCT01190475|561940138|FG001|Overall Study|Withdrawal by Subject|0|||
155685426|NCT01190475|561940139|FG002|Overall Study|Withdrawal by Subject|1|||
155685427|NCT00543803|561940140|FG000|Overall Study|Adverse Event|14|||
155685428|NCT00543803|561940140|FG000|Overall Study|Lack of Efficacy|22|||
155685429|NCT00543803|561940140|FG000|Overall Study|Lost to Follow-up|20|||
155685430|NCT00543803|561940140|FG000|Overall Study|Other|86|||
155685431|NCT00996281|561940141|FG000|Overall Study|Adverse Event|75|||
155685432|NCT00996281|561940142|FG001|Overall Study|Adverse Event|37|||
155685433|NCT00996281|561940141|FG000|Overall Study|Major Protocol Deviation|6|||
155685434|NCT00996281|561940142|FG001|Overall Study|Major Protocol Deviation|7|||
155685435|NCT00996281|561940141|FG000|Overall Study|Lost to Follow-up|14|||
155685436|NCT00996281|561940142|FG001|Overall Study|Lost to Follow-up|16|||
155685437|NCT00996281|561940141|FG000|Overall Study|Withdrawal by Subject|31|||
155685438|NCT00996281|561940142|FG001|Overall Study|Withdrawal by Subject|20|||
155685439|NCT00996281|561940141|FG000|Overall Study|Lack of Efficacy|0|||
155685440|NCT00996281|561940142|FG001|Overall Study|Lack of Efficacy|2|||
155685441|NCT00996281|561940141|FG000|Overall Study|Other|5|||
155685442|NCT00996281|561940142|FG001|Overall Study|Other|7|||
155685443|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
155685444|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
155685445|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
155685446|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
155685447|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
155685448|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
155685449|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
155685450|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
155685451|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
155685452|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
155685453|NCT01639339|561940149|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
155685454|NCT01639339|561940150|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
155685455|NCT01639339|561940149|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
155685456|NCT01639339|561940150|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
155685457|NCT01639339|561940149|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
155685458|NCT01639339|561940150|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
155685459|NCT01639339|561940149|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
155685460|NCT01639339|561940150|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
155685461|NCT01639339|561940149|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
155685462|NCT01639339|561940150|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
155685463|NCT02649218|561940151|FG000|Overall Study|Adverse Event|8|||
155685464|NCT02649218|561940151|FG000|Overall Study|Lack of Efficacy|8|||
155685465|NCT02649218|561940151|FG000|Overall Study|Pregnancy|3|||
155685466|NCT02649218|561940151|FG000|Overall Study|Protocol Violation|3|||
155685467|NCT02649218|561940151|FG000|Overall Study|Physician Decision|1|||
155685468|NCT02649218|561940151|FG000|Overall Study|Withdrawal by Subject|2|||
155685469|NCT04003207|561940156|FG000|Overall Study|Protocol Violation|1|||
155685470|NCT03894969|561940157|FG000|Overall Study|Adverse Event|0|||
155685471|NCT03894969|561940158|FG001|Overall Study|Adverse Event|2|||
155685472|NCT03894969|561940159|FG002|Overall Study|Adverse Event|0|||
155685473|NCT03894969|561940160|FG003|Overall Study|Adverse Event|1|||
155685474|NCT03894969|561940161|FG004|Overall Study|Adverse Event|2|||
155685475|NCT03894969|561940157|FG000|Overall Study|Lost to Follow-up|3|||
155685476|NCT03894969|561940158|FG001|Overall Study|Lost to Follow-up|1|||
155685477|NCT03894969|561940159|FG002|Overall Study|Lost to Follow-up|1|||
155685478|NCT03894969|561940160|FG003|Overall Study|Lost to Follow-up|0|||
155685479|NCT03894969|561940161|FG004|Overall Study|Lost to Follow-up|0|||
155685480|NCT03894969|561940157|FG000|Overall Study|Withdrawal by Subject|2|||
155685481|NCT03894969|561940158|FG001|Overall Study|Withdrawal by Subject|1|||
155685482|NCT03894969|561940159|FG002|Overall Study|Withdrawal by Subject|3|||
155685483|NCT03894969|561940160|FG003|Overall Study|Withdrawal by Subject|4|||
155685484|NCT03894969|561940161|FG004|Overall Study|Withdrawal by Subject|8|||
155685485|NCT03894969|561940157|FG000|Overall Study|Other|0|||
155685486|NCT03894969|561940158|FG001|Overall Study|Other|0|||
155685487|NCT03894969|561940159|FG002|Overall Study|Other|0|||
155685488|NCT03894969|561940160|FG003|Overall Study|Other|0|||
155685489|NCT03894969|561940161|FG004|Overall Study|Other|3|||
155685490|NCT03894969|561940157|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155685491|NCT03894969|561940158|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155685492|NCT03894969|561940159|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155685493|NCT03894969|561940160|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
155685494|NCT03894969|561940161|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
155685495|NCT03894969|561940157|FG000|Overall Study|Solicited Adverse Event|0|||
155685496|NCT03894969|561940158|FG001|Overall Study|Solicited Adverse Event|1|||
155685497|NCT03894969|561940159|FG002|Overall Study|Solicited Adverse Event|0|||
155685498|NCT03894969|561940160|FG003|Overall Study|Solicited Adverse Event|0|||
155685499|NCT03894969|561940161|FG004|Overall Study|Solicited Adverse Event|0|||
155685500|NCT00468676|561940163|FG000|Overall Study|Lost to Follow-up|14|||
155685501|NCT00468676|561940164|FG001|Overall Study|Lost to Follow-up|11|||
155685502|NCT00468676|561940163|FG000|Overall Study|Death|2|||
155685503|NCT00468676|561940164|FG001|Overall Study|Death|1|||
155685504|NCT02378298|561940167|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
155685505|NCT02378298|561940168|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
155685506|NCT02378298|561940169|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
155685507|NCT02378298|561940167|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
155685508|NCT02378298|561940168|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
155685509|NCT02378298|561940169|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
155685510|NCT02378298|561940167|FG000|Surveillance (19-68 Weeks)|Death|1|||
155685511|NCT02378298|561940168|FG001|Surveillance (19-68 Weeks)|Death|0|||
155685512|NCT02378298|561940169|FG002|Surveillance (19-68 Weeks)|Death|0|||
155685513|NCT04173260|561940170|FG000|Overall Study|Early termination|4|||
155685514|NCT02308163|561940173|FG000|Overall Study|Not fulfill eligible criteria|1|||
155685515|NCT02308163|561940174|FG001|Overall Study|Not fulfill eligible criteria|2|||
155685516|NCT02308163|561940175|FG002|Overall Study|Not fulfill eligible criteria|0|||
155685517|NCT02308163|561940176|FG003|Overall Study|Not fulfill eligible criteria|1|||
155685518|NCT02308163|561940177|FG004|Overall Study|Not fulfill eligible criteria|1|||
155685519|NCT02308163|561940173|FG000|Overall Study|Adverse Event|9|||
155685520|NCT02308163|561940174|FG001|Overall Study|Adverse Event|5|||
155685521|NCT02308163|561940175|FG002|Overall Study|Adverse Event|2|||
155685522|NCT02308163|561940176|FG003|Overall Study|Adverse Event|2|||
155685523|NCT02308163|561940177|FG004|Overall Study|Adverse Event|11|||
155685524|NCT02308163|561940173|FG000|Overall Study|Lack of Efficacy|11|||
155685525|NCT02308163|561940174|FG001|Overall Study|Lack of Efficacy|3|||
155685526|NCT02308163|561940175|FG002|Overall Study|Lack of Efficacy|8|||
155685527|NCT02308163|561940176|FG003|Overall Study|Lack of Efficacy|4|||
155685528|NCT02308163|561940177|FG004|Overall Study|Lack of Efficacy|6|||
155685529|NCT02308163|561940173|FG000|Overall Study|Withdrawal of consent|2|||
155685530|NCT02308163|561940174|FG001|Overall Study|Withdrawal of consent|3|||
155685531|NCT02308163|561940175|FG002|Overall Study|Withdrawal of consent|0|||
155685532|NCT02308163|561940176|FG003|Overall Study|Withdrawal of consent|2|||
155685533|NCT02308163|561940177|FG004|Overall Study|Withdrawal of consent|6|||
155685534|NCT02308163|561940173|FG000|Overall Study|Protocol Violation|3|||
155685535|NCT02308163|561940174|FG001|Overall Study|Protocol Violation|3|||
155685536|NCT02308163|561940175|FG002|Overall Study|Protocol Violation|3|||
155685537|NCT02308163|561940176|FG003|Overall Study|Protocol Violation|2|||
155685538|NCT02308163|561940177|FG004|Overall Study|Protocol Violation|5|||
155685539|NCT02308163|561940173|FG000|Overall Study|Lab data met discontinuation criteria|3|||
155685540|NCT02308163|561940174|FG001|Overall Study|Lab data met discontinuation criteria|0|||
155685541|NCT02308163|561940175|FG002|Overall Study|Lab data met discontinuation criteria|0|||
155685542|NCT02308163|561940176|FG003|Overall Study|Lab data met discontinuation criteria|2|||
155685543|NCT02308163|561940177|FG004|Overall Study|Lab data met discontinuation criteria|0|||
155685544|NCT02308163|561940173|FG000|Overall Study|Miscellaneous|2|||
155685545|NCT02308163|561940174|FG001|Overall Study|Miscellaneous|2|||
155685546|NCT02308163|561940175|FG002|Overall Study|Miscellaneous|1|||
155685547|NCT02308163|561940176|FG003|Overall Study|Miscellaneous|0|||
155685548|NCT02308163|561940177|FG004|Overall Study|Miscellaneous|5|||
155685549|NCT03505788|561942289|FG000|Overall Study|Lost to Follow-up|2|||
155685550|NCT03505788|561942290|FG001|Overall Study|Lost to Follow-up|1|||
155685551|NCT03505788|561942289|FG000|Overall Study|Withdrawal by Subject|1|||
155685552|NCT03505788|561942290|FG001|Overall Study|Withdrawal by Subject|3|||
155685553|NCT03505788|561942289|FG000|Overall Study|Physician Decision|0|||
155685554|NCT03505788|561942290|FG001|Overall Study|Physician Decision|1|||
155685555|NCT03575065|561942291|FG000|Overall Study|Death|31|||
155685556|NCT03575065|561942292|FG001|Overall Study|Death|12|||
155685557|NCT03575065|561942291|FG000|Overall Study|Sponsor's Decision|28|||
155685558|NCT03575065|561942292|FG001|Overall Study|Sponsor's Decision|13|||
155685559|NCT03575065|561942291|FG000|Overall Study|Withdrawal by Subject|2|||
155685560|NCT03575065|561942292|FG001|Overall Study|Withdrawal by Subject|1|||
155685561|NCT03575065|561942291|FG000|Overall Study|Lost to Follow-up|1|||
155685562|NCT03575065|561942292|FG001|Overall Study|Lost to Follow-up|0|||
155685563|NCT02323126|561942297|FG000|Overall Study|Patient / guardian decision|0|||
155685564|NCT02323126|561942298|FG001|Overall Study|Patient / guardian decision|1|||
155685565|NCT02323126|561942299|FG002|Overall Study|Patient / guardian decision|2|||
155685566|NCT02323126|561942297|FG000|Overall Study|Progressive disease|14|||
155685567|NCT02323126|561942298|FG001|Overall Study|Progressive disease|8|||
155685568|NCT02323126|561942299|FG002|Overall Study|Progressive disease|14|||
155685569|NCT02323126|561942297|FG000|Overall Study|Physician Decision|0|||
155685570|NCT02323126|561942298|FG001|Overall Study|Physician Decision|1|||
155685571|NCT02323126|561942299|FG002|Overall Study|Physician Decision|3|||
155685572|NCT02323126|561942297|FG000|Overall Study|Death|1|||
155685573|NCT02323126|561942298|FG001|Overall Study|Death|1|||
155685574|NCT02323126|561942299|FG002|Overall Study|Death|4|||
155685575|NCT02323126|561942297|FG000|Overall Study|Adverse Event|3|||
155685576|NCT02323126|561942298|FG001|Overall Study|Adverse Event|5|||
155685577|NCT02323126|561942299|FG002|Overall Study|Adverse Event|7|||
155685578|NCT00396136|561942300|FG000|Overall Study|Death|43|||
155685579|NCT00396136|561942300|FG000|Overall Study|Withdrawal by Subject|59|||
155685580|NCT00396136|561942300|FG000|Overall Study|Lost to Follow-up|15|||
155685581|NCT00396136|561942300|FG000|Overall Study|Study device explanted|8|||
155685582|NCT01779856|561942301|FG000|Overall Study|Withdrawal by Subject|15|||
155685583|NCT01779856|561942301|FG000|Overall Study|Death|3|||
155685584|NCT01779856|561942301|FG000|Overall Study|Physician Decision|1|||
155685585|NCT01779856|561942301|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
155685586|NCT01779856|561942301|FG000|Overall Study|Delays in scheduling implant|1|||
155685587|NCT01779856|561942301|FG000|Overall Study|Subject ineligible for Implant|2|||
155685588|NCT03960580|561942302|FG000|Overall Study|Adverse Event|2|||
155685589|NCT03960580|561942303|FG001|Overall Study|Adverse Event|1|||
155685590|NCT03960580|561942304|FG002|Overall Study|Adverse Event|1|||
155685591|NCT03960580|561942302|FG000|Overall Study|Lost to Follow-up|1|||
155685592|NCT03960580|561942303|FG001|Overall Study|Lost to Follow-up|0|||
155685593|NCT03960580|561942304|FG002|Overall Study|Lost to Follow-up|0|||
155685594|NCT03960580|561942302|FG000|Overall Study|Lack of Efficacy|2|||
155685595|NCT03960580|561942303|FG001|Overall Study|Lack of Efficacy|1|||
155685596|NCT03960580|561942304|FG002|Overall Study|Lack of Efficacy|0|||
155685597|NCT03960580|561942302|FG000|Overall Study|Protocol Violation|0|||
155605167|NCT01066793|561642903|FG005|Overall Study|Other|0|||
155605168|NCT01066793|561642898|FG000|Overall Study|Relapse|20|||
155605169|NCT01066793|561642899|FG001|Overall Study|Relapse|8|||
155605170|NCT01066793|561642900|FG002|Overall Study|Relapse|2|||
155605171|NCT01066793|561642901|FG003|Overall Study|Relapse|3|||
155605172|NCT01066793|561642902|FG004|Overall Study|Relapse|0|||
155605173|NCT01066793|561642903|FG005|Overall Study|Relapse|0|||
155605174|NCT01066793|561642898|FG000|Overall Study|Result Not Available|1|||
155605175|NCT01066793|561642899|FG001|Overall Study|Result Not Available|0|||
155605176|NCT01066793|561642900|FG002|Overall Study|Result Not Available|0|||
155605177|NCT01066793|561642901|FG003|Overall Study|Result Not Available|0|||
155605178|NCT01066793|561642902|FG004|Overall Study|Result Not Available|0|||
155605179|NCT01066793|561642903|FG005|Overall Study|Result Not Available|0|||
155605180|NCT01066793|561642898|FG000|Overall Study|Treatment Interrupted|1|||
155605181|NCT01066793|561642899|FG001|Overall Study|Treatment Interrupted|1|||
155605182|NCT01066793|561642900|FG002|Overall Study|Treatment Interrupted|0|||
155605183|NCT01066793|561642901|FG003|Overall Study|Treatment Interrupted|0|||
155605184|NCT01066793|561642902|FG004|Overall Study|Treatment Interrupted|0|||
155605185|NCT01066793|561642903|FG005|Overall Study|Treatment Interrupted|0|||
155605186|NCT01066793|561642898|FG000|Overall Study|Treatment Never Started|18|||
155605187|NCT01066793|561642899|FG001|Overall Study|Treatment Never Started|5|||
155605188|NCT01066793|561642900|FG002|Overall Study|Treatment Never Started|4|||
155605189|NCT01066793|561642901|FG003|Overall Study|Treatment Never Started|1|||
155605190|NCT01066793|561642902|FG004|Overall Study|Treatment Never Started|0|||
155605191|NCT01066793|561642903|FG005|Overall Study|Treatment Never Started|0|||
155605192|NCT01066793|561642898|FG000|Overall Study|Treatment Stopped|2|||
155685598|NCT03960580|561942303|FG001|Overall Study|Protocol Violation|0|||
155685599|NCT03960580|561942304|FG002|Overall Study|Protocol Violation|1|||
155685600|NCT03960580|561942302|FG000|Overall Study|Withdrawal by Subject|1|||
155685601|NCT03960580|561942303|FG001|Overall Study|Withdrawal by Subject|1|||
155685602|NCT03960580|561942304|FG002|Overall Study|Withdrawal by Subject|1|||
155685603|NCT03960580|561942302|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
155605193|NCT01066793|561642899|FG001|Overall Study|Treatment Stopped|1|||
155685604|NCT03960580|561942303|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
155685605|NCT03960580|561942304|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
155685606|NCT01774097|561942309|FG000|Overall Study|Withdrawal by Subject|1|||
155685607|NCT01774097|561942310|FG001|Overall Study|Withdrawal by Subject|1|||
155685608|NCT01774097|561942309|FG000|Overall Study|Adverse Event|1|||
155685609|NCT01774097|561942310|FG001|Overall Study|Adverse Event|1|||
155685610|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
155685611|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
155685612|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155685613|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
155685614|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
155685615|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155685616|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
155685617|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685618|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685619|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685620|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155685621|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
155685622|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685623|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685624|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685625|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685626|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685627|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155685628|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155685629|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685630|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155685631|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685632|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685633|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155685634|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155685635|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685636|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685637|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685638|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685639|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685640|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685641|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685642|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155605194|NCT01066793|561642900|FG002|Overall Study|Treatment Stopped|0|||
155605195|NCT01066793|561642901|FG003|Overall Study|Treatment Stopped|1|||
155605196|NCT01066793|561642902|FG004|Overall Study|Treatment Stopped|0|||
155605197|NCT01066793|561642903|FG005|Overall Study|Treatment Stopped|0|||
155605198|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155605199|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
155605200|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155605201|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155605202|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155605203|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155605204|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155605205|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
155605206|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
155605207|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155605208|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155605209|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155605210|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
155605211|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
155605212|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
155605213|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
155605214|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155605215|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155605216|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155605217|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
155605218|NCT00994214|561642905|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
155605219|NCT00994214|561642906|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
155605220|NCT00994214|561642907|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
155605221|NCT00994214|561642908|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
155685643|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155605222|NCT03246061|561642909|FG000|Overall Study|Still in follow-up|15|||
155605223|NCT03246061|561642910|FG001|Overall Study|Still in follow-up|21|||
155605224|NCT02864316|561642911|FG000|Overall Study|Progressive Disease|2|||
155605225|NCT02864316|561642912|FG001|Overall Study|Progressive Disease|1|||
155605226|NCT02864316|561642911|FG000|Overall Study|Adverse Event|0|||
155605227|NCT02864316|561642912|FG001|Overall Study|Adverse Event|1|||
155605228|NCT04710368|561642913|FG000|Overall Study|Withdrawal by Subject|9|||
155605229|NCT04710368|561642913|FG000|Overall Study|Lost to Follow-up|4|||
155605230|NCT04710368|561642913|FG000|Overall Study|Death|2|||
155605231|NCT04710368|561642913|FG000|Overall Study|Patient preference|11|||
155605232|NCT04710368|561642913|FG000|Overall Study|Treatment discontinuation|1|||
155605233|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
155605234|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
155605235|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
155605236|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
155605237|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
155605238|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
155605239|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
155605240|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
155605241|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
155605242|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
155605243|NCT01777139|561642919|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
155605244|NCT01777139|561642920|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
155605245|NCT01777139|561642919|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
155605246|NCT01777139|561642920|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
155605247|NCT01777139|561642919|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
155605248|NCT01777139|561642920|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
155605249|NCT00616603|561642923|FG000|Overall Study|Physician Decision|2|||
155605250|NCT00616603|561642924|FG001|Overall Study|Physician Decision|0|||
155605251|NCT00616603|561642925|FG002|Overall Study|Physician Decision|2|||
155605252|NCT00367484|561642929|FG000|Overall Study|Adverse Event|7|||
155605253|NCT00367484|561642929|FG000|Overall Study|Withdrew informed consent|5|||
155605254|NCT00367484|561642929|FG000|Overall Study|Travel to USA|1|||
155605255|NCT00367484|561642929|FG000|Overall Study|Lost to Follow-up|1|||
155605256|NCT00367484|561642929|FG000|Overall Study|Protocol Violation|1|||
155605257|NCT00367484|561642929|FG000|Overall Study|The choice of the patient|1|||
155605258|NCT00367484|561642929|FG000|Overall Study|Lack of Efficacy|1|||
155605259|NCT02470403|561642930|FG000|Overall Study|Adverse Event|1|||
155605260|NCT02470403|561642931|FG001|Overall Study|Adverse Event|0|||
155605261|NCT02470403|561642932|FG002|Overall Study|Adverse Event|0|||
155605262|NCT02470403|561642933|FG003|Overall Study|Adverse Event|0|||
155605263|NCT02470403|561642934|FG004|Overall Study|Adverse Event|0|||
155605264|NCT02470403|561642930|FG000|Overall Study|Lost to Follow-up|0|||
155605265|NCT02470403|561642931|FG001|Overall Study|Lost to Follow-up|1|||
155605266|NCT02470403|561642932|FG002|Overall Study|Lost to Follow-up|0|||
155605267|NCT02470403|561642933|FG003|Overall Study|Lost to Follow-up|0|||
155605268|NCT02470403|561642934|FG004|Overall Study|Lost to Follow-up|0|||
155605269|NCT02470403|561642930|FG000|Overall Study|Subject/guardian decision|1|||
155605270|NCT02470403|561642931|FG001|Overall Study|Subject/guardian decision|0|||
155605271|NCT02470403|561642932|FG002|Overall Study|Subject/guardian decision|0|||
155605272|NCT02470403|561642933|FG003|Overall Study|Subject/guardian decision|4|||
155605273|NCT02470403|561642934|FG004|Overall Study|Subject/guardian decision|0|||
155605274|NCT00987402|561642935|FG000|Overall Study|Insufficient data entry|86|||
155605275|NCT00987402|561642936|FG001|Overall Study|Insufficient data entry|98|||
155605276|NCT01362517|561642937|FG000|Overall Study|Protocol Violation|1|||
155605277|NCT01362517|561642937|FG000|Overall Study|Lost to Follow-up|1|||
155605278|NCT02273908|561642940|FG000|Overall Study|Adverse Event|16|||
155605279|NCT02273908|561642941|FG001|Overall Study|Adverse Event|0|||
155605280|NCT02273908|561642940|FG000|Overall Study|Lost to Follow-up|10|||
155605281|NCT02273908|561642941|FG001|Overall Study|Lost to Follow-up|1|||
155605282|NCT02273908|561642940|FG000|Overall Study|Did not meet entrance criteria|3|||
155605283|NCT02273908|561642941|FG001|Overall Study|Did not meet entrance criteria|2|||
155605284|NCT02273908|561642940|FG000|Overall Study|Withdrawal by Subject|4|||
155605285|NCT02273908|561642941|FG001|Overall Study|Withdrawal by Subject|2|||
155605286|NCT00369161|561642942|FG000|Overall Study|Adverse Event|15|||
155605287|NCT00369161|561642943|FG001|Overall Study|Adverse Event|13|||
155605288|NCT00369161|561642942|FG000|Overall Study|Abnormal laboratory value|0|||
155605289|NCT00369161|561642943|FG001|Overall Study|Abnormal laboratory value|1|||
155605290|NCT00369161|561642942|FG000|Overall Study|Lack of Efficacy|3|||
155605291|NCT00369161|561642943|FG001|Overall Study|Lack of Efficacy|1|||
155605292|NCT00369161|561642942|FG000|Overall Study|Protocol Violation|0|||
155605293|NCT00369161|561642943|FG001|Overall Study|Protocol Violation|2|||
155605294|NCT00369161|561642942|FG000|Overall Study|Withdrawal by Subject|2|||
155605295|NCT00369161|561642943|FG001|Overall Study|Withdrawal by Subject|3|||
155685644|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685645|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155685646|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685647|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685648|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
155685649|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685650|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685651|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685652|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685653|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685654|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685655|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685656|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685657|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685658|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685659|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685660|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685661|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685662|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685663|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155685664|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685665|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685666|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
155685667|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685668|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685669|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685670|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685671|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685672|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685673|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685674|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685675|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685676|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685677|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685678|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685679|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685680|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685681|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155685682|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685683|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685684|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685685|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685686|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685687|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685688|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685689|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685690|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685691|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685692|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
155685693|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685694|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685695|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685696|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685697|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685698|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685699|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155685700|NCT03447314|561942311|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685701|NCT03447314|561942312|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685702|NCT03447314|561942313|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685703|NCT03447314|561942314|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
155685704|NCT03447314|561942315|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685705|NCT03447314|561942316|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
155685706|NCT03447314|561942317|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685707|NCT03447314|561942318|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685708|NCT03447314|561942319|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685709|NCT03447314|561942320|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685710|NCT03447314|561942321|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685711|NCT03447314|561942322|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685712|NCT03447314|561942323|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685713|NCT03447314|561942324|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685714|NCT03447314|561942325|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685715|NCT03447314|561942326|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685716|NCT03447314|561942327|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685717|NCT03447314|561942328|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155685718|NCT01920568|561942329|FG000|Overall Study|Adverse Event|27|||
155685719|NCT01920568|561942330|FG001|Overall Study|Adverse Event|8|||
155685720|NCT01920568|561942329|FG000|Overall Study|Protocol Violation|5|||
155685721|NCT01920568|561942330|FG001|Overall Study|Protocol Violation|3|||
155685722|NCT01920568|561942329|FG000|Overall Study|Lost to Follow-up|2|||
155685723|NCT01920568|561942330|FG001|Overall Study|Lost to Follow-up|2|||
155685724|NCT01920568|561942329|FG000|Overall Study|Physician Decision|13|||
155685725|NCT01920568|561942330|FG001|Overall Study|Physician Decision|4|||
155685726|NCT01920568|561942329|FG000|Overall Study|Withdrawal by Subject|79|||
155685727|NCT01920568|561942330|FG001|Overall Study|Withdrawal by Subject|55|||
155685728|NCT01920568|561942329|FG000|Overall Study|Death due to disease progression|25|||
155685729|NCT01920568|561942330|FG001|Overall Study|Death due to disease progression|12|||
155685730|NCT01703208|561942332|FG000|Overall Study|Death|61|||
155685731|NCT01703208|561942333|FG001|Overall Study|Death|48|||
155685732|NCT01703208|561942332|FG000|Overall Study|Lack of Efficacy|1|||
155685733|NCT01703208|561942333|FG001|Overall Study|Lack of Efficacy|2|||
155685734|NCT01703208|561942332|FG000|Overall Study|Lost to Follow-up|68|||
155685735|NCT01703208|561942333|FG001|Overall Study|Lost to Follow-up|62|||
155685736|NCT01703208|561942332|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155685737|NCT01703208|561942333|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155685738|NCT01703208|561942332|FG000|Overall Study|Excluded Medication|1|||
155685739|NCT01703208|561942333|FG001|Overall Study|Excluded Medication|2|||
155685740|NCT01703208|561942332|FG000|Overall Study|Site Discontinued Study Participation|23|||
155685741|NCT01703208|561942333|FG001|Overall Study|Site Discontinued Study Participation|27|||
155685742|NCT01703208|561942332|FG000|Overall Study|Physician Decision|11|||
155685743|NCT01703208|561942333|FG001|Overall Study|Physician Decision|13|||
155685744|NCT01703208|561942332|FG000|Overall Study|Progressive disease|2|||
155685745|NCT01703208|561942333|FG001|Overall Study|Progressive disease|2|||
155685746|NCT01703208|561942332|FG000|Overall Study|Protocol Violation|1|||
155685747|NCT01703208|561942333|FG001|Overall Study|Protocol Violation|1|||
155685748|NCT01703208|561942332|FG000|Overall Study|Study Terminated by Sponsor|1710|||
155685749|NCT01703208|561942333|FG001|Overall Study|Study Terminated by Sponsor|1716|||
155685750|NCT01703208|561942332|FG000|Overall Study|Withdrawal by Subject|205|||
155685751|NCT01703208|561942333|FG001|Overall Study|Withdrawal by Subject|209|||
155685752|NCT01703208|561942332|FG000|Overall Study|Adverse Event|14|||
155685753|NCT01703208|561942333|FG001|Overall Study|Adverse Event|19|||
155685754|NCT01703208|561942332|FG000|Overall Study|Technical Problems|0|||
155685755|NCT01703208|561942333|FG001|Overall Study|Technical Problems|1|||
155685756|NCT01703208|561942332|FG000|Overall Study|Protocol Deviation|2|||
155685757|NCT01703208|561942333|FG001|Overall Study|Protocol Deviation|0|||
155685758|NCT00252694|561942334|FG000|Overall Study|Withdrawal by Subject|83|||
155685759|NCT00252694|561942335|FG001|Overall Study|Withdrawal by Subject|91|||
155685760|NCT00252694|561942334|FG000|Overall Study|Death|36|||
155685761|NCT00252694|561942335|FG001|Overall Study|Death|34|||
155685762|NCT00252694|561942334|FG000|Overall Study|Mostly Lost to Follow Up|8|||
155685763|NCT00252694|561942335|FG001|Overall Study|Mostly Lost to Follow Up|13|||
155685764|NCT00252694|561942334|FG000|Overall Study|Patient Moving|17|||
155685765|NCT00252694|561942335|FG001|Overall Study|Patient Moving|16|||
155685766|NCT01271712|561942341|FG000|Double Blind Treatment|Death|2|||
155685767|NCT01271712|561942342|FG001|Double Blind Treatment|Death|0|||
155685768|NCT01271712|561942341|FG000|Double Blind Treatment|Lack of Efficacy|1|||
155685769|NCT01271712|561942342|FG001|Double Blind Treatment|Lack of Efficacy|0|||
155685770|NCT01271712|561942341|FG000|Double Blind Treatment|Adverse Event|9|||
155685771|NCT01271712|561942342|FG001|Double Blind Treatment|Adverse Event|4|||
155685772|NCT01271712|561942341|FG000|Double Blind Treatment|Progressive disease|23|||
155685773|NCT01271712|561942342|FG001|Double Blind Treatment|Progressive disease|3|||
155685774|NCT01271712|561942341|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
155685775|NCT01271712|561942342|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
155685776|NCT01271712|561942341|FG000|Double Blind Treatment|Non compliance with study drug|2|||
155685777|NCT01271712|561942342|FG001|Double Blind Treatment|Non compliance with study drug|0|||
155685778|NCT01271712|561942341|FG000|Double Blind Treatment|receive no study drug|1|||
155685779|NCT01271712|561942342|FG001|Double Blind Treatment|receive no study drug|0|||
155685780|NCT01271712|561942341|FG000|Open Label Treatment|Death|6|||
155685781|NCT01271712|561942342|FG001|Open Label Treatment|Death|5|||
155685782|NCT01271712|561942341|FG000|Open Label Treatment|Withdrawal by Subject|6|||
155685783|NCT01271712|561942342|FG001|Open Label Treatment|Withdrawal by Subject|11|||
155685784|NCT01271712|561942341|FG000|Open Label Treatment|Physician Decision|2|||
155685785|NCT01271712|561942342|FG001|Open Label Treatment|Physician Decision|0|||
155685786|NCT01271712|561942341|FG000|Open Label Treatment|Adverse Event|14|||
155685787|NCT01271712|561942342|FG001|Open Label Treatment|Adverse Event|8|||
155685788|NCT01271712|561942341|FG000|Open Label Treatment|Progressive disease|59|||
155685789|NCT01271712|561942342|FG001|Open Label Treatment|Progressive disease|32|||
155685790|NCT01271712|561942341|FG000|Open Label Treatment|transferred to rollover study|1|||
155685791|NCT01271712|561942342|FG001|Open Label Treatment|transferred to rollover study|0|||
155685792|NCT01271712|561942341|FG000|Open Label Treatment|Non-compliance with study drug|1|||
155685793|NCT01271712|561942342|FG001|Open Label Treatment|Non-compliance with study drug|0|||
155685794|NCT01271712|561942341|FG000|Open Label Treatment|Protocol Violation|0|||
155685795|NCT01271712|561942342|FG001|Open Label Treatment|Protocol Violation|1|||
155685796|NCT01271712|561942341|FG000|Open Label Treatment|Switching to other therapy|2|||
155685797|NCT01271712|561942342|FG001|Open Label Treatment|Switching to other therapy|1|||
155685798|NCT01271712|561942341|FG000|Safety Follow-up|Death|11|||
155685799|NCT01271712|561942342|FG001|Safety Follow-up|Death|7|||
155685800|NCT01271712|561942341|FG000|Safety Follow-up|Withdrawal by Subject|4|||
155685801|NCT01271712|561942342|FG001|Safety Follow-up|Withdrawal by Subject|2|||
155685802|NCT01271712|561942341|FG000|Safety Follow-up|Protocol Violation|1|||
155685803|NCT01271712|561942342|FG001|Safety Follow-up|Protocol Violation|1|||
155685804|NCT01271712|561942341|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
155685805|NCT01271712|561942342|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
155685806|NCT01271712|561942341|FG000|Safety Follow-up|No follow-up|1|||
155685807|NCT01271712|561942342|FG001|Safety Follow-up|No follow-up|1|||
155685808|NCT01271712|561942341|FG000|Safety Follow-up|Progressive disease|1|||
155685809|NCT01271712|561942342|FG001|Safety Follow-up|Progressive disease|0|||
155685810|NCT01271712|561942341|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
155685811|NCT01271712|561942342|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
155685812|NCT00096226|561942345|FG000|Overall Study|Ineligible|2|||
155685813|NCT00096226|561942345|FG000|Overall Study|Protocol treatment not started|1|||
155685814|NCT03941964|561942347|FG000|Overall Study|Adverse Event|1|||
155685815|NCT03941964|561942348|FG001|Overall Study|Adverse Event|8|||
155685816|NCT03941964|561942347|FG000|Overall Study|Progressive disease|7|||
155685817|NCT03941964|561942348|FG001|Overall Study|Progressive disease|3|||
155685818|NCT03941964|561942347|FG000|Overall Study|Lack of Efficacy|0|||
155685819|NCT03941964|561942348|FG001|Overall Study|Lack of Efficacy|1|||
155685820|NCT03941964|561942347|FG000|Overall Study|Death|3|||
155685821|NCT03941964|561942348|FG001|Overall Study|Death|1|||
155685822|NCT03941964|561942347|FG000|Overall Study|Withdrew consent|1|||
155685823|NCT03941964|561942348|FG001|Overall Study|Withdrew consent|3|||
155685824|NCT03941964|561942347|FG000|Overall Study|Physician Decision|9|||
155685825|NCT03941964|561942348|FG001|Overall Study|Physician Decision|2|||
155685826|NCT03941964|561942347|FG000|Overall Study|Other, not specified|2|||
155685827|NCT03941964|561942348|FG001|Overall Study|Other, not specified|1|||
155685828|NCT03006458|561942349|FG000|First Intervention|Unsatisfied Vision|0|||
155685829|NCT03006458|561942350|FG001|First Intervention|Unsatisfied Vision|3|||
155685830|NCT00118846|561942351|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
155685831|NCT00118846|561942352|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
155685832|NCT00118846|561942351|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
155685833|NCT00118846|561942352|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
155685834|NCT00118846|561942351|FG000|Overall Study|Physician Decision|1|||
155685835|NCT00118846|561942352|FG001|Overall Study|Physician Decision|0|||
155685836|NCT00118846|561942351|FG000|Overall Study|Medical condition|2|||
155685837|NCT00118846|561942352|FG001|Overall Study|Medical condition|2|||
155685838|NCT00118846|561942351|FG000|Overall Study|Lost to Follow-up|0|||
155685839|NCT00118846|561942352|FG001|Overall Study|Lost to Follow-up|2|||
155685840|NCT00118846|561942351|FG000|Overall Study|Personal reason|4|||
155685841|NCT00118846|561942352|FG001|Overall Study|Personal reason|5|||
155685842|NCT01468233|561942353|FG000|Treatment Period 1|Adverse Event|5|||
155685843|NCT01468233|561942354|FG001|Treatment Period 1|Adverse Event|3|||
155685844|NCT01468233|561942355|FG002|Treatment Period 1|Adverse Event|0|||
155685845|NCT01468233|561942356|FG003|Treatment Period 1|Adverse Event|0|||
155685846|NCT01468233|561942357|FG004|Treatment Period 1|Adverse Event|0|||
155685847|NCT01468233|561942358|FG005|Treatment Period 1|Adverse Event|0|||
155685848|NCT01468233|561942353|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155685849|NCT01468233|561942354|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155685850|NCT01468233|561942355|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155685851|NCT01468233|561942356|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155685852|NCT01468233|561942357|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155685853|NCT01468233|561942358|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155685854|NCT01468233|561942353|FG000|Treatment Period 1|Lost to Follow-up|3|||
155685855|NCT01468233|561942354|FG001|Treatment Period 1|Lost to Follow-up|0|||
155685856|NCT01468233|561942355|FG002|Treatment Period 1|Lost to Follow-up|0|||
155685857|NCT01468233|561942356|FG003|Treatment Period 1|Lost to Follow-up|0|||
155685858|NCT01468233|561942357|FG004|Treatment Period 1|Lost to Follow-up|0|||
155685859|NCT01468233|561942358|FG005|Treatment Period 1|Lost to Follow-up|0|||
155685860|NCT01468233|561942353|FG000|Treatment Period 1|Other|1|||
155685861|NCT01468233|561942354|FG001|Treatment Period 1|Other|1|||
155685862|NCT01468233|561942355|FG002|Treatment Period 1|Other|0|||
155685863|NCT01468233|561942356|FG003|Treatment Period 1|Other|0|||
155685864|NCT01468233|561942357|FG004|Treatment Period 1|Other|0|||
155685865|NCT01468233|561942358|FG005|Treatment Period 1|Other|0|||
155685866|NCT01468233|561942353|FG000|Treatment Period 2|Adverse Event|0|||
155685867|NCT01468233|561942354|FG001|Treatment Period 2|Adverse Event|0|||
155685868|NCT01468233|561942355|FG002|Treatment Period 2|Adverse Event|3|||
155685869|NCT01468233|561942356|FG003|Treatment Period 2|Adverse Event|0|||
155685870|NCT01468233|561942357|FG004|Treatment Period 2|Adverse Event|2|||
155685871|NCT01468233|561942358|FG005|Treatment Period 2|Adverse Event|1|||
155685872|NCT01468233|561942353|FG000|Treatment Period 2|Lack of Efficacy|0|||
155685873|NCT01468233|561942354|FG001|Treatment Period 2|Lack of Efficacy|0|||
155685874|NCT01468233|561942355|FG002|Treatment Period 2|Lack of Efficacy|9|||
155685875|NCT01468233|561942356|FG003|Treatment Period 2|Lack of Efficacy|2|||
155685876|NCT01468233|561942357|FG004|Treatment Period 2|Lack of Efficacy|0|||
155685877|NCT01468233|561942358|FG005|Treatment Period 2|Lack of Efficacy|1|||
155685878|NCT01468233|561942353|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155685879|NCT01468233|561942354|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155685880|NCT01468233|561942355|FG002|Treatment Period 2|Withdrawal by Subject|9|||
155685881|NCT01468233|561942356|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155685882|NCT01468233|561942357|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155685883|NCT01468233|561942358|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155685884|NCT01468233|561942353|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
155685885|NCT01468233|561942354|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
155685886|NCT01468233|561942355|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
155685887|NCT01468233|561942356|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
155685888|NCT01468233|561942357|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
155685889|NCT01468233|561942358|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
155685890|NCT01468233|561942353|FG000|Treatment Period 2|Lost to Follow-up|0|||
155685891|NCT01468233|561942354|FG001|Treatment Period 2|Lost to Follow-up|0|||
155685892|NCT01468233|561942355|FG002|Treatment Period 2|Lost to Follow-up|3|||
155685893|NCT01468233|561942356|FG003|Treatment Period 2|Lost to Follow-up|0|||
155685894|NCT01468233|561942357|FG004|Treatment Period 2|Lost to Follow-up|2|||
155685895|NCT01468233|561942358|FG005|Treatment Period 2|Lost to Follow-up|0|||
155685896|NCT01468233|561942353|FG000|Treatment Period 2|Other|0|||
155685897|NCT01468233|561942354|FG001|Treatment Period 2|Other|0|||
155685898|NCT01468233|561942355|FG002|Treatment Period 2|Other|3|||
155685899|NCT01468233|561942356|FG003|Treatment Period 2|Other|0|||
155685900|NCT01468233|561942357|FG004|Treatment Period 2|Other|1|||
155685901|NCT01468233|561942358|FG005|Treatment Period 2|Other|0|||
155685902|NCT01574157|561942359|FG000|Overall Study|Withdrawal by Subject|4|||
155685903|NCT01574157|561942360|FG001|Overall Study|Withdrawal by Subject|5|||
155685904|NCT01574157|561942359|FG000|Overall Study|Lost to Follow-up|0|||
155685905|NCT01574157|561942360|FG001|Overall Study|Lost to Follow-up|3|||
155685906|NCT01944098|561942370|FG000|Overall Study|Physician Decision|1|||
155685907|NCT01944098|561942371|FG001|Overall Study|Physician Decision|0|||
155685908|NCT04669262|561942372|FG000|Overall Study|Withdrawal by Subject|0|||
155685909|NCT04669262|561942373|FG001|Overall Study|Withdrawal by Subject|0|||
155685910|NCT04669262|561942374|FG002|Overall Study|Withdrawal by Subject|0|||
155685911|NCT04669262|561942375|FG003|Overall Study|Withdrawal by Subject|1|||
155685912|NCT04669262|561942372|FG000|Overall Study|Randomized but Not Treated|0|||
155685913|NCT04669262|561942373|FG001|Overall Study|Randomized but Not Treated|1|||
155685914|NCT04669262|561942374|FG002|Overall Study|Randomized but Not Treated|0|||
155685915|NCT04669262|561942375|FG003|Overall Study|Randomized but Not Treated|0|||
155685916|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
155685917|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
155685918|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
155685919|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
155685920|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
155685921|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
155685922|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
155685923|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
155685924|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
155685925|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
155685926|NCT03549871|561942378|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
155685927|NCT03549871|561942379|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
155685928|NCT03549871|561942378|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
155685929|NCT03549871|561942379|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
155685930|NCT03549871|561942378|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
155685931|NCT03549871|561942379|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
155685932|NCT03549871|561942378|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
155685933|NCT03549871|561942379|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
155685934|NCT03549871|561942378|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
155685935|NCT03549871|561942379|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
155685936|NCT03549871|561942378|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
155685937|NCT03549871|561942379|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
155685938|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
155685939|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
155685940|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
155685941|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
155685942|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
155685943|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
155685944|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
155685945|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
155685946|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
155685947|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
155685948|NCT00737568|561942380|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
155685949|NCT00737568|561942381|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
155685950|NCT00737568|561942380|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
155685951|NCT00737568|561942381|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
155685952|NCT00737568|561942380|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
155685953|NCT00737568|561942381|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
155685954|NCT00737568|561942380|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
155685955|NCT00737568|561942381|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
155685956|NCT01133626|561942382|FG000|Overall Study|Adverse Event|0|||
155685957|NCT01133626|561942383|FG001|Overall Study|Adverse Event|1|||
155685958|NCT01133626|561942384|FG002|Overall Study|Adverse Event|0|||
155685959|NCT01133626|561942382|FG000|Overall Study|Withdrawal by Subject|1|||
155685960|NCT01133626|561942383|FG001|Overall Study|Withdrawal by Subject|2|||
155685961|NCT01133626|561942384|FG002|Overall Study|Withdrawal by Subject|2|||
155685962|NCT01133626|561942382|FG000|Overall Study|Other|0|||
155685963|NCT01133626|561942383|FG001|Overall Study|Other|2|||
155685964|NCT01133626|561942384|FG002|Overall Study|Other|0|||
155685965|NCT00855933|561942385|FG000|Overall Study|Withdrawal by Subject|0|||
155685966|NCT00855933|561942386|FG001|Overall Study|Withdrawal by Subject|1|||
155685967|NCT00951080|561942387|FG000|Overall Study|Adverse Event|3|||
155685968|NCT00951080|561942388|FG001|Overall Study|Adverse Event|3|||
155685969|NCT00951080|561942387|FG000|Overall Study|Lost to Follow-up|0|||
155685970|NCT00951080|561942388|FG001|Overall Study|Lost to Follow-up|1|||
155685971|NCT00951080|561942387|FG000|Overall Study|Physician Decision|4|||
155685972|NCT00951080|561942388|FG001|Overall Study|Physician Decision|1|||
155685973|NCT00951080|561942387|FG000|Overall Study|Other|19|||
155685974|NCT00951080|561942388|FG001|Overall Study|Other|22|||
155685975|NCT05463744|561942389|FG000|Treatment Period|Withdrawal by Subject|19|||
155685976|NCT05463744|561942390|FG001|Treatment Period|Withdrawal by Subject|16|||
155685977|NCT05463744|561942389|FG000|Treatment Period|Adverse Event|4|||
155685978|NCT05463744|561942390|FG001|Treatment Period|Adverse Event|4|||
155685979|NCT05463744|561942389|FG000|Treatment Period|Pregnancy|0|||
155685980|NCT05463744|561942390|FG001|Treatment Period|Pregnancy|3|||
155685981|NCT05463744|561942389|FG000|Treatment Period|Lost to Follow-up|1|||
155685982|NCT05463744|561942390|FG001|Treatment Period|Lost to Follow-up|3|||
155685983|NCT05463744|561942389|FG000|Treatment Period|Inadvertent enrollment|2|||
155685984|NCT05463744|561942390|FG001|Treatment Period|Inadvertent enrollment|1|||
155685985|NCT05463744|561942389|FG000|Treatment Period|Death|0|||
155685986|NCT05463744|561942390|FG001|Treatment Period|Death|1|||
155685987|NCT05463744|561942389|FG000|Treatment Period|Non-compliance with Study Drug|1|||
155685988|NCT05463744|561942390|FG001|Treatment Period|Non-compliance with Study Drug|0|||
155685989|NCT05463744|561942389|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
155685990|NCT05463744|561942390|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
155685991|NCT05463744|561942389|FG000|Treatment Period|Physician Decision|0|||
155685992|NCT05463744|561942390|FG001|Treatment Period|Physician Decision|1|||
155685993|NCT05463744|561942389|FG000|Follow-Up Period|Withdrawal by Subject|3|||
155685994|NCT05463744|561942390|FG001|Follow-Up Period|Withdrawal by Subject|1|||
155685995|NCT05463744|561942389|FG000|Follow-Up Period|Lost to Follow-up|1|||
155685996|NCT05463744|561942390|FG001|Follow-Up Period|Lost to Follow-up|1|||
155685997|NCT01960998|561942391|FG000|Overall Study|Lost to Follow-up|3|||
155685998|NCT01960998|561942392|FG001|Overall Study|Lost to Follow-up|7|||
155685999|NCT01960998|561942391|FG000|Overall Study|Death|0|||
155686000|NCT01960998|561942392|FG001|Overall Study|Death|1|||
155686001|NCT01960998|561942391|FG000|Overall Study|Withdrawal by Subject|8|||
155686002|NCT01960998|561942392|FG001|Overall Study|Withdrawal by Subject|2|||
155686003|NCT01960998|561942391|FG000|Overall Study|lost computer access|0|||
155686004|NCT01960998|561942392|FG001|Overall Study|lost computer access|1|||
155686005|NCT03761394|561942397|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
155686006|NCT03761394|561942398|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
155686007|NCT03761394|561942399|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
155686008|NCT03761394|561942400|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
155686009|NCT03761394|561942397|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
155686010|NCT03761394|561942398|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
155686011|NCT03761394|561942399|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
155686012|NCT03761394|561942400|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
155686013|NCT03761394|561942397|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155686014|NCT03761394|561942398|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155686015|NCT03761394|561942399|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
155686016|NCT03761394|561942400|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155686017|NCT03761394|561942397|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
155686018|NCT03761394|561942398|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
155686019|NCT03761394|561942399|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
155686020|NCT03761394|561942400|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
155686021|NCT01939002|561942407|FG000|Overall Study|Adverse Event|13|||
155686022|NCT01939002|561942408|FG001|Overall Study|Adverse Event|13|||
155686023|NCT01939002|561942407|FG000|Overall Study|Withdrawal by Subject|5|||
155686024|NCT01939002|561942408|FG001|Overall Study|Withdrawal by Subject|3|||
155686025|NCT01939002|561942407|FG000|Overall Study|Other|1|||
155686026|NCT01939002|561942408|FG001|Overall Study|Other|2|||
155686027|NCT02910401|561942411|FG000|Overall Study|Study closure Study closure|0|||
155686028|NCT02910401|561942412|FG001|Overall Study|Study closure Study closure|0|||
155686029|NCT02910401|561942413|FG002|Overall Study|Study closure Study closure|2|||
155686030|NCT02910401|561942411|FG000|Overall Study|Physician Decision|1|||
155686031|NCT02910401|561942412|FG001|Overall Study|Physician Decision|0|||
155686032|NCT02910401|561942413|FG002|Overall Study|Physician Decision|0|||
155686033|NCT00098748|561942416|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
155686034|NCT00098748|561942417|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
155686035|NCT00098748|561942418|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
155686036|NCT00098748|561942416|FG000|Received Study Treatment|Death|2|||
155686037|NCT00098748|561942417|FG001|Received Study Treatment|Death|1|||
155686038|NCT00098748|561942418|FG002|Received Study Treatment|Death|2|||
155686039|NCT00098748|561942416|FG000|Received Study Treatment|Adverse Event|1|||
155686040|NCT00098748|561942417|FG001|Received Study Treatment|Adverse Event|2|||
155686041|NCT00098748|561942418|FG002|Received Study Treatment|Adverse Event|5|||
155686042|NCT00098748|561942416|FG000|Received Study Treatment|Lack of Efficacy|40|||
155686043|NCT00098748|561942417|FG001|Received Study Treatment|Lack of Efficacy|27|||
155686044|NCT00098748|561942418|FG002|Received Study Treatment|Lack of Efficacy|27|||
155686045|NCT00098748|561942416|FG000|Received Study Treatment|Other|2|||
155686046|NCT00098748|561942417|FG001|Received Study Treatment|Other|2|||
155686047|NCT00098748|561942418|FG002|Received Study Treatment|Other|6|||
155686048|NCT00098748|561942416|FG000|Received Study Treatment|Subject defaulted|3|||
155686049|NCT00098748|561942417|FG001|Received Study Treatment|Subject defaulted|4|||
155686050|NCT00098748|561942418|FG002|Received Study Treatment|Subject defaulted|4|||
155686051|NCT00098748|561942416|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
155686052|NCT00098748|561942417|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
155686053|NCT00098748|561942418|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
155686054|NCT00098748|561942416|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
155686055|NCT00098748|561942417|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
155686056|NCT00098748|561942418|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
155686057|NCT00098748|561942416|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
155686058|NCT00098748|561942417|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
155686059|NCT00098748|561942418|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
155686060|NCT00098748|561942416|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
155686061|NCT00098748|561942417|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
155686062|NCT00098748|561942418|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
155686063|NCT00098748|561942416|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
155686064|NCT00098748|561942417|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
155686065|NCT00098748|561942418|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
155686066|NCT01774253|561942421|FG000|Overall Study|Lack of Efficacy|4|||
155686067|NCT01774253|561942421|FG000|Overall Study|Physician Decision|2|||
155686068|NCT01774253|561942421|FG000|Overall Study|Withdrawal by Subject|2|||
155686069|NCT01774253|561942421|FG000|Overall Study|Death|1|||
155686070|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
155686071|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
155686072|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Death|0|||
155686073|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Death|0|||
155686074|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155686075|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155686076|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
155686077|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
155686078|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
155686079|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
155686080|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
155686081|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
155686082|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
155686083|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
155686084|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
155686085|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
155686086|NCT00433160|561942422|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
155686087|NCT00433160|561942423|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
155686088|NCT00433160|561942422|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
155686089|NCT00433160|561942423|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
155686090|NCT00433160|561942422|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
155686091|NCT00433160|561942423|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
155686092|NCT00433160|561942422|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
155686093|NCT00433160|561942423|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
155686094|NCT00433160|561942422|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
155686095|NCT00433160|561942423|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
155686096|NCT00433160|561942422|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
155686097|NCT00433160|561942423|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
155686098|NCT00433160|561942422|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
155686099|NCT00433160|561942423|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
155686100|NCT00433160|561942422|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
155686101|NCT00433160|561942423|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
155686102|NCT02240368|561942424|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
155686103|NCT02240368|561942425|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
155686104|NCT02240368|561942426|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
155686105|NCT02240368|561942424|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
155686106|NCT02240368|561942425|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
155686107|NCT02240368|561942426|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
155686108|NCT00871117|561942437|FG000|Overall Study|Lost to Follow-up|5|||
155686109|NCT00871117|561942438|FG001|Overall Study|Lost to Follow-up|6|||
155686110|NCT00871117|561942437|FG000|Overall Study|Other|0|||
155686111|NCT00871117|561942438|FG001|Overall Study|Other|4|||
155686112|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
155686113|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155686114|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155686115|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155686116|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
155686117|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
155686118|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
155605296|NCT00369161|561642942|FG000|Overall Study|Death|1|||
155605297|NCT00369161|561642943|FG001|Overall Study|Death|2|||
155605298|NCT00369161|561642942|FG000|Overall Study|Graft loss|4|||
155605299|NCT00369161|561642943|FG001|Overall Study|Graft loss|0|||
155605300|NCT00369161|561642942|FG000|Overall Study|Administrative Problem|2|||
155605301|NCT00369161|561642943|FG001|Overall Study|Administrative Problem|2|||
155605302|NCT03008278|561642948|FG000|Overall Study|Progressive Disease|0|||
155605303|NCT03008278|561642949|FG001|Overall Study|Progressive Disease|0|||
155605304|NCT03008278|561642950|FG002|Overall Study|Progressive Disease|32|||
155605305|NCT03008278|561642948|FG000|Overall Study|Adverse Event|0|||
155605306|NCT03008278|561642949|FG001|Overall Study|Adverse Event|0|||
155605307|NCT03008278|561642950|FG002|Overall Study|Adverse Event|4|||
155605308|NCT03008278|561642948|FG000|Overall Study|Withdrawal by Subject|0|||
155605309|NCT03008278|561642949|FG001|Overall Study|Withdrawal by Subject|0|||
155605310|NCT03008278|561642950|FG002|Overall Study|Withdrawal by Subject|3|||
155605311|NCT03008278|561642948|FG000|Overall Study|Physician Decision|0|||
155605312|NCT03008278|561642949|FG001|Overall Study|Physician Decision|2|||
155605313|NCT03008278|561642950|FG002|Overall Study|Physician Decision|0|||
155605314|NCT00422422|561642951|FG000|Overall Study|Lack of Efficacy|1|||
155605315|NCT00422422|561642951|FG000|Overall Study|Protocol Violation|1|||
155605316|NCT00422422|561642951|FG000|Overall Study|Withdrawal by Subject|2|||
155605317|NCT00422422|561642951|FG000|Overall Study|SAE, non-fatal|1|||
155605318|NCT00422422|561642951|FG000|Overall Study|AE, non-serious non-fatal|5|||
155605319|NCT01389258|561642952|FG000|Overall Study|Lost to Follow-up|5|||
155605320|NCT03313310|561642953|FG000|Phase 2|Lost to Follow-up|4|||
155605321|NCT03313310|561642954|FG001|Phase 2|Lost to Follow-up|0|||
155605322|NCT03313310|561642953|FG000|Phase 3|Lost to Follow-up|0|||
155605323|NCT03313310|561642954|FG001|Phase 3|Lost to Follow-up|1|||
155605324|NCT01593254|561642958|FG000|Overall Study|Disease progression|2|||
155605325|NCT01593254|561642959|FG001|Overall Study|Disease progression|7|||
155605326|NCT01593254|561642958|FG000|Overall Study|Study drug toxicity|6|||
155605327|NCT01593254|561642959|FG001|Overall Study|Study drug toxicity|20|||
155605328|NCT01593254|561642958|FG000|Overall Study|Death|3|||
155605329|NCT01593254|561642959|FG001|Overall Study|Death|3|||
155605330|NCT01593254|561642958|FG000|Overall Study|AE unrelated to study drug|0|||
155605331|NCT01593254|561642959|FG001|Overall Study|AE unrelated to study drug|1|||
155605332|NCT01593254|561642958|FG000|Overall Study|participant request to discontinue study treatment|1|||
155605333|NCT01593254|561642959|FG001|Overall Study|participant request to discontinue study treatment|3|||
155605334|NCT01593254|561642958|FG000|Overall Study|participant withdrew consent|0|||
155605335|NCT01593254|561642959|FG001|Overall Study|participant withdrew consent|9|||
155605336|NCT01593254|561642958|FG000|Overall Study|lost to follow up|1|||
155605337|NCT01593254|561642959|FG001|Overall Study|lost to follow up|6|||
155605338|NCT01593254|561642958|FG000|Overall Study|maximum clinical benefit|1|||
155605339|NCT01593254|561642959|FG001|Overall Study|maximum clinical benefit|2|||
155605340|NCT01593254|561642958|FG000|Overall Study|Poor/non compliance|1|||
155605341|NCT01593254|561642959|FG001|Overall Study|Poor/non compliance|1|||
155605342|NCT01593254|561642958|FG000|Overall Study|Pregnancy|0|||
155605343|NCT01593254|561642959|FG001|Overall Study|Pregnancy|3|||
155605344|NCT01593254|561642958|FG000|Overall Study|participant no longer meets study criteria|1|||
155605345|NCT01593254|561642959|FG001|Overall Study|participant no longer meets study criteria|1|||
155605346|NCT01593254|561642958|FG000|Overall Study|Admin reason by sponsor|7|||
155605347|NCT01593254|561642959|FG001|Overall Study|Admin reason by sponsor|3|||
155605348|NCT01593254|561642958|FG000|Overall Study|Imatinib treatment failure|2|||
155605349|NCT01593254|561642959|FG001|Overall Study|Imatinib treatment failure|0|||
155605350|NCT01593254|561642958|FG000|Overall Study|Other Reasons|61|||
155605351|NCT01593254|561642959|FG001|Overall Study|Other Reasons|115|||
155605352|NCT00501059|561642962|FG000|Overall Study|Protocol Violation|80|||
155605353|NCT00501059|561642963|FG001|Overall Study|Protocol Violation|69|||
155605354|NCT00501059|561642962|FG000|Overall Study|Death|140|||
155605355|NCT00501059|561642963|FG001|Overall Study|Death|137|||
155605356|NCT00501059|561642962|FG000|Overall Study|Other|236|||
155686119|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
155686120|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
155686121|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
155686122|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
155605357|NCT00501059|561642963|FG001|Overall Study|Other|239|||
155605358|NCT00501059|561642962|FG000|Overall Study|Missing end-of-study page|91|||
155605359|NCT00501059|561642963|FG001|Overall Study|Missing end-of-study page|92|||
155605360|NCT00501059|561642962|FG000|Overall Study|Clinical endpoint reached|110|||
155605361|NCT00501059|561642963|FG001|Overall Study|Clinical endpoint reached|123|||
155605362|NCT00501059|561642962|FG000|Overall Study|Insufficient therapeutic effect|4|||
155605363|NCT00501059|561642963|FG001|Overall Study|Insufficient therapeutic effect|5|||
155605364|NCT00501059|561642962|FG000|Overall Study|Consent withdrawn by subject|817|||
155605365|NCT00501059|561642963|FG001|Overall Study|Consent withdrawn by subject|873|||
155605366|NCT00501059|561642962|FG000|Overall Study|Non-compliant with study treatment|23|||
155605367|NCT00501059|561642963|FG001|Overall Study|Non-compliant with study treatment|16|||
155605368|NCT00501059|561642962|FG000|Overall Study|Reason not given|3|||
155605369|NCT00501059|561642963|FG001|Overall Study|Reason not given|1|||
155605370|NCT00501059|561642962|FG000|Overall Study|Adverse Event|129|||
155605371|NCT00501059|561642963|FG001|Overall Study|Adverse Event|122|||
155605372|NCT00501059|561642962|FG000|Overall Study|Lost to Follow-up|210|||
155605373|NCT00501059|561642963|FG001|Overall Study|Lost to Follow-up|198|||
155605374|NCT00501059|561642962|FG000|Overall Study|Not treated|25|||
155605375|NCT00501059|561642963|FG001|Overall Study|Not treated|17|||
155605376|NCT02124759|561642966|FG000|Overall Study|Withdrawal by Subject|3|||
155605377|NCT02124759|561642967|FG001|Overall Study|Withdrawal by Subject|1|||
155605378|NCT02124759|561642968|FG002|Overall Study|Withdrawal by Subject|1|||
155605379|NCT02124759|561642966|FG000|Overall Study|Screen Fail|2|||
155605380|NCT02124759|561642967|FG001|Overall Study|Screen Fail|2|||
155605381|NCT02124759|561642968|FG002|Overall Study|Screen Fail|3|||
155605382|NCT04249622|561642971|FG000|Overall Study|Withdrawal by Subject|1|||
155605383|NCT04249622|561642972|FG001|Overall Study|Withdrawal by Subject|1|||
155605384|NCT04249622|561642971|FG000|Overall Study|Alternative therapy|1|||
155605385|NCT04249622|561642972|FG001|Overall Study|Alternative therapy|0|||
155605386|NCT04249622|561642971|FG000|Overall Study|Discontinuation of pertuzumab|1|||
155605387|NCT04249622|561642972|FG001|Overall Study|Discontinuation of pertuzumab|0|||
155605388|NCT03689543|561642975|FG000|Overall Study|Adverse Event|0|||
155605389|NCT03689543|561642976|FG001|Overall Study|Adverse Event|0|||
155605390|NCT03689543|561642977|FG002|Overall Study|Adverse Event|1|||
155605391|NCT00932451|561642978|FG000|Overall Study|Withdrawal by Subject|69|||
155605392|NCT00932451|561642978|FG000|Overall Study|Lost to Follow-up|22|||
155605393|NCT00932451|561642978|FG000|Overall Study|Death|726|||
155605394|NCT00932451|561642978|FG000|Overall Study|Other reasons|5|||
155605395|NCT01294371|561642979|FG000|Overall Study|Adverse Event|1|||
155605396|NCT01294371|561642979|FG000|Overall Study|Withdrawal by Subject|12|||
155605397|NCT01294371|561642979|FG000|Overall Study|Lost to Follow-up|6|||
155605398|NCT01294371|561642979|FG000|Overall Study|Administrative Reason|1|||
155605399|NCT01294371|561642979|FG000|Overall Study|Other|14|||
155605400|NCT05619536|561642980|FG000|Overall Study|Withdrawal by Subject|0|||
155605401|NCT05619536|561642981|FG001|Overall Study|Withdrawal by Subject|1|||
155605402|NCT05619536|561642982|FG002|Overall Study|Withdrawal by Subject|0|||
155605403|NCT05619536|561642983|FG003|Overall Study|Withdrawal by Subject|1|||
155605404|NCT05619536|561642980|FG000|Overall Study|Lost to Follow-up|0|||
155605405|NCT05619536|561642981|FG001|Overall Study|Lost to Follow-up|1|||
155605406|NCT05619536|561642982|FG002|Overall Study|Lost to Follow-up|1|||
155605407|NCT05619536|561642983|FG003|Overall Study|Lost to Follow-up|0|||
155605408|NCT04272606|561642984|FG000|Overall Study|Protocol Violation|1|||
155605409|NCT04272606|561642985|FG001|Overall Study|Protocol Violation|1|||
155605410|NCT04272606|561642984|FG000|Overall Study|Physician Decision|0|||
155605411|NCT04272606|561642985|FG001|Overall Study|Physician Decision|1|||
155605412|NCT00725101|561642986|FG000|Overall Study|Death|3|||
155605413|NCT00725101|561642986|FG000|Overall Study|Lost to Follow-up|353|||
155605414|NCT00725101|561642986|FG000|Overall Study|Protocol Violation|1|||
155605415|NCT00725101|561642986|FG000|Overall Study|Withdrawal by Subject|127|||
155605416|NCT00725101|561642986|FG000|Overall Study|not specified/no reason given|11|||
155605417|NCT00157248|561642990|FG000|Overall Study|Adverse Event|36|||
155605418|NCT00157248|561642991|FG001|Overall Study|Adverse Event|25|||
155605419|NCT00157248|561642992|FG002|Overall Study|Adverse Event|13|||
155605420|NCT00157248|561642993|FG003|Overall Study|Adverse Event|33|||
155605421|NCT00157248|561642990|FG000|Overall Study|Protocol Violation|4|||
155605422|NCT00157248|561642991|FG001|Overall Study|Protocol Violation|0|||
155605423|NCT00157248|561642992|FG002|Overall Study|Protocol Violation|2|||
155605424|NCT00157248|561642993|FG003|Overall Study|Protocol Violation|2|||
155605425|NCT00157248|561642990|FG000|Overall Study|Lost to Follow-up|0|||
155605426|NCT00157248|561642991|FG001|Overall Study|Lost to Follow-up|1|||
155605427|NCT00157248|561642992|FG002|Overall Study|Lost to Follow-up|0|||
155605428|NCT00157248|561642993|FG003|Overall Study|Lost to Follow-up|0|||
155605429|NCT00157248|561642990|FG000|Overall Study|Withdrawal by Subject|1|||
155605430|NCT00157248|561642991|FG001|Overall Study|Withdrawal by Subject|4|||
155686123|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
155686124|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
155686125|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
155686126|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
155686127|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
155686128|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155686129|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
155686130|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155686131|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155686132|NCT03222973|561942439|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
155686133|NCT03222973|561942440|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
155686134|NCT03222973|561942441|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
155686135|NCT03222973|561942442|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
155686136|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155686137|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155686138|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
155686139|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155686140|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
155686141|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
155686142|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
155686143|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
155686144|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
155686145|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
155686146|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
155686147|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
155686148|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
155686149|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
155686150|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
155686151|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
155686152|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
155686153|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
155686154|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
155686155|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
155686156|NCT03222973|561942439|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155686157|NCT03222973|561942440|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155686158|NCT03222973|561942441|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
155686159|NCT03222973|561942442|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155686160|NCT02080481|561942443|FG000|Overall Study|Never received a block.|1|||
155686161|NCT02080481|561942444|FG001|Overall Study|Never received a block.|0|||
155686162|NCT02439450|561942445|FG000|Overall Study|Adverse Event|4|||
155686163|NCT02439450|561942446|FG001|Overall Study|Adverse Event|1|||
155686164|NCT02439450|561942447|FG002|Overall Study|Adverse Event|0|||
155686165|NCT02439450|561942448|FG003|Overall Study|Adverse Event|0|||
155686166|NCT02439450|561942445|FG000|Overall Study|Withdrawal by Subject|1|||
155686167|NCT02439450|561942446|FG001|Overall Study|Withdrawal by Subject|2|||
155686168|NCT02439450|561942447|FG002|Overall Study|Withdrawal by Subject|0|||
155686169|NCT02439450|561942448|FG003|Overall Study|Withdrawal by Subject|0|||
155686170|NCT02439450|561942445|FG000|Overall Study|Death|3|||
155686171|NCT02439450|561942446|FG001|Overall Study|Death|0|||
155686172|NCT02439450|561942447|FG002|Overall Study|Death|0|||
155686173|NCT02439450|561942448|FG003|Overall Study|Death|1|||
155686174|NCT02439450|561942445|FG000|Overall Study|Progressive Disease|18|||
155686175|NCT02439450|561942446|FG001|Overall Study|Progressive Disease|41|||
155686176|NCT02439450|561942447|FG002|Overall Study|Progressive Disease|2|||
155686177|NCT02439450|561942448|FG003|Overall Study|Progressive Disease|3|||
155686178|NCT04508751|561942453|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
155686179|NCT04508751|561942454|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
155686180|NCT04508751|561942455|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
155686181|NCT03551665|561942458|FG000|Overall Study|Lost to Follow-up|11|||
155686182|NCT03551665|561942459|FG001|Overall Study|Lost to Follow-up|2|||
155686183|NCT00642174|561943626|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
155686184|NCT00642174|561943627|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
155686185|NCT01730339|561943628|FG000|Overall Study|Withdrawal by Subject|3|||
155686186|NCT01730339|561943629|FG001|Overall Study|Withdrawal by Subject|2|||
155686187|NCT01730339|561943628|FG000|Overall Study|Lost to Follow-up|1|||
155686188|NCT01730339|561943629|FG001|Overall Study|Lost to Follow-up|1|||
155686189|NCT01730339|561943628|FG000|Overall Study|Un-specified|1|||
155686190|NCT01730339|561943629|FG001|Overall Study|Un-specified|0|||
155686191|NCT00896363|561943630|FG000|Overall Study|Adverse Event|3|||
155686192|NCT00896363|561943631|FG001|Overall Study|Adverse Event|4|||
155686193|NCT00896363|561943632|FG002|Overall Study|Adverse Event|2|||
155686194|NCT00896363|561943630|FG000|Overall Study|Lack of Efficacy|0|||
155686195|NCT00896363|561943631|FG001|Overall Study|Lack of Efficacy|2|||
155686196|NCT00896363|561943632|FG002|Overall Study|Lack of Efficacy|1|||
155686197|NCT00896363|561943630|FG000|Overall Study|Withdrawal by Subject|3|||
155686198|NCT00896363|561943631|FG001|Overall Study|Withdrawal by Subject|5|||
155686199|NCT00896363|561943632|FG002|Overall Study|Withdrawal by Subject|5|||
155686200|NCT01145352|561943637|FG000|Overall Study|Found to have been registered twice|6|||
155605431|NCT00157248|561642992|FG002|Overall Study|Withdrawal by Subject|3|||
155605432|NCT00157248|561642993|FG003|Overall Study|Withdrawal by Subject|3|||
155605433|NCT00157248|561642990|FG000|Overall Study|site closures, subject moving|7|||
155605434|NCT00157248|561642991|FG001|Overall Study|site closures, subject moving|7|||
155605435|NCT00157248|561642992|FG002|Overall Study|site closures, subject moving|3|||
155605436|NCT00157248|561642993|FG003|Overall Study|site closures, subject moving|9|||
155605437|NCT03191864|561642994|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
155605438|NCT03191864|561642995|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
155605439|NCT03191864|561642996|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
155605440|NCT03191864|561642997|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
155605441|NCT03191864|561642998|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
155605442|NCT03191864|561642999|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
155605443|NCT03191864|561642994|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155605444|NCT03191864|561642995|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155605445|NCT03191864|561642996|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155605446|NCT03191864|561642997|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155605447|NCT03191864|561642998|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155605448|NCT03191864|561642999|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
155686201|NCT01145352|561943637|FG000|Overall Study|Treated before marketing approval|4|||
155686202|NCT01145352|561943637|FG000|Overall Study|Syringe formulation was used|1|||
155686203|NCT03095027|561943638|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
155686204|NCT03095027|561943639|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
155686205|NCT02982018|561943640|FG000|Overall Study|Incorrect Lens Dispensed|1|||
155686206|NCT02982018|561943641|FG001|Overall Study|Incorrect Lens Dispensed|0|||
155686207|NCT02982018|561943640|FG000|Overall Study|Protocol Violation|1|||
155686208|NCT02982018|561943641|FG001|Overall Study|Protocol Violation|1|||
155686209|NCT02982018|561943640|FG000|Overall Study|Adverse Event|1|||
155686210|NCT02982018|561943641|FG001|Overall Study|Adverse Event|1|||
155686211|NCT02982018|561943640|FG000|Overall Study|Lens Discomfort|2|||
155686212|NCT02982018|561943641|FG001|Overall Study|Lens Discomfort|0|||
155686213|NCT02982018|561943640|FG000|Overall Study|Withdrawal by Subject|0|||
155686214|NCT02982018|561943641|FG001|Overall Study|Withdrawal by Subject|1|||
155686215|NCT02251717|561943643|FG000|Overall Study|Adverse Event|0|||
155686216|NCT02251717|561943644|FG001|Overall Study|Adverse Event|1|||
155686217|NCT02251717|561943643|FG000|Overall Study|Withdrew Consent|1|||
155686218|NCT02251717|561943644|FG001|Overall Study|Withdrew Consent|0|||
155686219|NCT04098367|561943645|FG000|Overall Study|Adverse Event|0|||
155686220|NCT04098367|561943646|FG001|Overall Study|Adverse Event|0|||
155686221|NCT04098367|561943647|FG002|Overall Study|Adverse Event|1|||
155686222|NCT04098367|561943645|FG000|Overall Study|Lost to Follow-up|1|||
155686223|NCT04098367|561943646|FG001|Overall Study|Lost to Follow-up|5|||
155686224|NCT04098367|561943647|FG002|Overall Study|Lost to Follow-up|2|||
155686225|NCT04098367|561943645|FG000|Overall Study|Withdrawal by Subject|0|||
155686226|NCT04098367|561943646|FG001|Overall Study|Withdrawal by Subject|0|||
155686227|NCT04098367|561943647|FG002|Overall Study|Withdrawal by Subject|1|||
155686228|NCT04098367|561943645|FG000|Overall Study|Sick . Could not attend visit|1|||
155686229|NCT04098367|561943646|FG001|Overall Study|Sick . Could not attend visit|0|||
155686230|NCT04098367|561943647|FG002|Overall Study|Sick . Could not attend visit|0|||
155686231|NCT00322023|561943648|FG000|Overall Study|various|0|||
155686232|NCT00322023|561943649|FG001|Overall Study|various|2|||
155686233|NCT00322023|561943650|FG002|Overall Study|various|6|||
155686234|NCT03920293|561943651|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
155686235|NCT03920293|561943652|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
155686236|NCT03920293|561943651|FG000|Randomized-Controlled Period|Physician Decision|1|||
155686237|NCT03920293|561943652|FG001|Randomized-Controlled Period|Physician Decision|2|||
155686238|NCT03920293|561943651|FG000|Randomized-Controlled Period|Adverse Event|0|||
155686239|NCT03920293|561943652|FG001|Randomized-Controlled Period|Adverse Event|2|||
155686240|NCT03920293|561943651|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
155686241|NCT03920293|561943652|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
155686242|NCT03920293|561943651|FG000|Randomized-Controlled Period|Death|2|||
155686243|NCT03920293|561943652|FG001|Randomized-Controlled Period|Death|0|||
155686244|NCT03920293|561943651|FG000|Randomized-Controlled Period|Protocol Violation|1|||
155686245|NCT03920293|561943652|FG001|Randomized-Controlled Period|Protocol Violation|0|||
155686246|NCT03920293|561943651|FG000|Randomized-Controlled Period|Noncompliance|1|||
155686247|NCT03920293|561943652|FG001|Randomized-Controlled Period|Noncompliance|0|||
155686248|NCT03920293|561943651|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
155686249|NCT03920293|561943652|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
155686250|NCT03920293|561943651|FG000|Open- Label Extension Period|Death|3|||
155686251|NCT03920293|561943652|FG001|Open- Label Extension Period|Death|3|||
155686252|NCT03920293|561943651|FG000|Open- Label Extension Period|Physician Decision|5|||
155686253|NCT03920293|561943652|FG001|Open- Label Extension Period|Physician Decision|3|||
155686254|NCT03920293|561943651|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
155686255|NCT03920293|561943652|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
155686256|NCT01972308|561943655|FG000|Overall Study|Withdrawal by Subject|0|||
155686257|NCT01972308|561943656|FG001|Overall Study|Withdrawal by Subject|1|||
155686258|NCT01972308|561943655|FG000|Overall Study|Lost to Follow-up|4|||
155686259|NCT01972308|561943656|FG001|Overall Study|Lost to Follow-up|6|||
155686260|NCT01972308|561943655|FG000|Overall Study|Death|4|||
155686261|NCT01972308|561943656|FG001|Overall Study|Death|1|||
155686262|NCT01685801|561943660|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155686263|NCT01685801|561943661|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155686264|NCT01685801|561943662|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155686265|NCT01685801|561943663|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
155686266|NCT01685801|561943660|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
155686267|NCT01685801|561943661|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
155686268|NCT01685801|561943662|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
155686269|NCT01685801|561943663|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
155686270|NCT00113399|561943664|FG000|Overall Study|Death|1|||
155686271|NCT00113399|561943665|FG001|Overall Study|Death|1|||
155686272|NCT00113399|561943664|FG000|Overall Study|Withdrawal by Subject|1|||
155686273|NCT00113399|561943665|FG001|Overall Study|Withdrawal by Subject|2|||
155686274|NCT00113399|561943664|FG000|Overall Study|Complete Response|0|||
155686275|NCT00113399|561943665|FG001|Overall Study|Complete Response|1|||
155686276|NCT00113399|561943664|FG000|Overall Study|Other|0|||
155686277|NCT00113399|561943665|FG001|Overall Study|Other|1|||
155686278|NCT00666588|561943666|FG000|Overall Study|ineligible|2|||
155686279|NCT00666588|561943667|FG001|Overall Study|ineligible|0|||
155686280|NCT00666588|561943668|FG002|Overall Study|ineligible|0|||
155686281|NCT00666588|561943669|FG003|Overall Study|ineligible|2|||
155686282|NCT00666588|561943666|FG000|Overall Study|inevaluable|2|||
155686283|NCT00666588|561943667|FG001|Overall Study|inevaluable|0|||
155686284|NCT00666588|561943668|FG002|Overall Study|inevaluable|0|||
155686285|NCT00666588|561943669|FG003|Overall Study|inevaluable|0|||
155686286|NCT00521599|561943672|FG000|Overall Study|Adverse Event|5|||
155686287|NCT00521599|561943673|FG001|Overall Study|Adverse Event|7|||
155686288|NCT00521599|561943674|FG002|Overall Study|Adverse Event|6|||
155686289|NCT00521599|561943672|FG000|Overall Study|Treatment Failure|8|||
155686290|NCT00521599|561943673|FG001|Overall Study|Treatment Failure|9|||
155686291|NCT00521599|561943674|FG002|Overall Study|Treatment Failure|22|||
155686292|NCT00521599|561943672|FG000|Overall Study|Lost to Follow-up|2|||
155686293|NCT00521599|561943673|FG001|Overall Study|Lost to Follow-up|1|||
155686294|NCT00521599|561943674|FG002|Overall Study|Lost to Follow-up|2|||
155686295|NCT00521599|561943672|FG000|Overall Study|Withdrawal by Subject|3|||
155686296|NCT00521599|561943673|FG001|Overall Study|Withdrawal by Subject|5|||
155686297|NCT00521599|561943674|FG002|Overall Study|Withdrawal by Subject|1|||
155686298|NCT00521599|561943672|FG000|Overall Study|Withdrawal by subject treatment related|3|||
155686299|NCT00521599|561943673|FG001|Overall Study|Withdrawal by subject treatment related|1|||
155686300|NCT00521599|561943674|FG002|Overall Study|Withdrawal by subject treatment related|2|||
155686301|NCT00521599|561943672|FG000|Overall Study|Protocol Violation|2|||
155686302|NCT00521599|561943673|FG001|Overall Study|Protocol Violation|4|||
155686303|NCT00521599|561943674|FG002|Overall Study|Protocol Violation|2|||
155686304|NCT00521599|561943672|FG000|Overall Study|Did not meet protocol eligibility|2|||
155686305|NCT00521599|561943673|FG001|Overall Study|Did not meet protocol eligibility|2|||
155686306|NCT00521599|561943674|FG002|Overall Study|Did not meet protocol eligibility|1|||
155686307|NCT00791479|561943675|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155686308|NCT00791479|561943676|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155686309|NCT00791479|561943677|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155686310|NCT00791479|561943678|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155686311|NCT00791479|561943679|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
155686312|NCT00791479|561943680|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155686313|NCT00791479|561943675|FG000|Overall Study|Adverse Event|0|||
155686314|NCT00791479|561943676|FG001|Overall Study|Adverse Event|1|||
155686315|NCT00791479|561943677|FG002|Overall Study|Adverse Event|0|||
155686316|NCT00791479|561943678|FG003|Overall Study|Adverse Event|2|||
155686317|NCT00791479|561943679|FG004|Overall Study|Adverse Event|0|||
155686318|NCT00791479|561943680|FG005|Overall Study|Adverse Event|1|||
155686319|NCT00791479|561943675|FG000|Overall Study|Lost to Follow-up|0|||
155686320|NCT00791479|561943676|FG001|Overall Study|Lost to Follow-up|1|||
155686321|NCT00791479|561943677|FG002|Overall Study|Lost to Follow-up|0|||
155686322|NCT00791479|561943678|FG003|Overall Study|Lost to Follow-up|0|||
155686323|NCT00791479|561943679|FG004|Overall Study|Lost to Follow-up|0|||
155686324|NCT00791479|561943680|FG005|Overall Study|Lost to Follow-up|1|||
155686325|NCT00791479|561943675|FG000|Overall Study|Protocol Violation|2|||
155686326|NCT00791479|561943676|FG001|Overall Study|Protocol Violation|1|||
155686327|NCT00791479|561943677|FG002|Overall Study|Protocol Violation|0|||
155686328|NCT00791479|561943678|FG003|Overall Study|Protocol Violation|1|||
155686329|NCT00791479|561943679|FG004|Overall Study|Protocol Violation|0|||
155686330|NCT00791479|561943680|FG005|Overall Study|Protocol Violation|0|||
155686331|NCT00791479|561943675|FG000|Overall Study|Withdrawal by Subject|0|||
155686332|NCT00791479|561943676|FG001|Overall Study|Withdrawal by Subject|0|||
155686333|NCT00791479|561943677|FG002|Overall Study|Withdrawal by Subject|0|||
155686334|NCT00791479|561943678|FG003|Overall Study|Withdrawal by Subject|1|||
155686335|NCT00791479|561943679|FG004|Overall Study|Withdrawal by Subject|0|||
155686336|NCT00791479|561943680|FG005|Overall Study|Withdrawal by Subject|1|||
155686337|NCT00496197|561943681|FG000|Overall Study|Discontinued study due to death|43|||
155686338|NCT00496197|561943681|FG000|Overall Study|Adverse Event|13|||
155686339|NCT00496197|561943681|FG000|Overall Study|Does not meet entrance criteria|5|||
155686340|NCT00496197|561943681|FG000|Overall Study|Insufficient clinical response|3|||
155686341|NCT00496197|561943681|FG000|Overall Study|Insufficient bacteriological response|10|||
155686342|NCT00496197|561943681|FG000|Overall Study|Lost to Follow-up|11|||
155686343|NCT00496197|561943681|FG000|Overall Study|Withdrawal by Subject|11|||
155686344|NCT00496197|561943681|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
155686345|NCT00496197|561943681|FG000|Overall Study|Other|14|||
155686346|NCT00496197|561943681|FG000|Overall Study|Protocol Violation|8|||
155686347|NCT00149994|561943682|FG000|Overall Study|Administrative problems:|1|||
155686348|NCT00149994|561943683|FG001|Overall Study|Administrative problems:|0|||
155686349|NCT00149994|561943682|FG000|Overall Study|Protocol Violation|0|||
155686350|NCT00149994|561943683|FG001|Overall Study|Protocol Violation|1|||
155686351|NCT01610713|561943684|FG000|Overall Study|Adverse Event|3|||
155686352|NCT01610713|561943685|FG001|Overall Study|Adverse Event|0|||
155686353|NCT01610713|561943684|FG000|Overall Study|Lack of Efficacy|1|||
155686354|NCT01610713|561943685|FG001|Overall Study|Lack of Efficacy|0|||
155686355|NCT01610713|561943684|FG000|Overall Study|low mood and poor motivation|1|||
155686356|NCT01610713|561943685|FG001|Overall Study|low mood and poor motivation|0|||
155686357|NCT01610713|561943684|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
155686358|NCT01610713|561943685|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
155686359|NCT01610713|561943684|FG000|Overall Study|Lost to Follow-up|0|||
155686360|NCT01610713|561943685|FG001|Overall Study|Lost to Follow-up|1|||
155686361|NCT04049266|561943690|FG000|Overall Study|Adverse Event|16|||
155686362|NCT04049266|561943691|FG001|Overall Study|Adverse Event|9|||
155686363|NCT04049266|561943690|FG000|Overall Study|Non-compliance with study drug|0|||
155686364|NCT04049266|561943691|FG001|Overall Study|Non-compliance with study drug|3|||
155686365|NCT04049266|561943690|FG000|Overall Study|Withdrawal by Subject|6|||
155686366|NCT04049266|561943691|FG001|Overall Study|Withdrawal by Subject|10|||
155686367|NCT04049266|561943690|FG000|Overall Study|Lost to Follow-up|2|||
155686368|NCT04049266|561943691|FG001|Overall Study|Lost to Follow-up|2|||
155686369|NCT04049266|561943690|FG000|Overall Study|Progressive disease|11|||
155686370|NCT04049266|561943691|FG001|Overall Study|Progressive disease|2|||
155686371|NCT04049266|561943690|FG000|Overall Study|Physician Decision|1|||
155686372|NCT04049266|561943691|FG001|Overall Study|Physician Decision|0|||
155686373|NCT04049266|561943690|FG000|Overall Study|Patient moved out of state|1|||
155686374|NCT04049266|561943691|FG001|Overall Study|Patient moved out of state|0|||
155686375|NCT04600076|561943694|FG000|Overall Study|Lost to Follow-up|3|||
155686376|NCT03664674|561943695|FG000|Overall Study|Adverse Event|1|||
155686377|NCT03664674|561943696|FG001|Overall Study|Adverse Event|1|||
155686378|NCT03664674|561943695|FG000|Overall Study|Physician Decision|0|||
155686379|NCT03664674|561943696|FG001|Overall Study|Physician Decision|1|||
155686380|NCT03664674|561943695|FG000|Overall Study|Withdrawal by Subject|2|||
155686381|NCT03664674|561943696|FG001|Overall Study|Withdrawal by Subject|0|||
155686382|NCT01342965|561943697|FG000|Overall Study|Death|58|||
155686383|NCT01342965|561943698|FG001|Overall Study|Death|57|||
155686384|NCT01342965|561943697|FG000|Overall Study|Lost to Follow-up|5|||
155686385|NCT01342965|561943698|FG001|Overall Study|Lost to Follow-up|3|||
155686386|NCT01342965|561943697|FG000|Overall Study|Other Reasons- Unspecified|44|||
155686387|NCT01342965|561943698|FG001|Overall Study|Other Reasons- Unspecified|38|||
155686388|NCT01342965|561943697|FG000|Overall Study|Withdrawal by Subject|2|||
155686389|NCT01342965|561943698|FG001|Overall Study|Withdrawal by Subject|9|||
155686390|NCT00856206|561943699|FG000|Overall Study|Protocol Violation|6|||
155686391|NCT00856206|561943700|FG001|Overall Study|Protocol Violation|18|||
155686392|NCT00856206|561943699|FG000|Overall Study|Adverse Event|10|||
155686393|NCT00856206|561943700|FG001|Overall Study|Adverse Event|46|||
155686394|NCT00856206|561943699|FG000|Overall Study|Lack of Efficacy|1|||
155686395|NCT00856206|561943700|FG001|Overall Study|Lack of Efficacy|2|||
155686396|NCT00856206|561943699|FG000|Overall Study|Withdrawal by Subject|15|||
155686397|NCT00856206|561943700|FG001|Overall Study|Withdrawal by Subject|36|||
155686398|NCT00856206|561943699|FG000|Overall Study|Lost to Follow-up|13|||
155686399|NCT00856206|561943700|FG001|Overall Study|Lost to Follow-up|39|||
155686400|NCT00856206|561943699|FG000|Overall Study|Death|2|||
155686401|NCT00856206|561943700|FG001|Overall Study|Death|2|||
155686402|NCT00856206|561943699|FG000|Overall Study|Decision by the Sponsor|4|||
155686403|NCT00856206|561943700|FG001|Overall Study|Decision by the Sponsor|8|||
155686404|NCT00856206|561943699|FG000|Overall Study|Other than specified above|3|||
155686405|NCT00856206|561943700|FG001|Overall Study|Other than specified above|10|||
155686406|NCT01170598|561943706|FG000|Overall Study|Withdrawal by Subject|1|||
155686407|NCT01170598|561943706|FG000|Overall Study|Death|3|||
155686408|NCT01170598|561943706|FG000|Overall Study|Lost to Follow-up|1|||
155686409|NCT01170598|561943706|FG000|Overall Study|Refused|1|||
155686410|NCT04584346|561943707|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
155686411|NCT04584346|561943708|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
155686412|NCT02780856|561943709|FG000|Overall Study|Lost to Follow-up|1|||
155686413|NCT02437409|561943716|FG000|Overall Study|Withdrawal by Subject|3|||
155686414|NCT02437409|561943716|FG000|Overall Study|Screening failure|12|||
155686415|NCT00835640|561943730|FG000|Second Intervention|Protocol Violation|1|||
155686416|NCT00835640|561943731|FG001|Second Intervention|Protocol Violation|0|||
155686417|NCT00068250|561943732|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
155686418|NCT00068250|561943733|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
155686419|NCT00068250|561943734|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
155686420|NCT00068250|561943735|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
155686421|NCT01357161|561943736|FG000|Part 1 (Open Label Run-in)|Death|5|||
155686422|NCT01357161|561943737|FG001|Part 1 (Open Label Run-in)|Death|0|||
155686423|NCT01357161|561943738|FG002|Part 1 (Open Label Run-in)|Death|0|||
155686424|NCT01357161|561943736|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
155686425|NCT01357161|561943737|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
155686426|NCT01357161|561943738|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
155686427|NCT01357161|561943736|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
155686428|NCT01357161|561943737|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
155686429|NCT01357161|561943738|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
155686430|NCT01357161|561943736|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
155686431|NCT01357161|561943737|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
155686432|NCT01357161|561943738|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
155686433|NCT01357161|561943736|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
155686434|NCT01357161|561943737|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
155686435|NCT01357161|561943738|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
155686436|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
155686437|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
155686438|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
155686439|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
155686440|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
155686441|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
155686442|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
155686443|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
155686444|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
155686445|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
155686446|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
155686447|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
155686448|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
155686449|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
155686450|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
155686451|NCT01357161|561943736|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
155686452|NCT01357161|561943737|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
155686453|NCT01357161|561943738|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
155686454|NCT01824823|561943739|FG000|Overall Study|Lack of Efficacy|1|||
155686455|NCT01824823|561943740|FG001|Overall Study|Lack of Efficacy|1|||
155686456|NCT01824823|561943739|FG000|Overall Study|Off-treatment reason not submitted|1|||
155686457|NCT01824823|561943740|FG001|Overall Study|Off-treatment reason not submitted|0|||
155686458|NCT03730961|561943742|FG000|Overall Study|Adverse Event|0|||
155686459|NCT03730961|561943743|FG001|Overall Study|Adverse Event|1|||
155686460|NCT00840060|561945123|FG000|Overall Study|Withdrawal by Subject|1|||
155686461|NCT00840060|561945124|FG001|Overall Study|Withdrawal by Subject|0|||
155686462|NCT00840060|561945123|FG000|Overall Study|Change in emotional/behavioral status|0|||
155686463|NCT00840060|561945124|FG001|Overall Study|Change in emotional/behavioral status|1|||
155686464|NCT00428220|561945125|FG000|Overall Study|Participant died|8|||
155686465|NCT00428220|561945125|FG000|Overall Study|Global deterioration of health status|7|||
155686466|NCT00428220|561945125|FG000|Overall Study|Lost to Follow-up|4|||
155686467|NCT00428220|561945125|FG000|Overall Study|Objective progression or relapse|123|||
155686468|NCT00428220|561945125|FG000|Overall Study|Participant refused continued treatment|7|||
155686469|NCT00428220|561945125|FG000|Overall Study|Adverse Event|51|||
155686470|NCT00428220|561945125|FG000|Overall Study|Other|23|||
155686471|NCT00509093|561945126|FG000|Overall Study|Adverse Event|10|||
155686472|NCT00509093|561945126|FG000|Overall Study|Disease Progression|9|||
155686473|NCT00509093|561945126|FG000|Overall Study|Transformed into MDS|1|||
155686474|NCT00509093|561945126|FG000|Overall Study|Withdrawal by Subject|3|||
155686475|NCT00509093|561945126|FG000|Overall Study|Physician Decision|1|||
155686476|NCT01103063|561945127|FG000|Overall Study|Adverse Event|3|||
155686477|NCT01103063|561945128|FG001|Overall Study|Adverse Event|1|||
155686478|NCT01103063|561945127|FG000|Overall Study|Lost to Follow-up|68|||
155686479|NCT01103063|561945128|FG001|Overall Study|Lost to Follow-up|51|||
155686480|NCT01103063|561945127|FG000|Overall Study|Withdrawal by Subject|60|||
155686481|NCT01103063|561945128|FG001|Overall Study|Withdrawal by Subject|15|||
155686482|NCT01103063|561945127|FG000|Overall Study|Other|16|||
155686483|NCT01103063|561945128|FG001|Overall Study|Other|11|||
155686484|NCT01103063|561945127|FG000|Overall Study|Protocol Violation|1|||
155686485|NCT01103063|561945128|FG001|Overall Study|Protocol Violation|0|||
155686486|NCT01103063|561945127|FG000|Overall Study|Study terminated by Sponsor|326|||
155686487|NCT01103063|561945128|FG001|Overall Study|Study terminated by Sponsor|342|||
155686488|NCT01103063|561945127|FG000|Overall Study|Death|3|||
155686489|NCT01103063|561945128|FG001|Overall Study|Death|1|||
155686490|NCT04143217|561945135|FG000|Overall Study|Withdrawal by Subject|42|||
155686491|NCT04143217|561945135|FG000|Overall Study|Adverse Event|29|||
155686492|NCT04143217|561945135|FG000|Overall Study|Lost to Follow-up|29|||
155686493|NCT04143217|561945135|FG000|Overall Study|Lack of Efficacy|15|||
155686494|NCT04143217|561945135|FG000|Overall Study|Physician Decision|1|||
155686495|NCT04143217|561945135|FG000|Overall Study|Non-Compliance With Study Drug|6|||
155686496|NCT04143217|561945135|FG000|Overall Study|Other, Multiple Categories|11|||
155686497|NCT02210832|561945138|FG000|Overall Study|Pregnancy termination .|3|||
155686498|NCT02210832|561945139|FG001|Overall Study|Pregnancy termination .|4|||
155686499|NCT02210832|561945140|FG002|Overall Study|Pregnancy termination .|1|||
155686500|NCT02210832|561945138|FG000|Overall Study|Lost to Follow-up|26|||
155686501|NCT02210832|561945139|FG001|Overall Study|Lost to Follow-up|32|||
155686502|NCT02210832|561945140|FG002|Overall Study|Lost to Follow-up|17|||
155686503|NCT00445939|561945143|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
155686504|NCT00445939|561945144|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
155686505|NCT00445939|561945145|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
155686506|NCT00445939|561945146|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
155686507|NCT00445939|561945143|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
155686508|NCT00445939|561945144|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
155686509|NCT00445939|561945145|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
155686510|NCT00445939|561945146|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
155686511|NCT00919867|561945150|FG000|First Intervention|Withdrawal by Subject|0|||
155686512|NCT00919867|561945151|FG001|First Intervention|Withdrawal by Subject|0|||
155686513|NCT00919867|561945152|FG002|First Intervention|Withdrawal by Subject|1|||
155686514|NCT00919867|561945153|FG003|First Intervention|Withdrawal by Subject|0|||
155686515|NCT00919867|561945154|FG004|First Intervention|Withdrawal by Subject|0|||
155686516|NCT00919867|561945155|FG005|First Intervention|Withdrawal by Subject|0|||
155686517|NCT00919867|561945150|FG000|First Intervention|Physician Decision|0|||
155686518|NCT00919867|561945151|FG001|First Intervention|Physician Decision|0|||
155686519|NCT00919867|561945152|FG002|First Intervention|Physician Decision|0|||
155686520|NCT00919867|561945153|FG003|First Intervention|Physician Decision|0|||
155686521|NCT00919867|561945154|FG004|First Intervention|Physician Decision|0|||
155686522|NCT00919867|561945155|FG005|First Intervention|Physician Decision|1|||
155686523|NCT03555981|561945164|FG000|Overall Study|Lost to Follow-up|0|||
155686524|NCT03555981|561945165|FG001|Overall Study|Lost to Follow-up|2|||
155686525|NCT00354107|561945166|FG000|Overall Study|Adverse Event|2|||
155686526|NCT00354107|561945166|FG000|Overall Study|Physician Decision|2|||
155686527|NCT00354107|561945166|FG000|Overall Study|Withdrawal by Subject|1|||
155686528|NCT03361189|561945169|FG000|Overall Study|Received heart transplant|1|||
155686529|NCT03361189|561945170|FG001|Overall Study|Received heart transplant|0|||
155686530|NCT03361189|561945169|FG000|Overall Study|Pacemake replacement|0|||
155686531|NCT03361189|561945170|FG001|Overall Study|Pacemake replacement|1|||
155686532|NCT03344549|561945171|FG000|Overall Study|Withdrawal by Subject|3|||
155686533|NCT03344549|561945172|FG001|Overall Study|Withdrawal by Subject|2|||
155686534|NCT03344549|561945171|FG000|Overall Study|Dialysis|2|||
155686535|NCT03344549|561945172|FG001|Overall Study|Dialysis|0|||
155686536|NCT03344549|561945171|FG000|Overall Study|Cancer|1|||
155686537|NCT03344549|561945172|FG001|Overall Study|Cancer|0|||
155686538|NCT03344549|561945171|FG000|Overall Study|Lack of electronic device|1|||
155686539|NCT03344549|561945172|FG001|Overall Study|Lack of electronic device|0|||
155686540|NCT03344549|561945171|FG000|Overall Study|Transportation difficulty|0|||
155686541|NCT03344549|561945172|FG001|Overall Study|Transportation difficulty|13|||
155686542|NCT03333252|561945173|FG000|Overall Study|Adverse Event|10|||
155686543|NCT03333252|561945174|FG001|Overall Study|Adverse Event|6|||
155686544|NCT03333252|561945175|FG002|Overall Study|Adverse Event|5|||
155686545|NCT03333252|561945176|FG003|Overall Study|Adverse Event|2|||
155686546|NCT03333252|561945173|FG000|Overall Study|Death|1|||
155686547|NCT03333252|561945174|FG001|Overall Study|Death|3|||
155686548|NCT03333252|561945175|FG002|Overall Study|Death|0|||
155686549|NCT03333252|561945176|FG003|Overall Study|Death|0|||
155686550|NCT03333252|561945173|FG000|Overall Study|Lack of Efficacy|8|||
155686551|NCT03333252|561945174|FG001|Overall Study|Lack of Efficacy|4|||
155686552|NCT03333252|561945175|FG002|Overall Study|Lack of Efficacy|0|||
155686553|NCT03333252|561945176|FG003|Overall Study|Lack of Efficacy|7|||
155686554|NCT03333252|561945173|FG000|Overall Study|Lost to Follow-up|0|||
155686555|NCT03333252|561945174|FG001|Overall Study|Lost to Follow-up|5|||
155686556|NCT03333252|561945175|FG002|Overall Study|Lost to Follow-up|9|||
155686557|NCT03333252|561945176|FG003|Overall Study|Lost to Follow-up|3|||
155686558|NCT03333252|561945173|FG000|Overall Study|Withdrawal by Subject|14|||
155686559|NCT03333252|561945174|FG001|Overall Study|Withdrawal by Subject|24|||
155686560|NCT03333252|561945175|FG002|Overall Study|Withdrawal by Subject|11|||
155686561|NCT03333252|561945176|FG003|Overall Study|Withdrawal by Subject|17|||
155686562|NCT00557310|561945184|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
155686563|NCT00557310|561945184|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
155686564|NCT00557310|561945184|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
155686565|NCT00557310|561945184|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
155686566|NCT00557310|561945184|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
155686567|NCT00557310|561945184|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
155686568|NCT02781792|561945186|FG000|Overall Study|Adverse Event|1|||
155686569|NCT02781792|561945187|FG001|Overall Study|Adverse Event|2|||
155686570|NCT02781792|561945186|FG000|Overall Study|Withdrawal by Subject|3|||
155686571|NCT02781792|561945187|FG001|Overall Study|Withdrawal by Subject|1|||
155686572|NCT02781792|561945186|FG000|Overall Study|Lack of Efficacy|1|||
155686573|NCT02781792|561945187|FG001|Overall Study|Lack of Efficacy|1|||
155686574|NCT02781792|561945186|FG000|Overall Study|Hospice|0|||
155686575|NCT02781792|561945187|FG001|Overall Study|Hospice|1|||
155686576|NCT00794365|561945192|FG000|Overall Study|Lost to Follow-up|38|||
155686577|NCT00794365|561945192|FG000|Overall Study|Other|17|||
155686578|NCT00794365|561945192|FG000|Overall Study|Poor Compliance|11|||
155686579|NCT00794365|561945192|FG000|Overall Study|Adverse Event|10|||
155686580|NCT00794365|561945192|FG000|Overall Study|Lack of Efficacy|3|||
155686581|NCT03538444|561945195|FG000|Overall Study|opioid withdrawal|1|||
155686582|NCT03538444|561945196|FG001|Overall Study|opioid withdrawal|0|||
155686583|NCT03022097|561945197|FG000|Overall Study|Adverse Event|3|||
155686584|NCT03022097|561945198|FG001|Overall Study|Adverse Event|4|||
155686585|NCT03022097|561945199|FG002|Overall Study|Adverse Event|1|||
155686586|NCT03022097|561945200|FG003|Overall Study|Adverse Event|3|||
155686587|NCT03022097|561945197|FG000|Overall Study|Progressive Disease|2|||
155686588|NCT03022097|561945198|FG001|Overall Study|Progressive Disease|0|||
155686589|NCT03022097|561945199|FG002|Overall Study|Progressive Disease|5|||
155686590|NCT03022097|561945200|FG003|Overall Study|Progressive Disease|2|||
155686591|NCT03022097|561945197|FG000|Overall Study|Lack of Efficacy|0|||
155686592|NCT03022097|561945198|FG001|Overall Study|Lack of Efficacy|0|||
155686593|NCT03022097|561945199|FG002|Overall Study|Lack of Efficacy|3|||
155686594|NCT03022097|561945200|FG003|Overall Study|Lack of Efficacy|3|||
155686595|NCT03022097|561945197|FG000|Overall Study|Protocol Violation|1|||
155686596|NCT03022097|561945198|FG001|Overall Study|Protocol Violation|0|||
155686597|NCT03022097|561945199|FG002|Overall Study|Protocol Violation|1|||
155686598|NCT03022097|561945200|FG003|Overall Study|Protocol Violation|0|||
155686599|NCT03022097|561945197|FG000|Overall Study|Withdrawal by Subject|11|||
155686600|NCT03022097|561945198|FG001|Overall Study|Withdrawal by Subject|13|||
155686601|NCT03022097|561945199|FG002|Overall Study|Withdrawal by Subject|15|||
155686602|NCT03022097|561945200|FG003|Overall Study|Withdrawal by Subject|21|||
155686603|NCT03022097|561945197|FG000|Overall Study|Lost to Follow-up|0|||
155686604|NCT03022097|561945198|FG001|Overall Study|Lost to Follow-up|0|||
155686605|NCT03022097|561945199|FG002|Overall Study|Lost to Follow-up|1|||
155686606|NCT03022097|561945200|FG003|Overall Study|Lost to Follow-up|1|||
155686607|NCT03022097|561945197|FG000|Overall Study|Other|4|||
155686608|NCT03022097|561945198|FG001|Overall Study|Other|1|||
155686609|NCT03022097|561945199|FG002|Overall Study|Other|6|||
155686610|NCT03022097|561945200|FG003|Overall Study|Other|4|||
155686611|NCT03022097|561945197|FG000|Overall Study|Due to COVID-19 pandemic|0|||
155686612|NCT03022097|561945198|FG001|Overall Study|Due to COVID-19 pandemic|1|||
155686613|NCT03022097|561945199|FG002|Overall Study|Due to COVID-19 pandemic|0|||
155686614|NCT03022097|561945200|FG003|Overall Study|Due to COVID-19 pandemic|0|||
155686615|NCT00457821|561945205|FG000|Part 2|Withdrawal by Subject|0|||
155686616|NCT00457821|561945206|FG001|Part 2|Withdrawal by Subject|0|||
155686617|NCT00457821|561945207|FG002|Part 2|Withdrawal by Subject|0|||
155686618|NCT00457821|561945208|FG003|Part 2|Withdrawal by Subject|0|||
155686619|NCT00457821|561945209|FG004|Part 2|Withdrawal by Subject|0|||
155686620|NCT00457821|561945210|FG005|Part 2|Withdrawal by Subject|0|||
155686621|NCT00457821|561945211|FG006|Part 2|Withdrawal by Subject|0|||
155686622|NCT00457821|561945212|FG007|Part 2|Withdrawal by Subject|1|||
155686623|NCT00790647|561945215|FG000|Overall Study|Adverse Event|1|||
155686624|NCT00027378|561945216|FG000|Overall Study|Physician Decision|0|||
155686625|NCT00027378|561945217|FG001|Overall Study|Physician Decision|3|||
155686626|NCT02851407|561945223|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155686627|NCT02851407|561945224|FG001|Overall Study|Withdrawal by parent/guardian|7|||
155686628|NCT02851407|561945223|FG000|Overall Study|Protocol deviation|0|||
155686629|NCT02851407|561945224|FG001|Overall Study|Protocol deviation|1|||
155686630|NCT02851407|561945223|FG000|Overall Study|Transferred to another hospital to continue|1|||
155686631|NCT02851407|561945224|FG001|Overall Study|Transferred to another hospital to continue|0|||
155686632|NCT02851407|561945223|FG000|Overall Study|Other Death|30|||
155686633|NCT02851407|561945224|FG001|Overall Study|Other Death|20|||
155686634|NCT02851407|561945223|FG000|Overall Study|Adverse event, serious fatal|6|||
155686635|NCT02851407|561945224|FG001|Overall Study|Adverse event, serious fatal|8|||
155686636|NCT02851407|561945223|FG000|Overall Study|Consent withdrawn by participant|5|||
155686637|NCT02851407|561945224|FG001|Overall Study|Consent withdrawn by participant|3|||
155686638|NCT02851407|561945223|FG000|Overall Study|Screen failure|2|||
155686639|NCT02851407|561945224|FG001|Overall Study|Screen failure|1|||
155686640|NCT02851407|561945223|FG000|Overall Study|Disease relapse|9|||
155686641|NCT02851407|561945224|FG001|Overall Study|Disease relapse|6|||
155686642|NCT02851407|561945223|FG000|Overall Study|Physician Decision|7|||
155686643|NCT02851407|561945224|FG001|Overall Study|Physician Decision|6|||
155686644|NCT02851407|561945223|FG000|Overall Study|Transferred to hospital closer to home|0|||
155686645|NCT02851407|561945224|FG001|Overall Study|Transferred to hospital closer to home|1|||
155686646|NCT02851407|561945223|FG000|Overall Study|Enrolled in an investigational study|0|||
155686647|NCT02851407|561945224|FG001|Overall Study|Enrolled in an investigational study|1|||
155686648|NCT02851407|561945223|FG000|Overall Study|Early recovery|1|||
155686649|NCT02851407|561945224|FG001|Overall Study|Early recovery|0|||
155686650|NCT02851407|561945223|FG000|Overall Study|Adverse event, non-fatal|7|||
155686651|NCT02851407|561945224|FG001|Overall Study|Adverse event, non-fatal|5|||
155686652|NCT02851407|561945223|FG000|Overall Study|Lost to Follow-up|0|||
155686653|NCT02851407|561945224|FG001|Overall Study|Lost to Follow-up|2|||
155686654|NCT01713283|561945225|FG000|Overall Study|Lack of Efficacy|10|||
155686655|NCT01713283|561945226|FG001|Overall Study|Lack of Efficacy|2|||
155686656|NCT01713283|561945225|FG000|Overall Study|Lost to Follow-up|1|||
155686657|NCT01713283|561945226|FG001|Overall Study|Lost to Follow-up|1|||
155686658|NCT02585830|561945227|FG000|Overall Study|Withdrawal by Subject|3|||
155686659|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
155686660|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
155686661|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Death|1|||
155686662|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Death|0|||
155686663|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
155686664|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
155686665|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
155686666|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
155686667|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
155686668|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
155686669|NCT00350272|561945228|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
155686670|NCT00350272|561945229|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
155686671|NCT00350272|561945228|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
155686672|NCT00350272|561945229|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
155686673|NCT00350272|561945228|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
155686674|NCT00350272|561945229|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
155686675|NCT00350272|561945228|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
155686676|NCT00350272|561945229|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
155686677|NCT00350272|561945228|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
155686678|NCT00350272|561945229|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
155686679|NCT00350272|561945228|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
155686680|NCT00350272|561945229|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
155686681|NCT00235391|561945230|FG000|Overall Study|Adverse Event|4|||
155686682|NCT00235391|561945231|FG001|Overall Study|Adverse Event|5|||
155605449|NCT03191864|561642994|FG000|Baseline Symptom Assessment|Adverse Event|0|||
155605450|NCT03191864|561642995|FG001|Baseline Symptom Assessment|Adverse Event|0|||
155605451|NCT03191864|561642996|FG002|Baseline Symptom Assessment|Adverse Event|0|||
155605452|NCT03191864|561642997|FG003|Baseline Symptom Assessment|Adverse Event|0|||
155605453|NCT03191864|561642998|FG004|Baseline Symptom Assessment|Adverse Event|0|||
155605454|NCT03191864|561642999|FG005|Baseline Symptom Assessment|Adverse Event|2|||
155605455|NCT03191864|561642994|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155605456|NCT03191864|561642995|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155605457|NCT03191864|561642996|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155605458|NCT03191864|561642997|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155605459|NCT03191864|561642998|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155605460|NCT03191864|561642999|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
155605461|NCT03191864|561642994|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155605462|NCT03191864|561642995|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155605463|NCT03191864|561642996|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155605464|NCT03191864|561642997|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155605465|NCT03191864|561642998|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155605466|NCT03191864|561642999|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
155605467|NCT03191864|561642994|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155605468|NCT03191864|561642995|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155605469|NCT03191864|561642996|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
155605470|NCT03191864|561642997|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155605471|NCT03191864|561642998|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155605472|NCT03191864|561642999|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
155605473|NCT03191864|561642994|FG000|Part 1 - Induction|Adverse Event|0|||
155605474|NCT03191864|561642995|FG001|Part 1 - Induction|Adverse Event|2|||
155605475|NCT03191864|561642996|FG002|Part 1 - Induction|Adverse Event|0|||
155605476|NCT03191864|561642997|FG003|Part 1 - Induction|Adverse Event|1|||
155605477|NCT03191864|561642998|FG004|Part 1 - Induction|Adverse Event|0|||
155605478|NCT03191864|561642999|FG005|Part 1 - Induction|Adverse Event|2|||
155605479|NCT03191864|561642994|FG000|Part 1 - Induction|Randomized but never dosed|0|||
155605480|NCT03191864|561642995|FG001|Part 1 - Induction|Randomized but never dosed|0|||
155605481|NCT03191864|561642996|FG002|Part 1 - Induction|Randomized but never dosed|1|||
155605482|NCT03191864|561642997|FG003|Part 1 - Induction|Randomized but never dosed|0|||
155605483|NCT03191864|561642998|FG004|Part 1 - Induction|Randomized but never dosed|0|||
155605484|NCT03191864|561642999|FG005|Part 1 - Induction|Randomized but never dosed|0|||
155605485|NCT03191864|561642994|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
155605486|NCT03191864|561642995|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
155605487|NCT03191864|561642996|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
155605488|NCT03191864|561642997|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
155605489|NCT03191864|561642998|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
155605490|NCT03191864|561642999|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
155605491|NCT03191864|561642994|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155605492|NCT03191864|561642995|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155605493|NCT03191864|561642996|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
155605494|NCT03191864|561642997|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155605495|NCT03191864|561642998|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155605496|NCT03191864|561642999|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155605497|NCT03191864|561642994|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
155605498|NCT03191864|561642995|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155605499|NCT03191864|561642996|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155605500|NCT03191864|561642997|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155605501|NCT03191864|561642998|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155605502|NCT03191864|561642999|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155605503|NCT03191864|561642994|FG000|Part 2 - Maintenance|Physician Decision|1|||
155605504|NCT03191864|561642995|FG001|Part 2 - Maintenance|Physician Decision|0|||
155605505|NCT03191864|561642996|FG002|Part 2 - Maintenance|Physician Decision|0|||
155605506|NCT03191864|561642997|FG003|Part 2 - Maintenance|Physician Decision|0|||
155605507|NCT03191864|561642998|FG004|Part 2 - Maintenance|Physician Decision|0|||
155605508|NCT03191864|561642999|FG005|Part 2 - Maintenance|Physician Decision|0|||
155605509|NCT03191864|561642994|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
155605510|NCT03191864|561642995|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
155605511|NCT03191864|561642996|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
155605512|NCT03191864|561642997|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
155605513|NCT03191864|561642998|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
155605514|NCT03191864|561642999|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
155605515|NCT03191864|561642994|FG000|Part 2 - Maintenance|Adverse Event|0|||
155605516|NCT03191864|561642995|FG001|Part 2 - Maintenance|Adverse Event|0|||
155686683|NCT00235391|561945232|FG002|Overall Study|Adverse Event|10|||
155686684|NCT00235391|561945233|FG003|Overall Study|Adverse Event|72|||
155686685|NCT00235391|561945234|FG004|Overall Study|Adverse Event|5|||
155686686|NCT00235391|561945235|FG005|Overall Study|Adverse Event|2|||
155686687|NCT00235391|561945230|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155686688|NCT00235391|561945231|FG001|Overall Study|Abnormal laboratory value(s)|5|||
155686689|NCT00235391|561945232|FG002|Overall Study|Abnormal laboratory value(s)|4|||
155686690|NCT00235391|561945233|FG003|Overall Study|Abnormal laboratory value(s)|27|||
155686691|NCT00235391|561945234|FG004|Overall Study|Abnormal laboratory value(s)|1|||
155686692|NCT00235391|561945235|FG005|Overall Study|Abnormal laboratory value(s)|2|||
155686693|NCT00235391|561945230|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155686694|NCT00235391|561945231|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155686695|NCT00235391|561945232|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155686696|NCT00235391|561945233|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
155686697|NCT00235391|561945234|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
155686698|NCT00235391|561945235|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
155686699|NCT00235391|561945230|FG000|Overall Study|Condition no longer requires treatment|3|||
155686700|NCT00235391|561945231|FG001|Overall Study|Condition no longer requires treatment|0|||
155686701|NCT00235391|561945232|FG002|Overall Study|Condition no longer requires treatment|0|||
155686702|NCT00235391|561945233|FG003|Overall Study|Condition no longer requires treatment|11|||
155686703|NCT00235391|561945234|FG004|Overall Study|Condition no longer requires treatment|1|||
155686704|NCT00235391|561945235|FG005|Overall Study|Condition no longer requires treatment|0|||
155686705|NCT00235391|561945230|FG000|Overall Study|Protocol deviation|0|||
155686706|NCT00235391|561945231|FG001|Overall Study|Protocol deviation|0|||
155686707|NCT00235391|561945232|FG002|Overall Study|Protocol deviation|1|||
155686708|NCT00235391|561945233|FG003|Overall Study|Protocol deviation|11|||
155686709|NCT00235391|561945234|FG004|Overall Study|Protocol deviation|0|||
155686710|NCT00235391|561945235|FG005|Overall Study|Protocol deviation|0|||
155686711|NCT00235391|561945230|FG000|Overall Study|Withdrawal by Subject|2|||
155686712|NCT00235391|561945231|FG001|Overall Study|Withdrawal by Subject|3|||
155686713|NCT00235391|561945232|FG002|Overall Study|Withdrawal by Subject|3|||
155686714|NCT00235391|561945233|FG003|Overall Study|Withdrawal by Subject|61|||
155686715|NCT00235391|561945234|FG004|Overall Study|Withdrawal by Subject|5|||
155686716|NCT00235391|561945235|FG005|Overall Study|Withdrawal by Subject|0|||
155686717|NCT00235391|561945230|FG000|Overall Study|Lost to Follow-up|0|||
155686718|NCT00235391|561945231|FG001|Overall Study|Lost to Follow-up|3|||
155686719|NCT00235391|561945232|FG002|Overall Study|Lost to Follow-up|3|||
155686720|NCT00235391|561945233|FG003|Overall Study|Lost to Follow-up|16|||
155686721|NCT00235391|561945234|FG004|Overall Study|Lost to Follow-up|0|||
155686722|NCT00235391|561945235|FG005|Overall Study|Lost to Follow-up|0|||
155686723|NCT00235391|561945230|FG000|Overall Study|Administrative problems|0|||
155686724|NCT00235391|561945231|FG001|Overall Study|Administrative problems|0|||
155686725|NCT00235391|561945232|FG002|Overall Study|Administrative problems|0|||
155686726|NCT00235391|561945233|FG003|Overall Study|Administrative problems|1|||
155686727|NCT00235391|561945234|FG004|Overall Study|Administrative problems|0|||
155686728|NCT00235391|561945235|FG005|Overall Study|Administrative problems|0|||
155686729|NCT00235391|561945230|FG000|Overall Study|Death|0|||
155686730|NCT00235391|561945231|FG001|Overall Study|Death|0|||
155686731|NCT00235391|561945232|FG002|Overall Study|Death|1|||
155686732|NCT00235391|561945233|FG003|Overall Study|Death|4|||
155686733|NCT00235391|561945234|FG004|Overall Study|Death|0|||
155686734|NCT00235391|561945235|FG005|Overall Study|Death|0|||
155686735|NCT03349645|561945236|FG000|Overall Study|Sponsor Terminated Study|75|||
155686736|NCT03349645|561945236|FG000|Overall Study|Withdrawal by Subject|4|||
155686737|NCT03349645|561945236|FG000|Overall Study|Protocol Violation|1|||
155686738|NCT03349645|561945236|FG000|Overall Study|Other|2|||
155686739|NCT02927925|561945246|FG000|Overall Study|Death|16|||
155686740|NCT02927925|561945246|FG000|Overall Study|Physician Decision|1|||
155686741|NCT02927925|561945246|FG000|Overall Study|Withdrawal by Subject|11|||
155686742|NCT02927925|561945246|FG000|Overall Study|Other|3|||
155686743|NCT02927925|561945246|FG000|Overall Study|Disease progression at clinical cutoff|1|||
155686744|NCT01080768|561945247|FG000|Overall Study|Protocol Deviation|2|||
155686745|NCT01080768|561945248|FG001|Overall Study|Protocol Deviation|1|||
155686746|NCT03510468|561945249|FG000|Overall Study|Lost to Follow-up|1|||
155686747|NCT03510468|561945249|FG000|Overall Study|Adverse Event|5|||
155686748|NCT03510468|561945249|FG000|Overall Study|Physician Decision|1|||
155686749|NCT03510468|561945249|FG000|Overall Study|non-compliant with treatment|2|||
155686750|NCT03510468|561945249|FG000|Overall Study|Missed visit|1|||
155686751|NCT02752958|561945254|FG000|Overall Study|Adverse Event|3|||
155686752|NCT02752958|561945254|FG000|Overall Study|Lost to Follow-up|1|||
155686753|NCT02752958|561945254|FG000|Overall Study|Protocol Violation|1|||
155686754|NCT02752958|561945254|FG000|Overall Study|Withdrawal by Subject|2|||
155686755|NCT02752958|561945254|FG000|Overall Study|Other (Reason not specified)|2|||
155686756|NCT01799239|561945255|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
155686757|NCT01799239|561945256|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
155686758|NCT01799239|561945255|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
155686759|NCT01799239|561945256|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
155686760|NCT01799239|561945255|FG000|Period 1 (7 Days)|Protocol Violation|0|||
155686761|NCT01799239|561945256|FG001|Period 1 (7 Days)|Protocol Violation|1|||
155686762|NCT01799239|561945255|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
155686763|NCT01799239|561945256|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
155686764|NCT01799239|561945255|FG000|Period 2 (7 Days)|Protocol Violation|1|||
155686765|NCT01799239|561945256|FG001|Period 2 (7 Days)|Protocol Violation|0|||
155686766|NCT01300819|561945260|FG000|Overall Study|Adverse Event|9|||
155686767|NCT01300819|561945261|FG001|Overall Study|Adverse Event|27|||
155686768|NCT01300819|561945260|FG000|Overall Study|Lack of Efficacy|2|||
155686769|NCT01300819|561945261|FG001|Overall Study|Lack of Efficacy|1|||
155686770|NCT01300819|561945260|FG000|Overall Study|Withdrawal by Subject|10|||
155686771|NCT01300819|561945261|FG001|Overall Study|Withdrawal by Subject|12|||
155686772|NCT01300819|561945260|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
155686773|NCT01300819|561945261|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
155686774|NCT01300819|561945260|FG000|Overall Study|Refusal to down titrate study drug|0|||
155686775|NCT01300819|561945261|FG001|Overall Study|Refusal to down titrate study drug|1|||
155686776|NCT01300819|561945260|FG000|Overall Study|Administrative reason|0|||
155686777|NCT01300819|561945261|FG001|Overall Study|Administrative reason|1|||
155686778|NCT01300819|561945260|FG000|Overall Study|Safety follow up not done by mistake|0|||
155686779|NCT01300819|561945261|FG001|Overall Study|Safety follow up not done by mistake|1|||
155686780|NCT01300819|561945260|FG000|Overall Study|Follow up call was not done|1|||
155686781|NCT01300819|561945261|FG001|Overall Study|Follow up call was not done|0|||
155686782|NCT01444027|561945262|FG000|Overall Study|Withdrawal by Subject|4|||
155686783|NCT01444027|561945263|FG001|Overall Study|Withdrawal by Subject|10|||
155686784|NCT01444027|561945264|FG002|Overall Study|Withdrawal by Subject|24|||
155686785|NCT01444027|561945262|FG000|Overall Study|Lost to Follow-up|26|||
155686786|NCT01444027|561945263|FG001|Overall Study|Lost to Follow-up|20|||
155686787|NCT01444027|561945264|FG002|Overall Study|Lost to Follow-up|14|||
155686788|NCT03966885|561946945|FG000|Overall Study|Death|1|||
155686789|NCT03966885|561946946|FG001|Overall Study|Death|0|||
155686790|NCT03966885|561946945|FG000|Overall Study|Lost to Follow-up|1|||
155686791|NCT03966885|561946946|FG001|Overall Study|Lost to Follow-up|2|||
155686792|NCT03966885|561946945|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
155686793|NCT03966885|561946946|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
155686794|NCT03966885|561946945|FG000|Overall Study|Moved from study area.|0|||
155686795|NCT03966885|561946946|FG001|Overall Study|Moved from study area.|2|||
155686796|NCT01514240|561946947|FG000|Overall Study|Adverse Event|4|||
155686797|NCT01514240|561946948|FG001|Overall Study|Adverse Event|4|||
155686798|NCT01514240|561946947|FG000|Overall Study|Subject Decision|2|||
155686799|NCT01514240|561946948|FG001|Overall Study|Subject Decision|7|||
155686800|NCT05013424|561946949|FG000|Overall Study|Lost to Follow-up|1|||
155686801|NCT05013424|561946950|FG001|Overall Study|Lost to Follow-up|1|||
155686802|NCT05013424|561946951|FG002|Overall Study|Lost to Follow-up|1|||
155686803|NCT05013424|561946949|FG000|Overall Study|Withdrawal by Subject|0|||
155686804|NCT05013424|561946950|FG001|Overall Study|Withdrawal by Subject|1|||
155686805|NCT05013424|561946951|FG002|Overall Study|Withdrawal by Subject|0|||
155686806|NCT04411420|561946952|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
155686807|NCT04411420|561946953|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
155686808|NCT04411420|561946952|FG000|Survey Subset|Lost to Follow-up|134|||
155686809|NCT04411420|561946953|FG001|Survey Subset|Lost to Follow-up|120|||
155686810|NCT00549900|561946954|FG000|Overall Study|Adverse Event|1|||
155686811|NCT03899064|561946958|FG000|Overall Study|Lost to Follow-up|1|||
155686812|NCT03899064|561946958|FG000|Overall Study|Protocol Violation|2|||
155686813|NCT03899064|561946958|FG000|Overall Study|Withdrawal by Subject|2|||
155686814|NCT03899064|561946958|FG000|Overall Study|Other|2|||
155686815|NCT03283098|561946959|FG000|Overall Study|Withdrawal by Subject|0|||
155686816|NCT03283098|561946960|FG001|Overall Study|Withdrawal by Subject|1|||
155686817|NCT00798317|561946965|FG000|Overall Study|Physician Decision|0|||
155686818|NCT00798317|561946966|FG001|Overall Study|Physician Decision|1|||
155686819|NCT00798317|561946965|FG000|Overall Study|Withdrawal by Subject|5|||
155686820|NCT00798317|561946966|FG001|Overall Study|Withdrawal by Subject|4|||
155686821|NCT00798317|561946965|FG000|Overall Study|Lost to Follow-up|2|||
155686822|NCT00798317|561946966|FG001|Overall Study|Lost to Follow-up|2|||
155686823|NCT00798317|561946965|FG000|Overall Study|Adverse Event|2|||
155686824|NCT00798317|561946966|FG001|Overall Study|Adverse Event|0|||
155686825|NCT00798317|561946965|FG000|Overall Study|Death|1|||
155686826|NCT00798317|561946966|FG001|Overall Study|Death|0|||
155686827|NCT01278407|561946967|FG000|Confirmatory Phase|Adverse Event|5|||
155686828|NCT01278407|561946968|FG001|Confirmatory Phase|Adverse Event|10|||
155686829|NCT01278407|561946969|FG002|Confirmatory Phase|Adverse Event|1|||
155686830|NCT01278407|561946970|FG003|Confirmatory Phase|Adverse Event|0|||
155686831|NCT01278407|561946971|FG004|Confirmatory Phase|Adverse Event|0|||
155686832|NCT01278407|561946967|FG000|Confirmatory Phase|Participant's Choice|3|||
155686833|NCT01278407|561946968|FG001|Confirmatory Phase|Participant's Choice|5|||
155686834|NCT01278407|561946969|FG002|Confirmatory Phase|Participant's Choice|3|||
155686835|NCT01278407|561946970|FG003|Confirmatory Phase|Participant's Choice|0|||
155686836|NCT01278407|561946971|FG004|Confirmatory Phase|Participant's Choice|0|||
155686837|NCT01278407|561946967|FG000|Confirmatory Phase|Other|1|||
155686838|NCT01278407|561946968|FG001|Confirmatory Phase|Other|1|||
155686839|NCT01278407|561946969|FG002|Confirmatory Phase|Other|2|||
155686840|NCT01278407|561946970|FG003|Confirmatory Phase|Other|0|||
155686841|NCT01278407|561946971|FG004|Confirmatory Phase|Other|0|||
155686842|NCT01278407|561946967|FG000|Extension Phase|Adverse Event|0|||
155686843|NCT01278407|561946968|FG001|Extension Phase|Adverse Event|0|||
155686844|NCT01278407|561946969|FG002|Extension Phase|Adverse Event|0|||
155686845|NCT01278407|561946970|FG003|Extension Phase|Adverse Event|7|||
155686846|NCT01278407|561946971|FG004|Extension Phase|Adverse Event|16|||
155686847|NCT01278407|561946967|FG000|Extension Phase|Participant's Choice|0|||
155686848|NCT01278407|561946968|FG001|Extension Phase|Participant's Choice|0|||
155686849|NCT01278407|561946969|FG002|Extension Phase|Participant's Choice|0|||
155686850|NCT01278407|561946970|FG003|Extension Phase|Participant's Choice|4|||
155686851|NCT01278407|561946971|FG004|Extension Phase|Participant's Choice|11|||
155686852|NCT01278407|561946967|FG000|Extension Phase|Other|0|||
155686853|NCT01278407|561946968|FG001|Extension Phase|Other|0|||
155686854|NCT01278407|561946969|FG002|Extension Phase|Other|0|||
155686855|NCT01278407|561946970|FG003|Extension Phase|Other|1|||
155686856|NCT01278407|561946971|FG004|Extension Phase|Other|3|||
155686857|NCT02534935|561946972|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
155686858|NCT02534935|561946973|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
155686859|NCT02534935|561946974|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
155686860|NCT02534935|561946972|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
155686861|NCT02534935|561946973|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
155686862|NCT02534935|561946974|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
155686863|NCT02534935|561946972|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
155686864|NCT02534935|561946973|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
155686865|NCT02534935|561946974|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
155686866|NCT02534935|561946972|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
155686867|NCT02534935|561946973|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
155686868|NCT02534935|561946974|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
155686869|NCT02534935|561946972|FG000|Stage 1: 24 Months|Adverse Event|0|||
155686870|NCT02534935|561946973|FG001|Stage 1: 24 Months|Adverse Event|2|||
155686871|NCT02534935|561946974|FG002|Stage 1: 24 Months|Adverse Event|0|||
155686872|NCT02534935|561946972|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
155686873|NCT02534935|561946973|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
155686874|NCT02534935|561946974|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
155686875|NCT02534935|561946972|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
155686876|NCT02534935|561946973|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
155686877|NCT02534935|561946974|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
155686878|NCT01069861|561946975|FG000|Overall Study|Death|1|||
155686879|NCT01069861|561946975|FG000|Overall Study|Adverse Event|1|||
155686880|NCT01069861|561946975|FG000|Overall Study|Did not meet entrance criteria|1|||
155686881|NCT01596335|561946976|FG000|Overall Study|exacerbation of primary disease|5|||
155686882|NCT01596335|561946977|FG001|Overall Study|exacerbation of primary disease|9|||
155686883|NCT01460719|561946978|FG000|Overall Study|Adverse Event|1|||
155686884|NCT01460719|561946978|FG000|Overall Study|Withdrawal by Subject|1|||
155686885|NCT03350256|561946979|FG000|Overall Study|Inclusion/exclusion violation|4|||
155686886|NCT03350256|561946979|FG000|Overall Study|Recommended for other therapies|2|||
155686887|NCT03350256|561946979|FG000|Overall Study|Protocol Violation|3|||
155686888|NCT03350256|561946979|FG000|Overall Study|Non compliance|2|||
155686889|NCT03350256|561946979|FG000|Overall Study|Denial by insurance|1|||
155686890|NCT03350256|561946979|FG000|Overall Study|Adverse Event|2|||
155686891|NCT03350256|561946979|FG000|Overall Study|Trial failure|12|||
155686892|NCT03350256|561946979|FG000|Overall Study|Did not proceed to permanent implant|3|||
155686893|NCT03350256|561946979|FG000|Overall Study|Withdrawal by Subject|3|||
155686894|NCT03350256|561946979|FG000|Overall Study|Subject moving out of state|1|||
155686895|NCT03350256|561946979|FG000|Overall Study|Lost to Follow-up|1|||
155686896|NCT03350256|561946979|FG000|Overall Study|Lack of Efficacy|2|||
155686897|NCT02680041|561946980|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
155686898|NCT02680041|561946980|FG000|Overall Study|Lost to Follow-up|2|||
155686899|NCT03405935|561946985|FG000|Overall Study|Adverse Event|3|||
155686900|NCT03405935|561946985|FG000|Overall Study|Death|2|||
155686901|NCT03405935|561946985|FG000|Overall Study|Withdrawal by Subject|1|||
155686902|NCT03405935|561946985|FG000|Overall Study|Lost to Follow-up|2|||
155686903|NCT04979897|561946986|FG000|Overall Study|Death|1|||
155686904|NCT04979897|561946987|FG001|Overall Study|Death|8|||
155686905|NCT04979897|561946986|FG000|Overall Study|Lost to Follow-up|111|||
155686906|NCT04979897|561946987|FG001|Overall Study|Lost to Follow-up|56|||
155686907|NCT04979897|561946986|FG000|Overall Study|Withdrawal by Subject|7|||
155686908|NCT04979897|561946987|FG001|Overall Study|Withdrawal by Subject|2|||
155686909|NCT04195438|561946993|FG000|Overall Study|Withdrawal by Subject|1|||
155686910|NCT03136497|561946994|FG000|Overall Study|Screen Failure|1|||
155686911|NCT03136497|561946995|FG001|Overall Study|Screen Failure|0|||
155686912|NCT03136497|561946996|FG002|Overall Study|Screen Failure|0|||
155686913|NCT00934947|561946997|FG000|Overall Study|Adverse Event|0|||
155686914|NCT00934947|561946998|FG001|Overall Study|Adverse Event|2|||
155686915|NCT01451931|561947014|FG000|Overall Study|Lost to Follow-up|17|||
155686916|NCT01451931|561947015|FG001|Overall Study|Lost to Follow-up|36|||
155686917|NCT01451931|561947016|FG002|Overall Study|Lost to Follow-up|21|||
155686918|NCT01451931|561947014|FG000|Overall Study|Withdrawal by Subject|16|||
155686919|NCT01451931|561947015|FG001|Overall Study|Withdrawal by Subject|22|||
155686920|NCT01451931|561947016|FG002|Overall Study|Withdrawal by Subject|22|||
155686921|NCT00230282|561947021|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
155686922|NCT00230282|561947021|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
155686923|NCT00230282|561947021|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
155686924|NCT00230282|561947021|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
155686925|NCT01369680|561947023|FG000|Overall Study|Lost to Follow-up|0|||
155686926|NCT01369680|561947024|FG001|Overall Study|Lost to Follow-up|0|||
155686927|NCT01369680|561947025|FG002|Overall Study|Lost to Follow-up|1|||
155686928|NCT01369680|561947026|FG003|Overall Study|Lost to Follow-up|2|||
155686929|NCT01904149|561947028|FG000|Overall Study|Adverse Event|3|||
155686930|NCT01904149|561947029|FG001|Overall Study|Adverse Event|4|||
155686931|NCT01904149|561947030|FG002|Overall Study|Adverse Event|0|||
155686932|NCT01904149|561947031|FG003|Overall Study|Adverse Event|1|||
155686933|NCT01904149|561947032|FG004|Overall Study|Adverse Event|1|||
155686934|NCT01904149|561947033|FG005|Overall Study|Adverse Event|2|||
155686935|NCT01904149|561947028|FG000|Overall Study|Lack of Efficacy|0|||
155686936|NCT01904149|561947029|FG001|Overall Study|Lack of Efficacy|3|||
155686937|NCT01904149|561947030|FG002|Overall Study|Lack of Efficacy|1|||
155686938|NCT01904149|561947031|FG003|Overall Study|Lack of Efficacy|3|||
155686939|NCT01904149|561947032|FG004|Overall Study|Lack of Efficacy|3|||
155686940|NCT01904149|561947033|FG005|Overall Study|Lack of Efficacy|1|||
155686941|NCT01904149|561947028|FG000|Overall Study|Withdrawal by Subject|1|||
155686942|NCT01904149|561947029|FG001|Overall Study|Withdrawal by Subject|3|||
155686943|NCT01904149|561947030|FG002|Overall Study|Withdrawal by Subject|1|||
155686944|NCT01904149|561947031|FG003|Overall Study|Withdrawal by Subject|0|||
155686945|NCT01904149|561947032|FG004|Overall Study|Withdrawal by Subject|1|||
155686946|NCT01904149|561947033|FG005|Overall Study|Withdrawal by Subject|0|||
155686947|NCT01904149|561947028|FG000|Overall Study|Protocol Violation|0|||
155686948|NCT01904149|561947029|FG001|Overall Study|Protocol Violation|1|||
155686949|NCT01904149|561947030|FG002|Overall Study|Protocol Violation|0|||
155686950|NCT01904149|561947031|FG003|Overall Study|Protocol Violation|0|||
155605517|NCT03191864|561642996|FG002|Part 2 - Maintenance|Adverse Event|0|||
155605518|NCT03191864|561642997|FG003|Part 2 - Maintenance|Adverse Event|0|||
155605519|NCT03191864|561642998|FG004|Part 2 - Maintenance|Adverse Event|1|||
155605520|NCT03191864|561642999|FG005|Part 2 - Maintenance|Adverse Event|0|||
155605521|NCT03191864|561642994|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
155605522|NCT03191864|561642995|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
155605523|NCT03191864|561642996|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
155605524|NCT03191864|561642997|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
155605525|NCT03191864|561642998|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
155605526|NCT03191864|561642999|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
155605527|NCT03191864|561642994|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155605528|NCT03191864|561642995|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155605529|NCT03191864|561642996|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155605530|NCT03191864|561642997|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155605531|NCT03191864|561642998|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
155686951|NCT01904149|561947032|FG004|Overall Study|Protocol Violation|0|||
155686952|NCT01904149|561947033|FG005|Overall Study|Protocol Violation|0|||
155686953|NCT01904149|561947028|FG000|Overall Study|non compliance with study drug|1|||
155686954|NCT01904149|561947029|FG001|Overall Study|non compliance with study drug|0|||
155686955|NCT01904149|561947030|FG002|Overall Study|non compliance with study drug|0|||
155686956|NCT01904149|561947031|FG003|Overall Study|non compliance with study drug|0|||
155686957|NCT01904149|561947032|FG004|Overall Study|non compliance with study drug|0|||
155686958|NCT01904149|561947033|FG005|Overall Study|non compliance with study drug|0|||
155686959|NCT00812006|561947034|FG000|Overall Study|Lost to Follow-up|0|||
155686960|NCT00812006|561947035|FG001|Overall Study|Lost to Follow-up|0|||
155686961|NCT00812006|561947036|FG002|Overall Study|Lost to Follow-up|2|||
155686962|NCT00812006|561947034|FG000|Overall Study|Physician Decision|0|||
155686963|NCT00812006|561947035|FG001|Overall Study|Physician Decision|0|||
155686964|NCT00812006|561947036|FG002|Overall Study|Physician Decision|1|||
155686965|NCT00812006|561947034|FG000|Overall Study|Withdrawal by Subject|2|||
155686966|NCT00812006|561947035|FG001|Overall Study|Withdrawal by Subject|1|||
155686967|NCT00812006|561947036|FG002|Overall Study|Withdrawal by Subject|1|||
155686968|NCT00812006|561947034|FG000|Overall Study|Lack of Qualifying Event|4|||
155686969|NCT00812006|561947035|FG001|Overall Study|Lack of Qualifying Event|2|||
155686970|NCT00812006|561947036|FG002|Overall Study|Lack of Qualifying Event|2|||
155686971|NCT00580034|561947041|FG000|Overall Study|Toxicity|10|||
155686972|NCT00580034|561947042|FG001|Overall Study|Toxicity|0|||
155686973|NCT00772369|561947044|FG000|Overall Study|Did not return record release form|1|||
155686974|NCT03372460|561947045|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
155686975|NCT03372460|561947046|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
155686976|NCT02499900|561947047|FG000|Core Study Period|Other|1|||
155686977|NCT02499900|561947048|FG001|Core Study Period|Other|4|||
155686978|NCT02499900|561947047|FG000|Core Study Period|Lost to Follow-up|1|||
155686979|NCT02499900|561947048|FG001|Core Study Period|Lost to Follow-up|2|||
155686980|NCT02499900|561947047|FG000|Core Study Period|Per sponsor request|0|||
155686981|NCT02499900|561947048|FG001|Core Study Period|Per sponsor request|1|||
155686982|NCT02499900|561947047|FG000|Core Study Period|Pregnancy|1|||
155686983|NCT02499900|561947048|FG001|Core Study Period|Pregnancy|0|||
155686984|NCT02499900|561947047|FG000|Core Study Period|Protocol Violation|3|||
155686985|NCT02499900|561947048|FG001|Core Study Period|Protocol Violation|0|||
155686986|NCT02499900|561947047|FG000|Core Study Period|Withdrawal by Subject|11|||
155686987|NCT02499900|561947048|FG001|Core Study Period|Withdrawal by Subject|10|||
155686988|NCT02499900|561947047|FG000|Core Study Period|Adverse Event|18|||
155686989|NCT02499900|561947048|FG001|Core Study Period|Adverse Event|14|||
155686990|NCT02499900|561947047|FG000|Core Study Period|Death|0|||
155686991|NCT02499900|561947048|FG001|Core Study Period|Death|1|||
155686992|NCT02499900|561947047|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
155686993|NCT02499900|561947048|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
155686994|NCT02499900|561947047|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
155686995|NCT02499900|561947048|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
155686996|NCT02499900|561947047|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
155686997|NCT02499900|561947048|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
155686998|NCT02499900|561947047|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
155686999|NCT02499900|561947048|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
155687000|NCT02499900|561947047|FG000|Extension Study Period|Adverse Event|2|||
155687001|NCT02499900|561947048|FG001|Extension Study Period|Adverse Event|4|||
155687002|NCT02499900|561947047|FG000|Extension Study Period|Withdrawal by Subject|5|||
155687003|NCT02499900|561947048|FG001|Extension Study Period|Withdrawal by Subject|2|||
155687004|NCT02499900|561947047|FG000|Extension Study Period|Physician Decision|2|||
155687005|NCT02499900|561947048|FG001|Extension Study Period|Physician Decision|5|||
155687006|NCT02499900|561947047|FG000|Extension Study Period|Pregnancy|1|||
155687007|NCT02499900|561947048|FG001|Extension Study Period|Pregnancy|2|||
155687008|NCT02499900|561947047|FG000|Extension Study Period|Lost to Follow-up|2|||
155687009|NCT02499900|561947048|FG001|Extension Study Period|Lost to Follow-up|5|||
155687010|NCT02499900|561947047|FG000|Extension Study Period|Other|0|||
155687011|NCT02499900|561947048|FG001|Extension Study Period|Other|2|||
155687012|NCT00916058|561947049|FG000|Phase 1|Screen Failure|0|||
155687013|NCT00916058|561947050|FG001|Phase 1|Screen Failure|0|||
155687014|NCT00916058|561947051|FG002|Phase 1|Screen Failure|0|||
155687015|NCT00916058|561947052|FG003|Phase 1|Screen Failure|0|||
155687016|NCT00916058|561947053|FG004|Phase 1|Screen Failure|0|||
155687017|NCT00916058|561947054|FG005|Phase 1|Screen Failure|1|||
155687018|NCT00916058|561947055|FG006|Phase 1|Screen Failure|0|||
155687019|NCT00916058|561947049|FG000|Phase 2|Screen Failure|0|||
155687020|NCT00916058|561947050|FG001|Phase 2|Screen Failure|0|||
155687021|NCT00916058|561947051|FG002|Phase 2|Screen Failure|0|||
155687022|NCT00916058|561947052|FG003|Phase 2|Screen Failure|0|||
155687023|NCT00916058|561947053|FG004|Phase 2|Screen Failure|0|||
155687024|NCT00916058|561947054|FG005|Phase 2|Screen Failure|0|||
155687025|NCT00916058|561947055|FG006|Phase 2|Screen Failure|3|||
155687026|NCT03385265|561947056|FG000|Overall Study|Withdrawal by Subject|5|||
155687027|NCT03385265|561947057|FG001|Overall Study|Withdrawal by Subject|2|||
155687028|NCT03385265|561947058|FG002|Overall Study|Withdrawal by Subject|5|||
155687029|NCT03385265|561947059|FG003|Overall Study|Withdrawal by Subject|2|||
155687030|NCT01170065|561947079|FG000|Overall Study|Adverse Event|17|||
155687031|NCT01170065|561947080|FG001|Overall Study|Adverse Event|50|||
155687032|NCT01170065|561947081|FG002|Overall Study|Adverse Event|10|||
155687033|NCT01170065|561947079|FG000|Overall Study|Lost to Follow-up|1|||
155687034|NCT01170065|561947080|FG001|Overall Study|Lost to Follow-up|4|||
155687035|NCT01170065|561947081|FG002|Overall Study|Lost to Follow-up|1|||
155687036|NCT01170065|561947079|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
155687037|NCT01170065|561947080|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
155687038|NCT01170065|561947081|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
155687039|NCT01170065|561947079|FG000|Overall Study|Reason other than specified|3|||
155687040|NCT01170065|561947080|FG001|Overall Study|Reason other than specified|8|||
155687041|NCT01170065|561947081|FG002|Overall Study|Reason other than specified|3|||
155687042|NCT01170065|561947079|FG000|Overall Study|Ongoing after planned observation time|5|||
155687043|NCT01170065|561947080|FG001|Overall Study|Ongoing after planned observation time|26|||
155687044|NCT01170065|561947081|FG002|Overall Study|Ongoing after planned observation time|10|||
155687045|NCT01071200|561947082|FG000|Overall Study|Lack of ovarian response|1|||
155687046|NCT01071200|561947083|FG001|Overall Study|Lack of ovarian response|1|||
155687047|NCT01071200|561947082|FG000|Overall Study|No fertilization|4|||
155687048|NCT01071200|561947083|FG001|Overall Study|No fertilization|0|||
155687049|NCT01071200|561947082|FG000|Overall Study|No oocytes retrieved|1|||
155687050|NCT01071200|561947083|FG001|Overall Study|No oocytes retrieved|1|||
155687051|NCT01071200|561947082|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
155687052|NCT01071200|561947083|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
155687053|NCT01071200|561947082|FG000|Overall Study|No viable embryos|0|||
155687054|NCT01071200|561947083|FG001|Overall Study|No viable embryos|1|||
155687055|NCT02434354|561947084|FG000|Overall Study|screen fail|3|||
155687056|NCT01920893|561947085|FG000|Overall Study|Adverse Event|5|||
155687057|NCT01920893|561947086|FG001|Overall Study|Adverse Event|2|||
155687058|NCT01920893|561947085|FG000|Overall Study|Lack of Efficacy|2|||
155687059|NCT01920893|561947086|FG001|Overall Study|Lack of Efficacy|0|||
155687060|NCT01767493|561947088|FG000|Overall Study|screen failures|3|||
155687061|NCT00724854|561947091|FG000|Overall Study|Lack of Efficacy|187|||
155687062|NCT00724854|561947092|FG001|Overall Study|Lack of Efficacy|13|||
155687063|NCT00724854|561947091|FG000|Overall Study|Lost to Follow-up|87|||
155687064|NCT00724854|561947092|FG001|Overall Study|Lost to Follow-up|10|||
155687065|NCT00724854|561947091|FG000|Overall Study|Adverse Event|62|||
155687066|NCT00724854|561947092|FG001|Overall Study|Adverse Event|4|||
155687067|NCT00724854|561947091|FG000|Overall Study|Other|42|||
155687068|NCT00724854|561947092|FG001|Overall Study|Other|3|||
155687069|NCT00724854|561947091|FG000|Overall Study|Death|11|||
155687070|NCT00724854|561947092|FG001|Overall Study|Death|0|||
155687071|NCT00724854|561947091|FG000|Overall Study|Change of treatment|7|||
155687072|NCT00724854|561947092|FG001|Overall Study|Change of treatment|0|||
155687073|NCT00724854|561947091|FG000|Overall Study|Withdrawal by Subject|5|||
155687074|NCT00724854|561947092|FG001|Overall Study|Withdrawal by Subject|0|||
155687075|NCT00724854|561947091|FG000|Overall Study|Adverse event + lack of efficacy|2|||
155687076|NCT00724854|561947092|FG001|Overall Study|Adverse event + lack of efficacy|1|||
155687077|NCT01819129|561947093|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
155687078|NCT01819129|561947094|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
155687079|NCT01819129|561947093|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
155687080|NCT01819129|561947094|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
155687081|NCT01819129|561947093|FG000|Overall Study|Other, Subject moved out of the country|0|||
155687082|NCT01819129|561947094|FG001|Overall Study|Other, Subject moved out of the country|1|||
155687083|NCT01819129|561947093|FG000|Overall Study|Withdrawal by Subject|15|||
155687084|NCT01819129|561947094|FG001|Overall Study|Withdrawal by Subject|15|||
155687085|NCT01819129|561947093|FG000|Overall Study|Lost to Follow-up|5|||
155687086|NCT01819129|561947094|FG001|Overall Study|Lost to Follow-up|2|||
155687087|NCT01819129|561947093|FG000|Overall Study|Lack of Efficacy|0|||
155687088|NCT01819129|561947094|FG001|Overall Study|Lack of Efficacy|1|||
155687089|NCT01819129|561947093|FG000|Overall Study|Adverse Event|1|||
155687090|NCT01819129|561947094|FG001|Overall Study|Adverse Event|4|||
155687091|NCT01819129|561947093|FG000|Overall Study|Death|1|||
155687092|NCT01819129|561947094|FG001|Overall Study|Death|1|||
155687093|NCT01819129|561947093|FG000|Overall Study|Withdrawal Criteria|20|||
155687094|NCT01819129|561947094|FG001|Overall Study|Withdrawal Criteria|15|||
155687095|NCT02836873|561947097|FG000|Overall Study|Protocol Violation|0|||
155687096|NCT02836873|561947098|FG001|Overall Study|Protocol Violation|1|||
155687097|NCT02836873|561947097|FG000|Overall Study|Adverse Event|1|||
155687098|NCT02836873|561947098|FG001|Overall Study|Adverse Event|4|||
155687099|NCT02836873|561947097|FG000|Overall Study|Withdrawal by Subject|2|||
155687100|NCT02836873|561947098|FG001|Overall Study|Withdrawal by Subject|2|||
155687101|NCT02836873|561947097|FG000|Overall Study|Lost to Follow-up|1|||
155687102|NCT02836873|561947098|FG001|Overall Study|Lost to Follow-up|3|||
155687103|NCT02836873|561947097|FG000|Overall Study|Physician Decision|0|||
155687104|NCT02836873|561947098|FG001|Overall Study|Physician Decision|1|||
155687105|NCT02836873|561947097|FG000|Overall Study|Other|1|||
155687106|NCT02836873|561947098|FG001|Overall Study|Other|0|||
155687107|NCT00853125|561947105|FG000|Overall Study|Study participant's donor was CMV +|1|||
155687108|NCT01646645|561947113|FG000|Overall Study|No Treated|1|||
155687109|NCT01646645|561947113|FG000|Overall Study|Inevaluable Donor|29|||
155687110|NCT00884039|561947114|FG000|Overall Study|Withdrawal by Subject|0|||
155687111|NCT00884039|561947115|FG001|Overall Study|Withdrawal by Subject|1|||
155687112|NCT00884039|561947114|FG000|Overall Study|Lack of Efficacy|2|||
155687113|NCT00884039|561947115|FG001|Overall Study|Lack of Efficacy|0|||
155687114|NCT00717522|561947116|FG000|Overall Study|Disease Progression|5|||
155687115|NCT00717522|561947116|FG000|Overall Study|Adverse Event|1|||
155687116|NCT00717522|561947116|FG000|Overall Study|Death|1|||
155687117|NCT04431713|561949036|FG000|Overall Study|Withdrawal by Subject|2|||
155687118|NCT04431713|561949037|FG001|Overall Study|Withdrawal by Subject|0|||
155687119|NCT04431713|561949036|FG000|Overall Study|Death|2|||
155687120|NCT04431713|561949037|FG001|Overall Study|Death|2|||
155687121|NCT01344538|561949038|FG000|Overall Study|Adverse Event|1|||
155687122|NCT01344538|561949039|FG001|Overall Study|Adverse Event|1|||
155687123|NCT01344538|561949038|FG000|Overall Study|Lost to Follow-up|1|||
155687124|NCT01344538|561949039|FG001|Overall Study|Lost to Follow-up|0|||
155687125|NCT01655381|561949042|FG000|Overall Study|Investigator Decision|1|||
155687126|NCT01655381|561949042|FG000|Overall Study|Moved to Another City|1|||
155687127|NCT01655381|561949042|FG000|Overall Study|Insufficient Treatment Response|1|||
155687128|NCT02324205|561949043|FG000|Overall Study|Withdrawal by Subject|37|||
155687129|NCT00613925|561949051|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
155687130|NCT00613925|561949052|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
155687131|NCT00543296|561949053|FG000|Overall Study|Physician Decision|7|||
155687132|NCT02891681|561949058|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
155687133|NCT02891681|561949059|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
155687134|NCT02891681|561949060|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
155687135|NCT02891681|561949058|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
155687136|NCT02891681|561949059|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
155687137|NCT02891681|561949060|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
155687138|NCT02891681|561949058|FG000|Overall Study|Taken off study after first imaging appointment|1|||
155687139|NCT02891681|561949059|FG001|Overall Study|Taken off study after first imaging appointment|0|||
155687140|NCT02891681|561949060|FG002|Overall Study|Taken off study after first imaging appointment|0|||
155687141|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
155687142|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
155687143|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
155687144|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
155687145|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
155687146|NCT01224821|561949061|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
155687147|NCT01224821|561949061|FG000|Long-Term Follow-Up|Death|2|||
155687148|NCT01224821|561949061|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
155687149|NCT00683917|561949062|FG000|Overall Study|Study prematurely terminated|10|||
155687150|NCT02174523|561949063|FG000|Overall Study|Withdrawal by Subject|1|||
155687151|NCT02174523|561949064|FG001|Overall Study|Withdrawal by Subject|0|||
155687152|NCT04422561|561949065|FG000|Overall Study|Lost to Follow-up|25|||
155687153|NCT04422561|561949066|FG001|Overall Study|Lost to Follow-up|11|||
155687154|NCT03640052|561949067|FG000|Overall Study|Lost to Follow-up|0|||
155687155|NCT03640052|561949068|FG001|Overall Study|Lost to Follow-up|1|||
155687156|NCT03640052|561949069|FG002|Overall Study|Lost to Follow-up|0|||
155687157|NCT03640052|561949070|FG003|Overall Study|Lost to Follow-up|0|||
155687158|NCT03640052|561949071|FG004|Overall Study|Lost to Follow-up|0|||
155687159|NCT00623545|561949072|FG000|Overall Study|Adverse Event|6|||
155687160|NCT00623545|561949072|FG000|Overall Study|Withdrawal by Subject|4|||
155687161|NCT04239222|561949073|FG000|Baseline|Withdrawal by Subject|0|||
155687162|NCT04239222|561949074|FG001|Baseline|Withdrawal by Subject|0|||
155687163|NCT04239222|561949075|FG002|Baseline|Withdrawal by Subject|1|||
155687164|NCT04239222|561949076|FG003|Baseline|Withdrawal by Subject|1|||
155687165|NCT04239222|561949073|FG000|First Foot Assignment|Withdrawal by Subject|0|||
155687166|NCT04239222|561949074|FG001|First Foot Assignment|Withdrawal by Subject|0|||
155687167|NCT04239222|561949075|FG002|First Foot Assignment|Withdrawal by Subject|1|||
155687168|NCT04239222|561949076|FG003|First Foot Assignment|Withdrawal by Subject|0|||
155687169|NCT04239222|561949073|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155687170|NCT04239222|561949074|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155687171|NCT04239222|561949075|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
155687172|NCT04239222|561949076|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155687173|NCT02685748|561949080|FG000|Overall Study|Withdrawal by Subject|3|||
155687174|NCT02685748|561949081|FG001|Overall Study|Withdrawal by Subject|2|||
155687175|NCT05479097|561949082|FG000|Overall Study|Withdrawal by Subject|2|||
155687176|NCT00937404|561949083|FG000|Overall Study|Protocol Violation|1|||
155687177|NCT00937404|561949083|FG000|Overall Study|Withdrawal by Subject|1|||
155687178|NCT01482169|561949090|FG000|Overall Study|Physician Decision|2|||
155687179|NCT00445848|561949091|FG000|Overall Study|Adverse Event|14|||
155687180|NCT00445848|561949091|FG000|Overall Study|Withdrawal by Subject|4|||
155687181|NCT00445848|561949091|FG000|Overall Study|Progression|62|||
155687182|NCT00445848|561949091|FG000|Overall Study|Other-Not protocol specified|5|||
155687183|NCT03541187|561949094|FG000|Overall Study|Lost to Follow-up|2|||
155687184|NCT03541187|561949095|FG001|Overall Study|Lost to Follow-up|6|||
155687185|NCT03541187|561949094|FG000|Overall Study|Pregnancy|0|||
155687186|NCT03541187|561949095|FG001|Overall Study|Pregnancy|1|||
155687187|NCT03541187|561949094|FG000|Overall Study|Withdrawal by Subject|6|||
155687188|NCT03541187|561949095|FG001|Overall Study|Withdrawal by Subject|2|||
155687189|NCT03541187|561949094|FG000|Overall Study|Moved out of town|1|||
155687190|NCT03541187|561949095|FG001|Overall Study|Moved out of town|0|||
155687191|NCT03541187|561949094|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
155721146|NCT02587221|562077763|FG001|Overall Study|Other Reason or Unspecified|1|||
155605532|NCT03191864|561642999|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155605533|NCT00415597|561643000|FG000|Enrollment|Withdrawal by Subject|1|||
155605534|NCT00415597|561643000|FG000|Enrollment|Protocol Violation|1|||
155605535|NCT00415597|561643000|FG000|Treatment|Adverse Event|110|||
155605536|NCT00415597|561643000|FG000|Treatment|Lack of Efficacy|39|||
155605537|NCT00415597|561643000|FG000|Treatment|Protocol Violation|67|||
155605538|NCT00415597|561643000|FG000|Treatment|Physician Decision|3|||
155605539|NCT00415597|561643000|FG000|Treatment|Withdrawal by Subject|51|||
155605540|NCT00415597|561643000|FG000|Treatment|Lost to Follow-up|28|||
155605541|NCT00415597|561643000|FG000|Treatment|Drug Screen|2|||
155605542|NCT00415597|561643000|FG000|Treatment|Administrative|3|||
155605543|NCT00415597|561643000|FG000|Treatment|Sponsor Decision|1|||
155605544|NCT00415597|561643000|FG000|Treatment|Multiple Reasons|1|||
155605545|NCT01447927|561643001|FG000|Overall Study|Adverse Event|4|||
155605546|NCT01447927|561643002|FG001|Overall Study|Adverse Event|3|||
155605547|NCT01447927|561643001|FG000|Overall Study|Withdrawal by Subject|1|||
155605548|NCT01447927|561643002|FG001|Overall Study|Withdrawal by Subject|0|||
155605549|NCT04102865|561643003|FG000|Overall Study|Adverse Event|4|||
155605550|NCT04102865|561643004|FG001|Overall Study|Adverse Event|0|||
155605551|NCT04102865|561643003|FG000|Overall Study|Lost to Follow-up|1|||
155605552|NCT04102865|561643004|FG001|Overall Study|Lost to Follow-up|0|||
155605553|NCT04102865|561643003|FG000|Overall Study|Withdrawal by Subject|2|||
155605554|NCT04102865|561643004|FG001|Overall Study|Withdrawal by Subject|0|||
155605555|NCT04506905|561643007|FG000|Overall Study|Lost to Follow-up|1|||
155605556|NCT04506905|561643008|FG001|Overall Study|Lost to Follow-up|0|||
155605557|NCT04506905|561643009|FG002|Overall Study|Lost to Follow-up|0|||
155605558|NCT04506905|561643010|FG003|Overall Study|Lost to Follow-up|1|||
155605559|NCT04506905|561643011|FG004|Overall Study|Lost to Follow-up|0|||
155605560|NCT04506905|561643012|FG005|Overall Study|Lost to Follow-up|0|||
155605561|NCT04506905|561643013|FG006|Overall Study|Lost to Follow-up|0|||
155605562|NCT04506905|561643014|FG007|Overall Study|Lost to Follow-up|0|||
155605563|NCT04506905|561643015|FG008|Overall Study|Lost to Follow-up|0|||
155605564|NCT04506905|561643007|FG000|Overall Study|Withdrawal by Subject|0|||
155605565|NCT04506905|561643008|FG001|Overall Study|Withdrawal by Subject|0|||
155605566|NCT04506905|561643009|FG002|Overall Study|Withdrawal by Subject|0|||
155605567|NCT04506905|561643010|FG003|Overall Study|Withdrawal by Subject|2|||
155605568|NCT04506905|561643011|FG004|Overall Study|Withdrawal by Subject|0|||
155687192|NCT03541187|561949095|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
155687193|NCT03541187|561949094|FG000|Overall Study|Did not meet randomization criteria|1|||
155687194|NCT03541187|561949095|FG001|Overall Study|Did not meet randomization criteria|1|||
155687195|NCT03541187|561949094|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
155687196|NCT03541187|561949095|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
155687197|NCT03541187|561949094|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
155687198|NCT03541187|561949095|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
155687199|NCT02701777|561949096|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
155687200|NCT02701777|561949097|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
155687201|NCT02701777|561949098|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
155687202|NCT02701777|561949099|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
155687203|NCT02701777|561949096|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
155687204|NCT02701777|561949097|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
155687205|NCT02701777|561949098|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
155687206|NCT02701777|561949099|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
155687207|NCT01571284|561949103|FG000|Overall Study|Participant's decision|84|||
155687208|NCT01571284|561949103|FG000|Overall Study|Lost to Follow-up|3|||
155687209|NCT01571284|561949103|FG000|Overall Study|Enrolled but not treated|2|||
155687210|NCT01571284|561949103|FG000|Overall Study|Other than specified above|80|||
155687211|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Death|1|||
155687212|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Death|1|||
155687213|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Death|0|||
155687214|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Death|0|||
155687215|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Death|1|||
155687216|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Death|0|||
155687217|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Death|0|||
155687218|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Death|0|||
155687219|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Death|0|||
155687220|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Death|0|||
155687221|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
155687222|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
155687223|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
155687224|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687225|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
155687226|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687227|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687228|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687229|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687230|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
155687231|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687232|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687233|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687234|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687235|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
155687236|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687237|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687238|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687239|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687240|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155687241|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
155687242|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687243|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687244|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687245|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687246|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687247|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687248|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687249|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687250|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155687251|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
155687252|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687253|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687254|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
155687255|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
155687256|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687257|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687258|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687259|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687260|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155687261|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
155687262|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687263|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687264|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
155687265|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687266|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687267|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687268|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687269|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687270|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155687271|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
155687272|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155687273|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155687274|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155687275|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
155687276|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155687277|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155687278|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155687279|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155687280|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155687281|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
155687282|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155687283|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155687284|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687285|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
155687286|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687287|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687288|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687289|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687290|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687291|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
155687292|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687293|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687294|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
155687295|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
155687296|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687297|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687298|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687299|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687300|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155687301|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687302|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687303|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687304|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687305|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687306|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687307|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687308|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687309|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687310|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687311|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687312|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687313|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
155687314|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687315|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
155687316|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687317|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687318|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687319|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687320|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687321|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
155687322|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
155687323|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
155687324|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
155687325|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
155687326|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155687327|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155687328|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155687329|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155687330|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155687331|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687332|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687333|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687334|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
155687335|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
155687336|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687337|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687338|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687339|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687340|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687341|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155687342|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687343|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155687344|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155687345|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155687346|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687347|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687348|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687349|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687350|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687351|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
155687352|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687353|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687354|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687355|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
155687356|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687357|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687358|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687359|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687360|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155687361|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687362|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687363|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687364|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687365|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
155687366|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687367|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687368|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687369|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687370|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687371|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687372|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
155687373|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687374|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687375|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
155687376|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687377|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687378|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687379|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687380|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155687381|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
155687382|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687383|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687384|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687385|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
155687386|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687387|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687388|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687389|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687390|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155687391|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
155687392|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687393|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
155687394|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687395|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
155687396|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687397|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687398|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687399|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687400|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155687401|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Other|5|||
155687402|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Other|1|||
155687403|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Other|0|||
155687404|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Other|3|||
155687405|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Other|0|||
155687406|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Other|0|||
155687407|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Other|0|||
155687408|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Other|0|||
155687409|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Other|0|||
155687410|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Other|0|||
155687411|NCT03352557|561949104|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687412|NCT03352557|561949105|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687413|NCT03352557|561949106|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687414|NCT03352557|561949107|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687415|NCT03352557|561949108|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
155687416|NCT03352557|561949109|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687417|NCT03352557|561949110|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687418|NCT03352557|561949111|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687419|NCT03352557|561949112|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687420|NCT03352557|561949113|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
155687421|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Death|0|||
155687422|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Death|0|||
155687423|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Death|0|||
155687424|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Death|0|||
155687425|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Death|0|||
155687426|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Death|1|||
155687427|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Death|0|||
155687428|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Death|1|||
155687429|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Death|1|||
155687430|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Death|1|||
155687431|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687432|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687433|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687434|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687435|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687436|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
155687437|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687438|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687439|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687440|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155687441|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687442|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687443|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687444|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687445|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687446|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687447|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687448|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687449|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
155687450|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155687451|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155687452|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155687453|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155687454|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155687455|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155687456|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
155687457|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
155687458|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
155687459|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
155687460|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
155687461|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687462|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687463|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687464|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687465|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687466|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155687467|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155687468|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
155687469|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
155687470|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
155687471|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687472|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687473|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687474|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687475|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687476|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687477|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687478|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687479|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155687480|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155687481|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687482|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687483|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687484|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687485|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687486|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155687487|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155687488|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155687489|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155687490|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
155687491|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687492|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687493|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687494|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687495|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687496|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687497|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687498|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155687499|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
155687500|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
155687501|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687502|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687503|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687504|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687505|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687506|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687507|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687508|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155687509|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687510|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155687511|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687512|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687513|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687514|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687515|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687516|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687517|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687518|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
155687519|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687520|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155687521|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687522|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687523|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687524|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687525|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687526|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687527|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687528|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
155687529|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
155687530|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155687531|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687532|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687533|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687534|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687535|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687536|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
155687537|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687538|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687539|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
155687540|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155687541|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687542|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687543|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687544|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687545|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687546|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687547|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687548|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687549|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155687550|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
155687551|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687552|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687553|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687554|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687555|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687556|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687557|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687558|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155687559|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
155687560|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
155687561|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687562|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687563|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687564|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687565|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687566|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687567|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687568|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
155687569|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
155687570|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155687571|NCT03352557|561949104|FG000|LTE Period: Week 80 to Week 173|Other|0|||
155687572|NCT03352557|561949105|FG001|LTE Period: Week 80 to Week 173|Other|0|||
155687573|NCT03352557|561949106|FG002|LTE Period: Week 80 to Week 173|Other|0|||
155687574|NCT03352557|561949107|FG003|LTE Period: Week 80 to Week 173|Other|0|||
155687575|NCT03352557|561949108|FG004|LTE Period: Week 80 to Week 173|Other|0|||
155687576|NCT03352557|561949109|FG005|LTE Period: Week 80 to Week 173|Other|0|||
155687577|NCT03352557|561949110|FG006|LTE Period: Week 80 to Week 173|Other|0|||
155687578|NCT03352557|561949111|FG007|LTE Period: Week 80 to Week 173|Other|1|||
155687579|NCT03352557|561949112|FG008|LTE Period: Week 80 to Week 173|Other|0|||
155687580|NCT03352557|561949113|FG009|LTE Period: Week 80 to Week 173|Other|0|||
155687581|NCT03242772|561949114|FG000|Overall Study|Lost to Follow-up|2|||
155687582|NCT03242772|561949115|FG001|Overall Study|Lost to Follow-up|0|||
155687583|NCT03242772|561949114|FG000|Overall Study|Physician Decision|0|||
155687584|NCT03242772|561949115|FG001|Overall Study|Physician Decision|1|||
155687585|NCT03242772|561949114|FG000|Overall Study|Withdrawal by Subject|1|||
155687586|NCT03242772|561949115|FG001|Overall Study|Withdrawal by Subject|0|||
155687587|NCT01560637|561949121|FG000|Overall Study|Adverse Event|63|||
155687588|NCT01560637|561949121|FG000|Overall Study|Death|69|||
155687589|NCT01560637|561949121|FG000|Overall Study|Lost to Follow-up|8|||
155687590|NCT01560637|561949121|FG000|Overall Study|Protocol Violation|8|||
155687591|NCT01560637|561949121|FG000|Overall Study|Withdrawal by Subject|24|||
155687592|NCT01560637|561949121|FG000|Overall Study|Progressive Disease|20|||
155687593|NCT01560637|561949121|FG000|Overall Study|Other Reason Not Specified|6|||
155687594|NCT01089023|561949122|FG000|Overall Study|Lost to Follow-up|3|||
155687595|NCT01089023|561949122|FG000|Overall Study|Adverse Event|1|||
155687596|NCT01089023|561949122|FG000|Overall Study|Withdrawal by Subject|1|||
155687597|NCT01089023|561949122|FG000|Overall Study|Protocol Violation|1|||
155687598|NCT01089023|561949122|FG000|Overall Study|Lack of Efficacy|1|||
155687599|NCT03220581|561949123|FG000|Overall Study|Withdrawal by Subject|0|||
155687600|NCT03220581|561949124|FG001|Overall Study|Withdrawal by Subject|1|||
155687601|NCT03220581|561949123|FG000|Overall Study|Lost to Follow-up|3|||
155687602|NCT03220581|561949124|FG001|Overall Study|Lost to Follow-up|6|||
155687603|NCT01185964|561949127|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
155687604|NCT01185964|561949128|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
155687605|NCT01185964|561949129|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
155687606|NCT01185964|561949130|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
155687607|NCT01185964|561949127|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
155687608|NCT01185964|561949128|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
155687609|NCT01185964|561949129|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
155687610|NCT01185964|561949130|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
155687611|NCT01185964|561949127|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
155687612|NCT01185964|561949128|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
155687613|NCT01185964|561949129|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
155687614|NCT01185964|561949130|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
155687615|NCT01185964|561949127|FG000|Phase 1b and Phase 2|Adverse Event|1|||
155687616|NCT01185964|561949128|FG001|Phase 1b and Phase 2|Adverse Event|0|||
155687617|NCT01185964|561949129|FG002|Phase 1b and Phase 2|Adverse Event|2|||
155687618|NCT01185964|561949130|FG003|Phase 1b and Phase 2|Adverse Event|0|||
155687619|NCT01185964|561949127|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
155687620|NCT01185964|561949128|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
155687621|NCT01185964|561949129|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
155687622|NCT01185964|561949130|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
155687623|NCT01185964|561949127|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155687624|NCT01185964|561949128|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155687625|NCT01185964|561949129|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155687626|NCT01185964|561949130|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
155687627|NCT01185964|561949127|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155687628|NCT01185964|561949128|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155687629|NCT01185964|561949129|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155687630|NCT01185964|561949130|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
155687631|NCT01185964|561949127|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155687632|NCT01185964|561949128|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155687633|NCT01185964|561949129|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155687634|NCT01185964|561949130|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
155687635|NCT04465877|561949133|FG000|Overall Study|Noncompliant with study requirements|0|||
155687636|NCT04465877|561949134|FG001|Overall Study|Noncompliant with study requirements|0|||
155687637|NCT04465877|561949135|FG002|Overall Study|Noncompliant with study requirements|1|||
155687638|NCT04465877|561949136|FG003|Overall Study|Noncompliant with study requirements|0|||
155687639|NCT02323204|561949137|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
155687640|NCT02323204|561949138|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
155687641|NCT02323204|561949139|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
155687642|NCT02323204|561949140|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
155687643|NCT02323204|561949137|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
155687644|NCT02323204|561949138|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
155687645|NCT02323204|561949139|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
155687646|NCT02323204|561949140|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
155687647|NCT02323204|561949137|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
155687648|NCT02323204|561949138|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
155687649|NCT02323204|561949139|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
155687650|NCT02323204|561949140|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
155687651|NCT02323204|561949137|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
155687652|NCT02323204|561949138|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
155687653|NCT02323204|561949139|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
155687654|NCT02323204|561949140|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
155687655|NCT02323204|561949137|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
155687656|NCT02323204|561949138|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
155687657|NCT02323204|561949139|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
155687658|NCT02323204|561949140|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
155687659|NCT02323204|561949137|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
155687660|NCT02323204|561949138|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
155687661|NCT02323204|561949139|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
155687662|NCT02323204|561949140|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
155687663|NCT02323204|561949137|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155687664|NCT02323204|561949138|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
155687665|NCT02323204|561949139|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155687666|NCT02323204|561949140|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
155687667|NCT02323204|561949137|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
155687668|NCT02323204|561949138|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
155687669|NCT02323204|561949139|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
155687670|NCT02323204|561949140|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
155687671|NCT02323204|561949137|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155687672|NCT02323204|561949138|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155687673|NCT02323204|561949139|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
155687674|NCT02323204|561949140|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
155687675|NCT03440918|561949157|FG000|Overall Study|Protocol Violation|0|||
155687676|NCT03440918|561949158|FG001|Overall Study|Protocol Violation|16|||
155687677|NCT01396265|561949159|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
155687678|NCT03576755|561949160|FG000|Overall Study|Withdrawal by Subject|1|||
155687679|NCT03576755|561949161|FG001|Overall Study|Withdrawal by Subject|0|||
155687680|NCT03576755|561949162|FG002|Overall Study|Withdrawal by Subject|0|||
155687681|NCT03576755|561949163|FG003|Overall Study|Withdrawal by Subject|0|||
155687682|NCT04962230|561949164|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
155687683|NCT04962230|561949164|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
155687684|NCT03444766|561949165|FG000|Overall Study|Other Reasons|2|||
155687685|NCT03444766|561949165|FG000|Overall Study|Participant Withdrew Consent|5|||
155687686|NCT03444766|561949165|FG000|Overall Study|Lost to Follow-up|2|||
155687687|NCT03444766|561949165|FG000|Overall Study|Death|2|||
155687688|NCT03444766|561949165|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
155687689|NCT03444766|561949165|FG000|Overall Study|Disease Progression|49|||
155687690|NCT04346108|561949166|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
155687691|NCT04346108|561949167|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
155687692|NCT04346108|561949168|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
155687693|NCT04346108|561949166|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
155605569|NCT04506905|561643012|FG005|Overall Study|Withdrawal by Subject|0|||
155605570|NCT04506905|561643013|FG006|Overall Study|Withdrawal by Subject|0|||
155605571|NCT04506905|561643014|FG007|Overall Study|Withdrawal by Subject|0|||
155605572|NCT04506905|561643015|FG008|Overall Study|Withdrawal by Subject|0|||
155605573|NCT02093390|561643016|FG000|Overall Study|Withdrawal by Subject|0|||
155605574|NCT02093390|561643017|FG001|Overall Study|Withdrawal by Subject|1|||
155605575|NCT02168777|561645674|FG000|Overall Study|Withdrawal by Subject|1|||
155605576|NCT02168777|561645675|FG001|Overall Study|Withdrawal by Subject|0|||
155605577|NCT02168777|561645676|FG002|Overall Study|Withdrawal by Subject|2|||
155605578|NCT02168777|561645674|FG000|Overall Study|Adverse Event|1|||
155605579|NCT02168777|561645675|FG001|Overall Study|Adverse Event|0|||
155605580|NCT02168777|561645676|FG002|Overall Study|Adverse Event|1|||
155605581|NCT02168777|561645674|FG000|Overall Study|Disease recurrence|0|||
155605582|NCT02168777|561645675|FG001|Overall Study|Disease recurrence|0|||
155605583|NCT02168777|561645676|FG002|Overall Study|Disease recurrence|1|||
155605584|NCT02168777|561645674|FG000|Overall Study|Radiological disease progression|0|||
155605585|NCT02168777|561645675|FG001|Overall Study|Radiological disease progression|5|||
155605586|NCT02168777|561645676|FG002|Overall Study|Radiological disease progression|5|||
155605587|NCT02168777|561645674|FG000|Overall Study|Clinical disease progression|0|||
155605588|NCT02168777|561645675|FG001|Overall Study|Clinical disease progression|1|||
155605589|NCT02168777|561645676|FG002|Overall Study|Clinical disease progression|2|||
155605590|NCT02168777|561645674|FG000|Overall Study|Other reason|0|||
155605591|NCT02168777|561645675|FG001|Overall Study|Other reason|1|||
155605592|NCT02168777|561645676|FG002|Overall Study|Other reason|0|||
155605593|NCT00441363|561645677|FG000|Overall Study|Adverse Event|4|||
155605594|NCT00441363|561645678|FG001|Overall Study|Adverse Event|2|||
155605595|NCT00441363|561645677|FG000|Overall Study|Withdrawal by Subject|3|||
155605596|NCT00441363|561645678|FG001|Overall Study|Withdrawal by Subject|4|||
155605597|NCT00441363|561645677|FG000|Overall Study|Physician Decision|6|||
155605598|NCT00441363|561645678|FG001|Overall Study|Physician Decision|7|||
155605599|NCT00441363|561645677|FG000|Overall Study|Lost to Follow-up|2|||
155605600|NCT00441363|561645678|FG001|Overall Study|Lost to Follow-up|2|||
155605601|NCT00441363|561645677|FG000|Overall Study|Other|2|||
155605602|NCT00441363|561645678|FG001|Overall Study|Other|0|||
155605603|NCT01911793|561645683|FG000|Overall Study|Physician Decision|1|||
155605604|NCT01911793|561645684|FG001|Overall Study|Physician Decision|5|||
155605605|NCT03774394|561645685|FG000|Overall Study|Withdrawal by Subject|2|||
155605606|NCT03774394|561645686|FG001|Overall Study|Withdrawal by Subject|0|||
155605607|NCT02697916|561645687|FG000|Overall Study|Death|357|||
155605608|NCT02697916|561645688|FG001|Overall Study|Death|315|||
155687694|NCT04346108|561949167|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
155687695|NCT04346108|561949168|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
155605609|NCT02697916|561645687|FG000|Overall Study|Withdrawal by Subject|221|||
155687696|NCT01598753|561949169|FG000|Overall Study|Adverse Event|1|||
155687697|NCT01598753|561949170|FG001|Overall Study|Adverse Event|9|||
155687698|NCT01598753|561949171|FG002|Overall Study|Adverse Event|1|||
155687699|NCT01598753|561949172|FG003|Overall Study|Adverse Event|7|||
155687700|NCT01598753|561949169|FG000|Overall Study|Lost to Follow-up|4|||
155687701|NCT01598753|561949170|FG001|Overall Study|Lost to Follow-up|3|||
155687702|NCT01598753|561949171|FG002|Overall Study|Lost to Follow-up|7|||
155687703|NCT01598753|561949172|FG003|Overall Study|Lost to Follow-up|5|||
155687704|NCT01598753|561949169|FG000|Overall Study|Physician Decision|0|||
155687705|NCT01598753|561949170|FG001|Overall Study|Physician Decision|1|||
155687706|NCT01598753|561949171|FG002|Overall Study|Physician Decision|0|||
155687707|NCT01598753|561949172|FG003|Overall Study|Physician Decision|2|||
155687708|NCT01598753|561949169|FG000|Overall Study|Withdrawal by Subject|7|||
155687709|NCT01598753|561949170|FG001|Overall Study|Withdrawal by Subject|2|||
155687710|NCT01598753|561949171|FG002|Overall Study|Withdrawal by Subject|0|||
155687711|NCT01598753|561949172|FG003|Overall Study|Withdrawal by Subject|1|||
155687712|NCT02275117|561949173|FG000|Overall Study|Adverse Event|0|||
155687713|NCT02275117|561949174|FG001|Overall Study|Adverse Event|0|||
155687714|NCT02275117|561949175|FG002|Overall Study|Adverse Event|0|||
155687715|NCT02275117|561949176|FG003|Overall Study|Adverse Event|0|||
155687716|NCT02275117|561949177|FG004|Overall Study|Adverse Event|1|||
155687717|NCT02275117|561949173|FG000|Overall Study|Lack of Efficacy|6|||
155687718|NCT02275117|561949174|FG001|Overall Study|Lack of Efficacy|7|||
155687719|NCT02275117|561949175|FG002|Overall Study|Lack of Efficacy|5|||
155687720|NCT02275117|561949176|FG003|Overall Study|Lack of Efficacy|2|||
155687721|NCT02275117|561949177|FG004|Overall Study|Lack of Efficacy|10|||
155687722|NCT02275117|561949173|FG000|Overall Study|Lost to Follow-up|11|||
155687723|NCT02275117|561949174|FG001|Overall Study|Lost to Follow-up|16|||
155687724|NCT02275117|561949175|FG002|Overall Study|Lost to Follow-up|15|||
155687725|NCT02275117|561949176|FG003|Overall Study|Lost to Follow-up|16|||
155687726|NCT02275117|561949177|FG004|Overall Study|Lost to Follow-up|8|||
155687727|NCT02275117|561949173|FG000|Overall Study|Physician Decision|0|||
155605610|NCT02697916|561645688|FG001|Overall Study|Withdrawal by Subject|393|||
155605611|NCT00290693|561645689|FG000|Overall Study|Withdrawal by Subject|2|||
155605612|NCT05625477|561645690|FG000|Overall Study|Lost to Follow-up|2|||
155605613|NCT05625477|561645691|FG001|Overall Study|Lost to Follow-up|2|||
155605614|NCT05625477|561645692|FG002|Overall Study|Lost to Follow-up|1|||
155605615|NCT05625477|561645693|FG003|Overall Study|Lost to Follow-up|1|||
155605616|NCT05625477|561645694|FG004|Overall Study|Lost to Follow-up|0|||
155605617|NCT05625477|561645690|FG000|Overall Study|Covid quarantine|1|||
155605618|NCT05625477|561645691|FG001|Overall Study|Covid quarantine|0|||
155605619|NCT05625477|561645692|FG002|Overall Study|Covid quarantine|0|||
155605620|NCT05625477|561645693|FG003|Overall Study|Covid quarantine|0|||
155605621|NCT05625477|561645694|FG004|Overall Study|Covid quarantine|0|||
155605622|NCT04849416|561645697|FG000|Overall Study|Ongoing Treatment|12|||
155605623|NCT04849416|561645698|FG001|Overall Study|Ongoing Treatment|5|||
155605624|NCT04849416|561645699|FG002|Overall Study|Ongoing Treatment|3|||
155605625|NCT04849416|561645697|FG000|Overall Study|On Post-Treatment Follow-up|8|||
155605626|NCT04849416|561645698|FG001|Overall Study|On Post-Treatment Follow-up|9|||
155605627|NCT04849416|561645699|FG002|Overall Study|On Post-Treatment Follow-up|10|||
155605628|NCT04849416|561645697|FG000|Overall Study|Withdrawal by Subject|0|||
155605629|NCT04849416|561645698|FG001|Overall Study|Withdrawal by Subject|0|||
155605630|NCT04849416|561645699|FG002|Overall Study|Withdrawal by Subject|1|||
155605631|NCT04849416|561645697|FG000|Overall Study|Lost to Follow-up|1|||
155605632|NCT04849416|561645698|FG001|Overall Study|Lost to Follow-up|0|||
155605633|NCT04849416|561645699|FG002|Overall Study|Lost to Follow-up|0|||
155605636|NCT00981058|561645712|FG000|Overall Study|Progressive Disease|38|||
155605637|NCT00981058|561645713|FG001|Overall Study|Progressive Disease|31|||
155605638|NCT00981058|561645712|FG000|Overall Study|Lost to Follow-up|3|||
155605639|NCT00981058|561645713|FG001|Overall Study|Lost to Follow-up|2|||
155605640|NCT00981058|561645712|FG000|Overall Study|Physician Decision|4|||
155605641|NCT00981058|561645713|FG001|Overall Study|Physician Decision|5|||
155605642|NCT00981058|561645712|FG000|Overall Study|Randomization Error|0|||
155605643|NCT00981058|561645713|FG001|Overall Study|Randomization Error|1|||
155605644|NCT00981058|561645712|FG000|Overall Study|Withdrawal by Subject|24|||
155605645|NCT00981058|561645713|FG001|Overall Study|Withdrawal by Subject|22|||
155605646|NCT05916131|561645714|FG000|Overall Study|Lost to Follow-up|0|||
155605647|NCT05916131|561645715|FG001|Overall Study|Lost to Follow-up|0|||
155605648|NCT05916131|561645716|FG002|Overall Study|Lost to Follow-up|1|||
155605649|NCT05916131|561645717|FG003|Overall Study|Lost to Follow-up|0|||
155687728|NCT02275117|561949174|FG001|Overall Study|Physician Decision|1|||
155687729|NCT02275117|561949175|FG002|Overall Study|Physician Decision|1|||
155687730|NCT02275117|561949176|FG003|Overall Study|Physician Decision|0|||
155687731|NCT02275117|561949177|FG004|Overall Study|Physician Decision|1|||
155687732|NCT02275117|561949173|FG000|Overall Study|Protocol Violation|1|||
155687733|NCT02275117|561949174|FG001|Overall Study|Protocol Violation|0|||
155687734|NCT02275117|561949175|FG002|Overall Study|Protocol Violation|1|||
155687735|NCT02275117|561949176|FG003|Overall Study|Protocol Violation|1|||
155687736|NCT02275117|561949177|FG004|Overall Study|Protocol Violation|0|||
155687737|NCT02275117|561949173|FG000|Overall Study|Withdrawal by Subject|6|||
155687738|NCT02275117|561949174|FG001|Overall Study|Withdrawal by Subject|4|||
155687739|NCT02275117|561949175|FG002|Overall Study|Withdrawal by Subject|7|||
155687740|NCT02275117|561949176|FG003|Overall Study|Withdrawal by Subject|3|||
155687741|NCT02275117|561949177|FG004|Overall Study|Withdrawal by Subject|3|||
155687742|NCT02275117|561949173|FG000|Overall Study|Terminated by Sponsor|4|||
155687743|NCT02275117|561949174|FG001|Overall Study|Terminated by Sponsor|4|||
155687744|NCT02275117|561949175|FG002|Overall Study|Terminated by Sponsor|4|||
155687745|NCT02275117|561949176|FG003|Overall Study|Terminated by Sponsor|6|||
155687746|NCT02275117|561949177|FG004|Overall Study|Terminated by Sponsor|4|||
155687747|NCT02275117|561949173|FG000|Overall Study|Worsening of Study Indication|0|||
155687748|NCT02275117|561949174|FG001|Overall Study|Worsening of Study Indication|1|||
155687749|NCT02275117|561949175|FG002|Overall Study|Worsening of Study Indication|2|||
155687750|NCT02275117|561949176|FG003|Overall Study|Worsening of Study Indication|0|||
155687751|NCT02275117|561949177|FG004|Overall Study|Worsening of Study Indication|0|||
155687752|NCT02275117|561949173|FG000|Overall Study|Study Burden|5|||
155687753|NCT02275117|561949174|FG001|Overall Study|Study Burden|4|||
155687754|NCT02275117|561949175|FG002|Overall Study|Study Burden|7|||
155687755|NCT02275117|561949176|FG003|Overall Study|Study Burden|5|||
155687756|NCT02275117|561949177|FG004|Overall Study|Study Burden|7|||
155687757|NCT02275117|561949173|FG000|Overall Study|Other|1|||
155687758|NCT02275117|561949174|FG001|Overall Study|Other|0|||
155687759|NCT02275117|561949175|FG002|Overall Study|Other|0|||
155687760|NCT02275117|561949176|FG003|Overall Study|Other|0|||
155687761|NCT02275117|561949177|FG004|Overall Study|Other|2|||
155687762|NCT01081301|561949180|FG000|Overall Study|Bereaved|3|||
155687763|NCT01081301|561949180|FG000|Overall Study|Too busy|5|||
155687764|NCT01081301|561949180|FG000|Overall Study|Patient too ill|2|||
155687765|NCT01081301|561949180|FG000|Overall Study|Lost to Follow-up|4|||
155687766|NCT02014480|561949181|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155687767|NCT02014480|561949182|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155687768|NCT02014480|561949183|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155687769|NCT02014480|561949184|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155687770|NCT02014480|561949185|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155687771|NCT02014480|561949186|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155687772|NCT02014480|561949181|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155687773|NCT02014480|561949182|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155687774|NCT02014480|561949183|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155687775|NCT02014480|561949184|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
155687776|NCT02014480|561949185|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155687777|NCT02014480|561949186|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155687778|NCT02014480|561949181|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155687779|NCT02014480|561949182|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155687780|NCT02014480|561949183|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
155687781|NCT02014480|561949184|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155687782|NCT02014480|561949185|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155687783|NCT02014480|561949186|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155687784|NCT02014480|561949181|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155687785|NCT02014480|561949182|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155687786|NCT02014480|561949183|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
155687787|NCT02014480|561949184|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155687788|NCT02014480|561949185|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155687789|NCT02014480|561949186|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155687790|NCT02014480|561949181|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155687791|NCT02014480|561949182|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
155687792|NCT02014480|561949183|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155687793|NCT02014480|561949184|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155687794|NCT02014480|561949185|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155687795|NCT02014480|561949186|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155687796|NCT02014480|561949181|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
155687797|NCT02014480|561949182|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
155687798|NCT02014480|561949183|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
155687799|NCT02014480|561949184|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
155687800|NCT02014480|561949185|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
155687801|NCT02014480|561949186|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
155687802|NCT02014480|561949181|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155687803|NCT02014480|561949182|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155687804|NCT02014480|561949183|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155687805|NCT02014480|561949184|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155687806|NCT02014480|561949185|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155687807|NCT02014480|561949186|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155687808|NCT01865812|561949187|FG000|Primary Treatment Phase|Adverse Event|2|||
155687809|NCT01865812|561949188|FG001|Primary Treatment Phase|Adverse Event|0|||
155687810|NCT01865812|561949187|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
155687811|NCT01865812|561949188|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
155687812|NCT01865812|561949187|FG000|Long-term Safety Extension Phase|Pruritus|0|||
155687813|NCT01865812|561949188|FG001|Long-term Safety Extension Phase|Pruritus|3|||
155687814|NCT01865812|561949187|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
155687815|NCT01865812|561949188|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
155687816|NCT01865812|561949187|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
155687817|NCT01865812|561949188|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
155687818|NCT01338610|561949189|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
155687819|NCT01338610|561949190|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
155687820|NCT01338610|561949191|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
155687821|NCT01338610|561949189|FG000|Overall Study|Protocol Violation|1|||
155687822|NCT01338610|561949190|FG001|Overall Study|Protocol Violation|0|||
155687823|NCT01338610|561949191|FG002|Overall Study|Protocol Violation|1|||
155687824|NCT01338610|561949189|FG000|Overall Study|Adverse Event|3|||
155687825|NCT01338610|561949190|FG001|Overall Study|Adverse Event|0|||
155687826|NCT01338610|561949191|FG002|Overall Study|Adverse Event|0|||
155687827|NCT02046226|561949192|FG000|Overall Study|Lost to Follow-up|7|||
155687828|NCT01095653|561949193|FG000|Overall Study|Lack of Efficacy|3|||
155687829|NCT01095653|561949194|FG001|Overall Study|Lack of Efficacy|0|||
155687830|NCT01095653|561949195|FG002|Overall Study|Lack of Efficacy|0|||
155687831|NCT01095653|561949193|FG000|Overall Study|Adverse Event|1|||
155687832|NCT01095653|561949194|FG001|Overall Study|Adverse Event|4|||
155687833|NCT01095653|561949195|FG002|Overall Study|Adverse Event|4|||
155687834|NCT01095653|561949193|FG000|Overall Study|Lost to Follow-up|1|||
155687835|NCT01095653|561949194|FG001|Overall Study|Lost to Follow-up|0|||
155687836|NCT01095653|561949195|FG002|Overall Study|Lost to Follow-up|4|||
155687837|NCT01095653|561949193|FG000|Overall Study|Withdrawal by Subject|4|||
155687838|NCT01095653|561949194|FG001|Overall Study|Withdrawal by Subject|5|||
155687839|NCT01095653|561949195|FG002|Overall Study|Withdrawal by Subject|3|||
155687840|NCT01095653|561949193|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
155687841|NCT01095653|561949194|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
155687842|NCT01095653|561949195|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
155687843|NCT00171925|561949196|FG000|Overall Study|Adverse Event|10|||
155687844|NCT00171925|561949197|FG001|Overall Study|Adverse Event|6|||
155687845|NCT00171925|561949196|FG000|Overall Study|Protocol Violation|1|||
155687846|NCT00171925|561949197|FG001|Overall Study|Protocol Violation|1|||
155687847|NCT00171925|561949196|FG000|Overall Study|Withdrawal by Subject|6|||
155687848|NCT00171925|561949197|FG001|Overall Study|Withdrawal by Subject|9|||
155687849|NCT00171925|561949196|FG000|Overall Study|Lost to Follow-up|2|||
155687850|NCT00171925|561949197|FG001|Overall Study|Lost to Follow-up|2|||
155687851|NCT00171925|561949196|FG000|Overall Study|Administrative problems|10|||
155687852|NCT00171925|561949197|FG001|Overall Study|Administrative problems|11|||
155687853|NCT00171925|561949196|FG000|Overall Study|Death|1|||
155687854|NCT00171925|561949197|FG001|Overall Study|Death|2|||
155687855|NCT02692040|561949198|FG000|Overall Study|Protocol Violation|0|||
155687856|NCT02692040|561949199|FG001|Overall Study|Protocol Violation|0|||
155687857|NCT02692040|561949200|FG002|Overall Study|Protocol Violation|0|||
155687858|NCT02692040|561949201|FG003|Overall Study|Protocol Violation|0|||
155687859|NCT02692040|561949202|FG004|Overall Study|Protocol Violation|0|||
155687860|NCT02692040|561949203|FG005|Overall Study|Protocol Violation|0|||
155687861|NCT02692040|561949204|FG006|Overall Study|Protocol Violation|0|||
155687862|NCT02692040|561949205|FG007|Overall Study|Protocol Violation|0|||
155687863|NCT02692040|561949206|FG008|Overall Study|Protocol Violation|0|||
155687864|NCT02692040|561949207|FG009|Overall Study|Protocol Violation|0|||
155687865|NCT02692040|561949208|FG010|Overall Study|Protocol Violation|0|||
155687866|NCT02692040|561949209|FG011|Overall Study|Protocol Violation|0|||
155687867|NCT02692040|561949210|FG012|Overall Study|Protocol Violation|1|||
155687868|NCT02692040|561949211|FG013|Overall Study|Protocol Violation|0|||
155687869|NCT02692040|561949212|FG014|Overall Study|Protocol Violation|0|||
155687870|NCT02692040|561949213|FG015|Overall Study|Protocol Violation|0|||
155687871|NCT02692040|561949214|FG016|Overall Study|Protocol Violation|0|||
155687872|NCT02692040|561949198|FG000|Overall Study|Adverse Event|0|||
155687873|NCT02692040|561949199|FG001|Overall Study|Adverse Event|0|||
155687874|NCT02692040|561949200|FG002|Overall Study|Adverse Event|0|||
155687875|NCT02692040|561949201|FG003|Overall Study|Adverse Event|0|||
155687876|NCT02692040|561949202|FG004|Overall Study|Adverse Event|0|||
155687877|NCT02692040|561949203|FG005|Overall Study|Adverse Event|0|||
155687878|NCT02692040|561949204|FG006|Overall Study|Adverse Event|0|||
155687879|NCT02692040|561949205|FG007|Overall Study|Adverse Event|0|||
155687880|NCT02692040|561949206|FG008|Overall Study|Adverse Event|0|||
155687881|NCT02692040|561949207|FG009|Overall Study|Adverse Event|0|||
155687882|NCT02692040|561949208|FG010|Overall Study|Adverse Event|0|||
155687883|NCT02692040|561949209|FG011|Overall Study|Adverse Event|0|||
155687884|NCT02692040|561949210|FG012|Overall Study|Adverse Event|0|||
155687885|NCT02692040|561949211|FG013|Overall Study|Adverse Event|3|||
155687886|NCT02692040|561949212|FG014|Overall Study|Adverse Event|1|||
155687887|NCT02692040|561949213|FG015|Overall Study|Adverse Event|1|||
155687888|NCT02692040|561949214|FG016|Overall Study|Adverse Event|0|||
155687889|NCT00054691|561949221|FG000|Overall Study|Unmeasurable Disease|2|||
155687890|NCT00054691|561949221|FG000|Overall Study|Noncompliant|1|||
155687891|NCT02914548|561949226|FG000|Overall Study|Adverse Event|15|||
155687892|NCT02914548|561949227|FG001|Overall Study|Adverse Event|7|||
155687893|NCT02914548|561949228|FG002|Overall Study|Adverse Event|15|||
155687894|NCT02914548|561949226|FG000|Overall Study|Physician Decision|2|||
155687895|NCT02914548|561949227|FG001|Overall Study|Physician Decision|2|||
155687896|NCT02914548|561949228|FG002|Overall Study|Physician Decision|0|||
155687897|NCT02914548|561949226|FG000|Overall Study|Protocol Violation|1|||
155687898|NCT02914548|561949227|FG001|Overall Study|Protocol Violation|0|||
155687899|NCT02914548|561949228|FG002|Overall Study|Protocol Violation|0|||
155687900|NCT02914548|561949226|FG000|Overall Study|Withdrawal by Subject|3|||
155687901|NCT02914548|561949227|FG001|Overall Study|Withdrawal by Subject|4|||
155687902|NCT02914548|561949228|FG002|Overall Study|Withdrawal by Subject|4|||
155687903|NCT02914548|561949226|FG000|Overall Study|>40% of body surface area|0|||
155687904|NCT02914548|561949227|FG001|Overall Study|>40% of body surface area|1|||
155687905|NCT02914548|561949228|FG002|Overall Study|>40% of body surface area|1|||
155687906|NCT03023826|561949229|FG000|Period 1|Withdrawal by Subject|0|||
155687907|NCT03023826|561949230|FG001|Period 1|Withdrawal by Subject|0|||
155687908|NCT03023826|561949231|FG002|Period 1|Withdrawal by Subject|0|||
155687909|NCT03023826|561949232|FG003|Period 1|Withdrawal by Subject|0|||
155687910|NCT03023826|561949233|FG004|Period 1|Withdrawal by Subject|1|||
155687911|NCT03023826|561949234|FG005|Period 1|Withdrawal by Subject|0|||
155687912|NCT03746600|561949235|FG000|Overall Study|Withdrawal by Subject|3|||
155687913|NCT03746600|561949236|FG001|Overall Study|Withdrawal by Subject|3|||
155687914|NCT03746600|561949235|FG000|Overall Study|dismissed from study|1|||
155687915|NCT03746600|561949236|FG001|Overall Study|dismissed from study|0|||
155687916|NCT03746600|561949235|FG000|Overall Study|Lost to Follow-up|1|||
155687917|NCT03746600|561949236|FG001|Overall Study|Lost to Follow-up|0|||
155687918|NCT01371643|561949238|FG000|Overall Study|Withdrawal by Subject|3|||
155687919|NCT01371643|561949239|FG001|Overall Study|Withdrawal by Subject|0|||
155687920|NCT02374814|561949240|FG000|Overall Study|Lost to Follow-up|1|||
155687921|NCT02374814|561949241|FG001|Overall Study|Lost to Follow-up|1|||
155687922|NCT02374814|561949242|FG002|Overall Study|Lost to Follow-up|0|||
155687923|NCT02374814|561949243|FG003|Overall Study|Lost to Follow-up|1|||
155687924|NCT02374814|561949244|FG004|Overall Study|Lost to Follow-up|0|||
155687925|NCT02374814|561949245|FG005|Overall Study|Lost to Follow-up|0|||
155687926|NCT02374814|561949240|FG000|Overall Study|Withdrawal by Subject|0|||
155605650|NCT02667587|561645718|FG000|Pre-Treatment|Not reported|1|||
155605651|NCT02667587|561645719|FG001|Pre-Treatment|Not reported|0|||
155605652|NCT02667587|561645718|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155605653|NCT02667587|561645719|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
155605654|NCT02667587|561645718|FG000|Pre-Treatment|Participant withdrew consent|0|||
155605655|NCT02667587|561645719|FG001|Pre-Treatment|Participant withdrew consent|1|||
155605656|NCT02667587|561645718|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
155605657|NCT02667587|561645719|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
155605658|NCT02667587|561645718|FG000|End of Treatment|Disease Progression|193|||
155605659|NCT02667587|561645719|FG001|End of Treatment|Disease Progression|226|||
155605660|NCT02667587|561645718|FG000|End of Treatment|Study Drug Toxicity|75|||
155605661|NCT02667587|561645719|FG001|End of Treatment|Study Drug Toxicity|19|||
155605662|NCT02667587|561645718|FG000|End of Treatment|Death|2|||
155605663|NCT02667587|561645719|FG001|End of Treatment|Death|1|||
155605664|NCT02667587|561645718|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
155605665|NCT02667587|561645719|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
155605666|NCT02667587|561645718|FG000|End of Treatment|participant request to discontinue treatment|33|||
155605667|NCT02667587|561645719|FG001|End of Treatment|participant request to discontinue treatment|35|||
155605668|NCT02667587|561645718|FG000|End of Treatment|participant withdrew consent|5|||
155605669|NCT02667587|561645719|FG001|End of Treatment|participant withdrew consent|6|||
155605670|NCT02667587|561645718|FG000|End of Treatment|Lost to Follow-up|1|||
155687927|NCT02374814|561949241|FG001|Overall Study|Withdrawal by Subject|0|||
155687928|NCT02374814|561949242|FG002|Overall Study|Withdrawal by Subject|1|||
155687929|NCT02374814|561949243|FG003|Overall Study|Withdrawal by Subject|1|||
155687930|NCT02374814|561949244|FG004|Overall Study|Withdrawal by Subject|0|||
155687931|NCT02374814|561949245|FG005|Overall Study|Withdrawal by Subject|0|||
155687932|NCT00072293|561949248|FG000|Overall Study|Lost to Follow-up|1|||
155687933|NCT00072293|561949249|FG001|Overall Study|Lost to Follow-up|1|||
155687934|NCT00072293|561949248|FG000|Overall Study|Withdrawal by Subject|0|||
155687935|NCT00072293|561949249|FG001|Overall Study|Withdrawal by Subject|1|||
155687936|NCT04209114|561949250|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
155687937|NCT04209114|561949251|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
155687938|NCT04209114|561949252|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
155687939|NCT04209114|561949250|FG000|Pre-Treatment Phase|Other reasons|0|||
155687940|NCT04209114|561949251|FG001|Pre-Treatment Phase|Other reasons|0|||
155687941|NCT04209114|561949252|FG002|Pre-Treatment Phase|Other reasons|1|||
155687942|NCT04209114|561949250|FG000|Pre-Treatment Phase|Death|0|||
155687943|NCT04209114|561949251|FG001|Pre-Treatment Phase|Death|0|||
155687944|NCT04209114|561949252|FG002|Pre-Treatment Phase|Death|1|||
155687945|NCT04209114|561949250|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
155687946|NCT04209114|561949251|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
155687947|NCT04209114|561949252|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
155687948|NCT04209114|561949250|FG000|Treatment Phase|Other reasons|5|||
155687949|NCT04209114|561949251|FG001|Treatment Phase|Other reasons|3|||
155687950|NCT04209114|561949252|FG002|Treatment Phase|Other reasons|0|||
155687951|NCT04209114|561949250|FG000|Treatment Phase|Lost to Follow-up|1|||
155687952|NCT04209114|561949251|FG001|Treatment Phase|Lost to Follow-up|0|||
155687953|NCT04209114|561949252|FG002|Treatment Phase|Lost to Follow-up|0|||
155687954|NCT04209114|561949250|FG000|Treatment Phase|Participant withdrew consent|1|||
155687955|NCT04209114|561949251|FG001|Treatment Phase|Participant withdrew consent|0|||
155687956|NCT04209114|561949252|FG002|Treatment Phase|Participant withdrew consent|0|||
155687957|NCT04209114|561949250|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
155687958|NCT04209114|561949251|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
155687959|NCT04209114|561949252|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
155687960|NCT04209114|561949250|FG000|Treatment Phase|Death|4|||
155687961|NCT04209114|561949251|FG001|Treatment Phase|Death|1|||
155687962|NCT04209114|561949252|FG002|Treatment Phase|Death|0|||
155687963|NCT04209114|561949250|FG000|Treatment Phase|Study drug toxicity|4|||
155687964|NCT04209114|561949251|FG001|Treatment Phase|Study drug toxicity|6|||
155687965|NCT04209114|561949252|FG002|Treatment Phase|Study drug toxicity|0|||
155687966|NCT04209114|561949250|FG000|Treatment Phase|Disease progression|6|||
155687967|NCT04209114|561949251|FG001|Treatment Phase|Disease progression|9|||
155687968|NCT04209114|561949252|FG002|Treatment Phase|Disease progression|0|||
155687969|NCT02826421|561949260|FG000|Overall Study|Adverse Event|1|||
155687970|NCT02826421|561949261|FG001|Overall Study|Adverse Event|0|||
155687971|NCT02826421|561949262|FG002|Overall Study|Adverse Event|0|||
155687972|NCT02826421|561949263|FG003|Overall Study|Adverse Event|1|||
155687973|NCT02826421|561949260|FG000|Overall Study|Withdrawal by Subject|1|||
155687974|NCT02826421|561949261|FG001|Overall Study|Withdrawal by Subject|3|||
155687975|NCT02826421|561949262|FG002|Overall Study|Withdrawal by Subject|1|||
155687976|NCT02826421|561949263|FG003|Overall Study|Withdrawal by Subject|1|||
155687977|NCT02826421|561949260|FG000|Overall Study|Reason not given|1|||
155687978|NCT02826421|561949261|FG001|Overall Study|Reason not given|0|||
155687979|NCT02826421|561949262|FG002|Overall Study|Reason not given|1|||
155687980|NCT02826421|561949263|FG003|Overall Study|Reason not given|0|||
155687981|NCT02210221|561949266|FG000|Overall Study|Lack of Efficacy|7|||
155687982|NCT02210221|561949266|FG000|Overall Study|Withdrawal by Subject|43|||
155687983|NCT00405964|561949269|FG000|Overall Study|Treatment Failure|17|||
155687984|NCT00405964|561949270|FG001|Overall Study|Treatment Failure|45|||
155687985|NCT00405964|561949269|FG000|Overall Study|Adverse Event|7|||
155687986|NCT00405964|561949270|FG001|Overall Study|Adverse Event|16|||
155687987|NCT00405964|561949269|FG000|Overall Study|Lost to Follow-up|5|||
155687988|NCT00405964|561949270|FG001|Overall Study|Lost to Follow-up|5|||
155687989|NCT00405964|561949269|FG000|Overall Study|Withdrawal by Subject|19|||
155687990|NCT00405964|561949270|FG001|Overall Study|Withdrawal by Subject|23|||
155687991|NCT00405964|561949269|FG000|Overall Study|Protocol Violation|11|||
155687992|NCT00405964|561949270|FG001|Overall Study|Protocol Violation|6|||
155687993|NCT04030247|561951555|FG000|Overall Study|Withdrawal by Subject|4|||
155687994|NCT04030247|561951555|FG000|Overall Study|Lost to Follow-up|13|||
155687995|NCT05320393|561951556|FG000|Overall Study|Withdrawal by Subject|1|||
155687996|NCT05320393|561951557|FG001|Overall Study|Withdrawal by Subject|0|||
155687997|NCT05320393|561951558|FG002|Overall Study|Withdrawal by Subject|2|||
155687998|NCT05320393|561951556|FG000|Overall Study|Lost to Follow-up|1|||
155687999|NCT05320393|561951557|FG001|Overall Study|Lost to Follow-up|2|||
155688000|NCT05320393|561951558|FG002|Overall Study|Lost to Follow-up|1|||
155688001|NCT05320393|561951556|FG000|Overall Study|Moved; too much driving|0|||
155688002|NCT05320393|561951557|FG001|Overall Study|Moved; too much driving|0|||
155688003|NCT05320393|561951558|FG002|Overall Study|Moved; too much driving|2|||
155688004|NCT05320393|561951556|FG000|Overall Study|Did not receive treatment|0|||
155688005|NCT05320393|561951557|FG001|Overall Study|Did not receive treatment|0|||
155688006|NCT05320393|561951558|FG002|Overall Study|Did not receive treatment|1|||
155688007|NCT03187834|561951559|FG000|Overall Study|Lost to Follow-up|0|||
155688008|NCT03187834|561951560|FG001|Overall Study|Lost to Follow-up|1|||
155688009|NCT03187834|561951561|FG002|Overall Study|Lost to Follow-up|2|||
155688010|NCT03187834|561951562|FG003|Overall Study|Lost to Follow-up|2|||
155688011|NCT03187834|561951559|FG000|Overall Study|Had invalid anthropometric measurements|5|||
155688012|NCT03187834|561951560|FG001|Overall Study|Had invalid anthropometric measurements|3|||
155688013|NCT03187834|561951561|FG002|Overall Study|Had invalid anthropometric measurements|4|||
155688014|NCT03187834|561951562|FG003|Overall Study|Had invalid anthropometric measurements|2|||
155688015|NCT03559699|561951563|FG000|Overall Study|Withdrawal by Subject|6|||
155688016|NCT03559699|561951563|FG000|Overall Study|Lost to Follow-up|1|||
155688017|NCT00031460|561951564|FG000|Overall Study|Lost to Follow-up|0|||
155688018|NCT00031460|561951565|FG001|Overall Study|Lost to Follow-up|1|||
155688019|NCT00031460|561951564|FG000|Overall Study|Withdrawal by Subject|1|||
155688020|NCT00031460|561951565|FG001|Overall Study|Withdrawal by Subject|1|||
155688021|NCT00031460|561951564|FG000|Overall Study|Non-Compliant|1|||
155688022|NCT00031460|561951565|FG001|Overall Study|Non-Compliant|1|||
155688023|NCT00031460|561951564|FG000|Overall Study|Death|0|||
155688024|NCT00031460|561951565|FG001|Overall Study|Death|1|||
155688025|NCT00031460|561951564|FG000|Overall Study|Reactivation of Disease|5|||
155688026|NCT00031460|561951565|FG001|Overall Study|Reactivation of Disease|9|||
155688027|NCT00031460|561951564|FG000|Overall Study|Disruption of blinded drug supply|2|||
155688028|NCT00031460|561951565|FG001|Overall Study|Disruption of blinded drug supply|0|||
155688029|NCT00031460|561951564|FG000|Overall Study|Confirmed unevaluable|0|||
155688030|NCT00031460|561951565|FG001|Overall Study|Confirmed unevaluable|1|||
155688031|NCT00471887|561951572|FG000|Overall Study|Adverse Event|9|||
155688032|NCT01930890|561951573|FG000|Overall Study|Study Termination|14|||
155688033|NCT01930890|561951574|FG001|Overall Study|Study Termination|28|||
155688034|NCT01930890|561951575|FG002|Overall Study|Study Termination|13|||
155688035|NCT01930890|561951576|FG003|Overall Study|Study Termination|25|||
155688036|NCT01930890|561951573|FG000|Overall Study|Death|0|||
155688037|NCT01930890|561951574|FG001|Overall Study|Death|0|||
155688038|NCT01930890|561951575|FG002|Overall Study|Death|0|||
155688039|NCT01930890|561951576|FG003|Overall Study|Death|1|||
155688040|NCT01930890|561951573|FG000|Overall Study|Investigator Decision|0|||
155688041|NCT01930890|561951574|FG001|Overall Study|Investigator Decision|1|||
155688042|NCT01930890|561951575|FG002|Overall Study|Investigator Decision|0|||
155688043|NCT01930890|561951576|FG003|Overall Study|Investigator Decision|0|||
155688044|NCT01930890|561951573|FG000|Overall Study|Consent Withdrawn|0|||
155688045|NCT01930890|561951574|FG001|Overall Study|Consent Withdrawn|3|||
155688046|NCT01930890|561951575|FG002|Overall Study|Consent Withdrawn|0|||
155688047|NCT01930890|561951576|FG003|Overall Study|Consent Withdrawn|1|||
155688048|NCT01930890|561951573|FG000|Overall Study|Adverse Event|0|||
155688049|NCT01930890|561951574|FG001|Overall Study|Adverse Event|1|||
155688050|NCT01930890|561951575|FG002|Overall Study|Adverse Event|0|||
155688051|NCT01930890|561951576|FG003|Overall Study|Adverse Event|0|||
155688052|NCT03710876|561951577|FG000|Overall Study|Death|0|||
155688053|NCT03710876|561951578|FG001|Overall Study|Death|2|||
155688054|NCT03710876|561951577|FG000|Overall Study|Withdrawal by Subject|0|||
155688055|NCT03710876|561951578|FG001|Overall Study|Withdrawal by Subject|2|||
155688056|NCT01176565|561951586|FG000|Overall Study|Lost to Follow-up|12|||
155688057|NCT01176565|561951587|FG001|Overall Study|Lost to Follow-up|16|||
155688058|NCT01176565|561951586|FG000|Overall Study|Withdrawal by Subject|7|||
155688059|NCT01176565|561951587|FG001|Overall Study|Withdrawal by Subject|1|||
155688060|NCT01176565|561951586|FG000|Overall Study|Not Analyzed (any other reason)|1|||
155688061|NCT01176565|561951587|FG001|Overall Study|Not Analyzed (any other reason)|2|||
155688062|NCT03602885|561951589|FG000|Overall Study|Lost to Follow-up|3|||
155688063|NCT03602885|561951590|FG001|Overall Study|Lost to Follow-up|0|||
155688064|NCT02754141|561951591|FG000|Overall Study|Disease progression|11|||
155688065|NCT02754141|561951592|FG001|Overall Study|Disease progression|7|||
155688066|NCT02754141|561951593|FG002|Overall Study|Disease progression|8|||
155688067|NCT02754141|561951594|FG003|Overall Study|Disease progression|5|||
155688068|NCT02754141|561951595|FG004|Overall Study|Disease progression|7|||
155688069|NCT02754141|561951596|FG005|Overall Study|Disease progression|7|||
155688070|NCT02754141|561951597|FG006|Overall Study|Disease progression|7|||
155688071|NCT02754141|561951598|FG007|Overall Study|Disease progression|6|||
155688072|NCT02754141|561951599|FG008|Overall Study|Disease progression|11|||
155688073|NCT02754141|561951600|FG009|Overall Study|Disease progression|16|||
155688074|NCT02754141|561951601|FG010|Overall Study|Disease progression|18|||
155688075|NCT02754141|561951602|FG011|Overall Study|Disease progression|13|||
155688076|NCT02754141|561951603|FG012|Overall Study|Disease progression|10|||
155688077|NCT02754141|561951604|FG013|Overall Study|Disease progression|12|||
155688078|NCT02754141|561951605|FG014|Overall Study|Disease progression|12|||
155688079|NCT02754141|561951606|FG015|Overall Study|Disease progression|14|||
155688080|NCT02754141|561951607|FG016|Overall Study|Disease progression|0|||
155688081|NCT02754141|561951608|FG017|Overall Study|Disease progression|1|||
155688082|NCT02754141|561951591|FG000|Overall Study|Study drug toxicity|1|||
155688083|NCT02754141|561951592|FG001|Overall Study|Study drug toxicity|1|||
155688084|NCT02754141|561951593|FG002|Overall Study|Study drug toxicity|0|||
155688085|NCT02754141|561951594|FG003|Overall Study|Study drug toxicity|0|||
155688086|NCT02754141|561951595|FG004|Overall Study|Study drug toxicity|0|||
155688087|NCT02754141|561951596|FG005|Overall Study|Study drug toxicity|0|||
155688088|NCT02754141|561951597|FG006|Overall Study|Study drug toxicity|0|||
155688089|NCT02754141|561951598|FG007|Overall Study|Study drug toxicity|0|||
155688090|NCT02754141|561951599|FG008|Overall Study|Study drug toxicity|0|||
155688091|NCT02754141|561951600|FG009|Overall Study|Study drug toxicity|0|||
155688092|NCT02754141|561951601|FG010|Overall Study|Study drug toxicity|2|||
155688093|NCT02754141|561951602|FG011|Overall Study|Study drug toxicity|1|||
155688094|NCT02754141|561951603|FG012|Overall Study|Study drug toxicity|1|||
155688095|NCT02754141|561951604|FG013|Overall Study|Study drug toxicity|0|||
155688096|NCT02754141|561951605|FG014|Overall Study|Study drug toxicity|0|||
155688097|NCT02754141|561951606|FG015|Overall Study|Study drug toxicity|0|||
155688098|NCT02754141|561951607|FG016|Overall Study|Study drug toxicity|0|||
155688099|NCT02754141|561951608|FG017|Overall Study|Study drug toxicity|0|||
155688100|NCT02754141|561951591|FG000|Overall Study|AE unrelated to study drug|1|||
155605671|NCT02667587|561645719|FG001|End of Treatment|Lost to Follow-up|2|||
155605672|NCT02667587|561645718|FG000|End of Treatment|maximum clinical benefit|4|||
155605673|NCT02667587|561645719|FG001|End of Treatment|maximum clinical benefit|4|||
155605674|NCT02667587|561645718|FG000|End of Treatment|poor or non compliant|0|||
155605675|NCT02667587|561645719|FG001|End of Treatment|poor or non compliant|1|||
155605676|NCT02667587|561645718|FG000|End of Treatment|participant no longer meets study criteria|1|||
155605677|NCT02667587|561645719|FG001|End of Treatment|participant no longer meets study criteria|1|||
155605678|NCT02667587|561645718|FG000|End of Treatment|administrative reason by sponsor|1|||
155605679|NCT02667587|561645719|FG001|End of Treatment|administrative reason by sponsor|29|||
155605680|NCT02667587|561645718|FG000|End of Treatment|other reasonse|21|||
155605681|NCT02667587|561645719|FG001|End of Treatment|other reasonse|10|||
155605682|NCT02542293|561645720|FG000|Overall Study|Death|367|||
155605683|NCT02542293|561645721|FG001|Overall Study|Death|377|||
155605684|NCT02542293|561645720|FG000|Overall Study|Withdrawal by Subject|8|||
155605685|NCT02542293|561645721|FG001|Overall Study|Withdrawal by Subject|19|||
155605686|NCT03030118|561645722|FG000|Overall Study|Achieved SLE Diagnosis|11|||
155605687|NCT03030118|561645723|FG001|Overall Study|Achieved SLE Diagnosis|10|||
155605688|NCT03030118|561645722|FG000|Overall Study|Adverse Event|1|||
155605689|NCT03030118|561645723|FG001|Overall Study|Adverse Event|1|||
155605690|NCT03030118|561645722|FG000|Overall Study|Pregnancy|2|||
155605691|NCT03030118|561645723|FG001|Overall Study|Pregnancy|2|||
155605692|NCT03030118|561645722|FG000|Overall Study|Lost to Follow-up|5|||
155605693|NCT03030118|561645723|FG001|Overall Study|Lost to Follow-up|6|||
155605694|NCT03030118|561645722|FG000|Overall Study|Concomitant Medications|1|||
155605695|NCT03030118|561645723|FG001|Overall Study|Concomitant Medications|1|||
155605696|NCT03030118|561645722|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
155605697|NCT03030118|561645723|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
155605698|NCT03030118|561645722|FG000|Overall Study|Other|2|||
155605699|NCT03030118|561645723|FG001|Overall Study|Other|0|||
155605700|NCT03030118|561645722|FG000|Overall Study|Withdrawal by Subject|26|||
155605701|NCT03030118|561645723|FG001|Overall Study|Withdrawal by Subject|21|||
155605702|NCT03030118|561645722|FG000|Overall Study|Protocol Violation|1|||
155605703|NCT03030118|561645723|FG001|Overall Study|Protocol Violation|6|||
155605704|NCT04529850|561645724|FG000|Overall Study|Death|2|||
155688101|NCT02754141|561951592|FG001|Overall Study|AE unrelated to study drug|1|||
155688102|NCT02754141|561951593|FG002|Overall Study|AE unrelated to study drug|0|||
155688103|NCT02754141|561951594|FG003|Overall Study|AE unrelated to study drug|1|||
155688104|NCT02754141|561951595|FG004|Overall Study|AE unrelated to study drug|3|||
155688105|NCT02754141|561951596|FG005|Overall Study|AE unrelated to study drug|2|||
155688106|NCT02754141|561951597|FG006|Overall Study|AE unrelated to study drug|1|||
155688107|NCT02754141|561951598|FG007|Overall Study|AE unrelated to study drug|0|||
155688108|NCT02754141|561951599|FG008|Overall Study|AE unrelated to study drug|0|||
155688109|NCT02754141|561951600|FG009|Overall Study|AE unrelated to study drug|0|||
155688110|NCT02754141|561951601|FG010|Overall Study|AE unrelated to study drug|0|||
155688111|NCT02754141|561951602|FG011|Overall Study|AE unrelated to study drug|0|||
155688112|NCT02754141|561951603|FG012|Overall Study|AE unrelated to study drug|0|||
155688113|NCT02754141|561951604|FG013|Overall Study|AE unrelated to study drug|0|||
155688114|NCT02754141|561951605|FG014|Overall Study|AE unrelated to study drug|0|||
155688115|NCT02754141|561951606|FG015|Overall Study|AE unrelated to study drug|0|||
155688116|NCT02754141|561951607|FG016|Overall Study|AE unrelated to study drug|0|||
155688117|NCT02754141|561951608|FG017|Overall Study|AE unrelated to study drug|0|||
155688118|NCT02754141|561951591|FG000|Overall Study|Request to discontinue|0|||
155688119|NCT02754141|561951592|FG001|Overall Study|Request to discontinue|0|||
155688120|NCT02754141|561951593|FG002|Overall Study|Request to discontinue|0|||
155688121|NCT02754141|561951594|FG003|Overall Study|Request to discontinue|0|||
155688122|NCT02754141|561951595|FG004|Overall Study|Request to discontinue|0|||
155688123|NCT02754141|561951596|FG005|Overall Study|Request to discontinue|0|||
155688124|NCT02754141|561951597|FG006|Overall Study|Request to discontinue|0|||
155688125|NCT02754141|561951598|FG007|Overall Study|Request to discontinue|0|||
155688126|NCT02754141|561951599|FG008|Overall Study|Request to discontinue|1|||
155688127|NCT02754141|561951600|FG009|Overall Study|Request to discontinue|0|||
155688128|NCT02754141|561951601|FG010|Overall Study|Request to discontinue|0|||
155688129|NCT02754141|561951602|FG011|Overall Study|Request to discontinue|0|||
155688130|NCT02754141|561951603|FG012|Overall Study|Request to discontinue|0|||
155688131|NCT02754141|561951604|FG013|Overall Study|Request to discontinue|1|||
155688132|NCT02754141|561951605|FG014|Overall Study|Request to discontinue|1|||
155688133|NCT02754141|561951606|FG015|Overall Study|Request to discontinue|0|||
155688134|NCT02754141|561951607|FG016|Overall Study|Request to discontinue|0|||
155688135|NCT02754141|561951608|FG017|Overall Study|Request to discontinue|0|||
155688136|NCT02754141|561951591|FG000|Overall Study|Withdrew consent|0|||
155688137|NCT02754141|561951592|FG001|Overall Study|Withdrew consent|0|||
155688138|NCT02754141|561951593|FG002|Overall Study|Withdrew consent|0|||
155688139|NCT02754141|561951594|FG003|Overall Study|Withdrew consent|0|||
155688140|NCT02754141|561951595|FG004|Overall Study|Withdrew consent|0|||
155688141|NCT02754141|561951596|FG005|Overall Study|Withdrew consent|0|||
155688142|NCT02754141|561951597|FG006|Overall Study|Withdrew consent|0|||
155688143|NCT02754141|561951598|FG007|Overall Study|Withdrew consent|0|||
155688144|NCT02754141|561951599|FG008|Overall Study|Withdrew consent|0|||
155688145|NCT02754141|561951600|FG009|Overall Study|Withdrew consent|1|||
155688146|NCT02754141|561951601|FG010|Overall Study|Withdrew consent|0|||
155688147|NCT02754141|561951602|FG011|Overall Study|Withdrew consent|0|||
155688148|NCT02754141|561951603|FG012|Overall Study|Withdrew consent|0|||
155688149|NCT02754141|561951604|FG013|Overall Study|Withdrew consent|0|||
155688150|NCT02754141|561951605|FG014|Overall Study|Withdrew consent|0|||
155688151|NCT02754141|561951606|FG015|Overall Study|Withdrew consent|0|||
155688152|NCT02754141|561951607|FG016|Overall Study|Withdrew consent|0|||
155688153|NCT02754141|561951608|FG017|Overall Study|Withdrew consent|0|||
155688154|NCT02754141|561951591|FG000|Overall Study|Maximum clinical benefit|0|||
155688155|NCT02754141|561951592|FG001|Overall Study|Maximum clinical benefit|0|||
155688156|NCT02754141|561951593|FG002|Overall Study|Maximum clinical benefit|0|||
155688157|NCT02754141|561951594|FG003|Overall Study|Maximum clinical benefit|1|||
155688158|NCT02754141|561951595|FG004|Overall Study|Maximum clinical benefit|0|||
155688159|NCT02754141|561951596|FG005|Overall Study|Maximum clinical benefit|0|||
155688160|NCT02754141|561951597|FG006|Overall Study|Maximum clinical benefit|0|||
155688161|NCT02754141|561951598|FG007|Overall Study|Maximum clinical benefit|0|||
155688162|NCT02754141|561951599|FG008|Overall Study|Maximum clinical benefit|0|||
155688163|NCT02754141|561951600|FG009|Overall Study|Maximum clinical benefit|0|||
155688164|NCT02754141|561951601|FG010|Overall Study|Maximum clinical benefit|0|||
155688165|NCT02754141|561951602|FG011|Overall Study|Maximum clinical benefit|0|||
155688166|NCT02754141|561951603|FG012|Overall Study|Maximum clinical benefit|0|||
155688167|NCT02754141|561951604|FG013|Overall Study|Maximum clinical benefit|0|||
155688168|NCT02754141|561951605|FG014|Overall Study|Maximum clinical benefit|0|||
155688169|NCT02754141|561951606|FG015|Overall Study|Maximum clinical benefit|0|||
155688170|NCT02754141|561951607|FG016|Overall Study|Maximum clinical benefit|0|||
155688171|NCT02754141|561951608|FG017|Overall Study|Maximum clinical benefit|0|||
155688172|NCT02754141|561951591|FG000|Overall Study|No longer meets study criteria|0|||
155688173|NCT02754141|561951592|FG001|Overall Study|No longer meets study criteria|0|||
155688174|NCT02754141|561951593|FG002|Overall Study|No longer meets study criteria|0|||
155688175|NCT02754141|561951594|FG003|Overall Study|No longer meets study criteria|1|||
155688176|NCT02754141|561951595|FG004|Overall Study|No longer meets study criteria|0|||
155688177|NCT02754141|561951596|FG005|Overall Study|No longer meets study criteria|0|||
155688178|NCT02754141|561951597|FG006|Overall Study|No longer meets study criteria|0|||
155688179|NCT02754141|561951598|FG007|Overall Study|No longer meets study criteria|0|||
155688180|NCT02754141|561951599|FG008|Overall Study|No longer meets study criteria|0|||
155688181|NCT02754141|561951600|FG009|Overall Study|No longer meets study criteria|0|||
155688182|NCT02754141|561951601|FG010|Overall Study|No longer meets study criteria|0|||
155688183|NCT02754141|561951602|FG011|Overall Study|No longer meets study criteria|0|||
155688184|NCT02754141|561951603|FG012|Overall Study|No longer meets study criteria|0|||
155688185|NCT02754141|561951604|FG013|Overall Study|No longer meets study criteria|0|||
155688186|NCT02754141|561951605|FG014|Overall Study|No longer meets study criteria|0|||
155688187|NCT02754141|561951606|FG015|Overall Study|No longer meets study criteria|0|||
155688188|NCT02754141|561951607|FG016|Overall Study|No longer meets study criteria|0|||
155688189|NCT02754141|561951608|FG017|Overall Study|No longer meets study criteria|0|||
155688190|NCT02754141|561951591|FG000|Overall Study|Other reasons|0|||
155688191|NCT02754141|561951592|FG001|Overall Study|Other reasons|0|||
155688192|NCT02754141|561951593|FG002|Overall Study|Other reasons|0|||
155688193|NCT02754141|561951594|FG003|Overall Study|Other reasons|0|||
155688194|NCT02754141|561951595|FG004|Overall Study|Other reasons|0|||
155688195|NCT02754141|561951596|FG005|Overall Study|Other reasons|0|||
155688196|NCT02754141|561951597|FG006|Overall Study|Other reasons|0|||
155688197|NCT02754141|561951598|FG007|Overall Study|Other reasons|1|||
155688198|NCT02754141|561951599|FG008|Overall Study|Other reasons|0|||
155688199|NCT02754141|561951600|FG009|Overall Study|Other reasons|0|||
155688200|NCT02754141|561951601|FG010|Overall Study|Other reasons|0|||
155688201|NCT02754141|561951602|FG011|Overall Study|Other reasons|0|||
155688202|NCT02754141|561951603|FG012|Overall Study|Other reasons|2|||
155688203|NCT02754141|561951604|FG013|Overall Study|Other reasons|0|||
155688204|NCT02754141|561951605|FG014|Overall Study|Other reasons|0|||
155688205|NCT02754141|561951606|FG015|Overall Study|Other reasons|0|||
155688206|NCT02754141|561951607|FG016|Overall Study|Other reasons|0|||
155688207|NCT02754141|561951608|FG017|Overall Study|Other reasons|0|||
155688208|NCT02754141|561951591|FG000|Overall Study|Completed treatment as per protocol|0|||
155688209|NCT02754141|561951592|FG001|Overall Study|Completed treatment as per protocol|1|||
155688210|NCT02754141|561951593|FG002|Overall Study|Completed treatment as per protocol|0|||
155688211|NCT02754141|561951594|FG003|Overall Study|Completed treatment as per protocol|0|||
155688212|NCT02754141|561951595|FG004|Overall Study|Completed treatment as per protocol|0|||
155688213|NCT02754141|561951596|FG005|Overall Study|Completed treatment as per protocol|0|||
155688214|NCT02754141|561951597|FG006|Overall Study|Completed treatment as per protocol|0|||
155688215|NCT02754141|561951598|FG007|Overall Study|Completed treatment as per protocol|0|||
155688216|NCT02754141|561951599|FG008|Overall Study|Completed treatment as per protocol|0|||
155688217|NCT02754141|561951600|FG009|Overall Study|Completed treatment as per protocol|0|||
155688218|NCT02754141|561951601|FG010|Overall Study|Completed treatment as per protocol|0|||
155688219|NCT02754141|561951602|FG011|Overall Study|Completed treatment as per protocol|0|||
155688220|NCT02754141|561951603|FG012|Overall Study|Completed treatment as per protocol|1|||
155688221|NCT02754141|561951604|FG013|Overall Study|Completed treatment as per protocol|0|||
155688222|NCT02754141|561951605|FG014|Overall Study|Completed treatment as per protocol|0|||
155688223|NCT02754141|561951606|FG015|Overall Study|Completed treatment as per protocol|0|||
155688224|NCT02754141|561951607|FG016|Overall Study|Completed treatment as per protocol|0|||
155688225|NCT02754141|561951608|FG017|Overall Study|Completed treatment as per protocol|0|||
155688226|NCT02754141|561951591|FG000|Overall Study|Not completing monotherapy|0|||
155688227|NCT02754141|561951592|FG001|Overall Study|Not completing monotherapy|0|||
155688228|NCT02754141|561951593|FG002|Overall Study|Not completing monotherapy|0|||
155688229|NCT02754141|561951594|FG003|Overall Study|Not completing monotherapy|0|||
155688230|NCT02754141|561951595|FG004|Overall Study|Not completing monotherapy|0|||
155605705|NCT04529850|561645724|FG000|Overall Study|Physician Decision|1|||
155605706|NCT04529850|561645724|FG000|Overall Study|Withdrawal by Subject|2|||
155605707|NCT02278367|561645727|FG000|Overall Study|Physician Decision|5|||
155605708|NCT02278367|561645728|FG001|Overall Study|Physician Decision|0|||
155605709|NCT02278367|561645727|FG000|Overall Study|Withdrawal by Subject|5|||
155605710|NCT02278367|561645728|FG001|Overall Study|Withdrawal by Subject|0|||
155605711|NCT01472939|561645732|FG000|Overall Study|Adverse Event|3|||
155605712|NCT01472939|561645733|FG001|Overall Study|Adverse Event|7|||
155605713|NCT01472939|561645734|FG002|Overall Study|Adverse Event|7|||
155605714|NCT01472939|561645735|FG003|Overall Study|Adverse Event|14|||
155605715|NCT01472939|561645732|FG000|Overall Study|Lack of Efficacy|1|||
155605716|NCT01472939|561645733|FG001|Overall Study|Lack of Efficacy|0|||
155605717|NCT01472939|561645734|FG002|Overall Study|Lack of Efficacy|0|||
155605718|NCT01472939|561645735|FG003|Overall Study|Lack of Efficacy|1|||
155605719|NCT01472939|561645732|FG000|Overall Study|Lost to Follow-up|3|||
155605720|NCT01472939|561645733|FG001|Overall Study|Lost to Follow-up|0|||
155605721|NCT01472939|561645734|FG002|Overall Study|Lost to Follow-up|2|||
155605722|NCT01472939|561645735|FG003|Overall Study|Lost to Follow-up|0|||
155605723|NCT01472939|561645732|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155605724|NCT01472939|561645733|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155605725|NCT01472939|561645734|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
155605726|NCT01472939|561645735|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155605727|NCT01472939|561645732|FG000|Overall Study|Prohibited Medication|0|||
155605728|NCT01472939|561645733|FG001|Overall Study|Prohibited Medication|1|||
155605729|NCT01472939|561645734|FG002|Overall Study|Prohibited Medication|0|||
155605730|NCT01472939|561645735|FG003|Overall Study|Prohibited Medication|0|||
155605731|NCT01472939|561645732|FG000|Overall Study|Withdrawal By PI|1|||
155605732|NCT01472939|561645733|FG001|Overall Study|Withdrawal By PI|0|||
155605733|NCT01472939|561645734|FG002|Overall Study|Withdrawal By PI|0|||
155605734|NCT01472939|561645735|FG003|Overall Study|Withdrawal By PI|0|||
155605735|NCT01472939|561645732|FG000|Overall Study|Protocol Violation|3|||
155605736|NCT01472939|561645733|FG001|Overall Study|Protocol Violation|3|||
155605737|NCT01472939|561645734|FG002|Overall Study|Protocol Violation|0|||
155605738|NCT01472939|561645735|FG003|Overall Study|Protocol Violation|1|||
155605739|NCT01472939|561645732|FG000|Overall Study|Withdrawal by Subject|9|||
155605740|NCT01472939|561645733|FG001|Overall Study|Withdrawal by Subject|3|||
155605741|NCT01472939|561645734|FG002|Overall Study|Withdrawal by Subject|1|||
155605742|NCT01472939|561645735|FG003|Overall Study|Withdrawal by Subject|4|||
155605743|NCT00114738|561645736|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
155688231|NCT02754141|561951596|FG005|Overall Study|Not completing monotherapy|0|||
155688232|NCT02754141|561951597|FG006|Overall Study|Not completing monotherapy|0|||
155688233|NCT02754141|561951598|FG007|Overall Study|Not completing monotherapy|0|||
155688234|NCT02754141|561951599|FG008|Overall Study|Not completing monotherapy|0|||
155688235|NCT02754141|561951600|FG009|Overall Study|Not completing monotherapy|0|||
155688236|NCT02754141|561951601|FG010|Overall Study|Not completing monotherapy|0|||
155688237|NCT02754141|561951602|FG011|Overall Study|Not completing monotherapy|0|||
155688238|NCT02754141|561951603|FG012|Overall Study|Not completing monotherapy|0|||
155688239|NCT02754141|561951604|FG013|Overall Study|Not completing monotherapy|1|||
155688240|NCT02754141|561951605|FG014|Overall Study|Not completing monotherapy|0|||
155688241|NCT02754141|561951606|FG015|Overall Study|Not completing monotherapy|0|||
155688242|NCT02754141|561951607|FG016|Overall Study|Not completing monotherapy|0|||
155688243|NCT02754141|561951608|FG017|Overall Study|Not completing monotherapy|0|||
155688244|NCT01187446|561951612|FG000|Overall Study|Patient started non-protocol therapy|0|||
155688245|NCT01187446|561951613|FG001|Overall Study|Patient started non-protocol therapy|1|||
155688246|NCT02838901|561951618|FG000|Overall Study|Withdrawal by Subject|1|||
155688247|NCT02838901|561951619|FG001|Overall Study|Withdrawal by Subject|1|||
155688248|NCT02838901|561951618|FG000|Overall Study|Lost to Follow-up|1|||
155688249|NCT02838901|561951619|FG001|Overall Study|Lost to Follow-up|1|||
155688250|NCT01007123|561951620|FG000|Overall Study|Adverse Event|3|||
155688251|NCT01007123|561951621|FG001|Overall Study|Adverse Event|4|||
155688252|NCT01007123|561951622|FG002|Overall Study|Adverse Event|7|||
155688253|NCT01007123|561951623|FG003|Overall Study|Adverse Event|1|||
155688254|NCT01007123|561951620|FG000|Overall Study|Lack of Efficacy|1|||
155688255|NCT01007123|561951621|FG001|Overall Study|Lack of Efficacy|0|||
155688256|NCT01007123|561951622|FG002|Overall Study|Lack of Efficacy|1|||
155688257|NCT01007123|561951623|FG003|Overall Study|Lack of Efficacy|4|||
155688258|NCT01007123|561951620|FG000|Overall Study|Protocol Violation|1|||
155688259|NCT01007123|561951621|FG001|Overall Study|Protocol Violation|1|||
155688260|NCT01007123|561951622|FG002|Overall Study|Protocol Violation|2|||
155688261|NCT01007123|561951623|FG003|Overall Study|Protocol Violation|1|||
155688262|NCT01007123|561951620|FG000|Overall Study|Withdrawal by Subject|1|||
155688263|NCT01007123|561951621|FG001|Overall Study|Withdrawal by Subject|0|||
155688264|NCT01007123|561951622|FG002|Overall Study|Withdrawal by Subject|1|||
155688265|NCT01007123|561951623|FG003|Overall Study|Withdrawal by Subject|0|||
155688266|NCT01007123|561951620|FG000|Overall Study|Lost to Follow-up|0|||
155688267|NCT01007123|561951621|FG001|Overall Study|Lost to Follow-up|1|||
155688268|NCT01007123|561951622|FG002|Overall Study|Lost to Follow-up|0|||
155688269|NCT01007123|561951623|FG003|Overall Study|Lost to Follow-up|0|||
155688270|NCT00823212|561951624|FG000|Overall Study|Death|8|||
155688271|NCT00823212|561951625|FG001|Overall Study|Death|10|||
155688272|NCT00823212|561951624|FG000|Overall Study|Withdrawal by Subject|6|||
155688273|NCT00823212|561951625|FG001|Overall Study|Withdrawal by Subject|1|||
155688274|NCT00823212|561951624|FG000|Overall Study|Incarcerated|0|||
155688275|NCT00823212|561951625|FG001|Overall Study|Incarcerated|1|||
155688276|NCT00823212|561951624|FG000|Overall Study|Missed 12-month visit|21|||
155688277|NCT00823212|561951625|FG001|Overall Study|Missed 12-month visit|21|||
155688278|NCT02285114|561951627|FG000|Main Phase|Investigator's Discretion|0|||
155688279|NCT02285114|561951628|FG001|Main Phase|Investigator's Discretion|2|||
155688280|NCT02285114|561951629|FG002|Main Phase|Investigator's Discretion|0|||
155688281|NCT02285114|561951630|FG003|Main Phase|Investigator's Discretion|0|||
155688282|NCT02285114|561951631|FG004|Main Phase|Investigator's Discretion|0|||
155688283|NCT02285114|561951632|FG005|Main Phase|Investigator's Discretion|0|||
155688284|NCT02285114|561951627|FG000|Main Phase|Enrolled but Never Treated|1|||
155688285|NCT02285114|561951628|FG001|Main Phase|Enrolled but Never Treated|0|||
155688286|NCT02285114|561951629|FG002|Main Phase|Enrolled but Never Treated|0|||
155688287|NCT02285114|561951630|FG003|Main Phase|Enrolled but Never Treated|0|||
155688288|NCT02285114|561951631|FG004|Main Phase|Enrolled but Never Treated|0|||
155688289|NCT02285114|561951632|FG005|Main Phase|Enrolled but Never Treated|0|||
155688290|NCT02285114|561951627|FG000|Main Phase|Withdrew Consent|0|||
155688291|NCT02285114|561951628|FG001|Main Phase|Withdrew Consent|0|||
155688292|NCT02285114|561951629|FG002|Main Phase|Withdrew Consent|1|||
155688293|NCT02285114|561951630|FG003|Main Phase|Withdrew Consent|0|||
155688294|NCT02285114|561951631|FG004|Main Phase|Withdrew Consent|0|||
155688295|NCT02285114|561951632|FG005|Main Phase|Withdrew Consent|0|||
155688296|NCT02285114|561951627|FG000|Extension Phase|Investigator's Discretion|0|||
155688297|NCT02285114|561951628|FG001|Extension Phase|Investigator's Discretion|0|||
155688298|NCT02285114|561951629|FG002|Extension Phase|Investigator's Discretion|0|||
155688299|NCT02285114|561951630|FG003|Extension Phase|Investigator's Discretion|14|||
155688300|NCT02285114|561951631|FG004|Extension Phase|Investigator's Discretion|1|||
155688301|NCT02285114|561951632|FG005|Extension Phase|Investigator's Discretion|0|||
155688302|NCT02285114|561951627|FG000|Extension Phase|Lost to Follow-up|0|||
155688303|NCT02285114|561951628|FG001|Extension Phase|Lost to Follow-up|0|||
155688304|NCT02285114|561951629|FG002|Extension Phase|Lost to Follow-up|0|||
155688305|NCT02285114|561951630|FG003|Extension Phase|Lost to Follow-up|1|||
155688306|NCT02285114|561951631|FG004|Extension Phase|Lost to Follow-up|1|||
155688307|NCT02285114|561951632|FG005|Extension Phase|Lost to Follow-up|0|||
155688308|NCT02285114|561951627|FG000|Extension Phase|Non-compliance with Study Drug|0|||
155688309|NCT02285114|561951628|FG001|Extension Phase|Non-compliance with Study Drug|0|||
155688310|NCT02285114|561951629|FG002|Extension Phase|Non-compliance with Study Drug|0|||
155688311|NCT02285114|561951630|FG003|Extension Phase|Non-compliance with Study Drug|2|||
155688312|NCT02285114|561951631|FG004|Extension Phase|Non-compliance with Study Drug|0|||
155688313|NCT02285114|561951632|FG005|Extension Phase|Non-compliance with Study Drug|0|||
155688314|NCT02285114|561951627|FG000|Extension Phase|Pregnancy|0|||
155688315|NCT02285114|561951628|FG001|Extension Phase|Pregnancy|0|||
155688316|NCT02285114|561951629|FG002|Extension Phase|Pregnancy|0|||
155688317|NCT02285114|561951630|FG003|Extension Phase|Pregnancy|1|||
155688318|NCT02285114|561951631|FG004|Extension Phase|Pregnancy|0|||
155688319|NCT02285114|561951632|FG005|Extension Phase|Pregnancy|0|||
155688320|NCT00320255|561951633|FG000|Overall Study|Lack of Efficacy|1|||
155688321|NCT00320255|561951634|FG001|Overall Study|Lack of Efficacy|0|||
155688322|NCT00320255|561951635|FG002|Overall Study|Lack of Efficacy|0|||
155688323|NCT00320255|561951636|FG003|Overall Study|Lack of Efficacy|0|||
155688324|NCT00320255|561951637|FG004|Overall Study|Lack of Efficacy|0|||
155688325|NCT00320255|561951638|FG005|Overall Study|Lack of Efficacy|0|||
155688326|NCT00320255|561951633|FG000|Overall Study|Adverse Event|5|||
155688327|NCT00320255|561951634|FG001|Overall Study|Adverse Event|2|||
155688328|NCT00320255|561951635|FG002|Overall Study|Adverse Event|3|||
155688329|NCT00320255|561951636|FG003|Overall Study|Adverse Event|2|||
155688330|NCT00320255|561951637|FG004|Overall Study|Adverse Event|0|||
155688331|NCT00320255|561951638|FG005|Overall Study|Adverse Event|0|||
155688332|NCT00320255|561951633|FG000|Overall Study|Withdrawal by Subject|1|||
155688333|NCT00320255|561951634|FG001|Overall Study|Withdrawal by Subject|2|||
155688334|NCT00320255|561951635|FG002|Overall Study|Withdrawal by Subject|2|||
155688335|NCT00320255|561951636|FG003|Overall Study|Withdrawal by Subject|4|||
155688336|NCT00320255|561951637|FG004|Overall Study|Withdrawal by Subject|0|||
155688337|NCT00320255|561951638|FG005|Overall Study|Withdrawal by Subject|0|||
155688338|NCT00320255|561951633|FG000|Overall Study|Poor compliance/noncompliance|1|||
155688339|NCT00320255|561951634|FG001|Overall Study|Poor compliance/noncompliance|1|||
155688340|NCT00320255|561951635|FG002|Overall Study|Poor compliance/noncompliance|0|||
155688341|NCT00320255|561951636|FG003|Overall Study|Poor compliance/noncompliance|1|||
155688342|NCT00320255|561951637|FG004|Overall Study|Poor compliance/noncompliance|0|||
155688343|NCT00320255|561951638|FG005|Overall Study|Poor compliance/noncompliance|0|||
155688344|NCT00320255|561951633|FG000|Overall Study|No longer meets study criteria|0|||
155688345|NCT00320255|561951634|FG001|Overall Study|No longer meets study criteria|0|||
155688346|NCT00320255|561951635|FG002|Overall Study|No longer meets study criteria|0|||
155688347|NCT00320255|561951636|FG003|Overall Study|No longer meets study criteria|1|||
155688348|NCT00320255|561951637|FG004|Overall Study|No longer meets study criteria|0|||
155688349|NCT00320255|561951638|FG005|Overall Study|No longer meets study criteria|0|||
155688350|NCT00320255|561951633|FG000|Overall Study|Other|3|||
155688351|NCT00320255|561951634|FG001|Overall Study|Other|2|||
155688352|NCT00320255|561951635|FG002|Overall Study|Other|1|||
155688353|NCT00320255|561951636|FG003|Overall Study|Other|0|||
155688354|NCT00320255|561951637|FG004|Overall Study|Other|0|||
155688355|NCT00320255|561951638|FG005|Overall Study|Other|0|||
155688356|NCT01156389|561951639|FG000|Overall Study|Elevated liver enzymes|4|||
155688357|NCT01156389|561951640|FG001|Overall Study|Elevated liver enzymes|0|||
155688358|NCT01156389|561951639|FG000|Overall Study|Vomiting|0|||
155688359|NCT01156389|561951640|FG001|Overall Study|Vomiting|1|||
155688360|NCT02351349|561951641|FG000|Overall Study|Withdrawal by Subject|2|||
155688361|NCT02351349|561951642|FG001|Overall Study|Withdrawal by Subject|3|||
155688362|NCT00350623|561951643|FG000|Overall Study|Lost to Follow-up|8|||
155688363|NCT00350623|561951644|FG001|Overall Study|Lost to Follow-up|3|||
155688364|NCT00350623|561951645|FG002|Overall Study|Lost to Follow-up|4|||
155688365|NCT00350623|561951643|FG000|Overall Study|Withdrawal by Subject|0|||
155688366|NCT00350623|561951644|FG001|Overall Study|Withdrawal by Subject|1|||
155688367|NCT00350623|561951645|FG002|Overall Study|Withdrawal by Subject|1|||
155688368|NCT00350623|561951643|FG000|Overall Study|patient traveling outside the country|0|||
155688369|NCT00350623|561951644|FG001|Overall Study|patient traveling outside the country|0|||
155688370|NCT00350623|561951645|FG002|Overall Study|patient traveling outside the country|1|||
155688371|NCT04126564|561951649|FG000|Overall Study|Withdrawal by Subject|0|||
155688372|NCT04126564|561951650|FG001|Overall Study|Withdrawal by Subject|2|||
155688373|NCT04126564|561951649|FG000|Overall Study|Lost to Follow-up|0|||
155688374|NCT04126564|561951650|FG001|Overall Study|Lost to Follow-up|1|||
155688375|NCT00090233|561951657|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
155688376|NCT00090233|561951658|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
155688377|NCT00090233|561951657|FG000|Overall Study|Adverse Event|214|||
155688378|NCT00090233|561951658|FG001|Overall Study|Adverse Event|198|||
155688379|NCT00090233|561951657|FG000|Overall Study|Lost to Follow-up|68|||
155688380|NCT00090233|561951658|FG001|Overall Study|Lost to Follow-up|95|||
155688381|NCT00090233|561951657|FG000|Overall Study|Protocol Violation|960|||
155688382|NCT00090233|561951658|FG001|Overall Study|Protocol Violation|1022|||
155688383|NCT00090233|561951657|FG000|Overall Study|Withdrawal by Subject|182|||
155688384|NCT00090233|561951658|FG001|Overall Study|Withdrawal by Subject|211|||
155688385|NCT00090233|561951657|FG000|Overall Study|Moved|203|||
155688386|NCT00090233|561951658|FG001|Overall Study|Moved|189|||
155688387|NCT00090233|561951657|FG000|Overall Study|Other|1211|||
155688388|NCT00090233|561951658|FG001|Overall Study|Other|1160|||
155688389|NCT00090233|561951657|FG000|Overall Study|Data not available at data cut-off point|1552|||
155688390|NCT00090233|561951658|FG001|Overall Study|Data not available at data cut-off point|1563|||
155688391|NCT04863248|561951659|FG000|Overall Study|Sponsor Terminated|4|||
155688392|NCT04863248|561951660|FG001|Overall Study|Sponsor Terminated|1|||
155688393|NCT04863248|561951659|FG000|Overall Study|Death|0|||
155688394|NCT04863248|561951660|FG001|Overall Study|Death|1|||
155688395|NCT04863248|561951659|FG000|Overall Study|Withdrawal by Subject|0|||
155688396|NCT04863248|561951660|FG001|Overall Study|Withdrawal by Subject|1|||
155688397|NCT01779869|561951661|FG000|Overall Study|Physician Decision|2|||
155688398|NCT02536300|561951664|FG000|Overall Study|Investigator's Discretion|17|||
155688399|NCT02536300|561951665|FG001|Overall Study|Investigator's Discretion|11|||
155688400|NCT02536300|561951666|FG002|Overall Study|Investigator's Discretion|2|||
155688401|NCT02536300|561951664|FG000|Overall Study|Progressive Disease|11|||
155605744|NCT00114738|561645737|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
155605745|NCT00114738|561645738|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
155605746|NCT00114738|561645736|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
155688402|NCT02536300|561951665|FG001|Overall Study|Progressive Disease|7|||
155688403|NCT02536300|561951666|FG002|Overall Study|Progressive Disease|6|||
155688404|NCT02536300|561951664|FG000|Overall Study|Study Terminated by Sponsor|6|||
155688405|NCT02536300|561951665|FG001|Overall Study|Study Terminated by Sponsor|4|||
155688406|NCT02536300|561951666|FG002|Overall Study|Study Terminated by Sponsor|7|||
155688407|NCT02536300|561951664|FG000|Overall Study|Death|7|||
155688408|NCT02536300|561951665|FG001|Overall Study|Death|0|||
155688409|NCT02536300|561951666|FG002|Overall Study|Death|5|||
155688410|NCT02536300|561951664|FG000|Overall Study|Withdrew Consent|4|||
155688411|NCT02536300|561951665|FG001|Overall Study|Withdrew Consent|2|||
155688412|NCT02536300|561951666|FG002|Overall Study|Withdrew Consent|0|||
155688413|NCT02536300|561951664|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
155688414|NCT02536300|561951665|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
155688415|NCT02536300|561951666|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
155688416|NCT02536300|561951664|FG000|Overall Study|Enrolled but Never Treated|0|||
155688417|NCT02536300|561951665|FG001|Overall Study|Enrolled but Never Treated|0|||
155688418|NCT02536300|561951666|FG002|Overall Study|Enrolled but Never Treated|1|||
155688419|NCT02536300|561951664|FG000|Overall Study|Non-compliance With Study Drug|1|||
155688420|NCT02536300|561951665|FG001|Overall Study|Non-compliance With Study Drug|0|||
155688421|NCT02536300|561951666|FG002|Overall Study|Non-compliance With Study Drug|0|||
155688422|NCT02536300|561951664|FG000|Overall Study|Protocol Violation|0|||
155605747|NCT00114738|561645737|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
155605748|NCT00114738|561645738|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
155605749|NCT00114738|561645736|FG000|Screening for Randomization|Neuropathy|17|||
155688423|NCT02536300|561951665|FG001|Overall Study|Protocol Violation|1|||
155688424|NCT02536300|561951666|FG002|Overall Study|Protocol Violation|0|||
155688425|NCT01691105|561951674|FG000|1 Month Follow-up|Lost to Follow-up|41|||
155688426|NCT01691105|561951675|FG001|1 Month Follow-up|Lost to Follow-up|38|||
155688427|NCT01691105|561951674|FG000|1 Month Follow-up|Death|2|||
155688428|NCT01691105|561951675|FG001|1 Month Follow-up|Death|3|||
155688429|NCT01691105|561951674|FG000|6 Month Follow-up|Lost to Follow-up|39|||
155688430|NCT01691105|561951675|FG001|6 Month Follow-up|Lost to Follow-up|58|||
155688431|NCT01691105|561951674|FG000|6 Month Follow-up|Death|13|||
155688432|NCT01691105|561951675|FG001|6 Month Follow-up|Death|13|||
155688433|NCT01691105|561951674|FG000|12 Month Follow-up|Lost to Follow-up|50|||
155688434|NCT01691105|561951675|FG001|12 Month Follow-up|Lost to Follow-up|71|||
155688435|NCT01691105|561951674|FG000|12 Month Follow-up|Death|22|||
155688436|NCT01691105|561951675|FG001|12 Month Follow-up|Death|30|||
155688437|NCT01691105|561951674|FG000|12 Month Biochemical Verification|Death|22|||
155688438|NCT01691105|561951675|FG001|12 Month Biochemical Verification|Death|30|||
155688439|NCT01691105|561951674|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
155688440|NCT01691105|561951675|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
155688441|NCT01691105|561951674|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
155688442|NCT01691105|561951675|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
155688443|NCT00957944|561951676|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
155688444|NCT00957944|561951677|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
155688445|NCT01777542|561951680|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
155688446|NCT01777542|561951681|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
155688447|NCT05605691|561951684|FG000|Overall Study|Lost to Follow-up|1|||
155688448|NCT02279719|561951685|FG000|Overall Study|Patients randomized but never treated|0|||
155688449|NCT02279719|561951686|FG001|Overall Study|Patients randomized but never treated|0|||
155688450|NCT02279719|561951687|FG002|Overall Study|Patients randomized but never treated|0|||
155688451|NCT02279719|561951688|FG003|Overall Study|Patients randomized but never treated|0|||
155688452|NCT02279719|561951689|FG004|Overall Study|Patients randomized but never treated|3|||
155688453|NCT02279719|561951690|FG005|Overall Study|Patients randomized but never treated|0|||
155688454|NCT02279719|561951691|FG006|Overall Study|Patients randomized but never treated|3|||
155688455|NCT04706273|561951692|FG000|Overall Study|Withdrawal by Subject|27|||
155688456|NCT04706273|561951692|FG000|Overall Study|Physician Decision|1|||
155688457|NCT04706273|561951692|FG000|Overall Study|Lost to Follow-up|42|||
155688458|NCT04706273|561951692|FG000|Overall Study|Death|85|||
155688459|NCT04706273|561951692|FG000|Overall Study|Amputation that removes study device|2|||
155688460|NCT04706273|561951692|FG000|Overall Study|Surgical bypass|3|||
155688461|NCT04706273|561951692|FG000|Overall Study|Changing hospital|23|||
155688462|NCT04706273|561951692|FG000|Overall Study|Unable to attend hospital|2|||
155688463|NCT00869050|561951695|FG000|Overall Study|Screen Failure|3|||
155688464|NCT03199053|561951698|FG000|ST Period|Withdrawal by Subject|2|||
155688465|NCT03199053|561951699|FG001|ST Period|Withdrawal by Subject|4|||
155688466|NCT03199053|561951700|FG002|ST Period|Withdrawal by Subject|6|||
155688467|NCT03199053|561951698|FG000|ST Period|Withdrawal by parent/guardian|1|||
155688468|NCT03199053|561951699|FG001|ST Period|Withdrawal by parent/guardian|1|||
155688469|NCT03199053|561951700|FG002|ST Period|Withdrawal by parent/guardian|1|||
155688470|NCT03199053|561951698|FG000|ST Period|Lost to Follow-up|2|||
155688471|NCT03199053|561951699|FG001|ST Period|Lost to Follow-up|0|||
155688472|NCT03199053|561951700|FG002|ST Period|Lost to Follow-up|1|||
155688473|NCT03199053|561951698|FG000|LT Period|Withdrawal by Subject|1|||
155688474|NCT03199053|561951699|FG001|LT Period|Withdrawal by Subject|3|||
155688475|NCT03199053|561951700|FG002|LT Period|Withdrawal by Subject|3|||
155688476|NCT03199053|561951698|FG000|LT Period|Withdrawal by parent/guardian|0|||
155688477|NCT03199053|561951699|FG001|LT Period|Withdrawal by parent/guardian|0|||
155688478|NCT03199053|561951700|FG002|LT Period|Withdrawal by parent/guardian|1|||
155688479|NCT03199053|561951698|FG000|LT Period|Lost to Follow-up|0|||
155688480|NCT03199053|561951699|FG001|LT Period|Lost to Follow-up|1|||
155688481|NCT03199053|561951700|FG002|LT Period|Lost to Follow-up|1|||
155688482|NCT03199053|561951698|FG000|LT Period|Miscellaneous|0|||
155688483|NCT03199053|561951699|FG001|LT Period|Miscellaneous|0|||
155688484|NCT03199053|561951700|FG002|LT Period|Miscellaneous|2|||
155688485|NCT03199053|561951698|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
155688486|NCT03199053|561951699|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
155688487|NCT03199053|561951700|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
155688488|NCT03199053|561951698|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
155688489|NCT03199053|561951699|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
155688490|NCT03199053|561951700|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
155688491|NCT03199053|561951698|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
155688492|NCT03199053|561951699|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
155688493|NCT03199053|561951700|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
155688494|NCT03199053|561951698|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
155688495|NCT03199053|561951699|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
155688496|NCT03199053|561951700|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
155688497|NCT00759356|561951701|FG000|Overall Study|Adverse Event|0|||
155688498|NCT00759356|561951702|FG001|Overall Study|Adverse Event|1|||
155688499|NCT00759356|561951701|FG000|Overall Study|Withdrawal by Subject|0|||
155688500|NCT00759356|561951702|FG001|Overall Study|Withdrawal by Subject|2|||
155688501|NCT00759356|561951701|FG000|Overall Study|Subject was unable to return|1|||
155688502|NCT00759356|561951702|FG001|Overall Study|Subject was unable to return|0|||
155688503|NCT03298984|561951707|FG000|Overall Study|Physician Decision|1|||
155688504|NCT03298984|561951708|FG001|Overall Study|Physician Decision|0|||
155688505|NCT03298984|561951709|FG002|Overall Study|Physician Decision|0|||
155688506|NCT03298984|561951710|FG003|Overall Study|Physician Decision|6|||
155688507|NCT03298984|561951707|FG000|Overall Study|Lack of Efficacy|0|||
155605750|NCT00114738|561645737|FG001|Screening for Randomization|Neuropathy|0|||
155605751|NCT00114738|561645738|FG002|Screening for Randomization|Neuropathy|0|||
155605752|NCT00114738|561645736|FG000|Screening for Randomization|Progressive disease|2|||
155605753|NCT00114738|561645737|FG001|Screening for Randomization|Progressive disease|0|||
155605754|NCT00114738|561645738|FG002|Screening for Randomization|Progressive disease|0|||
155605755|NCT00114738|561645736|FG000|Screening for Randomization|CNS Hemorrhage|1|||
155605756|NCT00114738|561645737|FG001|Screening for Randomization|CNS Hemorrhage|0|||
155605757|NCT00114738|561645738|FG002|Screening for Randomization|CNS Hemorrhage|0|||
155605758|NCT00114738|561645736|FG000|Screening for Randomization|Other|1|||
155605759|NCT00114738|561645737|FG001|Screening for Randomization|Other|0|||
155605760|NCT00114738|561645738|FG002|Screening for Randomization|Other|0|||
155605761|NCT00316914|561645739|FG000|Overall Study|Withdrawal by Subject|5|||
155605762|NCT00316914|561645740|FG001|Overall Study|Withdrawal by Subject|3|||
155605763|NCT00316914|561645739|FG000|Overall Study|Adverse Event|8|||
155605764|NCT00316914|561645740|FG001|Overall Study|Adverse Event|7|||
155605765|NCT00316914|561645739|FG000|Overall Study|Other Problems|6|||
155605766|NCT00316914|561645740|FG001|Overall Study|Other Problems|11|||
155605767|NCT00316914|561645739|FG000|Overall Study|Missing end of treatment documentation|14|||
155605768|NCT00316914|561645740|FG001|Overall Study|Missing end of treatment documentation|15|||
155605769|NCT01675154|561645741|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155605770|NCT01675154|561645742|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
155605771|NCT01675154|561645743|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155605772|NCT01675154|561645744|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155605773|NCT02971800|561645745|FG000|Overall Study|Protocol Violation|1|||
155605774|NCT02971800|561645745|FG000|Overall Study|Withdrawal by Subject|1|||
155605775|NCT02971800|561645745|FG000|Overall Study|Exclusion criteria prior intervention|1|||
155605776|NCT02971800|561645745|FG000|Overall Study|Number evaluable participant already reached|4|||
155605777|NCT00766467|561645746|FG000|Overall Study|Withdrawal by Subject|7|||
155605778|NCT00766467|561645747|FG001|Overall Study|Withdrawal by Subject|2|||
155605779|NCT00766467|561645746|FG000|Overall Study|Adverse Event|1|||
155605780|NCT00766467|561645747|FG001|Overall Study|Adverse Event|1|||
155605781|NCT00766467|561645746|FG000|Overall Study|Protocol Violation|2|||
155605782|NCT00766467|561645747|FG001|Overall Study|Protocol Violation|4|||
155605783|NCT00766467|561645746|FG000|Overall Study|Tumor Progression on Study|0|||
155605784|NCT00766467|561645747|FG001|Overall Study|Tumor Progression on Study|1|||
155605785|NCT00766467|561645746|FG000|Overall Study|Physician Decision|1|||
155605786|NCT00766467|561645747|FG001|Overall Study|Physician Decision|0|||
155605787|NCT02223819|561645748|FG000|Overall Study|Lost to Follow-up|2|||
155605788|NCT01917344|561645751|FG000|Overall Study|Withdrawal by Subject|1|||
155605789|NCT00943670|561645752|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
155605790|NCT00943670|561645752|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
155605791|NCT00943670|561645752|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
155605792|NCT00943670|561645752|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
155605793|NCT00943670|561645752|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
155605794|NCT00943670|561645752|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
155605795|NCT00943670|561645752|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
155605796|NCT00943670|561645752|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
155605797|NCT00943670|561645752|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
155605798|NCT00943670|561645752|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
155605799|NCT01777295|561645753|FG000|Overall Study|Withdrawal by Subject|2|||
155605800|NCT01777295|561645754|FG001|Overall Study|Withdrawal by Subject|2|||
155605801|NCT01777295|561645753|FG000|Overall Study|Pregnancy|0|||
155605802|NCT01777295|561645754|FG001|Overall Study|Pregnancy|1|||
155605803|NCT01777295|561645753|FG000|Overall Study|Personal problem|1|||
155605804|NCT01777295|561645754|FG001|Overall Study|Personal problem|0|||
155605805|NCT01777295|561645753|FG000|Overall Study|Investigator call for AEs check|1|||
155605806|NCT01777295|561645754|FG001|Overall Study|Investigator call for AEs check|0|||
155605807|NCT00426660|561645759|FG000|Overall Study|Death|14|||
155605808|NCT00426660|561645759|FG000|Overall Study|Adverse Event|23|||
155605809|NCT00426660|561645759|FG000|Overall Study|Insufficient Clinical Response|22|||
155605810|NCT00426660|561645759|FG000|Overall Study|Lost to Follow-up|15|||
155605811|NCT00426660|561645759|FG000|Overall Study|Other|23|||
155605812|NCT00426660|561645759|FG000|Overall Study|Withdrawal by Subject|18|||
155605813|NCT00426660|561645759|FG000|Overall Study|Protocol Violation|1|||
155605814|NCT00426660|561645759|FG000|Overall Study|Enrolled Not Treated|15|||
155605815|NCT00980174|561645760|FG000|Overall Study|Withdrawal by Subject|1|||
155605816|NCT00980174|561645761|FG001|Overall Study|Withdrawal by Subject|4|||
155605817|NCT00980174|561645760|FG000|Overall Study|Adverse Event|0|||
155605818|NCT00980174|561645761|FG001|Overall Study|Adverse Event|3|||
155605819|NCT00980174|561645760|FG000|Overall Study|Ineligibility determined|2|||
155605820|NCT00980174|561645761|FG001|Overall Study|Ineligibility determined|1|||
155605821|NCT00980174|561645760|FG000|Overall Study|Death|1|||
155605822|NCT00980174|561645761|FG001|Overall Study|Death|1|||
155605823|NCT00980174|561645760|FG000|Overall Study|Other|0|||
155605824|NCT00980174|561645761|FG001|Overall Study|Other|1|||
155605825|NCT01546038|561645762|FG000|Overall Study|Death|15|||
155605826|NCT01546038|561645763|FG001|Overall Study|Death|6|||
155605827|NCT01546038|561645764|FG002|Overall Study|Death|4|||
155605828|NCT01546038|561645765|FG003|Overall Study|Death|2|||
155605829|NCT01546038|561645766|FG004|Overall Study|Death|9|||
155605830|NCT01546038|561645767|FG005|Overall Study|Death|3|||
155605831|NCT01546038|561645768|FG006|Overall Study|Death|46|||
155605832|NCT01546038|561645769|FG007|Overall Study|Death|76|||
155605833|NCT01546038|561645770|FG008|Overall Study|Death|39|||
155605834|NCT01546038|561645762|FG000|Overall Study|Lost to Follow-up|0|||
155605835|NCT01546038|561645763|FG001|Overall Study|Lost to Follow-up|0|||
155605836|NCT01546038|561645764|FG002|Overall Study|Lost to Follow-up|0|||
155605837|NCT01546038|561645765|FG003|Overall Study|Lost to Follow-up|0|||
155605838|NCT01546038|561645766|FG004|Overall Study|Lost to Follow-up|1|||
155605839|NCT01546038|561645767|FG005|Overall Study|Lost to Follow-up|0|||
155605840|NCT01546038|561645768|FG006|Overall Study|Lost to Follow-up|2|||
155605841|NCT01546038|561645769|FG007|Overall Study|Lost to Follow-up|1|||
155688508|NCT03298984|561951708|FG001|Overall Study|Lack of Efficacy|1|||
155688509|NCT03298984|561951709|FG002|Overall Study|Lack of Efficacy|1|||
155688510|NCT03298984|561951710|FG003|Overall Study|Lack of Efficacy|4|||
155688511|NCT03298984|561951707|FG000|Overall Study|Relapsed disease (following remission)|0|||
155688512|NCT03298984|561951708|FG001|Overall Study|Relapsed disease (following remission)|0|||
155688513|NCT03298984|561951709|FG002|Overall Study|Relapsed disease (following remission)|1|||
155688514|NCT03298984|561951710|FG003|Overall Study|Relapsed disease (following remission)|1|||
155688515|NCT03298984|561951707|FG000|Overall Study|Adverse Event|0|||
155688516|NCT03298984|561951708|FG001|Overall Study|Adverse Event|0|||
155688517|NCT03298984|561951709|FG002|Overall Study|Adverse Event|0|||
155688518|NCT03298984|561951710|FG003|Overall Study|Adverse Event|1|||
155688519|NCT03298984|561951707|FG000|Overall Study|Death|0|||
155688520|NCT03298984|561951708|FG001|Overall Study|Death|0|||
155688521|NCT03298984|561951709|FG002|Overall Study|Death|0|||
155688522|NCT03298984|561951710|FG003|Overall Study|Death|2|||
155688523|NCT03298984|561951707|FG000|Overall Study|Insurance Company Decision|0|||
155688524|NCT03298984|561951708|FG001|Overall Study|Insurance Company Decision|0|||
155688525|NCT03298984|561951709|FG002|Overall Study|Insurance Company Decision|0|||
155688526|NCT03298984|561951710|FG003|Overall Study|Insurance Company Decision|1|||
155688527|NCT02509052|561951718|FG000|Overall Study|Non compliance|0|||
155688528|NCT02509052|561951719|FG001|Overall Study|Non compliance|0|||
155688529|NCT02509052|561951720|FG002|Overall Study|Non compliance|1|||
155688530|NCT01323270|561951721|FG000|Overall Study|Withdrawal by Subject|19|||
155688531|NCT01323270|561951722|FG001|Overall Study|Withdrawal by Subject|10|||
155688532|NCT01323270|561951721|FG000|Overall Study|Protocol Violation|9|||
155688533|NCT01323270|561951722|FG001|Overall Study|Protocol Violation|7|||
155688534|NCT01323270|561951721|FG000|Overall Study|Lost to Follow-up|4|||
155688535|NCT01323270|561951722|FG001|Overall Study|Lost to Follow-up|6|||
155688536|NCT01323270|561951721|FG000|Overall Study|Adverse Event|8|||
155688537|NCT01323270|561951722|FG001|Overall Study|Adverse Event|0|||
155688538|NCT01323270|561951721|FG000|Overall Study|Other|0|||
155688539|NCT01323270|561951722|FG001|Overall Study|Other|3|||
155688540|NCT01323270|561951721|FG000|Overall Study|Physician Decision|0|||
155688541|NCT01323270|561951722|FG001|Overall Study|Physician Decision|2|||
155688542|NCT01323270|561951721|FG000|Overall Study|Not eligible|1|||
155688543|NCT01323270|561951722|FG001|Overall Study|Not eligible|1|||
155688544|NCT01323270|561951721|FG000|Overall Study|Death|1|||
155688545|NCT01323270|561951722|FG001|Overall Study|Death|0|||
155688546|NCT01323270|561951721|FG000|Overall Study|Randomized, but not vaccinated|1|||
155688547|NCT01323270|561951722|FG001|Overall Study|Randomized, but not vaccinated|0|||
155688548|NCT00075725|561951723|FG000|Overall Study|Adverse Event|6|||
155688549|NCT00075725|561951724|FG001|Overall Study|Adverse Event|6|||
155688550|NCT00075725|561951725|FG002|Overall Study|Adverse Event|20|||
155688551|NCT00075725|561951726|FG003|Overall Study|Adverse Event|8|||
155688552|NCT00075725|561951727|FG004|Overall Study|Adverse Event|4|||
155688553|NCT00075725|561951728|FG005|Overall Study|Adverse Event|38|||
155688554|NCT00075725|561951729|FG006|Overall Study|Adverse Event|3|||
155688555|NCT00075725|561951730|FG007|Overall Study|Adverse Event|51|||
155688556|NCT00075725|561951731|FG008|Overall Study|Adverse Event|15|||
155688557|NCT00075725|561951732|FG009|Overall Study|Adverse Event|4|||
155688558|NCT00075725|561951733|FG010|Overall Study|Adverse Event|2|||
155688559|NCT00075725|561951734|FG011|Overall Study|Adverse Event|2|||
155688560|NCT00075725|561951723|FG000|Overall Study|Death|3|||
155688561|NCT00075725|561951724|FG001|Overall Study|Death|5|||
155688562|NCT00075725|561951725|FG002|Overall Study|Death|10|||
155688563|NCT00075725|561951726|FG003|Overall Study|Death|2|||
155688564|NCT00075725|561951727|FG004|Overall Study|Death|3|||
155688565|NCT00075725|561951728|FG005|Overall Study|Death|25|||
155688566|NCT00075725|561951729|FG006|Overall Study|Death|4|||
155688567|NCT00075725|561951730|FG007|Overall Study|Death|22|||
155688568|NCT00075725|561951731|FG008|Overall Study|Death|14|||
155688569|NCT00075725|561951732|FG009|Overall Study|Death|4|||
155688570|NCT00075725|561951733|FG010|Overall Study|Death|3|||
155688571|NCT00075725|561951734|FG011|Overall Study|Death|0|||
155688572|NCT00075725|561951723|FG000|Overall Study|Lost to Follow-up|1|||
155688573|NCT00075725|561951724|FG001|Overall Study|Lost to Follow-up|1|||
155688574|NCT00075725|561951725|FG002|Overall Study|Lost to Follow-up|4|||
155688575|NCT00075725|561951726|FG003|Overall Study|Lost to Follow-up|1|||
155688576|NCT00075725|561951727|FG004|Overall Study|Lost to Follow-up|0|||
155688577|NCT00075725|561951728|FG005|Overall Study|Lost to Follow-up|13|||
155688578|NCT00075725|561951729|FG006|Overall Study|Lost to Follow-up|2|||
155688579|NCT00075725|561951730|FG007|Overall Study|Lost to Follow-up|4|||
155688580|NCT00075725|561951731|FG008|Overall Study|Lost to Follow-up|1|||
155688581|NCT00075725|561951732|FG009|Overall Study|Lost to Follow-up|0|||
155688582|NCT00075725|561951733|FG010|Overall Study|Lost to Follow-up|0|||
155688583|NCT00075725|561951734|FG011|Overall Study|Lost to Follow-up|0|||
155688584|NCT00075725|561951723|FG000|Overall Study|Physician Decision|2|||
155688585|NCT00075725|561951724|FG001|Overall Study|Physician Decision|6|||
155688586|NCT00075725|561951725|FG002|Overall Study|Physician Decision|5|||
155688587|NCT00075725|561951726|FG003|Overall Study|Physician Decision|8|||
155688588|NCT00075725|561951727|FG004|Overall Study|Physician Decision|4|||
155688589|NCT00075725|561951728|FG005|Overall Study|Physician Decision|19|||
155688590|NCT00075725|561951729|FG006|Overall Study|Physician Decision|3|||
155688591|NCT00075725|561951730|FG007|Overall Study|Physician Decision|17|||
155688592|NCT00075725|561951731|FG008|Overall Study|Physician Decision|5|||
155688593|NCT00075725|561951732|FG009|Overall Study|Physician Decision|0|||
155688594|NCT00075725|561951733|FG010|Overall Study|Physician Decision|1|||
155605842|NCT01546038|561645770|FG008|Overall Study|Lost to Follow-up|0|||
155605843|NCT01546038|561645762|FG000|Overall Study|Withdrawal by Subject|1|||
155605844|NCT01546038|561645763|FG001|Overall Study|Withdrawal by Subject|0|||
155605845|NCT01546038|561645764|FG002|Overall Study|Withdrawal by Subject|0|||
155605846|NCT01546038|561645765|FG003|Overall Study|Withdrawal by Subject|1|||
155605847|NCT01546038|561645766|FG004|Overall Study|Withdrawal by Subject|0|||
155605848|NCT01546038|561645767|FG005|Overall Study|Withdrawal by Subject|1|||
155605849|NCT01546038|561645768|FG006|Overall Study|Withdrawal by Subject|3|||
155605850|NCT01546038|561645769|FG007|Overall Study|Withdrawal by Subject|3|||
155605851|NCT01546038|561645770|FG008|Overall Study|Withdrawal by Subject|1|||
155605852|NCT01546038|561645762|FG000|Overall Study|: Randomized, not treated|0|||
155605853|NCT01546038|561645763|FG001|Overall Study|: Randomized, not treated|0|||
155605854|NCT01546038|561645764|FG002|Overall Study|: Randomized, not treated|0|||
155605855|NCT01546038|561645765|FG003|Overall Study|: Randomized, not treated|0|||
155605856|NCT01546038|561645766|FG004|Overall Study|: Randomized, not treated|0|||
155605857|NCT01546038|561645767|FG005|Overall Study|: Randomized, not treated|0|||
155605858|NCT01546038|561645768|FG006|Overall Study|: Randomized, not treated|2|||
155605859|NCT01546038|561645769|FG007|Overall Study|: Randomized, not treated|4|||
155605860|NCT01546038|561645770|FG008|Overall Study|: Randomized, not treated|3|||
155605861|NCT01398410|561645771|FG000|Overall Study|Adverse Event|12|||
155605862|NCT01398410|561645772|FG001|Overall Study|Adverse Event|16|||
155605863|NCT01398410|561645771|FG000|Overall Study|Participants Choice|8|||
155605864|NCT01398410|561645772|FG001|Overall Study|Participants Choice|11|||
155605865|NCT01398410|561645771|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
155605866|NCT01398410|561645772|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
155605867|NCT01398410|561645771|FG000|Overall Study|Other|36|||
155605868|NCT01398410|561645772|FG001|Overall Study|Other|29|||
155605869|NCT04245202|561645773|FG000|Overall Study|Lack of Efficacy|10|||
155605870|NCT04245202|561645774|FG001|Overall Study|Lack of Efficacy|1|||
155605871|NCT00717275|561645775|FG000|Overall Study|Premature study termination.|3|||
155605872|NCT03329248|561645776|FG000|Overall Study|Progressive Disease|6|||
155605873|NCT01522235|561645777|FG000|Overall Study|Physician Decision|1|||
155605874|NCT01522235|561645778|FG001|Overall Study|Physician Decision|1|||
155605875|NCT03769194|561645779|FG000|Overall Study|Withdrawal by Subject|0|||
155605876|NCT03769194|561645780|FG001|Overall Study|Withdrawal by Subject|7|||
155605877|NCT03769194|561645781|FG002|Overall Study|Withdrawal by Subject|4|||
155605878|NCT03769194|561645782|FG003|Overall Study|Withdrawal by Subject|1|||
155605879|NCT03769194|561645779|FG000|Overall Study|moved from study area|0|||
155605880|NCT03769194|561645780|FG001|Overall Study|moved from study area|2|||
155605881|NCT03769194|561645781|FG002|Overall Study|moved from study area|1|||
155605882|NCT03769194|561645782|FG003|Overall Study|moved from study area|1|||
155605883|NCT03769194|561645779|FG000|Overall Study|Lost to Follow-up|3|||
155605884|NCT03769194|561645780|FG001|Overall Study|Lost to Follow-up|6|||
155605885|NCT03769194|561645781|FG002|Overall Study|Lost to Follow-up|3|||
155605886|NCT03769194|561645782|FG003|Overall Study|Lost to Follow-up|6|||
155605887|NCT03769194|561645779|FG000|Overall Study|other|1|||
155605888|NCT03769194|561645780|FG001|Overall Study|other|3|||
155605889|NCT03769194|561645781|FG002|Overall Study|other|0|||
155605890|NCT03769194|561645782|FG003|Overall Study|other|1|||
155605891|NCT03000530|561645783|FG000|Overall Study|Adverse Event|0|||
155605892|NCT03000530|561645784|FG001|Overall Study|Adverse Event|0|||
155605893|NCT03000530|561645785|FG002|Overall Study|Adverse Event|2|||
155605894|NCT03000530|561645783|FG000|Overall Study|Lost to Follow-up|0|||
155605895|NCT03000530|561645784|FG001|Overall Study|Lost to Follow-up|3|||
155605896|NCT03000530|561645785|FG002|Overall Study|Lost to Follow-up|1|||
155605897|NCT03000530|561645783|FG000|Overall Study|Withdrawal by Subject|0|||
155605898|NCT03000530|561645784|FG001|Overall Study|Withdrawal by Subject|2|||
155605899|NCT03000530|561645785|FG002|Overall Study|Withdrawal by Subject|1|||
155605900|NCT01430624|561645791|FG000|Overall Study|Lost to Follow-up|23|||
155605901|NCT01430624|561645792|FG001|Overall Study|Lost to Follow-up|29|||
155605902|NCT01430624|561645793|FG002|Overall Study|Lost to Follow-up|27|||
155605903|NCT01430624|561645791|FG000|Overall Study|technical or eligibility|5|||
155605904|NCT01430624|561645792|FG001|Overall Study|technical or eligibility|5|||
155605905|NCT01430624|561645793|FG002|Overall Study|technical or eligibility|2|||
155605906|NCT01133288|561645794|FG000|Eligibility Assessment|met exclusion criteria|5|||
155605907|NCT01133288|561645794|FG000|Intervention Allocation|study terminated|2|||
155605908|NCT02565706|561645799|FG000|Overall Study|Withdrawal by Subject|5|||
155688595|NCT00075725|561951734|FG011|Overall Study|Physician Decision|0|||
155688596|NCT00075725|561951723|FG000|Overall Study|Pregnancy|0|||
155688597|NCT00075725|561951724|FG001|Overall Study|Pregnancy|0|||
155688598|NCT00075725|561951725|FG002|Overall Study|Pregnancy|0|||
155688599|NCT00075725|561951726|FG003|Overall Study|Pregnancy|0|||
155688600|NCT00075725|561951727|FG004|Overall Study|Pregnancy|0|||
155688601|NCT00075725|561951728|FG005|Overall Study|Pregnancy|1|||
155688602|NCT00075725|561951729|FG006|Overall Study|Pregnancy|0|||
155688603|NCT00075725|561951730|FG007|Overall Study|Pregnancy|1|||
155688604|NCT00075725|561951731|FG008|Overall Study|Pregnancy|0|||
155688605|NCT00075725|561951732|FG009|Overall Study|Pregnancy|0|||
155688606|NCT00075725|561951733|FG010|Overall Study|Pregnancy|0|||
155688607|NCT00075725|561951734|FG011|Overall Study|Pregnancy|0|||
155688608|NCT00075725|561951723|FG000|Overall Study|Protocol Violation|1|||
155688609|NCT00075725|561951724|FG001|Overall Study|Protocol Violation|1|||
155688610|NCT00075725|561951725|FG002|Overall Study|Protocol Violation|0|||
155688611|NCT00075725|561951726|FG003|Overall Study|Protocol Violation|3|||
155688612|NCT00075725|561951727|FG004|Overall Study|Protocol Violation|3|||
155688613|NCT00075725|561951728|FG005|Overall Study|Protocol Violation|2|||
155688614|NCT00075725|561951729|FG006|Overall Study|Protocol Violation|1|||
155688615|NCT00075725|561951730|FG007|Overall Study|Protocol Violation|2|||
155688616|NCT00075725|561951731|FG008|Overall Study|Protocol Violation|3|||
155688617|NCT00075725|561951732|FG009|Overall Study|Protocol Violation|0|||
155688618|NCT00075725|561951733|FG010|Overall Study|Protocol Violation|0|||
155688619|NCT00075725|561951734|FG011|Overall Study|Protocol Violation|1|||
155688620|NCT00075725|561951723|FG000|Overall Study|Withdrawal by Subject|12|||
155688621|NCT00075725|561951724|FG001|Overall Study|Withdrawal by Subject|3|||
155688622|NCT00075725|561951725|FG002|Overall Study|Withdrawal by Subject|6|||
155688623|NCT00075725|561951726|FG003|Overall Study|Withdrawal by Subject|10|||
155688624|NCT00075725|561951727|FG004|Overall Study|Withdrawal by Subject|6|||
155688625|NCT00075725|561951728|FG005|Overall Study|Withdrawal by Subject|27|||
155688626|NCT00075725|561951729|FG006|Overall Study|Withdrawal by Subject|7|||
155688627|NCT00075725|561951730|FG007|Overall Study|Withdrawal by Subject|31|||
155688628|NCT00075725|561951731|FG008|Overall Study|Withdrawal by Subject|10|||
155688629|NCT00075725|561951732|FG009|Overall Study|Withdrawal by Subject|2|||
155688630|NCT00075725|561951733|FG010|Overall Study|Withdrawal by Subject|0|||
155688631|NCT00075725|561951734|FG011|Overall Study|Withdrawal by Subject|0|||
155688632|NCT00075725|561951723|FG000|Overall Study|Disease Progression, all other reasons|17|||
155688633|NCT00075725|561951724|FG001|Overall Study|Disease Progression, all other reasons|5|||
155688634|NCT00075725|561951725|FG002|Overall Study|Disease Progression, all other reasons|33|||
155688635|NCT00075725|561951726|FG003|Overall Study|Disease Progression, all other reasons|6|||
155688636|NCT00075725|561951727|FG004|Overall Study|Disease Progression, all other reasons|21|||
155688637|NCT00075725|561951728|FG005|Overall Study|Disease Progression, all other reasons|59|||
155688638|NCT00075725|561951729|FG006|Overall Study|Disease Progression, all other reasons|20|||
155688639|NCT00075725|561951730|FG007|Overall Study|Disease Progression, all other reasons|46|||
155688640|NCT00075725|561951731|FG008|Overall Study|Disease Progression, all other reasons|21|||
155688641|NCT00075725|561951732|FG009|Overall Study|Disease Progression, all other reasons|4|||
155688642|NCT00075725|561951733|FG010|Overall Study|Disease Progression, all other reasons|0|||
155688643|NCT00075725|561951734|FG011|Overall Study|Disease Progression, all other reasons|5|||
155688644|NCT00075725|561951723|FG000|Overall Study|Patient off treatment|0|||
155688645|NCT00075725|561951724|FG001|Overall Study|Patient off treatment|0|||
155688646|NCT00075725|561951725|FG002|Overall Study|Patient off treatment|1|||
155688647|NCT00075725|561951726|FG003|Overall Study|Patient off treatment|2|||
155688648|NCT00075725|561951727|FG004|Overall Study|Patient off treatment|1|||
155688649|NCT00075725|561951728|FG005|Overall Study|Patient off treatment|0|||
155688650|NCT00075725|561951729|FG006|Overall Study|Patient off treatment|0|||
155688651|NCT00075725|561951730|FG007|Overall Study|Patient off treatment|2|||
155688652|NCT00075725|561951731|FG008|Overall Study|Patient off treatment|1|||
155688653|NCT00075725|561951732|FG009|Overall Study|Patient off treatment|0|||
155688654|NCT00075725|561951733|FG010|Overall Study|Patient off treatment|0|||
155688655|NCT00075725|561951734|FG011|Overall Study|Patient off treatment|0|||
155688656|NCT00075725|561951723|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
155688657|NCT00075725|561951724|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
155688658|NCT00075725|561951725|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
155688659|NCT00075725|561951726|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
155688660|NCT00075725|561951727|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
155688661|NCT00075725|561951728|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
155688662|NCT00075725|561951729|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
155688663|NCT00075725|561951730|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
155688664|NCT00075725|561951731|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
155688665|NCT00075725|561951732|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
155688666|NCT00075725|561951733|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
155688667|NCT00075725|561951734|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
155688668|NCT00075725|561951723|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
155688669|NCT00075725|561951724|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
155688670|NCT00075725|561951725|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
155688671|NCT00075725|561951726|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
155688672|NCT00075725|561951727|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
155688673|NCT00075725|561951728|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
155688674|NCT00075725|561951729|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
155688675|NCT00075725|561951730|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
155688676|NCT00075725|561951731|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
155688677|NCT00075725|561951732|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
155688678|NCT00075725|561951733|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
155688679|NCT00075725|561951734|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
155688680|NCT00075725|561951723|FG000|Overall Study|Pt non compliant with therapy|2|||
155688681|NCT00075725|561951724|FG001|Overall Study|Pt non compliant with therapy|1|||
155688682|NCT00075725|561951725|FG002|Overall Study|Pt non compliant with therapy|1|||
155688683|NCT00075725|561951726|FG003|Overall Study|Pt non compliant with therapy|0|||
155688684|NCT00075725|561951727|FG004|Overall Study|Pt non compliant with therapy|2|||
155688685|NCT00075725|561951728|FG005|Overall Study|Pt non compliant with therapy|14|||
155688686|NCT00075725|561951729|FG006|Overall Study|Pt non compliant with therapy|2|||
155688687|NCT00075725|561951730|FG007|Overall Study|Pt non compliant with therapy|5|||
155688688|NCT00075725|561951731|FG008|Overall Study|Pt non compliant with therapy|3|||
155688689|NCT00075725|561951732|FG009|Overall Study|Pt non compliant with therapy|0|||
155688690|NCT00075725|561951733|FG010|Overall Study|Pt non compliant with therapy|0|||
155688691|NCT00075725|561951734|FG011|Overall Study|Pt non compliant with therapy|0|||
155688692|NCT00075725|561951723|FG000|Overall Study|Pt age out of range for treatment|0|||
155688693|NCT00075725|561951724|FG001|Overall Study|Pt age out of range for treatment|1|||
155688694|NCT00075725|561951725|FG002|Overall Study|Pt age out of range for treatment|0|||
155688695|NCT00075725|561951726|FG003|Overall Study|Pt age out of range for treatment|0|||
155688696|NCT00075725|561951727|FG004|Overall Study|Pt age out of range for treatment|0|||
155688697|NCT00075725|561951728|FG005|Overall Study|Pt age out of range for treatment|1|||
155688698|NCT00075725|561951729|FG006|Overall Study|Pt age out of range for treatment|0|||
155688699|NCT00075725|561951730|FG007|Overall Study|Pt age out of range for treatment|1|||
155688700|NCT00075725|561951731|FG008|Overall Study|Pt age out of range for treatment|0|||
155688701|NCT00075725|561951732|FG009|Overall Study|Pt age out of range for treatment|0|||
155688702|NCT00075725|561951733|FG010|Overall Study|Pt age out of range for treatment|0|||
155688703|NCT00075725|561951734|FG011|Overall Study|Pt age out of range for treatment|0|||
155688704|NCT00075725|561951723|FG000|Overall Study|Insurance issues|0|||
155688705|NCT00075725|561951724|FG001|Overall Study|Insurance issues|1|||
155688706|NCT00075725|561951725|FG002|Overall Study|Insurance issues|0|||
155688707|NCT00075725|561951726|FG003|Overall Study|Insurance issues|1|||
155688708|NCT00075725|561951727|FG004|Overall Study|Insurance issues|1|||
155688709|NCT00075725|561951728|FG005|Overall Study|Insurance issues|1|||
155688710|NCT00075725|561951729|FG006|Overall Study|Insurance issues|0|||
155688711|NCT00075725|561951730|FG007|Overall Study|Insurance issues|1|||
155688712|NCT00075725|561951731|FG008|Overall Study|Insurance issues|0|||
155688713|NCT00075725|561951732|FG009|Overall Study|Insurance issues|0|||
155688714|NCT00075725|561951733|FG010|Overall Study|Insurance issues|0|||
155688715|NCT00075725|561951734|FG011|Overall Study|Insurance issues|0|||
155688716|NCT00075725|561951723|FG000|Overall Study|MRD positive after extended ind|0|||
155688717|NCT00075725|561951724|FG001|Overall Study|MRD positive after extended ind|1|||
155688718|NCT00075725|561951725|FG002|Overall Study|MRD positive after extended ind|1|||
155688719|NCT00075725|561951726|FG003|Overall Study|MRD positive after extended ind|0|||
155688720|NCT00075725|561951727|FG004|Overall Study|MRD positive after extended ind|1|||
155688721|NCT00075725|561951728|FG005|Overall Study|MRD positive after extended ind|2|||
155688722|NCT00075725|561951729|FG006|Overall Study|MRD positive after extended ind|0|||
155688723|NCT00075725|561951730|FG007|Overall Study|MRD positive after extended ind|1|||
155688724|NCT00075725|561951731|FG008|Overall Study|MRD positive after extended ind|0|||
155688725|NCT00075725|561951732|FG009|Overall Study|MRD positive after extended ind|0|||
155688726|NCT00075725|561951733|FG010|Overall Study|MRD positive after extended ind|0|||
155688727|NCT00075725|561951734|FG011|Overall Study|MRD positive after extended ind|0|||
155688728|NCT00075725|561951723|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
155688729|NCT00075725|561951724|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
155605909|NCT02565706|561645800|FG001|Overall Study|Withdrawal by Subject|7|||
155605910|NCT02565706|561645801|FG002|Overall Study|Withdrawal by Subject|7|||
155605911|NCT02565706|561645802|FG003|Overall Study|Withdrawal by Subject|11|||
155605912|NCT02565706|561645799|FG000|Overall Study|Lost to Follow-up|72|||
155605913|NCT02565706|561645800|FG001|Overall Study|Lost to Follow-up|75|||
155605914|NCT02565706|561645801|FG002|Overall Study|Lost to Follow-up|82|||
155605915|NCT02565706|561645802|FG003|Overall Study|Lost to Follow-up|74|||
155605916|NCT01672294|561645804|FG000|Overall Study|Withdrawal by Subject|4|||
155605917|NCT01672294|561645805|FG001|Overall Study|Withdrawal by Subject|4|||
155688730|NCT00075725|561951725|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
155688731|NCT00075725|561951726|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
155688732|NCT00075725|561951727|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
155688733|NCT00075725|561951728|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
155688734|NCT00075725|561951729|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
155688735|NCT00075725|561951730|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
155688736|NCT00075725|561951731|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
155688737|NCT00075725|561951732|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
155688738|NCT00075725|561951733|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
155688739|NCT00075725|561951734|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
155688740|NCT00075725|561951723|FG000|Overall Study|Inevaluable|1|||
155688741|NCT00075725|561951724|FG001|Overall Study|Inevaluable|1|||
155688742|NCT00075725|561951725|FG002|Overall Study|Inevaluable|4|||
155688743|NCT00075725|561951726|FG003|Overall Study|Inevaluable|2|||
155688744|NCT00075725|561951727|FG004|Overall Study|Inevaluable|2|||
155688745|NCT00075725|561951728|FG005|Overall Study|Inevaluable|9|||
155688746|NCT00075725|561951729|FG006|Overall Study|Inevaluable|1|||
155688747|NCT00075725|561951730|FG007|Overall Study|Inevaluable|11|||
155688748|NCT00075725|561951731|FG008|Overall Study|Inevaluable|2|||
155688749|NCT00075725|561951732|FG009|Overall Study|Inevaluable|0|||
155688750|NCT00075725|561951733|FG010|Overall Study|Inevaluable|1|||
155688751|NCT00075725|561951734|FG011|Overall Study|Inevaluable|0|||
155688752|NCT00075725|561951723|FG000|Overall Study|Other|4|||
155688753|NCT00075725|561951724|FG001|Overall Study|Other|2|||
155688754|NCT00075725|561951725|FG002|Overall Study|Other|1|||
155688755|NCT00075725|561951726|FG003|Overall Study|Other|1|||
155688756|NCT00075725|561951727|FG004|Overall Study|Other|1|||
155688757|NCT00075725|561951728|FG005|Overall Study|Other|4|||
155688758|NCT00075725|561951729|FG006|Overall Study|Other|2|||
155688759|NCT00075725|561951730|FG007|Overall Study|Other|9|||
155688760|NCT00075725|561951731|FG008|Overall Study|Other|2|||
155688761|NCT00075725|561951732|FG009|Overall Study|Other|1|||
155688762|NCT00075725|561951733|FG010|Overall Study|Other|0|||
155688763|NCT00075725|561951734|FG011|Overall Study|Other|3|||
155688764|NCT00075725|561951723|FG000|Overall Study|Pt trying to find a BM donor|0|||
155688765|NCT00075725|561951724|FG001|Overall Study|Pt trying to find a BM donor|1|||
155688766|NCT00075725|561951725|FG002|Overall Study|Pt trying to find a BM donor|0|||
155688767|NCT00075725|561951726|FG003|Overall Study|Pt trying to find a BM donor|0|||
155688768|NCT00075725|561951727|FG004|Overall Study|Pt trying to find a BM donor|0|||
155688769|NCT00075725|561951728|FG005|Overall Study|Pt trying to find a BM donor|0|||
155688770|NCT00075725|561951729|FG006|Overall Study|Pt trying to find a BM donor|0|||
155688771|NCT00075725|561951730|FG007|Overall Study|Pt trying to find a BM donor|0|||
155688772|NCT00075725|561951731|FG008|Overall Study|Pt trying to find a BM donor|0|||
155688773|NCT00075725|561951732|FG009|Overall Study|Pt trying to find a BM donor|0|||
155688774|NCT00075725|561951733|FG010|Overall Study|Pt trying to find a BM donor|0|||
155688775|NCT00075725|561951734|FG011|Overall Study|Pt trying to find a BM donor|0|||
155688776|NCT00075725|561951723|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
155688777|NCT00075725|561951724|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
155688778|NCT00075725|561951725|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
155688779|NCT00075725|561951726|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
155688780|NCT00075725|561951727|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
155688781|NCT00075725|561951728|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
155688782|NCT00075725|561951729|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
155688783|NCT00075725|561951730|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
155688784|NCT00075725|561951731|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
155688785|NCT00075725|561951732|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
155688786|NCT00075725|561951733|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
155688787|NCT00075725|561951734|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
155688788|NCT00075725|561951723|FG000|Overall Study|Unsuccessful institutional transfer|0|||
155688789|NCT00075725|561951724|FG001|Overall Study|Unsuccessful institutional transfer|0|||
155688790|NCT00075725|561951725|FG002|Overall Study|Unsuccessful institutional transfer|2|||
155688791|NCT00075725|561951726|FG003|Overall Study|Unsuccessful institutional transfer|0|||
155605918|NCT01672294|561645806|FG002|Overall Study|Withdrawal by Subject|4|||
155605919|NCT01672294|561645807|FG003|Overall Study|Withdrawal by Subject|4|||
155605920|NCT01672294|561645804|FG000|Overall Study|Excluded by study|1|||
155605921|NCT01672294|561645805|FG001|Overall Study|Excluded by study|1|||
155605922|NCT01672294|561645806|FG002|Overall Study|Excluded by study|0|||
155605923|NCT01672294|561645807|FG003|Overall Study|Excluded by study|0|||
155605924|NCT01672294|561645804|FG000|Overall Study|Lost to Follow-up|1|||
155605925|NCT01672294|561645805|FG001|Overall Study|Lost to Follow-up|16|||
155605926|NCT01672294|561645806|FG002|Overall Study|Lost to Follow-up|7|||
155605927|NCT01672294|561645807|FG003|Overall Study|Lost to Follow-up|9|||
155605928|NCT03379792|561645808|FG000|Overall Study|Physician Decision|0|||
155605929|NCT03379792|561645809|FG001|Overall Study|Physician Decision|0|||
155605930|NCT03379792|561645810|FG002|Overall Study|Physician Decision|0|||
155605931|NCT03379792|561645811|FG003|Overall Study|Physician Decision|1|||
155605932|NCT03379792|561645812|FG004|Overall Study|Physician Decision|0|||
155605933|NCT03379792|561645813|FG005|Overall Study|Physician Decision|0|||
155605934|NCT03379792|561645808|FG000|Overall Study|Withdrawal by Subject|0|||
155605935|NCT03379792|561645809|FG001|Overall Study|Withdrawal by Subject|0|||
155605936|NCT03379792|561645810|FG002|Overall Study|Withdrawal by Subject|0|||
155605937|NCT03379792|561645811|FG003|Overall Study|Withdrawal by Subject|0|||
155605938|NCT03379792|561645812|FG004|Overall Study|Withdrawal by Subject|1|||
155605939|NCT03379792|561645813|FG005|Overall Study|Withdrawal by Subject|1|||
155605940|NCT01285492|561645814|FG000|Overall Study|Adverse Event|11|||
155605941|NCT01285492|561645815|FG001|Overall Study|Adverse Event|0|||
155605942|NCT01285492|561645814|FG000|Overall Study|Protocol Violation|3|||
155605943|NCT01285492|561645815|FG001|Overall Study|Protocol Violation|0|||
155605944|NCT01285492|561645814|FG000|Overall Study|Withdrawal by Subject|2|||
155688792|NCT00075725|561951727|FG004|Overall Study|Unsuccessful institutional transfer|0|||
155688793|NCT00075725|561951728|FG005|Overall Study|Unsuccessful institutional transfer|0|||
155688794|NCT00075725|561951729|FG006|Overall Study|Unsuccessful institutional transfer|0|||
155688795|NCT00075725|561951730|FG007|Overall Study|Unsuccessful institutional transfer|0|||
155688796|NCT00075725|561951731|FG008|Overall Study|Unsuccessful institutional transfer|0|||
155688797|NCT00075725|561951732|FG009|Overall Study|Unsuccessful institutional transfer|1|||
155688798|NCT00075725|561951733|FG010|Overall Study|Unsuccessful institutional transfer|0|||
155688799|NCT00075725|561951734|FG011|Overall Study|Unsuccessful institutional transfer|0|||
155688800|NCT00075725|561951723|FG000|Overall Study|specimen(s) not submitted|0|||
155688801|NCT00075725|561951724|FG001|Overall Study|specimen(s) not submitted|0|||
155688802|NCT00075725|561951725|FG002|Overall Study|specimen(s) not submitted|2|||
155688803|NCT00075725|561951726|FG003|Overall Study|specimen(s) not submitted|0|||
155688804|NCT00075725|561951727|FG004|Overall Study|specimen(s) not submitted|0|||
155688805|NCT00075725|561951728|FG005|Overall Study|specimen(s) not submitted|0|||
155688806|NCT00075725|561951729|FG006|Overall Study|specimen(s) not submitted|0|||
155688807|NCT00075725|561951730|FG007|Overall Study|specimen(s) not submitted|0|||
155688808|NCT00075725|561951731|FG008|Overall Study|specimen(s) not submitted|0|||
155688809|NCT00075725|561951732|FG009|Overall Study|specimen(s) not submitted|0|||
155688810|NCT00075725|561951733|FG010|Overall Study|specimen(s) not submitted|0|||
155688811|NCT00075725|561951734|FG011|Overall Study|specimen(s) not submitted|0|||
155688812|NCT00075725|561951723|FG000|Overall Study|Pt went to transplant|0|||
155688813|NCT00075725|561951724|FG001|Overall Study|Pt went to transplant|0|||
155688814|NCT00075725|561951725|FG002|Overall Study|Pt went to transplant|0|||
155688815|NCT00075725|561951726|FG003|Overall Study|Pt went to transplant|1|||
155688816|NCT00075725|561951727|FG004|Overall Study|Pt went to transplant|0|||
155688817|NCT00075725|561951728|FG005|Overall Study|Pt went to transplant|1|||
155688818|NCT00075725|561951729|FG006|Overall Study|Pt went to transplant|0|||
155688819|NCT00075725|561951730|FG007|Overall Study|Pt went to transplant|0|||
155688820|NCT00075725|561951731|FG008|Overall Study|Pt went to transplant|0|||
155688821|NCT00075725|561951732|FG009|Overall Study|Pt went to transplant|0|||
155688822|NCT00075725|561951733|FG010|Overall Study|Pt went to transplant|0|||
155688823|NCT00075725|561951734|FG011|Overall Study|Pt went to transplant|0|||
155688824|NCT00075725|561951723|FG000|Overall Study|Pt received additional steroids|0|||
155688825|NCT00075725|561951724|FG001|Overall Study|Pt received additional steroids|0|||
155688826|NCT00075725|561951725|FG002|Overall Study|Pt received additional steroids|0|||
155688827|NCT00075725|561951726|FG003|Overall Study|Pt received additional steroids|1|||
155688828|NCT00075725|561951727|FG004|Overall Study|Pt received additional steroids|0|||
155688829|NCT00075725|561951728|FG005|Overall Study|Pt received additional steroids|0|||
155688830|NCT00075725|561951729|FG006|Overall Study|Pt received additional steroids|0|||
155688831|NCT00075725|561951730|FG007|Overall Study|Pt received additional steroids|0|||
155688832|NCT00075725|561951731|FG008|Overall Study|Pt received additional steroids|0|||
155688833|NCT00075725|561951732|FG009|Overall Study|Pt received additional steroids|0|||
155688834|NCT00075725|561951733|FG010|Overall Study|Pt received additional steroids|0|||
155688835|NCT00075725|561951734|FG011|Overall Study|Pt received additional steroids|0|||
155688836|NCT00075725|561951723|FG000|Overall Study|Pt relocated|0|||
155688837|NCT00075725|561951724|FG001|Overall Study|Pt relocated|0|||
155688838|NCT00075725|561951725|FG002|Overall Study|Pt relocated|0|||
155688839|NCT00075725|561951726|FG003|Overall Study|Pt relocated|2|||
155688840|NCT00075725|561951727|FG004|Overall Study|Pt relocated|0|||
155688841|NCT00075725|561951728|FG005|Overall Study|Pt relocated|1|||
155688842|NCT00075725|561951729|FG006|Overall Study|Pt relocated|1|||
155688843|NCT00075725|561951730|FG007|Overall Study|Pt relocated|2|||
155688844|NCT00075725|561951731|FG008|Overall Study|Pt relocated|1|||
155688845|NCT00075725|561951732|FG009|Overall Study|Pt relocated|0|||
155688846|NCT00075725|561951733|FG010|Overall Study|Pt relocated|0|||
155688847|NCT00075725|561951734|FG011|Overall Study|Pt relocated|0|||
155688848|NCT00075725|561951723|FG000|Overall Study|Institution Terminated|0|||
155688849|NCT00075725|561951724|FG001|Overall Study|Institution Terminated|0|||
155688850|NCT00075725|561951725|FG002|Overall Study|Institution Terminated|0|||
155688851|NCT00075725|561951726|FG003|Overall Study|Institution Terminated|0|||
155688852|NCT00075725|561951727|FG004|Overall Study|Institution Terminated|1|||
155688853|NCT00075725|561951728|FG005|Overall Study|Institution Terminated|0|||
155688854|NCT00075725|561951729|FG006|Overall Study|Institution Terminated|0|||
155688855|NCT00075725|561951730|FG007|Overall Study|Institution Terminated|3|||
155688856|NCT00075725|561951731|FG008|Overall Study|Institution Terminated|0|||
155688857|NCT00075725|561951732|FG009|Overall Study|Institution Terminated|0|||
155688858|NCT00075725|561951733|FG010|Overall Study|Institution Terminated|0|||
155688859|NCT00075725|561951734|FG011|Overall Study|Institution Terminated|0|||
155688860|NCT00075725|561951723|FG000|Overall Study|Study Closure|1|||
155688861|NCT00075725|561951724|FG001|Overall Study|Study Closure|0|||
155688862|NCT00075725|561951725|FG002|Overall Study|Study Closure|0|||
155688863|NCT00075725|561951726|FG003|Overall Study|Study Closure|0|||
155688864|NCT00075725|561951727|FG004|Overall Study|Study Closure|1|||
155688865|NCT00075725|561951728|FG005|Overall Study|Study Closure|3|||
155688866|NCT00075725|561951729|FG006|Overall Study|Study Closure|0|||
155688867|NCT00075725|561951730|FG007|Overall Study|Study Closure|1|||
155688868|NCT00075725|561951731|FG008|Overall Study|Study Closure|0|||
155688869|NCT00075725|561951732|FG009|Overall Study|Study Closure|0|||
155688870|NCT00075725|561951733|FG010|Overall Study|Study Closure|0|||
155688871|NCT00075725|561951734|FG011|Overall Study|Study Closure|0|||
155688872|NCT00075725|561951723|FG000|Overall Study|Other complications|0|||
155688873|NCT00075725|561951724|FG001|Overall Study|Other complications|0|||
155688874|NCT00075725|561951725|FG002|Overall Study|Other complications|0|||
155688875|NCT00075725|561951726|FG003|Overall Study|Other complications|0|||
155688876|NCT00075725|561951727|FG004|Overall Study|Other complications|0|||
155688877|NCT00075725|561951728|FG005|Overall Study|Other complications|1|||
155688878|NCT00075725|561951729|FG006|Overall Study|Other complications|0|||
155688879|NCT00075725|561951730|FG007|Overall Study|Other complications|0|||
155688880|NCT00075725|561951731|FG008|Overall Study|Other complications|0|||
155688881|NCT00075725|561951732|FG009|Overall Study|Other complications|0|||
155688882|NCT00075725|561951733|FG010|Overall Study|Other complications|0|||
155688883|NCT00075725|561951734|FG011|Overall Study|Other complications|0|||
155688884|NCT00075725|561951723|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
155688885|NCT00075725|561951724|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
155688886|NCT00075725|561951725|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
155688887|NCT00075725|561951726|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
155688888|NCT00075725|561951727|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
155688889|NCT00075725|561951728|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
155688890|NCT00075725|561951729|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
155688891|NCT00075725|561951730|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
155688892|NCT00075725|561951731|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
155688893|NCT00075725|561951732|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
155688894|NCT00075725|561951733|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
155688895|NCT00075725|561951734|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
155688896|NCT00075725|561951723|FG000|Overall Study|Pt incarcerated|0|||
155688897|NCT00075725|561951724|FG001|Overall Study|Pt incarcerated|0|||
155688898|NCT00075725|561951725|FG002|Overall Study|Pt incarcerated|0|||
155688899|NCT00075725|561951726|FG003|Overall Study|Pt incarcerated|0|||
155688900|NCT00075725|561951727|FG004|Overall Study|Pt incarcerated|0|||
155688901|NCT00075725|561951728|FG005|Overall Study|Pt incarcerated|0|||
155688902|NCT00075725|561951729|FG006|Overall Study|Pt incarcerated|0|||
155688903|NCT00075725|561951730|FG007|Overall Study|Pt incarcerated|1|||
155688904|NCT00075725|561951731|FG008|Overall Study|Pt incarcerated|0|||
155688905|NCT00075725|561951732|FG009|Overall Study|Pt incarcerated|0|||
155688906|NCT00075725|561951733|FG010|Overall Study|Pt incarcerated|0|||
155688907|NCT00075725|561951734|FG011|Overall Study|Pt incarcerated|0|||
155688908|NCT04677660|561951735|FG000|Overall Study|Lost to Follow-up|0|||
155688909|NCT04677660|561951736|FG001|Overall Study|Lost to Follow-up|2|||
155688910|NCT04677660|561951735|FG000|Overall Study|Withdrawal by Subject|0|||
155688911|NCT04677660|561951736|FG001|Overall Study|Withdrawal by Subject|1|||
155688912|NCT04677660|561951735|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
155688913|NCT04677660|561951736|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
155688914|NCT02182440|561951743|FG000|Overall Study|Adverse Event|0|||
155688915|NCT02182440|561951744|FG001|Overall Study|Adverse Event|1|||
155688916|NCT02182440|561951745|FG002|Overall Study|Adverse Event|0|||
155688917|NCT02182440|561951746|FG003|Overall Study|Adverse Event|0|||
155688918|NCT02182440|561951743|FG000|Overall Study|Death|31|||
155688919|NCT02182440|561951744|FG001|Overall Study|Death|8|||
155688920|NCT02182440|561951745|FG002|Overall Study|Death|5|||
155688921|NCT02182440|561951746|FG003|Overall Study|Death|16|||
155688922|NCT02182440|561951743|FG000|Overall Study|Protocol Violation|0|||
155688923|NCT02182440|561951744|FG001|Overall Study|Protocol Violation|1|||
155688924|NCT02182440|561951745|FG002|Overall Study|Protocol Violation|0|||
155688925|NCT02182440|561951746|FG003|Overall Study|Protocol Violation|0|||
155688926|NCT02182440|561951743|FG000|Overall Study|Physician Decision|1|||
155688927|NCT02182440|561951744|FG001|Overall Study|Physician Decision|0|||
155688928|NCT02182440|561951745|FG002|Overall Study|Physician Decision|0|||
155688929|NCT02182440|561951746|FG003|Overall Study|Physician Decision|0|||
155688930|NCT02182440|561951743|FG000|Overall Study|Withdrawal by Subject|1|||
155688931|NCT02182440|561951744|FG001|Overall Study|Withdrawal by Subject|1|||
155688932|NCT02182440|561951745|FG002|Overall Study|Withdrawal by Subject|3|||
155688933|NCT02182440|561951746|FG003|Overall Study|Withdrawal by Subject|4|||
155688934|NCT02182440|561951743|FG000|Overall Study|different, e.g adm other hospital|12|||
155688935|NCT02182440|561951744|FG001|Overall Study|different, e.g adm other hospital|3|||
155688936|NCT02182440|561951745|FG002|Overall Study|different, e.g adm other hospital|3|||
155688937|NCT02182440|561951746|FG003|Overall Study|different, e.g adm other hospital|10|||
155688938|NCT03754582|561951747|FG000|Treatment Phase|Adverse Event|0|||
155688939|NCT03754582|561951748|FG001|Treatment Phase|Adverse Event|1|||
155688940|NCT03754582|561951749|FG002|Treatment Phase|Adverse Event|0|||
155688941|NCT03754582|561951747|FG000|Follow-up Phase|Other|0|||
155688942|NCT03754582|561951748|FG001|Follow-up Phase|Other|0|||
155688943|NCT03754582|561951749|FG002|Follow-up Phase|Other|1|||
155688944|NCT01561755|561951752|FG000|Overall Study|Lost to Follow-up|0|||
155688945|NCT01561755|561951753|FG001|Overall Study|Lost to Follow-up|1|||
155688946|NCT02981407|561951754|FG000|Overall Study|Withdrawal by Subject|2|||
155688947|NCT02981407|561951755|FG001|Overall Study|Withdrawal by Subject|0|||
155688948|NCT02818036|561951760|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
155688949|NCT02818036|561951761|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
155688950|NCT02818036|561951760|FG000|Overall Study|Withdrawal by Subject|1|||
155688951|NCT02818036|561951761|FG001|Overall Study|Withdrawal by Subject|0|||
155688952|NCT01319721|561951765|FG000|Overall Study|Lost to Follow-up|1|||
155688953|NCT01319721|561951766|FG001|Overall Study|Lost to Follow-up|6|||
155688954|NCT00468845|561951767|FG000|Overall Study|Adverse Event|9|||
155688955|NCT00468845|561951768|FG001|Overall Study|Adverse Event|14|||
155688956|NCT00468845|561951769|FG002|Overall Study|Adverse Event|11|||
155688957|NCT00468845|561951767|FG000|Overall Study|Lost to Follow-up|2|||
155688958|NCT00468845|561951768|FG001|Overall Study|Lost to Follow-up|1|||
155688959|NCT00468845|561951769|FG002|Overall Study|Lost to Follow-up|2|||
155688960|NCT00468845|561951767|FG000|Overall Study|Other|4|||
155688961|NCT00468845|561951768|FG001|Overall Study|Other|9|||
155688962|NCT00468845|561951769|FG002|Overall Study|Other|5|||
155688963|NCT00468845|561951767|FG000|Overall Study|No longer willing to participate|5|||
155688964|NCT00468845|561951768|FG001|Overall Study|No longer willing to participate|6|||
155688965|NCT00468845|561951769|FG002|Overall Study|No longer willing to participate|10|||
155688966|NCT00468845|561951767|FG000|Overall Study|Randomized, not treated|1|||
155688967|NCT00468845|561951768|FG001|Overall Study|Randomized, not treated|4|||
155688968|NCT00468845|561951769|FG002|Overall Study|Randomized, not treated|2|||
155688969|NCT00585221|561954041|FG000|Overall Study|Protocol Violation|8|||
155688970|NCT03263923|561954043|FG000|Overall Study|Withdrawal by Subject|10|||
155688971|NCT03263923|561954044|FG001|Overall Study|Withdrawal by Subject|8|||
155688972|NCT03263923|561954043|FG000|Overall Study|Lost to Follow-up|15|||
155688973|NCT03263923|561954044|FG001|Overall Study|Lost to Follow-up|13|||
155688974|NCT02229214|561954055|FG000|Overall Study|Adverse Event|2|||
155688975|NCT02229214|561954056|FG001|Overall Study|Adverse Event|0|||
155688976|NCT02229214|561954055|FG000|Overall Study|Withdrawal by Subject|4|||
155688977|NCT02229214|561954056|FG001|Overall Study|Withdrawal by Subject|0|||
155688978|NCT00246025|561954057|FG000|Overall Study|Adverse Event|7|||
155688979|NCT00246025|561954058|FG001|Overall Study|Adverse Event|9|||
155688980|NCT00246025|561954059|FG002|Overall Study|Adverse Event|9|||
155688981|NCT00246025|561954060|FG003|Overall Study|Adverse Event|10|||
155688982|NCT00246025|561954057|FG000|Overall Study|Withdrawal by Subject|3|||
155688983|NCT00246025|561954058|FG001|Overall Study|Withdrawal by Subject|0|||
155688984|NCT00246025|561954059|FG002|Overall Study|Withdrawal by Subject|1|||
155688985|NCT00246025|561954060|FG003|Overall Study|Withdrawal by Subject|2|||
155688986|NCT00246025|561954057|FG000|Overall Study|unsuitable medical history was found|0|||
155688987|NCT00246025|561954058|FG001|Overall Study|unsuitable medical history was found|0|||
155688988|NCT00246025|561954059|FG002|Overall Study|unsuitable medical history was found|0|||
155688989|NCT00246025|561954060|FG003|Overall Study|unsuitable medical history was found|1|||
155688990|NCT03054350|561954061|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
155688991|NCT03054350|561954062|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
155688992|NCT03054350|561954063|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
155688993|NCT03054350|561954064|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
155688994|NCT03054350|561954065|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
155688995|NCT03054350|561954066|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
155688996|NCT03054350|561954061|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155688997|NCT03054350|561954062|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155688998|NCT03054350|561954063|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
155688999|NCT03054350|561954064|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155689000|NCT03054350|561954065|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155689001|NCT03054350|561954066|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155689002|NCT03054350|561954061|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
155689003|NCT03054350|561954062|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155689004|NCT03054350|561954063|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155689005|NCT03054350|561954064|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
155689006|NCT03054350|561954065|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155689007|NCT03054350|561954066|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155689008|NCT03054350|561954061|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155689009|NCT03054350|561954062|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155689010|NCT03054350|561954063|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
155689011|NCT03054350|561954064|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155689012|NCT03054350|561954065|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155689013|NCT03054350|561954066|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155689014|NCT01643850|561954069|FG000|Overall Study|Withdrawal by Subject|0|||
155689015|NCT01643850|561954070|FG001|Overall Study|Withdrawal by Subject|0|||
155689016|NCT01643850|561954071|FG002|Overall Study|Withdrawal by Subject|0|||
155689017|NCT01643850|561954072|FG003|Overall Study|Withdrawal by Subject|0|||
155689018|NCT01643850|561954073|FG004|Overall Study|Withdrawal by Subject|1|||
155689019|NCT01643850|561954074|FG005|Overall Study|Withdrawal by Subject|0|||
155689020|NCT01643850|561954075|FG006|Overall Study|Withdrawal by Subject|0|||
155689021|NCT01643850|561954076|FG007|Overall Study|Withdrawal by Subject|0|||
155689022|NCT01643850|561954077|FG008|Overall Study|Withdrawal by Subject|0|||
155689023|NCT01643850|561954069|FG000|Overall Study|Lost to Follow-up|0|||
155689024|NCT01643850|561954070|FG001|Overall Study|Lost to Follow-up|0|||
155689025|NCT01643850|561954071|FG002|Overall Study|Lost to Follow-up|0|||
155689026|NCT01643850|561954072|FG003|Overall Study|Lost to Follow-up|0|||
155689027|NCT01643850|561954073|FG004|Overall Study|Lost to Follow-up|0|||
155689028|NCT01643850|561954074|FG005|Overall Study|Lost to Follow-up|0|||
155689029|NCT01643850|561954075|FG006|Overall Study|Lost to Follow-up|1|||
155689030|NCT01643850|561954076|FG007|Overall Study|Lost to Follow-up|0|||
155689031|NCT01643850|561954077|FG008|Overall Study|Lost to Follow-up|1|||
155689032|NCT01643850|561954069|FG000|Overall Study|Adverse Event|0|||
155689033|NCT01643850|561954070|FG001|Overall Study|Adverse Event|0|||
155689034|NCT01643850|561954071|FG002|Overall Study|Adverse Event|0|||
155689035|NCT01643850|561954072|FG003|Overall Study|Adverse Event|0|||
155689036|NCT01643850|561954073|FG004|Overall Study|Adverse Event|1|||
155689037|NCT01643850|561954074|FG005|Overall Study|Adverse Event|0|||
155689038|NCT01643850|561954075|FG006|Overall Study|Adverse Event|0|||
155689039|NCT01643850|561954076|FG007|Overall Study|Adverse Event|0|||
155689040|NCT01643850|561954077|FG008|Overall Study|Adverse Event|0|||
155689041|NCT01643850|561954069|FG000|Overall Study|Administrative Problems|0|||
155689042|NCT01643850|561954070|FG001|Overall Study|Administrative Problems|0|||
155689043|NCT01643850|561954071|FG002|Overall Study|Administrative Problems|1|||
155689044|NCT01643850|561954072|FG003|Overall Study|Administrative Problems|0|||
155689045|NCT01643850|561954073|FG004|Overall Study|Administrative Problems|1|||
155689046|NCT01643850|561954074|FG005|Overall Study|Administrative Problems|0|||
155689047|NCT01643850|561954075|FG006|Overall Study|Administrative Problems|0|||
155689048|NCT01643850|561954076|FG007|Overall Study|Administrative Problems|0|||
155689049|NCT01643850|561954077|FG008|Overall Study|Administrative Problems|0|||
155689050|NCT00931723|561954078|FG000|Overall Study|Withdrawal by Subject|11|||
155689051|NCT00931723|561954079|FG001|Overall Study|Withdrawal by Subject|13|||
155689052|NCT00931723|561954078|FG000|Overall Study|Adverse Event|6|||
155689053|NCT00931723|561954079|FG001|Overall Study|Adverse Event|13|||
155689054|NCT00931723|561954078|FG000|Overall Study|Lithium found in blood|0|||
155689055|NCT00931723|561954079|FG001|Overall Study|Lithium found in blood|1|||
155689056|NCT00931723|561954078|FG000|Overall Study|Condition under investigation worsened|1|||
155689057|NCT00931723|561954079|FG001|Overall Study|Condition under investigation worsened|2|||
155689058|NCT00931723|561954078|FG000|Overall Study|Lost to Follow-up|1|||
155689059|NCT00931723|561954079|FG001|Overall Study|Lost to Follow-up|2|||
155689060|NCT00931723|561954078|FG000|Overall Study|Study-specific discontinuation criteria|1|||
155689061|NCT00931723|561954079|FG001|Overall Study|Study-specific discontinuation criteria|1|||
155689062|NCT00931723|561954078|FG000|Overall Study|Severe non-compliance to protocol|2|||
155689063|NCT00931723|561954079|FG001|Overall Study|Severe non-compliance to protocol|0|||
155689064|NCT00931723|561954078|FG000|Overall Study|Safety reasons|0|||
155689065|NCT00931723|561954079|FG001|Overall Study|Safety reasons|1|||
155689066|NCT00931723|561954078|FG000|Overall Study|Took prohibited concomitant medication|0|||
155689067|NCT00931723|561954079|FG001|Overall Study|Took prohibited concomitant medication|1|||
155689068|NCT00931723|561954078|FG000|Overall Study|Lack or insufficient theraputic response|2|||
155689069|NCT00931723|561954079|FG001|Overall Study|Lack or insufficient theraputic response|5|||
155689070|NCT00931723|561954078|FG000|Overall Study|Sponsor decision|1|||
155689071|NCT00931723|561954079|FG001|Overall Study|Sponsor decision|0|||
155689072|NCT00931723|561954078|FG000|Overall Study|Late hospital discharge|1|||
155689073|NCT00931723|561954079|FG001|Overall Study|Late hospital discharge|0|||
155689074|NCT03305081|561954080|FG000|Overall Study|Lost to Follow-up|10|||
155689075|NCT03305081|561954081|FG001|Overall Study|Lost to Follow-up|15|||
155689076|NCT04065074|561954088|FG000|Overall Study|Adverse Event|1|||
155689077|NCT04065074|561954088|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
155689078|NCT01218100|561954089|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
155689079|NCT01218100|561954090|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
155689080|NCT01218100|561954091|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
155689081|NCT01218100|561954092|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
155689082|NCT01218100|561954089|FG000|Overall Study|Adverse Event|4|||
155689083|NCT01218100|561954090|FG001|Overall Study|Adverse Event|6|||
155689084|NCT01218100|561954091|FG002|Overall Study|Adverse Event|6|||
155689085|NCT01218100|561954092|FG003|Overall Study|Adverse Event|7|||
155689086|NCT01218100|561954089|FG000|Overall Study|Lack of Efficacy|9|||
155689087|NCT01218100|561954090|FG001|Overall Study|Lack of Efficacy|6|||
155689088|NCT01218100|561954091|FG002|Overall Study|Lack of Efficacy|5|||
155689089|NCT01218100|561954092|FG003|Overall Study|Lack of Efficacy|12|||
155689090|NCT01218100|561954089|FG000|Overall Study|Protocol Violation|0|||
155689091|NCT01218100|561954090|FG001|Overall Study|Protocol Violation|0|||
155689092|NCT01218100|561954091|FG002|Overall Study|Protocol Violation|1|||
155689093|NCT01218100|561954092|FG003|Overall Study|Protocol Violation|1|||
155689094|NCT01218100|561954089|FG000|Overall Study|Withdrawal by Subject|5|||
155689095|NCT01218100|561954090|FG001|Overall Study|Withdrawal by Subject|2|||
155689096|NCT01218100|561954091|FG002|Overall Study|Withdrawal by Subject|6|||
155689097|NCT01218100|561954092|FG003|Overall Study|Withdrawal by Subject|7|||
155689098|NCT01218100|561954089|FG000|Overall Study|Lost to Follow-up|3|||
155689099|NCT01218100|561954090|FG001|Overall Study|Lost to Follow-up|8|||
155689100|NCT01218100|561954091|FG002|Overall Study|Lost to Follow-up|2|||
155689101|NCT01218100|561954092|FG003|Overall Study|Lost to Follow-up|1|||
155689102|NCT01218100|561954089|FG000|Overall Study|Other Reason|2|||
155689103|NCT01218100|561954090|FG001|Overall Study|Other Reason|2|||
155689104|NCT01218100|561954091|FG002|Overall Study|Other Reason|6|||
155689105|NCT01218100|561954092|FG003|Overall Study|Other Reason|4|||
155689106|NCT02437305|561954093|FG000|Overall Study|Lost to Follow-up|18|||
155689107|NCT02437305|561954094|FG001|Overall Study|Lost to Follow-up|12|||
155689108|NCT03883113|561954096|FG000|Overall Study|Physician Decision|4|||
155689109|NCT03883113|561954097|FG001|Overall Study|Physician Decision|2|||
155689110|NCT03883113|561954096|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
155689111|NCT03883113|561954097|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
155689112|NCT03883113|561954096|FG000|Overall Study|Pregnancy|1|||
155689113|NCT03883113|561954097|FG001|Overall Study|Pregnancy|0|||
155689114|NCT03883113|561954096|FG000|Overall Study|Adverse Event|0|||
155689115|NCT03883113|561954097|FG001|Overall Study|Adverse Event|1|||
155689116|NCT03883113|561954096|FG000|Overall Study|Withdrawal by Subject|1|||
155689117|NCT03883113|561954097|FG001|Overall Study|Withdrawal by Subject|2|||
155689118|NCT03883113|561954096|FG000|Overall Study|Lost to Follow-up|1|||
155689119|NCT03883113|561954097|FG001|Overall Study|Lost to Follow-up|0|||
155689120|NCT02446418|561954103|FG000|Overall Study|Adverse Event|4|||
155689121|NCT02446418|561954104|FG001|Overall Study|Adverse Event|8|||
155689122|NCT02446418|561954103|FG000|Overall Study|Physician Decision|5|||
155689123|NCT02446418|561954104|FG001|Overall Study|Physician Decision|1|||
155689124|NCT02446418|561954103|FG000|Overall Study|Withdrawal by Subject|3|||
155689125|NCT02446418|561954104|FG001|Overall Study|Withdrawal by Subject|3|||
155689126|NCT02446418|561954103|FG000|Overall Study|Lost to Follow-up|2|||
155689127|NCT02446418|561954104|FG001|Overall Study|Lost to Follow-up|2|||
155689128|NCT02446418|561954103|FG000|Overall Study|Protocol Violation|1|||
155689129|NCT02446418|561954104|FG001|Overall Study|Protocol Violation|2|||
155689130|NCT02446418|561954103|FG000|Overall Study|Lack of Efficacy|2|||
155689131|NCT02446418|561954104|FG001|Overall Study|Lack of Efficacy|0|||
155689132|NCT02446418|561954103|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
155689133|NCT02446418|561954104|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
155689134|NCT03421743|561954107|FG000|Overall Study|Lack of Efficacy|1|||
155689135|NCT03421743|561954108|FG001|Overall Study|Lack of Efficacy|0|||
155689136|NCT03421743|561954107|FG000|Overall Study|Adverse Event|2|||
155689137|NCT03421743|561954108|FG001|Overall Study|Adverse Event|1|||
155689138|NCT03421743|561954107|FG000|Overall Study|Withdrawal by Subject|0|||
155689139|NCT03421743|561954108|FG001|Overall Study|Withdrawal by Subject|1|||
155689140|NCT00435162|561954109|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
155689141|NCT00435162|561954110|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
155689142|NCT00435162|561954111|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
155689143|NCT00435162|561954112|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
155689144|NCT00435162|561954113|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
155689145|NCT00435162|561954114|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
155605945|NCT01285492|561645815|FG001|Overall Study|Withdrawal by Subject|1|||
155605946|NCT01285492|561645814|FG000|Overall Study|Death|1|||
155605947|NCT01285492|561645815|FG001|Overall Study|Death|0|||
155605948|NCT01121536|561645816|FG000|Overall Study|Adverse Event|63|||
155605949|NCT01121536|561645816|FG000|Overall Study|Lack of Efficacy|35|||
155605950|NCT01121536|561645816|FG000|Overall Study|Withdrawal by Subject|65|||
155605951|NCT01121536|561645816|FG000|Overall Study|Protocol Violation|20|||
155605952|NCT01121536|561645816|FG000|Overall Study|Noncompliance with study medication|12|||
155605953|NCT01121536|561645816|FG000|Overall Study|Noncompliance with study procedures|9|||
155605954|NCT01121536|561645816|FG000|Overall Study|Lost to Follow-up|39|||
155605955|NCT01121536|561645816|FG000|Overall Study|Other|118|||
155605956|NCT00401960|561645818|FG000|Overall Study|Lost to Follow-up|3|||
155605957|NCT00401960|561645819|FG001|Overall Study|Lost to Follow-up|0|||
155605958|NCT00401960|561645818|FG000|Overall Study|Death|2|||
155605959|NCT00401960|561645819|FG001|Overall Study|Death|0|||
155605960|NCT02649426|561645820|FG000|Overall Study|Follow-up on going|1|||
155605961|NCT02649426|561645821|FG001|Overall Study|Follow-up on going|26|||
155605962|NCT02649426|561645822|FG002|Overall Study|Follow-up on going|28|||
155605963|NCT02649426|561645823|FG003|Overall Study|Follow-up on going|31|||
155605964|NCT01606202|561645824|FG000|Overall Study|Adverse Event|5|||
155605965|NCT01606202|561645825|FG001|Overall Study|Adverse Event|0|||
155605966|NCT01606202|561645824|FG000|Overall Study|Withdrawal by Subject|2|||
155605967|NCT01606202|561645825|FG001|Overall Study|Withdrawal by Subject|1|||
155605968|NCT01606202|561645824|FG000|Overall Study|Personal problems|0|||
155605969|NCT01606202|561645825|FG001|Overall Study|Personal problems|1|||
155605970|NCT01606202|561645824|FG000|Overall Study|Problems with administration|0|||
155605971|NCT01606202|561645825|FG001|Overall Study|Problems with administration|1|||
155605972|NCT00306787|561645826|FG000|Overall Study|Discontinued without taking study drug|208|||
155605973|NCT00306787|561645827|FG001|Overall Study|Discontinued without taking study drug|215|||
155605974|NCT00306787|561645826|FG000|Overall Study|Adverse Event|1|||
155605975|NCT00306787|561645827|FG001|Overall Study|Adverse Event|1|||
155605976|NCT00306787|561645826|FG000|Overall Study|Lack of Efficacy|1|||
155605977|NCT00306787|561645827|FG001|Overall Study|Lack of Efficacy|0|||
155605978|NCT00306787|561645826|FG000|Overall Study|Protocol Violation|8|||
155605979|NCT00306787|561645827|FG001|Overall Study|Protocol Violation|10|||
155605980|NCT00306787|561645826|FG000|Overall Study|Withdrawal by Subject|2|||
155605981|NCT00306787|561645827|FG001|Overall Study|Withdrawal by Subject|9|||
155605982|NCT00306787|561645826|FG000|Overall Study|Lost to Follow-up|9|||
155605983|NCT00306787|561645827|FG001|Overall Study|Lost to Follow-up|6|||
155605984|NCT00306787|561645826|FG000|Overall Study|Administrative problems|4|||
155605985|NCT00306787|561645827|FG001|Overall Study|Administrative problems|0|||
155605986|NCT00306787|561645826|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155605987|NCT00306787|561645827|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155605988|NCT01870297|561645828|FG000|Overall Study|Adverse Event|0|||
155605989|NCT01870297|561645829|FG001|Overall Study|Adverse Event|0|||
155605990|NCT01870297|561645830|FG002|Overall Study|Adverse Event|0|||
155605991|NCT01870297|561645831|FG003|Overall Study|Adverse Event|0|||
155605992|NCT01870297|561645832|FG004|Overall Study|Adverse Event|2|||
155605993|NCT01870297|561645833|FG005|Overall Study|Adverse Event|0|||
155605994|NCT01870297|561645834|FG006|Overall Study|Adverse Event|0|||
155605995|NCT01870297|561645828|FG000|Overall Study|Lost to Follow-up|0|||
155605996|NCT01870297|561645829|FG001|Overall Study|Lost to Follow-up|1|||
155605997|NCT01870297|561645830|FG002|Overall Study|Lost to Follow-up|1|||
155605998|NCT01870297|561645831|FG003|Overall Study|Lost to Follow-up|0|||
155605999|NCT01870297|561645832|FG004|Overall Study|Lost to Follow-up|0|||
155606000|NCT01870297|561645833|FG005|Overall Study|Lost to Follow-up|0|||
155606001|NCT01870297|561645834|FG006|Overall Study|Lost to Follow-up|0|||
155606002|NCT01870297|561645828|FG000|Overall Study|Withdrawal by Subject|0|||
155606003|NCT01870297|561645829|FG001|Overall Study|Withdrawal by Subject|0|||
155606004|NCT01870297|561645830|FG002|Overall Study|Withdrawal by Subject|0|||
155606005|NCT01870297|561645831|FG003|Overall Study|Withdrawal by Subject|0|||
155606006|NCT01870297|561645832|FG004|Overall Study|Withdrawal by Subject|1|||
155606007|NCT01870297|561645833|FG005|Overall Study|Withdrawal by Subject|1|||
155689146|NCT00694096|561954115|FG000|Overall Study|Withdrawal by Subject|5|||
155606008|NCT01870297|561645834|FG006|Overall Study|Withdrawal by Subject|1|||
155606009|NCT01870297|561645828|FG000|Overall Study|Sponsor Decision|0|||
155606010|NCT01870297|561645829|FG001|Overall Study|Sponsor Decision|6|||
155606011|NCT01870297|561645830|FG002|Overall Study|Sponsor Decision|0|||
155606012|NCT01870297|561645831|FG003|Overall Study|Sponsor Decision|0|||
155606013|NCT01870297|561645832|FG004|Overall Study|Sponsor Decision|0|||
155606014|NCT01870297|561645833|FG005|Overall Study|Sponsor Decision|0|||
155606015|NCT01870297|561645834|FG006|Overall Study|Sponsor Decision|1|||
155606016|NCT00337779|561645835|FG000|Overall Study|Withdrawal by Subject|10|||
155606017|NCT00337779|561645836|FG001|Overall Study|Withdrawal by Subject|12|||
155606018|NCT00337779|561645835|FG000|Overall Study|Sponsor decision|1|||
155606019|NCT00337779|561645836|FG001|Overall Study|Sponsor decision|1|||
155606020|NCT00337779|561645835|FG000|Overall Study|Physician Decision|3|||
155606021|NCT00337779|561645836|FG001|Overall Study|Physician Decision|6|||
155606022|NCT00337779|561645835|FG000|Overall Study|Protocol Violation|1|||
155606023|NCT00337779|561645836|FG001|Overall Study|Protocol Violation|1|||
155606024|NCT00337779|561645835|FG000|Overall Study|Lost to Follow-up|6|||
155606025|NCT00337779|561645836|FG001|Overall Study|Lost to Follow-up|5|||
155606026|NCT00337779|561645835|FG000|Overall Study|Adverse Event|28|||
155606027|NCT00337779|561645836|FG001|Overall Study|Adverse Event|51|||
155606028|NCT00337779|561645835|FG000|Overall Study|Pregnancy|3|||
155606029|NCT00337779|561645836|FG001|Overall Study|Pregnancy|2|||
155606030|NCT00337779|561645835|FG000|Overall Study|Death|0|||
155606031|NCT00337779|561645836|FG001|Overall Study|Death|1|||
155606032|NCT01074255|561645837|FG000|Overall Study|Did not receive EMEND|2|||
155606033|NCT00314132|561645838|FG000|Overall Study|Lost to Follow-up|3|||
155606034|NCT00314132|561645839|FG001|Overall Study|Lost to Follow-up|13|||
155606035|NCT00314132|561645838|FG000|Overall Study|Withdrawal by Subject|3|||
155606036|NCT00314132|561645839|FG001|Overall Study|Withdrawal by Subject|5|||
155606037|NCT00314132|561645838|FG000|Overall Study|Adverse Event|1|||
155606038|NCT00314132|561645839|FG001|Overall Study|Adverse Event|0|||
155606039|NCT00314132|561645838|FG000|Overall Study|Physician Decision|1|||
155606040|NCT00314132|561645839|FG001|Overall Study|Physician Decision|0|||
155606041|NCT03627416|561645857|FG000|Overall Study|Adverse Event|0|||
155606042|NCT03627416|561645858|FG001|Overall Study|Adverse Event|1|||
155606043|NCT02968433|561645859|FG000|Overall Study|Withdrawal by Subject|1|||
155606044|NCT00875433|561645860|FG000|Overall Study|Progressive disease|41|||
155606045|NCT00875433|561645860|FG000|Overall Study|Other Adverse Event|14|||
155606046|NCT00875433|561645860|FG000|Overall Study|Withdrawal by Subject|2|||
155606047|NCT00875433|561645860|FG000|Overall Study|Other|3|||
155606048|NCT00637806|561645861|FG000|Double-blind Phase|Study Discontinued|2|||
155606049|NCT00637806|561645862|FG001|Double-blind Phase|Study Discontinued|0|||
155606050|NCT00637806|561645863|FG002|Double-blind Phase|Study Discontinued|1|||
155606051|NCT00637806|561645864|FG003|Double-blind Phase|Study Discontinued|0|||
155606052|NCT00637806|561645861|FG000|Extension Phase|Study Discontinued|0|||
155606053|NCT00637806|561645862|FG001|Extension Phase|Study Discontinued|0|||
155606054|NCT00637806|561645863|FG002|Extension Phase|Study Discontinued|0|||
155606055|NCT00637806|561645864|FG003|Extension Phase|Study Discontinued|1|||
155606056|NCT00622336|561645867|FG000|Treatment Phase|Progression of Disease|181|||
155606057|NCT00622336|561645867|FG000|Treatment Phase|Adverse Event|46|||
155606058|NCT00622336|561645867|FG000|Treatment Phase|Other|40|||
155606059|NCT00622336|561645867|FG000|Treatment Phase|Death|14|||
155606060|NCT00622336|561645867|FG000|Treatment Phase|Lack of therapeutic effect|13|||
155606061|NCT00622336|561645867|FG000|Treatment Phase|Withdrawal by Subject|13|||
155606062|NCT00622336|561645867|FG000|Treatment Phase|Lost to Follow-up|2|||
155606063|NCT00622336|561645867|FG000|Extension Phase|Adverse Event|2|||
155606064|NCT00622336|561645867|FG000|Extension Phase|Progressive Disease|6|||
155606065|NCT00622336|561645867|FG000|Extension Phase|Lack of therapeutic effect|2|||
155606066|NCT00622336|561645867|FG000|Extension Phase|Withdrawal by Subject|1|||
155606067|NCT00622336|561645867|FG000|Extension Phase|Lost to Follow-up|1|||
155606068|NCT00622336|561645867|FG000|Extension Phase|Other|9|||
155606069|NCT04148287|561645871|FG000|Overall Study|Death|2|||
155606070|NCT02923245|561645873|FG000|Overall Study|ultrasound order was cancelled|2|||
155606071|NCT02923245|561645874|FG001|Overall Study|ultrasound order was cancelled|1|||
155606072|NCT00824382|561645875|FG000|Overall Study|Adverse Event|4|||
155606073|NCT00824382|561645876|FG001|Overall Study|Adverse Event|1|||
155606074|NCT00824382|561645877|FG002|Overall Study|Adverse Event|1|||
155606075|NCT00824382|561645878|FG003|Overall Study|Adverse Event|4|||
155606076|NCT00824382|561645875|FG000|Overall Study|Protocol Violation|1|||
155606077|NCT00824382|561645876|FG001|Overall Study|Protocol Violation|0|||
155606078|NCT00824382|561645877|FG002|Overall Study|Protocol Violation|0|||
155606079|NCT00824382|561645878|FG003|Overall Study|Protocol Violation|1|||
155606080|NCT00824382|561645875|FG000|Overall Study|Investigator's decision|0|||
155606081|NCT00824382|561645876|FG001|Overall Study|Investigator's decision|1|||
155606082|NCT00824382|561645877|FG002|Overall Study|Investigator's decision|2|||
155606083|NCT00824382|561645878|FG003|Overall Study|Investigator's decision|0|||
155606084|NCT02680834|561645879|FG000|Overall Study|Physician Decision|5|||
155606085|NCT02680834|561645880|FG001|Overall Study|Physician Decision|2|||
155606086|NCT02680834|561645879|FG000|Overall Study|Withdrawal by Subject|6|||
155606087|NCT02680834|561645880|FG001|Overall Study|Withdrawal by Subject|0|||
155606088|NCT02680834|561645879|FG000|Overall Study|Lost to Follow-up|0|||
155606089|NCT02680834|561645880|FG001|Overall Study|Lost to Follow-up|1|||
155606090|NCT02520427|561645881|FG000|Overall Study|Decision by sponsor|0|||
155606091|NCT02520427|561645882|FG001|Overall Study|Decision by sponsor|0|||
155606092|NCT02520427|561645883|FG002|Overall Study|Decision by sponsor|0|||
155606093|NCT02520427|561645884|FG003|Overall Study|Decision by sponsor|0|||
155606094|NCT02520427|561645885|FG004|Overall Study|Decision by sponsor|0|||
155606095|NCT02520427|561645886|FG005|Overall Study|Decision by sponsor|0|||
155606096|NCT02520427|561645887|FG006|Overall Study|Decision by sponsor|0|||
155606097|NCT02520427|561645888|FG007|Overall Study|Decision by sponsor|0|||
155606098|NCT02520427|561645889|FG008|Overall Study|Decision by sponsor|1|||
155606099|NCT02520427|561645890|FG009|Overall Study|Decision by sponsor|1|||
155606100|NCT02520427|561645891|FG010|Overall Study|Decision by sponsor|0|||
155606101|NCT02520427|561645892|FG011|Overall Study|Decision by sponsor|0|||
155606102|NCT02520427|561645893|FG012|Overall Study|Decision by sponsor|0|||
155606103|NCT02520427|561645894|FG013|Overall Study|Decision by sponsor|0|||
155606104|NCT02520427|561645895|FG014|Overall Study|Decision by sponsor|0|||
155606105|NCT02520427|561645896|FG015|Overall Study|Decision by sponsor|0|||
155606106|NCT02520427|561645897|FG016|Overall Study|Decision by sponsor|0|||
155606107|NCT02520427|561645898|FG017|Overall Study|Decision by sponsor|0|||
155606108|NCT02520427|561645899|FG018|Overall Study|Decision by sponsor|0|||
155606109|NCT02520427|561645900|FG019|Overall Study|Decision by sponsor|0|||
155606110|NCT02520427|561645901|FG020|Overall Study|Decision by sponsor|0|||
155606111|NCT02520427|561645902|FG021|Overall Study|Decision by sponsor|0|||
155606112|NCT02520427|561645903|FG022|Overall Study|Decision by sponsor|0|||
155606113|NCT02520427|561645904|FG023|Overall Study|Decision by sponsor|0|||
155606114|NCT02520427|561645905|FG024|Overall Study|Decision by sponsor|0|||
155606115|NCT02520427|561645906|FG025|Overall Study|Decision by sponsor|0|||
155606116|NCT02520427|561645881|FG000|Overall Study|Withdrawal by Subject|0|||
155606117|NCT02520427|561645882|FG001|Overall Study|Withdrawal by Subject|0|||
155606118|NCT02520427|561645883|FG002|Overall Study|Withdrawal by Subject|1|||
155606119|NCT02520427|561645884|FG003|Overall Study|Withdrawal by Subject|0|||
155606120|NCT02520427|561645885|FG004|Overall Study|Withdrawal by Subject|0|||
155606121|NCT02520427|561645886|FG005|Overall Study|Withdrawal by Subject|0|||
155606122|NCT02520427|561645887|FG006|Overall Study|Withdrawal by Subject|0|||
155606123|NCT02520427|561645888|FG007|Overall Study|Withdrawal by Subject|0|||
155606124|NCT02520427|561645889|FG008|Overall Study|Withdrawal by Subject|0|||
155606125|NCT02520427|561645890|FG009|Overall Study|Withdrawal by Subject|0|||
155606126|NCT02520427|561645891|FG010|Overall Study|Withdrawal by Subject|0|||
155606127|NCT02520427|561645892|FG011|Overall Study|Withdrawal by Subject|0|||
155606128|NCT02520427|561645893|FG012|Overall Study|Withdrawal by Subject|1|||
155606129|NCT02520427|561645894|FG013|Overall Study|Withdrawal by Subject|1|||
155606130|NCT02520427|561645895|FG014|Overall Study|Withdrawal by Subject|1|||
155606131|NCT02520427|561645896|FG015|Overall Study|Withdrawal by Subject|0|||
155606132|NCT02520427|561645897|FG016|Overall Study|Withdrawal by Subject|1|||
155606133|NCT02520427|561645898|FG017|Overall Study|Withdrawal by Subject|0|||
155606134|NCT02520427|561645899|FG018|Overall Study|Withdrawal by Subject|0|||
155606135|NCT02520427|561645900|FG019|Overall Study|Withdrawal by Subject|3|||
155606136|NCT02520427|561645901|FG020|Overall Study|Withdrawal by Subject|2|||
155606137|NCT02520427|561645902|FG021|Overall Study|Withdrawal by Subject|0|||
155606138|NCT02520427|561645903|FG022|Overall Study|Withdrawal by Subject|0|||
155606139|NCT02520427|561645904|FG023|Overall Study|Withdrawal by Subject|0|||
155606140|NCT02520427|561645905|FG024|Overall Study|Withdrawal by Subject|0|||
155606141|NCT02520427|561645906|FG025|Overall Study|Withdrawal by Subject|0|||
155606142|NCT02520427|561645881|FG000|Overall Study|Death|1|||
155606143|NCT02520427|561645882|FG001|Overall Study|Death|0|||
155606144|NCT02520427|561645883|FG002|Overall Study|Death|0|||
155606145|NCT02520427|561645884|FG003|Overall Study|Death|0|||
155606146|NCT02520427|561645885|FG004|Overall Study|Death|0|||
155689147|NCT00977938|561954120|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
155689148|NCT00977938|561954121|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
155689149|NCT00977938|561954122|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
155689150|NCT00977938|561954123|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
155689151|NCT00977938|561954120|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
155689152|NCT00977938|561954121|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
155689153|NCT00977938|561954122|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
155689154|NCT00977938|561954123|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
155689155|NCT00977938|561954120|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
155689156|NCT00977938|561954121|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
155689157|NCT00977938|561954122|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
155689158|NCT00977938|561954123|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
155689159|NCT00977938|561954120|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
155689160|NCT00977938|561954121|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
155689161|NCT00977938|561954122|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
155689162|NCT00977938|561954123|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
155689163|NCT00977938|561954120|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
155689164|NCT00977938|561954121|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
155689165|NCT00977938|561954122|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
155689166|NCT00977938|561954123|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
155689167|NCT00977938|561954120|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
155689168|NCT00977938|561954121|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
155689169|NCT00977938|561954122|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
155689170|NCT00977938|561954123|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
155689171|NCT02142283|561954124|FG000|Overall Study|Death|20|||
155689172|NCT02142283|561954125|FG001|Overall Study|Death|18|||
155689173|NCT02142283|561954124|FG000|Overall Study|Withdrawal by Subject|1|||
155689174|NCT02142283|561954125|FG001|Overall Study|Withdrawal by Subject|3|||
155689175|NCT00747344|561954128|FG000|Controlled Period|Adverse Event|3|||
155689176|NCT00747344|561954129|FG001|Controlled Period|Adverse Event|0|||
155689177|NCT00747344|561954130|FG002|Controlled Period|Adverse Event|0|||
155689178|NCT00747344|561954131|FG003|Controlled Period|Adverse Event|0|||
155689179|NCT00747344|561954128|FG000|Controlled Period|Lack of Efficacy|2|||
155689180|NCT00747344|561954129|FG001|Controlled Period|Lack of Efficacy|1|||
155689181|NCT00747344|561954130|FG002|Controlled Period|Lack of Efficacy|0|||
155689182|NCT00747344|561954131|FG003|Controlled Period|Lack of Efficacy|0|||
155689183|NCT00747344|561954128|FG000|Controlled Period|Other|0|||
155689184|NCT00747344|561954129|FG001|Controlled Period|Other|3|||
155689185|NCT00747344|561954130|FG002|Controlled Period|Other|0|||
155689186|NCT00747344|561954131|FG003|Controlled Period|Other|0|||
155689187|NCT00747344|561954128|FG000|After Controlled Period|Adverse Event|0|||
155689188|NCT00747344|561954129|FG001|After Controlled Period|Adverse Event|0|||
155689189|NCT00747344|561954130|FG002|After Controlled Period|Adverse Event|0|||
155689190|NCT00747344|561954131|FG003|After Controlled Period|Adverse Event|1|||
155689191|NCT02460783|561954132|FG000|Overall Study|Withdrawal by Subject|1|||
155689192|NCT02460783|561954133|FG001|Overall Study|Withdrawal by Subject|3|||
155689193|NCT02460783|561954132|FG000|Overall Study|Lost to Follow-up|1|||
155689194|NCT02460783|561954133|FG001|Overall Study|Lost to Follow-up|1|||
155689195|NCT01484834|561954134|FG000|Overall Study|Lost to Follow-up|5|||
155689196|NCT01484834|561954135|FG001|Overall Study|Lost to Follow-up|8|||
155689197|NCT01484834|561954136|FG002|Overall Study|Lost to Follow-up|1|||
155689198|NCT01484834|561954137|FG003|Overall Study|Lost to Follow-up|4|||
155689199|NCT01166958|561954147|FG000|Overall Study|Withdrawal by Subject|1|||
155689200|NCT01166958|561954148|FG001|Overall Study|Withdrawal by Subject|0|||
155689201|NCT02680574|561954149|FG000|Overall Study|Death|137|||
155689202|NCT02680574|561954150|FG001|Overall Study|Death|137|||
155689203|NCT02680574|561954149|FG000|Overall Study|Withdrawal by Subject|17|||
155689204|NCT02680574|561954150|FG001|Overall Study|Withdrawal by Subject|9|||
155689205|NCT02680574|561954149|FG000|Overall Study|Lost to Follow-up|4|||
155689206|NCT02680574|561954150|FG001|Overall Study|Lost to Follow-up|6|||
155689207|NCT01605227|561954151|FG000|Overall Study|Did not receive study treatment|2|||
155689208|NCT01605227|561954152|FG001|Overall Study|Did not receive study treatment|3|||
155689209|NCT01605227|561954151|FG000|Overall Study|Adverse Event|228|||
155689210|NCT01605227|561954152|FG001|Overall Study|Adverse Event|42|||
155689211|NCT01605227|561954151|FG000|Overall Study|Progressive Disease|132|||
155689212|NCT01605227|561954152|FG001|Overall Study|Progressive Disease|128|||
155689213|NCT01605227|561954151|FG000|Overall Study|Clinical Deterioration|227|||
155689214|NCT01605227|561954152|FG001|Overall Study|Clinical Deterioration|133|||
155689215|NCT01605227|561954151|FG000|Overall Study|Lost to Follow-up|1|||
155689216|NCT01605227|561954152|FG001|Overall Study|Lost to Follow-up|0|||
155689217|NCT01605227|561954151|FG000|Overall Study|Protocol Violation|1|||
155689218|NCT01605227|561954152|FG001|Overall Study|Protocol Violation|0|||
155689219|NCT01605227|561954151|FG000|Overall Study|Physician Decision|9|||
155689220|NCT01605227|561954152|FG001|Overall Study|Physician Decision|7|||
155689221|NCT01605227|561954151|FG000|Overall Study|Withdrawal by Subject|18|||
155689222|NCT01605227|561954152|FG001|Overall Study|Withdrawal by Subject|14|||
155689223|NCT01605227|561954151|FG000|Overall Study|Sponsor Decision|2|||
155689224|NCT01605227|561954152|FG001|Overall Study|Sponsor Decision|0|||
155689225|NCT01605227|561954151|FG000|Overall Study|Started New Therapy|1|||
155689226|NCT01605227|561954152|FG001|Overall Study|Started New Therapy|0|||
155689227|NCT01605227|561954151|FG000|Overall Study|Subject Decision|0|||
155689228|NCT01605227|561954152|FG001|Overall Study|Subject Decision|1|||
155689229|NCT01605227|561954151|FG000|Overall Study|Dose Held >6 weeks|0|||
155689230|NCT01605227|561954152|FG001|Overall Study|Dose Held >6 weeks|1|||
155689231|NCT01286987|561954153|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
155689232|NCT01286987|561954154|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
155689233|NCT01286987|561954155|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
155689234|NCT01286987|561954156|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
155689235|NCT01286987|561954157|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
155689236|NCT01286987|561954158|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
155689237|NCT01286987|561954159|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
155689238|NCT01286987|561954160|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
155689239|NCT01286987|561954161|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
155689240|NCT01286987|561954162|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
155689241|NCT01286987|561954163|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
155689242|NCT01286987|561954164|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
155689243|NCT01286987|561954165|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
155689244|NCT01286987|561954166|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
155689245|NCT01286987|561954167|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
155606147|NCT02520427|561645886|FG005|Overall Study|Death|0|||
155606148|NCT02520427|561645887|FG006|Overall Study|Death|0|||
155606149|NCT02520427|561645888|FG007|Overall Study|Death|0|||
155689246|NCT01286987|561954153|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
155689247|NCT01286987|561954154|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
155689248|NCT01286987|561954155|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
155689249|NCT01286987|561954156|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
155689250|NCT01286987|561954157|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
155689251|NCT01286987|561954158|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
155689252|NCT01286987|561954159|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
155689253|NCT01286987|561954160|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
155689254|NCT01286987|561954161|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
155689255|NCT01286987|561954162|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
155689256|NCT01286987|561954163|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
155689257|NCT01286987|561954164|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
155689258|NCT01286987|561954165|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
155689259|NCT01286987|561954166|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
155689260|NCT01286987|561954167|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
155689261|NCT01286987|561954153|FG000|Part 1: Dose Escalation|Physician Decision|0|||
155689262|NCT01286987|561954154|FG001|Part 1: Dose Escalation|Physician Decision|0|||
155689263|NCT01286987|561954155|FG002|Part 1: Dose Escalation|Physician Decision|0|||
155689264|NCT01286987|561954156|FG003|Part 1: Dose Escalation|Physician Decision|0|||
155689265|NCT01286987|561954157|FG004|Part 1: Dose Escalation|Physician Decision|1|||
155689266|NCT01286987|561954158|FG005|Part 1: Dose Escalation|Physician Decision|0|||
155689267|NCT01286987|561954159|FG006|Part 1: Dose Escalation|Physician Decision|0|||
155689268|NCT01286987|561954160|FG007|Part 1: Dose Escalation|Physician Decision|0|||
155689269|NCT01286987|561954161|FG008|Part 1: Dose Escalation|Physician Decision|0|||
155689270|NCT01286987|561954162|FG009|Part 1: Dose Escalation|Physician Decision|0|||
155689271|NCT01286987|561954163|FG010|Part 1: Dose Escalation|Physician Decision|0|||
155689272|NCT01286987|561954164|FG011|Part 1: Dose Escalation|Physician Decision|0|||
155689273|NCT01286987|561954165|FG012|Part 1: Dose Escalation|Physician Decision|0|||
155689274|NCT01286987|561954166|FG013|Part 1: Dose Escalation|Physician Decision|0|||
155689275|NCT01286987|561954167|FG014|Part 1: Dose Escalation|Physician Decision|0|||
155689276|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Death|0|||
155689277|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Death|0|||
155689278|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Death|0|||
155689279|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Death|0|||
155689280|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Death|0|||
155689281|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Death|0|||
155689282|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Death|0|||
155689283|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Death|0|||
155689284|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Death|0|||
155689285|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Death|0|||
155689286|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Death|0|||
155689287|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Death|0|||
155689288|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Death|1|||
155689289|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Death|1|||
155689290|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Death|0|||
155689291|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Physician Decision|0|||
155689292|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Physician Decision|0|||
155689293|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Physician Decision|0|||
155689294|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Physician Decision|0|||
155689295|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Physician Decision|0|||
155689296|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Physician Decision|0|||
155689297|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Physician Decision|0|||
155689298|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Physician Decision|0|||
155689299|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Physician Decision|0|||
155689300|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Physician Decision|0|||
155689301|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Physician Decision|1|||
155689302|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Physician Decision|1|||
155689303|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Physician Decision|0|||
155689304|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Physician Decision|1|||
155689305|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Physician Decision|0|||
155689306|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Other|0|||
155689307|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Other|0|||
155689308|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Other|0|||
155689309|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Other|0|||
155689310|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Other|0|||
155689311|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Other|0|||
155689312|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Other|0|||
155689313|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Other|0|||
155689314|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Other|0|||
155689315|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Other|0|||
155689316|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Other|0|||
155689317|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Other|0|||
155689318|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Other|0|||
155689319|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Other|1|||
155689320|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Other|0|||
155689321|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
155689322|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
155689323|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
155689324|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
155689325|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
155689326|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
155689327|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
155689328|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
155689329|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
155689330|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
155689331|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
155689332|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
155689333|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
155689334|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
155689335|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
155689336|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
155689337|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
155689338|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
155689339|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
155689340|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
155689341|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
155689342|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
155689343|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
155689344|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
155689345|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
155689346|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
155689347|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
155689348|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
155689349|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
155689350|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
155689351|NCT01286987|561954153|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689352|NCT01286987|561954154|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689353|NCT01286987|561954155|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689354|NCT01286987|561954156|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689355|NCT01286987|561954157|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689356|NCT01286987|561954158|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689357|NCT01286987|561954159|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689358|NCT01286987|561954160|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689359|NCT01286987|561954161|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689360|NCT01286987|561954162|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689361|NCT01286987|561954163|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155689362|NCT01286987|561954164|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689363|NCT01286987|561954165|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689364|NCT01286987|561954166|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689365|NCT01286987|561954167|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155689366|NCT02847858|561954168|FG000|Overall Study|Lost to Follow-up|401|||
155689367|NCT02847858|561954169|FG001|Overall Study|Lost to Follow-up|269|||
155689368|NCT00624819|561954170|FG000|Follow-up Period: Year 4|Parents decision|0|||
155689369|NCT00624819|561954171|FG001|Follow-up Period: Year 4|Parents decision|0|||
155689370|NCT00624819|561954172|FG002|Follow-up Period: Year 4|Parents decision|1|||
155689371|NCT00624819|561954173|FG003|Follow-up Period: Year 4|Parents decision|0|||
155689372|NCT00624819|561954170|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
155689373|NCT00624819|561954171|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
155689374|NCT00624819|561954172|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
155689375|NCT00624819|561954173|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
155689376|NCT00681564|561954174|FG000|Overall Study|Lost to Follow-up|6|||
155689377|NCT00681564|561954175|FG001|Overall Study|Lost to Follow-up|6|||
155689378|NCT00681564|561954174|FG000|Overall Study|Withdrawal by Subject|0|||
155689379|NCT00681564|561954175|FG001|Overall Study|Withdrawal by Subject|1|||
155689380|NCT00681564|561954174|FG000|Overall Study|Death|0|||
155689381|NCT00681564|561954175|FG001|Overall Study|Death|1|||
155689382|NCT03093974|561954178|FG000|Overall Study|Withdrawal by Subject|32|||
155689383|NCT03093974|561954179|FG001|Overall Study|Withdrawal by Subject|27|||
155689384|NCT03093974|561954178|FG000|Overall Study|Adverse Event|17|||
155689385|NCT03093974|561954179|FG001|Overall Study|Adverse Event|24|||
155689386|NCT03093974|561954178|FG000|Overall Study|Death|0|||
155689387|NCT03093974|561954179|FG001|Overall Study|Death|1|||
155689388|NCT03093974|561954178|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155689389|NCT03093974|561954179|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155689390|NCT03093974|561954178|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
155689391|NCT03093974|561954179|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
155689392|NCT03093974|561954178|FG000|Overall Study|Lost to Follow-up|0|||
155689393|NCT03093974|561954179|FG001|Overall Study|Lost to Follow-up|1|||
155689394|NCT03093974|561954178|FG000|Overall Study|Other|1|||
155689395|NCT03093974|561954179|FG001|Overall Study|Other|2|||
155689396|NCT02387164|561954180|FG000|Overall Study|Lost to Follow-up|2|||
155689397|NCT02387164|561954181|FG001|Overall Study|Lost to Follow-up|0|||
155689398|NCT02387164|561954180|FG000|Overall Study|Diagnosed|1|||
155689399|NCT02387164|561954181|FG001|Overall Study|Diagnosed|2|||
155689400|NCT00541099|561954186|FG000|Overall Study|Ineligible|3|||
155689401|NCT00066469|561954187|FG000|Overall Study|Death|3|||
155689402|NCT00066469|561954187|FG000|Overall Study|Lack of Efficacy|9|||
155689403|NCT00066469|561954187|FG000|Overall Study|Lost to Follow-up|1|||
155689404|NCT00066469|561954187|FG000|Overall Study|Physician Decision|1|||
155689405|NCT00066469|561954187|FG000|Overall Study|Withdrawal by Subject|1|||
155689406|NCT00066469|561954187|FG000|Overall Study|ineligible|1|||
155689407|NCT01038713|561954188|FG000|Overall Study|Patient to hospice|1|||
155689408|NCT01038713|561954189|FG001|Overall Study|Patient to hospice|1|||
155689409|NCT01038713|561954190|FG002|Overall Study|Patient to hospice|1|||
155689410|NCT01038713|561954188|FG000|Overall Study|Lost to Follow-up|3|||
155689411|NCT01038713|561954189|FG001|Overall Study|Lost to Follow-up|0|||
155689412|NCT01038713|561954190|FG002|Overall Study|Lost to Follow-up|0|||
155689413|NCT01038713|561954188|FG000|Overall Study|Neuroendocrine Tumor|0|||
155689414|NCT01038713|561954189|FG001|Overall Study|Neuroendocrine Tumor|1|||
155689415|NCT01038713|561954190|FG002|Overall Study|Neuroendocrine Tumor|0|||
155689416|NCT01038713|561954188|FG000|Overall Study|died from PEP|0|||
155689417|NCT01038713|561954189|FG001|Overall Study|died from PEP|1|||
155689418|NCT01038713|561954190|FG002|Overall Study|died from PEP|0|||
155689419|NCT01038713|561954188|FG000|Overall Study|Autoimmune Pancreatitis|1|||
155689420|NCT01038713|561954189|FG001|Overall Study|Autoimmune Pancreatitis|0|||
155689421|NCT01038713|561954190|FG002|Overall Study|Autoimmune Pancreatitis|0|||
155689422|NCT01853072|561954191|FG000|Overall Study|Adverse event prior to treatment|0|||
155689423|NCT01853072|561954192|FG001|Overall Study|Adverse event prior to treatment|1|||
155689424|NCT01853072|561954191|FG000|Overall Study|Adverse Event|0|||
155689425|NCT01853072|561954192|FG001|Overall Study|Adverse Event|3|||
155689426|NCT01853072|561954191|FG000|Overall Study|Death|1|||
155689427|NCT01853072|561954192|FG001|Overall Study|Death|4|||
155689428|NCT01853072|561954191|FG000|Overall Study|Lost to Follow-up|0|||
155689429|NCT01853072|561954192|FG001|Overall Study|Lost to Follow-up|3|||
155689430|NCT01853072|561954191|FG000|Overall Study|Non-compliance with study drug|0|||
155689431|NCT01853072|561954192|FG001|Overall Study|Non-compliance with study drug|1|||
155689432|NCT01853072|561954191|FG000|Overall Study|Physician Decision|1|||
155689433|NCT01853072|561954192|FG001|Overall Study|Physician Decision|1|||
155689434|NCT01853072|561954191|FG000|Overall Study|Withdrawal by Subject|1|||
155689435|NCT01853072|561954192|FG001|Overall Study|Withdrawal by Subject|2|||
155689436|NCT01853072|561954191|FG000|Overall Study|Reason not specified|9|||
155689437|NCT01853072|561954192|FG001|Overall Study|Reason not specified|6|||
155689438|NCT00930969|561954193|FG000|Overall Study|Death|5|||
155689439|NCT00930969|561954193|FG000|Overall Study|Lost to Follow-up|1|||
155689440|NCT00930969|561954193|FG000|Overall Study|Physician Decision|13|||
155689441|NCT00930969|561954193|FG000|Overall Study|Withdrawal by Subject|19|||
155689442|NCT00657150|561954194|FG000|Overall Study|Adverse Event|19|||
155689443|NCT00657150|561954195|FG001|Overall Study|Adverse Event|10|||
155689444|NCT00657150|561954194|FG000|Overall Study|Non-compliant with protocol|5|||
155689445|NCT00657150|561954195|FG001|Overall Study|Non-compliant with protocol|9|||
155689446|NCT00657150|561954194|FG000|Overall Study|Lost to Follow-up|2|||
155689447|NCT00657150|561954195|FG001|Overall Study|Lost to Follow-up|0|||
155689448|NCT00657150|561954194|FG000|Overall Study|Withdrawal by Subject|51|||
155689449|NCT00657150|561954195|FG001|Overall Study|Withdrawal by Subject|36|||
155689450|NCT00657150|561954194|FG000|Overall Study|Other|38|||
155689451|NCT00657150|561954195|FG001|Overall Study|Other|38|||
155689452|NCT00657150|561954194|FG000|Treatment|Adverse Event|60|||
155689453|NCT00657150|561954195|FG001|Treatment|Adverse Event|53|||
155689454|NCT00657150|561954194|FG000|Treatment|Non-compliant with protocol|10|||
155689455|NCT00657150|561954195|FG001|Treatment|Non-compliant with protocol|9|||
155689456|NCT00657150|561954194|FG000|Treatment|Lost to Follow-up|1|||
155689457|NCT00657150|561954195|FG001|Treatment|Lost to Follow-up|0|||
155689458|NCT00657150|561954194|FG000|Treatment|Withdrawal by Subject|23|||
155689459|NCT00657150|561954195|FG001|Treatment|Withdrawal by Subject|20|||
155689460|NCT00657150|561954194|FG000|Treatment|Other|13|||
155689461|NCT00657150|561954195|FG001|Treatment|Other|15|||
155689462|NCT01416441|561954196|FG000|Overall Study|Lost to Follow-up|5|||
155689463|NCT01416441|561954196|FG000|Overall Study|Adverse Event|6|||
155689464|NCT01416441|561954196|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
155689465|NCT01416441|561954196|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
155689466|NCT01416441|561954196|FG000|Overall Study|Investigator Withdrew Subject|2|||
155689467|NCT01416441|561954196|FG000|Overall Study|Subject Withdrew Consent|12|||
155689468|NCT01416441|561954196|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
155689469|NCT02653495|561954211|FG000|Overall Study|Lost to Follow-up|2|||
155689470|NCT02653495|561954212|FG001|Overall Study|Lost to Follow-up|0|||
155689471|NCT02653495|561954211|FG000|Overall Study|Screening Failure|10|||
155689472|NCT02653495|561954212|FG001|Overall Study|Screening Failure|0|||
155689473|NCT03515941|561954215|FG000|Overall Study|Adverse Event|1|||
155689474|NCT03515941|561954216|FG001|Overall Study|Adverse Event|0|||
155689475|NCT00461305|561954217|FG000|Treatment|Adverse Event|26|||
155689476|NCT00461305|561954218|FG001|Treatment|Adverse Event|3|||
155689477|NCT00461305|561954217|FG000|Treatment|Lost to Follow-up|4|||
155689478|NCT00461305|561954218|FG001|Treatment|Lost to Follow-up|2|||
155689479|NCT00461305|561954217|FG000|Treatment|Protocol Violation|13|||
155689480|NCT00461305|561954218|FG001|Treatment|Protocol Violation|2|||
155689481|NCT00461305|561954217|FG000|Treatment|Withdrawal by Subject|48|||
155689482|NCT00461305|561954218|FG001|Treatment|Withdrawal by Subject|2|||
155689483|NCT00461305|561954217|FG000|Treatment|Never dispensed|5|||
155689484|NCT00461305|561954218|FG001|Treatment|Never dispensed|0|||
155689485|NCT00461305|561954217|FG000|Treatment|Study drug not taken|1|||
155689486|NCT00461305|561954218|FG001|Treatment|Study drug not taken|0|||
155689487|NCT00461305|561954217|FG000|Treatment|Partially missing diary|2|||
155689488|NCT00461305|561954218|FG001|Treatment|Partially missing diary|0|||
155689489|NCT00461305|561954217|FG000|Treatment|Other (missing drug etc)|2|||
155689490|NCT00461305|561954218|FG001|Treatment|Other (missing drug etc)|0|||
155689491|NCT00461305|561954217|FG000|Continued Treatment|Adverse Event|26|||
155689492|NCT00461305|561954218|FG001|Continued Treatment|Adverse Event|0|||
155689493|NCT00461305|561954217|FG000|Continued Treatment|Lost to Follow-up|4|||
155689494|NCT00461305|561954218|FG001|Continued Treatment|Lost to Follow-up|0|||
155689495|NCT00461305|561954217|FG000|Continued Treatment|Protocol Violation|13|||
155689496|NCT00461305|561954218|FG001|Continued Treatment|Protocol Violation|0|||
155689497|NCT00461305|561954217|FG000|Continued Treatment|Withdrawal by Subject|48|||
155689498|NCT00461305|561954218|FG001|Continued Treatment|Withdrawal by Subject|0|||
155689499|NCT00461305|561954217|FG000|Continued Treatment|Partially missing diary|2|||
155689500|NCT00461305|561954218|FG001|Continued Treatment|Partially missing diary|0|||
155689501|NCT00461305|561954217|FG000|Continued Treatment|Other (missing drug etc)|2|||
155689502|NCT00461305|561954218|FG001|Continued Treatment|Other (missing drug etc)|0|||
155689503|NCT01896271|561954220|FG000|Overall Study|Physician Decision|10|||
155689504|NCT01294462|561954221|FG000|Overall Study|Lost to Follow-up|1|||
155689505|NCT01294462|561954222|FG001|Overall Study|Lost to Follow-up|0|||
155689506|NCT01294462|561954221|FG000|Overall Study|Withdrawal by Subject|65|||
155689507|NCT01294462|561954222|FG001|Overall Study|Withdrawal by Subject|63|||
155689508|NCT02743780|561954223|FG000|Part 3 (7 Days)|Adverse Event|0|||
155689509|NCT02743780|561954224|FG001|Part 3 (7 Days)|Adverse Event|0|||
155689510|NCT02743780|561954225|FG002|Part 3 (7 Days)|Adverse Event|1|||
155689511|NCT02743780|561954226|FG003|Part 3 (7 Days)|Adverse Event|0|||
155689512|NCT02743780|561954227|FG004|Part 3 (7 Days)|Adverse Event|0|||
155689513|NCT01460407|561954233|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
155689514|NCT01460407|561954234|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
155689515|NCT00526110|561954235|FG000|Overall Study|Adverse Event|2|||
155689516|NCT00526110|561954236|FG001|Overall Study|Adverse Event|9|||
155689517|NCT00526110|561954235|FG000|Overall Study|Disease Progression|0|||
155689518|NCT00526110|561954236|FG001|Overall Study|Disease Progression|19|||
155689519|NCT00526110|561954235|FG000|Overall Study|Maximal Response|0|||
155689520|NCT00526110|561954236|FG001|Overall Study|Maximal Response|6|||
155689521|NCT00526110|561954235|FG000|Overall Study|Withdrawal by Subject|0|||
155689522|NCT00526110|561954236|FG001|Overall Study|Withdrawal by Subject|2|||
155689523|NCT00526110|561954235|FG000|Overall Study|Poor Tolerance|0|||
155689524|NCT00526110|561954236|FG001|Overall Study|Poor Tolerance|5|||
155689525|NCT01400243|561954237|FG000|Overall Study|Protocol Violation|8|||
155689526|NCT01400243|561954238|FG001|Overall Study|Protocol Violation|11|||
155689527|NCT00953680|561954239|FG000|Period 1|Withdrawal by Subject|0|||
155689528|NCT00953680|561954240|FG001|Period 1|Withdrawal by Subject|1|||
155689529|NCT01309269|561955892|FG000|Overall Study|Adverse Event|56|||
155689530|NCT01309269|561955892|FG000|Overall Study|Withdrawal by Subject|25|||
155689531|NCT01309269|561955892|FG000|Overall Study|Lack of Acceptance|15|||
155689532|NCT01309269|561955892|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
155689533|NCT01309269|561955892|FG000|Overall Study|Kidney Transplant|25|||
155689534|NCT01309269|561955892|FG000|Overall Study|Administrative Problems|141|||
155689535|NCT01309269|561955892|FG000|Overall Study|Other|256|||
155689536|NCT01309269|561955892|FG000|Overall Study|Other|1|||
155689537|NCT01309269|561955892|FG000|Overall Study|Study Completion Data Not Recorded|95|||
155689538|NCT01309269|561955892|FG000|Overall Study|Enrolled but not Treated|107|||
155689539|NCT03383783|561955909|FG000|Overall Study|Withdrawal by Subject|2|||
155689540|NCT01703117|561955915|FG000|Overall Study|Adverse Event|4|||
155689541|NCT01703117|561955916|FG001|Overall Study|Adverse Event|3|||
155689542|NCT01703117|561955915|FG000|Overall Study|Withdrawal by Subject|0|||
155689543|NCT01703117|561955916|FG001|Overall Study|Withdrawal by Subject|1|||
155689544|NCT00440310|561955918|FG000|Overall Study|Lost to Follow-up|4|||
155689545|NCT00440310|561955919|FG001|Overall Study|Lost to Follow-up|5|||
155689546|NCT00440310|561955918|FG000|Overall Study|Protocol Violation|0|||
155689547|NCT00440310|561955919|FG001|Overall Study|Protocol Violation|1|||
155689548|NCT00440310|561955918|FG000|Overall Study|Withdrawal by Subject|15|||
155689549|NCT00440310|561955919|FG001|Overall Study|Withdrawal by Subject|14|||
155689550|NCT00440310|561955918|FG000|Overall Study|No Reply at EOS|7|||
155689551|NCT00440310|561955919|FG001|Overall Study|No Reply at EOS|7|||
155689552|NCT00440310|561955918|FG000|Overall Study|Other|1|||
155689553|NCT00440310|561955919|FG001|Overall Study|Other|0|||
155689554|NCT00440310|561955918|FG000|Overall Study|Status Unknown|1|||
155689555|NCT00440310|561955919|FG001|Overall Study|Status Unknown|3|||
155689556|NCT02119156|561955920|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
155689557|NCT02119156|561955921|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
155689558|NCT02119156|561955922|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
155689559|NCT02119156|561955920|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
155689560|NCT02119156|561955921|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
155689561|NCT02119156|561955922|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
155689562|NCT02119156|561955920|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
155689563|NCT02119156|561955921|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
155689564|NCT02119156|561955922|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
155689565|NCT02119156|561955920|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
155689566|NCT02119156|561955921|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
155689567|NCT02119156|561955922|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
155689568|NCT02119156|561955920|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
155606150|NCT02520427|561645889|FG008|Overall Study|Death|0|||
155606151|NCT02520427|561645890|FG009|Overall Study|Death|0|||
155606152|NCT02520427|561645891|FG010|Overall Study|Death|0|||
155606153|NCT02520427|561645892|FG011|Overall Study|Death|0|||
155606154|NCT02520427|561645893|FG012|Overall Study|Death|0|||
155606155|NCT02520427|561645894|FG013|Overall Study|Death|0|||
155606156|NCT02520427|561645895|FG014|Overall Study|Death|0|||
155606157|NCT02520427|561645896|FG015|Overall Study|Death|0|||
155606158|NCT02520427|561645897|FG016|Overall Study|Death|2|||
155606159|NCT02520427|561645898|FG017|Overall Study|Death|1|||
155606160|NCT02520427|561645899|FG018|Overall Study|Death|3|||
155606161|NCT02520427|561645900|FG019|Overall Study|Death|2|||
155606162|NCT02520427|561645901|FG020|Overall Study|Death|0|||
155606163|NCT02520427|561645902|FG021|Overall Study|Death|0|||
155606164|NCT02520427|561645903|FG022|Overall Study|Death|1|||
155606165|NCT02520427|561645904|FG023|Overall Study|Death|0|||
155606166|NCT02520427|561645905|FG024|Overall Study|Death|1|||
155606167|NCT02520427|561645906|FG025|Overall Study|Death|0|||
155606168|NCT00793624|561645907|FG000|Overall Study|Adverse Event|18|||
155606169|NCT00793624|561645908|FG001|Overall Study|Adverse Event|16|||
155606170|NCT00793624|561645909|FG002|Overall Study|Adverse Event|15|||
155606171|NCT00793624|561645910|FG003|Overall Study|Adverse Event|20|||
155606172|NCT00793624|561645907|FG000|Overall Study|Lost to Follow-up|2|||
155606173|NCT00793624|561645908|FG001|Overall Study|Lost to Follow-up|2|||
155606174|NCT00793624|561645909|FG002|Overall Study|Lost to Follow-up|4|||
155606175|NCT00793624|561645910|FG003|Overall Study|Lost to Follow-up|0|||
155606176|NCT00793624|561645907|FG000|Overall Study|Withdrawal by Subject|20|||
155606177|NCT00793624|561645908|FG001|Overall Study|Withdrawal by Subject|9|||
155606178|NCT00793624|561645909|FG002|Overall Study|Withdrawal by Subject|11|||
155606179|NCT00793624|561645910|FG003|Overall Study|Withdrawal by Subject|14|||
155606180|NCT00793624|561645907|FG000|Overall Study|Lack of Efficacy|9|||
155606181|NCT00793624|561645908|FG001|Overall Study|Lack of Efficacy|2|||
155606182|NCT00793624|561645909|FG002|Overall Study|Lack of Efficacy|1|||
155606183|NCT00793624|561645910|FG003|Overall Study|Lack of Efficacy|3|||
155606184|NCT00793624|561645907|FG000|Overall Study|Non compliance with protocol|2|||
155606185|NCT00793624|561645908|FG001|Overall Study|Non compliance with protocol|3|||
155606186|NCT00793624|561645909|FG002|Overall Study|Non compliance with protocol|2|||
155606187|NCT00793624|561645910|FG003|Overall Study|Non compliance with protocol|3|||
155606188|NCT00793624|561645907|FG000|Overall Study|Other reason not described above|6|||
155606189|NCT00793624|561645908|FG001|Overall Study|Other reason not described above|4|||
155606190|NCT00793624|561645909|FG002|Overall Study|Other reason not described above|6|||
155606191|NCT00793624|561645910|FG003|Overall Study|Other reason not described above|3|||
155606192|NCT02227368|561647607|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
155606193|NCT02227368|561647608|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
155606194|NCT02227368|561647607|FG000|Overall Study|Lost to Follow-up|1|||
155606195|NCT02227368|561647608|FG001|Overall Study|Lost to Follow-up|0|||
155606196|NCT02227368|561647607|FG000|Overall Study|Adverse Event|1|||
155606197|NCT02227368|561647608|FG001|Overall Study|Adverse Event|0|||
155606198|NCT02437188|561647611|FG000|Overall Study|Randomized but did not receive surgery|4|||
155606199|NCT02437188|561647612|FG001|Overall Study|Randomized but did not receive surgery|8|||
155606200|NCT02437188|561647611|FG000|Overall Study|Adverse Event|0|||
155606201|NCT02437188|561647612|FG001|Overall Study|Adverse Event|1|||
155606202|NCT01663857|561647613|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
155606203|NCT01663857|561647614|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
155606204|NCT01663857|561647615|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
155606205|NCT01663857|561647616|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
155606206|NCT01663857|561647613|FG000|Overall Study|Lost to Follow-up|0|||
155606207|NCT01663857|561647614|FG001|Overall Study|Lost to Follow-up|0|||
155606208|NCT01663857|561647615|FG002|Overall Study|Lost to Follow-up|3|||
155606209|NCT01663857|561647616|FG003|Overall Study|Lost to Follow-up|1|||
155606210|NCT01172808|561647619|FG000|Overall Study|Adverse Event|8|||
155606211|NCT01172808|561647620|FG001|Overall Study|Adverse Event|4|||
155606212|NCT01172808|561647621|FG002|Overall Study|Adverse Event|8|||
155606213|NCT01172808|561647622|FG003|Overall Study|Adverse Event|3|||
155606214|NCT01172808|561647619|FG000|Overall Study|Lack of Efficacy|1|||
155606215|NCT01172808|561647620|FG001|Overall Study|Lack of Efficacy|0|||
155606216|NCT01172808|561647621|FG002|Overall Study|Lack of Efficacy|0|||
155606217|NCT01172808|561647622|FG003|Overall Study|Lack of Efficacy|0|||
155606218|NCT01172808|561647619|FG000|Overall Study|Protocol Violation|2|||
155606219|NCT01172808|561647620|FG001|Overall Study|Protocol Violation|2|||
155606220|NCT01172808|561647621|FG002|Overall Study|Protocol Violation|2|||
155606221|NCT01172808|561647622|FG003|Overall Study|Protocol Violation|0|||
155606222|NCT01172808|561647619|FG000|Overall Study|Lost to Follow-up|0|||
155606223|NCT01172808|561647620|FG001|Overall Study|Lost to Follow-up|1|||
155606224|NCT01172808|561647621|FG002|Overall Study|Lost to Follow-up|1|||
155606225|NCT01172808|561647622|FG003|Overall Study|Lost to Follow-up|3|||
155606226|NCT01172808|561647619|FG000|Overall Study|Withdrawal by Subject|4|||
155606227|NCT01172808|561647620|FG001|Overall Study|Withdrawal by Subject|1|||
155606228|NCT01172808|561647621|FG002|Overall Study|Withdrawal by Subject|3|||
155689569|NCT02119156|561955921|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
155689570|NCT02119156|561955922|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
155689571|NCT02469415|561955923|FG000|Overall Study|Withdrawal by Subject|1|||
155689572|NCT02469415|561955923|FG000|Overall Study|Investigational agent placed on hold|2|||
155689573|NCT00330928|561955934|FG000|Overall Study|Lost to Follow-up|6|||
155689574|NCT00330928|561955934|FG000|Overall Study|Physician Decision|9|||
155689575|NCT00330928|561955934|FG000|Overall Study|Death|1|||
155689576|NCT00330928|561955934|FG000|Overall Study|IVUS could not be performed.|1|||
155689577|NCT03028480|561955935|FG000|Overall Study|No revisit after the first prescription date|2|||
155689578|NCT03028480|561955935|FG000|Overall Study|Did not use the drug|1|||
155689579|NCT03028480|561955935|FG000|Overall Study|Violation of the enrollment deadline|10|||
155689580|NCT03028480|561955935|FG000|Overall Study|Case report forms were not collected|21|||
155689581|NCT01030874|561955938|FG000|Overall Study|Withdrawal by Subject|1|||
155689582|NCT01030874|561955939|FG001|Overall Study|Withdrawal by Subject|0|||
155689583|NCT01030874|561955938|FG000|Overall Study|Discharged in first 2 weeks|17|||
155689584|NCT01030874|561955939|FG001|Overall Study|Discharged in first 2 weeks|16|||
155689585|NCT02403635|561955943|FG000|Overall Study|Not eligible|9|||
155689586|NCT03554772|561955946|FG000|Overall Study|Lost to Follow-up|0|||
155689587|NCT03554772|561955947|FG001|Overall Study|Lost to Follow-up|0|||
155689588|NCT03554772|561955948|FG002|Overall Study|Lost to Follow-up|0|||
155689589|NCT03554772|561955949|FG003|Overall Study|Lost to Follow-up|2|||
155689590|NCT03362931|561955951|FG000|Overall Study|Adverse Event|1|||
155689591|NCT03362931|561955951|FG000|Overall Study|Death|2|||
155689592|NCT01998893|561955952|FG000|Overall Study|Adverse Event|2|||
155689593|NCT01998893|561955952|FG000|Overall Study|Death|1|||
155689594|NCT01998893|561955952|FG000|Overall Study|Lost to Follow-up|8|||
155689595|NCT01998893|561955952|FG000|Overall Study|Physician Decision|2|||
155689596|NCT01998893|561955952|FG000|Overall Study|Protocol Violation|2|||
155689597|NCT01998893|561955952|FG000|Overall Study|Withdrawal by Subject|1|||
155689598|NCT01998893|561955952|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
155689599|NCT03276052|561955953|FG000|Overall Study|Withdrawal by Subject|5|||
155689600|NCT03276052|561955953|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
155689601|NCT05136898|561955958|FG000|Overall Study|Adverse Event|2|||
155689602|NCT01133405|561955959|FG000|Period 1|Withdrawal by Subject|0|||
155689603|NCT01133405|561955960|FG001|Period 1|Withdrawal by Subject|1|||
155689604|NCT01133405|561955961|FG002|Period 1|Withdrawal by Subject|0|||
155689605|NCT01133405|561955962|FG003|Period 1|Withdrawal by Subject|1|||
155689606|NCT01133405|561955963|FG004|Period 1|Withdrawal by Subject|0|||
155689607|NCT01133405|561955964|FG005|Period 1|Withdrawal by Subject|1|||
155689608|NCT01133405|561955965|FG006|Period 1|Withdrawal by Subject|0|||
155689609|NCT01133405|561955966|FG007|Period 1|Withdrawal by Subject|0|||
155689610|NCT01133405|561955967|FG008|Period 1|Withdrawal by Subject|0|||
155689611|NCT01133405|561955968|FG009|Period 1|Withdrawal by Subject|0|||
155689612|NCT01133405|561955959|FG000|Period 1|Physician Decision|0|||
155689613|NCT01133405|561955960|FG001|Period 1|Physician Decision|0|||
155689614|NCT01133405|561955961|FG002|Period 1|Physician Decision|0|||
155689615|NCT01133405|561955962|FG003|Period 1|Physician Decision|1|||
155689616|NCT01133405|561955963|FG004|Period 1|Physician Decision|0|||
155689617|NCT01133405|561955964|FG005|Period 1|Physician Decision|0|||
155689618|NCT01133405|561955965|FG006|Period 1|Physician Decision|0|||
155689619|NCT01133405|561955966|FG007|Period 1|Physician Decision|0|||
155689620|NCT01133405|561955967|FG008|Period 1|Physician Decision|0|||
155689621|NCT01133405|561955968|FG009|Period 1|Physician Decision|0|||
155689622|NCT01133405|561955959|FG000|Period 1|Discontinued after randomization|1|||
155689623|NCT01133405|561955960|FG001|Period 1|Discontinued after randomization|0|||
155689624|NCT01133405|561955961|FG002|Period 1|Discontinued after randomization|0|||
155689625|NCT01133405|561955962|FG003|Period 1|Discontinued after randomization|0|||
155689626|NCT01133405|561955963|FG004|Period 1|Discontinued after randomization|0|||
155689627|NCT01133405|561955964|FG005|Period 1|Discontinued after randomization|0|||
155689628|NCT01133405|561955965|FG006|Period 1|Discontinued after randomization|1|||
155689629|NCT01133405|561955966|FG007|Period 1|Discontinued after randomization|0|||
155689630|NCT01133405|561955967|FG008|Period 1|Discontinued after randomization|0|||
155689631|NCT01133405|561955968|FG009|Period 1|Discontinued after randomization|0|||
155689632|NCT01133405|561955959|FG000|Period 1|Received drug only in period 2|0|||
155689633|NCT01133405|561955960|FG001|Period 1|Received drug only in period 2|1|||
155689634|NCT01133405|561955961|FG002|Period 1|Received drug only in period 2|0|||
155689635|NCT01133405|561955962|FG003|Period 1|Received drug only in period 2|2|||
155689636|NCT01133405|561955963|FG004|Period 1|Received drug only in period 2|0|||
155689637|NCT01133405|561955964|FG005|Period 1|Received drug only in period 2|1|||
155689638|NCT01133405|561955965|FG006|Period 1|Received drug only in period 2|0|||
155689639|NCT01133405|561955966|FG007|Period 1|Received drug only in period 2|0|||
155689640|NCT01133405|561955967|FG008|Period 1|Received drug only in period 2|0|||
155689641|NCT01133405|561955968|FG009|Period 1|Received drug only in period 2|0|||
155689642|NCT01133405|561955959|FG000|Period 1|Received drug only in period 3|0|||
155689643|NCT01133405|561955960|FG001|Period 1|Received drug only in period 3|1|||
155689644|NCT01133405|561955961|FG002|Period 1|Received drug only in period 3|1|||
155689645|NCT01133405|561955962|FG003|Period 1|Received drug only in period 3|0|||
155689646|NCT01133405|561955963|FG004|Period 1|Received drug only in period 3|0|||
155689647|NCT01133405|561955964|FG005|Period 1|Received drug only in period 3|0|||
155689648|NCT01133405|561955965|FG006|Period 1|Received drug only in period 3|0|||
155689649|NCT01133405|561955966|FG007|Period 1|Received drug only in period 3|0|||
155689650|NCT01133405|561955967|FG008|Period 1|Received drug only in period 3|0|||
155689651|NCT01133405|561955968|FG009|Period 1|Received drug only in period 3|0|||
155689652|NCT01133405|561955959|FG000|Period 2|Adverse Event|0|||
155689653|NCT01133405|561955960|FG001|Period 2|Adverse Event|0|||
155689654|NCT01133405|561955961|FG002|Period 2|Adverse Event|1|||
155689655|NCT01133405|561955962|FG003|Period 2|Adverse Event|0|||
155689656|NCT01133405|561955963|FG004|Period 2|Adverse Event|0|||
155689657|NCT01133405|561955964|FG005|Period 2|Adverse Event|0|||
155689658|NCT01133405|561955965|FG006|Period 2|Adverse Event|0|||
155689659|NCT01133405|561955966|FG007|Period 2|Adverse Event|0|||
155689660|NCT01133405|561955967|FG008|Period 2|Adverse Event|0|||
155689661|NCT01133405|561955968|FG009|Period 2|Adverse Event|0|||
155689662|NCT01133405|561955959|FG000|Period 2|Withdrawal by Subject|0|||
155689663|NCT01133405|561955960|FG001|Period 2|Withdrawal by Subject|0|||
155689664|NCT01133405|561955961|FG002|Period 2|Withdrawal by Subject|0|||
155689665|NCT01133405|561955962|FG003|Period 2|Withdrawal by Subject|1|||
155689666|NCT01133405|561955963|FG004|Period 2|Withdrawal by Subject|0|||
155689667|NCT01133405|561955964|FG005|Period 2|Withdrawal by Subject|1|||
155689668|NCT01133405|561955965|FG006|Period 2|Withdrawal by Subject|0|||
155689669|NCT01133405|561955966|FG007|Period 2|Withdrawal by Subject|0|||
155689670|NCT01133405|561955967|FG008|Period 2|Withdrawal by Subject|0|||
155689671|NCT01133405|561955968|FG009|Period 2|Withdrawal by Subject|0|||
155689672|NCT01133405|561955959|FG000|Period 2|Entry Criteria Not Met|0|||
155689673|NCT01133405|561955960|FG001|Period 2|Entry Criteria Not Met|1|||
155689674|NCT01133405|561955961|FG002|Period 2|Entry Criteria Not Met|0|||
155689675|NCT01133405|561955962|FG003|Period 2|Entry Criteria Not Met|0|||
155689676|NCT01133405|561955963|FG004|Period 2|Entry Criteria Not Met|0|||
155689677|NCT01133405|561955964|FG005|Period 2|Entry Criteria Not Met|0|||
155689678|NCT01133405|561955965|FG006|Period 2|Entry Criteria Not Met|0|||
155689679|NCT01133405|561955966|FG007|Period 2|Entry Criteria Not Met|0|||
155689680|NCT01133405|561955967|FG008|Period 2|Entry Criteria Not Met|0|||
155689681|NCT01133405|561955968|FG009|Period 2|Entry Criteria Not Met|0|||
155689682|NCT01133405|561955959|FG000|Period 2|Physician Decision|0|||
155689683|NCT01133405|561955960|FG001|Period 2|Physician Decision|0|||
155689684|NCT01133405|561955961|FG002|Period 2|Physician Decision|0|||
155689685|NCT01133405|561955962|FG003|Period 2|Physician Decision|0|||
155689686|NCT01133405|561955963|FG004|Period 2|Physician Decision|0|||
155689687|NCT01133405|561955964|FG005|Period 2|Physician Decision|1|||
155689688|NCT01133405|561955965|FG006|Period 2|Physician Decision|0|||
155689689|NCT01133405|561955966|FG007|Period 2|Physician Decision|0|||
155689690|NCT01133405|561955967|FG008|Period 2|Physician Decision|0|||
155689691|NCT01133405|561955968|FG009|Period 2|Physician Decision|0|||
155689692|NCT03300024|561955971|FG000|Overall Study|Physician Decision|4|||
155689693|NCT03300024|561955972|FG001|Overall Study|Physician Decision|6|||
155689694|NCT01238835|561955973|FG000|Overall Study|Death|124|||
155689695|NCT01238835|561955973|FG000|Overall Study|Withdrawal by Subject|9|||
155689696|NCT01238835|561955973|FG000|Overall Study|Lost to Follow-up|1|||
155689697|NCT01238835|561955973|FG000|Overall Study|Site early discontinuation|2|||
155689698|NCT00554619|561955974|FG000|Overall Study|Adverse Event|1|||
155689699|NCT00554619|561955974|FG000|Overall Study|Physician Decision|1|||
155689700|NCT00554619|561955974|FG000|Overall Study|Liver Function Test Abnormality|1|||
155689701|NCT00907803|561955978|FG000|Overall Study|Withdrawal of consent - long commute|1|||
155689702|NCT00907803|561955979|FG001|Overall Study|Withdrawal of consent - long commute|0|||
155689703|NCT00907803|561955980|FG002|Overall Study|Withdrawal of consent - long commute|0|||
155689704|NCT00907803|561955978|FG000|Overall Study|Adverse Event|2|||
155689705|NCT00907803|561955979|FG001|Overall Study|Adverse Event|0|||
155689706|NCT00907803|561955980|FG002|Overall Study|Adverse Event|0|||
155689707|NCT00907803|561955978|FG000|Overall Study|Withdrawal by Subject|0|||
155689708|NCT00907803|561955979|FG001|Overall Study|Withdrawal by Subject|1|||
155689709|NCT00907803|561955980|FG002|Overall Study|Withdrawal by Subject|0|||
155689710|NCT00907803|561955978|FG000|Overall Study|Lost to Follow-up|0|||
155689711|NCT00907803|561955979|FG001|Overall Study|Lost to Follow-up|1|||
155689712|NCT00907803|561955980|FG002|Overall Study|Lost to Follow-up|0|||
155689713|NCT00907803|561955978|FG000|Overall Study|Protocol Violation|0|||
155689714|NCT00907803|561955979|FG001|Overall Study|Protocol Violation|1|||
155689715|NCT00907803|561955980|FG002|Overall Study|Protocol Violation|0|||
155689716|NCT05426031|561955985|FG000|Overall Study|Circulatory Arrest|3|||
155689717|NCT05426031|561955986|FG001|Overall Study|Circulatory Arrest|2|||
155689718|NCT00241631|561955991|FG000|Run in (2 Weeks)|Physician Decision|3|||
155689719|NCT00241631|561955992|FG001|Run in (2 Weeks)|Physician Decision|3|||
155689720|NCT00241631|561955991|FG000|Phase 1 (4 Weeks)|sore throat|1|||
155689721|NCT00241631|561955992|FG001|Phase 1 (4 Weeks)|sore throat|0|||
155689722|NCT00241631|561955991|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
155689723|NCT00241631|561955992|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
155689724|NCT00241631|561955991|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
155689725|NCT00241631|561955992|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
155689726|NCT00241631|561955991|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
155689727|NCT00241631|561955992|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
155689728|NCT01118520|561955993|FG000|Overall Study|AAA repair|9|||
155689729|NCT01118520|561955994|FG001|Overall Study|AAA repair|7|||
155689730|NCT01118520|561955995|FG002|Overall Study|AAA repair|9|||
155689731|NCT01118520|561955993|FG000|Overall Study|Adverse Event|3|||
155689732|NCT01118520|561955994|FG001|Overall Study|Adverse Event|3|||
155689733|NCT01118520|561955995|FG002|Overall Study|Adverse Event|3|||
155689734|NCT01118520|561955993|FG000|Overall Study|Withdrawal by Subject|8|||
155689735|NCT01118520|561955994|FG001|Overall Study|Withdrawal by Subject|13|||
155689736|NCT01118520|561955995|FG002|Overall Study|Withdrawal by Subject|8|||
155689737|NCT03958656|561955996|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155689738|NCT03958656|561955997|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
155689739|NCT03958656|561955998|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155689740|NCT03958656|561955999|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155689741|NCT03958656|561955996|FG000|Overall Study|No longer meets eligibility criteria|0|||
155689742|NCT03958656|561955997|FG001|Overall Study|No longer meets eligibility criteria|0|||
155689743|NCT03958656|561955998|FG002|Overall Study|No longer meets eligibility criteria|1|||
155689744|NCT03958656|561955999|FG003|Overall Study|No longer meets eligibility criteria|0|||
155689745|NCT03958656|561955996|FG000|Overall Study|Started anti-cancer treatment|0|||
155689746|NCT03958656|561955997|FG001|Overall Study|Started anti-cancer treatment|0|||
155689747|NCT03958656|561955998|FG002|Overall Study|Started anti-cancer treatment|1|||
155689748|NCT03958656|561955999|FG003|Overall Study|Started anti-cancer treatment|0|||
155689749|NCT03158012|561956000|FG000|Overall Study|Withdrawal by Subject|0|||
155689750|NCT03158012|561956001|FG001|Overall Study|Withdrawal by Subject|1|||
155689751|NCT01852825|561956002|FG000|Overall Study|Withdrawal by Subject|2|||
155689752|NCT01852825|561956003|FG001|Overall Study|Withdrawal by Subject|0|||
155689753|NCT01852825|561956004|FG002|Overall Study|Withdrawal by Subject|0|||
155689754|NCT02214225|561956011|FG000|Overall Study|Lost to Follow-up|46|||
155689755|NCT02214225|561956012|FG001|Overall Study|Lost to Follow-up|18|||
155689756|NCT02214225|561956013|FG002|Overall Study|Lost to Follow-up|18|||
155689757|NCT02214225|561956011|FG000|Overall Study|Withdrawal by Subject|2|||
155689758|NCT02214225|561956012|FG001|Overall Study|Withdrawal by Subject|0|||
155689759|NCT02214225|561956013|FG002|Overall Study|Withdrawal by Subject|2|||
155689760|NCT02214225|561956011|FG000|Overall Study|Death|5|||
155689761|NCT02214225|561956012|FG001|Overall Study|Death|0|||
155689762|NCT02214225|561956013|FG002|Overall Study|Death|1|||
155689763|NCT02214225|561956011|FG000|Overall Study|randomized in error, not vaccinated|2|||
155689764|NCT02214225|561956012|FG001|Overall Study|randomized in error, not vaccinated|1|||
155689765|NCT02214225|561956013|FG002|Overall Study|randomized in error, not vaccinated|1|||
155689766|NCT03987932|561956014|FG000|Overall Study|Lost to Follow-up|2|||
155689767|NCT03987932|561956015|FG001|Overall Study|Lost to Follow-up|1|||
155689768|NCT03987932|561956016|FG002|Overall Study|Lost to Follow-up|1|||
155689769|NCT03987932|561956014|FG000|Overall Study|Non-study related elective surgery|0|||
155689770|NCT03987932|561956015|FG001|Overall Study|Non-study related elective surgery|0|||
155689771|NCT03987932|561956016|FG002|Overall Study|Non-study related elective surgery|1|||
155689772|NCT01669421|561956019|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
155689773|NCT01669421|561956019|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
155689774|NCT02961790|561956021|FG000|Overall Study|Canceled|4|||
155689775|NCT02961790|561956022|FG001|Overall Study|Canceled|5|||
155689776|NCT02961790|561956023|FG002|Overall Study|Canceled|1|||
155689777|NCT02961790|561956024|FG003|Overall Study|Canceled|4|||
155689778|NCT02961790|561956021|FG000|Overall Study|without baseline data|4|||
155689779|NCT02961790|561956022|FG001|Overall Study|without baseline data|0|||
155689780|NCT02961790|561956023|FG002|Overall Study|without baseline data|1|||
155689781|NCT02961790|561956024|FG003|Overall Study|without baseline data|0|||
155689782|NCT02961790|561956021|FG000|Overall Study|without post baseline data|7|||
155689783|NCT02961790|561956022|FG001|Overall Study|without post baseline data|6|||
155689784|NCT02961790|561956023|FG002|Overall Study|without post baseline data|4|||
155689785|NCT02961790|561956024|FG003|Overall Study|without post baseline data|1|||
155689786|NCT02078102|561956025|FG000|Overall Study|Adverse Event|1|||
155689787|NCT02078102|561956026|FG001|Overall Study|Adverse Event|0|||
155689788|NCT02078102|561956025|FG000|Overall Study|Withdrawal by Subject|1|||
155689789|NCT02078102|561956026|FG001|Overall Study|Withdrawal by Subject|0|||
155689790|NCT02078102|561956025|FG000|Overall Study|Physician Decision|0|||
155689791|NCT02078102|561956026|FG001|Overall Study|Physician Decision|1|||
155689792|NCT02185014|561956027|FG000|Overall Study|Adverse Event|18|||
155689793|NCT02185014|561956027|FG000|Overall Study|Withdrew Consent|8|||
155689794|NCT02185014|561956027|FG000|Overall Study|Lost to Follow-up|4|||
155689795|NCT02185014|561956027|FG000|Overall Study|Lack of Efficacy|14|||
155689796|NCT02185014|561956027|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
155689797|NCT02185014|561956027|FG000|Overall Study|Subject Noncompliance|1|||
155689798|NCT02185014|561956027|FG000|Overall Study|Other|4|||
155689799|NCT02141490|561956029|FG000|Overall Study|Screening failures|4|||
155689800|NCT02141490|561956030|FG001|Overall Study|Screening failures|0|||
155689801|NCT02141490|561956031|FG002|Overall Study|Screening failures|0|||
155689802|NCT01009346|561956032|FG000|Overall Study|Adverse Event|4|||
155689803|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
155689804|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
155689805|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
155689806|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
155689807|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
155689808|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
155689809|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
155689810|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
155689811|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
155689812|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
155689813|NCT03906656|561956033|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
155689814|NCT03906656|561956034|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
155689815|NCT03906656|561956033|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
155689816|NCT03906656|561956034|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
155689817|NCT03906656|561956033|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
155689818|NCT03906656|561956034|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
155689819|NCT03906656|561956033|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
155689820|NCT03906656|561956034|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
155689821|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
155689822|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
155689823|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
155689824|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
155689825|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
155689826|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
155689827|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
155689828|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
155689829|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
155689830|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
155689831|NCT03906656|561956033|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
155689832|NCT03906656|561956034|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
155689833|NCT03906656|561956033|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
155689834|NCT03906656|561956034|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
155689835|NCT03906656|561956033|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
155689836|NCT03906656|561956034|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
155689837|NCT03906656|561956033|FG000|Home Use 2 (3 Months)|Death|2|||
155689838|NCT03906656|561956034|FG001|Home Use 2 (3 Months)|Death|0|||
155689839|NCT03906656|561956033|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
155689840|NCT03906656|561956034|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
155689841|NCT03906656|561956033|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
155689842|NCT03906656|561956034|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
155689843|NCT00033540|561956035|FG000|Overall Study|Adverse Event|14|||
155689844|NCT00033540|561956035|FG000|Overall Study|Death|1|||
155689845|NCT00033540|561956035|FG000|Overall Study|Progression|26|||
155689846|NCT00033540|561956035|FG000|Overall Study|Withdrawal by Subject|6|||
155689847|NCT00033540|561956035|FG000|Overall Study|Other|5|||
155689848|NCT00033540|561956035|FG000|Overall Study|Ineligible|3|||
155689849|NCT00033540|561956035|FG000|Overall Study|Never received treatment|2|||
155689850|NCT01036529|561956036|FG000|Overall Study|Adverse Event|0|||
155689851|NCT01036529|561956037|FG001|Overall Study|Adverse Event|1|||
155689852|NCT01036529|561956036|FG000|Overall Study|Lost to Follow-up|0|||
155689853|NCT01036529|561956037|FG001|Overall Study|Lost to Follow-up|1|||
155689854|NCT01036529|561956036|FG000|Overall Study|Physician Decision|1|||
155689855|NCT01036529|561956037|FG001|Overall Study|Physician Decision|0|||
155689856|NCT01036529|561956036|FG000|Overall Study|Withdrawal by Subject|1|||
155689857|NCT01036529|561956037|FG001|Overall Study|Withdrawal by Subject|1|||
155689858|NCT01036529|561956036|FG000|Overall Study|Sponsor study termination|11|||
155689859|NCT01036529|561956037|FG001|Overall Study|Sponsor study termination|12|||
155689860|NCT01253265|561956046|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
155689861|NCT01253265|561956047|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
155689862|NCT01253265|561956048|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
155689863|NCT01253265|561956049|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
155689864|NCT01253265|561956050|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
155689865|NCT01253265|561956046|FG000|Overall Study|Withdrawal by Subject|0|||
155689866|NCT01253265|561956047|FG001|Overall Study|Withdrawal by Subject|0|||
155689867|NCT01253265|561956048|FG002|Overall Study|Withdrawal by Subject|0|||
155689868|NCT01253265|561956049|FG003|Overall Study|Withdrawal by Subject|0|||
155689869|NCT01253265|561956050|FG004|Overall Study|Withdrawal by Subject|1|||
155689870|NCT03271047|561956056|FG000|Phase 1b: Dose Finding Period|Death|8|||
155689871|NCT03271047|561956057|FG001|Phase 1b: Dose Finding Period|Death|8|||
155689872|NCT03271047|561956058|FG002|Phase 1b: Dose Finding Period|Death|0|||
155689873|NCT03271047|561956059|FG003|Phase 1b: Dose Finding Period|Death|0|||
155689874|NCT03271047|561956056|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
155689875|NCT03271047|561956057|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155689876|NCT03271047|561956058|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155689877|NCT03271047|561956059|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155689878|NCT03271047|561956056|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155689879|NCT03271047|561956057|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
155689880|NCT03271047|561956058|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155689881|NCT03271047|561956059|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155689882|NCT03271047|561956056|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
155689883|NCT03271047|561956057|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
155689884|NCT03271047|561956058|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
155689885|NCT03271047|561956059|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
155689886|NCT03271047|561956056|FG000|Randomized Phase 2 Period|Other|0|||
155689887|NCT03271047|561956057|FG001|Randomized Phase 2 Period|Other|0|||
155689888|NCT03271047|561956058|FG002|Randomized Phase 2 Period|Other|0|||
155689889|NCT03271047|561956059|FG003|Randomized Phase 2 Period|Other|1|||
155689890|NCT03271047|561956056|FG000|Randomized Phase 2 Period|Death|0|||
155689891|NCT03271047|561956057|FG001|Randomized Phase 2 Period|Death|0|||
155689892|NCT03271047|561956058|FG002|Randomized Phase 2 Period|Death|20|||
155689893|NCT03271047|561956059|FG003|Randomized Phase 2 Period|Death|21|||
155689894|NCT03271047|561956056|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
155689895|NCT03271047|561956057|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
155689896|NCT03271047|561956058|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
155689897|NCT03271047|561956059|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
155689898|NCT03271047|561956056|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155689899|NCT03271047|561956057|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155689900|NCT03271047|561956058|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
155689901|NCT03271047|561956059|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155689902|NCT03271047|561956056|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155689903|NCT03271047|561956057|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155689904|NCT03271047|561956058|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155689905|NCT03271047|561956059|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
155689906|NCT00711802|561956060|FG000|Overall Study|Not treated (no further detail)|2|||
155689907|NCT00711802|561956061|FG001|Overall Study|Not treated (no further detail)|1|||
155689908|NCT00711802|561956062|FG002|Overall Study|Not treated (no further detail)|2|||
155689909|NCT00711802|561956063|FG003|Overall Study|Not treated (no further detail)|0|||
155689910|NCT00711802|561956064|FG004|Overall Study|Not treated (no further detail)|2|||
155689911|NCT00711802|561956065|FG005|Overall Study|Not treated (no further detail)|0|||
155689912|NCT00711802|561956066|FG006|Overall Study|Not treated (no further detail)|0|||
155689913|NCT00711802|561956067|FG007|Overall Study|Not treated (no further detail)|0|||
155689914|NCT00711802|561956060|FG000|Overall Study|Adverse Event|0|||
155689915|NCT00711802|561956061|FG001|Overall Study|Adverse Event|0|||
155689916|NCT00711802|561956062|FG002|Overall Study|Adverse Event|0|||
155689917|NCT00711802|561956063|FG003|Overall Study|Adverse Event|0|||
155689918|NCT00711802|561956064|FG004|Overall Study|Adverse Event|1|||
155689919|NCT00711802|561956065|FG005|Overall Study|Adverse Event|1|||
155689920|NCT00711802|561956066|FG006|Overall Study|Adverse Event|0|||
155689921|NCT00711802|561956067|FG007|Overall Study|Adverse Event|0|||
155689922|NCT00711802|561956060|FG000|Overall Study|Microbiological failure|0|||
155689923|NCT00711802|561956061|FG001|Overall Study|Microbiological failure|1|||
155689924|NCT00711802|561956062|FG002|Overall Study|Microbiological failure|0|||
155689925|NCT00711802|561956063|FG003|Overall Study|Microbiological failure|0|||
155689926|NCT00711802|561956064|FG004|Overall Study|Microbiological failure|0|||
155689927|NCT00711802|561956065|FG005|Overall Study|Microbiological failure|1|||
155689928|NCT00711802|561956066|FG006|Overall Study|Microbiological failure|0|||
155689929|NCT00711802|561956067|FG007|Overall Study|Microbiological failure|0|||
155689930|NCT00711802|561956060|FG000|Overall Study|Protocol Violation|0|||
155689931|NCT00711802|561956061|FG001|Overall Study|Protocol Violation|0|||
155689932|NCT00711802|561956062|FG002|Overall Study|Protocol Violation|0|||
155689933|NCT00711802|561956063|FG003|Overall Study|Protocol Violation|1|||
155689934|NCT00711802|561956064|FG004|Overall Study|Protocol Violation|0|||
155689935|NCT00711802|561956065|FG005|Overall Study|Protocol Violation|0|||
155689936|NCT00711802|561956066|FG006|Overall Study|Protocol Violation|0|||
155689937|NCT00711802|561956067|FG007|Overall Study|Protocol Violation|0|||
155689938|NCT00711802|561956060|FG000|Overall Study|Physician Decision|0|||
155689939|NCT00711802|561956061|FG001|Overall Study|Physician Decision|2|||
155689940|NCT00711802|561956062|FG002|Overall Study|Physician Decision|0|||
155689941|NCT00711802|561956063|FG003|Overall Study|Physician Decision|0|||
155689942|NCT00711802|561956064|FG004|Overall Study|Physician Decision|0|||
155689943|NCT00711802|561956065|FG005|Overall Study|Physician Decision|0|||
155689944|NCT00711802|561956066|FG006|Overall Study|Physician Decision|0|||
155689945|NCT00711802|561956067|FG007|Overall Study|Physician Decision|0|||
155689946|NCT00711802|561956060|FG000|Overall Study|Withdrawal by Subject|0|||
155689947|NCT00711802|561956061|FG001|Overall Study|Withdrawal by Subject|1|||
155689948|NCT00711802|561956062|FG002|Overall Study|Withdrawal by Subject|0|||
155689949|NCT00711802|561956063|FG003|Overall Study|Withdrawal by Subject|1|||
155689950|NCT00711802|561956064|FG004|Overall Study|Withdrawal by Subject|0|||
155689951|NCT00711802|561956065|FG005|Overall Study|Withdrawal by Subject|0|||
155689952|NCT00711802|561956066|FG006|Overall Study|Withdrawal by Subject|0|||
155689953|NCT00711802|561956067|FG007|Overall Study|Withdrawal by Subject|0|||
155689954|NCT00711802|561956060|FG000|Overall Study|Lost to Follow-up|0|||
155689955|NCT00711802|561956061|FG001|Overall Study|Lost to Follow-up|0|||
155689956|NCT00711802|561956062|FG002|Overall Study|Lost to Follow-up|3|||
155689957|NCT00711802|561956063|FG003|Overall Study|Lost to Follow-up|1|||
155689958|NCT00711802|561956064|FG004|Overall Study|Lost to Follow-up|10|||
155689959|NCT00711802|561956065|FG005|Overall Study|Lost to Follow-up|6|||
155689960|NCT00711802|561956066|FG006|Overall Study|Lost to Follow-up|4|||
155689961|NCT00711802|561956067|FG007|Overall Study|Lost to Follow-up|2|||
155689962|NCT00711802|561956060|FG000|Overall Study|Reason not reported|0|||
155689963|NCT00711802|561956061|FG001|Overall Study|Reason not reported|1|||
155689964|NCT00711802|561956062|FG002|Overall Study|Reason not reported|1|||
155689965|NCT00711802|561956063|FG003|Overall Study|Reason not reported|0|||
155689966|NCT00711802|561956064|FG004|Overall Study|Reason not reported|1|||
155689967|NCT00711802|561956065|FG005|Overall Study|Reason not reported|0|||
155689968|NCT00711802|561956066|FG006|Overall Study|Reason not reported|1|||
155689969|NCT00711802|561956067|FG007|Overall Study|Reason not reported|0|||
155689970|NCT03283150|561956069|FG000|Overall Study|Withdrawal by Subject|6|||
155689971|NCT03283150|561956070|FG001|Overall Study|Withdrawal by Subject|0|||
155689972|NCT03283150|561956071|FG002|Overall Study|Withdrawal by Subject|0|||
155689973|NCT05291936|561956072|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155689974|NCT05291936|561956073|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
155689975|NCT05291936|561956072|FG000|Period 1|Withdrew Consent during study|1|||
155689976|NCT05291936|561956073|FG001|Period 1|Withdrew Consent during study|0|||
155689977|NCT05291936|561956072|FG000|Period 2|Adverse Event|0|||
155689978|NCT05291936|561956073|FG001|Period 2|Adverse Event|1|||
155689979|NCT05291936|561956072|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
155689980|NCT05291936|561956073|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155689981|NCT02032407|561958685|FG000|Overall Study|Lost to Follow-up|2|||
155689982|NCT02032407|561958685|FG000|Overall Study|Pregnancy|1|||
155689983|NCT02032407|561958685|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155689984|NCT02091284|561958686|FG000|Overall Study|Withdrawal by Subject|2|||
155689985|NCT02091284|561958687|FG001|Overall Study|Withdrawal by Subject|1|||
155689986|NCT02091284|561958686|FG000|Overall Study|unreliable data|1|||
155689987|NCT02091284|561958687|FG001|Overall Study|unreliable data|0|||
155689988|NCT01340937|561958688|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
155689989|NCT01340937|561958689|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
155689990|NCT01340937|561958690|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
155689991|NCT01340937|561958691|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
155689992|NCT01340937|561958688|FG000|Period 1: Infant Series|Adverse Event|0|||
155689993|NCT01340937|561958689|FG001|Period 1: Infant Series|Adverse Event|1|||
155689994|NCT01340937|561958690|FG002|Period 1: Infant Series|Adverse Event|4|||
155689995|NCT01340937|561958691|FG003|Period 1: Infant Series|Adverse Event|0|||
155689996|NCT01340937|561958688|FG000|Period 1: Infant Series|Death|2|||
155689997|NCT01340937|561958689|FG001|Period 1: Infant Series|Death|0|||
155689998|NCT01340937|561958690|FG002|Period 1: Infant Series|Death|2|||
155689999|NCT01340937|561958691|FG003|Period 1: Infant Series|Death|0|||
155690000|NCT01340937|561958688|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
155690001|NCT01340937|561958689|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
155690002|NCT01340937|561958690|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
155690003|NCT01340937|561958691|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
155690004|NCT01340937|561958688|FG000|Period 1: Infant Series|Physician Decision|2|||
155690005|NCT01340937|561958689|FG001|Period 1: Infant Series|Physician Decision|3|||
155690006|NCT01340937|561958690|FG002|Period 1: Infant Series|Physician Decision|1|||
155690007|NCT01340937|561958691|FG003|Period 1: Infant Series|Physician Decision|0|||
155690008|NCT01340937|561958688|FG000|Period 1: Infant Series|Protocol Violation|1|||
155690009|NCT01340937|561958689|FG001|Period 1: Infant Series|Protocol Violation|4|||
155690010|NCT01340937|561958690|FG002|Period 1: Infant Series|Protocol Violation|4|||
155690011|NCT01340937|561958691|FG003|Period 1: Infant Series|Protocol Violation|3|||
155690012|NCT01340937|561958688|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
155690013|NCT01340937|561958689|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
155690014|NCT01340937|561958690|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
155690015|NCT01340937|561958691|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
155690016|NCT01340937|561958688|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
155690017|NCT01340937|561958689|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
155690018|NCT01340937|561958690|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
155690019|NCT01340937|561958691|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
155690020|NCT01340937|561958688|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
155690021|NCT01340937|561958689|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
155690022|NCT01340937|561958690|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
155690023|NCT01340937|561958691|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
155690024|NCT01340937|561958688|FG000|Period 2: Interim Period|Adverse Event|1|||
155690025|NCT01340937|561958689|FG001|Period 2: Interim Period|Adverse Event|0|||
155690026|NCT01340937|561958690|FG002|Period 2: Interim Period|Adverse Event|1|||
155690027|NCT01340937|561958691|FG003|Period 2: Interim Period|Adverse Event|0|||
155690028|NCT01340937|561958688|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
155690029|NCT01340937|561958689|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
155690030|NCT01340937|561958690|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
155690031|NCT01340937|561958691|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
155690032|NCT01340937|561958688|FG000|Period 2: Interim Period|Physician Decision|0|||
155690033|NCT01340937|561958689|FG001|Period 2: Interim Period|Physician Decision|1|||
155690034|NCT01340937|561958690|FG002|Period 2: Interim Period|Physician Decision|1|||
155690035|NCT01340937|561958691|FG003|Period 2: Interim Period|Physician Decision|0|||
155690036|NCT01340937|561958688|FG000|Period 2: Interim Period|Protocol Violation|5|||
155690037|NCT01340937|561958689|FG001|Period 2: Interim Period|Protocol Violation|3|||
155690038|NCT01340937|561958690|FG002|Period 2: Interim Period|Protocol Violation|6|||
155690039|NCT01340937|561958691|FG003|Period 2: Interim Period|Protocol Violation|3|||
155690040|NCT01340937|561958688|FG000|Period 2: Interim Period|Technical problems|4|||
155690041|NCT01340937|561958689|FG001|Period 2: Interim Period|Technical problems|4|||
155690042|NCT01340937|561958690|FG002|Period 2: Interim Period|Technical problems|6|||
155690043|NCT01340937|561958691|FG003|Period 2: Interim Period|Technical problems|3|||
155690044|NCT01340937|561958688|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
155690045|NCT01340937|561958689|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
155690046|NCT01340937|561958690|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
155690047|NCT01340937|561958691|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
155690048|NCT01340937|561958688|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
155690049|NCT01340937|561958689|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
155690050|NCT01340937|561958690|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
155690051|NCT01340937|561958691|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
155690052|NCT01340937|561958688|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155690053|NCT01340937|561958689|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155690054|NCT01340937|561958690|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155690055|NCT01340937|561958691|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
155690056|NCT01340937|561958688|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
155690057|NCT01340937|561958689|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
155690058|NCT01340937|561958690|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
155690059|NCT01340937|561958691|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
155690060|NCT02233738|561958692|FG000|Overall Study|Lost to Follow-up|5|||
155690061|NCT02233738|561958693|FG001|Overall Study|Lost to Follow-up|12|||
155690062|NCT02233738|561958692|FG000|Overall Study|Death|0|||
155690063|NCT02233738|561958693|FG001|Overall Study|Death|1|||
155690064|NCT02233738|561958692|FG000|Overall Study|Withdrawal by Subject|0|||
155690065|NCT02233738|561958693|FG001|Overall Study|Withdrawal by Subject|1|||
155690066|NCT02233738|561958692|FG000|Overall Study|Did not return after Baseline|3|||
155690067|NCT02233738|561958693|FG001|Overall Study|Did not return after Baseline|2|||
155690068|NCT00096174|561958694|FG000|Overall Study|Lack of Efficacy|9|||
155690069|NCT00096174|561958694|FG000|Overall Study|Adverse Event|15|||
155690070|NCT00096174|561958694|FG000|Overall Study|Death|6|||
155690071|NCT00096174|561958694|FG000|Overall Study|Withdrawal by Subject|15|||
155690072|NCT00096174|561958694|FG000|Overall Study|Not started protocol therapy|3|||
155690073|NCT00096174|561958694|FG000|Overall Study|Ineligible|6|||
155690074|NCT00096174|561958694|FG000|Overall Study|other reason|8|||
155690075|NCT02098369|561958695|FG000|Overall Study|Withdrawal by Subject|1|||
155690076|NCT02098369|561958696|FG001|Overall Study|Withdrawal by Subject|5|||
155690077|NCT02098369|561958697|FG002|Overall Study|Withdrawal by Subject|0|||
155690078|NCT02098369|561958695|FG000|Overall Study|Lost to Follow-up|5|||
155690079|NCT02098369|561958696|FG001|Overall Study|Lost to Follow-up|1|||
155690080|NCT02098369|561958697|FG002|Overall Study|Lost to Follow-up|3|||
155690081|NCT02098369|561958695|FG000|Overall Study|Death|1|||
155690082|NCT02098369|561958696|FG001|Overall Study|Death|1|||
155690083|NCT02098369|561958697|FG002|Overall Study|Death|1|||
155690084|NCT02098369|561958695|FG000|Overall Study|Other|0|||
155690085|NCT02098369|561958696|FG001|Overall Study|Other|2|||
155690086|NCT02098369|561958697|FG002|Overall Study|Other|1|||
155690087|NCT01414205|561958698|FG000|Overall Study|Death|5|||
155690088|NCT01414205|561958699|FG001|Overall Study|Death|1|||
155690089|NCT01414205|561958698|FG000|Overall Study|Lost to Follow-up|1|||
155690090|NCT01414205|561958699|FG001|Overall Study|Lost to Follow-up|4|||
155690091|NCT01414205|561958698|FG000|Overall Study|Physician Decision|0|||
155690092|NCT01414205|561958699|FG001|Overall Study|Physician Decision|1|||
155690093|NCT01414205|561958698|FG000|Overall Study|Randomized but not Treated|1|||
155690094|NCT01414205|561958699|FG001|Overall Study|Randomized but not Treated|1|||
155690095|NCT01166373|561958700|FG000|Overall Study|Lost to Follow-up|3|||
155690096|NCT01166373|561958701|FG001|Overall Study|Lost to Follow-up|2|||
155690097|NCT01166373|561958702|FG002|Overall Study|Lost to Follow-up|2|||
155690098|NCT01166373|561958703|FG003|Overall Study|Lost to Follow-up|2|||
155690099|NCT01166373|561958700|FG000|Overall Study|Withdrawal by Subject|1|||
155690100|NCT01166373|561958701|FG001|Overall Study|Withdrawal by Subject|2|||
155690101|NCT01166373|561958702|FG002|Overall Study|Withdrawal by Subject|2|||
155690102|NCT01166373|561958703|FG003|Overall Study|Withdrawal by Subject|3|||
155690103|NCT01166373|561958700|FG000|Overall Study|Physician Decision|1|||
155690104|NCT01166373|561958701|FG001|Overall Study|Physician Decision|0|||
155690105|NCT01166373|561958702|FG002|Overall Study|Physician Decision|0|||
155690106|NCT01166373|561958703|FG003|Overall Study|Physician Decision|0|||
155690107|NCT01874275|561958704|FG000|Overall Study|Lost to Follow-up|1|||
155690108|NCT01874275|561958705|FG001|Overall Study|Lost to Follow-up|0|||
155690109|NCT02594098|561958715|FG000|Overall Study|Lack of Efficacy|17|||
155690110|NCT02594098|561958716|FG001|Overall Study|Lack of Efficacy|6|||
155690111|NCT02594098|561958715|FG000|Overall Study|Withdrawal by Subject|1|||
155690112|NCT02594098|561958716|FG001|Overall Study|Withdrawal by Subject|3|||
155690113|NCT02594098|561958715|FG000|Overall Study|Terminated participation|6|||
155690114|NCT02594098|561958716|FG001|Overall Study|Terminated participation|2|||
155690115|NCT02594098|561958715|FG000|Overall Study|Seek alternative treatment|2|||
155690116|NCT02594098|561958716|FG001|Overall Study|Seek alternative treatment|1|||
155690117|NCT02594098|561958715|FG000|Overall Study|Other|0|||
155690118|NCT02594098|561958716|FG001|Overall Study|Other|1|||
155690119|NCT02370641|561958723|FG000|Overall Study|dropped study|4|||
155690120|NCT02370641|561958724|FG001|Overall Study|dropped study|2|||
155690121|NCT02133664|561958725|FG000|Overall Study|Lost to Follow-up|2|||
155690122|NCT02133664|561958726|FG001|Overall Study|Lost to Follow-up|1|||
155690123|NCT02133664|561958725|FG000|Overall Study|Adverse Event|3|||
155690124|NCT02133664|561958726|FG001|Overall Study|Adverse Event|6|||
155690125|NCT00343915|561958730|FG000|Primary Study|Withdrawal by Subject|1|||
155690126|NCT00343915|561958731|FG001|Primary Study|Withdrawal by Subject|0|||
155690127|NCT00343915|561958730|FG000|Primary Study|Lost to Follow-up|2|||
155690128|NCT00343915|561958731|FG001|Primary Study|Lost to Follow-up|3|||
155690129|NCT00343915|561958730|FG000|Primary Study|Other|1|||
155690130|NCT00343915|561958731|FG001|Primary Study|Other|0|||
155690131|NCT01719003|561958732|FG000|Overall Study|Non compliant with protocol|1|||
155690132|NCT01719003|561958733|FG001|Overall Study|Non compliant with protocol|1|||
155690133|NCT01719003|561958734|FG002|Overall Study|Non compliant with protocol|0|||
155690134|NCT01719003|561958735|FG003|Overall Study|Non compliant with protocol|1|||
155690135|NCT01719003|561958736|FG004|Overall Study|Non compliant with protocol|2|||
155690136|NCT01719003|561958737|FG005|Overall Study|Non compliant with protocol|1|||
155690137|NCT01719003|561958738|FG006|Overall Study|Non compliant with protocol|2|||
155690138|NCT01719003|561958739|FG007|Overall Study|Non compliant with protocol|3|||
155690139|NCT01719003|561958740|FG008|Overall Study|Non compliant with protocol|0|||
155690140|NCT01719003|561958732|FG000|Overall Study|Adverse Event|6|||
155690141|NCT01719003|561958733|FG001|Overall Study|Adverse Event|5|||
155690142|NCT01719003|561958734|FG002|Overall Study|Adverse Event|4|||
155690143|NCT01719003|561958735|FG003|Overall Study|Adverse Event|3|||
155690144|NCT01719003|561958736|FG004|Overall Study|Adverse Event|4|||
155690145|NCT01719003|561958737|FG005|Overall Study|Adverse Event|3|||
155690146|NCT01719003|561958738|FG006|Overall Study|Adverse Event|6|||
155690147|NCT01719003|561958739|FG007|Overall Study|Adverse Event|5|||
155690148|NCT01719003|561958740|FG008|Overall Study|Adverse Event|0|||
155690149|NCT01719003|561958732|FG000|Overall Study|Lost to Follow-up|0|||
155690150|NCT01719003|561958733|FG001|Overall Study|Lost to Follow-up|6|||
155690151|NCT01719003|561958734|FG002|Overall Study|Lost to Follow-up|7|||
155690152|NCT01719003|561958735|FG003|Overall Study|Lost to Follow-up|2|||
155690153|NCT01719003|561958736|FG004|Overall Study|Lost to Follow-up|3|||
155690154|NCT01719003|561958737|FG005|Overall Study|Lost to Follow-up|4|||
155690155|NCT01719003|561958738|FG006|Overall Study|Lost to Follow-up|3|||
155690156|NCT01719003|561958739|FG007|Overall Study|Lost to Follow-up|2|||
155690157|NCT01719003|561958740|FG008|Overall Study|Lost to Follow-up|2|||
155690158|NCT01719003|561958732|FG000|Overall Study|Refusal to continue, not due to AE|2|||
155690159|NCT01719003|561958733|FG001|Overall Study|Refusal to continue, not due to AE|5|||
155690160|NCT01719003|561958734|FG002|Overall Study|Refusal to continue, not due to AE|4|||
155690161|NCT01719003|561958735|FG003|Overall Study|Refusal to continue, not due to AE|4|||
155690162|NCT01719003|561958736|FG004|Overall Study|Refusal to continue, not due to AE|4|||
155690163|NCT01719003|561958737|FG005|Overall Study|Refusal to continue, not due to AE|3|||
155690164|NCT01719003|561958738|FG006|Overall Study|Refusal to continue, not due to AE|8|||
155690165|NCT01719003|561958739|FG007|Overall Study|Refusal to continue, not due to AE|7|||
155690166|NCT01719003|561958740|FG008|Overall Study|Refusal to continue, not due to AE|1|||
155690167|NCT01719003|561958732|FG000|Overall Study|Reason other than those specified|0|||
155690168|NCT01719003|561958733|FG001|Overall Study|Reason other than those specified|0|||
155690169|NCT01719003|561958734|FG002|Overall Study|Reason other than those specified|2|||
155690170|NCT01719003|561958735|FG003|Overall Study|Reason other than those specified|3|||
155690171|NCT01719003|561958736|FG004|Overall Study|Reason other than those specified|4|||
155690172|NCT01719003|561958737|FG005|Overall Study|Reason other than those specified|1|||
155690173|NCT01719003|561958738|FG006|Overall Study|Reason other than those specified|0|||
155690174|NCT01719003|561958739|FG007|Overall Study|Reason other than those specified|3|||
155690175|NCT01719003|561958740|FG008|Overall Study|Reason other than those specified|1|||
155690176|NCT01719003|561958732|FG000|Overall Study|Lack of Efficacy|0|||
155690177|NCT01719003|561958733|FG001|Overall Study|Lack of Efficacy|0|||
155690178|NCT01719003|561958734|FG002|Overall Study|Lack of Efficacy|0|||
155690179|NCT01719003|561958735|FG003|Overall Study|Lack of Efficacy|0|||
155690180|NCT01719003|561958736|FG004|Overall Study|Lack of Efficacy|0|||
155690181|NCT01719003|561958737|FG005|Overall Study|Lack of Efficacy|0|||
155690182|NCT01719003|561958738|FG006|Overall Study|Lack of Efficacy|1|||
155690183|NCT01719003|561958739|FG007|Overall Study|Lack of Efficacy|0|||
155690184|NCT01719003|561958740|FG008|Overall Study|Lack of Efficacy|0|||
155690185|NCT00882908|561958742|FG000|Overall Study|Adverse Event|0|||
155690186|NCT00882908|561958743|FG001|Overall Study|Adverse Event|0|||
155690187|NCT00882908|561958744|FG002|Overall Study|Adverse Event|1|||
155690188|NCT00882908|561958745|FG003|Overall Study|Adverse Event|0|||
155690189|NCT00882908|561958746|FG004|Overall Study|Adverse Event|1|||
155690190|NCT00882908|561958742|FG000|Overall Study|Lost to Follow-up|3|||
155690191|NCT00882908|561958743|FG001|Overall Study|Lost to Follow-up|5|||
155690192|NCT00882908|561958744|FG002|Overall Study|Lost to Follow-up|3|||
155690193|NCT00882908|561958745|FG003|Overall Study|Lost to Follow-up|1|||
155690194|NCT00882908|561958746|FG004|Overall Study|Lost to Follow-up|2|||
155690195|NCT00882908|561958742|FG000|Overall Study|Protocol Violation|0|||
155690196|NCT00882908|561958743|FG001|Overall Study|Protocol Violation|1|||
155690197|NCT00882908|561958744|FG002|Overall Study|Protocol Violation|0|||
155690198|NCT00882908|561958745|FG003|Overall Study|Protocol Violation|0|||
155690199|NCT00882908|561958746|FG004|Overall Study|Protocol Violation|0|||
155690200|NCT00882908|561958742|FG000|Overall Study|Withdrawal by Subject|0|||
155690201|NCT00882908|561958743|FG001|Overall Study|Withdrawal by Subject|0|||
155690202|NCT00882908|561958744|FG002|Overall Study|Withdrawal by Subject|3|||
155690203|NCT00882908|561958745|FG003|Overall Study|Withdrawal by Subject|5|||
155690204|NCT00882908|561958746|FG004|Overall Study|Withdrawal by Subject|2|||
155690205|NCT00882908|561958742|FG000|Overall Study|Subject reached a virologic endpoint|0|||
155690206|NCT00882908|561958743|FG001|Overall Study|Subject reached a virologic endpoint|0|||
155690207|NCT00882908|561958744|FG002|Overall Study|Subject reached a virologic endpoint|0|||
155690208|NCT00882908|561958745|FG003|Overall Study|Subject reached a virologic endpoint|0|||
155690209|NCT00882908|561958746|FG004|Overall Study|Subject reached a virologic endpoint|1|||
155690210|NCT00882908|561958742|FG000|Overall Study|Study terminated in error|0|||
155690211|NCT00882908|561958743|FG001|Overall Study|Study terminated in error|0|||
155690212|NCT00882908|561958744|FG002|Overall Study|Study terminated in error|0|||
155690213|NCT00882908|561958745|FG003|Overall Study|Study terminated in error|1|||
155690214|NCT00882908|561958746|FG004|Overall Study|Study terminated in error|0|||
155690215|NCT02370095|561958747|FG000|Overall Study|Withdrawal by Subject|0|||
155690216|NCT02370095|561958748|FG001|Overall Study|Withdrawal by Subject|1|||
155690217|NCT00581828|561958749|FG000|Overall Study|Protocol Violation|1|||
155690218|NCT00700102|561958750|FG000|Overall Study|Died|394|||
155690219|NCT00700102|561958751|FG001|Overall Study|Died|385|||
155690220|NCT00700102|561958750|FG000|Overall Study|Lost to Follow-up|8|||
155690221|NCT00700102|561958751|FG001|Overall Study|Lost to Follow-up|10|||
155690222|NCT02525939|561958752|FG000|Overall Study|Lost to Follow-up|27|||
155690223|NCT02525939|561958753|FG001|Overall Study|Lost to Follow-up|24|||
155690224|NCT02525939|561958752|FG000|Overall Study|Physician Decision|0|||
155690225|NCT02525939|561958753|FG001|Overall Study|Physician Decision|1|||
155690226|NCT02525939|561958752|FG000|Overall Study|Withdrawal by Subject|24|||
155690227|NCT02525939|561958753|FG001|Overall Study|Withdrawal by Subject|39|||
155690228|NCT02525939|561958752|FG000|Overall Study|Death|180|||
155690229|NCT02525939|561958753|FG001|Overall Study|Death|179|||
155690230|NCT01667562|561958754|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
155690231|NCT01667562|561958755|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
155690232|NCT01667562|561958754|FG000|Erlotinib Phase|Lost to Follow-up|0|||
155690233|NCT01667562|561958755|FG001|Erlotinib Phase|Lost to Follow-up|1|||
155690234|NCT01667562|561958754|FG000|Erlotinib Phase|Adverse Event|0|||
155690235|NCT01667562|561958755|FG001|Erlotinib Phase|Adverse Event|1|||
155690236|NCT01667562|561958754|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
155690237|NCT01667562|561958755|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
155690238|NCT01028716|561958756|FG000|Overall Study|Physician Decision|1|||
155690239|NCT01129882|561958757|FG000|Overall Study|Adverse Event|39|||
155690240|NCT01129882|561958757|FG000|Overall Study|Death|6|||
155690241|NCT01129882|561958757|FG000|Overall Study|Lack of Efficacy|5|||
155690242|NCT01129882|561958757|FG000|Overall Study|Lost to Follow-up|13|||
155690243|NCT01129882|561958757|FG000|Overall Study|Physician Decision|27|||
155690244|NCT01129882|561958757|FG000|Overall Study|Protocol Deviation|3|||
155690245|NCT01129882|561958757|FG000|Overall Study|Withdrawal Criteria Met|19|||
155690246|NCT01129882|561958757|FG000|Overall Study|Trial Termination by Sponsor|6|||
155690247|NCT01129882|561958757|FG000|Overall Study|Withdrawal by Subject|160|||
155690248|NCT02130986|561958758|FG000|Overall Study|Withdrawal by Subject|4|||
155690249|NCT02130986|561958759|FG001|Overall Study|Withdrawal by Subject|4|||
155690250|NCT02130986|561958758|FG000|Overall Study|Lost to Follow-up|151|||
155690251|NCT02130986|561958759|FG001|Overall Study|Lost to Follow-up|160|||
155690252|NCT02305849|561958760|FG000|Overall Study|Adverse Event|10|||
155690253|NCT02305849|561958761|FG001|Overall Study|Adverse Event|12|||
155690254|NCT02305849|561958762|FG002|Overall Study|Adverse Event|7|||
155690255|NCT02305849|561958763|FG003|Overall Study|Adverse Event|3|||
155690256|NCT02305849|561958760|FG000|Overall Study|Lack of Efficacy|10|||
155690257|NCT02305849|561958761|FG001|Overall Study|Lack of Efficacy|6|||
155690258|NCT02305849|561958762|FG002|Overall Study|Lack of Efficacy|3|||
155690259|NCT02305849|561958763|FG003|Overall Study|Lack of Efficacy|9|||
155690260|NCT02305849|561958760|FG000|Overall Study|Withdrawal by Subject|2|||
155690261|NCT02305849|561958761|FG001|Overall Study|Withdrawal by Subject|2|||
155690262|NCT02305849|561958762|FG002|Overall Study|Withdrawal by Subject|1|||
155690263|NCT02305849|561958763|FG003|Overall Study|Withdrawal by Subject|4|||
155690264|NCT02305849|561958760|FG000|Overall Study|Lost to Follow-up|0|||
155690265|NCT02305849|561958761|FG001|Overall Study|Lost to Follow-up|2|||
155690266|NCT02305849|561958762|FG002|Overall Study|Lost to Follow-up|0|||
155690267|NCT02305849|561958763|FG003|Overall Study|Lost to Follow-up|0|||
155690268|NCT02305849|561958760|FG000|Overall Study|Protocol Violation|3|||
155690269|NCT02305849|561958761|FG001|Overall Study|Protocol Violation|2|||
155690270|NCT02305849|561958762|FG002|Overall Study|Protocol Violation|1|||
155690271|NCT02305849|561958763|FG003|Overall Study|Protocol Violation|1|||
155690272|NCT02305849|561958760|FG000|Overall Study|Lab data met discontinuation criteria|0|||
155690273|NCT02305849|561958761|FG001|Overall Study|Lab data met discontinuation criteria|1|||
155690274|NCT02305849|561958762|FG002|Overall Study|Lab data met discontinuation criteria|2|||
155690275|NCT02305849|561958763|FG003|Overall Study|Lab data met discontinuation criteria|1|||
155690276|NCT02305849|561958760|FG000|Overall Study|Miscellaneous|1|||
155690277|NCT02305849|561958761|FG001|Overall Study|Miscellaneous|2|||
155690278|NCT02305849|561958762|FG002|Overall Study|Miscellaneous|4|||
155690279|NCT02305849|561958763|FG003|Overall Study|Miscellaneous|1|||
155690280|NCT02305849|561958760|FG000|Overall Study|Not fulfill eligibility criteria|1|||
155690281|NCT02305849|561958761|FG001|Overall Study|Not fulfill eligibility criteria|1|||
155690282|NCT02305849|561958762|FG002|Overall Study|Not fulfill eligibility criteria|0|||
155690283|NCT02305849|561958763|FG003|Overall Study|Not fulfill eligibility criteria|0|||
155690284|NCT00355342|561958764|FG000|Overall Study|Adverse Event|13|||
155690285|NCT00355342|561958765|FG001|Overall Study|Adverse Event|15|||
155690286|NCT00355342|561958764|FG000|Overall Study|Lost to Follow-up|4|||
155690287|NCT00355342|561958765|FG001|Overall Study|Lost to Follow-up|2|||
155690288|NCT00355342|561958764|FG000|Overall Study|Withdrawal by Subject|14|||
155690289|NCT00355342|561958765|FG001|Overall Study|Withdrawal by Subject|11|||
155690290|NCT00355342|561958764|FG000|Overall Study|Sponsor terminated study|2|||
155690291|NCT00355342|561958765|FG001|Overall Study|Sponsor terminated study|2|||
155690292|NCT00355342|561958764|FG000|Overall Study|Overcompliant-PI discretion|1|||
155690293|NCT00355342|561958765|FG001|Overall Study|Overcompliant-PI discretion|0|||
155690294|NCT00355342|561958764|FG000|Overall Study|Use of prohibited medication|1|||
155690295|NCT00355342|561958765|FG001|Overall Study|Use of prohibited medication|0|||
155690296|NCT00355342|561958764|FG000|Overall Study|COPD exacerbation|1|||
155690297|NCT00355342|561958765|FG001|Overall Study|COPD exacerbation|1|||
155690298|NCT00355342|561958764|FG000|Overall Study|Dispensed wrong study drug kit|1|||
155690299|NCT00355342|561958765|FG001|Overall Study|Dispensed wrong study drug kit|0|||
155690300|NCT00355342|561958764|FG000|Overall Study|Non-compliance with Dexa scans|1|||
155690301|NCT00355342|561958765|FG001|Overall Study|Non-compliance with Dexa scans|0|||
155690302|NCT00355342|561958764|FG000|Overall Study|Withdrawal by participant and physician|1|||
155690303|NCT00355342|561958765|FG001|Overall Study|Withdrawal by participant and physician|0|||
155690304|NCT00355342|561958764|FG000|Overall Study|Participant relocated|0|||
155690305|NCT00355342|561958765|FG001|Overall Study|Participant relocated|1|||
155690306|NCT00355342|561958764|FG000|Overall Study|Participant discontinued study drug|0|||
155690307|NCT00355342|561958765|FG001|Overall Study|Participant discontinued study drug|1|||
155690308|NCT00355342|561958764|FG000|Overall Study|Study management|0|||
155690309|NCT00355342|561958765|FG001|Overall Study|Study management|1|||
155690310|NCT00355342|561958764|FG000|Overall Study|Protocol Violation|0|||
155690311|NCT00355342|561958765|FG001|Overall Study|Protocol Violation|1|||
155690312|NCT00355342|561958764|FG000|Overall Study|Use of protocol excluded medication|0|||
155690313|NCT00355342|561958765|FG001|Overall Study|Use of protocol excluded medication|1|||
155690314|NCT00536874|561958766|FG000|Overall Study|Adverse Event|1|||
155690315|NCT00536874|561958766|FG000|Overall Study|Death|2|||
155690316|NCT00536874|561958766|FG000|Overall Study|Withdrawal by Subject|1|||
155690317|NCT00762996|561958767|FG000|Period One|Protocol Violation|0|||
155690318|NCT00762996|561958768|FG001|Period One|Protocol Violation|0|||
155690319|NCT00762996|561958769|FG002|Period One|Protocol Violation|1|||
155690320|NCT00762996|561958770|FG003|Period One|Protocol Violation|0|||
155690321|NCT00762996|561958767|FG000|Period One|ineligible|0|||
155690322|NCT00762996|561958768|FG001|Period One|ineligible|0|||
155690323|NCT00762996|561958769|FG002|Period One|ineligible|1|||
155690324|NCT00762996|561958770|FG003|Period One|ineligible|1|||
155690325|NCT00762996|561958767|FG000|Period One|Adverse Event|0|||
155690326|NCT00762996|561958768|FG001|Period One|Adverse Event|0|||
155690327|NCT00762996|561958769|FG002|Period One|Adverse Event|1|||
155690328|NCT00762996|561958770|FG003|Period One|Adverse Event|0|||
155690329|NCT00762996|561958767|FG000|Period One|Withdrawal by Subject|0|||
155690330|NCT00762996|561958768|FG001|Period One|Withdrawal by Subject|0|||
155690331|NCT00762996|561958769|FG002|Period One|Withdrawal by Subject|1|||
155690332|NCT00762996|561958770|FG003|Period One|Withdrawal by Subject|0|||
155690333|NCT00434759|561958772|FG000|Overall Study|Lack of Efficacy|5|||
155690334|NCT00434759|561958773|FG001|Overall Study|Lack of Efficacy|4|||
155690335|NCT00434759|561958772|FG000|Overall Study|Withdrawal by Subject|17|||
155690336|NCT00434759|561958773|FG001|Overall Study|Withdrawal by Subject|1|||
155690337|NCT00434759|561958772|FG000|Overall Study|family affairs|2|||
155690338|NCT00434759|561958773|FG001|Overall Study|family affairs|0|||
155690339|NCT00495521|561958780|FG000|Overall Study|Physician Decision|0|||
155690340|NCT00495521|561958781|FG001|Overall Study|Physician Decision|1|||
155690341|NCT02410824|561958782|FG000|First Intervention (One Week)|Headache|0|||
155690342|NCT02410824|561958783|FG001|First Intervention (One Week)|Headache|1|||
155690343|NCT00392808|561958784|FG000|Overall Study|Lost to Follow-up|3|||
155690344|NCT00392808|561958785|FG001|Overall Study|Lost to Follow-up|2|||
155690345|NCT00392808|561958786|FG002|Overall Study|Lost to Follow-up|1|||
155690346|NCT00392808|561958787|FG003|Overall Study|Lost to Follow-up|2|||
155690347|NCT00392808|561958784|FG000|Overall Study|Unable to withdraw blood|3|||
155690348|NCT00392808|561958785|FG001|Overall Study|Unable to withdraw blood|1|||
155690349|NCT00392808|561958786|FG002|Overall Study|Unable to withdraw blood|1|||
155690350|NCT00392808|561958787|FG003|Overall Study|Unable to withdraw blood|2|||
155690351|NCT02436408|561958788|FG000|Overall Study|Death|1|||
155690352|NCT02084238|561958789|FG000|Overall Study|Lost to Follow-up|2|||
155690353|NCT00391391|561958790|FG000|Overall Study|Adverse Event|0|||
155690354|NCT00391391|561958791|FG001|Overall Study|Adverse Event|0|||
155690355|NCT00391391|561958792|FG002|Overall Study|Adverse Event|0|||
155690356|NCT00391391|561958793|FG003|Overall Study|Adverse Event|1|||
155690357|NCT00391391|561958790|FG000|Overall Study|Lost to Follow-up|1|||
155690358|NCT00391391|561958791|FG001|Overall Study|Lost to Follow-up|3|||
155690359|NCT00391391|561958792|FG002|Overall Study|Lost to Follow-up|7|||
155690360|NCT00391391|561958793|FG003|Overall Study|Lost to Follow-up|4|||
155690361|NCT00391391|561958790|FG000|Overall Study|Protocol Violation|2|||
155690362|NCT00391391|561958791|FG001|Overall Study|Protocol Violation|3|||
155690363|NCT00391391|561958792|FG002|Overall Study|Protocol Violation|6|||
155690364|NCT00391391|561958793|FG003|Overall Study|Protocol Violation|7|||
155690365|NCT00391391|561958790|FG000|Overall Study|Withdrawal by Subject|6|||
155690366|NCT00391391|561958791|FG001|Overall Study|Withdrawal by Subject|4|||
155690367|NCT00391391|561958792|FG002|Overall Study|Withdrawal by Subject|10|||
155690368|NCT00391391|561958793|FG003|Overall Study|Withdrawal by Subject|7|||
155690369|NCT02649855|561958794|FG000|Overall Study|Refused further treatment|2|||
155690370|NCT02649855|561958795|FG001|Overall Study|Refused further treatment|1|||
155690371|NCT02649855|561958796|FG002|Overall Study|Refused further treatment|1|||
155690372|NCT02649855|561958794|FG000|Overall Study|Withdrew consent|0|||
155690373|NCT02649855|561958795|FG001|Overall Study|Withdrew consent|1|||
155690374|NCT02649855|561958796|FG002|Overall Study|Withdrew consent|0|||
155690375|NCT02649855|561958794|FG000|Overall Study|Switched to alternative treatment|0|||
155690376|NCT02649855|561958795|FG001|Overall Study|Switched to alternative treatment|1|||
155690377|NCT02649855|561958796|FG002|Overall Study|Switched to alternative treatment|1|||
155690378|NCT02649855|561958794|FG000|Overall Study|Principal investigator discretion|0|||
155690379|NCT02649855|561958795|FG001|Overall Study|Principal investigator discretion|1|||
155690380|NCT02649855|561958796|FG002|Overall Study|Principal investigator discretion|1|||
155690381|NCT02649855|561958794|FG000|Overall Study|No treatment, per protocol|1|||
155690382|NCT02649855|561958795|FG001|Overall Study|No treatment, per protocol|0|||
155690383|NCT02649855|561958796|FG002|Overall Study|No treatment, per protocol|0|||
155690384|NCT02649855|561958794|FG000|Overall Study|Initiate new treatment|1|||
155690385|NCT02649855|561958795|FG001|Overall Study|Initiate new treatment|0|||
155690386|NCT02649855|561958796|FG002|Overall Study|Initiate new treatment|0|||
155690387|NCT02782325|561958797|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
155690388|NCT02782325|561958798|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
155690389|NCT02782325|561958799|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
155690390|NCT02782325|561958797|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
155690391|NCT02782325|561958798|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
155690392|NCT02782325|561958799|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
155690393|NCT03777917|561958800|FG000|Overall Study|Withdrawal by Subject|1|||
155690394|NCT03777917|561958801|FG001|Overall Study|Withdrawal by Subject|0|||
155690395|NCT03777917|561958800|FG000|Overall Study|Physician Decision|1|||
155690396|NCT03777917|561958801|FG001|Overall Study|Physician Decision|0|||
155690397|NCT03777917|561958800|FG000|Overall Study|Lost to Follow-up|6|||
155690398|NCT03777917|561958801|FG001|Overall Study|Lost to Follow-up|2|||
155690399|NCT03777917|561958800|FG000|Overall Study|Other|1|||
155690400|NCT03777917|561958801|FG001|Overall Study|Other|0|||
155690401|NCT01154283|561958802|FG000|0-6 Weeks|Withdrawal by Subject|7|||
155690402|NCT01154283|561958803|FG001|0-6 Weeks|Withdrawal by Subject|2|||
155690403|NCT01154283|561958802|FG000|0-6 Weeks|Death|0|||
155690404|NCT01154283|561958803|FG001|0-6 Weeks|Death|1|||
155690405|NCT01154283|561958802|FG000|7-12 Weeks|Death|1|||
155690406|NCT01154283|561958803|FG001|7-12 Weeks|Death|0|||
155690407|NCT01154283|561958802|FG000|7-12 Weeks|Withdrawal by Subject|0|||
155690408|NCT01154283|561958803|FG001|7-12 Weeks|Withdrawal by Subject|1|||
155690409|NCT00042432|561958804|FG000|Overall Study|Adverse Event|4|||
155690410|NCT00042432|561958805|FG001|Overall Study|Adverse Event|1|||
155690411|NCT00042432|561958804|FG000|Overall Study|Withdrawal by Subject|1|||
155690412|NCT00042432|561958805|FG001|Overall Study|Withdrawal by Subject|3|||
155690413|NCT00042432|561958804|FG000|Overall Study|Death|0|||
155690414|NCT00042432|561958805|FG001|Overall Study|Death|2|||
155690415|NCT00042432|561958804|FG000|Overall Study|Ineligibility determined|1|||
155690416|NCT00042432|561958805|FG001|Overall Study|Ineligibility determined|0|||
155690417|NCT00042432|561958804|FG000|Overall Study|Initiation of maintenance dialysis|1|||
155690418|NCT00042432|561958805|FG001|Overall Study|Initiation of maintenance dialysis|1|||
155690419|NCT00042432|561958804|FG000|Overall Study|Other|2|||
155690420|NCT00042432|561958805|FG001|Overall Study|Other|0|||
155690421|NCT04063787|561958806|FG000|Overall Study|Inadequate Doppler data|4|||
155690422|NCT04063787|561958806|FG000|Overall Study|Lost to Follow-up|2|||
155690423|NCT04063787|561958806|FG000|Overall Study|Death|3|||
155690424|NCT00320372|561958807|FG000|Overall Study|Physician Decision|4|||
155690425|NCT00320372|561958808|FG001|Overall Study|Physician Decision|7|||
155690426|NCT00320372|561958807|FG000|Overall Study|Death|7|||
155690427|NCT00320372|561958808|FG001|Overall Study|Death|8|||
155690428|NCT00320372|561958807|FG000|Overall Study|Withdrawal by Subject|55|||
155690429|NCT00320372|561958808|FG001|Overall Study|Withdrawal by Subject|37|||
155690430|NCT00320372|561958807|FG000|Overall Study|Non-Compliance|40|||
155690431|NCT00320372|561958808|FG001|Overall Study|Non-Compliance|39|||
155690432|NCT00320372|561958807|FG000|Overall Study|Did not Meet (I/E)|3|||
155690433|NCT00320372|561958808|FG001|Overall Study|Did not Meet (I/E)|1|||
155690434|NCT00320372|561958807|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
155690435|NCT00320372|561958808|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
155690436|NCT01527383|561958809|FG000|Overall Study|Adverse Event|5|||
155690437|NCT01527383|561958810|FG001|Overall Study|Adverse Event|0|||
155690438|NCT01527383|561958809|FG000|Overall Study|Lost to Follow-up|3|||
155690439|NCT01527383|561958810|FG001|Overall Study|Lost to Follow-up|0|||
155690440|NCT01527383|561958809|FG000|Overall Study|Physician Decision|2|||
155690441|NCT01527383|561958810|FG001|Overall Study|Physician Decision|0|||
155690442|NCT01527383|561958809|FG000|Overall Study|Pregnancy|1|||
155690443|NCT01527383|561958810|FG001|Overall Study|Pregnancy|0|||
155690444|NCT01527383|561958809|FG000|Overall Study|Protocol Violation|1|||
155690445|NCT01527383|561958810|FG001|Overall Study|Protocol Violation|0|||
155690446|NCT01527383|561958809|FG000|Overall Study|Screen failure|1|||
155690447|NCT01527383|561958810|FG001|Overall Study|Screen failure|0|||
155690448|NCT01527383|561958809|FG000|Overall Study|Participant moved|0|||
155690449|NCT01527383|561958810|FG001|Overall Study|Participant moved|1|||
155690450|NCT01527383|561958809|FG000|Overall Study|Withdrawal by Subject|2|||
155690451|NCT01527383|561958810|FG001|Overall Study|Withdrawal by Subject|3|||
155690452|NCT01287221|561958811|FG000|Overall Study|Lack of Perceived Benefit|1|||
155690453|NCT01287221|561958812|FG001|Overall Study|Lack of Perceived Benefit|1|||
155690454|NCT01287221|561958811|FG000|Overall Study|Adverse Event|3|||
155690455|NCT01287221|561958812|FG001|Overall Study|Adverse Event|3|||
155690456|NCT01287221|561958811|FG000|Overall Study|Withdrawal by Subject|0|||
155690457|NCT01287221|561958812|FG001|Overall Study|Withdrawal by Subject|1|||
155690458|NCT02966795|561958813|FG000|Overall Study|Patient Left the Country|0|||
155690459|NCT02966795|561958814|FG001|Overall Study|Patient Left the Country|1|||
155690460|NCT00432744|561958815|FG000|Months 0-6|Withdrawal by Subject|4|||
155690461|NCT00432744|561958816|FG001|Months 0-6|Withdrawal by Subject|4|||
155690462|NCT00432744|561958815|FG000|Months 0-6|Too disabled to score|1|||
155690463|NCT00432744|561958816|FG001|Months 0-6|Too disabled to score|0|||
155690464|NCT00432744|561958815|FG000|Months 7 - 12|Withdrawal by Subject|1|||
155690465|NCT00432744|561958816|FG001|Months 7 - 12|Withdrawal by Subject|0|||
155690466|NCT00432744|561958815|FG000|Months 7 - 12|Too disabled to score|0|||
155690467|NCT00432744|561958816|FG001|Months 7 - 12|Too disabled to score|1|||
155690468|NCT02761694|561958821|FG000|Overall Study|Lack of Efficacy|0|||
155690469|NCT02761694|561958822|FG001|Overall Study|Lack of Efficacy|0|||
155690470|NCT02761694|561958823|FG002|Overall Study|Lack of Efficacy|0|||
155690471|NCT02761694|561958824|FG003|Overall Study|Lack of Efficacy|0|||
155690472|NCT02761694|561958825|FG004|Overall Study|Lack of Efficacy|0|||
155690473|NCT02761694|561958826|FG005|Overall Study|Lack of Efficacy|0|||
155690474|NCT02761694|561958827|FG006|Overall Study|Lack of Efficacy|6|||
155690475|NCT02761694|561958828|FG007|Overall Study|Lack of Efficacy|0|||
155690476|NCT02761694|561958829|FG008|Overall Study|Lack of Efficacy|0|||
155690477|NCT02761694|561958830|FG009|Overall Study|Lack of Efficacy|1|||
155690478|NCT02761694|561958831|FG010|Overall Study|Lack of Efficacy|1|||
155690479|NCT02761694|561958832|FG011|Overall Study|Lack of Efficacy|4|||
155690480|NCT02761694|561958821|FG000|Overall Study|Death|0|||
155690481|NCT02761694|561958822|FG001|Overall Study|Death|0|||
155690482|NCT02761694|561958823|FG002|Overall Study|Death|0|||
155690483|NCT02761694|561958824|FG003|Overall Study|Death|0|||
155690484|NCT02761694|561958825|FG004|Overall Study|Death|0|||
155690485|NCT02761694|561958826|FG005|Overall Study|Death|0|||
155690486|NCT02761694|561958827|FG006|Overall Study|Death|2|||
155690487|NCT02761694|561958828|FG007|Overall Study|Death|0|||
155690488|NCT02761694|561958829|FG008|Overall Study|Death|2|||
155690489|NCT02761694|561958830|FG009|Overall Study|Death|2|||
155690490|NCT02761694|561958831|FG010|Overall Study|Death|1|||
155690491|NCT02761694|561958832|FG011|Overall Study|Death|0|||
155690492|NCT02761694|561958821|FG000|Overall Study|Physician Decision|0|||
155690493|NCT02761694|561958822|FG001|Overall Study|Physician Decision|0|||
155690494|NCT02761694|561958823|FG002|Overall Study|Physician Decision|0|||
155690495|NCT02761694|561958824|FG003|Overall Study|Physician Decision|0|||
155690496|NCT02761694|561958825|FG004|Overall Study|Physician Decision|0|||
155690497|NCT02761694|561958826|FG005|Overall Study|Physician Decision|0|||
155690498|NCT02761694|561958827|FG006|Overall Study|Physician Decision|1|||
155690499|NCT02761694|561958828|FG007|Overall Study|Physician Decision|0|||
155690500|NCT02761694|561958829|FG008|Overall Study|Physician Decision|0|||
155690501|NCT02761694|561958830|FG009|Overall Study|Physician Decision|0|||
155690502|NCT02761694|561958831|FG010|Overall Study|Physician Decision|0|||
155690503|NCT02761694|561958832|FG011|Overall Study|Physician Decision|0|||
155690504|NCT02761694|561958821|FG000|Overall Study|Withdrawal by Subject|0|||
155690505|NCT02761694|561958822|FG001|Overall Study|Withdrawal by Subject|0|||
155690506|NCT02761694|561958823|FG002|Overall Study|Withdrawal by Subject|0|||
155690507|NCT02761694|561958824|FG003|Overall Study|Withdrawal by Subject|1|||
155690508|NCT02761694|561958825|FG004|Overall Study|Withdrawal by Subject|0|||
155690509|NCT02761694|561958826|FG005|Overall Study|Withdrawal by Subject|0|||
155690510|NCT02761694|561958827|FG006|Overall Study|Withdrawal by Subject|4|||
155690511|NCT02761694|561958828|FG007|Overall Study|Withdrawal by Subject|0|||
155690512|NCT02761694|561958829|FG008|Overall Study|Withdrawal by Subject|2|||
155690513|NCT02761694|561958830|FG009|Overall Study|Withdrawal by Subject|1|||
155690514|NCT02761694|561958831|FG010|Overall Study|Withdrawal by Subject|0|||
155690515|NCT02761694|561958832|FG011|Overall Study|Withdrawal by Subject|0|||
155690516|NCT02761694|561958821|FG000|Overall Study|Lost to Follow-up|0|||
155690517|NCT02761694|561958822|FG001|Overall Study|Lost to Follow-up|0|||
155690518|NCT02761694|561958823|FG002|Overall Study|Lost to Follow-up|0|||
155690519|NCT02761694|561958824|FG003|Overall Study|Lost to Follow-up|0|||
155690520|NCT02761694|561958825|FG004|Overall Study|Lost to Follow-up|0|||
155690521|NCT02761694|561958826|FG005|Overall Study|Lost to Follow-up|0|||
155690522|NCT02761694|561958827|FG006|Overall Study|Lost to Follow-up|1|||
155690523|NCT02761694|561958828|FG007|Overall Study|Lost to Follow-up|0|||
155690524|NCT02761694|561958829|FG008|Overall Study|Lost to Follow-up|0|||
155690525|NCT02761694|561958830|FG009|Overall Study|Lost to Follow-up|0|||
155690526|NCT02761694|561958831|FG010|Overall Study|Lost to Follow-up|0|||
155690527|NCT02761694|561958832|FG011|Overall Study|Lost to Follow-up|1|||
155690528|NCT02761694|561958821|FG000|Overall Study|Adverse Event|0|||
155690529|NCT02761694|561958822|FG001|Overall Study|Adverse Event|0|||
155690530|NCT02761694|561958823|FG002|Overall Study|Adverse Event|0|||
155690531|NCT02761694|561958824|FG003|Overall Study|Adverse Event|0|||
155690532|NCT02761694|561958825|FG004|Overall Study|Adverse Event|0|||
155690533|NCT02761694|561958826|FG005|Overall Study|Adverse Event|0|||
155690534|NCT02761694|561958827|FG006|Overall Study|Adverse Event|1|||
155690535|NCT02761694|561958828|FG007|Overall Study|Adverse Event|0|||
155690536|NCT02761694|561958829|FG008|Overall Study|Adverse Event|1|||
155690537|NCT02761694|561958830|FG009|Overall Study|Adverse Event|0|||
155690538|NCT02761694|561958831|FG010|Overall Study|Adverse Event|0|||
155690539|NCT02761694|561958832|FG011|Overall Study|Adverse Event|1|||
155690540|NCT02761694|561958821|FG000|Overall Study|Other|4|||
155690541|NCT02761694|561958822|FG001|Overall Study|Other|4|||
155690542|NCT02761694|561958823|FG002|Overall Study|Other|1|||
155690543|NCT02761694|561958824|FG003|Overall Study|Other|2|||
155690544|NCT02761694|561958825|FG004|Overall Study|Other|3|||
155690545|NCT02761694|561958826|FG005|Overall Study|Other|3|||
155690546|NCT02761694|561958827|FG006|Overall Study|Other|18|||
155690547|NCT02761694|561958828|FG007|Overall Study|Other|8|||
155690548|NCT02761694|561958829|FG008|Overall Study|Other|0|||
155690549|NCT02761694|561958830|FG009|Overall Study|Other|1|||
155690550|NCT02761694|561958831|FG010|Overall Study|Other|1|||
155690551|NCT02761694|561958832|FG011|Overall Study|Other|0|||
155690552|NCT02395055|561958840|FG000|Overall Study|Withdrawal by Subject|7|||
155690553|NCT02395055|561958841|FG001|Overall Study|Withdrawal by Subject|3|||
155690554|NCT00787930|561958842|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
155690555|NCT02513823|561958843|FG000|Overall Study|Lost to Follow-up|4|||
155690556|NCT02513823|561958843|FG000|Overall Study|Physician Decision|1|||
155690557|NCT00394901|561958844|FG000|Baseline Phase|Protocol Violation|0|||
155690558|NCT00394901|561958845|FG001|Baseline Phase|Protocol Violation|0|||
155690559|NCT00394901|561958846|FG002|Baseline Phase|Protocol Violation|1|||
155690560|NCT00394901|561958847|FG003|Baseline Phase|Protocol Violation|0|||
155690561|NCT00394901|561958844|FG000|Double-blind Phase|Adverse Event|5|||
155690562|NCT00394901|561958845|FG001|Double-blind Phase|Adverse Event|7|||
155690563|NCT00394901|561958846|FG002|Double-blind Phase|Adverse Event|16|||
155690564|NCT00394901|561958847|FG003|Double-blind Phase|Adverse Event|20|||
155690565|NCT00394901|561958844|FG000|Double-blind Phase|Lack of Efficacy|6|||
155690566|NCT00394901|561958845|FG001|Double-blind Phase|Lack of Efficacy|4|||
155690567|NCT00394901|561958846|FG002|Double-blind Phase|Lack of Efficacy|1|||
155690568|NCT00394901|561958847|FG003|Double-blind Phase|Lack of Efficacy|3|||
155690569|NCT00394901|561958844|FG000|Double-blind Phase|Withdrawal by Subject|2|||
155690570|NCT00394901|561958845|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155690571|NCT00394901|561958846|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155690572|NCT00394901|561958847|FG003|Double-blind Phase|Withdrawal by Subject|0|||
155690573|NCT00394901|561958844|FG000|Double-blind Phase|Lost to Follow-up|0|||
155690574|NCT00394901|561958845|FG001|Double-blind Phase|Lost to Follow-up|0|||
155690575|NCT00394901|561958846|FG002|Double-blind Phase|Lost to Follow-up|0|||
155690576|NCT00394901|561958847|FG003|Double-blind Phase|Lost to Follow-up|1|||
155690577|NCT00394901|561958844|FG000|Double-blind Phase|Protocol Violation|0|||
155690578|NCT00394901|561958845|FG001|Double-blind Phase|Protocol Violation|0|||
155690579|NCT00394901|561958846|FG002|Double-blind Phase|Protocol Violation|0|||
155690580|NCT00394901|561958847|FG003|Double-blind Phase|Protocol Violation|1|||
155690581|NCT00394901|561958844|FG000|Double-blind Phase|Death|1|||
155690582|NCT00394901|561958845|FG001|Double-blind Phase|Death|0|||
155690583|NCT00394901|561958846|FG002|Double-blind Phase|Death|0|||
155690584|NCT00394901|561958847|FG003|Double-blind Phase|Death|0|||
155690585|NCT00394901|561958844|FG000|Double-blind Phase|Subject's Personal Reason|1|||
155690586|NCT00394901|561958845|FG001|Double-blind Phase|Subject's Personal Reason|0|||
155690587|NCT00394901|561958846|FG002|Double-blind Phase|Subject's Personal Reason|0|||
155690588|NCT00394901|561958847|FG003|Double-blind Phase|Subject's Personal Reason|1|||
155690589|NCT00394901|561958844|FG000|Double-blind Phase|Lack of Compliance|0|||
155690590|NCT00394901|561958845|FG001|Double-blind Phase|Lack of Compliance|3|||
155690591|NCT00394901|561958846|FG002|Double-blind Phase|Lack of Compliance|0|||
155690592|NCT00394901|561958847|FG003|Double-blind Phase|Lack of Compliance|0|||
155690593|NCT00394901|561958844|FG000|Double-blind Phase|Entry into another study was found|0|||
155690594|NCT00394901|561958845|FG001|Double-blind Phase|Entry into another study was found|0|||
155690595|NCT00394901|561958846|FG002|Double-blind Phase|Entry into another study was found|1|||
155690596|NCT00394901|561958847|FG003|Double-blind Phase|Entry into another study was found|0|||
155690597|NCT00394901|561958844|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
155690598|NCT00394901|561958845|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
155690599|NCT00394901|561958846|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
155690600|NCT00394901|561958847|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
155690601|NCT03002623|561958850|FG000|Overall Study|Lost to Follow-up|1|||
155690602|NCT03002623|561958851|FG001|Overall Study|Lost to Follow-up|0|||
155690603|NCT03002623|561958850|FG000|Overall Study|Physician Decision|1|||
155690604|NCT03002623|561958851|FG001|Overall Study|Physician Decision|1|||
155690605|NCT04342689|561958855|FG000|Overall Study|Withdrawal by Subject|32|||
155690606|NCT04342689|561958856|FG001|Overall Study|Withdrawal by Subject|33|||
155690607|NCT04342689|561958855|FG000|Overall Study|Lost to Follow-up|10|||
155690608|NCT04342689|561958856|FG001|Overall Study|Lost to Follow-up|12|||
155690609|NCT00844805|561958857|FG000|Treatment Phase|Adverse Event|5|||
155690610|NCT00844805|561958858|FG001|Treatment Phase|Adverse Event|1|||
155690611|NCT00844805|561958859|FG002|Treatment Phase|Adverse Event|0|||
155690612|NCT00844805|561958860|FG003|Treatment Phase|Adverse Event|0|||
155690613|NCT00844805|561958857|FG000|Treatment Phase|Withdrawal by Subject|3|||
155690614|NCT00844805|561958858|FG001|Treatment Phase|Withdrawal by Subject|4|||
155690615|NCT00844805|561958859|FG002|Treatment Phase|Withdrawal by Subject|0|||
155690616|NCT00844805|561958860|FG003|Treatment Phase|Withdrawal by Subject|0|||
155690617|NCT00844805|561958857|FG000|Treatment Phase|Noncompliance With Protocol|1|||
155690618|NCT00844805|561958858|FG001|Treatment Phase|Noncompliance With Protocol|0|||
155690619|NCT00844805|561958859|FG002|Treatment Phase|Noncompliance With Protocol|0|||
155690620|NCT00844805|561958860|FG003|Treatment Phase|Noncompliance With Protocol|0|||
155690621|NCT00844805|561958857|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
155690622|NCT00844805|561958858|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
155690623|NCT00844805|561958859|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
155690624|NCT00844805|561958860|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
155690625|NCT00844805|561958857|FG000|Follow-Up Phase|Adverse Event|0|||
155690626|NCT00844805|561958858|FG001|Follow-Up Phase|Adverse Event|0|||
155690627|NCT00844805|561958859|FG002|Follow-Up Phase|Adverse Event|1|||
155690628|NCT00844805|561958860|FG003|Follow-Up Phase|Adverse Event|0|||
155690629|NCT00844805|561958857|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
155690630|NCT00844805|561958858|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
155690631|NCT00844805|561958859|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
155690632|NCT00844805|561958860|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
155690633|NCT00844805|561958857|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
155690634|NCT00844805|561958858|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
155690635|NCT00844805|561958859|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
155690636|NCT00844805|561958860|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
155690637|NCT00844805|561958857|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
155690638|NCT00844805|561958858|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
155690639|NCT00844805|561958859|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
155690640|NCT00844805|561958860|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
155690641|NCT00844805|561958857|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
155690642|NCT00844805|561958858|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
155690643|NCT00844805|561958859|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
155690644|NCT00844805|561958860|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
155690645|NCT00475865|561958861|FG000|Overall Study|Adverse Event|0|||
155690646|NCT00475865|561958862|FG001|Overall Study|Adverse Event|3|||
155690647|NCT00475865|561958863|FG002|Overall Study|Adverse Event|4|||
155690648|NCT00475865|561958861|FG000|Overall Study|Lack of Efficacy|1|||
155690649|NCT00475865|561958862|FG001|Overall Study|Lack of Efficacy|0|||
155690650|NCT00475865|561958863|FG002|Overall Study|Lack of Efficacy|0|||
155690651|NCT00475865|561958861|FG000|Overall Study|Progressive disease|0|||
155690652|NCT00475865|561958862|FG001|Overall Study|Progressive disease|1|||
155690653|NCT00475865|561958863|FG002|Overall Study|Progressive disease|2|||
155690654|NCT00475865|561958861|FG000|Overall Study|Participant did not wish to continue|1|||
155690655|NCT00475865|561958862|FG001|Overall Study|Participant did not wish to continue|0|||
155690656|NCT00475865|561958863|FG002|Overall Study|Participant did not wish to continue|0|||
155690657|NCT00475865|561958861|FG000|Overall Study|Other than above|0|||
155690658|NCT00475865|561958862|FG001|Overall Study|Other than above|1|||
155690659|NCT00475865|561958863|FG002|Overall Study|Other than above|0|||
155690660|NCT04316741|561958864|FG000|Baseline Enrollment|Lost to Follow-up|1|||
155690661|NCT04316741|561958865|FG001|Baseline Enrollment|Lost to Follow-up|1|||
155690662|NCT04316741|561958864|FG000|Immediate Post-Test|Lost to Follow-up|5|||
155690663|NCT04316741|561958865|FG001|Immediate Post-Test|Lost to Follow-up|1|||
155690664|NCT04316741|561958864|FG000|1-month Post-test|Lost to Follow-up|7|||
155690665|NCT04316741|561958865|FG001|1-month Post-test|Lost to Follow-up|2|||
155690666|NCT04316741|561958864|FG000|3-month Follow-up|Lost to Follow-up|10|||
155690667|NCT04316741|561958865|FG001|3-month Follow-up|Lost to Follow-up|2|||
155690668|NCT02278614|561958869|FG000|Overall Study|Withdrawal by Subject|3|||
155690669|NCT02278614|561958870|FG001|Overall Study|Withdrawal by Subject|5|||
155690670|NCT02278614|561958869|FG000|Overall Study|Adverse Event|1|||
155690671|NCT02278614|561958870|FG001|Overall Study|Adverse Event|0|||
155690672|NCT02278614|561958869|FG000|Overall Study|left eye was not eligible|1|||
155690673|NCT02278614|561958870|FG001|Overall Study|left eye was not eligible|0|||
155690674|NCT02279498|561958871|FG000|Overall Study|Adverse Event|3|||
155690675|NCT02279498|561958872|FG001|Overall Study|Adverse Event|0|||
155690676|NCT02279498|561958871|FG000|Overall Study|Lack of Efficacy|4|||
155690677|NCT02279498|561958872|FG001|Overall Study|Lack of Efficacy|0|||
155690678|NCT02279498|561958871|FG000|Overall Study|Lost to Follow-up|0|||
155690679|NCT02279498|561958872|FG001|Overall Study|Lost to Follow-up|1|||
155690680|NCT02279498|561958871|FG000|Overall Study|Withdrawal by Subject|9|||
155690681|NCT02279498|561958872|FG001|Overall Study|Withdrawal by Subject|2|||
155690682|NCT02279498|561958871|FG000|Overall Study|Undefined|2|||
155690683|NCT02279498|561958872|FG001|Overall Study|Undefined|1|||
155690684|NCT00737711|561958873|FG000|Overall Study|Adverse Event|2|||
155690685|NCT00737711|561958873|FG000|Overall Study|Death|8|||
155690686|NCT00737711|561958873|FG000|Overall Study|Failure to return|4|||
155690687|NCT00737711|561958873|FG000|Overall Study|Protocol Violation|1|||
155690688|NCT00737711|561958873|FG000|Overall Study|Withdrawal by Subject|5|||
155690689|NCT00737711|561958873|FG000|Overall Study|Blood transfusion|6|||
155690690|NCT00737711|561958873|FG000|Overall Study|Other|5|||
155690691|NCT00624780|561958874|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
155690692|NCT00624780|561958875|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
155690693|NCT00624780|561958876|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
155690694|NCT00624780|561958877|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
155690695|NCT00624780|561958878|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
155690696|NCT00624780|561958879|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
155690697|NCT00624780|561958874|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
155690698|NCT00624780|561958875|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
155690699|NCT00624780|561958876|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
155690700|NCT00624780|561958877|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
155690701|NCT00624780|561958878|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
155690702|NCT00624780|561958879|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
155690703|NCT00624780|561958874|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
155690704|NCT00624780|561958875|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
155690705|NCT00624780|561958876|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
155690706|NCT00624780|561958877|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
155690707|NCT00624780|561958878|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
155690708|NCT00624780|561958879|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
155690709|NCT00624780|561958874|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
155690710|NCT00624780|561958875|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
155690711|NCT00624780|561958876|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
155690712|NCT00624780|561958877|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
155690713|NCT00624780|561958878|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
155690714|NCT00624780|561958879|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
155690715|NCT00624780|561958874|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
155690716|NCT00624780|561958875|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
155690717|NCT00624780|561958876|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
155690718|NCT00624780|561958877|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
155690719|NCT00624780|561958878|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
155690720|NCT00624780|561958879|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
155690721|NCT00624780|561958874|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
155690722|NCT00624780|561958875|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
155690723|NCT00624780|561958876|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
155690724|NCT00624780|561958877|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
155690725|NCT00624780|561958878|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
155690726|NCT00624780|561958879|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
155690727|NCT00624780|561958874|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155690728|NCT00624780|561958875|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
155690729|NCT00624780|561958876|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155690730|NCT00624780|561958877|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
155690731|NCT00624780|561958878|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
155690732|NCT00624780|561958879|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155690733|NCT00624780|561958874|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155690734|NCT00624780|561958875|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
155690735|NCT00624780|561958876|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155690736|NCT00624780|561958877|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
155690737|NCT00624780|561958878|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155690738|NCT00624780|561958879|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155690739|NCT00624780|561958874|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
155690740|NCT00624780|561958875|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
155690741|NCT00624780|561958876|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
155690742|NCT00624780|561958877|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
155690743|NCT00624780|561958878|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
155690744|NCT00624780|561958879|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
155690745|NCT00624780|561958874|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
155690746|NCT00624780|561958875|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
155690747|NCT00624780|561958876|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
155690748|NCT00624780|561958877|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
155690749|NCT00624780|561958878|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
155690750|NCT00624780|561958879|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
155690751|NCT00624780|561958874|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155690752|NCT00624780|561958875|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
155690753|NCT00624780|561958876|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
155690754|NCT00624780|561958877|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155690755|NCT00624780|561958878|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
155690756|NCT00624780|561958879|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155690757|NCT00624780|561958874|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
155690758|NCT00624780|561958875|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155690759|NCT00624780|561958876|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155690760|NCT00624780|561958877|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155690761|NCT00624780|561958878|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155690762|NCT00624780|561958879|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155690763|NCT00624780|561958874|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155690764|NCT00624780|561958875|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155690765|NCT00624780|561958876|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
155690766|NCT00624780|561958877|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155690767|NCT00624780|561958878|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155690768|NCT00624780|561958879|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155690769|NCT00624780|561958874|FG000|Follow-up (Week 26)|Death|0|||
155690770|NCT00624780|561958875|FG001|Follow-up (Week 26)|Death|0|||
155690771|NCT00624780|561958876|FG002|Follow-up (Week 26)|Death|1|||
155690772|NCT00624780|561958877|FG003|Follow-up (Week 26)|Death|0|||
155690773|NCT00624780|561958878|FG004|Follow-up (Week 26)|Death|0|||
155690774|NCT00624780|561958879|FG005|Follow-up (Week 26)|Death|0|||
155690775|NCT00624780|561958874|FG000|Follow-up (Week 26)|Adverse Event|0|||
155690776|NCT00624780|561958875|FG001|Follow-up (Week 26)|Adverse Event|0|||
155690777|NCT00624780|561958876|FG002|Follow-up (Week 26)|Adverse Event|0|||
155690778|NCT00624780|561958877|FG003|Follow-up (Week 26)|Adverse Event|0|||
155690779|NCT00624780|561958878|FG004|Follow-up (Week 26)|Adverse Event|1|||
155690780|NCT00624780|561958879|FG005|Follow-up (Week 26)|Adverse Event|0|||
155690781|NCT00624780|561958874|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
155690782|NCT00624780|561958875|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
155690783|NCT00624780|561958876|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
155690784|NCT00624780|561958877|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
155690785|NCT00624780|561958878|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
155690786|NCT00624780|561958879|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
155690787|NCT00624780|561958874|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
155690788|NCT00624780|561958875|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
155690789|NCT00624780|561958876|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
155690790|NCT00624780|561958877|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
155690791|NCT00624780|561958878|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
155690792|NCT00624780|561958879|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
155690793|NCT00624780|561958874|FG000|Follow-up (Week 26)|Other|1|||
155690794|NCT00624780|561958875|FG001|Follow-up (Week 26)|Other|1|||
155690795|NCT00624780|561958876|FG002|Follow-up (Week 26)|Other|0|||
155690796|NCT00624780|561958877|FG003|Follow-up (Week 26)|Other|0|||
155690797|NCT00624780|561958878|FG004|Follow-up (Week 26)|Other|0|||
155690798|NCT00624780|561958879|FG005|Follow-up (Week 26)|Other|0|||
155690799|NCT04068519|561958880|FG000|Dose Verification|Death|15|||
155690800|NCT04068519|561958880|FG000|Dose Verification|Withdrawal by Subject|1|||
155690801|NCT04068519|561958880|FG000|Pharmacokinetic Sub-study|Death|35|||
155690802|NCT04068519|561958880|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
155690803|NCT04068519|561958880|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
155690804|NCT04068519|561958880|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
155690805|NCT04068519|561958880|FG000|Indication Expansion|Death|152|||
155690806|NCT04068519|561958880|FG000|Indication Expansion|Withdrawal by Subject|10|||
155690807|NCT04068519|561958880|FG000|Indication Expansion|Lost to Follow-up|7|||
155690808|NCT03762616|561958881|FG000|Overall Study|Protocol Violation|2|||
155690809|NCT03081858|561961046|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
155690810|NCT03081858|561961047|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155690811|NCT03081858|561961048|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155690812|NCT03081858|561961049|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155690813|NCT05438602|561961052|FG000|Treatment (15 Days)|Adverse Event|2|||
155690814|NCT05438602|561961053|FG001|Treatment (15 Days)|Adverse Event|1|||
155690815|NCT05438602|561961054|FG002|Treatment (15 Days)|Adverse Event|3|||
155690816|NCT05438602|561961052|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
155690817|NCT05438602|561961053|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
155690818|NCT05438602|561961054|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
155690819|NCT05438602|561961052|FG000|Treatment (15 Days)|Other|0|||
155690820|NCT05438602|561961053|FG001|Treatment (15 Days)|Other|0|||
155690821|NCT05438602|561961054|FG002|Treatment (15 Days)|Other|1|||
155690822|NCT05438602|561961052|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
155690823|NCT05438602|561961053|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
155690824|NCT05438602|561961054|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
155690825|NCT05438602|561961052|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
155690826|NCT05438602|561961053|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
155690827|NCT05438602|561961054|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
155690828|NCT05438602|561961052|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
155690829|NCT05438602|561961053|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
155690830|NCT05438602|561961054|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
155690831|NCT05438602|561961052|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
155690832|NCT05438602|561961053|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
155690833|NCT05438602|561961054|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
155690834|NCT05438602|561961052|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
155690835|NCT05438602|561961053|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
155690836|NCT05438602|561961054|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
155690837|NCT05438602|561961052|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
155690838|NCT05438602|561961053|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
155690839|NCT05438602|561961054|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
155690840|NCT05438602|561961052|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
155690841|NCT05438602|561961053|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
155690842|NCT05438602|561961054|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
155690843|NCT04524455|561961064|FG000|Overall Study|Death|3|||
155690844|NCT04524455|561961065|FG001|Overall Study|Death|3|||
155690845|NCT04524455|561961064|FG000|Overall Study|Decision by Sponsor|0|||
155690846|NCT04524455|561961065|FG001|Overall Study|Decision by Sponsor|2|||
155690847|NCT04524455|561961064|FG000|Overall Study|Withdrawal of Consent From Study|1|||
155690848|NCT04524455|561961065|FG001|Overall Study|Withdrawal of Consent From Study|0|||
155690849|NCT04524455|561961064|FG000|Overall Study|Lost to Follow-up|0|||
155690850|NCT04524455|561961065|FG001|Overall Study|Lost to Follow-up|1|||
155690851|NCT01688739|561961066|FG000|Overall Study|Administrative Decision|1|||
155690852|NCT01688739|561961067|FG001|Overall Study|Administrative Decision|0|||
155690853|NCT01688739|561961068|FG002|Overall Study|Administrative Decision|0|||
155690854|NCT01688739|561961069|FG003|Overall Study|Administrative Decision|0|||
155690855|NCT01688739|561961070|FG004|Overall Study|Administrative Decision|0|||
155690856|NCT01688739|561961071|FG005|Overall Study|Administrative Decision|0|||
155690857|NCT01688739|561961072|FG006|Overall Study|Administrative Decision|0|||
155690858|NCT01688739|561961073|FG007|Overall Study|Administrative Decision|0|||
155690859|NCT01688739|561961074|FG008|Overall Study|Administrative Decision|0|||
155690860|NCT01688739|561961075|FG009|Overall Study|Administrative Decision|0|||
155690861|NCT01657760|561961079|FG000|Overall Study|Withdrawal by Subject|0|||
155690862|NCT01657760|561961080|FG001|Overall Study|Withdrawal by Subject|0|||
155690863|NCT01657760|561961081|FG002|Overall Study|Withdrawal by Subject|0|||
155690864|NCT01657760|561961082|FG003|Overall Study|Withdrawal by Subject|1|||
155690865|NCT01657760|561961079|FG000|Overall Study|Physician Decision|1|||
155690866|NCT01657760|561961080|FG001|Overall Study|Physician Decision|1|||
155690867|NCT01657760|561961081|FG002|Overall Study|Physician Decision|1|||
155690868|NCT01657760|561961082|FG003|Overall Study|Physician Decision|2|||
155690869|NCT02317809|561961096|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
155690870|NCT02317809|561961097|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
155690871|NCT02317809|561961096|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
155690872|NCT02317809|561961097|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
155690873|NCT00953524|561961098|FG000|Overall Study|Adverse Event|2|||
155690874|NCT00953524|561961099|FG001|Overall Study|Adverse Event|0|||
155690875|NCT00953524|561961100|FG002|Overall Study|Adverse Event|1|||
155690876|NCT00953524|561961101|FG003|Overall Study|Adverse Event|2|||
155690877|NCT00953524|561961098|FG000|Overall Study|Protocol Violation|18|||
155690878|NCT00953524|561961099|FG001|Overall Study|Protocol Violation|10|||
155690879|NCT00953524|561961100|FG002|Overall Study|Protocol Violation|11|||
155690880|NCT00953524|561961101|FG003|Overall Study|Protocol Violation|6|||
155690881|NCT00953524|561961098|FG000|Overall Study|Lost to Follow-up|0|||
155690882|NCT00953524|561961099|FG001|Overall Study|Lost to Follow-up|1|||
155690883|NCT00953524|561961100|FG002|Overall Study|Lost to Follow-up|1|||
155690884|NCT00953524|561961101|FG003|Overall Study|Lost to Follow-up|0|||
155690885|NCT00953524|561961098|FG000|Overall Study|Withdrawal by Subject|2|||
155690886|NCT00953524|561961099|FG001|Overall Study|Withdrawal by Subject|4|||
155690887|NCT00953524|561961100|FG002|Overall Study|Withdrawal by Subject|1|||
155690888|NCT00953524|561961101|FG003|Overall Study|Withdrawal by Subject|0|||
155690889|NCT00294645|561961104|FG000|Overall Study|Death|10|||
155690890|NCT00294645|561961105|FG001|Overall Study|Death|18|||
155690891|NCT00294645|561961104|FG000|Overall Study|Lost to Follow-up|1|||
155690892|NCT00294645|561961105|FG001|Overall Study|Lost to Follow-up|10|||
155690893|NCT00294645|561961104|FG000|Overall Study|Withdrawal by Subject|18|||
155690894|NCT00294645|561961105|FG001|Overall Study|Withdrawal by Subject|34|||
155690895|NCT00294645|561961104|FG000|Overall Study|Physician Decision|15|||
155690896|NCT00294645|561961105|FG001|Overall Study|Physician Decision|20|||
155690897|NCT00294645|561961104|FG000|Overall Study|Other|4|||
155690898|NCT00294645|561961105|FG001|Overall Study|Other|10|||
155690899|NCT01994863|561961108|FG000|Period 1|Adverse Event|4|||
155690900|NCT01994863|561961109|FG001|Period 1|Adverse Event|0|||
155690901|NCT01994863|561961108|FG000|Period 1|Withdrawal by Subject|1|||
155690902|NCT01994863|561961109|FG001|Period 1|Withdrawal by Subject|0|||
155690903|NCT01994863|561961108|FG000|Period 1|Trial stopped by sponsor|1|||
155690904|NCT01994863|561961109|FG001|Period 1|Trial stopped by sponsor|3|||
155690905|NCT01994863|561961108|FG000|Period 1|Lack of Efficacy|1|||
155690906|NCT01994863|561961109|FG001|Period 1|Lack of Efficacy|0|||
155690907|NCT01994863|561961108|FG000|Period 2|Adverse Event|0|||
155690908|NCT01994863|561961109|FG001|Period 2|Adverse Event|1|||
155690909|NCT01994863|561961108|FG000|Period 2|Lack of Efficacy|0|||
155690910|NCT01994863|561961109|FG001|Period 2|Lack of Efficacy|2|||
155690911|NCT01994863|561961108|FG000|Period 2|Withdrawal by Subject|1|||
155690912|NCT01994863|561961109|FG001|Period 2|Withdrawal by Subject|1|||
155690913|NCT03784846|561961110|FG000|Pre-COVID Study|Lost to Follow-up|3|||
155690914|NCT03784846|561961111|FG001|Pre-COVID Study|Lost to Follow-up|3|||
155690915|NCT03784846|561961112|FG002|Pre-COVID Study|Lost to Follow-up|2|||
155690916|NCT03784846|561961110|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
155690917|NCT03784846|561961111|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
155690918|NCT03784846|561961112|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
155690919|NCT03784846|561961110|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
155690920|NCT03784846|561961111|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
155690921|NCT03784846|561961112|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
155690922|NCT03784846|561961110|FG000|Post-COVID Study|Lost to Follow-up|3|||
155690923|NCT03784846|561961111|FG001|Post-COVID Study|Lost to Follow-up|5|||
155690924|NCT03784846|561961112|FG002|Post-COVID Study|Lost to Follow-up|1|||
155690925|NCT03784846|561961110|FG000|Post-COVID Study|Withdrawal by Subject|1|||
155690926|NCT03784846|561961111|FG001|Post-COVID Study|Withdrawal by Subject|2|||
155690927|NCT03784846|561961112|FG002|Post-COVID Study|Withdrawal by Subject|0|||
155690928|NCT00867087|561961113|FG000|Overall Study|Other|1|||
155690929|NCT00867087|561961113|FG000|Overall Study|Withdrawal by Subject|4|||
155690930|NCT00867087|561961113|FG000|Overall Study|Death|37|||
155690931|NCT00570037|561961114|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
155690932|NCT00570037|561961115|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
155690933|NCT04612842|561961116|FG000|Overall Study|Lost to Follow-up|20|||
155690934|NCT04612842|561961117|FG001|Overall Study|Lost to Follow-up|11|||
155690935|NCT04612842|561961116|FG000|Overall Study|Withdrawal by Subject|26|||
155690936|NCT04612842|561961117|FG001|Overall Study|Withdrawal by Subject|15|||
155690937|NCT04612842|561961116|FG000|Overall Study|Death|2|||
155690938|NCT04612842|561961117|FG001|Overall Study|Death|2|||
155690939|NCT02419131|561961118|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
155690940|NCT02419131|561961119|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
155690941|NCT02419131|561961120|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
155690942|NCT02419131|561961118|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
155690943|NCT02419131|561961119|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
155690944|NCT02419131|561961120|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
155690945|NCT03060512|561961121|FG000|Overall Study|Adverse Event|4|||
155690946|NCT03060512|561961122|FG001|Overall Study|Adverse Event|6|||
155690947|NCT03060512|561961121|FG000|Overall Study|Lost to Follow-up|1|||
155690948|NCT03060512|561961122|FG001|Overall Study|Lost to Follow-up|1|||
155690949|NCT03060512|561961121|FG000|Overall Study|Withdrawal by Subject|1|||
155690950|NCT03060512|561961122|FG001|Overall Study|Withdrawal by Subject|0|||
155690951|NCT03060512|561961121|FG000|Overall Study|Non-compliance with study medication|1|||
155690952|NCT03060512|561961122|FG001|Overall Study|Non-compliance with study medication|2|||
155690953|NCT00089986|561961123|FG000|Overall Study|Adverse Event|6|||
155690954|NCT00089986|561961124|FG001|Overall Study|Adverse Event|9|||
155690955|NCT00089986|561961125|FG002|Overall Study|Adverse Event|6|||
155690956|NCT00089986|561961123|FG000|Overall Study|Lost to Follow-up|3|||
155690957|NCT00089986|561961124|FG001|Overall Study|Lost to Follow-up|1|||
155690958|NCT00089986|561961125|FG002|Overall Study|Lost to Follow-up|1|||
155690959|NCT00089986|561961123|FG000|Overall Study|Protocol Violation|0|||
155690960|NCT00089986|561961124|FG001|Overall Study|Protocol Violation|1|||
155690961|NCT00089986|561961125|FG002|Overall Study|Protocol Violation|0|||
155690962|NCT00089986|561961123|FG000|Overall Study|Patient transferred to another hospital|2|||
155690963|NCT00089986|561961124|FG001|Overall Study|Patient transferred to another hospital|1|||
155690964|NCT00089986|561961125|FG002|Overall Study|Patient transferred to another hospital|0|||
155690965|NCT00089986|561961123|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
155690966|NCT00089986|561961124|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
155690967|NCT00089986|561961125|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
155690968|NCT00089986|561961123|FG000|Overall Study|Hemohlobin stopping rule|0|||
155690969|NCT00089986|561961124|FG001|Overall Study|Hemohlobin stopping rule|1|||
155690970|NCT00089986|561961125|FG002|Overall Study|Hemohlobin stopping rule|0|||
155690971|NCT00089986|561961123|FG000|Overall Study|Investigator decision to withdrew|0|||
155690972|NCT00089986|561961124|FG001|Overall Study|Investigator decision to withdrew|1|||
155690973|NCT00089986|561961125|FG002|Overall Study|Investigator decision to withdrew|0|||
155690974|NCT00089986|561961123|FG000|Overall Study|Enrollment in another study|0|||
155690975|NCT00089986|561961124|FG001|Overall Study|Enrollment in another study|1|||
155690976|NCT00089986|561961125|FG002|Overall Study|Enrollment in another study|0|||
155690977|NCT00089986|561961123|FG000|Overall Study|Family decision|0|||
155690978|NCT00089986|561961124|FG001|Overall Study|Family decision|1|||
155690979|NCT00089986|561961125|FG002|Overall Study|Family decision|0|||
155690980|NCT00089986|561961123|FG000|Overall Study|Do not resuscitate (DNR)|0|||
155690981|NCT00089986|561961124|FG001|Overall Study|Do not resuscitate (DNR)|0|||
155690982|NCT00089986|561961125|FG002|Overall Study|Do not resuscitate (DNR)|1|||
155690983|NCT00089986|561961123|FG000|Overall Study|Withdrawal by Subject|3|||
155690984|NCT00089986|561961124|FG001|Overall Study|Withdrawal by Subject|6|||
155690985|NCT00089986|561961125|FG002|Overall Study|Withdrawal by Subject|2|||
155690986|NCT03946124|561961126|FG000|Overall Study|Withdrawal by Subject|19|||
155690987|NCT02334683|561961128|FG000|First 12 Week Period|Lost to Follow-up|1|||
155690988|NCT02334683|561961129|FG001|First 12 Week Period|Lost to Follow-up|0|||
155690989|NCT02334683|561961128|FG000|Second 12 Week Period|Adverse Event|0|||
155690990|NCT02334683|561961129|FG001|Second 12 Week Period|Adverse Event|1|||
155690991|NCT01062841|561961130|FG000|Overall Study|Indwelling Device Removed|41|||
155690992|NCT01062841|561961131|FG001|Overall Study|Indwelling Device Removed|48|||
155690993|NCT01062841|561961130|FG000|Overall Study|Death|3|||
155690994|NCT01062841|561961131|FG001|Overall Study|Death|5|||
155690995|NCT01062841|561961130|FG000|Overall Study|Withdrawal by Subject|2|||
155690996|NCT01062841|561961131|FG001|Overall Study|Withdrawal by Subject|0|||
155690997|NCT01062841|561961130|FG000|Overall Study|Withdrawal by Study|3|||
155690998|NCT01062841|561961131|FG001|Overall Study|Withdrawal by Study|0|||
155690999|NCT02046174|561961132|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
155691000|NCT02046174|561961133|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
155691001|NCT00413920|561961137|FG000|Overall Study|Adverse Event|9|||
155691002|NCT00413920|561961138|FG001|Overall Study|Adverse Event|11|||
155691003|NCT00413920|561961137|FG000|Overall Study|Lack of Efficacy|11|||
155691004|NCT00413920|561961138|FG001|Overall Study|Lack of Efficacy|9|||
155691005|NCT00413920|561961137|FG000|Overall Study|Death|3|||
155691006|NCT00413920|561961138|FG001|Overall Study|Death|5|||
155691007|NCT00413920|561961137|FG000|Overall Study|Graft Loss|5|||
155691008|NCT00413920|561961138|FG001|Overall Study|Graft Loss|3|||
155691009|NCT03831880|561961139|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
155691010|NCT03831880|561961140|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
155691011|NCT03831880|561961139|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
155691012|NCT03831880|561961140|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
155691013|NCT01891344|561961141|FG000|Overall Study|Ongoing|6|||
155691014|NCT01891344|561961142|FG001|Overall Study|Ongoing|2|||
155691015|NCT01891344|561961143|FG002|Overall Study|Ongoing|0|||
155691016|NCT01891344|561961144|FG003|Overall Study|Ongoing|1|||
155691017|NCT01891344|561961145|FG004|Overall Study|Ongoing|4|||
155691018|NCT01891344|561961146|FG005|Overall Study|Ongoing|1|||
155691019|NCT01891344|561961147|FG006|Overall Study|Ongoing|0|||
155691020|NCT01891344|561961148|FG007|Overall Study|Ongoing|0|||
155691021|NCT02969590|561961152|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
155691022|NCT02969590|561961153|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
155691023|NCT02969590|561961154|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
155691024|NCT01765426|561961155|FG000|Overall Study|Lost to Follow-up|0|||
155691025|NCT01765426|561961156|FG001|Overall Study|Lost to Follow-up|1|||
155691026|NCT01765426|561961157|FG002|Overall Study|Lost to Follow-up|0|||
155691027|NCT01765426|561961158|FG003|Overall Study|Lost to Follow-up|0|||
155691028|NCT02498067|561961159|FG000|Overall Study|Lost to Follow-up|22|||
155691029|NCT02498067|561961159|FG000|Overall Study|Did not meet inclusion criteria|11|||
155691030|NCT03351114|561961163|FG000|Overall Study|Withdrawal by Subject|1|||
155691031|NCT01665430|561961164|FG000|Overall Study|Adverse Event|1|||
155691032|NCT01665430|561961164|FG000|Overall Study|Withdrawal by Subject|6|||
155691033|NCT01665430|561961164|FG000|Overall Study|Other Unspecified|2|||
155691034|NCT02310230|561961165|FG000|Overall Study|Physician Decision|1|||
155691035|NCT02310230|561961166|FG001|Overall Study|Physician Decision|3|||
155691036|NCT02310230|561961165|FG000|Overall Study|monitor baseline taken after induction|2|||
155691037|NCT02310230|561961166|FG001|Overall Study|monitor baseline taken after induction|7|||
155691038|NCT02310230|561961165|FG000|Overall Study|Poor signal quality|5|||
155691039|NCT02310230|561961166|FG001|Overall Study|Poor signal quality|8|||
155691040|NCT02310230|561961165|FG000|Overall Study|Case cancelled|1|||
155691041|NCT02310230|561961166|FG001|Overall Study|Case cancelled|0|||
155691042|NCT03249935|561961167|FG000|Overall Study|Discharged from facility early|36|||
155691043|NCT03249935|561961167|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
155691044|NCT03249935|561961167|FG000|Overall Study|Protocol Violation|5|||
155691045|NCT00989235|561961168|FG000|Overall Study|Death|0|||
155691046|NCT00989235|561961169|FG001|Overall Study|Death|1|||
155691047|NCT00989235|561961168|FG000|Overall Study|Adverse Event|0|||
155691048|NCT00989235|561961169|FG001|Overall Study|Adverse Event|1|||
155691049|NCT00989235|561961168|FG000|Overall Study|Lack of Efficacy|1|||
155691050|NCT00989235|561961169|FG001|Overall Study|Lack of Efficacy|0|||
155691051|NCT00989235|561961168|FG000|Overall Study|Withdrawal of Consent|1|||
155691052|NCT00989235|561961169|FG001|Overall Study|Withdrawal of Consent|1|||
155691053|NCT00989235|561961168|FG000|Overall Study|Desire to Become Pregnant|1|||
155691054|NCT00989235|561961169|FG001|Overall Study|Desire to Become Pregnant|0|||
155691055|NCT00989235|561961168|FG000|Overall Study|Randomized by Mistake|0|||
155691056|NCT00989235|561961169|FG001|Overall Study|Randomized by Mistake|2|||
155691057|NCT00989235|561961168|FG000|Overall Study|Lost to Follow-up|0|||
155691058|NCT00989235|561961169|FG001|Overall Study|Lost to Follow-up|1|||
155691059|NCT02813668|561961170|FG000|Overall Study|Death|4|||
155691060|NCT02813668|561961170|FG000|Overall Study|Lost to Follow-up|509|||
155691061|NCT02813668|561961170|FG000|Overall Study|Withdrawal by Subject|148|||
155691062|NCT02813668|561961170|FG000|Overall Study|No longer at worksite|85|||
155691063|NCT02813668|561961170|FG000|Overall Study|Medical reasons not related to the study|4|||
155691064|NCT04662073|561961171|FG000|Overall Study|Withdrawal by Subject|1|||
155691065|NCT04662073|561961172|FG001|Overall Study|Withdrawal by Subject|0|||
155691066|NCT01135914|561961173|FG000|Overall Study|Withdrawal by Subject|1|||
155691067|NCT01135914|561961174|FG001|Overall Study|Withdrawal by Subject|3|||
155691068|NCT01135914|561961175|FG002|Overall Study|Withdrawal by Subject|6|||
155691069|NCT01135914|561961173|FG000|Overall Study|Lost to Follow-up|1|||
155691070|NCT01135914|561961174|FG001|Overall Study|Lost to Follow-up|0|||
155691071|NCT01135914|561961175|FG002|Overall Study|Lost to Follow-up|1|||
155691072|NCT01135914|561961173|FG000|Overall Study|Protocol Violation|0|||
155691073|NCT01135914|561961174|FG001|Overall Study|Protocol Violation|0|||
155691074|NCT01135914|561961175|FG002|Overall Study|Protocol Violation|3|||
155691075|NCT01135914|561961173|FG000|Overall Study|Lack of Efficacy|2|||
155691076|NCT01135914|561961174|FG001|Overall Study|Lack of Efficacy|1|||
155691077|NCT01135914|561961175|FG002|Overall Study|Lack of Efficacy|10|||
155691078|NCT01135914|561961173|FG000|Overall Study|Adverse Event|0|||
155691079|NCT01135914|561961174|FG001|Overall Study|Adverse Event|1|||
155691080|NCT01135914|561961175|FG002|Overall Study|Adverse Event|2|||
155691081|NCT00598078|561961176|FG000|Period 2 (Day 2)|Adverse Event|1|||
155691082|NCT00598078|561961177|FG001|Period 2 (Day 2)|Adverse Event|0|||
155691083|NCT01813721|561961178|FG000|Overall Study|Ineligibility determined|63|||
155691084|NCT01813721|561961178|FG000|Overall Study|Withdrawal by Subject|1|||
155691085|NCT02120365|561961181|FG000|Overall Study|Withdrawal by Subject|0|||
155691086|NCT02120365|561961182|FG001|Overall Study|Withdrawal by Subject|0|||
155691087|NCT02120365|561961183|FG002|Overall Study|Withdrawal by Subject|2|||
155691088|NCT02120365|561961184|FG003|Overall Study|Withdrawal by Subject|4|||
155691089|NCT02120365|561961185|FG004|Overall Study|Withdrawal by Subject|0|||
155691090|NCT02120365|561961186|FG005|Overall Study|Withdrawal by Subject|2|||
155691091|NCT00900146|561961187|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
155691092|NCT00900146|561961188|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
155691093|NCT00900146|561961189|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
155691094|NCT00900146|561961190|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
155691095|NCT00900146|561961191|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
155691096|NCT00900146|561961187|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
155691097|NCT00900146|561961188|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
155691098|NCT00900146|561961189|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
155691099|NCT00900146|561961190|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
155691100|NCT00900146|561961191|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
155691101|NCT00900146|561961187|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
155691102|NCT00900146|561961188|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155691103|NCT00900146|561961189|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155691104|NCT00900146|561961190|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155691105|NCT00900146|561961191|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155691106|NCT00900146|561961187|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
155691107|NCT00900146|561961188|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
155691108|NCT00900146|561961189|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
155691109|NCT00900146|561961190|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
155691110|NCT00900146|561961191|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
155691111|NCT00900146|561961187|FG000|Intermediate: Period III|Lost to Follow-up|2|||
155691112|NCT00900146|561961188|FG001|Intermediate: Period III|Lost to Follow-up|0|||
155691113|NCT00900146|561961189|FG002|Intermediate: Period III|Lost to Follow-up|0|||
155691114|NCT00900146|561961190|FG003|Intermediate: Period III|Lost to Follow-up|0|||
155691115|NCT00900146|561961191|FG004|Intermediate: Period III|Lost to Follow-up|1|||
155691116|NCT00900146|561961187|FG000|Intermediate: Period III|Administrative problems|85|||
155691117|NCT00900146|561961188|FG001|Intermediate: Period III|Administrative problems|92|||
155691118|NCT00900146|561961189|FG002|Intermediate: Period III|Administrative problems|84|||
155691119|NCT00900146|561961190|FG003|Intermediate: Period III|Administrative problems|90|||
155691120|NCT00900146|561961191|FG004|Intermediate: Period III|Administrative problems|163|||
155691121|NCT01635764|561961192|FG000|Overall Study|Adverse Event|46|||
155691122|NCT01635764|561961192|FG000|Overall Study|Lack of Efficacy|76|||
155691123|NCT01635764|561961192|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
155691124|NCT01635764|561961192|FG000|Overall Study|Protocol Deviation|1|||
155691125|NCT01635764|561961192|FG000|Overall Study|Withdrew Consent|67|||
155691126|NCT01635764|561961192|FG000|Overall Study|Lost to Follow-up|53|||
155691127|NCT01635764|561961192|FG000|Overall Study|Other|28|||
155691128|NCT05590000|561961193|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
155691129|NCT00693472|561961194|FG000|Part 1|Adverse Event|1|||
155691130|NCT00693472|561961195|FG001|Part 1|Adverse Event|1|||
155691131|NCT00693472|561961196|FG002|Part 1|Adverse Event|0|||
155691132|NCT00693472|561961197|FG003|Part 1|Adverse Event|0|||
155691133|NCT00693472|561961194|FG000|Part 1|Lost to Follow-up|0|||
155691134|NCT00693472|561961195|FG001|Part 1|Lost to Follow-up|1|||
155691135|NCT00693472|561961196|FG002|Part 1|Lost to Follow-up|0|||
155691136|NCT00693472|561961197|FG003|Part 1|Lost to Follow-up|0|||
155691137|NCT00693472|561961194|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
155691138|NCT00693472|561961195|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
155691139|NCT00693472|561961196|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
155691140|NCT00693472|561961197|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
155691141|NCT00693472|561961194|FG000|Part 2|Adverse Event|0|||
155691142|NCT00693472|561961195|FG001|Part 2|Adverse Event|0|||
155691143|NCT00693472|561961196|FG002|Part 2|Adverse Event|1|||
155691144|NCT00693472|561961197|FG003|Part 2|Adverse Event|0|||
155691145|NCT00693472|561961194|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
155691146|NCT00693472|561961195|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
155691147|NCT00693472|561961196|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
155691148|NCT00693472|561961197|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
155691149|NCT02075632|561961199|FG000|Overall Study|Adverse Event|1|||
155691150|NCT02075632|561961200|FG001|Overall Study|Adverse Event|1|||
155691151|NCT02075632|561961199|FG000|Overall Study|Lost to Follow-up|0|||
155691152|NCT02075632|561961200|FG001|Overall Study|Lost to Follow-up|3|||
155691153|NCT02075632|561961199|FG000|Overall Study|Withdrawal by Subject|0|||
155691154|NCT02075632|561961200|FG001|Overall Study|Withdrawal by Subject|1|||
155691155|NCT00740714|561961203|FG000|Overall Study|Withdrawal by Subject|17|||
155691156|NCT00740714|561961204|FG001|Overall Study|Withdrawal by Subject|19|||
155691157|NCT00740714|561961205|FG002|Overall Study|Withdrawal by Subject|29|||
155691158|NCT04070326|561961208|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
155691159|NCT04070326|561961209|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
155691160|NCT01367704|561961213|FG000|Overall Study|Lost to Follow-up|47|||
155691161|NCT01367704|561961214|FG001|Overall Study|Lost to Follow-up|161|||
155691162|NCT02193087|561961216|FG000|Overall Study|Adverse Event|2|||
155691163|NCT02193087|561961217|FG001|Overall Study|Adverse Event|0|||
155691164|NCT02193087|561961218|FG002|Overall Study|Adverse Event|0|||
155691165|NCT02193087|561961219|FG003|Overall Study|Adverse Event|11|||
155691166|NCT02193087|561961216|FG000|Overall Study|Lost to Follow-up|14|||
155691167|NCT02193087|561961217|FG001|Overall Study|Lost to Follow-up|6|||
155691168|NCT02193087|561961218|FG002|Overall Study|Lost to Follow-up|4|||
155691169|NCT02193087|561961219|FG003|Overall Study|Lost to Follow-up|37|||
155691170|NCT02193087|561961216|FG000|Overall Study|Protocol Violation|2|||
155691171|NCT02193087|561961217|FG001|Overall Study|Protocol Violation|0|||
155691172|NCT02193087|561961218|FG002|Overall Study|Protocol Violation|1|||
155691173|NCT02193087|561961219|FG003|Overall Study|Protocol Violation|2|||
155691174|NCT02193087|561961216|FG000|Overall Study|Withdrawal by Subject|10|||
155691175|NCT02193087|561961217|FG001|Overall Study|Withdrawal by Subject|3|||
155691176|NCT02193087|561961218|FG002|Overall Study|Withdrawal by Subject|1|||
155691177|NCT02193087|561961219|FG003|Overall Study|Withdrawal by Subject|19|||
155691178|NCT02193087|561961216|FG000|Overall Study|Other Reason Not Specified|7|||
155691179|NCT02193087|561961217|FG001|Overall Study|Other Reason Not Specified|2|||
155691180|NCT02193087|561961218|FG002|Overall Study|Other Reason Not Specified|1|||
155691181|NCT02193087|561961219|FG003|Overall Study|Other Reason Not Specified|9|||
155691182|NCT02193087|561961216|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
155691183|NCT02193087|561961217|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
155691184|NCT02193087|561961218|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
155691185|NCT02193087|561961219|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
155691186|NCT02726880|561961220|FG000|Overall Study|Withdrawal by Subject|2|||
155691187|NCT02726880|561961221|FG001|Overall Study|Withdrawal by Subject|0|||
155691188|NCT02726880|561961220|FG000|Overall Study|Lost to Follow-up|1|||
155691189|NCT02726880|561961221|FG001|Overall Study|Lost to Follow-up|3|||
155691190|NCT00787202|561961222|FG000|Overall Study|Adverse Event|3|||
155691191|NCT00787202|561961223|FG001|Overall Study|Adverse Event|2|||
155691192|NCT00787202|561961224|FG002|Overall Study|Adverse Event|0|||
155691193|NCT00787202|561961225|FG003|Overall Study|Adverse Event|0|||
155691194|NCT00787202|561961226|FG004|Overall Study|Adverse Event|2|||
155691195|NCT00787202|561961222|FG000|Overall Study|Lack of Efficacy|5|||
155691196|NCT00787202|561961223|FG001|Overall Study|Lack of Efficacy|6|||
155691197|NCT00787202|561961224|FG002|Overall Study|Lack of Efficacy|5|||
155691198|NCT00787202|561961225|FG003|Overall Study|Lack of Efficacy|2|||
155691199|NCT00787202|561961226|FG004|Overall Study|Lack of Efficacy|1|||
155691200|NCT00787202|561961222|FG000|Overall Study|Lost to Follow-up|1|||
155691201|NCT00787202|561961223|FG001|Overall Study|Lost to Follow-up|0|||
155691202|NCT00787202|561961224|FG002|Overall Study|Lost to Follow-up|0|||
155691203|NCT00787202|561961225|FG003|Overall Study|Lost to Follow-up|0|||
155691204|NCT00787202|561961226|FG004|Overall Study|Lost to Follow-up|0|||
155691205|NCT00787202|561961222|FG000|Overall Study|Withdrawal by Subject|2|||
155691206|NCT00787202|561961223|FG001|Overall Study|Withdrawal by Subject|2|||
155691207|NCT00787202|561961224|FG002|Overall Study|Withdrawal by Subject|2|||
155691208|NCT00787202|561961225|FG003|Overall Study|Withdrawal by Subject|0|||
155691209|NCT00787202|561961226|FG004|Overall Study|Withdrawal by Subject|0|||
155691210|NCT00787202|561961222|FG000|Overall Study|Protocol Violation|2|||
155691211|NCT00787202|561961223|FG001|Overall Study|Protocol Violation|1|||
155691212|NCT00787202|561961224|FG002|Overall Study|Protocol Violation|0|||
155691213|NCT00787202|561961225|FG003|Overall Study|Protocol Violation|0|||
155691214|NCT00787202|561961226|FG004|Overall Study|Protocol Violation|1|||
155691215|NCT00787202|561961222|FG000|Overall Study|Randomized, not treated|1|||
155691216|NCT00787202|561961223|FG001|Overall Study|Randomized, not treated|0|||
155691217|NCT00787202|561961224|FG002|Overall Study|Randomized, not treated|0|||
155691218|NCT00787202|561961225|FG003|Overall Study|Randomized, not treated|0|||
155691219|NCT00787202|561961226|FG004|Overall Study|Randomized, not treated|0|||
155691220|NCT00969761|561961229|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155691221|NCT00969761|561961230|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691222|NCT00969761|561961231|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691223|NCT00969761|561961232|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155691224|NCT00969761|561961233|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691225|NCT00969761|561961234|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691226|NCT00969761|561961235|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691227|NCT00969761|561961236|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691228|NCT00969761|561961237|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155691229|NCT00969761|561961238|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155691230|NCT00969761|561961239|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691231|NCT00969761|561961240|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155691232|NCT00969761|561961229|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691233|NCT00969761|561961230|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691234|NCT00969761|561961231|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
155691235|NCT00969761|561961232|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691236|NCT00969761|561961233|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691237|NCT00969761|561961234|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691238|NCT00969761|561961235|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691239|NCT00969761|561961236|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691240|NCT00969761|561961237|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691241|NCT00969761|561961238|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691242|NCT00969761|561961239|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691243|NCT00969761|561961240|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155691244|NCT00969761|561961229|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691245|NCT00969761|561961230|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691246|NCT00969761|561961231|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
155691247|NCT00969761|561961232|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691248|NCT00969761|561961233|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691249|NCT00969761|561961234|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691250|NCT00969761|561961235|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691251|NCT00969761|561961236|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691252|NCT00969761|561961237|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691253|NCT00969761|561961238|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691254|NCT00969761|561961239|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691255|NCT00969761|561961240|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155691256|NCT00969761|561961229|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691257|NCT00969761|561961230|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691258|NCT00969761|561961231|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691259|NCT00969761|561961232|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691260|NCT00969761|561961233|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691261|NCT00969761|561961234|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691262|NCT00969761|561961235|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691263|NCT00969761|561961236|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691264|NCT00969761|561961237|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
155691265|NCT00969761|561961238|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691266|NCT00969761|561961239|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691267|NCT00969761|561961240|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155691268|NCT00969761|561961229|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155691269|NCT00969761|561961230|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691270|NCT00969761|561961231|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
155691271|NCT00969761|561961232|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691272|NCT00969761|561961233|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155691273|NCT00969761|561961234|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691274|NCT00969761|561961235|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691275|NCT00969761|561961236|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
155691276|NCT00969761|561961237|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
155691277|NCT00969761|561961238|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155691278|NCT00969761|561961239|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691279|NCT00969761|561961240|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155691280|NCT00969761|561961229|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691281|NCT00969761|561961230|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691282|NCT00969761|561961231|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691283|NCT00969761|561961232|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
155691284|NCT00969761|561961233|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
155691285|NCT00969761|561961234|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691286|NCT00969761|561961235|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691287|NCT00969761|561961236|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691288|NCT00969761|561961237|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
155691289|NCT00969761|561961238|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691290|NCT00969761|561961239|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691291|NCT00969761|561961240|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155691292|NCT03959982|561963278|FG000|Overall Study|Withdrawal by Subject|1|||
155691293|NCT03959982|561963279|FG001|Overall Study|Withdrawal by Subject|0|||
155691294|NCT03959982|561963278|FG000|Overall Study|Physician Decision|2|||
155691295|NCT03959982|561963279|FG001|Overall Study|Physician Decision|0|||
155691296|NCT03959982|561963278|FG000|Overall Study|Lost to Follow-up|1|||
155691297|NCT03959982|561963279|FG001|Overall Study|Lost to Follow-up|0|||
155691298|NCT00664326|561963280|FG000|Overall Study|Adverse Event|14|||
155691299|NCT00664326|561963280|FG000|Overall Study|Noncompliance with study medication|3|||
155691300|NCT00664326|561963280|FG000|Overall Study|Withdrawal by Subject|1|||
155691301|NCT00664326|561963280|FG000|Overall Study|Physician Decision|1|||
155691302|NCT00664326|561963280|FG000|Overall Study|Other Reasons|3|||
155691303|NCT00664326|561963280|FG000|Overall Study|Death|2|||
155691304|NCT00664326|561963280|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
155691305|NCT00262847|561963281|FG000|Overall Study|Disease Progression|309|||
155691306|NCT00262847|561963282|FG001|Overall Study|Disease Progression|274|||
155691307|NCT00262847|561963283|FG002|Overall Study|Disease Progression|195|||
155691308|NCT00262847|561963281|FG000|Overall Study|Patient Refusal|41|||
155691309|NCT00262847|561963282|FG001|Overall Study|Patient Refusal|52|||
155691310|NCT00262847|561963283|FG002|Overall Study|Patient Refusal|47|||
155691311|NCT00262847|561963281|FG000|Overall Study|Adverse Event|74|||
155691312|NCT00262847|561963282|FG001|Overall Study|Adverse Event|88|||
155691313|NCT00262847|561963283|FG002|Overall Study|Adverse Event|108|||
155691314|NCT00262847|561963281|FG000|Overall Study|Death|8|||
155691315|NCT00262847|561963282|FG001|Overall Study|Death|8|||
155691316|NCT00262847|561963283|FG002|Overall Study|Death|11|||
155691317|NCT00262847|561963281|FG000|Overall Study|Concomitant disease|3|||
155691318|NCT00262847|561963282|FG001|Overall Study|Concomitant disease|2|||
155691319|NCT00262847|561963283|FG002|Overall Study|Concomitant disease|4|||
155691320|NCT00262847|561963281|FG000|Overall Study|Other Reasons|79|||
155691321|NCT00262847|561963282|FG001|Overall Study|Other Reasons|88|||
155691322|NCT00262847|561963283|FG002|Overall Study|Other Reasons|27|||
155691323|NCT00262847|561963281|FG000|Overall Study|Did not receive study treatment|4|||
155691324|NCT00262847|561963282|FG001|Overall Study|Did not receive study treatment|1|||
155691325|NCT00262847|561963283|FG002|Overall Study|Did not receive study treatment|4|||
155691326|NCT00758589|561963284|FG000|Overall Study|Adverse Event|3|||
155691327|NCT00758589|561963285|FG001|Overall Study|Adverse Event|2|||
155691328|NCT00758589|561963286|FG002|Overall Study|Adverse Event|5|||
155691329|NCT00758589|561963287|FG003|Overall Study|Adverse Event|4|||
155691330|NCT00758589|561963284|FG000|Overall Study|Withdrawal by Subject|0|||
155691331|NCT00758589|561963285|FG001|Overall Study|Withdrawal by Subject|1|||
155691332|NCT00758589|561963286|FG002|Overall Study|Withdrawal by Subject|1|||
155691333|NCT00758589|561963287|FG003|Overall Study|Withdrawal by Subject|1|||
155691334|NCT00758589|561963284|FG000|Overall Study|Palm stopped to work|0|||
155691335|NCT00758589|561963285|FG001|Overall Study|Palm stopped to work|0|||
155691336|NCT00758589|561963286|FG002|Overall Study|Palm stopped to work|0|||
155691337|NCT00758589|561963287|FG003|Overall Study|Palm stopped to work|1|||
155691338|NCT00387647|561963288|FG000|Overall Study|Death|18|||
155691339|NCT02191605|561963289|FG000|Overall Study|Lost to Follow-up|9|||
155691340|NCT02191605|561963290|FG001|Overall Study|Lost to Follow-up|4|||
155691341|NCT02191605|561963291|FG002|Overall Study|Lost to Follow-up|7|||
155691342|NCT02191605|561963292|FG003|Overall Study|Lost to Follow-up|3|||
155691343|NCT02191605|561963293|FG004|Overall Study|Lost to Follow-up|4|||
155691344|NCT03647267|561963298|FG000|Overall Study|Lost to Follow-up|1|||
155691345|NCT03647267|561963299|FG001|Overall Study|Lost to Follow-up|0|||
155691346|NCT05079477|561963300|FG000|Overall Study|Lost to Follow-up|2|||
155691347|NCT05079477|561963301|FG001|Overall Study|Lost to Follow-up|0|||
155691348|NCT05079477|561963300|FG000|Overall Study|Withdrawal by Subject|1|||
155691349|NCT05079477|561963301|FG001|Overall Study|Withdrawal by Subject|0|||
155691350|NCT05079477|561963300|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
155691351|NCT05079477|561963301|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
155691352|NCT05079477|561963300|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
155691353|NCT05079477|561963301|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
155691354|NCT03131596|561963304|FG000|Overall Study|Protocol Violation|3|||
155691355|NCT03131596|561963305|FG001|Overall Study|Protocol Violation|3|||
155691356|NCT03131596|561963304|FG000|Overall Study|Lost to Follow-up|3|||
155691357|NCT03131596|561963305|FG001|Overall Study|Lost to Follow-up|0|||
155691358|NCT00734071|561963308|FG000|Overall Study|Adverse Event|4|||
155691359|NCT00734071|561963309|FG001|Overall Study|Adverse Event|3|||
155691360|NCT00734071|561963308|FG000|Overall Study|Lack of Efficacy|3|||
155691361|NCT00734071|561963309|FG001|Overall Study|Lack of Efficacy|1|||
155691362|NCT00734071|561963308|FG000|Overall Study|Noncompliance|2|||
155691363|NCT00734071|561963309|FG001|Overall Study|Noncompliance|2|||
155691364|NCT00734071|561963308|FG000|Overall Study|Protocol Deviations|3|||
155691365|NCT00734071|561963309|FG001|Overall Study|Protocol Deviations|4|||
155691366|NCT00734071|561963308|FG000|Overall Study|Voluntary Withdrawal|9|||
155691367|NCT00734071|561963309|FG001|Overall Study|Voluntary Withdrawal|7|||
155691368|NCT00734071|561963308|FG000|Overall Study|Lost to Follow-up|16|||
155691369|NCT00734071|561963309|FG001|Overall Study|Lost to Follow-up|8|||
155691370|NCT00734071|561963308|FG000|Overall Study|Other|1|||
155691371|NCT00734071|561963309|FG001|Overall Study|Other|2|||
155691372|NCT03654885|561963310|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
155691373|NCT03654885|561963311|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
155691374|NCT03654885|561963310|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
155691375|NCT03654885|561963311|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
155691376|NCT03654885|561963310|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
155691377|NCT03654885|561963311|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
155691378|NCT03654885|561963310|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
155691379|NCT03654885|561963311|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
155691380|NCT03654885|561963310|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
155691381|NCT03654885|561963311|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
155691382|NCT03654885|561963310|FG000|Overall Study|Adverse Event in Study Eye|3|||
155691383|NCT03654885|561963311|FG001|Overall Study|Adverse Event in Study Eye|0|||
155691384|NCT03654885|561963310|FG000|Overall Study|Consent Withdrawn|1|||
155691385|NCT03654885|561963311|FG001|Overall Study|Consent Withdrawn|0|||
155691386|NCT03654885|561963310|FG000|Overall Study|Death|3|||
155691387|NCT03654885|561963311|FG001|Overall Study|Death|1|||
155691388|NCT03654885|561963310|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
155691389|NCT03654885|561963311|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
155691390|NCT03654885|561963310|FG000|Overall Study|Lost to Follow-up|3|||
155691391|NCT03654885|561963311|FG001|Overall Study|Lost to Follow-up|3|||
155691392|NCT05275582|561963312|FG000|Overall Study|Lost to Follow-up|1|||
155691393|NCT05275582|561963313|FG001|Overall Study|Lost to Follow-up|0|||
155691394|NCT05275582|561963312|FG000|Overall Study|Withdrawal by Subject|0|||
155691395|NCT05275582|561963313|FG001|Overall Study|Withdrawal by Subject|2|||
155691396|NCT05275582|561963312|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
155691397|NCT05275582|561963313|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
155691398|NCT05275582|561963312|FG000|Overall Study|Death|1|||
155691399|NCT05275582|561963313|FG001|Overall Study|Death|0|||
155691400|NCT05275582|561963312|FG000|Overall Study|Protocol Violation|1|||
155691401|NCT05275582|561963313|FG001|Overall Study|Protocol Violation|0|||
155691402|NCT00240110|561963317|FG000|Overall Study|Lost to Follow-up|6|||
155691403|NCT00240110|561963318|FG001|Overall Study|Lost to Follow-up|7|||
155691404|NCT00583791|561963319|FG000|Overall Study|Other|67|||
155691405|NCT00583791|561963319|FG000|Overall Study|Death|6|||
155691406|NCT00203021|561963320|FG000|Overall Study|Death|4|||
155691407|NCT00203021|561963321|FG001|Overall Study|Death|1|||
155691408|NCT00203021|561963320|FG000|Overall Study|Adverse Event|10|||
155691409|NCT00203021|561963321|FG001|Overall Study|Adverse Event|5|||
155691410|NCT00203021|561963320|FG000|Overall Study|Withdrawal by Subject|45|||
155691411|NCT00203021|561963321|FG001|Overall Study|Withdrawal by Subject|48|||
155691412|NCT00203021|561963320|FG000|Overall Study|Lost to Follow-up|9|||
155691413|NCT00203021|561963321|FG001|Overall Study|Lost to Follow-up|7|||
155691414|NCT00203021|561963320|FG000|Overall Study|Other than specified|11|||
155691415|NCT00203021|561963321|FG001|Overall Study|Other than specified|16|||
155691416|NCT02080260|561963323|FG000|Overall Study|Death|18|||
155691417|NCT02080260|561963323|FG000|Overall Study|Withdrawal by Subject|1|||
155691418|NCT03204890|561963328|FG000|Overall Study|Withdrawal by Subject|1|||
155691419|NCT02943915|561963329|FG000|Overall Study|Withdrawal by Subject|2|||
155691420|NCT02943915|561963330|FG001|Overall Study|Withdrawal by Subject|1|||
155691421|NCT02943915|561963331|FG002|Overall Study|Withdrawal by Subject|0|||
155691422|NCT02943915|561963332|FG003|Overall Study|Withdrawal by Subject|0|||
155691423|NCT02943915|561963329|FG000|Overall Study|Lost to Follow-up|3|||
155691424|NCT02943915|561963330|FG001|Overall Study|Lost to Follow-up|1|||
155691425|NCT02943915|561963331|FG002|Overall Study|Lost to Follow-up|0|||
155691426|NCT02943915|561963332|FG003|Overall Study|Lost to Follow-up|0|||
155691427|NCT02943915|561963329|FG000|Overall Study|excluded|0|||
155691428|NCT02943915|561963330|FG001|Overall Study|excluded|1|||
155691429|NCT02943915|561963331|FG002|Overall Study|excluded|0|||
155691430|NCT02943915|561963332|FG003|Overall Study|excluded|0|||
155691431|NCT03769311|561963333|FG000|Overall Study|Withdrawal by Subject|1|||
155691432|NCT02853435|561963334|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155691433|NCT02853435|561963335|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155691434|NCT02853435|561963336|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155691435|NCT02853435|561963337|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155691436|NCT02853435|561963338|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
155691437|NCT02853435|561963339|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155691438|NCT03747120|561963342|FG000|Overall Study|treatment related toxicity|3|||
155691439|NCT03747120|561963343|FG001|Overall Study|treatment related toxicity|0|||
155691440|NCT03747120|561963344|FG002|Overall Study|treatment related toxicity|0|||
155691441|NCT03747120|561963342|FG000|Overall Study|Withdrawal by Subject|0|||
155691442|NCT03747120|561963343|FG001|Overall Study|Withdrawal by Subject|1|||
155691443|NCT03747120|561963344|FG002|Overall Study|Withdrawal by Subject|2|||
155691444|NCT03627065|561963345|FG000|Overall Study|Study Terminated by sponsor|1|||
155691445|NCT03627065|561963345|FG000|Overall Study|Withdrawal by Subject|2|||
155691446|NCT01266317|561963353|FG000|Overall Study|Withdrawal by Subject|2|||
155691447|NCT00490776|561963354|FG000|Overall Study|Withdrawal by Subject|1|||
155691448|NCT00490776|561963354|FG000|Overall Study|Administrative Problems|1|||
155691449|NCT00490776|561963354|FG000|Overall Study|Death|1|||
155691450|NCT00490776|561963354|FG000|Overall Study|New Cancer Therapy|1|||
155691451|NCT00490776|561963354|FG000|Overall Study|Disease Progression|5|||
155691452|NCT00098722|561963357|FG000|Double Blind Phase|Adverse Event|7|||
155691453|NCT00098722|561963358|FG001|Double Blind Phase|Adverse Event|7|||
155691454|NCT00098722|561963359|FG002|Double Blind Phase|Adverse Event|3|||
155691455|NCT00098722|561963360|FG003|Double Blind Phase|Adverse Event|0|||
155691456|NCT00098722|561963361|FG004|Double Blind Phase|Adverse Event|0|||
155691457|NCT00098722|561963362|FG005|Double Blind Phase|Adverse Event|0|||
155691458|NCT00098722|561963363|FG006|Double Blind Phase|Adverse Event|0|||
155691459|NCT00098722|561963357|FG000|Double Blind Phase|Death|2|||
155691460|NCT00098722|561963358|FG001|Double Blind Phase|Death|5|||
155691461|NCT00098722|561963359|FG002|Double Blind Phase|Death|0|||
155691462|NCT00098722|561963360|FG003|Double Blind Phase|Death|0|||
155691463|NCT00098722|561963361|FG004|Double Blind Phase|Death|0|||
155691464|NCT00098722|561963362|FG005|Double Blind Phase|Death|0|||
155691465|NCT00098722|561963363|FG006|Double Blind Phase|Death|0|||
155691466|NCT00098722|561963357|FG000|Double Blind Phase|Lack of Efficacy|21|||
155691467|NCT00098722|561963358|FG001|Double Blind Phase|Lack of Efficacy|23|||
155691468|NCT00098722|561963359|FG002|Double Blind Phase|Lack of Efficacy|15|||
155691469|NCT00098722|561963360|FG003|Double Blind Phase|Lack of Efficacy|0|||
155691470|NCT00098722|561963361|FG004|Double Blind Phase|Lack of Efficacy|0|||
155691471|NCT00098722|561963362|FG005|Double Blind Phase|Lack of Efficacy|0|||
155691472|NCT00098722|561963363|FG006|Double Blind Phase|Lack of Efficacy|0|||
155691473|NCT00098722|561963357|FG000|Double Blind Phase|Participant defaulted|16|||
155691474|NCT00098722|561963358|FG001|Double Blind Phase|Participant defaulted|11|||
155691475|NCT00098722|561963359|FG002|Double Blind Phase|Participant defaulted|9|||
155691476|NCT00098722|561963360|FG003|Double Blind Phase|Participant defaulted|0|||
155691477|NCT00098722|561963361|FG004|Double Blind Phase|Participant defaulted|0|||
155691478|NCT00098722|561963362|FG005|Double Blind Phase|Participant defaulted|0|||
155691479|NCT00098722|561963363|FG006|Double Blind Phase|Participant defaulted|0|||
155691480|NCT00098722|561963357|FG000|Double Blind Phase|Pregnancy|1|||
155691481|NCT00098722|561963358|FG001|Double Blind Phase|Pregnancy|0|||
155691482|NCT00098722|561963359|FG002|Double Blind Phase|Pregnancy|0|||
155691483|NCT00098722|561963360|FG003|Double Blind Phase|Pregnancy|0|||
155691484|NCT00098722|561963361|FG004|Double Blind Phase|Pregnancy|0|||
155691485|NCT00098722|561963362|FG005|Double Blind Phase|Pregnancy|0|||
155691486|NCT00098722|561963363|FG006|Double Blind Phase|Pregnancy|0|||
155691487|NCT00098722|561963357|FG000|Double Blind Phase|Randomized, not treated|4|||
155691488|NCT00098722|561963358|FG001|Double Blind Phase|Randomized, not treated|3|||
155691489|NCT00098722|561963359|FG002|Double Blind Phase|Randomized, not treated|3|||
155691490|NCT00098722|561963360|FG003|Double Blind Phase|Randomized, not treated|0|||
155691491|NCT00098722|561963361|FG004|Double Blind Phase|Randomized, not treated|0|||
155691492|NCT00098722|561963362|FG005|Double Blind Phase|Randomized, not treated|0|||
155691493|NCT00098722|561963363|FG006|Double Blind Phase|Randomized, not treated|0|||
155691494|NCT00098722|561963357|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
155691495|NCT00098722|561963358|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
155691496|NCT00098722|561963359|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
155691497|NCT00098722|561963360|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
155691498|NCT00098722|561963361|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
155691499|NCT00098722|561963362|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
155691500|NCT00098722|561963363|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
155691501|NCT00098722|561963357|FG000|Double Blind Phase|Other|7|||
155691502|NCT00098722|561963358|FG001|Double Blind Phase|Other|8|||
155691503|NCT00098722|561963359|FG002|Double Blind Phase|Other|7|||
155691504|NCT00098722|561963360|FG003|Double Blind Phase|Other|0|||
155691505|NCT00098722|561963361|FG004|Double Blind Phase|Other|0|||
155691506|NCT00098722|561963362|FG005|Double Blind Phase|Other|0|||
155691507|NCT00098722|561963363|FG006|Double Blind Phase|Other|0|||
155691508|NCT00098722|561963357|FG000|Open Label Phase|Adverse Event|0|||
155691509|NCT00098722|561963358|FG001|Open Label Phase|Adverse Event|0|||
155691510|NCT00098722|561963359|FG002|Open Label Phase|Adverse Event|0|||
155691511|NCT00098722|561963360|FG003|Open Label Phase|Adverse Event|5|||
155691512|NCT00098722|561963361|FG004|Open Label Phase|Adverse Event|0|||
155691513|NCT00098722|561963362|FG005|Open Label Phase|Adverse Event|0|||
155691514|NCT00098722|561963363|FG006|Open Label Phase|Adverse Event|0|||
155691515|NCT00098722|561963357|FG000|Open Label Phase|Death|0|||
155691516|NCT00098722|561963358|FG001|Open Label Phase|Death|0|||
155691517|NCT00098722|561963359|FG002|Open Label Phase|Death|0|||
155691518|NCT00098722|561963360|FG003|Open Label Phase|Death|2|||
155691519|NCT00098722|561963361|FG004|Open Label Phase|Death|0|||
155691520|NCT00098722|561963362|FG005|Open Label Phase|Death|0|||
155691521|NCT00098722|561963363|FG006|Open Label Phase|Death|0|||
155691522|NCT00098722|561963357|FG000|Open Label Phase|Lack of Efficacy|0|||
155691523|NCT00098722|561963358|FG001|Open Label Phase|Lack of Efficacy|0|||
155691524|NCT00098722|561963359|FG002|Open Label Phase|Lack of Efficacy|0|||
155691525|NCT00098722|561963360|FG003|Open Label Phase|Lack of Efficacy|8|||
155691526|NCT00098722|561963361|FG004|Open Label Phase|Lack of Efficacy|0|||
155691527|NCT00098722|561963362|FG005|Open Label Phase|Lack of Efficacy|0|||
155691528|NCT00098722|561963363|FG006|Open Label Phase|Lack of Efficacy|0|||
155691529|NCT00098722|561963357|FG000|Open Label Phase|Pregnancy|0|||
155691530|NCT00098722|561963358|FG001|Open Label Phase|Pregnancy|0|||
155691531|NCT00098722|561963359|FG002|Open Label Phase|Pregnancy|0|||
155691532|NCT00098722|561963360|FG003|Open Label Phase|Pregnancy|1|||
155691533|NCT00098722|561963361|FG004|Open Label Phase|Pregnancy|0|||
155691534|NCT00098722|561963362|FG005|Open Label Phase|Pregnancy|0|||
155691535|NCT00098722|561963363|FG006|Open Label Phase|Pregnancy|0|||
155691536|NCT00098722|561963357|FG000|Open Label Phase|Participant defaulted|0|||
155691537|NCT00098722|561963358|FG001|Open Label Phase|Participant defaulted|0|||
155691538|NCT00098722|561963359|FG002|Open Label Phase|Participant defaulted|0|||
155691539|NCT00098722|561963360|FG003|Open Label Phase|Participant defaulted|18|||
155691540|NCT00098722|561963361|FG004|Open Label Phase|Participant defaulted|0|||
155691541|NCT00098722|561963362|FG005|Open Label Phase|Participant defaulted|0|||
155691542|NCT00098722|561963363|FG006|Open Label Phase|Participant defaulted|0|||
155691543|NCT00098722|561963357|FG000|Open Label Phase|Ongoing at cut-off date|0|||
155691544|NCT00098722|561963358|FG001|Open Label Phase|Ongoing at cut-off date|0|||
155691545|NCT00098722|561963359|FG002|Open Label Phase|Ongoing at cut-off date|0|||
155691546|NCT00098722|561963360|FG003|Open Label Phase|Ongoing at cut-off date|220|||
155691547|NCT00098722|561963361|FG004|Open Label Phase|Ongoing at cut-off date|50|||
155691548|NCT00098722|561963362|FG005|Open Label Phase|Ongoing at cut-off date|0|||
155691549|NCT00098722|561963363|FG006|Open Label Phase|Ongoing at cut-off date|0|||
155691550|NCT00098722|561963357|FG000|Open Label Phase|Other|0|||
155691551|NCT00098722|561963358|FG001|Open Label Phase|Other|0|||
155691552|NCT00098722|561963359|FG002|Open Label Phase|Other|0|||
155691553|NCT00098722|561963360|FG003|Open Label Phase|Other|18|||
155691554|NCT00098722|561963361|FG004|Open Label Phase|Other|0|||
155691555|NCT00098722|561963362|FG005|Open Label Phase|Other|0|||
155691556|NCT00098722|561963363|FG006|Open Label Phase|Other|0|||
155691557|NCT00098722|561963357|FG000|Observation Phase|Death|0|||
155691558|NCT00098722|561963358|FG001|Observation Phase|Death|0|||
155691559|NCT00098722|561963359|FG002|Observation Phase|Death|0|||
155691560|NCT00098722|561963360|FG003|Observation Phase|Death|0|||
155691561|NCT00098722|561963361|FG004|Observation Phase|Death|0|||
155691562|NCT00098722|561963362|FG005|Observation Phase|Death|5|||
155691563|NCT00098722|561963363|FG006|Observation Phase|Death|3|||
155691564|NCT00098722|561963357|FG000|Observation Phase|Lack of Efficacy|0|||
155691565|NCT00098722|561963358|FG001|Observation Phase|Lack of Efficacy|0|||
155691566|NCT00098722|561963359|FG002|Observation Phase|Lack of Efficacy|0|||
155691567|NCT00098722|561963360|FG003|Observation Phase|Lack of Efficacy|0|||
155691568|NCT00098722|561963361|FG004|Observation Phase|Lack of Efficacy|0|||
155691569|NCT00098722|561963362|FG005|Observation Phase|Lack of Efficacy|2|||
155691570|NCT00098722|561963363|FG006|Observation Phase|Lack of Efficacy|0|||
155691571|NCT00098722|561963357|FG000|Observation Phase|Participant defaulted|0|||
155691572|NCT00098722|561963358|FG001|Observation Phase|Participant defaulted|0|||
155691573|NCT00098722|561963359|FG002|Observation Phase|Participant defaulted|0|||
155691574|NCT00098722|561963360|FG003|Observation Phase|Participant defaulted|0|||
155691575|NCT00098722|561963361|FG004|Observation Phase|Participant defaulted|0|||
155691576|NCT00098722|561963362|FG005|Observation Phase|Participant defaulted|17|||
155691577|NCT00098722|561963363|FG006|Observation Phase|Participant defaulted|4|||
155691578|NCT00098722|561963357|FG000|Observation Phase|Other|0|||
155691579|NCT00098722|561963358|FG001|Observation Phase|Other|0|||
155691580|NCT00098722|561963359|FG002|Observation Phase|Other|0|||
155691581|NCT00098722|561963360|FG003|Observation Phase|Other|0|||
155691582|NCT00098722|561963361|FG004|Observation Phase|Other|0|||
155691583|NCT00098722|561963362|FG005|Observation Phase|Other|21|||
155691584|NCT00098722|561963363|FG006|Observation Phase|Other|10|||
155691585|NCT04599166|561963366|FG000|Overall Study|Technological failure connecting to study app|80|||
155691586|NCT01974752|561963367|FG000|Overall Study|Death|33|||
155691587|NCT01974752|561963368|FG001|Overall Study|Death|11|||
155691588|NCT01974752|561963367|FG000|Overall Study|Lost to Follow-up|2|||
155691589|NCT01974752|561963368|FG001|Overall Study|Lost to Follow-up|0|||
155691590|NCT01974752|561963367|FG000|Overall Study|Withdrawal by Subject|2|||
155691591|NCT01974752|561963368|FG001|Overall Study|Withdrawal by Subject|3|||
155691592|NCT01974752|561963367|FG000|Overall Study|Other Eligibility Criteria|0|||
155691593|NCT01974752|561963368|FG001|Overall Study|Other Eligibility Criteria|1|||
155691594|NCT02435680|561963369|FG000|Overall Study|Physician Decision|3|||
155691595|NCT02435680|561963370|FG001|Overall Study|Physician Decision|0|||
155691596|NCT02435680|561963371|FG002|Overall Study|Physician Decision|0|||
155691597|NCT02435680|561963369|FG000|Overall Study|subject / guardian decision|0|||
155691598|NCT02435680|561963370|FG001|Overall Study|subject / guardian decision|3|||
155691599|NCT02435680|561963371|FG002|Overall Study|subject / guardian decision|2|||
155691600|NCT02435680|561963369|FG000|Overall Study|Adverse Event|8|||
155691601|NCT02435680|561963370|FG001|Overall Study|Adverse Event|3|||
155691602|NCT02435680|561963371|FG002|Overall Study|Adverse Event|2|||
155691603|NCT02435680|561963369|FG000|Overall Study|progressive disease|10|||
155691604|NCT02435680|561963370|FG001|Overall Study|progressive disease|7|||
155691605|NCT02435680|561963371|FG002|Overall Study|progressive disease|11|||
155691606|NCT02435680|561963369|FG000|Overall Study|not treated|0|||
155691607|NCT02435680|561963370|FG001|Overall Study|not treated|0|||
155691608|NCT02435680|561963371|FG002|Overall Study|not treated|1|||
155691609|NCT02088073|561963374|FG000|Acute Phase|Withdrawal by Subject|5|||
155691610|NCT02088073|561963375|FG001|Acute Phase|Withdrawal by Subject|0|||
155691611|NCT02088073|561963376|FG002|Acute Phase|Withdrawal by Subject|0|||
155691612|NCT02088073|561963377|FG003|Acute Phase|Withdrawal by Subject|0|||
155691613|NCT02088073|561963378|FG004|Acute Phase|Withdrawal by Subject|0|||
155691614|NCT02088073|561963374|FG000|Acute Phase|Hyperkalemia|2|||
155691615|NCT02088073|561963375|FG001|Acute Phase|Hyperkalemia|0|||
155691616|NCT02088073|561963376|FG002|Acute Phase|Hyperkalemia|0|||
155691617|NCT02088073|561963377|FG003|Acute Phase|Hyperkalemia|0|||
155691618|NCT02088073|561963378|FG004|Acute Phase|Hyperkalemia|0|||
155691619|NCT02088073|561963374|FG000|Maintanance Phase|Withdrawal by Subject|0|||
155691620|NCT02088073|561963375|FG001|Maintanance Phase|Withdrawal by Subject|2|||
155691621|NCT02088073|561963376|FG002|Maintanance Phase|Withdrawal by Subject|0|||
155691622|NCT02088073|561963377|FG003|Maintanance Phase|Withdrawal by Subject|0|||
155691623|NCT02088073|561963378|FG004|Maintanance Phase|Withdrawal by Subject|0|||
155691624|NCT02088073|561963374|FG000|Maintanance Phase|Adverse Event|0|||
155691625|NCT02088073|561963375|FG001|Maintanance Phase|Adverse Event|0|||
155691626|NCT02088073|561963376|FG002|Maintanance Phase|Adverse Event|3|||
155691627|NCT02088073|561963377|FG003|Maintanance Phase|Adverse Event|0|||
155691628|NCT02088073|561963378|FG004|Maintanance Phase|Adverse Event|1|||
155691629|NCT02088073|561963374|FG000|Maintanance Phase|Physician Decision|0|||
155691630|NCT02088073|561963375|FG001|Maintanance Phase|Physician Decision|0|||
155691631|NCT02088073|561963376|FG002|Maintanance Phase|Physician Decision|0|||
155691632|NCT02088073|561963377|FG003|Maintanance Phase|Physician Decision|0|||
155691633|NCT02088073|561963378|FG004|Maintanance Phase|Physician Decision|1|||
155691634|NCT02088073|561963374|FG000|Maintanance Phase|Sponsor's decision|0|||
155691635|NCT02088073|561963375|FG001|Maintanance Phase|Sponsor's decision|2|||
155691636|NCT02088073|561963376|FG002|Maintanance Phase|Sponsor's decision|0|||
155691637|NCT02088073|561963377|FG003|Maintanance Phase|Sponsor's decision|2|||
155691638|NCT02088073|561963378|FG004|Maintanance Phase|Sponsor's decision|1|||
155691639|NCT02088073|561963374|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
155691640|NCT02088073|561963375|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
155691641|NCT02088073|561963376|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
155691642|NCT02088073|561963377|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
155691643|NCT02088073|561963378|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
155691644|NCT02088073|561963374|FG000|Maintanance Phase|Miscellaneous|0|||
155691645|NCT02088073|561963375|FG001|Maintanance Phase|Miscellaneous|2|||
155691646|NCT02088073|561963376|FG002|Maintanance Phase|Miscellaneous|1|||
155691647|NCT02088073|561963377|FG003|Maintanance Phase|Miscellaneous|2|||
155691648|NCT02088073|561963378|FG004|Maintanance Phase|Miscellaneous|1|||
155691649|NCT02088073|561963374|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
155691650|NCT02088073|561963375|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
155691651|NCT02088073|561963376|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
155691652|NCT02088073|561963377|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
155691653|NCT02088073|561963378|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
155691654|NCT02088073|561963374|FG000|Maintanance Phase|Subject compliance|0|||
155691655|NCT02088073|561963375|FG001|Maintanance Phase|Subject compliance|1|||
155691656|NCT02088073|561963376|FG002|Maintanance Phase|Subject compliance|0|||
155691657|NCT02088073|561963377|FG003|Maintanance Phase|Subject compliance|0|||
155691658|NCT02088073|561963378|FG004|Maintanance Phase|Subject compliance|0|||
155691659|NCT02788201|561963383|FG000|Overall Study|Death|1|||
155691660|NCT02788201|561963384|FG001|Overall Study|Death|1|||
155691661|NCT02788201|561963385|FG002|Overall Study|Death|1|||
155691662|NCT02788201|561963386|FG003|Overall Study|Death|1|||
155691663|NCT02788201|561963387|FG004|Overall Study|Death|0|||
155691664|NCT02788201|561963388|FG005|Overall Study|Death|1|||
155691665|NCT02788201|561963383|FG000|Overall Study|Ineligible|0|||
155691666|NCT02788201|561963384|FG001|Overall Study|Ineligible|0|||
155691667|NCT02788201|561963385|FG002|Overall Study|Ineligible|0|||
155691668|NCT02788201|561963386|FG003|Overall Study|Ineligible|0|||
155691669|NCT02788201|561963387|FG004|Overall Study|Ineligible|0|||
155691670|NCT02788201|561963388|FG005|Overall Study|Ineligible|1|||
155691671|NCT02788201|561963383|FG000|Overall Study|Withdrawal by Subject|0|||
155691672|NCT02788201|561963384|FG001|Overall Study|Withdrawal by Subject|0|||
155691673|NCT02788201|561963385|FG002|Overall Study|Withdrawal by Subject|0|||
155691674|NCT02788201|561963386|FG003|Overall Study|Withdrawal by Subject|0|||
155691675|NCT02788201|561963387|FG004|Overall Study|Withdrawal by Subject|0|||
155691676|NCT02788201|561963388|FG005|Overall Study|Withdrawal by Subject|1|||
155691677|NCT00186537|561963391|FG000|Overall Study|Withdrawal by Subject|4|||
155691678|NCT00186537|561963392|FG001|Overall Study|Withdrawal by Subject|0|||
155691679|NCT00186537|561963393|FG002|Overall Study|Withdrawal by Subject|3|||
155691680|NCT00186537|561963391|FG000|Overall Study|ALT > 1.5 x ULN|3|||
155691681|NCT00186537|561963392|FG001|Overall Study|ALT > 1.5 x ULN|0|||
155691682|NCT00186537|561963393|FG002|Overall Study|ALT > 1.5 x ULN|0|||
155691683|NCT01510184|561963394|FG000|Overall Study|Sponsor discretion|28|||
155691684|NCT01510184|561963395|FG001|Overall Study|Sponsor discretion|28|||
155691685|NCT01510184|561963394|FG000|Overall Study|Death|1|||
155691686|NCT01510184|561963395|FG001|Overall Study|Death|2|||
155691687|NCT01510184|561963394|FG000|Overall Study|Withdrawal by Subject|1|||
155691688|NCT01510184|561963395|FG001|Overall Study|Withdrawal by Subject|4|||
155691689|NCT01510184|561963394|FG000|Overall Study|Other|0|||
155691690|NCT01510184|561963395|FG001|Overall Study|Other|1|||
155691691|NCT01143051|561963396|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
155691692|NCT01143051|561963397|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
155691693|NCT01143051|561963398|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
155691694|NCT01143051|561963399|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
155691695|NCT01143051|561963400|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
155691696|NCT01143051|561963401|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
155691697|NCT01143051|561963396|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
155691698|NCT01143051|561963397|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
155691699|NCT01143051|561963398|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
155691700|NCT01143051|561963399|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
155691701|NCT01143051|561963400|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
155691702|NCT01143051|561963401|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
155691703|NCT02231762|561963402|FG000|Combination Phase|Adverse Event|10|||
155691704|NCT02231762|561963403|FG001|Combination Phase|Adverse Event|0|||
155691705|NCT02231762|561963404|FG002|Combination Phase|Adverse Event|0|||
155691706|NCT02231762|561963405|FG003|Combination Phase|Adverse Event|0|||
155691707|NCT02231762|561963402|FG000|Combination Phase|Withdrawal by Subject|2|||
155691708|NCT02231762|561963403|FG001|Combination Phase|Withdrawal by Subject|0|||
155691709|NCT02231762|561963404|FG002|Combination Phase|Withdrawal by Subject|0|||
155691710|NCT02231762|561963405|FG003|Combination Phase|Withdrawal by Subject|0|||
155691711|NCT02231762|561963402|FG000|Combination Phase|Disease Progression|6|||
155691712|NCT02231762|561963403|FG001|Combination Phase|Disease Progression|0|||
155691713|NCT02231762|561963404|FG002|Combination Phase|Disease Progression|0|||
155691714|NCT02231762|561963405|FG003|Combination Phase|Disease Progression|0|||
155691715|NCT02231762|561963402|FG000|Combination Phase|Did not meet inclusion criteria|1|||
155691716|NCT02231762|561963403|FG001|Combination Phase|Did not meet inclusion criteria|0|||
155691717|NCT02231762|561963404|FG002|Combination Phase|Did not meet inclusion criteria|0|||
155691718|NCT02231762|561963405|FG003|Combination Phase|Did not meet inclusion criteria|0|||
155691719|NCT02231762|561963402|FG000|Combination Phase|Protocol Violation|1|||
155691720|NCT02231762|561963403|FG001|Combination Phase|Protocol Violation|0|||
155691721|NCT02231762|561963404|FG002|Combination Phase|Protocol Violation|0|||
155691722|NCT02231762|561963405|FG003|Combination Phase|Protocol Violation|0|||
155691723|NCT02231762|561963402|FG000|Maintenance Phase|Disease progression|0|||
155691724|NCT02231762|561963403|FG001|Maintenance Phase|Disease progression|3|||
155691725|NCT02231762|561963404|FG002|Maintenance Phase|Disease progression|4|||
155691726|NCT02231762|561963405|FG003|Maintenance Phase|Disease progression|3|||
155691727|NCT02231762|561963402|FG000|Maintenance Phase|Adverse Event|0|||
155691728|NCT02231762|561963403|FG001|Maintenance Phase|Adverse Event|0|||
155691729|NCT02231762|561963404|FG002|Maintenance Phase|Adverse Event|1|||
155691730|NCT02231762|561963405|FG003|Maintenance Phase|Adverse Event|2|||
155691731|NCT03593681|561963410|FG000|Overall Study|Inadequate sample collected|12|||
155691732|NCT03593681|561963410|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
155691733|NCT03593681|561963410|FG000|Overall Study|Protocol Violation|3|||
155691734|NCT03593681|561963410|FG000|Overall Study|Withdrawal by Subject|3|||
155691735|NCT03593681|561963410|FG000|Overall Study|Procedure not attempted|3|||
155691736|NCT03593681|561963410|FG000|Overall Study|Adverse Event|2|||
155691737|NCT03593681|561963410|FG000|Overall Study|Physician Decision|1|||
155691738|NCT01149486|561963413|FG000|First Intervention|Adverse Event|0|||
155691739|NCT01149486|561963414|FG001|First Intervention|Adverse Event|1|||
155691740|NCT03366103|561963417|FG000|Overall Study|Disease Progression|3|||
155691741|NCT03366103|561963418|FG001|Overall Study|Disease Progression|1|||
155691742|NCT03366103|561963419|FG002|Overall Study|Disease Progression|0|||
155691743|NCT03366103|561963417|FG000|Overall Study|Adverse Event|0|||
155691744|NCT03366103|561963418|FG001|Overall Study|Adverse Event|1|||
155691745|NCT03366103|561963419|FG002|Overall Study|Adverse Event|0|||
155691746|NCT01344629|561963422|FG000|Crossover Period 2|Withdrawal by Subject|0|||
155691747|NCT01344629|561963423|FG001|Crossover Period 2|Withdrawal by Subject|1|||
155691748|NCT00746733|561963429|FG000|Second Intervention|Adverse Event|1|||
155691749|NCT00746733|561963430|FG001|Second Intervention|Adverse Event|0|||
155691750|NCT00746733|561963429|FG000|Third Intervention|Withdrawal by Subject|1|||
155691751|NCT00746733|561963430|FG001|Third Intervention|Withdrawal by Subject|1|||
155691752|NCT00849875|561963431|FG000|Overall Study|Death|28|||
155691753|NCT00849875|561963431|FG000|Overall Study|Ongoing (unknown completion status)|11|||
155691754|NCT00849875|561963431|FG000|Overall Study|Others|6|||
155691755|NCT00849875|561963431|FG000|Overall Study|Lost to Follow-up|2|||
155691756|NCT04096820|561963438|FG000|Overall Study|Did not return for intervention|2|||
155691757|NCT04096820|561963438|FG000|Overall Study|Death|1|||
155691758|NCT00996801|561964764|FG000|Overall Study|Adverse Event|6|||
155691759|NCT00996801|561964765|FG001|Overall Study|Adverse Event|4|||
155691760|NCT00996801|561964766|FG002|Overall Study|Adverse Event|12|||
155691761|NCT00996801|561964767|FG003|Overall Study|Adverse Event|17|||
155691762|NCT00996801|561964768|FG004|Overall Study|Adverse Event|31|||
155691763|NCT00996801|561964769|FG005|Overall Study|Adverse Event|3|||
155691764|NCT00996801|561964764|FG000|Overall Study|Lack of Efficacy|3|||
155691765|NCT00996801|561964765|FG001|Overall Study|Lack of Efficacy|0|||
155691766|NCT00996801|561964766|FG002|Overall Study|Lack of Efficacy|1|||
155691767|NCT00996801|561964767|FG003|Overall Study|Lack of Efficacy|3|||
155691768|NCT00996801|561964768|FG004|Overall Study|Lack of Efficacy|0|||
155691769|NCT00996801|561964769|FG005|Overall Study|Lack of Efficacy|1|||
155691770|NCT00996801|561964764|FG000|Overall Study|Lost to Follow-up|0|||
155691771|NCT00996801|561964765|FG001|Overall Study|Lost to Follow-up|0|||
155691772|NCT00996801|561964766|FG002|Overall Study|Lost to Follow-up|0|||
155691773|NCT00996801|561964767|FG003|Overall Study|Lost to Follow-up|3|||
155691774|NCT00996801|561964768|FG004|Overall Study|Lost to Follow-up|3|||
155691775|NCT00996801|561964769|FG005|Overall Study|Lost to Follow-up|2|||
155691776|NCT00996801|561964764|FG000|Overall Study|Physician Decision|0|||
155691777|NCT00996801|561964765|FG001|Overall Study|Physician Decision|0|||
155691778|NCT00996801|561964766|FG002|Overall Study|Physician Decision|0|||
155691779|NCT00996801|561964767|FG003|Overall Study|Physician Decision|1|||
155691780|NCT00996801|561964768|FG004|Overall Study|Physician Decision|0|||
155691781|NCT00996801|561964769|FG005|Overall Study|Physician Decision|0|||
155691782|NCT00996801|561964764|FG000|Overall Study|Progressive Disease|0|||
155691783|NCT00996801|561964765|FG001|Overall Study|Progressive Disease|1|||
155691784|NCT00996801|561964766|FG002|Overall Study|Progressive Disease|0|||
155691785|NCT00996801|561964767|FG003|Overall Study|Progressive Disease|0|||
155691786|NCT00996801|561964768|FG004|Overall Study|Progressive Disease|0|||
155691787|NCT00996801|561964769|FG005|Overall Study|Progressive Disease|0|||
155691788|NCT00996801|561964764|FG000|Overall Study|Protocol Violation|3|||
155691789|NCT00996801|561964765|FG001|Overall Study|Protocol Violation|4|||
155691790|NCT00996801|561964766|FG002|Overall Study|Protocol Violation|1|||
155691791|NCT00996801|561964767|FG003|Overall Study|Protocol Violation|2|||
155691792|NCT00996801|561964768|FG004|Overall Study|Protocol Violation|3|||
155691793|NCT00996801|561964769|FG005|Overall Study|Protocol Violation|4|||
155691794|NCT00996801|561964764|FG000|Overall Study|Study Terminated by Sponsor|0|||
155691795|NCT00996801|561964765|FG001|Overall Study|Study Terminated by Sponsor|1|||
155691796|NCT00996801|561964766|FG002|Overall Study|Study Terminated by Sponsor|0|||
155691797|NCT00996801|561964767|FG003|Overall Study|Study Terminated by Sponsor|0|||
155691798|NCT00996801|561964768|FG004|Overall Study|Study Terminated by Sponsor|46|||
155691799|NCT00996801|561964769|FG005|Overall Study|Study Terminated by Sponsor|0|||
155691800|NCT00996801|561964764|FG000|Overall Study|Withdrawal by Subject|8|||
155691801|NCT00996801|561964765|FG001|Overall Study|Withdrawal by Subject|6|||
155691802|NCT00996801|561964766|FG002|Overall Study|Withdrawal by Subject|9|||
155691803|NCT00996801|561964767|FG003|Overall Study|Withdrawal by Subject|5|||
155691804|NCT00996801|561964768|FG004|Overall Study|Withdrawal by Subject|5|||
155691805|NCT00996801|561964769|FG005|Overall Study|Withdrawal by Subject|9|||
155691806|NCT00289198|561964770|FG000|Overall Study|Adverse Event|0|||
155691807|NCT00289198|561964771|FG001|Overall Study|Adverse Event|2|||
155691808|NCT00289198|561964770|FG000|Overall Study|Protocol Violation|2|||
155691809|NCT00289198|561964771|FG001|Overall Study|Protocol Violation|1|||
155691810|NCT00289198|561964770|FG000|Overall Study|Withdrawal by Subject|4|||
155691811|NCT00289198|561964771|FG001|Overall Study|Withdrawal by Subject|1|||
155691812|NCT00289198|561964770|FG000|Overall Study|Lack of Efficacy|2|||
155691813|NCT00289198|561964771|FG001|Overall Study|Lack of Efficacy|0|||
155691814|NCT00289198|561964770|FG000|Overall Study|Other: Low compliance|0|||
155691815|NCT00289198|561964771|FG001|Overall Study|Other: Low compliance|1|||
155691816|NCT00289198|561964770|FG000|Overall Study|Other: Physician's decision|0|||
155691817|NCT00289198|561964771|FG001|Overall Study|Other: Physician's decision|1|||
155691818|NCT00289198|561964770|FG000|Overall Study|Other: Unable to attend on schedule|2|||
155691819|NCT00289198|561964771|FG001|Overall Study|Other: Unable to attend on schedule|1|||
155691820|NCT00289198|561964770|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
155691821|NCT00289198|561964771|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
155691822|NCT00289198|561964770|FG000|Overall Study|Other: Impossible to come on visit|0|||
155691823|NCT00289198|561964771|FG001|Overall Study|Other: Impossible to come on visit|1|||
155691824|NCT03369431|561964779|FG000|Overall Study|Lost to Follow-up|1|||
155691825|NCT03369431|561964780|FG001|Overall Study|Lost to Follow-up|3|||
155691826|NCT03369431|561964779|FG000|Overall Study|Withdrawal by Subject|2|||
155691827|NCT03369431|561964780|FG001|Overall Study|Withdrawal by Subject|3|||
155691828|NCT03369431|561964779|FG000|Overall Study|Protocol Violation|1|||
155691829|NCT03369431|561964780|FG001|Overall Study|Protocol Violation|1|||
155691830|NCT01062061|561964781|FG000|Overall Study|Enrolled more than once|2|||
155691831|NCT01062061|561964781|FG000|Overall Study|Investigated before study start|13|||
155691832|NCT01062061|561964781|FG000|Overall Study|Outside chief indications|10|||
155691833|NCT01062061|561964781|FG000|Overall Study|Failed to meet inclusion criteria|2|||
155691834|NCT00004445|561964782|FG000|Overall Study|Physician Decision|2|||
155691835|NCT00004445|561964782|FG000|Overall Study|Withdrawal by Subject|1|||
155691836|NCT00076336|561964783|FG000|Overall Study|Death|13|||
155691837|NCT00076336|561964784|FG001|Overall Study|Death|17|||
155691838|NCT00076336|561964783|FG000|Overall Study|Adverse Event|4|||
155691839|NCT00076336|561964784|FG001|Overall Study|Adverse Event|4|||
155691840|NCT00076336|561964783|FG000|Overall Study|Lost to Follow-up|4|||
155691841|NCT00076336|561964784|FG001|Overall Study|Lost to Follow-up|4|||
155691842|NCT00076336|561964783|FG000|Overall Study|Non-Compliance|2|||
155691843|NCT00076336|561964784|FG001|Overall Study|Non-Compliance|0|||
155691844|NCT00076336|561964783|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
155691845|NCT00076336|561964784|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
155691846|NCT00076336|561964783|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
155691847|NCT00076336|561964784|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
155691848|NCT00076336|561964783|FG000|Overall Study|Liver Transplantation|3|||
155691849|NCT00076336|561964784|FG001|Overall Study|Liver Transplantation|3|||
155691850|NCT00076336|561964783|FG000|Overall Study|Virologic Breakthrough|14|||
155691851|NCT00076336|561964784|FG001|Overall Study|Virologic Breakthrough|16|||
155691852|NCT00076336|561964783|FG000|Overall Study|Treatment failure|4|||
155691853|NCT00076336|561964784|FG001|Overall Study|Treatment failure|5|||
155691854|NCT00524589|561964785|FG000|Overall Study|Withdrawal by Subject|2|||
155691855|NCT00524589|561964785|FG000|Overall Study|Disease Progression|16|||
155691856|NCT02753127|561964789|FG000|Overall Study|Lost to Follow-up|13|||
155691857|NCT02753127|561964790|FG001|Overall Study|Lost to Follow-up|11|||
155691858|NCT02753127|561964789|FG000|Overall Study|Withdrawal by Subject|37|||
155691859|NCT02753127|561964790|FG001|Overall Study|Withdrawal by Subject|47|||
155691860|NCT02753127|561964789|FG000|Overall Study|Other|3|||
155691861|NCT02753127|561964790|FG001|Overall Study|Other|8|||
155691862|NCT02753127|561964789|FG000|Overall Study|Hospice|0|||
155691863|NCT02753127|561964790|FG001|Overall Study|Hospice|2|||
155691864|NCT00046930|561964793|FG000|Overall Study|Ineligible|12|||
155691865|NCT00046930|561964794|FG001|Overall Study|Ineligible|4|||
155691866|NCT00940485|561964800|FG000|Overall Study|HBeAb positive at Baseline|3|||
155691867|NCT00940485|561964801|FG001|Overall Study|HBeAb positive at Baseline|2|||
155691868|NCT00940485|561964800|FG000|Overall Study|Lost to Follow-up|2|||
155691869|NCT00940485|561964801|FG001|Overall Study|Lost to Follow-up|3|||
155691870|NCT00940485|561964800|FG000|Overall Study|Adverse Event|8|||
155691871|NCT00940485|561964801|FG001|Overall Study|Adverse Event|0|||
155691872|NCT00940485|561964800|FG000|Overall Study|Withdrawal by Subject|1|||
155691873|NCT00940485|561964801|FG001|Overall Study|Withdrawal by Subject|1|||
155691874|NCT00940485|561964800|FG000|Overall Study|Others|1|||
155691875|NCT00940485|561964801|FG001|Overall Study|Others|1|||
155691876|NCT01113580|561964802|FG000|Overall Study|Protocol Violation|1|||
155691877|NCT01113580|561964803|FG001|Overall Study|Protocol Violation|0|||
155691878|NCT01519674|561964806|FG000|Overall Study|Adverse Event|3|||
155691879|NCT01519674|561964807|FG001|Overall Study|Adverse Event|3|||
155691880|NCT01519674|561964808|FG002|Overall Study|Adverse Event|0|||
155691881|NCT01519674|561964806|FG000|Overall Study|Lack of Efficacy|1|||
155691882|NCT01519674|561964807|FG001|Overall Study|Lack of Efficacy|1|||
155691883|NCT01519674|561964808|FG002|Overall Study|Lack of Efficacy|1|||
155691884|NCT01519674|561964806|FG000|Overall Study|Protocol Violation|0|||
155691885|NCT01519674|561964807|FG001|Overall Study|Protocol Violation|3|||
155691886|NCT01519674|561964808|FG002|Overall Study|Protocol Violation|1|||
155691887|NCT01519674|561964806|FG000|Overall Study|Withdrawal Criteria|7|||
155691888|NCT01519674|561964807|FG001|Overall Study|Withdrawal Criteria|2|||
155691889|NCT01519674|561964808|FG002|Overall Study|Withdrawal Criteria|7|||
155691890|NCT01519674|561964806|FG000|Overall Study|Unsclassified|10|||
155691891|NCT01519674|561964807|FG001|Overall Study|Unsclassified|4|||
155691892|NCT01519674|561964808|FG002|Overall Study|Unsclassified|3|||
155691893|NCT01610596|561964809|FG000|Overall Study|Lost to Follow-up|0|||
155691894|NCT01610596|561964810|FG001|Overall Study|Lost to Follow-up|1|||
155691895|NCT00799591|561964811|FG000|Overall Study|De-escalation of doses|20|||
155691896|NCT00799591|561964811|FG000|Overall Study|Death|14|||
155691897|NCT00799591|561964811|FG000|Overall Study|Technical failure|12|||
155691898|NCT00799591|561964811|FG000|Overall Study|Resistant germ|11|||
155691899|NCT00799591|561964811|FG000|Overall Study|New infection|4|||
155691900|NCT00799591|561964811|FG000|Overall Study|Resistance germ and technical failure|2|||
155691901|NCT00799591|561964811|FG000|Overall Study|Persistance of fever undetermined origin|1|||
155691902|NCT00799591|561964811|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
155691903|NCT00799591|561964811|FG000|Overall Study|Infectious origin not probable|1|||
155691904|NCT02590562|561964818|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
155691905|NCT01457950|561964819|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
155691906|NCT01457950|561964820|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
155691907|NCT01457950|561964821|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
155691908|NCT01457950|561964822|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
155691909|NCT01457950|561964819|FG000|Double-Blind Phase|Protocol Violation|2|||
155691910|NCT01457950|561964820|FG001|Double-Blind Phase|Protocol Violation|1|||
155691911|NCT01457950|561964821|FG002|Double-Blind Phase|Protocol Violation|0|||
155691912|NCT01457950|561964822|FG003|Double-Blind Phase|Protocol Violation|0|||
155691913|NCT01457950|561964819|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
155691914|NCT01457950|561964820|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
155691915|NCT01457950|561964821|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155691916|NCT01457950|561964822|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155691917|NCT01457950|561964819|FG000|Open-Label Phase|Adverse Event|0|||
155691918|NCT01457950|561964820|FG001|Open-Label Phase|Adverse Event|0|||
155691919|NCT01457950|561964821|FG002|Open-Label Phase|Adverse Event|0|||
155691920|NCT01457950|561964822|FG003|Open-Label Phase|Adverse Event|1|||
155691921|NCT01457950|561964819|FG000|Open-Label Phase|Protocol Violation|0|||
155691922|NCT01457950|561964820|FG001|Open-Label Phase|Protocol Violation|0|||
155691923|NCT01457950|561964821|FG002|Open-Label Phase|Protocol Violation|0|||
155691924|NCT01457950|561964822|FG003|Open-Label Phase|Protocol Violation|1|||
155691925|NCT01457950|561964819|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155691926|NCT01457950|561964820|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155691927|NCT01457950|561964821|FG002|Open-Label Phase|Withdrawal by Subject|2|||
155691928|NCT01457950|561964822|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155691929|NCT00765882|561964824|FG000|Overall Study|Adverse Event|10|||
155691930|NCT00765882|561964825|FG001|Overall Study|Adverse Event|21|||
155691931|NCT00765882|561964826|FG002|Overall Study|Adverse Event|20|||
155691932|NCT00765882|561964824|FG000|Overall Study|Lack of Efficacy|4|||
155691933|NCT00765882|561964825|FG001|Overall Study|Lack of Efficacy|0|||
155691934|NCT00765882|561964826|FG002|Overall Study|Lack of Efficacy|1|||
155691935|NCT00765882|561964824|FG000|Overall Study|Protocol Violation|4|||
155691936|NCT00765882|561964825|FG001|Overall Study|Protocol Violation|3|||
155691937|NCT00765882|561964826|FG002|Overall Study|Protocol Violation|1|||
155691938|NCT00765882|561964824|FG000|Overall Study|Withdrawal by Subject|2|||
155691939|NCT00765882|561964825|FG001|Overall Study|Withdrawal by Subject|6|||
155691940|NCT00765882|561964826|FG002|Overall Study|Withdrawal by Subject|6|||
155691941|NCT00765882|561964824|FG000|Overall Study|Lost to Follow-up|1|||
155691942|NCT00765882|561964825|FG001|Overall Study|Lost to Follow-up|9|||
155691943|NCT00765882|561964826|FG002|Overall Study|Lost to Follow-up|6|||
155691944|NCT00765882|561964824|FG000|Overall Study|Other Reason|3|||
155691945|NCT00765882|561964825|FG001|Overall Study|Other Reason|1|||
155691946|NCT00765882|561964826|FG002|Overall Study|Other Reason|2|||
155691947|NCT01866423|561964829|FG000|Overall Study|Lack of Efficacy|3|||
155691948|NCT01866423|561964829|FG000|Overall Study|Sponsor Decision|1|||
155691949|NCT01479595|561964830|FG000|Overall Study|Protocol deviation|0|||
155691950|NCT01479595|561964831|FG001|Overall Study|Protocol deviation|1|||
155691951|NCT01479595|561964830|FG000|Overall Study|Adverse Event|2|||
155691952|NCT01479595|561964831|FG001|Overall Study|Adverse Event|1|||
155691953|NCT01174004|561964842|FG000|Overall Study|Adverse Event|2|||
155691954|NCT01174004|561964843|FG001|Overall Study|Adverse Event|10|||
155691955|NCT01174004|561964842|FG000|Overall Study|Withdrawal by Subject|2|||
155691956|NCT01174004|561964843|FG001|Overall Study|Withdrawal by Subject|3|||
155691957|NCT01174004|561964842|FG000|Overall Study|At Discretion of Sponsor|2|||
155691958|NCT01174004|561964843|FG001|Overall Study|At Discretion of Sponsor|2|||
155691959|NCT01174004|561964842|FG000|Overall Study|Protocol Violation|0|||
155691960|NCT01174004|561964843|FG001|Overall Study|Protocol Violation|1|||
155691961|NCT01174004|561964842|FG000|Overall Study|Physician Decision|1|||
155691962|NCT01174004|561964843|FG001|Overall Study|Physician Decision|0|||
155691963|NCT00933244|561964844|FG000|Overall Study|Withdrawal by Subject|5|||
155691964|NCT00933244|561964845|FG001|Overall Study|Withdrawal by Subject|1|||
155691965|NCT00933244|561964846|FG002|Overall Study|Withdrawal by Subject|3|||
155691966|NCT02266875|561964847|FG000|Overall Study|Withdrawal by Subject|9|||
155691967|NCT02266875|561964848|FG001|Overall Study|Withdrawal by Subject|0|||
155691968|NCT02266875|561964847|FG000|Overall Study|Lost to Follow-up|2|||
155691969|NCT02266875|561964848|FG001|Overall Study|Lost to Follow-up|0|||
155691970|NCT01143896|561964849|FG000|Overall Study|Did not complete Baseline Interview|5|||
155691971|NCT01143896|561964850|FG001|Overall Study|Did not complete Baseline Interview|4|||
155691972|NCT01143896|561964849|FG000|Overall Study|Lost to Follow-up|18|||
155691973|NCT01143896|561964850|FG001|Overall Study|Lost to Follow-up|13|||
155691974|NCT01143896|561964849|FG000|Overall Study|Withdrawal by Subject|13|||
155691975|NCT01143896|561964850|FG001|Overall Study|Withdrawal by Subject|5|||
155691976|NCT01143896|561964849|FG000|Overall Study|Death|6|||
155691977|NCT01143896|561964850|FG001|Overall Study|Death|3|||
155691978|NCT01510145|561964860|FG000|Overall Study|Adverse Event|6|||
155691979|NCT01510145|561964860|FG000|Overall Study|Lost to Follow-up|5|||
155691980|NCT01510145|561964860|FG000|Overall Study|Withdrawal by Subject|6|||
155691981|NCT01510145|561964860|FG000|Overall Study|Relative reported subject withdrew|1|||
155691982|NCT01442064|561964861|FG000|Overall Study|Adverse Event|2|||
155691983|NCT01442064|561964862|FG001|Overall Study|Adverse Event|2|||
155691984|NCT01442064|561964863|FG002|Overall Study|Adverse Event|2|||
155691985|NCT01442064|561964864|FG003|Overall Study|Adverse Event|1|||
155691986|NCT01442064|561964865|FG004|Overall Study|Adverse Event|2|||
155691987|NCT01442064|561964866|FG005|Overall Study|Adverse Event|0|||
155691988|NCT01442064|561964861|FG000|Overall Study|Death|0|||
155691989|NCT01442064|561964862|FG001|Overall Study|Death|1|||
155691990|NCT01442064|561964863|FG002|Overall Study|Death|3|||
155691991|NCT01442064|561964864|FG003|Overall Study|Death|3|||
155691992|NCT01442064|561964865|FG004|Overall Study|Death|1|||
155691993|NCT01442064|561964866|FG005|Overall Study|Death|3|||
155691994|NCT01442064|561964861|FG000|Overall Study|Lost to Follow-up|5|||
155691995|NCT01442064|561964862|FG001|Overall Study|Lost to Follow-up|5|||
155691996|NCT01442064|561964863|FG002|Overall Study|Lost to Follow-up|1|||
155691997|NCT01442064|561964864|FG003|Overall Study|Lost to Follow-up|1|||
155691998|NCT01442064|561964865|FG004|Overall Study|Lost to Follow-up|3|||
155691999|NCT01442064|561964866|FG005|Overall Study|Lost to Follow-up|3|||
155692000|NCT01442064|561964861|FG000|Overall Study|Physician Decision|1|||
155692001|NCT01442064|561964862|FG001|Overall Study|Physician Decision|1|||
155692002|NCT01442064|561964863|FG002|Overall Study|Physician Decision|2|||
155692003|NCT01442064|561964864|FG003|Overall Study|Physician Decision|3|||
155692004|NCT01442064|561964865|FG004|Overall Study|Physician Decision|3|||
155692005|NCT01442064|561964866|FG005|Overall Study|Physician Decision|1|||
155692006|NCT01442064|561964861|FG000|Overall Study|Withdrawal by Subject|6|||
155692007|NCT01442064|561964862|FG001|Overall Study|Withdrawal by Subject|3|||
155692008|NCT01442064|561964863|FG002|Overall Study|Withdrawal by Subject|2|||
155692009|NCT01442064|561964864|FG003|Overall Study|Withdrawal by Subject|2|||
155692010|NCT01442064|561964865|FG004|Overall Study|Withdrawal by Subject|2|||
155692011|NCT01442064|561964866|FG005|Overall Study|Withdrawal by Subject|1|||
155692012|NCT01442064|561964861|FG000|Overall Study|Sponsor decision|82|||
155692013|NCT01442064|561964862|FG001|Overall Study|Sponsor decision|88|||
155692014|NCT01442064|561964863|FG002|Overall Study|Sponsor decision|92|||
155692015|NCT01442064|561964864|FG003|Overall Study|Sponsor decision|88|||
155692016|NCT01442064|561964865|FG004|Overall Study|Sponsor decision|95|||
155692017|NCT01442064|561964866|FG005|Overall Study|Sponsor decision|87|||
155692018|NCT01442064|561964861|FG000|Overall Study|Subject non-compliance|0|||
155692019|NCT01442064|561964862|FG001|Overall Study|Subject non-compliance|0|||
155692020|NCT01442064|561964863|FG002|Overall Study|Subject non-compliance|0|||
155692021|NCT01442064|561964864|FG003|Overall Study|Subject non-compliance|0|||
155692022|NCT01442064|561964865|FG004|Overall Study|Subject non-compliance|0|||
155692023|NCT01442064|561964866|FG005|Overall Study|Subject non-compliance|2|||
155692024|NCT01442064|561964861|FG000|Overall Study|Condition mandated other intervention|1|||
155692025|NCT01442064|561964862|FG001|Overall Study|Condition mandated other intervention|1|||
155692026|NCT01442064|561964863|FG002|Overall Study|Condition mandated other intervention|2|||
155692027|NCT01442064|561964864|FG003|Overall Study|Condition mandated other intervention|0|||
155692028|NCT01442064|561964865|FG004|Overall Study|Condition mandated other intervention|0|||
155692029|NCT01442064|561964866|FG005|Overall Study|Condition mandated other intervention|2|||
155692030|NCT01360398|561964867|FG000|Overall Study|Withdrawal by Subject|14|||
155692031|NCT01360398|561964867|FG000|Overall Study|Other|7|||
155692032|NCT01360398|561964867|FG000|Overall Study|Migrated/moved from study area|1|||
155692033|NCT00846040|561964868|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
155692034|NCT00846040|561964869|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
155692035|NCT00846040|561964870|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
155692036|NCT00846040|561964868|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
155692037|NCT00846040|561964869|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
155692038|NCT00846040|561964870|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
155692039|NCT02153346|561964871|FG000|Overall Study|Lost to Follow-up|11|||
155692040|NCT03158272|561964872|FG000|Overall Study|Disease progression|3|||
155692041|NCT03158272|561964873|FG001|Overall Study|Disease progression|3|||
155692042|NCT03158272|561964874|FG002|Overall Study|Disease progression|4|||
155692043|NCT03158272|561964875|FG003|Overall Study|Disease progression|6|||
155692044|NCT03158272|561964872|FG000|Overall Study|Death|0|||
155692045|NCT03158272|561964873|FG001|Overall Study|Death|0|||
155692046|NCT03158272|561964874|FG002|Overall Study|Death|1|||
155692047|NCT03158272|561964875|FG003|Overall Study|Death|0|||
155692048|NCT03158272|561964872|FG000|Overall Study|Other reasons|0|||
155692049|NCT03158272|561964873|FG001|Overall Study|Other reasons|0|||
155692050|NCT03158272|561964874|FG002|Overall Study|Other reasons|1|||
155692051|NCT03158272|561964875|FG003|Overall Study|Other reasons|0|||
155692052|NCT03158272|561964872|FG000|Overall Study|Adverse event unrelated to the drug|0|||
155692053|NCT03158272|561964873|FG001|Overall Study|Adverse event unrelated to the drug|1|||
155692054|NCT03158272|561964874|FG002|Overall Study|Adverse event unrelated to the drug|0|||
155692055|NCT03158272|561964875|FG003|Overall Study|Adverse event unrelated to the drug|0|||
155692056|NCT01822535|561964876|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
155692057|NCT01822535|561964877|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
155692058|NCT01822535|561964876|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
155692059|NCT01822535|561964877|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
155692060|NCT01822535|561964876|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
155692061|NCT01822535|561964877|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
155692062|NCT03582813|561964878|FG000|Overall Study|Lost to Follow-up|18|||
155692063|NCT03582813|561964879|FG001|Overall Study|Lost to Follow-up|21|||
155692064|NCT03582813|561964878|FG000|Overall Study|Withdrawal by Subject|1|||
155692065|NCT03582813|561964879|FG001|Overall Study|Withdrawal by Subject|0|||
155692066|NCT01048866|561964880|FG000|Overall Study|Adverse Event|1|||
155692067|NCT01048866|561964881|FG001|Overall Study|Adverse Event|0|||
155692068|NCT01048866|561964880|FG000|Overall Study|Protocol Violation|1|||
155692069|NCT01048866|561964881|FG001|Overall Study|Protocol Violation|0|||
155692070|NCT01048866|561964880|FG000|Overall Study|Physician Decision|1|||
155692071|NCT01048866|561964881|FG001|Overall Study|Physician Decision|0|||
155692072|NCT01048866|561964880|FG000|Overall Study|Withdrawal by Subject|0|||
155692073|NCT01048866|561964881|FG001|Overall Study|Withdrawal by Subject|2|||
155692074|NCT01048866|561964880|FG000|Overall Study|Lost to Follow-up|0|||
155692075|NCT01048866|561964881|FG001|Overall Study|Lost to Follow-up|2|||
155692076|NCT01048866|561964880|FG000|Overall Study|Other|1|||
155692077|NCT01048866|561964881|FG001|Overall Study|Other|1|||
155692078|NCT02366767|561964884|FG000|Overall Study|left for home after 1 day at camp|1|||
155692079|NCT02366767|561964885|FG001|Overall Study|left for home after 1 day at camp|0|||
155692080|NCT02230683|561964889|FG000|Overall Study|Adverse Event|1|||
155692081|NCT04573881|561964891|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
155692082|NCT00528996|561966568|FG000|Overall Study|Other reasons than listing|6|||
155692083|NCT00528996|561966569|FG001|Overall Study|Other reasons than listing|7|||
155692084|NCT00528996|561966570|FG002|Overall Study|Other reasons than listing|14|||
155692085|NCT00528996|561966571|FG003|Overall Study|Other reasons than listing|11|||
155692086|NCT00528996|561966572|FG004|Overall Study|Other reasons than listing|5|||
155692087|NCT00528996|561966568|FG000|Overall Study|Refused continue medication|16|||
155692088|NCT00528996|561966569|FG001|Overall Study|Refused continue medication|0|||
155692089|NCT00528996|561966570|FG002|Overall Study|Refused continue medication|3|||
155692090|NCT00528996|561966571|FG003|Overall Study|Refused continue medication|3|||
155692091|NCT00528996|561966572|FG004|Overall Study|Refused continue medication|6|||
155692092|NCT00528996|561966568|FG000|Overall Study|Lost to Follow-up|2|||
155692093|NCT00528996|561966569|FG001|Overall Study|Lost to Follow-up|0|||
155692094|NCT00528996|561966570|FG002|Overall Study|Lost to Follow-up|4|||
155692095|NCT00528996|561966571|FG003|Overall Study|Lost to Follow-up|1|||
155692096|NCT00528996|561966572|FG004|Overall Study|Lost to Follow-up|3|||
155692097|NCT00528996|561966568|FG000|Overall Study|Protocol Violation|1|||
155692098|NCT00528996|561966569|FG001|Overall Study|Protocol Violation|2|||
155692099|NCT00528996|561966570|FG002|Overall Study|Protocol Violation|3|||
155692100|NCT00528996|561966571|FG003|Overall Study|Protocol Violation|3|||
155692101|NCT00528996|561966572|FG004|Overall Study|Protocol Violation|2|||
155692102|NCT00528996|561966568|FG000|Overall Study|Lack of Efficacy|7|||
155692103|NCT00528996|561966569|FG001|Overall Study|Lack of Efficacy|2|||
155692104|NCT00528996|561966570|FG002|Overall Study|Lack of Efficacy|1|||
155692105|NCT00528996|561966571|FG003|Overall Study|Lack of Efficacy|3|||
155692106|NCT00528996|561966572|FG004|Overall Study|Lack of Efficacy|3|||
155692107|NCT00528996|561966568|FG000|Overall Study|Adverse Event|32|||
155692108|NCT00528996|561966569|FG001|Overall Study|Adverse Event|13|||
155692109|NCT00528996|561966570|FG002|Overall Study|Adverse Event|18|||
155692110|NCT00528996|561966571|FG003|Overall Study|Adverse Event|29|||
155692111|NCT00528996|561966572|FG004|Overall Study|Adverse Event|18|||
155692112|NCT02936284|561966573|FG000|Overall Study|Withdrawal by Subject|3|||
155692113|NCT02936284|561966574|FG001|Overall Study|Withdrawal by Subject|1|||
155692114|NCT02936284|561966573|FG000|Overall Study|Lost to Follow-up|7|||
155692115|NCT02936284|561966574|FG001|Overall Study|Lost to Follow-up|8|||
155692116|NCT02118597|561966579|FG000|Overall Study|Sponsor terminated the study|14|||
155692117|NCT02118597|561966579|FG000|Overall Study|Serious Adverse Event|1|||
155692118|NCT02118597|561966579|FG000|Overall Study|Investigator's decision|1|||
155692119|NCT03684304|561966582|FG000|Overall Study|Lost to Follow-up|19|||
155692120|NCT03684304|561966583|FG001|Overall Study|Lost to Follow-up|17|||
155692121|NCT02677844|561966584|FG000|Period 3|Withdrawal by Subject|0|||
155692122|NCT02677844|561966585|FG001|Period 3|Withdrawal by Subject|0|||
155692123|NCT02677844|561966586|FG002|Period 3|Withdrawal by Subject|0|||
155692124|NCT02677844|561966587|FG003|Period 3|Withdrawal by Subject|1|||
155692125|NCT02677844|561966588|FG004|Period 3|Withdrawal by Subject|0|||
155692126|NCT02677844|561966589|FG005|Period 3|Withdrawal by Subject|0|||
155692127|NCT02677844|561966590|FG006|Period 3|Withdrawal by Subject|0|||
155692128|NCT00545532|561966591|FG000|Overall Study|Withdrawal by Subject|1|||
155692129|NCT00545532|561966592|FG001|Overall Study|Withdrawal by Subject|3|||
155692130|NCT00545532|561966591|FG000|Overall Study|Lost to Follow-up|5|||
155692131|NCT00545532|561966592|FG001|Overall Study|Lost to Follow-up|6|||
155692132|NCT00545532|561966591|FG000|Overall Study|Death|0|||
155692133|NCT00545532|561966592|FG001|Overall Study|Death|1|||
155692134|NCT03630302|561966593|FG000|Surgery|hardware issue prevented LFP recordings|1|||
155692135|NCT03630302|561966593|FG000|3 Month Visit|Adverse Event|2|||
155692136|NCT03630302|561966593|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
155692137|NCT02255565|561966598|FG000|Overall Study|Withdrawal by Subject|0|||
155692138|NCT02255565|561966599|FG001|Overall Study|Withdrawal by Subject|1|||
155692139|NCT02255565|561966600|FG002|Overall Study|Withdrawal by Subject|0|||
155692140|NCT02699450|561966601|FG000|Overall Study|Death|2|||
155692141|NCT02699450|561966602|FG001|Overall Study|Death|1|||
155692142|NCT02699450|561966603|FG002|Overall Study|Death|2|||
155692143|NCT02699450|561966601|FG000|Overall Study|Met Criteria for Study Exit|0|||
155692144|NCT02699450|561966602|FG001|Overall Study|Met Criteria for Study Exit|0|||
155692145|NCT02699450|561966603|FG002|Overall Study|Met Criteria for Study Exit|1|||
155692146|NCT02699450|561966601|FG000|Overall Study|Protocol Violation|4|||
155692147|NCT02699450|561966602|FG001|Overall Study|Protocol Violation|3|||
155692148|NCT02699450|561966603|FG002|Overall Study|Protocol Violation|5|||
155692149|NCT02699450|561966601|FG000|Overall Study|Lost to Follow-up|3|||
155692150|NCT02699450|561966602|FG001|Overall Study|Lost to Follow-up|0|||
155692151|NCT02699450|561966603|FG002|Overall Study|Lost to Follow-up|5|||
155692152|NCT02699450|561966601|FG000|Overall Study|Physician Decision|2|||
155692153|NCT02699450|561966602|FG001|Overall Study|Physician Decision|0|||
155692154|NCT02699450|561966603|FG002|Overall Study|Physician Decision|0|||
155692155|NCT02699450|561966601|FG000|Overall Study|Withdrawal by Subject|3|||
155692156|NCT02699450|561966602|FG001|Overall Study|Withdrawal by Subject|1|||
155692157|NCT02699450|561966603|FG002|Overall Study|Withdrawal by Subject|2|||
155692158|NCT02699450|561966601|FG000|Overall Study|Adverse Event|1|||
155692159|NCT02699450|561966602|FG001|Overall Study|Adverse Event|0|||
155692160|NCT02699450|561966603|FG002|Overall Study|Adverse Event|0|||
155692161|NCT00810901|561966604|FG000|Overall Study|Lost to Follow-up|88|||
155692162|NCT00810901|561966605|FG001|Overall Study|Lost to Follow-up|58|||
155692163|NCT00931801|561966606|FG000|Overall Study|Adverse Event|0|||
155692164|NCT00931801|561966607|FG001|Overall Study|Adverse Event|0|||
155692165|NCT00931801|561966608|FG002|Overall Study|Adverse Event|1|||
155692166|NCT00931801|561966606|FG000|Overall Study|Lost to Follow-up|0|||
155692167|NCT00931801|561966607|FG001|Overall Study|Lost to Follow-up|1|||
155692168|NCT00931801|561966608|FG002|Overall Study|Lost to Follow-up|0|||
155692169|NCT00931801|561966606|FG000|Overall Study|Withdrawal by Subject|1|||
155692170|NCT00931801|561966607|FG001|Overall Study|Withdrawal by Subject|0|||
155692171|NCT00931801|561966608|FG002|Overall Study|Withdrawal by Subject|0|||
155692172|NCT00931801|561966606|FG000|Overall Study|Confirmed Virologic Failure|0|||
155692173|NCT00931801|561966607|FG001|Overall Study|Confirmed Virologic Failure|0|||
155692174|NCT00931801|561966608|FG002|Overall Study|Confirmed Virologic Failure|3|||
155692175|NCT01133275|561966609|FG000|Overall Study|Withdrawal by Subject|1|||
155692176|NCT01133275|561966609|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
155692177|NCT02689076|561966610|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
155692178|NCT02689076|561966611|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
155692179|NCT02689076|561966612|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
155692180|NCT02689076|561966610|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
155692181|NCT02689076|561966611|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
155692182|NCT02689076|561966612|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
155692183|NCT02689076|561966610|FG000|Overall Study|Did not have an HIE match|2|||
155606229|NCT01172808|561647622|FG003|Overall Study|Withdrawal by Subject|2|||
155606230|NCT01172808|561647619|FG000|Overall Study|Other|6|||
155606231|NCT01172808|561647620|FG001|Overall Study|Other|5|||
155606232|NCT01172808|561647621|FG002|Overall Study|Other|9|||
155606233|NCT01172808|561647622|FG003|Overall Study|Other|7|||
155606234|NCT03959488|561647625|FG000|Season 1|Other|6|||
155606235|NCT03959488|561647626|FG001|Season 1|Other|7|||
155606236|NCT03959488|561647627|FG002|Season 1|Other|0|||
155606237|NCT03959488|561647628|FG003|Season 1|Other|0|||
155606238|NCT03959488|561647629|FG004|Season 1|Other|0|||
155606239|NCT03959488|561647625|FG000|Season 1|Withdrawal by parent/guardian|43|||
155606240|NCT03959488|561647626|FG001|Season 1|Withdrawal by parent/guardian|28|||
155606241|NCT03959488|561647627|FG002|Season 1|Withdrawal by parent/guardian|0|||
155606242|NCT03959488|561647628|FG003|Season 1|Withdrawal by parent/guardian|0|||
155606243|NCT03959488|561647629|FG004|Season 1|Withdrawal by parent/guardian|0|||
155606244|NCT03959488|561647625|FG000|Season 1|Due to COVID-19 pandemic|2|||
155606245|NCT03959488|561647626|FG001|Season 1|Due to COVID-19 pandemic|3|||
155606246|NCT03959488|561647627|FG002|Season 1|Due to COVID-19 pandemic|0|||
155606247|NCT03959488|561647628|FG003|Season 1|Due to COVID-19 pandemic|0|||
155606248|NCT03959488|561647629|FG004|Season 1|Due to COVID-19 pandemic|0|||
155606249|NCT03959488|561647625|FG000|Season 1|Lost to Follow-up|17|||
155606250|NCT03959488|561647626|FG001|Season 1|Lost to Follow-up|7|||
155692184|NCT02689076|561966611|FG001|Overall Study|Did not have an HIE match|0|||
155692185|NCT02689076|561966612|FG002|Overall Study|Did not have an HIE match|0|||
155692186|NCT02689076|561966610|FG000|Overall Study|Death during non-VA encounter|2|||
155692187|NCT02689076|561966611|FG001|Overall Study|Death during non-VA encounter|5|||
155692188|NCT02689076|561966612|FG002|Overall Study|Death during non-VA encounter|0|||
155692189|NCT02689076|561966610|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
155692190|NCT02689076|561966611|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
155692191|NCT02689076|561966612|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
155606251|NCT03959488|561647627|FG002|Season 1|Lost to Follow-up|0|||
155606252|NCT03959488|561647628|FG003|Season 1|Lost to Follow-up|0|||
155606253|NCT03959488|561647629|FG004|Season 1|Lost to Follow-up|0|||
155606254|NCT03959488|561647625|FG000|Season 1|Death|5|||
155606255|NCT03959488|561647626|FG001|Season 1|Death|1|||
155606256|NCT03959488|561647627|FG002|Season 1|Death|0|||
155606257|NCT03959488|561647628|FG003|Season 1|Death|0|||
155606258|NCT03959488|561647629|FG004|Season 1|Death|0|||
155606259|NCT03959488|561647625|FG000|Season 2|Other|0|||
155692192|NCT02689076|561966610|FG000|Overall Study|Participant no longer active in VA system|1|||
155692193|NCT02689076|561966611|FG001|Overall Study|Participant no longer active in VA system|0|||
155692194|NCT02689076|561966612|FG002|Overall Study|Participant no longer active in VA system|0|||
155692195|NCT02689076|561966610|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
155692196|NCT02689076|561966611|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
155692197|NCT02689076|561966612|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
155692198|NCT01318070|561966613|FG000|Overall Study|Adverse Event|1|||
155692199|NCT01318070|561966614|FG001|Overall Study|Adverse Event|1|||
155692200|NCT01318070|561966615|FG002|Overall Study|Adverse Event|5|||
155692201|NCT01318070|561966613|FG000|Overall Study|Withdrawal by Subject|0|||
155692202|NCT01318070|561966614|FG001|Overall Study|Withdrawal by Subject|1|||
155692203|NCT01318070|561966615|FG002|Overall Study|Withdrawal by Subject|1|||
155692204|NCT01318070|561966613|FG000|Overall Study|Lack of Efficacy|0|||
155692205|NCT01318070|561966614|FG001|Overall Study|Lack of Efficacy|0|||
155692206|NCT01318070|561966615|FG002|Overall Study|Lack of Efficacy|1|||
155692207|NCT01318070|561966613|FG000|Overall Study|Principal Investigator Discretion|1|||
155692208|NCT01318070|561966614|FG001|Overall Study|Principal Investigator Discretion|0|||
155692209|NCT01318070|561966615|FG002|Overall Study|Principal Investigator Discretion|0|||
155692210|NCT01816906|561966618|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
155692211|NCT01816906|561966619|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
155692212|NCT01816906|561966618|FG000|Six Months|Lost to Follow-up|14|||
155692213|NCT01816906|561966619|FG001|Six Months|Lost to Follow-up|16|||
155692214|NCT01816906|561966618|FG000|12 Months|Adverse Event|2|||
155692215|NCT01816906|561966619|FG001|12 Months|Adverse Event|2|||
155692216|NCT01816906|561966618|FG000|12 Months|Death|0|||
155692217|NCT01816906|561966619|FG001|12 Months|Death|2|||
155692218|NCT01816906|561966618|FG000|12 Months|Lost to Follow-up|2|||
155692219|NCT01816906|561966619|FG001|12 Months|Lost to Follow-up|1|||
155692220|NCT04375397|561966620|FG000|Overall Study|Death|1|||
155692221|NCT04375397|561966621|FG001|Overall Study|Death|1|||
155692222|NCT04375397|561966620|FG000|Overall Study|Withdrew consent|2|||
155692223|NCT04375397|561966621|FG001|Overall Study|Withdrew consent|0|||
155692224|NCT04375397|561966620|FG000|Overall Study|Lost to Follow-up|6|||
155692225|NCT04375397|561966621|FG001|Overall Study|Lost to Follow-up|4|||
155692226|NCT04375397|561966620|FG000|Overall Study|Other, not specified|0|||
155692227|NCT04375397|561966621|FG001|Overall Study|Other, not specified|1|||
155692228|NCT00086502|561966622|FG000|Overall Study|Adverse Event|11|||
155692229|NCT00086502|561966623|FG001|Overall Study|Adverse Event|2|||
155692230|NCT00086502|561966622|FG000|Overall Study|Lack of Efficacy|0|||
155692231|NCT00086502|561966623|FG001|Overall Study|Lack of Efficacy|2|||
155692232|NCT00086502|561966622|FG000|Overall Study|Lost to Follow-up|3|||
155692233|NCT00086502|561966623|FG001|Overall Study|Lost to Follow-up|1|||
155692234|NCT00086502|561966622|FG000|Overall Study|Physician Decision|1|||
155692235|NCT00086502|561966623|FG001|Overall Study|Physician Decision|1|||
155692236|NCT00086502|561966622|FG000|Overall Study|Pregnancy|0|||
155606260|NCT03959488|561647626|FG001|Season 2|Other|0|||
155606261|NCT03959488|561647627|FG002|Season 2|Other|2|||
155606262|NCT03959488|561647628|FG003|Season 2|Other|0|||
155606263|NCT03959488|561647629|FG004|Season 2|Other|0|||
155606264|NCT03959488|561647625|FG000|Season 2|Withdrawal by parent/guardian|0|||
155606265|NCT03959488|561647626|FG001|Season 2|Withdrawal by parent/guardian|0|||
155606266|NCT03959488|561647627|FG002|Season 2|Withdrawal by parent/guardian|3|||
155606267|NCT03959488|561647628|FG003|Season 2|Withdrawal by parent/guardian|1|||
155606268|NCT03959488|561647629|FG004|Season 2|Withdrawal by parent/guardian|1|||
155606269|NCT03959488|561647625|FG000|Season 2|Lost to Follow-up|0|||
155606270|NCT03959488|561647626|FG001|Season 2|Lost to Follow-up|0|||
155606271|NCT03959488|561647627|FG002|Season 2|Lost to Follow-up|1|||
155606272|NCT03959488|561647628|FG003|Season 2|Lost to Follow-up|0|||
155606273|NCT03959488|561647629|FG004|Season 2|Lost to Follow-up|1|||
155606274|NCT01716520|561647630|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155606275|NCT01716520|561647631|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155606276|NCT01716520|561647632|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
155606277|NCT01716520|561647633|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
155606278|NCT01716520|561647634|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
155606279|NCT01716520|561647635|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
155606280|NCT01716520|561647630|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155606281|NCT01716520|561647631|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606282|NCT01716520|561647632|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
155606283|NCT01716520|561647633|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155606284|NCT01716520|561647634|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606285|NCT01716520|561647635|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155606286|NCT01716520|561647630|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155606287|NCT01716520|561647631|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155606288|NCT01716520|561647632|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155606289|NCT01716520|561647633|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155606290|NCT01716520|561647634|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155606291|NCT01716520|561647635|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155606292|NCT01716520|561647630|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155606293|NCT01716520|561647631|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
155606294|NCT01716520|561647632|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155606295|NCT01716520|561647633|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155606296|NCT01716520|561647634|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155606297|NCT01716520|561647635|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155606298|NCT01716520|561647630|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155606299|NCT01716520|561647631|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155606300|NCT01716520|561647632|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155606301|NCT01716520|561647633|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155606302|NCT01716520|561647634|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155606303|NCT01716520|561647635|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
155606304|NCT01716520|561647630|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155606305|NCT01716520|561647631|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155606306|NCT01716520|561647632|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
155606307|NCT01716520|561647633|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155606308|NCT01716520|561647634|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155606309|NCT01716520|561647635|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
155606310|NCT01716520|561647630|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
155606311|NCT01716520|561647631|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
155606312|NCT01716520|561647632|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
155606313|NCT01716520|561647633|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
155606314|NCT01716520|561647634|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
155606315|NCT01716520|561647635|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
155606316|NCT01716520|561647630|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155606317|NCT01716520|561647631|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155606318|NCT01716520|561647632|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155606319|NCT01716520|561647633|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155606320|NCT01716520|561647634|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155606321|NCT01716520|561647635|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155606322|NCT01716520|561647630|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606323|NCT01716520|561647631|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606324|NCT01716520|561647632|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606325|NCT01716520|561647633|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
155606326|NCT01716520|561647634|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606327|NCT01716520|561647635|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155606328|NCT01716520|561647630|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155692237|NCT00086502|561966623|FG001|Overall Study|Pregnancy|1|||
155692238|NCT00086502|561966622|FG000|Overall Study|Protocol Violation|3|||
155692239|NCT00086502|561966623|FG001|Overall Study|Protocol Violation|3|||
155692240|NCT00086502|561966622|FG000|Overall Study|Withdrawal by Subject|5|||
155692241|NCT00086502|561966623|FG001|Overall Study|Withdrawal by Subject|6|||
155692242|NCT00086502|561966622|FG000|Overall Study|Patient Moved|1|||
155692243|NCT00086502|561966623|FG001|Overall Study|Patient Moved|1|||
155692244|NCT00086502|561966622|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
155692245|NCT00086502|561966623|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
155692246|NCT00086502|561966622|FG000|Overall Study|Patient Accidentally Unblinded|1|||
155692247|NCT00086502|561966623|FG001|Overall Study|Patient Accidentally Unblinded|0|||
155692248|NCT01304329|561966624|FG000|Third Intervention (3 Days)|Adverse Event|0|||
155692249|NCT01304329|561966625|FG001|Third Intervention (3 Days)|Adverse Event|1|||
155692250|NCT01304329|561966626|FG002|Third Intervention (3 Days)|Adverse Event|0|||
155692251|NCT01304329|561966627|FG003|Third Intervention (3 Days)|Adverse Event|0|||
155692252|NCT01304329|561966628|FG004|Third Intervention (3 Days)|Adverse Event|0|||
155692253|NCT01304329|561966629|FG005|Third Intervention (3 Days)|Adverse Event|0|||
155692254|NCT05545644|561966631|FG000|Overall Study|Lost to Follow-up|4|||
155692255|NCT05545644|561966632|FG001|Overall Study|Lost to Follow-up|3|||
155692256|NCT00610441|561966633|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155692257|NCT00610441|561966634|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155692258|NCT00610441|561966635|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
155692259|NCT00610441|561966636|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155692260|NCT00610441|561966633|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155692261|NCT00610441|561966634|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155692262|NCT00610441|561966635|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
155692263|NCT00610441|561966636|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155692264|NCT00610441|561966633|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155692265|NCT00610441|561966634|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155692266|NCT00610441|561966635|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155692267|NCT00610441|561966636|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
155692268|NCT00610441|561966633|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155692269|NCT00610441|561966634|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
155692270|NCT00610441|561966635|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155692271|NCT00610441|561966636|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155692272|NCT00610441|561966633|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155692273|NCT00610441|561966634|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155692274|NCT00610441|561966635|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
155692275|NCT00610441|561966636|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155692276|NCT00610441|561966633|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155692277|NCT00610441|561966634|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
155692278|NCT00610441|561966635|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155692279|NCT00610441|561966636|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155692280|NCT00610441|561966633|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
155692281|NCT00610441|561966634|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
155692282|NCT00610441|561966635|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
155692283|NCT00610441|561966636|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
155692284|NCT00610441|561966633|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155692285|NCT00610441|561966634|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155692286|NCT00610441|561966635|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155692287|NCT00610441|561966636|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
155692288|NCT00610441|561966633|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
155692289|NCT00610441|561966634|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155692290|NCT00610441|561966635|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155692291|NCT00610441|561966636|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155692292|NCT01945775|561966646|FG000|Overall Study|Death|214|||
155692293|NCT01945775|561966647|FG001|Overall Study|Death|98|||
155692294|NCT01945775|561966646|FG000|Overall Study|Lost to Follow-up|12|||
155692295|NCT01945775|561966647|FG001|Overall Study|Lost to Follow-up|7|||
155692296|NCT01945775|561966646|FG000|Overall Study|Withdrawal by Subject|11|||
155692297|NCT01945775|561966647|FG001|Overall Study|Withdrawal by Subject|21|||
155692298|NCT01945775|561966646|FG000|Overall Study|Other|50|||
155692299|NCT01945775|561966647|FG001|Overall Study|Other|18|||
155692300|NCT02876328|561966648|FG000|Overall Study|Death|2|||
155692301|NCT02876328|561966649|FG001|Overall Study|Death|1|||
155692302|NCT02876328|561966650|FG002|Overall Study|Death|3|||
155692303|NCT02876328|561966651|FG003|Overall Study|Death|0|||
155692304|NCT02876328|561966652|FG004|Overall Study|Death|0|||
155692305|NCT02876328|561966653|FG005|Overall Study|Death|0|||
155692306|NCT02876328|561966654|FG006|Overall Study|Death|1|||
155692307|NCT02876328|561966655|FG007|Overall Study|Death|3|||
155692308|NCT02876328|561966656|FG008|Overall Study|Death|0|||
155692309|NCT02876328|561966657|FG009|Overall Study|Death|1|||
155692310|NCT02876328|561966658|FG010|Overall Study|Death|1|||
155692311|NCT02876328|561966659|FG011|Overall Study|Death|0|||
155692312|NCT02876328|561966660|FG012|Overall Study|Death|0|||
155692313|NCT02876328|561966661|FG013|Overall Study|Death|0|||
155692314|NCT02876328|561966662|FG014|Overall Study|Death|0|||
155692315|NCT02876328|561966663|FG015|Overall Study|Death|0|||
155692316|NCT02876328|561966664|FG016|Overall Study|Death|1|||
155692317|NCT02876328|561966665|FG017|Overall Study|Death|1|||
155692318|NCT02876328|561966666|FG018|Overall Study|Death|0|||
155692319|NCT02876328|561966667|FG019|Overall Study|Death|0|||
155692320|NCT02876328|561966668|FG020|Overall Study|Death|0|||
155692321|NCT02876328|561966669|FG021|Overall Study|Death|1|||
155692322|NCT02876328|561966670|FG022|Overall Study|Death|0|||
155692323|NCT02876328|561966671|FG023|Overall Study|Death|0|||
155692324|NCT02876328|561966648|FG000|Overall Study|Withdrawal by Subject|0|||
155692325|NCT02876328|561966649|FG001|Overall Study|Withdrawal by Subject|2|||
155692326|NCT02876328|561966650|FG002|Overall Study|Withdrawal by Subject|3|||
155692327|NCT02876328|561966651|FG003|Overall Study|Withdrawal by Subject|3|||
155692328|NCT02876328|561966652|FG004|Overall Study|Withdrawal by Subject|0|||
155692329|NCT02876328|561966653|FG005|Overall Study|Withdrawal by Subject|1|||
155692330|NCT02876328|561966654|FG006|Overall Study|Withdrawal by Subject|0|||
155692331|NCT02876328|561966655|FG007|Overall Study|Withdrawal by Subject|1|||
155692332|NCT02876328|561966656|FG008|Overall Study|Withdrawal by Subject|1|||
155692333|NCT02876328|561966657|FG009|Overall Study|Withdrawal by Subject|2|||
155692334|NCT02876328|561966658|FG010|Overall Study|Withdrawal by Subject|0|||
155692335|NCT02876328|561966659|FG011|Overall Study|Withdrawal by Subject|0|||
155692336|NCT02876328|561966660|FG012|Overall Study|Withdrawal by Subject|0|||
155692337|NCT02876328|561966661|FG013|Overall Study|Withdrawal by Subject|0|||
155692338|NCT02876328|561966662|FG014|Overall Study|Withdrawal by Subject|0|||
155692339|NCT02876328|561966663|FG015|Overall Study|Withdrawal by Subject|0|||
155692340|NCT02876328|561966664|FG016|Overall Study|Withdrawal by Subject|1|||
155692341|NCT02876328|561966665|FG017|Overall Study|Withdrawal by Subject|3|||
155692342|NCT02876328|561966666|FG018|Overall Study|Withdrawal by Subject|0|||
155692343|NCT02876328|561966667|FG019|Overall Study|Withdrawal by Subject|0|||
155692344|NCT02876328|561966668|FG020|Overall Study|Withdrawal by Subject|1|||
155692345|NCT02876328|561966669|FG021|Overall Study|Withdrawal by Subject|0|||
155692346|NCT02876328|561966670|FG022|Overall Study|Withdrawal by Subject|0|||
155692347|NCT02876328|561966671|FG023|Overall Study|Withdrawal by Subject|0|||
155692348|NCT02876328|561966648|FG000|Overall Study|Missed 12 Month Visit|15|||
155692349|NCT02876328|561966649|FG001|Overall Study|Missed 12 Month Visit|10|||
155692350|NCT02876328|561966650|FG002|Overall Study|Missed 12 Month Visit|11|||
155692351|NCT02876328|561966651|FG003|Overall Study|Missed 12 Month Visit|6|||
155692352|NCT02876328|561966652|FG004|Overall Study|Missed 12 Month Visit|10|||
155692353|NCT02876328|561966653|FG005|Overall Study|Missed 12 Month Visit|14|||
155692354|NCT02876328|561966654|FG006|Overall Study|Missed 12 Month Visit|3|||
155692355|NCT02876328|561966655|FG007|Overall Study|Missed 12 Month Visit|8|||
155692356|NCT02876328|561966656|FG008|Overall Study|Missed 12 Month Visit|9|||
155692357|NCT02876328|561966657|FG009|Overall Study|Missed 12 Month Visit|5|||
155692358|NCT02876328|561966658|FG010|Overall Study|Missed 12 Month Visit|4|||
155692359|NCT02876328|561966659|FG011|Overall Study|Missed 12 Month Visit|1|||
155692360|NCT02876328|561966660|FG012|Overall Study|Missed 12 Month Visit|5|||
155692361|NCT02876328|561966661|FG013|Overall Study|Missed 12 Month Visit|4|||
155692362|NCT02876328|561966662|FG014|Overall Study|Missed 12 Month Visit|4|||
155692363|NCT02876328|561966663|FG015|Overall Study|Missed 12 Month Visit|4|||
155692364|NCT02876328|561966664|FG016|Overall Study|Missed 12 Month Visit|3|||
155692365|NCT02876328|561966665|FG017|Overall Study|Missed 12 Month Visit|6|||
155692366|NCT02876328|561966666|FG018|Overall Study|Missed 12 Month Visit|2|||
155692367|NCT02876328|561966667|FG019|Overall Study|Missed 12 Month Visit|2|||
155692368|NCT02876328|561966668|FG020|Overall Study|Missed 12 Month Visit|11|||
155692369|NCT02876328|561966669|FG021|Overall Study|Missed 12 Month Visit|7|||
155692370|NCT02876328|561966670|FG022|Overall Study|Missed 12 Month Visit|1|||
155692371|NCT02876328|561966671|FG023|Overall Study|Missed 12 Month Visit|0|||
155692372|NCT00334282|561966679|FG000|Overall Study|Lost to Follow-up|11|||
155692373|NCT00334282|561966680|FG001|Overall Study|Lost to Follow-up|5|||
155692374|NCT00334282|561966679|FG000|Overall Study|Withdrawal by Subject|17|||
155692375|NCT00334282|561966680|FG001|Overall Study|Withdrawal by Subject|3|||
155692376|NCT00334282|561966679|FG000|Overall Study|Death|194|||
155692377|NCT00334282|561966680|FG001|Overall Study|Death|100|||
155692378|NCT01996592|561966687|FG000|Overall Study|no response to text/no diary entry|32|||
155692379|NCT01996592|561966687|FG000|Overall Study|change in surgical date|4|||
155692380|NCT01996592|561966687|FG000|Overall Study|Withdrawal by Subject|5|||
155692381|NCT01996592|561966687|FG000|Overall Study|change in mode of delivery|4|||
155692382|NCT02759315|561966688|FG000|Overall Study|Adverse Event|0|||
155692383|NCT02759315|561966689|FG001|Overall Study|Adverse Event|0|||
155692384|NCT02759315|561966690|FG002|Overall Study|Adverse Event|0|||
155692385|NCT02759315|561966691|FG003|Overall Study|Adverse Event|1|||
155692386|NCT02759315|561966692|FG004|Overall Study|Adverse Event|0|||
155692387|NCT02759315|561966688|FG000|Overall Study|Death|0|||
155692388|NCT02759315|561966689|FG001|Overall Study|Death|0|||
155692389|NCT02759315|561966690|FG002|Overall Study|Death|1|||
155692390|NCT02759315|561966691|FG003|Overall Study|Death|0|||
155692391|NCT02759315|561966692|FG004|Overall Study|Death|0|||
155692392|NCT02759315|561966688|FG000|Overall Study|Lost to Follow-up|2|||
155692393|NCT02759315|561966689|FG001|Overall Study|Lost to Follow-up|0|||
155692394|NCT02759315|561966690|FG002|Overall Study|Lost to Follow-up|4|||
155692395|NCT02759315|561966691|FG003|Overall Study|Lost to Follow-up|0|||
155692396|NCT02759315|561966692|FG004|Overall Study|Lost to Follow-up|0|||
155692397|NCT02759315|561966688|FG000|Overall Study|Protocol Violation|0|||
155692398|NCT02759315|561966689|FG001|Overall Study|Protocol Violation|1|||
155692399|NCT02759315|561966690|FG002|Overall Study|Protocol Violation|0|||
155692400|NCT02759315|561966691|FG003|Overall Study|Protocol Violation|0|||
155692401|NCT02759315|561966692|FG004|Overall Study|Protocol Violation|0|||
155692402|NCT02759315|561966688|FG000|Overall Study|Study terminated prior to completion|2|||
155692403|NCT02759315|561966689|FG001|Overall Study|Study terminated prior to completion|0|||
155692404|NCT02759315|561966690|FG002|Overall Study|Study terminated prior to completion|5|||
155692405|NCT02759315|561966691|FG003|Overall Study|Study terminated prior to completion|0|||
155692406|NCT02759315|561966692|FG004|Overall Study|Study terminated prior to completion|1|||
155692407|NCT01406015|561966693|FG000|Overall Study|Withdrawal by Subject|3|||
155692408|NCT01406015|561966694|FG001|Overall Study|Withdrawal by Subject|3|||
155692409|NCT00787137|561966695|FG000|Overall Study|Study Termination|0|||
155692410|NCT00787137|561966696|FG001|Overall Study|Study Termination|0|||
155692411|NCT00787137|561966697|FG002|Overall Study|Study Termination|1|||
155692412|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
155692413|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
155692414|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
155692415|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
155692416|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
155692417|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
155692418|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155692419|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155692420|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
155692421|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
155692422|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
155692423|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
155692424|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
155692425|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
155692426|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
155692427|NCT00554099|561966701|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155692428|NCT00554099|561966702|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155692429|NCT00554099|561966703|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155692430|NCT00554099|561966701|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
155692431|NCT00554099|561966702|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
155692432|NCT00554099|561966703|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
155692433|NCT00554099|561966701|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
155692434|NCT00554099|561966702|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
155692435|NCT00554099|561966703|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
155692436|NCT00554099|561966701|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
155692437|NCT00554099|561966702|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
155692438|NCT00554099|561966703|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
155692439|NCT03464422|561966704|FG000|Overall Study|Lost to Follow-up|2|||
155692440|NCT03464422|561966704|FG000|Overall Study|Withdrawal by Subject|2|||
155692441|NCT01628367|561966708|FG000|Overall Study|Adverse Event|1|||
155692442|NCT01628367|561966709|FG001|Overall Study|Adverse Event|0|||
155692443|NCT04957758|561966712|FG000|Overall Study|Adverse Event|1|||
155692444|NCT04957758|561966713|FG001|Overall Study|Adverse Event|0|||
155692445|NCT04957758|561966712|FG000|Overall Study|Lost to Follow-up|0|||
155692446|NCT04957758|561966713|FG001|Overall Study|Lost to Follow-up|2|||
155692447|NCT04957758|561966712|FG000|Overall Study|Withdrawal by Subject|4|||
155692448|NCT04957758|561966713|FG001|Overall Study|Withdrawal by Subject|2|||
155692449|NCT04957758|561966712|FG000|Overall Study|Protocol Violation|0|||
155692450|NCT04957758|561966713|FG001|Overall Study|Protocol Violation|1|||
155692451|NCT03353922|561966714|FG000|Overall Study|Withdrawal by Subject|1|||
155692452|NCT03353922|561966715|FG001|Overall Study|Withdrawal by Subject|0|||
155692453|NCT03353922|561966716|FG002|Overall Study|Withdrawal by Subject|1|||
155692454|NCT03353922|561966717|FG003|Overall Study|Withdrawal by Subject|1|||
155692455|NCT03353922|561966718|FG004|Overall Study|Withdrawal by Subject|0|||
155692456|NCT03353922|561966719|FG005|Overall Study|Withdrawal by Subject|0|||
155692457|NCT03353922|561966714|FG000|Overall Study|Adverse Event|0|||
155692458|NCT03353922|561966715|FG001|Overall Study|Adverse Event|1|||
155692459|NCT03353922|561966716|FG002|Overall Study|Adverse Event|0|||
155692460|NCT03353922|561966717|FG003|Overall Study|Adverse Event|0|||
155692461|NCT03353922|561966718|FG004|Overall Study|Adverse Event|0|||
155692462|NCT03353922|561966719|FG005|Overall Study|Adverse Event|0|||
155692463|NCT03688555|561966720|FG000|Treatment Period|Adverse Event|0|||
155692464|NCT03688555|561966721|FG001|Treatment Period|Adverse Event|0|||
155692465|NCT03688555|561966722|FG002|Treatment Period|Adverse Event|1|||
155692466|NCT03461406|561966730|FG000|Overall Study|Death|1|||
155692467|NCT03461406|561966731|FG001|Overall Study|Death|2|||
155692468|NCT03461406|561966730|FG000|Overall Study|Consent Withdrawn by Participant|0|||
155692469|NCT03461406|561966731|FG001|Overall Study|Consent Withdrawn by Participant|1|||
155692470|NCT03461406|561966730|FG000|Overall Study|Screen Failure|3|||
155692471|NCT03461406|561966731|FG001|Overall Study|Screen Failure|1|||
155692472|NCT03461406|561966730|FG000|Overall Study|Reason not Specified|1|||
155692473|NCT03461406|561966731|FG001|Overall Study|Reason not Specified|3|||
155692474|NCT03461406|561966730|FG000|Overall Study|Lost to Follow-up|3|||
155692475|NCT03461406|561966731|FG001|Overall Study|Lost to Follow-up|0|||
155692476|NCT01886690|561966732|FG000|Overall Study|Protocol Violation|0|||
155692477|NCT01886690|561966733|FG001|Overall Study|Protocol Violation|1|||
155692478|NCT01886690|561966732|FG000|Overall Study|Personal Reasons|0|||
155692479|NCT01886690|561966733|FG001|Overall Study|Personal Reasons|1|||
155692480|NCT01140568|561966734|FG000|Overall Study|disease progression|31|||
155692481|NCT01140568|561966734|FG000|Overall Study|Withdrawal by Subject|1|||
155692482|NCT01140568|561966734|FG000|Overall Study|Screen Fail|4|||
155692483|NCT03618628|561966735|FG000|Overall Study|Death|1|||
155692484|NCT03618628|561966735|FG000|Overall Study|Lost to Follow-up|1|||
155692485|NCT01591863|561966747|FG000|Overall Study|Adverse Event|3|||
155692486|NCT01591863|561966747|FG000|Overall Study|Withdrawal by Subject|1|||
155692487|NCT01591863|561966747|FG000|Overall Study|recurrence|9|||
155692488|NCT01591863|561966747|FG000|Overall Study|Lack of Efficacy|1|||
155692489|NCT00160654|561966748|FG000|Overall Study|Adverse Event|14|||
155692490|NCT00160654|561966748|FG000|Overall Study|Lack of Efficacy|4|||
155692491|NCT00160654|561966748|FG000|Overall Study|Lost to Follow-up|2|||
155692492|NCT00160654|561966748|FG000|Overall Study|Intake of expired drug|7|||
155692493|NCT00160654|561966748|FG000|Overall Study|Psychological trauma|1|||
155692494|NCT00160654|561966748|FG000|Overall Study|Sponsor decision|1|||
155692495|NCT00160654|561966748|FG000|Overall Study|Patient met exclusion criteria|1|||
155692496|NCT00160654|561966748|FG000|Overall Study|Patient decision|1|||
155692497|NCT00160654|561966748|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
155692498|NCT00160654|561966748|FG000|Overall Study|Met exclusion criteria|1|||
155692499|NCT03474081|561966753|FG000|Overall Study|Adverse Event|6|||
155692500|NCT03474081|561966754|FG001|Overall Study|Adverse Event|3|||
155692501|NCT03474081|561966753|FG000|Overall Study|Lost to Follow-up|2|||
155692502|NCT03474081|561966754|FG001|Overall Study|Lost to Follow-up|1|||
155692503|NCT03474081|561966753|FG000|Overall Study|Physician Decision|3|||
155692504|NCT03474081|561966754|FG001|Overall Study|Physician Decision|2|||
155692505|NCT03474081|561966753|FG000|Overall Study|Withdrawal by Subject|5|||
155692506|NCT03474081|561966754|FG001|Overall Study|Withdrawal by Subject|7|||
155692507|NCT03474081|561966753|FG000|Overall Study|Investigator site closed|1|||
155692508|NCT03474081|561966754|FG001|Overall Study|Investigator site closed|0|||
155692509|NCT02558400|561966757|FG000|Overall Study|Adverse Event|47|||
155692510|NCT02558400|561966758|FG001|Overall Study|Adverse Event|53|||
155692511|NCT02558400|561966759|FG002|Overall Study|Adverse Event|4|||
155692512|NCT02558400|561966757|FG000|Overall Study|Withdrawal by Subject|13|||
155692513|NCT02558400|561966758|FG001|Overall Study|Withdrawal by Subject|9|||
155692514|NCT02558400|561966759|FG002|Overall Study|Withdrawal by Subject|8|||
155692515|NCT02558400|561966757|FG000|Overall Study|Non-Compliant|0|||
155692516|NCT02558400|561966758|FG001|Overall Study|Non-Compliant|1|||
155692517|NCT02558400|561966759|FG002|Overall Study|Non-Compliant|3|||
155692518|NCT02558400|561966757|FG000|Overall Study|Lost to Follow-up|5|||
155692519|NCT02558400|561966758|FG001|Overall Study|Lost to Follow-up|5|||
155692520|NCT02558400|561966759|FG002|Overall Study|Lost to Follow-up|4|||
155692521|NCT02558400|561966757|FG000|Overall Study|Lack of Efficacy|0|||
155692522|NCT02558400|561966758|FG001|Overall Study|Lack of Efficacy|13|||
155692523|NCT02558400|561966759|FG002|Overall Study|Lack of Efficacy|1|||
155692524|NCT02558400|561966757|FG000|Overall Study|Disallowed Concurrent Medication|6|||
155692525|NCT02558400|561966758|FG001|Overall Study|Disallowed Concurrent Medication|7|||
155692526|NCT02558400|561966759|FG002|Overall Study|Disallowed Concurrent Medication|5|||
155692527|NCT02558400|561966757|FG000|Overall Study|Physician Decision|2|||
155692528|NCT02558400|561966758|FG001|Overall Study|Physician Decision|2|||
155692529|NCT02558400|561966759|FG002|Overall Study|Physician Decision|0|||
155692530|NCT02558400|561966757|FG000|Overall Study|Protocol Violation|6|||
155692531|NCT02558400|561966758|FG001|Overall Study|Protocol Violation|3|||
155692532|NCT02558400|561966759|FG002|Overall Study|Protocol Violation|8|||
155692533|NCT02558400|561966757|FG000|Overall Study|Death|0|||
155692534|NCT02558400|561966758|FG001|Overall Study|Death|1|||
155692535|NCT02558400|561966759|FG002|Overall Study|Death|0|||
155692536|NCT02558400|561966757|FG000|Overall Study|Ineligible for the study|0|||
155692537|NCT02558400|561966758|FG001|Overall Study|Ineligible for the study|2|||
155692538|NCT02558400|561966759|FG002|Overall Study|Ineligible for the study|0|||
155692539|NCT00456599|561966761|FG000|Overall Study|Non-compliance|1|||
155692540|NCT00456599|561966761|FG000|Overall Study|Withdrawal by Subject|2|||
155692541|NCT00260065|561966762|FG000|Overall Study|Progressive Disease|22|||
155692542|NCT00260065|561966762|FG000|Overall Study|Adverse Event|17|||
155692543|NCT00260065|561966762|FG000|Overall Study|Death|13|||
155692544|NCT00260065|561966762|FG000|Overall Study|Withdrawal by Subject|13|||
155692545|NCT00260065|561966762|FG000|Overall Study|Physician Decision|19|||
155692546|NCT00260065|561966762|FG000|Overall Study|Not otherwise specified|8|||
155692547|NCT00260065|561966762|FG000|Overall Study|Medication Noncompliance|1|||
155692548|NCT02198235|561966763|FG000|Overall Study|Lost to Follow-up|3|||
155692549|NCT02198235|561966764|FG001|Overall Study|Lost to Follow-up|2|||
155692550|NCT02198235|561966765|FG002|Overall Study|Lost to Follow-up|2|||
155692551|NCT01999218|561966769|FG000|Overall Study|Hyperglycemia|18|||
155692552|NCT01999218|561966770|FG001|Overall Study|Hyperglycemia|17|||
155692553|NCT01999218|561966771|FG002|Overall Study|Hyperglycemia|17|||
155692554|NCT01999218|561966769|FG000|Overall Study|Lack of Efficacy|1|||
155692555|NCT01999218|561966770|FG001|Overall Study|Lack of Efficacy|0|||
155692556|NCT01999218|561966771|FG002|Overall Study|Lack of Efficacy|1|||
155692557|NCT01999218|561966769|FG000|Overall Study|Lost to Follow-up|22|||
155692558|NCT01999218|561966770|FG001|Overall Study|Lost to Follow-up|17|||
155692559|NCT01999218|561966771|FG002|Overall Study|Lost to Follow-up|18|||
155692560|NCT01999218|561966769|FG000|Overall Study|Non-Compliance With Study Drug|6|||
155692561|NCT01999218|561966770|FG001|Overall Study|Non-Compliance With Study Drug|4|||
155692562|NCT01999218|561966771|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155692563|NCT01999218|561966769|FG000|Overall Study|Physician Decision|1|||
155692564|NCT01999218|561966770|FG001|Overall Study|Physician Decision|4|||
155692565|NCT01999218|561966771|FG002|Overall Study|Physician Decision|6|||
155692566|NCT01999218|561966769|FG000|Overall Study|Protocol Violation|4|||
155692567|NCT01999218|561966770|FG001|Overall Study|Protocol Violation|5|||
155692568|NCT01999218|561966771|FG002|Overall Study|Protocol Violation|4|||
155692569|NCT01999218|561966769|FG000|Overall Study|Screen failure|0|||
155692570|NCT01999218|561966770|FG001|Overall Study|Screen failure|1|||
155692571|NCT01999218|561966771|FG002|Overall Study|Screen failure|0|||
155692572|NCT01999218|561966769|FG000|Overall Study|Study Terminated By Sponsor|7|||
155692573|NCT01999218|561966770|FG001|Overall Study|Study Terminated By Sponsor|5|||
155692574|NCT01999218|561966771|FG002|Overall Study|Study Terminated By Sponsor|12|||
155692575|NCT01999218|561966769|FG000|Overall Study|Participant moves|2|||
155692576|NCT01999218|561966770|FG001|Overall Study|Participant moves|5|||
155692577|NCT01999218|561966771|FG002|Overall Study|Participant moves|3|||
155692578|NCT01999218|561966769|FG000|Overall Study|Withdrawal by Subject|28|||
155692579|NCT01999218|561966770|FG001|Overall Study|Withdrawal by Subject|29|||
155692580|NCT01999218|561966771|FG002|Overall Study|Withdrawal by Subject|34|||
155692581|NCT01999218|561966769|FG000|Overall Study|Creatinine/eGFR|0|||
155692582|NCT01999218|561966770|FG001|Overall Study|Creatinine/eGFR|0|||
155692583|NCT01999218|561966771|FG002|Overall Study|Creatinine/eGFR|1|||
155692584|NCT01999218|561966769|FG000|Overall Study|Death|7|||
155692585|NCT01999218|561966770|FG001|Overall Study|Death|1|||
155692586|NCT01999218|561966771|FG002|Overall Study|Death|2|||
155692587|NCT01999218|561966769|FG000|Overall Study|Excluded Medication|1|||
155692588|NCT01999218|561966770|FG001|Overall Study|Excluded Medication|1|||
155692589|NCT01999218|561966771|FG002|Overall Study|Excluded Medication|2|||
155692590|NCT01999218|561966769|FG000|Overall Study|Adverse Event|9|||
155692591|NCT01999218|561966770|FG001|Overall Study|Adverse Event|7|||
155692592|NCT01999218|561966771|FG002|Overall Study|Adverse Event|7|||
155692593|NCT01999218|561966769|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
155692594|NCT01999218|561966770|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
155692595|NCT01999218|561966771|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
155692596|NCT00546260|561966774|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
155692597|NCT00546260|561966775|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
155692598|NCT02559414|561968731|FG000|Overall Study|Lost to Follow-up|0|||
155692599|NCT02559414|561968732|FG001|Overall Study|Lost to Follow-up|1|||
155692600|NCT02559414|561968733|FG002|Overall Study|Lost to Follow-up|0|||
155692601|NCT02559414|561968731|FG000|Overall Study|Withdrawal by Subject|1|||
155692602|NCT02559414|561968732|FG001|Overall Study|Withdrawal by Subject|0|||
155692603|NCT02559414|561968733|FG002|Overall Study|Withdrawal by Subject|1|||
155692604|NCT02559414|561968731|FG000|Overall Study|Other|0|||
155692605|NCT02559414|561968732|FG001|Overall Study|Other|1|||
155692606|NCT02559414|561968733|FG002|Overall Study|Other|1|||
155692607|NCT02046070|561968736|FG000|Overall Study|Progressive Disease|18|||
155692608|NCT02046070|561968737|FG001|Overall Study|Progressive Disease|11|||
155692609|NCT02046070|561968738|FG002|Overall Study|Progressive Disease|40|||
155692610|NCT02046070|561968736|FG000|Overall Study|Adverse Event|8|||
155692611|NCT02046070|561968737|FG001|Overall Study|Adverse Event|10|||
155692612|NCT02046070|561968738|FG002|Overall Study|Adverse Event|17|||
155692613|NCT02046070|561968736|FG000|Overall Study|Withdrawal by Subject|1|||
155692614|NCT02046070|561968737|FG001|Overall Study|Withdrawal by Subject|2|||
155692615|NCT02046070|561968738|FG002|Overall Study|Withdrawal by Subject|6|||
155692616|NCT02046070|561968736|FG000|Overall Study|Study Terminated by Sponsor|1|||
155692617|NCT02046070|561968737|FG001|Overall Study|Study Terminated by Sponsor|1|||
155692618|NCT02046070|561968738|FG002|Overall Study|Study Terminated by Sponsor|1|||
155692619|NCT02046070|561968736|FG000|Overall Study|Reason not Specified|4|||
155692620|NCT02046070|561968737|FG001|Overall Study|Reason not Specified|4|||
155692621|NCT02046070|561968738|FG002|Overall Study|Reason not Specified|6|||
155692622|NCT04619004|561968739|FG000|Overall Study|Death|114|||
155692623|NCT04619004|561968740|FG001|Overall Study|Death|28|||
155692624|NCT04619004|561968739|FG000|Overall Study|Lost to Follow-up|1|||
155692625|NCT04619004|561968740|FG001|Overall Study|Lost to Follow-up|1|||
155692626|NCT04619004|561968739|FG000|Overall Study|Withdrawal by Subject|24|||
155692627|NCT04619004|561968740|FG001|Overall Study|Withdrawal by Subject|7|||
155692628|NCT04619004|561968739|FG000|Overall Study|Other - Not specified|0|||
155692629|NCT04619004|561968740|FG001|Overall Study|Other - Not specified|1|||
155692630|NCT03007745|561968744|FG000|Overall Study|Sleep test negative for OSA|53|||
155692631|NCT03007745|561968745|FG001|Overall Study|Sleep test negative for OSA|49|||
155692632|NCT03007745|561968744|FG000|Overall Study|Physician Decision|6|||
155692633|NCT03007745|561968745|FG001|Overall Study|Physician Decision|9|||
155692634|NCT03007745|561968744|FG000|Overall Study|Withdrawal by Subject|38|||
155692635|NCT03007745|561968745|FG001|Overall Study|Withdrawal by Subject|16|||
155692636|NCT03007745|561968744|FG000|Overall Study|Lost to Follow-up|19|||
155692637|NCT03007745|561968745|FG001|Overall Study|Lost to Follow-up|25|||
155692638|NCT03007745|561968744|FG000|Overall Study|Unable to login to website|17|||
155692639|NCT03007745|561968745|FG001|Overall Study|Unable to login to website|4|||
155692640|NCT04912895|561968746|FG000|Overall Study|Unable to provide specimen|2|||
155692641|NCT04912895|561968747|FG001|Overall Study|Unable to provide specimen|0|||
155692642|NCT04912895|561968748|FG002|Overall Study|Unable to provide specimen|0|||
155692643|NCT01145053|561968753|FG000|Overall Study|Adverse Event|22|||
155692644|NCT01145053|561968753|FG000|Overall Study|Lost to Follow-up|28|||
155692645|NCT01145053|561968753|FG000|Overall Study|Withdrawal by Subject|25|||
155692646|NCT01145053|561968753|FG000|Overall Study|Other|18|||
155692647|NCT00293709|561968754|FG000|Overall Study|Other|47|||
155692648|NCT02785458|561968755|FG000|1 Month|Withdrawal by Subject|2|||
155692649|NCT02785458|561968756|FG001|1 Month|Withdrawal by Subject|1|||
155692650|NCT02785458|561968755|FG000|1 Month|Lost to Follow-up|38|||
155692651|NCT02785458|561968756|FG001|1 Month|Lost to Follow-up|31|||
155692652|NCT02785458|561968755|FG000|1 Month|Deemed Ineligible|1|||
155692653|NCT02785458|561968756|FG001|1 Month|Deemed Ineligible|0|||
155692654|NCT02785458|561968755|FG000|1 Month|Completed Evaluation by Baseline|42|||
155692655|NCT02785458|561968756|FG001|1 Month|Completed Evaluation by Baseline|39|||
155692656|NCT02785458|561968755|FG000|1 Month|Partial Interview|0|||
155692657|NCT02785458|561968756|FG001|1 Month|Partial Interview|4|||
155692658|NCT02785458|561968755|FG000|3 Months|Withdrawal by Subject|3|||
155692659|NCT02785458|561968756|FG001|3 Months|Withdrawal by Subject|1|||
155692660|NCT02785458|561968755|FG000|3 Months|Lost to Follow-up|25|||
155692661|NCT02785458|561968756|FG001|3 Months|Lost to Follow-up|21|||
155692662|NCT02785458|561968755|FG000|3 Months|Completed Evaluation at 1 Month|100|||
155692663|NCT02785458|561968756|FG001|3 Months|Completed Evaluation at 1 Month|89|||
155692664|NCT01146652|561968757|FG000|Overall Study|Adverse Event|506|||
155692665|NCT01146652|561968758|FG001|Overall Study|Adverse Event|15|||
155692666|NCT01146652|561968757|FG000|Overall Study|Lack of Efficacy|91|||
155692667|NCT01146652|561968758|FG001|Overall Study|Lack of Efficacy|7|||
155692668|NCT01146652|561968757|FG000|Overall Study|Poor compliance to protocol|38|||
155692669|NCT01146652|561968758|FG001|Overall Study|Poor compliance to protocol|1|||
155692670|NCT01146652|561968757|FG000|Overall Study|Other unspecified reasons|314|||
155692671|NCT01146652|561968758|FG001|Overall Study|Other unspecified reasons|22|||
155692672|NCT01146652|561968757|FG000|Overall Study|Enrolled but not treated|2|||
155692673|NCT01146652|561968758|FG001|Overall Study|Enrolled but not treated|0|||
155692674|NCT00520013|561968759|FG000|Overall Study|Withdrawal by Subject|0|||
155692675|NCT00520013|561968760|FG001|Overall Study|Withdrawal by Subject|0|||
155692676|NCT00520013|561968761|FG002|Overall Study|Withdrawal by Subject|1|||
155692677|NCT00520013|561968759|FG000|Overall Study|Adverse Event|2|||
155692678|NCT00520013|561968760|FG001|Overall Study|Adverse Event|10|||
155692679|NCT00520013|561968761|FG002|Overall Study|Adverse Event|7|||
155692680|NCT00520013|561968759|FG000|Overall Study|Progressive Disease|7|||
155692681|NCT00520013|561968760|FG001|Overall Study|Progressive Disease|3|||
155692682|NCT00520013|561968761|FG002|Overall Study|Progressive Disease|0|||
155692683|NCT00520013|561968759|FG000|Overall Study|Clinical Progression|3|||
155692684|NCT00520013|561968760|FG001|Overall Study|Clinical Progression|1|||
155692685|NCT00520013|561968761|FG002|Overall Study|Clinical Progression|0|||
155692686|NCT00520013|561968759|FG000|Overall Study|Death|0|||
155692687|NCT00520013|561968760|FG001|Overall Study|Death|1|||
155692688|NCT00520013|561968761|FG002|Overall Study|Death|0|||
155692689|NCT00520013|561968759|FG000|Overall Study|Physician Decision|0|||
155692690|NCT00520013|561968760|FG001|Overall Study|Physician Decision|0|||
155692691|NCT00520013|561968761|FG002|Overall Study|Physician Decision|3|||
155692692|NCT02981524|561968762|FG000|Overall Study|Progressive Disease|14|||
155692693|NCT02981524|561968762|FG000|Overall Study|Death (unrelated)|1|||
155692694|NCT02981524|561968762|FG000|Overall Study|Treatment Related Toxicity|1|||
155692695|NCT02981524|561968762|FG000|Overall Study|Withdrawal by Subject|1|||
155692696|NCT00159913|561968766|FG000|Overall Study|Adverse Event|1|||
155692697|NCT00159913|561968767|FG001|Overall Study|Adverse Event|0|||
155692698|NCT00159913|561968768|FG002|Overall Study|Adverse Event|1|||
155692699|NCT00159913|561968769|FG003|Overall Study|Adverse Event|0|||
155692700|NCT00159913|561968766|FG000|Overall Study|Withdrawal by Subject|0|||
155692701|NCT00159913|561968767|FG001|Overall Study|Withdrawal by Subject|0|||
155692702|NCT00159913|561968768|FG002|Overall Study|Withdrawal by Subject|0|||
155692703|NCT00159913|561968769|FG003|Overall Study|Withdrawal by Subject|1|||
155692704|NCT00159913|561968766|FG000|Overall Study|Lost to Follow-up|0|||
155692705|NCT00159913|561968767|FG001|Overall Study|Lost to Follow-up|0|||
155692706|NCT00159913|561968768|FG002|Overall Study|Lost to Follow-up|0|||
155692707|NCT00159913|561968769|FG003|Overall Study|Lost to Follow-up|1|||
155692708|NCT00159913|561968766|FG000|Overall Study|Protocol Violation|1|||
155692709|NCT00159913|561968767|FG001|Overall Study|Protocol Violation|0|||
155692710|NCT00159913|561968768|FG002|Overall Study|Protocol Violation|1|||
155692711|NCT00159913|561968769|FG003|Overall Study|Protocol Violation|0|||
155692712|NCT03294135|561968770|FG000|Overall Study|Serious Adverse Event|1|||
155692713|NCT03294135|561968771|FG001|Overall Study|Serious Adverse Event|0|||
155692714|NCT03294135|561968772|FG002|Overall Study|Serious Adverse Event|0|||
155692715|NCT03294135|561968770|FG000|Overall Study|Lost to Follow-up|1|||
155692716|NCT03294135|561968771|FG001|Overall Study|Lost to Follow-up|0|||
155692717|NCT03294135|561968772|FG002|Overall Study|Lost to Follow-up|1|||
155692718|NCT03294135|561968770|FG000|Overall Study|Withdrawal by Subject|0|||
155692719|NCT03294135|561968771|FG001|Overall Study|Withdrawal by Subject|0|||
155692720|NCT03294135|561968772|FG002|Overall Study|Withdrawal by Subject|1|||
155692721|NCT03294135|561968770|FG000|Overall Study|Other|2|||
155692722|NCT03294135|561968771|FG001|Overall Study|Other|0|||
155692723|NCT03294135|561968772|FG002|Overall Study|Other|0|||
155692724|NCT02763254|561968773|FG000|Overall Study|Adverse Event|1|||
155692725|NCT00824005|561968776|FG000|Overall Study|Death|0|||
155692726|NCT00824005|561968777|FG001|Overall Study|Death|1|||
155692727|NCT00824005|561968776|FG000|Overall Study|Lost to Follow-up|0|||
155692728|NCT00824005|561968777|FG001|Overall Study|Lost to Follow-up|1|||
155692729|NCT00431951|561968778|FG000|Overall Study|Inability to follow study procedures|1|||
155692730|NCT00431951|561968779|FG001|Overall Study|Inability to follow study procedures|0|||
155692731|NCT00431951|561968780|FG002|Overall Study|Inability to follow study procedures|1|||
155692732|NCT00431951|561968781|FG003|Overall Study|Inability to follow study procedures|2|||
155692733|NCT00431951|561968778|FG000|Overall Study|Lost to Follow-up|0|||
155692734|NCT00431951|561968779|FG001|Overall Study|Lost to Follow-up|1|||
155692735|NCT00431951|561968780|FG002|Overall Study|Lost to Follow-up|0|||
155692736|NCT00431951|561968781|FG003|Overall Study|Lost to Follow-up|0|||
155692737|NCT00431951|561968778|FG000|Overall Study|Withdrawal by Subject|0|||
155692738|NCT00431951|561968779|FG001|Overall Study|Withdrawal by Subject|1|||
155692739|NCT00431951|561968780|FG002|Overall Study|Withdrawal by Subject|0|||
155692740|NCT00431951|561968781|FG003|Overall Study|Withdrawal by Subject|0|||
155692741|NCT00431951|561968778|FG000|Overall Study|Adverse Event|0|||
155692742|NCT00431951|561968779|FG001|Overall Study|Adverse Event|0|||
155692743|NCT00431951|561968780|FG002|Overall Study|Adverse Event|1|||
155692744|NCT00431951|561968781|FG003|Overall Study|Adverse Event|0|||
155692745|NCT01146288|561968782|FG000|First Intervention(1 Day)|Adverse Event|0|||
155692746|NCT01146288|561968783|FG001|First Intervention(1 Day)|Adverse Event|1|||
155692747|NCT03458702|561968784|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
155692748|NCT03458702|561968785|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
155692749|NCT03458702|561968784|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
155692750|NCT03458702|561968785|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
155692751|NCT01697462|561968786|FG000|Overall Study|Disease Progression|1|||
155692752|NCT01697462|561968786|FG000|Overall Study|Adverse Event|6|||
155692753|NCT01697462|561968786|FG000|Overall Study|Lost to Follow-up|21|||
155692754|NCT01697462|561968786|FG000|Overall Study|Withdrawal by Subject|12|||
155692755|NCT01697462|561968786|FG000|Overall Study|Investigator Decision|21|||
155692756|NCT01697462|561968786|FG000|Overall Study|Death|1|||
155692757|NCT01697462|561968786|FG000|Overall Study|Other|10|||
155692758|NCT01697462|561968786|FG000|Overall Study|Missing|5|||
155692759|NCT00168103|561968787|FG000|Overall Study|Withdrawal by Subject|1|||
155692760|NCT00168103|561968788|FG001|Overall Study|Withdrawal by Subject|2|||
155692761|NCT00168103|561968789|FG002|Overall Study|Withdrawal by Subject|1|||
155692762|NCT00168103|561968790|FG003|Overall Study|Withdrawal by Subject|0|||
155692763|NCT00168103|561968787|FG000|Overall Study|Lost to Follow-up|1|||
155692764|NCT00168103|561968788|FG001|Overall Study|Lost to Follow-up|3|||
155692765|NCT00168103|561968789|FG002|Overall Study|Lost to Follow-up|0|||
155692766|NCT00168103|561968790|FG003|Overall Study|Lost to Follow-up|0|||
155692767|NCT03532932|561968791|FG000|Overall Study|Protocol Deviation|33|||
155692768|NCT03532932|561968792|FG001|Overall Study|Protocol Deviation|31|||
155692769|NCT03532932|561968791|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
155692770|NCT03532932|561968792|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
155692771|NCT03532932|561968791|FG000|Overall Study|Withdrawal by Subject|2|||
155692772|NCT03532932|561968792|FG001|Overall Study|Withdrawal by Subject|0|||
155692773|NCT03532932|561968791|FG000|Overall Study|Lost to Follow-up|15|||
155692774|NCT03532932|561968792|FG001|Overall Study|Lost to Follow-up|9|||
155692775|NCT03532932|561968791|FG000|Overall Study|Adverse Event|4|||
155692776|NCT03532932|561968792|FG001|Overall Study|Adverse Event|3|||
155692777|NCT03532932|561968791|FG000|Overall Study|Death|0|||
155692778|NCT03532932|561968792|FG001|Overall Study|Death|2|||
155692779|NCT03532932|561968791|FG000|Overall Study|Other|11|||
155692780|NCT03532932|561968792|FG001|Overall Study|Other|16|||
155692781|NCT02956850|561968794|FG000|Overall Study|Withdrawal by Subject|0|||
155692782|NCT02956850|561968795|FG001|Overall Study|Withdrawal by Subject|0|||
155692783|NCT02956850|561968796|FG002|Overall Study|Withdrawal by Subject|0|||
155692784|NCT02956850|561968797|FG003|Overall Study|Withdrawal by Subject|0|||
155692785|NCT02956850|561968798|FG004|Overall Study|Withdrawal by Subject|0|||
155692786|NCT02956850|561968799|FG005|Overall Study|Withdrawal by Subject|0|||
155692787|NCT02956850|561968800|FG006|Overall Study|Withdrawal by Subject|0|||
155692788|NCT02956850|561968801|FG007|Overall Study|Withdrawal by Subject|0|||
155692789|NCT02956850|561968802|FG008|Overall Study|Withdrawal by Subject|0|||
155692790|NCT02956850|561968803|FG009|Overall Study|Withdrawal by Subject|0|||
155692791|NCT02956850|561968804|FG010|Overall Study|Withdrawal by Subject|0|||
155692792|NCT02956850|561968805|FG011|Overall Study|Withdrawal by Subject|0|||
155692793|NCT02956850|561968806|FG012|Overall Study|Withdrawal by Subject|0|||
155692794|NCT02956850|561968807|FG013|Overall Study|Withdrawal by Subject|0|||
155692795|NCT02956850|561968808|FG014|Overall Study|Withdrawal by Subject|0|||
155692796|NCT02956850|561968809|FG015|Overall Study|Withdrawal by Subject|0|||
155692797|NCT02956850|561968810|FG016|Overall Study|Withdrawal by Subject|0|||
155692798|NCT02956850|561968811|FG017|Overall Study|Withdrawal by Subject|1|||
155692799|NCT01920152|561968812|FG000|Overall Study|Withdrawal by Subject|1|||
155692800|NCT01920152|561968813|FG001|Overall Study|Withdrawal by Subject|2|||
155692801|NCT03412604|561968814|FG000|Overall Study|Withdrawal by Subject|1|||
155692802|NCT00993499|561968815|FG000|Run-in Period (8 Days)|Adverse Event|0|||
155692803|NCT00993499|561968816|FG001|Run-in Period (8 Days)|Adverse Event|1|||
155692804|NCT00993499|561968817|FG002|Run-in Period (8 Days)|Adverse Event|0|||
155692805|NCT00993499|561968818|FG003|Run-in Period (8 Days)|Adverse Event|0|||
155692806|NCT00993499|561968819|FG004|Run-in Period (8 Days)|Adverse Event|0|||
155692807|NCT00993499|561968820|FG005|Run-in Period (8 Days)|Adverse Event|0|||
155692808|NCT00993499|561968815|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
155692809|NCT00993499|561968816|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155692810|NCT00993499|561968817|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155692811|NCT00993499|561968818|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155692812|NCT00993499|561968819|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155692813|NCT00993499|561968820|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155692814|NCT00993499|561968815|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
155692815|NCT00993499|561968816|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
155692816|NCT00993499|561968817|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
155692817|NCT00993499|561968818|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
155692818|NCT00993499|561968819|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
155692819|NCT00993499|561968820|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
155692820|NCT00993499|561968815|FG000|Run-in Period (8 Days)|Progressive disease|0|||
155692821|NCT00993499|561968816|FG001|Run-in Period (8 Days)|Progressive disease|1|||
155692822|NCT00993499|561968817|FG002|Run-in Period (8 Days)|Progressive disease|1|||
155692823|NCT00993499|561968818|FG003|Run-in Period (8 Days)|Progressive disease|0|||
155692824|NCT00993499|561968819|FG004|Run-in Period (8 Days)|Progressive disease|0|||
155692825|NCT00993499|561968820|FG005|Run-in Period (8 Days)|Progressive disease|0|||
155692826|NCT00993499|561968815|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
155692827|NCT00993499|561968816|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
155692828|NCT00993499|561968817|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
155692829|NCT00993499|561968818|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
155692830|NCT00993499|561968819|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
155692831|NCT00993499|561968820|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
155692832|NCT00993499|561968815|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
155692833|NCT00993499|561968816|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
155692834|NCT00993499|561968817|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155692835|NCT00993499|561968818|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155692836|NCT00993499|561968819|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155692837|NCT00993499|561968820|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155692838|NCT00993499|561968815|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155692839|NCT00993499|561968816|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155692840|NCT00993499|561968817|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
155692841|NCT00993499|561968818|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
155692842|NCT00993499|561968819|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155692843|NCT00993499|561968820|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155692844|NCT00993499|561968815|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155692845|NCT00993499|561968816|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155692846|NCT00993499|561968817|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
155692847|NCT00993499|561968818|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155692848|NCT00993499|561968819|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155692849|NCT00993499|561968820|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155692850|NCT00993499|561968815|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155692851|NCT00993499|561968816|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
155692852|NCT00993499|561968817|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155692853|NCT00993499|561968818|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155692854|NCT00993499|561968819|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155692855|NCT00993499|561968820|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155692856|NCT00993499|561968815|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
155692857|NCT00993499|561968816|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
155692858|NCT00993499|561968817|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
155692859|NCT00993499|561968818|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
155692860|NCT00993499|561968819|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
155692861|NCT00993499|561968820|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
155692862|NCT00993499|561968815|FG000|Discontinued After Starting Course 3|DLT|1|||
155692863|NCT00993499|561968816|FG001|Discontinued After Starting Course 3|DLT|0|||
155692864|NCT00993499|561968817|FG002|Discontinued After Starting Course 3|DLT|2|||
155692865|NCT00993499|561968818|FG003|Discontinued After Starting Course 3|DLT|1|||
155692866|NCT00993499|561968819|FG004|Discontinued After Starting Course 3|DLT|0|||
155692867|NCT00993499|561968820|FG005|Discontinued After Starting Course 3|DLT|0|||
155692868|NCT00993499|561968815|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
155692869|NCT00993499|561968816|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
155692870|NCT00993499|561968817|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
155692871|NCT00993499|561968818|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
155692872|NCT00993499|561968819|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
155692873|NCT00993499|561968820|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
155692874|NCT01287195|561968821|FG000|Overall Study|Withdrawal by Subject|2|||
155692875|NCT01420627|561968822|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
155692876|NCT00837876|561968823|FG000|Overall Study|Death|2|||
155692877|NCT00837876|561968823|FG000|Overall Study|Adverse Event|7|||
155692878|NCT00837876|561968823|FG000|Overall Study|Physician Decision|1|||
155692879|NCT00837876|561968823|FG000|Overall Study|Withdrawal by Subject|3|||
155692880|NCT00837876|561968823|FG000|Overall Study|disease progression|24|||
155692881|NCT00453973|561968826|FG000|Overall Study|Adverse Event|4|||
155692882|NCT00453973|561968827|FG001|Overall Study|Adverse Event|9|||
155692883|NCT00453973|561968826|FG000|Overall Study|Withdrawal by Subject|7|||
155692884|NCT00453973|561968827|FG001|Overall Study|Withdrawal by Subject|6|||
155692885|NCT00453973|561968826|FG000|Overall Study|PI Decision|0|||
155692886|NCT00453973|561968827|FG001|Overall Study|PI Decision|2|||
155692887|NCT00453973|561968826|FG000|Overall Study|Relocation|1|||
155692888|NCT00453973|561968827|FG001|Overall Study|Relocation|0|||
155692889|NCT00453973|561968826|FG000|Overall Study|Renal transplant|1|||
155692890|NCT00453973|561968827|FG001|Overall Study|Renal transplant|1|||
155692891|NCT00453973|561968826|FG000|Overall Study|Site closed by sponsor|3|||
155692892|NCT00453973|561968827|FG001|Overall Study|Site closed by sponsor|0|||
155692893|NCT00453973|561968826|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
155692894|NCT00453973|561968827|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
155692895|NCT00276094|561968828|FG000|Overall Study|Adverse Event|15|||
155692896|NCT00276094|561968829|FG001|Overall Study|Adverse Event|13|||
155692897|NCT00276094|561968830|FG002|Overall Study|Adverse Event|11|||
155692898|NCT00276094|561968828|FG000|Overall Study|Withdrawal by Subject|14|||
155692899|NCT00276094|561968829|FG001|Overall Study|Withdrawal by Subject|14|||
155692900|NCT00276094|561968830|FG002|Overall Study|Withdrawal by Subject|12|||
155692901|NCT00276094|561968828|FG000|Overall Study|Protocol Violation|16|||
155692902|NCT00276094|561968829|FG001|Overall Study|Protocol Violation|7|||
155692903|NCT00276094|561968830|FG002|Overall Study|Protocol Violation|10|||
155692904|NCT00276094|561968828|FG000|Overall Study|Lost to Follow-up|8|||
155692905|NCT00276094|561968829|FG001|Overall Study|Lost to Follow-up|6|||
155692906|NCT00276094|561968830|FG002|Overall Study|Lost to Follow-up|4|||
155692907|NCT00276094|561968828|FG000|Overall Study|Other-Subject moved out of country|1|||
155692908|NCT00276094|561968829|FG001|Overall Study|Other-Subject moved out of country|0|||
155692909|NCT00276094|561968830|FG002|Overall Study|Other-Subject moved out of country|0|||
155692910|NCT00276094|561968828|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
155692911|NCT00276094|561968829|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
155692912|NCT00276094|561968830|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
155692913|NCT00276094|561968828|FG000|Overall Study|Other-Lack of efficacy|1|||
155692914|NCT00276094|561968829|FG001|Overall Study|Other-Lack of efficacy|0|||
155692915|NCT00276094|561968830|FG002|Overall Study|Other-Lack of efficacy|0|||
155692916|NCT00276094|561968828|FG000|Overall Study|Other-Refused follow-up visit|1|||
155692917|NCT00276094|561968829|FG001|Overall Study|Other-Refused follow-up visit|0|||
155692918|NCT00276094|561968830|FG002|Overall Study|Other-Refused follow-up visit|0|||
155692919|NCT00276094|561968828|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
155692920|NCT00276094|561968829|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
155692921|NCT00276094|561968830|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
155692922|NCT00276094|561968828|FG000|Overall Study|Other-Relocation|0|||
155692923|NCT00276094|561968829|FG001|Overall Study|Other-Relocation|1|||
155692924|NCT00276094|561968830|FG002|Overall Study|Other-Relocation|0|||
155692925|NCT00276094|561968828|FG000|Overall Study|Other-Study medication lost|0|||
155692926|NCT00276094|561968829|FG001|Overall Study|Other-Study medication lost|0|||
155692927|NCT00276094|561968830|FG002|Overall Study|Other-Study medication lost|1|||
155692928|NCT00707746|561968831|FG000|Treatment Period|Adverse Event|2|||
155692929|NCT00707746|561968832|FG001|Treatment Period|Adverse Event|4|||
155692930|NCT00707746|561968831|FG000|Treatment Period|Ineligibility|0|||
155692931|NCT00707746|561968832|FG001|Treatment Period|Ineligibility|1|||
155692932|NCT00886119|561968839|FG000|Period 1|Did not meet inclusion criteria|1|||
155692933|NCT00886119|561968840|FG001|Period 1|Did not meet inclusion criteria|0|||
155692934|NCT00357656|561968841|FG000|Overall Study|Other, No surgery performed|0|||
155692935|NCT00357656|561968842|FG001|Overall Study|Other, No surgery performed|3|||
155692936|NCT01219933|561968846|FG000|Overall Study|Adverse Event|8|||
155692937|NCT01219933|561968846|FG000|Overall Study|No LDA reached|5|||
155692938|NCT01219933|561968846|FG000|Overall Study|No LDA maintained|7|||
155692939|NCT01219933|561968846|FG000|Overall Study|Lost to Follow-up|3|||
155692940|NCT01219933|561968846|FG000|Overall Study|GC free|1|||
155692941|NCT01219933|561968846|FG000|Overall Study|Withdrawal by Subject|5|||
155692942|NCT01219933|561968846|FG000|Overall Study|Protocol Violation|8|||
155692943|NCT01219933|561968846|FG000|Overall Study|Lack of Efficacy|1|||
155692944|NCT01902888|561968847|FG000|Overall Study|Study Terminated|3|||
155692945|NCT02256267|561968848|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
155692946|NCT02256267|561968848|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
155692947|NCT01685983|561968849|FG000|Overall Study|Adverse Event|7|||
155692948|NCT01685983|561968849|FG000|Overall Study|Death|1|||
155692949|NCT01685983|561968849|FG000|Overall Study|Withdrawal by Subject|19|||
155692950|NCT01685983|561968849|FG000|Overall Study|Protocol Violation|2|||
155692951|NCT01685983|561968849|FG000|Overall Study|Physician Decision|13|||
155692952|NCT01685983|561968849|FG000|Overall Study|Other|7|||
155692953|NCT01685983|561968849|FG000|Overall Study|Progressive Disease|32|||
155692954|NCT01685983|561968849|FG000|Overall Study|Noncompliance with Study Drug|1|||
155692955|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
155692956|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
155692957|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
155692958|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
155692959|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
155692960|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
155692961|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
155692962|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
155692963|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
155692964|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
155692965|NCT01352741|561968850|FG000|Open-label Tapentadol Titration Period|Other|4|||
155692966|NCT01352741|561968851|FG001|Open-label Tapentadol Titration Period|Other|0|||
155692967|NCT01352741|561968850|FG000|Double-blind Comparative Period|Protocol Violation|2|||
155692968|NCT01352741|561968851|FG001|Double-blind Comparative Period|Protocol Violation|0|||
155692969|NCT01352741|561968850|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
155692970|NCT01352741|561968851|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
155692971|NCT01352741|561968850|FG000|Double-blind Comparative Period|Adverse Event|16|||
155692972|NCT01352741|561968851|FG001|Double-blind Comparative Period|Adverse Event|17|||
155692973|NCT01352741|561968850|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
155692974|NCT01352741|561968851|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
155692975|NCT01352741|561968850|FG000|Double-blind Comparative Period|Death|0|||
155692976|NCT01352741|561968851|FG001|Double-blind Comparative Period|Death|1|||
155692977|NCT01352741|561968850|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
155692978|NCT01352741|561968851|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
155692979|NCT01352741|561968850|FG000|Double-blind Comparative Period|Other|1|||
155692980|NCT01352741|561968851|FG001|Double-blind Comparative Period|Other|2|||
155692981|NCT01352741|561968850|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
155692982|NCT01352741|561968851|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
155692983|NCT01352741|561968850|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
155692984|NCT01352741|561968851|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
155692985|NCT01352741|561968850|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
155692986|NCT01352741|561968851|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
155692987|NCT01352741|561968850|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
155692988|NCT01352741|561968851|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
155692989|NCT00259298|561968852|FG000|Overall Study|Withdrawal by Subject|1|||
155692990|NCT00259298|561968852|FG000|Overall Study|Physician Decision|2|||
155692991|NCT00645528|561968853|FG000|Overall Study|Did not show up for Visit 2|7|||
155692992|NCT03077698|561968854|FG000|Progestin Monotherapy|Stable Disease|8|||
155692993|NCT03077698|561968855|FG001|Progestin Monotherapy|Stable Disease|0|||
155692994|NCT03077698|561968854|FG000|Progestin Monotherapy|Adverse Event|1|||
155692995|NCT03077698|561968855|FG001|Progestin Monotherapy|Adverse Event|0|||
155692996|NCT03077698|561968854|FG000|Progestin Monotherapy|Death|1|||
155692997|NCT03077698|561968855|FG001|Progestin Monotherapy|Death|0|||
155692998|NCT03077698|561968854|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
155692999|NCT03077698|561968855|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
155693000|NCT03077698|561968854|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
155693001|NCT03077698|561968855|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
155693002|NCT03077698|561968854|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
155693003|NCT03077698|561968855|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
155693004|NCT03077698|561968854|FG000|Safety Follow Up|Withdrawal by Subject|2|||
155693005|NCT03077698|561968855|FG001|Safety Follow Up|Withdrawal by Subject|1|||
155693006|NCT03077698|561968854|FG000|Safety Follow Up|Transfer of care to hospice|1|||
155693007|NCT03077698|561968855|FG001|Safety Follow Up|Transfer of care to hospice|0|||
155693008|NCT01969500|561968857|FG000|Overall Study|Death|0|||
155693009|NCT01969500|561968858|FG001|Overall Study|Death|1|||
155693010|NCT01969500|561968857|FG000|Overall Study|extended hospitalization|1|||
155693011|NCT01969500|561968858|FG001|Overall Study|extended hospitalization|1|||
155693012|NCT00612508|561968862|FG000|Overall Study|Withdrawal by Subject|3|||
155693013|NCT00612508|561968863|FG001|Overall Study|Withdrawal by Subject|4|||
155693014|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
155693015|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
155693016|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
155693017|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
155693018|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
155693019|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
155693020|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
155693021|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
155693022|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
155693023|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
155693024|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
155693025|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
155693026|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
155693027|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
155693028|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
155693029|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
155693030|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
155693031|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
155693032|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
155693033|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
155693034|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
155693035|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
155693036|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
155693037|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
155693038|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
155693039|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
155693040|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
155693041|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
155693042|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
155693043|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
155693044|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
155693045|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
155693046|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
155693047|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
155693048|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
155693049|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
155693050|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
155693051|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
155693052|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
155693053|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
155693054|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
155693055|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
155693056|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
155693057|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
155693058|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
155693059|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
155693060|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
155693061|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
155693062|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
155693063|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
155693064|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
155693065|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
155693066|NCT02008357|561968864|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
155693067|NCT02008357|561968865|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
155693068|NCT02008357|561968864|FG000|Open-label Extension Period|Adverse Event|8|||
155693069|NCT02008357|561968865|FG001|Open-label Extension Period|Adverse Event|7|||
155693070|NCT02008357|561968864|FG000|Open-label Extension Period|Death|7|||
155693071|NCT02008357|561968865|FG001|Open-label Extension Period|Death|4|||
155693072|NCT02008357|561968864|FG000|Open-label Extension Period|Lack of Efficacy|9|||
155693073|NCT02008357|561968865|FG001|Open-label Extension Period|Lack of Efficacy|5|||
155693074|NCT02008357|561968864|FG000|Open-label Extension Period|Lost to Follow-up|2|||
155693075|NCT02008357|561968865|FG001|Open-label Extension Period|Lost to Follow-up|2|||
155693076|NCT02008357|561968864|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
155693077|NCT02008357|561968865|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
155693078|NCT02008357|561968864|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
155693079|NCT02008357|561968865|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
155693080|NCT02008357|561968864|FG000|Open-label Extension Period|Safety Risk|2|||
155693081|NCT02008357|561968865|FG001|Open-label Extension Period|Safety Risk|1|||
155693082|NCT02008357|561968864|FG000|Open-label Extension Period|Non-Compliance|0|||
155693083|NCT02008357|561968865|FG001|Open-label Extension Period|Non-Compliance|1|||
155693084|NCT02008357|561968864|FG000|Open-label Extension Period|Investigator Recommendation|0|||
155693085|NCT02008357|561968865|FG001|Open-label Extension Period|Investigator Recommendation|1|||
155693086|NCT02008357|561968864|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
155693087|NCT02008357|561968865|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
155693088|NCT02008357|561968864|FG000|Open-label Extension Period|Coordinating Center Request|2|||
155693089|NCT02008357|561968865|FG001|Open-label Extension Period|Coordinating Center Request|4|||
155693090|NCT02008357|561968864|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
155693091|NCT02008357|561968865|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
155693092|NCT02008357|561968864|FG000|Open-label Extension Period|Study Ended|20|||
155693093|NCT02008357|561968865|FG001|Open-label Extension Period|Study Ended|25|||
155693094|NCT02008357|561968864|FG000|Open-label Extension Period|Personal Reasons|0|||
155693095|NCT02008357|561968865|FG001|Open-label Extension Period|Personal Reasons|1|||
155693096|NCT02008357|561968864|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
155693097|NCT02008357|561968865|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
155693098|NCT02008357|561968864|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
155693099|NCT02008357|561968865|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
155693100|NCT02008357|561968864|FG000|Open-label Extension Period|Other|2|||
155693101|NCT02008357|561968865|FG001|Open-label Extension Period|Other|0|||
155693102|NCT01269385|561968867|FG000|Overall Study|Adverse Event|1|||
155693103|NCT01269385|561968868|FG001|Overall Study|Adverse Event|1|||
155693104|NCT01269385|561968869|FG002|Overall Study|Adverse Event|0|||
155693105|NCT01269385|561968870|FG003|Overall Study|Adverse Event|0|||
155693106|NCT03553498|561968872|FG000|Overall Study|Missing primary outcome|1|||
155693107|NCT03553498|561968873|FG001|Overall Study|Missing primary outcome|2|||
155693108|NCT04941807|561968874|FG000|Overall Study|Lost to Follow-up|1|||
155693109|NCT04941807|561968875|FG001|Overall Study|Lost to Follow-up|1|||
155693110|NCT02741570|561968876|FG000|Pre-Treatment Period|Other reasons|0|||
155693111|NCT02741570|561968877|FG001|Pre-Treatment Period|Other reasons|3|||
155693112|NCT02741570|561968876|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
155693113|NCT02741570|561968877|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
155693114|NCT02741570|561968876|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
155693115|NCT02741570|561968877|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
155693116|NCT02741570|561968876|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
155693117|NCT02741570|561968877|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
155693118|NCT02741570|561968876|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
155693119|NCT02741570|561968877|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
155693120|NCT02741570|561968876|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155693121|NCT02741570|561968877|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
155693122|NCT02741570|561968876|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
155693123|NCT02741570|561968877|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155693124|NCT02741570|561968876|FG000|Pre-Treatment Period|Death|0|||
155693125|NCT02741570|561968877|FG001|Pre-Treatment Period|Death|1|||
155693126|NCT02741570|561968876|FG000|Pre-Treatment Period|Disease progression|0|||
155693127|NCT02741570|561968877|FG001|Pre-Treatment Period|Disease progression|1|||
155693128|NCT02741570|561968876|FG000|Treatment Period|Other reasons|47|||
155693129|NCT02741570|561968877|FG001|Treatment Period|Other reasons|12|||
155693130|NCT02741570|561968876|FG000|Treatment Period|Poor/non-compliance|0|||
155693131|NCT02741570|561968877|FG001|Treatment Period|Poor/non-compliance|2|||
155693132|NCT02741570|561968876|FG000|Treatment Period|Maximum clinical benefit|4|||
155693133|NCT02741570|561968877|FG001|Treatment Period|Maximum clinical benefit|6|||
155693134|NCT02741570|561968876|FG000|Treatment Period|Lost to Follow-up|1|||
155693135|NCT02741570|561968877|FG001|Treatment Period|Lost to Follow-up|3|||
155693136|NCT02741570|561968876|FG000|Treatment Period|Participant withdrew consent|9|||
155693137|NCT02741570|561968877|FG001|Treatment Period|Participant withdrew consent|13|||
155693138|NCT02741570|561968876|FG000|Treatment Period|Participant request to discontinue treatment|8|||
155693139|NCT02741570|561968877|FG001|Treatment Period|Participant request to discontinue treatment|23|||
155693140|NCT02741570|561968876|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
155693141|NCT02741570|561968877|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
155693142|NCT02741570|561968876|FG000|Treatment Period|Death|9|||
155693143|NCT02741570|561968877|FG001|Treatment Period|Death|7|||
155693144|NCT02741570|561968876|FG000|Treatment Period|Study drug toxicity|55|||
155693145|NCT02741570|561968877|FG001|Treatment Period|Study drug toxicity|47|||
155693146|NCT02741570|561968876|FG000|Treatment Period|Disease progression|294|||
155693147|NCT02741570|561968877|FG001|Treatment Period|Disease progression|301|||
155693148|NCT02741570|561968876|FG000|Treatment Period|Administrative reason by sponsor|0|||
155693149|NCT02741570|561968877|FG001|Treatment Period|Administrative reason by sponsor|1|||
155693150|NCT01453946|561968878|FG000|Overall Study|Did not receive drug for the taper phase|1|||
155693151|NCT01453946|561968878|FG000|Overall Study|Protocol Violation|2|||
155693152|NCT01453946|561968878|FG000|Overall Study|Lack of Efficacy|3|||
155693153|NCT01453946|561968878|FG000|Overall Study|Adverse Event|3|||
155693154|NCT01710527|561968879|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
155693155|NCT01710527|561968880|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
155693156|NCT01688921|561968882|FG000|Overall Study|Lost to Follow-up|7|||
155693157|NCT01688921|561968883|FG001|Overall Study|Lost to Follow-up|13|||
155693158|NCT01688921|561968882|FG000|Overall Study|Physician Decision|6|||
155693159|NCT01688921|561968883|FG001|Overall Study|Physician Decision|1|||
155693160|NCT01688921|561968882|FG000|Overall Study|Protocol Violation|0|||
155693161|NCT01688921|561968883|FG001|Overall Study|Protocol Violation|1|||
155693162|NCT01688921|561968882|FG000|Overall Study|informed consent|3|||
155693163|NCT01688921|561968883|FG001|Overall Study|informed consent|0|||
155693164|NCT03697993|561968886|FG000|Overall Study|Became Ineligible after Enrollment|1|||
155693165|NCT03697993|561968887|FG001|Overall Study|Became Ineligible after Enrollment|3|||
155693166|NCT03697993|561968886|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
155693167|NCT03697993|561968887|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
155693168|NCT03697993|561968886|FG000|Overall Study|Lost to Follow-up|3|||
155693169|NCT03697993|561968887|FG001|Overall Study|Lost to Follow-up|0|||
155693170|NCT03697993|561968886|FG000|Overall Study|Physician Decision|4|||
155693171|NCT03697993|561968887|FG001|Overall Study|Physician Decision|0|||
155693172|NCT03697993|561968886|FG000|Overall Study|Initial Urine Culture Negative|0|||
155693173|NCT03697993|561968887|FG001|Overall Study|Initial Urine Culture Negative|1|||
155693174|NCT04384107|561968888|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
155693175|NCT04384107|561968889|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155693176|NCT04384107|561968888|FG000|Overall Study|Lost to Follow-up|1|||
155693177|NCT04384107|561968889|FG001|Overall Study|Lost to Follow-up|0|||
155693178|NCT02242981|561968890|FG000|Overall Study|Withdrawal by Subject|1|||
155693179|NCT02739321|561968891|FG000|Overall Study|Lack of Efficacy|1|||
155693180|NCT02739321|561968892|FG001|Overall Study|Lack of Efficacy|1|||
155693181|NCT02739321|561968891|FG000|Overall Study|Lost to Follow-up|1|||
155693182|NCT02739321|561968892|FG001|Overall Study|Lost to Follow-up|1|||
155693183|NCT02739321|561968891|FG000|Overall Study|Withdrawal by Subject|1|||
155693184|NCT02739321|561968892|FG001|Overall Study|Withdrawal by Subject|2|||
155693185|NCT00459537|561968893|FG000|Overall Study|Adverse Event|1|||
155693186|NCT00459537|561968894|FG001|Overall Study|Adverse Event|6|||
155693187|NCT00459537|561968893|FG000|Overall Study|Lack of Efficacy|10|||
155693188|NCT00459537|561968894|FG001|Overall Study|Lack of Efficacy|11|||
155693189|NCT00459537|561968893|FG000|Overall Study|Withdrawal by Subject|20|||
155693190|NCT00459537|561968894|FG001|Overall Study|Withdrawal by Subject|26|||
155693191|NCT00459537|561968893|FG000|Overall Study|Lost to Follow-up|27|||
155693192|NCT00459537|561968894|FG001|Overall Study|Lost to Follow-up|30|||
155693193|NCT00459537|561968893|FG000|Overall Study|Administrative problems|3|||
155693194|NCT00459537|561968894|FG001|Overall Study|Administrative problems|0|||
155693195|NCT00459537|561968893|FG000|Overall Study|Protocol Violation|4|||
155693196|NCT00459537|561968894|FG001|Overall Study|Protocol Violation|3|||
155693197|NCT00459537|561968893|FG000|Overall Study|Missing|1|||
155693198|NCT00459537|561968894|FG001|Overall Study|Missing|0|||
155693199|NCT03780959|561968895|FG000|Part 1|Adverse Event|1|||
155693200|NCT03780959|561968896|FG001|Part 1|Adverse Event|0|||
155693201|NCT03780959|561968897|FG002|Part 1|Adverse Event|0|||
155693202|NCT03780959|561968895|FG000|Part 1|Withdrawal by Subject|1|||
155693203|NCT03780959|561968896|FG001|Part 1|Withdrawal by Subject|0|||
155693204|NCT03780959|561968897|FG002|Part 1|Withdrawal by Subject|0|||
155693205|NCT03780959|561968895|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
155693206|NCT03780959|561968896|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
155693207|NCT03780959|561968897|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
155693208|NCT03780959|561968895|FG000|Part 1|Response Status|2|||
155693209|NCT03780959|561968896|FG001|Part 1|Response Status|0|||
155693210|NCT03780959|561968897|FG002|Part 1|Response Status|0|||
155693211|NCT03780959|561968895|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
155693212|NCT03780959|561968896|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
155693213|NCT03780959|561968897|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
155693214|NCT03780959|561968895|FG000|Part 2|Response Status|0|||
155693215|NCT03780959|561968896|FG001|Part 2|Response Status|18|||
155693216|NCT03780959|561968897|FG002|Part 2|Response Status|6|||
155721147|NCT02546609|562077764|FG000|Overall Study|Withdrawal by Subject|0|||
155721148|NCT02546609|562077765|FG001|Overall Study|Withdrawal by Subject|1|||
155721149|NCT02546609|562077766|FG002|Overall Study|Withdrawal by Subject|2|||
155721150|NCT02546609|562077764|FG000|Overall Study|Adverse Event|0|||
155721151|NCT02546609|562077765|FG001|Overall Study|Adverse Event|6|||
155721152|NCT02546609|562077766|FG002|Overall Study|Adverse Event|1|||
155721153|NCT02546609|562077764|FG000|Overall Study|Protocol Violation|0|||
155721154|NCT02546609|562077765|FG001|Overall Study|Protocol Violation|1|||
155721155|NCT02546609|562077766|FG002|Overall Study|Protocol Violation|1|||
155721156|NCT02546609|562077764|FG000|Overall Study|Lost to Follow-up|2|||
155721157|NCT02546609|562077765|FG001|Overall Study|Lost to Follow-up|3|||
155721158|NCT02546609|562077766|FG002|Overall Study|Lost to Follow-up|1|||
155721159|NCT02546609|562077764|FG000|Overall Study|travel or work schedule restriction|0|||
155721160|NCT02546609|562077765|FG001|Overall Study|travel or work schedule restriction|0|||
155721161|NCT02546609|562077766|FG002|Overall Study|travel or work schedule restriction|2|||
155721162|NCT03988400|562077768|FG000|Overall Study|Adverse Event|1|||
155721163|NCT03988400|562077769|FG001|Overall Study|Adverse Event|0|||
155721164|NCT03988400|562077768|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
155721165|NCT03988400|562077769|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
155721166|NCT03988400|562077768|FG000|Overall Study|Lost to Follow-up|0|||
155721167|NCT03988400|562077769|FG001|Overall Study|Lost to Follow-up|1|||
155721168|NCT04913610|562077770|FG000|Randomized Participants|Did Not Receive Treatment|0|||
155721169|NCT04913610|562077771|FG001|Randomized Participants|Did Not Receive Treatment|0|||
155721170|NCT04913610|562077772|FG002|Randomized Participants|Did Not Receive Treatment|1|||
155721171|NCT04913610|562077773|FG003|Randomized Participants|Did Not Receive Treatment|1|||
155721172|NCT04913610|562077774|FG004|Randomized Participants|Did Not Receive Treatment|0|||
155721173|NCT04913610|562077770|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
155721174|NCT04913610|562077771|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155721175|NCT04913610|562077772|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155721176|NCT04913610|562077773|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155721177|NCT04913610|562077774|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
155721178|NCT03186209|562077775|FG000|Overall Study|Withdrawal by Subject|11|||
155721179|NCT03186209|562077776|FG001|Overall Study|Withdrawal by Subject|22|||
155721180|NCT03186209|562077775|FG000|Overall Study|Pregnancy|1|||
155721181|NCT03186209|562077776|FG001|Overall Study|Pregnancy|0|||
155721182|NCT03186209|562077775|FG000|Overall Study|Adverse Event|4|||
155721183|NCT03186209|562077776|FG001|Overall Study|Adverse Event|0|||
155721184|NCT03186209|562077775|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
155721185|NCT03186209|562077776|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
155721186|NCT03186209|562077775|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
155721187|NCT03186209|562077776|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
155721188|NCT03186209|562077775|FG000|Overall Study|Fail to meet randomization criteria|0|||
155721189|NCT03186209|562077776|FG001|Overall Study|Fail to meet randomization criteria|1|||
155721190|NCT03186209|562077775|FG000|Overall Study|Lost to Follow-up|0|||
155721191|NCT03186209|562077776|FG001|Overall Study|Lost to Follow-up|1|||
155721192|NCT05435339|562077779|FG000|Overall Study|Death|1|||
155721193|NCT05435339|562077780|FG001|Overall Study|Death|0|||
155721194|NCT05435339|562077781|FG002|Overall Study|Death|3|||
155721195|NCT05435339|562077782|FG003|Overall Study|Death|1|||
155721196|NCT05435339|562077783|FG004|Overall Study|Death|3|||
155721197|NCT05435339|562077784|FG005|Overall Study|Death|2|||
155721198|NCT05435339|562077785|FG006|Overall Study|Death|4|||
155721199|NCT05435339|562077786|FG007|Overall Study|Death|6|||
155721200|NCT05435339|562077779|FG000|Overall Study|Sponsor Decision|0|||
155721201|NCT05435339|562077780|FG001|Overall Study|Sponsor Decision|1|||
155721202|NCT05435339|562077781|FG002|Overall Study|Sponsor Decision|0|||
155693217|NCT03172130|561970415|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
155693218|NCT03172130|561970416|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
155693219|NCT02831933|561970418|FG000|Overall Study|Physician Decision|11|||
155693220|NCT02068118|561970421|FG000|18-month Comparative Study Period|Death|90|||
155693221|NCT02068118|561970422|FG001|18-month Comparative Study Period|Death|97|||
155693222|NCT02068118|561970421|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
155693223|NCT02068118|561970422|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
155693224|NCT02068118|561970421|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
155693225|NCT02068118|561970422|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
155693226|NCT02068118|561970421|FG000|18-month Comparative Study Period|Heart transplant|9|||
155693227|NCT02068118|561970422|FG001|18-month Comparative Study Period|Heart transplant|15|||
155693228|NCT02068118|561970421|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
155693229|NCT02068118|561970422|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
155693230|NCT02068118|561970421|FG000|18-month Comparative Study Period|Hemiplegia|0|||
155693231|NCT02068118|561970422|FG001|18-month Comparative Study Period|Hemiplegia|1|||
155693232|NCT02068118|561970421|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
155693233|NCT02068118|561970422|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
155693234|NCT02068118|561970421|FG000|18-month Comparative Study Period|Move|0|||
155693235|NCT02068118|561970422|FG001|18-month Comparative Study Period|Move|1|||
155693236|NCT02068118|561970421|FG000|18-month Comparative Study Period|Hearing loss|0|||
155693237|NCT02068118|561970422|FG001|18-month Comparative Study Period|Hearing loss|1|||
155693238|NCT02068118|561970421|FG000|Extension Period|Death|0|||
155693239|NCT02068118|561970422|FG001|Extension Period|Death|2|||
155693240|NCT02068118|561970421|FG000|Extension Period|Withdrawal by Subject|1|||
155693241|NCT02068118|561970422|FG001|Extension Period|Withdrawal by Subject|0|||
155693242|NCT02068118|561970421|FG000|Extension Period|Heart transplant|1|||
155693243|NCT02068118|561970422|FG001|Extension Period|Heart transplant|0|||
155693244|NCT02068118|561970421|FG000|Extension Period|Wrong device use|0|||
155693245|NCT02068118|561970422|FG001|Extension Period|Wrong device use|1|||
155693246|NCT00685373|561970426|FG000|Overall Study|Adverse Event|3|||
155693247|NCT00685373|561970426|FG000|Overall Study|Withdrawal by Subject|5|||
155693248|NCT00685373|561970426|FG000|Overall Study|Lack of Efficacy|3|||
155693249|NCT00685373|561970426|FG000|Overall Study|Condition no longer requires study drug|1|||
155693250|NCT00685373|561970426|FG000|Overall Study|Lost to Follow-up|2|||
155693251|NCT00685373|561970426|FG000|Overall Study|Protocol Violation|1|||
155693252|NCT02758301|561970427|FG000|Overall Study|Death|12|||
155693253|NCT02758301|561970428|FG001|Overall Study|Death|0|||
155693254|NCT02758301|561970427|FG000|Overall Study|Physician Decision|10|||
155693255|NCT02758301|561970428|FG001|Overall Study|Physician Decision|1|||
155693256|NCT02758301|561970427|FG000|Overall Study|Withdrawal by Subject|5|||
155693257|NCT02758301|561970428|FG001|Overall Study|Withdrawal by Subject|6|||
155693258|NCT02758301|561970427|FG000|Overall Study|Lost to Follow-up|7|||
155693259|NCT02758301|561970428|FG001|Overall Study|Lost to Follow-up|0|||
155693260|NCT02758301|561970427|FG000|Overall Study|Protocol Violation|0|||
155693261|NCT02758301|561970428|FG001|Overall Study|Protocol Violation|1|||
155693262|NCT00582738|561970429|FG000|Overall Study|Administrative Problems|7|||
155693263|NCT00582738|561970430|FG001|Overall Study|Administrative Problems|8|||
155693264|NCT00582738|561970429|FG000|Overall Study|Adverse Event|0|||
155693265|NCT00582738|561970430|FG001|Overall Study|Adverse Event|5|||
155693266|NCT00582738|561970429|FG000|Overall Study|Graft Lost|0|||
155693267|NCT00582738|561970430|FG001|Overall Study|Graft Lost|1|||
155693268|NCT00582738|561970429|FG000|Overall Study|Other|1|||
155693269|NCT00582738|561970430|FG001|Overall Study|Other|0|||
155693270|NCT00582738|561970429|FG000|Overall Study|Protocol Violation|1|||
155693271|NCT00582738|561970430|FG001|Overall Study|Protocol Violation|1|||
155693272|NCT00582738|561970429|FG000|Overall Study|Withdrawal by Subject|0|||
155693273|NCT00582738|561970430|FG001|Overall Study|Withdrawal by Subject|3|||
155693274|NCT01167907|561970433|FG000|Overall Study|Protocol Violation|1|||
155693275|NCT01167907|561970434|FG001|Overall Study|Protocol Violation|0|||
155693276|NCT01167907|561970433|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
155693277|NCT01167907|561970434|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
155693278|NCT01011933|561970438|FG000|Overall Study|Wrong cell type|1|||
155693279|NCT01011933|561970438|FG000|Overall Study|Improper pre-protocol Rx|1|||
155693280|NCT01011933|561970438|FG000|Overall Study|Inadequate pathology|1|||
155693281|NCT01011933|561970438|FG000|Overall Study|Never treated|1|||
155693282|NCT01439074|561970439|FG000|Overall Study|Lost to Follow-up|3|||
155693283|NCT01439074|561970440|FG001|Overall Study|Lost to Follow-up|4|||
155693284|NCT01439074|561970439|FG000|Overall Study|Subject shedding|1|||
155693285|NCT01439074|561970440|FG001|Overall Study|Subject shedding|0|||
155693286|NCT01439074|561970439|FG000|Overall Study|Withdrawal by Subject|1|||
155693287|NCT01439074|561970440|FG001|Overall Study|Withdrawal by Subject|5|||
155693288|NCT01439074|561970439|FG000|Overall Study|Other|4|||
155693289|NCT01439074|561970440|FG001|Overall Study|Other|4|||
155693290|NCT00815191|561970441|FG000|Overall Study|Protocol Violation|1|||
155693291|NCT00815191|561970442|FG001|Overall Study|Protocol Violation|1|||
155693292|NCT01873729|561970443|FG000|Overall Study|Withdrawal by Subject|1|||
155693293|NCT01741532|561970444|FG000|Overall Study|Adverse Event|4|||
155693294|NCT01741532|561970445|FG001|Overall Study|Adverse Event|0|||
155693295|NCT01741532|561970444|FG000|Overall Study|Withdrawal by Subject|1|||
155693296|NCT01741532|561970445|FG001|Overall Study|Withdrawal by Subject|1|||
155693297|NCT01741532|561970444|FG000|Overall Study|Protocol Violation|0|||
155693298|NCT01741532|561970445|FG001|Overall Study|Protocol Violation|1|||
155693299|NCT01741532|561970444|FG000|Overall Study|Worsening of the disease|3|||
155693300|NCT01741532|561970445|FG001|Overall Study|Worsening of the disease|1|||
155693301|NCT01741532|561970444|FG000|Overall Study|Sponsor decision|1|||
155693302|NCT01741532|561970445|FG001|Overall Study|Sponsor decision|0|||
155693303|NCT01741532|561970444|FG000|Overall Study|Medical event|1|||
155693304|NCT01741532|561970445|FG001|Overall Study|Medical event|0|||
155693305|NCT02463032|561970446|FG000|Overall Study|Lack of Efficacy|61|||
155693306|NCT02463032|561970447|FG001|Overall Study|Lack of Efficacy|50|||
155693307|NCT02463032|561970446|FG000|Overall Study|Death|8|||
155693308|NCT02463032|561970447|FG001|Overall Study|Death|8|||
155693309|NCT02463032|561970446|FG000|Overall Study|Adverse Event|2|||
155693310|NCT02463032|561970447|FG001|Overall Study|Adverse Event|6|||
155693311|NCT00613080|561970448|FG000|Overall Study|Ineligible / no protocol treatment|11|||
155693312|NCT01066780|561970449|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
155693313|NCT01066780|561970450|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
155693314|NCT02226549|561970451|FG000|Overall Study|Randomized but Never Treated|1|||
155693315|NCT02226549|561970452|FG001|Overall Study|Randomized but Never Treated|0|||
155693316|NCT02226549|561970451|FG000|Overall Study|Lost to Follow-up|0|||
155693317|NCT02226549|561970452|FG001|Overall Study|Lost to Follow-up|1|||
155693318|NCT03099148|561970454|FG000|Wash-out|scheduling conflict|0|||
155693319|NCT03099148|561970455|FG001|Wash-out|scheduling conflict|1|||
155693320|NCT03099148|561970456|FG002|Wash-out|scheduling conflict|0|||
155693321|NCT03099148|561970457|FG003|Wash-out|scheduling conflict|0|||
155693322|NCT03099148|561970454|FG000|Wash-out|Adverse Event|0|||
155693323|NCT03099148|561970455|FG001|Wash-out|Adverse Event|1|||
155693324|NCT03099148|561970456|FG002|Wash-out|Adverse Event|0|||
155693325|NCT03099148|561970457|FG003|Wash-out|Adverse Event|0|||
155693326|NCT02312219|561970458|FG000|Overall Study|Withdrawal by Subject|1|||
155693327|NCT02312219|561970459|FG001|Overall Study|Withdrawal by Subject|2|||
155693328|NCT02312219|561970458|FG000|Overall Study|could not schedule imaging in time|0|||
155693329|NCT02312219|561970459|FG001|Overall Study|could not schedule imaging in time|2|||
155693330|NCT02312219|561970458|FG000|Overall Study|Other|0|||
155693331|NCT02312219|561970459|FG001|Overall Study|Other|1|||
155693332|NCT02312219|561970458|FG000|Overall Study|Not randomized. Ineligible|0|||
155693333|NCT02312219|561970459|FG001|Overall Study|Not randomized. Ineligible|1|||
155693334|NCT01100567|561970460|FG000|Overall Study|Withdrawal by Subject|5|||
155693335|NCT01100567|561970461|FG001|Overall Study|Withdrawal by Subject|8|||
155693336|NCT01100567|561970460|FG000|Overall Study|Early Hospital Discharge|6|||
155693337|NCT01100567|561970461|FG001|Overall Study|Early Hospital Discharge|4|||
155693338|NCT01100567|561970460|FG000|Overall Study|Lost to Follow-up|1|||
155693339|NCT01100567|561970461|FG001|Overall Study|Lost to Follow-up|2|||
155693340|NCT01100567|561970460|FG000|Overall Study|Physician Decision|0|||
155693341|NCT01100567|561970461|FG001|Overall Study|Physician Decision|1|||
155693342|NCT01100567|561970460|FG000|Overall Study|Deemed ineligible after consent|0|||
155693343|NCT01100567|561970461|FG001|Overall Study|Deemed ineligible after consent|1|||
155693344|NCT01498185|561970463|FG000|Overall Study|Adverse Event|0|||
155693345|NCT01498185|561970464|FG001|Overall Study|Adverse Event|0|||
155693346|NCT01498185|561970465|FG002|Overall Study|Adverse Event|0|||
155693347|NCT01498185|561970466|FG003|Overall Study|Adverse Event|1|||
155693348|NCT01498185|561970467|FG004|Overall Study|Adverse Event|0|||
155693349|NCT01498185|561970463|FG000|Overall Study|Withdrawal by Subject|1|||
155693350|NCT01498185|561970464|FG001|Overall Study|Withdrawal by Subject|1|||
155693351|NCT01498185|561970465|FG002|Overall Study|Withdrawal by Subject|0|||
155693352|NCT01498185|561970466|FG003|Overall Study|Withdrawal by Subject|2|||
155693353|NCT01498185|561970467|FG004|Overall Study|Withdrawal by Subject|1|||
155693354|NCT01498185|561970463|FG000|Overall Study|No longer met criteria, etc|0|||
155693355|NCT01498185|561970464|FG001|Overall Study|No longer met criteria, etc|0|||
155693356|NCT01498185|561970465|FG002|Overall Study|No longer met criteria, etc|0|||
155693357|NCT01498185|561970466|FG003|Overall Study|No longer met criteria, etc|0|||
155693358|NCT01498185|561970467|FG004|Overall Study|No longer met criteria, etc|2|||
155693359|NCT00946322|561970468|FG000|Pre-treatment|participant failure to follow up|1|||
155693360|NCT00946322|561970468|FG000|Post-treatment|participant failure to follow up|2|||
155693361|NCT02713529|561970469|FG000|Overall Study|Withdrawal by Subject|3|||
155693362|NCT02713529|561970470|FG001|Overall Study|Withdrawal by Subject|1|||
155693363|NCT02713529|561970471|FG002|Overall Study|Withdrawal by Subject|4|||
155693364|NCT02713529|561970472|FG003|Overall Study|Withdrawal by Subject|2|||
155693365|NCT02713529|561970473|FG004|Overall Study|Withdrawal by Subject|0|||
155693366|NCT02713529|561970474|FG005|Overall Study|Withdrawal by Subject|1|||
155693367|NCT02713529|561970475|FG006|Overall Study|Withdrawal by Subject|1|||
155693368|NCT02713529|561970469|FG000|Overall Study|Lost to Follow-up|1|||
155693369|NCT02713529|561970470|FG001|Overall Study|Lost to Follow-up|0|||
155693370|NCT02713529|561970471|FG002|Overall Study|Lost to Follow-up|1|||
155693371|NCT02713529|561970472|FG003|Overall Study|Lost to Follow-up|0|||
155693372|NCT02713529|561970473|FG004|Overall Study|Lost to Follow-up|0|||
155693373|NCT02713529|561970474|FG005|Overall Study|Lost to Follow-up|0|||
155693374|NCT02713529|561970475|FG006|Overall Study|Lost to Follow-up|0|||
155693375|NCT02713529|561970469|FG000|Overall Study|Death|3|||
155693376|NCT02713529|561970470|FG001|Overall Study|Death|3|||
155693377|NCT02713529|561970471|FG002|Overall Study|Death|26|||
155693378|NCT02713529|561970472|FG003|Overall Study|Death|27|||
155693379|NCT02713529|561970473|FG004|Overall Study|Death|3|||
155693380|NCT02713529|561970474|FG005|Overall Study|Death|13|||
155693381|NCT02713529|561970475|FG006|Overall Study|Death|3|||
155693382|NCT03352453|561970476|FG000|Overall Study|Miscellaneous Reasons|1|||
155693383|NCT03352453|561970477|FG001|Overall Study|Miscellaneous Reasons|2|||
155693384|NCT03352453|561970476|FG000|Overall Study|Lack of Efficacy|1|||
155693385|NCT03352453|561970477|FG001|Overall Study|Lack of Efficacy|0|||
155693386|NCT03352453|561970476|FG000|Overall Study|Withdrawal by Subject|8|||
155693387|NCT03352453|561970477|FG001|Overall Study|Withdrawal by Subject|14|||
155693388|NCT03352453|561970476|FG000|Overall Study|Study Terminated by Sponsor|2|||
155693389|NCT03352453|561970477|FG001|Overall Study|Study Terminated by Sponsor|1|||
155693390|NCT03352453|561970476|FG000|Overall Study|Protocol Deviation|1|||
155693391|NCT03352453|561970477|FG001|Overall Study|Protocol Deviation|0|||
155693392|NCT03352453|561970476|FG000|Overall Study|Lost to Follow-up|7|||
155693393|NCT03352453|561970477|FG001|Overall Study|Lost to Follow-up|6|||
155693394|NCT03352453|561970476|FG000|Overall Study|Adverse Event|2|||
155693395|NCT03352453|561970477|FG001|Overall Study|Adverse Event|9|||
155693396|NCT02827500|561970480|FG000|Overall Study|Death|7|||
155693397|NCT02827500|561970481|FG001|Overall Study|Death|3|||
155693398|NCT02827500|561970480|FG000|Overall Study|Lost to Follow-up|1|||
155693399|NCT02827500|561970481|FG001|Overall Study|Lost to Follow-up|1|||
155693400|NCT02827500|561970480|FG000|Overall Study|Withdrawal by Subject|3|||
155693401|NCT02827500|561970481|FG001|Overall Study|Withdrawal by Subject|1|||
155693402|NCT02827500|561970480|FG000|Overall Study|Missing primary endpoint data|3|||
155693403|NCT02827500|561970481|FG001|Overall Study|Missing primary endpoint data|1|||
155693404|NCT02827500|561970480|FG000|Overall Study|Other|5|||
155693405|NCT02827500|561970481|FG001|Overall Study|Other|1|||
155693406|NCT01241760|561970484|FG000|Overall Study|Adverse Event|1|||
155693407|NCT01241760|561970485|FG001|Overall Study|Adverse Event|0|||
155693408|NCT01241760|561970484|FG000|Overall Study|Lost to Follow-up|18|||
155693409|NCT01241760|561970485|FG001|Overall Study|Lost to Follow-up|22|||
155693410|NCT01241760|561970484|FG000|Overall Study|Withdrawal by Subject|13|||
155693411|NCT01241760|561970485|FG001|Overall Study|Withdrawal by Subject|13|||
155693412|NCT01241760|561970484|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
155693413|NCT01241760|561970485|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
155693414|NCT01241760|561970484|FG000|Overall Study|Other|1|||
155693415|NCT01241760|561970485|FG001|Overall Study|Other|1|||
155693416|NCT00514020|561970486|FG000|Overall Study|Adverse Event|6|||
155693417|NCT00514020|561970486|FG000|Overall Study|Withdrawal by Subject|3|||
155693418|NCT00514020|561970486|FG000|Overall Study|Physician Decision|1|||
155693419|NCT00514020|561970486|FG000|Overall Study|disease progression|9|||
155693420|NCT00514020|561970486|FG000|Overall Study|other complicating disease|2|||
155693421|NCT00514020|561970486|FG000|Overall Study|patient went to radiation treatment|1|||
155693422|NCT00514020|561970486|FG000|Overall Study|"patients moved to the no tx group"|6|||
155693423|NCT01636713|561970491|FG000|Overall Study|Adverse Event|16|||
155693424|NCT01636713|561970492|FG001|Overall Study|Adverse Event|16|||
155693425|NCT01636713|561970493|FG002|Overall Study|Adverse Event|7|||
155693426|NCT01636713|561970491|FG000|Overall Study|Lack of Efficacy|6|||
155693427|NCT01636713|561970492|FG001|Overall Study|Lack of Efficacy|6|||
155693428|NCT01636713|561970493|FG002|Overall Study|Lack of Efficacy|2|||
155693429|NCT01636713|561970491|FG000|Overall Study|Protocol Violation|3|||
155693430|NCT01636713|561970492|FG001|Overall Study|Protocol Violation|0|||
155693431|NCT01636713|561970493|FG002|Overall Study|Protocol Violation|1|||
155693432|NCT01636713|561970491|FG000|Overall Study|Lost to Follow-up|0|||
155693433|NCT01636713|561970492|FG001|Overall Study|Lost to Follow-up|0|||
155693434|NCT01636713|561970493|FG002|Overall Study|Lost to Follow-up|1|||
155693435|NCT01636713|561970491|FG000|Overall Study|Withdrawal by Subject|5|||
155693436|NCT01636713|561970492|FG001|Overall Study|Withdrawal by Subject|4|||
155693437|NCT01636713|561970493|FG002|Overall Study|Withdrawal by Subject|8|||
155693438|NCT01636713|561970491|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155693439|NCT01636713|561970492|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155693440|NCT01636713|561970493|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155693441|NCT00276614|561970501|FG000|Overall Study|Progression of disease under study|3|||
155693442|NCT01522404|561970505|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
155693443|NCT01522404|561970506|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
155693444|NCT01522404|561970505|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
155693445|NCT01522404|561970506|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
155693446|NCT01522404|561970505|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
155693447|NCT01522404|561970506|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
155693448|NCT02525094|561970507|FG000|Overall Study|Lost to Follow-up|2|||
155693449|NCT02525094|561970508|FG001|Overall Study|Lost to Follow-up|1|||
155693450|NCT02525094|561970507|FG000|Overall Study|Withdrawal by Subject|5|||
155693451|NCT02525094|561970508|FG001|Overall Study|Withdrawal by Subject|6|||
155693452|NCT02525094|561970507|FG000|Overall Study|Not Treated|1|||
155693453|NCT02525094|561970508|FG001|Overall Study|Not Treated|1|||
155693454|NCT01490294|561970509|FG000|Overall Study|Prematurely discontinuation|4|||
155693455|NCT01490294|561970510|FG001|Overall Study|Prematurely discontinuation|0|||
155693456|NCT01490294|561970511|FG002|Overall Study|Prematurely discontinuation|1|||
155693457|NCT01490294|561970512|FG003|Overall Study|Prematurely discontinuation|1|||
155693458|NCT01490294|561970509|FG000|Overall Study|Adverse Event|1|||
155693459|NCT01490294|561970510|FG001|Overall Study|Adverse Event|0|||
155693460|NCT01490294|561970511|FG002|Overall Study|Adverse Event|0|||
155693461|NCT01490294|561970512|FG003|Overall Study|Adverse Event|0|||
155693462|NCT01751776|561970515|FG000|Overall Study|Adverse Event|0|||
155693463|NCT01751776|561970516|FG001|Overall Study|Adverse Event|0|||
155693464|NCT01751776|561970517|FG002|Overall Study|Adverse Event|0|||
155693465|NCT01751776|561970518|FG003|Overall Study|Adverse Event|0|||
155693466|NCT01751776|561970519|FG004|Overall Study|Adverse Event|0|||
155693467|NCT01751776|561970520|FG005|Overall Study|Adverse Event|0|||
155693468|NCT01751776|561970521|FG006|Overall Study|Adverse Event|4|||
155693469|NCT01751776|561970522|FG007|Overall Study|Adverse Event|2|||
155693470|NCT01751776|561970515|FG000|Overall Study|Consent withdrawn|0|||
155693471|NCT01751776|561970516|FG001|Overall Study|Consent withdrawn|0|||
155693472|NCT01751776|561970517|FG002|Overall Study|Consent withdrawn|0|||
155693473|NCT01751776|561970518|FG003|Overall Study|Consent withdrawn|0|||
155693474|NCT01751776|561970519|FG004|Overall Study|Consent withdrawn|0|||
155693475|NCT01751776|561970520|FG005|Overall Study|Consent withdrawn|0|||
155693476|NCT01751776|561970521|FG006|Overall Study|Consent withdrawn|0|||
155693477|NCT01751776|561970522|FG007|Overall Study|Consent withdrawn|1|||
155693478|NCT01751776|561970515|FG000|Overall Study|Other reason not specified above|0|||
155693479|NCT01751776|561970516|FG001|Overall Study|Other reason not specified above|0|||
155693480|NCT01751776|561970517|FG002|Overall Study|Other reason not specified above|0|||
155693481|NCT01751776|561970518|FG003|Overall Study|Other reason not specified above|0|||
155693482|NCT01751776|561970519|FG004|Overall Study|Other reason not specified above|0|||
155693483|NCT01751776|561970520|FG005|Overall Study|Other reason not specified above|0|||
155693484|NCT01751776|561970521|FG006|Overall Study|Other reason not specified above|0|||
155693485|NCT01751776|561970522|FG007|Overall Study|Other reason not specified above|1|||
155693486|NCT00831701|561970525|FG000|Overall Study|Withdrawal by Subject|2|||
155693487|NCT00831701|561970526|FG001|Overall Study|Withdrawal by Subject|0|||
155693488|NCT00831701|561970525|FG000|Overall Study|Stone expulsion before first medication|2|||
155693489|NCT00831701|561970526|FG001|Overall Study|Stone expulsion before first medication|2|||
155693490|NCT00831701|561970525|FG000|Overall Study|Lost to Follow-up|1|||
155693491|NCT00831701|561970526|FG001|Overall Study|Lost to Follow-up|3|||
155693492|NCT02117349|561970527|FG000|Overall Study|Withdrawal by Subject|1|||
155693493|NCT02117349|561970528|FG001|Overall Study|Withdrawal by Subject|0|||
155693494|NCT02117349|561970527|FG000|Overall Study|Lost to Follow-up|1|||
155693495|NCT02117349|561970528|FG001|Overall Study|Lost to Follow-up|1|||
155693496|NCT02117349|561970527|FG000|Overall Study|Death|1|||
155693497|NCT02117349|561970528|FG001|Overall Study|Death|0|||
155693498|NCT02535416|561970529|FG000|Overall Study|Family bereavement overseas|1|||
155693499|NCT02535416|561970530|FG001|Overall Study|Family bereavement overseas|0|||
155693500|NCT02535416|561970531|FG002|Overall Study|Family bereavement overseas|0|||
155693501|NCT02535416|561970532|FG003|Overall Study|Family bereavement overseas|0|||
155693502|NCT02535416|561970533|FG004|Overall Study|Family bereavement overseas|0|||
155693503|NCT02535416|561970534|FG005|Overall Study|Family bereavement overseas|0|||
155693504|NCT02535416|561970535|FG006|Overall Study|Family bereavement overseas|0|||
155693505|NCT02535416|561970536|FG007|Overall Study|Family bereavement overseas|0|||
155693506|NCT02535416|561970537|FG008|Overall Study|Family bereavement overseas|0|||
155693507|NCT01977690|561970540|FG000|Overall Study|Withdrawal by Subject|0|||
155693508|NCT01977690|561970541|FG001|Overall Study|Withdrawal by Subject|4|||
155693509|NCT02644356|561970544|FG000|Overall Study|Withdrawal by Subject|2|||
155693510|NCT02210091|561970546|FG000|Overall Study|Physician Decision|0|||
155693511|NCT02210091|561970547|FG001|Overall Study|Physician Decision|1|||
155693512|NCT02210091|561970546|FG000|Overall Study|Withdrawal by Sponsor|0|||
155693513|NCT02210091|561970547|FG001|Overall Study|Withdrawal by Sponsor|1|||
155693514|NCT01711866|561970551|FG000|Overall Study|Noncompliant|3|||
155693515|NCT01711866|561970551|FG000|Overall Study|Withdrawal by Subject|3|||
155693516|NCT01711866|561970551|FG000|Overall Study|Adverse Event|2|||
155693517|NCT00897390|561970552|FG000|Overall Study|Adverse Event|2|||
155693518|NCT00897390|561970552|FG000|Overall Study|No Longer Met Study Criteria|1|||
155693519|NCT00897390|561970552|FG000|Overall Study|Personal Reasons|1|||
155693520|NCT00897390|561970552|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
155693521|NCT01831817|561970553|FG000|Overall Study|Lost to Follow-up|1|||
155693522|NCT01831817|561970554|FG001|Overall Study|Lost to Follow-up|0|||
155693523|NCT01831817|561970555|FG002|Overall Study|Lost to Follow-up|0|||
155693524|NCT01831817|561970556|FG003|Overall Study|Lost to Follow-up|0|||
155693525|NCT01831817|561970553|FG000|Overall Study|Withdrawl of Consent|3|||
155693526|NCT01831817|561970554|FG001|Overall Study|Withdrawl of Consent|0|||
155693527|NCT01831817|561970555|FG002|Overall Study|Withdrawl of Consent|0|||
155693528|NCT01831817|561970556|FG003|Overall Study|Withdrawl of Consent|0|||
155693529|NCT03159104|561970557|FG000|Overall Study|Violation of inclusion criteria|1|||
155693530|NCT03159104|561970558|FG001|Overall Study|Violation of inclusion criteria|2|||
155693531|NCT00958217|561970559|FG000|Overall Study|Death|2|||
155693532|NCT00958217|561970560|FG001|Overall Study|Death|1|||
155693533|NCT00958217|561970559|FG000|Overall Study|Withdrawal by Subject|4|||
155693534|NCT00958217|561970560|FG001|Overall Study|Withdrawal by Subject|3|||
155693535|NCT00958217|561970559|FG000|Overall Study|Lost to Follow-up|17|||
155693536|NCT00958217|561970560|FG001|Overall Study|Lost to Follow-up|19|||
155693537|NCT00958217|561970559|FG000|Overall Study|Moved out of area|1|||
155693538|NCT00958217|561970560|FG001|Overall Study|Moved out of area|1|||
155693539|NCT00958217|561970559|FG000|Overall Study|Inpatient hospitalization|0|||
155693540|NCT00958217|561970560|FG001|Overall Study|Inpatient hospitalization|1|||
155693541|NCT02440789|561970563|FG000|Overall Study|Withdrawal by Subject|3|||
155693542|NCT02440789|561970563|FG000|Overall Study|Not willing to adhere to reqs|1|||
155693543|NCT05065190|561972262|FG000|Overall Study|Other than listed|2|||
155693544|NCT05065190|561972263|FG001|Overall Study|Other than listed|12|||
155693545|NCT05065190|561972262|FG000|Overall Study|Lack of Efficacy|4|||
155693546|NCT05065190|561972263|FG001|Overall Study|Lack of Efficacy|0|||
155693547|NCT05065190|561972262|FG000|Overall Study|Adverse Event|1|||
155693548|NCT05065190|561972263|FG001|Overall Study|Adverse Event|10|||
155693549|NCT04544683|561972264|FG000|Overall Study|Lost to Follow-up|2|||
155693550|NCT04544683|561972264|FG000|Overall Study|Underwent cervical spine surgery|6|||
155693551|NCT00151372|561972265|FG000|Overall Study|Death|12|||
155693552|NCT00151372|561972266|FG001|Overall Study|Death|11|||
155693553|NCT00151372|561972265|FG000|Overall Study|Lost to Follow-up|5|||
155693554|NCT00151372|561972266|FG001|Overall Study|Lost to Follow-up|5|||
155693555|NCT00151372|561972265|FG000|Overall Study|Too sick medically to continue|5|||
155693556|NCT00151372|561972266|FG001|Overall Study|Too sick medically to continue|6|||
155693557|NCT00151372|561972265|FG000|Overall Study|Withdrawal by Subject|7|||
155693558|NCT00151372|561972266|FG001|Overall Study|Withdrawal by Subject|7|||
155693559|NCT01266590|561972267|FG000|Overall Study|Adverse Event|3|||
155693560|NCT01266590|561972267|FG000|Overall Study|Lost to Follow-up|1|||
155693561|NCT01266590|561972267|FG000|Overall Study|Withdrawal by Subject|1|||
155693562|NCT01266590|561972267|FG000|Overall Study|Physician Decision|1|||
155693563|NCT04732949|561972270|FG000|Overall Study|Withdrawal by Subject|23|||
155693564|NCT04732949|561972271|FG001|Overall Study|Withdrawal by Subject|27|||
155693565|NCT04732949|561972270|FG000|Overall Study|Protocol Violation|0|||
155693566|NCT04732949|561972271|FG001|Overall Study|Protocol Violation|1|||
155693567|NCT04732949|561972270|FG000|Overall Study|Non-compliance|0|||
155693568|NCT04732949|561972271|FG001|Overall Study|Non-compliance|2|||
155693569|NCT04732949|561972270|FG000|Overall Study|Physician Decision|2|||
155693570|NCT04732949|561972271|FG001|Overall Study|Physician Decision|1|||
155693571|NCT04732949|561972270|FG000|Overall Study|Serious adverse event (Fatal)|16|||
155693572|NCT04732949|561972271|FG001|Overall Study|Serious adverse event (Fatal)|18|||
155693573|NCT04732949|561972270|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
155693574|NCT04732949|561972271|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
155693575|NCT04732949|561972270|FG000|Overall Study|Non-serious adverse event|1|||
155693576|NCT04732949|561972271|FG001|Overall Study|Non-serious adverse event|3|||
155693577|NCT04732949|561972270|FG000|Overall Study|Lost to Follow-up|26|||
155693578|NCT04732949|561972271|FG001|Overall Study|Lost to Follow-up|27|||
155693579|NCT04732949|561972270|FG000|Overall Study|Other|6|||
155693580|NCT04732949|561972271|FG001|Overall Study|Other|3|||
155693581|NCT05160766|561972272|FG000|Overall Study|Adverse Event|0|||
155693582|NCT05160766|561972273|FG001|Overall Study|Adverse Event|1|||
155693583|NCT05160766|561972274|FG002|Overall Study|Adverse Event|0|||
155693584|NCT05160766|561972275|FG003|Overall Study|Adverse Event|0|||
155693585|NCT05160766|561972272|FG000|Overall Study|COVID-19 infection|0|||
155693586|NCT05160766|561972273|FG001|Overall Study|COVID-19 infection|1|||
155693587|NCT05160766|561972274|FG002|Overall Study|COVID-19 infection|0|||
155693588|NCT05160766|561972275|FG003|Overall Study|COVID-19 infection|0|||
155693589|NCT05160766|561972272|FG000|Overall Study|travel time|1|||
155693590|NCT05160766|561972273|FG001|Overall Study|travel time|0|||
155693591|NCT05160766|561972274|FG002|Overall Study|travel time|0|||
155693592|NCT05160766|561972275|FG003|Overall Study|travel time|1|||
155693593|NCT05160766|561972272|FG000|Overall Study|Withdrawal by Subject|3|||
155693594|NCT05160766|561972273|FG001|Overall Study|Withdrawal by Subject|5|||
155693595|NCT05160766|561972274|FG002|Overall Study|Withdrawal by Subject|4|||
155693596|NCT05160766|561972275|FG003|Overall Study|Withdrawal by Subject|2|||
155693597|NCT05160766|561972272|FG000|Overall Study|Death|0|||
155693598|NCT05160766|561972273|FG001|Overall Study|Death|0|||
155693599|NCT05160766|561972274|FG002|Overall Study|Death|2|||
155693600|NCT05160766|561972275|FG003|Overall Study|Death|5|||
155693601|NCT05160766|561972272|FG000|Overall Study|Lost to Follow-up|0|||
155693602|NCT05160766|561972273|FG001|Overall Study|Lost to Follow-up|0|||
155693603|NCT05160766|561972274|FG002|Overall Study|Lost to Follow-up|1|||
155693604|NCT05160766|561972275|FG003|Overall Study|Lost to Follow-up|2|||
155693605|NCT05160766|561972272|FG000|Overall Study|No show|0|||
155693606|NCT05160766|561972273|FG001|Overall Study|No show|0|||
155693607|NCT05160766|561972274|FG002|Overall Study|No show|1|||
155693608|NCT05160766|561972275|FG003|Overall Study|No show|1|||
155693609|NCT05160766|561972272|FG000|Overall Study|Physician Decision|0|||
155693610|NCT05160766|561972273|FG001|Overall Study|Physician Decision|0|||
155693611|NCT05160766|561972274|FG002|Overall Study|Physician Decision|0|||
155693612|NCT05160766|561972275|FG003|Overall Study|Physician Decision|1|||
155693613|NCT05160766|561972272|FG000|Overall Study|Protocol Violation|0|||
155693614|NCT05160766|561972273|FG001|Overall Study|Protocol Violation|0|||
155693615|NCT05160766|561972274|FG002|Overall Study|Protocol Violation|1|||
155693616|NCT05160766|561972275|FG003|Overall Study|Protocol Violation|0|||
155693617|NCT01282294|561972276|FG000|Overall Study|Lost to Follow-up|14|||
155693618|NCT01282294|561972276|FG000|Overall Study|Screening failure|1|||
155693619|NCT01282294|561972276|FG000|Overall Study|Adverse Event|1|||
155721203|NCT05435339|562077782|FG003|Overall Study|Sponsor Decision|0|||
155721204|NCT05435339|562077783|FG004|Overall Study|Sponsor Decision|2|||
155721205|NCT05435339|562077784|FG005|Overall Study|Sponsor Decision|1|||
155721206|NCT05435339|562077785|FG006|Overall Study|Sponsor Decision|2|||
155721207|NCT05435339|562077786|FG007|Overall Study|Sponsor Decision|2|||
155721208|NCT05435339|562077779|FG000|Overall Study|Withdrawal by Subject|0|||
155721209|NCT05435339|562077780|FG001|Overall Study|Withdrawal by Subject|0|||
155721210|NCT05435339|562077781|FG002|Overall Study|Withdrawal by Subject|0|||
155693620|NCT01282294|561972276|FG000|Overall Study|Patient non-compliance|2|||
155693621|NCT01282294|561972276|FG000|Overall Study|Physician Decision|1|||
155693622|NCT04030962|561972283|FG000|Stage 2|Adverse Event|0|||
155693623|NCT04030962|561972284|FG001|Stage 2|Adverse Event|0|||
155693624|NCT04030962|561972285|FG002|Stage 2|Adverse Event|0|||
155693625|NCT04030962|561972286|FG003|Stage 2|Adverse Event|0|||
155693626|NCT04030962|561972287|FG004|Stage 2|Adverse Event|0|||
155693627|NCT04030962|561972288|FG005|Stage 2|Adverse Event|0|||
155693628|NCT04030962|561972289|FG006|Stage 2|Adverse Event|0|||
155693629|NCT04030962|561972290|FG007|Stage 2|Adverse Event|0|||
155693630|NCT04030962|561972291|FG008|Stage 2|Adverse Event|1|||
155693631|NCT04030962|561972292|FG009|Stage 2|Adverse Event|0|||
155693632|NCT04030962|561972293|FG010|Stage 2|Adverse Event|1|||
155693633|NCT04030962|561972294|FG011|Stage 2|Adverse Event|1|||
155693634|NCT04030962|561972295|FG012|Stage 2|Adverse Event|1|||
155693635|NCT04030962|561972283|FG000|Stage 2|Withdrawal by Subject|0|||
155693636|NCT04030962|561972284|FG001|Stage 2|Withdrawal by Subject|0|||
155693637|NCT04030962|561972285|FG002|Stage 2|Withdrawal by Subject|0|||
155693638|NCT04030962|561972286|FG003|Stage 2|Withdrawal by Subject|0|||
155693639|NCT04030962|561972287|FG004|Stage 2|Withdrawal by Subject|0|||
155693640|NCT04030962|561972288|FG005|Stage 2|Withdrawal by Subject|0|||
155693641|NCT04030962|561972289|FG006|Stage 2|Withdrawal by Subject|0|||
155693642|NCT04030962|561972290|FG007|Stage 2|Withdrawal by Subject|0|||
155693643|NCT04030962|561972291|FG008|Stage 2|Withdrawal by Subject|1|||
155693644|NCT04030962|561972292|FG009|Stage 2|Withdrawal by Subject|0|||
155693645|NCT04030962|561972293|FG010|Stage 2|Withdrawal by Subject|0|||
155693646|NCT04030962|561972294|FG011|Stage 2|Withdrawal by Subject|2|||
155693647|NCT04030962|561972295|FG012|Stage 2|Withdrawal by Subject|1|||
155693648|NCT04030962|561972283|FG000|Stage 2|Lost to Follow-up|0|||
155693649|NCT04030962|561972284|FG001|Stage 2|Lost to Follow-up|0|||
155693650|NCT04030962|561972285|FG002|Stage 2|Lost to Follow-up|0|||
155693651|NCT04030962|561972286|FG003|Stage 2|Lost to Follow-up|0|||
155693652|NCT04030962|561972287|FG004|Stage 2|Lost to Follow-up|0|||
155693653|NCT04030962|561972288|FG005|Stage 2|Lost to Follow-up|0|||
155693654|NCT04030962|561972289|FG006|Stage 2|Lost to Follow-up|0|||
155693655|NCT04030962|561972290|FG007|Stage 2|Lost to Follow-up|0|||
155693656|NCT04030962|561972291|FG008|Stage 2|Lost to Follow-up|1|||
155693657|NCT04030962|561972292|FG009|Stage 2|Lost to Follow-up|0|||
155693658|NCT04030962|561972293|FG010|Stage 2|Lost to Follow-up|0|||
155693659|NCT04030962|561972294|FG011|Stage 2|Lost to Follow-up|0|||
155693660|NCT04030962|561972295|FG012|Stage 2|Lost to Follow-up|0|||
155693661|NCT04030962|561972283|FG000|Stage 2|Technical Problems|0|||
155693662|NCT04030962|561972284|FG001|Stage 2|Technical Problems|0|||
155693663|NCT04030962|561972285|FG002|Stage 2|Technical Problems|0|||
155693664|NCT04030962|561972286|FG003|Stage 2|Technical Problems|0|||
155693665|NCT04030962|561972287|FG004|Stage 2|Technical Problems|0|||
155693666|NCT04030962|561972288|FG005|Stage 2|Technical Problems|0|||
155693667|NCT04030962|561972289|FG006|Stage 2|Technical Problems|0|||
155693668|NCT04030962|561972290|FG007|Stage 2|Technical Problems|0|||
155693669|NCT04030962|561972291|FG008|Stage 2|Technical Problems|0|||
155693670|NCT04030962|561972292|FG009|Stage 2|Technical Problems|0|||
155693671|NCT04030962|561972293|FG010|Stage 2|Technical Problems|0|||
155693672|NCT04030962|561972294|FG011|Stage 2|Technical Problems|1|||
155693673|NCT04030962|561972295|FG012|Stage 2|Technical Problems|0|||
155693674|NCT05601102|561972296|FG000|Overall Study|Death|1|||
155693675|NCT05601102|561972297|FG001|Overall Study|Death|2|||
155693676|NCT05601102|561972296|FG000|Overall Study|Withdrawal by Subject|1|||
155693677|NCT05601102|561972297|FG001|Overall Study|Withdrawal by Subject|1|||
155693678|NCT05601102|561972296|FG000|Overall Study|Lost to Follow-up|0|||
155693679|NCT05601102|561972297|FG001|Overall Study|Lost to Follow-up|2|||
155693680|NCT04284813|561972304|FG000|Overall Study|Withdrawal by Subject|1|||
155693681|NCT03106415|561972305|FG000|Phase 1|Withdrawal by Subject|1|||
155693682|NCT03106415|561972306|FG001|Phase 1|Withdrawal by Subject|0|||
155693683|NCT03106415|561972307|FG002|Phase 1|Withdrawal by Subject|0|||
155693684|NCT03106415|561972305|FG000|Phase 1|Adverse Event|1|||
155693685|NCT03106415|561972306|FG001|Phase 1|Adverse Event|1|||
155693686|NCT03106415|561972307|FG002|Phase 1|Adverse Event|0|||
155693687|NCT03106415|561972305|FG000|Phase 1|Protocol Violation|0|||
155693688|NCT03106415|561972306|FG001|Phase 1|Protocol Violation|1|||
155693689|NCT03106415|561972307|FG002|Phase 1|Protocol Violation|0|||
155693693|NCT01804582|561972309|FG000|Overall Study|Lost to Follow-up|47|||
155693694|NCT01804582|561972310|FG001|Overall Study|Lost to Follow-up|56|||
155693695|NCT01804582|561972309|FG000|Overall Study|Physician Decision|2|||
155693696|NCT01804582|561972310|FG001|Overall Study|Physician Decision|0|||
155693697|NCT00385723|561972312|FG000|Overall Study|Lost to Follow-up|1|||
155693698|NCT00385723|561972313|FG001|Overall Study|Lost to Follow-up|1|||
155693699|NCT00385723|561972314|FG002|Overall Study|Lost to Follow-up|0|||
155693700|NCT00385723|561972312|FG000|Overall Study|Withdrawal by Subject|1|||
155693701|NCT00385723|561972313|FG001|Overall Study|Withdrawal by Subject|0|||
155693702|NCT00385723|561972314|FG002|Overall Study|Withdrawal by Subject|2|||
155693703|NCT01390779|561972315|FG000|Overall Study|Physician Decision|1|||
155693704|NCT03455829|561972316|FG000|Overall Study|Death|2|||
155693705|NCT03455829|561972317|FG001|Overall Study|Death|3|||
155693706|NCT03455829|561972318|FG002|Overall Study|Death|2|||
155693707|NCT03455829|561972319|FG003|Overall Study|Death|4|||
155693708|NCT03455829|561972320|FG004|Overall Study|Death|2|||
155693709|NCT03455829|561972316|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
155693710|NCT03455829|561972317|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
155693711|NCT03455829|561972318|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
155693712|NCT03455829|561972319|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
155693713|NCT03455829|561972320|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
155693714|NCT03455829|561972316|FG000|Overall Study|Disease progression|0|||
155693715|NCT03455829|561972317|FG001|Overall Study|Disease progression|0|||
155693716|NCT03455829|561972318|FG002|Overall Study|Disease progression|0|||
155693717|NCT03455829|561972319|FG003|Overall Study|Disease progression|1|||
155693718|NCT03455829|561972320|FG004|Overall Study|Disease progression|1|||
155693719|NCT03689712|561972332|FG000|Overall Study|Adverse Event|1|||
155693720|NCT03689712|561972333|FG001|Overall Study|Adverse Event|0|||
155693721|NCT03689712|561972332|FG000|Overall Study|Death|20|||
155693722|NCT03689712|561972333|FG001|Overall Study|Death|10|||
155693723|NCT03689712|561972332|FG000|Overall Study|Lost to Follow-up|6|||
155693724|NCT03689712|561972333|FG001|Overall Study|Lost to Follow-up|6|||
155693725|NCT03689712|561972332|FG000|Overall Study|Other|1|||
155693726|NCT03689712|561972333|FG001|Overall Study|Other|0|||
155693727|NCT03689712|561972332|FG000|Overall Study|Patient Non-Compliance|0|||
155693728|NCT03689712|561972333|FG001|Overall Study|Patient Non-Compliance|1|||
155693729|NCT03689712|561972332|FG000|Overall Study|Withdrawal by Subject|20|||
155693730|NCT03689712|561972333|FG001|Overall Study|Withdrawal by Subject|4|||
155693731|NCT03689712|561972332|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
155693732|NCT03689712|561972333|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
155693733|NCT03689712|561972332|FG000|Overall Study|Randomized but not Treated|13|||
155693734|NCT03689712|561972333|FG001|Overall Study|Randomized but not Treated|7|||
155693735|NCT03689712|561972332|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
155693736|NCT03689712|561972333|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
155693737|NCT00689793|561972334|FG000|Overall Study|Lost to Follow-up|4|||
155693738|NCT00689793|561972335|FG001|Overall Study|Lost to Follow-up|5|||
155693739|NCT00875056|561972345|FG000|Overall Study|Adverse Event|6|||
155693740|NCT00875056|561972346|FG001|Overall Study|Adverse Event|1|||
155693741|NCT00875056|561972347|FG002|Overall Study|Adverse Event|2|||
155693742|NCT00875056|561972345|FG000|Overall Study|Progressive Disease|14|||
155693743|NCT00875056|561972346|FG001|Overall Study|Progressive Disease|8|||
155693744|NCT00875056|561972347|FG002|Overall Study|Progressive Disease|3|||
155693745|NCT00875056|561972345|FG000|Overall Study|Withdrawal by Subject|3|||
155693746|NCT00875056|561972346|FG001|Overall Study|Withdrawal by Subject|0|||
155693747|NCT00875056|561972347|FG002|Overall Study|Withdrawal by Subject|1|||
155693748|NCT00708734|561972348|FG000|Overall Study|scheduling conflict|2|||
155693749|NCT00708734|561972348|FG000|Overall Study|moved|1|||
155693750|NCT00708734|561972348|FG000|Overall Study|leg injury|1|||
155693751|NCT00708734|561972348|FG000|Overall Study|knee replacement|1|||
155693752|NCT00708734|561972348|FG000|Overall Study|vertigo|1|||
155693753|NCT00708734|561972348|FG000|Overall Study|leg fracture|1|||
155693754|NCT02634606|561972349|FG000|Overall Study|unable to obtain the drug at start|13|||
155693755|NCT01842581|561972350|FG000|Overall Study|Adverse Event|6|||
155693756|NCT01842581|561972351|FG001|Overall Study|Adverse Event|4|||
155693757|NCT01842581|561972350|FG000|Overall Study|HE breakthrough|26|||
155693758|NCT01842581|561972351|FG001|Overall Study|HE breakthrough|13|||
155693759|NCT01842581|561972350|FG000|Overall Study|Liver transplant|2|||
155693760|NCT01842581|561972351|FG001|Overall Study|Liver transplant|0|||
155693761|NCT01842581|561972350|FG000|Overall Study|Lost to Follow-up|2|||
155693762|NCT01842581|561972351|FG001|Overall Study|Lost to Follow-up|5|||
155693763|NCT01842581|561972350|FG000|Overall Study|Withdrawal by Subject|5|||
155693764|NCT01842581|561972351|FG001|Overall Study|Withdrawal by Subject|7|||
155693765|NCT01842581|561972350|FG000|Overall Study|Other than specified|3|||
155693766|NCT01842581|561972351|FG001|Overall Study|Other than specified|1|||
155693767|NCT01995552|561972352|FG000|Overall Study|Protocol Violation|1|||
155693768|NCT01995552|561972352|FG000|Overall Study|Lack of Efficacy|15|||
155693769|NCT01995552|561972352|FG000|Overall Study|Death|1|||
155693770|NCT00283868|561972355|FG000|Overall Study|Lost to Follow-up|7|||
155693771|NCT00283868|561972356|FG001|Overall Study|Lost to Follow-up|8|||
155693772|NCT00353873|561972357|FG000|Overall Study|Protocol Violation|1|||
155693773|NCT00353873|561972358|FG001|Overall Study|Protocol Violation|2|||
155693774|NCT00353873|561972357|FG000|Overall Study|Exacerbation|1|||
155693775|NCT00353873|561972358|FG001|Overall Study|Exacerbation|0|||
155693776|NCT00353873|561972357|FG000|Overall Study|Adverse Event|1|||
155693777|NCT00353873|561972358|FG001|Overall Study|Adverse Event|0|||
155693778|NCT00353873|561972357|FG000|Overall Study|Physician Decision|2|||
155693779|NCT00353873|561972358|FG001|Overall Study|Physician Decision|0|||
155693780|NCT00353873|561972357|FG000|Overall Study|Withdrawal by Subject|1|||
155606329|NCT01716520|561647631|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155606330|NCT01716520|561647632|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155606331|NCT01716520|561647633|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155606332|NCT01716520|561647634|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155606333|NCT01716520|561647635|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155606334|NCT01716520|561647630|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
155606335|NCT01716520|561647631|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155606336|NCT01716520|561647632|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155606337|NCT01716520|561647633|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155606338|NCT01716520|561647634|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155606339|NCT01716520|561647635|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155606340|NCT01716520|561647630|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155606341|NCT01716520|561647631|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155606342|NCT01716520|561647632|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155606343|NCT01716520|561647633|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155606344|NCT01716520|561647634|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155606345|NCT01716520|561647635|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
155606346|NCT01716520|561647630|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155606347|NCT01716520|561647631|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
155606348|NCT01716520|561647632|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155606349|NCT01716520|561647633|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155606350|NCT01716520|561647634|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155606351|NCT01716520|561647635|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155606352|NCT01716520|561647630|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155606353|NCT01716520|561647631|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155606354|NCT01716520|561647632|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155606355|NCT01716520|561647633|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155606356|NCT01716520|561647634|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155606357|NCT01716520|561647635|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
155606358|NCT01716520|561647630|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155606359|NCT01716520|561647631|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155606360|NCT01716520|561647632|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
155606361|NCT01716520|561647633|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155606362|NCT01716520|561647634|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155606363|NCT01716520|561647635|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155606364|NCT00593606|561647638|FG000|Overall Study|Adverse Event|13|||
155606365|NCT00593606|561647638|FG000|Overall Study|Withdrawal by Subject|1|||
155606366|NCT00593606|561647638|FG000|Overall Study|Protocol Violation|3|||
155606367|NCT00593606|561647638|FG000|Overall Study|Lost to Follow-up|2|||
155606368|NCT00593606|561647638|FG000|Overall Study|Run-In Failure|5|||
155606369|NCT00593606|561647638|FG000|Overall Study|Screen Failure|3|||
155693781|NCT00353873|561972358|FG001|Overall Study|Withdrawal by Subject|1|||
155693782|NCT03743064|561972360|FG000|Overall Study|Adverse Event|7|||
155693783|NCT03743064|561972361|FG001|Overall Study|Adverse Event|9|||
155693784|NCT03743064|561972360|FG000|Overall Study|Death|25|||
155693785|NCT03743064|561972361|FG001|Overall Study|Death|28|||
155693786|NCT03743064|561972360|FG000|Overall Study|Lost to Follow-up|3|||
155693787|NCT03743064|561972361|FG001|Overall Study|Lost to Follow-up|6|||
155693788|NCT03743064|561972360|FG000|Overall Study|Withdrawal by Subject|28|||
155693789|NCT03743064|561972361|FG001|Overall Study|Withdrawal by Subject|25|||
155693790|NCT03743064|561972360|FG000|Overall Study|Physician Decision|2|||
155693791|NCT03743064|561972361|FG001|Overall Study|Physician Decision|4|||
155693792|NCT03743064|561972360|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
155693793|NCT03743064|561972361|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
155693794|NCT00870194|561972362|FG000|Overall Study|Adverse Event|10|||
155693795|NCT00870194|561972363|FG001|Overall Study|Adverse Event|5|||
155693796|NCT00870194|561972362|FG000|Overall Study|Lack of Efficacy|0|||
155693797|NCT00870194|561972363|FG001|Overall Study|Lack of Efficacy|1|||
155693798|NCT00870194|561972362|FG000|Overall Study|Lost to Follow-up|2|||
155693799|NCT00870194|561972363|FG001|Overall Study|Lost to Follow-up|0|||
155693800|NCT00870194|561972362|FG000|Overall Study|Physician Decision|3|||
155693801|NCT00870194|561972363|FG001|Overall Study|Physician Decision|1|||
155693802|NCT00870194|561972362|FG000|Overall Study|Protocol Violation|3|||
155693803|NCT00870194|561972363|FG001|Overall Study|Protocol Violation|3|||
155693804|NCT00870194|561972362|FG000|Overall Study|Entry Criteria Not Met|1|||
155693805|NCT00870194|561972363|FG001|Overall Study|Entry Criteria Not Met|2|||
155693806|NCT00870194|561972362|FG000|Overall Study|Subject Decision|7|||
155693807|NCT00870194|561972363|FG001|Overall Study|Subject Decision|2|||
155693808|NCT02573246|561972365|FG000|Overall Study|Lost to Follow-up|2|||
155693809|NCT02573246|561972366|FG001|Overall Study|Lost to Follow-up|0|||
155693810|NCT02573246|561972367|FG002|Overall Study|Lost to Follow-up|0|||
155693811|NCT02573246|561972368|FG003|Overall Study|Lost to Follow-up|0|||
155693812|NCT02573246|561972369|FG004|Overall Study|Lost to Follow-up|1|||
155693813|NCT02573246|561972365|FG000|Overall Study|Withdrawal by Subject|0|||
155693814|NCT02573246|561972366|FG001|Overall Study|Withdrawal by Subject|0|||
155693815|NCT02573246|561972367|FG002|Overall Study|Withdrawal by Subject|0|||
155693816|NCT02573246|561972368|FG003|Overall Study|Withdrawal by Subject|0|||
155693817|NCT02573246|561972369|FG004|Overall Study|Withdrawal by Subject|1|||
155693818|NCT02573246|561972365|FG000|Overall Study|Physician Decision|1|||
155693819|NCT02573246|561972366|FG001|Overall Study|Physician Decision|1|||
155693820|NCT02573246|561972367|FG002|Overall Study|Physician Decision|3|||
155693821|NCT02573246|561972368|FG003|Overall Study|Physician Decision|2|||
155693822|NCT02573246|561972369|FG004|Overall Study|Physician Decision|2|||
155693823|NCT03149003|561972370|FG000|Overall Study|Randomized but not treated|0|||
155693824|NCT03149003|561972371|FG001|Overall Study|Randomized but not treated|1|||
155693825|NCT03149003|561972372|FG002|Overall Study|Randomized but not treated|18|||
155693826|NCT01443130|561972373|FG000|Overall Study|Lost to Follow-up|44|||
155693827|NCT01443130|561972374|FG001|Overall Study|Lost to Follow-up|42|||
155693828|NCT01443130|561972375|FG002|Overall Study|Lost to Follow-up|50|||
155693829|NCT01443130|561972376|FG003|Overall Study|Lost to Follow-up|23|||
155693830|NCT01443130|561972377|FG004|Overall Study|Lost to Follow-up|25|||
155693831|NCT01443130|561972378|FG005|Overall Study|Lost to Follow-up|21|||
155693832|NCT01443130|561972373|FG000|Overall Study|Death|0|||
155693833|NCT01443130|561972374|FG001|Overall Study|Death|1|||
155693834|NCT01443130|561972375|FG002|Overall Study|Death|0|||
155693835|NCT01443130|561972376|FG003|Overall Study|Death|7|||
155693836|NCT01443130|561972377|FG004|Overall Study|Death|10|||
155693837|NCT01443130|561972378|FG005|Overall Study|Death|8|||
155693838|NCT01443130|561972373|FG000|Overall Study|Adverse Event|2|||
155693839|NCT01443130|561972374|FG001|Overall Study|Adverse Event|1|||
155693840|NCT01443130|561972375|FG002|Overall Study|Adverse Event|1|||
155693841|NCT01443130|561972376|FG003|Overall Study|Adverse Event|0|||
155693842|NCT01443130|561972377|FG004|Overall Study|Adverse Event|0|||
155693843|NCT01443130|561972378|FG005|Overall Study|Adverse Event|0|||
155693844|NCT01443130|561972373|FG000|Overall Study|Protocol Violation|2|||
155693845|NCT01443130|561972374|FG001|Overall Study|Protocol Violation|1|||
155693846|NCT01443130|561972375|FG002|Overall Study|Protocol Violation|3|||
155693847|NCT01443130|561972376|FG003|Overall Study|Protocol Violation|2|||
155693848|NCT01443130|561972377|FG004|Overall Study|Protocol Violation|2|||
155693849|NCT01443130|561972378|FG005|Overall Study|Protocol Violation|3|||
155693850|NCT01443130|561972373|FG000|Overall Study|Withdrawal by Subject|15|||
155693851|NCT01443130|561972374|FG001|Overall Study|Withdrawal by Subject|14|||
155693852|NCT01443130|561972375|FG002|Overall Study|Withdrawal by Subject|12|||
155693853|NCT01443130|561972376|FG003|Overall Study|Withdrawal by Subject|7|||
155693854|NCT01443130|561972377|FG004|Overall Study|Withdrawal by Subject|7|||
155693855|NCT01443130|561972378|FG005|Overall Study|Withdrawal by Subject|2|||
155693856|NCT01443130|561972373|FG000|Overall Study|Death of Subject's Infant|5|||
155693857|NCT01443130|561972374|FG001|Overall Study|Death of Subject's Infant|10|||
155693858|NCT01443130|561972375|FG002|Overall Study|Death of Subject's Infant|11|||
155693859|NCT01443130|561972376|FG003|Overall Study|Death of Subject's Infant|0|||
155693860|NCT01443130|561972377|FG004|Overall Study|Death of Subject's Infant|0|||
155693861|NCT01443130|561972378|FG005|Overall Study|Death of Subject's Infant|0|||
155693862|NCT00364533|561972379|FG000|Overall Study|Adverse Event|8|||
155693863|NCT00364533|561972380|FG001|Overall Study|Adverse Event|7|||
155693864|NCT00364533|561972381|FG002|Overall Study|Adverse Event|15|||
155693865|NCT00364533|561972382|FG003|Overall Study|Adverse Event|5|||
155693866|NCT00364533|561972383|FG004|Overall Study|Adverse Event|2|||
155693867|NCT00364533|561972379|FG000|Overall Study|Withdrawal by Subject|4|||
155693868|NCT00364533|561972380|FG001|Overall Study|Withdrawal by Subject|8|||
155693869|NCT00364533|561972381|FG002|Overall Study|Withdrawal by Subject|6|||
155693870|NCT00364533|561972382|FG003|Overall Study|Withdrawal by Subject|6|||
155693871|NCT00364533|561972383|FG004|Overall Study|Withdrawal by Subject|6|||
155693872|NCT00364533|561972379|FG000|Overall Study|Lack of Efficacy|22|||
155693873|NCT00364533|561972380|FG001|Overall Study|Lack of Efficacy|22|||
155693874|NCT00364533|561972381|FG002|Overall Study|Lack of Efficacy|21|||
155693875|NCT00364533|561972382|FG003|Overall Study|Lack of Efficacy|17|||
155693876|NCT00364533|561972383|FG004|Overall Study|Lack of Efficacy|42|||
155693877|NCT00364533|561972379|FG000|Overall Study|Subject discharged from hospital|4|||
155693878|NCT00364533|561972380|FG001|Overall Study|Subject discharged from hospital|1|||
155693879|NCT00364533|561972381|FG002|Overall Study|Subject discharged from hospital|2|||
155693880|NCT00364533|561972382|FG003|Overall Study|Subject discharged from hospital|3|||
155693881|NCT00364533|561972383|FG004|Overall Study|Subject discharged from hospital|1|||
155693882|NCT00364533|561972379|FG000|Overall Study|Variations in drug compliance|2|||
155693883|NCT00364533|561972380|FG001|Overall Study|Variations in drug compliance|1|||
155693884|NCT00364533|561972381|FG002|Overall Study|Variations in drug compliance|1|||
155693885|NCT00364533|561972382|FG003|Overall Study|Variations in drug compliance|0|||
155693886|NCT00364533|561972383|FG004|Overall Study|Variations in drug compliance|0|||
155693887|NCT00364533|561972379|FG000|Overall Study|Non-compliance|1|||
155693888|NCT00364533|561972380|FG001|Overall Study|Non-compliance|0|||
155693889|NCT00364533|561972381|FG002|Overall Study|Non-compliance|0|||
155693890|NCT00364533|561972382|FG003|Overall Study|Non-compliance|0|||
155693891|NCT00364533|561972383|FG004|Overall Study|Non-compliance|0|||
155693892|NCT00364533|561972379|FG000|Overall Study|Protocol Violation|1|||
155693893|NCT00364533|561972380|FG001|Overall Study|Protocol Violation|1|||
155693894|NCT00364533|561972381|FG002|Overall Study|Protocol Violation|0|||
155693895|NCT00364533|561972382|FG003|Overall Study|Protocol Violation|0|||
155693896|NCT00364533|561972383|FG004|Overall Study|Protocol Violation|0|||
155693897|NCT02639338|561972392|FG000|Overall Study|Lost to Follow-up|2|||
155693898|NCT02639338|561972393|FG001|Overall Study|Lost to Follow-up|2|||
155693899|NCT02639338|561972392|FG000|Overall Study|Withdrew Consent|1|||
155693900|NCT02639338|561972393|FG001|Overall Study|Withdrew Consent|2|||
155693901|NCT02639338|561972392|FG000|Overall Study|Death|1|||
155693902|NCT02639338|561972393|FG001|Overall Study|Death|0|||
155693903|NCT02639338|561972392|FG000|Overall Study|Randomized but Not Treated|0|||
155693904|NCT02639338|561972393|FG001|Overall Study|Randomized but Not Treated|1|||
155693905|NCT00493636|561972394|FG000|Overall Study|Withdrawal by Subject|1|||
155693906|NCT00493636|561972395|FG001|Overall Study|Withdrawal by Subject|0|||
155693907|NCT00493636|561972394|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
155693908|NCT00493636|561972395|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
155693909|NCT00493636|561972394|FG000|Overall Study|Mis-randomization|1|||
155693910|NCT00493636|561972395|FG001|Overall Study|Mis-randomization|1|||
155693911|NCT02900170|561972397|FG000|Overall Study|Lost to Follow-up|8|||
155693912|NCT01703065|561972402|FG000|Overall Study|Lack of Efficacy|1|||
155693913|NCT01703065|561972403|FG001|Overall Study|Lack of Efficacy|0|||
155693914|NCT02124772|561972404|FG000|Overall Study|Lack of Efficacy|2|||
155693915|NCT02124772|561972405|FG001|Overall Study|Lack of Efficacy|0|||
155693916|NCT02124772|561972406|FG002|Overall Study|Lack of Efficacy|0|||
155693917|NCT02124772|561972407|FG003|Overall Study|Lack of Efficacy|1|||
155693918|NCT02124772|561972408|FG004|Overall Study|Lack of Efficacy|2|||
155693919|NCT02124772|561972409|FG005|Overall Study|Lack of Efficacy|3|||
155693920|NCT02124772|561972410|FG006|Overall Study|Lack of Efficacy|0|||
155693921|NCT02124772|561972411|FG007|Overall Study|Lack of Efficacy|2|||
155693922|NCT02124772|561972412|FG008|Overall Study|Lack of Efficacy|0|||
155693923|NCT02124772|561972413|FG009|Overall Study|Lack of Efficacy|1|||
155693924|NCT02124772|561972414|FG010|Overall Study|Lack of Efficacy|0|||
155693925|NCT02124772|561972415|FG011|Overall Study|Lack of Efficacy|0|||
155693926|NCT02124772|561972416|FG012|Overall Study|Lack of Efficacy|1|||
155693927|NCT02124772|561972404|FG000|Overall Study|Adverse Event|1|||
155693928|NCT02124772|561972405|FG001|Overall Study|Adverse Event|4|||
155693929|NCT02124772|561972406|FG002|Overall Study|Adverse Event|1|||
155693930|NCT02124772|561972407|FG003|Overall Study|Adverse Event|5|||
155693931|NCT02124772|561972408|FG004|Overall Study|Adverse Event|2|||
155693932|NCT02124772|561972409|FG005|Overall Study|Adverse Event|1|||
155693933|NCT02124772|561972410|FG006|Overall Study|Adverse Event|1|||
155693934|NCT02124772|561972411|FG007|Overall Study|Adverse Event|5|||
155693935|NCT02124772|561972412|FG008|Overall Study|Adverse Event|0|||
155693936|NCT02124772|561972413|FG009|Overall Study|Adverse Event|3|||
155693937|NCT02124772|561972414|FG010|Overall Study|Adverse Event|1|||
155693938|NCT02124772|561972415|FG011|Overall Study|Adverse Event|3|||
155693939|NCT02124772|561972416|FG012|Overall Study|Adverse Event|1|||
155693940|NCT02124772|561972404|FG000|Overall Study|Withdrawal consent|0|||
155693941|NCT02124772|561972405|FG001|Overall Study|Withdrawal consent|1|||
155693942|NCT02124772|561972406|FG002|Overall Study|Withdrawal consent|1|||
155693943|NCT02124772|561972407|FG003|Overall Study|Withdrawal consent|1|||
155693944|NCT02124772|561972408|FG004|Overall Study|Withdrawal consent|0|||
155693945|NCT02124772|561972409|FG005|Overall Study|Withdrawal consent|1|||
155693946|NCT02124772|561972410|FG006|Overall Study|Withdrawal consent|1|||
155693947|NCT02124772|561972411|FG007|Overall Study|Withdrawal consent|0|||
155693948|NCT02124772|561972412|FG008|Overall Study|Withdrawal consent|0|||
155693949|NCT02124772|561972413|FG009|Overall Study|Withdrawal consent|1|||
155693950|NCT02124772|561972414|FG010|Overall Study|Withdrawal consent|0|||
155693951|NCT02124772|561972415|FG011|Overall Study|Withdrawal consent|1|||
155693952|NCT02124772|561972416|FG012|Overall Study|Withdrawal consent|0|||
155693953|NCT02124772|561972404|FG000|Overall Study|Investigator discretion|0|||
155693954|NCT02124772|561972405|FG001|Overall Study|Investigator discretion|2|||
155693955|NCT02124772|561972406|FG002|Overall Study|Investigator discretion|2|||
155693956|NCT02124772|561972407|FG003|Overall Study|Investigator discretion|1|||
155693957|NCT02124772|561972408|FG004|Overall Study|Investigator discretion|1|||
155693958|NCT02124772|561972409|FG005|Overall Study|Investigator discretion|0|||
155693959|NCT02124772|561972410|FG006|Overall Study|Investigator discretion|1|||
155693960|NCT02124772|561972411|FG007|Overall Study|Investigator discretion|0|||
155693961|NCT02124772|561972412|FG008|Overall Study|Investigator discretion|0|||
155693962|NCT02124772|561972413|FG009|Overall Study|Investigator discretion|1|||
155693963|NCT02124772|561972414|FG010|Overall Study|Investigator discretion|0|||
155693964|NCT02124772|561972415|FG011|Overall Study|Investigator discretion|1|||
155693965|NCT02124772|561972416|FG012|Overall Study|Investigator discretion|0|||
155693966|NCT02124772|561972404|FG000|Overall Study|Progressive disease|0|||
155693967|NCT02124772|561972405|FG001|Overall Study|Progressive disease|0|||
155693968|NCT02124772|561972406|FG002|Overall Study|Progressive disease|0|||
155693969|NCT02124772|561972407|FG003|Overall Study|Progressive disease|0|||
155693970|NCT02124772|561972408|FG004|Overall Study|Progressive disease|0|||
155693971|NCT02124772|561972409|FG005|Overall Study|Progressive disease|0|||
155693972|NCT02124772|561972410|FG006|Overall Study|Progressive disease|1|||
155693973|NCT02124772|561972411|FG007|Overall Study|Progressive disease|1|||
155693974|NCT02124772|561972412|FG008|Overall Study|Progressive disease|0|||
155693975|NCT02124772|561972413|FG009|Overall Study|Progressive disease|0|||
155693976|NCT02124772|561972414|FG010|Overall Study|Progressive disease|0|||
155693977|NCT02124772|561972415|FG011|Overall Study|Progressive disease|0|||
155693978|NCT02124772|561972416|FG012|Overall Study|Progressive disease|0|||
155693979|NCT02124772|561972404|FG000|Overall Study|Other|0|||
155693980|NCT02124772|561972405|FG001|Overall Study|Other|7|||
155693981|NCT02124772|561972406|FG002|Overall Study|Other|2|||
155693982|NCT02124772|561972407|FG003|Overall Study|Other|5|||
155693983|NCT02124772|561972408|FG004|Overall Study|Other|4|||
155693984|NCT02124772|561972409|FG005|Overall Study|Other|3|||
155693985|NCT02124772|561972410|FG006|Overall Study|Other|4|||
155693986|NCT02124772|561972411|FG007|Overall Study|Other|1|||
155693987|NCT02124772|561972412|FG008|Overall Study|Other|1|||
155693988|NCT02124772|561972413|FG009|Overall Study|Other|1|||
155693989|NCT02124772|561972414|FG010|Overall Study|Other|1|||
155693990|NCT02124772|561972415|FG011|Overall Study|Other|1|||
155693991|NCT02124772|561972416|FG012|Overall Study|Other|0|||
155693992|NCT01827332|561972417|FG000|Overall Study|Lost to Follow-up|2|||
155693993|NCT01827332|561972418|FG001|Overall Study|Lost to Follow-up|1|||
155693994|NCT02725593|561972419|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
155693995|NCT02725593|561972420|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
155693996|NCT02725593|561972419|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
155693997|NCT02725593|561972420|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
155693998|NCT02725593|561972419|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
155693999|NCT02725593|561972420|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
155694000|NCT02725593|561972419|FG000|Long Term Extension|Withdrawal by Subject|1|||
155694001|NCT02725593|561972420|FG001|Long Term Extension|Withdrawal by Subject|3|||
155694002|NCT02698371|561972421|FG000|All Participants Flow|Lost to Follow-up|3|||
155694003|NCT02698371|561972421|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
155694004|NCT02698371|561972421|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
155694005|NCT02698371|561972421|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
155694006|NCT02698371|561972421|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
155694007|NCT02698371|561972421|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
155694008|NCT02698371|561972421|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
155694009|NCT01440881|561972427|FG000|Overall Study|Death|0|||
155694010|NCT01440881|561972428|FG001|Overall Study|Death|1|||
155694011|NCT02290938|561972429|FG000|Overall Study|Lost to Follow-up|14|||
155694012|NCT02290938|561972430|FG001|Overall Study|Lost to Follow-up|43|||
155694013|NCT01825941|561973512|FG000|Overall Study|Lost to Follow-up|4|||
155694014|NCT01825941|561973513|FG001|Overall Study|Lost to Follow-up|1|||
155694015|NCT03938324|561973521|FG000|Overall Study|Lost to Follow-up|42|||
155694016|NCT03938324|561973522|FG001|Overall Study|Lost to Follow-up|21|||
155694017|NCT03938324|561973521|FG000|Overall Study|Withdrawal by Subject|6|||
155694018|NCT03938324|561973522|FG001|Overall Study|Withdrawal by Subject|1|||
155694019|NCT02769962|561973523|FG000|Overall Study|Physician Decision|0|||
155694020|NCT02769962|561973524|FG001|Overall Study|Physician Decision|0|||
155694021|NCT02769962|561973525|FG002|Overall Study|Physician Decision|0|||
155694022|NCT02769962|561973526|FG003|Overall Study|Physician Decision|0|||
155694023|NCT02769962|561973527|FG004|Overall Study|Physician Decision|0|||
155694024|NCT02769962|561973528|FG005|Overall Study|Physician Decision|1|||
155694025|NCT02769962|561973529|FG006|Overall Study|Physician Decision|0|||
155694026|NCT02769962|561973530|FG007|Overall Study|Physician Decision|1|||
155694027|NCT02769962|561973523|FG000|Overall Study|Refused further treatment|0|||
155694028|NCT02769962|561973524|FG001|Overall Study|Refused further treatment|0|||
155694029|NCT02769962|561973525|FG002|Overall Study|Refused further treatment|0|||
155694030|NCT02769962|561973526|FG003|Overall Study|Refused further treatment|0|||
155694031|NCT02769962|561973527|FG004|Overall Study|Refused further treatment|0|||
155694032|NCT02769962|561973528|FG005|Overall Study|Refused further treatment|1|||
155694033|NCT02769962|561973529|FG006|Overall Study|Refused further treatment|1|||
155694034|NCT02769962|561973530|FG007|Overall Study|Refused further treatment|0|||
155694035|NCT05565937|561973531|FG000|Overall Study|Adverse Event|0|||
155694036|NCT05565937|561973532|FG001|Overall Study|Adverse Event|1|||
155694037|NCT05565937|561973531|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
155694038|NCT05565937|561973532|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
155694039|NCT05565937|561973531|FG000|Overall Study|Lost to Follow-up|2|||
155694040|NCT05565937|561973532|FG001|Overall Study|Lost to Follow-up|0|||
155694041|NCT05565937|561973531|FG000|Overall Study|Pregnancy|0|||
155694042|NCT05565937|561973532|FG001|Overall Study|Pregnancy|2|||
155694043|NCT05565937|561973531|FG000|Overall Study|Anisometropia|0|||
155694044|NCT05565937|561973532|FG001|Overall Study|Anisometropia|1|||
155694045|NCT01286077|561973533|FG000|Overall Study|Adverse Event|2|||
155694046|NCT01286077|561973534|FG001|Overall Study|Adverse Event|0|||
155694047|NCT01286077|561973533|FG000|Overall Study|Death|1|||
155694048|NCT01286077|561973534|FG001|Overall Study|Death|0|||
155694049|NCT01286077|561973533|FG000|Overall Study|Protocol Violation|1|||
155694050|NCT01286077|561973534|FG001|Overall Study|Protocol Violation|1|||
155694051|NCT01286077|561973533|FG000|Overall Study|Withdrawal by Subject|0|||
155694052|NCT01286077|561973534|FG001|Overall Study|Withdrawal by Subject|2|||
155694053|NCT01286077|561973533|FG000|Overall Study|Intercurrent illness|1|||
155694054|NCT01286077|561973534|FG001|Overall Study|Intercurrent illness|0|||
155694055|NCT01286077|561973533|FG000|Overall Study|Non-compliance|1|||
155694056|NCT01286077|561973534|FG001|Overall Study|Non-compliance|0|||
155694057|NCT01286077|561973533|FG000|Overall Study|The subject starts with alternative MMY|0|||
155694058|NCT01286077|561973534|FG001|Overall Study|The subject starts with alternative MMY|3|||
155694059|NCT01286077|561973533|FG000|Overall Study|Patient's decision to stop treatment|3|||
155694060|NCT01286077|561973534|FG001|Overall Study|Patient's decision to stop treatment|0|||
155694061|NCT01286077|561973533|FG000|Overall Study|Progression of disease|0|||
155694062|NCT01286077|561973534|FG001|Overall Study|Progression of disease|1|||
155694063|NCT01286077|561973533|FG000|Overall Study|refill medication not received in time|1|||
155694064|NCT01286077|561973534|FG001|Overall Study|refill medication not received in time|0|||
155694065|NCT02797184|561973539|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
155694066|NCT02797184|561973540|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
155694067|NCT02212678|561973552|FG000|Overall Study|Adverse Event|1|||
155694068|NCT06250738|561973553|FG000|Overall Study|Lost to Follow-up|1|||
155694069|NCT05288166|561973556|FG000|Overall Study|Adverse Event|1|||
155694070|NCT05288166|561973557|FG001|Overall Study|Adverse Event|0|||
155694071|NCT05288166|561973556|FG000|Overall Study|Lost to Follow-up|2|||
155694072|NCT05288166|561973557|FG001|Overall Study|Lost to Follow-up|0|||
155694073|NCT05288166|561973556|FG000|Overall Study|Physician Decision|0|||
155694074|NCT05288166|561973557|FG001|Overall Study|Physician Decision|2|||
155694075|NCT05288166|561973556|FG000|Overall Study|Screen Failure|1|||
155694076|NCT05288166|561973557|FG001|Overall Study|Screen Failure|1|||
155694077|NCT05288166|561973556|FG000|Overall Study|Withdrawal by Subject|4|||
155694078|NCT05288166|561973557|FG001|Overall Study|Withdrawal by Subject|2|||
155694079|NCT05288166|561973556|FG000|Overall Study|On Study Treatment|408|||
155694080|NCT05288166|561973557|FG001|Overall Study|On Study Treatment|418|||
155694081|NCT01114360|561973558|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
155694082|NCT01114360|561973559|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
155694083|NCT03344172|561973560|FG000|Overall Study|Received <1 dose of treatment|1|||
155694084|NCT03344172|561973561|FG001|Overall Study|Received <1 dose of treatment|0|||
155694085|NCT00673881|561973562|FG000|Overall Study|Withdrawal by Subject|1|||
155694086|NCT01299571|561973563|FG000|Overall Study|Protocol Violation|107|||
155694087|NCT00413010|561973564|FG000|Overall Study|Adverse Event|8|||
155694088|NCT00413010|561973565|FG001|Overall Study|Adverse Event|4|||
155694089|NCT00413010|561973564|FG000|Overall Study|Laboratory abnormality|0|||
155694090|NCT00413010|561973565|FG001|Overall Study|Laboratory abnormality|2|||
155606370|NCT00869557|561647639|FG000|Randomized Phase|Lost to Follow-up|2|||
155606371|NCT00869557|561647640|FG001|Randomized Phase|Lost to Follow-up|1|||
155606372|NCT00869557|561647639|FG000|Randomized Phase|Investigator's Discretion|1|||
155606373|NCT00869557|561647640|FG001|Randomized Phase|Investigator's Discretion|0|||
155606374|NCT00869557|561647639|FG000|Randomized Phase|Withdrew Consent|0|||
155606375|NCT00869557|561647640|FG001|Randomized Phase|Withdrew Consent|1|||
155606376|NCT00869557|561647639|FG000|Extension Phase|Adverse Event|2|||
155606377|NCT00869557|561647640|FG001|Extension Phase|Adverse Event|2|||
155606378|NCT00869557|561647639|FG000|Extension Phase|Lack of Efficacy|1|||
155606379|NCT00869557|561647640|FG001|Extension Phase|Lack of Efficacy|0|||
155606380|NCT00869557|561647639|FG000|Extension Phase|Lost to Follow-up|3|||
155606381|NCT00869557|561647640|FG001|Extension Phase|Lost to Follow-up|1|||
155606382|NCT00869557|561647639|FG000|Extension Phase|Investigator's Discretion|2|||
155606383|NCT00869557|561647640|FG001|Extension Phase|Investigator's Discretion|0|||
155606384|NCT00869557|561647639|FG000|Extension Phase|Withdrew Consent|2|||
155606385|NCT00869557|561647640|FG001|Extension Phase|Withdrew Consent|0|||
155606386|NCT02305446|561647641|FG000|Overall Study|Adverse Event|1|||
155606387|NCT05940077|561647642|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
155694091|NCT00413010|561973564|FG000|Overall Study|Lack of Efficacy|0|||
155694092|NCT00413010|561973565|FG001|Overall Study|Lack of Efficacy|3|||
155694093|NCT00413010|561973564|FG000|Overall Study|Lost to Follow-up|3|||
155694094|NCT00413010|561973565|FG001|Overall Study|Lost to Follow-up|0|||
155606388|NCT00388297|561647643|FG000|Overall Study|Lost to Follow-up|16|||
155606389|NCT00388297|561647644|FG001|Overall Study|Lost to Follow-up|12|||
155606390|NCT00388297|561647645|FG002|Overall Study|Lost to Follow-up|11|||
155606391|NCT00388297|561647646|FG003|Overall Study|Lost to Follow-up|8|||
155606392|NCT01492101|561647647|FG000|Overall Study|Death|323|||
155606393|NCT01492101|561647648|FG001|Overall Study|Death|322|||
155606394|NCT01492101|561647647|FG000|Overall Study|Withdrawal by Subject|14|||
155606395|NCT01492101|561647648|FG001|Overall Study|Withdrawal by Subject|18|||
155606396|NCT01492101|561647647|FG000|Overall Study|Lost to Follow-up|0|||
155606397|NCT01492101|561647648|FG001|Overall Study|Lost to Follow-up|2|||
155606398|NCT04105010|561647653|FG000|Overall Study|Death|3|||
155606399|NCT04105010|561647654|FG001|Overall Study|Death|1|||
155606400|NCT04105010|561647655|FG002|Overall Study|Death|1|||
155606401|NCT04105010|561647656|FG003|Overall Study|Death|54|||
155606402|NCT04105010|561647653|FG000|Overall Study|Lost to Follow-up|0|||
155694095|NCT00413010|561973564|FG000|Overall Study|Withdrawal by Subject|7|||
155694096|NCT00413010|561973565|FG001|Overall Study|Withdrawal by Subject|2|||
155694097|NCT00413010|561973564|FG000|Overall Study|Due to termination of the study|54|||
155694098|NCT00413010|561973565|FG001|Overall Study|Due to termination of the study|52|||
155694099|NCT05432167|561973568|FG000|Overall Study|Adverse Event|0|||
155694100|NCT05432167|561973569|FG001|Overall Study|Adverse Event|2|||
155694101|NCT05432167|561973570|FG002|Overall Study|Adverse Event|1|||
155694102|NCT05432167|561973568|FG000|Overall Study|Lost to Follow-up|3|||
155694103|NCT05432167|561973569|FG001|Overall Study|Lost to Follow-up|3|||
155694104|NCT05432167|561973570|FG002|Overall Study|Lost to Follow-up|2|||
155694105|NCT05432167|561973568|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
155694106|NCT05432167|561973569|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
155694107|NCT05432167|561973570|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155694108|NCT05432167|561973568|FG000|Overall Study|Physician Decision|1|||
155694109|NCT05432167|561973569|FG001|Overall Study|Physician Decision|0|||
155694110|NCT05432167|561973570|FG002|Overall Study|Physician Decision|0|||
155694111|NCT05432167|561973568|FG000|Overall Study|Withdrawal by Subject|7|||
155694112|NCT05432167|561973569|FG001|Overall Study|Withdrawal by Subject|4|||
155694113|NCT05432167|561973570|FG002|Overall Study|Withdrawal by Subject|11|||
155694114|NCT05432167|561973568|FG000|Overall Study|Other|0|||
155694115|NCT05432167|561973569|FG001|Overall Study|Other|0|||
155694116|NCT05432167|561973570|FG002|Overall Study|Other|1|||
155694117|NCT01515475|561973571|FG000|Overall Study|Lost to Follow-up|20|||
155694118|NCT01515475|561973572|FG001|Overall Study|Lost to Follow-up|15|||
155694119|NCT01515475|561973573|FG002|Overall Study|Lost to Follow-up|12|||
155694120|NCT01515475|561973574|FG003|Overall Study|Lost to Follow-up|12|||
155694121|NCT01814670|561973575|FG000|Overall Study|Protocol Violation|12|||
155694122|NCT02360293|561973579|FG000|Overall Study|Lost to Follow-up|73|||
155694123|NCT02360293|561973580|FG001|Overall Study|Lost to Follow-up|95|||
155694124|NCT02360293|561973579|FG000|Overall Study|Withdrawal by Subject|2|||
155694125|NCT02360293|561973580|FG001|Overall Study|Withdrawal by Subject|1|||
155694126|NCT02360293|561973579|FG000|Overall Study|Excluded|1|||
155694127|NCT02360293|561973580|FG001|Overall Study|Excluded|0|||
155694128|NCT02012686|561973583|FG000|Overall Study|muscle contraction|0|||
155694129|NCT02012686|561973584|FG001|Overall Study|muscle contraction|1|||
155694130|NCT02012686|561973583|FG000|Overall Study|electrocardiography monitoring noise|0|||
155694131|NCT02012686|561973584|FG001|Overall Study|electrocardiography monitoring noise|1|||
155694132|NCT00966719|561973585|FG000|Overall Study|Lost to Follow-up|6|||
155694133|NCT00966719|561973586|FG001|Overall Study|Lost to Follow-up|11|||
155694134|NCT03242018|561973587|FG000|Overall Study|Adverse Event|7|||
155694135|NCT03242018|561973588|FG001|Overall Study|Adverse Event|7|||
155694136|NCT03242018|561973589|FG002|Overall Study|Adverse Event|6|||
155694137|NCT03242018|561973587|FG000|Overall Study|Lost to Follow-up|2|||
155694138|NCT03242018|561973588|FG001|Overall Study|Lost to Follow-up|2|||
155694139|NCT03242018|561973589|FG002|Overall Study|Lost to Follow-up|2|||
155694140|NCT03242018|561973587|FG000|Overall Study|At the Participant's Own Request|5|||
155694141|NCT03242018|561973588|FG001|Overall Study|At the Participant's Own Request|1|||
155694142|NCT03242018|561973589|FG002|Overall Study|At the Participant's Own Request|4|||
155694143|NCT03242018|561973587|FG000|Overall Study|Reason Not Specified|3|||
155694144|NCT03242018|561973588|FG001|Overall Study|Reason Not Specified|4|||
155694145|NCT03242018|561973589|FG002|Overall Study|Reason Not Specified|1|||
155694146|NCT03242018|561973587|FG000|Overall Study|Study Terminated by Sponsor|1|||
155694147|NCT03242018|561973588|FG001|Overall Study|Study Terminated by Sponsor|0|||
155694148|NCT03242018|561973589|FG002|Overall Study|Study Terminated by Sponsor|1|||
155694149|NCT02635347|561973591|FG000|Overall Study|Failed screening|20|||
155694150|NCT02635347|561973592|FG001|Overall Study|Failed screening|7|||
155694151|NCT03089944|561973593|FG000|Overall Study|Lost to Follow-up|8|||
155694152|NCT03089944|561973593|FG000|Overall Study|Withdrew Consent|2|||
155694153|NCT03089944|561973593|FG000|Overall Study|Adverse Event|1|||
155694154|NCT03089944|561973593|FG000|Overall Study|Other|1|||
155694155|NCT03689244|561973594|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
155694156|NCT03689244|561973595|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
155694157|NCT03689244|561973596|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
155694158|NCT03689244|561973597|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
155694159|NCT03689244|561973594|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
155694160|NCT03689244|561973595|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
155694161|NCT03689244|561973596|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
155694162|NCT03689244|561973597|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
155694163|NCT03689244|561973594|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
155694164|NCT03689244|561973595|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
155694165|NCT03689244|561973596|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
155694166|NCT03689244|561973597|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
155694167|NCT03689244|561973594|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
155694168|NCT03689244|561973595|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
155694169|NCT03689244|561973596|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
155694170|NCT03689244|561973597|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
155694171|NCT03689244|561973594|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
155694172|NCT03689244|561973595|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
155694173|NCT03689244|561973596|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
155694174|NCT03689244|561973597|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
155694175|NCT03689244|561973594|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155694176|NCT03689244|561973595|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155694177|NCT03689244|561973596|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
155694178|NCT03689244|561973597|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155694179|NCT03689244|561973594|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155694180|NCT03689244|561973595|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155694181|NCT03689244|561973596|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
155694182|NCT03689244|561973597|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155694183|NCT03689244|561973594|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
155694184|NCT03689244|561973595|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
155694185|NCT03689244|561973596|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
155694186|NCT03689244|561973597|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
155694187|NCT02308488|561973600|FG000|Overall Study|Withdrawal by Subject|2|||
155694188|NCT01541917|561973601|FG000|Overall Study|Lost to Follow-up|2|||
155694189|NCT01541917|561973602|FG001|Overall Study|Lost to Follow-up|2|||
155694190|NCT01541917|561973601|FG000|Overall Study|Withdrawal by Subject|13|||
155694191|NCT01541917|561973602|FG001|Overall Study|Withdrawal by Subject|7|||
155694192|NCT01739803|561973609|FG000|Overall Study|Lost to Follow-up|9|||
155694193|NCT01739803|561973610|FG001|Overall Study|Lost to Follow-up|6|||
155694194|NCT01565564|561973615|FG000|Overall Study|Lost to Follow-up|5|||
155694195|NCT01565564|561973616|FG001|Overall Study|Lost to Follow-up|1|||
155694196|NCT03759041|561973617|FG000|Overall Study|Withdrawal by Subject|4|||
155694197|NCT03759041|561973618|FG001|Overall Study|Withdrawal by Subject|10|||
155694198|NCT03759041|561973619|FG002|Overall Study|Withdrawal by Subject|10|||
155694199|NCT03759041|561973617|FG000|Overall Study|Adverse Event|1|||
155694200|NCT03759041|561973618|FG001|Overall Study|Adverse Event|3|||
155694201|NCT03759041|561973619|FG002|Overall Study|Adverse Event|4|||
155694202|NCT03759041|561973617|FG000|Overall Study|Lack of Efficacy|0|||
155694203|NCT03759041|561973618|FG001|Overall Study|Lack of Efficacy|0|||
155694204|NCT03759041|561973619|FG002|Overall Study|Lack of Efficacy|1|||
155694205|NCT03759041|561973617|FG000|Overall Study|Study Terminated by Sponsor|15|||
155694206|NCT03759041|561973618|FG001|Overall Study|Study Terminated by Sponsor|16|||
155694207|NCT03759041|561973619|FG002|Overall Study|Study Terminated by Sponsor|10|||
155694208|NCT03759041|561973617|FG000|Overall Study|Other reason for discontinuation|0|||
155694209|NCT03759041|561973618|FG001|Overall Study|Other reason for discontinuation|2|||
155694210|NCT03759041|561973619|FG002|Overall Study|Other reason for discontinuation|1|||
155694211|NCT03759041|561973617|FG000|Overall Study|Lost to Follow-up|7|||
155694212|NCT03759041|561973618|FG001|Overall Study|Lost to Follow-up|2|||
155694213|NCT03759041|561973619|FG002|Overall Study|Lost to Follow-up|2|||
155694214|NCT03759041|561973617|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
155694215|NCT03759041|561973618|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
155694216|NCT03759041|561973619|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
155694217|NCT02449018|561973620|FG000|Overall Study|Abnormal laboratory value|0|||
155694218|NCT02449018|561973621|FG001|Overall Study|Abnormal laboratory value|1|||
155694219|NCT02449018|561973620|FG000|Overall Study|Administrative problems|1|||
155694220|NCT02449018|561973621|FG001|Overall Study|Administrative problems|0|||
155694221|NCT02449018|561973620|FG000|Overall Study|Adverse Event|5|||
155694222|NCT02449018|561973621|FG001|Overall Study|Adverse Event|1|||
155694223|NCT02449018|561973620|FG000|Overall Study|Protocol deviation|4|||
155694224|NCT02449018|561973621|FG001|Overall Study|Protocol deviation|0|||
155694225|NCT02449018|561973620|FG000|Overall Study|Patient decision|2|||
155694226|NCT02449018|561973621|FG001|Overall Study|Patient decision|0|||
155694227|NCT00525824|561973626|FG000|Overall Study|Adverse Event|7|||
155694228|NCT00525824|561973627|FG001|Overall Study|Adverse Event|11|||
155694229|NCT00525824|561973628|FG002|Overall Study|Adverse Event|6|||
155694230|NCT00525824|561973629|FG003|Overall Study|Adverse Event|7|||
155694231|NCT00525824|561973626|FG000|Overall Study|Withdrawal by Subject|5|||
155694232|NCT00525824|561973627|FG001|Overall Study|Withdrawal by Subject|9|||
155694233|NCT00525824|561973628|FG002|Overall Study|Withdrawal by Subject|3|||
155694234|NCT00525824|561973629|FG003|Overall Study|Withdrawal by Subject|4|||
155694235|NCT00525824|561973626|FG000|Overall Study|Lost to Follow-up|4|||
155694236|NCT00525824|561973627|FG001|Overall Study|Lost to Follow-up|2|||
155694237|NCT00525824|561973628|FG002|Overall Study|Lost to Follow-up|4|||
155694238|NCT00525824|561973629|FG003|Overall Study|Lost to Follow-up|0|||
155694239|NCT00525824|561973626|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
155694240|NCT00525824|561973627|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
155694241|NCT00525824|561973628|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
155694242|NCT00525824|561973629|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
155694243|NCT00525824|561973626|FG000|Overall Study|Severe non-compliance|0|||
155694244|NCT00525824|561973627|FG001|Overall Study|Severe non-compliance|1|||
155694245|NCT00525824|561973628|FG002|Overall Study|Severe non-compliance|1|||
155694246|NCT00525824|561973629|FG003|Overall Study|Severe non-compliance|1|||
155694247|NCT00525824|561973626|FG000|Overall Study|Safety reasons|1|||
155694248|NCT00525824|561973627|FG001|Overall Study|Safety reasons|0|||
155694249|NCT00525824|561973628|FG002|Overall Study|Safety reasons|1|||
155694250|NCT00525824|561973629|FG003|Overall Study|Safety reasons|0|||
155694251|NCT00525824|561973626|FG000|Overall Study|Other|1|||
155694252|NCT00525824|561973627|FG001|Overall Study|Other|3|||
155694253|NCT00525824|561973628|FG002|Overall Study|Other|3|||
155694254|NCT00525824|561973629|FG003|Overall Study|Other|1|||
155694255|NCT05011513|561974943|FG000|Overall Study|Death|0|||
155694256|NCT05011513|561974944|FG001|Overall Study|Death|1|||
155694257|NCT05011513|561974943|FG000|Overall Study|Lost to Follow-up|4|||
155694258|NCT05011513|561974944|FG001|Overall Study|Lost to Follow-up|0|||
155694259|NCT05011513|561974943|FG000|Overall Study|Withdrawal by Subject|18|||
155694260|NCT05011513|561974944|FG001|Overall Study|Withdrawal by Subject|17|||
155694261|NCT05011513|561974943|FG000|Overall Study|Other|4|||
155694262|NCT05011513|561974944|FG001|Overall Study|Other|2|||
155694263|NCT03495102|561974945|FG000|Overall Study|Adverse Event|5|||
155694264|NCT03495102|561974946|FG001|Overall Study|Adverse Event|7|||
155694265|NCT03495102|561974947|FG002|Overall Study|Adverse Event|10|||
155694266|NCT03495102|561974945|FG000|Overall Study|Death|3|||
155694267|NCT03495102|561974946|FG001|Overall Study|Death|4|||
155694268|NCT03495102|561974947|FG002|Overall Study|Death|4|||
155694269|NCT03495102|561974945|FG000|Overall Study|Lost to Follow-up|15|||
155694270|NCT03495102|561974946|FG001|Overall Study|Lost to Follow-up|16|||
155694271|NCT03495102|561974947|FG002|Overall Study|Lost to Follow-up|17|||
155694272|NCT03495102|561974945|FG000|Overall Study|Physician Decision|2|||
155694273|NCT03495102|561974946|FG001|Overall Study|Physician Decision|0|||
155694274|NCT03495102|561974947|FG002|Overall Study|Physician Decision|2|||
155694275|NCT03495102|561974945|FG000|Overall Study|Withdrawal by Subject|25|||
155694276|NCT03495102|561974946|FG001|Overall Study|Withdrawal by Subject|36|||
155694277|NCT03495102|561974947|FG002|Overall Study|Withdrawal by Subject|18|||
155694278|NCT03495102|561974945|FG000|Overall Study|Protocol Violation|1|||
155694279|NCT03495102|561974946|FG001|Overall Study|Protocol Violation|1|||
155694280|NCT03495102|561974947|FG002|Overall Study|Protocol Violation|0|||
155694281|NCT03495102|561974945|FG000|Overall Study|Site Closure|3|||
155694282|NCT03495102|561974946|FG001|Overall Study|Site Closure|1|||
155694283|NCT03495102|561974947|FG002|Overall Study|Site Closure|2|||
155694284|NCT03495102|561974945|FG000|Overall Study|Non-compliance|1|||
155694285|NCT03495102|561974946|FG001|Overall Study|Non-compliance|0|||
155694286|NCT03495102|561974947|FG002|Overall Study|Non-compliance|0|||
155694287|NCT03495102|561974945|FG000|Overall Study|Participant Duplicated at Another Site|0|||
155694288|NCT03495102|561974946|FG001|Overall Study|Participant Duplicated at Another Site|0|||
155694289|NCT03495102|561974947|FG002|Overall Study|Participant Duplicated at Another Site|1|||
155694290|NCT03495102|561974945|FG000|Overall Study|Primary Care Physician Recommendation|0|||
155694291|NCT03495102|561974946|FG001|Overall Study|Primary Care Physician Recommendation|1|||
155694292|NCT03495102|561974947|FG002|Overall Study|Primary Care Physician Recommendation|0|||
155694293|NCT03495102|561974945|FG000|Overall Study|Relocated to Another Country|0|||
155694294|NCT03495102|561974946|FG001|Overall Study|Relocated to Another Country|1|||
155694295|NCT03495102|561974947|FG002|Overall Study|Relocated to Another Country|0|||
155694296|NCT03495102|561974945|FG000|Overall Study|Participant was in Rehabilitation|1|||
155694297|NCT03495102|561974946|FG001|Overall Study|Participant was in Rehabilitation|0|||
155694298|NCT03495102|561974947|FG002|Overall Study|Participant was in Rehabilitation|0|||
155694299|NCT01161537|561974953|FG000|Part B|Withdrawal by Subject|2|||
155694300|NCT00358436|561974956|FG000|Overall Study|Adverse Event|29|||
155694301|NCT00358436|561974957|FG001|Overall Study|Adverse Event|13|||
155694302|NCT00358436|561974956|FG000|Overall Study|Lack of Efficacy|34|||
155694303|NCT00358436|561974957|FG001|Overall Study|Lack of Efficacy|36|||
155694304|NCT00358436|561974956|FG000|Overall Study|Lost to Follow-up|11|||
155694305|NCT00358436|561974957|FG001|Overall Study|Lost to Follow-up|6|||
155694306|NCT00358436|561974956|FG000|Overall Study|Protocol Violation|8|||
155694307|NCT00358436|561974957|FG001|Overall Study|Protocol Violation|3|||
155694308|NCT00358436|561974956|FG000|Overall Study|Withdrawal by Subject|40|||
155694309|NCT00358436|561974957|FG001|Overall Study|Withdrawal by Subject|17|||
155606403|NCT04105010|561647654|FG001|Overall Study|Lost to Follow-up|0|||
155606404|NCT04105010|561647655|FG002|Overall Study|Lost to Follow-up|0|||
155606405|NCT04105010|561647656|FG003|Overall Study|Lost to Follow-up|4|||
155606406|NCT04105010|561647653|FG000|Overall Study|Withdrawal by Subject|8|||
155606407|NCT04105010|561647654|FG001|Overall Study|Withdrawal by Subject|1|||
155606408|NCT04105010|561647655|FG002|Overall Study|Withdrawal by Subject|1|||
155606409|NCT04105010|561647656|FG003|Overall Study|Withdrawal by Subject|4|||
155606410|NCT04105010|561647653|FG000|Overall Study|Other reason|4|||
155606411|NCT04105010|561647654|FG001|Overall Study|Other reason|7|||
155606412|NCT04105010|561647655|FG002|Overall Study|Other reason|0|||
155606413|NCT04105010|561647656|FG003|Overall Study|Other reason|19|||
155606414|NCT01211483|561647657|FG000|Phase 1b|Death|6|||
155606415|NCT01211483|561647658|FG001|Phase 1b|Death|0|||
155606416|NCT01211483|561647659|FG002|Phase 1b|Death|0|||
155606417|NCT01211483|561647660|FG003|Phase 1b|Death|0|||
155606418|NCT01211483|561647657|FG000|Phase 1b|Withdrawal by Subject|1|||
155606419|NCT01211483|561647658|FG001|Phase 1b|Withdrawal by Subject|0|||
155606420|NCT01211483|561647659|FG002|Phase 1b|Withdrawal by Subject|0|||
155606421|NCT01211483|561647660|FG003|Phase 1b|Withdrawal by Subject|0|||
155606422|NCT01211483|561647657|FG000|Phase 2|Lost to Follow-up|0|||
155606423|NCT01211483|561647658|FG001|Phase 2|Lost to Follow-up|1|||
155606424|NCT01211483|561647659|FG002|Phase 2|Lost to Follow-up|1|||
155606425|NCT01211483|561647660|FG003|Phase 2|Lost to Follow-up|2|||
155606426|NCT01211483|561647657|FG000|Phase 2|Death|0|||
155606427|NCT01211483|561647658|FG001|Phase 2|Death|64|||
155606428|NCT01211483|561647659|FG002|Phase 2|Death|53|||
155606429|NCT01211483|561647660|FG003|Phase 2|Death|53|||
155606430|NCT01211483|561647657|FG000|Phase 2|Withdrawal by Subject|0|||
155606431|NCT01211483|561647658|FG001|Phase 2|Withdrawal by Subject|1|||
155606432|NCT01211483|561647659|FG002|Phase 2|Withdrawal by Subject|10|||
155606433|NCT01211483|561647660|FG003|Phase 2|Withdrawal by Subject|5|||
155606434|NCT01211483|561647657|FG000|Phase 2|Study terminated by Sponsor|0|||
155606435|NCT01211483|561647658|FG001|Phase 2|Study terminated by Sponsor|6|||
155606436|NCT01211483|561647659|FG002|Phase 2|Study terminated by Sponsor|8|||
155606437|NCT01211483|561647660|FG003|Phase 2|Study terminated by Sponsor|11|||
155606438|NCT01149421|561647663|FG000|Overall Study|Adverse Event|22|||
155606439|NCT01149421|561647664|FG001|Overall Study|Adverse Event|6|||
155606440|NCT01149421|561647665|FG002|Overall Study|Adverse Event|11|||
155606441|NCT01149421|561647663|FG000|Overall Study|Withdrawal by Subject|20|||
155606442|NCT01149421|561647664|FG001|Overall Study|Withdrawal by Subject|12|||
155606443|NCT01149421|561647665|FG002|Overall Study|Withdrawal by Subject|13|||
155606444|NCT01149421|561647663|FG000|Overall Study|Sponsor Decision|0|||
155606445|NCT01149421|561647664|FG001|Overall Study|Sponsor Decision|1|||
155606446|NCT01149421|561647665|FG002|Overall Study|Sponsor Decision|1|||
155606447|NCT01149421|561647663|FG000|Overall Study|Lost to Follow-up|2|||
155606448|NCT01149421|561647664|FG001|Overall Study|Lost to Follow-up|4|||
155606449|NCT01149421|561647665|FG002|Overall Study|Lost to Follow-up|5|||
155606450|NCT01149421|561647663|FG000|Overall Study|Physician Decision|5|||
155606451|NCT01149421|561647664|FG001|Overall Study|Physician Decision|3|||
155606452|NCT01149421|561647665|FG002|Overall Study|Physician Decision|6|||
155606453|NCT01149421|561647663|FG000|Overall Study|Entry Criteria Not Met|1|||
155606454|NCT01149421|561647664|FG001|Overall Study|Entry Criteria Not Met|1|||
155606455|NCT01149421|561647665|FG002|Overall Study|Entry Criteria Not Met|2|||
155606456|NCT01149421|561647663|FG000|Overall Study|Protocol Violation|2|||
155606457|NCT01149421|561647664|FG001|Overall Study|Protocol Violation|2|||
155606458|NCT01149421|561647665|FG002|Overall Study|Protocol Violation|6|||
155606459|NCT03570554|561647666|FG000|Overall Study|Non-compliance with study drug|0|||
155606460|NCT03570554|561647667|FG001|Overall Study|Non-compliance with study drug|0|||
155606461|NCT03570554|561647668|FG002|Overall Study|Non-compliance with study drug|1|||
155606462|NCT03570554|561647669|FG003|Overall Study|Non-compliance with study drug|0|||
155606463|NCT03570554|561647666|FG000|Overall Study|Adverse Event|0|||
155606464|NCT03570554|561647667|FG001|Overall Study|Adverse Event|0|||
155606465|NCT03570554|561647668|FG002|Overall Study|Adverse Event|0|||
155606466|NCT03570554|561647669|FG003|Overall Study|Adverse Event|1|||
155606467|NCT03738800|561647670|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
155606468|NCT03738800|561647671|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155694310|NCT00358436|561974956|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
155694311|NCT00358436|561974957|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
155694312|NCT00358436|561974956|FG000|Overall Study|COPD exacerbation|22|||
155694313|NCT00358436|561974957|FG001|Overall Study|COPD exacerbation|10|||
155694314|NCT00358436|561974956|FG000|Overall Study|Other|6|||
155694315|NCT00358436|561974957|FG001|Overall Study|Other|1|||
155694316|NCT01597635|561974959|FG000|Part A|Adverse Event|3|||
155694317|NCT01597635|561974960|FG001|Part A|Adverse Event|0|||
155694318|NCT01597635|561974961|FG002|Part A|Adverse Event|0|||
155694319|NCT01597635|561974959|FG000|Part B|Adverse Event|0|||
155694320|NCT01597635|561974960|FG001|Part B|Adverse Event|0|||
155694321|NCT01597635|561974961|FG002|Part B|Adverse Event|1|||
155694322|NCT01597635|561974959|FG000|Part B|Protocol Violation|0|||
155694323|NCT01597635|561974960|FG001|Part B|Protocol Violation|1|||
155694324|NCT01597635|561974961|FG002|Part B|Protocol Violation|0|||
155694325|NCT01597635|561974959|FG000|Part B|Protocol-defined stopping criteria|0|||
155694326|NCT01597635|561974960|FG001|Part B|Protocol-defined stopping criteria|4|||
155694327|NCT01597635|561974961|FG002|Part B|Protocol-defined stopping criteria|3|||
155694328|NCT01597635|561974959|FG000|Part B|Withdrawal by Subject|0|||
155694329|NCT01597635|561974960|FG001|Part B|Withdrawal by Subject|1|||
155694330|NCT01597635|561974961|FG002|Part B|Withdrawal by Subject|0|||
155694331|NCT01073930|561974962|FG000|Overall Study|Withdrawal by Subject|3|||
155694332|NCT01073930|561974963|FG001|Overall Study|Withdrawal by Subject|2|||
155694333|NCT01073930|561974962|FG000|Overall Study|Lost to Follow-up|0|||
155694334|NCT01073930|561974963|FG001|Overall Study|Lost to Follow-up|1|||
155694335|NCT01073930|561974962|FG000|Overall Study|Adverse Event|0|||
155694336|NCT01073930|561974963|FG001|Overall Study|Adverse Event|1|||
155694337|NCT01073930|561974962|FG000|Overall Study|Noncompliance with study drug|0|||
155694338|NCT01073930|561974963|FG001|Overall Study|Noncompliance with study drug|1|||
155694339|NCT01073930|561974962|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
155694340|NCT01073930|561974963|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
155694341|NCT00541346|561974968|FG000|Follow-up|Adverse Event|1|||
155694342|NCT02008773|561974969|FG000|Overall Study|Adverse Event|3|||
155694343|NCT02008773|561974970|FG001|Overall Study|Adverse Event|3|||
155694344|NCT02008773|561974971|FG002|Overall Study|Adverse Event|1|||
155694345|NCT02008773|561974972|FG003|Overall Study|Adverse Event|2|||
155694346|NCT02008773|561974969|FG000|Overall Study|Medication Non-compliance|2|||
155694347|NCT02008773|561974970|FG001|Overall Study|Medication Non-compliance|1|||
155694348|NCT02008773|561974971|FG002|Overall Study|Medication Non-compliance|3|||
155694349|NCT02008773|561974972|FG003|Overall Study|Medication Non-compliance|2|||
155694350|NCT02008773|561974969|FG000|Overall Study|Withdrawal by Subject|8|||
155694351|NCT02008773|561974970|FG001|Overall Study|Withdrawal by Subject|4|||
155694352|NCT02008773|561974971|FG002|Overall Study|Withdrawal by Subject|7|||
155694353|NCT02008773|561974972|FG003|Overall Study|Withdrawal by Subject|6|||
155694354|NCT02008773|561974969|FG000|Overall Study|Lost to Follow-up|0|||
155694355|NCT02008773|561974970|FG001|Overall Study|Lost to Follow-up|1|||
155694356|NCT02008773|561974971|FG002|Overall Study|Lost to Follow-up|3|||
155694357|NCT02008773|561974972|FG003|Overall Study|Lost to Follow-up|2|||
155694358|NCT04938037|561974973|FG000|Overall Study|Lost to Follow-up|4|||
155694359|NCT04938037|561974974|FG001|Overall Study|Lost to Follow-up|3|||
155694360|NCT03323736|561974977|FG000|Overall Study|Screen Failure|14|||
155694361|NCT03323736|561974978|FG001|Overall Study|Screen Failure|9|||
155694362|NCT03323736|561974979|FG002|Overall Study|Screen Failure|1|||
155694363|NCT03323736|561974977|FG000|Overall Study|Withdrawal Before Treatment|3|||
155694364|NCT03323736|561974978|FG001|Overall Study|Withdrawal Before Treatment|1|||
155694365|NCT03323736|561974979|FG002|Overall Study|Withdrawal Before Treatment|1|||
155694366|NCT03323736|561974977|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
155694367|NCT03323736|561974978|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
155694368|NCT03323736|561974979|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
155694369|NCT01806064|561974981|FG000|Overall Study|Randomized Not Enrolled|0|||
155694370|NCT01806064|561974982|FG001|Overall Study|Randomized Not Enrolled|0|||
155694371|NCT01806064|561974983|FG002|Overall Study|Randomized Not Enrolled|0|||
155694372|NCT01806064|561974984|FG003|Overall Study|Randomized Not Enrolled|1|||
155694373|NCT01806064|561974985|FG004|Overall Study|Randomized Not Enrolled|2|||
155694374|NCT01023672|561974987|FG000|Overall Study|Worsening disease|2|||
155694375|NCT01023672|561974987|FG000|Overall Study|Death|1|||
155694376|NCT02654236|561974992|FG000|Overall Study|Withdrawal by Subject|0|||
155694377|NCT02654236|561974993|FG001|Overall Study|Withdrawal by Subject|0|||
155694378|NCT02654236|561974994|FG002|Overall Study|Withdrawal by Subject|2|||
155694379|NCT02408523|561974995|FG000|Overall Study|Adverse Event|4|||
155694380|NCT02408523|561974996|FG001|Overall Study|Adverse Event|10|||
155694381|NCT02408523|561974995|FG000|Overall Study|Lack of Efficacy|0|||
155694382|NCT02408523|561974996|FG001|Overall Study|Lack of Efficacy|1|||
155694383|NCT02408523|561974995|FG000|Overall Study|Protocol Violation|1|||
155694384|NCT02408523|561974996|FG001|Overall Study|Protocol Violation|2|||
155694385|NCT02408523|561974995|FG000|Overall Study|Lost to Follow-up|2|||
155694386|NCT02408523|561974996|FG001|Overall Study|Lost to Follow-up|3|||
155694387|NCT02408523|561974995|FG000|Overall Study|Withdrawal by Subject|3|||
155694388|NCT02408523|561974996|FG001|Overall Study|Withdrawal by Subject|1|||
155694389|NCT02408523|561974995|FG000|Overall Study|Sponsor request|1|||
155694390|NCT02408523|561974996|FG001|Overall Study|Sponsor request|0|||
155694391|NCT02408523|561974995|FG000|Overall Study|Did not satisfy extension conditions|0|||
155694392|NCT02408523|561974996|FG001|Overall Study|Did not satisfy extension conditions|1|||
155694393|NCT01549873|561974997|FG000|Overall Study|Physician Decision|0|||
155694394|NCT01549873|561974998|FG001|Overall Study|Physician Decision|1|||
155694395|NCT00701805|561974999|FG000|Overall Study|Withdrawal by Subject|3|||
155694396|NCT00701805|561975000|FG001|Overall Study|Withdrawal by Subject|1|||
155694397|NCT00701805|561975001|FG002|Overall Study|Withdrawal by Subject|4|||
155694398|NCT00701805|561975002|FG003|Overall Study|Withdrawal by Subject|3|||
155694399|NCT00701805|561974999|FG000|Overall Study|Adverse Event|0|||
155694400|NCT00701805|561975000|FG001|Overall Study|Adverse Event|1|||
155694401|NCT00701805|561975001|FG002|Overall Study|Adverse Event|1|||
155694402|NCT00701805|561975002|FG003|Overall Study|Adverse Event|0|||
155694403|NCT00701805|561974999|FG000|Overall Study|Missed 7 consecutive doses|0|||
155694404|NCT00701805|561975000|FG001|Overall Study|Missed 7 consecutive doses|1|||
155694405|NCT00701805|561975001|FG002|Overall Study|Missed 7 consecutive doses|0|||
155694406|NCT00701805|561975002|FG003|Overall Study|Missed 7 consecutive doses|0|||
155694407|NCT00701805|561974999|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
155694408|NCT00701805|561975000|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
155694409|NCT00701805|561975001|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
155694410|NCT00701805|561975002|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
155694411|NCT00701805|561974999|FG000|Overall Study|Physician decision, change of therapy|0|||
155694412|NCT00701805|561975000|FG001|Overall Study|Physician decision, change of therapy|0|||
155694413|NCT00701805|561975001|FG002|Overall Study|Physician decision, change of therapy|0|||
155694414|NCT00701805|561975002|FG003|Overall Study|Physician decision, change of therapy|1|||
155694415|NCT00701805|561974999|FG000|Overall Study|Difficult to travel to dialysis site|0|||
155694416|NCT00701805|561975000|FG001|Overall Study|Difficult to travel to dialysis site|0|||
155694417|NCT00701805|561975001|FG002|Overall Study|Difficult to travel to dialysis site|1|||
155694418|NCT00701805|561975002|FG003|Overall Study|Difficult to travel to dialysis site|0|||
155694419|NCT00701805|561974999|FG000|Overall Study|Resumption criteria were not met|0|||
155694420|NCT00701805|561975000|FG001|Overall Study|Resumption criteria were not met|1|||
155694421|NCT00701805|561975001|FG002|Overall Study|Resumption criteria were not met|0|||
155694422|NCT00701805|561975002|FG003|Overall Study|Resumption criteria were not met|0|||
155694423|NCT02905006|561975003|FG000|Overall Study|Adverse Event|1|||
155694424|NCT02905006|561975004|FG001|Overall Study|Adverse Event|1|||
155694425|NCT02905006|561975005|FG002|Overall Study|Adverse Event|1|||
155694426|NCT02905006|561975006|FG003|Overall Study|Adverse Event|1|||
155694427|NCT02905006|561975007|FG004|Overall Study|Adverse Event|0|||
155694428|NCT02905006|561975008|FG005|Overall Study|Adverse Event|1|||
155694429|NCT02905006|561975003|FG000|Overall Study|Lack of Efficacy|1|||
155694430|NCT02905006|561975004|FG001|Overall Study|Lack of Efficacy|0|||
155694431|NCT02905006|561975005|FG002|Overall Study|Lack of Efficacy|0|||
155694432|NCT02905006|561975006|FG003|Overall Study|Lack of Efficacy|0|||
155694433|NCT02905006|561975007|FG004|Overall Study|Lack of Efficacy|0|||
155694434|NCT02905006|561975008|FG005|Overall Study|Lack of Efficacy|0|||
155694435|NCT02905006|561975003|FG000|Overall Study|Protocol Violation|2|||
155694436|NCT02905006|561975004|FG001|Overall Study|Protocol Violation|0|||
155694437|NCT02905006|561975005|FG002|Overall Study|Protocol Violation|0|||
155694438|NCT02905006|561975006|FG003|Overall Study|Protocol Violation|0|||
155694439|NCT02905006|561975007|FG004|Overall Study|Protocol Violation|0|||
155694440|NCT02905006|561975008|FG005|Overall Study|Protocol Violation|0|||
155694441|NCT02905006|561975003|FG000|Overall Study|Lost to Follow-up|0|||
155694442|NCT02905006|561975004|FG001|Overall Study|Lost to Follow-up|0|||
155694443|NCT02905006|561975005|FG002|Overall Study|Lost to Follow-up|0|||
155694444|NCT02905006|561975006|FG003|Overall Study|Lost to Follow-up|1|||
155694445|NCT02905006|561975007|FG004|Overall Study|Lost to Follow-up|1|||
155694446|NCT02905006|561975008|FG005|Overall Study|Lost to Follow-up|0|||
155694447|NCT02905006|561975003|FG000|Overall Study|Withdrawal by Subject|0|||
155694448|NCT02905006|561975004|FG001|Overall Study|Withdrawal by Subject|0|||
155694449|NCT02905006|561975005|FG002|Overall Study|Withdrawal by Subject|1|||
155694450|NCT02905006|561975006|FG003|Overall Study|Withdrawal by Subject|1|||
155694451|NCT02905006|561975007|FG004|Overall Study|Withdrawal by Subject|0|||
155694452|NCT02905006|561975008|FG005|Overall Study|Withdrawal by Subject|1|||
155694453|NCT02905006|561975003|FG000|Overall Study|Screening exclusion criteria met|1|||
155694454|NCT02905006|561975004|FG001|Overall Study|Screening exclusion criteria met|0|||
155694455|NCT02905006|561975005|FG002|Overall Study|Screening exclusion criteria met|0|||
155694456|NCT02905006|561975006|FG003|Overall Study|Screening exclusion criteria met|0|||
155694457|NCT02905006|561975007|FG004|Overall Study|Screening exclusion criteria met|0|||
155694458|NCT02905006|561975008|FG005|Overall Study|Screening exclusion criteria met|0|||
155694459|NCT02905006|561975003|FG000|Overall Study|Lab withdrawal criterion met|0|||
155694460|NCT02905006|561975004|FG001|Overall Study|Lab withdrawal criterion met|1|||
155694461|NCT02905006|561975005|FG002|Overall Study|Lab withdrawal criterion met|2|||
155694462|NCT02905006|561975006|FG003|Overall Study|Lab withdrawal criterion met|2|||
155694463|NCT02905006|561975007|FG004|Overall Study|Lab withdrawal criterion met|2|||
155694464|NCT02905006|561975008|FG005|Overall Study|Lab withdrawal criterion met|1|||
155694465|NCT02905006|561975003|FG000|Overall Study|Positive for Tuberculosis|0|||
155694466|NCT02905006|561975004|FG001|Overall Study|Positive for Tuberculosis|1|||
155694467|NCT02905006|561975005|FG002|Overall Study|Positive for Tuberculosis|0|||
155694468|NCT02905006|561975006|FG003|Overall Study|Positive for Tuberculosis|0|||
155694469|NCT02905006|561975007|FG004|Overall Study|Positive for Tuberculosis|0|||
155694470|NCT02905006|561975008|FG005|Overall Study|Positive for Tuberculosis|0|||
155694471|NCT02905006|561975003|FG000|Overall Study|Subject positive for Hep B|0|||
155694472|NCT02905006|561975004|FG001|Overall Study|Subject positive for Hep B|0|||
155694473|NCT02905006|561975005|FG002|Overall Study|Subject positive for Hep B|1|||
155694474|NCT02905006|561975006|FG003|Overall Study|Subject positive for Hep B|0|||
155694475|NCT02905006|561975007|FG004|Overall Study|Subject positive for Hep B|0|||
155694476|NCT02905006|561975008|FG005|Overall Study|Subject positive for Hep B|0|||
155694477|NCT02905006|561975003|FG000|Overall Study|Patient moved abroad|0|||
155694478|NCT02905006|561975004|FG001|Overall Study|Patient moved abroad|0|||
155694479|NCT02905006|561975005|FG002|Overall Study|Patient moved abroad|0|||
155694480|NCT02905006|561975006|FG003|Overall Study|Patient moved abroad|1|||
155694481|NCT02905006|561975007|FG004|Overall Study|Patient moved abroad|0|||
155694482|NCT02905006|561975008|FG005|Overall Study|Patient moved abroad|0|||
155694483|NCT02905006|561975003|FG000|Overall Study|Patient randomized by mistake|0|||
155694484|NCT02905006|561975004|FG001|Overall Study|Patient randomized by mistake|0|||
155694485|NCT02905006|561975005|FG002|Overall Study|Patient randomized by mistake|0|||
155694486|NCT02905006|561975006|FG003|Overall Study|Patient randomized by mistake|0|||
155694487|NCT02905006|561975007|FG004|Overall Study|Patient randomized by mistake|0|||
155694488|NCT02905006|561975008|FG005|Overall Study|Patient randomized by mistake|1|||
155694489|NCT05063539|561975009|FG000|Overall Study|Adverse Event|1|||
155694490|NCT05063539|561975010|FG001|Overall Study|Adverse Event|2|||
155694491|NCT05063539|561975011|FG002|Overall Study|Adverse Event|1|||
155694492|NCT05063539|561975009|FG000|Overall Study|Death|0|||
155694493|NCT05063539|561975010|FG001|Overall Study|Death|1|||
155694494|NCT05063539|561975011|FG002|Overall Study|Death|1|||
155694495|NCT05063539|561975009|FG000|Overall Study|Lost to Follow-up|0|||
155694496|NCT05063539|561975010|FG001|Overall Study|Lost to Follow-up|1|||
155694497|NCT05063539|561975011|FG002|Overall Study|Lost to Follow-up|0|||
155694498|NCT05063539|561975009|FG000|Overall Study|Physician Decision|4|||
155694499|NCT05063539|561975010|FG001|Overall Study|Physician Decision|3|||
155694500|NCT05063539|561975011|FG002|Overall Study|Physician Decision|1|||
155694501|NCT05063539|561975009|FG000|Overall Study|Progressive Disease|0|||
155694502|NCT05063539|561975010|FG001|Overall Study|Progressive Disease|2|||
155694503|NCT05063539|561975011|FG002|Overall Study|Progressive Disease|0|||
155694504|NCT05063539|561975009|FG000|Overall Study|Withdrawal by Subject|17|||
155694505|NCT05063539|561975010|FG001|Overall Study|Withdrawal by Subject|26|||
155694506|NCT05063539|561975011|FG002|Overall Study|Withdrawal by Subject|14|||
155694507|NCT05063539|561975009|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155694508|NCT05063539|561975010|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155694509|NCT05063539|561975011|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
155694510|NCT05063539|561975009|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
155694511|NCT05063539|561975010|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
155694512|NCT05063539|561975011|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
155694513|NCT05063539|561975009|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
155694514|NCT05063539|561975010|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
155694515|NCT05063539|561975011|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
155694516|NCT05063539|561975009|FG000|Overall Study|Discontinued due to Common Close Design|0|||
155694517|NCT05063539|561975010|FG001|Overall Study|Discontinued due to Common Close Design|1|||
155694518|NCT05063539|561975011|FG002|Overall Study|Discontinued due to Common Close Design|0|||
155694519|NCT05063539|561975009|FG000|Overall Study|Participant not co-operative|0|||
155694520|NCT05063539|561975010|FG001|Overall Study|Participant not co-operative|1|||
155694521|NCT05063539|561975011|FG002|Overall Study|Participant not co-operative|0|||
155694522|NCT05063539|561975009|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
155694523|NCT05063539|561975010|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
155694524|NCT05063539|561975011|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
155694525|NCT05063539|561975009|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
155694526|NCT05063539|561975010|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
155694527|NCT05063539|561975011|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
155694528|NCT04256512|561975012|FG000|Overall Study|Withdrawal by Subject|1|||
155694529|NCT04435600|561975023|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694530|NCT04435600|561975024|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694531|NCT04435600|561975025|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
155694532|NCT04435600|561975026|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694533|NCT04435600|561975027|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694534|NCT04435600|561975028|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694535|NCT04435600|561975029|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694536|NCT04435600|561975030|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694537|NCT04435600|561975031|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694538|NCT04435600|561975032|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155694539|NCT04435600|561975023|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694540|NCT04435600|561975024|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694541|NCT04435600|561975025|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694542|NCT04435600|561975026|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694543|NCT04435600|561975027|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694544|NCT04435600|561975028|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694545|NCT04435600|561975029|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694546|NCT04435600|561975030|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694547|NCT04435600|561975031|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155694548|NCT04435600|561975032|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
155694549|NCT04435600|561975023|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694550|NCT04435600|561975024|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694551|NCT04435600|561975025|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694552|NCT04435600|561975026|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694553|NCT04435600|561975027|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694554|NCT04435600|561975028|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694555|NCT04435600|561975029|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694556|NCT04435600|561975030|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694557|NCT04435600|561975031|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155694558|NCT04435600|561975032|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
155694559|NCT04435600|561975023|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694560|NCT04435600|561975024|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694561|NCT04435600|561975025|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694562|NCT04435600|561975026|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694563|NCT04435600|561975027|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694564|NCT04435600|561975028|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694565|NCT04435600|561975029|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694566|NCT04435600|561975030|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694567|NCT04435600|561975031|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
155694568|NCT04435600|561975032|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
155694569|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
155694570|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
155694571|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
155694572|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
155694573|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
155694574|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
155694575|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
155694576|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
155694577|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
155694578|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155694579|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155694580|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155694581|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
155694582|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
155694583|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
155694584|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
155694585|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
155694586|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155606469|NCT03738800|561647672|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155606470|NCT03738800|561647670|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
155606471|NCT03738800|561647671|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
155606472|NCT03738800|561647672|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
155606473|NCT03738800|561647670|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
155606474|NCT03738800|561647671|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155606475|NCT03738800|561647672|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155606476|NCT02719353|561647675|FG000|First Intervention|Physician Decision|0|||
155606477|NCT02719353|561647676|FG001|First Intervention|Physician Decision|1|||
155606478|NCT03515629|561647682|FG000|Overall Study|Death|0|||
155606479|NCT03515629|561647683|FG001|Overall Study|Death|1|||
155606480|NCT03515629|561647684|FG002|Overall Study|Death|1|||
155606481|NCT03515629|561647682|FG000|Overall Study|Progressive disease|0|||
155606482|NCT03515629|561647683|FG001|Overall Study|Progressive disease|1|||
155606483|NCT03515629|561647684|FG002|Overall Study|Progressive disease|0|||
155606484|NCT00424021|561647685|FG000|NCT00046319 Study Period|Adverse Event|1|||
155606485|NCT00424021|561647686|FG001|NCT00046319 Study Period|Adverse Event|0|||
155606486|NCT00424021|561647687|FG002|NCT00046319 Study Period|Adverse Event|1|||
155606487|NCT00424021|561647688|FG003|NCT00046319 Study Period|Adverse Event|1|||
155606488|NCT00424021|561647685|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
155606489|NCT00424021|561647686|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
155606490|NCT00424021|561647687|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
155606491|NCT00424021|561647688|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
155606492|NCT00424021|561647685|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
155606493|NCT00424021|561647686|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
155606494|NCT00424021|561647687|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
155606495|NCT00424021|561647688|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
155606496|NCT00424021|561647685|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
155606497|NCT00424021|561647686|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
155606498|NCT00424021|561647687|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
155606499|NCT00424021|561647688|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
155606500|NCT00424021|561647685|FG000|AMB-220-E Study Period|Adverse Event|1|||
155606501|NCT00424021|561647686|FG001|AMB-220-E Study Period|Adverse Event|1|||
155606502|NCT00424021|561647687|FG002|AMB-220-E Study Period|Adverse Event|3|||
155606503|NCT00424021|561647688|FG003|AMB-220-E Study Period|Adverse Event|7|||
155606504|NCT00424021|561647685|FG000|AMB-220-E Study Period|Death|0|||
155606505|NCT00424021|561647686|FG001|AMB-220-E Study Period|Death|0|||
155606506|NCT00424021|561647687|FG002|AMB-220-E Study Period|Death|1|||
155606507|NCT00424021|561647688|FG003|AMB-220-E Study Period|Death|1|||
155606508|NCT00424021|561647685|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
155606509|NCT00424021|561647686|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
155606510|NCT00424021|561647687|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
155606511|NCT00424021|561647688|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
155606512|NCT00424021|561647685|FG000|AMB-220-E Study Period|Physician Decision|0|||
155606513|NCT00424021|561647686|FG001|AMB-220-E Study Period|Physician Decision|0|||
155606514|NCT00424021|561647687|FG002|AMB-220-E Study Period|Physician Decision|0|||
155606515|NCT00424021|561647688|FG003|AMB-220-E Study Period|Physician Decision|1|||
155606516|NCT01254721|561647689|FG000|Overall Study|Lost to Follow-up|0|||
155606517|NCT01254721|561647690|FG001|Overall Study|Lost to Follow-up|4|||
155606518|NCT01254721|561647689|FG000|Overall Study|Lack of Efficacy|4|||
155606519|NCT01254721|561647690|FG001|Overall Study|Lack of Efficacy|2|||
155606520|NCT01254721|561647689|FG000|Overall Study|Death|0|||
155606521|NCT01254721|561647690|FG001|Overall Study|Death|1|||
155606522|NCT01254721|561647689|FG000|Overall Study|technical problum|1|||
155606523|NCT01254721|561647690|FG001|Overall Study|technical problum|0|||
155606524|NCT01254721|561647689|FG000|Overall Study|Adverse Event|2|||
155606525|NCT01254721|561647690|FG001|Overall Study|Adverse Event|3|||
155606526|NCT01254721|561647689|FG000|Overall Study|Withdrawal by Subject|8|||
155606527|NCT01254721|561647690|FG001|Overall Study|Withdrawal by Subject|11|||
155606528|NCT01254721|561647689|FG000|Overall Study|Wrongly randomization|0|||
155694587|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155694588|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155694589|NCT05149313|561975033|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
155694590|NCT05149313|561975034|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
155694591|NCT05149313|561975035|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
155694592|NCT05149313|561975036|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
155694593|NCT05149313|561975033|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
155694594|NCT05149313|561975034|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
155694595|NCT05149313|561975035|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
155694596|NCT05149313|561975036|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
155694597|NCT05149313|561975033|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155694598|NCT05149313|561975034|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155694599|NCT05149313|561975035|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
155694600|NCT05149313|561975036|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
155694601|NCT05149313|561975033|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155694602|NCT05149313|561975034|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155694603|NCT05149313|561975035|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
155694604|NCT05149313|561975036|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
155694605|NCT05149313|561975033|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155694606|NCT05149313|561975034|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155694607|NCT05149313|561975035|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
155694608|NCT05149313|561975036|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155694609|NCT05149313|561975033|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155694610|NCT05149313|561975034|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155694611|NCT05149313|561975035|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
155694612|NCT05149313|561975036|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155694613|NCT04271475|561975037|FG000|DB Period: Day 1 up to EODBT|Death|1|||
155694614|NCT04271475|561975038|FG001|DB Period: Day 1 up to EODBT|Death|0|||
155694615|NCT04271475|561975039|FG002|DB Period: Day 1 up to EODBT|Death|0|||
155694616|NCT04271475|561975040|FG003|DB Period: Day 1 up to EODBT|Death|0|||
155694617|NCT04271475|561975037|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
155694618|NCT04271475|561975038|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
155694619|NCT04271475|561975039|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
155694620|NCT04271475|561975040|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
155694621|NCT04271475|561975037|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
155694622|NCT04271475|561975038|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
155694623|NCT04271475|561975039|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
155694624|NCT04271475|561975040|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
155694625|NCT04271475|561975037|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
155694626|NCT04271475|561975038|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
155694627|NCT04271475|561975039|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
155694628|NCT04271475|561975040|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
155694629|NCT04271475|561975037|FG000|DB Period: Day 1 up to EODBT|Other|8|||
155694630|NCT04271475|561975038|FG001|DB Period: Day 1 up to EODBT|Other|5|||
155694631|NCT04271475|561975039|FG002|DB Period: Day 1 up to EODBT|Other|0|||
155694632|NCT04271475|561975040|FG003|DB Period: Day 1 up to EODBT|Other|0|||
155694633|NCT04271475|561975037|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
155694634|NCT04271475|561975038|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
155694635|NCT04271475|561975039|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
155694636|NCT04271475|561975040|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
155694637|NCT04271475|561975037|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155694638|NCT04271475|561975038|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155694639|NCT04271475|561975039|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155694640|NCT04271475|561975040|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
155694641|NCT02337634|561975041|FG000|Overall Study|Protocol Violation|3|||
155694642|NCT02337634|561975042|FG001|Overall Study|Protocol Violation|1|||
155694643|NCT02337634|561975041|FG000|Overall Study|Lost to Follow-up|1|||
155694644|NCT02337634|561975042|FG001|Overall Study|Lost to Follow-up|0|||
155694645|NCT01300351|561975047|FG000|Overall Study|Did not receive treatment|2|||
155694646|NCT01300351|561975048|FG001|Overall Study|Did not receive treatment|0|||
155694647|NCT01300351|561975047|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
155694648|NCT01300351|561975048|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
155694649|NCT01300351|561975047|FG000|Overall Study|Lost to Follow-up|0|||
155694650|NCT01300351|561975048|FG001|Overall Study|Lost to Follow-up|1|||
155694651|NCT01300351|561975047|FG000|Overall Study|Adverse Event|0|||
155694652|NCT01300351|561975048|FG001|Overall Study|Adverse Event|4|||
155694653|NCT01300351|561975047|FG000|Overall Study|Withdrawal by Subject|7|||
155694654|NCT01300351|561975048|FG001|Overall Study|Withdrawal by Subject|10|||
155694655|NCT03968159|561975051|FG000|Overall Study|Adverse Event|4|||
155694656|NCT03968159|561975052|FG001|Overall Study|Adverse Event|4|||
155694657|NCT03968159|561975051|FG000|Overall Study|Lost to Follow-up|1|||
155694658|NCT03968159|561975052|FG001|Overall Study|Lost to Follow-up|1|||
155694659|NCT03968159|561975051|FG000|Overall Study|Use of prohibited medication|0|||
155694660|NCT03968159|561975052|FG001|Overall Study|Use of prohibited medication|1|||
155694661|NCT03968159|561975051|FG000|Overall Study|Protocol Violation|2|||
155694662|NCT03968159|561975052|FG001|Overall Study|Protocol Violation|2|||
155694663|NCT03968159|561975051|FG000|Overall Study|Withdrawal by Subject|4|||
155694664|NCT03968159|561975052|FG001|Overall Study|Withdrawal by Subject|6|||
155694665|NCT03968159|561975051|FG000|Overall Study|Lack of Efficacy|0|||
155694666|NCT03968159|561975052|FG001|Overall Study|Lack of Efficacy|1|||
155694667|NCT03968159|561975051|FG000|Overall Study|Not further specified|2|||
155694668|NCT03968159|561975052|FG001|Overall Study|Not further specified|0|||
155694669|NCT02258529|561975053|FG000|Overall Study|Study Terminated by Sponsor|9|||
155694670|NCT02258529|561975053|FG000|Overall Study|Adverse Event|1|||
155694671|NCT00443781|561975054|FG000|Overall Study|Lost to Follow-up|10|||
155694672|NCT00443781|561975054|FG000|Overall Study|Physician Decision|2|||
155694673|NCT00443781|561975054|FG000|Overall Study|Protocol Violation|1|||
155694674|NCT00443781|561975054|FG000|Overall Study|Withdrawal by Subject|6|||
155694675|NCT00443781|561975054|FG000|Overall Study|Unable to comply with study follow up|2|||
155694676|NCT00443781|561975054|FG000|Overall Study|Investigator terminated participation|1|||
155694677|NCT00443781|561975054|FG000|Overall Study|Insurance not covered|2|||
155694678|NCT00443781|561975054|FG000|Overall Study|PD/FAD not done|1|||
155694679|NCT00430937|561975055|FG000|Overall Study|Adverse Event|3|||
155694680|NCT00430937|561975056|FG001|Overall Study|Adverse Event|8|||
155694681|NCT00430937|561975055|FG000|Overall Study|Death|0|||
155694682|NCT00430937|561975056|FG001|Overall Study|Death|1|||
155694683|NCT00430937|561975055|FG000|Overall Study|Lost to Follow-up|6|||
155694684|NCT00430937|561975056|FG001|Overall Study|Lost to Follow-up|6|||
155694685|NCT00430937|561975055|FG000|Overall Study|Withdrawal by Subject|5|||
155694686|NCT00430937|561975056|FG001|Overall Study|Withdrawal by Subject|2|||
155694687|NCT00430937|561975055|FG000|Overall Study|Protocol Violation|3|||
155694688|NCT00430937|561975056|FG001|Overall Study|Protocol Violation|2|||
155694689|NCT00430937|561975055|FG000|Overall Study|Lack of Efficacy|6|||
155694690|NCT00430937|561975056|FG001|Overall Study|Lack of Efficacy|5|||
155694691|NCT00430937|561975055|FG000|Overall Study|Inappropriate enrollment|2|||
155694692|NCT00430937|561975056|FG001|Overall Study|Inappropriate enrollment|1|||
155694693|NCT00430937|561975055|FG000|Overall Study|Administrative reasons|1|||
155694694|NCT00430937|561975056|FG001|Overall Study|Administrative reasons|0|||
155694695|NCT00430937|561975055|FG000|Overall Study|Protocol discontinuation criteria met|1|||
155694696|NCT00430937|561975056|FG001|Overall Study|Protocol discontinuation criteria met|2|||
155694697|NCT00430937|561975055|FG000|Overall Study|Unable to classify|0|||
155694698|NCT00430937|561975056|FG001|Overall Study|Unable to classify|1|||
155694699|NCT02006069|561975061|FG000|Overall Study|MPP other programming|239|||
155694700|NCT02006069|561975062|FG001|Overall Study|MPP other programming|0|||
155694701|NCT02006069|561975061|FG000|Overall Study|RV only pacing|0|||
155694702|NCT02006069|561975062|FG001|Overall Study|RV only pacing|3|||
155694703|NCT02276547|561975065|FG000|Overall Study|Death|2|||
155694704|NCT02276547|561975065|FG000|Overall Study|Explant|2|||
155694705|NCT02066129|561975066|FG000|Overall Study|Lost to Follow-up|13|||
155694706|NCT02066129|561975067|FG001|Overall Study|Lost to Follow-up|12|||
155694707|NCT02066129|561975066|FG000|Overall Study|Withdrawal by Subject|7|||
155694708|NCT02066129|561975067|FG001|Overall Study|Withdrawal by Subject|10|||
155694709|NCT02066129|561975066|FG000|Overall Study|Lack of Efficacy|8|||
155694710|NCT02066129|561975067|FG001|Overall Study|Lack of Efficacy|10|||
155694711|NCT02066129|561975066|FG000|Overall Study|Physician Decision|1|||
155694712|NCT02066129|561975067|FG001|Overall Study|Physician Decision|1|||
155694713|NCT02642965|561975068|FG000|Overall Study|Lack of Efficacy|4|||
155694714|NCT02642965|561975068|FG000|Overall Study|Physician Decision|9|||
155694715|NCT00973102|561975071|FG000|Overall Study|Protocol Violation|1|||
155694716|NCT00973102|561975072|FG001|Overall Study|Protocol Violation|0|||
155694717|NCT00973102|561975071|FG000|Overall Study|Prisoner|0|||
155694718|NCT00973102|561975072|FG001|Overall Study|Prisoner|1|||
155694719|NCT01439126|561975073|FG000|Overall Study|Adverse Event|2|||
155694720|NCT01439126|561975074|FG001|Overall Study|Adverse Event|0|||
155694721|NCT01439126|561975073|FG000|Overall Study|Withdrawal by Subject|5|||
155694722|NCT01439126|561975074|FG001|Overall Study|Withdrawal by Subject|21|||
155694723|NCT01439126|561975073|FG000|Overall Study|Protocol Violation|6|||
155694724|NCT01439126|561975074|FG001|Overall Study|Protocol Violation|4|||
155694725|NCT01439126|561975073|FG000|Overall Study|Lost to Follow-up|6|||
155694726|NCT01439126|561975074|FG001|Overall Study|Lost to Follow-up|3|||
155694727|NCT01439126|561975073|FG000|Overall Study|Other-Use of prohibited treatment|0|||
155694728|NCT01439126|561975074|FG001|Overall Study|Other-Use of prohibited treatment|2|||
155694729|NCT01439126|561975073|FG000|Overall Study|Other-Miscellaneous|12|||
155694730|NCT01439126|561975074|FG001|Overall Study|Other-Miscellaneous|12|||
155694731|NCT00687609|561975075|FG000|Overall Study|Physician Decision|1|||
155694732|NCT00687609|561975075|FG000|Overall Study|Withdrawal by Subject|2|||
155694733|NCT00160199|561975076|FG000|Overall Study|Adverse Event|5|||
155694734|NCT00160199|561975077|FG001|Overall Study|Adverse Event|14|||
155694735|NCT00160199|561975076|FG000|Overall Study|Lack of Efficacy|0|||
155694736|NCT00160199|561975077|FG001|Overall Study|Lack of Efficacy|1|||
155694737|NCT00160199|561975076|FG000|Overall Study|Lost to Follow-up|7|||
155694738|NCT00160199|561975077|FG001|Overall Study|Lost to Follow-up|7|||
155694739|NCT00160199|561975076|FG000|Overall Study|Withdrawal by Subject|4|||
155694740|NCT00160199|561975077|FG001|Overall Study|Withdrawal by Subject|6|||
155694741|NCT00160199|561975076|FG000|Overall Study|Administrative|0|||
155694742|NCT00160199|561975077|FG001|Overall Study|Administrative|1|||
155694743|NCT00160199|561975076|FG000|Overall Study|Protocol Violation|8|||
155694744|NCT00160199|561975077|FG001|Overall Study|Protocol Violation|8|||
155694745|NCT00969436|561975078|FG000|Overall Study|Protocol Violation|1|||
155694746|NCT00969436|561975079|FG001|Overall Study|Protocol Violation|3|||
155694747|NCT00969436|561975080|FG002|Overall Study|Protocol Violation|0|||
155694748|NCT00969436|561975078|FG000|Overall Study|Migrated/moved from study area|12|||
155694749|NCT00969436|561975079|FG001|Overall Study|Migrated/moved from study area|10|||
155694750|NCT00969436|561975080|FG002|Overall Study|Migrated/moved from study area|2|||
155694751|NCT00969436|561975078|FG000|Overall Study|Father - serious health problem|0|||
155694752|NCT00969436|561975079|FG001|Overall Study|Father - serious health problem|0|||
155694753|NCT00969436|561975080|FG002|Overall Study|Father - serious health problem|1|||
155694754|NCT00969436|561975078|FG000|Overall Study|Parents personal problem|0|||
155694755|NCT00969436|561975079|FG001|Overall Study|Parents personal problem|0|||
155694756|NCT00969436|561975080|FG002|Overall Study|Parents personal problem|1|||
155694757|NCT00969436|561975078|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
155694758|NCT00969436|561975079|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
155694759|NCT00969436|561975080|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
155694760|NCT00969436|561975078|FG000|Overall Study|Withdrawal by Subject|3|||
155694761|NCT00969436|561975079|FG001|Overall Study|Withdrawal by Subject|0|||
155694762|NCT00969436|561975080|FG002|Overall Study|Withdrawal by Subject|2|||
155694763|NCT00969436|561975078|FG000|Overall Study|Lost to Follow-up|8|||
155694764|NCT00969436|561975079|FG001|Overall Study|Lost to Follow-up|8|||
155694765|NCT00969436|561975080|FG002|Overall Study|Lost to Follow-up|5|||
155694766|NCT02544373|561975085|FG000|Overall Study|Lost to Follow-up|5|||
155694767|NCT02544373|561975086|FG001|Overall Study|Lost to Follow-up|3|||
155694768|NCT02544373|561975085|FG000|Overall Study|Withdrawal by Subject|8|||
155694769|NCT02544373|561975086|FG001|Overall Study|Withdrawal by Subject|2|||
155694770|NCT03667690|561976312|FG000|Overall Study|Adverse Event|0|||
155694771|NCT03667690|561976313|FG001|Overall Study|Adverse Event|3|||
155694772|NCT03667690|561976312|FG000|Overall Study|Death|22|||
155694773|NCT03667690|561976313|FG001|Overall Study|Death|21|||
155694774|NCT03667690|561976312|FG000|Overall Study|Lost to Follow-up|4|||
155694775|NCT03667690|561976313|FG001|Overall Study|Lost to Follow-up|5|||
155694776|NCT03667690|561976312|FG000|Overall Study|Withdrawal by Subject|7|||
155694777|NCT03667690|561976313|FG001|Overall Study|Withdrawal by Subject|8|||
155694778|NCT03667690|561976312|FG000|Overall Study|Subject could not return for additional investigational product|1|||
155694779|NCT03667690|561976313|FG001|Overall Study|Subject could not return for additional investigational product|0|||
155694780|NCT03667690|561976312|FG000|Overall Study|Subject discharged to hospice care|2|||
155694781|NCT03667690|561976313|FG001|Overall Study|Subject discharged to hospice care|0|||
155694782|NCT03667690|561976312|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
155694783|NCT03667690|561976313|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
155694784|NCT03667690|561976312|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
155694785|NCT03667690|561976313|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
155694786|NCT03667690|561976312|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
155694787|NCT03667690|561976313|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
155694788|NCT03667690|561976312|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
155694789|NCT03667690|561976313|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
155694790|NCT03667690|561976312|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
155694791|NCT03667690|561976313|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
155694792|NCT01350115|561976314|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
155694793|NCT01350115|561976315|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
155694794|NCT01350115|561976314|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
155694795|NCT01350115|561976315|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
155694796|NCT01350115|561976314|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
155694797|NCT01350115|561976315|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
155694798|NCT04327024|561976316|FG000|Overall Study|Death|1|||
155694799|NCT04327024|561976317|FG001|Overall Study|Death|2|||
155694800|NCT04327024|561976318|FG002|Overall Study|Death|1|||
155694801|NCT04327024|561976316|FG000|Overall Study|Non-compliance with study drug|0|||
155694802|NCT04327024|561976317|FG001|Overall Study|Non-compliance with study drug|1|||
155694803|NCT04327024|561976318|FG002|Overall Study|Non-compliance with study drug|0|||
155694804|NCT04327024|561976316|FG000|Overall Study|Withdrawal by Subject|1|||
155694805|NCT04327024|561976317|FG001|Overall Study|Withdrawal by Subject|1|||
155694806|NCT04327024|561976318|FG002|Overall Study|Withdrawal by Subject|2|||
155694807|NCT00837759|561976321|FG000|Overall Study|Protocol Violation|3|||
155694808|NCT00837759|561976321|FG000|Overall Study|Lost to Follow-up|1|||
155694809|NCT01192568|561976322|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
155694810|NCT01192568|561976323|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
155694811|NCT01192568|561976324|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
155694812|NCT01192568|561976325|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
155694813|NCT01192568|561976322|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
155694814|NCT01192568|561976323|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
155694815|NCT01192568|561976324|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
155694816|NCT01192568|561976325|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
155694817|NCT02783170|561976326|FG000|Overall Study|Randomized but not Vaccinated|1|||
155694818|NCT02783170|561976327|FG001|Overall Study|Randomized but not Vaccinated|0|||
155694819|NCT02804750|561976328|FG000|Period 1|Adverse Event|0|||
155694820|NCT02804750|561976329|FG001|Period 1|Adverse Event|2|||
155694821|NCT02804750|561976328|FG000|Period 1|Withdrawal by Subject|0|||
155694822|NCT02804750|561976329|FG001|Period 1|Withdrawal by Subject|1|||
155694823|NCT02804750|561976328|FG000|Period 2|Adverse Event|1|||
155694824|NCT02804750|561976329|FG001|Period 2|Adverse Event|0|||
155694825|NCT02804750|561976328|FG000|Period 3|Adverse Event|0|||
155694826|NCT02804750|561976329|FG001|Period 3|Adverse Event|2|||
155694827|NCT02804750|561976328|FG000|Period 4|Adverse Event|0|||
155694828|NCT02804750|561976329|FG001|Period 4|Adverse Event|5|||
155694829|NCT04692077|561976333|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
155694830|NCT01751139|561976338|FG000|Overall Study|Other|135|||
155694831|NCT01751139|561976338|FG000|Overall Study|Sponsor study termination|1609|||
155694832|NCT01751139|561976338|FG000|Overall Study|Lost to Follow-up|240|||
155694833|NCT01751139|561976338|FG000|Overall Study|Withdrawal by Subject|251|||
155694834|NCT01751139|561976338|FG000|Overall Study|Adverse Event|1|||
155694835|NCT01751139|561976338|FG000|Overall Study|Death|31|||
155694836|NCT03199391|561976339|FG000|Overall Study|Death|1|||
155694837|NCT03199391|561976339|FG000|Overall Study|Lost to Follow-up|3|||
155694838|NCT03199391|561976339|FG000|Overall Study|Adverse Event|2|||
155694839|NCT03199391|561976339|FG000|Overall Study|Withdrawal by Subject|10|||
155694840|NCT01867086|561976340|FG000|Overall Study|Disease Progression|1|||
155694841|NCT03826342|561976341|FG000|Overall Study|Withdrawal by Subject|8|||
155694842|NCT03826342|561976342|FG001|Overall Study|Withdrawal by Subject|1|||
155694843|NCT03826342|561976341|FG000|Overall Study|Lost to Follow-up|7|||
155694844|NCT03826342|561976342|FG001|Overall Study|Lost to Follow-up|7|||
155694845|NCT03826342|561976341|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
155694846|NCT03826342|561976342|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
155694847|NCT01818284|561976348|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
155694848|NCT01818284|561976349|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
155694849|NCT01818284|561976348|FG000|Overall Study|Death|0|||
155694850|NCT01818284|561976349|FG001|Overall Study|Death|2|||
155694851|NCT00527319|561976350|FG000|Overall Study|Withdrawal by Subject|5|||
155694852|NCT00527319|561976351|FG001|Overall Study|Withdrawal by Subject|0|||
155694853|NCT00527319|561976352|FG002|Overall Study|Withdrawal by Subject|1|||
155694854|NCT00527319|561976350|FG000|Overall Study|Lost to Follow-up|1|||
155694855|NCT00527319|561976351|FG001|Overall Study|Lost to Follow-up|0|||
155694856|NCT00527319|561976352|FG002|Overall Study|Lost to Follow-up|0|||
155694857|NCT00527319|561976350|FG000|Overall Study|Death|0|||
155694858|NCT00527319|561976351|FG001|Overall Study|Death|3|||
155694859|NCT00527319|561976352|FG002|Overall Study|Death|1|||
155694860|NCT00527319|561976350|FG000|Overall Study|Intercurrent Medical Illness|0|||
155694861|NCT00527319|561976351|FG001|Overall Study|Intercurrent Medical Illness|1|||
155694862|NCT00527319|561976352|FG002|Overall Study|Intercurrent Medical Illness|3|||
155694863|NCT00527319|561976350|FG000|Overall Study|Adverse Event|0|||
155694864|NCT00527319|561976351|FG001|Overall Study|Adverse Event|0|||
155694865|NCT00527319|561976352|FG002|Overall Study|Adverse Event|1|||
155694866|NCT03779503|561976356|FG000|First Intervention|Adverse Event|0|||
155694867|NCT03779503|561976357|FG001|First Intervention|Adverse Event|1|||
155694868|NCT03779503|561976356|FG000|First Intervention|Withdrawal by Subject|1|||
155694869|NCT03779503|561976357|FG001|First Intervention|Withdrawal by Subject|0|||
155694870|NCT00864851|561976358|FG000|Overall Study|Withdrawal by Subject|0|||
155694871|NCT00864851|561976359|FG001|Overall Study|Withdrawal by Subject|1|||
155694872|NCT00864851|561976360|FG002|Overall Study|Withdrawal by Subject|0|||
155694873|NCT00864851|561976358|FG000|Overall Study|Physician Decision|1|||
155694874|NCT00864851|561976359|FG001|Overall Study|Physician Decision|0|||
155694875|NCT00864851|561976360|FG002|Overall Study|Physician Decision|0|||
155694876|NCT00864851|561976358|FG000|Overall Study|Death|1|||
155694877|NCT00864851|561976359|FG001|Overall Study|Death|0|||
155694878|NCT00864851|561976360|FG002|Overall Study|Death|0|||
155694879|NCT00864851|561976358|FG000|Overall Study|Patient uncooperative|1|||
155694880|NCT00864851|561976359|FG001|Overall Study|Patient uncooperative|0|||
155694881|NCT00864851|561976360|FG002|Overall Study|Patient uncooperative|0|||
155694882|NCT02066415|561976361|FG000|Overall Study|Decision by Sponsor|5|||
155694883|NCT02066415|561976362|FG001|Overall Study|Decision by Sponsor|4|||
155694884|NCT02066415|561976363|FG002|Overall Study|Decision by Sponsor|2|||
155694885|NCT02066415|561976361|FG000|Overall Study|Withdrawal by Subject|9|||
155694886|NCT02066415|561976362|FG001|Overall Study|Withdrawal by Subject|1|||
155694887|NCT02066415|561976363|FG002|Overall Study|Withdrawal by Subject|4|||
155694888|NCT02066415|561976361|FG000|Overall Study|Lost to Follow-up|7|||
155694889|NCT02066415|561976362|FG001|Overall Study|Lost to Follow-up|2|||
155694890|NCT02066415|561976363|FG002|Overall Study|Lost to Follow-up|2|||
155694891|NCT03242252|561976365|FG000|Overall Study|At the Participant's own Request|18|||
155694892|NCT03242252|561976366|FG001|Overall Study|At the Participant's own Request|10|||
155694893|NCT03242252|561976367|FG002|Overall Study|At the Participant's own Request|15|||
155694894|NCT03242252|561976365|FG000|Overall Study|Adverse Event|8|||
155694895|NCT03242252|561976366|FG001|Overall Study|Adverse Event|6|||
155694896|NCT03242252|561976367|FG002|Overall Study|Adverse Event|9|||
155694897|NCT03242252|561976365|FG000|Overall Study|Poor Compliance to Protocol|0|||
155694898|NCT03242252|561976366|FG001|Overall Study|Poor Compliance to Protocol|2|||
155694899|NCT03242252|561976367|FG002|Overall Study|Poor Compliance to Protocol|3|||
155694900|NCT03242252|561976365|FG000|Overall Study|Study Terminated by Sponsor|1|||
155694901|NCT03242252|561976366|FG001|Overall Study|Study Terminated by Sponsor|0|||
155694902|NCT03242252|561976367|FG002|Overall Study|Study Terminated by Sponsor|0|||
155694903|NCT03242252|561976365|FG000|Overall Study|Reason not Specified|4|||
155694904|NCT03242252|561976366|FG001|Overall Study|Reason not Specified|4|||
155694905|NCT03242252|561976367|FG002|Overall Study|Reason not Specified|1|||
155694906|NCT03242252|561976365|FG000|Overall Study|Lost to Follow-up|5|||
155694907|NCT03242252|561976366|FG001|Overall Study|Lost to Follow-up|1|||
155694908|NCT03242252|561976367|FG002|Overall Study|Lost to Follow-up|4|||
155694909|NCT01267175|561976370|FG000|Overall Study|Withdrawal by Subject|1|||
155694910|NCT01267175|561976370|FG000|Overall Study|Lost to Follow-up|1|||
155694911|NCT00895661|561976371|FG000|Overall Study|Death|1|||
155694912|NCT00895661|561976371|FG000|Overall Study|reason unknown|2|||
155694913|NCT02989805|561976374|FG000|Overall Study|invalid consent|6|||
155694914|NCT02989805|561976375|FG001|Overall Study|invalid consent|4|||
155694915|NCT00286221|561976376|FG000|Overall Study|Protocol Violation|2|||
155694916|NCT00286221|561976377|FG001|Overall Study|Protocol Violation|1|||
155694917|NCT00286221|561976378|FG002|Overall Study|Protocol Violation|6|||
155694918|NCT00286221|561976379|FG003|Overall Study|Protocol Violation|4|||
155694919|NCT00286221|561976376|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
155694920|NCT00286221|561976377|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
155694921|NCT00286221|561976378|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
155694922|NCT00286221|561976379|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
155694923|NCT00286221|561976376|FG000|Overall Study|Inability to trigger PCA|2|||
155694924|NCT00286221|561976377|FG001|Overall Study|Inability to trigger PCA|0|||
155694925|NCT00286221|561976378|FG002|Overall Study|Inability to trigger PCA|0|||
155694926|NCT00286221|561976379|FG003|Overall Study|Inability to trigger PCA|0|||
155694927|NCT00286221|561976376|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
155694928|NCT00286221|561976377|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
155694929|NCT00286221|561976378|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
155694930|NCT00286221|561976379|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
155694931|NCT02771626|561976380|FG000|Overall Study|Adverse Event|1|||
155694932|NCT02771626|561976381|FG001|Overall Study|Adverse Event|5|||
155694933|NCT02771626|561976382|FG002|Overall Study|Adverse Event|3|||
155694934|NCT02771626|561976383|FG003|Overall Study|Adverse Event|0|||
155694935|NCT02771626|561976384|FG004|Overall Study|Adverse Event|1|||
155694936|NCT02771626|561976385|FG005|Overall Study|Adverse Event|1|||
155694937|NCT02771626|561976380|FG000|Overall Study|Radiologic Disease Progression|6|||
155694938|NCT02771626|561976381|FG001|Overall Study|Radiologic Disease Progression|13|||
155694939|NCT02771626|561976382|FG002|Overall Study|Radiologic Disease Progression|10|||
155694940|NCT02771626|561976383|FG003|Overall Study|Radiologic Disease Progression|7|||
155694941|NCT02771626|561976384|FG004|Overall Study|Radiologic Disease Progression|28|||
155694942|NCT02771626|561976385|FG005|Overall Study|Radiologic Disease Progression|15|||
155694943|NCT02771626|561976380|FG000|Overall Study|Symptomatic Deterioration|0|||
155694944|NCT02771626|561976381|FG001|Overall Study|Symptomatic Deterioration|4|||
155694945|NCT02771626|561976382|FG002|Overall Study|Symptomatic Deterioration|2|||
155694946|NCT02771626|561976383|FG003|Overall Study|Symptomatic Deterioration|0|||
155694947|NCT02771626|561976384|FG004|Overall Study|Symptomatic Deterioration|5|||
155694948|NCT02771626|561976385|FG005|Overall Study|Symptomatic Deterioration|2|||
155694949|NCT02771626|561976380|FG000|Overall Study|Participant Request|0|||
155694950|NCT02771626|561976381|FG001|Overall Study|Participant Request|1|||
155694951|NCT02771626|561976382|FG002|Overall Study|Participant Request|0|||
155694952|NCT02771626|561976383|FG003|Overall Study|Participant Request|2|||
155694953|NCT02771626|561976384|FG004|Overall Study|Participant Request|0|||
155694954|NCT02771626|561976385|FG005|Overall Study|Participant Request|1|||
155694955|NCT02771626|561976380|FG000|Overall Study|Investigator Decision|0|||
155694956|NCT02771626|561976381|FG001|Overall Study|Investigator Decision|1|||
155694957|NCT02771626|561976382|FG002|Overall Study|Investigator Decision|0|||
155694958|NCT02771626|561976383|FG003|Overall Study|Investigator Decision|0|||
155694959|NCT02771626|561976384|FG004|Overall Study|Investigator Decision|1|||
155694960|NCT02771626|561976385|FG005|Overall Study|Investigator Decision|0|||
155694961|NCT02771626|561976380|FG000|Overall Study|Study Termination by Sponsor|0|||
155694962|NCT02771626|561976381|FG001|Overall Study|Study Termination by Sponsor|2|||
155694963|NCT02771626|561976382|FG002|Overall Study|Study Termination by Sponsor|1|||
155694964|NCT02771626|561976383|FG003|Overall Study|Study Termination by Sponsor|0|||
155694965|NCT02771626|561976384|FG004|Overall Study|Study Termination by Sponsor|1|||
155694966|NCT02771626|561976385|FG005|Overall Study|Study Termination by Sponsor|0|||
155694967|NCT02771626|561976380|FG000|Overall Study|Informed Consent Withdrawn|0|||
155694968|NCT02771626|561976381|FG001|Overall Study|Informed Consent Withdrawn|0|||
155694969|NCT02771626|561976382|FG002|Overall Study|Informed Consent Withdrawn|1|||
155694970|NCT02771626|561976383|FG003|Overall Study|Informed Consent Withdrawn|0|||
155694971|NCT02771626|561976384|FG004|Overall Study|Informed Consent Withdrawn|1|||
155694972|NCT02771626|561976385|FG005|Overall Study|Informed Consent Withdrawn|1|||
155694973|NCT02771626|561976380|FG000|Overall Study|Other, Not Specified|1|||
155694974|NCT02771626|561976381|FG001|Overall Study|Other, Not Specified|0|||
155694975|NCT02771626|561976382|FG002|Overall Study|Other, Not Specified|0|||
155694976|NCT02771626|561976383|FG003|Overall Study|Other, Not Specified|0|||
155694977|NCT02771626|561976384|FG004|Overall Study|Other, Not Specified|0|||
155694978|NCT02771626|561976385|FG005|Overall Study|Other, Not Specified|1|||
155694979|NCT02553538|561976386|FG000|Overall Study|Could Not Reach by Telephone|133|||
155694980|NCT02553538|561976387|FG001|Overall Study|Could Not Reach by Telephone|0|||
155694981|NCT02553538|561976386|FG000|Overall Study|Died or Left Network|54|||
155694982|NCT02553538|561976387|FG001|Overall Study|Died or Left Network|56|||
155694983|NCT02690649|561976388|FG000|Overall Study|Withdrawal by Subject|1|||
155694984|NCT02690649|561976389|FG001|Overall Study|Withdrawal by Subject|1|||
155694985|NCT02690649|561976388|FG000|Overall Study|Protocol Violation|0|||
155694986|NCT02690649|561976389|FG001|Overall Study|Protocol Violation|3|||
155694987|NCT00530920|561976390|FG000|Overall Study|Randomized but not treated|0|||
155694988|NCT00530920|561976391|FG001|Overall Study|Randomized but not treated|2|||
155694989|NCT00530920|561976392|FG002|Overall Study|Randomized but not treated|0|||
155694990|NCT00530920|561976390|FG000|Overall Study|Adverse Event|0|||
155694991|NCT00530920|561976391|FG001|Overall Study|Adverse Event|0|||
155694992|NCT00530920|561976392|FG002|Overall Study|Adverse Event|3|||
155694993|NCT00530920|561976390|FG000|Overall Study|Withdrawal by Subject|0|||
155694994|NCT00530920|561976391|FG001|Overall Study|Withdrawal by Subject|0|||
155694995|NCT00530920|561976392|FG002|Overall Study|Withdrawal by Subject|1|||
155694996|NCT01754194|561976393|FG000|Overall Study|Lost to Follow-up|39|||
155694997|NCT01754194|561976394|FG001|Overall Study|Lost to Follow-up|14|||
155694998|NCT01754194|561976393|FG000|Overall Study|Withdrawal by Subject|4|||
155694999|NCT01754194|561976394|FG001|Overall Study|Withdrawal by Subject|5|||
155695000|NCT01754194|561976393|FG000|Overall Study|Other|9|||
155695001|NCT01754194|561976394|FG001|Overall Study|Other|8|||
155695002|NCT02392403|561976395|FG000|Overall Study|Adverse Event|1|||
155695003|NCT02392403|561976395|FG000|Overall Study|Death|1|||
155695004|NCT02392403|561976395|FG000|Overall Study|Withdrawal by Subject|1|||
155695005|NCT03757130|561976399|FG000|Overall Study|Lost to Follow-up|0|||
155695006|NCT03757130|561976400|FG001|Overall Study|Lost to Follow-up|0|||
155695007|NCT03757130|561976401|FG002|Overall Study|Lost to Follow-up|0|||
155695008|NCT03757130|561976402|FG003|Overall Study|Lost to Follow-up|1|||
155695009|NCT03757130|561976403|FG004|Overall Study|Lost to Follow-up|0|||
155695010|NCT03757130|561976404|FG005|Overall Study|Lost to Follow-up|0|||
155695011|NCT03757130|561976405|FG006|Overall Study|Lost to Follow-up|0|||
155695012|NCT03757130|561976406|FG007|Overall Study|Lost to Follow-up|1|||
155695013|NCT03757130|561976399|FG000|Overall Study|Withdrawal by Subject|0|||
155695014|NCT03757130|561976400|FG001|Overall Study|Withdrawal by Subject|0|||
155695015|NCT03757130|561976401|FG002|Overall Study|Withdrawal by Subject|0|||
155695016|NCT03757130|561976402|FG003|Overall Study|Withdrawal by Subject|0|||
155695017|NCT03757130|561976403|FG004|Overall Study|Withdrawal by Subject|0|||
155695018|NCT03757130|561976404|FG005|Overall Study|Withdrawal by Subject|0|||
155695019|NCT03757130|561976405|FG006|Overall Study|Withdrawal by Subject|1|||
155695020|NCT03757130|561976406|FG007|Overall Study|Withdrawal by Subject|0|||
155695021|NCT02391961|561976407|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
155695022|NCT02391961|561976408|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
155695023|NCT02391961|561976407|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155695024|NCT02391961|561976408|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
155695025|NCT02391961|561976407|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155695026|NCT02391961|561976408|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155695027|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
155695028|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
155695029|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
155695030|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
155695031|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
155695032|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
155695033|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
155695034|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
155695035|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
155695036|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
155695037|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
155695038|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
155695039|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
155695040|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
155695041|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
155695042|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
155695043|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
155695044|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
155695045|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
155695046|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
155695047|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
155695048|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
155695049|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
155695050|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
155695051|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
155695052|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155695053|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155695054|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
155695055|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
155695056|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155695057|NCT00121641|561976409|FG000|24-week Short-term Treatment Period|Other Reason|1|||
155695058|NCT00121641|561976410|FG001|24-week Short-term Treatment Period|Other Reason|0|||
155695059|NCT00121641|561976411|FG002|24-week Short-term Treatment Period|Other Reason|0|||
155695060|NCT00121641|561976412|FG003|24-week Short-term Treatment Period|Other Reason|0|||
155695061|NCT00121641|561976413|FG004|24-week Short-term Treatment Period|Other Reason|0|||
155695062|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
155695063|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
155695064|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
155695065|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
155695066|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
155695067|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
155695068|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
155695069|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
155695070|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
155695071|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
155695072|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
155695073|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
155695074|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
155695075|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
155695076|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
155695077|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
155695078|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
155695079|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
155695080|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
155695081|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
155695082|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
155695083|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
155695084|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
155695085|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
155695086|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
155695087|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
155695088|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
155695089|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
155695090|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
155695091|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
155695092|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
155695093|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
155695094|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
155695095|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
155695096|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
155695097|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
155695098|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
155695099|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
155695100|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
155695101|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
155695102|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Death|0|||
155695103|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Death|0|||
155695104|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Death|0|||
155695105|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Death|1|||
155695106|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Death|0|||
155695107|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Missing|0|||
155695108|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Missing|0|||
155695109|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Missing|1|||
155695110|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Missing|0|||
155695111|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Missing|0|||
155695112|NCT00121641|561976409|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
155695113|NCT00121641|561976410|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
155695114|NCT00121641|561976411|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
155695115|NCT00121641|561976412|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
155695116|NCT00121641|561976413|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
155695117|NCT03263780|561976414|FG000|Overall Study|Withdrawal by Subject|3|||
155695118|NCT03263780|561976414|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
155695119|NCT03995355|561976417|FG000|Overall Study|Adverse Event|1|||
155695120|NCT03995355|561976418|FG001|Overall Study|Adverse Event|0|||
155695121|NCT03995355|561976417|FG000|Overall Study|Withdrawal by Subject|1|||
155695122|NCT03995355|561976418|FG001|Overall Study|Withdrawal by Subject|0|||
155695123|NCT03995355|561976417|FG000|Overall Study|Scheduling Issues|0|||
155695124|NCT03995355|561976418|FG001|Overall Study|Scheduling Issues|1|||
155695125|NCT00249613|561976419|FG000|12 Month Follow-up|Death|1|||
155695126|NCT00249613|561976420|FG001|12 Month Follow-up|Death|1|||
155695127|NCT00249613|561976419|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
155695128|NCT00249613|561976420|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
155695129|NCT00249613|561976419|FG000|12 Month Follow-up|Lost to Follow-up|10|||
155695130|NCT00249613|561976420|FG001|12 Month Follow-up|Lost to Follow-up|8|||
155695131|NCT00094107|561976421|FG000|Overall Study|Lack of Efficacy|23|||
155695132|NCT00094107|561976421|FG000|Overall Study|Death|5|||
155695133|NCT00094107|561976421|FG000|Overall Study|Adverse Event|3|||
155695134|NCT00094107|561976421|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
155695135|NCT00806442|561976446|FG000|Overall Study|Lost to Follow-up|3|||
155695136|NCT00806442|561976447|FG001|Overall Study|Lost to Follow-up|2|||
155695137|NCT00806442|561976446|FG000|Overall Study|Withdrawal by Subject|1|||
155695138|NCT00806442|561976447|FG001|Overall Study|Withdrawal by Subject|5|||
155695139|NCT01455220|561976450|FG000|Overall Study|screen fail|30|||
155695140|NCT00267150|561976451|FG000|Overall Study|Adverse Event|1|||
155695141|NCT00424190|561976453|FG000|Overall Study|Withdrew consent|3|||
155695142|NCT00424190|561976454|FG001|Overall Study|Withdrew consent|4|||
155695143|NCT00424190|561976453|FG000|Overall Study|Death|3|||
155695144|NCT00424190|561976454|FG001|Overall Study|Death|0|||
155695145|NCT00424190|561976453|FG000|Overall Study|Noncompliance|1|||
155695146|NCT00424190|561976454|FG001|Overall Study|Noncompliance|2|||
155695147|NCT00424190|561976453|FG000|Overall Study|Request of sponsor or investigator|0|||
155695148|NCT00424190|561976454|FG001|Overall Study|Request of sponsor or investigator|2|||
155695149|NCT00424190|561976453|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
155695150|NCT00424190|561976454|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
155695151|NCT00424190|561976453|FG000|Overall Study|Other|15|||
155695152|NCT00424190|561976454|FG001|Overall Study|Other|21|||
155695153|NCT00351273|561976455|FG000|Overall Study|Lost to Follow-up|1|||
155695154|NCT00351273|561976456|FG001|Overall Study|Lost to Follow-up|2|||
155695155|NCT00351273|561976457|FG002|Overall Study|Lost to Follow-up|5|||
155695156|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
155695157|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
155695158|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
155695159|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
155695160|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
155695161|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
155695162|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
155695163|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
155695164|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
155695165|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155695166|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155695167|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155695168|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
155695169|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
155695170|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
155695171|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
155695172|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
155695173|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
155695174|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
155695175|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
155695176|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
155695177|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
155695178|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
155695179|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
155695180|NCT01672866|561976458|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
155695181|NCT01672866|561976459|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
155695182|NCT01672866|561976460|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
155695183|NCT01672866|561976458|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
155695184|NCT01672866|561976459|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
155695185|NCT01672866|561976460|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
155695186|NCT01672866|561976458|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
155695187|NCT01672866|561976459|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
155695188|NCT01672866|561976460|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
155695189|NCT01672866|561976458|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
155695190|NCT01672866|561976459|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
155695191|NCT01672866|561976460|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
155695192|NCT01672866|561976458|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
155695193|NCT01672866|561976459|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
155695194|NCT01672866|561976460|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
155695195|NCT00619489|561976463|FG000|Overall Study|Adverse Event|0|||
155695196|NCT00619489|561976464|FG001|Overall Study|Adverse Event|7|||
155695197|NCT00619489|561976463|FG000|Overall Study|Withdrawal by Subject|1|||
155695198|NCT00619489|561976464|FG001|Overall Study|Withdrawal by Subject|1|||
155695199|NCT00619489|561976463|FG000|Overall Study|Lack of Efficacy|0|||
155695200|NCT00619489|561976464|FG001|Overall Study|Lack of Efficacy|11|||
155695201|NCT00619489|561976463|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
155695202|NCT00619489|561976464|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
155695203|NCT03320330|561978296|FG000|Overall Study|Lack of Efficacy|5|||
155695204|NCT03320330|561978297|FG001|Overall Study|Lack of Efficacy|5|||
155695205|NCT03320330|561978298|FG002|Overall Study|Lack of Efficacy|14|||
155695206|NCT03320330|561978296|FG000|Overall Study|Physician Decision|1|||
155695207|NCT03320330|561978297|FG001|Overall Study|Physician Decision|0|||
155695208|NCT03320330|561978298|FG002|Overall Study|Physician Decision|0|||
155695209|NCT02428205|561978301|FG000|Overall Study|Lack of Efficacy|1|||
155695210|NCT02428205|561978302|FG001|Overall Study|Lack of Efficacy|0|||
155695211|NCT02428205|561978301|FG000|Overall Study|Lost to Follow-up|1|||
155695212|NCT02428205|561978302|FG001|Overall Study|Lost to Follow-up|1|||
155695213|NCT02428205|561978301|FG000|Overall Study|Worse behavior|0|||
155695214|NCT02428205|561978302|FG001|Overall Study|Worse behavior|1|||
155695215|NCT02888743|561978303|FG000|Overall Study|Withdrawal by Subject|1|||
155695216|NCT02888743|561978304|FG001|Overall Study|Withdrawal by Subject|2|||
155695217|NCT02888743|561978305|FG002|Overall Study|Withdrawal by Subject|2|||
155695218|NCT02888743|561978306|FG003|Overall Study|Withdrawal by Subject|0|||
155695219|NCT02888743|561978307|FG004|Overall Study|Withdrawal by Subject|1|||
155695220|NCT02888743|561978303|FG000|Overall Study|Disease progression before treatment|2|||
155695221|NCT02888743|561978304|FG001|Overall Study|Disease progression before treatment|0|||
155695222|NCT02888743|561978305|FG002|Overall Study|Disease progression before treatment|2|||
155695223|NCT02888743|561978306|FG003|Overall Study|Disease progression before treatment|0|||
155695224|NCT02888743|561978307|FG004|Overall Study|Disease progression before treatment|0|||
155695225|NCT02888743|561978303|FG000|Overall Study|Patient ineligible|1|||
155695226|NCT02888743|561978304|FG001|Overall Study|Patient ineligible|2|||
155695227|NCT02888743|561978305|FG002|Overall Study|Patient ineligible|0|||
155695228|NCT02888743|561978306|FG003|Overall Study|Patient ineligible|0|||
155695229|NCT02888743|561978307|FG004|Overall Study|Patient ineligible|0|||
155695230|NCT05824936|561978313|FG000|Overall Study|Lost to Follow-up|1|||
155695231|NCT00096018|561978314|FG000|Overall Study|Became Ineligible (not treated)|0|||
155695232|NCT00096018|561978315|FG001|Overall Study|Became Ineligible (not treated)|3|||
155695233|NCT00096018|561978314|FG000|Overall Study|Miscellaneous (not treated)|0|||
155695234|NCT00096018|561978315|FG001|Overall Study|Miscellaneous (not treated)|2|||
155695235|NCT00096018|561978314|FG000|Overall Study|Adverse Event|0|||
155695236|NCT00096018|561978315|FG001|Overall Study|Adverse Event|5|||
155695237|NCT00096018|561978314|FG000|Overall Study|Death|0|||
155695238|NCT00096018|561978315|FG001|Overall Study|Death|1|||
155695239|NCT00096018|561978314|FG000|Overall Study|Withdrawal by Subject|0|||
155695240|NCT00096018|561978315|FG001|Overall Study|Withdrawal by Subject|2|||
155695241|NCT00096018|561978314|FG000|Overall Study|Miscellaneous|2|||
155695242|NCT00096018|561978315|FG001|Overall Study|Miscellaneous|1|||
155695243|NCT01533922|561978316|FG000|Overall Study|Adverse Event|5|||
155695244|NCT01533922|561978317|FG001|Overall Study|Adverse Event|8|||
155695245|NCT01533922|561978318|FG002|Overall Study|Adverse Event|6|||
155695246|NCT01533922|561978319|FG003|Overall Study|Adverse Event|3|||
155695247|NCT01533922|561978320|FG004|Overall Study|Adverse Event|4|||
155695248|NCT01533922|561978316|FG000|Overall Study|Lack of Efficacy|0|||
155695249|NCT01533922|561978317|FG001|Overall Study|Lack of Efficacy|0|||
155695250|NCT01533922|561978318|FG002|Overall Study|Lack of Efficacy|1|||
155695251|NCT01533922|561978319|FG003|Overall Study|Lack of Efficacy|0|||
155695252|NCT01533922|561978320|FG004|Overall Study|Lack of Efficacy|0|||
155695253|NCT01533922|561978316|FG000|Overall Study|Protocol Violation|0|||
155695254|NCT01533922|561978317|FG001|Overall Study|Protocol Violation|3|||
155695255|NCT01533922|561978318|FG002|Overall Study|Protocol Violation|0|||
155695256|NCT01533922|561978319|FG003|Overall Study|Protocol Violation|0|||
155695257|NCT01533922|561978320|FG004|Overall Study|Protocol Violation|1|||
155695258|NCT01533922|561978316|FG000|Overall Study|Withdrawal by Subject|3|||
155695259|NCT01533922|561978317|FG001|Overall Study|Withdrawal by Subject|1|||
155695260|NCT01533922|561978318|FG002|Overall Study|Withdrawal by Subject|2|||
155695261|NCT01533922|561978319|FG003|Overall Study|Withdrawal by Subject|2|||
155695262|NCT01533922|561978320|FG004|Overall Study|Withdrawal by Subject|1|||
155695263|NCT01533922|561978316|FG000|Overall Study|Other reason not defined above|2|||
155695264|NCT01533922|561978317|FG001|Overall Study|Other reason not defined above|0|||
155695265|NCT01533922|561978318|FG002|Overall Study|Other reason not defined above|1|||
155695266|NCT01533922|561978319|FG003|Overall Study|Other reason not defined above|0|||
155695267|NCT01533922|561978320|FG004|Overall Study|Other reason not defined above|0|||
155695268|NCT00106691|561978322|FG000|Overall Study|Adverse Event|60|||
155695269|NCT00106691|561978323|FG001|Overall Study|Adverse Event|64|||
155695270|NCT00106691|561978322|FG000|Overall Study|Lost to Follow-up|23|||
155695271|NCT00106691|561978323|FG001|Overall Study|Lost to Follow-up|18|||
155695272|NCT00106691|561978322|FG000|Overall Study|Physician Decision|18|||
155695273|NCT00106691|561978323|FG001|Overall Study|Physician Decision|21|||
155695274|NCT00106691|561978322|FG000|Overall Study|Protocol Violation|13|||
155695275|NCT00106691|561978323|FG001|Overall Study|Protocol Violation|18|||
155695276|NCT00106691|561978322|FG000|Overall Study|Withdrawal by Subject|75|||
155695277|NCT00106691|561978323|FG001|Overall Study|Withdrawal by Subject|70|||
155695278|NCT00106691|561978322|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
155695279|NCT00106691|561978323|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
155695280|NCT00106691|561978322|FG000|Overall Study|QTc>480|3|||
155695281|NCT00106691|561978323|FG001|Overall Study|QTc>480|1|||
155695282|NCT00106691|561978322|FG000|Overall Study|mililtary deployment|2|||
155695283|NCT00106691|561978323|FG001|Overall Study|mililtary deployment|0|||
155695284|NCT00106691|561978322|FG000|Overall Study|Study Site Closing/PI Moved|1|||
155695285|NCT00106691|561978323|FG001|Overall Study|Study Site Closing/PI Moved|2|||
155695286|NCT00106691|561978322|FG000|Overall Study|Cardiologist recommendation|1|||
155695287|NCT00106691|561978323|FG001|Overall Study|Cardiologist recommendation|0|||
155695288|NCT00106691|561978322|FG000|Overall Study|Pt. moved to another state|1|||
155695289|NCT00106691|561978323|FG001|Overall Study|Pt. moved to another state|0|||
155695290|NCT00106691|561978322|FG000|Overall Study|Taking exclusionary avodart|1|||
155695291|NCT00106691|561978323|FG001|Overall Study|Taking exclusionary avodart|0|||
155695292|NCT00106691|561978322|FG000|Overall Study|Not able to discontinue plavix|0|||
155695293|NCT00106691|561978323|FG001|Overall Study|Not able to discontinue plavix|1|||
155695294|NCT00907296|561978324|FG000|Overall Study|Ineligibility Determined|1|||
155695295|NCT00907296|561978325|FG001|Overall Study|Ineligibility Determined|0|||
155695296|NCT00907296|561978326|FG002|Overall Study|Ineligibility Determined|0|||
155695297|NCT00907296|561978327|FG003|Overall Study|Ineligibility Determined|1|||
155695298|NCT00907296|561978328|FG004|Overall Study|Ineligibility Determined|0|||
155695299|NCT00907296|561978329|FG005|Overall Study|Ineligibility Determined|0|||
155695300|NCT00907296|561978330|FG006|Overall Study|Ineligibility Determined|0|||
155695301|NCT00907296|561978331|FG007|Overall Study|Ineligibility Determined|1|||
155695302|NCT00907296|561978332|FG008|Overall Study|Ineligibility Determined|0|||
155695303|NCT00907296|561978333|FG009|Overall Study|Ineligibility Determined|0|||
155695304|NCT00907296|561978324|FG000|Overall Study|Protocol Deviation|0|||
155695305|NCT00907296|561978325|FG001|Overall Study|Protocol Deviation|1|||
155695306|NCT00907296|561978326|FG002|Overall Study|Protocol Deviation|0|||
155695307|NCT00907296|561978327|FG003|Overall Study|Protocol Deviation|0|||
155695308|NCT00907296|561978328|FG004|Overall Study|Protocol Deviation|0|||
155695309|NCT00907296|561978329|FG005|Overall Study|Protocol Deviation|0|||
155695310|NCT00907296|561978330|FG006|Overall Study|Protocol Deviation|0|||
155695311|NCT00907296|561978331|FG007|Overall Study|Protocol Deviation|0|||
155695312|NCT00907296|561978332|FG008|Overall Study|Protocol Deviation|0|||
155695313|NCT00907296|561978333|FG009|Overall Study|Protocol Deviation|0|||
155695314|NCT00907296|561978324|FG000|Overall Study|Noncompliance|1|||
155695315|NCT00907296|561978325|FG001|Overall Study|Noncompliance|1|||
155695316|NCT00907296|561978326|FG002|Overall Study|Noncompliance|1|||
155695317|NCT00907296|561978327|FG003|Overall Study|Noncompliance|0|||
155695318|NCT00907296|561978328|FG004|Overall Study|Noncompliance|0|||
155695319|NCT00907296|561978329|FG005|Overall Study|Noncompliance|1|||
155695320|NCT00907296|561978330|FG006|Overall Study|Noncompliance|0|||
155695321|NCT00907296|561978331|FG007|Overall Study|Noncompliance|2|||
155695322|NCT00907296|561978332|FG008|Overall Study|Noncompliance|0|||
155695323|NCT00907296|561978333|FG009|Overall Study|Noncompliance|0|||
155695324|NCT00907296|561978324|FG000|Overall Study|Adverse Event|2|||
155695325|NCT00907296|561978325|FG001|Overall Study|Adverse Event|0|||
155695326|NCT00907296|561978326|FG002|Overall Study|Adverse Event|0|||
155695327|NCT00907296|561978327|FG003|Overall Study|Adverse Event|0|||
155695328|NCT00907296|561978328|FG004|Overall Study|Adverse Event|0|||
155695329|NCT00907296|561978329|FG005|Overall Study|Adverse Event|0|||
155695330|NCT00907296|561978330|FG006|Overall Study|Adverse Event|1|||
155695331|NCT00907296|561978331|FG007|Overall Study|Adverse Event|0|||
155695332|NCT00907296|561978332|FG008|Overall Study|Adverse Event|0|||
155695333|NCT00907296|561978333|FG009|Overall Study|Adverse Event|1|||
155695334|NCT00907296|561978324|FG000|Overall Study|Withdrawal by Subject|7|||
155695335|NCT00907296|561978325|FG001|Overall Study|Withdrawal by Subject|2|||
155695336|NCT00907296|561978326|FG002|Overall Study|Withdrawal by Subject|1|||
155695337|NCT00907296|561978327|FG003|Overall Study|Withdrawal by Subject|1|||
155695338|NCT00907296|561978328|FG004|Overall Study|Withdrawal by Subject|1|||
155695339|NCT00907296|561978329|FG005|Overall Study|Withdrawal by Subject|5|||
155695340|NCT00907296|561978330|FG006|Overall Study|Withdrawal by Subject|3|||
155695341|NCT00907296|561978331|FG007|Overall Study|Withdrawal by Subject|2|||
155695342|NCT00907296|561978332|FG008|Overall Study|Withdrawal by Subject|4|||
155695343|NCT00907296|561978333|FG009|Overall Study|Withdrawal by Subject|2|||
155695344|NCT00907296|561978324|FG000|Overall Study|Lost to Follow-up|9|||
155695345|NCT00907296|561978325|FG001|Overall Study|Lost to Follow-up|1|||
155695346|NCT00907296|561978326|FG002|Overall Study|Lost to Follow-up|0|||
155695347|NCT00907296|561978327|FG003|Overall Study|Lost to Follow-up|2|||
155695348|NCT00907296|561978328|FG004|Overall Study|Lost to Follow-up|0|||
155695349|NCT00907296|561978329|FG005|Overall Study|Lost to Follow-up|3|||
155695350|NCT00907296|561978330|FG006|Overall Study|Lost to Follow-up|2|||
155695351|NCT00907296|561978331|FG007|Overall Study|Lost to Follow-up|2|||
155695352|NCT00907296|561978332|FG008|Overall Study|Lost to Follow-up|0|||
155695353|NCT00907296|561978333|FG009|Overall Study|Lost to Follow-up|4|||
155695354|NCT02776033|561978338|FG000|Overall Study|Withdrawal by Subject|0|||
155695355|NCT02776033|561978339|FG001|Overall Study|Withdrawal by Subject|0|||
155695356|NCT02776033|561978340|FG002|Overall Study|Withdrawal by Subject|2|||
155695357|NCT02776033|561978338|FG000|Overall Study|Physician Decision|2|||
155695358|NCT02776033|561978339|FG001|Overall Study|Physician Decision|0|||
155695359|NCT02776033|561978340|FG002|Overall Study|Physician Decision|0|||
155695360|NCT02776033|561978338|FG000|Overall Study|Lost to Follow-up|1|||
155695361|NCT02776033|561978339|FG001|Overall Study|Lost to Follow-up|0|||
155695362|NCT02776033|561978340|FG002|Overall Study|Lost to Follow-up|0|||
155695363|NCT02776033|561978338|FG000|Overall Study|Adverse Event|1|||
155695364|NCT02776033|561978339|FG001|Overall Study|Adverse Event|2|||
155695365|NCT02776033|561978340|FG002|Overall Study|Adverse Event|0|||
155695366|NCT02616393|561978344|FG000|Overall Study|Death|5|||
155695367|NCT02616393|561978345|FG001|Overall Study|Death|12|||
155695368|NCT02616393|561978346|FG002|Overall Study|Death|1|||
155695369|NCT02616393|561978344|FG000|Overall Study|Termination by Sponsor|4|||
155695370|NCT02616393|561978345|FG001|Overall Study|Termination by Sponsor|5|||
155695371|NCT02616393|561978346|FG002|Overall Study|Termination by Sponsor|2|||
155695372|NCT02616393|561978344|FG000|Overall Study|Other|3|||
155695373|NCT02616393|561978345|FG001|Overall Study|Other|0|||
155695374|NCT02616393|561978346|FG002|Overall Study|Other|0|||
155695375|NCT02616393|561978344|FG000|Overall Study|Withdrawal by Subject|1|||
155695376|NCT02616393|561978345|FG001|Overall Study|Withdrawal by Subject|1|||
155695377|NCT02616393|561978346|FG002|Overall Study|Withdrawal by Subject|0|||
155695378|NCT02616393|561978344|FG000|Overall Study|Lost to Follow-up|0|||
155695379|NCT02616393|561978345|FG001|Overall Study|Lost to Follow-up|2|||
155695380|NCT02616393|561978346|FG002|Overall Study|Lost to Follow-up|0|||
155695381|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
155695382|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
155695383|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
155695384|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
155695385|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
155695386|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
155695387|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
155695388|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
155695389|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
155695390|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
155695391|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
155695392|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
155695393|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
155695394|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
155695395|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
155695396|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
155695397|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
155695398|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
155695399|NCT01302054|561978347|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
155695400|NCT01302054|561978348|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
155695401|NCT01302054|561978349|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
155695402|NCT01302054|561978347|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
155695403|NCT01302054|561978348|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
155606529|NCT01254721|561647690|FG001|Overall Study|Wrongly randomization|1|||
155606530|NCT03170609|561647692|FG000|Overall Study|Death|0|||
155606531|NCT03170609|561647693|FG001|Overall Study|Death|0|||
155606532|NCT03170609|561647694|FG002|Overall Study|Death|1|||
155606533|NCT03170609|561647695|FG003|Overall Study|Death|0|||
155606534|NCT03170609|561647696|FG004|Overall Study|Death|0|||
155606535|NCT03170609|561647697|FG005|Overall Study|Death|0|||
155606536|NCT03170609|561647698|FG006|Overall Study|Death|0|||
155606537|NCT03170609|561647692|FG000|Overall Study|Withdrawal by Subject|1|||
155606538|NCT03170609|561647693|FG001|Overall Study|Withdrawal by Subject|2|||
155606539|NCT03170609|561647694|FG002|Overall Study|Withdrawal by Subject|0|||
155606540|NCT03170609|561647695|FG003|Overall Study|Withdrawal by Subject|0|||
155606541|NCT03170609|561647696|FG004|Overall Study|Withdrawal by Subject|0|||
155606542|NCT03170609|561647697|FG005|Overall Study|Withdrawal by Subject|0|||
155606543|NCT03170609|561647698|FG006|Overall Study|Withdrawal by Subject|1|||
155606544|NCT03170609|561647692|FG000|Overall Study|Lost to Follow-up|1|||
155606545|NCT03170609|561647693|FG001|Overall Study|Lost to Follow-up|0|||
155606546|NCT03170609|561647694|FG002|Overall Study|Lost to Follow-up|5|||
155606547|NCT03170609|561647695|FG003|Overall Study|Lost to Follow-up|2|||
155606548|NCT03170609|561647696|FG004|Overall Study|Lost to Follow-up|1|||
155606549|NCT03170609|561647697|FG005|Overall Study|Lost to Follow-up|1|||
155606550|NCT03170609|561647698|FG006|Overall Study|Lost to Follow-up|0|||
155606551|NCT03170609|561647692|FG000|Overall Study|Other|1|||
155695404|NCT01302054|561978349|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
155695405|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155695406|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
155695407|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
155695408|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155695409|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
155695410|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155695411|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155695412|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
155606552|NCT03170609|561647693|FG001|Overall Study|Other|0|||
155606553|NCT03170609|561647694|FG002|Overall Study|Other|0|||
155606554|NCT03170609|561647695|FG003|Overall Study|Other|0|||
155695413|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
155695414|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
155606555|NCT03170609|561647696|FG004|Overall Study|Other|0|||
155606556|NCT03170609|561647697|FG005|Overall Study|Other|1|||
155606557|NCT03170609|561647698|FG006|Overall Study|Other|0|||
155606558|NCT01592292|561647702|FG000|Overall Study|Follow-up loss|3|||
155606559|NCT01592292|561647703|FG001|Overall Study|Follow-up loss|3|||
155606560|NCT01592292|561647704|FG002|Overall Study|Follow-up loss|1|||
155695415|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
155695416|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
155695417|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155695418|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
155695419|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
155695420|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
155695421|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
155695422|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
155695423|NCT01302054|561978347|FG000|Double-Blind Treatment Phase|Other|0|||
155695424|NCT01302054|561978348|FG001|Double-Blind Treatment Phase|Other|4|||
155695425|NCT01302054|561978349|FG002|Double-Blind Treatment Phase|Other|9|||
155695426|NCT02445573|561978351|FG000|Overall Study|Withdrawal by Subject|1|||
155695427|NCT02445573|561978352|FG001|Overall Study|Withdrawal by Subject|1|||
155695428|NCT02445573|561978351|FG000|Overall Study|Lost to Follow-up|0|||
155695429|NCT02445573|561978352|FG001|Overall Study|Lost to Follow-up|1|||
155695430|NCT04047420|561978353|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
155695431|NCT04047420|561978353|FG000|Washout Period|Refused Participation|2|||
155695432|NCT01639755|561978354|FG000|Overall Study|Study Ongoing|15|||
155695433|NCT01639755|561978354|FG000|Overall Study|Patient had device explantation|4|||
155695434|NCT02365285|561978355|FG000|Overall Study|Physician Decision|0|||
155695435|NCT02365285|561978356|FG001|Overall Study|Physician Decision|1|||
155695436|NCT02365285|561978357|FG002|Overall Study|Physician Decision|1|||
155695437|NCT02365285|561978358|FG003|Overall Study|Physician Decision|0|||
155695438|NCT02365285|561978355|FG000|Overall Study|Adverse Event|0|||
155695439|NCT02365285|561978356|FG001|Overall Study|Adverse Event|0|||
155695440|NCT02365285|561978357|FG002|Overall Study|Adverse Event|0|||
155695441|NCT02365285|561978358|FG003|Overall Study|Adverse Event|2|||
155695442|NCT03262116|561978359|FG000|Overall Study|Physician Decision|0|||
155695443|NCT03262116|561978360|FG001|Overall Study|Physician Decision|2|||
155695444|NCT03262116|561978361|FG002|Overall Study|Physician Decision|1|||
155695445|NCT03262116|561978362|FG003|Overall Study|Physician Decision|1|||
155695446|NCT03262116|561978363|FG004|Overall Study|Physician Decision|1|||
155695447|NCT03262116|561978364|FG005|Overall Study|Physician Decision|2|||
155695448|NCT02608450|561978367|FG000|Overall Study|Lost to Follow-up|39|||
155695449|NCT02608450|561978368|FG001|Overall Study|Lost to Follow-up|32|||
155695450|NCT02608450|561978367|FG000|Overall Study|Withdrawal by Subject|21|||
155695451|NCT02608450|561978368|FG001|Overall Study|Withdrawal by Subject|15|||
155695452|NCT02608450|561978367|FG000|Overall Study|Adverse Event|3|||
155695453|NCT02608450|561978368|FG001|Overall Study|Adverse Event|6|||
155695454|NCT02608450|561978367|FG000|Overall Study|Withdrawal by parent|2|||
155695455|NCT02608450|561978368|FG001|Overall Study|Withdrawal by parent|3|||
155695456|NCT02608450|561978367|FG000|Overall Study|Lack of Efficacy|0|||
155695457|NCT02608450|561978368|FG001|Overall Study|Lack of Efficacy|3|||
155695458|NCT02608450|561978367|FG000|Overall Study|Noncompliance with study drug|0|||
155695459|NCT02608450|561978368|FG001|Overall Study|Noncompliance with study drug|2|||
155695460|NCT02608450|561978367|FG000|Overall Study|Physician Decision|0|||
155695461|NCT02608450|561978368|FG001|Overall Study|Physician Decision|1|||
155695462|NCT02608450|561978367|FG000|Overall Study|Pregnancy|0|||
155695463|NCT02608450|561978368|FG001|Overall Study|Pregnancy|1|||
155695464|NCT02608450|561978367|FG000|Overall Study|Progressive disease|1|||
155695465|NCT02608450|561978368|FG001|Overall Study|Progressive disease|0|||
155695466|NCT02608450|561978367|FG000|Overall Study|Multiple reasons|0|||
155695467|NCT02608450|561978368|FG001|Overall Study|Multiple reasons|2|||
155695468|NCT00635089|561978373|FG000|Overall Study|Adverse Event|7|||
155695469|NCT00635089|561978373|FG000|Overall Study|Lack of Efficacy|28|||
155695470|NCT00635089|561978373|FG000|Overall Study|Protocol Deviation|4|||
155695471|NCT00635089|561978373|FG000|Overall Study|Lost to Follow-up|8|||
155695472|NCT00635089|561978373|FG000|Overall Study|Other|31|||
155695473|NCT01617447|561978374|FG000|Overall Study|Adverse Event|0|||
155695474|NCT01617447|561978375|FG001|Overall Study|Adverse Event|1|||
155695475|NCT01617447|561978374|FG000|Overall Study|Physician Decision|0|||
155695476|NCT01617447|561978375|FG001|Overall Study|Physician Decision|2|||
155695477|NCT01283542|561978377|FG000|Main Phase|Acute or progressive vision loss|1|||
155695478|NCT01283542|561978377|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
155695479|NCT01283542|561978377|FG000|Main Phase|abnormal laboratory values|5|||
155695480|NCT01283542|561978377|FG000|Extension Phase|Physician Decision|1|||
155695481|NCT01283542|561978377|FG000|Extension Phase|Adverse Event|1|||
155695482|NCT01283542|561978377|FG000|Extension Phase|Administrative problems|1|||
155695483|NCT02636946|561978378|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
155695484|NCT02636946|561978379|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
155695485|NCT02636946|561978378|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
155695486|NCT02636946|561978379|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
155695487|NCT02636946|561978378|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
155695488|NCT02636946|561978379|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
155695489|NCT02636946|561978378|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
155695490|NCT02636946|561978379|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
155695491|NCT02636946|561978378|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
155695492|NCT02636946|561978379|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
155695493|NCT02636946|561978378|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
155695494|NCT02636946|561978379|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
155695495|NCT05059977|561978380|FG000|Overall Study|Withdrawal by Subject|0|||
155695496|NCT05059977|561978381|FG001|Overall Study|Withdrawal by Subject|0|||
155695497|NCT05059977|561978382|FG002|Overall Study|Withdrawal by Subject|1|||
155606561|NCT01592292|561647705|FG003|Overall Study|Follow-up loss|0|||
155606562|NCT01592292|561647702|FG000|Overall Study|Withdrew consent|2|||
155606563|NCT01592292|561647703|FG001|Overall Study|Withdrew consent|1|||
155606564|NCT01592292|561647704|FG002|Overall Study|Withdrew consent|0|||
155606565|NCT01592292|561647705|FG003|Overall Study|Withdrew consent|0|||
155606566|NCT01592292|561647702|FG000|Overall Study|Other|1|||
155606567|NCT01592292|561647703|FG001|Overall Study|Other|1|||
155606568|NCT01592292|561647704|FG002|Overall Study|Other|2|||
155606569|NCT01592292|561647705|FG003|Overall Study|Other|1|||
155606570|NCT00335959|561647706|FG000|Overall Study|Adverse Event|2|||
155606571|NCT00335959|561647706|FG000|Overall Study|Ineligible|1|||
155606572|NCT02028169|561647707|FG000|Overall Study|Lost to Follow-up|21|||
155606573|NCT02028169|561647707|FG000|Overall Study|Lack of Efficacy|2|||
155606574|NCT02028169|561647707|FG000|Overall Study|Withdrawal by Subject|2|||
155606575|NCT02028169|561647707|FG000|Overall Study|Adverse Event|1|||
155606576|NCT02028169|561647707|FG000|Overall Study|Cessation of Drug|1|||
155606577|NCT02028169|561647707|FG000|Overall Study|Concomitant Medication Usage|1|||
155606578|NCT03482167|561647708|FG000|Allocated to Intervention|Physician Decision|1|||
155606579|NCT03482167|561647709|FG001|Allocated to Intervention|Physician Decision|2|||
155606580|NCT03482167|561647708|FG000|Received Intervention|Adverse Event|3|||
155606581|NCT03482167|561647709|FG001|Received Intervention|Adverse Event|1|||
155606582|NCT03482167|561647708|FG000|Received Intervention|Physician Decision|1|||
155606583|NCT03482167|561647709|FG001|Received Intervention|Physician Decision|1|||
155606584|NCT03482167|561647708|FG000|Received Intervention|Withdrawal by Subject|1|||
155606585|NCT03482167|561647709|FG001|Received Intervention|Withdrawal by Subject|0|||
155606586|NCT01001598|561647712|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
155606587|NCT01001598|561647712|FG000|Overall Study|Adverse Event|1|||
155606588|NCT02240069|561647719|FG000|Overall Study|Withdrawal by Subject|5|||
155606589|NCT02240069|561647720|FG001|Overall Study|Withdrawal by Subject|5|||
155606590|NCT02240069|561647721|FG002|Overall Study|Withdrawal by Subject|2|||
155606591|NCT00106639|561647722|FG000|Overall Study|Adverse Event|3|||
155606592|NCT00106639|561647723|FG001|Overall Study|Adverse Event|4|||
155606593|NCT00106639|561647724|FG002|Overall Study|Adverse Event|1|||
155606594|NCT00106639|561647722|FG000|Overall Study|Protocol Violation|0|||
155606595|NCT00106639|561647723|FG001|Overall Study|Protocol Violation|1|||
155606596|NCT00106639|561647724|FG002|Overall Study|Protocol Violation|0|||
155606597|NCT00106639|561647722|FG000|Overall Study|Withdrawal by Subject|0|||
155606598|NCT00106639|561647723|FG001|Overall Study|Withdrawal by Subject|1|||
155606599|NCT00106639|561647724|FG002|Overall Study|Withdrawal by Subject|0|||
155606600|NCT00106639|561647722|FG000|Overall Study|Participant defaulted|0|||
155606601|NCT00106639|561647723|FG001|Overall Study|Participant defaulted|1|||
155606602|NCT00106639|561647724|FG002|Overall Study|Participant defaulted|1|||
155606603|NCT01096589|561647725|FG000|Overall Study|Adverse Event|2|||
155606604|NCT01096589|561647726|FG001|Overall Study|Adverse Event|1|||
155606605|NCT01096589|561647727|FG002|Overall Study|Adverse Event|2|||
155606606|NCT01096589|561647728|FG003|Overall Study|Adverse Event|1|||
155606607|NCT01096589|561647725|FG000|Overall Study|Withdrawal by Subject|2|||
155606608|NCT01096589|561647726|FG001|Overall Study|Withdrawal by Subject|1|||
155606609|NCT01096589|561647727|FG002|Overall Study|Withdrawal by Subject|1|||
155606610|NCT01096589|561647728|FG003|Overall Study|Withdrawal by Subject|1|||
155606611|NCT01096589|561647725|FG000|Overall Study|Compliance with protocol|0|||
155606612|NCT01096589|561647726|FG001|Overall Study|Compliance with protocol|0|||
155606613|NCT01096589|561647727|FG002|Overall Study|Compliance with protocol|1|||
155606614|NCT01096589|561647728|FG003|Overall Study|Compliance with protocol|0|||
155606615|NCT01096589|561647725|FG000|Overall Study|found treatment exhausting|0|||
155606616|NCT01096589|561647726|FG001|Overall Study|found treatment exhausting|0|||
155606617|NCT01096589|561647727|FG002|Overall Study|found treatment exhausting|0|||
155606618|NCT01096589|561647728|FG003|Overall Study|found treatment exhausting|1|||
155606619|NCT00948506|561647729|FG000|Overall Study|Withdrawal by Subject|3|||
155606620|NCT00948506|561647730|FG001|Overall Study|Withdrawal by Subject|1|||
155606621|NCT03233204|561647732|FG000|Overall Study|Adverse Event|1|||
155606622|NCT03233204|561647732|FG000|Overall Study|Death|1|||
155606623|NCT03233204|561647732|FG000|Overall Study|Withdrawal by Subject|1|||
155606624|NCT03233204|561647732|FG000|Overall Study|Progressive Disease|3|||
155606625|NCT02908074|561647734|FG000|Overall Study|sponsor/ICON decision|0|||
155606626|NCT02908074|561647735|FG001|Overall Study|sponsor/ICON decision|0|||
155606627|NCT02908074|561647736|FG002|Overall Study|sponsor/ICON decision|1|||
155606628|NCT02908074|561647737|FG003|Overall Study|sponsor/ICON decision|0|||
155606629|NCT02908074|561647738|FG004|Overall Study|sponsor/ICON decision|0|||
155606630|NCT02908074|561647739|FG005|Overall Study|sponsor/ICON decision|0|||
155606631|NCT02908074|561647734|FG000|Overall Study|Protocol Violation|0|||
155606632|NCT02908074|561647735|FG001|Overall Study|Protocol Violation|1|||
155606633|NCT02908074|561647736|FG002|Overall Study|Protocol Violation|0|||
155606634|NCT02908074|561647737|FG003|Overall Study|Protocol Violation|0|||
155606635|NCT02908074|561647738|FG004|Overall Study|Protocol Violation|0|||
155695498|NCT00576472|561978383|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695499|NCT00576472|561978384|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695500|NCT00576472|561978385|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695501|NCT00576472|561978386|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
155695502|NCT00576472|561978387|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695503|NCT00576472|561978388|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695504|NCT00576472|561978389|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695505|NCT00576472|561978390|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695506|NCT00576472|561978391|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695507|NCT00576472|561978392|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695508|NCT00576472|561978393|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695509|NCT00576472|561978394|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695510|NCT00576472|561978395|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695511|NCT00576472|561978396|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695512|NCT00576472|561978397|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
155695513|NCT00576472|561978383|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
155695514|NCT00576472|561978384|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
155695515|NCT00576472|561978385|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
155695516|NCT00576472|561978386|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
155695517|NCT00576472|561978387|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
155695518|NCT00576472|561978388|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
155695519|NCT00576472|561978389|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
155695520|NCT00576472|561978390|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
155695521|NCT00576472|561978391|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
155695522|NCT00576472|561978392|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
155695523|NCT00576472|561978393|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
155695524|NCT00576472|561978394|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
155695525|NCT00576472|561978395|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
155695526|NCT00576472|561978396|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
155695527|NCT00576472|561978397|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
155695528|NCT00576472|561978383|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695529|NCT00576472|561978384|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695530|NCT00576472|561978385|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695531|NCT00576472|561978386|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
155695532|NCT00576472|561978387|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695533|NCT00576472|561978388|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695534|NCT00576472|561978389|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695535|NCT00576472|561978390|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695536|NCT00576472|561978391|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695537|NCT00576472|561978392|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695538|NCT00576472|561978393|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695539|NCT00576472|561978394|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695540|NCT00576472|561978395|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695541|NCT00576472|561978396|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695542|NCT00576472|561978397|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155695543|NCT00576472|561978383|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
155695544|NCT00576472|561978384|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
155695545|NCT00576472|561978385|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
155695546|NCT00576472|561978386|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
155695547|NCT00576472|561978387|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
155695548|NCT00576472|561978388|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
155695549|NCT00576472|561978389|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
155695550|NCT00576472|561978390|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
155695551|NCT00576472|561978391|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
155695552|NCT00576472|561978392|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
155695553|NCT00576472|561978393|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
155695554|NCT00576472|561978394|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
155695555|NCT00576472|561978395|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
155695556|NCT00576472|561978396|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
155695557|NCT00576472|561978397|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
155695558|NCT00576472|561978383|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695559|NCT00576472|561978384|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695560|NCT00576472|561978385|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695561|NCT00576472|561978386|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
155695562|NCT00576472|561978387|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695563|NCT00576472|561978388|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695564|NCT00576472|561978389|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695565|NCT00576472|561978390|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695566|NCT00576472|561978391|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695567|NCT00576472|561978392|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695568|NCT00576472|561978393|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695569|NCT00576472|561978394|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695570|NCT00576472|561978395|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695571|NCT00576472|561978396|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695572|NCT00576472|561978397|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
155695573|NCT00576472|561978383|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695574|NCT00576472|561978384|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695575|NCT00576472|561978385|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695576|NCT00576472|561978386|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695577|NCT00576472|561978387|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695578|NCT00576472|561978388|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695579|NCT00576472|561978389|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
155695580|NCT00576472|561978390|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695581|NCT00576472|561978391|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695582|NCT00576472|561978392|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695583|NCT00576472|561978393|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695584|NCT00576472|561978394|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695585|NCT00576472|561978395|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695586|NCT00576472|561978396|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695587|NCT00576472|561978397|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
155695588|NCT00576472|561978383|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
155695589|NCT00576472|561978384|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
155695590|NCT00576472|561978385|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
155695591|NCT00576472|561978386|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
155695592|NCT00576472|561978387|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
155695593|NCT00576472|561978388|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
155695594|NCT00576472|561978389|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
155695595|NCT00576472|561978390|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
155695596|NCT00576472|561978391|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
155695597|NCT00576472|561978392|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
155695598|NCT00576472|561978393|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
155695599|NCT00576472|561978394|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
155695600|NCT00576472|561978395|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
155695601|NCT00576472|561978396|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
155695602|NCT00576472|561978397|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
155695603|NCT00576472|561978383|FG000|MPH Cross Over Phase|Physician Decision|0|||
155695604|NCT00576472|561978384|FG001|MPH Cross Over Phase|Physician Decision|0|||
155695605|NCT00576472|561978385|FG002|MPH Cross Over Phase|Physician Decision|0|||
155695606|NCT00576472|561978386|FG003|MPH Cross Over Phase|Physician Decision|0|||
155695607|NCT00576472|561978387|FG004|MPH Cross Over Phase|Physician Decision|0|||
155695608|NCT00576472|561978388|FG005|MPH Cross Over Phase|Physician Decision|0|||
155695609|NCT00576472|561978389|FG006|MPH Cross Over Phase|Physician Decision|4|||
155695610|NCT00576472|561978390|FG007|MPH Cross Over Phase|Physician Decision|0|||
155695611|NCT00576472|561978391|FG008|MPH Cross Over Phase|Physician Decision|0|||
155695612|NCT00576472|561978392|FG009|MPH Cross Over Phase|Physician Decision|0|||
155695613|NCT00576472|561978393|FG010|MPH Cross Over Phase|Physician Decision|0|||
155695614|NCT00576472|561978394|FG011|MPH Cross Over Phase|Physician Decision|0|||
155695615|NCT00576472|561978395|FG012|MPH Cross Over Phase|Physician Decision|0|||
155695616|NCT00576472|561978396|FG013|MPH Cross Over Phase|Physician Decision|0|||
155695617|NCT00576472|561978397|FG014|MPH Cross Over Phase|Physician Decision|0|||
155695618|NCT00576472|561978383|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695619|NCT00576472|561978384|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695620|NCT00576472|561978385|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695621|NCT00576472|561978386|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695622|NCT00576472|561978387|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695623|NCT00576472|561978388|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695624|NCT00576472|561978389|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695625|NCT00576472|561978390|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695626|NCT00576472|561978391|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
155695627|NCT00576472|561978392|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695628|NCT00576472|561978393|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
155695629|NCT00576472|561978394|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
155695630|NCT00576472|561978395|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695631|NCT00576472|561978396|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695632|NCT00576472|561978397|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
155695633|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695634|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695635|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695636|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695637|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695638|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695639|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695640|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695641|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695642|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695643|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695644|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695645|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695646|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
155695647|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155695648|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
155695649|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
155695650|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
155695651|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
155695652|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
155695653|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
155695654|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
155695655|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
155695656|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
155695657|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
155695658|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
155695659|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
155695660|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
155695661|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
155695662|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
155695663|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
155695664|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
155695665|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
155695666|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
155695667|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
155695668|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
155695669|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
155695670|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
155695671|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
155695672|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
155695673|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
155695674|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
155695675|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
155695676|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
155695677|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
155695678|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Side effects|0|||
155695679|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Side effects|0|||
155695680|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Side effects|0|||
155695681|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Side effects|0|||
155695682|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Side effects|0|||
155695683|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Side effects|0|||
155695684|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Side effects|0|||
155695685|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Side effects|0|||
155695686|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Side effects|0|||
155695687|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Side effects|0|||
155695688|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Side effects|0|||
155606636|NCT02908074|561647739|FG005|Overall Study|Protocol Violation|0|||
155606637|NCT02908074|561647734|FG000|Overall Study|Adverse Event|5|||
155606638|NCT02908074|561647735|FG001|Overall Study|Adverse Event|2|||
155606639|NCT02908074|561647736|FG002|Overall Study|Adverse Event|0|||
155606640|NCT02908074|561647737|FG003|Overall Study|Adverse Event|0|||
155606641|NCT02908074|561647738|FG004|Overall Study|Adverse Event|1|||
155606642|NCT02908074|561647739|FG005|Overall Study|Adverse Event|0|||
155606643|NCT02908074|561647734|FG000|Overall Study|AESI|1|||
155606644|NCT02908074|561647735|FG001|Overall Study|AESI|0|||
155606645|NCT02908074|561647736|FG002|Overall Study|AESI|1|||
155606646|NCT02908074|561647737|FG003|Overall Study|AESI|0|||
155606647|NCT02908074|561647738|FG004|Overall Study|AESI|1|||
155606648|NCT02908074|561647739|FG005|Overall Study|AESI|0|||
155606649|NCT02908074|561647734|FG000|Overall Study|Discontinuation criteria per protocol|0|||
155606650|NCT02908074|561647735|FG001|Overall Study|Discontinuation criteria per protocol|0|||
155606651|NCT02908074|561647736|FG002|Overall Study|Discontinuation criteria per protocol|1|||
155606652|NCT02908074|561647737|FG003|Overall Study|Discontinuation criteria per protocol|0|||
155606653|NCT02908074|561647738|FG004|Overall Study|Discontinuation criteria per protocol|0|||
155606654|NCT02908074|561647739|FG005|Overall Study|Discontinuation criteria per protocol|1|||
155606655|NCT02908074|561647734|FG000|Overall Study|Withdrawal by Subject|3|||
155606656|NCT02908074|561647735|FG001|Overall Study|Withdrawal by Subject|2|||
155606657|NCT02908074|561647736|FG002|Overall Study|Withdrawal by Subject|2|||
155606658|NCT02908074|561647737|FG003|Overall Study|Withdrawal by Subject|2|||
155606659|NCT02908074|561647738|FG004|Overall Study|Withdrawal by Subject|2|||
155606660|NCT02908074|561647739|FG005|Overall Study|Withdrawal by Subject|2|||
155606661|NCT02908074|561647734|FG000|Overall Study|Lost to Follow-up|0|||
155606662|NCT02908074|561647735|FG001|Overall Study|Lost to Follow-up|1|||
155606663|NCT02908074|561647736|FG002|Overall Study|Lost to Follow-up|1|||
155606664|NCT02908074|561647737|FG003|Overall Study|Lost to Follow-up|1|||
155606665|NCT02908074|561647738|FG004|Overall Study|Lost to Follow-up|0|||
155606666|NCT02908074|561647739|FG005|Overall Study|Lost to Follow-up|1|||
155606667|NCT02073565|561647740|FG000|Cohort A|Withdrawal by Subject|1|||
155606668|NCT02073565|561647741|FG001|Cohort A|Withdrawal by Subject|0|||
155606669|NCT02073565|561647740|FG000|Cohort B|Withdrawal by Subject|1|||
155606670|NCT02073565|561647741|FG001|Cohort B|Withdrawal by Subject|2|||
155695689|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Side effects|0|||
155695690|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Side effects|0|||
155695691|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Side effects|0|||
155695692|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Side effects|8|||
155695693|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695694|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695695|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695696|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695697|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695698|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695699|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695700|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695701|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695702|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695703|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695704|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695705|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695706|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155695707|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
155695708|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
155695709|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
155695710|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
155695711|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
155695712|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
155695713|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
155695714|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
155695715|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
155695716|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
155695717|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
155695718|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
155695719|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
155695720|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
155695721|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
155695722|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
155695723|NCT00576472|561978383|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695724|NCT00576472|561978384|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695725|NCT00576472|561978385|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695726|NCT00576472|561978386|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695727|NCT00576472|561978387|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695728|NCT00576472|561978388|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695729|NCT00576472|561978389|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695730|NCT00576472|561978390|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695731|NCT00576472|561978391|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695732|NCT00576472|561978392|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695733|NCT00576472|561978393|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695734|NCT00576472|561978394|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695735|NCT00576472|561978395|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695736|NCT00576472|561978396|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155695737|NCT00576472|561978397|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
155695738|NCT03443427|561978398|FG000|Overall Study|Adverse Event|2|||
155695739|NCT03443427|561978399|FG001|Overall Study|Adverse Event|3|||
155695740|NCT03443427|561978398|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
155695741|NCT03443427|561978399|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155695742|NCT03443427|561978398|FG000|Overall Study|Other|4|||
155695743|NCT03443427|561978399|FG001|Overall Study|Other|6|||
155695744|NCT04405245|561978401|FG000|Overall Study|Adverse Event|0|||
155695745|NCT04405245|561978402|FG001|Overall Study|Adverse Event|1|||
155695746|NCT04405245|561978403|FG002|Overall Study|Adverse Event|0|||
155695747|NCT00780273|561978404|FG000|Overall Study|Death|1|||
155695748|NCT00780273|561978404|FG000|Overall Study|Lost to Follow-up|1|||
155695749|NCT02576860|561978405|FG000|Overall Study|Adverse Event|6|||
155695750|NCT02576860|561978406|FG001|Overall Study|Adverse Event|6|||
155695751|NCT02576860|561978405|FG000|Overall Study|Lost to Follow-up|5|||
155695752|NCT02576860|561978406|FG001|Overall Study|Lost to Follow-up|7|||
155695753|NCT02576860|561978405|FG000|Overall Study|Physician Decision|0|||
155695754|NCT02576860|561978406|FG001|Overall Study|Physician Decision|1|||
155695755|NCT02576860|561978405|FG000|Overall Study|Protocol Violation|0|||
155695756|NCT02576860|561978406|FG001|Overall Study|Protocol Violation|2|||
155695757|NCT02576860|561978405|FG000|Overall Study|Withdrawal by Subject|13|||
155695758|NCT02576860|561978406|FG001|Overall Study|Withdrawal by Subject|8|||
155695759|NCT02576860|561978405|FG000|Overall Study|Disallowed medication|1|||
155695760|NCT02576860|561978406|FG001|Overall Study|Disallowed medication|0|||
155695761|NCT00477269|561978407|FG000|Core Study|Adverse Event|6|||
155695762|NCT00477269|561978408|FG001|Core Study|Adverse Event|4|||
155695763|NCT00477269|561978409|FG002|Core Study|Adverse Event|0|||
155695764|NCT00477269|561978407|FG000|Core Study|Death|3|||
155695765|NCT00477269|561978408|FG001|Core Study|Death|3|||
155695766|NCT00477269|561978409|FG002|Core Study|Death|0|||
155695767|NCT00477269|561978407|FG000|Core Study|Withdrawn Consent|0|||
155695768|NCT00477269|561978408|FG001|Core Study|Withdrawn Consent|1|||
155695769|NCT00477269|561978409|FG002|Core Study|Withdrawn Consent|0|||
155695770|NCT00477269|561978407|FG000|Open Label Extension|Adverse Event|0|||
155695771|NCT00477269|561978408|FG001|Open Label Extension|Adverse Event|0|||
155695772|NCT00477269|561978409|FG002|Open Label Extension|Adverse Event|4|||
155695773|NCT00477269|561978407|FG000|Open Label Extension|Abnormal laboratory values|0|||
155695774|NCT00477269|561978408|FG001|Open Label Extension|Abnormal laboratory values|0|||
155695775|NCT00477269|561978409|FG002|Open Label Extension|Abnormal laboratory values|1|||
155695776|NCT00477269|561978407|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
155695777|NCT00477269|561978408|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
155695778|NCT00477269|561978409|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
155695779|NCT00477269|561978407|FG000|Open Label Extension|Adminiatrative problems|0|||
155695780|NCT00477269|561978408|FG001|Open Label Extension|Adminiatrative problems|0|||
155695781|NCT00477269|561978409|FG002|Open Label Extension|Adminiatrative problems|2|||
155695782|NCT00477269|561978407|FG000|Open Label Extension|Death|0|||
155695783|NCT00477269|561978408|FG001|Open Label Extension|Death|0|||
155695784|NCT00477269|561978409|FG002|Open Label Extension|Death|4|||
155695785|NCT01792518|561978410|FG000|Overall Study|Adverse Event|3|||
155695786|NCT01792518|561978411|FG001|Overall Study|Adverse Event|4|||
155695787|NCT01792518|561978410|FG000|Overall Study|Protocol Violation|0|||
155695788|NCT01792518|561978411|FG001|Overall Study|Protocol Violation|1|||
155695789|NCT01792518|561978410|FG000|Overall Study|Lost to Follow-up|3|||
155695790|NCT01792518|561978411|FG001|Overall Study|Lost to Follow-up|1|||
155695791|NCT01792518|561978410|FG000|Overall Study|Withdrawal by Subject|2|||
155695792|NCT01792518|561978411|FG001|Overall Study|Withdrawal by Subject|0|||
155695793|NCT01792518|561978410|FG000|Overall Study|Other Reason|0|||
155695794|NCT01792518|561978411|FG001|Overall Study|Other Reason|1|||
155695795|NCT02528357|561978426|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695796|NCT02528357|561978427|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
155695797|NCT02528357|561978428|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695798|NCT02528357|561978429|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695799|NCT02528357|561978430|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695800|NCT02528357|561978431|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695801|NCT02528357|561978432|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695802|NCT02528357|561978433|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695803|NCT02528357|561978434|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695804|NCT02528357|561978435|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695805|NCT02528357|561978436|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695806|NCT02528357|561978437|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695807|NCT02528357|561978438|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695808|NCT02528357|561978439|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695809|NCT02528357|561978440|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695810|NCT02528357|561978441|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695811|NCT02528357|561978442|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695812|NCT02528357|561978443|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695813|NCT02528357|561978444|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155695814|NCT02528357|561978426|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695815|NCT02528357|561978427|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695816|NCT02528357|561978428|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695817|NCT02528357|561978429|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
155695818|NCT02528357|561978430|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695819|NCT02528357|561978431|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
155695820|NCT02528357|561978432|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695821|NCT02528357|561978433|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
155695822|NCT02528357|561978434|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695823|NCT02528357|561978435|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695824|NCT02528357|561978436|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695825|NCT02528357|561978437|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695826|NCT02528357|561978438|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155606671|NCT02073565|561647740|FG000|Cohort C|Withdrawal by Subject|0|||
155606672|NCT02073565|561647741|FG001|Cohort C|Withdrawal by Subject|2|||
155606673|NCT02073565|561647740|FG000|Cohort C|Lost to Follow-up|0|||
155606674|NCT02073565|561647741|FG001|Cohort C|Lost to Follow-up|2|||
155606675|NCT01764997|561647742|FG000|Run-in Period|Adverse Event|15|||
155606676|NCT01764997|561647743|FG001|Run-in Period|Adverse Event|0|||
155606677|NCT01764997|561647744|FG002|Run-in Period|Adverse Event|0|||
155695827|NCT02528357|561978439|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695828|NCT02528357|561978440|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695829|NCT02528357|561978441|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695830|NCT02528357|561978442|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695831|NCT02528357|561978443|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695832|NCT02528357|561978444|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155695833|NCT02528357|561978426|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155606678|NCT01764997|561647745|FG003|Run-in Period|Adverse Event|0|||
155606679|NCT01764997|561647746|FG004|Run-in Period|Adverse Event|0|||
155606680|NCT01764997|561647742|FG000|Run-in Period|Lack of Efficacy|5|||
155606681|NCT01764997|561647743|FG001|Run-in Period|Lack of Efficacy|0|||
155606682|NCT01764997|561647744|FG002|Run-in Period|Lack of Efficacy|0|||
155606683|NCT01764997|561647745|FG003|Run-in Period|Lack of Efficacy|0|||
155606684|NCT01764997|561647746|FG004|Run-in Period|Lack of Efficacy|0|||
155606685|NCT01764997|561647742|FG000|Run-in Period|Poor compliance to protocol|1|||
155606686|NCT01764997|561647743|FG001|Run-in Period|Poor compliance to protocol|0|||
155606687|NCT01764997|561647744|FG002|Run-in Period|Poor compliance to protocol|0|||
155695834|NCT02528357|561978427|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695835|NCT02528357|561978428|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
155695836|NCT02528357|561978429|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695837|NCT02528357|561978430|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
155695838|NCT02528357|561978431|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695839|NCT02528357|561978432|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
155695840|NCT02528357|561978433|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
155695841|NCT02528357|561978434|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695842|NCT02528357|561978435|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695843|NCT02528357|561978436|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695844|NCT02528357|561978437|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695845|NCT02528357|561978438|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695846|NCT02528357|561978439|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695847|NCT02528357|561978440|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695848|NCT02528357|561978441|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695849|NCT02528357|561978442|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695850|NCT02528357|561978443|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695851|NCT02528357|561978444|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155695852|NCT02528357|561978426|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695853|NCT02528357|561978427|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695854|NCT02528357|561978428|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695855|NCT02528357|561978429|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695856|NCT02528357|561978430|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695857|NCT02528357|561978431|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695858|NCT02528357|561978432|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695859|NCT02528357|561978433|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695860|NCT02528357|561978434|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695861|NCT02528357|561978435|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695862|NCT02528357|561978436|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695863|NCT02528357|561978437|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695864|NCT02528357|561978438|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695865|NCT02528357|561978439|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695866|NCT02528357|561978440|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695867|NCT02528357|561978441|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695868|NCT02528357|561978442|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695869|NCT02528357|561978443|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695870|NCT02528357|561978444|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695871|NCT02528357|561978426|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695872|NCT02528357|561978427|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695873|NCT02528357|561978428|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695874|NCT02528357|561978429|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695875|NCT02528357|561978430|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695876|NCT02528357|561978431|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695877|NCT02528357|561978432|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695878|NCT02528357|561978433|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695879|NCT02528357|561978434|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695880|NCT02528357|561978435|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695881|NCT02528357|561978436|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695882|NCT02528357|561978437|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695883|NCT02528357|561978438|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695884|NCT02528357|561978439|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
155695885|NCT02528357|561978440|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
155695886|NCT02528357|561978441|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695887|NCT02528357|561978442|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695888|NCT02528357|561978443|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695889|NCT02528357|561978444|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155695890|NCT02528357|561978426|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695891|NCT02528357|561978427|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695892|NCT02528357|561978428|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695893|NCT02528357|561978429|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695894|NCT02528357|561978430|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695895|NCT02528357|561978431|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695896|NCT02528357|561978432|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695897|NCT02528357|561978433|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695898|NCT02528357|561978434|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695899|NCT02528357|561978435|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695900|NCT02528357|561978436|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695901|NCT02528357|561978437|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695902|NCT02528357|561978438|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695903|NCT02528357|561978439|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
155695904|NCT02528357|561978440|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695905|NCT02528357|561978441|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695906|NCT02528357|561978442|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695907|NCT02528357|561978443|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695908|NCT02528357|561978444|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155695909|NCT02528357|561978426|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695910|NCT02528357|561978427|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695911|NCT02528357|561978428|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695912|NCT02528357|561978429|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695913|NCT02528357|561978430|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695914|NCT02528357|561978431|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695915|NCT02528357|561978432|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695916|NCT02528357|561978433|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695917|NCT02528357|561978434|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695918|NCT02528357|561978435|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695919|NCT02528357|561978436|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
155695920|NCT02528357|561978437|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695921|NCT02528357|561978438|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
155695922|NCT02528357|561978439|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
155695923|NCT02528357|561978440|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
155695924|NCT02528357|561978441|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695925|NCT02528357|561978442|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695926|NCT02528357|561978443|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695927|NCT02528357|561978444|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155695928|NCT02528357|561978426|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695929|NCT02528357|561978427|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695930|NCT02528357|561978428|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695931|NCT02528357|561978429|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695932|NCT02528357|561978430|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695933|NCT02528357|561978431|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695934|NCT02528357|561978432|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695935|NCT02528357|561978433|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695936|NCT02528357|561978434|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695937|NCT02528357|561978435|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695938|NCT02528357|561978436|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695939|NCT02528357|561978437|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
155695940|NCT02528357|561978438|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
155695941|NCT02528357|561978439|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695942|NCT02528357|561978440|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695943|NCT02528357|561978441|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695944|NCT02528357|561978442|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695945|NCT02528357|561978443|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695946|NCT02528357|561978444|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695947|NCT02528357|561978426|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695948|NCT02528357|561978427|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695949|NCT02528357|561978428|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695950|NCT02528357|561978429|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695951|NCT02528357|561978430|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695952|NCT02528357|561978431|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695953|NCT02528357|561978432|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695954|NCT02528357|561978433|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695955|NCT02528357|561978434|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695956|NCT02528357|561978435|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695957|NCT02528357|561978436|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695958|NCT02528357|561978437|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695959|NCT02528357|561978438|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695960|NCT02528357|561978439|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695961|NCT02528357|561978440|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695962|NCT02528357|561978441|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695963|NCT02528357|561978442|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
155695964|NCT02528357|561978443|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695965|NCT02528357|561978444|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155695966|NCT02528357|561978426|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695967|NCT02528357|561978427|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695968|NCT02528357|561978428|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695969|NCT02528357|561978429|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695970|NCT02528357|561978430|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695971|NCT02528357|561978431|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695972|NCT02528357|561978432|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695973|NCT02528357|561978433|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695974|NCT02528357|561978434|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695975|NCT02528357|561978435|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695976|NCT02528357|561978436|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695977|NCT02528357|561978437|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695978|NCT02528357|561978438|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695979|NCT02528357|561978439|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695980|NCT02528357|561978440|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695981|NCT02528357|561978441|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155695982|NCT02528357|561978442|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155695983|NCT02528357|561978443|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
155695984|NCT02528357|561978444|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
155695985|NCT01378429|561978449|FG000|Overall Study|Noncompliance with study drug|1|||
155695986|NCT01378429|561978450|FG001|Overall Study|Noncompliance with study drug|0|||
155695987|NCT02356887|561978451|FG000|Overall Study|poor compliance|2|||
155695988|NCT04208087|561978452|FG000|Overall Study|Adverse Event|1|||
155695989|NCT04208087|561978453|FG001|Overall Study|Adverse Event|0|||
155695990|NCT04208087|561978454|FG002|Overall Study|Adverse Event|0|||
155695991|NCT04208087|561978455|FG003|Overall Study|Adverse Event|0|||
155695992|NCT04208087|561978456|FG004|Overall Study|Adverse Event|0|||
155695993|NCT04208087|561978452|FG000|Overall Study|Withdrawal by Subject|0|||
155695994|NCT04208087|561978453|FG001|Overall Study|Withdrawal by Subject|0|||
155695995|NCT04208087|561978454|FG002|Overall Study|Withdrawal by Subject|1|||
155695996|NCT04208087|561978455|FG003|Overall Study|Withdrawal by Subject|0|||
155695997|NCT04208087|561978456|FG004|Overall Study|Withdrawal by Subject|0|||
155695998|NCT04208087|561978452|FG000|Overall Study|Other|0|||
155695999|NCT04208087|561978453|FG001|Overall Study|Other|0|||
155696000|NCT04208087|561978454|FG002|Overall Study|Other|0|||
155606688|NCT01764997|561647745|FG003|Run-in Period|Poor compliance to protocol|0|||
155606689|NCT01764997|561647746|FG004|Run-in Period|Poor compliance to protocol|0|||
155606690|NCT01764997|561647742|FG000|Run-in Period|Other than specified above|17|||
155606691|NCT01764997|561647743|FG001|Run-in Period|Other than specified above|0|||
155606692|NCT01764997|561647744|FG002|Run-in Period|Other than specified above|0|||
155606693|NCT01764997|561647745|FG003|Run-in Period|Other than specified above|0|||
155606694|NCT01764997|561647746|FG004|Run-in Period|Other than specified above|0|||
155606695|NCT01764997|561647742|FG000|Study Drug Treatment Period|Adverse Event|0|||
155606696|NCT01764997|561647743|FG001|Study Drug Treatment Period|Adverse Event|1|||
155606697|NCT01764997|561647744|FG002|Study Drug Treatment Period|Adverse Event|0|||
155606698|NCT01764997|561647745|FG003|Study Drug Treatment Period|Adverse Event|0|||
155606699|NCT01764997|561647746|FG004|Study Drug Treatment Period|Adverse Event|24|||
155606700|NCT01764997|561647742|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
155606701|NCT01764997|561647743|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
155606702|NCT01764997|561647744|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
155606703|NCT01764997|561647745|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
155606704|NCT01764997|561647746|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
155606705|NCT01764997|561647742|FG000|Study Drug Treatment Period|Other than specified above|0|||
155606706|NCT01764997|561647743|FG001|Study Drug Treatment Period|Other than specified above|0|||
155606707|NCT01764997|561647744|FG002|Study Drug Treatment Period|Other than specified above|0|||
155606708|NCT01764997|561647745|FG003|Study Drug Treatment Period|Other than specified above|0|||
155606709|NCT01764997|561647746|FG004|Study Drug Treatment Period|Other than specified above|10|||
155606710|NCT03046056|561649517|FG000|Overall Study|Non-responder at Week 10|6|||
155606711|NCT03046056|561649518|FG001|Overall Study|Non-responder at Week 10|6|||
155606712|NCT03046056|561649519|FG002|Overall Study|Non-responder at Week 10|4|||
155606713|NCT03046056|561649517|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
155606714|NCT03046056|561649518|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
155606715|NCT03046056|561649519|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
155606716|NCT03046056|561649517|FG000|Overall Study|Adverse Event|1|||
155606717|NCT03046056|561649518|FG001|Overall Study|Adverse Event|5|||
155606718|NCT03046056|561649519|FG002|Overall Study|Adverse Event|0|||
155606719|NCT03046056|561649517|FG000|Overall Study|Non-compliance With Study Drug|0|||
155606720|NCT03046056|561649518|FG001|Overall Study|Non-compliance With Study Drug|0|||
155606721|NCT03046056|561649519|FG002|Overall Study|Non-compliance With Study Drug|2|||
155606722|NCT03046056|561649517|FG000|Overall Study|Protocol Violation|1|||
155606723|NCT03046056|561649518|FG001|Overall Study|Protocol Violation|1|||
155606724|NCT03046056|561649519|FG002|Overall Study|Protocol Violation|0|||
155606725|NCT03046056|561649517|FG000|Overall Study|Investigator's Discretion|0|||
155606726|NCT03046056|561649518|FG001|Overall Study|Investigator's Discretion|1|||
155606727|NCT03046056|561649519|FG002|Overall Study|Investigator's Discretion|0|||
155606728|NCT03046056|561649517|FG000|Overall Study|Withdrew Consent|1|||
155606729|NCT03046056|561649518|FG001|Overall Study|Withdrew Consent|0|||
155606730|NCT03046056|561649519|FG002|Overall Study|Withdrew Consent|0|||
155606731|NCT02290925|561649525|FG000|First Period of Three Months|Lost to Follow-up|2|||
155606732|NCT02290925|561649526|FG001|First Period of Three Months|Lost to Follow-up|1|||
155606733|NCT02290925|561649525|FG000|First Period of Three Months|Death|1|||
155606734|NCT02290925|561649526|FG001|First Period of Three Months|Death|0|||
155606735|NCT02290925|561649525|FG000|First Period of Three Months|Insulin Started|1|||
155606736|NCT02290925|561649526|FG001|First Period of Three Months|Insulin Started|1|||
155606737|NCT02290925|561649525|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
155606738|NCT02290925|561649526|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
155606739|NCT02290925|561649525|FG000|Second Period of 3 Months|insulin started|0|||
155606740|NCT02290925|561649526|FG001|Second Period of 3 Months|insulin started|1|||
155606741|NCT02956057|561649543|FG000|Overall Study|Discontinued intervention|14|||
155606742|NCT02956057|561649544|FG001|Overall Study|Discontinued intervention|10|||
155606743|NCT02956057|561649545|FG002|Overall Study|Discontinued intervention|7|||
155606744|NCT02956057|561649546|FG003|Overall Study|Discontinued intervention|14|||
155606745|NCT02956057|561649547|FG004|Overall Study|Discontinued intervention|4|||
155606746|NCT02956057|561649548|FG005|Overall Study|Discontinued intervention|17|||
155606747|NCT02956057|561649543|FG000|Overall Study|Lost to Follow-up|0|||
155606748|NCT02956057|561649544|FG001|Overall Study|Lost to Follow-up|2|||
155606749|NCT02956057|561649545|FG002|Overall Study|Lost to Follow-up|1|||
155606750|NCT02956057|561649546|FG003|Overall Study|Lost to Follow-up|1|||
155606751|NCT02956057|561649547|FG004|Overall Study|Lost to Follow-up|1|||
155606752|NCT02956057|561649548|FG005|Overall Study|Lost to Follow-up|0|||
155606753|NCT01420679|561649555|FG000|Overall Study|Disease Progression|3|||
155606754|NCT01420679|561649556|FG001|Overall Study|Disease Progression|2|||
155606755|NCT01420679|561649555|FG000|Overall Study|Adverse Event|4|||
155606756|NCT01420679|561649556|FG001|Overall Study|Adverse Event|0|||
155606757|NCT01420679|561649555|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
155606758|NCT01420679|561649556|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
155606759|NCT01420679|561649555|FG000|Overall Study|Patient Decision|1|||
155606760|NCT01420679|561649556|FG001|Overall Study|Patient Decision|0|||
155696001|NCT04208087|561978455|FG003|Overall Study|Other|0|||
155696002|NCT04208087|561978456|FG004|Overall Study|Other|1|||
155696003|NCT01012323|561978457|FG000|Overall Study|Investigator Judgment|1|||
155696004|NCT02920957|561978458|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
155696005|NCT02920957|561978459|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
155696006|NCT02920957|561978458|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
155696007|NCT02920957|561978459|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
155696008|NCT02920957|561978458|FG000|First Intervention : 1 Month|Adverse Event|1|||
155696009|NCT02920957|561978459|FG001|First Intervention : 1 Month|Adverse Event|0|||
155696010|NCT02920957|561978458|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
155696011|NCT02920957|561978459|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
155696012|NCT01789606|561978460|FG000|Overall Study|Participant not Purchased the Product|0|||
155696013|NCT01789606|561978461|FG001|Overall Study|Participant not Purchased the Product|20|||
155696014|NCT01789606|561978460|FG000|Overall Study|Withdrawal by Subject|0|||
155696015|NCT01789606|561978461|FG001|Overall Study|Withdrawal by Subject|1|||
155696016|NCT01789606|561978460|FG000|Overall Study|Ineligible|6|||
155696017|NCT01789606|561978461|FG001|Overall Study|Ineligible|2|||
155696018|NCT01789606|561978460|FG000|Overall Study|Administrative Reasons|17|||
155696019|NCT01789606|561978461|FG001|Overall Study|Administrative Reasons|6|||
155696020|NCT01789606|561978460|FG000|Overall Study|No Study Medication Taken|0|||
155696021|NCT01789606|561978461|FG001|Overall Study|No Study Medication Taken|1|||
155696022|NCT01789606|561978460|FG000|Overall Study|Protocol Violation|0|||
155696023|NCT01789606|561978461|FG001|Overall Study|Protocol Violation|55|||
155696024|NCT01789606|561978460|FG000|Overall Study|Adverse Event|0|||
155696025|NCT01789606|561978461|FG001|Overall Study|Adverse Event|3|||
155696026|NCT01789606|561978460|FG000|Overall Study|Lost to Follow-up|0|||
155696027|NCT01789606|561978461|FG001|Overall Study|Lost to Follow-up|14|||
155696028|NCT01789606|561978460|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
155696029|NCT01789606|561978461|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
155696030|NCT01563172|561978464|FG000|Overall Study|Adverse Event|5|||
155696031|NCT01563172|561978464|FG000|Overall Study|Lost to Follow-up|2|||
155696032|NCT01563172|561978464|FG000|Overall Study|Other (Protocol deviation)|5|||
155696033|NCT01563172|561978464|FG000|Overall Study|Other (Not specified)|1|||
155696034|NCT01638559|561978468|FG000|Overall Study|Lost to Follow-up|1|||
155696035|NCT01638559|561978468|FG000|Overall Study|Withdrawal by Subject|1|||
155696036|NCT01638559|561978468|FG000|Overall Study|Subject declined to travel for biopsy|1|||
155696037|NCT01216683|561980269|FG000|Induction|Never started treatment|0|||
155696038|NCT01216683|561980270|FG001|Induction|Never started treatment|6|||
155696039|NCT01216683|561980271|FG002|Induction|Never started treatment|3|||
155696040|NCT01216683|561980269|FG000|Induction|Lack of Efficacy|4|||
155696041|NCT01216683|561980270|FG001|Induction|Lack of Efficacy|3|||
155696042|NCT01216683|561980271|FG002|Induction|Lack of Efficacy|7|||
155696043|NCT01216683|561980269|FG000|Induction|Adverse Event|0|||
155696044|NCT01216683|561980270|FG001|Induction|Adverse Event|5|||
155696045|NCT01216683|561980271|FG002|Induction|Adverse Event|5|||
155696046|NCT01216683|561980269|FG000|Induction|Death|0|||
155696047|NCT01216683|561980270|FG001|Induction|Death|0|||
155696048|NCT01216683|561980271|FG002|Induction|Death|2|||
155696049|NCT01216683|561980269|FG000|Induction|Withdrawal by Subject|0|||
155696050|NCT01216683|561980270|FG001|Induction|Withdrawal by Subject|4|||
155696051|NCT01216683|561980271|FG002|Induction|Withdrawal by Subject|2|||
155696052|NCT01216683|561980269|FG000|Induction|Other disease|0|||
155696053|NCT01216683|561980270|FG001|Induction|Other disease|1|||
155696054|NCT01216683|561980271|FG002|Induction|Other disease|2|||
155696055|NCT01216683|561980269|FG000|Continuation|Lack of Efficacy|3|||
155696056|NCT01216683|561980270|FG001|Continuation|Lack of Efficacy|2|||
155696057|NCT01216683|561980271|FG002|Continuation|Lack of Efficacy|7|||
155696058|NCT01216683|561980269|FG000|Continuation|Adverse Event|5|||
155696059|NCT01216683|561980270|FG001|Continuation|Adverse Event|3|||
155696060|NCT01216683|561980271|FG002|Continuation|Adverse Event|16|||
155696061|NCT01216683|561980269|FG000|Continuation|Death|1|||
155696062|NCT01216683|561980270|FG001|Continuation|Death|0|||
155696063|NCT01216683|561980271|FG002|Continuation|Death|2|||
155696064|NCT01216683|561980269|FG000|Continuation|Withdrawal by Subject|4|||
155696065|NCT01216683|561980270|FG001|Continuation|Withdrawal by Subject|5|||
155696066|NCT01216683|561980271|FG002|Continuation|Withdrawal by Subject|9|||
155696067|NCT01216683|561980269|FG000|Continuation|Other diseases|0|||
155696068|NCT01216683|561980270|FG001|Continuation|Other diseases|2|||
155696069|NCT01216683|561980271|FG002|Continuation|Other diseases|1|||
155696070|NCT01216683|561980269|FG000|Continuation|Physician Decision|1|||
155696071|NCT01216683|561980270|FG001|Continuation|Physician Decision|0|||
155696072|NCT01216683|561980271|FG002|Continuation|Physician Decision|1|||
155696073|NCT01216683|561980269|FG000|Continuation|Non-compliance|1|||
155696074|NCT01216683|561980270|FG001|Continuation|Non-compliance|0|||
155696075|NCT01216683|561980271|FG002|Continuation|Non-compliance|1|||
155696076|NCT01216683|561980269|FG000|Continuation|Insurance change|0|||
155696077|NCT01216683|561980270|FG001|Continuation|Insurance change|1|||
155696078|NCT01216683|561980271|FG002|Continuation|Insurance change|0|||
155696079|NCT01216683|561980269|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
155696080|NCT01216683|561980270|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
155696081|NCT01216683|561980271|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
155696082|NCT01216683|561980269|FG000|Continuation|Not reported|0|||
155696083|NCT01216683|561980270|FG001|Continuation|Not reported|0|||
155696084|NCT01216683|561980271|FG002|Continuation|Not reported|1|||
155696085|NCT01216683|561980269|FG000|Continuation|Never started treatment|0|||
155696086|NCT01216683|561980270|FG001|Continuation|Never started treatment|1|||
155696087|NCT01216683|561980271|FG002|Continuation|Never started treatment|5|||
155696088|NCT00652951|561980278|FG000|Booster Phase|Adverse event, non-fatal|0|||
155696089|NCT00652951|561980279|FG001|Booster Phase|Adverse event, non-fatal|1|||
155696090|NCT00652951|561980280|FG002|Booster Phase|Adverse event, non-fatal|0|||
155696091|NCT00652951|561980278|FG000|Booster Phase|Other|1|||
155696092|NCT00652951|561980279|FG001|Booster Phase|Other|0|||
155696093|NCT00652951|561980280|FG002|Booster Phase|Other|0|||
155696094|NCT02593825|561980281|FG000|Intervention|Lost to Follow-up|10|||
155696095|NCT02593825|561980282|FG001|Intervention|Lost to Follow-up|12|||
155696096|NCT01022424|561980283|FG000|Overall Study|Adverse Event|1|||
155696097|NCT01022424|561980283|FG000|Overall Study|Physician Decision|1|||
155696098|NCT01022424|561980283|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
155696099|NCT06359080|561980284|FG000|Overall Study|Withdrawal by Subject|3|||
155696100|NCT00511134|561980285|FG000|Overall Study|Withdrawal by Subject|0|||
155696101|NCT00511134|561980286|FG001|Overall Study|Withdrawal by Subject|2|||
155696102|NCT01949090|561980287|FG000|Overall Study|Serious Adverse Event|0|||
155696103|NCT01949090|561980288|FG001|Overall Study|Serious Adverse Event|1|||
155696104|NCT01949090|561980289|FG002|Overall Study|Serious Adverse Event|2|||
155696105|NCT01949090|561980290|FG003|Overall Study|Serious Adverse Event|0|||
155696106|NCT01949090|561980291|FG004|Overall Study|Serious Adverse Event|1|||
155696107|NCT01949090|561980287|FG000|Overall Study|Withdrawal by Subject|2|||
155696108|NCT01949090|561980288|FG001|Overall Study|Withdrawal by Subject|0|||
155696109|NCT01949090|561980289|FG002|Overall Study|Withdrawal by Subject|0|||
155696110|NCT01949090|561980290|FG003|Overall Study|Withdrawal by Subject|0|||
155696111|NCT01949090|561980291|FG004|Overall Study|Withdrawal by Subject|1|||
155696112|NCT01949090|561980287|FG000|Overall Study|Protocol non-compliance|0|||
155696113|NCT01949090|561980288|FG001|Overall Study|Protocol non-compliance|0|||
155696114|NCT01949090|561980289|FG002|Overall Study|Protocol non-compliance|0|||
155696115|NCT01949090|561980290|FG003|Overall Study|Protocol non-compliance|0|||
155696116|NCT01949090|561980291|FG004|Overall Study|Protocol non-compliance|1|||
155696117|NCT01949090|561980287|FG000|Overall Study|Lost to Follow-up|2|||
155696118|NCT01949090|561980288|FG001|Overall Study|Lost to Follow-up|1|||
155696119|NCT01949090|561980289|FG002|Overall Study|Lost to Follow-up|0|||
155696120|NCT01949090|561980290|FG003|Overall Study|Lost to Follow-up|1|||
155696121|NCT01949090|561980291|FG004|Overall Study|Lost to Follow-up|1|||
155696122|NCT03459365|561980292|FG000|Overall Study|Withdrawal by Subject|6|||
155696123|NCT03459365|561980292|FG000|Overall Study|Protocol Violation|8|||
155696124|NCT00599755|561980293|FG000|Overall Study|Adverse Event|11|||
155696125|NCT00599755|561980293|FG000|Overall Study|Withdrawal by Subject|2|||
155696126|NCT00599755|561980293|FG000|Overall Study|Progression of Disease|3|||
155696127|NCT00599755|561980293|FG000|Overall Study|Other Reason|2|||
155696128|NCT00599755|561980293|FG000|Overall Study|No data available|1|||
155696129|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
155696130|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155696131|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155696132|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155696133|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
155696134|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155696135|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155696136|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155696137|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
155696138|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155696139|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155696140|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155696141|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
155696142|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155696143|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155696144|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155696145|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
155696146|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
155696147|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
155696148|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
155696149|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
155696150|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155696151|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155696152|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155696153|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
155696154|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155696155|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155696156|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155696157|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
155696158|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155696159|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155696160|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155696161|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
155696162|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155696163|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155696164|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155696165|NCT02198794|561980294|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
155696166|NCT02198794|561980295|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155696167|NCT02198794|561980296|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155696168|NCT02198794|561980297|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155696169|NCT02198794|561980294|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
155696170|NCT02198794|561980295|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
155696171|NCT02198794|561980296|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
155696172|NCT02198794|561980297|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
155696173|NCT02198794|561980294|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
155696174|NCT02198794|561980295|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
155696175|NCT02198794|561980296|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
155696176|NCT02198794|561980297|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
155696177|NCT02198794|561980294|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155696178|NCT02198794|561980295|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155696179|NCT02198794|561980296|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155696180|NCT02198794|561980297|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
155696181|NCT02198794|561980294|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155696182|NCT02198794|561980295|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155696183|NCT02198794|561980296|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155696184|NCT02198794|561980297|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
155696185|NCT02198794|561980294|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
155696186|NCT02198794|561980295|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
155696187|NCT02198794|561980296|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
155696188|NCT02198794|561980297|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
155696189|NCT01306656|561980298|FG000|Overall Study|Lost to Follow-up|1|||
155696190|NCT01306656|561980299|FG001|Overall Study|Lost to Follow-up|0|||
155696191|NCT00477152|561980300|FG000|Overall Study|Parent withdrew consent|2|||
155696192|NCT00477152|561980300|FG000|Overall Study|Adverse Event|1|||
155696193|NCT01918332|561980302|FG000|Overall Study|Adverse Event|0|||
155696194|NCT01918332|561980303|FG001|Overall Study|Adverse Event|0|||
155696195|NCT01918332|561980304|FG002|Overall Study|Adverse Event|0|||
155696196|NCT01918332|561980305|FG003|Overall Study|Adverse Event|1|||
155696197|NCT01918332|561980302|FG000|Overall Study|Withdrawal by Subject|2|||
155696198|NCT01918332|561980303|FG001|Overall Study|Withdrawal by Subject|3|||
155696199|NCT01918332|561980304|FG002|Overall Study|Withdrawal by Subject|2|||
155696200|NCT01918332|561980305|FG003|Overall Study|Withdrawal by Subject|3|||
155696201|NCT01918332|561980302|FG000|Overall Study|Protocol Violation|6|||
155696202|NCT01918332|561980303|FG001|Overall Study|Protocol Violation|2|||
155696203|NCT01918332|561980304|FG002|Overall Study|Protocol Violation|6|||
155696204|NCT01918332|561980305|FG003|Overall Study|Protocol Violation|3|||
155696205|NCT01918332|561980302|FG000|Overall Study|lipid result by central lab did not meet|0|||
155696206|NCT01918332|561980303|FG001|Overall Study|lipid result by central lab did not meet|0|||
155696207|NCT01918332|561980304|FG002|Overall Study|lipid result by central lab did not meet|1|||
155696208|NCT01918332|561980305|FG003|Overall Study|lipid result by central lab did not meet|0|||
155696209|NCT04736628|561980306|FG000|Overall Study|Not treated|0|||
155696210|NCT04736628|561980307|FG001|Overall Study|Not treated|0|||
155696211|NCT04736628|561980308|FG002|Overall Study|Not treated|0|||
155696212|NCT04736628|561980309|FG003|Overall Study|Not treated|2|||
155696213|NCT04736628|561980306|FG000|Overall Study|Other reason than listed|1|||
155696214|NCT04736628|561980307|FG001|Overall Study|Other reason than listed|2|||
155696215|NCT04736628|561980308|FG002|Overall Study|Other reason than listed|2|||
155696216|NCT04736628|561980309|FG003|Overall Study|Other reason than listed|3|||
155696217|NCT04736628|561980306|FG000|Overall Study|Protocol deviation|0|||
155696218|NCT04736628|561980307|FG001|Overall Study|Protocol deviation|0|||
155696219|NCT04736628|561980308|FG002|Overall Study|Protocol deviation|0|||
155696220|NCT04736628|561980309|FG003|Overall Study|Protocol deviation|1|||
155696221|NCT04736628|561980306|FG000|Overall Study|Burden of study procedures|1|||
155696222|NCT04736628|561980307|FG001|Overall Study|Burden of study procedures|0|||
155696223|NCT04736628|561980308|FG002|Overall Study|Burden of study procedures|0|||
155696224|NCT04736628|561980309|FG003|Overall Study|Burden of study procedures|1|||
155696225|NCT04736628|561980306|FG000|Overall Study|Change of residence|0|||
155696226|NCT04736628|561980307|FG001|Overall Study|Change of residence|1|||
155696227|NCT04736628|561980308|FG002|Overall Study|Change of residence|0|||
155696228|NCT04736628|561980309|FG003|Overall Study|Change of residence|0|||
155696229|NCT04736628|561980306|FG000|Overall Study|Perceived lack of efficacy|1|||
155696230|NCT04736628|561980307|FG001|Overall Study|Perceived lack of efficacy|0|||
155696231|NCT04736628|561980308|FG002|Overall Study|Perceived lack of efficacy|0|||
155696232|NCT04736628|561980309|FG003|Overall Study|Perceived lack of efficacy|1|||
155696233|NCT04736628|561980306|FG000|Overall Study|Adverse Event|3|||
155696234|NCT04736628|561980307|FG001|Overall Study|Adverse Event|2|||
155696235|NCT04736628|561980308|FG002|Overall Study|Adverse Event|4|||
155696236|NCT04736628|561980309|FG003|Overall Study|Adverse Event|3|||
155696237|NCT00680368|561980312|FG000|Overall Study|not supervised, not eligible|15|||
155696238|NCT00483041|561980313|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
155696239|NCT00483041|561980314|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
155696240|NCT02648217|561980318|FG000|Overall Study|Adverse Event|0|||
155696241|NCT02648217|561980319|FG001|Overall Study|Adverse Event|1|||
155696242|NCT02648217|561980318|FG000|Overall Study|Lost to Follow-up|1|||
155696243|NCT02648217|561980319|FG001|Overall Study|Lost to Follow-up|1|||
155696244|NCT02648217|561980318|FG000|Overall Study|Withdrawal by Subject|4|||
155696245|NCT02648217|561980319|FG001|Overall Study|Withdrawal by Subject|3|||
155696246|NCT02648217|561980318|FG000|Overall Study|Unclassified|5|||
155696247|NCT02648217|561980319|FG001|Overall Study|Unclassified|0|||
155696248|NCT04094584|561980320|FG000|Overall Study|No interest in study|88|||
155696249|NCT04094584|561980320|FG000|Overall Study|Unwilling to undergo screening tests|36|||
155696250|NCT04094584|561980320|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
155696251|NCT04094584|561980320|FG000|Overall Study|Opioid use|7|||
155696252|NCT04094584|561980320|FG000|Overall Study|Need for major surgery in study period|4|||
155696253|NCT04094584|561980320|FG000|Overall Study|eligible but declined enrollment|4|||
155696254|NCT04094584|561980320|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
155696255|NCT04094584|561980320|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
155696256|NCT04094584|561980320|FG000|Overall Study|Lost to Follow-up|3|||
155696257|NCT04094584|561980320|FG000|Overall Study|Withdrawal by Subject|2|||
155696258|NCT00316888|561980321|FG000|Overall Study|Adverse Event|4|||
155696259|NCT00316888|561980322|FG001|Overall Study|Adverse Event|5|||
155696260|NCT00316888|561980321|FG000|Overall Study|Withdrawal by Subject|2|||
155696261|NCT00316888|561980322|FG001|Overall Study|Withdrawal by Subject|2|||
155696262|NCT00316888|561980321|FG000|Overall Study|Not start protocol therapy|0|||
155696263|NCT00316888|561980322|FG001|Overall Study|Not start protocol therapy|1|||
155696264|NCT02715726|561980323|FG000|Overall Study|Adverse Event|2|||
155696265|NCT02715726|561980324|FG001|Overall Study|Adverse Event|6|||
155696266|NCT02715726|561980323|FG000|Overall Study|Protocol Violation|1|||
155696267|NCT02715726|561980324|FG001|Overall Study|Protocol Violation|0|||
155696268|NCT02715726|561980323|FG000|Overall Study|Death|2|||
155696269|NCT02715726|561980324|FG001|Overall Study|Death|1|||
155696270|NCT02715726|561980323|FG000|Overall Study|Participant moved|1|||
155696271|NCT02715726|561980324|FG001|Overall Study|Participant moved|3|||
155696272|NCT02715726|561980323|FG000|Overall Study|Other than specified above|11|||
155696273|NCT02715726|561980324|FG001|Overall Study|Other than specified above|15|||
155696274|NCT02715726|561980323|FG000|Overall Study|Randomized but not treated|1|||
155696275|NCT02715726|561980324|FG001|Overall Study|Randomized but not treated|2|||
155696276|NCT01565941|561980325|FG000|Overall Study|Withdrawn by parent/guardian|3|||
155696277|NCT01565941|561980326|FG001|Overall Study|Withdrawn by parent/guardian|2|||
155696278|NCT01565941|561980325|FG000|Overall Study|Randomized; did not receive intevention|8|||
155696279|NCT01565941|561980326|FG001|Overall Study|Randomized; did not receive intevention|2|||
155696280|NCT03230292|561980327|FG000|Overall Study|Adverse Event|1|||
155696281|NCT03230292|561980327|FG000|Overall Study|Protocol Violation|1|||
155696282|NCT03230292|561980327|FG000|Overall Study|Lost to Follow-up|1|||
155696283|NCT03230292|561980327|FG000|Overall Study|Withdrawal by Subject|3|||
155696284|NCT02855944|561980330|FG000|Period 1: Treatment|Ongoing|14|||
155696285|NCT02855944|561980331|FG001|Period 1: Treatment|Ongoing|0|||
155696286|NCT02855944|561980330|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
155696287|NCT02855944|561980331|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
155696288|NCT02855944|561980330|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
155696289|NCT02855944|561980331|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
155696290|NCT03629912|561980337|FG000|Overall Study|Lost to Follow-up|19|||
155696291|NCT03629912|561980338|FG001|Overall Study|Lost to Follow-up|7|||
155696292|NCT03629912|561980339|FG002|Overall Study|Lost to Follow-up|5|||
155696293|NCT03629912|561980340|FG003|Overall Study|Lost to Follow-up|1|||
155696294|NCT03629912|561980337|FG000|Overall Study|Withdrawal by Subject|6|||
155696295|NCT03629912|561980338|FG001|Overall Study|Withdrawal by Subject|0|||
155696296|NCT03629912|561980339|FG002|Overall Study|Withdrawal by Subject|1|||
155696297|NCT03629912|561980340|FG003|Overall Study|Withdrawal by Subject|2|||
155696298|NCT03629912|561980337|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
155696299|NCT03629912|561980338|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
155696300|NCT03629912|561980339|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
155696301|NCT03629912|561980340|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
155696302|NCT03629912|561980337|FG000|Overall Study|Death|1|||
155696303|NCT03629912|561980338|FG001|Overall Study|Death|0|||
155696304|NCT03629912|561980339|FG002|Overall Study|Death|0|||
155696305|NCT03629912|561980340|FG003|Overall Study|Death|0|||
155696306|NCT01504204|561980350|FG000|Overall Study|Lost to Follow-up|1|||
155696307|NCT01504204|561980351|FG001|Overall Study|Lost to Follow-up|1|||
155696308|NCT00654004|561980353|FG000|Overall Study|Lost to Follow-up|1|||
155696309|NCT00654004|561980354|FG001|Overall Study|Lost to Follow-up|0|||
155696310|NCT01571453|561980355|FG000|Overall Study|Adverse Event|14|||
155696311|NCT01571453|561980356|FG001|Overall Study|Adverse Event|32|||
155696312|NCT01571453|561980355|FG000|Overall Study|Lack of Efficacy|8|||
155696313|NCT01571453|561980356|FG001|Overall Study|Lack of Efficacy|3|||
155696314|NCT01571453|561980355|FG000|Overall Study|Non-compliance|2|||
155696315|NCT01571453|561980356|FG001|Overall Study|Non-compliance|4|||
155696316|NCT01571453|561980355|FG000|Overall Study|Protocol Violation|1|||
155696317|NCT01571453|561980356|FG001|Overall Study|Protocol Violation|5|||
155696318|NCT01571453|561980355|FG000|Overall Study|Withdrawal of consent|5|||
155696319|NCT01571453|561980356|FG001|Overall Study|Withdrawal of consent|13|||
155696320|NCT01571453|561980355|FG000|Overall Study|Lost to Follow-up|4|||
155696321|NCT01571453|561980356|FG001|Overall Study|Lost to Follow-up|2|||
155696322|NCT01571453|561980355|FG000|Overall Study|Administrative or other reason(s)|4|||
155696323|NCT01571453|561980356|FG001|Overall Study|Administrative or other reason(s)|3|||
155696324|NCT00444067|561980357|FG000|Overall Study|Lost to Follow-up|0|||
155696325|NCT00444067|561980358|FG001|Overall Study|Lost to Follow-up|1|||
155696326|NCT02966015|561980362|FG000|Inclusion Visit|did not answer questionnaire|8|||
155696327|NCT02966015|561980363|FG001|Inclusion Visit|did not answer questionnaire|3|||
155696328|NCT02241187|561980364|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
155696329|NCT00199888|561980365|FG000|Overall Study|Lost to Follow-up|1|||
155696330|NCT01198509|561980366|FG000|Overall Study|Withdrawal by Subject|1|||
155696331|NCT01198509|561980367|FG001|Overall Study|Withdrawal by Subject|0|||
155696332|NCT01198509|561980368|FG002|Overall Study|Withdrawal by Subject|0|||
155696333|NCT01198509|561980369|FG003|Overall Study|Withdrawal by Subject|0|||
155696334|NCT01198509|561980370|FG004|Overall Study|Withdrawal by Subject|0|||
155696335|NCT01198509|561980371|FG005|Overall Study|Withdrawal by Subject|0|||
155696336|NCT00330668|561980372|FG000|BID Dosing Period|Adverse Event|1|||
155696337|NCT00330668|561980372|FG000|BID Dosing Period|Lost to Follow-up|7|||
155696338|NCT00330668|561980372|FG000|BID Dosing Period|Non-Compliance|5|||
155696339|NCT00330668|561980372|FG000|BID Dosing Period|Withdrawal by Subject|19|||
155696340|NCT00330668|561980372|FG000|BID Dosing Period|Sponsor's decision|1|||
155696341|NCT00330668|561980372|FG000|BID Dosing Period|Other|3|||
155696342|NCT00330668|561980372|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
155696343|NCT00330668|561980372|FG000|QD Dosing Period|Other|1|||
155696344|NCT00330668|561980372|FG000|QD Dosing Period|Withdrawal by Subject|1|||
155696345|NCT00330668|561980372|FG000|QD Dosing Period|Lost to Follow-up|2|||
155696346|NCT02621073|561980373|FG000|Overall Study|Lost to Follow-up|0|||
155696347|NCT02621073|561980374|FG001|Overall Study|Lost to Follow-up|1|||
155696348|NCT02621073|561980373|FG000|Overall Study|Physician Decision|3|||
155696349|NCT02621073|561980374|FG001|Overall Study|Physician Decision|2|||
155696350|NCT01595581|561980380|FG000|Overall Study|Withdrawal by Subject|1|||
155696351|NCT01595581|561980381|FG001|Overall Study|Withdrawal by Subject|0|||
155696352|NCT01969721|561980393|FG000|Overall Study|Adverse Event|3|||
155696353|NCT01969721|561980394|FG001|Overall Study|Adverse Event|8|||
155696354|NCT01969721|561980395|FG002|Overall Study|Adverse Event|3|||
155696355|NCT01969721|561980396|FG003|Overall Study|Adverse Event|2|||
155696356|NCT01969721|561980393|FG000|Overall Study|Lack of Efficacy|0|||
155696357|NCT01969721|561980394|FG001|Overall Study|Lack of Efficacy|0|||
155696358|NCT01969721|561980395|FG002|Overall Study|Lack of Efficacy|1|||
155696359|NCT01969721|561980396|FG003|Overall Study|Lack of Efficacy|0|||
155696360|NCT01969721|561980393|FG000|Overall Study|Non compliant with protocol|1|||
155696361|NCT01969721|561980394|FG001|Overall Study|Non compliant with protocol|1|||
155696362|NCT01969721|561980395|FG002|Overall Study|Non compliant with protocol|0|||
155696363|NCT01969721|561980396|FG003|Overall Study|Non compliant with protocol|2|||
155696364|NCT01969721|561980393|FG000|Overall Study|Other not defined above|0|||
155696365|NCT01969721|561980394|FG001|Overall Study|Other not defined above|2|||
155696366|NCT01969721|561980395|FG002|Overall Study|Other not defined above|0|||
155696367|NCT01969721|561980396|FG003|Overall Study|Other not defined above|0|||
155696368|NCT01969721|561980393|FG000|Overall Study|Discontinued during washout periods.|0|||
155696369|NCT01969721|561980394|FG001|Overall Study|Discontinued during washout periods.|1|||
155696370|NCT01969721|561980395|FG002|Overall Study|Discontinued during washout periods.|1|||
155696371|NCT01969721|561980396|FG003|Overall Study|Discontinued during washout periods.|2|||
155696372|NCT00495755|561980398|FG000|Overall Study|Adverse Event|3|||
155696373|NCT02273960|561980399|FG000|Short Term Period|Lost to Follow-up|1|||
155696374|NCT02273960|561980400|FG001|Short Term Period|Lost to Follow-up|0|||
155696375|NCT02273960|561980401|FG002|Short Term Period|Lost to Follow-up|0|||
155696376|NCT02273960|561980402|FG003|Short Term Period|Lost to Follow-up|0|||
155696377|NCT02273960|561980399|FG000|Short Term Period|Lack of Efficacy|0|||
155696378|NCT02273960|561980400|FG001|Short Term Period|Lack of Efficacy|0|||
155696379|NCT02273960|561980401|FG002|Short Term Period|Lack of Efficacy|0|||
155696380|NCT02273960|561980402|FG003|Short Term Period|Lack of Efficacy|1|||
155696381|NCT02273960|561980399|FG000|Short Term Period|ST complete, not entering LTE|4|||
155696382|NCT02273960|561980400|FG001|Short Term Period|ST complete, not entering LTE|6|||
155696383|NCT02273960|561980401|FG002|Short Term Period|ST complete, not entering LTE|4|||
155696384|NCT02273960|561980402|FG003|Short Term Period|ST complete, not entering LTE|5|||
155696385|NCT02273960|561980399|FG000|Long Term Extension|Death|0|||
155696386|NCT02273960|561980400|FG001|Long Term Extension|Death|0|||
155696387|NCT02273960|561980401|FG002|Long Term Extension|Death|0|||
155696388|NCT02273960|561980402|FG003|Long Term Extension|Death|1|||
155696389|NCT03180307|561980405|FG000|Overall Study|Lost to Follow-up|2|||
155696390|NCT03180307|561980406|FG001|Overall Study|Lost to Follow-up|0|||
155696391|NCT03180307|561980405|FG000|Overall Study|Death|1|||
155696392|NCT03180307|561980406|FG001|Overall Study|Death|0|||
155721211|NCT05435339|562077782|FG003|Overall Study|Withdrawal by Subject|0|||
155721212|NCT05435339|562077783|FG004|Overall Study|Withdrawal by Subject|1|||
155696393|NCT03180307|561980405|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
155696394|NCT03180307|561980406|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
155696395|NCT01105377|561980410|FG000|Overall Study|Withdrawal by Subject|0|||
155696396|NCT01105377|561980411|FG001|Overall Study|Withdrawal by Subject|1|||
155696397|NCT02014584|561980413|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155696398|NCT02014584|561980414|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
155696399|NCT02014584|561980415|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155696400|NCT02014584|561980416|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155696401|NCT02014584|561980417|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155696402|NCT02014584|561980418|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155696403|NCT02014584|561980413|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
155696404|NCT02014584|561980414|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
155696405|NCT02014584|561980415|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155696406|NCT02014584|561980416|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155696407|NCT02014584|561980417|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155696408|NCT02014584|561980418|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155696409|NCT02014584|561980413|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155696410|NCT02014584|561980414|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155696411|NCT02014584|561980415|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
155696412|NCT02014584|561980416|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155696413|NCT02014584|561980417|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155696414|NCT02014584|561980418|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155696415|NCT02014584|561980413|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155696416|NCT02014584|561980414|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155696417|NCT02014584|561980415|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
155696418|NCT02014584|561980416|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
155696419|NCT02014584|561980417|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155696420|NCT02014584|561980418|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155696421|NCT02014584|561980413|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155696422|NCT02014584|561980414|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155696423|NCT02014584|561980415|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155696424|NCT02014584|561980416|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155696425|NCT02014584|561980417|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
155696426|NCT02014584|561980418|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155696427|NCT00483002|561980419|FG000|Overall Study|Adverse Event|68|||
155696428|NCT00483002|561980419|FG000|Overall Study|Lack of Efficacy|555|||
155696429|NCT00483002|561980419|FG000|Overall Study|Lost to Follow-up|962|||
155696430|NCT00483002|561980419|FG000|Overall Study|Other|2|||
155696431|NCT00483002|561980419|FG000|Overall Study|Other|967|||
155696432|NCT02651220|561980420|FG000|Overall Study|Adverse Event|1|||
155696433|NCT02651220|561980421|FG001|Overall Study|Adverse Event|5|||
155696434|NCT02651220|561980422|FG002|Overall Study|Adverse Event|1|||
155696435|NCT02651220|561980420|FG000|Overall Study|Lost to Follow-up|8|||
155696436|NCT02651220|561980421|FG001|Overall Study|Lost to Follow-up|14|||
155696437|NCT02651220|561980422|FG002|Overall Study|Lost to Follow-up|14|||
155696438|NCT02651220|561980420|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155696439|NCT02651220|561980421|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155696440|NCT02651220|561980422|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155696441|NCT02651220|561980420|FG000|Overall Study|Pregnancy|1|||
155696442|NCT02651220|561980421|FG001|Overall Study|Pregnancy|0|||
155696443|NCT02651220|561980422|FG002|Overall Study|Pregnancy|1|||
155696444|NCT02651220|561980420|FG000|Overall Study|Protocol Violation|0|||
155696445|NCT02651220|561980421|FG001|Overall Study|Protocol Violation|0|||
155696446|NCT02651220|561980422|FG002|Overall Study|Protocol Violation|1|||
155696447|NCT02651220|561980420|FG000|Overall Study|Withdrawal by Subject|5|||
155696448|NCT02651220|561980421|FG001|Overall Study|Withdrawal by Subject|6|||
155696449|NCT02651220|561980422|FG002|Overall Study|Withdrawal by Subject|8|||
155696450|NCT02651220|561980420|FG000|Overall Study|Miscellaneous|4|||
155696451|NCT02651220|561980421|FG001|Overall Study|Miscellaneous|1|||
155696452|NCT02651220|561980422|FG002|Overall Study|Miscellaneous|2|||
155696453|NCT02651220|561980420|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155696454|NCT02651220|561980421|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155696455|NCT02651220|561980422|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
155696456|NCT00447122|561980423|FG000|Overall Study|worsening medical condition -came off|0|||
155696457|NCT00447122|561980424|FG001|Overall Study|worsening medical condition -came off|1|||
155696458|NCT00447122|561980425|FG002|Overall Study|worsening medical condition -came off|0|||
155696459|NCT00447122|561980426|FG003|Overall Study|worsening medical condition -came off|0|||
155696460|NCT01439373|561980431|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
155696461|NCT01439373|561980432|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
155696462|NCT01439373|561980431|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
155696463|NCT01439373|561980432|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
155696464|NCT04046250|561980435|FG000|Overall Study|Death|0|||
155696465|NCT04046250|561980436|FG001|Overall Study|Death|1|||
155696466|NCT04046250|561980435|FG000|Overall Study|Withdrawal by Subject|3|||
155696467|NCT04046250|561980436|FG001|Overall Study|Withdrawal by Subject|3|||
155696468|NCT03834220|561980441|FG000|Overall Study|Adverse Event|1|||
155696469|NCT03834220|561980442|FG001|Overall Study|Adverse Event|0|||
155696470|NCT03834220|561980443|FG002|Overall Study|Adverse Event|0|||
155696471|NCT03834220|561980441|FG000|Overall Study|Death|8|||
155696472|NCT03834220|561980442|FG001|Overall Study|Death|1|||
155696473|NCT03834220|561980443|FG002|Overall Study|Death|17|||
155696474|NCT03834220|561980441|FG000|Overall Study|Reason not Specified|9|||
155696475|NCT03834220|561980442|FG001|Overall Study|Reason not Specified|0|||
155696476|NCT03834220|561980443|FG002|Overall Study|Reason not Specified|6|||
155696477|NCT03834220|561980441|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
155696478|NCT03834220|561980442|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
155696479|NCT03834220|561980443|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
155696480|NCT03834220|561980441|FG000|Overall Study|Withdrawal of Consent|2|||
155696481|NCT03834220|561980442|FG001|Overall Study|Withdrawal of Consent|2|||
155696482|NCT03834220|561980443|FG002|Overall Study|Withdrawal of Consent|2|||
155696483|NCT02593318|561980446|FG000|Overall Study|Withdrawal by Subject|1|||
155696484|NCT02593318|561980447|FG001|Overall Study|Withdrawal by Subject|1|||
155696485|NCT03684694|561980449|FG000|Phase 1|Withdrawal by Subject|1|||
155696486|NCT03684694|561980450|FG001|Phase 1|Withdrawal by Subject|0|||
155696487|NCT03684694|561980451|FG002|Phase 1|Withdrawal by Subject|0|||
155696488|NCT03684694|561980452|FG003|Phase 1|Withdrawal by Subject|0|||
155696489|NCT03684694|561980453|FG004|Phase 1|Withdrawal by Subject|0|||
155696490|NCT03684694|561980454|FG005|Phase 1|Withdrawal by Subject|0|||
155696491|NCT03684694|561980449|FG000|Phase 1|Investigator/Sponsor Decision|12|||
155696492|NCT03684694|561980450|FG001|Phase 1|Investigator/Sponsor Decision|2|||
155696493|NCT03684694|561980451|FG002|Phase 1|Investigator/Sponsor Decision|1|||
155696494|NCT03684694|561980452|FG003|Phase 1|Investigator/Sponsor Decision|0|||
155696495|NCT03684694|561980453|FG004|Phase 1|Investigator/Sponsor Decision|0|||
155696496|NCT03684694|561980454|FG005|Phase 1|Investigator/Sponsor Decision|0|||
155696497|NCT03684694|561980449|FG000|Phase 1|Death|24|||
155696498|NCT03684694|561980450|FG001|Phase 1|Death|0|||
155696499|NCT03684694|561980451|FG002|Phase 1|Death|3|||
155696500|NCT03684694|561980452|FG003|Phase 1|Death|0|||
155696501|NCT03684694|561980453|FG004|Phase 1|Death|0|||
155696502|NCT03684694|561980454|FG005|Phase 1|Death|0|||
155696503|NCT03684694|561980449|FG000|Phase 1|Lost to Follow-up|0|||
155696504|NCT03684694|561980450|FG001|Phase 1|Lost to Follow-up|0|||
155696505|NCT03684694|561980451|FG002|Phase 1|Lost to Follow-up|1|||
155696506|NCT03684694|561980452|FG003|Phase 1|Lost to Follow-up|0|||
155696507|NCT03684694|561980453|FG004|Phase 1|Lost to Follow-up|0|||
155696508|NCT03684694|561980454|FG005|Phase 1|Lost to Follow-up|0|||
155696509|NCT03684694|561980449|FG000|Phase 1|Miscellaneous|0|||
155696510|NCT03684694|561980450|FG001|Phase 1|Miscellaneous|1|||
155696511|NCT03684694|561980451|FG002|Phase 1|Miscellaneous|0|||
155696512|NCT03684694|561980452|FG003|Phase 1|Miscellaneous|0|||
155696513|NCT03684694|561980453|FG004|Phase 1|Miscellaneous|0|||
155696514|NCT03684694|561980454|FG005|Phase 1|Miscellaneous|0|||
155696515|NCT03684694|561980449|FG000|Phase 2|Withdrawal by Subject|0|||
155696516|NCT03684694|561980450|FG001|Phase 2|Withdrawal by Subject|0|||
155696517|NCT03684694|561980451|FG002|Phase 2|Withdrawal by Subject|0|||
155696518|NCT03684694|561980452|FG003|Phase 2|Withdrawal by Subject|0|||
155696519|NCT03684694|561980453|FG004|Phase 2|Withdrawal by Subject|0|||
155696520|NCT03684694|561980454|FG005|Phase 2|Withdrawal by Subject|1|||
155696521|NCT03684694|561980449|FG000|Phase 2|Investigator/Sponsor Decision|0|||
155696522|NCT03684694|561980450|FG001|Phase 2|Investigator/Sponsor Decision|0|||
155696523|NCT03684694|561980451|FG002|Phase 2|Investigator/Sponsor Decision|0|||
155696524|NCT03684694|561980452|FG003|Phase 2|Investigator/Sponsor Decision|17|||
155696525|NCT03684694|561980453|FG004|Phase 2|Investigator/Sponsor Decision|16|||
155696526|NCT03684694|561980454|FG005|Phase 2|Investigator/Sponsor Decision|6|||
155696527|NCT03684694|561980449|FG000|Phase 2|Death|0|||
155696528|NCT03684694|561980450|FG001|Phase 2|Death|0|||
155696529|NCT03684694|561980451|FG002|Phase 2|Death|0|||
155696530|NCT03684694|561980452|FG003|Phase 2|Death|28|||
155696531|NCT03684694|561980453|FG004|Phase 2|Death|14|||
155696532|NCT03684694|561980454|FG005|Phase 2|Death|3|||
155696533|NCT03684694|561980449|FG000|Phase 2|Lost to Follow-up|0|||
155696534|NCT03684694|561980450|FG001|Phase 2|Lost to Follow-up|0|||
155696535|NCT03684694|561980451|FG002|Phase 2|Lost to Follow-up|0|||
155696536|NCT03684694|561980452|FG003|Phase 2|Lost to Follow-up|1|||
155696537|NCT03684694|561980453|FG004|Phase 2|Lost to Follow-up|0|||
155696538|NCT03684694|561980454|FG005|Phase 2|Lost to Follow-up|0|||
155696539|NCT03684694|561980449|FG000|Phase 2|Miscellaneous|0|||
155696540|NCT03684694|561980450|FG001|Phase 2|Miscellaneous|0|||
155696541|NCT03684694|561980451|FG002|Phase 2|Miscellaneous|0|||
155696542|NCT03684694|561980452|FG003|Phase 2|Miscellaneous|3|||
155696543|NCT03684694|561980453|FG004|Phase 2|Miscellaneous|0|||
155696544|NCT03684694|561980454|FG005|Phase 2|Miscellaneous|0|||
155696545|NCT03268941|561982526|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696546|NCT03268941|561982527|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696547|NCT03268941|561982528|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696548|NCT03268941|561982529|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
155696549|NCT03268941|561982530|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696550|NCT03268941|561982531|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696551|NCT03268941|561982532|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155696552|NCT03268941|561982526|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696553|NCT03268941|561982527|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696554|NCT03268941|561982528|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696555|NCT03268941|561982529|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
155696556|NCT03268941|561982530|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696557|NCT03268941|561982531|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696558|NCT03268941|561982532|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
155696559|NCT03268941|561982526|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
155696560|NCT03268941|561982527|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696561|NCT03268941|561982528|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696562|NCT03268941|561982529|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696563|NCT03268941|561982530|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696564|NCT03268941|561982531|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696565|NCT03268941|561982532|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155696566|NCT03268941|561982526|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
155696567|NCT03268941|561982527|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
155696568|NCT03268941|561982528|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
155696569|NCT03268941|561982529|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
155696570|NCT03268941|561982530|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
155696571|NCT03268941|561982531|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
155696572|NCT03268941|561982532|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
155696573|NCT03268941|561982526|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696574|NCT03268941|561982527|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696575|NCT03268941|561982528|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696576|NCT03268941|561982529|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696577|NCT03268941|561982530|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696578|NCT03268941|561982531|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155696579|NCT03268941|561982532|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
155696580|NCT02720692|561982537|FG000|Overall Study|Withdrawal by Subject|3|||
155696581|NCT02720692|561982538|FG001|Overall Study|Withdrawal by Subject|0|||
155696582|NCT02720692|561982537|FG000|Overall Study|Physician Decision|1|||
155696583|NCT02720692|561982538|FG001|Overall Study|Physician Decision|0|||
155696584|NCT02720692|561982537|FG000|Overall Study|Lost to Follow-up|8|||
155696585|NCT02720692|561982538|FG001|Overall Study|Lost to Follow-up|3|||
155696586|NCT02720692|561982537|FG000|Overall Study|Subject unable to return for visit|1|||
155696587|NCT02720692|561982538|FG001|Overall Study|Subject unable to return for visit|0|||
155696588|NCT03878758|561982539|FG000|Overall Study|Withdrawal by Subject|1|||
155696589|NCT03878758|561982539|FG000|Overall Study|Protocol defined|2|||
155696590|NCT03878758|561982539|FG000|Overall Study|Improper consent documentation|1|||
155696591|NCT01769196|561982540|FG000|Overall Study|Adverse Event|24|||
155696592|NCT01769196|561982541|FG001|Overall Study|Adverse Event|20|||
155696593|NCT01769196|561982540|FG000|Overall Study|Death|21|||
155696594|NCT01769196|561982541|FG001|Overall Study|Death|26|||
155696595|NCT01769196|561982540|FG000|Overall Study|Investigator Discretion|7|||
155696596|NCT01769196|561982541|FG001|Overall Study|Investigator Discretion|3|||
155696597|NCT01769196|561982540|FG000|Overall Study|Lack of Efficacy|3|||
155696598|NCT01769196|561982541|FG001|Overall Study|Lack of Efficacy|2|||
155696599|NCT01769196|561982540|FG000|Overall Study|Progressive disease|11|||
155696600|NCT01769196|561982541|FG001|Overall Study|Progressive disease|6|||
155696601|NCT01769196|561982540|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
155696602|NCT01769196|561982541|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
155696603|NCT01769196|561982540|FG000|Overall Study|Protocol Violation|0|||
155696604|NCT01769196|561982541|FG001|Overall Study|Protocol Violation|3|||
155696605|NCT01769196|561982540|FG000|Overall Study|Study terminated by sponsor|160|||
155696606|NCT01769196|561982541|FG001|Overall Study|Study terminated by sponsor|161|||
155696607|NCT01769196|561982540|FG000|Overall Study|Participant never dosed with study drug|1|||
155696608|NCT01769196|561982541|FG001|Overall Study|Participant never dosed with study drug|0|||
155696609|NCT01769196|561982540|FG000|Overall Study|Withdrew consent|36|||
155696610|NCT01769196|561982541|FG001|Overall Study|Withdrew consent|40|||
155696611|NCT00765063|561982542|FG000|Overall Study|Lack of Efficacy|5|||
155696612|NCT00765063|561982542|FG000|Overall Study|Withdrawal by Subject|1|||
155696613|NCT00765063|561982542|FG000|Overall Study|Other|16|||
155696614|NCT00765063|561982542|FG000|Overall Study|Protocol Violation|6|||
155696615|NCT00765063|561982542|FG000|Overall Study|Adverse Event|4|||
155696616|NCT03614325|561982543|FG000|Overall Study|Withdrawal by Subject|0|||
155696617|NCT03614325|561982544|FG001|Overall Study|Withdrawal by Subject|2|||
155696618|NCT03614325|561982543|FG000|Overall Study|Surgery Cancelled|2|||
155696619|NCT03614325|561982544|FG001|Overall Study|Surgery Cancelled|1|||
155696620|NCT03614325|561982543|FG000|Overall Study|Lost to Follow-up|2|||
155696621|NCT03614325|561982544|FG001|Overall Study|Lost to Follow-up|1|||
155696622|NCT03614325|561982543|FG000|Overall Study|Surgery never scheduled|1|||
155696623|NCT03614325|561982544|FG001|Overall Study|Surgery never scheduled|0|||
155696624|NCT01206582|561982550|FG000|Overall Study|Withdrew prior to study|1|||
155696625|NCT01206582|561982551|FG001|Overall Study|Withdrew prior to study|0|||
155696626|NCT01206582|561982550|FG000|Overall Study|Discontinued intervention before week 8|1|||
155696627|NCT01206582|561982551|FG001|Overall Study|Discontinued intervention before week 8|2|||
155696628|NCT02522325|561982552|FG000|Overall Study|Adverse Event|0|||
155696629|NCT02522325|561982553|FG001|Overall Study|Adverse Event|1|||
155696630|NCT02100969|561982554|FG000|Overall Study|Did not pass screening phase|1|||
155696631|NCT02081599|561982557|FG000|Period 1：Double-blind Period|Adverse Event|3|||
155696632|NCT02081599|561982558|FG001|Period 1：Double-blind Period|Adverse Event|0|||
155696633|NCT02081599|561982557|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
155696634|NCT02081599|561982558|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
155696635|NCT02081599|561982557|FG000|Period 1：Double-blind Period|Physician Decision|1|||
155696636|NCT02081599|561982558|FG001|Period 1：Double-blind Period|Physician Decision|0|||
155696637|NCT02081599|561982557|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
155696638|NCT02081599|561982558|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
155696639|NCT02081599|561982557|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
155696640|NCT02081599|561982558|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
155696641|NCT02081599|561982557|FG000|Period 1：Double-blind Period|stopping criteria|1|||
155696642|NCT02081599|561982558|FG001|Period 1：Double-blind Period|stopping criteria|0|||
155696643|NCT02081599|561982557|FG000|Period 2：Open-label Period|Adverse Event|1|||
155696644|NCT02081599|561982558|FG001|Period 2：Open-label Period|Adverse Event|0|||
155696645|NCT02081599|561982557|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
155696646|NCT02081599|561982558|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
155696647|NCT02081599|561982557|FG000|Period 2：Open-label Period|Physician Decision|1|||
155696648|NCT02081599|561982558|FG001|Period 2：Open-label Period|Physician Decision|0|||
155696649|NCT02081599|561982557|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
155696650|NCT02081599|561982558|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
155696651|NCT01629953|561982559|FG000|Overall Study|Death|3|||
155696652|NCT01629953|561982560|FG001|Overall Study|Death|1|||
155696653|NCT01629953|561982559|FG000|Overall Study|Lost to Follow-up|10|||
155696654|NCT01629953|561982560|FG001|Overall Study|Lost to Follow-up|14|||
155696655|NCT00720343|561982561|FG000|Overall Study|Lost to Follow-up|1|||
155696656|NCT00720343|561982562|FG001|Overall Study|Lost to Follow-up|0|||
155696657|NCT00720343|561982561|FG000|Overall Study|Protocol Violation|0|||
155696658|NCT00720343|561982562|FG001|Overall Study|Protocol Violation|2|||
155696659|NCT00707954|561982565|FG000|Overall Study|Physician Decision|0|||
155696660|NCT00707954|561982566|FG001|Overall Study|Physician Decision|0|||
155696661|NCT00707954|561982567|FG002|Overall Study|Physician Decision|0|||
155696662|NCT00707954|561982568|FG003|Overall Study|Physician Decision|0|||
155696663|NCT00707954|561982569|FG004|Overall Study|Physician Decision|1|||
155696664|NCT04037254|561982571|FG000|Overall Study|Protocol Violation|1|||
155696665|NCT04037254|561982572|FG001|Overall Study|Protocol Violation|0|||
155696666|NCT04037254|561982573|FG002|Overall Study|Protocol Violation|0|||
155696667|NCT04037254|561982574|FG003|Overall Study|Protocol Violation|0|||
155696668|NCT04037254|561982575|FG004|Overall Study|Protocol Violation|0|||
155696669|NCT04037254|561982571|FG000|Overall Study|Withdrawal by Subject|0|||
155696670|NCT04037254|561982572|FG001|Overall Study|Withdrawal by Subject|0|||
155696671|NCT04037254|561982573|FG002|Overall Study|Withdrawal by Subject|1|||
155696672|NCT04037254|561982574|FG003|Overall Study|Withdrawal by Subject|0|||
155696673|NCT04037254|561982575|FG004|Overall Study|Withdrawal by Subject|0|||
155696674|NCT04037254|561982571|FG000|Overall Study|Delayed or incomplete treatment|0|||
155696675|NCT04037254|561982572|FG001|Overall Study|Delayed or incomplete treatment|2|||
155696676|NCT04037254|561982573|FG002|Overall Study|Delayed or incomplete treatment|1|||
155696677|NCT04037254|561982574|FG003|Overall Study|Delayed or incomplete treatment|0|||
155696678|NCT04037254|561982575|FG004|Overall Study|Delayed or incomplete treatment|0|||
155696679|NCT02504580|561982579|FG000|Overall Study|Other|1|||
155696680|NCT02504580|561982580|FG001|Overall Study|Other|0|||
155696681|NCT02504580|561982581|FG002|Overall Study|Other|0|||
155696682|NCT02504580|561982582|FG003|Overall Study|Other|2|||
155696683|NCT02504580|561982583|FG004|Overall Study|Other|1|||
155696684|NCT02504580|561982584|FG005|Overall Study|Other|1|||
155696685|NCT02504580|561982585|FG006|Overall Study|Other|1|||
155696686|NCT02504580|561982586|FG007|Overall Study|Other|2|||
155696687|NCT02504580|561982587|FG008|Overall Study|Other|0|||
155696688|NCT02504580|561982588|FG009|Overall Study|Other|0|||
155696689|NCT02504580|561982589|FG010|Overall Study|Other|0|||
155696690|NCT02504580|561982590|FG011|Overall Study|Other|2|||
155696691|NCT02504580|561982579|FG000|Overall Study|Subject refusal to continue|0|||
155696692|NCT02504580|561982580|FG001|Overall Study|Subject refusal to continue|1|||
155696693|NCT02504580|561982581|FG002|Overall Study|Subject refusal to continue|0|||
155696694|NCT02504580|561982582|FG003|Overall Study|Subject refusal to continue|0|||
155696695|NCT02504580|561982583|FG004|Overall Study|Subject refusal to continue|0|||
155696696|NCT02504580|561982584|FG005|Overall Study|Subject refusal to continue|0|||
155696697|NCT02504580|561982585|FG006|Overall Study|Subject refusal to continue|0|||
155696698|NCT02504580|561982586|FG007|Overall Study|Subject refusal to continue|0|||
155696699|NCT02504580|561982587|FG008|Overall Study|Subject refusal to continue|0|||
155696700|NCT02504580|561982588|FG009|Overall Study|Subject refusal to continue|0|||
155696701|NCT02504580|561982589|FG010|Overall Study|Subject refusal to continue|0|||
155696702|NCT02504580|561982590|FG011|Overall Study|Subject refusal to continue|0|||
155696703|NCT02478164|561982596|FG000|Overall Study|Lack of Efficacy|13|||
155696704|NCT02478164|561982596|FG000|Overall Study|Adverse Event|1|||
155696705|NCT02478164|561982596|FG000|Overall Study|Withdrawal by Subject|1|||
155696706|NCT01116427|561982597|FG000|Core Phase|Adverse Event|0|||
155696707|NCT01116427|561982598|FG001|Core Phase|Adverse Event|1|||
155696708|NCT01116427|561982597|FG000|Core Phase|Lost to Follow-up|1|||
155696709|NCT01116427|561982598|FG001|Core Phase|Lost to Follow-up|0|||
155696710|NCT01116427|561982597|FG000|Core Phase|Withdrawal by Subject|3|||
155696711|NCT01116427|561982598|FG001|Core Phase|Withdrawal by Subject|0|||
155696712|NCT01116427|561982597|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
155696713|NCT01116427|561982598|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
155696714|NCT01116427|561982597|FG000|Extension Phase|Adverse Event|1|||
155696715|NCT01116427|561982598|FG001|Extension Phase|Adverse Event|1|||
155696716|NCT01116427|561982597|FG000|Extension Phase|Lost to Follow-up|2|||
155696717|NCT01116427|561982598|FG001|Extension Phase|Lost to Follow-up|0|||
155696718|NCT01116427|561982597|FG000|Extension Phase|Withdrawal by Subject|5|||
155696719|NCT01116427|561982598|FG001|Extension Phase|Withdrawal by Subject|1|||
155696720|NCT01116427|561982597|FG000|Extension Phase|Not using appropriate birth control|1|||
155696721|NCT01116427|561982598|FG001|Extension Phase|Not using appropriate birth control|0|||
155696722|NCT00791557|561982601|FG000|Overall Study|Adverse Event|1|||
155696723|NCT01079936|561982602|FG000|Phase I: MTD|First Remission Status|2|||
155696724|NCT01079936|561982603|FG001|Phase I: MTD|First Remission Status|0|||
155696725|NCT01079936|561982604|FG002|Phase I: MTD|First Remission Status|0|||
155696726|NCT01079936|561982605|FG003|Phase I: MTD|First Remission Status|0|||
155696727|NCT01079936|561982606|FG004|Phase I: MTD|First Remission Status|0|||
155696728|NCT01079936|561982602|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
155696729|NCT01079936|561982603|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
155696730|NCT01079936|561982604|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
155696731|NCT01079936|561982605|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
155696732|NCT01079936|561982606|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
155696733|NCT01079936|561982602|FG000|Phase II|Adverse Event|0|||
155696734|NCT01079936|561982603|FG001|Phase II|Adverse Event|0|||
155696735|NCT01079936|561982604|FG002|Phase II|Adverse Event|1|||
155696736|NCT01079936|561982605|FG003|Phase II|Adverse Event|0|||
155696737|NCT01079936|561982606|FG004|Phase II|Adverse Event|0|||
155696738|NCT01079936|561982602|FG000|Phase II|Insurance Issue|0|||
155696739|NCT01079936|561982603|FG001|Phase II|Insurance Issue|0|||
155696740|NCT01079936|561982604|FG002|Phase II|Insurance Issue|0|||
155696741|NCT01079936|561982605|FG003|Phase II|Insurance Issue|0|||
155696742|NCT01079936|561982606|FG004|Phase II|Insurance Issue|1|||
155696743|NCT02322190|561982607|FG000|Overall Study|Death on study|1|||
155696744|NCT02322190|561982608|FG001|Overall Study|Death on study|0|||
155696745|NCT03344640|561982609|FG000|Overall Study|Adverse Event|1|||
155696746|NCT03344640|561982610|FG001|Overall Study|Adverse Event|0|||
155696747|NCT03344640|561982609|FG000|Overall Study|Physician Decision|1|||
155696748|NCT03344640|561982610|FG001|Overall Study|Physician Decision|1|||
155696749|NCT03344640|561982609|FG000|Overall Study|Withdrawal by Subject|1|||
155696750|NCT03344640|561982610|FG001|Overall Study|Withdrawal by Subject|2|||
155696751|NCT03344640|561982609|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
155696752|NCT03344640|561982610|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
155696753|NCT00657371|561982616|FG000|Overall Study|Poor bowel preparation|15|||
155696754|NCT00657371|561982616|FG000|Overall Study|Unable to intubate the cecum|5|||
155696755|NCT00657371|561982616|FG000|Overall Study|Protocol Violation|2|||
155696756|NCT00657371|561982616|FG000|Overall Study|Device- related reasons|13|||
155696757|NCT00657371|561982616|FG000|Overall Study|Pre-existing medical condition|4|||
155696758|NCT00652899|561982622|FG000|Overall Study|Death|1|||
155696759|NCT00652899|561982622|FG000|Overall Study|Treating physician decision|1|||
155696760|NCT02713867|561982623|FG000|Randomization|Other Reason|2|||
155696761|NCT02713867|561982624|FG001|Randomization|Other Reason|1|||
155696762|NCT02713867|561982623|FG000|Randomization|Participant Withdrew consent|0|||
155696763|NCT02713867|561982624|FG001|Randomization|Participant Withdrew consent|2|||
155696764|NCT02713867|561982623|FG000|Treatment Period|Other Reasons|22|||
155696765|NCT02713867|561982624|FG001|Treatment Period|Other Reasons|28|||
155696766|NCT02713867|561982623|FG000|Treatment Period|Administrative reason by sponsor|21|||
155696767|NCT02713867|561982624|FG001|Treatment Period|Administrative reason by sponsor|16|||
155696768|NCT02713867|561982623|FG000|Treatment Period|No longer meets study criteria|2|||
155696769|NCT02713867|561982624|FG001|Treatment Period|No longer meets study criteria|1|||
155696770|NCT02713867|561982623|FG000|Treatment Period|Poor/Non Compliance|1|||
155696771|NCT02713867|561982624|FG001|Treatment Period|Poor/Non Compliance|0|||
155696772|NCT02713867|561982623|FG000|Treatment Period|Maximum Clinical Benefit|5|||
155696773|NCT02713867|561982624|FG001|Treatment Period|Maximum Clinical Benefit|6|||
155696774|NCT02713867|561982623|FG000|Treatment Period|Withdrew consent|3|||
155696775|NCT02713867|561982624|FG001|Treatment Period|Withdrew consent|6|||
155696776|NCT02713867|561982623|FG000|Treatment Period|Requested to Discontinue|8|||
155696777|NCT02713867|561982624|FG001|Treatment Period|Requested to Discontinue|8|||
155696778|NCT02713867|561982623|FG000|Treatment Period|AE unrelated to Study Drug|11|||
155696779|NCT02713867|561982624|FG001|Treatment Period|AE unrelated to Study Drug|10|||
155696780|NCT02713867|561982623|FG000|Treatment Period|Death|7|||
155696781|NCT02713867|561982624|FG001|Treatment Period|Death|3|||
155696782|NCT02713867|561982623|FG000|Treatment Period|Study Drug Toxicity|16|||
155696783|NCT02713867|561982624|FG001|Treatment Period|Study Drug Toxicity|19|||
155696784|NCT02713867|561982623|FG000|Treatment Period|Disease Progression|82|||
155696785|NCT02713867|561982624|FG001|Treatment Period|Disease Progression|83|||
155696786|NCT00857948|561982625|FG000|Overall Study|Withdrawal by Subject|2|||
155696787|NCT00857948|561982626|FG001|Overall Study|Withdrawal by Subject|0|||
155696788|NCT00857948|561982627|FG002|Overall Study|Withdrawal by Subject|0|||
155696789|NCT00857948|561982628|FG003|Overall Study|Withdrawal by Subject|0|||
155696790|NCT00857948|561982625|FG000|Overall Study|Protocol Violation|1|||
155696791|NCT00857948|561982626|FG001|Overall Study|Protocol Violation|0|||
155696792|NCT00857948|561982627|FG002|Overall Study|Protocol Violation|1|||
155696793|NCT00857948|561982628|FG003|Overall Study|Protocol Violation|0|||
155696794|NCT04135859|561982629|FG000|Overall Study|Withdrawal by Subject|1|||
155696795|NCT04135859|561982630|FG001|Overall Study|Withdrawal by Subject|0|||
155696796|NCT04135859|561982629|FG000|Overall Study|Withdrawal due to screening failure|1|||
155696797|NCT04135859|561982630|FG001|Overall Study|Withdrawal due to screening failure|2|||
155696798|NCT04135859|561982629|FG000|Overall Study|Did not complete stress test|3|||
155696799|NCT04135859|561982630|FG001|Overall Study|Did not complete stress test|3|||
155696800|NCT04135859|561982629|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
155696801|NCT04135859|561982630|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
155696802|NCT01600053|561982631|FG000|Overall Study|Adverse Event|2|||
155696803|NCT01600053|561982631|FG000|Overall Study|trial will not meet the interim endpoint|9|||
155696804|NCT02049138|561982640|FG000|Overall Study|Adverse Event|46|||
155696805|NCT02049138|561982641|FG001|Overall Study|Adverse Event|25|||
155696806|NCT02049138|561982642|FG002|Overall Study|Adverse Event|1|||
155696807|NCT02049138|561982640|FG000|Overall Study|Withdrawal by Subject|57|||
155696808|NCT02049138|561982641|FG001|Overall Study|Withdrawal by Subject|21|||
155696809|NCT02049138|561982642|FG002|Overall Study|Withdrawal by Subject|5|||
155696810|NCT02049138|561982640|FG000|Overall Study|Lost to Follow-up|18|||
155696811|NCT02049138|561982641|FG001|Overall Study|Lost to Follow-up|5|||
155696812|NCT02049138|561982642|FG002|Overall Study|Lost to Follow-up|1|||
155696813|NCT02049138|561982640|FG000|Overall Study|Lack of Efficacy|10|||
155696814|NCT02049138|561982641|FG001|Overall Study|Lack of Efficacy|26|||
155696815|NCT02049138|561982642|FG002|Overall Study|Lack of Efficacy|1|||
155696816|NCT02049138|561982640|FG000|Overall Study|Non-Compliance|15|||
155696817|NCT02049138|561982641|FG001|Overall Study|Non-Compliance|6|||
155696818|NCT02049138|561982642|FG002|Overall Study|Non-Compliance|0|||
155696819|NCT02049138|561982640|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
155696820|NCT02049138|561982641|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
155696821|NCT02049138|561982642|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
155696822|NCT02049138|561982640|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
155696823|NCT02049138|561982641|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155696824|NCT02049138|561982642|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155696825|NCT02049138|561982640|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155696826|NCT02049138|561982641|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
155696827|NCT02049138|561982642|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155696828|NCT02049138|561982640|FG000|Overall Study|Other|15|||
155696829|NCT02049138|561982641|FG001|Overall Study|Other|13|||
155696830|NCT02049138|561982642|FG002|Overall Study|Other|0|||
155696831|NCT02049138|561982640|FG000|Overall Study|Missing|0|||
155696832|NCT02049138|561982641|FG001|Overall Study|Missing|1|||
155696833|NCT02049138|561982642|FG002|Overall Study|Missing|0|||
155696834|NCT05086510|561982643|FG000|Overall Study|Lost to Follow-up|0|||
155696835|NCT05086510|561982644|FG001|Overall Study|Lost to Follow-up|2|||
155696836|NCT05086510|561982643|FG000|Overall Study|Death|0|||
155696837|NCT05086510|561982644|FG001|Overall Study|Death|2|||
155696838|NCT04881747|561982645|FG000|Period 2 Washout|Adverse Event|1|||
155696839|NCT04881747|561982646|FG001|Period 2 Washout|Adverse Event|0|||
155696840|NCT04881747|561982647|FG002|Period 2 Washout|Adverse Event|0|||
155696841|NCT04881747|561982648|FG003|Period 2 Washout|Adverse Event|0|||
155696842|NCT04881747|561982649|FG004|Period 2 Washout|Adverse Event|1|||
155696843|NCT04881747|561982650|FG005|Period 2 Washout|Adverse Event|0|||
155696844|NCT04881747|561982645|FG000|Period 2 Washout|Withdrawal by Subject|1|||
155696845|NCT04881747|561982646|FG001|Period 2 Washout|Withdrawal by Subject|0|||
155696846|NCT04881747|561982647|FG002|Period 2 Washout|Withdrawal by Subject|0|||
155696847|NCT04881747|561982648|FG003|Period 2 Washout|Withdrawal by Subject|1|||
155696848|NCT04881747|561982649|FG004|Period 2 Washout|Withdrawal by Subject|0|||
155696849|NCT04881747|561982650|FG005|Period 2 Washout|Withdrawal by Subject|0|||
155696850|NCT00521222|561982651|FG000|Overall Study|Lost to Follow-up|0|||
155696851|NCT00521222|561982652|FG001|Overall Study|Lost to Follow-up|0|||
155696852|NCT00521222|561982653|FG002|Overall Study|Lost to Follow-up|1|||
155696853|NCT00521222|561982654|FG003|Overall Study|Lost to Follow-up|1|||
155696854|NCT00521222|561982651|FG000|Overall Study|Withdrawal by Subject|0|||
155696855|NCT00521222|561982652|FG001|Overall Study|Withdrawal by Subject|0|||
155696856|NCT00521222|561982653|FG002|Overall Study|Withdrawal by Subject|2|||
155696857|NCT00521222|561982654|FG003|Overall Study|Withdrawal by Subject|0|||
155696858|NCT00521222|561982651|FG000|Overall Study|Physician Decision|0|||
155696859|NCT00521222|561982652|FG001|Overall Study|Physician Decision|1|||
155696860|NCT00521222|561982653|FG002|Overall Study|Physician Decision|0|||
155696861|NCT00521222|561982654|FG003|Overall Study|Physician Decision|1|||
155696862|NCT03869333|561982660|FG000|Overall Study|Lost to Follow-up|1|||
155696863|NCT03869333|561982661|FG001|Overall Study|Lost to Follow-up|0|||
155696864|NCT03869333|561982662|FG002|Overall Study|Lost to Follow-up|0|||
155696865|NCT03869333|561982663|FG003|Overall Study|Lost to Follow-up|0|||
155696866|NCT03869333|561982660|FG000|Overall Study|Pregnancy|1|||
155696867|NCT03869333|561982661|FG001|Overall Study|Pregnancy|0|||
155696868|NCT03869333|561982662|FG002|Overall Study|Pregnancy|0|||
155696869|NCT03869333|561982663|FG003|Overall Study|Pregnancy|0|||
155696870|NCT03869333|561982660|FG000|Overall Study|Physician Decision|0|||
155696871|NCT03869333|561982661|FG001|Overall Study|Physician Decision|1|||
155696872|NCT03869333|561982662|FG002|Overall Study|Physician Decision|0|||
155696873|NCT03869333|561982663|FG003|Overall Study|Physician Decision|0|||
155696874|NCT01927055|561982664|FG000|Open-label|Adverse Event|6|||
155696875|NCT01927055|561982665|FG001|Open-label|Adverse Event|0|||
155696876|NCT01927055|561982666|FG002|Open-label|Adverse Event|0|||
155696877|NCT01927055|561982664|FG000|Open-label|Withdrawal by Subject|1|||
155696878|NCT01927055|561982665|FG001|Open-label|Withdrawal by Subject|0|||
155696879|NCT01927055|561982666|FG002|Open-label|Withdrawal by Subject|0|||
155696880|NCT01927055|561982664|FG000|Open-label|Study Stopped|4|||
155696881|NCT01927055|561982665|FG001|Open-label|Study Stopped|0|||
155696882|NCT01927055|561982666|FG002|Open-label|Study Stopped|0|||
155696883|NCT01927055|561982664|FG000|Open-label|Supine Hypertension|4|||
155696884|NCT01927055|561982665|FG001|Open-label|Supine Hypertension|0|||
155696885|NCT01927055|561982666|FG002|Open-label|Supine Hypertension|0|||
155696886|NCT01927055|561982664|FG000|Open-label|Difficulty attending study visits|1|||
155696887|NCT01927055|561982665|FG001|Open-label|Difficulty attending study visits|0|||
155696888|NCT01927055|561982666|FG002|Open-label|Difficulty attending study visits|0|||
155696889|NCT01927055|561982664|FG000|Double-Blind|Adverse Event|0|||
155696890|NCT01927055|561982665|FG001|Double-Blind|Adverse Event|1|||
155696891|NCT01927055|561982666|FG002|Double-Blind|Adverse Event|1|||
155696892|NCT01927055|561982664|FG000|Double-Blind|Protocol Violation|0|||
155696893|NCT01927055|561982665|FG001|Double-Blind|Protocol Violation|0|||
155696894|NCT01927055|561982666|FG002|Double-Blind|Protocol Violation|1|||
155696895|NCT01927055|561982664|FG000|Double-Blind|Withdrawal by Subject|0|||
155696896|NCT01927055|561982665|FG001|Double-Blind|Withdrawal by Subject|2|||
155696897|NCT01927055|561982666|FG002|Double-Blind|Withdrawal by Subject|3|||
155696898|NCT01927055|561982664|FG000|Double-Blind|Study Stopped|0|||
155696899|NCT01927055|561982665|FG001|Double-Blind|Study Stopped|7|||
155696900|NCT01927055|561982666|FG002|Double-Blind|Study Stopped|7|||
155696901|NCT01927055|561982664|FG000|Double-Blind|Supine Hypertension|0|||
155696902|NCT01927055|561982665|FG001|Double-Blind|Supine Hypertension|0|||
155696903|NCT01927055|561982666|FG002|Double-Blind|Supine Hypertension|1|||
155696904|NCT01927055|561982664|FG000|Double-Blind|Extended Vacation|0|||
155696905|NCT01927055|561982665|FG001|Double-Blind|Extended Vacation|1|||
155696906|NCT01927055|561982666|FG002|Double-Blind|Extended Vacation|0|||
155696907|NCT02598128|561982667|FG000|Period A: Days -7 to -1|Adverse Event|1|||
155696908|NCT02598128|561982668|FG001|Period A: Days -7 to -1|Adverse Event|0|||
155696909|NCT02598128|561982669|FG002|Period A: Days -7 to -1|Adverse Event|0|||
155696910|NCT02598128|561982670|FG003|Period A: Days -7 to -1|Adverse Event|0|||
155696911|NCT01064687|561982673|FG000|Overall Study|Adverse Event|9|||
155696912|NCT01064687|561982674|FG001|Overall Study|Adverse Event|4|||
155696913|NCT01064687|561982675|FG002|Overall Study|Adverse Event|10|||
155696914|NCT01064687|561982676|FG003|Overall Study|Adverse Event|3|||
155696915|NCT01064687|561982673|FG000|Overall Study|Death|1|||
155696916|NCT01064687|561982674|FG001|Overall Study|Death|1|||
155696917|NCT01064687|561982675|FG002|Overall Study|Death|0|||
155696918|NCT01064687|561982676|FG003|Overall Study|Death|0|||
155696919|NCT01064687|561982673|FG000|Overall Study|Entry Criteria Not Met|3|||
155696920|NCT01064687|561982674|FG001|Overall Study|Entry Criteria Not Met|0|||
155696921|NCT01064687|561982675|FG002|Overall Study|Entry Criteria Not Met|0|||
155696922|NCT01064687|561982676|FG003|Overall Study|Entry Criteria Not Met|0|||
155696923|NCT01064687|561982673|FG000|Overall Study|Lack of Efficacy|1|||
155696924|NCT01064687|561982674|FG001|Overall Study|Lack of Efficacy|0|||
155696925|NCT01064687|561982675|FG002|Overall Study|Lack of Efficacy|2|||
155696926|NCT01064687|561982676|FG003|Overall Study|Lack of Efficacy|3|||
155696927|NCT01064687|561982673|FG000|Overall Study|Lost to Follow-up|7|||
155696928|NCT01064687|561982674|FG001|Overall Study|Lost to Follow-up|10|||
155696929|NCT01064687|561982675|FG002|Overall Study|Lost to Follow-up|13|||
155696930|NCT01064687|561982676|FG003|Overall Study|Lost to Follow-up|5|||
155696931|NCT01064687|561982673|FG000|Overall Study|Physician Decision|2|||
155696932|NCT01064687|561982674|FG001|Overall Study|Physician Decision|2|||
155696933|NCT01064687|561982675|FG002|Overall Study|Physician Decision|0|||
155696934|NCT01064687|561982676|FG003|Overall Study|Physician Decision|0|||
155696935|NCT01064687|561982673|FG000|Overall Study|Protocol Violation|1|||
155696936|NCT01064687|561982674|FG001|Overall Study|Protocol Violation|1|||
155696937|NCT01064687|561982675|FG002|Overall Study|Protocol Violation|0|||
155696938|NCT01064687|561982676|FG003|Overall Study|Protocol Violation|1|||
155696939|NCT01064687|561982673|FG000|Overall Study|Sponsor Decision|0|||
155696940|NCT01064687|561982674|FG001|Overall Study|Sponsor Decision|0|||
155696941|NCT01064687|561982675|FG002|Overall Study|Sponsor Decision|3|||
155696942|NCT01064687|561982676|FG003|Overall Study|Sponsor Decision|0|||
155696943|NCT01064687|561982673|FG000|Overall Study|Withdrawal by Subject|9|||
155696944|NCT01064687|561982674|FG001|Overall Study|Withdrawal by Subject|7|||
155696945|NCT01064687|561982675|FG002|Overall Study|Withdrawal by Subject|12|||
155696946|NCT01064687|561982676|FG003|Overall Study|Withdrawal by Subject|5|||
155696947|NCT01064687|561982673|FG000|Overall Study|Treatment Noncompliance|1|||
155696948|NCT01064687|561982674|FG001|Overall Study|Treatment Noncompliance|1|||
155696949|NCT01064687|561982675|FG002|Overall Study|Treatment Noncompliance|1|||
155696950|NCT01064687|561982676|FG003|Overall Study|Treatment Noncompliance|0|||
155696951|NCT05219669|561982681|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
155696952|NCT05219669|561982682|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
155696953|NCT05219669|561982683|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
155696954|NCT05219669|561982684|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
155696955|NCT05219669|561982685|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
155696956|NCT05219669|561982686|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
155696957|NCT03134183|561982688|FG000|Overall Study|Withdrawal by Subject|1|||
155696958|NCT03134183|561982689|FG001|Overall Study|Withdrawal by Subject|1|||
155696959|NCT02177838|561982692|FG000|Overall Study|Withdrawal by Subject|1|||
155696960|NCT02177838|561982692|FG000|Overall Study|Physician Decision|1|||
155696961|NCT02177838|561982692|FG000|Overall Study|Death|1|||
155696962|NCT02404649|561982694|FG000|Overall Study|Adverse Event|1|||
155696963|NCT02404649|561982695|FG001|Overall Study|Adverse Event|2|||
155696964|NCT00162266|561982699|FG000|Double-Blind Period|Adverse Event|5|||
155696965|NCT00162266|561982700|FG001|Double-Blind Period|Adverse Event|9|||
155696966|NCT00162266|561982701|FG002|Double-Blind Period|Adverse Event|11|||
155696967|NCT00162266|561982702|FG003|Double-Blind Period|Adverse Event|0|||
155696968|NCT00162266|561982699|FG000|Double-Blind Period|Death|0|||
155696969|NCT00162266|561982700|FG001|Double-Blind Period|Death|1|||
155696970|NCT00162266|561982701|FG002|Double-Blind Period|Death|0|||
155696971|NCT00162266|561982702|FG003|Double-Blind Period|Death|0|||
155696972|NCT00162266|561982699|FG000|Double-Blind Period|Lost to Follow-up|1|||
155696973|NCT00162266|561982700|FG001|Double-Blind Period|Lost to Follow-up|2|||
155696974|NCT00162266|561982701|FG002|Double-Blind Period|Lost to Follow-up|0|||
155696975|NCT00162266|561982702|FG003|Double-Blind Period|Lost to Follow-up|0|||
155696976|NCT00162266|561982699|FG000|Double-Blind Period|Other Reason|1|||
155696977|NCT00162266|561982700|FG001|Double-Blind Period|Other Reason|0|||
155696978|NCT00162266|561982701|FG002|Double-Blind Period|Other Reason|1|||
155696979|NCT00162266|561982702|FG003|Double-Blind Period|Other Reason|0|||
155696980|NCT00162266|561982699|FG000|Double-Blind Period|Lack of Efficacy|13|||
155696981|NCT00162266|561982700|FG001|Double-Blind Period|Lack of Efficacy|17|||
155696982|NCT00162266|561982701|FG002|Double-Blind Period|Lack of Efficacy|30|||
155696983|NCT00162266|561982702|FG003|Double-Blind Period|Lack of Efficacy|0|||
155696984|NCT00162266|561982699|FG000|Double-Blind Period|Withdrawal by Subject|5|||
155696985|NCT00162266|561982700|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155696986|NCT00162266|561982701|FG002|Double-Blind Period|Withdrawal by Subject|6|||
155696987|NCT00162266|561982702|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155696988|NCT00162266|561982699|FG000|Open-Label Period|Death|0|||
155696989|NCT00162266|561982700|FG001|Open-Label Period|Death|0|||
155696990|NCT00162266|561982701|FG002|Open-Label Period|Death|0|||
155696991|NCT00162266|561982702|FG003|Open-Label Period|Death|7|||
155696992|NCT00162266|561982699|FG000|Open-Label Period|Adverse Event|0|||
155696993|NCT00162266|561982700|FG001|Open-Label Period|Adverse Event|0|||
155696994|NCT00162266|561982701|FG002|Open-Label Period|Adverse Event|0|||
155696995|NCT00162266|561982702|FG003|Open-Label Period|Adverse Event|46|||
155696996|NCT00162266|561982699|FG000|Open-Label Period|Lack of Efficacy|0|||
155696997|NCT00162266|561982700|FG001|Open-Label Period|Lack of Efficacy|0|||
155696998|NCT00162266|561982701|FG002|Open-Label Period|Lack of Efficacy|0|||
155696999|NCT00162266|561982702|FG003|Open-Label Period|Lack of Efficacy|26|||
155697000|NCT00162266|561982699|FG000|Open-Label Period|Lost to Follow-up|0|||
155697001|NCT00162266|561982700|FG001|Open-Label Period|Lost to Follow-up|0|||
155697002|NCT00162266|561982701|FG002|Open-Label Period|Lost to Follow-up|0|||
155697003|NCT00162266|561982702|FG003|Open-Label Period|Lost to Follow-up|3|||
155697004|NCT00162266|561982699|FG000|Open-Label Period|Withdrawal by Subject|0|||
155697005|NCT00162266|561982700|FG001|Open-Label Period|Withdrawal by Subject|0|||
155697006|NCT00162266|561982701|FG002|Open-Label Period|Withdrawal by Subject|0|||
155697007|NCT00162266|561982702|FG003|Open-Label Period|Withdrawal by Subject|31|||
155697008|NCT00162266|561982699|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
155697009|NCT00162266|561982700|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
155697010|NCT00162266|561982701|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
155697011|NCT00162266|561982702|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
155697012|NCT00162266|561982699|FG000|Open-Label Period|Other Reasons|0|||
155697013|NCT00162266|561982700|FG001|Open-Label Period|Other Reasons|0|||
155697014|NCT00162266|561982701|FG002|Open-Label Period|Other Reasons|0|||
155697015|NCT00162266|561982702|FG003|Open-Label Period|Other Reasons|15|||
155697016|NCT02299076|561982703|FG000|Overall Study|Fraudulent Entries|20|||
155697017|NCT02299076|561982704|FG001|Overall Study|Fraudulent Entries|14|||
155697018|NCT01839656|561982705|FG000|Overall Study|Withdrawal by Subject|1|||
155697019|NCT01839656|561982706|FG001|Overall Study|Withdrawal by Subject|1|||
155697020|NCT01839656|561982705|FG000|Overall Study|Adverse event, serious fatal|1|||
155697021|NCT01839656|561982706|FG001|Overall Study|Adverse event, serious fatal|4|||
155697022|NCT01839656|561982705|FG000|Overall Study|Early study closure|0|||
155697023|NCT01839656|561982706|FG001|Overall Study|Early study closure|11|||
155697024|NCT01839656|561982705|FG000|Overall Study|Adverse Event|1|||
155697025|NCT01839656|561982706|FG001|Overall Study|Adverse Event|0|||
155697026|NCT00499746|561982707|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
155697027|NCT00499746|561982707|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
155697028|NCT00499746|561982707|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
155697029|NCT00499746|561982707|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
155697030|NCT00558272|561982710|FG000|Overall Study|Adverse Event|10|||
155697031|NCT00558272|561982711|FG001|Overall Study|Adverse Event|0|||
155697032|NCT00558272|561982710|FG000|Overall Study|Death|1|||
155697033|NCT00558272|561982711|FG001|Overall Study|Death|0|||
155697034|NCT00558272|561982710|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
155697035|NCT00558272|561982711|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
155697036|NCT00558272|561982710|FG000|Overall Study|AZ study team decision|0|||
155697037|NCT00558272|561982711|FG001|Overall Study|AZ study team decision|1|||
155697038|NCT00558272|561982710|FG000|Overall Study|Incorrectly enrolled|1|||
155697039|NCT00558272|561982711|FG001|Overall Study|Incorrectly enrolled|0|||
155697040|NCT00558272|561982710|FG000|Overall Study|Withdrawal by Subject|0|||
155697041|NCT00558272|561982711|FG001|Overall Study|Withdrawal by Subject|1|||
155697042|NCT04311463|561982712|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
155697043|NCT04311463|561982713|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
155697044|NCT04311463|561982712|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
155697045|NCT04311463|561982713|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
155697046|NCT04311463|561982712|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
155697047|NCT04311463|561982713|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
155697048|NCT01291277|561982719|FG000|Overall Study|Death|2|||
155697049|NCT01291277|561982720|FG001|Overall Study|Death|2|||
155697050|NCT01291277|561982719|FG000|Overall Study|Lost to Follow-up|3|||
155697051|NCT01291277|561982720|FG001|Overall Study|Lost to Follow-up|1|||
155697052|NCT02963701|561982721|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
155697053|NCT02963701|561982722|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
155697054|NCT03480009|561982723|FG000|Overall Study|Lost to Follow-up|4|||
155697055|NCT03480009|561982724|FG001|Overall Study|Lost to Follow-up|5|||
155697056|NCT03480009|561982725|FG002|Overall Study|Lost to Follow-up|4|||
155697057|NCT03480009|561982726|FG003|Overall Study|Lost to Follow-up|0|||
155697058|NCT00637572|561982727|FG000|Overall Study|Adverse Event|1|||
155697059|NCT00637572|561982728|FG001|Overall Study|Adverse Event|2|||
155697060|NCT00637572|561982727|FG000|Overall Study|Death|0|||
155697061|NCT00637572|561982728|FG001|Overall Study|Death|1|||
155697062|NCT00637572|561982727|FG000|Overall Study|Lost to Follow-up|0|||
155697063|NCT00637572|561982728|FG001|Overall Study|Lost to Follow-up|1|||
155697064|NCT00637572|561982727|FG000|Overall Study|Physician Decision|1|||
155697065|NCT00637572|561982728|FG001|Overall Study|Physician Decision|1|||
155697066|NCT00637572|561982727|FG000|Overall Study|Withdrawal by Subject|0|||
155697067|NCT00637572|561982728|FG001|Overall Study|Withdrawal by Subject|2|||
155697068|NCT00637572|561982727|FG000|Overall Study|Illicit Drug Use|1|||
155697069|NCT00637572|561982728|FG001|Overall Study|Illicit Drug Use|0|||
155697070|NCT00896649|561982729|FG000|Overall Study|Physician Decision|1|||
155697071|NCT00896649|561982729|FG000|Overall Study|Pregnancy|1|||
155697072|NCT00896649|561982729|FG000|Overall Study|missing documentation|1|||
155697073|NCT00896649|561982729|FG000|Overall Study|technical difficulties|2|||
155697074|NCT03652675|561982730|FG000|Overall Study|Lost to Follow-up|4|||
155697075|NCT03652675|561982731|FG001|Overall Study|Lost to Follow-up|4|||
155697076|NCT03442296|561982734|FG000|3 Month Follow-up|Death|3|||
155697077|NCT03442296|561982735|FG001|3 Month Follow-up|Death|1|||
155697078|NCT03442296|561982734|FG000|3 Month Follow-up|Lost to Follow-up|1|||
155697079|NCT03442296|561982735|FG001|3 Month Follow-up|Lost to Follow-up|1|||
155697080|NCT03442296|561982734|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
155697081|NCT03442296|561982735|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
155697082|NCT03442296|561982734|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
155697083|NCT03442296|561982735|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
155697084|NCT03442296|561982734|FG000|12 Month Follow-up|Incomplete measurement|1|||
155697085|NCT03442296|561982735|FG001|12 Month Follow-up|Incomplete measurement|1|||
155697086|NCT01673620|561984464|FG000|Overall Study|Adverse Event|1|||
155697087|NCT01673620|561984465|FG001|Overall Study|Adverse Event|0|||
155697088|NCT00528801|561984466|FG000|Overall Study|Withdrawal by Subject|1|||
155697089|NCT00528801|561984467|FG001|Overall Study|Withdrawal by Subject|1|||
155697090|NCT00528801|561984466|FG000|Overall Study|Protocol Violation|11|||
155697091|NCT00528801|561984467|FG001|Overall Study|Protocol Violation|5|||
155697092|NCT00528801|561984466|FG000|Overall Study|Lost to Follow-up|15|||
155697093|NCT00528801|561984467|FG001|Overall Study|Lost to Follow-up|4|||
155697094|NCT00528801|561984466|FG000|Overall Study|Administrative Reasons|0|||
155697095|NCT00528801|561984467|FG001|Overall Study|Administrative Reasons|1|||
155697096|NCT00344500|561984468|FG000|Overall Study|Adverse Event|6|||
155697097|NCT00344500|561984469|FG001|Overall Study|Adverse Event|2|||
155697098|NCT00344500|561984470|FG002|Overall Study|Adverse Event|0|||
155697099|NCT00344500|561984468|FG000|Overall Study|Lost to Follow-up|5|||
155697100|NCT00344500|561984469|FG001|Overall Study|Lost to Follow-up|13|||
155697101|NCT00344500|561984470|FG002|Overall Study|Lost to Follow-up|1|||
155697102|NCT00344500|561984468|FG000|Overall Study|Withdrawal by Subject|7|||
155697103|NCT00344500|561984469|FG001|Overall Study|Withdrawal by Subject|10|||
155697104|NCT00344500|561984470|FG002|Overall Study|Withdrawal by Subject|0|||
155697105|NCT00344500|561984468|FG000|Overall Study|Protocol Violation|4|||
155697106|NCT00344500|561984469|FG001|Overall Study|Protocol Violation|7|||
155697107|NCT00344500|561984470|FG002|Overall Study|Protocol Violation|1|||
155697108|NCT00344500|561984468|FG000|Overall Study|Not Noted|1|||
155697109|NCT00344500|561984469|FG001|Overall Study|Not Noted|3|||
155697110|NCT00344500|561984470|FG002|Overall Study|Not Noted|0|||
155697111|NCT02252965|561984471|FG000|Overall Study|Adverse Event|9|||
155697112|NCT02252965|561984472|FG001|Overall Study|Adverse Event|14|||
155697113|NCT02252965|561984471|FG000|Overall Study|Lost to Follow-up|16|||
155697114|NCT02252965|561984472|FG001|Overall Study|Lost to Follow-up|8|||
155697115|NCT02252965|561984471|FG000|Overall Study|Protocol Violation|4|||
155697116|NCT02252965|561984472|FG001|Overall Study|Protocol Violation|5|||
155697117|NCT02252965|561984471|FG000|Overall Study|Lack of Efficacy|0|||
155697118|NCT02252965|561984472|FG001|Overall Study|Lack of Efficacy|2|||
155697119|NCT02252965|561984471|FG000|Overall Study|Withdrawal by Subject|7|||
155697120|NCT02252965|561984472|FG001|Overall Study|Withdrawal by Subject|9|||
155697121|NCT02252965|561984471|FG000|Overall Study|Other|4|||
155697122|NCT02252965|561984472|FG001|Overall Study|Other|5|||
155697123|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
155697124|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
155697125|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
155697126|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
155697127|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
155697128|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
155697129|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155697130|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
155697131|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
155697132|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
155697133|NCT02429791|561984479|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
155697134|NCT02429791|561984480|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
155697135|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
155697136|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
155697137|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
155697138|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
155697139|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
155697140|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
155697141|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
155697142|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
155697143|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155697144|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155697145|NCT02429791|561984479|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
155697146|NCT02429791|561984480|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
155697147|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
155697148|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
155697149|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
155697150|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
155697151|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
155697152|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
155697153|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
155697154|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
155697155|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
155697156|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
155697157|NCT02429791|561984479|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
155697158|NCT02429791|561984480|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
155697159|NCT02615691|561984481|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
155697160|NCT02615691|561984481|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
155697161|NCT02615691|561984481|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
155697162|NCT02615691|561984481|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
155697163|NCT04201093|561984482|FG000|Overall Study|Adverse Event|6|||
155697164|NCT04201093|561984483|FG001|Overall Study|Adverse Event|29|||
155697165|NCT04201093|561984484|FG002|Overall Study|Adverse Event|35|||
155697166|NCT04201093|561984482|FG000|Overall Study|Death|2|||
155697167|NCT04201093|561984483|FG001|Overall Study|Death|1|||
155697168|NCT04201093|561984484|FG002|Overall Study|Death|0|||
155697169|NCT04201093|561984482|FG000|Overall Study|Lack of Efficacy|5|||
155697170|NCT04201093|561984483|FG001|Overall Study|Lack of Efficacy|1|||
155697171|NCT04201093|561984484|FG002|Overall Study|Lack of Efficacy|2|||
155697172|NCT04201093|561984482|FG000|Overall Study|Lost to Follow-up|0|||
155697173|NCT04201093|561984483|FG001|Overall Study|Lost to Follow-up|0|||
155697174|NCT04201093|561984484|FG002|Overall Study|Lost to Follow-up|1|||
155697175|NCT04201093|561984482|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
155697176|NCT04201093|561984483|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155697177|NCT04201093|561984484|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
155697178|NCT04201093|561984482|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155697179|NCT04201093|561984483|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155697180|NCT04201093|561984484|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155697181|NCT04201093|561984482|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
155697182|NCT04201093|561984483|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
155697183|NCT04201093|561984484|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
155697184|NCT04201093|561984482|FG000|Overall Study|Physician Decision|1|||
155697185|NCT04201093|561984483|FG001|Overall Study|Physician Decision|0|||
155697186|NCT04201093|561984484|FG002|Overall Study|Physician Decision|0|||
155697187|NCT04201093|561984482|FG000|Overall Study|Protocol Deviation|1|||
155697188|NCT04201093|561984483|FG001|Overall Study|Protocol Deviation|0|||
155697189|NCT04201093|561984484|FG002|Overall Study|Protocol Deviation|0|||
155697190|NCT04201093|561984482|FG000|Overall Study|Site Terminated by Sponsor|5|||
155697191|NCT04201093|561984483|FG001|Overall Study|Site Terminated by Sponsor|3|||
155697192|NCT04201093|561984484|FG002|Overall Study|Site Terminated by Sponsor|1|||
155697193|NCT04201093|561984482|FG000|Overall Study|Withdrawal by Subject|7|||
155697194|NCT04201093|561984483|FG001|Overall Study|Withdrawal by Subject|8|||
155697195|NCT04201093|561984484|FG002|Overall Study|Withdrawal by Subject|15|||
155697196|NCT04201093|561984482|FG000|Overall Study|Other|0|||
155697197|NCT04201093|561984483|FG001|Overall Study|Other|1|||
155697198|NCT04201093|561984484|FG002|Overall Study|Other|2|||
155697199|NCT00881504|561984485|FG000|Overall Study|Withdrawal by Subject|1|||
155697200|NCT01276223|561984486|FG000|Overall Study|Adverse Event|7|||
155697201|NCT01276223|561984487|FG001|Overall Study|Adverse Event|4|||
155697202|NCT01276223|561984488|FG002|Overall Study|Adverse Event|1|||
155697203|NCT01276223|561984486|FG000|Overall Study|Lost to Follow-up|0|||
155697204|NCT01276223|561984487|FG001|Overall Study|Lost to Follow-up|0|||
155697205|NCT01276223|561984488|FG002|Overall Study|Lost to Follow-up|1|||
155697206|NCT01276223|561984486|FG000|Overall Study|Other|0|||
155697207|NCT01276223|561984487|FG001|Overall Study|Other|0|||
155697208|NCT01276223|561984488|FG002|Overall Study|Other|1|||
155697209|NCT01276223|561984486|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
155697210|NCT01276223|561984487|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
155697211|NCT01276223|561984488|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
155697212|NCT01276223|561984486|FG000|Overall Study|Protocol Violation|1|||
155697213|NCT01276223|561984487|FG001|Overall Study|Protocol Violation|0|||
155697214|NCT01276223|561984488|FG002|Overall Study|Protocol Violation|0|||
155697215|NCT02017522|561984489|FG000|Overall Study|Withdrawal by Subject|1|||
155697216|NCT02596230|561984490|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
155697217|NCT02596230|561984491|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
155697218|NCT02596230|561984492|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
155697219|NCT02596230|561984493|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
155697220|NCT02596230|561984494|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
155697221|NCT02596230|561984490|FG000|Objective 2, One Year|Lost to Follow-up|0|||
155697222|NCT02596230|561984491|FG001|Objective 2, One Year|Lost to Follow-up|41|||
155697223|NCT02596230|561984492|FG002|Objective 2, One Year|Lost to Follow-up|41|||
155697224|NCT02596230|561984493|FG003|Objective 2, One Year|Lost to Follow-up|32|||
155697225|NCT02596230|561984494|FG004|Objective 2, One Year|Lost to Follow-up|46|||
155697226|NCT02596230|561984490|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
155697227|NCT02596230|561984491|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
155697228|NCT02596230|561984492|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
155697229|NCT02596230|561984493|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
155697230|NCT02596230|561984494|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
155697231|NCT02596230|561984490|FG000|Objective 2, One Year|Adverse drug reaction|0|||
155697232|NCT02596230|561984491|FG001|Objective 2, One Year|Adverse drug reaction|1|||
155697233|NCT02596230|561984492|FG002|Objective 2, One Year|Adverse drug reaction|0|||
155697234|NCT02596230|561984493|FG003|Objective 2, One Year|Adverse drug reaction|0|||
155697235|NCT02596230|561984494|FG004|Objective 2, One Year|Adverse drug reaction|0|||
155697236|NCT02596230|561984490|FG000|Objective 2, One Year|Death|0|||
155697237|NCT02596230|561984491|FG001|Objective 2, One Year|Death|12|||
155697238|NCT02596230|561984492|FG002|Objective 2, One Year|Death|41|||
155697239|NCT02596230|561984493|FG003|Objective 2, One Year|Death|21|||
155697240|NCT02596230|561984494|FG004|Objective 2, One Year|Death|30|||
155697241|NCT02596230|561984490|FG000|Objective 2, One Year|Other|0|||
155697242|NCT02596230|561984491|FG001|Objective 2, One Year|Other|3|||
155697243|NCT02596230|561984492|FG002|Objective 2, One Year|Other|2|||
155697244|NCT02596230|561984493|FG003|Objective 2, One Year|Other|0|||
155697245|NCT02596230|561984494|FG004|Objective 2, One Year|Other|0|||
155697246|NCT00771615|561984495|FG000|Overall Study|Withdrawal by Subject|0|||
155697247|NCT00771615|561984496|FG001|Overall Study|Withdrawal by Subject|1|||
155697248|NCT00771615|561984497|FG002|Overall Study|Withdrawal by Subject|0|||
155697249|NCT00771615|561984498|FG003|Overall Study|Withdrawal by Subject|0|||
155697250|NCT00771615|561984499|FG004|Overall Study|Withdrawal by Subject|0|||
155697251|NCT00771615|561984500|FG005|Overall Study|Withdrawal by Subject|0|||
155697252|NCT00771615|561984501|FG006|Overall Study|Withdrawal by Subject|0|||
155697253|NCT00771615|561984502|FG007|Overall Study|Withdrawal by Subject|1|||
155697254|NCT00771615|561984503|FG008|Overall Study|Withdrawal by Subject|0|||
155697255|NCT00771615|561984495|FG000|Overall Study|Lost to Follow-up|1|||
155697256|NCT00771615|561984496|FG001|Overall Study|Lost to Follow-up|1|||
155697257|NCT00771615|561984497|FG002|Overall Study|Lost to Follow-up|1|||
155697258|NCT00771615|561984498|FG003|Overall Study|Lost to Follow-up|1|||
155697259|NCT00771615|561984499|FG004|Overall Study|Lost to Follow-up|0|||
155697260|NCT00771615|561984500|FG005|Overall Study|Lost to Follow-up|1|||
155697261|NCT00771615|561984501|FG006|Overall Study|Lost to Follow-up|1|||
155697262|NCT00771615|561984502|FG007|Overall Study|Lost to Follow-up|0|||
155697263|NCT00771615|561984503|FG008|Overall Study|Lost to Follow-up|0|||
155697264|NCT04279613|561984505|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155697265|NCT04279613|561984506|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155697266|NCT04279613|561984507|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155697267|NCT04279613|561984508|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155697268|NCT04279613|561984509|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
155697269|NCT04279613|561984505|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155697270|NCT04279613|561984506|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
155697271|NCT04279613|561984507|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155697272|NCT04279613|561984508|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155697273|NCT04279613|561984509|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155697274|NCT04279613|561984505|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155697275|NCT04279613|561984506|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155697276|NCT04279613|561984507|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
155697277|NCT04279613|561984508|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155697278|NCT04279613|561984509|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155697279|NCT04279613|561984505|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155697280|NCT04279613|561984506|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155697281|NCT04279613|561984507|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155697282|NCT04279613|561984508|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155697283|NCT04279613|561984509|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
155697284|NCT04279613|561984505|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155697285|NCT04279613|561984506|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155697286|NCT04279613|561984507|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155697287|NCT04279613|561984508|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
155697288|NCT04279613|561984509|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155697289|NCT02704689|561984510|FG000|Overall Study|Physician Decision|1|||
155697290|NCT02704689|561984510|FG000|Overall Study|Study device not implanted|2|||
155697291|NCT00802893|561984511|FG000|Overall Study|study terminated|3|||
155697292|NCT00320424|561984512|FG000|Overall Study|Adverse Event|3|||
155697293|NCT00320424|561984512|FG000|Overall Study|Other|3|||
155697294|NCT03270891|561984514|FG000|Overall Study|Lost to Follow-up|3|||
155697295|NCT03270891|561984515|FG001|Overall Study|Lost to Follow-up|6|||
155697296|NCT03270891|561984516|FG002|Overall Study|Lost to Follow-up|0|||
155697297|NCT03270891|561984514|FG000|Overall Study|Withdrawal by Subject|1|||
155697298|NCT03270891|561984515|FG001|Overall Study|Withdrawal by Subject|0|||
155697299|NCT03270891|561984516|FG002|Overall Study|Withdrawal by Subject|0|||
155697300|NCT03270891|561984514|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
155697301|NCT03270891|561984515|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
155697302|NCT03270891|561984516|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
155697303|NCT02540668|561984517|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
155697304|NCT02540668|561984518|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
155697305|NCT04051827|561984519|FG000|Overall Study|Death|1|||
155697306|NCT04051827|561984519|FG000|Overall Study|Withdrawal by Subject|4|||
155697307|NCT04051827|561984519|FG000|Overall Study|Progressive disease|16|||
155697308|NCT04051827|561984519|FG000|Overall Study|Physician Decision|1|||
155697309|NCT04051827|561984519|FG000|Overall Study|Other|4|||
155697310|NCT05779007|561984520|FG000|Overall Study|not meeting eligibility criteria|3517|||
155697311|NCT05779007|561984521|FG001|Overall Study|not meeting eligibility criteria|2009|||
155697312|NCT01424566|561984522|FG000|Single-blind Treatment|Adverse Event|71|||
155697313|NCT01424566|561984523|FG001|Single-blind Treatment|Adverse Event|0|||
155697314|NCT01424566|561984524|FG002|Single-blind Treatment|Adverse Event|0|||
155697315|NCT01424566|561984522|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
155697316|NCT01424566|561984523|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
155697317|NCT01424566|561984524|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
155697318|NCT01424566|561984522|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
155697319|NCT01424566|561984523|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
155697320|NCT01424566|561984524|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
155697321|NCT01424566|561984522|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
155697322|NCT01424566|561984523|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
155697323|NCT01424566|561984524|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
155697324|NCT01424566|561984522|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
155697325|NCT01424566|561984523|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
155697326|NCT01424566|561984524|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
155697327|NCT01424566|561984522|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
155697328|NCT01424566|561984523|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
155697329|NCT01424566|561984524|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
155697330|NCT01424566|561984522|FG000|Double-blind Treatment|Adverse Event|0|||
155697331|NCT01424566|561984523|FG001|Double-blind Treatment|Adverse Event|21|||
155697332|NCT01424566|561984524|FG002|Double-blind Treatment|Adverse Event|13|||
155697333|NCT01424566|561984522|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
155697334|NCT01424566|561984523|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
155697335|NCT01424566|561984524|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
155697336|NCT01424566|561984522|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
155697337|NCT01424566|561984523|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
155697338|NCT01424566|561984524|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
155697339|NCT01424566|561984522|FG000|Double-blind Treatment|Lack of Efficacy|0|||
155697340|NCT01424566|561984523|FG001|Double-blind Treatment|Lack of Efficacy|1|||
155697341|NCT01424566|561984524|FG002|Double-blind Treatment|Lack of Efficacy|1|||
155697342|NCT00849108|561984525|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
155697343|NCT00849108|561984526|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
155697344|NCT00849108|561984525|FG000|Cohort 2 Efficacy|Adverse Event|0|||
155697345|NCT00849108|561984526|FG001|Cohort 2 Efficacy|Adverse Event|1|||
155697346|NCT00849108|561984525|FG000|Cohort 2 Efficacy|Other|0|||
155697347|NCT00849108|561984526|FG001|Cohort 2 Efficacy|Other|9|||
155697348|NCT05147662|561984531|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155697349|NCT05147662|561984531|FG000|Overall Study|Assigned to treatment but never treated|1|||
155697350|NCT01100528|561984535|FG000|Overall Study|Death|1|||
155697351|NCT01100528|561984535|FG000|Overall Study|Withdrawal by Subject|2|||
155697352|NCT02211313|561984536|FG000|Overall Study|Treatment Failure|5|||
155697353|NCT02211313|561984537|FG001|Overall Study|Treatment Failure|2|||
155697354|NCT02211313|561984536|FG000|Overall Study|No Follow up Questionnaires|1|||
155697355|NCT02211313|561984537|FG001|Overall Study|No Follow up Questionnaires|1|||
155697356|NCT00551291|561984538|FG000|Overall Study|Physician Decision|1|||
155697357|NCT01943552|561984539|FG000|Overall Study|Adverse Event|3|||
155697358|NCT01943552|561984540|FG001|Overall Study|Adverse Event|2|||
155697359|NCT01943552|561984539|FG000|Overall Study|Withdrawal by Subject|6|||
155697360|NCT01943552|561984540|FG001|Overall Study|Withdrawal by Subject|6|||
155697361|NCT01943552|561984539|FG000|Overall Study|Other Reasons|16|||
155697362|NCT01943552|561984540|FG001|Overall Study|Other Reasons|17|||
155697363|NCT01177969|561984541|FG000|Overall Study|Protocol Violation|2|||
155697364|NCT01177969|561984542|FG001|Overall Study|Protocol Violation|1|||
155697365|NCT01177969|561984541|FG000|Overall Study|Withdrawal by Subject|1|||
155697366|NCT01177969|561984542|FG001|Overall Study|Withdrawal by Subject|2|||
155697367|NCT01475162|561984544|FG000|Overall Study|Physician Decision|1|||
155697368|NCT01475162|561984544|FG000|Overall Study|Death|10|||
155697369|NCT01475162|561984544|FG000|Overall Study|Study closed for safety|3|||
155697370|NCT00025155|561984545|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
155697371|NCT00025155|561984545|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
155697372|NCT00552760|561984546|FG000|Overall Study|Adverse Event|3|||
155697373|NCT00552760|561984547|FG001|Overall Study|Adverse Event|5|||
155697374|NCT00552760|561984546|FG000|Overall Study|Relapsed- Depressed Event|10|||
155697375|NCT00552760|561984547|FG001|Overall Study|Relapsed- Depressed Event|16|||
155697376|NCT00552760|561984546|FG000|Overall Study|Relapse- Manic Event|3|||
155697377|NCT00552760|561984547|FG001|Overall Study|Relapse- Manic Event|3|||
155697378|NCT00552760|561984546|FG000|Overall Study|Relapsed- Mixed Event|3|||
155697379|NCT00552760|561984547|FG001|Overall Study|Relapsed- Mixed Event|5|||
155697380|NCT00552760|561984546|FG000|Overall Study|Protocol Violation|0|||
155697381|NCT00552760|561984547|FG001|Overall Study|Protocol Violation|1|||
155697382|NCT00552760|561984546|FG000|Overall Study|Lost to Follow-up|1|||
155697383|NCT00552760|561984547|FG001|Overall Study|Lost to Follow-up|1|||
155697384|NCT00552760|561984546|FG000|Overall Study|Non-compliance|1|||
155697385|NCT00552760|561984547|FG001|Overall Study|Non-compliance|1|||
155697386|NCT00552760|561984546|FG000|Overall Study|Medical Condition|1|||
155697387|NCT00552760|561984547|FG001|Overall Study|Medical Condition|1|||
155697388|NCT00552760|561984546|FG000|Overall Study|Withdrawal by Subject|3|||
155697389|NCT00552760|561984547|FG001|Overall Study|Withdrawal by Subject|0|||
155697390|NCT00552760|561984546|FG000|Overall Study|Medication Change|1|||
155697391|NCT00552760|561984547|FG001|Overall Study|Medication Change|0|||
155697392|NCT03426631|561984550|FG000|Overall Study|Lost to Follow-up|0|||
155697393|NCT03426631|561984551|FG001|Overall Study|Lost to Follow-up|1|||
155697394|NCT00710385|561984558|FG000|Overall Study|Did not qualify|1|||
155697395|NCT00710385|561984558|FG000|Overall Study|Withdrawal by Subject|1|||
155697396|NCT00710385|561984558|FG000|Overall Study|Undisclosed back pain|1|||
155697397|NCT00710385|561984558|FG000|Overall Study|Physician Decision|1|||
155697398|NCT00710385|561984558|FG000|Overall Study|Undisclosed excessive methadone use|1|||
155697399|NCT01264770|561984559|FG000|Overall Study|Not reported|0|||
155697400|NCT01264770|561984560|FG001|Overall Study|Not reported|0|||
155697401|NCT01264770|561984561|FG002|Overall Study|Not reported|1|||
155697402|NCT01264770|561984562|FG003|Overall Study|Not reported|0|||
155697403|NCT01264770|561984563|FG004|Overall Study|Not reported|0|||
155697404|NCT01264770|561984564|FG005|Overall Study|Not reported|0|||
155697405|NCT01264770|561984559|FG000|Overall Study|e.g., change in circumstances|8|||
155697406|NCT01264770|561984560|FG001|Overall Study|e.g., change in circumstances|3|||
155697407|NCT01264770|561984561|FG002|Overall Study|e.g., change in circumstances|3|||
155697408|NCT01264770|561984562|FG003|Overall Study|e.g., change in circumstances|3|||
155697409|NCT01264770|561984563|FG004|Overall Study|e.g., change in circumstances|4|||
155697410|NCT01264770|561984564|FG005|Overall Study|e.g., change in circumstances|4|||
155697411|NCT01264770|561984559|FG000|Overall Study|Severe non-compliance to protocol|0|||
155697412|NCT01264770|561984560|FG001|Overall Study|Severe non-compliance to protocol|0|||
155697413|NCT01264770|561984561|FG002|Overall Study|Severe non-compliance to protocol|1|||
155697414|NCT01264770|561984562|FG003|Overall Study|Severe non-compliance to protocol|1|||
155697415|NCT01264770|561984563|FG004|Overall Study|Severe non-compliance to protocol|0|||
155697416|NCT01264770|561984564|FG005|Overall Study|Severe non-compliance to protocol|0|||
155697417|NCT01264770|561984559|FG000|Overall Study|Lack of therapeutic response|1|||
155697418|NCT01264770|561984560|FG001|Overall Study|Lack of therapeutic response|0|||
155697419|NCT01264770|561984561|FG002|Overall Study|Lack of therapeutic response|2|||
155697420|NCT01264770|561984562|FG003|Overall Study|Lack of therapeutic response|1|||
155697421|NCT01264770|561984563|FG004|Overall Study|Lack of therapeutic response|1|||
155697422|NCT01264770|561984564|FG005|Overall Study|Lack of therapeutic response|0|||
155697423|NCT01264770|561984559|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
155697424|NCT01264770|561984560|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
155697425|NCT01264770|561984561|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
155697426|NCT01264770|561984562|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
155697427|NCT01264770|561984563|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
155697428|NCT01264770|561984564|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
155697429|NCT01264770|561984559|FG000|Overall Study|Lost to Follow-up|0|||
155697430|NCT01264770|561984560|FG001|Overall Study|Lost to Follow-up|0|||
155697431|NCT01264770|561984561|FG002|Overall Study|Lost to Follow-up|1|||
155697432|NCT01264770|561984562|FG003|Overall Study|Lost to Follow-up|1|||
155697433|NCT01264770|561984563|FG004|Overall Study|Lost to Follow-up|0|||
155697434|NCT01264770|561984564|FG005|Overall Study|Lost to Follow-up|0|||
155697435|NCT01264770|561984559|FG000|Overall Study|Adverse Event|7|||
155697436|NCT01264770|561984560|FG001|Overall Study|Adverse Event|7|||
155697437|NCT01264770|561984561|FG002|Overall Study|Adverse Event|8|||
155697438|NCT01264770|561984562|FG003|Overall Study|Adverse Event|0|||
155697439|NCT01264770|561984563|FG004|Overall Study|Adverse Event|2|||
155697440|NCT01264770|561984564|FG005|Overall Study|Adverse Event|1|||
155697441|NCT00129961|561984565|FG000|Overall Study|Adverse Event|1|||
155697442|NCT00129961|561984566|FG001|Overall Study|Adverse Event|0|||
155697443|NCT00129961|561984565|FG000|Overall Study|Death|1|||
155697444|NCT00129961|561984566|FG001|Overall Study|Death|1|||
155697445|NCT00129961|561984565|FG000|Overall Study|Withdrawal by Sponsor|14|||
155697446|NCT00129961|561984566|FG001|Overall Study|Withdrawal by Sponsor|20|||
155697447|NCT00129961|561984565|FG000|Overall Study|Physician Decision|1|||
155697448|NCT00129961|561984566|FG001|Overall Study|Physician Decision|0|||
155697449|NCT00129961|561984565|FG000|Overall Study|Withdrawal by Subject|2|||
155697450|NCT00129961|561984566|FG001|Overall Study|Withdrawal by Subject|1|||
155697451|NCT00129961|561984565|FG000|Overall Study|Missing Record|0|||
155697452|NCT00129961|561984566|FG001|Overall Study|Missing Record|1|||
155697453|NCT01985360|561984569|FG000|Overall Study|Withdrawal by Subject|4|||
155697454|NCT01985360|561984570|FG001|Overall Study|Withdrawal by Subject|0|||
155697455|NCT01985360|561984569|FG000|Overall Study|Lost to Follow-up|5|||
155697456|NCT01985360|561984570|FG001|Overall Study|Lost to Follow-up|3|||
155697457|NCT03691779|561984571|FG000|Part B (24 Weeks)|Adverse Event|0|||
155697458|NCT03691779|561984572|FG001|Part B (24 Weeks)|Adverse Event|1|||
155697459|NCT03691779|561984571|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
155697460|NCT03691779|561984572|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
155697461|NCT00737633|561984574|FG000|Overall Study|Study terminated by sponsor|44|||
155697462|NCT00737633|561984575|FG001|Overall Study|Study terminated by sponsor|55|||
155697463|NCT00737633|561984574|FG000|Overall Study|Lost to Follow-up|0|||
155697464|NCT00737633|561984575|FG001|Overall Study|Lost to Follow-up|1|||
155697465|NCT00737633|561984574|FG000|Overall Study|protocol non-compliance|0|||
155697466|NCT00737633|561984575|FG001|Overall Study|protocol non-compliance|1|||
155697467|NCT02745535|561984576|FG000|Overall Study|Death|1|||
155697468|NCT02745535|561984576|FG000|Overall Study|Adverse Event|3|||
155697469|NCT02745535|561984576|FG000|Overall Study|Lost to Follow-up|2|||
155697470|NCT00377364|561984581|FG000|Overall Study|Lost to Follow-up|1|||
155697471|NCT00377364|561984582|FG001|Overall Study|Lost to Follow-up|0|||
155697472|NCT00377364|561984581|FG000|Overall Study|Withdrawal by Subject|1|||
155697473|NCT00377364|561984582|FG001|Overall Study|Withdrawal by Subject|0|||
155697474|NCT01345682|561984591|FG000|Overall Study|Progressive disease per RECIST|226|||
155697475|NCT01345682|561984592|FG001|Overall Study|Progressive disease per RECIST|93|||
155697476|NCT01345682|561984591|FG000|Overall Study|Worsening of underlying cancer disease|23|||
155697477|NCT01345682|561984592|FG001|Overall Study|Worsening of underlying cancer disease|12|||
155697478|NCT01345682|561984591|FG000|Overall Study|Adverse Event|51|||
155697479|NCT01345682|561984592|FG001|Overall Study|Adverse Event|41|||
155697480|NCT01345682|561984591|FG000|Overall Study|Non-compliance with protocol|0|||
155697481|NCT01345682|561984592|FG001|Overall Study|Non-compliance with protocol|1|||
155697482|NCT01345682|561984591|FG000|Overall Study|Lost to Follow-up|0|||
155697483|NCT01345682|561984592|FG001|Overall Study|Lost to Follow-up|1|||
155697484|NCT01345682|561984591|FG000|Overall Study|Refused to continue trial medication|16|||
155697485|NCT01345682|561984592|FG001|Overall Study|Refused to continue trial medication|9|||
155697486|NCT01345682|561984591|FG000|Overall Study|Not treated|2|||
155697487|NCT01345682|561984592|FG001|Overall Study|Not treated|1|||
155697488|NCT01345682|561984591|FG000|Overall Study|Reason other than those specified above|4|||
155697489|NCT01345682|561984592|FG001|Overall Study|Reason other than those specified above|3|||
155697490|NCT01075984|561984593|FG000|Treatment Phase|Adverse Event|0|||
155697491|NCT01075984|561984594|FG001|Treatment Phase|Adverse Event|1|||
155697492|NCT01075984|561984595|FG002|Treatment Phase|Adverse Event|3|||
155697493|NCT01075984|561984596|FG003|Treatment Phase|Adverse Event|7|||
155697494|NCT01075984|561984597|FG004|Treatment Phase|Adverse Event|35|||
155697495|NCT01075984|561984593|FG000|Treatment Phase|Protocol Violation|0|||
155697496|NCT01075984|561984594|FG001|Treatment Phase|Protocol Violation|0|||
155697497|NCT01075984|561984595|FG002|Treatment Phase|Protocol Violation|1|||
155697498|NCT01075984|561984596|FG003|Treatment Phase|Protocol Violation|0|||
155697499|NCT01075984|561984597|FG004|Treatment Phase|Protocol Violation|3|||
155697500|NCT01075984|561984593|FG000|Treatment Phase|Withdrawal by Subject|0|||
155697501|NCT01075984|561984594|FG001|Treatment Phase|Withdrawal by Subject|0|||
155697502|NCT01075984|561984595|FG002|Treatment Phase|Withdrawal by Subject|2|||
155697503|NCT01075984|561984596|FG003|Treatment Phase|Withdrawal by Subject|0|||
155697504|NCT01075984|561984597|FG004|Treatment Phase|Withdrawal by Subject|15|||
155697505|NCT01075984|561984593|FG000|Treatment Phase|Treatment Failure|0|||
155697506|NCT01075984|561984594|FG001|Treatment Phase|Treatment Failure|0|||
155697507|NCT01075984|561984595|FG002|Treatment Phase|Treatment Failure|1|||
155697508|NCT01075984|561984596|FG003|Treatment Phase|Treatment Failure|0|||
155697509|NCT01075984|561984597|FG004|Treatment Phase|Treatment Failure|5|||
155697510|NCT01075984|561984593|FG000|Treatment Phase|Progression of disease|0|||
155697511|NCT01075984|561984594|FG001|Treatment Phase|Progression of disease|0|||
155697512|NCT01075984|561984595|FG002|Treatment Phase|Progression of disease|0|||
155697513|NCT01075984|561984596|FG003|Treatment Phase|Progression of disease|0|||
155697514|NCT01075984|561984597|FG004|Treatment Phase|Progression of disease|2|||
155697515|NCT01075984|561984593|FG000|Follow-up Phase|Protocol Violation|0|||
155697516|NCT01075984|561984594|FG001|Follow-up Phase|Protocol Violation|0|||
155697517|NCT01075984|561984595|FG002|Follow-up Phase|Protocol Violation|1|||
155697518|NCT01075984|561984596|FG003|Follow-up Phase|Protocol Violation|0|||
155697519|NCT01075984|561984597|FG004|Follow-up Phase|Protocol Violation|3|||
155697520|NCT01075984|561984593|FG000|Follow-up Phase|Adverse Event|0|||
155697521|NCT01075984|561984594|FG001|Follow-up Phase|Adverse Event|0|||
155697522|NCT01075984|561984595|FG002|Follow-up Phase|Adverse Event|0|||
155697523|NCT01075984|561984596|FG003|Follow-up Phase|Adverse Event|2|||
155697524|NCT01075984|561984597|FG004|Follow-up Phase|Adverse Event|27|||
155697525|NCT01075984|561984593|FG000|Follow-up Phase|Administrative|0|||
155697526|NCT01075984|561984594|FG001|Follow-up Phase|Administrative|0|||
155697527|NCT01075984|561984595|FG002|Follow-up Phase|Administrative|0|||
155697528|NCT01075984|561984596|FG003|Follow-up Phase|Administrative|0|||
155198473|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
155697529|NCT01075984|561984597|FG004|Follow-up Phase|Administrative|1|||
155697530|NCT01075984|561984593|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155697531|NCT01075984|561984594|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155697532|NCT01075984|561984595|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155697533|NCT01075984|561984596|FG003|Follow-up Phase|Withdrawal by Subject|0|||
155697534|NCT01075984|561984597|FG004|Follow-up Phase|Withdrawal by Subject|10|||
155697535|NCT01075984|561984593|FG000|Follow-up Phase|Progression of disease|0|||
155697536|NCT01075984|561984594|FG001|Follow-up Phase|Progression of disease|0|||
155697537|NCT01075984|561984595|FG002|Follow-up Phase|Progression of disease|0|||
155697538|NCT01075984|561984596|FG003|Follow-up Phase|Progression of disease|0|||
155697539|NCT01075984|561984597|FG004|Follow-up Phase|Progression of disease|2|||
155697540|NCT01075984|561984593|FG000|Follow-up Phase|Treatment failure|0|||
155697541|NCT01075984|561984594|FG001|Follow-up Phase|Treatment failure|0|||
155697542|NCT01075984|561984595|FG002|Follow-up Phase|Treatment failure|0|||
155697543|NCT01075984|561984596|FG003|Follow-up Phase|Treatment failure|0|||
155697544|NCT01075984|561984597|FG004|Follow-up Phase|Treatment failure|4|||
155697545|NCT03101085|561984598|FG000|Overall Study|Lost to Follow-up|0|||
155697546|NCT03101085|561984599|FG001|Overall Study|Lost to Follow-up|1|||
155697547|NCT02986854|561984601|FG000|Overall Study|Withdrawal by Subject|0|||
155697548|NCT02986854|561984602|FG001|Overall Study|Withdrawal by Subject|1|||
155697549|NCT02986854|561984603|FG002|Overall Study|Withdrawal by Subject|1|||
155697550|NCT02986854|561984601|FG000|Overall Study|Lost to Follow-up|3|||
155697551|NCT02986854|561984602|FG001|Overall Study|Lost to Follow-up|11|||
155697552|NCT02986854|561984603|FG002|Overall Study|Lost to Follow-up|2|||
155697553|NCT02409342|561984609|FG000|Overall Study|Death|211|||
155697554|NCT02409342|561984610|FG001|Overall Study|Death|201|||
155697555|NCT02409342|561984609|FG000|Overall Study|Withdrawal by Subject|24|||
155697556|NCT02409342|561984610|FG001|Overall Study|Withdrawal by Subject|17|||
155697557|NCT02409342|561984609|FG000|Overall Study|Study Terminated By Sponsor|48|||
155697558|NCT02409342|561984610|FG001|Overall Study|Study Terminated By Sponsor|59|||
155697559|NCT02409342|561984609|FG000|Overall Study|Lost to Follow-up|3|||
155697560|NCT02409342|561984610|FG001|Overall Study|Lost to Follow-up|5|||
155697561|NCT02409342|561984609|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
155697562|NCT02409342|561984610|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
155697563|NCT02409342|561984609|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
155697564|NCT02409342|561984610|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
155697565|NCT02409342|561984609|FG000|Overall Study|Sponsor Decision|1|||
155697566|NCT02409342|561984610|FG001|Overall Study|Sponsor Decision|0|||
155697567|NCT00279812|561984611|FG000|Overall Study|Protocol Violation|1|||
155697568|NCT00279812|561984612|FG001|Overall Study|Protocol Violation|1|||
155697569|NCT00279812|561984613|FG002|Overall Study|Protocol Violation|0|||
155697570|NCT00279812|561984614|FG003|Overall Study|Protocol Violation|0|||
155697571|NCT00279812|561984615|FG004|Overall Study|Protocol Violation|1|||
155697572|NCT00279812|561984616|FG005|Overall Study|Protocol Violation|0|||
155697573|NCT00279812|561984611|FG000|Overall Study|Withdrawal by Subject|0|||
155697574|NCT00279812|561984612|FG001|Overall Study|Withdrawal by Subject|4|||
155697575|NCT00279812|561984613|FG002|Overall Study|Withdrawal by Subject|2|||
155697576|NCT00279812|561984614|FG003|Overall Study|Withdrawal by Subject|0|||
155697577|NCT00279812|561984615|FG004|Overall Study|Withdrawal by Subject|0|||
155697578|NCT00279812|561984616|FG005|Overall Study|Withdrawal by Subject|0|||
155697579|NCT00279812|561984611|FG000|Overall Study|Adverse Event|0|||
155697580|NCT00279812|561984612|FG001|Overall Study|Adverse Event|1|||
155697581|NCT00279812|561984613|FG002|Overall Study|Adverse Event|1|||
155697582|NCT00279812|561984614|FG003|Overall Study|Adverse Event|0|||
155697583|NCT00279812|561984615|FG004|Overall Study|Adverse Event|2|||
155697584|NCT00279812|561984616|FG005|Overall Study|Adverse Event|1|||
155697585|NCT01274429|561984617|FG000|Overall Study|Study closed do to lack of funding|5|||
155697586|NCT04576897|561984622|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
155697587|NCT00527332|561984623|FG000|Overall Study|Protocol Violation|4|||
155697588|NCT00527332|561984624|FG001|Overall Study|Protocol Violation|8|||
155697589|NCT00527332|561984623|FG000|Overall Study|Withdrew consent|5|||
155697590|NCT00527332|561984624|FG001|Overall Study|Withdrew consent|1|||
155697591|NCT02100475|561986206|FG000|Overall Study|Unclassified|1|||
155697592|NCT02100475|561986207|FG001|Overall Study|Unclassified|2|||
155697593|NCT02100475|561986206|FG000|Overall Study|Withdrawal criteria|1|||
155697594|NCT02100475|561986207|FG001|Overall Study|Withdrawal criteria|0|||
155697595|NCT03109184|561986208|FG000|Overall Study|Lost to Follow-up|6|||
155697596|NCT03109184|561986209|FG001|Overall Study|Lost to Follow-up|6|||
155697597|NCT03109184|561986208|FG000|Overall Study|Withdrawal by Subject|1|||
155697598|NCT03109184|561986209|FG001|Overall Study|Withdrawal by Subject|1|||
155697599|NCT02503501|561986210|FG000|Overall Study|Physician Decision|1|||
155697600|NCT02503501|561986211|FG001|Overall Study|Physician Decision|0|||
155697601|NCT02503501|561986210|FG000|Overall Study|Protocol Violation|0|||
155697602|NCT02503501|561986211|FG001|Overall Study|Protocol Violation|1|||
155697603|NCT02503501|561986210|FG000|Overall Study|Withdrawal by Subject|0|||
155697604|NCT02503501|561986211|FG001|Overall Study|Withdrawal by Subject|2|||
155697605|NCT01740401|561986212|FG000|Overall Study|Progression of disease|6|||
155697606|NCT01740401|561986212|FG000|Overall Study|Adverse Event|2|||
155697607|NCT01740401|561986212|FG000|Overall Study|Did not reach primary endpoint|2|||
155697608|NCT02806960|561986213|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155697609|NCT02806960|561986214|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155697610|NCT02806960|561986215|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155697611|NCT02806960|561986216|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155697612|NCT00321464|561986217|FG000|Overall Study|Death|169|||
155697613|NCT00321464|561986218|FG001|Overall Study|Death|174|||
155697614|NCT00321464|561986217|FG000|Overall Study|Disease progression|124|||
155697615|NCT00321464|561986218|FG001|Overall Study|Disease progression|124|||
155697616|NCT00321464|561986217|FG000|Overall Study|Withdrawal by Subject|117|||
155697617|NCT00321464|561986218|FG001|Overall Study|Withdrawal by Subject|118|||
155697618|NCT00321464|561986217|FG000|Overall Study|Participant request|57|||
155697619|NCT00321464|561986218|FG001|Overall Study|Participant request|61|||
155697620|NCT00321464|561986217|FG000|Overall Study|Adverse Event|43|||
155697621|NCT00321464|561986218|FG001|Overall Study|Adverse Event|28|||
155697622|NCT00321464|561986217|FG000|Overall Study|Physician Decision|15|||
155697623|NCT00321464|561986218|FG001|Overall Study|Physician Decision|14|||
155697624|NCT00321464|561986217|FG000|Overall Study|Noncompliance|4|||
155697625|NCT00321464|561986218|FG001|Overall Study|Noncompliance|10|||
155697626|NCT00321464|561986217|FG000|Overall Study|Lost to Follow-up|7|||
155697627|NCT00321464|561986218|FG001|Overall Study|Lost to Follow-up|8|||
155697628|NCT00321464|561986217|FG000|Overall Study|Protocol deviation|0|||
155697629|NCT00321464|561986218|FG001|Overall Study|Protocol deviation|2|||
155697630|NCT00321464|561986217|FG000|Overall Study|Ineligibility determined|2|||
155697631|NCT00321464|561986218|FG001|Overall Study|Ineligibility determined|1|||
155697632|NCT00321464|561986217|FG000|Overall Study|Other|21|||
155697633|NCT00321464|561986218|FG001|Overall Study|Other|18|||
155697634|NCT01209078|561986219|FG000|Overall Study|Adverse Event|5|||
155697635|NCT01209078|561986220|FG001|Overall Study|Adverse Event|0|||
155697636|NCT01209078|561986219|FG000|Overall Study|Lost to Follow-up|4|||
155697637|NCT01209078|561986220|FG001|Overall Study|Lost to Follow-up|0|||
155697638|NCT01209078|561986219|FG000|Overall Study|Physician Decision|5|||
155697639|NCT01209078|561986220|FG001|Overall Study|Physician Decision|2|||
155697640|NCT01209078|561986219|FG000|Overall Study|Withdrawal by Subject|2|||
155697641|NCT01209078|561986220|FG001|Overall Study|Withdrawal by Subject|1|||
155697642|NCT02207491|561986223|FG000|Overall Study|Adverse Event|20|||
155697643|NCT02207491|561986224|FG001|Overall Study|Adverse Event|4|||
155697644|NCT02207491|561986223|FG000|Overall Study|Withdrawal by Subject|3|||
155697645|NCT02207491|561986224|FG001|Overall Study|Withdrawal by Subject|2|||
155697646|NCT02207491|561986223|FG000|Overall Study|Non-compliant|0|||
155697647|NCT02207491|561986224|FG001|Overall Study|Non-compliant|1|||
155697648|NCT02207491|561986223|FG000|Overall Study|Lost to Follow-up|0|||
155697649|NCT02207491|561986224|FG001|Overall Study|Lost to Follow-up|1|||
155697650|NCT02207491|561986223|FG000|Overall Study|Lack of Efficacy|3|||
155697651|NCT02207491|561986224|FG001|Overall Study|Lack of Efficacy|0|||
155697652|NCT02207491|561986223|FG000|Overall Study|Physician Decision|2|||
155697653|NCT02207491|561986224|FG001|Overall Study|Physician Decision|0|||
155697654|NCT02207491|561986223|FG000|Overall Study|Protocol Violation|3|||
155697655|NCT02207491|561986224|FG001|Overall Study|Protocol Violation|5|||
155697656|NCT00126776|561986225|FG000|Overall Study|follow up complete on all patients|0|||
155697657|NCT00126776|561986226|FG001|Overall Study|follow up complete on all patients|0|||
155697658|NCT00372697|561986238|FG000|Overall Study|Protocol Violation|1|||
155697659|NCT00372697|561986239|FG001|Overall Study|Protocol Violation|1|||
155697660|NCT03221842|561986240|FG000|Period 1 (Open-label)|Adverse Event|4|||
155697661|NCT03221842|561986241|FG001|Period 1 (Open-label)|Adverse Event|0|||
155697662|NCT03221842|561986240|FG000|Period 1 (Open-label)|Physician Decision|2|||
155697663|NCT03221842|561986241|FG001|Period 1 (Open-label)|Physician Decision|0|||
155697664|NCT03221842|561986240|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
155697665|NCT03221842|561986241|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
155697666|NCT03221842|561986240|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
155697667|NCT03221842|561986241|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
155697668|NCT03221842|561986240|FG000|Period 1 (Open-label)|Other|2|||
155697669|NCT03221842|561986241|FG001|Period 1 (Open-label)|Other|0|||
155697670|NCT03221842|561986240|FG000|Period 2 (Randomized, Blinded)|Death|0|||
155697671|NCT03221842|561986241|FG001|Period 2 (Randomized, Blinded)|Death|1|||
155697672|NCT03221842|561986240|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
155697673|NCT03221842|561986241|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
155697674|NCT00448747|561986242|FG000|Overall Study|collapsed veins|1|||
155697675|NCT00448747|561986243|FG001|Overall Study|collapsed veins|0|||
155697676|NCT00387725|561986244|FG000|Overall Study|Adverse Event|0|||
155697677|NCT00387725|561986245|FG001|Overall Study|Adverse Event|0|||
155697678|NCT00387725|561986246|FG002|Overall Study|Adverse Event|0|||
155697679|NCT00387725|561986247|FG003|Overall Study|Adverse Event|1|||
155697680|NCT00387725|561986244|FG000|Overall Study|Protocol Violation|0|||
155697681|NCT00387725|561986245|FG001|Overall Study|Protocol Violation|1|||
155697682|NCT00387725|561986246|FG002|Overall Study|Protocol Violation|0|||
155697683|NCT00387725|561986247|FG003|Overall Study|Protocol Violation|0|||
155697684|NCT00387725|561986244|FG000|Overall Study|Withdrawal by Subject|1|||
155697685|NCT00387725|561986245|FG001|Overall Study|Withdrawal by Subject|0|||
155697686|NCT00387725|561986246|FG002|Overall Study|Withdrawal by Subject|1|||
155697687|NCT00387725|561986247|FG003|Overall Study|Withdrawal by Subject|0|||
155697688|NCT00387725|561986244|FG000|Overall Study|Parent/legal guardian request|0|||
155697689|NCT00387725|561986245|FG001|Overall Study|Parent/legal guardian request|0|||
155697690|NCT00387725|561986246|FG002|Overall Study|Parent/legal guardian request|1|||
155697691|NCT00387725|561986247|FG003|Overall Study|Parent/legal guardian request|1|||
155697692|NCT00568126|561986248|FG000|Overall Study|Adverse Event|3|||
155697693|NCT00568126|561986249|FG001|Overall Study|Adverse Event|0|||
155697694|NCT00568126|561986248|FG000|Overall Study|Withdrawal by Subject|2|||
155697695|NCT00568126|561986249|FG001|Overall Study|Withdrawal by Subject|3|||
155697696|NCT00568126|561986248|FG000|Overall Study|Lost to Follow-up|4|||
155697697|NCT00568126|561986249|FG001|Overall Study|Lost to Follow-up|3|||
155697698|NCT00568126|561986248|FG000|Overall Study|Lack of Efficacy|0|||
155697699|NCT00568126|561986249|FG001|Overall Study|Lack of Efficacy|1|||
155697700|NCT00568126|561986248|FG000|Overall Study|Physician Decision|2|||
155697701|NCT00568126|561986249|FG001|Overall Study|Physician Decision|2|||
155697702|NCT00527982|561986251|FG000|Overall Study|Physician Decision|1|||
155697703|NCT00527982|561986252|FG001|Overall Study|Physician Decision|0|||
155697704|NCT01939366|561986253|FG000|Overall Study|Adverse Event|8|||
155697705|NCT01939366|561986254|FG001|Overall Study|Adverse Event|17|||
155697706|NCT01939366|561986255|FG002|Overall Study|Adverse Event|30|||
155697707|NCT01939366|561986256|FG003|Overall Study|Adverse Event|8|||
155697708|NCT01939366|561986257|FG004|Overall Study|Adverse Event|5|||
155697709|NCT01939366|561986253|FG000|Overall Study|Lack of Efficacy|2|||
155697710|NCT01939366|561986254|FG001|Overall Study|Lack of Efficacy|1|||
155697711|NCT01939366|561986255|FG002|Overall Study|Lack of Efficacy|1|||
155697712|NCT01939366|561986256|FG003|Overall Study|Lack of Efficacy|1|||
155697713|NCT01939366|561986257|FG004|Overall Study|Lack of Efficacy|3|||
155697714|NCT01939366|561986253|FG000|Overall Study|Lost to Follow-up|1|||
155697715|NCT01939366|561986254|FG001|Overall Study|Lost to Follow-up|1|||
155697716|NCT01939366|561986255|FG002|Overall Study|Lost to Follow-up|0|||
155697717|NCT01939366|561986256|FG003|Overall Study|Lost to Follow-up|0|||
155697718|NCT01939366|561986257|FG004|Overall Study|Lost to Follow-up|0|||
155697719|NCT01939366|561986253|FG000|Overall Study|Withdrawal by Subject|1|||
155697720|NCT01939366|561986254|FG001|Overall Study|Withdrawal by Subject|0|||
155697721|NCT01939366|561986255|FG002|Overall Study|Withdrawal by Subject|2|||
155697722|NCT01939366|561986256|FG003|Overall Study|Withdrawal by Subject|2|||
155697723|NCT01939366|561986257|FG004|Overall Study|Withdrawal by Subject|3|||
155697724|NCT01939366|561986253|FG000|Overall Study|Inclusion criteria not met|0|||
155697725|NCT01939366|561986254|FG001|Overall Study|Inclusion criteria not met|1|||
155697726|NCT01939366|561986255|FG002|Overall Study|Inclusion criteria not met|1|||
155697727|NCT01939366|561986256|FG003|Overall Study|Inclusion criteria not met|0|||
155697728|NCT01939366|561986257|FG004|Overall Study|Inclusion criteria not met|1|||
155697729|NCT01939366|561986253|FG000|Overall Study|Other|0|||
155697730|NCT01939366|561986254|FG001|Overall Study|Other|0|||
155697731|NCT01939366|561986255|FG002|Overall Study|Other|2|||
155697732|NCT01939366|561986256|FG003|Overall Study|Other|2|||
155697733|NCT01939366|561986257|FG004|Overall Study|Other|1|||
155697734|NCT01939366|561986253|FG000|Overall Study|Protocol Violation|0|||
155697735|NCT01939366|561986254|FG001|Overall Study|Protocol Violation|0|||
155697736|NCT01939366|561986255|FG002|Overall Study|Protocol Violation|0|||
155697737|NCT01939366|561986256|FG003|Overall Study|Protocol Violation|1|||
155697738|NCT01939366|561986257|FG004|Overall Study|Protocol Violation|0|||
155697739|NCT01939366|561986253|FG000|Overall Study|Sponsor decision|0|||
155697740|NCT01939366|561986254|FG001|Overall Study|Sponsor decision|0|||
155697741|NCT01939366|561986255|FG002|Overall Study|Sponsor decision|0|||
155697742|NCT01939366|561986256|FG003|Overall Study|Sponsor decision|0|||
155697743|NCT01939366|561986257|FG004|Overall Study|Sponsor decision|2|||
155697744|NCT01939366|561986253|FG000|Overall Study|GCP non-compliance at site|2|||
155697745|NCT01939366|561986254|FG001|Overall Study|GCP non-compliance at site|3|||
155697746|NCT01939366|561986255|FG002|Overall Study|GCP non-compliance at site|2|||
155697747|NCT01939366|561986256|FG003|Overall Study|GCP non-compliance at site|3|||
155697748|NCT01939366|561986257|FG004|Overall Study|GCP non-compliance at site|3|||
155697749|NCT00007020|561986259|FG000|Overall Study|Death|16|||
155697750|NCT00007020|561986259|FG000|Overall Study|Lost to Follow-up|13|||
155697751|NCT00007020|561986259|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
155697752|NCT00007020|561986259|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
155697753|NCT00007020|561986259|FG000|Overall Study|Pt cared for by outside physician|4|||
155697754|NCT00007020|561986259|FG000|Overall Study|No evidence of treatment|6|||
155697755|NCT00548717|561986260|FG000|Overall Study|Death|5|||
155697756|NCT00548717|561986261|FG001|Overall Study|Death|2|||
155697757|NCT00548717|561986260|FG000|Overall Study|Relapse|3|||
155697758|NCT00548717|561986261|FG001|Overall Study|Relapse|0|||
155697759|NCT00548717|561986260|FG000|Overall Study|Alternative treatment for GVHD|1|||
155697760|NCT00548717|561986261|FG001|Overall Study|Alternative treatment for GVHD|0|||
155697761|NCT02712424|561986262|FG000|Overall Study|Lost to Follow-up|34|||
155697762|NCT02712424|561986263|FG001|Overall Study|Lost to Follow-up|32|||
155697763|NCT02809053|561986267|FG000|Overall Study|Death|0|||
155697764|NCT02809053|561986268|FG001|Overall Study|Death|1|||
155697765|NCT02809053|561986267|FG000|Overall Study|Lost to Follow-up|3|||
155697766|NCT02809053|561986268|FG001|Overall Study|Lost to Follow-up|1|||
155697767|NCT02809053|561986267|FG000|Overall Study|Withdrawal by Subject|2|||
155697768|NCT02809053|561986268|FG001|Overall Study|Withdrawal by Subject|3|||
155697769|NCT02809053|561986267|FG000|Overall Study|Disease Progression|2|||
155697770|NCT02809053|561986268|FG001|Overall Study|Disease Progression|1|||
155697771|NCT00908037|561986273|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697772|NCT00908037|561986274|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697773|NCT00908037|561986275|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697774|NCT00908037|561986276|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697775|NCT00908037|561986277|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
155697776|NCT00908037|561986278|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697777|NCT00908037|561986279|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
155697778|NCT00908037|561986280|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697779|NCT00908037|561986281|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
155697780|NCT00908037|561986282|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697781|NCT00908037|561986283|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697782|NCT00908037|561986284|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155697783|NCT00908037|561986273|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697784|NCT00908037|561986274|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697785|NCT00908037|561986275|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697786|NCT00908037|561986276|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697787|NCT00908037|561986277|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
155697788|NCT00908037|561986278|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697789|NCT00908037|561986279|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697790|NCT00908037|561986280|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697791|NCT00908037|561986281|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
155697792|NCT00908037|561986282|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697793|NCT00908037|561986283|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697794|NCT00908037|561986284|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155697795|NCT00908037|561986273|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697796|NCT00908037|561986274|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697797|NCT00908037|561986275|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697798|NCT00908037|561986276|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
155697799|NCT00908037|561986277|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697800|NCT00908037|561986278|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697801|NCT00908037|561986279|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
155697802|NCT00908037|561986280|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697803|NCT00908037|561986281|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697804|NCT00908037|561986282|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697805|NCT00908037|561986283|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697806|NCT00908037|561986284|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155697807|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697808|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697809|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697810|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697811|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697812|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697813|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697814|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697815|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697816|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697817|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155697818|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
155697819|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697820|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697821|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697822|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697823|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697824|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697825|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697826|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697827|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697828|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
155697829|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155697830|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
155697831|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697832|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697833|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697834|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697835|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697836|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697837|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697838|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697839|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697840|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
155697841|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697842|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155697843|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697844|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697845|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697846|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697847|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697848|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697849|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697850|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697851|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697852|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697853|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
155697854|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155697855|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697856|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697857|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697858|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697859|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697860|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697861|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697862|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697863|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697864|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
155697865|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697866|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155697867|NCT00908037|561986273|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697868|NCT00908037|561986274|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697869|NCT00908037|561986275|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697870|NCT00908037|561986276|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697871|NCT00908037|561986277|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697872|NCT00908037|561986278|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697873|NCT00908037|561986279|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155721213|NCT05435339|562077784|FG005|Overall Study|Withdrawal by Subject|0|||
155721214|NCT05435339|562077785|FG006|Overall Study|Withdrawal by Subject|1|||
155721215|NCT05435339|562077786|FG007|Overall Study|Withdrawal by Subject|1|||
155721216|NCT01283139|562077787|FG000|Overall Study|Lost to Follow-up|5|||
155721217|NCT01283139|562077788|FG001|Overall Study|Lost to Follow-up|2|||
155721218|NCT01283139|562077789|FG002|Overall Study|Lost to Follow-up|3|||
155721219|NCT01283139|562077790|FG003|Overall Study|Lost to Follow-up|1|||
155721220|NCT01283139|562077787|FG000|Overall Study|Withdrawal by Subject|8|||
155721221|NCT01283139|562077788|FG001|Overall Study|Withdrawal by Subject|8|||
155721222|NCT01283139|562077789|FG002|Overall Study|Withdrawal by Subject|6|||
155721223|NCT01283139|562077790|FG003|Overall Study|Withdrawal by Subject|8|||
155697874|NCT00908037|561986280|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697875|NCT00908037|561986281|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697876|NCT00908037|561986282|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697877|NCT00908037|561986283|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
155697878|NCT00908037|561986284|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155697879|NCT02565810|561986285|FG000|Overall Study|Withdrawal by Subject|1|||
155697880|NCT02358044|561986286|FG000|Overall Study|Adverse Event|0|||
155697881|NCT02358044|561986287|FG001|Overall Study|Adverse Event|1|||
155697882|NCT02358044|561986286|FG000|Overall Study|Lost to Follow-up|2|||
155697883|NCT02358044|561986287|FG001|Overall Study|Lost to Follow-up|1|||
155697884|NCT02358044|561986286|FG000|Overall Study|Physician Decision|0|||
155697885|NCT02358044|561986287|FG001|Overall Study|Physician Decision|1|||
155697886|NCT02358044|561986286|FG000|Overall Study|Withdrawal by Subject|0|||
155697887|NCT02358044|561986287|FG001|Overall Study|Withdrawal by Subject|4|||
155697888|NCT02723175|561986290|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
155697889|NCT02723175|561986291|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
155697890|NCT02723175|561986290|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
155697891|NCT02723175|561986291|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
155697892|NCT00491608|561986294|FG000|Overall Study|Death|2|||
155697893|NCT00491608|561986294|FG000|Overall Study|Withdrawal by Subject|1|||
155697894|NCT03022981|561986299|FG000|Overall Study|Adverse Event|0|||
155697895|NCT03022981|561986300|FG001|Overall Study|Adverse Event|1|||
155697896|NCT03022981|561986301|FG002|Overall Study|Adverse Event|0|||
155697897|NCT03022981|561986299|FG000|Overall Study|Investigator's Discretion|0|||
155697898|NCT03022981|561986300|FG001|Overall Study|Investigator's Discretion|1|||
155697899|NCT03022981|561986301|FG002|Overall Study|Investigator's Discretion|2|||
155697900|NCT03022981|561986299|FG000|Overall Study|Lost to Follow-up|6|||
155697901|NCT03022981|561986300|FG001|Overall Study|Lost to Follow-up|2|||
155697902|NCT03022981|561986301|FG002|Overall Study|Lost to Follow-up|1|||
155697903|NCT03022981|561986299|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155697904|NCT03022981|561986300|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155697905|NCT03022981|561986301|FG002|Overall Study|Non-Compliance With Study Drug|2|||
155697906|NCT03022981|561986299|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
155697907|NCT03022981|561986300|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
155697908|NCT03022981|561986301|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
155697909|NCT03615066|561986303|FG000|Main Study|Withdrew Consent|0|||
155697910|NCT03615066|561986304|FG001|Main Study|Withdrew Consent|1|||
155697911|NCT03615066|561986305|FG002|Main Study|Withdrew Consent|1|||
155697912|NCT03615066|561986303|FG000|Main Study|Lost to Follow-up|0|||
155697913|NCT03615066|561986304|FG001|Main Study|Lost to Follow-up|0|||
155697914|NCT03615066|561986305|FG002|Main Study|Lost to Follow-up|1|||
155697915|NCT03615066|561986303|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
155697916|NCT03615066|561986304|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
155697917|NCT03615066|561986305|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
155697918|NCT03615066|561986303|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
155697919|NCT03615066|561986304|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
155697920|NCT03615066|561986305|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
155697921|NCT03615066|561986303|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
155697922|NCT03615066|561986304|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
155697923|NCT03615066|561986305|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
155697924|NCT00924404|561986306|FG000|Overall Study|Lost to Follow-up|6|||
155697925|NCT00924404|561986307|FG001|Overall Study|Lost to Follow-up|4|||
155697926|NCT02437084|561986308|FG000|Overall Study|Withdrawal by Subject|2|||
155697927|NCT02437084|561986308|FG000|Overall Study|Physician Decision|1|||
155697928|NCT00587847|561986309|FG000|Overall Study|Lack of Efficacy|5|||
155697929|NCT00587847|561986309|FG000|Overall Study|Adverse Event|2|||
155697930|NCT00343382|561986310|FG000|Overall Study|Adverse Event|2|||
155697931|NCT00343382|561986311|FG001|Overall Study|Adverse Event|10|||
155697932|NCT00343382|561986312|FG002|Overall Study|Adverse Event|7|||
155697933|NCT00343382|561986310|FG000|Overall Study|Withdrawal by Subject|1|||
155697934|NCT00343382|561986311|FG001|Overall Study|Withdrawal by Subject|2|||
155697935|NCT00343382|561986312|FG002|Overall Study|Withdrawal by Subject|6|||
155697936|NCT00343382|561986310|FG000|Overall Study|Other Reason Not Specified|1|||
155697937|NCT00343382|561986311|FG001|Overall Study|Other Reason Not Specified|2|||
155697938|NCT00343382|561986312|FG002|Overall Study|Other Reason Not Specified|4|||
155697939|NCT04032080|561986313|FG000|Overall Study|Death|6|||
155697940|NCT02337725|561986318|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
155697941|NCT02337725|561986319|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
155697942|NCT02337725|561986318|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
155697943|NCT02337725|561986319|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
155697944|NCT02337725|561986318|FG000|Overall Study|Major Protocol Deviation|0|||
155697945|NCT02337725|561986319|FG001|Overall Study|Major Protocol Deviation|1|||
155697946|NCT02337725|561986318|FG000|Overall Study|Voluntary Withdrawal|14|||
155697947|NCT02337725|561986319|FG001|Overall Study|Voluntary Withdrawal|3|||
155697948|NCT02337725|561986318|FG000|Overall Study|Lack of Efficacy|4|||
155697949|NCT02337725|561986319|FG001|Overall Study|Lack of Efficacy|0|||
155697950|NCT00845065|561986325|FG000|Overall Study|Adverse Event|3|||
155697951|NCT00845065|561986326|FG001|Overall Study|Adverse Event|23|||
155697952|NCT00845065|561986325|FG000|Overall Study|Lack of Efficacy|43|||
155697953|NCT00845065|561986326|FG001|Overall Study|Lack of Efficacy|21|||
155697954|NCT00845065|561986325|FG000|Overall Study|Non-Medical Reasons|1|||
155697955|NCT00845065|561986326|FG001|Overall Study|Non-Medical Reasons|11|||
155697956|NCT02228096|561986330|FG000|Overall Study|Study terminated by Sponsor|24|||
155697957|NCT02228096|561986330|FG000|Overall Study|Lack of Efficacy|18|||
155697958|NCT02228096|561986330|FG000|Overall Study|Death|12|||
155697959|NCT02228096|561986330|FG000|Overall Study|Physician Decision|3|||
155697960|NCT02228096|561986330|FG000|Overall Study|Subject/guardian decision|2|||
155697961|NCT02228096|561986330|FG000|Overall Study|New therapy for study indication|1|||
155697962|NCT02228096|561986330|FG000|Overall Study|Enrolled, not infused|11|||
155697963|NCT02265796|561986331|FG000|Overall Study|Death|1|||
155697964|NCT02265796|561986332|FG001|Overall Study|Death|0|||
155697965|NCT02265796|561986331|FG000|Overall Study|started on excluded medication|1|||
155697966|NCT02265796|561986332|FG001|Overall Study|started on excluded medication|0|||
155697967|NCT02265796|561986331|FG000|Overall Study|Withdrawal by Subject|1|||
155697968|NCT02265796|561986332|FG001|Overall Study|Withdrawal by Subject|1|||
155697969|NCT00952614|561986335|FG000|Overall Study|Death|3|||
155697970|NCT00952614|561986335|FG000|Overall Study|Lost to Follow-up|3|||
155697971|NCT00952614|561986335|FG000|Overall Study|other reason|1|||
155697972|NCT01624090|561986340|FG000|Overall Study|DLT, taken off therapy|0|||
155697973|NCT01624090|561986341|FG001|Overall Study|DLT, taken off therapy|1|||
155697974|NCT01624090|561986342|FG002|Overall Study|DLT, taken off therapy|0|||
155697975|NCT01624090|561986343|FG003|Overall Study|DLT, taken off therapy|0|||
155697976|NCT01624090|561986340|FG000|Overall Study|Withdrew prior to treatment|0|||
155697977|NCT01624090|561986341|FG001|Overall Study|Withdrew prior to treatment|1|||
155697978|NCT01624090|561986342|FG002|Overall Study|Withdrew prior to treatment|0|||
155697979|NCT01624090|561986343|FG003|Overall Study|Withdrew prior to treatment|0|||
155697980|NCT01624090|561986340|FG000|Overall Study|Died on study|0|||
155697981|NCT01624090|561986341|FG001|Overall Study|Died on study|0|||
155697982|NCT01624090|561986342|FG002|Overall Study|Died on study|2|||
155697983|NCT01624090|561986343|FG003|Overall Study|Died on study|0|||
155697984|NCT01624090|561986340|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
155697985|NCT01624090|561986341|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
155697986|NCT01624090|561986342|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
155697987|NCT01624090|561986343|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
155697988|NCT01624090|561986340|FG000|Overall Study|Dose escalated|0|||
155697989|NCT01624090|561986341|FG001|Overall Study|Dose escalated|0|||
155697990|NCT01624090|561986342|FG002|Overall Study|Dose escalated|3|||
155697991|NCT01624090|561986343|FG003|Overall Study|Dose escalated|0|||
155697992|NCT01403116|561986344|FG000|Overall Study|Adverse Event|7|||
155697993|NCT01403116|561986345|FG001|Overall Study|Adverse Event|4|||
155697994|NCT01403116|561986344|FG000|Overall Study|Lost to Follow-up|7|||
155697995|NCT01403116|561986345|FG001|Overall Study|Lost to Follow-up|5|||
155697996|NCT01403116|561986344|FG000|Overall Study|Withdrawal by Subject|12|||
155697997|NCT01403116|561986345|FG001|Overall Study|Withdrawal by Subject|15|||
155697998|NCT01403116|561986344|FG000|Overall Study|Non-compliance of study drug|3|||
155697999|NCT01403116|561986345|FG001|Overall Study|Non-compliance of study drug|0|||
155698000|NCT01403116|561986344|FG000|Overall Study|Protocol Violation|0|||
155698001|NCT01403116|561986345|FG001|Overall Study|Protocol Violation|1|||
155698002|NCT01403116|561986344|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
155698003|NCT01403116|561986345|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
155698004|NCT01403116|561986344|FG000|Overall Study|Hct >54%|2|||
155698005|NCT01403116|561986345|FG001|Overall Study|Hct >54%|0|||
155698006|NCT01403116|561986344|FG000|Overall Study|unable to keep appointments|0|||
155698007|NCT01403116|561986345|FG001|Overall Study|unable to keep appointments|2|||
155698008|NCT01895309|561986346|FG000|Overall Study|Adverse Event|13|||
155698009|NCT01895309|561986347|FG001|Overall Study|Adverse Event|17|||
155698010|NCT01895309|561986346|FG000|Overall Study|Protocol Violation|1|||
155698011|NCT01895309|561986347|FG001|Overall Study|Protocol Violation|0|||
155698012|NCT01895309|561986346|FG000|Overall Study|Lack of Efficacy|1|||
155698013|NCT01895309|561986347|FG001|Overall Study|Lack of Efficacy|3|||
155698014|NCT01895309|561986346|FG000|Overall Study|Lost to Follow-up|1|||
155698015|NCT01895309|561986347|FG001|Overall Study|Lost to Follow-up|3|||
155698016|NCT01895309|561986346|FG000|Overall Study|Physician Decision|15|||
155698017|NCT01895309|561986347|FG001|Overall Study|Physician Decision|10|||
155698018|NCT01895309|561986346|FG000|Overall Study|Withdrawal by Subject|9|||
155698019|NCT01895309|561986347|FG001|Overall Study|Withdrawal by Subject|18|||
155698020|NCT00042666|561986348|FG000|Overall Study|Adverse Event|2|||
155698021|NCT00042666|561986348|FG000|Overall Study|Death|4|||
155698022|NCT00042666|561986348|FG000|Overall Study|Protocol Violation|1|||
155698023|NCT00042666|561986348|FG000|Overall Study|Participant/Physician Perception|1|||
155698024|NCT00042666|561986348|FG000|Overall Study|Progressive Disease|41|||
155698025|NCT00042666|561986348|FG000|Overall Study|Other|1|||
155698026|NCT00042666|561986348|FG000|Overall Study|Other|4|||
155698027|NCT01555125|561986351|FG000|Induction Period|Lost to Follow-up|0|||
155698028|NCT01555125|561986352|FG001|Induction Period|Lost to Follow-up|2|||
155698029|NCT01555125|561986353|FG002|Induction Period|Lost to Follow-up|0|||
155698030|NCT01555125|561986354|FG003|Induction Period|Lost to Follow-up|0|||
155698031|NCT01555125|561986355|FG004|Induction Period|Lost to Follow-up|0|||
155698032|NCT01555125|561986351|FG000|Induction Period|Adverse Event|0|||
155698033|NCT01555125|561986352|FG001|Induction Period|Adverse Event|1|||
155698034|NCT01555125|561986353|FG002|Induction Period|Adverse Event|0|||
155698035|NCT01555125|561986354|FG003|Induction Period|Adverse Event|0|||
155698036|NCT01555125|561986355|FG004|Induction Period|Adverse Event|1|||
155698037|NCT01555125|561986351|FG000|Induction Period|Subject / guardian decision|0|||
155698038|NCT01555125|561986352|FG001|Induction Period|Subject / guardian decision|0|||
155698039|NCT01555125|561986353|FG002|Induction Period|Subject / guardian decision|0|||
155698040|NCT01555125|561986354|FG003|Induction Period|Subject / guardian decision|0|||
155698041|NCT01555125|561986355|FG004|Induction Period|Subject / guardian decision|2|||
155698042|NCT01555125|561986351|FG000|Induction Period|Death|1|||
155698043|NCT01555125|561986352|FG001|Induction Period|Death|0|||
155698044|NCT01555125|561986353|FG002|Induction Period|Death|0|||
155698045|NCT01555125|561986354|FG003|Induction Period|Death|0|||
155698046|NCT01555125|561986355|FG004|Induction Period|Death|0|||
155698047|NCT01555125|561986351|FG000|Maintenance Period|Adverse Event|1|||
155698048|NCT01555125|561986352|FG001|Maintenance Period|Adverse Event|1|||
155698049|NCT01555125|561986353|FG002|Maintenance Period|Adverse Event|0|||
155698050|NCT01555125|561986354|FG003|Maintenance Period|Adverse Event|0|||
155698051|NCT01555125|561986355|FG004|Maintenance Period|Adverse Event|0|||
155698052|NCT01555125|561986351|FG000|Maintenance Period|Subject / guardian decision|1|||
155698053|NCT01555125|561986352|FG001|Maintenance Period|Subject / guardian decision|2|||
155698054|NCT01555125|561986353|FG002|Maintenance Period|Subject / guardian decision|0|||
155698055|NCT01555125|561986354|FG003|Maintenance Period|Subject / guardian decision|0|||
155698056|NCT01555125|561986355|FG004|Maintenance Period|Subject / guardian decision|0|||
155698057|NCT01555125|561986351|FG000|Maintenance Period|Lost to Follow-up|2|||
155698058|NCT01555125|561986352|FG001|Maintenance Period|Lost to Follow-up|0|||
155698059|NCT01555125|561986353|FG002|Maintenance Period|Lost to Follow-up|0|||
155698060|NCT01555125|561986354|FG003|Maintenance Period|Lost to Follow-up|1|||
155698061|NCT01555125|561986355|FG004|Maintenance Period|Lost to Follow-up|0|||
155721224|NCT01283139|562077787|FG000|Overall Study|Death|2|||
155721225|NCT01283139|562077788|FG001|Overall Study|Death|0|||
155721226|NCT01283139|562077789|FG002|Overall Study|Death|2|||
155721227|NCT01283139|562077790|FG003|Overall Study|Death|2|||
155721228|NCT01283139|562077787|FG000|Overall Study|Lack of Efficacy|1|||
155721229|NCT01283139|562077788|FG001|Overall Study|Lack of Efficacy|2|||
155721230|NCT01283139|562077789|FG002|Overall Study|Lack of Efficacy|2|||
155721231|NCT01283139|562077790|FG003|Overall Study|Lack of Efficacy|1|||
155721232|NCT01283139|562077787|FG000|Overall Study|Early termination due to AE/SAE|1|||
155721233|NCT01283139|562077788|FG001|Overall Study|Early termination due to AE/SAE|1|||
155721234|NCT01283139|562077789|FG002|Overall Study|Early termination due to AE/SAE|0|||
155721235|NCT01283139|562077790|FG003|Overall Study|Early termination due to AE/SAE|0|||
155721236|NCT01283139|562077787|FG000|Overall Study|Participant's refusal to continue|0|||
155721237|NCT01283139|562077788|FG001|Overall Study|Participant's refusal to continue|3|||
155721238|NCT01283139|562077789|FG002|Overall Study|Participant's refusal to continue|1|||
155721239|NCT01283139|562077790|FG003|Overall Study|Participant's refusal to continue|1|||
155721240|NCT01283139|562077787|FG000|Overall Study|Pregnancy|0|||
155721241|NCT01283139|562077788|FG001|Overall Study|Pregnancy|1|||
155721242|NCT01283139|562077789|FG002|Overall Study|Pregnancy|1|||
155721243|NCT01283139|562077790|FG003|Overall Study|Pregnancy|0|||
155721244|NCT01283139|562077787|FG000|Overall Study|Missed follow-up visit|0|||
155721245|NCT01283139|562077788|FG001|Overall Study|Missed follow-up visit|1|||
155721246|NCT01283139|562077789|FG002|Overall Study|Missed follow-up visit|2|||
155721247|NCT01283139|562077790|FG003|Overall Study|Missed follow-up visit|2|||
155721248|NCT01283139|562077787|FG000|Overall Study|Participant randomized in error|0|||
155721249|NCT01283139|562077788|FG001|Overall Study|Participant randomized in error|0|||
155721250|NCT01283139|562077789|FG002|Overall Study|Participant randomized in error|1|||
155721251|NCT01283139|562077790|FG003|Overall Study|Participant randomized in error|0|||
155721252|NCT02025179|562077793|FG000|Overall Study|Lost to Follow-up|0|||
155721253|NCT02025179|562077794|FG001|Overall Study|Lost to Follow-up|0|||
155721254|NCT02025179|562077795|FG002|Overall Study|Lost to Follow-up|1|||
155721255|NCT02362724|562077796|FG000|Overall Study|Withdrawal by Subject|3|||
155721256|NCT02362724|562077797|FG001|Overall Study|Withdrawal by Subject|1|||
155721257|NCT02362724|562077796|FG000|Overall Study|Adverse Event|3|||
155721258|NCT02362724|562077797|FG001|Overall Study|Adverse Event|0|||
155721259|NCT01927497|562077800|FG000|Overall Study|Death|0|||
155721260|NCT01927497|562077801|FG001|Overall Study|Death|1|||
155721261|NCT01927497|562077800|FG000|Overall Study|Protocol Violation|2|||
155721262|NCT01927497|562077801|FG001|Overall Study|Protocol Violation|0|||
155721263|NCT00395746|562077802|FG000|Overall Study|Adverse Event|5|||
155721264|NCT00395746|562077803|FG001|Overall Study|Adverse Event|2|||
155721265|NCT00395746|562077804|FG002|Overall Study|Adverse Event|2|||
155721266|NCT00395746|562077802|FG000|Overall Study|Protocol Violation|0|||
155721267|NCT00395746|562077803|FG001|Overall Study|Protocol Violation|1|||
155721268|NCT00395746|562077804|FG002|Overall Study|Protocol Violation|0|||
155721269|NCT00395746|562077802|FG000|Overall Study|Lack of Efficacy|2|||
155721270|NCT00395746|562077803|FG001|Overall Study|Lack of Efficacy|0|||
155721271|NCT00395746|562077804|FG002|Overall Study|Lack of Efficacy|17|||
155721272|NCT00395746|562077802|FG000|Overall Study|Hypoglycaemia|2|||
155721273|NCT00395746|562077803|FG001|Overall Study|Hypoglycaemia|1|||
155721274|NCT00395746|562077804|FG002|Overall Study|Hypoglycaemia|0|||
155721275|NCT00395746|562077802|FG000|Overall Study|Subject decision|0|||
155721276|NCT00395746|562077803|FG001|Overall Study|Subject decision|0|||
155721277|NCT00395746|562077804|FG002|Overall Study|Subject decision|1|||
155721278|NCT00395746|562077802|FG000|Overall Study|Withdrawal of consent|0|||
155721279|NCT00395746|562077803|FG001|Overall Study|Withdrawal of consent|0|||
155721280|NCT00395746|562077804|FG002|Overall Study|Withdrawal of consent|1|||
155721281|NCT00395746|562077802|FG000|Overall Study|Difficultulty in use of device|0|||
155721282|NCT00395746|562077803|FG001|Overall Study|Difficultulty in use of device|0|||
155721283|NCT00395746|562077804|FG002|Overall Study|Difficultulty in use of device|1|||
155721284|NCT00395746|562077802|FG000|Overall Study|Unable to visit site on schedule|1|||
155721285|NCT00395746|562077803|FG001|Overall Study|Unable to visit site on schedule|0|||
155721286|NCT00395746|562077804|FG002|Overall Study|Unable to visit site on schedule|0|||
155721287|NCT04528641|562077805|FG000|Overall Study|Withdrawal by Subject|0|||
155721288|NCT04528641|562077806|FG001|Overall Study|Withdrawal by Subject|0|||
155721289|NCT04528641|562077807|FG002|Overall Study|Withdrawal by Subject|0|||
155721290|NCT04528641|562077808|FG003|Overall Study|Withdrawal by Subject|1|||
155721291|NCT04528641|562077809|FG004|Overall Study|Withdrawal by Subject|0|||
155721292|NCT04528641|562077810|FG005|Overall Study|Withdrawal by Subject|1|||
155721293|NCT00517296|562077811|FG000|Overall Study|Withdrawal by Subject|1|||
155721294|NCT00517296|562077812|FG001|Overall Study|Withdrawal by Subject|0|||
155721295|NCT04764162|562077813|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
155721296|NCT04764162|562077814|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
155698062|NCT01555125|561986351|FG000|Maintenance Period|Lack of Efficacy|6|||
155698063|NCT01555125|561986352|FG001|Maintenance Period|Lack of Efficacy|1|||
155698064|NCT01555125|561986353|FG002|Maintenance Period|Lack of Efficacy|3|||
155698065|NCT01555125|561986354|FG003|Maintenance Period|Lack of Efficacy|0|||
155698066|NCT01555125|561986355|FG004|Maintenance Period|Lack of Efficacy|0|||
155698067|NCT01555125|561986351|FG000|Maintenance Period|Physician Decision|0|||
155698068|NCT01555125|561986352|FG001|Maintenance Period|Physician Decision|0|||
155698069|NCT01555125|561986353|FG002|Maintenance Period|Physician Decision|1|||
155698070|NCT01555125|561986354|FG003|Maintenance Period|Physician Decision|0|||
155698071|NCT01555125|561986355|FG004|Maintenance Period|Physician Decision|0|||
155698072|NCT01555125|561986351|FG000|Maintenance Period|Death|0|||
155698073|NCT01555125|561986352|FG001|Maintenance Period|Death|0|||
155698074|NCT01555125|561986353|FG002|Maintenance Period|Death|0|||
155698075|NCT01555125|561986354|FG003|Maintenance Period|Death|1|||
155698076|NCT01555125|561986355|FG004|Maintenance Period|Death|0|||
155698077|NCT01555125|561986351|FG000|Extension|Adverse Event|1|||
155698078|NCT01555125|561986352|FG001|Extension|Adverse Event|2|||
155698079|NCT01555125|561986353|FG002|Extension|Adverse Event|1|||
155698080|NCT01555125|561986354|FG003|Extension|Adverse Event|1|||
155698081|NCT01555125|561986355|FG004|Extension|Adverse Event|0|||
155698082|NCT01555125|561986351|FG000|Extension|Protocol deviation|1|||
155698083|NCT01555125|561986352|FG001|Extension|Protocol deviation|0|||
155698084|NCT01555125|561986353|FG002|Extension|Protocol deviation|0|||
155698085|NCT01555125|561986354|FG003|Extension|Protocol deviation|0|||
155698086|NCT01555125|561986355|FG004|Extension|Protocol deviation|0|||
155698087|NCT01555125|561986351|FG000|Extension|Lack of Efficacy|7|||
155698088|NCT01555125|561986352|FG001|Extension|Lack of Efficacy|6|||
155698089|NCT01555125|561986353|FG002|Extension|Lack of Efficacy|3|||
155698090|NCT01555125|561986354|FG003|Extension|Lack of Efficacy|0|||
155698091|NCT01555125|561986355|FG004|Extension|Lack of Efficacy|0|||
155698092|NCT01555125|561986351|FG000|Extension|Lost to Follow-up|2|||
155698093|NCT01555125|561986352|FG001|Extension|Lost to Follow-up|1|||
155698094|NCT01555125|561986353|FG002|Extension|Lost to Follow-up|2|||
155698095|NCT01555125|561986354|FG003|Extension|Lost to Follow-up|0|||
155698096|NCT01555125|561986355|FG004|Extension|Lost to Follow-up|0|||
155698097|NCT01555125|561986351|FG000|Extension|Study terminated by sponsor|32|||
155698098|NCT01555125|561986352|FG001|Extension|Study terminated by sponsor|33|||
155698099|NCT01555125|561986353|FG002|Extension|Study terminated by sponsor|16|||
155698100|NCT01555125|561986354|FG003|Extension|Study terminated by sponsor|20|||
155698101|NCT01555125|561986355|FG004|Extension|Study terminated by sponsor|0|||
155698102|NCT01555125|561986351|FG000|Extension|Subject/guardian decision|1|||
155698103|NCT01555125|561986352|FG001|Extension|Subject/guardian decision|9|||
155698104|NCT01555125|561986353|FG002|Extension|Subject/guardian decision|1|||
155698105|NCT01555125|561986354|FG003|Extension|Subject/guardian decision|0|||
155698106|NCT01555125|561986355|FG004|Extension|Subject/guardian decision|0|||
155698107|NCT01555125|561986351|FG000|Extension|Technical Problems|1|||
155698108|NCT01555125|561986352|FG001|Extension|Technical Problems|0|||
155698109|NCT01555125|561986353|FG002|Extension|Technical Problems|0|||
155698110|NCT01555125|561986354|FG003|Extension|Technical Problems|1|||
155698111|NCT01555125|561986355|FG004|Extension|Technical Problems|0|||
155698112|NCT01555125|561986351|FG000|Follow-Up Period|Lost to Follow-up|1|||
155698113|NCT01555125|561986352|FG001|Follow-Up Period|Lost to Follow-up|0|||
155698114|NCT01555125|561986353|FG002|Follow-Up Period|Lost to Follow-up|0|||
155698115|NCT01555125|561986354|FG003|Follow-Up Period|Lost to Follow-up|0|||
155698116|NCT01555125|561986355|FG004|Follow-Up Period|Lost to Follow-up|0|||
155698117|NCT01555125|561986351|FG000|Follow-Up Period|Subject / guardian decision|3|||
155698118|NCT01555125|561986352|FG001|Follow-Up Period|Subject / guardian decision|1|||
155698119|NCT01555125|561986353|FG002|Follow-Up Period|Subject / guardian decision|1|||
155698120|NCT01555125|561986354|FG003|Follow-Up Period|Subject / guardian decision|1|||
155698121|NCT01555125|561986355|FG004|Follow-Up Period|Subject / guardian decision|0|||
155698122|NCT04268745|561986356|FG000|Overall Study|Lost to Follow-up|2|||
155698123|NCT04268745|561986357|FG001|Overall Study|Lost to Follow-up|3|||
155698124|NCT04268745|561986356|FG000|Overall Study|Withdrawal by Subject|4|||
155698125|NCT04268745|561986357|FG001|Overall Study|Withdrawal by Subject|2|||
155698126|NCT04268745|561986356|FG000|Overall Study|Death in the family|1|||
155698127|NCT04268745|561986357|FG001|Overall Study|Death in the family|0|||
155698128|NCT05327361|561986361|FG000|Overall Study|Lost to Follow-up|4|||
155698129|NCT00626405|561986362|FG000|Overall Study|Deemed Ineligible|1|||
155698130|NCT00626405|561986363|FG001|Overall Study|Deemed Ineligible|0|||
155698131|NCT00626405|561986362|FG000|Overall Study|Withdrawal by Subject|0|||
155698132|NCT00626405|561986363|FG001|Overall Study|Withdrawal by Subject|1|||
155698133|NCT01174173|561986364|FG000|Overall Study|drug-drug interaction|1|||
155698134|NCT05856227|561988641|FG000|Overall Study|Adverse Event|0|||
155698135|NCT05856227|561988642|FG001|Overall Study|Adverse Event|1|||
155698136|NCT05856227|561988641|FG000|Overall Study|Due to Investigator absence|1|||
155698137|NCT05856227|561988642|FG001|Overall Study|Due to Investigator absence|0|||
155698138|NCT05856227|561988641|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
155698139|NCT05856227|561988642|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
155698140|NCT05011058|561988643|FG000|Overall Study|Sponsor Decision|2|||
155698141|NCT05011058|561988644|FG001|Overall Study|Sponsor Decision|0|||
155698142|NCT05011058|561988645|FG002|Overall Study|Sponsor Decision|14|||
155698143|NCT05011058|561988646|FG003|Overall Study|Sponsor Decision|0|||
155698144|NCT05011058|561988647|FG004|Overall Study|Sponsor Decision|0|||
155698145|NCT05011058|561988648|FG005|Overall Study|Sponsor Decision|1|||
155698146|NCT05011058|561988649|FG006|Overall Study|Sponsor Decision|0|||
155698147|NCT05011058|561988650|FG007|Overall Study|Sponsor Decision|5|||
155698148|NCT01272869|561988651|FG000|Period 2 (14 Days)|Adverse Event|1|||
155698149|NCT01272869|561988652|FG001|Period 2 (14 Days)|Adverse Event|0|||
155698150|NCT01571232|561988653|FG000|Overall Study|Lost to Follow-up|0|||
155698151|NCT01571232|561988654|FG001|Overall Study|Lost to Follow-up|1|||
155698152|NCT01571232|561988653|FG000|Overall Study|Withdrawal by Subject|1|||
155698153|NCT01571232|561988654|FG001|Overall Study|Withdrawal by Subject|0|||
155698154|NCT02455076|561988655|FG000|Inpatient|Withdrawal by Subject|1|||
155698155|NCT02455076|561988656|FG001|Inpatient|Withdrawal by Subject|0|||
155698156|NCT02455076|561988657|FG002|Inpatient|Withdrawal by Subject|0|||
155698157|NCT02455076|561988658|FG003|Inpatient|Withdrawal by Subject|0|||
155698158|NCT02455076|561988659|FG004|Inpatient|Withdrawal by Subject|0|||
155698159|NCT02455076|561988655|FG000|Inpatient|Discharged <24 h after admission|0|||
155698160|NCT02455076|561988656|FG001|Inpatient|Discharged <24 h after admission|1|||
155698161|NCT02455076|561988657|FG002|Inpatient|Discharged <24 h after admission|0|||
155698162|NCT02455076|561988658|FG003|Inpatient|Discharged <24 h after admission|0|||
155698163|NCT02455076|561988659|FG004|Inpatient|Discharged <24 h after admission|0|||
155698164|NCT02455076|561988655|FG000|Inpatient|Adverse Event|3|||
155698165|NCT02455076|561988656|FG001|Inpatient|Adverse Event|0|||
155698166|NCT02455076|561988657|FG002|Inpatient|Adverse Event|0|||
155698167|NCT02455076|561988658|FG003|Inpatient|Adverse Event|0|||
155698168|NCT02455076|561988659|FG004|Inpatient|Adverse Event|0|||
155698169|NCT02455076|561988655|FG000|Outpatient|Adverse Event|0|||
155698170|NCT02455076|561988656|FG001|Outpatient|Adverse Event|0|||
155698171|NCT02455076|561988657|FG002|Outpatient|Adverse Event|0|||
155698172|NCT02455076|561988658|FG003|Outpatient|Adverse Event|5|||
155698173|NCT02455076|561988659|FG004|Outpatient|Adverse Event|0|||
155698174|NCT02455076|561988655|FG000|Outpatient|Lost to Follow-up|0|||
155698175|NCT02455076|561988656|FG001|Outpatient|Lost to Follow-up|0|||
155698176|NCT02455076|561988657|FG002|Outpatient|Lost to Follow-up|0|||
155698177|NCT02455076|561988658|FG003|Outpatient|Lost to Follow-up|1|||
155698178|NCT02455076|561988659|FG004|Outpatient|Lost to Follow-up|12|||
155698179|NCT03908476|561988660|FG000|Overall Study|Death|3|||
155698180|NCT03908476|561988661|FG001|Overall Study|Death|0|||
155698181|NCT03908476|561988660|FG000|Overall Study|Lost to Follow-up|3|||
155698182|NCT03908476|561988661|FG001|Overall Study|Lost to Follow-up|1|||
155698183|NCT03908476|561988660|FG000|Overall Study|Withdrawal by Subject|7|||
155698184|NCT03908476|561988661|FG001|Overall Study|Withdrawal by Subject|1|||
155698185|NCT03908476|561988660|FG000|Overall Study|Physician Decision|2|||
155698186|NCT03908476|561988661|FG001|Overall Study|Physician Decision|0|||
155698187|NCT03908476|561988660|FG000|Overall Study|System Explanted and not Replaced|4|||
155698188|NCT03908476|561988661|FG001|Overall Study|System Explanted and not Replaced|0|||
155698189|NCT03908476|561988660|FG000|Overall Study|Intrathecal Pump|1|||
155698190|NCT03908476|561988661|FG001|Overall Study|Intrathecal Pump|0|||
155698191|NCT03908476|561988660|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
155698192|NCT03908476|561988661|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
155698193|NCT05194267|561988662|FG000|Overall Study|Withdrawal by Subject|2|||
155698194|NCT02868229|561988663|FG000|Overall Study|Adverse Event|1|||
155698195|NCT02868229|561988664|FG001|Overall Study|Adverse Event|0|||
155698196|NCT02868229|561988665|FG002|Overall Study|Adverse Event|0|||
155698197|NCT02868229|561988666|FG003|Overall Study|Adverse Event|1|||
155698198|NCT02868229|561988663|FG000|Overall Study|Death|0|||
155698199|NCT02868229|561988664|FG001|Overall Study|Death|0|||
155698200|NCT02868229|561988665|FG002|Overall Study|Death|1|||
155698201|NCT02868229|561988666|FG003|Overall Study|Death|1|||
155698202|NCT02868229|561988663|FG000|Overall Study|Missed dose|0|||
155698203|NCT02868229|561988664|FG001|Overall Study|Missed dose|0|||
155698204|NCT02868229|561988665|FG002|Overall Study|Missed dose|0|||
155698205|NCT02868229|561988666|FG003|Overall Study|Missed dose|3|||
155698206|NCT06151288|561988667|FG000|Overall Study|Lost to Follow-up|4|||
155698207|NCT06151288|561988668|FG001|Overall Study|Lost to Follow-up|2|||
155698208|NCT06151288|561988669|FG002|Overall Study|Lost to Follow-up|4|||
155698209|NCT06151288|561988670|FG003|Overall Study|Lost to Follow-up|3|||
155698210|NCT06151288|561988667|FG000|Overall Study|Withdrawal by Subject|4|||
155698211|NCT06151288|561988668|FG001|Overall Study|Withdrawal by Subject|5|||
155698212|NCT06151288|561988669|FG002|Overall Study|Withdrawal by Subject|1|||
155698213|NCT06151288|561988670|FG003|Overall Study|Withdrawal by Subject|1|||
155698214|NCT03194438|561988679|FG000|Overall Study|Withdrawal by Subject|2|||
155698215|NCT02708485|561988682|FG000|Overall Study|Withdrawal by Subject|3|||
155698216|NCT02708485|561988683|FG001|Overall Study|Withdrawal by Subject|2|||
155698217|NCT00231413|561988684|FG000|Overall Study|Non-serious AE|0|||
155698218|NCT00231413|561988685|FG001|Overall Study|Non-serious AE|0|||
155698219|NCT00231413|561988686|FG002|Overall Study|Non-serious AE|1|||
155698220|NCT00231413|561988687|FG003|Overall Study|Non-serious AE|0|||
155698221|NCT00231413|561988688|FG004|Overall Study|Non-serious AE|0|||
155698222|NCT00231413|561988689|FG005|Overall Study|Non-serious AE|0|||
155698223|NCT00231413|561988690|FG006|Overall Study|Non-serious AE|1|||
155698224|NCT00231413|561988684|FG000|Overall Study|Withdrawal by Subject|3|||
155698225|NCT00231413|561988685|FG001|Overall Study|Withdrawal by Subject|1|||
155698226|NCT00231413|561988686|FG002|Overall Study|Withdrawal by Subject|4|||
155698227|NCT00231413|561988687|FG003|Overall Study|Withdrawal by Subject|2|||
155698228|NCT00231413|561988688|FG004|Overall Study|Withdrawal by Subject|2|||
155698229|NCT00231413|561988689|FG005|Overall Study|Withdrawal by Subject|0|||
155698230|NCT00231413|561988690|FG006|Overall Study|Withdrawal by Subject|3|||
155698231|NCT00231413|561988684|FG000|Overall Study|Migrated/moved from study area|0|||
155698232|NCT00231413|561988685|FG001|Overall Study|Migrated/moved from study area|0|||
155698233|NCT00231413|561988686|FG002|Overall Study|Migrated/moved from study area|1|||
155698234|NCT00231413|561988687|FG003|Overall Study|Migrated/moved from study area|0|||
155698235|NCT00231413|561988688|FG004|Overall Study|Migrated/moved from study area|0|||
155698236|NCT00231413|561988689|FG005|Overall Study|Migrated/moved from study area|1|||
155698237|NCT00231413|561988690|FG006|Overall Study|Migrated/moved from study area|0|||
155698238|NCT00231413|561988684|FG000|Overall Study|Lost to Follow-up|4|||
155698239|NCT00231413|561988685|FG001|Overall Study|Lost to Follow-up|4|||
155698240|NCT00231413|561988686|FG002|Overall Study|Lost to Follow-up|1|||
155698241|NCT00231413|561988687|FG003|Overall Study|Lost to Follow-up|1|||
155698242|NCT00231413|561988688|FG004|Overall Study|Lost to Follow-up|1|||
155698243|NCT00231413|561988689|FG005|Overall Study|Lost to Follow-up|4|||
155698244|NCT00231413|561988690|FG006|Overall Study|Lost to Follow-up|0|||
155698245|NCT00231413|561988684|FG000|Overall Study|Pregnancy|1|||
155698246|NCT00231413|561988685|FG001|Overall Study|Pregnancy|0|||
155698247|NCT00231413|561988686|FG002|Overall Study|Pregnancy|0|||
155698248|NCT00231413|561988687|FG003|Overall Study|Pregnancy|0|||
155698249|NCT00231413|561988688|FG004|Overall Study|Pregnancy|0|||
155698250|NCT00231413|561988689|FG005|Overall Study|Pregnancy|0|||
155698251|NCT00231413|561988690|FG006|Overall Study|Pregnancy|0|||
155698252|NCT01646203|561988691|FG000|Overall Study|Adverse Event|2|||
155698253|NCT01646203|561988692|FG001|Overall Study|Adverse Event|0|||
155698254|NCT01646203|561988693|FG002|Overall Study|Adverse Event|1|||
155698255|NCT01646203|561988691|FG000|Overall Study|Withdrawal by Subject|0|||
155698256|NCT01646203|561988692|FG001|Overall Study|Withdrawal by Subject|1|||
155698257|NCT01646203|561988693|FG002|Overall Study|Withdrawal by Subject|0|||
155698258|NCT01646203|561988691|FG000|Overall Study|Physician's Decision|0|||
155698259|NCT01646203|561988692|FG001|Overall Study|Physician's Decision|1|||
155698260|NCT01646203|561988693|FG002|Overall Study|Physician's Decision|0|||
155698261|NCT01659255|561988694|FG000|Overall Study|Adverse Event|0|||
155698262|NCT01659255|561988695|FG001|Overall Study|Adverse Event|0|||
155698263|NCT01659255|561988696|FG002|Overall Study|Adverse Event|0|||
155698264|NCT01659255|561988697|FG003|Overall Study|Adverse Event|0|||
155698265|NCT01659255|561988698|FG004|Overall Study|Adverse Event|0|||
155698266|NCT01659255|561988699|FG005|Overall Study|Adverse Event|1|||
155698267|NCT01659255|561988700|FG006|Overall Study|Adverse Event|1|||
155698268|NCT01659255|561988701|FG007|Overall Study|Adverse Event|0|||
155698269|NCT01659255|561988702|FG008|Overall Study|Adverse Event|0|||
155698270|NCT01659255|561988703|FG009|Overall Study|Adverse Event|1|||
155698271|NCT01659255|561988704|FG010|Overall Study|Adverse Event|0|||
155698272|NCT01659255|561988705|FG011|Overall Study|Adverse Event|1|||
155698273|NCT01659255|561988706|FG012|Overall Study|Adverse Event|0|||
155698274|NCT01659255|561988707|FG013|Overall Study|Adverse Event|2|||
155698275|NCT01659255|561988708|FG014|Overall Study|Adverse Event|0|||
155698276|NCT01659255|561988709|FG015|Overall Study|Adverse Event|1|||
155698277|NCT01659255|561988710|FG016|Overall Study|Adverse Event|0|||
155698278|NCT01659255|561988694|FG000|Overall Study|Death|0|||
155698279|NCT01659255|561988695|FG001|Overall Study|Death|1|||
155698280|NCT01659255|561988696|FG002|Overall Study|Death|0|||
155698281|NCT01659255|561988697|FG003|Overall Study|Death|0|||
155698282|NCT01659255|561988698|FG004|Overall Study|Death|0|||
155698283|NCT01659255|561988699|FG005|Overall Study|Death|0|||
155698284|NCT01659255|561988700|FG006|Overall Study|Death|0|||
155698285|NCT01659255|561988701|FG007|Overall Study|Death|1|||
155698286|NCT01659255|561988702|FG008|Overall Study|Death|1|||
155698287|NCT01659255|561988703|FG009|Overall Study|Death|0|||
155698288|NCT01659255|561988704|FG010|Overall Study|Death|0|||
155698289|NCT01659255|561988705|FG011|Overall Study|Death|0|||
155698290|NCT01659255|561988706|FG012|Overall Study|Death|1|||
155698291|NCT01659255|561988707|FG013|Overall Study|Death|1|||
155698292|NCT01659255|561988708|FG014|Overall Study|Death|2|||
155698293|NCT01659255|561988709|FG015|Overall Study|Death|1|||
155698294|NCT01659255|561988710|FG016|Overall Study|Death|0|||
155698295|NCT01659255|561988694|FG000|Overall Study|Progressive Disease|2|||
155698296|NCT01659255|561988695|FG001|Overall Study|Progressive Disease|0|||
155698297|NCT01659255|561988696|FG002|Overall Study|Progressive Disease|0|||
155698298|NCT01659255|561988697|FG003|Overall Study|Progressive Disease|0|||
155698299|NCT01659255|561988698|FG004|Overall Study|Progressive Disease|0|||
155698300|NCT01659255|561988699|FG005|Overall Study|Progressive Disease|0|||
155698301|NCT01659255|561988700|FG006|Overall Study|Progressive Disease|0|||
155698302|NCT01659255|561988701|FG007|Overall Study|Progressive Disease|1|||
155698303|NCT01659255|561988702|FG008|Overall Study|Progressive Disease|0|||
155698304|NCT01659255|561988703|FG009|Overall Study|Progressive Disease|2|||
155698305|NCT01659255|561988704|FG010|Overall Study|Progressive Disease|2|||
155698306|NCT01659255|561988705|FG011|Overall Study|Progressive Disease|3|||
155698307|NCT01659255|561988706|FG012|Overall Study|Progressive Disease|5|||
155698308|NCT01659255|561988707|FG013|Overall Study|Progressive Disease|13|||
155698309|NCT01659255|561988708|FG014|Overall Study|Progressive Disease|6|||
155698310|NCT01659255|561988709|FG015|Overall Study|Progressive Disease|2|||
155698311|NCT01659255|561988710|FG016|Overall Study|Progressive Disease|3|||
155698312|NCT01659255|561988694|FG000|Overall Study|Withdrew Consent|0|||
155698313|NCT01659255|561988695|FG001|Overall Study|Withdrew Consent|0|||
155698314|NCT01659255|561988696|FG002|Overall Study|Withdrew Consent|0|||
155698315|NCT01659255|561988697|FG003|Overall Study|Withdrew Consent|0|||
155698316|NCT01659255|561988698|FG004|Overall Study|Withdrew Consent|0|||
155698317|NCT01659255|561988699|FG005|Overall Study|Withdrew Consent|0|||
155698318|NCT01659255|561988700|FG006|Overall Study|Withdrew Consent|0|||
155698319|NCT01659255|561988701|FG007|Overall Study|Withdrew Consent|0|||
155698320|NCT01659255|561988702|FG008|Overall Study|Withdrew Consent|0|||
155698321|NCT01659255|561988703|FG009|Overall Study|Withdrew Consent|0|||
155698322|NCT01659255|561988704|FG010|Overall Study|Withdrew Consent|1|||
155698323|NCT01659255|561988705|FG011|Overall Study|Withdrew Consent|0|||
155698324|NCT01659255|561988706|FG012|Overall Study|Withdrew Consent|0|||
155698325|NCT01659255|561988707|FG013|Overall Study|Withdrew Consent|1|||
155698326|NCT01659255|561988708|FG014|Overall Study|Withdrew Consent|0|||
155698327|NCT01659255|561988709|FG015|Overall Study|Withdrew Consent|0|||
155698328|NCT01659255|561988710|FG016|Overall Study|Withdrew Consent|0|||
155698329|NCT01659255|561988694|FG000|Overall Study|Investigator Decision|0|||
155698330|NCT01659255|561988695|FG001|Overall Study|Investigator Decision|0|||
155698331|NCT01659255|561988696|FG002|Overall Study|Investigator Decision|0|||
155698332|NCT01659255|561988697|FG003|Overall Study|Investigator Decision|0|||
155698333|NCT01659255|561988698|FG004|Overall Study|Investigator Decision|0|||
155698334|NCT01659255|561988699|FG005|Overall Study|Investigator Decision|0|||
155698335|NCT01659255|561988700|FG006|Overall Study|Investigator Decision|0|||
155698336|NCT01659255|561988701|FG007|Overall Study|Investigator Decision|0|||
155698337|NCT01659255|561988702|FG008|Overall Study|Investigator Decision|0|||
155698338|NCT01659255|561988703|FG009|Overall Study|Investigator Decision|0|||
155698339|NCT01659255|561988704|FG010|Overall Study|Investigator Decision|0|||
155698340|NCT01659255|561988705|FG011|Overall Study|Investigator Decision|0|||
155698341|NCT01659255|561988706|FG012|Overall Study|Investigator Decision|1|||
155698342|NCT01659255|561988707|FG013|Overall Study|Investigator Decision|1|||
155698343|NCT01659255|561988708|FG014|Overall Study|Investigator Decision|0|||
155698344|NCT01659255|561988709|FG015|Overall Study|Investigator Decision|0|||
155698345|NCT01659255|561988710|FG016|Overall Study|Investigator Decision|0|||
155698346|NCT01659255|561988694|FG000|Overall Study|Sponsor's Decision|0|||
155698347|NCT01659255|561988695|FG001|Overall Study|Sponsor's Decision|0|||
155698348|NCT01659255|561988696|FG002|Overall Study|Sponsor's Decision|0|||
155698349|NCT01659255|561988697|FG003|Overall Study|Sponsor's Decision|0|||
155698350|NCT01659255|561988698|FG004|Overall Study|Sponsor's Decision|0|||
155698351|NCT01659255|561988699|FG005|Overall Study|Sponsor's Decision|0|||
155698352|NCT01659255|561988700|FG006|Overall Study|Sponsor's Decision|1|||
155698353|NCT01659255|561988701|FG007|Overall Study|Sponsor's Decision|0|||
155698354|NCT01659255|561988702|FG008|Overall Study|Sponsor's Decision|0|||
155698355|NCT01659255|561988703|FG009|Overall Study|Sponsor's Decision|0|||
155698356|NCT01659255|561988704|FG010|Overall Study|Sponsor's Decision|0|||
155698357|NCT01659255|561988705|FG011|Overall Study|Sponsor's Decision|0|||
155698358|NCT01659255|561988706|FG012|Overall Study|Sponsor's Decision|0|||
155698359|NCT01659255|561988707|FG013|Overall Study|Sponsor's Decision|0|||
155698360|NCT01659255|561988708|FG014|Overall Study|Sponsor's Decision|0|||
155698361|NCT01659255|561988709|FG015|Overall Study|Sponsor's Decision|0|||
155698362|NCT01659255|561988710|FG016|Overall Study|Sponsor's Decision|0|||
155698363|NCT01659255|561988694|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698364|NCT01659255|561988695|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698365|NCT01659255|561988696|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698366|NCT01659255|561988697|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698367|NCT01659255|561988698|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698368|NCT01659255|561988699|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698369|NCT01659255|561988700|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698370|NCT01659255|561988701|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698371|NCT01659255|561988702|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698372|NCT01659255|561988703|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698373|NCT01659255|561988704|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698374|NCT01659255|561988705|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698375|NCT01659255|561988706|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698376|NCT01659255|561988707|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698377|NCT01659255|561988708|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698378|NCT01659255|561988709|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
155698379|NCT01659255|561988710|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155698380|NCT01659255|561988694|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
155698381|NCT01659255|561988695|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
155698382|NCT01659255|561988696|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
155698383|NCT01659255|561988697|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
155698384|NCT01659255|561988698|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
155698385|NCT01659255|561988699|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
155698386|NCT01659255|561988700|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
155698387|NCT01659255|561988701|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
155698388|NCT01659255|561988702|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
155698389|NCT01659255|561988703|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
155698390|NCT01659255|561988704|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
155698391|NCT01659255|561988705|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
155698392|NCT01659255|561988706|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
155698393|NCT01659255|561988707|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
155698394|NCT01659255|561988708|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
155698395|NCT01659255|561988709|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
155698396|NCT01659255|561988710|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
155698397|NCT01423916|561988711|FG000|Overall Study|Adverse Event|5|||
155698398|NCT01423916|561988712|FG001|Overall Study|Adverse Event|9|||
155698399|NCT01423916|561988713|FG002|Overall Study|Adverse Event|2|||
155698400|NCT01423916|561988711|FG000|Overall Study|Met Withdrawal Criteria|1|||
155698401|NCT01423916|561988712|FG001|Overall Study|Met Withdrawal Criteria|1|||
155698402|NCT01423916|561988713|FG002|Overall Study|Met Withdrawal Criteria|1|||
155698403|NCT01423916|561988711|FG000|Overall Study|Physician Decision|1|||
155698404|NCT01423916|561988712|FG001|Overall Study|Physician Decision|0|||
155698405|NCT01423916|561988713|FG002|Overall Study|Physician Decision|1|||
155698406|NCT01423916|561988711|FG000|Overall Study|Withdrawal by Subject|3|||
155698407|NCT01423916|561988712|FG001|Overall Study|Withdrawal by Subject|10|||
155698408|NCT01423916|561988713|FG002|Overall Study|Withdrawal by Subject|3|||
155698409|NCT01423916|561988711|FG000|Overall Study|Protocol Deviation|1|||
155698410|NCT01423916|561988712|FG001|Overall Study|Protocol Deviation|0|||
155698411|NCT01423916|561988713|FG002|Overall Study|Protocol Deviation|0|||
155698412|NCT03316950|561988714|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
155698413|NCT03316950|561988715|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
155698414|NCT03316950|561988716|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
155698415|NCT03316950|561988717|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
155698416|NCT03316950|561988714|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
155698417|NCT03316950|561988715|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
155698418|NCT03316950|561988716|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
155698419|NCT03316950|561988717|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
155698420|NCT03316950|561988714|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
155698421|NCT03316950|561988715|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
155698422|NCT03316950|561988716|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
155698423|NCT03316950|561988717|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
155698424|NCT02717130|561988718|FG000|Overall Study|Withdrawal by Subject|1|||
155698425|NCT02717130|561988718|FG000|Overall Study|Adverse Event|1|||
155698426|NCT02717130|561988718|FG000|Overall Study|Physician Decision|1|||
155698427|NCT02717130|561988718|FG000|Overall Study|Study Closure|4|||
155698428|NCT02294734|561988721|FG000|Overall Study|Adverse Event|5|||
155698429|NCT02294734|561988722|FG001|Overall Study|Adverse Event|5|||
155698430|NCT02294734|561988721|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
155698431|NCT02294734|561988722|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
155698432|NCT02294734|561988721|FG000|Overall Study|Lost to Follow-up|2|||
155698433|NCT02294734|561988722|FG001|Overall Study|Lost to Follow-up|0|||
155698434|NCT02294734|561988721|FG000|Overall Study|Physician Decision|2|||
155698435|NCT02294734|561988722|FG001|Overall Study|Physician Decision|1|||
155698436|NCT02294734|561988721|FG000|Overall Study|Withdrawal by Subject|4|||
155698437|NCT02294734|561988722|FG001|Overall Study|Withdrawal by Subject|2|||
155698438|NCT02335424|561988723|FG000|Overall Study|Withdrawal by Subject|19|||
155698439|NCT02335424|561988723|FG000|Overall Study|Adverse Event|25|||
155698440|NCT02335424|561988723|FG000|Overall Study|Death|273|||
155698441|NCT02335424|561988723|FG000|Overall Study|Lost to Follow-up|3|||
155698442|NCT02335424|561988723|FG000|Overall Study|Physician Decision|13|||
155698443|NCT02335424|561988723|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
155698444|NCT02335424|561988723|FG000|Overall Study|Protocol Violation|1|||
155698445|NCT02335424|561988723|FG000|Overall Study|Screen failure|1|||
155698446|NCT03847909|561988724|FG000|Overall Study|Withdrawal by Subject|1|||
155698447|NCT03847909|561988725|FG001|Overall Study|Withdrawal by Subject|1|||
155698448|NCT01147900|561988726|FG000|At Year 10|Lost to Follow-up|0|||
155698449|NCT01147900|561988727|FG001|At Year 10|Lost to Follow-up|1|||
155698450|NCT01147900|561988728|FG002|At Year 10|Lost to Follow-up|0|||
155698451|NCT00903331|561988729|FG000|Overall Study|Death|4|||
155698452|NCT00903331|561988730|FG001|Overall Study|Death|8|||
155698453|NCT00903331|561988729|FG000|Overall Study|Withdrawal of consent|1|||
155698454|NCT00903331|561988730|FG001|Overall Study|Withdrawal of consent|8|||
155698455|NCT00903331|561988729|FG000|Overall Study|Lung transplant|0|||
155698456|NCT00903331|561988730|FG001|Overall Study|Lung transplant|2|||
155698457|NCT04109976|561988732|FG000|Overall Study|Withdrawal by Subject|1|||
155698458|NCT04109976|561988733|FG001|Overall Study|Withdrawal by Subject|0|||
155698459|NCT00257660|561988734|FG000|Overall Study|Lack of Efficacy|5|||
155698460|NCT00257660|561988735|FG001|Overall Study|Lack of Efficacy|23|||
155698461|NCT00257660|561988734|FG000|Overall Study|Withdrawal by Subject|2|||
155698462|NCT00257660|561988735|FG001|Overall Study|Withdrawal by Subject|0|||
155698463|NCT00257660|561988734|FG000|Overall Study|Lost to Follow-up|1|||
155698464|NCT00257660|561988735|FG001|Overall Study|Lost to Follow-up|0|||
155698465|NCT00257660|561988734|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
155698466|NCT00257660|561988735|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
155698467|NCT00257660|561988734|FG000|Overall Study|No longer wanted to do blood draws|1|||
155698468|NCT00257660|561988735|FG001|Overall Study|No longer wanted to do blood draws|0|||
155698469|NCT01600092|561988737|FG000|Overall Study|Adverse Event|2|||
155698470|NCT01600092|561988738|FG001|Overall Study|Adverse Event|0|||
155698471|NCT01600092|561988737|FG000|Overall Study|Lost to Follow-up|4|||
155698472|NCT01600092|561988738|FG001|Overall Study|Lost to Follow-up|6|||
155698473|NCT01600092|561988737|FG000|Overall Study|Withdrawal by parent/guardian|8|||
155698474|NCT01600092|561988738|FG001|Overall Study|Withdrawal by parent/guardian|6|||
155698475|NCT01600092|561988737|FG000|Overall Study|Physician Decision|1|||
155698476|NCT01600092|561988738|FG001|Overall Study|Physician Decision|1|||
155698477|NCT01600092|561988737|FG000|Overall Study|Randomized but not vaccinated|3|||
155698478|NCT01600092|561988738|FG001|Overall Study|Randomized but not vaccinated|3|||
155698479|NCT02976103|561988739|FG000|Overall Study|Withdrawal by Subject|1|||
155698480|NCT02976103|561988740|FG001|Overall Study|Withdrawal by Subject|0|||
155698481|NCT02976103|561988739|FG000|Overall Study|Lost to Follow-up|12|||
155698482|NCT02976103|561988740|FG001|Overall Study|Lost to Follow-up|8|||
155698483|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
155698484|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
155698485|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
155698486|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
155698487|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
155698488|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
155698489|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155698490|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155698491|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155698492|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155698493|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155698494|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
155698495|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
155698496|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
155698497|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698498|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
155698499|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
155698500|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698501|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698502|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698503|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698504|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155698505|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698506|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
155698507|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155698508|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155698509|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
155698510|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155698511|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698512|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698513|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698514|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698515|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155698516|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
155698517|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
155698518|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
155698519|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698520|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
155698521|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
155698522|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698523|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698524|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698525|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698526|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155698527|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698528|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698529|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
155698530|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698531|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698532|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
155698533|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698534|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698535|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698536|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698537|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155698538|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
155698539|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698540|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698541|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698542|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698543|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698544|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698545|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698546|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698547|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698548|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155698549|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698550|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698551|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
155698552|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698553|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698554|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698555|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698556|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698557|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698558|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698559|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155698560|NCT02914561|561988741|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
155698561|NCT02914561|561988742|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698562|NCT02914561|561988743|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155698563|NCT02914561|561988744|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155698564|NCT02914561|561988745|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155698565|NCT02914561|561988746|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155698566|NCT02914561|561988747|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698567|NCT02914561|561988748|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698568|NCT02914561|561988749|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698569|NCT02914561|561988750|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698570|NCT02914561|561988751|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155698571|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698572|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698573|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698574|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698575|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698576|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155698577|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
155698578|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
155698579|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
155698580|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
155698581|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
155698582|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698583|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698584|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698585|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698586|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698587|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155698588|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
155698589|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
155698590|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
155698591|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
155698592|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
155698593|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698594|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698595|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698596|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698597|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698598|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155698599|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
155698600|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
155698601|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
155698602|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
155698603|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
155698604|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698605|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698606|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698607|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698608|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698609|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698610|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
155698611|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698612|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
155698613|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155698614|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
155698615|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698616|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698617|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698618|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698619|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698620|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698621|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
155698622|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155698623|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
155698624|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
155698625|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
155698626|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698627|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698628|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698629|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698630|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698631|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698632|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
155698633|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698634|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
155698635|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698636|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155698637|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698638|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698639|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698640|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698641|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698642|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698643|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698644|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698645|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
155698646|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698647|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155698648|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698649|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698650|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698651|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698652|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698653|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698654|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
155698655|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698656|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698657|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698658|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155698659|NCT02914561|561988741|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698660|NCT02914561|561988742|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698661|NCT02914561|561988743|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698662|NCT02914561|561988744|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698663|NCT02914561|561988745|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698664|NCT02914561|561988746|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698665|NCT02914561|561988747|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698666|NCT02914561|561988748|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155698667|NCT02914561|561988749|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155698668|NCT02914561|561988750|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155698669|NCT02914561|561988751|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155698670|NCT00084487|561988752|FG000|Overall Study|Death|1|||
155698671|NCT01561963|561988759|FG000|Overall Study|Adverse Event|1|||
155698672|NCT04598269|561988760|FG000|Overall Study|Adverse Event|0|||
155698673|NCT04598269|561988761|FG001|Overall Study|Adverse Event|3|||
155698674|NCT04598269|561988760|FG000|Overall Study|Withdrawal by Subject|1|||
155698675|NCT04598269|561988761|FG001|Overall Study|Withdrawal by Subject|4|||
155698676|NCT04598269|561988760|FG000|Overall Study|Lost to Follow-up|1|||
155698677|NCT04598269|561988761|FG001|Overall Study|Lost to Follow-up|0|||
155698678|NCT04598269|561988760|FG000|Overall Study|Not Treated|2|||
155698679|NCT04598269|561988761|FG001|Overall Study|Not Treated|0|||
155698680|NCT03040986|561988770|FG000|Overall Study|Hospice|1|||
155698681|NCT03040986|561988771|FG001|Overall Study|Hospice|0|||
155698682|NCT03040986|561988770|FG000|Overall Study|Adverse Event|2|||
155698683|NCT03040986|561988771|FG001|Overall Study|Adverse Event|1|||
155698684|NCT03040986|561988770|FG000|Overall Study|Disease progression on study|3|||
155698685|NCT03040986|561988771|FG001|Overall Study|Disease progression on study|1|||
155698686|NCT02383433|561988772|FG000|Overall Study|Disease progression|2|||
155698687|NCT02477553|561988773|FG000|Overall Study|Screening up-to-date|12|||
155698688|NCT02477553|561988774|FG001|Overall Study|Screening up-to-date|13|||
155698689|NCT02477553|561988773|FG000|Overall Study|No MD visit|1|||
155698690|NCT02477553|561988774|FG001|Overall Study|No MD visit|1|||
155698691|NCT02477553|561988773|FG000|Overall Study|Workup consistent w/CRC|1|||
155698692|NCT02477553|561988774|FG001|Overall Study|Workup consistent w/CRC|1|||
155698693|NCT02477553|561988773|FG000|Overall Study|Technical issues with intervention|2|||
155698694|NCT02477553|561988774|FG001|Overall Study|Technical issues with intervention|0|||
155698695|NCT02477553|561988773|FG000|Overall Study|Elevated risk for CRC|2|||
155698696|NCT02477553|561988774|FG001|Overall Study|Elevated risk for CRC|2|||
155698697|NCT02477553|561988773|FG000|Overall Study|MD advised against screening|1|||
155698698|NCT02477553|561988774|FG001|Overall Study|MD advised against screening|3|||
155698699|NCT02477553|561988773|FG000|Overall Study|patient deceased|1|||
155698700|NCT02477553|561988774|FG001|Overall Study|patient deceased|0|||
155698701|NCT04023682|561988779|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
155698702|NCT00695864|561988785|FG000|Placebo|Withdrawal by Subject|1|||
155698703|NCT00695864|561988785|FG000|Placebo|Physician Decision|4|||
155698704|NCT00772109|561988791|FG000|Overall Study|Serious adverse event|1|||
155698705|NCT00772109|561988792|FG001|Overall Study|Serious adverse event|0|||
155698706|NCT00772109|561988793|FG002|Overall Study|Serious adverse event|1|||
155698707|NCT00772109|561988794|FG003|Overall Study|Serious adverse event|0|||
155698708|NCT00772109|561988791|FG000|Overall Study|Protocol Violation|5|||
155698709|NCT00772109|561988792|FG001|Overall Study|Protocol Violation|8|||
155698710|NCT00772109|561988793|FG002|Overall Study|Protocol Violation|7|||
155698711|NCT00772109|561988794|FG003|Overall Study|Protocol Violation|6|||
155698712|NCT00772109|561988791|FG000|Overall Study|Lost to Follow-up|7|||
155698713|NCT00772109|561988792|FG001|Overall Study|Lost to Follow-up|3|||
155698714|NCT00772109|561988793|FG002|Overall Study|Lost to Follow-up|5|||
155698715|NCT00772109|561988794|FG003|Overall Study|Lost to Follow-up|9|||
155698716|NCT00772109|561988791|FG000|Overall Study|Withdrawal by Subject|8|||
155698717|NCT00772109|561988792|FG001|Overall Study|Withdrawal by Subject|8|||
155698718|NCT00772109|561988793|FG002|Overall Study|Withdrawal by Subject|6|||
155698719|NCT00772109|561988794|FG003|Overall Study|Withdrawal by Subject|16|||
155698720|NCT00752726|561988795|FG000|Overall Study|Lost to Follow-up|2|||
155698721|NCT00752726|561988796|FG001|Overall Study|Lost to Follow-up|1|||
155698722|NCT00752726|561988795|FG000|Overall Study|Adverse Event|3|||
155698723|NCT00752726|561988796|FG001|Overall Study|Adverse Event|0|||
155698724|NCT00752726|561988795|FG000|Overall Study|Withdrawal by Subject|5|||
155698725|NCT00752726|561988796|FG001|Overall Study|Withdrawal by Subject|10|||
155698726|NCT00752726|561988795|FG000|Overall Study|Other Reason|1|||
155698727|NCT00752726|561988796|FG001|Overall Study|Other Reason|2|||
155698728|NCT04232215|561988797|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155698729|NCT04232215|561988798|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155698730|NCT00410605|561988799|FG000|Overall Study|Adverse Event|12|||
155698731|NCT00410605|561988799|FG000|Overall Study|Physician Decision|3|||
155698732|NCT00410605|561988799|FG000|Overall Study|Withdrawal by Subject|5|||
155698733|NCT00410605|561988799|FG000|Overall Study|Started Non-Protocol Therapy|3|||
155698734|NCT00410605|561988799|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
155698735|NCT00410605|561988799|FG000|Overall Study|Transferred to another Institution|1|||
155698736|NCT01887353|561988802|FG000|Overall Study|Study stopped early|4|||
155698737|NCT01887353|561988803|FG001|Overall Study|Study stopped early|3|||
155698738|NCT02039856|561988804|FG000|Overall Study|Death|5|||
155698739|NCT02039856|561988805|FG001|Overall Study|Death|3|||
155698740|NCT02039856|561988804|FG000|Overall Study|Partial survey completion|61|||
155698741|NCT02039856|561988805|FG001|Overall Study|Partial survey completion|26|||
155698742|NCT02039856|561988804|FG000|Overall Study|Lost to Follow-up|388|||
155698743|NCT02039856|561988805|FG001|Overall Study|Lost to Follow-up|206|||
155698744|NCT02039856|561988804|FG000|Overall Study|Withdrawal by Subject|1573|||
155698745|NCT02039856|561988805|FG001|Overall Study|Withdrawal by Subject|618|||
155698746|NCT00602420|561990536|FG000|Overall Study|Death|1|||
155698747|NCT00602420|561990537|FG001|Overall Study|Death|4|||
155698748|NCT00602420|561990536|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
155698749|NCT00602420|561990537|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
155698750|NCT00602420|561990536|FG000|Overall Study|Withdrawal by Subject|18|||
155698751|NCT00602420|561990537|FG001|Overall Study|Withdrawal by Subject|17|||
155698752|NCT00602420|561990536|FG000|Overall Study|Adverse Event|1|||
155698753|NCT00602420|561990537|FG001|Overall Study|Adverse Event|0|||
155698754|NCT00649428|561990546|FG000|Overall Study|Adverse Event|2|||
155698755|NCT00649428|561990547|FG001|Overall Study|Adverse Event|2|||
155698756|NCT00649428|561990546|FG000|Overall Study|Withdrawal by Subject|6|||
155698757|NCT00649428|561990547|FG001|Overall Study|Withdrawal by Subject|6|||
155698758|NCT00649428|561990546|FG000|Overall Study|Lost to Follow-up|1|||
155698759|NCT00649428|561990547|FG001|Overall Study|Lost to Follow-up|3|||
155698760|NCT00649428|561990546|FG000|Overall Study|Insufficient manufacturing yield|5|||
155698761|NCT00649428|561990547|FG001|Overall Study|Insufficient manufacturing yield|1|||
155698762|NCT00649428|561990546|FG000|Overall Study|Protocol Violation|6|||
155698763|NCT00649428|561990547|FG001|Overall Study|Protocol Violation|2|||
155698764|NCT00649428|561990546|FG000|Overall Study|Physician Decision|0|||
155698765|NCT00649428|561990547|FG001|Overall Study|Physician Decision|1|||
155698766|NCT02315560|561990548|FG000|Overall Study|noncompliance by subjects|3|||
155698767|NCT02008227|561990549|FG000|Overall Study|Lost to Follow-up|7|||
155698768|NCT02008227|561990550|FG001|Overall Study|Lost to Follow-up|9|||
155698769|NCT02008227|561990549|FG000|Overall Study|Death|494|||
155698770|NCT02008227|561990550|FG001|Overall Study|Death|485|||
155698771|NCT02008227|561990549|FG000|Overall Study|Withdrawal by Subject|67|||
155698772|NCT02008227|561990550|FG001|Overall Study|Withdrawal by Subject|36|||
155698773|NCT02008227|561990549|FG000|Overall Study|Study Terminated By Sponsor|44|||
155698774|NCT02008227|561990550|FG001|Overall Study|Study Terminated By Sponsor|83|||
155698775|NCT04599465|561990551|FG000|Overall Study|Physician Decision|1|||
155698776|NCT04599465|561990551|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
155698777|NCT00742417|561990552|FG000|Randomized|Withdrawal by legal representative|0|||
155698778|NCT00742417|561990553|FG001|Randomized|Withdrawal by legal representative|1|||
155698779|NCT00742417|561990552|FG000|Randomized|Withdrawal by Subject|1|||
155698780|NCT00742417|561990553|FG001|Randomized|Withdrawal by Subject|0|||
155698781|NCT00742417|561990552|FG000|Randomized|Physician Decision|1|||
155698782|NCT00742417|561990553|FG001|Randomized|Physician Decision|0|||
155698783|NCT00742417|561990552|FG000|Intensive Period|Withdrawal by Subject|1|||
155698784|NCT00742417|561990553|FG001|Intensive Period|Withdrawal by Subject|1|||
155698785|NCT00742417|561990552|FG000|Intensive Period|Adverse Event|2|||
155698786|NCT00742417|561990553|FG001|Intensive Period|Adverse Event|0|||
155698787|NCT00965575|561990558|FG000|Overall Study|subject unwillingness to swallow study c|1|||
155698788|NCT00965575|561990559|FG001|Overall Study|subject unwillingness to swallow study c|0|||
155698789|NCT01041287|561990562|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
155698790|NCT01041287|561990563|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
155698791|NCT01041287|561990562|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
155698792|NCT01041287|561990563|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
155698793|NCT03157583|561990565|FG000|Overall Study|Other (did not meet study criteria)|1|||
155698794|NCT01141478|561990566|FG000|Overall Study|Withdrawal by Subject|1|||
155698795|NCT01141478|561990567|FG001|Overall Study|Withdrawal by Subject|1|||
155698796|NCT00290498|561990572|FG000|Overall Study|Death|2|||
155698797|NCT00290498|561990573|FG001|Overall Study|Death|0|||
155698798|NCT00290498|561990572|FG000|Overall Study|Physician Decision|1|||
155698799|NCT00290498|561990573|FG001|Overall Study|Physician Decision|0|||
155698800|NCT00290498|561990572|FG000|Overall Study|Withdrawal by Subject|1|||
155698801|NCT00290498|561990573|FG001|Overall Study|Withdrawal by Subject|0|||
155698802|NCT00290498|561990572|FG000|Overall Study|Ineligible|3|||
155698803|NCT00290498|561990573|FG001|Overall Study|Ineligible|0|||
155698804|NCT00290498|561990572|FG000|Overall Study|Non-Compliance|1|||
155698805|NCT00290498|561990573|FG001|Overall Study|Non-Compliance|0|||
155698806|NCT00490022|561990576|FG000|Overall Study|Adverse Event|0|||
155698807|NCT00490022|561990577|FG001|Overall Study|Adverse Event|2|||
155698808|NCT00490022|561990576|FG000|Overall Study|Withdrawal by Subject|1|||
155698809|NCT00490022|561990577|FG001|Overall Study|Withdrawal by Subject|0|||
155698810|NCT00490022|561990576|FG000|Overall Study|Subject failed to disclose concommitant|0|||
155698811|NCT00490022|561990577|FG001|Overall Study|Subject failed to disclose concommitant|1|||
155698812|NCT04268173|561990578|FG000|Overall Study|Lost to Follow-up|75|||
155698813|NCT04268173|561990579|FG001|Overall Study|Lost to Follow-up|108|||
155698814|NCT00869401|561990580|FG000|Overall Study|Withdrawal by Subject|0|||
155698815|NCT00869401|561990581|FG001|Overall Study|Withdrawal by Subject|0|||
155698816|NCT00869401|561990582|FG002|Overall Study|Withdrawal by Subject|0|||
155698817|NCT00869401|561990583|FG003|Overall Study|Withdrawal by Subject|5|||
155698818|NCT00869401|561990584|FG004|Overall Study|Withdrawal by Subject|3|||
155698819|NCT00545103|561990585|FG000|Overall Study|Lack of Efficacy|48|||
155698820|NCT00545103|561990586|FG001|Overall Study|Lack of Efficacy|45|||
155698821|NCT00545103|561990587|FG002|Overall Study|Lack of Efficacy|31|||
155698822|NCT00545103|561990588|FG003|Overall Study|Lack of Efficacy|27|||
155698823|NCT00545103|561990585|FG000|Overall Study|Withdrawal by Subject|6|||
155698824|NCT00545103|561990586|FG001|Overall Study|Withdrawal by Subject|10|||
155698825|NCT00545103|561990587|FG002|Overall Study|Withdrawal by Subject|18|||
155698826|NCT00545103|561990588|FG003|Overall Study|Withdrawal by Subject|22|||
155698827|NCT00545103|561990585|FG000|Overall Study|Adverse Event|11|||
155698828|NCT00545103|561990586|FG001|Overall Study|Adverse Event|12|||
155698829|NCT00545103|561990587|FG002|Overall Study|Adverse Event|17|||
155698830|NCT00545103|561990588|FG003|Overall Study|Adverse Event|10|||
155698831|NCT00545103|561990585|FG000|Overall Study|Lost to Follow-up|4|||
155698832|NCT00545103|561990586|FG001|Overall Study|Lost to Follow-up|6|||
155698833|NCT00545103|561990587|FG002|Overall Study|Lost to Follow-up|3|||
155698834|NCT00545103|561990588|FG003|Overall Study|Lost to Follow-up|4|||
155698835|NCT00545103|561990585|FG000|Overall Study|Protocol Violation|1|||
155698836|NCT00545103|561990586|FG001|Overall Study|Protocol Violation|2|||
155698837|NCT00545103|561990587|FG002|Overall Study|Protocol Violation|3|||
155698838|NCT00545103|561990588|FG003|Overall Study|Protocol Violation|0|||
155698839|NCT00545103|561990585|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
155698840|NCT00545103|561990586|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
155698841|NCT00545103|561990587|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
155698842|NCT00545103|561990588|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
155698843|NCT00545103|561990585|FG000|Overall Study|Difficult to open package|0|||
155698844|NCT00545103|561990586|FG001|Overall Study|Difficult to open package|0|||
155698845|NCT00545103|561990587|FG002|Overall Study|Difficult to open package|0|||
155698846|NCT00545103|561990588|FG003|Overall Study|Difficult to open package|1|||
155698847|NCT00545103|561990585|FG000|Overall Study|Investigational product not taken|1|||
155698848|NCT00545103|561990586|FG001|Overall Study|Investigational product not taken|0|||
155698849|NCT00545103|561990587|FG002|Overall Study|Investigational product not taken|0|||
155698850|NCT00545103|561990588|FG003|Overall Study|Investigational product not taken|1|||
155698851|NCT00545103|561990585|FG000|Overall Study|Wish to start a family|0|||
155698852|NCT00545103|561990586|FG001|Overall Study|Wish to start a family|0|||
155698853|NCT00545103|561990587|FG002|Overall Study|Wish to start a family|0|||
155698854|NCT00545103|561990588|FG003|Overall Study|Wish to start a family|1|||
155698855|NCT00545103|561990585|FG000|Overall Study|Diverticulitis crisis|0|||
155698856|NCT00545103|561990586|FG001|Overall Study|Diverticulitis crisis|0|||
155698857|NCT00545103|561990587|FG002|Overall Study|Diverticulitis crisis|0|||
155698858|NCT00545103|561990588|FG003|Overall Study|Diverticulitis crisis|1|||
155698859|NCT00545103|561990585|FG000|Overall Study|Personal reasons|1|||
155698860|NCT00545103|561990586|FG001|Overall Study|Personal reasons|0|||
155698861|NCT00545103|561990587|FG002|Overall Study|Personal reasons|0|||
155698862|NCT00545103|561990588|FG003|Overall Study|Personal reasons|0|||
155698863|NCT00545103|561990585|FG000|Overall Study|Subject's decision|1|||
155698864|NCT00545103|561990586|FG001|Overall Study|Subject's decision|0|||
155698865|NCT00545103|561990587|FG002|Overall Study|Subject's decision|0|||
155698866|NCT00545103|561990588|FG003|Overall Study|Subject's decision|0|||
155698867|NCT00545103|561990585|FG000|Overall Study|Noncompliance|0|||
155698868|NCT00545103|561990586|FG001|Overall Study|Noncompliance|1|||
155698869|NCT00545103|561990587|FG002|Overall Study|Noncompliance|0|||
155698870|NCT00545103|561990588|FG003|Overall Study|Noncompliance|0|||
155698871|NCT00545103|561990585|FG000|Overall Study|Investigator decision|0|||
155698872|NCT00545103|561990586|FG001|Overall Study|Investigator decision|0|||
155698873|NCT00545103|561990587|FG002|Overall Study|Investigator decision|1|||
155698874|NCT00545103|561990588|FG003|Overall Study|Investigator decision|0|||
155698875|NCT00545103|561990585|FG000|Overall Study|Subject moved|0|||
155698876|NCT00545103|561990586|FG001|Overall Study|Subject moved|1|||
155698877|NCT00545103|561990587|FG002|Overall Study|Subject moved|0|||
155698878|NCT00545103|561990588|FG003|Overall Study|Subject moved|0|||
155698879|NCT00545103|561990585|FG000|Overall Study|Use of prohibited medication|0|||
155698880|NCT00545103|561990586|FG001|Overall Study|Use of prohibited medication|0|||
155698881|NCT00545103|561990587|FG002|Overall Study|Use of prohibited medication|1|||
155698882|NCT00545103|561990588|FG003|Overall Study|Use of prohibited medication|0|||
155698883|NCT00545103|561990585|FG000|Overall Study|Does not want to take study drug anymore|1|||
155698884|NCT00545103|561990586|FG001|Overall Study|Does not want to take study drug anymore|0|||
155698885|NCT00545103|561990587|FG002|Overall Study|Does not want to take study drug anymore|1|||
155698886|NCT00545103|561990588|FG003|Overall Study|Does not want to take study drug anymore|0|||
155698887|NCT00545103|561990585|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
155698888|NCT00545103|561990586|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
155698889|NCT00545103|561990587|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
155698890|NCT00545103|561990588|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
155698891|NCT00545103|561990585|FG000|Overall Study|Death|0|||
155698892|NCT00545103|561990586|FG001|Overall Study|Death|1|||
155698893|NCT00545103|561990587|FG002|Overall Study|Death|0|||
155698894|NCT00545103|561990588|FG003|Overall Study|Death|0|||
155698895|NCT01953913|561990589|FG000|Overall Study|Disease Progression|349|||
155698896|NCT01953913|561990589|FG000|Overall Study|Worsening of underlying cancer|22|||
155698897|NCT01953913|561990589|FG000|Overall Study|Adverse Event|20|||
155698898|NCT01953913|561990589|FG000|Overall Study|Protocol Violation|6|||
155698899|NCT01953913|561990589|FG000|Overall Study|Lost to Follow-up|4|||
155698900|NCT01953913|561990589|FG000|Overall Study|Withdrawal by Subject|32|||
155698901|NCT01953913|561990589|FG000|Overall Study|Other than listed|108|||
155698902|NCT01953913|561990589|FG000|Overall Study|Not Treated|1|||
155698903|NCT05026853|561990590|FG000|Overall Study|Cancelled appointment|1|||
155698904|NCT05026853|561990591|FG001|Overall Study|Cancelled appointment|0|||
155698905|NCT05026853|561990590|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
155698906|NCT05026853|561990591|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
155698907|NCT05026853|561990590|FG000|Overall Study|Did not complete 12-week survey|16|||
155698908|NCT05026853|561990591|FG001|Overall Study|Did not complete 12-week survey|16|||
155698909|NCT01732913|561990592|FG000|Overall Study|Study Terminated by Sponsor|105|||
155698910|NCT01732913|561990593|FG001|Overall Study|Study Terminated by Sponsor|55|||
155698911|NCT01732913|561990592|FG000|Overall Study|Withdrawal by Subject|27|||
155698912|NCT01732913|561990593|FG001|Overall Study|Withdrawal by Subject|4|||
155698913|NCT01732913|561990592|FG000|Overall Study|Physician Decision|14|||
155698914|NCT01732913|561990593|FG001|Overall Study|Physician Decision|7|||
155698915|NCT01732913|561990592|FG000|Overall Study|Other|7|||
155698916|NCT01732913|561990593|FG001|Overall Study|Other|1|||
155698917|NCT01732913|561990592|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
155698918|NCT01732913|561990593|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
155698919|NCT01353911|561990594|FG000|Overall Study|Lost to Follow-up|2|||
155698920|NCT01353911|561990595|FG001|Overall Study|Lost to Follow-up|6|||
155698921|NCT01353911|561990596|FG002|Overall Study|Lost to Follow-up|4|||
155698922|NCT01353911|561990597|FG003|Overall Study|Lost to Follow-up|0|||
155698923|NCT01353911|561990598|FG004|Overall Study|Lost to Follow-up|4|||
155698924|NCT01353911|561990599|FG005|Overall Study|Lost to Follow-up|4|||
155698925|NCT01353911|561990600|FG006|Overall Study|Lost to Follow-up|3|||
155698926|NCT01353911|561990601|FG007|Overall Study|Lost to Follow-up|6|||
155698927|NCT01353911|561990594|FG000|Overall Study|Withdrawal by Subject|2|||
155698928|NCT01353911|561990595|FG001|Overall Study|Withdrawal by Subject|3|||
155698929|NCT01353911|561990596|FG002|Overall Study|Withdrawal by Subject|4|||
155698930|NCT01353911|561990597|FG003|Overall Study|Withdrawal by Subject|2|||
155698931|NCT01353911|561990598|FG004|Overall Study|Withdrawal by Subject|2|||
155698932|NCT01353911|561990599|FG005|Overall Study|Withdrawal by Subject|3|||
155698933|NCT01353911|561990600|FG006|Overall Study|Withdrawal by Subject|3|||
155698934|NCT01353911|561990601|FG007|Overall Study|Withdrawal by Subject|9|||
155698935|NCT01353911|561990594|FG000|Overall Study|Status Not Recorded|4|||
155698936|NCT01353911|561990595|FG001|Overall Study|Status Not Recorded|0|||
155698937|NCT01353911|561990596|FG002|Overall Study|Status Not Recorded|1|||
155698938|NCT01353911|561990597|FG003|Overall Study|Status Not Recorded|0|||
155698939|NCT01353911|561990598|FG004|Overall Study|Status Not Recorded|0|||
155698940|NCT01353911|561990599|FG005|Overall Study|Status Not Recorded|0|||
155698941|NCT01353911|561990600|FG006|Overall Study|Status Not Recorded|0|||
155698942|NCT01353911|561990601|FG007|Overall Study|Status Not Recorded|0|||
155698943|NCT03233438|561990602|FG000|Overall Study|Lost to Follow-up|4|||
155698944|NCT03233438|561990603|FG001|Overall Study|Lost to Follow-up|9|||
155698945|NCT03233438|561990602|FG000|Overall Study|Withdrawal by Subject|2|||
155698946|NCT03233438|561990603|FG001|Overall Study|Withdrawal by Subject|1|||
155698947|NCT03233438|561990602|FG000|Overall Study|No recording of dalbavancin|0|||
155698948|NCT03233438|561990603|FG001|Overall Study|No recording of dalbavancin|1|||
155698949|NCT02925741|561990605|FG000|Overall Study|Withdrawal by Subject|11|||
155698950|NCT02925741|561990606|FG001|Overall Study|Withdrawal by Subject|0|||
155698951|NCT00413374|561990609|FG000|Overall Study|Ineligible due to screening criteria.|3|||
155698952|NCT00413374|561990610|FG001|Overall Study|Ineligible due to screening criteria.|0|||
155698953|NCT00413374|561990609|FG000|Overall Study|Adverse Event|1|||
155698954|NCT00413374|561990610|FG001|Overall Study|Adverse Event|0|||
155698955|NCT00413374|561990609|FG000|Overall Study|Lost to Follow-up|1|||
155698956|NCT00413374|561990610|FG001|Overall Study|Lost to Follow-up|0|||
155698957|NCT00413374|561990609|FG000|Overall Study|Surgery|1|||
155698958|NCT00413374|561990610|FG001|Overall Study|Surgery|0|||
155698959|NCT02345330|561990614|FG000|Overall Study|Death|1|||
155698960|NCT02345330|561990614|FG000|Overall Study|Progressive Disease|2|||
155698961|NCT00494507|561990615|FG000|Double-Blind Phase|Adverse Event|2|||
155698962|NCT00494507|561990616|FG001|Double-Blind Phase|Adverse Event|0|||
155698963|NCT00494507|561990617|FG002|Double-Blind Phase|Adverse Event|1|||
155698964|NCT00494507|561990618|FG003|Double-Blind Phase|Adverse Event|0|||
155698965|NCT00494507|561990615|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
155698966|NCT00494507|561990616|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
155698967|NCT00494507|561990617|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155698968|NCT00494507|561990618|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155698969|NCT00494507|561990615|FG000|Double-Blind Phase|Subject Non-compliance|0|||
155698970|NCT00494507|561990616|FG001|Double-Blind Phase|Subject Non-compliance|0|||
155698971|NCT00494507|561990617|FG002|Double-Blind Phase|Subject Non-compliance|1|||
155698972|NCT00494507|561990618|FG003|Double-Blind Phase|Subject Non-compliance|0|||
155698973|NCT00494507|561990615|FG000|Double-Blind Phase|Negative DNA test|0|||
155698974|NCT00494507|561990616|FG001|Double-Blind Phase|Negative DNA test|0|||
155698975|NCT00494507|561990617|FG002|Double-Blind Phase|Negative DNA test|0|||
155698976|NCT00494507|561990618|FG003|Double-Blind Phase|Negative DNA test|1|||
155698977|NCT00494507|561990615|FG000|Open-Label Phase|Adverse Event|0|||
155698978|NCT00494507|561990616|FG001|Open-Label Phase|Adverse Event|1|||
155698979|NCT00494507|561990617|FG002|Open-Label Phase|Adverse Event|5|||
155698980|NCT00494507|561990618|FG003|Open-Label Phase|Adverse Event|3|||
155698981|NCT00494507|561990615|FG000|Open-Label Phase|Worsening Disease|0|||
155698982|NCT00494507|561990616|FG001|Open-Label Phase|Worsening Disease|0|||
155698983|NCT00494507|561990617|FG002|Open-Label Phase|Worsening Disease|0|||
155698984|NCT00494507|561990618|FG003|Open-Label Phase|Worsening Disease|2|||
155698985|NCT03831945|561990621|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
155698986|NCT03831945|561990622|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
155698987|NCT03831945|561990621|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
155698988|NCT03831945|561990622|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
155698989|NCT03831945|561990621|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
155698990|NCT03831945|561990622|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
155698991|NCT00295932|561990623|FG000|Overall Study|Not Treated|0|||
155698992|NCT00295932|561990624|FG001|Overall Study|Not Treated|0|||
155698993|NCT00295932|561990625|FG002|Overall Study|Not Treated|0|||
155698994|NCT00295932|561990626|FG003|Overall Study|Not Treated|0|||
155698995|NCT00295932|561990627|FG004|Overall Study|Not Treated|0|||
155698996|NCT00295932|561990628|FG005|Overall Study|Not Treated|0|||
155698997|NCT00295932|561990629|FG006|Overall Study|Not Treated|0|||
155698998|NCT00295932|561990630|FG007|Overall Study|Not Treated|0|||
155698999|NCT00295932|561990631|FG008|Overall Study|Not Treated|0|||
155699000|NCT00295932|561990632|FG009|Overall Study|Not Treated|0|||
155699001|NCT00295932|561990633|FG010|Overall Study|Not Treated|1|||
155699002|NCT00454181|561990634|FG000|Overall Study|Adverse Event|1|||
155699003|NCT00454181|561990635|FG001|Overall Study|Adverse Event|1|||
155699004|NCT00454181|561990634|FG000|Overall Study|Lost to Follow-up|11|||
155699005|NCT00454181|561990635|FG001|Overall Study|Lost to Follow-up|1|||
155699006|NCT00454181|561990634|FG000|Overall Study|Protocol Violation|1|||
155699007|NCT00454181|561990635|FG001|Overall Study|Protocol Violation|1|||
155699008|NCT00454181|561990634|FG000|Overall Study|Withdrawal by Subject|2|||
155699009|NCT00454181|561990635|FG001|Overall Study|Withdrawal by Subject|0|||
155699010|NCT02613169|561990636|FG000|Overall Study|Withdrawal by Subject|4|||
155699011|NCT02613169|561990637|FG001|Overall Study|Withdrawal by Subject|1|||
155699012|NCT02613169|561990636|FG000|Overall Study|Lost to Follow-up|0|||
155699013|NCT02613169|561990637|FG001|Overall Study|Lost to Follow-up|5|||
155699014|NCT02613169|561990636|FG000|Overall Study|HIV|0|||
155699015|NCT02613169|561990637|FG001|Overall Study|HIV|2|||
155699016|NCT02613169|561990636|FG000|Overall Study|No TB infection endpoint|14|||
155699017|NCT02613169|561990637|FG001|Overall Study|No TB infection endpoint|9|||
155699018|NCT03729245|561990638|FG000|Overall Study|Lost to Follow-up|5|||
155699019|NCT03729245|561990639|FG001|Overall Study|Lost to Follow-up|6|||
155699020|NCT03729245|561990638|FG000|Overall Study|Withdrawal by Subject|16|||
155699021|NCT03729245|561990639|FG001|Overall Study|Withdrawal by Subject|19|||
155699022|NCT03729245|561990638|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
155699023|NCT03729245|561990639|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
155699024|NCT00884832|561990640|FG000|Overall Study|Withdrawal by Subject|0|||
155699025|NCT00884832|561990641|FG001|Overall Study|Withdrawal by Subject|1|||
155699026|NCT02096263|561990642|FG000|Overall Study|Adverse Event|1|||
155699027|NCT02096263|561990643|FG001|Overall Study|Adverse Event|0|||
155699028|NCT02096263|561990644|FG002|Overall Study|Adverse Event|1|||
155699029|NCT02096263|561990642|FG000|Overall Study|Lost to Follow-up|14|||
155699030|NCT02096263|561990643|FG001|Overall Study|Lost to Follow-up|18|||
155699031|NCT02096263|561990644|FG002|Overall Study|Lost to Follow-up|15|||
155699032|NCT02096263|561990642|FG000|Overall Study|Other|7|||
155699033|NCT02096263|561990643|FG001|Overall Study|Other|9|||
155699034|NCT02096263|561990644|FG002|Overall Study|Other|6|||
155699035|NCT02096263|561990642|FG000|Overall Study|Sponsor study termination|0|||
155699036|NCT02096263|561990643|FG001|Overall Study|Sponsor study termination|0|||
155699037|NCT02096263|561990644|FG002|Overall Study|Sponsor study termination|1|||
155699038|NCT02096263|561990642|FG000|Overall Study|Protocol Violation|7|||
155699039|NCT02096263|561990643|FG001|Overall Study|Protocol Violation|2|||
155699040|NCT02096263|561990644|FG002|Overall Study|Protocol Violation|8|||
155699041|NCT02096263|561990642|FG000|Overall Study|Withdrawal by Subject|5|||
155699042|NCT02096263|561990643|FG001|Overall Study|Withdrawal by Subject|7|||
155699043|NCT02096263|561990644|FG002|Overall Study|Withdrawal by Subject|8|||
155699044|NCT00500760|561990652|FG000|Overall Study|Death|32|||
155699045|NCT00500760|561990653|FG001|Overall Study|Death|15|||
155699046|NCT00500760|561990652|FG000|Overall Study|Withdrawal by Subject|5|||
155699047|NCT00500760|561990653|FG001|Overall Study|Withdrawal by Subject|7|||
155699048|NCT00500760|561990652|FG000|Overall Study|Administrative decision|2|||
155699049|NCT00500760|561990653|FG001|Overall Study|Administrative decision|0|||
155699050|NCT00500760|561990652|FG000|Overall Study|Lost to Follow-up|3|||
155699051|NCT00500760|561990653|FG001|Overall Study|Lost to Follow-up|0|||
155699052|NCT00500760|561990652|FG000|Overall Study|Other|1|||
155699053|NCT00500760|561990653|FG001|Overall Study|Other|2|||
155699054|NCT03178669|561990654|FG000|Overall Study|Adverse Event|4|||
155699055|NCT03178669|561990655|FG001|Overall Study|Adverse Event|1|||
155699056|NCT03178669|561990656|FG002|Overall Study|Adverse Event|4|||
155699057|NCT03178669|561990657|FG003|Overall Study|Adverse Event|2|||
155699058|NCT03178669|561990658|FG004|Overall Study|Adverse Event|2|||
155699059|NCT03178669|561990654|FG000|Overall Study|Lack of Efficacy|0|||
155699060|NCT03178669|561990655|FG001|Overall Study|Lack of Efficacy|0|||
155699061|NCT03178669|561990656|FG002|Overall Study|Lack of Efficacy|2|||
155699062|NCT03178669|561990657|FG003|Overall Study|Lack of Efficacy|0|||
155699063|NCT03178669|561990658|FG004|Overall Study|Lack of Efficacy|1|||
155699064|NCT03178669|561990654|FG000|Overall Study|Physician Decision|0|||
155699065|NCT03178669|561990655|FG001|Overall Study|Physician Decision|0|||
155699066|NCT03178669|561990656|FG002|Overall Study|Physician Decision|0|||
155699067|NCT03178669|561990657|FG003|Overall Study|Physician Decision|0|||
155699068|NCT03178669|561990658|FG004|Overall Study|Physician Decision|1|||
155699069|NCT03178669|561990654|FG000|Overall Study|Withdrawal by Subject|1|||
155699070|NCT03178669|561990655|FG001|Overall Study|Withdrawal by Subject|0|||
155699071|NCT03178669|561990656|FG002|Overall Study|Withdrawal by Subject|1|||
155699072|NCT03178669|561990657|FG003|Overall Study|Withdrawal by Subject|1|||
155699073|NCT03178669|561990658|FG004|Overall Study|Withdrawal by Subject|0|||
155699074|NCT03178669|561990654|FG000|Overall Study|Lost to Follow-up|0|||
155699075|NCT03178669|561990655|FG001|Overall Study|Lost to Follow-up|0|||
155699076|NCT03178669|561990656|FG002|Overall Study|Lost to Follow-up|0|||
155699077|NCT03178669|561990657|FG003|Overall Study|Lost to Follow-up|1|||
155699078|NCT03178669|561990658|FG004|Overall Study|Lost to Follow-up|0|||
155699079|NCT00079677|561990660|FG000|Overall Study|Adverse Event|5|||
155699080|NCT00079677|561990661|FG001|Overall Study|Adverse Event|6|||
155699081|NCT00079677|561990660|FG000|Overall Study|Lack of Efficacy|1|||
155699082|NCT00079677|561990661|FG001|Overall Study|Lack of Efficacy|0|||
155699083|NCT00079677|561990660|FG000|Overall Study|Lost to Follow-up|2|||
155699084|NCT00079677|561990661|FG001|Overall Study|Lost to Follow-up|2|||
155699085|NCT00079677|561990660|FG000|Overall Study|Physician Decision|3|||
155699086|NCT00079677|561990661|FG001|Overall Study|Physician Decision|0|||
155699087|NCT00079677|561990660|FG000|Overall Study|Protocol Violation|2|||
155699088|NCT00079677|561990661|FG001|Overall Study|Protocol Violation|3|||
155699089|NCT00079677|561990660|FG000|Overall Study|Withdrawal by Subject|5|||
155699090|NCT00079677|561990661|FG001|Overall Study|Withdrawal by Subject|3|||
155699091|NCT00079677|561990660|FG000|Overall Study|Miscellaneous|2|||
155699092|NCT00079677|561990661|FG001|Overall Study|Miscellaneous|0|||
155699093|NCT01300455|561990662|FG000|Washout|Withdrawal by Subject|1|||
155699094|NCT01300455|561990663|FG001|Washout|Withdrawal by Subject|0|||
155699095|NCT03332160|561990664|FG000|Overall Study|Withdrawal by Subject|1|||
155699096|NCT03332160|561990665|FG001|Overall Study|Withdrawal by Subject|1|||
155699097|NCT03332160|561990664|FG000|Overall Study|Adverse Event|0|||
155699098|NCT03332160|561990665|FG001|Overall Study|Adverse Event|1|||
155699099|NCT03332160|561990664|FG000|Overall Study|Developed Exclusion Criteria|0|||
155699100|NCT03332160|561990665|FG001|Overall Study|Developed Exclusion Criteria|1|||
155699101|NCT03332160|561990664|FG000|Overall Study|Non-adherence to treatment|0|||
155699102|NCT03332160|561990665|FG001|Overall Study|Non-adherence to treatment|2|||
155699103|NCT01459913|561990668|FG000|Overall Study|Adverse Event|0|||
155699104|NCT01459913|561990669|FG001|Overall Study|Adverse Event|0|||
155699105|NCT01459913|561990670|FG002|Overall Study|Adverse Event|0|||
155699106|NCT01459913|561990671|FG003|Overall Study|Adverse Event|3|||
155699107|NCT01459913|561990668|FG000|Overall Study|Withdrawal by Subject|4|||
155699108|NCT01459913|561990669|FG001|Overall Study|Withdrawal by Subject|0|||
155699109|NCT01459913|561990670|FG002|Overall Study|Withdrawal by Subject|0|||
155699110|NCT01459913|561990671|FG003|Overall Study|Withdrawal by Subject|5|||
155699111|NCT01459913|561990668|FG000|Overall Study|Lost to Follow-up|7|||
155699112|NCT01459913|561990669|FG001|Overall Study|Lost to Follow-up|4|||
155699113|NCT01459913|561990670|FG002|Overall Study|Lost to Follow-up|1|||
155699114|NCT01459913|561990671|FG003|Overall Study|Lost to Follow-up|8|||
155699115|NCT01459913|561990668|FG000|Overall Study|Death|0|||
155699116|NCT01459913|561990669|FG001|Overall Study|Death|0|||
155699117|NCT01459913|561990670|FG002|Overall Study|Death|0|||
155699118|NCT01459913|561990671|FG003|Overall Study|Death|1|||
155699119|NCT01459913|561990668|FG000|Overall Study|Non- Compliance|0|||
155699120|NCT01459913|561990669|FG001|Overall Study|Non- Compliance|0|||
155699121|NCT01459913|561990670|FG002|Overall Study|Non- Compliance|0|||
155699122|NCT01459913|561990671|FG003|Overall Study|Non- Compliance|3|||
155699123|NCT01459913|561990668|FG000|Overall Study|Physician Decision|0|||
155699124|NCT01459913|561990669|FG001|Overall Study|Physician Decision|1|||
155699125|NCT01459913|561990670|FG002|Overall Study|Physician Decision|0|||
155699126|NCT01459913|561990671|FG003|Overall Study|Physician Decision|0|||
155699127|NCT01459913|561990668|FG000|Overall Study|Study Terminated by Sponsor|30|||
155699128|NCT01459913|561990669|FG001|Overall Study|Study Terminated by Sponsor|15|||
155699129|NCT01459913|561990670|FG002|Overall Study|Study Terminated by Sponsor|9|||
155699130|NCT01459913|561990671|FG003|Overall Study|Study Terminated by Sponsor|11|||
155699131|NCT01459913|561990668|FG000|Overall Study|Other|0|||
155699132|NCT01459913|561990669|FG001|Overall Study|Other|0|||
155699133|NCT01459913|561990670|FG002|Overall Study|Other|3|||
155699134|NCT01459913|561990671|FG003|Overall Study|Other|1|||
155699135|NCT01459913|561990668|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
155699136|NCT01459913|561990669|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
155699137|NCT01459913|561990670|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
155699138|NCT01459913|561990671|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
155699139|NCT00454649|561990674|FG000|Overall Study|Lack of Efficacy|2|||
155699140|NCT00454649|561990675|FG001|Overall Study|Lack of Efficacy|2|||
155699141|NCT00454649|561990676|FG002|Overall Study|Lack of Efficacy|10|||
155699142|NCT00454649|561990677|FG003|Overall Study|Lack of Efficacy|3|||
155699143|NCT00454649|561990678|FG004|Overall Study|Lack of Efficacy|0|||
155699144|NCT00454649|561990679|FG005|Overall Study|Lack of Efficacy|4|||
155699145|NCT00454649|561990680|FG006|Overall Study|Lack of Efficacy|5|||
155699146|NCT00454649|561990681|FG007|Overall Study|Lack of Efficacy|13|||
155699147|NCT00454649|561990682|FG008|Overall Study|Lack of Efficacy|10|||
155699148|NCT00454649|561990683|FG009|Overall Study|Lack of Efficacy|2|||
155699149|NCT00454649|561990674|FG000|Overall Study|Adverse Event|0|||
155699150|NCT00454649|561990675|FG001|Overall Study|Adverse Event|1|||
155699151|NCT00454649|561990676|FG002|Overall Study|Adverse Event|3|||
155699152|NCT00454649|561990677|FG003|Overall Study|Adverse Event|0|||
155699153|NCT00454649|561990678|FG004|Overall Study|Adverse Event|1|||
155699154|NCT00454649|561990679|FG005|Overall Study|Adverse Event|2|||
155699155|NCT00454649|561990680|FG006|Overall Study|Adverse Event|3|||
155699156|NCT00454649|561990681|FG007|Overall Study|Adverse Event|4|||
155699157|NCT00454649|561990682|FG008|Overall Study|Adverse Event|6|||
155699158|NCT00454649|561990683|FG009|Overall Study|Adverse Event|2|||
155699159|NCT00454649|561990674|FG000|Overall Study|Lost to Follow-up|0|||
155699160|NCT00454649|561990675|FG001|Overall Study|Lost to Follow-up|0|||
155699161|NCT00454649|561990676|FG002|Overall Study|Lost to Follow-up|1|||
155699162|NCT00454649|561990677|FG003|Overall Study|Lost to Follow-up|0|||
155699163|NCT00454649|561990678|FG004|Overall Study|Lost to Follow-up|0|||
155699164|NCT00454649|561990679|FG005|Overall Study|Lost to Follow-up|0|||
155699165|NCT00454649|561990680|FG006|Overall Study|Lost to Follow-up|1|||
155699166|NCT00454649|561990681|FG007|Overall Study|Lost to Follow-up|0|||
155699167|NCT00454649|561990682|FG008|Overall Study|Lost to Follow-up|0|||
155699168|NCT00454649|561990683|FG009|Overall Study|Lost to Follow-up|0|||
155699169|NCT00454649|561990674|FG000|Overall Study|Other|1|||
155699170|NCT00454649|561990675|FG001|Overall Study|Other|1|||
155699171|NCT00454649|561990676|FG002|Overall Study|Other|5|||
155699172|NCT00454649|561990677|FG003|Overall Study|Other|3|||
155699173|NCT00454649|561990678|FG004|Overall Study|Other|0|||
155699174|NCT00454649|561990679|FG005|Overall Study|Other|0|||
155699175|NCT00454649|561990680|FG006|Overall Study|Other|0|||
155699176|NCT00454649|561990681|FG007|Overall Study|Other|0|||
155699177|NCT00454649|561990682|FG008|Overall Study|Other|3|||
155699178|NCT00454649|561990683|FG009|Overall Study|Other|1|||
155699179|NCT00454649|561990674|FG000|Overall Study|Withdrawal by Subject|0|||
155699180|NCT00454649|561990675|FG001|Overall Study|Withdrawal by Subject|0|||
155699181|NCT00454649|561990676|FG002|Overall Study|Withdrawal by Subject|0|||
155699182|NCT00454649|561990677|FG003|Overall Study|Withdrawal by Subject|0|||
155699183|NCT00454649|561990678|FG004|Overall Study|Withdrawal by Subject|0|||
155699184|NCT00454649|561990679|FG005|Overall Study|Withdrawal by Subject|1|||
155699185|NCT00454649|561990680|FG006|Overall Study|Withdrawal by Subject|0|||
155699186|NCT00454649|561990681|FG007|Overall Study|Withdrawal by Subject|2|||
155699187|NCT00454649|561990682|FG008|Overall Study|Withdrawal by Subject|1|||
155699188|NCT00454649|561990683|FG009|Overall Study|Withdrawal by Subject|0|||
155699189|NCT02925728|561990684|FG000|Overall Study|Death|3|||
155699190|NCT02925728|561990685|FG001|Overall Study|Death|5|||
155699191|NCT02925728|561990684|FG000|Overall Study|Physician Decision|1|||
155699192|NCT02925728|561990685|FG001|Overall Study|Physician Decision|0|||
155699193|NCT02925728|561990684|FG000|Overall Study|Withdrawal by Subject|1|||
155699194|NCT02925728|561990685|FG001|Overall Study|Withdrawal by Subject|0|||
155699195|NCT00086411|561990688|FG000|Overall Study|Lost to Follow-up|11|||
155699196|NCT00086411|561990689|FG001|Overall Study|Lost to Follow-up|11|||
155699197|NCT00086411|561990690|FG002|Overall Study|Lost to Follow-up|13|||
155699198|NCT00086411|561990691|FG003|Overall Study|Lost to Follow-up|12|||
155699199|NCT00718770|561990692|FG000|Overall Study|Adverse Event|1|||
155699200|NCT00718770|561990692|FG000|Overall Study|Lack of Efficacy|1|||
155699201|NCT00718770|561990692|FG000|Overall Study|Lack of Efficacy|1|||
155699202|NCT00718770|561990692|FG000|Overall Study|Adverse Event|1|||
155699203|NCT00718770|561990692|FG000|Overall Study|Lack of Efficacy|1|||
155699204|NCT00718770|561990692|FG000|Overall Study|Adverse Event|1|||
155699205|NCT00718770|561990692|FG000|Overall Study|Lack of Efficacy|1|||
155699206|NCT00718770|561990692|FG000|Overall Study|Adverse Event|1|||
155699207|NCT02540291|561990698|FG000|Overall Study|Death|7|||
155699208|NCT02540291|561990699|FG001|Overall Study|Death|7|||
155699209|NCT02540291|561990700|FG002|Overall Study|Death|5|||
155699210|NCT02540291|561990701|FG003|Overall Study|Death|7|||
155699211|NCT02540291|561990698|FG000|Overall Study|Lost to Follow-up|0|||
155699212|NCT02540291|561990699|FG001|Overall Study|Lost to Follow-up|0|||
155699213|NCT02540291|561990700|FG002|Overall Study|Lost to Follow-up|1|||
155699214|NCT02540291|561990701|FG003|Overall Study|Lost to Follow-up|0|||
155699215|NCT02540291|561990698|FG000|Overall Study|Withdrawal Of Consent|0|||
155699216|NCT02540291|561990699|FG001|Overall Study|Withdrawal Of Consent|1|||
155699217|NCT02540291|561990700|FG002|Overall Study|Withdrawal Of Consent|0|||
155699218|NCT02540291|561990701|FG003|Overall Study|Withdrawal Of Consent|0|||
155699219|NCT02540291|561990698|FG000|Overall Study|Study Terminated By Sponsor|1|||
155699220|NCT02540291|561990699|FG001|Overall Study|Study Terminated By Sponsor|0|||
155699221|NCT02540291|561990700|FG002|Overall Study|Study Terminated By Sponsor|0|||
155699222|NCT02540291|561990701|FG003|Overall Study|Study Terminated By Sponsor|0|||
155699223|NCT02540291|561990698|FG000|Overall Study|Other|0|||
155699224|NCT02540291|561990699|FG001|Overall Study|Other|0|||
155699225|NCT02540291|561990700|FG002|Overall Study|Other|1|||
155699226|NCT02540291|561990701|FG003|Overall Study|Other|0|||
155699227|NCT01879072|561990715|FG000|Overall Study|Withdrawal by Subject|121|||
155699228|NCT01879072|561990715|FG000|Overall Study|Not Transplanted|30|||
155699229|NCT04667104|561990724|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
155699230|NCT04667104|561990725|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
155699231|NCT04667104|561990726|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
155699232|NCT02666105|561990727|FG000|Overall Study|Death|1|||
155699233|NCT01078168|561990728|FG000|Overall Study|Physician Decision|0|||
155699234|NCT01078168|561990729|FG001|Overall Study|Physician Decision|1|||
155699235|NCT01264419|561990731|FG000|Overall Study|Lost to Follow-up|3|||
155699236|NCT02814175|561992376|FG000|Part 1|Adverse Event|2|||
155699237|NCT02814175|561992377|FG001|Part 1|Adverse Event|3|||
155699238|NCT02814175|561992378|FG002|Part 1|Adverse Event|0|||
155699239|NCT02814175|561992379|FG003|Part 1|Adverse Event|0|||
155699240|NCT02814175|561992380|FG004|Part 1|Adverse Event|0|||
155699241|NCT02814175|561992381|FG005|Part 1|Adverse Event|0|||
155699242|NCT02814175|561992376|FG000|Part 1|Withdrawal Consent|8|||
155699243|NCT02814175|561992377|FG001|Part 1|Withdrawal Consent|1|||
155699244|NCT02814175|561992378|FG002|Part 1|Withdrawal Consent|0|||
155699245|NCT02814175|561992379|FG003|Part 1|Withdrawal Consent|0|||
155699246|NCT02814175|561992380|FG004|Part 1|Withdrawal Consent|0|||
155699247|NCT02814175|561992381|FG005|Part 1|Withdrawal Consent|0|||
155699248|NCT02814175|561992376|FG000|Part 1|Lost to Follow-up|1|||
155699249|NCT02814175|561992377|FG001|Part 1|Lost to Follow-up|0|||
155699250|NCT02814175|561992378|FG002|Part 1|Lost to Follow-up|0|||
155699251|NCT02814175|561992379|FG003|Part 1|Lost to Follow-up|0|||
155699252|NCT02814175|561992380|FG004|Part 1|Lost to Follow-up|0|||
155699253|NCT02814175|561992381|FG005|Part 1|Lost to Follow-up|0|||
155699254|NCT02814175|561992376|FG000|Part 1|Lack of Efficacy|1|||
155699255|NCT02814175|561992377|FG001|Part 1|Lack of Efficacy|2|||
155699256|NCT02814175|561992378|FG002|Part 1|Lack of Efficacy|0|||
155699257|NCT02814175|561992379|FG003|Part 1|Lack of Efficacy|0|||
155699258|NCT02814175|561992380|FG004|Part 1|Lack of Efficacy|0|||
155699259|NCT02814175|561992381|FG005|Part 1|Lack of Efficacy|0|||
155699260|NCT02814175|561992376|FG000|Part 2|Adverse Event|0|||
155699261|NCT02814175|561992377|FG001|Part 2|Adverse Event|0|||
155699262|NCT02814175|561992378|FG002|Part 2|Adverse Event|0|||
155699263|NCT02814175|561992379|FG003|Part 2|Adverse Event|1|||
155699264|NCT02814175|561992380|FG004|Part 2|Adverse Event|1|||
155699265|NCT02814175|561992381|FG005|Part 2|Adverse Event|2|||
155699266|NCT02814175|561992376|FG000|Part 2|Withdrawal Consent|0|||
155699267|NCT02814175|561992377|FG001|Part 2|Withdrawal Consent|0|||
155699268|NCT02814175|561992378|FG002|Part 2|Withdrawal Consent|0|||
155699269|NCT02814175|561992379|FG003|Part 2|Withdrawal Consent|2|||
155699270|NCT02814175|561992380|FG004|Part 2|Withdrawal Consent|1|||
155699271|NCT02814175|561992381|FG005|Part 2|Withdrawal Consent|1|||
155699272|NCT02814175|561992376|FG000|Part 2|Lost to Follow-up|0|||
155699273|NCT02814175|561992377|FG001|Part 2|Lost to Follow-up|0|||
155699274|NCT02814175|561992378|FG002|Part 2|Lost to Follow-up|0|||
155699275|NCT02814175|561992379|FG003|Part 2|Lost to Follow-up|1|||
155699276|NCT02814175|561992380|FG004|Part 2|Lost to Follow-up|0|||
155699277|NCT02814175|561992381|FG005|Part 2|Lost to Follow-up|0|||
155699278|NCT02814175|561992376|FG000|Part 2|Lack of Efficacy|0|||
155699279|NCT02814175|561992377|FG001|Part 2|Lack of Efficacy|0|||
155699280|NCT02814175|561992378|FG002|Part 2|Lack of Efficacy|0|||
155699281|NCT02814175|561992379|FG003|Part 2|Lack of Efficacy|0|||
155699282|NCT02814175|561992380|FG004|Part 2|Lack of Efficacy|0|||
155699283|NCT02814175|561992381|FG005|Part 2|Lack of Efficacy|3|||
155699284|NCT01971008|561992386|FG000|Overall Study|Protocol Violation|2|||
155699285|NCT01971008|561992387|FG001|Overall Study|Protocol Violation|1|||
155699286|NCT00924508|561992388|FG000|Overall Study|Withdrawal by Subject|3|||
155699287|NCT03775512|561992389|FG000|Overall Study|Death|1|||
155699288|NCT03775512|561992390|FG001|Overall Study|Death|1|||
155699289|NCT03775512|561992389|FG000|Overall Study|Withdrawal by Subject|7|||
155699290|NCT03775512|561992390|FG001|Overall Study|Withdrawal by Subject|4|||
155699291|NCT03775512|561992389|FG000|Overall Study|Lost to Follow-up|5|||
155699292|NCT03775512|561992390|FG001|Overall Study|Lost to Follow-up|5|||
155699293|NCT03775512|561992389|FG000|Overall Study|Excluded before Catheter insertion|14|||
155699294|NCT03775512|561992390|FG001|Overall Study|Excluded before Catheter insertion|5|||
155699295|NCT03775512|561992389|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
155699296|NCT03775512|561992390|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
155699297|NCT03775512|561992389|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
155699298|NCT03775512|561992390|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
155699299|NCT03679624|561992391|FG000|Overall Study|Adverse Event|1|||
155699300|NCT03679624|561992392|FG001|Overall Study|Adverse Event|0|||
155699301|NCT01610336|561992393|FG000|Overall Study|Progressive Disease|4|||
155699302|NCT01610336|561992394|FG001|Overall Study|Progressive Disease|6|||
155699303|NCT01610336|561992395|FG002|Overall Study|Progressive Disease|6|||
155699304|NCT01610336|561992396|FG003|Overall Study|Progressive Disease|5|||
155699305|NCT01610336|561992397|FG004|Overall Study|Progressive Disease|3|||
155699306|NCT01610336|561992398|FG005|Overall Study|Progressive Disease|10|||
155699307|NCT01610336|561992399|FG006|Overall Study|Progressive Disease|1|||
155699308|NCT01610336|561992400|FG007|Overall Study|Progressive Disease|6|||
155699309|NCT01610336|561992401|FG008|Overall Study|Progressive Disease|6|||
155699310|NCT01610336|561992402|FG009|Overall Study|Progressive Disease|40|||
155699311|NCT01610336|561992403|FG010|Overall Study|Progressive Disease|36|||
155699312|NCT01610336|561992393|FG000|Overall Study|Adverse Event|0|||
155699313|NCT01610336|561992394|FG001|Overall Study|Adverse Event|0|||
155699314|NCT01610336|561992395|FG002|Overall Study|Adverse Event|0|||
155699315|NCT01610336|561992396|FG003|Overall Study|Adverse Event|1|||
155699316|NCT01610336|561992397|FG004|Overall Study|Adverse Event|1|||
155699317|NCT01610336|561992398|FG005|Overall Study|Adverse Event|1|||
155699318|NCT01610336|561992399|FG006|Overall Study|Adverse Event|0|||
155699319|NCT01610336|561992400|FG007|Overall Study|Adverse Event|0|||
155699320|NCT01610336|561992401|FG008|Overall Study|Adverse Event|2|||
155699321|NCT01610336|561992402|FG009|Overall Study|Adverse Event|8|||
155699322|NCT01610336|561992403|FG010|Overall Study|Adverse Event|6|||
155699323|NCT01610336|561992393|FG000|Overall Study|Subject/Guardian decision|1|||
155699324|NCT01610336|561992394|FG001|Overall Study|Subject/Guardian decision|1|||
155699325|NCT01610336|561992395|FG002|Overall Study|Subject/Guardian decision|0|||
155699326|NCT01610336|561992396|FG003|Overall Study|Subject/Guardian decision|1|||
155699327|NCT01610336|561992397|FG004|Overall Study|Subject/Guardian decision|0|||
155699328|NCT01610336|561992398|FG005|Overall Study|Subject/Guardian decision|0|||
155699329|NCT01610336|561992399|FG006|Overall Study|Subject/Guardian decision|0|||
155699330|NCT01610336|561992400|FG007|Overall Study|Subject/Guardian decision|1|||
155699331|NCT01610336|561992401|FG008|Overall Study|Subject/Guardian decision|0|||
155699332|NCT01610336|561992402|FG009|Overall Study|Subject/Guardian decision|2|||
155699333|NCT01610336|561992403|FG010|Overall Study|Subject/Guardian decision|2|||
155699334|NCT01610336|561992393|FG000|Overall Study|Death|0|||
155699335|NCT01610336|561992394|FG001|Overall Study|Death|0|||
155699336|NCT01610336|561992395|FG002|Overall Study|Death|0|||
155699337|NCT01610336|561992396|FG003|Overall Study|Death|0|||
155699338|NCT01610336|561992397|FG004|Overall Study|Death|0|||
155699339|NCT01610336|561992398|FG005|Overall Study|Death|1|||
155699340|NCT01610336|561992399|FG006|Overall Study|Death|3|||
155699341|NCT01610336|561992400|FG007|Overall Study|Death|0|||
155699342|NCT01610336|561992401|FG008|Overall Study|Death|0|||
155699343|NCT01610336|561992402|FG009|Overall Study|Death|1|||
155699344|NCT01610336|561992403|FG010|Overall Study|Death|2|||
155699345|NCT01610336|561992393|FG000|Overall Study|Non-Compliance with study treatment|0|||
155699346|NCT01610336|561992394|FG001|Overall Study|Non-Compliance with study treatment|0|||
155699347|NCT01610336|561992395|FG002|Overall Study|Non-Compliance with study treatment|0|||
155699348|NCT01610336|561992396|FG003|Overall Study|Non-Compliance with study treatment|0|||
155699349|NCT01610336|561992397|FG004|Overall Study|Non-Compliance with study treatment|0|||
155699350|NCT01610336|561992398|FG005|Overall Study|Non-Compliance with study treatment|0|||
155699351|NCT01610336|561992399|FG006|Overall Study|Non-Compliance with study treatment|0|||
155699352|NCT01610336|561992400|FG007|Overall Study|Non-Compliance with study treatment|0|||
155699353|NCT01610336|561992401|FG008|Overall Study|Non-Compliance with study treatment|0|||
155699354|NCT01610336|561992402|FG009|Overall Study|Non-Compliance with study treatment|1|||
155699355|NCT01610336|561992403|FG010|Overall Study|Non-Compliance with study treatment|0|||
155699356|NCT01610336|561992393|FG000|Overall Study|Physician Decision|0|||
155699357|NCT01610336|561992394|FG001|Overall Study|Physician Decision|0|||
155699358|NCT01610336|561992395|FG002|Overall Study|Physician Decision|0|||
155699359|NCT01610336|561992396|FG003|Overall Study|Physician Decision|0|||
155699360|NCT01610336|561992397|FG004|Overall Study|Physician Decision|0|||
155699361|NCT01610336|561992398|FG005|Overall Study|Physician Decision|0|||
155699362|NCT01610336|561992399|FG006|Overall Study|Physician Decision|1|||
155699363|NCT01610336|561992400|FG007|Overall Study|Physician Decision|0|||
155699364|NCT01610336|561992401|FG008|Overall Study|Physician Decision|0|||
155699365|NCT01610336|561992402|FG009|Overall Study|Physician Decision|0|||
155699366|NCT01610336|561992403|FG010|Overall Study|Physician Decision|0|||
155699367|NCT01610336|561992393|FG000|Overall Study|Protocol Deviation|0|||
155699368|NCT01610336|561992394|FG001|Overall Study|Protocol Deviation|0|||
155699369|NCT01610336|561992395|FG002|Overall Study|Protocol Deviation|0|||
155699370|NCT01610336|561992396|FG003|Overall Study|Protocol Deviation|0|||
155699371|NCT01610336|561992397|FG004|Overall Study|Protocol Deviation|0|||
155699372|NCT01610336|561992398|FG005|Overall Study|Protocol Deviation|0|||
155699373|NCT01610336|561992399|FG006|Overall Study|Protocol Deviation|0|||
155699374|NCT01610336|561992400|FG007|Overall Study|Protocol Deviation|0|||
155699375|NCT01610336|561992401|FG008|Overall Study|Protocol Deviation|0|||
155699376|NCT01610336|561992402|FG009|Overall Study|Protocol Deviation|1|||
155699377|NCT01610336|561992403|FG010|Overall Study|Protocol Deviation|0|||
155699378|NCT01610336|561992393|FG000|Overall Study|Transfer to another trial|0|||
155699379|NCT01610336|561992394|FG001|Overall Study|Transfer to another trial|0|||
155699380|NCT01610336|561992395|FG002|Overall Study|Transfer to another trial|0|||
155699381|NCT01610336|561992396|FG003|Overall Study|Transfer to another trial|0|||
155699382|NCT01610336|561992397|FG004|Overall Study|Transfer to another trial|0|||
155699383|NCT01610336|561992398|FG005|Overall Study|Transfer to another trial|0|||
155699384|NCT01610336|561992399|FG006|Overall Study|Transfer to another trial|0|||
155699385|NCT01610336|561992400|FG007|Overall Study|Transfer to another trial|0|||
155699386|NCT01610336|561992401|FG008|Overall Study|Transfer to another trial|0|||
155699387|NCT01610336|561992402|FG009|Overall Study|Transfer to another trial|0|||
155699388|NCT01610336|561992403|FG010|Overall Study|Transfer to another trial|1|||
155699389|NCT02629822|561992404|FG000|Base Study|Lost to Follow-up|2|||
155699390|NCT02629822|561992404|FG000|Base Study|Non-Compliance With Study Drug|1|||
155699391|NCT02629822|561992404|FG000|Extension Study|Adverse Event|1|||
155699392|NCT02629822|561992404|FG000|Extension Study|Lost to Follow-up|1|||
155699393|NCT01912339|561992405|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
155699394|NCT01912339|561992406|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
155699395|NCT01912339|561992407|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
155699396|NCT01912339|561992405|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
155699397|NCT01912339|561992406|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
155699398|NCT01912339|561992407|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
155699399|NCT01912339|561992405|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
155699400|NCT01912339|561992406|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
155699401|NCT01912339|561992407|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
155699402|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
155699403|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
155699404|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
155699405|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
155699406|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
155699407|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
155699408|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
155699409|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
155699410|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
155699411|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
155699412|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
155699413|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
155699414|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
155699415|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
155699416|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
155699417|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
155699418|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
155699419|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
155699420|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
155699421|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
155699422|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
155699423|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
155699424|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
155699425|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
155699426|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
155699427|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
155699428|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
155699429|NCT01912339|561992405|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
155699430|NCT01912339|561992406|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
155699431|NCT01912339|561992407|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
155699432|NCT00741013|561992408|FG000|Overall Study|Adverse Event|1|||
155699433|NCT00741013|561992409|FG001|Overall Study|Adverse Event|0|||
155699434|NCT00741013|561992410|FG002|Overall Study|Adverse Event|0|||
155699435|NCT00741013|561992408|FG000|Overall Study|Withdrawal by Subject|0|||
155699436|NCT00741013|561992409|FG001|Overall Study|Withdrawal by Subject|0|||
155699437|NCT00741013|561992410|FG002|Overall Study|Withdrawal by Subject|1|||
155699438|NCT00741013|561992408|FG000|Overall Study|Discovered failed screen after enrolled|0|||
155699439|NCT00741013|561992409|FG001|Overall Study|Discovered failed screen after enrolled|2|||
155699440|NCT00741013|561992410|FG002|Overall Study|Discovered failed screen after enrolled|0|||
155699441|NCT00082407|561992412|FG000|Overall Study|Adverse Event|20|||
155699442|NCT00082407|561992413|FG001|Overall Study|Adverse Event|0|||
155699443|NCT00082407|561992412|FG000|Overall Study|Protocol Violation|14|||
155699444|NCT00082407|561992413|FG001|Overall Study|Protocol Violation|12|||
155699445|NCT00082407|561992412|FG000|Overall Study|Patient Decision|13|||
155699446|NCT00082407|561992413|FG001|Overall Study|Patient Decision|6|||
155699447|NCT00082407|561992412|FG000|Overall Study|Physician Decision|5|||
155699448|NCT00082407|561992413|FG001|Overall Study|Physician Decision|3|||
155699449|NCT00082407|561992412|FG000|Overall Study|Loss of Glucose Control|2|||
155699450|NCT00082407|561992413|FG001|Overall Study|Loss of Glucose Control|2|||
155699451|NCT00082407|561992412|FG000|Overall Study|Death|2|||
155699452|NCT00082407|561992413|FG001|Overall Study|Death|1|||
155699453|NCT00082407|561992412|FG000|Overall Study|Lost to Follow-up|0|||
155699454|NCT00082407|561992413|FG001|Overall Study|Lost to Follow-up|3|||
155699455|NCT03464019|561992414|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
155699456|NCT03464019|561992415|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
155699457|NCT03464019|561992416|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
155699458|NCT03464019|561992414|FG000|NODE-301 Part 1|Ablation|0|||
155699459|NCT03464019|561992415|FG001|NODE-301 Part 1|Ablation|0|||
155699460|NCT03464019|561992416|FG002|NODE-301 Part 1|Ablation|16|||
155699461|NCT03464019|561992414|FG000|NODE-301 Part 1|Test Dose Failure|0|||
155699462|NCT03464019|561992415|FG001|NODE-301 Part 1|Test Dose Failure|0|||
155699463|NCT03464019|561992416|FG002|NODE-301 Part 1|Test Dose Failure|8|||
155699464|NCT03464019|561992414|FG000|NODE-301 Part 1|Adverse Event|0|||
155699465|NCT03464019|561992415|FG001|NODE-301 Part 1|Adverse Event|0|||
155699466|NCT03464019|561992416|FG002|NODE-301 Part 1|Adverse Event|5|||
155699467|NCT03464019|561992414|FG000|NODE-301 Part 1|Physician Decision|0|||
155699468|NCT03464019|561992415|FG001|NODE-301 Part 1|Physician Decision|0|||
155699469|NCT03464019|561992416|FG002|NODE-301 Part 1|Physician Decision|4|||
155699470|NCT03464019|561992414|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
155699471|NCT03464019|561992415|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
155699472|NCT03464019|561992416|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
155699473|NCT03464019|561992414|FG000|NODE-301 Part 1|Protocol Violation|0|||
155699474|NCT03464019|561992415|FG001|NODE-301 Part 1|Protocol Violation|0|||
155699475|NCT03464019|561992416|FG002|NODE-301 Part 1|Protocol Violation|2|||
155699476|NCT03464019|561992414|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
155699477|NCT03464019|561992415|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
155699478|NCT03464019|561992416|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
155699479|NCT03464019|561992414|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
155699480|NCT03464019|561992415|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
155699481|NCT03464019|561992416|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
155699482|NCT03464019|561992414|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
155699483|NCT03464019|561992415|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
155699484|NCT03464019|561992416|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
155699485|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
155699486|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
155699487|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
155699488|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
155699489|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
155699490|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
155699491|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
155699492|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
155699493|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
155699494|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
155699495|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
155699496|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
155699497|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
155699498|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
155699499|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
155699500|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
155699501|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
155699502|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
155699503|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
155699504|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
155699505|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
155699506|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
155699507|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
155699508|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
155699509|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
155699510|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
155699511|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
155699512|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
155699513|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
155699514|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
155699515|NCT03464019|561992414|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
155699516|NCT03464019|561992415|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
155699517|NCT03464019|561992416|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
155699518|NCT01754493|561992417|FG000|Overall Study|Adverse Event|1|||
155699519|NCT01754493|561992417|FG000|Overall Study|Lost to Follow-up|3|||
155699520|NCT01754493|561992417|FG000|Overall Study|Withdrawal by Subject|1|||
155699521|NCT01754493|561992417|FG000|Overall Study|Moved out of town|1|||
155699522|NCT01754493|561992417|FG000|Overall Study|Scheduling conflict|1|||
155699523|NCT00767806|561992418|FG000|Overall Study|Adverse Event|30|||
155699524|NCT00767806|561992419|FG001|Overall Study|Adverse Event|11|||
155699525|NCT00767806|561992418|FG000|Overall Study|Withdrawal by Subject|8|||
155699526|NCT00767806|561992419|FG001|Overall Study|Withdrawal by Subject|13|||
155699527|NCT00767806|561992418|FG000|Overall Study|Protocol Violation|6|||
155699528|NCT00767806|561992419|FG001|Overall Study|Protocol Violation|5|||
155699529|NCT00767806|561992418|FG000|Overall Study|Lack of Efficacy|1|||
155699530|NCT00767806|561992419|FG001|Overall Study|Lack of Efficacy|9|||
155699531|NCT00767806|561992418|FG000|Overall Study|Physician Decision|4|||
155699532|NCT00767806|561992419|FG001|Overall Study|Physician Decision|3|||
155699533|NCT00767806|561992418|FG000|Overall Study|Lost to Follow-up|1|||
155699534|NCT00767806|561992419|FG001|Overall Study|Lost to Follow-up|4|||
155699535|NCT00767806|561992418|FG000|Overall Study|Entry Criteria Not Met|1|||
155699536|NCT00767806|561992419|FG001|Overall Study|Entry Criteria Not Met|1|||
155699537|NCT00767806|561992418|FG000|Overall Study|Sponsor Decision|0|||
155699538|NCT00767806|561992419|FG001|Overall Study|Sponsor Decision|1|||
155699539|NCT02489942|561992420|FG000|Overall Study|Request by patient|602|||
155699540|NCT02489942|561992420|FG000|Overall Study|Improvement/remission|157|||
155699541|NCT02489942|561992420|FG000|Overall Study|No change/Progressive disease|263|||
155699542|NCT02489942|561992420|FG000|Overall Study|Adverse Event|522|||
155699543|NCT02489942|561992420|FG000|Overall Study|Other personal reasons|1218|||
155699544|NCT02489942|561992420|FG000|Overall Study|Lost to Follow-up|456|||
155699545|NCT02489942|561992420|FG000|Overall Study|Not continuously investigated|7|||
155699546|NCT02489942|561992420|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
155699547|NCT02489942|561992420|FG000|Overall Study|Multiple registration|1|||
155699548|NCT02489942|561992420|FG000|Overall Study|No patient visit after entry|100|||
155699549|NCT02489942|561992420|FG000|Overall Study|No treatment with Jardiance|2|||
155699550|NCT02489942|561992420|FG000|Overall Study|Patient received Jardiance before registration|1|||
155699551|NCT02489942|561992420|FG000|Overall Study|No CRF collected|86|||
155699552|NCT00858208|561992421|FG000|Overall Study|Adverse Event|3|||
155699553|NCT00858208|561992421|FG000|Overall Study|Lost to Follow-up|26|||
155699554|NCT00858208|561992421|FG000|Overall Study|Participant refused|40|||
155699555|NCT00858208|561992421|FG000|Overall Study|Other|10|||
155699556|NCT01272635|561992422|FG000|Overall Study|Lost to Follow-up|31|||
155699557|NCT01272635|561992423|FG001|Overall Study|Lost to Follow-up|20|||
155699558|NCT01272635|561992424|FG002|Overall Study|Lost to Follow-up|31|||
155699559|NCT01272635|561992425|FG003|Overall Study|Lost to Follow-up|23|||
155699560|NCT01543776|561992428|FG000|Overall Study|Withdrawal by Subject|2|||
155699561|NCT01543776|561992429|FG001|Overall Study|Withdrawal by Subject|2|||
155699562|NCT00306527|561992430|FG000|Overall Study|Lost to Follow-up|3|||
155699563|NCT00306527|561992431|FG001|Overall Study|Lost to Follow-up|4|||
155699564|NCT00306527|561992432|FG002|Overall Study|Lost to Follow-up|3|||
155699565|NCT00306527|561992433|FG003|Overall Study|Lost to Follow-up|0|||
155699566|NCT00306527|561992430|FG000|Overall Study|Withdrawal by Subject|2|||
155699567|NCT00306527|561992431|FG001|Overall Study|Withdrawal by Subject|3|||
155699568|NCT00306527|561992432|FG002|Overall Study|Withdrawal by Subject|0|||
155699569|NCT00306527|561992433|FG003|Overall Study|Withdrawal by Subject|3|||
155699570|NCT00306527|561992430|FG000|Overall Study|Adverse Event|0|||
155699571|NCT00306527|561992431|FG001|Overall Study|Adverse Event|0|||
155699572|NCT00306527|561992432|FG002|Overall Study|Adverse Event|1|||
155699573|NCT00306527|561992433|FG003|Overall Study|Adverse Event|1|||
155699574|NCT00306527|561992430|FG000|Overall Study|Death|1|||
155699575|NCT00306527|561992431|FG001|Overall Study|Death|0|||
155699576|NCT00306527|561992432|FG002|Overall Study|Death|1|||
155699577|NCT00306527|561992433|FG003|Overall Study|Death|2|||
155699578|NCT02702180|561992434|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155699579|NCT02702180|561992435|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155699580|NCT02702180|561992436|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155699581|NCT02702180|561992434|FG000|Double-blind Treatment Period|Adverse Event|0|||
155699582|NCT02702180|561992435|FG001|Double-blind Treatment Period|Adverse Event|0|||
155699583|NCT02702180|561992436|FG002|Double-blind Treatment Period|Adverse Event|1|||
155699584|NCT02702180|561992434|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155699585|NCT02702180|561992435|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155699586|NCT02702180|561992436|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155699587|NCT02702180|561992434|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155699588|NCT02702180|561992435|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155699589|NCT02702180|561992436|FG002|Double-blind Treatment Period|Protocol Violation|2|||
155699590|NCT02702180|561992434|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155699591|NCT02702180|561992435|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
155699592|NCT02702180|561992436|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
155699593|NCT02702180|561992434|FG000|Open-label Treatment Period|Withdrawn in error|0|||
155699594|NCT02702180|561992435|FG001|Open-label Treatment Period|Withdrawn in error|0|||
155699595|NCT02702180|561992436|FG002|Open-label Treatment Period|Withdrawn in error|1|||
155699596|NCT00785980|561992437|FG000|7 Day Washout Period|Protocol Violation|3|||
155699597|NCT00417963|561992438|FG000|Overall Study|Lost to Follow-up|3|||
155699598|NCT00417963|561992438|FG000|Overall Study|Withdrawal by Subject|18|||
155699599|NCT00417963|561992438|FG000|Overall Study|Death|17|||
155699600|NCT00417963|561992438|FG000|Overall Study|Study device could not be deployed|3|||
155699601|NCT01815840|561992439|FG000|Overall Study|Missing|1|||
155699602|NCT01815840|561992440|FG001|Overall Study|Missing|0|||
155699603|NCT01815840|561992439|FG000|Overall Study|Withdrew Consent|31|||
155699604|NCT01815840|561992440|FG001|Overall Study|Withdrew Consent|30|||
155699605|NCT01815840|561992439|FG000|Overall Study|Administrative/Other|1|||
155699606|NCT01815840|561992440|FG001|Overall Study|Administrative/Other|3|||
155699607|NCT01815840|561992439|FG000|Overall Study|Adverse Event|10|||
155699608|NCT01815840|561992440|FG001|Overall Study|Adverse Event|16|||
155699609|NCT01815840|561992439|FG000|Overall Study|Death|2|||
155699610|NCT01815840|561992440|FG001|Overall Study|Death|2|||
155699611|NCT01815840|561992439|FG000|Overall Study|Disease progression|3|||
155699612|NCT01815840|561992440|FG001|Overall Study|Disease progression|2|||
155699613|NCT01815840|561992439|FG000|Overall Study|Investigators Decision|2|||
155699614|NCT01815840|561992440|FG001|Overall Study|Investigators Decision|3|||
155699615|NCT01815840|561992439|FG000|Overall Study|Lost to Follow-up|3|||
155699616|NCT01815840|561992440|FG001|Overall Study|Lost to Follow-up|6|||
155699617|NCT01815840|561992439|FG000|Overall Study|Refused Treatment|5|||
155699618|NCT01815840|561992440|FG001|Overall Study|Refused Treatment|1|||
155699619|NCT01815840|561992439|FG000|Overall Study|Sponsor Termination Treatment|1|||
155699620|NCT01815840|561992440|FG001|Overall Study|Sponsor Termination Treatment|0|||
155699621|NCT00704288|561992441|FG000|Overall Treatment Period|Adverse Event|11|||
155699622|NCT00704288|561992442|FG001|Overall Treatment Period|Adverse Event|8|||
155699623|NCT00704288|561992443|FG002|Overall Treatment Period|Adverse Event|22|||
155699624|NCT00704288|561992441|FG000|Overall Treatment Period|Death|0|||
155699625|NCT00704288|561992442|FG001|Overall Treatment Period|Death|0|||
155699626|NCT00704288|561992443|FG002|Overall Treatment Period|Death|1|||
155699627|NCT00704288|561992441|FG000|Overall Treatment Period|Physician Decision|0|||
155699628|NCT00704288|561992442|FG001|Overall Treatment Period|Physician Decision|2|||
155699629|NCT00704288|561992443|FG002|Overall Treatment Period|Physician Decision|0|||
155699630|NCT00704288|561992441|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
155699631|NCT00704288|561992442|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
155699632|NCT00704288|561992443|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
155699633|NCT00704288|561992441|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
155699634|NCT00704288|561992442|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
155699635|NCT00704288|561992443|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
155699636|NCT00704288|561992441|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
155699637|NCT00704288|561992442|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
155699638|NCT00704288|561992443|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
155699639|NCT00704288|561992441|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
155699640|NCT00704288|561992442|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
155699641|NCT00704288|561992443|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
155699642|NCT00704288|561992441|FG000|Overall Treatment Period|Roll-over to another study|1|||
155699643|NCT00704288|561992442|FG001|Overall Treatment Period|Roll-over to another study|0|||
155699644|NCT00704288|561992443|FG002|Overall Treatment Period|Roll-over to another study|4|||
155699645|NCT00704288|561992441|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
155699646|NCT00704288|561992442|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
155699647|NCT00704288|561992443|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
155699648|NCT00704288|561992441|FG000|Extended Post Treatment Follow Up Period|Death|41|||
155699649|NCT00704288|561992442|FG001|Extended Post Treatment Follow Up Period|Death|50|||
155699650|NCT00704288|561992443|FG002|Extended Post Treatment Follow Up Period|Death|93|||
155699651|NCT00704288|561992441|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
155699652|NCT00704288|561992442|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
155699653|NCT00704288|561992443|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
155699654|NCT00704288|561992441|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
155699655|NCT00704288|561992442|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
155699656|NCT00704288|561992443|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
155699657|NCT00704288|561992441|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
155699658|NCT00704288|561992442|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
155699659|NCT00704288|561992443|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
155699660|NCT01055314|561992444|FG000|Overall Study|Adverse Event|7|||
155699661|NCT01055314|561992445|FG001|Overall Study|Adverse Event|4|||
155699662|NCT01055314|561992444|FG000|Overall Study|Death|2|||
155699663|NCT01055314|561992445|FG001|Overall Study|Death|1|||
155699664|NCT01055314|561992444|FG000|Overall Study|Lack of Efficacy|11|||
155699665|NCT01055314|561992445|FG001|Overall Study|Lack of Efficacy|19|||
155699666|NCT01055314|561992444|FG000|Overall Study|Physician Decision|10|||
155699667|NCT01055314|561992445|FG001|Overall Study|Physician Decision|5|||
155699668|NCT01055314|561992444|FG000|Overall Study|Withdrawal by Subject|1|||
155699669|NCT01055314|561992445|FG001|Overall Study|Withdrawal by Subject|0|||
155699670|NCT01055314|561992444|FG000|Overall Study|Ineligible|3|||
155699671|NCT01055314|561992445|FG001|Overall Study|Ineligible|5|||
155699672|NCT01055314|561992444|FG000|Overall Study|Refusal of further protocol therapy|10|||
155699673|NCT01055314|561992445|FG001|Overall Study|Refusal of further protocol therapy|4|||
155699674|NCT01055314|561992444|FG000|Overall Study|No treatment|1|||
155699675|NCT01055314|561992445|FG001|Overall Study|No treatment|0|||
155699676|NCT02241343|561992446|FG000|Overall Study|Adverse Event|1|||
155699677|NCT04680975|561992447|FG000|Overall Study|Adverse Event|3|||
155699678|NCT04680975|561992447|FG000|Overall Study|Death|1|||
155699679|NCT04680975|561992447|FG000|Overall Study|Progressive Disease|1|||
155699680|NCT04680975|561992447|FG000|Overall Study|Withdrawal by Subject|1|||
155699681|NCT03927144|561992448|FG000|Core Phase|Adverse Event|9|||
155699682|NCT03927144|561992449|FG001|Core Phase|Adverse Event|5|||
155699683|NCT03927144|561992448|FG000|Core Phase|Lost to Follow-up|3|||
155699684|NCT03927144|561992449|FG001|Core Phase|Lost to Follow-up|2|||
155699685|NCT03927144|561992448|FG000|Core Phase|New Therapy for Study Indication|0|||
155699686|NCT03927144|561992449|FG001|Core Phase|New Therapy for Study Indication|1|||
155699687|NCT03927144|561992448|FG000|Core Phase|No Longer Clinically Benefiting|4|||
155699688|NCT03927144|561992449|FG001|Core Phase|No Longer Clinically Benefiting|4|||
155699689|NCT03927144|561992448|FG000|Core Phase|Physician Decision|2|||
155699690|NCT03927144|561992449|FG001|Core Phase|Physician Decision|8|||
155699691|NCT03927144|561992448|FG000|Core Phase|Protocol Violation|2|||
155699692|NCT03927144|561992449|FG001|Core Phase|Protocol Violation|2|||
155699693|NCT03927144|561992448|FG000|Core Phase|Withdrawal by Subject|16|||
155699694|NCT03927144|561992449|FG001|Core Phase|Withdrawal by Subject|40|||
155699695|NCT03927144|561992448|FG000|Extension Phase|Adverse Event|2|||
155699696|NCT03927144|561992449|FG001|Extension Phase|Adverse Event|1|||
155699697|NCT03927144|561992448|FG000|Extension Phase|No longer clinically benefiting|4|||
155699698|NCT03927144|561992449|FG001|Extension Phase|No longer clinically benefiting|5|||
155699699|NCT03927144|561992448|FG000|Extension Phase|Pregnancy|1|||
155699700|NCT03927144|561992449|FG001|Extension Phase|Pregnancy|0|||
155699701|NCT03927144|561992448|FG000|Extension Phase|Protocol Violation|0|||
155699702|NCT03927144|561992449|FG001|Extension Phase|Protocol Violation|1|||
155699703|NCT03927144|561992448|FG000|Extension Phase|Withdrawal by Subject|8|||
155699704|NCT03927144|561992449|FG001|Extension Phase|Withdrawal by Subject|3|||
155699705|NCT03909152|561992450|FG000|Overall Study|Adverse Event|14|||
155699706|NCT03909152|561992451|FG001|Overall Study|Adverse Event|5|||
155699707|NCT03909152|561992452|FG002|Overall Study|Adverse Event|1|||
155699708|NCT03909152|561992453|FG003|Overall Study|Adverse Event|14|||
155699709|NCT02702414|561992458|FG000|Overall Study|Death|96|||
155699710|NCT02702414|561992459|FG001|Overall Study|Death|42|||
155699711|NCT02702414|561992458|FG000|Overall Study|Lost to Follow-up|0|||
155699712|NCT02702414|561992459|FG001|Overall Study|Lost to Follow-up|1|||
155699713|NCT02702414|561992458|FG000|Overall Study|Withdrawal by Subject|0|||
155699714|NCT02702414|561992459|FG001|Overall Study|Withdrawal by Subject|1|||
155699715|NCT02702414|561992458|FG000|Overall Study|Protocol Violation|1|||
155699716|NCT02702414|561992459|FG001|Overall Study|Protocol Violation|0|||
155699717|NCT02702414|561992458|FG000|Overall Study|Sponsor Decision|8|||
155699718|NCT02702414|561992459|FG001|Overall Study|Sponsor Decision|7|||
155699719|NCT04099511|561992461|FG000|Overall Study|Lost to Follow-up|2|||
155699720|NCT04099511|561992462|FG001|Overall Study|Lost to Follow-up|2|||
155699721|NCT04099511|561992461|FG000|Overall Study|Withdrawal by Subject|8|||
155699722|NCT04099511|561992462|FG001|Overall Study|Withdrawal by Subject|4|||
155699723|NCT04369950|561992463|FG000|Overall Study|Protocol Violation|2|||
155699724|NCT04369950|561992464|FG001|Overall Study|Protocol Violation|2|||
155699725|NCT02473367|561992465|FG000|Wait 1|Withdrawal by Subject|1|||
155699726|NCT02473367|561992465|FG000|Period 4|Lost to Follow-up|1|||
155699727|NCT04816721|561992466|FG000|Overall Study|Withdrawal by Subject|0|||
155699728|NCT04816721|561992467|FG001|Overall Study|Withdrawal by Subject|2|||
155699729|NCT04816721|561992468|FG002|Overall Study|Withdrawal by Subject|0|||
155699730|NCT04816721|561992469|FG003|Overall Study|Withdrawal by Subject|1|||
155699731|NCT04816721|561992470|FG004|Overall Study|Withdrawal by Subject|1|||
155699732|NCT04816721|561992471|FG005|Overall Study|Withdrawal by Subject|0|||
155699733|NCT04816721|561992472|FG006|Overall Study|Withdrawal by Subject|0|||
155699734|NCT04816721|561992473|FG007|Overall Study|Withdrawal by Subject|0|||
155699735|NCT04816721|561992466|FG000|Overall Study|Miscellaneous|0|||
155699736|NCT04816721|561992467|FG001|Overall Study|Miscellaneous|0|||
155699737|NCT04816721|561992468|FG002|Overall Study|Miscellaneous|0|||
155699738|NCT04816721|561992469|FG003|Overall Study|Miscellaneous|0|||
155699739|NCT04816721|561992470|FG004|Overall Study|Miscellaneous|0|||
155699740|NCT04816721|561992471|FG005|Overall Study|Miscellaneous|1|||
155699741|NCT04816721|561992472|FG006|Overall Study|Miscellaneous|0|||
155699742|NCT04816721|561992473|FG007|Overall Study|Miscellaneous|0|||
155699743|NCT04816721|561992466|FG000|Overall Study|Lost to Follow-up|0|||
155699744|NCT04816721|561992467|FG001|Overall Study|Lost to Follow-up|0|||
155699745|NCT04816721|561992468|FG002|Overall Study|Lost to Follow-up|0|||
155699746|NCT04816721|561992469|FG003|Overall Study|Lost to Follow-up|1|||
155699747|NCT04816721|561992470|FG004|Overall Study|Lost to Follow-up|0|||
155699748|NCT04816721|561992471|FG005|Overall Study|Lost to Follow-up|0|||
155699749|NCT04816721|561992472|FG006|Overall Study|Lost to Follow-up|0|||
155699750|NCT04816721|561992473|FG007|Overall Study|Lost to Follow-up|0|||
155699751|NCT01286740|561992478|FG000|Overall Study|Enrolled but not treated|1|||
155699752|NCT01286740|561992478|FG000|Overall Study|Protocol Violation|1|||
155699753|NCT04676867|561992479|FG000|Overall Study|Screen failure|0|||
155699754|NCT04676867|561992480|FG001|Overall Study|Screen failure|0|||
155699755|NCT04676867|561992481|FG002|Overall Study|Screen failure|6|||
155699756|NCT04676867|561992482|FG003|Overall Study|Screen failure|2|||
155699757|NCT04676867|561992479|FG000|Overall Study|Death|0|||
155699758|NCT04676867|561992480|FG001|Overall Study|Death|0|||
155699759|NCT04676867|561992481|FG002|Overall Study|Death|1|||
155699760|NCT04676867|561992482|FG003|Overall Study|Death|0|||
155699761|NCT04676867|561992479|FG000|Overall Study|Withdrawal by Subject|2|||
155699762|NCT04676867|561992480|FG001|Overall Study|Withdrawal by Subject|2|||
155699763|NCT04676867|561992481|FG002|Overall Study|Withdrawal by Subject|4|||
155699764|NCT04676867|561992482|FG003|Overall Study|Withdrawal by Subject|4|||
155699765|NCT04676867|561992479|FG000|Overall Study|Lost to Follow-up|1|||
155699766|NCT04676867|561992480|FG001|Overall Study|Lost to Follow-up|0|||
155699767|NCT04676867|561992481|FG002|Overall Study|Lost to Follow-up|0|||
155699768|NCT04676867|561992482|FG003|Overall Study|Lost to Follow-up|0|||
155699769|NCT01554514|561992487|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
155699770|NCT01554514|561992487|FG000|Overall Study|Physician Decision|1|||
155699771|NCT00549770|561992490|FG000|Overall Study|Protocol deviation|1|||
155699772|NCT00549770|561992491|FG001|Overall Study|Protocol deviation|1|||
155699773|NCT00549770|561992492|FG002|Overall Study|Protocol deviation|1|||
155699774|NCT00549770|561992493|FG003|Overall Study|Protocol deviation|2|||
155699775|NCT00549770|561992494|FG004|Overall Study|Protocol deviation|2|||
155699776|NCT00549770|561992495|FG005|Overall Study|Protocol deviation|2|||
155699777|NCT00549770|561992496|FG006|Overall Study|Protocol deviation|1|||
155699778|NCT00549770|561992497|FG007|Overall Study|Protocol deviation|2|||
155699779|NCT00549770|561992490|FG000|Overall Study|Administrative problems|0|||
155699780|NCT00549770|561992491|FG001|Overall Study|Administrative problems|1|||
155699781|NCT00549770|561992492|FG002|Overall Study|Administrative problems|0|||
155699782|NCT00549770|561992493|FG003|Overall Study|Administrative problems|0|||
155699783|NCT00549770|561992494|FG004|Overall Study|Administrative problems|0|||
155699784|NCT00549770|561992495|FG005|Overall Study|Administrative problems|0|||
155699785|NCT00549770|561992496|FG006|Overall Study|Administrative problems|0|||
155699786|NCT00549770|561992497|FG007|Overall Study|Administrative problems|1|||
155699787|NCT00549770|561992490|FG000|Overall Study|Lost to Follow-up|0|||
155699788|NCT00549770|561992491|FG001|Overall Study|Lost to Follow-up|0|||
155699789|NCT00549770|561992492|FG002|Overall Study|Lost to Follow-up|2|||
155699790|NCT00549770|561992493|FG003|Overall Study|Lost to Follow-up|2|||
155699791|NCT00549770|561992494|FG004|Overall Study|Lost to Follow-up|3|||
155699792|NCT00549770|561992495|FG005|Overall Study|Lost to Follow-up|2|||
155699793|NCT00549770|561992496|FG006|Overall Study|Lost to Follow-up|0|||
155699794|NCT00549770|561992497|FG007|Overall Study|Lost to Follow-up|0|||
155699795|NCT00549770|561992490|FG000|Overall Study|Withdrawal by Subject|4|||
155699796|NCT00549770|561992491|FG001|Overall Study|Withdrawal by Subject|6|||
155699797|NCT00549770|561992492|FG002|Overall Study|Withdrawal by Subject|4|||
155699798|NCT00549770|561992493|FG003|Overall Study|Withdrawal by Subject|5|||
155699799|NCT00549770|561992494|FG004|Overall Study|Withdrawal by Subject|6|||
155699800|NCT00549770|561992495|FG005|Overall Study|Withdrawal by Subject|6|||
155699801|NCT00549770|561992496|FG006|Overall Study|Withdrawal by Subject|4|||
155699802|NCT00549770|561992497|FG007|Overall Study|Withdrawal by Subject|9|||
155699803|NCT00549770|561992490|FG000|Overall Study|Lack of Efficacy|1|||
155699804|NCT00549770|561992491|FG001|Overall Study|Lack of Efficacy|0|||
155699805|NCT00549770|561992492|FG002|Overall Study|Lack of Efficacy|2|||
155699806|NCT00549770|561992493|FG003|Overall Study|Lack of Efficacy|3|||
155699807|NCT00549770|561992494|FG004|Overall Study|Lack of Efficacy|5|||
155699808|NCT00549770|561992495|FG005|Overall Study|Lack of Efficacy|1|||
155699809|NCT00549770|561992496|FG006|Overall Study|Lack of Efficacy|3|||
155699810|NCT00549770|561992497|FG007|Overall Study|Lack of Efficacy|8|||
155699811|NCT00549770|561992490|FG000|Overall Study|Abnormal test procedure results|0|||
155699812|NCT00549770|561992491|FG001|Overall Study|Abnormal test procedure results|0|||
155699813|NCT00549770|561992492|FG002|Overall Study|Abnormal test procedure results|0|||
155699814|NCT00549770|561992493|FG003|Overall Study|Abnormal test procedure results|2|||
155699815|NCT00549770|561992494|FG004|Overall Study|Abnormal test procedure results|0|||
155699816|NCT00549770|561992495|FG005|Overall Study|Abnormal test procedure results|1|||
155699817|NCT00549770|561992496|FG006|Overall Study|Abnormal test procedure results|1|||
155699818|NCT00549770|561992497|FG007|Overall Study|Abnormal test procedure results|1|||
155699819|NCT00549770|561992490|FG000|Overall Study|Abnormal laboratory values|0|||
155699820|NCT00549770|561992491|FG001|Overall Study|Abnormal laboratory values|0|||
155699821|NCT00549770|561992492|FG002|Overall Study|Abnormal laboratory values|0|||
155699822|NCT00549770|561992493|FG003|Overall Study|Abnormal laboratory values|0|||
155699823|NCT00549770|561992494|FG004|Overall Study|Abnormal laboratory values|0|||
155699824|NCT00549770|561992495|FG005|Overall Study|Abnormal laboratory values|1|||
155699825|NCT00549770|561992496|FG006|Overall Study|Abnormal laboratory values|0|||
155699826|NCT00549770|561992497|FG007|Overall Study|Abnormal laboratory values|0|||
155699827|NCT00549770|561992490|FG000|Overall Study|Adverse Event|1|||
155699828|NCT00549770|561992491|FG001|Overall Study|Adverse Event|3|||
155699829|NCT00549770|561992492|FG002|Overall Study|Adverse Event|1|||
155699830|NCT00549770|561992493|FG003|Overall Study|Adverse Event|2|||
155699831|NCT00549770|561992494|FG004|Overall Study|Adverse Event|1|||
155699832|NCT00549770|561992495|FG005|Overall Study|Adverse Event|0|||
155699833|NCT00549770|561992496|FG006|Overall Study|Adverse Event|5|||
155699834|NCT00549770|561992497|FG007|Overall Study|Adverse Event|4|||
155699835|NCT00847015|561992498|FG000|Overall Study|Withdrawal by Subject|1|||
155699836|NCT00847015|561992498|FG000|Overall Study|declined any surgery|1|||
155699837|NCT00847015|561992498|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
155699838|NCT00565136|561992506|FG000|Overall Study|Lost to Follow-up|1|||
155699839|NCT00565136|561992506|FG000|Overall Study|Withdrawal by Subject|1|||
155699840|NCT00565136|561992506|FG000|Overall Study|Protocol Violation|1|||
155699841|NCT00694304|561992511|FG000|Overall Study|Adverse Event|42|||
155699842|NCT00694304|561992511|FG000|Overall Study|Lack of Efficacy|35|||
155699843|NCT00694304|561992511|FG000|Overall Study|Non-compliance With Study Product|16|||
155699844|NCT00694304|561992511|FG000|Overall Study|Protocol Violation|6|||
155699845|NCT00694304|561992511|FG000|Overall Study|Withdrawal of Consent|61|||
155699846|NCT00694304|561992511|FG000|Overall Study|Lost to Follow-up|15|||
155699847|NCT00694304|561992511|FG000|Overall Study|Administrative or Other Reasons|32|||
155699848|NCT00576576|561992512|FG000|Overall Study|Lost to Follow-up|6|||
155699849|NCT00576576|561992512|FG000|Overall Study|Protocol Violation|1|||
155699850|NCT02102399|561992515|FG000|Overall Study|Withdrawal by Subject|6|||
155699851|NCT02102399|561992516|FG001|Overall Study|Withdrawal by Subject|4|||
155699852|NCT04566601|561994116|FG000|Overall Study|Other than listed|13|||
155699853|NCT04566601|561994117|FG001|Overall Study|Other than listed|4|||
155699854|NCT04566601|561994118|FG002|Overall Study|Other than listed|2|||
155699855|NCT04566601|561994119|FG003|Overall Study|Other than listed|1|||
155699856|NCT04566601|561994120|FG004|Overall Study|Other than listed|4|||
155699857|NCT04566601|561994116|FG000|Overall Study|Protocol deviation|3|||
155699858|NCT04566601|561994117|FG001|Overall Study|Protocol deviation|0|||
155699859|NCT04566601|561994118|FG002|Overall Study|Protocol deviation|1|||
155699860|NCT04566601|561994119|FG003|Overall Study|Protocol deviation|1|||
155699861|NCT04566601|561994120|FG004|Overall Study|Protocol deviation|1|||
155699862|NCT04566601|561994116|FG000|Overall Study|Technical problems|0|||
155699863|NCT04566601|561994117|FG001|Overall Study|Technical problems|0|||
155699864|NCT04566601|561994118|FG002|Overall Study|Technical problems|1|||
155699865|NCT04566601|561994119|FG003|Overall Study|Technical problems|0|||
155699866|NCT04566601|561994120|FG004|Overall Study|Technical problems|0|||
155699867|NCT04566601|561994116|FG000|Overall Study|No reason available|3|||
155699868|NCT04566601|561994117|FG001|Overall Study|No reason available|2|||
155699869|NCT04566601|561994118|FG002|Overall Study|No reason available|7|||
155699870|NCT04566601|561994119|FG003|Overall Study|No reason available|1|||
155699871|NCT04566601|561994120|FG004|Overall Study|No reason available|5|||
155699872|NCT04566601|561994116|FG000|Overall Study|Burden of study procedures|3|||
155699873|NCT04566601|561994117|FG001|Overall Study|Burden of study procedures|0|||
155699874|NCT04566601|561994118|FG002|Overall Study|Burden of study procedures|0|||
155699875|NCT04566601|561994119|FG003|Overall Study|Burden of study procedures|3|||
155699876|NCT04566601|561994120|FG004|Overall Study|Burden of study procedures|1|||
155699877|NCT04566601|561994116|FG000|Overall Study|Change of residence|2|||
155699878|NCT04566601|561994117|FG001|Overall Study|Change of residence|2|||
155699879|NCT04566601|561994118|FG002|Overall Study|Change of residence|0|||
155699880|NCT04566601|561994119|FG003|Overall Study|Change of residence|1|||
155699881|NCT04566601|561994120|FG004|Overall Study|Change of residence|2|||
155699882|NCT04566601|561994116|FG000|Overall Study|Perceived lack of efficacy|2|||
155699883|NCT04566601|561994117|FG001|Overall Study|Perceived lack of efficacy|0|||
155699884|NCT04566601|561994118|FG002|Overall Study|Perceived lack of efficacy|1|||
155699885|NCT04566601|561994119|FG003|Overall Study|Perceived lack of efficacy|1|||
155699886|NCT04566601|561994120|FG004|Overall Study|Perceived lack of efficacy|2|||
155699887|NCT04566601|561994116|FG000|Overall Study|Adverse Event|7|||
155699888|NCT04566601|561994117|FG001|Overall Study|Adverse Event|4|||
155699889|NCT04566601|561994118|FG002|Overall Study|Adverse Event|6|||
155699890|NCT04566601|561994119|FG003|Overall Study|Adverse Event|5|||
155699891|NCT04566601|561994120|FG004|Overall Study|Adverse Event|12|||
155699892|NCT00495625|561994124|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
155699893|NCT00567359|561994125|FG000|Overall Study|Withdrawal by Subject|1|||
155699894|NCT02397057|561994126|FG000|Overall Study|Withdrawal by Subject|6|||
155699895|NCT02397057|561994127|FG001|Overall Study|Withdrawal by Subject|7|||
155699896|NCT02397057|561994126|FG000|Overall Study|Lost to Follow-up|4|||
155699897|NCT02397057|561994127|FG001|Overall Study|Lost to Follow-up|3|||
155699898|NCT02397057|561994126|FG000|Overall Study|Death|1|||
155699899|NCT02397057|561994127|FG001|Overall Study|Death|0|||
155699900|NCT02397057|561994126|FG000|Overall Study|Adverse Event|0|||
155699901|NCT02397057|561994127|FG001|Overall Study|Adverse Event|1|||
155699902|NCT02397057|561994126|FG000|Overall Study|Physician Decision|0|||
155699903|NCT02397057|561994127|FG001|Overall Study|Physician Decision|1|||
155699904|NCT02397057|561994126|FG000|Overall Study|Subject did not receive study drug|0|||
155699905|NCT02397057|561994127|FG001|Overall Study|Subject did not receive study drug|1|||
155699906|NCT02352753|561994128|FG000|6-Month Dosing Period|Decision by sponsor|2|||
155699907|NCT02352753|561994128|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
155699908|NCT02352753|561994128|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
155699909|NCT02352753|561994128|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
155699910|NCT02352753|561994128|FG000|3-Month Dosing Period|Decision by sponsor|14|||
155699911|NCT02352753|561994128|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
155699912|NCT00539305|561994129|FG000|Overall Study|Adverse Event|1|||
155699913|NCT00539305|561994130|FG001|Overall Study|Adverse Event|0|||
155699914|NCT00539305|561994129|FG000|Overall Study|Substance Use|0|||
155699915|NCT00539305|561994130|FG001|Overall Study|Substance Use|1|||
155699916|NCT00539305|561994129|FG000|Overall Study|Withdrawal by Subject|0|||
155699917|NCT00539305|561994130|FG001|Overall Study|Withdrawal by Subject|1|||
155699918|NCT00679172|561994135|FG000|Overall Study|Non-compliance|1|||
155699919|NCT00679172|561994136|FG001|Overall Study|Non-compliance|1|||
155699920|NCT00679172|561994137|FG002|Overall Study|Non-compliance|0|||
155699921|NCT00679172|561994138|FG003|Overall Study|Non-compliance|1|||
155699922|NCT00679172|561994139|FG004|Overall Study|Non-compliance|0|||
155699923|NCT00679172|561994135|FG000|Overall Study|Other not specified|0|||
155699924|NCT00679172|561994136|FG001|Overall Study|Other not specified|0|||
155699925|NCT00679172|561994137|FG002|Overall Study|Other not specified|1|||
155699926|NCT00679172|561994138|FG003|Overall Study|Other not specified|0|||
155699927|NCT00679172|561994139|FG004|Overall Study|Other not specified|0|||
155699928|NCT04395690|561994142|FG000|Overall Study|Lost to Follow-up|1|||
155699929|NCT04395690|561994143|FG001|Overall Study|Lost to Follow-up|1|||
155699930|NCT00434642|561994144|FG000|Blinded Treatment Phase|Adverse Event|12|||
155699931|NCT00434642|561994145|FG001|Blinded Treatment Phase|Adverse Event|58|||
155699932|NCT00434642|561994144|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
155699933|NCT00434642|561994145|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
155699934|NCT00434642|561994144|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
155699935|NCT00434642|561994145|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
155699936|NCT00434642|561994144|FG000|Blinded Treatment Phase|Physician Decision|19|||
155699937|NCT00434642|561994145|FG001|Blinded Treatment Phase|Physician Decision|27|||
155699938|NCT00434642|561994144|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
155699939|NCT00434642|561994145|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
155699940|NCT00434642|561994144|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
155699941|NCT00434642|561994145|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
155699942|NCT00434642|561994144|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
155699943|NCT00434642|561994145|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
155699944|NCT00434642|561994144|FG000|Open-label Treatment Phase|Adverse Event|0|||
155699945|NCT00434642|561994145|FG001|Open-label Treatment Phase|Adverse Event|5|||
155699946|NCT00434642|561994144|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
155699947|NCT00434642|561994145|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
155699948|NCT00753454|561994150|FG000|Overall Study|Adverse Event|4|||
155699949|NCT00753454|561994150|FG000|Overall Study|Lack of Efficacy|1|||
155699950|NCT00753454|561994150|FG000|Overall Study|Lost to Follow-up|3|||
155699951|NCT00753454|561994150|FG000|Overall Study|Withdrawal by Subject|5|||
155699952|NCT00753454|561994150|FG000|Overall Study|Investigator Decision|1|||
155699953|NCT05249569|561994151|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
155699954|NCT04541628|561994152|FG000|Overall Study|Study Terminated|1|||
155699955|NCT04541628|561994153|FG001|Overall Study|Study Terminated|1|||
155699956|NCT04541628|561994154|FG002|Overall Study|Study Terminated|1|||
155699957|NCT02271945|561994158|FG000|Overall Study|Death|3|||
155699958|NCT02271945|561994159|FG001|Overall Study|Death|3|||
155699959|NCT02271945|561994158|FG000|Overall Study|Withdrawal by Subject|1|||
155699960|NCT02271945|561994159|FG001|Overall Study|Withdrawal by Subject|1|||
155699961|NCT02271945|561994158|FG000|Overall Study|Other|1|||
155699962|NCT02271945|561994159|FG001|Overall Study|Other|1|||
155699963|NCT01192412|561994160|FG000|Overall Study|Lost to Follow-up|2|||
155699964|NCT01192412|561994161|FG001|Overall Study|Lost to Follow-up|1|||
155699965|NCT01192412|561994160|FG000|Overall Study|Withdrawal by Subject|2|||
155699966|NCT01192412|561994161|FG001|Overall Study|Withdrawal by Subject|1|||
155699967|NCT00859937|561994162|FG000|Overall Study|Protocol Violation|1|||
155699968|NCT00859937|561994163|FG001|Overall Study|Protocol Violation|0|||
155699969|NCT00308074|561994166|FG000|Overall Study|Withdrawal by Subject|1|||
155699970|NCT01240200|561994168|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
155699971|NCT01240200|561994169|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
155699972|NCT01529034|561994172|FG000|Overall Study|Discontinued prior to study treatment|14|||
155699973|NCT01529034|561994172|FG000|Overall Study|Site closure|62|||
155699974|NCT01529034|561994172|FG000|Overall Study|Study termination|29|||
155699975|NCT01529034|561994172|FG000|Overall Study|Withdrawal by Subject|25|||
155699976|NCT01529034|561994172|FG000|Overall Study|No treated SCs within protocol window|13|||
155699977|NCT01529034|561994172|FG000|Overall Study|Noncompliance|8|||
155699978|NCT01529034|561994172|FG000|Overall Study|Caregiver no longer available|7|||
155699979|NCT01529034|561994172|FG000|Overall Study|Adverse Event|4|||
155699980|NCT01529034|561994172|FG000|Overall Study|Protocol Violation|4|||
155699981|NCT01529034|561994172|FG000|Overall Study|Lack of Efficacy|4|||
155699982|NCT01529034|561994172|FG000|Overall Study|Investigator no longer available|2|||
155699983|NCT01529034|561994172|FG000|Overall Study|Study drug not available|2|||
155699984|NCT02911142|561994173|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
155699985|NCT02911142|561994173|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
155699986|NCT02911142|561994173|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
155699987|NCT02911142|561994173|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
155699988|NCT01178099|561994174|FG000|Overall Study|Physician Decision|0|||
155699989|NCT01178099|561994175|FG001|Overall Study|Physician Decision|1|||
155699990|NCT03266172|561994176|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
155699991|NCT03266172|561994177|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
155699992|NCT03266172|561994178|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
155699993|NCT03266172|561994176|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
155699994|NCT03266172|561994177|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
155699995|NCT03266172|561994178|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
155699996|NCT03266172|561994176|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
155699997|NCT03266172|561994177|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
155699998|NCT03266172|561994178|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
155699999|NCT03266172|561994176|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
155700000|NCT03266172|561994177|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
155700001|NCT03266172|561994178|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
155700002|NCT03266172|561994176|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155700003|NCT03266172|561994177|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155700004|NCT03266172|561994178|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
155700005|NCT03266172|561994176|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155700006|NCT03266172|561994177|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155700007|NCT03266172|561994178|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
155700008|NCT05222555|561994179|FG000|Overall Study|Ongoing|2|||
155700009|NCT05222555|561994180|FG001|Overall Study|Ongoing|18|||
155700010|NCT05222555|561994179|FG000|Overall Study|Adverse Event|1|||
155700011|NCT05222555|561994180|FG001|Overall Study|Adverse Event|1|||
155700012|NCT05222555|561994179|FG000|Overall Study|Death|0|||
155700013|NCT05222555|561994180|FG001|Overall Study|Death|6|||
155700014|NCT05222555|561994179|FG000|Overall Study|Withdrawal by Subject|0|||
155700015|NCT05222555|561994180|FG001|Overall Study|Withdrawal by Subject|11|||
155700016|NCT00300365|561994181|FG000|Overall Study|Lost to Follow-up|1|||
155700017|NCT00300365|561994182|FG001|Overall Study|Lost to Follow-up|0|||
155700018|NCT00300365|561994181|FG000|Overall Study|Physician Decision|2|||
155700019|NCT00300365|561994182|FG001|Overall Study|Physician Decision|0|||
155700020|NCT00300365|561994181|FG000|Overall Study|Withdrawal by Subject|1|||
155700021|NCT00300365|561994182|FG001|Overall Study|Withdrawal by Subject|0|||
155700022|NCT00300365|561994181|FG000|Overall Study|Adverse Event|0|||
155700023|NCT00300365|561994182|FG001|Overall Study|Adverse Event|2|||
155700024|NCT01422824|561994187|FG000|Overall Study|Case record form not evaluated|1|||
155700025|NCT01422824|561994187|FG000|Overall Study|Lost to Follow-up|37|||
155700026|NCT00902174|561994188|FG000|Overall Study|Adverse Event|27|||
155700027|NCT00902174|561994189|FG001|Overall Study|Adverse Event|7|||
155700028|NCT00902174|561994188|FG000|Overall Study|Lack of Efficacy|1|||
155700029|NCT00902174|561994189|FG001|Overall Study|Lack of Efficacy|5|||
155700030|NCT00902174|561994188|FG000|Overall Study|Death|2|||
155700031|NCT00902174|561994189|FG001|Overall Study|Death|2|||
155700032|NCT00902174|561994188|FG000|Overall Study|Withdrawal by Subject|2|||
155700033|NCT00902174|561994189|FG001|Overall Study|Withdrawal by Subject|1|||
155700034|NCT00902174|561994188|FG000|Overall Study|Abnormal labs|1|||
155700035|NCT00902174|561994189|FG001|Overall Study|Abnormal labs|1|||
155700036|NCT00902174|561994188|FG000|Overall Study|Protocol Violation|1|||
155700037|NCT00902174|561994189|FG001|Overall Study|Protocol Violation|1|||
155700038|NCT00902174|561994188|FG000|Overall Study|Administration problem|0|||
155700039|NCT00902174|561994189|FG001|Overall Study|Administration problem|1|||
155700040|NCT01641822|561994190|FG000|Run-in Phase|Noncompliance with study drug|1|||
155700041|NCT01641822|561994191|FG001|Run-in Phase|Noncompliance with study drug|0|||
155700042|NCT01641822|561994192|FG002|Run-in Phase|Noncompliance with study drug|0|||
155700043|NCT01641822|561994190|FG000|Run-in Phase|Adverse Event|3|||
155700044|NCT01641822|561994191|FG001|Run-in Phase|Adverse Event|0|||
155700045|NCT01641822|561994192|FG002|Run-in Phase|Adverse Event|0|||
155700046|NCT01641822|561994190|FG000|Run-in Phase|Withdrew consent|1|||
155700047|NCT01641822|561994191|FG001|Run-in Phase|Withdrew consent|0|||
155700048|NCT01641822|561994192|FG002|Run-in Phase|Withdrew consent|0|||
155700049|NCT01641822|561994190|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
155700050|NCT01641822|561994191|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
155700051|NCT01641822|561994192|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
155700052|NCT01641822|561994190|FG000|Comparative Phase|Noncompliance with study drug|0|||
155700053|NCT01641822|561994191|FG001|Comparative Phase|Noncompliance with study drug|1|||
155700054|NCT01641822|561994192|FG002|Comparative Phase|Noncompliance with study drug|0|||
155700055|NCT01641822|561994190|FG000|Comparative Phase|Investigator's discretion|0|||
155700056|NCT01641822|561994191|FG001|Comparative Phase|Investigator's discretion|0|||
155700057|NCT01641822|561994192|FG002|Comparative Phase|Investigator's discretion|1|||
155700058|NCT01641822|561994190|FG000|Comparative Phase|Pregnancy|0|||
155700059|NCT01641822|561994191|FG001|Comparative Phase|Pregnancy|0|||
155700060|NCT01641822|561994192|FG002|Comparative Phase|Pregnancy|1|||
155700061|NCT01641822|561994190|FG000|Comparative Phase|Adverse event, serious fatal|0|||
155700062|NCT01641822|561994191|FG001|Comparative Phase|Adverse event, serious fatal|1|||
155700063|NCT01641822|561994192|FG002|Comparative Phase|Adverse event, serious fatal|0|||
155700064|NCT01641822|561994190|FG000|Comparative Phase|Withdrew consent|0|||
155700065|NCT01641822|561994191|FG001|Comparative Phase|Withdrew consent|3|||
155700066|NCT01641822|561994192|FG002|Comparative Phase|Withdrew consent|7|||
155700067|NCT01641822|561994190|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
155700068|NCT01641822|561994191|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
155700069|NCT01641822|561994192|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
155700070|NCT00454584|561994193|FG000|Controlled Period|Adverse Event|5|||
155700071|NCT00454584|561994194|FG001|Controlled Period|Adverse Event|2|||
155700072|NCT00454584|561994195|FG002|Controlled Period|Adverse Event|1|||
155700073|NCT00454584|561994196|FG003|Controlled Period|Adverse Event|0|||
155700074|NCT00454584|561994197|FG004|Controlled Period|Adverse Event|0|||
155700075|NCT00454584|561994198|FG005|Controlled Period|Adverse Event|0|||
155700076|NCT00454584|561994193|FG000|Controlled Period|Lost to Follow-up|1|||
155700077|NCT00454584|561994194|FG001|Controlled Period|Lost to Follow-up|2|||
155700078|NCT00454584|561994195|FG002|Controlled Period|Lost to Follow-up|2|||
155700079|NCT00454584|561994196|FG003|Controlled Period|Lost to Follow-up|0|||
155700080|NCT00454584|561994197|FG004|Controlled Period|Lost to Follow-up|0|||
155700081|NCT00454584|561994198|FG005|Controlled Period|Lost to Follow-up|0|||
155700082|NCT00454584|561994193|FG000|Controlled Period|Other|5|||
155700083|NCT00454584|561994194|FG001|Controlled Period|Other|4|||
155700084|NCT00454584|561994195|FG002|Controlled Period|Other|2|||
155700085|NCT00454584|561994196|FG003|Controlled Period|Other|0|||
155700086|NCT00454584|561994197|FG004|Controlled Period|Other|0|||
155700087|NCT00454584|561994198|FG005|Controlled Period|Other|0|||
155700088|NCT00454584|561994193|FG000|After Controlled Period|Adverse Event|0|||
155700089|NCT00454584|561994194|FG001|After Controlled Period|Adverse Event|0|||
155700090|NCT00454584|561994195|FG002|After Controlled Period|Adverse Event|0|||
155700091|NCT00454584|561994196|FG003|After Controlled Period|Adverse Event|9|||
155700092|NCT00454584|561994197|FG004|After Controlled Period|Adverse Event|3|||
155700093|NCT00454584|561994198|FG005|After Controlled Period|Adverse Event|9|||
155700094|NCT00454584|561994193|FG000|After Controlled Period|Lack of Efficacy|0|||
155700095|NCT00454584|561994194|FG001|After Controlled Period|Lack of Efficacy|0|||
155700096|NCT00454584|561994195|FG002|After Controlled Period|Lack of Efficacy|0|||
155700097|NCT00454584|561994196|FG003|After Controlled Period|Lack of Efficacy|1|||
155700098|NCT00454584|561994197|FG004|After Controlled Period|Lack of Efficacy|0|||
155700099|NCT00454584|561994198|FG005|After Controlled Period|Lack of Efficacy|0|||
155700100|NCT00454584|561994193|FG000|After Controlled Period|Lost to Follow-up|0|||
155700101|NCT00454584|561994194|FG001|After Controlled Period|Lost to Follow-up|0|||
155700102|NCT00454584|561994195|FG002|After Controlled Period|Lost to Follow-up|0|||
155700103|NCT00454584|561994196|FG003|After Controlled Period|Lost to Follow-up|2|||
155700104|NCT00454584|561994197|FG004|After Controlled Period|Lost to Follow-up|4|||
155700105|NCT00454584|561994198|FG005|After Controlled Period|Lost to Follow-up|6|||
155700106|NCT00454584|561994193|FG000|After Controlled Period|Other|0|||
155700107|NCT00454584|561994194|FG001|After Controlled Period|Other|0|||
155700108|NCT00454584|561994195|FG002|After Controlled Period|Other|0|||
155700109|NCT00454584|561994196|FG003|After Controlled Period|Other|1|||
155700110|NCT00454584|561994197|FG004|After Controlled Period|Other|0|||
155700111|NCT00454584|561994198|FG005|After Controlled Period|Other|0|||
155700112|NCT00454584|561994193|FG000|After Controlled Period|Other|0|||
155700113|NCT00454584|561994194|FG001|After Controlled Period|Other|0|||
155700114|NCT00454584|561994195|FG002|After Controlled Period|Other|0|||
155700115|NCT00454584|561994196|FG003|After Controlled Period|Other|13|||
155700116|NCT00454584|561994197|FG004|After Controlled Period|Other|5|||
155700117|NCT00454584|561994198|FG005|After Controlled Period|Other|17|||
155700118|NCT02760810|561994199|FG000|Overall Study|Protocol Violation|1|||
155700119|NCT02421601|561994200|FG000|Overall Study|Adverse Event|4|||
155700120|NCT02421601|561994200|FG000|Overall Study|Lack of Efficacy|5|||
155700121|NCT02421601|561994200|FG000|Overall Study|Physician Decision|1|||
155700122|NCT02421601|561994200|FG000|Overall Study|Withdrawal by Subject|31|||
155700123|NCT02421601|561994200|FG000|Overall Study|Others|41|||
155700124|NCT01581619|561994201|FG000|Overall Study|Withdrawal by Subject|1|||
155700125|NCT01581619|561994201|FG000|Overall Study|Lost to Follow-up|1|||
155700126|NCT02250664|561994202|FG000|Overall Study|Lost to Follow-up|18|||
155700127|NCT02250664|561994203|FG001|Overall Study|Lost to Follow-up|28|||
155700128|NCT02250664|561994204|FG002|Overall Study|Lost to Follow-up|33|||
155700129|NCT02250664|561994202|FG000|Overall Study|Personal Reasons|7|||
155700130|NCT02250664|561994203|FG001|Overall Study|Personal Reasons|8|||
155700131|NCT02250664|561994204|FG002|Overall Study|Personal Reasons|14|||
155700132|NCT02250664|561994202|FG000|Overall Study|Adverse Event|6|||
155700133|NCT02250664|561994203|FG001|Overall Study|Adverse Event|3|||
155700134|NCT02250664|561994204|FG002|Overall Study|Adverse Event|8|||
155700135|NCT02250664|561994202|FG000|Overall Study|Incarcerated|2|||
155700136|NCT02250664|561994203|FG001|Overall Study|Incarcerated|1|||
155700137|NCT02250664|561994204|FG002|Overall Study|Incarcerated|2|||
155700138|NCT02250664|561994202|FG000|Overall Study|Withdrawal by Subject|0|||
155700139|NCT02250664|561994203|FG001|Overall Study|Withdrawal by Subject|1|||
155700140|NCT02250664|561994204|FG002|Overall Study|Withdrawal by Subject|2|||
155700141|NCT02250664|561994202|FG000|Overall Study|Death|0|||
155700142|NCT02250664|561994203|FG001|Overall Study|Death|1|||
155700143|NCT02250664|561994204|FG002|Overall Study|Death|1|||
155700144|NCT02250664|561994202|FG000|Overall Study|Physician Decision|1|||
155700145|NCT02250664|561994203|FG001|Overall Study|Physician Decision|3|||
155700146|NCT02250664|561994204|FG002|Overall Study|Physician Decision|1|||
155700147|NCT02250664|561994202|FG000|Overall Study|Protocol Violation|1|||
155700148|NCT02250664|561994203|FG001|Overall Study|Protocol Violation|0|||
155700149|NCT02250664|561994204|FG002|Overall Study|Protocol Violation|1|||
155700150|NCT02250664|561994202|FG000|Overall Study|Reason unknown|1|||
155700151|NCT02250664|561994203|FG001|Overall Study|Reason unknown|0|||
155700152|NCT02250664|561994204|FG002|Overall Study|Reason unknown|0|||
155700153|NCT01716104|561994205|FG000|Overall Study|Do not meet inclusion criteria|6|||
155700154|NCT01716104|561994206|FG001|Overall Study|Do not meet inclusion criteria|7|||
155700155|NCT00117793|561994207|FG000|Overall Study|Withdrawal by Subject|12|||
155700156|NCT00975143|561994210|FG000|Overall Study|Adverse Event|19|||
155700157|NCT00975143|561994211|FG001|Overall Study|Adverse Event|15|||
155700158|NCT00975143|561994210|FG000|Overall Study|Withdrawal by Subject|15|||
155700159|NCT00975143|561994211|FG001|Overall Study|Withdrawal by Subject|15|||
155700160|NCT00975143|561994210|FG000|Overall Study|Lost to Follow-up|20|||
155700161|NCT00975143|561994211|FG001|Overall Study|Lost to Follow-up|16|||
155700162|NCT00975143|561994210|FG000|Overall Study|Non-compliance|5|||
155700163|NCT00975143|561994211|FG001|Overall Study|Non-compliance|8|||
155700164|NCT00975143|561994210|FG000|Overall Study|Physician Decision|1|||
155700165|NCT00975143|561994211|FG001|Overall Study|Physician Decision|2|||
155700166|NCT00975143|561994210|FG000|Overall Study|Details not available|10|||
155700167|NCT00975143|561994211|FG001|Overall Study|Details not available|4|||
155700168|NCT01753401|561994212|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
155700169|NCT01753401|561994213|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
155700170|NCT01753401|561994214|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
155700171|NCT01753401|561994215|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
155700172|NCT01753401|561994212|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
155700173|NCT01753401|561994213|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
155700174|NCT01753401|561994214|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
155700175|NCT01753401|561994215|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
155700176|NCT01753401|561994212|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155700177|NCT01753401|561994213|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
155700178|NCT01753401|561994214|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155700179|NCT01753401|561994215|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155700180|NCT01753401|561994212|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
155700181|NCT01753401|561994213|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
155700182|NCT01753401|561994214|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
155700183|NCT01753401|561994215|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
155700184|NCT01753401|561994212|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155700185|NCT01753401|561994213|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155700186|NCT01753401|561994214|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155700187|NCT01753401|561994215|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
155700188|NCT01753401|561994212|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
155700189|NCT01753401|561994213|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
155700190|NCT01753401|561994214|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
155700191|NCT01753401|561994215|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
155700192|NCT01753401|561994212|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
155700193|NCT01753401|561994213|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
155700194|NCT01753401|561994214|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
155700195|NCT01753401|561994215|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
155700196|NCT00581360|561994216|FG000|Overall Study|Withdrawal by Subject|1|||
155700197|NCT03129360|561994217|FG000|Overall Study|Did not meet entry criteria|0|||
155700198|NCT03129360|561994218|FG001|Overall Study|Did not meet entry criteria|2|||
155700199|NCT03129360|561994219|FG002|Overall Study|Did not meet entry criteria|1|||
155700200|NCT03129360|561994217|FG000|Overall Study|Excluded due to motion in scanner|1|||
155700201|NCT03129360|561994218|FG001|Overall Study|Excluded due to motion in scanner|0|||
155700202|NCT03129360|561994219|FG002|Overall Study|Excluded due to motion in scanner|0|||
155700203|NCT00599638|561994220|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
155700204|NCT00599638|561994221|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
155700205|NCT00599638|561994222|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
155700206|NCT00599638|561994223|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
155700207|NCT00599638|561994220|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
155700208|NCT00599638|561994221|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
155700209|NCT00599638|561994222|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
155700210|NCT00599638|561994223|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
155700211|NCT00599638|561994220|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
155700212|NCT00599638|561994221|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
155700213|NCT00599638|561994222|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
155700214|NCT00599638|561994223|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
155700215|NCT00599638|561994220|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
155700216|NCT00599638|561994221|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
155700217|NCT00599638|561994222|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
155700218|NCT00599638|561994223|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
155700219|NCT00599638|561994220|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
155700220|NCT00599638|561994221|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
155700221|NCT00599638|561994222|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
155700222|NCT00599638|561994223|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
155700223|NCT00599638|561994220|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
155700224|NCT00599638|561994221|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
155700225|NCT00599638|561994222|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
155700226|NCT00599638|561994223|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
155700227|NCT00599638|561994220|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155700228|NCT00599638|561994221|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155700229|NCT00599638|561994222|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155700230|NCT00599638|561994223|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
155700231|NCT00599638|561994220|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
155700232|NCT00599638|561994221|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
155700233|NCT00599638|561994222|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
155700234|NCT00599638|561994223|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
155700235|NCT00599638|561994220|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
155700236|NCT00599638|561994221|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155700237|NCT00599638|561994222|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155700238|NCT00599638|561994223|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155700239|NCT03006887|561994227|FG000|Overall Study|Adverse Event|1|||
155700240|NCT03836677|561994228|FG000|Period 1|Adverse Event|0|||
155700241|NCT03836677|561994229|FG001|Period 1|Adverse Event|1|||
155700242|NCT03836677|561994228|FG000|Period 2|Severe non-compliance to protocol|1|||
155700243|NCT03836677|561994229|FG001|Period 2|Severe non-compliance to protocol|0|||
155700244|NCT02895945|561994230|FG000|Overall Study|Physician Decision|2|||
155700245|NCT02895945|561994231|FG001|Overall Study|Physician Decision|1|||
155700246|NCT00462748|561994232|FG000|Overall Study|Adverse Event|7|||
155700247|NCT00462748|561994233|FG001|Overall Study|Adverse Event|5|||
155700248|NCT00462748|561994234|FG002|Overall Study|Adverse Event|9|||
155700249|NCT00462748|561994232|FG000|Overall Study|Protocol Violation|0|||
155700250|NCT00462748|561994233|FG001|Overall Study|Protocol Violation|2|||
155700251|NCT00462748|561994234|FG002|Overall Study|Protocol Violation|1|||
155700252|NCT00462748|561994232|FG000|Overall Study|Withdrew consent|3|||
155700253|NCT00462748|561994233|FG001|Overall Study|Withdrew consent|3|||
155700254|NCT00462748|561994234|FG002|Overall Study|Withdrew consent|0|||
155700255|NCT00462748|561994232|FG000|Overall Study|Lost to Follow-up|1|||
155700256|NCT00462748|561994233|FG001|Overall Study|Lost to Follow-up|1|||
155700257|NCT00462748|561994234|FG002|Overall Study|Lost to Follow-up|1|||
155700258|NCT00462748|561994232|FG000|Overall Study|Discontinued after 41 days Rx|1|||
155700259|NCT00462748|561994233|FG001|Overall Study|Discontinued after 41 days Rx|0|||
155700260|NCT00462748|561994234|FG002|Overall Study|Discontinued after 41 days Rx|0|||
155700261|NCT01818492|561994235|FG000|Overall Study|Adverse Event|2|||
155700262|NCT01818492|561994235|FG000|Overall Study|Death|3|||
155700263|NCT01818492|561994235|FG000|Overall Study|Withdrawal by Subject|1|||
155700264|NCT01818492|561994235|FG000|Overall Study|Additional therapy when not allowed PP|4|||
155700265|NCT00082381|561994236|FG000|Overall Study|Adverse Event|27|||
155700266|NCT00082381|561994237|FG001|Overall Study|Adverse Event|2|||
155700267|NCT00082381|561994236|FG000|Overall Study|Lost to Follow-up|5|||
155700268|NCT00082381|561994237|FG001|Overall Study|Lost to Follow-up|7|||
155700269|NCT00082381|561994236|FG000|Overall Study|Patient Decision|8|||
155700270|NCT00082381|561994237|FG001|Overall Study|Patient Decision|4|||
155700271|NCT00082381|561994236|FG000|Overall Study|Physician Decision|1|||
155700272|NCT00082381|561994237|FG001|Overall Study|Physician Decision|2|||
155700273|NCT00082381|561994236|FG000|Overall Study|Protocol Violation|10|||
155700274|NCT00082381|561994237|FG001|Overall Study|Protocol Violation|11|||
155700275|NCT00082381|561994236|FG000|Overall Study|Loss of Glucose Control|4|||
155700276|NCT00082381|561994237|FG001|Overall Study|Loss of Glucose Control|0|||
155700277|NCT01729208|561994238|FG000|Baseline|Physician Decision|5|||
155700278|NCT01729208|561994239|FG001|Baseline|Physician Decision|4|||
155700279|NCT01729208|561994238|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
155700280|NCT01729208|561994239|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
155700281|NCT01729208|561994238|FG000|12 Months Follow-up|Lost to Follow-up|3|||
155700282|NCT01729208|561994239|FG001|12 Months Follow-up|Lost to Follow-up|3|||
155700283|NCT01729208|561994238|FG000|24 Months Follow-up|Lost to Follow-up|3|||
155700284|NCT01729208|561994239|FG001|24 Months Follow-up|Lost to Follow-up|0|||
155700285|NCT01729208|561994238|FG000|36 Months Follow-up|Physician Decision|1|||
155700286|NCT01729208|561994239|FG001|36 Months Follow-up|Physician Decision|0|||
155700287|NCT01729208|561994238|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
155700288|NCT01729208|561994239|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
155700289|NCT02428413|561994240|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
155700290|NCT02428413|561994241|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
155700291|NCT02428413|561994240|FG000|Overall Study|Protocol Violation|1|||
155700292|NCT02428413|561994241|FG001|Overall Study|Protocol Violation|2|||
155700293|NCT02428413|561994240|FG000|Overall Study|Case Cancelled|2|||
155700294|NCT02428413|561994241|FG001|Overall Study|Case Cancelled|0|||
155700295|NCT02428413|561994240|FG000|Overall Study|Missed Cases|1|||
155700296|NCT02428413|561994241|FG001|Overall Study|Missed Cases|2|||
155700297|NCT02428413|561994240|FG000|Overall Study|Nurse Refusal|1|||
155700298|NCT02428413|561994241|FG001|Overall Study|Nurse Refusal|0|||
155700299|NCT00109577|561994242|FG000|Overall Study|Withdrawal by Subject|3|||
155700300|NCT00109577|561994243|FG001|Overall Study|Withdrawal by Subject|3|||
155700301|NCT04891107|561994244|FG000|Overall Study|Physician Decision|1|||
155700302|NCT04891107|561994244|FG000|Overall Study|Withdrawal by Subject|1|||
155700303|NCT04891107|561994244|FG000|Overall Study|Screen failure after consent|1|||
155700304|NCT02879578|561994247|FG000|Overall Study|Adverse Event|1|||
155700305|NCT02879578|561994248|FG001|Overall Study|Adverse Event|2|||
155700306|NCT02879578|561994249|FG002|Overall Study|Adverse Event|14|||
155700307|NCT02879578|561994247|FG000|Overall Study|Protocol Violation|0|||
155700308|NCT02879578|561994248|FG001|Overall Study|Protocol Violation|1|||
155700309|NCT02879578|561994249|FG002|Overall Study|Protocol Violation|1|||
155700310|NCT02879578|561994247|FG000|Overall Study|Withdrawal by Subject|8|||
155700311|NCT02879578|561994248|FG001|Overall Study|Withdrawal by Subject|6|||
155700312|NCT02879578|561994249|FG002|Overall Study|Withdrawal by Subject|9|||
155700313|NCT02879578|561994247|FG000|Overall Study|Lost to Follow-up|1|||
155700314|NCT02879578|561994248|FG001|Overall Study|Lost to Follow-up|0|||
155700315|NCT02879578|561994249|FG002|Overall Study|Lost to Follow-up|4|||
155700316|NCT02879578|561994247|FG000|Overall Study|Physician Decision|0|||
155700317|NCT02879578|561994248|FG001|Overall Study|Physician Decision|0|||
155700318|NCT02879578|561994249|FG002|Overall Study|Physician Decision|4|||
155700319|NCT03517566|561994251|FG000|Overall Study|Adverse Event|5|||
155700320|NCT03517566|561994252|FG001|Overall Study|Adverse Event|2|||
155700321|NCT03517566|561994253|FG002|Overall Study|Adverse Event|2|||
155700322|NCT03517566|561994254|FG003|Overall Study|Adverse Event|8|||
155700323|NCT03517566|561994255|FG004|Overall Study|Adverse Event|7|||
155700324|NCT03517566|561994251|FG000|Overall Study|Lack of Efficacy|3|||
155700325|NCT03517566|561994252|FG001|Overall Study|Lack of Efficacy|2|||
155700326|NCT03517566|561994253|FG002|Overall Study|Lack of Efficacy|1|||
155700327|NCT03517566|561994254|FG003|Overall Study|Lack of Efficacy|1|||
155700328|NCT03517566|561994255|FG004|Overall Study|Lack of Efficacy|4|||
155700329|NCT03517566|561994251|FG000|Overall Study|Lost to Follow-up|3|||
155700330|NCT03517566|561994252|FG001|Overall Study|Lost to Follow-up|1|||
155700331|NCT03517566|561994253|FG002|Overall Study|Lost to Follow-up|1|||
155700332|NCT03517566|561994254|FG003|Overall Study|Lost to Follow-up|1|||
155700333|NCT03517566|561994255|FG004|Overall Study|Lost to Follow-up|0|||
155700334|NCT03517566|561994251|FG000|Overall Study|Physician Decision|1|||
155700335|NCT03517566|561994252|FG001|Overall Study|Physician Decision|1|||
155700336|NCT03517566|561994253|FG002|Overall Study|Physician Decision|0|||
155700337|NCT03517566|561994254|FG003|Overall Study|Physician Decision|1|||
155700338|NCT03517566|561994255|FG004|Overall Study|Physician Decision|0|||
155700339|NCT03517566|561994251|FG000|Overall Study|Pregnancy|0|||
155700340|NCT03517566|561994252|FG001|Overall Study|Pregnancy|1|||
155700341|NCT03517566|561994253|FG002|Overall Study|Pregnancy|0|||
155700342|NCT03517566|561994254|FG003|Overall Study|Pregnancy|0|||
155700343|NCT03517566|561994255|FG004|Overall Study|Pregnancy|0|||
155700344|NCT03517566|561994251|FG000|Overall Study|Protocol Deviation|0|||
155700345|NCT03517566|561994252|FG001|Overall Study|Protocol Deviation|1|||
155700346|NCT03517566|561994253|FG002|Overall Study|Protocol Deviation|0|||
155700347|NCT03517566|561994254|FG003|Overall Study|Protocol Deviation|1|||
155700348|NCT03517566|561994255|FG004|Overall Study|Protocol Deviation|1|||
155700349|NCT03517566|561994251|FG000|Overall Study|Study terminated by Sponsor|11|||
155700350|NCT03517566|561994252|FG001|Overall Study|Study terminated by Sponsor|5|||
155700351|NCT03517566|561994253|FG002|Overall Study|Study terminated by Sponsor|6|||
155700352|NCT03517566|561994254|FG003|Overall Study|Study terminated by Sponsor|14|||
155700353|NCT03517566|561994255|FG004|Overall Study|Study terminated by Sponsor|12|||
155700354|NCT03517566|561994251|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
155700355|NCT03517566|561994252|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
155700356|NCT03517566|561994253|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
155700357|NCT03517566|561994254|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
155700358|NCT03517566|561994255|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
155700359|NCT04566692|561994256|FG000|Overall Study|Adverse Event|2|||
155700360|NCT04566692|561994257|FG001|Overall Study|Adverse Event|0|||
155700361|NCT04566692|561994256|FG000|Overall Study|Withdrawal by Subject|1|||
155700362|NCT04566692|561994257|FG001|Overall Study|Withdrawal by Subject|1|||
155700363|NCT00671437|561994258|FG000|Overall Study|Progressive disease before C1 week 8|8|||
155700364|NCT00671437|561994258|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
155700365|NCT00671437|561994258|FG000|Overall Study|Adverse Event|3|||
155700366|NCT00671437|561994258|FG000|Overall Study|Ineligible post-hoc|1|||
155700367|NCT00590577|561994259|FG000|Overall Study|Lack of Efficacy|31|||
155700368|NCT00590577|561994260|FG001|Overall Study|Lack of Efficacy|28|||
155700369|NCT00590577|561994261|FG002|Overall Study|Lack of Efficacy|23|||
155700370|NCT00590577|561994262|FG003|Overall Study|Lack of Efficacy|45|||
155700371|NCT00590577|561994259|FG000|Overall Study|Withdrawal by Subject|23|||
155700372|NCT00590577|561994260|FG001|Overall Study|Withdrawal by Subject|28|||
155700373|NCT00590577|561994261|FG002|Overall Study|Withdrawal by Subject|30|||
155700374|NCT00590577|561994262|FG003|Overall Study|Withdrawal by Subject|26|||
155700375|NCT00590577|561994259|FG000|Overall Study|Adverse Event|10|||
155700376|NCT00590577|561994260|FG001|Overall Study|Adverse Event|10|||
155700377|NCT00590577|561994261|FG002|Overall Study|Adverse Event|13|||
155700378|NCT00590577|561994262|FG003|Overall Study|Adverse Event|11|||
155700379|NCT00590577|561994259|FG000|Overall Study|Lost to Follow-up|12|||
155700380|NCT00590577|561994260|FG001|Overall Study|Lost to Follow-up|6|||
155700381|NCT00590577|561994261|FG002|Overall Study|Lost to Follow-up|6|||
155700382|NCT00590577|561994262|FG003|Overall Study|Lost to Follow-up|9|||
155700383|NCT00590577|561994259|FG000|Overall Study|Pregnancy|0|||
155700384|NCT00590577|561994260|FG001|Overall Study|Pregnancy|1|||
155700385|NCT00590577|561994261|FG002|Overall Study|Pregnancy|0|||
155700386|NCT00590577|561994262|FG003|Overall Study|Pregnancy|0|||
155700387|NCT00590577|561994259|FG000|Overall Study|Various reasons|1|||
155700388|NCT00590577|561994260|FG001|Overall Study|Various reasons|3|||
155700389|NCT00590577|561994261|FG002|Overall Study|Various reasons|1|||
155700390|NCT00590577|561994262|FG003|Overall Study|Various reasons|2|||
155700391|NCT04512976|561996202|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155700392|NCT04512976|561996203|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155700393|NCT04512976|561996204|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155700394|NCT04512976|561996205|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155700395|NCT04512976|561996206|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155700396|NCT04512976|561996207|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
155700397|NCT00615030|561996212|FG000|Period I|Administrative problem|0|||
155700398|NCT00615030|561996213|FG001|Period I|Administrative problem|0|||
155700399|NCT00615030|561996214|FG002|Period I|Administrative problem|0|||
155700400|NCT00615030|561996215|FG003|Period I|Administrative problem|0|||
155700401|NCT00615030|561996216|FG004|Period I|Administrative problem|1|||
155700402|NCT00615030|561996217|FG005|Period I|Administrative problem|0|||
155700403|NCT00615030|561996218|FG006|Period I|Administrative problem|0|||
155700404|NCT00615030|561996219|FG007|Period I|Administrative problem|0|||
155700405|NCT00615030|561996220|FG008|Period I|Administrative problem|0|||
155700406|NCT00615030|561996221|FG009|Period I|Administrative problem|0|||
155700407|NCT00615030|561996222|FG010|Period I|Administrative problem|0|||
155700408|NCT00615030|561996223|FG011|Period I|Administrative problem|0|||
155700409|NCT00615030|561996212|FG000|Period I|Protocol deviation|1|||
155700410|NCT00615030|561996213|FG001|Period I|Protocol deviation|0|||
155700411|NCT00615030|561996214|FG002|Period I|Protocol deviation|0|||
155700412|NCT00615030|561996215|FG003|Period I|Protocol deviation|0|||
155700413|NCT00615030|561996216|FG004|Period I|Protocol deviation|0|||
155700414|NCT00615030|561996217|FG005|Period I|Protocol deviation|0|||
155700415|NCT00615030|561996218|FG006|Period I|Protocol deviation|0|||
155700416|NCT00615030|561996219|FG007|Period I|Protocol deviation|0|||
155700417|NCT00615030|561996220|FG008|Period I|Protocol deviation|0|||
155700418|NCT00615030|561996221|FG009|Period I|Protocol deviation|0|||
155700419|NCT00615030|561996222|FG010|Period I|Protocol deviation|0|||
155700420|NCT00615030|561996223|FG011|Period I|Protocol deviation|0|||
155700421|NCT00615030|561996212|FG000|Period I|Subject withdrew consent|0|||
155700422|NCT00615030|561996213|FG001|Period I|Subject withdrew consent|0|||
155700423|NCT00615030|561996214|FG002|Period I|Subject withdrew consent|0|||
155700424|NCT00615030|561996215|FG003|Period I|Subject withdrew consent|0|||
155700425|NCT00615030|561996216|FG004|Period I|Subject withdrew consent|0|||
155700426|NCT00615030|561996217|FG005|Period I|Subject withdrew consent|0|||
155700427|NCT00615030|561996218|FG006|Period I|Subject withdrew consent|0|||
155700428|NCT00615030|561996219|FG007|Period I|Subject withdrew consent|0|||
155700429|NCT00615030|561996220|FG008|Period I|Subject withdrew consent|1|||
155700430|NCT00615030|561996221|FG009|Period I|Subject withdrew consent|0|||
155700431|NCT00615030|561996222|FG010|Period I|Subject withdrew consent|1|||
155700432|NCT00615030|561996223|FG011|Period I|Subject withdrew consent|1|||
155700433|NCT00615030|561996212|FG000|Period I|Abnormal laboratory value(s)|0|||
155700434|NCT00615030|561996213|FG001|Period I|Abnormal laboratory value(s)|0|||
155700435|NCT00615030|561996214|FG002|Period I|Abnormal laboratory value(s)|0|||
155700436|NCT00615030|561996215|FG003|Period I|Abnormal laboratory value(s)|0|||
155700437|NCT00615030|561996216|FG004|Period I|Abnormal laboratory value(s)|0|||
155700438|NCT00615030|561996217|FG005|Period I|Abnormal laboratory value(s)|1|||
155700439|NCT00615030|561996218|FG006|Period I|Abnormal laboratory value(s)|0|||
155700440|NCT00615030|561996219|FG007|Period I|Abnormal laboratory value(s)|0|||
155700441|NCT00615030|561996220|FG008|Period I|Abnormal laboratory value(s)|0|||
155700442|NCT00615030|561996221|FG009|Period I|Abnormal laboratory value(s)|0|||
155700443|NCT00615030|561996222|FG010|Period I|Abnormal laboratory value(s)|0|||
155700444|NCT00615030|561996223|FG011|Period I|Abnormal laboratory value(s)|0|||
155700445|NCT00615030|561996212|FG000|Period II|Adverse Event|0|||
155700446|NCT00615030|561996213|FG001|Period II|Adverse Event|0|||
155700447|NCT00615030|561996214|FG002|Period II|Adverse Event|1|||
155700448|NCT00615030|561996215|FG003|Period II|Adverse Event|0|||
155700449|NCT00615030|561996216|FG004|Period II|Adverse Event|0|||
155700450|NCT00615030|561996217|FG005|Period II|Adverse Event|0|||
155700451|NCT00615030|561996218|FG006|Period II|Adverse Event|0|||
155700452|NCT00615030|561996219|FG007|Period II|Adverse Event|0|||
155700453|NCT00615030|561996220|FG008|Period II|Adverse Event|1|||
155700454|NCT00615030|561996221|FG009|Period II|Adverse Event|0|||
155700455|NCT00615030|561996222|FG010|Period II|Adverse Event|0|||
155700456|NCT00615030|561996223|FG011|Period II|Adverse Event|0|||
155700457|NCT00615030|561996212|FG000|Period II|Subject withdrew consent|0|||
155700458|NCT00615030|561996213|FG001|Period II|Subject withdrew consent|0|||
155700459|NCT00615030|561996214|FG002|Period II|Subject withdrew consent|0|||
155700460|NCT00615030|561996215|FG003|Period II|Subject withdrew consent|1|||
155700461|NCT00615030|561996216|FG004|Period II|Subject withdrew consent|0|||
155700462|NCT00615030|561996217|FG005|Period II|Subject withdrew consent|0|||
155700463|NCT00615030|561996218|FG006|Period II|Subject withdrew consent|1|||
155700464|NCT00615030|561996219|FG007|Period II|Subject withdrew consent|0|||
155700465|NCT00615030|561996220|FG008|Period II|Subject withdrew consent|0|||
155700466|NCT00615030|561996221|FG009|Period II|Subject withdrew consent|0|||
155700467|NCT00615030|561996222|FG010|Period II|Subject withdrew consent|0|||
155700468|NCT00615030|561996223|FG011|Period II|Subject withdrew consent|0|||
155700469|NCT00615030|561996212|FG000|Period III|Administrative problems|1|||
155700470|NCT00615030|561996213|FG001|Period III|Administrative problems|0|||
155700471|NCT00615030|561996214|FG002|Period III|Administrative problems|0|||
155700472|NCT00615030|561996215|FG003|Period III|Administrative problems|1|||
155700473|NCT00615030|561996216|FG004|Period III|Administrative problems|0|||
155700474|NCT00615030|561996217|FG005|Period III|Administrative problems|0|||
155700475|NCT00615030|561996218|FG006|Period III|Administrative problems|0|||
155700476|NCT00615030|561996219|FG007|Period III|Administrative problems|0|||
155700477|NCT00615030|561996220|FG008|Period III|Administrative problems|0|||
155700478|NCT00615030|561996221|FG009|Period III|Administrative problems|0|||
155700479|NCT00615030|561996222|FG010|Period III|Administrative problems|0|||
155700480|NCT00615030|561996223|FG011|Period III|Administrative problems|0|||
155700481|NCT00151476|561996224|FG000|FAP Identified Subjects|Protocol Violation|0|||
155700482|NCT00151476|561996225|FG001|FAP Identified Subjects|Protocol Violation|1|||
155700483|NCT00151476|561996224|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
155700484|NCT00151476|561996225|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
155700485|NCT00151476|561996224|FG000|FAP Analyzed Subjects|Other study participation|0|||
155700486|NCT00151476|561996225|FG001|FAP Analyzed Subjects|Other study participation|1|||
155700487|NCT03446456|561996226|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
155700488|NCT03446456|561996227|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
155700489|NCT03446456|561996226|FG000|Overall Study|Lost to Follow-up|1|||
155700490|NCT03446456|561996227|FG001|Overall Study|Lost to Follow-up|3|||
155700491|NCT03446456|561996226|FG000|Overall Study|Participant failed the toxicology test|1|||
155700492|NCT03446456|561996227|FG001|Overall Study|Participant failed the toxicology test|0|||
155700493|NCT03446456|561996226|FG000|Overall Study|Break down of the experimental equipment|1|||
155700494|NCT03446456|561996227|FG001|Overall Study|Break down of the experimental equipment|0|||
155700495|NCT03002311|561996240|FG000|Overall Study|Lost to Follow-up|13|||
155700496|NCT03002311|561996241|FG001|Overall Study|Lost to Follow-up|26|||
155700497|NCT03002311|561996240|FG000|Overall Study|Referral provider called to schedule app|3|||
155700498|NCT03002311|561996241|FG001|Overall Study|Referral provider called to schedule app|3|||
155700499|NCT03002311|561996240|FG000|Overall Study|Physician Decision|3|||
155700500|NCT03002311|561996241|FG001|Overall Study|Physician Decision|1|||
155700501|NCT01329939|561996245|FG000|Overall Study|Lost to Follow-up|3|||
155700502|NCT01329939|561996246|FG001|Overall Study|Lost to Follow-up|0|||
155700503|NCT01329939|561996247|FG002|Overall Study|Lost to Follow-up|1|||
155700504|NCT01329939|561996248|FG003|Overall Study|Lost to Follow-up|2|||
155700505|NCT01329939|561996245|FG000|Overall Study|Withdrawal by Subject|0|||
155700506|NCT01329939|561996246|FG001|Overall Study|Withdrawal by Subject|1|||
155700507|NCT01329939|561996247|FG002|Overall Study|Withdrawal by Subject|0|||
155700508|NCT01329939|561996248|FG003|Overall Study|Withdrawal by Subject|0|||
155700509|NCT01329939|561996245|FG000|Overall Study|Adverse Event|0|||
155700510|NCT01329939|561996246|FG001|Overall Study|Adverse Event|0|||
155700511|NCT01329939|561996247|FG002|Overall Study|Adverse Event|0|||
155700512|NCT01329939|561996248|FG003|Overall Study|Adverse Event|3|||
155700513|NCT03722524|561996249|FG000|Overall Study|Protocol Violation|86|||
155700514|NCT03722524|561996249|FG000|Overall Study|Adverse Event|7|||
155700515|NCT03722524|561996249|FG000|Overall Study|Lost to Follow-up|1|||
155700516|NCT03722524|561996249|FG000|Overall Study|Reason is not stated|1|||
155700517|NCT03722524|561996249|FG000|Overall Study|Physician Decision|1|||
155700518|NCT03722524|561996249|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
155700519|NCT00989963|561996250|FG000|Overall Study|Adverse Event|1|||
155700520|NCT00989963|561996251|FG001|Overall Study|Adverse Event|1|||
155700521|NCT00989963|561996252|FG002|Overall Study|Adverse Event|1|||
155700522|NCT04588389|561996259|FG000|Overall Study|Issues with anesthesia during surgery|2|||
155700523|NCT04588389|561996260|FG001|Overall Study|Issues with anesthesia during surgery|0|||
155700524|NCT04588389|561996261|FG002|Overall Study|Issues with anesthesia during surgery|0|||
155700525|NCT00719680|561996265|FG000|Overall Study|Adverse Event|1|||
155700526|NCT00719680|561996265|FG000|Overall Study|Lost to Follow-up|1|||
155700527|NCT00719680|561996265|FG000|Overall Study|Withdrawal by Subject|3|||
155700528|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
155700529|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
155700530|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
155700531|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
155700532|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
155700533|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
155700534|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Death|1|||
155700535|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Death|4|||
155700536|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
155700537|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
155700538|NCT00658814|561996266|FG000|Remission Induction Chemotherapy|Not eligible|1|||
155700539|NCT00658814|561996267|FG001|Remission Induction Chemotherapy|Not eligible|2|||
155700540|NCT00658814|561996266|FG000|Consolidation Therapy|Not protocol specified|0|||
155700541|NCT00658814|561996267|FG001|Consolidation Therapy|Not protocol specified|1|||
155700542|NCT00658814|561996266|FG000|Consolidation Therapy|Not eligible|2|||
155700543|NCT00658814|561996267|FG001|Consolidation Therapy|Not eligible|2|||
155700544|NCT00658814|561996266|FG000|Maintenance Therapy|Adverse Event|1|||
155700545|NCT00658814|561996267|FG001|Maintenance Therapy|Adverse Event|1|||
155700546|NCT00658814|561996266|FG000|Maintenance Therapy|Not protocol specified|1|||
155700547|NCT00658814|561996267|FG001|Maintenance Therapy|Not protocol specified|0|||
155700548|NCT00658814|561996266|FG000|Maintenance Therapy|Not eligible|1|||
155700549|NCT00658814|561996267|FG001|Maintenance Therapy|Not eligible|0|||
155700550|NCT04071158|561996268|FG000|Overall Study|Lost to Follow-up|1|||
155700551|NCT04071158|561996269|FG001|Overall Study|Lost to Follow-up|2|||
155700552|NCT04071158|561996270|FG002|Overall Study|Lost to Follow-up|3|||
155700553|NCT04071158|561996271|FG003|Overall Study|Lost to Follow-up|3|||
155700554|NCT04071158|561996272|FG004|Overall Study|Lost to Follow-up|5|||
155700555|NCT04071158|561996268|FG000|Overall Study|Randomized but not treated|2|||
155700556|NCT04071158|561996269|FG001|Overall Study|Randomized but not treated|2|||
155700557|NCT04071158|561996270|FG002|Overall Study|Randomized but not treated|0|||
155700558|NCT04071158|561996271|FG003|Overall Study|Randomized but not treated|0|||
155700559|NCT04071158|561996272|FG004|Overall Study|Randomized but not treated|0|||
155700560|NCT02678923|561996285|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
155700561|NCT02678923|561996286|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
155700562|NCT02678923|561996285|FG000|Overall Study|Withdrawal by Subject|3|||
155700563|NCT02678923|561996286|FG001|Overall Study|Withdrawal by Subject|2|||
155700564|NCT02678923|561996285|FG000|Overall Study|Lost to Follow-up|1|||
155700565|NCT02678923|561996286|FG001|Overall Study|Lost to Follow-up|0|||
155700566|NCT02678923|561996285|FG000|Overall Study|Did Not Return for Study Visits|1|||
155700567|NCT02678923|561996286|FG001|Overall Study|Did Not Return for Study Visits|0|||
155700568|NCT00455143|561996287|FG000|Overall Study|Physician Decision|1|||
155700569|NCT00455143|561996287|FG000|Overall Study|Withdrawal by Subject|1|||
155700570|NCT00455143|561996287|FG000|Overall Study|Staff was not avail to follow patient|2|||
155700571|NCT00455143|561996287|FG000|Overall Study|No longer met Inclusion Criteria|1|||
155700572|NCT00455143|561996287|FG000|Overall Study|Surgical time, staff not available|1|||
155700573|NCT01966445|561996289|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155700574|NCT01966445|561996290|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155700575|NCT01966445|561996291|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155700576|NCT01966445|561996292|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
155700577|NCT01966445|561996293|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155700578|NCT01966445|561996294|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
155700579|NCT01966445|561996295|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155700580|NCT01966445|561996289|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155700581|NCT01966445|561996290|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155700582|NCT01966445|561996291|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155700583|NCT01966445|561996292|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155700584|NCT01966445|561996293|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155700585|NCT01966445|561996294|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155700586|NCT01966445|561996295|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155700587|NCT01966445|561996289|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155700588|NCT01966445|561996290|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
155700589|NCT01966445|561996291|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
155700590|NCT01966445|561996292|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155700591|NCT01966445|561996293|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
155700592|NCT01966445|561996294|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155700593|NCT01966445|561996295|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155700594|NCT01966445|561996289|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700595|NCT01966445|561996290|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700596|NCT01966445|561996291|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700597|NCT01966445|561996292|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700598|NCT01966445|561996293|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700599|NCT01966445|561996294|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155700600|NCT01966445|561996295|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
155700601|NCT01966445|561996289|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700602|NCT01966445|561996290|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700603|NCT01966445|561996291|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700604|NCT01966445|561996292|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700605|NCT01966445|561996293|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700606|NCT01966445|561996294|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155700607|NCT01966445|561996295|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
155700608|NCT01374178|561996296|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
155700609|NCT01374178|561996297|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
155700610|NCT01374178|561996296|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
155700611|NCT01374178|561996297|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
155700612|NCT04856904|561996298|FG000|Overall Study|Physician Decision|1|||
155700613|NCT04856904|561996299|FG001|Overall Study|Physician Decision|1|||
155700614|NCT04856904|561996298|FG000|Overall Study|Withdrawal by Subject|13|||
155700615|NCT04856904|561996299|FG001|Overall Study|Withdrawal by Subject|13|||
155700616|NCT04856904|561996298|FG000|Overall Study|Adverse Event|1|||
155700617|NCT04856904|561996299|FG001|Overall Study|Adverse Event|1|||
155700618|NCT04856904|561996298|FG000|Overall Study|Non-compliance with study drug|1|||
155700619|NCT04856904|561996299|FG001|Overall Study|Non-compliance with study drug|1|||
155700620|NCT04856904|561996298|FG000|Overall Study|Lost to Follow-up|4|||
155700621|NCT04856904|561996299|FG001|Overall Study|Lost to Follow-up|4|||
155700622|NCT04856904|561996298|FG000|Overall Study|Withdrawal by Subject|1|||
155700623|NCT04856904|561996299|FG001|Overall Study|Withdrawal by Subject|1|||
155700624|NCT04856904|561996298|FG000|Overall Study|Protocol Violation|1|||
155700625|NCT04856904|561996299|FG001|Overall Study|Protocol Violation|1|||
155700626|NCT01375608|561996300|FG000|Overall Study|Withdrawal by Subject|2|||
155700627|NCT03429543|561996301|FG000|Overall Study|Adverse Event|1|||
155700628|NCT03429543|561996302|FG001|Overall Study|Adverse Event|1|||
155700629|NCT03429543|561996303|FG002|Overall Study|Adverse Event|0|||
155700630|NCT03429543|561996304|FG003|Overall Study|Adverse Event|0|||
155700631|NCT03429543|561996305|FG004|Overall Study|Adverse Event|0|||
155700632|NCT03429543|561996306|FG005|Overall Study|Adverse Event|2|||
155700633|NCT03429543|561996307|FG006|Overall Study|Adverse Event|0|||
155700634|NCT03429543|561996301|FG000|Overall Study|Lost to Follow-up|1|||
155700635|NCT03429543|561996302|FG001|Overall Study|Lost to Follow-up|0|||
155700636|NCT03429543|561996303|FG002|Overall Study|Lost to Follow-up|0|||
155700637|NCT03429543|561996304|FG003|Overall Study|Lost to Follow-up|0|||
155700638|NCT03429543|561996305|FG004|Overall Study|Lost to Follow-up|1|||
155700639|NCT03429543|561996306|FG005|Overall Study|Lost to Follow-up|0|||
155700640|NCT03429543|561996307|FG006|Overall Study|Lost to Follow-up|0|||
155700641|NCT03429543|561996301|FG000|Overall Study|Withdrawal by Subject|5|||
155700642|NCT03429543|561996302|FG001|Overall Study|Withdrawal by Subject|0|||
155700643|NCT03429543|561996303|FG002|Overall Study|Withdrawal by Subject|1|||
155700644|NCT03429543|561996304|FG003|Overall Study|Withdrawal by Subject|2|||
155700645|NCT03429543|561996305|FG004|Overall Study|Withdrawal by Subject|6|||
155700646|NCT03429543|561996306|FG005|Overall Study|Withdrawal by Subject|3|||
155700647|NCT03429543|561996307|FG006|Overall Study|Withdrawal by Subject|1|||
155700648|NCT03429543|561996301|FG000|Overall Study|Other reason than listed|0|||
155700649|NCT03429543|561996302|FG001|Overall Study|Other reason than listed|1|||
155700650|NCT03429543|561996303|FG002|Overall Study|Other reason than listed|0|||
155700651|NCT03429543|561996304|FG003|Overall Study|Other reason than listed|0|||
155700652|NCT03429543|561996305|FG004|Overall Study|Other reason than listed|4|||
155700653|NCT03429543|561996306|FG005|Overall Study|Other reason than listed|4|||
155700654|NCT03429543|561996307|FG006|Overall Study|Other reason than listed|0|||
155700655|NCT03429543|561996301|FG000|Overall Study|Not treated|0|||
155700656|NCT03429543|561996302|FG001|Overall Study|Not treated|0|||
155700657|NCT03429543|561996303|FG002|Overall Study|Not treated|0|||
155700658|NCT03429543|561996304|FG003|Overall Study|Not treated|0|||
155700659|NCT03429543|561996305|FG004|Overall Study|Not treated|1|||
155700660|NCT03429543|561996306|FG005|Overall Study|Not treated|0|||
155700661|NCT03429543|561996307|FG006|Overall Study|Not treated|0|||
155700662|NCT03322423|561996309|FG000|Period 1|Subject no longer eligible|0|||
155700663|NCT03322423|561996310|FG001|Period 1|Subject no longer eligible|1|||
155700664|NCT03322423|561996309|FG000|Period 1|Withdrawal by Subject|0|||
155700665|NCT03322423|561996310|FG001|Period 1|Withdrawal by Subject|1|||
155700666|NCT03322423|561996309|FG000|Period 1|Incorrect Lens Dispensed|1|||
155700667|NCT03322423|561996310|FG001|Period 1|Incorrect Lens Dispensed|0|||
155700668|NCT03322423|561996309|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
155700669|NCT03322423|561996310|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
155700670|NCT03322423|561996309|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
155700671|NCT03322423|561996310|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
155700672|NCT03322423|561996309|FG000|Period 2|Protocol Violation|1|||
155700673|NCT03322423|561996310|FG001|Period 2|Protocol Violation|0|||
155700674|NCT03322423|561996309|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
155700675|NCT03322423|561996310|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
155700676|NCT02453555|561996313|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
155700677|NCT02453555|561996314|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
155700678|NCT02453555|561996315|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
155700679|NCT02453555|561996316|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
155700680|NCT02453555|561996317|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
155700681|NCT02453555|561996318|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
155700682|NCT02453555|561996313|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
155700683|NCT02453555|561996314|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155700684|NCT02453555|561996315|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155700685|NCT02453555|561996316|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155700686|NCT02453555|561996317|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155700687|NCT02453555|561996318|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155700688|NCT02453555|561996313|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
155700689|NCT02453555|561996314|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
155700690|NCT02453555|561996315|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155700691|NCT02453555|561996316|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155700692|NCT02453555|561996317|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155700693|NCT02453555|561996318|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155700694|NCT02453555|561996313|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
155700695|NCT02453555|561996314|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
155700696|NCT02453555|561996315|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
155700697|NCT02453555|561996316|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
155700698|NCT02453555|561996317|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
155700699|NCT02453555|561996318|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
155700700|NCT02453555|561996313|FG000|Extension Period|Adverse Event|0|||
155700701|NCT02453555|561996314|FG001|Extension Period|Adverse Event|0|||
155700702|NCT02453555|561996315|FG002|Extension Period|Adverse Event|1|||
155700703|NCT02453555|561996316|FG003|Extension Period|Adverse Event|2|||
155700704|NCT02453555|561996317|FG004|Extension Period|Adverse Event|1|||
155700705|NCT02453555|561996318|FG005|Extension Period|Adverse Event|1|||
155700706|NCT02453555|561996313|FG000|Extension Period|Protocol Violation|0|||
155700707|NCT02453555|561996314|FG001|Extension Period|Protocol Violation|0|||
155700708|NCT02453555|561996315|FG002|Extension Period|Protocol Violation|1|||
155700709|NCT02453555|561996316|FG003|Extension Period|Protocol Violation|0|||
155700710|NCT02453555|561996317|FG004|Extension Period|Protocol Violation|0|||
155700711|NCT02453555|561996318|FG005|Extension Period|Protocol Violation|0|||
155700712|NCT02453555|561996313|FG000|Extension Period|Withdrawal by Subject|0|||
155700713|NCT02453555|561996314|FG001|Extension Period|Withdrawal by Subject|0|||
155700714|NCT02453555|561996315|FG002|Extension Period|Withdrawal by Subject|1|||
155700715|NCT02453555|561996316|FG003|Extension Period|Withdrawal by Subject|0|||
155700716|NCT02453555|561996317|FG004|Extension Period|Withdrawal by Subject|0|||
155700717|NCT02453555|561996318|FG005|Extension Period|Withdrawal by Subject|0|||
155700718|NCT02409719|561996323|FG000|Overall Study|Lost to Follow-up|3|||
155700719|NCT02409719|561996324|FG001|Overall Study|Lost to Follow-up|3|||
155700720|NCT03689855|561996328|FG000|Overall Study|Adverse Event|3|||
155700721|NCT03689855|561996328|FG000|Overall Study|Withdrawal by Subject|1|||
155700722|NCT00619099|561996329|FG000|Overall Study|Progressive Disease|7|||
155700723|NCT00619099|561996330|FG001|Overall Study|Progressive Disease|5|||
155700724|NCT00619099|561996329|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
155700725|NCT00619099|561996330|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
155700726|NCT00619099|561996329|FG000|Overall Study|Adverse Event|4|||
155700727|NCT00619099|561996330|FG001|Overall Study|Adverse Event|3|||
155700728|NCT00619099|561996329|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
155700729|NCT00619099|561996330|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
155700730|NCT00619099|561996329|FG000|Overall Study|Withdrawal by Subject|10|||
155700731|NCT00619099|561996330|FG001|Overall Study|Withdrawal by Subject|2|||
155700732|NCT00619099|561996329|FG000|Overall Study|Physician Decision|9|||
155700733|NCT00619099|561996330|FG001|Overall Study|Physician Decision|6|||
155700734|NCT00885482|561996331|FG000|Overall Study|Pregnancy|1|||
155700735|NCT00885482|561996331|FG000|Overall Study|Lack of Efficacy|1|||
155700736|NCT00885482|561996331|FG000|Overall Study|Death|1|||
155700737|NCT00885482|561996331|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
155700738|NCT00989781|561996332|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
155700739|NCT00989781|561996333|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
155700740|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
155700741|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
155700742|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
155700743|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
155700744|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
155700745|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
155700746|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
155700747|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
155700748|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
155700749|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
155700750|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
155700751|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
155700752|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
155700753|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
155700754|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
155700755|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
155700756|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
155700757|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
155700758|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
155700759|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
155700760|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
155700761|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
155700762|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
155700763|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
155700764|NCT01532869|561996334|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
155700765|NCT01532869|561996335|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
155700766|NCT01532869|561996334|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
155700767|NCT01532869|561996335|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
155700768|NCT01532869|561996334|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
155700769|NCT01532869|561996335|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
155700770|NCT01532869|561996334|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
155700771|NCT01532869|561996335|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
155700772|NCT01532869|561996334|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
155700773|NCT01532869|561996335|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
155700774|NCT02438813|561996336|FG000|Overall Study|Patient Decision|59|||
155700775|NCT02438813|561996336|FG000|Overall Study|Patient Lost to Follow-Up|137|||
155700776|NCT02438813|561996336|FG000|Overall Study|Study Ended by Sponsor|80|||
155700777|NCT02438813|561996336|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
155700778|NCT00778895|561996337|FG000|Active Phase|Adverse Event|3|||
155700779|NCT00778895|561996338|FG001|Active Phase|Adverse Event|1|||
155700780|NCT00778895|561996339|FG002|Active Phase|Adverse Event|0|||
155700781|NCT00778895|561996337|FG000|Active Phase|Withdrawal by Subject|1|||
155700782|NCT00778895|561996338|FG001|Active Phase|Withdrawal by Subject|4|||
155700783|NCT00778895|561996339|FG002|Active Phase|Withdrawal by Subject|0|||
155700784|NCT00778895|561996337|FG000|Active Phase|Lost to Follow-up|1|||
155700785|NCT00778895|561996338|FG001|Active Phase|Lost to Follow-up|1|||
155700786|NCT00778895|561996339|FG002|Active Phase|Lost to Follow-up|0|||
155700787|NCT00778895|561996337|FG000|Active Phase|Other|2|||
155700788|NCT00778895|561996338|FG001|Active Phase|Other|0|||
155700789|NCT00778895|561996339|FG002|Active Phase|Other|0|||
155700790|NCT00778895|561996337|FG000|ESFU Phase|Adverse Event|2|||
155700791|NCT00778895|561996338|FG001|ESFU Phase|Adverse Event|1|||
155700792|NCT00778895|561996339|FG002|ESFU Phase|Adverse Event|0|||
155700793|NCT00778895|561996337|FG000|ESFU Phase|Withdrawal by Subject|1|||
155700794|NCT00778895|561996338|FG001|ESFU Phase|Withdrawal by Subject|4|||
155700795|NCT00778895|561996339|FG002|ESFU Phase|Withdrawal by Subject|0|||
155700796|NCT00778895|561996337|FG000|ESFU Phase|Lost to Follow-up|6|||
155700797|NCT00778895|561996338|FG001|ESFU Phase|Lost to Follow-up|7|||
155700798|NCT00778895|561996339|FG002|ESFU Phase|Lost to Follow-up|2|||
155700799|NCT00778895|561996337|FG000|ESFU Phase|Other|2|||
155700800|NCT00778895|561996338|FG001|ESFU Phase|Other|0|||
155700801|NCT00778895|561996339|FG002|ESFU Phase|Other|0|||
155700802|NCT05096312|561996340|FG000|Overall Study|Lost to Follow-up|2|||
155700803|NCT05096312|561996341|FG001|Overall Study|Lost to Follow-up|4|||
155700804|NCT05096312|561996340|FG000|Overall Study|Adverse Event|1|||
155700805|NCT05096312|561996341|FG001|Overall Study|Adverse Event|0|||
155700806|NCT03135210|561996342|FG000|Overall Study|Death|0|||
155700807|NCT03135210|561996343|FG001|Overall Study|Death|1|||
155700808|NCT01805037|561996347|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
155700809|NCT01805037|561996348|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
155700810|NCT01805037|561996347|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
155700811|NCT01805037|561996348|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
155700812|NCT01805037|561996347|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
155700813|NCT01805037|561996348|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
155700814|NCT01805037|561996347|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
155700815|NCT01805037|561996348|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
155700816|NCT01805037|561996347|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
155700817|NCT01805037|561996348|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
155700818|NCT01805037|561996347|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
155700819|NCT01805037|561996348|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
155700820|NCT01805037|561996347|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
155700821|NCT01805037|561996348|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
155700822|NCT01805037|561996347|FG000|Follow Up (up to 3 Years)|Death|0|||
155700823|NCT01805037|561996348|FG001|Follow Up (up to 3 Years)|Death|2|||
155700824|NCT01805037|561996347|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
155700825|NCT01805037|561996348|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
155700826|NCT01805037|561996347|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
155700827|NCT01805037|561996348|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
155700828|NCT01270256|561996349|FG000|Overall Study|Withdrawal by Subject|1|||
155700829|NCT01270256|561996350|FG001|Overall Study|Withdrawal by Subject|0|||
155700830|NCT01229449|561996351|FG000|Overall Study|Withdrawal by Subject|0|||
155700831|NCT01229449|561996352|FG001|Overall Study|Withdrawal by Subject|3|||
155700832|NCT01229449|561996353|FG002|Overall Study|Withdrawal by Subject|0|||
155700833|NCT01229449|561996354|FG003|Overall Study|Withdrawal by Subject|1|||
155700834|NCT01229449|561996355|FG004|Overall Study|Withdrawal by Subject|1|||
155700835|NCT01229449|561996351|FG000|Overall Study|Lost to Follow-up|1|||
155700836|NCT01229449|561996352|FG001|Overall Study|Lost to Follow-up|1|||
155700837|NCT01229449|561996353|FG002|Overall Study|Lost to Follow-up|1|||
155700838|NCT01229449|561996354|FG003|Overall Study|Lost to Follow-up|0|||
155700839|NCT01229449|561996355|FG004|Overall Study|Lost to Follow-up|0|||
155700840|NCT01229449|561996351|FG000|Overall Study|Physician Decision|0|||
155700841|NCT01229449|561996352|FG001|Overall Study|Physician Decision|0|||
155700842|NCT01229449|561996353|FG002|Overall Study|Physician Decision|1|||
155700843|NCT01229449|561996354|FG003|Overall Study|Physician Decision|0|||
155700844|NCT01229449|561996355|FG004|Overall Study|Physician Decision|0|||
155700845|NCT03203291|561996356|FG000|Overall Study|Withdrawal by Subject|1|||
155700846|NCT05098509|561996359|FG000|Overall Study|Withdrawal by Subject|0|||
155700847|NCT05098509|561996360|FG001|Overall Study|Withdrawal by Subject|0|||
155700848|NCT05098509|561996361|FG002|Overall Study|Withdrawal by Subject|1|||
155700849|NCT05098509|561996362|FG003|Overall Study|Withdrawal by Subject|0|||
155700850|NCT05098509|561996359|FG000|Overall Study|Early study termination|1|||
155700851|NCT05098509|561996360|FG001|Overall Study|Early study termination|1|||
155700852|NCT05098509|561996361|FG002|Overall Study|Early study termination|1|||
155700853|NCT05098509|561996362|FG003|Overall Study|Early study termination|0|||
155700854|NCT03157037|561996365|FG000|Overall Study|Death|1|||
155700855|NCT04349033|561996369|FG000|Overall Study|Lost to Follow-up|3|||
155700856|NCT04349033|561996370|FG001|Overall Study|Lost to Follow-up|1|||
155700857|NCT04349033|561996371|FG002|Overall Study|Lost to Follow-up|1|||
155700858|NCT00324233|561996372|FG000|First Period|unable to insert catheter|1|||
155700859|NCT00324233|561996373|FG001|First Period|unable to insert catheter|0|||
155700860|NCT00324233|561996372|FG000|Second Period|unable to insert catheter|1|||
155700861|NCT00324233|561996373|FG001|Second Period|unable to insert catheter|1|||
155700862|NCT00324233|561996372|FG000|Second Period|Protocol Violation|4|||
155700863|NCT00324233|561996373|FG001|Second Period|Protocol Violation|6|||
155700864|NCT01704456|561996376|FG000|Overall Study|Lost to Follow-up|8|||
155700865|NCT01704456|561996377|FG001|Overall Study|Lost to Follow-up|14|||
155700866|NCT04583956|561996378|FG000|Overall Study|Death|9|||
155700867|NCT04583956|561996379|FG001|Overall Study|Death|11|||
155700868|NCT04583956|561996378|FG000|Overall Study|Lost to Follow-up|7|||
155700869|NCT04583956|561996379|FG001|Overall Study|Lost to Follow-up|9|||
155700870|NCT04583956|561996378|FG000|Overall Study|Protocol Violation|2|||
155700871|NCT04583956|561996379|FG001|Overall Study|Protocol Violation|0|||
155700872|NCT04583956|561996378|FG000|Overall Study|Withdrawal by Subject|0|||
155700873|NCT04583956|561996379|FG001|Overall Study|Withdrawal by Subject|2|||
155700874|NCT04583956|561996378|FG000|Overall Study|Randomized but not dosed|2|||
155700875|NCT04583956|561996379|FG001|Overall Study|Randomized but not dosed|3|||
155700876|NCT04583956|561996378|FG000|Overall Study|Withdrawal of consent before product administration|1|||
155700877|NCT04583956|561996379|FG001|Overall Study|Withdrawal of consent before product administration|0|||
155700878|NCT00915551|561996382|FG000|Overall Study|Withdrawal by Subject|0|||
155700879|NCT00915551|561996383|FG001|Overall Study|Withdrawal by Subject|1|||
155700880|NCT03908970|561996384|FG000|Overall Study|Adverse Event|7|||
155700881|NCT03908970|561996385|FG001|Overall Study|Adverse Event|21|||
155700882|NCT03908970|561996384|FG000|Overall Study|Physician Decision|1|||
155700883|NCT03908970|561996385|FG001|Overall Study|Physician Decision|4|||
155700884|NCT03908970|561996384|FG000|Overall Study|Withdrawal by Subject|9|||
155700885|NCT03908970|561996385|FG001|Overall Study|Withdrawal by Subject|22|||
155700886|NCT01123707|561996390|FG000|Overall Study|Lost to Follow-up|3|||
155700887|NCT01123707|561996391|FG001|Overall Study|Lost to Follow-up|1|||
155700888|NCT01123707|561996392|FG002|Overall Study|Lost to Follow-up|3|||
155700889|NCT01123707|561996393|FG003|Overall Study|Lost to Follow-up|2|||
155700890|NCT01123707|561996390|FG000|Overall Study|Adverse Event|5|||
155700891|NCT01123707|561996391|FG001|Overall Study|Adverse Event|7|||
155700892|NCT01123707|561996392|FG002|Overall Study|Adverse Event|5|||
155700893|NCT01123707|561996393|FG003|Overall Study|Adverse Event|3|||
155700894|NCT01123707|561996390|FG000|Overall Study|Sponsor Discontinued Study|30|||
155700895|NCT01123707|561996391|FG001|Overall Study|Sponsor Discontinued Study|24|||
155700896|NCT01123707|561996392|FG002|Overall Study|Sponsor Discontinued Study|25|||
155700897|NCT01123707|561996393|FG003|Overall Study|Sponsor Discontinued Study|40|||
155700898|NCT01123707|561996390|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155700899|NCT01123707|561996391|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
155700900|NCT01123707|561996392|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
155700901|NCT01123707|561996393|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155700902|NCT01123707|561996390|FG000|Overall Study|Investigator Withdrew Participant|0|||
155700903|NCT01123707|561996391|FG001|Overall Study|Investigator Withdrew Participant|1|||
155700904|NCT01123707|561996392|FG002|Overall Study|Investigator Withdrew Participant|1|||
155700905|NCT01123707|561996393|FG003|Overall Study|Investigator Withdrew Participant|1|||
155700906|NCT01123707|561996390|FG000|Overall Study|Subject Withdrew Consent|4|||
155700907|NCT01123707|561996391|FG001|Overall Study|Subject Withdrew Consent|5|||
155700908|NCT01123707|561996392|FG002|Overall Study|Subject Withdrew Consent|1|||
155700909|NCT01123707|561996393|FG003|Overall Study|Subject Withdrew Consent|2|||
155700910|NCT01123707|561996390|FG000|Overall Study|Lack of Efficacy|1|||
155700911|NCT01123707|561996391|FG001|Overall Study|Lack of Efficacy|2|||
155700912|NCT01123707|561996392|FG002|Overall Study|Lack of Efficacy|1|||
155700913|NCT01123707|561996393|FG003|Overall Study|Lack of Efficacy|0|||
155700914|NCT01123707|561996390|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
155700915|NCT01123707|561996391|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
155700916|NCT01123707|561996392|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
155700917|NCT01123707|561996393|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
155700918|NCT00488826|561996398|FG000|Overall Study|Withdrawal by Subject|40|||
155700919|NCT00488826|561996399|FG001|Overall Study|Withdrawal by Subject|35|||
155700920|NCT00488826|561996400|FG002|Overall Study|Withdrawal by Subject|19|||
155700921|NCT00488826|561996398|FG000|Overall Study|Protocol Violation|0|||
155700922|NCT00488826|561996399|FG001|Overall Study|Protocol Violation|0|||
155700923|NCT00488826|561996400|FG002|Overall Study|Protocol Violation|2|||
155700924|NCT00488826|561996398|FG000|Overall Study|Adverse Event|9|||
155700925|NCT00488826|561996399|FG001|Overall Study|Adverse Event|15|||
155700926|NCT00488826|561996400|FG002|Overall Study|Adverse Event|4|||
155700927|NCT00488826|561996398|FG000|Overall Study|Lost to Follow-up|5|||
155700928|NCT00488826|561996399|FG001|Overall Study|Lost to Follow-up|1|||
155700929|NCT00488826|561996400|FG002|Overall Study|Lost to Follow-up|0|||
155700930|NCT00488826|561996398|FG000|Overall Study|Protocol Deviations|2|||
155700931|NCT00488826|561996399|FG001|Overall Study|Protocol Deviations|1|||
155700932|NCT00488826|561996400|FG002|Overall Study|Protocol Deviations|1|||
155700933|NCT02725866|561996401|FG000|Overall Study|Failure to return|6|||
155700934|NCT02725866|561996401|FG000|Overall Study|Withdrew consent|3|||
155700935|NCT02725866|561996401|FG000|Overall Study|Insufficient virological response|1|||
155700936|NCT02725866|561996401|FG000|Overall Study|Other, not specified|4|||
155700937|NCT00605345|561996408|FG000|Overall Study|Withdrawal by Subject|1|||
155700938|NCT00605345|561996409|FG001|Overall Study|Withdrawal by Subject|0|||
155700939|NCT00605345|561996408|FG000|Overall Study|Adverse Event|0|||
155700940|NCT00605345|561996409|FG001|Overall Study|Adverse Event|1|||
155700941|NCT00605345|561996408|FG000|Overall Study|Protocol Violation|0|||
155700942|NCT00605345|561996409|FG001|Overall Study|Protocol Violation|2|||
155700943|NCT02577016|561996410|FG000|Overall Study|Adverse Event|2|||
155700944|NCT02577016|561996411|FG001|Overall Study|Adverse Event|1|||
155700945|NCT02577016|561996410|FG000|Overall Study|Physician Decision|0|||
155700946|NCT02577016|561996411|FG001|Overall Study|Physician Decision|1|||
155700947|NCT02126839|561996412|FG000|Overall Study|Adverse Event|0|||
155700948|NCT02126839|561996413|FG001|Overall Study|Adverse Event|1|||
155700949|NCT02126839|561996412|FG000|Overall Study|Withdrawal by Subject|1|||
155700950|NCT02126839|561996413|FG001|Overall Study|Withdrawal by Subject|0|||
155700951|NCT02126839|561996412|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155700952|NCT02126839|561996413|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155700953|NCT02126839|561996412|FG000|Overall Study|Protocol Violation|2|||
155700954|NCT02126839|561996413|FG001|Overall Study|Protocol Violation|3|||
155700955|NCT02126839|561996412|FG000|Overall Study|Sponsor request|0|||
155700956|NCT02126839|561996413|FG001|Overall Study|Sponsor request|1|||
155700957|NCT02126839|561996412|FG000|Overall Study|Lost to Follow-up|1|||
155700958|NCT02126839|561996413|FG001|Overall Study|Lost to Follow-up|4|||
155700959|NCT02126839|561996412|FG000|Overall Study|Other|5|||
155700960|NCT02126839|561996413|FG001|Overall Study|Other|5|||
155700961|NCT00411632|561996414|FG000|Overall Study|Death|1|||
155700962|NCT01108523|561996415|FG000|Overall Study|Protocol Violation|4|||
155700963|NCT00761527|561996416|FG000|Overall Study|Adverse Event|3|||
155700964|NCT00761527|561996416|FG000|Overall Study|Poor Compliance|8|||
155700965|NCT00761527|561996416|FG000|Overall Study|Lost to Follow-up|9|||
155700966|NCT00761527|561996416|FG000|Overall Study|Unknown reason|2|||
155700967|NCT03210961|561998847|FG000|Overall Study|Adverse Event|0|||
155700968|NCT03210961|561998848|FG001|Overall Study|Adverse Event|0|||
155700969|NCT03210961|561998849|FG002|Overall Study|Adverse Event|0|||
155700970|NCT03210961|561998850|FG003|Overall Study|Adverse Event|0|||
155700971|NCT03210961|561998851|FG004|Overall Study|Adverse Event|0|||
155700972|NCT03210961|561998852|FG005|Overall Study|Adverse Event|0|||
155700973|NCT03210961|561998853|FG006|Overall Study|Adverse Event|0|||
155700974|NCT03210961|561998854|FG007|Overall Study|Adverse Event|0|||
155700975|NCT03210961|561998855|FG008|Overall Study|Adverse Event|0|||
155700976|NCT03210961|561998856|FG009|Overall Study|Adverse Event|0|||
155700977|NCT03210961|561998857|FG010|Overall Study|Adverse Event|0|||
155700978|NCT03210961|561998858|FG011|Overall Study|Adverse Event|0|||
155700979|NCT03210961|561998859|FG012|Overall Study|Adverse Event|0|||
155700980|NCT03210961|561998860|FG013|Overall Study|Adverse Event|1|||
155700981|NCT03210961|561998861|FG014|Overall Study|Adverse Event|0|||
155700982|NCT03210961|561998847|FG000|Overall Study|Lost to Follow-up|0|||
155700983|NCT03210961|561998848|FG001|Overall Study|Lost to Follow-up|0|||
155700984|NCT03210961|561998849|FG002|Overall Study|Lost to Follow-up|0|||
155700985|NCT03210961|561998850|FG003|Overall Study|Lost to Follow-up|0|||
155700986|NCT03210961|561998851|FG004|Overall Study|Lost to Follow-up|0|||
155700987|NCT03210961|561998852|FG005|Overall Study|Lost to Follow-up|0|||
155700988|NCT03210961|561998853|FG006|Overall Study|Lost to Follow-up|0|||
155700989|NCT03210961|561998854|FG007|Overall Study|Lost to Follow-up|0|||
155700990|NCT03210961|561998855|FG008|Overall Study|Lost to Follow-up|0|||
155700991|NCT03210961|561998856|FG009|Overall Study|Lost to Follow-up|0|||
155700992|NCT03210961|561998857|FG010|Overall Study|Lost to Follow-up|0|||
155700993|NCT03210961|561998858|FG011|Overall Study|Lost to Follow-up|0|||
155700994|NCT03210961|561998859|FG012|Overall Study|Lost to Follow-up|0|||
155700995|NCT03210961|561998860|FG013|Overall Study|Lost to Follow-up|0|||
155700996|NCT03210961|561998861|FG014|Overall Study|Lost to Follow-up|1|||
155700997|NCT03210961|561998847|FG000|Overall Study|Withdrawal by Subject|0|||
155700998|NCT03210961|561998848|FG001|Overall Study|Withdrawal by Subject|0|||
155700999|NCT03210961|561998849|FG002|Overall Study|Withdrawal by Subject|0|||
155701000|NCT03210961|561998850|FG003|Overall Study|Withdrawal by Subject|0|||
155701001|NCT03210961|561998851|FG004|Overall Study|Withdrawal by Subject|0|||
155701002|NCT03210961|561998852|FG005|Overall Study|Withdrawal by Subject|0|||
155701003|NCT03210961|561998853|FG006|Overall Study|Withdrawal by Subject|0|||
155701004|NCT03210961|561998854|FG007|Overall Study|Withdrawal by Subject|0|||
155701005|NCT03210961|561998855|FG008|Overall Study|Withdrawal by Subject|0|||
155701006|NCT03210961|561998856|FG009|Overall Study|Withdrawal by Subject|0|||
155701007|NCT03210961|561998857|FG010|Overall Study|Withdrawal by Subject|0|||
155701008|NCT03210961|561998858|FG011|Overall Study|Withdrawal by Subject|0|||
155701009|NCT03210961|561998859|FG012|Overall Study|Withdrawal by Subject|0|||
155701010|NCT03210961|561998860|FG013|Overall Study|Withdrawal by Subject|0|||
155701011|NCT03210961|561998861|FG014|Overall Study|Withdrawal by Subject|1|||
155701012|NCT03210961|561998847|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701013|NCT03210961|561998848|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701014|NCT03210961|561998849|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701015|NCT03210961|561998850|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701016|NCT03210961|561998851|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701017|NCT03210961|561998852|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701018|NCT03210961|561998853|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701019|NCT03210961|561998854|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701020|NCT03210961|561998855|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701021|NCT03210961|561998856|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701022|NCT03210961|561998857|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701023|NCT03210961|561998858|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701024|NCT03210961|561998859|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701025|NCT03210961|561998860|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
155701026|NCT03210961|561998861|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
155701027|NCT03210961|561998847|FG000|Overall Study|Other|0|||
155701028|NCT03210961|561998848|FG001|Overall Study|Other|0|||
155701029|NCT03210961|561998849|FG002|Overall Study|Other|0|||
155701030|NCT03210961|561998850|FG003|Overall Study|Other|1|||
155701031|NCT03210961|561998851|FG004|Overall Study|Other|0|||
155701032|NCT03210961|561998852|FG005|Overall Study|Other|0|||
155701033|NCT03210961|561998853|FG006|Overall Study|Other|1|||
155701034|NCT03210961|561998854|FG007|Overall Study|Other|0|||
155701035|NCT03210961|561998855|FG008|Overall Study|Other|0|||
155701036|NCT03210961|561998856|FG009|Overall Study|Other|0|||
155701037|NCT03210961|561998857|FG010|Overall Study|Other|1|||
155701038|NCT03210961|561998858|FG011|Overall Study|Other|0|||
155701039|NCT03210961|561998859|FG012|Overall Study|Other|2|||
155701040|NCT03210961|561998860|FG013|Overall Study|Other|2|||
155701041|NCT03210961|561998861|FG014|Overall Study|Other|0|||
155701042|NCT02454478|561998867|FG000|Overall Study|Incomplete DLT Evaluation|1|||
155701043|NCT01732770|561998869|FG000|Overall Study|Lost to Follow-up|2|||
155701044|NCT01732770|561998870|FG001|Overall Study|Lost to Follow-up|3|||
155701045|NCT01732770|561998869|FG000|Overall Study|Withdrawal by Subject|5|||
155701046|NCT01732770|561998870|FG001|Overall Study|Withdrawal by Subject|3|||
155701047|NCT01732770|561998869|FG000|Overall Study|Decision by Sponsor|2|||
155701048|NCT01732770|561998870|FG001|Overall Study|Decision by Sponsor|2|||
155701049|NCT01732770|561998869|FG000|Overall Study|Death|1|||
155701050|NCT01732770|561998870|FG001|Overall Study|Death|0|||
155701051|NCT01959841|561998876|FG000|Overall Study|Adverse Event|1|||
155701052|NCT01959841|561998877|FG001|Overall Study|Adverse Event|3|||
155701053|NCT01959841|561998878|FG002|Overall Study|Adverse Event|2|||
155701054|NCT01959841|561998876|FG000|Overall Study|Lack of Efficacy|5|||
155701055|NCT01959841|561998877|FG001|Overall Study|Lack of Efficacy|0|||
155701056|NCT01959841|561998878|FG002|Overall Study|Lack of Efficacy|0|||
155701057|NCT01959841|561998876|FG000|Overall Study|Lost to Follow-up|1|||
155701058|NCT01959841|561998877|FG001|Overall Study|Lost to Follow-up|1|||
155701059|NCT01959841|561998878|FG002|Overall Study|Lost to Follow-up|0|||
155701060|NCT01959841|561998876|FG000|Overall Study|Physician Decision|0|||
155701061|NCT01959841|561998877|FG001|Overall Study|Physician Decision|2|||
155701062|NCT01959841|561998878|FG002|Overall Study|Physician Decision|3|||
155701063|NCT01959841|561998876|FG000|Overall Study|Protocol Violation|16|||
155701064|NCT01959841|561998877|FG001|Overall Study|Protocol Violation|23|||
155701065|NCT01959841|561998878|FG002|Overall Study|Protocol Violation|16|||
155701066|NCT01959841|561998876|FG000|Overall Study|Withdrawal by Subject|7|||
155701067|NCT01959841|561998877|FG001|Overall Study|Withdrawal by Subject|7|||
155701068|NCT01959841|561998878|FG002|Overall Study|Withdrawal by Subject|5|||
155701069|NCT01959841|561998876|FG000|Overall Study|Clinical laboratory value|2|||
155701070|NCT01959841|561998877|FG001|Overall Study|Clinical laboratory value|6|||
155701071|NCT01959841|561998878|FG002|Overall Study|Clinical laboratory value|6|||
155701072|NCT01959841|561998876|FG000|Overall Study|Platelet count below on day1 or 4|11|||
155701073|NCT01959841|561998877|FG001|Overall Study|Platelet count below on day1 or 4|15|||
155701074|NCT01959841|561998878|FG002|Overall Study|Platelet count below on day1 or 4|11|||
155701075|NCT00780416|561998880|FG000|Overall Study|Physician Decision|3|||
155701076|NCT00780416|561998881|FG001|Overall Study|Physician Decision|3|||
155701077|NCT00780416|561998880|FG000|Overall Study|Protocol Violation|1|||
155701078|NCT00780416|561998881|FG001|Overall Study|Protocol Violation|0|||
155701079|NCT00780416|561998880|FG000|Overall Study|Withdrawal by Subject|8|||
155701080|NCT00780416|561998881|FG001|Overall Study|Withdrawal by Subject|6|||
155701081|NCT01450098|561998888|FG000|Period 3|Protocol Violation|0|||
155701082|NCT01450098|561998889|FG001|Period 3|Protocol Violation|1|||
155701083|NCT01450098|561998888|FG000|Period 3|Withdrawal by Subject|0|||
155701084|NCT01450098|561998889|FG001|Period 3|Withdrawal by Subject|2|||
155701085|NCT03828617|561998900|FG000|Overall Study|Lost to Follow-up|22|||
155701086|NCT03828617|561998901|FG001|Overall Study|Lost to Follow-up|12|||
155701087|NCT03828617|561998902|FG002|Overall Study|Lost to Follow-up|23|||
155701088|NCT03828617|561998903|FG003|Overall Study|Lost to Follow-up|7|||
155701089|NCT03828617|561998900|FG000|Overall Study|No longer met eligibility criteria|0|||
155701090|NCT03828617|561998901|FG001|Overall Study|No longer met eligibility criteria|1|||
155701091|NCT03828617|561998902|FG002|Overall Study|No longer met eligibility criteria|1|||
155701092|NCT03828617|561998903|FG003|Overall Study|No longer met eligibility criteria|3|||
155701093|NCT03828617|561998900|FG000|Overall Study|Protocol Violation|0|||
155701094|NCT03828617|561998901|FG001|Overall Study|Protocol Violation|2|||
155701095|NCT03828617|561998902|FG002|Overall Study|Protocol Violation|0|||
155701096|NCT03828617|561998903|FG003|Overall Study|Protocol Violation|0|||
155701097|NCT03828617|561998900|FG000|Overall Study|Withdrawal by Subject|2|||
155701098|NCT03828617|561998901|FG001|Overall Study|Withdrawal by Subject|0|||
155701099|NCT03828617|561998902|FG002|Overall Study|Withdrawal by Subject|2|||
155701100|NCT03828617|561998903|FG003|Overall Study|Withdrawal by Subject|0|||
155701101|NCT03354273|561998904|FG000|Overall Study|Adverse Event|5|||
155701102|NCT03354273|561998904|FG000|Overall Study|Screen Failure|21|||
155701103|NCT03354273|561998904|FG000|Overall Study|Withdrawal by Subject|34|||
155701104|NCT03354273|561998904|FG000|Overall Study|Technical Problems|30|||
155701105|NCT03354273|561998904|FG000|Overall Study|Lost to Follow-up|4|||
155701106|NCT03354273|561998904|FG000|Overall Study|Investigator Decision|3|||
155701107|NCT03354273|561998904|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
155701108|NCT03354273|561998904|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
155701109|NCT03354273|561998904|FG000|Overall Study|COVID-19 Restrictions|9|||
155701110|NCT03354273|561998904|FG000|Overall Study|Other|5|||
155701111|NCT03229109|561998907|FG000|Overall Study|Withdrawal by Subject|0|||
155701112|NCT03229109|561998908|FG001|Overall Study|Withdrawal by Subject|0|||
155701113|NCT03229109|561998909|FG002|Overall Study|Withdrawal by Subject|0|||
155701114|NCT03229109|561998910|FG003|Overall Study|Withdrawal by Subject|1|||
155701115|NCT04207749|561998913|FG000|Overall Study|Lost to Follow-up|0|||
155701116|NCT04207749|561998914|FG001|Overall Study|Lost to Follow-up|2|||
155701117|NCT04207749|561998913|FG000|Overall Study|Protocol Violation|0|||
155701118|NCT04207749|561998914|FG001|Overall Study|Protocol Violation|1|||
155701119|NCT04207749|561998913|FG000|Overall Study|Withdrawal by Subject|3|||
155701120|NCT04207749|561998914|FG001|Overall Study|Withdrawal by Subject|0|||
155701121|NCT04207749|561998913|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
155701122|NCT04207749|561998914|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
155701123|NCT00655629|561998915|FG000|Overall Study|Adverse Event|4|||
155701124|NCT00655629|561998916|FG001|Overall Study|Adverse Event|1|||
155701125|NCT00655629|561998915|FG000|Overall Study|Lack of Efficacy|2|||
155701126|NCT00655629|561998916|FG001|Overall Study|Lack of Efficacy|12|||
155701127|NCT00655629|561998915|FG000|Overall Study|Lost to Follow-up|4|||
155701128|NCT00655629|561998916|FG001|Overall Study|Lost to Follow-up|3|||
155701129|NCT00655629|561998915|FG000|Overall Study|Protocol Violation|5|||
155701130|NCT00655629|561998916|FG001|Overall Study|Protocol Violation|3|||
155701131|NCT00655629|561998915|FG000|Overall Study|consent withdrawn|6|||
155701132|NCT00655629|561998916|FG001|Overall Study|consent withdrawn|4|||
155701133|NCT03416127|561998917|FG000|Overall Study|Withdrawal by Subject|0|||
155701134|NCT03416127|561998918|FG001|Overall Study|Withdrawal by Subject|1|||
155701135|NCT03416127|561998919|FG002|Overall Study|Withdrawal by Subject|1|||
155701136|NCT03387020|561998923|FG000|Overall Study|Adverse Event|0|||
155701137|NCT03387020|561998924|FG001|Overall Study|Adverse Event|2|||
155701138|NCT03387020|561998925|FG002|Overall Study|Adverse Event|0|||
155701139|NCT03387020|561998923|FG000|Overall Study|Withdrawal by Subject|2|||
155701140|NCT03387020|561998924|FG001|Overall Study|Withdrawal by Subject|0|||
155701141|NCT03387020|561998925|FG002|Overall Study|Withdrawal by Subject|0|||
155701142|NCT01452919|561998926|FG000|Open-Label Treatment|Adverse Event|5|||
155701143|NCT01452919|561998927|FG001|Open-Label Treatment|Adverse Event|0|||
155701144|NCT01452919|561998928|FG002|Open-Label Treatment|Adverse Event|0|||
155701145|NCT01452919|561998926|FG000|Open-Label Treatment|Lost to Follow-up|4|||
155701146|NCT01452919|561998927|FG001|Open-Label Treatment|Lost to Follow-up|0|||
155701147|NCT01452919|561998928|FG002|Open-Label Treatment|Lost to Follow-up|0|||
155701148|NCT01452919|561998926|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
155701149|NCT01452919|561998927|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
155701150|NCT01452919|561998928|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
155701151|NCT01452919|561998926|FG000|Open-Label Treatment|Protocol Violation|4|||
155701152|NCT01452919|561998927|FG001|Open-Label Treatment|Protocol Violation|0|||
155701153|NCT01452919|561998928|FG002|Open-Label Treatment|Protocol Violation|0|||
155701154|NCT01452919|561998926|FG000|Open-Label Treatment|Sponsor Decision|1|||
155701155|NCT01452919|561998927|FG001|Open-Label Treatment|Sponsor Decision|0|||
155701156|NCT01452919|561998928|FG002|Open-Label Treatment|Sponsor Decision|0|||
155701157|NCT01452919|561998926|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
155701158|NCT01452919|561998927|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155701159|NCT01452919|561998928|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
155701160|NCT01452919|561998926|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
155701161|NCT01452919|561998927|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
155701162|NCT01452919|561998928|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
155701163|NCT01452919|561998926|FG000|Randomization Treatment|Adverse Event|0|||
155701164|NCT01452919|561998927|FG001|Randomization Treatment|Adverse Event|0|||
155701165|NCT01452919|561998928|FG002|Randomization Treatment|Adverse Event|2|||
155701166|NCT01452919|561998926|FG000|Randomization Treatment|Sponsor Decision|0|||
155701167|NCT01452919|561998927|FG001|Randomization Treatment|Sponsor Decision|1|||
155701168|NCT01452919|561998928|FG002|Randomization Treatment|Sponsor Decision|0|||
155701169|NCT01452919|561998926|FG000|Randomization Treatment|Withdrawal by Subject|0|||
155701170|NCT01452919|561998927|FG001|Randomization Treatment|Withdrawal by Subject|1|||
155701171|NCT01452919|561998928|FG002|Randomization Treatment|Withdrawal by Subject|0|||
155701172|NCT01452919|561998926|FG000|Randomization Treatment|Subject is moving or has moved|0|||
155701173|NCT01452919|561998927|FG001|Randomization Treatment|Subject is moving or has moved|1|||
155701174|NCT01452919|561998928|FG002|Randomization Treatment|Subject is moving or has moved|0|||
155701175|NCT02421588|561998929|FG000|Overall Study|Non-treatment-related AE|8|||
155701176|NCT02421588|561998930|FG001|Overall Study|Non-treatment-related AE|8|||
155701177|NCT02421588|561998929|FG000|Overall Study|Progressive disease|152|||
155701178|NCT02421588|561998930|FG001|Overall Study|Progressive disease|135|||
155701179|NCT02421588|561998929|FG000|Overall Study|Death|11|||
155701180|NCT02421588|561998930|FG001|Overall Study|Death|3|||
155701181|NCT02421588|561998929|FG000|Overall Study|Physician Decision|8|||
155701182|NCT02421588|561998930|FG001|Overall Study|Physician Decision|17|||
155701183|NCT02421588|561998929|FG000|Overall Study|Other reason not specified|3|||
155701184|NCT02421588|561998930|FG001|Overall Study|Other reason not specified|1|||
155701185|NCT02421588|561998929|FG000|Overall Study|Symptomatic deterioration|13|||
155701186|NCT02421588|561998930|FG001|Overall Study|Symptomatic deterioration|19|||
155701187|NCT02421588|561998929|FG000|Overall Study|Treatment-related AE|10|||
155701188|NCT02421588|561998930|FG001|Overall Study|Treatment-related AE|14|||
155701189|NCT02421588|561998929|FG000|Overall Study|Withdrawal by Subject|14|||
155701190|NCT02421588|561998930|FG001|Overall Study|Withdrawal by Subject|16|||
155701191|NCT02421588|561998929|FG000|Overall Study|Not treated|2|||
155701192|NCT02421588|561998930|FG001|Overall Study|Not treated|8|||
155701193|NCT01359943|561998931|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
155701194|NCT01359943|561998932|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
155701195|NCT01359943|561998933|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
155701196|NCT01359943|561998931|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
155701197|NCT01359943|561998932|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
155701198|NCT01359943|561998933|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
155701199|NCT01359943|561998931|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
155701200|NCT01359943|561998932|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
155701201|NCT01359943|561998933|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
155701202|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
155701203|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
155701204|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
155701205|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
155701206|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
155701207|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
155701208|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
155701209|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
155701210|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
155701211|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155701212|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155701213|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155701214|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
155701215|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
155701216|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
155701217|NCT01359943|561998931|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
155701218|NCT01359943|561998932|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
155701219|NCT01359943|561998933|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
155701220|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
155701221|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
155701222|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
155701223|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
155701224|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
155701225|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
155701226|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
155701227|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
155701228|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
155701229|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155701230|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155701231|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155701232|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
155701233|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
155701234|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
155701235|NCT01359943|561998931|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
155701236|NCT01359943|561998932|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
155701237|NCT01359943|561998933|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
155701238|NCT02516592|561998934|FG000|Overall Study|Patient withdrew consent|5|||
155701239|NCT02516592|561998935|FG001|Overall Study|Patient withdrew consent|2|||
155701240|NCT02516592|561998934|FG000|Overall Study|Protocol deviation|4|||
155701241|NCT02516592|561998935|FG001|Overall Study|Protocol deviation|4|||
155701242|NCT02516592|561998934|FG000|Overall Study|Lost to Follow-up|2|||
155701243|NCT02516592|561998935|FG001|Overall Study|Lost to Follow-up|3|||
155701244|NCT02516592|561998934|FG000|Overall Study|Patient/guardian decision|2|||
155701245|NCT02516592|561998935|FG001|Overall Study|Patient/guardian decision|1|||
155701246|NCT02516592|561998934|FG000|Overall Study|Adverse Event|1|||
155701247|NCT02516592|561998935|FG001|Overall Study|Adverse Event|2|||
155701248|NCT02516592|561998934|FG000|Overall Study|Abnormal test procedure result|1|||
155701249|NCT02516592|561998935|FG001|Overall Study|Abnormal test procedure result|0|||
155701250|NCT02516592|561998934|FG000|Overall Study|Death|1|||
155701251|NCT02516592|561998935|FG001|Overall Study|Death|1|||
155701252|NCT01110382|561998936|FG000|Overall Study|Withdrawal by Subject|0|||
155701253|NCT01110382|561998937|FG001|Overall Study|Withdrawal by Subject|1|||
155701254|NCT01110382|561998936|FG000|Overall Study|Protocol Violation|0|||
155701255|NCT01110382|561998937|FG001|Overall Study|Protocol Violation|1|||
155701256|NCT00098306|561998940|FG000|Double Blind|Randomized, not treated|9|||
155701257|NCT00098306|561998941|FG001|Double Blind|Randomized, not treated|5|||
155701258|NCT00098306|561998942|FG002|Double Blind|Randomized, not treated|2|||
155701259|NCT00098306|561998943|FG003|Double Blind|Randomized, not treated|0|||
155701260|NCT00098306|561998944|FG004|Double Blind|Randomized, not treated|0|||
155701261|NCT00098306|561998945|FG005|Double Blind|Randomized, not treated|0|||
155701262|NCT00098306|561998946|FG006|Double Blind|Randomized, not treated|0|||
155701263|NCT00098306|561998940|FG000|Double Blind|Ongoing at cut-off date|151|||
155701264|NCT00098306|561998941|FG001|Double Blind|Ongoing at cut-off date|166|||
155701265|NCT00098306|561998942|FG002|Double Blind|Ongoing at cut-off date|72|||
155701266|NCT00098306|561998943|FG003|Double Blind|Ongoing at cut-off date|0|||
155701267|NCT00098306|561998944|FG004|Double Blind|Ongoing at cut-off date|0|||
155701268|NCT00098306|561998945|FG005|Double Blind|Ongoing at cut-off date|0|||
155701269|NCT00098306|561998946|FG006|Double Blind|Ongoing at cut-off date|0|||
155701270|NCT00098306|561998940|FG000|Double Blind|Adverse Event|11|||
155701271|NCT00098306|561998941|FG001|Double Blind|Adverse Event|10|||
155701272|NCT00098306|561998942|FG002|Double Blind|Adverse Event|6|||
155701273|NCT00098306|561998943|FG003|Double Blind|Adverse Event|0|||
155701274|NCT00098306|561998944|FG004|Double Blind|Adverse Event|0|||
155701275|NCT00098306|561998945|FG005|Double Blind|Adverse Event|0|||
155701276|NCT00098306|561998946|FG006|Double Blind|Adverse Event|0|||
155701277|NCT00098306|561998940|FG000|Double Blind|Lack of Efficacy|43|||
155701278|NCT00098306|561998941|FG001|Double Blind|Lack of Efficacy|34|||
155701279|NCT00098306|561998942|FG002|Double Blind|Lack of Efficacy|17|||
155701280|NCT00098306|561998943|FG003|Double Blind|Lack of Efficacy|0|||
155701281|NCT00098306|561998944|FG004|Double Blind|Lack of Efficacy|0|||
155701282|NCT00098306|561998945|FG005|Double Blind|Lack of Efficacy|0|||
155701283|NCT00098306|561998946|FG006|Double Blind|Lack of Efficacy|0|||
155701284|NCT00098306|561998940|FG000|Double Blind|Death|1|||
155701285|NCT00098306|561998941|FG001|Double Blind|Death|4|||
155701286|NCT00098306|561998942|FG002|Double Blind|Death|1|||
155701287|NCT00098306|561998943|FG003|Double Blind|Death|0|||
155701288|NCT00098306|561998944|FG004|Double Blind|Death|0|||
155701289|NCT00098306|561998945|FG005|Double Blind|Death|0|||
155701290|NCT00098306|561998946|FG006|Double Blind|Death|0|||
155701291|NCT00098306|561998940|FG000|Double Blind|Participant defaulted|19|||
155701292|NCT00098306|561998941|FG001|Double Blind|Participant defaulted|18|||
155701293|NCT00098306|561998942|FG002|Double Blind|Participant defaulted|11|||
155701294|NCT00098306|561998943|FG003|Double Blind|Participant defaulted|0|||
155701295|NCT00098306|561998944|FG004|Double Blind|Participant defaulted|0|||
155701296|NCT00098306|561998945|FG005|Double Blind|Participant defaulted|0|||
155701297|NCT00098306|561998946|FG006|Double Blind|Participant defaulted|0|||
155701298|NCT00098306|561998940|FG000|Double Blind|Un-specified|7|||
155701299|NCT00098306|561998941|FG001|Double Blind|Un-specified|3|||
155701300|NCT00098306|561998942|FG002|Double Blind|Un-specified|11|||
155701301|NCT00098306|561998943|FG003|Double Blind|Un-specified|0|||
155701302|NCT00098306|561998944|FG004|Double Blind|Un-specified|0|||
155701303|NCT00098306|561998945|FG005|Double Blind|Un-specified|0|||
155701304|NCT00098306|561998946|FG006|Double Blind|Un-specified|0|||
155701305|NCT00098306|561998940|FG000|Open Label|Lack of Efficacy|0|||
155701306|NCT00098306|561998941|FG001|Open Label|Lack of Efficacy|0|||
155701307|NCT00098306|561998942|FG002|Open Label|Lack of Efficacy|0|||
155701308|NCT00098306|561998943|FG003|Open Label|Lack of Efficacy|13|||
155701309|NCT00098306|561998944|FG004|Open Label|Lack of Efficacy|0|||
155701310|NCT00098306|561998945|FG005|Open Label|Lack of Efficacy|0|||
155701311|NCT00098306|561998946|FG006|Open Label|Lack of Efficacy|0|||
155701312|NCT00098306|561998940|FG000|Open Label|Adverse Event|0|||
155701313|NCT00098306|561998941|FG001|Open Label|Adverse Event|0|||
155701314|NCT00098306|561998942|FG002|Open Label|Adverse Event|0|||
155701315|NCT00098306|561998943|FG003|Open Label|Adverse Event|2|||
155701316|NCT00098306|561998944|FG004|Open Label|Adverse Event|0|||
155701317|NCT00098306|561998945|FG005|Open Label|Adverse Event|0|||
155701318|NCT00098306|561998946|FG006|Open Label|Adverse Event|0|||
155701319|NCT00098306|561998940|FG000|Open Label|Death|0|||
155701320|NCT00098306|561998941|FG001|Open Label|Death|0|||
155701321|NCT00098306|561998942|FG002|Open Label|Death|0|||
155701322|NCT00098306|561998943|FG003|Open Label|Death|4|||
155701323|NCT00098306|561998944|FG004|Open Label|Death|0|||
155701324|NCT00098306|561998945|FG005|Open Label|Death|0|||
155701325|NCT00098306|561998946|FG006|Open Label|Death|0|||
155701326|NCT00098306|561998940|FG000|Open Label|Participant defaulted|0|||
155701327|NCT00098306|561998941|FG001|Open Label|Participant defaulted|0|||
155701328|NCT00098306|561998942|FG002|Open Label|Participant defaulted|0|||
155701329|NCT00098306|561998943|FG003|Open Label|Participant defaulted|24|||
155701330|NCT00098306|561998944|FG004|Open Label|Participant defaulted|0|||
155701331|NCT00098306|561998945|FG005|Open Label|Participant defaulted|0|||
155701332|NCT00098306|561998946|FG006|Open Label|Participant defaulted|0|||
155701333|NCT00098306|561998940|FG000|Open Label|Un-specified|0|||
155701334|NCT00098306|561998941|FG001|Open Label|Un-specified|0|||
155701335|NCT00098306|561998942|FG002|Open Label|Un-specified|0|||
155701336|NCT00098306|561998943|FG003|Open Label|Un-specified|15|||
155701337|NCT00098306|561998944|FG004|Open Label|Un-specified|0|||
155701338|NCT00098306|561998945|FG005|Open Label|Un-specified|0|||
155701339|NCT00098306|561998946|FG006|Open Label|Un-specified|0|||
155701340|NCT00098306|561998940|FG000|Open Label|Ongoing at cut-off date|0|||
155701341|NCT00098306|561998941|FG001|Open Label|Ongoing at cut-off date|0|||
155701342|NCT00098306|561998942|FG002|Open Label|Ongoing at cut-off date|0|||
155701343|NCT00098306|561998943|FG003|Open Label|Ongoing at cut-off date|269|||
155701344|NCT00098306|561998944|FG004|Open Label|Ongoing at cut-off date|62|||
155701345|NCT00098306|561998945|FG005|Open Label|Ongoing at cut-off date|0|||
155701346|NCT00098306|561998946|FG006|Open Label|Ongoing at cut-off date|0|||
155701347|NCT00098306|561998940|FG000|Observational Phase|Death|0|||
155701348|NCT00098306|561998941|FG001|Observational Phase|Death|0|||
155701349|NCT00098306|561998942|FG002|Observational Phase|Death|0|||
155701350|NCT00098306|561998943|FG003|Observational Phase|Death|0|||
155701351|NCT00098306|561998944|FG004|Observational Phase|Death|0|||
155701352|NCT00098306|561998945|FG005|Observational Phase|Death|5|||
155701353|NCT00098306|561998946|FG006|Observational Phase|Death|4|||
155701354|NCT00098306|561998940|FG000|Observational Phase|Participant defaulted|0|||
155701355|NCT00098306|561998941|FG001|Observational Phase|Participant defaulted|0|||
155701356|NCT00098306|561998942|FG002|Observational Phase|Participant defaulted|0|||
155701357|NCT00098306|561998943|FG003|Observational Phase|Participant defaulted|0|||
155701358|NCT00098306|561998944|FG004|Observational Phase|Participant defaulted|0|||
155701359|NCT00098306|561998945|FG005|Observational Phase|Participant defaulted|34|||
155701360|NCT00098306|561998946|FG006|Observational Phase|Participant defaulted|18|||
155701361|NCT00098306|561998940|FG000|Observational Phase|Un-specified|0|||
155701362|NCT00098306|561998941|FG001|Observational Phase|Un-specified|0|||
155701363|NCT00098306|561998942|FG002|Observational Phase|Un-specified|0|||
155701364|NCT00098306|561998943|FG003|Observational Phase|Un-specified|0|||
155701365|NCT00098306|561998944|FG004|Observational Phase|Un-specified|0|||
155701366|NCT00098306|561998945|FG005|Observational Phase|Un-specified|7|||
155701367|NCT00098306|561998946|FG006|Observational Phase|Un-specified|4|||
155701368|NCT00470418|561998947|FG000|Overall Study|Withdrawal by Subject|1|||
155701369|NCT00470418|561998948|FG001|Overall Study|Withdrawal by Subject|0|||
155701370|NCT03688100|561998951|FG000|Overall Study|Lost to Follow-up|21|||
155701371|NCT03688100|561998952|FG001|Overall Study|Lost to Follow-up|15|||
155701372|NCT03688100|561998953|FG002|Overall Study|Lost to Follow-up|15|||
155701373|NCT03688100|561998954|FG003|Overall Study|Lost to Follow-up|18|||
155701374|NCT03688100|561998951|FG000|Overall Study|Withdrawal by Subject|19|||
155701375|NCT03688100|561998952|FG001|Overall Study|Withdrawal by Subject|16|||
155701376|NCT03688100|561998953|FG002|Overall Study|Withdrawal by Subject|0|||
155701377|NCT03688100|561998954|FG003|Overall Study|Withdrawal by Subject|0|||
155701378|NCT03688100|561998951|FG000|Overall Study|Death|36|||
155701379|NCT03688100|561998952|FG001|Overall Study|Death|27|||
155701380|NCT03688100|561998953|FG002|Overall Study|Death|0|||
155701381|NCT03688100|561998954|FG003|Overall Study|Death|0|||
155701382|NCT01331291|561998960|FG000|Overall Study|Lack of Efficacy|2|||
155701383|NCT01331291|561998961|FG001|Overall Study|Lack of Efficacy|8|||
155701384|NCT01331291|561998960|FG000|Overall Study|Death|0|||
155701385|NCT01331291|561998961|FG001|Overall Study|Death|1|||
155701386|NCT01026220|561998962|FG000|Induction|Death|1|||
155701387|NCT01026220|561998963|FG001|Induction|Death|0|||
155701388|NCT01026220|561998964|FG002|Induction|Death|0|||
155701389|NCT01026220|561998962|FG000|Induction|Lack of Efficacy|2|||
155701390|NCT01026220|561998963|FG001|Induction|Lack of Efficacy|0|||
155701391|NCT01026220|561998964|FG002|Induction|Lack of Efficacy|0|||
155701392|NCT01026220|561998962|FG000|Induction|Physician Decision|12|||
155701393|NCT01026220|561998963|FG001|Induction|Physician Decision|0|||
155701394|NCT01026220|561998964|FG002|Induction|Physician Decision|0|||
155701395|NCT01026220|561998962|FG000|Induction|Withdrawal by Subject|9|||
155701396|NCT01026220|561998963|FG001|Induction|Withdrawal by Subject|0|||
155701397|NCT01026220|561998964|FG002|Induction|Withdrawal by Subject|0|||
155701398|NCT01026220|561998962|FG000|Induction|Ineligible|1|||
155701399|NCT01026220|561998963|FG001|Induction|Ineligible|0|||
155701400|NCT01026220|561998964|FG002|Induction|Ineligible|0|||
155701401|NCT01026220|561998962|FG000|Consolidation Maintenance|Death|0|||
155701402|NCT01026220|561998963|FG001|Consolidation Maintenance|Death|1|||
155701403|NCT01026220|561998964|FG002|Consolidation Maintenance|Death|0|||
155701404|NCT01026220|561998962|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
155701405|NCT01026220|561998963|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
155701406|NCT01026220|561998964|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
155701407|NCT01026220|561998962|FG000|Consolidation Maintenance|Physician Decision|0|||
155701408|NCT01026220|561998963|FG001|Consolidation Maintenance|Physician Decision|2|||
155701409|NCT01026220|561998964|FG002|Consolidation Maintenance|Physician Decision|7|||
155701410|NCT01026220|561998962|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
155701411|NCT01026220|561998963|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
155701412|NCT01026220|561998964|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
155701413|NCT00409344|561998966|FG000|Overall Study|no enrollment|0|||
155701414|NCT00409344|561998967|FG001|Overall Study|no enrollment|0|||
155701415|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
155701416|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
155701417|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
155701418|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
155701419|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
155701420|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
155701421|NCT01389323|561998973|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
155701422|NCT01389323|561998973|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
155701423|NCT01389323|561998973|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
155701424|NCT01389323|561998973|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
155701425|NCT01389323|561998973|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
155701426|NCT01183468|561998974|FG000|Overall Study|Lost to Follow-up|2|||
155701427|NCT01183468|561998975|FG001|Overall Study|Lost to Follow-up|1|||
155701428|NCT01183468|561998976|FG002|Overall Study|Lost to Follow-up|0|||
155701429|NCT01183468|561998977|FG003|Overall Study|Lost to Follow-up|0|||
155701430|NCT01183468|561998974|FG000|Overall Study|Physician Decision|1|||
155701431|NCT01183468|561998975|FG001|Overall Study|Physician Decision|0|||
155701432|NCT01183468|561998976|FG002|Overall Study|Physician Decision|0|||
155701433|NCT01183468|561998977|FG003|Overall Study|Physician Decision|0|||
155701434|NCT01183468|561998974|FG000|Overall Study|Withdrawal by Subject|0|||
155701435|NCT01183468|561998975|FG001|Overall Study|Withdrawal by Subject|1|||
155701436|NCT01183468|561998976|FG002|Overall Study|Withdrawal by Subject|0|||
155701437|NCT01183468|561998977|FG003|Overall Study|Withdrawal by Subject|0|||
155701438|NCT03927404|561998978|FG000|Overall Study|Withdrawal by Subject|1|||
155701439|NCT01300260|561998982|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
155701440|NCT01300260|561998983|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
155701441|NCT01300260|561998982|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
155701442|NCT01300260|561998983|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
155701443|NCT01300260|561998982|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
155701444|NCT01300260|561998983|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
155701445|NCT04033068|561998985|FG000|Overall Study|Withdrawal by Subject|0|||
155701446|NCT04033068|561998986|FG001|Overall Study|Withdrawal by Subject|0|||
155701447|NCT04033068|561998987|FG002|Overall Study|Withdrawal by Subject|1|||
155701448|NCT04033068|561998988|FG003|Overall Study|Withdrawal by Subject|0|||
155701449|NCT04033068|561998985|FG000|Overall Study|Lost to Follow-up|0|||
155701450|NCT04033068|561998986|FG001|Overall Study|Lost to Follow-up|1|||
155701451|NCT04033068|561998987|FG002|Overall Study|Lost to Follow-up|0|||
155701452|NCT04033068|561998988|FG003|Overall Study|Lost to Follow-up|0|||
155701453|NCT04033068|561998985|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155701454|NCT04033068|561998986|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155701455|NCT04033068|561998987|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155701456|NCT04033068|561998988|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
155701457|NCT01069705|561998989|FG000|Overall Study|Adverse Event|1|||
155701458|NCT01069705|561998989|FG000|Overall Study|Withdrawal by Subject|2|||
155701459|NCT02607228|561998990|FG000|Overall Study|Progressive Disease|4|||
155701460|NCT02607228|561998991|FG001|Overall Study|Progressive Disease|3|||
155701461|NCT02607228|561998992|FG002|Overall Study|Progressive Disease|1|||
155701462|NCT02607228|561998993|FG003|Overall Study|Progressive Disease|5|||
155701463|NCT02607228|561998994|FG004|Overall Study|Progressive Disease|4|||
155701464|NCT02607228|561998995|FG005|Overall Study|Progressive Disease|3|||
155701465|NCT02607228|561998996|FG006|Overall Study|Progressive Disease|1|||
155701466|NCT02607228|561998990|FG000|Overall Study|Adverse Event|1|||
155701467|NCT02607228|561998991|FG001|Overall Study|Adverse Event|0|||
155701468|NCT02607228|561998992|FG002|Overall Study|Adverse Event|1|||
155701469|NCT02607228|561998993|FG003|Overall Study|Adverse Event|0|||
155701470|NCT02607228|561998994|FG004|Overall Study|Adverse Event|1|||
155701471|NCT02607228|561998995|FG005|Overall Study|Adverse Event|1|||
155701472|NCT02607228|561998996|FG006|Overall Study|Adverse Event|1|||
155701473|NCT02607228|561998990|FG000|Overall Study|Investigator's Discretion|0|||
155701474|NCT02607228|561998991|FG001|Overall Study|Investigator's Discretion|0|||
155701475|NCT02607228|561998992|FG002|Overall Study|Investigator's Discretion|1|||
155701476|NCT02607228|561998993|FG003|Overall Study|Investigator's Discretion|0|||
155701477|NCT02607228|561998994|FG004|Overall Study|Investigator's Discretion|0|||
155701478|NCT02607228|561998995|FG005|Overall Study|Investigator's Discretion|1|||
155701479|NCT02607228|561998996|FG006|Overall Study|Investigator's Discretion|0|||
155701480|NCT02607228|561998990|FG000|Overall Study|Withdrew Consent|0|||
155701481|NCT02607228|561998991|FG001|Overall Study|Withdrew Consent|1|||
155701482|NCT02607228|561998992|FG002|Overall Study|Withdrew Consent|0|||
155701483|NCT02607228|561998993|FG003|Overall Study|Withdrew Consent|0|||
155701484|NCT02607228|561998994|FG004|Overall Study|Withdrew Consent|0|||
155701485|NCT02607228|561998995|FG005|Overall Study|Withdrew Consent|1|||
155701486|NCT02607228|561998996|FG006|Overall Study|Withdrew Consent|0|||
155701487|NCT02607228|561998990|FG000|Overall Study|Study Terminated by Sponsor|0|||
155701488|NCT02607228|561998991|FG001|Overall Study|Study Terminated by Sponsor|0|||
155701489|NCT02607228|561998992|FG002|Overall Study|Study Terminated by Sponsor|0|||
155701490|NCT02607228|561998993|FG003|Overall Study|Study Terminated by Sponsor|1|||
155701491|NCT02607228|561998994|FG004|Overall Study|Study Terminated by Sponsor|0|||
155701492|NCT02607228|561998995|FG005|Overall Study|Study Terminated by Sponsor|0|||
155701493|NCT02607228|561998996|FG006|Overall Study|Study Terminated by Sponsor|0|||
155701494|NCT04407234|561998997|FG000|Overall Study|Adverse Event|3|||
155701495|NCT04407234|561998998|FG001|Overall Study|Adverse Event|3|||
155701496|NCT00727558|561998999|FG000|Overall Study|Lens issue|0|||
155701497|NCT00727558|561999000|FG001|Overall Study|Lens issue|1|||
155701498|NCT00727558|561998999|FG000|Overall Study|Adverse Event|0|||
155701499|NCT00727558|561999000|FG001|Overall Study|Adverse Event|1|||
155701500|NCT00727558|561998999|FG000|Overall Study|Subject unable to return for follow-up|1|||
155701501|NCT00727558|561999000|FG001|Overall Study|Subject unable to return for follow-up|1|||
155701502|NCT00727558|561998999|FG000|Overall Study|Lost to Follow-up|1|||
155701503|NCT00727558|561999000|FG001|Overall Study|Lost to Follow-up|0|||
155701504|NCT01717326|561999006|FG000|Overall Study|Death|0|||
155701505|NCT01717326|561999007|FG001|Overall Study|Death|0|||
155701506|NCT01717326|561999008|FG002|Overall Study|Death|0|||
155701507|NCT01717326|561999009|FG003|Overall Study|Death|0|||
155701508|NCT01717326|561999010|FG004|Overall Study|Death|0|||
155701509|NCT01717326|561999011|FG005|Overall Study|Death|0|||
155701510|NCT01717326|561999012|FG006|Overall Study|Death|0|||
155701511|NCT01717326|561999013|FG007|Overall Study|Death|0|||
155701512|NCT01717326|561999014|FG008|Overall Study|Death|0|||
155701513|NCT01717326|561999015|FG009|Overall Study|Death|0|||
155701514|NCT01717326|561999016|FG010|Overall Study|Death|1|||
155701515|NCT01717326|561999017|FG011|Overall Study|Death|0|||
155701516|NCT01717326|561999018|FG012|Overall Study|Death|0|||
155701517|NCT01717326|561999019|FG013|Overall Study|Death|0|||
155701518|NCT01717326|561999020|FG014|Overall Study|Death|0|||
155701519|NCT01717326|561999021|FG015|Overall Study|Death|0|||
155701520|NCT01717326|561999022|FG016|Overall Study|Death|0|||
155701521|NCT01717326|561999023|FG017|Overall Study|Death|0|||
155701522|NCT01717326|561999024|FG018|Overall Study|Death|0|||
155701523|NCT01717326|561999025|FG019|Overall Study|Death|0|||
155701524|NCT01717326|561999006|FG000|Overall Study|Lost to Follow-up|3|||
155701525|NCT01717326|561999007|FG001|Overall Study|Lost to Follow-up|0|||
155701526|NCT01717326|561999008|FG002|Overall Study|Lost to Follow-up|0|||
155701527|NCT01717326|561999009|FG003|Overall Study|Lost to Follow-up|2|||
155701528|NCT01717326|561999010|FG004|Overall Study|Lost to Follow-up|1|||
155701529|NCT01717326|561999011|FG005|Overall Study|Lost to Follow-up|0|||
155701530|NCT01717326|561999012|FG006|Overall Study|Lost to Follow-up|1|||
155701531|NCT01717326|561999013|FG007|Overall Study|Lost to Follow-up|0|||
155701532|NCT01717326|561999014|FG008|Overall Study|Lost to Follow-up|0|||
155701533|NCT01717326|561999015|FG009|Overall Study|Lost to Follow-up|0|||
155701534|NCT01717326|561999016|FG010|Overall Study|Lost to Follow-up|1|||
155701535|NCT01717326|561999017|FG011|Overall Study|Lost to Follow-up|0|||
155701536|NCT01717326|561999018|FG012|Overall Study|Lost to Follow-up|0|||
155701537|NCT01717326|561999019|FG013|Overall Study|Lost to Follow-up|0|||
155701538|NCT01717326|561999020|FG014|Overall Study|Lost to Follow-up|0|||
155701539|NCT01717326|561999021|FG015|Overall Study|Lost to Follow-up|2|||
155701540|NCT01717326|561999022|FG016|Overall Study|Lost to Follow-up|1|||
155701541|NCT01717326|561999023|FG017|Overall Study|Lost to Follow-up|0|||
155701542|NCT01717326|561999024|FG018|Overall Study|Lost to Follow-up|2|||
155701543|NCT01717326|561999025|FG019|Overall Study|Lost to Follow-up|3|||
155701544|NCT01717326|561999006|FG000|Overall Study|Physician Decision|0|||
155701545|NCT01717326|561999007|FG001|Overall Study|Physician Decision|0|||
155701546|NCT01717326|561999008|FG002|Overall Study|Physician Decision|0|||
155701547|NCT01717326|561999009|FG003|Overall Study|Physician Decision|0|||
155701548|NCT01717326|561999010|FG004|Overall Study|Physician Decision|0|||
155701549|NCT01717326|561999011|FG005|Overall Study|Physician Decision|0|||
155701550|NCT01717326|561999012|FG006|Overall Study|Physician Decision|0|||
155701551|NCT01717326|561999013|FG007|Overall Study|Physician Decision|0|||
155701552|NCT01717326|561999014|FG008|Overall Study|Physician Decision|0|||
155701553|NCT01717326|561999015|FG009|Overall Study|Physician Decision|1|||
155701554|NCT01717326|561999016|FG010|Overall Study|Physician Decision|0|||
155701555|NCT01717326|561999017|FG011|Overall Study|Physician Decision|0|||
155701556|NCT01717326|561999018|FG012|Overall Study|Physician Decision|0|||
155701557|NCT01717326|561999019|FG013|Overall Study|Physician Decision|0|||
155701558|NCT01717326|561999020|FG014|Overall Study|Physician Decision|0|||
155701559|NCT01717326|561999021|FG015|Overall Study|Physician Decision|0|||
155701560|NCT01717326|561999022|FG016|Overall Study|Physician Decision|0|||
155701561|NCT01717326|561999023|FG017|Overall Study|Physician Decision|0|||
155701562|NCT01717326|561999024|FG018|Overall Study|Physician Decision|0|||
155701563|NCT01717326|561999025|FG019|Overall Study|Physician Decision|0|||
155701564|NCT01717326|561999006|FG000|Overall Study|Protocol Violation|0|||
155701565|NCT01717326|561999007|FG001|Overall Study|Protocol Violation|0|||
155701566|NCT01717326|561999008|FG002|Overall Study|Protocol Violation|0|||
155701567|NCT01717326|561999009|FG003|Overall Study|Protocol Violation|0|||
155701568|NCT01717326|561999010|FG004|Overall Study|Protocol Violation|1|||
155701569|NCT01717326|561999011|FG005|Overall Study|Protocol Violation|0|||
155701570|NCT01717326|561999012|FG006|Overall Study|Protocol Violation|0|||
155701571|NCT01717326|561999013|FG007|Overall Study|Protocol Violation|0|||
155701572|NCT01717326|561999014|FG008|Overall Study|Protocol Violation|0|||
155701573|NCT01717326|561999015|FG009|Overall Study|Protocol Violation|0|||
155701574|NCT01717326|561999016|FG010|Overall Study|Protocol Violation|0|||
155701575|NCT01717326|561999017|FG011|Overall Study|Protocol Violation|0|||
155701576|NCT01717326|561999018|FG012|Overall Study|Protocol Violation|0|||
155701577|NCT01717326|561999019|FG013|Overall Study|Protocol Violation|0|||
155701578|NCT01717326|561999020|FG014|Overall Study|Protocol Violation|0|||
155701579|NCT01717326|561999021|FG015|Overall Study|Protocol Violation|0|||
155701580|NCT01717326|561999022|FG016|Overall Study|Protocol Violation|0|||
155701581|NCT01717326|561999023|FG017|Overall Study|Protocol Violation|0|||
155701582|NCT01717326|561999024|FG018|Overall Study|Protocol Violation|0|||
155701583|NCT01717326|561999025|FG019|Overall Study|Protocol Violation|0|||
155701584|NCT01717326|561999006|FG000|Overall Study|Withdrawal by Subject|0|||
155701585|NCT01717326|561999007|FG001|Overall Study|Withdrawal by Subject|1|||
155701586|NCT01717326|561999008|FG002|Overall Study|Withdrawal by Subject|0|||
155701587|NCT01717326|561999009|FG003|Overall Study|Withdrawal by Subject|0|||
155701588|NCT01717326|561999010|FG004|Overall Study|Withdrawal by Subject|0|||
155701589|NCT01717326|561999011|FG005|Overall Study|Withdrawal by Subject|0|||
155701590|NCT01717326|561999012|FG006|Overall Study|Withdrawal by Subject|0|||
155701591|NCT01717326|561999013|FG007|Overall Study|Withdrawal by Subject|0|||
155701592|NCT01717326|561999014|FG008|Overall Study|Withdrawal by Subject|0|||
155701593|NCT01717326|561999015|FG009|Overall Study|Withdrawal by Subject|1|||
155701594|NCT01717326|561999016|FG010|Overall Study|Withdrawal by Subject|0|||
155701595|NCT01717326|561999017|FG011|Overall Study|Withdrawal by Subject|0|||
155701596|NCT01717326|561999018|FG012|Overall Study|Withdrawal by Subject|1|||
155701597|NCT01717326|561999019|FG013|Overall Study|Withdrawal by Subject|0|||
155701598|NCT01717326|561999020|FG014|Overall Study|Withdrawal by Subject|0|||
155701599|NCT01717326|561999021|FG015|Overall Study|Withdrawal by Subject|1|||
155701600|NCT01717326|561999022|FG016|Overall Study|Withdrawal by Subject|0|||
155701601|NCT01717326|561999023|FG017|Overall Study|Withdrawal by Subject|0|||
155701602|NCT01717326|561999024|FG018|Overall Study|Withdrawal by Subject|2|||
155701603|NCT01717326|561999025|FG019|Overall Study|Withdrawal by Subject|3|||
155701604|NCT00428844|561999030|FG000|Completed Study Drug Treatment|Adverse Event|2|||
155701605|NCT00428844|561999031|FG001|Completed Study Drug Treatment|Adverse Event|4|||
155701606|NCT00428844|561999032|FG002|Completed Study Drug Treatment|Adverse Event|4|||
155701607|NCT00428844|561999030|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
155701608|NCT00428844|561999031|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
155701609|NCT00428844|561999032|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
155701610|NCT00428844|561999030|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
155701611|NCT00428844|561999031|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
155701612|NCT00428844|561999032|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
155701613|NCT00428844|561999030|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
155701614|NCT00428844|561999031|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
155701615|NCT00428844|561999032|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
155701616|NCT00428844|561999030|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
155701617|NCT00428844|561999031|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
155701618|NCT00428844|561999032|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
155701619|NCT00428844|561999030|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
155701620|NCT00428844|561999031|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
155701621|NCT00428844|561999032|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
155701622|NCT00428844|561999030|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
155701623|NCT00428844|561999031|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
155701624|NCT00428844|561999032|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
155701625|NCT00428844|561999030|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
155701626|NCT00428844|561999031|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
155701627|NCT00428844|561999032|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
155701628|NCT00428844|561999030|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
155701629|NCT00428844|561999031|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
155701630|NCT00428844|561999032|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
155701631|NCT02292706|561999035|FG000|Overall Study|Lost to Follow-up|20|||
155701632|NCT02292706|561999036|FG001|Overall Study|Lost to Follow-up|44|||
155701633|NCT02292706|561999037|FG002|Overall Study|Lost to Follow-up|24|||
155701634|NCT02292706|561999038|FG003|Overall Study|Lost to Follow-up|61|||
155701635|NCT02292706|561999039|FG004|Overall Study|Lost to Follow-up|21|||
155701636|NCT02292706|561999040|FG005|Overall Study|Lost to Follow-up|52|||
155701637|NCT02292706|561999041|FG006|Overall Study|Lost to Follow-up|25|||
155701638|NCT02292706|561999042|FG007|Overall Study|Lost to Follow-up|0|||
155701639|NCT02292706|561999035|FG000|Overall Study|Withdrew consent|15|||
155701640|NCT02292706|561999036|FG001|Overall Study|Withdrew consent|56|||
155701641|NCT02292706|561999037|FG002|Overall Study|Withdrew consent|43|||
155701642|NCT02292706|561999038|FG003|Overall Study|Withdrew consent|36|||
155701643|NCT02292706|561999039|FG004|Overall Study|Withdrew consent|13|||
155701644|NCT02292706|561999040|FG005|Overall Study|Withdrew consent|51|||
155701645|NCT02292706|561999041|FG006|Overall Study|Withdrew consent|20|||
155701646|NCT02292706|561999042|FG007|Overall Study|Withdrew consent|0|||
155701647|NCT02292706|561999035|FG000|Overall Study|Death|3|||
155701648|NCT02292706|561999036|FG001|Overall Study|Death|11|||
155701649|NCT02292706|561999037|FG002|Overall Study|Death|16|||
155701650|NCT02292706|561999038|FG003|Overall Study|Death|22|||
155701651|NCT02292706|561999039|FG004|Overall Study|Death|8|||
155701652|NCT02292706|561999040|FG005|Overall Study|Death|17|||
155701653|NCT02292706|561999041|FG006|Overall Study|Death|3|||
155701654|NCT02292706|561999042|FG007|Overall Study|Death|0|||
155701655|NCT02292706|561999035|FG000|Overall Study|Study terminated by sponsor|0|||
155701656|NCT02292706|561999036|FG001|Overall Study|Study terminated by sponsor|9|||
155701657|NCT02292706|561999037|FG002|Overall Study|Study terminated by sponsor|4|||
155701658|NCT02292706|561999038|FG003|Overall Study|Study terminated by sponsor|21|||
155701659|NCT02292706|561999039|FG004|Overall Study|Study terminated by sponsor|11|||
155701660|NCT02292706|561999040|FG005|Overall Study|Study terminated by sponsor|13|||
155701661|NCT02292706|561999041|FG006|Overall Study|Study terminated by sponsor|3|||
155701662|NCT02292706|561999042|FG007|Overall Study|Study terminated by sponsor|0|||
155701663|NCT02292706|561999035|FG000|Overall Study|Investigator's discretion|4|||
155701664|NCT02292706|561999036|FG001|Overall Study|Investigator's discretion|9|||
155701665|NCT02292706|561999037|FG002|Overall Study|Investigator's discretion|7|||
155701666|NCT02292706|561999038|FG003|Overall Study|Investigator's discretion|11|||
155701667|NCT02292706|561999039|FG004|Overall Study|Investigator's discretion|4|||
155701668|NCT02292706|561999040|FG005|Overall Study|Investigator's discretion|10|||
155701669|NCT02292706|561999041|FG006|Overall Study|Investigator's discretion|1|||
155701670|NCT02292706|561999042|FG007|Overall Study|Investigator's discretion|0|||
155701671|NCT02292706|561999035|FG000|Overall Study|Liver transplant|1|||
155701672|NCT02292706|561999036|FG001|Overall Study|Liver transplant|1|||
155701673|NCT02292706|561999037|FG002|Overall Study|Liver transplant|11|||
155701674|NCT02292706|561999038|FG003|Overall Study|Liver transplant|16|||
155701675|NCT02292706|561999039|FG004|Overall Study|Liver transplant|5|||
155701676|NCT02292706|561999040|FG005|Overall Study|Liver transplant|6|||
155701677|NCT02292706|561999041|FG006|Overall Study|Liver transplant|5|||
155701678|NCT02292706|561999042|FG007|Overall Study|Liver transplant|0|||
155701679|NCT02292706|561999035|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
155701680|NCT02292706|561999036|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
155701681|NCT02292706|561999037|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
155701682|NCT02292706|561999038|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
155701683|NCT02292706|561999039|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
155701684|NCT02292706|561999040|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
155701685|NCT02292706|561999041|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
155701686|NCT02292706|561999042|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
155701687|NCT02292706|561999035|FG000|Overall Study|Subject terminated by sponsor|1|||
155701688|NCT02292706|561999036|FG001|Overall Study|Subject terminated by sponsor|0|||
155701689|NCT02292706|561999037|FG002|Overall Study|Subject terminated by sponsor|0|||
155701690|NCT02292706|561999038|FG003|Overall Study|Subject terminated by sponsor|2|||
155701691|NCT02292706|561999039|FG004|Overall Study|Subject terminated by sponsor|1|||
155701692|NCT02292706|561999040|FG005|Overall Study|Subject terminated by sponsor|0|||
155701693|NCT02292706|561999041|FG006|Overall Study|Subject terminated by sponsor|0|||
155701694|NCT02292706|561999042|FG007|Overall Study|Subject terminated by sponsor|0|||
155701695|NCT02292706|561999035|FG000|Overall Study|Missing|0|||
155701696|NCT02292706|561999036|FG001|Overall Study|Missing|0|||
155701697|NCT02292706|561999037|FG002|Overall Study|Missing|1|||
155701698|NCT02292706|561999038|FG003|Overall Study|Missing|1|||
155701699|NCT02292706|561999039|FG004|Overall Study|Missing|0|||
155701700|NCT02292706|561999040|FG005|Overall Study|Missing|1|||
155701701|NCT02292706|561999041|FG006|Overall Study|Missing|0|||
155701702|NCT02292706|561999042|FG007|Overall Study|Missing|0|||
155701703|NCT02292706|561999035|FG000|Overall Study|Virologic relapse or reinfection|1|||
155701704|NCT02292706|561999036|FG001|Overall Study|Virologic relapse or reinfection|0|||
155701705|NCT02292706|561999037|FG002|Overall Study|Virologic relapse or reinfection|0|||
155701706|NCT02292706|561999038|FG003|Overall Study|Virologic relapse or reinfection|1|||
155701707|NCT02292706|561999039|FG004|Overall Study|Virologic relapse or reinfection|0|||
155701708|NCT02292706|561999040|FG005|Overall Study|Virologic relapse or reinfection|1|||
155701709|NCT02292706|561999041|FG006|Overall Study|Virologic relapse or reinfection|0|||
155701710|NCT02292706|561999042|FG007|Overall Study|Virologic relapse or reinfection|0|||
155701711|NCT01990612|561999045|FG000|Overall Study|Lost to Follow-up|2|||
155701712|NCT01990612|561999046|FG001|Overall Study|Lost to Follow-up|1|||
155701713|NCT01990612|561999045|FG000|Overall Study|Withdrawal by Subject|5|||
155701714|NCT01990612|561999046|FG001|Overall Study|Withdrawal by Subject|2|||
155701715|NCT02188849|561999048|FG000|Overall Study|Lost to Follow-up|3|||
155701716|NCT02188849|561999049|FG001|Overall Study|Lost to Follow-up|8|||
155701717|NCT03208088|561999051|FG000|Period 2|Withdrawal by Subject|0|||
155701718|NCT03208088|561999052|FG001|Period 2|Withdrawal by Subject|0|||
155701719|NCT03208088|561999053|FG002|Period 2|Withdrawal by Subject|0|||
155701720|NCT03208088|561999054|FG003|Period 2|Withdrawal by Subject|0|||
155701721|NCT03208088|561999055|FG004|Period 2|Withdrawal by Subject|0|||
155701722|NCT03208088|561999056|FG005|Period 2|Withdrawal by Subject|0|||
155701723|NCT03208088|561999057|FG006|Period 2|Withdrawal by Subject|0|||
155701724|NCT03208088|561999058|FG007|Period 2|Withdrawal by Subject|0|||
155701725|NCT03208088|561999059|FG008|Period 2|Withdrawal by Subject|1|||
155701726|NCT03208088|561999060|FG009|Period 2|Withdrawal by Subject|0|||
155701727|NCT03208088|561999051|FG000|Period 3|Unsatisfactory Test Article|0|||
155701728|NCT03208088|561999052|FG001|Period 3|Unsatisfactory Test Article|0|||
155701729|NCT03208088|561999053|FG002|Period 3|Unsatisfactory Test Article|0|||
155701730|NCT03208088|561999054|FG003|Period 3|Unsatisfactory Test Article|1|||
155701731|NCT03208088|561999055|FG004|Period 3|Unsatisfactory Test Article|0|||
155701732|NCT03208088|561999056|FG005|Period 3|Unsatisfactory Test Article|0|||
155701733|NCT03208088|561999057|FG006|Period 3|Unsatisfactory Test Article|0|||
155701734|NCT03208088|561999058|FG007|Period 3|Unsatisfactory Test Article|0|||
155701735|NCT03208088|561999059|FG008|Period 3|Unsatisfactory Test Article|0|||
155701736|NCT03208088|561999060|FG009|Period 3|Unsatisfactory Test Article|0|||
155701737|NCT03208088|561999051|FG000|Period 4|Unsatisfactory Test Article|0|||
155701738|NCT03208088|561999052|FG001|Period 4|Unsatisfactory Test Article|0|||
155701739|NCT03208088|561999053|FG002|Period 4|Unsatisfactory Test Article|0|||
155701740|NCT03208088|561999054|FG003|Period 4|Unsatisfactory Test Article|1|||
155701741|NCT03208088|561999055|FG004|Period 4|Unsatisfactory Test Article|0|||
155701742|NCT03208088|561999056|FG005|Period 4|Unsatisfactory Test Article|0|||
155701743|NCT03208088|561999057|FG006|Period 4|Unsatisfactory Test Article|0|||
155701744|NCT03208088|561999058|FG007|Period 4|Unsatisfactory Test Article|0|||
155701745|NCT03208088|561999059|FG008|Period 4|Unsatisfactory Test Article|0|||
155701746|NCT03208088|561999060|FG009|Period 4|Unsatisfactory Test Article|0|||
155701747|NCT00812565|561999063|FG000|Overall Study|Did Not Receive Study Medication|1|||
155701748|NCT00812565|561999064|FG001|Overall Study|Did Not Receive Study Medication|1|||
155701749|NCT00812565|561999065|FG002|Overall Study|Did Not Receive Study Medication|0|||
155701750|NCT00812565|561999066|FG003|Overall Study|Did Not Receive Study Medication|0|||
155701751|NCT00812565|561999067|FG004|Overall Study|Did Not Receive Study Medication|0|||
155701752|NCT00812565|561999068|FG005|Overall Study|Did Not Receive Study Medication|0|||
155701753|NCT00812565|561999069|FG006|Overall Study|Did Not Receive Study Medication|0|||
155701754|NCT00812565|561999070|FG007|Overall Study|Did Not Receive Study Medication|0|||
155701755|NCT00812565|561999063|FG000|Overall Study|Adverse Event|0|||
155701756|NCT00812565|561999064|FG001|Overall Study|Adverse Event|0|||
155701757|NCT00812565|561999065|FG002|Overall Study|Adverse Event|0|||
155701758|NCT00812565|561999066|FG003|Overall Study|Adverse Event|2|||
155701759|NCT00812565|561999067|FG004|Overall Study|Adverse Event|0|||
155701760|NCT00812565|561999068|FG005|Overall Study|Adverse Event|0|||
155701761|NCT00812565|561999069|FG006|Overall Study|Adverse Event|0|||
155701762|NCT00812565|561999070|FG007|Overall Study|Adverse Event|1|||
155701763|NCT00812565|561999063|FG000|Overall Study|Did Not Come to Study Visit|1|||
155701764|NCT00812565|561999064|FG001|Overall Study|Did Not Come to Study Visit|0|||
155701765|NCT00812565|561999065|FG002|Overall Study|Did Not Come to Study Visit|0|||
155701766|NCT00812565|561999066|FG003|Overall Study|Did Not Come to Study Visit|0|||
155701767|NCT00812565|561999067|FG004|Overall Study|Did Not Come to Study Visit|0|||
155701768|NCT00812565|561999068|FG005|Overall Study|Did Not Come to Study Visit|0|||
155701769|NCT00812565|561999069|FG006|Overall Study|Did Not Come to Study Visit|0|||
155701770|NCT00812565|561999070|FG007|Overall Study|Did Not Come to Study Visit|0|||
155701771|NCT00812565|561999063|FG000|Overall Study|Withdrawal of Consent|1|||
155701772|NCT00812565|561999064|FG001|Overall Study|Withdrawal of Consent|0|||
155701773|NCT00812565|561999065|FG002|Overall Study|Withdrawal of Consent|0|||
155701774|NCT00812565|561999066|FG003|Overall Study|Withdrawal of Consent|0|||
155701775|NCT00812565|561999067|FG004|Overall Study|Withdrawal of Consent|1|||
155701776|NCT00812565|561999068|FG005|Overall Study|Withdrawal of Consent|0|||
155701777|NCT00812565|561999069|FG006|Overall Study|Withdrawal of Consent|0|||
155701778|NCT00812565|561999070|FG007|Overall Study|Withdrawal of Consent|0|||
155701779|NCT00812565|561999063|FG000|Overall Study|Reason Not Specified|0|||
155701780|NCT00812565|561999064|FG001|Overall Study|Reason Not Specified|0|||
155701781|NCT00812565|561999065|FG002|Overall Study|Reason Not Specified|0|||
155701782|NCT00812565|561999066|FG003|Overall Study|Reason Not Specified|0|||
155701783|NCT00812565|561999067|FG004|Overall Study|Reason Not Specified|0|||
155701784|NCT00812565|561999068|FG005|Overall Study|Reason Not Specified|1|||
155701785|NCT00812565|561999069|FG006|Overall Study|Reason Not Specified|0|||
155701786|NCT00812565|561999070|FG007|Overall Study|Reason Not Specified|0|||
155701787|NCT00422383|561999073|FG000|Overall Study|Adverse Event|5|||
155701788|NCT00422383|561999074|FG001|Overall Study|Adverse Event|3|||
155701789|NCT00422383|561999075|FG002|Overall Study|Adverse Event|1|||
155701790|NCT00422383|561999076|FG003|Overall Study|Adverse Event|1|||
155701791|NCT00422383|561999077|FG004|Overall Study|Adverse Event|0|||
155701792|NCT00422383|561999073|FG000|Overall Study|Lack of Efficacy|4|||
155701793|NCT00422383|561999074|FG001|Overall Study|Lack of Efficacy|4|||
155701794|NCT00422383|561999075|FG002|Overall Study|Lack of Efficacy|2|||
155701795|NCT00422383|561999076|FG003|Overall Study|Lack of Efficacy|1|||
155701796|NCT00422383|561999077|FG004|Overall Study|Lack of Efficacy|1|||
155701797|NCT00422383|561999073|FG000|Overall Study|Lost to Follow-up|0|||
155701798|NCT00422383|561999074|FG001|Overall Study|Lost to Follow-up|1|||
155701799|NCT00422383|561999075|FG002|Overall Study|Lost to Follow-up|0|||
155701800|NCT00422383|561999076|FG003|Overall Study|Lost to Follow-up|0|||
155701801|NCT00422383|561999077|FG004|Overall Study|Lost to Follow-up|1|||
155701802|NCT00422383|561999073|FG000|Overall Study|Protocol Violation|1|||
155701803|NCT00422383|561999074|FG001|Overall Study|Protocol Violation|1|||
155701804|NCT00422383|561999075|FG002|Overall Study|Protocol Violation|1|||
155701805|NCT00422383|561999076|FG003|Overall Study|Protocol Violation|0|||
155701806|NCT00422383|561999077|FG004|Overall Study|Protocol Violation|0|||
155701807|NCT00422383|561999073|FG000|Overall Study|Withdrawal by Subject|5|||
155701808|NCT00422383|561999074|FG001|Overall Study|Withdrawal by Subject|5|||
155701809|NCT00422383|561999075|FG002|Overall Study|Withdrawal by Subject|0|||
155701810|NCT00422383|561999076|FG003|Overall Study|Withdrawal by Subject|0|||
155701811|NCT00422383|561999077|FG004|Overall Study|Withdrawal by Subject|1|||
155701812|NCT00566254|561999078|FG000|Overall Study|Adverse Event|3|||
155701813|NCT00566254|561999079|FG001|Overall Study|Adverse Event|1|||
155701814|NCT00566254|561999078|FG000|Overall Study|Protocol Violation|1|||
155701815|NCT00566254|561999079|FG001|Overall Study|Protocol Violation|3|||
155701816|NCT00566254|561999078|FG000|Overall Study|Withdrawal by Subject|1|||
155701817|NCT00566254|561999079|FG001|Overall Study|Withdrawal by Subject|2|||
155701818|NCT00566254|561999078|FG000|Overall Study|Lack of Efficacy|5|||
155701819|NCT00566254|561999079|FG001|Overall Study|Lack of Efficacy|6|||
155701820|NCT00566254|561999078|FG000|Overall Study|Other|0|||
155701821|NCT00566254|561999079|FG001|Overall Study|Other|2|||
155701822|NCT01793883|561999080|FG000|Overall Study|Withdrawal by Subject|3|||
155701823|NCT01793883|561999081|FG001|Overall Study|Withdrawal by Subject|7|||
155701824|NCT01793883|561999082|FG002|Overall Study|Withdrawal by Subject|3|||
155701825|NCT01793883|561999080|FG000|Overall Study|Subject noncompliance|0|||
155701826|NCT01793883|561999081|FG001|Overall Study|Subject noncompliance|1|||
155701827|NCT01793883|561999082|FG002|Overall Study|Subject noncompliance|1|||
155701828|NCT01793883|561999080|FG000|Overall Study|Lost to Follow-up|5|||
155701829|NCT01793883|561999081|FG001|Overall Study|Lost to Follow-up|1|||
155701830|NCT01793883|561999082|FG002|Overall Study|Lost to Follow-up|3|||
155701831|NCT01793883|561999080|FG000|Overall Study|Randomized in error|1|||
155701832|NCT01793883|561999081|FG001|Overall Study|Randomized in error|0|||
155701833|NCT01793883|561999082|FG002|Overall Study|Randomized in error|0|||
155701834|NCT01793883|561999080|FG000|Overall Study|Unable to complete spriometry|1|||
155701835|NCT01793883|561999081|FG001|Overall Study|Unable to complete spriometry|0|||
155701836|NCT01793883|561999082|FG002|Overall Study|Unable to complete spriometry|0|||
155701837|NCT01793883|561999080|FG000|Overall Study|Unable to complete measurements|1|||
155701838|NCT01793883|561999081|FG001|Overall Study|Unable to complete measurements|0|||
155701839|NCT01793883|561999082|FG002|Overall Study|Unable to complete measurements|0|||
155701840|NCT01793883|561999080|FG000|Overall Study|Met exclusion criteria|1|||
155701841|NCT01793883|561999081|FG001|Overall Study|Met exclusion criteria|0|||
155701842|NCT01793883|561999082|FG002|Overall Study|Met exclusion criteria|0|||
155701843|NCT01793883|561999080|FG000|Overall Study|Dosing error|0|||
155701844|NCT01793883|561999081|FG001|Overall Study|Dosing error|1|||
155701845|NCT01793883|561999082|FG002|Overall Study|Dosing error|0|||
155701846|NCT01793883|561999080|FG000|Overall Study|Respiratory distress during spirometry|0|||
155701847|NCT01793883|561999081|FG001|Overall Study|Respiratory distress during spirometry|0|||
155701848|NCT01793883|561999082|FG002|Overall Study|Respiratory distress during spirometry|1|||
155701849|NCT00687531|561999085|FG000|Overall Study|Did not meet protocol eligibility|104|||
155701850|NCT00687531|561999085|FG000|Overall Study|Adverse Event|5|||
155701851|NCT00687531|561999085|FG000|Overall Study|Lost to Follow-up|26|||
155701852|NCT02353728|561999086|FG000|Overall Study|Subject non-compliance|1|||
155701853|NCT00895310|561999087|FG000|Overall Study|Withdrawal by Subject|1|||
155701854|NCT00659230|561999088|FG000|Overall Study|Lost to Follow-up|2|||
155701855|NCT00659230|561999089|FG001|Overall Study|Lost to Follow-up|5|||
155701856|NCT00659230|561999088|FG000|Overall Study|Lost source documentation|5|||
155701857|NCT00659230|561999089|FG001|Overall Study|Lost source documentation|4|||
155701858|NCT00659230|561999088|FG000|Overall Study|Did not return post-randomization|2|||
155701859|NCT00659230|561999089|FG001|Overall Study|Did not return post-randomization|3|||
155701860|NCT05066165|562001085|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
155701861|NCT05066165|562001086|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
155701862|NCT05066165|562001085|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
155701863|NCT05066165|562001086|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
155701864|NCT02467582|562001087|FG000|Allocation|Withdrawal by Subject|1|||
155701865|NCT02467582|562001088|FG001|Allocation|Withdrawal by Subject|0|||
155701866|NCT02467582|562001087|FG000|Follow-up|Death|5|||
155701867|NCT02467582|562001088|FG001|Follow-up|Death|4|||
155701868|NCT02467582|562001087|FG000|Follow-up|Lost to Follow-up|6|||
155701869|NCT02467582|562001088|FG001|Follow-up|Lost to Follow-up|5|||
155701870|NCT01370265|562001089|FG000|First Intervention|Adverse Event|1|||
155701871|NCT01370265|562001090|FG001|First Intervention|Adverse Event|1|||
155701872|NCT03343626|562001091|FG000|Overall Study|Lost to Follow-up|4|||
155701873|NCT03343626|562001092|FG001|Overall Study|Lost to Follow-up|3|||
155701874|NCT03343626|562001093|FG002|Overall Study|Lost to Follow-up|2|||
155701875|NCT03343626|562001094|FG003|Overall Study|Lost to Follow-up|5|||
155701876|NCT03343626|562001095|FG004|Overall Study|Lost to Follow-up|4|||
155701877|NCT03343626|562001096|FG005|Overall Study|Lost to Follow-up|4|||
155701878|NCT03343626|562001097|FG006|Overall Study|Lost to Follow-up|4|||
155701879|NCT03343626|562001098|FG007|Overall Study|Lost to Follow-up|7|||
155701880|NCT03343626|562001091|FG000|Overall Study|Withdrawal of Consent|2|||
155701881|NCT03343626|562001092|FG001|Overall Study|Withdrawal of Consent|1|||
155701882|NCT03343626|562001093|FG002|Overall Study|Withdrawal of Consent|0|||
155701883|NCT03343626|562001094|FG003|Overall Study|Withdrawal of Consent|3|||
155701884|NCT03343626|562001095|FG004|Overall Study|Withdrawal of Consent|3|||
155701885|NCT03343626|562001096|FG005|Overall Study|Withdrawal of Consent|1|||
155701886|NCT03343626|562001097|FG006|Overall Study|Withdrawal of Consent|1|||
155701887|NCT03343626|562001098|FG007|Overall Study|Withdrawal of Consent|2|||
155701888|NCT03343626|562001091|FG000|Overall Study|Reason not Specified|0|||
155701889|NCT03343626|562001092|FG001|Overall Study|Reason not Specified|1|||
155701890|NCT03343626|562001093|FG002|Overall Study|Reason not Specified|0|||
155701891|NCT03343626|562001094|FG003|Overall Study|Reason not Specified|0|||
155701892|NCT03343626|562001095|FG004|Overall Study|Reason not Specified|0|||
155701893|NCT03343626|562001096|FG005|Overall Study|Reason not Specified|0|||
155701894|NCT03343626|562001097|FG006|Overall Study|Reason not Specified|0|||
155701895|NCT03343626|562001098|FG007|Overall Study|Reason not Specified|1|||
155701896|NCT03343626|562001091|FG000|Overall Study|Data Entry Error|0|||
155701897|NCT03343626|562001092|FG001|Overall Study|Data Entry Error|0|||
155701898|NCT03343626|562001093|FG002|Overall Study|Data Entry Error|0|||
155701899|NCT03343626|562001094|FG003|Overall Study|Data Entry Error|0|||
155701900|NCT03343626|562001095|FG004|Overall Study|Data Entry Error|0|||
155701901|NCT03343626|562001096|FG005|Overall Study|Data Entry Error|0|||
155701902|NCT03343626|562001097|FG006|Overall Study|Data Entry Error|0|||
155701903|NCT03343626|562001098|FG007|Overall Study|Data Entry Error|1|||
155701904|NCT00703924|562001099|FG000|Overall Study|Withdrawal by Subject|1|||
155701905|NCT00703924|562001100|FG001|Overall Study|Withdrawal by Subject|1|||
155701906|NCT01031979|562001103|FG000|Overall Study|Lost to Follow-up|5|||
155701907|NCT01031979|562001104|FG001|Overall Study|Lost to Follow-up|4|||
155701908|NCT03592368|562001106|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155701909|NCT03592368|562001107|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
155701910|NCT03592368|562001108|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155701911|NCT03592368|562001109|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155701912|NCT03592368|562001106|FG000|Overall Study|Adverse Event|0|||
155701913|NCT03592368|562001107|FG001|Overall Study|Adverse Event|0|||
155701914|NCT03592368|562001108|FG002|Overall Study|Adverse Event|0|||
155701915|NCT03592368|562001109|FG003|Overall Study|Adverse Event|1|||
155701916|NCT03592368|562001106|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
155701917|NCT03592368|562001107|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
155701918|NCT03592368|562001108|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
155701919|NCT03592368|562001109|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
155701920|NCT03831100|562001110|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
155701921|NCT03831100|562001111|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
155701922|NCT03047031|562001119|FG000|Overall Study|Other than listed|1|||
155701923|NCT03047031|562001120|FG001|Overall Study|Other than listed|0|||
155701924|NCT03047031|562001121|FG002|Overall Study|Other than listed|0|||
155701925|NCT03047031|562001119|FG000|Overall Study|Lost to Follow-up|4|||
155701926|NCT03047031|562001120|FG001|Overall Study|Lost to Follow-up|0|||
155701927|NCT03047031|562001121|FG002|Overall Study|Lost to Follow-up|0|||
155701928|NCT03047031|562001119|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
155701929|NCT03047031|562001120|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
155701930|NCT03047031|562001121|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
155701931|NCT03047031|562001119|FG000|Overall Study|Adverse Event|1|||
155701932|NCT03047031|562001120|FG001|Overall Study|Adverse Event|0|||
155701933|NCT03047031|562001121|FG002|Overall Study|Adverse Event|0|||
155701934|NCT03047031|562001119|FG000|Overall Study|Withdrawal by Subject|2|||
155701935|NCT03047031|562001120|FG001|Overall Study|Withdrawal by Subject|0|||
155701936|NCT03047031|562001121|FG002|Overall Study|Withdrawal by Subject|0|||
155701937|NCT03047031|562001119|FG000|Overall Study|Change to other medication|2|||
155701938|NCT03047031|562001120|FG001|Overall Study|Change to other medication|0|||
155701939|NCT03047031|562001121|FG002|Overall Study|Change to other medication|0|||
155701940|NCT03047031|562001119|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
155701941|NCT03047031|562001120|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
155701942|NCT03047031|562001121|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
155701943|NCT00666224|562001124|FG000|Double-Blind|Adverse Event|15|||
155701944|NCT00666224|562001125|FG001|Double-Blind|Adverse Event|5|||
155701945|NCT00666224|562001124|FG000|Double-Blind|Lost to Follow-up|2|||
155701946|NCT00666224|562001125|FG001|Double-Blind|Lost to Follow-up|2|||
155701947|NCT00666224|562001124|FG000|Double-Blind|Withdrawal by Subject|18|||
155701948|NCT00666224|562001125|FG001|Double-Blind|Withdrawal by Subject|14|||
155701949|NCT00666224|562001124|FG000|Double-Blind|Physician Decision|0|||
155701950|NCT00666224|562001125|FG001|Double-Blind|Physician Decision|3|||
155701951|NCT00666224|562001124|FG000|Double-Blind|Sponsor decision|1|||
155701952|NCT00666224|562001125|FG001|Double-Blind|Sponsor decision|0|||
155701953|NCT00666224|562001124|FG000|Double-Blind|Pregnancy|3|||
155701954|NCT00666224|562001125|FG001|Double-Blind|Pregnancy|2|||
155701955|NCT00666224|562001124|FG000|Double-Blind|Noncompliance|1|||
155701956|NCT00666224|562001125|FG001|Double-Blind|Noncompliance|0|||
155701957|NCT00666224|562001124|FG000|Double-Blind|Death|1|||
155701958|NCT00666224|562001125|FG001|Double-Blind|Death|0|||
155701959|NCT00666224|562001124|FG000|Double-Blind|Undefined/Unknown|4|||
155701960|NCT00666224|562001125|FG001|Double-Blind|Undefined/Unknown|1|||
155701961|NCT00666224|562001124|FG000|Open-Label|Adverse Event|8|||
155701962|NCT00666224|562001125|FG001|Open-Label|Adverse Event|43|||
155701963|NCT00666224|562001124|FG000|Open-Label|Lost to Follow-up|4|||
155701964|NCT00666224|562001125|FG001|Open-Label|Lost to Follow-up|5|||
155701965|NCT00666224|562001124|FG000|Open-Label|Withdrawal by Subject|12|||
155701966|NCT00666224|562001125|FG001|Open-Label|Withdrawal by Subject|25|||
155701967|NCT00666224|562001124|FG000|Open-Label|Physician Decision|7|||
155701968|NCT00666224|562001125|FG001|Open-Label|Physician Decision|5|||
155701969|NCT00666224|562001124|FG000|Open-Label|Pregnancy|1|||
155701970|NCT00666224|562001125|FG001|Open-Label|Pregnancy|5|||
155701971|NCT00666224|562001124|FG000|Open-Label|Noncompliance|2|||
155701972|NCT00666224|562001125|FG001|Open-Label|Noncompliance|1|||
155701973|NCT00666224|562001124|FG000|Open-Label|Undefined/Unknown|1|||
155701974|NCT00666224|562001125|FG001|Open-Label|Undefined/Unknown|1|||
155701975|NCT03521141|562001126|FG000|Overall Study|Death|1|||
155701976|NCT03521141|562001127|FG001|Overall Study|Death|0|||
155701977|NCT03521141|562001128|FG002|Overall Study|Death|1|||
155701978|NCT00705367|562001135|FG000|Long-term Extension Period|Adverse Event|2|||
155701979|NCT00705367|562001136|FG001|Long-term Extension Period|Adverse Event|0|||
155701980|NCT00705367|562001135|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
155701981|NCT00705367|562001136|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
155701982|NCT00705367|562001135|FG000|Long-term Extension Period|Lack of Efficacy|1|||
155701983|NCT00705367|562001136|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155701984|NCT00705367|562001135|FG000|Long-term Extension Period|No longer met study criteria|1|||
155701985|NCT00705367|562001136|FG001|Long-term Extension Period|No longer met study criteria|0|||
155701986|NCT00705367|562001135|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
155701987|NCT00705367|562001136|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
155701988|NCT00303485|562001139|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
155701989|NCT00303485|562001140|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
155701990|NCT00303485|562001139|FG000|Overall Study|Failure to return|0|||
155701991|NCT00303485|562001140|FG001|Overall Study|Failure to return|1|||
155701992|NCT00303485|562001139|FG000|Overall Study|Withdrawal by Subject|1|||
155701993|NCT00303485|562001140|FG001|Overall Study|Withdrawal by Subject|0|||
155701994|NCT01959139|562001141|FG000|Phase II|Disease progression|0|||
155701995|NCT01959139|562001142|FG001|Phase II|Disease progression|0|||
155701996|NCT01959139|562001143|FG002|Phase II|Disease progression|26|||
155701997|NCT01959139|562001144|FG003|Phase II|Disease progression|34|||
155701998|NCT01959139|562001141|FG000|Phase II|Adverse Event|0|||
155701999|NCT01959139|562001142|FG001|Phase II|Adverse Event|0|||
155702000|NCT01959139|562001143|FG002|Phase II|Adverse Event|10|||
155702001|NCT01959139|562001144|FG003|Phase II|Adverse Event|11|||
155702002|NCT01959139|562001141|FG000|Phase II|Patient Refusal|0|||
155702003|NCT01959139|562001142|FG001|Phase II|Patient Refusal|0|||
155702004|NCT01959139|562001143|FG002|Phase II|Patient Refusal|5|||
155702005|NCT01959139|562001144|FG003|Phase II|Patient Refusal|4|||
155702006|NCT01959139|562001141|FG000|Phase II|Death|0|||
155702007|NCT01959139|562001142|FG001|Phase II|Death|0|||
155702008|NCT01959139|562001143|FG002|Phase II|Death|3|||
155702009|NCT01959139|562001144|FG003|Phase II|Death|1|||
155702010|NCT01959139|562001141|FG000|Phase II|Other/Unknown|0|||
155702011|NCT01959139|562001142|FG001|Phase II|Other/Unknown|0|||
155702012|NCT01959139|562001143|FG002|Phase II|Other/Unknown|8|||
155702013|NCT01959139|562001144|FG003|Phase II|Other/Unknown|5|||
155702014|NCT01959139|562001141|FG000|Phase II|On treatment|0|||
155702015|NCT01959139|562001142|FG001|Phase II|On treatment|0|||
155702016|NCT01959139|562001143|FG002|Phase II|On treatment|4|||
155702017|NCT01959139|562001144|FG003|Phase II|On treatment|0|||
155702018|NCT01378325|562001150|FG000|Overall Study|Protocol Violation|0|||
155702019|NCT01378325|562001151|FG001|Overall Study|Protocol Violation|1|||
155702020|NCT01559675|562001152|FG000|Overall Study|Protocol Violation|1|||
155702021|NCT01559675|562001153|FG001|Overall Study|Protocol Violation|2|||
155702022|NCT01559675|562001152|FG000|Overall Study|2nd operation on same patient excluded|14|||
155702023|NCT01559675|562001153|FG001|Overall Study|2nd operation on same patient excluded|12|||
155702024|NCT01496469|562001154|FG000|Overall Study|Adverse Event|1|||
155702025|NCT01496469|562001155|FG001|Overall Study|Adverse Event|0|||
155702026|NCT01496469|562001154|FG000|Overall Study|Protocol Violation|2|||
155702027|NCT01496469|562001155|FG001|Overall Study|Protocol Violation|0|||
155702028|NCT01496469|562001154|FG000|Overall Study|Lost to Follow-up|1|||
155702029|NCT01496469|562001155|FG001|Overall Study|Lost to Follow-up|1|||
155702030|NCT01496469|562001154|FG000|Overall Study|Withdrawal by Subject|4|||
155702031|NCT01496469|562001155|FG001|Overall Study|Withdrawal by Subject|4|||
155702032|NCT01496469|562001154|FG000|Overall Study|BP exceeds protocol limits|1|||
155702033|NCT01496469|562001155|FG001|Overall Study|BP exceeds protocol limits|2|||
155702034|NCT01496469|562001154|FG000|Overall Study|Other|1|||
155702035|NCT01496469|562001155|FG001|Overall Study|Other|1|||
155702036|NCT00193180|562001159|FG000|Overall Study|Lack of Efficacy|1|||
155702037|NCT00193180|562001159|FG000|Overall Study|Adverse Event|8|||
155702038|NCT00193180|562001159|FG000|Overall Study|Protocol Violation|1|||
155702039|NCT00891228|562001161|FG000|Overall Study|Adverse Event|0|||
155702040|NCT00891228|562001162|FG001|Overall Study|Adverse Event|2|||
155702041|NCT00891228|562001163|FG002|Overall Study|Adverse Event|3|||
155702042|NCT00891228|562001161|FG000|Overall Study|Withdrawal by Subject|2|||
155702043|NCT00891228|562001162|FG001|Overall Study|Withdrawal by Subject|4|||
155702044|NCT00891228|562001163|FG002|Overall Study|Withdrawal by Subject|5|||
155702045|NCT00891228|562001161|FG000|Overall Study|Protocol Violation|3|||
155702046|NCT00891228|562001162|FG001|Overall Study|Protocol Violation|1|||
155702047|NCT00891228|562001163|FG002|Overall Study|Protocol Violation|2|||
155702048|NCT00891228|562001161|FG000|Overall Study|Physician Decision|2|||
155702049|NCT00891228|562001162|FG001|Overall Study|Physician Decision|1|||
155702050|NCT00891228|562001163|FG002|Overall Study|Physician Decision|0|||
155702051|NCT00891228|562001161|FG000|Overall Study|Lost to Follow-up|4|||
155702052|NCT00891228|562001162|FG001|Overall Study|Lost to Follow-up|4|||
155702053|NCT00891228|562001163|FG002|Overall Study|Lost to Follow-up|5|||
155702054|NCT00891228|562001161|FG000|Overall Study|Pregnancy|0|||
155702055|NCT00891228|562001162|FG001|Overall Study|Pregnancy|1|||
155702056|NCT00891228|562001163|FG002|Overall Study|Pregnancy|0|||
155702057|NCT02688985|562001172|FG000|Overall Study|Adverse Event|1|||
155702058|NCT02688985|562001173|FG001|Overall Study|Adverse Event|2|||
155702059|NCT02688985|562001174|FG002|Overall Study|Adverse Event|2|||
155702060|NCT02688985|562001175|FG003|Overall Study|Adverse Event|0|||
155702061|NCT02688985|562001176|FG004|Overall Study|Adverse Event|0|||
155702062|NCT02688985|562001172|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
155702063|NCT02688985|562001173|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
155702064|NCT02688985|562001174|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
155702065|NCT02688985|562001175|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
155702066|NCT02688985|562001176|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
155702067|NCT02688985|562001172|FG000|Overall Study|Death|0|||
155702068|NCT02688985|562001173|FG001|Overall Study|Death|0|||
155702069|NCT02688985|562001174|FG002|Overall Study|Death|0|||
155702070|NCT02688985|562001175|FG003|Overall Study|Death|0|||
155702071|NCT02688985|562001176|FG004|Overall Study|Death|1|||
155702072|NCT02688985|562001172|FG000|Overall Study|Lack of Efficacy|0|||
155702073|NCT02688985|562001173|FG001|Overall Study|Lack of Efficacy|0|||
155702074|NCT02688985|562001174|FG002|Overall Study|Lack of Efficacy|0|||
155702075|NCT02688985|562001175|FG003|Overall Study|Lack of Efficacy|0|||
155702076|NCT02688985|562001176|FG004|Overall Study|Lack of Efficacy|1|||
155702077|NCT02688985|562001172|FG000|Overall Study|Lost to Follow-up|2|||
155702078|NCT02688985|562001173|FG001|Overall Study|Lost to Follow-up|0|||
155702079|NCT02688985|562001174|FG002|Overall Study|Lost to Follow-up|1|||
155702080|NCT02688985|562001175|FG003|Overall Study|Lost to Follow-up|1|||
155702081|NCT02688985|562001176|FG004|Overall Study|Lost to Follow-up|1|||
155702082|NCT02688985|562001172|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155702083|NCT02688985|562001173|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155702084|NCT02688985|562001174|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155702085|NCT02688985|562001175|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155702086|NCT02688985|562001176|FG004|Overall Study|Non-Compliance With Study Drug|1|||
155702087|NCT02688985|562001172|FG000|Overall Study|Other|3|||
155702088|NCT02688985|562001173|FG001|Overall Study|Other|4|||
155702089|NCT02688985|562001174|FG002|Overall Study|Other|1|||
155702090|NCT02688985|562001175|FG003|Overall Study|Other|0|||
155702091|NCT02688985|562001176|FG004|Overall Study|Other|0|||
155702092|NCT02688985|562001172|FG000|Overall Study|Physician Decision|2|||
155702093|NCT02688985|562001173|FG001|Overall Study|Physician Decision|2|||
155702094|NCT02688985|562001174|FG002|Overall Study|Physician Decision|0|||
155702095|NCT02688985|562001175|FG003|Overall Study|Physician Decision|0|||
155702096|NCT02688985|562001176|FG004|Overall Study|Physician Decision|1|||
155702097|NCT02688985|562001172|FG000|Overall Study|Pregnancy|0|||
155702098|NCT02688985|562001173|FG001|Overall Study|Pregnancy|0|||
155702099|NCT02688985|562001174|FG002|Overall Study|Pregnancy|2|||
155702100|NCT02688985|562001175|FG003|Overall Study|Pregnancy|1|||
155702101|NCT02688985|562001176|FG004|Overall Study|Pregnancy|0|||
155702102|NCT02688985|562001172|FG000|Overall Study|Study Terminated By Sponsor|0|||
155702103|NCT02688985|562001173|FG001|Overall Study|Study Terminated By Sponsor|0|||
155702104|NCT02688985|562001174|FG002|Overall Study|Study Terminated By Sponsor|0|||
155702105|NCT02688985|562001175|FG003|Overall Study|Study Terminated By Sponsor|1|||
155702106|NCT02688985|562001176|FG004|Overall Study|Study Terminated By Sponsor|0|||
155702107|NCT02688985|562001172|FG000|Overall Study|Withdrawal by Subject|2|||
155702108|NCT02688985|562001173|FG001|Overall Study|Withdrawal by Subject|8|||
155702109|NCT02688985|562001174|FG002|Overall Study|Withdrawal by Subject|7|||
155702110|NCT02688985|562001175|FG003|Overall Study|Withdrawal by Subject|1|||
155702111|NCT02688985|562001176|FG004|Overall Study|Withdrawal by Subject|4|||
155702112|NCT00930553|562001179|FG000|Overall Study|Adverse Event|1|||
155702113|NCT00930553|562001179|FG000|Overall Study|Lack of Efficacy|7|||
155702114|NCT00930553|562001179|FG000|Overall Study|Physician Decision|39|||
155702115|NCT00930553|562001179|FG000|Overall Study|Protocol Violation|1|||
155702116|NCT00930553|562001179|FG000|Overall Study|Pregnancy|1|||
155702117|NCT00930553|562001179|FG000|Overall Study|Withdrawal by Subject|88|||
155702118|NCT00930553|562001179|FG000|Overall Study|Lost to Follow-up|25|||
155702119|NCT00930553|562001179|FG000|Overall Study|Death|9|||
155702120|NCT00930553|562001179|FG000|Overall Study|Study terminated by sponsor|24|||
155702121|NCT00930553|562001179|FG000|Overall Study|Other than specified above|28|||
155702122|NCT01964963|562001180|FG000|Overall Study|Case Report Forms Uncollected|888|||
155702123|NCT01964963|562001180|FG000|Overall Study|Protocol Deviation|50|||
155702124|NCT01964963|562001180|FG000|Overall Study|Data Reliability was not Assured|5|||
155702125|NCT01235234|562001181|FG000|Overall Study|Adverse Event|2|||
155702126|NCT01235234|562001182|FG001|Overall Study|Adverse Event|2|||
155702127|NCT01235234|562001183|FG002|Overall Study|Adverse Event|1|||
155702128|NCT01726582|562001184|FG000|Overall Study|Physician Decision|99|||
155702129|NCT01726582|562001184|FG000|Overall Study|Death|85|||
155702130|NCT02630472|562001185|FG000|Overall Study|Physician Decision|10|||
155702131|NCT02630472|562001186|FG001|Overall Study|Physician Decision|0|||
155702132|NCT01279616|562001187|FG000|Overall Study|donor could not be located|5|||
155702133|NCT01279616|562001187|FG000|Overall Study|no signs of sickle cell disease|2|||
155702134|NCT00183625|562001188|FG000|Overall Study|Withdrawal by Subject|18|||
155702135|NCT00183625|562001189|FG001|Overall Study|Withdrawal by Subject|18|||
155702136|NCT00183625|562001190|FG002|Overall Study|Withdrawal by Subject|19|||
155702137|NCT00183625|562001191|FG003|Overall Study|Withdrawal by Subject|14|||
155702138|NCT01369641|562001192|FG000|Overall Study|Withdrawal by Subject|1|||
155702139|NCT00842543|562001193|FG000|Overall Study|Withdrawal by Subject|2|||
155702140|NCT00842543|562001194|FG001|Overall Study|Withdrawal by Subject|0|||
155702141|NCT00842543|562001195|FG002|Overall Study|Withdrawal by Subject|3|||
155702142|NCT00842543|562001196|FG003|Overall Study|Withdrawal by Subject|4|||
155702143|NCT01483183|562001201|FG000|Overall Study|Physician Decision|0|||
155702144|NCT01483183|562001202|FG001|Overall Study|Physician Decision|0|||
155702145|NCT01483183|562001203|FG002|Overall Study|Physician Decision|0|||
155702146|NCT01483183|562001204|FG003|Overall Study|Physician Decision|0|||
155702147|NCT01483183|562001205|FG004|Overall Study|Physician Decision|0|||
155702148|NCT01483183|562001206|FG005|Overall Study|Physician Decision|0|||
155702149|NCT01483183|562001207|FG006|Overall Study|Physician Decision|2|||
155702150|NCT01483183|562001208|FG007|Overall Study|Physician Decision|0|||
155702151|NCT01483183|562001209|FG008|Overall Study|Physician Decision|0|||
155702152|NCT01483183|562001210|FG009|Overall Study|Physician Decision|0|||
155702153|NCT01483183|562001201|FG000|Overall Study|Withdrawal by Subject|0|||
155702154|NCT01483183|562001202|FG001|Overall Study|Withdrawal by Subject|0|||
155702155|NCT01483183|562001203|FG002|Overall Study|Withdrawal by Subject|0|||
155702156|NCT01483183|562001204|FG003|Overall Study|Withdrawal by Subject|0|||
155702157|NCT01483183|562001205|FG004|Overall Study|Withdrawal by Subject|0|||
155702158|NCT01483183|562001206|FG005|Overall Study|Withdrawal by Subject|0|||
155702159|NCT01483183|562001207|FG006|Overall Study|Withdrawal by Subject|0|||
155702160|NCT01483183|562001208|FG007|Overall Study|Withdrawal by Subject|0|||
155702161|NCT01483183|562001209|FG008|Overall Study|Withdrawal by Subject|0|||
155702162|NCT01483183|562001210|FG009|Overall Study|Withdrawal by Subject|1|||
155702163|NCT00239928|562001211|FG000|Overall Study|Lack of Efficacy|1|||
155702164|NCT00239928|562001211|FG000|Overall Study|Adverse Event|4|||
155702165|NCT00239928|562001211|FG000|Overall Study|Not need to continue study|3|||
155702166|NCT00239928|562001211|FG000|Overall Study|Withdrawal by Subject|2|||
155702167|NCT00077649|562001216|FG000|Overall Study|Adverse Event|5|||
155702168|NCT00077649|562001217|FG001|Overall Study|Adverse Event|1|||
155702169|NCT00077649|562001218|FG002|Overall Study|Adverse Event|7|||
155702170|NCT00077649|562001219|FG003|Overall Study|Adverse Event|9|||
155702171|NCT00077649|562001216|FG000|Overall Study|Lack of Efficacy|5|||
155702172|NCT00077649|562001217|FG001|Overall Study|Lack of Efficacy|3|||
155702173|NCT00077649|562001218|FG002|Overall Study|Lack of Efficacy|3|||
155702174|NCT00077649|562001219|FG003|Overall Study|Lack of Efficacy|2|||
155702175|NCT00077649|562001216|FG000|Overall Study|Withdrawal by Subject|0|||
155702176|NCT00077649|562001217|FG001|Overall Study|Withdrawal by Subject|1|||
155702177|NCT00077649|562001218|FG002|Overall Study|Withdrawal by Subject|1|||
155702178|NCT00077649|562001219|FG003|Overall Study|Withdrawal by Subject|2|||
155702179|NCT00077649|562001216|FG000|Overall Study|Lost to Follow-up|2|||
155702180|NCT00077649|562001217|FG001|Overall Study|Lost to Follow-up|2|||
155702181|NCT00077649|562001218|FG002|Overall Study|Lost to Follow-up|3|||
155702182|NCT00077649|562001219|FG003|Overall Study|Lost to Follow-up|2|||
155702183|NCT00077649|562001216|FG000|Overall Study|Abnormality of Laboratory Test|1|||
155702184|NCT00077649|562001217|FG001|Overall Study|Abnormality of Laboratory Test|2|||
155702185|NCT00077649|562001218|FG002|Overall Study|Abnormality of Laboratory Test|1|||
155702186|NCT00077649|562001219|FG003|Overall Study|Abnormality of Laboratory Test|2|||
155702187|NCT00077649|562001216|FG000|Overall Study|Randomized but never dosed|1|||
155702188|NCT00077649|562001217|FG001|Overall Study|Randomized but never dosed|0|||
155702189|NCT00077649|562001218|FG002|Overall Study|Randomized but never dosed|0|||
155702190|NCT00077649|562001219|FG003|Overall Study|Randomized but never dosed|0|||
155702191|NCT02479139|562001220|FG000|Overall Study|Lost to Follow-up|2|||
155702192|NCT02479139|562001221|FG001|Overall Study|Lost to Follow-up|4|||
155702193|NCT02479139|562001222|FG002|Overall Study|Lost to Follow-up|4|||
155702194|NCT02479139|562001223|FG003|Overall Study|Lost to Follow-up|2|||
155702195|NCT02479139|562001224|FG004|Overall Study|Lost to Follow-up|3|||
155702196|NCT02479139|562001225|FG005|Overall Study|Lost to Follow-up|5|||
155702197|NCT02479139|562001220|FG000|Overall Study|Withdrew Consent|5|||
155702198|NCT02479139|562001221|FG001|Overall Study|Withdrew Consent|6|||
155702199|NCT02479139|562001222|FG002|Overall Study|Withdrew Consent|1|||
155702200|NCT02479139|562001223|FG003|Overall Study|Withdrew Consent|4|||
155702201|NCT02479139|562001224|FG004|Overall Study|Withdrew Consent|1|||
155702202|NCT02479139|562001225|FG005|Overall Study|Withdrew Consent|1|||
155702203|NCT02479139|562001220|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155702204|NCT02479139|562001221|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155702205|NCT02479139|562001222|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
155702206|NCT02479139|562001223|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155702207|NCT02479139|562001224|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155702208|NCT02479139|562001225|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155702209|NCT02479139|562001220|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155702210|NCT02479139|562001221|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155702211|NCT02479139|562001222|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155702212|NCT02479139|562001223|FG003|Overall Study|Other Miscellaneous Reasons|1|||
155702213|NCT02479139|562001224|FG004|Overall Study|Other Miscellaneous Reasons|1|||
155702214|NCT02479139|562001225|FG005|Overall Study|Other Miscellaneous Reasons|0|||
155702215|NCT00764673|562001226|FG000|Overall Study|Death|1|||
155702216|NCT00764673|562001226|FG000|Overall Study|Lost to Follow-up|3|||
155702217|NCT00764673|562001226|FG000|Overall Study|Withdrawal by Subject|6|||
155702218|NCT00764673|562001226|FG000|Overall Study|Revision of Device|2|||
155702219|NCT01438177|562001227|FG000|Overall Study|Withdrawal by Subject|1|||
155702220|NCT01438177|562001227|FG000|Overall Study|Initiation of new therapy|1|||
155702221|NCT01727336|562001230|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155702222|NCT01727336|562001231|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
155702223|NCT01727336|562001232|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
155702224|NCT01727336|562001233|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155702225|NCT01727336|562001234|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155702226|NCT01727336|562001235|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155702227|NCT01727336|562001230|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
155702228|NCT01727336|562001231|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
155702229|NCT01727336|562001232|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
155702230|NCT01727336|562001233|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155702231|NCT01727336|562001234|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155702232|NCT01727336|562001235|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155702233|NCT01727336|562001230|FG000|Part 2 Blinded|Death|0|||
155702234|NCT01727336|562001231|FG001|Part 2 Blinded|Death|0|||
155702235|NCT01727336|562001232|FG002|Part 2 Blinded|Death|0|||
155702236|NCT01727336|562001233|FG003|Part 2 Blinded|Death|0|||
155702237|NCT01727336|562001234|FG004|Part 2 Blinded|Death|20|||
155702238|NCT01727336|562001235|FG005|Part 2 Blinded|Death|16|||
155702239|NCT01727336|562001230|FG000|Part 2 Blinded|Lack of Efficacy|0|||
155702240|NCT01727336|562001231|FG001|Part 2 Blinded|Lack of Efficacy|0|||
155702241|NCT01727336|562001232|FG002|Part 2 Blinded|Lack of Efficacy|0|||
155702242|NCT01727336|562001233|FG003|Part 2 Blinded|Lack of Efficacy|0|||
155702243|NCT01727336|562001234|FG004|Part 2 Blinded|Lack of Efficacy|42|||
155702244|NCT01727336|562001235|FG005|Part 2 Blinded|Lack of Efficacy|44|||
155702245|NCT01727336|562001230|FG000|Part 2 Blinded|Lost to Follow-up|0|||
155702246|NCT01727336|562001231|FG001|Part 2 Blinded|Lost to Follow-up|0|||
155702247|NCT01727336|562001232|FG002|Part 2 Blinded|Lost to Follow-up|0|||
155702248|NCT01727336|562001233|FG003|Part 2 Blinded|Lost to Follow-up|0|||
155702249|NCT01727336|562001234|FG004|Part 2 Blinded|Lost to Follow-up|0|||
155702250|NCT01727336|562001235|FG005|Part 2 Blinded|Lost to Follow-up|1|||
155702251|NCT01727336|562001230|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
155702252|NCT01727336|562001231|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
155702253|NCT01727336|562001232|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
155702254|NCT01727336|562001233|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
155702255|NCT01727336|562001234|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
155702256|NCT01727336|562001235|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
155702257|NCT01727336|562001230|FG000|Part 2 Blinded|use of prohibited medications|0|||
155702258|NCT01727336|562001231|FG001|Part 2 Blinded|use of prohibited medications|0|||
155702259|NCT01727336|562001232|FG002|Part 2 Blinded|use of prohibited medications|0|||
155702260|NCT01727336|562001233|FG003|Part 2 Blinded|use of prohibited medications|0|||
155702261|NCT01727336|562001234|FG004|Part 2 Blinded|use of prohibited medications|1|||
155702262|NCT01727336|562001235|FG005|Part 2 Blinded|use of prohibited medications|3|||
155702263|NCT02772978|562001236|FG000|Overall Study|Withdrawal by Subject|1|||
155702264|NCT02772978|562001237|FG001|Overall Study|Withdrawal by Subject|1|||
155702265|NCT00820222|562001239|FG000|Overall Study|Lost to Follow-up|10|||
155702266|NCT00820222|562001240|FG001|Overall Study|Lost to Follow-up|9|||
155702267|NCT00820222|562001239|FG000|Overall Study|Withdrawal by Subject|19|||
155702268|NCT00820222|562001240|FG001|Overall Study|Withdrawal by Subject|21|||
155702269|NCT00820222|562001239|FG000|Overall Study|Physician Decision|93|||
155702270|NCT00820222|562001240|FG001|Overall Study|Physician Decision|88|||
155702271|NCT00820222|562001239|FG000|Overall Study|Sponsor Terminated Study|43|||
155702272|NCT00820222|562001240|FG001|Overall Study|Sponsor Terminated Study|65|||
155702273|NCT00820222|562001239|FG000|Overall Study|Unkown|11|||
155702274|NCT00820222|562001240|FG001|Overall Study|Unkown|7|||
155702275|NCT02690714|562001241|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
155702276|NCT02690714|562001241|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
155702277|NCT00293020|562001242|FG000|Overall Study|Withdrawal by Subject|34|||
155702278|NCT00293020|562001242|FG000|Overall Study|Adverse Event|30|||
155702279|NCT00293020|562001242|FG000|Overall Study|Death|32|||
155702280|NCT00293020|562001242|FG000|Overall Study|Lack of Efficacy|12|||
155702281|NCT00293020|562001242|FG000|Overall Study|Lost to Follow-up|4|||
155702282|NCT00293020|562001242|FG000|Overall Study|Protocol Violation|6|||
155702283|NCT00293020|562001242|FG000|Overall Study|Physician Decision|21|||
155702284|NCT00293020|562001242|FG000|Overall Study|Other Reason|22|||
155702285|NCT00293020|562001242|FG000|Overall Study|No dose taken|1|||
155702286|NCT01147848|562001243|FG000|Run-in Period|Screen Failure|623|||
155702287|NCT01147848|562001244|FG001|Run-in Period|Screen Failure|0|||
155702288|NCT01147848|562001245|FG002|Run-in Period|Screen Failure|0|||
155702289|NCT01147848|562001243|FG000|Run-in Period|Run-in Failure|135|||
155702290|NCT01147848|562001244|FG001|Run-in Period|Run-in Failure|0|||
155702291|NCT01147848|562001245|FG002|Run-in Period|Run-in Failure|0|||
155702292|NCT01147848|562001243|FG000|Randomized Phase|Adverse Event|0|||
155702293|NCT01147848|562001244|FG001|Randomized Phase|Adverse Event|6|||
155702294|NCT01147848|562001245|FG002|Randomized Phase|Adverse Event|8|||
155702295|NCT01147848|562001243|FG000|Randomized Phase|Lack of Efficacy|0|||
155702296|NCT01147848|562001244|FG001|Randomized Phase|Lack of Efficacy|20|||
155702297|NCT01147848|562001245|FG002|Randomized Phase|Lack of Efficacy|11|||
155702298|NCT01147848|562001243|FG000|Randomized Phase|Protocol Violation|0|||
155702299|NCT01147848|562001244|FG001|Randomized Phase|Protocol Violation|7|||
155702300|NCT01147848|562001245|FG002|Randomized Phase|Protocol Violation|10|||
155702301|NCT01147848|562001243|FG000|Randomized Phase|Lost to Follow-up|0|||
155702302|NCT01147848|562001244|FG001|Randomized Phase|Lost to Follow-up|5|||
155702303|NCT01147848|562001245|FG002|Randomized Phase|Lost to Follow-up|7|||
155702304|NCT01147848|562001243|FG000|Randomized Phase|Physician Decision|0|||
155702305|NCT01147848|562001244|FG001|Randomized Phase|Physician Decision|0|||
155702306|NCT01147848|562001245|FG002|Randomized Phase|Physician Decision|1|||
155702307|NCT01147848|562001243|FG000|Randomized Phase|Withdrawal by Subject|0|||
155702308|NCT01147848|562001244|FG001|Randomized Phase|Withdrawal by Subject|7|||
155702309|NCT01147848|562001245|FG002|Randomized Phase|Withdrawal by Subject|9|||
155702310|NCT02540265|562001246|FG000|Overall Study|Lost to Follow-up|0|||
155702311|NCT02540265|562001247|FG001|Overall Study|Lost to Follow-up|0|||
155702312|NCT02540265|562001248|FG002|Overall Study|Lost to Follow-up|1|||
155702313|NCT01972789|562001259|FG000|Overall Study|Adverse Event|11|||
155702314|NCT01972789|562001260|FG001|Overall Study|Adverse Event|4|||
155702315|NCT01972789|562001259|FG000|Overall Study|Subject withdrew consent|14|||
155702316|NCT01972789|562001260|FG001|Overall Study|Subject withdrew consent|12|||
155702317|NCT01972789|562001259|FG000|Overall Study|Lost to Follow-up|4|||
155702318|NCT01972789|562001260|FG001|Overall Study|Lost to Follow-up|7|||
155702319|NCT01972789|562001259|FG000|Overall Study|Death|7|||
155702320|NCT01972789|562001260|FG001|Overall Study|Death|5|||
155702321|NCT01972789|562001259|FG000|Overall Study|Protocol deviation|1|||
155702322|NCT01972789|562001260|FG001|Overall Study|Protocol deviation|0|||
155702323|NCT01972789|562001259|FG000|Overall Study|Physician Decision|3|||
155702324|NCT01972789|562001260|FG001|Overall Study|Physician Decision|2|||
155702325|NCT03596450|562001264|FG000|Overall Study|Death|9|||
155702326|NCT03596450|562001265|FG001|Overall Study|Death|9|||
155702327|NCT03596450|562001264|FG000|Overall Study|Protocol Violation|18|||
155702328|NCT03596450|562001265|FG001|Overall Study|Protocol Violation|26|||
155702329|NCT03596450|562001264|FG000|Overall Study|Lost to Follow-up|50|||
155702330|NCT03596450|562001265|FG001|Overall Study|Lost to Follow-up|56|||
155702331|NCT03596450|562001264|FG000|Overall Study|Adverse Event|14|||
155702332|NCT03596450|562001265|FG001|Overall Study|Adverse Event|7|||
155702333|NCT03596450|562001264|FG000|Overall Study|Withdrawal by Subject|38|||
155702334|NCT03596450|562001265|FG001|Overall Study|Withdrawal by Subject|36|||
155702335|NCT03596450|562001264|FG000|Overall Study|Accidentally Randomized|2|||
155702336|NCT03596450|562001265|FG001|Overall Study|Accidentally Randomized|0|||
155702337|NCT03596450|562001264|FG000|Overall Study|Other reasons|48|||
155702338|NCT03596450|562001265|FG001|Overall Study|Other reasons|53|||
155702339|NCT03596450|562001264|FG000|Overall Study|Pregnancy|2|||
155702340|NCT03596450|562001265|FG001|Overall Study|Pregnancy|0|||
155702341|NCT00498355|562001266|FG000|Overall Study|Lost to Follow-up|1|||
155702342|NCT04496453|562001267|FG000|Overall Study|Lost to Follow-up|6|||
155702343|NCT04058886|562001272|FG000|Overall Study|Withdrawal by Subject|4|||
155702344|NCT04058886|562001272|FG000|Overall Study|Inadequate deafness interpreter service|1|||
155702345|NCT04390841|562001275|FG000|Overall Study|Withdrawal by Subject|2|||
155702346|NCT02999633|562001276|FG000|Overall Study|Adverse Event|2|||
155702347|NCT02999633|562001276|FG000|Overall Study|Progressive disease|12|||
155702348|NCT03262441|562001277|FG000|Overall Study|Withdrawal by Subject|1|||
155702349|NCT04356040|562001278|FG000|Overall Study|Death|2|||
155702350|NCT04356040|562001279|FG001|Overall Study|Death|0|||
155702351|NCT04356040|562001278|FG000|Overall Study|Lost to Follow-up|1|||
155702352|NCT04356040|562001279|FG001|Overall Study|Lost to Follow-up|0|||
155702353|NCT04356040|562001278|FG000|Overall Study|Physician Decision|0|||
155702354|NCT04356040|562001279|FG001|Overall Study|Physician Decision|1|||
155702355|NCT04356040|562001278|FG000|Overall Study|Withdrawal by Subject|13|||
155702356|NCT04356040|562001279|FG001|Overall Study|Withdrawal by Subject|1|||
155702357|NCT04356040|562001278|FG000|Overall Study|Enrollment Pause|10|||
155702358|NCT04356040|562001279|FG001|Overall Study|Enrollment Pause|0|||
155702359|NCT04356040|562001278|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
155702360|NCT04356040|562001279|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
155702361|NCT04356040|562001278|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
155702362|NCT04356040|562001279|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
155702363|NCT04356040|562001278|FG000|Overall Study|PI left institution|3|||
155702364|NCT04356040|562001279|FG001|Overall Study|PI left institution|0|||
155702365|NCT00360568|562001280|FG000|Overall Study|Adverse Event|1|||
155702366|NCT00360568|562001281|FG001|Overall Study|Adverse Event|2|||
155702367|NCT00360568|562001280|FG000|Overall Study|Lack of Efficacy|1|||
155702368|NCT00360568|562001281|FG001|Overall Study|Lack of Efficacy|0|||
155702369|NCT00360568|562001280|FG000|Overall Study|Withdrawal by Subject|0|||
155702370|NCT00360568|562001281|FG001|Overall Study|Withdrawal by Subject|3|||
155702371|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
155702372|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
155702373|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
155702374|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
155702375|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
155702376|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
155702377|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
155702378|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
155702379|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Death|0|||
155702380|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Death|1|||
155702381|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
155702382|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
155702383|NCT03281304|562001282|FG000|Treatment Phase (up to 42 Months)|Other|0|||
155702384|NCT03281304|562001283|FG001|Treatment Phase (up to 42 Months)|Other|2|||
155702385|NCT03281304|562001282|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
155702386|NCT03281304|562001283|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
155702387|NCT01114438|562001284|FG000|Overall Study|Adverse Event|10|||
155702388|NCT01114438|562001284|FG000|Overall Study|concomitant medication|1|||
155702389|NCT01114438|562001284|FG000|Overall Study|Physician Decision|1|||
155702390|NCT01114438|562001284|FG000|Overall Study|Withdrawal by Subject|2|||
155702391|NCT01835223|562002842|FG000|Overall Study|Adverse Event|1|||
155702392|NCT01835223|562002843|FG001|Overall Study|Adverse Event|0|||
155702393|NCT01835223|562002842|FG000|Overall Study|Withdrawal by Subject|2|||
155702394|NCT01835223|562002843|FG001|Overall Study|Withdrawal by Subject|0|||
155702395|NCT01835223|562002842|FG000|Overall Study|Disease progression|2|||
155702396|NCT01835223|562002843|FG001|Overall Study|Disease progression|1|||
155702397|NCT01835223|562002842|FG000|Overall Study|Became Inelligible|4|||
155702398|NCT01835223|562002843|FG001|Overall Study|Became Inelligible|0|||
155702399|NCT00787189|562002844|FG000|Overall Study|Lost to Follow-up|2|||
155702400|NCT00787189|562002845|FG001|Overall Study|Lost to Follow-up|2|||
155702401|NCT02718716|562002850|FG000|Overall Study|Lack of Efficacy|1|||
155702402|NCT02718716|562002851|FG001|Overall Study|Lack of Efficacy|0|||
155702403|NCT02718716|562002852|FG002|Overall Study|Lack of Efficacy|0|||
155702404|NCT02718716|562002853|FG003|Overall Study|Lack of Efficacy|0|||
155702405|NCT02718716|562002854|FG004|Overall Study|Lack of Efficacy|0|||
155702406|NCT02942485|562002855|FG000|Overall Study|Lost to Follow-up|1|||
155702407|NCT02942485|562002856|FG001|Overall Study|Lost to Follow-up|0|||
155702408|NCT04302545|562002861|FG000|Overall Study|Lost to Follow-up|3|||
155702409|NCT04302545|562002862|FG001|Overall Study|Lost to Follow-up|4|||
155702410|NCT00084656|562002865|FG000|Overall Study|Other reasons|0|||
155702411|NCT00084656|562002866|FG001|Overall Study|Other reasons|12|||
155702412|NCT00084656|562002867|FG002|Overall Study|Other reasons|11|||
155702413|NCT00084656|562002865|FG000|Overall Study|Withdrawal by Subject|15|||
155702414|NCT00084656|562002866|FG001|Overall Study|Withdrawal by Subject|4|||
155702415|NCT00084656|562002867|FG002|Overall Study|Withdrawal by Subject|4|||
155702416|NCT00084656|562002865|FG000|Overall Study|Disease relapse|0|||
155702417|NCT00084656|562002866|FG001|Overall Study|Disease relapse|9|||
155702418|NCT00084656|562002867|FG002|Overall Study|Disease relapse|10|||
155702419|NCT00084656|562002865|FG000|Overall Study|Disease progression|9|||
155702420|NCT00084656|562002866|FG001|Overall Study|Disease progression|0|||
155702421|NCT00084656|562002867|FG002|Overall Study|Disease progression|0|||
155702422|NCT00084656|562002865|FG000|Overall Study|Lost to Follow-up|1|||
155702423|NCT00084656|562002866|FG001|Overall Study|Lost to Follow-up|0|||
155702424|NCT00084656|562002867|FG002|Overall Study|Lost to Follow-up|1|||
155702425|NCT03550404|562002870|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
155702426|NCT03550404|562002871|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
155702427|NCT03550404|562002872|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
155702428|NCT03550404|562002870|FG000|Phase 2|Vacated position|1|||
155702429|NCT03550404|562002871|FG001|Phase 2|Vacated position|0|||
155702430|NCT03550404|562002872|FG002|Phase 2|Vacated position|0|||
155702431|NCT00666965|562002875|FG000|Overall Study|Adverse Event|0|||
155702432|NCT00666965|562002876|FG001|Overall Study|Adverse Event|2|||
155702433|NCT00666965|562002877|FG002|Overall Study|Adverse Event|1|||
155702434|NCT00666965|562002878|FG003|Overall Study|Adverse Event|9|||
155702435|NCT00666965|562002875|FG000|Overall Study|Lack of Efficacy|1|||
155702436|NCT00666965|562002876|FG001|Overall Study|Lack of Efficacy|1|||
155702437|NCT00666965|562002877|FG002|Overall Study|Lack of Efficacy|0|||
155702438|NCT00666965|562002878|FG003|Overall Study|Lack of Efficacy|0|||
155702439|NCT00666965|562002875|FG000|Overall Study|Protocol Violation|0|||
155702440|NCT00666965|562002876|FG001|Overall Study|Protocol Violation|0|||
155702441|NCT00666965|562002877|FG002|Overall Study|Protocol Violation|0|||
155702442|NCT00666965|562002878|FG003|Overall Study|Protocol Violation|2|||
155702443|NCT00666965|562002875|FG000|Overall Study|Discontinuation criteria|2|||
155702444|NCT00666965|562002876|FG001|Overall Study|Discontinuation criteria|1|||
155702445|NCT00666965|562002877|FG002|Overall Study|Discontinuation criteria|1|||
155702446|NCT00666965|562002878|FG003|Overall Study|Discontinuation criteria|2|||
155702447|NCT00666965|562002875|FG000|Overall Study|Withdrawal by Subject|0|||
155702448|NCT00666965|562002876|FG001|Overall Study|Withdrawal by Subject|0|||
155702449|NCT00666965|562002877|FG002|Overall Study|Withdrawal by Subject|0|||
155702450|NCT00666965|562002878|FG003|Overall Study|Withdrawal by Subject|2|||
155702451|NCT03624127|562002879|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
155702452|NCT03624127|562002880|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
155702453|NCT03624127|562002881|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
155702454|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
155702455|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
155702456|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
155702457|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Death|0|||
155702458|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Death|1|||
155702459|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Death|0|||
155702460|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
155702461|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
155702462|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
155702463|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
155702464|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
155702465|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
155702466|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
155702467|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
155702468|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
155702469|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
155702470|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
155702471|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
155702472|NCT03624127|562002879|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
155702473|NCT03624127|562002880|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
155702474|NCT03624127|562002881|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
155702475|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
155702476|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
155702477|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
155702478|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
155702479|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
155702480|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
155702481|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155702482|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155702483|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
155702484|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
155702485|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
155702486|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
155702487|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
155702488|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
155702489|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
155702490|NCT03624127|562002879|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
155702491|NCT03624127|562002880|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
155702492|NCT03624127|562002881|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
155702493|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
155702494|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
155702495|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
155702496|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
155702497|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
155702498|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
155702499|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
155702500|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
155702501|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
155702502|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
155702503|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
155702504|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
155702505|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
155702506|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
155702507|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
155702508|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
155702509|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
155702510|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
155702511|NCT03624127|562002879|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
155702512|NCT03624127|562002880|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
155702513|NCT03624127|562002881|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
155702514|NCT03238924|562002895|FG000|Overall Study|Withdrawal by Subject|2|||
155702515|NCT03238924|562002896|FG001|Overall Study|Withdrawal by Subject|2|||
155702516|NCT03576716|562002897|FG000|Overall Study|Withdrawal by Subject|0|||
155702517|NCT03576716|562002898|FG001|Overall Study|Withdrawal by Subject|1|||
155702518|NCT00559988|562002899|FG000|Overall Study|Death|147|||
155702519|NCT00559988|562002900|FG001|Overall Study|Death|140|||
155702520|NCT00559988|562002899|FG000|Overall Study|Withdrawal by Subject|152|||
155702521|NCT00559988|562002900|FG001|Overall Study|Withdrawal by Subject|139|||
155702522|NCT00559988|562002899|FG000|Overall Study|Lost to Follow-up|42|||
155702523|NCT00559988|562002900|FG001|Overall Study|Lost to Follow-up|56|||
155702524|NCT00559988|562002899|FG000|Overall Study|ICD device explanted|10|||
155702525|NCT00559988|562002900|FG001|Overall Study|ICD device explanted|17|||
155702526|NCT02891382|562002901|FG000|Overall Study|Lost to Follow-up|3|||
155702527|NCT02891382|562002902|FG001|Overall Study|Lost to Follow-up|4|||
155702528|NCT02891382|562002903|FG002|Overall Study|Lost to Follow-up|5|||
155702529|NCT02891382|562002904|FG003|Overall Study|Lost to Follow-up|3|||
155702530|NCT02891382|562002905|FG004|Overall Study|Lost to Follow-up|4|||
155702531|NCT01455194|562002906|FG000|Overall Study|Screen Failure|20|||
155702532|NCT01455194|562002907|FG001|Overall Study|Screen Failure|0|||
155702533|NCT01455194|562002908|FG002|Overall Study|Screen Failure|0|||
155702534|NCT01455194|562002909|FG003|Overall Study|Screen Failure|0|||
155702535|NCT01455194|562002906|FG000|Overall Study|Randomisation Failure|90|||
155702536|NCT01455194|562002907|FG001|Overall Study|Randomisation Failure|0|||
155702537|NCT01455194|562002908|FG002|Overall Study|Randomisation Failure|0|||
155702538|NCT01455194|562002909|FG003|Overall Study|Randomisation Failure|0|||
155702539|NCT01455194|562002906|FG000|Overall Study|Deterioration in asthma|12|||
155702540|NCT01455194|562002907|FG001|Overall Study|Deterioration in asthma|6|||
155702541|NCT01455194|562002908|FG002|Overall Study|Deterioration in asthma|14|||
155702542|NCT01455194|562002909|FG003|Overall Study|Deterioration in asthma|9|||
155702543|NCT01455194|562002906|FG000|Overall Study|Adverse Event|1|||
155702544|NCT01455194|562002907|FG001|Overall Study|Adverse Event|1|||
155702545|NCT01455194|562002908|FG002|Overall Study|Adverse Event|1|||
155702546|NCT01455194|562002909|FG003|Overall Study|Adverse Event|3|||
155702547|NCT01455194|562002906|FG000|Overall Study|Withdrawal by Subject|21|||
155702548|NCT01455194|562002907|FG001|Overall Study|Withdrawal by Subject|16|||
155702549|NCT01455194|562002908|FG002|Overall Study|Withdrawal by Subject|12|||
155702550|NCT01455194|562002909|FG003|Overall Study|Withdrawal by Subject|9|||
155702551|NCT01455194|562002906|FG000|Overall Study|Lost to Follow-up|2|||
155702552|NCT01455194|562002907|FG001|Overall Study|Lost to Follow-up|0|||
155702553|NCT01455194|562002908|FG002|Overall Study|Lost to Follow-up|1|||
155702554|NCT01455194|562002909|FG003|Overall Study|Lost to Follow-up|1|||
155702555|NCT01455194|562002906|FG000|Overall Study|Pregnancy|0|||
155702556|NCT01455194|562002907|FG001|Overall Study|Pregnancy|1|||
155702557|NCT01455194|562002908|FG002|Overall Study|Pregnancy|1|||
155702558|NCT01455194|562002909|FG003|Overall Study|Pregnancy|0|||
155702559|NCT01455194|562002906|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
155702560|NCT01455194|562002907|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
155702561|NCT01455194|562002908|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
155702562|NCT01455194|562002909|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
155702563|NCT01455194|562002906|FG000|Overall Study|Miscellaneous|4|||
155702564|NCT01455194|562002907|FG001|Overall Study|Miscellaneous|5|||
155702565|NCT01455194|562002908|FG002|Overall Study|Miscellaneous|1|||
155702566|NCT01455194|562002909|FG003|Overall Study|Miscellaneous|4|||
155702567|NCT02249182|562002910|FG000|Treatment Phase|Lost to Follow-up|4|||
155702568|NCT02249182|562002911|FG001|Treatment Phase|Lost to Follow-up|0|||
155702569|NCT02249182|562002912|FG002|Treatment Phase|Lost to Follow-up|0|||
155702570|NCT02249182|562002913|FG003|Treatment Phase|Lost to Follow-up|0|||
155702571|NCT02249182|562002914|FG004|Treatment Phase|Lost to Follow-up|0|||
155702572|NCT02516228|562002915|FG000|Overall Study|Lost to Follow-up|1|||
155702573|NCT02516228|562002915|FG000|Overall Study|Withdrawal by Subject|1|||
155702574|NCT02516228|562002915|FG000|Overall Study|Physician Decision|1|||
155702575|NCT03916484|562002916|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155702576|NCT03916484|562002917|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
155702577|NCT03916484|562002918|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155702578|NCT03916484|562002919|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155702579|NCT03916484|562002916|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
155702580|NCT03916484|562002917|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
155702581|NCT03916484|562002918|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
155702582|NCT03916484|562002919|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155702583|NCT05090852|562002920|FG000|Overall Study|Physician Decision|5|||
155702584|NCT01196416|562002921|FG000|Overall Study|Withdrawal by Subject|2|||
155702585|NCT00504894|562002922|FG000|Overall Study|fMRI technical problems|1|||
155702586|NCT00504894|562002923|FG001|Overall Study|fMRI technical problems|1|||
155702587|NCT00504894|562002924|FG002|Overall Study|fMRI technical problems|0|||
155702588|NCT00504894|562002922|FG000|Overall Study|Withdrawal by Subject|0|||
155702589|NCT00504894|562002923|FG001|Overall Study|Withdrawal by Subject|1|||
155702590|NCT00504894|562002924|FG002|Overall Study|Withdrawal by Subject|0|||
155702591|NCT00504894|562002922|FG000|Overall Study|Infusion technical problems|0|||
155702592|NCT00504894|562002923|FG001|Overall Study|Infusion technical problems|1|||
155702593|NCT00504894|562002924|FG002|Overall Study|Infusion technical problems|0|||
155702594|NCT00504894|562002922|FG000|Overall Study|poor subject data|2|||
155702595|NCT00504894|562002923|FG001|Overall Study|poor subject data|0|||
155702596|NCT00504894|562002924|FG002|Overall Study|poor subject data|0|||
155702597|NCT00148941|562002925|FG000|Overall Study|Lost to Follow-up|17|||
155702598|NCT00148941|562002926|FG001|Overall Study|Lost to Follow-up|24|||
155702599|NCT00148941|562002927|FG002|Overall Study|Lost to Follow-up|18|||
155702600|NCT00148941|562002928|FG003|Overall Study|Lost to Follow-up|22|||
155702601|NCT00148941|562002925|FG000|Overall Study|Withdrawal by Subject|1|||
155702602|NCT00148941|562002926|FG001|Overall Study|Withdrawal by Subject|0|||
155702603|NCT00148941|562002927|FG002|Overall Study|Withdrawal by Subject|1|||
155702604|NCT00148941|562002928|FG003|Overall Study|Withdrawal by Subject|0|||
155702605|NCT00148941|562002925|FG000|Overall Study|Other|0|||
155702606|NCT00148941|562002926|FG001|Overall Study|Other|0|||
155702607|NCT00148941|562002927|FG002|Overall Study|Other|1|||
155702608|NCT00148941|562002928|FG003|Overall Study|Other|2|||
155702609|NCT01092663|562002931|FG000|Overall Study|Withdrawal by Subject|3|||
155702610|NCT01092663|562002932|FG001|Overall Study|Withdrawal by Subject|2|||
155702611|NCT01092663|562002931|FG000|Overall Study|Glucose >300mg/dL|1|||
155702612|NCT01092663|562002932|FG001|Overall Study|Glucose >300mg/dL|0|||
155702613|NCT01092663|562002931|FG000|Overall Study|High fasting triglyceride|2|||
155702614|NCT01092663|562002932|FG001|Overall Study|High fasting triglyceride|0|||
155702615|NCT01092663|562002931|FG000|Overall Study|Adverse Event|1|||
155702616|NCT01092663|562002932|FG001|Overall Study|Adverse Event|1|||
155702617|NCT01092663|562002931|FG000|Overall Study|Protocol Violation|0|||
155702618|NCT01092663|562002932|FG001|Overall Study|Protocol Violation|1|||
155702619|NCT00788710|562002933|FG000|Overall Study|Adverse Event|1|||
155702620|NCT00788710|562002934|FG001|Overall Study|Adverse Event|3|||
155702621|NCT00788710|562002935|FG002|Overall Study|Adverse Event|4|||
155702622|NCT00788710|562002933|FG000|Overall Study|Lack of Efficacy|0|||
155702623|NCT00788710|562002934|FG001|Overall Study|Lack of Efficacy|0|||
155702624|NCT00788710|562002935|FG002|Overall Study|Lack of Efficacy|1|||
155702625|NCT00788710|562002933|FG000|Overall Study|Lost to Follow-up|0|||
155702626|NCT00788710|562002934|FG001|Overall Study|Lost to Follow-up|1|||
155702627|NCT00788710|562002935|FG002|Overall Study|Lost to Follow-up|0|||
155702628|NCT00788710|562002933|FG000|Overall Study|Physician Decision|2|||
155702629|NCT00788710|562002934|FG001|Overall Study|Physician Decision|1|||
155702630|NCT00788710|562002935|FG002|Overall Study|Physician Decision|0|||
155702631|NCT00788710|562002933|FG000|Overall Study|Protocol Violation|0|||
155702632|NCT00788710|562002934|FG001|Overall Study|Protocol Violation|1|||
155702633|NCT00788710|562002935|FG002|Overall Study|Protocol Violation|1|||
155702634|NCT00788710|562002933|FG000|Overall Study|Withdrawal by Subject|2|||
155702635|NCT00788710|562002934|FG001|Overall Study|Withdrawal by Subject|2|||
155702636|NCT00788710|562002935|FG002|Overall Study|Withdrawal by Subject|0|||
155702637|NCT01008904|562002936|FG000|Overall Study|Lost to Follow-up|1|||
155702638|NCT01008904|562002936|FG000|Overall Study|Adverse Event|2|||
155702639|NCT01008904|562002936|FG000|Overall Study|unexpected unrelated surgery|1|||
155702640|NCT01008449|562002940|FG000|Overall Study|Lost to Follow-up|29|||
155702641|NCT01008449|562002941|FG001|Overall Study|Lost to Follow-up|19|||
155702642|NCT01220180|562002942|FG000|Overall Study|Lost to Follow-up|76|||
155702643|NCT01220180|562002942|FG000|Overall Study|Other|72|||
155702644|NCT01220180|562002942|FG000|Overall Study|Adverse Event|35|||
155702645|NCT01220180|562002942|FG000|Overall Study|Lack of Efficacy|22|||
155702646|NCT01220180|562002942|FG000|Overall Study|Death|1|||
155702647|NCT01220180|562002942|FG000|Overall Study|Randomized but not treated|1|||
155702648|NCT02262754|562002944|FG000|Overall Study|Adverse Event|3|||
155702649|NCT02262754|562002945|FG001|Overall Study|Adverse Event|4|||
155702650|NCT02262754|562002946|FG002|Overall Study|Adverse Event|0|||
155702651|NCT02262754|562002944|FG000|Overall Study|Lack of Efficacy|2|||
155702652|NCT02262754|562002945|FG001|Overall Study|Lack of Efficacy|0|||
155702653|NCT02262754|562002946|FG002|Overall Study|Lack of Efficacy|1|||
155702654|NCT02262754|562002944|FG000|Overall Study|Lost to Follow-up|0|||
155702655|NCT02262754|562002945|FG001|Overall Study|Lost to Follow-up|0|||
155702656|NCT02262754|562002946|FG002|Overall Study|Lost to Follow-up|1|||
155702657|NCT02262754|562002944|FG000|Overall Study|No longer meets eligibility criteria|0|||
155702658|NCT02262754|562002945|FG001|Overall Study|No longer meets eligibility criteria|1|||
155702659|NCT02262754|562002946|FG002|Overall Study|No longer meets eligibility criteria|0|||
155702660|NCT02262754|562002944|FG000|Overall Study|Study terminated by sponsor|5|||
155702661|NCT02262754|562002945|FG001|Overall Study|Study terminated by sponsor|4|||
155702662|NCT02262754|562002946|FG002|Overall Study|Study terminated by sponsor|4|||
155702663|NCT02262754|562002944|FG000|Overall Study|Protocol Violation|1|||
155702664|NCT02262754|562002945|FG001|Overall Study|Protocol Violation|0|||
155702665|NCT02262754|562002946|FG002|Overall Study|Protocol Violation|0|||
155702666|NCT02262754|562002944|FG000|Overall Study|Withdrawal by Subject|1|||
155702667|NCT02262754|562002945|FG001|Overall Study|Withdrawal by Subject|0|||
155702668|NCT02262754|562002946|FG002|Overall Study|Withdrawal by Subject|1|||
155702669|NCT02262754|562002944|FG000|Overall Study|Other|4|||
155702670|NCT02262754|562002945|FG001|Overall Study|Other|0|||
155702671|NCT02262754|562002946|FG002|Overall Study|Other|2|||
155702672|NCT01299116|562002950|FG000|Overall Study|Lost to Follow-up|65|||
155702673|NCT01299116|562002951|FG001|Overall Study|Lost to Follow-up|9|||
155702674|NCT01299116|562002952|FG002|Overall Study|Lost to Follow-up|11|||
155702675|NCT04079114|562002954|FG000|Overall Study|Study prematuely terminated.|166|||
155702676|NCT01364389|562002958|FG000|Overall Study|Withdrawal by Subject|0|||
155702677|NCT01364389|562002959|FG001|Overall Study|Withdrawal by Subject|1|||
155702678|NCT01364389|562002960|FG002|Overall Study|Withdrawal by Subject|0|||
155702679|NCT01364389|562002958|FG000|Overall Study|Protocol deviation|0|||
155702680|NCT01364389|562002959|FG001|Overall Study|Protocol deviation|0|||
155702681|NCT01364389|562002960|FG002|Overall Study|Protocol deviation|1|||
155702682|NCT01364389|562002958|FG000|Overall Study|Administrative problems|1|||
155702683|NCT01364389|562002959|FG001|Overall Study|Administrative problems|0|||
155702684|NCT01364389|562002960|FG002|Overall Study|Administrative problems|0|||
155702685|NCT01364389|562002958|FG000|Overall Study|Adverse Event|1|||
155702686|NCT01364389|562002959|FG001|Overall Study|Adverse Event|0|||
155702687|NCT01364389|562002960|FG002|Overall Study|Adverse Event|0|||
155702688|NCT01534195|562002961|FG000|Overall Study|Withdrawal by Subject|1|||
155702689|NCT01534195|562002962|FG001|Overall Study|Withdrawal by Subject|1|||
155702690|NCT00629798|562002965|FG000|Overall Study|Not Treated|4|||
155702691|NCT02554981|562002966|FG000|Overall Study|Adverse Event|1|||
155702692|NCT02554981|562002966|FG000|Overall Study|Administrative Reasons|1|||
155702693|NCT02554981|562002966|FG000|Overall Study|Other Miscellaneous Reasons|3|||
155702694|NCT03043651|562002972|FG000|Overall Study|Death|1|||
155702695|NCT03043651|562002972|FG000|Overall Study|Progressive Disease|2|||
155702696|NCT03043651|562002972|FG000|Overall Study|Adverse Event|2|||
155702697|NCT03043651|562002972|FG000|Overall Study|Withdrawal by Subject|4|||
155702698|NCT03043651|562002972|FG000|Overall Study|Study Terminated by Sponsor|39|||
155702699|NCT01630889|562002973|FG000|Overall Study|Death|2|||
155702700|NCT01630889|562002973|FG000|Overall Study|Withdrawal by Subject|1|||
155702701|NCT01630889|562002973|FG000|Overall Study|Other than Specified|2|||
155702702|NCT01630889|562002973|FG000|Overall Study|Lost to Follow-up|4|||
155702703|NCT01630889|562002973|FG000|Overall Study|Other|1|||
155702704|NCT02974842|562002974|FG000|Overall Study|Withdrawal by Subject|4|||
155702705|NCT02974842|562002974|FG000|Overall Study|Screen failures|4|||
155702706|NCT02980133|562002975|FG000|Overall Study|Other than specified|1|||
155702707|NCT02980133|562002976|FG001|Overall Study|Other than specified|1|||
155702708|NCT02980133|562002977|FG002|Overall Study|Other than specified|2|||
155702709|NCT02980133|562002978|FG003|Overall Study|Other than specified|2|||
155702710|NCT02980133|562002975|FG000|Overall Study|Lost to Follow-up|0|||
155702711|NCT02980133|562002976|FG001|Overall Study|Lost to Follow-up|0|||
155702712|NCT02980133|562002977|FG002|Overall Study|Lost to Follow-up|1|||
155702713|NCT02980133|562002978|FG003|Overall Study|Lost to Follow-up|3|||
155702714|NCT02980133|562002975|FG000|Overall Study|Protocol Violation|0|||
155702715|NCT02980133|562002976|FG001|Overall Study|Protocol Violation|1|||
155702716|NCT02980133|562002977|FG002|Overall Study|Protocol Violation|0|||
155702717|NCT02980133|562002978|FG003|Overall Study|Protocol Violation|0|||
155702718|NCT02980133|562002975|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155702719|NCT02980133|562002976|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155702720|NCT02980133|562002977|FG002|Overall Study|Withdrawal by parent/guardian|3|||
155702721|NCT02980133|562002978|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155702722|NCT02980133|562002975|FG000|Overall Study|Withdrawal by Subject|0|||
155702723|NCT02980133|562002976|FG001|Overall Study|Withdrawal by Subject|0|||
155702724|NCT02980133|562002977|FG002|Overall Study|Withdrawal by Subject|1|||
155702725|NCT02980133|562002978|FG003|Overall Study|Withdrawal by Subject|0|||
155702726|NCT01068158|562002988|FG000|Overall Study|Withdrawal by Subject|1|||
155702727|NCT01068158|562002989|FG001|Overall Study|Withdrawal by Subject|2|||
155702728|NCT01068158|562002988|FG000|Overall Study|Lost to Follow-up|7|||
155702729|NCT01068158|562002989|FG001|Overall Study|Lost to Follow-up|0|||
155702730|NCT01068158|562002988|FG000|Overall Study|Protocol Violation|0|||
155702731|NCT01068158|562002989|FG001|Overall Study|Protocol Violation|2|||
155702732|NCT01959243|562002990|FG000|Overall Study|Investigator Decision|3|||
155702733|NCT01959243|562002991|FG001|Overall Study|Investigator Decision|0|||
155702734|NCT01959243|562002990|FG000|Overall Study|Adverse Event|5|||
155702735|NCT01959243|562002991|FG001|Overall Study|Adverse Event|2|||
155702736|NCT01959243|562002990|FG000|Overall Study|Administrative reasons|2|||
155702737|NCT01959243|562002991|FG001|Overall Study|Administrative reasons|1|||
155702738|NCT01959243|562002990|FG000|Overall Study|Lost to Follow-up|3|||
155702739|NCT01959243|562002991|FG001|Overall Study|Lost to Follow-up|1|||
155702740|NCT02596945|562002992|FG000|Overall Study|No documentation of study drug dosing|3|||
155702741|NCT02596945|562002992|FG000|Overall Study|Other|32|||
155702742|NCT02596945|562002992|FG000|Overall Study|Change to hemodialysis|15|||
155702743|NCT02596945|562002992|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
155702744|NCT02596945|562002992|FG000|Overall Study|Withdrawal by Subject|1|||
155702745|NCT02596945|562002992|FG000|Overall Study|Missing|1|||
155702746|NCT01368081|562002993|FG000|Overall Study|Adverse Event|4|||
155702747|NCT01368081|562002994|FG001|Overall Study|Adverse Event|4|||
155702748|NCT01368081|562002995|FG002|Overall Study|Adverse Event|3|||
155702749|NCT01368081|562002996|FG003|Overall Study|Adverse Event|2|||
155702750|NCT01368081|562002997|FG004|Overall Study|Adverse Event|2|||
155702751|NCT01368081|562002998|FG005|Overall Study|Adverse Event|5|||
155702752|NCT01368081|562002999|FG006|Overall Study|Adverse Event|6|||
155702753|NCT01368081|562003000|FG007|Overall Study|Adverse Event|2|||
155702754|NCT01368081|562003001|FG008|Overall Study|Adverse Event|3|||
155702755|NCT01368081|562003002|FG009|Overall Study|Adverse Event|5|||
155702756|NCT01368081|562003003|FG010|Overall Study|Adverse Event|6|||
155702757|NCT01368081|562003004|FG011|Overall Study|Adverse Event|1|||
155702758|NCT01368081|562003005|FG012|Overall Study|Adverse Event|3|||
155702759|NCT01368081|562002993|FG000|Overall Study|Lack of Efficacy|0|||
155702760|NCT01368081|562002994|FG001|Overall Study|Lack of Efficacy|1|||
155702761|NCT01368081|562002995|FG002|Overall Study|Lack of Efficacy|0|||
155702762|NCT01368081|562002996|FG003|Overall Study|Lack of Efficacy|1|||
155702763|NCT01368081|562002997|FG004|Overall Study|Lack of Efficacy|0|||
155702764|NCT01368081|562002998|FG005|Overall Study|Lack of Efficacy|0|||
155702765|NCT01368081|562002999|FG006|Overall Study|Lack of Efficacy|0|||
155702766|NCT01368081|562003000|FG007|Overall Study|Lack of Efficacy|2|||
155702767|NCT01368081|562003001|FG008|Overall Study|Lack of Efficacy|0|||
155702768|NCT01368081|562003002|FG009|Overall Study|Lack of Efficacy|0|||
155702769|NCT01368081|562003003|FG010|Overall Study|Lack of Efficacy|0|||
155702770|NCT01368081|562003004|FG011|Overall Study|Lack of Efficacy|0|||
155702771|NCT01368081|562003005|FG012|Overall Study|Lack of Efficacy|0|||
155702772|NCT01368081|562002993|FG000|Overall Study|Protocol Violation|0|||
155702773|NCT01368081|562002994|FG001|Overall Study|Protocol Violation|0|||
155702774|NCT01368081|562002995|FG002|Overall Study|Protocol Violation|0|||
155702775|NCT01368081|562002996|FG003|Overall Study|Protocol Violation|0|||
155702776|NCT01368081|562002997|FG004|Overall Study|Protocol Violation|0|||
155702777|NCT01368081|562002998|FG005|Overall Study|Protocol Violation|1|||
155702778|NCT01368081|562002999|FG006|Overall Study|Protocol Violation|0|||
155702779|NCT01368081|562003000|FG007|Overall Study|Protocol Violation|1|||
155702780|NCT01368081|562003001|FG008|Overall Study|Protocol Violation|0|||
155702781|NCT01368081|562003002|FG009|Overall Study|Protocol Violation|0|||
155702782|NCT01368081|562003003|FG010|Overall Study|Protocol Violation|0|||
155702783|NCT01368081|562003004|FG011|Overall Study|Protocol Violation|0|||
155702784|NCT01368081|562003005|FG012|Overall Study|Protocol Violation|0|||
155702785|NCT01368081|562002993|FG000|Overall Study|Lost to Follow-up|0|||
155702786|NCT01368081|562002994|FG001|Overall Study|Lost to Follow-up|0|||
155702787|NCT01368081|562002995|FG002|Overall Study|Lost to Follow-up|0|||
155702788|NCT01368081|562002996|FG003|Overall Study|Lost to Follow-up|0|||
155702789|NCT01368081|562002997|FG004|Overall Study|Lost to Follow-up|0|||
155702790|NCT01368081|562002998|FG005|Overall Study|Lost to Follow-up|0|||
155702791|NCT01368081|562002999|FG006|Overall Study|Lost to Follow-up|0|||
155702792|NCT01368081|562003000|FG007|Overall Study|Lost to Follow-up|0|||
155702793|NCT01368081|562003001|FG008|Overall Study|Lost to Follow-up|0|||
155702794|NCT01368081|562003002|FG009|Overall Study|Lost to Follow-up|0|||
155702795|NCT01368081|562003003|FG010|Overall Study|Lost to Follow-up|0|||
155702796|NCT01368081|562003004|FG011|Overall Study|Lost to Follow-up|0|||
155702797|NCT01368081|562003005|FG012|Overall Study|Lost to Follow-up|1|||
155702798|NCT01368081|562002993|FG000|Overall Study|Withdrawal by Subject|4|||
155702799|NCT01368081|562002994|FG001|Overall Study|Withdrawal by Subject|4|||
155702800|NCT01368081|562002995|FG002|Overall Study|Withdrawal by Subject|1|||
155702801|NCT01368081|562002996|FG003|Overall Study|Withdrawal by Subject|1|||
155702802|NCT01368081|562002997|FG004|Overall Study|Withdrawal by Subject|0|||
155702803|NCT01368081|562002998|FG005|Overall Study|Withdrawal by Subject|3|||
155702804|NCT01368081|562002999|FG006|Overall Study|Withdrawal by Subject|4|||
155702805|NCT01368081|562003000|FG007|Overall Study|Withdrawal by Subject|2|||
155702806|NCT01368081|562003001|FG008|Overall Study|Withdrawal by Subject|5|||
155702807|NCT01368081|562003002|FG009|Overall Study|Withdrawal by Subject|4|||
155702808|NCT01368081|562003003|FG010|Overall Study|Withdrawal by Subject|3|||
155702809|NCT01368081|562003004|FG011|Overall Study|Withdrawal by Subject|2|||
155702810|NCT01368081|562003005|FG012|Overall Study|Withdrawal by Subject|0|||
155702811|NCT01368081|562002993|FG000|Overall Study|Other reason not defined above|2|||
155702812|NCT01368081|562002994|FG001|Overall Study|Other reason not defined above|0|||
155702813|NCT01368081|562002995|FG002|Overall Study|Other reason not defined above|0|||
155702814|NCT01368081|562002996|FG003|Overall Study|Other reason not defined above|1|||
155702815|NCT01368081|562002997|FG004|Overall Study|Other reason not defined above|0|||
155702816|NCT01368081|562002998|FG005|Overall Study|Other reason not defined above|1|||
155702817|NCT01368081|562002999|FG006|Overall Study|Other reason not defined above|2|||
155702818|NCT01368081|562003000|FG007|Overall Study|Other reason not defined above|0|||
155702819|NCT01368081|562003001|FG008|Overall Study|Other reason not defined above|0|||
155702820|NCT01368081|562003002|FG009|Overall Study|Other reason not defined above|1|||
155702821|NCT01368081|562003003|FG010|Overall Study|Other reason not defined above|0|||
155702822|NCT01368081|562003004|FG011|Overall Study|Other reason not defined above|0|||
155702823|NCT01368081|562003005|FG012|Overall Study|Other reason not defined above|3|||
155702824|NCT00238238|562003006|FG000|Overall Study|Withdrawal by Subject|0|||
155702825|NCT00238238|562003007|FG001|Overall Study|Withdrawal by Subject|3|||
155702826|NCT00238238|562003008|FG002|Overall Study|Withdrawal by Subject|0|||
155702827|NCT01007838|562003012|FG000|Overall Study|Withdrawal by Subject|1|||
155702828|NCT01007838|562003013|FG001|Overall Study|Withdrawal by Subject|0|||
155702829|NCT01007838|562003014|FG002|Overall Study|Withdrawal by Subject|0|||
155702830|NCT01007838|562003015|FG003|Overall Study|Withdrawal by Subject|0|||
155702831|NCT01007838|562003012|FG000|Overall Study|Physician Decision|1|||
155702832|NCT01007838|562003013|FG001|Overall Study|Physician Decision|0|||
155702833|NCT01007838|562003014|FG002|Overall Study|Physician Decision|0|||
155702834|NCT01007838|562003015|FG003|Overall Study|Physician Decision|0|||
155702835|NCT01007838|562003012|FG000|Overall Study|Started home haemodialysis|1|||
155702836|NCT01007838|562003013|FG001|Overall Study|Started home haemodialysis|0|||
155702837|NCT01007838|562003014|FG002|Overall Study|Started home haemodialysis|0|||
155702838|NCT01007838|562003015|FG003|Overall Study|Started home haemodialysis|0|||
155702839|NCT02277119|562003016|FG000|Overall Study|Lack of Efficacy|1|||
155702840|NCT02277119|562003017|FG001|Overall Study|Lack of Efficacy|1|||
155702841|NCT02277119|562003018|FG002|Overall Study|Lack of Efficacy|1|||
155702842|NCT02277119|562003016|FG000|Overall Study|Protocol Violation|2|||
155702843|NCT02277119|562003017|FG001|Overall Study|Protocol Violation|3|||
155702844|NCT02277119|562003018|FG002|Overall Study|Protocol Violation|7|||
155702845|NCT01345669|562003019|FG000|Overall Study|Primary tumour recurrence|53|||
155702846|NCT01345669|562003020|FG001|Overall Study|Primary tumour recurrence|32|||
155702847|NCT01345669|562003019|FG000|Overall Study|Second primary tumour|4|||
155702848|NCT01345669|562003020|FG001|Overall Study|Second primary tumour|3|||
155702849|NCT01345669|562003019|FG000|Overall Study|Adverse Event|63|||
155702850|NCT01345669|562003020|FG001|Overall Study|Adverse Event|9|||
155702851|NCT01345669|562003019|FG000|Overall Study|Protocol Violation|3|||
155702852|NCT01345669|562003020|FG001|Overall Study|Protocol Violation|1|||
155702853|NCT01345669|562003019|FG000|Overall Study|Lost to Follow-up|1|||
155702854|NCT01345669|562003020|FG001|Overall Study|Lost to Follow-up|1|||
155702855|NCT01345669|562003019|FG000|Overall Study|Withdrawal by Subject|52|||
155702856|NCT01345669|562003020|FG001|Overall Study|Withdrawal by Subject|13|||
155702857|NCT01345669|562003019|FG000|Overall Study|Other Reasons|111|||
155702858|NCT01345669|562003020|FG001|Overall Study|Other Reasons|60|||
155702859|NCT02478255|562003022|FG000|Overall Study|Physician Decision|6|||
155702860|NCT02478255|562003023|FG001|Overall Study|Physician Decision|0|||
155702861|NCT02478255|562003022|FG000|Overall Study|Withdrawal by Subject|2|||
155702862|NCT02478255|562003023|FG001|Overall Study|Withdrawal by Subject|0|||
155702863|NCT03068767|562003024|FG000|Overall Study|Lost to Follow-up|7|||
155702864|NCT03068767|562003025|FG001|Overall Study|Lost to Follow-up|3|||
155702865|NCT03068767|562003024|FG000|Overall Study|Protocol Violation|3|||
155702866|NCT03068767|562003025|FG001|Overall Study|Protocol Violation|0|||
155702867|NCT02611817|562005918|FG000|Open-label Induction Phase|Reason not Specified|9|||
155702868|NCT02611817|562005919|FG001|Open-label Induction Phase|Reason not Specified|0|||
155702869|NCT02611817|562005920|FG002|Open-label Induction Phase|Reason not Specified|0|||
155702870|NCT02611817|562005918|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
155702871|NCT02611817|562005919|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
155702872|NCT02611817|562005920|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
155702873|NCT02611817|562005918|FG000|Open-label Induction Phase|Pregnancy|1|||
155702874|NCT02611817|562005919|FG001|Open-label Induction Phase|Pregnancy|0|||
155702875|NCT02611817|562005920|FG002|Open-label Induction Phase|Pregnancy|0|||
155702876|NCT02611817|562005918|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
155702877|NCT02611817|562005919|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
155702878|NCT02611817|562005920|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
155702879|NCT02611817|562005918|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
155702880|NCT02611817|562005919|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
155702881|NCT02611817|562005920|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
155702882|NCT02611817|562005918|FG000|Open-label Induction Phase|Protocol Violation|5|||
155702883|NCT02611817|562005919|FG001|Open-label Induction Phase|Protocol Violation|0|||
155702884|NCT02611817|562005920|FG002|Open-label Induction Phase|Protocol Violation|0|||
155702885|NCT02611817|562005918|FG000|Open-label Induction Phase|Adverse Event|16|||
155702886|NCT02611817|562005919|FG001|Open-label Induction Phase|Adverse Event|0|||
155702887|NCT02611817|562005920|FG002|Open-label Induction Phase|Adverse Event|0|||
155702888|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
155702889|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
155702890|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
155702891|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
155702892|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
155702893|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
155702894|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
155702895|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
155702896|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
155702897|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
155702898|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
155702899|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
155702900|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
155702901|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
155702902|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
155702903|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
155702904|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
155702905|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
155702906|NCT02611817|562005918|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
155702907|NCT02611817|562005919|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
155702908|NCT02611817|562005920|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
155702909|NCT03077919|562005921|FG000|Overall Study|Lost to Follow-up|4|||
155702910|NCT03077919|562005922|FG001|Overall Study|Lost to Follow-up|1|||
155702911|NCT03738618|562005923|FG000|Overall Study|Protocol deviation|23|||
155702912|NCT03738618|562005924|FG001|Overall Study|Protocol deviation|0|||
155702913|NCT03738618|562005923|FG000|Overall Study|Adverse Event|4|||
155702914|NCT03738618|562005924|FG001|Overall Study|Adverse Event|0|||
155702915|NCT03738618|562005923|FG000|Overall Study|Lost to Follow-up|2|||
155702916|NCT03738618|562005924|FG001|Overall Study|Lost to Follow-up|0|||
155702917|NCT03738618|562005923|FG000|Overall Study|Randomization failure|1|||
155702918|NCT03738618|562005924|FG001|Overall Study|Randomization failure|0|||
155702919|NCT03738618|562005923|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
155702920|NCT03738618|562005924|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
155702921|NCT03738618|562005923|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
155702922|NCT03738618|562005924|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
155702923|NCT00826618|562005925|FG000|Overall Study|Withdrawal by Subject|1|||
155702924|NCT01487265|562005930|FG000|Overall Study|Adverse Event|8|||
155702925|NCT01487265|562005930|FG000|Overall Study|Withdrawal by Subject|5|||
155702926|NCT01487265|562005930|FG000|Overall Study|Disease Progression|21|||
155702927|NCT01487265|562005930|FG000|Overall Study|Death|2|||
155702928|NCT01487265|562005930|FG000|Overall Study|Still on Treatment|1|||
155702929|NCT03499314|562005931|FG000|Overall Study|Time Commitment|1|||
155702930|NCT03499314|562005932|FG001|Overall Study|Time Commitment|2|||
155702931|NCT03499314|562005931|FG000|Overall Study|Medical issue unrelated to research study|1|||
155702932|NCT03499314|562005932|FG001|Overall Study|Medical issue unrelated to research study|1|||
155702933|NCT01618695|562005933|FG000|Core Phase|Adverse Event|4|||
155702934|NCT01618695|562005934|FG001|Core Phase|Adverse Event|5|||
155702935|NCT01618695|562005935|FG002|Core Phase|Adverse Event|15|||
155702936|NCT01618695|562005936|FG003|Core Phase|Adverse Event|20|||
155702937|NCT01618695|562005933|FG000|Core Phase|Lost to Follow-up|0|||
155702938|NCT01618695|562005934|FG001|Core Phase|Lost to Follow-up|0|||
155702939|NCT01618695|562005935|FG002|Core Phase|Lost to Follow-up|1|||
155702940|NCT01618695|562005936|FG003|Core Phase|Lost to Follow-up|0|||
155702941|NCT01618695|562005933|FG000|Core Phase|Withdrawal by Subject|16|||
155702942|NCT01618695|562005934|FG001|Core Phase|Withdrawal by Subject|11|||
155702943|NCT01618695|562005935|FG002|Core Phase|Withdrawal by Subject|9|||
155702944|NCT01618695|562005936|FG003|Core Phase|Withdrawal by Subject|13|||
155702945|NCT01618695|562005933|FG000|Core Phase|Pregnancy|2|||
155702946|NCT01618695|562005934|FG001|Core Phase|Pregnancy|0|||
155702947|NCT01618695|562005935|FG002|Core Phase|Pregnancy|0|||
155702948|NCT01618695|562005936|FG003|Core Phase|Pregnancy|0|||
155702949|NCT01618695|562005933|FG000|Core Phase|Lack of Efficacy|1|||
155702950|NCT01618695|562005934|FG001|Core Phase|Lack of Efficacy|2|||
155702951|NCT01618695|562005935|FG002|Core Phase|Lack of Efficacy|1|||
155702952|NCT01618695|562005936|FG003|Core Phase|Lack of Efficacy|1|||
155702953|NCT01618695|562005933|FG000|Core Phase|Other than specified|1|||
155702954|NCT01618695|562005934|FG001|Core Phase|Other than specified|2|||
155702955|NCT01618695|562005935|FG002|Core Phase|Other than specified|2|||
155702956|NCT01618695|562005936|FG003|Core Phase|Other than specified|2|||
155702957|NCT01618695|562005933|FG000|Core Phase|Not treated|1|||
155702958|NCT01618695|562005934|FG001|Core Phase|Not treated|0|||
155702959|NCT01618695|562005935|FG002|Core Phase|Not treated|2|||
155702960|NCT01618695|562005936|FG003|Core Phase|Not treated|0|||
155702961|NCT01618695|562005933|FG000|Extension Phase|Lack of Efficacy|17|||
155702962|NCT01618695|562005934|FG001|Extension Phase|Lack of Efficacy|33|||
155702963|NCT01618695|562005935|FG002|Extension Phase|Lack of Efficacy|26|||
155702964|NCT01618695|562005936|FG003|Extension Phase|Lack of Efficacy|24|||
155702965|NCT01618695|562005933|FG000|Extension Phase|Pregnancy|2|||
155702966|NCT01618695|562005934|FG001|Extension Phase|Pregnancy|0|||
155702967|NCT01618695|562005935|FG002|Extension Phase|Pregnancy|1|||
155702968|NCT01618695|562005936|FG003|Extension Phase|Pregnancy|1|||
155702969|NCT01618695|562005933|FG000|Extension Phase|Withdrawal by Subject|43|||
155702970|NCT01618695|562005934|FG001|Extension Phase|Withdrawal by Subject|48|||
155702971|NCT01618695|562005935|FG002|Extension Phase|Withdrawal by Subject|42|||
155702972|NCT01618695|562005936|FG003|Extension Phase|Withdrawal by Subject|33|||
155702973|NCT01618695|562005933|FG000|Extension Phase|Adverse Event|18|||
155702974|NCT01618695|562005934|FG001|Extension Phase|Adverse Event|16|||
155702975|NCT01618695|562005935|FG002|Extension Phase|Adverse Event|9|||
155702976|NCT01618695|562005936|FG003|Extension Phase|Adverse Event|20|||
155702977|NCT01618695|562005933|FG000|Extension Phase|Lost to Follow-up|2|||
155702978|NCT01618695|562005934|FG001|Extension Phase|Lost to Follow-up|1|||
155702979|NCT01618695|562005935|FG002|Extension Phase|Lost to Follow-up|1|||
155702980|NCT01618695|562005936|FG003|Extension Phase|Lost to Follow-up|1|||
155702981|NCT01618695|562005933|FG000|Extension Phase|Other than specified|13|||
155702982|NCT01618695|562005934|FG001|Extension Phase|Other than specified|18|||
155702983|NCT01618695|562005935|FG002|Extension Phase|Other than specified|13|||
155702984|NCT01618695|562005936|FG003|Extension Phase|Other than specified|18|||
155702985|NCT02291419|562005940|FG000|Overall Study|Early study termination|1|||
155702986|NCT02291419|562005941|FG001|Overall Study|Early study termination|5|||
155702987|NCT00931606|562005942|FG000|Overall Study|Death|1|||
155702988|NCT00931606|562005943|FG001|Overall Study|Death|3|||
155702989|NCT00931606|562005944|FG002|Overall Study|Death|2|||
155702990|NCT00931606|562005945|FG003|Overall Study|Death|0|||
155702991|NCT00931606|562005942|FG000|Overall Study|Lost to Follow-up|0|||
155702992|NCT00931606|562005943|FG001|Overall Study|Lost to Follow-up|1|||
155702993|NCT00931606|562005944|FG002|Overall Study|Lost to Follow-up|0|||
155702994|NCT00931606|562005945|FG003|Overall Study|Lost to Follow-up|0|||
155702995|NCT00931606|562005942|FG000|Overall Study|Physician Decision|0|||
155702996|NCT00931606|562005943|FG001|Overall Study|Physician Decision|0|||
155702997|NCT00931606|562005944|FG002|Overall Study|Physician Decision|3|||
155702998|NCT00931606|562005945|FG003|Overall Study|Physician Decision|0|||
155702999|NCT00931606|562005942|FG000|Overall Study|Sponsor Decision|1|||
155703000|NCT00931606|562005943|FG001|Overall Study|Sponsor Decision|4|||
155703001|NCT00931606|562005944|FG002|Overall Study|Sponsor Decision|0|||
155703002|NCT00931606|562005945|FG003|Overall Study|Sponsor Decision|2|||
155703003|NCT00931606|562005942|FG000|Overall Study|Withdrawal by Subject|3|||
155703004|NCT00931606|562005943|FG001|Overall Study|Withdrawal by Subject|1|||
155703005|NCT00931606|562005944|FG002|Overall Study|Withdrawal by Subject|1|||
155703006|NCT00931606|562005945|FG003|Overall Study|Withdrawal by Subject|1|||
155703007|NCT00871338|562005946|FG000|Prior to Booster|Withdrawal by Subject|1|||
155703008|NCT00871338|562005947|FG001|Prior to Booster|Withdrawal by Subject|3|||
155703009|NCT00871338|562005946|FG000|Prior to Booster|Lost to Follow-up|1|||
155703010|NCT00871338|562005947|FG001|Prior to Booster|Lost to Follow-up|0|||
155703011|NCT02391363|562005948|FG000|Overall Study|Lost to Follow-up|5|||
155703012|NCT02391363|562005949|FG001|Overall Study|Lost to Follow-up|5|||
155703013|NCT02391363|562005948|FG000|Overall Study|Withdrawal by Subject|6|||
155703014|NCT02391363|562005949|FG001|Overall Study|Withdrawal by Subject|3|||
155703015|NCT01016600|562005950|FG000|Overall Study|Did not start treatment|1|||
155703016|NCT01016600|562005951|FG001|Overall Study|Did not start treatment|0|||
155703017|NCT01016600|562005952|FG002|Overall Study|Did not start treatment|0|||
155703018|NCT01016600|562005953|FG003|Overall Study|Did not start treatment|0|||
155703019|NCT00872599|562005954|FG000|Second Washout Period|Adverse Event|1|||
155703020|NCT00872599|562005955|FG001|Second Washout Period|Adverse Event|1|||
155703021|NCT03826186|562005958|FG000|Overall Study|Protocol Violation|2|||
155703022|NCT03826186|562005959|FG001|Overall Study|Protocol Violation|0|||
155703023|NCT03826186|562005958|FG000|Overall Study|Withdrawal by Subject|1|||
155703024|NCT03826186|562005959|FG001|Overall Study|Withdrawal by Subject|0|||
155703025|NCT02737475|562005962|FG000|Overall Study|Other reasons|0|||
155703026|NCT02737475|562005963|FG001|Overall Study|Other reasons|0|||
155703027|NCT02737475|562005964|FG002|Overall Study|Other reasons|0|||
155703028|NCT02737475|562005965|FG003|Overall Study|Other reasons|0|||
155703029|NCT02737475|562005966|FG004|Overall Study|Other reasons|1|||
155703030|NCT02737475|562005967|FG005|Overall Study|Other reasons|1|||
155703031|NCT02737475|562005968|FG006|Overall Study|Other reasons|0|||
155703032|NCT02737475|562005969|FG007|Overall Study|Other reasons|0|||
155703033|NCT02737475|562005970|FG008|Overall Study|Other reasons|1|||
155703034|NCT02737475|562005971|FG009|Overall Study|Other reasons|0|||
155703035|NCT02737475|562005972|FG010|Overall Study|Other reasons|1|||
155703036|NCT02737475|562005973|FG011|Overall Study|Other reasons|0|||
155703037|NCT02737475|562005974|FG012|Overall Study|Other reasons|0|||
155703038|NCT02737475|562005975|FG013|Overall Study|Other reasons|0|||
155703039|NCT02737475|562005976|FG014|Overall Study|Other reasons|0|||
155703040|NCT02737475|562005977|FG015|Overall Study|Other reasons|0|||
155703041|NCT02737475|562005978|FG016|Overall Study|Other reasons|0|||
155703042|NCT02737475|562005979|FG017|Overall Study|Other reasons|0|||
155703043|NCT02737475|562005980|FG018|Overall Study|Other reasons|0|||
155703044|NCT02737475|562005981|FG019|Overall Study|Other reasons|0|||
155703045|NCT02737475|562005982|FG020|Overall Study|Other reasons|0|||
155703046|NCT02737475|562005983|FG021|Overall Study|Other reasons|1|||
155703047|NCT02737475|562005984|FG022|Overall Study|Other reasons|0|||
155703048|NCT02737475|562005985|FG023|Overall Study|Other reasons|1|||
155703049|NCT02737475|562005986|FG024|Overall Study|Other reasons|1|||
155703050|NCT02737475|562005987|FG025|Overall Study|Other reasons|1|||
155703051|NCT02737475|562005988|FG026|Overall Study|Other reasons|0|||
155703052|NCT02737475|562005962|FG000|Overall Study|Death|1|||
155703053|NCT02737475|562005963|FG001|Overall Study|Death|0|||
155703054|NCT02737475|562005964|FG002|Overall Study|Death|0|||
155703055|NCT02737475|562005965|FG003|Overall Study|Death|1|||
155703056|NCT02737475|562005966|FG004|Overall Study|Death|0|||
155703057|NCT02737475|562005967|FG005|Overall Study|Death|0|||
155703058|NCT02737475|562005968|FG006|Overall Study|Death|0|||
155703059|NCT02737475|562005969|FG007|Overall Study|Death|2|||
155703060|NCT02737475|562005970|FG008|Overall Study|Death|0|||
155703061|NCT02737475|562005971|FG009|Overall Study|Death|0|||
155703062|NCT02737475|562005972|FG010|Overall Study|Death|0|||
155703063|NCT02737475|562005973|FG011|Overall Study|Death|4|||
155703064|NCT02737475|562005974|FG012|Overall Study|Death|2|||
155703065|NCT02737475|562005975|FG013|Overall Study|Death|2|||
155703066|NCT02737475|562005976|FG014|Overall Study|Death|0|||
155703067|NCT02737475|562005977|FG015|Overall Study|Death|2|||
155703068|NCT02737475|562005978|FG016|Overall Study|Death|2|||
155703069|NCT02737475|562005979|FG017|Overall Study|Death|2|||
155703070|NCT02737475|562005980|FG018|Overall Study|Death|1|||
155703071|NCT02737475|562005981|FG019|Overall Study|Death|0|||
155703072|NCT02737475|562005982|FG020|Overall Study|Death|0|||
155703073|NCT02737475|562005983|FG021|Overall Study|Death|0|||
155703074|NCT02737475|562005984|FG022|Overall Study|Death|0|||
155703075|NCT02737475|562005985|FG023|Overall Study|Death|0|||
155703076|NCT02737475|562005986|FG024|Overall Study|Death|0|||
155703077|NCT02737475|562005987|FG025|Overall Study|Death|0|||
155703078|NCT02737475|562005988|FG026|Overall Study|Death|0|||
155703079|NCT02737475|562005962|FG000|Overall Study|Participant withdrew consent|0|||
155703080|NCT02737475|562005963|FG001|Overall Study|Participant withdrew consent|0|||
155703081|NCT02737475|562005964|FG002|Overall Study|Participant withdrew consent|0|||
155703082|NCT02737475|562005965|FG003|Overall Study|Participant withdrew consent|0|||
155703083|NCT02737475|562005966|FG004|Overall Study|Participant withdrew consent|0|||
155703084|NCT02737475|562005967|FG005|Overall Study|Participant withdrew consent|2|||
155703085|NCT02737475|562005968|FG006|Overall Study|Participant withdrew consent|0|||
155703086|NCT02737475|562005969|FG007|Overall Study|Participant withdrew consent|0|||
155703087|NCT02737475|562005970|FG008|Overall Study|Participant withdrew consent|0|||
155703088|NCT02737475|562005971|FG009|Overall Study|Participant withdrew consent|0|||
155703089|NCT02737475|562005972|FG010|Overall Study|Participant withdrew consent|0|||
155703090|NCT02737475|562005973|FG011|Overall Study|Participant withdrew consent|0|||
155703091|NCT02737475|562005974|FG012|Overall Study|Participant withdrew consent|0|||
155703092|NCT02737475|562005975|FG013|Overall Study|Participant withdrew consent|0|||
155703093|NCT02737475|562005976|FG014|Overall Study|Participant withdrew consent|1|||
155703094|NCT02737475|562005977|FG015|Overall Study|Participant withdrew consent|0|||
155703095|NCT02737475|562005978|FG016|Overall Study|Participant withdrew consent|0|||
155703096|NCT02737475|562005979|FG017|Overall Study|Participant withdrew consent|2|||
155703097|NCT02737475|562005980|FG018|Overall Study|Participant withdrew consent|1|||
155703098|NCT02737475|562005981|FG019|Overall Study|Participant withdrew consent|0|||
155703099|NCT02737475|562005982|FG020|Overall Study|Participant withdrew consent|2|||
155703100|NCT02737475|562005983|FG021|Overall Study|Participant withdrew consent|0|||
155703101|NCT02737475|562005984|FG022|Overall Study|Participant withdrew consent|0|||
155703102|NCT02737475|562005985|FG023|Overall Study|Participant withdrew consent|0|||
155703103|NCT02737475|562005986|FG024|Overall Study|Participant withdrew consent|0|||
155703104|NCT02737475|562005987|FG025|Overall Study|Participant withdrew consent|0|||
155703105|NCT02737475|562005988|FG026|Overall Study|Participant withdrew consent|0|||
155703106|NCT02737475|562005962|FG000|Overall Study|Lost to Follow-up|0|||
155703107|NCT02737475|562005963|FG001|Overall Study|Lost to Follow-up|0|||
155703108|NCT02737475|562005964|FG002|Overall Study|Lost to Follow-up|0|||
155703109|NCT02737475|562005965|FG003|Overall Study|Lost to Follow-up|0|||
155703110|NCT02737475|562005966|FG004|Overall Study|Lost to Follow-up|0|||
155703111|NCT02737475|562005967|FG005|Overall Study|Lost to Follow-up|0|||
155703112|NCT02737475|562005968|FG006|Overall Study|Lost to Follow-up|0|||
155703113|NCT02737475|562005969|FG007|Overall Study|Lost to Follow-up|0|||
155703114|NCT02737475|562005970|FG008|Overall Study|Lost to Follow-up|0|||
155703115|NCT02737475|562005971|FG009|Overall Study|Lost to Follow-up|0|||
155703116|NCT02737475|562005972|FG010|Overall Study|Lost to Follow-up|0|||
155703117|NCT02737475|562005973|FG011|Overall Study|Lost to Follow-up|0|||
155703118|NCT02737475|562005974|FG012|Overall Study|Lost to Follow-up|0|||
155703119|NCT02737475|562005975|FG013|Overall Study|Lost to Follow-up|0|||
155703120|NCT02737475|562005976|FG014|Overall Study|Lost to Follow-up|0|||
155703121|NCT02737475|562005977|FG015|Overall Study|Lost to Follow-up|1|||
155703122|NCT02737475|562005978|FG016|Overall Study|Lost to Follow-up|0|||
155703123|NCT02737475|562005979|FG017|Overall Study|Lost to Follow-up|0|||
155703124|NCT02737475|562005980|FG018|Overall Study|Lost to Follow-up|0|||
155703125|NCT02737475|562005981|FG019|Overall Study|Lost to Follow-up|0|||
155703126|NCT02737475|562005982|FG020|Overall Study|Lost to Follow-up|0|||
155703127|NCT02737475|562005983|FG021|Overall Study|Lost to Follow-up|0|||
155703128|NCT02737475|562005984|FG022|Overall Study|Lost to Follow-up|0|||
155703129|NCT02737475|562005985|FG023|Overall Study|Lost to Follow-up|0|||
155703130|NCT02737475|562005986|FG024|Overall Study|Lost to Follow-up|0|||
155703131|NCT02737475|562005987|FG025|Overall Study|Lost to Follow-up|0|||
155703132|NCT02737475|562005988|FG026|Overall Study|Lost to Follow-up|0|||
155703133|NCT02737475|562005962|FG000|Overall Study|Disease Progression|0|||
155703134|NCT02737475|562005963|FG001|Overall Study|Disease Progression|0|||
155703135|NCT02737475|562005964|FG002|Overall Study|Disease Progression|0|||
155703136|NCT02737475|562005965|FG003|Overall Study|Disease Progression|0|||
155703137|NCT02737475|562005966|FG004|Overall Study|Disease Progression|0|||
155703138|NCT02737475|562005967|FG005|Overall Study|Disease Progression|0|||
155703139|NCT02737475|562005968|FG006|Overall Study|Disease Progression|0|||
155703140|NCT02737475|562005969|FG007|Overall Study|Disease Progression|0|||
155703141|NCT02737475|562005970|FG008|Overall Study|Disease Progression|0|||
155703142|NCT02737475|562005971|FG009|Overall Study|Disease Progression|0|||
155703143|NCT02737475|562005972|FG010|Overall Study|Disease Progression|0|||
155703144|NCT02737475|562005973|FG011|Overall Study|Disease Progression|0|||
155703145|NCT02737475|562005974|FG012|Overall Study|Disease Progression|0|||
155703146|NCT02737475|562005975|FG013|Overall Study|Disease Progression|0|||
155703147|NCT02737475|562005976|FG014|Overall Study|Disease Progression|0|||
155703148|NCT02737475|562005977|FG015|Overall Study|Disease Progression|0|||
155703149|NCT02737475|562005978|FG016|Overall Study|Disease Progression|0|||
155703150|NCT02737475|562005979|FG017|Overall Study|Disease Progression|0|||
155703151|NCT02737475|562005980|FG018|Overall Study|Disease Progression|0|||
155703152|NCT02737475|562005981|FG019|Overall Study|Disease Progression|0|||
155703153|NCT02737475|562005982|FG020|Overall Study|Disease Progression|0|||
155703154|NCT02737475|562005983|FG021|Overall Study|Disease Progression|0|||
155703155|NCT02737475|562005984|FG022|Overall Study|Disease Progression|0|||
155703156|NCT02737475|562005985|FG023|Overall Study|Disease Progression|0|||
155703157|NCT02737475|562005986|FG024|Overall Study|Disease Progression|0|||
155703158|NCT02737475|562005987|FG025|Overall Study|Disease Progression|0|||
155703159|NCT02737475|562005988|FG026|Overall Study|Disease Progression|1|||
155703160|NCT02950480|562005995|FG000|Overall Study|Withdrawal by Subject|1|||
155703161|NCT02950480|562005996|FG001|Overall Study|Withdrawal by Subject|0|||
155703162|NCT01363661|562005998|FG000|Overall Study|Adverse Event|9|||
155703163|NCT01363661|562005999|FG001|Overall Study|Adverse Event|2|||
155703164|NCT01363661|562005998|FG000|Overall Study|Withdrawal by Subject|1|||
155703165|NCT01363661|562005999|FG001|Overall Study|Withdrawal by Subject|1|||
155703166|NCT01363661|562005998|FG000|Overall Study|Protocol Violation|1|||
155703167|NCT01363661|562005999|FG001|Overall Study|Protocol Violation|0|||
155703168|NCT01363661|562005998|FG000|Overall Study|Lost to Follow-up|3|||
155703169|NCT01363661|562005999|FG001|Overall Study|Lost to Follow-up|1|||
155703170|NCT02219334|562006002|FG000|Overall Study|Withdrawal by Subject|1|||
155703171|NCT02219334|562006003|FG001|Overall Study|Withdrawal by Subject|0|||
155703172|NCT02219334|562006002|FG000|Overall Study|Protocol Violation|7|||
155703173|NCT02219334|562006003|FG001|Overall Study|Protocol Violation|3|||
155703174|NCT00711971|562006010|FG000|Overall Study|Lost to Follow-up|3|||
155703175|NCT00711971|562006011|FG001|Overall Study|Lost to Follow-up|4|||
155703176|NCT00711971|562006012|FG002|Overall Study|Lost to Follow-up|1|||
155703177|NCT03704688|562006017|FG000|Overall Study|Adverse Event|0|||
155703178|NCT03704688|562006018|FG001|Overall Study|Adverse Event|0|||
155703179|NCT03704688|562006019|FG002|Overall Study|Adverse Event|0|||
155703180|NCT03704688|562006020|FG003|Overall Study|Adverse Event|4|||
155703181|NCT03704688|562006021|FG004|Overall Study|Adverse Event|1|||
155703182|NCT03704688|562006022|FG005|Overall Study|Adverse Event|0|||
155703183|NCT03704688|562006017|FG000|Overall Study|Disease Progression|0|||
155703184|NCT03704688|562006018|FG001|Overall Study|Disease Progression|0|||
155703185|NCT03704688|562006019|FG002|Overall Study|Disease Progression|0|||
155703186|NCT03704688|562006020|FG003|Overall Study|Disease Progression|3|||
155703187|NCT03704688|562006021|FG004|Overall Study|Disease Progression|1|||
155703188|NCT03704688|562006022|FG005|Overall Study|Disease Progression|0|||
155703189|NCT03704688|562006017|FG000|Overall Study|Death|0|||
155703190|NCT03704688|562006018|FG001|Overall Study|Death|0|||
155703191|NCT03704688|562006019|FG002|Overall Study|Death|0|||
155703192|NCT03704688|562006020|FG003|Overall Study|Death|0|||
155703193|NCT03704688|562006021|FG004|Overall Study|Death|3|||
155703194|NCT03704688|562006022|FG005|Overall Study|Death|0|||
155703195|NCT04774926|562006024|FG000|Overall Study|Adverse Event|15|||
155703196|NCT04774926|562006024|FG000|Overall Study|Lost to Follow-up|3|||
155703197|NCT04774926|562006024|FG000|Overall Study|Physician Decision|6|||
155703198|NCT04774926|562006024|FG000|Overall Study|Withdrawal by Subject|3|||
155703199|NCT04774926|562006024|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
155703200|NCT01393639|562006025|FG000|Overall Study|Protocol Violation|0|||
155703201|NCT01393639|562006026|FG001|Overall Study|Protocol Violation|0|||
155703202|NCT01393639|562006027|FG002|Overall Study|Protocol Violation|0|||
155703203|NCT01393639|562006028|FG003|Overall Study|Protocol Violation|1|||
155703204|NCT01393639|562006029|FG004|Overall Study|Protocol Violation|0|||
155703205|NCT01393639|562006030|FG005|Overall Study|Protocol Violation|0|||
155703206|NCT01393639|562006031|FG006|Overall Study|Protocol Violation|0|||
155703207|NCT01393639|562006025|FG000|Overall Study|Other|0|||
155703208|NCT01393639|562006026|FG001|Overall Study|Other|2|||
155703209|NCT01393639|562006027|FG002|Overall Study|Other|0|||
155703210|NCT01393639|562006028|FG003|Overall Study|Other|2|||
155703211|NCT01393639|562006029|FG004|Overall Study|Other|1|||
155703212|NCT01393639|562006030|FG005|Overall Study|Other|0|||
155703213|NCT01393639|562006031|FG006|Overall Study|Other|1|||
155703214|NCT01393639|562006025|FG000|Overall Study|Withdrawal by Subject|1|||
155703215|NCT01393639|562006026|FG001|Overall Study|Withdrawal by Subject|1|||
155703216|NCT01393639|562006027|FG002|Overall Study|Withdrawal by Subject|0|||
155703217|NCT01393639|562006028|FG003|Overall Study|Withdrawal by Subject|0|||
155703218|NCT01393639|562006029|FG004|Overall Study|Withdrawal by Subject|0|||
155703219|NCT01393639|562006030|FG005|Overall Study|Withdrawal by Subject|0|||
155703220|NCT01393639|562006031|FG006|Overall Study|Withdrawal by Subject|1|||
155703221|NCT01393639|562006025|FG000|Overall Study|Medication error without associated AE|0|||
155703222|NCT01393639|562006026|FG001|Overall Study|Medication error without associated AE|0|||
155703223|NCT01393639|562006027|FG002|Overall Study|Medication error without associated AE|0|||
155703224|NCT01393639|562006028|FG003|Overall Study|Medication error without associated AE|0|||
155703225|NCT01393639|562006029|FG004|Overall Study|Medication error without associated AE|0|||
155703226|NCT01393639|562006030|FG005|Overall Study|Medication error without associated AE|0|||
155703227|NCT01393639|562006031|FG006|Overall Study|Medication error without associated AE|1|||
155703228|NCT01393639|562006025|FG000|Overall Study|Lost to Follow-up|0|||
155703229|NCT01393639|562006026|FG001|Overall Study|Lost to Follow-up|1|||
155703230|NCT01393639|562006027|FG002|Overall Study|Lost to Follow-up|0|||
155703231|NCT01393639|562006028|FG003|Overall Study|Lost to Follow-up|0|||
155703232|NCT01393639|562006029|FG004|Overall Study|Lost to Follow-up|0|||
155703233|NCT01393639|562006030|FG005|Overall Study|Lost to Follow-up|0|||
155703234|NCT01393639|562006031|FG006|Overall Study|Lost to Follow-up|1|||
155703235|NCT01393639|562006025|FG000|Overall Study|Lack of Efficacy|0|||
155703236|NCT01393639|562006026|FG001|Overall Study|Lack of Efficacy|0|||
155703237|NCT01393639|562006027|FG002|Overall Study|Lack of Efficacy|0|||
155703238|NCT01393639|562006028|FG003|Overall Study|Lack of Efficacy|0|||
155703239|NCT01393639|562006029|FG004|Overall Study|Lack of Efficacy|0|||
155703240|NCT01393639|562006030|FG005|Overall Study|Lack of Efficacy|0|||
155703241|NCT01393639|562006031|FG006|Overall Study|Lack of Efficacy|1|||
155703242|NCT01393639|562006025|FG000|Overall Study|Adverse Event|2|||
155703243|NCT01393639|562006026|FG001|Overall Study|Adverse Event|3|||
155703244|NCT01393639|562006027|FG002|Overall Study|Adverse Event|1|||
155703245|NCT01393639|562006028|FG003|Overall Study|Adverse Event|2|||
155703246|NCT01393639|562006029|FG004|Overall Study|Adverse Event|0|||
155703247|NCT01393639|562006030|FG005|Overall Study|Adverse Event|2|||
155703248|NCT01393639|562006031|FG006|Overall Study|Adverse Event|3|||
155703249|NCT03626545|562006032|FG000|Overall Study|Progressive disease|3|||
155703250|NCT03626545|562006033|FG001|Overall Study|Progressive disease|82|||
155703251|NCT03626545|562006034|FG002|Overall Study|Progressive disease|85|||
155703252|NCT03626545|562006032|FG000|Overall Study|Adverse Event|3|||
155703253|NCT03626545|562006033|FG001|Overall Study|Adverse Event|13|||
155703254|NCT03626545|562006034|FG002|Overall Study|Adverse Event|10|||
155703255|NCT03626545|562006032|FG000|Overall Study|Physician Decision|1|||
155703256|NCT03626545|562006033|FG001|Overall Study|Physician Decision|18|||
155703257|NCT03626545|562006034|FG002|Overall Study|Physician Decision|14|||
155703258|NCT03626545|562006032|FG000|Overall Study|Subject Decision|0|||
155703259|NCT03626545|562006033|FG001|Overall Study|Subject Decision|5|||
155703260|NCT03626545|562006034|FG002|Overall Study|Subject Decision|5|||
155703261|NCT03626545|562006032|FG000|Overall Study|Death|1|||
155703262|NCT03626545|562006033|FG001|Overall Study|Death|1|||
155703263|NCT03626545|562006034|FG002|Overall Study|Death|1|||
155703264|NCT03626545|562006032|FG000|Overall Study|Protocol Deviation|0|||
155703265|NCT03626545|562006033|FG001|Overall Study|Protocol Deviation|1|||
155703266|NCT03626545|562006034|FG002|Overall Study|Protocol Deviation|1|||
155703267|NCT03626545|562006032|FG000|Overall Study|Guardian Decision|0|||
155703268|NCT03626545|562006033|FG001|Overall Study|Guardian Decision|0|||
155703269|NCT03626545|562006034|FG002|Overall Study|Guardian Decision|1|||
155703270|NCT00793325|562006036|FG000|Overall Study|Protocol Violation|18|||
155703271|NCT00793325|562006036|FG000|Overall Study|Lost to Follow-up|1|||
155703272|NCT00413036|562006037|FG000|Overall Study|Adverse Event|44|||
155703273|NCT00413036|562006037|FG000|Overall Study|Lack of Efficacy|129|||
155703274|NCT00413036|562006037|FG000|Overall Study|Withdrawal by Subject|7|||
155703275|NCT00413036|562006037|FG000|Overall Study|Death|9|||
155703276|NCT00413036|562006037|FG000|Overall Study|Other|26|||
155703277|NCT00413036|562006037|FG000|Overall Study|Missing|2|||
155703278|NCT02524158|562006046|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
155703279|NCT02524158|562006047|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
155703280|NCT02524158|562006046|FG000|12-weeks Assessment|Lost to Follow-up|18|||
155703281|NCT02524158|562006047|FG001|12-weeks Assessment|Lost to Follow-up|12|||
155703282|NCT02524158|562006046|FG000|6-month Assessment|Withdrawal by Subject|1|||
155703283|NCT02524158|562006047|FG001|6-month Assessment|Withdrawal by Subject|1|||
155703284|NCT02524158|562006046|FG000|6-month Assessment|Lost to Follow-up|21|||
155703285|NCT02524158|562006047|FG001|6-month Assessment|Lost to Follow-up|20|||
155703286|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703287|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703288|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
155703289|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
155703290|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
155703291|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703292|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
155703293|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
155703294|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
155703295|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703296|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703297|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703298|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155703299|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
155703300|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155703301|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
155703302|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155703303|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155703304|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155703305|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155703306|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155703307|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
155703308|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155703309|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155703310|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155703311|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155703312|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703313|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155703314|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155703315|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703316|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703317|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155703318|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155703319|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703320|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703321|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703322|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703323|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703324|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155703325|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703326|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155703327|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155703328|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703329|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703330|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703331|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155703332|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703333|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155703334|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703335|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703336|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703337|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155703338|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703339|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703340|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703341|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
155703342|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703343|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703344|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703345|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
155703346|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703347|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703348|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703349|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703350|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155703351|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703352|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703353|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703354|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
155703355|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703356|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703357|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
155703358|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703359|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703360|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703361|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703362|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703363|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155703364|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703365|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
155703366|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703367|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703368|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703369|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703370|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703371|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703372|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703373|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703374|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703375|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703376|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155703377|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
155703378|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703379|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703380|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703381|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703382|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703383|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703384|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703385|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703386|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703387|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703388|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703389|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155703390|NCT03100058|562006048|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703391|NCT03100058|562006049|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703392|NCT03100058|562006050|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703393|NCT03100058|562006051|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703394|NCT03100058|562006052|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703395|NCT03100058|562006053|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703396|NCT03100058|562006054|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
155703397|NCT03100058|562006055|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703398|NCT03100058|562006056|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703399|NCT03100058|562006057|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703400|NCT03100058|562006058|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703401|NCT03100058|562006059|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703402|NCT03100058|562006060|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155703403|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703404|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703405|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703406|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703407|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703408|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703409|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703410|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703411|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703412|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155703413|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
155703414|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
155703415|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
155703416|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703417|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703418|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703419|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703420|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703421|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703422|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703423|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703424|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703425|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703426|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
155703427|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
155703428|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155703429|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703430|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703431|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703432|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703433|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703434|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703435|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703436|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703437|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703438|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
155703439|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
155703440|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155703441|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
155703442|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703443|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703444|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703445|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703446|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703447|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703448|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703449|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703450|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703451|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703452|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
155703453|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703454|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155703455|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703456|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703457|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703458|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703459|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703460|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703461|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703462|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703463|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703464|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703465|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703466|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155703467|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
155703468|NCT03100058|562006048|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703469|NCT03100058|562006049|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703470|NCT03100058|562006050|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703471|NCT03100058|562006051|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703472|NCT03100058|562006052|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703473|NCT03100058|562006053|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703474|NCT03100058|562006054|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703475|NCT03100058|562006055|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703476|NCT03100058|562006056|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703477|NCT03100058|562006057|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
155703478|NCT03100058|562006058|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703479|NCT03100058|562006059|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703480|NCT03100058|562006060|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155703481|NCT03671304|562006061|FG000|Overall Study|study terminated|7|||
155703482|NCT00596830|562006066|FG000|Overall Study|Death|258|||
155703483|NCT00596830|562006067|FG001|Overall Study|Death|247|||
155703484|NCT00596830|562006066|FG000|Overall Study|Lost to Follow-up|7|||
155703485|NCT00596830|562006067|FG001|Overall Study|Lost to Follow-up|11|||
155703486|NCT00596830|562006066|FG000|Overall Study|Withdrawal by Subject|22|||
155703487|NCT00596830|562006067|FG001|Overall Study|Withdrawal by Subject|12|||
155703488|NCT00596830|562006066|FG000|Overall Study|Study terminated by sponsor|51|||
155703489|NCT00596830|562006067|FG001|Overall Study|Study terminated by sponsor|62|||
155703490|NCT00596830|562006066|FG000|Overall Study|Follow-up was discontinued|1|||
155703491|NCT00596830|562006067|FG001|Overall Study|Follow-up was discontinued|0|||
155703492|NCT00596830|562006066|FG000|Overall Study|Randomized but not treated|3|||
155703493|NCT00596830|562006067|FG001|Overall Study|Randomized but not treated|7|||
155703494|NCT00887926|562006068|FG000|Overall Study|Withdrawal by Subject|0|||
155703495|NCT00887926|562006069|FG001|Overall Study|Withdrawal by Subject|1|||
155703496|NCT00887926|562006070|FG002|Overall Study|Withdrawal by Subject|0|||
155703497|NCT00887926|562006071|FG003|Overall Study|Withdrawal by Subject|0|||
155703498|NCT02097030|562006072|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
155703499|NCT02097030|562006073|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
155703500|NCT02097030|562006072|FG000|First Intervention (3 Days)|Visual Acuity|0|||
155703501|NCT02097030|562006073|FG001|First Intervention (3 Days)|Visual Acuity|1|||
155703502|NCT04869358|562006074|FG000|Overall Study|Wish to have children.|1|||
155703503|NCT04869358|562006075|FG001|Overall Study|Wish to have children.|0|||
155703504|NCT04869358|562006076|FG002|Overall Study|Wish to have children.|0|||
155703505|NCT04869358|562006077|FG003|Overall Study|Wish to have children.|0|||
155703506|NCT01336023|562006079|FG000|Week 0 to Week 26|Adverse Event|8|||
155703507|NCT01336023|562006080|FG001|Week 0 to Week 26|Adverse Event|10|||
155703508|NCT01336023|562006081|FG002|Week 0 to Week 26|Adverse Event|24|||
155703509|NCT01336023|562006079|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
155703510|NCT01336023|562006080|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
155703511|NCT01336023|562006081|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
155703512|NCT01336023|562006079|FG000|Week 0 to Week 26|Protocol Violation|1|||
155703513|NCT01336023|562006080|FG001|Week 0 to Week 26|Protocol Violation|2|||
155703514|NCT01336023|562006081|FG002|Week 0 to Week 26|Protocol Violation|0|||
155703515|NCT01336023|562006079|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
155703516|NCT01336023|562006080|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
155703517|NCT01336023|562006081|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
155703518|NCT01336023|562006079|FG000|Week 0 to Week 26|Unclassified|5|||
155703519|NCT01336023|562006080|FG001|Week 0 to Week 26|Unclassified|16|||
155703520|NCT01336023|562006081|FG002|Week 0 to Week 26|Unclassified|9|||
155703521|NCT01336023|562006079|FG000|Week 27 to 52|Adverse Event|1|||
155703522|NCT01336023|562006080|FG001|Week 27 to 52|Adverse Event|5|||
155703523|NCT01336023|562006081|FG002|Week 27 to 52|Adverse Event|2|||
155703524|NCT01336023|562006079|FG000|Week 27 to 52|Protocol Violation|0|||
155703525|NCT01336023|562006080|FG001|Week 27 to 52|Protocol Violation|2|||
155703526|NCT01336023|562006081|FG002|Week 27 to 52|Protocol Violation|1|||
155703527|NCT01336023|562006079|FG000|Week 27 to 52|Withdrawal Criteria|14|||
155703528|NCT01336023|562006080|FG001|Week 27 to 52|Withdrawal Criteria|19|||
155703529|NCT01336023|562006081|FG002|Week 27 to 52|Withdrawal Criteria|16|||
155703530|NCT01336023|562006079|FG000|Week 27 to 52|Unclassified|13|||
155703531|NCT01336023|562006080|FG001|Week 27 to 52|Unclassified|18|||
155703532|NCT01336023|562006081|FG002|Week 27 to 52|Unclassified|9|||
155703533|NCT01894022|562006084|FG000|Overall Study|Death|1|||
155703534|NCT01894022|562006085|FG001|Overall Study|Death|0|||
155703535|NCT01894022|562006084|FG000|Overall Study|Adverse Event, non-fatal|1|||
155703536|NCT01894022|562006085|FG001|Overall Study|Adverse Event, non-fatal|0|||
155703537|NCT01894022|562006084|FG000|Overall Study|Study Closed/terminated|7|||
155703538|NCT01894022|562006085|FG001|Overall Study|Study Closed/terminated|10|||
155703539|NCT00235716|562006088|FG000|Overall Study|Death|26|||
155703540|NCT00235716|562006089|FG001|Overall Study|Death|39|||
155703541|NCT00235716|562006090|FG002|Overall Study|Death|32|||
155703542|NCT00235716|562006091|FG003|Overall Study|Death|31|||
155703543|NCT00235716|562006088|FG000|Overall Study|Withdrawal by Subject|23|||
155703544|NCT00235716|562006089|FG001|Overall Study|Withdrawal by Subject|19|||
155703545|NCT00235716|562006090|FG002|Overall Study|Withdrawal by Subject|17|||
155703546|NCT00235716|562006091|FG003|Overall Study|Withdrawal by Subject|18|||
155703547|NCT00235716|562006088|FG000|Overall Study|Lost to Follow-up|12|||
155703548|NCT00235716|562006089|FG001|Overall Study|Lost to Follow-up|7|||
155703549|NCT00235716|562006090|FG002|Overall Study|Lost to Follow-up|14|||
155703550|NCT00235716|562006091|FG003|Overall Study|Lost to Follow-up|10|||
155703551|NCT00235716|562006088|FG000|Overall Study|Adverse Event|1|||
155703552|NCT00235716|562006089|FG001|Overall Study|Adverse Event|1|||
155703553|NCT00235716|562006090|FG002|Overall Study|Adverse Event|1|||
155703554|NCT00235716|562006091|FG003|Overall Study|Adverse Event|0|||
155703555|NCT00235716|562006088|FG000|Overall Study|Physician Decision|0|||
155703556|NCT00235716|562006089|FG001|Overall Study|Physician Decision|1|||
155703557|NCT00235716|562006090|FG002|Overall Study|Physician Decision|1|||
155703558|NCT00235716|562006091|FG003|Overall Study|Physician Decision|3|||
155703559|NCT01545050|562006092|FG000|Overall Study|Lack of Efficacy|0|||
155703560|NCT01545050|562006093|FG001|Overall Study|Lack of Efficacy|0|||
155703561|NCT01545050|562006094|FG002|Overall Study|Lack of Efficacy|0|||
155703562|NCT01545050|562006095|FG003|Overall Study|Lack of Efficacy|3|||
155703563|NCT01545050|562006096|FG004|Overall Study|Lack of Efficacy|2|||
155703564|NCT01545050|562006092|FG000|Overall Study|Adverse Event|1|||
155703565|NCT01545050|562006093|FG001|Overall Study|Adverse Event|1|||
155703566|NCT01545050|562006094|FG002|Overall Study|Adverse Event|2|||
155703567|NCT01545050|562006095|FG003|Overall Study|Adverse Event|2|||
155703568|NCT01545050|562006096|FG004|Overall Study|Adverse Event|0|||
155703569|NCT01545050|562006092|FG000|Overall Study|Discontinued study treatment|1|||
155703570|NCT01545050|562006093|FG001|Overall Study|Discontinued study treatment|0|||
155703571|NCT01545050|562006094|FG002|Overall Study|Discontinued study treatment|0|||
155703572|NCT01545050|562006095|FG003|Overall Study|Discontinued study treatment|0|||
155703573|NCT01545050|562006096|FG004|Overall Study|Discontinued study treatment|0|||
155703574|NCT01545050|562006092|FG000|Overall Study|Withdrawal by Subject|1|||
155703575|NCT01545050|562006093|FG001|Overall Study|Withdrawal by Subject|0|||
155703576|NCT01545050|562006094|FG002|Overall Study|Withdrawal by Subject|0|||
155703577|NCT01545050|562006095|FG003|Overall Study|Withdrawal by Subject|2|||
155703578|NCT01545050|562006096|FG004|Overall Study|Withdrawal by Subject|1|||
155703579|NCT01545050|562006092|FG000|Overall Study|Participant no longer meets study criteria|0|||
155703580|NCT01545050|562006093|FG001|Overall Study|Participant no longer meets study criteria|2|||
155703581|NCT01545050|562006094|FG002|Overall Study|Participant no longer meets study criteria|0|||
155703582|NCT01545050|562006095|FG003|Overall Study|Participant no longer meets study criteria|0|||
155703583|NCT01545050|562006096|FG004|Overall Study|Participant no longer meets study criteria|1|||
155703584|NCT01545050|562006092|FG000|Overall Study|Administrative reason by sponsor|4|||
155703585|NCT01545050|562006093|FG001|Overall Study|Administrative reason by sponsor|2|||
155703586|NCT01545050|562006094|FG002|Overall Study|Administrative reason by sponsor|3|||
155703587|NCT01545050|562006095|FG003|Overall Study|Administrative reason by sponsor|5|||
155703588|NCT01545050|562006096|FG004|Overall Study|Administrative reason by sponsor|5|||
155703589|NCT03235089|562006097|FG000|Overall Study|Lost to Follow-up|1|||
155703590|NCT03235089|562006098|FG001|Overall Study|Lost to Follow-up|1|||
155703591|NCT03235089|562006097|FG000|Overall Study|Physician Decision|2|||
155703592|NCT03235089|562006098|FG001|Overall Study|Physician Decision|2|||
155703593|NCT02673684|562006099|FG000|Overall Study|Study not completed d/t loss of funding|9|||
155703594|NCT02673684|562006100|FG001|Overall Study|Study not completed d/t loss of funding|8|||
155703595|NCT04699461|562006107|FG000|Overall Study|Withdrawal by Subject|1|||
155703596|NCT04699461|562006108|FG001|Overall Study|Withdrawal by Subject|0|||
155703597|NCT04699461|562006107|FG000|Overall Study|Study termination by sponsor|2|||
155703598|NCT04699461|562006108|FG001|Overall Study|Study termination by sponsor|1|||
155703599|NCT04699461|562006107|FG000|Overall Study|Death|1|||
155703600|NCT04699461|562006108|FG001|Overall Study|Death|0|||
155703601|NCT04699461|562006107|FG000|Overall Study|Radiographic progression|0|||
155703602|NCT04699461|562006108|FG001|Overall Study|Radiographic progression|1|||
155703603|NCT00061633|562006116|FG000|Overall Study|Adverse Event|1|||
155703604|NCT00061633|562006117|FG001|Overall Study|Adverse Event|2|||
155703605|NCT00061633|562006116|FG000|Overall Study|Withdrawal by Subject|2|||
155703606|NCT00061633|562006117|FG001|Overall Study|Withdrawal by Subject|2|||
155703607|NCT00061633|562006116|FG000|Overall Study|Lost to Follow-up|1|||
155703608|NCT00061633|562006117|FG001|Overall Study|Lost to Follow-up|4|||
155703609|NCT00061633|562006116|FG000|Overall Study|Other|1|||
155703610|NCT00061633|562006117|FG001|Overall Study|Other|1|||
155703611|NCT00061633|562006116|FG000|Overall Study|Never received study treatment|0|||
155703612|NCT00061633|562006117|FG001|Overall Study|Never received study treatment|2|||
155703613|NCT01431963|562006118|FG000|Overall Study|Adverse Event|18|||
155703614|NCT01431963|562006118|FG000|Overall Study|Lack of Efficacy|7|||
155703615|NCT01431963|562006118|FG000|Overall Study|Protocol Violation|1|||
155703616|NCT01431963|562006118|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
155703617|NCT01431963|562006118|FG000|Overall Study|Physician Decision|4|||
155703618|NCT01431963|562006118|FG000|Overall Study|Withdrawal by Subject|3|||
155703619|NCT02301624|562006123|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
155703620|NCT02301624|562006124|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
155703621|NCT02301624|562006123|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
155703622|NCT02301624|562006124|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
155703623|NCT02301624|562006123|FG000|Open-label Maintenance Phase|Adverse Event|2|||
155703624|NCT02301624|562006124|FG001|Open-label Maintenance Phase|Adverse Event|5|||
155703625|NCT02301624|562006123|FG000|Open-label Maintenance Phase|Physician Decision|3|||
155703626|NCT02301624|562006124|FG001|Open-label Maintenance Phase|Physician Decision|3|||
155703627|NCT02301624|562006123|FG000|Open-label Maintenance Phase|Death|2|||
155703628|NCT02301624|562006124|FG001|Open-label Maintenance Phase|Death|1|||
155703629|NCT02301624|562006123|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
155703630|NCT02301624|562006124|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
155703631|NCT00547521|562006125|FG000|Short Term Study (4 Months)|Adverse Event|1|||
155703632|NCT00547521|562006126|FG001|Short Term Study (4 Months)|Adverse Event|0|||
155703633|NCT00547521|562006125|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
155703634|NCT00547521|562006126|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
155703635|NCT00547521|562006125|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
155703636|NCT00547521|562006126|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
155703637|NCT00547521|562006125|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
155703638|NCT00547521|562006126|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
155703639|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
155703640|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
155703641|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
155703642|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
155703643|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
155703644|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
155703645|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
155703646|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
155703647|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Other|0|||
155703648|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Other|2|||
155703649|NCT00547521|562006125|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
155703650|NCT00547521|562006126|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
155703651|NCT02475278|562008296|FG000|Overall Study|Lost to Follow-up|1|||
155703652|NCT02475278|562008296|FG000|Overall Study|Reason Not Specified|1|||
155703653|NCT04794270|562008297|FG000|Period 1|Non Compliance|1|||
155703654|NCT04794270|562008298|FG001|Period 1|Non Compliance|0|||
155703655|NCT04794270|562008297|FG000|Period 1|Adverse Event|1|||
155703656|NCT04794270|562008298|FG001|Period 1|Adverse Event|0|||
155703657|NCT04794270|562008297|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
155703658|NCT04794270|562008298|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
155703659|NCT01271725|562008299|FG000|Part A|Progressive disease according to RECIST|8|||
155703660|NCT01271725|562008300|FG001|Part A|Progressive disease according to RECIST|0|||
155703661|NCT01271725|562008299|FG000|Part A|Clinical signs/symptoms of progression|2|||
155703662|NCT01271725|562008300|FG001|Part A|Clinical signs/symptoms of progression|0|||
155703663|NCT01271725|562008299|FG000|Part A|Other Adverse Event|8|||
155703664|NCT01271725|562008300|FG001|Part A|Other Adverse Event|0|||
155703665|NCT01271725|562008299|FG000|Part A|Lost to Follow-up|1|||
155703666|NCT01271725|562008300|FG001|Part A|Lost to Follow-up|0|||
155703667|NCT01271725|562008299|FG000|Part A|Withdrawal by Subject|12|||
155703668|NCT01271725|562008300|FG001|Part A|Withdrawal by Subject|0|||
155703669|NCT01271725|562008299|FG000|Part A|Other than specified|3|||
155703670|NCT01271725|562008300|FG001|Part A|Other than specified|0|||
155703671|NCT01271725|562008299|FG000|Part A|Protocol Violation|1|||
155703672|NCT01271725|562008300|FG001|Part A|Protocol Violation|0|||
155703673|NCT01271725|562008299|FG000|Part B|Other than specified|0|||
155703674|NCT01271725|562008300|FG001|Part B|Other than specified|2|||
155703675|NCT01271725|562008299|FG000|Part B|Clinical signs/symptoms of progression|0|||
155703676|NCT01271725|562008300|FG001|Part B|Clinical signs/symptoms of progression|2|||
155703677|NCT01271725|562008299|FG000|Part B|Other Adverse Event|0|||
155703678|NCT01271725|562008300|FG001|Part B|Other Adverse Event|1|||
155703679|NCT01271725|562008299|FG000|Part B|Protocol Violation|0|||
155703680|NCT01271725|562008300|FG001|Part B|Protocol Violation|1|||
155703681|NCT01271725|562008299|FG000|Part B|Withdrawal by Subject|0|||
155703682|NCT01271725|562008300|FG001|Part B|Withdrawal by Subject|6|||
155703683|NCT00801229|562008303|FG000|Signed Consent|Withdrawal by Subject|2|||
155703684|NCT00801229|562008304|FG001|Signed Consent|Withdrawal by Subject|2|||
155703685|NCT00801229|562008303|FG000|Signed Consent|Found Ineligible|1|||
155703686|NCT00801229|562008304|FG001|Signed Consent|Found Ineligible|1|||
155703687|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
155703688|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
155703689|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
155703690|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
155703691|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
155703692|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
155703693|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
155703694|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
155703695|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
155703696|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
155703697|NCT00801229|562008303|FG000|Received Study Drug/Placebo|Adverse Event|1|||
155703698|NCT00801229|562008304|FG001|Received Study Drug/Placebo|Adverse Event|1|||
155703699|NCT02300259|562008305|FG000|Period 1|Adverse Event|0|||
155703700|NCT02300259|562008306|FG001|Period 1|Adverse Event|0|||
155703701|NCT02300259|562008307|FG002|Period 1|Adverse Event|1|||
155703702|NCT02300259|562008305|FG000|Period 1|Withdrawal by Subject|0|||
155703703|NCT02300259|562008306|FG001|Period 1|Withdrawal by Subject|0|||
155703704|NCT02300259|562008307|FG002|Period 1|Withdrawal by Subject|1|||
155703705|NCT02300259|562008305|FG000|Period 2|Adverse Event|1|||
155703706|NCT02300259|562008306|FG001|Period 2|Adverse Event|0|||
155703707|NCT02300259|562008307|FG002|Period 2|Adverse Event|0|||
155703708|NCT02300259|562008305|FG000|Period 2|Withdrawal by Subject|0|||
155703709|NCT02300259|562008306|FG001|Period 2|Withdrawal by Subject|0|||
155703710|NCT02300259|562008307|FG002|Period 2|Withdrawal by Subject|1|||
155703711|NCT02510001|562008308|FG000|Overall Study|Early disease progression|0|||
155703712|NCT02510001|562008309|FG001|Overall Study|Early disease progression|0|||
155703713|NCT02510001|562008310|FG002|Overall Study|Early disease progression|0|||
155703714|NCT02510001|562008311|FG003|Overall Study|Early disease progression|1|||
155703715|NCT02510001|562008312|FG004|Overall Study|Early disease progression|1|||
155703716|NCT02510001|562008313|FG005|Overall Study|Early disease progression|1|||
155703717|NCT02510001|562008314|FG006|Overall Study|Early disease progression|0|||
155703718|NCT02510001|562008315|FG007|Overall Study|Early disease progression|0|||
155703719|NCT02510001|562008308|FG000|Overall Study|Adverse Event|0|||
155703720|NCT02510001|562008309|FG001|Overall Study|Adverse Event|0|||
155703721|NCT02510001|562008310|FG002|Overall Study|Adverse Event|0|||
155703722|NCT02510001|562008311|FG003|Overall Study|Adverse Event|1|||
155703723|NCT02510001|562008312|FG004|Overall Study|Adverse Event|2|||
155703724|NCT02510001|562008313|FG005|Overall Study|Adverse Event|1|||
155703725|NCT02510001|562008314|FG006|Overall Study|Adverse Event|2|||
155703726|NCT02510001|562008315|FG007|Overall Study|Adverse Event|5|||
155703727|NCT02510001|562008308|FG000|Overall Study|Physician Decision|0|||
155703728|NCT02510001|562008309|FG001|Overall Study|Physician Decision|0|||
155703729|NCT02510001|562008310|FG002|Overall Study|Physician Decision|0|||
155703730|NCT02510001|562008311|FG003|Overall Study|Physician Decision|0|||
155703731|NCT02510001|562008312|FG004|Overall Study|Physician Decision|1|||
155703732|NCT02510001|562008313|FG005|Overall Study|Physician Decision|0|||
155703733|NCT02510001|562008314|FG006|Overall Study|Physician Decision|0|||
155703734|NCT02510001|562008315|FG007|Overall Study|Physician Decision|0|||
155703735|NCT02510001|562008308|FG000|Overall Study|Withdrawal by Subject|0|||
155703736|NCT02510001|562008309|FG001|Overall Study|Withdrawal by Subject|0|||
155703737|NCT02510001|562008310|FG002|Overall Study|Withdrawal by Subject|0|||
155703738|NCT02510001|562008311|FG003|Overall Study|Withdrawal by Subject|0|||
155703739|NCT02510001|562008312|FG004|Overall Study|Withdrawal by Subject|0|||
155703740|NCT02510001|562008313|FG005|Overall Study|Withdrawal by Subject|0|||
155703741|NCT02510001|562008314|FG006|Overall Study|Withdrawal by Subject|0|||
155703742|NCT02510001|562008315|FG007|Overall Study|Withdrawal by Subject|2|||
155703743|NCT01504841|562008323|FG000|Overall Study|Withdrawal by Subject|1|||
155703744|NCT01504841|562008324|FG001|Overall Study|Withdrawal by Subject|1|||
155703745|NCT01504841|562008325|FG002|Overall Study|Withdrawal by Subject|0|||
155703746|NCT03149055|562008330|FG000|Overall Study|Not treated|4|||
155703747|NCT04440813|562008331|FG000|Overall Study|Lost to Follow-up|5|||
155703748|NCT04440813|562008332|FG001|Overall Study|Lost to Follow-up|5|||
155703749|NCT02255461|562008333|FG000|Overall Study|Adverse Event|0|||
155703750|NCT02255461|562008334|FG001|Overall Study|Adverse Event|1|||
155703751|NCT02255461|562008335|FG002|Overall Study|Adverse Event|0|||
155703752|NCT02255461|562008336|FG003|Overall Study|Adverse Event|0|||
155703753|NCT02255461|562008337|FG004|Overall Study|Adverse Event|1|||
155703754|NCT02255461|562008333|FG000|Overall Study|Withdrawal by Subject|0|||
155703755|NCT02255461|562008334|FG001|Overall Study|Withdrawal by Subject|0|||
155703756|NCT02255461|562008335|FG002|Overall Study|Withdrawal by Subject|1|||
155703757|NCT02255461|562008336|FG003|Overall Study|Withdrawal by Subject|0|||
155703758|NCT02255461|562008337|FG004|Overall Study|Withdrawal by Subject|1|||
155703759|NCT02255461|562008333|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
155703760|NCT02255461|562008334|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
155703761|NCT02255461|562008335|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
155703762|NCT02255461|562008336|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
155703763|NCT02255461|562008337|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
155703764|NCT00291018|562008342|FG000|Overall Study|Not Consented or Declined PAS|12|||
155703765|NCT00291018|562008343|FG001|Overall Study|Not Consented or Declined PAS|15|||
155703766|NCT00291018|562008344|FG002|Overall Study|Not Consented or Declined PAS|15|||
155703767|NCT00291018|562008342|FG000|Overall Study|Death|3|||
155703768|NCT00291018|562008343|FG001|Overall Study|Death|3|||
155703769|NCT00291018|562008344|FG002|Overall Study|Death|4|||
155703770|NCT00291018|562008342|FG000|Overall Study|Withdrawal by Subject|2|||
155703771|NCT00291018|562008343|FG001|Overall Study|Withdrawal by Subject|8|||
155703772|NCT00291018|562008344|FG002|Overall Study|Withdrawal by Subject|1|||
155703773|NCT00291018|562008342|FG000|Overall Study|Failures|5|||
155703774|NCT00291018|562008343|FG001|Overall Study|Failures|12|||
155703775|NCT00291018|562008344|FG002|Overall Study|Failures|5|||
155703776|NCT00291018|562008342|FG000|Overall Study|Lost to Follow-up|3|||
155703777|NCT00291018|562008343|FG001|Overall Study|Lost to Follow-up|4|||
155703778|NCT00291018|562008344|FG002|Overall Study|Lost to Follow-up|18|||
155703779|NCT00630344|562008345|FG000|Overall Study|Adverse Event|5|||
155703780|NCT00630344|562008345|FG000|Overall Study|Progressive Disease|19|||
155703781|NCT00630344|562008345|FG000|Overall Study|Physician Decision|9|||
155703782|NCT00630344|562008345|FG000|Overall Study|Withdrawal by Subject|1|||
155703783|NCT00630344|562008345|FG000|Overall Study|Intercurrent Illness|1|||
155703784|NCT00630344|562008345|FG000|Overall Study|Other|1|||
155703785|NCT01357551|562008346|FG000|Overall Study|Withdrawal by Subject|6|||
155703786|NCT01357551|562008347|FG001|Overall Study|Withdrawal by Subject|4|||
155703787|NCT01357551|562008346|FG000|Overall Study|Death|0|||
155703788|NCT01357551|562008347|FG001|Overall Study|Death|1|||
155703789|NCT01357551|562008346|FG000|Overall Study|Lost to Follow-up|16|||
155703790|NCT01357551|562008347|FG001|Overall Study|Lost to Follow-up|6|||
155703791|NCT01440816|562008357|FG000|Overall Study|Disease Progression|0|||
155703792|NCT01440816|562008358|FG001|Overall Study|Disease Progression|9|||
155703793|NCT01440816|562008357|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
155703794|NCT01440816|562008358|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
155703795|NCT01832155|562008359|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
155703796|NCT01832155|562008360|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
155703797|NCT01832155|562008359|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
155703798|NCT01832155|562008360|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
155703799|NCT00847886|562008361|FG000|Overall Study|Adverse Event|0|||
155703800|NCT00847886|562008362|FG001|Overall Study|Adverse Event|1|||
155703801|NCT02462720|562008363|FG000|Part 2|Withdrawal by Subject|1|||
155703802|NCT02462720|562008364|FG001|Part 2|Withdrawal by Subject|0|||
155703803|NCT02462720|562008363|FG000|Part 2|Protocol Violation|0|||
155703804|NCT02462720|562008364|FG001|Part 2|Protocol Violation|1|||
155703805|NCT03250182|562008365|FG000|Overall Study|Withdrawal by Subject|1|||
155703806|NCT03668613|562008367|FG000|Overall Study|Adverse Event|1|||
155703807|NCT03668613|562008368|FG001|Overall Study|Adverse Event|2|||
155703808|NCT03668613|562008367|FG000|Overall Study|Lack of Efficacy|5|||
155703809|NCT03668613|562008368|FG001|Overall Study|Lack of Efficacy|1|||
155703810|NCT03668613|562008367|FG000|Overall Study|Pregnancy|0|||
155703811|NCT03668613|562008368|FG001|Overall Study|Pregnancy|2|||
155703812|NCT03668613|562008367|FG000|Overall Study|Protocol Violation|1|||
155703813|NCT03668613|562008368|FG001|Overall Study|Protocol Violation|0|||
155703814|NCT03668613|562008367|FG000|Overall Study|Physician Decision|1|||
155703815|NCT03668613|562008368|FG001|Overall Study|Physician Decision|0|||
155703816|NCT03668613|562008367|FG000|Overall Study|Withdrawal by Subject|2|||
155703817|NCT03668613|562008368|FG001|Overall Study|Withdrawal by Subject|1|||
155703818|NCT03668613|562008367|FG000|Overall Study|Guardian decision|1|||
155703819|NCT03668613|562008368|FG001|Overall Study|Guardian decision|0|||
155703820|NCT01858740|562008371|FG000|Overall Study|Death|4|||
155703821|NCT03386487|562008372|FG000|Overall Study|Lost to Follow-up|5|||
155703822|NCT03386487|562008373|FG001|Overall Study|Lost to Follow-up|6|||
155703823|NCT03386487|562008372|FG000|Overall Study|Withdrawal by Subject|11|||
155703824|NCT03386487|562008373|FG001|Overall Study|Withdrawal by Subject|7|||
155703825|NCT03386487|562008372|FG000|Overall Study|Physician Decision|11|||
155703826|NCT03386487|562008373|FG001|Overall Study|Physician Decision|8|||
155703827|NCT01068769|562008374|FG000|Overall Study|Ineligible|1|||
155703828|NCT04776317|562008377|FG000|Overall Study|Physician Decision|0|||
155703829|NCT04776317|562008378|FG001|Overall Study|Physician Decision|1|||
155703830|NCT04776317|562008379|FG002|Overall Study|Physician Decision|0|||
155703831|NCT04776317|562008380|FG003|Overall Study|Physician Decision|0|||
155703832|NCT04776317|562008381|FG004|Overall Study|Physician Decision|0|||
155703833|NCT04776317|562008382|FG005|Overall Study|Physician Decision|0|||
155703834|NCT04776317|562008383|FG006|Overall Study|Physician Decision|0|||
155703835|NCT04776317|562008384|FG007|Overall Study|Physician Decision|0|||
155703836|NCT04776317|562008385|FG008|Overall Study|Physician Decision|0|||
155703837|NCT04776317|562008386|FG009|Overall Study|Physician Decision|0|||
155703838|NCT04776317|562008387|FG010|Overall Study|Physician Decision|0|||
155703839|NCT04776317|562008388|FG011|Overall Study|Physician Decision|0|||
155703840|NCT04776317|562008389|FG012|Overall Study|Physician Decision|0|||
155703841|NCT04776317|562008390|FG013|Overall Study|Physician Decision|0|||
155703842|NCT04776317|562008391|FG014|Overall Study|Physician Decision|0|||
155703843|NCT04776317|562008377|FG000|Overall Study|Protocol Violation|0|||
155703844|NCT04776317|562008378|FG001|Overall Study|Protocol Violation|0|||
155703845|NCT04776317|562008379|FG002|Overall Study|Protocol Violation|1|||
155703846|NCT04776317|562008380|FG003|Overall Study|Protocol Violation|0|||
155703847|NCT04776317|562008381|FG004|Overall Study|Protocol Violation|0|||
155703848|NCT04776317|562008382|FG005|Overall Study|Protocol Violation|0|||
155703849|NCT04776317|562008383|FG006|Overall Study|Protocol Violation|0|||
155703850|NCT04776317|562008384|FG007|Overall Study|Protocol Violation|0|||
155703851|NCT04776317|562008385|FG008|Overall Study|Protocol Violation|0|||
155703852|NCT04776317|562008386|FG009|Overall Study|Protocol Violation|0|||
155703853|NCT04776317|562008387|FG010|Overall Study|Protocol Violation|0|||
155703854|NCT04776317|562008388|FG011|Overall Study|Protocol Violation|0|||
155703855|NCT04776317|562008389|FG012|Overall Study|Protocol Violation|0|||
155703856|NCT04776317|562008390|FG013|Overall Study|Protocol Violation|0|||
155703857|NCT04776317|562008391|FG014|Overall Study|Protocol Violation|0|||
155703858|NCT04776317|562008377|FG000|Overall Study|Withdrawal by Subject|0|||
155703859|NCT04776317|562008378|FG001|Overall Study|Withdrawal by Subject|0|||
155703860|NCT04776317|562008379|FG002|Overall Study|Withdrawal by Subject|0|||
155703861|NCT04776317|562008380|FG003|Overall Study|Withdrawal by Subject|0|||
155703862|NCT04776317|562008381|FG004|Overall Study|Withdrawal by Subject|1|||
155703863|NCT04776317|562008382|FG005|Overall Study|Withdrawal by Subject|0|||
155703864|NCT04776317|562008383|FG006|Overall Study|Withdrawal by Subject|0|||
155703865|NCT04776317|562008384|FG007|Overall Study|Withdrawal by Subject|0|||
155703866|NCT04776317|562008385|FG008|Overall Study|Withdrawal by Subject|0|||
155703867|NCT04776317|562008386|FG009|Overall Study|Withdrawal by Subject|0|||
155703868|NCT04776317|562008387|FG010|Overall Study|Withdrawal by Subject|0|||
155703869|NCT04776317|562008388|FG011|Overall Study|Withdrawal by Subject|0|||
155703870|NCT04776317|562008389|FG012|Overall Study|Withdrawal by Subject|0|||
155703871|NCT04776317|562008390|FG013|Overall Study|Withdrawal by Subject|0|||
155703872|NCT04776317|562008391|FG014|Overall Study|Withdrawal by Subject|0|||
155703873|NCT01067144|562008393|FG000|Treatment|Did not receive allocated intervention|4|||
155703874|NCT01067144|562008394|FG001|Treatment|Did not receive allocated intervention|7|||
155703875|NCT01067144|562008393|FG000|Follow-up|Lost to Follow-up|22|||
155703876|NCT01067144|562008394|FG001|Follow-up|Lost to Follow-up|12|||
155703877|NCT01067144|562008393|FG000|Follow-up|Censored owing to second surgery|19|||
155703878|NCT01067144|562008394|FG001|Follow-up|Censored owing to second surgery|28|||
155703879|NCT01067144|562008393|FG000|Follow-up|Withdrawal by Subject|18|||
155703880|NCT01067144|562008394|FG001|Follow-up|Withdrawal by Subject|14|||
155703881|NCT01067144|562008393|FG000|Follow-up|Surgery cancelled|0|||
155703882|NCT01067144|562008394|FG001|Follow-up|Surgery cancelled|1|||
155703883|NCT01067144|562008393|FG000|Follow-up|Death|0|||
155703884|NCT01067144|562008394|FG001|Follow-up|Death|1|||
155703885|NCT01843062|562008397|FG000|Overall Study|Protocol Violation|1|||
155703886|NCT01843062|562008398|FG001|Overall Study|Protocol Violation|0|||
155703887|NCT01843062|562008397|FG000|Overall Study|New treatment following progression|2|||
155703888|NCT01843062|562008398|FG001|Overall Study|New treatment following progression|0|||
155703889|NCT01843062|562008397|FG000|Overall Study|Pregnancy|1|||
155703890|NCT01843062|562008398|FG001|Overall Study|Pregnancy|0|||
155703891|NCT01843062|562008397|FG000|Overall Study|Adverse Event|2|||
155703892|NCT01843062|562008398|FG001|Overall Study|Adverse Event|0|||
155703893|NCT01843062|562008397|FG000|Overall Study|Incorrect randomisation|1|||
155703894|NCT01843062|562008398|FG001|Overall Study|Incorrect randomisation|0|||
155703895|NCT01843062|562008397|FG000|Overall Study|Withdrawal by Subject|12|||
155703896|NCT01843062|562008398|FG001|Overall Study|Withdrawal by Subject|3|||
155703897|NCT01843062|562008397|FG000|Overall Study|Death|1|||
155703898|NCT01843062|562008398|FG001|Overall Study|Death|2|||
155703899|NCT01843062|562008397|FG000|Overall Study|Lost to Follow-up|2|||
155703900|NCT01843062|562008398|FG001|Overall Study|Lost to Follow-up|4|||
155703901|NCT03194646|562008406|FG000|Overall Study|Adverse Event|24|||
155703902|NCT03194646|562008407|FG001|Overall Study|Adverse Event|25|||
155703903|NCT03194646|562008408|FG002|Overall Study|Adverse Event|14|||
155703904|NCT03194646|562008409|FG003|Overall Study|Adverse Event|17|||
155703905|NCT03194646|562008406|FG000|Overall Study|Lack of Efficacy|4|||
155703906|NCT03194646|562008407|FG001|Overall Study|Lack of Efficacy|2|||
155703907|NCT03194646|562008408|FG002|Overall Study|Lack of Efficacy|2|||
155703908|NCT03194646|562008409|FG003|Overall Study|Lack of Efficacy|12|||
155703909|NCT03194646|562008406|FG000|Overall Study|Lost to Follow-up|30|||
155703910|NCT03194646|562008407|FG001|Overall Study|Lost to Follow-up|22|||
155703911|NCT03194646|562008408|FG002|Overall Study|Lost to Follow-up|12|||
155703912|NCT03194646|562008409|FG003|Overall Study|Lost to Follow-up|35|||
155703913|NCT03194646|562008406|FG000|Overall Study|Non-compliance with study drug|4|||
155703914|NCT03194646|562008407|FG001|Overall Study|Non-compliance with study drug|0|||
155703915|NCT03194646|562008408|FG002|Overall Study|Non-compliance with study drug|1|||
155703916|NCT03194646|562008409|FG003|Overall Study|Non-compliance with study drug|1|||
155703917|NCT03194646|562008406|FG000|Overall Study|Other|89|||
155703918|NCT03194646|562008407|FG001|Overall Study|Other|68|||
155703919|NCT03194646|562008408|FG002|Overall Study|Other|34|||
155703920|NCT03194646|562008409|FG003|Overall Study|Other|31|||
155703921|NCT03194646|562008406|FG000|Overall Study|Physician Decision|7|||
155703922|NCT03194646|562008407|FG001|Overall Study|Physician Decision|9|||
155703923|NCT03194646|562008408|FG002|Overall Study|Physician Decision|5|||
155703924|NCT03194646|562008409|FG003|Overall Study|Physician Decision|4|||
155703925|NCT03194646|562008406|FG000|Overall Study|Pregnancy|4|||
155703926|NCT03194646|562008407|FG001|Overall Study|Pregnancy|5|||
155703927|NCT03194646|562008408|FG002|Overall Study|Pregnancy|1|||
155703928|NCT03194646|562008409|FG003|Overall Study|Pregnancy|2|||
155703929|NCT03194646|562008406|FG000|Overall Study|Protocol Violation|4|||
155703930|NCT03194646|562008407|FG001|Overall Study|Protocol Violation|2|||
155703931|NCT03194646|562008408|FG002|Overall Study|Protocol Violation|1|||
155703932|NCT03194646|562008409|FG003|Overall Study|Protocol Violation|1|||
155703933|NCT03194646|562008406|FG000|Overall Study|Site terminated by sponsor|0|||
155703934|NCT03194646|562008407|FG001|Overall Study|Site terminated by sponsor|0|||
155703935|NCT03194646|562008408|FG002|Overall Study|Site terminated by sponsor|2|||
155703936|NCT03194646|562008409|FG003|Overall Study|Site terminated by sponsor|0|||
155703937|NCT03194646|562008406|FG000|Overall Study|Study terminated by sponsor|62|||
155703938|NCT03194646|562008407|FG001|Overall Study|Study terminated by sponsor|61|||
155703939|NCT03194646|562008408|FG002|Overall Study|Study terminated by sponsor|30|||
155703940|NCT03194646|562008409|FG003|Overall Study|Study terminated by sponsor|34|||
155703941|NCT03194646|562008406|FG000|Overall Study|Withdrawal by Subject|75|||
155703942|NCT03194646|562008407|FG001|Overall Study|Withdrawal by Subject|74|||
155703943|NCT03194646|562008408|FG002|Overall Study|Withdrawal by Subject|36|||
155703944|NCT03194646|562008409|FG003|Overall Study|Withdrawal by Subject|131|||
155703945|NCT03194646|562008406|FG000|Overall Study|Missing|1|||
155703946|NCT03194646|562008407|FG001|Overall Study|Missing|0|||
155703947|NCT03194646|562008408|FG002|Overall Study|Missing|1|||
155703948|NCT03194646|562008409|FG003|Overall Study|Missing|12|||
155703949|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
155703950|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
155703951|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
155703952|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
155703953|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Death|2|||
155703954|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Death|2|||
155703955|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Death|0|||
155703956|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Death|0|||
155703957|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
155703958|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
155703959|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
155703960|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
155703961|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
155703962|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155703963|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155703964|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155703965|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
155703966|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
155703967|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
155703968|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
155703969|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
155703970|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155703971|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155703972|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155703973|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155703974|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
155703975|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155703976|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155703977|NCT03068754|562008414|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
155703978|NCT03068754|562008415|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
155703979|NCT03068754|562008416|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
155703980|NCT03068754|562008417|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
155703981|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
155703982|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
155703983|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
155703984|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
155703985|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Death|0|||
155703986|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Death|0|||
155703987|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Death|0|||
155703988|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Death|1|||
155703989|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
155703990|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
155703991|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
155703992|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
155703993|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155703994|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155703995|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
155703996|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155703997|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155703998|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155703999|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
155704000|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155704001|NCT03068754|562008414|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
155704002|NCT03068754|562008415|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
155704003|NCT03068754|562008416|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
155704004|NCT03068754|562008417|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
155704005|NCT01361178|562008421|FG000|Overall Study|Death|13|||
155704006|NCT01361178|562008422|FG001|Overall Study|Death|0|||
155704007|NCT02726022|562008427|FG000|Overall Study|Adverse Event|14|||
155704008|NCT02726022|562008427|FG000|Overall Study|Treatment Failure|8|||
155704009|NCT02726022|562008427|FG000|Overall Study|Poor Compliance|13|||
155704010|NCT02726022|562008427|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
155704011|NCT00781859|562008432|FG000|Overall Study|Adverse Event|2|||
155704012|NCT00781859|562008433|FG001|Overall Study|Adverse Event|2|||
155704013|NCT00781859|562008432|FG000|Overall Study|Withdrawal by Subject|8|||
155704014|NCT00781859|562008433|FG001|Overall Study|Withdrawal by Subject|4|||
155704015|NCT00781859|562008432|FG000|Overall Study|Lost to Follow-up|6|||
155704016|NCT00781859|562008433|FG001|Overall Study|Lost to Follow-up|3|||
155704017|NCT00781859|562008432|FG000|Overall Study|Death|3|||
155704018|NCT00781859|562008433|FG001|Overall Study|Death|0|||
155704019|NCT01339897|562008434|FG000|Overall Study|Adverse Event|1|||
155704020|NCT01339897|562008435|FG001|Overall Study|Adverse Event|0|||
155704021|NCT01339897|562008436|FG002|Overall Study|Adverse Event|0|||
155704022|NCT01339897|562008437|FG003|Overall Study|Adverse Event|1|||
155704023|NCT01990859|562008438|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
155704024|NCT01990859|562008438|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
155704025|NCT00622388|562008441|FG000|Overall Study|Disease Progression|47|||
155704026|NCT00622388|562008441|FG000|Overall Study|Adverse Event|6|||
155704027|NCT00622388|562008441|FG000|Overall Study|Protocol Violation|3|||
155704028|NCT00622388|562008441|FG000|Overall Study|Participant Refusal|1|||
155704029|NCT00622388|562008441|FG000|Overall Study|Death|3|||
155704030|NCT00622388|562008441|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
155704031|NCT00622388|562008441|FG000|Overall Study|Took Prohibited Medication|2|||
155704032|NCT00622388|562008441|FG000|Overall Study|Withdrew Consent|1|||
155704033|NCT00622388|562008441|FG000|Overall Study|Insurance Expired|1|||
155704034|NCT00348309|562008442|FG000|Overall Study|Adverse Event|56|||
155704035|NCT00348309|562008443|FG001|Overall Study|Adverse Event|28|||
155704036|NCT00348309|562008444|FG002|Overall Study|Adverse Event|63|||
155704037|NCT00348309|562008442|FG000|Overall Study|Lost to Follow-up|6|||
155704038|NCT00348309|562008443|FG001|Overall Study|Lost to Follow-up|7|||
155704039|NCT00348309|562008444|FG002|Overall Study|Lost to Follow-up|4|||
155704040|NCT00348309|562008442|FG000|Overall Study|Protocol Violation|7|||
155704041|NCT00348309|562008443|FG001|Overall Study|Protocol Violation|12|||
155704042|NCT00348309|562008444|FG002|Overall Study|Protocol Violation|7|||
155704043|NCT00348309|562008442|FG000|Overall Study|Withdrawal by Subject|33|||
155704044|NCT00348309|562008443|FG001|Overall Study|Withdrawal by Subject|37|||
155704045|NCT00348309|562008444|FG002|Overall Study|Withdrawal by Subject|40|||
155704046|NCT00348309|562008442|FG000|Overall Study|Non-compliance|8|||
155704047|NCT00348309|562008443|FG001|Overall Study|Non-compliance|6|||
155704048|NCT00348309|562008444|FG002|Overall Study|Non-compliance|8|||
155704049|NCT00348309|562008442|FG000|Overall Study|Death of caregiver|1|||
155704050|NCT00348309|562008443|FG001|Overall Study|Death of caregiver|0|||
155704051|NCT00348309|562008444|FG002|Overall Study|Death of caregiver|1|||
155704052|NCT00348309|562008442|FG000|Overall Study|Lack of insight, dementia|1|||
155704053|NCT00348309|562008443|FG001|Overall Study|Lack of insight, dementia|0|||
155704054|NCT00348309|562008444|FG002|Overall Study|Lack of insight, dementia|0|||
155704055|NCT00348309|562008442|FG000|Overall Study|Wrong bottle allocated|1|||
155704056|NCT00348309|562008443|FG001|Overall Study|Wrong bottle allocated|0|||
155704057|NCT00348309|562008444|FG002|Overall Study|Wrong bottle allocated|0|||
155704058|NCT00348309|562008442|FG000|Overall Study|Caregiver sick|1|||
155704059|NCT00348309|562008443|FG001|Overall Study|Caregiver sick|0|||
155704060|NCT00348309|562008444|FG002|Overall Study|Caregiver sick|0|||
155704061|NCT00348309|562008442|FG000|Overall Study|Use of prohibited medication|5|||
155704062|NCT00348309|562008443|FG001|Overall Study|Use of prohibited medication|2|||
155704063|NCT00348309|562008444|FG002|Overall Study|Use of prohibited medication|2|||
155704064|NCT00348309|562008442|FG000|Overall Study|Caregiver withdrawal|3|||
155704065|NCT00348309|562008443|FG001|Overall Study|Caregiver withdrawal|0|||
155704066|NCT00348309|562008444|FG002|Overall Study|Caregiver withdrawal|7|||
155704067|NCT00348309|562008442|FG000|Overall Study|Unable to complete ET visit|1|||
155704068|NCT00348309|562008443|FG001|Overall Study|Unable to complete ET visit|0|||
155704069|NCT00348309|562008444|FG002|Overall Study|Unable to complete ET visit|0|||
155704070|NCT00348309|562008442|FG000|Overall Study|PI closing medical practice|1|||
155704071|NCT00348309|562008443|FG001|Overall Study|PI closing medical practice|0|||
155704072|NCT00348309|562008444|FG002|Overall Study|PI closing medical practice|0|||
155704073|NCT00348309|562008442|FG000|Overall Study|Principal investigator's decision|1|||
155704074|NCT00348309|562008443|FG001|Overall Study|Principal investigator's decision|0|||
155704075|NCT00348309|562008444|FG002|Overall Study|Principal investigator's decision|0|||
155704076|NCT00348309|562008442|FG000|Overall Study|No disponibility of medication|1|||
155704077|NCT00348309|562008443|FG001|Overall Study|No disponibility of medication|0|||
155704078|NCT00348309|562008444|FG002|Overall Study|No disponibility of medication|0|||
155704079|NCT00348309|562008442|FG000|Overall Study|Worsened neurodegenerative disease|1|||
155704080|NCT00348309|562008443|FG001|Overall Study|Worsened neurodegenerative disease|0|||
155704081|NCT00348309|562008444|FG002|Overall Study|Worsened neurodegenerative disease|0|||
155704082|NCT00348309|562008442|FG000|Overall Study|Cognitive and behaviour worsening|2|||
155704083|NCT00348309|562008443|FG001|Overall Study|Cognitive and behaviour worsening|0|||
155704084|NCT00348309|562008444|FG002|Overall Study|Cognitive and behaviour worsening|0|||
155704085|NCT00348309|562008442|FG000|Overall Study|Worsening of alzheimer|1|||
155704086|NCT00348309|562008443|FG001|Overall Study|Worsening of alzheimer|0|||
155704087|NCT00348309|562008444|FG002|Overall Study|Worsening of alzheimer|1|||
155704088|NCT00348309|562008442|FG000|Overall Study|Did not appear in time for Visit 3|1|||
155704089|NCT00348309|562008443|FG001|Overall Study|Did not appear in time for Visit 3|0|||
155704090|NCT00348309|562008444|FG002|Overall Study|Did not appear in time for Visit 3|0|||
155704091|NCT00348309|562008442|FG000|Overall Study|Participant died|2|||
155704092|NCT00348309|562008443|FG001|Overall Study|Participant died|1|||
155704093|NCT00348309|562008444|FG002|Overall Study|Participant died|1|||
155704094|NCT00348309|562008442|FG000|Overall Study|Decision of sponsor|1|||
155704095|NCT00348309|562008443|FG001|Overall Study|Decision of sponsor|0|||
155704096|NCT00348309|562008444|FG002|Overall Study|Decision of sponsor|0|||
155704097|NCT00348309|562008442|FG000|Overall Study|Ineffectiveness of treatment|0|||
155704098|NCT00348309|562008443|FG001|Overall Study|Ineffectiveness of treatment|1|||
155704099|NCT00348309|562008444|FG002|Overall Study|Ineffectiveness of treatment|0|||
155704100|NCT00348309|562008442|FG000|Overall Study|A foul of exclusion criteria|0|||
155704101|NCT00348309|562008443|FG001|Overall Study|A foul of exclusion criteria|1|||
155704102|NCT00348309|562008444|FG002|Overall Study|A foul of exclusion criteria|0|||
155704103|NCT00348309|562008442|FG000|Overall Study|Participant was hospitalized|0|||
155704104|NCT00348309|562008443|FG001|Overall Study|Participant was hospitalized|1|||
155704105|NCT00348309|562008444|FG002|Overall Study|Participant was hospitalized|0|||
155704106|NCT00348309|562008442|FG000|Overall Study|Sponsor refuseal|0|||
155704107|NCT00348309|562008443|FG001|Overall Study|Sponsor refuseal|1|||
155704108|NCT00348309|562008444|FG002|Overall Study|Sponsor refuseal|1|||
155704109|NCT00348309|562008442|FG000|Overall Study|Forgot often medication|0|||
155704110|NCT00348309|562008443|FG001|Overall Study|Forgot often medication|1|||
155704111|NCT00348309|562008444|FG002|Overall Study|Forgot often medication|0|||
155704112|NCT00348309|562008442|FG000|Overall Study|Medical Monitor decision|0|||
155704113|NCT00348309|562008443|FG001|Overall Study|Medical Monitor decision|0|||
155704114|NCT00348309|562008444|FG002|Overall Study|Medical Monitor decision|1|||
155704115|NCT00348309|562008442|FG000|Overall Study|Increased dose of Aricept|0|||
155704116|NCT00348309|562008443|FG001|Overall Study|Increased dose of Aricept|0|||
155704117|NCT00348309|562008444|FG002|Overall Study|Increased dose of Aricept|1|||
155704118|NCT00348309|562008442|FG000|Overall Study|Site closure|0|||
155704119|NCT00348309|562008443|FG001|Overall Study|Site closure|0|||
155704120|NCT00348309|562008444|FG002|Overall Study|Site closure|1|||
155704121|NCT00348309|562008442|FG000|Overall Study|Adverse event not attended|0|||
155704122|NCT00348309|562008443|FG001|Overall Study|Adverse event not attended|0|||
155704123|NCT00348309|562008444|FG002|Overall Study|Adverse event not attended|1|||
155704124|NCT00348309|562008442|FG000|Overall Study|ECG abnormal|0|||
155704125|NCT00348309|562008443|FG001|Overall Study|ECG abnormal|0|||
155704126|NCT00348309|562008444|FG002|Overall Study|ECG abnormal|2|||
155704127|NCT00348309|562008442|FG000|Overall Study|Cardiologist recommendations|0|||
155704128|NCT00348309|562008443|FG001|Overall Study|Cardiologist recommendations|0|||
155704129|NCT00348309|562008444|FG002|Overall Study|Cardiologist recommendations|1|||
155704130|NCT00348309|562008442|FG000|Overall Study|HCV career|0|||
155704131|NCT00348309|562008443|FG001|Overall Study|HCV career|0|||
155704132|NCT00348309|562008444|FG002|Overall Study|HCV career|1|||
155704133|NCT01743040|562008445|FG000|Overall Study|Death|1|||
155704134|NCT01743040|562008445|FG000|Overall Study|Lost to Follow-up|66|||
155704135|NCT01743040|562008445|FG000|Overall Study|Physician Decision|40|||
155704136|NCT01743040|562008445|FG000|Overall Study|Protocol Violation|1|||
155704137|NCT01743040|562008445|FG000|Overall Study|Withdrawal by Subject|121|||
155704138|NCT01894243|562008446|FG000|Overall Study|Adverse Event|0|||
155704139|NCT01894243|562008447|FG001|Overall Study|Adverse Event|1|||
155704140|NCT01894243|562008448|FG002|Overall Study|Adverse Event|2|||
155704141|NCT01894243|562008446|FG000|Overall Study|Death|0|||
155704142|NCT01894243|562008447|FG001|Overall Study|Death|0|||
155704143|NCT01894243|562008448|FG002|Overall Study|Death|3|||
155704144|NCT01894243|562008446|FG000|Overall Study|Lack of Efficacy|3|||
155704145|NCT01894243|562008447|FG001|Overall Study|Lack of Efficacy|3|||
155704146|NCT01894243|562008448|FG002|Overall Study|Lack of Efficacy|1|||
155704147|NCT01894243|562008446|FG000|Overall Study|Condition under investigation worsened|8|||
155704148|NCT01894243|562008447|FG001|Overall Study|Condition under investigation worsened|6|||
155704149|NCT01894243|562008448|FG002|Overall Study|Condition under investigation worsened|2|||
155704150|NCT01894243|562008446|FG000|Overall Study|Subject decision|1|||
155704151|NCT01894243|562008447|FG001|Overall Study|Subject decision|0|||
155704152|NCT01894243|562008448|FG002|Overall Study|Subject decision|0|||
155704153|NCT01894243|562008446|FG000|Overall Study|Other|1|||
155704154|NCT01894243|562008447|FG001|Overall Study|Other|0|||
155704155|NCT01894243|562008448|FG002|Overall Study|Other|0|||
155704156|NCT01067469|562008449|FG000|Overall Study|Withdrawal by Subject|0|||
155704157|NCT01067469|562008450|FG001|Overall Study|Withdrawal by Subject|1|||
155704158|NCT01067469|562008449|FG000|Overall Study|Disease Progression|0|||
155704159|NCT01067469|562008450|FG001|Overall Study|Disease Progression|1|||
155704160|NCT04006392|562008451|FG000|Overall Study|Lost to Follow-up|0|||
155704161|NCT04006392|562008452|FG001|Overall Study|Lost to Follow-up|1|||
155704162|NCT01946152|562010443|FG000|Overall Study|Adverse Event|1|||
155704163|NCT01946152|562010444|FG001|Overall Study|Adverse Event|0|||
155704164|NCT01946152|562010445|FG002|Overall Study|Adverse Event|0|||
155704165|NCT01946152|562010446|FG003|Overall Study|Adverse Event|0|||
155704166|NCT01946152|562010443|FG000|Overall Study|Withdrawal by Subject|0|||
155704167|NCT01946152|562010444|FG001|Overall Study|Withdrawal by Subject|2|||
155704168|NCT01946152|562010445|FG002|Overall Study|Withdrawal by Subject|0|||
155704169|NCT01946152|562010446|FG003|Overall Study|Withdrawal by Subject|0|||
155704170|NCT01946152|562010443|FG000|Overall Study|Progression|0|||
155704171|NCT01946152|562010444|FG001|Overall Study|Progression|1|||
155704172|NCT01946152|562010445|FG002|Overall Study|Progression|4|||
155704173|NCT01946152|562010446|FG003|Overall Study|Progression|7|||
155704174|NCT01946152|562010443|FG000|Overall Study|Physician Decision|0|||
155704175|NCT01946152|562010444|FG001|Overall Study|Physician Decision|0|||
155704176|NCT01946152|562010445|FG002|Overall Study|Physician Decision|1|||
155704177|NCT01946152|562010446|FG003|Overall Study|Physician Decision|0|||
155704178|NCT01946152|562010443|FG000|Overall Study|Second malignancy|0|||
155704179|NCT01946152|562010444|FG001|Overall Study|Second malignancy|0|||
155704180|NCT01946152|562010445|FG002|Overall Study|Second malignancy|1|||
155704181|NCT01946152|562010446|FG003|Overall Study|Second malignancy|0|||
155704182|NCT01946152|562010443|FG000|Overall Study|Adverse Event|0|||
155704183|NCT01946152|562010444|FG001|Overall Study|Adverse Event|0|||
155704184|NCT01946152|562010445|FG002|Overall Study|Adverse Event|0|||
155704185|NCT01946152|562010446|FG003|Overall Study|Adverse Event|1|||
155704186|NCT00894361|562010447|FG000|Overall Study|deaths and less than 2 years followup|24|||
155704187|NCT00894361|562010448|FG001|Overall Study|deaths and less than 2 years followup|64|||
155704188|NCT00286494|562010449|FG000|Overall Study|Hyperglycemic rescue|12|||
155704189|NCT00286494|562010450|FG001|Overall Study|Hyperglycemic rescue|19|||
155704190|NCT00286494|562010451|FG002|Overall Study|Hyperglycemic rescue|18|||
155704191|NCT00286494|562010449|FG000|Overall Study|Withdrawal by Subject|2|||
155704192|NCT00286494|562010450|FG001|Overall Study|Withdrawal by Subject|10|||
155704193|NCT00286494|562010451|FG002|Overall Study|Withdrawal by Subject|9|||
155704194|NCT00286494|562010449|FG000|Overall Study|Adverse Event|3|||
155704195|NCT00286494|562010450|FG001|Overall Study|Adverse Event|8|||
155704196|NCT00286494|562010451|FG002|Overall Study|Adverse Event|6|||
155704197|NCT00286494|562010449|FG000|Overall Study|Physician Decision|5|||
155704198|NCT00286494|562010450|FG001|Overall Study|Physician Decision|5|||
155704199|NCT00286494|562010451|FG002|Overall Study|Physician Decision|1|||
155704200|NCT00286494|562010449|FG000|Overall Study|Lost to Follow-up|3|||
155704201|NCT00286494|562010450|FG001|Overall Study|Lost to Follow-up|1|||
155704202|NCT00286494|562010451|FG002|Overall Study|Lost to Follow-up|3|||
155704203|NCT00286494|562010449|FG000|Overall Study|Protocol Violation|1|||
155704204|NCT00286494|562010450|FG001|Overall Study|Protocol Violation|1|||
155704205|NCT00286494|562010451|FG002|Overall Study|Protocol Violation|2|||
155704206|NCT04207060|562010452|FG000|Overall Study|Lost to Follow-up|2|||
155704207|NCT04207060|562010453|FG001|Overall Study|Lost to Follow-up|0|||
155704208|NCT01835158|562010457|FG000|Overall Study|Withdrawal by Subject|1|||
155704209|NCT01835158|562010458|FG001|Overall Study|Withdrawal by Subject|6|||
155704210|NCT00296140|562010459|FG000|Overall Study|Lost to Follow-up|1|||
155704211|NCT00296140|562010460|FG001|Overall Study|Lost to Follow-up|0|||
155704212|NCT00296140|562010459|FG000|Overall Study|Withdrawal by Subject|1|||
155704213|NCT00296140|562010460|FG001|Overall Study|Withdrawal by Subject|0|||
155704214|NCT00296140|562010459|FG000|Overall Study|Discharge to Nursing Home|1|||
155704215|NCT00296140|562010460|FG001|Overall Study|Discharge to Nursing Home|0|||
155704216|NCT00880191|562010467|FG000|Overall Study|Refused further treatment|4|||
155704217|NCT00880191|562010468|FG001|Overall Study|Refused further treatment|1|||
155704218|NCT00880191|562010467|FG000|Overall Study|Adverse Event|8|||
155704219|NCT00880191|562010468|FG001|Overall Study|Adverse Event|6|||
155704220|NCT00880191|562010467|FG000|Overall Study|Hospitalization/efficacy|1|||
155704221|NCT00880191|562010468|FG001|Overall Study|Hospitalization/efficacy|1|||
155704222|NCT00774800|562010472|FG000|Intervention 4|Withdrawal by Subject|1|||
155704223|NCT01919801|562010473|FG000|Overall Study|Withdrawal by Subject|1|||
155704224|NCT01919801|562010474|FG001|Overall Study|Withdrawal by Subject|0|||
155704225|NCT01919801|562010473|FG000|Overall Study|Physician Decision|0|||
155704226|NCT01919801|562010474|FG001|Overall Study|Physician Decision|1|||
155704227|NCT01919801|562010473|FG000|Overall Study|Lost to Follow-up|0|||
155704228|NCT01919801|562010474|FG001|Overall Study|Lost to Follow-up|1|||
155704229|NCT01919801|562010473|FG000|Overall Study|Other|0|||
155704230|NCT01919801|562010474|FG001|Overall Study|Other|1|||
155704231|NCT01677858|562010475|FG000|Overall Study|Adverse Event|0|||
155704232|NCT01677858|562010476|FG001|Overall Study|Adverse Event|0|||
155704233|NCT01677858|562010477|FG002|Overall Study|Adverse Event|2|||
155704234|NCT01677858|562010478|FG003|Overall Study|Adverse Event|3|||
155704235|NCT01677858|562010479|FG004|Overall Study|Adverse Event|13|||
155704236|NCT01677858|562010475|FG000|Overall Study|Death|0|||
155704237|NCT01677858|562010476|FG001|Overall Study|Death|0|||
155704238|NCT01677858|562010477|FG002|Overall Study|Death|0|||
155704239|NCT01677858|562010478|FG003|Overall Study|Death|0|||
155704240|NCT01677858|562010479|FG004|Overall Study|Death|1|||
155704241|NCT01677858|562010475|FG000|Overall Study|Physician Decision|1|||
155704242|NCT01677858|562010476|FG001|Overall Study|Physician Decision|0|||
155704243|NCT01677858|562010477|FG002|Overall Study|Physician Decision|2|||
155704244|NCT01677858|562010478|FG003|Overall Study|Physician Decision|0|||
155704245|NCT01677858|562010479|FG004|Overall Study|Physician Decision|12|||
155704246|NCT01677858|562010475|FG000|Overall Study|Progressive Disease|2|||
155704247|NCT01677858|562010476|FG001|Overall Study|Progressive Disease|1|||
155704248|NCT01677858|562010477|FG002|Overall Study|Progressive Disease|9|||
155704249|NCT01677858|562010478|FG003|Overall Study|Progressive Disease|3|||
155704250|NCT01677858|562010479|FG004|Overall Study|Progressive Disease|43|||
155704251|NCT01677858|562010475|FG000|Overall Study|Withdrawal by Subject|0|||
155704252|NCT01677858|562010476|FG001|Overall Study|Withdrawal by Subject|1|||
155704253|NCT01677858|562010477|FG002|Overall Study|Withdrawal by Subject|1|||
155704254|NCT01677858|562010478|FG003|Overall Study|Withdrawal by Subject|0|||
155704255|NCT01677858|562010479|FG004|Overall Study|Withdrawal by Subject|15|||
155704256|NCT01677858|562010475|FG000|Overall Study|Lost to Follow-up|0|||
155704257|NCT01677858|562010476|FG001|Overall Study|Lost to Follow-up|0|||
155704258|NCT01677858|562010477|FG002|Overall Study|Lost to Follow-up|0|||
155704259|NCT01677858|562010478|FG003|Overall Study|Lost to Follow-up|0|||
155704260|NCT01677858|562010479|FG004|Overall Study|Lost to Follow-up|1|||
155704261|NCT01331109|562010480|FG000|Overall Study|Adverse Event|6|||
155704262|NCT01331109|562010480|FG000|Overall Study|Lack of Efficacy|2|||
155704263|NCT01331109|562010480|FG000|Overall Study|Protocol Violation|3|||
155704264|NCT01331109|562010480|FG000|Overall Study|Withdrawal by Subject|7|||
155704265|NCT01331109|562010480|FG000|Overall Study|Lost to Follow-up|1|||
155704266|NCT01331109|562010480|FG000|Overall Study|Study Terminated by Sponsor|38|||
155704267|NCT00988091|562010481|FG000|Double-blind Period|Withdrawal by Subject|15|||
155704268|NCT00988091|562010482|FG001|Double-blind Period|Withdrawal by Subject|13|||
155704269|NCT00988091|562010481|FG000|Double-blind Period|Lost to Follow-up|12|||
155704270|NCT00988091|562010482|FG001|Double-blind Period|Lost to Follow-up|14|||
155704271|NCT00988091|562010481|FG000|Double-blind Period|Other|8|||
155704272|NCT00988091|562010482|FG001|Double-blind Period|Other|8|||
155704273|NCT00988091|562010481|FG000|Double-blind Period|Adverse Event|6|||
155704274|NCT00988091|562010482|FG001|Double-blind Period|Adverse Event|9|||
155704275|NCT00988091|562010481|FG000|Double-blind Period|Use of exclusionary medication|2|||
155704276|NCT00988091|562010482|FG001|Double-blind Period|Use of exclusionary medication|3|||
155704277|NCT00988091|562010481|FG000|Open-label Period|Adverse Event|4|||
155704278|NCT00988091|562010482|FG001|Open-label Period|Adverse Event|7|||
155704279|NCT00988091|562010481|FG000|Open-label Period|Use of exclusionary medication|1|||
155704280|NCT00988091|562010482|FG001|Open-label Period|Use of exclusionary medication|1|||
155704281|NCT00988091|562010481|FG000|Open-label Period|Protocol Violation|1|||
155704282|NCT00988091|562010482|FG001|Open-label Period|Protocol Violation|1|||
155704283|NCT00988091|562010481|FG000|Open-label Period|Withdrawal by Subject|10|||
155704284|NCT00988091|562010482|FG001|Open-label Period|Withdrawal by Subject|16|||
155704285|NCT00988091|562010481|FG000|Open-label Period|Lost to Follow-up|3|||
155704286|NCT00988091|562010482|FG001|Open-label Period|Lost to Follow-up|5|||
155704287|NCT00988091|562010481|FG000|Open-label Period|Other|2|||
155704288|NCT00988091|562010482|FG001|Open-label Period|Other|3|||
155704289|NCT00773747|562010483|FG000|Overall Study|Lack of Efficacy|112|||
155704290|NCT00773747|562010484|FG001|Overall Study|Lack of Efficacy|144|||
155704291|NCT00773747|562010483|FG000|Overall Study|Physician Decision|26|||
155704292|NCT00773747|562010484|FG001|Overall Study|Physician Decision|18|||
155704293|NCT00773747|562010483|FG000|Overall Study|Lost to Follow-up|0|||
155704294|NCT00773747|562010484|FG001|Overall Study|Lost to Follow-up|1|||
155704295|NCT00773747|562010483|FG000|Overall Study|Protocol Violation|2|||
155704296|NCT00773747|562010484|FG001|Overall Study|Protocol Violation|2|||
155704297|NCT00773747|562010483|FG000|Overall Study|Withdrawal by Subject|89|||
155704298|NCT00773747|562010484|FG001|Overall Study|Withdrawal by Subject|61|||
155704299|NCT00773747|562010483|FG000|Overall Study|Adverse Event|61|||
155704300|NCT00773747|562010484|FG001|Overall Study|Adverse Event|62|||
155704301|NCT00773747|562010483|FG000|Overall Study|Death|5|||
155704302|NCT00773747|562010484|FG001|Overall Study|Death|8|||
155704303|NCT00773747|562010483|FG000|Overall Study|Not Treated|2|||
155704304|NCT00773747|562010484|FG001|Overall Study|Not Treated|0|||
155704305|NCT00994422|562010487|FG000|Overall Study|Lost to Follow-up|7|||
155704306|NCT00994422|562010488|FG001|Overall Study|Lost to Follow-up|1|||
155704307|NCT02669212|562010489|FG000|Overall Study|Lost to Follow-up|1|||
155704308|NCT02669212|562010490|FG001|Overall Study|Lost to Follow-up|0|||
155704309|NCT02669212|562010489|FG000|Overall Study|Medical Condition|3|||
155704310|NCT02669212|562010490|FG001|Overall Study|Medical Condition|4|||
155704311|NCT02669212|562010489|FG000|Overall Study|Withdrawal by Subject|0|||
155704312|NCT02669212|562010490|FG001|Overall Study|Withdrawal by Subject|2|||
155704313|NCT02669212|562010489|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
155704314|NCT02669212|562010490|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
155704315|NCT03549104|562010491|FG000|Overall Study|Withdrawal by Subject|5|||
155704316|NCT03549104|562010492|FG001|Overall Study|Withdrawal by Subject|2|||
155704317|NCT03549104|562010491|FG000|Overall Study|Covid shelter in place|1|||
155704318|NCT03549104|562010492|FG001|Overall Study|Covid shelter in place|2|||
155704319|NCT03078855|562010496|FG000|Overall Study|Lack of Efficacy|62|||
155704320|NCT03078855|562010497|FG001|Overall Study|Lack of Efficacy|31|||
155704321|NCT03078855|562010496|FG000|Overall Study|Death|1|||
155704322|NCT03078855|562010497|FG001|Overall Study|Death|0|||
155704323|NCT03078855|562010496|FG000|Overall Study|Withdrawal by Subject|12|||
155704324|NCT03078855|562010497|FG001|Overall Study|Withdrawal by Subject|6|||
155704325|NCT03078855|562010496|FG000|Overall Study|Physician Decision|3|||
155704326|NCT03078855|562010497|FG001|Overall Study|Physician Decision|2|||
155704327|NCT03078855|562010496|FG000|Overall Study|Second Malignancy|4|||
155704328|NCT03078855|562010497|FG001|Overall Study|Second Malignancy|0|||
155704329|NCT03078855|562010496|FG000|Overall Study|Ineligible|2|||
155704330|NCT03078855|562010497|FG001|Overall Study|Ineligible|0|||
155704331|NCT03078855|562010496|FG000|Overall Study|Withdrew before day 1 treatment|2|||
155704332|NCT03078855|562010497|FG001|Overall Study|Withdrew before day 1 treatment|1|||
155704333|NCT00391027|562010498|FG000|Overall Study|Adverse Event|8|||
155704334|NCT00391027|562010499|FG001|Overall Study|Adverse Event|8|||
155704335|NCT00391027|562010498|FG000|Overall Study|Lack of Efficacy|3|||
155704336|NCT00391027|562010499|FG001|Overall Study|Lack of Efficacy|0|||
155704337|NCT00391027|562010498|FG000|Overall Study|Withdrawal by Subject|10|||
155704338|NCT00391027|562010499|FG001|Overall Study|Withdrawal by Subject|1|||
155704339|NCT00391027|562010498|FG000|Overall Study|Other|4|||
155704340|NCT00391027|562010499|FG001|Overall Study|Other|3|||
155704341|NCT03422536|562010500|FG000|Randomized|Physician Decision|1|||
155704342|NCT03422536|562010501|FG001|Randomized|Physician Decision|1|||
155704343|NCT03422536|562010500|FG000|Allocation - Received Intervention|Disease progression|19|||
155704344|NCT03422536|562010501|FG001|Allocation - Received Intervention|Disease progression|25|||
155704345|NCT03422536|562010500|FG000|Allocation - Received Intervention|Death|1|||
155704346|NCT03422536|562010501|FG001|Allocation - Received Intervention|Death|3|||
155704347|NCT03422536|562010500|FG000|Allocation - Received Intervention|Adverse Event|1|||
155704348|NCT03422536|562010501|FG001|Allocation - Received Intervention|Adverse Event|0|||
155704349|NCT03422536|562010500|FG000|Allocation - Received Intervention|Physician Decision|1|||
155704350|NCT03422536|562010501|FG001|Allocation - Received Intervention|Physician Decision|1|||
155704351|NCT03422536|562010500|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
155704352|NCT03422536|562010501|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
155704353|NCT03422536|562010500|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
155704354|NCT03422536|562010501|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
155704355|NCT00532298|562010502|FG000|Overall Study|Adverse Event|1|||
155704356|NCT00532298|562010503|FG001|Overall Study|Adverse Event|0|||
155704357|NCT00532298|562010504|FG002|Overall Study|Adverse Event|0|||
155704358|NCT00532298|562010505|FG003|Overall Study|Adverse Event|0|||
155704359|NCT00532298|562010506|FG004|Overall Study|Adverse Event|1|||
155704360|NCT00532298|562010507|FG005|Overall Study|Adverse Event|1|||
155704361|NCT00532298|562010502|FG000|Overall Study|Lost to Follow-up|1|||
155704362|NCT00532298|562010503|FG001|Overall Study|Lost to Follow-up|1|||
155704363|NCT00532298|562010504|FG002|Overall Study|Lost to Follow-up|1|||
155704364|NCT00532298|562010505|FG003|Overall Study|Lost to Follow-up|0|||
155704365|NCT00532298|562010506|FG004|Overall Study|Lost to Follow-up|0|||
155704366|NCT00532298|562010507|FG005|Overall Study|Lost to Follow-up|1|||
155704367|NCT00479856|562010508|FG000|Overall Study|Adverse Event|1|||
155704368|NCT00479856|562010508|FG000|Overall Study|Withdrawal by Subject|1|||
155704369|NCT00479856|562010508|FG000|Overall Study|Physician Decision|1|||
155704370|NCT01973998|562010509|FG000|Overall Study|Death|2|||
155704371|NCT01973998|562010510|FG001|Overall Study|Death|2|||
155704372|NCT04164732|562010511|FG000|Treatment run-in Period|Adverse Event|4|||
155704373|NCT04164732|562010512|FG001|Treatment run-in Period|Adverse Event|0|||
155704374|NCT04164732|562010513|FG002|Treatment run-in Period|Adverse Event|0|||
155704375|NCT04164732|562010511|FG000|Treatment run-in Period|Physician Decision|1|||
155704376|NCT04164732|562010512|FG001|Treatment run-in Period|Physician Decision|0|||
155704377|NCT04164732|562010513|FG002|Treatment run-in Period|Physician Decision|0|||
155704378|NCT04164732|562010511|FG000|Treatment run-in Period|Screen Failure|1|||
155704379|NCT04164732|562010512|FG001|Treatment run-in Period|Screen Failure|0|||
155704380|NCT04164732|562010513|FG002|Treatment run-in Period|Screen Failure|0|||
155704381|NCT04164732|562010511|FG000|Randomized Treatment Period|Adverse Event|0|||
155704382|NCT04164732|562010512|FG001|Randomized Treatment Period|Adverse Event|1|||
155704383|NCT04164732|562010513|FG002|Randomized Treatment Period|Adverse Event|0|||
155704384|NCT04164732|562010511|FG000|Randomized Treatment Period|Protocol Deviation|0|||
155704385|NCT04164732|562010512|FG001|Randomized Treatment Period|Protocol Deviation|1|||
155704386|NCT04164732|562010513|FG002|Randomized Treatment Period|Protocol Deviation|1|||
155704387|NCT04164732|562010511|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
155704388|NCT04164732|562010512|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
155704389|NCT04164732|562010513|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
155704390|NCT02141360|562010514|FG000|Overall Study|Withdrawal by Subject|6|||
155704391|NCT02141360|562010515|FG001|Overall Study|Withdrawal by Subject|0|||
155704392|NCT02141360|562010516|FG002|Overall Study|Withdrawal by Subject|0|||
155704393|NCT02141360|562010514|FG000|Overall Study|Study Terminated before Visit|1|||
155704394|NCT02141360|562010515|FG001|Overall Study|Study Terminated before Visit|0|||
155704395|NCT02141360|562010516|FG002|Overall Study|Study Terminated before Visit|0|||
155704396|NCT00129467|562010521|FG000|Received Intervention|Death|1|||
155704397|NCT00129467|562010522|FG001|Received Intervention|Death|1|||
155704398|NCT00129467|562010521|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
155704399|NCT00129467|562010522|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
155704400|NCT00129467|562010521|FG000|Received Intervention|Delirium|2|||
155704401|NCT00129467|562010522|FG001|Received Intervention|Delirium|0|||
155704402|NCT00129467|562010521|FG000|Received Intervention|Withdrawal by Subject|1|||
155704403|NCT00129467|562010522|FG001|Received Intervention|Withdrawal by Subject|0|||
155704404|NCT00129467|562010521|FG000|Received Intervention|Nausea|1|||
155704405|NCT00129467|562010522|FG001|Received Intervention|Nausea|0|||
155704406|NCT00129467|562010521|FG000|Received Intervention|Intolerance to citalopram|0|||
155704407|NCT00129467|562010522|FG001|Received Intervention|Intolerance to citalopram|1|||
155704408|NCT00129467|562010521|FG000|Received Intervention|Dizzyness, fatigue|0|||
155704409|NCT00129467|562010522|FG001|Received Intervention|Dizzyness, fatigue|1|||
155704410|NCT00129467|562010521|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
155704411|NCT00129467|562010522|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
155704412|NCT00129467|562010521|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
155704413|NCT00129467|562010522|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
155704414|NCT01009086|562010523|FG000|Overall Study|Lack of Efficacy|16|||
155704415|NCT01009086|562010524|FG001|Overall Study|Lack of Efficacy|15|||
155704416|NCT01009086|562010525|FG002|Overall Study|Lack of Efficacy|9|||
155704417|NCT01009086|562010523|FG000|Overall Study|Lost to Follow-up|4|||
155704418|NCT01009086|562010524|FG001|Overall Study|Lost to Follow-up|5|||
155704419|NCT01009086|562010525|FG002|Overall Study|Lost to Follow-up|3|||
155704420|NCT01009086|562010523|FG000|Overall Study|Adverse Event|12|||
155704421|NCT01009086|562010524|FG001|Overall Study|Adverse Event|11|||
155704422|NCT01009086|562010525|FG002|Overall Study|Adverse Event|8|||
155704423|NCT01009086|562010523|FG000|Overall Study|Withdrawal by Subject|9|||
155704424|NCT01009086|562010524|FG001|Overall Study|Withdrawal by Subject|11|||
155704425|NCT01009086|562010525|FG002|Overall Study|Withdrawal by Subject|13|||
155704426|NCT01009086|562010523|FG000|Overall Study|Other|3|||
155704427|NCT01009086|562010524|FG001|Overall Study|Other|5|||
155704428|NCT01009086|562010525|FG002|Overall Study|Other|1|||
155704429|NCT01424228|562010526|FG000|Overall Study|Withdrawal by Subject|27|||
155704430|NCT01424228|562010527|FG001|Overall Study|Withdrawal by Subject|11|||
155704431|NCT01424228|562010526|FG000|Overall Study|Adverse Event|10|||
155704432|NCT01424228|562010527|FG001|Overall Study|Adverse Event|14|||
155704433|NCT01424228|562010526|FG000|Overall Study|Sponsor's decision|9|||
155704434|NCT01424228|562010527|FG001|Overall Study|Sponsor's decision|12|||
155704435|NCT01424228|562010526|FG000|Overall Study|Lack of Efficacy|5|||
155704436|NCT01424228|562010527|FG001|Overall Study|Lack of Efficacy|7|||
155704437|NCT01424228|562010526|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
155704438|NCT01424228|562010527|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
155704439|NCT01424228|562010526|FG000|Overall Study|Non-compliance|2|||
155704440|NCT01424228|562010527|FG001|Overall Study|Non-compliance|0|||
155704441|NCT01424228|562010526|FG000|Overall Study|Worsening of symptoms|1|||
155704442|NCT01424228|562010527|FG001|Overall Study|Worsening of symptoms|0|||
155704443|NCT01424228|562010526|FG000|Overall Study|Unplanned journey|0|||
155704444|NCT01424228|562010527|FG001|Overall Study|Unplanned journey|1|||
155704445|NCT00932165|562010530|FG000|Overall Study|Lost to Follow-up|1|||
155704446|NCT01846741|562010531|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
155704447|NCT00767819|562010532|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
155704448|NCT00767819|562010533|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
155704449|NCT00767819|562010534|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155704450|NCT00767819|562010532|FG000|Overall Study|Withdrawal by Subject|1|||
155704451|NCT00767819|562010533|FG001|Overall Study|Withdrawal by Subject|1|||
155704452|NCT00767819|562010534|FG002|Overall Study|Withdrawal by Subject|0|||
155704453|NCT00767819|562010532|FG000|Overall Study|Administrative problems|0|||
155704454|NCT00767819|562010533|FG001|Overall Study|Administrative problems|1|||
155704455|NCT00767819|562010534|FG002|Overall Study|Administrative problems|0|||
155704456|NCT00767819|562010532|FG000|Overall Study|Death|2|||
155704457|NCT00767819|562010533|FG001|Overall Study|Death|3|||
155704458|NCT00767819|562010534|FG002|Overall Study|Death|0|||
155704459|NCT00767819|562010532|FG000|Overall Study|Adverse Event|2|||
155704460|NCT00767819|562010533|FG001|Overall Study|Adverse Event|0|||
155704461|NCT00767819|562010534|FG002|Overall Study|Adverse Event|0|||
155704462|NCT00767819|562010532|FG000|Overall Study|Abnormal lab values|1|||
155704463|NCT00767819|562010533|FG001|Overall Study|Abnormal lab values|0|||
155704464|NCT00767819|562010534|FG002|Overall Study|Abnormal lab values|0|||
155704465|NCT00767819|562010532|FG000|Overall Study|Lost to Follow-up|1|||
155704466|NCT00767819|562010533|FG001|Overall Study|Lost to Follow-up|0|||
155704467|NCT00767819|562010534|FG002|Overall Study|Lost to Follow-up|0|||
155704468|NCT05392803|562010538|FG000|Overall Study|Lost to Follow-up|0|||
155704469|NCT05392803|562010539|FG001|Overall Study|Lost to Follow-up|2|||
155704470|NCT04294147|562010540|FG000|Overall Study|Protocol Violation|2|||
155704471|NCT04294147|562010541|FG001|Overall Study|Protocol Violation|0|||
155704472|NCT03916081|562010546|FG000|Overall Study|Adverse Event|1|||
155704473|NCT03916081|562010547|FG001|Overall Study|Adverse Event|0|||
155704474|NCT03916081|562010548|FG002|Overall Study|Adverse Event|0|||
155704475|NCT03916081|562010546|FG000|Overall Study|Physician Decision|0|||
155704476|NCT03916081|562010547|FG001|Overall Study|Physician Decision|0|||
155704477|NCT03916081|562010548|FG002|Overall Study|Physician Decision|1|||
155704478|NCT03916081|562010546|FG000|Overall Study|Lost to Follow-up|0|||
155704479|NCT03916081|562010547|FG001|Overall Study|Lost to Follow-up|1|||
155704480|NCT03916081|562010548|FG002|Overall Study|Lost to Follow-up|0|||
155704481|NCT03916081|562010546|FG000|Overall Study|Withdrawal by Subject|3|||
155704482|NCT03916081|562010547|FG001|Overall Study|Withdrawal by Subject|0|||
155704483|NCT03916081|562010548|FG002|Overall Study|Withdrawal by Subject|1|||
155704484|NCT03916081|562010546|FG000|Overall Study|Worsening of AD|0|||
155704485|NCT03916081|562010547|FG001|Overall Study|Worsening of AD|0|||
155704486|NCT03916081|562010548|FG002|Overall Study|Worsening of AD|1|||
155704487|NCT01240135|562010551|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
155704488|NCT01240135|562010552|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
155704489|NCT01240135|562010551|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
155704490|NCT01240135|562010552|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
155704491|NCT00699335|562010557|FG000|Overall Study|Combination of multiple reasons|176|||
155704492|NCT00699335|562010557|FG000|Overall Study|Missing data|52|||
155704493|NCT01371305|562010558|FG000|Overall Study|Adverse Event|0|||
155704494|NCT01371305|562010559|FG001|Overall Study|Adverse Event|0|||
155704495|NCT01371305|562010560|FG002|Overall Study|Adverse Event|0|||
155704496|NCT01371305|562010561|FG003|Overall Study|Adverse Event|2|||
155704497|NCT01371305|562010562|FG004|Overall Study|Adverse Event|1|||
155704498|NCT01371305|562010563|FG005|Overall Study|Adverse Event|0|||
155704499|NCT01371305|562010558|FG000|Overall Study|Study terminated by sponsor|0|||
155704500|NCT01371305|562010559|FG001|Overall Study|Study terminated by sponsor|0|||
155704501|NCT01371305|562010560|FG002|Overall Study|Study terminated by sponsor|0|||
155704502|NCT01371305|562010561|FG003|Overall Study|Study terminated by sponsor|0|||
155704503|NCT01371305|562010562|FG004|Overall Study|Study terminated by sponsor|3|||
155704504|NCT01371305|562010563|FG005|Overall Study|Study terminated by sponsor|1|||
155704505|NCT01371305|562010558|FG000|Overall Study|Subject request|0|||
155704506|NCT01371305|562010559|FG001|Overall Study|Subject request|0|||
155704507|NCT01371305|562010560|FG002|Overall Study|Subject request|0|||
155704508|NCT01371305|562010561|FG003|Overall Study|Subject request|0|||
155704509|NCT01371305|562010562|FG004|Overall Study|Subject request|0|||
155704510|NCT01371305|562010563|FG005|Overall Study|Subject request|1|||
155704511|NCT04038567|562010564|FG000|Overall Study|Lost to Follow-up|6|||
155704512|NCT04038567|562010565|FG001|Overall Study|Lost to Follow-up|4|||
155704513|NCT04038567|562010566|FG002|Overall Study|Lost to Follow-up|5|||
155704514|NCT04038567|562010567|FG003|Overall Study|Lost to Follow-up|4|||
155704515|NCT04038567|562010568|FG004|Overall Study|Lost to Follow-up|6|||
155704516|NCT04038567|562010569|FG005|Overall Study|Lost to Follow-up|4|||
155704517|NCT04038567|562010570|FG006|Overall Study|Lost to Follow-up|4|||
155704518|NCT04038567|562010571|FG007|Overall Study|Lost to Follow-up|1|||
155704519|NCT04038567|562010564|FG000|Overall Study|Withdrawal by Subject|2|||
155704520|NCT04038567|562010565|FG001|Overall Study|Withdrawal by Subject|1|||
155704521|NCT04038567|562010566|FG002|Overall Study|Withdrawal by Subject|1|||
155704522|NCT04038567|562010567|FG003|Overall Study|Withdrawal by Subject|1|||
155704523|NCT04038567|562010568|FG004|Overall Study|Withdrawal by Subject|4|||
155704524|NCT04038567|562010569|FG005|Overall Study|Withdrawal by Subject|1|||
155704525|NCT04038567|562010570|FG006|Overall Study|Withdrawal by Subject|1|||
155704526|NCT04038567|562010571|FG007|Overall Study|Withdrawal by Subject|1|||
155704527|NCT04038567|562010564|FG000|Overall Study|missed survey window|1|||
155704528|NCT04038567|562010565|FG001|Overall Study|missed survey window|2|||
155704529|NCT04038567|562010566|FG002|Overall Study|missed survey window|0|||
155704530|NCT04038567|562010567|FG003|Overall Study|missed survey window|0|||
155704531|NCT04038567|562010568|FG004|Overall Study|missed survey window|1|||
155704532|NCT04038567|562010569|FG005|Overall Study|missed survey window|1|||
155704533|NCT04038567|562010570|FG006|Overall Study|missed survey window|2|||
155704534|NCT04038567|562010571|FG007|Overall Study|missed survey window|2|||
155704535|NCT04038567|562010564|FG000|Overall Study|technical issues|0|||
155704536|NCT04038567|562010565|FG001|Overall Study|technical issues|0|||
155704537|NCT04038567|562010566|FG002|Overall Study|technical issues|0|||
155704538|NCT04038567|562010567|FG003|Overall Study|technical issues|0|||
155704539|NCT04038567|562010568|FG004|Overall Study|technical issues|0|||
155704540|NCT04038567|562010569|FG005|Overall Study|technical issues|0|||
155704541|NCT04038567|562010570|FG006|Overall Study|technical issues|1|||
155704542|NCT04038567|562010571|FG007|Overall Study|technical issues|0|||
155704543|NCT04038567|562010564|FG000|Overall Study|Medical issues (i.e., illness)|0|||
155704544|NCT04038567|562010565|FG001|Overall Study|Medical issues (i.e., illness)|1|||
155704545|NCT04038567|562010566|FG002|Overall Study|Medical issues (i.e., illness)|2|||
155704546|NCT04038567|562010567|FG003|Overall Study|Medical issues (i.e., illness)|1|||
155704547|NCT04038567|562010568|FG004|Overall Study|Medical issues (i.e., illness)|1|||
155704548|NCT04038567|562010569|FG005|Overall Study|Medical issues (i.e., illness)|1|||
155704549|NCT04038567|562010570|FG006|Overall Study|Medical issues (i.e., illness)|0|||
155704550|NCT04038567|562010571|FG007|Overall Study|Medical issues (i.e., illness)|0|||
155704551|NCT04038567|562010564|FG000|Overall Study|Death|0|||
155704552|NCT04038567|562010565|FG001|Overall Study|Death|0|||
155704553|NCT04038567|562010566|FG002|Overall Study|Death|0|||
155704554|NCT04038567|562010567|FG003|Overall Study|Death|1|||
155704555|NCT04038567|562010568|FG004|Overall Study|Death|1|||
155704556|NCT04038567|562010569|FG005|Overall Study|Death|0|||
155704557|NCT04038567|562010570|FG006|Overall Study|Death|0|||
155704558|NCT04038567|562010571|FG007|Overall Study|Death|1|||
155704559|NCT01817959|562010572|FG000|Overall Study|Graft loss|1|||
155704560|NCT01817959|562010573|FG001|Overall Study|Graft loss|1|||
155704561|NCT01817959|562010572|FG000|Overall Study|forbidden medication|1|||
155704562|NCT01817959|562010573|FG001|Overall Study|forbidden medication|1|||
155704563|NCT01817959|562010572|FG000|Overall Study|Adverse Event|1|||
155704564|NCT01817959|562010573|FG001|Overall Study|Adverse Event|0|||
155704565|NCT01817959|562010572|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
155704566|NCT01817959|562010573|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
155704567|NCT03244826|562010583|FG000|Overall Study|Withdrawal by Subject|2|||
155704568|NCT03244826|562010584|FG001|Overall Study|Withdrawal by Subject|0|||
155704569|NCT03244826|562010583|FG000|Overall Study|Transplant delayed or withdrawn|12|||
155704570|NCT03244826|562010584|FG001|Overall Study|Transplant delayed or withdrawn|10|||
155704571|NCT04356352|562010588|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
155704572|NCT04356352|562010589|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
155704573|NCT04356352|562010590|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
155704574|NCT04356352|562010588|FG000|Overall Study|Protocol Violation|0|||
155704575|NCT04356352|562010589|FG001|Overall Study|Protocol Violation|3|||
155704576|NCT04356352|562010590|FG002|Overall Study|Protocol Violation|1|||
155704577|NCT00416455|562010592|FG000|Overall Study|PET / CT not done|3|||
155704578|NCT00416455|562010593|FG001|Overall Study|PET / CT not done|5|||
155704579|NCT00416455|562010592|FG000|Overall Study|PET / CT poor quality|2|||
155704580|NCT00416455|562010593|FG001|Overall Study|PET / CT poor quality|1|||
155704581|NCT00416455|562010592|FG000|Overall Study|Inadequate pathology|11|||
155704582|NCT00416455|562010593|FG001|Overall Study|Inadequate pathology|2|||
155704583|NCT02456857|562010594|FG000|Overall Study|Disease Progression|4|||
155704584|NCT01983774|562010595|FG000|Overall Study|Lung Transplant|0|||
155704585|NCT01983774|562010596|FG001|Overall Study|Lung Transplant|1|||
155704586|NCT01983774|562010595|FG000|Overall Study|Lost to Follow-up|1|||
155704587|NCT01983774|562010596|FG001|Overall Study|Lost to Follow-up|0|||
155704588|NCT01138501|562010597|FG000|Overall Study|Protocol Violation|2|||
155704589|NCT01138501|562010597|FG000|Overall Study|Withdrawal by Subject|3|||
155704590|NCT00847197|562010599|FG000|Overall Study|Adverse Event|21|||
155704591|NCT00847197|562010600|FG001|Overall Study|Adverse Event|3|||
155704592|NCT00847197|562010599|FG000|Overall Study|Protocol Violation|0|||
155704593|NCT00847197|562010600|FG001|Overall Study|Protocol Violation|1|||
155704594|NCT00847197|562010599|FG000|Overall Study|Withdrawal by Subject|3|||
155704595|NCT00847197|562010600|FG001|Overall Study|Withdrawal by Subject|1|||
155704596|NCT00828750|562010601|FG000|Overall Study|Lack of Efficacy|3|||
155704597|NCT00828750|562010601|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
155704598|NCT04378114|562010602|FG000|Overall Study|Withdrawal by Subject|5|||
155704599|NCT00830180|562010603|FG000|Overall Study|Adverse Event|6|||
155704600|NCT00830180|562010603|FG000|Overall Study|Death|11|||
155704601|NCT00830180|562010603|FG000|Overall Study|Insufficient clinical response|1|||
155704602|NCT00830180|562010603|FG000|Overall Study|Withdrawal by Subject|5|||
155704603|NCT00830180|562010603|FG000|Overall Study|Progressive disease|2|||
155704604|NCT00830180|562010603|FG000|Overall Study|Other - Unspecified|1|||
155704605|NCT01832532|562010604|FG000|Overall Study|Withdrawal by Subject|5|||
155704606|NCT01832532|562010605|FG001|Overall Study|Withdrawal by Subject|2|||
155704607|NCT01730586|562010607|FG000|Overall Study|Progressive Disease|2|||
155704608|NCT01730586|562010607|FG000|Overall Study|Inadequate Trial|8|||
155704609|NCT01730586|562010607|FG000|Overall Study|Adverse Event|2|||
155704610|NCT01730586|562010607|FG000|Overall Study|Hospice|1|||
155704611|NCT03712787|562012527|FG000|Overall Study|Adverse Event|2|||
155704612|NCT03712787|562012528|FG001|Overall Study|Adverse Event|3|||
155704613|NCT03712787|562012529|FG002|Overall Study|Adverse Event|0|||
155704614|NCT03712787|562012530|FG003|Overall Study|Adverse Event|4|||
155704615|NCT03712787|562012527|FG000|Overall Study|Withdrawal by Subject|4|||
155704616|NCT03712787|562012528|FG001|Overall Study|Withdrawal by Subject|14|||
155704617|NCT03712787|562012529|FG002|Overall Study|Withdrawal by Subject|12|||
155704618|NCT03712787|562012530|FG003|Overall Study|Withdrawal by Subject|8|||
155704619|NCT03712787|562012527|FG000|Overall Study|Lost to Follow-up|1|||
155704620|NCT03712787|562012528|FG001|Overall Study|Lost to Follow-up|1|||
155704621|NCT03712787|562012529|FG002|Overall Study|Lost to Follow-up|2|||
155704622|NCT03712787|562012530|FG003|Overall Study|Lost to Follow-up|1|||
155704623|NCT03712787|562012527|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155704624|NCT03712787|562012528|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
155704625|NCT03712787|562012529|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155704626|NCT03712787|562012530|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
155704627|NCT03712787|562012527|FG000|Overall Study|COVID-19 Infection|0|||
155704628|NCT03712787|562012528|FG001|Overall Study|COVID-19 Infection|1|||
155704629|NCT03712787|562012529|FG002|Overall Study|COVID-19 Infection|0|||
155704630|NCT03712787|562012530|FG003|Overall Study|COVID-19 Infection|0|||
155704631|NCT03712787|562012527|FG000|Overall Study|Other, Not Specified|79|||
155704632|NCT03712787|562012528|FG001|Overall Study|Other, Not Specified|77|||
155704633|NCT03712787|562012529|FG002|Overall Study|Other, Not Specified|74|||
155704634|NCT03712787|562012530|FG003|Overall Study|Other, Not Specified|78|||
155704635|NCT01865448|562012531|FG000|Overall Study|Adverse Event|1|||
155704636|NCT01865448|562012532|FG001|Overall Study|Adverse Event|1|||
155704637|NCT01865448|562012531|FG000|Overall Study|Pregnancy|0|||
155704638|NCT01865448|562012532|FG001|Overall Study|Pregnancy|1|||
155704639|NCT01865448|562012531|FG000|Overall Study|dropout unrelated to study|1|||
155704640|NCT01865448|562012532|FG001|Overall Study|dropout unrelated to study|1|||
155704641|NCT05111249|562012537|FG000|Overall Study|Lost to Follow-up|0|||
155704642|NCT05111249|562012538|FG001|Overall Study|Lost to Follow-up|2|||
155704643|NCT05111249|562012537|FG000|Overall Study|Physician Decision|0|||
155704644|NCT05111249|562012538|FG001|Overall Study|Physician Decision|1|||
155704645|NCT05111249|562012537|FG000|Overall Study|Participant decision|1|||
155704646|NCT05111249|562012538|FG001|Overall Study|Participant decision|5|||
155704647|NCT05128578|562012539|FG000|Overall Study|Withdrawal by Subject|9|||
155704648|NCT05128578|562012539|FG000|Overall Study|Lost to Follow-up|5|||
155704649|NCT00799266|562012540|FG000|Overall Study|Adverse Event|0|||
155704650|NCT00799266|562012541|FG001|Overall Study|Adverse Event|1|||
155704651|NCT00799266|562012540|FG000|Overall Study|Subject withdrew consent|3|||
155704652|NCT00799266|562012541|FG001|Overall Study|Subject withdrew consent|0|||
155704653|NCT00265317|562012543|FG000|Lead-In|Objective progression or relapse|6|||
155704654|NCT00265317|562012544|FG001|Lead-In|Objective progression or relapse|11|||
155704655|NCT00265317|562012545|FG002|Lead-In|Objective progression or relapse|0|||
155704656|NCT00265317|562012546|FG003|Lead-In|Objective progression or relapse|0|||
155704657|NCT00265317|562012543|FG000|Lead-In|Adverse Event|2|||
155704658|NCT00265317|562012544|FG001|Lead-In|Adverse Event|1|||
155704659|NCT00265317|562012545|FG002|Lead-In|Adverse Event|0|||
155704660|NCT00265317|562012546|FG003|Lead-In|Adverse Event|0|||
155704661|NCT00265317|562012543|FG000|Lead-In|Death|3|||
155704662|NCT00265317|562012544|FG001|Lead-In|Death|5|||
155704663|NCT00265317|562012545|FG002|Lead-In|Death|0|||
155704664|NCT00265317|562012546|FG003|Lead-In|Death|0|||
155704665|NCT00265317|562012543|FG000|Lead-In|Withdrawal/other than adverse event|1|||
155704666|NCT00265317|562012544|FG001|Lead-In|Withdrawal/other than adverse event|0|||
155704667|NCT00265317|562012545|FG002|Lead-In|Withdrawal/other than adverse event|0|||
155704668|NCT00265317|562012546|FG003|Lead-In|Withdrawal/other than adverse event|0|||
155704669|NCT00265317|562012543|FG000|Phase 2|Objective progression or relapse|0|||
155704670|NCT00265317|562012544|FG001|Phase 2|Objective progression or relapse|0|||
155704671|NCT00265317|562012545|FG002|Phase 2|Objective progression or relapse|37|||
155704672|NCT00265317|562012546|FG003|Phase 2|Objective progression or relapse|38|||
155704673|NCT00265317|562012543|FG000|Phase 2|Global deterioration of health status|0|||
155704674|NCT00265317|562012544|FG001|Phase 2|Global deterioration of health status|0|||
155704675|NCT00265317|562012545|FG002|Phase 2|Global deterioration of health status|3|||
155704676|NCT00265317|562012546|FG003|Phase 2|Global deterioration of health status|0|||
155704677|NCT00265317|562012543|FG000|Phase 2|Adverse Event|0|||
155704678|NCT00265317|562012544|FG001|Phase 2|Adverse Event|0|||
155704679|NCT00265317|562012545|FG002|Phase 2|Adverse Event|7|||
155704680|NCT00265317|562012546|FG003|Phase 2|Adverse Event|5|||
155704681|NCT00265317|562012543|FG000|Phase 2|Death|0|||
155704682|NCT00265317|562012544|FG001|Phase 2|Death|0|||
155704683|NCT00265317|562012545|FG002|Phase 2|Death|12|||
155704684|NCT00265317|562012546|FG003|Phase 2|Death|15|||
155704685|NCT00265317|562012543|FG000|Phase 2|Protocol Violation|0|||
155704686|NCT00265317|562012544|FG001|Phase 2|Protocol Violation|0|||
155704687|NCT00265317|562012545|FG002|Phase 2|Protocol Violation|1|||
155704688|NCT00265317|562012546|FG003|Phase 2|Protocol Violation|4|||
155704689|NCT00265317|562012543|FG000|Phase 2|Lost to Follow-up|0|||
155704690|NCT00265317|562012544|FG001|Phase 2|Lost to Follow-up|0|||
155704691|NCT00265317|562012545|FG002|Phase 2|Lost to Follow-up|0|||
155704692|NCT00265317|562012546|FG003|Phase 2|Lost to Follow-up|1|||
155704693|NCT00265317|562012543|FG000|Phase 2|Withdrawal/other than adverse event|0|||
155704694|NCT00265317|562012544|FG001|Phase 2|Withdrawal/other than adverse event|0|||
155704695|NCT00265317|562012545|FG002|Phase 2|Withdrawal/other than adverse event|2|||
155704696|NCT00265317|562012546|FG003|Phase 2|Withdrawal/other than adverse event|1|||
155704697|NCT00265317|562012543|FG000|Phase 2|Study terminated by sponsor|0|||
155704698|NCT00265317|562012544|FG001|Phase 2|Study terminated by sponsor|0|||
155704699|NCT00265317|562012545|FG002|Phase 2|Study terminated by sponsor|1|||
155704700|NCT00265317|562012546|FG003|Phase 2|Study terminated by sponsor|0|||
155704701|NCT00265317|562012543|FG000|Phase 2|Other|0|||
155704702|NCT00265317|562012544|FG001|Phase 2|Other|0|||
155704703|NCT00265317|562012545|FG002|Phase 2|Other|1|||
155704704|NCT00265317|562012546|FG003|Phase 2|Other|1|||
155704705|NCT00732875|562012549|FG000|Overall Study|Adverse Event|16|||
155704706|NCT00732875|562012549|FG000|Overall Study|Withdrawal by Subject|6|||
155704707|NCT00732875|562012549|FG000|Overall Study|Lack of Efficacy|13|||
155704708|NCT00660179|562012552|FG000|Overall Study|Death|44|||
155704709|NCT00660179|562012553|FG001|Overall Study|Death|47|||
155704710|NCT00660179|562012554|FG002|Overall Study|Death|34|||
155704711|NCT00660179|562012552|FG000|Overall Study|Withdrawal of consent|4|||
155704712|NCT00660179|562012553|FG001|Overall Study|Withdrawal of consent|6|||
155704713|NCT00660179|562012554|FG002|Overall Study|Withdrawal of consent|4|||
155704714|NCT00660179|562012552|FG000|Overall Study|Lost to Follow-up|7|||
155704715|NCT00660179|562012553|FG001|Overall Study|Lost to Follow-up|5|||
155704716|NCT00660179|562012554|FG002|Overall Study|Lost to Follow-up|2|||
155704717|NCT00660179|562012552|FG000|Overall Study|Administrative reason|0|||
155704718|NCT00660179|562012553|FG001|Overall Study|Administrative reason|0|||
155704719|NCT00660179|562012554|FG002|Overall Study|Administrative reason|1|||
155704720|NCT00660179|562012552|FG000|Overall Study|Incorrect randomization|1|||
155704721|NCT00660179|562012553|FG001|Overall Study|Incorrect randomization|0|||
155704722|NCT00660179|562012554|FG002|Overall Study|Incorrect randomization|0|||
155704723|NCT05362058|562012557|FG000|Treatment Period|Adverse Event|3|||
155704724|NCT05362058|562012558|FG001|Treatment Period|Adverse Event|3|||
155704725|NCT05362058|562012557|FG000|Treatment Period|Assigned treatment by mistake|3|||
155704726|NCT05362058|562012558|FG001|Treatment Period|Assigned treatment by mistake|4|||
155704727|NCT05362058|562012557|FG000|Treatment Period|Death|1|||
155704728|NCT05362058|562012558|FG001|Treatment Period|Death|1|||
155704729|NCT05362058|562012557|FG000|Treatment Period|Lost to Follow-up|6|||
155704730|NCT05362058|562012558|FG001|Treatment Period|Lost to Follow-up|3|||
155704731|NCT05362058|562012557|FG000|Treatment Period|Non-compliance with study drug|0|||
155704732|NCT05362058|562012558|FG001|Treatment Period|Non-compliance with study drug|1|||
155704733|NCT05362058|562012557|FG000|Treatment Period|Physician Decision|1|||
155704734|NCT05362058|562012558|FG001|Treatment Period|Physician Decision|0|||
155704735|NCT05362058|562012557|FG000|Treatment Period|Protocol deviation|1|||
155704736|NCT05362058|562012558|FG001|Treatment Period|Protocol deviation|0|||
155704737|NCT05362058|562012557|FG000|Treatment Period|Withdrawal by Subject|10|||
155704738|NCT05362058|562012558|FG001|Treatment Period|Withdrawal by Subject|11|||
155704739|NCT05362058|562012557|FG000|Follow-Up Period|Death|1|||
155704740|NCT05362058|562012558|FG001|Follow-Up Period|Death|0|||
155704741|NCT05362058|562012557|FG000|Follow-Up Period|Lost to Follow-up|2|||
155704742|NCT05362058|562012558|FG001|Follow-Up Period|Lost to Follow-up|1|||
155704743|NCT05362058|562012557|FG000|Follow-Up Period|Protocol deviation|1|||
155704744|NCT05362058|562012558|FG001|Follow-Up Period|Protocol deviation|1|||
155704745|NCT05362058|562012557|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155704746|NCT05362058|562012558|FG001|Follow-Up Period|Withdrawal by Subject|3|||
155704747|NCT00398567|562012560|FG000|Overall Study|Disease Progression|3|||
155704748|NCT00398567|562012561|FG001|Overall Study|Disease Progression|4|||
155704749|NCT00398567|562012562|FG002|Overall Study|Disease Progression|27|||
155704750|NCT00398567|562012560|FG000|Overall Study|Withdrawal by Subject|1|||
155704751|NCT00398567|562012561|FG001|Overall Study|Withdrawal by Subject|0|||
155704752|NCT00398567|562012562|FG002|Overall Study|Withdrawal by Subject|4|||
155704753|NCT00398567|562012560|FG000|Overall Study|Adverse Event|0|||
155704754|NCT00398567|562012561|FG001|Overall Study|Adverse Event|0|||
155704755|NCT00398567|562012562|FG002|Overall Study|Adverse Event|2|||
155704756|NCT00398567|562012560|FG000|Overall Study|Protocol Violation|0|||
155704757|NCT00398567|562012561|FG001|Overall Study|Protocol Violation|0|||
155704758|NCT00398567|562012562|FG002|Overall Study|Protocol Violation|1|||
155704759|NCT04273893|562012565|FG000|Overall Study|Withdrawal by Subject|0|||
155704760|NCT04273893|562012566|FG001|Overall Study|Withdrawal by Subject|2|||
155704761|NCT04273893|562012565|FG000|Overall Study|Treatment of Disease Progression|0|||
155704762|NCT04273893|562012566|FG001|Overall Study|Treatment of Disease Progression|2|||
155704763|NCT04273893|562012565|FG000|Overall Study|Death|1|||
155704764|NCT04273893|562012566|FG001|Overall Study|Death|2|||
155704765|NCT04273893|562012565|FG000|Overall Study|Lost to Follow-up|0|||
155704766|NCT04273893|562012566|FG001|Overall Study|Lost to Follow-up|2|||
155704767|NCT04273893|562012565|FG000|Overall Study|Physician Decision|1|||
155704768|NCT04273893|562012566|FG001|Overall Study|Physician Decision|0|||
155704769|NCT01036321|562012571|FG000|Overall Study|Ineligible after randomization|0|||
155704770|NCT01036321|562012572|FG001|Overall Study|Ineligible after randomization|1|||
155704771|NCT01036321|562012571|FG000|Overall Study|Withdrawal by Subject|3|||
155704772|NCT01036321|562012572|FG001|Overall Study|Withdrawal by Subject|2|||
155704773|NCT01036321|562012571|FG000|Overall Study|Adverse Event|2|||
155704774|NCT01036321|562012572|FG001|Overall Study|Adverse Event|1|||
155704775|NCT05438576|562012577|FG000|Overall Study|Death|1|||
155704776|NCT05438576|562012578|FG001|Overall Study|Death|1|||
155704777|NCT05438576|562012577|FG000|Overall Study|Withdrawal by Subject|4|||
155704778|NCT05438576|562012578|FG001|Overall Study|Withdrawal by Subject|2|||
155704779|NCT05438576|562012577|FG000|Overall Study|Not Eligible|2|||
155704780|NCT05438576|562012578|FG001|Overall Study|Not Eligible|1|||
155704781|NCT05438576|562012577|FG000|Overall Study|Did not complete baseline testing|22|||
155704782|NCT05438576|562012578|FG001|Overall Study|Did not complete baseline testing|4|||
155704783|NCT02881762|562012579|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155704784|NCT02881762|562012580|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155704785|NCT01856582|562012583|FG000|Overall Study|Died prior to Boost infusion|1|||
155704786|NCT00646399|562012586|FG000|Overall Study|Death|63|||
155704787|NCT00646399|562012587|FG001|Overall Study|Death|53|||
155704788|NCT00646399|562012586|FG000|Overall Study|Withdrawal by Subject|9|||
155704789|NCT00646399|562012587|FG001|Overall Study|Withdrawal by Subject|10|||
155704790|NCT00646399|562012586|FG000|Overall Study|Other Reason|11|||
155704791|NCT00646399|562012587|FG001|Overall Study|Other Reason|11|||
155704792|NCT02160145|562012591|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
155704793|NCT02160145|562012592|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
155704794|NCT02160145|562012593|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
155704795|NCT02160145|562012591|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
155704796|NCT02160145|562012592|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
155704797|NCT02160145|562012593|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
155704798|NCT02160145|562012591|FG000|Randomized Double-blind Period|Subject decision|0|||
155704799|NCT02160145|562012592|FG001|Randomized Double-blind Period|Subject decision|21|||
155704800|NCT02160145|562012593|FG002|Randomized Double-blind Period|Subject decision|20|||
155704801|NCT02160145|562012591|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
155704802|NCT02160145|562012592|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
155704803|NCT02160145|562012593|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
155704804|NCT02160145|562012591|FG000|Randomized Double-blind Period|Physician Decision|0|||
155704805|NCT02160145|562012592|FG001|Randomized Double-blind Period|Physician Decision|7|||
155704806|NCT02160145|562012593|FG002|Randomized Double-blind Period|Physician Decision|5|||
155704807|NCT00395850|562012594|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
155704808|NCT00395850|562012595|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155704809|NCT00395850|562012596|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155704810|NCT00395850|562012597|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155704811|NCT00395850|562012594|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
155704812|NCT00395850|562012595|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155704813|NCT00395850|562012596|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155704814|NCT00395850|562012597|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155704815|NCT00395850|562012594|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
155704816|NCT00395850|562012595|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155704817|NCT00395850|562012596|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155704818|NCT00395850|562012597|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155704819|NCT00395850|562012594|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
155704820|NCT00395850|562012595|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
155704821|NCT00395850|562012596|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
155704822|NCT00395850|562012597|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
155704823|NCT00395850|562012594|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
155704824|NCT00395850|562012595|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155704825|NCT00395850|562012596|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155704826|NCT00395850|562012597|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155704827|NCT00395850|562012594|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
155704828|NCT00395850|562012595|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155704829|NCT00395850|562012596|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155704830|NCT00395850|562012597|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155704831|NCT00395850|562012594|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
155704832|NCT00395850|562012595|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155704833|NCT00395850|562012596|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155704834|NCT00395850|562012597|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155704835|NCT02540993|562012598|FG000|Overall Study|Lost to Follow-up|5|||
155704836|NCT02540993|562012599|FG001|Overall Study|Lost to Follow-up|3|||
155704837|NCT02540993|562012598|FG000|Overall Study|Withdrawal by Subject|4|||
155704838|NCT02540993|562012599|FG001|Overall Study|Withdrawal by Subject|6|||
155704839|NCT02540993|562012598|FG000|Overall Study|GCP violations|33|||
155704840|NCT02540993|562012599|FG001|Overall Study|GCP violations|27|||
155704841|NCT00844558|562012600|FG000|Overall Study|Withdrawal by Subject|9|||
155704842|NCT00844558|562012601|FG001|Overall Study|Withdrawal by Subject|2|||
155704843|NCT00844558|562012600|FG000|Overall Study|Death|1|||
155704844|NCT00844558|562012601|FG001|Overall Study|Death|0|||
155704845|NCT00844558|562012600|FG000|Overall Study|Protocol Violation|1|||
155704846|NCT00844558|562012601|FG001|Overall Study|Protocol Violation|1|||
155704847|NCT00844558|562012600|FG000|Overall Study|Lost to Follow-up|0|||
155704848|NCT00844558|562012601|FG001|Overall Study|Lost to Follow-up|1|||
155704849|NCT00844558|562012600|FG000|Overall Study|Physician Decision|1|||
155704850|NCT00844558|562012601|FG001|Overall Study|Physician Decision|0|||
155704851|NCT00588094|562012602|FG000|Overall Study|Adverse Event|3|||
155704852|NCT00588094|562012602|FG000|Overall Study|Progression of Disease|2|||
155704853|NCT02951429|562012609|FG000|Overall Study|Adverse Event|3|||
155704854|NCT02951429|562012610|FG001|Overall Study|Adverse Event|7|||
155704855|NCT02951429|562012609|FG000|Overall Study|Death|28|||
155704856|NCT02951429|562012610|FG001|Overall Study|Death|36|||
155704857|NCT02951429|562012609|FG000|Overall Study|Lack of Efficacy|0|||
155704858|NCT02951429|562012610|FG001|Overall Study|Lack of Efficacy|1|||
155704859|NCT02951429|562012609|FG000|Overall Study|Lost to Follow-up|0|||
155704860|NCT02951429|562012610|FG001|Overall Study|Lost to Follow-up|1|||
155704861|NCT02951429|562012609|FG000|Overall Study|Lung Transplantation|9|||
155704862|NCT02951429|562012610|FG001|Overall Study|Lung Transplantation|6|||
155704863|NCT02951429|562012609|FG000|Overall Study|Other|1|||
155704864|NCT02951429|562012610|FG001|Overall Study|Other|3|||
155704865|NCT02951429|562012609|FG000|Overall Study|Progressive Disease|1|||
155704866|NCT02951429|562012610|FG001|Overall Study|Progressive Disease|1|||
155704867|NCT02951429|562012609|FG000|Overall Study|Withdrawal by Subject|7|||
155704868|NCT02951429|562012610|FG001|Overall Study|Withdrawal by Subject|11|||
155704869|NCT02951429|562012609|FG000|Overall Study|Participant ongoing in the study|23|||
155704870|NCT02951429|562012610|FG001|Overall Study|Participant ongoing in the study|17|||
155704871|NCT02202538|562012613|FG000|Overall Study|Withdrawal by Subject|5|||
155704872|NCT02202538|562012613|FG000|Overall Study|Did not meet all inclusion criteria|2|||
155704873|NCT02202538|562012613|FG000|Overall Study|Investigator Decision|1|||
155704874|NCT01457846|562012614|FG000|Overall Study|Death before treatment|1|||
155704875|NCT01457846|562012615|FG001|Overall Study|Death before treatment|2|||
155704876|NCT01457846|562012614|FG000|Overall Study|Did not receive treatment|0|||
155704877|NCT01457846|562012615|FG001|Overall Study|Did not receive treatment|1|||
155704878|NCT01457846|562012614|FG000|Overall Study|Death|27|||
155704879|NCT01457846|562012615|FG001|Overall Study|Death|16|||
155704880|NCT01457846|562012614|FG000|Overall Study|Unclassified reason for not completed|11|||
155704881|NCT01457846|562012615|FG001|Overall Study|Unclassified reason for not completed|10|||
155704882|NCT01457846|562012614|FG000|Overall Study|Withdrawal by Subject|1|||
155704883|NCT01457846|562012615|FG001|Overall Study|Withdrawal by Subject|1|||
155704884|NCT01457846|562012614|FG000|Overall Study|Lost to Follow-up|1|||
155704885|NCT01457846|562012615|FG001|Overall Study|Lost to Follow-up|0|||
155704886|NCT01853878|562012616|FG000|Overall Study|Recurrence|2|||
155704887|NCT01853878|562012617|FG001|Overall Study|Recurrence|0|||
155704888|NCT01853878|562012616|FG000|Overall Study|Adverse Event|2|||
155704889|NCT01853878|562012617|FG001|Overall Study|Adverse Event|0|||
155704890|NCT01853878|562012616|FG000|Overall Study|Withdrawal by Subject|3|||
155704891|NCT01853878|562012617|FG001|Overall Study|Withdrawal by Subject|1|||
155704892|NCT01853878|562012616|FG000|Overall Study|Migrated/moved from the study area|1|||
155704893|NCT01853878|562012617|FG001|Overall Study|Migrated/moved from the study area|0|||
155704894|NCT01853878|562012616|FG000|Overall Study|Other|55|||
155704895|NCT01853878|562012617|FG001|Overall Study|Other|43|||
155704896|NCT02828020|562012620|FG000|Treatment Period|Adverse Event|3|||
155704897|NCT02828020|562012621|FG001|Treatment Period|Adverse Event|1|||
155704898|NCT02828020|562012622|FG002|Treatment Period|Adverse Event|1|||
155704899|NCT02828020|562012620|FG000|Treatment Period|Withdrawal of Consent|10|||
155704900|NCT02828020|562012621|FG001|Treatment Period|Withdrawal of Consent|14|||
155704901|NCT02828020|562012622|FG002|Treatment Period|Withdrawal of Consent|9|||
155704902|NCT02828020|562012620|FG000|Treatment Period|Lost to Follow-up|21|||
155704903|NCT02828020|562012621|FG001|Treatment Period|Lost to Follow-up|24|||
155704904|NCT02828020|562012622|FG002|Treatment Period|Lost to Follow-up|18|||
155704905|NCT02828020|562012620|FG000|Treatment Period|Lack of Qualifying Event|44|||
155704906|NCT02828020|562012621|FG001|Treatment Period|Lack of Qualifying Event|53|||
155704907|NCT02828020|562012622|FG002|Treatment Period|Lack of Qualifying Event|43|||
155704908|NCT02828020|562012620|FG000|Treatment Period|Pregnancy|0|||
155704909|NCT02828020|562012621|FG001|Treatment Period|Pregnancy|2|||
155704910|NCT02828020|562012622|FG002|Treatment Period|Pregnancy|0|||
155704911|NCT02828020|562012620|FG000|Treatment Period|Protocol Violation|2|||
155704912|NCT02828020|562012621|FG001|Treatment Period|Protocol Violation|4|||
155704913|NCT02828020|562012622|FG002|Treatment Period|Protocol Violation|7|||
155704914|NCT02828020|562012620|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
155704915|NCT02828020|562012621|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
155704916|NCT02828020|562012622|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
155704917|NCT02828020|562012620|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
155704918|NCT02828020|562012621|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
155704919|NCT02828020|562012622|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
155704920|NCT02828020|562012620|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
155704921|NCT02828020|562012621|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
155704922|NCT02828020|562012622|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
155704923|NCT02828020|562012620|FG000|Safety Follow-up Period|Protocol Violation|0|||
155704924|NCT02828020|562012621|FG001|Safety Follow-up Period|Protocol Violation|2|||
155704925|NCT02828020|562012622|FG002|Safety Follow-up Period|Protocol Violation|1|||
155704926|NCT02828020|562012620|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
155704927|NCT02828020|562012621|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155704928|NCT02828020|562012622|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155704929|NCT03688620|562012623|FG000|Overall Study|Other|0|||
155704930|NCT03688620|562012624|FG001|Overall Study|Other|0|||
155704931|NCT03688620|562012625|FG002|Overall Study|Other|1|||
155704932|NCT03688620|562012623|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
155704933|NCT03688620|562012624|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
155704934|NCT03688620|562012625|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
155704935|NCT03688620|562012623|FG000|Overall Study|Lost to Follow-up|16|||
155704936|NCT03688620|562012624|FG001|Overall Study|Lost to Follow-up|0|||
155704937|NCT03688620|562012625|FG002|Overall Study|Lost to Follow-up|1|||
155704938|NCT03688620|562012623|FG000|Overall Study|Withdrawal by Subject|0|||
155704939|NCT03688620|562012624|FG001|Overall Study|Withdrawal by Subject|0|||
155704940|NCT03688620|562012625|FG002|Overall Study|Withdrawal by Subject|6|||
155704941|NCT01183065|562012626|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
155704942|NCT03657095|562012630|FG000|Overall Study|Withdrawal by Subject|1|||
155704943|NCT03657095|562012631|FG001|Overall Study|Withdrawal by Subject|1|||
155704944|NCT03657095|562012630|FG000|Overall Study|Adverse Event|0|||
155704945|NCT03657095|562012631|FG001|Overall Study|Adverse Event|3|||
155704946|NCT03657095|562012630|FG000|Overall Study|Study Terminated by Sponsor|58|||
155704947|NCT03657095|562012631|FG001|Overall Study|Study Terminated by Sponsor|49|||
155704948|NCT00392990|562012634|FG000|Treatment on Study|Adverse Event|3|||
155704949|NCT00392990|562012635|FG001|Treatment on Study|Adverse Event|1|||
155704950|NCT00392990|562012634|FG000|Follow up for 2 Years|Death|4|||
155704951|NCT00392990|562012635|FG001|Follow up for 2 Years|Death|0|||
155704952|NCT00825812|562012639|FG000|Overall Study|Never entered follow up|0|||
155704953|NCT00825812|562012640|FG001|Overall Study|Never entered follow up|0|||
155704954|NCT00825812|562012641|FG002|Overall Study|Never entered follow up|0|||
155704955|NCT00825812|562012642|FG003|Overall Study|Never entered follow up|1|||
155704956|NCT00825812|562012639|FG000|Overall Study|Adverse Event|0|||
155704957|NCT00825812|562012640|FG001|Overall Study|Adverse Event|0|||
155704958|NCT00825812|562012641|FG002|Overall Study|Adverse Event|0|||
155704959|NCT00825812|562012642|FG003|Overall Study|Adverse Event|1|||
155704960|NCT00825812|562012639|FG000|Overall Study|Subject withdrew consent|0|||
155704961|NCT00825812|562012640|FG001|Overall Study|Subject withdrew consent|0|||
155704962|NCT00825812|562012641|FG002|Overall Study|Subject withdrew consent|3|||
155704963|NCT00825812|562012642|FG003|Overall Study|Subject withdrew consent|2|||
155704964|NCT00825812|562012639|FG000|Overall Study|Non-compliance with protocol|0|||
155704965|NCT00825812|562012640|FG001|Overall Study|Non-compliance with protocol|0|||
155704966|NCT00825812|562012641|FG002|Overall Study|Non-compliance with protocol|0|||
155704967|NCT00825812|562012642|FG003|Overall Study|Non-compliance with protocol|1|||
155704968|NCT00825812|562012639|FG000|Overall Study|Administrative|0|||
155704969|NCT00825812|562012640|FG001|Overall Study|Administrative|1|||
155704970|NCT00825812|562012641|FG002|Overall Study|Administrative|3|||
155704971|NCT00825812|562012642|FG003|Overall Study|Administrative|5|||
155704972|NCT00991406|562012644|FG000|Overall Study|One participant did not respond to FES.|1|||
155704973|NCT03597061|562012645|FG000|Overall Study|Lost to Follow-up|1|||
155704974|NCT03597061|562012646|FG001|Overall Study|Lost to Follow-up|0|||
155704975|NCT03597061|562012645|FG000|Overall Study|Protocol Violation|0|||
155704976|NCT03597061|562012646|FG001|Overall Study|Protocol Violation|1|||
155704977|NCT02006979|562012647|FG000|Overall Study|Withdrawal by Subject|1|||
155704978|NCT02006979|562012648|FG001|Overall Study|Withdrawal by Subject|1|||
155704979|NCT02006979|562012647|FG000|Overall Study|Protocol Violation|0|||
155704980|NCT02006979|562012648|FG001|Overall Study|Protocol Violation|1|||
155704981|NCT02038075|562012649|FG000|Overall Study|Withdrawal by Subject|3|||
155704982|NCT02038075|562012650|FG001|Overall Study|Withdrawal by Subject|0|||
155704983|NCT03477838|562012651|FG000|Overall Study|Lost to Follow-up|14|||
155704984|NCT02519595|562012653|FG000|Overall Study|Protocol Violation|8|||
155704985|NCT02519595|562012654|FG001|Overall Study|Protocol Violation|22|||
155704986|NCT02519595|562012655|FG002|Overall Study|Protocol Violation|16|||
155704987|NCT00850538|562012658|FG000|Overall Study|unable/unwilling to complete MRI|13|||
155704988|NCT00850538|562012658|FG000|Overall Study|specimen missed due to scheduling error|14|||
155704989|NCT00850538|562012658|FG000|Overall Study|specimen unusable|7|||
155704990|NCT00850538|562012658|FG000|Overall Study|Withdrawal by Subject|3|||
155704991|NCT00850538|562012658|FG000|Overall Study|radiology error|2|||
155704992|NCT00850538|562012658|FG000|Overall Study|Protocol Violation|2|||
155704993|NCT03188510|562012659|FG000|Overall Study|Inappropriate behavior with site staff|0|||
155704994|NCT03188510|562012660|FG001|Overall Study|Inappropriate behavior with site staff|1|||
155704995|NCT03188510|562012661|FG002|Overall Study|Inappropriate behavior with site staff|0|||
155704996|NCT01736618|562012664|FG000|Overall Study|Death|294|||
155704997|NCT01736618|562012664|FG000|Overall Study|Lost to Follow-up|193|||
155704998|NCT01736618|562012664|FG000|Overall Study|Withdrawal by Subject|54|||
155704999|NCT01736618|562012664|FG000|Overall Study|Subject unable to be followed at study location|223|||
155705000|NCT01736618|562012664|FG000|Overall Study|Physician Decision|33|||
155705001|NCT01736618|562012664|FG000|Overall Study|Transplant or removal of target organ|19|||
155705002|NCT01736618|562012664|FG000|Overall Study|Change in indication or condition|78|||
155705003|NCT01736618|562012664|FG000|Overall Study|Study device explant|103|||
155705004|NCT01736618|562012664|FG000|Overall Study|Unable to complete implant|2|||
155705005|NCT04167137|562012665|FG000|Overall Study|Disease progression|1|||
155705006|NCT04167137|562012666|FG001|Overall Study|Disease progression|1|||
155705007|NCT04167137|562012667|FG002|Overall Study|Disease progression|3|||
155705008|NCT04167137|562012668|FG003|Overall Study|Disease progression|3|||
155705009|NCT04167137|562012669|FG004|Overall Study|Disease progression|2|||
155705010|NCT04167137|562012670|FG005|Overall Study|Disease progression|3|||
155705011|NCT04167137|562012671|FG006|Overall Study|Disease progression|2|||
155705012|NCT04167137|562012672|FG007|Overall Study|Disease progression|2|||
155705013|NCT04167137|562012665|FG000|Overall Study|Withdrawal by Subject|1|||
155705014|NCT04167137|562012666|FG001|Overall Study|Withdrawal by Subject|0|||
155705015|NCT04167137|562012667|FG002|Overall Study|Withdrawal by Subject|0|||
155705016|NCT04167137|562012668|FG003|Overall Study|Withdrawal by Subject|1|||
155705017|NCT04167137|562012669|FG004|Overall Study|Withdrawal by Subject|0|||
155705018|NCT04167137|562012670|FG005|Overall Study|Withdrawal by Subject|2|||
155705019|NCT04167137|562012671|FG006|Overall Study|Withdrawal by Subject|1|||
155705020|NCT04167137|562012672|FG007|Overall Study|Withdrawal by Subject|0|||
155705021|NCT04167137|562012665|FG000|Overall Study|Adverse Event|0|||
155705022|NCT04167137|562012666|FG001|Overall Study|Adverse Event|0|||
155705023|NCT04167137|562012667|FG002|Overall Study|Adverse Event|0|||
155705024|NCT04167137|562012668|FG003|Overall Study|Adverse Event|0|||
155705025|NCT04167137|562012669|FG004|Overall Study|Adverse Event|0|||
155705026|NCT04167137|562012670|FG005|Overall Study|Adverse Event|1|||
155705027|NCT04167137|562012671|FG006|Overall Study|Adverse Event|0|||
155705028|NCT04167137|562012672|FG007|Overall Study|Adverse Event|1|||
155705029|NCT04167137|562012665|FG000|Overall Study|Physician Decision|0|||
155705030|NCT04167137|562012666|FG001|Overall Study|Physician Decision|0|||
155705031|NCT04167137|562012667|FG002|Overall Study|Physician Decision|0|||
155705032|NCT04167137|562012668|FG003|Overall Study|Physician Decision|1|||
155705033|NCT04167137|562012669|FG004|Overall Study|Physician Decision|0|||
155705034|NCT04167137|562012670|FG005|Overall Study|Physician Decision|0|||
155705035|NCT04167137|562012671|FG006|Overall Study|Physician Decision|1|||
155705036|NCT04167137|562012672|FG007|Overall Study|Physician Decision|0|||
155705037|NCT04167137|562012665|FG000|Overall Study|Death|0|||
155705038|NCT04167137|562012666|FG001|Overall Study|Death|1|||
155705039|NCT04167137|562012667|FG002|Overall Study|Death|0|||
155705040|NCT04167137|562012668|FG003|Overall Study|Death|0|||
155705041|NCT04167137|562012669|FG004|Overall Study|Death|0|||
155705042|NCT04167137|562012670|FG005|Overall Study|Death|0|||
155705043|NCT04167137|562012671|FG006|Overall Study|Death|0|||
155705044|NCT04167137|562012672|FG007|Overall Study|Death|0|||
155705045|NCT04167137|562012665|FG000|Overall Study|Study terminated by Sponsor|0|||
155705046|NCT04167137|562012666|FG001|Overall Study|Study terminated by Sponsor|0|||
155705047|NCT04167137|562012667|FG002|Overall Study|Study terminated by Sponsor|0|||
155705048|NCT04167137|562012668|FG003|Overall Study|Study terminated by Sponsor|0|||
155705049|NCT04167137|562012669|FG004|Overall Study|Study terminated by Sponsor|0|||
155705050|NCT04167137|562012670|FG005|Overall Study|Study terminated by Sponsor|0|||
155705051|NCT04167137|562012671|FG006|Overall Study|Study terminated by Sponsor|0|||
155705052|NCT04167137|562012672|FG007|Overall Study|Study terminated by Sponsor|1|||
155705053|NCT02461745|562012679|FG000|Overall Study|Lack of Efficacy|9|||
155705054|NCT02461745|562012680|FG001|Overall Study|Lack of Efficacy|1|||
155705055|NCT02461745|562012679|FG000|Overall Study|Lost to Follow-up|2|||
155705056|NCT02461745|562012680|FG001|Overall Study|Lost to Follow-up|2|||
155705057|NCT02461745|562012679|FG000|Overall Study|Withdrawal by Subject|3|||
155705058|NCT02461745|562012680|FG001|Overall Study|Withdrawal by Subject|1|||
155705059|NCT02921087|562012681|FG000|Overall Study|Withdrawal by Subject|0|||
155705060|NCT02921087|562012682|FG001|Overall Study|Withdrawal by Subject|1|||
155705061|NCT00211887|562012683|FG000|Overall Study|Adverse Event|8|||
155705062|NCT00211887|562012684|FG001|Overall Study|Adverse Event|4|||
155705063|NCT00211887|562012685|FG002|Overall Study|Adverse Event|6|||
155705064|NCT00211887|562012683|FG000|Overall Study|Death|1|||
155705065|NCT00211887|562012684|FG001|Overall Study|Death|1|||
155705066|NCT00211887|562012685|FG002|Overall Study|Death|1|||
155705067|NCT00211887|562012683|FG000|Overall Study|Lost to Follow-up|28|||
155705068|NCT00211887|562012684|FG001|Overall Study|Lost to Follow-up|13|||
155705069|NCT00211887|562012685|FG002|Overall Study|Lost to Follow-up|9|||
155705070|NCT00211887|562012683|FG000|Overall Study|Non-medical reason|31|||
155705071|NCT00211887|562012684|FG001|Overall Study|Non-medical reason|14|||
155705072|NCT00211887|562012685|FG002|Overall Study|Non-medical reason|8|||
155705073|NCT00211887|562012683|FG000|Overall Study|Other medical reason|15|||
155705074|NCT00211887|562012684|FG001|Overall Study|Other medical reason|11|||
155705075|NCT00211887|562012685|FG002|Overall Study|Other medical reason|7|||
155705076|NCT00211887|562012683|FG000|Overall Study|Side effects|19|||
155705077|NCT00211887|562012684|FG001|Overall Study|Side effects|13|||
155705078|NCT00211887|562012685|FG002|Overall Study|Side effects|5|||
155705079|NCT02813889|562014382|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
155705080|NCT02813889|562014383|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
155705081|NCT01702025|562014390|FG000|Overall Study|Equipment failure|1|||
155705082|NCT01702025|562014391|FG001|Overall Study|Equipment failure|0|||
155705083|NCT01702025|562014392|FG002|Overall Study|Equipment failure|0|||
155705084|NCT01702025|562014393|FG003|Overall Study|Equipment failure|0|||
155705085|NCT01702025|562014390|FG000|Overall Study|Adverse Event|1|||
155705086|NCT01702025|562014391|FG001|Overall Study|Adverse Event|1|||
155705087|NCT01702025|562014392|FG002|Overall Study|Adverse Event|1|||
155705088|NCT01702025|562014393|FG003|Overall Study|Adverse Event|0|||
155705089|NCT01504412|562014402|FG000|Overall Study|Adverse Event|1|||
155705090|NCT01504412|562014403|FG001|Overall Study|Adverse Event|8|||
155705091|NCT01504412|562014404|FG002|Overall Study|Adverse Event|1|||
155705092|NCT01504412|562014405|FG003|Overall Study|Adverse Event|7|||
155705093|NCT01504412|562014406|FG004|Overall Study|Adverse Event|10|||
155705094|NCT01504412|562014402|FG000|Overall Study|Withdrawal by Subject|2|||
155705095|NCT01504412|562014403|FG001|Overall Study|Withdrawal by Subject|1|||
155705096|NCT01504412|562014404|FG002|Overall Study|Withdrawal by Subject|1|||
155705097|NCT01504412|562014405|FG003|Overall Study|Withdrawal by Subject|5|||
155705098|NCT01504412|562014406|FG004|Overall Study|Withdrawal by Subject|1|||
155705099|NCT01504412|562014402|FG000|Overall Study|Other|2|||
155705100|NCT01504412|562014403|FG001|Overall Study|Other|1|||
155705101|NCT01504412|562014404|FG002|Overall Study|Other|1|||
155705102|NCT01504412|562014405|FG003|Overall Study|Other|6|||
155705103|NCT01504412|562014406|FG004|Overall Study|Other|1|||
155705104|NCT01504412|562014402|FG000|Overall Study|Lost to Follow-up|0|||
155705105|NCT01504412|562014403|FG001|Overall Study|Lost to Follow-up|2|||
155705106|NCT01504412|562014404|FG002|Overall Study|Lost to Follow-up|0|||
155705107|NCT01504412|562014405|FG003|Overall Study|Lost to Follow-up|0|||
155705108|NCT01504412|562014406|FG004|Overall Study|Lost to Follow-up|0|||
155705109|NCT01504412|562014402|FG000|Overall Study|Lack of Efficacy|0|||
155705110|NCT01504412|562014403|FG001|Overall Study|Lack of Efficacy|0|||
155705111|NCT01504412|562014404|FG002|Overall Study|Lack of Efficacy|1|||
155705112|NCT01504412|562014405|FG003|Overall Study|Lack of Efficacy|0|||
155705113|NCT01504412|562014406|FG004|Overall Study|Lack of Efficacy|1|||
155705114|NCT01504412|562014402|FG000|Overall Study|Death|0|||
155705115|NCT01504412|562014403|FG001|Overall Study|Death|0|||
155705116|NCT01504412|562014404|FG002|Overall Study|Death|0|||
155705117|NCT01504412|562014405|FG003|Overall Study|Death|1|||
155705118|NCT01504412|562014406|FG004|Overall Study|Death|0|||
155705119|NCT02837029|562014409|FG000|Screening|Failed to meet screening requirements.|7|||
155705120|NCT02837029|562014410|FG001|Screening|Failed to meet screening requirements.|3|||
155705121|NCT02837029|562014411|FG002|Screening|Failed to meet screening requirements.|0|||
155705122|NCT02837029|562014409|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
155705123|NCT02837029|562014410|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
155705124|NCT02837029|562014411|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
155705125|NCT02837029|562014409|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
155705126|NCT02837029|562014410|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
155705127|NCT02837029|562014411|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
155705128|NCT02837029|562014409|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
155705129|NCT02837029|562014410|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
155705130|NCT02837029|562014411|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
155705131|NCT02837029|562014409|FG000|Cycle 2 and Beyond|Adverse Event|1|||
155705132|NCT02837029|562014410|FG001|Cycle 2 and Beyond|Adverse Event|0|||
155705133|NCT02837029|562014411|FG002|Cycle 2 and Beyond|Adverse Event|0|||
155705134|NCT02837029|562014409|FG000|2 Year Follow-up|Death|6|||
155705135|NCT02837029|562014410|FG001|2 Year Follow-up|Death|7|||
155705136|NCT02837029|562014411|FG002|2 Year Follow-up|Death|0|||
155705137|NCT03437577|562014414|FG000|Pre-Randomization|Withdrawal by Subject|0|||
155705138|NCT03437577|562014415|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155705139|NCT03437577|562014416|FG002|Pre-Randomization|Withdrawal by Subject|10|||
155705140|NCT03437577|562014414|FG000|Post-Randomization|Physician Decision|0|||
155705141|NCT03437577|562014415|FG001|Post-Randomization|Physician Decision|2|||
155705142|NCT03437577|562014416|FG002|Post-Randomization|Physician Decision|0|||
155705143|NCT00381693|562014421|FG000|Overall Study|Death|1|||
155705144|NCT00381693|562014421|FG000|Overall Study|Adverse Event|4|||
155705145|NCT00381693|562014421|FG000|Overall Study|Patient Choice|1|||
155705146|NCT00381693|562014421|FG000|Overall Study|Progression|2|||
155705147|NCT02598297|562014422|FG000|Overall Study|Study terminated by Sponsor|21|||
155705148|NCT02598297|562014423|FG001|Overall Study|Study terminated by Sponsor|23|||
155705149|NCT02598297|562014422|FG000|Overall Study|Adverse Event|1|||
155705150|NCT02598297|562014423|FG001|Overall Study|Adverse Event|1|||
155705151|NCT02598297|562014422|FG000|Overall Study|Physician Decision|1|||
155705152|NCT02598297|562014423|FG001|Overall Study|Physician Decision|0|||
155705153|NCT02598297|562014422|FG000|Overall Study|Subject/guardian decision|1|||
155705154|NCT02598297|562014423|FG001|Overall Study|Subject/guardian decision|0|||
155705155|NCT02598297|562014422|FG000|Overall Study|Followed for survival|1|||
155705156|NCT02598297|562014423|FG001|Overall Study|Followed for survival|0|||
155705157|NCT02206035|562014434|FG000|Overall Study|Physician Decision|10|||
155705158|NCT02206035|562014435|FG001|Overall Study|Physician Decision|0|||
155705159|NCT02206035|562014436|FG002|Overall Study|Physician Decision|175|||
155705160|NCT00887549|562014437|FG000|Induction Therapy|Adverse Event|8|||
155705161|NCT00887549|562014437|FG000|Induction Therapy|Physician Decision|1|||
155705162|NCT00887549|562014437|FG000|Induction Therapy|Progressive Disease|13|||
155705163|NCT00887549|562014437|FG000|Induction Therapy|Death due to Study Disease|4|||
155705164|NCT00887549|562014437|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
155705165|NCT00887549|562014437|FG000|Maintenance Therapy|Adverse Event|16|||
155705166|NCT00887549|562014437|FG000|Maintenance Therapy|Physician Decision|1|||
155705167|NCT00887549|562014437|FG000|Maintenance Therapy|Progressive Disease|25|||
155705168|NCT00887549|562014437|FG000|Maintenance Therapy|Death due to adverse event|1|||
155705169|NCT05173012|562014438|FG000|Overall Study|Adverse Event|2|||
155705170|NCT05173012|562014439|FG001|Overall Study|Adverse Event|3|||
155705171|NCT05173012|562014440|FG002|Overall Study|Adverse Event|4|||
155705172|NCT05173012|562014441|FG003|Overall Study|Adverse Event|13|||
155705173|NCT05173012|562014442|FG004|Overall Study|Adverse Event|0|||
155705174|NCT05173012|562014443|FG005|Overall Study|Adverse Event|0|||
155705175|NCT05173012|562014444|FG006|Overall Study|Adverse Event|2|||
155705176|NCT05173012|562014445|FG007|Overall Study|Adverse Event|4|||
155705177|NCT05173012|562014438|FG000|Overall Study|Lost to Follow-up|0|||
155705178|NCT05173012|562014439|FG001|Overall Study|Lost to Follow-up|0|||
155705179|NCT05173012|562014440|FG002|Overall Study|Lost to Follow-up|0|||
155705180|NCT05173012|562014441|FG003|Overall Study|Lost to Follow-up|1|||
155705181|NCT05173012|562014442|FG004|Overall Study|Lost to Follow-up|0|||
155705182|NCT05173012|562014443|FG005|Overall Study|Lost to Follow-up|0|||
155705183|NCT05173012|562014444|FG006|Overall Study|Lost to Follow-up|0|||
155705184|NCT05173012|562014445|FG007|Overall Study|Lost to Follow-up|0|||
155705185|NCT05173012|562014438|FG000|Overall Study|Withdrawal by Subject|1|||
155705186|NCT05173012|562014439|FG001|Overall Study|Withdrawal by Subject|0|||
155705187|NCT05173012|562014440|FG002|Overall Study|Withdrawal by Subject|1|||
155705188|NCT05173012|562014441|FG003|Overall Study|Withdrawal by Subject|3|||
155705189|NCT05173012|562014442|FG004|Overall Study|Withdrawal by Subject|1|||
155705190|NCT05173012|562014443|FG005|Overall Study|Withdrawal by Subject|0|||
155705191|NCT05173012|562014444|FG006|Overall Study|Withdrawal by Subject|1|||
155705192|NCT05173012|562014445|FG007|Overall Study|Withdrawal by Subject|0|||
155705193|NCT05173012|562014438|FG000|Overall Study|Protocol Deviation|0|||
155705194|NCT05173012|562014439|FG001|Overall Study|Protocol Deviation|0|||
155705195|NCT05173012|562014440|FG002|Overall Study|Protocol Deviation|0|||
155705196|NCT05173012|562014441|FG003|Overall Study|Protocol Deviation|1|||
155705197|NCT05173012|562014442|FG004|Overall Study|Protocol Deviation|0|||
155705198|NCT05173012|562014443|FG005|Overall Study|Protocol Deviation|0|||
155705199|NCT05173012|562014444|FG006|Overall Study|Protocol Deviation|0|||
155705200|NCT05173012|562014445|FG007|Overall Study|Protocol Deviation|0|||
155705201|NCT05173012|562014438|FG000|Overall Study|Other|0|||
155705202|NCT05173012|562014439|FG001|Overall Study|Other|0|||
155705203|NCT05173012|562014440|FG002|Overall Study|Other|0|||
155705204|NCT05173012|562014441|FG003|Overall Study|Other|2|||
155705205|NCT05173012|562014442|FG004|Overall Study|Other|0|||
155705206|NCT05173012|562014443|FG005|Overall Study|Other|0|||
155705207|NCT05173012|562014444|FG006|Overall Study|Other|0|||
155705208|NCT05173012|562014445|FG007|Overall Study|Other|0|||
155705209|NCT00100789|562014446|FG000|Overall Study|Adverse Event|10|||
155705210|NCT00100789|562014446|FG000|Overall Study|Withdrawal by Subject|1|||
155705211|NCT00100789|562014446|FG000|Overall Study|Progression/relapse|42|||
155705212|NCT00100789|562014446|FG000|Overall Study|Death|2|||
155705213|NCT00100789|562014446|FG000|Overall Study|Not protocol specified|5|||
155705214|NCT00100789|562014446|FG000|Overall Study|Ineligible|3|||
155705215|NCT00100789|562014446|FG000|Overall Study|Never received treatment|1|||
155705216|NCT02936843|562014447|FG000|Overall Study|Lost to Follow-up|3|||
155705217|NCT02936843|562014448|FG001|Overall Study|Lost to Follow-up|1|||
155705218|NCT02936843|562014447|FG000|Overall Study|Withdrawal by Subject|1|||
155705219|NCT02936843|562014448|FG001|Overall Study|Withdrawal by Subject|1|||
155705220|NCT03472950|562014449|FG000|Overall Study|Lost to Follow-up|0|||
155705221|NCT03472950|562014450|FG001|Overall Study|Lost to Follow-up|1|||
155705222|NCT03472950|562014449|FG000|Overall Study|Adverse Event|0|||
155705223|NCT03472950|562014450|FG001|Overall Study|Adverse Event|3|||
155705224|NCT01393821|562014451|FG000|Overall Study|Cancel|1|||
155705225|NCT01393821|562014452|FG001|Overall Study|Cancel|1|||
155705226|NCT01393821|562014451|FG000|Overall Study|not evaluable for primary endpoint|4|||
155705227|NCT01393821|562014452|FG001|Overall Study|not evaluable for primary endpoint|2|||
155705228|NCT00377858|562014464|FG000|Overall Study|Withdrawal by Subject|12|||
155705229|NCT00377858|562014465|FG001|Overall Study|Withdrawal by Subject|11|||
155705230|NCT00377858|562014464|FG000|Overall Study|Lost to Follow-up|6|||
155705231|NCT00377858|562014465|FG001|Overall Study|Lost to Follow-up|1|||
155705232|NCT00377858|562014464|FG000|Overall Study|Physician Decision|5|||
155705233|NCT00377858|562014465|FG001|Overall Study|Physician Decision|5|||
155705234|NCT00377858|562014464|FG000|Overall Study|Protocol Violation|3|||
155705235|NCT00377858|562014465|FG001|Overall Study|Protocol Violation|4|||
155705236|NCT00377858|562014464|FG000|Overall Study|Adverse Event|2|||
155705237|NCT00377858|562014465|FG001|Overall Study|Adverse Event|1|||
155705238|NCT00377858|562014464|FG000|Overall Study|Entry Criteria Not Met|2|||
155705239|NCT00377858|562014465|FG001|Overall Study|Entry Criteria Not Met|0|||
155705240|NCT00377858|562014464|FG000|Overall Study|Sponsor Decision|1|||
155705241|NCT00377858|562014465|FG001|Overall Study|Sponsor Decision|2|||
155705242|NCT00377858|562014464|FG000|Overall Study|Death|0|||
155705243|NCT00377858|562014465|FG001|Overall Study|Death|3|||
155705244|NCT03534141|562014466|FG000|Overall Study|Enrolled in other clinical trial|1|||
155705245|NCT03534141|562014467|FG001|Overall Study|Enrolled in other clinical trial|0|||
155705246|NCT03534141|562014466|FG000|Overall Study|Liver transplant aborted after randomization|0|||
155705247|NCT03534141|562014467|FG001|Overall Study|Liver transplant aborted after randomization|2|||
155705248|NCT03534141|562014466|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
155705249|NCT03534141|562014467|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
155705250|NCT00517361|562014468|FG000|Overall Study|Death|6|||
155705251|NCT00517361|562014468|FG000|Overall Study|The study was terminated|5|||
155705252|NCT01824355|562014472|FG000|Overall Study|Adverse Event|2|||
155705253|NCT01824355|562014472|FG000|Overall Study|unevaluable reference method results per|1|||
155705254|NCT04124705|562014473|FG000|Titration Period|Adverse Event|9|||
155705255|NCT04124705|562014474|FG001|Titration Period|Adverse Event|5|||
155705256|NCT04124705|562014473|FG000|Titration Period|Withdrawal by Subject|6|||
155705257|NCT04124705|562014474|FG001|Titration Period|Withdrawal by Subject|3|||
155705258|NCT04124705|562014473|FG000|Titration Period|Lost to Follow-up|0|||
155705259|NCT04124705|562014474|FG001|Titration Period|Lost to Follow-up|1|||
155705260|NCT04124705|562014473|FG000|Titration Period|Death|1|||
155705261|NCT04124705|562014474|FG001|Titration Period|Death|1|||
155705262|NCT04124705|562014473|FG000|Titration Period|Lack of Efficacy|2|||
155705263|NCT04124705|562014474|FG001|Titration Period|Lack of Efficacy|0|||
155705264|NCT04124705|562014473|FG000|Titration Period|Physician Decision|2|||
155705265|NCT04124705|562014474|FG001|Titration Period|Physician Decision|0|||
155705266|NCT04124705|562014473|FG000|Titration Period|Non-compliance with Study Drug|2|||
155705267|NCT04124705|562014474|FG001|Titration Period|Non-compliance with Study Drug|0|||
155705268|NCT04124705|562014473|FG000|Titration Period|Other|4|||
155705269|NCT04124705|562014474|FG001|Titration Period|Other|9|||
155705270|NCT04124705|562014473|FG000|Stabilization Period|Adverse Event|4|||
155705271|NCT04124705|562014474|FG001|Stabilization Period|Adverse Event|2|||
155705272|NCT04124705|562014473|FG000|Stabilization Period|Withdrawal by Subject|1|||
155705273|NCT04124705|562014474|FG001|Stabilization Period|Withdrawal by Subject|1|||
155705274|NCT04124705|562014473|FG000|Stabilization Period|Lost to Follow-up|0|||
155705275|NCT04124705|562014474|FG001|Stabilization Period|Lost to Follow-up|1|||
155705276|NCT04124705|562014473|FG000|Stabilization Period|Lack of Efficacy|4|||
155705277|NCT04124705|562014474|FG001|Stabilization Period|Lack of Efficacy|2|||
155705278|NCT04124705|562014473|FG000|Stabilization Period|Protocol Deviation|0|||
155705279|NCT04124705|562014474|FG001|Stabilization Period|Protocol Deviation|2|||
155705280|NCT04124705|562014473|FG000|Stabilization Period|Other|2|||
155705281|NCT04124705|562014474|FG001|Stabilization Period|Other|2|||
155705282|NCT00661622|562014475|FG000|Overall Study|Protocol Violation|1|||
155705283|NCT00661622|562014476|FG001|Overall Study|Protocol Violation|0|||
155705284|NCT04765202|562014481|FG000|Overall Study|Lost to Follow-up|1|||
155705285|NCT04765202|562014482|FG001|Overall Study|Lost to Follow-up|1|||
155705286|NCT04765202|562014483|FG002|Overall Study|Lost to Follow-up|2|||
155705287|NCT04765202|562014484|FG003|Overall Study|Lost to Follow-up|2|||
155705288|NCT04765202|562014481|FG000|Overall Study|Physician Decision|0|||
155705289|NCT04765202|562014482|FG001|Overall Study|Physician Decision|0|||
155705290|NCT04765202|562014483|FG002|Overall Study|Physician Decision|1|||
155705291|NCT04765202|562014484|FG003|Overall Study|Physician Decision|1|||
155705292|NCT04929249|562014485|FG000|Overall Study|Adverse Event|2|||
155705293|NCT04929249|562014486|FG001|Overall Study|Adverse Event|1|||
155705294|NCT04929249|562014485|FG000|Overall Study|Death|2|||
155705295|NCT04929249|562014486|FG001|Overall Study|Death|1|||
155705296|NCT04929249|562014485|FG000|Overall Study|Lost to Follow-up|3|||
155705297|NCT04929249|562014486|FG001|Overall Study|Lost to Follow-up|11|||
155705298|NCT04929249|562014485|FG000|Overall Study|Technical problems|0|||
155705299|NCT04929249|562014486|FG001|Overall Study|Technical problems|1|||
155705300|NCT04929249|562014485|FG000|Overall Study|Subject decision|6|||
155705301|NCT04929249|562014486|FG001|Overall Study|Subject decision|8|||
155705302|NCT04929249|562014485|FG000|Overall Study|Withdrew consent|0|||
155705303|NCT04929249|562014486|FG001|Overall Study|Withdrew consent|8|||
155705304|NCT02332291|562014489|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
155705305|NCT02332291|562014490|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
155705306|NCT02332291|562014489|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
155705307|NCT02332291|562014490|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
155705308|NCT02332291|562014489|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
155705309|NCT02332291|562014490|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
155705310|NCT02332291|562014489|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
155705311|NCT02332291|562014490|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
155705312|NCT02332291|562014489|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
155705313|NCT02332291|562014490|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
155705314|NCT02332291|562014489|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
155705315|NCT02332291|562014490|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
155705316|NCT01620762|562014504|FG000|Overall Study|Protocol Violation|1|||
155705317|NCT01620762|562014505|FG001|Overall Study|Protocol Violation|1|||
155705318|NCT01620762|562014506|FG002|Overall Study|Protocol Violation|1|||
155705319|NCT01620762|562014504|FG000|Overall Study|Adverse Event|9|||
155705320|NCT01620762|562014505|FG001|Overall Study|Adverse Event|5|||
155705321|NCT01620762|562014506|FG002|Overall Study|Adverse Event|2|||
155705322|NCT01620762|562014504|FG000|Overall Study|Withdrawal by Subject|23|||
155705323|NCT01620762|562014505|FG001|Overall Study|Withdrawal by Subject|26|||
155705324|NCT01620762|562014506|FG002|Overall Study|Withdrawal by Subject|27|||
155705325|NCT01620762|562014504|FG000|Overall Study|Lost to Follow-up|11|||
155705326|NCT01620762|562014505|FG001|Overall Study|Lost to Follow-up|17|||
155705327|NCT01620762|562014506|FG002|Overall Study|Lost to Follow-up|10|||
155705328|NCT01620762|562014504|FG000|Overall Study|Protocol deviation|1|||
155705329|NCT01620762|562014505|FG001|Overall Study|Protocol deviation|1|||
155705330|NCT01620762|562014506|FG002|Overall Study|Protocol deviation|6|||
155705331|NCT01620762|562014504|FG000|Overall Study|Subject deterioration|0|||
155705332|NCT01620762|562014505|FG001|Overall Study|Subject deterioration|1|||
155705333|NCT01620762|562014506|FG002|Overall Study|Subject deterioration|1|||
155705334|NCT01620762|562014504|FG000|Overall Study|Non-specified|3|||
155705335|NCT01620762|562014505|FG001|Overall Study|Non-specified|6|||
155705336|NCT01620762|562014506|FG002|Overall Study|Non-specified|5|||
155705337|NCT01620762|562014504|FG000|Overall Study|Use of prohibted therapies|0|||
155705338|NCT01620762|562014505|FG001|Overall Study|Use of prohibted therapies|1|||
155705339|NCT01620762|562014506|FG002|Overall Study|Use of prohibted therapies|1|||
155705340|NCT00095173|562014511|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
155705341|NCT00095173|562014512|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155705342|NCT00095173|562014513|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155705343|NCT00095173|562014514|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155705344|NCT00095173|562014515|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155705345|NCT00095173|562014516|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155705346|NCT00095173|562014511|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
155705347|NCT00095173|562014512|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155705348|NCT00095173|562014513|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155705349|NCT00095173|562014514|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155705350|NCT00095173|562014515|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155705351|NCT00095173|562014516|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155705352|NCT00095173|562014511|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
155705353|NCT00095173|562014512|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155705354|NCT00095173|562014513|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155705355|NCT00095173|562014514|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155705356|NCT00095173|562014515|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155705357|NCT00095173|562014516|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155705358|NCT00095173|562014511|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
155705359|NCT00095173|562014512|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
155705360|NCT00095173|562014513|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
155705361|NCT00095173|562014514|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
155705362|NCT00095173|562014515|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
155705363|NCT00095173|562014516|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
155705364|NCT00095173|562014511|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155705365|NCT00095173|562014512|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
155705366|NCT00095173|562014513|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
155705367|NCT00095173|562014514|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155705368|NCT00095173|562014515|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155705369|NCT00095173|562014516|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155705370|NCT00095173|562014511|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155705371|NCT00095173|562014512|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
155705372|NCT00095173|562014513|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155705373|NCT00095173|562014514|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155705374|NCT00095173|562014515|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155705375|NCT00095173|562014516|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155705376|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Death|0|||
155705377|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Death|0|||
155705378|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Death|0|||
155705379|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Death|0|||
155705380|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Death|0|||
155705381|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Death|1|||
155705382|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155705383|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155705384|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155705385|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
155705386|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
155705387|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
155705388|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155705389|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155705390|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155705391|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
155705392|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
155705393|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
155705394|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155705395|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155705396|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155705397|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
155705398|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
155705399|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
155705400|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155705401|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155705402|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155705403|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
155705404|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
155705405|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155705406|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155705407|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155705408|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155705409|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155705410|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
155705411|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
155705412|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155705413|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155705414|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155705415|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155705416|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
155705417|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
155705418|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155705419|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155705420|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155705421|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
155705422|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
155705423|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
155705424|NCT00095173|562014511|FG000|Open-Label Extension Phase (Period C)|Other|0|||
155705425|NCT00095173|562014512|FG001|Open-Label Extension Phase (Period C)|Other|0|||
155705426|NCT00095173|562014513|FG002|Open-Label Extension Phase (Period C)|Other|0|||
155705427|NCT00095173|562014514|FG003|Open-Label Extension Phase (Period C)|Other|4|||
155705428|NCT00095173|562014515|FG004|Open-Label Extension Phase (Period C)|Other|6|||
155705429|NCT00095173|562014516|FG005|Open-Label Extension Phase (Period C)|Other|8|||
155705430|NCT01620528|562014517|FG000|Treatment Period|Did Not Receive Study Drug|0|||
155705431|NCT01620528|562014518|FG001|Treatment Period|Did Not Receive Study Drug|0|||
155705432|NCT01620528|562014519|FG002|Treatment Period|Did Not Receive Study Drug|1|||
155705433|NCT01620528|562014517|FG000|Treatment Period|Withdrawal by Subject|35|||
155705434|NCT01620528|562014518|FG001|Treatment Period|Withdrawal by Subject|21|||
155705435|NCT01620528|562014519|FG002|Treatment Period|Withdrawal by Subject|16|||
155705436|NCT01620528|562014517|FG000|Treatment Period|Adverse Event|17|||
155705437|NCT01620528|562014518|FG001|Treatment Period|Adverse Event|13|||
155705438|NCT01620528|562014519|FG002|Treatment Period|Adverse Event|21|||
155705439|NCT01620528|562014517|FG000|Treatment Period|Lost to Follow-up|16|||
155705440|NCT01620528|562014518|FG001|Treatment Period|Lost to Follow-up|8|||
155705441|NCT01620528|562014519|FG002|Treatment Period|Lost to Follow-up|14|||
155705442|NCT01620528|562014517|FG000|Treatment Period|Other|9|||
155705443|NCT01620528|562014518|FG001|Treatment Period|Other|5|||
155705444|NCT01620528|562014519|FG002|Treatment Period|Other|7|||
155705445|NCT01620528|562014517|FG000|Treatment Period|Subject Noncompliant|11|||
155705446|NCT01620528|562014518|FG001|Treatment Period|Subject Noncompliant|2|||
155705447|NCT01620528|562014519|FG002|Treatment Period|Subject Noncompliant|2|||
155705448|NCT01620528|562014517|FG000|Treatment Period|Pregnancy|7|||
155705449|NCT01620528|562014518|FG001|Treatment Period|Pregnancy|2|||
155705450|NCT01620528|562014519|FG002|Treatment Period|Pregnancy|2|||
155705451|NCT01620528|562014517|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
155705452|NCT01620528|562014518|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
155705453|NCT01620528|562014519|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
155705454|NCT01620528|562014517|FG000|Treatment Period|Exclusionary Medication Received|0|||
155705455|NCT01620528|562014518|FG001|Treatment Period|Exclusionary Medication Received|1|||
155705456|NCT01620528|562014519|FG002|Treatment Period|Exclusionary Medication Received|0|||
155705457|NCT01620528|562014517|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
155705458|NCT01620528|562014518|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
155705459|NCT01620528|562014519|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
155705460|NCT01620528|562014517|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155705461|NCT01620528|562014518|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155705462|NCT01620528|562014519|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155705463|NCT01620528|562014517|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
155705464|NCT01620528|562014518|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
155705465|NCT01620528|562014519|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
155705466|NCT01620528|562014517|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
155705467|NCT01620528|562014518|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
155705468|NCT01620528|562014519|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
155705469|NCT01620528|562014517|FG000|Post-Treatment Follow-Up Period|Other|6|||
155705470|NCT01620528|562014518|FG001|Post-Treatment Follow-Up Period|Other|4|||
155705471|NCT01620528|562014519|FG002|Post-Treatment Follow-Up Period|Other|2|||
155705472|NCT03997825|562014531|FG000|Overall Study|Death|3|||
155705473|NCT03997825|562014531|FG000|Overall Study|Lost to Follow-up|10|||
155705474|NCT03997825|562014531|FG000|Overall Study|Withdrawal by Subject|3|||
155705475|NCT03997825|562014531|FG000|Overall Study|Refused participation|1|||
155705476|NCT01153698|562014532|FG000|Overall Study|Adverse Event|12|||
155705477|NCT01153698|562014532|FG000|Overall Study|Lost to Follow-up|4|||
155705478|NCT01153698|562014532|FG000|Overall Study|Withdrawal by Subject|2|||
155705479|NCT01153698|562014532|FG000|Overall Study|Switch to other anticoagulants|4|||
155705480|NCT01153698|562014532|FG000|Overall Study|Other|2|||
155705481|NCT01153698|562014532|FG000|Overall Study|Not treated with Pradaxa|5|||
155705482|NCT00465647|562014533|FG000|Overall Study|Administrative|2|||
155705483|NCT00465647|562014534|FG001|Overall Study|Administrative|2|||
155705484|NCT00465647|562014535|FG002|Overall Study|Administrative|3|||
155705485|NCT00465647|562014536|FG003|Overall Study|Administrative|2|||
155705486|NCT00465647|562014533|FG000|Overall Study|Adverse Event|2|||
155705487|NCT00465647|562014534|FG001|Overall Study|Adverse Event|0|||
155705488|NCT00465647|562014535|FG002|Overall Study|Adverse Event|3|||
155705489|NCT00465647|562014536|FG003|Overall Study|Adverse Event|2|||
155705490|NCT00465647|562014533|FG000|Overall Study|Withdrawal by Subject|1|||
155705491|NCT00465647|562014534|FG001|Overall Study|Withdrawal by Subject|2|||
155705492|NCT00465647|562014535|FG002|Overall Study|Withdrawal by Subject|2|||
155705493|NCT00465647|562014536|FG003|Overall Study|Withdrawal by Subject|7|||
155705494|NCT00465647|562014533|FG000|Overall Study|"The other reasons included loss of IV"|8|||
155705495|NCT00465647|562014534|FG001|Overall Study|"The other reasons included loss of IV"|4|||
155705496|NCT00465647|562014535|FG002|Overall Study|"The other reasons included loss of IV"|3|||
155705497|NCT00465647|562014536|FG003|Overall Study|"The other reasons included loss of IV"|2|||
155705498|NCT02220712|562014537|FG000|Overall Study|Adverse Event|1|||
155705499|NCT02220712|562014537|FG000|Overall Study|Withdrawal by Subject|2|||
155705500|NCT02220712|562014537|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
155705501|NCT00760838|562014538|FG000|Overall Study|Adverse Event|1|||
155705502|NCT00760838|562014539|FG001|Overall Study|Adverse Event|1|||
155705503|NCT00760838|562014538|FG000|Overall Study|Lack of Efficacy|1|||
155705504|NCT00760838|562014539|FG001|Overall Study|Lack of Efficacy|0|||
155705505|NCT00760838|562014538|FG000|Overall Study|Lost to Follow-up|2|||
155705506|NCT00760838|562014539|FG001|Overall Study|Lost to Follow-up|0|||
155705507|NCT00760838|562014538|FG000|Overall Study|Withdrawal by Subject|1|||
155705508|NCT00760838|562014539|FG001|Overall Study|Withdrawal by Subject|1|||
155705509|NCT01628965|562014540|FG000|Overall Study|Adverse Event|30|||
155705510|NCT01628965|562014540|FG000|Overall Study|Lack of Efficacy|7|||
155705511|NCT01628965|562014540|FG000|Overall Study|Withdrawal by Subject|3|||
155705512|NCT01628965|562014540|FG000|Overall Study|Lost to Follow-up|1|||
155705513|NCT01628965|562014540|FG000|Overall Study|Discontinuation criteria|8|||
155705514|NCT00330681|562014543|FG000|Overall Study|Adverse Event|3|||
155705515|NCT00330681|562014544|FG001|Overall Study|Adverse Event|6|||
155705516|NCT00330681|562014543|FG000|Overall Study|Protocol Violation|0|||
155705517|NCT00330681|562014544|FG001|Overall Study|Protocol Violation|1|||
155705518|NCT00330681|562014543|FG000|Overall Study|Withdrawal by Subject|5|||
155705519|NCT00330681|562014544|FG001|Overall Study|Withdrawal by Subject|5|||
155705520|NCT00330681|562014543|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
155705521|NCT00330681|562014544|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
155705522|NCT02578186|562014545|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
155705523|NCT02578186|562014546|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
155705524|NCT02578186|562014545|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
155705525|NCT02578186|562014546|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
155705526|NCT03824587|562014547|FG000|Run-in Period|Screen Failure|0|||
155705527|NCT03824587|562014548|FG001|Run-in Period|Screen Failure|275|||
155705528|NCT03824587|562014547|FG000|Treatment Period|Adverse Event|4|||
155705529|NCT03824587|562014548|FG001|Treatment Period|Adverse Event|1|||
155705530|NCT03824587|562014547|FG000|Treatment Period|Withdrawal by Subject|0|||
155705531|NCT03824587|562014548|FG001|Treatment Period|Withdrawal by Subject|1|||
155705532|NCT03824587|562014547|FG000|Treatment Period|Kidney Transplant|1|||
155705533|NCT03824587|562014548|FG001|Treatment Period|Kidney Transplant|1|||
155705534|NCT01300572|562014549|FG000|Overall Study|HAMA + post dosimetry|1|||
155705535|NCT00986362|562014550|FG000|Overall Study|Death|2|||
155705536|NCT00986362|562014551|FG001|Overall Study|Death|0|||
155705537|NCT00986362|562014550|FG000|Overall Study|Lost to Follow-up|0|||
155705538|NCT00986362|562014551|FG001|Overall Study|Lost to Follow-up|1|||
155705539|NCT03058692|562016486|FG000|Overall Study|Lost to Follow-up|2|||
155705540|NCT03058692|562016487|FG001|Overall Study|Lost to Follow-up|1|||
155705541|NCT03058692|562016486|FG000|Overall Study|Withdrawal by Subject|1|||
155705542|NCT03058692|562016487|FG001|Overall Study|Withdrawal by Subject|1|||
155705543|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
155705544|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
155705545|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
155705546|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
155705547|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
155705548|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
155705549|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
155705550|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
155705551|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
155705552|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
155705553|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
155705554|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
155705555|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
155705556|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
155705557|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
155705558|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
155705559|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155705560|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
155705561|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155705562|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155705563|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
155705564|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
155705565|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
155705566|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
155705567|NCT03777059|562016488|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
155705568|NCT03777059|562016489|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
155705569|NCT03777059|562016490|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
155705570|NCT03777059|562016491|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
155705571|NCT03777059|562016488|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
155705572|NCT03777059|562016489|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
155705573|NCT03777059|562016490|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
155705574|NCT03777059|562016491|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
155705575|NCT03777059|562016488|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
155705576|NCT03777059|562016489|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
155705577|NCT03777059|562016490|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
155705578|NCT03777059|562016491|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
155705579|NCT03777059|562016488|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
155705580|NCT03777059|562016489|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
155705581|NCT03777059|562016490|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
155705582|NCT03777059|562016491|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
155705583|NCT03777059|562016488|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
155705584|NCT03777059|562016489|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
155705585|NCT03777059|562016490|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
155705586|NCT03777059|562016491|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
155705587|NCT02679755|562016494|FG000|Overall Study|Death|0|||
155705588|NCT02679755|562016495|FG001|Overall Study|Death|3|||
155705589|NCT02679755|562016494|FG000|Overall Study|Global deterioration of health status|1|||
155705590|NCT02679755|562016495|FG001|Overall Study|Global deterioration of health status|8|||
155705591|NCT02679755|562016494|FG000|Overall Study|Lost to Follow-up|1|||
155705592|NCT02679755|562016495|FG001|Overall Study|Lost to Follow-up|0|||
155705593|NCT02679755|562016494|FG000|Overall Study|Objective progression or relapse|24|||
155705594|NCT02679755|562016495|FG001|Overall Study|Objective progression or relapse|83|||
155705595|NCT02679755|562016494|FG000|Overall Study|Not defined|0|||
155705596|NCT02679755|562016495|FG001|Overall Study|Not defined|2|||
155705597|NCT02679755|562016494|FG000|Overall Study|Withdrawal by participant|6|||
155705598|NCT02679755|562016495|FG001|Overall Study|Withdrawal by participant|3|||
155705599|NCT02679755|562016494|FG000|Overall Study|Adverse Event|1|||
155705600|NCT02679755|562016495|FG001|Overall Study|Adverse Event|4|||
155705601|NCT02679755|562016494|FG000|Overall Study|Adverse events not related to study drug|1|||
155705602|NCT02679755|562016495|FG001|Overall Study|Adverse events not related to study drug|2|||
155705603|NCT01061359|562016496|FG000|Overall Study|Death|32|||
155705604|NCT01061359|562016496|FG000|Overall Study|Lost to Follow-up|1072|||
155705605|NCT01061359|562016496|FG000|Overall Study|Relapse|187|||
155705606|NCT01061359|562016496|FG000|Overall Study|Secondary neoplasm|11|||
155705607|NCT02610777|562016497|FG000|Overall Study|Lost to Follow-up|1|||
155705608|NCT02610777|562016498|FG001|Overall Study|Lost to Follow-up|0|||
155705609|NCT02610777|562016497|FG000|Overall Study|Site Terminated by Sponsor|9|||
155705610|NCT02610777|562016498|FG001|Overall Study|Site Terminated by Sponsor|8|||
155705611|NCT02610777|562016497|FG000|Overall Study|Withdrawal by Subject|2|||
155705612|NCT02610777|562016498|FG001|Overall Study|Withdrawal by Subject|2|||
155705613|NCT02610777|562016497|FG000|Overall Study|Reason not Specified|0|||
155705614|NCT02610777|562016498|FG001|Overall Study|Reason not Specified|1|||
155705615|NCT02610777|562016497|FG000|Overall Study|Death|50|||
155705616|NCT02610777|562016498|FG001|Overall Study|Death|47|||
155705617|NCT00411671|562016501|FG000|Overall Study|Adverse Event|15|||
155705618|NCT00411671|562016501|FG000|Overall Study|Death|2|||
155705619|NCT00411671|562016501|FG000|Overall Study|Lost to Follow-up|3|||
155705620|NCT04737278|562016502|FG000|Overall Study|Lost to Follow-up|1|||
155705621|NCT04737278|562016503|FG001|Overall Study|Lost to Follow-up|1|||
155705622|NCT04737278|562016502|FG000|Overall Study|Withdrawal by Subject|1|||
155705623|NCT04737278|562016503|FG001|Overall Study|Withdrawal by Subject|0|||
155705624|NCT04737278|562016502|FG000|Overall Study|Protocol Violation|1|||
155705625|NCT04737278|562016503|FG001|Overall Study|Protocol Violation|1|||
155705626|NCT04737278|562016502|FG000|Overall Study|failure to complete questionnaire|1|||
155705627|NCT04737278|562016503|FG001|Overall Study|failure to complete questionnaire|1|||
155705628|NCT00546000|562016508|FG000|Overall Study|Adverse Event|1|||
155705629|NCT00546000|562016508|FG000|Overall Study|Lost to Follow-up|1|||
155705630|NCT00546000|562016508|FG000|Overall Study|Baseline HPA Axis Supression|2|||
155705631|NCT03688074|562016513|FG000|Overall Study|Adverse Event|0|||
155705632|NCT03688074|562016514|FG001|Overall Study|Adverse Event|1|||
155705633|NCT03688074|562016513|FG000|Overall Study|Other|1|||
155705634|NCT03688074|562016514|FG001|Overall Study|Other|0|||
155705635|NCT01362608|562016517|FG000|Overall Study|Protocol Violation|0|||
155705636|NCT01362608|562016518|FG001|Overall Study|Protocol Violation|1|||
155705637|NCT01362608|562016517|FG000|Overall Study|Lost to Follow-up|3|||
155705638|NCT01362608|562016518|FG001|Overall Study|Lost to Follow-up|1|||
155705639|NCT01362608|562016517|FG000|Overall Study|Withdrawal by Subject|1|||
155705640|NCT01362608|562016518|FG001|Overall Study|Withdrawal by Subject|2|||
155705641|NCT01362608|562016517|FG000|Overall Study|Lack of Efficacy|0|||
155705642|NCT01362608|562016518|FG001|Overall Study|Lack of Efficacy|2|||
155705643|NCT01362608|562016517|FG000|Overall Study|Adverse Event|0|||
155705644|NCT01362608|562016518|FG001|Overall Study|Adverse Event|2|||
155705645|NCT03056339|562016520|FG000|Overall Study|Failed Requirements|0|||
155705646|NCT03056339|562016521|FG001|Overall Study|Failed Requirements|2|||
155705647|NCT03056339|562016522|FG002|Overall Study|Failed Requirements|7|||
155705648|NCT03056339|562016523|FG003|Overall Study|Failed Requirements|1|||
155705649|NCT04171219|562016531|FG000|Overall Study|Adverse Event|1|||
155705650|NCT04171219|562016532|FG001|Overall Study|Adverse Event|0|||
155705651|NCT04171219|562016531|FG000|Overall Study|Death|0|||
155705652|NCT04171219|562016532|FG001|Overall Study|Death|1|||
155705653|NCT04171219|562016531|FG000|Overall Study|Lack of Efficacy|9|||
155705654|NCT04171219|562016532|FG001|Overall Study|Lack of Efficacy|13|||
155705655|NCT04171219|562016531|FG000|Overall Study|Withdrawal by Subject|1|||
155705656|NCT04171219|562016532|FG001|Overall Study|Withdrawal by Subject|2|||
155705657|NCT04171219|562016531|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
155705658|NCT04171219|562016532|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
155705659|NCT04171219|562016531|FG000|Overall Study|Clinical PD/Patient choice|1|||
155705660|NCT04171219|562016532|FG001|Overall Study|Clinical PD/Patient choice|0|||
155705661|NCT04171219|562016531|FG000|Overall Study|Toxicity/ Patient choice|1|||
155705662|NCT04171219|562016532|FG001|Overall Study|Toxicity/ Patient choice|0|||
155705663|NCT04809285|562016535|FG000|Phase 1|Lost to Follow-up|6|||
155705664|NCT04809285|562016535|FG000|Phase 1|Protocol Violation|2|||
155705665|NCT04809285|562016535|FG000|Phase 1|Physician Decision|3|||
155705666|NCT04809285|562016535|FG000|Phase 1|Withdrawal by Subject|29|||
155705667|NCT04809285|562016535|FG000|Phase 2|Protocol Violation|3|||
155705668|NCT04809285|562016535|FG000|Phase 2|Withdrawal by Subject|4|||
155705669|NCT02974257|562016536|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
155705670|NCT02974257|562016537|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
155705671|NCT02974257|562016536|FG000|Overall Study|Clinical indication for thiamine|1|||
155705672|NCT02974257|562016537|FG001|Overall Study|Clinical indication for thiamine|0|||
155705673|NCT02974257|562016536|FG000|Overall Study|Already on thiamine|1|||
155705674|NCT02974257|562016537|FG001|Overall Study|Already on thiamine|0|||
155705675|NCT02974257|562016536|FG000|Overall Study|Extubated prior to study drug|0|||
155705676|NCT02974257|562016537|FG001|Overall Study|Extubated prior to study drug|1|||
155705677|NCT02974257|562016536|FG000|Overall Study|Death|0|||
155705678|NCT02974257|562016537|FG001|Overall Study|Death|1|||
155705679|NCT03526146|562016538|FG000|Overall Study|Lost to Follow-up|5|||
155705680|NCT03526146|562016538|FG000|Overall Study|Withdrawal by Subject|6|||
155705681|NCT03526146|562016538|FG000|Overall Study|class canceled due to COVID-19|4|||
155705682|NCT02644343|562016539|FG000|Overall Study|Withdrawal by Subject|1|||
155705683|NCT02034877|562016540|FG000|Overall Study|Lost to Follow-up|0|||
155705684|NCT02034877|562016541|FG001|Overall Study|Lost to Follow-up|3|||
155705685|NCT02034877|562016540|FG000|Overall Study|No Longer Willing to Participate|0|||
155705686|NCT02034877|562016541|FG001|Overall Study|No Longer Willing to Participate|3|||
155705687|NCT00536471|562016542|FG000|Overall Study|Lost to Follow-up|48|||
155705688|NCT00536471|562016543|FG001|Overall Study|Lost to Follow-up|23|||
155705689|NCT00536471|562016544|FG002|Overall Study|Lost to Follow-up|48|||
155705690|NCT00536471|562016545|FG003|Overall Study|Lost to Follow-up|22|||
155705691|NCT00536471|562016542|FG000|Overall Study|Adverse Event|32|||
155705692|NCT00536471|562016543|FG001|Overall Study|Adverse Event|16|||
155705693|NCT00536471|562016544|FG002|Overall Study|Adverse Event|28|||
155705694|NCT00536471|562016545|FG003|Overall Study|Adverse Event|13|||
155705695|NCT00536471|562016542|FG000|Overall Study|Withdrawal by Subject|40|||
155705696|NCT00536471|562016543|FG001|Overall Study|Withdrawal by Subject|24|||
155705697|NCT00536471|562016544|FG002|Overall Study|Withdrawal by Subject|43|||
155705698|NCT00536471|562016545|FG003|Overall Study|Withdrawal by Subject|21|||
155705699|NCT00536471|562016542|FG000|Overall Study|Lack of Efficacy|17|||
155705700|NCT00536471|562016543|FG001|Overall Study|Lack of Efficacy|18|||
155705701|NCT00536471|562016544|FG002|Overall Study|Lack of Efficacy|11|||
155705702|NCT00536471|562016545|FG003|Overall Study|Lack of Efficacy|9|||
155705703|NCT00536471|562016542|FG000|Overall Study|Protocol Violation|8|||
155705704|NCT00536471|562016543|FG001|Overall Study|Protocol Violation|1|||
155705705|NCT00536471|562016544|FG002|Overall Study|Protocol Violation|2|||
155705706|NCT00536471|562016545|FG003|Overall Study|Protocol Violation|3|||
155705707|NCT00536471|562016542|FG000|Overall Study|Physician Decision|11|||
155705708|NCT00536471|562016543|FG001|Overall Study|Physician Decision|1|||
155705709|NCT00536471|562016544|FG002|Overall Study|Physician Decision|3|||
155705710|NCT00536471|562016545|FG003|Overall Study|Physician Decision|2|||
155705711|NCT00536471|562016542|FG000|Overall Study|Death|0|||
155705712|NCT00536471|562016543|FG001|Overall Study|Death|0|||
155705713|NCT00536471|562016544|FG002|Overall Study|Death|1|||
155705714|NCT00536471|562016545|FG003|Overall Study|Death|2|||
155705715|NCT00536471|562016542|FG000|Overall Study|Sponsor Decision|0|||
155705716|NCT00536471|562016543|FG001|Overall Study|Sponsor Decision|1|||
155705717|NCT00536471|562016544|FG002|Overall Study|Sponsor Decision|3|||
155705718|NCT00536471|562016545|FG003|Overall Study|Sponsor Decision|2|||
155705719|NCT04878211|562016551|FG000|Overall Study|Lost to Follow-up|0|||
155705720|NCT04878211|562016552|FG001|Overall Study|Lost to Follow-up|0|||
155705721|NCT04878211|562016553|FG002|Overall Study|Lost to Follow-up|0|||
155705722|NCT04878211|562016554|FG003|Overall Study|Lost to Follow-up|1|||
155705723|NCT04878211|562016555|FG004|Overall Study|Lost to Follow-up|0|||
155705724|NCT04878211|562016556|FG005|Overall Study|Lost to Follow-up|1|||
155705725|NCT04878211|562016551|FG000|Overall Study|Protocol deviation|1|||
155705726|NCT04878211|562016552|FG001|Overall Study|Protocol deviation|0|||
155705727|NCT04878211|562016553|FG002|Overall Study|Protocol deviation|0|||
155705728|NCT04878211|562016554|FG003|Overall Study|Protocol deviation|0|||
155705729|NCT04878211|562016555|FG004|Overall Study|Protocol deviation|0|||
155705730|NCT04878211|562016556|FG005|Overall Study|Protocol deviation|0|||
155705731|NCT04878211|562016551|FG000|Overall Study|Study terminated by sponsor|0|||
155705732|NCT04878211|562016552|FG001|Overall Study|Study terminated by sponsor|0|||
155705733|NCT04878211|562016553|FG002|Overall Study|Study terminated by sponsor|0|||
155705734|NCT04878211|562016554|FG003|Overall Study|Study terminated by sponsor|0|||
155705735|NCT04878211|562016555|FG004|Overall Study|Study terminated by sponsor|9|||
155705736|NCT04878211|562016556|FG005|Overall Study|Study terminated by sponsor|4|||
155705737|NCT04878211|562016551|FG000|Overall Study|Subject decision|0|||
155705738|NCT04878211|562016552|FG001|Overall Study|Subject decision|0|||
155705739|NCT04878211|562016553|FG002|Overall Study|Subject decision|0|||
155705740|NCT04878211|562016554|FG003|Overall Study|Subject decision|0|||
155705741|NCT04878211|562016555|FG004|Overall Study|Subject decision|1|||
155705742|NCT04878211|562016556|FG005|Overall Study|Subject decision|0|||
155705743|NCT03574779|562016563|FG000|Overall Study|Screening failure|13|||
155705744|NCT03574779|562016564|FG001|Overall Study|Screening failure|83|||
155705745|NCT02783599|562016565|FG000|Overall Study|Progressive disease|23|||
155705746|NCT02783599|562016565|FG000|Overall Study|Surgical Resection|10|||
155705747|NCT02783599|562016565|FG000|Overall Study|Adverse Event|4|||
155705748|NCT02783599|562016565|FG000|Overall Study|Physician Decision|2|||
155705749|NCT02783599|562016565|FG000|Overall Study|Death|1|||
155705750|NCT00856544|562016573|FG000|Overall Study|Randomized but not treated|3|||
155705751|NCT00856544|562016574|FG001|Overall Study|Randomized but not treated|0|||
155705752|NCT00856544|562016575|FG002|Overall Study|Randomized but not treated|0|||
155705753|NCT00856544|562016576|FG003|Overall Study|Randomized but not treated|0|||
155705754|NCT00856544|562016573|FG000|Overall Study|Death|0|||
155705755|NCT00856544|562016574|FG001|Overall Study|Death|2|||
155705756|NCT00856544|562016575|FG002|Overall Study|Death|0|||
155705757|NCT00856544|562016576|FG003|Overall Study|Death|0|||
155705758|NCT00856544|562016573|FG000|Overall Study|Adverse Event|20|||
155705759|NCT00856544|562016574|FG001|Overall Study|Adverse Event|29|||
155705760|NCT00856544|562016575|FG002|Overall Study|Adverse Event|2|||
155705761|NCT00856544|562016576|FG003|Overall Study|Adverse Event|3|||
155705762|NCT00856544|562016573|FG000|Overall Study|Lack of Efficacy|16|||
155705763|NCT00856544|562016574|FG001|Overall Study|Lack of Efficacy|12|||
155705764|NCT00856544|562016575|FG002|Overall Study|Lack of Efficacy|3|||
155705765|NCT00856544|562016576|FG003|Overall Study|Lack of Efficacy|3|||
155705766|NCT00856544|562016573|FG000|Overall Study|Other|9|||
155705767|NCT00856544|562016574|FG001|Overall Study|Other|16|||
155705768|NCT00856544|562016575|FG002|Overall Study|Other|1|||
155705769|NCT00856544|562016576|FG003|Overall Study|Other|6|||
155705770|NCT00856544|562016573|FG000|Overall Study|Lost to Follow-up|1|||
155705771|NCT00856544|562016574|FG001|Overall Study|Lost to Follow-up|2|||
155705772|NCT00856544|562016575|FG002|Overall Study|Lost to Follow-up|2|||
155705773|NCT00856544|562016576|FG003|Overall Study|Lost to Follow-up|0|||
155705774|NCT00856544|562016573|FG000|Overall Study|Withdrawal by Subject|8|||
155705775|NCT00856544|562016574|FG001|Overall Study|Withdrawal by Subject|5|||
155705776|NCT00856544|562016575|FG002|Overall Study|Withdrawal by Subject|0|||
155705777|NCT00856544|562016576|FG003|Overall Study|Withdrawal by Subject|1|||
155705778|NCT01564732|562016577|FG000|Overall Study|Early termination by the study sponsor|6|||
155705779|NCT01564732|562016578|FG001|Overall Study|Early termination by the study sponsor|5|||
155705780|NCT01687101|562016581|FG000|Overall Study|Lost to Follow-up|7|||
155705781|NCT05274269|562016585|FG000|Overall Study|Adverse Event|0|||
155705782|NCT05274269|562016586|FG001|Overall Study|Adverse Event|3|||
155705783|NCT05274269|562016585|FG000|Overall Study|Death|0|||
155705784|NCT05274269|562016586|FG001|Overall Study|Death|1|||
155705785|NCT05274269|562016585|FG000|Overall Study|Other|0|||
155705786|NCT05274269|562016586|FG001|Overall Study|Other|2|||
155705787|NCT05274269|562016585|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155705788|NCT05274269|562016586|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155705789|NCT01685697|562016587|FG000|Overall Study|Protocol Violation|3|||
155705790|NCT01685697|562016588|FG001|Overall Study|Protocol Violation|3|||
155705791|NCT01948063|562016590|FG000|Overall Study|Boston MCI halted research protocol|0|||
155705792|NCT01948063|562016591|FG001|Overall Study|Boston MCI halted research protocol|1|||
155705793|NCT01948063|562016590|FG000|Overall Study|Discovered an enrollment in other study|0|||
155705794|NCT01948063|562016591|FG001|Overall Study|Discovered an enrollment in other study|1|||
155705795|NCT01948063|562016590|FG000|Overall Study|Blood samples were accidentally thawed|1|||
155705796|NCT01948063|562016591|FG001|Overall Study|Blood samples were accidentally thawed|0|||
155705797|NCT04427072|562016600|FG000|Randomized Treatment Phase|Progressive disease|9|||
155705798|NCT04427072|562016601|FG001|Randomized Treatment Phase|Progressive disease|4|||
155705799|NCT04427072|562016600|FG000|Randomized Treatment Phase|Adverse Event|3|||
155705800|NCT04427072|562016601|FG001|Randomized Treatment Phase|Adverse Event|1|||
155705801|NCT04427072|562016600|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
155705802|NCT04427072|562016601|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
155705803|NCT04427072|562016600|FG000|Randomized Treatment Phase|Death|0|||
155705804|NCT04427072|562016601|FG001|Randomized Treatment Phase|Death|1|||
155705805|NCT04427072|562016600|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
155705806|NCT04427072|562016601|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
155705807|NCT04427072|562016600|FG000|Extension Treatment Phase|Progressive disease|0|||
155705808|NCT04427072|562016601|FG001|Extension Treatment Phase|Progressive disease|5|||
155705809|NCT05232864|562016602|FG000|Overall Study|Adverse Event|0|||
155705810|NCT05232864|562016603|FG001|Overall Study|Adverse Event|1|||
155705811|NCT05232864|562016602|FG000|Overall Study|Study terminated by sponsor|16|||
155705812|NCT05232864|562016603|FG001|Overall Study|Study terminated by sponsor|14|||
155705813|NCT01636986|562016604|FG000|Overall Study|Withdrawal by Subject|0|||
155705814|NCT01636986|562016605|FG001|Overall Study|Withdrawal by Subject|1|||
155705815|NCT01636986|562016604|FG000|Overall Study|Corneal Staining|0|||
155705816|NCT01636986|562016605|FG001|Overall Study|Corneal Staining|1|||
155705817|NCT00705146|562016606|FG000|Overall Study|Lost to Follow-up|1|||
155705818|NCT00705146|562016607|FG001|Overall Study|Lost to Follow-up|1|||
155705819|NCT03664765|562016609|FG000|Overall Study|Withdrawal by Subject|4|||
155705820|NCT03664765|562016610|FG001|Overall Study|Withdrawal by Subject|1|||
155705821|NCT03664765|562016609|FG000|Overall Study|Lost to Follow-up|0|||
155705822|NCT03664765|562016610|FG001|Overall Study|Lost to Follow-up|1|||
155705823|NCT00383162|562016611|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
155705824|NCT00383162|562016612|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
155705825|NCT00383162|562016611|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
155705826|NCT00383162|562016612|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
155705827|NCT00383162|562016611|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
155705828|NCT00383162|562016612|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
155705829|NCT00383162|562016611|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
155705830|NCT00383162|562016612|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
155705831|NCT00383162|562016611|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
155705832|NCT00383162|562016612|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
155705833|NCT00383162|562016611|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
155705834|NCT00383162|562016612|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
155705835|NCT00383162|562016611|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
155705836|NCT00383162|562016612|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
155705837|NCT00383162|562016611|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
155705838|NCT00383162|562016612|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
155705839|NCT00383162|562016611|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
155705840|NCT00383162|562016612|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
155705841|NCT01496846|562016616|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
155705842|NCT01496846|562016617|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
155705843|NCT01496846|562016618|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155705844|NCT01496846|562016619|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155705845|NCT01496846|562016620|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155705846|NCT01496846|562016621|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155705847|NCT01772576|562016622|FG000|Overall Study|Death|15|||
155705848|NCT01772576|562016622|FG000|Overall Study|Protocol Violation|1|||
155705849|NCT01772576|562016622|FG000|Overall Study|Lost to Follow-up|3|||
155705850|NCT01772576|562016622|FG000|Overall Study|Study device not used|3|||
155705851|NCT01772576|562016622|FG000|Overall Study|Adverse Event|6|||
155705852|NCT01772576|562016622|FG000|Overall Study|Withdrawal by Subject|6|||
155705853|NCT00923845|562016623|FG000|Induction Therapy|Poor performance status|0|||
155705854|NCT00923845|562016624|FG001|Induction Therapy|Poor performance status|2|||
155705855|NCT02873338|562016633|FG000|Overall Study|Adverse Event|0|||
155705856|NCT02873338|562016634|FG001|Overall Study|Adverse Event|2|||
155705857|NCT02873338|562016635|FG002|Overall Study|Adverse Event|1|||
155705858|NCT02873338|562016633|FG000|Overall Study|Death|2|||
155705859|NCT02873338|562016634|FG001|Overall Study|Death|1|||
155705860|NCT02873338|562016635|FG002|Overall Study|Death|1|||
155705861|NCT02873338|562016633|FG000|Overall Study|Withdrawal by Subject|2|||
155705862|NCT02873338|562016634|FG001|Overall Study|Withdrawal by Subject|1|||
155705863|NCT02873338|562016635|FG002|Overall Study|Withdrawal by Subject|3|||
155705864|NCT02873338|562016633|FG000|Overall Study|Lack of Efficacy|0|||
155705865|NCT02873338|562016634|FG001|Overall Study|Lack of Efficacy|2|||
155705866|NCT02873338|562016635|FG002|Overall Study|Lack of Efficacy|0|||
155705867|NCT02873338|562016633|FG000|Overall Study|Other or Missing|14|||
155705868|NCT02873338|562016634|FG001|Overall Study|Other or Missing|15|||
155705869|NCT02873338|562016635|FG002|Overall Study|Other or Missing|13|||
155705870|NCT01620944|562016636|FG000|Overall Study|Early termination of Study|2|||
155705871|NCT01620944|562016637|FG001|Overall Study|Early termination of Study|1|||
155705872|NCT03170193|562016638|FG000|Overall Study|Withdrawal by Subject|0|||
155705873|NCT03170193|562016639|FG001|Overall Study|Withdrawal by Subject|0|||
155705874|NCT03170193|562016640|FG002|Overall Study|Withdrawal by Subject|0|||
155705875|NCT03170193|562016641|FG003|Overall Study|Withdrawal by Subject|1|||
155705876|NCT03170193|562016642|FG004|Overall Study|Withdrawal by Subject|0|||
155705877|NCT03170193|562016643|FG005|Overall Study|Withdrawal by Subject|0|||
155705878|NCT03170193|562016644|FG006|Overall Study|Withdrawal by Subject|0|||
155705879|NCT03170193|562016638|FG000|Overall Study|Lost to Follow-up|1|||
155705880|NCT03170193|562016639|FG001|Overall Study|Lost to Follow-up|1|||
155705881|NCT03170193|562016640|FG002|Overall Study|Lost to Follow-up|0|||
155705882|NCT03170193|562016641|FG003|Overall Study|Lost to Follow-up|0|||
155705883|NCT03170193|562016642|FG004|Overall Study|Lost to Follow-up|0|||
155705884|NCT03170193|562016643|FG005|Overall Study|Lost to Follow-up|0|||
155705885|NCT03170193|562016644|FG006|Overall Study|Lost to Follow-up|0|||
155705886|NCT00375518|562016645|FG000|Overall Study|Withdrawal by Subject|2|||
155705887|NCT00375518|562016646|FG001|Overall Study|Withdrawal by Subject|10|||
155705888|NCT00375518|562016645|FG000|Overall Study|Patient Not Treated|6|||
155705889|NCT00375518|562016646|FG001|Overall Study|Patient Not Treated|6|||
155705890|NCT00375518|562016645|FG000|Overall Study|Death|0|||
155705891|NCT00375518|562016646|FG001|Overall Study|Death|1|||
155705892|NCT03052816|562016651|FG000|Overall Study|Withdrawal by Subject|1|||
155705893|NCT03052816|562016652|FG001|Overall Study|Withdrawal by Subject|0|||
155705894|NCT03052816|562016651|FG000|Overall Study|Desired opioids|2|||
155705895|NCT03052816|562016652|FG001|Overall Study|Desired opioids|0|||
155705896|NCT03755661|562016653|FG000|Overall Study|Lost to Follow-up|1|||
155705897|NCT03755661|562016654|FG001|Overall Study|Lost to Follow-up|0|||
155705898|NCT04000581|562016655|FG000|Overall Study|Withdrawal by Subject|0|||
155705899|NCT04000581|562016656|FG001|Overall Study|Withdrawal by Subject|1|||
155705900|NCT00895453|562016657|FG000|Overall Study|Lost to Follow-up|25|||
155705901|NCT00895453|562016658|FG001|Overall Study|Lost to Follow-up|25|||
155705902|NCT00895453|562016659|FG002|Overall Study|Lost to Follow-up|23|||
155705903|NCT01748825|562016663|FG000|Dose Escalation|Refused further treatment|2|||
155705904|NCT01748825|562016664|FG001|Dose Escalation|Refused further treatment|2|||
155705905|NCT01748825|562016665|FG002|Dose Escalation|Refused further treatment|0|||
155705906|NCT01748825|562016666|FG003|Dose Escalation|Refused further treatment|0|||
155705907|NCT01748825|562016667|FG004|Dose Escalation|Refused further treatment|1|||
155705908|NCT01748825|562016668|FG005|Dose Escalation|Refused further treatment|2|||
155705909|NCT01748825|562016669|FG006|Dose Escalation|Refused further treatment|0|||
155705910|NCT01748825|562016670|FG007|Dose Escalation|Refused further treatment|0|||
155705911|NCT01748825|562016671|FG008|Dose Escalation|Refused further treatment|0|||
155705912|NCT01748825|562016672|FG009|Dose Escalation|Refused further treatment|0|||
155705913|NCT01748825|562016663|FG000|Dose Escalation|Switched to alternative treatment|0|||
155705914|NCT01748825|562016664|FG001|Dose Escalation|Switched to alternative treatment|0|||
155705915|NCT01748825|562016665|FG002|Dose Escalation|Switched to alternative treatment|0|||
155705916|NCT01748825|562016666|FG003|Dose Escalation|Switched to alternative treatment|1|||
155705917|NCT01748825|562016667|FG004|Dose Escalation|Switched to alternative treatment|0|||
155705918|NCT01748825|562016668|FG005|Dose Escalation|Switched to alternative treatment|0|||
155705919|NCT01748825|562016669|FG006|Dose Escalation|Switched to alternative treatment|0|||
155705920|NCT01748825|562016670|FG007|Dose Escalation|Switched to alternative treatment|0|||
155705921|NCT01748825|562016671|FG008|Dose Escalation|Switched to alternative treatment|0|||
155705922|NCT01748825|562016672|FG009|Dose Escalation|Switched to alternative treatment|0|||
155705923|NCT01748825|562016663|FG000|Dose Escalation|Adverse Event|0|||
155705924|NCT01748825|562016664|FG001|Dose Escalation|Adverse Event|0|||
155705925|NCT01748825|562016665|FG002|Dose Escalation|Adverse Event|0|||
155705926|NCT01748825|562016666|FG003|Dose Escalation|Adverse Event|0|||
155705927|NCT01748825|562016667|FG004|Dose Escalation|Adverse Event|0|||
155705928|NCT01748825|562016668|FG005|Dose Escalation|Adverse Event|0|||
155705929|NCT01748825|562016669|FG006|Dose Escalation|Adverse Event|1|||
155705930|NCT01748825|562016670|FG007|Dose Escalation|Adverse Event|0|||
155705931|NCT01748825|562016671|FG008|Dose Escalation|Adverse Event|0|||
155705932|NCT01748825|562016672|FG009|Dose Escalation|Adverse Event|0|||
155705933|NCT01748825|562016663|FG000|Dose Expansion|Refused further treatment|0|||
155705934|NCT01748825|562016664|FG001|Dose Expansion|Refused further treatment|0|||
155705935|NCT01748825|562016665|FG002|Dose Expansion|Refused further treatment|0|||
155705936|NCT01748825|562016666|FG003|Dose Expansion|Refused further treatment|0|||
155705937|NCT01748825|562016667|FG004|Dose Expansion|Refused further treatment|0|||
155705938|NCT01748825|562016668|FG005|Dose Expansion|Refused further treatment|0|||
155705939|NCT01748825|562016669|FG006|Dose Expansion|Refused further treatment|0|||
155705940|NCT01748825|562016670|FG007|Dose Expansion|Refused further treatment|0|||
155705941|NCT01748825|562016671|FG008|Dose Expansion|Refused further treatment|1|||
155705942|NCT01748825|562016672|FG009|Dose Expansion|Refused further treatment|1|||
155705943|NCT01748825|562016663|FG000|Dose Expansion|Switched to alternative treatment|0|||
155705944|NCT01748825|562016664|FG001|Dose Expansion|Switched to alternative treatment|0|||
155705945|NCT01748825|562016665|FG002|Dose Expansion|Switched to alternative treatment|0|||
155705946|NCT01748825|562016666|FG003|Dose Expansion|Switched to alternative treatment|0|||
155705947|NCT01748825|562016667|FG004|Dose Expansion|Switched to alternative treatment|0|||
155705948|NCT01748825|562016668|FG005|Dose Expansion|Switched to alternative treatment|0|||
155705949|NCT01748825|562016669|FG006|Dose Expansion|Switched to alternative treatment|0|||
155705950|NCT01748825|562016670|FG007|Dose Expansion|Switched to alternative treatment|0|||
155705951|NCT01748825|562016671|FG008|Dose Expansion|Switched to alternative treatment|0|||
155705952|NCT01748825|562016672|FG009|Dose Expansion|Switched to alternative treatment|1|||
155705953|NCT01748825|562016663|FG000|Dose Expansion|Adverse Event|0|||
155705954|NCT01748825|562016664|FG001|Dose Expansion|Adverse Event|0|||
155705955|NCT01748825|562016665|FG002|Dose Expansion|Adverse Event|0|||
155705956|NCT01748825|562016666|FG003|Dose Expansion|Adverse Event|0|||
155705957|NCT01748825|562016667|FG004|Dose Expansion|Adverse Event|0|||
155705958|NCT01748825|562016668|FG005|Dose Expansion|Adverse Event|0|||
155705959|NCT01748825|562016669|FG006|Dose Expansion|Adverse Event|0|||
155705960|NCT01748825|562016670|FG007|Dose Expansion|Adverse Event|0|||
155705961|NCT01748825|562016671|FG008|Dose Expansion|Adverse Event|0|||
155705962|NCT01748825|562016672|FG009|Dose Expansion|Adverse Event|3|||
155705963|NCT01748825|562016663|FG000|Dose Expansion|Physician Decision|0|||
155705964|NCT01748825|562016664|FG001|Dose Expansion|Physician Decision|0|||
155705965|NCT01748825|562016665|FG002|Dose Expansion|Physician Decision|0|||
155705966|NCT01748825|562016666|FG003|Dose Expansion|Physician Decision|0|||
155705967|NCT01748825|562016667|FG004|Dose Expansion|Physician Decision|0|||
155705968|NCT01748825|562016668|FG005|Dose Expansion|Physician Decision|0|||
155705969|NCT01748825|562016669|FG006|Dose Expansion|Physician Decision|0|||
155705970|NCT01748825|562016670|FG007|Dose Expansion|Physician Decision|0|||
155705971|NCT01748825|562016671|FG008|Dose Expansion|Physician Decision|1|||
155705972|NCT01748825|562016672|FG009|Dose Expansion|Physician Decision|0|||
155705973|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Adverse Event|33|||
155705974|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
155705975|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
155705976|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
155705977|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Physician Decision|6|||
155705978|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
155705979|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
155705980|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
155705981|NCT00965419|562016673|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
155705982|NCT00965419|562016673|FG000|Follow-up Phase|Adverse Event|9|||
155705983|NCT00965419|562016673|FG000|Follow-up Phase|Protocol Violation|4|||
155705984|NCT00965419|562016673|FG000|Follow-up Phase|Withdrawal by Subject|8|||
155705985|NCT00965419|562016673|FG000|Follow-up Phase|Physician Decision|4|||
155705986|NCT00965419|562016673|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
155705987|NCT00965419|562016673|FG000|Follow-up Phase|Lack of Efficacy|28|||
155705988|NCT01128244|562018369|FG000|Overall Study|Adverse Event|1|||
155705989|NCT01128244|562018369|FG000|Overall Study|Scheduling conflict|2|||
155705990|NCT00699608|562018376|FG000|First Intervention|Withdrawal by Subject|0|||
155705991|NCT00699608|562018377|FG001|First Intervention|Withdrawal by Subject|0|||
155705992|NCT00699608|562018378|FG002|First Intervention|Withdrawal by Subject|1|||
155705993|NCT00699608|562018379|FG003|First Intervention|Withdrawal by Subject|0|||
155705994|NCT00699608|562018380|FG004|First Intervention|Withdrawal by Subject|0|||
155705995|NCT00699608|562018381|FG005|First Intervention|Withdrawal by Subject|0|||
155705996|NCT00699608|562018376|FG000|First Intervention|Protocol Violation|0|||
155705997|NCT00699608|562018377|FG001|First Intervention|Protocol Violation|0|||
155705998|NCT00699608|562018378|FG002|First Intervention|Protocol Violation|0|||
155705999|NCT00699608|562018379|FG003|First Intervention|Protocol Violation|0|||
155706000|NCT00699608|562018380|FG004|First Intervention|Protocol Violation|1|||
155706001|NCT00699608|562018381|FG005|First Intervention|Protocol Violation|0|||
155706002|NCT00699608|562018376|FG000|Second Intervention|Adverse Event|0|||
155706003|NCT00699608|562018377|FG001|Second Intervention|Adverse Event|0|||
155706004|NCT00699608|562018378|FG002|Second Intervention|Adverse Event|1|||
155706005|NCT00699608|562018379|FG003|Second Intervention|Adverse Event|0|||
155706006|NCT00699608|562018380|FG004|Second Intervention|Adverse Event|0|||
155706007|NCT00699608|562018381|FG005|Second Intervention|Adverse Event|0|||
155706008|NCT00699608|562018376|FG000|Second Intervention|Withdrawal by Subject|0|||
155706009|NCT00699608|562018377|FG001|Second Intervention|Withdrawal by Subject|0|||
155706010|NCT00699608|562018378|FG002|Second Intervention|Withdrawal by Subject|0|||
155706011|NCT00699608|562018379|FG003|Second Intervention|Withdrawal by Subject|1|||
155706012|NCT00699608|562018380|FG004|Second Intervention|Withdrawal by Subject|0|||
155706013|NCT00699608|562018381|FG005|Second Intervention|Withdrawal by Subject|0|||
155706014|NCT01363908|562018384|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
155706015|NCT01363908|562018385|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
155706016|NCT01363908|562018384|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
155706017|NCT01363908|562018385|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
155706018|NCT01363908|562018384|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
155706019|NCT01363908|562018385|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
155706020|NCT01363908|562018384|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
155706021|NCT01363908|562018385|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
155706022|NCT05258149|562018386|FG000|Period 1|Protocol Deviation|1|||
155706023|NCT05258149|562018387|FG001|Period 1|Protocol Deviation|0|||
155706024|NCT05258149|562018386|FG000|Period 1|Adverse Event|0|||
155706025|NCT05258149|562018387|FG001|Period 1|Adverse Event|1|||
155706026|NCT05258149|562018386|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
155706027|NCT05258149|562018387|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155706028|NCT05258149|562018386|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
155706029|NCT05258149|562018387|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
155706030|NCT05258149|562018386|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
155706031|NCT05258149|562018387|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
155706032|NCT01442714|562018388|FG000|Overall Study|Death|11|||
155706033|NCT01442714|562018388|FG000|Overall Study|Withdrawal by Subject|1|||
155706034|NCT00394706|562018391|FG000|Overall Study|Withdrawal by Subject|2|||
155706035|NCT00394706|562018392|FG001|Overall Study|Withdrawal by Subject|0|||
155706036|NCT00394706|562018393|FG002|Overall Study|Withdrawal by Subject|1|||
155706037|NCT00394706|562018394|FG003|Overall Study|Withdrawal by Subject|0|||
155706038|NCT00394706|562018395|FG004|Overall Study|Withdrawal by Subject|0|||
155706039|NCT00394706|562018396|FG005|Overall Study|Withdrawal by Subject|2|||
155706040|NCT00394706|562018397|FG006|Overall Study|Withdrawal by Subject|1|||
155706041|NCT00394706|562018398|FG007|Overall Study|Withdrawal by Subject|0|||
155706042|NCT00394706|562018391|FG000|Overall Study|Lost to Follow-up|2|||
155706043|NCT00394706|562018392|FG001|Overall Study|Lost to Follow-up|2|||
155706044|NCT00394706|562018393|FG002|Overall Study|Lost to Follow-up|8|||
155706045|NCT00394706|562018394|FG003|Overall Study|Lost to Follow-up|1|||
155706046|NCT00394706|562018395|FG004|Overall Study|Lost to Follow-up|2|||
155706047|NCT00394706|562018396|FG005|Overall Study|Lost to Follow-up|5|||
155706048|NCT00394706|562018397|FG006|Overall Study|Lost to Follow-up|2|||
155706049|NCT00394706|562018398|FG007|Overall Study|Lost to Follow-up|0|||
155706050|NCT02003534|562018403|FG000|Overall Study|Lost to Follow-up|47|||
155706051|NCT03920254|562018404|FG000|Overall Study|Adverse Event|1|||
155706052|NCT03920254|562018405|FG001|Overall Study|Adverse Event|0|||
155706053|NCT03920254|562018406|FG002|Overall Study|Adverse Event|0|||
155706054|NCT03920254|562018404|FG000|Overall Study|Physician Decision|0|||
155706055|NCT03920254|562018405|FG001|Overall Study|Physician Decision|1|||
155706056|NCT03920254|562018406|FG002|Overall Study|Physician Decision|2|||
155706057|NCT03920254|562018404|FG000|Overall Study|Study Terminated By Sponsor|12|||
155706058|NCT03920254|562018405|FG001|Overall Study|Study Terminated By Sponsor|17|||
155706059|NCT03920254|562018406|FG002|Overall Study|Study Terminated By Sponsor|12|||
155706060|NCT03920254|562018404|FG000|Overall Study|Withdrawal by Subject|0|||
155706061|NCT03920254|562018405|FG001|Overall Study|Withdrawal by Subject|0|||
155706062|NCT03920254|562018406|FG002|Overall Study|Withdrawal by Subject|1|||
155706063|NCT03040674|562018407|FG000|Overall Study|Lost to Follow-up|225|||
155706064|NCT03040674|562018407|FG000|Overall Study|Death|23|||
155706065|NCT01934010|562018408|FG000|Overall Study|Adverse Event|1|||
155706066|NCT01934010|562018409|FG001|Overall Study|Adverse Event|1|||
155706067|NCT01934010|562018410|FG002|Overall Study|Adverse Event|0|||
155706068|NCT01934010|562018408|FG000|Overall Study|Withdrawal by Subject|15|||
155706069|NCT01934010|562018409|FG001|Overall Study|Withdrawal by Subject|6|||
155706070|NCT01934010|562018410|FG002|Overall Study|Withdrawal by Subject|2|||
155706071|NCT01934010|562018408|FG000|Overall Study|Lost to Follow-up|7|||
155706072|NCT01934010|562018409|FG001|Overall Study|Lost to Follow-up|4|||
155706073|NCT01934010|562018410|FG002|Overall Study|Lost to Follow-up|0|||
155706074|NCT04112303|562018411|FG000|Overall Study|Death|1|||
155706075|NCT02506192|562018412|FG000|Overall Study|Withdrawal by Subject|1|||
155706076|NCT02506192|562018413|FG001|Overall Study|Withdrawal by Subject|1|||
155706077|NCT00709618|562018414|FG000|Overall Study|Withdrawal by Subject|4|||
155706078|NCT00709618|562018414|FG000|Overall Study|Lost to Follow-up|1|||
155706079|NCT00709618|562018414|FG000|Overall Study|Study Closed/Terminated|25|||
155706080|NCT02703324|562018415|FG000|Period Two|Withdrawal by Subject|0|||
155706081|NCT02703324|562018416|FG001|Period Two|Withdrawal by Subject|0|||
155706082|NCT02703324|562018417|FG002|Period Two|Withdrawal by Subject|1|||
155706083|NCT02703324|562018418|FG003|Period Two|Withdrawal by Subject|0|||
155706084|NCT02703324|562018419|FG004|Period Two|Withdrawal by Subject|0|||
155706085|NCT02703324|562018420|FG005|Period Two|Withdrawal by Subject|0|||
155706086|NCT04042909|562018422|FG000|Overall Study|Withdrawal by Subject|1|||
155706087|NCT04042909|562018423|FG001|Overall Study|Withdrawal by Subject|0|||
155706088|NCT04042909|562018424|FG002|Overall Study|Withdrawal by Subject|0|||
155706089|NCT04042909|562018422|FG000|Overall Study|duplicate cases|2|||
155706090|NCT04042909|562018423|FG001|Overall Study|duplicate cases|0|||
155706091|NCT04042909|562018424|FG002|Overall Study|duplicate cases|0|||
155706092|NCT04042909|562018422|FG000|Overall Study|technical problem|0|||
155706093|NCT04042909|562018423|FG001|Overall Study|technical problem|1|||
155706094|NCT04042909|562018424|FG002|Overall Study|technical problem|0|||
155706095|NCT04303572|562018425|FG000|Overall Study|Study closed due to poor enrollment|1|||
155706096|NCT06312592|562018426|FG000|Overall Study|Lost to Follow-up|29|||
155706097|NCT06312592|562018427|FG001|Overall Study|Lost to Follow-up|13|||
155706098|NCT03785405|562018430|FG000|Overall Study|Adverse Event|16|||
155706099|NCT03785405|562018431|FG001|Overall Study|Adverse Event|1|||
155706100|NCT03785405|562018430|FG000|Overall Study|Death|6|||
155706101|NCT03785405|562018431|FG001|Overall Study|Death|4|||
155706102|NCT03785405|562018430|FG000|Overall Study|Guardian decision|4|||
155706103|NCT03785405|562018431|FG001|Overall Study|Guardian decision|1|||
155706104|NCT03785405|562018430|FG000|Overall Study|Lost to Follow-up|1|||
155706105|NCT03785405|562018431|FG001|Overall Study|Lost to Follow-up|0|||
155706106|NCT03785405|562018430|FG000|Overall Study|Physician Decision|8|||
155706107|NCT03785405|562018431|FG001|Overall Study|Physician Decision|5|||
155706108|NCT03785405|562018430|FG000|Overall Study|Participant decision|2|||
155706109|NCT03785405|562018431|FG001|Overall Study|Participant decision|0|||
155706110|NCT03785405|562018430|FG000|Overall Study|Other|1|||
155706111|NCT03785405|562018431|FG001|Overall Study|Other|0|||
155706112|NCT03785405|562018430|FG000|Overall Study|No treatment was received|0|||
155706113|NCT03785405|562018431|FG001|Overall Study|No treatment was received|1|||
155706114|NCT03705559|562018432|FG000|Overall Study|COVID Shut down|1|||
155706115|NCT01858766|562018433|FG000|Overall Study|Randomized but Never Treated|0|||
155706116|NCT01858766|562018434|FG001|Overall Study|Randomized but Never Treated|0|||
155706117|NCT01858766|562018435|FG002|Overall Study|Randomized but Never Treated|0|||
155706118|NCT01858766|562018436|FG003|Overall Study|Randomized but Never Treated|0|||
155706119|NCT01858766|562018437|FG004|Overall Study|Randomized but Never Treated|0|||
155706120|NCT01858766|562018438|FG005|Overall Study|Randomized but Never Treated|1|||
155706121|NCT01858766|562018439|FG006|Overall Study|Randomized but Never Treated|0|||
155706122|NCT01858766|562018440|FG007|Overall Study|Randomized but Never Treated|0|||
155706123|NCT01858766|562018441|FG008|Overall Study|Randomized but Never Treated|0|||
155706124|NCT01858766|562018442|FG009|Overall Study|Randomized but Never Treated|0|||
155706125|NCT01858766|562018443|FG010|Overall Study|Randomized but Never Treated|0|||
155706126|NCT01858766|562018444|FG011|Overall Study|Randomized but Never Treated|0|||
155706127|NCT01858766|562018445|FG012|Overall Study|Randomized but Never Treated|0|||
155706128|NCT01858766|562018446|FG013|Overall Study|Randomized but Never Treated|0|||
155706129|NCT01858766|562018447|FG014|Overall Study|Randomized but Never Treated|0|||
155706130|NCT01858766|562018448|FG015|Overall Study|Randomized but Never Treated|0|||
155706131|NCT01858766|562018449|FG016|Overall Study|Randomized but Never Treated|0|||
155706132|NCT01858766|562018450|FG017|Overall Study|Randomized but Never Treated|1|||
155706133|NCT01858766|562018451|FG018|Overall Study|Randomized but Never Treated|0|||
155706134|NCT01858766|562018433|FG000|Overall Study|Death|0|||
155706135|NCT01858766|562018434|FG001|Overall Study|Death|0|||
155706136|NCT01858766|562018435|FG002|Overall Study|Death|1|||
155706137|NCT01858766|562018436|FG003|Overall Study|Death|0|||
155706138|NCT01858766|562018437|FG004|Overall Study|Death|0|||
155706139|NCT01858766|562018438|FG005|Overall Study|Death|0|||
155706140|NCT01858766|562018439|FG006|Overall Study|Death|0|||
155706141|NCT01858766|562018440|FG007|Overall Study|Death|0|||
155706142|NCT01858766|562018441|FG008|Overall Study|Death|0|||
155706143|NCT01858766|562018442|FG009|Overall Study|Death|0|||
155706144|NCT01858766|562018443|FG010|Overall Study|Death|0|||
155706145|NCT01858766|562018444|FG011|Overall Study|Death|0|||
155706146|NCT01858766|562018445|FG012|Overall Study|Death|0|||
155706147|NCT01858766|562018446|FG013|Overall Study|Death|0|||
155706148|NCT01858766|562018447|FG014|Overall Study|Death|0|||
155706149|NCT01858766|562018448|FG015|Overall Study|Death|0|||
155706150|NCT01858766|562018449|FG016|Overall Study|Death|0|||
155706151|NCT01858766|562018450|FG017|Overall Study|Death|0|||
155706152|NCT01858766|562018451|FG018|Overall Study|Death|0|||
155706153|NCT01858766|562018433|FG000|Overall Study|Lack of Efficacy|1|||
155706154|NCT01858766|562018434|FG001|Overall Study|Lack of Efficacy|0|||
155706155|NCT01858766|562018435|FG002|Overall Study|Lack of Efficacy|0|||
155706156|NCT01858766|562018436|FG003|Overall Study|Lack of Efficacy|0|||
155706157|NCT01858766|562018437|FG004|Overall Study|Lack of Efficacy|1|||
155706158|NCT01858766|562018438|FG005|Overall Study|Lack of Efficacy|2|||
155706159|NCT01858766|562018439|FG006|Overall Study|Lack of Efficacy|0|||
155706160|NCT01858766|562018440|FG007|Overall Study|Lack of Efficacy|0|||
155706161|NCT01858766|562018441|FG008|Overall Study|Lack of Efficacy|0|||
155706162|NCT01858766|562018442|FG009|Overall Study|Lack of Efficacy|0|||
155706163|NCT01858766|562018443|FG010|Overall Study|Lack of Efficacy|0|||
155706164|NCT01858766|562018444|FG011|Overall Study|Lack of Efficacy|3|||
155706165|NCT01858766|562018445|FG012|Overall Study|Lack of Efficacy|5|||
155706166|NCT01858766|562018446|FG013|Overall Study|Lack of Efficacy|3|||
155706167|NCT01858766|562018447|FG014|Overall Study|Lack of Efficacy|5|||
155706168|NCT01858766|562018448|FG015|Overall Study|Lack of Efficacy|5|||
155706169|NCT01858766|562018449|FG016|Overall Study|Lack of Efficacy|2|||
155706170|NCT01858766|562018450|FG017|Overall Study|Lack of Efficacy|3|||
155706171|NCT01858766|562018451|FG018|Overall Study|Lack of Efficacy|3|||
155706172|NCT01858766|562018433|FG000|Overall Study|Lost to Follow-up|0|||
155706173|NCT01858766|562018434|FG001|Overall Study|Lost to Follow-up|0|||
155706174|NCT01858766|562018435|FG002|Overall Study|Lost to Follow-up|0|||
155706175|NCT01858766|562018436|FG003|Overall Study|Lost to Follow-up|0|||
155706176|NCT01858766|562018437|FG004|Overall Study|Lost to Follow-up|0|||
155706177|NCT01858766|562018438|FG005|Overall Study|Lost to Follow-up|1|||
155706178|NCT01858766|562018439|FG006|Overall Study|Lost to Follow-up|0|||
155706179|NCT01858766|562018440|FG007|Overall Study|Lost to Follow-up|2|||
155706180|NCT01858766|562018441|FG008|Overall Study|Lost to Follow-up|0|||
155706181|NCT01858766|562018442|FG009|Overall Study|Lost to Follow-up|0|||
155706182|NCT01858766|562018443|FG010|Overall Study|Lost to Follow-up|0|||
155706183|NCT01858766|562018444|FG011|Overall Study|Lost to Follow-up|1|||
155706184|NCT01858766|562018445|FG012|Overall Study|Lost to Follow-up|0|||
155706185|NCT01858766|562018446|FG013|Overall Study|Lost to Follow-up|0|||
155706186|NCT01858766|562018447|FG014|Overall Study|Lost to Follow-up|3|||
155706187|NCT01858766|562018448|FG015|Overall Study|Lost to Follow-up|1|||
155706188|NCT01858766|562018449|FG016|Overall Study|Lost to Follow-up|1|||
155706189|NCT01858766|562018450|FG017|Overall Study|Lost to Follow-up|0|||
155706190|NCT01858766|562018451|FG018|Overall Study|Lost to Follow-up|1|||
155706191|NCT01858766|562018433|FG000|Overall Study|Withdrew Consent|0|||
155706192|NCT01858766|562018434|FG001|Overall Study|Withdrew Consent|0|||
155706193|NCT01858766|562018435|FG002|Overall Study|Withdrew Consent|0|||
155706194|NCT01858766|562018436|FG003|Overall Study|Withdrew Consent|0|||
155706195|NCT01858766|562018437|FG004|Overall Study|Withdrew Consent|0|||
155706196|NCT01858766|562018438|FG005|Overall Study|Withdrew Consent|0|||
155706197|NCT01858766|562018439|FG006|Overall Study|Withdrew Consent|0|||
155706198|NCT01858766|562018440|FG007|Overall Study|Withdrew Consent|0|||
155706199|NCT01858766|562018441|FG008|Overall Study|Withdrew Consent|0|||
155706200|NCT01858766|562018442|FG009|Overall Study|Withdrew Consent|0|||
155706201|NCT01858766|562018443|FG010|Overall Study|Withdrew Consent|0|||
155706202|NCT01858766|562018444|FG011|Overall Study|Withdrew Consent|1|||
155706203|NCT01858766|562018445|FG012|Overall Study|Withdrew Consent|0|||
155706204|NCT01858766|562018446|FG013|Overall Study|Withdrew Consent|0|||
155706205|NCT01858766|562018447|FG014|Overall Study|Withdrew Consent|0|||
155706206|NCT01858766|562018448|FG015|Overall Study|Withdrew Consent|0|||
155706207|NCT01858766|562018449|FG016|Overall Study|Withdrew Consent|0|||
155706208|NCT01858766|562018450|FG017|Overall Study|Withdrew Consent|0|||
155706209|NCT01858766|562018451|FG018|Overall Study|Withdrew Consent|0|||
155706210|NCT03517228|562018452|FG000|Overall Study|Withdrawal by Subject|2|||
155706211|NCT03517228|562018452|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
155706212|NCT03517228|562018452|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
155706213|NCT03517228|562018452|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
155706214|NCT03517228|562018452|FG000|Overall Study|Canceled due to device being updated|1|||
155706215|NCT03517228|562018452|FG000|Overall Study|No V Cares in stock|1|||
155706216|NCT03517228|562018452|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
155706217|NCT01979952|562018462|FG000|Overall Study|Adverse Event|4|||
155706218|NCT01979952|562018463|FG001|Overall Study|Adverse Event|5|||
155706219|NCT01979952|562018462|FG000|Overall Study|Protocol Violation|1|||
155706220|NCT01979952|562018463|FG001|Overall Study|Protocol Violation|0|||
155706221|NCT01979952|562018462|FG000|Overall Study|Withdrawal by Subject|2|||
155706222|NCT01979952|562018463|FG001|Overall Study|Withdrawal by Subject|1|||
155706223|NCT01979952|562018462|FG000|Overall Study|Other than specified above|1|||
155706224|NCT01979952|562018463|FG001|Overall Study|Other than specified above|0|||
155706225|NCT03781414|562018464|FG000|Overall Study|Study terminated by sponsor|39|||
155706226|NCT03781414|562018465|FG001|Overall Study|Study terminated by sponsor|34|||
155706227|NCT03781414|562018466|FG002|Overall Study|Study terminated by sponsor|25|||
155706228|NCT03781414|562018464|FG000|Overall Study|Adverse Event|3|||
155706229|NCT03781414|562018465|FG001|Overall Study|Adverse Event|6|||
155706230|NCT03781414|562018466|FG002|Overall Study|Adverse Event|3|||
155706231|NCT03781414|562018464|FG000|Overall Study|Physician Decision|2|||
155706232|NCT03781414|562018465|FG001|Overall Study|Physician Decision|0|||
155706233|NCT03781414|562018466|FG002|Overall Study|Physician Decision|1|||
155706234|NCT03781414|562018464|FG000|Overall Study|Withdrawal by Subject|2|||
155706235|NCT03781414|562018465|FG001|Overall Study|Withdrawal by Subject|3|||
155706236|NCT03781414|562018466|FG002|Overall Study|Withdrawal by Subject|3|||
155706237|NCT03781414|562018464|FG000|Overall Study|Death|1|||
155706238|NCT03781414|562018465|FG001|Overall Study|Death|4|||
155706239|NCT03781414|562018466|FG002|Overall Study|Death|0|||
155706240|NCT03781414|562018464|FG000|Overall Study|Lost to Follow-up|1|||
155706241|NCT03781414|562018465|FG001|Overall Study|Lost to Follow-up|1|||
155706242|NCT03781414|562018466|FG002|Overall Study|Lost to Follow-up|0|||
155706243|NCT00245037|562018469|FG000|Overall Study|Death|17|||
155706244|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
155706245|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155706246|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155706247|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155706248|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155706249|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155706250|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
155706251|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155706252|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155706253|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155706254|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155706255|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155706256|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
155706257|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155706258|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155706259|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155706260|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155706261|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155706262|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
155706263|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
155706264|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
155706265|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
155706266|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
155706267|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
155706268|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
155706269|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
155706270|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
155706271|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
155706272|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
155706273|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
155706274|NCT01053988|562018471|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
155706275|NCT01053988|562018472|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155706276|NCT01053988|562018473|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155706277|NCT01053988|562018474|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155706278|NCT01053988|562018475|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155706279|NCT01053988|562018476|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155706280|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155706281|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
155706282|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
155706283|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
155706284|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
155706285|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
155706286|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155706287|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155706288|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
155706289|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
155706290|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155706291|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155706292|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155706293|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
155706294|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
155706295|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
155706296|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
155706297|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
155706298|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155706299|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155706300|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155706301|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155706302|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
155706303|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155706304|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155706305|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
155706306|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
155706307|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
155706308|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
155706309|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
155706310|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155706311|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
155706312|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155706313|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155706314|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155706315|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
155706316|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155706317|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
155706318|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
155706319|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
155706320|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
155706321|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
155706322|NCT01053988|562018471|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155706323|NCT01053988|562018472|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
155706324|NCT01053988|562018473|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155706325|NCT01053988|562018474|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
155706326|NCT01053988|562018475|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
155706327|NCT01053988|562018476|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155706328|NCT01922271|562018477|FG000|WASHOUT Period|Withdrawal by Subject|1|||
155706329|NCT01922271|562018478|FG001|WASHOUT Period|Withdrawal by Subject|0|||
155706330|NCT00719355|562018479|FG000|Overall Study|Death|0|||
155706331|NCT00719355|562018480|FG001|Overall Study|Death|1|||
155706332|NCT00719355|562018479|FG000|Overall Study|Medical|14|||
155706333|NCT00719355|562018480|FG001|Overall Study|Medical|5|||
155706334|NCT00719355|562018479|FG000|Overall Study|Compliance|4|||
155706335|NCT00719355|562018480|FG001|Overall Study|Compliance|6|||
155706336|NCT00719355|562018479|FG000|Overall Study|Moved|0|||
155706337|NCT00719355|562018480|FG001|Overall Study|Moved|1|||
155706338|NCT03724890|562018481|FG000|Overall Study|Death|2|||
155706339|NCT03724890|562018482|FG001|Overall Study|Death|6|||
155706340|NCT03724890|562018483|FG002|Overall Study|Death|3|||
155706341|NCT03724890|562018484|FG003|Overall Study|Death|5|||
155706342|NCT03724890|562018485|FG004|Overall Study|Death|2|||
155706343|NCT03724890|562018486|FG005|Overall Study|Death|0|||
155706344|NCT03724890|562018487|FG006|Overall Study|Death|2|||
155706345|NCT03724890|562018488|FG007|Overall Study|Death|3|||
155706346|NCT03724890|562018489|FG008|Overall Study|Death|4|||
155706347|NCT03724890|562018490|FG009|Overall Study|Death|2|||
155706348|NCT03724890|562018491|FG010|Overall Study|Death|2|||
155706349|NCT03724890|562018481|FG000|Overall Study|Lost to Follow-up|0|||
155706350|NCT03724890|562018482|FG001|Overall Study|Lost to Follow-up|3|||
155706351|NCT03724890|562018483|FG002|Overall Study|Lost to Follow-up|0|||
155706352|NCT03724890|562018484|FG003|Overall Study|Lost to Follow-up|1|||
155706353|NCT03724890|562018485|FG004|Overall Study|Lost to Follow-up|2|||
155706354|NCT03724890|562018486|FG005|Overall Study|Lost to Follow-up|2|||
155706355|NCT03724890|562018487|FG006|Overall Study|Lost to Follow-up|1|||
155706356|NCT03724890|562018488|FG007|Overall Study|Lost to Follow-up|0|||
155706357|NCT03724890|562018489|FG008|Overall Study|Lost to Follow-up|2|||
155706358|NCT03724890|562018490|FG009|Overall Study|Lost to Follow-up|0|||
155706359|NCT03724890|562018491|FG010|Overall Study|Lost to Follow-up|0|||
155706360|NCT03724890|562018481|FG000|Overall Study|Withdrawal by Subject|1|||
155706361|NCT03724890|562018482|FG001|Overall Study|Withdrawal by Subject|2|||
155706362|NCT03724890|562018483|FG002|Overall Study|Withdrawal by Subject|1|||
155706363|NCT03724890|562018484|FG003|Overall Study|Withdrawal by Subject|0|||
155706364|NCT03724890|562018485|FG004|Overall Study|Withdrawal by Subject|0|||
155706365|NCT03724890|562018486|FG005|Overall Study|Withdrawal by Subject|1|||
155706366|NCT03724890|562018487|FG006|Overall Study|Withdrawal by Subject|0|||
155706367|NCT03724890|562018488|FG007|Overall Study|Withdrawal by Subject|0|||
155706368|NCT03724890|562018489|FG008|Overall Study|Withdrawal by Subject|2|||
155706369|NCT03724890|562018490|FG009|Overall Study|Withdrawal by Subject|2|||
155706370|NCT03724890|562018491|FG010|Overall Study|Withdrawal by Subject|1|||
155706371|NCT03724890|562018481|FG000|Overall Study|Other|1|||
155706372|NCT03724890|562018482|FG001|Overall Study|Other|0|||
155706373|NCT03724890|562018483|FG002|Overall Study|Other|0|||
155706374|NCT03724890|562018484|FG003|Overall Study|Other|0|||
155706375|NCT03724890|562018485|FG004|Overall Study|Other|0|||
155706376|NCT03724890|562018486|FG005|Overall Study|Other|0|||
155706377|NCT03724890|562018487|FG006|Overall Study|Other|0|||
155706378|NCT03724890|562018488|FG007|Overall Study|Other|1|||
155706379|NCT03724890|562018489|FG008|Overall Study|Other|1|||
155706380|NCT03724890|562018490|FG009|Overall Study|Other|0|||
155706381|NCT03724890|562018491|FG010|Overall Study|Other|2|||
155706382|NCT01844778|562018495|FG000|Overall Study|Protocol deviation|0|||
155706383|NCT01844778|562018496|FG001|Overall Study|Protocol deviation|1|||
155706384|NCT01844778|562018497|FG002|Overall Study|Protocol deviation|2|||
155706385|NCT01844778|562018495|FG000|Overall Study|Withdrawal by Subject|2|||
155706386|NCT01844778|562018496|FG001|Overall Study|Withdrawal by Subject|0|||
155706387|NCT01844778|562018497|FG002|Overall Study|Withdrawal by Subject|0|||
155706388|NCT01844778|562018495|FG000|Overall Study|Adverse Event|0|||
155706389|NCT01844778|562018496|FG001|Overall Study|Adverse Event|2|||
155706390|NCT01844778|562018497|FG002|Overall Study|Adverse Event|2|||
155706391|NCT02161757|562018500|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
155706392|NCT02161757|562018501|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
155706393|NCT02161757|562018502|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
155706394|NCT02161757|562018500|FG000|Treatment Through Study Completion|Adverse Event|1|||
155706395|NCT02161757|562018501|FG001|Treatment Through Study Completion|Adverse Event|1|||
155706396|NCT02161757|562018502|FG002|Treatment Through Study Completion|Adverse Event|0|||
155706397|NCT02161757|562018500|FG000|Treatment Through Study Completion|Protocol Violation|0|||
155706398|NCT02161757|562018501|FG001|Treatment Through Study Completion|Protocol Violation|1|||
155706399|NCT02161757|562018502|FG002|Treatment Through Study Completion|Protocol Violation|2|||
155706400|NCT02161757|562018500|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
155706401|NCT02161757|562018501|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
155706402|NCT02161757|562018502|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
155706403|NCT02161757|562018500|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
155706404|NCT02161757|562018501|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
155706405|NCT02161757|562018502|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
155706406|NCT02161757|562018500|FG000|Treatment Through Study Completion|Other|20|||
155706407|NCT02161757|562018501|FG001|Treatment Through Study Completion|Other|19|||
155706408|NCT02161757|562018502|FG002|Treatment Through Study Completion|Other|12|||
155706409|NCT02161757|562018500|FG000|Treatment Through Study Completion|Death|2|||
155706410|NCT02161757|562018501|FG001|Treatment Through Study Completion|Death|1|||
155706411|NCT02161757|562018502|FG002|Treatment Through Study Completion|Death|1|||
155706412|NCT00391625|562018503|FG000|Month 14|Withdrawal by Subject|1|||
155706413|NCT00391625|562018503|FG000|Month 50|Physician Decision|1|||
155706414|NCT02106403|562018510|FG000|Follow-Up Visit 3|Other Reason|0|||
155706415|NCT02106403|562018511|FG001|Follow-Up Visit 3|Other Reason|0|||
155706416|NCT02106403|562018512|FG002|Follow-Up Visit 3|Other Reason|0|||
155706417|NCT02106403|562018513|FG003|Follow-Up Visit 3|Other Reason|0|||
155706418|NCT02106403|562018514|FG004|Follow-Up Visit 3|Other Reason|0|||
155706419|NCT02106403|562018515|FG005|Follow-Up Visit 3|Other Reason|1|||
155706420|NCT00379912|562018519|FG000|Overall Study|Lack of Efficacy|1|||
155706421|NCT00379912|562018520|FG001|Overall Study|Lack of Efficacy|0|||
155706422|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
155706423|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
155706424|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
155706425|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706426|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706427|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706428|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706429|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706430|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
155706431|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Physician Decision|1|||
155706432|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Physician Decision|2|||
155706433|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Physician Decision|0|||
155706434|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Physician Decision|0|||
155706435|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Physician Decision|0|||
155706436|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Physician Decision|0|||
155706437|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Physician Decision|0|||
155706438|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Physician Decision|0|||
155706439|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Physician Decision|0|||
155706440|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
155706441|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
155706442|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
155706443|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
155706444|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
155706445|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
155706446|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
155706447|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
155706448|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
155706449|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
155706450|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706451|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706452|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706453|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706454|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706455|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706456|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706457|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155706458|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
155706459|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
155706460|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706461|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706462|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706463|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706464|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706465|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706466|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155706467|NCT04405076|562018521|FG000|Part A (Blinded Phase)|Other than Specified|0|||
155706468|NCT04405076|562018522|FG001|Part A (Blinded Phase)|Other than Specified|0|||
155706469|NCT04405076|562018523|FG002|Part A (Blinded Phase)|Other than Specified|3|||
155706470|NCT04405076|562018524|FG003|Part A (Blinded Phase)|Other than Specified|0|||
155706471|NCT04405076|562018525|FG004|Part A (Blinded Phase)|Other than Specified|0|||
155706472|NCT04405076|562018526|FG005|Part A (Blinded Phase)|Other than Specified|0|||
155706473|NCT04405076|562018527|FG006|Part A (Blinded Phase)|Other than Specified|0|||
155706474|NCT04405076|562018528|FG007|Part A (Blinded Phase)|Other than Specified|0|||
155706475|NCT04405076|562018529|FG008|Part A (Blinded Phase)|Other than Specified|0|||
155706476|NCT04405076|562018521|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706477|NCT04405076|562018522|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706478|NCT04405076|562018523|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706479|NCT04405076|562018524|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
155706480|NCT04405076|562018525|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
155706481|NCT04405076|562018526|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
155706482|NCT04405076|562018527|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706483|NCT04405076|562018528|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706484|NCT04405076|562018529|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155706485|NCT04405076|562018521|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706486|NCT04405076|562018522|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706487|NCT04405076|562018523|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706488|NCT04405076|562018524|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706489|NCT04405076|562018525|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
155706490|NCT04405076|562018526|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706491|NCT04405076|562018527|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706492|NCT04405076|562018528|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706493|NCT04405076|562018529|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155706494|NCT04405076|562018521|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706495|NCT04405076|562018522|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706496|NCT04405076|562018523|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706497|NCT04405076|562018524|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
155706498|NCT04405076|562018525|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
155706499|NCT04405076|562018526|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
155706500|NCT04405076|562018527|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706501|NCT04405076|562018528|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706502|NCT04405076|562018529|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155706503|NCT04405076|562018521|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706504|NCT04405076|562018522|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706505|NCT04405076|562018523|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706506|NCT04405076|562018524|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706507|NCT04405076|562018525|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706508|NCT04405076|562018526|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706509|NCT04405076|562018527|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155706510|NCT04405076|562018528|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
155706511|NCT04405076|562018529|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
155706512|NCT04405076|562018521|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706513|NCT04405076|562018522|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706514|NCT04405076|562018523|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706515|NCT04405076|562018524|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706516|NCT04405076|562018525|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706517|NCT04405076|562018526|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706518|NCT04405076|562018527|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
155706519|NCT04405076|562018528|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706520|NCT04405076|562018529|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155706521|NCT04310566|562018530|FG000|Period 1|Study Termination due to COVID-19|15|||
155706522|NCT04310566|562018531|FG001|Period 1|Study Termination due to COVID-19|17|||
155706523|NCT04310566|562018530|FG000|Period 1|Protocol Violation|0|||
155706524|NCT04310566|562018531|FG001|Period 1|Protocol Violation|1|||
155706525|NCT04310566|562018530|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
155706526|NCT04310566|562018531|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
155706527|NCT04310566|562018530|FG000|Period 1|Lost to Follow-up|1|||
155706528|NCT04310566|562018531|FG001|Period 1|Lost to Follow-up|0|||
155706529|NCT04310566|562018530|FG000|Period 1|Withdrawal by Subject|0|||
155706530|NCT04310566|562018531|FG001|Period 1|Withdrawal by Subject|1|||
155706531|NCT04310566|562018530|FG000|Period 2|Study Termination|7|||
155706532|NCT04310566|562018531|FG001|Period 2|Study Termination|5|||
155706533|NCT02560012|562018539|FG000|Overall Study|Study Terminated|2|||
155706534|NCT02218008|562018540|FG000|Stage 1 (S1)|Adverse Event|6|||
155706535|NCT02218008|562018541|FG001|Stage 1 (S1)|Adverse Event|5|||
155706536|NCT02218008|562018542|FG002|Stage 1 (S1)|Adverse Event|11|||
155706537|NCT02218008|562018543|FG003|Stage 1 (S1)|Adverse Event|0|||
155706538|NCT02218008|562018544|FG004|Stage 1 (S1)|Adverse Event|0|||
155706539|NCT02218008|562018545|FG005|Stage 1 (S1)|Adverse Event|0|||
155706540|NCT02218008|562018540|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
155706541|NCT02218008|562018541|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
155706542|NCT02218008|562018542|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
155706543|NCT02218008|562018543|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
155706544|NCT02218008|562018544|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
155706545|NCT02218008|562018545|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
155706546|NCT02218008|562018540|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
155706547|NCT02218008|562018541|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
155706548|NCT02218008|562018542|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
155706549|NCT02218008|562018543|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
155706550|NCT02218008|562018544|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
155706551|NCT02218008|562018545|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
155706552|NCT02218008|562018540|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
155706553|NCT02218008|562018541|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
155706554|NCT02218008|562018542|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
155706555|NCT02218008|562018543|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
155706556|NCT02218008|562018544|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
155706557|NCT02218008|562018545|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
155706558|NCT02218008|562018540|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
155706559|NCT02218008|562018541|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
155706560|NCT02218008|562018542|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155706561|NCT02218008|562018543|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155706562|NCT02218008|562018544|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155706563|NCT02218008|562018545|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155706564|NCT02218008|562018540|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
155706565|NCT02218008|562018541|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
155706566|NCT02218008|562018542|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
155706567|NCT02218008|562018543|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
155706568|NCT02218008|562018544|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
155706569|NCT02218008|562018545|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
155706570|NCT02218008|562018540|FG000|Stage 1 (S1)|Pregnancy|0|||
155706571|NCT02218008|562018541|FG001|Stage 1 (S1)|Pregnancy|0|||
155706572|NCT02218008|562018542|FG002|Stage 1 (S1)|Pregnancy|1|||
155706573|NCT02218008|562018543|FG003|Stage 1 (S1)|Pregnancy|0|||
155706574|NCT02218008|562018544|FG004|Stage 1 (S1)|Pregnancy|0|||
155706575|NCT02218008|562018545|FG005|Stage 1 (S1)|Pregnancy|0|||
155706576|NCT02218008|562018540|FG000|Stage 1 (S1)|Protocol Violation|0|||
155706577|NCT02218008|562018541|FG001|Stage 1 (S1)|Protocol Violation|0|||
155706578|NCT02218008|562018542|FG002|Stage 1 (S1)|Protocol Violation|1|||
155706579|NCT02218008|562018543|FG003|Stage 1 (S1)|Protocol Violation|0|||
155706580|NCT02218008|562018544|FG004|Stage 1 (S1)|Protocol Violation|0|||
155706581|NCT02218008|562018545|FG005|Stage 1 (S1)|Protocol Violation|0|||
155706582|NCT02218008|562018540|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
155706583|NCT02218008|562018541|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155706584|NCT02218008|562018542|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155706585|NCT02218008|562018543|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155706586|NCT02218008|562018544|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155706587|NCT02218008|562018545|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155706588|NCT02218008|562018540|FG000|Stage 2 (S2)|Adverse Event|0|||
155706589|NCT02218008|562018541|FG001|Stage 2 (S2)|Adverse Event|0|||
155706590|NCT02218008|562018542|FG002|Stage 2 (S2)|Adverse Event|0|||
155706591|NCT02218008|562018543|FG003|Stage 2 (S2)|Adverse Event|2|||
155706592|NCT02218008|562018544|FG004|Stage 2 (S2)|Adverse Event|3|||
155706593|NCT02218008|562018545|FG005|Stage 2 (S2)|Adverse Event|3|||
155706594|NCT02218008|562018540|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
155706595|NCT02218008|562018541|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
155706596|NCT02218008|562018542|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
155706597|NCT02218008|562018543|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
155706598|NCT02218008|562018544|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
155706599|NCT02218008|562018545|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
155706600|NCT02218008|562018540|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
155706601|NCT02218008|562018541|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
155706602|NCT02218008|562018542|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
155706603|NCT02218008|562018543|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
155706604|NCT02218008|562018544|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
155706605|NCT02218008|562018545|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
155706606|NCT02218008|562018540|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155706607|NCT02218008|562018541|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155706608|NCT02218008|562018542|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155706609|NCT02218008|562018543|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
155706610|NCT02218008|562018544|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155706611|NCT02218008|562018545|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155706612|NCT02218008|562018540|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
155706613|NCT02218008|562018541|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
155706614|NCT02218008|562018542|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
155706615|NCT02218008|562018543|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
155706616|NCT02218008|562018544|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
155706617|NCT02218008|562018545|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
155706618|NCT00408434|562018546|FG000|Overall Study|Adverse Event|0|||
155706619|NCT00408434|562018547|FG001|Overall Study|Adverse Event|0|||
155706620|NCT00408434|562018548|FG002|Overall Study|Adverse Event|1|||
155706621|NCT00408434|562018549|FG003|Overall Study|Adverse Event|0|||
155706622|NCT00408434|562018550|FG004|Overall Study|Adverse Event|0|||
155706623|NCT00408434|562018551|FG005|Overall Study|Adverse Event|0|||
155706624|NCT00408434|562018552|FG006|Overall Study|Adverse Event|0|||
155706625|NCT00408434|562018546|FG000|Overall Study|Progressive disease|6|||
155706626|NCT00408434|562018547|FG001|Overall Study|Progressive disease|3|||
155706627|NCT00408434|562018548|FG002|Overall Study|Progressive disease|4|||
155706628|NCT00408434|562018549|FG003|Overall Study|Progressive disease|3|||
155706629|NCT00408434|562018550|FG004|Overall Study|Progressive disease|3|||
155706630|NCT00408434|562018551|FG005|Overall Study|Progressive disease|1|||
155706631|NCT00408434|562018552|FG006|Overall Study|Progressive disease|4|||
155706632|NCT00408434|562018546|FG000|Overall Study|Other|0|||
155706633|NCT00408434|562018547|FG001|Overall Study|Other|0|||
155706634|NCT00408434|562018548|FG002|Overall Study|Other|1|||
155706635|NCT00408434|562018549|FG003|Overall Study|Other|0|||
155706636|NCT00408434|562018550|FG004|Overall Study|Other|2|||
155706637|NCT00408434|562018551|FG005|Overall Study|Other|1|||
155706638|NCT00408434|562018552|FG006|Overall Study|Other|0|||
155706639|NCT00408434|562018546|FG000|Overall Study|Terminated by Investigator|0|||
155706640|NCT00408434|562018547|FG001|Overall Study|Terminated by Investigator|0|||
155706641|NCT00408434|562018548|FG002|Overall Study|Terminated by Investigator|0|||
155706642|NCT00408434|562018549|FG003|Overall Study|Terminated by Investigator|0|||
155706643|NCT00408434|562018550|FG004|Overall Study|Terminated by Investigator|1|||
155706644|NCT00408434|562018551|FG005|Overall Study|Terminated by Investigator|1|||
155706645|NCT00408434|562018552|FG006|Overall Study|Terminated by Investigator|0|||
155706646|NCT01088399|562018558|FG000|Overall Study|Adverse Event|211|||
155706647|NCT01088399|562018559|FG001|Overall Study|Adverse Event|16|||
155706648|NCT01088399|562018560|FG002|Overall Study|Adverse Event|0|||
155706649|NCT01088399|562018558|FG000|Overall Study|Death|204|||
155706650|NCT01088399|562018559|FG001|Overall Study|Death|45|||
155706651|NCT01088399|562018560|FG002|Overall Study|Death|0|||
155706652|NCT01088399|562018558|FG000|Overall Study|Lack of Efficacy|298|||
155706653|NCT01088399|562018559|FG001|Overall Study|Lack of Efficacy|7|||
155706654|NCT01088399|562018560|FG002|Overall Study|Lack of Efficacy|5|||
155706655|NCT01088399|562018558|FG000|Overall Study|Lost to Follow-up|1070|||
155706656|NCT01088399|562018559|FG001|Overall Study|Lost to Follow-up|278|||
155706657|NCT01088399|562018560|FG002|Overall Study|Lost to Follow-up|58|||
155706658|NCT01088399|562018558|FG000|Overall Study|Physician Decision|531|||
155706659|NCT01088399|562018559|FG001|Overall Study|Physician Decision|88|||
155706660|NCT01088399|562018560|FG002|Overall Study|Physician Decision|16|||
155706661|NCT01088399|562018558|FG000|Overall Study|Withdrawal by Subject|544|||
155706662|NCT01088399|562018559|FG001|Overall Study|Withdrawal by Subject|195|||
155706663|NCT01088399|562018560|FG002|Overall Study|Withdrawal by Subject|33|||
155706664|NCT01088399|562018558|FG000|Overall Study|Change to or start of somatropin therapy|234|||
155706665|NCT01088399|562018559|FG001|Overall Study|Change to or start of somatropin therapy|17|||
155706666|NCT01088399|562018560|FG002|Overall Study|Change to or start of somatropin therapy|12|||
155706667|NCT01088399|562018558|FG000|Overall Study|Sponsor decision|1573|||
155706668|NCT01088399|562018559|FG001|Overall Study|Sponsor decision|298|||
155706669|NCT01088399|562018560|FG002|Overall Study|Sponsor decision|7|||
155706670|NCT01088399|562018558|FG000|Overall Study|Protocol Violation|10|||
155706671|NCT01088399|562018559|FG001|Overall Study|Protocol Violation|1|||
155706672|NCT01088399|562018560|FG002|Overall Study|Protocol Violation|0|||
155706673|NCT01088399|562018558|FG000|Overall Study|Enrollment criteria not met|48|||
155706674|NCT01088399|562018559|FG001|Overall Study|Enrollment criteria not met|119|||
155706675|NCT01088399|562018560|FG002|Overall Study|Enrollment criteria not met|70|||
155706676|NCT01088399|562018558|FG000|Overall Study|Study summary visit not completed|2398|||
155706677|NCT01088399|562018559|FG001|Overall Study|Study summary visit not completed|283|||
155706678|NCT01088399|562018560|FG002|Overall Study|Study summary visit not completed|80|||
155706679|NCT00118430|562018563|FG000|Overall Study|Withdrawal by Subject|6|||
155706680|NCT00118430|562018564|FG001|Overall Study|Withdrawal by Subject|2|||
155706681|NCT00118430|562018565|FG002|Overall Study|Withdrawal by Subject|0|||
155706682|NCT00118430|562018563|FG000|Overall Study|Lost to Follow-up|15|||
155706683|NCT00118430|562018564|FG001|Overall Study|Lost to Follow-up|22|||
155706684|NCT00118430|562018565|FG002|Overall Study|Lost to Follow-up|28|||
155706685|NCT02147288|562018566|FG000|Overall Study|post-operative hematoma|1|||
155706686|NCT02147288|562018567|FG001|Overall Study|post-operative hematoma|1|||
155706687|NCT02147288|562018568|FG002|Overall Study|post-operative hematoma|0|||
155706688|NCT02147288|562018569|FG003|Overall Study|post-operative hematoma|0|||
155706689|NCT02147288|562018570|FG004|Overall Study|post-operative hematoma|0|||
155706690|NCT02147288|562018571|FG005|Overall Study|post-operative hematoma|0|||
155706691|NCT02147288|562018572|FG006|Overall Study|post-operative hematoma|0|||
155706692|NCT02147288|562018573|FG007|Overall Study|post-operative hematoma|0|||
155706693|NCT02147288|562018574|FG008|Overall Study|post-operative hematoma|0|||
155706694|NCT02147288|562018575|FG009|Overall Study|post-operative hematoma|0|||
155706695|NCT02147288|562018566|FG000|Overall Study|complications from concurrent hernia rep|0|||
155706696|NCT02147288|562018567|FG001|Overall Study|complications from concurrent hernia rep|1|||
155706697|NCT02147288|562018568|FG002|Overall Study|complications from concurrent hernia rep|0|||
155706698|NCT02147288|562018569|FG003|Overall Study|complications from concurrent hernia rep|0|||
155706699|NCT02147288|562018570|FG004|Overall Study|complications from concurrent hernia rep|0|||
155706700|NCT02147288|562018571|FG005|Overall Study|complications from concurrent hernia rep|0|||
155706701|NCT02147288|562018572|FG006|Overall Study|complications from concurrent hernia rep|0|||
155706702|NCT02147288|562018573|FG007|Overall Study|complications from concurrent hernia rep|0|||
155706703|NCT02147288|562018574|FG008|Overall Study|complications from concurrent hernia rep|0|||
155706704|NCT02147288|562018575|FG009|Overall Study|complications from concurrent hernia rep|0|||
155706705|NCT02069392|562018576|FG000|Overall Study|Withdrawal by Subject|4|||
155706706|NCT02069392|562018577|FG001|Overall Study|Withdrawal by Subject|2|||
155706707|NCT00269633|562018578|FG000|Overall Study|Withdrawal by Subject|1|||
155706708|NCT00269633|562018579|FG001|Overall Study|Withdrawal by Subject|0|||
155706709|NCT04412707|562018580|FG000|Cycle 1|Death|0|||
155706710|NCT04412707|562018581|FG001|Cycle 1|Death|3|||
155706711|NCT04412707|562018580|FG000|Cycle 1|Disease progression|1|||
155706712|NCT04412707|562018581|FG001|Cycle 1|Disease progression|2|||
155706713|NCT04412707|562018580|FG000|Cycle 2|Death|0|||
155706714|NCT04412707|562018581|FG001|Cycle 2|Death|1|||
155706715|NCT04412707|562018580|FG000|Cycle 2|Disease progression|3|||
155706716|NCT04412707|562018581|FG001|Cycle 2|Disease progression|0|||
155706717|NCT04412707|562018580|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
155706718|NCT04412707|562018581|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
155706719|NCT04412707|562018580|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
155706720|NCT04412707|562018581|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
155706721|NCT04412707|562018580|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
155706722|NCT04412707|562018581|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
155706723|NCT04412707|562018580|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
155706724|NCT04412707|562018581|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
155706725|NCT00615017|562020927|FG000|Overall Study|Adverse Event|0|||
155706726|NCT00615017|562020928|FG001|Overall Study|Adverse Event|1|||
155706727|NCT00615017|562020929|FG002|Overall Study|Adverse Event|2|||
155706728|NCT00615017|562020930|FG003|Overall Study|Adverse Event|0|||
155706729|NCT00615017|562020931|FG004|Overall Study|Adverse Event|0|||
155706730|NCT00615017|562020932|FG005|Overall Study|Adverse Event|1|||
155706731|NCT00615017|562020927|FG000|Overall Study|Death|0|||
155706732|NCT00615017|562020928|FG001|Overall Study|Death|0|||
155706733|NCT00615017|562020929|FG002|Overall Study|Death|2|||
155706734|NCT00615017|562020930|FG003|Overall Study|Death|0|||
155706735|NCT00615017|562020931|FG004|Overall Study|Death|1|||
155706736|NCT00615017|562020932|FG005|Overall Study|Death|1|||
155706737|NCT00615017|562020927|FG000|Overall Study|Sepsis resolved|0|||
155706738|NCT00615017|562020928|FG001|Overall Study|Sepsis resolved|0|||
155706739|NCT00615017|562020929|FG002|Overall Study|Sepsis resolved|1|||
155706740|NCT00615017|562020930|FG003|Overall Study|Sepsis resolved|0|||
155706741|NCT00615017|562020931|FG004|Overall Study|Sepsis resolved|0|||
155706742|NCT00615017|562020932|FG005|Overall Study|Sepsis resolved|0|||
155706743|NCT00615017|562020927|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
155706744|NCT00615017|562020928|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
155706745|NCT00615017|562020929|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
155706746|NCT00615017|562020930|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
155706747|NCT00615017|562020931|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
155706748|NCT00615017|562020932|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
155706749|NCT00615017|562020927|FG000|Overall Study|Physician discontinued drug|0|||
155706750|NCT00615017|562020928|FG001|Overall Study|Physician discontinued drug|0|||
155706751|NCT00615017|562020929|FG002|Overall Study|Physician discontinued drug|0|||
155706752|NCT00615017|562020930|FG003|Overall Study|Physician discontinued drug|0|||
155706753|NCT00615017|562020931|FG004|Overall Study|Physician discontinued drug|0|||
155706754|NCT00615017|562020932|FG005|Overall Study|Physician discontinued drug|1|||
155706755|NCT04775953|562020934|FG000|Overall Study|Lost to Follow-up|6|||
155706756|NCT04775953|562020935|FG001|Overall Study|Lost to Follow-up|11|||
155706757|NCT04775953|562020934|FG000|Overall Study|Death|5|||
155706758|NCT04775953|562020935|FG001|Overall Study|Death|4|||
155706759|NCT04775953|562020934|FG000|Overall Study|Withdrawal by Subject|3|||
155706760|NCT04775953|562020935|FG001|Overall Study|Withdrawal by Subject|3|||
155706761|NCT04775953|562020934|FG000|Overall Study|Protocol Violation|2|||
155706762|NCT04775953|562020935|FG001|Overall Study|Protocol Violation|0|||
155706763|NCT04775953|562020934|FG000|Overall Study|Participant non-compliance|0|||
155706764|NCT04775953|562020935|FG001|Overall Study|Participant non-compliance|1|||
155706765|NCT01698814|562020936|FG000|Overall Study|Adverse Event|0|||
155706766|NCT01698814|562020937|FG001|Overall Study|Adverse Event|2|||
155706767|NCT01698814|562020936|FG000|Overall Study|Lost to Follow-up|0|||
155706768|NCT01698814|562020937|FG001|Overall Study|Lost to Follow-up|1|||
155706769|NCT01698814|562020936|FG000|Overall Study|Pregnancy|1|||
155706770|NCT01698814|562020937|FG001|Overall Study|Pregnancy|0|||
155706771|NCT01698814|562020936|FG000|Overall Study|Randomized in error|1|||
155706772|NCT01698814|562020937|FG001|Overall Study|Randomized in error|0|||
155706773|NCT00855959|562020938|FG000|Overall Study|Adverse Event|2|||
155706774|NCT00855959|562020938|FG000|Overall Study|Lost to Follow-up|2|||
155706775|NCT00855959|562020938|FG000|Overall Study|Withdrawal by Subject|3|||
155706776|NCT00855959|562020938|FG000|Overall Study|Pregnancy|1|||
155706777|NCT00855959|562020938|FG000|Overall Study|Incorrect enrolment|1|||
155706778|NCT00368641|562020941|FG000|Overall Study|Adverse Event|2|||
155706779|NCT00368641|562020942|FG001|Overall Study|Adverse Event|1|||
155706780|NCT00368641|562020941|FG000|Overall Study|Death|1|||
155706781|NCT00368641|562020942|FG001|Overall Study|Death|0|||
155706782|NCT00368641|562020941|FG000|Overall Study|Withdrawal by Subject|1|||
155706783|NCT00368641|562020942|FG001|Overall Study|Withdrawal by Subject|0|||
155706784|NCT00368641|562020941|FG000|Overall Study|Sponsor decision to terminate study|2|||
155706785|NCT00368641|562020942|FG001|Overall Study|Sponsor decision to terminate study|5|||
155706786|NCT04014062|562020943|FG000|Period I: Dosing|Medical Grounds|4|||
155706787|NCT04014062|562020944|FG001|Period I: Dosing|Medical Grounds|5|||
155706788|NCT04014062|562020943|FG000|Period I: Dosing|Withdrawal by Subject|3|||
155706789|NCT04014062|562020944|FG001|Period I: Dosing|Withdrawal by Subject|1|||
155706790|NCT03038126|562020946|FG000|Overall Study|Death|1|||
155706791|NCT03038126|562020947|FG001|Overall Study|Death|1|||
155706792|NCT03038126|562020946|FG000|Overall Study|Withdrawal by Subject|5|||
155706793|NCT03038126|562020947|FG001|Overall Study|Withdrawal by Subject|0|||
155706794|NCT03038126|562020946|FG000|Overall Study|Lost to Follow-up|0|||
155706795|NCT03038126|562020947|FG001|Overall Study|Lost to Follow-up|1|||
155706796|NCT03038126|562020946|FG000|Overall Study|Long Term Hospitalization|2|||
155706797|NCT03038126|562020947|FG001|Overall Study|Long Term Hospitalization|0|||
155706798|NCT03038126|562020946|FG000|Overall Study|Too Ill to Participate|1|||
155706799|NCT03038126|562020947|FG001|Overall Study|Too Ill to Participate|2|||
155706800|NCT01724866|562020948|FG000|Overall Study|Adverse Event|0|||
155706801|NCT01724866|562020949|FG001|Overall Study|Adverse Event|0|||
155706802|NCT01724866|562020950|FG002|Overall Study|Adverse Event|1|||
155706803|NCT01724866|562020951|FG003|Overall Study|Adverse Event|1|||
155706804|NCT01724866|562020948|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155706805|NCT01724866|562020949|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
155706806|NCT01724866|562020950|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155706807|NCT01724866|562020951|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155706808|NCT01724866|562020948|FG000|Overall Study|Investigator's Discretion|0|||
155706809|NCT01724866|562020949|FG001|Overall Study|Investigator's Discretion|1|||
155706810|NCT01724866|562020950|FG002|Overall Study|Investigator's Discretion|1|||
155706811|NCT01724866|562020951|FG003|Overall Study|Investigator's Discretion|0|||
155706812|NCT01724866|562020948|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
155706813|NCT01724866|562020949|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155706814|NCT01724866|562020950|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155706815|NCT01724866|562020951|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155706816|NCT01724866|562020948|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
155706817|NCT01724866|562020949|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
155706818|NCT01724866|562020950|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
155706819|NCT01724866|562020951|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
155706820|NCT01424501|562020954|FG000|Overall Study|Withdrawal by Subject|1|||
155706821|NCT01424501|562020955|FG001|Overall Study|Withdrawal by Subject|0|||
155706822|NCT01424501|562020956|FG002|Overall Study|Withdrawal by Subject|1|||
155706823|NCT01424501|562020957|FG003|Overall Study|Withdrawal by Subject|0|||
155706824|NCT01424501|562020958|FG004|Overall Study|Withdrawal by Subject|0|||
155706825|NCT01424501|562020959|FG005|Overall Study|Withdrawal by Subject|0|||
155706826|NCT01424501|562020954|FG000|Overall Study|Lost to Follow-up|0|||
155706827|NCT01424501|562020955|FG001|Overall Study|Lost to Follow-up|1|||
155706828|NCT01424501|562020956|FG002|Overall Study|Lost to Follow-up|1|||
155706829|NCT01424501|562020957|FG003|Overall Study|Lost to Follow-up|0|||
155706830|NCT01424501|562020958|FG004|Overall Study|Lost to Follow-up|0|||
155706831|NCT01424501|562020959|FG005|Overall Study|Lost to Follow-up|0|||
155706832|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
155706833|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155706834|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155706835|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155706836|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155706837|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
155706838|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155706839|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155706840|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155706841|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155706842|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
155706843|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155706844|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155706845|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155706846|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155706847|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
155706848|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155706849|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155706850|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155706851|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155706852|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
155706853|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155706854|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155706855|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155706856|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155706857|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
155706858|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155706859|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155706860|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155706861|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155706862|NCT01173601|562020960|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
155706863|NCT01173601|562020961|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155706864|NCT01173601|562020962|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155706865|NCT01173601|562020963|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155706866|NCT01173601|562020964|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155706867|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155706868|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
155706869|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
155706870|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
155706871|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
155706872|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155706873|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
155706874|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
155706875|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
155706876|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
155706877|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155706878|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
155706879|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155706880|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
155706881|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
155706882|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155706883|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155706884|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155706885|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155706886|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155706887|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155706888|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
155706889|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155706890|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
155706891|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155706892|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155706893|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155706894|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
155706895|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
155706896|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
155706897|NCT01173601|562020960|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155706898|NCT01173601|562020961|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155706899|NCT01173601|562020962|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155706900|NCT01173601|562020963|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155706901|NCT01173601|562020964|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
155706902|NCT01980095|562020965|FG000|Overall Study|Lost to Follow-up|6|||
155706903|NCT01980095|562020966|FG001|Overall Study|Lost to Follow-up|7|||
155706904|NCT01980095|562020965|FG000|Overall Study|Withdrawal by Subject|2|||
155706905|NCT01980095|562020966|FG001|Overall Study|Withdrawal by Subject|3|||
155706906|NCT01980095|562020965|FG000|Overall Study|Poor compliance|5|||
155706907|NCT01980095|562020966|FG001|Overall Study|Poor compliance|0|||
155706908|NCT01980095|562020965|FG000|Overall Study|Safety issue|0|||
155706909|NCT01980095|562020966|FG001|Overall Study|Safety issue|1|||
155706910|NCT01980095|562020965|FG000|Overall Study|Study drug discontinued|1|||
155706911|NCT01980095|562020966|FG001|Overall Study|Study drug discontinued|0|||
155706912|NCT01980095|562020965|FG000|Overall Study|Randomized by mistake|1|||
155706913|NCT01980095|562020966|FG001|Overall Study|Randomized by mistake|0|||
155706914|NCT04506502|562020969|FG000|Overall Study|Withdrawal by Subject|1|||
155706915|NCT04506502|562020969|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
155706916|NCT01449006|562020970|FG000|Overall Study|Lost to Follow-up|1|||
155706917|NCT01449006|562020971|FG001|Overall Study|Lost to Follow-up|0|||
155706918|NCT01449006|562020970|FG000|Overall Study|Withdrawal by Subject|1|||
155706919|NCT01449006|562020971|FG001|Overall Study|Withdrawal by Subject|0|||
155706920|NCT01449006|562020970|FG000|Overall Study|Protocol Violation|1|||
155706921|NCT01449006|562020971|FG001|Overall Study|Protocol Violation|0|||
155706922|NCT03350815|562020972|FG000|Period 1|Adverse Event|10|||
155706923|NCT03350815|562020973|FG001|Period 1|Adverse Event|0|||
155706924|NCT03350815|562020974|FG002|Period 1|Adverse Event|0|||
155706925|NCT03350815|562020975|FG003|Period 1|Adverse Event|0|||
155706926|NCT03350815|562020972|FG000|Period 1|Technical problems|1|||
155706927|NCT03350815|562020973|FG001|Period 1|Technical problems|0|||
155706928|NCT03350815|562020974|FG002|Period 1|Technical problems|0|||
155706929|NCT03350815|562020975|FG003|Period 1|Technical problems|0|||
155706930|NCT03350815|562020972|FG000|Period 1|Lost to Follow-up|3|||
155706931|NCT03350815|562020973|FG001|Period 1|Lost to Follow-up|0|||
155706932|NCT03350815|562020974|FG002|Period 1|Lost to Follow-up|0|||
155706933|NCT03350815|562020975|FG003|Period 1|Lost to Follow-up|0|||
155706934|NCT03350815|562020972|FG000|Period 1|Physician Decision|1|||
155706935|NCT03350815|562020973|FG001|Period 1|Physician Decision|0|||
155706936|NCT03350815|562020974|FG002|Period 1|Physician Decision|0|||
155706937|NCT03350815|562020975|FG003|Period 1|Physician Decision|0|||
155706938|NCT03350815|562020972|FG000|Period 1|Withdrawal by Subject|8|||
155706939|NCT03350815|562020973|FG001|Period 1|Withdrawal by Subject|0|||
155706940|NCT03350815|562020974|FG002|Period 1|Withdrawal by Subject|0|||
155706941|NCT03350815|562020975|FG003|Period 1|Withdrawal by Subject|0|||
155706942|NCT03350815|562020972|FG000|Period 1|Lack of Efficacy|15|||
155706943|NCT03350815|562020973|FG001|Period 1|Lack of Efficacy|0|||
155706944|NCT03350815|562020974|FG002|Period 1|Lack of Efficacy|0|||
155706945|NCT03350815|562020975|FG003|Period 1|Lack of Efficacy|0|||
155706946|NCT03350815|562020972|FG000|Period 1|Non-compliance with study treatment|2|||
155706947|NCT03350815|562020973|FG001|Period 1|Non-compliance with study treatment|0|||
155706948|NCT03350815|562020974|FG002|Period 1|Non-compliance with study treatment|0|||
155706949|NCT03350815|562020975|FG003|Period 1|Non-compliance with study treatment|0|||
155706950|NCT03350815|562020972|FG000|Period 1|Protocol Violation|3|||
155706951|NCT03350815|562020973|FG001|Period 1|Protocol Violation|0|||
155706952|NCT03350815|562020974|FG002|Period 1|Protocol Violation|0|||
155706953|NCT03350815|562020975|FG003|Period 1|Protocol Violation|0|||
155706954|NCT03350815|562020972|FG000|Period 2|Adverse Event|0|||
155706955|NCT03350815|562020973|FG001|Period 2|Adverse Event|3|||
155706956|NCT03350815|562020974|FG002|Period 2|Adverse Event|5|||
155706957|NCT03350815|562020975|FG003|Period 2|Adverse Event|0|||
155706958|NCT03350815|562020972|FG000|Period 2|Technical problem|0|||
155706959|NCT03350815|562020973|FG001|Period 2|Technical problem|1|||
155706960|NCT03350815|562020974|FG002|Period 2|Technical problem|0|||
155706961|NCT03350815|562020975|FG003|Period 2|Technical problem|0|||
155706962|NCT03350815|562020972|FG000|Period 2|Lost to Follow-up|0|||
155706963|NCT03350815|562020973|FG001|Period 2|Lost to Follow-up|3|||
155706964|NCT03350815|562020974|FG002|Period 2|Lost to Follow-up|3|||
155706965|NCT03350815|562020975|FG003|Period 2|Lost to Follow-up|0|||
155706966|NCT03350815|562020972|FG000|Period 2|Physician Decision|0|||
155706967|NCT03350815|562020973|FG001|Period 2|Physician Decision|0|||
155706968|NCT03350815|562020974|FG002|Period 2|Physician Decision|1|||
155706969|NCT03350815|562020975|FG003|Period 2|Physician Decision|0|||
155706970|NCT03350815|562020972|FG000|Period 2|Withdrawal by Subject|0|||
155706971|NCT03350815|562020973|FG001|Period 2|Withdrawal by Subject|3|||
155706972|NCT03350815|562020974|FG002|Period 2|Withdrawal by Subject|4|||
155706973|NCT03350815|562020975|FG003|Period 2|Withdrawal by Subject|0|||
155706974|NCT03350815|562020972|FG000|Period 2|Lack of Efficacy|0|||
155706975|NCT03350815|562020973|FG001|Period 2|Lack of Efficacy|6|||
155706976|NCT03350815|562020974|FG002|Period 2|Lack of Efficacy|2|||
155706977|NCT03350815|562020975|FG003|Period 2|Lack of Efficacy|0|||
155706978|NCT03350815|562020972|FG000|Period 2|Protocol Violation|0|||
155706979|NCT03350815|562020973|FG001|Period 2|Protocol Violation|0|||
155706980|NCT03350815|562020974|FG002|Period 2|Protocol Violation|1|||
155706981|NCT03350815|562020975|FG003|Period 2|Protocol Violation|0|||
155706982|NCT03350815|562020972|FG000|Period 2|New therapy for study indication|0|||
155706983|NCT03350815|562020973|FG001|Period 2|New therapy for study indication|0|||
155706984|NCT03350815|562020974|FG002|Period 2|New therapy for study indication|1|||
155706985|NCT03350815|562020975|FG003|Period 2|New therapy for study indication|0|||
155706986|NCT02517541|562020976|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
155706987|NCT02517541|562020976|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
155706988|NCT02517541|562020976|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
155706989|NCT02517541|562020976|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
155706990|NCT02517541|562020976|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
155706991|NCT02517541|562020976|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
155706992|NCT02828436|562020977|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
155706993|NCT02828436|562020978|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
155706994|NCT02828436|562020977|FG000|Period 1|Lost to Follow-up|0|||
155706995|NCT02828436|562020978|FG001|Period 1|Lost to Follow-up|1|||
155706996|NCT02828436|562020977|FG000|Period 2|Withdrawal by Subject|4|||
155706997|NCT02828436|562020978|FG001|Period 2|Withdrawal by Subject|0|||
155706998|NCT02828436|562020977|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
155706999|NCT02828436|562020978|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
155707000|NCT02828436|562020977|FG000|Period 2|Lost to Follow-up|1|||
155707001|NCT02828436|562020978|FG001|Period 2|Lost to Follow-up|0|||
155707002|NCT04720417|562020986|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
155707003|NCT03329092|562020987|FG000|Overall Study|Other|2|||
155707004|NCT03329092|562020988|FG001|Overall Study|Other|2|||
155707005|NCT03329092|562020987|FG000|Overall Study|Withdrawal by Subject|16|||
155707006|NCT03329092|562020988|FG001|Overall Study|Withdrawal by Subject|3|||
155707007|NCT03329092|562020987|FG000|Overall Study|Physician Decision|1|||
155707008|NCT03329092|562020988|FG001|Overall Study|Physician Decision|0|||
155707009|NCT03329092|562020987|FG000|Overall Study|Death|17|||
155707010|NCT03329092|562020988|FG001|Overall Study|Death|11|||
155707011|NCT03329092|562020987|FG000|Overall Study|Adverse Event|3|||
155707012|NCT03329092|562020988|FG001|Overall Study|Adverse Event|1|||
155707013|NCT03329092|562020987|FG000|Overall Study|Lost to Follow-up|1|||
155707014|NCT03329092|562020988|FG001|Overall Study|Lost to Follow-up|1|||
155707015|NCT03314987|562020989|FG000|Overall Study|Lost to Follow-up|13|||
155707016|NCT03314987|562020990|FG001|Overall Study|Lost to Follow-up|13|||
155707017|NCT00203424|562020994|FG000|Treatment Period|Withdrawal by Subject|4|||
155707018|NCT00203424|562020994|FG000|Treatment Period|Adverse Event|5|||
155707019|NCT00203424|562020994|FG000|Treatment Period|progressive disease|2|||
155707020|NCT00203424|562020994|FG000|Follow-up Period|Withdrawal by Subject|1|||
155707021|NCT00203424|562020994|FG000|Follow-up Period|progressive disease|4|||
155707022|NCT00203424|562020994|FG000|Follow-up Period|Lost to Follow-up|1|||
155707023|NCT01415401|562020999|FG000|Overall Study|Adverse Event|5|||
155707024|NCT01415401|562020999|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
155707025|NCT01415401|562020999|FG000|Overall Study|Terminated by Sponsor|1|||
155707026|NCT00836186|562021000|FG000|Overall Study|Blood could not be drawn|1|||
155707027|NCT04079816|562021001|FG000|Overall Study|Request of Subject|2|||
155707028|NCT04079816|562021001|FG000|Overall Study|Unable to draw samples|1|||
155707029|NCT01128946|562021002|FG000|Period I|Protocol Violation|0|||
155707030|NCT01128946|562021003|FG001|Period I|Protocol Violation|1|||
155707031|NCT01128946|562021004|FG002|Period I|Protocol Violation|0|||
155707032|NCT01128946|562021005|FG003|Period I|Protocol Violation|0|||
155707033|NCT01128946|562021002|FG000|Period I|Withdrawal by Subject|0|||
155707034|NCT01128946|562021003|FG001|Period I|Withdrawal by Subject|0|||
155707035|NCT01128946|562021004|FG002|Period I|Withdrawal by Subject|1|||
155707036|NCT01128946|562021005|FG003|Period I|Withdrawal by Subject|1|||
155707037|NCT01128946|562021002|FG000|Period II|Protocol Violation|0|||
155707038|NCT01128946|562021003|FG001|Period II|Protocol Violation|1|||
155707039|NCT01128946|562021004|FG002|Period II|Protocol Violation|0|||
155707040|NCT01128946|562021005|FG003|Period II|Protocol Violation|0|||
155707041|NCT01128946|562021002|FG000|Period II|Withdrawal by Subject|0|||
155707042|NCT01128946|562021003|FG001|Period II|Withdrawal by Subject|0|||
155707043|NCT01128946|562021004|FG002|Period II|Withdrawal by Subject|0|||
155707044|NCT01128946|562021005|FG003|Period II|Withdrawal by Subject|1|||
155707045|NCT01128946|562021002|FG000|Period III|Protocol Violation|1|||
155707046|NCT01128946|562021003|FG001|Period III|Protocol Violation|0|||
155707047|NCT01128946|562021004|FG002|Period III|Protocol Violation|0|||
155707048|NCT01128946|562021005|FG003|Period III|Protocol Violation|0|||
155707049|NCT00621140|562021006|FG000|Overall Study|Adverse Event|4|||
155707050|NCT00621140|562021007|FG001|Overall Study|Adverse Event|5|||
155707051|NCT00621140|562021006|FG000|Overall Study|Lost to Follow-up|1|||
155707052|NCT00621140|562021007|FG001|Overall Study|Lost to Follow-up|2|||
155707053|NCT00621140|562021006|FG000|Overall Study|Withdrawal by Subject|4|||
155707054|NCT00621140|562021007|FG001|Overall Study|Withdrawal by Subject|6|||
155707055|NCT00621140|562021006|FG000|Overall Study|Other incl. lack of efficacy|6|||
155707056|NCT00621140|562021007|FG001|Overall Study|Other incl. lack of efficacy|5|||
155707057|NCT00145574|562021008|FG000|Double Blind|Adverse Event|0|||
155707058|NCT00145574|562021009|FG001|Double Blind|Adverse Event|3|||
155707059|NCT00145574|562021010|FG002|Double Blind|Adverse Event|1|||
155707060|NCT00145574|562021008|FG000|Double Blind|Withdrawal by Subject|1|||
155707061|NCT00145574|562021009|FG001|Double Blind|Withdrawal by Subject|1|||
155707062|NCT00145574|562021010|FG002|Double Blind|Withdrawal by Subject|1|||
155707063|NCT00145574|562021008|FG000|Double Blind|required restricted medicine|0|||
155707064|NCT00145574|562021009|FG001|Double Blind|required restricted medicine|1|||
155707065|NCT00145574|562021010|FG002|Double Blind|required restricted medicine|0|||
155707066|NCT00145574|562021008|FG000|Open Label Long-term Extension|Adverse Event|0|||
155707067|NCT00145574|562021009|FG001|Open Label Long-term Extension|Adverse Event|0|||
155707068|NCT00145574|562021010|FG002|Open Label Long-term Extension|Adverse Event|5|||
155707069|NCT00145574|562021008|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
155707070|NCT00145574|562021009|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
155707071|NCT00145574|562021010|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
155707072|NCT00145574|562021008|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
155707073|NCT00145574|562021009|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
155707074|NCT00145574|562021010|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
155707075|NCT00145574|562021008|FG000|Open Label Long-term Extension|required restricted medicine|0|||
155707076|NCT00145574|562021009|FG001|Open Label Long-term Extension|required restricted medicine|0|||
155707077|NCT00145574|562021010|FG002|Open Label Long-term Extension|required restricted medicine|1|||
155707078|NCT00527904|562021011|FG000|Overall Study|Adverse Event|45|||
155707079|NCT00527904|562021011|FG000|Overall Study|Withdrawal by Subject|21|||
155707080|NCT00527904|562021011|FG000|Overall Study|Lost to Follow-up|8|||
155707081|NCT00527904|562021011|FG000|Overall Study|misc|22|||
155707082|NCT00766051|562021013|FG000|Overall Study|Withdrawal by Subject|2|||
155707083|NCT00766051|562021014|FG001|Overall Study|Withdrawal by Subject|0|||
155707084|NCT02669121|562021015|FG000|Overall Study|Adverse Event|4|||
155707085|NCT02669121|562021016|FG001|Overall Study|Adverse Event|5|||
155707086|NCT02669121|562021015|FG000|Overall Study|Lost to Follow-up|15|||
155707087|NCT02669121|562021016|FG001|Overall Study|Lost to Follow-up|27|||
155707088|NCT02669121|562021015|FG000|Overall Study|Withdrawal by Subject|132|||
155707089|NCT02669121|562021016|FG001|Overall Study|Withdrawal by Subject|140|||
155707090|NCT02669121|562021015|FG000|Overall Study|Pregnancy|0|||
155707091|NCT02669121|562021016|FG001|Overall Study|Pregnancy|1|||
155707092|NCT02669121|562021015|FG000|Overall Study|Discharged from US Military Active Service|117|||
155707093|NCT02669121|562021016|FG001|Overall Study|Discharged from US Military Active Service|91|||
155707094|NCT02669121|562021015|FG000|Overall Study|Reason not Specified|22|||
155707095|NCT02669121|562021016|FG001|Overall Study|Reason not Specified|18|||
155707096|NCT02708355|562021017|FG000|Overall Study|Adverse Event|1|||
155707097|NCT02708355|562021018|FG001|Overall Study|Adverse Event|0|||
155707098|NCT02708355|562021019|FG002|Overall Study|Adverse Event|0|||
155707099|NCT03216746|562021020|FG000|Overall Study|Lost to Follow-up|6|||
155707100|NCT03216746|562021021|FG001|Overall Study|Lost to Follow-up|8|||
155707101|NCT03216746|562021022|FG002|Overall Study|Lost to Follow-up|5|||
155707102|NCT03216746|562021023|FG003|Overall Study|Lost to Follow-up|6|||
155707103|NCT01320202|562021024|FG000|Overall Study|Adverse Event|5|||
155707104|NCT01320202|562021025|FG001|Overall Study|Adverse Event|5|||
155707105|NCT01320202|562021024|FG000|Overall Study|Death|5|||
155707106|NCT01320202|562021025|FG001|Overall Study|Death|3|||
155707107|NCT01320202|562021024|FG000|Overall Study|Lost to Follow-up|1|||
155707108|NCT01320202|562021025|FG001|Overall Study|Lost to Follow-up|0|||
155707109|NCT01320202|562021024|FG000|Overall Study|Physician Decision|3|||
155707110|NCT01320202|562021025|FG001|Overall Study|Physician Decision|1|||
155707111|NCT01320202|562021024|FG000|Overall Study|Protocol Violation|2|||
155707112|NCT01320202|562021025|FG001|Overall Study|Protocol Violation|1|||
155707113|NCT01320202|562021024|FG000|Overall Study|Withdrawal by Subject|10|||
155707114|NCT01320202|562021025|FG001|Overall Study|Withdrawal by Subject|3|||
155707115|NCT01320202|562021024|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
155707116|NCT01320202|562021025|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
155707117|NCT01320202|562021024|FG000|Overall Study|kidney transplant|1|||
155707118|NCT01320202|562021025|FG001|Overall Study|kidney transplant|2|||
155707119|NCT01320202|562021024|FG000|Overall Study|blood transfusion|1|||
155707120|NCT01320202|562021025|FG001|Overall Study|blood transfusion|7|||
155707121|NCT01320202|562021024|FG000|Overall Study|moved/changed dialysis|5|||
155707122|NCT01320202|562021025|FG001|Overall Study|moved/changed dialysis|2|||
155707123|NCT01320202|562021024|FG000|Overall Study|sponsor request|2|||
155707124|NCT01320202|562021025|FG001|Overall Study|sponsor request|0|||
155707125|NCT01320202|562021024|FG000|Overall Study|ineligible|3|||
155707126|NCT01320202|562021025|FG001|Overall Study|ineligible|0|||
155707127|NCT01320202|562021024|FG000|Overall Study|regained renal function|1|||
155707128|NCT01320202|562021025|FG001|Overall Study|regained renal function|0|||
155707129|NCT00635882|562021026|FG000|Overall Study|Protocol Violation|1|||
155707130|NCT00635882|562021027|FG001|Overall Study|Protocol Violation|0|||
155707131|NCT00635882|562021028|FG002|Overall Study|Protocol Violation|0|||
155707132|NCT00635882|562021029|FG003|Overall Study|Protocol Violation|0|||
155707133|NCT00635882|562021030|FG004|Overall Study|Protocol Violation|0|||
155707134|NCT00635882|562021031|FG005|Overall Study|Protocol Violation|0|||
155707135|NCT00835341|562021032|FG000|Overall Study|Lost to Follow-up|3|||
155707136|NCT00835341|562021033|FG001|Overall Study|Lost to Follow-up|12|||
155707137|NCT02513472|562021034|FG000|Overall Study|Radiological Disease Progression|45|||
155707138|NCT02513472|562021035|FG001|Overall Study|Radiological Disease Progression|57|||
155707139|NCT02513472|562021034|FG000|Overall Study|Clinical Disease Progression|5|||
155707140|NCT02513472|562021035|FG001|Overall Study|Clinical Disease Progression|13|||
155707141|NCT02513472|562021034|FG000|Overall Study|Adverse Event|8|||
155707142|NCT02513472|562021035|FG001|Overall Study|Adverse Event|11|||
155707143|NCT02513472|562021034|FG000|Overall Study|Withdrawal by Subject|0|||
155707144|NCT02513472|562021035|FG001|Overall Study|Withdrawal by Subject|4|||
155707145|NCT02513472|562021034|FG000|Overall Study|Subject Choice|2|||
155707146|NCT02513472|562021035|FG001|Overall Study|Subject Choice|7|||
155707147|NCT02513472|562021034|FG000|Overall Study|Treatment Completed as per Protocol|3|||
155707148|NCT02513472|562021035|FG001|Overall Study|Treatment Completed as per Protocol|3|||
155707149|NCT02513472|562021034|FG000|Overall Study|Other|3|||
155707150|NCT02513472|562021035|FG001|Overall Study|Other|6|||
155707151|NCT01711645|562021039|FG000|Overall Study|Withdrawal by Subject|8|||
155707152|NCT01711645|562021039|FG000|Overall Study|Lost to Follow-up|6|||
155707153|NCT01711645|562021039|FG000|Overall Study|Physician Decision|5|||
155707154|NCT01746173|562021044|FG000|Overall Study|Disease Progression|2|||
155707155|NCT01278797|562021047|FG000|Period 1|Adverse Event|0|||
155707156|NCT01278797|562021048|FG001|Period 1|Adverse Event|1|||
155707157|NCT01278797|562021047|FG000|Period 1|Protocol Violation|1|||
155707158|NCT01278797|562021048|FG001|Period 1|Protocol Violation|0|||
155707159|NCT00588354|562021049|FG000|Baseline to 2 Weeks|Adverse Event|1|||
155707160|NCT00588354|562021050|FG001|Baseline to 2 Weeks|Adverse Event|0|||
155707161|NCT00588354|562021049|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
155707162|NCT00588354|562021050|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
155707163|NCT00588354|562021049|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
155707164|NCT00588354|562021050|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
155707165|NCT04522141|562021052|FG000|Overall Study|Withdrawal by Subject|1|||
155707166|NCT04522141|562021053|FG001|Overall Study|Withdrawal by Subject|0|||
155707167|NCT03052049|562021054|FG000|Overall Study|Withdrawal by Subject|2|||
155707168|NCT02328027|562021055|FG000|Overall Study|Withdrawal by Subject|0|||
155707169|NCT02328027|562021056|FG001|Overall Study|Withdrawal by Subject|1|||
155707170|NCT03304873|562021057|FG000|Overall Study|Lost to Follow-up|1|||
155707171|NCT03304873|562021058|FG001|Overall Study|Lost to Follow-up|8|||
155707172|NCT03319212|562021059|FG000|Overall Study|Discontinued as moving out of local area|0|||
155707173|NCT03319212|562021060|FG001|Overall Study|Discontinued as moving out of local area|1|||
155707174|NCT03319212|562021059|FG000|Overall Study|Adverse Event|2|||
155707175|NCT03319212|562021060|FG001|Overall Study|Adverse Event|2|||
155707176|NCT03319212|562021059|FG000|Overall Study|Withdrawal by Subject|0|||
155707177|NCT03319212|562021060|FG001|Overall Study|Withdrawal by Subject|1|||
155707178|NCT03319212|562021059|FG000|Overall Study|Lost to Follow-up|0|||
155707179|NCT03319212|562021060|FG001|Overall Study|Lost to Follow-up|1|||
155707180|NCT03319212|562021059|FG000|Overall Study|Physician Decision|1|||
155707181|NCT03319212|562021060|FG001|Overall Study|Physician Decision|0|||
155707182|NCT00400569|562021064|FG000|Overall Study|Death|1|||
155707183|NCT00620113|562021065|FG000|Overall Study|Adverse Event|3|||
155707184|NCT00620113|562021066|FG001|Overall Study|Adverse Event|2|||
155707185|NCT00620113|562021067|FG002|Overall Study|Adverse Event|2|||
155707186|NCT00620113|562021068|FG003|Overall Study|Adverse Event|1|||
155707187|NCT00620113|562021065|FG000|Overall Study|Lack of Efficacy|2|||
155707188|NCT00620113|562021066|FG001|Overall Study|Lack of Efficacy|3|||
155707189|NCT00620113|562021067|FG002|Overall Study|Lack of Efficacy|0|||
155707190|NCT00620113|562021068|FG003|Overall Study|Lack of Efficacy|2|||
155707191|NCT00620113|562021065|FG000|Overall Study|Physician Decision|1|||
155707192|NCT00620113|562021066|FG001|Overall Study|Physician Decision|0|||
155707193|NCT00620113|562021067|FG002|Overall Study|Physician Decision|0|||
155707194|NCT00620113|562021068|FG003|Overall Study|Physician Decision|2|||
155707195|NCT00620113|562021065|FG000|Overall Study|Protocol Violation|2|||
155707196|NCT00620113|562021066|FG001|Overall Study|Protocol Violation|1|||
155707197|NCT00620113|562021067|FG002|Overall Study|Protocol Violation|0|||
155707198|NCT00620113|562021068|FG003|Overall Study|Protocol Violation|0|||
155707199|NCT00620113|562021065|FG000|Overall Study|Withdrawal by Subject|5|||
155707200|NCT00620113|562021066|FG001|Overall Study|Withdrawal by Subject|1|||
155707201|NCT00620113|562021067|FG002|Overall Study|Withdrawal by Subject|3|||
155707202|NCT00620113|562021068|FG003|Overall Study|Withdrawal by Subject|5|||
155707203|NCT00852241|562021069|FG000|Overall Study|Physician Decision|18|||
155707204|NCT03848949|562021070|FG000|Overall Study|Lost to Follow-up|5|||
155707205|NCT03848949|562021071|FG001|Overall Study|Lost to Follow-up|7|||
155707206|NCT04230213|562021077|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
155707207|NCT04230213|562021078|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
155707208|NCT04230213|562021079|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
155707209|NCT04230213|562021077|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
155707210|NCT04230213|562021078|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
155707211|NCT04230213|562021079|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
155707212|NCT04230213|562021077|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
155707213|NCT04230213|562021078|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
155707214|NCT04230213|562021079|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
155707215|NCT04230213|562021077|FG000|TP2: Week 10 to Week 16|Other|0|||
155707216|NCT04230213|562021078|FG001|TP2: Week 10 to Week 16|Other|2|||
155707217|NCT04230213|562021079|FG002|TP2: Week 10 to Week 16|Other|1|||
155707218|NCT04230213|562021077|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
155707219|NCT04230213|562021078|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
155707220|NCT04230213|562021079|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
155707221|NCT04230213|562021077|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
155707222|NCT04230213|562021078|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
155707223|NCT04230213|562021079|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
155707224|NCT04230213|562021077|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
155707225|NCT04230213|562021078|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
155707226|NCT04230213|562021079|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
155707227|NCT04230213|562021077|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
155707228|NCT04230213|562021078|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
155707229|NCT04230213|562021079|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
155707230|NCT04230213|562021077|FG000|TP3: Week 16 to Week 22|Other|0|||
155707231|NCT04230213|562021078|FG001|TP3: Week 16 to Week 22|Other|1|||
155707232|NCT04230213|562021079|FG002|TP3: Week 16 to Week 22|Other|3|||
155707233|NCT04230213|562021077|FG000|TP4: Week 22 to Week 32|Other|0|||
155707234|NCT04230213|562021078|FG001|TP4: Week 22 to Week 32|Other|5|||
155707235|NCT04230213|562021079|FG002|TP4: Week 22 to Week 32|Other|5|||
155707236|NCT04230213|562021077|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
155707237|NCT04230213|562021078|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
155707238|NCT04230213|562021079|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
155707239|NCT04230213|562021077|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
155707240|NCT04230213|562021078|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
155707241|NCT04230213|562021079|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
155707242|NCT04230213|562021077|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
155707243|NCT04230213|562021078|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
155707244|NCT04230213|562021079|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
155707245|NCT04230213|562021077|FG000|Follow up: Week 32 to Week 36|Other|0|||
155707246|NCT04230213|562021078|FG001|Follow up: Week 32 to Week 36|Other|1|||
155707247|NCT04230213|562021079|FG002|Follow up: Week 32 to Week 36|Other|1|||
155707248|NCT00619307|562021092|FG000|Overall Study|Adverse Event|0|||
155707249|NCT00619307|562021093|FG001|Overall Study|Adverse Event|1|||
155707250|NCT00619307|562021092|FG000|Overall Study|Lost to Follow-up|0|||
155707251|NCT00619307|562021093|FG001|Overall Study|Lost to Follow-up|1|||
155707252|NCT00619307|562021092|FG000|Overall Study|Protocol Violation|3|||
155707253|NCT00619307|562021093|FG001|Overall Study|Protocol Violation|0|||
155707254|NCT00619307|562021092|FG000|Overall Study|Withdrew consent|1|||
155707255|NCT00619307|562021093|FG001|Overall Study|Withdrew consent|0|||
155707256|NCT00619307|562021092|FG000|Overall Study|Severe migraine|0|||
155707257|NCT00619307|562021093|FG001|Overall Study|Severe migraine|1|||
155707258|NCT00619307|562021092|FG000|Overall Study|MS attack plus steroids|0|||
155707259|NCT00619307|562021093|FG001|Overall Study|MS attack plus steroids|1|||
155707260|NCT00534976|562021100|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
155707261|NCT00534976|562021101|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
155707262|NCT00534976|562021100|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
155707263|NCT00534976|562021101|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
155707264|NCT00534976|562021100|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
155707265|NCT00534976|562021101|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
155707266|NCT00861471|562021102|FG000|Overall Study|Withdrawal by Subject|1|||
155707267|NCT00861471|562021102|FG000|Overall Study|Adverse Event|2|||
155707268|NCT00861471|562021102|FG000|Overall Study|Lack of Efficacy|3|||
155707269|NCT00861471|562021102|FG000|Overall Study|treatment for lumbar laminectomy|1|||
155707270|NCT00861471|562021102|FG000|Overall Study|Physician Decision|2|||
155707271|NCT02476006|562021105|FG000|Overall Study|Death|4|||
155707272|NCT02476006|562021105|FG000|Overall Study|Lack of treatment efficacy|2|||
155707273|NCT02476006|562021105|FG000|Overall Study|Pregnancy|1|||
155707274|NCT02476006|562021105|FG000|Overall Study|Participant did not wish to continue|39|||
155707275|NCT02476006|562021105|FG000|Overall Study|Adverse Event|41|||
155707276|NCT02476006|562021105|FG000|Overall Study|Poor compliance to study protocol|3|||
155707277|NCT02476006|562021105|FG000|Overall Study|Sponsor decision|6|||
155707278|NCT02476006|562021105|FG000|Overall Study|Lost to Follow-up|5|||
155707279|NCT02476006|562021105|FG000|Overall Study|Physician Decision|5|||
155707280|NCT02476006|562021105|FG000|Overall Study|Study ended treatment not available|4|||
155707281|NCT02476006|562021105|FG000|Overall Study|Switched to commercial drug|4|||
155707282|NCT02476006|562021105|FG000|Overall Study|Excluded from study|1|||
155707283|NCT02476006|562021105|FG000|Overall Study|Protocol Violation|1|||
155707284|NCT02476006|562021105|FG000|Overall Study|Enrolled but not treated|4|||
155707285|NCT00806988|562022230|FG000|Overall Study|Death|15|||
155707286|NCT00806988|562022231|FG001|Overall Study|Death|16|||
155707287|NCT00806988|562022230|FG000|Overall Study|Withdrawal by Subject|8|||
155707288|NCT00806988|562022231|FG001|Overall Study|Withdrawal by Subject|8|||
155707289|NCT00806988|562022230|FG000|Overall Study|Lost to Follow-up|4|||
155707290|NCT00806988|562022231|FG001|Overall Study|Lost to Follow-up|19|||
155707291|NCT04306510|562022232|FG000|Overall Study|Voluntarily withdrawal|1|||
155707292|NCT04306510|562022232|FG000|Overall Study|Enrolled but Not Treated|1|||
155707293|NCT03755882|562022239|FG000|Period 1|Protocol Violation|1|||
155707294|NCT03755882|562022240|FG001|Period 1|Protocol Violation|0|||
155707295|NCT03755882|562022239|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
155707296|NCT03755882|562022240|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
155707297|NCT01746368|562022242|FG000|Overall Study|Lost to Follow-up|2|||
155707298|NCT01746368|562022243|FG001|Overall Study|Lost to Follow-up|0|||
155707299|NCT01746368|562022242|FG000|Overall Study|Withdrawal by Subject|0|||
155707300|NCT01746368|562022243|FG001|Overall Study|Withdrawal by Subject|1|||
155707301|NCT05636852|562022244|FG000|Overall Study|Withdrawal by Subject|1|||
155707302|NCT05636852|562022244|FG000|Overall Study|Other than specified|1|||
155707303|NCT02221674|562022247|FG000|Overall Study|Lost to Follow-up|1|||
155707304|NCT02221674|562022248|FG001|Overall Study|Lost to Follow-up|0|||
155707305|NCT02221674|562022249|FG002|Overall Study|Lost to Follow-up|0|||
155707306|NCT02557542|562022250|FG000|Overall Study|Poor recruitment|3|||
155707307|NCT02557542|562022251|FG001|Overall Study|Poor recruitment|0|||
155707308|NCT04390880|562022252|FG000|Overall Study|Withdrawal by Subject|1|||
155707309|NCT00195091|562022253|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
155707310|NCT00475709|562022259|FG000|Overall Study|Did not meet eligibility criteria|8|||
155707311|NCT00475709|562022259|FG000|Overall Study|Death|41|||
155707312|NCT00475709|562022259|FG000|Overall Study|Device Explant|6|||
155707313|NCT00475709|562022259|FG000|Overall Study|Lost to Follow-up|21|||
155707314|NCT04752358|562022260|FG000|Overall Study|Death|2|||
155707315|NCT04752358|562022261|FG001|Overall Study|Death|1|||
155707316|NCT00555672|562022264|FG000|Overall Study|Death|0|||
155707317|NCT00555672|562022265|FG001|Overall Study|Death|2|||
155707318|NCT00555672|562022264|FG000|Overall Study|Adverse Event|8|||
155707319|NCT00555672|562022265|FG001|Overall Study|Adverse Event|2|||
155707320|NCT00555672|562022264|FG000|Overall Study|Objective progression or relapse|11|||
155707321|NCT00555672|562022265|FG001|Overall Study|Objective progression or relapse|5|||
155707322|NCT00555672|562022264|FG000|Overall Study|Other|3|||
155707323|NCT00555672|562022265|FG001|Overall Study|Other|1|||
155707324|NCT00555672|562022264|FG000|Overall Study|Participant refused|2|||
155707325|NCT00555672|562022265|FG001|Overall Study|Participant refused|0|||
155707326|NCT06041919|562022266|FG000|Overall Study|Lost to Follow-up|1|||
155707327|NCT06041919|562022267|FG001|Overall Study|Lost to Follow-up|0|||
155707328|NCT06041919|562022268|FG002|Overall Study|Lost to Follow-up|0|||
155707329|NCT06041919|562022269|FG003|Overall Study|Lost to Follow-up|0|||
155707330|NCT06041919|562022270|FG004|Overall Study|Lost to Follow-up|0|||
155707331|NCT06041919|562022266|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
155707332|NCT06041919|562022267|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
155707333|NCT06041919|562022268|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
155707334|NCT06041919|562022269|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
155707335|NCT06041919|562022270|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
155707336|NCT01147055|562022274|FG000|First Intervention Period|Lost to Follow-up|1|||
155707337|NCT01147055|562022275|FG001|First Intervention Period|Lost to Follow-up|0|||
155707338|NCT02023996|562022281|FG000|Overall Study|Protocol Violation|6|||
155707339|NCT03400176|562022282|FG000|Dose Escalation|Progressive disease|1|||
155707340|NCT03400176|562022283|FG001|Dose Escalation|Progressive disease|1|||
155707341|NCT03400176|562022284|FG002|Dose Escalation|Progressive disease|0|||
155707342|NCT03400176|562022285|FG003|Dose Escalation|Progressive disease|0|||
155707343|NCT03400176|562022286|FG004|Dose Escalation|Progressive disease|1|||
155707344|NCT03400176|562022282|FG000|Dose Escalation|Patient decision|0|||
155707345|NCT03400176|562022283|FG001|Dose Escalation|Patient decision|0|||
155707346|NCT03400176|562022284|FG002|Dose Escalation|Patient decision|0|||
155707347|NCT03400176|562022285|FG003|Dose Escalation|Patient decision|0|||
155707348|NCT03400176|562022286|FG004|Dose Escalation|Patient decision|1|||
155707349|NCT03400176|562022282|FG000|Dose Expansion|Patient decision|0|||
155707350|NCT03400176|562022283|FG001|Dose Expansion|Patient decision|0|||
155707351|NCT03400176|562022284|FG002|Dose Expansion|Patient decision|0|||
155707352|NCT03400176|562022285|FG003|Dose Expansion|Patient decision|1|||
155707353|NCT03400176|562022286|FG004|Dose Expansion|Patient decision|0|||
155707354|NCT03400176|562022282|FG000|Dose Expansion|Adverse Event|0|||
155707355|NCT03400176|562022283|FG001|Dose Expansion|Adverse Event|0|||
155707356|NCT03400176|562022284|FG002|Dose Expansion|Adverse Event|0|||
155707357|NCT03400176|562022285|FG003|Dose Expansion|Adverse Event|1|||
155707358|NCT03400176|562022286|FG004|Dose Expansion|Adverse Event|0|||
155707359|NCT03400176|562022282|FG000|Dose Expansion|Physician Decision|0|||
155707360|NCT03400176|562022283|FG001|Dose Expansion|Physician Decision|0|||
155707361|NCT03400176|562022284|FG002|Dose Expansion|Physician Decision|0|||
155707362|NCT03400176|562022285|FG003|Dose Expansion|Physician Decision|1|||
155707363|NCT03400176|562022286|FG004|Dose Expansion|Physician Decision|0|||
155707364|NCT03400176|562022282|FG000|Dose Expansion|Progressive disease|0|||
155707365|NCT03400176|562022283|FG001|Dose Expansion|Progressive disease|0|||
155707366|NCT03400176|562022284|FG002|Dose Expansion|Progressive disease|1|||
155707367|NCT03400176|562022285|FG003|Dose Expansion|Progressive disease|1|||
155707368|NCT03400176|562022286|FG004|Dose Expansion|Progressive disease|0|||
155707369|NCT01090063|562022292|FG000|Screen|Screen Failed|4|||
155707370|NCT01090063|562022292|FG000|Treatment|Withdrawal by Subject|4|||
155707371|NCT00874848|562022293|FG000|Overall Study|Adverse Event|13|||
155707372|NCT00874848|562022294|FG001|Overall Study|Adverse Event|2|||
155707373|NCT00874848|562022293|FG000|Overall Study|Progressive neoplastic disease|38|||
155707374|NCT00874848|562022294|FG001|Overall Study|Progressive neoplastic disease|18|||
155707375|NCT00874848|562022293|FG000|Overall Study|Withdrawal by Subject|7|||
155707376|NCT00874848|562022294|FG001|Overall Study|Withdrawal by Subject|4|||
155707377|NCT00874848|562022293|FG000|Overall Study|Noncompliance|1|||
155707378|NCT00874848|562022294|FG001|Overall Study|Noncompliance|1|||
155707379|NCT00874848|562022293|FG000|Overall Study|Failure to comply with protocol|0|||
155707380|NCT00874848|562022294|FG001|Overall Study|Failure to comply with protocol|1|||
155707381|NCT00874848|562022293|FG000|Overall Study|Physician Decision|0|||
155707382|NCT00874848|562022294|FG001|Overall Study|Physician Decision|2|||
155707383|NCT04698993|562022301|FG000|Overall Study|PCR results not accessible|2|||
155707384|NCT04698993|562022302|FG001|Overall Study|PCR results not accessible|7|||
155707385|NCT04698993|562022301|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
155707386|NCT04698993|562022302|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
155707387|NCT01371734|562022303|FG000|Overall Study|Other|2|||
155707388|NCT01371734|562022304|FG001|Overall Study|Other|1|||
155707389|NCT01371734|562022305|FG002|Overall Study|Other|2|||
155707390|NCT01371734|562022303|FG000|Overall Study|Withdrawal by Subject|3|||
155707391|NCT01371734|562022304|FG001|Overall Study|Withdrawal by Subject|4|||
155707392|NCT01371734|562022305|FG002|Overall Study|Withdrawal by Subject|9|||
155707393|NCT01371734|562022303|FG000|Overall Study|Lost to Follow-up|5|||
155707394|NCT01371734|562022304|FG001|Overall Study|Lost to Follow-up|3|||
155707395|NCT01371734|562022305|FG002|Overall Study|Lost to Follow-up|1|||
155707396|NCT01371734|562022303|FG000|Overall Study|Protocol Violation|3|||
155707397|NCT01371734|562022304|FG001|Overall Study|Protocol Violation|1|||
155707398|NCT01371734|562022305|FG002|Overall Study|Protocol Violation|2|||
155707399|NCT01371734|562022303|FG000|Overall Study|Adverse Event|8|||
155707400|NCT01371734|562022304|FG001|Overall Study|Adverse Event|8|||
155707401|NCT01371734|562022305|FG002|Overall Study|Adverse Event|3|||
155707402|NCT01371734|562022303|FG000|Overall Study|Lack of Efficacy|2|||
155707403|NCT01371734|562022304|FG001|Overall Study|Lack of Efficacy|2|||
155707404|NCT01371734|562022305|FG002|Overall Study|Lack of Efficacy|0|||
155707405|NCT00206440|562022306|FG000|Overall Study|Protocol Violation|1|||
155707406|NCT00206440|562022307|FG001|Overall Study|Protocol Violation|2|||
155707407|NCT00206440|562022306|FG000|Overall Study|Adverse Event|4|||
155707408|NCT00206440|562022307|FG001|Overall Study|Adverse Event|2|||
155707409|NCT00958165|562022308|FG000|Overall Study|Lost to Follow-up|5|||
155707410|NCT00958165|562022308|FG000|Overall Study|Not eligible|9|||
155707411|NCT01298765|562022309|FG000|Titration Period|Adverse Event|26|||
155707412|NCT01298765|562022309|FG000|Titration Period|Death|1|||
155707413|NCT01298765|562022309|FG000|Titration Period|Lack of Efficacy|21|||
155707414|NCT01298765|562022309|FG000|Titration Period|Lost to Follow-up|9|||
155707415|NCT01298765|562022309|FG000|Titration Period|Physician Decision|1|||
155707416|NCT01298765|562022309|FG000|Titration Period|Withdrawal by Subject|10|||
155707417|NCT01298765|562022309|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
155707418|NCT01298765|562022309|FG000|Long-Term Treatment Period|Adverse Event|19|||
155707419|NCT01298765|562022309|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
155707420|NCT01298765|562022309|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
155707421|NCT01298765|562022309|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
155707422|NCT01298765|562022309|FG000|Long-Term Treatment Period|Physician Decision|1|||
155707423|NCT01298765|562022309|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
155707424|NCT03565237|562022310|FG000|Overall Study|Non-compliance of Investigational Product|1|||
155707425|NCT03565237|562022310|FG000|Overall Study|Physician Decision|1|||
155707426|NCT01140061|562022314|FG000|Part I|Adverse Event|1|||
155707427|NCT01140061|562022315|FG001|Part I|Adverse Event|0|||
155707428|NCT01140061|562022316|FG002|Part I|Adverse Event|0|||
155707429|NCT01140061|562022317|FG003|Part I|Adverse Event|0|||
155707430|NCT01140061|562022318|FG004|Part I|Adverse Event|0|||
155707431|NCT01140061|562022319|FG005|Part I|Adverse Event|0|||
155707432|NCT01140061|562022320|FG006|Part I|Adverse Event|0|||
155707433|NCT01140061|562022321|FG007|Part I|Adverse Event|0|||
155707434|NCT01140061|562022322|FG008|Part I|Adverse Event|0|||
155707435|NCT01140061|562022323|FG009|Part I|Adverse Event|0|||
155707436|NCT01140061|562022314|FG000|Extension|Laboratory Adverse Event|0|||
155707437|NCT01140061|562022315|FG001|Extension|Laboratory Adverse Event|0|||
155707438|NCT01140061|562022316|FG002|Extension|Laboratory Adverse Event|0|||
155707439|NCT01140061|562022317|FG003|Extension|Laboratory Adverse Event|0|||
155707440|NCT01140061|562022318|FG004|Extension|Laboratory Adverse Event|0|||
155707441|NCT01140061|562022319|FG005|Extension|Laboratory Adverse Event|0|||
155707442|NCT01140061|562022320|FG006|Extension|Laboratory Adverse Event|0|||
155707443|NCT01140061|562022321|FG007|Extension|Laboratory Adverse Event|0|||
155707444|NCT01140061|562022322|FG008|Extension|Laboratory Adverse Event|0|||
155707445|NCT01140061|562022323|FG009|Extension|Laboratory Adverse Event|1|||
155707446|NCT00428389|562022325|FG000|Core Phase|Adverse Event|6|||
155707447|NCT00428389|562022326|FG001|Core Phase|Adverse Event|4|||
155707448|NCT00428389|562022325|FG000|Core Phase|Lack of Efficacy|2|||
155707449|NCT00428389|562022326|FG001|Core Phase|Lack of Efficacy|0|||
155707450|NCT00428389|562022325|FG000|Core Phase|Abnormal test procedure result(s)|0|||
155707451|NCT00428389|562022326|FG001|Core Phase|Abnormal test procedure result(s)|1|||
155707452|NCT00428389|562022325|FG000|Core Phase|Withdrawal by Subject|3|||
155707453|NCT00428389|562022326|FG001|Core Phase|Withdrawal by Subject|4|||
155707454|NCT00428389|562022325|FG000|Core Phase|Protocol deviation|0|||
155707455|NCT00428389|562022326|FG001|Core Phase|Protocol deviation|2|||
155707456|NCT00428389|562022325|FG000|Extension Phase|Adverse Event|17|||
155707457|NCT00428389|562022326|FG001|Extension Phase|Adverse Event|11|||
155707458|NCT00428389|562022325|FG000|Extension Phase|Lack of Efficacy|4|||
155707459|NCT00428389|562022326|FG001|Extension Phase|Lack of Efficacy|3|||
155707460|NCT00428389|562022325|FG000|Extension Phase|Withdrawal by Subject|6|||
155707461|NCT00428389|562022326|FG001|Extension Phase|Withdrawal by Subject|6|||
155707462|NCT00428389|562022325|FG000|Extension Phase|Lost to Follow-up|0|||
155707463|NCT00428389|562022326|FG001|Extension Phase|Lost to Follow-up|3|||
155707464|NCT00428389|562022325|FG000|Extension Phase|Death|1|||
155707465|NCT00428389|562022326|FG001|Extension Phase|Death|0|||
155707466|NCT00428389|562022325|FG000|Extension Phase|Protocol Violation|3|||
155707467|NCT00428389|562022326|FG001|Extension Phase|Protocol Violation|2|||
155707468|NCT00428389|562022325|FG000|Extension Phase|Administrative problems|1|||
155707469|NCT00428389|562022326|FG001|Extension Phase|Administrative problems|1|||
155707470|NCT04090242|562022327|FG000|Overall Study|Withdrawal by Subject|1|||
155707471|NCT04090242|562022328|FG001|Overall Study|Withdrawal by Subject|0|||
155707472|NCT02687581|562022329|FG000|Overall Study|Withdrawal by Subject|1|||
155707473|NCT02687581|562022330|FG001|Overall Study|Withdrawal by Subject|0|||
155707474|NCT02687581|562022331|FG002|Overall Study|Withdrawal by Subject|0|||
155707475|NCT02687581|562022332|FG003|Overall Study|Withdrawal by Subject|1|||
155707476|NCT02687581|562022329|FG000|Overall Study|Lost to Follow-up|2|||
155707477|NCT02687581|562022330|FG001|Overall Study|Lost to Follow-up|2|||
155707478|NCT02687581|562022331|FG002|Overall Study|Lost to Follow-up|0|||
155707479|NCT02687581|562022332|FG003|Overall Study|Lost to Follow-up|0|||
155707480|NCT02687581|562022329|FG000|Overall Study|the device is too small for the patient.|1|||
155707481|NCT02687581|562022330|FG001|Overall Study|the device is too small for the patient.|0|||
155707482|NCT02687581|562022331|FG002|Overall Study|the device is too small for the patient.|0|||
155707483|NCT02687581|562022332|FG003|Overall Study|the device is too small for the patient.|0|||
155707484|NCT01019369|562022334|FG000|Overall Study|Lost to Follow-up|10|||
155707485|NCT01019369|562022335|FG001|Overall Study|Lost to Follow-up|6|||
155707486|NCT01019369|562022334|FG000|Overall Study|Withdrawal by Subject|0|||
155707487|NCT01019369|562022335|FG001|Overall Study|Withdrawal by Subject|1|||
155707488|NCT01098305|562022336|FG000|Overall Study|Lost to Follow-up|31|||
155707489|NCT01098305|562022337|FG001|Overall Study|Lost to Follow-up|33|||
155707490|NCT00172042|562022338|FG000|Overall Study|Adverse Event|27|||
155707491|NCT00172042|562022339|FG001|Overall Study|Adverse Event|13|||
155707492|NCT00172042|562022338|FG000|Overall Study|Abnormal laboratory value(s)|5|||
155707493|NCT00172042|562022339|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155707494|NCT00172042|562022338|FG000|Overall Study|Abnormal test procedure(s)|0|||
155707495|NCT00172042|562022339|FG001|Overall Study|Abnormal test procedure(s)|3|||
155707496|NCT00172042|562022338|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
155707497|NCT00172042|562022339|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
155707498|NCT00172042|562022338|FG000|Overall Study|Patient no longer requires study drug|10|||
155707499|NCT00172042|562022339|FG001|Overall Study|Patient no longer requires study drug|8|||
155707500|NCT00172042|562022338|FG000|Overall Study|Protocol Violation|8|||
155707501|NCT00172042|562022339|FG001|Overall Study|Protocol Violation|7|||
155707502|NCT00172042|562022338|FG000|Overall Study|Withdrawal by Subject|37|||
155707503|NCT00172042|562022339|FG001|Overall Study|Withdrawal by Subject|25|||
155707504|NCT00172042|562022338|FG000|Overall Study|Lost to Follow-up|3|||
155707505|NCT00172042|562022339|FG001|Overall Study|Lost to Follow-up|5|||
155707506|NCT00172042|562022338|FG000|Overall Study|Administrative problems|13|||
155707507|NCT00172042|562022339|FG001|Overall Study|Administrative problems|10|||
155707508|NCT00172042|562022338|FG000|Overall Study|Death|42|||
155707509|NCT00172042|562022339|FG001|Overall Study|Death|42|||
155707510|NCT04371666|562022343|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
155707511|NCT04371666|562022344|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
155707512|NCT04371666|562022343|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
155707513|NCT04371666|562022344|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
155707514|NCT04371666|562022343|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
155707515|NCT04371666|562022344|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
155707516|NCT04371666|562022343|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
155707517|NCT04371666|562022344|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
155707518|NCT04371666|562022343|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
155707519|NCT04371666|562022344|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
155707520|NCT04371666|562022343|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
155707521|NCT04371666|562022344|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
155707522|NCT02092025|562022345|FG000|Overall Study|Case Report Forms Uncollected|44|||
155707523|NCT02092025|562022345|FG000|Overall Study|Protocol Deviation|24|||
155707524|NCT02927938|562022346|FG000|Overall Study|Death|0|||
155707525|NCT02927938|562022347|FG001|Overall Study|Death|1|||
155707526|NCT02927938|562022348|FG002|Overall Study|Death|0|||
155707527|NCT02927938|562022349|FG003|Overall Study|Death|4|||
155707528|NCT02927938|562022346|FG000|Overall Study|Early Study Termination|1|||
155707529|NCT02927938|562022347|FG001|Overall Study|Early Study Termination|5|||
155707530|NCT02927938|562022348|FG002|Overall Study|Early Study Termination|4|||
155707531|NCT02927938|562022349|FG003|Overall Study|Early Study Termination|3|||
155707532|NCT00264537|562022350|FG000|Overall Study|Death|0|||
155707533|NCT00264537|562022351|FG001|Overall Study|Death|3|||
155707534|NCT00264537|562022352|FG002|Overall Study|Death|3|||
155707535|NCT00264537|562022353|FG003|Overall Study|Death|2|||
155707536|NCT00264537|562022350|FG000|Overall Study|Lost to Follow-up|3|||
155707537|NCT00264537|562022351|FG001|Overall Study|Lost to Follow-up|4|||
155707538|NCT00264537|562022352|FG002|Overall Study|Lost to Follow-up|7|||
155707539|NCT00264537|562022353|FG003|Overall Study|Lost to Follow-up|6|||
155707540|NCT00264537|562022350|FG000|Overall Study|Adverse Event|21|||
155707541|NCT00264537|562022351|FG001|Overall Study|Adverse Event|32|||
155707542|NCT00264537|562022352|FG002|Overall Study|Adverse Event|24|||
155707543|NCT00264537|562022353|FG003|Overall Study|Adverse Event|34|||
155707544|NCT00264537|562022350|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155707545|NCT00264537|562022351|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155707546|NCT00264537|562022352|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
155707547|NCT00264537|562022353|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
155707548|NCT00264537|562022350|FG000|Overall Study|Other|21|||
155707549|NCT00264537|562022351|FG001|Overall Study|Other|11|||
155707550|NCT00264537|562022352|FG002|Overall Study|Other|10|||
155707551|NCT00264537|562022353|FG003|Overall Study|Other|11|||
155707552|NCT00264537|562022350|FG000|Overall Study|Not treated|0|||
155707553|NCT00264537|562022351|FG001|Overall Study|Not treated|2|||
155707554|NCT00264537|562022352|FG002|Overall Study|Not treated|1|||
155707555|NCT00264537|562022353|FG003|Overall Study|Not treated|0|||
155707556|NCT02834247|562022354|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
155707557|NCT02834247|562022355|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
155707558|NCT02834247|562022356|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
155707559|NCT02834247|562022357|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
155707560|NCT02834247|562022354|FG000|Dose Escalation Phase|Death|5|||
155707561|NCT02834247|562022355|FG001|Dose Escalation Phase|Death|6|||
155707562|NCT02834247|562022356|FG002|Dose Escalation Phase|Death|5|||
155707563|NCT02834247|562022357|FG003|Dose Escalation Phase|Death|0|||
155707564|NCT02834247|562022354|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
155707565|NCT02834247|562022355|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
155707566|NCT02834247|562022356|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
155707567|NCT02834247|562022357|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
155707568|NCT02834247|562022354|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
155707569|NCT02834247|562022355|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
155707570|NCT02834247|562022356|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155707571|NCT02834247|562022357|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155707572|NCT02834247|562022354|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155707573|NCT02834247|562022355|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155707574|NCT02834247|562022356|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155707575|NCT02834247|562022357|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
155707576|NCT02834247|562022354|FG000|Dose Expansion Phase|Death|0|||
155707577|NCT02834247|562022355|FG001|Dose Expansion Phase|Death|0|||
155707578|NCT02834247|562022356|FG002|Dose Expansion Phase|Death|0|||
155707579|NCT02834247|562022357|FG003|Dose Expansion Phase|Death|8|||
155707580|NCT02834247|562022354|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
155707581|NCT02834247|562022355|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
155707582|NCT02834247|562022356|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
155707583|NCT02834247|562022357|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
155707584|NCT02834247|562022354|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
155707585|NCT02834247|562022355|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
155707586|NCT02834247|562022356|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
155707587|NCT02834247|562022357|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
155707588|NCT00811174|562022358|FG000|Overall Study|Protocol Violation|2|||
155707589|NCT00811174|562022358|FG000|Overall Study|Sponsors Decision|1|||
155707590|NCT00108862|562023819|FG000|Overall Study|Death|31|||
155707591|NCT00108862|562023820|FG001|Overall Study|Death|37|||
155707592|NCT00108862|562023819|FG000|Overall Study|Withdrawal by Subject|10|||
155707593|NCT00108862|562023820|FG001|Overall Study|Withdrawal by Subject|6|||
155707594|NCT00108862|562023819|FG000|Overall Study|Lost to Follow-up|27|||
155707595|NCT00108862|562023820|FG001|Overall Study|Lost to Follow-up|19|||
155707596|NCT01076036|562023822|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
155707597|NCT01345188|562023823|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
155707598|NCT01345188|562023823|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
155707599|NCT04526145|562023824|FG000|Overall Study|Withdrawal by Subject|5|||
155707600|NCT03364738|562023829|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
155707601|NCT03364738|562023829|FG000|Overall Study|Withdrawal by Subject|1|||
155707602|NCT03364738|562023829|FG000|Overall Study|Adverse Event|1|||
155707603|NCT03245398|562023830|FG000|Overall Study|Travelled to another island|1|||
155707604|NCT03245398|562023831|FG001|Overall Study|Travelled to another island|0|||
155707605|NCT02576795|562023832|FG000|Overall Study|Lost to Follow-up|0|||
155707606|NCT02576795|562023833|FG001|Overall Study|Lost to Follow-up|0|||
155707607|NCT02576795|562023834|FG002|Overall Study|Lost to Follow-up|1|||
155707608|NCT02576795|562023835|FG003|Overall Study|Lost to Follow-up|0|||
155707609|NCT01702246|562023836|FG000|Overall Study|Lost to Follow-up|2|||
155707610|NCT01702246|562023836|FG000|Overall Study|Withdrawal by Subject|2|||
155707611|NCT01702246|562023836|FG000|Overall Study|Physician Decision|1|||
155707612|NCT01518374|562023837|FG000|Overall Study|Withdrawal by Subject|2|||
155707613|NCT01518374|562023837|FG000|Overall Study|Protocol Violation|3|||
155707614|NCT01518374|562023837|FG000|Overall Study|Lost to Follow-up|2|||
155707615|NCT02123823|562023838|FG000|Overall Study|Lack of Efficacy|0|||
155707616|NCT02123823|562023839|FG001|Overall Study|Lack of Efficacy|2|||
155707617|NCT02123823|562023840|FG002|Overall Study|Lack of Efficacy|8|||
155707618|NCT02123823|562023841|FG003|Overall Study|Lack of Efficacy|10|||
155707619|NCT02123823|562023838|FG000|Overall Study|Progressive disease|3|||
155707620|NCT02123823|562023839|FG001|Overall Study|Progressive disease|19|||
155707621|NCT02123823|562023840|FG002|Overall Study|Progressive disease|52|||
155707622|NCT02123823|562023841|FG003|Overall Study|Progressive disease|53|||
155707623|NCT02123823|562023838|FG000|Overall Study|Withdrawal by Subject|0|||
155707624|NCT02123823|562023839|FG001|Overall Study|Withdrawal by Subject|0|||
155707625|NCT02123823|562023840|FG002|Overall Study|Withdrawal by Subject|7|||
155707626|NCT02123823|562023841|FG003|Overall Study|Withdrawal by Subject|2|||
155707627|NCT02123823|562023838|FG000|Overall Study|Adverse Event|0|||
155707628|NCT02123823|562023839|FG001|Overall Study|Adverse Event|0|||
155707629|NCT02123823|562023840|FG002|Overall Study|Adverse Event|3|||
155707630|NCT02123823|562023841|FG003|Overall Study|Adverse Event|5|||
155707631|NCT00465452|562023851|FG000|Overall Study|Adverse Event|1|||
155707632|NCT01635855|562023885|FG000|Overall Study|Withdrawal by Subject|4|||
155707633|NCT03828019|562023889|FG000|Overall Study|Withdrawal by Subject|3|||
155707634|NCT03828019|562023890|FG001|Overall Study|Withdrawal by Subject|8|||
155707635|NCT03828019|562023889|FG000|Overall Study|Lost to Follow-up|1|||
155707636|NCT03828019|562023890|FG001|Overall Study|Lost to Follow-up|6|||
155707637|NCT03828019|562023889|FG000|Overall Study|Incarcerated|1|||
155707638|NCT03828019|562023890|FG001|Overall Study|Incarcerated|0|||
155707639|NCT03828019|562023889|FG000|Overall Study|Adverse Event|0|||
155707640|NCT03828019|562023890|FG001|Overall Study|Adverse Event|1|||
155707641|NCT05715242|562023891|FG000|Overall Study|Lost to Follow-up|0|||
155707642|NCT05715242|562023892|FG001|Overall Study|Lost to Follow-up|0|||
155707643|NCT05715242|562023893|FG002|Overall Study|Lost to Follow-up|1|||
155707644|NCT05715242|562023894|FG003|Overall Study|Lost to Follow-up|0|||
155707645|NCT05715242|562023895|FG004|Overall Study|Lost to Follow-up|0|||
155707646|NCT05715242|562023896|FG005|Overall Study|Lost to Follow-up|1|||
155707647|NCT05715242|562023897|FG006|Overall Study|Lost to Follow-up|0|||
155707648|NCT05715242|562023898|FG007|Overall Study|Lost to Follow-up|0|||
155707649|NCT05715242|562023899|FG008|Overall Study|Lost to Follow-up|0|||
155707650|NCT05715242|562023900|FG009|Overall Study|Lost to Follow-up|0|||
155707651|NCT05715242|562023901|FG010|Overall Study|Lost to Follow-up|0|||
155707652|NCT05715242|562023902|FG011|Overall Study|Lost to Follow-up|0|||
155707653|NCT05715242|562023903|FG012|Overall Study|Lost to Follow-up|0|||
155707654|NCT05715242|562023904|FG013|Overall Study|Lost to Follow-up|0|||
155707655|NCT05715242|562023905|FG014|Overall Study|Lost to Follow-up|0|||
155707656|NCT05715242|562023906|FG015|Overall Study|Lost to Follow-up|0|||
155707657|NCT04384523|562023912|FG000|Overall Study|Lost to Follow-up|0|||
155707658|NCT04384523|562023913|FG001|Overall Study|Lost to Follow-up|0|||
155707659|NCT04384523|562023914|FG002|Overall Study|Lost to Follow-up|0|||
155707660|NCT04384523|562023915|FG003|Overall Study|Lost to Follow-up|0|||
155707661|NCT04384523|562023916|FG004|Overall Study|Lost to Follow-up|0|||
155707662|NCT04384523|562023917|FG005|Overall Study|Lost to Follow-up|1|||
155707663|NCT04384523|562023912|FG000|Overall Study|Protocol Violation|0|||
155707664|NCT04384523|562023913|FG001|Overall Study|Protocol Violation|1|||
155707665|NCT04384523|562023914|FG002|Overall Study|Protocol Violation|0|||
155707666|NCT04384523|562023915|FG003|Overall Study|Protocol Violation|0|||
155707667|NCT04384523|562023916|FG004|Overall Study|Protocol Violation|0|||
155707668|NCT04384523|562023917|FG005|Overall Study|Protocol Violation|0|||
155707669|NCT04384523|562023912|FG000|Overall Study|Withdrawal by Subject|1|||
155707670|NCT04384523|562023913|FG001|Overall Study|Withdrawal by Subject|0|||
155707671|NCT04384523|562023914|FG002|Overall Study|Withdrawal by Subject|0|||
155707672|NCT04384523|562023915|FG003|Overall Study|Withdrawal by Subject|0|||
155707673|NCT04384523|562023916|FG004|Overall Study|Withdrawal by Subject|0|||
155707674|NCT04384523|562023917|FG005|Overall Study|Withdrawal by Subject|0|||
155707675|NCT04565951|562023918|FG000|Overall Study|Lost to Follow-up|66|||
155707676|NCT04565951|562023919|FG001|Overall Study|Lost to Follow-up|38|||
155707677|NCT04565951|562023918|FG000|Overall Study|Withdrawal by Subject|14|||
155707678|NCT04565951|562023919|FG001|Overall Study|Withdrawal by Subject|7|||
155707679|NCT04565951|562023918|FG000|Overall Study|Death|0|||
155707680|NCT04565951|562023919|FG001|Overall Study|Death|1|||
155707681|NCT04677504|562023921|FG000|Overall Study|Death|51|||
155707682|NCT04677504|562023922|FG001|Overall Study|Death|49|||
155707683|NCT04677504|562023921|FG000|Overall Study|Progressive Disease|1|||
155707684|NCT04677504|562023922|FG001|Overall Study|Progressive Disease|0|||
155707685|NCT04677504|562023921|FG000|Overall Study|Symptomatic Deterioration|1|||
155707686|NCT04677504|562023922|FG001|Overall Study|Symptomatic Deterioration|0|||
155707687|NCT04677504|562023921|FG000|Overall Study|Withdrawal by Subject|2|||
155707688|NCT04677504|562023922|FG001|Overall Study|Withdrawal by Subject|5|||
155707689|NCT04677504|562023921|FG000|Overall Study|Study Terminated By Sponsor|28|||
155707690|NCT04677504|562023922|FG001|Overall Study|Study Terminated By Sponsor|24|||
155707691|NCT04677504|562023921|FG000|Overall Study|Adverse Event|0|||
155707692|NCT04677504|562023922|FG001|Overall Study|Adverse Event|1|||
155707693|NCT03182907|562023923|FG000|Overall Study|Death|3|||
155707694|NCT03182907|562023924|FG001|Overall Study|Death|0|||
155707695|NCT03182907|562023923|FG000|Overall Study|Protocol Violation|4|||
155707696|NCT03182907|562023924|FG001|Overall Study|Protocol Violation|0|||
155707697|NCT03182907|562023923|FG000|Overall Study|Lost to Follow-up|1|||
155707698|NCT03182907|562023924|FG001|Overall Study|Lost to Follow-up|0|||
155707699|NCT03182907|562023923|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155707700|NCT03182907|562023924|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155707701|NCT00384332|562023929|FG000|Overall Study|Lost to Follow-up|4|||
155707702|NCT00384332|562023930|FG001|Overall Study|Lost to Follow-up|0|||
155707703|NCT01771250|562023931|FG000|Period 1|Met exclusion criteria|1|||
155707704|NCT01771250|562023932|FG001|Period 1|Met exclusion criteria|0|||
155707705|NCT02058563|562023933|FG000|Overall Study|Lost to Follow-up|26|||
155707706|NCT02058563|562023934|FG001|Overall Study|Lost to Follow-up|22|||
155707707|NCT02058563|562023933|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
155707708|NCT02058563|562023934|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
155707709|NCT02058563|562023933|FG000|Overall Study|Consent Withdrawal|1|||
155707710|NCT02058563|562023934|FG001|Overall Study|Consent Withdrawal|1|||
155707711|NCT02058563|562023933|FG000|Overall Study|Other (patient incarcerated)|0|||
155707712|NCT02058563|562023934|FG001|Overall Study|Other (patient incarcerated)|1|||
155707713|NCT00483938|562023935|FG000|Overall Study|Protocol Violation|0|||
155707714|NCT00483938|562023936|FG001|Overall Study|Protocol Violation|0|||
155707715|NCT00483938|562023937|FG002|Overall Study|Protocol Violation|0|||
155707716|NCT00483938|562023938|FG003|Overall Study|Protocol Violation|0|||
155707717|NCT00483938|562023939|FG004|Overall Study|Protocol Violation|0|||
155707718|NCT00483938|562023940|FG005|Overall Study|Protocol Violation|0|||
155707719|NCT00483938|562023941|FG006|Overall Study|Protocol Violation|3|||
155707720|NCT00483938|562023935|FG000|Overall Study|Withdrawal by Subject|1|||
155707721|NCT00483938|562023936|FG001|Overall Study|Withdrawal by Subject|6|||
155707722|NCT00483938|562023937|FG002|Overall Study|Withdrawal by Subject|0|||
155707723|NCT00483938|562023938|FG003|Overall Study|Withdrawal by Subject|0|||
155707724|NCT00483938|562023939|FG004|Overall Study|Withdrawal by Subject|1|||
155707725|NCT00483938|562023940|FG005|Overall Study|Withdrawal by Subject|3|||
155707726|NCT00483938|562023941|FG006|Overall Study|Withdrawal by Subject|2|||
155707727|NCT00483938|562023935|FG000|Overall Study|Lost to Follow-up|1|||
155707728|NCT00483938|562023936|FG001|Overall Study|Lost to Follow-up|2|||
155707729|NCT00483938|562023937|FG002|Overall Study|Lost to Follow-up|0|||
155707730|NCT00483938|562023938|FG003|Overall Study|Lost to Follow-up|2|||
155707731|NCT00483938|562023939|FG004|Overall Study|Lost to Follow-up|1|||
155707732|NCT00483938|562023940|FG005|Overall Study|Lost to Follow-up|1|||
155707733|NCT00483938|562023941|FG006|Overall Study|Lost to Follow-up|3|||
155707734|NCT00483938|562023935|FG000|Overall Study|Death|0|||
155707735|NCT00483938|562023936|FG001|Overall Study|Death|2|||
155707736|NCT00483938|562023937|FG002|Overall Study|Death|0|||
155707737|NCT00483938|562023938|FG003|Overall Study|Death|0|||
155707738|NCT00483938|562023939|FG004|Overall Study|Death|0|||
155707739|NCT00483938|562023940|FG005|Overall Study|Death|0|||
155707740|NCT00483938|562023941|FG006|Overall Study|Death|0|||
155707741|NCT00483938|562023935|FG000|Overall Study|Other|3|||
155707742|NCT00483938|562023936|FG001|Overall Study|Other|9|||
155707743|NCT00483938|562023937|FG002|Overall Study|Other|0|||
155707744|NCT00483938|562023938|FG003|Overall Study|Other|4|||
155707745|NCT00483938|562023939|FG004|Overall Study|Other|0|||
155707746|NCT00483938|562023940|FG005|Overall Study|Other|4|||
155707747|NCT00483938|562023941|FG006|Overall Study|Other|32|||
155707748|NCT04039217|562023944|FG000|Overall Study|Lost to Follow-up|1|||
155707749|NCT00106353|562023945|FG000|Part 1|Disease progression|3|||
155707750|NCT00106353|562023946|FG001|Part 1|Disease progression|4|||
155707751|NCT00106353|562023947|FG002|Part 1|Disease progression|1|||
155707752|NCT00106353|562023948|FG003|Part 1|Disease progression|3|||
155707753|NCT00106353|562023949|FG004|Part 1|Disease progression|0|||
155707754|NCT00106353|562023950|FG005|Part 1|Disease progression|0|||
155707755|NCT00106353|562023951|FG006|Part 1|Disease progression|0|||
155707756|NCT00106353|562023945|FG000|Part 1|Withdrawal by Subject|0|||
155707757|NCT00106353|562023946|FG001|Part 1|Withdrawal by Subject|0|||
155707758|NCT00106353|562023947|FG002|Part 1|Withdrawal by Subject|1|||
155707759|NCT00106353|562023948|FG003|Part 1|Withdrawal by Subject|2|||
155707760|NCT00106353|562023949|FG004|Part 1|Withdrawal by Subject|0|||
155707761|NCT00106353|562023950|FG005|Part 1|Withdrawal by Subject|0|||
155707762|NCT00106353|562023951|FG006|Part 1|Withdrawal by Subject|0|||
155707763|NCT00106353|562023945|FG000|Part 1|Symptomatic deterioration|0|||
155707764|NCT00106353|562023946|FG001|Part 1|Symptomatic deterioration|0|||
155707765|NCT00106353|562023947|FG002|Part 1|Symptomatic deterioration|1|||
155707766|NCT00106353|562023948|FG003|Part 1|Symptomatic deterioration|0|||
155707767|NCT00106353|562023949|FG004|Part 1|Symptomatic deterioration|0|||
155707768|NCT00106353|562023950|FG005|Part 1|Symptomatic deterioration|0|||
155707769|NCT00106353|562023951|FG006|Part 1|Symptomatic deterioration|0|||
155707770|NCT00106353|562023945|FG000|Part 1|Entered follow-up phase|1|||
155707771|NCT00106353|562023946|FG001|Part 1|Entered follow-up phase|1|||
155707772|NCT00106353|562023947|FG002|Part 1|Entered follow-up phase|0|||
155707773|NCT00106353|562023948|FG003|Part 1|Entered follow-up phase|1|||
155707774|NCT00106353|562023949|FG004|Part 1|Entered follow-up phase|0|||
155707775|NCT00106353|562023950|FG005|Part 1|Entered follow-up phase|0|||
155707776|NCT00106353|562023951|FG006|Part 1|Entered follow-up phase|0|||
155707777|NCT00106353|562023945|FG000|Part 1|Adverse Event|0|||
155707778|NCT00106353|562023946|FG001|Part 1|Adverse Event|0|||
155707779|NCT00106353|562023947|FG002|Part 1|Adverse Event|0|||
155707780|NCT00106353|562023948|FG003|Part 1|Adverse Event|1|||
155707781|NCT00106353|562023949|FG004|Part 1|Adverse Event|0|||
155707782|NCT00106353|562023950|FG005|Part 1|Adverse Event|0|||
155707783|NCT00106353|562023951|FG006|Part 1|Adverse Event|0|||
155707784|NCT00106353|562023945|FG000|Part 2|Disease progression|0|||
155707785|NCT00106353|562023946|FG001|Part 2|Disease progression|0|||
155707786|NCT00106353|562023947|FG002|Part 2|Disease progression|0|||
155707787|NCT00106353|562023948|FG003|Part 2|Disease progression|0|||
155707788|NCT00106353|562023949|FG004|Part 2|Disease progression|8|||
155707789|NCT00106353|562023950|FG005|Part 2|Disease progression|14|||
155707790|NCT00106353|562023951|FG006|Part 2|Disease progression|13|||
155707791|NCT00106353|562023945|FG000|Part 2|Death|0|||
155707792|NCT00106353|562023946|FG001|Part 2|Death|0|||
155707793|NCT00106353|562023947|FG002|Part 2|Death|0|||
155707794|NCT00106353|562023948|FG003|Part 2|Death|0|||
155707795|NCT00106353|562023949|FG004|Part 2|Death|3|||
155707796|NCT00106353|562023950|FG005|Part 2|Death|0|||
155707797|NCT00106353|562023951|FG006|Part 2|Death|1|||
155707798|NCT00106353|562023945|FG000|Part 2|Symptomatic deterioration|0|||
155707799|NCT00106353|562023946|FG001|Part 2|Symptomatic deterioration|0|||
155707800|NCT00106353|562023947|FG002|Part 2|Symptomatic deterioration|0|||
155707801|NCT00106353|562023948|FG003|Part 2|Symptomatic deterioration|0|||
155707802|NCT00106353|562023949|FG004|Part 2|Symptomatic deterioration|3|||
155707803|NCT00106353|562023950|FG005|Part 2|Symptomatic deterioration|0|||
155707804|NCT00106353|562023951|FG006|Part 2|Symptomatic deterioration|0|||
155707805|NCT00106353|562023945|FG000|Part 2|Adverse Event|0|||
155707806|NCT00106353|562023946|FG001|Part 2|Adverse Event|0|||
155707807|NCT00106353|562023947|FG002|Part 2|Adverse Event|0|||
155707808|NCT00106353|562023948|FG003|Part 2|Adverse Event|0|||
155707809|NCT00106353|562023949|FG004|Part 2|Adverse Event|0|||
155707810|NCT00106353|562023950|FG005|Part 2|Adverse Event|2|||
155707811|NCT00106353|562023951|FG006|Part 2|Adverse Event|1|||
155707812|NCT00106353|562023945|FG000|Part 2|Other|0|||
155707813|NCT00106353|562023946|FG001|Part 2|Other|0|||
155707814|NCT00106353|562023947|FG002|Part 2|Other|0|||
155707815|NCT00106353|562023948|FG003|Part 2|Other|0|||
155707816|NCT00106353|562023949|FG004|Part 2|Other|1|||
155707817|NCT00106353|562023950|FG005|Part 2|Other|1|||
155707818|NCT00106353|562023951|FG006|Part 2|Other|1|||
155707819|NCT00106353|562023945|FG000|Part 2|Withdrawal by Subject|0|||
155707820|NCT00106353|562023946|FG001|Part 2|Withdrawal by Subject|0|||
155707821|NCT00106353|562023947|FG002|Part 2|Withdrawal by Subject|0|||
155707822|NCT00106353|562023948|FG003|Part 2|Withdrawal by Subject|0|||
155707823|NCT00106353|562023949|FG004|Part 2|Withdrawal by Subject|1|||
155707824|NCT00106353|562023950|FG005|Part 2|Withdrawal by Subject|0|||
155707825|NCT00106353|562023951|FG006|Part 2|Withdrawal by Subject|0|||
155707826|NCT00106353|562023945|FG000|Part 2|Physician Decision|0|||
155707827|NCT00106353|562023946|FG001|Part 2|Physician Decision|0|||
155707828|NCT00106353|562023947|FG002|Part 2|Physician Decision|0|||
155707829|NCT00106353|562023948|FG003|Part 2|Physician Decision|0|||
155707830|NCT00106353|562023949|FG004|Part 2|Physician Decision|0|||
155707831|NCT00106353|562023950|FG005|Part 2|Physician Decision|1|||
155707832|NCT00106353|562023951|FG006|Part 2|Physician Decision|0|||
155707833|NCT01371552|562023952|FG000|Part 1, First 3 Days|Inconvenience|0|||
155707834|NCT01371552|562023953|FG001|Part 1, First 3 Days|Inconvenience|0|||
155707835|NCT01371552|562023954|FG002|Part 1, First 3 Days|Inconvenience|1|||
155707836|NCT01371552|562023955|FG003|Part 1, First 3 Days|Inconvenience|0|||
155707837|NCT01371552|562023956|FG004|Part 1, First 3 Days|Inconvenience|0|||
155707838|NCT01371552|562023957|FG005|Part 1, First 3 Days|Inconvenience|0|||
155707839|NCT03364309|562023958|FG000|Induction Period|Adverse Event|4|||
155707840|NCT03364309|562023959|FG001|Induction Period|Adverse Event|0|||
155707841|NCT03364309|562023960|FG002|Induction Period|Adverse Event|1|||
155707842|NCT03364309|562023961|FG003|Induction Period|Adverse Event|0|||
155707843|NCT03364309|562023962|FG004|Induction Period|Adverse Event|0|||
155707844|NCT03364309|562023963|FG005|Induction Period|Adverse Event|0|||
155707845|NCT03364309|562023964|FG006|Induction Period|Adverse Event|0|||
155707846|NCT03364309|562023965|FG007|Induction Period|Adverse Event|0|||
155707847|NCT03364309|562023966|FG008|Induction Period|Adverse Event|0|||
155707848|NCT03364309|562023967|FG009|Induction Period|Adverse Event|0|||
155707849|NCT03364309|562023968|FG010|Induction Period|Adverse Event|0|||
155707850|NCT03364309|562023969|FG011|Induction Period|Adverse Event|0|||
155707851|NCT03364309|562023970|FG012|Induction Period|Adverse Event|0|||
155707852|NCT03364309|562023971|FG013|Induction Period|Adverse Event|0|||
155707853|NCT03364309|562023972|FG014|Induction Period|Adverse Event|0|||
155707854|NCT03364309|562023973|FG015|Induction Period|Adverse Event|0|||
155707855|NCT03364309|562023974|FG016|Induction Period|Adverse Event|0|||
155707856|NCT03364309|562023975|FG017|Induction Period|Adverse Event|0|||
155707857|NCT03364309|562023976|FG018|Induction Period|Adverse Event|0|||
155707858|NCT03364309|562023958|FG000|Induction Period|Withdrawal by Subject|1|||
155707859|NCT03364309|562023959|FG001|Induction Period|Withdrawal by Subject|3|||
155707860|NCT03364309|562023960|FG002|Induction Period|Withdrawal by Subject|0|||
155707861|NCT03364309|562023961|FG003|Induction Period|Withdrawal by Subject|0|||
155707862|NCT03364309|562023962|FG004|Induction Period|Withdrawal by Subject|0|||
155707863|NCT03364309|562023963|FG005|Induction Period|Withdrawal by Subject|0|||
155707864|NCT03364309|562023964|FG006|Induction Period|Withdrawal by Subject|0|||
155707865|NCT03364309|562023965|FG007|Induction Period|Withdrawal by Subject|0|||
155707866|NCT03364309|562023966|FG008|Induction Period|Withdrawal by Subject|0|||
155707867|NCT03364309|562023967|FG009|Induction Period|Withdrawal by Subject|0|||
155707868|NCT03364309|562023968|FG010|Induction Period|Withdrawal by Subject|0|||
155707869|NCT03364309|562023969|FG011|Induction Period|Withdrawal by Subject|0|||
155707870|NCT03364309|562023970|FG012|Induction Period|Withdrawal by Subject|0|||
155707871|NCT03364309|562023971|FG013|Induction Period|Withdrawal by Subject|0|||
155707872|NCT03364309|562023972|FG014|Induction Period|Withdrawal by Subject|0|||
155707873|NCT03364309|562023973|FG015|Induction Period|Withdrawal by Subject|0|||
155707874|NCT03364309|562023974|FG016|Induction Period|Withdrawal by Subject|0|||
155707875|NCT03364309|562023975|FG017|Induction Period|Withdrawal by Subject|0|||
155707876|NCT03364309|562023976|FG018|Induction Period|Withdrawal by Subject|0|||
155707877|NCT03364309|562023958|FG000|Induction Period|Lost to Follow-up|1|||
155707878|NCT03364309|562023959|FG001|Induction Period|Lost to Follow-up|0|||
155707879|NCT03364309|562023960|FG002|Induction Period|Lost to Follow-up|0|||
155707880|NCT03364309|562023961|FG003|Induction Period|Lost to Follow-up|0|||
155707881|NCT03364309|562023962|FG004|Induction Period|Lost to Follow-up|0|||
155707882|NCT03364309|562023963|FG005|Induction Period|Lost to Follow-up|0|||
155707883|NCT03364309|562023964|FG006|Induction Period|Lost to Follow-up|0|||
155707884|NCT03364309|562023965|FG007|Induction Period|Lost to Follow-up|0|||
155707885|NCT03364309|562023966|FG008|Induction Period|Lost to Follow-up|0|||
155707886|NCT03364309|562023967|FG009|Induction Period|Lost to Follow-up|0|||
155707887|NCT03364309|562023968|FG010|Induction Period|Lost to Follow-up|0|||
155707888|NCT03364309|562023969|FG011|Induction Period|Lost to Follow-up|0|||
155707889|NCT03364309|562023970|FG012|Induction Period|Lost to Follow-up|0|||
155707890|NCT03364309|562023971|FG013|Induction Period|Lost to Follow-up|0|||
155707891|NCT03364309|562023972|FG014|Induction Period|Lost to Follow-up|0|||
155707892|NCT03364309|562023973|FG015|Induction Period|Lost to Follow-up|0|||
155707893|NCT03364309|562023974|FG016|Induction Period|Lost to Follow-up|0|||
155707894|NCT03364309|562023975|FG017|Induction Period|Lost to Follow-up|0|||
155707895|NCT03364309|562023976|FG018|Induction Period|Lost to Follow-up|0|||
155707896|NCT03364309|562023958|FG000|Induction Period|Physician Decision|0|||
155707897|NCT03364309|562023959|FG001|Induction Period|Physician Decision|1|||
155707898|NCT03364309|562023960|FG002|Induction Period|Physician Decision|0|||
155707899|NCT03364309|562023961|FG003|Induction Period|Physician Decision|0|||
155707900|NCT03364309|562023962|FG004|Induction Period|Physician Decision|0|||
155707901|NCT03364309|562023963|FG005|Induction Period|Physician Decision|0|||
155707902|NCT03364309|562023964|FG006|Induction Period|Physician Decision|0|||
155707903|NCT03364309|562023965|FG007|Induction Period|Physician Decision|0|||
155707904|NCT03364309|562023966|FG008|Induction Period|Physician Decision|0|||
155707905|NCT03364309|562023967|FG009|Induction Period|Physician Decision|0|||
155707906|NCT03364309|562023968|FG010|Induction Period|Physician Decision|0|||
155707907|NCT03364309|562023969|FG011|Induction Period|Physician Decision|0|||
155707908|NCT03364309|562023970|FG012|Induction Period|Physician Decision|0|||
155707909|NCT03364309|562023971|FG013|Induction Period|Physician Decision|0|||
155707910|NCT03364309|562023972|FG014|Induction Period|Physician Decision|0|||
155707911|NCT03364309|562023973|FG015|Induction Period|Physician Decision|0|||
155707912|NCT03364309|562023974|FG016|Induction Period|Physician Decision|0|||
155707913|NCT03364309|562023975|FG017|Induction Period|Physician Decision|0|||
155707914|NCT03364309|562023976|FG018|Induction Period|Physician Decision|0|||
155707915|NCT03364309|562023958|FG000|Maintenance Period|Withdrawal by Subject|0|||
155707916|NCT03364309|562023959|FG001|Maintenance Period|Withdrawal by Subject|0|||
155707917|NCT03364309|562023960|FG002|Maintenance Period|Withdrawal by Subject|0|||
155707918|NCT03364309|562023961|FG003|Maintenance Period|Withdrawal by Subject|1|||
155707919|NCT03364309|562023962|FG004|Maintenance Period|Withdrawal by Subject|3|||
155707920|NCT03364309|562023963|FG005|Maintenance Period|Withdrawal by Subject|1|||
155707921|NCT03364309|562023964|FG006|Maintenance Period|Withdrawal by Subject|3|||
155707922|NCT03364309|562023965|FG007|Maintenance Period|Withdrawal by Subject|0|||
155707923|NCT03364309|562023966|FG008|Maintenance Period|Withdrawal by Subject|1|||
155707924|NCT03364309|562023967|FG009|Maintenance Period|Withdrawal by Subject|1|||
155707925|NCT03364309|562023968|FG010|Maintenance Period|Withdrawal by Subject|2|||
155707926|NCT03364309|562023969|FG011|Maintenance Period|Withdrawal by Subject|0|||
155707927|NCT03364309|562023970|FG012|Maintenance Period|Withdrawal by Subject|0|||
155707928|NCT03364309|562023971|FG013|Maintenance Period|Withdrawal by Subject|0|||
155707929|NCT03364309|562023972|FG014|Maintenance Period|Withdrawal by Subject|0|||
155707930|NCT03364309|562023973|FG015|Maintenance Period|Withdrawal by Subject|0|||
155707931|NCT03364309|562023974|FG016|Maintenance Period|Withdrawal by Subject|0|||
155707932|NCT03364309|562023975|FG017|Maintenance Period|Withdrawal by Subject|0|||
155707933|NCT03364309|562023976|FG018|Maintenance Period|Withdrawal by Subject|0|||
155707934|NCT03364309|562023958|FG000|Maintenance Period|Adverse Event|0|||
155707935|NCT03364309|562023959|FG001|Maintenance Period|Adverse Event|0|||
155707936|NCT03364309|562023960|FG002|Maintenance Period|Adverse Event|0|||
155707937|NCT03364309|562023961|FG003|Maintenance Period|Adverse Event|0|||
155707938|NCT03364309|562023962|FG004|Maintenance Period|Adverse Event|2|||
155707939|NCT03364309|562023963|FG005|Maintenance Period|Adverse Event|0|||
155707940|NCT03364309|562023964|FG006|Maintenance Period|Adverse Event|3|||
155707941|NCT03364309|562023965|FG007|Maintenance Period|Adverse Event|0|||
155707942|NCT03364309|562023966|FG008|Maintenance Period|Adverse Event|1|||
155707943|NCT03364309|562023967|FG009|Maintenance Period|Adverse Event|0|||
155707944|NCT03364309|562023968|FG010|Maintenance Period|Adverse Event|2|||
155707945|NCT03364309|562023969|FG011|Maintenance Period|Adverse Event|0|||
155707946|NCT03364309|562023970|FG012|Maintenance Period|Adverse Event|0|||
155707947|NCT03364309|562023971|FG013|Maintenance Period|Adverse Event|0|||
155707948|NCT03364309|562023972|FG014|Maintenance Period|Adverse Event|0|||
155707949|NCT03364309|562023973|FG015|Maintenance Period|Adverse Event|0|||
155707950|NCT03364309|562023974|FG016|Maintenance Period|Adverse Event|0|||
155707951|NCT03364309|562023975|FG017|Maintenance Period|Adverse Event|0|||
155707952|NCT03364309|562023976|FG018|Maintenance Period|Adverse Event|0|||
155707953|NCT03364309|562023958|FG000|Maintenance Period|Relapsed|0|||
155707954|NCT03364309|562023959|FG001|Maintenance Period|Relapsed|0|||
155707955|NCT03364309|562023960|FG002|Maintenance Period|Relapsed|0|||
155707956|NCT03364309|562023961|FG003|Maintenance Period|Relapsed|43|||
155707957|NCT03364309|562023962|FG004|Maintenance Period|Relapsed|7|||
155707958|NCT03364309|562023963|FG005|Maintenance Period|Relapsed|45|||
155707959|NCT03364309|562023964|FG006|Maintenance Period|Relapsed|10|||
155707960|NCT03364309|562023965|FG007|Maintenance Period|Relapsed|2|||
155707961|NCT03364309|562023966|FG008|Maintenance Period|Relapsed|0|||
155707962|NCT03364309|562023967|FG009|Maintenance Period|Relapsed|0|||
155707963|NCT03364309|562023968|FG010|Maintenance Period|Relapsed|0|||
155707964|NCT03364309|562023969|FG011|Maintenance Period|Relapsed|0|||
155707965|NCT03364309|562023970|FG012|Maintenance Period|Relapsed|0|||
155707966|NCT03364309|562023971|FG013|Maintenance Period|Relapsed|0|||
155707967|NCT03364309|562023972|FG014|Maintenance Period|Relapsed|0|||
155707968|NCT03364309|562023973|FG015|Maintenance Period|Relapsed|0|||
155707969|NCT03364309|562023974|FG016|Maintenance Period|Relapsed|0|||
155707970|NCT03364309|562023975|FG017|Maintenance Period|Relapsed|0|||
155707971|NCT03364309|562023976|FG018|Maintenance Period|Relapsed|0|||
155707972|NCT03364309|562023958|FG000|Maintenance Period|Lack of Efficacy|0|||
155707973|NCT03364309|562023959|FG001|Maintenance Period|Lack of Efficacy|0|||
155707974|NCT03364309|562023960|FG002|Maintenance Period|Lack of Efficacy|0|||
155707975|NCT03364309|562023961|FG003|Maintenance Period|Lack of Efficacy|0|||
155707976|NCT03364309|562023962|FG004|Maintenance Period|Lack of Efficacy|0|||
155707977|NCT03364309|562023963|FG005|Maintenance Period|Lack of Efficacy|0|||
155707978|NCT03364309|562023964|FG006|Maintenance Period|Lack of Efficacy|0|||
155707979|NCT03364309|562023965|FG007|Maintenance Period|Lack of Efficacy|0|||
155707980|NCT03364309|562023966|FG008|Maintenance Period|Lack of Efficacy|1|||
155707981|NCT03364309|562023967|FG009|Maintenance Period|Lack of Efficacy|3|||
155707982|NCT03364309|562023968|FG010|Maintenance Period|Lack of Efficacy|2|||
155707983|NCT03364309|562023969|FG011|Maintenance Period|Lack of Efficacy|0|||
155707984|NCT03364309|562023970|FG012|Maintenance Period|Lack of Efficacy|0|||
155707985|NCT03364309|562023971|FG013|Maintenance Period|Lack of Efficacy|0|||
155707986|NCT03364309|562023972|FG014|Maintenance Period|Lack of Efficacy|0|||
155707987|NCT03364309|562023973|FG015|Maintenance Period|Lack of Efficacy|0|||
155707988|NCT03364309|562023974|FG016|Maintenance Period|Lack of Efficacy|0|||
155707989|NCT03364309|562023975|FG017|Maintenance Period|Lack of Efficacy|0|||
155707990|NCT03364309|562023976|FG018|Maintenance Period|Lack of Efficacy|0|||
155707991|NCT03364309|562023958|FG000|Maintenance Period|Death|0|||
155707992|NCT03364309|562023959|FG001|Maintenance Period|Death|0|||
155707993|NCT03364309|562023960|FG002|Maintenance Period|Death|0|||
155707994|NCT03364309|562023961|FG003|Maintenance Period|Death|0|||
155707995|NCT03364309|562023962|FG004|Maintenance Period|Death|0|||
155707996|NCT03364309|562023963|FG005|Maintenance Period|Death|0|||
155707997|NCT03364309|562023964|FG006|Maintenance Period|Death|0|||
155707998|NCT03364309|562023965|FG007|Maintenance Period|Death|0|||
155707999|NCT03364309|562023966|FG008|Maintenance Period|Death|1|||
155708000|NCT03364309|562023967|FG009|Maintenance Period|Death|0|||
155708001|NCT03364309|562023968|FG010|Maintenance Period|Death|0|||
155708002|NCT03364309|562023969|FG011|Maintenance Period|Death|0|||
155708003|NCT03364309|562023970|FG012|Maintenance Period|Death|0|||
155708004|NCT03364309|562023971|FG013|Maintenance Period|Death|0|||
155708005|NCT03364309|562023972|FG014|Maintenance Period|Death|0|||
155708006|NCT03364309|562023973|FG015|Maintenance Period|Death|0|||
155708007|NCT03364309|562023974|FG016|Maintenance Period|Death|0|||
155708008|NCT03364309|562023975|FG017|Maintenance Period|Death|0|||
155708009|NCT03364309|562023976|FG018|Maintenance Period|Death|0|||
155708010|NCT03364309|562023958|FG000|Maintenance Period|Lost to Follow-up|0|||
155708011|NCT03364309|562023959|FG001|Maintenance Period|Lost to Follow-up|0|||
155708012|NCT03364309|562023960|FG002|Maintenance Period|Lost to Follow-up|0|||
155708013|NCT03364309|562023961|FG003|Maintenance Period|Lost to Follow-up|0|||
155708014|NCT03364309|562023962|FG004|Maintenance Period|Lost to Follow-up|0|||
155708015|NCT03364309|562023963|FG005|Maintenance Period|Lost to Follow-up|0|||
155708016|NCT03364309|562023964|FG006|Maintenance Period|Lost to Follow-up|0|||
155708017|NCT03364309|562023965|FG007|Maintenance Period|Lost to Follow-up|0|||
155708018|NCT03364309|562023966|FG008|Maintenance Period|Lost to Follow-up|1|||
155708019|NCT03364309|562023967|FG009|Maintenance Period|Lost to Follow-up|0|||
155708020|NCT03364309|562023968|FG010|Maintenance Period|Lost to Follow-up|0|||
155708021|NCT03364309|562023969|FG011|Maintenance Period|Lost to Follow-up|0|||
155708022|NCT03364309|562023970|FG012|Maintenance Period|Lost to Follow-up|0|||
155708023|NCT03364309|562023971|FG013|Maintenance Period|Lost to Follow-up|0|||
155708024|NCT03364309|562023972|FG014|Maintenance Period|Lost to Follow-up|0|||
155708025|NCT03364309|562023973|FG015|Maintenance Period|Lost to Follow-up|0|||
155708026|NCT03364309|562023974|FG016|Maintenance Period|Lost to Follow-up|0|||
155708027|NCT03364309|562023975|FG017|Maintenance Period|Lost to Follow-up|0|||
155708028|NCT03364309|562023976|FG018|Maintenance Period|Lost to Follow-up|0|||
155708029|NCT03364309|562023958|FG000|Maintenance Period|Miscellaneous|0|||
155708030|NCT03364309|562023959|FG001|Maintenance Period|Miscellaneous|0|||
155708031|NCT03364309|562023960|FG002|Maintenance Period|Miscellaneous|0|||
155708032|NCT03364309|562023961|FG003|Maintenance Period|Miscellaneous|0|||
155708033|NCT03364309|562023962|FG004|Maintenance Period|Miscellaneous|0|||
155708034|NCT03364309|562023963|FG005|Maintenance Period|Miscellaneous|0|||
155708035|NCT03364309|562023964|FG006|Maintenance Period|Miscellaneous|0|||
155708036|NCT03364309|562023965|FG007|Maintenance Period|Miscellaneous|0|||
155708037|NCT03364309|562023966|FG008|Maintenance Period|Miscellaneous|1|||
155708038|NCT03364309|562023967|FG009|Maintenance Period|Miscellaneous|0|||
155708039|NCT03364309|562023968|FG010|Maintenance Period|Miscellaneous|0|||
155708040|NCT03364309|562023969|FG011|Maintenance Period|Miscellaneous|0|||
155708041|NCT03364309|562023970|FG012|Maintenance Period|Miscellaneous|0|||
155708042|NCT03364309|562023971|FG013|Maintenance Period|Miscellaneous|0|||
155708043|NCT03364309|562023972|FG014|Maintenance Period|Miscellaneous|0|||
155708044|NCT03364309|562023973|FG015|Maintenance Period|Miscellaneous|0|||
155708045|NCT03364309|562023974|FG016|Maintenance Period|Miscellaneous|0|||
155708046|NCT03364309|562023975|FG017|Maintenance Period|Miscellaneous|0|||
155708047|NCT03364309|562023976|FG018|Maintenance Period|Miscellaneous|0|||
155708048|NCT03364309|562023958|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708049|NCT03364309|562023959|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708050|NCT03364309|562023960|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708051|NCT03364309|562023961|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708052|NCT03364309|562023962|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708053|NCT03364309|562023963|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708054|NCT03364309|562023964|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708055|NCT03364309|562023965|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708056|NCT03364309|562023966|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708057|NCT03364309|562023967|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708058|NCT03364309|562023968|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708059|NCT03364309|562023969|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708060|NCT03364309|562023970|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708061|NCT03364309|562023971|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155708062|NCT03364309|562023972|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155708063|NCT03364309|562023973|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155708064|NCT03364309|562023974|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708065|NCT03364309|562023975|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708066|NCT03364309|562023976|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155708067|NCT03364309|562023958|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708068|NCT03364309|562023959|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708069|NCT03364309|562023960|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708070|NCT03364309|562023961|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708071|NCT03364309|562023962|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708072|NCT03364309|562023963|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708073|NCT03364309|562023964|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708074|NCT03364309|562023965|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708075|NCT03364309|562023966|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708076|NCT03364309|562023967|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708077|NCT03364309|562023968|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708078|NCT03364309|562023969|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708079|NCT03364309|562023970|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708080|NCT03364309|562023971|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708081|NCT03364309|562023972|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
155708082|NCT03364309|562023973|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708083|NCT03364309|562023974|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708084|NCT03364309|562023975|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708085|NCT03364309|562023976|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
155708086|NCT03364309|562023958|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
155708087|NCT03364309|562023959|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
155708088|NCT03364309|562023960|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
155708089|NCT03364309|562023961|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
155708090|NCT03364309|562023962|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
155708091|NCT03364309|562023963|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
155708092|NCT03364309|562023964|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
155708093|NCT03364309|562023965|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
155708094|NCT03364309|562023966|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
155708095|NCT03364309|562023967|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
155708096|NCT03364309|562023968|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
155708097|NCT03364309|562023969|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
155708098|NCT03364309|562023970|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
155708099|NCT03364309|562023971|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
155708100|NCT03364309|562023972|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
155708101|NCT03364309|562023973|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
155708102|NCT03364309|562023974|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
155708103|NCT03364309|562023975|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
155708104|NCT03364309|562023976|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
155708105|NCT03364309|562023958|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708106|NCT03364309|562023959|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708107|NCT03364309|562023960|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708108|NCT03364309|562023961|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708109|NCT03364309|562023962|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708110|NCT03364309|562023963|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708111|NCT03364309|562023964|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708112|NCT03364309|562023965|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708113|NCT03364309|562023966|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708114|NCT03364309|562023967|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708115|NCT03364309|562023968|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708116|NCT03364309|562023969|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708117|NCT03364309|562023970|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708118|NCT03364309|562023971|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708119|NCT03364309|562023972|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708120|NCT03364309|562023973|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155708121|NCT03364309|562023974|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
155708122|NCT03364309|562023975|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
155708123|NCT03364309|562023976|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
155708124|NCT03364309|562023958|FG000|Post-Treatment Followup Period|Adverse Event|0|||
155708125|NCT03364309|562023959|FG001|Post-Treatment Followup Period|Adverse Event|0|||
155708126|NCT03364309|562023960|FG002|Post-Treatment Followup Period|Adverse Event|0|||
155708127|NCT03364309|562023961|FG003|Post-Treatment Followup Period|Adverse Event|0|||
155708128|NCT03364309|562023962|FG004|Post-Treatment Followup Period|Adverse Event|0|||
155708129|NCT03364309|562023963|FG005|Post-Treatment Followup Period|Adverse Event|0|||
155708130|NCT03364309|562023964|FG006|Post-Treatment Followup Period|Adverse Event|0|||
155708131|NCT03364309|562023965|FG007|Post-Treatment Followup Period|Adverse Event|0|||
155708132|NCT03364309|562023966|FG008|Post-Treatment Followup Period|Adverse Event|0|||
155708133|NCT03364309|562023967|FG009|Post-Treatment Followup Period|Adverse Event|0|||
155708134|NCT03364309|562023968|FG010|Post-Treatment Followup Period|Adverse Event|0|||
155708135|NCT03364309|562023969|FG011|Post-Treatment Followup Period|Adverse Event|0|||
155708136|NCT03364309|562023970|FG012|Post-Treatment Followup Period|Adverse Event|0|||
155708137|NCT03364309|562023971|FG013|Post-Treatment Followup Period|Adverse Event|0|||
155708138|NCT03364309|562023972|FG014|Post-Treatment Followup Period|Adverse Event|0|||
155708139|NCT03364309|562023973|FG015|Post-Treatment Followup Period|Adverse Event|0|||
155708140|NCT03364309|562023974|FG016|Post-Treatment Followup Period|Adverse Event|2|||
155708141|NCT03364309|562023975|FG017|Post-Treatment Followup Period|Adverse Event|6|||
155708142|NCT03364309|562023976|FG018|Post-Treatment Followup Period|Adverse Event|1|||
155708143|NCT03364309|562023958|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708144|NCT03364309|562023959|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708145|NCT03364309|562023960|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708146|NCT03364309|562023961|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708147|NCT03364309|562023962|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708148|NCT03364309|562023963|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708149|NCT03364309|562023964|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708150|NCT03364309|562023965|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708151|NCT03364309|562023966|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708152|NCT03364309|562023967|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708153|NCT03364309|562023968|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708154|NCT03364309|562023969|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708155|NCT03364309|562023970|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708156|NCT03364309|562023971|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708157|NCT03364309|562023972|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708158|NCT03364309|562023973|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708159|NCT03364309|562023974|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708160|NCT03364309|562023975|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
155708161|NCT03364309|562023976|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
155708162|NCT03364309|562023958|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
155708163|NCT03364309|562023959|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
155708164|NCT03364309|562023960|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
155708165|NCT03364309|562023961|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
155708166|NCT03364309|562023962|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
155708167|NCT03364309|562023963|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
155708168|NCT03364309|562023964|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
155708169|NCT03364309|562023965|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
155708170|NCT03364309|562023966|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
155708171|NCT03364309|562023967|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
155708172|NCT03364309|562023968|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
155708173|NCT03364309|562023969|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
155708174|NCT03364309|562023970|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
155708175|NCT03364309|562023971|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
155708176|NCT03364309|562023972|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
155708177|NCT03364309|562023973|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
155708178|NCT03364309|562023974|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
155708179|NCT03364309|562023975|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
155708180|NCT03364309|562023976|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
155708181|NCT00167310|562023977|FG000|Overall Study|Protocol Violation|5|||
155708182|NCT00167310|562023978|FG001|Overall Study|Protocol Violation|3|||
155708183|NCT00167310|562023977|FG000|Overall Study|Withdrawal by Subject|3|||
155708184|NCT00167310|562023978|FG001|Overall Study|Withdrawal by Subject|7|||
155708185|NCT00615992|562023979|FG000|Overall Study|Protocol Violation|67|||
155708186|NCT01868477|562023981|FG000|Overall Study|Adverse Event|2|||
155708187|NCT01868477|562023982|FG001|Overall Study|Adverse Event|4|||
155708188|NCT01868477|562023981|FG000|Overall Study|Disease progression|1|||
155708189|NCT01868477|562023982|FG001|Overall Study|Disease progression|1|||
155708190|NCT01868477|562023981|FG000|Overall Study|Withdrawal by Subject|1|||
155708191|NCT01868477|562023982|FG001|Overall Study|Withdrawal by Subject|0|||
155708192|NCT01811186|562023984|FG000|Overall Study|Adverse Event|54|||
155708193|NCT01811186|562023985|FG001|Overall Study|Adverse Event|38|||
155708194|NCT01811186|562023984|FG000|Overall Study|Protocol Violation|5|||
155708195|NCT01811186|562023985|FG001|Overall Study|Protocol Violation|6|||
155708196|NCT01811186|562023984|FG000|Overall Study|Withdrawal by Subject|5|||
155708197|NCT01811186|562023985|FG001|Overall Study|Withdrawal by Subject|10|||
155708198|NCT01811186|562023984|FG000|Overall Study|Lack of Efficacy|3|||
155708199|NCT01811186|562023985|FG001|Overall Study|Lack of Efficacy|6|||
155708200|NCT01811186|562023984|FG000|Overall Study|Lost to Follow-up|4|||
155708201|NCT01811186|562023985|FG001|Overall Study|Lost to Follow-up|2|||
155708202|NCT02465203|562023986|FG000|Overall Study|Protocol Violation|1|||
155708203|NCT02465203|562023987|FG001|Overall Study|Protocol Violation|1|||
155708204|NCT02465203|562023988|FG002|Overall Study|Protocol Violation|1|||
155708205|NCT02465203|562023986|FG000|Overall Study|Study terminated by sponsor|50|||
155708206|NCT02465203|562023987|FG001|Overall Study|Study terminated by sponsor|34|||
155708207|NCT02465203|562023988|FG002|Overall Study|Study terminated by sponsor|11|||
155708208|NCT02465203|562023986|FG000|Overall Study|New therapy for study indication|4|||
155708209|NCT02465203|562023987|FG001|Overall Study|New therapy for study indication|0|||
155708210|NCT02465203|562023988|FG002|Overall Study|New therapy for study indication|0|||
155708211|NCT02465203|562023986|FG000|Overall Study|Patient/guardian decision|1|||
155708212|NCT02465203|562023987|FG001|Overall Study|Patient/guardian decision|1|||
155708213|NCT02465203|562023988|FG002|Overall Study|Patient/guardian decision|1|||
155708214|NCT00042991|562023991|FG000|Overall Study|Adverse Event|1|||
155708215|NCT00042991|562023992|FG001|Overall Study|Adverse Event|4|||
155708216|NCT00042991|562023993|FG002|Overall Study|Adverse Event|2|||
155708217|NCT00042991|562023994|FG003|Overall Study|Adverse Event|0|||
155708218|NCT00042991|562023995|FG004|Overall Study|Adverse Event|0|||
155708219|NCT00042991|562023996|FG005|Overall Study|Adverse Event|1|||
155708220|NCT00042991|562023997|FG006|Overall Study|Adverse Event|0|||
155708221|NCT00042991|562023991|FG000|Overall Study|Withdrawal by Subject|0|||
155708222|NCT00042991|562023992|FG001|Overall Study|Withdrawal by Subject|7|||
155708223|NCT00042991|562023993|FG002|Overall Study|Withdrawal by Subject|2|||
155708224|NCT00042991|562023994|FG003|Overall Study|Withdrawal by Subject|0|||
155708225|NCT00042991|562023995|FG004|Overall Study|Withdrawal by Subject|1|||
155708226|NCT00042991|562023996|FG005|Overall Study|Withdrawal by Subject|0|||
155708227|NCT00042991|562023997|FG006|Overall Study|Withdrawal by Subject|0|||
155708228|NCT00042991|562023991|FG000|Overall Study|Disease Progression|5|||
155708229|NCT00042991|562023992|FG001|Overall Study|Disease Progression|29|||
155708230|NCT00042991|562023993|FG002|Overall Study|Disease Progression|2|||
155708231|NCT00042991|562023994|FG003|Overall Study|Disease Progression|2|||
155708232|NCT00042991|562023995|FG004|Overall Study|Disease Progression|1|||
155708233|NCT00042991|562023996|FG005|Overall Study|Disease Progression|4|||
155708234|NCT00042991|562023997|FG006|Overall Study|Disease Progression|2|||
155708235|NCT00042991|562023991|FG000|Overall Study|Alternative Therapy|0|||
155708236|NCT00042991|562023992|FG001|Overall Study|Alternative Therapy|0|||
155708237|NCT00042991|562023993|FG002|Overall Study|Alternative Therapy|0|||
155708238|NCT00042991|562023994|FG003|Overall Study|Alternative Therapy|0|||
155708239|NCT00042991|562023995|FG004|Overall Study|Alternative Therapy|1|||
155708240|NCT00042991|562023996|FG005|Overall Study|Alternative Therapy|0|||
155708241|NCT00042991|562023997|FG006|Overall Study|Alternative Therapy|0|||
155708242|NCT03193736|562024004|FG000|Overall Study|Death|2|||
155708243|NCT03193736|562024004|FG000|Overall Study|Withdrawal by Subject|1|||
155708244|NCT03193736|562024004|FG000|Overall Study|Lost to Follow-up|1|||
155708245|NCT03193736|562024004|FG000|Overall Study|implant not received|1|||
155708246|NCT03369236|562024007|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
155708247|NCT03369236|562024008|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
155708248|NCT03369236|562024007|FG000|Open-label Extension Period|Lack of Efficacy|2|||
155708249|NCT03369236|562024008|FG001|Open-label Extension Period|Lack of Efficacy|1|||
155708250|NCT03369236|562024007|FG000|Open-label Extension Period|Adverse Event|0|||
155708251|NCT03369236|562024008|FG001|Open-label Extension Period|Adverse Event|1|||
155708252|NCT03369236|562024007|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
155708253|NCT03369236|562024008|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
155708254|NCT00423449|562024009|FG000|Overall Study|Clinical Adverse Event|1|||
155708255|NCT00423449|562024010|FG001|Overall Study|Clinical Adverse Event|0|||
155708256|NCT00423449|562024011|FG002|Overall Study|Clinical Adverse Event|1|||
155708257|NCT00423449|562024012|FG003|Overall Study|Clinical Adverse Event|8|||
155708258|NCT00423449|562024013|FG004|Overall Study|Clinical Adverse Event|2|||
155708259|NCT00423449|562024009|FG000|Overall Study|Death|1|||
155708260|NCT00423449|562024010|FG001|Overall Study|Death|0|||
155708261|NCT00423449|562024011|FG002|Overall Study|Death|2|||
155708262|NCT00423449|562024012|FG003|Overall Study|Death|1|||
155708263|NCT00423449|562024013|FG004|Overall Study|Death|1|||
155708264|NCT00423449|562024009|FG000|Overall Study|Progressive Disease|1|||
155708265|NCT00423449|562024010|FG001|Overall Study|Progressive Disease|3|||
155708266|NCT00423449|562024011|FG002|Overall Study|Progressive Disease|8|||
155708267|NCT00423449|562024012|FG003|Overall Study|Progressive Disease|11|||
155708268|NCT00423449|562024013|FG004|Overall Study|Progressive Disease|4|||
155708269|NCT00423449|562024009|FG000|Overall Study|Laboratory Adverse Event|0|||
155708270|NCT00423449|562024010|FG001|Overall Study|Laboratory Adverse Event|1|||
155708271|NCT00423449|562024011|FG002|Overall Study|Laboratory Adverse Event|2|||
155708272|NCT00423449|562024012|FG003|Overall Study|Laboratory Adverse Event|0|||
155708273|NCT00423449|562024013|FG004|Overall Study|Laboratory Adverse Event|0|||
155708274|NCT00423449|562024009|FG000|Overall Study|Other|0|||
155708275|NCT00423449|562024010|FG001|Overall Study|Other|0|||
155708276|NCT00423449|562024011|FG002|Overall Study|Other|0|||
155708277|NCT00423449|562024012|FG003|Overall Study|Other|1|||
155708278|NCT00423449|562024013|FG004|Overall Study|Other|0|||
155708279|NCT00423449|562024009|FG000|Overall Study|Protocol Violation|0|||
155708280|NCT00423449|562024010|FG001|Overall Study|Protocol Violation|0|||
155708281|NCT00423449|562024011|FG002|Overall Study|Protocol Violation|2|||
155708282|NCT00423449|562024012|FG003|Overall Study|Protocol Violation|1|||
155708283|NCT00423449|562024013|FG004|Overall Study|Protocol Violation|0|||
155708284|NCT01153724|562024018|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155708285|NCT01153724|562024018|FG000|Treatment Period 2|Adverse Event|1|||
155708286|NCT01153724|562024018|FG000|Treatment Period 2|Other reason not defined above|1|||
155708287|NCT02697435|562024019|FG000|Overall Study|Withdrawal by Subject|1|||
155708288|NCT02697435|562024020|FG001|Overall Study|Withdrawal by Subject|0|||
155708289|NCT02697435|562024019|FG000|Overall Study|Physician Decision|0|||
155708290|NCT02697435|562024020|FG001|Overall Study|Physician Decision|4|||
155708291|NCT02508428|562024024|FG000|Overall Study|Death|32|||
155708292|NCT02508428|562024025|FG001|Overall Study|Death|33|||
155708293|NCT02508428|562024024|FG000|Overall Study|Liner revised|3|||
155708294|NCT02508428|562024025|FG001|Overall Study|Liner revised|19|||
155708295|NCT02508428|562024024|FG000|Overall Study|Incomplete follow-up|17|||
155708296|NCT02508428|562024025|FG001|Overall Study|Incomplete follow-up|15|||
155708297|NCT01574651|562024026|FG000|Overall Study|Lost to Follow-up|2|||
155708298|NCT01574651|562024027|FG001|Overall Study|Lost to Follow-up|4|||
155708299|NCT01574651|562024026|FG000|Overall Study|Administrative problems|0|||
155708300|NCT01574651|562024027|FG001|Overall Study|Administrative problems|1|||
155708301|NCT01574651|562024026|FG000|Overall Study|Death|3|||
155708302|NCT01574651|562024027|FG001|Overall Study|Death|3|||
155708303|NCT01574651|562024026|FG000|Overall Study|Patient's inability to use the device|0|||
155708304|NCT01574651|562024027|FG001|Overall Study|Patient's inability to use the device|1|||
155708305|NCT01574651|562024026|FG000|Overall Study|Adverse Event|36|||
155708306|NCT01574651|562024027|FG001|Overall Study|Adverse Event|27|||
155708307|NCT01574651|562024026|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155708308|NCT01574651|562024027|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155708309|NCT01574651|562024026|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155708310|NCT01574651|562024027|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155708311|NCT01574651|562024026|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155708312|NCT01574651|562024027|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155708313|NCT01574651|562024026|FG000|Overall Study|Protocol Violation|3|||
155708314|NCT01574651|562024027|FG001|Overall Study|Protocol Violation|5|||
155708315|NCT01574651|562024026|FG000|Overall Study|Withdrawal by Subject|9|||
155708316|NCT01574651|562024027|FG001|Overall Study|Withdrawal by Subject|10|||
155708317|NCT00445770|562024028|FG000|Overall Study|Adverse Event|9|||
155708318|NCT00445770|562024029|FG001|Overall Study|Adverse Event|15|||
155708319|NCT00445770|562024030|FG002|Overall Study|Adverse Event|19|||
155708320|NCT00445770|562024028|FG000|Overall Study|Lack of Efficacy|38|||
155708321|NCT00445770|562024029|FG001|Overall Study|Lack of Efficacy|13|||
155708322|NCT00445770|562024030|FG002|Overall Study|Lack of Efficacy|6|||
155708323|NCT00445770|562024028|FG000|Overall Study|Lost to Follow-up|0|||
155708324|NCT00445770|562024029|FG001|Overall Study|Lost to Follow-up|2|||
155708325|NCT00445770|562024030|FG002|Overall Study|Lost to Follow-up|0|||
155708326|NCT00445770|562024028|FG000|Overall Study|Other|6|||
155708327|NCT00445770|562024029|FG001|Overall Study|Other|5|||
155708328|NCT00445770|562024030|FG002|Overall Study|Other|6|||
155708329|NCT00947115|562024031|FG000|Overall Study|Missed reporting interval|3|||
155708330|NCT00947115|562024032|FG001|Overall Study|Missed reporting interval|4|||
155708331|NCT00947115|562024033|FG002|Overall Study|Missed reporting interval|2|||
155708332|NCT00947115|562024031|FG000|Overall Study|Physician Decision|0|||
155708333|NCT00947115|562024032|FG001|Overall Study|Physician Decision|2|||
155708334|NCT00947115|562024033|FG002|Overall Study|Physician Decision|0|||
155708335|NCT00947115|562024031|FG000|Overall Study|Death|0|||
155708336|NCT00947115|562024032|FG001|Overall Study|Death|1|||
155708337|NCT00947115|562024033|FG002|Overall Study|Death|1|||
155708338|NCT00947115|562024031|FG000|Overall Study|Migrated from study area|2|||
155708339|NCT00947115|562024032|FG001|Overall Study|Migrated from study area|0|||
155708340|NCT00947115|562024033|FG002|Overall Study|Migrated from study area|0|||
155708341|NCT00947115|562024031|FG000|Overall Study|Withdrawal by Subject|1|||
155708342|NCT00947115|562024032|FG001|Overall Study|Withdrawal by Subject|3|||
155708343|NCT00947115|562024033|FG002|Overall Study|Withdrawal by Subject|4|||
155708344|NCT00947115|562024031|FG000|Overall Study|Lost to Follow-up|11|||
155708345|NCT00947115|562024032|FG001|Overall Study|Lost to Follow-up|12|||
155708346|NCT00947115|562024033|FG002|Overall Study|Lost to Follow-up|8|||
155708347|NCT03228212|562024036|FG000|Period 1|Adverse Event|1|||
155708348|NCT03228212|562024037|FG001|Period 1|Adverse Event|0|||
155708349|NCT03228212|562024036|FG000|Period 1|no longer meets eligibility criteria|0|||
155708350|NCT03228212|562024037|FG001|Period 1|no longer meets eligibility criteria|1|||
155708351|NCT03228212|562024036|FG000|Period 2|Lost to Follow-up|1|||
155708352|NCT03228212|562024037|FG001|Period 2|Lost to Follow-up|0|||
155708353|NCT00934128|562024038|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
155708354|NCT00934128|562024039|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
155708355|NCT00934128|562024038|FG000|First Intervention (2 Hours)|Adverse Event|4|||
155708356|NCT00934128|562024039|FG001|First Intervention (2 Hours)|Adverse Event|1|||
155708357|NCT00934128|562024038|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
155708358|NCT00934128|562024039|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
155708359|NCT00934128|562024038|FG000|Washout Period (1 Hour)|Patient preference|1|||
155708360|NCT00934128|562024039|FG001|Washout Period (1 Hour)|Patient preference|3|||
155708361|NCT00934128|562024038|FG000|Washout Period (1 Hour)|Pain|1|||
155708362|NCT00934128|562024039|FG001|Washout Period (1 Hour)|Pain|0|||
155708363|NCT00934128|562024038|FG000|Washout Period (1 Hour)|Too tired|1|||
155708364|NCT00934128|562024039|FG001|Washout Period (1 Hour)|Too tired|0|||
155708365|NCT00934128|562024038|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
155708366|NCT00934128|562024039|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
155708367|NCT00934128|562024038|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
155708368|NCT00934128|562024039|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
155708369|NCT01807299|562024040|FG000|Overall Study|Protocol Violation|3|||
155708370|NCT01807299|562024041|FG001|Overall Study|Protocol Violation|1|||
155708371|NCT01807299|562024042|FG002|Overall Study|Protocol Violation|0|||
155708372|NCT01807299|562024043|FG003|Overall Study|Protocol Violation|2|||
155708373|NCT01392547|562025791|FG000|Overall Study|Adverse Event|2|||
155708374|NCT01392547|562025791|FG000|Overall Study|Non-compliance|2|||
155708375|NCT01392547|562025791|FG000|Overall Study|Withdrawal criteria|3|||
155708376|NCT01392547|562025791|FG000|Overall Study|Unclassified|1|||
155708377|NCT04404556|562025792|FG000|Intervention|Withdrawal by Subject|15|||
155708378|NCT04404556|562025793|FG001|Intervention|Withdrawal by Subject|3|||
155708379|NCT04404556|562025792|FG000|Intervention|Did not complete all intervention sessions|2|||
155708380|NCT04404556|562025793|FG001|Intervention|Did not complete all intervention sessions|1|||
155708381|NCT04404556|562025792|FG000|Post-Intervention|Missing Data|1|||
155708382|NCT04404556|562025793|FG001|Post-Intervention|Missing Data|2|||
155708383|NCT04404556|562025792|FG000|Follow-up 1|Withdrawal by Subject|5|||
155708384|NCT04404556|562025793|FG001|Follow-up 1|Withdrawal by Subject|1|||
155708385|NCT04404556|562025792|FG000|Follow-up 1|Missing Data|4|||
155708386|NCT04404556|562025793|FG001|Follow-up 1|Missing Data|7|||
155708387|NCT04404556|562025792|FG000|Follow-up 2|Withdrawal by Subject|1|||
155708388|NCT04404556|562025793|FG001|Follow-up 2|Withdrawal by Subject|1|||
155708389|NCT04404556|562025792|FG000|Follow-up 2|Missing Data|6|||
155708390|NCT04404556|562025793|FG001|Follow-up 2|Missing Data|5|||
155708391|NCT02451917|562025794|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
155708392|NCT02451917|562025795|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
155708393|NCT02451917|562025794|FG000|First Intervention (24 Weeks)|Death|0|||
155708394|NCT02451917|562025795|FG001|First Intervention (24 Weeks)|Death|1|||
155708395|NCT02451917|562025794|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
155708396|NCT02451917|562025795|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
155708397|NCT02871635|562025796|FG000|Overall Study|Primary lack of efficacy|4|||
155708398|NCT02871635|562025797|FG001|Overall Study|Primary lack of efficacy|4|||
155708399|NCT02871635|562025796|FG000|Overall Study|Protocol Violation|3|||
155708400|NCT02871635|562025797|FG001|Overall Study|Protocol Violation|1|||
155708401|NCT02871635|562025796|FG000|Overall Study|Lost to Follow-up|1|||
155708402|NCT02871635|562025797|FG001|Overall Study|Lost to Follow-up|2|||
155708403|NCT02871635|562025796|FG000|Overall Study|Pregnancy|0|||
155708404|NCT02871635|562025797|FG001|Overall Study|Pregnancy|2|||
155708405|NCT02871635|562025796|FG000|Overall Study|Physician Decision|1|||
155708406|NCT02871635|562025797|FG001|Overall Study|Physician Decision|1|||
155708407|NCT02871635|562025796|FG000|Overall Study|Withdrawal by Subject|3|||
155708408|NCT02871635|562025797|FG001|Overall Study|Withdrawal by Subject|4|||
155708409|NCT02871635|562025796|FG000|Overall Study|Adverse Event|4|||
155708410|NCT02871635|562025797|FG001|Overall Study|Adverse Event|4|||
155708411|NCT02871635|562025796|FG000|Overall Study|Secondary lack of efficacy|2|||
155708412|NCT02871635|562025797|FG001|Overall Study|Secondary lack of efficacy|1|||
155708413|NCT00502671|562025798|FG000|Overall Study|Disease Progression|13|||
155708414|NCT00502671|562025798|FG000|Overall Study|Personal Reasons|22|||
155708415|NCT00502671|562025798|FG000|Overall Study|Lost to Follow-up|7|||
155708416|NCT00502671|562025798|FG000|Overall Study|Protocol Violation|16|||
155708417|NCT00502671|562025798|FG000|Overall Study|Adverse Event|19|||
155708418|NCT00853151|562025800|FG000|Overall Study|Adverse Event|1|||
155708419|NCT00853151|562025801|FG001|Overall Study|Adverse Event|4|||
155708420|NCT00853151|562025802|FG002|Overall Study|Adverse Event|2|||
155708421|NCT00853151|562025803|FG003|Overall Study|Adverse Event|0|||
155708422|NCT00853151|562025800|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155708423|NCT00853151|562025801|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155708424|NCT00853151|562025802|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155708425|NCT00853151|562025803|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155708426|NCT00853151|562025800|FG000|Overall Study|Lost to Follow-up|2|||
155708427|NCT00853151|562025801|FG001|Overall Study|Lost to Follow-up|0|||
155708428|NCT00853151|562025802|FG002|Overall Study|Lost to Follow-up|3|||
155708429|NCT00853151|562025803|FG003|Overall Study|Lost to Follow-up|0|||
155708430|NCT00853151|562025800|FG000|Overall Study|Death|1|||
155708431|NCT00853151|562025801|FG001|Overall Study|Death|0|||
155708432|NCT00853151|562025802|FG002|Overall Study|Death|0|||
155708433|NCT00853151|562025803|FG003|Overall Study|Death|1|||
155708434|NCT00853151|562025800|FG000|Overall Study|Protocol Violation|0|||
155708435|NCT00853151|562025801|FG001|Overall Study|Protocol Violation|0|||
155708436|NCT00853151|562025802|FG002|Overall Study|Protocol Violation|0|||
155708437|NCT00853151|562025803|FG003|Overall Study|Protocol Violation|1|||
155708438|NCT00853151|562025800|FG000|Overall Study|Withdrawal by Subject|5|||
155708439|NCT00853151|562025801|FG001|Overall Study|Withdrawal by Subject|4|||
155708440|NCT00853151|562025802|FG002|Overall Study|Withdrawal by Subject|2|||
155708441|NCT00853151|562025803|FG003|Overall Study|Withdrawal by Subject|1|||
155708442|NCT00853151|562025800|FG000|Overall Study|Physician Decision|0|||
155708443|NCT00853151|562025801|FG001|Overall Study|Physician Decision|2|||
155708444|NCT00853151|562025802|FG002|Overall Study|Physician Decision|1|||
155708445|NCT00853151|562025803|FG003|Overall Study|Physician Decision|0|||
155708446|NCT00853151|562025800|FG000|Overall Study|Sponsor Decision|0|||
155708447|NCT00853151|562025801|FG001|Overall Study|Sponsor Decision|3|||
155708448|NCT00853151|562025802|FG002|Overall Study|Sponsor Decision|0|||
155708449|NCT00853151|562025803|FG003|Overall Study|Sponsor Decision|0|||
155708450|NCT01510158|562025804|FG000|Overall Study|Adverse Event|7|||
155708451|NCT01510158|562025805|FG001|Overall Study|Adverse Event|8|||
155708452|NCT01510158|562025806|FG002|Overall Study|Adverse Event|5|||
155708453|NCT01510158|562025804|FG000|Overall Study|Gout flare|1|||
155708454|NCT01510158|562025805|FG001|Overall Study|Gout flare|0|||
155708455|NCT01510158|562025806|FG002|Overall Study|Gout flare|0|||
155708456|NCT01510158|562025804|FG000|Overall Study|Protocol Violation|17|||
155708457|NCT01510158|562025805|FG001|Overall Study|Protocol Violation|16|||
155708458|NCT01510158|562025806|FG002|Overall Study|Protocol Violation|24|||
155708459|NCT01510158|562025804|FG000|Overall Study|Sponsor terminated study.|2|||
155708460|NCT01510158|562025805|FG001|Overall Study|Sponsor terminated study.|0|||
155708461|NCT01510158|562025806|FG002|Overall Study|Sponsor terminated study.|2|||
155708462|NCT01510158|562025804|FG000|Overall Study|Lost to Follow-up|13|||
155708463|NCT01510158|562025805|FG001|Overall Study|Lost to Follow-up|16|||
155708464|NCT01510158|562025806|FG002|Overall Study|Lost to Follow-up|9|||
155708465|NCT01510158|562025804|FG000|Overall Study|Withdrawal by Subject|10|||
155708466|NCT01510158|562025805|FG001|Overall Study|Withdrawal by Subject|13|||
155708467|NCT01510158|562025806|FG002|Overall Study|Withdrawal by Subject|10|||
155708468|NCT01510158|562025804|FG000|Overall Study|Death|1|||
155708469|NCT01510158|562025805|FG001|Overall Study|Death|0|||
155708470|NCT01510158|562025806|FG002|Overall Study|Death|0|||
155708471|NCT03078556|562025807|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
155708472|NCT03078556|562025808|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
155708473|NCT03078556|562025809|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
155708474|NCT03078556|562025810|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
155708475|NCT03078556|562025807|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
155708476|NCT03078556|562025808|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
155708477|NCT03078556|562025809|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
155708478|NCT03078556|562025810|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
155708479|NCT03078556|562025807|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155708480|NCT03078556|562025808|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
155708481|NCT03078556|562025809|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155708482|NCT03078556|562025810|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
155708483|NCT03078556|562025807|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
155708484|NCT03078556|562025808|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
155708485|NCT03078556|562025809|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
155708486|NCT03078556|562025810|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
155708487|NCT00832416|562025811|FG000|Overall Study|Lack of Efficacy|17|||
155708488|NCT00832416|562025812|FG001|Overall Study|Lack of Efficacy|15|||
155708489|NCT00832416|562025813|FG002|Overall Study|Lack of Efficacy|13|||
155708490|NCT00832416|562025814|FG003|Overall Study|Lack of Efficacy|52|||
155708491|NCT00832416|562025811|FG000|Overall Study|Withdrawal by Subject|5|||
155708492|NCT00832416|562025812|FG001|Overall Study|Withdrawal by Subject|7|||
155708493|NCT00832416|562025813|FG002|Overall Study|Withdrawal by Subject|2|||
155708494|NCT00832416|562025814|FG003|Overall Study|Withdrawal by Subject|10|||
155708495|NCT00832416|562025811|FG000|Overall Study|Physician Decision|2|||
155708496|NCT00832416|562025812|FG001|Overall Study|Physician Decision|12|||
155708497|NCT00832416|562025813|FG002|Overall Study|Physician Decision|5|||
155708498|NCT00832416|562025814|FG003|Overall Study|Physician Decision|10|||
155708499|NCT00832416|562025811|FG000|Overall Study|Administrative|0|||
155708500|NCT00832416|562025812|FG001|Overall Study|Administrative|0|||
155708501|NCT00832416|562025813|FG002|Overall Study|Administrative|0|||
155708502|NCT00832416|562025814|FG003|Overall Study|Administrative|1|||
155708503|NCT00832416|562025811|FG000|Overall Study|Adverse Event|21|||
155708504|NCT00832416|562025812|FG001|Overall Study|Adverse Event|19|||
155708505|NCT00832416|562025813|FG002|Overall Study|Adverse Event|41|||
155708506|NCT00832416|562025814|FG003|Overall Study|Adverse Event|10|||
155708507|NCT00832416|562025811|FG000|Overall Study|Death|1|||
155708508|NCT00832416|562025812|FG001|Overall Study|Death|0|||
155708509|NCT00832416|562025813|FG002|Overall Study|Death|0|||
155708510|NCT00832416|562025814|FG003|Overall Study|Death|0|||
155708511|NCT02114606|562025815|FG000|Overall Study|Unable to swallow Cytosponge|6|||
155708512|NCT04421482|562025822|FG000|Overall Study|Physician Decision|1|||
155708513|NCT03010319|562025825|FG000|Overall Study|Adverse Event|15|||
155708514|NCT03010319|562025826|FG001|Overall Study|Adverse Event|9|||
155708515|NCT03010319|562025825|FG000|Overall Study|Withdrawal by Subject|1|||
155708516|NCT03010319|562025826|FG001|Overall Study|Withdrawal by Subject|6|||
155708517|NCT03010319|562025825|FG000|Overall Study|Physician Decision|2|||
155708518|NCT03010319|562025826|FG001|Overall Study|Physician Decision|4|||
155708519|NCT03010319|562025825|FG000|Overall Study|Sponsor requested withdrawal|2|||
155708520|NCT03010319|562025826|FG001|Overall Study|Sponsor requested withdrawal|2|||
155708521|NCT03010319|562025825|FG000|Overall Study|Death|1|||
155708522|NCT03010319|562025826|FG001|Overall Study|Death|0|||
155708523|NCT03010319|562025825|FG000|Overall Study|Lost to Follow-up|0|||
155708524|NCT03010319|562025826|FG001|Overall Study|Lost to Follow-up|1|||
155708525|NCT03010319|562025825|FG000|Overall Study|Other Reason|5|||
155708526|NCT03010319|562025826|FG001|Overall Study|Other Reason|7|||
155708527|NCT02128724|562025827|FG000|Overall Study|Death|1|||
155708528|NCT02128724|562025828|FG001|Overall Study|Death|0|||
155708529|NCT02128724|562025829|FG002|Overall Study|Death|0|||
155708530|NCT02128724|562025830|FG003|Overall Study|Death|0|||
155708531|NCT02128724|562025827|FG000|Overall Study|Adverse Event|0|||
155708532|NCT02128724|562025828|FG001|Overall Study|Adverse Event|1|||
155708533|NCT02128724|562025829|FG002|Overall Study|Adverse Event|0|||
155708534|NCT02128724|562025830|FG003|Overall Study|Adverse Event|0|||
155708535|NCT02128724|562025827|FG000|Overall Study|Physician Decision|0|||
155708536|NCT02128724|562025828|FG001|Overall Study|Physician Decision|0|||
155708537|NCT02128724|562025829|FG002|Overall Study|Physician Decision|0|||
155708538|NCT02128724|562025830|FG003|Overall Study|Physician Decision|2|||
155708539|NCT02128724|562025827|FG000|Overall Study|Withdrawal by Subject|0|||
155708540|NCT02128724|562025828|FG001|Overall Study|Withdrawal by Subject|0|||
155708541|NCT02128724|562025829|FG002|Overall Study|Withdrawal by Subject|0|||
155708542|NCT02128724|562025830|FG003|Overall Study|Withdrawal by Subject|1|||
155708543|NCT02751580|562025832|FG000|Overall Study|Lost to Follow-up|4|||
155708544|NCT02751580|562025832|FG000|Overall Study|Death|2|||
155708545|NCT02588261|562025833|FG000|Overall Study|Study Terminated by Sponsor|157|||
155708546|NCT02588261|562025834|FG001|Overall Study|Study Terminated by Sponsor|142|||
155708547|NCT02588261|562025833|FG000|Overall Study|Protocol Deviation|1|||
155708548|NCT02588261|562025834|FG001|Overall Study|Protocol Deviation|0|||
155708549|NCT02588261|562025833|FG000|Overall Study|Death|1|||
155708550|NCT02588261|562025834|FG001|Overall Study|Death|2|||
155708551|NCT02588261|562025833|FG000|Overall Study|Withdrawal by Subject|12|||
155708552|NCT02588261|562025834|FG001|Overall Study|Withdrawal by Subject|8|||
155708553|NCT02588261|562025833|FG000|Overall Study|Noncompliance with Study Drug|0|||
155708554|NCT02588261|562025834|FG001|Overall Study|Noncompliance with Study Drug|1|||
155708555|NCT02588261|562025833|FG000|Overall Study|Miscellaneous|5|||
155708556|NCT02588261|562025834|FG001|Overall Study|Miscellaneous|4|||
155708557|NCT02588261|562025833|FG000|Overall Study|Progressive Disease|61|||
155708558|NCT02588261|562025834|FG001|Overall Study|Progressive Disease|82|||
155708559|NCT02588261|562025833|FG000|Overall Study|Adverse Event|29|||
155708560|NCT02588261|562025834|FG001|Overall Study|Adverse Event|24|||
155708561|NCT02588261|562025833|FG000|Overall Study|Lost to Follow-up|1|||
155708562|NCT02588261|562025834|FG001|Overall Study|Lost to Follow-up|0|||
155708563|NCT04829916|562025835|FG000|Overall Study|Withdrawal by Subject|1|||
155708564|NCT04829916|562025836|FG001|Overall Study|Withdrawal by Subject|0|||
155708565|NCT02287467|562025837|FG000|Overall Study|Protocol Violation|12|||
155708566|NCT02287467|562025838|FG001|Overall Study|Protocol Violation|9|||
155708567|NCT04343755|562025839|FG000|Overall Study|Death|11|||
155708568|NCT04343755|562025839|FG000|Overall Study|Screen Failure|1|||
155708569|NCT02292446|562025840|FG000|Overall Study|Adverse Event|12|||
155708570|NCT02292446|562025840|FG000|Overall Study|Death|1|||
155708571|NCT02292446|562025840|FG000|Overall Study|Disease progression|2|||
155708572|NCT02292446|562025840|FG000|Overall Study|Subject/guardian decision|2|||
155708573|NCT02292446|562025840|FG000|Overall Study|Withdrawal by Subject|3|||
155708574|NCT05292131|562025842|FG000|Overall Study|Lost to Follow-up|1|||
155708575|NCT05292131|562025843|FG001|Overall Study|Lost to Follow-up|1|||
155708576|NCT05292131|562025842|FG000|Overall Study|Withdrawal by Subject|0|||
155708577|NCT05292131|562025843|FG001|Overall Study|Withdrawal by Subject|1|||
155708578|NCT02735343|562025846|FG000|Overall Study|screen fail|0|||
155708579|NCT02735343|562025847|FG001|Overall Study|screen fail|2|||
155708580|NCT01625000|562025852|FG000|Overall Study|Physician Decision|15|||
155708581|NCT01625000|562025853|FG001|Overall Study|Physician Decision|7|||
155708582|NCT01625000|562025854|FG002|Overall Study|Physician Decision|7|||
155708583|NCT01625000|562025855|FG003|Overall Study|Physician Decision|2|||
155708584|NCT01625000|562025856|FG004|Overall Study|Physician Decision|15|||
155708585|NCT01625000|562025852|FG000|Overall Study|Protocol Violation|3|||
155708586|NCT01625000|562025853|FG001|Overall Study|Protocol Violation|10|||
155708587|NCT01625000|562025854|FG002|Overall Study|Protocol Violation|4|||
155708588|NCT01625000|562025855|FG003|Overall Study|Protocol Violation|1|||
155708589|NCT01625000|562025856|FG004|Overall Study|Protocol Violation|2|||
155708590|NCT01625000|562025852|FG000|Overall Study|Withdrawal by Subject|19|||
155708591|NCT01625000|562025853|FG001|Overall Study|Withdrawal by Subject|16|||
155708592|NCT01625000|562025854|FG002|Overall Study|Withdrawal by Subject|11|||
155708593|NCT01625000|562025855|FG003|Overall Study|Withdrawal by Subject|9|||
155708594|NCT01625000|562025856|FG004|Overall Study|Withdrawal by Subject|17|||
155708595|NCT01625000|562025852|FG000|Overall Study|Adverse Event (including Death)|15|||
155708596|NCT01625000|562025853|FG001|Overall Study|Adverse Event (including Death)|19|||
155708597|NCT01625000|562025854|FG002|Overall Study|Adverse Event (including Death)|11|||
155708598|NCT01625000|562025855|FG003|Overall Study|Adverse Event (including Death)|7|||
155708599|NCT01625000|562025856|FG004|Overall Study|Adverse Event (including Death)|21|||
155708600|NCT00566852|562025857|FG000|Overall Study|Protocol Violation|22|||
155708601|NCT00566852|562025858|FG001|Overall Study|Protocol Violation|24|||
155708602|NCT00566852|562025857|FG000|Overall Study|Death|95|||
155708603|NCT00566852|562025858|FG001|Overall Study|Death|78|||
155708604|NCT00566852|562025857|FG000|Overall Study|Withdrawal by Subject|30|||
155708605|NCT00566852|562025858|FG001|Overall Study|Withdrawal by Subject|25|||
155708606|NCT00566852|562025857|FG000|Overall Study|Patient refusal|37|||
155708607|NCT00566852|562025858|FG001|Overall Study|Patient refusal|37|||
155708608|NCT00566852|562025857|FG000|Overall Study|Not tested due to disability|6|||
155708609|NCT00566852|562025858|FG001|Overall Study|Not tested due to disability|12|||
155708610|NCT00566852|562025857|FG000|Overall Study|Missing reason not specified|1|||
155708611|NCT00566852|562025858|FG001|Overall Study|Missing reason not specified|2|||
155708612|NCT00566852|562025857|FG000|Overall Study|Missing reason not reported|16|||
155708613|NCT00566852|562025858|FG001|Overall Study|Missing reason not reported|20|||
155708614|NCT00132808|562025859|FG000|Stratum I|Adverse Event|2|||
155708615|NCT00132808|562025860|FG001|Stratum I|Adverse Event|1|||
155708616|NCT00132808|562025861|FG002|Stratum I|Adverse Event|0|||
155708617|NCT00132808|562025859|FG000|Stratum I|Lost to Follow-up|3|||
155708618|NCT00132808|562025860|FG001|Stratum I|Lost to Follow-up|4|||
155708619|NCT00132808|562025861|FG002|Stratum I|Lost to Follow-up|1|||
155708620|NCT00132808|562025859|FG000|Stratum I|Withdrawal by Subject|4|||
155708621|NCT00132808|562025860|FG001|Stratum I|Withdrawal by Subject|7|||
155708622|NCT00132808|562025861|FG002|Stratum I|Withdrawal by Subject|3|||
155708623|NCT00132808|562025859|FG000|Stratum I|Abnormal test procedure result (s)|0|||
155708624|NCT00132808|562025860|FG001|Stratum I|Abnormal test procedure result (s)|0|||
155708625|NCT00132808|562025861|FG002|Stratum I|Abnormal test procedure result (s)|1|||
155708626|NCT00132808|562025859|FG000|Stratum II|Adverse Event|1|||
155708627|NCT00132808|562025860|FG001|Stratum II|Adverse Event|2|||
155708628|NCT00132808|562025861|FG002|Stratum II|Adverse Event|1|||
155708629|NCT00132808|562025859|FG000|Stratum II|Death|1|||
155708630|NCT00132808|562025860|FG001|Stratum II|Death|0|||
155708631|NCT00132808|562025861|FG002|Stratum II|Death|0|||
155708632|NCT00132808|562025859|FG000|Stratum II|Lost to Follow-up|2|||
155708633|NCT00132808|562025860|FG001|Stratum II|Lost to Follow-up|2|||
155708634|NCT00132808|562025861|FG002|Stratum II|Lost to Follow-up|1|||
155708635|NCT00132808|562025859|FG000|Stratum II|Protocol Violation|0|||
155708636|NCT00132808|562025860|FG001|Stratum II|Protocol Violation|2|||
155708637|NCT00132808|562025861|FG002|Stratum II|Protocol Violation|1|||
155708638|NCT00132808|562025859|FG000|Stratum II|Withdrawal by Subject|4|||
155708639|NCT00132808|562025860|FG001|Stratum II|Withdrawal by Subject|9|||
155708640|NCT00132808|562025861|FG002|Stratum II|Withdrawal by Subject|6|||
155708641|NCT00577824|562025863|FG000|Overall Study|Adverse Event|6|||
155708642|NCT00577824|562025864|FG001|Overall Study|Adverse Event|18|||
155708643|NCT00577824|562025865|FG002|Overall Study|Adverse Event|1|||
155708644|NCT00577824|562025863|FG000|Overall Study|Patient decision|0|||
155708645|NCT00577824|562025864|FG001|Overall Study|Patient decision|1|||
155708646|NCT00577824|562025865|FG002|Overall Study|Patient decision|1|||
155708647|NCT00577824|562025863|FG000|Overall Study|Protocol Violation|1|||
155708648|NCT00577824|562025864|FG001|Overall Study|Protocol Violation|1|||
155708649|NCT00577824|562025865|FG002|Overall Study|Protocol Violation|0|||
155708650|NCT04531241|562025866|FG000|Period 1|Withdrawal by Subject|2|||
155708651|NCT04531241|562025867|FG001|Period 1|Withdrawal by Subject|0|||
155708652|NCT04531241|562025866|FG000|Period 1|Dispesed incorrect lens power|1|||
155708653|NCT04531241|562025867|FG001|Period 1|Dispesed incorrect lens power|0|||
155708654|NCT04531241|562025866|FG000|Period 1|Protocol Violation|1|||
155708655|NCT04531241|562025867|FG001|Period 1|Protocol Violation|0|||
155708656|NCT04531241|562025866|FG000|Period 1|No longer eligible|0|||
155708657|NCT04531241|562025867|FG001|Period 1|No longer eligible|1|||
155708658|NCT04531241|562025866|FG000|Period 1|Lens Discomfort|0|||
155708659|NCT04531241|562025867|FG001|Period 1|Lens Discomfort|1|||
155708660|NCT04531241|562025866|FG000|Period 2|Covid-19 Related|1|||
155708661|NCT04531241|562025867|FG001|Period 2|Covid-19 Related|1|||
155708662|NCT02362464|562025868|FG000|Overall Study|Switched to alternative therapy|1|||
155708663|NCT02362464|562025868|FG000|Overall Study|Refused further treatment|1|||
155708664|NCT02362464|562025868|FG000|Overall Study|Physician Decision|4|||
155708665|NCT05870865|562025869|FG000|Randomized|Did not receive study treatment|2|||
155708666|NCT05870865|562025870|FG001|Randomized|Did not receive study treatment|4|||
155708667|NCT05870865|562025871|FG002|Randomized|Did not receive study treatment|4|||
155708668|NCT05870865|562025872|FG003|Randomized|Did not receive study treatment|3|||
155708669|NCT05870865|562025869|FG000|Treatment Period|Adverse Event|1|||
155708670|NCT05870865|562025870|FG001|Treatment Period|Adverse Event|1|||
155708671|NCT05870865|562025871|FG002|Treatment Period|Adverse Event|1|||
155708672|NCT05870865|562025872|FG003|Treatment Period|Adverse Event|1|||
155708673|NCT05870865|562025869|FG000|Treatment Period|Lost to Follow-up|0|||
155708674|NCT05870865|562025870|FG001|Treatment Period|Lost to Follow-up|1|||
155708675|NCT05870865|562025871|FG002|Treatment Period|Lost to Follow-up|2|||
155708676|NCT05870865|562025872|FG003|Treatment Period|Lost to Follow-up|0|||
155708677|NCT05870865|562025869|FG000|Treatment Period|Protocol Violation|0|||
155708678|NCT05870865|562025870|FG001|Treatment Period|Protocol Violation|0|||
155708679|NCT05870865|562025871|FG002|Treatment Period|Protocol Violation|0|||
155708680|NCT05870865|562025872|FG003|Treatment Period|Protocol Violation|1|||
155708681|NCT05870865|562025869|FG000|Treatment Period|Withdrawal by Subject|0|||
155708682|NCT05870865|562025870|FG001|Treatment Period|Withdrawal by Subject|1|||
155708683|NCT05870865|562025871|FG002|Treatment Period|Withdrawal by Subject|1|||
155708684|NCT05870865|562025872|FG003|Treatment Period|Withdrawal by Subject|1|||
155708685|NCT02104947|562025874|FG000|Overall Study|Withdrawal by Subject|10|||
155708686|NCT02104947|562025875|FG001|Overall Study|Withdrawal by Subject|3|||
155708687|NCT02104947|562025874|FG000|Overall Study|Lost to Follow-up|4|||
155708688|NCT02104947|562025875|FG001|Overall Study|Lost to Follow-up|4|||
155708689|NCT02104947|562025874|FG000|Overall Study|Protocol Violation|6|||
155708690|NCT02104947|562025875|FG001|Overall Study|Protocol Violation|8|||
155708691|NCT02104947|562025874|FG000|Overall Study|Adverse Event|57|||
155708692|NCT02104947|562025875|FG001|Overall Study|Adverse Event|38|||
155708693|NCT02104947|562025874|FG000|Overall Study|Other than stated above|2|||
155708694|NCT02104947|562025875|FG001|Overall Study|Other than stated above|3|||
155708695|NCT00548145|562025876|FG000|Overall Study|Death|0|||
155708696|NCT00548145|562025877|FG001|Overall Study|Death|1|||
155708697|NCT00548145|562025876|FG000|Overall Study|Withdrawal by Subject|0|||
155708698|NCT00548145|562025877|FG001|Overall Study|Withdrawal by Subject|2|||
155708699|NCT00548145|562025876|FG000|Overall Study|Physician Decision|1|||
155708700|NCT00548145|562025877|FG001|Overall Study|Physician Decision|1|||
155708701|NCT02863328|562025880|FG000|Overall Study|Lost to Follow-up|4|||
155708702|NCT02863328|562025881|FG001|Overall Study|Lost to Follow-up|10|||
155708703|NCT02863328|562025880|FG000|Overall Study|Withdrawal by Subject|7|||
155708704|NCT02863328|562025881|FG001|Overall Study|Withdrawal by Subject|12|||
155708705|NCT02863328|562025880|FG000|Overall Study|Died|0|||
155708706|NCT02863328|562025881|FG001|Overall Study|Died|1|||
155708707|NCT03301350|562025883|FG000|Overall Study|Withdrawal by Subject|4|||
155708708|NCT03301350|562025883|FG000|Overall Study|Adverse Event|1|||
155708709|NCT03301350|562025883|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
155708710|NCT03301350|562025883|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
155708711|NCT03301350|562025883|FG000|Overall Study|no detail provided|1|||
155708712|NCT00858637|562025884|FG000|Active Comparison Phase|Adverse Event|14|||
155708713|NCT00858637|562025885|FG001|Active Comparison Phase|Adverse Event|0|||
155708714|NCT00858637|562025886|FG002|Active Comparison Phase|Adverse Event|0|||
155708715|NCT00858637|562025887|FG003|Active Comparison Phase|Adverse Event|9|||
155708716|NCT00858637|562025888|FG004|Active Comparison Phase|Adverse Event|0|||
155708717|NCT00858637|562025889|FG005|Active Comparison Phase|Adverse Event|0|||
155708718|NCT00858637|562025884|FG000|Active Comparison Phase|Death|1|||
155708719|NCT00858637|562025885|FG001|Active Comparison Phase|Death|0|||
155708720|NCT00858637|562025886|FG002|Active Comparison Phase|Death|0|||
155708721|NCT00858637|562025887|FG003|Active Comparison Phase|Death|1|||
155708722|NCT00858637|562025888|FG004|Active Comparison Phase|Death|0|||
155708723|NCT00858637|562025889|FG005|Active Comparison Phase|Death|0|||
155708724|NCT00858637|562025884|FG000|Active Comparison Phase|Physician Decision|1|||
155708725|NCT00858637|562025885|FG001|Active Comparison Phase|Physician Decision|0|||
155708726|NCT00858637|562025886|FG002|Active Comparison Phase|Physician Decision|0|||
155708727|NCT00858637|562025887|FG003|Active Comparison Phase|Physician Decision|1|||
155708728|NCT00858637|562025888|FG004|Active Comparison Phase|Physician Decision|0|||
155708729|NCT00858637|562025889|FG005|Active Comparison Phase|Physician Decision|0|||
155708730|NCT00858637|562025884|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
155708731|NCT00858637|562025885|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
155708732|NCT00858637|562025886|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
155708733|NCT00858637|562025887|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
155708734|NCT00858637|562025888|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
155708735|NCT00858637|562025889|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
155708736|NCT00858637|562025884|FG000|Active Comparison Phase|Other Reasons|1|||
155708737|NCT00858637|562025885|FG001|Active Comparison Phase|Other Reasons|0|||
155708738|NCT00858637|562025886|FG002|Active Comparison Phase|Other Reasons|0|||
155708739|NCT00858637|562025887|FG003|Active Comparison Phase|Other Reasons|1|||
155708740|NCT00858637|562025888|FG004|Active Comparison Phase|Other Reasons|0|||
155708741|NCT00858637|562025889|FG005|Active Comparison Phase|Other Reasons|0|||
155708742|NCT00858637|562025884|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
155708743|NCT00858637|562025885|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
155708744|NCT00858637|562025886|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
155708745|NCT00858637|562025887|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
155708746|NCT00858637|562025888|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
155708747|NCT00858637|562025889|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
155708748|NCT00858637|562025884|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155708749|NCT00858637|562025885|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155708750|NCT00858637|562025886|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155708751|NCT00858637|562025887|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155708752|NCT00858637|562025888|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155708753|NCT00858637|562025889|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
155708754|NCT02305238|562025890|FG000|Overall Study|Death|2|||
155708755|NCT02305238|562025891|FG001|Overall Study|Death|1|||
155708756|NCT02305238|562025892|FG002|Overall Study|Death|0|||
155708757|NCT02305238|562025890|FG000|Overall Study|Progressive disease|4|||
155708758|NCT02305238|562025891|FG001|Overall Study|Progressive disease|4|||
155708759|NCT02305238|562025892|FG002|Overall Study|Progressive disease|0|||
155708760|NCT02305238|562025890|FG000|Overall Study|Logistical difficulties|1|||
155708761|NCT02305238|562025891|FG001|Overall Study|Logistical difficulties|3|||
155708762|NCT02305238|562025892|FG002|Overall Study|Logistical difficulties|0|||
155708763|NCT02305238|562025890|FG000|Overall Study|Protocol Violation|0|||
155708764|NCT02305238|562025891|FG001|Overall Study|Protocol Violation|3|||
155708765|NCT02305238|562025892|FG002|Overall Study|Protocol Violation|0|||
155708766|NCT02305238|562025890|FG000|Overall Study|Physician Decision|2|||
155708767|NCT02305238|562025891|FG001|Overall Study|Physician Decision|1|||
155708768|NCT02305238|562025892|FG002|Overall Study|Physician Decision|0|||
155708769|NCT02305238|562025890|FG000|Overall Study|Adverse Event|4|||
155708770|NCT02305238|562025891|FG001|Overall Study|Adverse Event|2|||
155708771|NCT02305238|562025892|FG002|Overall Study|Adverse Event|0|||
155708772|NCT02305238|562025890|FG000|Overall Study|Withdrawal by Subject|3|||
155708773|NCT02305238|562025891|FG001|Overall Study|Withdrawal by Subject|4|||
155708774|NCT02305238|562025892|FG002|Overall Study|Withdrawal by Subject|0|||
155708775|NCT02305238|562025890|FG000|Overall Study|Randomized failure|0|||
155708776|NCT02305238|562025891|FG001|Overall Study|Randomized failure|0|||
155708777|NCT02305238|562025892|FG002|Overall Study|Randomized failure|8|||
155708778|NCT02305238|562025890|FG000|Overall Study|Required procedure failed|0|||
155708779|NCT02305238|562025891|FG001|Overall Study|Required procedure failed|1|||
155708780|NCT02305238|562025892|FG002|Overall Study|Required procedure failed|0|||
155708781|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
155708782|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
155708783|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
155708784|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Death|0|||
155708785|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Death|2|||
155708786|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Death|0|||
155708787|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
155708788|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
155708789|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
155708790|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
155708791|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
155708792|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
155708793|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
155708794|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
155708795|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
155708796|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
155708797|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
155708798|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
155708799|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
155708800|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
155708801|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
155708802|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Recovery|1|||
155708803|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Recovery|0|||
155708804|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Recovery|1|||
155708805|NCT00195663|562025893|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
155708806|NCT00195663|562025894|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
155708807|NCT00195663|562025895|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
155708808|NCT00195663|562025893|FG000|Open-Label Extension Period|Adverse Event|21|||
155708809|NCT00195663|562025894|FG001|Open-Label Extension Period|Adverse Event|32|||
155708810|NCT00195663|562025895|FG002|Open-Label Extension Period|Adverse Event|36|||
155708811|NCT00195663|562025893|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
155708812|NCT00195663|562025894|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
155708813|NCT00195663|562025895|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
155708814|NCT00195663|562025893|FG000|Open-Label Extension Period|Recovery|0|||
155708815|NCT00195663|562025894|FG001|Open-Label Extension Period|Recovery|2|||
155708816|NCT00195663|562025895|FG002|Open-Label Extension Period|Recovery|2|||
155708817|NCT00195663|562025893|FG000|Open-Label Extension Period|Protocol Violation|3|||
155708818|NCT00195663|562025894|FG001|Open-Label Extension Period|Protocol Violation|4|||
155708819|NCT00195663|562025895|FG002|Open-Label Extension Period|Protocol Violation|4|||
155708820|NCT00195663|562025893|FG000|Open-Label Extension Period|Death|2|||
155708821|NCT00195663|562025894|FG001|Open-Label Extension Period|Death|2|||
155708822|NCT00195663|562025895|FG002|Open-Label Extension Period|Death|2|||
155708823|NCT00195663|562025893|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
155708824|NCT00195663|562025894|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
155708825|NCT00195663|562025895|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
155708826|NCT00195663|562025893|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
155708827|NCT00195663|562025894|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
155708828|NCT00195663|562025895|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
155708829|NCT00195663|562025893|FG000|Open-Label Extension Period|Administrative reasons|11|||
155708830|NCT00195663|562025894|FG001|Open-Label Extension Period|Administrative reasons|11|||
155708831|NCT00195663|562025895|FG002|Open-Label Extension Period|Administrative reasons|13|||
155708832|NCT01380834|562025896|FG000|Overall Study|Physician Decision|1|||
155708833|NCT01380834|562025897|FG001|Overall Study|Physician Decision|0|||
155708834|NCT03214406|562025898|FG000|Overall Study|did not meet enrollment criteria|9|||
155708835|NCT03214406|562025899|FG001|Overall Study|did not meet enrollment criteria|13|||
155708836|NCT03214406|562025898|FG000|Overall Study|Withdrawal by Subject|1|||
155708837|NCT03214406|562025899|FG001|Overall Study|Withdrawal by Subject|0|||
155708838|NCT03214406|562025898|FG000|Overall Study|Lost to Follow-up|0|||
155708839|NCT03214406|562025899|FG001|Overall Study|Lost to Follow-up|2|||
155708840|NCT00604695|562025900|FG000|Overall Study|Did not receive first bolus.|0|||
155708841|NCT00604695|562025901|FG001|Overall Study|Did not receive first bolus.|4|||
155708842|NCT00429169|562025911|FG000|Overall Study|Lost to Follow-up|0|||
155708843|NCT00429169|562025912|FG001|Overall Study|Lost to Follow-up|1|||
155708844|NCT00429169|562025911|FG000|Overall Study|Ineligibility discovered after entry|2|||
155708845|NCT00429169|562025912|FG001|Overall Study|Ineligibility discovered after entry|1|||
155708846|NCT01180296|562025913|FG000|Overall Study|Protocol Violation|1|||
155708847|NCT01180296|562025914|FG001|Overall Study|Protocol Violation|2|||
155708848|NCT00166439|562025915|FG000|Overall Study|Ineligible|5|||
155708849|NCT04072887|562025918|FG000|Overall Study|Withdrawal by Subject|3|||
155708850|NCT04072887|562025919|FG001|Overall Study|Withdrawal by Subject|8|||
155708851|NCT04072887|562025920|FG002|Overall Study|Withdrawal by Subject|1|||
155708852|NCT04072887|562025921|FG003|Overall Study|Withdrawal by Subject|3|||
155708853|NCT04072887|562025922|FG004|Overall Study|Withdrawal by Subject|3|||
155708854|NCT04072887|562025923|FG005|Overall Study|Withdrawal by Subject|13|||
155708855|NCT04072887|562025918|FG000|Overall Study|Adverse Event|2|||
155708856|NCT04072887|562025919|FG001|Overall Study|Adverse Event|4|||
155708857|NCT04072887|562025920|FG002|Overall Study|Adverse Event|1|||
155708858|NCT04072887|562025921|FG003|Overall Study|Adverse Event|4|||
155708859|NCT04072887|562025922|FG004|Overall Study|Adverse Event|0|||
155708860|NCT04072887|562025923|FG005|Overall Study|Adverse Event|1|||
155708861|NCT04072887|562025918|FG000|Overall Study|Physician Decision|2|||
155708862|NCT04072887|562025919|FG001|Overall Study|Physician Decision|0|||
155708863|NCT04072887|562025920|FG002|Overall Study|Physician Decision|0|||
155708864|NCT04072887|562025921|FG003|Overall Study|Physician Decision|0|||
155708865|NCT04072887|562025922|FG004|Overall Study|Physician Decision|0|||
155708866|NCT04072887|562025923|FG005|Overall Study|Physician Decision|1|||
155708867|NCT04072887|562025918|FG000|Overall Study|Lost to Follow-up|1|||
155708868|NCT04072887|562025919|FG001|Overall Study|Lost to Follow-up|3|||
155708869|NCT04072887|562025920|FG002|Overall Study|Lost to Follow-up|0|||
155708870|NCT04072887|562025921|FG003|Overall Study|Lost to Follow-up|0|||
155708871|NCT04072887|562025922|FG004|Overall Study|Lost to Follow-up|0|||
155708872|NCT04072887|562025923|FG005|Overall Study|Lost to Follow-up|0|||
155708873|NCT04072887|562025918|FG000|Overall Study|Death|0|||
155708874|NCT04072887|562025919|FG001|Overall Study|Death|2|||
155708875|NCT04072887|562025920|FG002|Overall Study|Death|0|||
155708876|NCT04072887|562025921|FG003|Overall Study|Death|2|||
155708877|NCT04072887|562025922|FG004|Overall Study|Death|3|||
155708878|NCT04072887|562025923|FG005|Overall Study|Death|0|||
155708879|NCT00856297|562025924|FG000|Overall Study|Unable to classify|2|||
155708880|NCT00856297|562025925|FG001|Overall Study|Unable to classify|0|||
155708881|NCT00856297|562025926|FG002|Overall Study|Unable to classify|0|||
155708882|NCT00856297|562025927|FG003|Overall Study|Unable to classify|0|||
155708883|NCT00856297|562025928|FG004|Overall Study|Unable to classify|0|||
155708884|NCT03887221|562025931|FG000|Overall Study|Protocol Violation|1|||
155708885|NCT03887221|562025932|FG001|Overall Study|Protocol Violation|0|||
155708886|NCT02487030|562025933|FG000|Overall Study|Lack of Efficacy|2|||
155708887|NCT02487030|562025934|FG001|Overall Study|Lack of Efficacy|4|||
155708888|NCT02487030|562025935|FG002|Overall Study|Lack of Efficacy|1|||
155708889|NCT02487030|562025936|FG003|Overall Study|Lack of Efficacy|0|||
155708890|NCT02487030|562025937|FG004|Overall Study|Lack of Efficacy|1|||
155708891|NCT02487030|562025938|FG005|Overall Study|Lack of Efficacy|0|||
155708892|NCT02487030|562025939|FG006|Overall Study|Lack of Efficacy|0|||
155708893|NCT02487030|562025933|FG000|Overall Study|Lost to Follow-up|0|||
155708894|NCT02487030|562025934|FG001|Overall Study|Lost to Follow-up|0|||
155708895|NCT02487030|562025935|FG002|Overall Study|Lost to Follow-up|1|||
155708896|NCT02487030|562025936|FG003|Overall Study|Lost to Follow-up|1|||
155708897|NCT02487030|562025937|FG004|Overall Study|Lost to Follow-up|0|||
155708898|NCT02487030|562025938|FG005|Overall Study|Lost to Follow-up|1|||
155708899|NCT02487030|562025939|FG006|Overall Study|Lost to Follow-up|0|||
155708900|NCT02487030|562025933|FG000|Overall Study|Adverse Event|0|||
155708901|NCT02487030|562025934|FG001|Overall Study|Adverse Event|0|||
155708902|NCT02487030|562025935|FG002|Overall Study|Adverse Event|0|||
155708903|NCT02487030|562025936|FG003|Overall Study|Adverse Event|1|||
155708904|NCT02487030|562025937|FG004|Overall Study|Adverse Event|0|||
155708905|NCT02487030|562025938|FG005|Overall Study|Adverse Event|0|||
155708906|NCT02487030|562025939|FG006|Overall Study|Adverse Event|0|||
155708907|NCT02487030|562025933|FG000|Overall Study|Death|0|||
155708908|NCT02487030|562025934|FG001|Overall Study|Death|0|||
155708909|NCT02487030|562025935|FG002|Overall Study|Death|0|||
155708910|NCT02487030|562025936|FG003|Overall Study|Death|0|||
155708911|NCT02487030|562025937|FG004|Overall Study|Death|1|||
155708912|NCT02487030|562025938|FG005|Overall Study|Death|0|||
155708913|NCT02487030|562025939|FG006|Overall Study|Death|0|||
155708914|NCT02123576|562025940|FG000|Overall Study|Adverse Event|1|||
155708915|NCT02123576|562025941|FG001|Overall Study|Adverse Event|0|||
155708916|NCT00999544|562027523|FG000|Overall Study|Withdrawal by Subject|1|||
155708917|NCT02936635|562027525|FG000|Overall Study|Adverse Event|43|||
155708918|NCT02936635|562027526|FG001|Overall Study|Adverse Event|25|||
155708919|NCT02936635|562027525|FG000|Overall Study|Progressive Disease|10|||
155708920|NCT02936635|562027526|FG001|Overall Study|Progressive Disease|18|||
155708921|NCT02936635|562027525|FG000|Overall Study|Sponsor Discretion|10|||
155708922|NCT02936635|562027526|FG001|Overall Study|Sponsor Discretion|16|||
155708923|NCT02936635|562027525|FG000|Overall Study|Death|9|||
155708924|NCT02936635|562027526|FG001|Overall Study|Death|15|||
155708925|NCT02936635|562027525|FG000|Overall Study|Withdrawal by Subject|8|||
155708926|NCT02936635|562027526|FG001|Overall Study|Withdrawal by Subject|15|||
155708927|NCT02936635|562027525|FG000|Overall Study|Physician Decision|2|||
155708928|NCT02936635|562027526|FG001|Overall Study|Physician Decision|9|||
155708929|NCT02936635|562027525|FG000|Overall Study|Lost to Follow-up|1|||
155708930|NCT02936635|562027526|FG001|Overall Study|Lost to Follow-up|2|||
155708931|NCT02936635|562027525|FG000|Overall Study|Protocol Violation|1|||
155708932|NCT02936635|562027526|FG001|Overall Study|Protocol Violation|0|||
155708933|NCT02936635|562027525|FG000|Overall Study|Lack of effect/Entry into other study|31|||
155708934|NCT02936635|562027526|FG001|Overall Study|Lack of effect/Entry into other study|65|||
155708935|NCT02407223|562027527|FG000|Overall Study|Adverse Event|1|||
155708936|NCT02407223|562027528|FG001|Overall Study|Adverse Event|0|||
155708937|NCT02407223|562027529|FG002|Overall Study|Adverse Event|1|||
155708938|NCT02407223|562027527|FG000|Overall Study|Lack of Efficacy|6|||
155708939|NCT02407223|562027528|FG001|Overall Study|Lack of Efficacy|6|||
155708940|NCT02407223|562027529|FG002|Overall Study|Lack of Efficacy|4|||
155708941|NCT02407223|562027527|FG000|Overall Study|Lost to Follow-up|1|||
155708942|NCT02407223|562027528|FG001|Overall Study|Lost to Follow-up|0|||
155708943|NCT02407223|562027529|FG002|Overall Study|Lost to Follow-up|2|||
155708944|NCT02407223|562027527|FG000|Overall Study|Withdrawal by Subject|2|||
155708945|NCT02407223|562027528|FG001|Overall Study|Withdrawal by Subject|4|||
155708946|NCT02407223|562027529|FG002|Overall Study|Withdrawal by Subject|4|||
155708947|NCT02407223|562027527|FG000|Overall Study|Study Terminated by Sponsor|77|||
155708948|NCT02407223|562027528|FG001|Overall Study|Study Terminated by Sponsor|80|||
155708949|NCT02407223|562027529|FG002|Overall Study|Study Terminated by Sponsor|86|||
155708950|NCT02407223|562027527|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
155708951|NCT02407223|562027528|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
155708952|NCT02407223|562027529|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
155708953|NCT02407223|562027527|FG000|Overall Study|Other|29|||
155708954|NCT02407223|562027528|FG001|Overall Study|Other|27|||
155708955|NCT02407223|562027529|FG002|Overall Study|Other|25|||
155708956|NCT00447226|562027530|FG000|12-Week Open-label Phase|Adverse Event|0|||
155708957|NCT00447226|562027531|FG001|12-Week Open-label Phase|Adverse Event|3|||
155708958|NCT00447226|562027530|FG000|12-Week Open-label Phase|Protocol Violation|0|||
155708959|NCT00447226|562027531|FG001|12-Week Open-label Phase|Protocol Violation|1|||
155708960|NCT00447226|562027530|FG000|12-Week Open-label Phase|Disease Progression|0|||
155708961|NCT00447226|562027531|FG001|12-Week Open-label Phase|Disease Progression|20|||
155708962|NCT00447226|562027530|FG000|12-Week Open-label Phase|Physician Decision|0|||
155708963|NCT00447226|562027531|FG001|12-Week Open-label Phase|Physician Decision|1|||
155708964|NCT00447226|562027530|FG000|Double-blind Phase|Disease Progression|4|||
155708965|NCT00447226|562027531|FG001|Double-blind Phase|Disease Progression|3|||
155708966|NCT01478971|562027542|FG000|Standard of Care Period|Adverse Event|1|||
155708967|NCT01478971|562027542|FG000|Standard of Care Period|Withdrawal by Subject|3|||
155708968|NCT01478971|562027542|FG000|Standard of Care Period|Death|8|||
155708969|NCT01478971|562027542|FG000|Standard of Care Period|Lost to Follow-up|9|||
155708970|NCT01478971|562027542|FG000|Standard of Care Period|Other|4|||
155708971|NCT01478971|562027542|FG000|Peginesatide Treatment Period|Adverse Event|1|||
155708972|NCT01478971|562027542|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
155708973|NCT01478971|562027542|FG000|Peginesatide Treatment Period|Death|4|||
155708974|NCT01478971|562027542|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
155708975|NCT01478971|562027542|FG000|Peginesatide Treatment Period|Other|4|||
155708976|NCT01402817|562027547|FG000|Overall Study|Withdrawal by Subject|3|||
155708977|NCT01402817|562027547|FG000|Overall Study|Study Suspended by FDA|8|||
155708978|NCT00681629|562027548|FG000|Overall Study|Study termination|4|||
155708979|NCT00681629|562027549|FG001|Overall Study|Study termination|2|||
155708980|NCT00681629|562027548|FG000|Overall Study|Adverse Event|1|||
155708981|NCT00681629|562027549|FG001|Overall Study|Adverse Event|0|||
155708982|NCT00412893|562027550|FG000|Overall Study|Adverse Event|31|||
155708983|NCT00412893|562027551|FG001|Overall Study|Adverse Event|53|||
155708984|NCT00412893|562027550|FG000|Overall Study|Death|17|||
155708985|NCT00412893|562027551|FG001|Overall Study|Death|21|||
155708986|NCT00412893|562027550|FG000|Overall Study|Insufficient Therapeutic Response|39|||
155708987|NCT00412893|562027551|FG001|Overall Study|Insufficient Therapeutic Response|23|||
155708988|NCT00412893|562027550|FG000|Overall Study|Lost to Follow-up|2|||
155708989|NCT00412893|562027551|FG001|Overall Study|Lost to Follow-up|1|||
155708990|NCT00412893|562027550|FG000|Overall Study|Violation of Selection at Entry|17|||
155708991|NCT00412893|562027551|FG001|Overall Study|Violation of Selection at Entry|10|||
155708992|NCT00412893|562027550|FG000|Overall Study|Other Protocol Violation|10|||
155708993|NCT00412893|562027551|FG001|Overall Study|Other Protocol Violation|6|||
155708994|NCT00412893|562027550|FG000|Overall Study|Did Not Cooperate|12|||
155708995|NCT00412893|562027551|FG001|Overall Study|Did Not Cooperate|9|||
155708996|NCT00412893|562027550|FG000|Overall Study|Administrative Reason|12|||
155708997|NCT00412893|562027551|FG001|Overall Study|Administrative Reason|15|||
155708998|NCT00412893|562027550|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
155708999|NCT00412893|562027551|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
155709000|NCT01751984|562027552|FG000|Overall Study|Adverse Event|5|||
155709001|NCT01751984|562027553|FG001|Overall Study|Adverse Event|3|||
155709002|NCT01751984|562027552|FG000|Overall Study|Withdrawal by Subject|0|||
155709003|NCT01751984|562027553|FG001|Overall Study|Withdrawal by Subject|1|||
155709004|NCT01751984|562027552|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
155709005|NCT01751984|562027553|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155709006|NCT00587158|562027554|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
155709007|NCT00587158|562027555|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
155709008|NCT00587158|562027554|FG000|Overall Study|Physician Decision|0|||
155709009|NCT00587158|562027555|FG001|Overall Study|Physician Decision|1|||
155709010|NCT00587158|562027554|FG000|Overall Study|Lost to Follow-up|1|||
155709011|NCT00587158|562027555|FG001|Overall Study|Lost to Follow-up|2|||
155709012|NCT00587158|562027554|FG000|Overall Study|Death|0|||
155709013|NCT00587158|562027555|FG001|Overall Study|Death|1|||
155709014|NCT00587158|562027554|FG000|Overall Study|Subject did not want to take study med|0|||
155709015|NCT00587158|562027555|FG001|Overall Study|Subject did not want to take study med|1|||
155709016|NCT01136408|562027556|FG000|Overall Study|Adverse Event|4|||
155709017|NCT01136408|562027557|FG001|Overall Study|Adverse Event|8|||
155709018|NCT01136408|562027558|FG002|Overall Study|Adverse Event|4|||
155709019|NCT01136408|562027556|FG000|Overall Study|Protocol Violation|1|||
155709020|NCT01136408|562027557|FG001|Overall Study|Protocol Violation|1|||
155709021|NCT01136408|562027558|FG002|Overall Study|Protocol Violation|1|||
155709022|NCT02274792|562027559|FG000|Overall Study|Withdrawal by Subject|13|||
155709023|NCT02274792|562027559|FG000|Overall Study|Lost to Follow-up|8|||
155709024|NCT02274792|562027559|FG000|Overall Study|Protocol Specified Criteria|2|||
155709025|NCT02274792|562027559|FG000|Overall Study|Sponsor Decision|2|||
155709026|NCT00981461|562027566|FG000|Overall Study|Lost to Follow-up|5|||
155709027|NCT00981461|562027567|FG001|Overall Study|Lost to Follow-up|2|||
155709028|NCT00571038|562027568|FG000|Overall Study|Lost to Follow-up|1|||
155709029|NCT00571038|562027569|FG001|Overall Study|Lost to Follow-up|4|||
155709030|NCT00571038|562027568|FG000|Overall Study|Death|7|||
155709031|NCT00571038|562027569|FG001|Overall Study|Death|5|||
155709032|NCT00571038|562027568|FG000|Overall Study|Withdrawal by Subject|1|||
155709033|NCT00571038|562027569|FG001|Overall Study|Withdrawal by Subject|3|||
155709034|NCT00571038|562027568|FG000|Overall Study|Moved out of state|2|||
155709035|NCT00571038|562027569|FG001|Overall Study|Moved out of state|2|||
155709036|NCT05786508|562027570|FG000|Overall Study|Withdrawal by Subject|2|||
155709037|NCT05786508|562027571|FG001|Overall Study|Withdrawal by Subject|0|||
155709038|NCT03781778|562027573|FG000|Overall Study|Withdrawal by Subject|2|||
155709039|NCT03781778|562027574|FG001|Overall Study|Withdrawal by Subject|2|||
155709040|NCT01456169|562027576|FG000|Overall Study|Adverse Event|1|||
155709041|NCT01456169|562027577|FG001|Overall Study|Adverse Event|2|||
155709042|NCT01456169|562027578|FG002|Overall Study|Adverse Event|7|||
155709043|NCT01456169|562027576|FG000|Overall Study|Major Protocol Deviation|3|||
155709044|NCT01456169|562027577|FG001|Overall Study|Major Protocol Deviation|2|||
155709045|NCT01456169|562027578|FG002|Overall Study|Major Protocol Deviation|3|||
155709046|NCT01456169|562027576|FG000|Overall Study|Voluntary Withdrawal|3|||
155709047|NCT01456169|562027577|FG001|Overall Study|Voluntary Withdrawal|0|||
155709048|NCT01456169|562027578|FG002|Overall Study|Voluntary Withdrawal|2|||
155709049|NCT01456169|562027576|FG000|Overall Study|Lack of Efficacy|2|||
155709050|NCT01456169|562027577|FG001|Overall Study|Lack of Efficacy|0|||
155709051|NCT01456169|562027578|FG002|Overall Study|Lack of Efficacy|0|||
155709052|NCT01456169|562027576|FG000|Overall Study|Other|1|||
155709053|NCT01456169|562027577|FG001|Overall Study|Other|1|||
155709054|NCT01456169|562027578|FG002|Overall Study|Other|0|||
155709055|NCT02652156|562027582|FG000|Overall Study|Physician Decision|1|||
155709056|NCT02652156|562027583|FG001|Overall Study|Physician Decision|0|||
155709057|NCT02652156|562027584|FG002|Overall Study|Physician Decision|0|||
155709058|NCT00496080|562027589|FG000|Overall Study|Lost to Follow-up|9|||
155709059|NCT00496080|562027589|FG000|Overall Study|Surgical re-intervention|7|||
155709060|NCT00496080|562027589|FG000|Overall Study|Withdrawal by Subject|5|||
155709061|NCT00496080|562027589|FG000|Overall Study|Physician Decision|6|||
155709062|NCT04098809|562027590|FG000|Overall Study|Withdrawal by Subject|1|||
155709063|NCT04098809|562027591|FG001|Overall Study|Withdrawal by Subject|3|||
155709064|NCT04098809|562027590|FG000|Overall Study|Physician Decision|2|||
155709065|NCT04098809|562027591|FG001|Overall Study|Physician Decision|1|||
155709066|NCT00570310|562027596|FG000|Overall Study|Adverse Event|1|||
155709067|NCT00570310|562027597|FG001|Overall Study|Adverse Event|2|||
155709068|NCT00570310|562027596|FG000|Overall Study|Lack of Efficacy|1|||
155709069|NCT00570310|562027597|FG001|Overall Study|Lack of Efficacy|4|||
155709070|NCT03329846|562027599|FG000|Overall Study|Disease progression|4|||
155709071|NCT03329846|562027600|FG001|Overall Study|Disease progression|6|||
155709072|NCT03329846|562027599|FG000|Overall Study|Study drug toxicity|1|||
155709073|NCT03329846|562027600|FG001|Overall Study|Study drug toxicity|0|||
155709074|NCT03329846|562027599|FG000|Overall Study|Participant request to discontinue treatment|0|||
155709075|NCT03329846|562027600|FG001|Overall Study|Participant request to discontinue treatment|1|||
155709076|NCT03329846|562027599|FG000|Overall Study|Participant withdrew consent|1|||
155709077|NCT03329846|562027600|FG001|Overall Study|Participant withdrew consent|0|||
155709078|NCT03329846|562027599|FG000|Overall Study|Other reasons|2|||
155709079|NCT03329846|562027600|FG001|Overall Study|Other reasons|2|||
155709080|NCT02741596|562027601|FG000|Overall Study|Adverse Event|1|||
155709081|NCT02741596|562027602|FG001|Overall Study|Adverse Event|5|||
155709082|NCT02741596|562027601|FG000|Overall Study|Lost to Follow-up|1|||
155709083|NCT02741596|562027602|FG001|Overall Study|Lost to Follow-up|1|||
155709084|NCT02741596|562027601|FG000|Overall Study|Physician Decision|2|||
155709085|NCT02741596|562027602|FG001|Overall Study|Physician Decision|1|||
155709086|NCT02741596|562027601|FG000|Overall Study|Pregnancy|3|||
155709087|NCT02741596|562027602|FG001|Overall Study|Pregnancy|1|||
155709088|NCT02741596|562027601|FG000|Overall Study|Other (Unspecified)|0|||
155709089|NCT02741596|562027602|FG001|Overall Study|Other (Unspecified)|3|||
155709090|NCT02741596|562027601|FG000|Overall Study|Subject withdrawn-Other|17|||
155709091|NCT02741596|562027602|FG001|Overall Study|Subject withdrawn-Other|4|||
155709092|NCT02741596|562027601|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
155709093|NCT02741596|562027602|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
155709094|NCT00479336|562027603|FG000|Overall Study|Adverse Event|1|||
155709095|NCT00479336|562027604|FG001|Overall Study|Adverse Event|1|||
155709096|NCT00479336|562027605|FG002|Overall Study|Adverse Event|1|||
155709097|NCT00479336|562027606|FG003|Overall Study|Adverse Event|3|||
155709098|NCT00479336|562027603|FG000|Overall Study|Lack of Efficacy|1|||
155709099|NCT00479336|562027604|FG001|Overall Study|Lack of Efficacy|0|||
155709100|NCT00479336|562027605|FG002|Overall Study|Lack of Efficacy|0|||
155709101|NCT00479336|562027606|FG003|Overall Study|Lack of Efficacy|0|||
155709102|NCT00479336|562027603|FG000|Overall Study|Protocol Violation|0|||
155709103|NCT00479336|562027604|FG001|Overall Study|Protocol Violation|1|||
155709104|NCT00479336|562027605|FG002|Overall Study|Protocol Violation|0|||
155709105|NCT00479336|562027606|FG003|Overall Study|Protocol Violation|0|||
155709106|NCT00479336|562027603|FG000|Overall Study|Withdrawal by Subject|1|||
155709107|NCT00479336|562027604|FG001|Overall Study|Withdrawal by Subject|2|||
155709108|NCT00479336|562027605|FG002|Overall Study|Withdrawal by Subject|0|||
155709109|NCT00479336|562027606|FG003|Overall Study|Withdrawal by Subject|0|||
155709110|NCT00479336|562027603|FG000|Overall Study|Physician Decision|0|||
155709111|NCT00479336|562027604|FG001|Overall Study|Physician Decision|1|||
155709112|NCT00479336|562027605|FG002|Overall Study|Physician Decision|0|||
155709113|NCT00479336|562027606|FG003|Overall Study|Physician Decision|2|||
155709114|NCT00479336|562027603|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
155709115|NCT00479336|562027604|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
155709116|NCT00479336|562027605|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
155709117|NCT00479336|562027606|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
155709118|NCT03066193|562027607|FG000|Overall Study|Withdrawal by Subject|1|||
155709119|NCT04854551|562027612|FG000|Overall Study|Withdrawal by Subject|1|||
155709120|NCT04854551|562027613|FG001|Overall Study|Withdrawal by Subject|1|||
155709121|NCT02859246|562027615|FG000|Overall Study|Screen fails|3|||
155709122|NCT02859246|562027615|FG000|Overall Study|Adverse Event|1|||
155709123|NCT02859246|562027615|FG000|Overall Study|Withdrawal by Subject|1|||
155709124|NCT05280717|562027616|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
155709125|NCT05280717|562027617|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
155709126|NCT05280717|562027618|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
155709127|NCT05280717|562027619|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155709128|NCT05280717|562027620|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155709129|NCT05280717|562027621|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155709130|NCT05280717|562027622|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155709131|NCT05280717|562027616|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
155709132|NCT05280717|562027617|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709133|NCT05280717|562027618|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709134|NCT05280717|562027619|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709135|NCT05280717|562027620|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709136|NCT05280717|562027621|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709137|NCT05280717|562027622|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155709138|NCT05280717|562027616|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709139|NCT05280717|562027617|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
155709140|NCT05280717|562027618|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709141|NCT05280717|562027619|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709142|NCT05280717|562027620|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709143|NCT05280717|562027621|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709144|NCT05280717|562027622|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155709145|NCT05280717|562027616|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709146|NCT05280717|562027617|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709147|NCT05280717|562027618|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
155709148|NCT05280717|562027619|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709149|NCT05280717|562027620|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709150|NCT05280717|562027621|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709151|NCT05280717|562027622|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155709152|NCT05280717|562027616|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709153|NCT05280717|562027617|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709154|NCT05280717|562027618|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709155|NCT05280717|562027619|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709156|NCT05280717|562027620|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709157|NCT05280717|562027621|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
155709158|NCT05280717|562027622|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155709159|NCT05280717|562027616|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709160|NCT05280717|562027617|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709161|NCT05280717|562027618|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709162|NCT05280717|562027619|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709163|NCT05280717|562027620|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709164|NCT05280717|562027621|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
155709165|NCT05280717|562027622|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155709166|NCT00080301|562027623|FG000|Overall Study|Randomized but Never Treated|5|||
155709167|NCT00080301|562027624|FG001|Overall Study|Randomized but Never Treated|10|||
155709168|NCT00080301|562027623|FG000|Overall Study|Still on Treatment as of CSR date|0|||
155709169|NCT00080301|562027624|FG001|Overall Study|Still on Treatment as of CSR date|1|||
155709170|NCT01521507|562027625|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
155709171|NCT01521507|562027626|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
155709172|NCT01521507|562027625|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
155709173|NCT01521507|562027626|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
155709174|NCT01521507|562027625|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
155709175|NCT01521507|562027626|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
155709176|NCT01521507|562027625|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
155709177|NCT01521507|562027626|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
155709178|NCT01521507|562027625|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
155709179|NCT01521507|562027626|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
155709180|NCT01521507|562027625|FG000|Stage 2: Observational Design|Physician Decision|1|||
155709181|NCT01521507|562027626|FG001|Stage 2: Observational Design|Physician Decision|0|||
155709182|NCT04034004|562027627|FG000|Overall Study|Withdrawal by Subject|1|||
155709183|NCT04034004|562027628|FG001|Overall Study|Withdrawal by Subject|2|||
155709184|NCT04034004|562027629|FG002|Overall Study|Withdrawal by Subject|2|||
155709185|NCT04034004|562027630|FG003|Overall Study|Withdrawal by Subject|3|||
155709186|NCT04034004|562027627|FG000|Overall Study|could not find vein to administer IV|2|||
155709187|NCT04034004|562027628|FG001|Overall Study|could not find vein to administer IV|1|||
155709188|NCT04034004|562027629|FG002|Overall Study|could not find vein to administer IV|0|||
155709189|NCT04034004|562027630|FG003|Overall Study|could not find vein to administer IV|0|||
155709190|NCT04034004|562027627|FG000|Overall Study|nurse accidentally unblinded subject|0|||
155709191|NCT04034004|562027628|FG001|Overall Study|nurse accidentally unblinded subject|0|||
155709192|NCT04034004|562027629|FG002|Overall Study|nurse accidentally unblinded subject|0|||
155709193|NCT04034004|562027630|FG003|Overall Study|nurse accidentally unblinded subject|1|||
155709194|NCT04317040|562027631|FG000|Overall Study|Lost to Follow-up|2|||
155709195|NCT04317040|562027632|FG001|Overall Study|Lost to Follow-up|0|||
155709196|NCT04317040|562027631|FG000|Overall Study|Death|16|||
155709197|NCT04317040|562027632|FG001|Overall Study|Death|18|||
155709198|NCT04317040|562027631|FG000|Overall Study|Withdrawal by Subject|0|||
155709199|NCT04317040|562027632|FG001|Overall Study|Withdrawal by Subject|1|||
155709200|NCT04317040|562027631|FG000|Overall Study|Incomplete assessments|0|||
155709201|NCT04317040|562027632|FG001|Overall Study|Incomplete assessments|1|||
155709202|NCT02518971|562027633|FG000|Overall Study|Lost to Follow-up|0|||
155709203|NCT02518971|562027634|FG001|Overall Study|Lost to Follow-up|1|||
155709204|NCT02518971|562027633|FG000|Overall Study|Physician Decision|6|||
155709205|NCT02518971|562027634|FG001|Overall Study|Physician Decision|6|||
155709206|NCT02518971|562027633|FG000|Overall Study|Protocol Violation|6|||
155709207|NCT02518971|562027634|FG001|Overall Study|Protocol Violation|4|||
155709208|NCT02518971|562027633|FG000|Overall Study|Withdrawal by Subject|4|||
155709209|NCT02518971|562027634|FG001|Overall Study|Withdrawal by Subject|5|||
155709210|NCT02518971|562027633|FG000|Overall Study|Side effects|1|||
155709211|NCT02518971|562027634|FG001|Overall Study|Side effects|0|||
155709212|NCT02518971|562027633|FG000|Overall Study|medication lost in mail|0|||
155709213|NCT02518971|562027634|FG001|Overall Study|medication lost in mail|1|||
155709214|NCT02518971|562027633|FG000|Overall Study|eligibility criteria no longer met|6|||
155709215|NCT02518971|562027634|FG001|Overall Study|eligibility criteria no longer met|3|||
155709216|NCT00757237|562027635|FG000|Overall Study|Lost to Follow-up|0|||
155709217|NCT00757237|562027636|FG001|Overall Study|Lost to Follow-up|1|||
155709218|NCT00757237|562027635|FG000|Overall Study|Protocol Violation|0|||
155709219|NCT00757237|562027636|FG001|Overall Study|Protocol Violation|2|||
155709220|NCT00757237|562027635|FG000|Overall Study|Physician Decision|2|||
155709221|NCT00757237|562027636|FG001|Overall Study|Physician Decision|3|||
155709222|NCT00757237|562027635|FG000|Overall Study|Withdrawal by Subject|8|||
155709223|NCT00757237|562027636|FG001|Overall Study|Withdrawal by Subject|12|||
155709224|NCT00757237|562027635|FG000|Overall Study|Safety or Tolerability|3|||
155709225|NCT00757237|562027636|FG001|Overall Study|Safety or Tolerability|5|||
155709226|NCT00757237|562027635|FG000|Overall Study|Other|0|||
155709227|NCT00757237|562027636|FG001|Overall Study|Other|2|||
155709228|NCT05150990|562027641|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
155709229|NCT05150990|562027642|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
155709230|NCT05150990|562027641|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
155709231|NCT05150990|562027642|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
155709232|NCT05150990|562027641|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
155709233|NCT05150990|562027642|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
155709234|NCT05150990|562027641|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
155709235|NCT05150990|562027642|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
155709236|NCT05150990|562027641|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
155709237|NCT05150990|562027642|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
155709238|NCT05150990|562027641|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
155709239|NCT05150990|562027642|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
155709240|NCT05150990|562027641|FG000|Overall Study|Death (unrelated to the intervention)|1|||
155709241|NCT05150990|562027642|FG001|Overall Study|Death (unrelated to the intervention)|2|||
155709242|NCT01397461|562027644|FG000|Overall Study|Withdrawal by Subject|2|||
155709243|NCT01397461|562027645|FG001|Overall Study|Withdrawal by Subject|1|||
155709244|NCT01397461|562027646|FG002|Overall Study|Withdrawal by Subject|0|||
155709245|NCT01397461|562027644|FG000|Overall Study|Lost to Follow-up|0|||
155709246|NCT01397461|562027645|FG001|Overall Study|Lost to Follow-up|2|||
155709247|NCT01397461|562027646|FG002|Overall Study|Lost to Follow-up|1|||
155709248|NCT01397461|562027644|FG000|Overall Study|Lack of Efficacy|0|||
155709249|NCT01397461|562027645|FG001|Overall Study|Lack of Efficacy|3|||
155709250|NCT01397461|562027646|FG002|Overall Study|Lack of Efficacy|0|||
155709251|NCT01397461|562027644|FG000|Overall Study|Not treated|0|||
155709252|NCT01397461|562027645|FG001|Overall Study|Not treated|0|||
155709253|NCT01397461|562027646|FG002|Overall Study|Not treated|1|||
155709254|NCT01514201|562027649|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
155709255|NCT01514201|562027650|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709256|NCT01514201|562027651|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709257|NCT01514201|562027652|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709258|NCT01514201|562027649|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155709259|NCT01514201|562027650|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
155709260|NCT01514201|562027651|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
155709261|NCT01514201|562027652|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155709262|NCT01514201|562027649|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
155709263|NCT01514201|562027650|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
155709264|NCT01514201|562027651|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
155709265|NCT01514201|562027652|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155709266|NCT01514201|562027649|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
155709267|NCT01514201|562027650|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
155709268|NCT01514201|562027651|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155709269|NCT01514201|562027652|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155709270|NCT01514201|562027649|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155709271|NCT01514201|562027650|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155709272|NCT01514201|562027651|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155709273|NCT01514201|562027652|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
155709274|NCT01514201|562027649|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155709275|NCT01514201|562027650|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155709276|NCT01514201|562027651|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155709277|NCT01514201|562027652|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
155709278|NCT01514201|562027649|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155709279|NCT01514201|562027650|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155709280|NCT01514201|562027651|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155709281|NCT01514201|562027652|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
155709282|NCT01514201|562027649|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709283|NCT01514201|562027650|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709284|NCT01514201|562027651|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155709285|NCT01514201|562027652|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
155709286|NCT01514201|562027649|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155709287|NCT01514201|562027650|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155709288|NCT01514201|562027651|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155709289|NCT01514201|562027652|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
155709290|NCT01514201|562027649|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155709291|NCT01514201|562027650|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155709292|NCT01514201|562027651|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155709293|NCT01514201|562027652|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
155709294|NCT01514201|562027649|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155709295|NCT01514201|562027650|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155709296|NCT01514201|562027651|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155709297|NCT01514201|562027652|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
155709298|NCT01514201|562027649|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155709299|NCT01514201|562027650|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155709300|NCT01514201|562027651|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155709301|NCT01514201|562027652|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
155709302|NCT00637416|562027657|FG000|Overall Study|Lost to Follow-up|1|||
155709303|NCT00637416|562027658|FG001|Overall Study|Lost to Follow-up|1|||
155709304|NCT00637416|562027657|FG000|Overall Study|Unable to take study drug|0|||
155709305|NCT00637416|562027658|FG001|Overall Study|Unable to take study drug|1|||
155709306|NCT02715609|562027670|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
155709307|NCT02715609|562027671|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
155709308|NCT02715609|562027672|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
155709309|NCT02715609|562027670|FG000|Overall Study|Withdrawal by Subject|0|||
155709310|NCT02715609|562027671|FG001|Overall Study|Withdrawal by Subject|0|||
155709311|NCT02715609|562027672|FG002|Overall Study|Withdrawal by Subject|1|||
155709312|NCT00310817|562027673|FG000|Overall Study|AE or Death|3|||
155709313|NCT00310817|562027674|FG001|Overall Study|AE or Death|1|||
155709314|NCT00310817|562027675|FG002|Overall Study|AE or Death|0|||
155709315|NCT00310817|562027676|FG003|Overall Study|AE or Death|0|||
155709316|NCT00310817|562027673|FG000|Overall Study|Withdrawal by Subject|1|||
155709317|NCT00310817|562027674|FG001|Overall Study|Withdrawal by Subject|4|||
155709318|NCT00310817|562027675|FG002|Overall Study|Withdrawal by Subject|6|||
155709319|NCT00310817|562027676|FG003|Overall Study|Withdrawal by Subject|7|||
155709320|NCT00310817|562027673|FG000|Overall Study|Lost to Follow-up|2|||
155709321|NCT00310817|562027674|FG001|Overall Study|Lost to Follow-up|1|||
155709322|NCT00310817|562027675|FG002|Overall Study|Lost to Follow-up|0|||
155709323|NCT00310817|562027676|FG003|Overall Study|Lost to Follow-up|0|||
155709324|NCT00310817|562027673|FG000|Overall Study|Inappropriate Enrollment|1|||
155709325|NCT00310817|562027674|FG001|Overall Study|Inappropriate Enrollment|0|||
155709326|NCT00310817|562027675|FG002|Overall Study|Inappropriate Enrollment|1|||
155709327|NCT00310817|562027676|FG003|Overall Study|Inappropriate Enrollment|0|||
155709328|NCT00310817|562027673|FG000|Overall Study|Protocol Violation|1|||
155709329|NCT00310817|562027674|FG001|Overall Study|Protocol Violation|1|||
155709330|NCT00310817|562027675|FG002|Overall Study|Protocol Violation|1|||
155709331|NCT00310817|562027676|FG003|Overall Study|Protocol Violation|1|||
155709332|NCT00310817|562027673|FG000|Overall Study|Unable to classify|3|||
155709333|NCT00310817|562027674|FG001|Overall Study|Unable to classify|1|||
155709334|NCT00310817|562027675|FG002|Overall Study|Unable to classify|0|||
155709335|NCT00310817|562027676|FG003|Overall Study|Unable to classify|0|||
155709336|NCT04300309|562027682|FG000|Overall Study|Lost to Follow-up|1|||
155709337|NCT04300309|562027683|FG001|Overall Study|Lost to Follow-up|0|||
155709338|NCT04607837|562027685|FG000|Overall Study|Adverse Event|8|||
155709339|NCT04607837|562027686|FG001|Overall Study|Adverse Event|2|||
155709340|NCT04607837|562027685|FG000|Overall Study|Withdrawal by Subject|8|||
155709341|NCT04607837|562027686|FG001|Overall Study|Withdrawal by Subject|7|||
155709342|NCT04607837|562027685|FG000|Overall Study|Physician Decision|2|||
155709343|NCT04607837|562027686|FG001|Overall Study|Physician Decision|0|||
155709344|NCT04607837|562027685|FG000|Overall Study|Lack of Efficacy|2|||
155709345|NCT04607837|562027686|FG001|Overall Study|Lack of Efficacy|0|||
155709346|NCT04607837|562027685|FG000|Overall Study|Participant terminated by sponsor|1|||
155709347|NCT04607837|562027686|FG001|Overall Study|Participant terminated by sponsor|0|||
155709348|NCT04607837|562027685|FG000|Overall Study|Disease worsening|36|||
155709349|NCT04607837|562027686|FG001|Overall Study|Disease worsening|36|||
155709350|NCT04607837|562027685|FG000|Overall Study|Other|1|||
155709351|NCT04607837|562027686|FG001|Overall Study|Other|0|||
155709352|NCT00367835|562027687|FG000|Overall Study|Adverse Event|14|||
155709353|NCT00367835|562027688|FG001|Overall Study|Adverse Event|1|||
155709354|NCT00367835|562027687|FG000|Overall Study|Protocol Violation|1|||
155709355|NCT00367835|562027688|FG001|Overall Study|Protocol Violation|7|||
155709356|NCT00367835|562027687|FG000|Overall Study|Withdrawal by Subject|7|||
155709357|NCT00367835|562027688|FG001|Overall Study|Withdrawal by Subject|6|||
155709358|NCT00367835|562027687|FG000|Overall Study|Lost to Follow-up|1|||
155709359|NCT00367835|562027688|FG001|Overall Study|Lost to Follow-up|4|||
155709360|NCT00367835|562027687|FG000|Overall Study|Lack of Efficacy|3|||
155709361|NCT00367835|562027688|FG001|Overall Study|Lack of Efficacy|12|||
155709362|NCT00367835|562027687|FG000|Overall Study|Subject in juvenile detention center|1|||
155709363|NCT00367835|562027688|FG001|Overall Study|Subject in juvenile detention center|0|||
155709364|NCT00367835|562027687|FG000|Overall Study|refused blood collection|1|||
155709365|NCT00367835|562027688|FG001|Overall Study|refused blood collection|0|||
155709366|NCT00367835|562027687|FG000|Overall Study|Did not respond to calls|1|||
155709367|NCT00367835|562027688|FG001|Overall Study|Did not respond to calls|0|||
155709368|NCT00367835|562027687|FG000|Overall Study|History of lead poisoning|0|||
155709369|NCT00367835|562027688|FG001|Overall Study|History of lead poisoning|1|||
155709370|NCT04346654|562027689|FG000|Overall Study|Adverse Event|2|||
155709371|NCT04346654|562027690|FG001|Overall Study|Adverse Event|0|||
155709372|NCT04346654|562027689|FG000|Overall Study|Non-response|1|||
155709373|NCT04346654|562027690|FG001|Overall Study|Non-response|1|||
155709374|NCT04346654|562027689|FG000|Overall Study|Withdrawal by Subject|2|||
155709375|NCT04346654|562027690|FG001|Overall Study|Withdrawal by Subject|0|||
155709376|NCT04346654|562027689|FG000|Overall Study|Lost to Follow-up|0|||
155709377|NCT04346654|562027690|FG001|Overall Study|Lost to Follow-up|1|||
155709378|NCT04346654|562027689|FG000|Overall Study|Pregnancy|0|||
155709379|NCT04346654|562027690|FG001|Overall Study|Pregnancy|1|||
155709380|NCT04209205|562027697|FG000|Overall Study|Adverse Event|2|||
155709381|NCT04209205|562027698|FG001|Overall Study|Adverse Event|3|||
155709382|NCT04209205|562027697|FG000|Overall Study|Lost to Follow-up|3|||
155709383|NCT04209205|562027698|FG001|Overall Study|Lost to Follow-up|1|||
155709384|NCT04209205|562027697|FG000|Overall Study|Physician Decision|1|||
155709385|NCT04209205|562027698|FG001|Overall Study|Physician Decision|1|||
155709386|NCT04209205|562027697|FG000|Overall Study|Subject decision|10|||
155709387|NCT04209205|562027698|FG001|Overall Study|Subject decision|10|||
155709388|NCT04209205|562027697|FG000|Overall Study|Progressive disease|1|||
155709389|NCT04209205|562027698|FG001|Overall Study|Progressive disease|0|||
155709390|NCT04209205|562027697|FG000|Overall Study|Protocol deviation|0|||
155709391|NCT04209205|562027698|FG001|Overall Study|Protocol deviation|1|||
155709392|NCT04209205|562027697|FG000|Overall Study|New therapy for study indication|1|||
155709393|NCT04209205|562027698|FG001|Overall Study|New therapy for study indication|0|||
155709394|NCT04209205|562027697|FG000|Overall Study|Adverse event - placebo not switched|0|||
155709395|NCT04209205|562027698|FG001|Overall Study|Adverse event - placebo not switched|1|||
155709396|NCT04209205|562027697|FG000|Overall Study|Subject decision - placebo not switched|0|||
155709397|NCT04209205|562027698|FG001|Overall Study|Subject decision - placebo not switched|5|||
155709398|NCT04209205|562027697|FG000|Overall Study|Death - placebo not switched|0|||
155709399|NCT04209205|562027698|FG001|Overall Study|Death - placebo not switched|1|||
155709400|NCT04864639|562029663|FG000|Overall Study|Death|1|||
155709401|NCT04864639|562029663|FG000|Overall Study|Lost to Follow-up|1|||
155709402|NCT03449758|562029664|FG000|Overall Study|Major protocol deviation|1|||
155709403|NCT03449758|562029664|FG000|Overall Study|Treatment inefficacy|5|||
155709404|NCT03449758|562029664|FG000|Overall Study|Adverse Event|9|||
155709405|NCT03449758|562029664|FG000|Overall Study|Consent withdrawal|1|||
155709406|NCT03449758|562029664|FG000|Overall Study|Other unspecified reason|3|||
155709407|NCT00584012|562029670|FG000|Overall Study|Withdrawal by Subject|1|||
155709408|NCT02451943|562029674|FG000|Overall Study|Withdrawal by Subject|13|||
155709409|NCT02451943|562029675|FG001|Overall Study|Withdrawal by Subject|16|||
155709410|NCT02451943|562029674|FG000|Overall Study|Lost to Follow-up|3|||
155709411|NCT02451943|562029675|FG001|Overall Study|Lost to Follow-up|4|||
155709412|NCT02451943|562029674|FG000|Overall Study|Sponsor Decision|0|||
155709413|NCT02451943|562029675|FG001|Overall Study|Sponsor Decision|4|||
155709414|NCT03937713|562029676|FG000|Overall Study|Withdrawal by Subject|3|||
155709415|NCT03937713|562029677|FG001|Overall Study|Withdrawal by Subject|6|||
155709416|NCT03937713|562029676|FG000|Overall Study|Lost to Follow-up|1|||
155709417|NCT03937713|562029677|FG001|Overall Study|Lost to Follow-up|0|||
155709418|NCT00763386|562029680|FG000|Overall Study|Adverse Event|43|||
155709419|NCT00763386|562029681|FG001|Overall Study|Adverse Event|33|||
155709420|NCT00763386|562029680|FG000|Overall Study|Death|1|||
155709421|NCT00763386|562029681|FG001|Overall Study|Death|2|||
155709422|NCT00763386|562029680|FG000|Overall Study|Lost to Follow-up|3|||
155709423|NCT00763386|562029681|FG001|Overall Study|Lost to Follow-up|3|||
155709424|NCT00763386|562029680|FG000|Overall Study|Withdrawal by Subject|0|||
155709425|NCT00763386|562029681|FG001|Overall Study|Withdrawal by Subject|1|||
155709426|NCT00763386|562029680|FG000|Overall Study|CRF missing|0|||
155709427|NCT00763386|562029681|FG001|Overall Study|CRF missing|1|||
155709428|NCT00763386|562029680|FG000|Overall Study|Study Prosthesis Removed|1|||
155709429|NCT00763386|562029681|FG001|Overall Study|Study Prosthesis Removed|0|||
155709430|NCT01217944|562029682|FG000|Overall Study|Protocol Violation|1|||
155709431|NCT01217944|562029683|FG001|Overall Study|Protocol Violation|1|||
155709432|NCT01217944|562029684|FG002|Overall Study|Protocol Violation|0|||
155709433|NCT01217944|562029682|FG000|Overall Study|Lost to Follow-up|3|||
155709434|NCT01217944|562029683|FG001|Overall Study|Lost to Follow-up|1|||
155709435|NCT01217944|562029684|FG002|Overall Study|Lost to Follow-up|0|||
155709436|NCT01217944|562029682|FG000|Overall Study|Withdrawal by Subject|1|||
155709437|NCT01217944|562029683|FG001|Overall Study|Withdrawal by Subject|2|||
155709438|NCT01217944|562029684|FG002|Overall Study|Withdrawal by Subject|0|||
155709439|NCT01217944|562029682|FG000|Overall Study|Lack of Efficacy|1|||
155709440|NCT01217944|562029683|FG001|Overall Study|Lack of Efficacy|0|||
155709441|NCT01217944|562029684|FG002|Overall Study|Lack of Efficacy|0|||
155709442|NCT00950846|562029685|FG000|Overall Study|Death|6|||
155709443|NCT00950846|562029685|FG000|Overall Study|Lost to Follow-up|3|||
155709444|NCT00950846|562029685|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
155709445|NCT00483405|562029688|FG000|Overall Study|Adverse Event|8|||
155709446|NCT00483405|562029688|FG000|Overall Study|Lack of Efficacy|14|||
155709447|NCT00483405|562029688|FG000|Overall Study|Death|3|||
155709448|NCT00483405|562029688|FG000|Overall Study|Withdrawal by Subject|2|||
155709449|NCT00483405|562029688|FG000|Overall Study|Other complicating disease|1|||
155709450|NCT04426318|562029689|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
155709451|NCT04426318|562029690|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
155709452|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Technical problems|0|||
155709453|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Technical problems|0|||
155709454|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Technical problems|0|||
155709455|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Technical problems|1|||
155709456|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155709457|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
155709458|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155709459|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155709460|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
155709461|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
155709462|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
155709463|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
155709464|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
155709465|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
155709466|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
155709467|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
155709468|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Death|0|||
155709469|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Death|3|||
155709470|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Death|1|||
155709471|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Death|0|||
155709472|NCT02152761|562029693|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
155709473|NCT02152761|562029694|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
155709474|NCT02152761|562029695|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
155709475|NCT02152761|562029696|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
155709476|NCT02152761|562029693|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
155709477|NCT02152761|562029694|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
155709478|NCT02152761|562029695|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
155709479|NCT02152761|562029696|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
155709480|NCT02152761|562029693|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
155709481|NCT02152761|562029694|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
155709482|NCT02152761|562029695|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
155709483|NCT02152761|562029696|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
155709484|NCT02152761|562029693|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
155709485|NCT02152761|562029694|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155709486|NCT02152761|562029695|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155709487|NCT02152761|562029696|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155709488|NCT02152761|562029693|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
155709489|NCT02152761|562029694|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
155709490|NCT02152761|562029695|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
155709491|NCT02152761|562029696|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
155709492|NCT01957202|562029697|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709493|NCT01957202|562029698|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
155709494|NCT01957202|562029699|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709495|NCT01957202|562029700|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709496|NCT01957202|562029701|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709497|NCT01957202|562029702|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709498|NCT01957202|562029703|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709499|NCT01957202|562029704|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709500|NCT01957202|562029705|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709501|NCT01957202|562029706|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709502|NCT01957202|562029707|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709503|NCT01957202|562029708|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709504|NCT01957202|562029709|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709505|NCT01957202|562029710|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709506|NCT01957202|562029711|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709507|NCT01957202|562029712|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709508|NCT01957202|562029713|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
155709509|NCT01957202|562029714|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155709510|NCT01957202|562029697|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709511|NCT01957202|562029698|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709512|NCT01957202|562029699|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709513|NCT01957202|562029700|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709514|NCT01957202|562029701|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709515|NCT01957202|562029702|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709516|NCT01957202|562029703|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709517|NCT01957202|562029704|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709518|NCT01957202|562029705|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709519|NCT01957202|562029706|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709520|NCT01957202|562029707|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709521|NCT01957202|562029708|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709522|NCT01957202|562029709|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709523|NCT01957202|562029710|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709524|NCT01957202|562029711|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709525|NCT01957202|562029712|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709526|NCT01957202|562029713|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
155709527|NCT01957202|562029714|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
155709528|NCT01290757|562029715|FG000|Overall Study|Adverse Event|1|||
155709529|NCT01290757|562029716|FG001|Overall Study|Adverse Event|0|||
155709530|NCT01290757|562029715|FG000|Overall Study|Protocol Violation|1|||
155709531|NCT01290757|562029716|FG001|Overall Study|Protocol Violation|1|||
155709532|NCT01290757|562029715|FG000|Overall Study|Other|0|||
155709533|NCT01290757|562029716|FG001|Overall Study|Other|1|||
155709534|NCT02021643|562029718|FG000|Overall Study|Enrolled but Never Treated|1|||
155709535|NCT02021643|562029719|FG001|Overall Study|Enrolled but Never Treated|0|||
155709536|NCT02021643|562029720|FG002|Overall Study|Enrolled but Never Treated|0|||
155709537|NCT02021643|562029721|FG003|Overall Study|Enrolled but Never Treated|0|||
155709538|NCT02021643|562029718|FG000|Overall Study|Adverse Event|0|||
155709539|NCT02021643|562029719|FG001|Overall Study|Adverse Event|1|||
155709540|NCT02021643|562029720|FG002|Overall Study|Adverse Event|0|||
155709541|NCT02021643|562029721|FG003|Overall Study|Adverse Event|0|||
155709542|NCT02021643|562029718|FG000|Overall Study|Death|0|||
155709543|NCT02021643|562029719|FG001|Overall Study|Death|1|||
155709544|NCT02021643|562029720|FG002|Overall Study|Death|0|||
155709545|NCT02021643|562029721|FG003|Overall Study|Death|0|||
155709546|NCT02021643|562029718|FG000|Overall Study|Investigator's Discretion|1|||
155709547|NCT02021643|562029719|FG001|Overall Study|Investigator's Discretion|0|||
155709548|NCT02021643|562029720|FG002|Overall Study|Investigator's Discretion|0|||
155709549|NCT02021643|562029721|FG003|Overall Study|Investigator's Discretion|0|||
155709550|NCT02021643|562029718|FG000|Overall Study|Lack of Efficacy|7|||
155709551|NCT02021643|562029719|FG001|Overall Study|Lack of Efficacy|6|||
155709552|NCT02021643|562029720|FG002|Overall Study|Lack of Efficacy|0|||
155709553|NCT02021643|562029721|FG003|Overall Study|Lack of Efficacy|12|||
155709554|NCT02021643|562029718|FG000|Overall Study|Lost to Follow-up|0|||
155709555|NCT02021643|562029719|FG001|Overall Study|Lost to Follow-up|1|||
155709556|NCT02021643|562029720|FG002|Overall Study|Lost to Follow-up|0|||
155709557|NCT02021643|562029721|FG003|Overall Study|Lost to Follow-up|0|||
155709558|NCT02021643|562029718|FG000|Overall Study|Withdrew Consent|0|||
155709559|NCT02021643|562029719|FG001|Overall Study|Withdrew Consent|1|||
155709560|NCT02021643|562029720|FG002|Overall Study|Withdrew Consent|0|||
155709561|NCT02021643|562029721|FG003|Overall Study|Withdrew Consent|0|||
155709562|NCT02631551|562029722|FG000|Overall Study|Adverse Event|1|||
155709563|NCT02631551|562029723|FG001|Overall Study|Adverse Event|2|||
155709564|NCT02631551|562029724|FG002|Overall Study|Adverse Event|4|||
155709565|NCT02631551|562029725|FG003|Overall Study|Adverse Event|0|||
155709566|NCT02631551|562029722|FG000|Overall Study|Lack of Efficacy|0|||
155709567|NCT02631551|562029723|FG001|Overall Study|Lack of Efficacy|0|||
155709568|NCT02631551|562029724|FG002|Overall Study|Lack of Efficacy|1|||
155709569|NCT02631551|562029725|FG003|Overall Study|Lack of Efficacy|0|||
155709570|NCT02631551|562029722|FG000|Overall Study|Lost to Follow-up|1|||
155709571|NCT02631551|562029723|FG001|Overall Study|Lost to Follow-up|2|||
155709572|NCT02631551|562029724|FG002|Overall Study|Lost to Follow-up|0|||
155709573|NCT02631551|562029725|FG003|Overall Study|Lost to Follow-up|3|||
155709574|NCT02631551|562029722|FG000|Overall Study|Withdrawal by Subject|2|||
155709575|NCT02631551|562029723|FG001|Overall Study|Withdrawal by Subject|2|||
155709576|NCT02631551|562029724|FG002|Overall Study|Withdrawal by Subject|0|||
155709577|NCT02631551|562029725|FG003|Overall Study|Withdrawal by Subject|5|||
155709578|NCT02631551|562029722|FG000|Overall Study|Protocol deviation|3|||
155709579|NCT02631551|562029723|FG001|Overall Study|Protocol deviation|6|||
155709580|NCT02631551|562029724|FG002|Overall Study|Protocol deviation|3|||
155709581|NCT02631551|562029725|FG003|Overall Study|Protocol deviation|0|||
155709582|NCT02631551|562029722|FG000|Overall Study|Non-compliance with study procedures|0|||
155709583|NCT02631551|562029723|FG001|Overall Study|Non-compliance with study procedures|0|||
155709584|NCT02631551|562029724|FG002|Overall Study|Non-compliance with study procedures|1|||
155709585|NCT02631551|562029725|FG003|Overall Study|Non-compliance with study procedures|1|||
155709586|NCT02631551|562029722|FG000|Overall Study|Non-compliance with study drug|1|||
155709587|NCT02631551|562029723|FG001|Overall Study|Non-compliance with study drug|0|||
155709588|NCT02631551|562029724|FG002|Overall Study|Non-compliance with study drug|0|||
155709589|NCT02631551|562029725|FG003|Overall Study|Non-compliance with study drug|0|||
155709590|NCT02631551|562029722|FG000|Overall Study|Other, specific reasons not collected|5|||
155709591|NCT02631551|562029723|FG001|Overall Study|Other, specific reasons not collected|7|||
155709592|NCT02631551|562029724|FG002|Overall Study|Other, specific reasons not collected|2|||
155709593|NCT02631551|562029725|FG003|Overall Study|Other, specific reasons not collected|2|||
155709594|NCT04390243|562029731|FG000|Overall Study|Death|1|||
155709595|NCT04390243|562029731|FG000|Overall Study|Disease Progression|4|||
155709596|NCT04390243|562029731|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
155709597|NCT01196026|562029738|FG000|Overall Study|Withdrawal by Subject|1|||
155709598|NCT01196026|562029739|FG001|Overall Study|Withdrawal by Subject|4|||
155709599|NCT01196026|562029740|FG002|Overall Study|Withdrawal by Subject|0|||
155709600|NCT01196026|562029741|FG003|Overall Study|Withdrawal by Subject|0|||
155709601|NCT01196026|562029742|FG004|Overall Study|Withdrawal by Subject|0|||
155709602|NCT01196026|562029743|FG005|Overall Study|Withdrawal by Subject|0|||
155709603|NCT01196026|562029738|FG000|Overall Study|Lost to Follow-up|0|||
155709604|NCT01196026|562029739|FG001|Overall Study|Lost to Follow-up|3|||
155709605|NCT01196026|562029740|FG002|Overall Study|Lost to Follow-up|0|||
155709606|NCT01196026|562029741|FG003|Overall Study|Lost to Follow-up|0|||
155709607|NCT01196026|562029742|FG004|Overall Study|Lost to Follow-up|1|||
155709608|NCT01196026|562029743|FG005|Overall Study|Lost to Follow-up|0|||
155709609|NCT01196026|562029738|FG000|Overall Study|Other|0|||
155709610|NCT01196026|562029739|FG001|Overall Study|Other|1|||
155709611|NCT01196026|562029740|FG002|Overall Study|Other|0|||
155709612|NCT01196026|562029741|FG003|Overall Study|Other|0|||
155709613|NCT01196026|562029742|FG004|Overall Study|Other|0|||
155709614|NCT01196026|562029743|FG005|Overall Study|Other|0|||
155709615|NCT01843023|562029744|FG000|Overall Study|Death|1|||
155709616|NCT01843023|562029745|FG001|Overall Study|Death|0|||
155709617|NCT01843023|562029744|FG000|Overall Study|Lost to Follow-up|24|||
155709618|NCT01843023|562029745|FG001|Overall Study|Lost to Follow-up|29|||
155709619|NCT01843023|562029744|FG000|Overall Study|Withdrawal by Subject|8|||
155709620|NCT01843023|562029745|FG001|Overall Study|Withdrawal by Subject|6|||
155709621|NCT04980612|562029762|FG000|Overall Study|Withdrawal by Subject|7|||
155709622|NCT04980612|562029763|FG001|Overall Study|Withdrawal by Subject|5|||
155709623|NCT01502228|562029764|FG000|Overall Study|Death|1|||
155709624|NCT05730387|562029765|FG000|Overall Study|Stillbirth|0|||
155709625|NCT05730387|562029766|FG001|Overall Study|Stillbirth|262|||
155709626|NCT05730387|562029765|FG000|Overall Study|Died during or after delivery|2|||
155709627|NCT05730387|562029766|FG001|Overall Study|Died during or after delivery|85|||
155709628|NCT05730387|562029765|FG000|Overall Study|Died after being admitted|0|||
155709629|NCT05730387|562029766|FG001|Overall Study|Died after being admitted|44|||
155709630|NCT05730387|562029765|FG000|Overall Study|Lost to Follow-up|69|||
155709631|NCT05730387|562029766|FG001|Overall Study|Lost to Follow-up|77|||
155709632|NCT02728089|562029767|FG000|Overall Study|Physician Decision|2|||
155709633|NCT02728089|562029767|FG000|Overall Study|Withdrawal by Subject|1|||
155709634|NCT04669301|562029768|FG000|Overall Study|Lost to Follow-up|0|||
155709635|NCT04669301|562029769|FG001|Overall Study|Lost to Follow-up|1|||
155709636|NCT04669301|562029770|FG002|Overall Study|Lost to Follow-up|0|||
155709637|NCT04669301|562029768|FG000|Overall Study|Withdrawal by Subject|3|||
155709638|NCT04669301|562029769|FG001|Overall Study|Withdrawal by Subject|2|||
155709639|NCT04669301|562029770|FG002|Overall Study|Withdrawal by Subject|0|||
155709640|NCT01221350|562029773|FG000|Overall Study|Discontinued intervention (GERD)|1|||
155709641|NCT01221350|562029774|FG001|Overall Study|Discontinued intervention (GERD)|0|||
155709642|NCT01221350|562029773|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
155709643|NCT01221350|562029774|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
155709644|NCT01221350|562029773|FG000|Overall Study|Withdrawal by Subject|4|||
155709645|NCT01221350|562029774|FG001|Overall Study|Withdrawal by Subject|2|||
155709646|NCT05888181|562029776|FG000|Overall Study|Lost to Follow-up|1|||
155709647|NCT05888181|562029777|FG001|Overall Study|Lost to Follow-up|1|||
155709648|NCT05888181|562029778|FG002|Overall Study|Lost to Follow-up|0|||
155709649|NCT04137731|562029781|FG000|Overall Study|Surgery Cancellation|1|||
155709650|NCT04137731|562029782|FG001|Overall Study|Surgery Cancellation|2|||
155709651|NCT04137731|562029781|FG000|Overall Study|Withdrawal by Subject|2|||
155709652|NCT04137731|562029782|FG001|Overall Study|Withdrawal by Subject|0|||
155709653|NCT04137731|562029781|FG000|Overall Study|Protocol Violation|0|||
155709654|NCT04137731|562029782|FG001|Overall Study|Protocol Violation|1|||
155709655|NCT00362648|562029784|FG000|Overall Study|Adverse Event|12|||
155709656|NCT00362648|562029785|FG001|Overall Study|Adverse Event|21|||
155709657|NCT00362648|562029786|FG002|Overall Study|Adverse Event|1|||
155709658|NCT00362648|562029787|FG003|Overall Study|Adverse Event|0|||
155709659|NCT00362648|562029784|FG000|Overall Study|Lost to Follow-up|62|||
155709660|NCT00362648|562029785|FG001|Overall Study|Lost to Follow-up|69|||
155709661|NCT00362648|562029786|FG002|Overall Study|Lost to Follow-up|4|||
155709662|NCT00362648|562029787|FG003|Overall Study|Lost to Follow-up|3|||
155709663|NCT00362648|562029784|FG000|Overall Study|Protocol Violation|4|||
155709664|NCT00362648|562029785|FG001|Overall Study|Protocol Violation|2|||
155709665|NCT00362648|562029786|FG002|Overall Study|Protocol Violation|2|||
155709666|NCT00362648|562029787|FG003|Overall Study|Protocol Violation|2|||
155709667|NCT00362648|562029784|FG000|Overall Study|Withdrawal by Subject|48|||
155709668|NCT00362648|562029785|FG001|Overall Study|Withdrawal by Subject|42|||
155709669|NCT00362648|562029786|FG002|Overall Study|Withdrawal by Subject|2|||
155709670|NCT00362648|562029787|FG003|Overall Study|Withdrawal by Subject|6|||
155709671|NCT02204072|562029788|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
155709672|NCT02204072|562029789|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
155709673|NCT02204072|562029790|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
155709674|NCT02204072|562029791|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
155709675|NCT02204072|562029792|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
155709676|NCT02204072|562029788|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
155709677|NCT02204072|562029789|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
155709678|NCT02204072|562029790|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
155709679|NCT02204072|562029791|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
155709680|NCT02204072|562029792|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
155709681|NCT02204072|562029788|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
155709682|NCT02204072|562029789|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
155709683|NCT02204072|562029790|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
155709684|NCT02204072|562029791|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
155709685|NCT02204072|562029792|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
155709686|NCT02204072|562029788|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155709687|NCT02204072|562029789|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155709688|NCT02204072|562029790|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
155709689|NCT02204072|562029791|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155709690|NCT02204072|562029792|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155709691|NCT03983304|562029793|FG000|Overall Study|Withdrawal by Subject|5|||
155709692|NCT03983304|562029793|FG000|Overall Study|Lost to Follow-up|2|||
155709693|NCT01587040|562029794|FG000|Overall Study|Protocol Violation|0|||
155709694|NCT01587040|562029795|FG001|Overall Study|Protocol Violation|0|||
155709695|NCT01587040|562029796|FG002|Overall Study|Protocol Violation|1|||
155709696|NCT01587040|562029797|FG003|Overall Study|Protocol Violation|0|||
155709697|NCT01587040|562029794|FG000|Overall Study|Adverse Event|0|||
155709698|NCT01587040|562029795|FG001|Overall Study|Adverse Event|1|||
155709699|NCT01587040|562029796|FG002|Overall Study|Adverse Event|10|||
155709700|NCT01587040|562029797|FG003|Overall Study|Adverse Event|0|||
155709701|NCT01587040|562029794|FG000|Overall Study|Disease progression|12|||
155709702|NCT01587040|562029795|FG001|Overall Study|Disease progression|1|||
155709703|NCT01587040|562029796|FG002|Overall Study|Disease progression|15|||
155709704|NCT01587040|562029797|FG003|Overall Study|Disease progression|3|||
155709705|NCT01587040|562029794|FG000|Overall Study|Other than specified|5|||
155709706|NCT01587040|562029795|FG001|Overall Study|Other than specified|1|||
155709707|NCT01587040|562029796|FG002|Overall Study|Other than specified|11|||
155709708|NCT01587040|562029797|FG003|Overall Study|Other than specified|1|||
155709709|NCT05236257|562029807|FG000|Overall Study|Ongoing with study treatment|29|||
155709710|NCT05236257|562029808|FG001|Overall Study|Ongoing with study treatment|1|||
155709711|NCT05236257|562029807|FG000|Overall Study|Discontinued study treatment|22|||
155709712|NCT05236257|562029808|FG001|Overall Study|Discontinued study treatment|41|||
155709713|NCT00048347|562029814|FG000|Overall Study|Screen failure|2|||
155709714|NCT02343406|562029815|FG000|Overall Study|Progressive disease|72|||
155709715|NCT02343406|562029816|FG001|Overall Study|Progressive disease|70|||
155709716|NCT02343406|562029817|FG002|Overall Study|Progressive disease|43|||
155709717|NCT02343406|562029818|FG003|Overall Study|Progressive disease|15|||
155709718|NCT02343406|562029819|FG004|Overall Study|Progressive disease|5|||
155709719|NCT02343406|562029815|FG000|Overall Study|Adverse Event|6|||
155709720|NCT02343406|562029816|FG001|Overall Study|Adverse Event|8|||
155709721|NCT02343406|562029817|FG002|Overall Study|Adverse Event|6|||
155709722|NCT02343406|562029818|FG003|Overall Study|Adverse Event|3|||
155709723|NCT02343406|562029819|FG004|Overall Study|Adverse Event|0|||
155709724|NCT02343406|562029815|FG000|Overall Study|Withdrawal by Subject|6|||
155709725|NCT02343406|562029816|FG001|Overall Study|Withdrawal by Subject|4|||
155709726|NCT02343406|562029817|FG002|Overall Study|Withdrawal by Subject|8|||
155709727|NCT02343406|562029818|FG003|Overall Study|Withdrawal by Subject|3|||
155709728|NCT02343406|562029819|FG004|Overall Study|Withdrawal by Subject|0|||
155709729|NCT02343406|562029815|FG000|Overall Study|Death|2|||
155709730|NCT02343406|562029816|FG001|Overall Study|Death|1|||
155709731|NCT02343406|562029817|FG002|Overall Study|Death|0|||
155709732|NCT02343406|562029818|FG003|Overall Study|Death|0|||
155709733|NCT02343406|562029819|FG004|Overall Study|Death|0|||
155709734|NCT02343406|562029815|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
155709735|NCT02343406|562029816|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
155709736|NCT02343406|562029817|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
155709737|NCT02343406|562029818|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
155709738|NCT02343406|562029819|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
155709739|NCT02343406|562029815|FG000|Overall Study|Other primary malignancy|0|||
155709740|NCT02343406|562029816|FG001|Overall Study|Other primary malignancy|1|||
155709741|NCT02343406|562029817|FG002|Overall Study|Other primary malignancy|0|||
155709742|NCT02343406|562029818|FG003|Overall Study|Other primary malignancy|0|||
155709743|NCT02343406|562029819|FG004|Overall Study|Other primary malignancy|0|||
155709744|NCT02343406|562029815|FG000|Overall Study|Other, not specified|2|||
155709745|NCT02343406|562029816|FG001|Overall Study|Other, not specified|1|||
155709746|NCT02343406|562029817|FG002|Overall Study|Other, not specified|1|||
155709747|NCT02343406|562029818|FG003|Overall Study|Other, not specified|4|||
155709748|NCT02343406|562029819|FG004|Overall Study|Other, not specified|0|||
155709749|NCT01746225|562029822|FG000|Overall Study|Death|1|||
155709750|NCT01746225|562029823|FG001|Overall Study|Death|0|||
155709751|NCT01746225|562029824|FG002|Overall Study|Death|1|||
155709752|NCT01746225|562029822|FG000|Overall Study|Withdrawal by Subject|5|||
155709753|NCT01746225|562029823|FG001|Overall Study|Withdrawal by Subject|15|||
155709754|NCT01746225|562029824|FG002|Overall Study|Withdrawal by Subject|19|||
155709755|NCT01746225|562029822|FG000|Overall Study|Physician Decision|14|||
155709756|NCT01746225|562029823|FG001|Overall Study|Physician Decision|11|||
155709757|NCT01746225|562029824|FG002|Overall Study|Physician Decision|3|||
155709758|NCT01746225|562029822|FG000|Overall Study|Adverse Event|15|||
155709759|NCT01746225|562029823|FG001|Overall Study|Adverse Event|12|||
155709760|NCT01746225|562029824|FG002|Overall Study|Adverse Event|17|||
155709761|NCT01746225|562029822|FG000|Overall Study|Continuing Treatment|5|||
155709762|NCT01746225|562029823|FG001|Overall Study|Continuing Treatment|8|||
155709763|NCT01746225|562029824|FG002|Overall Study|Continuing Treatment|3|||
155709764|NCT00595478|562029825|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
155709765|NCT00595478|562029826|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
155709766|NCT00595478|562029825|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
155709767|NCT00595478|562029826|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
155709768|NCT02713828|562029829|FG000|Overall Study|Death|2|||
155709769|NCT02713828|562029830|FG001|Overall Study|Death|0|||
155709770|NCT02713828|562029829|FG000|Overall Study|Withdrawal by Subject|1|||
155709771|NCT02713828|562029830|FG001|Overall Study|Withdrawal by Subject|0|||
155709772|NCT02713828|562029829|FG000|Overall Study|study terminated but patient allowed to|2|||
155709773|NCT02713828|562029830|FG001|Overall Study|study terminated but patient allowed to|0|||
155709774|NCT03302247|562029834|FG000|Overall Study|the study has closed prematurely|2|||
155709775|NCT03302247|562029834|FG000|Overall Study|Death|1|||
155709776|NCT03197376|562029835|FG000|Primary and Booster Phase|Adverse Event|0|||
155709777|NCT03197376|562029836|FG001|Primary and Booster Phase|Adverse Event|0|||
155709778|NCT03197376|562029837|FG002|Primary and Booster Phase|Adverse Event|0|||
155709779|NCT03197376|562029838|FG003|Primary and Booster Phase|Adverse Event|1|||
155709780|NCT03197376|562029835|FG000|Primary and Booster Phase|Death|1|||
155709781|NCT03197376|562029836|FG001|Primary and Booster Phase|Death|0|||
155709782|NCT03197376|562029837|FG002|Primary and Booster Phase|Death|0|||
155709783|NCT03197376|562029838|FG003|Primary and Booster Phase|Death|2|||
155709784|NCT03197376|562029835|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
155709785|NCT03197376|562029836|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
155709786|NCT03197376|562029837|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
155709787|NCT03197376|562029838|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
155709788|NCT03197376|562029835|FG000|Primary and Booster Phase|Physician Decision|1|||
155709789|NCT03197376|562029836|FG001|Primary and Booster Phase|Physician Decision|0|||
155709790|NCT03197376|562029837|FG002|Primary and Booster Phase|Physician Decision|1|||
155709791|NCT03197376|562029838|FG003|Primary and Booster Phase|Physician Decision|3|||
155709792|NCT03197376|562029835|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
155709793|NCT03197376|562029836|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
155709794|NCT03197376|562029837|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
155709795|NCT03197376|562029838|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
155709796|NCT03197376|562029835|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
155709797|NCT03197376|562029836|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
155709798|NCT03197376|562029837|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
155709799|NCT03197376|562029838|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
155709800|NCT03197376|562029835|FG000|Primary and Booster Phase|Not vaccine related|1|||
155709801|NCT03197376|562029836|FG001|Primary and Booster Phase|Not vaccine related|2|||
155709802|NCT03197376|562029837|FG002|Primary and Booster Phase|Not vaccine related|0|||
155709803|NCT03197376|562029838|FG003|Primary and Booster Phase|Not vaccine related|6|||
155709804|NCT03197376|562029835|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
155709805|NCT03197376|562029836|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
155709806|NCT03197376|562029837|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
155709807|NCT03197376|562029838|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
155709808|NCT03197376|562029835|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
155709809|NCT03197376|562029836|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
155709810|NCT03197376|562029837|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
155709811|NCT03197376|562029838|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
155709812|NCT03197376|562029835|FG000|Immune Persistence Phase|Not vaccine related|1|||
155709813|NCT03197376|562029836|FG001|Immune Persistence Phase|Not vaccine related|0|||
155709814|NCT03197376|562029837|FG002|Immune Persistence Phase|Not vaccine related|1|||
155709815|NCT03197376|562029838|FG003|Immune Persistence Phase|Not vaccine related|1|||
155709816|NCT03508609|562029841|FG000|Overall Study|Withdrawal by Subject|1|||
155709817|NCT00999518|562029842|FG000|Overall Study|Adverse Event|1|||
155709818|NCT00999518|562029843|FG001|Overall Study|Adverse Event|6|||
155709819|NCT00999518|562029844|FG002|Overall Study|Adverse Event|3|||
155709820|NCT00999518|562029845|FG003|Overall Study|Adverse Event|1|||
155709821|NCT00999518|562029846|FG004|Overall Study|Adverse Event|2|||
155709822|NCT00999518|562029842|FG000|Overall Study|Lack of Efficacy|2|||
155709823|NCT00999518|562029843|FG001|Overall Study|Lack of Efficacy|0|||
155709824|NCT00999518|562029844|FG002|Overall Study|Lack of Efficacy|0|||
155709825|NCT00999518|562029845|FG003|Overall Study|Lack of Efficacy|2|||
155709826|NCT00999518|562029846|FG004|Overall Study|Lack of Efficacy|2|||
155709827|NCT00999518|562029842|FG000|Overall Study|Lost to Follow-up|0|||
155709828|NCT00999518|562029843|FG001|Overall Study|Lost to Follow-up|0|||
155709829|NCT00999518|562029844|FG002|Overall Study|Lost to Follow-up|0|||
155709830|NCT00999518|562029845|FG003|Overall Study|Lost to Follow-up|4|||
155709831|NCT00999518|562029846|FG004|Overall Study|Lost to Follow-up|1|||
155709832|NCT00999518|562029842|FG000|Overall Study|Did not meet entrance criteria|0|||
155709833|NCT00999518|562029843|FG001|Overall Study|Did not meet entrance criteria|0|||
155709834|NCT00999518|562029844|FG002|Overall Study|Did not meet entrance criteria|0|||
155709835|NCT00999518|562029845|FG003|Overall Study|Did not meet entrance criteria|0|||
155709836|NCT00999518|562029846|FG004|Overall Study|Did not meet entrance criteria|1|||
155709837|NCT00999518|562029842|FG000|Overall Study|Study terminated by sponsor|10|||
155709838|NCT00999518|562029843|FG001|Overall Study|Study terminated by sponsor|6|||
155709839|NCT00999518|562029844|FG002|Overall Study|Study terminated by sponsor|5|||
155709840|NCT00999518|562029845|FG003|Overall Study|Study terminated by sponsor|5|||
155709841|NCT00999518|562029846|FG004|Overall Study|Study terminated by sponsor|9|||
155709842|NCT00999518|562029842|FG000|Overall Study|Pregnancy|0|||
155709843|NCT00999518|562029843|FG001|Overall Study|Pregnancy|0|||
155709844|NCT00999518|562029844|FG002|Overall Study|Pregnancy|1|||
155709845|NCT00999518|562029845|FG003|Overall Study|Pregnancy|0|||
155709846|NCT00999518|562029846|FG004|Overall Study|Pregnancy|0|||
155709847|NCT00999518|562029842|FG000|Overall Study|Protocol Violation|0|||
155709848|NCT00999518|562029843|FG001|Overall Study|Protocol Violation|1|||
155709849|NCT00999518|562029844|FG002|Overall Study|Protocol Violation|0|||
155709850|NCT00999518|562029845|FG003|Overall Study|Protocol Violation|0|||
155709851|NCT00999518|562029846|FG004|Overall Study|Protocol Violation|2|||
155709852|NCT00999518|562029842|FG000|Overall Study|Withdrawal by Subject|5|||
155709853|NCT00999518|562029843|FG001|Overall Study|Withdrawal by Subject|4|||
155709854|NCT00999518|562029844|FG002|Overall Study|Withdrawal by Subject|10|||
155709855|NCT00999518|562029845|FG003|Overall Study|Withdrawal by Subject|6|||
155709856|NCT00999518|562029846|FG004|Overall Study|Withdrawal by Subject|1|||
155709857|NCT00999518|562029842|FG000|Overall Study|Other|5|||
155709858|NCT00999518|562029843|FG001|Overall Study|Other|7|||
155709859|NCT00999518|562029844|FG002|Overall Study|Other|1|||
155709860|NCT00999518|562029845|FG003|Overall Study|Other|4|||
155709861|NCT00999518|562029846|FG004|Overall Study|Other|5|||
155709862|NCT00999518|562029842|FG000|Overall Study|Randomized but not Treated|1|||
155709863|NCT00999518|562029843|FG001|Overall Study|Randomized but not Treated|1|||
155709864|NCT00999518|562029844|FG002|Overall Study|Randomized but not Treated|2|||
155709865|NCT00999518|562029845|FG003|Overall Study|Randomized but not Treated|0|||
155709866|NCT00999518|562029846|FG004|Overall Study|Randomized but not Treated|1|||
155709867|NCT01445080|562029852|FG000|Overall Study|Adverse Event|5|||
155709868|NCT01445080|562029853|FG001|Overall Study|Adverse Event|3|||
155709869|NCT01445080|562029854|FG002|Overall Study|Adverse Event|11|||
155709870|NCT01445080|562029855|FG003|Overall Study|Adverse Event|6|||
155709871|NCT01445080|562029856|FG004|Overall Study|Adverse Event|2|||
155709872|NCT01445080|562029857|FG005|Overall Study|Adverse Event|3|||
155709873|NCT01445080|562029858|FG006|Overall Study|Adverse Event|0|||
155709874|NCT01445080|562029859|FG007|Overall Study|Adverse Event|3|||
155709875|NCT01445080|562029860|FG008|Overall Study|Adverse Event|10|||
155709876|NCT01445080|562029852|FG000|Overall Study|Physician Decision|0|||
155709877|NCT01445080|562029853|FG001|Overall Study|Physician Decision|0|||
155709878|NCT01445080|562029854|FG002|Overall Study|Physician Decision|1|||
155709879|NCT01445080|562029855|FG003|Overall Study|Physician Decision|0|||
155709880|NCT01445080|562029856|FG004|Overall Study|Physician Decision|0|||
155709881|NCT01445080|562029857|FG005|Overall Study|Physician Decision|3|||
155709882|NCT01445080|562029858|FG006|Overall Study|Physician Decision|2|||
155709883|NCT01445080|562029859|FG007|Overall Study|Physician Decision|2|||
155709884|NCT01445080|562029860|FG008|Overall Study|Physician Decision|0|||
155709885|NCT01445080|562029852|FG000|Overall Study|Withdrawal by Subject|1|||
155709886|NCT01445080|562029853|FG001|Overall Study|Withdrawal by Subject|0|||
155709887|NCT01445080|562029854|FG002|Overall Study|Withdrawal by Subject|0|||
155709888|NCT01445080|562029855|FG003|Overall Study|Withdrawal by Subject|1|||
155709889|NCT01445080|562029856|FG004|Overall Study|Withdrawal by Subject|0|||
155709890|NCT01445080|562029857|FG005|Overall Study|Withdrawal by Subject|0|||
155709891|NCT01445080|562029858|FG006|Overall Study|Withdrawal by Subject|0|||
155709892|NCT01445080|562029859|FG007|Overall Study|Withdrawal by Subject|0|||
155709893|NCT01445080|562029860|FG008|Overall Study|Withdrawal by Subject|2|||
155709894|NCT01445080|562029852|FG000|Overall Study|Ineligible/Inevaluable|1|||
155709895|NCT01445080|562029853|FG001|Overall Study|Ineligible/Inevaluable|2|||
155709896|NCT01445080|562029854|FG002|Overall Study|Ineligible/Inevaluable|0|||
155709897|NCT01445080|562029855|FG003|Overall Study|Ineligible/Inevaluable|1|||
155709898|NCT01445080|562029856|FG004|Overall Study|Ineligible/Inevaluable|2|||
155709899|NCT01445080|562029857|FG005|Overall Study|Ineligible/Inevaluable|3|||
155709900|NCT01445080|562029858|FG006|Overall Study|Ineligible/Inevaluable|0|||
155709901|NCT01445080|562029859|FG007|Overall Study|Ineligible/Inevaluable|0|||
155709902|NCT01445080|562029860|FG008|Overall Study|Ineligible/Inevaluable|6|||
155709903|NCT03857542|562029861|FG000|Overall Study|Adverse Event|1|||
155709904|NCT03857542|562029862|FG001|Overall Study|Adverse Event|3|||
155709905|NCT03857542|562029861|FG000|Overall Study|Withdrawal by Subject|2|||
155709906|NCT03857542|562029862|FG001|Overall Study|Withdrawal by Subject|1|||
155709907|NCT03857542|562029861|FG000|Overall Study|Lost to Follow-up|2|||
155709908|NCT03857542|562029862|FG001|Overall Study|Lost to Follow-up|1|||
155709909|NCT03857542|562029861|FG000|Overall Study|Reason not Specified|1|||
155709910|NCT03857542|562029862|FG001|Overall Study|Reason not Specified|0|||
155709911|NCT01594931|562031733|FG000|Overall Study|Adverse Event|3|||
155709912|NCT01594931|562031734|FG001|Overall Study|Adverse Event|1|||
155709913|NCT01594931|562031735|FG002|Overall Study|Adverse Event|1|||
155709914|NCT01594931|562031733|FG000|Overall Study|Withdrawal by Subject|2|||
155709915|NCT01594931|562031734|FG001|Overall Study|Withdrawal by Subject|1|||
155709916|NCT01594931|562031735|FG002|Overall Study|Withdrawal by Subject|1|||
155709917|NCT01594931|562031733|FG000|Overall Study|Lack of Efficacy|7|||
155709918|NCT01594931|562031734|FG001|Overall Study|Lack of Efficacy|2|||
155709919|NCT01594931|562031735|FG002|Overall Study|Lack of Efficacy|2|||
155709920|NCT01594931|562031733|FG000|Overall Study|Lost to Follow-up|4|||
155709921|NCT01594931|562031734|FG001|Overall Study|Lost to Follow-up|3|||
155709922|NCT01594931|562031735|FG002|Overall Study|Lost to Follow-up|3|||
155709923|NCT01594931|562031733|FG000|Overall Study|Protocol Violation|2|||
155709924|NCT01594931|562031734|FG001|Overall Study|Protocol Violation|1|||
155709925|NCT01594931|562031735|FG002|Overall Study|Protocol Violation|0|||
155709926|NCT01594931|562031733|FG000|Overall Study|No defiined|11|||
155709927|NCT01594931|562031734|FG001|Overall Study|No defiined|4|||
155709928|NCT01594931|562031735|FG002|Overall Study|No defiined|7|||
155709929|NCT01525615|562031738|FG000|Overall Study|Adverse Event|11|||
155709930|NCT01525615|562031739|FG001|Overall Study|Adverse Event|7|||
155709931|NCT01525615|562031740|FG002|Overall Study|Adverse Event|5|||
155709932|NCT01525615|562031738|FG000|Overall Study|Lost to Follow-up|1|||
155709933|NCT01525615|562031739|FG001|Overall Study|Lost to Follow-up|0|||
155709934|NCT01525615|562031740|FG002|Overall Study|Lost to Follow-up|0|||
155709935|NCT01525615|562031738|FG000|Overall Study|Withdrawal by Subject|1|||
155709936|NCT01525615|562031739|FG001|Overall Study|Withdrawal by Subject|0|||
155709937|NCT01525615|562031740|FG002|Overall Study|Withdrawal by Subject|0|||
155709938|NCT01525615|562031738|FG000|Overall Study|Other reason not described above|1|||
155709939|NCT01525615|562031739|FG001|Overall Study|Other reason not described above|0|||
155709940|NCT01525615|562031740|FG002|Overall Study|Other reason not described above|1|||
155709941|NCT04050618|562031741|FG000|First Intervention|Withdrawal by Subject|2|||
155709942|NCT04050618|562031742|FG001|First Intervention|Withdrawal by Subject|0|||
155709943|NCT04050618|562031741|FG000|Second Intervention|Withdrawal by Subject|1|||
155709944|NCT04050618|562031742|FG001|Second Intervention|Withdrawal by Subject|0|||
155709945|NCT01101035|562031748|FG000|Overall Study|Adverse Event|191|||
155709946|NCT01101035|562031749|FG001|Overall Study|Adverse Event|172|||
155709947|NCT01101035|562031748|FG000|Overall Study|Major Protocol Deviation|52|||
155709948|NCT01101035|562031749|FG001|Overall Study|Major Protocol Deviation|46|||
155709949|NCT01101035|562031748|FG000|Overall Study|Lost to Follow-up|226|||
155709950|NCT01101035|562031749|FG001|Overall Study|Lost to Follow-up|223|||
155709951|NCT01101035|562031748|FG000|Overall Study|Voluntary Withdrawal|595|||
155709952|NCT01101035|562031749|FG001|Overall Study|Voluntary Withdrawal|587|||
155709953|NCT01101035|562031748|FG000|Overall Study|Reason not Specified|333|||
155709954|NCT01101035|562031749|FG001|Overall Study|Reason not Specified|363|||
155709955|NCT00922623|562031750|FG000|Overall Study|Other|4|||
155709956|NCT00922623|562031750|FG000|Overall Study|Lost to Follow-up|1|||
155709957|NCT02420379|562031751|FG000|Overall Study|Withdrawal by Subject|0|||
155709958|NCT02420379|562031752|FG001|Overall Study|Withdrawal by Subject|3|||
155709959|NCT02420379|562031751|FG000|Overall Study|Unable to complete due to schooling|0|||
155709960|NCT02420379|562031752|FG001|Overall Study|Unable to complete due to schooling|1|||
155709961|NCT02420379|562031751|FG000|Overall Study|Transitioned to commercial drug|1|||
155709962|NCT02420379|562031752|FG001|Overall Study|Transitioned to commercial drug|0|||
155709963|NCT01410890|562031764|FG000|Overall Study|Withdrawal by Subject|0|||
155709964|NCT01410890|562031765|FG001|Overall Study|Withdrawal by Subject|1|||
155709965|NCT00217425|562031766|FG000|Overall Study|Never started treatment|2|||
155709966|NCT00217425|562031766|FG000|Overall Study|Patient ineligible|5|||
155709967|NCT00217425|562031766|FG000|Overall Study|Lack of Efficacy|13|||
155709968|NCT00217425|562031766|FG000|Overall Study|Adverse Event|8|||
155709969|NCT00217425|562031766|FG000|Overall Study|Withdrawal by Subject|4|||
155709970|NCT00217425|562031766|FG000|Overall Study|Other complicating disease|1|||
155709971|NCT00217425|562031766|FG000|Overall Study|Other|4|||
155709972|NCT03951077|562031767|FG000|Overall Study|Adverse Event|1|||
155709973|NCT03951077|562031768|FG001|Overall Study|Adverse Event|0|||
155709974|NCT03951077|562031769|FG002|Overall Study|Adverse Event|0|||
155709975|NCT03951077|562031770|FG003|Overall Study|Adverse Event|0|||
155709976|NCT03951077|562031771|FG004|Overall Study|Adverse Event|0|||
155709977|NCT03951077|562031772|FG005|Overall Study|Adverse Event|0|||
155709978|NCT03951077|562031767|FG000|Overall Study|Withdrawal by Subject|3|||
155709979|NCT03951077|562031768|FG001|Overall Study|Withdrawal by Subject|3|||
155709980|NCT03951077|562031769|FG002|Overall Study|Withdrawal by Subject|0|||
155709981|NCT03951077|562031770|FG003|Overall Study|Withdrawal by Subject|3|||
155709982|NCT03951077|562031771|FG004|Overall Study|Withdrawal by Subject|3|||
155709983|NCT03951077|562031772|FG005|Overall Study|Withdrawal by Subject|2|||
155709984|NCT03951077|562031767|FG000|Overall Study|Lost to Follow-up|1|||
155709985|NCT03951077|562031768|FG001|Overall Study|Lost to Follow-up|1|||
155709986|NCT03951077|562031769|FG002|Overall Study|Lost to Follow-up|2|||
155709987|NCT03951077|562031770|FG003|Overall Study|Lost to Follow-up|3|||
155709988|NCT03951077|562031771|FG004|Overall Study|Lost to Follow-up|2|||
155709989|NCT03951077|562031772|FG005|Overall Study|Lost to Follow-up|3|||
155709990|NCT03951077|562031767|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
155709991|NCT03951077|562031768|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
155709992|NCT03951077|562031769|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
155709993|NCT03951077|562031770|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
155709994|NCT03951077|562031771|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
155709995|NCT03951077|562031772|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
155709996|NCT03951077|562031767|FG000|Overall Study|Other, Not Specified|12|||
155709997|NCT03951077|562031768|FG001|Overall Study|Other, Not Specified|10|||
155709998|NCT03951077|562031769|FG002|Overall Study|Other, Not Specified|10|||
155709999|NCT03951077|562031770|FG003|Overall Study|Other, Not Specified|5|||
155710000|NCT03951077|562031771|FG004|Overall Study|Other, Not Specified|9|||
155710001|NCT03951077|562031772|FG005|Overall Study|Other, Not Specified|6|||
155710002|NCT03951077|562031767|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
155710003|NCT03951077|562031768|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
155710004|NCT03951077|562031769|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
155710005|NCT03951077|562031770|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
155710006|NCT03951077|562031771|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
155710007|NCT03951077|562031772|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
155710008|NCT00086047|562031774|FG000|Overall Study|Lost to Follow-up|7|||
155710009|NCT00086047|562031775|FG001|Overall Study|Lost to Follow-up|6|||
155710010|NCT00086047|562031774|FG000|Overall Study|Physician Decision|0|||
155710011|NCT00086047|562031775|FG001|Overall Study|Physician Decision|1|||
155710012|NCT01395901|562031776|FG000|Overall Study|Lost to Follow-up|4|||
155710013|NCT01395901|562031777|FG001|Overall Study|Lost to Follow-up|0|||
155710014|NCT01395901|562031776|FG000|Overall Study|Randomized but not received study drug|5|||
155710015|NCT01395901|562031777|FG001|Overall Study|Randomized but not received study drug|4|||
155710016|NCT01395901|562031776|FG000|Overall Study|Adverse Event|0|||
155710017|NCT01395901|562031777|FG001|Overall Study|Adverse Event|1|||
155710018|NCT01395901|562031776|FG000|Overall Study|Withdrawal of consent|1|||
155710019|NCT01395901|562031777|FG001|Overall Study|Withdrawal of consent|0|||
155710020|NCT03579940|562031783|FG000|Period 2|Withdrawal by Subject|0|||
155710021|NCT03579940|562031784|FG001|Period 2|Withdrawal by Subject|0|||
155710022|NCT03579940|562031785|FG002|Period 2|Withdrawal by Subject|1|||
155710023|NCT03579940|562031786|FG003|Period 2|Withdrawal by Subject|0|||
155710024|NCT03579940|562031787|FG004|Period 2|Withdrawal by Subject|0|||
155710025|NCT03579940|562031788|FG005|Period 2|Withdrawal by Subject|0|||
155710026|NCT03579940|562031789|FG006|Period 2|Withdrawal by Subject|0|||
155710027|NCT03579940|562031790|FG007|Period 2|Withdrawal by Subject|0|||
155710028|NCT03579940|562031791|FG008|Period 2|Withdrawal by Subject|0|||
155710029|NCT03579940|562031792|FG009|Period 2|Withdrawal by Subject|0|||
155710030|NCT03579940|562031793|FG010|Period 2|Withdrawal by Subject|0|||
155710031|NCT00671034|562031794|FG000|Overall Study|Adverse Event|5|||
155710032|NCT00671034|562031795|FG001|Overall Study|Adverse Event|7|||
155710033|NCT00671034|562031796|FG002|Overall Study|Adverse Event|1|||
155710034|NCT00671034|562031794|FG000|Overall Study|Death|3|||
155710035|NCT00671034|562031795|FG001|Overall Study|Death|2|||
155710036|NCT00671034|562031796|FG002|Overall Study|Death|1|||
155710037|NCT00671034|562031794|FG000|Overall Study|Physician Decision|12|||
155710038|NCT00671034|562031795|FG001|Overall Study|Physician Decision|4|||
155710039|NCT00671034|562031796|FG002|Overall Study|Physician Decision|5|||
155710040|NCT00671034|562031794|FG000|Overall Study|VHR ALL feature|8|||
155710041|NCT00671034|562031795|FG001|Overall Study|VHR ALL feature|3|||
155710042|NCT00671034|562031796|FG002|Overall Study|VHR ALL feature|5|||
155710043|NCT00671034|562031794|FG000|Overall Study|Refusal|5|||
155710044|NCT00671034|562031795|FG001|Overall Study|Refusal|3|||
155710045|NCT00671034|562031796|FG002|Overall Study|Refusal|5|||
155710046|NCT00671034|562031794|FG000|Overall Study|includes Alternative therapy, etc.|6|||
155710047|NCT00671034|562031795|FG001|Overall Study|includes Alternative therapy, etc.|1|||
155710048|NCT00671034|562031796|FG002|Overall Study|includes Alternative therapy, etc.|7|||
155710049|NCT00713544|562031802|FG000|Overall Study|Adverse Event|5|||
155710050|NCT00713544|562031803|FG001|Overall Study|Adverse Event|3|||
155710051|NCT00713544|562031804|FG002|Overall Study|Adverse Event|7|||
155710052|NCT00713544|562031805|FG003|Overall Study|Adverse Event|7|||
155710053|NCT00713544|562031806|FG004|Overall Study|Adverse Event|3|||
155710054|NCT00713544|562031807|FG005|Overall Study|Adverse Event|5|||
155710055|NCT00713544|562031802|FG000|Overall Study|Withdrawal by Subject|2|||
155710056|NCT00713544|562031803|FG001|Overall Study|Withdrawal by Subject|0|||
155710057|NCT00713544|562031804|FG002|Overall Study|Withdrawal by Subject|3|||
155710058|NCT00713544|562031805|FG003|Overall Study|Withdrawal by Subject|2|||
155710059|NCT00713544|562031806|FG004|Overall Study|Withdrawal by Subject|3|||
155710060|NCT00713544|562031807|FG005|Overall Study|Withdrawal by Subject|1|||
155710061|NCT00713544|562031802|FG000|Overall Study|Protocol Violation|0|||
155710062|NCT00713544|562031803|FG001|Overall Study|Protocol Violation|0|||
155710063|NCT00713544|562031804|FG002|Overall Study|Protocol Violation|0|||
155710064|NCT00713544|562031805|FG003|Overall Study|Protocol Violation|0|||
155710065|NCT00713544|562031806|FG004|Overall Study|Protocol Violation|0|||
155710066|NCT00713544|562031807|FG005|Overall Study|Protocol Violation|1|||
155710067|NCT00713544|562031802|FG000|Overall Study|Physician Decision|0|||
155710068|NCT00713544|562031803|FG001|Overall Study|Physician Decision|0|||
155710069|NCT00713544|562031804|FG002|Overall Study|Physician Decision|0|||
155710070|NCT00713544|562031805|FG003|Overall Study|Physician Decision|0|||
155710071|NCT00713544|562031806|FG004|Overall Study|Physician Decision|0|||
155710072|NCT00713544|562031807|FG005|Overall Study|Physician Decision|2|||
155710073|NCT00713544|562031802|FG000|Overall Study|Lack of Efficacy|0|||
155710074|NCT00713544|562031803|FG001|Overall Study|Lack of Efficacy|1|||
155710075|NCT00713544|562031804|FG002|Overall Study|Lack of Efficacy|0|||
155710076|NCT00713544|562031805|FG003|Overall Study|Lack of Efficacy|1|||
155710077|NCT00713544|562031806|FG004|Overall Study|Lack of Efficacy|1|||
155710078|NCT00713544|562031807|FG005|Overall Study|Lack of Efficacy|0|||
155710079|NCT00713544|562031802|FG000|Overall Study|Lost to Follow-up|0|||
155710080|NCT00713544|562031803|FG001|Overall Study|Lost to Follow-up|0|||
155710081|NCT00713544|562031804|FG002|Overall Study|Lost to Follow-up|1|||
155710082|NCT00713544|562031805|FG003|Overall Study|Lost to Follow-up|0|||
155710083|NCT00713544|562031806|FG004|Overall Study|Lost to Follow-up|0|||
155710084|NCT00713544|562031807|FG005|Overall Study|Lost to Follow-up|0|||
155710085|NCT00713544|562031802|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155710086|NCT00713544|562031803|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
155710087|NCT00713544|562031804|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155710088|NCT00713544|562031805|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155710089|NCT00713544|562031806|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155710090|NCT00713544|562031807|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155710091|NCT00713544|562031802|FG000|Overall Study|Incorrect enrollment|0|||
155710092|NCT00713544|562031803|FG001|Overall Study|Incorrect enrollment|1|||
155710093|NCT00713544|562031804|FG002|Overall Study|Incorrect enrollment|0|||
155710094|NCT00713544|562031805|FG003|Overall Study|Incorrect enrollment|0|||
155710095|NCT00713544|562031806|FG004|Overall Study|Incorrect enrollment|0|||
155710096|NCT00713544|562031807|FG005|Overall Study|Incorrect enrollment|0|||
155710097|NCT00713544|562031802|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
155710098|NCT00713544|562031803|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
155710099|NCT00713544|562031804|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
155710100|NCT00713544|562031805|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
155710101|NCT00713544|562031806|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
155710102|NCT00713544|562031807|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
155710103|NCT00786799|562031810|FG000|Overall Study|Lost to Follow-up|1|||
155710104|NCT00786799|562031811|FG001|Overall Study|Lost to Follow-up|1|||
155710105|NCT02544503|562031812|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
155710106|NCT02544503|562031813|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
155710107|NCT02544503|562031812|FG000|Overall Study|Lost to Follow-up|9|||
155710108|NCT02544503|562031813|FG001|Overall Study|Lost to Follow-up|0|||
155710109|NCT02544503|562031812|FG000|Overall Study|Withdrawal by Subject|1|||
155710110|NCT02544503|562031813|FG001|Overall Study|Withdrawal by Subject|0|||
155710111|NCT02380287|562031814|FG000|Overall Study|Adverse Event|0|||
155710112|NCT02380287|562031815|FG001|Overall Study|Adverse Event|0|||
155710113|NCT02380287|562031816|FG002|Overall Study|Adverse Event|1|||
155710114|NCT02380287|562031817|FG003|Overall Study|Adverse Event|0|||
155710115|NCT02380287|562031818|FG004|Overall Study|Adverse Event|0|||
155710116|NCT02380287|562031819|FG005|Overall Study|Adverse Event|0|||
155710117|NCT02380287|562031820|FG006|Overall Study|Adverse Event|0|||
155710118|NCT02380287|562031821|FG007|Overall Study|Adverse Event|0|||
155710119|NCT04473963|562031822|FG000|Overall Study|Withdrawal by Subject|1|||
155710120|NCT04473963|562031823|FG001|Overall Study|Withdrawal by Subject|1|||
155710121|NCT04473963|562031824|FG002|Overall Study|Withdrawal by Subject|0|||
155710122|NCT04473963|562031822|FG000|Overall Study|Not inducible in AF|0|||
155710123|NCT04473963|562031823|FG001|Overall Study|Not inducible in AF|0|||
155710124|NCT04473963|562031824|FG002|Overall Study|Not inducible in AF|2|||
155710125|NCT04640311|562031825|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
155710126|NCT04640311|562031826|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710127|NCT04640311|562031827|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710128|NCT04640311|562031828|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710129|NCT04640311|562031829|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710130|NCT04640311|562031830|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710131|NCT04640311|562031831|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710132|NCT04640311|562031832|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710133|NCT04640311|562031833|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710134|NCT04640311|562031834|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710135|NCT04640311|562031835|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710136|NCT04640311|562031836|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710137|NCT04640311|562031837|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710138|NCT04640311|562031825|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710139|NCT04640311|562031826|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
155710140|NCT04640311|562031827|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710141|NCT04640311|562031828|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710142|NCT04640311|562031829|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710143|NCT04640311|562031830|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710144|NCT04640311|562031831|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710145|NCT04640311|562031832|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710146|NCT04640311|562031833|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710147|NCT04640311|562031834|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710148|NCT04640311|562031835|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710149|NCT04640311|562031836|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710150|NCT04640311|562031837|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155710151|NCT04640311|562031825|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710152|NCT04640311|562031826|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
155710153|NCT04640311|562031827|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710154|NCT04640311|562031828|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710155|NCT04640311|562031829|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710156|NCT04640311|562031830|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710157|NCT04640311|562031831|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710158|NCT04640311|562031832|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710159|NCT04640311|562031833|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710160|NCT04640311|562031834|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710161|NCT04640311|562031835|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710162|NCT04640311|562031836|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710163|NCT04640311|562031837|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710164|NCT04640311|562031825|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
155710165|NCT04640311|562031826|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
155721297|NCT03361137|562077815|FG000|Overall Study|Reason not specified|1|||
155710166|NCT04640311|562031827|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
155710167|NCT04640311|562031828|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710168|NCT04640311|562031829|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710169|NCT04640311|562031830|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710170|NCT04640311|562031831|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710171|NCT04640311|562031832|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710172|NCT04640311|562031833|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710173|NCT04640311|562031834|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710174|NCT04640311|562031835|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710175|NCT04640311|562031836|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710176|NCT04640311|562031837|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155710177|NCT04640311|562031825|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710178|NCT04640311|562031826|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710179|NCT04640311|562031827|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
155710180|NCT04640311|562031828|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710181|NCT04640311|562031829|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710182|NCT04640311|562031830|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710183|NCT04640311|562031831|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710184|NCT04640311|562031832|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710185|NCT04640311|562031833|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710186|NCT04640311|562031834|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710187|NCT04640311|562031835|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710188|NCT04640311|562031836|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710189|NCT04640311|562031837|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155710190|NCT04640311|562031825|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710191|NCT04640311|562031826|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710192|NCT04640311|562031827|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710193|NCT04640311|562031828|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
155710194|NCT04640311|562031829|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710195|NCT04640311|562031830|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710196|NCT04640311|562031831|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
155710197|NCT04640311|562031832|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710198|NCT04640311|562031833|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710199|NCT04640311|562031834|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710200|NCT04640311|562031835|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710201|NCT04640311|562031836|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710202|NCT04640311|562031837|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155710203|NCT04640311|562031825|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710204|NCT04640311|562031826|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710205|NCT04640311|562031827|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710206|NCT04640311|562031828|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710207|NCT04640311|562031829|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710208|NCT04640311|562031830|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
155710209|NCT04640311|562031831|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710210|NCT04640311|562031832|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710211|NCT04640311|562031833|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
155710212|NCT04640311|562031834|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710213|NCT04640311|562031835|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710214|NCT04640311|562031836|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710215|NCT04640311|562031837|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155710216|NCT04640311|562031825|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710217|NCT04640311|562031826|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710218|NCT04640311|562031827|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710219|NCT04640311|562031828|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710220|NCT04640311|562031829|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710221|NCT04640311|562031830|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710222|NCT04640311|562031831|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
155710223|NCT04640311|562031832|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710224|NCT04640311|562031833|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710225|NCT04640311|562031834|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710226|NCT04640311|562031835|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
155710227|NCT04640311|562031836|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710228|NCT04640311|562031837|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155710229|NCT04640311|562031825|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710230|NCT04640311|562031826|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710231|NCT04640311|562031827|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710232|NCT04640311|562031828|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710233|NCT04640311|562031829|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710234|NCT04640311|562031830|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710235|NCT04640311|562031831|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710236|NCT04640311|562031832|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710237|NCT04640311|562031833|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710238|NCT04640311|562031834|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710239|NCT04640311|562031835|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710240|NCT04640311|562031836|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
155710241|NCT04640311|562031837|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155710242|NCT01641601|562031838|FG000|Overall Study|Study discontinued.|3|||
155710243|NCT01641601|562031839|FG001|Overall Study|Study discontinued.|5|||
155710244|NCT01799226|562031842|FG000|Overall Study|Withdrawal by Subject|1|||
155710245|NCT01799226|562031843|FG001|Overall Study|Withdrawal by Subject|0|||
155710246|NCT01799226|562031842|FG000|Overall Study|Disqualified at Day 14|1|||
155710247|NCT01799226|562031843|FG001|Overall Study|Disqualified at Day 14|0|||
155710248|NCT02178995|562031844|FG000|Double Blind|Adverse Event|0|||
155710249|NCT02178995|562031845|FG001|Double Blind|Adverse Event|0|||
155710250|NCT02178995|562031846|FG002|Double Blind|Adverse Event|0|||
155710251|NCT02178995|562031847|FG003|Double Blind|Adverse Event|0|||
155710252|NCT02178995|562031848|FG004|Double Blind|Adverse Event|0|||
155710253|NCT02178995|562031849|FG005|Double Blind|Adverse Event|1|||
155710254|NCT02178995|562031850|FG006|Double Blind|Adverse Event|0|||
155710255|NCT02178995|562031851|FG007|Double Blind|Adverse Event|1|||
155710256|NCT02178995|562031852|FG008|Double Blind|Adverse Event|1|||
155710257|NCT02178995|562031844|FG000|Double Blind|Lost to Follow-up|0|||
155710258|NCT02178995|562031845|FG001|Double Blind|Lost to Follow-up|1|||
155710259|NCT02178995|562031846|FG002|Double Blind|Lost to Follow-up|0|||
155710260|NCT02178995|562031847|FG003|Double Blind|Lost to Follow-up|0|||
155710261|NCT02178995|562031848|FG004|Double Blind|Lost to Follow-up|0|||
155710262|NCT02178995|562031849|FG005|Double Blind|Lost to Follow-up|0|||
155710263|NCT02178995|562031850|FG006|Double Blind|Lost to Follow-up|0|||
155710264|NCT02178995|562031851|FG007|Double Blind|Lost to Follow-up|1|||
155710265|NCT02178995|562031852|FG008|Double Blind|Lost to Follow-up|0|||
155710266|NCT02178995|562031844|FG000|Open Label|Adverse Event|2|||
155710267|NCT02178995|562031845|FG001|Open Label|Adverse Event|0|||
155710268|NCT02178995|562031846|FG002|Open Label|Adverse Event|0|||
155710269|NCT02178995|562031847|FG003|Open Label|Adverse Event|0|||
155710270|NCT02178995|562031848|FG004|Open Label|Adverse Event|0|||
155710271|NCT02178995|562031849|FG005|Open Label|Adverse Event|0|||
155710272|NCT02178995|562031850|FG006|Open Label|Adverse Event|0|||
155710273|NCT02178995|562031851|FG007|Open Label|Adverse Event|0|||
155710274|NCT02178995|562031852|FG008|Open Label|Adverse Event|0|||
155710275|NCT01388907|562031853|FG000|Overall Study|Adverse Event|2|||
155710276|NCT01388907|562031854|FG001|Overall Study|Adverse Event|0|||
155710277|NCT03361293|562031855|FG000|Overall Study|Lost to Follow-up|0|||
155710278|NCT03361293|562031856|FG001|Overall Study|Lost to Follow-up|2|||
155710279|NCT03361293|562031855|FG000|Overall Study|Withdrawal by Subject|1|||
155710280|NCT03361293|562031856|FG001|Overall Study|Withdrawal by Subject|3|||
155710281|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
155710282|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
155710283|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
155710284|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
155710285|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
155710286|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
155710287|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
155710288|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
155710289|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
155710290|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
155710291|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
155710292|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
155710293|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
155710294|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
155710295|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
155710296|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
155710297|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
155710298|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
155710299|NCT01910402|562031857|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
155710300|NCT01910402|562031858|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
155710301|NCT01910402|562031859|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
155710302|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
155710303|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
155710304|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
155710305|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
155710306|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
155710307|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
155710308|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
155710309|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
155710310|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
155710311|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
155710312|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
155710313|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
155710314|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
155710315|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
155710316|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
155710317|NCT01910402|562031857|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
155710318|NCT01910402|562031858|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
155710319|NCT01910402|562031859|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
155710320|NCT01797263|562031860|FG000|Overall Study|Withdrawal by Subject|21|||
155710321|NCT01797263|562031861|FG001|Overall Study|Withdrawal by Subject|25|||
155710322|NCT01797263|562031860|FG000|Overall Study|Death|1|||
155710323|NCT01797263|562031861|FG001|Overall Study|Death|0|||
155710324|NCT01797263|562031860|FG000|Overall Study|Lost to Follow-up|15|||
155710325|NCT01797263|562031861|FG001|Overall Study|Lost to Follow-up|15|||
155710326|NCT02342223|562031862|FG000|Overall Study|Lost to Follow-up|1|||
155710327|NCT01200368|562031863|FG000|Infant Series|Adverse Event|2|||
155710328|NCT01200368|562031864|FG001|Infant Series|Adverse Event|2|||
155710329|NCT01200368|562031865|FG002|Infant Series|Adverse Event|3|||
155710330|NCT01200368|562031863|FG000|Infant Series|Withdrawal by Subject|0|||
155710331|NCT01200368|562031864|FG001|Infant Series|Withdrawal by Subject|2|||
155710332|NCT01200368|562031865|FG002|Infant Series|Withdrawal by Subject|2|||
155710333|NCT01200368|562031863|FG000|Infant Series|Did not meet entrance criteria|0|||
155710334|NCT01200368|562031864|FG001|Infant Series|Did not meet entrance criteria|1|||
155710335|NCT01200368|562031865|FG002|Infant Series|Did not meet entrance criteria|0|||
155710336|NCT01200368|562031863|FG000|Infant Series|Randomized, not vaccinated|0|||
155710337|NCT01200368|562031864|FG001|Infant Series|Randomized, not vaccinated|1|||
155710338|NCT01200368|562031865|FG002|Infant Series|Randomized, not vaccinated|1|||
155710339|NCT01200368|562031863|FG000|Infant Series|Other|1|||
155710340|NCT01200368|562031864|FG001|Infant Series|Other|0|||
155710341|NCT01200368|562031865|FG002|Infant Series|Other|0|||
155710342|NCT01200368|562031863|FG000|After Infant Series|Adverse Event|6|||
155710343|NCT01200368|562031864|FG001|After Infant Series|Adverse Event|6|||
155710344|NCT01200368|562031865|FG002|After Infant Series|Adverse Event|3|||
155710345|NCT01200368|562031863|FG000|After Infant Series|Withdrawal by Subject|10|||
155710346|NCT01200368|562031864|FG001|After Infant Series|Withdrawal by Subject|8|||
155710347|NCT01200368|562031865|FG002|After Infant Series|Withdrawal by Subject|4|||
155710348|NCT01200368|562031863|FG000|After Infant Series|Lost to Follow-up|1|||
155710349|NCT01200368|562031864|FG001|After Infant Series|Lost to Follow-up|0|||
155710350|NCT01200368|562031865|FG002|After Infant Series|Lost to Follow-up|0|||
155710351|NCT01200368|562031863|FG000|After Infant Series|Other|1|||
155710352|NCT01200368|562031864|FG001|After Infant Series|Other|2|||
155710353|NCT01200368|562031865|FG002|After Infant Series|Other|2|||
155710354|NCT01200368|562031863|FG000|Toddler Dose|Adverse Event|0|||
155710355|NCT01200368|562031864|FG001|Toddler Dose|Adverse Event|3|||
155710356|NCT01200368|562031865|FG002|Toddler Dose|Adverse Event|1|||
155710357|NCT00181766|562031875|FG000|Overall Study|Lost to Follow-up|6|||
155710358|NCT00181766|562031875|FG000|Overall Study|Adverse Event|4|||
155710359|NCT00181766|562031875|FG000|Overall Study|non-compliance|2|||
155710360|NCT00687804|562031883|FG000|Core Study|Adverse Event|5|||
155710361|NCT00687804|562031884|FG001|Core Study|Adverse Event|3|||
155710362|NCT00687804|562031885|FG002|Core Study|Adverse Event|3|||
155710363|NCT00687804|562031883|FG000|Core Study|Abnormal laboratory value(s)|1|||
155710364|NCT00687804|562031884|FG001|Core Study|Abnormal laboratory value(s)|0|||
155710365|NCT00687804|562031885|FG002|Core Study|Abnormal laboratory value(s)|0|||
155710366|NCT00687804|562031883|FG000|Core Study|Lack of Efficacy|1|||
155710367|NCT00687804|562031884|FG001|Core Study|Lack of Efficacy|1|||
155710368|NCT00687804|562031885|FG002|Core Study|Lack of Efficacy|1|||
155710369|NCT00687804|562031883|FG000|Core Study|Withdrawal by Subject|4|||
155710370|NCT00687804|562031884|FG001|Core Study|Withdrawal by Subject|7|||
155710371|NCT00687804|562031885|FG002|Core Study|Withdrawal by Subject|7|||
155710372|NCT00687804|562031883|FG000|Core Study|Lost to Follow-up|0|||
155710373|NCT00687804|562031884|FG001|Core Study|Lost to Follow-up|1|||
155710374|NCT00687804|562031885|FG002|Core Study|Lost to Follow-up|0|||
155710375|NCT00687804|562031883|FG000|Core Study|Death|2|||
155710376|NCT00687804|562031884|FG001|Core Study|Death|2|||
155710377|NCT00687804|562031885|FG002|Core Study|Death|2|||
155710378|NCT00687804|562031883|FG000|Core Study|Protocol Violation|1|||
155710379|NCT00687804|562031884|FG001|Core Study|Protocol Violation|1|||
155710380|NCT00687804|562031885|FG002|Core Study|Protocol Violation|0|||
155710381|NCT00687804|562031883|FG000|Open-Label Extension Study|Adverse Event|2|||
155710382|NCT00687804|562031884|FG001|Open-Label Extension Study|Adverse Event|2|||
155710383|NCT00687804|562031885|FG002|Open-Label Extension Study|Adverse Event|2|||
155710384|NCT00687804|562031883|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
155710385|NCT00687804|562031884|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
155710386|NCT00687804|562031885|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
155710387|NCT00687804|562031883|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
155710388|NCT00687804|562031884|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
155710389|NCT00687804|562031885|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
155710390|NCT00687804|562031883|FG000|Open-Label Extension Study|Administrative problems|1|||
155710391|NCT00687804|562031884|FG001|Open-Label Extension Study|Administrative problems|1|||
155710392|NCT00687804|562031885|FG002|Open-Label Extension Study|Administrative problems|0|||
155710393|NCT00687804|562031883|FG000|Open-Label Extension Study|Death|2|||
155710394|NCT00687804|562031884|FG001|Open-Label Extension Study|Death|3|||
155710395|NCT00687804|562031885|FG002|Open-Label Extension Study|Death|3|||
155710396|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
155710397|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
155710398|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
155710399|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
155710400|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
155710401|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
155710402|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
155710403|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
155710404|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
155710405|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
155710406|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
155710407|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
155710408|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
155710409|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
155710410|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
155710411|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
155710412|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
155710413|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
155710414|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
155710415|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
155710416|NCT03573323|562031886|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
155710417|NCT03573323|562031887|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
155710418|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
155710419|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
155710420|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
155710421|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
155710422|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
155710423|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
155710424|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
155710425|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
155710426|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
155710427|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
155710428|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
155710429|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
155710430|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
155710431|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
155710432|NCT03573323|562031886|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
155710433|NCT03573323|562031887|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
155710434|NCT03188432|562031888|FG000|Overall Study|Death|3|||
155710435|NCT03188432|562031888|FG000|Overall Study|Withdrawal by Subject|15|||
155710436|NCT03188432|562031888|FG000|Overall Study|Did not complete protocol treatment|9|||
155710437|NCT00413218|562031894|FG000|Overall Study|Randomized but didn't receive study drug|2|||
155710438|NCT00413218|562031895|FG001|Overall Study|Randomized but didn't receive study drug|8|||
155710439|NCT00413218|562031894|FG000|Overall Study|Death|57|||
155710440|NCT00413218|562031895|FG001|Overall Study|Death|56|||
155710441|NCT00413218|562031894|FG000|Overall Study|Lost to Follow-up|14|||
155710442|NCT00413218|562031895|FG001|Overall Study|Lost to Follow-up|17|||
155710443|NCT00413218|562031894|FG000|Overall Study|Admin|20|||
155710444|NCT00413218|562031895|FG001|Overall Study|Admin|14|||
155710445|NCT00413218|562031894|FG000|Overall Study|Missing|1|||
155710446|NCT00413218|562031895|FG001|Overall Study|Missing|0|||
155710447|NCT00413218|562031894|FG000|Overall Study|Withdrawal by Subject|9|||
155710448|NCT00413218|562031895|FG001|Overall Study|Withdrawal by Subject|1|||
155710449|NCT03672292|562031900|FG000|Overall Study|Adverse Event|3|||
155710450|NCT03672292|562031901|FG001|Overall Study|Adverse Event|1|||
155710451|NCT03672292|562031900|FG000|Overall Study|Physician Decision|0|||
155710452|NCT03672292|562031901|FG001|Overall Study|Physician Decision|1|||
155710453|NCT03672292|562031900|FG000|Overall Study|Withdrawal by Subject|1|||
155710454|NCT03672292|562031901|FG001|Overall Study|Withdrawal by Subject|2|||
155710455|NCT00799903|562031902|FG000|Overall Study|Investigator Site Closed|25|||
155710456|NCT00799903|562031903|FG001|Overall Study|Investigator Site Closed|23|||
155710457|NCT00799903|562031902|FG000|Overall Study|Withdrawal by Subject|179|||
155710458|NCT00799903|562031903|FG001|Overall Study|Withdrawal by Subject|175|||
155710459|NCT00799903|562031902|FG000|Overall Study|Lost to Follow-up|69|||
155710460|NCT00799903|562031903|FG001|Overall Study|Lost to Follow-up|80|||
155710461|NCT03088917|562031904|FG000|Overall Study|In care/cured elsewhere|15|||
155710462|NCT03088917|562031904|FG000|Overall Study|Refuse re-evaluation|13|||
155710463|NCT03088917|562031904|FG000|Overall Study|Contact not established|13|||
155710464|NCT03088917|562031904|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
155710465|NCT03088917|562031904|FG000|Overall Study|Moved outside study region|50|||
155710466|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Progressive disease|50|||
155710467|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Progressive disease|110|||
155710468|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Progressive disease|0|||
155710469|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Progressive disease|0|||
155710470|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155710471|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
155710472|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155710473|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155710474|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Adverse Event|7|||
155710475|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Adverse Event|7|||
155710476|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155710477|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Adverse Event|0|||
155710478|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Other|1|||
155710479|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Other|3|||
155710480|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Other|0|||
155710481|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Other|0|||
155710482|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Physician Decision|6|||
155710483|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Physician Decision|3|||
155710484|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Physician Decision|0|||
155710485|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Physician Decision|0|||
155710486|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Death|1|||
155710487|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Death|1|||
155710488|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Death|0|||
155710489|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Death|0|||
155710490|NCT01695135|562031905|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155710491|NCT01695135|562031906|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
155710492|NCT01695135|562031907|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155710493|NCT01695135|562031908|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155710494|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
155710495|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
155710496|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
155710497|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
155710498|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
155710499|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
155710500|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
155710501|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
155710502|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
155710503|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
155710504|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
155710505|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
155710506|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Other|0|||
155710507|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Other|0|||
155710508|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Other|4|||
155710509|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Other|7|||
155710510|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
155710511|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
155710512|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
155710513|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
155710514|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Death|0|||
155710515|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Death|0|||
155710516|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Death|2|||
155710517|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Death|7|||
155710518|NCT01695135|562031905|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155710519|NCT01695135|562031906|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155710520|NCT01695135|562031907|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155710521|NCT01695135|562031908|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
155710522|NCT02753946|562031909|FG000|Overall Study|Adverse Event|7|||
155710523|NCT02753946|562031910|FG001|Overall Study|Adverse Event|6|||
155710524|NCT02753946|562031909|FG000|Overall Study|Withdrawal by Subject|6|||
155710525|NCT02753946|562031910|FG001|Overall Study|Withdrawal by Subject|1|||
155710526|NCT02753946|562031909|FG000|Overall Study|Lack of Efficacy|1|||
155710527|NCT02753946|562031910|FG001|Overall Study|Lack of Efficacy|0|||
155710528|NCT02753946|562031909|FG000|Overall Study|Physician Decision|0|||
155710529|NCT02753946|562031910|FG001|Overall Study|Physician Decision|2|||
155710530|NCT01633541|562031913|FG000|Overall Study|Death|1|||
155710531|NCT01633541|562031914|FG001|Overall Study|Death|0|||
155710532|NCT00286429|562031919|FG000|Overall Study|Adverse Event|4|||
155710533|NCT00286429|562031920|FG001|Overall Study|Adverse Event|1|||
155710534|NCT00286429|562031921|FG002|Overall Study|Adverse Event|6|||
155710535|NCT00286429|562031919|FG000|Overall Study|Lack of Efficacy|52|||
155710536|NCT00286429|562031920|FG001|Overall Study|Lack of Efficacy|27|||
155710537|NCT00286429|562031921|FG002|Overall Study|Lack of Efficacy|25|||
155710538|NCT00286429|562031919|FG000|Overall Study|Lost to Follow-up|2|||
155710539|NCT00286429|562031920|FG001|Overall Study|Lost to Follow-up|4|||
155710540|NCT00286429|562031921|FG002|Overall Study|Lost to Follow-up|3|||
155710541|NCT00286429|562031919|FG000|Overall Study|Physician Decision|10|||
155710542|NCT00286429|562031920|FG001|Overall Study|Physician Decision|7|||
155710543|NCT00286429|562031921|FG002|Overall Study|Physician Decision|7|||
155710544|NCT00286429|562031919|FG000|Overall Study|Protocol Violation|3|||
155710545|NCT00286429|562031920|FG001|Overall Study|Protocol Violation|5|||
155710546|NCT00286429|562031921|FG002|Overall Study|Protocol Violation|4|||
155710547|NCT00286429|562031919|FG000|Overall Study|Withdrawal by Subject|3|||
155710548|NCT00286429|562031920|FG001|Overall Study|Withdrawal by Subject|2|||
155710549|NCT00286429|562031921|FG002|Overall Study|Withdrawal by Subject|6|||
155710550|NCT00286429|562031919|FG000|Overall Study|Administrative Error|1|||
155710551|NCT00286429|562031920|FG001|Overall Study|Administrative Error|1|||
155710552|NCT00286429|562031921|FG002|Overall Study|Administrative Error|1|||
155710553|NCT00286429|562031919|FG000|Overall Study|Administrative Decision|0|||
155710554|NCT00286429|562031920|FG001|Overall Study|Administrative Decision|1|||
155710555|NCT00286429|562031921|FG002|Overall Study|Administrative Decision|0|||
155710556|NCT03245775|562031922|FG000|Overall Study|Lost to Follow-up|25|||
155710557|NCT03245775|562031923|FG001|Overall Study|Lost to Follow-up|26|||
155710558|NCT03245775|562031924|FG002|Overall Study|Lost to Follow-up|16|||
155710559|NCT03245775|562031925|FG003|Overall Study|Lost to Follow-up|16|||
155710560|NCT02709330|562031928|FG000|Overall Study|Death|5|||
155710561|NCT02709330|562031929|FG001|Overall Study|Death|0|||
155710562|NCT02709330|562031928|FG000|Overall Study|Lost to Follow-up|2|||
155710563|NCT02709330|562031929|FG001|Overall Study|Lost to Follow-up|0|||
155710564|NCT02709330|562031928|FG000|Overall Study|Physician Decision|2|||
155710565|NCT02709330|562031929|FG001|Overall Study|Physician Decision|0|||
155710566|NCT02709330|562031928|FG000|Overall Study|Withdrawal by Subject|4|||
155710567|NCT02709330|562031929|FG001|Overall Study|Withdrawal by Subject|0|||
155710568|NCT01550757|562033520|FG000|Overall Study|Lost to Follow-up|21|||
155710569|NCT01550757|562033521|FG001|Overall Study|Lost to Follow-up|14|||
155710570|NCT01550757|562033522|FG002|Overall Study|Lost to Follow-up|42|||
155710571|NCT01550757|562033523|FG003|Overall Study|Lost to Follow-up|53|||
155710572|NCT01550757|562033520|FG000|Overall Study|Withdrawal by Subject|2|||
155710573|NCT01550757|562033521|FG001|Overall Study|Withdrawal by Subject|0|||
155710574|NCT01550757|562033522|FG002|Overall Study|Withdrawal by Subject|3|||
155710575|NCT01550757|562033523|FG003|Overall Study|Withdrawal by Subject|1|||
155710576|NCT01426958|562033524|FG000|Overall Study|Adverse Event|2|||
155710577|NCT00991939|562033531|FG000|Overall Study|Lost to Follow-up|0|||
155710578|NCT00991939|562033532|FG001|Overall Study|Lost to Follow-up|1|||
155710579|NCT00991939|562033531|FG000|Overall Study|Withdrawal by Subject|1|||
155710580|NCT00991939|562033532|FG001|Overall Study|Withdrawal by Subject|0|||
155710581|NCT00991939|562033531|FG000|Overall Study|Entire study terminated|4|||
155710582|NCT00991939|562033532|FG001|Overall Study|Entire study terminated|1|||
155710583|NCT00740584|562033533|FG000|Overall Study|Withdrawal by Subject|1|||
155710584|NCT01461707|562033534|FG000|Overall Study|Withdrawal by Subject|1|||
155710585|NCT01461707|562033535|FG001|Overall Study|Withdrawal by Subject|0|||
155710586|NCT00855816|562033538|FG000|Overall Study|Withdrawal by Subject|22|||
155710587|NCT00855816|562033539|FG001|Overall Study|Withdrawal by Subject|15|||
155710588|NCT00855816|562033538|FG000|Overall Study|Lost to Follow-up|3|||
155710589|NCT00855816|562033539|FG001|Overall Study|Lost to Follow-up|5|||
155710590|NCT00855816|562033538|FG000|Overall Study|Death|1|||
155710591|NCT00855816|562033539|FG001|Overall Study|Death|0|||
155710592|NCT00855816|562033538|FG000|Overall Study|Became ineligible|0|||
155710593|NCT00855816|562033539|FG001|Overall Study|Became ineligible|1|||
155710594|NCT00837213|562033541|FG000|Overall Study|Lost to Follow-up|3|||
155710595|NCT00837213|562033542|FG001|Overall Study|Lost to Follow-up|2|||
155710596|NCT00837213|562033541|FG000|Overall Study|Withdrawal by Subject|2|||
155710597|NCT00837213|562033542|FG001|Overall Study|Withdrawal by Subject|2|||
155710598|NCT00837213|562033541|FG000|Overall Study|not stated|1|||
155710599|NCT00837213|562033542|FG001|Overall Study|not stated|1|||
155710600|NCT02524171|562033546|FG000|6-month Follow-up|Lost to Follow-up|53|||
155710601|NCT02524171|562033547|FG001|6-month Follow-up|Lost to Follow-up|45|||
155710602|NCT02524171|562033546|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
155710603|NCT02524171|562033547|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
155710604|NCT02868554|562033554|FG000|Overall Study|Lost to Follow-up|3|||
155710605|NCT02868554|562033555|FG001|Overall Study|Lost to Follow-up|0|||
155710606|NCT02868554|562033556|FG002|Overall Study|Lost to Follow-up|1|||
155710607|NCT00216671|562033557|FG000|Overall Study|Adverse Event|4|||
155710608|NCT00216671|562033558|FG001|Overall Study|Adverse Event|9|||
155710609|NCT00216671|562033557|FG000|Overall Study|Pregnancy|0|||
155710610|NCT00216671|562033558|FG001|Overall Study|Pregnancy|1|||
155710611|NCT00216671|562033557|FG000|Overall Study|Withdrawal by Subject|4|||
155710612|NCT00216671|562033558|FG001|Overall Study|Withdrawal by Subject|2|||
155710613|NCT00216671|562033557|FG000|Overall Study|Refused Injections|3|||
155710614|NCT00216671|562033558|FG001|Overall Study|Refused Injections|13|||
155710615|NCT00216671|562033557|FG000|Overall Study|No Need to Continue Medication|1|||
155710616|NCT00216671|562033558|FG001|Overall Study|No Need to Continue Medication|1|||
155710617|NCT00216671|562033557|FG000|Overall Study|Insufficient Response|9|||
155710618|NCT00216671|562033558|FG001|Overall Study|Insufficient Response|4|||
155710619|NCT00216671|562033557|FG000|Overall Study|Lost to Follow-up|3|||
155710620|NCT00216671|562033558|FG001|Overall Study|Lost to Follow-up|5|||
155710621|NCT00216671|562033557|FG000|Overall Study|Non compliant|2|||
155710622|NCT00216671|562033558|FG001|Overall Study|Non compliant|2|||
155710623|NCT00216671|562033557|FG000|Overall Study|Ineligible|0|||
155710624|NCT00216671|562033558|FG001|Overall Study|Ineligible|2|||
155710625|NCT00216671|562033557|FG000|Overall Study|Physician Decision|1|||
155710626|NCT00216671|562033558|FG001|Overall Study|Physician Decision|1|||
155710627|NCT00216671|562033557|FG000|Overall Study|Protocol Violation|3|||
155710628|NCT00216671|562033558|FG001|Overall Study|Protocol Violation|5|||
155710629|NCT00216671|562033557|FG000|Overall Study|Relapse|1|||
155710630|NCT00216671|562033558|FG001|Overall Study|Relapse|0|||
155710631|NCT00216671|562033557|FG000|Overall Study|Investigator Illness|0|||
155710632|NCT00216671|562033558|FG001|Overall Study|Investigator Illness|1|||
155710633|NCT00216671|562033557|FG000|Overall Study|Patient Moved|0|||
155710634|NCT00216671|562033558|FG001|Overall Study|Patient Moved|1|||
155710635|NCT00216671|562033557|FG000|Overall Study|Ineligible, no efficacy data|2|||
155710636|NCT00216671|562033558|FG001|Overall Study|Ineligible, no efficacy data|2|||
155710637|NCT00216671|562033557|FG000|Overall Study|Insufficient Response Adverse Event|2|||
155710638|NCT00216671|562033558|FG001|Overall Study|Insufficient Response Adverse Event|1|||
155710639|NCT02714569|562033559|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
155710640|NCT02714569|562033560|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
155710641|NCT02714569|562033561|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
155710642|NCT02714569|562033562|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
155710643|NCT02714569|562033563|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
155710644|NCT02714569|562033564|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
155710645|NCT02714569|562033565|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
155710646|NCT02714569|562033566|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
155710647|NCT02714569|562033567|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
155710648|NCT02714569|562033568|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
155710649|NCT02714569|562033569|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
155710650|NCT02714569|562033559|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710651|NCT02714569|562033560|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710652|NCT02714569|562033561|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710653|NCT02714569|562033562|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
155710654|NCT02714569|562033563|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710655|NCT02714569|562033564|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710656|NCT02714569|562033565|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710657|NCT02714569|562033566|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710658|NCT02714569|562033567|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710659|NCT02714569|562033568|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710660|NCT02714569|562033569|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155710661|NCT02714569|562033559|FG000|Part A Third Intervention|Adverse Event|0|||
155710662|NCT02714569|562033560|FG001|Part A Third Intervention|Adverse Event|0|||
155710663|NCT02714569|562033561|FG002|Part A Third Intervention|Adverse Event|1|||
155710664|NCT02714569|562033562|FG003|Part A Third Intervention|Adverse Event|0|||
155710665|NCT02714569|562033563|FG004|Part A Third Intervention|Adverse Event|0|||
155710666|NCT02714569|562033564|FG005|Part A Third Intervention|Adverse Event|0|||
155710667|NCT02714569|562033565|FG006|Part A Third Intervention|Adverse Event|0|||
155710668|NCT02714569|562033566|FG007|Part A Third Intervention|Adverse Event|0|||
155710669|NCT02714569|562033567|FG008|Part A Third Intervention|Adverse Event|0|||
155710670|NCT02714569|562033568|FG009|Part A Third Intervention|Adverse Event|0|||
155710671|NCT02714569|562033569|FG010|Part A Third Intervention|Adverse Event|0|||
155710672|NCT02714569|562033559|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
155710673|NCT02714569|562033560|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710674|NCT02714569|562033561|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710675|NCT02714569|562033562|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710676|NCT02714569|562033563|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710677|NCT02714569|562033564|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
155710678|NCT02714569|562033565|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710679|NCT02714569|562033566|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710680|NCT02714569|562033567|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710681|NCT02714569|562033568|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710682|NCT02714569|562033569|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155710683|NCT02714569|562033559|FG000|Part B (Overall)|Lost to Follow-up|0|||
155710684|NCT02714569|562033560|FG001|Part B (Overall)|Lost to Follow-up|0|||
155710685|NCT02714569|562033561|FG002|Part B (Overall)|Lost to Follow-up|0|||
155710686|NCT02714569|562033562|FG003|Part B (Overall)|Lost to Follow-up|0|||
155710687|NCT02714569|562033563|FG004|Part B (Overall)|Lost to Follow-up|0|||
155710688|NCT02714569|562033564|FG005|Part B (Overall)|Lost to Follow-up|0|||
155710689|NCT02714569|562033565|FG006|Part B (Overall)|Lost to Follow-up|1|||
155710690|NCT02714569|562033566|FG007|Part B (Overall)|Lost to Follow-up|0|||
155710691|NCT02714569|562033567|FG008|Part B (Overall)|Lost to Follow-up|0|||
155710692|NCT02714569|562033568|FG009|Part B (Overall)|Lost to Follow-up|0|||
155710693|NCT02714569|562033569|FG010|Part B (Overall)|Lost to Follow-up|0|||
155710694|NCT02714569|562033559|FG000|Part B (Overall)|Withdrawal by Subject|0|||
155710695|NCT02714569|562033560|FG001|Part B (Overall)|Withdrawal by Subject|0|||
155710696|NCT02714569|562033561|FG002|Part B (Overall)|Withdrawal by Subject|0|||
155710697|NCT02714569|562033562|FG003|Part B (Overall)|Withdrawal by Subject|0|||
155710698|NCT02714569|562033563|FG004|Part B (Overall)|Withdrawal by Subject|0|||
155710699|NCT02714569|562033564|FG005|Part B (Overall)|Withdrawal by Subject|0|||
155710700|NCT02714569|562033565|FG006|Part B (Overall)|Withdrawal by Subject|0|||
155710701|NCT02714569|562033566|FG007|Part B (Overall)|Withdrawal by Subject|1|||
155710702|NCT02714569|562033567|FG008|Part B (Overall)|Withdrawal by Subject|0|||
155710703|NCT02714569|562033568|FG009|Part B (Overall)|Withdrawal by Subject|1|||
155710704|NCT02714569|562033569|FG010|Part B (Overall)|Withdrawal by Subject|0|||
155710705|NCT02714569|562033559|FG000|Part B (Overall)|Adverse Event|0|||
155710706|NCT02714569|562033560|FG001|Part B (Overall)|Adverse Event|0|||
155710707|NCT02714569|562033561|FG002|Part B (Overall)|Adverse Event|0|||
155710708|NCT02714569|562033562|FG003|Part B (Overall)|Adverse Event|0|||
155710709|NCT02714569|562033563|FG004|Part B (Overall)|Adverse Event|0|||
155710710|NCT02714569|562033564|FG005|Part B (Overall)|Adverse Event|0|||
155710711|NCT02714569|562033565|FG006|Part B (Overall)|Adverse Event|0|||
155710712|NCT02714569|562033566|FG007|Part B (Overall)|Adverse Event|0|||
155710713|NCT02714569|562033567|FG008|Part B (Overall)|Adverse Event|0|||
155710714|NCT02714569|562033568|FG009|Part B (Overall)|Adverse Event|1|||
155710715|NCT02714569|562033569|FG010|Part B (Overall)|Adverse Event|0|||
155710716|NCT01684202|562033570|FG000|Dose-escalation Period|Adverse Event|0|||
155710717|NCT01684202|562033571|FG001|Dose-escalation Period|Adverse Event|1|||
155710718|NCT01684202|562033572|FG002|Dose-escalation Period|Adverse Event|0|||
155710719|NCT01684202|562033573|FG003|Dose-escalation Period|Adverse Event|0|||
155710720|NCT01684202|562033570|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
155710721|NCT01684202|562033571|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
155710722|NCT01684202|562033572|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
155710723|NCT01684202|562033573|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
155710724|NCT01684202|562033570|FG000|Maintenance Period|Adverse Event|1|||
155710725|NCT01684202|562033571|FG001|Maintenance Period|Adverse Event|1|||
155710726|NCT01684202|562033572|FG002|Maintenance Period|Adverse Event|1|||
155710727|NCT01684202|562033573|FG003|Maintenance Period|Adverse Event|1|||
155710728|NCT01684202|562033570|FG000|Maintenance Period|Physician Decision|0|||
155710729|NCT01684202|562033571|FG001|Maintenance Period|Physician Decision|1|||
155710730|NCT01684202|562033572|FG002|Maintenance Period|Physician Decision|0|||
155710731|NCT01684202|562033573|FG003|Maintenance Period|Physician Decision|0|||
155710732|NCT01684202|562033570|FG000|Maintenance Period|Withdrawal by Subject|0|||
155710733|NCT01684202|562033571|FG001|Maintenance Period|Withdrawal by Subject|1|||
155710734|NCT01684202|562033572|FG002|Maintenance Period|Withdrawal by Subject|0|||
155710735|NCT01684202|562033573|FG003|Maintenance Period|Withdrawal by Subject|0|||
155710736|NCT00191308|562033574|FG000|Overall Study|Adverse Event|1|||
155710737|NCT00466921|562033575|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
155710738|NCT00466921|562033575|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
155710739|NCT00466921|562033575|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
155710740|NCT00466921|562033575|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
155710741|NCT00466921|562033575|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
155710742|NCT00466921|562033575|FG000|Follow up for a Minimum of 1 Year|Death|6|||
155710743|NCT00779025|562033576|FG000|Overall Study|Withdrawal by Subject|1|||
155710744|NCT03710642|562033577|FG000|Overall Study|Adverse Event|5|||
155710745|NCT03710642|562033578|FG001|Overall Study|Adverse Event|1|||
155710746|NCT03710642|562033577|FG000|Overall Study|non-site physician recommendation|1|||
155710747|NCT03710642|562033578|FG001|Overall Study|non-site physician recommendation|0|||
155710748|NCT03710642|562033577|FG000|Overall Study|Participant unwilling or unable to participate|1|||
155710749|NCT03710642|562033578|FG001|Overall Study|Participant unwilling or unable to participate|1|||
155710750|NCT03710642|562033577|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
155710751|NCT03710642|562033578|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
155710752|NCT03710642|562033577|FG000|Overall Study|NA-no code provided|1|||
155710753|NCT03710642|562033578|FG001|Overall Study|NA-no code provided|0|||
155710754|NCT03710642|562033577|FG000|Overall Study|Withdrawal by Subject|1|||
155710755|NCT03710642|562033578|FG001|Overall Study|Withdrawal by Subject|0|||
155710756|NCT00226811|562033582|FG000|Overall Study|Death|8|||
155710757|NCT00226811|562033582|FG000|Overall Study|Adverse Event|11|||
155710758|NCT00226811|562033582|FG000|Overall Study|Lack of Efficacy|55|||
155710759|NCT00226811|562033582|FG000|Overall Study|Withdrawal by Subject|2|||
155710760|NCT02741635|562033585|FG000|Overall Study|Withdrawal by Subject|1|||
155710761|NCT01427933|562033589|FG000|Overall Study|Withdrawal by Subject|5|||
155710762|NCT01427933|562033590|FG001|Overall Study|Withdrawal by Subject|8|||
155710763|NCT01427933|562033589|FG000|Overall Study|Lost to Follow-up|1|||
155710764|NCT01427933|562033590|FG001|Overall Study|Lost to Follow-up|5|||
155710765|NCT01427933|562033589|FG000|Overall Study|Other|1|||
155710766|NCT01427933|562033590|FG001|Overall Study|Other|0|||
155710767|NCT01427933|562033589|FG000|Overall Study|Investigator's Decision|1|||
155710768|NCT01427933|562033590|FG001|Overall Study|Investigator's Decision|0|||
155710769|NCT01010971|562033593|FG000|Overall Study|Adverse Event|2|||
155710770|NCT01010971|562033594|FG001|Overall Study|Adverse Event|4|||
155710771|NCT01010971|562033595|FG002|Overall Study|Adverse Event|3|||
155710772|NCT01010971|562033593|FG000|Overall Study|Withdrawal by Subject|0|||
155710773|NCT01010971|562033594|FG001|Overall Study|Withdrawal by Subject|2|||
155710774|NCT01010971|562033595|FG002|Overall Study|Withdrawal by Subject|5|||
155710775|NCT01010971|562033593|FG000|Overall Study|Lost to Follow-up|0|||
155710776|NCT01010971|562033594|FG001|Overall Study|Lost to Follow-up|2|||
155710777|NCT01010971|562033595|FG002|Overall Study|Lost to Follow-up|3|||
155710778|NCT01010971|562033593|FG000|Overall Study|Other|1|||
155710779|NCT01010971|562033594|FG001|Overall Study|Other|0|||
155710780|NCT01010971|562033595|FG002|Overall Study|Other|2|||
155710781|NCT05447663|562033596|FG000|Overall Study|Study terminated by Sponsor|5|||
155710782|NCT05447663|562033596|FG000|Overall Study|Death|2|||
155710783|NCT05447663|562033596|FG000|Overall Study|Withdrawal by Subject|1|||
155710784|NCT01100320|562033598|FG000|Period 1|Withdrawal by Subject|2|||
155710785|NCT01100320|562033599|FG001|Period 1|Withdrawal by Subject|4|||
155710786|NCT01100320|562033598|FG000|Period 1|Positive Drug Screen|1|||
155710787|NCT01100320|562033599|FG001|Period 1|Positive Drug Screen|1|||
155710788|NCT01100320|562033598|FG000|Period 1|Adverse Event|2|||
155710789|NCT01100320|562033599|FG001|Period 1|Adverse Event|2|||
155710790|NCT01100320|562033598|FG000|Period 2|Withdrawal by Subject|1|||
155710791|NCT01100320|562033599|FG001|Period 2|Withdrawal by Subject|1|||
155710792|NCT05729568|562033600|FG000|Overall Study|Still on Study|52|||
155710793|NCT05729568|562033601|FG001|Overall Study|Still on Study|26|||
155710794|NCT05729568|562033600|FG000|Overall Study|Randomized but Never Treated|3|||
155710795|NCT05729568|562033601|FG001|Overall Study|Randomized but Never Treated|0|||
155710796|NCT05729568|562033600|FG000|Overall Study|Adverse Event|0|||
155710797|NCT05729568|562033601|FG001|Overall Study|Adverse Event|1|||
155710798|NCT05729568|562033600|FG000|Overall Study|Investigator's Discretion|1|||
155710799|NCT05729568|562033601|FG001|Overall Study|Investigator's Discretion|0|||
155710800|NCT04181762|562033602|FG000|Overall Study|Adverse Event|1|||
155710801|NCT04181762|562033603|FG001|Overall Study|Adverse Event|3|||
155710802|NCT04181762|562033602|FG000|Overall Study|Lost to Follow-up|1|||
155710803|NCT04181762|562033603|FG001|Overall Study|Lost to Follow-up|1|||
155710804|NCT04181762|562033602|FG000|Overall Study|Physician Decision|1|||
155710805|NCT04181762|562033603|FG001|Overall Study|Physician Decision|3|||
155710806|NCT04181762|562033602|FG000|Overall Study|Pregnancy|0|||
155710807|NCT04181762|562033603|FG001|Overall Study|Pregnancy|1|||
155710808|NCT04181762|562033602|FG000|Overall Study|Lack of Efficacy|2|||
155710809|NCT04181762|562033603|FG001|Overall Study|Lack of Efficacy|2|||
155710810|NCT04181762|562033602|FG000|Overall Study|Study terminated by sponsor|95|||
155710811|NCT04181762|562033603|FG001|Overall Study|Study terminated by sponsor|97|||
155710812|NCT04181762|562033602|FG000|Overall Study|Subject decision|11|||
155710813|NCT04181762|562033603|FG001|Overall Study|Subject decision|4|||
155710814|NCT04181762|562033602|FG000|Overall Study|Death|1|||
155710815|NCT04181762|562033603|FG001|Overall Study|Death|1|||
155710816|NCT04181762|562033602|FG000|Overall Study|Protocol deviation|1|||
155710817|NCT04181762|562033603|FG001|Overall Study|Protocol deviation|0|||
155710818|NCT04181762|562033602|FG000|Overall Study|Withdrawal of informed consent|1|||
155710819|NCT04181762|562033603|FG001|Overall Study|Withdrawal of informed consent|3|||
155710820|NCT02534909|562033606|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
155710821|NCT04752332|562033608|FG000|Overall Study|Adverse Event|3|||
155710822|NCT04752332|562033609|FG001|Overall Study|Adverse Event|1|||
155710823|NCT04752332|562033608|FG000|Overall Study|Disease Relapse|1|||
155710824|NCT04752332|562033609|FG001|Overall Study|Disease Relapse|0|||
155710825|NCT04752332|562033608|FG000|Overall Study|Non-compliance With Study Drug|2|||
155710826|NCT04752332|562033609|FG001|Overall Study|Non-compliance With Study Drug|0|||
155710827|NCT04752332|562033608|FG000|Overall Study|Physician Decision|2|||
155710828|NCT04752332|562033609|FG001|Overall Study|Physician Decision|1|||
155710829|NCT04752332|562033608|FG000|Overall Study|Protocol Violation|1|||
155710830|NCT04752332|562033609|FG001|Overall Study|Protocol Violation|1|||
155710831|NCT04752332|562033608|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
155710832|NCT04752332|562033609|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
155710833|NCT04752332|562033608|FG000|Overall Study|Study Terminated by Sponsor|10|||
155710834|NCT04752332|562033609|FG001|Overall Study|Study Terminated by Sponsor|48|||
155710835|NCT04752332|562033608|FG000|Overall Study|Withdrawal by Subject|11|||
155710836|NCT04752332|562033609|FG001|Overall Study|Withdrawal by Subject|3|||
155710837|NCT02915978|562033612|FG000|Overall Study|Adverse Event|2|||
155710838|NCT02915978|562033613|FG001|Overall Study|Adverse Event|1|||
155710839|NCT02915978|562033614|FG002|Overall Study|Adverse Event|0|||
155710840|NCT00924443|562033615|FG000|Overall Study|Physician Decision|2|||
155710841|NCT00924443|562033615|FG000|Overall Study|Protocol Violation|1|||
155710842|NCT02451124|562033619|FG000|Overall Study|Withdrawal by Subject|1|||
155710843|NCT01248949|562033620|FG000|Overall Study|Lost to Follow-up|2|||
155710844|NCT01248949|562033621|FG001|Overall Study|Lost to Follow-up|2|||
155710845|NCT01248949|562033622|FG002|Overall Study|Lost to Follow-up|2|||
155710846|NCT01248949|562033623|FG003|Overall Study|Lost to Follow-up|1|||
155710847|NCT01248949|562033624|FG004|Overall Study|Lost to Follow-up|0|||
155710848|NCT01248949|562033620|FG000|Overall Study|Withdrawal by Subject|5|||
155710849|NCT01248949|562033621|FG001|Overall Study|Withdrawal by Subject|3|||
155710850|NCT01248949|562033622|FG002|Overall Study|Withdrawal by Subject|11|||
155710851|NCT01248949|562033623|FG003|Overall Study|Withdrawal by Subject|3|||
155710852|NCT01248949|562033624|FG004|Overall Study|Withdrawal by Subject|1|||
155710853|NCT01248949|562033620|FG000|Overall Study|Death|22|||
155710854|NCT01248949|562033621|FG001|Overall Study|Death|7|||
155710855|NCT01248949|562033622|FG002|Overall Study|Death|21|||
155710856|NCT01248949|562033623|FG003|Overall Study|Death|6|||
155710857|NCT01248949|562033624|FG004|Overall Study|Death|2|||
155710858|NCT01248949|562033620|FG000|Overall Study|Alternative Therapy|1|||
155710859|NCT01248949|562033621|FG001|Overall Study|Alternative Therapy|0|||
155710860|NCT01248949|562033622|FG002|Overall Study|Alternative Therapy|0|||
155710861|NCT01248949|562033623|FG003|Overall Study|Alternative Therapy|0|||
155710862|NCT01248949|562033624|FG004|Overall Study|Alternative Therapy|0|||
155710863|NCT01248949|562033620|FG000|Overall Study|Alternative Therapy.|1|||
155710864|NCT01248949|562033621|FG001|Overall Study|Alternative Therapy.|0|||
155710865|NCT01248949|562033622|FG002|Overall Study|Alternative Therapy.|0|||
155710866|NCT01248949|562033623|FG003|Overall Study|Alternative Therapy.|0|||
155710867|NCT01248949|562033624|FG004|Overall Study|Alternative Therapy.|0|||
155710868|NCT01248949|562033620|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
155710869|NCT01248949|562033621|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
155710870|NCT01248949|562033622|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
155710871|NCT01248949|562033623|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
155710872|NCT01248949|562033624|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
155710873|NCT01248949|562033620|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
155710874|NCT01248949|562033621|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
155710875|NCT01248949|562033622|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
155710876|NCT01248949|562033623|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
155710877|NCT01248949|562033624|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
155710878|NCT01248949|562033620|FG000|Overall Study|Participant Went To Hospice|0|||
155710879|NCT01248949|562033621|FG001|Overall Study|Participant Went To Hospice|0|||
155710880|NCT01248949|562033622|FG002|Overall Study|Participant Went To Hospice|1|||
155710881|NCT01248949|562033623|FG003|Overall Study|Participant Went To Hospice|0|||
155710882|NCT01248949|562033624|FG004|Overall Study|Participant Went To Hospice|0|||
155710883|NCT01248949|562033620|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
155710884|NCT01248949|562033621|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155710885|NCT01248949|562033622|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155710886|NCT01248949|562033623|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155710887|NCT01248949|562033624|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155710888|NCT01248949|562033620|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
155710889|NCT01248949|562033621|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
155710890|NCT01248949|562033622|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
155710891|NCT01248949|562033623|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
155710892|NCT01248949|562033624|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
155710893|NCT01248949|562033620|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155710894|NCT01248949|562033621|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
155710895|NCT01248949|562033622|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155710896|NCT01248949|562033623|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155710897|NCT01248949|562033624|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155710898|NCT01248949|562033620|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155710899|NCT01248949|562033621|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155710900|NCT01248949|562033622|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
155710901|NCT01248949|562033623|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155710902|NCT01248949|562033624|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155710903|NCT00186901|562033629|FG000|Overall Study|Pregnancy|6|||
155710904|NCT00186901|562033630|FG001|Overall Study|Pregnancy|3|||
155710905|NCT00186901|562033631|FG002|Overall Study|Pregnancy|0|||
155710906|NCT00186901|562033629|FG000|Overall Study|Lost to Follow-up|6|||
155710907|NCT00186901|562033630|FG001|Overall Study|Lost to Follow-up|3|||
155710908|NCT00186901|562033631|FG002|Overall Study|Lost to Follow-up|0|||
155710909|NCT00186901|562033629|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
155710910|NCT00186901|562033630|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
155710911|NCT00186901|562033631|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
155710912|NCT00186901|562033629|FG000|Overall Study|ALL relapse or second malignancy|1|||
155710913|NCT00186901|562033630|FG001|Overall Study|ALL relapse or second malignancy|2|||
155710914|NCT00186901|562033631|FG002|Overall Study|ALL relapse or second malignancy|0|||
155710915|NCT00186901|562033629|FG000|Overall Study|Withdrawal by Subject|4|||
155710916|NCT00186901|562033630|FG001|Overall Study|Withdrawal by Subject|5|||
155710917|NCT00186901|562033631|FG002|Overall Study|Withdrawal by Subject|0|||
155710918|NCT00186901|562033629|FG000|Overall Study|Open label|3|||
155710919|NCT00186901|562033630|FG001|Overall Study|Open label|2|||
155710920|NCT00186901|562033631|FG002|Overall Study|Open label|0|||
155710921|NCT00186901|562033629|FG000|Overall Study|Limited adherence to study requirements|20|||
155710922|NCT00186901|562033630|FG001|Overall Study|Limited adherence to study requirements|23|||
155710923|NCT00186901|562033631|FG002|Overall Study|Limited adherence to study requirements|0|||
155710924|NCT00186901|562033629|FG000|Overall Study|Bone Mineral Density > 0|0|||
155710925|NCT00186901|562033630|FG001|Overall Study|Bone Mineral Density > 0|0|||
155710926|NCT00186901|562033631|FG002|Overall Study|Bone Mineral Density > 0|149|||
155710927|NCT01546688|562033632|FG000|Overall Study|Adverse Event|0|||
155710928|NCT01546688|562033633|FG001|Overall Study|Adverse Event|4|||
155710929|NCT01546688|562033632|FG000|Overall Study|Withdrawal by Subject|2|||
155710930|NCT01546688|562033633|FG001|Overall Study|Withdrawal by Subject|1|||
155710931|NCT01546688|562033632|FG000|Overall Study|Lack of Efficacy|1|||
155710932|NCT01546688|562033633|FG001|Overall Study|Lack of Efficacy|0|||
155710933|NCT00782483|562033637|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
155710934|NCT03543137|562033638|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
155710935|NCT03543137|562033639|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
155710936|NCT03543137|562033638|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
155710937|NCT03543137|562033639|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
155710938|NCT03543137|562033638|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
155710939|NCT03543137|562033639|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
155710940|NCT01052077|562033640|FG000|Phase A|Lost to Follow-up|22|||
155710941|NCT01052077|562033641|FG001|Phase A|Lost to Follow-up|0|||
155710942|NCT01052077|562033642|FG002|Phase A|Lost to Follow-up|0|||
155710943|NCT01052077|562033643|FG003|Phase A|Lost to Follow-up|0|||
155710944|NCT01052077|562033640|FG000|Phase A|Adverse Event|32|||
155710945|NCT01052077|562033641|FG001|Phase A|Adverse Event|0|||
155710946|NCT01052077|562033642|FG002|Phase A|Adverse Event|0|||
155710947|NCT01052077|562033643|FG003|Phase A|Adverse Event|0|||
155710948|NCT01052077|562033640|FG000|Phase A|Met Withdrawal Criteria|26|||
155710949|NCT01052077|562033641|FG001|Phase A|Met Withdrawal Criteria|0|||
155710950|NCT01052077|562033642|FG002|Phase A|Met Withdrawal Criteria|0|||
155710951|NCT01052077|562033643|FG003|Phase A|Met Withdrawal Criteria|0|||
155710952|NCT01052077|562033640|FG000|Phase A|Physician Decision|10|||
155710953|NCT01052077|562033641|FG001|Phase A|Physician Decision|0|||
155710954|NCT01052077|562033642|FG002|Phase A|Physician Decision|0|||
155710955|NCT01052077|562033643|FG003|Phase A|Physician Decision|0|||
155710956|NCT01052077|562033640|FG000|Phase A|Withdrawal by Subject|29|||
155710957|NCT01052077|562033641|FG001|Phase A|Withdrawal by Subject|0|||
155710958|NCT01052077|562033642|FG002|Phase A|Withdrawal by Subject|0|||
155710959|NCT01052077|562033643|FG003|Phase A|Withdrawal by Subject|0|||
155710960|NCT01052077|562033640|FG000|Phase A|Protocol Deviation|27|||
155710961|NCT01052077|562033641|FG001|Phase A|Protocol Deviation|0|||
155710962|NCT01052077|562033642|FG002|Phase A|Protocol Deviation|0|||
155710963|NCT01052077|562033643|FG003|Phase A|Protocol Deviation|0|||
155710964|NCT01052077|562033640|FG000|Phase B|Lost to Follow-up|0|||
155710965|NCT01052077|562033641|FG001|Phase B|Lost to Follow-up|2|||
155710966|NCT01052077|562033642|FG002|Phase B|Lost to Follow-up|3|||
155710967|NCT01052077|562033643|FG003|Phase B|Lost to Follow-up|0|||
155710968|NCT01052077|562033640|FG000|Phase B|Adverse Event|0|||
155710969|NCT01052077|562033641|FG001|Phase B|Adverse Event|9|||
155710970|NCT01052077|562033642|FG002|Phase B|Adverse Event|2|||
155710971|NCT01052077|562033643|FG003|Phase B|Adverse Event|0|||
155710972|NCT01052077|562033640|FG000|Phase B|Met Withdrawal Criteria|0|||
155710973|NCT01052077|562033641|FG001|Phase B|Met Withdrawal Criteria|2|||
155710974|NCT01052077|562033642|FG002|Phase B|Met Withdrawal Criteria|1|||
155710975|NCT01052077|562033643|FG003|Phase B|Met Withdrawal Criteria|0|||
155710976|NCT01052077|562033640|FG000|Phase B|Physician Decision|0|||
155710977|NCT01052077|562033641|FG001|Phase B|Physician Decision|1|||
155710978|NCT01052077|562033642|FG002|Phase B|Physician Decision|1|||
155710979|NCT01052077|562033643|FG003|Phase B|Physician Decision|0|||
155710980|NCT01052077|562033640|FG000|Phase B|Withdrawal by Subject|0|||
155710981|NCT01052077|562033641|FG001|Phase B|Withdrawal by Subject|0|||
155710982|NCT01052077|562033642|FG002|Phase B|Withdrawal by Subject|5|||
155710983|NCT01052077|562033643|FG003|Phase B|Withdrawal by Subject|0|||
155710984|NCT01052077|562033640|FG000|Phase B|Protocol Deviation|0|||
155710985|NCT01052077|562033641|FG001|Phase B|Protocol Deviation|3|||
155710986|NCT01052077|562033642|FG002|Phase B|Protocol Deviation|4|||
155710987|NCT01052077|562033643|FG003|Phase B|Protocol Deviation|0|||
155710988|NCT01052077|562033640|FG000|Phase B|Lack of Efficacy|0|||
155710989|NCT01052077|562033641|FG001|Phase B|Lack of Efficacy|1|||
155710990|NCT01052077|562033642|FG002|Phase B|Lack of Efficacy|0|||
155710991|NCT01052077|562033643|FG003|Phase B|Lack of Efficacy|0|||
155710992|NCT01052077|562033640|FG000|Phase A+|Lost to Follow-up|0|||
155710993|NCT01052077|562033641|FG001|Phase A+|Lost to Follow-up|0|||
155710994|NCT01052077|562033642|FG002|Phase A+|Lost to Follow-up|0|||
155710995|NCT01052077|562033643|FG003|Phase A+|Lost to Follow-up|8|||
155710996|NCT01052077|562033640|FG000|Phase A+|Adverse Event|0|||
155710997|NCT01052077|562033641|FG001|Phase A+|Adverse Event|0|||
155710998|NCT01052077|562033642|FG002|Phase A+|Adverse Event|0|||
155710999|NCT01052077|562033643|FG003|Phase A+|Adverse Event|4|||
155711000|NCT01052077|562033640|FG000|Phase A+|Met Withdrawal Criteria|0|||
155711001|NCT01052077|562033641|FG001|Phase A+|Met Withdrawal Criteria|0|||
155711002|NCT01052077|562033642|FG002|Phase A+|Met Withdrawal Criteria|0|||
155711003|NCT01052077|562033643|FG003|Phase A+|Met Withdrawal Criteria|2|||
155711004|NCT01052077|562033640|FG000|Phase A+|Withdrawal by Subject|0|||
155711005|NCT01052077|562033641|FG001|Phase A+|Withdrawal by Subject|0|||
155711006|NCT01052077|562033642|FG002|Phase A+|Withdrawal by Subject|0|||
155711007|NCT01052077|562033643|FG003|Phase A+|Withdrawal by Subject|7|||
155711008|NCT01099397|562033647|FG000|Overall Study|Lost to Follow-up|4|||
155711009|NCT01099397|562033647|FG000|Overall Study|Protocol Violation|4|||
155711010|NCT01099397|562033647|FG000|Overall Study|Withdrawal by Subject|5|||
155711011|NCT02363959|562033648|FG000|Overall Study|Medical instability|1|||
155711012|NCT02363959|562033649|FG001|Overall Study|Medical instability|0|||
155711013|NCT00003199|562033651|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
155711014|NCT00003199|562033651|FG000|Overall Study|Lack of insurance clearance|2|||
155711015|NCT00003199|562033651|FG000|Overall Study|Screen fail|15|||
155711016|NCT00940498|562033652|FG000|Overall Study|Death|2|||
155711017|NCT00940498|562033653|FG001|Overall Study|Death|0|||
155711018|NCT00940498|562033654|FG002|Overall Study|Death|0|||
155711019|NCT00940498|562033655|FG003|Overall Study|Death|1|||
155711020|NCT00940498|562033656|FG004|Overall Study|Death|5|||
155711021|NCT00940498|562033657|FG005|Overall Study|Death|0|||
155711022|NCT00940498|562033658|FG006|Overall Study|Death|1|||
155711023|NCT00940498|562033659|FG007|Overall Study|Death|0|||
155711024|NCT00940498|562033652|FG000|Overall Study|Lost to Follow-up|1|||
155711025|NCT00940498|562033653|FG001|Overall Study|Lost to Follow-up|1|||
155711026|NCT00940498|562033654|FG002|Overall Study|Lost to Follow-up|2|||
155711027|NCT00940498|562033655|FG003|Overall Study|Lost to Follow-up|0|||
155711028|NCT00940498|562033656|FG004|Overall Study|Lost to Follow-up|1|||
155711029|NCT00940498|562033657|FG005|Overall Study|Lost to Follow-up|0|||
155711030|NCT00940498|562033658|FG006|Overall Study|Lost to Follow-up|0|||
155711031|NCT00940498|562033659|FG007|Overall Study|Lost to Follow-up|1|||
155711032|NCT00940498|562033652|FG000|Overall Study|Disease Progression|0|||
155711033|NCT00940498|562033653|FG001|Overall Study|Disease Progression|0|||
155711034|NCT00940498|562033654|FG002|Overall Study|Disease Progression|1|||
155711035|NCT00940498|562033655|FG003|Overall Study|Disease Progression|1|||
155711036|NCT00940498|562033656|FG004|Overall Study|Disease Progression|0|||
155711037|NCT00940498|562033657|FG005|Overall Study|Disease Progression|1|||
155711038|NCT00940498|562033658|FG006|Overall Study|Disease Progression|0|||
155711039|NCT00940498|562033659|FG007|Overall Study|Disease Progression|0|||
155711040|NCT00940498|562033652|FG000|Overall Study|Physician Decision|0|||
155711041|NCT00940498|562033653|FG001|Overall Study|Physician Decision|0|||
155711042|NCT00940498|562033654|FG002|Overall Study|Physician Decision|0|||
155711043|NCT00940498|562033655|FG003|Overall Study|Physician Decision|0|||
155711044|NCT00940498|562033656|FG004|Overall Study|Physician Decision|2|||
155711045|NCT00940498|562033657|FG005|Overall Study|Physician Decision|0|||
155711046|NCT00940498|562033658|FG006|Overall Study|Physician Decision|0|||
155711047|NCT00940498|562033659|FG007|Overall Study|Physician Decision|0|||
155711048|NCT00940498|562033652|FG000|Overall Study|Not treated due to disease related pain|0|||
155711049|NCT00940498|562033653|FG001|Overall Study|Not treated due to disease related pain|0|||
155711050|NCT00940498|562033654|FG002|Overall Study|Not treated due to disease related pain|0|||
155711051|NCT00940498|562033655|FG003|Overall Study|Not treated due to disease related pain|0|||
155711052|NCT00940498|562033656|FG004|Overall Study|Not treated due to disease related pain|1|||
155711053|NCT00940498|562033657|FG005|Overall Study|Not treated due to disease related pain|0|||
155711054|NCT00940498|562033658|FG006|Overall Study|Not treated due to disease related pain|0|||
155711055|NCT00940498|562033659|FG007|Overall Study|Not treated due to disease related pain|0|||
155711056|NCT00983385|562033660|FG000|Observation Period|Not eligible to be dosed|20|||
155711057|NCT00983385|562033660|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
155711058|NCT00930930|562033661|FG000|Overall Study|Death|1|||
155711059|NCT00930930|562033662|FG001|Overall Study|Death|0|||
155711060|NCT00930930|562033661|FG000|Overall Study|Physician Decision|1|||
155711061|NCT00930930|562033662|FG001|Overall Study|Physician Decision|0|||
155711062|NCT00930930|562033661|FG000|Overall Study|Adverse Event|13|||
155711063|NCT00930930|562033662|FG001|Overall Study|Adverse Event|3|||
155711064|NCT00930930|562033661|FG000|Overall Study|Withdrawal by Subject|3|||
155711065|NCT00930930|562033662|FG001|Overall Study|Withdrawal by Subject|1|||
155711066|NCT00930930|562033661|FG000|Overall Study|Disease progression|2|||
155711067|NCT00930930|562033662|FG001|Overall Study|Disease progression|3|||
155711068|NCT00930930|562033661|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
155711069|NCT00930930|562033662|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
155711070|NCT00930930|562033661|FG000|Overall Study|patients not compliant|1|||
155711071|NCT00930930|562033662|FG001|Overall Study|patients not compliant|1|||
155711072|NCT00900029|562033663|FG000|Overall Study|Lost to Follow-up|0|||
155711073|NCT00900029|562033664|FG001|Overall Study|Lost to Follow-up|2|||
155711074|NCT00900029|562033665|FG002|Overall Study|Lost to Follow-up|1|||
155711075|NCT00900029|562033666|FG003|Overall Study|Lost to Follow-up|4|||
155711076|NCT00900029|562033667|FG004|Overall Study|Lost to Follow-up|4|||
155711077|NCT00900029|562033663|FG000|Overall Study|Withdrawal by Subject|2|||
155711078|NCT00900029|562033664|FG001|Overall Study|Withdrawal by Subject|2|||
155711079|NCT00900029|562033665|FG002|Overall Study|Withdrawal by Subject|1|||
155711080|NCT00900029|562033666|FG003|Overall Study|Withdrawal by Subject|1|||
155711081|NCT00900029|562033667|FG004|Overall Study|Withdrawal by Subject|1|||
155711082|NCT00900029|562033663|FG000|Overall Study|Adverse Event|0|||
155711083|NCT00900029|562033664|FG001|Overall Study|Adverse Event|0|||
155711084|NCT00900029|562033665|FG002|Overall Study|Adverse Event|1|||
155711085|NCT00900029|562033666|FG003|Overall Study|Adverse Event|1|||
155711086|NCT00900029|562033667|FG004|Overall Study|Adverse Event|1|||
155711087|NCT00900029|562033663|FG000|Overall Study|Death|1|||
155711088|NCT00900029|562033664|FG001|Overall Study|Death|0|||
155711089|NCT00900029|562033665|FG002|Overall Study|Death|0|||
155711090|NCT00900029|562033666|FG003|Overall Study|Death|1|||
155711091|NCT00900029|562033667|FG004|Overall Study|Death|0|||
155711092|NCT02587819|562033670|FG000|Overall Study|Adverse Event|1|||
155711093|NCT02587819|562033670|FG000|Overall Study|Lost to Follow-up|1|||
155711094|NCT00859547|562035196|FG000|Overall Study|Lost to Follow-up|1|||
155711095|NCT00859547|562035196|FG000|Overall Study|Parent withdrew consent|1|||
155711096|NCT01473732|562035197|FG000|Overall Study|Adverse Event|1|||
155711097|NCT01473732|562035198|FG001|Overall Study|Adverse Event|0|||
155711098|NCT01473732|562035197|FG000|Overall Study|Death|1|||
155711099|NCT01473732|562035198|FG001|Overall Study|Death|0|||
155711100|NCT00997035|562035202|FG000|3-week Followup Visit|Lost to Follow-up|9|||
155711101|NCT00997035|562035203|FG001|3-week Followup Visit|Lost to Follow-up|6|||
155711102|NCT00997035|562035202|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
155711103|NCT00997035|562035203|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
155711104|NCT00269919|562035204|FG000|Overall Study|Other|26|||
155711105|NCT00269919|562035204|FG000|Overall Study|Started but not treated|1|||
155711106|NCT02471014|562035205|FG000|Overall Study|Lost to Follow-up|2|||
155711107|NCT02471014|562035206|FG001|Overall Study|Lost to Follow-up|2|||
155711108|NCT04685798|562035207|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
155711109|NCT00824473|562035213|FG000|Overall Study|Adverse Event|4|||
155711110|NCT00824473|562035214|FG001|Overall Study|Adverse Event|5|||
155711111|NCT00824473|562035213|FG000|Overall Study|Lack of Efficacy|2|||
155711112|NCT00824473|562035214|FG001|Overall Study|Lack of Efficacy|2|||
155711113|NCT00824473|562035213|FG000|Overall Study|Protocol Violation|2|||
155711114|NCT00824473|562035214|FG001|Overall Study|Protocol Violation|0|||
155711115|NCT00824473|562035213|FG000|Overall Study|Non-Compliance|4|||
155711116|NCT00824473|562035214|FG001|Overall Study|Non-Compliance|2|||
155711117|NCT00824473|562035213|FG000|Overall Study|Withdrawal by Subject|2|||
155711118|NCT00824473|562035214|FG001|Overall Study|Withdrawal by Subject|3|||
155711119|NCT00824473|562035213|FG000|Overall Study|Other|1|||
155711120|NCT00824473|562035214|FG001|Overall Study|Other|1|||
155711121|NCT01965704|562035215|FG000|Overall Study|Withdrawal by Subject|2|||
155711122|NCT01965704|562035216|FG001|Overall Study|Withdrawal by Subject|2|||
155711123|NCT01965704|562035217|FG002|Overall Study|Withdrawal by Subject|1|||
155711124|NCT01965704|562035218|FG003|Overall Study|Withdrawal by Subject|1|||
155711125|NCT01965704|562035215|FG000|Overall Study|Delivered at home|1|||
155711126|NCT01965704|562035216|FG001|Overall Study|Delivered at home|1|||
155711127|NCT01965704|562035217|FG002|Overall Study|Delivered at home|0|||
155711128|NCT01965704|562035218|FG003|Overall Study|Delivered at home|0|||
155711129|NCT01965704|562035215|FG000|Overall Study|Experienced complications|0|||
155711130|NCT01965704|562035216|FG001|Overall Study|Experienced complications|0|||
155711131|NCT01965704|562035217|FG002|Overall Study|Experienced complications|2|||
155711132|NCT01965704|562035218|FG003|Overall Study|Experienced complications|2|||
155711133|NCT01965704|562035215|FG000|Overall Study|Adverse Event|0|||
155711134|NCT01965704|562035216|FG001|Overall Study|Adverse Event|0|||
155711135|NCT01965704|562035217|FG002|Overall Study|Adverse Event|1|||
155711136|NCT01965704|562035218|FG003|Overall Study|Adverse Event|1|||
155711137|NCT01965704|562035215|FG000|Overall Study|Did not meet inclusion criteria|0|||
155711138|NCT01965704|562035216|FG001|Overall Study|Did not meet inclusion criteria|0|||
155711139|NCT01965704|562035217|FG002|Overall Study|Did not meet inclusion criteria|1|||
155711140|NCT01965704|562035218|FG003|Overall Study|Did not meet inclusion criteria|1|||
155711141|NCT00337207|562035219|FG000|Overall Study|Withdrawal by Subject|3|||
155711142|NCT01479868|562035220|FG000|Overall Study|Adverse Event|1|||
155711143|NCT01479868|562035220|FG000|Overall Study|Lost to Follow-up|4|||
155711144|NCT01479868|562035220|FG000|Overall Study|Protocol Violation|1|||
155711145|NCT01479868|562035220|FG000|Overall Study|Withdrawal by Subject|1|||
155711146|NCT01479868|562035220|FG000|Overall Study|Sponsor's Decision|1|||
155711147|NCT01479868|562035220|FG000|Overall Study|Initiation of new HCV Therapy|1|||
155711148|NCT01177007|562035221|FG000|Overall Study|Lost to Follow-up|2|||
155711149|NCT01177007|562035221|FG000|Overall Study|Death|4|||
155711150|NCT01177007|562035221|FG000|Overall Study|Entered hospice care|5|||
155711151|NCT01177007|562035221|FG000|Overall Study|Required additional Y90 treatment|6|||
155711152|NCT01177007|562035221|FG000|Overall Study|Change in treatment modality|21|||
155711153|NCT02336230|562035227|FG000|Overall Study|Adverse Event|1|||
155711154|NCT02336230|562035227|FG000|Overall Study|Withdrawal of consent|1|||
155711155|NCT02336230|562035227|FG000|Overall Study|Death|9|||
155711156|NCT02336230|562035227|FG000|Overall Study|Dose not received due to shipping delay|1|||
155711157|NCT02336230|562035227|FG000|Overall Study|Discontinuation of MSC infusion|1|||
155711158|NCT03305770|562035235|FG000|Overall Study|Physician Decision - prior to dispense|0|||
155711159|NCT03305770|562035236|FG001|Overall Study|Physician Decision - prior to dispense|1|||
155711160|NCT03305770|562035235|FG000|Overall Study|Subject moved|1|||
155711161|NCT03305770|562035236|FG001|Overall Study|Subject moved|0|||
155711162|NCT03539601|562035237|FG000|Overall Study|Withdraw by parent/guardian|1|||
155711163|NCT03539601|562035238|FG001|Overall Study|Withdraw by parent/guardian|0|||
155711164|NCT03539601|562035239|FG002|Overall Study|Withdraw by parent/guardian|1|||
155711165|NCT03539601|562035240|FG003|Overall Study|Withdraw by parent/guardian|0|||
155711166|NCT03539601|562035237|FG000|Overall Study|Adverse Event|0|||
155711167|NCT03539601|562035238|FG001|Overall Study|Adverse Event|2|||
155711168|NCT03539601|562035239|FG002|Overall Study|Adverse Event|0|||
155711169|NCT03539601|562035240|FG003|Overall Study|Adverse Event|0|||
155711170|NCT03539601|562035237|FG000|Overall Study|Lost to Follow-up|2|||
155711171|NCT03539601|562035238|FG001|Overall Study|Lost to Follow-up|4|||
155711172|NCT03539601|562035239|FG002|Overall Study|Lost to Follow-up|5|||
155711173|NCT03539601|562035240|FG003|Overall Study|Lost to Follow-up|0|||
155711174|NCT03539601|562035237|FG000|Overall Study|Withdrawal by Subject|2|||
155711175|NCT03539601|562035238|FG001|Overall Study|Withdrawal by Subject|0|||
155711176|NCT03539601|562035239|FG002|Overall Study|Withdrawal by Subject|0|||
155711177|NCT03539601|562035240|FG003|Overall Study|Withdrawal by Subject|1|||
155711178|NCT03539601|562035237|FG000|Overall Study|Randomized but not treated|1|||
155711179|NCT03539601|562035238|FG001|Overall Study|Randomized but not treated|1|||
155711180|NCT03539601|562035239|FG002|Overall Study|Randomized but not treated|0|||
155711181|NCT03539601|562035240|FG003|Overall Study|Randomized but not treated|0|||
155711182|NCT01970306|562035241|FG000|Overall Study|Not eligible|3|||
155711183|NCT01970306|562035241|FG000|Overall Study|Not able to be treated|9|||
155711184|NCT03472326|562035242|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
155711185|NCT03472326|562035243|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
155711186|NCT03472326|562035244|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
155711187|NCT03472326|562035245|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
155711188|NCT03472326|562035242|FG000|Part 2: Combination Therapy|Pregnancy|0|||
155711189|NCT03472326|562035243|FG001|Part 2: Combination Therapy|Pregnancy|0|||
155711190|NCT03472326|562035244|FG002|Part 2: Combination Therapy|Pregnancy|0|||
155711191|NCT03472326|562035245|FG003|Part 2: Combination Therapy|Pregnancy|1|||
155711192|NCT03386721|562035246|FG000|Overall Study|Death|12|||
155711193|NCT03386721|562035247|FG001|Overall Study|Death|21|||
155711194|NCT03386721|562035248|FG002|Overall Study|Death|2|||
155711195|NCT03386721|562035249|FG003|Overall Study|Death|5|||
155711196|NCT03386721|562035250|FG004|Overall Study|Death|1|||
155711197|NCT03386721|562035251|FG005|Overall Study|Death|12|||
155711198|NCT03386721|562035252|FG006|Overall Study|Death|1|||
155711199|NCT03386721|562035253|FG007|Overall Study|Death|1|||
155711200|NCT03386721|562035254|FG008|Overall Study|Death|12|||
155711201|NCT03386721|562035255|FG009|Overall Study|Death|20|||
155711202|NCT03386721|562035256|FG010|Overall Study|Death|21|||
155711203|NCT03386721|562035257|FG011|Overall Study|Death|21|||
155711204|NCT03386721|562035258|FG012|Overall Study|Death|14|||
155711205|NCT03386721|562035259|FG013|Overall Study|Death|2|||
155711206|NCT03386721|562035260|FG014|Overall Study|Death|1|||
155711207|NCT03386721|562035246|FG000|Overall Study|Lost to Follow-up|1|||
155711208|NCT03386721|562035247|FG001|Overall Study|Lost to Follow-up|3|||
155711209|NCT03386721|562035248|FG002|Overall Study|Lost to Follow-up|0|||
155711210|NCT03386721|562035249|FG003|Overall Study|Lost to Follow-up|0|||
155711211|NCT03386721|562035250|FG004|Overall Study|Lost to Follow-up|0|||
155711212|NCT03386721|562035251|FG005|Overall Study|Lost to Follow-up|2|||
155711213|NCT03386721|562035252|FG006|Overall Study|Lost to Follow-up|1|||
155711214|NCT03386721|562035253|FG007|Overall Study|Lost to Follow-up|0|||
155711215|NCT03386721|562035254|FG008|Overall Study|Lost to Follow-up|1|||
155711216|NCT03386721|562035255|FG009|Overall Study|Lost to Follow-up|2|||
155711217|NCT03386721|562035256|FG010|Overall Study|Lost to Follow-up|1|||
155711218|NCT03386721|562035257|FG011|Overall Study|Lost to Follow-up|0|||
155711219|NCT03386721|562035258|FG012|Overall Study|Lost to Follow-up|0|||
155711220|NCT03386721|562035259|FG013|Overall Study|Lost to Follow-up|0|||
155711221|NCT03386721|562035260|FG014|Overall Study|Lost to Follow-up|0|||
155711222|NCT03386721|562035246|FG000|Overall Study|Reason not specified|3|||
155711223|NCT03386721|562035247|FG001|Overall Study|Reason not specified|0|||
155711224|NCT03386721|562035248|FG002|Overall Study|Reason not specified|0|||
155711225|NCT03386721|562035249|FG003|Overall Study|Reason not specified|0|||
155711226|NCT03386721|562035250|FG004|Overall Study|Reason not specified|0|||
155711227|NCT03386721|562035251|FG005|Overall Study|Reason not specified|3|||
155711228|NCT03386721|562035252|FG006|Overall Study|Reason not specified|1|||
155711229|NCT03386721|562035253|FG007|Overall Study|Reason not specified|0|||
155711230|NCT03386721|562035254|FG008|Overall Study|Reason not specified|0|||
155711231|NCT03386721|562035255|FG009|Overall Study|Reason not specified|1|||
155711232|NCT03386721|562035256|FG010|Overall Study|Reason not specified|2|||
155711233|NCT03386721|562035257|FG011|Overall Study|Reason not specified|6|||
155711234|NCT03386721|562035258|FG012|Overall Study|Reason not specified|1|||
155711235|NCT03386721|562035259|FG013|Overall Study|Reason not specified|0|||
155711236|NCT03386721|562035260|FG014|Overall Study|Reason not specified|0|||
155711237|NCT03386721|562035246|FG000|Overall Study|Progressive Disease|0|||
155711238|NCT03386721|562035247|FG001|Overall Study|Progressive Disease|0|||
155711239|NCT03386721|562035248|FG002|Overall Study|Progressive Disease|1|||
155711240|NCT03386721|562035249|FG003|Overall Study|Progressive Disease|0|||
155711241|NCT03386721|562035250|FG004|Overall Study|Progressive Disease|0|||
155711242|NCT03386721|562035251|FG005|Overall Study|Progressive Disease|1|||
155711243|NCT03386721|562035252|FG006|Overall Study|Progressive Disease|0|||
155711244|NCT03386721|562035253|FG007|Overall Study|Progressive Disease|0|||
155711245|NCT03386721|562035254|FG008|Overall Study|Progressive Disease|2|||
155711246|NCT03386721|562035255|FG009|Overall Study|Progressive Disease|1|||
155711247|NCT03386721|562035256|FG010|Overall Study|Progressive Disease|1|||
155711248|NCT03386721|562035257|FG011|Overall Study|Progressive Disease|0|||
155711249|NCT03386721|562035258|FG012|Overall Study|Progressive Disease|1|||
155711250|NCT03386721|562035259|FG013|Overall Study|Progressive Disease|0|||
155711251|NCT03386721|562035260|FG014|Overall Study|Progressive Disease|0|||
155711252|NCT03386721|562035246|FG000|Overall Study|Site Terminated by Sponsor|5|||
155711253|NCT03386721|562035247|FG001|Overall Study|Site Terminated by Sponsor|5|||
155711254|NCT03386721|562035248|FG002|Overall Study|Site Terminated by Sponsor|0|||
155711255|NCT03386721|562035249|FG003|Overall Study|Site Terminated by Sponsor|0|||
155711256|NCT03386721|562035250|FG004|Overall Study|Site Terminated by Sponsor|1|||
155711257|NCT03386721|562035251|FG005|Overall Study|Site Terminated by Sponsor|3|||
155711258|NCT03386721|562035252|FG006|Overall Study|Site Terminated by Sponsor|0|||
155711259|NCT03386721|562035253|FG007|Overall Study|Site Terminated by Sponsor|1|||
155711260|NCT03386721|562035254|FG008|Overall Study|Site Terminated by Sponsor|4|||
155711261|NCT03386721|562035255|FG009|Overall Study|Site Terminated by Sponsor|5|||
155711262|NCT03386721|562035256|FG010|Overall Study|Site Terminated by Sponsor|3|||
155711263|NCT03386721|562035257|FG011|Overall Study|Site Terminated by Sponsor|11|||
155711264|NCT03386721|562035258|FG012|Overall Study|Site Terminated by Sponsor|6|||
155711265|NCT03386721|562035259|FG013|Overall Study|Site Terminated by Sponsor|0|||
155711266|NCT03386721|562035260|FG014|Overall Study|Site Terminated by Sponsor|0|||
155711267|NCT03386721|562035246|FG000|Overall Study|Symptomatic Deterioration|0|||
155711268|NCT03386721|562035247|FG001|Overall Study|Symptomatic Deterioration|0|||
155711269|NCT03386721|562035248|FG002|Overall Study|Symptomatic Deterioration|0|||
155711270|NCT03386721|562035249|FG003|Overall Study|Symptomatic Deterioration|0|||
155711271|NCT03386721|562035250|FG004|Overall Study|Symptomatic Deterioration|0|||
155711272|NCT03386721|562035251|FG005|Overall Study|Symptomatic Deterioration|0|||
155711273|NCT03386721|562035252|FG006|Overall Study|Symptomatic Deterioration|0|||
155711274|NCT03386721|562035253|FG007|Overall Study|Symptomatic Deterioration|0|||
155711275|NCT03386721|562035254|FG008|Overall Study|Symptomatic Deterioration|1|||
155711276|NCT03386721|562035255|FG009|Overall Study|Symptomatic Deterioration|0|||
155711277|NCT03386721|562035256|FG010|Overall Study|Symptomatic Deterioration|0|||
155711278|NCT03386721|562035257|FG011|Overall Study|Symptomatic Deterioration|1|||
155711279|NCT03386721|562035258|FG012|Overall Study|Symptomatic Deterioration|0|||
155711280|NCT03386721|562035259|FG013|Overall Study|Symptomatic Deterioration|0|||
155711281|NCT03386721|562035260|FG014|Overall Study|Symptomatic Deterioration|0|||
155711282|NCT03386721|562035246|FG000|Overall Study|Withdrawal by Subject|1|||
155711283|NCT03386721|562035247|FG001|Overall Study|Withdrawal by Subject|2|||
155711284|NCT03386721|562035248|FG002|Overall Study|Withdrawal by Subject|0|||
155711285|NCT03386721|562035249|FG003|Overall Study|Withdrawal by Subject|0|||
155711286|NCT03386721|562035250|FG004|Overall Study|Withdrawal by Subject|0|||
155711287|NCT03386721|562035251|FG005|Overall Study|Withdrawal by Subject|0|||
155711288|NCT03386721|562035252|FG006|Overall Study|Withdrawal by Subject|0|||
155711289|NCT03386721|562035253|FG007|Overall Study|Withdrawal by Subject|0|||
155711290|NCT03386721|562035254|FG008|Overall Study|Withdrawal by Subject|2|||
155711291|NCT03386721|562035255|FG009|Overall Study|Withdrawal by Subject|1|||
155711292|NCT03386721|562035256|FG010|Overall Study|Withdrawal by Subject|3|||
155711293|NCT03386721|562035257|FG011|Overall Study|Withdrawal by Subject|2|||
155711294|NCT03386721|562035258|FG012|Overall Study|Withdrawal by Subject|3|||
155711295|NCT03386721|562035259|FG013|Overall Study|Withdrawal by Subject|0|||
155711296|NCT03386721|562035260|FG014|Overall Study|Withdrawal by Subject|0|||
155711297|NCT00700713|562035261|FG000|Overall Study|Protocol Violation|1|||
155711298|NCT00700713|562035262|FG001|Overall Study|Protocol Violation|0|||
155711299|NCT00700713|562035263|FG002|Overall Study|Protocol Violation|1|||
155711300|NCT00700713|562035261|FG000|Overall Study|Withdrawal by Subject|0|||
155711301|NCT00700713|562035262|FG001|Overall Study|Withdrawal by Subject|0|||
155711302|NCT00700713|562035263|FG002|Overall Study|Withdrawal by Subject|1|||
155711303|NCT01369784|562035267|FG000|Overall Study|Protocol Violation|12|||
155711304|NCT00596752|562035270|FG000|Overall Study|Other Reason|44|||
155711305|NCT00596752|562035271|FG001|Overall Study|Other Reason|49|||
155711306|NCT00596752|562035270|FG000|Overall Study|Adverse Event|34|||
155711307|NCT00596752|562035271|FG001|Overall Study|Adverse Event|34|||
155711308|NCT00596752|562035270|FG000|Overall Study|Lost to Follow-up|22|||
155711309|NCT00596752|562035271|FG001|Overall Study|Lost to Follow-up|38|||
155711310|NCT00596752|562035270|FG000|Overall Study|Withdrawal by Subject|12|||
155711311|NCT00596752|562035271|FG001|Overall Study|Withdrawal by Subject|9|||
155711312|NCT00596752|562035270|FG000|Overall Study|Unsatisfactory Compliance|9|||
155711313|NCT00596752|562035271|FG001|Overall Study|Unsatisfactory Compliance|6|||
155711314|NCT00596752|562035270|FG000|Overall Study|Lack of Efficacy|4|||
155711315|NCT00596752|562035271|FG001|Overall Study|Lack of Efficacy|7|||
155711316|NCT00596752|562035270|FG000|Overall Study|Protocol Violation|1|||
155711317|NCT00596752|562035271|FG001|Overall Study|Protocol Violation|0|||
155711318|NCT04797780|562035274|FG000|Overall Study|Lost to Follow-up|1|||
155711319|NCT04797780|562035275|FG001|Overall Study|Lost to Follow-up|1|||
155711320|NCT04797780|562035274|FG000|Overall Study|Withdrawal by Subject|14|||
155711321|NCT04797780|562035275|FG001|Overall Study|Withdrawal by Subject|9|||
155711322|NCT04797780|562035274|FG000|Overall Study|Death|49|||
155711323|NCT04797780|562035275|FG001|Overall Study|Death|20|||
155711324|NCT02586727|562035276|FG000|Overall Study|Lost to Follow-up|1|||
155711325|NCT02586727|562035277|FG001|Overall Study|Lost to Follow-up|0|||
155711326|NCT05167825|562035278|FG000|Overall Study|Ongoing|3|||
155711327|NCT02326597|562035290|FG000|Overall Study|Lost to Follow-up|42|||
155711328|NCT02326597|562035291|FG001|Overall Study|Lost to Follow-up|32|||
155711329|NCT02119663|562035292|FG000|Overall Study|Disease progression|26|||
155711330|NCT02119663|562035293|FG001|Overall Study|Disease progression|27|||
155711331|NCT02119663|562035292|FG000|Overall Study|Adverse Event|5|||
155711332|NCT02119663|562035293|FG001|Overall Study|Adverse Event|5|||
155711333|NCT02119663|562035292|FG000|Overall Study|Death|3|||
155711334|NCT02119663|562035293|FG001|Overall Study|Death|2|||
155711335|NCT02119663|562035292|FG000|Overall Study|Physician Decision|1|||
155711336|NCT02119663|562035293|FG001|Overall Study|Physician Decision|2|||
155711337|NCT02119663|562035292|FG000|Overall Study|Other unspecified|2|||
155711338|NCT02119663|562035293|FG001|Overall Study|Other unspecified|0|||
155711339|NCT02119663|562035292|FG000|Overall Study|Subject decision|0|||
155711340|NCT02119663|562035293|FG001|Overall Study|Subject decision|1|||
155711341|NCT02119663|562035292|FG000|Overall Study|Study Terminated by the Sponsor|3|||
155711342|NCT02119663|562035293|FG001|Overall Study|Study Terminated by the Sponsor|4|||
155711343|NCT01870726|562035294|FG000|Overall Study|Withdrawal of informed consent|0|||
155711344|NCT01870726|562035295|FG001|Overall Study|Withdrawal of informed consent|0|||
155711345|NCT01870726|562035296|FG002|Overall Study|Withdrawal of informed consent|0|||
155711346|NCT01870726|562035297|FG003|Overall Study|Withdrawal of informed consent|1|||
155711347|NCT01870726|562035298|FG004|Overall Study|Withdrawal of informed consent|0|||
155711348|NCT01870726|562035299|FG005|Overall Study|Withdrawal of informed consent|0|||
155711349|NCT01870726|562035300|FG006|Overall Study|Withdrawal of informed consent|0|||
155711350|NCT01870726|562035294|FG000|Overall Study|Withdrawal by Subject|0|||
155711351|NCT01870726|562035295|FG001|Overall Study|Withdrawal by Subject|1|||
155711352|NCT01870726|562035296|FG002|Overall Study|Withdrawal by Subject|0|||
155711353|NCT01870726|562035297|FG003|Overall Study|Withdrawal by Subject|0|||
155711354|NCT01870726|562035298|FG004|Overall Study|Withdrawal by Subject|0|||
155711355|NCT01870726|562035299|FG005|Overall Study|Withdrawal by Subject|0|||
155711356|NCT01870726|562035300|FG006|Overall Study|Withdrawal by Subject|0|||
155711357|NCT01870726|562035294|FG000|Overall Study|Adverse Event|0|||
155711358|NCT01870726|562035295|FG001|Overall Study|Adverse Event|0|||
155711359|NCT01870726|562035296|FG002|Overall Study|Adverse Event|0|||
155711360|NCT01870726|562035297|FG003|Overall Study|Adverse Event|0|||
155711361|NCT01870726|562035298|FG004|Overall Study|Adverse Event|1|||
155711362|NCT01870726|562035299|FG005|Overall Study|Adverse Event|1|||
155711363|NCT01870726|562035300|FG006|Overall Study|Adverse Event|0|||
155711364|NCT01870726|562035294|FG000|Overall Study|Progressive disease|5|||
155711365|NCT01870726|562035295|FG001|Overall Study|Progressive disease|5|||
155711366|NCT01870726|562035296|FG002|Overall Study|Progressive disease|4|||
155711367|NCT01870726|562035297|FG003|Overall Study|Progressive disease|5|||
155711368|NCT01870726|562035298|FG004|Overall Study|Progressive disease|6|||
155711369|NCT01870726|562035299|FG005|Overall Study|Progressive disease|4|||
155711370|NCT01870726|562035300|FG006|Overall Study|Progressive disease|10|||
155711371|NCT02978833|562035303|FG000|Overall Study|Study terminated|1|||
155711372|NCT02978833|562035304|FG001|Overall Study|Study terminated|1|||
155711373|NCT01123395|562035305|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
155711374|NCT01123395|562035306|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
155711375|NCT03691571|562035307|FG000|Overall Study|Withdrawal by Subject|9|||
155711376|NCT03691571|562035308|FG001|Overall Study|Withdrawal by Subject|2|||
155711377|NCT04186871|562035309|FG000|Overall Study|Lack of Efficacy|0|||
155711378|NCT04186871|562035310|FG001|Overall Study|Lack of Efficacy|1|||
155711379|NCT04186871|562035311|FG002|Overall Study|Lack of Efficacy|0|||
155711380|NCT04186871|562035312|FG003|Overall Study|Lack of Efficacy|0|||
155711381|NCT04186871|562035313|FG004|Overall Study|Lack of Efficacy|1|||
155711382|NCT04186871|562035314|FG005|Overall Study|Lack of Efficacy|1|||
155711383|NCT04186871|562035309|FG000|Overall Study|Adverse Event|1|||
155711384|NCT04186871|562035310|FG001|Overall Study|Adverse Event|1|||
155711385|NCT04186871|562035311|FG002|Overall Study|Adverse Event|0|||
155711386|NCT04186871|562035312|FG003|Overall Study|Adverse Event|0|||
155711387|NCT04186871|562035313|FG004|Overall Study|Adverse Event|0|||
155711388|NCT04186871|562035314|FG005|Overall Study|Adverse Event|2|||
155711389|NCT04186871|562035309|FG000|Overall Study|Study terminated by sponsor|1|||
155711390|NCT04186871|562035310|FG001|Overall Study|Study terminated by sponsor|2|||
155711391|NCT04186871|562035311|FG002|Overall Study|Study terminated by sponsor|0|||
155711392|NCT04186871|562035312|FG003|Overall Study|Study terminated by sponsor|1|||
155711393|NCT04186871|562035313|FG004|Overall Study|Study terminated by sponsor|0|||
155711394|NCT04186871|562035314|FG005|Overall Study|Study terminated by sponsor|0|||
155711395|NCT04186871|562035309|FG000|Overall Study|Other reasons|0|||
155711396|NCT04186871|562035310|FG001|Overall Study|Other reasons|0|||
155711397|NCT04186871|562035311|FG002|Overall Study|Other reasons|0|||
155711398|NCT04186871|562035312|FG003|Overall Study|Other reasons|0|||
155711399|NCT04186871|562035313|FG004|Overall Study|Other reasons|0|||
155711400|NCT04186871|562035314|FG005|Overall Study|Other reasons|1|||
155711401|NCT04186871|562035309|FG000|Overall Study|Withdrawal by Subject|0|||
155711402|NCT04186871|562035310|FG001|Overall Study|Withdrawal by Subject|0|||
155711403|NCT04186871|562035311|FG002|Overall Study|Withdrawal by Subject|0|||
155711404|NCT04186871|562035312|FG003|Overall Study|Withdrawal by Subject|0|||
155711405|NCT04186871|562035313|FG004|Overall Study|Withdrawal by Subject|0|||
155711406|NCT04186871|562035314|FG005|Overall Study|Withdrawal by Subject|1|||
155711407|NCT04186871|562035309|FG000|Overall Study|Lost to Follow-up|0|||
155711408|NCT04186871|562035310|FG001|Overall Study|Lost to Follow-up|0|||
155711409|NCT04186871|562035311|FG002|Overall Study|Lost to Follow-up|0|||
155711410|NCT04186871|562035312|FG003|Overall Study|Lost to Follow-up|0|||
155711411|NCT04186871|562035313|FG004|Overall Study|Lost to Follow-up|0|||
155711412|NCT04186871|562035314|FG005|Overall Study|Lost to Follow-up|1|||
155711413|NCT00250276|562035316|FG000|Overall Study|Serious Adverse Event|0|||
155711414|NCT00250276|562035317|FG001|Overall Study|Serious Adverse Event|0|||
155711415|NCT00250276|562035318|FG002|Overall Study|Serious Adverse Event|1|||
155711416|NCT00250276|562035319|FG003|Overall Study|Serious Adverse Event|0|||
155711417|NCT00250276|562035316|FG000|Overall Study|Non-serious Adverse Event|2|||
155711418|NCT00250276|562035317|FG001|Overall Study|Non-serious Adverse Event|0|||
155711419|NCT00250276|562035318|FG002|Overall Study|Non-serious Adverse Event|0|||
155711420|NCT00250276|562035319|FG003|Overall Study|Non-serious Adverse Event|2|||
155711421|NCT00250276|562035316|FG000|Overall Study|Protocol Violation|0|||
155711422|NCT00250276|562035317|FG001|Overall Study|Protocol Violation|1|||
155711423|NCT00250276|562035318|FG002|Overall Study|Protocol Violation|0|||
155711424|NCT00250276|562035319|FG003|Overall Study|Protocol Violation|0|||
155711425|NCT00250276|562035316|FG000|Overall Study|Withdrawal by Subject|1|||
155711426|NCT00250276|562035317|FG001|Overall Study|Withdrawal by Subject|2|||
155711427|NCT00250276|562035318|FG002|Overall Study|Withdrawal by Subject|3|||
155711428|NCT00250276|562035319|FG003|Overall Study|Withdrawal by Subject|2|||
155711429|NCT00250276|562035316|FG000|Overall Study|Migrated/moved from study area|3|||
155711430|NCT00250276|562035317|FG001|Overall Study|Migrated/moved from study area|0|||
155711431|NCT00250276|562035318|FG002|Overall Study|Migrated/moved from study area|2|||
155711432|NCT00250276|562035319|FG003|Overall Study|Migrated/moved from study area|7|||
155711433|NCT00250276|562035316|FG000|Overall Study|Lost to Follow-up|11|||
155711434|NCT00250276|562035317|FG001|Overall Study|Lost to Follow-up|18|||
155711435|NCT00250276|562035318|FG002|Overall Study|Lost to Follow-up|13|||
155711436|NCT00250276|562035319|FG003|Overall Study|Lost to Follow-up|8|||
155711437|NCT00555217|562035320|FG000|Overall Study|Withdrawal by Subject|35|||
155711438|NCT00555217|562035321|FG001|Overall Study|Withdrawal by Subject|31|||
155711439|NCT00555217|562035320|FG000|Overall Study|Lost to Follow-up|19|||
155711440|NCT00555217|562035321|FG001|Overall Study|Lost to Follow-up|20|||
155711441|NCT00555217|562035320|FG000|Overall Study|close out sites|21|||
155711442|NCT00555217|562035321|FG001|Overall Study|close out sites|17|||
155711443|NCT00950248|562035325|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
155711444|NCT00950248|562035326|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
155711445|NCT00950248|562035327|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
155711446|NCT00950248|562035325|FG000|Year 1: Baseline|worsening of symptoms|2|||
155711447|NCT00950248|562035326|FG001|Year 1: Baseline|worsening of symptoms|0|||
155711448|NCT00950248|562035327|FG002|Year 1: Baseline|worsening of symptoms|0|||
155711449|NCT00950248|562035325|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
155711450|NCT00950248|562035326|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
155711451|NCT00950248|562035327|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
155711452|NCT00950248|562035325|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
155711453|NCT00950248|562035326|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
155711454|NCT00950248|562035327|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
155711455|NCT00950248|562035325|FG000|Year 2&3 Treatment Randomization|Death|0|||
155711456|NCT00950248|562035326|FG001|Year 2&3 Treatment Randomization|Death|0|||
155711457|NCT00950248|562035327|FG002|Year 2&3 Treatment Randomization|Death|1|||
155711458|NCT00950248|562035325|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
155711459|NCT00950248|562035326|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
155711460|NCT00950248|562035327|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
155711461|NCT01657292|562035331|FG000|Overall Study|Adverse Event|6|||
155711462|NCT01657292|562035331|FG000|Overall Study|Withdrawal by Subject|2|||
155711463|NCT01657292|562035331|FG000|Overall Study|Violation of eligibility criteria|1|||
155711464|NCT01657292|562035331|FG000|Overall Study|Change of therapy|1|||
155711465|NCT00650845|562035333|FG000|Overall Study|Withdrawal by Subject|5|||
155711466|NCT00650845|562035334|FG001|Overall Study|Withdrawal by Subject|0|||
155711467|NCT00650845|562035333|FG000|Overall Study|Protocol Violation|0|||
155711468|NCT00650845|562035334|FG001|Overall Study|Protocol Violation|13|||
155711469|NCT01900652|562035335|FG000|Overall Study|Progressive Disease|1|||
155711470|NCT01900652|562035336|FG001|Overall Study|Progressive Disease|0|||
155711471|NCT01900652|562035335|FG000|Overall Study|Consent withdrawn by subject|1|||
155711472|NCT01900652|562035336|FG001|Overall Study|Consent withdrawn by subject|1|||
155711473|NCT01900652|562035335|FG000|Overall Study|Death|3|||
155711474|NCT01900652|562035336|FG001|Overall Study|Death|0|||
155711475|NCT01900652|562035335|FG000|Overall Study|Adverse Event|2|||
155711476|NCT01900652|562035336|FG001|Overall Study|Adverse Event|1|||
155711477|NCT01900652|562035335|FG000|Overall Study|Physician Decision|1|||
155711478|NCT01900652|562035336|FG001|Overall Study|Physician Decision|1|||
155711479|NCT03761810|562035337|FG000|Overall Study|Adverse Event|12|||
155711480|NCT03761810|562035338|FG001|Overall Study|Adverse Event|0|||
155711481|NCT03761810|562035337|FG000|Overall Study|Lost to Follow-up|15|||
155711482|NCT03761810|562035338|FG001|Overall Study|Lost to Follow-up|7|||
155711483|NCT03761810|562035337|FG000|Overall Study|Pregnancy|1|||
155711484|NCT03761810|562035338|FG001|Overall Study|Pregnancy|0|||
155711485|NCT03761810|562035337|FG000|Overall Study|Withdrawal by Subject|14|||
155711486|NCT03761810|562035338|FG001|Overall Study|Withdrawal by Subject|5|||
155711487|NCT03761810|562035337|FG000|Overall Study|Physician Decision|1|||
155711488|NCT03761810|562035338|FG001|Overall Study|Physician Decision|0|||
155711489|NCT03761810|562035337|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
155711490|NCT03761810|562035338|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155711491|NCT03761810|562035337|FG000|Overall Study|Other Than Specified|1|||
155711492|NCT03761810|562035338|FG001|Overall Study|Other Than Specified|0|||
155711493|NCT00869518|562035339|FG000|Overall Study|Lost to Follow-up|1|||
155711494|NCT00869518|562035340|FG001|Overall Study|Lost to Follow-up|1|||
155711495|NCT04178720|562035341|FG000|Overall Study|Withdrawal by Subject|2|||
155711496|NCT04178720|562035342|FG001|Overall Study|Withdrawal by Subject|0|||
155711497|NCT04178720|562035341|FG000|Overall Study|Relocation|0|||
155711498|NCT04178720|562035342|FG001|Overall Study|Relocation|1|||
155711499|NCT03922620|562035343|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
155711500|NCT03922620|562035344|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
155711501|NCT03566082|562035345|FG000|Overall Study|Death|7|||
155711502|NCT03566082|562035345|FG000|Overall Study|Failures (revision required)|2|||
155711503|NCT03566082|562035345|FG000|Overall Study|Lost to Follow-up|8|||
155711504|NCT02663622|562035346|FG000|Overall Study|Death|3|||
155711505|NCT02663622|562035347|FG001|Overall Study|Death|1|||
155711506|NCT02663622|562035348|FG002|Overall Study|Death|1|||
155711507|NCT02663622|562035349|FG003|Overall Study|Death|8|||
155711508|NCT02663622|562035346|FG000|Overall Study|Protocol Violation|0|||
155711509|NCT02663622|562035347|FG001|Overall Study|Protocol Violation|0|||
155711510|NCT02663622|562035348|FG002|Overall Study|Protocol Violation|0|||
155711511|NCT02663622|562035349|FG003|Overall Study|Protocol Violation|1|||
155711512|NCT04618744|562035352|FG000|Overall Study|Adverse Event|0|||
155711513|NCT04618744|562035353|FG001|Overall Study|Adverse Event|1|||
155711514|NCT04618744|562035352|FG000|Overall Study|Withdrawal by Subject|0|||
155711515|NCT04618744|562035353|FG001|Overall Study|Withdrawal by Subject|1|||
155711516|NCT00511238|562035354|FG000|Overall Study|Adverse Event|13|||
155711517|NCT00511238|562035355|FG001|Overall Study|Adverse Event|33|||
155711518|NCT00511238|562035354|FG000|Overall Study|Withdrawal by Subject|2|||
155711519|NCT00511238|562035355|FG001|Overall Study|Withdrawal by Subject|22|||
155711520|NCT00511238|562035354|FG000|Overall Study|Progressive Disease|23|||
155711521|NCT00511238|562035355|FG001|Overall Study|Progressive Disease|157|||
155711522|NCT00511238|562035354|FG000|Overall Study|various reasons|4|||
155711523|NCT00511238|562035355|FG001|Overall Study|various reasons|14|||
155711524|NCT00163020|562035356|FG000|Overall Study|Lost to Follow-up|0|||
155711525|NCT00163020|562035357|FG001|Overall Study|Lost to Follow-up|2|||
155711526|NCT01929226|562036843|FG000|Overall Study|Lost to Follow-up|4|||
155711527|NCT01929226|562036844|FG001|Overall Study|Lost to Follow-up|0|||
155711528|NCT01929226|562036843|FG000|Overall Study|Withdrawal by Subject|1|||
155711529|NCT01929226|562036844|FG001|Overall Study|Withdrawal by Subject|1|||
155711530|NCT00330759|562036850|FG000|Overall Study|Death|316|||
155711531|NCT00330759|562036851|FG001|Overall Study|Death|310|||
155711532|NCT00330759|562036850|FG000|Overall Study|Disease progression|104|||
155711533|NCT00330759|562036851|FG001|Overall Study|Disease progression|126|||
155711534|NCT00330759|562036850|FG000|Overall Study|Withdrawal by Subject|143|||
155711535|NCT00330759|562036851|FG001|Overall Study|Withdrawal by Subject|124|||
155711536|NCT00330759|562036850|FG000|Overall Study|Adverse Event|48|||
155711537|NCT00330759|562036851|FG001|Overall Study|Adverse Event|36|||
155711538|NCT00330759|562036850|FG000|Overall Study|Participant request|31|||
155711539|NCT00330759|562036851|FG001|Overall Study|Participant request|22|||
155711540|NCT00330759|562036850|FG000|Overall Study|Lost to Follow-up|16|||
155711541|NCT00330759|562036851|FG001|Overall Study|Lost to Follow-up|22|||
155711542|NCT00330759|562036850|FG000|Overall Study|Noncompliance|15|||
155711543|NCT00330759|562036851|FG001|Overall Study|Noncompliance|17|||
155711544|NCT00330759|562036850|FG000|Overall Study|Physician Decision|1|||
155711545|NCT00330759|562036851|FG001|Overall Study|Physician Decision|2|||
155711546|NCT00330759|562036850|FG000|Overall Study|Protocol deviation|0|||
155711547|NCT00330759|562036851|FG001|Overall Study|Protocol deviation|2|||
155711548|NCT00330759|562036850|FG000|Overall Study|Ineligibility determined|2|||
155711549|NCT00330759|562036851|FG001|Overall Study|Ineligibility determined|1|||
155711550|NCT00330759|562036850|FG000|Overall Study|Other|36|||
155711551|NCT00330759|562036851|FG001|Overall Study|Other|44|||
155711552|NCT00592904|562036876|FG000|Overall Study|Adverse Event|15|||
155711553|NCT00592904|562036877|FG001|Overall Study|Adverse Event|25|||
155711554|NCT00592904|562036878|FG002|Overall Study|Adverse Event|13|||
155711555|NCT00592904|562036879|FG003|Overall Study|Adverse Event|5|||
155711556|NCT00592904|562036876|FG000|Overall Study|Protocol Violation|1|||
155711557|NCT00592904|562036877|FG001|Overall Study|Protocol Violation|1|||
155711558|NCT00592904|562036878|FG002|Overall Study|Protocol Violation|0|||
155711559|NCT00592904|562036879|FG003|Overall Study|Protocol Violation|1|||
155711560|NCT00592904|562036876|FG000|Overall Study|Withdrawal by Subject|4|||
155711561|NCT00592904|562036877|FG001|Overall Study|Withdrawal by Subject|16|||
155711562|NCT00592904|562036878|FG002|Overall Study|Withdrawal by Subject|1|||
155711563|NCT00592904|562036879|FG003|Overall Study|Withdrawal by Subject|2|||
155711564|NCT00592904|562036876|FG000|Overall Study|Lack of Efficacy|2|||
155711565|NCT00592904|562036877|FG001|Overall Study|Lack of Efficacy|7|||
155711566|NCT00592904|562036878|FG002|Overall Study|Lack of Efficacy|2|||
155711567|NCT00592904|562036879|FG003|Overall Study|Lack of Efficacy|3|||
155711568|NCT00592904|562036876|FG000|Overall Study|Physician Decision|0|||
155711569|NCT00592904|562036877|FG001|Overall Study|Physician Decision|3|||
155711570|NCT00592904|562036878|FG002|Overall Study|Physician Decision|1|||
155711571|NCT00592904|562036879|FG003|Overall Study|Physician Decision|0|||
155711572|NCT00592904|562036876|FG000|Overall Study|Other|3|||
155711573|NCT00592904|562036877|FG001|Overall Study|Other|3|||
155711574|NCT00592904|562036878|FG002|Overall Study|Other|0|||
155711575|NCT00592904|562036879|FG003|Overall Study|Other|0|||
155711576|NCT03456076|562036880|FG000|Overall Study|Withdrawal by Subject|5|||
155711577|NCT03456076|562036881|FG001|Overall Study|Withdrawal by Subject|9|||
155711578|NCT03456076|562036880|FG000|Overall Study|Protocol deviation|0|||
155711579|NCT03456076|562036881|FG001|Overall Study|Protocol deviation|1|||
155711580|NCT03456076|562036880|FG000|Overall Study|Lost to Follow-up|0|||
155711581|NCT03456076|562036881|FG001|Overall Study|Lost to Follow-up|1|||
155711582|NCT03456076|562036880|FG000|Overall Study|Death|2|||
155711583|NCT03456076|562036881|FG001|Overall Study|Death|5|||
155711584|NCT03456076|562036880|FG000|Overall Study|Study ongoing|123|||
155711585|NCT03456076|562036881|FG001|Overall Study|Study ongoing|111|||
155711586|NCT03906071|562036882|FG000|Overall Study|Death|180|||
155711587|NCT03906071|562036883|FG001|Overall Study|Death|185|||
155711588|NCT03906071|562036882|FG000|Overall Study|Lost to Follow-up|3|||
155711589|NCT03906071|562036883|FG001|Overall Study|Lost to Follow-up|3|||
155711590|NCT03906071|562036882|FG000|Overall Study|Withdrawal by Subject|15|||
155711591|NCT03906071|562036883|FG001|Overall Study|Withdrawal by Subject|27|||
155711592|NCT03906071|562036882|FG000|Overall Study|Other|2|||
155711593|NCT03906071|562036883|FG001|Overall Study|Other|1|||
155711594|NCT01359904|562036884|FG000|Overall Study|Withdrawal by Subject|1|||
155711595|NCT01359904|562036885|FG001|Overall Study|Withdrawal by Subject|0|||
155711596|NCT03594773|562036886|FG000|Overall Study|Withdrawal by Subject|3|||
155711597|NCT03594773|562036887|FG001|Overall Study|Withdrawal by Subject|2|||
155711598|NCT03594773|562036886|FG000|Overall Study|Lost to Follow-up|3|||
155711599|NCT03594773|562036887|FG001|Overall Study|Lost to Follow-up|4|||
155711600|NCT03191630|562036888|FG000|Overall Study|Lost to Follow-up|7|||
155711601|NCT03191630|562036889|FG001|Overall Study|Lost to Follow-up|7|||
155711602|NCT02640547|562036892|FG000|Overall Study|Failure to Return|1|||
155711603|NCT02640547|562036892|FG000|Overall Study|Withdrawal by Subject|1|||
155711604|NCT02640547|562036892|FG000|Overall Study|Death|6|||
155711605|NCT02640547|562036892|FG000|Overall Study|Miscellaneous|3|||
155711606|NCT00193206|562036894|FG000|Preoperative Therapy|Lack of Efficacy|2|||
155711607|NCT00193206|562036894|FG000|Preoperative Therapy|Adverse Event|2|||
155711608|NCT00193206|562036894|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
155711609|NCT00193206|562036894|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
155711610|NCT00193206|562036894|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
155711611|NCT00193206|562036894|FG000|Postoperative Therapy|Physician Decision|3|||
155711612|NCT00193206|562036894|FG000|Postoperative Therapy|Intercurrent Illness|2|||
155711613|NCT00193206|562036894|FG000|Postoperative Therapy|Lack of Efficacy|1|||
155711614|NCT00193206|562036894|FG000|Postoperative Therapy|Protocol Violation|1|||
155711615|NCT03018691|562036895|FG000|Overall Study|Adverse Event|1|||
155711616|NCT03018691|562036896|FG001|Overall Study|Adverse Event|1|||
155711617|NCT03018691|562036897|FG002|Overall Study|Adverse Event|4|||
155711618|NCT03018691|562036895|FG000|Overall Study|Lack of Efficacy|0|||
155711619|NCT03018691|562036896|FG001|Overall Study|Lack of Efficacy|0|||
155711620|NCT03018691|562036897|FG002|Overall Study|Lack of Efficacy|1|||
155711621|NCT03018691|562036895|FG000|Overall Study|Withdrawal by Subject|0|||
155711622|NCT03018691|562036896|FG001|Overall Study|Withdrawal by Subject|0|||
155711623|NCT03018691|562036897|FG002|Overall Study|Withdrawal by Subject|1|||
155711624|NCT03018691|562036895|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155711625|NCT03018691|562036896|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155711626|NCT03018691|562036897|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155711627|NCT03369418|562036900|FG000|Overall Study|Withdrawal by Subject|3|||
155711628|NCT03369418|562036901|FG001|Overall Study|Withdrawal by Subject|3|||
155711629|NCT01485094|562036902|FG000|Overall Study|Adverse Event|1|||
155711630|NCT01485094|562036903|FG001|Overall Study|Adverse Event|1|||
155711631|NCT01485094|562036904|FG002|Overall Study|Adverse Event|1|||
155711632|NCT01485094|562036902|FG000|Overall Study|Lost to Follow-up|1|||
155711633|NCT01485094|562036903|FG001|Overall Study|Lost to Follow-up|0|||
155711634|NCT01485094|562036904|FG002|Overall Study|Lost to Follow-up|0|||
155711635|NCT01485094|562036902|FG000|Overall Study|Withdrawal by Subject|1|||
155711636|NCT01485094|562036903|FG001|Overall Study|Withdrawal by Subject|1|||
155711637|NCT01485094|562036904|FG002|Overall Study|Withdrawal by Subject|0|||
155711638|NCT01450761|562036910|FG000|Randomization|Subject no longer meets study criteria|1|||
155711639|NCT01450761|562036911|FG001|Randomization|Subject no longer meets study criteria|2|||
155711640|NCT01450761|562036910|FG000|Randomization|Withdrawal by Subject|2|||
155711641|NCT01450761|562036911|FG001|Randomization|Withdrawal by Subject|0|||
155711642|NCT01450761|562036910|FG000|Randomization|Disease progression|0|||
155711643|NCT01450761|562036911|FG001|Randomization|Disease progression|2|||
155711644|NCT01450761|562036910|FG000|Randomization|Adverse Event unrelated to study drug|1|||
155711645|NCT01450761|562036911|FG001|Randomization|Adverse Event unrelated to study drug|0|||
155711646|NCT01450761|562036910|FG000|Randomization|Other|0|||
155711647|NCT01450761|562036911|FG001|Randomization|Other|1|||
155711648|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Disease progression|33|||
155711649|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Disease progression|32|||
155711650|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
155711651|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
155711652|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
155711653|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
155711654|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
155711655|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
155711656|NCT01450761|562036910|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
155711657|NCT01450761|562036911|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
155711658|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Death|3|||
155711659|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Death|3|||
155711660|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Other|2|||
155711661|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Other|2|||
155711662|NCT01450761|562036910|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
155711663|NCT01450761|562036911|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
155711664|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
155711665|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
155711666|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
155711667|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
155711668|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
155711669|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
155711670|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
155711671|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
155711672|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
155711673|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
155711674|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Death|5|||
155711675|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Death|6|||
155711676|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
155711677|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
155711678|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
155711679|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
155711680|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
155711681|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
155711682|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
155711683|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
155711684|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
155711685|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
155711686|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
155711687|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
155711688|NCT01450761|562036910|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
155711689|NCT01450761|562036911|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
155711690|NCT03801174|562036916|FG000|Overall Study|Withdrawal by Subject|14|||
155711691|NCT03801174|562036917|FG001|Overall Study|Withdrawal by Subject|15|||
155711692|NCT03801174|562036916|FG000|Overall Study|Death|1|||
155711693|NCT03801174|562036917|FG001|Overall Study|Death|0|||
155711694|NCT03801174|562036916|FG000|Overall Study|Pregnancy|2|||
155711695|NCT03801174|562036917|FG001|Overall Study|Pregnancy|2|||
155711696|NCT03801174|562036916|FG000|Overall Study|Lost to Follow-up|19|||
155711697|NCT03801174|562036917|FG001|Overall Study|Lost to Follow-up|10|||
155711698|NCT03801174|562036916|FG000|Overall Study|Other|4|||
155711699|NCT03801174|562036917|FG001|Overall Study|Other|3|||
155711700|NCT03801174|562036916|FG000|Overall Study|Lack of Efficacy|4|||
155711701|NCT03801174|562036917|FG001|Overall Study|Lack of Efficacy|0|||
155711702|NCT03801174|562036916|FG000|Overall Study|Unwilling to complete activities|5|||
155711703|NCT03801174|562036917|FG001|Overall Study|Unwilling to complete activities|6|||
155711704|NCT03801174|562036916|FG000|Overall Study|Moved out of area|3|||
155711705|NCT03801174|562036917|FG001|Overall Study|Moved out of area|0|||
155711706|NCT04435366|562036921|FG000|Year 1 (12 Months)|Adverse Event|3|||
155711707|NCT04435366|562036922|FG001|Year 1 (12 Months)|Adverse Event|0|||
155711708|NCT04435366|562036923|FG002|Year 1 (12 Months)|Adverse Event|2|||
155711709|NCT04435366|562036921|FG000|Year 1 (12 Months)|Death|2|||
155711710|NCT04435366|562036922|FG001|Year 1 (12 Months)|Death|0|||
155711711|NCT04435366|562036923|FG002|Year 1 (12 Months)|Death|1|||
155711712|NCT04435366|562036921|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
155711713|NCT04435366|562036922|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
155711714|NCT04435366|562036923|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
155711715|NCT04435366|562036921|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
155711716|NCT04435366|562036922|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
155711717|NCT04435366|562036923|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
155711718|NCT04435366|562036921|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
155711719|NCT04435366|562036922|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
155711720|NCT04435366|562036923|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
155711721|NCT04435366|562036921|FG000|Year 1 (12 Months)|Not treated|0|||
155711722|NCT04435366|562036922|FG001|Year 1 (12 Months)|Not treated|0|||
155711723|NCT04435366|562036923|FG002|Year 1 (12 Months)|Not treated|1|||
155711724|NCT04435366|562036921|FG000|Year 2 (12 Months)|Death|1|||
155711725|NCT04435366|562036922|FG001|Year 2 (12 Months)|Death|4|||
155711726|NCT04435366|562036923|FG002|Year 2 (12 Months)|Death|6|||
155711727|NCT04435366|562036921|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
155711728|NCT04435366|562036922|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
155711729|NCT04435366|562036923|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
155711730|NCT04435366|562036921|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
155711731|NCT04435366|562036922|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
155711732|NCT04435366|562036923|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
155711733|NCT04435366|562036921|FG000|Year 2 (12 Months)|Adverse Event|2|||
155711734|NCT04435366|562036922|FG001|Year 2 (12 Months)|Adverse Event|1|||
155711735|NCT04435366|562036923|FG002|Year 2 (12 Months)|Adverse Event|6|||
155711736|NCT04112810|562036924|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
155711737|NCT01687296|562036925|FG000|Overall Study|Lack of Efficacy|1|||
155711738|NCT01687296|562036926|FG001|Overall Study|Lack of Efficacy|1|||
155711739|NCT01687296|562036925|FG000|Overall Study|Protocol Violation|0|||
155711740|NCT01687296|562036926|FG001|Overall Study|Protocol Violation|1|||
155711741|NCT01687296|562036925|FG000|Overall Study|Withdrawal by Subject|6|||
155711742|NCT01687296|562036926|FG001|Overall Study|Withdrawal by Subject|3|||
155711743|NCT01618669|562036927|FG000|Overall Study|Lost to Follow-up|1|||
155711744|NCT01618669|562036928|FG001|Overall Study|Lost to Follow-up|1|||
155711745|NCT01618669|562036927|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
155711746|NCT01618669|562036928|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
155711747|NCT01618669|562036927|FG000|Overall Study|Adverse Event|16|||
155711748|NCT01618669|562036928|FG001|Overall Study|Adverse Event|7|||
155711749|NCT01618669|562036927|FG000|Overall Study|Protocol Violation|5|||
155711750|NCT01618669|562036928|FG001|Overall Study|Protocol Violation|3|||
155711751|NCT01618669|562036927|FG000|Overall Study|Withdrawal by Subject|9|||
155711752|NCT01618669|562036928|FG001|Overall Study|Withdrawal by Subject|9|||
155711753|NCT01618669|562036927|FG000|Overall Study|Miscellaneous Reason|0|||
155711754|NCT01618669|562036928|FG001|Overall Study|Miscellaneous Reason|1|||
155711755|NCT03259087|562036931|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155711756|NCT03259087|562036932|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155711757|NCT03259087|562036933|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155711758|NCT03259087|562036934|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155711759|NCT03259087|562036935|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
155711760|NCT03259087|562036931|FG000|Period 2 of Part 2|Adverse Event|0|||
155711761|NCT03259087|562036932|FG001|Period 2 of Part 2|Adverse Event|0|||
155711762|NCT03259087|562036933|FG002|Period 2 of Part 2|Adverse Event|0|||
155711763|NCT03259087|562036934|FG003|Period 2 of Part 2|Adverse Event|0|||
155711764|NCT03259087|562036935|FG004|Period 2 of Part 2|Adverse Event|1|||
155711765|NCT02396212|562036936|FG000|Overall Study|Adverse Event|1|||
155711766|NCT02396212|562036936|FG000|Overall Study|Lack of Efficacy|2|||
155711767|NCT04950465|562036937|FG000|Overall Study|Lost to Follow-up|1|||
155711768|NCT04950465|562036938|FG001|Overall Study|Lost to Follow-up|0|||
155711769|NCT04950465|562036939|FG002|Overall Study|Lost to Follow-up|0|||
155711770|NCT00580723|562036951|FG000|Overall Study|Did not want to participate in extension|3|||
155711771|NCT00580723|562036951|FG000|Overall Study|Lost to Follow-up|5|||
155711772|NCT00684996|562036952|FG000|Overall Study|Adverse Event|1|||
155711773|NCT00684996|562036952|FG000|Overall Study|Refusal unrelated to adverse event|1|||
155711774|NCT00684996|562036952|FG000|Overall Study|Progression/relapse|2|||
155711775|NCT00684996|562036952|FG000|Overall Study|Other reasons not protocol specified|1|||
155711776|NCT00550953|562036954|FG000|Overall Study|Adverse Event|4|||
155711777|NCT00550953|562036955|FG001|Overall Study|Adverse Event|3|||
155711778|NCT00550953|562036954|FG000|Overall Study|Not able to visit the site|2|||
155711779|NCT00550953|562036955|FG001|Overall Study|Not able to visit the site|3|||
155711780|NCT03797586|562036956|FG000|Overall Study|Lost to Follow-up|3|||
155711781|NCT03797586|562036957|FG001|Overall Study|Lost to Follow-up|6|||
155711782|NCT03797586|562036956|FG000|Overall Study|Death|1|||
155711783|NCT03797586|562036957|FG001|Overall Study|Death|1|||
155711784|NCT03797586|562036956|FG000|Overall Study|Adverse Event|0|||
155711785|NCT03797586|562036957|FG001|Overall Study|Adverse Event|2|||
155711786|NCT01219985|562036958|FG000|Overall Study|Physician Decision|20|||
155711787|NCT02680665|562036959|FG000|Overall Study|No visit after the first prescription|5|||
155711788|NCT02292719|562036960|FG000|Overall Study|Withdrawal by Subject|0|||
155711789|NCT02292719|562036961|FG001|Overall Study|Withdrawal by Subject|0|||
155711790|NCT02292719|562036962|FG002|Overall Study|Withdrawal by Subject|0|||
155711791|NCT02292719|562036963|FG003|Overall Study|Withdrawal by Subject|1|||
155711792|NCT02292719|562036964|FG004|Overall Study|Withdrawal by Subject|1|||
155711793|NCT02292719|562036965|FG005|Overall Study|Withdrawal by Subject|0|||
155711794|NCT02292719|562036960|FG000|Overall Study|Subject enrolled in new study.|0|||
155711795|NCT02292719|562036961|FG001|Overall Study|Subject enrolled in new study.|0|||
155711796|NCT02292719|562036962|FG002|Overall Study|Subject enrolled in new study.|1|||
155711797|NCT02292719|562036963|FG003|Overall Study|Subject enrolled in new study.|0|||
155711798|NCT02292719|562036964|FG004|Overall Study|Subject enrolled in new study.|0|||
155711799|NCT02292719|562036965|FG005|Overall Study|Subject enrolled in new study.|0|||
155711800|NCT02940496|562036966|FG000|Overall Study|Adverse Event|1|||
155711801|NCT02940496|562036967|FG001|Overall Study|Adverse Event|0|||
155711802|NCT02940496|562036966|FG000|Overall Study|Death|2|||
155711803|NCT02940496|562036967|FG001|Overall Study|Death|0|||
155711804|NCT02940496|562036966|FG000|Overall Study|Hospice Care|1|||
155711805|NCT02940496|562036967|FG001|Overall Study|Hospice Care|0|||
155711806|NCT02940496|562036966|FG000|Overall Study|No MRE Done|1|||
155711807|NCT02940496|562036967|FG001|Overall Study|No MRE Done|0|||
155711808|NCT02940496|562036966|FG000|Overall Study|MRE Failure|1|||
155711809|NCT02940496|562036967|FG001|Overall Study|MRE Failure|0|||
155711810|NCT04089761|562036974|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
155711811|NCT04089761|562036974|FG000|"Run In Phase"|Lost to Follow-up|1|||
155711812|NCT04089761|562036974|FG000|"Treatment Phase"|No evaluable data|5|||
155711813|NCT04089761|562036974|FG000|"Treatment Phase"|Lost to Follow-up|1|||
155711814|NCT00770601|562036975|FG000|Overall Study|Withdrawal by Subject|1|||
155711815|NCT04739436|562036976|FG000|Overall Study|Lost to Follow-up|21|||
155711816|NCT04739436|562036977|FG001|Overall Study|Lost to Follow-up|23|||
155711817|NCT04739436|562036976|FG000|Overall Study|Withdrawal by Subject|4|||
155711818|NCT04739436|562036977|FG001|Overall Study|Withdrawal by Subject|6|||
155711819|NCT04739436|562036976|FG000|Overall Study|not randomized properly|1|||
155711820|NCT04739436|562036977|FG001|Overall Study|not randomized properly|0|||
155711821|NCT00428948|562036979|FG000|Overall Study|Lost to Follow-up|15|||
155711822|NCT00428948|562036980|FG001|Overall Study|Lost to Follow-up|8|||
155711823|NCT00428948|562036979|FG000|Overall Study|Adverse Event|148|||
155711824|NCT00428948|562036980|FG001|Overall Study|Adverse Event|24|||
155711825|NCT00428948|562036979|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
155711826|NCT00428948|562036980|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
155711827|NCT00428948|562036979|FG000|Overall Study|Investigator Withdrew Subject|3|||
155711828|NCT00428948|562036980|FG001|Overall Study|Investigator Withdrew Subject|4|||
155711829|NCT00428948|562036979|FG000|Overall Study|Subject Withdrew Consent|50|||
155711830|NCT00428948|562036980|FG001|Overall Study|Subject Withdrew Consent|30|||
155711831|NCT00428948|562036979|FG000|Overall Study|Protocol Deviation|1|||
155711832|NCT00428948|562036980|FG001|Overall Study|Protocol Deviation|1|||
155711833|NCT03622814|562036982|FG000|Overall Study|Lost to Follow-up|8|||
155711834|NCT03622814|562036983|FG001|Overall Study|Lost to Follow-up|14|||
155711835|NCT04417361|562036984|FG000|Overall Study|Withdrawal by Subject|1|||
155711836|NCT04417361|562036985|FG001|Overall Study|Withdrawal by Subject|0|||
155711837|NCT04417361|562036984|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
155711838|NCT04417361|562036985|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
155711839|NCT00892775|562036986|FG000|Overall Study|Protocol Violation|1|||
155711840|NCT00892775|562036987|FG001|Overall Study|Protocol Violation|0|||
155711841|NCT00892775|562036986|FG000|Overall Study|Subject difficulties with blood drawing|1|||
155711842|NCT00892775|562036987|FG001|Overall Study|Subject difficulties with blood drawing|0|||
155711843|NCT00892775|562036986|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
155711844|NCT00892775|562036987|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
155711845|NCT00892775|562036986|FG000|Overall Study|Migrated/ moved from study area|1|||
155711846|NCT00892775|562036987|FG001|Overall Study|Migrated/ moved from study area|0|||
155711847|NCT00892775|562036986|FG000|Overall Study|Withdrawal by Subject|0|||
155711848|NCT00892775|562036987|FG001|Overall Study|Withdrawal by Subject|1|||
155711849|NCT00892775|562036986|FG000|Overall Study|Lost to Follow-up|1|||
155711850|NCT00892775|562036987|FG001|Overall Study|Lost to Follow-up|0|||
155711851|NCT00699660|562036988|FG000|Overall Study|Lost to Follow-up|4|||
155711852|NCT00699660|562036989|FG001|Overall Study|Lost to Follow-up|2|||
155711853|NCT00699660|562036988|FG000|Overall Study|missing reports and recording failures|10|||
155711854|NCT00699660|562036989|FG001|Overall Study|missing reports and recording failures|6|||
155711855|NCT01633788|562040058|FG000|Overall Study|Adverse Event|1|||
155711856|NCT01633788|562040059|FG001|Overall Study|Adverse Event|3|||
155711857|NCT01633788|562040060|FG002|Overall Study|Adverse Event|3|||
155711858|NCT01633788|562040061|FG003|Overall Study|Adverse Event|3|||
155711859|NCT01633788|562040058|FG000|Overall Study|Lost to Follow-up|2|||
155711860|NCT01633788|562040059|FG001|Overall Study|Lost to Follow-up|2|||
155711861|NCT01633788|562040060|FG002|Overall Study|Lost to Follow-up|2|||
155711862|NCT01633788|562040061|FG003|Overall Study|Lost to Follow-up|0|||
155711863|NCT01633788|562040058|FG000|Overall Study|Personal Reasons|3|||
155711864|NCT01633788|562040059|FG001|Overall Study|Personal Reasons|1|||
155711865|NCT01633788|562040060|FG002|Overall Study|Personal Reasons|1|||
155711866|NCT01633788|562040061|FG003|Overall Study|Personal Reasons|3|||
155711867|NCT01633788|562040058|FG000|Overall Study|Protocol Violation|1|||
155711868|NCT01633788|562040059|FG001|Overall Study|Protocol Violation|0|||
155711869|NCT01633788|562040060|FG002|Overall Study|Protocol Violation|1|||
155711870|NCT01633788|562040061|FG003|Overall Study|Protocol Violation|0|||
155711871|NCT01633788|562040058|FG000|Overall Study|Other Reasons|0|||
155711872|NCT01633788|562040059|FG001|Overall Study|Other Reasons|2|||
155711873|NCT01633788|562040060|FG002|Overall Study|Other Reasons|3|||
155711874|NCT01633788|562040061|FG003|Overall Study|Other Reasons|7|||
155711875|NCT01389882|562040066|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
155711876|NCT01389882|562040067|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
155711877|NCT01389882|562040066|FG000|Overall Study|Withdrawal by Subject|0|||
155711878|NCT01389882|562040067|FG001|Overall Study|Withdrawal by Subject|1|||
155711879|NCT03790111|562040068|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
155711880|NCT03811340|562040071|FG000|Overall Study|subjects did not complete the survey.|90|||
155711881|NCT00280917|562040072|FG000|Overall Study|Adverse Event|1|||
155711882|NCT00280917|562040073|FG001|Overall Study|Adverse Event|1|||
155711883|NCT00280917|562040074|FG002|Overall Study|Adverse Event|4|||
155711884|NCT00280917|562040075|FG003|Overall Study|Adverse Event|1|||
155711885|NCT00280917|562040072|FG000|Overall Study|Change Therapy|1|||
155711886|NCT00280917|562040073|FG001|Overall Study|Change Therapy|2|||
155711887|NCT00280917|562040074|FG002|Overall Study|Change Therapy|0|||
155711888|NCT00280917|562040075|FG003|Overall Study|Change Therapy|0|||
155711889|NCT00280917|562040072|FG000|Overall Study|Withdrawal by Subject|0|||
155711890|NCT00280917|562040073|FG001|Overall Study|Withdrawal by Subject|2|||
155711891|NCT00280917|562040074|FG002|Overall Study|Withdrawal by Subject|0|||
155711892|NCT00280917|562040075|FG003|Overall Study|Withdrawal by Subject|1|||
155711893|NCT00280917|562040072|FG000|Overall Study|Noncompliance|0|||
155711894|NCT00280917|562040073|FG001|Overall Study|Noncompliance|1|||
155711895|NCT00280917|562040074|FG002|Overall Study|Noncompliance|2|||
155711896|NCT00280917|562040075|FG003|Overall Study|Noncompliance|0|||
155711897|NCT03529110|562040076|FG000|Overall Study|Progressive Disease|66|||
155711898|NCT03529110|562040077|FG001|Overall Study|Progressive Disease|158|||
155711899|NCT03529110|562040076|FG000|Overall Study|Clinical Progression|4|||
155711900|NCT03529110|562040077|FG001|Overall Study|Clinical Progression|12|||
155711901|NCT03529110|562040076|FG000|Overall Study|Adverse Event|35|||
155711902|NCT03529110|562040077|FG001|Overall Study|Adverse Event|17|||
155711903|NCT03529110|562040076|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
155711904|NCT03529110|562040077|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
155711905|NCT03529110|562040076|FG000|Overall Study|Lack of Efficacy|3|||
155711906|NCT03529110|562040077|FG001|Overall Study|Lack of Efficacy|3|||
155711907|NCT03529110|562040076|FG000|Overall Study|Physician Decision|2|||
155711908|NCT03529110|562040077|FG001|Overall Study|Physician Decision|8|||
155711909|NCT03529110|562040076|FG000|Overall Study|Miscellaneous|2|||
155711910|NCT03529110|562040077|FG001|Overall Study|Miscellaneous|5|||
155711911|NCT05104450|562040078|FG000|Overall Study|Death|1|||
155711912|NCT05104450|562040079|FG001|Overall Study|Death|2|||
155711913|NCT05104450|562040078|FG000|Overall Study|Withdrawal by Subject|3|||
155711914|NCT05104450|562040079|FG001|Overall Study|Withdrawal by Subject|1|||
155711915|NCT01172535|562040084|FG000|Overall Study|Death|3|||
155711916|NCT01172535|562040084|FG000|Overall Study|Withdrawal by Subject|2|||
155711917|NCT01172535|562040084|FG000|Overall Study|Lost to Follow-up|1|||
155711918|NCT01172535|562040084|FG000|Overall Study|Ineligible at study entry|1|||
155711919|NCT01172535|562040084|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
155711920|NCT00714415|562040092|FG000|Overall Study|Lack of Efficacy|1|||
155711921|NCT00714415|562040093|FG001|Overall Study|Lack of Efficacy|0|||
155711922|NCT00714415|562040092|FG000|Overall Study|Death|1|||
155711923|NCT00714415|562040093|FG001|Overall Study|Death|0|||
155711924|NCT01818596|562040096|FG000|Overall Study|Enrolled but Not Treated|4|||
155711925|NCT01818596|562040097|FG001|Overall Study|Enrolled but Not Treated|0|||
155711926|NCT01818596|562040096|FG000|Overall Study|Adverse Event|7|||
155711927|NCT01818596|562040097|FG001|Overall Study|Adverse Event|0|||
155711928|NCT01818596|562040096|FG000|Overall Study|Death|3|||
155711929|NCT01818596|562040097|FG001|Overall Study|Death|0|||
155711930|NCT01818596|562040096|FG000|Overall Study|Investigator's Discretion|4|||
155711931|NCT01818596|562040097|FG001|Overall Study|Investigator's Discretion|0|||
155711932|NCT01818596|562040096|FG000|Overall Study|Protocol Violation|1|||
155711933|NCT01818596|562040097|FG001|Overall Study|Protocol Violation|0|||
155711934|NCT01818596|562040096|FG000|Overall Study|Withdrew Consent|5|||
155711935|NCT01818596|562040097|FG001|Overall Study|Withdrew Consent|0|||
155711936|NCT01818596|562040096|FG000|Overall Study|Lost to Follow-up|7|||
155711937|NCT01818596|562040097|FG001|Overall Study|Lost to Follow-up|0|||
155711938|NCT03461146|562040106|FG000|Overall Study|Adverse Event|2|||
155711939|NCT03461146|562040106|FG000|Overall Study|Physician Decision|1|||
155711940|NCT02073682|562040107|FG000|Overall Study|Low Creatinine Clearance|1|||
155711941|NCT02073682|562040108|FG001|Overall Study|Low Creatinine Clearance|2|||
155711942|NCT02073682|562040107|FG000|Overall Study|Death|86|||
155711943|NCT02073682|562040108|FG001|Overall Study|Death|100|||
155711944|NCT02073682|562040107|FG000|Overall Study|Cancer Cured|10|||
155711945|NCT02073682|562040108|FG001|Overall Study|Cancer Cured|15|||
155711946|NCT02073682|562040107|FG000|Overall Study|ID: Patient Noncompliance|1|||
155711947|NCT02073682|562040108|FG001|Overall Study|ID: Patient Noncompliance|2|||
155711948|NCT02073682|562040107|FG000|Overall Study|ID: Palliative Treatment Only|10|||
155711949|NCT02073682|562040108|FG001|Overall Study|ID: Palliative Treatment Only|7|||
155711950|NCT02073682|562040107|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
155711951|NCT02073682|562040108|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
155711952|NCT02073682|562040107|FG000|Overall Study|Platelet Count <50,000/mL|1|||
155711953|NCT02073682|562040108|FG001|Overall Study|Platelet Count <50,000/mL|2|||
155711954|NCT02073682|562040107|FG000|Overall Study|Surgery/Medical Procedure|3|||
155711955|NCT02073682|562040108|FG001|Overall Study|Surgery/Medical Procedure|1|||
155711956|NCT02073682|562040107|FG000|Overall Study|Withdrawal by Subject|6|||
155711957|NCT02073682|562040108|FG001|Overall Study|Withdrawal by Subject|8|||
155711958|NCT02073682|562040107|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
155711959|NCT02073682|562040108|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
155711960|NCT02073682|562040107|FG000|Overall Study|Cancer Progression|53|||
155711961|NCT02073682|562040108|FG001|Overall Study|Cancer Progression|33|||
155711962|NCT02073682|562040107|FG000|Overall Study|Protocol Violation|1|||
155711963|NCT02073682|562040108|FG001|Overall Study|Protocol Violation|0|||
155711964|NCT02073682|562040107|FG000|Overall Study|Adverse Event|79|||
155711965|NCT02073682|562040108|FG001|Overall Study|Adverse Event|62|||
155711966|NCT02073682|562040107|FG000|Overall Study|No reason provided|11|||
155711967|NCT02073682|562040108|FG001|Overall Study|No reason provided|9|||
155711968|NCT02073682|562040107|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
155711969|NCT02073682|562040108|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
155711970|NCT02073682|562040107|FG000|Overall Study|Lost to Follow-up|1|||
155711971|NCT02073682|562040108|FG001|Overall Study|Lost to Follow-up|1|||
155711972|NCT02073682|562040107|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
155711973|NCT02073682|562040108|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
155711974|NCT04524858|562040121|FG000|Overall Study|Adverse Event|1|||
155711975|NCT01623115|562040122|FG000|Overall Study|Randomized but not treated|0|||
155711976|NCT01623115|562040123|FG001|Overall Study|Randomized but not treated|1|||
155711977|NCT01623115|562040122|FG000|Overall Study|Physician Decision|1|||
155711978|NCT01623115|562040123|FG001|Overall Study|Physician Decision|0|||
155711979|NCT01623115|562040122|FG000|Overall Study|Participants moved|1|||
155711980|NCT01623115|562040123|FG001|Overall Study|Participants moved|5|||
155711981|NCT01623115|562040122|FG000|Overall Study|Adverse Event|10|||
155711982|NCT01623115|562040123|FG001|Overall Study|Adverse Event|13|||
155711983|NCT01623115|562040122|FG000|Overall Study|Poor compliance to protocol|4|||
155711984|NCT01623115|562040123|FG001|Overall Study|Poor compliance to protocol|10|||
155711985|NCT01623115|562040122|FG000|Overall Study|Consent withdrawn by participant|2|||
155711986|NCT01623115|562040123|FG001|Overall Study|Consent withdrawn by participant|6|||
155711987|NCT01623115|562040122|FG000|Overall Study|Related to study drug administration|0|||
155711988|NCT01623115|562040123|FG001|Overall Study|Related to study drug administration|2|||
155711989|NCT01623115|562040122|FG000|Overall Study|Last visit outside protocol visit window|14|||
155711990|NCT01623115|562040123|FG001|Overall Study|Last visit outside protocol visit window|26|||
155711991|NCT01623115|562040122|FG000|Overall Study|Site closure|1|||
155711992|NCT01623115|562040123|FG001|Overall Study|Site closure|7|||
155711993|NCT01623115|562040122|FG000|Overall Study|Death|0|||
155711994|NCT01623115|562040123|FG001|Overall Study|Death|4|||
155711995|NCT01623115|562040122|FG000|Overall Study|Other than specified above|0|||
155711996|NCT01623115|562040123|FG001|Overall Study|Other than specified above|3|||
155711997|NCT05202418|562040124|FG000|Overall Study|Withdrawal by Subject|2|||
155711998|NCT05202418|562040125|FG001|Overall Study|Withdrawal by Subject|1|||
155711999|NCT05202418|562040124|FG000|Overall Study|Lost to Follow-up|1|||
155712000|NCT05202418|562040125|FG001|Overall Study|Lost to Follow-up|1|||
155712001|NCT02562716|562040126|FG000|Overall Study|Adverse Event|7|||
155712002|NCT02562716|562040127|FG001|Overall Study|Adverse Event|14|||
155712003|NCT02562716|562040126|FG000|Overall Study|Withdrawal unrelated to AE|7|||
155712004|NCT02562716|562040127|FG001|Overall Study|Withdrawal unrelated to AE|1|||
155712005|NCT02562716|562040126|FG000|Overall Study|Progression|8|||
155712006|NCT02562716|562040127|FG001|Overall Study|Progression|10|||
155712007|NCT02562716|562040126|FG000|Overall Study|Death|2|||
155712008|NCT02562716|562040127|FG001|Overall Study|Death|1|||
155712009|NCT02562716|562040126|FG000|Overall Study|Not protocol specified|4|||
155712010|NCT02562716|562040127|FG001|Overall Study|Not protocol specified|2|||
155712011|NCT00556998|562040128|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
155712012|NCT00556998|562040128|FG000|Voriconazole Intravenous (IV)|Other|4|||
155712013|NCT00556998|562040128|FG000|Voriconazole Oral|Adverse Event|1|||
155712014|NCT00556998|562040128|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
155712015|NCT02519439|562040129|FG000|Overall Study|Study Termination|19|||
155712016|NCT02519439|562040129|FG000|Overall Study|Withdrawal by Subject|1|||
155712017|NCT02519439|562040129|FG000|Overall Study|Adverse Event|1|||
155712018|NCT04961541|562040132|FG000|Overall Study|Adverse Event|0|||
155712019|NCT04961541|562040133|FG001|Overall Study|Adverse Event|0|||
155712020|NCT04961541|562040134|FG002|Overall Study|Adverse Event|0|||
155712021|NCT04961541|562040135|FG003|Overall Study|Adverse Event|0|||
155712022|NCT04961541|562040136|FG004|Overall Study|Adverse Event|0|||
155712023|NCT04961541|562040137|FG005|Overall Study|Adverse Event|1|||
155712024|NCT04961541|562040138|FG006|Overall Study|Adverse Event|0|||
155712025|NCT04961541|562040139|FG007|Overall Study|Adverse Event|0|||
155712026|NCT04961541|562040140|FG008|Overall Study|Adverse Event|0|||
155712027|NCT04961541|562040141|FG009|Overall Study|Adverse Event|0|||
155712028|NCT04961541|562040142|FG010|Overall Study|Adverse Event|0|||
155712029|NCT04961541|562040143|FG011|Overall Study|Adverse Event|0|||
155712030|NCT04961541|562040144|FG012|Overall Study|Adverse Event|0|||
155712031|NCT04961541|562040145|FG013|Overall Study|Adverse Event|0|||
155712032|NCT04961541|562040132|FG000|Overall Study|Lost to Follow-up|0|||
155712033|NCT04961541|562040133|FG001|Overall Study|Lost to Follow-up|0|||
155712034|NCT04961541|562040134|FG002|Overall Study|Lost to Follow-up|3|||
155712035|NCT04961541|562040135|FG003|Overall Study|Lost to Follow-up|0|||
155712036|NCT04961541|562040136|FG004|Overall Study|Lost to Follow-up|0|||
155712037|NCT04961541|562040137|FG005|Overall Study|Lost to Follow-up|0|||
155712038|NCT04961541|562040138|FG006|Overall Study|Lost to Follow-up|1|||
155712039|NCT04961541|562040139|FG007|Overall Study|Lost to Follow-up|1|||
155712040|NCT04961541|562040140|FG008|Overall Study|Lost to Follow-up|0|||
155712041|NCT04961541|562040141|FG009|Overall Study|Lost to Follow-up|1|||
155712042|NCT04961541|562040142|FG010|Overall Study|Lost to Follow-up|0|||
155712043|NCT04961541|562040143|FG011|Overall Study|Lost to Follow-up|0|||
155712044|NCT04961541|562040144|FG012|Overall Study|Lost to Follow-up|1|||
155712045|NCT04961541|562040145|FG013|Overall Study|Lost to Follow-up|0|||
155712046|NCT04961541|562040132|FG000|Overall Study|Withdrawal by Subject|0|||
155712047|NCT04961541|562040133|FG001|Overall Study|Withdrawal by Subject|0|||
155712048|NCT04961541|562040134|FG002|Overall Study|Withdrawal by Subject|1|||
155712049|NCT04961541|562040135|FG003|Overall Study|Withdrawal by Subject|1|||
155712050|NCT04961541|562040136|FG004|Overall Study|Withdrawal by Subject|0|||
155712051|NCT04961541|562040137|FG005|Overall Study|Withdrawal by Subject|0|||
155712052|NCT04961541|562040138|FG006|Overall Study|Withdrawal by Subject|0|||
155712053|NCT04961541|562040139|FG007|Overall Study|Withdrawal by Subject|0|||
155712054|NCT04961541|562040140|FG008|Overall Study|Withdrawal by Subject|0|||
155712055|NCT04961541|562040141|FG009|Overall Study|Withdrawal by Subject|1|||
155712056|NCT04961541|562040142|FG010|Overall Study|Withdrawal by Subject|0|||
155712057|NCT04961541|562040143|FG011|Overall Study|Withdrawal by Subject|0|||
155712058|NCT04961541|562040144|FG012|Overall Study|Withdrawal by Subject|0|||
155712059|NCT04961541|562040145|FG013|Overall Study|Withdrawal by Subject|0|||
155712060|NCT02330055|562040147|FG000|Overall Study|technical issues|2|||
155712061|NCT02330055|562040148|FG001|Overall Study|technical issues|0|||
155712062|NCT02330055|562040147|FG000|Overall Study|participant forgot to wear device|5|||
155712063|NCT02330055|562040148|FG001|Overall Study|participant forgot to wear device|5|||
155712064|NCT02330055|562040147|FG000|Overall Study|data for less than 60 minutes|3|||
155712065|NCT02330055|562040148|FG001|Overall Study|data for less than 60 minutes|3|||
155712066|NCT02330055|562040147|FG000|Overall Study|participant did not sleep|0|||
155712067|NCT02330055|562040148|FG001|Overall Study|participant did not sleep|1|||
155712068|NCT02959437|562040149|FG000|Overall Study|Death|33|||
155712069|NCT02959437|562040150|FG001|Overall Study|Death|3|||
155712070|NCT02959437|562040151|FG002|Overall Study|Death|0|||
155712071|NCT02959437|562040152|FG003|Overall Study|Death|0|||
155712072|NCT02959437|562040149|FG000|Overall Study|Lost to Follow-up|3|||
155712073|NCT02959437|562040150|FG001|Overall Study|Lost to Follow-up|1|||
155712074|NCT02959437|562040151|FG002|Overall Study|Lost to Follow-up|0|||
155712075|NCT02959437|562040152|FG003|Overall Study|Lost to Follow-up|0|||
155712076|NCT02959437|562040149|FG000|Overall Study|Withdrawal by Subject|11|||
155712077|NCT02959437|562040150|FG001|Overall Study|Withdrawal by Subject|3|||
155712078|NCT02959437|562040151|FG002|Overall Study|Withdrawal by Subject|0|||
155712079|NCT02959437|562040152|FG003|Overall Study|Withdrawal by Subject|0|||
155712080|NCT02959437|562040149|FG000|Overall Study|Progressive Disease|9|||
155712081|NCT02959437|562040150|FG001|Overall Study|Progressive Disease|1|||
155712082|NCT02959437|562040151|FG002|Overall Study|Progressive Disease|0|||
155712083|NCT02959437|562040152|FG003|Overall Study|Progressive Disease|0|||
155712084|NCT02959437|562040149|FG000|Overall Study|Study Terminated by Sponsor|4|||
155712085|NCT02959437|562040150|FG001|Overall Study|Study Terminated by Sponsor|0|||
155712086|NCT02959437|562040151|FG002|Overall Study|Study Terminated by Sponsor|0|||
155712087|NCT02959437|562040152|FG003|Overall Study|Study Terminated by Sponsor|0|||
155712088|NCT02959437|562040149|FG000|Overall Study|Other Unspecified|2|||
155712089|NCT02959437|562040150|FG001|Overall Study|Other Unspecified|0|||
155712090|NCT02959437|562040151|FG002|Overall Study|Other Unspecified|0|||
155712091|NCT02959437|562040152|FG003|Overall Study|Other Unspecified|0|||
155712092|NCT02905266|562040153|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
155712093|NCT02905266|562040154|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
155712094|NCT02905266|562040153|FG000|Treatment Phase Part 1|Disease Progression|6|||
155712095|NCT02905266|562040154|FG001|Treatment Phase Part 1|Disease Progression|7|||
155712096|NCT02905266|562040153|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
155712097|NCT02905266|562040154|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
155712098|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
155712099|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
155712100|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
155712101|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
155712102|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
155712103|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
155712104|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Death|0|||
155712105|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Death|1|||
155712106|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
155712107|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
155712108|NCT02905266|562040153|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
155712109|NCT02905266|562040154|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
155712110|NCT02905266|562040153|FG000|Maintenance Phase Part 2|Disease Progression|9|||
155712111|NCT02905266|562040154|FG001|Maintenance Phase Part 2|Disease Progression|2|||
155712112|NCT02905266|562040153|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
155712113|NCT02905266|562040154|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
155712114|NCT02905266|562040153|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
155712115|NCT02905266|562040154|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
155712116|NCT05973006|562040155|FG000|Overall Study|Early termination|3|||
155712117|NCT05973006|562040156|FG001|Overall Study|Early termination|9|||
155712118|NCT03201419|562040164|FG000|Overall Study|Adverse Event|3|||
155712119|NCT03201419|562040165|FG001|Overall Study|Adverse Event|1|||
155712120|NCT03201419|562040166|FG002|Overall Study|Adverse Event|0|||
155712121|NCT03201419|562040167|FG003|Overall Study|Adverse Event|0|||
155712122|NCT03201419|562040168|FG004|Overall Study|Adverse Event|1|||
155712123|NCT03201419|562040169|FG005|Overall Study|Adverse Event|1|||
155712124|NCT03201419|562040170|FG006|Overall Study|Adverse Event|5|||
155712125|NCT03201419|562040171|FG007|Overall Study|Adverse Event|0|||
155712126|NCT03201419|562040172|FG008|Overall Study|Adverse Event|0|||
155712127|NCT03201419|562040164|FG000|Overall Study|Lost to Follow-up|1|||
155712128|NCT03201419|562040165|FG001|Overall Study|Lost to Follow-up|0|||
155712129|NCT03201419|562040166|FG002|Overall Study|Lost to Follow-up|0|||
155712130|NCT03201419|562040167|FG003|Overall Study|Lost to Follow-up|0|||
155712131|NCT03201419|562040168|FG004|Overall Study|Lost to Follow-up|0|||
155712132|NCT03201419|562040169|FG005|Overall Study|Lost to Follow-up|0|||
155712133|NCT03201419|562040170|FG006|Overall Study|Lost to Follow-up|0|||
155712134|NCT03201419|562040171|FG007|Overall Study|Lost to Follow-up|0|||
155712135|NCT03201419|562040172|FG008|Overall Study|Lost to Follow-up|0|||
155712136|NCT03201419|562040164|FG000|Overall Study|Protocol Deviation|0|||
155712137|NCT03201419|562040165|FG001|Overall Study|Protocol Deviation|0|||
155712138|NCT03201419|562040166|FG002|Overall Study|Protocol Deviation|0|||
155712139|NCT03201419|562040167|FG003|Overall Study|Protocol Deviation|0|||
155712140|NCT03201419|562040168|FG004|Overall Study|Protocol Deviation|0|||
155712141|NCT03201419|562040169|FG005|Overall Study|Protocol Deviation|0|||
155712142|NCT03201419|562040170|FG006|Overall Study|Protocol Deviation|1|||
155712143|NCT03201419|562040171|FG007|Overall Study|Protocol Deviation|0|||
155712144|NCT03201419|562040172|FG008|Overall Study|Protocol Deviation|0|||
155712145|NCT03201419|562040164|FG000|Overall Study|Withdrawal by Subject|4|||
155712146|NCT03201419|562040165|FG001|Overall Study|Withdrawal by Subject|2|||
155712147|NCT03201419|562040166|FG002|Overall Study|Withdrawal by Subject|1|||
155712148|NCT03201419|562040167|FG003|Overall Study|Withdrawal by Subject|0|||
155712149|NCT03201419|562040168|FG004|Overall Study|Withdrawal by Subject|0|||
155712150|NCT03201419|562040169|FG005|Overall Study|Withdrawal by Subject|0|||
155712151|NCT03201419|562040170|FG006|Overall Study|Withdrawal by Subject|0|||
155712152|NCT03201419|562040171|FG007|Overall Study|Withdrawal by Subject|1|||
155712153|NCT03201419|562040172|FG008|Overall Study|Withdrawal by Subject|2|||
155712154|NCT03201419|562040164|FG000|Overall Study|Other|0|||
155712155|NCT03201419|562040165|FG001|Overall Study|Other|0|||
155712156|NCT03201419|562040166|FG002|Overall Study|Other|1|||
155712157|NCT03201419|562040167|FG003|Overall Study|Other|0|||
155712158|NCT03201419|562040168|FG004|Overall Study|Other|0|||
155712159|NCT03201419|562040169|FG005|Overall Study|Other|0|||
155712160|NCT03201419|562040170|FG006|Overall Study|Other|0|||
155712161|NCT03201419|562040171|FG007|Overall Study|Other|0|||
155712162|NCT03201419|562040172|FG008|Overall Study|Other|0|||
155712163|NCT03868943|562040173|FG000|Overall Study|Adverse Event|1|||
155712164|NCT02777827|562040174|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
155712165|NCT02777827|562040175|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
155712166|NCT02777827|562040176|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
155712167|NCT02777827|562040177|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
155712168|NCT02777827|562040178|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
155712169|NCT02777827|562040179|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
155712170|NCT04551066|562040180|FG000|Overall Study|Death|5|||
155712171|NCT04551066|562040181|FG001|Overall Study|Death|3|||
155712172|NCT04551066|562040180|FG000|Overall Study|Lost to Follow-up|1|||
155712173|NCT04551066|562040181|FG001|Overall Study|Lost to Follow-up|0|||
155712174|NCT04551066|562040180|FG000|Overall Study|Sponsor Decision|104|||
155712175|NCT04551066|562040181|FG001|Overall Study|Sponsor Decision|117|||
155712176|NCT04551066|562040180|FG000|Overall Study|Withdrawal by Subject|8|||
155712177|NCT04551066|562040181|FG001|Overall Study|Withdrawal by Subject|2|||
155712178|NCT04551066|562040180|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
155712179|NCT04551066|562040181|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
155712180|NCT04551066|562040180|FG000|Overall Study|Adverse Event|2|||
155712181|NCT04551066|562040181|FG001|Overall Study|Adverse Event|0|||
155712182|NCT04551066|562040180|FG000|Overall Study|Physician Decision|2|||
155712183|NCT04551066|562040181|FG001|Overall Study|Physician Decision|0|||
155712184|NCT04551066|562040180|FG000|Overall Study|Protocol Violation|1|||
155712185|NCT04551066|562040181|FG001|Overall Study|Protocol Violation|0|||
155712186|NCT04551066|562040180|FG000|Overall Study|Lack of Efficacy|0|||
155712187|NCT04551066|562040181|FG001|Overall Study|Lack of Efficacy|1|||
155712188|NCT04551066|562040180|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
155712189|NCT04551066|562040181|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
155712190|NCT00369577|562040182|FG000|Overall Study|Withdrawal by Subject|0|||
155712191|NCT00369577|562040183|FG001|Overall Study|Withdrawal by Subject|0|||
155712192|NCT00369577|562040184|FG002|Overall Study|Withdrawal by Subject|1|||
155712193|NCT00398320|562040185|FG000|Overall Study|Death|1|||
155712194|NCT00398320|562040185|FG000|Overall Study|Adverse Event|4|||
155712195|NCT00398320|562040185|FG000|Overall Study|Physician Decision|1|||
155712196|NCT00064792|562040186|FG000|Overall Study|Withdrawal by Subject|2|||
155712197|NCT00064792|562040187|FG001|Overall Study|Withdrawal by Subject|0|||
155712198|NCT00064792|562040186|FG000|Overall Study|Adverse Event|3|||
155712199|NCT00064792|562040187|FG001|Overall Study|Adverse Event|0|||
155712200|NCT03915470|562040190|FG000|Overall Study|Death|3|||
155712201|NCT03915470|562040191|FG001|Overall Study|Death|1|||
155712202|NCT03915470|562040190|FG000|Overall Study|Adverse Event|1|||
155712203|NCT03915470|562040191|FG001|Overall Study|Adverse Event|0|||
155712204|NCT03915470|562040190|FG000|Overall Study|Physician Decision|1|||
155712205|NCT03915470|562040191|FG001|Overall Study|Physician Decision|0|||
155712206|NCT03915470|562040190|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
155712207|NCT03915470|562040191|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
155712208|NCT03160898|562040192|FG000|Overall Study|Adverse Event|4|||
155712209|NCT03160898|562040193|FG001|Overall Study|Adverse Event|8|||
155712210|NCT03160898|562040194|FG002|Overall Study|Adverse Event|7|||
155712211|NCT03160898|562040195|FG003|Overall Study|Adverse Event|10|||
155712212|NCT03160898|562040192|FG000|Overall Study|Death|1|||
155712213|NCT03160898|562040193|FG001|Overall Study|Death|0|||
155712214|NCT03160898|562040194|FG002|Overall Study|Death|0|||
155712215|NCT03160898|562040195|FG003|Overall Study|Death|1|||
155712216|NCT03160898|562040192|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
155712217|NCT03160898|562040193|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
155712218|NCT03160898|562040194|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
155712219|NCT03160898|562040195|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
155712220|NCT03160898|562040192|FG000|Overall Study|Lost to Follow-up|1|||
155712221|NCT03160898|562040193|FG001|Overall Study|Lost to Follow-up|1|||
155712222|NCT03160898|562040194|FG002|Overall Study|Lost to Follow-up|1|||
155712223|NCT03160898|562040195|FG003|Overall Study|Lost to Follow-up|2|||
155712224|NCT03160898|562040192|FG000|Overall Study|Physician Decision|1|||
155712225|NCT03160898|562040193|FG001|Overall Study|Physician Decision|0|||
155712226|NCT03160898|562040194|FG002|Overall Study|Physician Decision|0|||
155712227|NCT03160898|562040195|FG003|Overall Study|Physician Decision|1|||
155712228|NCT03160898|562040192|FG000|Overall Study|Progressive Disease|4|||
155712229|NCT03160898|562040193|FG001|Overall Study|Progressive Disease|1|||
155712230|NCT03160898|562040194|FG002|Overall Study|Progressive Disease|2|||
155712231|NCT03160898|562040195|FG003|Overall Study|Progressive Disease|1|||
155712232|NCT03160898|562040192|FG000|Overall Study|Protocol Violation|1|||
155712233|NCT03160898|562040193|FG001|Overall Study|Protocol Violation|0|||
155712234|NCT03160898|562040194|FG002|Overall Study|Protocol Violation|2|||
155712235|NCT03160898|562040195|FG003|Overall Study|Protocol Violation|0|||
155712236|NCT03160898|562040192|FG000|Overall Study|Sponsor Discretion|2|||
155712237|NCT03160898|562040193|FG001|Overall Study|Sponsor Discretion|0|||
155712238|NCT03160898|562040194|FG002|Overall Study|Sponsor Discretion|0|||
155712239|NCT03160898|562040195|FG003|Overall Study|Sponsor Discretion|0|||
155712240|NCT03160898|562040192|FG000|Overall Study|Withdrawal by Subject|1|||
155712241|NCT03160898|562040193|FG001|Overall Study|Withdrawal by Subject|3|||
155712242|NCT03160898|562040194|FG002|Overall Study|Withdrawal by Subject|2|||
155712243|NCT03160898|562040195|FG003|Overall Study|Withdrawal by Subject|1|||
155712244|NCT03160898|562040192|FG000|Overall Study|Other|2|||
155712245|NCT03160898|562040193|FG001|Overall Study|Other|0|||
155712246|NCT03160898|562040194|FG002|Overall Study|Other|2|||
155712247|NCT03160898|562040195|FG003|Overall Study|Other|2|||
155712248|NCT00434109|562040198|FG000|Overall Study|Physician Decision|9|||
155712249|NCT00434109|562040198|FG000|Overall Study|Adverse Event|5|||
155712250|NCT00434109|562040198|FG000|Overall Study|Protocol Violation|1|||
155712251|NCT00434109|562040198|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
155712252|NCT00103740|562040199|FG000|Period 1 - Core|Adverse Event|1|||
155712253|NCT00103740|562040200|FG001|Period 1 - Core|Adverse Event|0|||
155712254|NCT00103740|562040199|FG000|Period 1 - Core|Protocol Violation|3|||
155712255|NCT00103740|562040200|FG001|Period 1 - Core|Protocol Violation|2|||
155712256|NCT00103740|562040199|FG000|Period 1 - Core|Patient withdrew consent|3|||
155712257|NCT00103740|562040200|FG001|Period 1 - Core|Patient withdrew consent|2|||
155712258|NCT00103740|562040199|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
155712259|NCT00103740|562040200|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
155712260|NCT00103740|562040199|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
155712261|NCT00103740|562040200|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
155712262|NCT00103740|562040199|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
155712263|NCT00103740|562040200|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
155712264|NCT00103740|562040199|FG000|Period 2 - Extended Observation Period|Death|6|||
155712265|NCT00103740|562040200|FG001|Period 2 - Extended Observation Period|Death|2|||
155712266|NCT00103740|562040199|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
155712267|NCT00103740|562040200|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
155712268|NCT01463306|562040201|FG000|Overall Study|Adverse Event|6|||
155712269|NCT01463306|562040202|FG001|Overall Study|Adverse Event|9|||
155712270|NCT01463306|562040203|FG002|Overall Study|Adverse Event|3|||
155712271|NCT01463306|562040201|FG000|Overall Study|Death|3|||
155712272|NCT01463306|562040202|FG001|Overall Study|Death|3|||
155712273|NCT01463306|562040203|FG002|Overall Study|Death|0|||
155712274|NCT01463306|562040201|FG000|Overall Study|Lack of Efficacy|22|||
155712275|NCT01463306|562040202|FG001|Overall Study|Lack of Efficacy|16|||
155712276|NCT01463306|562040203|FG002|Overall Study|Lack of Efficacy|1|||
155712277|NCT01463306|562040201|FG000|Overall Study|Lost to Follow-up|5|||
155712278|NCT01463306|562040202|FG001|Overall Study|Lost to Follow-up|2|||
155712279|NCT01463306|562040203|FG002|Overall Study|Lost to Follow-up|0|||
155712280|NCT01463306|562040201|FG000|Overall Study|Protocol Violation|4|||
155712281|NCT01463306|562040202|FG001|Overall Study|Protocol Violation|0|||
155712282|NCT01463306|562040203|FG002|Overall Study|Protocol Violation|0|||
155712283|NCT01463306|562040201|FG000|Overall Study|Withdrawal by Subject|19|||
155712284|NCT01463306|562040202|FG001|Overall Study|Withdrawal by Subject|9|||
155712285|NCT01463306|562040203|FG002|Overall Study|Withdrawal by Subject|1|||
155712286|NCT01463306|562040201|FG000|Overall Study|Other|26|||
155712287|NCT01463306|562040202|FG001|Overall Study|Other|13|||
155712288|NCT01463306|562040203|FG002|Overall Study|Other|0|||
155712289|NCT01463306|562040201|FG000|Overall Study|Approval expiry at site|1|||
155712290|NCT01463306|562040202|FG001|Overall Study|Approval expiry at site|0|||
155712291|NCT01463306|562040203|FG002|Overall Study|Approval expiry at site|0|||
155712292|NCT00291486|562040210|FG000|Overall Study|Adverse Event|0|||
155712293|NCT00291486|562040211|FG001|Overall Study|Adverse Event|3|||
155712294|NCT00291486|562040212|FG002|Overall Study|Adverse Event|0|||
155712295|NCT00291486|562040213|FG003|Overall Study|Adverse Event|1|||
155712296|NCT00291486|562040214|FG004|Overall Study|Adverse Event|0|||
155712297|NCT00291486|562040210|FG000|Overall Study|Withdrawal by Subject|0|||
155712298|NCT00291486|562040211|FG001|Overall Study|Withdrawal by Subject|0|||
155712299|NCT00291486|562040212|FG002|Overall Study|Withdrawal by Subject|0|||
155712300|NCT00291486|562040213|FG003|Overall Study|Withdrawal by Subject|0|||
155712301|NCT00291486|562040214|FG004|Overall Study|Withdrawal by Subject|1|||
155712302|NCT00291486|562040210|FG000|Overall Study|Disease progression|1|||
155712303|NCT00291486|562040211|FG001|Overall Study|Disease progression|0|||
155712304|NCT00291486|562040212|FG002|Overall Study|Disease progression|1|||
155712305|NCT00291486|562040213|FG003|Overall Study|Disease progression|0|||
155712306|NCT00291486|562040214|FG004|Overall Study|Disease progression|0|||
155712307|NCT01045694|562040215|FG000|Overall Study|Withdrawal by Subject|2|||
155712308|NCT04725500|562040216|FG000|Screening|Screen Failure|26|||
155712309|NCT04725500|562040216|FG000|Screening|Withdrawal by Subject|1|||
155712310|NCT04725500|562040216|FG000|2 Week Take Home|Screen Fail|5|||
155712311|NCT03310723|562042435|FG000|Overall Study|Withdrawal by Subject|0|||
155712312|NCT03310723|562042436|FG001|Overall Study|Withdrawal by Subject|1|||
155712313|NCT03310723|562042435|FG000|Overall Study|Protocol Violation|0|||
155712314|NCT03310723|562042436|FG001|Overall Study|Protocol Violation|2|||
155712315|NCT02098746|562042437|FG000|Overall Study|Changes of Investigator|2|||
155712316|NCT02098746|562042437|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155712317|NCT02098746|562042437|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
155712318|NCT02098746|562042437|FG000|Overall Study|Data Not Available After Treatment|1|||
155712319|NCT01132807|562042445|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
155712320|NCT01132807|562042446|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
155712321|NCT01132807|562042447|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
155712322|NCT01132807|562042445|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
155712323|NCT01132807|562042446|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
155712324|NCT01132807|562042447|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
155712325|NCT00742183|562042448|FG000|Overall Study|Adverse Event|2|||
155712326|NCT00742183|562042449|FG001|Overall Study|Adverse Event|2|||
155712327|NCT00742183|562042448|FG000|Overall Study|Death|1|||
155712328|NCT00742183|562042449|FG001|Overall Study|Death|0|||
155712329|NCT00742183|562042448|FG000|Overall Study|Physician Decision|0|||
155712330|NCT00742183|562042449|FG001|Overall Study|Physician Decision|2|||
155712331|NCT00742183|562042448|FG000|Overall Study|Lost to Follow-up|4|||
155712332|NCT00742183|562042449|FG001|Overall Study|Lost to Follow-up|4|||
155712333|NCT00742183|562042448|FG000|Overall Study|Required skin-graft|1|||
155712334|NCT00742183|562042449|FG001|Overall Study|Required skin-graft|1|||
155712335|NCT00742183|562042448|FG000|Overall Study|Withdrawal by Subject|1|||
155712336|NCT00742183|562042449|FG001|Overall Study|Withdrawal by Subject|0|||
155712337|NCT00742183|562042448|FG000|Overall Study|Lack of Efficacy|0|||
155712338|NCT00742183|562042449|FG001|Overall Study|Lack of Efficacy|3|||
155712339|NCT01080807|562042455|FG000|Overall Study|Adverse Event|9|||
155712340|NCT01080807|562042456|FG001|Overall Study|Adverse Event|1|||
155712341|NCT01080807|562042455|FG000|Overall Study|Lack of Efficacy|0|||
155712342|NCT01080807|562042456|FG001|Overall Study|Lack of Efficacy|1|||
155712343|NCT01080807|562042455|FG000|Overall Study|Withdrawal by Subject|7|||
155712344|NCT01080807|562042456|FG001|Overall Study|Withdrawal by Subject|2|||
155712345|NCT01080807|562042455|FG000|Overall Study|Protocol Violation|7|||
155712346|NCT01080807|562042456|FG001|Overall Study|Protocol Violation|6|||
155712347|NCT01080807|562042455|FG000|Overall Study|Lost to Follow-up|6|||
155712348|NCT01080807|562042456|FG001|Overall Study|Lost to Follow-up|4|||
155712349|NCT01080807|562042455|FG000|Overall Study|Noncompliance with drug administration|1|||
155712350|NCT01080807|562042456|FG001|Overall Study|Noncompliance with drug administration|1|||
155712351|NCT01080807|562042455|FG000|Overall Study|Noncompliance to study procedures|1|||
155712352|NCT01080807|562042456|FG001|Overall Study|Noncompliance to study procedures|1|||
155712353|NCT01080807|562042455|FG000|Overall Study|Began working day shift|0|||
155712354|NCT01080807|562042456|FG001|Overall Study|Began working day shift|2|||
155712355|NCT01080807|562042455|FG000|Overall Study|Laid off or terminated from job|1|||
155712356|NCT01080807|562042456|FG001|Overall Study|Laid off or terminated from job|2|||
155712357|NCT01080807|562042455|FG000|Overall Study|Stopped working consistent night shifts|0|||
155712358|NCT01080807|562042456|FG001|Overall Study|Stopped working consistent night shifts|1|||
155712359|NCT01080807|562042455|FG000|Overall Study|Work schedule changing|1|||
155712360|NCT01080807|562042456|FG001|Overall Study|Work schedule changing|1|||
155712361|NCT01080807|562042455|FG000|Overall Study|Work schedule and travel|0|||
155712362|NCT01080807|562042456|FG001|Overall Study|Work schedule and travel|1|||
155712363|NCT01080807|562042455|FG000|Overall Study|Switched to first shift|1|||
155712364|NCT01080807|562042456|FG001|Overall Study|Switched to first shift|0|||
155712365|NCT01080807|562042455|FG000|Overall Study|Moved away without notifying center|1|||
155712366|NCT01080807|562042456|FG001|Overall Study|Moved away without notifying center|0|||
155712367|NCT00936702|562042467|FG000|Overall Study|Disease progression|34|||
155712368|NCT00936702|562042467|FG000|Overall Study|Adverse Event|8|||
155712369|NCT00936702|562042467|FG000|Overall Study|Withdrawal by Subject|2|||
155712370|NCT00936702|562042467|FG000|Overall Study|Alternative Treatment|1|||
155712371|NCT00936702|562042467|FG000|Overall Study|Other|1|||
155712372|NCT02532465|562042468|FG000|Overall Study|Protocol Violation|1|||
155712373|NCT02532465|562042469|FG001|Overall Study|Protocol Violation|0|||
155712374|NCT02532465|562042468|FG000|Overall Study|Lack of Efficacy|0|||
155712375|NCT02532465|562042469|FG001|Overall Study|Lack of Efficacy|1|||
155712376|NCT00354679|562042474|FG000|Overall Study|Patient Not Treated|1|||
155712377|NCT00466440|562042475|FG000|Overall Study|Adverse Event|0|||
155712378|NCT00466440|562042476|FG001|Overall Study|Adverse Event|3|||
155712379|NCT00466440|562042477|FG002|Overall Study|Adverse Event|1|||
155712380|NCT00466440|562042475|FG000|Overall Study|Death|1|||
155712381|NCT00466440|562042476|FG001|Overall Study|Death|1|||
155712382|NCT00466440|562042477|FG002|Overall Study|Death|0|||
155712383|NCT00466440|562042475|FG000|Overall Study|Progressive disease|13|||
155712384|NCT00466440|562042476|FG001|Overall Study|Progressive disease|5|||
155712385|NCT00466440|562042477|FG002|Overall Study|Progressive disease|4|||
155712386|NCT00466440|562042475|FG000|Overall Study|Lost to Follow-up|0|||
155712387|NCT00466440|562042476|FG001|Overall Study|Lost to Follow-up|1|||
155712388|NCT00466440|562042477|FG002|Overall Study|Lost to Follow-up|0|||
155712389|NCT00466440|562042475|FG000|Overall Study|Physician Decision|0|||
155712390|NCT00466440|562042476|FG001|Overall Study|Physician Decision|1|||
155712391|NCT00466440|562042477|FG002|Overall Study|Physician Decision|2|||
155712392|NCT00466440|562042475|FG000|Overall Study|Protocol entry criteria not met|0|||
155712393|NCT00466440|562042476|FG001|Overall Study|Protocol entry criteria not met|0|||
155712394|NCT00466440|562042477|FG002|Overall Study|Protocol entry criteria not met|4|||
155712395|NCT00466440|562042475|FG000|Overall Study|Withdrawal by Subject|0|||
155712396|NCT00466440|562042476|FG001|Overall Study|Withdrawal by Subject|1|||
155712397|NCT00466440|562042477|FG002|Overall Study|Withdrawal by Subject|0|||
155712398|NCT00466440|562042475|FG000|Overall Study|Sponsor decision|0|||
155712399|NCT00466440|562042476|FG001|Overall Study|Sponsor decision|0|||
155712400|NCT00466440|562042477|FG002|Overall Study|Sponsor decision|1|||
155712401|NCT03187132|562042483|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
155712402|NCT03187132|562042484|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
155712403|NCT03187132|562042483|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
155712404|NCT03187132|562042484|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
155712405|NCT03187132|562042483|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
155712406|NCT03187132|562042484|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
155712407|NCT03187132|562042483|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
155712408|NCT03187132|562042484|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
155712409|NCT03187132|562042483|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
155712410|NCT03187132|562042484|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
155712411|NCT03187132|562042483|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
155712412|NCT03187132|562042484|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
155712413|NCT03187132|562042483|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
155712414|NCT03187132|562042484|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
155712415|NCT03187132|562042483|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
155712416|NCT03187132|562042484|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
155712417|NCT03187132|562042483|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
155712418|NCT03187132|562042484|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
155712419|NCT03187132|562042483|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
155712420|NCT03187132|562042484|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
155712421|NCT03187132|562042483|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
155712422|NCT03187132|562042484|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
155712423|NCT02045095|562042485|FG000|Overall Study|Other|0|||
155712424|NCT02045095|562042486|FG001|Overall Study|Other|0|||
155712425|NCT02045095|562042487|FG002|Overall Study|Other|1|||
155712426|NCT02045095|562042488|FG003|Overall Study|Other|0|||
155712427|NCT02045095|562042489|FG004|Overall Study|Other|0|||
155712428|NCT02045095|562042490|FG005|Overall Study|Other|2|||
155712429|NCT02045095|562042491|FG006|Overall Study|Other|0|||
155712430|NCT02045095|562042485|FG000|Overall Study|Progressive Disease|3|||
155712431|NCT02045095|562042486|FG001|Overall Study|Progressive Disease|3|||
155712432|NCT02045095|562042487|FG002|Overall Study|Progressive Disease|2|||
155712433|NCT02045095|562042488|FG003|Overall Study|Progressive Disease|4|||
155712434|NCT02045095|562042489|FG004|Overall Study|Progressive Disease|2|||
155712435|NCT02045095|562042490|FG005|Overall Study|Progressive Disease|4|||
155712436|NCT02045095|562042491|FG006|Overall Study|Progressive Disease|1|||
155712437|NCT02045095|562042485|FG000|Overall Study|Withdrawal by Subject|0|||
155712438|NCT02045095|562042486|FG001|Overall Study|Withdrawal by Subject|0|||
155712439|NCT02045095|562042487|FG002|Overall Study|Withdrawal by Subject|0|||
155712440|NCT02045095|562042488|FG003|Overall Study|Withdrawal by Subject|0|||
155712441|NCT02045095|562042489|FG004|Overall Study|Withdrawal by Subject|3|||
155712442|NCT02045095|562042490|FG005|Overall Study|Withdrawal by Subject|0|||
155712443|NCT02045095|562042491|FG006|Overall Study|Withdrawal by Subject|0|||
155712444|NCT02045095|562042485|FG000|Overall Study|Adverse Event|0|||
155712445|NCT02045095|562042486|FG001|Overall Study|Adverse Event|1|||
155712446|NCT02045095|562042487|FG002|Overall Study|Adverse Event|1|||
155712447|NCT02045095|562042488|FG003|Overall Study|Adverse Event|0|||
155712448|NCT02045095|562042489|FG004|Overall Study|Adverse Event|0|||
155712449|NCT02045095|562042490|FG005|Overall Study|Adverse Event|2|||
155712450|NCT02045095|562042491|FG006|Overall Study|Adverse Event|0|||
155712451|NCT02525588|562042492|FG000|Overall Study|Death|3|||
155712452|NCT02525588|562042493|FG001|Overall Study|Death|1|||
155712453|NCT02525588|562042492|FG000|Overall Study|Lost to Follow-up|2|||
155712454|NCT02525588|562042493|FG001|Overall Study|Lost to Follow-up|0|||
155712455|NCT02525588|562042492|FG000|Overall Study|Withdrawal by Subject|1|||
155712456|NCT02525588|562042493|FG001|Overall Study|Withdrawal by Subject|1|||
155712457|NCT02525588|562042492|FG000|Overall Study|Adverse Event|0|||
155712458|NCT02525588|562042493|FG001|Overall Study|Adverse Event|1|||
155712459|NCT04497116|562042497|FG000|Overall Study|Lost to Follow-up|1|||
155712460|NCT04497116|562042498|FG001|Overall Study|Lost to Follow-up|0|||
155712461|NCT04497116|562042499|FG002|Overall Study|Lost to Follow-up|0|||
155712462|NCT04497116|562042500|FG003|Overall Study|Lost to Follow-up|0|||
155712463|NCT04497116|562042501|FG004|Overall Study|Lost to Follow-up|0|||
155712464|NCT04497116|562042502|FG005|Overall Study|Lost to Follow-up|0|||
155712465|NCT04497116|562042503|FG006|Overall Study|Lost to Follow-up|0|||
155712466|NCT04497116|562042504|FG007|Overall Study|Lost to Follow-up|3|||
155712467|NCT04497116|562042505|FG008|Overall Study|Lost to Follow-up|3|||
155712468|NCT04497116|562042506|FG009|Overall Study|Lost to Follow-up|0|||
155712469|NCT04497116|562042507|FG010|Overall Study|Lost to Follow-up|0|||
155712470|NCT04497116|562042508|FG011|Overall Study|Lost to Follow-up|0|||
155712471|NCT04497116|562042509|FG012|Overall Study|Lost to Follow-up|0|||
155712472|NCT04497116|562042510|FG013|Overall Study|Lost to Follow-up|0|||
155712473|NCT04497116|562042511|FG014|Overall Study|Lost to Follow-up|0|||
155712474|NCT04497116|562042512|FG015|Overall Study|Lost to Follow-up|0|||
155712475|NCT04497116|562042513|FG016|Overall Study|Lost to Follow-up|0|||
155712476|NCT04497116|562042514|FG017|Overall Study|Lost to Follow-up|0|||
155712477|NCT04497116|562042515|FG018|Overall Study|Lost to Follow-up|0|||
155712478|NCT04497116|562042516|FG019|Overall Study|Lost to Follow-up|0|||
155712479|NCT04497116|562042517|FG020|Overall Study|Lost to Follow-up|0|||
155712480|NCT04497116|562042518|FG021|Overall Study|Lost to Follow-up|0|||
155712481|NCT04497116|562042519|FG022|Overall Study|Lost to Follow-up|1|||
155712482|NCT04497116|562042520|FG023|Overall Study|Lost to Follow-up|0|||
155712483|NCT04497116|562042521|FG024|Overall Study|Lost to Follow-up|0|||
155712484|NCT04497116|562042497|FG000|Overall Study|Sponsor decision to terminate study|0|||
155712485|NCT04497116|562042498|FG001|Overall Study|Sponsor decision to terminate study|0|||
155712486|NCT04497116|562042499|FG002|Overall Study|Sponsor decision to terminate study|0|||
155712487|NCT04497116|562042500|FG003|Overall Study|Sponsor decision to terminate study|0|||
155712488|NCT04497116|562042501|FG004|Overall Study|Sponsor decision to terminate study|0|||
155712489|NCT04497116|562042502|FG005|Overall Study|Sponsor decision to terminate study|0|||
155712490|NCT04497116|562042503|FG006|Overall Study|Sponsor decision to terminate study|1|||
155712491|NCT04497116|562042504|FG007|Overall Study|Sponsor decision to terminate study|0|||
155712492|NCT04497116|562042505|FG008|Overall Study|Sponsor decision to terminate study|0|||
155712493|NCT04497116|562042506|FG009|Overall Study|Sponsor decision to terminate study|1|||
155712494|NCT04497116|562042507|FG010|Overall Study|Sponsor decision to terminate study|0|||
155712495|NCT04497116|562042508|FG011|Overall Study|Sponsor decision to terminate study|0|||
155712496|NCT04497116|562042509|FG012|Overall Study|Sponsor decision to terminate study|0|||
155712497|NCT04497116|562042510|FG013|Overall Study|Sponsor decision to terminate study|0|||
155712498|NCT04497116|562042511|FG014|Overall Study|Sponsor decision to terminate study|0|||
155712499|NCT04497116|562042512|FG015|Overall Study|Sponsor decision to terminate study|0|||
155712500|NCT04497116|562042513|FG016|Overall Study|Sponsor decision to terminate study|0|||
155712501|NCT04497116|562042514|FG017|Overall Study|Sponsor decision to terminate study|0|||
155712502|NCT04497116|562042515|FG018|Overall Study|Sponsor decision to terminate study|0|||
155712503|NCT04497116|562042516|FG019|Overall Study|Sponsor decision to terminate study|1|||
155712504|NCT04497116|562042517|FG020|Overall Study|Sponsor decision to terminate study|0|||
155712505|NCT04497116|562042518|FG021|Overall Study|Sponsor decision to terminate study|0|||
155712506|NCT04497116|562042519|FG022|Overall Study|Sponsor decision to terminate study|0|||
155712507|NCT04497116|562042520|FG023|Overall Study|Sponsor decision to terminate study|0|||
155712508|NCT04497116|562042521|FG024|Overall Study|Sponsor decision to terminate study|0|||
155712509|NCT04497116|562042497|FG000|Overall Study|Death|4|||
155712510|NCT04497116|562042498|FG001|Overall Study|Death|5|||
155712511|NCT04497116|562042499|FG002|Overall Study|Death|2|||
155712512|NCT04497116|562042500|FG003|Overall Study|Death|2|||
155712513|NCT04497116|562042501|FG004|Overall Study|Death|1|||
155712514|NCT04497116|562042502|FG005|Overall Study|Death|1|||
155712515|NCT04497116|562042503|FG006|Overall Study|Death|3|||
155712516|NCT04497116|562042504|FG007|Overall Study|Death|10|||
155712517|NCT04497116|562042505|FG008|Overall Study|Death|37|||
155712518|NCT04497116|562042506|FG009|Overall Study|Death|17|||
155712519|NCT04497116|562042507|FG010|Overall Study|Death|2|||
155712520|NCT04497116|562042508|FG011|Overall Study|Death|1|||
155712521|NCT04497116|562042509|FG012|Overall Study|Death|1|||
155712522|NCT04497116|562042510|FG013|Overall Study|Death|3|||
155712523|NCT04497116|562042511|FG014|Overall Study|Death|18|||
155712524|NCT04497116|562042512|FG015|Overall Study|Death|3|||
155712525|NCT04497116|562042513|FG016|Overall Study|Death|2|||
155712526|NCT04497116|562042514|FG017|Overall Study|Death|1|||
155712527|NCT04497116|562042515|FG018|Overall Study|Death|4|||
155712528|NCT04497116|562042516|FG019|Overall Study|Death|17|||
155712529|NCT04497116|562042517|FG020|Overall Study|Death|1|||
155712530|NCT04497116|562042518|FG021|Overall Study|Death|0|||
155712531|NCT04497116|562042519|FG022|Overall Study|Death|3|||
155712532|NCT04497116|562042520|FG023|Overall Study|Death|5|||
155712533|NCT04497116|562042521|FG024|Overall Study|Death|4|||
155712534|NCT04497116|562042497|FG000|Overall Study|Withdrawal by Subject|1|||
155712535|NCT04497116|562042498|FG001|Overall Study|Withdrawal by Subject|0|||
155712536|NCT04497116|562042499|FG002|Overall Study|Withdrawal by Subject|1|||
155712537|NCT04497116|562042500|FG003|Overall Study|Withdrawal by Subject|0|||
155712538|NCT04497116|562042501|FG004|Overall Study|Withdrawal by Subject|0|||
155712539|NCT04497116|562042502|FG005|Overall Study|Withdrawal by Subject|0|||
155712540|NCT04497116|562042503|FG006|Overall Study|Withdrawal by Subject|0|||
155712541|NCT04497116|562042504|FG007|Overall Study|Withdrawal by Subject|7|||
155712542|NCT04497116|562042505|FG008|Overall Study|Withdrawal by Subject|14|||
155712543|NCT04497116|562042506|FG009|Overall Study|Withdrawal by Subject|3|||
155712544|NCT04497116|562042507|FG010|Overall Study|Withdrawal by Subject|3|||
155712545|NCT04497116|562042508|FG011|Overall Study|Withdrawal by Subject|0|||
155712546|NCT04497116|562042509|FG012|Overall Study|Withdrawal by Subject|1|||
155712547|NCT04497116|562042510|FG013|Overall Study|Withdrawal by Subject|0|||
155712548|NCT04497116|562042511|FG014|Overall Study|Withdrawal by Subject|7|||
155712549|NCT04497116|562042512|FG015|Overall Study|Withdrawal by Subject|1|||
155712550|NCT04497116|562042513|FG016|Overall Study|Withdrawal by Subject|3|||
155712551|NCT04497116|562042514|FG017|Overall Study|Withdrawal by Subject|1|||
155712552|NCT04497116|562042515|FG018|Overall Study|Withdrawal by Subject|1|||
155712553|NCT04497116|562042516|FG019|Overall Study|Withdrawal by Subject|5|||
155712554|NCT04497116|562042517|FG020|Overall Study|Withdrawal by Subject|2|||
155712555|NCT04497116|562042518|FG021|Overall Study|Withdrawal by Subject|2|||
155712556|NCT04497116|562042519|FG022|Overall Study|Withdrawal by Subject|2|||
155712557|NCT04497116|562042520|FG023|Overall Study|Withdrawal by Subject|4|||
155712558|NCT04497116|562042521|FG024|Overall Study|Withdrawal by Subject|3|||
155712559|NCT04497116|562042497|FG000|Overall Study|Physician Decision|0|||
155712560|NCT04497116|562042498|FG001|Overall Study|Physician Decision|0|||
155712561|NCT04497116|562042499|FG002|Overall Study|Physician Decision|0|||
155712562|NCT04497116|562042500|FG003|Overall Study|Physician Decision|0|||
155712563|NCT04497116|562042501|FG004|Overall Study|Physician Decision|0|||
155712564|NCT04497116|562042502|FG005|Overall Study|Physician Decision|0|||
155712565|NCT04497116|562042503|FG006|Overall Study|Physician Decision|0|||
155712566|NCT04497116|562042504|FG007|Overall Study|Physician Decision|0|||
155712567|NCT04497116|562042505|FG008|Overall Study|Physician Decision|0|||
155712568|NCT04497116|562042506|FG009|Overall Study|Physician Decision|0|||
155712569|NCT04497116|562042507|FG010|Overall Study|Physician Decision|0|||
155712570|NCT04497116|562042508|FG011|Overall Study|Physician Decision|0|||
155712571|NCT04497116|562042509|FG012|Overall Study|Physician Decision|0|||
155712572|NCT04497116|562042510|FG013|Overall Study|Physician Decision|0|||
155712573|NCT04497116|562042511|FG014|Overall Study|Physician Decision|0|||
155712574|NCT04497116|562042512|FG015|Overall Study|Physician Decision|0|||
155712575|NCT04497116|562042513|FG016|Overall Study|Physician Decision|0|||
155712576|NCT04497116|562042514|FG017|Overall Study|Physician Decision|0|||
155712577|NCT04497116|562042515|FG018|Overall Study|Physician Decision|0|||
155712578|NCT04497116|562042516|FG019|Overall Study|Physician Decision|0|||
155712579|NCT04497116|562042517|FG020|Overall Study|Physician Decision|0|||
155712580|NCT04497116|562042518|FG021|Overall Study|Physician Decision|0|||
155712581|NCT04497116|562042519|FG022|Overall Study|Physician Decision|0|||
155712582|NCT04497116|562042520|FG023|Overall Study|Physician Decision|1|||
155712583|NCT04497116|562042521|FG024|Overall Study|Physician Decision|0|||
155712584|NCT04497116|562042497|FG000|Overall Study|Clinical Progression Related|0|||
155712585|NCT04497116|562042498|FG001|Overall Study|Clinical Progression Related|0|||
155712586|NCT04497116|562042499|FG002|Overall Study|Clinical Progression Related|0|||
155712587|NCT04497116|562042500|FG003|Overall Study|Clinical Progression Related|0|||
155712588|NCT04497116|562042501|FG004|Overall Study|Clinical Progression Related|0|||
155712589|NCT04497116|562042502|FG005|Overall Study|Clinical Progression Related|0|||
155712590|NCT04497116|562042503|FG006|Overall Study|Clinical Progression Related|0|||
155712591|NCT04497116|562042504|FG007|Overall Study|Clinical Progression Related|0|||
155712592|NCT04497116|562042505|FG008|Overall Study|Clinical Progression Related|0|||
155712593|NCT04497116|562042506|FG009|Overall Study|Clinical Progression Related|1|||
155712594|NCT04497116|562042507|FG010|Overall Study|Clinical Progression Related|0|||
155712595|NCT04497116|562042508|FG011|Overall Study|Clinical Progression Related|0|||
155712596|NCT04497116|562042509|FG012|Overall Study|Clinical Progression Related|0|||
155712597|NCT04497116|562042510|FG013|Overall Study|Clinical Progression Related|0|||
155712598|NCT04497116|562042511|FG014|Overall Study|Clinical Progression Related|0|||
155712599|NCT04497116|562042512|FG015|Overall Study|Clinical Progression Related|0|||
155712600|NCT04497116|562042513|FG016|Overall Study|Clinical Progression Related|0|||
155712601|NCT04497116|562042514|FG017|Overall Study|Clinical Progression Related|0|||
155712602|NCT04497116|562042515|FG018|Overall Study|Clinical Progression Related|0|||
155712603|NCT04497116|562042516|FG019|Overall Study|Clinical Progression Related|0|||
155712604|NCT04497116|562042517|FG020|Overall Study|Clinical Progression Related|0|||
155712605|NCT04497116|562042518|FG021|Overall Study|Clinical Progression Related|0|||
155712606|NCT04497116|562042519|FG022|Overall Study|Clinical Progression Related|0|||
155712607|NCT04497116|562042520|FG023|Overall Study|Clinical Progression Related|0|||
155712608|NCT04497116|562042521|FG024|Overall Study|Clinical Progression Related|0|||
155712609|NCT05963022|562042522|FG000|Overall Study|Adverse Event|0|||
155712610|NCT05963022|562042523|FG001|Overall Study|Adverse Event|1|||
155712611|NCT05963022|562042524|FG002|Overall Study|Adverse Event|1|||
155712612|NCT05963022|562042525|FG003|Overall Study|Adverse Event|0|||
155712613|NCT05963022|562042522|FG000|Overall Study|Protocol Violation|0|||
155712614|NCT05963022|562042523|FG001|Overall Study|Protocol Violation|3|||
155712615|NCT05963022|562042524|FG002|Overall Study|Protocol Violation|0|||
155712616|NCT05963022|562042525|FG003|Overall Study|Protocol Violation|0|||
155712617|NCT05963022|562042522|FG000|Overall Study|Pregnancy|0|||
155712618|NCT05963022|562042523|FG001|Overall Study|Pregnancy|1|||
155712619|NCT05963022|562042524|FG002|Overall Study|Pregnancy|1|||
155712620|NCT05963022|562042525|FG003|Overall Study|Pregnancy|1|||
155712621|NCT05963022|562042522|FG000|Overall Study|Withdrawal by Subject|0|||
155712622|NCT05963022|562042523|FG001|Overall Study|Withdrawal by Subject|0|||
155712623|NCT05963022|562042524|FG002|Overall Study|Withdrawal by Subject|2|||
155712624|NCT05963022|562042525|FG003|Overall Study|Withdrawal by Subject|1|||
155712625|NCT05963022|562042522|FG000|Overall Study|Lost to Follow-up|0|||
155712626|NCT05963022|562042523|FG001|Overall Study|Lost to Follow-up|0|||
155712627|NCT05963022|562042524|FG002|Overall Study|Lost to Follow-up|0|||
155712628|NCT05963022|562042525|FG003|Overall Study|Lost to Follow-up|1|||
155712629|NCT05963022|562042522|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155712630|NCT05963022|562042523|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155712631|NCT05963022|562042524|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155712632|NCT05963022|562042525|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
155712633|NCT02698826|562042526|FG000|Overall Study|Death|13|||
155712634|NCT02698826|562042526|FG000|Overall Study|Adverse Event|1|||
155712635|NCT02915263|562042529|FG000|Overall Study|Covid|3|||
155712636|NCT02915263|562042530|FG001|Overall Study|Covid|2|||
155712637|NCT02478463|562042531|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
155712638|NCT02478463|562042531|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
155712639|NCT02478463|562042531|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
155712640|NCT01879683|562042532|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
155712641|NCT01508169|562042533|FG000|Overall Study|Adverse Event|1|||
155712642|NCT01508169|562042534|FG001|Overall Study|Adverse Event|0|||
155712643|NCT01508169|562042533|FG000|Overall Study|Withdrawal by Subject|1|||
155712644|NCT01508169|562042534|FG001|Overall Study|Withdrawal by Subject|0|||
155712645|NCT01508169|562042533|FG000|Overall Study|Lost to Follow-up|1|||
155712646|NCT01508169|562042534|FG001|Overall Study|Lost to Follow-up|2|||
155712647|NCT03600740|562042543|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
155712648|NCT01702558|562042544|FG000|Overall Study|Withdrawal by Subject|0|||
155712649|NCT01702558|562042545|FG001|Overall Study|Withdrawal by Subject|0|||
155712650|NCT01702558|562042546|FG002|Overall Study|Withdrawal by Subject|0|||
155712651|NCT01702558|562042547|FG003|Overall Study|Withdrawal by Subject|12|||
155712652|NCT01702558|562042548|FG004|Overall Study|Withdrawal by Subject|4|||
155712653|NCT01702558|562042544|FG000|Overall Study|Lost to Follow-up|0|||
155712654|NCT01702558|562042545|FG001|Overall Study|Lost to Follow-up|0|||
155712655|NCT01702558|562042546|FG002|Overall Study|Lost to Follow-up|0|||
155712656|NCT01702558|562042547|FG003|Overall Study|Lost to Follow-up|3|||
155712657|NCT01702558|562042548|FG004|Overall Study|Lost to Follow-up|0|||
155712658|NCT01702558|562042544|FG000|Overall Study|Death|4|||
155712659|NCT01702558|562042545|FG001|Overall Study|Death|3|||
155712660|NCT01702558|562042546|FG002|Overall Study|Death|3|||
155712661|NCT01702558|562042547|FG003|Overall Study|Death|16|||
155712662|NCT01702558|562042548|FG004|Overall Study|Death|20|||
155712663|NCT01702558|562042544|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
155712664|NCT01702558|562042545|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
155712665|NCT01702558|562042546|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
155712666|NCT01702558|562042547|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
155712667|NCT01702558|562042548|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
155712668|NCT01702558|562042544|FG000|Overall Study|Study Terminated by Sponsor|0|||
155712669|NCT01702558|562042545|FG001|Overall Study|Study Terminated by Sponsor|1|||
155712670|NCT01702558|562042546|FG002|Overall Study|Study Terminated by Sponsor|0|||
155712671|NCT01702558|562042547|FG003|Overall Study|Study Terminated by Sponsor|0|||
155712672|NCT01702558|562042548|FG004|Overall Study|Study Terminated by Sponsor|1|||
155712673|NCT01702558|562042544|FG000|Overall Study|Other|0|||
155712674|NCT01702558|562042545|FG001|Overall Study|Other|0|||
155712675|NCT01702558|562042546|FG002|Overall Study|Other|0|||
155712676|NCT01702558|562042547|FG003|Overall Study|Other|16|||
155712677|NCT01702558|562042548|FG004|Overall Study|Other|17|||
155712678|NCT01788566|562042554|FG000|Overall Study|Death|4|||
155712679|NCT01788566|562042554|FG000|Overall Study|Adverse Event|1|||
155712680|NCT01788566|562042554|FG000|Overall Study|Clinical Progressive Disease|3|||
155712681|NCT01338818|562042555|FG000|Overall Study|Adverse Event|8|||
155712682|NCT01338818|562042555|FG000|Overall Study|Lack of Efficacy|5|||
155712683|NCT01338818|562042555|FG000|Overall Study|no longer require study drug|1|||
155712684|NCT01338818|562042555|FG000|Overall Study|Withdrawal by Subject|11|||
155712685|NCT01338818|562042555|FG000|Overall Study|Lost to Follow-up|4|||
155712686|NCT01338818|562042555|FG000|Overall Study|Administrative problems|3|||
155712687|NCT01338818|562042555|FG000|Overall Study|Protocol Deviation|4|||
155712688|NCT01620086|562042556|FG000|Overall Study|Withdrawal by Subject|3|||
155712689|NCT01620086|562042557|FG001|Overall Study|Withdrawal by Subject|3|||
155712690|NCT01620086|562042558|FG002|Overall Study|Withdrawal by Subject|0|||
155712691|NCT01620086|562042556|FG000|Overall Study|failed study criteria|1|||
155712692|NCT01620086|562042557|FG001|Overall Study|failed study criteria|4|||
155712693|NCT01620086|562042558|FG002|Overall Study|failed study criteria|0|||
155712694|NCT01620086|562042556|FG000|Overall Study|Physician Decision|1|||
155712695|NCT01620086|562042557|FG001|Overall Study|Physician Decision|0|||
155712696|NCT01620086|562042558|FG002|Overall Study|Physician Decision|0|||
155712697|NCT03030417|562042561|FG000|Dose Expansion|Disease progression before treatment|0|||
155712698|NCT03030417|562042562|FG001|Dose Expansion|Disease progression before treatment|0|||
155712699|NCT03030417|562042563|FG002|Dose Expansion|Disease progression before treatment|0|||
155712700|NCT03030417|562042564|FG003|Dose Expansion|Disease progression before treatment|0|||
155712701|NCT03030417|562042565|FG004|Dose Expansion|Disease progression before treatment|0|||
155712702|NCT03030417|562042566|FG005|Dose Expansion|Disease progression before treatment|0|||
155712703|NCT03030417|562042567|FG006|Dose Expansion|Disease progression before treatment|0|||
155712704|NCT03030417|562042568|FG007|Dose Expansion|Disease progression before treatment|0|||
155712705|NCT03030417|562042569|FG008|Dose Expansion|Disease progression before treatment|0|||
155712706|NCT03030417|562042570|FG009|Dose Expansion|Disease progression before treatment|0|||
155712707|NCT03030417|562042571|FG010|Dose Expansion|Disease progression before treatment|0|||
155712708|NCT03030417|562042572|FG011|Dose Expansion|Disease progression before treatment|0|||
155712709|NCT03030417|562042573|FG012|Dose Expansion|Disease progression before treatment|1|||
155712710|NCT01539759|562042574|FG000|Overall Study|Lost to Follow-up|6|||
155712711|NCT01539759|562042575|FG001|Overall Study|Lost to Follow-up|8|||
155712712|NCT01078441|562042576|FG000|Overall Study|Withdrawal by Subject|1|||
155712713|NCT01425801|562042577|FG000|Period 1|Withdrawal by Subject|0|||
155712714|NCT01425801|562042578|FG001|Period 1|Withdrawal by Subject|0|||
155712715|NCT01425801|562042579|FG002|Period 1|Withdrawal by Subject|0|||
155712716|NCT01425801|562042580|FG003|Period 1|Withdrawal by Subject|0|||
155712717|NCT01425801|562042581|FG004|Period 1|Withdrawal by Subject|1|||
155712718|NCT01425801|562042582|FG005|Period 1|Withdrawal by Subject|0|||
155712719|NCT01425801|562042577|FG000|Period 2|Withdrawal by Subject|0|||
155712720|NCT01425801|562042578|FG001|Period 2|Withdrawal by Subject|0|||
155712721|NCT01425801|562042579|FG002|Period 2|Withdrawal by Subject|0|||
155712722|NCT01425801|562042580|FG003|Period 2|Withdrawal by Subject|0|||
155712723|NCT01425801|562042581|FG004|Period 2|Withdrawal by Subject|1|||
155712724|NCT01425801|562042582|FG005|Period 2|Withdrawal by Subject|0|||
155712725|NCT01425801|562042577|FG000|Period 3|Stability criteria not fullfilled|0|||
155712726|NCT01425801|562042578|FG001|Period 3|Stability criteria not fullfilled|0|||
155712727|NCT01425801|562042579|FG002|Period 3|Stability criteria not fullfilled|1|||
155712728|NCT01425801|562042580|FG003|Period 3|Stability criteria not fullfilled|0|||
155712729|NCT01425801|562042581|FG004|Period 3|Stability criteria not fullfilled|0|||
155712730|NCT01425801|562042582|FG005|Period 3|Stability criteria not fullfilled|0|||
155712731|NCT01425801|562042577|FG000|Period 4|Not able to maintain visit schedule|0|||
155712732|NCT01425801|562042578|FG001|Period 4|Not able to maintain visit schedule|0|||
155712733|NCT01425801|562042579|FG002|Period 4|Not able to maintain visit schedule|1|||
155712734|NCT01425801|562042580|FG003|Period 4|Not able to maintain visit schedule|0|||
155712735|NCT01425801|562042581|FG004|Period 4|Not able to maintain visit schedule|0|||
155712736|NCT01425801|562042582|FG005|Period 4|Not able to maintain visit schedule|0|||
155712737|NCT02175017|562042583|FG000|Overall Study|Did not receive the investigational product|1|||
155712738|NCT02175017|562042584|FG001|Overall Study|Did not receive the investigational product|2|||
155712739|NCT02175017|562042583|FG000|Overall Study|Withdrawal by Subject|6|||
155712740|NCT02175017|562042584|FG001|Overall Study|Withdrawal by Subject|3|||
155712741|NCT02175017|562042583|FG000|Overall Study|Met an exclusion criteria|0|||
155712742|NCT02175017|562042584|FG001|Overall Study|Met an exclusion criteria|1|||
155712743|NCT02175017|562042583|FG000|Overall Study|Adverse Event|3|||
155712744|NCT02175017|562042584|FG001|Overall Study|Adverse Event|10|||
155712745|NCT02175017|562042583|FG000|Overall Study|Disease progression|20|||
155712746|NCT02175017|562042584|FG001|Overall Study|Disease progression|27|||
155712747|NCT02175017|562042583|FG000|Overall Study|Other than above reasons|3|||
155712748|NCT02175017|562042584|FG001|Overall Study|Other than above reasons|0|||
155712749|NCT04915729|562042585|FG000|Overall Study|Lost to Follow-up|20|||
155712750|NCT04915729|562042586|FG001|Overall Study|Lost to Follow-up|10|||
155712751|NCT04915729|562042585|FG000|Overall Study|Withdrawal by Subject|12|||
155712752|NCT04915729|562042586|FG001|Overall Study|Withdrawal by Subject|5|||
155712753|NCT04915729|562042585|FG000|Overall Study|Death|34|||
155712754|NCT04915729|562042586|FG001|Overall Study|Death|44|||
155712755|NCT04915729|562042585|FG000|Overall Study|not treated|3|||
155712756|NCT04915729|562042586|FG001|Overall Study|not treated|6|||
155712757|NCT04915729|562042585|FG000|Overall Study|Investigator removed subject|1|||
155712758|NCT04915729|562042586|FG001|Overall Study|Investigator removed subject|2|||
155712759|NCT04915729|562042585|FG000|Overall Study|questionnaire result not evaluated|1|||
155712760|NCT04915729|562042586|FG001|Overall Study|questionnaire result not evaluated|0|||
155712761|NCT04915729|562042585|FG000|Overall Study|refuse of hospital visit|1|||
155712762|NCT04915729|562042586|FG001|Overall Study|refuse of hospital visit|3|||
155712763|NCT04915729|562042585|FG000|Overall Study|Subject withdrew|1|||
155712764|NCT04915729|562042586|FG001|Overall Study|Subject withdrew|0|||
155712765|NCT03575403|562042587|FG000|Overall Study|Adverse Event|1|||
155712766|NCT03575403|562042588|FG001|Overall Study|Adverse Event|0|||
155712767|NCT03575403|562042589|FG002|Overall Study|Adverse Event|0|||
155712768|NCT03575403|562042587|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
155712769|NCT03575403|562042588|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
155712770|NCT03575403|562042589|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
155712771|NCT03066596|562042590|FG000|Overall Study|Withdrawal by Subject|4|||
155712772|NCT03066596|562042591|FG001|Overall Study|Withdrawal by Subject|2|||
155712773|NCT03066596|562042590|FG000|Overall Study|Lost to Follow-up|14|||
155712774|NCT03066596|562042591|FG001|Overall Study|Lost to Follow-up|10|||
155712775|NCT00773513|562042592|FG000|Overall Study|Renal Transplant|254|||
155712776|NCT00773513|562042593|FG001|Overall Study|Renal Transplant|263|||
155712777|NCT00773513|562042592|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
155712778|NCT00773513|562042593|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
155712779|NCT00773513|562042592|FG000|Overall Study|Withdrew Consent|68|||
155712780|NCT00773513|562042593|FG001|Overall Study|Withdrew Consent|69|||
155712781|NCT00773513|562042592|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
155712782|NCT00773513|562042593|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
155712783|NCT00773513|562042592|FG000|Overall Study|Failure to Return|22|||
155712784|NCT00773513|562042593|FG001|Overall Study|Failure to Return|8|||
155712785|NCT00773513|562042592|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155712786|NCT00773513|562042593|FG001|Overall Study|Insufficient Therapeutic Response|18|||
155712787|NCT00773513|562042592|FG000|Overall Study|Reason Not Specified|159|||
155712788|NCT00773513|562042593|FG001|Overall Study|Reason Not Specified|126|||
155712789|NCT00773513|562042592|FG000|Overall Study|Death|531|||
155712790|NCT00773513|562042593|FG001|Overall Study|Death|545|||
155712791|NCT02864901|562042594|FG000|Overall Study|Withdrawal by Subject|1|||
155712792|NCT02864901|562042595|FG001|Overall Study|Withdrawal by Subject|0|||
155712793|NCT00782717|562042601|FG000|Overall Study|Adverse Event|2|||
155712794|NCT00782717|562042602|FG001|Overall Study|Adverse Event|5|||
155712795|NCT00782717|562042601|FG000|Overall Study|Patient decision unrelated to AE|6|||
155712796|NCT00782717|562042602|FG001|Overall Study|Patient decision unrelated to AE|3|||
155712797|NCT00782717|562042601|FG000|Overall Study|Noncompliance|2|||
155712798|NCT00782717|562042602|FG001|Overall Study|Noncompliance|1|||
155712799|NCT00782717|562042601|FG000|Overall Study|Treatment failure|3|||
155712800|NCT00782717|562042602|FG001|Overall Study|Treatment failure|14|||
155712801|NCT00782717|562042601|FG000|Overall Study|Enrollment close prior to surgery|1|||
155712802|NCT00782717|562042602|FG001|Overall Study|Enrollment close prior to surgery|0|||
155712803|NCT00782717|562042601|FG000|Overall Study|Did not meet entrance criteria|1|||
155712804|NCT00782717|562042602|FG001|Overall Study|Did not meet entrance criteria|3|||
155712805|NCT00782717|562042601|FG000|Overall Study|Exited in error|0|||
155712806|NCT00782717|562042602|FG001|Overall Study|Exited in error|2|||
155712807|NCT03359174|562042603|FG000|Overall Study|Adverse Event|1|||
155712808|NCT02446717|562042604|FG000|Overall Study|Adverse Event|0|||
155712809|NCT02446717|562042605|FG001|Overall Study|Adverse Event|0|||
155712810|NCT02446717|562042606|FG002|Overall Study|Adverse Event|1|||
155712811|NCT02446717|562042607|FG003|Overall Study|Adverse Event|0|||
155712812|NCT02446717|562042608|FG004|Overall Study|Adverse Event|0|||
155712813|NCT02446717|562042604|FG000|Overall Study|Lost to Follow-up|0|||
155712814|NCT02446717|562042605|FG001|Overall Study|Lost to Follow-up|1|||
155712815|NCT02446717|562042606|FG002|Overall Study|Lost to Follow-up|1|||
155712816|NCT02446717|562042607|FG003|Overall Study|Lost to Follow-up|0|||
155712817|NCT02446717|562042608|FG004|Overall Study|Lost to Follow-up|1|||
155712818|NCT02446717|562042604|FG000|Overall Study|Withdrew consent|0|||
155712819|NCT02446717|562042605|FG001|Overall Study|Withdrew consent|0|||
155712820|NCT02446717|562042606|FG002|Overall Study|Withdrew consent|0|||
155712821|NCT02446717|562042607|FG003|Overall Study|Withdrew consent|1|||
155712822|NCT02446717|562042608|FG004|Overall Study|Withdrew consent|0|||
155712823|NCT01332994|562042615|FG000|Overall Study|Adverse Event|34|||
155712824|NCT01332994|562042615|FG000|Overall Study|Death|1|||
155712825|NCT01332994|562042615|FG000|Overall Study|Lack of Efficacy|1|||
155712826|NCT01332994|562042615|FG000|Overall Study|Lost to Follow-up|4|||
155712827|NCT01332994|562042615|FG000|Overall Study|Protocol Violation|6|||
155712828|NCT01332994|562042615|FG000|Overall Study|Withdrawal by Subject|15|||
155712829|NCT01332994|562042615|FG000|Overall Study|Administrative Problem|2|||
155712830|NCT01332994|562042615|FG000|Overall Study|Other|8|||
155712831|NCT01807598|562042616|FG000|Overall Study|Withdrawal by Subject|4|||
155712832|NCT01807598|562042616|FG000|Overall Study|Adverse Event|1|||
155712833|NCT01807598|562042616|FG000|Overall Study|Other Physician Decision|1|||
155712834|NCT04170543|562042617|FG000|Overall Study|Death|1|||
155712835|NCT04170543|562042618|FG001|Overall Study|Death|1|||
155712836|NCT04170543|562042619|FG002|Overall Study|Death|1|||
155712837|NCT04170543|562042620|FG003|Overall Study|Death|1|||
155712838|NCT04170543|562042621|FG004|Overall Study|Death|1|||
155712839|NCT04170543|562042617|FG000|Overall Study|Lost to Follow-up|3|||
155712840|NCT04170543|562042618|FG001|Overall Study|Lost to Follow-up|3|||
155712841|NCT04170543|562042619|FG002|Overall Study|Lost to Follow-up|0|||
155712842|NCT04170543|562042620|FG003|Overall Study|Lost to Follow-up|3|||
155712843|NCT04170543|562042621|FG004|Overall Study|Lost to Follow-up|1|||
155712844|NCT04170543|562042617|FG000|Overall Study|Withdrawal by Subject|13|||
155712845|NCT04170543|562042618|FG001|Overall Study|Withdrawal by Subject|6|||
155712846|NCT04170543|562042619|FG002|Overall Study|Withdrawal by Subject|5|||
155712847|NCT04170543|562042620|FG003|Overall Study|Withdrawal by Subject|4|||
155712848|NCT04170543|562042621|FG004|Overall Study|Withdrawal by Subject|9|||
155712849|NCT04170543|562042617|FG000|Overall Study|Not able to transition to phase 2b|8|||
155712850|NCT04170543|562042618|FG001|Overall Study|Not able to transition to phase 2b|0|||
155712851|NCT04170543|562042619|FG002|Overall Study|Not able to transition to phase 2b|10|||
155712852|NCT04170543|562042620|FG003|Overall Study|Not able to transition to phase 2b|0|||
155712853|NCT04170543|562042621|FG004|Overall Study|Not able to transition to phase 2b|6|||
155712854|NCT04170543|562042617|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
155712855|NCT04170543|562042618|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
155712856|NCT04170543|562042619|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
155712857|NCT04170543|562042620|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
155712858|NCT04170543|562042621|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
155712859|NCT04170543|562042617|FG000|Overall Study|Not Treated|0|||
155712860|NCT04170543|562042618|FG001|Overall Study|Not Treated|0|||
155712861|NCT04170543|562042619|FG002|Overall Study|Not Treated|0|||
155712862|NCT04170543|562042620|FG003|Overall Study|Not Treated|0|||
155712863|NCT04170543|562042621|FG004|Overall Study|Not Treated|2|||
155712864|NCT04170543|562042617|FG000|Overall Study|(CRF)|16|||
155712865|NCT04170543|562042618|FG001|Overall Study|(CRF)|15|||
155712866|NCT04170543|562042619|FG002|Overall Study|(CRF)|12|||
155712867|NCT04170543|562042620|FG003|Overall Study|(CRF)|17|||
155712868|NCT04170543|562042621|FG004|Overall Study|(CRF)|17|||
155712869|NCT04170543|562042617|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
155712870|NCT04170543|562042618|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
155712871|NCT04170543|562042619|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
155712872|NCT04170543|562042620|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
155712873|NCT04170543|562042621|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
155712874|NCT04378270|562042622|FG000|Overall Study|Lack of Efficacy|1|||
155712875|NCT04378270|562042622|FG000|Overall Study|Withdrawal by Subject|1|||
155712876|NCT04378270|562042622|FG000|Overall Study|Screen Failure|1|||
155712877|NCT04378270|562042622|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
155712878|NCT01156714|562042623|FG000|Overall Study|Withdrawal by Subject|9|||
155712879|NCT01156714|562042624|FG001|Overall Study|Withdrawal by Subject|4|||
155712880|NCT01156714|562042625|FG002|Overall Study|Withdrawal by Subject|3|||
155712881|NCT01236521|562042626|FG000|Overall Study|Withdrawal by Subject|12|||
155712882|NCT01236521|562042627|FG001|Overall Study|Withdrawal by Subject|17|||
155712883|NCT01236521|562042626|FG000|Overall Study|Death|2|||
155712884|NCT01236521|562042627|FG001|Overall Study|Death|1|||
155712885|NCT01236521|562042626|FG000|Overall Study|Lost to Follow-up|9|||
155712886|NCT01236521|562042627|FG001|Overall Study|Lost to Follow-up|7|||
155712887|NCT04661150|562042634|FG000|Overall Study|Ongoing in study|19|||
155712888|NCT04661150|562042635|FG001|Overall Study|Ongoing in study|20|||
155712889|NCT04661150|562042634|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
155712890|NCT04661150|562042635|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
155712891|NCT04661150|562042634|FG000|Overall Study|Death|2|||
155712892|NCT04661150|562042635|FG001|Overall Study|Death|0|||
155712893|NCT04965688|562042636|FG000|Overall Study|Withdrawal by Subject|2|||
155712894|NCT05907395|562042637|FG000|Period 1|No longer met eligibility criteria|0|||
155712895|NCT05907395|562042638|FG001|Period 1|No longer met eligibility criteria|1|||
155712896|NCT05907395|562042639|FG002|Period 1|No longer met eligibility criteria|0|||
155712897|NCT05907395|562042640|FG003|Period 1|No longer met eligibility criteria|0|||
155712898|NCT05907395|562042641|FG004|Period 1|No longer met eligibility criteria|0|||
155712899|NCT05907395|562042642|FG005|Period 1|No longer met eligibility criteria|1|||
155712900|NCT05907395|562042643|FG006|Period 1|No longer met eligibility criteria|1|||
155712901|NCT05907395|562042644|FG007|Period 1|No longer met eligibility criteria|0|||
155712902|NCT05907395|562042645|FG008|Period 1|No longer met eligibility criteria|0|||
155712903|NCT05907395|562042646|FG009|Period 1|No longer met eligibility criteria|0|||
155712904|NCT05907395|562042647|FG010|Period 1|No longer met eligibility criteria|0|||
155712905|NCT05907395|562042648|FG011|Period 1|No longer met eligibility criteria|0|||
155712906|NCT05907395|562042637|FG000|Period 2|Adverse Event|0|||
155712907|NCT05907395|562042638|FG001|Period 2|Adverse Event|0|||
155712908|NCT05907395|562042639|FG002|Period 2|Adverse Event|0|||
155712909|NCT05907395|562042640|FG003|Period 2|Adverse Event|1|||
155712910|NCT05907395|562042641|FG004|Period 2|Adverse Event|0|||
155712911|NCT05907395|562042642|FG005|Period 2|Adverse Event|0|||
155712912|NCT05907395|562042643|FG006|Period 2|Adverse Event|0|||
155712913|NCT05907395|562042644|FG007|Period 2|Adverse Event|1|||
155712914|NCT05907395|562042645|FG008|Period 2|Adverse Event|0|||
155712915|NCT05907395|562042646|FG009|Period 2|Adverse Event|0|||
155712916|NCT05907395|562042647|FG010|Period 2|Adverse Event|0|||
155712917|NCT05907395|562042648|FG011|Period 2|Adverse Event|0|||
155712918|NCT05907395|562042637|FG000|Period 2|Personal reason|0|||
155712919|NCT05907395|562042638|FG001|Period 2|Personal reason|0|||
155712920|NCT05907395|562042639|FG002|Period 2|Personal reason|0|||
155712921|NCT05907395|562042640|FG003|Period 2|Personal reason|0|||
155712922|NCT05907395|562042641|FG004|Period 2|Personal reason|0|||
155712923|NCT05907395|562042642|FG005|Period 2|Personal reason|0|||
155712924|NCT05907395|562042643|FG006|Period 2|Personal reason|0|||
155712925|NCT05907395|562042644|FG007|Period 2|Personal reason|0|||
155712926|NCT05907395|562042645|FG008|Period 2|Personal reason|0|||
155712927|NCT05907395|562042646|FG009|Period 2|Personal reason|1|||
155712928|NCT05907395|562042647|FG010|Period 2|Personal reason|0|||
155712929|NCT05907395|562042648|FG011|Period 2|Personal reason|0|||
155712930|NCT05907395|562042637|FG000|Period 3|Adverse Event|0|||
155712931|NCT05907395|562042638|FG001|Period 3|Adverse Event|0|||
155712932|NCT05907395|562042639|FG002|Period 3|Adverse Event|0|||
155712933|NCT05907395|562042640|FG003|Period 3|Adverse Event|0|||
155712934|NCT05907395|562042641|FG004|Period 3|Adverse Event|1|||
155712935|NCT05907395|562042642|FG005|Period 3|Adverse Event|0|||
155712936|NCT05907395|562042643|FG006|Period 3|Adverse Event|0|||
155712937|NCT05907395|562042644|FG007|Period 3|Adverse Event|0|||
155712938|NCT05907395|562042645|FG008|Period 3|Adverse Event|0|||
155712939|NCT05907395|562042646|FG009|Period 3|Adverse Event|0|||
155712940|NCT05907395|562042647|FG010|Period 3|Adverse Event|0|||
155712941|NCT05907395|562042648|FG011|Period 3|Adverse Event|0|||
155712942|NCT02701283|562042649|FG000|Overall Study|Death|25|||
155712943|NCT02701283|562042650|FG001|Overall Study|Death|29|||
155712944|NCT02701283|562042651|FG002|Overall Study|Death|19|||
155712945|NCT02701283|562042649|FG000|Overall Study|Lost to Follow-up|3|||
155712946|NCT02701283|562042650|FG001|Overall Study|Lost to Follow-up|8|||
155712947|NCT02701283|562042651|FG002|Overall Study|Lost to Follow-up|1|||
155712948|NCT02701283|562042649|FG000|Overall Study|Withdrawal by Subject|12|||
155712949|NCT02701283|562042650|FG001|Overall Study|Withdrawal by Subject|41|||
155712950|NCT02701283|562042651|FG002|Overall Study|Withdrawal by Subject|1|||
155712951|NCT02701283|562042649|FG000|Overall Study|Missed 2-year visit|22|||
155712952|NCT02701283|562042650|FG001|Overall Study|Missed 2-year visit|27|||
155712953|NCT02701283|562042651|FG002|Overall Study|Missed 2-year visit|0|||
155712954|NCT02701283|562042649|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
155712955|NCT02701283|562042650|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
155712956|NCT02701283|562042651|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
155712957|NCT04544956|562042652|FG000|Overall Study|Withdrawal by Subject|1|||
155712958|NCT04266795|562042653|FG000|Overall Study|Adverse Event|10|||
155712959|NCT04266795|562042654|FG001|Overall Study|Adverse Event|19|||
155712960|NCT04266795|562042653|FG000|Overall Study|Death|7|||
155712961|NCT04266795|562042654|FG001|Overall Study|Death|8|||
155712962|NCT04266795|562042653|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
155712963|NCT04266795|562042654|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
155712964|NCT04266795|562042653|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155712965|NCT04266795|562042654|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155712966|NCT04266795|562042653|FG000|Overall Study|Progressive Disease|12|||
155712967|NCT04266795|562042654|FG001|Overall Study|Progressive Disease|9|||
155712968|NCT04266795|562042653|FG000|Overall Study|Withdrawal by Patient|5|||
155712969|NCT04266795|562042654|FG001|Overall Study|Withdrawal by Patient|6|||
155712970|NCT04266795|562042653|FG000|Overall Study|Disease Relapse|3|||
155712971|NCT04266795|562042654|FG001|Overall Study|Disease Relapse|6|||
155712972|NCT04266795|562042653|FG000|Overall Study|Reason not Specified|12|||
155712973|NCT04266795|562042654|FG001|Overall Study|Reason not Specified|10|||
155712974|NCT04266795|562042653|FG000|Overall Study|Participants Ongoing on Treatment|25|||
155712975|NCT04266795|562042654|FG001|Overall Study|Participants Ongoing on Treatment|23|||
155712976|NCT03043872|562042655|FG000|Overall Study|Withdrawal by Subject|6|||
155712977|NCT03043872|562042656|FG001|Overall Study|Withdrawal by Subject|6|||
155712978|NCT03043872|562042657|FG002|Overall Study|Withdrawal by Subject|15|||
155712979|NCT03043872|562042655|FG000|Overall Study|Lost to Follow-up|2|||
155712980|NCT03043872|562042656|FG001|Overall Study|Lost to Follow-up|1|||
155712981|NCT03043872|562042657|FG002|Overall Study|Lost to Follow-up|1|||
155712982|NCT03043872|562042655|FG000|Overall Study|Death|270|||
155712983|NCT03043872|562042656|FG001|Overall Study|Death|269|||
155712984|NCT03043872|562042657|FG002|Overall Study|Death|296|||
155712985|NCT00543387|562042658|FG000|Panel 1 + Panel 2|Adverse Event|0|||
155712986|NCT00543387|562042659|FG001|Panel 1 + Panel 2|Adverse Event|1|||
155712987|NCT00543387|562042660|FG002|Panel 1 + Panel 2|Adverse Event|0|||
155712988|NCT00543387|562042661|FG003|Panel 1 + Panel 2|Adverse Event|0|||
155712989|NCT00543387|562042662|FG004|Panel 1 + Panel 2|Adverse Event|0|||
155712990|NCT00543387|562042663|FG005|Panel 1 + Panel 2|Adverse Event|0|||
155712991|NCT00543387|562042664|FG006|Panel 1 + Panel 2|Adverse Event|0|||
155712992|NCT00543387|562042665|FG007|Panel 1 + Panel 2|Adverse Event|1|||
155712993|NCT00543387|562042666|FG008|Panel 1 + Panel 2|Adverse Event|1|||
155712994|NCT00543387|562042667|FG009|Panel 1 + Panel 2|Adverse Event|0|||
155712995|NCT00543387|562042668|FG010|Panel 1 + Panel 2|Adverse Event|0|||
155712996|NCT00543387|562042658|FG000|Panel 1 + Panel 2|Physician Decision|0|||
155712997|NCT00543387|562042659|FG001|Panel 1 + Panel 2|Physician Decision|0|||
155712998|NCT00543387|562042660|FG002|Panel 1 + Panel 2|Physician Decision|1|||
155712999|NCT00543387|562042661|FG003|Panel 1 + Panel 2|Physician Decision|0|||
155713000|NCT00543387|562042662|FG004|Panel 1 + Panel 2|Physician Decision|0|||
155713001|NCT00543387|562042663|FG005|Panel 1 + Panel 2|Physician Decision|0|||
155713002|NCT00543387|562042664|FG006|Panel 1 + Panel 2|Physician Decision|0|||
155713003|NCT00543387|562042665|FG007|Panel 1 + Panel 2|Physician Decision|1|||
155713004|NCT00543387|562042666|FG008|Panel 1 + Panel 2|Physician Decision|0|||
155713005|NCT00543387|562042667|FG009|Panel 1 + Panel 2|Physician Decision|0|||
155713006|NCT00543387|562042668|FG010|Panel 1 + Panel 2|Physician Decision|0|||
155713007|NCT00543387|562042658|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155713008|NCT00543387|562042659|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
155713009|NCT00543387|562042660|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
155713010|NCT00543387|562042661|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155713011|NCT00543387|562042662|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155713012|NCT00543387|562042663|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155713013|NCT00543387|562042664|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
155713014|NCT00543387|562042665|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
155713015|NCT00543387|562042666|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
155713016|NCT00543387|562042667|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
155713017|NCT00543387|562042668|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
155713018|NCT00543387|562042658|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713019|NCT00543387|562042659|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713020|NCT00543387|562042660|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713021|NCT00543387|562042661|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713022|NCT00543387|562042662|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713023|NCT00543387|562042663|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713024|NCT00543387|562042664|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
155713025|NCT00543387|562042665|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713026|NCT00543387|562042666|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713027|NCT00543387|562042667|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713028|NCT00543387|562042668|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155713029|NCT00543387|562042658|FG000|Crossover Participants|Progressive Disease|0|||
155713030|NCT00543387|562042659|FG001|Crossover Participants|Progressive Disease|0|||
155713031|NCT00543387|562042660|FG002|Crossover Participants|Progressive Disease|0|||
155713032|NCT00543387|562042661|FG003|Crossover Participants|Progressive Disease|0|||
155713033|NCT00543387|562042662|FG004|Crossover Participants|Progressive Disease|0|||
155713034|NCT00543387|562042663|FG005|Crossover Participants|Progressive Disease|0|||
155713035|NCT00543387|562042664|FG006|Crossover Participants|Progressive Disease|0|||
155713036|NCT00543387|562042665|FG007|Crossover Participants|Progressive Disease|0|||
155713037|NCT00543387|562042666|FG008|Crossover Participants|Progressive Disease|0|||
155713038|NCT00543387|562042667|FG009|Crossover Participants|Progressive Disease|1|||
155713039|NCT00543387|562042668|FG010|Crossover Participants|Progressive Disease|2|||
155713040|NCT00543387|562042658|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
155713041|NCT00543387|562042659|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
155713042|NCT00543387|562042660|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
155713043|NCT00543387|562042661|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
155713044|NCT00543387|562042662|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
155713045|NCT00543387|562042663|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
155713046|NCT00543387|562042664|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
155713047|NCT00543387|562042665|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
155713048|NCT00543387|562042666|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
155713049|NCT00543387|562042667|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
155713050|NCT00543387|562042668|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
155713051|NCT03932760|562042671|FG000|Overall Study|Became Ineligible|2|||
155713052|NCT03932760|562042672|FG001|Overall Study|Became Ineligible|5|||
155713053|NCT03932760|562042671|FG000|Overall Study|Withdrawal by Subject|6|||
155713054|NCT03932760|562042672|FG001|Overall Study|Withdrawal by Subject|6|||
155713055|NCT01223183|562042676|FG000|Imaging Day 1|Physician Decision|0|||
155713056|NCT01223183|562042677|FG001|Imaging Day 1|Physician Decision|1|||
155713057|NCT01223183|562042676|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
155713058|NCT01223183|562042677|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
155713059|NCT01223183|562042676|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
155713060|NCT01223183|562042677|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
155713061|NCT03772665|562042678|FG000|Overall Study|Protocol Violation|1|||
155713062|NCT03772665|562042679|FG001|Overall Study|Protocol Violation|0|||
155713063|NCT03553758|562044318|FG000|Overall Study|Lost to Follow-up|1|||
155713064|NCT01467505|562044321|FG000|Overall Study|Adverse Event|1|||
155713065|NCT01467505|562044322|FG001|Overall Study|Adverse Event|0|||
155713066|NCT01467505|562044321|FG000|Overall Study|Withdrawal by Subject|4|||
155713067|NCT01467505|562044322|FG001|Overall Study|Withdrawal by Subject|0|||
155713068|NCT01467505|562044321|FG000|Overall Study|Study Terminated by Sponsor|28|||
155713069|NCT01467505|562044322|FG001|Overall Study|Study Terminated by Sponsor|3|||
155713070|NCT02719171|562044323|FG000|Overall Study|Adverse Event|1|||
155713071|NCT02719171|562044324|FG001|Overall Study|Adverse Event|2|||
155713072|NCT02719171|562044325|FG002|Overall Study|Adverse Event|0|||
155713073|NCT02719171|562044326|FG003|Overall Study|Adverse Event|0|||
155713074|NCT02719171|562044327|FG004|Overall Study|Adverse Event|2|||
155713075|NCT02719171|562044323|FG000|Overall Study|Lost to Follow-up|0|||
155713076|NCT02719171|562044324|FG001|Overall Study|Lost to Follow-up|0|||
155713077|NCT02719171|562044325|FG002|Overall Study|Lost to Follow-up|1|||
155713078|NCT02719171|562044326|FG003|Overall Study|Lost to Follow-up|0|||
155713079|NCT02719171|562044327|FG004|Overall Study|Lost to Follow-up|0|||
155713080|NCT02719171|562044323|FG000|Overall Study|Subject Withdrawal|0|||
155713081|NCT02719171|562044324|FG001|Overall Study|Subject Withdrawal|2|||
155713082|NCT02719171|562044325|FG002|Overall Study|Subject Withdrawal|2|||
155713083|NCT02719171|562044326|FG003|Overall Study|Subject Withdrawal|1|||
155713084|NCT02719171|562044327|FG004|Overall Study|Subject Withdrawal|0|||
155713085|NCT02719171|562044323|FG000|Overall Study|Other|0|||
155713086|NCT02719171|562044324|FG001|Overall Study|Other|0|||
155713087|NCT02719171|562044325|FG002|Overall Study|Other|0|||
155713088|NCT02719171|562044326|FG003|Overall Study|Other|1|||
155713089|NCT02719171|562044327|FG004|Overall Study|Other|0|||
155713090|NCT02807623|562044328|FG000|Overall Study|Lost to Follow-up|23|||
155713091|NCT02807623|562044329|FG001|Overall Study|Lost to Follow-up|18|||
155713092|NCT02807623|562044330|FG002|Overall Study|Lost to Follow-up|22|||
155713093|NCT02807623|562044328|FG000|Overall Study|Drug intolerance|0|||
155713094|NCT02807623|562044329|FG001|Overall Study|Drug intolerance|1|||
155713095|NCT02807623|562044330|FG002|Overall Study|Drug intolerance|0|||
155713096|NCT02807623|562044328|FG000|Overall Study|incomplete blood draw|0|||
155713097|NCT02807623|562044329|FG001|Overall Study|incomplete blood draw|2|||
155713098|NCT02807623|562044330|FG002|Overall Study|incomplete blood draw|1|||
155713099|NCT02614729|562044331|FG000|Overall Study|Withdrawal by Subject|1|||
155713100|NCT02614729|562044332|FG001|Overall Study|Withdrawal by Subject|0|||
155713101|NCT01045967|562044342|FG000|Second Intervention|Protocol Violation|0|||
155713102|NCT01045967|562044343|FG001|Second Intervention|Protocol Violation|1|||
155713103|NCT03493945|562044344|FG000|Phase I Dose Escalation|Ineligible|0|||
155713104|NCT03493945|562044345|FG001|Phase I Dose Escalation|Ineligible|0|||
155713105|NCT03493945|562044346|FG002|Phase I Dose Escalation|Ineligible|1|||
155713106|NCT03493945|562044347|FG003|Phase I Dose Escalation|Ineligible|0|||
155713107|NCT03493945|562044348|FG004|Phase I Dose Escalation|Ineligible|0|||
155713108|NCT03493945|562044349|FG005|Phase I Dose Escalation|Ineligible|0|||
155713109|NCT03493945|562044350|FG006|Phase I Dose Escalation|Ineligible|0|||
155713110|NCT03493945|562044344|FG000|Phase I Dose Escalation|New therapy|0|||
155713111|NCT03493945|562044345|FG001|Phase I Dose Escalation|New therapy|1|||
155713112|NCT03493945|562044346|FG002|Phase I Dose Escalation|New therapy|0|||
155713113|NCT03493945|562044347|FG003|Phase I Dose Escalation|New therapy|0|||
155713114|NCT03493945|562044348|FG004|Phase I Dose Escalation|New therapy|0|||
155713115|NCT03493945|562044349|FG005|Phase I Dose Escalation|New therapy|0|||
155713116|NCT03493945|562044350|FG006|Phase I Dose Escalation|New therapy|0|||
155713117|NCT03493945|562044344|FG000|Phase II Dose Expansion|Refused further treatment|0|||
155713118|NCT03493945|562044345|FG001|Phase II Dose Expansion|Refused further treatment|0|||
155713119|NCT03493945|562044346|FG002|Phase II Dose Expansion|Refused further treatment|0|||
155713120|NCT03493945|562044347|FG003|Phase II Dose Expansion|Refused further treatment|0|||
155713121|NCT03493945|562044348|FG004|Phase II Dose Expansion|Refused further treatment|1|||
155713122|NCT03493945|562044349|FG005|Phase II Dose Expansion|Refused further treatment|1|||
155713123|NCT03493945|562044350|FG006|Phase II Dose Expansion|Refused further treatment|0|||
155713124|NCT03493945|562044344|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713125|NCT03493945|562044345|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713126|NCT03493945|562044346|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713127|NCT03493945|562044347|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
155713128|NCT03493945|562044348|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713129|NCT03493945|562044349|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713130|NCT03493945|562044350|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
155713131|NCT01121146|562044355|FG000|Overall Study|Death|17|||
155713132|NCT01121146|562044356|FG001|Overall Study|Death|15|||
155713133|NCT01121146|562044355|FG000|Overall Study|Adverse Event|2|||
155713134|NCT01121146|562044356|FG001|Overall Study|Adverse Event|11|||
155713135|NCT01121146|562044355|FG000|Overall Study|Lost to Follow-up|7|||
155713136|NCT01121146|562044356|FG001|Overall Study|Lost to Follow-up|16|||
155713137|NCT03922581|562044359|FG000|Overall Study|Lost to Follow-up|20|||
155713138|NCT03922581|562044360|FG001|Overall Study|Lost to Follow-up|9|||
155713139|NCT03922581|562044359|FG000|Overall Study|Physician Decision|1|||
155713140|NCT03922581|562044360|FG001|Overall Study|Physician Decision|1|||
155713141|NCT03922581|562044359|FG000|Overall Study|Withdrawal by Subject|1|||
155713142|NCT03922581|562044360|FG001|Overall Study|Withdrawal by Subject|0|||
155713143|NCT00764699|562044363|FG000|Overall Study|PI left and study terminated|3|||
155713144|NCT01508312|562044369|FG000|Overall Study|Lost to Follow-up|1|||
155713145|NCT01508312|562044370|FG001|Overall Study|Lost to Follow-up|0|||
155713146|NCT01508312|562044371|FG002|Overall Study|Lost to Follow-up|0|||
155713147|NCT01508312|562044372|FG003|Overall Study|Lost to Follow-up|0|||
155713148|NCT01508312|562044369|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155713149|NCT01508312|562044370|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
155713150|NCT01508312|562044371|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155713151|NCT01508312|562044372|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155713152|NCT01508312|562044369|FG000|Overall Study|Adverse Event|0|||
155713153|NCT01508312|562044370|FG001|Overall Study|Adverse Event|0|||
155713154|NCT01508312|562044371|FG002|Overall Study|Adverse Event|2|||
155713155|NCT01508312|562044372|FG003|Overall Study|Adverse Event|0|||
155713156|NCT01508312|562044369|FG000|Overall Study|Lack of Efficacy|0|||
155713157|NCT01508312|562044370|FG001|Overall Study|Lack of Efficacy|0|||
155713158|NCT01508312|562044371|FG002|Overall Study|Lack of Efficacy|1|||
155713159|NCT01508312|562044372|FG003|Overall Study|Lack of Efficacy|0|||
155713160|NCT01508312|562044369|FG000|Overall Study|Withdrawal by Subject|0|||
155713161|NCT01508312|562044370|FG001|Overall Study|Withdrawal by Subject|0|||
155713162|NCT01508312|562044371|FG002|Overall Study|Withdrawal by Subject|1|||
155713163|NCT01508312|562044372|FG003|Overall Study|Withdrawal by Subject|0|||
155713164|NCT02223715|562044373|FG000|Overall Study|Death|31|||
155713165|NCT02223715|562044373|FG000|Overall Study|Lost to Follow-up|73|||
155713166|NCT02222558|562044374|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
155713167|NCT02222558|562044375|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
155713168|NCT02222558|562044376|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
155713169|NCT02222558|562044377|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
155713170|NCT02222558|562044378|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
155713171|NCT02222558|562044379|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
155713172|NCT02222558|562044374|FG000|Period 3|Withdrawal by Subject|0|||
155713173|NCT02222558|562044375|FG001|Period 3|Withdrawal by Subject|0|||
155713174|NCT02222558|562044376|FG002|Period 3|Withdrawal by Subject|0|||
155713175|NCT02222558|562044377|FG003|Period 3|Withdrawal by Subject|0|||
155713176|NCT02222558|562044378|FG004|Period 3|Withdrawal by Subject|0|||
155713177|NCT02222558|562044379|FG005|Period 3|Withdrawal by Subject|1|||
155713178|NCT01745367|562044380|FG000|Overall Study|Death|1|||
155713179|NCT01745367|562044381|FG001|Overall Study|Death|0|||
155713180|NCT01745367|562044380|FG000|Overall Study|Withdrawal by Subject|1|||
155713181|NCT01745367|562044381|FG001|Overall Study|Withdrawal by Subject|2|||
155713182|NCT01745367|562044380|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
155713183|NCT01745367|562044381|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
155713184|NCT01745367|562044380|FG000|Overall Study|Other Reasons Unspecified|0|||
155713185|NCT01745367|562044381|FG001|Overall Study|Other Reasons Unspecified|2|||
155713186|NCT02322281|562044384|FG000|Overall Study|Progressive Disease|42|||
155713187|NCT02322281|562044385|FG001|Overall Study|Progressive Disease|14|||
155713188|NCT02322281|562044386|FG002|Overall Study|Progressive Disease|49|||
155713189|NCT02322281|562044384|FG000|Overall Study|Adverse Event|3|||
155713190|NCT02322281|562044385|FG001|Overall Study|Adverse Event|4|||
155713191|NCT02322281|562044386|FG002|Overall Study|Adverse Event|6|||
155713192|NCT02322281|562044384|FG000|Overall Study|Death|3|||
155713193|NCT02322281|562044385|FG001|Overall Study|Death|3|||
155713194|NCT02322281|562044386|FG002|Overall Study|Death|3|||
155713195|NCT02322281|562044384|FG000|Overall Study|Withdrawal by Subject|1|||
155713196|NCT02322281|562044385|FG001|Overall Study|Withdrawal by Subject|1|||
155713197|NCT02322281|562044386|FG002|Overall Study|Withdrawal by Subject|6|||
155713198|NCT02322281|562044384|FG000|Overall Study|Physician Decision|2|||
155713199|NCT02322281|562044385|FG001|Overall Study|Physician Decision|0|||
155713200|NCT02322281|562044386|FG002|Overall Study|Physician Decision|5|||
155713201|NCT02322281|562044384|FG000|Overall Study|Study Terminated by Sponsor|2|||
155713202|NCT02322281|562044385|FG001|Overall Study|Study Terminated by Sponsor|0|||
155713203|NCT02322281|562044386|FG002|Overall Study|Study Terminated by Sponsor|0|||
155713204|NCT02322281|562044384|FG000|Overall Study|Missing|0|||
155713205|NCT02322281|562044385|FG001|Overall Study|Missing|0|||
155713206|NCT02322281|562044386|FG002|Overall Study|Missing|1|||
155713207|NCT02322281|562044384|FG000|Overall Study|Miscellaneous|0|||
155713208|NCT02322281|562044385|FG001|Overall Study|Miscellaneous|0|||
155713209|NCT02322281|562044386|FG002|Overall Study|Miscellaneous|4|||
155713210|NCT01020786|562044387|FG000|Induction Period|Entry Criteria Not Met|2|||
155713211|NCT01020786|562044387|FG000|Induction Period|Adverse Event|10|||
155713212|NCT01020786|562044387|FG000|Induction Period|Progressive Disease|31|||
155713213|NCT01020786|562044387|FG000|Induction Period|Investigator Decision|3|||
155713214|NCT01020786|562044387|FG000|Induction Period|Withdrawal by Subject|3|||
155713215|NCT01020786|562044387|FG000|Maintenance Period|Adverse Event|8|||
155713216|NCT01020786|562044387|FG000|Maintenance Period|Progressive Disease|43|||
155713217|NCT01020786|562044387|FG000|Maintenance Period|Withdrawal by Subject|8|||
155713218|NCT01020786|562044387|FG000|Maintenance Period|Sponsor Decision|1|||
155713219|NCT01358825|562044388|FG000|Overall Study|Blood sample not drawn|0|||
155713220|NCT01358825|562044389|FG001|Overall Study|Blood sample not drawn|1|||
155713221|NCT03571204|562044390|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
155713222|NCT03571204|562044391|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
155713223|NCT03571204|562044392|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
155713224|NCT03571204|562044390|FG000|Overall Study|Physician Decision|0|||
155713225|NCT03571204|562044391|FG001|Overall Study|Physician Decision|1|||
155713226|NCT03571204|562044392|FG002|Overall Study|Physician Decision|0|||
155713227|NCT02721875|562044393|FG000|Overall Study|Progressive disease/relapse|1|||
155713228|NCT02721875|562044394|FG001|Overall Study|Progressive disease/relapse|0|||
155713229|NCT02888106|562044395|FG000|Overall Study|Withdrawal by Subject|1|||
155713230|NCT02888106|562044396|FG001|Overall Study|Withdrawal by Subject|2|||
155713231|NCT02888106|562044397|FG002|Overall Study|Withdrawal by Subject|0|||
155713232|NCT02888106|562044398|FG003|Overall Study|Withdrawal by Subject|1|||
155713233|NCT02888106|562044399|FG004|Overall Study|Withdrawal by Subject|0|||
155713234|NCT02888106|562044400|FG005|Overall Study|Withdrawal by Subject|0|||
155713235|NCT02888106|562044395|FG000|Overall Study|Lost to Follow-up|1|||
155713236|NCT02888106|562044396|FG001|Overall Study|Lost to Follow-up|0|||
155713237|NCT02888106|562044397|FG002|Overall Study|Lost to Follow-up|0|||
155713238|NCT02888106|562044398|FG003|Overall Study|Lost to Follow-up|1|||
155713239|NCT02888106|562044399|FG004|Overall Study|Lost to Follow-up|0|||
155713240|NCT02888106|562044400|FG005|Overall Study|Lost to Follow-up|1|||
155713241|NCT02888106|562044395|FG000|Overall Study|Adverse Event|2|||
155713242|NCT02888106|562044396|FG001|Overall Study|Adverse Event|0|||
155713243|NCT02888106|562044397|FG002|Overall Study|Adverse Event|0|||
155713244|NCT02888106|562044398|FG003|Overall Study|Adverse Event|0|||
155713245|NCT02888106|562044399|FG004|Overall Study|Adverse Event|0|||
155713246|NCT02888106|562044400|FG005|Overall Study|Adverse Event|0|||
155713247|NCT02888106|562044395|FG000|Overall Study|Withdrawal of consent|0|||
155713248|NCT02888106|562044396|FG001|Overall Study|Withdrawal of consent|0|||
155713249|NCT02888106|562044397|FG002|Overall Study|Withdrawal of consent|0|||
155713250|NCT02888106|562044398|FG003|Overall Study|Withdrawal of consent|0|||
155713251|NCT02888106|562044399|FG004|Overall Study|Withdrawal of consent|1|||
155713252|NCT02888106|562044400|FG005|Overall Study|Withdrawal of consent|0|||
155713253|NCT02888106|562044395|FG000|Overall Study|Pregnancy|1|||
155713254|NCT02888106|562044396|FG001|Overall Study|Pregnancy|0|||
155713255|NCT02888106|562044397|FG002|Overall Study|Pregnancy|0|||
155713256|NCT02888106|562044398|FG003|Overall Study|Pregnancy|0|||
155713257|NCT02888106|562044399|FG004|Overall Study|Pregnancy|0|||
155713258|NCT02888106|562044400|FG005|Overall Study|Pregnancy|0|||
155713259|NCT00857285|562044401|FG000|Overall Study|Adverse Event|4|||
155713260|NCT00857285|562044402|FG001|Overall Study|Adverse Event|2|||
155713261|NCT00857285|562044401|FG000|Overall Study|Lack of Efficacy|0|||
155713262|NCT00857285|562044402|FG001|Overall Study|Lack of Efficacy|2|||
155713263|NCT00857285|562044401|FG000|Overall Study|Protocol Violation|3|||
155713264|NCT00857285|562044402|FG001|Overall Study|Protocol Violation|1|||
155713265|NCT00857285|562044401|FG000|Overall Study|Withdrawal by Subject|4|||
155713266|NCT00857285|562044402|FG001|Overall Study|Withdrawal by Subject|0|||
155713267|NCT00857285|562044401|FG000|Overall Study|Randomization criteria not met|1|||
155713268|NCT00857285|562044402|FG001|Overall Study|Randomization criteria not met|1|||
155713269|NCT01076959|562044410|FG000|Overall Study|Adverse Event|767|||
155713270|NCT01076959|562044410|FG000|Overall Study|Lack of Efficacy|849|||
155713271|NCT01076959|562044410|FG000|Overall Study|Non-compliance|274|||
155713272|NCT01076959|562044410|FG000|Overall Study|Lost to Follow-up|241|||
155713273|NCT01076959|562044410|FG000|Overall Study|Other|119|||
155713274|NCT02491983|562044411|FG000|Overall Study|Physician Decision|1|||
155713275|NCT02491983|562044412|FG001|Overall Study|Physician Decision|0|||
155713276|NCT02491983|562044411|FG000|Overall Study|Not meet selection criteria|1|||
155713277|NCT02491983|562044412|FG001|Overall Study|Not meet selection criteria|0|||
155713278|NCT02491983|562044411|FG000|Overall Study|Withdrawal by Subject|0|||
155713279|NCT02491983|562044412|FG001|Overall Study|Withdrawal by Subject|1|||
155713280|NCT04445662|562044414|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
155713281|NCT04445662|562044415|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
155713282|NCT04445662|562044414|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
155713283|NCT04445662|562044415|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
155713284|NCT04445662|562044414|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
155713285|NCT04445662|562044415|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
155713286|NCT04445662|562044414|FG000|Post-treatment (12-24 weeks)|Death|1|||
155713287|NCT04445662|562044415|FG001|Post-treatment (12-24 weeks)|Death|0|||
155713288|NCT00279916|562044416|FG000|Overall Study|Withdrawal by Subject|4|||
155713289|NCT00279916|562044417|FG001|Overall Study|Withdrawal by Subject|3|||
155713290|NCT00279916|562044416|FG000|Overall Study|Lost to Follow-up|3|||
155713291|NCT00279916|562044417|FG001|Overall Study|Lost to Follow-up|2|||
155713292|NCT00731679|562044418|FG000|Overall Study|Adverse Event|7|||
155713293|NCT00731679|562044419|FG001|Overall Study|Adverse Event|8|||
155713294|NCT00731679|562044418|FG000|Overall Study|Withdrawal by Subject|8|||
155713295|NCT00731679|562044419|FG001|Overall Study|Withdrawal by Subject|8|||
155713296|NCT00731679|562044418|FG000|Overall Study|Lost to Follow-up|7|||
155713297|NCT00731679|562044419|FG001|Overall Study|Lost to Follow-up|8|||
155198474|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
155198475|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
155198476|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
155198477|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
155198478|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
155198479|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
155198480|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
155198481|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
155198482|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
155198483|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
155198484|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
155198485|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
155198486|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
155713298|NCT00731679|562044418|FG000|Overall Study|Noncompliance|0|||
155713299|NCT00731679|562044419|FG001|Overall Study|Noncompliance|1|||
155713300|NCT00731679|562044418|FG000|Overall Study|Pregnancy|0|||
155713301|NCT00731679|562044419|FG001|Overall Study|Pregnancy|1|||
155713302|NCT02488005|562044420|FG000|Overall Study|Lost to Follow-up|2|||
155713303|NCT03384940|562044421|FG000|Overall Study|Progressive disease|36|||
155713304|NCT03384940|562044422|FG001|Overall Study|Progressive disease|11|||
155713305|NCT03384940|562044423|FG002|Overall Study|Progressive disease|13|||
155713306|NCT03384940|562044421|FG000|Overall Study|Clinical progression|4|||
155713307|NCT03384940|562044422|FG001|Overall Study|Clinical progression|0|||
155713308|NCT03384940|562044423|FG002|Overall Study|Clinical progression|3|||
155713309|NCT03384940|562044421|FG000|Overall Study|Adverse Event|7|||
155713310|NCT03384940|562044422|FG001|Overall Study|Adverse Event|1|||
155713311|NCT03384940|562044423|FG002|Overall Study|Adverse Event|1|||
155713312|NCT03384940|562044421|FG000|Overall Study|Withdrawal by Subject|3|||
155713313|NCT03384940|562044422|FG001|Overall Study|Withdrawal by Subject|1|||
155713314|NCT03384940|562044423|FG002|Overall Study|Withdrawal by Subject|0|||
155713315|NCT03384940|562044421|FG000|Overall Study|Physician Decision|1|||
155713316|NCT03384940|562044422|FG001|Overall Study|Physician Decision|1|||
155713317|NCT03384940|562044423|FG002|Overall Study|Physician Decision|0|||
155713318|NCT03384940|562044421|FG000|Overall Study|Death|2|||
155713319|NCT03384940|562044422|FG001|Overall Study|Death|1|||
155713320|NCT03384940|562044423|FG002|Overall Study|Death|0|||
155713321|NCT03384940|562044421|FG000|Overall Study|Other|0|||
155713322|NCT03384940|562044422|FG001|Overall Study|Other|0|||
155713323|NCT03384940|562044423|FG002|Overall Study|Other|1|||
155713324|NCT03087513|562044424|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
155713325|NCT04628780|562044425|FG000|Overall Study|Death|0|||
155713326|NCT04628780|562044426|FG001|Overall Study|Death|1|||
155713327|NCT04628780|562044427|FG002|Overall Study|Death|0|||
155713328|NCT04628780|562044428|FG003|Overall Study|Death|0|||
155713329|NCT04628780|562044429|FG004|Overall Study|Death|1|||
155713330|NCT04628780|562044430|FG005|Overall Study|Death|0|||
155713331|NCT04628780|562044425|FG000|Overall Study|Physician Decision|2|||
155713332|NCT04628780|562044426|FG001|Overall Study|Physician Decision|0|||
155713333|NCT04628780|562044427|FG002|Overall Study|Physician Decision|0|||
155713334|NCT04628780|562044428|FG003|Overall Study|Physician Decision|0|||
155713335|NCT04628780|562044429|FG004|Overall Study|Physician Decision|2|||
155713336|NCT04628780|562044430|FG005|Overall Study|Physician Decision|0|||
155713337|NCT04628780|562044425|FG000|Overall Study|Progressive disease|2|||
155713338|NCT04628780|562044426|FG001|Overall Study|Progressive disease|2|||
155713339|NCT04628780|562044427|FG002|Overall Study|Progressive disease|2|||
155713340|NCT04628780|562044428|FG003|Overall Study|Progressive disease|3|||
155713341|NCT04628780|562044429|FG004|Overall Study|Progressive disease|9|||
155713342|NCT04628780|562044430|FG005|Overall Study|Progressive disease|4|||
155713343|NCT04628780|562044425|FG000|Overall Study|Withdrawal by Subject|0|||
155713344|NCT04628780|562044426|FG001|Overall Study|Withdrawal by Subject|1|||
155713345|NCT04628780|562044427|FG002|Overall Study|Withdrawal by Subject|2|||
155713346|NCT04628780|562044428|FG003|Overall Study|Withdrawal by Subject|0|||
155713347|NCT04628780|562044429|FG004|Overall Study|Withdrawal by Subject|3|||
155713348|NCT04628780|562044430|FG005|Overall Study|Withdrawal by Subject|1|||
155713349|NCT04628780|562044425|FG000|Overall Study|Global deterioration of health status|0|||
155713350|NCT04628780|562044426|FG001|Overall Study|Global deterioration of health status|0|||
155713351|NCT04628780|562044427|FG002|Overall Study|Global deterioration of health status|0|||
155713352|NCT04628780|562044428|FG003|Overall Study|Global deterioration of health status|0|||
155713353|NCT04628780|562044429|FG004|Overall Study|Global deterioration of health status|1|||
155713354|NCT04628780|562044430|FG005|Overall Study|Global deterioration of health status|1|||
155713355|NCT03269994|562044432|FG000|Overall Study|Withdrawal by Subject|4|||
155713356|NCT03269994|562044433|FG001|Overall Study|Withdrawal by Subject|5|||
155713357|NCT03269994|562044432|FG000|Overall Study|Unresectable at surgery|39|||
155713358|NCT03269994|562044433|FG001|Overall Study|Unresectable at surgery|58|||
155713359|NCT03269994|562044432|FG000|Overall Study|Patient canceled surgery|5|||
155713360|NCT03269994|562044433|FG001|Overall Study|Patient canceled surgery|14|||
155713361|NCT03269994|562044432|FG000|Overall Study|Preoperative progression|14|||
155713362|NCT03269994|562044433|FG001|Overall Study|Preoperative progression|9|||
155713363|NCT03269994|562044432|FG000|Overall Study|Preoperative infection|10|||
155713364|NCT03269994|562044433|FG001|Overall Study|Preoperative infection|4|||
155713365|NCT03269994|562044432|FG000|Overall Study|Kidney insufficiency|1|||
155713366|NCT03269994|562044433|FG001|Overall Study|Kidney insufficiency|0|||
155713367|NCT03269994|562044432|FG000|Overall Study|Drug allergy|0|||
155713368|NCT03269994|562044433|FG001|Overall Study|Drug allergy|2|||
155713369|NCT03269994|562044432|FG000|Overall Study|Operation changed to different resection|9|||
155713370|NCT03269994|562044433|FG001|Overall Study|Operation changed to different resection|0|||
155713371|NCT03269994|562044432|FG000|Overall Study|Preoperative steroid|0|||
155713372|NCT03269994|562044433|FG001|Overall Study|Preoperative steroid|3|||
155713373|NCT03269994|562044432|FG000|Overall Study|Accrual Closed|2|||
155713374|NCT03269994|562044433|FG001|Overall Study|Accrual Closed|0|||
155713375|NCT03269994|562044432|FG000|Overall Study|Operation changed to different resection|0|||
155713376|NCT03269994|562044433|FG001|Overall Study|Operation changed to different resection|10|||
155713377|NCT04303559|562044434|FG000|Overall Study|Study closed due to poor enrollment.|1|||
155713378|NCT01987102|562044437|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
155713379|NCT01987102|562044438|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
155713380|NCT01987102|562044437|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
155713381|NCT01987102|562044438|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
155713382|NCT01987102|562044437|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
155713383|NCT01987102|562044438|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
155713384|NCT01987102|562044437|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
155713385|NCT01987102|562044438|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
155713386|NCT01987102|562044437|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
155713387|NCT01987102|562044438|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
155713388|NCT01987102|562044437|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
155713389|NCT01987102|562044438|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
155713390|NCT01288989|562044439|FG000|Overall Study|Death|0|||
155713391|NCT01288989|562044440|FG001|Overall Study|Death|0|||
155713392|NCT01288989|562044441|FG002|Overall Study|Death|0|||
155713393|NCT01288989|562044442|FG003|Overall Study|Death|1|||
155713394|NCT01288989|562044443|FG004|Overall Study|Death|0|||
155713395|NCT01288989|562044439|FG000|Overall Study|Dose limiting toxicity|1|||
155713396|NCT01288989|562044440|FG001|Overall Study|Dose limiting toxicity|0|||
155713397|NCT01288989|562044441|FG002|Overall Study|Dose limiting toxicity|0|||
155713398|NCT01288989|562044442|FG003|Overall Study|Dose limiting toxicity|0|||
155713399|NCT01288989|562044443|FG004|Overall Study|Dose limiting toxicity|0|||
155713400|NCT01288989|562044439|FG000|Overall Study|Adverse Event|0|||
155713401|NCT01288989|562044440|FG001|Overall Study|Adverse Event|0|||
155713402|NCT01288989|562044441|FG002|Overall Study|Adverse Event|0|||
155713403|NCT01288989|562044442|FG003|Overall Study|Adverse Event|0|||
155713404|NCT01288989|562044443|FG004|Overall Study|Adverse Event|2|||
155713405|NCT01288989|562044439|FG000|Overall Study|Physician Decision|0|||
155713406|NCT01288989|562044440|FG001|Overall Study|Physician Decision|0|||
155713407|NCT01288989|562044441|FG002|Overall Study|Physician Decision|0|||
155713408|NCT01288989|562044442|FG003|Overall Study|Physician Decision|0|||
155713409|NCT01288989|562044443|FG004|Overall Study|Physician Decision|1|||
155713410|NCT01288989|562044439|FG000|Overall Study|Withdrawal by Subject|0|||
155713411|NCT01288989|562044440|FG001|Overall Study|Withdrawal by Subject|0|||
155713412|NCT01288989|562044441|FG002|Overall Study|Withdrawal by Subject|0|||
155713413|NCT01288989|562044442|FG003|Overall Study|Withdrawal by Subject|0|||
155713414|NCT01288989|562044443|FG004|Overall Study|Withdrawal by Subject|3|||
155713415|NCT01327599|562044444|FG000|Overall Study|Adverse Event|1|||
155713416|NCT01327599|562044444|FG000|Overall Study|Could Not Attend Visit|1|||
155713417|NCT01327599|562044444|FG000|Overall Study|Withdrawal of Consent|1|||
155713418|NCT01132313|562044445|FG000|Overall Study|Lack of Efficacy|1|||
155713419|NCT01132313|562044446|FG001|Overall Study|Lack of Efficacy|0|||
155713420|NCT01132313|562044447|FG002|Overall Study|Lack of Efficacy|0|||
155713421|NCT01132313|562044448|FG003|Overall Study|Lack of Efficacy|0|||
155713422|NCT01132313|562044449|FG004|Overall Study|Lack of Efficacy|0|||
155713423|NCT01132313|562044450|FG005|Overall Study|Lack of Efficacy|0|||
155713424|NCT01132313|562044451|FG006|Overall Study|Lack of Efficacy|0|||
155713425|NCT01132313|562044452|FG007|Overall Study|Lack of Efficacy|3|||
155713426|NCT01132313|562044453|FG008|Overall Study|Lack of Efficacy|14|||
155713427|NCT01132313|562044454|FG009|Overall Study|Lack of Efficacy|16|||
155713428|NCT01132313|562044455|FG010|Overall Study|Lack of Efficacy|0|||
155713429|NCT01132313|562044456|FG011|Overall Study|Lack of Efficacy|0|||
155713430|NCT01132313|562044445|FG000|Overall Study|Not treated|2|||
155713431|NCT01132313|562044446|FG001|Overall Study|Not treated|0|||
155713432|NCT01132313|562044447|FG002|Overall Study|Not treated|0|||
155713433|NCT01132313|562044448|FG003|Overall Study|Not treated|0|||
155713434|NCT01132313|562044449|FG004|Overall Study|Not treated|2|||
155713435|NCT01132313|562044450|FG005|Overall Study|Not treated|1|||
155713436|NCT01132313|562044451|FG006|Overall Study|Not treated|3|||
155713437|NCT01132313|562044452|FG007|Overall Study|Not treated|0|||
155713438|NCT01132313|562044453|FG008|Overall Study|Not treated|0|||
155713439|NCT01132313|562044454|FG009|Overall Study|Not treated|0|||
155713440|NCT01132313|562044455|FG010|Overall Study|Not treated|0|||
155713441|NCT01132313|562044456|FG011|Overall Study|Not treated|0|||
155713442|NCT01132313|562044445|FG000|Overall Study|Adverse Event|0|||
155713443|NCT01132313|562044446|FG001|Overall Study|Adverse Event|0|||
155713444|NCT01132313|562044447|FG002|Overall Study|Adverse Event|4|||
155713445|NCT01132313|562044448|FG003|Overall Study|Adverse Event|10|||
155713446|NCT01132313|562044449|FG004|Overall Study|Adverse Event|19|||
155713447|NCT01132313|562044450|FG005|Overall Study|Adverse Event|6|||
155713448|NCT01132313|562044451|FG006|Overall Study|Adverse Event|5|||
155713449|NCT01132313|562044452|FG007|Overall Study|Adverse Event|3|||
155713450|NCT01132313|562044453|FG008|Overall Study|Adverse Event|7|||
155713451|NCT01132313|562044454|FG009|Overall Study|Adverse Event|2|||
155713452|NCT01132313|562044455|FG010|Overall Study|Adverse Event|0|||
155713453|NCT01132313|562044456|FG011|Overall Study|Adverse Event|0|||
155713454|NCT01132313|562044445|FG000|Overall Study|Protocol Violation|0|||
155713455|NCT01132313|562044446|FG001|Overall Study|Protocol Violation|0|||
155713456|NCT01132313|562044447|FG002|Overall Study|Protocol Violation|0|||
155713457|NCT01132313|562044448|FG003|Overall Study|Protocol Violation|1|||
155713458|NCT01132313|562044449|FG004|Overall Study|Protocol Violation|0|||
155713459|NCT01132313|562044450|FG005|Overall Study|Protocol Violation|0|||
155713460|NCT01132313|562044451|FG006|Overall Study|Protocol Violation|0|||
155713461|NCT01132313|562044452|FG007|Overall Study|Protocol Violation|0|||
155713462|NCT01132313|562044453|FG008|Overall Study|Protocol Violation|0|||
155713463|NCT01132313|562044454|FG009|Overall Study|Protocol Violation|0|||
155713464|NCT01132313|562044455|FG010|Overall Study|Protocol Violation|0|||
155713465|NCT01132313|562044456|FG011|Overall Study|Protocol Violation|0|||
155713466|NCT01132313|562044445|FG000|Overall Study|Lost to Follow-up|0|||
155713467|NCT01132313|562044446|FG001|Overall Study|Lost to Follow-up|0|||
155713468|NCT01132313|562044447|FG002|Overall Study|Lost to Follow-up|1|||
155713469|NCT01132313|562044448|FG003|Overall Study|Lost to Follow-up|0|||
155713470|NCT01132313|562044449|FG004|Overall Study|Lost to Follow-up|0|||
155713471|NCT01132313|562044450|FG005|Overall Study|Lost to Follow-up|0|||
155713472|NCT01132313|562044451|FG006|Overall Study|Lost to Follow-up|0|||
155713473|NCT01132313|562044452|FG007|Overall Study|Lost to Follow-up|1|||
155713474|NCT01132313|562044453|FG008|Overall Study|Lost to Follow-up|0|||
155713475|NCT01132313|562044454|FG009|Overall Study|Lost to Follow-up|0|||
155713476|NCT01132313|562044455|FG010|Overall Study|Lost to Follow-up|0|||
155713477|NCT01132313|562044456|FG011|Overall Study|Lost to Follow-up|0|||
155713478|NCT01132313|562044445|FG000|Overall Study|Withdrawal by Subject|0|||
155713479|NCT01132313|562044446|FG001|Overall Study|Withdrawal by Subject|0|||
155713480|NCT01132313|562044447|FG002|Overall Study|Withdrawal by Subject|3|||
155713481|NCT01132313|562044448|FG003|Overall Study|Withdrawal by Subject|3|||
155713482|NCT01132313|562044449|FG004|Overall Study|Withdrawal by Subject|6|||
155713483|NCT01132313|562044450|FG005|Overall Study|Withdrawal by Subject|0|||
155713484|NCT01132313|562044451|FG006|Overall Study|Withdrawal by Subject|1|||
155713485|NCT01132313|562044452|FG007|Overall Study|Withdrawal by Subject|0|||
155713486|NCT01132313|562044453|FG008|Overall Study|Withdrawal by Subject|0|||
155713487|NCT01132313|562044454|FG009|Overall Study|Withdrawal by Subject|2|||
155713488|NCT01132313|562044455|FG010|Overall Study|Withdrawal by Subject|0|||
155713489|NCT01132313|562044456|FG011|Overall Study|Withdrawal by Subject|0|||
155713490|NCT01132313|562044445|FG000|Overall Study|Lack of antiviral response|0|||
155713491|NCT01132313|562044446|FG001|Overall Study|Lack of antiviral response|0|||
155713492|NCT01132313|562044447|FG002|Overall Study|Lack of antiviral response|12|||
155713493|NCT01132313|562044448|FG003|Overall Study|Lack of antiviral response|18|||
155713494|NCT01132313|562044449|FG004|Overall Study|Lack of antiviral response|18|||
155713495|NCT01132313|562044450|FG005|Overall Study|Lack of antiviral response|18|||
155713496|NCT01132313|562044451|FG006|Overall Study|Lack of antiviral response|21|||
155713497|NCT01132313|562044452|FG007|Overall Study|Lack of antiviral response|0|||
155713498|NCT01132313|562044453|FG008|Overall Study|Lack of antiviral response|0|||
155713499|NCT01132313|562044454|FG009|Overall Study|Lack of antiviral response|0|||
155713500|NCT01132313|562044455|FG010|Overall Study|Lack of antiviral response|1|||
155713501|NCT01132313|562044456|FG011|Overall Study|Lack of antiviral response|0|||
155713502|NCT01132313|562044445|FG000|Overall Study|Other reason not defined above|0|||
155713503|NCT01132313|562044446|FG001|Overall Study|Other reason not defined above|0|||
155713504|NCT01132313|562044447|FG002|Overall Study|Other reason not defined above|0|||
155713505|NCT01132313|562044448|FG003|Overall Study|Other reason not defined above|0|||
155713506|NCT01132313|562044449|FG004|Overall Study|Other reason not defined above|0|||
155713507|NCT01132313|562044450|FG005|Overall Study|Other reason not defined above|0|||
155713508|NCT01132313|562044451|FG006|Overall Study|Other reason not defined above|0|||
155713509|NCT01132313|562044452|FG007|Overall Study|Other reason not defined above|1|||
155713510|NCT01132313|562044453|FG008|Overall Study|Other reason not defined above|0|||
155713511|NCT01132313|562044454|FG009|Overall Study|Other reason not defined above|0|||
155713512|NCT01132313|562044455|FG010|Overall Study|Other reason not defined above|0|||
155713513|NCT01132313|562044456|FG011|Overall Study|Other reason not defined above|0|||
155713514|NCT00165672|562044459|FG000|Overall Study|Adverse Event|0|||
155713515|NCT00165672|562044460|FG001|Overall Study|Adverse Event|1|||
155713516|NCT05864586|562044466|FG000|Overall Study|Ineligible|4|||
155713517|NCT05864586|562044467|FG001|Overall Study|Ineligible|12|||
155713518|NCT05864586|562044466|FG000|Overall Study|Pregnancy|0|||
155713519|NCT05864586|562044467|FG001|Overall Study|Pregnancy|1|||
155713520|NCT05864586|562044466|FG000|Overall Study|Withdrawal by Subject|0|||
155713521|NCT05864586|562044467|FG001|Overall Study|Withdrawal by Subject|1|||
155713522|NCT03635424|562044468|FG000|Overall Study|Adverse Event|1|||
155713523|NCT03635424|562044468|FG000|Overall Study|Death|1|||
155713524|NCT03635424|562044468|FG000|Overall Study|Device not implanted|1|||
155713525|NCT04896593|562044471|FG000|Overall Study|Withdrawal by Subject|2|||
155713526|NCT04896593|562044471|FG000|Overall Study|Lost to Follow-up|1|||
155713527|NCT04896593|562044471|FG000|Overall Study|Did not complete onboarding|2|||
155713528|NCT03405818|562044472|FG000|Overall Study|Withdrawal by Subject|4|||
155713529|NCT03405818|562044472|FG000|Overall Study|Lost to Follow-up|4|||
155713530|NCT00992459|562044479|FG000|Overall Study|Withdrawal by Subject|0|||
155713531|NCT00992459|562044480|FG001|Overall Study|Withdrawal by Subject|1|||
155713532|NCT00992459|562044479|FG000|Overall Study|Adverse Event|1|||
155713533|NCT00992459|562044480|FG001|Overall Study|Adverse Event|0|||
155713534|NCT00549445|562044485|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
155713535|NCT00549445|562044486|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
155713536|NCT00227721|562046170|FG000|Overall Study|On study, but never treated.|1|||
155713537|NCT02539797|562046173|FG000|Overall Study|Lost to Follow-up|0|||
155713538|NCT02539797|562046174|FG001|Overall Study|Lost to Follow-up|1|||
155713539|NCT02539797|562046175|FG002|Overall Study|Lost to Follow-up|0|||
155713540|NCT02796677|562046181|FG000|Overall Study|Adverse Event|11|||
155713541|NCT02796677|562046182|FG001|Overall Study|Adverse Event|22|||
155713542|NCT02796677|562046183|FG002|Overall Study|Adverse Event|14|||
155713543|NCT02796677|562046184|FG003|Overall Study|Adverse Event|14|||
155713544|NCT02796677|562046181|FG000|Overall Study|Protocol Violation|7|||
155713545|NCT02796677|562046182|FG001|Overall Study|Protocol Violation|5|||
155713546|NCT02796677|562046183|FG002|Overall Study|Protocol Violation|4|||
155713547|NCT02796677|562046184|FG003|Overall Study|Protocol Violation|8|||
155713548|NCT02796677|562046181|FG000|Overall Study|Lost to Follow-up|1|||
155713549|NCT02796677|562046182|FG001|Overall Study|Lost to Follow-up|5|||
155713550|NCT02796677|562046183|FG002|Overall Study|Lost to Follow-up|2|||
155713551|NCT02796677|562046184|FG003|Overall Study|Lost to Follow-up|2|||
155713552|NCT02796677|562046181|FG000|Overall Study|Lack of Efficacy|7|||
155713553|NCT02796677|562046182|FG001|Overall Study|Lack of Efficacy|9|||
155713554|NCT02796677|562046183|FG002|Overall Study|Lack of Efficacy|14|||
155713555|NCT02796677|562046184|FG003|Overall Study|Lack of Efficacy|20|||
155713556|NCT02796677|562046181|FG000|Overall Study|Withdrawal by Subject|4|||
155713557|NCT02796677|562046182|FG001|Overall Study|Withdrawal by Subject|14|||
155713558|NCT02796677|562046183|FG002|Overall Study|Withdrawal by Subject|6|||
155713559|NCT02796677|562046184|FG003|Overall Study|Withdrawal by Subject|7|||
155713560|NCT02796677|562046181|FG000|Overall Study|Progressive disease|6|||
155713561|NCT02796677|562046182|FG001|Overall Study|Progressive disease|15|||
155713562|NCT02796677|562046183|FG002|Overall Study|Progressive disease|13|||
155713563|NCT02796677|562046184|FG003|Overall Study|Progressive disease|18|||
155713564|NCT02796677|562046181|FG000|Overall Study|Reason not mentioned|2|||
155713565|NCT02796677|562046182|FG001|Overall Study|Reason not mentioned|3|||
155713566|NCT02796677|562046183|FG002|Overall Study|Reason not mentioned|0|||
155713567|NCT02796677|562046184|FG003|Overall Study|Reason not mentioned|5|||
155713568|NCT04002960|562046186|FG000|Overall Study|Withdrawn prior to Completion|2|||
155713569|NCT00961181|562046187|FG000|Overall Study|Death|2|||
155713570|NCT00961181|562046187|FG000|Overall Study|Withdrawal by Subject|2|||
155713571|NCT00961181|562046187|FG000|Overall Study|Lost to Follow-up|1|||
155713572|NCT01777308|562046190|FG000|Overall Study|Withdrawal by Subject|5|||
155713573|NCT01777308|562046191|FG001|Overall Study|Withdrawal by Subject|1|||
155713574|NCT01777308|562046190|FG000|Overall Study|Migrated/moved from study area|1|||
155713575|NCT01777308|562046191|FG001|Overall Study|Migrated/moved from study area|0|||
155713576|NCT01777308|562046190|FG000|Overall Study|Lost to Follow-up|7|||
155713577|NCT01777308|562046191|FG001|Overall Study|Lost to Follow-up|2|||
155713578|NCT01777308|562046190|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
155713579|NCT01777308|562046191|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
155713580|NCT03212326|562046193|FG000|Overall Study|Physician Decision|4|||
155713581|NCT00383786|562046196|FG000|Overall Study|Protocol Violation|2|||
155713582|NCT00383786|562046197|FG001|Overall Study|Protocol Violation|6|||
155713583|NCT00383786|562046196|FG000|Overall Study|Withdrawal by Subject|2|||
155713584|NCT00383786|562046197|FG001|Overall Study|Withdrawal by Subject|5|||
155713585|NCT00383786|562046196|FG000|Overall Study|Physician Decision|0|||
155713586|NCT00383786|562046197|FG001|Overall Study|Physician Decision|1|||
155713587|NCT00985673|562046198|FG000|Overall Study|Lost to Follow-up|6|||
155713588|NCT00985673|562046199|FG001|Overall Study|Lost to Follow-up|7|||
155713589|NCT00985673|562046200|FG002|Overall Study|Lost to Follow-up|6|||
155713590|NCT00985673|562046201|FG003|Overall Study|Lost to Follow-up|10|||
155713591|NCT00985673|562046202|FG004|Overall Study|Lost to Follow-up|5|||
155713592|NCT00985673|562046203|FG005|Overall Study|Lost to Follow-up|3|||
155713593|NCT00985673|562046198|FG000|Overall Study|Withdrawal by Subject|0|||
155713594|NCT00985673|562046199|FG001|Overall Study|Withdrawal by Subject|4|||
155713595|NCT00985673|562046200|FG002|Overall Study|Withdrawal by Subject|5|||
155713596|NCT00985673|562046201|FG003|Overall Study|Withdrawal by Subject|2|||
155713597|NCT00985673|562046202|FG004|Overall Study|Withdrawal by Subject|2|||
155713598|NCT00985673|562046203|FG005|Overall Study|Withdrawal by Subject|3|||
155713599|NCT00985673|562046198|FG000|Overall Study|Other|1|||
155713600|NCT00985673|562046199|FG001|Overall Study|Other|0|||
155713601|NCT00985673|562046200|FG002|Overall Study|Other|1|||
155713602|NCT00985673|562046201|FG003|Overall Study|Other|0|||
155713603|NCT00985673|562046202|FG004|Overall Study|Other|1|||
155713604|NCT00985673|562046203|FG005|Overall Study|Other|0|||
155713605|NCT02252146|562046204|FG000|Overall Study|Lack of Efficacy|4|||
155713606|NCT02252146|562046204|FG000|Overall Study|Entered hospice care|1|||
155713607|NCT02252146|562046204|FG000|Overall Study|Inability to travel to study site|1|||
155713608|NCT00531284|562046205|FG000|Overall Study|Progressive Disease|1|||
155713609|NCT00531284|562046206|FG001|Overall Study|Progressive Disease|3|||
155713610|NCT00531284|562046207|FG002|Overall Study|Progressive Disease|5|||
155713611|NCT00531284|562046208|FG003|Overall Study|Progressive Disease|42|||
155713612|NCT00531284|562046209|FG004|Overall Study|Progressive Disease|4|||
155713613|NCT00531284|562046210|FG005|Overall Study|Progressive Disease|4|||
155713614|NCT00531284|562046211|FG006|Overall Study|Progressive Disease|3|||
155713615|NCT00531284|562046212|FG007|Overall Study|Progressive Disease|8|||
155713616|NCT00531284|562046213|FG008|Overall Study|Progressive Disease|6|||
155713617|NCT00531284|562046214|FG009|Overall Study|Progressive Disease|3|||
155713618|NCT00531284|562046215|FG010|Overall Study|Progressive Disease|3|||
155713619|NCT00531284|562046216|FG011|Overall Study|Progressive Disease|14|||
155713620|NCT00531284|562046217|FG012|Overall Study|Progressive Disease|2|||
155713621|NCT00531284|562046218|FG013|Overall Study|Progressive Disease|1|||
155713622|NCT00531284|562046219|FG014|Overall Study|Progressive Disease|2|||
155713623|NCT00531284|562046220|FG015|Overall Study|Progressive Disease|11|||
155713624|NCT00531284|562046221|FG016|Overall Study|Progressive Disease|5|||
155713625|NCT00531284|562046205|FG000|Overall Study|Adverse Event|0|||
155713626|NCT00531284|562046206|FG001|Overall Study|Adverse Event|1|||
155713627|NCT00531284|562046207|FG002|Overall Study|Adverse Event|1|||
155713628|NCT00531284|562046208|FG003|Overall Study|Adverse Event|7|||
155713629|NCT00531284|562046209|FG004|Overall Study|Adverse Event|0|||
155713630|NCT00531284|562046210|FG005|Overall Study|Adverse Event|2|||
155713631|NCT00531284|562046211|FG006|Overall Study|Adverse Event|3|||
155713632|NCT00531284|562046212|FG007|Overall Study|Adverse Event|2|||
155713633|NCT00531284|562046213|FG008|Overall Study|Adverse Event|3|||
155713634|NCT00531284|562046214|FG009|Overall Study|Adverse Event|0|||
155713635|NCT00531284|562046215|FG010|Overall Study|Adverse Event|0|||
155713636|NCT00531284|562046216|FG011|Overall Study|Adverse Event|5|||
155713637|NCT00531284|562046217|FG012|Overall Study|Adverse Event|0|||
155713638|NCT00531284|562046218|FG013|Overall Study|Adverse Event|1|||
155713639|NCT00531284|562046219|FG014|Overall Study|Adverse Event|1|||
155713640|NCT00531284|562046220|FG015|Overall Study|Adverse Event|0|||
155713641|NCT00531284|562046221|FG016|Overall Study|Adverse Event|2|||
155713642|NCT00531284|562046205|FG000|Overall Study|Withdrawal by Subject|1|||
155713643|NCT00531284|562046206|FG001|Overall Study|Withdrawal by Subject|0|||
155713644|NCT00531284|562046207|FG002|Overall Study|Withdrawal by Subject|0|||
155713645|NCT00531284|562046208|FG003|Overall Study|Withdrawal by Subject|4|||
155713646|NCT00531284|562046209|FG004|Overall Study|Withdrawal by Subject|0|||
155713647|NCT00531284|562046210|FG005|Overall Study|Withdrawal by Subject|0|||
155713648|NCT00531284|562046211|FG006|Overall Study|Withdrawal by Subject|0|||
155713649|NCT00531284|562046212|FG007|Overall Study|Withdrawal by Subject|0|||
155713650|NCT00531284|562046213|FG008|Overall Study|Withdrawal by Subject|0|||
155713651|NCT00531284|562046214|FG009|Overall Study|Withdrawal by Subject|0|||
155713652|NCT00531284|562046215|FG010|Overall Study|Withdrawal by Subject|0|||
155713653|NCT00531284|562046216|FG011|Overall Study|Withdrawal by Subject|3|||
155713654|NCT00531284|562046217|FG012|Overall Study|Withdrawal by Subject|0|||
155713655|NCT00531284|562046218|FG013|Overall Study|Withdrawal by Subject|1|||
155713656|NCT00531284|562046219|FG014|Overall Study|Withdrawal by Subject|0|||
155713657|NCT00531284|562046220|FG015|Overall Study|Withdrawal by Subject|1|||
155713658|NCT00531284|562046221|FG016|Overall Study|Withdrawal by Subject|1|||
155713659|NCT00531284|562046205|FG000|Overall Study|Other|1|||
155713660|NCT00531284|562046206|FG001|Overall Study|Other|0|||
155713661|NCT00531284|562046207|FG002|Overall Study|Other|0|||
155713662|NCT00531284|562046208|FG003|Overall Study|Other|10|||
155713663|NCT00531284|562046209|FG004|Overall Study|Other|2|||
155713664|NCT00531284|562046210|FG005|Overall Study|Other|1|||
155713665|NCT00531284|562046211|FG006|Overall Study|Other|0|||
155713666|NCT00531284|562046212|FG007|Overall Study|Other|0|||
155713667|NCT00531284|562046213|FG008|Overall Study|Other|2|||
155713668|NCT00531284|562046214|FG009|Overall Study|Other|1|||
155713669|NCT00531284|562046215|FG010|Overall Study|Other|0|||
155713670|NCT00531284|562046216|FG011|Overall Study|Other|2|||
155713671|NCT00531284|562046217|FG012|Overall Study|Other|0|||
155713672|NCT00531284|562046218|FG013|Overall Study|Other|0|||
155713673|NCT00531284|562046219|FG014|Overall Study|Other|1|||
155713674|NCT00531284|562046220|FG015|Overall Study|Other|0|||
155713675|NCT00531284|562046221|FG016|Overall Study|Other|0|||
155713676|NCT02219464|562046223|FG000|Overall Study|Withdrawal by Subject|1|||
155713677|NCT02219464|562046224|FG001|Overall Study|Withdrawal by Subject|0|||
155713678|NCT02219464|562046223|FG000|Overall Study|case cancelled|1|||
155713679|NCT02219464|562046224|FG001|Overall Study|case cancelled|0|||
155713680|NCT02219464|562046223|FG000|Overall Study|catheter malfunction|1|||
155713681|NCT02219464|562046224|FG001|Overall Study|catheter malfunction|0|||
155713682|NCT03057496|562046225|FG000|Overall Study|Withdrawal by Subject|8|||
155713683|NCT03057496|562046225|FG000|Overall Study|Lost to Follow-up|5|||
155713684|NCT03057496|562046225|FG000|Overall Study|Did not use device during home trial|3|||
155713685|NCT03057496|562046225|FG000|Overall Study|Device failure|2|||
155713686|NCT02544321|562046231|FG000|Overall Study|Withdrawal by Subject|1|||
155713687|NCT02544321|562046232|FG001|Overall Study|Withdrawal by Subject|2|||
155713688|NCT02544321|562046231|FG000|Overall Study|Adverse Event|1|||
155713689|NCT02544321|562046232|FG001|Overall Study|Adverse Event|1|||
155713690|NCT02544321|562046231|FG000|Overall Study|Protocol Violation|0|||
155713691|NCT02544321|562046232|FG001|Overall Study|Protocol Violation|1|||
155713692|NCT01517750|562046233|FG000|Overall Study|Lost to Follow-up|1|||
155713693|NCT01517750|562046234|FG001|Overall Study|Lost to Follow-up|2|||
155713694|NCT01517750|562046235|FG002|Overall Study|Lost to Follow-up|4|||
155713695|NCT01517750|562046236|FG003|Overall Study|Lost to Follow-up|1|||
155713696|NCT01584232|562046237|FG000|Overall Study|Adverse Event|3|||
155713697|NCT01584232|562046238|FG001|Overall Study|Adverse Event|1|||
155713698|NCT01584232|562046237|FG000|Overall Study|Withdrawal by Subject|2|||
155713699|NCT01584232|562046238|FG001|Overall Study|Withdrawal by Subject|1|||
155713700|NCT01584232|562046237|FG000|Overall Study|Physician Decision|2|||
155713701|NCT01584232|562046238|FG001|Overall Study|Physician Decision|1|||
155713702|NCT01584232|562046237|FG000|Overall Study|Lost to Follow-up|1|||
155713703|NCT01584232|562046238|FG001|Overall Study|Lost to Follow-up|0|||
155713704|NCT01307319|562046239|FG000|Overall Study|Adverse Event|2|||
155713705|NCT01307319|562046240|FG001|Overall Study|Adverse Event|2|||
155713706|NCT01307319|562046241|FG002|Overall Study|Adverse Event|1|||
155713707|NCT01307319|562046239|FG000|Overall Study|Lost to Follow-up|1|||
155713708|NCT01307319|562046240|FG001|Overall Study|Lost to Follow-up|0|||
155713709|NCT01307319|562046241|FG002|Overall Study|Lost to Follow-up|1|||
155713710|NCT01307319|562046239|FG000|Overall Study|Protocol Violation|1|||
155713711|NCT01307319|562046240|FG001|Overall Study|Protocol Violation|1|||
155713712|NCT01307319|562046241|FG002|Overall Study|Protocol Violation|0|||
155713713|NCT01307319|562046239|FG000|Overall Study|Withdrawal by Subject|0|||
155713714|NCT01307319|562046240|FG001|Overall Study|Withdrawal by Subject|1|||
155713715|NCT01307319|562046241|FG002|Overall Study|Withdrawal by Subject|2|||
155713716|NCT01307319|562046239|FG000|Overall Study|Other|0|||
155713717|NCT01307319|562046240|FG001|Overall Study|Other|4|||
155713718|NCT01307319|562046241|FG002|Overall Study|Other|3|||
155713719|NCT02735239|562046242|FG000|Overall Study|Adverse Event|0|||
155713720|NCT02735239|562046243|FG001|Overall Study|Adverse Event|0|||
155713721|NCT02735239|562046244|FG002|Overall Study|Adverse Event|4|||
155713722|NCT02735239|562046245|FG003|Overall Study|Adverse Event|0|||
155713723|NCT02735239|562046246|FG004|Overall Study|Adverse Event|0|||
155713724|NCT02735239|562046247|FG005|Overall Study|Adverse Event|0|||
155713725|NCT02735239|562046242|FG000|Overall Study|Death|1|||
155713726|NCT02735239|562046243|FG001|Overall Study|Death|1|||
155713727|NCT02735239|562046244|FG002|Overall Study|Death|0|||
155713728|NCT02735239|562046245|FG003|Overall Study|Death|0|||
155713729|NCT02735239|562046246|FG004|Overall Study|Death|0|||
155713730|NCT02735239|562046247|FG005|Overall Study|Death|0|||
155713731|NCT02735239|562046242|FG000|Overall Study|Physician Decision|0|||
155713732|NCT02735239|562046243|FG001|Overall Study|Physician Decision|0|||
155713733|NCT02735239|562046244|FG002|Overall Study|Physician Decision|1|||
155713734|NCT02735239|562046245|FG003|Overall Study|Physician Decision|0|||
155713735|NCT02735239|562046246|FG004|Overall Study|Physician Decision|0|||
155713736|NCT02735239|562046247|FG005|Overall Study|Physician Decision|0|||
155713737|NCT02735239|562046242|FG000|Overall Study|Progressive disease|3|||
155713738|NCT02735239|562046243|FG001|Overall Study|Progressive disease|1|||
155713739|NCT02735239|562046244|FG002|Overall Study|Progressive disease|3|||
155713740|NCT02735239|562046245|FG003|Overall Study|Progressive disease|0|||
155713741|NCT02735239|562046246|FG004|Overall Study|Progressive disease|0|||
155713742|NCT02735239|562046247|FG005|Overall Study|Progressive disease|2|||
155713743|NCT02735239|562046242|FG000|Overall Study|Withdrawal by Subject|0|||
155713744|NCT02735239|562046243|FG001|Overall Study|Withdrawal by Subject|1|||
155713745|NCT02735239|562046244|FG002|Overall Study|Withdrawal by Subject|0|||
155713746|NCT02735239|562046245|FG003|Overall Study|Withdrawal by Subject|0|||
155713747|NCT02735239|562046246|FG004|Overall Study|Withdrawal by Subject|0|||
155713748|NCT02735239|562046247|FG005|Overall Study|Withdrawal by Subject|0|||
155713749|NCT02152631|562046248|FG000|Overall Study|Adverse Event|32|||
155713750|NCT02152631|562046249|FG001|Overall Study|Adverse Event|4|||
155713751|NCT02152631|562046248|FG000|Overall Study|Withdrawal by Subject|13|||
155713752|NCT02152631|562046249|FG001|Overall Study|Withdrawal by Subject|16|||
155713753|NCT02152631|562046248|FG000|Overall Study|Noncompliance with study drug|1|||
155713754|NCT02152631|562046249|FG001|Overall Study|Noncompliance with study drug|0|||
155713755|NCT02152631|562046248|FG000|Overall Study|Physician Decision|1|||
155713756|NCT02152631|562046249|FG001|Overall Study|Physician Decision|2|||
155713757|NCT02152631|562046248|FG000|Overall Study|Lost to Follow-up|0|||
155713758|NCT02152631|562046249|FG001|Overall Study|Lost to Follow-up|1|||
155713759|NCT02152631|562046248|FG000|Overall Study|On Treatment|19|||
155713760|NCT02152631|562046249|FG001|Overall Study|On Treatment|3|||
155713761|NCT01380769|562046262|FG000|Overall Study|Withdrawal by Subject|7|||
155713762|NCT01380769|562046263|FG001|Overall Study|Withdrawal by Subject|11|||
155713763|NCT01380769|562046262|FG000|Overall Study|Physician Decision|1|||
155713764|NCT01380769|562046263|FG001|Overall Study|Physician Decision|1|||
155713765|NCT01380769|562046262|FG000|Overall Study|Adverse Event|1|||
155713766|NCT01380769|562046263|FG001|Overall Study|Adverse Event|1|||
155713767|NCT01380769|562046262|FG000|Overall Study|Protocol Violation|0|||
155713768|NCT01380769|562046263|FG001|Overall Study|Protocol Violation|1|||
155713769|NCT05030350|562046265|FG000|Overall Study|Adverse Event|13|||
155713770|NCT05030350|562046265|FG000|Overall Study|Lack of Efficacy|8|||
155713771|NCT05030350|562046265|FG000|Overall Study|Lost to Follow-up|35|||
155713772|NCT05030350|562046265|FG000|Overall Study|Pregnancy|2|||
155713773|NCT05030350|562046265|FG000|Overall Study|Protocol Violation|2|||
155713774|NCT05030350|562046265|FG000|Overall Study|Withdrawal by Subject|60|||
155713775|NCT05030350|562046265|FG000|Overall Study|Study terminated by sponsor|349|||
155713776|NCT05030350|562046265|FG000|Overall Study|Positive Drug Screen|4|||
155713777|NCT05030350|562046265|FG000|Overall Study|Other|8|||
155713778|NCT03654690|562046266|FG000|Overall Study|Withdrawal by Subject|1|||
155713779|NCT03654690|562046267|FG001|Overall Study|Withdrawal by Subject|0|||
155713780|NCT03654690|562046268|FG002|Overall Study|Withdrawal by Subject|0|||
155713781|NCT02711137|562046269|FG000|Overall Study|Death|1|||
155713782|NCT02711137|562046270|FG001|Overall Study|Death|4|||
155713783|NCT02711137|562046271|FG002|Overall Study|Death|5|||
155713784|NCT02711137|562046272|FG003|Overall Study|Death|5|||
155713785|NCT02711137|562046273|FG004|Overall Study|Death|3|||
155713786|NCT02711137|562046274|FG005|Overall Study|Death|1|||
155713787|NCT02711137|562046275|FG006|Overall Study|Death|61|||
155713788|NCT02711137|562046276|FG007|Overall Study|Death|3|||
155713789|NCT02711137|562046277|FG008|Overall Study|Death|0|||
155713790|NCT02711137|562046278|FG009|Overall Study|Death|1|||
155713791|NCT02711137|562046279|FG010|Overall Study|Death|1|||
155713792|NCT02711137|562046280|FG011|Overall Study|Death|1|||
155713793|NCT02711137|562046281|FG012|Overall Study|Death|0|||
155713794|NCT02711137|562046282|FG013|Overall Study|Death|0|||
155713795|NCT02711137|562046283|FG014|Overall Study|Death|0|||
155713796|NCT02711137|562046269|FG000|Overall Study|Study Terminated by Sponsor|0|||
155713797|NCT02711137|562046270|FG001|Overall Study|Study Terminated by Sponsor|0|||
155713798|NCT02711137|562046271|FG002|Overall Study|Study Terminated by Sponsor|1|||
155713799|NCT02711137|562046272|FG003|Overall Study|Study Terminated by Sponsor|0|||
155713800|NCT02711137|562046273|FG004|Overall Study|Study Terminated by Sponsor|0|||
155713801|NCT02711137|562046274|FG005|Overall Study|Study Terminated by Sponsor|0|||
155713802|NCT02711137|562046275|FG006|Overall Study|Study Terminated by Sponsor|1|||
155713803|NCT02711137|562046276|FG007|Overall Study|Study Terminated by Sponsor|0|||
155713804|NCT02711137|562046277|FG008|Overall Study|Study Terminated by Sponsor|0|||
155713805|NCT02711137|562046278|FG009|Overall Study|Study Terminated by Sponsor|0|||
155713806|NCT02711137|562046279|FG010|Overall Study|Study Terminated by Sponsor|0|||
155713807|NCT02711137|562046280|FG011|Overall Study|Study Terminated by Sponsor|0|||
155713808|NCT02711137|562046281|FG012|Overall Study|Study Terminated by Sponsor|0|||
155713809|NCT02711137|562046282|FG013|Overall Study|Study Terminated by Sponsor|0|||
155713810|NCT02711137|562046283|FG014|Overall Study|Study Terminated by Sponsor|0|||
155713811|NCT02711137|562046269|FG000|Overall Study|Physician Decision|1|||
155713812|NCT02711137|562046270|FG001|Overall Study|Physician Decision|0|||
155713813|NCT02711137|562046271|FG002|Overall Study|Physician Decision|2|||
155713814|NCT02711137|562046272|FG003|Overall Study|Physician Decision|1|||
155713815|NCT02711137|562046273|FG004|Overall Study|Physician Decision|1|||
155713816|NCT02711137|562046274|FG005|Overall Study|Physician Decision|0|||
155713817|NCT02711137|562046275|FG006|Overall Study|Physician Decision|12|||
155713818|NCT02711137|562046276|FG007|Overall Study|Physician Decision|2|||
155713819|NCT02711137|562046277|FG008|Overall Study|Physician Decision|1|||
155713820|NCT02711137|562046278|FG009|Overall Study|Physician Decision|1|||
155713821|NCT02711137|562046279|FG010|Overall Study|Physician Decision|3|||
155713822|NCT02711137|562046280|FG011|Overall Study|Physician Decision|2|||
155713823|NCT02711137|562046281|FG012|Overall Study|Physician Decision|1|||
155713824|NCT02711137|562046282|FG013|Overall Study|Physician Decision|1|||
155713825|NCT02711137|562046283|FG014|Overall Study|Physician Decision|2|||
155713826|NCT02711137|562046269|FG000|Overall Study|Other|0|||
155713827|NCT02711137|562046270|FG001|Overall Study|Other|1|||
155713828|NCT02711137|562046271|FG002|Overall Study|Other|0|||
155713829|NCT02711137|562046272|FG003|Overall Study|Other|0|||
155713830|NCT02711137|562046273|FG004|Overall Study|Other|0|||
155713831|NCT02711137|562046274|FG005|Overall Study|Other|0|||
155713832|NCT02711137|562046275|FG006|Overall Study|Other|3|||
155713833|NCT02711137|562046276|FG007|Overall Study|Other|0|||
155713834|NCT02711137|562046277|FG008|Overall Study|Other|0|||
155713835|NCT02711137|562046278|FG009|Overall Study|Other|0|||
155713836|NCT02711137|562046279|FG010|Overall Study|Other|0|||
155713837|NCT02711137|562046280|FG011|Overall Study|Other|0|||
155713838|NCT02711137|562046281|FG012|Overall Study|Other|0|||
155713839|NCT02711137|562046282|FG013|Overall Study|Other|0|||
155713840|NCT02711137|562046283|FG014|Overall Study|Other|1|||
155713841|NCT02711137|562046269|FG000|Overall Study|Withdrawal by Subject|1|||
155713842|NCT02711137|562046270|FG001|Overall Study|Withdrawal by Subject|0|||
155713843|NCT02711137|562046271|FG002|Overall Study|Withdrawal by Subject|0|||
155713844|NCT02711137|562046272|FG003|Overall Study|Withdrawal by Subject|1|||
155713845|NCT02711137|562046273|FG004|Overall Study|Withdrawal by Subject|1|||
155713846|NCT02711137|562046274|FG005|Overall Study|Withdrawal by Subject|0|||
155713847|NCT02711137|562046275|FG006|Overall Study|Withdrawal by Subject|7|||
155713848|NCT02711137|562046276|FG007|Overall Study|Withdrawal by Subject|0|||
155713849|NCT02711137|562046277|FG008|Overall Study|Withdrawal by Subject|0|||
155713850|NCT02711137|562046278|FG009|Overall Study|Withdrawal by Subject|0|||
155713851|NCT02711137|562046279|FG010|Overall Study|Withdrawal by Subject|0|||
155713852|NCT02711137|562046280|FG011|Overall Study|Withdrawal by Subject|0|||
155713853|NCT02711137|562046281|FG012|Overall Study|Withdrawal by Subject|0|||
155713854|NCT02711137|562046282|FG013|Overall Study|Withdrawal by Subject|1|||
155713855|NCT02711137|562046283|FG014|Overall Study|Withdrawal by Subject|0|||
155713856|NCT02711137|562046269|FG000|Overall Study|Lost to Follow-up|1|||
155713857|NCT02711137|562046270|FG001|Overall Study|Lost to Follow-up|0|||
155713858|NCT02711137|562046271|FG002|Overall Study|Lost to Follow-up|0|||
155713859|NCT02711137|562046272|FG003|Overall Study|Lost to Follow-up|0|||
155713860|NCT02711137|562046273|FG004|Overall Study|Lost to Follow-up|0|||
155713861|NCT02711137|562046274|FG005|Overall Study|Lost to Follow-up|0|||
155713862|NCT02711137|562046275|FG006|Overall Study|Lost to Follow-up|2|||
155713863|NCT02711137|562046276|FG007|Overall Study|Lost to Follow-up|0|||
155713864|NCT02711137|562046277|FG008|Overall Study|Lost to Follow-up|0|||
155713865|NCT02711137|562046278|FG009|Overall Study|Lost to Follow-up|0|||
155713866|NCT02711137|562046279|FG010|Overall Study|Lost to Follow-up|0|||
155713867|NCT02711137|562046280|FG011|Overall Study|Lost to Follow-up|0|||
155713868|NCT02711137|562046281|FG012|Overall Study|Lost to Follow-up|0|||
155713869|NCT02711137|562046282|FG013|Overall Study|Lost to Follow-up|0|||
155713870|NCT02711137|562046283|FG014|Overall Study|Lost to Follow-up|0|||
155713871|NCT01544920|562046286|FG000|Overall Study|Adverse Event|0|||
155713872|NCT01544920|562046287|FG001|Overall Study|Adverse Event|3|||
155713873|NCT01544920|562046286|FG000|Overall Study|Death|0|||
155713874|NCT01544920|562046287|FG001|Overall Study|Death|1|||
155713875|NCT01544920|562046286|FG000|Overall Study|Lost to Follow-up|11|||
155713876|NCT01544920|562046287|FG001|Overall Study|Lost to Follow-up|12|||
155713877|NCT01544920|562046286|FG000|Overall Study|Protocol Violation|0|||
155713878|NCT01544920|562046287|FG001|Overall Study|Protocol Violation|2|||
155713879|NCT01544920|562046286|FG000|Overall Study|Physician Decision|4|||
155713880|NCT01544920|562046287|FG001|Overall Study|Physician Decision|1|||
155713881|NCT01544920|562046286|FG000|Overall Study|Withdrawal by Subject|4|||
155713882|NCT01544920|562046287|FG001|Overall Study|Withdrawal by Subject|4|||
155713883|NCT00965081|562046288|FG000|Overall Study|Adverse Event|14|||
155713884|NCT00965081|562046289|FG001|Overall Study|Adverse Event|9|||
155713885|NCT00965081|562046288|FG000|Overall Study|Lack of Efficacy|2|||
155713886|NCT00965081|562046289|FG001|Overall Study|Lack of Efficacy|5|||
155713887|NCT00965081|562046288|FG000|Overall Study|Lost to Follow-up|4|||
155713888|NCT00965081|562046289|FG001|Overall Study|Lost to Follow-up|5|||
155713889|NCT00965081|562046288|FG000|Overall Study|Physician Decision|2|||
155713890|NCT00965081|562046289|FG001|Overall Study|Physician Decision|0|||
155713891|NCT00965081|562046288|FG000|Overall Study|Protocol Violation|2|||
155713892|NCT00965081|562046289|FG001|Overall Study|Protocol Violation|5|||
155713893|NCT00965081|562046288|FG000|Overall Study|Sponsor Decision|1|||
155713894|NCT00965081|562046289|FG001|Overall Study|Sponsor Decision|0|||
155713895|NCT00965081|562046288|FG000|Overall Study|Withdrawal by Subject|4|||
155713896|NCT00965081|562046289|FG001|Overall Study|Withdrawal by Subject|7|||
155713897|NCT00965081|562046288|FG000|Overall Study|Switched to Rescue Arm|5|||
155713898|NCT00965081|562046289|FG001|Overall Study|Switched to Rescue Arm|12|||
155713899|NCT01367834|562046292|FG000|Overall Study|Withdrawal by Subject|2|||
155713900|NCT01367834|562046293|FG001|Overall Study|Withdrawal by Subject|2|||
155713901|NCT01367834|562046292|FG000|Overall Study|Study was ended.|0|||
155713902|NCT01367834|562046293|FG001|Overall Study|Study was ended.|1|||
155713903|NCT01569841|562046298|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
155713904|NCT01569841|562046299|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
155182896|NCT04854642|560108358|FG000|Overall Study|Adverse Event|1|||
155182897|NCT04854642|560108359|FG001|Overall Study|Adverse Event|2|||
155182898|NCT04854642|560108358|FG000|Overall Study|Withdrawal by Subject|0|||
155182899|NCT04854642|560108359|FG001|Overall Study|Withdrawal by Subject|1|||
155182953|NCT05007717|560108390|FG000|Overall Study|Death|3|||
155182954|NCT05007717|560108391|FG001|Overall Study|Death|2|||
155182955|NCT04565236|560108392|FG000|Overall Study|Patient/Guardian Decision|0|||
155182956|NCT04565236|560108393|FG001|Overall Study|Patient/Guardian Decision|0|||
155182957|NCT04565236|560108394|FG002|Overall Study|Patient/Guardian Decision|1|||
155182958|NCT04565236|560108395|FG003|Overall Study|Patient/Guardian Decision|0|||
155713905|NCT01859923|562046300|FG000|Overall Study|Adverse Event|0|||
155713906|NCT01859923|562046301|FG001|Overall Study|Adverse Event|0|||
155713907|NCT01859923|562046302|FG002|Overall Study|Adverse Event|1|||
155713908|NCT01859923|562046303|FG003|Overall Study|Adverse Event|1|||
155713909|NCT00113841|562046318|FG000|Overall Study|Disease progression|0|||
155713910|NCT00113841|562046319|FG001|Overall Study|Disease progression|2|||
155713911|NCT00113841|562046318|FG000|Overall Study|Non-compliant|1|||
155713912|NCT00113841|562046319|FG001|Overall Study|Non-compliant|0|||
155713913|NCT03901144|562046323|FG000|Overall Study|Lost to Follow-up|1|||
155713914|NCT03901144|562046324|FG001|Overall Study|Lost to Follow-up|1|||
155713915|NCT03901144|562046325|FG002|Overall Study|Lost to Follow-up|1|||
155713916|NCT03901144|562046326|FG003|Overall Study|Lost to Follow-up|1|||
155713917|NCT02021565|562046327|FG000|Baseline Through Intervention|Death|0|||
155713918|NCT02021565|562046328|FG001|Baseline Through Intervention|Death|1|||
155713919|NCT02021565|562046327|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
155182991|NCT00662532|560108404|FG000|Overall Study|Adverse Event|0|||
155182992|NCT00662532|560108405|FG001|Overall Study|Adverse Event|1|||
155182993|NCT00662532|560108404|FG000|Overall Study|Lost to Follow-up|0|||
155182994|NCT00662532|560108405|FG001|Overall Study|Lost to Follow-up|1|||
155713920|NCT02021565|562046328|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
155183029|NCT00442468|560108413|FG000|Overall Study|Adverse Event|4|||
155183030|NCT00442468|560108413|FG000|Overall Study|Withdrawal by Subject|91|||
155183031|NCT00442468|560108413|FG000|Overall Study|Did not complete all study procedures|88|||
155183032|NCT00589784|560108414|FG000|Overall Study|Withdrawal by Subject|0|||
155183033|NCT00589784|560108415|FG001|Overall Study|Withdrawal by Subject|6|||
155183034|NCT00589784|560108414|FG000|Overall Study|Patient inevaluable|1|||
155183035|NCT00589784|560108415|FG001|Overall Study|Patient inevaluable|0|||
155183036|NCT00589784|560108414|FG000|Overall Study|Adverse Event|0|||
155183037|NCT00589784|560108415|FG001|Overall Study|Adverse Event|4|||
155183038|NCT00287079|560108417|FG000|Overall Study|Qualifying relapse|12|||
155183039|NCT00287079|560108418|FG001|Overall Study|Qualifying relapse|1|||
155183040|NCT00287079|560108417|FG000|Overall Study|Non-qualifying relapse|1|||
155183041|NCT00287079|560108418|FG001|Overall Study|Non-qualifying relapse|0|||
155183042|NCT00287079|560108417|FG000|Overall Study|Adverse Event|5|||
155183043|NCT00287079|560108418|FG001|Overall Study|Adverse Event|0|||
155183044|NCT00287079|560108417|FG000|Overall Study|Protocol Violation|1|||
155183045|NCT00287079|560108418|FG001|Overall Study|Protocol Violation|0|||
155183046|NCT00287079|560108417|FG000|Overall Study|Other|3|||
155183047|NCT00287079|560108418|FG001|Overall Study|Other|0|||
155183048|NCT00470184|560108419|FG000|Overall Study|Not Treated(became ineligible)|4|||
155183049|NCT00470184|560108419|FG000|Overall Study|Not treated (other)|1|||
155183050|NCT00470184|560108419|FG000|Overall Study|disease Progression|4|||
155183051|NCT00470184|560108419|FG000|Overall Study|Adverse Event|3|||
155183052|NCT00470184|560108419|FG000|Overall Study|Withdrawal by Subject|4|||
155183053|NCT00470184|560108419|FG000|Overall Study|other|5|||
155183054|NCT00470184|560108419|FG000|Overall Study|recurrence|1|||
155713921|NCT02021565|562046327|FG000|Baseline Through Intervention|Protocol Violation|0|||
155713922|NCT02021565|562046328|FG001|Baseline Through Intervention|Protocol Violation|7|||
155713923|NCT02021565|562046327|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
155713924|NCT02021565|562046328|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
155713925|NCT02021565|562046327|FG000|3-month Follow-up|Death|3|||
155713926|NCT02021565|562046328|FG001|3-month Follow-up|Death|0|||
155713927|NCT02021565|562046327|FG000|3-month Follow-up|Withdrawal by Subject|4|||
155713928|NCT02021565|562046328|FG001|3-month Follow-up|Withdrawal by Subject|0|||
155713929|NCT02021565|562046327|FG000|3-month Follow-up|Protocol Violation|3|||
155713930|NCT02021565|562046328|FG001|3-month Follow-up|Protocol Violation|2|||
155183060|NCT02195011|560108424|FG000|Overall Study|Adverse Event|4|||
155183061|NCT02195011|560108425|FG001|Overall Study|Adverse Event|0|||
155183062|NCT02195011|560108424|FG000|Overall Study|Progressive Disease|18|||
155183063|NCT02195011|560108425|FG001|Overall Study|Progressive Disease|1|||
155183064|NCT02195011|560108424|FG000|Overall Study|Withdrawal by Subject|3|||
155183065|NCT02195011|560108425|FG001|Overall Study|Withdrawal by Subject|0|||
155183066|NCT03418571|560108426|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
155183067|NCT03418571|560108427|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
155183068|NCT03170232|560108428|FG000|Overall Study|Adverse Event|0|||
155183069|NCT03170232|560108429|FG001|Overall Study|Adverse Event|1|||
155183070|NCT03170232|560108428|FG000|Overall Study|Protocol Violation|0|||
155183071|NCT03170232|560108429|FG001|Overall Study|Protocol Violation|1|||
155183072|NCT03170232|560108428|FG000|Overall Study|Lack of Efficacy|0|||
155183073|NCT03170232|560108429|FG001|Overall Study|Lack of Efficacy|1|||
155183074|NCT03170232|560108428|FG000|Overall Study|Study closed/terminated|26|||
155183075|NCT03170232|560108429|FG001|Overall Study|Study closed/terminated|23|||
155183076|NCT03170232|560108428|FG000|Overall Study|Lost to Follow-up|1|||
155183077|NCT03170232|560108429|FG001|Overall Study|Lost to Follow-up|0|||
155183078|NCT03170232|560108428|FG000|Overall Study|Withdrawal by Subject|0|||
155183079|NCT03170232|560108429|FG001|Overall Study|Withdrawal by Subject|1|||
155183080|NCT03882008|560108430|FG000|Overall Study|Withdrawal by Subject|1|||
155183081|NCT03882008|560108430|FG000|Overall Study|Lost to Follow-up|1|||
155183082|NCT01222403|560108433|FG000|Overall Study|Inappropriate enrollment|0|||
155183083|NCT01222403|560108434|FG001|Overall Study|Inappropriate enrollment|2|||
155183092|NCT02068768|560108437|FG000|Overall Study|Lost to Follow-up|5|||
155183093|NCT02068768|560108437|FG000|Overall Study|Early Termination by Sponsor|2|||
155183094|NCT01262352|560108438|FG000|Period 1|Illness after randomization|1|||
155183095|NCT01262352|560108439|FG001|Period 1|Illness after randomization|0|||
155183096|NCT01262352|560108438|FG000|Washout|Adverse Event|1|||
155183097|NCT01262352|560108439|FG001|Washout|Adverse Event|1|||
155183098|NCT01262352|560108438|FG000|Washout|Extended Washout|0|||
155183099|NCT01262352|560108439|FG001|Washout|Extended Washout|1|||
155183100|NCT01185834|560108440|FG000|Overall Study|Lost to Follow-up|2|||
155183101|NCT01185834|560108440|FG000|Overall Study|Discomfort|4|||
155183102|NCT01185834|560108440|FG000|Overall Study|Biomicroscopy|4|||
155183103|NCT01185834|560108440|FG000|Overall Study|Time/Job Conflict|2|||
155183104|NCT01185834|560108440|FG000|Overall Study|Early exit - Site error|2|||
155183105|NCT01401959|560108441|FG000|Enrolled|Withdrawal by Subject|1|||
155183106|NCT01401959|560108442|FG001|Enrolled|Withdrawal by Subject|0|||
155183107|NCT01401959|560108443|FG002|Enrolled|Withdrawal by Subject|0|||
155713931|NCT05114473|562046331|FG000|Overall Study|Lost to Follow-up|2|||
155713932|NCT05114473|562046332|FG001|Overall Study|Lost to Follow-up|2|||
155713933|NCT05114473|562046333|FG002|Overall Study|Lost to Follow-up|0|||
155713934|NCT03089580|562046345|FG000|Overall Study|Lost to Follow-up|2|||
155713935|NCT04491136|562046346|FG000|Overall Study|Patient withdraw informed consent|9|||
155713936|NCT04491136|562046346|FG000|Overall Study|Adverse Event|2|||
155713937|NCT04491136|562046346|FG000|Overall Study|Death|3|||
155713938|NCT04491136|562046346|FG000|Overall Study|Lost to Follow-up|3|||
155713939|NCT04491136|562046346|FG000|Overall Study|Physician Decision|45|||
155713940|NCT04491136|562046346|FG000|Overall Study|sponsor terminated the study early|16|||
155713941|NCT04491136|562046346|FG000|Overall Study|Patient/guardian's decision|1|||
155713942|NCT02452424|562046347|FG000|Overall Study|Death|2|||
155713943|NCT02452424|562046348|FG001|Overall Study|Death|2|||
155713944|NCT02452424|562046349|FG002|Overall Study|Death|2|||
155713945|NCT02452424|562046350|FG003|Overall Study|Death|6|||
155183108|NCT01401959|560108441|FG000|Treated|Disease Progression|2|||
155183109|NCT01401959|560108442|FG001|Treated|Disease Progression|2|||
155183110|NCT01401959|560108443|FG002|Treated|Disease Progression|1|||
155713946|NCT02452424|562046351|FG004|Overall Study|Death|2|||
155713947|NCT02452424|562046352|FG005|Overall Study|Death|0|||
155713948|NCT02452424|562046353|FG006|Overall Study|Death|5|||
155713949|NCT02452424|562046354|FG007|Overall Study|Death|1|||
155713950|NCT02452424|562046355|FG008|Overall Study|Death|3|||
155713951|NCT02452424|562046356|FG009|Overall Study|Death|1|||
155713952|NCT02452424|562046357|FG010|Overall Study|Death|0|||
155713953|NCT02452424|562046347|FG000|Overall Study|Lost to Follow-up|0|||
155713954|NCT02452424|562046348|FG001|Overall Study|Lost to Follow-up|1|||
155713955|NCT02452424|562046349|FG002|Overall Study|Lost to Follow-up|1|||
155713956|NCT02452424|562046350|FG003|Overall Study|Lost to Follow-up|0|||
155183111|NCT01401959|560108441|FG000|Treated|Adverse Event|4|||
155183112|NCT01401959|560108442|FG001|Treated|Adverse Event|3|||
155183113|NCT01401959|560108443|FG002|Treated|Adverse Event|2|||
155183114|NCT01401959|560108441|FG000|Treated|Withdrawal by Subject|1|||
155183115|NCT01401959|560108442|FG001|Treated|Withdrawal by Subject|2|||
155183116|NCT01401959|560108443|FG002|Treated|Withdrawal by Subject|2|||
155183117|NCT01401959|560108441|FG000|Treated|Protocol Violation|0|||
155183118|NCT01401959|560108442|FG001|Treated|Protocol Violation|1|||
155183119|NCT01401959|560108443|FG002|Treated|Protocol Violation|0|||
155183120|NCT02694718|560108448|FG000|Overall Study|Death|1|||
155183121|NCT02694718|560108448|FG000|Overall Study|Withdrawal by Subject|1|||
155183122|NCT02925793|560108449|FG000|Overall Study|Adverse Event|3|||
155183123|NCT02925793|560108450|FG001|Overall Study|Adverse Event|3|||
155183124|NCT02925793|560108451|FG002|Overall Study|Adverse Event|6|||
155183125|NCT02925793|560108449|FG000|Overall Study|Withdrawal by Subject|16|||
155183126|NCT02925793|560108450|FG001|Overall Study|Withdrawal by Subject|15|||
155183127|NCT02925793|560108451|FG002|Overall Study|Withdrawal by Subject|13|||
155183128|NCT02925793|560108449|FG000|Overall Study|Investigator Discretion|0|||
155183129|NCT02925793|560108450|FG001|Overall Study|Investigator Discretion|1|||
155183130|NCT02925793|560108451|FG002|Overall Study|Investigator Discretion|1|||
155183131|NCT02925793|560108449|FG000|Overall Study|Lost to Follow-up|2|||
155183132|NCT02925793|560108450|FG001|Overall Study|Lost to Follow-up|3|||
155183133|NCT02925793|560108451|FG002|Overall Study|Lost to Follow-up|1|||
155183134|NCT02925793|560108449|FG000|Overall Study|Lack of Efficacy|2|||
155183135|NCT02925793|560108450|FG001|Overall Study|Lack of Efficacy|6|||
155183136|NCT02925793|560108451|FG002|Overall Study|Lack of Efficacy|4|||
155183137|NCT02925793|560108449|FG000|Overall Study|Other:|2|||
155183138|NCT02925793|560108450|FG001|Overall Study|Other:|1|||
155183139|NCT02925793|560108451|FG002|Overall Study|Other:|3|||
155183140|NCT00393042|560108452|FG000|First Intervention|Withdrawal by Subject|1|||
155183141|NCT00393042|560108453|FG001|First Intervention|Withdrawal by Subject|2|||
155183142|NCT00393042|560108452|FG000|First Intervention|Lost to Follow-up|3|||
155183143|NCT00393042|560108453|FG001|First Intervention|Lost to Follow-up|3|||
155183144|NCT00393042|560108452|FG000|First Intervention|Protocol Violation|1|||
155183145|NCT00393042|560108453|FG001|First Intervention|Protocol Violation|0|||
155183146|NCT00393042|560108452|FG000|First Intervention|Adverse Event|0|||
155183147|NCT00393042|560108453|FG001|First Intervention|Adverse Event|1|||
155183148|NCT00393042|560108452|FG000|Second Intervetion|Adverse Event|0|||
155183149|NCT00393042|560108453|FG001|Second Intervetion|Adverse Event|3|||
155183150|NCT00393042|560108452|FG000|Second Intervetion|Withdrawal by Subject|0|||
155183151|NCT00393042|560108453|FG001|Second Intervetion|Withdrawal by Subject|2|||
155183152|NCT00393042|560108452|FG000|Second Intervetion|Lack of Efficacy|1|||
155183153|NCT00393042|560108453|FG001|Second Intervetion|Lack of Efficacy|0|||
155183154|NCT00393042|560108452|FG000|Second Intervetion|Lost to Follow-up|0|||
155183155|NCT00393042|560108453|FG001|Second Intervetion|Lost to Follow-up|2|||
155183156|NCT00393042|560108452|FG000|Second Intervetion|Protocol Violation|1|||
155713957|NCT02452424|562046351|FG004|Overall Study|Lost to Follow-up|0|||
155713958|NCT02452424|562046352|FG005|Overall Study|Lost to Follow-up|0|||
155713959|NCT02452424|562046353|FG006|Overall Study|Lost to Follow-up|0|||
155713960|NCT02452424|562046354|FG007|Overall Study|Lost to Follow-up|0|||
155713961|NCT02452424|562046355|FG008|Overall Study|Lost to Follow-up|0|||
155713962|NCT02452424|562046356|FG009|Overall Study|Lost to Follow-up|0|||
155713963|NCT02452424|562046357|FG010|Overall Study|Lost to Follow-up|0|||
155713964|NCT02452424|562046347|FG000|Overall Study|Withdrawal by Subject|0|||
155713965|NCT02452424|562046348|FG001|Overall Study|Withdrawal by Subject|0|||
155713966|NCT02452424|562046349|FG002|Overall Study|Withdrawal by Subject|3|||
155713967|NCT02452424|562046350|FG003|Overall Study|Withdrawal by Subject|2|||
155713968|NCT02452424|562046351|FG004|Overall Study|Withdrawal by Subject|0|||
155713969|NCT02452424|562046352|FG005|Overall Study|Withdrawal by Subject|0|||
155713970|NCT02452424|562046353|FG006|Overall Study|Withdrawal by Subject|1|||
155713971|NCT02452424|562046354|FG007|Overall Study|Withdrawal by Subject|0|||
155713972|NCT02452424|562046355|FG008|Overall Study|Withdrawal by Subject|1|||
155713973|NCT02452424|562046356|FG009|Overall Study|Withdrawal by Subject|1|||
155713974|NCT02452424|562046357|FG010|Overall Study|Withdrawal by Subject|0|||
155713975|NCT02452424|562046347|FG000|Overall Study|Other|0|||
155713976|NCT02452424|562046348|FG001|Overall Study|Other|0|||
155713977|NCT02452424|562046349|FG002|Overall Study|Other|1|||
155713978|NCT02452424|562046350|FG003|Overall Study|Other|0|||
155183157|NCT00393042|560108453|FG001|Second Intervetion|Protocol Violation|1|||
155183158|NCT00322153|560108458|FG000|Overall Study|Adverse Event|21|||
155183159|NCT00322153|560108459|FG001|Overall Study|Adverse Event|34|||
155183160|NCT00322153|560108458|FG000|Overall Study|Protocol Violation|6|||
155183161|NCT00322153|560108459|FG001|Overall Study|Protocol Violation|14|||
155183162|NCT00322153|560108458|FG000|Overall Study|Withdrawal by Subject|18|||
155183163|NCT00322153|560108459|FG001|Overall Study|Withdrawal by Subject|10|||
155183164|NCT00322153|560108458|FG000|Overall Study|Lack of Efficacy|8|||
155183165|NCT00322153|560108459|FG001|Overall Study|Lack of Efficacy|3|||
155183166|NCT00322153|560108458|FG000|Overall Study|Lost to Follow-up|5|||
155183167|NCT00322153|560108459|FG001|Overall Study|Lost to Follow-up|4|||
155183168|NCT00322153|560108458|FG000|Overall Study|Withdrawn for other reasons|5|||
155183169|NCT00322153|560108459|FG001|Overall Study|Withdrawn for other reasons|4|||
155713979|NCT02452424|562046351|FG004|Overall Study|Other|0|||
155713980|NCT02452424|562046352|FG005|Overall Study|Other|1|||
155713981|NCT02452424|562046353|FG006|Overall Study|Other|4|||
155713982|NCT02452424|562046354|FG007|Overall Study|Other|3|||
155713983|NCT02452424|562046355|FG008|Overall Study|Other|0|||
155713984|NCT02452424|562046356|FG009|Overall Study|Other|0|||
155713985|NCT02452424|562046357|FG010|Overall Study|Other|1|||
155713986|NCT02452424|562046347|FG000|Overall Study|Progressive disease (per RECIST)|0|||
155713987|NCT02452424|562046348|FG001|Overall Study|Progressive disease (per RECIST)|0|||
155713988|NCT02452424|562046349|FG002|Overall Study|Progressive disease (per RECIST)|0|||
155713989|NCT02452424|562046350|FG003|Overall Study|Progressive disease (per RECIST)|0|||
155713990|NCT02452424|562046351|FG004|Overall Study|Progressive disease (per RECIST)|0|||
155713991|NCT02452424|562046352|FG005|Overall Study|Progressive disease (per RECIST)|0|||
155713992|NCT02452424|562046353|FG006|Overall Study|Progressive disease (per RECIST)|0|||
155713993|NCT02452424|562046354|FG007|Overall Study|Progressive disease (per RECIST)|0|||
155713994|NCT02452424|562046355|FG008|Overall Study|Progressive disease (per RECIST)|2|||
155713995|NCT02452424|562046356|FG009|Overall Study|Progressive disease (per RECIST)|0|||
155713996|NCT02452424|562046357|FG010|Overall Study|Progressive disease (per RECIST)|0|||
155713997|NCT02452424|562046347|FG000|Overall Study|Adverse Event|0|||
155713998|NCT02452424|562046348|FG001|Overall Study|Adverse Event|0|||
155713999|NCT02452424|562046349|FG002|Overall Study|Adverse Event|0|||
155714000|NCT02452424|562046350|FG003|Overall Study|Adverse Event|0|||
155714001|NCT02452424|562046351|FG004|Overall Study|Adverse Event|0|||
155714002|NCT02452424|562046352|FG005|Overall Study|Adverse Event|0|||
155714003|NCT02452424|562046353|FG006|Overall Study|Adverse Event|0|||
155714004|NCT02452424|562046354|FG007|Overall Study|Adverse Event|0|||
155714005|NCT02452424|562046355|FG008|Overall Study|Adverse Event|0|||
155714006|NCT02452424|562046356|FG009|Overall Study|Adverse Event|0|||
155714007|NCT02452424|562046357|FG010|Overall Study|Adverse Event|1|||
155714008|NCT03790917|562046358|FG000|Overall Study|Death|1|||
155714009|NCT00176462|562046361|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
155714010|NCT00176462|562046362|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
155714011|NCT00176462|562046361|FG000|Induction (4 Weeks)|Death|1|||
155714012|NCT00176462|562046362|FG001|Induction (4 Weeks)|Death|2|||
155714013|NCT00176462|562046361|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
155714014|NCT00176462|562046362|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
155714015|NCT00176462|562046361|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
155714016|NCT00176462|562046362|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
155714017|NCT00176462|562046361|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
155714018|NCT00176462|562046362|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
155714019|NCT00176462|562046361|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
155714020|NCT00176462|562046362|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
155714021|NCT00176462|562046361|FG000|Consolidation (12 Weeks)|Not documented|0|||
155714022|NCT00176462|562046362|FG001|Consolidation (12 Weeks)|Not documented|1|||
155714023|NCT00176462|562046361|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
155714024|NCT00176462|562046362|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
155714025|NCT00176462|562046361|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
155714026|NCT00176462|562046362|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
155714027|NCT01150097|562046366|FG000|Months 24 to 36 Post-transplantation|Death|2|||
155183310|NCT03523000|560108475|FG000|Overall Study|Withdrawal by Subject|3|||
155183311|NCT03523000|560108476|FG001|Overall Study|Withdrawal by Subject|0|||
155183312|NCT03523000|560108475|FG000|Overall Study|Unsuccessful trial|2|||
155183313|NCT03523000|560108476|FG001|Overall Study|Unsuccessful trial|0|||
155183314|NCT00772070|560108477|FG000|Overall Study|Lost to Follow-up|0|||
155183315|NCT00772070|560108478|FG001|Overall Study|Lost to Follow-up|8|||
155183316|NCT00772070|560108477|FG000|Overall Study|Withdrawal by Subject|0|||
155183317|NCT00772070|560108478|FG001|Overall Study|Withdrawal by Subject|2|||
155183318|NCT00772070|560108477|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
155183319|NCT00772070|560108478|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
155183320|NCT01309308|560108479|FG000|Overall Study|Lost to Follow-up|6|||
155183321|NCT01309308|560108480|FG001|Overall Study|Lost to Follow-up|4|||
155183322|NCT01307020|560108483|FG000|Overall Study|Lost to Follow-up|0|||
155183323|NCT01307020|560108484|FG001|Overall Study|Lost to Follow-up|0|||
155183324|NCT01307020|560108485|FG002|Overall Study|Lost to Follow-up|1|||
155183325|NCT01307020|560108486|FG003|Overall Study|Lost to Follow-up|1|||
155183326|NCT01307020|560108487|FG004|Overall Study|Lost to Follow-up|0|||
155183327|NCT01307020|560108488|FG005|Overall Study|Lost to Follow-up|0|||
155183328|NCT01307020|560108489|FG006|Overall Study|Lost to Follow-up|1|||
155183329|NCT01307020|560108490|FG007|Overall Study|Lost to Follow-up|0|||
155183330|NCT01307020|560108491|FG008|Overall Study|Lost to Follow-up|0|||
155183331|NCT01307020|560108492|FG009|Overall Study|Lost to Follow-up|0|||
155183332|NCT01307020|560108483|FG000|Overall Study|Electronic data capture failure|0|||
155183333|NCT01307020|560108484|FG001|Overall Study|Electronic data capture failure|1|||
155183334|NCT01307020|560108485|FG002|Overall Study|Electronic data capture failure|0|||
155183335|NCT01307020|560108486|FG003|Overall Study|Electronic data capture failure|0|||
155183336|NCT01307020|560108487|FG004|Overall Study|Electronic data capture failure|0|||
155183337|NCT01307020|560108488|FG005|Overall Study|Electronic data capture failure|0|||
155183338|NCT01307020|560108489|FG006|Overall Study|Electronic data capture failure|0|||
155183339|NCT01307020|560108490|FG007|Overall Study|Electronic data capture failure|0|||
155183340|NCT01307020|560108491|FG008|Overall Study|Electronic data capture failure|0|||
155183341|NCT01307020|560108492|FG009|Overall Study|Electronic data capture failure|0|||
155183342|NCT00266864|560108493|FG000|Overall Study|Lost to Follow-up|4|||
155183343|NCT00266864|560108494|FG001|Overall Study|Lost to Follow-up|1|||
155183344|NCT00266864|560108493|FG000|Overall Study|Withdrawal by Subject|1|||
155183345|NCT00266864|560108494|FG001|Overall Study|Withdrawal by Subject|1|||
155183346|NCT00727532|560108495|FG000|Overall Study|Adverse Event|1|||
155183347|NCT00727532|560108495|FG000|Overall Study|Withdrawal by Subject|1|||
155183348|NCT00829933|560108496|FG000|Overall Study|Adverse Event|2|||
155183349|NCT00829933|560108497|FG001|Overall Study|Adverse Event|3|||
155183350|NCT00829933|560108498|FG002|Overall Study|Adverse Event|2|||
155183351|NCT00829933|560108499|FG003|Overall Study|Adverse Event|1|||
155183352|NCT00829933|560108496|FG000|Overall Study|Death|0|||
155183353|NCT00829933|560108497|FG001|Overall Study|Death|0|||
155183354|NCT00829933|560108498|FG002|Overall Study|Death|1|||
155183355|NCT00829933|560108499|FG003|Overall Study|Death|1|||
155183356|NCT00829933|560108496|FG000|Overall Study|Lack of Efficacy|0|||
155183357|NCT00829933|560108497|FG001|Overall Study|Lack of Efficacy|1|||
155183358|NCT00829933|560108498|FG002|Overall Study|Lack of Efficacy|0|||
155183359|NCT00829933|560108499|FG003|Overall Study|Lack of Efficacy|0|||
155183360|NCT00829933|560108496|FG000|Overall Study|Physician Decision|5|||
155183361|NCT00829933|560108497|FG001|Overall Study|Physician Decision|7|||
155183362|NCT00829933|560108498|FG002|Overall Study|Physician Decision|8|||
155183363|NCT00829933|560108499|FG003|Overall Study|Physician Decision|1|||
155183364|NCT00829933|560108496|FG000|Overall Study|Pregnancy|0|||
155183365|NCT00829933|560108497|FG001|Overall Study|Pregnancy|0|||
155183366|NCT00829933|560108498|FG002|Overall Study|Pregnancy|0|||
155183367|NCT00829933|560108499|FG003|Overall Study|Pregnancy|2|||
155183368|NCT00829933|560108496|FG000|Overall Study|Protocol Violation|2|||
155183369|NCT00829933|560108497|FG001|Overall Study|Protocol Violation|1|||
155183370|NCT00829933|560108498|FG002|Overall Study|Protocol Violation|0|||
155183371|NCT00829933|560108499|FG003|Overall Study|Protocol Violation|0|||
155183372|NCT00829933|560108496|FG000|Overall Study|withdrew before treatment started|5|||
155183373|NCT00829933|560108497|FG001|Overall Study|withdrew before treatment started|1|||
155183374|NCT00829933|560108498|FG002|Overall Study|withdrew before treatment started|2|||
155183375|NCT00829933|560108499|FG003|Overall Study|withdrew before treatment started|9|||
155183376|NCT03687970|560108503|FG000|Overall Study|visit scheduling conflicts|2|||
155183377|NCT03687970|560108504|FG001|Overall Study|visit scheduling conflicts|0|||
155183378|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183379|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183380|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183381|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183382|NCT01683019|560110346|FG000|Overall Study|Withdrawal by Subject|2|||
155183383|NCT01683019|560110347|FG001|Overall Study|Withdrawal by Subject|1|||
155183384|NCT01683019|560110348|FG002|Overall Study|Withdrawal by Subject|4|||
155183385|NCT03437512|560110349|FG000|Randomized|Withdrawal by Subject|0|||
155183386|NCT03437512|560110350|FG001|Randomized|Withdrawal by Subject|2|||
155183387|NCT03437512|560110349|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
155183388|NCT03437512|560110350|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
155183389|NCT00543855|560110351|FG000|Overall Study|Adverse Event|3|||
155183390|NCT00543855|560110352|FG001|Overall Study|Adverse Event|1|||
155183391|NCT00543855|560110353|FG002|Overall Study|Adverse Event|3|||
155183392|NCT00543855|560110354|FG003|Overall Study|Adverse Event|4|||
155183393|NCT00543855|560110351|FG000|Overall Study|Lost to Follow-up|0|||
155183394|NCT00543855|560110352|FG001|Overall Study|Lost to Follow-up|0|||
155183395|NCT00543855|560110353|FG002|Overall Study|Lost to Follow-up|1|||
155183396|NCT00543855|560110354|FG003|Overall Study|Lost to Follow-up|0|||
155183397|NCT00543855|560110351|FG000|Overall Study|Withdrawal by Subject|0|||
155183398|NCT00543855|560110352|FG001|Overall Study|Withdrawal by Subject|1|||
155183399|NCT00543855|560110353|FG002|Overall Study|Withdrawal by Subject|2|||
155183400|NCT00543855|560110354|FG003|Overall Study|Withdrawal by Subject|0|||
155183401|NCT00543855|560110351|FG000|Overall Study|Protocol Violation|1|||
155183402|NCT00543855|560110352|FG001|Overall Study|Protocol Violation|0|||
155183403|NCT00543855|560110353|FG002|Overall Study|Protocol Violation|0|||
155183404|NCT00543855|560110354|FG003|Overall Study|Protocol Violation|0|||
155183405|NCT00301821|560110358|FG000|Overall Study|Ineligible|25|||
155183406|NCT00301821|560110358|FG000|Overall Study|Cancel|1|||
155183407|NCT02294773|560110359|FG000|Overall Study|Withdrawal by Subject|0|||
155183408|NCT02294773|560110360|FG001|Overall Study|Withdrawal by Subject|2|||
155183409|NCT01865084|560110361|FG000|Double Blind Period (DB)|Adverse Event|2|||
155183410|NCT01865084|560110362|FG001|Double Blind Period (DB)|Adverse Event|2|||
155183411|NCT01865084|560110363|FG002|Double Blind Period (DB)|Adverse Event|1|||
155183412|NCT01865084|560110361|FG000|Double Blind Period (DB)|Protocol Violation|0|||
155183413|NCT01865084|560110362|FG001|Double Blind Period (DB)|Protocol Violation|0|||
155183414|NCT01865084|560110363|FG002|Double Blind Period (DB)|Protocol Violation|1|||
155183415|NCT01865084|560110361|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
155183416|NCT01865084|560110362|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
155183417|NCT01865084|560110363|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
155183418|NCT01865084|560110361|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
155183419|NCT01865084|560110362|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
155183420|NCT01865084|560110363|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
155183421|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
155183422|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
155183423|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
155183424|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
155183425|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
155183426|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
155183427|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
155183428|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
155183429|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
155183430|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
155183431|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
155183432|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
155183433|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
155183434|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
155183435|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
155183436|NCT05828095|560110364|FG000|Overall Study|Lost to Follow-up|1|||
155183437|NCT05828095|560110365|FG001|Overall Study|Lost to Follow-up|0|||
155183438|NCT05828095|560110364|FG000|Overall Study|Reactogenicity symptom|0|||
155183439|NCT05828095|560110365|FG001|Overall Study|Reactogenicity symptom|1|||
155183440|NCT01994590|560110368|FG000|Overall Study|Adverse Event|1|||
155183441|NCT01994590|560110368|FG000|Overall Study|Trial Terminated|1|||
155183442|NCT03206073|560110369|FG000|Overall Study|Participant Noncompliance|0|||
155183443|NCT03206073|560110370|FG001|Overall Study|Participant Noncompliance|1|||
155183444|NCT03206073|560110371|FG002|Overall Study|Participant Noncompliance|0|||
155183445|NCT03206073|560110372|FG003|Overall Study|Participant Noncompliance|0|||
155183446|NCT03206073|560110369|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
155183447|NCT03206073|560110370|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183448|NCT03206073|560110371|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183449|NCT03206073|560110372|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183450|NCT03206073|560110369|FG000|Overall Study|Death|0|||
155183451|NCT03206073|560110370|FG001|Overall Study|Death|0|||
155183452|NCT03206073|560110371|FG002|Overall Study|Death|1|||
155183453|NCT03206073|560110372|FG003|Overall Study|Death|0|||
155183454|NCT03206073|560110369|FG000|Overall Study|Taken off active treatment|0|||
155183455|NCT03206073|560110370|FG001|Overall Study|Taken off active treatment|0|||
155183456|NCT03206073|560110371|FG002|Overall Study|Taken off active treatment|3|||
155183457|NCT03206073|560110372|FG003|Overall Study|Taken off active treatment|0|||
155183458|NCT03332771|560110374|FG000|Overall Study|Adverse Event|6|||
155183459|NCT03332771|560110375|FG001|Overall Study|Adverse Event|4|||
155183460|NCT03332771|560110376|FG002|Overall Study|Adverse Event|1|||
155183461|NCT03332771|560110377|FG003|Overall Study|Adverse Event|3|||
155183462|NCT03332771|560110374|FG000|Overall Study|Poor Compliance to Protocol|0|||
155183463|NCT03332771|560110375|FG001|Overall Study|Poor Compliance to Protocol|1|||
155183464|NCT03332771|560110376|FG002|Overall Study|Poor Compliance to Protocol|0|||
155183465|NCT03332771|560110377|FG003|Overall Study|Poor Compliance to Protocol|1|||
155183466|NCT03332771|560110374|FG000|Overall Study|Lost to Follow-up|2|||
155183467|NCT03332771|560110375|FG001|Overall Study|Lost to Follow-up|2|||
155183468|NCT03332771|560110376|FG002|Overall Study|Lost to Follow-up|1|||
155183469|NCT03332771|560110377|FG003|Overall Study|Lost to Follow-up|2|||
155183470|NCT03332771|560110374|FG000|Overall Study|At the Participant's own request|20|||
155183471|NCT03332771|560110375|FG001|Overall Study|At the Participant's own request|26|||
155183472|NCT03332771|560110376|FG002|Overall Study|At the Participant's own request|14|||
155183473|NCT03332771|560110377|FG003|Overall Study|At the Participant's own request|23|||
155183474|NCT03332771|560110374|FG000|Overall Study|Reason Not Specified|6|||
155183475|NCT03332771|560110375|FG001|Overall Study|Reason Not Specified|18|||
155183476|NCT03332771|560110376|FG002|Overall Study|Reason Not Specified|16|||
155183477|NCT03332771|560110377|FG003|Overall Study|Reason Not Specified|19|||
155183478|NCT03442764|560110378|FG000|Overall Study|Adverse Event|1|||
155183479|NCT03442764|560110379|FG001|Overall Study|Adverse Event|0|||
155183480|NCT03442764|560110380|FG002|Overall Study|Adverse Event|0|||
155183481|NCT01801072|560110381|FG000|Overall Study|Lost to Follow-up|17|||
155183482|NCT01801072|560110382|FG001|Overall Study|Lost to Follow-up|14|||
155183483|NCT01801072|560110381|FG000|Overall Study|Physician Decision|2|||
155714028|NCT01150097|562046367|FG001|Months 24 to 36 Post-transplantation|Death|0|||
155183484|NCT01801072|560110382|FG001|Overall Study|Physician Decision|3|||
155183485|NCT01801072|560110381|FG000|Overall Study|Withdrawal by Subject|1|||
155183486|NCT01801072|560110382|FG001|Overall Study|Withdrawal by Subject|0|||
155183487|NCT01801072|560110381|FG000|Overall Study|Protocol Violation|2|||
155183488|NCT01801072|560110382|FG001|Overall Study|Protocol Violation|0|||
155183489|NCT01801072|560110381|FG000|Overall Study|Death|7|||
155183490|NCT01801072|560110382|FG001|Overall Study|Death|8|||
155183491|NCT00719264|560110383|FG000|Overall Study|Adverse Event|41|||
155714029|NCT01150097|562046368|FG002|Months 24 to 36 Post-transplantation|Death|0|||
155714030|NCT01150097|562046366|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
155714031|NCT01150097|562046367|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
155714032|NCT01150097|562046368|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
155714033|NCT01150097|562046366|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
155714034|NCT01150097|562046367|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
155714035|NCT01150097|562046368|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
155714036|NCT01150097|562046366|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
155714037|NCT01150097|562046367|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
155714038|NCT01150097|562046368|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
155714039|NCT01150097|562046366|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
155714040|NCT01150097|562046367|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
155714041|NCT01150097|562046368|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
155714042|NCT01150097|562046366|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
155714043|NCT01150097|562046367|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
155714044|NCT01150097|562046368|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
155714045|NCT01150097|562046366|FG000|Months 24 to 48 Post-transplantation|Death|2|||
155714046|NCT01150097|562046367|FG001|Months 24 to 48 Post-transplantation|Death|0|||
155714047|NCT01150097|562046368|FG002|Months 24 to 48 Post-transplantation|Death|0|||
155714048|NCT01301833|562046369|FG000|Overall Study|Adverse Event|7|||
155714049|NCT01301833|562046370|FG001|Overall Study|Adverse Event|5|||
155714050|NCT01301833|562046371|FG002|Overall Study|Adverse Event|5|||
155714051|NCT01301833|562046372|FG003|Overall Study|Adverse Event|5|||
155714052|NCT01301833|562046369|FG000|Overall Study|Lack of Efficacy|1|||
155714053|NCT01301833|562046370|FG001|Overall Study|Lack of Efficacy|1|||
155714054|NCT01301833|562046371|FG002|Overall Study|Lack of Efficacy|0|||
155714055|NCT01301833|562046372|FG003|Overall Study|Lack of Efficacy|0|||
155714056|NCT01301833|562046369|FG000|Overall Study|Physician Decision|3|||
155714057|NCT01301833|562046370|FG001|Overall Study|Physician Decision|1|||
155714058|NCT01301833|562046371|FG002|Overall Study|Physician Decision|1|||
155714059|NCT01301833|562046372|FG003|Overall Study|Physician Decision|0|||
155714060|NCT01301833|562046369|FG000|Overall Study|Withdrawal by Subject|3|||
155714061|NCT01301833|562046370|FG001|Overall Study|Withdrawal by Subject|1|||
155714062|NCT01301833|562046371|FG002|Overall Study|Withdrawal by Subject|1|||
155714063|NCT01301833|562046372|FG003|Overall Study|Withdrawal by Subject|2|||
155714064|NCT01301833|562046369|FG000|Overall Study|Personal matter|1|||
155183492|NCT00719264|560110384|FG001|Overall Study|Adverse Event|49|||
155183493|NCT00719264|560110383|FG000|Overall Study|Death|13|||
155183494|NCT00719264|560110384|FG001|Overall Study|Death|10|||
155183495|NCT00719264|560110383|FG000|Overall Study|Administrative Problems|6|||
155183496|NCT00719264|560110384|FG001|Overall Study|Administrative Problems|4|||
155183497|NCT00719264|560110383|FG000|Overall Study|Lost to Follow-up|1|||
155183498|NCT00719264|560110384|FG001|Overall Study|Lost to Follow-up|1|||
155183499|NCT00719264|560110383|FG000|Overall Study|Withdrawal by Subject|12|||
155183500|NCT00719264|560110384|FG001|Overall Study|Withdrawal by Subject|7|||
155183501|NCT00719264|560110383|FG000|Overall Study|Protocol Deviation|1|||
155183502|NCT00719264|560110384|FG001|Overall Study|Protocol Deviation|3|||
155183503|NCT00719264|560110383|FG000|Overall Study|New Cancer Therapy|4|||
155183504|NCT00719264|560110384|FG001|Overall Study|New Cancer Therapy|2|||
155183505|NCT00719264|560110383|FG000|Overall Study|Disease Progression|104|||
155183506|NCT00719264|560110384|FG001|Overall Study|Disease Progression|107|||
155183507|NCT01277042|560110385|FG000|Overall Study|Adverse Event|4|||
155183508|NCT01277042|560110386|FG001|Overall Study|Adverse Event|3|||
155183509|NCT01277042|560110385|FG000|Overall Study|Lost to Follow-up|2|||
155183510|NCT01277042|560110386|FG001|Overall Study|Lost to Follow-up|2|||
155183511|NCT01277042|560110385|FG000|Overall Study|Withdrawal by Subject|2|||
155183512|NCT01277042|560110386|FG001|Overall Study|Withdrawal by Subject|0|||
155183513|NCT03034200|560110387|FG000|Overall Study|Disease progression|8|||
155183514|NCT03034200|560110388|FG001|Overall Study|Disease progression|10|||
155183515|NCT03034200|560110389|FG002|Overall Study|Disease progression|4|||
155183516|NCT03034200|560110387|FG000|Overall Study|Physician Decision|2|||
155183517|NCT03034200|560110388|FG001|Overall Study|Physician Decision|0|||
155183518|NCT03034200|560110389|FG002|Overall Study|Physician Decision|3|||
155183519|NCT03034200|560110387|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
155183520|NCT03034200|560110388|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
155183521|NCT03034200|560110389|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
155183522|NCT03034200|560110387|FG000|Overall Study|Adjuvant Therapy|0|||
155183523|NCT03034200|560110388|FG001|Overall Study|Adjuvant Therapy|0|||
155183524|NCT03034200|560110389|FG002|Overall Study|Adjuvant Therapy|1|||
155183525|NCT02469038|560110396|FG000|Overall Study|Physician Decision|4|||
155183526|NCT02469038|560110397|FG001|Overall Study|Physician Decision|5|||
155183527|NCT03435640|560110398|FG000|Overall Study|Withdrawal by Subject|0|||
155183528|NCT03435640|560110399|FG001|Overall Study|Withdrawal by Subject|1|||
155183529|NCT03435640|560110400|FG002|Overall Study|Withdrawal by Subject|0|||
155183530|NCT03435640|560110401|FG003|Overall Study|Withdrawal by Subject|2|||
155183531|NCT03435640|560110402|FG004|Overall Study|Withdrawal by Subject|0|||
155183532|NCT03435640|560110403|FG005|Overall Study|Withdrawal by Subject|0|||
155183533|NCT03435640|560110404|FG006|Overall Study|Withdrawal by Subject|3|||
155183534|NCT03435640|560110405|FG007|Overall Study|Withdrawal by Subject|0|||
155183535|NCT03435640|560110406|FG008|Overall Study|Withdrawal by Subject|0|||
155183536|NCT03435640|560110407|FG009|Overall Study|Withdrawal by Subject|2|||
155183537|NCT03435640|560110408|FG010|Overall Study|Withdrawal by Subject|3|||
155183538|NCT03435640|560110398|FG000|Overall Study|Lost to Follow-up|0|||
155183539|NCT03435640|560110399|FG001|Overall Study|Lost to Follow-up|0|||
155183540|NCT03435640|560110400|FG002|Overall Study|Lost to Follow-up|1|||
155183541|NCT03435640|560110401|FG003|Overall Study|Lost to Follow-up|0|||
155183542|NCT03435640|560110402|FG004|Overall Study|Lost to Follow-up|0|||
155183543|NCT03435640|560110403|FG005|Overall Study|Lost to Follow-up|0|||
155183544|NCT03435640|560110404|FG006|Overall Study|Lost to Follow-up|0|||
155183545|NCT03435640|560110405|FG007|Overall Study|Lost to Follow-up|0|||
155183546|NCT03435640|560110406|FG008|Overall Study|Lost to Follow-up|0|||
155183547|NCT03435640|560110407|FG009|Overall Study|Lost to Follow-up|0|||
155183548|NCT03435640|560110408|FG010|Overall Study|Lost to Follow-up|0|||
155183549|NCT00510874|560110409|FG000|Overall Study|Withdrawal by Subject|1|||
155183550|NCT00510874|560110410|FG001|Overall Study|Withdrawal by Subject|1|||
155183551|NCT00510874|560110411|FG002|Overall Study|Withdrawal by Subject|0|||
155183552|NCT00510874|560110412|FG003|Overall Study|Withdrawal by Subject|0|||
155183553|NCT00510874|560110413|FG004|Overall Study|Withdrawal by Subject|3|||
155183554|NCT00510874|560110414|FG005|Overall Study|Withdrawal by Subject|0|||
155183555|NCT00510874|560110415|FG006|Overall Study|Withdrawal by Subject|0|||
155183556|NCT00510874|560110409|FG000|Overall Study|Lost to Follow-up|2|||
155183557|NCT00510874|560110410|FG001|Overall Study|Lost to Follow-up|3|||
155183558|NCT00510874|560110411|FG002|Overall Study|Lost to Follow-up|1|||
155183559|NCT00510874|560110412|FG003|Overall Study|Lost to Follow-up|3|||
155183560|NCT00510874|560110413|FG004|Overall Study|Lost to Follow-up|4|||
155183561|NCT00510874|560110414|FG005|Overall Study|Lost to Follow-up|0|||
155183562|NCT00510874|560110415|FG006|Overall Study|Lost to Follow-up|1|||
155183563|NCT00636987|560110416|FG000|Overall Study|Death|44|||
155183564|NCT00636987|560110416|FG000|Overall Study|Explanted|13|||
155183565|NCT00636987|560110416|FG000|Overall Study|Lost to Follow-up|63|||
155183566|NCT00636987|560110416|FG000|Overall Study|5 year visit window not complete|69|||
155183567|NCT01251146|560110417|FG000|Overall Study|Lost to Follow-up|3|||
155183568|NCT01251146|560110418|FG001|Overall Study|Lost to Follow-up|10|||
155183569|NCT01347307|560110419|FG000|Overall Study|Death|0|||
155183570|NCT01347307|560110420|FG001|Overall Study|Death|4|||
155183571|NCT01347307|560110419|FG000|Overall Study|Physician Decision|0|||
155183572|NCT01347307|560110420|FG001|Overall Study|Physician Decision|1|||
155183573|NCT02239224|560110422|FG000|Overall Study|Administrative|0|||
155183574|NCT02239224|560110423|FG001|Overall Study|Administrative|0|||
155183575|NCT02239224|560110424|FG002|Overall Study|Administrative|3|||
155183576|NCT02239224|560110425|FG003|Overall Study|Administrative|1|||
155183577|NCT03183778|560110426|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
155183578|NCT00737464|560110428|FG000|Overall Study|Adverse Event|1|||
155183579|NCT00737464|560110428|FG000|Overall Study|Death|6|||
155183580|NCT00737464|560110428|FG000|Overall Study|Other - Failure to Return|1|||
155183581|NCT00737464|560110428|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
155183582|NCT00737464|560110428|FG000|Overall Study|Other reasons|4|||
155183583|NCT03228420|560110440|FG000|Overall Study|Lost to Follow-up|5|||
155183584|NCT03228420|560110441|FG001|Overall Study|Lost to Follow-up|3|||
155183585|NCT03228420|560110440|FG000|Overall Study|Withdrawal by Subject|10|||
155183586|NCT03228420|560110441|FG001|Overall Study|Withdrawal by Subject|0|||
155183587|NCT03228420|560110440|FG000|Overall Study|Adverse Event|5|||
155183588|NCT03228420|560110441|FG001|Overall Study|Adverse Event|2|||
155183589|NCT03954041|560110443|FG000|Overall Study|Lost to Follow-up|3|||
155183590|NCT03954041|560110444|FG001|Overall Study|Lost to Follow-up|3|||
155183591|NCT03954041|560110445|FG002|Overall Study|Lost to Follow-up|6|||
155183592|NCT03954041|560110443|FG000|Overall Study|Death|4|||
155183593|NCT03954041|560110444|FG001|Overall Study|Death|0|||
155183594|NCT03954041|560110445|FG002|Overall Study|Death|1|||
155183595|NCT03954041|560110443|FG000|Overall Study|Death by neurologic criteria|0|||
155183596|NCT03954041|560110444|FG001|Overall Study|Death by neurologic criteria|0|||
155183597|NCT03954041|560110445|FG002|Overall Study|Death by neurologic criteria|1|||
155183598|NCT03954041|560110443|FG000|Overall Study|Reason not specified|7|||
155183599|NCT03954041|560110444|FG001|Overall Study|Reason not specified|4|||
155183600|NCT03954041|560110445|FG002|Overall Study|Reason not specified|2|||
155183601|NCT03954041|560110443|FG000|Overall Study|Withdrew prior to dosing|4|||
155714065|NCT01301833|562046370|FG001|Overall Study|Personal matter|0|||
155714066|NCT01301833|562046371|FG002|Overall Study|Personal matter|0|||
155714067|NCT01301833|562046372|FG003|Overall Study|Personal matter|0|||
155714068|NCT00984256|562048421|FG000|Overall Study|Withdrawal by Subject|0|||
155714069|NCT00984256|562048422|FG001|Overall Study|Withdrawal by Subject|1|||
155183602|NCT03954041|560110444|FG001|Overall Study|Withdrew prior to dosing|2|||
155183603|NCT03954041|560110445|FG002|Overall Study|Withdrew prior to dosing|0|||
155183604|NCT03868124|560110448|FG000|Overall Study|Withdrawal by Subject|4|||
155183605|NCT03868124|560110449|FG001|Overall Study|Withdrawal by Subject|0|||
155183606|NCT03868124|560110450|FG002|Overall Study|Withdrawal by Subject|1|||
155183607|NCT03868124|560110448|FG000|Overall Study|Physician Decision|1|||
155183608|NCT03868124|560110449|FG001|Overall Study|Physician Decision|0|||
155183609|NCT03868124|560110450|FG002|Overall Study|Physician Decision|1|||
155183610|NCT03868124|560110448|FG000|Overall Study|Lost to Follow-up|1|||
155183611|NCT03868124|560110449|FG001|Overall Study|Lost to Follow-up|1|||
155183612|NCT03868124|560110450|FG002|Overall Study|Lost to Follow-up|2|||
155183613|NCT03868124|560110448|FG000|Overall Study|Death|1|||
155714070|NCT01131507|562048427|FG000|Overall Study|Adverse Event|1|||
155183614|NCT03868124|560110449|FG001|Overall Study|Death|1|||
155183615|NCT03868124|560110450|FG002|Overall Study|Death|2|||
155183616|NCT03868124|560110448|FG000|Overall Study|Adverse Event|0|||
155183617|NCT03868124|560110449|FG001|Overall Study|Adverse Event|0|||
155183618|NCT03868124|560110450|FG002|Overall Study|Adverse Event|3|||
155183619|NCT03868124|560110448|FG000|Overall Study|Explanted|2|||
155183620|NCT03868124|560110449|FG001|Overall Study|Explanted|1|||
155183621|NCT03868124|560110450|FG002|Overall Study|Explanted|0|||
155183622|NCT03868124|560110448|FG000|Overall Study|Ongoing in study|176|||
155183623|NCT03868124|560110449|FG001|Overall Study|Ongoing in study|180|||
155183624|NCT03868124|560110450|FG002|Overall Study|Ongoing in study|183|||
155183625|NCT04177355|560110451|FG000|Overall Study|Lost to Follow-up|0|||
155183626|NCT04177355|560110452|FG001|Overall Study|Lost to Follow-up|2|||
155183627|NCT04177355|560110453|FG002|Overall Study|Lost to Follow-up|0|||
155183628|NCT04177355|560110454|FG003|Overall Study|Lost to Follow-up|1|||
155183629|NCT04177355|560110455|FG004|Overall Study|Lost to Follow-up|2|||
155183630|NCT04177355|560110456|FG005|Overall Study|Lost to Follow-up|0|||
155183631|NCT04177355|560110457|FG006|Overall Study|Lost to Follow-up|1|||
155183632|NCT04177355|560110458|FG007|Overall Study|Lost to Follow-up|0|||
155183633|NCT04177355|560110459|FG008|Overall Study|Lost to Follow-up|0|||
155183634|NCT04177355|560110460|FG009|Overall Study|Lost to Follow-up|0|||
155183635|NCT04177355|560110461|FG010|Overall Study|Lost to Follow-up|0|||
155183636|NCT04177355|560110451|FG000|Overall Study|Withdrawal by Subject|0|||
155183637|NCT04177355|560110452|FG001|Overall Study|Withdrawal by Subject|0|||
155183638|NCT04177355|560110453|FG002|Overall Study|Withdrawal by Subject|0|||
155183639|NCT04177355|560110454|FG003|Overall Study|Withdrawal by Subject|1|||
155183640|NCT04177355|560110455|FG004|Overall Study|Withdrawal by Subject|1|||
155183641|NCT04177355|560110456|FG005|Overall Study|Withdrawal by Subject|0|||
155183642|NCT04177355|560110457|FG006|Overall Study|Withdrawal by Subject|0|||
155183643|NCT04177355|560110458|FG007|Overall Study|Withdrawal by Subject|0|||
155183644|NCT04177355|560110459|FG008|Overall Study|Withdrawal by Subject|1|||
155183645|NCT04177355|560110460|FG009|Overall Study|Withdrawal by Subject|0|||
155183646|NCT04177355|560110461|FG010|Overall Study|Withdrawal by Subject|0|||
155183647|NCT03823378|560110466|FG000|Overall Study|Adverse Event|2|||
155183648|NCT03823378|560110467|FG001|Overall Study|Adverse Event|2|||
155183649|NCT03823378|560110468|FG002|Overall Study|Adverse Event|0|||
155183650|NCT03823378|560110469|FG003|Overall Study|Adverse Event|0|||
155183651|NCT03823378|560110470|FG004|Overall Study|Adverse Event|0|||
155183652|NCT03823378|560110471|FG005|Overall Study|Adverse Event|0|||
155183653|NCT03823378|560110466|FG000|Overall Study|Lost to Follow-up|0|||
155183654|NCT03823378|560110467|FG001|Overall Study|Lost to Follow-up|1|||
155183655|NCT03823378|560110468|FG002|Overall Study|Lost to Follow-up|0|||
155183656|NCT03823378|560110469|FG003|Overall Study|Lost to Follow-up|0|||
155183657|NCT03823378|560110470|FG004|Overall Study|Lost to Follow-up|1|||
155183658|NCT03823378|560110471|FG005|Overall Study|Lost to Follow-up|0|||
155183659|NCT03823378|560110466|FG000|Overall Study|Withdrawal by Subject|0|||
155183660|NCT03823378|560110467|FG001|Overall Study|Withdrawal by Subject|1|||
155183661|NCT03823378|560110468|FG002|Overall Study|Withdrawal by Subject|4|||
155183662|NCT03823378|560110469|FG003|Overall Study|Withdrawal by Subject|2|||
155183663|NCT03823378|560110470|FG004|Overall Study|Withdrawal by Subject|0|||
155183664|NCT03823378|560110471|FG005|Overall Study|Withdrawal by Subject|1|||
155183665|NCT03823378|560110466|FG000|Overall Study|Other, not specified|19|||
155183666|NCT03823378|560110467|FG001|Overall Study|Other, not specified|12|||
155183667|NCT03823378|560110468|FG002|Overall Study|Other, not specified|6|||
155183668|NCT03823378|560110469|FG003|Overall Study|Other, not specified|8|||
155183669|NCT03823378|560110470|FG004|Overall Study|Other, not specified|17|||
155183670|NCT03823378|560110471|FG005|Overall Study|Other, not specified|7|||
155183671|NCT01606254|560110472|FG000|Overall Study|Withdrawal by Subject|1|||
155183672|NCT01606254|560110473|FG001|Overall Study|Withdrawal by Subject|3|||
155183673|NCT01606254|560110474|FG002|Overall Study|Withdrawal by Subject|0|||
155183674|NCT01606254|560110475|FG003|Overall Study|Withdrawal by Subject|2|||
155183675|NCT01606254|560110472|FG000|Overall Study|Adverse Event|1|||
155183676|NCT01606254|560110473|FG001|Overall Study|Adverse Event|1|||
155183677|NCT01606254|560110474|FG002|Overall Study|Adverse Event|0|||
155183678|NCT01606254|560110475|FG003|Overall Study|Adverse Event|1|||
155183679|NCT02131532|560110476|FG000|Overall Study|Withdrawal by Subject|1|||
155183680|NCT02131532|560110476|FG000|Overall Study|Physician Decision|1|||
155183681|NCT02131532|560110476|FG000|Overall Study|Other health conditions|2|||
155183682|NCT02093026|560110477|FG000|Overall Study|Adverse Event|26|||
155183683|NCT02093026|560110477|FG000|Overall Study|Death|10|||
155183684|NCT02093026|560110477|FG000|Overall Study|Other|157|||
155183685|NCT00174291|560110482|FG000|Overall Study|Lost to Follow-up|1|||
155183686|NCT00174291|560110483|FG001|Overall Study|Lost to Follow-up|1|||
155183687|NCT00174291|560110482|FG000|Overall Study|Protocol Violation|0|||
155183688|NCT00174291|560110483|FG001|Overall Study|Protocol Violation|2|||
155183689|NCT00174291|560110482|FG000|Overall Study|Study terminated by sponsor|1|||
155183690|NCT00174291|560110483|FG001|Overall Study|Study terminated by sponsor|0|||
155183691|NCT00174291|560110482|FG000|Overall Study|Withdrawal by Subject|3|||
155183692|NCT00174291|560110483|FG001|Overall Study|Withdrawal by Subject|3|||
155183693|NCT01582854|560110486|FG000|Overall Study|Death|8|||
155183694|NCT01582854|560110487|FG001|Overall Study|Death|5|||
155183695|NCT01582854|560110486|FG000|Overall Study|Adverse Event|2|||
155183696|NCT01582854|560110487|FG001|Overall Study|Adverse Event|3|||
155183697|NCT01582854|560110486|FG000|Overall Study|Withdrawal by Participant|8|||
155183698|NCT01582854|560110487|FG001|Overall Study|Withdrawal by Participant|11|||
155183699|NCT01582854|560110486|FG000|Overall Study|Lost to Follow-up|1|||
155183700|NCT01582854|560110487|FG001|Overall Study|Lost to Follow-up|2|||
155183701|NCT01582854|560110486|FG000|Overall Study|Physician Decision|0|||
155183702|NCT01582854|560110487|FG001|Overall Study|Physician Decision|1|||
155183703|NCT01582854|560110486|FG000|Overall Study|Recurrent Stroke|13|||
155183704|NCT01582854|560110487|FG001|Overall Study|Recurrent Stroke|8|||
155183705|NCT01582854|560110486|FG000|Overall Study|Disallowed Concomitant Medication|3|||
155183706|NCT01582854|560110487|FG001|Overall Study|Disallowed Concomitant Medication|2|||
155183707|NCT01582854|560110486|FG000|Overall Study|Carotid or Neurosurgery|0|||
155183708|NCT01582854|560110487|FG001|Overall Study|Carotid or Neurosurgery|1|||
155183709|NCT01582854|560110486|FG000|Overall Study|General Anaesthesia|0|||
155183710|NCT01582854|560110487|FG001|Overall Study|General Anaesthesia|1|||
155183711|NCT01582854|560110486|FG000|Overall Study|Other Miscellaneous Reason|1|||
155183712|NCT01582854|560110487|FG001|Overall Study|Other Miscellaneous Reason|0|||
155183713|NCT03101267|560110488|FG000|Primary Study Period|Withdrawal by Subject|1|||
155183714|NCT03101267|560110489|FG001|Primary Study Period|Withdrawal by Subject|2|||
155183715|NCT03101267|560110490|FG002|Primary Study Period|Withdrawal by Subject|3|||
155183716|NCT03101267|560110488|FG000|Primary Study Period|Miscellaneous|2|||
155183717|NCT03101267|560110489|FG001|Primary Study Period|Miscellaneous|0|||
155183718|NCT03101267|560110490|FG002|Primary Study Period|Miscellaneous|0|||
155183719|NCT04068896|560110491|FG000|Overall Study|Adverse Event|2|||
155183720|NCT04068896|560110492|FG001|Overall Study|Adverse Event|0|||
155183721|NCT04068896|560110493|FG002|Overall Study|Adverse Event|1|||
155183722|NCT04068896|560110494|FG003|Overall Study|Adverse Event|0|||
155183723|NCT04068896|560110495|FG004|Overall Study|Adverse Event|0|||
155183724|NCT04068896|560110496|FG005|Overall Study|Adverse Event|0|||
155183725|NCT04068896|560110491|FG000|Overall Study|Death|3|||
155183726|NCT04068896|560110492|FG001|Overall Study|Death|1|||
155183727|NCT04068896|560110493|FG002|Overall Study|Death|3|||
155183728|NCT04068896|560110494|FG003|Overall Study|Death|19|||
155183729|NCT04068896|560110495|FG004|Overall Study|Death|17|||
155183730|NCT04068896|560110496|FG005|Overall Study|Death|0|||
155183731|NCT04068896|560110491|FG000|Overall Study|Physician Decision|0|||
155183732|NCT04068896|560110492|FG001|Overall Study|Physician Decision|0|||
155183733|NCT04068896|560110493|FG002|Overall Study|Physician Decision|0|||
155183734|NCT04068896|560110494|FG003|Overall Study|Physician Decision|1|||
155183735|NCT04068896|560110495|FG004|Overall Study|Physician Decision|0|||
155183736|NCT04068896|560110496|FG005|Overall Study|Physician Decision|0|||
155183737|NCT04068896|560110491|FG000|Overall Study|progressive disease|3|||
155183738|NCT04068896|560110492|FG001|Overall Study|progressive disease|5|||
155183739|NCT04068896|560110493|FG002|Overall Study|progressive disease|3|||
155183740|NCT04068896|560110494|FG003|Overall Study|progressive disease|2|||
155183741|NCT04068896|560110495|FG004|Overall Study|progressive disease|1|||
155183742|NCT04068896|560110496|FG005|Overall Study|progressive disease|2|||
155183743|NCT04068896|560110491|FG000|Overall Study|Study terminated by sponsor|0|||
155183744|NCT04068896|560110492|FG001|Overall Study|Study terminated by sponsor|0|||
155183745|NCT04068896|560110493|FG002|Overall Study|Study terminated by sponsor|1|||
155183746|NCT04068896|560110494|FG003|Overall Study|Study terminated by sponsor|2|||
155183747|NCT04068896|560110495|FG004|Overall Study|Study terminated by sponsor|1|||
155183748|NCT04068896|560110496|FG005|Overall Study|Study terminated by sponsor|4|||
155183749|NCT04068896|560110491|FG000|Overall Study|Protocol Violation|0|||
155183750|NCT04068896|560110492|FG001|Overall Study|Protocol Violation|0|||
155183751|NCT04068896|560110493|FG002|Overall Study|Protocol Violation|0|||
155183752|NCT04068896|560110494|FG003|Overall Study|Protocol Violation|1|||
155183753|NCT04068896|560110495|FG004|Overall Study|Protocol Violation|0|||
155183754|NCT04068896|560110496|FG005|Overall Study|Protocol Violation|0|||
155183755|NCT04068896|560110491|FG000|Overall Study|Withdrawal by Subject|0|||
155183756|NCT04068896|560110492|FG001|Overall Study|Withdrawal by Subject|3|||
155183757|NCT04068896|560110493|FG002|Overall Study|Withdrawal by Subject|0|||
155183758|NCT04068896|560110494|FG003|Overall Study|Withdrawal by Subject|2|||
155183759|NCT04068896|560110495|FG004|Overall Study|Withdrawal by Subject|1|||
155183760|NCT04068896|560110496|FG005|Overall Study|Withdrawal by Subject|0|||
155183761|NCT04068896|560110491|FG000|Overall Study|Symptomatic deterioration|2|||
155183762|NCT04068896|560110492|FG001|Overall Study|Symptomatic deterioration|0|||
155183763|NCT04068896|560110493|FG002|Overall Study|Symptomatic deterioration|0|||
155183764|NCT04068896|560110494|FG003|Overall Study|Symptomatic deterioration|0|||
155183765|NCT04068896|560110495|FG004|Overall Study|Symptomatic deterioration|0|||
155183766|NCT04068896|560110496|FG005|Overall Study|Symptomatic deterioration|0|||
155183767|NCT02953509|560110497|FG000|Overall Study|Death|1|||
155183768|NCT02953509|560110498|FG001|Overall Study|Death|3|||
155183769|NCT02953509|560110499|FG002|Overall Study|Death|3|||
155183770|NCT02953509|560110500|FG003|Overall Study|Death|4|||
155183771|NCT02953509|560110501|FG004|Overall Study|Death|12|||
155183772|NCT02953509|560110502|FG005|Overall Study|Death|3|||
155183773|NCT02953509|560110503|FG006|Overall Study|Death|25|||
155183774|NCT02953509|560110504|FG007|Overall Study|Death|10|||
155183775|NCT02953509|560110505|FG008|Overall Study|Death|21|||
155183776|NCT02953509|560110506|FG009|Overall Study|Death|20|||
155183777|NCT02953509|560110497|FG000|Overall Study|Reason Not Specified|0|||
155183778|NCT02953509|560110498|FG001|Overall Study|Reason Not Specified|2|||
155183779|NCT02953509|560110499|FG002|Overall Study|Reason Not Specified|8|||
155183780|NCT02953509|560110500|FG003|Overall Study|Reason Not Specified|2|||
155183781|NCT02953509|560110501|FG004|Overall Study|Reason Not Specified|11|||
155183782|NCT02953509|560110502|FG005|Overall Study|Reason Not Specified|4|||
155183783|NCT02953509|560110503|FG006|Overall Study|Reason Not Specified|12|||
155183784|NCT02953509|560110504|FG007|Overall Study|Reason Not Specified|2|||
155183785|NCT02953509|560110505|FG008|Overall Study|Reason Not Specified|7|||
155183786|NCT02953509|560110506|FG009|Overall Study|Reason Not Specified|2|||
155183787|NCT02953509|560110497|FG000|Overall Study|Consent Withdrawn|1|||
155183788|NCT02953509|560110498|FG001|Overall Study|Consent Withdrawn|1|||
155183789|NCT02953509|560110499|FG002|Overall Study|Consent Withdrawn|2|||
155183790|NCT02953509|560110500|FG003|Overall Study|Consent Withdrawn|1|||
155183791|NCT02953509|560110501|FG004|Overall Study|Consent Withdrawn|3|||
155183792|NCT02953509|560110502|FG005|Overall Study|Consent Withdrawn|0|||
155183793|NCT02953509|560110503|FG006|Overall Study|Consent Withdrawn|4|||
155183794|NCT02953509|560110504|FG007|Overall Study|Consent Withdrawn|1|||
155183795|NCT02953509|560110505|FG008|Overall Study|Consent Withdrawn|1|||
155183796|NCT02953509|560110506|FG009|Overall Study|Consent Withdrawn|4|||
155183797|NCT02953509|560110497|FG000|Overall Study|Lost to Follow-up|0|||
155183798|NCT02953509|560110498|FG001|Overall Study|Lost to Follow-up|0|||
155183799|NCT02953509|560110499|FG002|Overall Study|Lost to Follow-up|0|||
155183800|NCT02953509|560110500|FG003|Overall Study|Lost to Follow-up|0|||
155183801|NCT02953509|560110501|FG004|Overall Study|Lost to Follow-up|0|||
155183802|NCT02953509|560110502|FG005|Overall Study|Lost to Follow-up|0|||
155183803|NCT02953509|560110503|FG006|Overall Study|Lost to Follow-up|1|||
155183804|NCT02953509|560110504|FG007|Overall Study|Lost to Follow-up|1|||
155183805|NCT02953509|560110505|FG008|Overall Study|Lost to Follow-up|1|||
155183806|NCT02953509|560110506|FG009|Overall Study|Lost to Follow-up|1|||
155183807|NCT02953509|560110497|FG000|Overall Study|Study terminated by sponsor|1|||
155183808|NCT02953509|560110498|FG001|Overall Study|Study terminated by sponsor|0|||
155183809|NCT02953509|560110499|FG002|Overall Study|Study terminated by sponsor|0|||
155183810|NCT02953509|560110500|FG003|Overall Study|Study terminated by sponsor|0|||
155183811|NCT02953509|560110501|FG004|Overall Study|Study terminated by sponsor|0|||
155183812|NCT02953509|560110502|FG005|Overall Study|Study terminated by sponsor|0|||
155183813|NCT02953509|560110503|FG006|Overall Study|Study terminated by sponsor|1|||
155183814|NCT02953509|560110504|FG007|Overall Study|Study terminated by sponsor|0|||
155183815|NCT02953509|560110505|FG008|Overall Study|Study terminated by sponsor|1|||
155183816|NCT02953509|560110506|FG009|Overall Study|Study terminated by sponsor|1|||
155183817|NCT00913692|560110508|FG000|Screening (4 Months)|Physician Decision|3|||
155714071|NCT01131507|562048427|FG000|Overall Study|Lost to Follow-up|1|||
155714072|NCT01131507|562048427|FG000|Overall Study|Withdrawal by Subject|1|||
155714073|NCT01790594|562048428|FG000|Overall Study|Death|1|||
155714074|NCT01790594|562048429|FG001|Overall Study|Death|0|||
155183818|NCT00913692|560110508|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
155183819|NCT00913692|560110508|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
155183820|NCT00256282|560110509|FG000|Overall Study|Disease progression, relapse during acti|12|||
155183821|NCT00256282|560110509|FG000|Overall Study|Adverse Event|3|||
155183822|NCT00256282|560110509|FG000|Overall Study|Physician Decision|1|||
155183823|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
155183824|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
155183825|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
155183826|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
155183827|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
155183828|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
155183829|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
155183830|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
155183831|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
155183832|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
155183833|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
155183834|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
155183835|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
155183836|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
155183837|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
155183838|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
155183839|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
155183840|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
155183841|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
155183842|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
155183843|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
155183844|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
155183845|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
155183846|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
155183847|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155183848|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155183849|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
155183850|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155183851|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155183852|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
155183853|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155183854|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155183855|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
155183856|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155183857|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155183858|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
155183859|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155183860|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155183861|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
155183862|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155183863|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155183864|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
155183865|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
155183866|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
155714075|NCT01790594|562048430|FG002|Overall Study|Death|0|||
155183867|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Other|2|||
155183868|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Other|2|||
155183869|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Personal reasons|2|||
155714076|NCT01790594|562048428|FG000|Overall Study|Physician Decision|2|||
155714077|NCT01790594|562048429|FG001|Overall Study|Physician Decision|1|||
155714078|NCT01790594|562048430|FG002|Overall Study|Physician Decision|0|||
155183870|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Personal reasons|2|||
155183871|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
155183872|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
155183873|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
155183874|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
155183875|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
155183876|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
155714079|NCT01790594|562048428|FG000|Overall Study|Withdrawal by Subject|2|||
155714080|NCT01790594|562048429|FG001|Overall Study|Withdrawal by Subject|0|||
155714081|NCT01790594|562048430|FG002|Overall Study|Withdrawal by Subject|0|||
155714082|NCT01790594|562048428|FG000|Overall Study|Transplant was not done|0|||
155714083|NCT01790594|562048429|FG001|Overall Study|Transplant was not done|0|||
155714084|NCT01790594|562048430|FG002|Overall Study|Transplant was not done|3|||
155714085|NCT01790594|562048428|FG000|Overall Study|Terminated prior to week 76|0|||
155714086|NCT01790594|562048429|FG001|Overall Study|Terminated prior to week 76|2|||
155714087|NCT01790594|562048430|FG002|Overall Study|Terminated prior to week 76|0|||
155714088|NCT02038153|562048431|FG000|Overall Study|Withdrawal by Subject|1|||
155714089|NCT02647281|562048432|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714090|NCT02647281|562048433|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714091|NCT02647281|562048434|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714092|NCT02647281|562048435|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714093|NCT02647281|562048436|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714094|NCT02647281|562048437|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714095|NCT02647281|562048438|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714096|NCT02647281|562048439|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155714097|NCT02647281|562048440|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
155714098|NCT00527735|562048441|FG000|Overall Study|Disease progression|47|||
155714099|NCT00527735|562048442|FG001|Overall Study|Disease progression|61|||
155714100|NCT00527735|562048443|FG002|Overall Study|Disease progression|53|||
155714101|NCT00527735|562048441|FG000|Overall Study|Death|23|||
155714102|NCT00527735|562048442|FG001|Overall Study|Death|13|||
155714103|NCT00527735|562048443|FG002|Overall Study|Death|15|||
155714104|NCT00527735|562048441|FG000|Overall Study|Completed treatment in treatment phase|14|||
155714105|NCT00527735|562048442|FG001|Overall Study|Completed treatment in treatment phase|13|||
155714106|NCT00527735|562048443|FG002|Overall Study|Completed treatment in treatment phase|18|||
155714107|NCT00527735|562048441|FG000|Overall Study|Adverse Event|10|||
155714108|NCT00527735|562048442|FG001|Overall Study|Adverse Event|6|||
155714109|NCT00527735|562048443|FG002|Overall Study|Adverse Event|7|||
155714110|NCT00527735|562048441|FG000|Overall Study|Not identified|5|||
155714111|NCT00527735|562048442|FG001|Overall Study|Not identified|5|||
155714112|NCT00527735|562048443|FG002|Overall Study|Not identified|5|||
155714113|NCT00527735|562048441|FG000|Overall Study|Withdrawal by Subject|5|||
155714114|NCT00527735|562048442|FG001|Overall Study|Withdrawal by Subject|4|||
155714115|NCT00527735|562048443|FG002|Overall Study|Withdrawal by Subject|3|||
155714116|NCT00527735|562048441|FG000|Overall Study|No longer met study criteria|2|||
155714117|NCT00527735|562048442|FG001|Overall Study|No longer met study criteria|2|||
155714118|NCT00527735|562048443|FG002|Overall Study|No longer met study criteria|1|||
155714119|NCT00527735|562048441|FG000|Overall Study|Lost to Follow-up|0|||
155714120|NCT00527735|562048442|FG001|Overall Study|Lost to Follow-up|0|||
155714121|NCT00527735|562048443|FG002|Overall Study|Lost to Follow-up|3|||
155714122|NCT00527735|562048441|FG000|Overall Study|Poor compliance or noncompliance|0|||
155714123|NCT00527735|562048442|FG001|Overall Study|Poor compliance or noncompliance|1|||
155714124|NCT00527735|562048443|FG002|Overall Study|Poor compliance or noncompliance|1|||
155714125|NCT00527735|562048441|FG000|Overall Study|Completed treatment during maintenance|2|||
155714126|NCT00527735|562048442|FG001|Overall Study|Completed treatment during maintenance|2|||
155714127|NCT00527735|562048443|FG002|Overall Study|Completed treatment during maintenance|1|||
155714128|NCT01855412|562048444|FG000|Overall Study|Death|77|||
155714129|NCT01855412|562048445|FG001|Overall Study|Death|123|||
155714130|NCT01855412|562048446|FG002|Overall Study|Death|30|||
155714131|NCT01855412|562048444|FG000|Overall Study|Lost to Follow-up|28|||
155714132|NCT01855412|562048445|FG001|Overall Study|Lost to Follow-up|46|||
155714133|NCT01855412|562048446|FG002|Overall Study|Lost to Follow-up|15|||
155714134|NCT01855412|562048444|FG000|Overall Study|Withdrawal by Subject|77|||
155714135|NCT01855412|562048445|FG001|Overall Study|Withdrawal by Subject|123|||
155714136|NCT01855412|562048446|FG002|Overall Study|Withdrawal by Subject|24|||
155714137|NCT01855412|562048444|FG000|Overall Study|Physician Decision|25|||
155714138|NCT01855412|562048445|FG001|Overall Study|Physician Decision|31|||
155714139|NCT01855412|562048446|FG002|Overall Study|Physician Decision|3|||
155714140|NCT01855412|562048444|FG000|Overall Study|Site Closure|4|||
155714141|NCT01855412|562048445|FG001|Overall Study|Site Closure|18|||
155714142|NCT01855412|562048446|FG002|Overall Study|Site Closure|1|||
155183877|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
155183878|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
155183879|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
155183880|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
155183881|NCT00667446|560110513|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
155183882|NCT00667446|560110514|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
155183883|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
155183884|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
155183885|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
155183886|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
155183887|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
155183888|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
155183889|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
155183890|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
155183891|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
155183892|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183893|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183894|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183895|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
155183896|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
155183897|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
155183898|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
155183899|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
155183900|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
155183901|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Other|4|||
155183902|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Other|9|||
155183903|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Other|4|||
155183904|NCT00591578|560110515|FG000|Open-Label Extension Phase|Adverse Event|3|||
155183905|NCT00591578|560110516|FG001|Open-Label Extension Phase|Adverse Event|5|||
155183906|NCT00591578|560110517|FG002|Open-Label Extension Phase|Adverse Event|0|||
155183907|NCT00591578|560110515|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
155183908|NCT00591578|560110516|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
155183909|NCT00591578|560110517|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155183910|NCT00591578|560110515|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
155183911|NCT00591578|560110516|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
155183912|NCT00591578|560110517|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
155183913|NCT00591578|560110515|FG000|Open-Label Extension Phase|Other|1|||
155183914|NCT00591578|560110516|FG001|Open-Label Extension Phase|Other|0|||
155183915|NCT00591578|560110517|FG002|Open-Label Extension Phase|Other|0|||
155183916|NCT02380690|560110518|FG000|Overall Study|Lost to Follow-up|14|||
155183917|NCT02380690|560110519|FG001|Overall Study|Lost to Follow-up|4|||
155183918|NCT02380690|560110518|FG000|Overall Study|Withdrawal by Subject|20|||
155183919|NCT02380690|560110519|FG001|Overall Study|Withdrawal by Subject|8|||
155183920|NCT00523367|560110526|FG000|Overall Study|19 screen failures|19|||
155183921|NCT00523367|560110526|FG000|Overall Study|4 Withdrawn by PI|4|||
155183922|NCT00356122|560110530|FG000|TREATMENT|Lack of Efficacy|26|||
155183923|NCT00356122|560110530|FG000|TREATMENT|Adverse Event|10|||
155183924|NCT00356122|560110530|FG000|TREATMENT|Subject's request|4|||
155183925|NCT00356122|560110530|FG000|TREATMENT|Other|4|||
155183926|NCT00356122|560110530|FG000|TREATMENT|Did not receive study medication|1|||
155183927|NCT00356122|560110530|FG000|FOLLOW-UP|Death|37|||
155183928|NCT00356122|560110530|FG000|FOLLOW-UP|Lost to Follow-up|2|||
155183929|NCT00356122|560110530|FG000|FOLLOW-UP|Other|2|||
155183930|NCT00782795|560110531|FG000|Overall Study|Withdrawal by Subject|1|||
155183931|NCT00782795|560110532|FG001|Overall Study|Withdrawal by Subject|2|||
155183932|NCT04480424|560110533|FG000|Overall Study|Withdrawal by Subject|0|||
155183933|NCT04480424|560110534|FG001|Overall Study|Withdrawal by Subject|2|||
155183934|NCT04480424|560110533|FG000|Overall Study|Lost to Follow-up|3|||
155183935|NCT04480424|560110534|FG001|Overall Study|Lost to Follow-up|3|||
155183936|NCT04480424|560110533|FG000|Overall Study|Death|14|||
155183937|NCT04480424|560110534|FG001|Overall Study|Death|16|||
155183938|NCT04480424|560110533|FG000|Overall Study|Reason not Specified|5|||
155183939|NCT04480424|560110534|FG001|Overall Study|Reason not Specified|5|||
155183940|NCT03693170|560112410|FG000|Overall Study|Disease Progression|48|||
155183941|NCT03693170|560112410|FG000|Overall Study|Adverse Event|16|||
155183942|NCT03693170|560112410|FG000|Overall Study|Physician Decision|6|||
155183943|NCT03693170|560112410|FG000|Overall Study|Protocol Violation|2|||
155183944|NCT03693170|560112410|FG000|Overall Study|Death|1|||
155183945|NCT03693170|560112410|FG000|Overall Study|Non compliance with study drug|1|||
155183946|NCT03693170|560112410|FG000|Overall Study|Withdrawal by Subject|1|||
155183947|NCT04444895|560112411|FG000|Overall Study|Adverse Event|2|||
155183948|NCT04444895|560112411|FG000|Overall Study|Lost to Follow-up|2|||
155183949|NCT04444895|560112411|FG000|Overall Study|Withdrawal by Subject|5|||
155183950|NCT03581786|560112412|FG000|Overall Study|Death|67|||
155183951|NCT03581786|560112413|FG001|Overall Study|Death|47|||
155183952|NCT03581786|560112412|FG000|Overall Study|Withdrawal by Subject|2|||
155183953|NCT03581786|560112413|FG001|Overall Study|Withdrawal by Subject|5|||
155183954|NCT03581786|560112412|FG000|Overall Study|Lost to Follow-up|7|||
155183955|NCT03581786|560112413|FG001|Overall Study|Lost to Follow-up|4|||
155183956|NCT03581786|560112412|FG000|Overall Study|reason other than specified above|0|||
155183957|NCT03581786|560112413|FG001|Overall Study|reason other than specified above|1|||
155183958|NCT05523323|560112414|FG000|Overall Study|Death|26|||
155183959|NCT05523323|560112415|FG001|Overall Study|Death|21|||
155183960|NCT05523323|560112414|FG000|Overall Study|Ongoing participants|35|||
155183961|NCT05523323|560112415|FG001|Overall Study|Ongoing participants|30|||
155183962|NCT00920829|560112416|FG000|Allocation|No post randomization data|3|||
155183963|NCT00920829|560112417|FG001|Allocation|No post randomization data|1|||
155183964|NCT00920829|560112418|FG002|Allocation|No post randomization data|0|||
155183965|NCT00920829|560112419|FG003|Allocation|No post randomization data|2|||
155183966|NCT00920829|560112416|FG000|Available for Analysis|Withdrawal by Subject|6|||
155183967|NCT00920829|560112417|FG001|Available for Analysis|Withdrawal by Subject|6|||
155183968|NCT00920829|560112418|FG002|Available for Analysis|Withdrawal by Subject|6|||
155183969|NCT00920829|560112419|FG003|Available for Analysis|Withdrawal by Subject|10|||
155183970|NCT00920829|560112416|FG000|Available for Analysis|Required Medical Treatment|0|||
155183971|NCT00920829|560112417|FG001|Available for Analysis|Required Medical Treatment|1|||
155183972|NCT00920829|560112418|FG002|Available for Analysis|Required Medical Treatment|2|||
155183973|NCT00920829|560112419|FG003|Available for Analysis|Required Medical Treatment|0|||
155183974|NCT00920829|560112416|FG000|Available for Analysis|Adverse Event|1|||
155183975|NCT00920829|560112417|FG001|Available for Analysis|Adverse Event|2|||
155183976|NCT00920829|560112418|FG002|Available for Analysis|Adverse Event|1|||
155183977|NCT00920829|560112419|FG003|Available for Analysis|Adverse Event|0|||
155183978|NCT00920829|560112416|FG000|Available for Analysis|Death|1|||
155183979|NCT00920829|560112417|FG001|Available for Analysis|Death|0|||
155183980|NCT00920829|560112418|FG002|Available for Analysis|Death|0|||
155183981|NCT00920829|560112419|FG003|Available for Analysis|Death|0|||
155183982|NCT00920829|560112416|FG000|Available for Analysis|Protocol Violation|0|||
155183983|NCT00920829|560112417|FG001|Available for Analysis|Protocol Violation|0|||
155183984|NCT00920829|560112418|FG002|Available for Analysis|Protocol Violation|1|||
155183985|NCT00920829|560112419|FG003|Available for Analysis|Protocol Violation|0|||
155183986|NCT00920829|560112416|FG000|Available for Analysis|Required more treatment|0|||
155183987|NCT00920829|560112417|FG001|Available for Analysis|Required more treatment|2|||
155183988|NCT00920829|560112418|FG002|Available for Analysis|Required more treatment|0|||
155183989|NCT00920829|560112419|FG003|Available for Analysis|Required more treatment|1|||
155183990|NCT00053365|560112424|FG000|Overall Study|Incorrect cell type|1|||
155183991|NCT00053365|560112424|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
155183992|NCT00053365|560112424|FG000|Overall Study|Never treated|4|||
155183993|NCT01483690|560112426|FG000|Overall Study|Adverse Event|1|||
155183994|NCT01483690|560112427|FG001|Overall Study|Adverse Event|2|||
155183995|NCT01483690|560112426|FG000|Overall Study|clinical deterioration|1|||
155183996|NCT01483690|560112427|FG001|Overall Study|clinical deterioration|0|||
155183997|NCT01483690|560112426|FG000|Overall Study|Physician Decision|0|||
155183998|NCT01483690|560112427|FG001|Overall Study|Physician Decision|2|||
155183999|NCT01483690|560112426|FG000|Overall Study|exclusionary procedure|0|||
155184000|NCT01483690|560112427|FG001|Overall Study|exclusionary procedure|1|||
155184001|NCT03981822|560112428|FG000|Overall Study|Lost to Follow-up|0|||
155184002|NCT03981822|560112429|FG001|Overall Study|Lost to Follow-up|1|||
155184003|NCT03981822|560112430|FG002|Overall Study|Lost to Follow-up|1|||
155184004|NCT03981822|560112431|FG003|Overall Study|Lost to Follow-up|0|||
155184005|NCT03981822|560112432|FG004|Overall Study|Lost to Follow-up|6|||
155184006|NCT03981822|560112433|FG005|Overall Study|Lost to Follow-up|4|||
155184007|NCT03981822|560112434|FG006|Overall Study|Lost to Follow-up|4|||
155184008|NCT03981822|560112435|FG007|Overall Study|Lost to Follow-up|2|||
155184009|NCT03981822|560112428|FG000|Overall Study|Withdrawal by Subject|0|||
155184010|NCT03981822|560112429|FG001|Overall Study|Withdrawal by Subject|1|||
155184011|NCT03981822|560112430|FG002|Overall Study|Withdrawal by Subject|0|||
155184012|NCT03981822|560112431|FG003|Overall Study|Withdrawal by Subject|0|||
155184013|NCT03981822|560112432|FG004|Overall Study|Withdrawal by Subject|0|||
155184014|NCT03981822|560112433|FG005|Overall Study|Withdrawal by Subject|1|||
155184015|NCT03981822|560112434|FG006|Overall Study|Withdrawal by Subject|0|||
155184016|NCT03981822|560112435|FG007|Overall Study|Withdrawal by Subject|2|||
155184017|NCT03981822|560112428|FG000|Overall Study|COVID-19 Related|0|||
155184018|NCT03981822|560112429|FG001|Overall Study|COVID-19 Related|0|||
155184019|NCT03981822|560112430|FG002|Overall Study|COVID-19 Related|0|||
155184020|NCT03981822|560112431|FG003|Overall Study|COVID-19 Related|0|||
155184021|NCT03981822|560112432|FG004|Overall Study|COVID-19 Related|2|||
155184022|NCT03981822|560112433|FG005|Overall Study|COVID-19 Related|1|||
155184023|NCT03981822|560112434|FG006|Overall Study|COVID-19 Related|2|||
155184024|NCT03981822|560112435|FG007|Overall Study|COVID-19 Related|1|||
155184025|NCT02742246|560112436|FG000|Overall Study|Never initiated treatment|5|||
155184026|NCT02742246|560112437|FG001|Overall Study|Never initiated treatment|3|||
155184027|NCT02742246|560112438|FG002|Overall Study|Never initiated treatment|1|||
155184028|NCT02742246|560112436|FG000|Overall Study|dropped out during treatment|7|||
155184029|NCT02742246|560112437|FG001|Overall Study|dropped out during treatment|13|||
155184030|NCT02742246|560112438|FG002|Overall Study|dropped out during treatment|10|||
155184031|NCT02742246|560112436|FG000|Overall Study|Death|1|||
155184032|NCT02742246|560112437|FG001|Overall Study|Death|0|||
155184033|NCT02742246|560112438|FG002|Overall Study|Death|0|||
155184034|NCT03489551|560112439|FG000|Overall Study|Withdrawal by Subject|2|||
155184035|NCT00054717|560112440|FG000|Overall Study|Randomized but not treated|2|||
155184036|NCT00054717|560112441|FG001|Overall Study|Randomized but not treated|8|||
155184037|NCT00054717|560112440|FG000|Overall Study|Adverse Event|70|||
155184038|NCT00054717|560112441|FG001|Overall Study|Adverse Event|22|||
155184039|NCT00054717|560112440|FG000|Overall Study|Protocol Violation|18|||
155184040|NCT00054717|560112441|FG001|Overall Study|Protocol Violation|19|||
155184041|NCT00054717|560112440|FG000|Overall Study|Lost to Follow-up|23|||
155184042|NCT00054717|560112441|FG001|Overall Study|Lost to Follow-up|13|||
155184043|NCT00054717|560112440|FG000|Overall Study|Withdrawal by Subject|32|||
155184044|NCT00054717|560112441|FG001|Overall Study|Withdrawal by Subject|20|||
155184045|NCT00054717|560112440|FG000|Overall Study|Other reason not defined above|117|||
155184046|NCT00054717|560112441|FG001|Overall Study|Other reason not defined above|217|||
155184047|NCT01117051|560112445|FG000|Overall Study|Withdrawal by Subject|5|||
155184048|NCT01117051|560112446|FG001|Overall Study|Withdrawal by Subject|3|||
155184049|NCT01117051|560112445|FG000|Overall Study|Adverse Event|4|||
155184050|NCT01117051|560112446|FG001|Overall Study|Adverse Event|3|||
155184051|NCT01117051|560112445|FG000|Overall Study|Lost to Follow-up|0|||
155184052|NCT01117051|560112446|FG001|Overall Study|Lost to Follow-up|1|||
155184053|NCT01117051|560112445|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
155184054|NCT01117051|560112446|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
155184055|NCT01117051|560112445|FG000|Overall Study|Sponsor's decision|3|||
155184056|NCT01117051|560112446|FG001|Overall Study|Sponsor's decision|1|||
155184057|NCT01117051|560112445|FG000|Overall Study|Surgical procedure|0|||
155184058|NCT01117051|560112446|FG001|Overall Study|Surgical procedure|1|||
155184059|NCT01117051|560112445|FG000|Overall Study|Randomized by mistake|0|||
155184060|NCT01117051|560112446|FG001|Overall Study|Randomized by mistake|1|||
155184061|NCT01117051|560112445|FG000|Overall Study|Convenience issue|1|||
155184062|NCT01117051|560112446|FG001|Overall Study|Convenience issue|0|||
155184063|NCT00206076|560112447|FG000|Overall Study|Physician Decision|2|||
155184064|NCT00206076|560112448|FG001|Overall Study|Physician Decision|0|||
155184065|NCT00206076|560112447|FG000|Overall Study|Withdrawal by Subject|1|||
155184066|NCT00206076|560112448|FG001|Overall Study|Withdrawal by Subject|1|||
155184067|NCT00427960|560112449|FG000|Overall Study|Adverse Event|2|||
155184068|NCT00427960|560112450|FG001|Overall Study|Adverse Event|0|||
155184069|NCT00427960|560112449|FG000|Overall Study|Withdrawal by Subject|0|||
155184070|NCT00427960|560112450|FG001|Overall Study|Withdrawal by Subject|3|||
155184071|NCT00427960|560112449|FG000|Overall Study|Other|0|||
155184072|NCT00427960|560112450|FG001|Overall Study|Other|1|||
155184073|NCT01142128|560112451|FG000|Overall Study|Physician Decision|1|||
155184074|NCT01142128|560112451|FG000|Overall Study|Lost to Follow-up|1|||
155184075|NCT01142128|560112451|FG000|Overall Study|Withdrawal by Subject|2|||
155184076|NCT03355664|560112452|FG000|Overall Study|Adverse Event|1|||
155184077|NCT03355664|560112453|FG001|Overall Study|Adverse Event|2|||
155184078|NCT03355664|560112452|FG000|Overall Study|Lost to Follow-up|11|||
155184079|NCT03355664|560112453|FG001|Overall Study|Lost to Follow-up|7|||
155184080|NCT03355664|560112452|FG000|Overall Study|Protocol Violation|1|||
155184081|NCT03355664|560112453|FG001|Overall Study|Protocol Violation|2|||
155184082|NCT03355664|560112452|FG000|Overall Study|Withdrawal by Subject|2|||
155184083|NCT03355664|560112453|FG001|Overall Study|Withdrawal by Subject|1|||
155184084|NCT03190369|560112455|FG000|Overall Study|Poor compliance to protocol|0|||
155184085|NCT03190369|560112456|FG001|Overall Study|Poor compliance to protocol|1|||
155184086|NCT03190369|560112455|FG000|Overall Study|Withdraw before treatment|1|||
155714143|NCT01855412|562048444|FG000|Overall Study|Reason not Specified|1|||
155714144|NCT01855412|562048445|FG001|Overall Study|Reason not Specified|2|||
155714145|NCT01855412|562048446|FG002|Overall Study|Reason not Specified|3|||
155714146|NCT00404651|562048447|FG000|Overall Study|Serious Adverse Event|0|||
155714147|NCT00404651|562048448|FG001|Overall Study|Serious Adverse Event|0|||
155714148|NCT00404651|562048449|FG002|Overall Study|Serious Adverse Event|2|||
155714149|NCT00404651|562048450|FG003|Overall Study|Serious Adverse Event|0|||
155714150|NCT00404651|562048447|FG000|Overall Study|Protocol Violation|10|||
155714151|NCT00404651|562048448|FG001|Overall Study|Protocol Violation|5|||
155714152|NCT00404651|562048449|FG002|Overall Study|Protocol Violation|14|||
155714153|NCT00404651|562048450|FG003|Overall Study|Protocol Violation|5|||
155714154|NCT00404651|562048447|FG000|Overall Study|Lost to Follow-up|15|||
155184087|NCT03190369|560112456|FG001|Overall Study|Withdraw before treatment|5|||
155184088|NCT03190369|560112455|FG000|Overall Study|Randomized but not treated|0|||
155184089|NCT03190369|560112456|FG001|Overall Study|Randomized but not treated|2|||
155184090|NCT04163718|560112457|FG000|Overall Study|Study terminated|12|||
155184091|NCT01289782|560112458|FG000|Overall Study|Lost to Follow-up|14|||
155184092|NCT01289782|560112459|FG001|Overall Study|Lost to Follow-up|7|||
155184093|NCT01289782|560112458|FG000|Overall Study|Protocol Violation|1|||
155184094|NCT01289782|560112459|FG001|Overall Study|Protocol Violation|1|||
155184095|NCT01289782|560112458|FG000|Overall Study|Withdrawal by Subject|8|||
155184096|NCT01289782|560112459|FG001|Overall Study|Withdrawal by Subject|2|||
155714155|NCT00404651|562048448|FG001|Overall Study|Lost to Follow-up|11|||
155714156|NCT00404651|562048449|FG002|Overall Study|Lost to Follow-up|13|||
155714157|NCT00404651|562048450|FG003|Overall Study|Lost to Follow-up|10|||
155714158|NCT00404651|562048447|FG000|Overall Study|Withdrawal by Subject|14|||
155714159|NCT00404651|562048448|FG001|Overall Study|Withdrawal by Subject|12|||
155714160|NCT00404651|562048449|FG002|Overall Study|Withdrawal by Subject|16|||
155714161|NCT00404651|562048450|FG003|Overall Study|Withdrawal by Subject|6|||
155714162|NCT03347123|562048453|FG000|Overall Study|Death|1|||
155714163|NCT03347123|562048454|FG001|Overall Study|Death|2|||
155714164|NCT03347123|562048455|FG002|Overall Study|Death|0|||
155714165|NCT03347123|562048456|FG003|Overall Study|Death|0|||
155714166|NCT03347123|562048457|FG004|Overall Study|Death|0|||
155714167|NCT03347123|562048458|FG005|Overall Study|Death|0|||
155714168|NCT03347123|562048459|FG006|Overall Study|Death|0|||
155714169|NCT03347123|562048453|FG000|Overall Study|Withdrawal by Subject|1|||
155714170|NCT03347123|562048454|FG001|Overall Study|Withdrawal by Subject|0|||
155714171|NCT03347123|562048455|FG002|Overall Study|Withdrawal by Subject|0|||
155714172|NCT03347123|562048456|FG003|Overall Study|Withdrawal by Subject|0|||
155714173|NCT03347123|562048457|FG004|Overall Study|Withdrawal by Subject|0|||
155714174|NCT03347123|562048458|FG005|Overall Study|Withdrawal by Subject|0|||
155714175|NCT03347123|562048459|FG006|Overall Study|Withdrawal by Subject|0|||
155714176|NCT03347123|562048453|FG000|Overall Study|Reason not Specified|3|||
155714177|NCT03347123|562048454|FG001|Overall Study|Reason not Specified|4|||
155714178|NCT03347123|562048455|FG002|Overall Study|Reason not Specified|0|||
155714179|NCT03347123|562048456|FG003|Overall Study|Reason not Specified|0|||
155714180|NCT03347123|562048457|FG004|Overall Study|Reason not Specified|0|||
155714181|NCT03347123|562048458|FG005|Overall Study|Reason not Specified|0|||
155714182|NCT03347123|562048459|FG006|Overall Study|Reason not Specified|0|||
155714183|NCT03431441|562048468|FG000|Overall Study|Withdrawal by Subject|2|||
155714184|NCT03431441|562048468|FG000|Overall Study|Adverse Event|2|||
155714185|NCT03431441|562048468|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
155714186|NCT01276639|562048469|FG000|Week 0 to 16|Death|1|||
155714187|NCT01276639|562048470|FG001|Week 0 to 16|Death|0|||
155714188|NCT01276639|562048471|FG002|Week 0 to 16|Death|0|||
155714189|NCT01276639|562048472|FG003|Week 0 to 16|Death|0|||
155714190|NCT01276639|562048473|FG004|Week 0 to 16|Death|0|||
155714191|NCT01276639|562048469|FG000|Week 0 to 16|Adverse Event|11|||
155714192|NCT01276639|562048470|FG001|Week 0 to 16|Adverse Event|8|||
155714193|NCT01276639|562048471|FG002|Week 0 to 16|Adverse Event|11|||
155714194|NCT01276639|562048472|FG003|Week 0 to 16|Adverse Event|0|||
155714195|NCT01276639|562048473|FG004|Week 0 to 16|Adverse Event|0|||
155714196|NCT01276639|562048469|FG000|Week 0 to 16|Lack of Efficacy|20|||
155714197|NCT01276639|562048470|FG001|Week 0 to 16|Lack of Efficacy|15|||
155714198|NCT01276639|562048471|FG002|Week 0 to 16|Lack of Efficacy|25|||
155714199|NCT01276639|562048472|FG003|Week 0 to 16|Lack of Efficacy|0|||
155714200|NCT01276639|562048473|FG004|Week 0 to 16|Lack of Efficacy|0|||
155714201|NCT01276639|562048469|FG000|Week 0 to 16|Lost to Follow-up|3|||
155184097|NCT01289782|560112458|FG000|Overall Study|Sponsor's Decision|1|||
155184098|NCT01289782|560112459|FG001|Overall Study|Sponsor's Decision|0|||
155184099|NCT01289782|560112458|FG000|Overall Study|Reason not specified|1|||
155184100|NCT01289782|560112459|FG001|Overall Study|Reason not specified|2|||
155184101|NCT00450112|560112476|FG000|Overall Study|Other Treatment Required|5|||
155714202|NCT01276639|562048470|FG001|Week 0 to 16|Lost to Follow-up|5|||
155714203|NCT01276639|562048471|FG002|Week 0 to 16|Lost to Follow-up|3|||
155714204|NCT01276639|562048472|FG003|Week 0 to 16|Lost to Follow-up|0|||
155184102|NCT00450112|560112477|FG001|Overall Study|Other Treatment Required|1|||
155714205|NCT01276639|562048473|FG004|Week 0 to 16|Lost to Follow-up|0|||
155184103|NCT00450112|560112476|FG000|Overall Study|Withdrawal by Subject|4|||
155184104|NCT00450112|560112477|FG001|Overall Study|Withdrawal by Subject|1|||
155184105|NCT00450112|560112476|FG000|Overall Study|Lost to Follow-up|2|||
155184106|NCT00450112|560112477|FG001|Overall Study|Lost to Follow-up|1|||
155184107|NCT00450112|560112476|FG000|Overall Study|Others|2|||
155714206|NCT01276639|562048469|FG000|Week 0 to 16|Withdrawal by Subject|8|||
155714207|NCT01276639|562048470|FG001|Week 0 to 16|Withdrawal by Subject|5|||
155714208|NCT01276639|562048471|FG002|Week 0 to 16|Withdrawal by Subject|4|||
155714209|NCT01276639|562048472|FG003|Week 0 to 16|Withdrawal by Subject|0|||
155714210|NCT01276639|562048473|FG004|Week 0 to 16|Withdrawal by Subject|0|||
155714211|NCT01276639|562048469|FG000|Week 0 to 16|Other|7|||
155714212|NCT01276639|562048470|FG001|Week 0 to 16|Other|7|||
155184108|NCT00450112|560112477|FG001|Overall Study|Others|3|||
155184109|NCT01056380|560112478|FG000|Overall Study|Lost to Follow-up|2|||
155184110|NCT01056380|560112479|FG001|Overall Study|Lost to Follow-up|3|||
155184111|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
155184112|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
155184113|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
155184114|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
155184115|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
155184116|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
155184117|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
155184118|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
155184119|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
155184120|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
155184121|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
155184122|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
155184123|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
155184124|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
155184125|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
155184126|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
155184127|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
155184128|NCT03595774|560112481|FG000|Overall Study|Adverse Event|1|||
155184129|NCT03595774|560112482|FG001|Overall Study|Adverse Event|0|||
155184130|NCT03595774|560112483|FG002|Overall Study|Adverse Event|1|||
155184131|NCT03595774|560112484|FG003|Overall Study|Adverse Event|0|||
155184132|NCT03595774|560112481|FG000|Overall Study|screen failure|0|||
155184133|NCT03595774|560112482|FG001|Overall Study|screen failure|1|||
155184134|NCT03595774|560112483|FG002|Overall Study|screen failure|0|||
155184135|NCT03595774|560112484|FG003|Overall Study|screen failure|1|||
155184136|NCT00484185|560112490|FG000|Overall Study|Lost to Follow-up|44|||
155184137|NCT00484185|560112490|FG000|Overall Study|Other|20|||
155184138|NCT00484185|560112490|FG000|Overall Study|Randomized but not treated|5|||
155184139|NCT00484185|560112490|FG000|Overall Study|Death|2|||
155184140|NCT02325791|560112493|FG000|Overall Study|Adverse Event|0|||
155184141|NCT02325791|560112494|FG001|Overall Study|Adverse Event|1|||
155184142|NCT02325791|560112495|FG002|Overall Study|Adverse Event|1|||
155184143|NCT02325791|560112496|FG003|Overall Study|Adverse Event|0|||
155184144|NCT02325791|560112493|FG000|Overall Study|Death|0|||
155184145|NCT02325791|560112494|FG001|Overall Study|Death|3|||
155184146|NCT02325791|560112495|FG002|Overall Study|Death|0|||
155184147|NCT02325791|560112496|FG003|Overall Study|Death|1|||
155184148|NCT02325791|560112493|FG000|Overall Study|Lost to Follow-up|0|||
155184149|NCT02325791|560112494|FG001|Overall Study|Lost to Follow-up|15|||
155184150|NCT02325791|560112495|FG002|Overall Study|Lost to Follow-up|14|||
155184151|NCT02325791|560112496|FG003|Overall Study|Lost to Follow-up|9|||
155184152|NCT02325791|560112493|FG000|Overall Study|Physician Decision|0|||
155184153|NCT02325791|560112494|FG001|Overall Study|Physician Decision|1|||
155184154|NCT02325791|560112495|FG002|Overall Study|Physician Decision|1|||
155184155|NCT02325791|560112496|FG003|Overall Study|Physician Decision|0|||
155184156|NCT02325791|560112493|FG000|Overall Study|Protocol Violation|0|||
155184157|NCT02325791|560112494|FG001|Overall Study|Protocol Violation|0|||
155184158|NCT02325791|560112495|FG002|Overall Study|Protocol Violation|1|||
155714213|NCT01276639|562048471|FG002|Week 0 to 16|Other|2|||
155714214|NCT01276639|562048472|FG003|Week 0 to 16|Other|0|||
155714215|NCT01276639|562048473|FG004|Week 0 to 16|Other|0|||
155714216|NCT01276639|562048469|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
155714217|NCT01276639|562048470|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
155714218|NCT01276639|562048471|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
155714219|NCT01276639|562048472|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
155714220|NCT01276639|562048473|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
155714221|NCT01276639|562048469|FG000|Week 16 to 52|Death|1|||
155714222|NCT01276639|562048470|FG001|Week 16 to 52|Death|0|||
155184159|NCT02325791|560112496|FG003|Overall Study|Protocol Violation|0|||
155184160|NCT02325791|560112493|FG000|Overall Study|Withdrawal by Subject|0|||
155184161|NCT02325791|560112494|FG001|Overall Study|Withdrawal by Subject|5|||
155714223|NCT01276639|562048471|FG002|Week 16 to 52|Death|0|||
155714224|NCT01276639|562048472|FG003|Week 16 to 52|Death|0|||
155184162|NCT02325791|560112495|FG002|Overall Study|Withdrawal by Subject|8|||
155184163|NCT02325791|560112496|FG003|Overall Study|Withdrawal by Subject|16|||
155184164|NCT00555425|560112498|FG000|Overall Study|Missed Medication > 1 wk|34|||
155184165|NCT00555425|560112499|FG001|Overall Study|Missed Medication > 1 wk|15|||
155184166|NCT00555425|560112498|FG000|Overall Study|Missed 3 physician management visits|1|||
155184167|NCT00555425|560112499|FG001|Overall Study|Missed 3 physician management visits|0|||
155184168|NCT00555425|560112498|FG000|Overall Study|Met criteria for protective transfer|16|||
155184169|NCT00555425|560112499|FG001|Overall Study|Met criteria for protective transfer|3|||
155714225|NCT01276639|562048473|FG004|Week 16 to 52|Death|0|||
155714226|NCT01276639|562048469|FG000|Week 16 to 52|Adverse Event|10|||
155714227|NCT01276639|562048470|FG001|Week 16 to 52|Adverse Event|13|||
155714228|NCT01276639|562048471|FG002|Week 16 to 52|Adverse Event|0|||
155714229|NCT01276639|562048472|FG003|Week 16 to 52|Adverse Event|1|||
155714230|NCT01276639|562048473|FG004|Week 16 to 52|Adverse Event|3|||
155184170|NCT00555425|560112498|FG000|Overall Study|Became pregnant and transferred care|0|||
155184171|NCT00555425|560112499|FG001|Overall Study|Became pregnant and transferred care|1|||
155184172|NCT03189381|560112500|FG000|Overall Study|Death|1|||
155714231|NCT01276639|562048469|FG000|Week 16 to 52|Lack of Efficacy|99|||
155714232|NCT01276639|562048470|FG001|Week 16 to 52|Lack of Efficacy|71|||
155714233|NCT01276639|562048471|FG002|Week 16 to 52|Lack of Efficacy|0|||
155714234|NCT01276639|562048472|FG003|Week 16 to 52|Lack of Efficacy|14|||
155714235|NCT01276639|562048473|FG004|Week 16 to 52|Lack of Efficacy|13|||
155714236|NCT01276639|562048469|FG000|Week 16 to 52|Lost to Follow-up|3|||
155714237|NCT01276639|562048470|FG001|Week 16 to 52|Lost to Follow-up|1|||
155714238|NCT01276639|562048471|FG002|Week 16 to 52|Lost to Follow-up|0|||
155714239|NCT01276639|562048472|FG003|Week 16 to 52|Lost to Follow-up|0|||
155714240|NCT01276639|562048473|FG004|Week 16 to 52|Lost to Follow-up|1|||
155714241|NCT01276639|562048469|FG000|Week 16 to 52|Withdrawal by Subject|4|||
155714242|NCT01276639|562048470|FG001|Week 16 to 52|Withdrawal by Subject|4|||
155714243|NCT01276639|562048471|FG002|Week 16 to 52|Withdrawal by Subject|0|||
155714244|NCT01276639|562048472|FG003|Week 16 to 52|Withdrawal by Subject|0|||
155714245|NCT01276639|562048473|FG004|Week 16 to 52|Withdrawal by Subject|1|||
155714246|NCT01276639|562048469|FG000|Week 16 to 52|Other|10|||
155714247|NCT01276639|562048470|FG001|Week 16 to 52|Other|12|||
155714248|NCT01276639|562048471|FG002|Week 16 to 52|Other|0|||
155714249|NCT01276639|562048472|FG003|Week 16 to 52|Other|1|||
155714250|NCT01276639|562048473|FG004|Week 16 to 52|Other|3|||
155714251|NCT03985761|562048475|FG000|Overall Study|Withdrawal by Subject|2|||
155714252|NCT03985761|562048476|FG001|Overall Study|Withdrawal by Subject|3|||
155714253|NCT01285401|562048477|FG000|Overall Study|Prematurely withdrawn from the study|17|||
155714254|NCT01285401|562048478|FG001|Overall Study|Prematurely withdrawn from the study|29|||
155714255|NCT02107703|562048482|FG000|Overall Study|Withdrawal by Subject|46|||
155714256|NCT02107703|562048483|FG001|Overall Study|Withdrawal by Subject|21|||
155714257|NCT02107703|562048482|FG000|Overall Study|Lost to Follow-up|20|||
155714258|NCT02107703|562048483|FG001|Overall Study|Lost to Follow-up|9|||
155714259|NCT02107703|562048482|FG000|Overall Study|On study treatment/follow up|48|||
155714260|NCT02107703|562048483|FG001|Overall Study|On study treatment/follow up|5|||
155714261|NCT02366312|562048484|FG000|Overall Study|Lost to Follow-up|0|||
155714262|NCT02366312|562048485|FG001|Overall Study|Lost to Follow-up|1|||
155714263|NCT03719131|562048487|FG000|Overall Study|Death|1|||
155714264|NCT03719131|562048488|FG001|Overall Study|Death|2|||
155714265|NCT02420093|562048489|FG000|Overall Study|Withdrawal by Subject|1|||
155714266|NCT02420093|562048490|FG001|Overall Study|Withdrawal by Subject|1|||
155714267|NCT03244917|562048493|FG000|Overall Study|Lost to Follow-up|2|||
155714268|NCT03244917|562048494|FG001|Overall Study|Lost to Follow-up|2|||
155714269|NCT01272232|562048497|FG000|Weeks 0-56|Adverse Event|39|||
155714270|NCT01272232|562048498|FG001|Weeks 0-56|Adverse Event|18|||
155714271|NCT01272232|562048499|FG002|Weeks 0-56|Adverse Event|7|||
155714272|NCT01272232|562048497|FG000|Weeks 0-56|Lack of Efficacy|0|||
155714273|NCT01272232|562048498|FG001|Weeks 0-56|Lack of Efficacy|0|||
155714274|NCT01272232|562048499|FG002|Weeks 0-56|Lack of Efficacy|3|||
155714275|NCT01272232|562048497|FG000|Weeks 0-56|Protocol Violation|12|||
155714276|NCT01272232|562048498|FG001|Weeks 0-56|Protocol Violation|8|||
155714277|NCT01272232|562048499|FG002|Weeks 0-56|Protocol Violation|13|||
155714278|NCT01272232|562048497|FG000|Weeks 0-56|Withdrawal criteria|32|||
155714279|NCT01272232|562048498|FG001|Weeks 0-56|Withdrawal criteria|14|||
155714280|NCT01272232|562048499|FG002|Weeks 0-56|Withdrawal criteria|37|||
155714281|NCT01272232|562048497|FG000|Weeks 0-56|Unclassified|16|||
155714282|NCT01272232|562048498|FG001|Weeks 0-56|Unclassified|7|||
155714283|NCT01272232|562048499|FG002|Weeks 0-56|Unclassified|12|||
155714284|NCT01272232|562048497|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
155714285|NCT01272232|562048498|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
155714286|NCT01272232|562048499|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
155714287|NCT01272232|562048497|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
155714288|NCT01272232|562048498|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
155714289|NCT01272232|562048499|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
155714290|NCT01272232|562048497|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
155714291|NCT01272232|562048498|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
155714292|NCT01272232|562048499|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
155714293|NCT01272232|562048497|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
155714294|NCT01272232|562048498|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
155714295|NCT01272232|562048499|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
155714296|NCT01272232|562048497|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
155714297|NCT01272232|562048498|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
155714298|NCT01272232|562048499|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
155714299|NCT02159066|562048500|FG000|Part I|Adverse Event|7|||
155714300|NCT02159066|562048501|FG001|Part I|Adverse Event|5|||
155184173|NCT03189381|560112501|FG001|Overall Study|Death|0|||
155184174|NCT01975831|560112502|FG000|Overall Study|Adverse Event|1|||
155184175|NCT01975831|560112503|FG001|Overall Study|Adverse Event|2|||
155184176|NCT01975831|560112504|FG002|Overall Study|Adverse Event|2|||
155184177|NCT01975831|560112505|FG003|Overall Study|Adverse Event|0|||
155184178|NCT01975831|560112506|FG004|Overall Study|Adverse Event|1|||
155184179|NCT01975831|560112507|FG005|Overall Study|Adverse Event|1|||
155184180|NCT01975831|560112508|FG006|Overall Study|Adverse Event|3|||
155184181|NCT01975831|560112509|FG007|Overall Study|Adverse Event|4|||
155184182|NCT01975831|560112510|FG008|Overall Study|Adverse Event|1|||
155184183|NCT01975831|560112502|FG000|Overall Study|Death|1|||
155184184|NCT01975831|560112503|FG001|Overall Study|Death|1|||
155184185|NCT01975831|560112504|FG002|Overall Study|Death|0|||
155184186|NCT01975831|560112505|FG003|Overall Study|Death|0|||
155184187|NCT01975831|560112506|FG004|Overall Study|Death|1|||
155184188|NCT01975831|560112507|FG005|Overall Study|Death|0|||
155184189|NCT01975831|560112508|FG006|Overall Study|Death|1|||
155184190|NCT01975831|560112509|FG007|Overall Study|Death|0|||
155184191|NCT01975831|560112510|FG008|Overall Study|Death|0|||
155184192|NCT01975831|560112502|FG000|Overall Study|Progressive Disease|1|||
155184193|NCT01975831|560112503|FG001|Overall Study|Progressive Disease|3|||
155184194|NCT01975831|560112504|FG002|Overall Study|Progressive Disease|2|||
155184195|NCT01975831|560112505|FG003|Overall Study|Progressive Disease|4|||
155184196|NCT01975831|560112506|FG004|Overall Study|Progressive Disease|13|||
155184197|NCT01975831|560112507|FG005|Overall Study|Progressive Disease|9|||
155184198|NCT01975831|560112508|FG006|Overall Study|Progressive Disease|10|||
155184199|NCT01975831|560112509|FG007|Overall Study|Progressive Disease|8|||
155184200|NCT01975831|560112510|FG008|Overall Study|Progressive Disease|10|||
155184201|NCT01975831|560112502|FG000|Overall Study|Withdrawal by Subject|0|||
155184202|NCT01975831|560112503|FG001|Overall Study|Withdrawal by Subject|3|||
155184203|NCT01975831|560112504|FG002|Overall Study|Withdrawal by Subject|0|||
155184204|NCT01975831|560112505|FG003|Overall Study|Withdrawal by Subject|0|||
155184205|NCT01975831|560112506|FG004|Overall Study|Withdrawal by Subject|3|||
155184206|NCT01975831|560112507|FG005|Overall Study|Withdrawal by Subject|1|||
155184207|NCT01975831|560112508|FG006|Overall Study|Withdrawal by Subject|1|||
155184208|NCT01975831|560112509|FG007|Overall Study|Withdrawal by Subject|0|||
155184209|NCT01975831|560112510|FG008|Overall Study|Withdrawal by Subject|0|||
155184210|NCT01975831|560112502|FG000|Overall Study|Physician Decision|0|||
155184211|NCT01975831|560112503|FG001|Overall Study|Physician Decision|0|||
155184212|NCT01975831|560112504|FG002|Overall Study|Physician Decision|0|||
155184213|NCT01975831|560112505|FG003|Overall Study|Physician Decision|0|||
155184214|NCT01975831|560112506|FG004|Overall Study|Physician Decision|0|||
155184215|NCT01975831|560112507|FG005|Overall Study|Physician Decision|1|||
155184216|NCT01975831|560112508|FG006|Overall Study|Physician Decision|0|||
155184217|NCT01975831|560112509|FG007|Overall Study|Physician Decision|1|||
155184218|NCT01975831|560112510|FG008|Overall Study|Physician Decision|0|||
155184219|NCT01975831|560112502|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
155184220|NCT01975831|560112503|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
155184221|NCT01975831|560112504|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
155184222|NCT01975831|560112505|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
155184223|NCT01975831|560112506|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
155184224|NCT01975831|560112507|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
155184225|NCT01975831|560112508|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
155184226|NCT01975831|560112509|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
155184227|NCT01975831|560112510|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
155184228|NCT01975831|560112502|FG000|Overall Study|Entered Hospice|0|||
155184229|NCT01975831|560112503|FG001|Overall Study|Entered Hospice|0|||
155184230|NCT01975831|560112504|FG002|Overall Study|Entered Hospice|0|||
155184231|NCT01975831|560112505|FG003|Overall Study|Entered Hospice|0|||
155184232|NCT01975831|560112506|FG004|Overall Study|Entered Hospice|0|||
155184233|NCT01975831|560112507|FG005|Overall Study|Entered Hospice|1|||
155184234|NCT01975831|560112508|FG006|Overall Study|Entered Hospice|0|||
155184235|NCT01975831|560112509|FG007|Overall Study|Entered Hospice|0|||
155184236|NCT01975831|560112510|FG008|Overall Study|Entered Hospice|0|||
155184237|NCT01975831|560112502|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184238|NCT01975831|560112503|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184239|NCT01975831|560112504|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184240|NCT01975831|560112505|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184241|NCT01975831|560112506|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184242|NCT01975831|560112507|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184243|NCT01975831|560112508|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
155184244|NCT01975831|560112509|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184245|NCT01975831|560112510|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
155184246|NCT00251004|560112511|FG000|Overall Study|Withdrawal by Subject|23|||
155184247|NCT00251004|560112512|FG001|Overall Study|Withdrawal by Subject|16|||
155184248|NCT00251004|560112513|FG002|Overall Study|Withdrawal by Subject|14|||
155184249|NCT00251004|560112511|FG000|Overall Study|Death|9|||
155184250|NCT00251004|560112512|FG001|Overall Study|Death|10|||
155184251|NCT00251004|560112513|FG002|Overall Study|Death|8|||
155184252|NCT00251004|560112511|FG000|Overall Study|Lost to Follow-up|1|||
155184253|NCT00251004|560112512|FG001|Overall Study|Lost to Follow-up|2|||
155184254|NCT00251004|560112513|FG002|Overall Study|Lost to Follow-up|1|||
155184255|NCT00251004|560112511|FG000|Overall Study|Graft Loss|12|||
155184256|NCT00251004|560112512|FG001|Overall Study|Graft Loss|13|||
155714301|NCT02159066|562048502|FG002|Part I|Adverse Event|0|||
155714302|NCT02159066|562048503|FG003|Part I|Adverse Event|0|||
155714303|NCT02159066|562048504|FG004|Part I|Adverse Event|0|||
155714304|NCT02159066|562048505|FG005|Part I|Adverse Event|0|||
155714305|NCT02159066|562048500|FG000|Part I|Death|11|||
155714306|NCT02159066|562048501|FG001|Part I|Death|9|||
155714307|NCT02159066|562048502|FG002|Part I|Death|0|||
155714308|NCT02159066|562048503|FG003|Part I|Death|0|||
155714309|NCT02159066|562048504|FG004|Part I|Death|0|||
155714310|NCT02159066|562048505|FG005|Part I|Death|0|||
155714311|NCT02159066|562048500|FG000|Part I|Progressive Disease|37|||
155714312|NCT02159066|562048501|FG001|Part I|Progressive Disease|46|||
155714313|NCT02159066|562048502|FG002|Part I|Progressive Disease|0|||
155714314|NCT02159066|562048503|FG003|Part I|Progressive Disease|0|||
155714315|NCT02159066|562048504|FG004|Part I|Progressive Disease|0|||
155714316|NCT02159066|562048505|FG005|Part I|Progressive Disease|0|||
155714317|NCT02159066|562048500|FG000|Part I|New Therapy for Study Indication|5|||
155714318|NCT02159066|562048501|FG001|Part I|New Therapy for Study Indication|4|||
155714319|NCT02159066|562048502|FG002|Part I|New Therapy for Study Indication|0|||
155714320|NCT02159066|562048503|FG003|Part I|New Therapy for Study Indication|0|||
155714321|NCT02159066|562048504|FG004|Part I|New Therapy for Study Indication|0|||
155714322|NCT02159066|562048505|FG005|Part I|New Therapy for Study Indication|0|||
155714323|NCT02159066|562048500|FG000|Part I|Termination of participants from the study|3|||
155714324|NCT02159066|562048501|FG001|Part I|Termination of participants from the study|3|||
155714325|NCT02159066|562048502|FG002|Part I|Termination of participants from the study|0|||
155714326|NCT02159066|562048503|FG003|Part I|Termination of participants from the study|0|||
155714327|NCT02159066|562048504|FG004|Part I|Termination of participants from the study|0|||
155714328|NCT02159066|562048505|FG005|Part I|Termination of participants from the study|0|||
155714329|NCT02159066|562048500|FG000|Part I|Physician Decision|2|||
155714330|NCT02159066|562048501|FG001|Part I|Physician Decision|9|||
155714331|NCT02159066|562048502|FG002|Part I|Physician Decision|0|||
155714332|NCT02159066|562048503|FG003|Part I|Physician Decision|0|||
155714333|NCT02159066|562048504|FG004|Part I|Physician Decision|0|||
155714334|NCT02159066|562048505|FG005|Part I|Physician Decision|0|||
155714335|NCT02159066|562048500|FG000|Part I|Participant/Guardian Decision|9|||
155714336|NCT02159066|562048501|FG001|Part I|Participant/Guardian Decision|3|||
155714337|NCT02159066|562048502|FG002|Part I|Participant/Guardian Decision|0|||
155714338|NCT02159066|562048503|FG003|Part I|Participant/Guardian Decision|0|||
155714339|NCT02159066|562048504|FG004|Part I|Participant/Guardian Decision|0|||
155714340|NCT02159066|562048505|FG005|Part I|Participant/Guardian Decision|0|||
155714341|NCT02159066|562048500|FG000|Part I|Missing Data|1|||
155714342|NCT02159066|562048501|FG001|Part I|Missing Data|0|||
155714343|NCT02159066|562048502|FG002|Part I|Missing Data|0|||
155714344|NCT02159066|562048503|FG003|Part I|Missing Data|0|||
155714345|NCT02159066|562048504|FG004|Part I|Missing Data|0|||
155714346|NCT02159066|562048505|FG005|Part I|Missing Data|0|||
155714347|NCT02159066|562048500|FG000|Part II|Adverse Event|0|||
155714348|NCT02159066|562048501|FG001|Part II|Adverse Event|0|||
155714349|NCT02159066|562048502|FG002|Part II|Adverse Event|1|||
155714350|NCT02159066|562048503|FG003|Part II|Adverse Event|0|||
155714351|NCT02159066|562048504|FG004|Part II|Adverse Event|1|||
155714352|NCT02159066|562048505|FG005|Part II|Adverse Event|1|||
155714353|NCT02159066|562048500|FG000|Part II|Death|0|||
155714354|NCT02159066|562048501|FG001|Part II|Death|0|||
155714355|NCT02159066|562048502|FG002|Part II|Death|1|||
155714356|NCT02159066|562048503|FG003|Part II|Death|0|||
155714357|NCT02159066|562048504|FG004|Part II|Death|2|||
155714358|NCT02159066|562048505|FG005|Part II|Death|1|||
155714359|NCT02159066|562048500|FG000|Part II|Progressive Disease|0|||
155714360|NCT02159066|562048501|FG001|Part II|Progressive Disease|0|||
155714361|NCT02159066|562048502|FG002|Part II|Progressive Disease|35|||
155714362|NCT02159066|562048503|FG003|Part II|Progressive Disease|1|||
155714363|NCT02159066|562048504|FG004|Part II|Progressive Disease|7|||
155714364|NCT02159066|562048505|FG005|Part II|Progressive Disease|4|||
155714365|NCT02159066|562048500|FG000|Part II|New Therapy for Study Indication|0|||
155714366|NCT02159066|562048501|FG001|Part II|New Therapy for Study Indication|0|||
155714367|NCT02159066|562048502|FG002|Part II|New Therapy for Study Indication|0|||
155714368|NCT02159066|562048503|FG003|Part II|New Therapy for Study Indication|0|||
155714369|NCT02159066|562048504|FG004|Part II|New Therapy for Study Indication|1|||
155714370|NCT02159066|562048505|FG005|Part II|New Therapy for Study Indication|0|||
155714371|NCT02159066|562048500|FG000|Part II|Physician Decision|0|||
155714372|NCT02159066|562048501|FG001|Part II|Physician Decision|0|||
155714373|NCT02159066|562048502|FG002|Part II|Physician Decision|1|||
155714374|NCT02159066|562048503|FG003|Part II|Physician Decision|0|||
155714375|NCT02159066|562048504|FG004|Part II|Physician Decision|0|||
155714376|NCT02159066|562048505|FG005|Part II|Physician Decision|0|||
155714377|NCT02159066|562048500|FG000|Part II|Participant/Guardian Decision|0|||
155714378|NCT02159066|562048501|FG001|Part II|Participant/Guardian Decision|0|||
155714379|NCT02159066|562048502|FG002|Part II|Participant/Guardian Decision|0|||
155714380|NCT02159066|562048503|FG003|Part II|Participant/Guardian Decision|0|||
155714381|NCT02159066|562048504|FG004|Part II|Participant/Guardian Decision|2|||
155714382|NCT02159066|562048505|FG005|Part II|Participant/Guardian Decision|0|||
155714383|NCT00255190|562048506|FG000|Overall Study|Adverse Event|17|||
155714384|NCT00255190|562048507|FG001|Overall Study|Adverse Event|36|||
155714385|NCT00255190|562048506|FG000|Overall Study|Protocol Violation|2|||
155714386|NCT00255190|562048507|FG001|Overall Study|Protocol Violation|2|||
155714387|NCT00255190|562048506|FG000|Overall Study|Lost to Follow-up|10|||
155714388|NCT00255190|562048507|FG001|Overall Study|Lost to Follow-up|27|||
155714389|NCT00255190|562048506|FG000|Overall Study|Withdrew Consent|17|||
155714390|NCT00255190|562048507|FG001|Overall Study|Withdrew Consent|48|||
155714391|NCT00255190|562048506|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155714392|NCT00255190|562048507|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155714393|NCT00255190|562048506|FG000|Overall Study|Erosive esophagitis not healed|0|||
155714394|NCT00255190|562048507|FG001|Overall Study|Erosive esophagitis not healed|20|||
155714395|NCT00255190|562048506|FG000|Overall Study|Various|4|||
155714396|NCT00255190|562048507|FG001|Overall Study|Various|23|||
155714397|NCT04537793|562048512|FG000|Part B (24 Weeks)|Adverse Event|0|||
155714398|NCT04537793|562048513|FG001|Part B (24 Weeks)|Adverse Event|1|||
155714399|NCT00256724|562048518|FG000|Overall Study|Physician Decision|2|||
155714400|NCT00256724|562048519|FG001|Overall Study|Physician Decision|5|||
155714401|NCT00256724|562048518|FG000|Overall Study|Protocol Violation|3|||
155714402|NCT00256724|562048519|FG001|Overall Study|Protocol Violation|3|||
155714403|NCT01217463|562048520|FG000|Overall Study|Adverse Event|8|||
155714404|NCT01217463|562048521|FG001|Overall Study|Adverse Event|5|||
155714405|NCT01217463|562048520|FG000|Overall Study|Physician Decision|0|||
155714406|NCT01217463|562048521|FG001|Overall Study|Physician Decision|1|||
155714407|NCT01217463|562048520|FG000|Overall Study|Withdrawal by Subject|3|||
155714408|NCT01217463|562048521|FG001|Overall Study|Withdrawal by Subject|0|||
155714409|NCT01217463|562048520|FG000|Overall Study|Surgery on the Target Limb|0|||
155714410|NCT01217463|562048521|FG001|Overall Study|Surgery on the Target Limb|1|||
155714411|NCT01217463|562048520|FG000|Overall Study|Patient Non-compliant|1|||
155714412|NCT01217463|562048521|FG001|Overall Study|Patient Non-compliant|0|||
155714413|NCT01217463|562048520|FG000|Overall Study|Other|1|||
155714414|NCT01217463|562048521|FG001|Overall Study|Other|1|||
155714415|NCT00057863|562048537|FG000|Overall Study|Death|1|||
155714416|NCT00057863|562048537|FG000|Overall Study|Withdrawal by Subject|2|||
155714417|NCT01308736|562048541|FG000|Overall Study|Did not attend a single session|6|||
155714418|NCT01308736|562048542|FG001|Overall Study|Did not attend a single session|5|||
155714419|NCT03948334|562048549|FG000|Overall Study|Adverse Event|1|||
155714420|NCT03948334|562048550|FG001|Overall Study|Adverse Event|4|||
155714421|NCT03948334|562048549|FG000|Overall Study|Lack of Efficacy|2|||
155714422|NCT03948334|562048550|FG001|Overall Study|Lack of Efficacy|0|||
155714423|NCT03948334|562048549|FG000|Overall Study|Lost to Follow-up|1|||
155184257|NCT00251004|560112513|FG002|Overall Study|Graft Loss|8|||
155714424|NCT03948334|562048550|FG001|Overall Study|Lost to Follow-up|0|||
155714425|NCT03948334|562048549|FG000|Overall Study|Physician Decision|1|||
155714426|NCT03948334|562048550|FG001|Overall Study|Physician Decision|0|||
155714427|NCT03948334|562048549|FG000|Overall Study|Pregnancy|0|||
155714428|NCT03948334|562048550|FG001|Overall Study|Pregnancy|1|||
155714429|NCT03948334|562048549|FG000|Overall Study|Protocol Deviation|1|||
155184258|NCT02045303|560112516|FG000|Overall Study|Protocol Violation|2|||
155714430|NCT03948334|562048550|FG001|Overall Study|Protocol Deviation|0|||
155714431|NCT03948334|562048549|FG000|Overall Study|Study terminated by Sponsor|50|||
155184259|NCT02045303|560112517|FG001|Overall Study|Protocol Violation|1|||
155184260|NCT02045303|560112518|FG002|Overall Study|Protocol Violation|0|||
155184261|NCT02045303|560112516|FG000|Overall Study|Withdrawal by Subject|0|||
155184262|NCT02045303|560112517|FG001|Overall Study|Withdrawal by Subject|2|||
155184263|NCT02045303|560112518|FG002|Overall Study|Withdrawal by Subject|0|||
155184264|NCT01856023|560112519|FG000|Overall Study|Death|1|||
155184265|NCT01856023|560112520|FG001|Overall Study|Death|2|||
155184266|NCT01856023|560112519|FG000|Overall Study|Adverse Event|2|||
155184267|NCT01856023|560112520|FG001|Overall Study|Adverse Event|1|||
155184268|NCT01856023|560112519|FG000|Overall Study|Lack of Efficacy|5|||
155184269|NCT01856023|560112520|FG001|Overall Study|Lack of Efficacy|5|||
155184270|NCT01856023|560112519|FG000|Overall Study|non compliance, study closure|1|||
155184271|NCT01856023|560112520|FG001|Overall Study|non compliance, study closure|3|||
155184272|NCT01856023|560112519|FG000|Overall Study|Withdrawal by Subject|1|||
155184273|NCT01856023|560112520|FG001|Overall Study|Withdrawal by Subject|1|||
155184274|NCT00829283|560112521|FG000|Overall Study|Lost to Follow-up|7|||
155184275|NCT00829283|560112522|FG001|Overall Study|Lost to Follow-up|25|||
155184276|NCT03631355|560112523|FG000|Overall Study|Lost to Follow-up|1|||
155184277|NCT03631355|560112524|FG001|Overall Study|Lost to Follow-up|2|||
155184278|NCT02810340|560112525|FG000|Overall Study|Withdrawal by Subject|1|||
155184279|NCT02810340|560112526|FG001|Overall Study|Withdrawal by Subject|0|||
155184280|NCT02810340|560112527|FG002|Overall Study|Withdrawal by Subject|0|||
155184281|NCT02810340|560112525|FG000|Overall Study|Incarceration|0|||
155184282|NCT02810340|560112526|FG001|Overall Study|Incarceration|1|||
155184283|NCT02810340|560112527|FG002|Overall Study|Incarceration|0|||
155184284|NCT02810340|560112525|FG000|Overall Study|Lost to Follow-up|0|||
155184285|NCT02810340|560112526|FG001|Overall Study|Lost to Follow-up|0|||
155184286|NCT02810340|560112527|FG002|Overall Study|Lost to Follow-up|1|||
155184287|NCT00870233|560112533|FG000|Overall Study|Withdrawal by Subject|18|||
155184288|NCT00870233|560112533|FG000|Overall Study|Did not undergo laparotomy|3|||
155184289|NCT00870233|560112533|FG000|Overall Study|Incompatible internet browser|2|||
155184290|NCT00870233|560112533|FG000|Overall Study|Death|1|||
155184291|NCT00769483|560112534|FG000|Overall Study|Withdrawal by Subject|0|||
155184292|NCT00769483|560112535|FG001|Overall Study|Withdrawal by Subject|1|||
155184293|NCT00769483|560112536|FG002|Overall Study|Withdrawal by Subject|0|||
155184294|NCT00769483|560112537|FG003|Overall Study|Withdrawal by Subject|0|||
155184295|NCT00769483|560112538|FG004|Overall Study|Withdrawal by Subject|1|||
155184296|NCT00769483|560112539|FG005|Overall Study|Withdrawal by Subject|0|||
155184297|NCT00495131|560112552|FG000|Overall Study|Adverse Event|6|||
155184298|NCT00495131|560112553|FG001|Overall Study|Adverse Event|2|||
155184299|NCT00495131|560112552|FG000|Overall Study|Lack of Efficacy|0|||
155184300|NCT00495131|560112553|FG001|Overall Study|Lack of Efficacy|2|||
155184301|NCT00495131|560112552|FG000|Overall Study|Lost to Follow-up|0|||
155184302|NCT00495131|560112553|FG001|Overall Study|Lost to Follow-up|2|||
155184303|NCT00495131|560112552|FG000|Overall Study|Withdrawal by Subject|1|||
155184304|NCT00495131|560112553|FG001|Overall Study|Withdrawal by Subject|0|||
155184305|NCT00976573|560112560|FG000|Overall Study|Ineligible|0|||
155184306|NCT00976573|560112561|FG001|Overall Study|Ineligible|1|||
155184307|NCT00976573|560112560|FG000|Overall Study|Cancel prior to receiving treatment|4|||
155184308|NCT00976573|560112561|FG001|Overall Study|Cancel prior to receiving treatment|2|||
155184309|NCT02117427|560112562|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
155184310|NCT02117427|560112563|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
155184311|NCT02117427|560112564|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
155184312|NCT02117427|560112562|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
155184313|NCT02117427|560112563|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
155184314|NCT02117427|560112564|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
155184315|NCT02117427|560112562|FG000|Overall Study|Physician Decision|0|||
155184316|NCT02117427|560112563|FG001|Overall Study|Physician Decision|2|||
155184317|NCT02117427|560112564|FG002|Overall Study|Physician Decision|0|||
155184318|NCT02117427|560112562|FG000|Overall Study|No longer meets inclusion criteria|0|||
155184319|NCT02117427|560112563|FG001|Overall Study|No longer meets inclusion criteria|1|||
155184320|NCT02117427|560112564|FG002|Overall Study|No longer meets inclusion criteria|0|||
155184321|NCT02117427|560112562|FG000|Overall Study|Death|0|||
155184322|NCT02117427|560112563|FG001|Overall Study|Death|1|||
155184323|NCT02117427|560112564|FG002|Overall Study|Death|0|||
155184324|NCT02730208|560112565|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155184325|NCT02730208|560112566|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155184326|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
155184327|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
155184328|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
155184329|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
155184330|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
155184331|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
155184332|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
155184333|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
155714432|NCT03948334|562048550|FG001|Overall Study|Study terminated by Sponsor|51|||
155714433|NCT03948334|562048549|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
155714434|NCT03948334|562048550|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
155714435|NCT03775486|562048555|FG000|Initial Therapy Phase|Other reason provided|0|||
155714436|NCT03775486|562048556|FG001|Initial Therapy Phase|Other reason provided|15|||
155714437|NCT03775486|562048555|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
155714438|NCT03775486|562048556|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
155714439|NCT03775486|562048555|FG000|Initial Therapy Phase|Protocol Violation|0|||
155714440|NCT03775486|562048556|FG001|Initial Therapy Phase|Protocol Violation|2|||
155714441|NCT03775486|562048555|FG000|Initial Therapy Phase|Adverse Event|0|||
155714442|NCT03775486|562048556|FG001|Initial Therapy Phase|Adverse Event|34|||
155714443|NCT03775486|562048555|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
155184334|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
155714444|NCT03775486|562048556|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
155714445|NCT03775486|562048555|FG000|Maintenance Phase|Withdrawal by Subject|13|||
155714446|NCT03775486|562048556|FG001|Maintenance Phase|Withdrawal by Subject|12|||
155714447|NCT03775486|562048555|FG000|Maintenance Phase|Death|44|||
155714448|NCT03775486|562048556|FG001|Maintenance Phase|Death|45|||
155714449|NCT05477485|562048557|FG000|Overall Study|Lost to Follow-up|0|||
155714450|NCT05477485|562048558|FG001|Overall Study|Lost to Follow-up|4|||
155714451|NCT05081219|562048559|FG000|Overall Study|Withdrawal by Subject|4|||
155714452|NCT05081219|562048560|FG001|Overall Study|Withdrawal by Subject|0|||
155714453|NCT05081219|562048561|FG002|Overall Study|Withdrawal by Subject|0|||
155714454|NCT05081219|562048562|FG003|Overall Study|Withdrawal by Subject|1|||
155714455|NCT05274958|562048563|FG000|Overall Study|Only completed 1 set of PROMs|22|||
155714456|NCT05274958|562048564|FG001|Overall Study|Only completed 1 set of PROMs|35|||
155714457|NCT06235905|562048565|FG000|Overall Study|Adverse Event|1|||
155714458|NCT06235905|562048565|FG000|Overall Study|Non-compliant with protocol procedures|1|||
155714459|NCT00866814|562048566|FG000|Overall Study|Lost to Follow-up|12|||
155714460|NCT00866814|562048566|FG000|Overall Study|Adverse Event|2|||
155714461|NCT00866814|562048566|FG000|Overall Study|Physician Decision|1|||
155714462|NCT00866814|562048566|FG000|Overall Study|Death|1|||
155714463|NCT00866814|562048566|FG000|Overall Study|No longer wished to participate|1|||
155714464|NCT00866814|562048566|FG000|Overall Study|Unable to meet follow-up requirements|2|||
155714465|NCT00866814|562048566|FG000|Overall Study|Moved to area without study site|1|||
155714466|NCT00319254|562048569|FG000|Overall Study|Withdrawal by Subject|4|||
155714467|NCT00319254|562048569|FG000|Overall Study|Death|46|||
155714468|NCT00319254|562048569|FG000|Overall Study|Lost to Follow-up|2|||
155714469|NCT00319254|562048569|FG000|Overall Study|Enrolled, Not Treated|2|||
155714470|NCT01712204|562048573|FG000|Overall Study|Adverse Event|3|||
155714471|NCT01712204|562048574|FG001|Overall Study|Adverse Event|1|||
155714472|NCT01712204|562048573|FG000|Overall Study|Withdrawal by Subject|3|||
155714473|NCT01712204|562048574|FG001|Overall Study|Withdrawal by Subject|3|||
155184335|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
155184336|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
155184337|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
155184338|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
155184339|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
155184340|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
155184341|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
155714474|NCT01712204|562048573|FG000|Overall Study|Lost to Follow-up|1|||
155714475|NCT01712204|562048574|FG001|Overall Study|Lost to Follow-up|0|||
155714476|NCT01712204|562048573|FG000|Overall Study|Protocol Violation|1|||
155714477|NCT01712204|562048574|FG001|Overall Study|Protocol Violation|1|||
155714478|NCT01059318|562048577|FG000|Core Study (26 Week)|Adverse Event|3|||
155714479|NCT01059318|562048577|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
155184342|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
155184343|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
155184344|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
155184345|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
155184346|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
155184347|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
155184348|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
155184349|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
155184350|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
155184351|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
155184352|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
155184353|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
155184354|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
155184355|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
155184356|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
155184357|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
155184358|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
155184359|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
155184360|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
155184361|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
155184362|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
155184363|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
155184364|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
155184365|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
155184366|NCT02418156|560112586|FG000|Overall Study|Lost to Follow-up|12|||
155184367|NCT02418156|560112586|FG000|Overall Study|Death|2|||
155184368|NCT02418156|560112586|FG000|Overall Study|Physician Decision|1|||
155184369|NCT02418156|560112586|FG000|Overall Study|Withdrawal by Subject|1|||
155184370|NCT02418156|560112586|FG000|Overall Study|Subject refused to return|1|||
155184371|NCT01909453|560112587|FG000|Overall Study|Ongoing|118|||
155184372|NCT01909453|560112588|FG001|Overall Study|Ongoing|103|||
155184373|NCT01909453|560112589|FG002|Overall Study|Ongoing|83|||
155184374|NCT01909453|560112590|FG003|Overall Study|Ongoing|164|||
155184375|NCT01909453|560112591|FG004|Overall Study|Ongoing|50|||
155184376|NCT01909453|560112587|FG000|Overall Study|Death|69|||
155184377|NCT01909453|560112588|FG001|Overall Study|Death|74|||
155184378|NCT01909453|560112589|FG002|Overall Study|Death|88|||
155184379|NCT01909453|560112590|FG003|Overall Study|Death|86|||
155184380|NCT01909453|560112591|FG004|Overall Study|Death|29|||
155184381|NCT01909453|560112587|FG000|Overall Study|Lost to Follow-up|3|||
155184382|NCT01909453|560112588|FG001|Overall Study|Lost to Follow-up|4|||
155184383|NCT01909453|560112589|FG002|Overall Study|Lost to Follow-up|4|||
155184384|NCT01909453|560112590|FG003|Overall Study|Lost to Follow-up|3|||
155184385|NCT01909453|560112591|FG004|Overall Study|Lost to Follow-up|3|||
155184386|NCT01909453|560112587|FG000|Overall Study|Withdrawal by Subject|2|||
155184387|NCT01909453|560112588|FG001|Overall Study|Withdrawal by Subject|13|||
155184388|NCT01909453|560112589|FG002|Overall Study|Withdrawal by Subject|16|||
155184389|NCT01909453|560112590|FG003|Overall Study|Withdrawal by Subject|5|||
155184390|NCT01909453|560112591|FG004|Overall Study|Withdrawal by Subject|4|||
155184391|NCT02423109|560114554|FG000|Lens 1|Adverse Event|1|||
155184392|NCT02423109|560114555|FG001|Lens 1|Adverse Event|0|||
155184393|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
155184394|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
155184395|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
155184396|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
155184397|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
155184398|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
155184399|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
155184400|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
155184401|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
155184402|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
155184403|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
155184404|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
155184405|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
155184406|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
155184407|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
155184408|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
155184409|NCT00397943|560114558|FG000|Overall Study|Unspecified reasons|12|||
155184410|NCT00397943|560114559|FG001|Overall Study|Unspecified reasons|9|||
155184411|NCT00397943|560114560|FG002|Overall Study|Unspecified reasons|0|||
155184412|NCT00397943|560114561|FG003|Overall Study|Unspecified reasons|0|||
155184413|NCT00397943|560114562|FG004|Overall Study|Unspecified reasons|0|||
155184414|NCT03139604|560114563|FG000|Overall Study|Other|7|||
155184415|NCT03139604|560114564|FG001|Overall Study|Other|3|||
155184416|NCT03139604|560114563|FG000|Overall Study|Withdrawal by Subject|16|||
155184417|NCT03139604|560114564|FG001|Overall Study|Withdrawal by Subject|17|||
155184418|NCT03139604|560114563|FG000|Overall Study|Physician Decision|1|||
155714480|NCT01059318|562048577|FG000|Extension (36 Week)|Adverse Event|3|||
155714481|NCT02679287|562048581|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
155714482|NCT02679287|562048582|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
155714483|NCT02679287|562048581|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
155714484|NCT02679287|562048582|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
155714485|NCT02679287|562048581|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
155714486|NCT02679287|562048582|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
155714487|NCT02679287|562048581|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
155714488|NCT02679287|562048582|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
155714489|NCT02679287|562048581|FG000|Period 2|Work/Scheduling Conflict|1|||
155714490|NCT02679287|562048582|FG001|Period 2|Work/Scheduling Conflict|0|||
155714491|NCT02679287|562048581|FG000|Period 2|Disliked Mobile System|2|||
155714492|NCT02679287|562048582|FG001|Period 2|Disliked Mobile System|0|||
155714493|NCT02679287|562048581|FG000|Period 3|Work/Scheduling Conflict|0|||
155714494|NCT02679287|562048582|FG001|Period 3|Work/Scheduling Conflict|1|||
155714495|NCT01408459|562048583|FG000|Overall Study|Withdrawal by Subject|1|||
155714496|NCT01408459|562048584|FG001|Overall Study|Withdrawal by Subject|1|||
155714497|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155714498|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
155714499|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155714500|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155714501|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155714502|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
155714503|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
155714504|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155714505|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155714506|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155714507|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
155714508|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
155714509|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155714510|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155714511|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155714512|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
155714513|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
155714514|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155714515|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155714516|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155714517|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
155714518|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
155714519|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155714520|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155714521|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155714522|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
155714523|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
155714524|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155714525|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155714526|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155714527|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
155714528|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
155714529|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155714530|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155714531|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155714532|NCT02831764|562050861|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155714533|NCT02831764|562050862|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
155714534|NCT02831764|562050863|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155714535|NCT02831764|562050864|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155714536|NCT02831764|562050865|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155714537|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155184419|NCT03139604|560114564|FG001|Overall Study|Physician Decision|2|||
155184420|NCT03139604|560114563|FG000|Overall Study|Lost to Follow-up|3|||
155714538|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155714539|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
155714540|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
155714541|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155714542|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155714543|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155714544|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
155714545|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155714546|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155714547|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155714548|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155714549|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
155714550|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
155714551|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155714552|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155714553|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155714554|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
155184421|NCT03139604|560114564|FG001|Overall Study|Lost to Follow-up|1|||
155184422|NCT03139604|560114563|FG000|Overall Study|Death|65|||
155184423|NCT03139604|560114564|FG001|Overall Study|Death|67|||
155184424|NCT03139604|560114563|FG000|Overall Study|Study Terminated by Sponsor|122|||
155184425|NCT03139604|560114564|FG001|Overall Study|Study Terminated by Sponsor|127|||
155184426|NCT03139604|560114563|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
155184427|NCT03139604|560114564|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
155184428|NCT04209426|560114567|FG000|Overall Study|Lost to Follow-up|3|||
155184429|NCT04209426|560114568|FG001|Overall Study|Lost to Follow-up|2|||
155184430|NCT01751802|560114580|FG000|Overall Study|Adverse Event|4|||
155184431|NCT01751802|560114581|FG001|Overall Study|Adverse Event|2|||
155184432|NCT00521001|560114585|FG000|Overall Study|Ineligible|1|||
155184433|NCT02821910|560114586|FG000|Overall Study|Withdrawal by Subject|0|||
155184434|NCT02821910|560114587|FG001|Overall Study|Withdrawal by Subject|0|||
155184435|NCT02821910|560114588|FG002|Overall Study|Withdrawal by Subject|1|||
155184436|NCT02821910|560114589|FG003|Overall Study|Withdrawal by Subject|0|||
155184437|NCT02821910|560114590|FG004|Overall Study|Withdrawal by Subject|0|||
155184438|NCT02821910|560114591|FG005|Overall Study|Withdrawal by Subject|1|||
155184439|NCT02821910|560114586|FG000|Overall Study|Other than specified|1|||
155184440|NCT02821910|560114587|FG001|Overall Study|Other than specified|0|||
155184441|NCT02821910|560114588|FG002|Overall Study|Other than specified|1|||
155184442|NCT02821910|560114589|FG003|Overall Study|Other than specified|0|||
155184443|NCT02821910|560114590|FG004|Overall Study|Other than specified|0|||
155184444|NCT02821910|560114591|FG005|Overall Study|Other than specified|0|||
155184445|NCT00423670|560114594|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
155184446|NCT00423670|560114595|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184447|NCT00423670|560114596|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184448|NCT00423670|560114597|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184449|NCT00423670|560114598|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184450|NCT00423670|560114599|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184451|NCT00423670|560114600|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184452|NCT00423670|560114601|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184453|NCT00423670|560114594|FG000|Treatment Period|Adverse Event|8|||
155184454|NCT00423670|560114595|FG001|Treatment Period|Adverse Event|12|||
155184455|NCT00423670|560114596|FG002|Treatment Period|Adverse Event|15|||
155184456|NCT00423670|560114597|FG003|Treatment Period|Adverse Event|20|||
155184457|NCT00423670|560114598|FG004|Treatment Period|Adverse Event|9|||
155184458|NCT00423670|560114599|FG005|Treatment Period|Adverse Event|4|||
155184459|NCT00423670|560114600|FG006|Treatment Period|Adverse Event|7|||
155184460|NCT00423670|560114601|FG007|Treatment Period|Adverse Event|2|||
155184461|NCT00423670|560114594|FG000|Treatment Period|Protocol-defined clinical event|0|||
155184462|NCT00423670|560114595|FG001|Treatment Period|Protocol-defined clinical event|7|||
155184463|NCT00423670|560114596|FG002|Treatment Period|Protocol-defined clinical event|4|||
155184464|NCT00423670|560114597|FG003|Treatment Period|Protocol-defined clinical event|12|||
155184465|NCT00423670|560114598|FG004|Treatment Period|Protocol-defined clinical event|5|||
155184466|NCT00423670|560114599|FG005|Treatment Period|Protocol-defined clinical event|4|||
155184467|NCT00423670|560114600|FG006|Treatment Period|Protocol-defined clinical event|16|||
155184468|NCT00423670|560114601|FG007|Treatment Period|Protocol-defined clinical event|15|||
155184469|NCT00423670|560114594|FG000|Treatment Period|Lost to Follow-up|2|||
155184470|NCT00423670|560114595|FG001|Treatment Period|Lost to Follow-up|1|||
155184471|NCT00423670|560114596|FG002|Treatment Period|Lost to Follow-up|3|||
155184472|NCT00423670|560114597|FG003|Treatment Period|Lost to Follow-up|1|||
155184473|NCT00423670|560114598|FG004|Treatment Period|Lost to Follow-up|6|||
155184474|NCT00423670|560114599|FG005|Treatment Period|Lost to Follow-up|0|||
155184475|NCT00423670|560114600|FG006|Treatment Period|Lost to Follow-up|3|||
155714555|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155714556|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155714557|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155184476|NCT00423670|560114601|FG007|Treatment Period|Lost to Follow-up|1|||
155184477|NCT00423670|560114594|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
155184478|NCT00423670|560114595|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
155184479|NCT00423670|560114596|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
155184480|NCT00423670|560114597|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
155714558|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155714559|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
155184481|NCT00423670|560114598|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
155184482|NCT00423670|560114599|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
155184483|NCT00423670|560114600|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
155184484|NCT00423670|560114601|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
155184485|NCT00423670|560114594|FG000|Treatment Period|Investigator decision|0|||
155184486|NCT00423670|560114595|FG001|Treatment Period|Investigator decision|0|||
155184487|NCT00423670|560114596|FG002|Treatment Period|Investigator decision|0|||
155184488|NCT00423670|560114597|FG003|Treatment Period|Investigator decision|0|||
155184489|NCT00423670|560114598|FG004|Treatment Period|Investigator decision|0|||
155184490|NCT00423670|560114599|FG005|Treatment Period|Investigator decision|0|||
155184491|NCT00423670|560114600|FG006|Treatment Period|Investigator decision|0|||
155184492|NCT00423670|560114601|FG007|Treatment Period|Investigator decision|1|||
155184493|NCT00423670|560114594|FG000|Treatment Period|Non-compliance with protocol|3|||
155184494|NCT00423670|560114595|FG001|Treatment Period|Non-compliance with protocol|1|||
155184495|NCT00423670|560114596|FG002|Treatment Period|Non-compliance with protocol|1|||
155184496|NCT00423670|560114597|FG003|Treatment Period|Non-compliance with protocol|3|||
155184497|NCT00423670|560114598|FG004|Treatment Period|Non-compliance with protocol|2|||
155184498|NCT00423670|560114599|FG005|Treatment Period|Non-compliance with protocol|0|||
155184499|NCT00423670|560114600|FG006|Treatment Period|Non-compliance with protocol|2|||
155184500|NCT00423670|560114601|FG007|Treatment Period|Non-compliance with protocol|2|||
155184501|NCT00423670|560114594|FG000|Follow-up Period|Lost to Follow-up|0|||
155184502|NCT00423670|560114595|FG001|Follow-up Period|Lost to Follow-up|12|||
155184503|NCT00423670|560114596|FG002|Follow-up Period|Lost to Follow-up|8|||
155184504|NCT00423670|560114597|FG003|Follow-up Period|Lost to Follow-up|3|||
155184505|NCT00423670|560114598|FG004|Follow-up Period|Lost to Follow-up|1|||
155184506|NCT00423670|560114599|FG005|Follow-up Period|Lost to Follow-up|0|||
155184507|NCT00423670|560114600|FG006|Follow-up Period|Lost to Follow-up|5|||
155184508|NCT00423670|560114601|FG007|Follow-up Period|Lost to Follow-up|0|||
155184509|NCT00423670|560114594|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184510|NCT00423670|560114595|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
155184511|NCT00423670|560114596|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
155184512|NCT00423670|560114597|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184513|NCT00423670|560114598|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184514|NCT00423670|560114599|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
155184515|NCT00423670|560114600|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184516|NCT00423670|560114601|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184517|NCT00423670|560114594|FG000|Follow-up Period|Non-compliance with protocol|2|||
155184518|NCT00423670|560114595|FG001|Follow-up Period|Non-compliance with protocol|0|||
155184519|NCT00423670|560114596|FG002|Follow-up Period|Non-compliance with protocol|1|||
155184520|NCT00423670|560114597|FG003|Follow-up Period|Non-compliance with protocol|1|||
155184521|NCT00423670|560114598|FG004|Follow-up Period|Non-compliance with protocol|0|||
155184522|NCT00423670|560114599|FG005|Follow-up Period|Non-compliance with protocol|0|||
155184523|NCT00423670|560114600|FG006|Follow-up Period|Non-compliance with protocol|3|||
155184524|NCT00423670|560114601|FG007|Follow-up Period|Non-compliance with protocol|2|||
155184525|NCT00900601|560114602|FG000|Overall Study|Physician Decision|1|||
155184526|NCT01082640|560114604|FG000|Overall Study|Adverse Event|9|||
155184527|NCT01082640|560114605|FG001|Overall Study|Adverse Event|5|||
155184528|NCT01082640|560114606|FG002|Overall Study|Adverse Event|3|||
155184529|NCT01082640|560114604|FG000|Overall Study|Withdrawal by Subject|3|||
155184530|NCT01082640|560114605|FG001|Overall Study|Withdrawal by Subject|3|||
155184531|NCT01082640|560114606|FG002|Overall Study|Withdrawal by Subject|2|||
155184532|NCT01082640|560114604|FG000|Overall Study|Major protocol deviation|3|||
155184533|NCT01082640|560114605|FG001|Overall Study|Major protocol deviation|3|||
155184534|NCT01082640|560114606|FG002|Overall Study|Major protocol deviation|0|||
155184535|NCT01082640|560114604|FG000|Overall Study|Lost to Follow-up|0|||
155184536|NCT01082640|560114605|FG001|Overall Study|Lost to Follow-up|3|||
155184537|NCT01082640|560114606|FG002|Overall Study|Lost to Follow-up|0|||
155184538|NCT01082640|560114604|FG000|Overall Study|Other|2|||
155184539|NCT01082640|560114605|FG001|Overall Study|Other|1|||
155184540|NCT01082640|560114606|FG002|Overall Study|Other|3|||
155184541|NCT04543409|560114618|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155714560|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
155714561|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155714562|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155184542|NCT04543409|560114619|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155184543|NCT04543409|560114618|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
155184544|NCT04543409|560114619|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
155184545|NCT04543409|560114618|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
155184546|NCT04543409|560114619|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155184547|NCT04543409|560114618|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
155184548|NCT04543409|560114619|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
155184549|NCT04543409|560114618|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
155184550|NCT04543409|560114619|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
155184551|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
155184552|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
155184553|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
155184554|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
155184555|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
155184556|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
155184557|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
155184558|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
155184559|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
155184560|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
155184561|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
155184562|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
155184563|NCT01052844|560114620|FG000|Overall Study|Adverse Event|0|||
155184564|NCT01052844|560114621|FG001|Overall Study|Adverse Event|1|||
155184565|NCT03519386|560114624|FG000|Overall Study|Withdrawal by Subject|4|||
155184566|NCT03519386|560114625|FG001|Overall Study|Withdrawal by Subject|1|||
155184567|NCT03519386|560114626|FG002|Overall Study|Withdrawal by Subject|2|||
155184568|NCT03519386|560114624|FG000|Overall Study|Physician Decision|1|||
155184569|NCT03519386|560114625|FG001|Overall Study|Physician Decision|1|||
155184570|NCT03519386|560114626|FG002|Overall Study|Physician Decision|1|||
155184571|NCT03519386|560114624|FG000|Overall Study|Lost to Follow-up|0|||
155184572|NCT03519386|560114625|FG001|Overall Study|Lost to Follow-up|1|||
155184573|NCT03519386|560114626|FG002|Overall Study|Lost to Follow-up|1|||
155184574|NCT03519386|560114624|FG000|Overall Study|Death|1|||
155184575|NCT03519386|560114625|FG001|Overall Study|Death|0|||
155184576|NCT03519386|560114626|FG002|Overall Study|Death|4|||
155184577|NCT03519386|560114624|FG000|Overall Study|Adverse Event|2|||
155184578|NCT03519386|560114625|FG001|Overall Study|Adverse Event|1|||
155184579|NCT03519386|560114626|FG002|Overall Study|Adverse Event|2|||
155184580|NCT03519386|560114624|FG000|Overall Study|Explanted|2|||
155184581|NCT03519386|560114625|FG001|Overall Study|Explanted|1|||
155184582|NCT03519386|560114626|FG002|Overall Study|Explanted|0|||
155184583|NCT03519386|560114624|FG000|Overall Study|Ongoing in study|190|||
155184584|NCT03519386|560114625|FG001|Overall Study|Ongoing in study|192|||
155184585|NCT03519386|560114626|FG002|Overall Study|Ongoing in study|183|||
155184586|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
155184587|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
155184588|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
155184589|NCT01298193|560114628|FG000|Efficacy Phase (Second Cycle)|Death|1|||
155184590|NCT00107952|560114629|FG000|Overall Study|Death|75|||
155184591|NCT00107952|560114630|FG001|Overall Study|Death|61|||
155184592|NCT00107952|560114629|FG000|Overall Study|Lost to Follow-up|0|||
155184593|NCT00107952|560114630|FG001|Overall Study|Lost to Follow-up|3|||
155184594|NCT00107952|560114629|FG000|Overall Study|Withdrawal by Subject|9|||
155184595|NCT00107952|560114630|FG001|Overall Study|Withdrawal by Subject|6|||
155184596|NCT00107952|560114629|FG000|Overall Study|Other|2|||
155184597|NCT00107952|560114630|FG001|Overall Study|Other|5|||
155184598|NCT00107952|560114629|FG000|Overall Study|Never received study treatment|9|||
155184599|NCT00107952|560114630|FG001|Overall Study|Never received study treatment|6|||
155184600|NCT03475875|560114631|FG000|Period 1|Lost to Follow-up|1|||
155184601|NCT03475875|560114632|FG001|Period 1|Lost to Follow-up|0|||
155184602|NCT03475875|560114631|FG000|Period 1|Adverse Event|2|||
155184603|NCT03475875|560114632|FG001|Period 1|Adverse Event|1|||
155184604|NCT03475875|560114631|FG000|Period 2|Adverse Event|3|||
155184605|NCT03475875|560114632|FG001|Period 2|Adverse Event|0|||
155184606|NCT03475875|560114631|FG000|Period 2|Protocol Violation|0|||
155184607|NCT03475875|560114632|FG001|Period 2|Protocol Violation|1|||
155184608|NCT01642407|560114633|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
155184609|NCT01642407|560114633|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
155714563|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155714564|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
155714565|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
155714566|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155184610|NCT01642407|560114633|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
155184611|NCT00424255|560114634|FG000|Overall Study|Death|115|||
155184612|NCT00424255|560114635|FG001|Overall Study|Death|111|||
155184613|NCT00424255|560114634|FG000|Overall Study|Lost to Follow-up|26|||
155184614|NCT00424255|560114635|FG001|Overall Study|Lost to Follow-up|20|||
155184615|NCT00424255|560114634|FG000|Overall Study|Protocol Violation|0|||
155184616|NCT00424255|560114635|FG001|Overall Study|Protocol Violation|1|||
155714567|NCT02831764|562050861|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155714568|NCT02831764|562050862|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155184617|NCT00424255|560114634|FG000|Overall Study|Withdrawal by Subject|34|||
155184618|NCT00424255|560114635|FG001|Overall Study|Withdrawal by Subject|38|||
155184619|NCT00424255|560114634|FG000|Overall Study|Physician Decision|3|||
155184620|NCT00424255|560114635|FG001|Overall Study|Physician Decision|7|||
155184621|NCT00424255|560114634|FG000|Overall Study|Cognitive Disturbance|1|||
155184622|NCT00424255|560114635|FG001|Overall Study|Cognitive Disturbance|0|||
155184623|NCT00424255|560114634|FG000|Overall Study|Non-compliance by Participants|1|||
155184624|NCT00424255|560114635|FG001|Overall Study|Non-compliance by Participants|0|||
155184625|NCT00424255|560114634|FG000|Overall Study|Fatigue|1|||
155184626|NCT00424255|560114635|FG001|Overall Study|Fatigue|0|||
155184627|NCT00424255|560114634|FG000|Overall Study|Disease Progression|0|||
155184628|NCT00424255|560114635|FG001|Overall Study|Disease Progression|2|||
155184629|NCT00424255|560114634|FG000|Overall Study|Sponsor Terminated Study|161|||
155184630|NCT00424255|560114635|FG001|Overall Study|Sponsor Terminated Study|167|||
155184631|NCT02632838|560114637|FG000|Overall Study|Withdrawal by Subject|3|||
155184632|NCT02632838|560114638|FG001|Overall Study|Withdrawal by Subject|0|||
155714569|NCT02831764|562050863|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
155714570|NCT02831764|562050864|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
155714571|NCT02831764|562050865|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155714572|NCT02831764|562050861|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155184633|NCT02632838|560114637|FG000|Overall Study|Lost to Follow-up|0|||
155184634|NCT02632838|560114638|FG001|Overall Study|Lost to Follow-up|2|||
155184635|NCT03945175|560114639|FG000|Overall Study|Did not meet inclusion criteria|31|||
155714573|NCT02831764|562050862|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155714574|NCT02831764|562050863|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155714575|NCT02831764|562050864|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155714576|NCT02831764|562050865|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
155714577|NCT02831764|562050861|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155714578|NCT02831764|562050862|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155714579|NCT02831764|562050863|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155714580|NCT02831764|562050864|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155714581|NCT02831764|562050865|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
155714582|NCT02831764|562050861|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155714583|NCT02831764|562050862|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155714584|NCT02831764|562050863|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155714585|NCT02831764|562050864|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155714586|NCT02831764|562050865|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
155714587|NCT02831764|562050861|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155714588|NCT02831764|562050862|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155714589|NCT02831764|562050863|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155714590|NCT02831764|562050864|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155714591|NCT02831764|562050865|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
155714592|NCT03400852|562050866|FG000|Blinded Treatment Period|Physician Decision|0|||
155714593|NCT03400852|562050867|FG001|Blinded Treatment Period|Physician Decision|1|||
155714594|NCT03400852|562050868|FG002|Blinded Treatment Period|Physician Decision|0|||
155714595|NCT03400852|562050866|FG000|Blinded Treatment Period|Adverse Event|1|||
155714596|NCT03400852|562050867|FG001|Blinded Treatment Period|Adverse Event|1|||
155714597|NCT03400852|562050868|FG002|Blinded Treatment Period|Adverse Event|0|||
155714598|NCT03400852|562050866|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
155714599|NCT03400852|562050867|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
155714600|NCT03400852|562050868|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
155714601|NCT03400852|562050866|FG000|Open Label Period|Physician Decision|0|||
155714602|NCT03400852|562050867|FG001|Open Label Period|Physician Decision|0|||
155714603|NCT03400852|562050868|FG002|Open Label Period|Physician Decision|1|||
155714604|NCT03400852|562050866|FG000|Open Label Period|Study terminated by sponsor|0|||
155714605|NCT03400852|562050867|FG001|Open Label Period|Study terminated by sponsor|0|||
155714606|NCT03400852|562050868|FG002|Open Label Period|Study terminated by sponsor|21|||
155714607|NCT03001557|562050875|FG000|Core Phase|Randomized but not treated|0|||
155714608|NCT03001557|562050876|FG001|Core Phase|Randomized but not treated|0|||
155714609|NCT03001557|562050877|FG002|Core Phase|Randomized but not treated|1|||
155714610|NCT03001557|562050878|FG003|Core Phase|Randomized but not treated|0|||
155714611|NCT03001557|562050879|FG004|Core Phase|Randomized but not treated|0|||
155714612|NCT03001557|562050880|FG005|Core Phase|Randomized but not treated|0|||
155714613|NCT03001557|562050881|FG006|Core Phase|Randomized but not treated|0|||
155714614|NCT03001557|562050882|FG007|Core Phase|Randomized but not treated|0|||
155714615|NCT03001557|562050875|FG000|Extension Phase|Adverse Event|0|||
155714616|NCT03001557|562050876|FG001|Extension Phase|Adverse Event|0|||
155714617|NCT03001557|562050877|FG002|Extension Phase|Adverse Event|0|||
155714618|NCT03001557|562050878|FG003|Extension Phase|Adverse Event|0|||
155714619|NCT03001557|562050879|FG004|Extension Phase|Adverse Event|0|||
155714620|NCT03001557|562050880|FG005|Extension Phase|Adverse Event|2|||
155714621|NCT03001557|562050881|FG006|Extension Phase|Adverse Event|0|||
155714622|NCT03001557|562050882|FG007|Extension Phase|Adverse Event|0|||
155714623|NCT03001557|562050875|FG000|Extension Phase|Withdrawal by Subject|0|||
155714624|NCT03001557|562050876|FG001|Extension Phase|Withdrawal by Subject|0|||
155714625|NCT03001557|562050877|FG002|Extension Phase|Withdrawal by Subject|0|||
155714626|NCT03001557|562050878|FG003|Extension Phase|Withdrawal by Subject|0|||
155714627|NCT03001557|562050879|FG004|Extension Phase|Withdrawal by Subject|0|||
155184636|NCT03945175|560114639|FG000|Overall Study|Withdrew consent|2|||
155184637|NCT03945175|560114639|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
155184638|NCT03945175|560114639|FG000|Overall Study|Early termination during Mydayis treatment|1|||
155184639|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
155184640|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
155184641|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
155184642|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
155184643|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
155184644|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
155184645|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
155184646|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
155184647|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
155184648|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
155184649|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
155184650|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
155184651|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
155184652|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
155184653|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
155184654|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
155184655|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
155184656|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
155184657|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
155184658|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
155184659|NCT01306877|560114644|FG000|Overall Study|Lost to Follow-up|3|||
155184660|NCT01306877|560114645|FG001|Overall Study|Lost to Follow-up|3|||
155184661|NCT01306877|560114644|FG000|Overall Study|Physician Decision|0|||
155184662|NCT01306877|560114645|FG001|Overall Study|Physician Decision|1|||
155184663|NCT00006389|560114646|FG000|Overall Study|Adverse Event|1|||
155184664|NCT00999921|560114652|FG000|Overall Study|Lost to Follow-up|10|||
155184665|NCT00999921|560114653|FG001|Overall Study|Lost to Follow-up|19|||
155184666|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Adverse Event|1|||
155184667|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Adverse Event|0|||
155184668|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Adverse Event|0|||
155184669|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Adverse Event|0|||
155184670|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Adverse Event|0|||
155184671|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184672|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
155184673|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184674|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184675|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184676|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
155184677|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
155184678|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
155184679|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
155184680|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
155184681|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184682|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
155184683|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184684|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184685|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184686|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Reason not specified|0|||
155184687|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Reason not specified|1|||
155184688|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Reason not specified|0|||
155184689|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Reason not specified|0|||
155184690|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Reason not specified|0|||
155184691|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Adverse Event|0|||
155184692|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Adverse Event|0|||
155184693|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Adverse Event|0|||
155184694|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Adverse Event|0|||
155714628|NCT03001557|562050880|FG005|Extension Phase|Withdrawal by Subject|1|||
155714629|NCT03001557|562050881|FG006|Extension Phase|Withdrawal by Subject|5|||
155714630|NCT03001557|562050882|FG007|Extension Phase|Withdrawal by Subject|2|||
155714631|NCT03001557|562050875|FG000|Extension Phase|Lost to Follow-up|0|||
155714632|NCT03001557|562050876|FG001|Extension Phase|Lost to Follow-up|0|||
155714633|NCT03001557|562050877|FG002|Extension Phase|Lost to Follow-up|0|||
155184695|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Adverse Event|3|||
155184696|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Death|0|||
155184697|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Death|0|||
155184698|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Death|0|||
155184699|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Death|0|||
155184700|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Death|1|||
155184701|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
155714634|NCT03001557|562050878|FG003|Extension Phase|Lost to Follow-up|0|||
155184702|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
155184703|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
155184704|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
155184705|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
155184706|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Reason not specified|0|||
155184707|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Reason not specified|0|||
155184708|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Reason not specified|0|||
155184709|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Reason not specified|0|||
155184710|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Reason not specified|3|||
155184711|NCT01017575|560114672|FG000|Overall Study|Lack of Efficacy|0|||
155184712|NCT01017575|560114673|FG001|Overall Study|Lack of Efficacy|1|||
155184713|NCT01017575|560114674|FG002|Overall Study|Lack of Efficacy|0|||
155184714|NCT01017575|560114675|FG003|Overall Study|Lack of Efficacy|1|||
155184715|NCT01017575|560114676|FG004|Overall Study|Lack of Efficacy|1|||
155184716|NCT01017575|560114672|FG000|Overall Study|Adverse Event|0|||
155184717|NCT01017575|560114673|FG001|Overall Study|Adverse Event|1|||
155184718|NCT01017575|560114674|FG002|Overall Study|Adverse Event|0|||
155184719|NCT01017575|560114675|FG003|Overall Study|Adverse Event|0|||
155184720|NCT01017575|560114676|FG004|Overall Study|Adverse Event|2|||
155184721|NCT01017575|560114672|FG000|Overall Study|Withdrawal by Subject|1|||
155184722|NCT01017575|560114673|FG001|Overall Study|Withdrawal by Subject|0|||
155184723|NCT01017575|560114674|FG002|Overall Study|Withdrawal by Subject|0|||
155184724|NCT01017575|560114675|FG003|Overall Study|Withdrawal by Subject|0|||
155184725|NCT01017575|560114676|FG004|Overall Study|Withdrawal by Subject|0|||
155184726|NCT01962922|560114679|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
155184727|NCT01962922|560114680|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
155184728|NCT01962922|560114679|FG000|PK Portion Day 7|non-compliance|1|||
155184729|NCT01962922|560114680|FG001|PK Portion Day 7|non-compliance|0|||
155714635|NCT03001557|562050879|FG004|Extension Phase|Lost to Follow-up|0|||
155714636|NCT03001557|562050880|FG005|Extension Phase|Lost to Follow-up|0|||
155714637|NCT03001557|562050881|FG006|Extension Phase|Lost to Follow-up|2|||
155714638|NCT03001557|562050882|FG007|Extension Phase|Lost to Follow-up|1|||
155714639|NCT03001557|562050875|FG000|Extension Phase|Administrative Reason|0|||
155714640|NCT03001557|562050876|FG001|Extension Phase|Administrative Reason|0|||
155714641|NCT03001557|562050877|FG002|Extension Phase|Administrative Reason|0|||
155714642|NCT03001557|562050878|FG003|Extension Phase|Administrative Reason|0|||
155714643|NCT03001557|562050879|FG004|Extension Phase|Administrative Reason|0|||
155714644|NCT03001557|562050880|FG005|Extension Phase|Administrative Reason|1|||
155714645|NCT03001557|562050881|FG006|Extension Phase|Administrative Reason|3|||
155714646|NCT03001557|562050882|FG007|Extension Phase|Administrative Reason|3|||
155714647|NCT03001557|562050875|FG000|Extension Phase|Loss of caregiver|0|||
155714648|NCT03001557|562050876|FG001|Extension Phase|Loss of caregiver|0|||
155714649|NCT03001557|562050877|FG002|Extension Phase|Loss of caregiver|0|||
155714650|NCT03001557|562050878|FG003|Extension Phase|Loss of caregiver|0|||
155714651|NCT03001557|562050879|FG004|Extension Phase|Loss of caregiver|0|||
155714652|NCT03001557|562050880|FG005|Extension Phase|Loss of caregiver|0|||
155714653|NCT03001557|562050881|FG006|Extension Phase|Loss of caregiver|1|||
155714654|NCT03001557|562050882|FG007|Extension Phase|Loss of caregiver|0|||
155714655|NCT03001557|562050875|FG000|Extension Phase|Others|0|||
155714656|NCT03001557|562050876|FG001|Extension Phase|Others|0|||
155714657|NCT03001557|562050877|FG002|Extension Phase|Others|0|||
155714658|NCT03001557|562050878|FG003|Extension Phase|Others|0|||
155714659|NCT03001557|562050879|FG004|Extension Phase|Others|0|||
155714660|NCT03001557|562050880|FG005|Extension Phase|Others|1|||
155714661|NCT03001557|562050881|FG006|Extension Phase|Others|3|||
155714662|NCT03001557|562050882|FG007|Extension Phase|Others|0|||
155714663|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
155714664|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
155714665|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Death|1|||
155714666|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Death|2|||
155714667|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
155714668|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
155714669|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
155714670|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
155714671|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
155714672|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
155714673|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
155714674|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
155714675|NCT01794000|562050883|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
155714676|NCT01794000|562050884|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
155714677|NCT01794000|562050883|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
155714678|NCT01794000|562050884|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155714679|NCT00796666|562050885|FG000|Overall Study|Death|2|||
155714680|NCT00796666|562050886|FG001|Overall Study|Death|4|||
155714681|NCT00796666|562050885|FG000|Overall Study|Withdrawal by Subject|2|||
155714682|NCT00796666|562050886|FG001|Overall Study|Withdrawal by Subject|0|||
155714683|NCT00796666|562050885|FG000|Overall Study|Adverse Event|7|||
155714684|NCT00796666|562050886|FG001|Overall Study|Adverse Event|5|||
155714685|NCT00796666|562050885|FG000|Overall Study|Protocol Violation|1|||
155714686|NCT00796666|562050886|FG001|Overall Study|Protocol Violation|0|||
155714687|NCT00796666|562050885|FG000|Overall Study|Other|1|||
155714688|NCT00796666|562050886|FG001|Overall Study|Other|0|||
155714689|NCT00796666|562050885|FG000|Overall Study|Terminated by sponsor|53|||
155714690|NCT00796666|562050886|FG001|Overall Study|Terminated by sponsor|55|||
155714691|NCT00796666|562050885|FG000|Overall Study|Randomized and not treated|1|||
155714692|NCT00796666|562050886|FG001|Overall Study|Randomized and not treated|0|||
155184730|NCT01962922|560114679|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
155184731|NCT01962922|560114680|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
155184732|NCT01962922|560114679|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
155184733|NCT01962922|560114680|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
155184734|NCT00744471|560114681|FG000|Overall Study|Randomized but not treated|1|||
155184735|NCT00744471|560114682|FG001|Overall Study|Randomized but not treated|1|||
155184736|NCT00744471|560114683|FG002|Overall Study|Randomized but not treated|4|||
155184737|NCT00744471|560114684|FG003|Overall Study|Randomized but not treated|0|||
155184738|NCT00744471|560114681|FG000|Overall Study|Death|0|||
155184739|NCT00744471|560114682|FG001|Overall Study|Death|0|||
155714693|NCT01135134|562050888|FG000|Overall Study|Adverse Event|1|||
155714694|NCT01135134|562050889|FG001|Overall Study|Adverse Event|1|||
155714695|NCT01135134|562050888|FG000|Overall Study|Did not meet protocol eligibility|1|||
155714696|NCT01135134|562050889|FG001|Overall Study|Did not meet protocol eligibility|0|||
155714697|NCT02576639|562050890|FG000|Overall Study|Withdrawal by Subject|1|||
155714698|NCT02576639|562050891|FG001|Overall Study|Withdrawal by Subject|2|||
155184740|NCT00744471|560114683|FG002|Overall Study|Death|0|||
155714699|NCT02576639|562050892|FG002|Overall Study|Withdrawal by Subject|1|||
155714700|NCT02576639|562050893|FG003|Overall Study|Withdrawal by Subject|0|||
155714701|NCT02576639|562050894|FG004|Overall Study|Withdrawal by Subject|1|||
155714702|NCT02576639|562050890|FG000|Overall Study|Adverse Event|1|||
155714703|NCT02576639|562050891|FG001|Overall Study|Adverse Event|0|||
155714704|NCT02576639|562050892|FG002|Overall Study|Adverse Event|1|||
155714705|NCT02576639|562050893|FG003|Overall Study|Adverse Event|1|||
155714706|NCT02576639|562050894|FG004|Overall Study|Adverse Event|2|||
155714707|NCT02576639|562050890|FG000|Overall Study|Physician Decision|0|||
155714708|NCT02576639|562050891|FG001|Overall Study|Physician Decision|0|||
155714709|NCT02576639|562050892|FG002|Overall Study|Physician Decision|0|||
155714710|NCT02576639|562050893|FG003|Overall Study|Physician Decision|0|||
155714711|NCT02576639|562050894|FG004|Overall Study|Physician Decision|1|||
155714712|NCT00628030|562050895|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
155714713|NCT00628030|562050896|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
155714714|NCT00628030|562050895|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
155714715|NCT00628030|562050896|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
155714716|NCT00628030|562050895|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
155714717|NCT00628030|562050896|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
155714718|NCT01156480|562050898|FG000|Overall Study|change in diagnosis|0|||
155714719|NCT01156480|562050899|FG001|Overall Study|change in diagnosis|1|||
155714720|NCT01255423|562050900|FG000|Overall Study|Abnormal Laboratory value|3|||
155714721|NCT01255423|562050901|FG001|Overall Study|Abnormal Laboratory value|2|||
155714722|NCT01255423|562050900|FG000|Overall Study|Use of prohibited medications|0|||
155714723|NCT01255423|562050901|FG001|Overall Study|Use of prohibited medications|1|||
155714724|NCT00988598|562050902|FG000|Overall Study|Withdrawal by Subject|2|||
155714725|NCT00988598|562050903|FG001|Overall Study|Withdrawal by Subject|0|||
155714726|NCT01176058|562050904|FG000|Overall Study|Adverse Event|1|||
155714727|NCT01176058|562050905|FG001|Overall Study|Adverse Event|0|||
155714728|NCT01176058|562050904|FG000|Overall Study|Insufficient clinical response|2|||
155714729|NCT01176058|562050905|FG001|Overall Study|Insufficient clinical response|2|||
155714730|NCT01176058|562050904|FG000|Overall Study|Insufficient mycological response|0|||
155714731|NCT01176058|562050905|FG001|Overall Study|Insufficient mycological response|1|||
155714732|NCT01176058|562050904|FG000|Overall Study|Withdrawal by Subject|1|||
155714733|NCT01176058|562050905|FG001|Overall Study|Withdrawal by Subject|0|||
155714734|NCT01858363|562050906|FG000|Overall Study|Death|35|||
155714735|NCT01858363|562050907|FG001|Overall Study|Death|9|||
155714736|NCT01858363|562050906|FG000|Overall Study|Withdrawal by Subject|28|||
155714737|NCT01858363|562050907|FG001|Overall Study|Withdrawal by Subject|14|||
155714738|NCT01858363|562050906|FG000|Overall Study|Lost to Follow-up|13|||
155714739|NCT01858363|562050907|FG001|Overall Study|Lost to Follow-up|3|||
155714740|NCT00764361|562050909|FG000|Overall Study|Withdrawal by Subject|2|||
155714741|NCT00764361|562050910|FG001|Overall Study|Withdrawal by Subject|3|||
155714742|NCT00764361|562050909|FG000|Overall Study|Adverse Event|0|||
155714743|NCT00764361|562050910|FG001|Overall Study|Adverse Event|1|||
155714744|NCT02090426|562050911|FG000|Overall Study|Lost to Follow-up|12|||
155714745|NCT02090426|562050912|FG001|Overall Study|Lost to Follow-up|6|||
155714746|NCT02079038|562050913|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
155714747|NCT02079038|562050914|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
155714748|NCT02079038|562050913|FG000|Modified Intent to Treat Population|Death|1|||
155714749|NCT02079038|562050914|FG001|Modified Intent to Treat Population|Death|0|||
155714750|NCT02079038|562050913|FG000|Completed 6 Months|Lost to Follow-up|2|||
155714751|NCT02079038|562050914|FG001|Completed 6 Months|Lost to Follow-up|1|||
155714752|NCT01141712|562050915|FG000|Overall Study|Disease progression|3|||
155714753|NCT03480152|562050916|FG000|Phase I|Signed consent. Died before treatment.|1|||
155714754|NCT03480152|562050917|FG001|Phase I|Signed consent. Died before treatment.|0|||
155184741|NCT00744471|560114684|FG003|Overall Study|Death|1|||
155184742|NCT00744471|560114681|FG000|Overall Study|Adverse Event|6|||
155184743|NCT00744471|560114682|FG001|Overall Study|Adverse Event|7|||
155184744|NCT00744471|560114683|FG002|Overall Study|Adverse Event|5|||
155184745|NCT00744471|560114684|FG003|Overall Study|Adverse Event|9|||
155184746|NCT00744471|560114681|FG000|Overall Study|Withdrawal by Subject|9|||
155184747|NCT00744471|560114682|FG001|Overall Study|Withdrawal by Subject|9|||
155184748|NCT00744471|560114683|FG002|Overall Study|Withdrawal by Subject|15|||
155184749|NCT00744471|560114684|FG003|Overall Study|Withdrawal by Subject|12|||
155184750|NCT00744471|560114681|FG000|Overall Study|Protocol Violation|1|||
155184751|NCT00744471|560114682|FG001|Overall Study|Protocol Violation|4|||
155184752|NCT00744471|560114683|FG002|Overall Study|Protocol Violation|1|||
155184753|NCT00744471|560114684|FG003|Overall Study|Protocol Violation|2|||
155184754|NCT00744471|560114681|FG000|Overall Study|Entered extension study|41|||
155714755|NCT03480152|562050918|FG002|Phase I|Signed consent. Died before treatment.|0|||
155714756|NCT03634085|562050919|FG000|Overall Study|Adverse Event|1|||
155714757|NCT03634085|562050920|FG001|Overall Study|Adverse Event|0|||
155714758|NCT03634085|562050919|FG000|Overall Study|Withdrawal by Subject|0|||
155714759|NCT03634085|562050920|FG001|Overall Study|Withdrawal by Subject|2|||
155714760|NCT04276233|562050921|FG000|Overall Study|Adverse Event|1|||
155714761|NCT04276233|562050921|FG000|Overall Study|Lost to Follow-up|3|||
155714762|NCT04276233|562050921|FG000|Overall Study|Physician Decision|4|||
155184755|NCT00744471|560114682|FG001|Overall Study|Entered extension study|84|||
155184756|NCT00744471|560114683|FG002|Overall Study|Entered extension study|100|||
155714763|NCT04276233|562050921|FG000|Overall Study|Withdrawal by Subject|2|||
155714764|NCT01946139|562050924|FG000|Overall Study|Withdrawal by Subject|8|||
155714765|NCT01946139|562050924|FG000|Overall Study|ineligible|8|||
155714766|NCT01946139|562050924|FG000|Overall Study|Specimens not available|4|||
155714767|NCT00296816|562050925|FG000|Overall Study|Disease Progression|37|||
155714768|NCT00296816|562050925|FG000|Overall Study|Adverse Event|18|||
155714769|NCT00296816|562050925|FG000|Overall Study|Investigator/Participant request|5|||
155714770|NCT00296816|562050925|FG000|Overall Study|Non-compliance|1|||
155714771|NCT00296816|562050925|FG000|Overall Study|Missing for end of treatment|4|||
155714772|NCT00296816|562050925|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
155714773|NCT00296816|562050925|FG000|Overall Study|Poor performance status|1|||
155714774|NCT00296816|562050925|FG000|Overall Study|Relocation to Florida|1|||
155714775|NCT00296816|562050925|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
155714776|NCT00296816|562050925|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
155714777|NCT00296816|562050925|FG000|Overall Study|Neuropathy/patient preference|1|||
155714778|NCT00296816|562050925|FG000|Overall Study|Proteinuria|1|||
155714779|NCT00296816|562050925|FG000|Overall Study|ineligibility due to radiation treatment|1|||
155714780|NCT01012258|562050926|FG000|Overall Study|Death|14|||
155714781|NCT01012258|562050926|FG000|Overall Study|Lost to Follow-up|1|||
155714782|NCT01012258|562050926|FG000|Overall Study|Adverse Event|1|||
155184757|NCT00744471|560114684|FG003|Overall Study|Entered extension study|91|||
155184758|NCT00744471|560114681|FG000|Overall Study|Other|2|||
155184759|NCT00744471|560114682|FG001|Overall Study|Other|3|||
155184760|NCT00744471|560114683|FG002|Overall Study|Other|6|||
155184761|NCT00744471|560114684|FG003|Overall Study|Other|2|||
155184762|NCT00744471|560114681|FG000|Overall Study|Lack of Efficacy|83|||
155184763|NCT00744471|560114682|FG001|Overall Study|Lack of Efficacy|37|||
155184764|NCT00744471|560114683|FG002|Overall Study|Lack of Efficacy|19|||
155184765|NCT00744471|560114684|FG003|Overall Study|Lack of Efficacy|31|||
155184766|NCT00744471|560114681|FG000|Overall Study|Lost to Follow-up|0|||
155184767|NCT00744471|560114682|FG001|Overall Study|Lost to Follow-up|0|||
155184768|NCT00744471|560114683|FG002|Overall Study|Lost to Follow-up|2|||
155184769|NCT00744471|560114684|FG003|Overall Study|Lost to Follow-up|0|||
155184770|NCT03224546|560114685|FG000|Overall Study|Lost to Follow-up|9|||
155184771|NCT03224546|560114686|FG001|Overall Study|Lost to Follow-up|8|||
155184772|NCT03224546|560114687|FG002|Overall Study|Lost to Follow-up|3|||
155184773|NCT03224546|560114685|FG000|Overall Study|Withdrawal by Subject|7|||
155184774|NCT03224546|560114686|FG001|Overall Study|Withdrawal by Subject|14|||
155184775|NCT03224546|560114687|FG002|Overall Study|Withdrawal by Subject|12|||
155184776|NCT04706416|560114688|FG000|Overall Study|Lost to Follow-up|2|||
155184777|NCT04706416|560114689|FG001|Overall Study|Lost to Follow-up|0|||
155184778|NCT01280955|560114691|FG000|Overall Study|Death|2|||
155184779|NCT01280955|560114691|FG000|Overall Study|Withdrawal by Subject|1|||
155184780|NCT00596362|560114692|FG000|Overall Study|Progressive Disease|1|||
155184781|NCT00817479|560114693|FG000|Overall Study|Physician Decision|1|||
155184782|NCT00817479|560114694|FG001|Overall Study|Physician Decision|1|||
155184783|NCT02793128|560114695|FG000|Overall Study|Death|4|||
155184784|NCT02793128|560114695|FG000|Overall Study|Withdrawal by Subject|2|||
155184785|NCT02793128|560114695|FG000|Overall Study|Physician Decision|1|||
155184786|NCT02793128|560114695|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
155184787|NCT02793128|560114695|FG000|Overall Study|Patient elected nephroureterectomy|1|||
155184788|NCT02359851|560114696|FG000|Overall Study|Death|1|||
155184789|NCT02359851|560114696|FG000|Overall Study|Disease progression|1|||
155184790|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
155184791|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
155184792|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
155184793|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
155184794|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
155184795|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
155184796|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
155184797|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
155184798|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
155184799|NCT01854944|560114700|FG000|Overall Study|Withdrawal by Subject|0|||
155184800|NCT01854944|560114701|FG001|Overall Study|Withdrawal by Subject|0|||
155184801|NCT01854944|560114702|FG002|Overall Study|Withdrawal by Subject|1|||
155184802|NCT00282347|560114705|FG000|Treatment Period|Death|2|||
155184803|NCT00282347|560114706|FG001|Treatment Period|Death|0|||
155184804|NCT00282347|560114705|FG000|Treatment Period|Lost to Follow-up|2|||
155184805|NCT00282347|560114706|FG001|Treatment Period|Lost to Follow-up|5|||
155184806|NCT00282347|560114705|FG000|Treatment Period|Withdrawal by Subject|1|||
155184807|NCT00282347|560114706|FG001|Treatment Period|Withdrawal by Subject|3|||
155184808|NCT00282347|560114705|FG000|Treatment Period|Physician Decision|0|||
155184809|NCT00282347|560114706|FG001|Treatment Period|Physician Decision|1|||
155184810|NCT00282347|560114705|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
155184811|NCT00282347|560114706|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
155184812|NCT00282347|560114705|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
155184813|NCT00282347|560114706|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
155184814|NCT00282347|560114705|FG000|Safety Follow-up Period|Physician Decision|1|||
155184815|NCT00282347|560114706|FG001|Safety Follow-up Period|Physician Decision|1|||
155184816|NCT00282347|560114705|FG000|Safety Follow-up Period|Protocol Deviation|0|||
155184817|NCT00282347|560114706|FG001|Safety Follow-up Period|Protocol Deviation|2|||
155184818|NCT00282347|560114705|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
155184819|NCT00282347|560114706|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
155184820|NCT00282347|560114705|FG000|B Cell Follow-up Period|Physician Decision|1|||
155184821|NCT00282347|560114706|FG001|B Cell Follow-up Period|Physician Decision|0|||
155184822|NCT00282347|560114705|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
155184823|NCT00282347|560114706|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
155184824|NCT02782923|560114707|FG000|Overall Study|Lost to Follow-up|15|||
155184825|NCT01659658|560116211|FG000|Overall Study|Withdrawal by Patient|18|||
155184826|NCT01659658|560116212|FG001|Overall Study|Withdrawal by Patient|4|||
155184827|NCT01659658|560116213|FG002|Overall Study|Withdrawal by Patient|2|||
155184828|NCT01659658|560116214|FG003|Overall Study|Withdrawal by Patient|0|||
155184829|NCT01659658|560116215|FG004|Overall Study|Withdrawal by Patient|11|||
155184830|NCT01659658|560116211|FG000|Overall Study|Study Terminated by Sponsor|9|||
155184831|NCT01659658|560116212|FG001|Overall Study|Study Terminated by Sponsor|7|||
155714783|NCT01012258|562050926|FG000|Overall Study|Progressive Disease (PD)|18|||
155714784|NCT01012258|562050926|FG000|Overall Study|Symptomatic Deterioration|1|||
155714785|NCT01012258|562050926|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
155714786|NCT01012258|562050926|FG000|Overall Study|Another Tumor Discovered|1|||
155714787|NCT01012258|562050926|FG000|Overall Study|Ongoing|29|||
155714788|NCT01814527|562050929|FG000|Overall Study|RTP greater than 30 days|6|||
155714789|NCT01814527|562050930|FG001|Overall Study|RTP greater than 30 days|1|||
155714790|NCT00687401|562050931|FG000|Overall Study|Protocol Violation|7|||
155714791|NCT00687401|562050931|FG000|Overall Study|Adverse Event|6|||
155714792|NCT00687401|562050931|FG000|Overall Study|Lack of Efficacy|6|||
155714793|NCT00687401|562050931|FG000|Overall Study|Withdrawal by Subject|4|||
155714794|NCT00687401|562050931|FG000|Overall Study|Did not return for visit|3|||
155714795|NCT00687401|562050931|FG000|Overall Study|For reasons different from those above|4|||
155714796|NCT02366195|562050932|FG000|Overall Study|Protocol-specified criteria|3|||
155714797|NCT02366195|562050932|FG000|Overall Study|Withdrawal by Subject|9|||
155714798|NCT02366195|562050932|FG000|Overall Study|Lost to Follow-up|1|||
155714799|NCT02366195|562050932|FG000|Overall Study|Death|41|||
155714800|NCT02520726|562050933|FG000|Overall Study|Lost to Follow-up|3|||
155714801|NCT02520726|562050934|FG001|Overall Study|Lost to Follow-up|2|||
155714802|NCT00721396|562050937|FG000|Overall Study|Adverse Event|4|||
155714803|NCT00721396|562050938|FG001|Overall Study|Adverse Event|7|||
155714804|NCT00721396|562050939|FG002|Overall Study|Adverse Event|2|||
155714805|NCT00721396|562050940|FG003|Overall Study|Adverse Event|0|||
155714806|NCT00721396|562050937|FG000|Overall Study|Withdrawal by Subject|12|||
155714807|NCT00721396|562050938|FG001|Overall Study|Withdrawal by Subject|15|||
155714808|NCT00721396|562050939|FG002|Overall Study|Withdrawal by Subject|3|||
155714809|NCT00721396|562050940|FG003|Overall Study|Withdrawal by Subject|7|||
155714810|NCT00721396|562050937|FG000|Overall Study|Lost to Follow-up|7|||
155714811|NCT00721396|562050938|FG001|Overall Study|Lost to Follow-up|9|||
155714812|NCT00721396|562050939|FG002|Overall Study|Lost to Follow-up|3|||
155714813|NCT00721396|562050940|FG003|Overall Study|Lost to Follow-up|3|||
155714814|NCT00721396|562050937|FG000|Overall Study|Protocol Violation|4|||
155714815|NCT00721396|562050938|FG001|Overall Study|Protocol Violation|3|||
155714816|NCT00721396|562050939|FG002|Overall Study|Protocol Violation|1|||
155714817|NCT00721396|562050940|FG003|Overall Study|Protocol Violation|0|||
155714818|NCT00721396|562050937|FG000|Overall Study|Inappropriate enrollment|0|||
155714819|NCT00721396|562050938|FG001|Overall Study|Inappropriate enrollment|2|||
155714820|NCT00721396|562050939|FG002|Overall Study|Inappropriate enrollment|0|||
155714821|NCT00721396|562050940|FG003|Overall Study|Inappropriate enrollment|0|||
155714822|NCT00721396|562050937|FG000|Overall Study|Administrative reason|3|||
155714823|NCT00721396|562050938|FG001|Overall Study|Administrative reason|0|||
155714824|NCT00721396|562050939|FG002|Overall Study|Administrative reason|1|||
155714825|NCT00721396|562050940|FG003|Overall Study|Administrative reason|0|||
155714826|NCT00148759|562050941|FG000|Overall Study|Withdrawal by Subject|1|||
155714827|NCT00148759|562050942|FG001|Overall Study|Withdrawal by Subject|1|||
155714828|NCT00148759|562050941|FG000|Overall Study|Lost to Follow-up|1|||
155714829|NCT00148759|562050942|FG001|Overall Study|Lost to Follow-up|0|||
155714830|NCT00430716|562050946|FG000|Double Blind Phase|Death|1|||
155714831|NCT00430716|562050947|FG001|Double Blind Phase|Death|0|||
155714832|NCT00430716|562050948|FG002|Double Blind Phase|Death|0|||
155714833|NCT00430716|562050946|FG000|Double Blind Phase|No longer willing to participate|2|||
155714834|NCT00430716|562050947|FG001|Double Blind Phase|No longer willing to participate|1|||
155714835|NCT00430716|562050948|FG002|Double Blind Phase|No longer willing to participate|1|||
155714836|NCT00430716|562050946|FG000|Double Blind Phase|Other|0|||
155714837|NCT00430716|562050947|FG001|Double Blind Phase|Other|2|||
155714838|NCT00430716|562050948|FG002|Double Blind Phase|Other|0|||
155714839|NCT00430716|562050946|FG000|Double Blind Phase|Study terminated by sponsor|1|||
155714840|NCT00430716|562050947|FG001|Double Blind Phase|Study terminated by sponsor|1|||
155714841|NCT00430716|562050948|FG002|Double Blind Phase|Study terminated by sponsor|2|||
155714842|NCT00430716|562050946|FG000|Double Blind Phase|Adverse Event|1|||
155714843|NCT00430716|562050947|FG001|Double Blind Phase|Adverse Event|1|||
155714844|NCT00430716|562050948|FG002|Double Blind Phase|Adverse Event|3|||
155714845|NCT00430716|562050946|FG000|Double Blind Phase|Not treated|1|||
155714846|NCT00430716|562050947|FG001|Double Blind Phase|Not treated|0|||
155714847|NCT00430716|562050948|FG002|Double Blind Phase|Not treated|0|||
155714848|NCT00430716|562050946|FG000|Open Label Phase|Lost to Follow-up|1|||
155714849|NCT00430716|562050947|FG001|Open Label Phase|Lost to Follow-up|0|||
155714850|NCT00430716|562050948|FG002|Open Label Phase|Lost to Follow-up|1|||
155714851|NCT00430716|562050946|FG000|Open Label Phase|No longer willing to participate|0|||
155714852|NCT00430716|562050947|FG001|Open Label Phase|No longer willing to participate|1|||
155714853|NCT00430716|562050948|FG002|Open Label Phase|No longer willing to participate|1|||
155714854|NCT00430716|562050946|FG000|Open Label Phase|Other|3|||
155714855|NCT00430716|562050947|FG001|Open Label Phase|Other|1|||
155714856|NCT00430716|562050948|FG002|Open Label Phase|Other|1|||
155714857|NCT00430716|562050946|FG000|Open Label Phase|Protocol Violation|1|||
155714858|NCT00430716|562050947|FG001|Open Label Phase|Protocol Violation|0|||
155714859|NCT00430716|562050948|FG002|Open Label Phase|Protocol Violation|0|||
155714860|NCT00430716|562050946|FG000|Open Label Phase|Study terminated by sponsor|4|||
155714861|NCT00430716|562050947|FG001|Open Label Phase|Study terminated by sponsor|5|||
155714862|NCT00430716|562050948|FG002|Open Label Phase|Study terminated by sponsor|4|||
155714863|NCT01329978|562050954|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
155714864|NCT01329978|562050955|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
155714865|NCT01329978|562050956|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155714866|NCT01329978|562050957|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155714867|NCT01329978|562050958|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155714868|NCT01329978|562050954|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
155714869|NCT01329978|562050955|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
155714870|NCT01329978|562050956|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
155714871|NCT01329978|562050957|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
155714872|NCT01329978|562050958|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
155714873|NCT01329978|562050954|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
155714874|NCT01329978|562050955|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
155714875|NCT01329978|562050956|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
155714876|NCT01329978|562050957|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
155714877|NCT01329978|562050958|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
155714878|NCT01329978|562050954|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155714879|NCT01329978|562050955|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
155714880|NCT01329978|562050956|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155714881|NCT01329978|562050957|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155184832|NCT01659658|560116213|FG002|Overall Study|Study Terminated by Sponsor|0|||
155184833|NCT01659658|560116214|FG003|Overall Study|Study Terminated by Sponsor|1|||
155184834|NCT01659658|560116215|FG004|Overall Study|Study Terminated by Sponsor|4|||
155184835|NCT01659658|560116211|FG000|Overall Study|Reason not Specified|61|||
155184836|NCT01659658|560116212|FG001|Overall Study|Reason not Specified|15|||
155184837|NCT01659658|560116213|FG002|Overall Study|Reason not Specified|8|||
155184838|NCT01659658|560116214|FG003|Overall Study|Reason not Specified|1|||
155184839|NCT01659658|560116215|FG004|Overall Study|Reason not Specified|34|||
155184840|NCT01659658|560116211|FG000|Overall Study|Lost to Follow-up|2|||
155184841|NCT01659658|560116212|FG001|Overall Study|Lost to Follow-up|0|||
155184842|NCT01659658|560116213|FG002|Overall Study|Lost to Follow-up|0|||
155184843|NCT01659658|560116214|FG003|Overall Study|Lost to Follow-up|0|||
155184844|NCT01659658|560116215|FG004|Overall Study|Lost to Follow-up|0|||
155184845|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Disease progression|3|||
155184846|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Disease progression|5|||
155184847|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Disease progression|1|||
155184848|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Disease progression|3|||
155184849|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Disease progression|0|||
155184850|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Disease progression|0|||
155184851|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
155184852|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
155184853|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
155184854|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
155184855|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
155184856|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
155184857|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Other|0|||
155184858|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Other|1|||
155184859|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Other|0|||
155184860|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Other|0|||
155184861|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Other|0|||
155184862|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Other|0|||
155184863|NCT01897714|560116216|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
155184864|NCT01897714|560116217|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
155184865|NCT01897714|560116218|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
155184866|NCT01897714|560116219|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
155184867|NCT01897714|560116220|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
155184868|NCT01897714|560116221|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
155184869|NCT01897714|560116216|FG000|Phase II (MTD)|Lost to Follow-up|0|||
155184870|NCT01897714|560116217|FG001|Phase II (MTD)|Lost to Follow-up|0|||
155184871|NCT01897714|560116218|FG002|Phase II (MTD)|Lost to Follow-up|0|||
155184872|NCT01897714|560116219|FG003|Phase II (MTD)|Lost to Follow-up|0|||
155184873|NCT01897714|560116220|FG004|Phase II (MTD)|Lost to Follow-up|1|||
155714882|NCT01329978|562050958|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155184874|NCT01897714|560116221|FG005|Phase II (MTD)|Lost to Follow-up|0|||
155184875|NCT01897714|560116216|FG000|Phase II (MTD)|Death|0|||
155714883|NCT01329978|562050954|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155184876|NCT01897714|560116217|FG001|Phase II (MTD)|Death|0|||
155184877|NCT01897714|560116218|FG002|Phase II (MTD)|Death|0|||
155184878|NCT01897714|560116219|FG003|Phase II (MTD)|Death|0|||
155184879|NCT01897714|560116220|FG004|Phase II (MTD)|Death|25|||
155714884|NCT01329978|562050955|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
155714885|NCT01329978|562050956|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155714886|NCT01329978|562050957|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155714887|NCT01329978|562050958|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155714888|NCT01329978|562050954|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
155714889|NCT01329978|562050955|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
155714890|NCT01329978|562050956|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
155714891|NCT01329978|562050957|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
155714892|NCT01329978|562050958|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
155714893|NCT01329978|562050954|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155714894|NCT01329978|562050955|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155714895|NCT01329978|562050956|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155714896|NCT01329978|562050957|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155714897|NCT01329978|562050958|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
155714898|NCT01188772|562050962|FG000|Overall Study|Randomized but Not Treated|0|||
155714899|NCT01188772|562050963|FG001|Overall Study|Randomized but Not Treated|1|||
155714900|NCT01188772|562050964|FG002|Overall Study|Randomized but Not Treated|0|||
155714901|NCT01188772|562050965|FG003|Overall Study|Randomized but Not Treated|0|||
155714902|NCT01188772|562050962|FG000|Overall Study|Adverse Event|0|||
155714903|NCT01188772|562050963|FG001|Overall Study|Adverse Event|1|||
155714904|NCT01188772|562050964|FG002|Overall Study|Adverse Event|2|||
155714905|NCT01188772|562050965|FG003|Overall Study|Adverse Event|0|||
155714906|NCT01188772|562050962|FG000|Overall Study|Lost to Follow-up|4|||
155714907|NCT01188772|562050963|FG001|Overall Study|Lost to Follow-up|1|||
155714908|NCT01188772|562050964|FG002|Overall Study|Lost to Follow-up|1|||
155184880|NCT01897714|560116221|FG005|Phase II (MTD)|Death|10|||
155184881|NCT01897714|560116216|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
155184882|NCT01897714|560116217|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
155184883|NCT01897714|560116218|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
155184884|NCT01897714|560116219|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
155184885|NCT01897714|560116220|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
155184886|NCT01897714|560116221|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
155184887|NCT01897714|560116216|FG000|Phase II (MTD)|Other|0|||
155184888|NCT01897714|560116217|FG001|Phase II (MTD)|Other|0|||
155184889|NCT01897714|560116218|FG002|Phase II (MTD)|Other|0|||
155184890|NCT01897714|560116219|FG003|Phase II (MTD)|Other|0|||
155714909|NCT01188772|562050965|FG003|Overall Study|Lost to Follow-up|1|||
155714910|NCT01188772|562050962|FG000|Overall Study|Non-responder|0|||
155714911|NCT01188772|562050963|FG001|Overall Study|Non-responder|0|||
155714912|NCT01188772|562050964|FG002|Overall Study|Non-responder|3|||
155714913|NCT01188772|562050965|FG003|Overall Study|Non-responder|0|||
155714914|NCT01188772|562050962|FG000|Overall Study|Physician Decision|0|||
155714915|NCT01188772|562050963|FG001|Overall Study|Physician Decision|0|||
155714916|NCT01188772|562050964|FG002|Overall Study|Physician Decision|1|||
155714917|NCT01188772|562050965|FG003|Overall Study|Physician Decision|0|||
155714918|NCT01188772|562050962|FG000|Overall Study|Terminated by Sponsor|0|||
155714919|NCT01188772|562050963|FG001|Overall Study|Terminated by Sponsor|0|||
155714920|NCT01188772|562050964|FG002|Overall Study|Terminated by Sponsor|1|||
155714921|NCT01188772|562050965|FG003|Overall Study|Terminated by Sponsor|0|||
155714922|NCT01188772|562050962|FG000|Overall Study|Treatment Failure|0|||
155714923|NCT01188772|562050963|FG001|Overall Study|Treatment Failure|0|||
155714924|NCT01188772|562050964|FG002|Overall Study|Treatment Failure|1|||
155714925|NCT01188772|562050965|FG003|Overall Study|Treatment Failure|0|||
155714926|NCT01188772|562050962|FG000|Overall Study|Virologic Failure|1|||
155714927|NCT01188772|562050963|FG001|Overall Study|Virologic Failure|0|||
155714928|NCT01188772|562050964|FG002|Overall Study|Virologic Failure|0|||
155714929|NCT01188772|562050965|FG003|Overall Study|Virologic Failure|0|||
155714930|NCT01188772|562050962|FG000|Overall Study|Withdrawal by Subject|0|||
155184891|NCT01897714|560116220|FG004|Phase II (MTD)|Other|3|||
155184892|NCT01897714|560116221|FG005|Phase II (MTD)|Other|0|||
155184893|NCT03875118|560116226|FG000|Overall Study|Withdrawal by Subject|4|||
155184894|NCT03875118|560116227|FG001|Overall Study|Withdrawal by Subject|4|||
155184895|NCT02237911|560116228|FG000|Overall Study|Withdrawal by Subject|4|||
155184896|NCT02237911|560116229|FG001|Overall Study|Withdrawal by Subject|7|||
155184897|NCT02237911|560116230|FG002|Overall Study|Withdrawal by Subject|2|||
155184898|NCT02237911|560116228|FG000|Overall Study|Lost to Follow-up|3|||
155184899|NCT02237911|560116229|FG001|Overall Study|Lost to Follow-up|1|||
155184900|NCT02237911|560116230|FG002|Overall Study|Lost to Follow-up|1|||
155184901|NCT00721123|560116231|FG000|Overall Study|Adverse Event|96|||
155184902|NCT00721123|560116231|FG000|Overall Study|Death|10|||
155184903|NCT00721123|560116231|FG000|Overall Study|Insufficient Therapeutic Response|21|||
155184904|NCT00721123|560116231|FG000|Overall Study|Protocol Violation|1|||
155184905|NCT00721123|560116231|FG000|Overall Study|Refused Treatment|41|||
155184906|NCT00721123|560116231|FG000|Overall Study|Failure to Return|9|||
155184907|NCT00721123|560116231|FG000|Overall Study|Withdrawal by Subject|5|||
155714931|NCT01188772|562050963|FG001|Overall Study|Withdrawal by Subject|0|||
155714932|NCT01188772|562050964|FG002|Overall Study|Withdrawal by Subject|2|||
155714933|NCT01188772|562050965|FG003|Overall Study|Withdrawal by Subject|0|||
155714934|NCT03081884|562050969|FG000|Overall Study|deferred prostate cancer treatment|1|||
155714935|NCT03081884|562050969|FG000|Overall Study|metastasis managed with systemic therapy|3|||
155714936|NCT02294058|562050970|FG000|Overall Study|Adverse Event|16|||
155714937|NCT02294058|562050971|FG001|Overall Study|Adverse Event|7|||
155184908|NCT02428608|560116234|FG000|Overall Study|Pregnancy|2|||
155184909|NCT02428608|560116234|FG000|Overall Study|Lost to Follow-up|37|||
155184910|NCT02428608|560116234|FG000|Overall Study|Withdrawal by Subject|2|||
155184911|NCT02428608|560116234|FG000|Overall Study|scheduling conflicts|15|||
155184912|NCT02428608|560116234|FG000|Overall Study|moved away|10|||
155184913|NCT02428608|560116234|FG000|Overall Study|Death|1|||
155184914|NCT02428608|560116234|FG000|Overall Study|various|16|||
155184915|NCT01143207|560116237|FG000|Overall Study|Lost to Follow-up|2|||
155184916|NCT01466595|560116238|FG000|Overall Study|Withdrawal by Subject|0|||
155184917|NCT01466595|560116239|FG001|Overall Study|Withdrawal by Subject|1|||
155184918|NCT02376829|560116240|FG000|Overall Study|Withdrawal by Subject|27|||
155184919|NCT02376829|560116241|FG001|Overall Study|Withdrawal by Subject|44|||
155714938|NCT02294058|562050972|FG002|Overall Study|Adverse Event|13|||
155714939|NCT02294058|562050970|FG000|Overall Study|Lack of Efficacy|3|||
155714940|NCT02294058|562050971|FG001|Overall Study|Lack of Efficacy|3|||
155714941|NCT02294058|562050972|FG002|Overall Study|Lack of Efficacy|0|||
155714942|NCT02294058|562050970|FG000|Overall Study|Lost to Follow-up|1|||
155714943|NCT02294058|562050971|FG001|Overall Study|Lost to Follow-up|0|||
155184920|NCT00057954|560116242|FG000|Overall Study|Death|1|||
155714944|NCT02294058|562050972|FG002|Overall Study|Lost to Follow-up|2|||
155714945|NCT02294058|562050970|FG000|Overall Study|Withdrawal by Subject|10|||
155714946|NCT02294058|562050971|FG001|Overall Study|Withdrawal by Subject|14|||
155714947|NCT02294058|562050972|FG002|Overall Study|Withdrawal by Subject|13|||
155714948|NCT02294058|562050970|FG000|Overall Study|Physician Decision|2|||
155714949|NCT02294058|562050971|FG001|Overall Study|Physician Decision|1|||
155714950|NCT02294058|562050972|FG002|Overall Study|Physician Decision|0|||
155714951|NCT02294058|562050970|FG000|Overall Study|Miscellaneous|4|||
155714952|NCT02294058|562050971|FG001|Overall Study|Miscellaneous|1|||
155714953|NCT02294058|562050972|FG002|Overall Study|Miscellaneous|1|||
155714954|NCT00154297|562050980|FG000|Overall Study|Death|5|||
155714955|NCT00154297|562050981|FG001|Overall Study|Death|2|||
155714956|NCT00154297|562050980|FG000|Overall Study|Withdrawal by Subject|0|||
155714957|NCT00154297|562050981|FG001|Overall Study|Withdrawal by Subject|5|||
155714958|NCT00154297|562050980|FG000|Overall Study|Lost to Follow-up|3|||
155714959|NCT00154297|562050981|FG001|Overall Study|Lost to Follow-up|0|||
155714960|NCT00650767|562050982|FG000|Overall Study|Adverse Event|0|||
155714961|NCT00650767|562050983|FG001|Overall Study|Adverse Event|3|||
155714962|NCT00650767|562050984|FG002|Overall Study|Adverse Event|10|||
155714963|NCT00650767|562050985|FG003|Overall Study|Adverse Event|8|||
155714964|NCT00650767|562050982|FG000|Overall Study|Death|1|||
155714965|NCT00650767|562050983|FG001|Overall Study|Death|0|||
155714966|NCT00650767|562050984|FG002|Overall Study|Death|0|||
155714967|NCT00650767|562050985|FG003|Overall Study|Death|0|||
155714968|NCT00650767|562050982|FG000|Overall Study|Withdrawal by Subject|2|||
155714969|NCT00650767|562050983|FG001|Overall Study|Withdrawal by Subject|4|||
155714970|NCT00650767|562050984|FG002|Overall Study|Withdrawal by Subject|3|||
155714971|NCT00650767|562050985|FG003|Overall Study|Withdrawal by Subject|3|||
155714972|NCT00650767|562050982|FG000|Overall Study|Lost to Follow-up|1|||
155714973|NCT00650767|562050983|FG001|Overall Study|Lost to Follow-up|1|||
155714974|NCT00650767|562050984|FG002|Overall Study|Lost to Follow-up|1|||
155714975|NCT00650767|562050985|FG003|Overall Study|Lost to Follow-up|0|||
155714976|NCT00650767|562050982|FG000|Overall Study|Other|1|||
155714977|NCT00650767|562050983|FG001|Overall Study|Other|1|||
155714978|NCT00650767|562050984|FG002|Overall Study|Other|0|||
155714979|NCT00650767|562050985|FG003|Overall Study|Other|0|||
155714980|NCT01125800|562050986|FG000|Phase I|Protocol Violation|0|||
155714981|NCT01125800|562050987|FG001|Phase I|Protocol Violation|3|||
155714982|NCT01125800|562050988|FG002|Phase I|Protocol Violation|1|||
155714983|NCT01125800|562050989|FG003|Phase I|Protocol Violation|1|||
155714984|NCT01125800|562050990|FG004|Phase I|Protocol Violation|0|||
155714985|NCT01125800|562050986|FG000|Phase I|Adverse Event|2|||
155714986|NCT01125800|562050987|FG001|Phase I|Adverse Event|2|||
155714987|NCT01125800|562050988|FG002|Phase I|Adverse Event|1|||
155714988|NCT01125800|562050989|FG003|Phase I|Adverse Event|7|||
155714989|NCT01125800|562050990|FG004|Phase I|Adverse Event|0|||
155714990|NCT01125800|562050986|FG000|Phase I|Administrative problems|1|||
155714991|NCT01125800|562050987|FG001|Phase I|Administrative problems|0|||
155714992|NCT01125800|562050988|FG002|Phase I|Administrative problems|0|||
155714993|NCT01125800|562050989|FG003|Phase I|Administrative problems|0|||
155714994|NCT01125800|562050990|FG004|Phase I|Administrative problems|0|||
155714995|NCT01125800|562050986|FG000|Phase I|Withdrawal by Subject|0|||
155714996|NCT01125800|562050987|FG001|Phase I|Withdrawal by Subject|0|||
155714997|NCT01125800|562050988|FG002|Phase I|Withdrawal by Subject|1|||
155714998|NCT01125800|562050989|FG003|Phase I|Withdrawal by Subject|0|||
155714999|NCT01125800|562050990|FG004|Phase I|Withdrawal by Subject|0|||
155715000|NCT01125800|562050986|FG000|Phase I|Disease progression|5|||
155715001|NCT01125800|562050987|FG001|Phase I|Disease progression|4|||
155715002|NCT01125800|562050988|FG002|Phase I|Disease progression|1|||
155715003|NCT01125800|562050989|FG003|Phase I|Disease progression|3|||
155715004|NCT01125800|562050990|FG004|Phase I|Disease progression|0|||
155715005|NCT01125800|562050986|FG000|Phase II|Protocol Violation|0|||
155715006|NCT01125800|562050987|FG001|Phase II|Protocol Violation|0|||
155715007|NCT01125800|562050988|FG002|Phase II|Protocol Violation|0|||
155715008|NCT01125800|562050989|FG003|Phase II|Protocol Violation|0|||
155715009|NCT01125800|562050990|FG004|Phase II|Protocol Violation|1|||
155715010|NCT01125800|562050986|FG000|Phase II|Adverse Event|0|||
155715011|NCT01125800|562050987|FG001|Phase II|Adverse Event|0|||
155715012|NCT01125800|562050988|FG002|Phase II|Adverse Event|0|||
155715013|NCT01125800|562050989|FG003|Phase II|Adverse Event|0|||
155715014|NCT01125800|562050990|FG004|Phase II|Adverse Event|2|||
155715015|NCT01125800|562050986|FG000|Phase II|Disease progression|0|||
155715016|NCT01125800|562050987|FG001|Phase II|Disease progression|0|||
155715017|NCT01125800|562050988|FG002|Phase II|Disease progression|0|||
155715018|NCT01125800|562050989|FG003|Phase II|Disease progression|1|||
155715019|NCT01125800|562050990|FG004|Phase II|Disease progression|8|||
155715020|NCT00801216|562050991|FG000|Overall Study|Screening Failure|2|||
155715021|NCT05481359|562050992|FG000|Overall Study|Lost to Follow-up|3|||
155715022|NCT05481359|562050992|FG000|Overall Study|Withdrawal by Subject|1|||
155715023|NCT00348673|562050995|FG000|Stage 1|Randomized but not Treated|0|||
155715024|NCT00348673|562050996|FG001|Stage 1|Randomized but not Treated|0|||
155715025|NCT00348673|562050997|FG002|Stage 1|Randomized but not Treated|1|||
155715026|NCT00348673|562050998|FG003|Stage 1|Randomized but not Treated|0|||
155715027|NCT00348673|562050999|FG004|Stage 1|Randomized but not Treated|0|||
155715028|NCT00348673|562051000|FG005|Stage 1|Randomized but not Treated|0|||
155715029|NCT00348673|562051001|FG006|Stage 1|Randomized but not Treated|0|||
155715030|NCT00348673|562051002|FG007|Stage 1|Randomized but not Treated|0|||
155715031|NCT00348673|562051003|FG008|Stage 1|Randomized but not Treated|0|||
155715032|NCT01505374|562051005|FG000|Overall Study|Lost to Follow-up|1|||
155715033|NCT01505374|562051006|FG001|Overall Study|Lost to Follow-up|0|||
155715034|NCT00320515|562051008|FG000|Overall Study|Death|33|||
155715035|NCT00320515|562051008|FG000|Overall Study|Lost to Follow-up|6|||
155715036|NCT00320515|562051008|FG000|Overall Study|Physician Decision|2|||
155715037|NCT00320515|562051008|FG000|Overall Study|Withdrawal by Subject|8|||
155715038|NCT01114828|562051009|FG000|Overall Study|Adverse Event|1|||
155715039|NCT01114828|562051010|FG001|Overall Study|Adverse Event|1|||
155715040|NCT01114828|562051009|FG000|Overall Study|Lack of Efficacy|0|||
155715041|NCT01114828|562051010|FG001|Overall Study|Lack of Efficacy|2|||
155715042|NCT01114828|562051009|FG000|Overall Study|Protocol Violation|2|||
155715043|NCT01114828|562051010|FG001|Overall Study|Protocol Violation|0|||
155715044|NCT01114828|562051009|FG000|Overall Study|Withdrawal by Subject|0|||
155715045|NCT01114828|562051010|FG001|Overall Study|Withdrawal by Subject|1|||
155715046|NCT00851786|562051013|FG000|Overall Study|Withdrawal by Subject|0|||
155715047|NCT00851786|562051014|FG001|Overall Study|Withdrawal by Subject|1|||
155715048|NCT00851786|562051013|FG000|Overall Study|Protocol Violation|0|||
155715049|NCT00851786|562051014|FG001|Overall Study|Protocol Violation|1|||
155715050|NCT00851786|562051013|FG000|Overall Study|Lost to Follow-up|1|||
155715051|NCT00851786|562051014|FG001|Overall Study|Lost to Follow-up|0|||
155715052|NCT00851786|562051013|FG000|Overall Study|Incarceration|1|||
155715053|NCT00851786|562051014|FG001|Overall Study|Incarceration|0|||
155715054|NCT00851786|562051013|FG000|Overall Study|Site Closure|1|||
155715055|NCT00851786|562051014|FG001|Overall Study|Site Closure|0|||
155715056|NCT00851786|562051013|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
155715057|NCT00851786|562051014|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
155184921|NCT00057954|560116242|FG000|Overall Study|Disease progression|1|||
155184922|NCT00559754|560116243|FG000|Overall Study|Disease progression|1|||
155184923|NCT00559754|560116243|FG000|Overall Study|Adverse Event|5|||
155715058|NCT04177212|562051016|FG000|Overall Study|Withdrawal by Subject|9|||
155715059|NCT04177212|562051017|FG001|Overall Study|Withdrawal by Subject|7|||
155715060|NCT04177212|562051016|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
155184924|NCT00559754|560116243|FG000|Overall Study|Protocol Violation|1|||
155715061|NCT04177212|562051017|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
155715062|NCT04177212|562051016|FG000|Overall Study|Physician Decision|1|||
155715063|NCT04177212|562051017|FG001|Overall Study|Physician Decision|0|||
155715064|NCT04177212|562051016|FG000|Overall Study|Lost to Follow-up|0|||
155715065|NCT04177212|562051017|FG001|Overall Study|Lost to Follow-up|3|||
155715066|NCT04177212|562051016|FG000|Overall Study|Adverse Event|0|||
155715067|NCT04177212|562051017|FG001|Overall Study|Adverse Event|1|||
155184925|NCT00559754|560116243|FG000|Overall Study|Investigator criteria|2|||
155184926|NCT00559754|560116243|FG000|Overall Study|Withdrawal by Subject|2|||
155184927|NCT01264016|560116244|FG000|Overall Study|Withdrawal by Subject|1|||
155184928|NCT01264016|560116244|FG000|Overall Study|Felt faint at sight of blood|1|||
155184929|NCT01629706|560116245|FG000|Phase 1 PureVision|Screen Failure|4|||
155184930|NCT01629706|560116245|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
155184931|NCT01629706|560116245|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
155184932|NCT01629706|560116245|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
155184933|NCT01629706|560116245|FG000|Phase 2 Habitual|Screen Failure|6|||
155184934|NCT01629706|560116245|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
155184935|NCT01629706|560116245|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
155184936|NCT01629706|560116245|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
155184937|NCT01629706|560116245|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
155184938|NCT02117414|560116246|FG000|Overall Study|Death|5|||
155184939|NCT02117414|560116247|FG001|Overall Study|Death|2|||
155184940|NCT02117414|560116246|FG000|Overall Study|Withdrawal by Subject|10|||
155184941|NCT02117414|560116247|FG001|Overall Study|Withdrawal by Subject|4|||
155184942|NCT01439347|560116248|FG000|Overall Study|Death|10|||
155184943|NCT01439347|560116249|FG001|Overall Study|Death|9|||
155184944|NCT01439347|560116248|FG000|Overall Study|Withdrawal by Subject|0|||
155184945|NCT01439347|560116249|FG001|Overall Study|Withdrawal by Subject|1|||
155184946|NCT01439347|560116248|FG000|Overall Study|Physician Decision|1|||
155184947|NCT01439347|560116249|FG001|Overall Study|Physician Decision|0|||
155184948|NCT01439347|560116248|FG000|Overall Study|Sponsor Terminated Study|2|||
155184949|NCT01439347|560116249|FG001|Overall Study|Sponsor Terminated Study|3|||
155184950|NCT02537574|560116250|FG000|Overall Study|Adverse Event|1|||
155184951|NCT02537574|560116251|FG001|Overall Study|Adverse Event|3|||
155184952|NCT02537574|560116252|FG002|Overall Study|Adverse Event|2|||
155184953|NCT02537574|560116250|FG000|Overall Study|Lost to Follow-up|40|||
155184954|NCT02537574|560116251|FG001|Overall Study|Lost to Follow-up|51|||
155184955|NCT02537574|560116252|FG002|Overall Study|Lost to Follow-up|55|||
155184956|NCT02537574|560116250|FG000|Overall Study|Noncompliance with study drug|0|||
155184957|NCT02537574|560116251|FG001|Overall Study|Noncompliance with study drug|1|||
155184958|NCT02537574|560116252|FG002|Overall Study|Noncompliance with study drug|1|||
155184959|NCT02537574|560116250|FG000|Overall Study|Physician Decision|2|||
155184960|NCT02537574|560116251|FG001|Overall Study|Physician Decision|0|||
155715068|NCT04177212|562051016|FG000|Overall Study|Other|1|||
155715069|NCT04177212|562051017|FG001|Overall Study|Other|2|||
155715070|NCT01792115|562051018|FG000|Overall Study|Lost to Follow-up|0|||
155715071|NCT01792115|562051019|FG001|Overall Study|Lost to Follow-up|1|||
155715072|NCT01792115|562051020|FG002|Overall Study|Lost to Follow-up|0|||
155715073|NCT01279681|562051021|FG000|Overall Study|Disease Progression|9|||
155715074|NCT01279681|562051022|FG001|Overall Study|Disease Progression|6|||
155184961|NCT02537574|560116252|FG002|Overall Study|Physician Decision|0|||
155184962|NCT02537574|560116250|FG000|Overall Study|Protocol Violation|4|||
155184963|NCT02537574|560116251|FG001|Overall Study|Protocol Violation|2|||
155184964|NCT02537574|560116252|FG002|Overall Study|Protocol Violation|3|||
155184965|NCT02537574|560116250|FG000|Overall Study|Withdrawal by Subject|37|||
155184966|NCT02537574|560116251|FG001|Overall Study|Withdrawal by Subject|27|||
155184967|NCT02537574|560116252|FG002|Overall Study|Withdrawal by Subject|29|||
155184968|NCT02537574|560116250|FG000|Overall Study|Lack of Efficacy|14|||
155715075|NCT01279681|562051021|FG000|Overall Study|Withdrawal by Subject|3|||
155715076|NCT01279681|562051022|FG001|Overall Study|Withdrawal by Subject|4|||
155715077|NCT01279681|562051021|FG000|Overall Study|Adverse Event|2|||
155715078|NCT01279681|562051022|FG001|Overall Study|Adverse Event|3|||
155715079|NCT01279681|562051021|FG000|Overall Study|Death|0|||
155715080|NCT01279681|562051022|FG001|Overall Study|Death|1|||
155715081|NCT01279681|562051021|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
155715082|NCT01279681|562051022|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
155715083|NCT01279681|562051021|FG000|Overall Study|Physician Decision|1|||
155715084|NCT01279681|562051022|FG001|Overall Study|Physician Decision|0|||
155715085|NCT01279681|562051021|FG000|Overall Study|Other Reason|0|||
155715086|NCT01279681|562051022|FG001|Overall Study|Other Reason|2|||
155715087|NCT01943591|562051023|FG000|Overall Study|Lost to Follow-up|3|||
155715088|NCT01943591|562051024|FG001|Overall Study|Lost to Follow-up|4|||
155715089|NCT01943591|562051023|FG000|Overall Study|Death|2|||
155184969|NCT02537574|560116251|FG001|Overall Study|Lack of Efficacy|16|||
155184970|NCT02537574|560116252|FG002|Overall Study|Lack of Efficacy|15|||
155184971|NCT02537574|560116250|FG000|Overall Study|Duplicate Patient|1|||
155184972|NCT02537574|560116251|FG001|Overall Study|Duplicate Patient|0|||
155184973|NCT02537574|560116252|FG002|Overall Study|Duplicate Patient|0|||
155715090|NCT01943591|562051024|FG001|Overall Study|Death|7|||
155715091|NCT03798717|562052926|FG000|Overall Study|Failed Screening|0|||
155715092|NCT03798717|562052927|FG001|Overall Study|Failed Screening|0|||
155715093|NCT03798717|562052928|FG002|Overall Study|Failed Screening|0|||
155715094|NCT03798717|562052929|FG003|Overall Study|Failed Screening|0|||
155715095|NCT03798717|562052930|FG004|Overall Study|Failed Screening|0|||
155715096|NCT03798717|562052931|FG005|Overall Study|Failed Screening|1|||
155715097|NCT03798717|562052926|FG000|Overall Study|Physician Decision|1|||
155715098|NCT03798717|562052927|FG001|Overall Study|Physician Decision|0|||
155715099|NCT03798717|562052928|FG002|Overall Study|Physician Decision|1|||
155715100|NCT03798717|562052929|FG003|Overall Study|Physician Decision|0|||
155184974|NCT02537574|560116250|FG000|Overall Study|Patient not Stable|0|||
155184975|NCT02537574|560116251|FG001|Overall Study|Patient not Stable|1|||
155184976|NCT02537574|560116252|FG002|Overall Study|Patient not Stable|0|||
155184977|NCT02537574|560116250|FG000|Overall Study|Incarceration|0|||
155715101|NCT03798717|562052930|FG004|Overall Study|Physician Decision|0|||
155715102|NCT03798717|562052931|FG005|Overall Study|Physician Decision|0|||
155715103|NCT03798717|562052926|FG000|Overall Study|Withdrawal by Subject|0|||
155715104|NCT03798717|562052927|FG001|Overall Study|Withdrawal by Subject|0|||
155715105|NCT03798717|562052928|FG002|Overall Study|Withdrawal by Subject|0|||
155715106|NCT03798717|562052929|FG003|Overall Study|Withdrawal by Subject|1|||
155715107|NCT03798717|562052930|FG004|Overall Study|Withdrawal by Subject|0|||
155715108|NCT03798717|562052931|FG005|Overall Study|Withdrawal by Subject|0|||
155184978|NCT02537574|560116251|FG001|Overall Study|Incarceration|1|||
155715109|NCT03798717|562052926|FG000|Overall Study|Lost to Follow-up|1|||
155715110|NCT03798717|562052927|FG001|Overall Study|Lost to Follow-up|0|||
155715111|NCT03798717|562052928|FG002|Overall Study|Lost to Follow-up|0|||
155715112|NCT03798717|562052929|FG003|Overall Study|Lost to Follow-up|1|||
155715113|NCT03798717|562052930|FG004|Overall Study|Lost to Follow-up|0|||
155715114|NCT03798717|562052931|FG005|Overall Study|Lost to Follow-up|0|||
155715115|NCT03798717|562052926|FG000|Overall Study|Adverse Event|0|||
155715116|NCT03798717|562052927|FG001|Overall Study|Adverse Event|1|||
155715117|NCT03798717|562052928|FG002|Overall Study|Adverse Event|0|||
155715118|NCT03798717|562052929|FG003|Overall Study|Adverse Event|0|||
155715119|NCT03798717|562052930|FG004|Overall Study|Adverse Event|0|||
155715120|NCT03798717|562052931|FG005|Overall Study|Adverse Event|0|||
155715121|NCT03798717|562052926|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155715122|NCT03798717|562052927|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155715123|NCT03798717|562052928|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155715124|NCT03798717|562052929|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155715125|NCT03798717|562052930|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
155715126|NCT03798717|562052931|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155715127|NCT04388111|562052936|FG000|Overall Study|Lost to Follow-up|5|||
155715128|NCT04388111|562052937|FG001|Overall Study|Lost to Follow-up|3|||
155715129|NCT04388111|562052936|FG000|Overall Study|Adverse Event|1|||
155715130|NCT04388111|562052937|FG001|Overall Study|Adverse Event|1|||
155715131|NCT04388111|562052936|FG000|Overall Study|Protocol Violation|2|||
155715132|NCT04388111|562052937|FG001|Overall Study|Protocol Violation|4|||
155715133|NCT04388111|562052936|FG000|Overall Study|Withdrawal by Subject|1|||
155715134|NCT04388111|562052937|FG001|Overall Study|Withdrawal by Subject|0|||
155715135|NCT00387881|562052938|FG000|Overall Study|Lost to Follow-up|23|||
155715136|NCT00387881|562052939|FG001|Overall Study|Lost to Follow-up|23|||
155715137|NCT00387881|562052938|FG000|Overall Study|Protocol Violation|2|||
155715138|NCT00387881|562052939|FG001|Overall Study|Protocol Violation|12|||
155715139|NCT00387881|562052938|FG000|Overall Study|Withdrawal by Subject|15|||
155715140|NCT00387881|562052939|FG001|Overall Study|Withdrawal by Subject|18|||
155715141|NCT00387881|562052938|FG000|Overall Study|Sponsor terminated Study|0|||
155715142|NCT00387881|562052939|FG001|Overall Study|Sponsor terminated Study|1|||
155715143|NCT00387881|562052938|FG000|Overall Study|Not eligible|6|||
155715144|NCT00387881|562052939|FG001|Overall Study|Not eligible|7|||
155715145|NCT00387881|562052938|FG000|Overall Study|No opportunity to treat headache|32|||
155715146|NCT00387881|562052939|FG001|Overall Study|No opportunity to treat headache|34|||
155715147|NCT00387881|562052938|FG000|Overall Study|Not otherwise specified|11|||
155715148|NCT00387881|562052939|FG001|Overall Study|Not otherwise specified|7|||
155715149|NCT05473026|562052941|FG000|Overall Study|Lost to Follow-up|5|||
155715150|NCT05473026|562052942|FG001|Overall Study|Lost to Follow-up|2|||
155715151|NCT01050634|562052943|FG000|Overall Study|Enrolled, but Not Treated|56|||
155715152|NCT01050634|562052943|FG000|Overall Study|Death|2|||
155715153|NCT01050634|562052943|FG000|Overall Study|Adverse Event|42|||
155715154|NCT01050634|562052943|FG000|Overall Study|Lost to Follow-up|2|||
155715155|NCT01050634|562052943|FG000|Overall Study|Other|21|||
155715156|NCT01050634|562052943|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
155715157|NCT00496015|562052944|FG000|Overall Study|Other|1|||
155715158|NCT00496015|562052945|FG001|Overall Study|Other|0|||
155715159|NCT00496015|562052946|FG002|Overall Study|Other|0|||
155715160|NCT00496015|562052947|FG003|Overall Study|Other|1|||
155715161|NCT00496015|562052948|FG004|Overall Study|Other|0|||
155715162|NCT02730728|562052952|FG000|Overall Study|Withdrawal by Subject|0|||
155715163|NCT02730728|562052953|FG001|Overall Study|Withdrawal by Subject|1|||
155715164|NCT02730728|562052954|FG002|Overall Study|Withdrawal by Subject|0|||
155715165|NCT02730728|562052952|FG000|Overall Study|Lack of Efficacy|0|||
155715166|NCT02730728|562052953|FG001|Overall Study|Lack of Efficacy|1|||
155715167|NCT02730728|562052954|FG002|Overall Study|Lack of Efficacy|1|||
155715168|NCT00346216|562052956|FG000|Overall Study|Other|181|||
155715169|NCT00346216|562052957|FG001|Overall Study|Other|231|||
155715170|NCT00346216|562052958|FG002|Overall Study|Other|205|||
155715171|NCT00346216|562052956|FG000|Overall Study|No longer willing to participate|600|||
155715172|NCT00346216|562052957|FG001|Overall Study|No longer willing to participate|606|||
155715173|NCT00346216|562052958|FG002|Overall Study|No longer willing to participate|585|||
155715174|NCT00346216|562052956|FG000|Overall Study|Withdrawal by Subject|661|||
155715175|NCT00346216|562052957|FG001|Overall Study|Withdrawal by Subject|692|||
155715176|NCT00346216|562052958|FG002|Overall Study|Withdrawal by Subject|651|||
155715177|NCT00346216|562052956|FG000|Overall Study|Lost to Follow-up|611|||
155715178|NCT00346216|562052957|FG001|Overall Study|Lost to Follow-up|588|||
155715179|NCT00346216|562052958|FG002|Overall Study|Lost to Follow-up|542|||
155715180|NCT00346216|562052956|FG000|Overall Study|Physician Decision|80|||
155715181|NCT00346216|562052957|FG001|Overall Study|Physician Decision|76|||
155715182|NCT00346216|562052958|FG002|Overall Study|Physician Decision|59|||
155715183|NCT00346216|562052956|FG000|Overall Study|Does not meet entrance criteria|13|||
155715184|NCT00346216|562052957|FG001|Overall Study|Does not meet entrance criteria|10|||
155715185|NCT00346216|562052958|FG002|Overall Study|Does not meet entrance criteria|8|||
155715186|NCT00346216|562052956|FG000|Overall Study|Death|189|||
155715187|NCT00346216|562052957|FG001|Overall Study|Death|192|||
155715188|NCT00346216|562052958|FG002|Overall Study|Death|228|||
155715189|NCT00346216|562052956|FG000|Overall Study|Study terminated by sponsor|11|||
155715190|NCT00346216|562052957|FG001|Overall Study|Study terminated by sponsor|4|||
155715191|NCT00346216|562052958|FG002|Overall Study|Study terminated by sponsor|8|||
155715192|NCT00346216|562052956|FG000|Overall Study|Missing Subject Summary Status|62|||
155715193|NCT00346216|562052957|FG001|Overall Study|Missing Subject Summary Status|61|||
155715194|NCT00346216|562052958|FG002|Overall Study|Missing Subject Summary Status|62|||
155715195|NCT03956550|562052964|FG000|Overall Study|Sponsor decision|65|||
155715196|NCT03956550|562052965|FG001|Overall Study|Sponsor decision|66|||
155715197|NCT03956550|562052966|FG002|Overall Study|Sponsor decision|64|||
155715198|NCT03956550|562052964|FG000|Overall Study|Adverse Event|0|||
155715199|NCT03956550|562052965|FG001|Overall Study|Adverse Event|1|||
155715200|NCT03956550|562052966|FG002|Overall Study|Adverse Event|0|||
155715201|NCT03956550|562052964|FG000|Overall Study|Withdrawal by Subject|5|||
155715202|NCT03956550|562052965|FG001|Overall Study|Withdrawal by Subject|5|||
155715203|NCT03956550|562052966|FG002|Overall Study|Withdrawal by Subject|6|||
155715204|NCT04244253|562052967|FG000|Overall Study|Adverse Event|2|||
155715205|NCT04244253|562052968|FG001|Overall Study|Adverse Event|2|||
155715206|NCT04244253|562052969|FG002|Overall Study|Adverse Event|4|||
155715207|NCT04244253|562052967|FG000|Overall Study|Protocol Violation|1|||
155715208|NCT04244253|562052968|FG001|Overall Study|Protocol Violation|2|||
155715209|NCT04244253|562052969|FG002|Overall Study|Protocol Violation|1|||
155715210|NCT04244253|562052967|FG000|Overall Study|Withdrawal by Subject|0|||
155715211|NCT04244253|562052968|FG001|Overall Study|Withdrawal by Subject|1|||
155715212|NCT04244253|562052969|FG002|Overall Study|Withdrawal by Subject|6|||
155715213|NCT04244253|562052967|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155715214|NCT04244253|562052968|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155715215|NCT04244253|562052969|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155715216|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155715217|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155715218|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155715219|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715220|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715221|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715222|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715223|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715224|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715225|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715226|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715227|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715228|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155715229|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715230|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155715231|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715232|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155715233|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715234|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155184979|NCT02537574|560116252|FG002|Overall Study|Incarceration|0|||
155715235|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
155715236|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155715237|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
155715238|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
155715239|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715240|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155715241|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715242|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715243|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155715244|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155715245|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
155715246|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
155715247|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
155715248|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
155715249|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
155715250|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
155715251|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
155715252|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
155715253|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
155715254|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
155715255|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
155715256|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
155715257|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
155715258|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
155715259|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
155715260|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
155715261|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155715262|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715263|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715264|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155715265|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715266|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715267|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715268|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715269|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715270|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715271|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155715272|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715273|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715274|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715275|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155715276|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715277|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715278|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715279|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715280|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715281|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715282|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715283|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715284|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715285|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715286|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715287|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715288|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715289|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155715290|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155715291|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715292|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715293|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715294|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
155715295|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715296|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715297|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715298|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715299|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715300|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715301|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
155715302|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715303|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715304|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715305|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155715306|NCT01147666|562052971|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715307|NCT01147666|562052972|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715308|NCT01147666|562052973|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715309|NCT01147666|562052974|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715310|NCT01147666|562052975|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715311|NCT01147666|562052976|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715312|NCT01147666|562052977|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715313|NCT01147666|562052978|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715314|NCT01147666|562052979|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715315|NCT01147666|562052980|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715316|NCT01147666|562052981|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715317|NCT01147666|562052982|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155715318|NCT01147666|562052983|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155715319|NCT01147666|562052984|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155715320|NCT01147666|562052985|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155715321|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
155715322|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
155715323|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
155715324|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
155715325|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
155715326|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
155715327|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
155715328|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
155715329|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
155715330|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
155715331|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
155715332|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
155715333|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
155715334|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
155715335|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
155715336|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715337|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715338|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715339|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715340|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
155715341|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155715342|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155715343|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155715344|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715345|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155715346|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715347|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715348|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155715349|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155715350|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155715351|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715352|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715353|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715354|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
155715355|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715356|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715357|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715358|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715359|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715360|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715361|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715362|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715363|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715364|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715365|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155715366|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715367|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715368|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715369|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715370|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155715371|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155715372|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715373|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155715374|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715375|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155715376|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715377|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715378|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715379|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155715380|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155715381|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715382|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715383|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715384|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
155715385|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715386|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715387|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715388|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715389|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715390|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715391|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
155715392|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715393|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715394|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715395|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155715396|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715397|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715398|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715399|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715400|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715401|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715402|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715403|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715404|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715405|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715406|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715407|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715408|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
155715409|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715410|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155715411|NCT01147666|562052971|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715412|NCT01147666|562052972|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715413|NCT01147666|562052973|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715414|NCT01147666|562052974|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715415|NCT01147666|562052975|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715416|NCT01147666|562052976|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715417|NCT01147666|562052977|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715418|NCT01147666|562052978|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715419|NCT01147666|562052979|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715420|NCT01147666|562052980|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715421|NCT01147666|562052981|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715422|NCT01147666|562052982|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715423|NCT01147666|562052983|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
155715424|NCT01147666|562052984|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155715425|NCT01147666|562052985|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
155715426|NCT05470387|562052986|FG000|Overall Study|Protocol Violation|0|||
155715427|NCT05470387|562052987|FG001|Overall Study|Protocol Violation|3|||
155715428|NCT03367858|562052988|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
155715429|NCT03367858|562052989|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
155715430|NCT03367858|562052988|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
155715431|NCT03367858|562052989|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
155715432|NCT03367858|562052988|FG000|3 Month Follow Up|Lost to Follow-up|8|||
155715433|NCT03367858|562052989|FG001|3 Month Follow Up|Lost to Follow-up|3|||
155715434|NCT03367858|562052988|FG000|3 Month Follow Up|Moved out of study area|2|||
155715435|NCT03367858|562052989|FG001|3 Month Follow Up|Moved out of study area|6|||
155715436|NCT03367858|562052988|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
155715437|NCT03367858|562052989|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
155715438|NCT03367858|562052988|FG000|3 Month Follow Up|MRI contraindication|2|||
155715439|NCT03367858|562052989|FG001|3 Month Follow Up|MRI contraindication|1|||
155715440|NCT03367858|562052988|FG000|3 Month Follow Up|Incarcerated|0|||
155715441|NCT03367858|562052989|FG001|3 Month Follow Up|Incarcerated|1|||
155715442|NCT03367858|562052988|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
155715443|NCT03367858|562052989|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
155715444|NCT03367858|562052988|FG000|6 Month Follow Up|Lost to Follow-up|5|||
155715445|NCT03367858|562052989|FG001|6 Month Follow Up|Lost to Follow-up|2|||
155715446|NCT03367858|562052988|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
155715447|NCT03367858|562052989|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
155715448|NCT03367858|562052988|FG000|12 Month Follow Up|Lost to Follow-up|3|||
155715449|NCT03367858|562052989|FG001|12 Month Follow Up|Lost to Follow-up|3|||
155715450|NCT03367858|562052988|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
155715451|NCT03367858|562052989|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
155715452|NCT00101686|562053004|FG000|Overall Study|Progressive Disease|37|||
155715453|NCT00101686|562053005|FG001|Overall Study|Progressive Disease|28|||
155715454|NCT00101686|562053006|FG002|Overall Study|Progressive Disease|37|||
155715455|NCT00101686|562053007|FG003|Overall Study|Progressive Disease|38|||
155715456|NCT00101686|562053008|FG004|Overall Study|Progressive Disease|28|||
155715457|NCT00101686|562053009|FG005|Overall Study|Progressive Disease|25|||
155715458|NCT00101686|562053010|FG006|Overall Study|Progressive Disease|5|||
155715459|NCT00101686|562053011|FG007|Overall Study|Progressive Disease|7|||
155715460|NCT00101686|562053012|FG008|Overall Study|Progressive Disease|10|||
155715461|NCT00101686|562053013|FG009|Overall Study|Progressive Disease|8|||
155715462|NCT00101686|562053004|FG000|Overall Study|initiation other anti-cancer treatment|4|||
155715463|NCT00101686|562053005|FG001|Overall Study|initiation other anti-cancer treatment|3|||
155715464|NCT00101686|562053006|FG002|Overall Study|initiation other anti-cancer treatment|4|||
155715465|NCT00101686|562053007|FG003|Overall Study|initiation other anti-cancer treatment|3|||
155715466|NCT00101686|562053008|FG004|Overall Study|initiation other anti-cancer treatment|1|||
155715467|NCT00101686|562053009|FG005|Overall Study|initiation other anti-cancer treatment|1|||
155715468|NCT00101686|562053010|FG006|Overall Study|initiation other anti-cancer treatment|2|||
155715469|NCT00101686|562053011|FG007|Overall Study|initiation other anti-cancer treatment|2|||
155715470|NCT00101686|562053012|FG008|Overall Study|initiation other anti-cancer treatment|3|||
155715471|NCT00101686|562053013|FG009|Overall Study|initiation other anti-cancer treatment|3|||
155715472|NCT00101686|562053004|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
155715473|NCT00101686|562053005|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
155715474|NCT00101686|562053006|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
155715475|NCT00101686|562053007|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
155715476|NCT00101686|562053008|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
155715477|NCT00101686|562053009|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
155715478|NCT00101686|562053010|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
155715479|NCT00101686|562053011|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
155715480|NCT00101686|562053012|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
155715481|NCT00101686|562053013|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
155715482|NCT00101686|562053004|FG000|Overall Study|unacceptable toxicity|3|||
155715483|NCT00101686|562053005|FG001|Overall Study|unacceptable toxicity|9|||
155715484|NCT00101686|562053006|FG002|Overall Study|unacceptable toxicity|10|||
155715485|NCT00101686|562053007|FG003|Overall Study|unacceptable toxicity|6|||
155715486|NCT00101686|562053008|FG004|Overall Study|unacceptable toxicity|16|||
155715487|NCT00101686|562053009|FG005|Overall Study|unacceptable toxicity|10|||
155715488|NCT00101686|562053010|FG006|Overall Study|unacceptable toxicity|4|||
155715489|NCT00101686|562053011|FG007|Overall Study|unacceptable toxicity|2|||
155715490|NCT00101686|562053012|FG008|Overall Study|unacceptable toxicity|1|||
155715491|NCT00101686|562053013|FG009|Overall Study|unacceptable toxicity|4|||
155715492|NCT00101686|562053004|FG000|Overall Study|Randomized but did not receive treament|1|||
155715493|NCT00101686|562053005|FG001|Overall Study|Randomized but did not receive treament|6|||
155715494|NCT00101686|562053006|FG002|Overall Study|Randomized but did not receive treament|2|||
155715495|NCT00101686|562053007|FG003|Overall Study|Randomized but did not receive treament|2|||
155715496|NCT00101686|562053008|FG004|Overall Study|Randomized but did not receive treament|2|||
155715497|NCT00101686|562053009|FG005|Overall Study|Randomized but did not receive treament|2|||
155715498|NCT00101686|562053010|FG006|Overall Study|Randomized but did not receive treament|0|||
155715499|NCT00101686|562053011|FG007|Overall Study|Randomized but did not receive treament|1|||
155715500|NCT00101686|562053012|FG008|Overall Study|Randomized but did not receive treament|0|||
155715501|NCT00101686|562053013|FG009|Overall Study|Randomized but did not receive treament|1|||
155715502|NCT00101686|562053004|FG000|Overall Study|intercurrent non-cancer related illness|0|||
155715503|NCT00101686|562053005|FG001|Overall Study|intercurrent non-cancer related illness|0|||
155715504|NCT00101686|562053006|FG002|Overall Study|intercurrent non-cancer related illness|2|||
155715505|NCT00101686|562053007|FG003|Overall Study|intercurrent non-cancer related illness|0|||
155715506|NCT00101686|562053008|FG004|Overall Study|intercurrent non-cancer related illness|1|||
155715507|NCT00101686|562053009|FG005|Overall Study|intercurrent non-cancer related illness|3|||
155715508|NCT00101686|562053010|FG006|Overall Study|intercurrent non-cancer related illness|1|||
155715509|NCT00101686|562053011|FG007|Overall Study|intercurrent non-cancer related illness|0|||
155715510|NCT00101686|562053012|FG008|Overall Study|intercurrent non-cancer related illness|1|||
155715511|NCT00101686|562053013|FG009|Overall Study|intercurrent non-cancer related illness|1|||
155715512|NCT00101686|562053004|FG000|Overall Study|Physician Decision|10|||
155715513|NCT00101686|562053005|FG001|Overall Study|Physician Decision|13|||
155715514|NCT00101686|562053006|FG002|Overall Study|Physician Decision|6|||
155715515|NCT00101686|562053007|FG003|Overall Study|Physician Decision|7|||
155715516|NCT00101686|562053008|FG004|Overall Study|Physician Decision|8|||
155715517|NCT00101686|562053009|FG005|Overall Study|Physician Decision|9|||
155715518|NCT00101686|562053010|FG006|Overall Study|Physician Decision|5|||
155715519|NCT00101686|562053011|FG007|Overall Study|Physician Decision|5|||
155715520|NCT00101686|562053012|FG008|Overall Study|Physician Decision|1|||
155715521|NCT00101686|562053013|FG009|Overall Study|Physician Decision|1|||
155715522|NCT00101686|562053004|FG000|Overall Study|Other|1|||
155715523|NCT00101686|562053005|FG001|Overall Study|Other|4|||
155715524|NCT00101686|562053006|FG002|Overall Study|Other|1|||
155715525|NCT00101686|562053007|FG003|Overall Study|Other|6|||
155715526|NCT00101686|562053008|FG004|Overall Study|Other|2|||
155715527|NCT00101686|562053009|FG005|Overall Study|Other|12|||
155715528|NCT00101686|562053010|FG006|Overall Study|Other|1|||
155715529|NCT00101686|562053011|FG007|Overall Study|Other|5|||
155715530|NCT00101686|562053012|FG008|Overall Study|Other|3|||
155715531|NCT00101686|562053013|FG009|Overall Study|Other|3|||
155715532|NCT00101686|562053004|FG000|Overall Study|Withdrawal by Subject|9|||
155715533|NCT00101686|562053005|FG001|Overall Study|Withdrawal by Subject|8|||
155715534|NCT00101686|562053006|FG002|Overall Study|Withdrawal by Subject|6|||
155715535|NCT00101686|562053007|FG003|Overall Study|Withdrawal by Subject|8|||
155715536|NCT00101686|562053008|FG004|Overall Study|Withdrawal by Subject|8|||
155715537|NCT00101686|562053009|FG005|Overall Study|Withdrawal by Subject|7|||
155715538|NCT00101686|562053010|FG006|Overall Study|Withdrawal by Subject|7|||
155715539|NCT00101686|562053011|FG007|Overall Study|Withdrawal by Subject|7|||
155715540|NCT00101686|562053012|FG008|Overall Study|Withdrawal by Subject|8|||
155715541|NCT00101686|562053013|FG009|Overall Study|Withdrawal by Subject|9|||
155715542|NCT00985465|562053014|FG000|Overall Study|Withdrawal by Subject|1|||
155715543|NCT00985465|562053015|FG001|Overall Study|Withdrawal by Subject|2|||
155715544|NCT00985465|562053014|FG000|Overall Study|Considered to be part of the other group|0|||
155715545|NCT00985465|562053015|FG001|Overall Study|Considered to be part of the other group|1|||
155715546|NCT01054456|562053016|FG000|Overall Study|Other|1|||
155715547|NCT04701333|562053017|FG000|Overall Study|Lost to Follow-up|3|||
155715548|NCT04701333|562053018|FG001|Overall Study|Lost to Follow-up|7|||
155715549|NCT04701333|562053017|FG000|Overall Study|Withdrawal by Subject|0|||
155715550|NCT04701333|562053018|FG001|Overall Study|Withdrawal by Subject|1|||
155715551|NCT01292187|562053019|FG000|Overall Study|Adverse Event|10|||
155715552|NCT01292187|562053020|FG001|Overall Study|Adverse Event|5|||
155715553|NCT01292187|562053019|FG000|Overall Study|Withdrawal by Subject|6|||
155715554|NCT01292187|562053020|FG001|Overall Study|Withdrawal by Subject|5|||
155715555|NCT01292187|562053019|FG000|Overall Study|All other reasons|1|||
155715556|NCT01292187|562053020|FG001|Overall Study|All other reasons|3|||
155715557|NCT03957551|562053026|FG000|Overall Study|Adverse Event|2|||
155715558|NCT03957551|562053027|FG001|Overall Study|Adverse Event|2|||
155715559|NCT03957551|562053028|FG002|Overall Study|Adverse Event|6|||
155715560|NCT03957551|562053026|FG000|Overall Study|Physician Decision|1|||
155715561|NCT03957551|562053027|FG001|Overall Study|Physician Decision|0|||
155715562|NCT03957551|562053028|FG002|Overall Study|Physician Decision|2|||
155715563|NCT03957551|562053026|FG000|Overall Study|Withdrawal by Subject|1|||
155715564|NCT03957551|562053027|FG001|Overall Study|Withdrawal by Subject|0|||
155715565|NCT03957551|562053028|FG002|Overall Study|Withdrawal by Subject|2|||
155715566|NCT03957551|562053026|FG000|Overall Study|Disease progression|1|||
155715567|NCT03957551|562053027|FG001|Overall Study|Disease progression|0|||
155715568|NCT03957551|562053028|FG002|Overall Study|Disease progression|8|||
155715569|NCT02717494|562053032|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
155715570|NCT02717494|562053033|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
155715571|NCT02717494|562053034|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
155715572|NCT02717494|562053032|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
155715573|NCT02717494|562053033|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
155715574|NCT02717494|562053034|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
155715575|NCT02717494|562053032|FG000|First Intervention (Step 1)|Death|0|||
155715576|NCT02717494|562053033|FG001|First Intervention (Step 1)|Death|0|||
155715577|NCT02717494|562053034|FG002|First Intervention (Step 1)|Death|1|||
155715578|NCT02717494|562053032|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
155715579|NCT02717494|562053033|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
155715580|NCT02717494|562053034|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
155715581|NCT01808196|562053041|FG000|Overall Study|Lost to Follow-up|1|||
155715582|NCT03370718|562053042|FG000|Overall Study|Withdrawal by Subject|1|||
155715583|NCT00479713|562053043|FG000|Overall Study|Adverse Event|8|||
155715584|NCT00479713|562053044|FG001|Overall Study|Adverse Event|6|||
155715585|NCT00479713|562053043|FG000|Overall Study|Death|1|||
155715586|NCT00479713|562053044|FG001|Overall Study|Death|0|||
155715587|NCT00479713|562053043|FG000|Overall Study|Lost to Follow-up|0|||
155715588|NCT00479713|562053044|FG001|Overall Study|Lost to Follow-up|1|||
155715589|NCT00479713|562053043|FG000|Overall Study|Protocol Violation|0|||
155715590|NCT00479713|562053044|FG001|Overall Study|Protocol Violation|1|||
155715591|NCT00479713|562053043|FG000|Overall Study|Withdrawal by Subject|4|||
155715592|NCT00479713|562053044|FG001|Overall Study|Withdrawal by Subject|1|||
155715593|NCT00141102|562053049|FG000|Overall Study|Adverse Event|233|||
155715594|NCT00141102|562053050|FG001|Overall Study|Adverse Event|305|||
155715595|NCT00141102|562053049|FG000|Overall Study|Laboratory Abnormality|9|||
155715596|NCT00141102|562053050|FG001|Overall Study|Laboratory Abnormality|33|||
155715597|NCT00141102|562053049|FG000|Overall Study|Lack of Efficacy|21|||
155715598|NCT00141102|562053050|FG001|Overall Study|Lack of Efficacy|26|||
155715599|NCT00141102|562053049|FG000|Overall Study|Lost to Follow-up|29|||
155715600|NCT00141102|562053050|FG001|Overall Study|Lost to Follow-up|32|||
155715601|NCT00141102|562053049|FG000|Overall Study|Other|87|||
155715602|NCT00141102|562053050|FG001|Overall Study|Other|76|||
155715603|NCT00141102|562053049|FG000|Overall Study|Withdrawal by Subject|112|||
155715604|NCT00141102|562053050|FG001|Overall Study|Withdrawal by Subject|142|||
155715605|NCT00141102|562053049|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
155715606|NCT00141102|562053050|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
155715607|NCT00141102|562053049|FG000|Overall Study|Death|2|||
155715608|NCT00141102|562053050|FG001|Overall Study|Death|2|||
155715609|NCT03061201|562053051|FG000|Overall Study|Participants Terminated at Month 36|0|||
155715610|NCT03061201|562053052|FG001|Overall Study|Participants Terminated at Month 36|1|||
155715611|NCT03061201|562053053|FG002|Overall Study|Participants Terminated at Month 36|0|||
155715612|NCT03061201|562053054|FG003|Overall Study|Participants Terminated at Month 36|1|||
155715613|NCT03061201|562053051|FG000|Overall Study|Lost to Follow-up|1|||
155715614|NCT03061201|562053052|FG001|Overall Study|Lost to Follow-up|0|||
155715615|NCT03061201|562053053|FG002|Overall Study|Lost to Follow-up|0|||
155715616|NCT03061201|562053054|FG003|Overall Study|Lost to Follow-up|0|||
155715617|NCT01572480|562053055|FG000|Participants Enrolled|Withdrawal by Subject|1|||
155715618|NCT01572480|562053055|FG000|Drug Administration|Discontinued drug/Off Study|1|||
155715619|NCT01572480|562053055|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
155715620|NCT01572480|562053055|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
155715621|NCT03116685|562053056|FG000|Overall Study|Physician Decision|0|||
155715622|NCT03116685|562053057|FG001|Overall Study|Physician Decision|1|||
155715623|NCT04194944|562053058|FG000|Overall Study|Lost to Follow-up|3|||
155715624|NCT04194944|562053059|FG001|Overall Study|Lost to Follow-up|0|||
155715625|NCT04194944|562053058|FG000|Overall Study|Withdrawal by Subject|2|||
155715626|NCT04194944|562053059|FG001|Overall Study|Withdrawal by Subject|2|||
155715627|NCT04194944|562053058|FG000|Overall Study|On Treatment|93|||
155715628|NCT04194944|562053059|FG001|Overall Study|On Treatment|30|||
155715629|NCT03100149|562053060|FG000|Overall Study|Adverse Event|0|||
155715630|NCT03100149|562053061|FG001|Overall Study|Adverse Event|1|||
155715631|NCT03100149|562053062|FG002|Overall Study|Adverse Event|0|||
155715632|NCT03100149|562053060|FG000|Overall Study|Participant Moved out of Country|0|||
155715633|NCT03100149|562053061|FG001|Overall Study|Participant Moved out of Country|0|||
155715634|NCT03100149|562053062|FG002|Overall Study|Participant Moved out of Country|1|||
155715635|NCT03100149|562053060|FG000|Overall Study|Withdrawal by Subject|0|||
155715636|NCT03100149|562053061|FG001|Overall Study|Withdrawal by Subject|3|||
155715637|NCT03100149|562053062|FG002|Overall Study|Withdrawal by Subject|1|||
155715638|NCT05214768|562053065|FG000|Induction Period|Withdrawal by Subject|1|||
155715639|NCT05214768|562053066|FG001|Induction Period|Withdrawal by Subject|0|||
155715640|NCT05214768|562053067|FG002|Induction Period|Withdrawal by Subject|0|||
155715641|NCT05214768|562053068|FG003|Induction Period|Withdrawal by Subject|0|||
155715642|NCT05214768|562053069|FG004|Induction Period|Withdrawal by Subject|0|||
155715643|NCT05214768|562053070|FG005|Induction Period|Withdrawal by Subject|0|||
155715644|NCT05214768|562053065|FG000|Induction Period|Physician Decision|1|||
155715645|NCT05214768|562053066|FG001|Induction Period|Physician Decision|0|||
155715646|NCT05214768|562053067|FG002|Induction Period|Physician Decision|0|||
155715647|NCT05214768|562053068|FG003|Induction Period|Physician Decision|0|||
155715648|NCT05214768|562053069|FG004|Induction Period|Physician Decision|0|||
155715649|NCT05214768|562053070|FG005|Induction Period|Physician Decision|0|||
155715650|NCT05214768|562053065|FG000|Maintenance Period|Other Reasons|0|||
155715651|NCT05214768|562053066|FG001|Maintenance Period|Other Reasons|0|||
155715652|NCT05214768|562053067|FG002|Maintenance Period|Other Reasons|1|||
155715653|NCT05214768|562053068|FG003|Maintenance Period|Other Reasons|1|||
155715654|NCT05214768|562053069|FG004|Maintenance Period|Other Reasons|0|||
155715655|NCT05214768|562053070|FG005|Maintenance Period|Other Reasons|0|||
155715656|NCT05214768|562053065|FG000|Maintenance Period|Withdrawal by Subject|0|||
155715657|NCT05214768|562053066|FG001|Maintenance Period|Withdrawal by Subject|0|||
155715658|NCT05214768|562053067|FG002|Maintenance Period|Withdrawal by Subject|0|||
155715659|NCT05214768|562053068|FG003|Maintenance Period|Withdrawal by Subject|1|||
155715660|NCT05214768|562053069|FG004|Maintenance Period|Withdrawal by Subject|0|||
155715661|NCT05214768|562053070|FG005|Maintenance Period|Withdrawal by Subject|0|||
155715662|NCT05214768|562053065|FG000|Maintenance Period|Lack of Efficacy|0|||
155715663|NCT05214768|562053066|FG001|Maintenance Period|Lack of Efficacy|0|||
155715664|NCT05214768|562053067|FG002|Maintenance Period|Lack of Efficacy|1|||
155715665|NCT05214768|562053068|FG003|Maintenance Period|Lack of Efficacy|0|||
155715666|NCT05214768|562053069|FG004|Maintenance Period|Lack of Efficacy|1|||
155715667|NCT05214768|562053070|FG005|Maintenance Period|Lack of Efficacy|0|||
155715668|NCT05214768|562053065|FG000|Open Label Extension Period|Physician Decision|0|||
155715669|NCT05214768|562053066|FG001|Open Label Extension Period|Physician Decision|0|||
155715670|NCT05214768|562053067|FG002|Open Label Extension Period|Physician Decision|0|||
155715671|NCT05214768|562053068|FG003|Open Label Extension Period|Physician Decision|0|||
155715672|NCT05214768|562053069|FG004|Open Label Extension Period|Physician Decision|0|||
155715673|NCT05214768|562053070|FG005|Open Label Extension Period|Physician Decision|1|||
155715674|NCT05214768|562053065|FG000|Open Label Extension Period|Lack of Efficacy|0|||
155715675|NCT05214768|562053066|FG001|Open Label Extension Period|Lack of Efficacy|0|||
155715676|NCT05214768|562053067|FG002|Open Label Extension Period|Lack of Efficacy|0|||
155715677|NCT05214768|562053068|FG003|Open Label Extension Period|Lack of Efficacy|0|||
155715678|NCT05214768|562053069|FG004|Open Label Extension Period|Lack of Efficacy|0|||
155715679|NCT05214768|562053070|FG005|Open Label Extension Period|Lack of Efficacy|1|||
155715680|NCT05214768|562053065|FG000|Open Label Extension Period|Ongoing Study|0|||
155715681|NCT05214768|562053066|FG001|Open Label Extension Period|Ongoing Study|0|||
155715682|NCT05214768|562053067|FG002|Open Label Extension Period|Ongoing Study|0|||
155715683|NCT05214768|562053068|FG003|Open Label Extension Period|Ongoing Study|0|||
155715684|NCT05214768|562053069|FG004|Open Label Extension Period|Ongoing Study|0|||
155715685|NCT05214768|562053070|FG005|Open Label Extension Period|Ongoing Study|42|||
155715686|NCT05579977|562053080|FG000|Treatment Phase|Other|0|||
155715687|NCT05579977|562053081|FG001|Treatment Phase|Other|0|||
155715688|NCT05579977|562053082|FG002|Treatment Phase|Other|0|||
155715689|NCT05579977|562053083|FG003|Treatment Phase|Other|2|||
155715690|NCT05579977|562053084|FG004|Treatment Phase|Other|1|||
155715691|NCT05579977|562053085|FG005|Treatment Phase|Other|2|||
155715692|NCT05579977|562053086|FG006|Treatment Phase|Other|1|||
155715693|NCT05579977|562053087|FG007|Treatment Phase|Other|2|||
155715694|NCT05579977|562053088|FG008|Treatment Phase|Other|2|||
155715695|NCT05579977|562053089|FG009|Treatment Phase|Other|1|||
155715696|NCT05579977|562053090|FG010|Treatment Phase|Other|0|||
155715697|NCT05579977|562053091|FG011|Treatment Phase|Other|0|||
155715698|NCT05579977|562053092|FG012|Treatment Phase|Other|3|||
155715699|NCT05579977|562053080|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
155715700|NCT05579977|562053081|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
155715701|NCT05579977|562053082|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
155715702|NCT05579977|562053083|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
155715703|NCT05579977|562053084|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
155715704|NCT05579977|562053085|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
155715705|NCT05579977|562053086|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
155715706|NCT05579977|562053087|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
155715707|NCT05579977|562053088|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
155715708|NCT05579977|562053089|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
155715709|NCT05579977|562053090|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
155715710|NCT05579977|562053091|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
155715711|NCT05579977|562053092|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
155715712|NCT05579977|562053080|FG000|Treatment Phase|Withdrawal by Subject|2|||
155715713|NCT05579977|562053081|FG001|Treatment Phase|Withdrawal by Subject|0|||
155715714|NCT05579977|562053082|FG002|Treatment Phase|Withdrawal by Subject|0|||
155715715|NCT05579977|562053083|FG003|Treatment Phase|Withdrawal by Subject|1|||
155715716|NCT05579977|562053084|FG004|Treatment Phase|Withdrawal by Subject|2|||
155715717|NCT05579977|562053085|FG005|Treatment Phase|Withdrawal by Subject|0|||
155715718|NCT05579977|562053086|FG006|Treatment Phase|Withdrawal by Subject|1|||
155715719|NCT05579977|562053087|FG007|Treatment Phase|Withdrawal by Subject|8|||
155715720|NCT05579977|562053088|FG008|Treatment Phase|Withdrawal by Subject|3|||
155715721|NCT05579977|562053089|FG009|Treatment Phase|Withdrawal by Subject|3|||
155715722|NCT05579977|562053090|FG010|Treatment Phase|Withdrawal by Subject|5|||
155715723|NCT05579977|562053091|FG011|Treatment Phase|Withdrawal by Subject|1|||
155715724|NCT05579977|562053092|FG012|Treatment Phase|Withdrawal by Subject|3|||
155715725|NCT05579977|562053080|FG000|Treatment Phase|Study terminated by sponsor|70|||
155715726|NCT05579977|562053081|FG001|Treatment Phase|Study terminated by sponsor|70|||
155715727|NCT05579977|562053082|FG002|Treatment Phase|Study terminated by sponsor|61|||
155715728|NCT05579977|562053083|FG003|Treatment Phase|Study terminated by sponsor|59|||
155715729|NCT05579977|562053084|FG004|Treatment Phase|Study terminated by sponsor|63|||
155715730|NCT05579977|562053085|FG005|Treatment Phase|Study terminated by sponsor|53|||
155715731|NCT05579977|562053086|FG006|Treatment Phase|Study terminated by sponsor|66|||
155715732|NCT05579977|562053087|FG007|Treatment Phase|Study terminated by sponsor|48|||
155715733|NCT05579977|562053088|FG008|Treatment Phase|Study terminated by sponsor|47|||
155715734|NCT05579977|562053089|FG009|Treatment Phase|Study terminated by sponsor|37|||
155715735|NCT05579977|562053090|FG010|Treatment Phase|Study terminated by sponsor|44|||
155715736|NCT05579977|562053091|FG011|Treatment Phase|Study terminated by sponsor|36|||
155715737|NCT05579977|562053092|FG012|Treatment Phase|Study terminated by sponsor|32|||
155715738|NCT05579977|562053080|FG000|Treatment Phase|Pregnancy|0|||
155715739|NCT05579977|562053081|FG001|Treatment Phase|Pregnancy|0|||
155715740|NCT05579977|562053082|FG002|Treatment Phase|Pregnancy|0|||
155715741|NCT05579977|562053083|FG003|Treatment Phase|Pregnancy|0|||
155715742|NCT05579977|562053084|FG004|Treatment Phase|Pregnancy|0|||
155715743|NCT05579977|562053085|FG005|Treatment Phase|Pregnancy|0|||
155715744|NCT05579977|562053086|FG006|Treatment Phase|Pregnancy|0|||
155715745|NCT05579977|562053087|FG007|Treatment Phase|Pregnancy|0|||
155715746|NCT05579977|562053088|FG008|Treatment Phase|Pregnancy|0|||
155715747|NCT05579977|562053089|FG009|Treatment Phase|Pregnancy|1|||
155715748|NCT05579977|562053090|FG010|Treatment Phase|Pregnancy|0|||
155715749|NCT05579977|562053091|FG011|Treatment Phase|Pregnancy|0|||
155715750|NCT05579977|562053092|FG012|Treatment Phase|Pregnancy|0|||
155715751|NCT05579977|562053080|FG000|Treatment Phase|Physician Decision|0|||
155715752|NCT05579977|562053081|FG001|Treatment Phase|Physician Decision|0|||
155715753|NCT05579977|562053082|FG002|Treatment Phase|Physician Decision|0|||
155715754|NCT05579977|562053083|FG003|Treatment Phase|Physician Decision|0|||
155715755|NCT05579977|562053084|FG004|Treatment Phase|Physician Decision|0|||
155715756|NCT05579977|562053085|FG005|Treatment Phase|Physician Decision|0|||
155715757|NCT05579977|562053086|FG006|Treatment Phase|Physician Decision|0|||
155715758|NCT05579977|562053087|FG007|Treatment Phase|Physician Decision|0|||
155715759|NCT05579977|562053088|FG008|Treatment Phase|Physician Decision|0|||
155715760|NCT05579977|562053089|FG009|Treatment Phase|Physician Decision|0|||
155715761|NCT05579977|562053090|FG010|Treatment Phase|Physician Decision|0|||
155715762|NCT05579977|562053091|FG011|Treatment Phase|Physician Decision|1|||
155715763|NCT05579977|562053092|FG012|Treatment Phase|Physician Decision|0|||
155715764|NCT05579977|562053080|FG000|Treatment Phase|Lost to Follow-up|0|||
155715765|NCT05579977|562053081|FG001|Treatment Phase|Lost to Follow-up|0|||
155715766|NCT05579977|562053082|FG002|Treatment Phase|Lost to Follow-up|0|||
155715767|NCT05579977|562053083|FG003|Treatment Phase|Lost to Follow-up|1|||
155715768|NCT05579977|562053084|FG004|Treatment Phase|Lost to Follow-up|1|||
155715769|NCT05579977|562053085|FG005|Treatment Phase|Lost to Follow-up|1|||
155715770|NCT05579977|562053086|FG006|Treatment Phase|Lost to Follow-up|0|||
155715771|NCT05579977|562053087|FG007|Treatment Phase|Lost to Follow-up|1|||
155715772|NCT05579977|562053088|FG008|Treatment Phase|Lost to Follow-up|2|||
155715773|NCT05579977|562053089|FG009|Treatment Phase|Lost to Follow-up|2|||
155715774|NCT05579977|562053090|FG010|Treatment Phase|Lost to Follow-up|1|||
155715775|NCT05579977|562053091|FG011|Treatment Phase|Lost to Follow-up|4|||
155715776|NCT05579977|562053092|FG012|Treatment Phase|Lost to Follow-up|3|||
155715777|NCT05579977|562053080|FG000|Treatment Phase|Death|1|||
155715778|NCT05579977|562053081|FG001|Treatment Phase|Death|0|||
155715779|NCT05579977|562053082|FG002|Treatment Phase|Death|0|||
155715780|NCT05579977|562053083|FG003|Treatment Phase|Death|0|||
155715781|NCT05579977|562053084|FG004|Treatment Phase|Death|0|||
155715782|NCT05579977|562053085|FG005|Treatment Phase|Death|0|||
155715783|NCT05579977|562053086|FG006|Treatment Phase|Death|0|||
155715784|NCT05579977|562053087|FG007|Treatment Phase|Death|0|||
155715785|NCT05579977|562053088|FG008|Treatment Phase|Death|0|||
155715786|NCT05579977|562053089|FG009|Treatment Phase|Death|0|||
155715787|NCT05579977|562053090|FG010|Treatment Phase|Death|0|||
155715788|NCT05579977|562053091|FG011|Treatment Phase|Death|0|||
155715789|NCT05579977|562053092|FG012|Treatment Phase|Death|0|||
155715790|NCT05579977|562053080|FG000|Treatment Phase|Adverse Event|0|||
155715791|NCT05579977|562053081|FG001|Treatment Phase|Adverse Event|3|||
155715792|NCT05579977|562053082|FG002|Treatment Phase|Adverse Event|11|||
155715793|NCT05579977|562053083|FG003|Treatment Phase|Adverse Event|10|||
155715794|NCT05579977|562053084|FG004|Treatment Phase|Adverse Event|5|||
155715795|NCT05579977|562053085|FG005|Treatment Phase|Adverse Event|17|||
155715796|NCT05579977|562053086|FG006|Treatment Phase|Adverse Event|5|||
155715797|NCT05579977|562053087|FG007|Treatment Phase|Adverse Event|5|||
155715798|NCT05579977|562053088|FG008|Treatment Phase|Adverse Event|12|||
155715799|NCT05579977|562053089|FG009|Treatment Phase|Adverse Event|20|||
155715800|NCT05579977|562053090|FG010|Treatment Phase|Adverse Event|15|||
155715801|NCT05579977|562053091|FG011|Treatment Phase|Adverse Event|24|||
155715802|NCT05579977|562053092|FG012|Treatment Phase|Adverse Event|23|||
155715803|NCT05579977|562053080|FG000|Treatment Phase|Randomized not treated|0|||
155715804|NCT05579977|562053081|FG001|Treatment Phase|Randomized not treated|0|||
155715805|NCT05579977|562053082|FG002|Treatment Phase|Randomized not treated|0|||
155715806|NCT05579977|562053083|FG003|Treatment Phase|Randomized not treated|0|||
155715807|NCT05579977|562053084|FG004|Treatment Phase|Randomized not treated|1|||
155715808|NCT05579977|562053085|FG005|Treatment Phase|Randomized not treated|0|||
155715809|NCT05579977|562053086|FG006|Treatment Phase|Randomized not treated|0|||
155715810|NCT05579977|562053087|FG007|Treatment Phase|Randomized not treated|0|||
155715811|NCT05579977|562053088|FG008|Treatment Phase|Randomized not treated|0|||
155715812|NCT05579977|562053089|FG009|Treatment Phase|Randomized not treated|0|||
155715813|NCT05579977|562053090|FG010|Treatment Phase|Randomized not treated|0|||
155715814|NCT05579977|562053091|FG011|Treatment Phase|Randomized not treated|0|||
155715815|NCT05579977|562053092|FG012|Treatment Phase|Randomized not treated|0|||
155715816|NCT05579977|562053080|FG000|Follow up|Death|1|||
155715817|NCT05579977|562053081|FG001|Follow up|Death|0|||
155715818|NCT05579977|562053082|FG002|Follow up|Death|0|||
155715819|NCT05579977|562053083|FG003|Follow up|Death|0|||
155715820|NCT05579977|562053084|FG004|Follow up|Death|0|||
155715821|NCT05579977|562053085|FG005|Follow up|Death|0|||
155715822|NCT05579977|562053086|FG006|Follow up|Death|0|||
155715823|NCT05579977|562053087|FG007|Follow up|Death|0|||
155715824|NCT05579977|562053088|FG008|Follow up|Death|0|||
155715825|NCT05579977|562053089|FG009|Follow up|Death|0|||
155715826|NCT05579977|562053090|FG010|Follow up|Death|0|||
155715827|NCT05579977|562053091|FG011|Follow up|Death|0|||
155715828|NCT05579977|562053092|FG012|Follow up|Death|0|||
155715829|NCT05579977|562053080|FG000|Follow up|Lost to Follow-up|0|||
155715830|NCT05579977|562053081|FG001|Follow up|Lost to Follow-up|0|||
155715831|NCT05579977|562053082|FG002|Follow up|Lost to Follow-up|0|||
155715832|NCT05579977|562053083|FG003|Follow up|Lost to Follow-up|1|||
155715833|NCT05579977|562053084|FG004|Follow up|Lost to Follow-up|1|||
155715834|NCT05579977|562053085|FG005|Follow up|Lost to Follow-up|2|||
155715835|NCT05579977|562053086|FG006|Follow up|Lost to Follow-up|1|||
155715836|NCT05579977|562053087|FG007|Follow up|Lost to Follow-up|1|||
155715837|NCT05579977|562053088|FG008|Follow up|Lost to Follow-up|3|||
155715838|NCT05579977|562053089|FG009|Follow up|Lost to Follow-up|2|||
155715839|NCT05579977|562053090|FG010|Follow up|Lost to Follow-up|2|||
155715840|NCT05579977|562053091|FG011|Follow up|Lost to Follow-up|4|||
155715841|NCT05579977|562053092|FG012|Follow up|Lost to Follow-up|4|||
155715842|NCT05579977|562053080|FG000|Follow up|Withdrawal by Subject|2|||
155715843|NCT05579977|562053081|FG001|Follow up|Withdrawal by Subject|0|||
155715844|NCT05579977|562053082|FG002|Follow up|Withdrawal by Subject|0|||
155715845|NCT05579977|562053083|FG003|Follow up|Withdrawal by Subject|0|||
155715846|NCT05579977|562053084|FG004|Follow up|Withdrawal by Subject|1|||
155715847|NCT05579977|562053085|FG005|Follow up|Withdrawal by Subject|0|||
155715848|NCT05579977|562053086|FG006|Follow up|Withdrawal by Subject|1|||
155715849|NCT05579977|562053087|FG007|Follow up|Withdrawal by Subject|4|||
155715850|NCT05579977|562053088|FG008|Follow up|Withdrawal by Subject|2|||
155715851|NCT05579977|562053089|FG009|Follow up|Withdrawal by Subject|3|||
155715852|NCT05579977|562053090|FG010|Follow up|Withdrawal by Subject|3|||
155715853|NCT05579977|562053091|FG011|Follow up|Withdrawal by Subject|1|||
155715854|NCT05579977|562053092|FG012|Follow up|Withdrawal by Subject|3|||
155715855|NCT01611194|562053094|FG000|Overall Study|Lost to Follow-up|0|||
155715856|NCT01611194|562053095|FG001|Overall Study|Lost to Follow-up|1|||
155715857|NCT01611194|562053094|FG000|Overall Study|Withdrawal by Subject|0|||
155715858|NCT01611194|562053095|FG001|Overall Study|Withdrawal by Subject|1|||
155715859|NCT01611194|562053094|FG000|Overall Study|drug use|0|||
155715860|NCT01611194|562053095|FG001|Overall Study|drug use|1|||
155715861|NCT00452790|562053096|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
155184980|NCT02537574|560116250|FG000|Overall Study|Failed Naloxone Challenge|0|||
155184981|NCT02537574|560116251|FG001|Overall Study|Failed Naloxone Challenge|1|||
155184982|NCT02537574|560116252|FG002|Overall Study|Failed Naloxone Challenge|0|||
155184983|NCT02537574|560116250|FG000|Overall Study|Transportation Issues|0|||
155184984|NCT02537574|560116251|FG001|Overall Study|Transportation Issues|0|||
155184985|NCT02537574|560116252|FG002|Overall Study|Transportation Issues|1|||
155184986|NCT02537574|560116250|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
155184987|NCT02537574|560116251|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
155184988|NCT02537574|560116252|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
155184989|NCT02537574|560116250|FG000|Overall Study|Noncompliance with Protocol|0|||
155184990|NCT02537574|560116251|FG001|Overall Study|Noncompliance with Protocol|0|||
155184991|NCT02537574|560116252|FG002|Overall Study|Noncompliance with Protocol|1|||
155184992|NCT02663687|560116253|FG000|Overall Study|Adverse Event|1|||
155715862|NCT00452790|562053097|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
155715863|NCT00452790|562053096|FG000|Infant Series|Parent/legal guardian request|8|||
155715864|NCT00452790|562053097|FG001|Infant Series|Parent/legal guardian request|6|||
155715865|NCT00452790|562053096|FG000|Infant Series|Failed to return|4|||
155715866|NCT00452790|562053097|FG001|Infant Series|Failed to return|1|||
155715867|NCT00452790|562053096|FG000|Infant Series|Protocol Violation|1|||
155715868|NCT00452790|562053097|FG001|Infant Series|Protocol Violation|3|||
155715869|NCT00452790|562053096|FG000|Infant Series|Lost to Follow-up|2|||
155715870|NCT00452790|562053097|FG001|Infant Series|Lost to Follow-up|2|||
155715871|NCT00452790|562053096|FG000|Infant Series|Adverse Event|1|||
155715872|NCT00452790|562053097|FG001|Infant Series|Adverse Event|2|||
155715873|NCT00452790|562053096|FG000|Infant Series|Other reasons|1|||
155715874|NCT00452790|562053097|FG001|Infant Series|Other reasons|2|||
155715875|NCT00452790|562053096|FG000|Infant Series|Investigator request|0|||
155715876|NCT00452790|562053097|FG001|Infant Series|Investigator request|1|||
155715877|NCT00452790|562053096|FG000|Infant Series|Death|0|||
155715878|NCT00452790|562053097|FG001|Infant Series|Death|1|||
155715879|NCT00452790|562053096|FG000|After Infant Series|Investigator request|10|||
155715880|NCT00452790|562053097|FG001|After Infant Series|Investigator request|10|||
155715881|NCT00452790|562053096|FG000|After Infant Series|Adverse Event|4|||
155715882|NCT00452790|562053097|FG001|After Infant Series|Adverse Event|1|||
155715883|NCT00452790|562053096|FG000|After Infant Series|Parent/legal guardian request|1|||
155715884|NCT00452790|562053097|FG001|After Infant Series|Parent/legal guardian request|3|||
155715885|NCT00452790|562053096|FG000|After Infant Series|Lost to Follow-up|4|||
155715886|NCT00452790|562053097|FG001|After Infant Series|Lost to Follow-up|0|||
155184993|NCT02663687|560116254|FG001|Overall Study|Adverse Event|0|||
155184994|NCT02663687|560116255|FG002|Overall Study|Adverse Event|0|||
155715887|NCT00452790|562053096|FG000|After Infant Series|Failed to return|1|||
155715888|NCT00452790|562053097|FG001|After Infant Series|Failed to return|0|||
155715889|NCT00452790|562053096|FG000|After Infant Series|Other reasons|1|||
155715890|NCT00452790|562053097|FG001|After Infant Series|Other reasons|0|||
155715891|NCT00452790|562053096|FG000|Toddler Dose|Failed to return|0|||
155715892|NCT00452790|562053097|FG001|Toddler Dose|Failed to return|1|||
155715893|NCT00452790|562053096|FG000|Toddler Dose|Parent/legal guardian request|0|||
155715894|NCT00452790|562053097|FG001|Toddler Dose|Parent/legal guardian request|1|||
155715895|NCT01871519|562053103|FG000|Overall Study|Death|26|||
155715896|NCT01871519|562053103|FG000|Overall Study|Lost to Follow-up|15|||
155715897|NCT01871519|562053103|FG000|Overall Study|Withdrawal by Subject|49|||
155715898|NCT00794950|562053104|FG000|BCG Induction|Withdrawal by Subject|2|||
155715899|NCT00794950|562053104|FG000|BCG Induction|ineligible|3|||
155715900|NCT00794950|562053104|FG000|BCG Induction|noncompliant w. BCG|1|||
155715901|NCT00794950|562053104|FG000|BCG Induction|Adverse Event|1|||
155715902|NCT00794950|562053104|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
155715903|NCT00794950|562053104|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
155715904|NCT00794950|562053104|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
155715905|NCT00794950|562053104|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
155715906|NCT02485704|562053105|FG000|Overall Study|Lost to Follow-up|4|||
155715907|NCT02485704|562053106|FG001|Overall Study|Lost to Follow-up|5|||
155715908|NCT02485704|562053105|FG000|Overall Study|Withdrawal by Subject|0|||
155715909|NCT02485704|562053106|FG001|Overall Study|Withdrawal by Subject|3|||
155715910|NCT02485704|562053105|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
155715911|NCT02485704|562053106|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
155715912|NCT01474317|562054638|FG000|Overall Study|Adverse Event|1|||
155715913|NCT01474317|562054638|FG000|Overall Study|Subject ineligible for study|1|||
155715914|NCT00453154|562054639|FG000|Double BIind Maintenance|Adverse Event|0|||
155715915|NCT00453154|562054640|FG001|Double BIind Maintenance|Adverse Event|0|||
155715916|NCT00453154|562054641|FG002|Double BIind Maintenance|Adverse Event|3|||
155715917|NCT00453154|562054642|FG003|Double BIind Maintenance|Adverse Event|12|||
155715918|NCT00453154|562054639|FG000|Double BIind Maintenance|Death|0|||
155715919|NCT00453154|562054640|FG001|Double BIind Maintenance|Death|0|||
155715920|NCT00453154|562054641|FG002|Double BIind Maintenance|Death|2|||
155715921|NCT00453154|562054642|FG003|Double BIind Maintenance|Death|1|||
155715922|NCT00453154|562054639|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
155715923|NCT00453154|562054640|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
155715924|NCT00453154|562054641|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
155715925|NCT00453154|562054642|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
155715926|NCT00453154|562054639|FG000|Double BIind Maintenance|Progression|0|||
155715927|NCT00453154|562054640|FG001|Double BIind Maintenance|Progression|0|||
155715928|NCT00453154|562054641|FG002|Double BIind Maintenance|Progression|29|||
155715929|NCT00453154|562054642|FG003|Double BIind Maintenance|Progression|26|||
155715930|NCT00453154|562054639|FG000|Double BIind Maintenance|Medical Issues|0|||
155715931|NCT00453154|562054640|FG001|Double BIind Maintenance|Medical Issues|0|||
155715932|NCT00453154|562054641|FG002|Double BIind Maintenance|Medical Issues|3|||
155715933|NCT00453154|562054642|FG003|Double BIind Maintenance|Medical Issues|1|||
155715934|NCT00453154|562054639|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
155715935|NCT00453154|562054640|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
155715936|NCT00453154|562054641|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
155715937|NCT00453154|562054642|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
155715938|NCT01169103|562054645|FG000|Overall Study|Lost to Follow-up|3|||
155715939|NCT01169103|562054646|FG001|Overall Study|Lost to Follow-up|3|||
155715940|NCT01169103|562054645|FG000|Overall Study|Withdrawal by Subject|3|||
155715941|NCT01169103|562054646|FG001|Overall Study|Withdrawal by Subject|1|||
155715942|NCT00248495|562054649|FG000|Overall Study|Withdrawal by Subject|1|||
155715943|NCT03360682|562054654|FG000|Overall Study|Adverse Event|3|||
155715944|NCT01363700|562054657|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155715945|NCT01363700|562054658|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
155715946|NCT01363700|562054659|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155715947|NCT01363700|562054660|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155715948|NCT01363700|562054661|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155715949|NCT03827655|562054662|FG000|Overall Study|Death|0|||
155715950|NCT03827655|562054663|FG001|Overall Study|Death|0|||
155715951|NCT03827655|562054664|FG002|Overall Study|Death|0|||
155715952|NCT03827655|562054665|FG003|Overall Study|Death|0|||
155715953|NCT03827655|562054666|FG004|Overall Study|Death|1|||
155715954|NCT03827655|562054662|FG000|Overall Study|Protocol Deviation|1|||
155715955|NCT03827655|562054663|FG001|Overall Study|Protocol Deviation|0|||
155715956|NCT03827655|562054664|FG002|Overall Study|Protocol Deviation|1|||
155715957|NCT03827655|562054665|FG003|Overall Study|Protocol Deviation|1|||
155715958|NCT03827655|562054666|FG004|Overall Study|Protocol Deviation|0|||
155715959|NCT03827655|562054662|FG000|Overall Study|Withdrawal by Subject|3|||
155715960|NCT03827655|562054663|FG001|Overall Study|Withdrawal by Subject|2|||
155715961|NCT03827655|562054664|FG002|Overall Study|Withdrawal by Subject|2|||
155715962|NCT03827655|562054665|FG003|Overall Study|Withdrawal by Subject|0|||
155715963|NCT03827655|562054666|FG004|Overall Study|Withdrawal by Subject|1|||
155715964|NCT03827655|562054662|FG000|Overall Study|Reason not Specified|3|||
155715965|NCT03827655|562054663|FG001|Overall Study|Reason not Specified|1|||
155715966|NCT03827655|562054664|FG002|Overall Study|Reason not Specified|1|||
155715967|NCT03827655|562054665|FG003|Overall Study|Reason not Specified|1|||
155715968|NCT03827655|562054666|FG004|Overall Study|Reason not Specified|1|||
155715969|NCT03649217|562054667|FG000|Overall Study|subject had severe ataxia not initially found|1|||
155715970|NCT03649217|562054667|FG000|Overall Study|subject had cognitive issues not initially found|1|||
155715971|NCT02552966|562054670|FG000|Overall Study|Lost to Follow-up|2|||
155715972|NCT02552966|562054670|FG000|Overall Study|Withdrawal by Subject|3|||
155715973|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715974|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715975|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715976|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
155715977|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715978|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715979|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715980|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715981|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715982|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155715983|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
155715984|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
155715985|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155715986|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
155715987|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
155715988|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
155715989|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155715990|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155715991|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155715992|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155715993|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
155715994|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155715995|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155715996|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155715997|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
155715998|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155715999|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155716000|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155716001|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155716002|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155716003|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
155716004|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716005|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
155716006|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716007|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
155716008|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
155716009|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716010|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716011|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716012|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
155716013|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
155716014|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716015|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
155716016|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716017|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
155716018|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716019|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716020|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716021|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716022|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155716023|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155716024|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716025|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716026|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716027|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155716028|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155716029|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716030|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716031|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716032|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155716033|NCT02365649|562054674|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716034|NCT02365649|562054675|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716035|NCT02365649|562054676|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
155716036|NCT02365649|562054677|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716037|NCT02365649|562054678|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716038|NCT02365649|562054679|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716039|NCT02365649|562054680|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716040|NCT02365649|562054681|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716041|NCT02365649|562054682|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716042|NCT02365649|562054683|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155716043|NCT02365649|562054674|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716044|NCT02365649|562054675|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716045|NCT02365649|562054676|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716046|NCT02365649|562054677|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716047|NCT02365649|562054678|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716048|NCT02365649|562054679|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716049|NCT02365649|562054680|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
155716050|NCT02365649|562054681|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716051|NCT02365649|562054682|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716052|NCT02365649|562054683|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155716053|NCT02365649|562054674|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716054|NCT02365649|562054675|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716055|NCT02365649|562054676|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716056|NCT02365649|562054677|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716057|NCT02365649|562054678|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716058|NCT02365649|562054679|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716059|NCT02365649|562054680|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
155716060|NCT02365649|562054681|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155716061|NCT02365649|562054682|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
155716062|NCT02365649|562054683|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
155716063|NCT02365649|562054674|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716064|NCT02365649|562054675|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716065|NCT02365649|562054676|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716066|NCT02365649|562054677|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716067|NCT02365649|562054678|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716068|NCT02365649|562054679|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155716069|NCT02365649|562054680|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
155716070|NCT02365649|562054681|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
155716071|NCT02365649|562054682|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
155716072|NCT02365649|562054683|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
155716073|NCT02365649|562054674|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716074|NCT02365649|562054675|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716075|NCT02365649|562054676|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716076|NCT02365649|562054677|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716077|NCT02365649|562054678|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716078|NCT02365649|562054679|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716079|NCT02365649|562054680|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
155716080|NCT02365649|562054681|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155716081|NCT02365649|562054682|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
155716082|NCT02365649|562054683|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
155716083|NCT02365649|562054674|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716084|NCT02365649|562054675|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716085|NCT02365649|562054676|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716086|NCT02365649|562054677|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716087|NCT02365649|562054678|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716088|NCT02365649|562054679|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716089|NCT02365649|562054680|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
155716090|NCT02365649|562054681|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716091|NCT02365649|562054682|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
155716092|NCT02365649|562054683|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155716093|NCT01433172|562054691|FG000|Overall Study|Withdrawal by Subject|0|||
155716094|NCT01433172|562054692|FG001|Overall Study|Withdrawal by Subject|1|||
155716095|NCT01433172|562054693|FG002|Overall Study|Withdrawal by Subject|0|||
155716096|NCT01433172|562054691|FG000|Overall Study|Disease Progression|0|||
155716097|NCT01433172|562054692|FG001|Overall Study|Disease Progression|0|||
155716098|NCT01433172|562054693|FG002|Overall Study|Disease Progression|1|||
155716099|NCT01433172|562054691|FG000|Overall Study|Death|0|||
155716100|NCT01433172|562054692|FG001|Overall Study|Death|2|||
155716101|NCT01433172|562054693|FG002|Overall Study|Death|0|||
155716102|NCT03084796|562054696|FG000|Overall Study|Adverse Event|4|||
155716103|NCT03084796|562054697|FG001|Overall Study|Adverse Event|5|||
155716104|NCT03084796|562054698|FG002|Overall Study|Adverse Event|6|||
155716105|NCT03084796|562054699|FG003|Overall Study|Adverse Event|2|||
155716106|NCT03084796|562054700|FG004|Overall Study|Adverse Event|3|||
155716107|NCT03084796|562054701|FG005|Overall Study|Adverse Event|5|||
155716108|NCT03084796|562054696|FG000|Overall Study|Withdrawal by Subject|3|||
155716109|NCT03084796|562054697|FG001|Overall Study|Withdrawal by Subject|5|||
155716110|NCT03084796|562054698|FG002|Overall Study|Withdrawal by Subject|2|||
155716111|NCT03084796|562054699|FG003|Overall Study|Withdrawal by Subject|1|||
155716112|NCT03084796|562054700|FG004|Overall Study|Withdrawal by Subject|3|||
155716113|NCT03084796|562054701|FG005|Overall Study|Withdrawal by Subject|0|||
155716114|NCT03084796|562054696|FG000|Overall Study|Protocol Violation|0|||
155716115|NCT03084796|562054697|FG001|Overall Study|Protocol Violation|0|||
155716116|NCT03084796|562054698|FG002|Overall Study|Protocol Violation|1|||
155716117|NCT03084796|562054699|FG003|Overall Study|Protocol Violation|0|||
155716118|NCT03084796|562054700|FG004|Overall Study|Protocol Violation|1|||
155716119|NCT03084796|562054701|FG005|Overall Study|Protocol Violation|1|||
155716120|NCT03084796|562054696|FG000|Overall Study|Lack of Efficacy|0|||
155716121|NCT03084796|562054697|FG001|Overall Study|Lack of Efficacy|0|||
155716122|NCT03084796|562054698|FG002|Overall Study|Lack of Efficacy|1|||
155716123|NCT03084796|562054699|FG003|Overall Study|Lack of Efficacy|0|||
155716124|NCT03084796|562054700|FG004|Overall Study|Lack of Efficacy|1|||
155716125|NCT03084796|562054701|FG005|Overall Study|Lack of Efficacy|0|||
155716126|NCT03084796|562054696|FG000|Overall Study|Lost to Follow-up|0|||
155716127|NCT03084796|562054697|FG001|Overall Study|Lost to Follow-up|0|||
155716128|NCT03084796|562054698|FG002|Overall Study|Lost to Follow-up|1|||
155716129|NCT03084796|562054699|FG003|Overall Study|Lost to Follow-up|1|||
155716130|NCT03084796|562054700|FG004|Overall Study|Lost to Follow-up|3|||
155716131|NCT03084796|562054701|FG005|Overall Study|Lost to Follow-up|1|||
155716132|NCT03084796|562054696|FG000|Overall Study|Randomization error|0|||
155716133|NCT03084796|562054697|FG001|Overall Study|Randomization error|0|||
155716134|NCT03084796|562054698|FG002|Overall Study|Randomization error|1|||
155716135|NCT03084796|562054699|FG003|Overall Study|Randomization error|0|||
155716136|NCT03084796|562054700|FG004|Overall Study|Randomization error|0|||
155716137|NCT03084796|562054701|FG005|Overall Study|Randomization error|0|||
155716138|NCT02741245|562054703|FG000|Overall Study|Adverse Event|0|||
155716139|NCT02741245|562054704|FG001|Overall Study|Adverse Event|0|||
155716140|NCT02741245|562054705|FG002|Overall Study|Adverse Event|0|||
155716141|NCT02741245|562054706|FG003|Overall Study|Adverse Event|2|||
155716142|NCT02741245|562054707|FG004|Overall Study|Adverse Event|2|||
155716143|NCT02741245|562054703|FG000|Overall Study|Protocol Violation|0|||
155716144|NCT02741245|562054704|FG001|Overall Study|Protocol Violation|1|||
155716145|NCT02741245|562054705|FG002|Overall Study|Protocol Violation|0|||
155716146|NCT02741245|562054706|FG003|Overall Study|Protocol Violation|1|||
155716147|NCT02741245|562054707|FG004|Overall Study|Protocol Violation|0|||
155716148|NCT02741245|562054703|FG000|Overall Study|Withdrawal by Subject|0|||
155716149|NCT02741245|562054704|FG001|Overall Study|Withdrawal by Subject|0|||
155716150|NCT02741245|562054705|FG002|Overall Study|Withdrawal by Subject|0|||
155716151|NCT02741245|562054706|FG003|Overall Study|Withdrawal by Subject|1|||
155716152|NCT02741245|562054707|FG004|Overall Study|Withdrawal by Subject|0|||
155716153|NCT01787461|562054708|FG000|Overall Study|Adverse Event|4|||
155716154|NCT01787461|562054709|FG001|Overall Study|Adverse Event|3|||
155716155|NCT01787461|562054708|FG000|Overall Study|Lost to Follow-up|3|||
155716156|NCT01787461|562054709|FG001|Overall Study|Lost to Follow-up|2|||
155716157|NCT01787461|562054708|FG000|Overall Study|No longer met eligibility criteria|1|||
155716158|NCT01787461|562054709|FG001|Overall Study|No longer met eligibility criteria|0|||
155716159|NCT01787461|562054708|FG000|Overall Study|Withdrawal by Subject|3|||
155716160|NCT01787461|562054709|FG001|Overall Study|Withdrawal by Subject|4|||
155716161|NCT01787461|562054708|FG000|Overall Study|Protocol Violation|3|||
155716162|NCT01787461|562054709|FG001|Overall Study|Protocol Violation|0|||
155716163|NCT03259555|562054710|FG000|Overall Study|Adverse Event|6|||
155716164|NCT03259555|562054711|FG001|Overall Study|Adverse Event|4|||
155716165|NCT03259555|562054710|FG000|Overall Study|Lack of Efficacy|6|||
155716166|NCT03259555|562054711|FG001|Overall Study|Lack of Efficacy|4|||
155716167|NCT03259555|562054710|FG000|Overall Study|Lost to Follow-up|0|||
155716168|NCT03259555|562054711|FG001|Overall Study|Lost to Follow-up|2|||
155716169|NCT03259555|562054710|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155716170|NCT03259555|562054711|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155716171|NCT03259555|562054710|FG000|Overall Study|Progressive Disease|0|||
155716172|NCT03259555|562054711|FG001|Overall Study|Progressive Disease|2|||
155716173|NCT03259555|562054710|FG000|Overall Study|Withdrawal by Subject|19|||
155716174|NCT03259555|562054711|FG001|Overall Study|Withdrawal by Subject|16|||
155716175|NCT03259555|562054710|FG000|Overall Study|Physician Decision|1|||
155716176|NCT03259555|562054711|FG001|Overall Study|Physician Decision|2|||
155716177|NCT03259555|562054710|FG000|Overall Study|Other|1|||
155716178|NCT03259555|562054711|FG001|Overall Study|Other|0|||
155716179|NCT02800863|562054712|FG000|Overall Study|Adverse Event|14|||
155716180|NCT02800863|562054712|FG000|Overall Study|Another Device Implanted|1|||
155716181|NCT02800863|562054712|FG000|Overall Study|Device Explanted|1|||
155716182|NCT02800863|562054712|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
155716183|NCT02800863|562054712|FG000|Overall Study|Health Issues|1|||
155716184|NCT02800863|562054712|FG000|Overall Study|Insurance Denial|8|||
155716185|NCT02800863|562054712|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
155716186|NCT02800863|562054712|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
155716187|NCT02800863|562054712|FG000|Overall Study|Screen Failure|1|||
155716188|NCT02800863|562054712|FG000|Overall Study|Sponsor Request|6|||
155716189|NCT02800863|562054712|FG000|Overall Study|Death|3|||
155716190|NCT02800863|562054712|FG000|Overall Study|Subject Implant at Another Facility|1|||
155716191|NCT02800863|562054712|FG000|Overall Study|Lost to Follow-up|26|||
155716192|NCT02800863|562054712|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
155716193|NCT02800863|562054712|FG000|Overall Study|Subject and/or Family Request|64|||
155716194|NCT02800863|562054712|FG000|Overall Study|Trial Failure|81|||
155716195|NCT02800863|562054712|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
155716196|NCT00607087|562054713|FG000|Overall Study|Withdrawal by Subject|9|||
155716197|NCT00607087|562054714|FG001|Overall Study|Withdrawal by Subject|4|||
155716198|NCT00607087|562054715|FG002|Overall Study|Withdrawal by Subject|4|||
155716199|NCT00607087|562054713|FG000|Overall Study|Adverse Event|3|||
155716200|NCT00607087|562054714|FG001|Overall Study|Adverse Event|2|||
155716201|NCT00607087|562054715|FG002|Overall Study|Adverse Event|3|||
155716202|NCT00607087|562054713|FG000|Overall Study|Other reason|1|||
155716203|NCT00607087|562054714|FG001|Overall Study|Other reason|5|||
155716204|NCT00607087|562054715|FG002|Overall Study|Other reason|2|||
155716205|NCT00607087|562054713|FG000|Overall Study|Poor compliance to protocol|1|||
155716206|NCT00607087|562054714|FG001|Overall Study|Poor compliance to protocol|0|||
155716207|NCT00607087|562054715|FG002|Overall Study|Poor compliance to protocol|1|||
155716208|NCT00607087|562054713|FG000|Overall Study|Lost to Follow-up|1|||
155716209|NCT00607087|562054714|FG001|Overall Study|Lost to Follow-up|0|||
155716210|NCT00607087|562054715|FG002|Overall Study|Lost to Follow-up|0|||
155716211|NCT00607087|562054713|FG000|Period 1|Withdrawal by Subject|7|||
155716212|NCT00607087|562054714|FG001|Period 1|Withdrawal by Subject|2|||
155716213|NCT00607087|562054715|FG002|Period 1|Withdrawal by Subject|3|||
155716214|NCT00607087|562054713|FG000|Period 1|Adverse Event|3|||
155716215|NCT00607087|562054714|FG001|Period 1|Adverse Event|0|||
155716216|NCT00607087|562054715|FG002|Period 1|Adverse Event|0|||
155716217|NCT00607087|562054713|FG000|Period 1|Poor compliance to protocol|1|||
155716218|NCT00607087|562054714|FG001|Period 1|Poor compliance to protocol|0|||
155716219|NCT00607087|562054715|FG002|Period 1|Poor compliance to protocol|0|||
155716220|NCT00607087|562054713|FG000|Period 1|Lost to Follow-up|1|||
155716221|NCT00607087|562054714|FG001|Period 1|Lost to Follow-up|0|||
155716222|NCT00607087|562054715|FG002|Period 1|Lost to Follow-up|0|||
155716223|NCT00607087|562054713|FG000|Period 1|Other reason|0|||
155716224|NCT00607087|562054714|FG001|Period 1|Other reason|4|||
155716225|NCT00607087|562054715|FG002|Period 1|Other reason|2|||
155716226|NCT00607087|562054713|FG000|Period 2|Withdrawal by Subject|0|||
155716227|NCT00607087|562054714|FG001|Period 2|Withdrawal by Subject|1|||
155716228|NCT00607087|562054715|FG002|Period 2|Withdrawal by Subject|1|||
155716229|NCT00607087|562054713|FG000|Period 2|Other reason|1|||
155716230|NCT00607087|562054714|FG001|Period 2|Other reason|1|||
155716231|NCT00607087|562054715|FG002|Period 2|Other reason|0|||
155716232|NCT00607087|562054713|FG000|Period 2|Adverse Event|0|||
155716233|NCT00607087|562054714|FG001|Period 2|Adverse Event|1|||
155716234|NCT00607087|562054715|FG002|Period 2|Adverse Event|3|||
155716235|NCT00607087|562054713|FG000|Period 2|Poor compliance to protocol|0|||
155716236|NCT00607087|562054714|FG001|Period 2|Poor compliance to protocol|0|||
155716237|NCT00607087|562054715|FG002|Period 2|Poor compliance to protocol|1|||
155716238|NCT00607087|562054713|FG000|Period 3|Withdrawal by Subject|2|||
155716239|NCT00607087|562054714|FG001|Period 3|Withdrawal by Subject|1|||
155716240|NCT00607087|562054715|FG002|Period 3|Withdrawal by Subject|0|||
155716241|NCT00607087|562054713|FG000|Period 3|Adverse Event|0|||
155716242|NCT00607087|562054714|FG001|Period 3|Adverse Event|1|||
155716243|NCT00607087|562054715|FG002|Period 3|Adverse Event|0|||
155716244|NCT01774799|562054717|FG000|Overall Study|Lost to Follow-up|1|||
155716245|NCT01774799|562054718|FG001|Overall Study|Lost to Follow-up|1|||
155716246|NCT01774799|562054719|FG002|Overall Study|Lost to Follow-up|0|||
155716247|NCT01774799|562054720|FG003|Overall Study|Lost to Follow-up|0|||
155716248|NCT03649074|562054721|FG000|Overall Study|Lost to Follow-up|2|||
155716249|NCT03649074|562054722|FG001|Overall Study|Lost to Follow-up|1|||
155716250|NCT03649074|562054721|FG000|Overall Study|Adverse Event|1|||
155184995|NCT02663687|560116256|FG003|Overall Study|Adverse Event|0|||
155716251|NCT03649074|562054722|FG001|Overall Study|Adverse Event|0|||
155716252|NCT03649074|562054721|FG000|Overall Study|Physician Decision|1|||
155716253|NCT03649074|562054722|FG001|Overall Study|Physician Decision|0|||
155716254|NCT03649074|562054721|FG000|Overall Study|Withdrawal by Subject|0|||
155716255|NCT03649074|562054722|FG001|Overall Study|Withdrawal by Subject|2|||
155716256|NCT03649074|562054721|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
155716257|NCT03649074|562054722|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
155716258|NCT03649074|562054721|FG000|Overall Study|Other|1|||
155716259|NCT03649074|562054722|FG001|Overall Study|Other|0|||
155716260|NCT04332107|562054725|FG000|Day 3|Lost to Follow-up|23|||
155716261|NCT04332107|562054726|FG001|Day 3|Lost to Follow-up|14|||
155716262|NCT04332107|562054725|FG000|Day 3|Missing outcome data|3|||
155716263|NCT04332107|562054726|FG001|Day 3|Missing outcome data|6|||
155716264|NCT04332107|562054725|FG000|Day 14|Lost to Follow-up|13|||
155716265|NCT04332107|562054726|FG001|Day 14|Lost to Follow-up|4|||
155716266|NCT04332107|562054725|FG000|Day 14|Missing outcome data|4|||
155716267|NCT04332107|562054726|FG001|Day 14|Missing outcome data|4|||
155716268|NCT04332107|562054725|FG000|Day 21|Lost to Follow-up|10|||
155716269|NCT04332107|562054726|FG001|Day 21|Lost to Follow-up|2|||
155716270|NCT00717249|562054727|FG000|Overall Study|Lens Discomfort|4|||
155716271|NCT00717249|562054728|FG001|Overall Study|Lens Discomfort|1|||
155716272|NCT00717249|562054727|FG000|Overall Study|Unsatisfactory visual Response|0|||
155716273|NCT00717249|562054728|FG001|Overall Study|Unsatisfactory visual Response|2|||
155716274|NCT00717249|562054727|FG000|Overall Study|Adverse Event|4|||
155716275|NCT00717249|562054728|FG001|Overall Study|Adverse Event|2|||
155716276|NCT00717249|562054727|FG000|Overall Study|Lost to Follow-up|2|||
155716277|NCT00717249|562054728|FG001|Overall Study|Lost to Follow-up|0|||
155716278|NCT00717249|562054727|FG000|Overall Study|Withdrawal by Subject|1|||
155716279|NCT00717249|562054728|FG001|Overall Study|Withdrawal by Subject|2|||
155716280|NCT00717249|562054727|FG000|Overall Study|Pregnancy|6|||
155716281|NCT00717249|562054728|FG001|Overall Study|Pregnancy|3|||
155716282|NCT00717249|562054727|FG000|Overall Study|Protocol Violation|0|||
155716283|NCT00717249|562054728|FG001|Overall Study|Protocol Violation|2|||
155716284|NCT00717249|562054727|FG000|Overall Study|Subject became Ineligible|1|||
155716285|NCT00717249|562054728|FG001|Overall Study|Subject became Ineligible|1|||
155716286|NCT00717249|562054727|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
155716287|NCT00717249|562054728|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
155716288|NCT00717249|562054727|FG000|Overall Study|Gastric Surgery|0|||
155716289|NCT00717249|562054728|FG001|Overall Study|Gastric Surgery|1|||
155716290|NCT00717249|562054727|FG000|Overall Study|Diagnosed with Diabetes|1|||
155716291|NCT00717249|562054728|FG001|Overall Study|Diagnosed with Diabetes|0|||
155716292|NCT00717249|562054727|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
155716293|NCT00717249|562054728|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
155716294|NCT00717249|562054727|FG000|Overall Study|Subject relocated|1|||
155716295|NCT00717249|562054728|FG001|Overall Study|Subject relocated|0|||
155716296|NCT00717249|562054727|FG000|Overall Study|Headaches|1|||
155716297|NCT00717249|562054728|FG001|Overall Study|Headaches|0|||
155716298|NCT01670721|562054729|FG000|Overall Study|Participant's decision|15|||
155716299|NCT01670721|562054729|FG000|Overall Study|Other than specified above|38|||
155184996|NCT02663687|560116257|FG004|Overall Study|Adverse Event|0|||
155184997|NCT02663687|560116253|FG000|Overall Study|Other|1|||
155184998|NCT02663687|560116254|FG001|Overall Study|Other|0|||
155184999|NCT02663687|560116255|FG002|Overall Study|Other|1|||
155185000|NCT02663687|560116256|FG003|Overall Study|Other|0|||
155185001|NCT02663687|560116257|FG004|Overall Study|Other|0|||
155185002|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
155185003|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
155185004|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
155185005|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
155185006|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
155716300|NCT06172348|562054730|FG000|Treatment Period 2|Adverse Event|0|||
155716301|NCT06172348|562054731|FG001|Treatment Period 2|Adverse Event|0|||
155185007|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
155185008|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
155185009|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
155185010|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
155185011|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Death|1|||
155185012|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Death|0|||
155185013|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Death|0|||
155716302|NCT06172348|562054732|FG002|Treatment Period 2|Adverse Event|1|||
155716303|NCT06172348|562054733|FG003|Treatment Period 2|Adverse Event|0|||
155185014|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
155716304|NCT06172348|562054734|FG004|Treatment Period 2|Adverse Event|0|||
155716305|NCT06172348|562054735|FG005|Treatment Period 2|Adverse Event|0|||
155716306|NCT03799341|562054736|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
155716307|NCT03799341|562054737|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
155716308|NCT03799341|562054738|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
155716309|NCT03799341|562054736|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
155716310|NCT03799341|562054737|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
155716311|NCT03799341|562054738|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
155716312|NCT03799341|562054736|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
155716313|NCT03799341|562054737|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
155716314|NCT03799341|562054738|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
155716315|NCT03799341|562054736|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
155716316|NCT03799341|562054737|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
155716317|NCT03799341|562054738|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
155716318|NCT03799341|562054736|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
155716319|NCT03799341|562054737|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
155716320|NCT03799341|562054738|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
155716321|NCT03799341|562054736|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
155716322|NCT03799341|562054737|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
155716323|NCT03799341|562054738|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
155716324|NCT04037891|562054739|FG000|Open-label Period|Withdrawal by Subject|1|||
155716325|NCT04037891|562054740|FG001|Open-label Period|Withdrawal by Subject|0|||
155716326|NCT04037891|562054741|FG002|Open-label Period|Withdrawal by Subject|0|||
155716327|NCT04037891|562054739|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
155716328|NCT04037891|562054740|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
155716329|NCT04037891|562054741|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
155716330|NCT03446313|562054742|FG000|Overall Study|Lost to Follow-up|1|||
155716331|NCT03446313|562054743|FG001|Overall Study|Lost to Follow-up|2|||
155716332|NCT03446313|562054742|FG000|Overall Study|Failed primary screening|3|||
155716333|NCT03446313|562054743|FG001|Overall Study|Failed primary screening|0|||
155716334|NCT03446313|562054742|FG000|Overall Study|Diagnosed with terminal cancer|1|||
155716335|NCT03446313|562054743|FG001|Overall Study|Diagnosed with terminal cancer|0|||
155716336|NCT03446313|562054742|FG000|Overall Study|Excluded from analysis|1|||
155716337|NCT03446313|562054743|FG001|Overall Study|Excluded from analysis|1|||
155716338|NCT02360228|562054747|FG000|Overall Study|Withdrawal by Subject|1|||
155716339|NCT02360228|562054748|FG001|Overall Study|Withdrawal by Subject|0|||
155716340|NCT02360228|562054749|FG002|Overall Study|Withdrawal by Subject|0|||
155716341|NCT02360228|562054747|FG000|Overall Study|Self-discontinued medication|0|||
155716342|NCT02360228|562054748|FG001|Overall Study|Self-discontinued medication|1|||
155716343|NCT02360228|562054749|FG002|Overall Study|Self-discontinued medication|0|||
155716344|NCT02360228|562054747|FG000|Overall Study|Unstable symptoms during screening|0|||
155716345|NCT02360228|562054748|FG001|Overall Study|Unstable symptoms during screening|0|||
155716346|NCT02360228|562054749|FG002|Overall Study|Unstable symptoms during screening|1|||
155716347|NCT00350844|562054752|FG000|Overall Study|Lost to Follow-up|1|||
155716348|NCT01232868|562056144|FG000|Overall Study|Lost to Follow-up|2|||
155716349|NCT01232868|562056145|FG001|Overall Study|Lost to Follow-up|4|||
155716350|NCT04481243|562056146|FG000|Overall Study|Withdrawal by Subject|4|||
155716351|NCT04564846|562056147|FG000|Overall Study|Withdrawal by Subject|2|||
155716352|NCT04564846|562056148|FG001|Overall Study|Withdrawal by Subject|1|||
155716353|NCT04564846|562056147|FG000|Overall Study|Physician Decision|0|||
155716354|NCT04564846|562056148|FG001|Overall Study|Physician Decision|1|||
155716355|NCT04564846|562056147|FG000|Overall Study|Lost to Follow-up|0|||
155716356|NCT04564846|562056148|FG001|Overall Study|Lost to Follow-up|1|||
155716357|NCT04564846|562056147|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
155716358|NCT04564846|562056148|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
155716359|NCT04564846|562056147|FG000|Overall Study|Subject non-compliance|1|||
155716360|NCT04564846|562056148|FG001|Overall Study|Subject non-compliance|0|||
155716361|NCT00865345|562056149|FG000|Overall Study|Withdrawal by Subject|2|||
155716362|NCT03737123|562056150|FG000|Study Treatment|Adverse Event|2|||
155716363|NCT03737123|562056151|FG001|Study Treatment|Adverse Event|0|||
155716364|NCT03737123|562056150|FG000|Study Treatment|Disease Progression|2|||
155716365|NCT03737123|562056151|FG001|Study Treatment|Disease Progression|0|||
155716366|NCT03737123|562056150|FG000|Study Treatment|Withdrawal by Subject|2|||
155716367|NCT03737123|562056151|FG001|Study Treatment|Withdrawal by Subject|0|||
155716368|NCT03737123|562056150|FG000|Follow up|Death|1|||
155716369|NCT03737123|562056151|FG001|Follow up|Death|0|||
155716370|NCT03737123|562056150|FG000|Follow up|Withdrawal by Subject|1|||
155716371|NCT03737123|562056151|FG001|Follow up|Withdrawal by Subject|0|||
155716372|NCT03737123|562056150|FG000|Follow up|Termination of study|4|||
155716373|NCT03737123|562056151|FG001|Follow up|Termination of study|0|||
155716374|NCT01519323|562056152|FG000|Overall Study|Death|3|||
155716375|NCT01519323|562056153|FG001|Overall Study|Death|2|||
155716376|NCT01519323|562056152|FG000|Overall Study|Study terminated by sponsor|0|||
155716377|NCT01519323|562056153|FG001|Overall Study|Study terminated by sponsor|1|||
155716378|NCT00445549|562056154|FG000|Overall Study|progressive disease|12|||
155716379|NCT03629886|562056167|FG000|Overall Study|Migrated / moved from the study area|0|||
155716380|NCT03629886|562056168|FG001|Overall Study|Migrated / moved from the study area|55|||
155185015|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
155185016|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
155185017|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
155185018|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
155185019|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
155185020|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
155185021|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
155185022|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
155185023|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Death|1|||
155185024|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Death|1|||
155716381|NCT03629886|562056167|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
155716382|NCT03629886|562056168|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
155716383|NCT03629886|562056167|FG000|Overall Study|Study vaccine not administrated|0|||
155716384|NCT03629886|562056168|FG001|Overall Study|Study vaccine not administrated|3|||
155716385|NCT03629886|562056167|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
155716386|NCT03629886|562056168|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
155716387|NCT03629886|562056167|FG000|Overall Study|Refused vaccination step of the study|0|||
155716388|NCT03629886|562056168|FG001|Overall Study|Refused vaccination step of the study|44|||
155716413|NCT03683173|562056173|FG000|Completed Follow-up|Unavailable|235|||
155716414|NCT03683173|562056174|FG001|Completed Follow-up|Unavailable|217|||
155716415|NCT03683173|562056173|FG000|Completed Follow-up|Refused|69|||
155716416|NCT03683173|562056174|FG001|Completed Follow-up|Refused|59|||
155716417|NCT03683173|562056173|FG000|Completed Follow-up|Disconnected phone|65|||
155716418|NCT03683173|562056174|FG001|Completed Follow-up|Disconnected phone|95|||
155716419|NCT03683173|562056173|FG000|Completed Follow-up|Health issue/deceased|10|||
155185025|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Death|0|||
155185026|NCT03343067|560116263|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
155185027|NCT03343067|560116264|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
155185028|NCT03343067|560116265|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
155716420|NCT03683173|562056174|FG001|Completed Follow-up|Health issue/deceased|4|||
155716421|NCT03683173|562056173|FG000|Completed Follow-up|Moved away|8|||
155716422|NCT03683173|562056174|FG001|Completed Follow-up|Moved away|1|||
155716423|NCT01535807|562056175|FG000|Overall Study|Withdrawal by Subject|1|||
155716424|NCT01535807|562056176|FG001|Overall Study|Withdrawal by Subject|1|||
155716425|NCT01535807|562056175|FG000|Overall Study|Data collection error|1|||
155716426|NCT01535807|562056176|FG001|Overall Study|Data collection error|1|||
155716427|NCT01329263|562056181|FG000|Overall Study|Lost to Follow-up|4|||
155716428|NCT01329263|562056182|FG001|Overall Study|Lost to Follow-up|21|||
155716429|NCT01329263|562056181|FG000|Overall Study|Withdrawal by Subject|1|||
155716430|NCT01329263|562056182|FG001|Overall Study|Withdrawal by Subject|2|||
155716431|NCT01702844|562056192|FG000|Overall Study|Adverse Event|9|||
155185029|NCT00116168|560116266|FG000|Overall Study|Lost to Follow-up|6|||
155185030|NCT00116168|560116267|FG001|Overall Study|Lost to Follow-up|5|||
155185031|NCT00116168|560116268|FG002|Overall Study|Lost to Follow-up|0|||
155185032|NCT00116168|560116269|FG003|Overall Study|Lost to Follow-up|0|||
155185033|NCT00048061|560116270|FG000|Overall Study|Adverse Event|41|||
155716432|NCT01702844|562056192|FG000|Overall Study|Death|1|||
155716433|NCT01702844|562056192|FG000|Overall Study|Withdrawal by Subject|3|||
155716434|NCT01702844|562056192|FG000|Overall Study|Physician Decision|6|||
155716435|NCT02995980|562056193|FG000|Overall Study|Lost to Follow-up|14|||
155716436|NCT02920892|562056196|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
155716437|NCT02920892|562056197|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
155716438|NCT02920892|562056198|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
155716439|NCT02920892|562056196|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
155716440|NCT02920892|562056197|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
155716441|NCT02920892|562056198|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
155716442|NCT02920892|562056196|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
155185034|NCT00048061|560116271|FG001|Overall Study|Adverse Event|32|||
155185035|NCT00048061|560116272|FG002|Overall Study|Adverse Event|44|||
155185036|NCT00048061|560116273|FG003|Overall Study|Adverse Event|37|||
155185037|NCT00048061|560116270|FG000|Overall Study|Lost to Follow-up|3|||
155185038|NCT00048061|560116271|FG001|Overall Study|Lost to Follow-up|2|||
155185039|NCT00048061|560116272|FG002|Overall Study|Lost to Follow-up|4|||
155185040|NCT00048061|560116273|FG003|Overall Study|Lost to Follow-up|5|||
155185041|NCT00048061|560116270|FG000|Overall Study|Withdrawal by Subject|20|||
155185042|NCT00048061|560116271|FG001|Overall Study|Withdrawal by Subject|29|||
155185043|NCT00048061|560116272|FG002|Overall Study|Withdrawal by Subject|29|||
155185044|NCT00048061|560116273|FG003|Overall Study|Withdrawal by Subject|32|||
155185045|NCT00048061|560116270|FG000|Overall Study|Did not follow-up|5|||
155185046|NCT00048061|560116271|FG001|Overall Study|Did not follow-up|5|||
155185047|NCT00048061|560116272|FG002|Overall Study|Did not follow-up|4|||
155185048|NCT00048061|560116273|FG003|Overall Study|Did not follow-up|5|||
155185049|NCT00048061|560116270|FG000|Overall Study|Early improvement|6|||
155185050|NCT00048061|560116271|FG001|Overall Study|Early improvement|5|||
155716443|NCT02920892|562056197|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
155716444|NCT02920892|562056198|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
155185051|NCT00048061|560116272|FG002|Overall Study|Early improvement|3|||
155185052|NCT00048061|560116273|FG003|Overall Study|Early improvement|0|||
155185053|NCT03583073|560116274|FG000|Overall Study|Lost to Follow-up|8|||
155185054|NCT03583073|560116275|FG001|Overall Study|Lost to Follow-up|12|||
155185055|NCT01569464|560116278|FG000|Overall Study|Adverse Event|4|||
155716445|NCT02920892|562056196|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
155185056|NCT01569464|560116279|FG001|Overall Study|Adverse Event|0|||
155185057|NCT01569464|560116278|FG000|Overall Study|Lack of Efficacy|1|||
155716446|NCT02920892|562056197|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
155716447|NCT02920892|562056198|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
155716448|NCT02920892|562056196|FG000|Placebo-Controlled Period|Physician Decision|0|||
155716449|NCT02920892|562056197|FG001|Placebo-Controlled Period|Physician Decision|0|||
155716450|NCT02920892|562056198|FG002|Placebo-Controlled Period|Physician Decision|1|||
155716451|NCT02920892|562056196|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
155716452|NCT02920892|562056197|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
155185058|NCT01569464|560116279|FG001|Overall Study|Lack of Efficacy|0|||
155185059|NCT01569464|560116278|FG000|Overall Study|Protocol Violation|1|||
155185060|NCT01569464|560116279|FG001|Overall Study|Protocol Violation|0|||
155185061|NCT01569464|560116278|FG000|Overall Study|Lost to Follow-up|2|||
155185062|NCT01569464|560116279|FG001|Overall Study|Lost to Follow-up|3|||
155185063|NCT01569464|560116278|FG000|Overall Study|Withdrawal by Subject|1|||
155185064|NCT01569464|560116279|FG001|Overall Study|Withdrawal by Subject|1|||
155185065|NCT01569464|560116278|FG000|Overall Study|Other|1|||
155185066|NCT01569464|560116279|FG001|Overall Study|Other|1|||
155185067|NCT03063203|560116285|FG000|Overall Study|Chose alternative therapy|3|||
155185068|NCT03063203|560116285|FG000|Overall Study|Death|2|||
155185069|NCT03063203|560116285|FG000|Overall Study|Disease progression|4|||
155185070|NCT03063203|560116285|FG000|Overall Study|Physician Decision|5|||
155716453|NCT02920892|562056198|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
155716454|NCT02920892|562056196|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155716455|NCT02920892|562056197|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
155716456|NCT02920892|562056198|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155716457|NCT02920892|562056196|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
155716458|NCT02920892|562056197|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
155716459|NCT02920892|562056198|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
155185071|NCT04025710|560116286|FG000|Overall Study|Death|3|||
155185072|NCT04025710|560116286|FG000|Overall Study|Lost to Follow-up|5|||
155185073|NCT04025710|560116286|FG000|Overall Study|Withdrawal by Subject|1|||
155185074|NCT04025710|560116286|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
155185075|NCT04025710|560116286|FG000|Overall Study|Drop-out according to protocol|34|||
155185076|NCT00245583|560116289|FG000|Overall Study|Lost to Follow-up|1|||
155185077|NCT00245583|560116290|FG001|Overall Study|Lost to Follow-up|5|||
155185078|NCT00245583|560116289|FG000|Overall Study|Adverse Event|2|||
155185079|NCT00245583|560116290|FG001|Overall Study|Adverse Event|1|||
155185080|NCT00245583|560116289|FG000|Overall Study|Lack of Efficacy|1|||
155185081|NCT00245583|560116290|FG001|Overall Study|Lack of Efficacy|0|||
155185082|NCT00245583|560116289|FG000|Overall Study|Withdrawal by Subject|2|||
155185083|NCT00245583|560116290|FG001|Overall Study|Withdrawal by Subject|3|||
155185084|NCT04718103|560116291|FG000|Overall Study|Adverse Event|1|||
155185085|NCT04718103|560116292|FG001|Overall Study|Adverse Event|1|||
155185086|NCT04718103|560116291|FG000|Overall Study|Lack of Efficacy|4|||
155185087|NCT04718103|560116292|FG001|Overall Study|Lack of Efficacy|1|||
155185088|NCT04718103|560116291|FG000|Overall Study|Lost to Follow-up|2|||
155185089|NCT04718103|560116292|FG001|Overall Study|Lost to Follow-up|2|||
155185090|NCT04718103|560116291|FG000|Overall Study|Physician Decision|2|||
155185091|NCT04718103|560116292|FG001|Overall Study|Physician Decision|0|||
155185092|NCT04718103|560116291|FG000|Overall Study|Pregnancy|0|||
155185093|NCT04718103|560116292|FG001|Overall Study|Pregnancy|1|||
155185094|NCT04718103|560116291|FG000|Overall Study|Withdrawal by Subject|10|||
155185095|NCT04718103|560116292|FG001|Overall Study|Withdrawal by Subject|6|||
155185096|NCT04718103|560116291|FG000|Overall Study|Randomized, not treated|4|||
155185097|NCT04718103|560116292|FG001|Overall Study|Randomized, not treated|1|||
155185098|NCT04718103|560116291|FG000|Overall Study|GCP violations|7|||
155185099|NCT04718103|560116292|FG001|Overall Study|GCP violations|5|||
155185100|NCT01309893|560116293|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
155185101|NCT01309893|560116294|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
155185102|NCT01309893|560116293|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
155185103|NCT01309893|560116294|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
155185104|NCT01343901|560116295|FG000|Overall Study|Death|85|||
155185105|NCT01343901|560116295|FG000|Overall Study|Physician Decision|4|||
155185106|NCT01343901|560116295|FG000|Overall Study|Lost to Follow-up|12|||
155185107|NCT01343901|560116295|FG000|Overall Study|Management by another medical team|11|||
155185108|NCT01343901|560116295|FG000|Overall Study|Participant decision|1|||
155185109|NCT01484938|560116296|FG000|Overall Study|Adverse Event|2|||
155185110|NCT01484938|560116296|FG000|Overall Study|Lost to Follow-up|1|||
155716460|NCT01092728|562056199|FG000|Overall Study|Withdrawal by Subject|2|||
155716461|NCT01092728|562056200|FG001|Overall Study|Withdrawal by Subject|0|||
155716462|NCT01092728|562056199|FG000|Overall Study|Adverse Event|0|||
155716463|NCT01092728|562056200|FG001|Overall Study|Adverse Event|1|||
155185111|NCT01484938|560116296|FG000|Overall Study|Noncompliance|1|||
155185112|NCT02942576|560116297|FG000|Overall Study|Adverse Event|28|||
155185113|NCT02942576|560116298|FG001|Overall Study|Adverse Event|6|||
155716464|NCT01092728|562056199|FG000|Overall Study|Disease Progression|1|||
155716465|NCT01092728|562056200|FG001|Overall Study|Disease Progression|13|||
155716466|NCT01092728|562056199|FG000|Overall Study|Prohibited Concomitant Medications|1|||
155716467|NCT01092728|562056200|FG001|Overall Study|Prohibited Concomitant Medications|0|||
155716468|NCT02336607|562056201|FG000|Overall Study|Physician Decision|1|||
155716469|NCT02336607|562056202|FG001|Overall Study|Physician Decision|4|||
155716470|NCT02336607|562056203|FG002|Overall Study|Physician Decision|3|||
155716471|NCT02336607|562056204|FG003|Overall Study|Physician Decision|15|||
155716472|NCT02336607|562056201|FG000|Overall Study|Lack of Efficacy|1|||
155716473|NCT02336607|562056202|FG001|Overall Study|Lack of Efficacy|0|||
155716474|NCT02336607|562056203|FG002|Overall Study|Lack of Efficacy|0|||
155716475|NCT02336607|562056204|FG003|Overall Study|Lack of Efficacy|2|||
155716476|NCT02336607|562056201|FG000|Overall Study|Lost to Follow-up|2|||
155716477|NCT02336607|562056202|FG001|Overall Study|Lost to Follow-up|1|||
155716478|NCT02336607|562056203|FG002|Overall Study|Lost to Follow-up|0|||
155716479|NCT02336607|562056204|FG003|Overall Study|Lost to Follow-up|21|||
155716480|NCT02336607|562056201|FG000|Overall Study|Protocol Violation|0|||
155716481|NCT02336607|562056202|FG001|Overall Study|Protocol Violation|1|||
155716482|NCT02336607|562056203|FG002|Overall Study|Protocol Violation|1|||
155716483|NCT02336607|562056204|FG003|Overall Study|Protocol Violation|3|||
155716484|NCT02336607|562056201|FG000|Overall Study|Adverse Event|0|||
155716485|NCT02336607|562056202|FG001|Overall Study|Adverse Event|2|||
155716486|NCT02336607|562056203|FG002|Overall Study|Adverse Event|2|||
155716487|NCT02336607|562056204|FG003|Overall Study|Adverse Event|26|||
155716488|NCT02336607|562056201|FG000|Overall Study|Withdrawal by Subject|0|||
155716489|NCT02336607|562056202|FG001|Overall Study|Withdrawal by Subject|2|||
155716490|NCT02336607|562056203|FG002|Overall Study|Withdrawal by Subject|0|||
155716491|NCT02336607|562056204|FG003|Overall Study|Withdrawal by Subject|20|||
155716492|NCT01721161|562056205|FG000|Overall Study|Adverse Event|2|||
155716493|NCT01721161|562056206|FG001|Overall Study|Adverse Event|3|||
155716494|NCT01721161|562056205|FG000|Overall Study|Lost to Follow-up|1|||
155716495|NCT01721161|562056206|FG001|Overall Study|Lost to Follow-up|2|||
155716496|NCT01721161|562056205|FG000|Overall Study|Withdrawal by Subject|1|||
155716497|NCT01721161|562056206|FG001|Overall Study|Withdrawal by Subject|1|||
155716498|NCT01721161|562056205|FG000|Overall Study|Other|0|||
155716499|NCT01721161|562056206|FG001|Overall Study|Other|1|||
155716500|NCT01454596|562056209|FG000|Overall Study|Death|0|||
155716501|NCT01454596|562056210|FG001|Overall Study|Death|0|||
155716502|NCT01454596|562056211|FG002|Overall Study|Death|0|||
155716503|NCT01454596|562056212|FG003|Overall Study|Death|0|||
155716504|NCT01454596|562056213|FG004|Overall Study|Death|0|||
155716505|NCT01454596|562056214|FG005|Overall Study|Death|0|||
155716506|NCT01454596|562056215|FG006|Overall Study|Death|0|||
155716507|NCT01454596|562056216|FG007|Overall Study|Death|0|||
155716508|NCT01454596|562056217|FG008|Overall Study|Death|0|||
155716509|NCT01454596|562056218|FG009|Overall Study|Death|1|||
155716510|NCT01454596|562056219|FG010|Overall Study|Death|1|||
155716511|NCT01454596|562056220|FG011|Overall Study|Death|0|||
155716512|NCT00614380|562056227|FG000|Overall Study|Adverse Event|14|||
155716513|NCT00614380|562056228|FG001|Overall Study|Adverse Event|4|||
155716514|NCT00614380|562056229|FG002|Overall Study|Adverse Event|0|||
155716515|NCT00614380|562056230|FG003|Overall Study|Adverse Event|0|||
155716516|NCT00614380|562056227|FG000|Overall Study|Lost to Follow-up|6|||
155716517|NCT00614380|562056228|FG001|Overall Study|Lost to Follow-up|1|||
155716518|NCT00614380|562056229|FG002|Overall Study|Lost to Follow-up|0|||
155716519|NCT00614380|562056230|FG003|Overall Study|Lost to Follow-up|0|||
155716520|NCT00614380|562056227|FG000|Overall Study|Non compliant with the protocol|12|||
155716521|NCT00614380|562056228|FG001|Overall Study|Non compliant with the protocol|2|||
155716522|NCT00614380|562056229|FG002|Overall Study|Non compliant with the protocol|1|||
155716523|NCT00614380|562056230|FG003|Overall Study|Non compliant with the protocol|2|||
155716524|NCT00614380|562056227|FG000|Overall Study|Consent withdrawn|3|||
155716525|NCT00614380|562056228|FG001|Overall Study|Consent withdrawn|1|||
155716526|NCT00614380|562056229|FG002|Overall Study|Consent withdrawn|0|||
155716527|NCT00614380|562056230|FG003|Overall Study|Consent withdrawn|0|||
155716528|NCT01506271|562056235|FG000|Overall Study|Progressive disease|0|||
155716529|NCT01506271|562056236|FG001|Overall Study|Progressive disease|1|||
155716530|NCT01506271|562056237|FG002|Overall Study|Progressive disease|0|||
155716531|NCT01506271|562056235|FG000|Overall Study|Protocol Violation|3|||
155716532|NCT01506271|562056236|FG001|Overall Study|Protocol Violation|1|||
155716533|NCT01506271|562056237|FG002|Overall Study|Protocol Violation|0|||
155716534|NCT01506271|562056235|FG000|Overall Study|Death|0|||
155716535|NCT01506271|562056236|FG001|Overall Study|Death|1|||
155716536|NCT01506271|562056237|FG002|Overall Study|Death|0|||
155716537|NCT01506271|562056235|FG000|Overall Study|Adverse Event|0|||
155716538|NCT01506271|562056236|FG001|Overall Study|Adverse Event|2|||
155716539|NCT01506271|562056237|FG002|Overall Study|Adverse Event|0|||
155716540|NCT01506271|562056235|FG000|Overall Study|Insufficient supply of study drug|1|||
155716541|NCT01506271|562056236|FG001|Overall Study|Insufficient supply of study drug|0|||
155716542|NCT01506271|562056237|FG002|Overall Study|Insufficient supply of study drug|0|||
155716543|NCT01506271|562056235|FG000|Overall Study|Withdrawal by Subject|0|||
155716544|NCT01506271|562056236|FG001|Overall Study|Withdrawal by Subject|1|||
155716545|NCT01506271|562056237|FG002|Overall Study|Withdrawal by Subject|1|||
155716546|NCT01506271|562056235|FG000|Overall Study|Lost to Follow-up|0|||
155716547|NCT01506271|562056236|FG001|Overall Study|Lost to Follow-up|1|||
155716548|NCT01506271|562056237|FG002|Overall Study|Lost to Follow-up|2|||
155716549|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
155716550|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
155716551|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
155716552|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
155716553|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
155716554|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
155716555|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Death|7|||
155716556|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Death|5|||
155716557|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Death|6|||
155716558|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
155716559|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
155716560|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
155716561|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
155716562|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
155716563|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
155716564|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Other|1|||
155716565|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Other|0|||
155716566|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Other|0|||
155716567|NCT00104650|562056241|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
155716568|NCT00104650|562056242|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
155716569|NCT00104650|562056243|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
155716570|NCT00104650|562056241|FG000|Follow-up Period|Physician Decision|1|||
155716571|NCT00104650|562056242|FG001|Follow-up Period|Physician Decision|1|||
155716572|NCT00104650|562056243|FG002|Follow-up Period|Physician Decision|0|||
155716573|NCT00104650|562056241|FG000|Follow-up Period|Adverse Event|1|||
155716574|NCT00104650|562056242|FG001|Follow-up Period|Adverse Event|0|||
155716575|NCT00104650|562056243|FG002|Follow-up Period|Adverse Event|1|||
155716576|NCT00104650|562056241|FG000|Follow-up Period|Withdrawal by Subject|0|||
155716577|NCT00104650|562056242|FG001|Follow-up Period|Withdrawal by Subject|3|||
155716578|NCT00104650|562056243|FG002|Follow-up Period|Withdrawal by Subject|3|||
155716579|NCT00104650|562056241|FG000|Follow-up Period|Death|6|||
155716580|NCT00104650|562056242|FG001|Follow-up Period|Death|6|||
155716581|NCT00104650|562056243|FG002|Follow-up Period|Death|4|||
155716582|NCT00104650|562056241|FG000|Follow-up Period|Disease progression|3|||
155716583|NCT00104650|562056242|FG001|Follow-up Period|Disease progression|1|||
155716584|NCT00104650|562056243|FG002|Follow-up Period|Disease progression|0|||
155716585|NCT00104650|562056241|FG000|Follow-up Period|Lost to Follow-up|0|||
155716586|NCT00104650|562056242|FG001|Follow-up Period|Lost to Follow-up|1|||
155716587|NCT00104650|562056243|FG002|Follow-up Period|Lost to Follow-up|2|||
155716588|NCT00104650|562056241|FG000|Follow-up Period|Other|0|||
155716589|NCT00104650|562056242|FG001|Follow-up Period|Other|1|||
155716590|NCT00104650|562056243|FG002|Follow-up Period|Other|0|||
155716591|NCT01391663|562056244|FG000|Overall Study|Withdrawal by Subject|0|||
155716592|NCT01391663|562056245|FG001|Overall Study|Withdrawal by Subject|0|||
155716593|NCT01391663|562056246|FG002|Overall Study|Withdrawal by Subject|1|||
155716594|NCT01391663|562056247|FG003|Overall Study|Withdrawal by Subject|0|||
155716595|NCT01894607|562056248|FG000|Overall Study|Ineligible|1|||
155716596|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
155716597|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
155716598|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
155716599|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
155716600|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
155716601|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
155716602|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
155716603|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
155716604|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
155716605|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
155716606|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
155716607|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
155716608|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
155716609|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
155716610|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
155716611|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
155716612|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
155716613|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
155716614|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
155716615|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
155716616|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
155716617|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
155716618|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
155716619|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
155716620|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
155716621|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
155716622|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
155716623|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
155716624|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
155716625|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
155716626|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
155716627|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
155716628|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
155716629|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
155716630|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
155716631|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
155716632|NCT02586623|562056259|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
155716633|NCT02586623|562056260|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
155716634|NCT02586623|562056261|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
155716635|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
155716636|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
155716637|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
155716638|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
155716639|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
155716640|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
155716641|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
155716642|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
155716643|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
155716644|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
155716645|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
155716646|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
155716647|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
155716648|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
155716649|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
155716650|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
155716651|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
155716652|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
155716653|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
155716654|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
155716655|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
155716656|NCT02586623|562056259|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
155716657|NCT02586623|562056260|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
155716658|NCT02586623|562056261|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
155716659|NCT02910466|562056262|FG000|Overall Study|Adverse Event|1|||
155716660|NCT02910466|562056262|FG000|Overall Study|Withdrawal by Subject|3|||
155716661|NCT02910466|562056262|FG000|Overall Study|Lost to Follow-up|5|||
155716662|NCT02910466|562056262|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
155716663|NCT02910466|562056262|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
155716664|NCT05051579|562056267|FG000|Overall Study|Withdrawal by Subject|3|||
155716665|NCT05051579|562056268|FG001|Overall Study|Withdrawal by Subject|5|||
155716666|NCT05051579|562056269|FG002|Overall Study|Withdrawal by Subject|2|||
155716667|NCT05051579|562056270|FG003|Overall Study|Withdrawal by Subject|1|||
155716668|NCT05051579|562056271|FG004|Overall Study|Withdrawal by Subject|4|||
155716669|NCT05051579|562056272|FG005|Overall Study|Withdrawal by Subject|0|||
155716670|NCT05051579|562056273|FG006|Overall Study|Withdrawal by Subject|4|||
155716671|NCT05051579|562056267|FG000|Overall Study|Lost to Follow-up|1|||
155716672|NCT05051579|562056268|FG001|Overall Study|Lost to Follow-up|0|||
155716673|NCT05051579|562056269|FG002|Overall Study|Lost to Follow-up|0|||
155716674|NCT05051579|562056270|FG003|Overall Study|Lost to Follow-up|0|||
155716675|NCT05051579|562056271|FG004|Overall Study|Lost to Follow-up|1|||
155716676|NCT05051579|562056272|FG005|Overall Study|Lost to Follow-up|0|||
155716677|NCT05051579|562056273|FG006|Overall Study|Lost to Follow-up|1|||
155716678|NCT05051579|562056267|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716679|NCT05051579|562056268|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716680|NCT05051579|562056269|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716681|NCT05051579|562056270|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716682|NCT05051579|562056271|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716683|NCT05051579|562056272|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155716684|NCT05051579|562056273|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
155716685|NCT05051579|562056267|FG000|Overall Study|Adverse Event|2|||
155716686|NCT05051579|562056268|FG001|Overall Study|Adverse Event|1|||
155716687|NCT05051579|562056269|FG002|Overall Study|Adverse Event|0|||
155716688|NCT05051579|562056270|FG003|Overall Study|Adverse Event|4|||
155716689|NCT05051579|562056271|FG004|Overall Study|Adverse Event|1|||
155716690|NCT05051579|562056272|FG005|Overall Study|Adverse Event|2|||
155716691|NCT05051579|562056273|FG006|Overall Study|Adverse Event|0|||
155716692|NCT05051579|562056267|FG000|Overall Study|Inadvertent Enrollment|0|||
155716693|NCT05051579|562056268|FG001|Overall Study|Inadvertent Enrollment|0|||
155716694|NCT05051579|562056269|FG002|Overall Study|Inadvertent Enrollment|0|||
155716695|NCT05051579|562056270|FG003|Overall Study|Inadvertent Enrollment|0|||
155716696|NCT05051579|562056271|FG004|Overall Study|Inadvertent Enrollment|0|||
155716697|NCT05051579|562056272|FG005|Overall Study|Inadvertent Enrollment|0|||
155716698|NCT05051579|562056273|FG006|Overall Study|Inadvertent Enrollment|1|||
155716699|NCT05051579|562056267|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716700|NCT05051579|562056268|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
155716701|NCT05051579|562056269|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716702|NCT05051579|562056270|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716703|NCT05051579|562056271|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716704|NCT05051579|562056272|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716705|NCT05051579|562056273|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155716706|NCT05051579|562056267|FG000|Overall Study|Sponsor Decision|0|||
155716707|NCT05051579|562056268|FG001|Overall Study|Sponsor Decision|0|||
155716708|NCT05051579|562056269|FG002|Overall Study|Sponsor Decision|0|||
155716709|NCT05051579|562056270|FG003|Overall Study|Sponsor Decision|0|||
155716710|NCT05051579|562056271|FG004|Overall Study|Sponsor Decision|1|||
155716711|NCT05051579|562056272|FG005|Overall Study|Sponsor Decision|0|||
155716712|NCT05051579|562056273|FG006|Overall Study|Sponsor Decision|0|||
155716713|NCT05051579|562056267|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716714|NCT05051579|562056268|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716715|NCT05051579|562056269|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716716|NCT05051579|562056270|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716717|NCT05051579|562056271|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
155185114|NCT02942576|560116297|FG000|Overall Study|Withdrawal by Subject|7|||
155716718|NCT05051579|562056272|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716719|NCT05051579|562056273|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155716720|NCT01116648|562056281|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
155716721|NCT01116648|562056282|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
155716722|NCT01116648|562056283|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
155716723|NCT01116648|562056284|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
155716724|NCT01116648|562056285|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
155716725|NCT01116648|562056286|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
155716726|NCT01116648|562056287|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
155716727|NCT01116648|562056288|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
155716728|NCT01116648|562056289|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
155716729|NCT01116648|562056290|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
155716730|NCT01116648|562056291|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
155716731|NCT01116648|562056292|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
155716732|NCT01116648|562056293|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
155716733|NCT01116648|562056294|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
155716734|NCT01116648|562056295|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
155716735|NCT04539938|562056296|FG000|Overall Study|Death|30|||
155716736|NCT04539938|562056296|FG000|Overall Study|Withdrawal by Subject|4|||
155716737|NCT01420926|562056311|FG000|Overall Study|Adverse Event|6|||
155716738|NCT01420926|562056312|FG001|Overall Study|Adverse Event|4|||
155716739|NCT01420926|562056311|FG000|Overall Study|Death|18|||
155716740|NCT01420926|562056312|FG001|Overall Study|Death|17|||
155716741|NCT01420926|562056311|FG000|Overall Study|Withdrawal by Subject|11|||
155716742|NCT01420926|562056312|FG001|Overall Study|Withdrawal by Subject|17|||
155716743|NCT01420926|562056311|FG000|Overall Study|Non-protocol treatment|17|||
155716744|NCT01420926|562056312|FG001|Overall Study|Non-protocol treatment|20|||
155716745|NCT01420926|562056311|FG000|Overall Study|Physician Decision|8|||
155716746|NCT01420926|562056312|FG001|Overall Study|Physician Decision|5|||
155716747|NCT03858049|562057650|FG000|Overall Study|Adverse Event|16|||
155716748|NCT03858049|562057651|FG001|Overall Study|Adverse Event|9|||
155716749|NCT03858049|562057650|FG000|Overall Study|Other|1|||
155716750|NCT03858049|562057651|FG001|Overall Study|Other|1|||
155716751|NCT02079740|562057652|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
155716752|NCT02079740|562057653|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
155716753|NCT02079740|562057654|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
155716754|NCT02079740|562057655|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
155716755|NCT02079740|562057656|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
155716756|NCT02079740|562057657|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
155716757|NCT02079740|562057658|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
155716758|NCT02079740|562057659|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
155716759|NCT02079740|562057660|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
155716760|NCT02079740|562057661|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
155716761|NCT02079740|562057662|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
155716762|NCT02079740|562057663|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
155716763|NCT02079740|562057664|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
155716764|NCT02079740|562057652|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
155716765|NCT02079740|562057653|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
155716766|NCT02079740|562057654|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
155716767|NCT02079740|562057655|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
155716768|NCT02079740|562057656|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
155716769|NCT02079740|562057657|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
155716770|NCT02079740|562057658|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
155716771|NCT02079740|562057659|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
155716772|NCT02079740|562057660|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
155716773|NCT02079740|562057661|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
155716774|NCT02079740|562057662|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
155716775|NCT02079740|562057663|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
155716776|NCT02079740|562057664|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
155716777|NCT02079740|562057652|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716778|NCT02079740|562057653|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716779|NCT02079740|562057654|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716780|NCT02079740|562057655|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716781|NCT02079740|562057656|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716782|NCT02079740|562057657|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716783|NCT02079740|562057658|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716784|NCT02079740|562057659|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
155716785|NCT02079740|562057660|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716786|NCT02079740|562057661|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716787|NCT02079740|562057662|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716788|NCT02079740|562057663|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716789|NCT02079740|562057664|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
155716790|NCT02079740|562057652|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716791|NCT02079740|562057653|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716792|NCT02079740|562057654|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155185115|NCT02942576|560116298|FG001|Overall Study|Withdrawal by Subject|5|||
155716793|NCT02079740|562057655|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155185116|NCT02942576|560116297|FG000|Overall Study|Physician Decision|1|||
155716794|NCT02079740|562057656|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716795|NCT02079740|562057657|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716796|NCT02079740|562057658|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716797|NCT02079740|562057659|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
155716798|NCT02079740|562057660|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716799|NCT02079740|562057661|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716800|NCT02079740|562057662|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716801|NCT02079740|562057663|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716802|NCT02079740|562057664|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155716803|NCT02079740|562057652|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716804|NCT02079740|562057653|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716805|NCT02079740|562057654|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716806|NCT02079740|562057655|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716807|NCT02079740|562057656|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716808|NCT02079740|562057657|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716809|NCT02079740|562057658|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716810|NCT02079740|562057659|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716811|NCT02079740|562057660|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716812|NCT02079740|562057661|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
155716813|NCT02079740|562057662|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155716814|NCT02079740|562057663|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
155716815|NCT02079740|562057664|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
155716816|NCT04617782|562057665|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
155716817|NCT04617782|562057665|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
155716818|NCT04617782|562057665|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
155716819|NCT04617782|562057665|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
155716820|NCT04617782|562057665|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
155716821|NCT04617782|562057665|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
155716822|NCT01405768|562057674|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
155716823|NCT01405768|562057675|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
155716824|NCT05482308|562057681|FG000|Overall Study|Withdrawal by Subject|1|||
155716825|NCT05482308|562057682|FG001|Overall Study|Withdrawal by Subject|0|||
155716826|NCT05482308|562057681|FG000|Overall Study|No longer meets eligibility criteria|0|||
155716827|NCT05482308|562057682|FG001|Overall Study|No longer meets eligibility criteria|1|||
155716828|NCT03016312|562057683|FG000|Overall Study|discontinued before the treatment started|0|||
155716829|NCT03016312|562057684|FG001|Overall Study|discontinued before the treatment started|1|||
155716830|NCT03016312|562057683|FG000|Overall Study|Withdrawal by Subject|37|||
155716831|NCT03016312|562057684|FG001|Overall Study|Withdrawal by Subject|44|||
155716832|NCT03016312|562057683|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
155716833|NCT03016312|562057684|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
155716834|NCT03016312|562057683|FG000|Overall Study|Physician Decision|1|||
155716835|NCT03016312|562057684|FG001|Overall Study|Physician Decision|3|||
155716836|NCT03016312|562057683|FG000|Overall Study|Lost to Follow-up|12|||
155716837|NCT03016312|562057684|FG001|Overall Study|Lost to Follow-up|12|||
155716838|NCT03016312|562057683|FG000|Overall Study|Death|210|||
155716839|NCT03016312|562057684|FG001|Overall Study|Death|184|||
155716840|NCT03016312|562057683|FG000|Overall Study|loss to contact|1|||
155716841|NCT03016312|562057684|FG001|Overall Study|loss to contact|0|||
155716842|NCT03016312|562057683|FG000|Overall Study|started a new cancer therapy|1|||
155716843|NCT03016312|562057684|FG001|Overall Study|started a new cancer therapy|0|||
155716844|NCT01631435|562057686|FG000|Overall Study|Adverse Event|2|||
155716845|NCT01631435|562057686|FG000|Overall Study|Withdrawal by Subject|2|||
155716846|NCT01631435|562057686|FG000|Overall Study|incomplete study procedure|5|||
155716847|NCT01421017|562057687|FG000|Overall Study|Withdrawal by Subject|2|||
155716848|NCT01421017|562057688|FG001|Overall Study|Withdrawal by Subject|0|||
155716849|NCT01421017|562057689|FG002|Overall Study|Withdrawal by Subject|0|||
155716850|NCT01421017|562057687|FG000|Overall Study|POD|0|||
155716851|NCT01421017|562057688|FG001|Overall Study|POD|6|||
155716852|NCT01421017|562057689|FG002|Overall Study|POD|3|||
155716853|NCT02313766|562057690|FG000|Overall Study|surgery cancelled|1|||
155716854|NCT02313766|562057691|FG001|Overall Study|surgery cancelled|0|||
155716855|NCT02313766|562057692|FG002|Overall Study|surgery cancelled|0|||
155716856|NCT02313766|562057690|FG000|Overall Study|Lost to Follow-up|0|||
155716857|NCT02313766|562057691|FG001|Overall Study|Lost to Follow-up|2|||
155716858|NCT02313766|562057692|FG002|Overall Study|Lost to Follow-up|0|||
155716859|NCT02313766|562057690|FG000|Overall Study|Adverse Event|0|||
155716860|NCT02313766|562057691|FG001|Overall Study|Adverse Event|1|||
155716861|NCT02313766|562057692|FG002|Overall Study|Adverse Event|0|||
155716862|NCT00416624|562057695|FG000|Overall Study|Withdrawal by Subject|1|||
155716863|NCT00416624|562057696|FG001|Overall Study|Withdrawal by Subject|6|||
155716864|NCT00416624|562057697|FG002|Overall Study|Withdrawal by Subject|4|||
155716865|NCT00416624|562057698|FG003|Overall Study|Withdrawal by Subject|9|||
155716866|NCT00416624|562057695|FG000|Overall Study|Death|4|||
155716867|NCT00416624|562057696|FG001|Overall Study|Death|7|||
155716868|NCT00416624|562057697|FG002|Overall Study|Death|7|||
155716869|NCT00416624|562057698|FG003|Overall Study|Death|1|||
155716870|NCT00416624|562057695|FG000|Overall Study|Adverse Event|8|||
155716871|NCT00416624|562057696|FG001|Overall Study|Adverse Event|3|||
155716872|NCT00416624|562057697|FG002|Overall Study|Adverse Event|2|||
155716873|NCT00416624|562057698|FG003|Overall Study|Adverse Event|2|||
155716874|NCT00416624|562057695|FG000|Overall Study|Other|8|||
155716875|NCT00416624|562057696|FG001|Overall Study|Other|11|||
155716876|NCT00416624|562057697|FG002|Overall Study|Other|5|||
155716877|NCT00416624|562057698|FG003|Overall Study|Other|5|||
155716878|NCT00416624|562057695|FG000|Overall Study|Cancel|1|||
155716879|NCT00416624|562057696|FG001|Overall Study|Cancel|0|||
155716880|NCT00416624|562057697|FG002|Overall Study|Cancel|0|||
155716881|NCT00416624|562057698|FG003|Overall Study|Cancel|0|||
155716882|NCT01005251|562057699|FG000|Overall Study|Withdrawal by Subject|2|||
155716883|NCT01005251|562057700|FG001|Overall Study|Withdrawal by Subject|5|||
155716884|NCT01005251|562057701|FG002|Overall Study|Withdrawal by Subject|3|||
155716885|NCT01005251|562057702|FG003|Overall Study|Withdrawal by Subject|4|||
155716886|NCT01005251|562057703|FG004|Overall Study|Withdrawal by Subject|9|||
155716887|NCT01005251|562057699|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
155716888|NCT01005251|562057700|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155716889|NCT01005251|562057701|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
155716890|NCT01005251|562057702|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155716891|NCT01005251|562057703|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155716892|NCT01005251|562057699|FG000|Overall Study|Adverse Event|2|||
155716893|NCT01005251|562057700|FG001|Overall Study|Adverse Event|6|||
155716894|NCT01005251|562057701|FG002|Overall Study|Adverse Event|8|||
155716895|NCT01005251|562057702|FG003|Overall Study|Adverse Event|5|||
155716896|NCT01005251|562057703|FG004|Overall Study|Adverse Event|4|||
155716897|NCT01005251|562057699|FG000|Overall Study|Protocol Violation|1|||
155716898|NCT01005251|562057700|FG001|Overall Study|Protocol Violation|0|||
155716899|NCT01005251|562057701|FG002|Overall Study|Protocol Violation|0|||
155716900|NCT01005251|562057702|FG003|Overall Study|Protocol Violation|0|||
155716901|NCT01005251|562057703|FG004|Overall Study|Protocol Violation|2|||
155716902|NCT01005251|562057699|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
155716903|NCT01005251|562057700|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
155716904|NCT01005251|562057701|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
155716905|NCT01005251|562057702|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
155716906|NCT01005251|562057703|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
155716907|NCT01005251|562057699|FG000|Overall Study|Lost to Follow-up|1|||
155716908|NCT01005251|562057700|FG001|Overall Study|Lost to Follow-up|4|||
155716909|NCT01005251|562057701|FG002|Overall Study|Lost to Follow-up|2|||
155716910|NCT01005251|562057702|FG003|Overall Study|Lost to Follow-up|0|||
155716911|NCT01005251|562057703|FG004|Overall Study|Lost to Follow-up|0|||
155716912|NCT01005251|562057699|FG000|Overall Study|Physician Decision|0|||
155716913|NCT01005251|562057700|FG001|Overall Study|Physician Decision|0|||
155716914|NCT01005251|562057701|FG002|Overall Study|Physician Decision|0|||
155716915|NCT01005251|562057702|FG003|Overall Study|Physician Decision|0|||
155716916|NCT01005251|562057703|FG004|Overall Study|Physician Decision|2|||
155716917|NCT01005251|562057699|FG000|Overall Study|Patient moved|1|||
155716918|NCT01005251|562057700|FG001|Overall Study|Patient moved|0|||
155716919|NCT01005251|562057701|FG002|Overall Study|Patient moved|0|||
155716920|NCT01005251|562057702|FG003|Overall Study|Patient moved|0|||
155716921|NCT01005251|562057703|FG004|Overall Study|Patient moved|0|||
155716922|NCT01005251|562057699|FG000|Overall Study|Wrong drug dispensed|0|||
155716923|NCT01005251|562057700|FG001|Overall Study|Wrong drug dispensed|1|||
155716924|NCT01005251|562057701|FG002|Overall Study|Wrong drug dispensed|0|||
155716925|NCT01005251|562057702|FG003|Overall Study|Wrong drug dispensed|0|||
155716926|NCT01005251|562057703|FG004|Overall Study|Wrong drug dispensed|0|||
155716927|NCT01005251|562057699|FG000|Overall Study|Randomized in error|0|||
155716928|NCT01005251|562057700|FG001|Overall Study|Randomized in error|0|||
155716929|NCT01005251|562057701|FG002|Overall Study|Randomized in error|1|||
155185117|NCT02942576|560116298|FG001|Overall Study|Physician Decision|4|||
155716930|NCT01005251|562057702|FG003|Overall Study|Randomized in error|1|||
155716931|NCT01005251|562057703|FG004|Overall Study|Randomized in error|0|||
155716932|NCT01005251|562057699|FG000|Overall Study|Lack of Efficacy|0|||
155716933|NCT01005251|562057700|FG001|Overall Study|Lack of Efficacy|0|||
155716934|NCT01005251|562057701|FG002|Overall Study|Lack of Efficacy|1|||
155716935|NCT01005251|562057702|FG003|Overall Study|Lack of Efficacy|1|||
155716936|NCT01005251|562057703|FG004|Overall Study|Lack of Efficacy|0|||
155716937|NCT02193776|562057704|FG000|Overall Study|Consent withdrawn|1|||
155716938|NCT02193776|562057705|FG001|Overall Study|Consent withdrawn|0|||
155716939|NCT02193776|562057706|FG002|Overall Study|Consent withdrawn|0|||
155716940|NCT02193776|562057707|FG003|Overall Study|Consent withdrawn|0|||
155716941|NCT02193776|562057704|FG000|Overall Study|Failure to comply with protocol|0|||
155716942|NCT02193776|562057705|FG001|Overall Study|Failure to comply with protocol|1|||
155716943|NCT02193776|562057706|FG002|Overall Study|Failure to comply with protocol|0|||
155716944|NCT02193776|562057707|FG003|Overall Study|Failure to comply with protocol|0|||
155716945|NCT02193776|562057704|FG000|Overall Study|Investigator/Sponsor decision|1|||
155716946|NCT02193776|562057705|FG001|Overall Study|Investigator/Sponsor decision|1|||
155716947|NCT02193776|562057706|FG002|Overall Study|Investigator/Sponsor decision|0|||
155716948|NCT02193776|562057707|FG003|Overall Study|Investigator/Sponsor decision|0|||
155716949|NCT02193776|562057704|FG000|Overall Study|Death|1|||
155716950|NCT02193776|562057705|FG001|Overall Study|Death|0|||
155716951|NCT02193776|562057706|FG002|Overall Study|Death|0|||
155716952|NCT02193776|562057707|FG003|Overall Study|Death|0|||
155716953|NCT02193776|562057704|FG000|Overall Study|Adverse event/Specific toxicity|5|||
155716954|NCT02193776|562057705|FG001|Overall Study|Adverse event/Specific toxicity|5|||
155716955|NCT02193776|562057706|FG002|Overall Study|Adverse event/Specific toxicity|2|||
155716956|NCT02193776|562057707|FG003|Overall Study|Adverse event/Specific toxicity|2|||
155716957|NCT01755234|562057709|FG000|Overall Study|Lost to Follow-up|11|||
155716958|NCT01755234|562057710|FG001|Overall Study|Lost to Follow-up|6|||
155716959|NCT01755234|562057709|FG000|Overall Study|Change in surgical case|2|||
155716960|NCT01755234|562057710|FG001|Overall Study|Change in surgical case|1|||
155716961|NCT01755234|562057709|FG000|Overall Study|case cancelled|1|||
155716962|NCT01755234|562057710|FG001|Overall Study|case cancelled|0|||
155716963|NCT01755234|562057709|FG000|Overall Study|Withdrawal by Subject|0|||
155716964|NCT01755234|562057710|FG001|Overall Study|Withdrawal by Subject|1|||
155716965|NCT01755234|562057709|FG000|Overall Study|unblinded|1|||
155716966|NCT01755234|562057710|FG001|Overall Study|unblinded|0|||
155716967|NCT03812380|562057711|FG000|Overall Study|Protocol Violation|3|||
155716968|NCT03812380|562057712|FG001|Overall Study|Protocol Violation|3|||
155716969|NCT03812380|562057711|FG000|Overall Study|Withdrawal by Subject|5|||
155185118|NCT02942576|560116297|FG000|Overall Study|Other|10|||
155185119|NCT02942576|560116298|FG001|Overall Study|Other|8|||
155185120|NCT01484054|560116309|FG000|Period 1|Withdrawal by Subject|0|||
155185121|NCT01484054|560116310|FG001|Period 1|Withdrawal by Subject|1|||
155185122|NCT05281601|560116311|FG000|Overall Study|Physician Decision|2|||
155185123|NCT05281601|560116312|FG001|Overall Study|Physician Decision|0|||
155185124|NCT05281601|560116311|FG000|Overall Study|Lost to Follow-up|2|||
155185125|NCT05281601|560116312|FG001|Overall Study|Lost to Follow-up|0|||
155185126|NCT05281601|560116311|FG000|Overall Study|Death|1|||
155185127|NCT05281601|560116312|FG001|Overall Study|Death|0|||
155185128|NCT05281601|560116311|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155185129|NCT05281601|560116312|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155185130|NCT00995865|560116319|FG000|Overall Study|Protocol Violation|2|||
155185131|NCT00995865|560116320|FG001|Overall Study|Protocol Violation|0|||
155185132|NCT00995865|560116321|FG002|Overall Study|Protocol Violation|0|||
155185133|NCT00995865|560116319|FG000|Overall Study|Lost to Follow-up|0|||
155185134|NCT00995865|560116320|FG001|Overall Study|Lost to Follow-up|0|||
155185135|NCT00995865|560116321|FG002|Overall Study|Lost to Follow-up|1|||
155185136|NCT02101112|560116323|FG000|Overall Study|Adverse Event|0|||
155185137|NCT02101112|560116324|FG001|Overall Study|Adverse Event|0|||
155185138|NCT02101112|560116325|FG002|Overall Study|Adverse Event|1|||
155185139|NCT02101112|560116326|FG003|Overall Study|Adverse Event|0|||
155185140|NCT02101112|560116327|FG004|Overall Study|Adverse Event|0|||
155185141|NCT02101112|560116328|FG005|Overall Study|Adverse Event|0|||
155185142|NCT02101112|560116323|FG000|Overall Study|Withdrawal by Subject|0|||
155185143|NCT02101112|560116324|FG001|Overall Study|Withdrawal by Subject|0|||
155185144|NCT02101112|560116325|FG002|Overall Study|Withdrawal by Subject|0|||
155185145|NCT02101112|560116326|FG003|Overall Study|Withdrawal by Subject|0|||
155185146|NCT02101112|560116327|FG004|Overall Study|Withdrawal by Subject|1|||
155185147|NCT02101112|560116328|FG005|Overall Study|Withdrawal by Subject|0|||
155185148|NCT04340063|560116329|FG000|Overall Study|Withdrawal by Subject|1|||
155185149|NCT04340063|560116330|FG001|Overall Study|Withdrawal by Subject|2|||
155185150|NCT04340063|560116329|FG000|Overall Study|Lost to Follow-up|3|||
155185151|NCT04340063|560116330|FG001|Overall Study|Lost to Follow-up|1|||
155185152|NCT04340063|560116329|FG000|Overall Study|Protocol Violation|0|||
155185153|NCT04340063|560116330|FG001|Overall Study|Protocol Violation|1|||
155185154|NCT00993044|560116335|FG000|Irinotecan 50 mg|Physician Decision|1|||
155185155|NCT00734747|560116337|FG000|SRS Procedure|No staples placed|3|||
155185156|NCT00734747|560116337|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
155185157|NCT05063318|560116341|FG000|Overall Study|Progressive disease|2|||
155185158|NCT05063318|560116342|FG001|Overall Study|Progressive disease|0|||
155185159|NCT05063318|560116343|FG002|Overall Study|Progressive disease|3|||
155185160|NCT05063318|560116341|FG000|Overall Study|Compassionate use|1|||
155185161|NCT05063318|560116342|FG001|Overall Study|Compassionate use|3|||
155185162|NCT05063318|560116343|FG002|Overall Study|Compassionate use|3|||
155185163|NCT05063318|560116341|FG000|Overall Study|Adverse Event|0|||
155185164|NCT05063318|560116342|FG001|Overall Study|Adverse Event|1|||
155185165|NCT05063318|560116343|FG002|Overall Study|Adverse Event|0|||
155185166|NCT05063318|560116341|FG000|Overall Study|Withdrawal by Subject|0|||
155185167|NCT05063318|560116342|FG001|Overall Study|Withdrawal by Subject|1|||
155185168|NCT05063318|560116343|FG002|Overall Study|Withdrawal by Subject|0|||
155185169|NCT03287635|560116344|FG000|Overall Study|Lost to Follow-up|5|||
155185170|NCT03287635|560116344|FG000|Overall Study|Withdrawal by Subject|1|||
155185171|NCT03287635|560116344|FG000|Overall Study|Physician Decision|1|||
155185172|NCT00323869|560116347|FG000|Overall Study|Death|1|||
155185173|NCT03172910|560117895|FG000|Overall Study|Adverse Event|0|||
155185174|NCT03172910|560117896|FG001|Overall Study|Adverse Event|0|||
155185175|NCT03172910|560117897|FG002|Overall Study|Adverse Event|0|||
155185176|NCT03172910|560117898|FG003|Overall Study|Adverse Event|0|||
155185177|NCT03172910|560117899|FG004|Overall Study|Adverse Event|1|||
155185178|NCT03468985|560117911|FG000|Overall Study|Adverse Event|0|||
155185179|NCT03468985|560117912|FG001|Overall Study|Adverse Event|2|||
155185180|NCT03468985|560117913|FG002|Overall Study|Adverse Event|0|||
155185181|NCT03468985|560117914|FG003|Overall Study|Adverse Event|0|||
155185182|NCT03468985|560117911|FG000|Overall Study|Withdrawal by Subject|0|||
155185183|NCT03468985|560117912|FG001|Overall Study|Withdrawal by Subject|0|||
155185184|NCT03468985|560117913|FG002|Overall Study|Withdrawal by Subject|0|||
155185185|NCT03468985|560117914|FG003|Overall Study|Withdrawal by Subject|1|||
155185186|NCT02806973|560117915|FG000|Period 1|Withdrawal by Subject|0|||
155185187|NCT02806973|560117916|FG001|Period 1|Withdrawal by Subject|2|||
155185188|NCT02806973|560117917|FG002|Period 1|Withdrawal by Subject|1|||
155185189|NCT02806973|560117918|FG003|Period 1|Withdrawal by Subject|1|||
155185190|NCT02806973|560117915|FG000|Period 1|Adverse Event|0|||
155185191|NCT02806973|560117916|FG001|Period 1|Adverse Event|0|||
155185192|NCT02806973|560117917|FG002|Period 1|Adverse Event|0|||
155185193|NCT02806973|560117918|FG003|Period 1|Adverse Event|1|||
155185194|NCT02806973|560117915|FG000|Period 3|Withdrawal by Subject|0|||
155185195|NCT02806973|560117916|FG001|Period 3|Withdrawal by Subject|0|||
155185196|NCT02806973|560117917|FG002|Period 3|Withdrawal by Subject|0|||
155185197|NCT02806973|560117918|FG003|Period 3|Withdrawal by Subject|3|||
155185198|NCT02806973|560117915|FG000|Period 3|Adverse Event|0|||
155185199|NCT02806973|560117916|FG001|Period 3|Adverse Event|0|||
155185200|NCT02806973|560117917|FG002|Period 3|Adverse Event|1|||
155185201|NCT02806973|560117918|FG003|Period 3|Adverse Event|0|||
155185202|NCT04060862|560117919|FG000|Overall Study|Symptomatic Deterioration|1|||
155185203|NCT04060862|560117919|FG000|Overall Study|Un-specified|6|||
155185204|NCT04060862|560117919|FG000|Overall Study|Progressive disease|12|||
155185205|NCT04060862|560117919|FG000|Overall Study|Physician Decision|1|||
155185206|NCT01229397|560117920|FG000|Overall Study|Withdrawal by Subject|3|||
155185207|NCT01229397|560117921|FG001|Overall Study|Withdrawal by Subject|3|||
155185208|NCT01229397|560117920|FG000|Overall Study|Lost to Follow-up|7|||
155185209|NCT01229397|560117921|FG001|Overall Study|Lost to Follow-up|6|||
155185210|NCT01229397|560117920|FG000|Overall Study|Migrated/moved from study area|1|||
155185211|NCT01229397|560117921|FG001|Overall Study|Migrated/moved from study area|0|||
155185212|NCT01869725|560117923|FG000|Overall Study|ineligible after registration|1|||
155185213|NCT01869725|560117923|FG000|Overall Study|Death|1|||
155185214|NCT01869725|560117923|FG000|Overall Study|Lost to Follow-up|2|||
155185215|NCT03416374|560117924|FG000|Between Treatment Period I and II|Other|0|||
155185216|NCT03416374|560117925|FG001|Between Treatment Period I and II|Other|9|||
155185217|NCT03416374|560117924|FG000|Treatment Period II|Lack of Efficacy|3|||
155185218|NCT03416374|560117925|FG001|Treatment Period II|Lack of Efficacy|11|||
155185219|NCT03416374|560117924|FG000|Treatment Period II|Adverse Event|1|||
155185220|NCT03416374|560117925|FG001|Treatment Period II|Adverse Event|4|||
155185221|NCT03416374|560117924|FG000|Treatment Period II|Death|0|||
155185222|NCT03416374|560117925|FG001|Treatment Period II|Death|1|||
155185223|NCT03416374|560117924|FG000|Treatment Period II|Other|0|||
155185224|NCT03416374|560117925|FG001|Treatment Period II|Other|2|||
155185225|NCT03463031|560117928|FG000|Overall Study|Withdrawal by Subject|4|||
155185226|NCT03463031|560117929|FG001|Overall Study|Withdrawal by Subject|2|||
155185227|NCT03463031|560117928|FG000|Overall Study|Investigator/Sponsor Decision|0|||
155185228|NCT03463031|560117929|FG001|Overall Study|Investigator/Sponsor Decision|1|||
155185229|NCT03463031|560117928|FG000|Overall Study|Lost to Follow-up|1|||
155185230|NCT03463031|560117929|FG001|Overall Study|Lost to Follow-up|1|||
155185231|NCT03463031|560117928|FG000|Overall Study|Adverse Event|4|||
155185232|NCT03463031|560117929|FG001|Overall Study|Adverse Event|1|||
155185233|NCT03463031|560117928|FG000|Overall Study|Use of prohibited medication by subject|1|||
155185234|NCT03463031|560117929|FG001|Overall Study|Use of prohibited medication by subject|0|||
155185235|NCT01241240|560117930|FG000|Overall Study|Adverse Event|5|||
155185236|NCT01241240|560117931|FG001|Overall Study|Adverse Event|4|||
155185237|NCT01241240|560117930|FG000|Overall Study|Lost to Follow-up|2|||
155185238|NCT01241240|560117931|FG001|Overall Study|Lost to Follow-up|4|||
155185239|NCT01241240|560117930|FG000|Overall Study|Personal Reasons|1|||
155185240|NCT01241240|560117931|FG001|Overall Study|Personal Reasons|1|||
155185241|NCT01025154|560117932|FG000|Overall Study|Lost to Follow-up|1|||
155185242|NCT01025154|560117932|FG000|Overall Study|Withdrawal by Subject|1|||
155185243|NCT01810432|560117933|FG000|Washout|Protocol Violation|0|||
155185244|NCT01810432|560117934|FG001|Washout|Protocol Violation|1|||
155185245|NCT01810432|560117933|FG000|Washout|Adverse Event|1|||
155185246|NCT01810432|560117934|FG001|Washout|Adverse Event|0|||
155185247|NCT01810432|560117933|FG000|Period 2|Withdrawal by Subject|2|||
155185248|NCT01810432|560117934|FG001|Period 2|Withdrawal by Subject|1|||
155185249|NCT01810432|560117933|FG000|Period 2|Physician Decision|1|||
155185250|NCT01810432|560117934|FG001|Period 2|Physician Decision|0|||
155185251|NCT01810432|560117933|FG000|Period 2|Lost to Follow-up|1|||
155185252|NCT01810432|560117934|FG001|Period 2|Lost to Follow-up|1|||
155185253|NCT01251744|560117935|FG000|Overall Study|Lost to Follow-up|1|||
155185254|NCT01251744|560117936|FG001|Overall Study|Lost to Follow-up|0|||
155185255|NCT02147184|560117937|FG000|Overall Study|Lost to Follow-up|28|||
155185256|NCT02147184|560117938|FG001|Overall Study|Lost to Follow-up|15|||
155185257|NCT02147184|560117937|FG000|Overall Study|Study Burden|11|||
155185258|NCT02147184|560117938|FG001|Overall Study|Study Burden|7|||
155185259|NCT02147184|560117937|FG000|Overall Study|Pregnancy|6|||
155185260|NCT02147184|560117938|FG001|Overall Study|Pregnancy|0|||
155185261|NCT02147184|560117937|FG000|Overall Study|Moved out of state|3|||
155185262|NCT02147184|560117938|FG001|Overall Study|Moved out of state|3|||
155185263|NCT02147184|560117937|FG000|Overall Study|Physician Decision|0|||
155185264|NCT02147184|560117938|FG001|Overall Study|Physician Decision|2|||
155185265|NCT02147184|560117937|FG000|Overall Study|Other|1|||
155185266|NCT02147184|560117938|FG001|Overall Study|Other|0|||
155185267|NCT01151098|560117940|FG000|Overall Study|Adverse Event|82|||
155185268|NCT01151098|560117940|FG000|Overall Study|Lost to Follow-up|6|||
155185269|NCT01151098|560117940|FG000|Overall Study|Lack of Efficacy|15|||
155185270|NCT01151098|560117940|FG000|Overall Study|Protocol Violation|1|||
155185271|NCT01151098|560117940|FG000|Overall Study|Miscellaneous|13|||
155185272|NCT00542451|560117941|FG000|Overall Study|Adverse Event|31|||
155185273|NCT00542451|560117941|FG000|Overall Study|Withdrawal by Subject|30|||
155185274|NCT00542451|560117941|FG000|Overall Study|Physician Decision|4|||
155185275|NCT00542451|560117941|FG000|Overall Study|Recurrent disease|1|||
155185276|NCT00542451|560117941|FG000|Overall Study|unknown reason|1|||
155185277|NCT00542451|560117941|FG000|Overall Study|Death|2|||
155716970|NCT03812380|562057712|FG001|Overall Study|Withdrawal by Subject|4|||
155716971|NCT03812380|562057711|FG000|Overall Study|Early termination of study|14|||
155716972|NCT03812380|562057712|FG001|Overall Study|Early termination of study|14|||
155716973|NCT00981149|562057716|FG000|Overall Study|Lost to Follow-up|1|||
155716974|NCT00981149|562057717|FG001|Overall Study|Lost to Follow-up|2|||
155716975|NCT00981149|562057716|FG000|Overall Study|Withdrawal by Subject|1|||
155716976|NCT00981149|562057717|FG001|Overall Study|Withdrawal by Subject|1|||
155716977|NCT01220167|562057718|FG000|Period 3|Urine positive for substance abuse|0|||
155716978|NCT01220167|562057719|FG001|Period 3|Urine positive for substance abuse|1|||
155716979|NCT01220167|562057720|FG002|Period 3|Urine positive for substance abuse|0|||
155716980|NCT00622505|562057721|FG000|Overall Study|Adverse Event|9|||
155716981|NCT00622505|562057722|FG001|Overall Study|Adverse Event|7|||
155716982|NCT00622505|562057721|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
155716983|NCT00622505|562057722|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
155716984|NCT00622505|562057721|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155716985|NCT00622505|562057722|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155716986|NCT00622505|562057721|FG000|Overall Study|Withdrawal by Subject|12|||
155716987|NCT00622505|562057722|FG001|Overall Study|Withdrawal by Subject|5|||
155716988|NCT00622505|562057721|FG000|Overall Study|Administrative Problems|2|||
155716989|NCT00622505|562057722|FG001|Overall Study|Administrative Problems|4|||
155716990|NCT00622505|562057721|FG000|Overall Study|Death|2|||
155716991|NCT00622505|562057722|FG001|Overall Study|Death|2|||
155716992|NCT00619515|562057723|FG000|Overall Study|Study Termination by IRB|73|||
155716993|NCT01453140|562057726|FG000|Overall Study|Adverse Event|3|||
155716994|NCT02634333|562057727|FG000|Overall Study|Completed out of Window|3|||
155716995|NCT02634333|562057728|FG001|Overall Study|Completed out of Window|2|||
155716996|NCT02634333|562057727|FG000|Overall Study|Missed Visit|5|||
155716997|NCT02634333|562057728|FG001|Overall Study|Missed Visit|2|||
155716998|NCT02634333|562057727|FG000|Overall Study|Lost to Follow-up|12|||
155716999|NCT02634333|562057728|FG001|Overall Study|Lost to Follow-up|7|||
155717000|NCT02634333|562057727|FG000|Overall Study|Withdrawal by Subject|9|||
155717001|NCT02634333|562057728|FG001|Overall Study|Withdrawal by Subject|13|||
155717002|NCT02634333|562057727|FG000|Overall Study|Death|11|||
155717003|NCT02634333|562057728|FG001|Overall Study|Death|8|||
155717004|NCT02748863|562057732|FG000|Treatment Period 1|Adverse Event|0|||
155717005|NCT02748863|562057733|FG001|Treatment Period 1|Adverse Event|1|||
155717006|NCT02748863|562057734|FG002|Treatment Period 1|Adverse Event|0|||
155717007|NCT02748863|562057735|FG003|Treatment Period 1|Adverse Event|0|||
155717008|NCT02748863|562057736|FG004|Treatment Period 1|Adverse Event|0|||
155717009|NCT02748863|562057732|FG000|Treatment Period 1|Lack of Efficacy|0|||
155717010|NCT02748863|562057733|FG001|Treatment Period 1|Lack of Efficacy|0|||
155717011|NCT02748863|562057734|FG002|Treatment Period 1|Lack of Efficacy|1|||
155717012|NCT02748863|562057735|FG003|Treatment Period 1|Lack of Efficacy|0|||
155717013|NCT02748863|562057736|FG004|Treatment Period 1|Lack of Efficacy|0|||
155717014|NCT02748863|562057732|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155717015|NCT02748863|562057733|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155717016|NCT02748863|562057734|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155717017|NCT02748863|562057735|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155717018|NCT02748863|562057736|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155717019|NCT02748863|562057732|FG000|Treatment Period 2|Lost to Follow-up|2|||
155717020|NCT02748863|562057733|FG001|Treatment Period 2|Lost to Follow-up|0|||
155717021|NCT02748863|562057734|FG002|Treatment Period 2|Lost to Follow-up|0|||
155717022|NCT02748863|562057735|FG003|Treatment Period 2|Lost to Follow-up|0|||
155717023|NCT02748863|562057736|FG004|Treatment Period 2|Lost to Follow-up|0|||
155717024|NCT02748863|562057732|FG000|Treatment Period 2|Adverse Event|3|||
155717025|NCT02748863|562057733|FG001|Treatment Period 2|Adverse Event|2|||
155717026|NCT02748863|562057734|FG002|Treatment Period 2|Adverse Event|0|||
155717027|NCT02748863|562057735|FG003|Treatment Period 2|Adverse Event|2|||
155717028|NCT02748863|562057736|FG004|Treatment Period 2|Adverse Event|0|||
155717029|NCT02748863|562057732|FG000|Treatment Period 2|Lack of Efficacy|0|||
155717030|NCT02748863|562057733|FG001|Treatment Period 2|Lack of Efficacy|1|||
155717031|NCT02748863|562057734|FG002|Treatment Period 2|Lack of Efficacy|0|||
155717032|NCT02748863|562057735|FG003|Treatment Period 2|Lack of Efficacy|0|||
155717033|NCT02748863|562057736|FG004|Treatment Period 2|Lack of Efficacy|0|||
155717034|NCT02748863|562057732|FG000|Treatment Period 2|Pregnancy|0|||
155717035|NCT02748863|562057733|FG001|Treatment Period 2|Pregnancy|0|||
155717036|NCT02748863|562057734|FG002|Treatment Period 2|Pregnancy|0|||
155717037|NCT02748863|562057735|FG003|Treatment Period 2|Pregnancy|0|||
155717038|NCT02748863|562057736|FG004|Treatment Period 2|Pregnancy|1|||
155717039|NCT00231777|562057737|FG000|Overall Study|Lost to Follow-up|3|||
155717040|NCT00231777|562057738|FG001|Overall Study|Lost to Follow-up|0|||
155717041|NCT00231777|562057737|FG000|Overall Study|Other|3|||
155717042|NCT00231777|562057738|FG001|Overall Study|Other|2|||
155717043|NCT00657046|562057739|FG000|Overall Study|Adverse Event|1|||
155717044|NCT00657046|562057740|FG001|Overall Study|Adverse Event|1|||
155717045|NCT00657046|562057741|FG002|Overall Study|Adverse Event|0|||
155717046|NCT00657046|562057739|FG000|Overall Study|Protocol Violation|2|||
155717047|NCT00657046|562057740|FG001|Overall Study|Protocol Violation|2|||
155717048|NCT00657046|562057741|FG002|Overall Study|Protocol Violation|0|||
155717049|NCT00657046|562057739|FG000|Overall Study|Withdrawal by Subject|1|||
155717050|NCT00657046|562057740|FG001|Overall Study|Withdrawal by Subject|0|||
155717051|NCT00657046|562057741|FG002|Overall Study|Withdrawal by Subject|0|||
155717052|NCT00657046|562057739|FG000|Overall Study|Death|0|||
155717053|NCT00657046|562057740|FG001|Overall Study|Death|0|||
155717054|NCT00657046|562057741|FG002|Overall Study|Death|1|||
155717055|NCT00657046|562057739|FG000|Overall Study|Surgery|0|||
155717056|NCT00657046|562057740|FG001|Overall Study|Surgery|0|||
155717057|NCT00657046|562057741|FG002|Overall Study|Surgery|1|||
155717058|NCT04678115|562057742|FG000|Overall Study|Lost to Follow-up|1|||
155717059|NCT04678115|562057743|FG001|Overall Study|Lost to Follow-up|0|||
155717060|NCT00890825|562057744|FG000|Overall Study|Withdrawal by Subject|1|||
155717061|NCT00890825|562057745|FG001|Overall Study|Withdrawal by Subject|0|||
155717062|NCT00890825|562057744|FG000|Overall Study|Alive at data cut off (DCO)|13|||
155717063|NCT00890825|562057745|FG001|Overall Study|Alive at data cut off (DCO)|14|||
155717064|NCT00844376|562057746|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
155717065|NCT00844376|562057747|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
155717066|NCT00920855|562057748|FG000|Overall Study|Adverse Event|1|||
155717067|NCT00920855|562057749|FG001|Overall Study|Adverse Event|1|||
155717068|NCT00920855|562057750|FG002|Overall Study|Adverse Event|4|||
155717069|NCT00920855|562057748|FG000|Overall Study|Withdrawal by Subject|2|||
155717070|NCT00920855|562057749|FG001|Overall Study|Withdrawal by Subject|1|||
155717071|NCT00920855|562057750|FG002|Overall Study|Withdrawal by Subject|6|||
155717072|NCT00920855|562057748|FG000|Overall Study|Disease progression|2|||
155717073|NCT00920855|562057749|FG001|Overall Study|Disease progression|1|||
155717074|NCT00920855|562057750|FG002|Overall Study|Disease progression|10|||
155717075|NCT00920855|562057748|FG000|Overall Study|Noncompliance to study medication|0|||
155717076|NCT00920855|562057749|FG001|Overall Study|Noncompliance to study medication|0|||
155717077|NCT00920855|562057750|FG002|Overall Study|Noncompliance to study medication|1|||
155717078|NCT00920855|562057748|FG000|Overall Study|Response plateau; started maintenance|0|||
155717079|NCT00920855|562057749|FG001|Overall Study|Response plateau; started maintenance|0|||
155717080|NCT00920855|562057750|FG002|Overall Study|Response plateau; started maintenance|1|||
155717081|NCT00510835|562057753|FG000|Overall Study|Withdrawal by Subject|6|||
155717082|NCT00510835|562057754|FG001|Overall Study|Withdrawal by Subject|2|||
155717083|NCT00510835|562057755|FG002|Overall Study|Withdrawal by Subject|2|||
155717084|NCT00152503|562057757|FG000|Overall Study|Adverse Event|4|||
155717085|NCT03253679|562057758|FG000|Overall Study|Screen Failure|1|||
155717086|NCT04816214|562057759|FG000|Overall Study|Progressive Disease|4|||
155717087|NCT04816214|562057760|FG001|Overall Study|Progressive Disease|0|||
155717088|NCT04816214|562057761|FG002|Overall Study|Progressive Disease|0|||
155717089|NCT04816214|562057759|FG000|Overall Study|Death|1|||
155717090|NCT04816214|562057760|FG001|Overall Study|Death|0|||
155717091|NCT04816214|562057761|FG002|Overall Study|Death|0|||
155717092|NCT04816214|562057759|FG000|Overall Study|Study Terminated by Sponsor|1|||
155717093|NCT04816214|562057760|FG001|Overall Study|Study Terminated by Sponsor|0|||
155717094|NCT04816214|562057761|FG002|Overall Study|Study Terminated by Sponsor|0|||
155717095|NCT04393493|562057762|FG000|First 4 Days of Intervention|Early improvement|5|||
155717096|NCT04393493|562057763|FG001|First 4 Days of Intervention|Early improvement|7|||
155717097|NCT03863509|562057764|FG000|Overall Study|COVID-19 shutdown period|0|||
155717098|NCT03863509|562057765|FG001|Overall Study|COVID-19 shutdown period|4|||
155717099|NCT03863509|562057766|FG002|Overall Study|COVID-19 shutdown period|0|||
155717100|NCT03863509|562057764|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
155717101|NCT03863509|562057765|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
155717102|NCT03863509|562057766|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
155717103|NCT03863509|562057764|FG000|Overall Study|Lost to Follow-up|8|||
155717104|NCT03863509|562057765|FG001|Overall Study|Lost to Follow-up|0|||
155717105|NCT03863509|562057766|FG002|Overall Study|Lost to Follow-up|2|||
155717106|NCT03863509|562057764|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
155717107|NCT03863509|562057765|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
155717108|NCT03863509|562057766|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
155717109|NCT03863509|562057764|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
155717110|NCT03863509|562057765|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
155717111|NCT03863509|562057766|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
155717112|NCT00990106|562057769|FG000|Overall Study|"too busy to continue"|1|||
155717113|NCT00990106|562057770|FG001|Overall Study|"too busy to continue"|2|||
155717114|NCT00990106|562057769|FG000|Overall Study|Lost to Follow-up|1|||
155717115|NCT00990106|562057770|FG001|Overall Study|Lost to Follow-up|3|||
155717116|NCT00990106|562057769|FG000|Overall Study|Withdrawal by Subject|2|||
155717117|NCT00990106|562057770|FG001|Overall Study|Withdrawal by Subject|1|||
155717118|NCT00990106|562057769|FG000|Overall Study|opted for open label prazosin|1|||
155185278|NCT00542451|560117941|FG000|Overall Study|Lost to Follow-up|10|||
155717119|NCT00990106|562057770|FG001|Overall Study|opted for open label prazosin|1|||
155717120|NCT00990106|562057769|FG000|Overall Study|relocation/deployment|4|||
155717121|NCT00990106|562057770|FG001|Overall Study|relocation/deployment|1|||
155185279|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
155185280|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
155185281|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
155185282|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
155185283|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155185284|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
155185285|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155185286|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
155185287|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
155185288|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
155185289|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
155185290|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
155185291|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185292|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
155185293|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185294|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185295|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Program Termination|3|||
155185296|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Program Termination|0|||
155185297|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Program Termination|1|||
155185298|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Program Termination|1|||
155185299|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
155185300|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185301|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185302|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185303|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
155185304|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
155185305|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
155185306|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
155185307|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
155185308|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
155185309|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
155185310|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
155185311|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185312|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
155185313|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185314|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185315|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185316|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
155185317|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185318|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185319|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185320|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
155185321|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185322|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185323|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
155185324|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
155185325|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
155185326|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
155185327|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155717122|NCT00990106|562057769|FG000|Overall Study|started exclusionary medication|0|||
155717123|NCT00990106|562057770|FG001|Overall Study|started exclusionary medication|1|||
155717124|NCT00990106|562057769|FG000|Overall Study|planned major surgery|0|||
155717125|NCT00990106|562057770|FG001|Overall Study|planned major surgery|1|||
155717126|NCT00990106|562057769|FG000|Overall Study|scheduling conflicts|0|||
155717127|NCT00990106|562057770|FG001|Overall Study|scheduling conflicts|2|||
155717128|NCT02926638|562057771|FG000|Overall Study|Progression|2|||
155717129|NCT02926638|562057772|FG001|Overall Study|Progression|5|||
155717130|NCT02926638|562057771|FG000|Overall Study|Ineligible|1|||
155185328|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155185329|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
155185330|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155185331|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155185332|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155717131|NCT02926638|562057772|FG001|Overall Study|Ineligible|0|||
155717132|NCT02926638|562057771|FG000|Overall Study|Not protocol specified|1|||
155717133|NCT02926638|562057772|FG001|Overall Study|Not protocol specified|0|||
155185333|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
155185334|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155185335|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185336|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185337|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185338|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
155185339|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185340|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185341|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185342|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
155185343|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185344|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185345|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185346|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
155185347|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
155185348|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185349|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185350|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185351|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185352|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185353|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185354|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
155185355|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
155185356|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185357|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185358|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185359|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185360|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
155185361|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185362|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185363|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185364|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
155185365|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185366|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185367|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185368|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185369|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
155717134|NCT02464410|562057775|FG000|Overall Study|Death|3|||
155185370|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185371|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185372|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185373|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
155185374|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185375|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185376|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185377|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
155185378|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185379|NCT01058265|560117948|FG000|Overall Study|Lost to Follow-up|11|||
155185380|NCT01058265|560117949|FG001|Overall Study|Lost to Follow-up|12|||
155185381|NCT01243671|560117950|FG000|Overall Study|Adverse Event|3|||
155717135|NCT02464410|562057776|FG001|Overall Study|Death|4|||
155717136|NCT02464410|562057775|FG000|Overall Study|Lost to Follow-up|7|||
155717137|NCT02464410|562057776|FG001|Overall Study|Lost to Follow-up|9|||
155717138|NCT02464410|562057775|FG000|Overall Study|Withdrawal by Subject|12|||
155717139|NCT02464410|562057776|FG001|Overall Study|Withdrawal by Subject|3|||
155717140|NCT00882440|562059452|FG000|Overall Study|Adverse Event|2|||
155717141|NCT00882440|562059453|FG001|Overall Study|Adverse Event|2|||
155717142|NCT00882440|562059454|FG002|Overall Study|Adverse Event|2|||
155717143|NCT00882440|562059455|FG003|Overall Study|Adverse Event|1|||
155717144|NCT00882440|562059456|FG004|Overall Study|Adverse Event|1|||
155717145|NCT00882440|562059457|FG005|Overall Study|Adverse Event|4|||
155717146|NCT00882440|562059458|FG006|Overall Study|Adverse Event|2|||
155717147|NCT00882440|562059452|FG000|Overall Study|Lack of Efficacy|3|||
155717148|NCT00882440|562059453|FG001|Overall Study|Lack of Efficacy|5|||
155717149|NCT00882440|562059454|FG002|Overall Study|Lack of Efficacy|2|||
155717150|NCT00882440|562059455|FG003|Overall Study|Lack of Efficacy|0|||
155717151|NCT00882440|562059456|FG004|Overall Study|Lack of Efficacy|0|||
155717152|NCT00882440|562059457|FG005|Overall Study|Lack of Efficacy|3|||
155717153|NCT00882440|562059458|FG006|Overall Study|Lack of Efficacy|0|||
155185382|NCT01243671|560117950|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
155185383|NCT01243671|560117950|FG000|Overall Study|Other|1|||
155185384|NCT02869438|560117951|FG000|Overall Study|Lost to Follow-up|1|||
155185385|NCT02869438|560117952|FG001|Overall Study|Lost to Follow-up|0|||
155185386|NCT02869438|560117951|FG000|Overall Study|Adverse Event|1|||
155185387|NCT02869438|560117952|FG001|Overall Study|Adverse Event|0|||
155185388|NCT02869438|560117951|FG000|Overall Study|Withdrawal by Subject|1|||
155185389|NCT02869438|560117952|FG001|Overall Study|Withdrawal by Subject|2|||
155185390|NCT02962765|560117953|FG000|Overall Study|Protocol Violation|9|||
155185391|NCT02962765|560117953|FG000|Overall Study|Withdrawal by Subject|3|||
155185392|NCT02962765|560117953|FG000|Overall Study|Lost to Follow-up|1|||
155185393|NCT02962765|560117953|FG000|Overall Study|Death|1|||
155185394|NCT02962765|560117953|FG000|Overall Study|Limited access to study medication|3|||
155185395|NCT02169284|560117956|FG000|Overall Study|Physician Decision|0|||
155185396|NCT02169284|560117957|FG001|Overall Study|Physician Decision|1|||
155185397|NCT02764190|560117959|FG000|Overall Study|Lost to Follow-up|17|||
155185398|NCT02764190|560117960|FG001|Overall Study|Lost to Follow-up|13|||
155185399|NCT02140775|560117966|FG000|Overall Study|Withdrawal by Subject|30|||
155185400|NCT02140775|560117967|FG001|Overall Study|Withdrawal by Subject|7|||
155717154|NCT00882440|562059452|FG000|Overall Study|Lost to Follow-up|2|||
155717155|NCT00882440|562059453|FG001|Overall Study|Lost to Follow-up|0|||
155717156|NCT00882440|562059454|FG002|Overall Study|Lost to Follow-up|1|||
155717157|NCT00882440|562059455|FG003|Overall Study|Lost to Follow-up|1|||
155717158|NCT00882440|562059456|FG004|Overall Study|Lost to Follow-up|1|||
155717159|NCT00882440|562059457|FG005|Overall Study|Lost to Follow-up|0|||
155717160|NCT00882440|562059458|FG006|Overall Study|Lost to Follow-up|1|||
155717161|NCT00882440|562059452|FG000|Overall Study|Protocol Violation|0|||
155717162|NCT00882440|562059453|FG001|Overall Study|Protocol Violation|0|||
155717163|NCT00882440|562059454|FG002|Overall Study|Protocol Violation|1|||
155717164|NCT00882440|562059455|FG003|Overall Study|Protocol Violation|1|||
155717165|NCT00882440|562059456|FG004|Overall Study|Protocol Violation|1|||
155185401|NCT00938964|560117971|FG000|Overall Study|Death|3|||
155185402|NCT00938964|560117972|FG001|Overall Study|Death|3|||
155185403|NCT00938964|560117971|FG000|Overall Study|Lost to Follow-up|2|||
155717166|NCT00882440|562059457|FG005|Overall Study|Protocol Violation|0|||
155717167|NCT00882440|562059458|FG006|Overall Study|Protocol Violation|0|||
155717168|NCT00882440|562059452|FG000|Overall Study|Withdrawal by Subject|2|||
155717169|NCT00882440|562059453|FG001|Overall Study|Withdrawal by Subject|1|||
155717170|NCT00882440|562059454|FG002|Overall Study|Withdrawal by Subject|1|||
155717171|NCT00882440|562059455|FG003|Overall Study|Withdrawal by Subject|0|||
155717172|NCT00882440|562059456|FG004|Overall Study|Withdrawal by Subject|6|||
155717173|NCT00882440|562059457|FG005|Overall Study|Withdrawal by Subject|0|||
155717174|NCT00882440|562059458|FG006|Overall Study|Withdrawal by Subject|1|||
155717175|NCT00882440|562059452|FG000|Overall Study|Patient Uncooperative|2|||
155717176|NCT00882440|562059453|FG001|Overall Study|Patient Uncooperative|0|||
155717177|NCT00882440|562059454|FG002|Overall Study|Patient Uncooperative|0|||
155717178|NCT00882440|562059455|FG003|Overall Study|Patient Uncooperative|0|||
155717179|NCT00882440|562059456|FG004|Overall Study|Patient Uncooperative|1|||
155717180|NCT00882440|562059457|FG005|Overall Study|Patient Uncooperative|0|||
155717181|NCT00882440|562059458|FG006|Overall Study|Patient Uncooperative|0|||
155717182|NCT04319198|562059459|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
155717183|NCT04319198|562059460|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
155717184|NCT04319198|562059461|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
155717185|NCT04319198|562059459|FG000|Overall Study|Death|0|||
155717186|NCT04319198|562059460|FG001|Overall Study|Death|3|||
155717187|NCT04319198|562059461|FG002|Overall Study|Death|3|||
155717188|NCT04319198|562059459|FG000|Overall Study|Reason Not Specified|0|||
155717189|NCT04319198|562059460|FG001|Overall Study|Reason Not Specified|2|||
155717190|NCT04319198|562059461|FG002|Overall Study|Reason Not Specified|4|||
155717191|NCT04319198|562059459|FG000|Overall Study|Withdrawal of Consent|0|||
155717192|NCT04319198|562059460|FG001|Overall Study|Withdrawal of Consent|0|||
155717193|NCT04319198|562059461|FG002|Overall Study|Withdrawal of Consent|5|||
155717194|NCT04319198|562059459|FG000|Overall Study|Site Terminated by Sponsor|0|||
155717195|NCT04319198|562059460|FG001|Overall Study|Site Terminated by Sponsor|1|||
155717196|NCT04319198|562059461|FG002|Overall Study|Site Terminated by Sponsor|0|||
155717197|NCT02123134|562059471|FG000|Overall Study|Withdrawal of consent|3|||
155717198|NCT02123134|562059472|FG001|Overall Study|Withdrawal of consent|2|||
155717199|NCT02123134|562059471|FG000|Overall Study|Administrative decision|0|||
155717200|NCT02123134|562059472|FG001|Overall Study|Administrative decision|1|||
155717201|NCT00962208|562059473|FG000|Overall Study|Could not achieve good vision|9|||
155717202|NCT00962208|562059474|FG001|Overall Study|Could not achieve good vision|0|||
155717203|NCT00962208|562059473|FG000|Overall Study|Contraindicated to continue study|5|||
155717204|NCT00962208|562059474|FG001|Overall Study|Contraindicated to continue study|1|||
155717205|NCT00962208|562059473|FG000|Overall Study|Lost to Follow-up|0|||
155717206|NCT00962208|562059474|FG001|Overall Study|Lost to Follow-up|9|||
155717207|NCT00657540|562059481|FG000|Overall Study|Lost to Follow-up|1|||
155717208|NCT00657540|562059482|FG001|Overall Study|Lost to Follow-up|4|||
155717209|NCT01731912|562059483|FG000|Overall Study|noncompliance|2|||
155717210|NCT00141453|562059484|FG000|Overall Study|Protocol Violation|6|||
155717211|NCT00141453|562059485|FG001|Overall Study|Protocol Violation|5|||
155717212|NCT02043938|562059486|FG000|Overall Study|Withdrawal by Subject|7|||
155717213|NCT02043938|562059486|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
155717214|NCT02043938|562059486|FG000|Overall Study|No show by subject|1|||
155717215|NCT02043938|562059486|FG000|Overall Study|Investigator decision|1|||
155717216|NCT03010527|562059487|FG000|Overall Study|Death|0|||
155717217|NCT03010527|562059488|FG001|Overall Study|Death|0|||
155185404|NCT00938964|560117972|FG001|Overall Study|Lost to Follow-up|3|||
155185405|NCT00938964|560117971|FG000|Overall Study|Withdrawal by Subject|22|||
155717218|NCT03010527|562059489|FG002|Overall Study|Death|1|||
155185406|NCT00938964|560117972|FG001|Overall Study|Withdrawal by Subject|18|||
155185407|NCT00938964|560117971|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
155185408|NCT00938964|560117972|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
155717219|NCT03010527|562059487|FG000|Overall Study|Adverse Event|0|||
155717220|NCT03010527|562059488|FG001|Overall Study|Adverse Event|4|||
155717221|NCT03010527|562059489|FG002|Overall Study|Adverse Event|2|||
155717222|NCT03010527|562059487|FG000|Overall Study|Protocol Violation|0|||
155717223|NCT03010527|562059488|FG001|Overall Study|Protocol Violation|1|||
155717224|NCT03010527|562059489|FG002|Overall Study|Protocol Violation|0|||
155717225|NCT03010527|562059487|FG000|Overall Study|Lost to Follow-up|0|||
155717226|NCT03010527|562059488|FG001|Overall Study|Lost to Follow-up|2|||
155717227|NCT03010527|562059489|FG002|Overall Study|Lost to Follow-up|1|||
155717228|NCT03010527|562059487|FG000|Overall Study|Withdrawal by Subject|0|||
155185409|NCT01858636|560117973|FG000|Overall Study|No Device Deployment Attempted|24|||
155185410|NCT01858636|560117973|FG000|Overall Study|Physician Decision|1|||
155185411|NCT01858636|560117973|FG000|Overall Study|Death|1|||
155185412|NCT01858636|560117973|FG000|Overall Study|Lost to Follow-up|1|||
155185413|NCT01858636|560117973|FG000|Overall Study|Withdrawal by Subject|1|||
155185414|NCT01227564|560117977|FG000|Overall Study|No Longer Willing to Participate|4|||
155185415|NCT01227564|560117978|FG001|Overall Study|No Longer Willing to Participate|2|||
155185416|NCT01227564|560117979|FG002|Overall Study|No Longer Willing to Participate|5|||
155185417|NCT01227564|560117977|FG000|Overall Study|Participant moved to another town|0|||
155185418|NCT01227564|560117978|FG001|Overall Study|Participant moved to another town|0|||
155185419|NCT01227564|560117979|FG002|Overall Study|Participant moved to another town|1|||
155185420|NCT04650854|560117982|FG000|Overall Study|Adverse Event|1|||
155185421|NCT04650854|560117983|FG001|Overall Study|Adverse Event|12|||
155185422|NCT04650854|560117984|FG002|Overall Study|Adverse Event|14|||
155185423|NCT04650854|560117982|FG000|Overall Study|Lack of Efficacy|1|||
155185424|NCT04650854|560117983|FG001|Overall Study|Lack of Efficacy|3|||
155185425|NCT04650854|560117984|FG002|Overall Study|Lack of Efficacy|6|||
155185426|NCT04650854|560117982|FG000|Overall Study|Lost to Follow-up|1|||
155185427|NCT04650854|560117983|FG001|Overall Study|Lost to Follow-up|1|||
155185428|NCT04650854|560117984|FG002|Overall Study|Lost to Follow-up|0|||
155185429|NCT04650854|560117982|FG000|Overall Study|Withdrawal by Subject|2|||
155185430|NCT04650854|560117983|FG001|Overall Study|Withdrawal by Subject|17|||
155185431|NCT04650854|560117984|FG002|Overall Study|Withdrawal by Subject|9|||
155185432|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
155185433|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
155185434|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
155185435|NCT04650854|560117982|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
155185436|NCT04650854|560117983|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
155185437|NCT04650854|560117984|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
155185438|NCT04650854|560117982|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
155185439|NCT04650854|560117983|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
155185440|NCT04650854|560117984|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
155185441|NCT04650854|560117982|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
155185442|NCT04650854|560117983|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
155185443|NCT04650854|560117984|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
155185444|NCT04650854|560117982|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
155185445|NCT04650854|560117983|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
155185446|NCT04650854|560117984|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
155185447|NCT04650854|560117982|FG000|Overall Study|Use of Rescue Medication|0|||
155185448|NCT04650854|560117983|FG001|Overall Study|Use of Rescue Medication|0|||
155185449|NCT04650854|560117984|FG002|Overall Study|Use of Rescue Medication|1|||
155185450|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor|0|||
155185451|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor|0|||
155185452|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor|2|||
155185453|NCT04650854|560117982|FG000|Overall Study|Rescue Medication|0|||
155185454|NCT04650854|560117983|FG001|Overall Study|Rescue Medication|0|||
155185455|NCT04650854|560117984|FG002|Overall Study|Rescue Medication|1|||
155185456|NCT04650854|560117982|FG000|Overall Study|Participant Want to Start a Family|0|||
155185457|NCT04650854|560117983|FG001|Overall Study|Participant Want to Start a Family|0|||
155185458|NCT04650854|560117984|FG002|Overall Study|Participant Want to Start a Family|1|||
155717229|NCT03010527|562059488|FG001|Overall Study|Withdrawal by Subject|3|||
155185459|NCT04650854|560117982|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
155185460|NCT04650854|560117983|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
155185461|NCT04650854|560117984|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
155185462|NCT04650854|560117982|FG000|Overall Study|Participant Screened For MG0020|0|||
155185463|NCT04650854|560117983|FG001|Overall Study|Participant Screened For MG0020|2|||
155717230|NCT03010527|562059489|FG002|Overall Study|Withdrawal by Subject|4|||
155185464|NCT04650854|560117984|FG002|Overall Study|Participant Screened For MG0020|3|||
155185465|NCT04650854|560117982|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
155717231|NCT03010527|562059487|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
155717232|NCT03010527|562059488|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
155717233|NCT03010527|562059489|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
155717234|NCT03010527|562059487|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
155717235|NCT03010527|562059488|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
155717236|NCT03010527|562059489|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
155717237|NCT03010527|562059487|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
155717238|NCT03010527|562059488|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
155717239|NCT03010527|562059489|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
155717240|NCT01458639|562059490|FG000|Overall Study|Physician Decision|4|||
155717241|NCT01458639|562059490|FG000|Overall Study|Equipment issue|1|||
155717242|NCT01458639|562059490|FG000|Overall Study|Inability to obtain subject blood sample|1|||
155717243|NCT04245111|562059491|FG000|Overall Study|Lost to Follow-up|5|||
155717244|NCT04245111|562059492|FG001|Overall Study|Lost to Follow-up|1|||
155717245|NCT04245111|562059493|FG002|Overall Study|Lost to Follow-up|1|||
155717246|NCT06039579|562059494|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717247|NCT06039579|562059495|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717248|NCT06039579|562059496|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717249|NCT06039579|562059497|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717250|NCT06039579|562059498|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717251|NCT06039579|562059499|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717252|NCT06039579|562059500|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155717253|NCT06039579|562059501|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
155717254|NCT02349633|562059502|FG000|Overall Study|Death|0|||
155717255|NCT02349633|562059503|FG001|Overall Study|Death|1|||
155717256|NCT02349633|562059504|FG002|Overall Study|Death|0|||
155717257|NCT02349633|562059505|FG003|Overall Study|Death|0|||
155717258|NCT02349633|562059506|FG004|Overall Study|Death|0|||
155717259|NCT02349633|562059507|FG005|Overall Study|Death|1|||
155717260|NCT02349633|562059508|FG006|Overall Study|Death|1|||
155717261|NCT02349633|562059509|FG007|Overall Study|Death|1|||
155717262|NCT02349633|562059510|FG008|Overall Study|Death|0|||
155717263|NCT02349633|562059511|FG009|Overall Study|Death|1|||
155717264|NCT02349633|562059512|FG010|Overall Study|Death|0|||
155717265|NCT02349633|562059513|FG011|Overall Study|Death|0|||
155717266|NCT02349633|562059514|FG012|Overall Study|Death|0|||
155717267|NCT02349633|562059515|FG013|Overall Study|Death|0|||
155717268|NCT02349633|562059502|FG000|Overall Study|Withdrawal by Subject|0|||
155717269|NCT02349633|562059503|FG001|Overall Study|Withdrawal by Subject|0|||
155717270|NCT02349633|562059504|FG002|Overall Study|Withdrawal by Subject|0|||
155717271|NCT02349633|562059505|FG003|Overall Study|Withdrawal by Subject|1|||
155717272|NCT02349633|562059506|FG004|Overall Study|Withdrawal by Subject|0|||
155717273|NCT02349633|562059507|FG005|Overall Study|Withdrawal by Subject|0|||
155717274|NCT02349633|562059508|FG006|Overall Study|Withdrawal by Subject|0|||
155717275|NCT02349633|562059509|FG007|Overall Study|Withdrawal by Subject|2|||
155717276|NCT02349633|562059510|FG008|Overall Study|Withdrawal by Subject|2|||
155717277|NCT02349633|562059511|FG009|Overall Study|Withdrawal by Subject|1|||
155717278|NCT02349633|562059512|FG010|Overall Study|Withdrawal by Subject|0|||
155717279|NCT02349633|562059513|FG011|Overall Study|Withdrawal by Subject|0|||
155717280|NCT02349633|562059514|FG012|Overall Study|Withdrawal by Subject|0|||
155717281|NCT02349633|562059515|FG013|Overall Study|Withdrawal by Subject|0|||
155717282|NCT02349633|562059502|FG000|Overall Study|Withdrawal of informed consent|0|||
155717283|NCT02349633|562059503|FG001|Overall Study|Withdrawal of informed consent|0|||
155717284|NCT02349633|562059504|FG002|Overall Study|Withdrawal of informed consent|0|||
155717285|NCT02349633|562059505|FG003|Overall Study|Withdrawal of informed consent|1|||
155717286|NCT02349633|562059506|FG004|Overall Study|Withdrawal of informed consent|1|||
155717287|NCT02349633|562059507|FG005|Overall Study|Withdrawal of informed consent|0|||
155717288|NCT02349633|562059508|FG006|Overall Study|Withdrawal of informed consent|0|||
155717289|NCT02349633|562059509|FG007|Overall Study|Withdrawal of informed consent|3|||
155717290|NCT02349633|562059510|FG008|Overall Study|Withdrawal of informed consent|0|||
155717291|NCT02349633|562059511|FG009|Overall Study|Withdrawal of informed consent|0|||
155717292|NCT02349633|562059512|FG010|Overall Study|Withdrawal of informed consent|0|||
155717293|NCT02349633|562059513|FG011|Overall Study|Withdrawal of informed consent|0|||
155717294|NCT02349633|562059514|FG012|Overall Study|Withdrawal of informed consent|0|||
155717295|NCT02349633|562059515|FG013|Overall Study|Withdrawal of informed consent|0|||
155717296|NCT02349633|562059502|FG000|Overall Study|Transition to compassionate use|0|||
155717297|NCT02349633|562059503|FG001|Overall Study|Transition to compassionate use|0|||
155717298|NCT02349633|562059504|FG002|Overall Study|Transition to compassionate use|0|||
155717299|NCT02349633|562059505|FG003|Overall Study|Transition to compassionate use|0|||
155717300|NCT02349633|562059506|FG004|Overall Study|Transition to compassionate use|1|||
155717301|NCT02349633|562059507|FG005|Overall Study|Transition to compassionate use|0|||
155717302|NCT02349633|562059508|FG006|Overall Study|Transition to compassionate use|0|||
155717303|NCT02349633|562059509|FG007|Overall Study|Transition to compassionate use|3|||
155717304|NCT02349633|562059510|FG008|Overall Study|Transition to compassionate use|0|||
155717305|NCT02349633|562059511|FG009|Overall Study|Transition to compassionate use|1|||
155717306|NCT02349633|562059512|FG010|Overall Study|Transition to compassionate use|0|||
155717307|NCT02349633|562059513|FG011|Overall Study|Transition to compassionate use|0|||
155717308|NCT02349633|562059514|FG012|Overall Study|Transition to compassionate use|0|||
155717309|NCT02349633|562059515|FG013|Overall Study|Transition to compassionate use|0|||
155717310|NCT02349633|562059502|FG000|Overall Study|Early termination of survival follow-up|0|||
155717311|NCT02349633|562059503|FG001|Overall Study|Early termination of survival follow-up|0|||
155717312|NCT02349633|562059504|FG002|Overall Study|Early termination of survival follow-up|0|||
155717313|NCT02349633|562059505|FG003|Overall Study|Early termination of survival follow-up|0|||
155717314|NCT02349633|562059506|FG004|Overall Study|Early termination of survival follow-up|0|||
155717315|NCT02349633|562059507|FG005|Overall Study|Early termination of survival follow-up|0|||
155717316|NCT02349633|562059508|FG006|Overall Study|Early termination of survival follow-up|0|||
155717317|NCT02349633|562059509|FG007|Overall Study|Early termination of survival follow-up|4|||
155717318|NCT02349633|562059510|FG008|Overall Study|Early termination of survival follow-up|0|||
155717319|NCT02349633|562059511|FG009|Overall Study|Early termination of survival follow-up|0|||
155717320|NCT02349633|562059512|FG010|Overall Study|Early termination of survival follow-up|0|||
155717321|NCT02349633|562059513|FG011|Overall Study|Early termination of survival follow-up|0|||
155717322|NCT02349633|562059514|FG012|Overall Study|Early termination of survival follow-up|0|||
155717323|NCT02349633|562059515|FG013|Overall Study|Early termination of survival follow-up|0|||
155717324|NCT02349633|562059502|FG000|Overall Study|Termination by sponsor|0|||
155717325|NCT02349633|562059503|FG001|Overall Study|Termination by sponsor|0|||
155717326|NCT02349633|562059504|FG002|Overall Study|Termination by sponsor|0|||
155185466|NCT04650854|560117983|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
155185467|NCT04650854|560117984|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
155185468|NCT04650854|560117982|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
155185469|NCT04650854|560117983|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
155185470|NCT04650854|560117984|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
155185471|NCT04650854|560117982|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
155185472|NCT04650854|560117983|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
155185473|NCT04650854|560117984|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
155185474|NCT04650854|560117982|FG000|Overall Study|End Of Study|0|||
155185475|NCT04650854|560117983|FG001|Overall Study|End Of Study|2|||
155185476|NCT04650854|560117984|FG002|Overall Study|End Of Study|1|||
155185477|NCT04650854|560117982|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
155185478|NCT04650854|560117983|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
155185479|NCT04650854|560117984|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
155185480|NCT04650854|560117982|FG000|Overall Study|Participant Received Rescue Medication|0|||
155185481|NCT04650854|560117983|FG001|Overall Study|Participant Received Rescue Medication|1|||
155185482|NCT04650854|560117984|FG002|Overall Study|Participant Received Rescue Medication|0|||
155185483|NCT04650854|560117982|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
155185484|NCT04650854|560117983|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
155185485|NCT04650854|560117984|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
155185486|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
155185487|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
155185488|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
155185489|NCT04650854|560117982|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
155185490|NCT04650854|560117983|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
155185491|NCT04650854|560117984|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
155185492|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
155185493|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
155185494|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
155185495|NCT04650854|560117982|FG000|Overall Study|Enrollment Cup|0|||
155185496|NCT04650854|560117983|FG001|Overall Study|Enrollment Cup|0|||
155185497|NCT04650854|560117984|FG002|Overall Study|Enrollment Cup|1|||
155185498|NCT00194675|560117990|FG000|Overall Study|Lost to Follow-up|1|||
155185499|NCT00194675|560117991|FG001|Overall Study|Lost to Follow-up|1|||
155185500|NCT00194675|560117990|FG000|Overall Study|lack of interest|1|||
155185501|NCT00194675|560117991|FG001|Overall Study|lack of interest|1|||
155185502|NCT00194675|560117990|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
155185503|NCT00194675|560117991|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
155185504|NCT00194675|560117990|FG000|Overall Study|Protocol Violation|1|||
155185505|NCT00194675|560117991|FG001|Overall Study|Protocol Violation|0|||
155185506|NCT00194675|560117990|FG000|Overall Study|Death|1|||
155185507|NCT00194675|560117991|FG001|Overall Study|Death|0|||
155185508|NCT00704808|560117992|FG000|Overall Study|Discontinued prior to starting treatment|14|||
155717327|NCT02349633|562059505|FG003|Overall Study|Termination by sponsor|0|||
155717328|NCT02349633|562059506|FG004|Overall Study|Termination by sponsor|0|||
155717329|NCT02349633|562059507|FG005|Overall Study|Termination by sponsor|0|||
155717330|NCT02349633|562059508|FG006|Overall Study|Termination by sponsor|0|||
155717331|NCT02349633|562059509|FG007|Overall Study|Termination by sponsor|1|||
155717332|NCT02349633|562059510|FG008|Overall Study|Termination by sponsor|0|||
155717333|NCT02349633|562059511|FG009|Overall Study|Termination by sponsor|2|||
155717334|NCT02349633|562059512|FG010|Overall Study|Termination by sponsor|0|||
155717335|NCT02349633|562059513|FG011|Overall Study|Termination by sponsor|0|||
155717336|NCT02349633|562059514|FG012|Overall Study|Termination by sponsor|0|||
155717337|NCT02349633|562059515|FG013|Overall Study|Termination by sponsor|0|||
155717338|NCT02349633|562059502|FG000|Overall Study|Other|0|||
155717339|NCT02349633|562059503|FG001|Overall Study|Other|0|||
155717340|NCT02349633|562059504|FG002|Overall Study|Other|0|||
155717341|NCT02349633|562059505|FG003|Overall Study|Other|0|||
155717342|NCT02349633|562059506|FG004|Overall Study|Other|0|||
155717343|NCT02349633|562059507|FG005|Overall Study|Other|0|||
155717344|NCT02349633|562059508|FG006|Overall Study|Other|0|||
155717345|NCT02349633|562059509|FG007|Overall Study|Other|2|||
155185509|NCT00704808|560117992|FG000|Overall Study|Death|7|||
155717346|NCT02349633|562059510|FG008|Overall Study|Other|0|||
155185510|NCT00704808|560117992|FG000|Overall Study|Tumor progression|80|||
155185511|NCT00704808|560117992|FG000|Overall Study|Patient's decision|11|||
155185512|NCT00704808|560117992|FG000|Overall Study|Early therapy discontinuation|16|||
155185513|NCT00704808|560117992|FG000|Overall Study|Adverse Event|1|||
155185514|NCT00704808|560117992|FG000|Overall Study|Lost to Follow-up|1|||
155717347|NCT02349633|562059511|FG009|Overall Study|Other|0|||
155717348|NCT02349633|562059512|FG010|Overall Study|Other|0|||
155717349|NCT02349633|562059513|FG011|Overall Study|Other|0|||
155717350|NCT02349633|562059514|FG012|Overall Study|Other|0|||
155717351|NCT02349633|562059515|FG013|Overall Study|Other|0|||
155717352|NCT00667628|562059516|FG000|Overall Study|Lost to Follow-up|1|||
155717353|NCT00667628|562059517|FG001|Overall Study|Lost to Follow-up|0|||
155717354|NCT00667628|562059516|FG000|Overall Study|Death|6|||
155717355|NCT00667628|562059517|FG001|Overall Study|Death|6|||
155717356|NCT00667628|562059516|FG000|Overall Study|Investigator Considers in Best Interest|1|||
155717357|NCT00667628|562059517|FG001|Overall Study|Investigator Considers in Best Interest|0|||
155717358|NCT00667628|562059516|FG000|Overall Study|Sponsor Terminated Study|17|||
155717359|NCT00667628|562059517|FG001|Overall Study|Sponsor Terminated Study|21|||
155717360|NCT04663321|562059518|FG000|Overall Study|Study terminated by Sponsor|2|||
155717361|NCT04663321|562059519|FG001|Overall Study|Study terminated by Sponsor|1|||
155717362|NCT04663321|562059520|FG002|Overall Study|Study terminated by Sponsor|2|||
155717363|NCT04663321|562059518|FG000|Overall Study|Withdrawal by Subject|10|||
155717364|NCT04663321|562059519|FG001|Overall Study|Withdrawal by Subject|3|||
155717365|NCT04663321|562059520|FG002|Overall Study|Withdrawal by Subject|2|||
155717366|NCT04663321|562059518|FG000|Overall Study|Not provided|0|||
155717367|NCT04663321|562059519|FG001|Overall Study|Not provided|0|||
155717368|NCT04663321|562059520|FG002|Overall Study|Not provided|1|||
155717369|NCT04862065|562059521|FG000|Screening|Protocol Violation|54|||
155717370|NCT04862065|562059522|FG001|Screening|Protocol Violation|0|||
155717371|NCT04862065|562059523|FG002|Screening|Protocol Violation|0|||
155717372|NCT04862065|562059521|FG000|Screening|Insufficient Sample|1|||
155717373|NCT04862065|562059522|FG001|Screening|Insufficient Sample|0|||
155717374|NCT04862065|562059523|FG002|Screening|Insufficient Sample|0|||
155717375|NCT04862065|562059521|FG000|Follow-Up|Lost to Follow-up|3|||
155717376|NCT04862065|562059522|FG001|Follow-Up|Lost to Follow-up|0|||
155717377|NCT04862065|562059523|FG002|Follow-Up|Lost to Follow-up|0|||
155717378|NCT02611479|562059524|FG000|Baseline Enrollment|Exited study|13|||
155717379|NCT02611479|562059524|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
155717380|NCT02611479|562059524|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
155717381|NCT02611479|562059524|FG000|Data Cleaning|No baseline function or pain metrics|2|||
155717382|NCT00743249|562059525|FG000|Overall Study|Adverse Event|0|||
155717383|NCT00743249|562059526|FG001|Overall Study|Adverse Event|4|||
155717384|NCT00743249|562059525|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
155717385|NCT00743249|562059526|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
155717386|NCT00743249|562059525|FG000|Overall Study|Unsuccessful insertion of stent|2|||
155717387|NCT00743249|562059526|FG001|Overall Study|Unsuccessful insertion of stent|1|||
155717388|NCT01960140|562059527|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
155717389|NCT02269124|562059528|FG000|Overall Study|Lost to Follow-up|1|||
155717390|NCT02269124|562059529|FG001|Overall Study|Lost to Follow-up|0|||
155717391|NCT02269124|562059528|FG000|Overall Study|Withdrawal by Subject|0|||
155717392|NCT02269124|562059529|FG001|Overall Study|Withdrawal by Subject|2|||
155717393|NCT03452540|562059531|FG000|Overall Study|Adverse Event|1|||
155717394|NCT03452540|562059531|FG000|Overall Study|Withdrawal by Subject|1|||
155717395|NCT03452540|562059531|FG000|Overall Study|Other SAE and AE|2|||
155717396|NCT01009060|562059538|FG000|Overall Study|Adverse Event|1|||
155717397|NCT01009060|562059539|FG001|Overall Study|Adverse Event|2|||
155717398|NCT01009060|562059538|FG000|Overall Study|Protocol Violation|0|||
155717399|NCT01009060|562059539|FG001|Overall Study|Protocol Violation|1|||
155717400|NCT01009060|562059538|FG000|Overall Study|Lost to Follow-up|1|||
155717401|NCT01009060|562059539|FG001|Overall Study|Lost to Follow-up|0|||
155717402|NCT01009060|562059538|FG000|Overall Study|Physician Decision|1|||
155717403|NCT01009060|562059539|FG001|Overall Study|Physician Decision|1|||
155717404|NCT01009060|562059538|FG000|Overall Study|Withdrawal by Subject|1|||
155717405|NCT01009060|562059539|FG001|Overall Study|Withdrawal by Subject|1|||
155717406|NCT00739401|562059547|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
155717407|NCT00739401|562059547|FG000|Overall Study|Death|3|||
155717408|NCT00739401|562059547|FG000|Overall Study|Withdrawal by Subject|4|||
155717409|NCT01239381|562059548|FG000|Overall Study|Protocol Violation|1|||
155717410|NCT01239381|562059548|FG000|Overall Study|Withdrawal by Subject|1|||
155717411|NCT00988884|562059549|FG000|Overall Study|Adverse Event|0|||
155717412|NCT00988884|562059550|FG001|Overall Study|Adverse Event|1|||
155717413|NCT00988884|562059549|FG000|Overall Study|Lost to Follow-up|20|||
155717414|NCT00988884|562059550|FG001|Overall Study|Lost to Follow-up|16|||
155717415|NCT00988884|562059549|FG000|Overall Study|Protocol Violation|0|||
155717416|NCT00988884|562059550|FG001|Overall Study|Protocol Violation|1|||
155717417|NCT00988884|562059549|FG000|Overall Study|Withdrawal by Subject|15|||
155717418|NCT00988884|562059550|FG001|Overall Study|Withdrawal by Subject|18|||
155717419|NCT02738008|562059551|FG000|Overall Study|Study Terminated by Sponsor|1|||
155717420|NCT02738008|562059552|FG001|Overall Study|Study Terminated by Sponsor|5|||
155717421|NCT02738008|562059553|FG002|Overall Study|Study Terminated by Sponsor|3|||
155717422|NCT02738008|562059551|FG000|Overall Study|Adverse Event|0|||
155717423|NCT02738008|562059552|FG001|Overall Study|Adverse Event|1|||
155717424|NCT02738008|562059553|FG002|Overall Study|Adverse Event|2|||
155717425|NCT04621448|562059554|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
155717426|NCT04621448|562059555|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
155717427|NCT04621448|562059556|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
155717428|NCT04621448|562059557|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
155717429|NCT04621448|562059554|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
155717430|NCT04621448|562059555|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
155717431|NCT04621448|562059556|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
155717432|NCT04621448|562059557|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
155717433|NCT04621448|562059554|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
155717434|NCT04621448|562059555|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
155717435|NCT04621448|562059556|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
155717436|NCT04621448|562059557|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
155717437|NCT04621448|562059554|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
155717438|NCT04621448|562059555|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
155717439|NCT04621448|562059556|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
155717440|NCT04621448|562059557|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
155717441|NCT04590014|562059564|FG000|Overall Study|Withdrawal by Subject|1|||
155717442|NCT04590014|562059565|FG001|Overall Study|Withdrawal by Subject|0|||
155717443|NCT00468299|562059566|FG000|Overall Study|Withdrawal by Subject|0|||
155717444|NCT00468299|562059567|FG001|Overall Study|Withdrawal by Subject|1|||
155717445|NCT01216202|562059568|FG000|Overall Study|Withdrawal by Subject|8|||
155717446|NCT01216202|562059569|FG001|Overall Study|Withdrawal by Subject|0|||
155717447|NCT01216202|562059568|FG000|Overall Study|Death|0|||
155717448|NCT01216202|562059569|FG001|Overall Study|Death|2|||
155717449|NCT01216202|562059568|FG000|Overall Study|Lost to Follow-up|14|||
155717450|NCT01216202|562059569|FG001|Overall Study|Lost to Follow-up|0|||
155717451|NCT03546621|562059570|FG000|Overall Study|Withdrawal by Subject|0|||
155717452|NCT03546621|562059571|FG001|Overall Study|Withdrawal by Subject|1|||
155717453|NCT03546621|562059572|FG002|Overall Study|Withdrawal by Subject|2|||
155717454|NCT03546621|562059573|FG003|Overall Study|Withdrawal by Subject|1|||
155717455|NCT03546621|562059570|FG000|Overall Study|Lost to Follow-up|0|||
155717456|NCT03546621|562059571|FG001|Overall Study|Lost to Follow-up|1|||
155185515|NCT00704808|560117992|FG000|Overall Study|Treatment change|1|||
155185516|NCT00667420|560117993|FG000|Overall Study|Adverse Event|2|||
155185517|NCT00667420|560117993|FG000|Overall Study|Lack of Efficacy|5|||
155185518|NCT00667420|560117993|FG000|Overall Study|Physician Decision|1|||
155185519|NCT00667420|560117993|FG000|Overall Study|Withdrawal by Subject|2|||
155185520|NCT03500679|560117994|FG000|Overall Study|Lost to Follow-up|6|||
155185521|NCT03500679|560117995|FG001|Overall Study|Lost to Follow-up|3|||
155185522|NCT03500679|560117994|FG000|Overall Study|Withdrawal by Subject|3|||
155185523|NCT03500679|560117995|FG001|Overall Study|Withdrawal by Subject|0|||
155185524|NCT04223232|560117997|FG000|Overall Study|Withdrawal by Subject|1|||
155185525|NCT00586846|560117998|FG000|Overall Study|Physician Decision|1|||
155185526|NCT00586846|560117998|FG000|Overall Study|Death|1|||
155185527|NCT00586846|560117998|FG000|Overall Study|Evaluable for Toxicity Only|4|||
155185528|NCT00410202|560117999|FG000|On-Treatment|Continuing treatment|69|||
155185529|NCT00410202|560118000|FG001|On-Treatment|Continuing treatment|71|||
155185530|NCT00410202|560118001|FG002|On-Treatment|Continuing treatment|66|||
155185531|NCT00410202|560117999|FG000|On-Treatment|Adverse Event|1|||
155185532|NCT00410202|560118000|FG001|On-Treatment|Adverse Event|3|||
155185533|NCT00410202|560118001|FG002|On-Treatment|Adverse Event|2|||
155185534|NCT00410202|560117999|FG000|On-Treatment|Death|1|||
155185535|NCT00410202|560118000|FG001|On-Treatment|Death|0|||
155185536|NCT00410202|560118001|FG002|On-Treatment|Death|0|||
155185537|NCT00410202|560117999|FG000|On-Treatment|Lost to Follow-up|1|||
155185538|NCT00410202|560118000|FG001|On-Treatment|Lost to Follow-up|0|||
155185539|NCT00410202|560118001|FG002|On-Treatment|Lost to Follow-up|1|||
155185540|NCT00410202|560117999|FG000|On-Treatment|Lack of Efficacy|1|||
155185541|NCT00410202|560118000|FG001|On-Treatment|Lack of Efficacy|4|||
155185542|NCT00410202|560118001|FG002|On-Treatment|Lack of Efficacy|0|||
155185543|NCT00410202|560117999|FG000|On-Treatment|Withdrawal by Subject|2|||
155185544|NCT00410202|560118000|FG001|On-Treatment|Withdrawal by Subject|1|||
155185545|NCT00410202|560118001|FG002|On-Treatment|Withdrawal by Subject|1|||
155185546|NCT00410202|560117999|FG000|On-Treatment|Other Reason|0|||
155185547|NCT00410202|560118000|FG001|On-Treatment|Other Reason|0|||
155185548|NCT00410202|560118001|FG002|On-Treatment|Other Reason|1|||
155185549|NCT00410202|560117999|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
155717457|NCT03546621|562059572|FG002|Overall Study|Lost to Follow-up|0|||
155717458|NCT03546621|562059573|FG003|Overall Study|Lost to Follow-up|0|||
155717459|NCT03546621|562059570|FG000|Overall Study|Adverse Event|0|||
155717460|NCT03546621|562059571|FG001|Overall Study|Adverse Event|1|||
155717461|NCT03546621|562059572|FG002|Overall Study|Adverse Event|0|||
155717462|NCT03546621|562059573|FG003|Overall Study|Adverse Event|1|||
155717463|NCT03546621|562059570|FG000|Overall Study|Progressive disease|0|||
155717464|NCT03546621|562059571|FG001|Overall Study|Progressive disease|0|||
155185550|NCT00410202|560118000|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
155185551|NCT00410202|560118001|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
155185552|NCT00410202|560117999|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
155717465|NCT03546621|562059572|FG002|Overall Study|Progressive disease|0|||
155717466|NCT03546621|562059573|FG003|Overall Study|Progressive disease|1|||
155185553|NCT00410202|560118000|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
155185554|NCT00410202|560118001|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
155185555|NCT00410202|560117999|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
155185556|NCT00410202|560118000|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
155185557|NCT00410202|560118001|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
155185558|NCT00144027|560118002|FG000|Overall Study|Lost to Follow-up|1|||
155185559|NCT00144027|560118003|FG001|Overall Study|Lost to Follow-up|3|||
155185560|NCT00144027|560118002|FG000|Overall Study|Withdrawal by Subject|2|||
155185561|NCT00144027|560118003|FG001|Overall Study|Withdrawal by Subject|2|||
155185562|NCT00144027|560118002|FG000|Overall Study|did not complete baseline assessment|0|||
155185563|NCT00144027|560118003|FG001|Overall Study|did not complete baseline assessment|6|||
155185564|NCT00937391|560118004|FG000|Stage 2|Withdrawal by Subject|1|||
155185565|NCT02021656|560118013|FG000|Overall Study|Adverse Event|1|||
155185566|NCT02021656|560118013|FG000|Overall Study|Lack of Efficacy|2|||
155185567|NCT02021656|560118013|FG000|Overall Study|Lost to Follow-up|1|||
155185568|NCT02021656|560118013|FG000|Overall Study|Withdrew Consent|2|||
155185569|NCT00510952|560118014|FG000|Overall Study|Adverse Event|1|||
155185570|NCT00510952|560118015|FG001|Overall Study|Adverse Event|0|||
155185571|NCT00510952|560118014|FG000|Overall Study|Entry Criteria Not Met|3|||
155185572|NCT00510952|560118015|FG001|Overall Study|Entry Criteria Not Met|1|||
155185573|NCT00510952|560118014|FG000|Overall Study|Lost to Follow-up|5|||
155185574|NCT00510952|560118015|FG001|Overall Study|Lost to Follow-up|3|||
155185575|NCT00510952|560118014|FG000|Overall Study|Physician Decision|1|||
155185576|NCT00510952|560118015|FG001|Overall Study|Physician Decision|1|||
155185577|NCT00510952|560118014|FG000|Overall Study|Protocol Violation|7|||
155185578|NCT00510952|560118015|FG001|Overall Study|Protocol Violation|4|||
155185579|NCT00510952|560118014|FG000|Overall Study|Sponsor Decision|1|||
155185580|NCT00510952|560118015|FG001|Overall Study|Sponsor Decision|0|||
155185581|NCT00510952|560118014|FG000|Overall Study|Withdrawal by Subject|6|||
155185582|NCT00510952|560118015|FG001|Overall Study|Withdrawal by Subject|7|||
155185583|NCT00510952|560118014|FG000|Overall Study|Did Not Receive Study Drug|2|||
155185584|NCT00510952|560118015|FG001|Overall Study|Did Not Receive Study Drug|0|||
155185585|NCT03119701|560118016|FG000|6-day Dosing|Death|4|||
155185586|NCT03119701|560118017|FG001|6-day Dosing|Death|1|||
155185587|NCT03119701|560118016|FG000|6-day Dosing|Adverse Event|3|||
155185588|NCT03119701|560118017|FG001|6-day Dosing|Adverse Event|0|||
155185589|NCT03119701|560118016|FG000|6-day Dosing|Physician Decision|0|||
155185590|NCT03119701|560118017|FG001|6-day Dosing|Physician Decision|1|||
155185591|NCT03119701|560118016|FG000|6-day Dosing|Withdrawal by Subject|0|||
155185592|NCT03119701|560118017|FG001|6-day Dosing|Withdrawal by Subject|1|||
155185593|NCT03119701|560118016|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
155185594|NCT03119701|560118017|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
155185595|NCT02125604|560118021|FG000|Overall Study|Other|4|||
155185596|NCT02125604|560118021|FG000|Overall Study|Investigator Decision|1|||
155185597|NCT02125604|560118021|FG000|Overall Study|Lost to Follow-up|2|||
155185598|NCT02125604|560118021|FG000|Overall Study|Consent Withdrawn|4|||
155185599|NCT02125604|560118021|FG000|Overall Study|Adverse Event|20|||
155185600|NCT00122278|560119596|FG000|Overall Study|Lost to Follow-up|2|||
155185601|NCT00122278|560119597|FG001|Overall Study|Lost to Follow-up|0|||
155185602|NCT01002482|560119598|FG000|Overall Study|Withdrawal by Subject|14|||
155185603|NCT01002482|560119599|FG001|Overall Study|Withdrawal by Subject|21|||
155185604|NCT01002482|560119598|FG000|Overall Study|Included twice|1|||
155185605|NCT01002482|560119599|FG001|Overall Study|Included twice|0|||
155185606|NCT02247531|560119600|FG000|Overall Study|Adverse Event|3|||
155185607|NCT02247531|560119601|FG001|Overall Study|Adverse Event|4|||
155185608|NCT02247531|560119602|FG002|Overall Study|Adverse Event|9|||
155185609|NCT02247531|560119600|FG000|Overall Study|Death|8|||
155185610|NCT02247531|560119601|FG001|Overall Study|Death|9|||
155185611|NCT02247531|560119602|FG002|Overall Study|Death|5|||
155185612|NCT02247531|560119600|FG000|Overall Study|Lost to Follow-up|1|||
155185613|NCT02247531|560119601|FG001|Overall Study|Lost to Follow-up|8|||
155185614|NCT02247531|560119602|FG002|Overall Study|Lost to Follow-up|3|||
155185615|NCT02247531|560119600|FG000|Overall Study|Non-compliance|2|||
155185616|NCT02247531|560119601|FG001|Overall Study|Non-compliance|2|||
155185617|NCT02247531|560119602|FG002|Overall Study|Non-compliance|0|||
155185618|NCT02247531|560119600|FG000|Overall Study|Withdrawal by Subject|26|||
155185619|NCT02247531|560119601|FG001|Overall Study|Withdrawal by Subject|31|||
155185620|NCT02247531|560119602|FG002|Overall Study|Withdrawal by Subject|25|||
155185621|NCT02247531|560119600|FG000|Overall Study|Study Terminated by Sponsor|64|||
155185622|NCT02247531|560119601|FG001|Overall Study|Study Terminated by Sponsor|66|||
155185623|NCT02247531|560119602|FG002|Overall Study|Study Terminated by Sponsor|62|||
155185624|NCT02247531|560119600|FG000|Overall Study|Physician Decision|0|||
155185625|NCT02247531|560119601|FG001|Overall Study|Physician Decision|2|||
155185626|NCT02247531|560119602|FG002|Overall Study|Physician Decision|2|||
155185627|NCT02247531|560119600|FG000|Overall Study|Unspecified Reason|2|||
155185628|NCT02247531|560119601|FG001|Overall Study|Unspecified Reason|3|||
155185629|NCT02247531|560119602|FG002|Overall Study|Unspecified Reason|4|||
155185630|NCT04879225|560119603|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
155185631|NCT04879225|560119603|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
155185632|NCT01298531|560119606|FG000|Overall Study|Lack of Efficacy|0|||
155185633|NCT01298531|560119607|FG001|Overall Study|Lack of Efficacy|1|||
155185634|NCT01298531|560119606|FG000|Overall Study|Lost to Follow-up|2|||
155185635|NCT01298531|560119607|FG001|Overall Study|Lost to Follow-up|0|||
155185636|NCT01298531|560119606|FG000|Overall Study|Protocol Violation|1|||
155185637|NCT01298531|560119607|FG001|Overall Study|Protocol Violation|1|||
155185638|NCT01298531|560119606|FG000|Overall Study|Adverse Event|4|||
155185639|NCT01298531|560119607|FG001|Overall Study|Adverse Event|3|||
155185640|NCT01298531|560119606|FG000|Overall Study|Does not meet entrance criteria|0|||
155185641|NCT01298531|560119607|FG001|Overall Study|Does not meet entrance criteria|1|||
155185642|NCT01298531|560119606|FG000|Overall Study|Other|2|||
155185643|NCT01298531|560119607|FG001|Overall Study|Other|1|||
155185644|NCT00736957|560119608|FG000|Overall Study|Adverse Event|43|||
155185645|NCT00736957|560119608|FG000|Overall Study|Withdrawal by Subject|49|||
155185646|NCT00736957|560119608|FG000|Overall Study|violation of eligibility criteria|2|||
155185647|NCT00736957|560119608|FG000|Overall Study|did not attend hospital appointments|1|||
155185648|NCT00736957|560119608|FG000|Overall Study|not eligible for Treatment Period I|22|||
155185649|NCT00736957|560119608|FG000|Overall Study|Physician Decision|5|||
155185650|NCT04521777|560119609|FG000|Overall Study|Death|2|||
155185651|NCT04521777|560119609|FG000|Overall Study|Withdrawal by Subject|2|||
155185652|NCT00608543|560119610|FG000|Overall Study|Adverse Event|4|||
155185653|NCT01068652|560119620|FG000|Overall Study|Adverse Event|4|||
155185654|NCT01068652|560119621|FG001|Overall Study|Adverse Event|0|||
155185655|NCT01068652|560119620|FG000|Overall Study|Lack of Efficacy|0|||
155185656|NCT01068652|560119621|FG001|Overall Study|Lack of Efficacy|2|||
155185657|NCT01068652|560119620|FG000|Overall Study|Lost to Follow-up|2|||
155717467|NCT00377520|562059579|FG000|Overall Study|Ineligible (Prior radiation)|1|||
155717468|NCT00660192|562059580|FG000|Overall Study|Lost to Follow-up|2|||
155717469|NCT00660192|562059581|FG001|Overall Study|Lost to Follow-up|3|||
155717470|NCT01091675|562059586|FG000|Overall Study|Adverse Event|7|||
155717471|NCT01091675|562059586|FG000|Overall Study|Lack of Efficacy|27|||
155717472|NCT04908397|562059589|FG000|Overall Study|Withdrawal by Subject|2|||
155717473|NCT03318549|562059590|FG000|Overall Study|Withdrawal by Subject|5|||
155717474|NCT03318549|562059591|FG001|Overall Study|Withdrawal by Subject|19|||
155717475|NCT03318549|562059592|FG002|Overall Study|Withdrawal by Subject|2|||
155717476|NCT03318549|562059593|FG003|Overall Study|Withdrawal by Subject|0|||
155185658|NCT01068652|560119621|FG001|Overall Study|Lost to Follow-up|1|||
155185659|NCT01068652|560119620|FG000|Overall Study|Protocol Violation|3|||
155185660|NCT01068652|560119621|FG001|Overall Study|Protocol Violation|6|||
155185661|NCT01068652|560119620|FG000|Overall Study|Withdrawal criteria|1|||
155185662|NCT01068652|560119621|FG001|Overall Study|Withdrawal criteria|2|||
155185663|NCT01068652|560119620|FG000|Overall Study|Patient was not eligible|1|||
155185664|NCT01068652|560119621|FG001|Overall Study|Patient was not eligible|0|||
155185665|NCT01068652|560119620|FG000|Overall Study|Unclassified|7|||
155185666|NCT01068652|560119621|FG001|Overall Study|Unclassified|4|||
155185667|NCT05153473|560119622|FG000|Overall Study|Death|46|||
155717477|NCT03318549|562059594|FG004|Overall Study|Withdrawal by Subject|0|||
155717478|NCT03318549|562059595|FG005|Overall Study|Withdrawal by Subject|0|||
155717479|NCT03318549|562059596|FG006|Overall Study|Withdrawal by Subject|0|||
155717480|NCT03318549|562059590|FG000|Overall Study|Physician Decision|0|||
155717481|NCT03318549|562059591|FG001|Overall Study|Physician Decision|4|||
155717482|NCT03318549|562059592|FG002|Overall Study|Physician Decision|1|||
155717483|NCT03318549|562059593|FG003|Overall Study|Physician Decision|0|||
155717484|NCT03318549|562059594|FG004|Overall Study|Physician Decision|0|||
155717485|NCT03318549|562059595|FG005|Overall Study|Physician Decision|0|||
155717486|NCT03318549|562059596|FG006|Overall Study|Physician Decision|0|||
155717487|NCT03318549|562059590|FG000|Overall Study|Lost to Follow-up|0|||
155717488|NCT03318549|562059591|FG001|Overall Study|Lost to Follow-up|3|||
155717489|NCT03318549|562059592|FG002|Overall Study|Lost to Follow-up|3|||
155717490|NCT03318549|562059593|FG003|Overall Study|Lost to Follow-up|0|||
155717491|NCT03318549|562059594|FG004|Overall Study|Lost to Follow-up|0|||
155717492|NCT03318549|562059595|FG005|Overall Study|Lost to Follow-up|0|||
155185668|NCT05153473|560119622|FG000|Overall Study|Lost to Follow-up|3|||
155185669|NCT02788474|560119623|FG000|Double Blind Treatment Period|Not treated|1|||
155185670|NCT02788474|560119624|FG001|Double Blind Treatment Period|Not treated|0|||
155717493|NCT03318549|562059596|FG006|Overall Study|Lost to Follow-up|0|||
155717494|NCT00462306|562059597|FG000|Overall Study|insufficient data|0|||
155717495|NCT00462306|562059598|FG001|Overall Study|insufficient data|13|||
155717496|NCT03515824|562059599|FG000|Overall Study|Death|3|||
155185671|NCT02788474|560119623|FG000|Double Blind Treatment Period|Patient's refusal|3|||
155185672|NCT02788474|560119624|FG001|Double Blind Treatment Period|Patient's refusal|0|||
155185673|NCT02788474|560119623|FG000|Double Blind Treatment Period|Adverse Event|6|||
155185674|NCT02788474|560119624|FG001|Double Blind Treatment Period|Adverse Event|4|||
155185675|NCT02788474|560119623|FG000|Open Label Treatment Period|Adverse Event|29|||
155717497|NCT03515824|562059600|FG001|Overall Study|Death|2|||
155717498|NCT03515824|562059601|FG002|Overall Study|Death|6|||
155717499|NCT03515824|562059602|FG003|Overall Study|Death|0|||
155717500|NCT03515824|562059599|FG000|Overall Study|Lost to Follow-up|0|||
155717501|NCT03515824|562059600|FG001|Overall Study|Lost to Follow-up|1|||
155717502|NCT03515824|562059601|FG002|Overall Study|Lost to Follow-up|1|||
155717503|NCT03515824|562059602|FG003|Overall Study|Lost to Follow-up|0|||
155717504|NCT03515824|562059599|FG000|Overall Study|Study terminated by sponsor|0|||
155717505|NCT03515824|562059600|FG001|Overall Study|Study terminated by sponsor|1|||
155717506|NCT03515824|562059601|FG002|Overall Study|Study terminated by sponsor|6|||
155717507|NCT03515824|562059602|FG003|Overall Study|Study terminated by sponsor|0|||
155717508|NCT03515824|562059599|FG000|Overall Study|Status not recorded|0|||
155717509|NCT03515824|562059600|FG001|Overall Study|Status not recorded|0|||
155717510|NCT03515824|562059601|FG002|Overall Study|Status not recorded|2|||
155717511|NCT03515824|562059602|FG003|Overall Study|Status not recorded|0|||
155717512|NCT00539994|562059603|FG000|Overall Study|Lost to Follow-up|2|||
155717513|NCT00539994|562059604|FG001|Overall Study|Lost to Follow-up|1|||
155717514|NCT00539994|562059605|FG002|Overall Study|Lost to Follow-up|0|||
155717515|NCT00539994|562059603|FG000|Overall Study|Withdrawal by Subject|1|||
155717516|NCT00539994|562059604|FG001|Overall Study|Withdrawal by Subject|0|||
155717517|NCT00539994|562059605|FG002|Overall Study|Withdrawal by Subject|1|||
155717518|NCT00539994|562059603|FG000|Overall Study|Physician Decision|0|||
155717519|NCT00539994|562059604|FG001|Overall Study|Physician Decision|0|||
155717520|NCT00539994|562059605|FG002|Overall Study|Physician Decision|1|||
155717521|NCT05470985|562059608|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
155717522|NCT05470985|562059609|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
155717523|NCT05470985|562059608|FG000|Double Blind Treatment Period|Physician Decision|0|||
155717524|NCT05470985|562059609|FG001|Double Blind Treatment Period|Physician Decision|1|||
155717525|NCT05470985|562059608|FG000|Long Term Extension|Adverse Event|0|||
155717526|NCT05470985|562059609|FG001|Long Term Extension|Adverse Event|1|||
155717527|NCT05470985|562059608|FG000|Long Term Extension|Study terminated by sponsor|2|||
155717528|NCT05470985|562059609|FG001|Long Term Extension|Study terminated by sponsor|0|||
155185676|NCT02788474|560119624|FG001|Open Label Treatment Period|Adverse Event|9|||
155185677|NCT02788474|560119623|FG000|Open Label Treatment Period|Other than reason specified|1|||
155185678|NCT02788474|560119624|FG001|Open Label Treatment Period|Other than reason specified|0|||
155185679|NCT02788474|560119623|FG000|Open Label Treatment Period|Patient's refusal|1|||
155185680|NCT02788474|560119624|FG001|Open Label Treatment Period|Patient's refusal|3|||
155185681|NCT02788474|560119623|FG000|Open Label Treatment Period|Non-compliance|1|||
155717529|NCT01917747|562059610|FG000|Overall Study|Withdrawal by Subject|1|||
155717530|NCT01917747|562059611|FG001|Overall Study|Withdrawal by Subject|2|||
155717531|NCT01917747|562059610|FG000|Overall Study|Lost to Follow-up|18|||
155717532|NCT01917747|562059611|FG001|Overall Study|Lost to Follow-up|9|||
155717533|NCT04879628|562059613|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155717534|NCT04879628|562059614|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155717535|NCT04879628|562059615|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
155717536|NCT04879628|562059616|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155717537|NCT04879628|562059613|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155717538|NCT04879628|562059614|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155717539|NCT04879628|562059615|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
155717540|NCT04879628|562059616|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155717541|NCT04879628|562059613|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155717542|NCT04879628|562059614|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155717543|NCT04879628|562059615|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155717544|NCT04879628|562059616|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
155717545|NCT04879628|562059613|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
155717546|NCT04879628|562059614|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
155717547|NCT04879628|562059615|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
155717548|NCT04879628|562059616|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
155717549|NCT00360412|562059622|FG000|Overall Study|Adverse Event|37|||
155717550|NCT00360412|562059623|FG001|Overall Study|Adverse Event|65|||
155717551|NCT00360412|562059622|FG000|Overall Study|Protocol Violation|2|||
155717552|NCT00360412|562059623|FG001|Overall Study|Protocol Violation|5|||
155717553|NCT00360412|562059622|FG000|Overall Study|Patient withdrew consent|27|||
155717554|NCT00360412|562059623|FG001|Overall Study|Patient withdrew consent|52|||
155717555|NCT00360412|562059622|FG000|Overall Study|Lack of therapeutic efficacy|46|||
155717556|NCT00360412|562059623|FG001|Overall Study|Lack of therapeutic efficacy|61|||
155717557|NCT00360412|562059622|FG000|Overall Study|Physician Decision|2|||
155717558|NCT00360412|562059623|FG001|Overall Study|Physician Decision|4|||
155185682|NCT02788474|560119624|FG001|Open Label Treatment Period|Non-compliance|0|||
155717559|NCT00360412|562059622|FG000|Overall Study|Other|5|||
155717560|NCT00360412|562059623|FG001|Overall Study|Other|6|||
155717561|NCT00360412|562059622|FG000|Overall Study|Study termination by Sponsor|214|||
155717562|NCT00360412|562059623|FG001|Overall Study|Study termination by Sponsor|469|||
155717563|NCT03861273|562059624|FG000|Screening Phase (3 Weeks)|Other|1|||
155185683|NCT03555435|560119625|FG000|Overall Study|Lost to Follow-up|17|||
155717564|NCT03861273|562059624|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
155717565|NCT03861273|562059624|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
155717566|NCT03861273|562059624|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
155717567|NCT03861273|562059624|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
155717568|NCT00191334|562059625|FG000|Overall Study|Adverse Event|4|||
155717569|NCT00191334|562059625|FG000|Overall Study|Disease Progression or Relapse|8|||
155717570|NCT00191334|562059625|FG000|Overall Study|Physician Decision|1|||
155717571|NCT00191334|562059625|FG000|Overall Study|Withdrawal by Subject|4|||
155717572|NCT03064490|562059626|FG000|Overall Study|Physician Decision|5|||
155717573|NCT01063153|562059628|FG000|Overall Study|Found Ineligible During Screening|2|||
155717574|NCT01063153|562059629|FG001|Overall Study|Found Ineligible During Screening|0|||
155717575|NCT01063153|562059628|FG000|Overall Study|Lost to Follow-up|0|||
155717576|NCT01063153|562059629|FG001|Overall Study|Lost to Follow-up|7|||
155717577|NCT01063153|562059628|FG000|Overall Study|Withdrawal by Subject|0|||
155717578|NCT01063153|562059629|FG001|Overall Study|Withdrawal by Subject|1|||
155717579|NCT01063153|562059628|FG000|Overall Study|Physician Decision|0|||
155717580|NCT01063153|562059629|FG001|Overall Study|Physician Decision|4|||
155717581|NCT01777776|562059630|FG000|Overall Study|Adverse Event|2|||
155717582|NCT01777776|562059631|FG001|Overall Study|Adverse Event|4|||
155717583|NCT01777776|562059632|FG002|Overall Study|Adverse Event|0|||
155717584|NCT01777776|562059633|FG003|Overall Study|Adverse Event|0|||
155717585|NCT01777776|562059630|FG000|Overall Study|Disease Progression|4|||
155185684|NCT03555435|560119626|FG001|Overall Study|Lost to Follow-up|19|||
155185685|NCT03555435|560119627|FG002|Overall Study|Lost to Follow-up|8|||
155185686|NCT01323946|560119630|FG000|Overall Study|Lost to Follow-up|0|||
155185687|NCT01323946|560119631|FG001|Overall Study|Lost to Follow-up|1|||
155717586|NCT01777776|562059631|FG001|Overall Study|Disease Progression|8|||
155717587|NCT01777776|562059632|FG002|Overall Study|Disease Progression|6|||
155717588|NCT01777776|562059633|FG003|Overall Study|Disease Progression|3|||
155717589|NCT01777776|562059630|FG000|Overall Study|Withdrawal by Subject|0|||
155717590|NCT01777776|562059631|FG001|Overall Study|Withdrawal by Subject|0|||
155717591|NCT01777776|562059632|FG002|Overall Study|Withdrawal by Subject|0|||
155717592|NCT01777776|562059633|FG003|Overall Study|Withdrawal by Subject|1|||
155717593|NCT02426580|562061739|FG000|Overall Study|Death|2|||
155717594|NCT02426580|562061740|FG001|Overall Study|Death|2|||
155717595|NCT02426580|562061739|FG000|Overall Study|Lost to Follow-up|0|||
155185688|NCT01323946|560119632|FG002|Overall Study|Lost to Follow-up|0|||
155185689|NCT01323946|560119630|FG000|Overall Study|Parents refused the last blood draw|1|||
155185690|NCT01323946|560119631|FG001|Overall Study|Parents refused the last blood draw|0|||
155185691|NCT01323946|560119632|FG002|Overall Study|Parents refused the last blood draw|0|||
155185692|NCT01323946|560119630|FG000|Overall Study|Withdrawal by Subject|2|||
155185693|NCT01323946|560119631|FG001|Overall Study|Withdrawal by Subject|2|||
155185694|NCT01323946|560119632|FG002|Overall Study|Withdrawal by Subject|0|||
155185695|NCT02964507|560119633|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185696|NCT02964507|560119634|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
155185697|NCT02964507|560119635|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185698|NCT02964507|560119636|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185699|NCT02964507|560119637|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
155185700|NCT02964507|560119638|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185701|NCT02964507|560119639|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185702|NCT02964507|560119640|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185703|NCT02964507|560119633|FG000|Overall Study|Study terminated by Sponsor|9|||
155185704|NCT02964507|560119634|FG001|Overall Study|Study terminated by Sponsor|1|||
155185705|NCT02964507|560119635|FG002|Overall Study|Study terminated by Sponsor|9|||
155185706|NCT02964507|560119636|FG003|Overall Study|Study terminated by Sponsor|3|||
155185707|NCT02964507|560119637|FG004|Overall Study|Study terminated by Sponsor|3|||
155185708|NCT02964507|560119638|FG005|Overall Study|Study terminated by Sponsor|2|||
155185709|NCT02964507|560119639|FG006|Overall Study|Study terminated by Sponsor|0|||
155185710|NCT02964507|560119640|FG007|Overall Study|Study terminated by Sponsor|0|||
155185711|NCT02964507|560119633|FG000|Overall Study|Other|3|||
155185712|NCT02964507|560119634|FG001|Overall Study|Other|0|||
155185713|NCT02964507|560119635|FG002|Overall Study|Other|0|||
155185714|NCT02964507|560119636|FG003|Overall Study|Other|0|||
155185715|NCT02964507|560119637|FG004|Overall Study|Other|1|||
155185716|NCT02964507|560119638|FG005|Overall Study|Other|0|||
155185717|NCT02964507|560119639|FG006|Overall Study|Other|0|||
155185718|NCT02964507|560119640|FG007|Overall Study|Other|0|||
155185719|NCT02964507|560119633|FG000|Overall Study|Death|11|||
155185720|NCT02964507|560119634|FG001|Overall Study|Death|9|||
155185721|NCT02964507|560119635|FG002|Overall Study|Death|12|||
155185722|NCT02964507|560119636|FG003|Overall Study|Death|2|||
155185723|NCT02964507|560119637|FG004|Overall Study|Death|10|||
155185724|NCT02964507|560119638|FG005|Overall Study|Death|5|||
155185725|NCT02964507|560119639|FG006|Overall Study|Death|0|||
155185726|NCT02964507|560119640|FG007|Overall Study|Death|0|||
155185727|NCT02964507|560119633|FG000|Overall Study|Withdrawal by Subject|1|||
155185728|NCT02964507|560119634|FG001|Overall Study|Withdrawal by Subject|0|||
155185729|NCT02964507|560119635|FG002|Overall Study|Withdrawal by Subject|1|||
155185730|NCT02964507|560119636|FG003|Overall Study|Withdrawal by Subject|1|||
155185731|NCT02964507|560119637|FG004|Overall Study|Withdrawal by Subject|0|||
155185732|NCT02964507|560119638|FG005|Overall Study|Withdrawal by Subject|1|||
155185733|NCT02964507|560119639|FG006|Overall Study|Withdrawal by Subject|0|||
155185734|NCT02964507|560119640|FG007|Overall Study|Withdrawal by Subject|0|||
155185735|NCT02964507|560119633|FG000|Overall Study|Physician Decision|2|||
155717596|NCT02426580|562061740|FG001|Overall Study|Lost to Follow-up|9|||
155717597|NCT02426580|562061739|FG000|Overall Study|transfer to hemodialysis|5|||
155717598|NCT02426580|562061740|FG001|Overall Study|transfer to hemodialysis|5|||
155185736|NCT02964507|560119634|FG001|Overall Study|Physician Decision|0|||
155717599|NCT02426580|562061739|FG000|Overall Study|Kidney transplant|3|||
155185737|NCT02964507|560119635|FG002|Overall Study|Physician Decision|3|||
155185738|NCT02964507|560119636|FG003|Overall Study|Physician Decision|0|||
155185739|NCT02964507|560119637|FG004|Overall Study|Physician Decision|1|||
155185740|NCT02964507|560119638|FG005|Overall Study|Physician Decision|0|||
155185741|NCT02964507|560119639|FG006|Overall Study|Physician Decision|0|||
155185742|NCT02964507|560119640|FG007|Overall Study|Physician Decision|0|||
155717600|NCT02426580|562061740|FG001|Overall Study|Kidney transplant|0|||
155717601|NCT02426580|562061739|FG000|Overall Study|Allergic to egg white|1|||
155717602|NCT02426580|562061740|FG001|Overall Study|Allergic to egg white|0|||
155185743|NCT04341662|560119641|FG000|Overall Study|Did not have source-verified blood loss data|423|||
155717603|NCT00383552|562061741|FG000|Overall Study|Adverse Event|7|||
155185744|NCT04341662|560119642|FG001|Overall Study|Did not have source-verified blood loss data|514|||
155185745|NCT03953183|560119643|FG000|Overall Study|Physician Decision|0|||
155185746|NCT03953183|560119644|FG001|Overall Study|Physician Decision|1|||
155185747|NCT03953183|560119643|FG000|Overall Study|Withdrawal by Subject|0|||
155185748|NCT03953183|560119644|FG001|Overall Study|Withdrawal by Subject|1|||
155185749|NCT02273739|560119648|FG000|Overall Study|Progression of Disease|3|||
155185750|NCT02273739|560119649|FG001|Overall Study|Progression of Disease|4|||
155185751|NCT02273739|560119650|FG002|Overall Study|Progression of Disease|5|||
155185752|NCT02273739|560119651|FG003|Overall Study|Progression of Disease|2|||
155185753|NCT02273739|560119648|FG000|Overall Study|Death|0|||
155185754|NCT02273739|560119649|FG001|Overall Study|Death|0|||
155185755|NCT02273739|560119650|FG002|Overall Study|Death|0|||
155185756|NCT02273739|560119651|FG003|Overall Study|Death|2|||
155185757|NCT02273739|560119648|FG000|Overall Study|Adverse Event|0|||
155185758|NCT02273739|560119649|FG001|Overall Study|Adverse Event|0|||
155185759|NCT02273739|560119650|FG002|Overall Study|Adverse Event|0|||
155185760|NCT02273739|560119651|FG003|Overall Study|Adverse Event|1|||
155185761|NCT02273739|560119648|FG000|Overall Study|Withdrawal by Subject|0|||
155185762|NCT02273739|560119649|FG001|Overall Study|Withdrawal by Subject|0|||
155185763|NCT02273739|560119650|FG002|Overall Study|Withdrawal by Subject|2|||
155185764|NCT02273739|560119651|FG003|Overall Study|Withdrawal by Subject|1|||
155185765|NCT02273739|560119648|FG000|Overall Study|Physician Decision|0|||
155185766|NCT02273739|560119649|FG001|Overall Study|Physician Decision|0|||
155185767|NCT02273739|560119650|FG002|Overall Study|Physician Decision|0|||
155185768|NCT02273739|560119651|FG003|Overall Study|Physician Decision|1|||
155185769|NCT01562873|560119652|FG000|Overall Study|Disease Progression per RECIST|10|||
155185770|NCT01562873|560119653|FG001|Overall Study|Disease Progression per RECIST|0|||
155185771|NCT01562873|560119652|FG000|Overall Study|Adverse Event|1|||
155185772|NCT01562873|560119653|FG001|Overall Study|Adverse Event|0|||
155185773|NCT01562873|560119652|FG000|Overall Study|Clinical Disease Progression|9|||
155185774|NCT01562873|560119653|FG001|Overall Study|Clinical Disease Progression|0|||
155185775|NCT01562873|560119652|FG000|Overall Study|Clinical PD and adverse event|1|||
155185776|NCT01562873|560119653|FG001|Overall Study|Clinical PD and adverse event|0|||
155185777|NCT03370289|560119656|FG000|Overall Study|Screen Failure|1|||
155185778|NCT03370289|560119656|FG000|Overall Study|Sample Size Sufficient|4|||
155185779|NCT00873860|560119658|FG000|Overall Study|Lost to Follow-up|1|||
155185780|NCT00873860|560119659|FG001|Overall Study|Lost to Follow-up|0|||
155185781|NCT00873860|560119660|FG002|Overall Study|Lost to Follow-up|0|||
155185782|NCT00873860|560119661|FG003|Overall Study|Lost to Follow-up|1|||
155185783|NCT00873860|560119658|FG000|Overall Study|Withdrawal by Subject|1|||
155185784|NCT00873860|560119659|FG001|Overall Study|Withdrawal by Subject|0|||
155185785|NCT00873860|560119660|FG002|Overall Study|Withdrawal by Subject|2|||
155185786|NCT00873860|560119661|FG003|Overall Study|Withdrawal by Subject|0|||
155185787|NCT00873860|560119658|FG000|Overall Study|Death|1|||
155185788|NCT00873860|560119659|FG001|Overall Study|Death|0|||
155185789|NCT00873860|560119660|FG002|Overall Study|Death|0|||
155185790|NCT00873860|560119661|FG003|Overall Study|Death|0|||
155185791|NCT00873860|560119658|FG000|Overall Study|Other|1|||
155185792|NCT00873860|560119659|FG001|Overall Study|Other|0|||
155185793|NCT00873860|560119660|FG002|Overall Study|Other|1|||
155185794|NCT00873860|560119661|FG003|Overall Study|Other|0|||
155185795|NCT01172275|560119664|FG000|Overall Study|Lost to Follow-up|1|||
155185796|NCT01172275|560119665|FG001|Overall Study|Lost to Follow-up|0|||
155185797|NCT01172275|560119664|FG000|Overall Study|Protocol Violation|1|||
155185798|NCT01172275|560119665|FG001|Overall Study|Protocol Violation|0|||
155185799|NCT05308290|560119673|FG000|Overall Study|Death|1|||
155185800|NCT05308290|560119674|FG001|Overall Study|Death|0|||
155185801|NCT05308290|560119673|FG000|Overall Study|Lost to Follow-up|2|||
155185802|NCT05308290|560119674|FG001|Overall Study|Lost to Follow-up|1|||
155185803|NCT05308290|560119673|FG000|Overall Study|still in study followup|0|||
155185804|NCT05308290|560119674|FG001|Overall Study|still in study followup|1|||
155185805|NCT01285960|560119675|FG000|Overall Study|Withdrawal by Subject|2|||
155185806|NCT01285960|560119675|FG000|Overall Study|Lost to Follow-up|2|||
155185807|NCT01285960|560119675|FG000|Overall Study|2 subjects received less 10 sonications|2|||
155185808|NCT04437368|560119682|FG000|Overall Study|Death|3|||
155185809|NCT04437368|560119683|FG001|Overall Study|Death|0|||
155185810|NCT04437368|560119684|FG002|Overall Study|Death|2|||
155185811|NCT04437368|560119682|FG000|Overall Study|Study terminated by sponsor|16|||
155185812|NCT04437368|560119683|FG001|Overall Study|Study terminated by sponsor|1|||
155185813|NCT04437368|560119684|FG002|Overall Study|Study terminated by sponsor|25|||
155185814|NCT04437368|560119682|FG000|Overall Study|Withdrawal by Subject|4|||
155185815|NCT04437368|560119683|FG001|Overall Study|Withdrawal by Subject|0|||
155185816|NCT04437368|560119684|FG002|Overall Study|Withdrawal by Subject|3|||
155185817|NCT04437368|560119682|FG000|Overall Study|Sponsor instructions|23|||
155185818|NCT04437368|560119683|FG001|Overall Study|Sponsor instructions|0|||
155185819|NCT04437368|560119684|FG002|Overall Study|Sponsor instructions|0|||
155185820|NCT00095628|560119685|FG000|Overall Study|Disease progression prior to treatment|1|||
155185821|NCT04271280|560119686|FG000|Overall Study|Lost to Follow-up|300|||
155185822|NCT04271280|560119686|FG000|Overall Study|Death|153|||
155185823|NCT04271280|560119686|FG000|Overall Study|Withdrawal of consent by patient|59|||
155185824|NCT04271280|560119686|FG000|Overall Study|Other|51|||
155185825|NCT04271280|560119686|FG000|Overall Study|No end of study information|42|||
155185826|NCT00364130|560119687|FG000|Intervention Period|Lost to Follow-up|4|||
155185827|NCT00364130|560119688|FG001|Intervention Period|Lost to Follow-up|3|||
155185828|NCT00364130|560119687|FG000|Intervention Period|Pregnancy|1|||
155185829|NCT00364130|560119688|FG001|Intervention Period|Pregnancy|0|||
155185830|NCT00364130|560119687|FG000|Intervention Period|Withdrawal by Subject|4|||
155185831|NCT00364130|560119688|FG001|Intervention Period|Withdrawal by Subject|5|||
155185832|NCT00364130|560119687|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
155185833|NCT00364130|560119688|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
155185834|NCT01178073|560119693|FG000|Overall Study|Adverse Event|34|||
155185835|NCT01178073|560119694|FG001|Overall Study|Adverse Event|27|||
155185836|NCT01178073|560119695|FG002|Overall Study|Adverse Event|24|||
155185837|NCT01178073|560119693|FG000|Overall Study|Protocol Violation|1|||
155185838|NCT01178073|560119694|FG001|Overall Study|Protocol Violation|1|||
155185839|NCT01178073|560119695|FG002|Overall Study|Protocol Violation|1|||
155185840|NCT01178073|560119693|FG000|Overall Study|Lost to Follow-up|2|||
155185841|NCT01178073|560119694|FG001|Overall Study|Lost to Follow-up|0|||
155185842|NCT01178073|560119695|FG002|Overall Study|Lost to Follow-up|3|||
155185843|NCT01178073|560119693|FG000|Overall Study|Physician Decision|14|||
155185844|NCT01178073|560119694|FG001|Overall Study|Physician Decision|10|||
155185845|NCT01178073|560119695|FG002|Overall Study|Physician Decision|10|||
155185846|NCT01178073|560119693|FG000|Overall Study|Withdrawal by Subject|10|||
155185847|NCT01178073|560119694|FG001|Overall Study|Withdrawal by Subject|6|||
155185848|NCT01178073|560119695|FG002|Overall Study|Withdrawal by Subject|8|||
155185849|NCT01178073|560119693|FG000|Overall Study|Missing Completion Status|1|||
155185850|NCT01178073|560119694|FG001|Overall Study|Missing Completion Status|0|||
155185851|NCT01178073|560119695|FG002|Overall Study|Missing Completion Status|0|||
155185852|NCT01674634|560119696|FG000|Overall Study|Withdrawal by Subject|3|||
155185853|NCT01674634|560119696|FG000|Overall Study|Lost to Follow-up|3|||
155185854|NCT05080660|560119697|FG000|Overall Study|Adverse Event|4|||
155185855|NCT05080660|560119698|FG001|Overall Study|Adverse Event|0|||
155185856|NCT05080660|560119697|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
155185857|NCT05080660|560119698|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
155185858|NCT05080660|560119697|FG000|Overall Study|Physician Decision|1|||
155185859|NCT05080660|560119698|FG001|Overall Study|Physician Decision|0|||
155185860|NCT05080660|560119697|FG000|Overall Study|Protocol Deviation|2|||
155185861|NCT05080660|560119698|FG001|Overall Study|Protocol Deviation|0|||
155185862|NCT05080660|560119697|FG000|Overall Study|Withdrawal by Subject|5|||
155185863|NCT05080660|560119698|FG001|Overall Study|Withdrawal by Subject|2|||
155185864|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
155185865|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
155185866|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
155185867|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
155185868|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185869|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
155185870|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185871|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185872|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
155185873|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185874|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185875|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185876|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185877|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
155185878|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185879|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185880|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185881|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
155185882|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185883|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185884|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
155185885|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
155717604|NCT00383552|562061742|FG001|Overall Study|Adverse Event|6|||
155185886|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
155185887|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
155717605|NCT00383552|562061743|FG002|Overall Study|Adverse Event|9|||
155185888|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Adverse Event|0|||
155185889|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Adverse Event|0|||
155185890|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Adverse Event|1|||
155185891|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Adverse Event|1|||
155717606|NCT00383552|562061744|FG003|Overall Study|Adverse Event|6|||
155717607|NCT00383552|562061741|FG000|Overall Study|Lack of Efficacy|4|||
155717608|NCT00383552|562061742|FG001|Overall Study|Lack of Efficacy|13|||
155717609|NCT00383552|562061743|FG002|Overall Study|Lack of Efficacy|29|||
155717610|NCT00383552|562061744|FG003|Overall Study|Lack of Efficacy|42|||
155717611|NCT00383552|562061741|FG000|Overall Study|Lost to Follow-up|0|||
155717612|NCT00383552|562061742|FG001|Overall Study|Lost to Follow-up|1|||
155717613|NCT00383552|562061743|FG002|Overall Study|Lost to Follow-up|5|||
155717614|NCT00383552|562061744|FG003|Overall Study|Lost to Follow-up|1|||
155717615|NCT00383552|562061741|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
155717616|NCT00383552|562061742|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
155717617|NCT00383552|562061743|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
155717618|NCT00383552|562061744|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
155717619|NCT00383552|562061741|FG000|Overall Study|Did not wish to continue (related)|1|||
155717620|NCT00383552|562061742|FG001|Overall Study|Did not wish to continue (related)|0|||
155717621|NCT00383552|562061743|FG002|Overall Study|Did not wish to continue (related)|2|||
155717622|NCT00383552|562061744|FG003|Overall Study|Did not wish to continue (related)|3|||
155717623|NCT00383552|562061741|FG000|Overall Study|Noncompliance with the protocol|11|||
155717624|NCT00383552|562061742|FG001|Overall Study|Noncompliance with the protocol|6|||
155717625|NCT00383552|562061743|FG002|Overall Study|Noncompliance with the protocol|8|||
155717626|NCT00383552|562061744|FG003|Overall Study|Noncompliance with the protocol|10|||
155717627|NCT00383552|562061741|FG000|Overall Study|Did not meet protocol eligibility|8|||
155717628|NCT00383552|562061742|FG001|Overall Study|Did not meet protocol eligibility|6|||
155717629|NCT00383552|562061743|FG002|Overall Study|Did not meet protocol eligibility|2|||
155717630|NCT00383552|562061744|FG003|Overall Study|Did not meet protocol eligibility|3|||
155717631|NCT00383552|562061741|FG000|Overall Study|Administrative|1|||
155717632|NCT00383552|562061742|FG001|Overall Study|Administrative|0|||
155717633|NCT00383552|562061743|FG002|Overall Study|Administrative|1|||
155717634|NCT00383552|562061744|FG003|Overall Study|Administrative|1|||
155717635|NCT03096834|562061745|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
155717636|NCT03096834|562061746|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
155717637|NCT03096834|562061747|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
155717638|NCT03096834|562061748|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
155717639|NCT03096834|562061745|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
155717640|NCT03096834|562061746|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
155717641|NCT03096834|562061747|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
155717642|NCT03096834|562061748|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
155717643|NCT03096834|562061745|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
155717644|NCT03096834|562061746|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
155717645|NCT03096834|562061747|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
155717646|NCT03096834|562061748|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
155717647|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
155717648|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
155717649|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
155717650|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
155717651|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
155717652|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
155717653|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
155717654|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
155717655|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
155717656|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
155717657|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
155717658|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
155717659|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
155717660|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
155717661|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
155717662|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
155717663|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
155717664|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
155717665|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
155717666|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
155717667|NCT03096834|562061745|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
155717668|NCT03096834|562061746|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
155717669|NCT03096834|562061747|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
155717670|NCT03096834|562061748|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
155717671|NCT03096834|562061745|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
155717672|NCT03096834|562061746|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
155717673|NCT03096834|562061747|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
155717674|NCT03096834|562061748|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
155717675|NCT03096834|562061745|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
155717676|NCT03096834|562061746|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
155717677|NCT03096834|562061747|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
155717678|NCT03096834|562061748|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
155717679|NCT03096834|562061745|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155717680|NCT03096834|562061746|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155717681|NCT03096834|562061747|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
155717682|NCT03096834|562061748|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155717683|NCT00966654|562061749|FG000|Overall Study|Study was terminated,PI left institution|12|||
155717684|NCT01600326|562061756|FG000|Overall Study|Lost to Follow-up|1|||
155717685|NCT01600326|562061757|FG001|Overall Study|Lost to Follow-up|1|||
155717686|NCT04456504|562061758|FG000|Overall Study|Lost to Follow-up|2|||
155717687|NCT00762359|562061759|FG000|Overall Study|Adverse Event|20|||
155717688|NCT00762359|562061760|FG001|Overall Study|Adverse Event|23|||
155717689|NCT00762359|562061759|FG000|Overall Study|Protocol Violation|21|||
155717690|NCT00762359|562061760|FG001|Overall Study|Protocol Violation|13|||
155717691|NCT00762359|562061759|FG000|Overall Study|Withdrawal by Subject|13|||
155717692|NCT00762359|562061760|FG001|Overall Study|Withdrawal by Subject|10|||
155717693|NCT00762359|562061759|FG000|Overall Study|Lack of Efficacy|0|||
155717694|NCT00762359|562061760|FG001|Overall Study|Lack of Efficacy|4|||
155717695|NCT00762359|562061759|FG000|Overall Study|Institution closed|2|||
155717696|NCT00762359|562061760|FG001|Overall Study|Institution closed|3|||
155717697|NCT00762359|562061759|FG000|Overall Study|Physician Decision|2|||
155717698|NCT00762359|562061760|FG001|Overall Study|Physician Decision|3|||
155717699|NCT00762359|562061759|FG000|Overall Study|Removal|0|||
155717700|NCT00762359|562061760|FG001|Overall Study|Removal|1|||
155717701|NCT00762359|562061759|FG000|Overall Study|Withdrew consent|1|||
155717702|NCT00762359|562061760|FG001|Overall Study|Withdrew consent|0|||
155717703|NCT01342913|562061761|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
155717704|NCT01342913|562061762|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155717705|NCT01342913|562061763|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155717706|NCT01342913|562061761|FG000|2-week Run-in Period|Physician Decision|6|||
155717707|NCT01342913|562061762|FG001|2-week Run-in Period|Physician Decision|0|||
155717708|NCT01342913|562061763|FG002|2-week Run-in Period|Physician Decision|0|||
155717709|NCT01342913|562061761|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
155717710|NCT01342913|562061762|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155717711|NCT01342913|562061763|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155717712|NCT01342913|562061761|FG000|2-week Run-in Period|Adverse Event|2|||
155717713|NCT01342913|562061762|FG001|2-week Run-in Period|Adverse Event|0|||
155717714|NCT01342913|562061763|FG002|2-week Run-in Period|Adverse Event|0|||
155717715|NCT01342913|562061761|FG000|2-week Run-in Period|Protocol Violation|5|||
155717716|NCT01342913|562061762|FG001|2-week Run-in Period|Protocol Violation|0|||
155717717|NCT01342913|562061763|FG002|2-week Run-in Period|Protocol Violation|0|||
155717718|NCT01342913|562061761|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
155717719|NCT01342913|562061762|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155717720|NCT01342913|562061763|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155717721|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155717722|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Adverse Event|3|||
155717723|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Adverse Event|6|||
155717724|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155717725|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
155717726|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
155717727|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155717728|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
155717729|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
155717730|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155717731|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155717732|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
155717733|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Physician Decision|0|||
155717734|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Physician Decision|2|||
155717735|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Physician Decision|0|||
155717736|NCT01342913|562061761|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155717737|NCT01342913|562061762|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155717738|NCT01342913|562061763|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155717739|NCT02656017|562061767|FG000|Overall Study|Study burden|3|||
155717740|NCT02656017|562061768|FG001|Overall Study|Study burden|3|||
155717741|NCT02656017|562061767|FG000|Overall Study|Adverse Event|2|||
155717742|NCT02656017|562061768|FG001|Overall Study|Adverse Event|1|||
155717743|NCT02656017|562061767|FG000|Overall Study|Unable/unwilling to take study medication|2|||
155717744|NCT02656017|562061768|FG001|Overall Study|Unable/unwilling to take study medication|1|||
155717745|NCT02656017|562061767|FG000|Overall Study|Began Tolvaptan|1|||
155717746|NCT02656017|562061768|FG001|Overall Study|Began Tolvaptan|1|||
155717747|NCT02656017|562061767|FG000|Overall Study|Withdrawal by Subject|1|||
155717748|NCT02656017|562061768|FG001|Overall Study|Withdrawal by Subject|0|||
155717749|NCT02792231|562061775|FG000|Overall Study|Patient/guardian decision|32|||
155717750|NCT02792231|562061776|FG001|Overall Study|Patient/guardian decision|42|||
155717751|NCT02792231|562061775|FG000|Overall Study|Adverse Event|15|||
155717752|NCT02792231|562061776|FG001|Overall Study|Adverse Event|11|||
155717753|NCT02792231|562061775|FG000|Overall Study|Physician Decision|14|||
155717754|NCT02792231|562061776|FG001|Overall Study|Physician Decision|12|||
155717755|NCT02792231|562061775|FG000|Overall Study|Lack of Efficacy|7|||
155717756|NCT02792231|562061776|FG001|Overall Study|Lack of Efficacy|9|||
155717757|NCT02792231|562061775|FG000|Overall Study|Lost to Follow-up|9|||
155717758|NCT02792231|562061776|FG001|Overall Study|Lost to Follow-up|5|||
155717759|NCT02792231|562061775|FG000|Overall Study|Pregnancy|1|||
155717760|NCT02792231|562061776|FG001|Overall Study|Pregnancy|3|||
155717761|NCT02792231|562061775|FG000|Overall Study|Non-compliance with study treatment|2|||
155717762|NCT02792231|562061776|FG001|Overall Study|Non-compliance with study treatment|1|||
155717763|NCT02792231|562061775|FG000|Overall Study|Protocol deviation|2|||
155717764|NCT02792231|562061776|FG001|Overall Study|Protocol deviation|0|||
155717765|NCT02792231|562061775|FG000|Overall Study|Technical problems|0|||
155717766|NCT02792231|562061776|FG001|Overall Study|Technical problems|1|||
155717767|NCT02469623|562061777|FG000|Overall Study|Not consented for long-term follow-up|4|||
155717768|NCT02469623|562061777|FG000|Overall Study|Lost to Follow-up|4|||
155717769|NCT02469623|562061777|FG000|Overall Study|Withdrawal by Subject|2|||
155717770|NCT02469623|562061777|FG000|Overall Study|Death|3|||
155717771|NCT04073186|562061778|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
155717772|NCT04073186|562061778|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
155717773|NCT04073186|562061778|FG000|First Wearing Cycle|Protocol Violation|1|||
155717774|NCT04073186|562061778|FG000|First Wearing Cycle|Lens Discomfort|2|||
155717775|NCT04073186|562061778|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
155717776|NCT04073186|562061778|FG000|Second Wearing Cycle|Adverse Event|1|||
155717777|NCT03309878|562061779|FG000|Overall Study|Adverse Event|1|||
155717778|NCT03309878|562061780|FG001|Overall Study|Adverse Event|0|||
155717779|NCT03309878|562061781|FG002|Overall Study|Adverse Event|0|||
155717780|NCT03309878|562061782|FG003|Overall Study|Adverse Event|0|||
155717781|NCT03309878|562061779|FG000|Overall Study|Did not maintain eligibility|2|||
155717782|NCT03309878|562061780|FG001|Overall Study|Did not maintain eligibility|1|||
155717783|NCT03309878|562061781|FG002|Overall Study|Did not maintain eligibility|0|||
155717784|NCT03309878|562061782|FG003|Overall Study|Did not maintain eligibility|0|||
155717785|NCT03309878|562061779|FG000|Overall Study|Withdrawal by Subject|0|||
155717786|NCT03309878|562061780|FG001|Overall Study|Withdrawal by Subject|1|||
155717787|NCT03309878|562061781|FG002|Overall Study|Withdrawal by Subject|0|||
155717788|NCT03309878|562061782|FG003|Overall Study|Withdrawal by Subject|0|||
155717789|NCT01884077|562061783|FG000|Overall Study|screen fail|0|||
155717790|NCT01884077|562061784|FG001|Overall Study|screen fail|2|||
155717791|NCT01884077|562061783|FG000|Overall Study|canceled surgery|2|||
155717792|NCT01884077|562061784|FG001|Overall Study|canceled surgery|0|||
155717793|NCT01884077|562061783|FG000|Overall Study|Lost to Follow-up|0|||
155717794|NCT01884077|562061784|FG001|Overall Study|Lost to Follow-up|4|||
155717795|NCT01884077|562061783|FG000|Overall Study|study closed|6|||
155717796|NCT01884077|562061784|FG001|Overall Study|study closed|4|||
155717797|NCT00473434|562061785|FG000|Overall Study|Physician Decision|3|||
155717798|NCT00473434|562061785|FG000|Overall Study|Withdrawal by Subject|9|||
155717799|NCT00473434|562061785|FG000|Overall Study|Compliance|3|||
155717800|NCT00473434|562061785|FG000|Overall Study|Lack of Efficacy|3|||
155717801|NCT00473434|562061785|FG000|Overall Study|Adverse Event|3|||
155717802|NCT00473434|562061785|FG000|Overall Study|Patient was selling medication to others|1|||
155717803|NCT00473434|562061785|FG000|Overall Study|Safety evaluation|1|||
155717804|NCT00473434|562061785|FG000|Overall Study|Reason not specified|6|||
155717805|NCT00473434|562061785|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
155717806|NCT00473434|562061785|FG000|Overall Study|Switching to trial medication|1|||
155717807|NCT00473434|562061785|FG000|Overall Study|No longer required|1|||
155717808|NCT02836652|562061786|FG000|Overall Study|Death|3|||
155717809|NCT02836652|562061787|FG001|Overall Study|Death|3|||
155717810|NCT02836652|562061786|FG000|Overall Study|Transplant/Explant|3|||
155717811|NCT02836652|562061787|FG001|Overall Study|Transplant/Explant|4|||
155717812|NCT02836652|562061786|FG000|Overall Study|Withdrawn|9|||
155717813|NCT02836652|562061787|FG001|Overall Study|Withdrawn|9|||
155717814|NCT02836652|562061786|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
155717815|NCT02836652|562061787|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
155717816|NCT01008943|562061793|FG000|Overall Study|Withdrawal by Subject|1|||
155717817|NCT00861705|562061794|FG000|Overall Study|Never Began Treatment|7|||
155717818|NCT00861705|562061795|FG001|Overall Study|Never Began Treatment|3|||
155717819|NCT00861705|562061796|FG002|Overall Study|Never Began Treatment|0|||
155717820|NCT00861705|562061797|FG003|Overall Study|Never Began Treatment|1|||
155717821|NCT05789745|562061798|FG000|Overall Study|Withdrawal by Subject|0|||
155717822|NCT05789745|562061799|FG001|Overall Study|Withdrawal by Subject|0|||
155717823|NCT05789745|562061800|FG002|Overall Study|Withdrawal by Subject|0|||
155717824|NCT05789745|562061801|FG003|Overall Study|Withdrawal by Subject|0|||
155717825|NCT05789745|562061802|FG004|Overall Study|Withdrawal by Subject|1|||
155717826|NCT03294590|562061803|FG000|Overall Study|Lost to Follow-up|105|||
155717827|NCT03294590|562061804|FG001|Overall Study|Lost to Follow-up|107|||
155717828|NCT01962441|562061805|FG000|Randomized Period|Randomized but Never Treated|4|||
155717829|NCT01962441|562061806|FG001|Randomized Period|Randomized but Never Treated|2|||
155717830|NCT01962441|562061807|FG002|Randomized Period|Randomized but Never Treated|3|||
155717831|NCT01962441|562061805|FG000|Randomized Period|Lost to Follow-up|2|||
155717832|NCT01962441|562061806|FG001|Randomized Period|Lost to Follow-up|4|||
155717833|NCT01962441|562061807|FG002|Randomized Period|Lost to Follow-up|4|||
155717834|NCT01962441|562061805|FG000|Randomized Period|Withdrew Consent|3|||
155717835|NCT01962441|562061806|FG001|Randomized Period|Withdrew Consent|3|||
155717836|NCT01962441|562061807|FG002|Randomized Period|Withdrew Consent|2|||
155717837|NCT01962441|562061805|FG000|Randomized Period|Adverse Event|1|||
155717838|NCT01962441|562061806|FG001|Randomized Period|Adverse Event|1|||
155717839|NCT01962441|562061807|FG002|Randomized Period|Adverse Event|0|||
155717840|NCT01962441|562061805|FG000|Randomized Period|Death|0|||
155717841|NCT01962441|562061806|FG001|Randomized Period|Death|0|||
155717842|NCT01962441|562061807|FG002|Randomized Period|Death|2|||
155717843|NCT01962441|562061805|FG000|Randomized Period|Protocol Violation|0|||
155717844|NCT01962441|562061806|FG001|Randomized Period|Protocol Violation|1|||
155717845|NCT01962441|562061807|FG002|Randomized Period|Protocol Violation|0|||
155717846|NCT01962441|562061805|FG000|Retreatment Substudy|Lack of Efficacy|1|||
155717847|NCT01962441|562061806|FG001|Retreatment Substudy|Lack of Efficacy|0|||
155717848|NCT01962441|562061807|FG002|Retreatment Substudy|Lack of Efficacy|0|||
155717849|NCT01962441|562061805|FG000|Retreatment Substudy|Lost to Follow-up|1|||
155717850|NCT01962441|562061806|FG001|Retreatment Substudy|Lost to Follow-up|0|||
155717851|NCT01962441|562061807|FG002|Retreatment Substudy|Lost to Follow-up|0|||
155717852|NCT02055898|562061808|FG000|First Intervention (5 Days)|Physician Decision|2|||
155717853|NCT02055898|562061809|FG001|First Intervention (5 Days)|Physician Decision|0|||
155717854|NCT02055898|562061808|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
155717855|NCT02055898|562061809|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
155717856|NCT00718510|562061811|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155717857|NCT00718510|562061812|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155717858|NCT00718510|562061811|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
155717859|NCT00718510|562061812|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155717860|NCT02201524|562061813|FG000|Overall Study|Adverse Event|0|||
155717861|NCT02201524|562061814|FG001|Overall Study|Adverse Event|2|||
155717862|NCT02201524|562061815|FG002|Overall Study|Adverse Event|1|||
155717863|NCT02201524|562061816|FG003|Overall Study|Adverse Event|0|||
155717864|NCT02201524|562061813|FG000|Overall Study|Insufficient clinical response|1|||
155717865|NCT02201524|562061814|FG001|Overall Study|Insufficient clinical response|0|||
155717866|NCT02201524|562061815|FG002|Overall Study|Insufficient clinical response|0|||
155717867|NCT02201524|562061816|FG003|Overall Study|Insufficient clinical response|0|||
155717868|NCT02201524|562061813|FG000|Overall Study|Lost to Follow-up|0|||
155717869|NCT02201524|562061814|FG001|Overall Study|Lost to Follow-up|0|||
155717870|NCT02201524|562061815|FG002|Overall Study|Lost to Follow-up|2|||
155717871|NCT02201524|562061816|FG003|Overall Study|Lost to Follow-up|0|||
155717872|NCT02201524|562061813|FG000|Overall Study|No longer meets eligibility criteria|0|||
155717873|NCT02201524|562061814|FG001|Overall Study|No longer meets eligibility criteria|0|||
155717874|NCT02201524|562061815|FG002|Overall Study|No longer meets eligibility criteria|0|||
155717875|NCT02201524|562061816|FG003|Overall Study|No longer meets eligibility criteria|2|||
155717876|NCT02201524|562061813|FG000|Overall Study|Protocol Violation|0|||
155717877|NCT02201524|562061814|FG001|Overall Study|Protocol Violation|0|||
155717878|NCT02201524|562061815|FG002|Overall Study|Protocol Violation|0|||
155717879|NCT02201524|562061816|FG003|Overall Study|Protocol Violation|1|||
155717880|NCT02201524|562061813|FG000|Overall Study|Withdrawal by Subject|0|||
155717881|NCT02201524|562061814|FG001|Overall Study|Withdrawal by Subject|0|||
155717882|NCT02201524|562061815|FG002|Overall Study|Withdrawal by Subject|1|||
155717883|NCT02201524|562061816|FG003|Overall Study|Withdrawal by Subject|1|||
155717884|NCT02201524|562061813|FG000|Overall Study|Other|1|||
155717885|NCT02201524|562061814|FG001|Overall Study|Other|1|||
155717886|NCT02201524|562061815|FG002|Overall Study|Other|0|||
155717887|NCT02201524|562061816|FG003|Overall Study|Other|0|||
155717888|NCT00423657|562061817|FG000|Overall Study|Withdrew consent|10|||
155717889|NCT00423657|562061818|FG001|Overall Study|Withdrew consent|8|||
155717890|NCT00423657|562061817|FG000|Overall Study|Non-compliance|0|||
155717891|NCT00423657|562061818|FG001|Overall Study|Non-compliance|1|||
155717892|NCT00423657|562061817|FG000|Overall Study|Other|15|||
155717893|NCT00423657|562061818|FG001|Overall Study|Other|16|||
155717894|NCT00423657|562061817|FG000|Overall Study|Request of sponsor/investigator|1|||
155717895|NCT00423657|562061818|FG001|Overall Study|Request of sponsor/investigator|0|||
155717896|NCT00474955|562061819|FG000|Overall Study|Adverse Event|2|||
155717897|NCT00474955|562061819|FG000|Overall Study|Drug unavailability|1|||
155717898|NCT00474955|562061819|FG000|Overall Study|Personal reasons|5|||
155717899|NCT01620060|562061822|FG000|Overall Study|Adverse Event|9|||
155717900|NCT01620060|562061822|FG000|Overall Study|Protocol Violation|1|||
155717901|NCT01620060|562061822|FG000|Overall Study|Withdrawal by Subject|1|||
155717902|NCT01620060|562061822|FG000|Overall Study|Did not comply with Study Produre|1|||
155717903|NCT01620060|562061822|FG000|Overall Study|Family emergency|1|||
155717904|NCT01620060|562061822|FG000|Overall Study|Per Sponsor Decision|2|||
155717905|NCT00499681|562061823|FG000|Overall Study|toxicity|0|||
155717906|NCT00499681|562061824|FG001|Overall Study|toxicity|1|||
155717907|NCT00499681|562061823|FG000|Overall Study|disease progression|0|||
155185892|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
155185893|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
155185894|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
155185895|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
155185896|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
155185897|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
155185898|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
155185899|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
155185900|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
155185901|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
155185902|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
155185903|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
155185904|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Physician Decision|0|||
155185905|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Physician Decision|0|||
155185906|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Physician Decision|3|||
155185907|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Physician Decision|2|||
155185908|NCT01226043|560119711|FG000|6-week Re-randomization Phase|completed in error|0|||
155185909|NCT01226043|560119712|FG001|6-week Re-randomization Phase|completed in error|0|||
155185910|NCT01226043|560119713|FG002|6-week Re-randomization Phase|completed in error|0|||
155185911|NCT01226043|560119714|FG003|6-week Re-randomization Phase|completed in error|1|||
155185912|NCT01226043|560119711|FG000|30-week Observational Phase|Adverse Event|0|||
155185913|NCT01226043|560119712|FG001|30-week Observational Phase|Adverse Event|0|||
155185914|NCT01226043|560119713|FG002|30-week Observational Phase|Adverse Event|1|||
155185915|NCT01226043|560119714|FG003|30-week Observational Phase|Adverse Event|1|||
155185916|NCT01226043|560119711|FG000|30-week Observational Phase|Protocol Violation|0|||
155185917|NCT01226043|560119712|FG001|30-week Observational Phase|Protocol Violation|0|||
155185918|NCT01226043|560119713|FG002|30-week Observational Phase|Protocol Violation|0|||
155185919|NCT01226043|560119714|FG003|30-week Observational Phase|Protocol Violation|1|||
155185920|NCT01226043|560119711|FG000|30-week Observational Phase|Lost to Follow-up|0|||
155185921|NCT01226043|560119712|FG001|30-week Observational Phase|Lost to Follow-up|0|||
155185922|NCT01226043|560119713|FG002|30-week Observational Phase|Lost to Follow-up|2|||
155185923|NCT01226043|560119714|FG003|30-week Observational Phase|Lost to Follow-up|2|||
155185924|NCT01226043|560119711|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
155185925|NCT01226043|560119712|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
155185926|NCT01226043|560119713|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
155185927|NCT01226043|560119714|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
155185928|NCT01226043|560119711|FG000|30-week Observational Phase|Physician Decision|0|||
155185929|NCT01226043|560119712|FG001|30-week Observational Phase|Physician Decision|0|||
155185930|NCT01226043|560119713|FG002|30-week Observational Phase|Physician Decision|2|||
155185931|NCT01226043|560119714|FG003|30-week Observational Phase|Physician Decision|2|||
155185932|NCT01977937|560119719|FG000|Overall Study|Withdrawal by Subject|2|||
155185933|NCT01977937|560119720|FG001|Overall Study|Withdrawal by Subject|1|||
155185934|NCT01977937|560119719|FG000|Overall Study|Adverse Event|1|||
155185935|NCT01977937|560119720|FG001|Overall Study|Adverse Event|0|||
155185936|NCT01977937|560119719|FG000|Overall Study|Physician Decision|0|||
155185937|NCT01977937|560119720|FG001|Overall Study|Physician Decision|1|||
155185938|NCT03004443|560119724|FG000|Overall Study|Pregnancy|0|||
155185939|NCT03004443|560119725|FG001|Overall Study|Pregnancy|1|||
155185940|NCT00406718|560119727|FG000|Overall Study|Withdrawal by Subject|2|||
155185941|NCT00406718|560119728|FG001|Overall Study|Withdrawal by Subject|9|||
155185942|NCT00406718|560119729|FG002|Overall Study|Withdrawal by Subject|4|||
155185943|NCT00406718|560119727|FG000|Overall Study|Lost to Follow-up|2|||
155185944|NCT00406718|560119728|FG001|Overall Study|Lost to Follow-up|5|||
155185945|NCT00406718|560119729|FG002|Overall Study|Lost to Follow-up|4|||
155185946|NCT01888003|560119732|FG000|Overall Study|Study Terminated|5|||
155185947|NCT01888003|560119733|FG001|Overall Study|Study Terminated|6|||
155185948|NCT01888003|560119734|FG002|Overall Study|Study Terminated|40|||
155185949|NCT03187756|560119735|FG000|Overall Study|Termination of study|4|||
155185950|NCT01927341|560121256|FG000|Phase 1b|Lost to Follow-up|1|||
155185951|NCT01927341|560121257|FG001|Phase 1b|Lost to Follow-up|0|||
155185952|NCT01927341|560121258|FG002|Phase 1b|Lost to Follow-up|0|||
155717908|NCT00499681|562061824|FG001|Overall Study|disease progression|1|||
155717909|NCT04575155|562061825|FG000|2 Month|Withdrawal by Subject|1|||
155185953|NCT01927341|560121259|FG003|Phase 1b|Lost to Follow-up|0|||
155185954|NCT01927341|560121260|FG004|Phase 1b|Lost to Follow-up|0|||
155185955|NCT01927341|560121256|FG000|Phase 1b|Death|2|||
155185956|NCT01927341|560121257|FG001|Phase 1b|Death|0|||
155185957|NCT01927341|560121258|FG002|Phase 1b|Death|0|||
155185958|NCT01927341|560121259|FG003|Phase 1b|Death|0|||
155185959|NCT01927341|560121260|FG004|Phase 1b|Death|0|||
155185960|NCT01927341|560121256|FG000|Phase 1b|Follow-up completed|7|||
155717910|NCT04575155|562061826|FG001|2 Month|Withdrawal by Subject|1|||
155185961|NCT01927341|560121257|FG001|Phase 1b|Follow-up completed|0|||
155185962|NCT01927341|560121258|FG002|Phase 1b|Follow-up completed|0|||
155185963|NCT01927341|560121259|FG003|Phase 1b|Follow-up completed|0|||
155185964|NCT01927341|560121260|FG004|Phase 1b|Follow-up completed|0|||
155185965|NCT01927341|560121256|FG000|Phase 2|Lost to Follow-up|0|||
155185966|NCT01927341|560121257|FG001|Phase 2|Lost to Follow-up|1|||
155185967|NCT01927341|560121258|FG002|Phase 2|Lost to Follow-up|0|||
155185968|NCT01927341|560121259|FG003|Phase 2|Lost to Follow-up|0|||
155185969|NCT01927341|560121260|FG004|Phase 2|Lost to Follow-up|0|||
155185970|NCT01927341|560121256|FG000|Phase 2|Participant withdrew consent|0|||
155185971|NCT01927341|560121257|FG001|Phase 2|Participant withdrew consent|2|||
155185972|NCT01927341|560121258|FG002|Phase 2|Participant withdrew consent|1|||
155185973|NCT01927341|560121259|FG003|Phase 2|Participant withdrew consent|2|||
155185974|NCT01927341|560121260|FG004|Phase 2|Participant withdrew consent|3|||
155185975|NCT01927341|560121256|FG000|Phase 2|Death|0|||
155185976|NCT01927341|560121257|FG001|Phase 2|Death|4|||
155185977|NCT01927341|560121258|FG002|Phase 2|Death|0|||
155185978|NCT01927341|560121259|FG003|Phase 2|Death|3|||
155185979|NCT01927341|560121260|FG004|Phase 2|Death|2|||
155185980|NCT01927341|560121256|FG000|Phase 2|New cancer therapy|0|||
155185981|NCT01927341|560121257|FG001|Phase 2|New cancer therapy|1|||
155185982|NCT01927341|560121258|FG002|Phase 2|New cancer therapy|0|||
155185983|NCT01927341|560121259|FG003|Phase 2|New cancer therapy|4|||
155185984|NCT01927341|560121260|FG004|Phase 2|New cancer therapy|1|||
155185985|NCT01927341|560121256|FG000|Phase 2|Disease progression|0|||
155185986|NCT01927341|560121257|FG001|Phase 2|Disease progression|1|||
155185987|NCT01927341|560121258|FG002|Phase 2|Disease progression|1|||
155185988|NCT01927341|560121259|FG003|Phase 2|Disease progression|1|||
155185989|NCT01927341|560121260|FG004|Phase 2|Disease progression|0|||
155185990|NCT01927341|560121256|FG000|Phase 2|Follow-up completed|0|||
155185991|NCT01927341|560121257|FG001|Phase 2|Follow-up completed|6|||
155185992|NCT01927341|560121258|FG002|Phase 2|Follow-up completed|3|||
155185993|NCT01927341|560121259|FG003|Phase 2|Follow-up completed|5|||
155185994|NCT01927341|560121260|FG004|Phase 2|Follow-up completed|2|||
155185995|NCT00451451|560121261|FG000|Overall Study|Adverse Event|11|||
155185996|NCT00451451|560121262|FG001|Overall Study|Adverse Event|21|||
155185997|NCT00451451|560121263|FG002|Overall Study|Adverse Event|26|||
155185998|NCT00451451|560121264|FG003|Overall Study|Adverse Event|10|||
155185999|NCT00451451|560121261|FG000|Overall Study|Lost to Follow-up|11|||
155186000|NCT00451451|560121262|FG001|Overall Study|Lost to Follow-up|9|||
155186001|NCT00451451|560121263|FG002|Overall Study|Lost to Follow-up|8|||
155186002|NCT00451451|560121264|FG003|Overall Study|Lost to Follow-up|11|||
155186003|NCT00451451|560121261|FG000|Overall Study|Consent Withdrawn|14|||
155186004|NCT00451451|560121262|FG001|Overall Study|Consent Withdrawn|9|||
155186005|NCT00451451|560121263|FG002|Overall Study|Consent Withdrawn|17|||
155186006|NCT00451451|560121264|FG003|Overall Study|Consent Withdrawn|17|||
155186007|NCT00451451|560121261|FG000|Overall Study|Investigator Decision|6|||
155186008|NCT00451451|560121262|FG001|Overall Study|Investigator Decision|2|||
155186009|NCT00451451|560121263|FG002|Overall Study|Investigator Decision|1|||
155186010|NCT00451451|560121264|FG003|Overall Study|Investigator Decision|2|||
155186011|NCT00451451|560121261|FG000|Overall Study|Subject Non-Compliance|8|||
155186012|NCT00451451|560121262|FG001|Overall Study|Subject Non-Compliance|4|||
155186013|NCT00451451|560121263|FG002|Overall Study|Subject Non-Compliance|3|||
155186014|NCT00451451|560121264|FG003|Overall Study|Subject Non-Compliance|3|||
155186015|NCT00451451|560121261|FG000|Overall Study|Death|1|||
155186016|NCT00451451|560121262|FG001|Overall Study|Death|0|||
155186017|NCT00451451|560121263|FG002|Overall Study|Death|0|||
155186018|NCT00451451|560121264|FG003|Overall Study|Death|1|||
155186019|NCT00451451|560121261|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
155186020|NCT00451451|560121262|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
155186021|NCT00451451|560121263|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
155186022|NCT00451451|560121264|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
155186023|NCT01442038|560121272|FG000|Overall Study|Death|35|||
155186024|NCT01442038|560121273|FG001|Overall Study|Death|29|||
155186025|NCT01442038|560121272|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
155186026|NCT01442038|560121273|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
155186027|NCT01442038|560121272|FG000|Overall Study|Participant Withdrew Consent|137|||
155186028|NCT01442038|560121273|FG001|Overall Study|Participant Withdrew Consent|102|||
155186029|NCT01442038|560121272|FG000|Overall Study|Lost to Follow-up|37|||
155186030|NCT01442038|560121273|FG001|Overall Study|Lost to Follow-up|51|||
155186031|NCT01442038|560121272|FG000|Overall Study|Adverse Event|26|||
155186032|NCT01442038|560121273|FG001|Overall Study|Adverse Event|15|||
155186033|NCT01442038|560121272|FG000|Overall Study|Protocol Deviation|9|||
155186034|NCT01442038|560121273|FG001|Overall Study|Protocol Deviation|20|||
155186035|NCT01442038|560121272|FG000|Overall Study|Investigator's Discretion|13|||
155186036|NCT01442038|560121273|FG001|Overall Study|Investigator's Discretion|16|||
155186037|NCT01442038|560121272|FG000|Overall Study|Study Terminated By Sponsor|2|||
155186038|NCT01442038|560121273|FG001|Overall Study|Study Terminated By Sponsor|3|||
155186039|NCT00089284|560121274|FG000|Overall Study|Adverse event before starting treatment|0|||
155186040|NCT00089284|560121275|FG001|Overall Study|Adverse event before starting treatment|0|||
155186041|NCT00089284|560121276|FG002|Overall Study|Adverse event before starting treatment|0|||
155186042|NCT00089284|560121277|FG003|Overall Study|Adverse event before starting treatment|0|||
155717911|NCT04575155|562061825|FG000|2 Month|Lost to Follow-up|5|||
155717912|NCT04575155|562061826|FG001|2 Month|Lost to Follow-up|3|||
155717913|NCT04575155|562061825|FG000|2 Month|Ineligible|1|||
155717914|NCT04575155|562061826|FG001|2 Month|Ineligible|0|||
155717915|NCT06237049|562061828|FG000|Overall Study|Death|0|||
155717916|NCT06237049|562061829|FG001|Overall Study|Death|0|||
155717917|NCT06237049|562061830|FG002|Overall Study|Death|0|||
155717918|NCT06237049|562061831|FG003|Overall Study|Death|1|||
155717919|NCT06237049|562061828|FG000|Overall Study|Lost to Follow-up|11|||
155717920|NCT06237049|562061829|FG001|Overall Study|Lost to Follow-up|5|||
155717921|NCT06237049|562061830|FG002|Overall Study|Lost to Follow-up|8|||
155717922|NCT06237049|562061831|FG003|Overall Study|Lost to Follow-up|8|||
155717923|NCT06237049|562061828|FG000|Overall Study|Protocol Violation|0|||
155717924|NCT06237049|562061829|FG001|Overall Study|Protocol Violation|1|||
155717925|NCT06237049|562061830|FG002|Overall Study|Protocol Violation|0|||
155717926|NCT06237049|562061831|FG003|Overall Study|Protocol Violation|1|||
155717927|NCT06237049|562061828|FG000|Overall Study|Withdrawal by Subject|4|||
155717928|NCT06237049|562061829|FG001|Overall Study|Withdrawal by Subject|2|||
155717929|NCT06237049|562061830|FG002|Overall Study|Withdrawal by Subject|1|||
155717930|NCT06237049|562061831|FG003|Overall Study|Withdrawal by Subject|0|||
155717931|NCT03748823|562061832|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155717932|NCT03748823|562061833|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155717933|NCT03748823|562061832|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
155717934|NCT03748823|562061833|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
155717935|NCT03748823|562061832|FG000|Extension Period|Withdrawal by Subject|9|||
155717936|NCT03748823|562061833|FG001|Extension Period|Withdrawal by Subject|12|||
155717937|NCT03748823|562061832|FG000|Extension Period|Death|2|||
155717938|NCT03748823|562061833|FG001|Extension Period|Death|2|||
155717939|NCT03748823|562061832|FG000|Extension Period|Other than Specified|0|||
155186043|NCT00089284|560121278|FG004|Overall Study|Adverse event before starting treatment|0|||
155186044|NCT00089284|560121279|FG005|Overall Study|Adverse event before starting treatment|0|||
155186045|NCT00089284|560121280|FG006|Overall Study|Adverse event before starting treatment|1|||
155186046|NCT03646643|560121281|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
155186047|NCT03646643|560121282|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
155186048|NCT03646643|560121281|FG000|Overall Study|Lost to Follow-up|0|||
155186049|NCT03646643|560121282|FG001|Overall Study|Lost to Follow-up|1|||
155186050|NCT05314478|560121283|FG000|Overall Study|Physician Decision|1|||
155186051|NCT03583164|560121284|FG000|Overall Study|Death in Main Phase|35|||
155186052|NCT03583164|560121284|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
155186053|NCT03583164|560121284|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
155186054|NCT03583164|560121284|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
155186055|NCT03583164|560121284|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
155186056|NCT03583164|560121284|FG000|Overall Study|Physician decision in Main Phase|1|||
155186057|NCT03583164|560121284|FG000|Overall Study|Physician decision in Extended Phase|2|||
155186058|NCT03583164|560121284|FG000|Overall Study|Death in Extended Phase|13|||
155186059|NCT03583164|560121284|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
155186060|NCT03583164|560121284|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
155717940|NCT03748823|562061833|FG001|Extension Period|Other than Specified|1|||
155717941|NCT03748823|562061832|FG000|Extension Period|Protocol Violation|1|||
155717942|NCT03748823|562061833|FG001|Extension Period|Protocol Violation|0|||
155717943|NCT03748823|562061832|FG000|Extension Period|Lost to Follow-up|0|||
155717944|NCT03748823|562061833|FG001|Extension Period|Lost to Follow-up|1|||
155717945|NCT03748823|562061832|FG000|Extension Period|Lack of Efficacy|0|||
155717946|NCT03748823|562061833|FG001|Extension Period|Lack of Efficacy|1|||
155717947|NCT03748823|562061832|FG000|Extension Period|Physician Decision|1|||
155717948|NCT03748823|562061833|FG001|Extension Period|Physician Decision|2|||
155717949|NCT03275740|562061834|FG000|Overall Study|Adverse Event|0|||
155717950|NCT03275740|562061835|FG001|Overall Study|Adverse Event|0|||
155717951|NCT03275740|562061836|FG002|Overall Study|Adverse Event|0|||
155717952|NCT03275740|562061837|FG003|Overall Study|Adverse Event|0|||
155717953|NCT03275740|562061838|FG004|Overall Study|Adverse Event|1|||
155717954|NCT03275740|562061839|FG005|Overall Study|Adverse Event|0|||
155717955|NCT03275740|562061840|FG006|Overall Study|Adverse Event|0|||
155717956|NCT03275740|562061841|FG007|Overall Study|Adverse Event|0|||
155717957|NCT03275740|562061842|FG008|Overall Study|Adverse Event|0|||
155717958|NCT03275740|562061843|FG009|Overall Study|Adverse Event|0|||
155717959|NCT03275740|562061844|FG010|Overall Study|Adverse Event|0|||
155717960|NCT03275740|562061845|FG011|Overall Study|Adverse Event|0|||
155717961|NCT03275740|562061834|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717962|NCT03275740|562061835|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717963|NCT03275740|562061836|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717964|NCT03275740|562061837|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717965|NCT03275740|562061838|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717966|NCT03275740|562061839|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
155717967|NCT03275740|562061840|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717968|NCT03275740|562061841|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717969|NCT03275740|562061842|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717970|NCT03275740|562061843|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717971|NCT03275740|562061844|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717972|NCT03275740|562061845|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155717973|NCT03275740|562061834|FG000|Overall Study|Withdrawal by Subject|0|||
155717974|NCT03275740|562061835|FG001|Overall Study|Withdrawal by Subject|0|||
155717975|NCT03275740|562061836|FG002|Overall Study|Withdrawal by Subject|0|||
155717976|NCT03275740|562061837|FG003|Overall Study|Withdrawal by Subject|0|||
155717977|NCT03275740|562061838|FG004|Overall Study|Withdrawal by Subject|0|||
155717978|NCT03275740|562061839|FG005|Overall Study|Withdrawal by Subject|0|||
155717979|NCT03275740|562061840|FG006|Overall Study|Withdrawal by Subject|0|||
155717980|NCT03275740|562061841|FG007|Overall Study|Withdrawal by Subject|0|||
155717981|NCT03275740|562061842|FG008|Overall Study|Withdrawal by Subject|1|||
155717982|NCT03275740|562061843|FG009|Overall Study|Withdrawal by Subject|1|||
155717983|NCT03275740|562061844|FG010|Overall Study|Withdrawal by Subject|0|||
155717984|NCT03275740|562061845|FG011|Overall Study|Withdrawal by Subject|0|||
155717985|NCT04486235|562061850|FG000|Overall Study|Pregnancy|1|||
155717986|NCT04486235|562061851|FG001|Overall Study|Pregnancy|0|||
155717987|NCT04486235|562061850|FG000|Overall Study|Lost to Follow-up|1|||
155717988|NCT04486235|562061851|FG001|Overall Study|Lost to Follow-up|0|||
155717989|NCT03935126|562061852|FG000|Overall Study|Study termination by sponsor|3|||
155717990|NCT00982735|562061853|FG000|Overall Study|Lost to Follow-up|6|||
155717991|NCT00982735|562061853|FG000|Overall Study|Patient ineligible for trial|224|||
155717992|NCT02898454|562061855|FG000|Overall Study|Adverse Event|4|||
155717993|NCT02898454|562061856|FG001|Overall Study|Adverse Event|1|||
155717994|NCT02898454|562061857|FG002|Overall Study|Adverse Event|2|||
155717995|NCT02898454|562061855|FG000|Overall Study|Protocol Violation|1|||
155717996|NCT02898454|562061856|FG001|Overall Study|Protocol Violation|0|||
155717997|NCT02898454|562061857|FG002|Overall Study|Protocol Violation|1|||
155717998|NCT02898454|562061855|FG000|Overall Study|Lack of Efficacy|4|||
155717999|NCT02898454|562061856|FG001|Overall Study|Lack of Efficacy|1|||
155718000|NCT02898454|562061857|FG002|Overall Study|Lack of Efficacy|0|||
155718001|NCT02898454|562061855|FG000|Overall Study|Withdrawal by Subject|6|||
155718002|NCT02898454|562061856|FG001|Overall Study|Withdrawal by Subject|3|||
155718003|NCT02898454|562061857|FG002|Overall Study|Withdrawal by Subject|3|||
155718004|NCT02898454|562061855|FG000|Overall Study|Lost to Follow-up|1|||
155718005|NCT02898454|562061856|FG001|Overall Study|Lost to Follow-up|0|||
155718006|NCT02898454|562061857|FG002|Overall Study|Lost to Follow-up|0|||
155718007|NCT02898454|562061855|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
155718008|NCT02898454|562061856|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
155718009|NCT02898454|562061857|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
155718010|NCT00689390|562061858|FG000|Overall Study|Adverse Event|19|||
155718011|NCT00689390|562061859|FG001|Overall Study|Adverse Event|0|||
155718012|NCT00689390|562061858|FG000|Overall Study|Lost to Follow-up|179|||
155718013|NCT00689390|562061859|FG001|Overall Study|Lost to Follow-up|7|||
155718014|NCT00689390|562061858|FG000|Overall Study|Withdrawal by Subject|117|||
155186061|NCT03583164|560121284|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
155186062|NCT03583164|560121284|FG000|Overall Study|Treatment failure in Main Phase|2|||
155186063|NCT03583164|560121284|FG000|Overall Study|Treatment failure in Extended Phase|4|||
155186064|NCT03583164|560121284|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
155186065|NCT03583164|560121284|FG000|Overall Study|Other not specified reason in Main Phase|2|||
155186066|NCT00214500|560121285|FG000|Treatment Period|Adverse Event|1|||
155186067|NCT00214500|560121285|FG000|Extension Period|Withdrawal by Subject|2|||
155186068|NCT02675231|560121294|FG000|Overall Study|Withdrawal by Subject|2|||
155186069|NCT02675231|560121295|FG001|Overall Study|Withdrawal by Subject|4|||
155186070|NCT02675231|560121296|FG002|Overall Study|Withdrawal by Subject|2|||
155186071|NCT02675231|560121294|FG000|Overall Study|Lost to Follow-up|3|||
155186072|NCT02675231|560121295|FG001|Overall Study|Lost to Follow-up|4|||
155186073|NCT02675231|560121296|FG002|Overall Study|Lost to Follow-up|3|||
155186074|NCT05323656|560121297|FG000|Overall Study|Still On-Treatment|6|||
155186075|NCT05323656|560121298|FG001|Overall Study|Still On-Treatment|6|||
155186076|NCT05323656|560121297|FG000|Overall Study|Progressive Disease|15|||
155186077|NCT05323656|560121298|FG001|Overall Study|Progressive Disease|14|||
155186078|NCT05323656|560121297|FG000|Overall Study|Adverse Event|2|||
155186079|NCT05323656|560121298|FG001|Overall Study|Adverse Event|3|||
155186080|NCT05323656|560121297|FG000|Overall Study|Death|1|||
155186081|NCT05323656|560121298|FG001|Overall Study|Death|2|||
155186082|NCT05323656|560121297|FG000|Overall Study|Withdrawal by Subject|1|||
155186083|NCT05323656|560121298|FG001|Overall Study|Withdrawal by Subject|0|||
155186084|NCT05323656|560121297|FG000|Overall Study|Clinical disease progression|0|||
155186085|NCT05323656|560121298|FG001|Overall Study|Clinical disease progression|1|||
155186086|NCT05323656|560121297|FG000|Overall Study|Patient and Investigator decision|1|||
155186087|NCT05323656|560121298|FG001|Overall Study|Patient and Investigator decision|0|||
155186088|NCT05323656|560121297|FG000|Overall Study|Physician Decision|0|||
155186089|NCT05323656|560121298|FG001|Overall Study|Physician Decision|1|||
155186090|NCT02495233|560121299|FG000|Overall Study|Miscellaneous|0|||
155186091|NCT02495233|560121300|FG001|Overall Study|Miscellaneous|1|||
155186092|NCT03880461|560121301|FG000|Overall Study|Determined ineligible after enrollment|45|||
155186093|NCT03880461|560121302|FG001|Overall Study|Determined ineligible after enrollment|44|||
155186094|NCT03880461|560121301|FG000|Overall Study|No weight measurement after enrollment|24|||
155186095|NCT03880461|560121302|FG001|Overall Study|No weight measurement after enrollment|17|||
155186096|NCT02652767|560121305|FG000|Overall Study|Death|2|||
155186097|NCT02652767|560121305|FG000|Overall Study|Lost to Follow-up|1|||
155186098|NCT02652767|560121305|FG000|Overall Study|Withdrawal by Subject|1|||
155186099|NCT00887744|560121316|FG000|Overall Study|Adverse Event|3|||
155186100|NCT00887744|560121316|FG000|Overall Study|Death|1|||
155186101|NCT00887744|560121316|FG000|Overall Study|Lost to Follow-up|3|||
155186102|NCT00887744|560121316|FG000|Overall Study|Withdrawal by Subject|18|||
155186103|NCT00887744|560121316|FG000|Overall Study|Various reasons|9|||
155186104|NCT01115803|560121317|FG000|Overall Study|Withdrawal by Subject|0|||
155186105|NCT01115803|560121318|FG001|Overall Study|Withdrawal by Subject|0|||
155186106|NCT01115803|560121319|FG002|Overall Study|Withdrawal by Subject|0|||
155186107|NCT01115803|560121320|FG003|Overall Study|Withdrawal by Subject|0|||
155186108|NCT01115803|560121321|FG004|Overall Study|Withdrawal by Subject|0|||
155186109|NCT01115803|560121322|FG005|Overall Study|Withdrawal by Subject|0|||
155186110|NCT01115803|560121323|FG006|Overall Study|Withdrawal by Subject|1|||
155186111|NCT01115803|560121317|FG000|Overall Study|Lost to Follow-up|0|||
155186112|NCT01115803|560121318|FG001|Overall Study|Lost to Follow-up|0|||
155186113|NCT01115803|560121319|FG002|Overall Study|Lost to Follow-up|1|||
155186114|NCT01115803|560121320|FG003|Overall Study|Lost to Follow-up|0|||
155186115|NCT01115803|560121321|FG004|Overall Study|Lost to Follow-up|0|||
155186116|NCT01115803|560121322|FG005|Overall Study|Lost to Follow-up|0|||
155186117|NCT01115803|560121323|FG006|Overall Study|Lost to Follow-up|0|||
155186118|NCT01115803|560121317|FG000|Overall Study|Progressive Disease during Cycle1|0|||
155186119|NCT01115803|560121318|FG001|Overall Study|Progressive Disease during Cycle1|0|||
155186120|NCT01115803|560121319|FG002|Overall Study|Progressive Disease during Cycle1|0|||
155186121|NCT01115803|560121320|FG003|Overall Study|Progressive Disease during Cycle1|0|||
155186122|NCT01115803|560121321|FG004|Overall Study|Progressive Disease during Cycle1|0|||
155186123|NCT01115803|560121322|FG005|Overall Study|Progressive Disease during Cycle1|0|||
155186124|NCT01115803|560121323|FG006|Overall Study|Progressive Disease during Cycle1|1|||
155186125|NCT03533686|560121324|FG000|Overall Study|Withdrawal by Subject|1|||
155186126|NCT03533686|560121325|FG001|Overall Study|Withdrawal by Subject|0|||
155186127|NCT03533686|560121326|FG002|Overall Study|Withdrawal by Subject|0|||
155186128|NCT03533686|560121327|FG003|Overall Study|Withdrawal by Subject|3|||
155186129|NCT03533686|560121328|FG004|Overall Study|Withdrawal by Subject|5|||
155186130|NCT03533686|560121329|FG005|Overall Study|Withdrawal by Subject|1|||
155186131|NCT03533686|560121324|FG000|Overall Study|Lost to Follow-up|0|||
155186132|NCT03533686|560121325|FG001|Overall Study|Lost to Follow-up|1|||
155186133|NCT03533686|560121326|FG002|Overall Study|Lost to Follow-up|0|||
155186134|NCT03533686|560121327|FG003|Overall Study|Lost to Follow-up|0|||
155186135|NCT03533686|560121328|FG004|Overall Study|Lost to Follow-up|2|||
155186136|NCT03533686|560121329|FG005|Overall Study|Lost to Follow-up|0|||
155186137|NCT03533686|560121324|FG000|Overall Study|Screen Failure|0|||
155186138|NCT03533686|560121325|FG001|Overall Study|Screen Failure|0|||
155186139|NCT03533686|560121326|FG002|Overall Study|Screen Failure|0|||
155186140|NCT03533686|560121327|FG003|Overall Study|Screen Failure|2|||
155186141|NCT03533686|560121328|FG004|Overall Study|Screen Failure|0|||
155186142|NCT03533686|560121329|FG005|Overall Study|Screen Failure|0|||
155186143|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
155186144|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
155186145|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
155186146|NCT02862600|560121331|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
155186147|NCT02961218|560121340|FG000|Overall Study|Lost to Follow-up|0|||
155186148|NCT02961218|560121341|FG001|Overall Study|Lost to Follow-up|2|||
155186149|NCT02961218|560121340|FG000|Overall Study|Physician Decision|0|||
155186150|NCT02961218|560121341|FG001|Overall Study|Physician Decision|2|||
155186151|NCT02961218|560121340|FG000|Overall Study|Subject/Guardian Decision|3|||
155186152|NCT02961218|560121341|FG001|Overall Study|Subject/Guardian Decision|1|||
155186153|NCT01462227|560121347|FG000|Second Assignment|Lost to Follow-up|1|||
155186154|NCT01462227|560121348|FG001|Second Assignment|Lost to Follow-up|0|||
155186155|NCT01462227|560121349|FG002|Second Assignment|Lost to Follow-up|0|||
155186156|NCT01462227|560121350|FG003|Second Assignment|Lost to Follow-up|0|||
155186157|NCT01462227|560121347|FG000|Second Assignment|Protocol Violation|0|||
155186158|NCT01462227|560121348|FG001|Second Assignment|Protocol Violation|1|||
155186159|NCT01462227|560121349|FG002|Second Assignment|Protocol Violation|1|||
155186160|NCT01462227|560121350|FG003|Second Assignment|Protocol Violation|0|||
155186161|NCT00901927|560121355|FG000|Overall Study|Lack of Efficacy|1|||
155186162|NCT00901927|560121355|FG000|Overall Study|Protocol Violation|3|||
155186163|NCT00901927|560121355|FG000|Overall Study|Withdrawal by Subject|2|||
155186164|NCT01702571|560121359|FG000|Overall Study|Death|1067|||
155186165|NCT01702571|560121360|FG001|Overall Study|Death|76|||
155186166|NCT01702571|560121359|FG000|Overall Study|Lost to Follow-up|144|||
155186167|NCT01702571|560121360|FG001|Overall Study|Lost to Follow-up|10|||
155186168|NCT01702571|560121359|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
155186169|NCT01702571|560121360|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
155186170|NCT01702571|560121359|FG000|Overall Study|Investigator Decision|5|||
155186171|NCT01702571|560121360|FG001|Overall Study|Investigator Decision|0|||
155186172|NCT01702571|560121359|FG000|Overall Study|Not Classifiable|1|||
155186173|NCT01702571|560121360|FG001|Overall Study|Not Classifiable|0|||
155186174|NCT01702571|560121359|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
155186175|NCT01702571|560121360|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
155186176|NCT01702571|560121359|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
155186177|NCT01702571|560121360|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
155186178|NCT01702571|560121359|FG000|Overall Study|Progressive Disease|3|||
155186179|NCT01702571|560121360|FG001|Overall Study|Progressive Disease|0|||
155186180|NCT01702571|560121359|FG000|Overall Study|Protocol Violation|2|||
155186181|NCT01702571|560121360|FG001|Overall Study|Protocol Violation|0|||
155186182|NCT01702571|560121359|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
155186183|NCT01702571|560121360|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
155186184|NCT01702571|560121359|FG000|Overall Study|Termination By Sponsor|4|||
155186185|NCT01702571|560121360|FG001|Overall Study|Termination By Sponsor|0|||
155718015|NCT00689390|562061859|FG001|Overall Study|Withdrawal by Subject|3|||
155718016|NCT00689390|562061858|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
155718017|NCT00689390|562061859|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
155718018|NCT00689390|562061858|FG000|Overall Study|Non-Compliance With Protocol|21|||
155718019|NCT00689390|562061859|FG001|Overall Study|Non-Compliance With Protocol|0|||
155718020|NCT00689390|562061858|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155718021|NCT00689390|562061859|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155718022|NCT00689390|562061858|FG000|Overall Study|Administrative|37|||
155186186|NCT01702571|560121359|FG000|Overall Study|Withdrawal by Subject|177|||
155186187|NCT01702571|560121360|FG001|Overall Study|Withdrawal by Subject|29|||
155186188|NCT00828854|560121361|FG000|Overall Study|Disease Progression|17|||
155186189|NCT00828854|560121361|FG000|Overall Study|Adverse Event|9|||
155186190|NCT00828854|560121361|FG000|Overall Study|Reason not Specified|1|||
155186191|NCT04221230|560121362|FG000|Overall Study|Lost to Follow-up|12|||
155186192|NCT04221230|560121363|FG001|Overall Study|Lost to Follow-up|12|||
155186193|NCT04221230|560121362|FG000|Overall Study|Protocol Violation|2|||
155186194|NCT04221230|560121363|FG001|Overall Study|Protocol Violation|2|||
155186195|NCT04221230|560121362|FG000|Overall Study|Adverse Event|0|||
155186196|NCT04221230|560121363|FG001|Overall Study|Adverse Event|8|||
155186197|NCT04221230|560121362|FG000|Overall Study|Physician Decision|1|||
155186198|NCT04221230|560121363|FG001|Overall Study|Physician Decision|0|||
155186199|NCT04221230|560121362|FG000|Overall Study|Withdrawal by Subject|13|||
155186200|NCT04221230|560121363|FG001|Overall Study|Withdrawal by Subject|11|||
155186201|NCT04221230|560121362|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155186202|NCT04221230|560121363|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155186203|NCT04221230|560121362|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155186204|NCT04221230|560121363|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155186205|NCT04221230|560121362|FG000|Overall Study|Pregnancy|0|||
155186206|NCT04221230|560121363|FG001|Overall Study|Pregnancy|1|||
155186207|NCT04221230|560121362|FG000|Overall Study|Other|1|||
155186208|NCT04221230|560121363|FG001|Overall Study|Other|2|||
155186209|NCT00915356|560121364|FG000|Overall Study|Withdrawal by Subject|1|||
155186210|NCT00915356|560121365|FG001|Overall Study|Withdrawal by Subject|0|||
155186211|NCT00915356|560121366|FG002|Overall Study|Withdrawal by Subject|0|||
155186212|NCT00915356|560121367|FG003|Overall Study|Withdrawal by Subject|0|||
155186213|NCT00915356|560121368|FG004|Overall Study|Withdrawal by Subject|0|||
155186214|NCT00191646|560121370|FG000|Overall Study|Toxicity|26|||
155186215|NCT00191646|560121371|FG001|Overall Study|Toxicity|37|||
155186216|NCT00191646|560121370|FG000|Overall Study|Disease Progression|5|||
155186217|NCT00191646|560121371|FG001|Overall Study|Disease Progression|6|||
155186218|NCT00191646|560121370|FG000|Overall Study|Physician Decision|20|||
155186219|NCT00191646|560121371|FG001|Overall Study|Physician Decision|11|||
155186220|NCT00191646|560121370|FG000|Overall Study|Withdrawal by Subject|58|||
155186221|NCT00191646|560121371|FG001|Overall Study|Withdrawal by Subject|39|||
155186222|NCT00191646|560121370|FG000|Overall Study|Protocol Violation|5|||
155186223|NCT00191646|560121371|FG001|Overall Study|Protocol Violation|7|||
155186224|NCT00191646|560121370|FG000|Overall Study|Death|6|||
155186225|NCT00191646|560121371|FG001|Overall Study|Death|8|||
155186226|NCT00191646|560121370|FG000|Overall Study|Other|33|||
155186227|NCT00191646|560121371|FG001|Overall Study|Other|34|||
155186228|NCT00191646|560121370|FG000|Overall Study|Missing Data|18|||
155186229|NCT00191646|560121371|FG001|Overall Study|Missing Data|11|||
155186230|NCT05211284|560121380|FG000|Overall Study|Study Terminated|3|||
155186231|NCT05211284|560121381|FG001|Overall Study|Study Terminated|1|||
155186232|NCT03194490|560121383|FG000|Overall Study|Lost to Follow-up|1|||
155186233|NCT03194490|560121384|FG001|Overall Study|Lost to Follow-up|3|||
155186234|NCT03194490|560121383|FG000|Overall Study|participant developed specific neck pain|1|||
155186235|NCT03194490|560121384|FG001|Overall Study|participant developed specific neck pain|0|||
155186236|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
155186237|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
155186238|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
155186239|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
155186240|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
155186241|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
155186242|NCT01505647|560121385|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
155718023|NCT00689390|562061859|FG001|Overall Study|Administrative|0|||
155718024|NCT02343263|562061860|FG000|Overall Study|Physician Decision|5|||
155718025|NCT02343263|562061861|FG001|Overall Study|Physician Decision|3|||
155186243|NCT01505647|560121386|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
155186244|NCT01505647|560121385|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
155718026|NCT02343263|562061862|FG002|Overall Study|Physician Decision|1|||
155718027|NCT03040141|562061865|FG000|Overall Study|Death|1|||
155718028|NCT03040141|562061866|FG001|Overall Study|Death|2|||
155718029|NCT03040141|562061867|FG002|Overall Study|Death|3|||
155718030|NCT03040141|562061865|FG000|Overall Study|Withdrawal by Subject|3|||
155718031|NCT03040141|562061866|FG001|Overall Study|Withdrawal by Subject|1|||
155718032|NCT03040141|562061867|FG002|Overall Study|Withdrawal by Subject|1|||
155718033|NCT03040141|562061865|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
155718034|NCT03040141|562061866|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
155718035|NCT03040141|562061867|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
155718036|NCT03040141|562061865|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
155718037|NCT03040141|562061866|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
155718038|NCT03040141|562061867|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
155718039|NCT01384734|562061870|FG000|Overall Study|Adverse Event|0|||
155718040|NCT01384734|562061871|FG001|Overall Study|Adverse Event|3|||
155718041|NCT01384734|562061872|FG002|Overall Study|Adverse Event|0|||
155718042|NCT01384734|562061873|FG003|Overall Study|Adverse Event|2|||
155718043|NCT01384734|562061874|FG004|Overall Study|Adverse Event|7|||
155718044|NCT01384734|562061870|FG000|Overall Study|Death|1|||
155718045|NCT01384734|562061871|FG001|Overall Study|Death|0|||
155718046|NCT01384734|562061872|FG002|Overall Study|Death|1|||
155718047|NCT01384734|562061873|FG003|Overall Study|Death|0|||
155718048|NCT01384734|562061874|FG004|Overall Study|Death|0|||
155718049|NCT01384734|562061870|FG000|Overall Study|Continuation criteria not met|0|||
155718050|NCT01384734|562061871|FG001|Overall Study|Continuation criteria not met|0|||
155718051|NCT01384734|562061872|FG002|Overall Study|Continuation criteria not met|1|||
155718052|NCT01384734|562061873|FG003|Overall Study|Continuation criteria not met|1|||
155718053|NCT01384734|562061874|FG004|Overall Study|Continuation criteria not met|0|||
155718054|NCT01384734|562061870|FG000|Overall Study|Lack of Efficacy|3|||
155718055|NCT01384734|562061871|FG001|Overall Study|Lack of Efficacy|7|||
155718056|NCT01384734|562061872|FG002|Overall Study|Lack of Efficacy|4|||
155718057|NCT01384734|562061873|FG003|Overall Study|Lack of Efficacy|4|||
155718058|NCT01384734|562061874|FG004|Overall Study|Lack of Efficacy|2|||
155718059|NCT01384734|562061870|FG000|Overall Study|Lost to Follow-up|5|||
155718060|NCT01384734|562061871|FG001|Overall Study|Lost to Follow-up|3|||
155718061|NCT01384734|562061872|FG002|Overall Study|Lost to Follow-up|3|||
155718062|NCT01384734|562061873|FG003|Overall Study|Lost to Follow-up|8|||
155718063|NCT01384734|562061874|FG004|Overall Study|Lost to Follow-up|5|||
155718064|NCT01384734|562061870|FG000|Overall Study|Non-compliance with study drug|1|||
155718065|NCT01384734|562061871|FG001|Overall Study|Non-compliance with study drug|2|||
155718066|NCT01384734|562061872|FG002|Overall Study|Non-compliance with study drug|6|||
155718067|NCT01384734|562061873|FG003|Overall Study|Non-compliance with study drug|0|||
155718068|NCT01384734|562061874|FG004|Overall Study|Non-compliance with study drug|2|||
155718069|NCT01384734|562061870|FG000|Overall Study|Pregnancy|0|||
155718070|NCT01384734|562061871|FG001|Overall Study|Pregnancy|1|||
155718071|NCT01384734|562061872|FG002|Overall Study|Pregnancy|0|||
155718072|NCT01384734|562061873|FG003|Overall Study|Pregnancy|0|||
155718073|NCT01384734|562061874|FG004|Overall Study|Pregnancy|1|||
155718074|NCT01384734|562061870|FG000|Overall Study|Sponsor terminated|0|||
155718075|NCT01384734|562061871|FG001|Overall Study|Sponsor terminated|0|||
155718076|NCT01384734|562061872|FG002|Overall Study|Sponsor terminated|0|||
155718077|NCT01384734|562061873|FG003|Overall Study|Sponsor terminated|0|||
155718078|NCT01384734|562061874|FG004|Overall Study|Sponsor terminated|1|||
155718079|NCT01384734|562061870|FG000|Overall Study|Withdrawal by Subject|5|||
155718080|NCT01384734|562061871|FG001|Overall Study|Withdrawal by Subject|5|||
155718081|NCT01384734|562061872|FG002|Overall Study|Withdrawal by Subject|6|||
155718082|NCT01384734|562061873|FG003|Overall Study|Withdrawal by Subject|7|||
155718083|NCT01384734|562061874|FG004|Overall Study|Withdrawal by Subject|9|||
155718084|NCT01384734|562061870|FG000|Overall Study|Investigator relocating|0|||
155718085|NCT01384734|562061871|FG001|Overall Study|Investigator relocating|2|||
155718086|NCT01384734|562061872|FG002|Overall Study|Investigator relocating|0|||
155718087|NCT01384734|562061873|FG003|Overall Study|Investigator relocating|3|||
155718088|NCT01384734|562061874|FG004|Overall Study|Investigator relocating|1|||
155718089|NCT01384734|562061870|FG000|Overall Study|Unable to come back for visit|1|||
155718090|NCT01384734|562061871|FG001|Overall Study|Unable to come back for visit|0|||
155718091|NCT01384734|562061872|FG002|Overall Study|Unable to come back for visit|1|||
155718092|NCT01384734|562061873|FG003|Overall Study|Unable to come back for visit|1|||
155718093|NCT01384734|562061874|FG004|Overall Study|Unable to come back for visit|0|||
155718094|NCT01384734|562061870|FG000|Overall Study|Prison|0|||
155718095|NCT01384734|562061871|FG001|Overall Study|Prison|0|||
155718096|NCT01384734|562061872|FG002|Overall Study|Prison|1|||
155718097|NCT01384734|562061873|FG003|Overall Study|Prison|0|||
155718098|NCT01384734|562061874|FG004|Overall Study|Prison|0|||
155718099|NCT01384734|562061870|FG000|Overall Study|As per Exclusion criteria|0|||
155718100|NCT01384734|562061871|FG001|Overall Study|As per Exclusion criteria|1|||
155718101|NCT01384734|562061872|FG002|Overall Study|As per Exclusion criteria|0|||
155718102|NCT01384734|562061873|FG003|Overall Study|As per Exclusion criteria|0|||
155718103|NCT01384734|562061874|FG004|Overall Study|As per Exclusion criteria|0|||
155718104|NCT01384734|562061870|FG000|Overall Study|Missed End of treatment visit|0|||
155186245|NCT01505647|560121386|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
155186246|NCT01574079|560121387|FG000|Overall Study|Physician Decision|0|||
155186247|NCT01574079|560121388|FG001|Overall Study|Physician Decision|2|||
155186248|NCT01574079|560121387|FG000|Overall Study|Lost to Follow-up|1|||
155186249|NCT01574079|560121388|FG001|Overall Study|Lost to Follow-up|0|||
155186250|NCT03640559|560121392|FG000|Overall Study|Physician Decision|1|||
155186251|NCT03640559|560121393|FG001|Overall Study|Physician Decision|1|||
155186252|NCT03640559|560121392|FG000|Overall Study|Withdrawal by Subject|1|||
155186253|NCT03640559|560121393|FG001|Overall Study|Withdrawal by Subject|0|||
155186254|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
155186255|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
155186256|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
155186257|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
155186258|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
155186259|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
155186260|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
155186261|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
155186262|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
155186263|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
155186264|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
155186265|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
155186266|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
155186267|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155186268|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155186269|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Other|107|||
155186270|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Other|0|||
155186271|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Other|0|||
155186272|NCT01436162|560121394|FG000|Randomized Phase|Adverse Event|1|||
155186273|NCT01436162|560121395|FG001|Randomized Phase|Adverse Event|5|||
155186274|NCT01436162|560121396|FG002|Randomized Phase|Adverse Event|6|||
155186275|NCT01436162|560121394|FG000|Randomized Phase|Protocol Violation|4|||
155186276|NCT01436162|560121395|FG001|Randomized Phase|Protocol Violation|4|||
155186277|NCT01436162|560121396|FG002|Randomized Phase|Protocol Violation|2|||
155186278|NCT01436162|560121394|FG000|Randomized Phase|Withdrawal by Subject|16|||
155186279|NCT01436162|560121395|FG001|Randomized Phase|Withdrawal by Subject|9|||
155186280|NCT01436162|560121396|FG002|Randomized Phase|Withdrawal by Subject|8|||
155186281|NCT01436162|560121394|FG000|Randomized Phase|Lost to Follow-up|17|||
155186282|NCT01436162|560121395|FG001|Randomized Phase|Lost to Follow-up|5|||
155186283|NCT01436162|560121396|FG002|Randomized Phase|Lost to Follow-up|4|||
155186284|NCT01436162|560121394|FG000|Randomized Phase|Lack of Efficacy|0|||
155718105|NCT01384734|562061871|FG001|Overall Study|Missed End of treatment visit|0|||
155718106|NCT01384734|562061872|FG002|Overall Study|Missed End of treatment visit|0|||
155718107|NCT01384734|562061873|FG003|Overall Study|Missed End of treatment visit|1|||
155718108|NCT01384734|562061874|FG004|Overall Study|Missed End of treatment visit|0|||
155718109|NCT01384734|562061870|FG000|Overall Study|Adhesion problem|0|||
155718110|NCT01384734|562061871|FG001|Overall Study|Adhesion problem|0|||
155718111|NCT01384734|562061872|FG002|Overall Study|Adhesion problem|0|||
155718112|NCT01384734|562061873|FG003|Overall Study|Adhesion problem|1|||
155718113|NCT01384734|562061874|FG004|Overall Study|Adhesion problem|0|||
155718114|NCT01384734|562061870|FG000|Overall Study|Early termination|0|||
155718115|NCT01384734|562061871|FG001|Overall Study|Early termination|0|||
155718116|NCT01384734|562061872|FG002|Overall Study|Early termination|0|||
155718117|NCT01384734|562061873|FG003|Overall Study|Early termination|0|||
155718118|NCT01384734|562061874|FG004|Overall Study|Early termination|1|||
155718119|NCT01384734|562061870|FG000|Overall Study|Physician Decision|1|||
155718120|NCT01384734|562061871|FG001|Overall Study|Physician Decision|0|||
155718121|NCT01384734|562061872|FG002|Overall Study|Physician Decision|0|||
155718122|NCT01384734|562061873|FG003|Overall Study|Physician Decision|0|||
155718123|NCT01384734|562061874|FG004|Overall Study|Physician Decision|0|||
155718124|NCT02922725|562061875|FG000|Overall Study|Withdrawal by Subject|1|||
155718125|NCT02922725|562061876|FG001|Overall Study|Withdrawal by Subject|0|||
155718126|NCT02922725|562061877|FG002|Overall Study|Withdrawal by Subject|0|||
155718127|NCT01300234|562061878|FG000|Overall Study|Adverse Event|1|||
155718128|NCT01300234|562061879|FG001|Overall Study|Adverse Event|1|||
155718129|NCT01300234|562061878|FG000|Overall Study|Protocol Violation|2|||
155718130|NCT01300234|562061879|FG001|Overall Study|Protocol Violation|3|||
155718131|NCT01300234|562061878|FG000|Overall Study|Withdrawal by Subject|5|||
155718132|NCT01300234|562061879|FG001|Overall Study|Withdrawal by Subject|9|||
155718133|NCT01300234|562061878|FG000|Overall Study|Lost to Follow-up|14|||
155718134|NCT01300234|562061879|FG001|Overall Study|Lost to Follow-up|12|||
155718135|NCT01300234|562061878|FG000|Overall Study|Pregnancy|2|||
155718136|NCT01300234|562061879|FG001|Overall Study|Pregnancy|1|||
155718137|NCT01300234|562061878|FG000|Overall Study|Participant reached stopping critera|2|||
155718138|NCT01300234|562061879|FG001|Overall Study|Participant reached stopping critera|0|||
155718139|NCT01300234|562061878|FG000|Overall Study|Participant stopped medication|1|||
155718140|NCT01300234|562061879|FG001|Overall Study|Participant stopped medication|1|||
155718141|NCT01300234|562061878|FG000|Overall Study|Participant refused return to hospital|1|||
155718142|NCT01300234|562061879|FG001|Overall Study|Participant refused return to hospital|0|||
155718143|NCT04612725|562061881|FG000|Overall Study|Adverse Event|1|||
155718144|NCT04612725|562061882|FG001|Overall Study|Adverse Event|3|||
155718145|NCT04612725|562061883|FG002|Overall Study|Adverse Event|1|||
155718146|NCT04612725|562061884|FG003|Overall Study|Adverse Event|0|||
155718147|NCT04612725|562061885|FG004|Overall Study|Adverse Event|1|||
155718148|NCT04612725|562061881|FG000|Overall Study|Lost to Follow-up|0|||
155718149|NCT04612725|562061882|FG001|Overall Study|Lost to Follow-up|1|||
155718150|NCT04612725|562061883|FG002|Overall Study|Lost to Follow-up|0|||
155718151|NCT04612725|562061884|FG003|Overall Study|Lost to Follow-up|0|||
155718152|NCT04612725|562061885|FG004|Overall Study|Lost to Follow-up|0|||
155718153|NCT04612725|562061881|FG000|Overall Study|Physician Decision|2|||
155718154|NCT04612725|562061882|FG001|Overall Study|Physician Decision|0|||
155718155|NCT04612725|562061883|FG002|Overall Study|Physician Decision|0|||
155718156|NCT04612725|562061884|FG003|Overall Study|Physician Decision|0|||
155718157|NCT04612725|562061885|FG004|Overall Study|Physician Decision|0|||
155718158|NCT04612725|562061881|FG000|Overall Study|Study terminated by sponsor|3|||
155718159|NCT04612725|562061882|FG001|Overall Study|Study terminated by sponsor|1|||
155718160|NCT04612725|562061883|FG002|Overall Study|Study terminated by sponsor|2|||
155718161|NCT04612725|562061884|FG003|Overall Study|Study terminated by sponsor|4|||
155718162|NCT04612725|562061885|FG004|Overall Study|Study terminated by sponsor|5|||
155718163|NCT04612725|562061881|FG000|Overall Study|Withdrawal by Subject|8|||
155718164|NCT04612725|562061882|FG001|Overall Study|Withdrawal by Subject|3|||
155718165|NCT04612725|562061883|FG002|Overall Study|Withdrawal by Subject|5|||
155718166|NCT04612725|562061884|FG003|Overall Study|Withdrawal by Subject|1|||
155718167|NCT04612725|562061885|FG004|Overall Study|Withdrawal by Subject|9|||
155718168|NCT04612725|562061881|FG000|Overall Study|Other|0|||
155718169|NCT04612725|562061882|FG001|Overall Study|Other|0|||
155718170|NCT04612725|562061883|FG002|Overall Study|Other|0|||
155718171|NCT04612725|562061884|FG003|Overall Study|Other|0|||
155718172|NCT04612725|562061885|FG004|Overall Study|Other|1|||
155718173|NCT01928927|562061886|FG000|Overall Study|Lost to Follow-up|1|||
155718174|NCT01928927|562061887|FG001|Overall Study|Lost to Follow-up|0|||
155718175|NCT01928927|562061886|FG000|Overall Study|Withdrawal by Subject|1|||
155718176|NCT01928927|562061887|FG001|Overall Study|Withdrawal by Subject|1|||
155718177|NCT02775916|562061888|FG000|Overall Study|Adverse Event|1|||
155718178|NCT02775916|562061889|FG001|Overall Study|Adverse Event|0|||
155718179|NCT02775916|562061888|FG000|Overall Study|Subject/Guardian Decision|2|||
155718180|NCT02775916|562061889|FG001|Overall Study|Subject/Guardian Decision|0|||
155718181|NCT00948064|562063382|FG000|Phase I|No treatment received|1|||
155718182|NCT00948064|562063383|FG001|Phase I|No treatment received|0|||
155718183|NCT00948064|562063384|FG002|Phase I|No treatment received|0|||
155718184|NCT00948064|562063382|FG000|Phase II|Physician Decision|0|||
155718185|NCT00948064|562063383|FG001|Phase II|Physician Decision|0|||
155718186|NCT00948064|562063384|FG002|Phase II|Physician Decision|1|||
155718187|NCT00948064|562063382|FG000|Phase II|Withdrawal by Subject|0|||
155718188|NCT00948064|562063383|FG001|Phase II|Withdrawal by Subject|1|||
155718189|NCT00948064|562063384|FG002|Phase II|Withdrawal by Subject|0|||
155718190|NCT00179621|562063385|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
155718191|NCT00179621|562063386|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
155718192|NCT00179621|562063387|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
155718193|NCT00179621|562063388|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
155718194|NCT00179621|562063385|FG000|Double-Blind Period|Adverse Event|2|||
155718195|NCT00179621|562063386|FG001|Double-Blind Period|Adverse Event|7|||
155718196|NCT00179621|562063387|FG002|Double-Blind Period|Adverse Event|4|||
155718197|NCT00179621|562063388|FG003|Double-Blind Period|Adverse Event|0|||
155718198|NCT00179621|562063385|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155718199|NCT00179621|562063386|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155718200|NCT00179621|562063387|FG002|Double-Blind Period|Withdrawal by Subject|3|||
155718201|NCT00179621|562063388|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155718202|NCT00179621|562063385|FG000|Double-Blind Period|Death|0|||
155718203|NCT00179621|562063386|FG001|Double-Blind Period|Death|1|||
155718204|NCT00179621|562063387|FG002|Double-Blind Period|Death|2|||
155718205|NCT00179621|562063388|FG003|Double-Blind Period|Death|0|||
155718206|NCT00179621|562063385|FG000|Double-Blind Period|Protocol Violation|1|||
155718207|NCT00179621|562063386|FG001|Double-Blind Period|Protocol Violation|0|||
155718208|NCT00179621|562063387|FG002|Double-Blind Period|Protocol Violation|0|||
155718209|NCT00179621|562063388|FG003|Double-Blind Period|Protocol Violation|0|||
155718210|NCT00179621|562063385|FG000|Double-Blind Period|Other|0|||
155718211|NCT00179621|562063386|FG001|Double-Blind Period|Other|2|||
155718212|NCT00179621|562063387|FG002|Double-Blind Period|Other|2|||
155718213|NCT00179621|562063388|FG003|Double-Blind Period|Other|0|||
155718214|NCT00179621|562063385|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
155718215|NCT00179621|562063386|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
155718216|NCT00179621|562063387|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
155718217|NCT00179621|562063388|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
155718218|NCT00179621|562063385|FG000|Open-Label Period|Adverse Event|0|||
155718219|NCT00179621|562063386|FG001|Open-Label Period|Adverse Event|6|||
155718220|NCT00179621|562063387|FG002|Open-Label Period|Adverse Event|5|||
155718221|NCT00179621|562063388|FG003|Open-Label Period|Adverse Event|6|||
155718222|NCT00179621|562063385|FG000|Open-Label Period|Withdrawal by Subject|0|||
155718223|NCT00179621|562063386|FG001|Open-Label Period|Withdrawal by Subject|2|||
155718224|NCT00179621|562063387|FG002|Open-Label Period|Withdrawal by Subject|2|||
155718225|NCT00179621|562063388|FG003|Open-Label Period|Withdrawal by Subject|2|||
155718226|NCT00179621|562063385|FG000|Open-Label Period|Death|0|||
155718227|NCT00179621|562063386|FG001|Open-Label Period|Death|0|||
155186285|NCT01436162|560121395|FG001|Randomized Phase|Lack of Efficacy|1|||
155186286|NCT01436162|560121396|FG002|Randomized Phase|Lack of Efficacy|1|||
155186287|NCT01436162|560121394|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
155186288|NCT01436162|560121395|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
155186289|NCT01436162|560121396|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155186290|NCT01436162|560121394|FG000|Randomized Phase|Other|2|||
155186291|NCT01436162|560121395|FG001|Randomized Phase|Other|5|||
155186292|NCT01436162|560121396|FG002|Randomized Phase|Other|4|||
155186293|NCT02750943|560121399|FG000|Overall Study|Lost to Follow-up|1|||
155186294|NCT02750943|560121400|FG001|Overall Study|Lost to Follow-up|2|||
155186295|NCT02750943|560121399|FG000|Overall Study|Withdrawal by Subject|5|||
155186296|NCT02750943|560121400|FG001|Overall Study|Withdrawal by Subject|7|||
155186297|NCT04597918|560121401|FG000|Overall Study|Withdrawal by Subject|6|||
155186298|NCT04597918|560121401|FG000|Overall Study|Lost to Follow-up|3|||
155186299|NCT04597918|560121401|FG000|Overall Study|Death|1|||
155186300|NCT05140382|560121402|FG000|Overall Study|Death|3|||
155186301|NCT05140382|560121403|FG001|Overall Study|Death|0|||
155186302|NCT05140382|560121404|FG002|Overall Study|Death|0|||
155186303|NCT05140382|560121402|FG000|Overall Study|Investigator decision|1|||
155186304|NCT05140382|560121403|FG001|Overall Study|Investigator decision|0|||
155186305|NCT05140382|560121404|FG002|Overall Study|Investigator decision|0|||
155186306|NCT05140382|560121402|FG000|Overall Study|Other|4|||
155186307|NCT05140382|560121403|FG001|Overall Study|Other|0|||
155186308|NCT05140382|560121404|FG002|Overall Study|Other|1|||
155186309|NCT05140382|560121402|FG000|Overall Study|Progressive disease|20|||
155186310|NCT05140382|560121403|FG001|Overall Study|Progressive disease|1|||
155186311|NCT05140382|560121404|FG002|Overall Study|Progressive disease|12|||
155186312|NCT05140382|560121402|FG000|Overall Study|Subjective disease progression|2|||
155186313|NCT05140382|560121403|FG001|Overall Study|Subjective disease progression|1|||
155186314|NCT05140382|560121404|FG002|Overall Study|Subjective disease progression|0|||
155186315|NCT05140382|560121402|FG000|Overall Study|Unknown at data cut-off|0|||
155186316|NCT05140382|560121403|FG001|Overall Study|Unknown at data cut-off|0|||
155186317|NCT05140382|560121404|FG002|Overall Study|Unknown at data cut-off|1|||
155186318|NCT05140382|560121402|FG000|Overall Study|Withdrawal by Subject|1|||
155718228|NCT00179621|562063387|FG002|Open-Label Period|Death|1|||
155718229|NCT00179621|562063388|FG003|Open-Label Period|Death|2|||
155718230|NCT00179621|562063385|FG000|Open-Label Period|Other|0|||
155718231|NCT00179621|562063386|FG001|Open-Label Period|Other|1|||
155718232|NCT00179621|562063387|FG002|Open-Label Period|Other|1|||
155718233|NCT00179621|562063388|FG003|Open-Label Period|Other|2|||
155718234|NCT02973100|562063389|FG000|Overall Study|Adverse Event|1|||
155718235|NCT02973100|562063390|FG001|Overall Study|Adverse Event|2|||
155718236|NCT02973100|562063391|FG002|Overall Study|Adverse Event|1|||
155718237|NCT02973100|562063392|FG003|Overall Study|Adverse Event|2|||
155718238|NCT02973100|562063389|FG000|Overall Study|Lost to Follow-up|3|||
155718239|NCT02973100|562063390|FG001|Overall Study|Lost to Follow-up|1|||
155718240|NCT02973100|562063391|FG002|Overall Study|Lost to Follow-up|1|||
155718241|NCT02973100|562063392|FG003|Overall Study|Lost to Follow-up|0|||
155718242|NCT02973100|562063389|FG000|Overall Study|Withdrawal by Subject|3|||
155718243|NCT02973100|562063390|FG001|Overall Study|Withdrawal by Subject|5|||
155718244|NCT02973100|562063391|FG002|Overall Study|Withdrawal by Subject|1|||
155718245|NCT02973100|562063392|FG003|Overall Study|Withdrawal by Subject|4|||
155718246|NCT02973100|562063389|FG000|Overall Study|Notification of change in address|0|||
155718247|NCT02973100|562063390|FG001|Overall Study|Notification of change in address|0|||
155718248|NCT02973100|562063391|FG002|Overall Study|Notification of change in address|0|||
155718249|NCT02973100|562063392|FG003|Overall Study|Notification of change in address|1|||
155718250|NCT02973100|562063389|FG000|Overall Study|Failed to attend Safety followup period|0|||
155718251|NCT02973100|562063390|FG001|Overall Study|Failed to attend Safety followup period|0|||
155718252|NCT02973100|562063391|FG002|Overall Study|Failed to attend Safety followup period|1|||
155718253|NCT02973100|562063392|FG003|Overall Study|Failed to attend Safety followup period|0|||
155718254|NCT01393158|562063394|FG000|Overall Study|Adverse Event|1|||
155718255|NCT01393158|562063395|FG001|Overall Study|Adverse Event|0|||
155718256|NCT04233801|562063397|FG000|Overall Study|Other than listed|0|||
155718257|NCT04233801|562063398|FG001|Overall Study|Other than listed|0|||
155718258|NCT04233801|562063399|FG002|Overall Study|Other than listed|1|||
155718259|NCT04233801|562063397|FG000|Overall Study|Withdrawal by Subject|0|||
155718260|NCT04233801|562063398|FG001|Overall Study|Withdrawal by Subject|2|||
155718261|NCT04233801|562063399|FG002|Overall Study|Withdrawal by Subject|3|||
155718262|NCT01690052|562063404|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
155718263|NCT01690052|562063405|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
155718264|NCT01453049|562063406|FG000|Overall Study|Protocol Violation|2|||
155718265|NCT01453049|562063407|FG001|Overall Study|Protocol Violation|5|||
155718266|NCT01453049|562063406|FG000|Overall Study|Lost to Follow-up|2|||
155718267|NCT01453049|562063407|FG001|Overall Study|Lost to Follow-up|1|||
155718268|NCT01453049|562063406|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
155718269|NCT01453049|562063407|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
155718270|NCT01453049|562063406|FG000|Overall Study|Withdrawal by Subject|1|||
155718271|NCT01453049|562063407|FG001|Overall Study|Withdrawal by Subject|0|||
155718272|NCT01453049|562063406|FG000|Overall Study|Randomized in Error|1|||
155718273|NCT01453049|562063407|FG001|Overall Study|Randomized in Error|0|||
155718274|NCT02421172|562063408|FG000|Period 1|Adverse Event|1|||
155718275|NCT02421172|562063409|FG001|Period 1|Adverse Event|0|||
155718276|NCT02421172|562063410|FG002|Period 1|Adverse Event|0|||
155186319|NCT05140382|560121403|FG001|Overall Study|Withdrawal by Subject|0|||
155186320|NCT05140382|560121404|FG002|Overall Study|Withdrawal by Subject|4|||
155186321|NCT05140382|560121402|FG000|Overall Study|Withdrawal of consent|0|||
155186322|NCT05140382|560121403|FG001|Overall Study|Withdrawal of consent|0|||
155186323|NCT05140382|560121404|FG002|Overall Study|Withdrawal of consent|1|||
155186324|NCT05419908|560121406|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
155186325|NCT05419908|560121407|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
155186326|NCT05419908|560121406|FG000|Overall Study|Serious Adverse Event|0|||
155186327|NCT05419908|560121407|FG001|Overall Study|Serious Adverse Event|2|||
155186328|NCT05419908|560121406|FG000|Overall Study|Withdrawal by Subject|2|||
155186329|NCT05419908|560121407|FG001|Overall Study|Withdrawal by Subject|0|||
155186330|NCT05419908|560121406|FG000|Overall Study|Miscellaneous|1|||
155186331|NCT05419908|560121407|FG001|Overall Study|Miscellaneous|1|||
155186332|NCT03670836|560121408|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
155186333|NCT03670836|560121409|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
155186334|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Physician Decision|9|||
155186335|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Physician Decision|10|||
155186336|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Physician Decision|4|||
155186337|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Physician Decision|6|||
155186338|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
155718277|NCT02421172|562063411|FG003|Period 1|Adverse Event|0|||
155718278|NCT02421172|562063412|FG004|Period 1|Adverse Event|0|||
155718279|NCT02421172|562063408|FG000|Period 1|Lost to Follow-up|3|||
155718280|NCT02421172|562063409|FG001|Period 1|Lost to Follow-up|1|||
155718281|NCT02421172|562063410|FG002|Period 1|Lost to Follow-up|0|||
155718282|NCT02421172|562063411|FG003|Period 1|Lost to Follow-up|0|||
155718283|NCT02421172|562063412|FG004|Period 1|Lost to Follow-up|0|||
155186339|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
155718284|NCT02421172|562063408|FG000|Period 1|Patient/guardian decision|0|||
155718285|NCT02421172|562063409|FG001|Period 1|Patient/guardian decision|1|||
155718286|NCT02421172|562063410|FG002|Period 1|Patient/guardian decision|0|||
155718287|NCT02421172|562063411|FG003|Period 1|Patient/guardian decision|0|||
155718288|NCT02421172|562063412|FG004|Period 1|Patient/guardian decision|0|||
155718289|NCT02421172|562063408|FG000|Period 2|Adverse Event|0|||
155718290|NCT02421172|562063409|FG001|Period 2|Adverse Event|0|||
155718291|NCT02421172|562063410|FG002|Period 2|Adverse Event|4|||
155718292|NCT02421172|562063411|FG003|Period 2|Adverse Event|0|||
155718293|NCT02421172|562063412|FG004|Period 2|Adverse Event|0|||
155718294|NCT02421172|562063408|FG000|Period 2|Lost to Follow-up|0|||
155718295|NCT02421172|562063409|FG001|Period 2|Lost to Follow-up|0|||
155718296|NCT02421172|562063410|FG002|Period 2|Lost to Follow-up|0|||
155718297|NCT02421172|562063411|FG003|Period 2|Lost to Follow-up|1|||
155718298|NCT02421172|562063412|FG004|Period 2|Lost to Follow-up|0|||
155718299|NCT02421172|562063408|FG000|Period 2|Patient/guardian decision|0|||
155718300|NCT02421172|562063409|FG001|Period 2|Patient/guardian decision|0|||
155718301|NCT02421172|562063410|FG002|Period 2|Patient/guardian decision|3|||
155718302|NCT02421172|562063411|FG003|Period 2|Patient/guardian decision|2|||
155718303|NCT02421172|562063412|FG004|Period 2|Patient/guardian decision|1|||
155718304|NCT00928486|562063413|FG000|Overall Study|Adverse Event|2|||
155718305|NCT00928486|562063413|FG000|Overall Study|Disease Progression|7|||
155718306|NCT00928486|562063413|FG000|Overall Study|Withdrawal by Subject|1|||
155718307|NCT00683878|562063418|FG000|Overall Study|Lack of Efficacy|3|||
155718308|NCT00683878|562063419|FG001|Overall Study|Lack of Efficacy|0|||
155718309|NCT00683878|562063420|FG002|Overall Study|Lack of Efficacy|1|||
155718310|NCT00683878|562063418|FG000|Overall Study|Adverse Event|4|||
155718311|NCT00683878|562063419|FG001|Overall Study|Adverse Event|3|||
155718312|NCT00683878|562063420|FG002|Overall Study|Adverse Event|3|||
155718313|NCT00683878|562063418|FG000|Overall Study|Withdrawal by Subject|9|||
155718314|NCT00683878|562063419|FG001|Overall Study|Withdrawal by Subject|8|||
155718315|NCT00683878|562063420|FG002|Overall Study|Withdrawal by Subject|6|||
155718316|NCT00683878|562063418|FG000|Overall Study|Death|0|||
155718317|NCT00683878|562063419|FG001|Overall Study|Death|1|||
155718318|NCT00683878|562063420|FG002|Overall Study|Death|0|||
155718319|NCT00683878|562063418|FG000|Overall Study|Lost to Follow-up|4|||
155718320|NCT00683878|562063419|FG001|Overall Study|Lost to Follow-up|2|||
155718321|NCT00683878|562063420|FG002|Overall Study|Lost to Follow-up|4|||
155718322|NCT00683878|562063418|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
155718323|NCT00683878|562063419|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
155718324|NCT00683878|562063420|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
155718325|NCT02869633|562063424|FG000|Overall Study|Death|2|||
155718326|NCT02869633|562063425|FG001|Overall Study|Death|1|||
155718327|NCT02869633|562063424|FG000|Overall Study|Patient refused follow-up|1|||
155718328|NCT02869633|562063425|FG001|Overall Study|Patient refused follow-up|0|||
155718329|NCT02869633|562063424|FG000|Overall Study|Provider discretion|1|||
155718330|NCT02869633|562063425|FG001|Overall Study|Provider discretion|0|||
155718331|NCT02869633|562063424|FG000|Overall Study|Investigator decision|1|||
155718332|NCT02869633|562063425|FG001|Overall Study|Investigator decision|0|||
155718333|NCT02869633|562063424|FG000|Overall Study|Lost to Follow-up|0|||
155718334|NCT02869633|562063425|FG001|Overall Study|Lost to Follow-up|1|||
155718335|NCT02869633|562063424|FG000|Overall Study|Not eligible|6|||
155718336|NCT02869633|562063425|FG001|Overall Study|Not eligible|1|||
155718337|NCT02869633|562063424|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
155718338|NCT02869633|562063425|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
155718339|NCT02869633|562063424|FG000|Overall Study|Withdrawal by Subject|0|||
155718340|NCT02869633|562063425|FG001|Overall Study|Withdrawal by Subject|1|||
155718341|NCT04024891|562063426|FG000|Overall Study|Pregnancy|0|||
155718342|NCT04024891|562063427|FG001|Overall Study|Pregnancy|1|||
155718343|NCT03287791|562063433|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155718344|NCT03287791|562063434|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155718345|NCT03287791|562063435|FG002|Overall Study|Insufficient Therapeutic Response|1|||
155718346|NCT03287791|562063433|FG000|Overall Study|Adverse Event|0|||
155718347|NCT03287791|562063434|FG001|Overall Study|Adverse Event|4|||
155718348|NCT03287791|562063435|FG002|Overall Study|Adverse Event|3|||
155718349|NCT03287791|562063433|FG000|Overall Study|Withdrawal by Subject|12|||
155718350|NCT03287791|562063434|FG001|Overall Study|Withdrawal by Subject|12|||
155718351|NCT03287791|562063435|FG002|Overall Study|Withdrawal by Subject|17|||
155718352|NCT03287791|562063433|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
155718353|NCT03287791|562063434|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
155718354|NCT03287791|562063435|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
155718355|NCT03287791|562063433|FG000|Overall Study|Lost to Follow-up|8|||
155718356|NCT03287791|562063434|FG001|Overall Study|Lost to Follow-up|14|||
155718357|NCT03287791|562063435|FG002|Overall Study|Lost to Follow-up|11|||
155718358|NCT03287791|562063433|FG000|Overall Study|Protocol Violation|7|||
155718359|NCT03287791|562063434|FG001|Overall Study|Protocol Violation|2|||
155718360|NCT03287791|562063435|FG002|Overall Study|Protocol Violation|1|||
155718361|NCT03287791|562063433|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
155718362|NCT03287791|562063434|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
155718363|NCT03287791|562063435|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
155718364|NCT03287791|562063433|FG000|Overall Study|Too much time between 2 visits|0|||
155718365|NCT03287791|562063434|FG001|Overall Study|Too much time between 2 visits|1|||
155718366|NCT03287791|562063435|FG002|Overall Study|Too much time between 2 visits|0|||
155718367|NCT03287791|562063433|FG000|Overall Study|Non-compliance|0|||
155718368|NCT03287791|562063434|FG001|Overall Study|Non-compliance|1|||
155718369|NCT03287791|562063435|FG002|Overall Study|Non-compliance|0|||
155718370|NCT03287791|562063433|FG000|Overall Study|Did not meet inclusion criteria|1|||
155718371|NCT03287791|562063434|FG001|Overall Study|Did not meet inclusion criteria|0|||
155718372|NCT03287791|562063435|FG002|Overall Study|Did not meet inclusion criteria|0|||
155718373|NCT03095651|562063437|FG000|Overall Study|Lost to Follow-up|1|||
155718374|NCT03095651|562063438|FG001|Overall Study|Lost to Follow-up|1|||
155718375|NCT03095651|562063439|FG002|Overall Study|Lost to Follow-up|0|||
155718376|NCT03095651|562063440|FG003|Overall Study|Lost to Follow-up|1|||
155718377|NCT03095651|562063441|FG004|Overall Study|Lost to Follow-up|0|||
155718378|NCT03095651|562063442|FG005|Overall Study|Lost to Follow-up|0|||
155718379|NCT03095651|562063443|FG006|Overall Study|Lost to Follow-up|0|||
155718380|NCT03095651|562063444|FG007|Overall Study|Lost to Follow-up|0|||
155718381|NCT03095651|562063437|FG000|Overall Study|Withdrawal by Subject|0|||
155718382|NCT03095651|562063438|FG001|Overall Study|Withdrawal by Subject|0|||
155718383|NCT03095651|562063439|FG002|Overall Study|Withdrawal by Subject|0|||
155718384|NCT03095651|562063440|FG003|Overall Study|Withdrawal by Subject|0|||
155718385|NCT03095651|562063441|FG004|Overall Study|Withdrawal by Subject|0|||
155718386|NCT03095651|562063442|FG005|Overall Study|Withdrawal by Subject|1|||
155718387|NCT03095651|562063443|FG006|Overall Study|Withdrawal by Subject|0|||
155718388|NCT03095651|562063444|FG007|Overall Study|Withdrawal by Subject|0|||
155718389|NCT01381016|562063445|FG000|Overall Study|Lost to Follow-up|1|||
155718390|NCT01381016|562063446|FG001|Overall Study|Lost to Follow-up|1|||
155718391|NCT01381016|562063445|FG000|Overall Study|Screen Failure|2|||
155718392|NCT01381016|562063446|FG001|Overall Study|Screen Failure|2|||
155718393|NCT01381016|562063445|FG000|Overall Study|Withdrawal by Subject|0|||
155718394|NCT01381016|562063446|FG001|Overall Study|Withdrawal by Subject|1|||
155718395|NCT01381016|562063445|FG000|Overall Study|Physician Decision|0|||
155718396|NCT01381016|562063446|FG001|Overall Study|Physician Decision|2|||
155718397|NCT02891174|562063450|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
155718398|NCT02891174|562063451|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
155718399|NCT02891174|562063450|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
155718400|NCT02891174|562063451|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
155718401|NCT02891174|562063450|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
155718402|NCT02891174|562063451|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
155718403|NCT02891174|562063450|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
155718404|NCT02891174|562063451|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
155718405|NCT02891174|562063450|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
155718406|NCT02891174|562063451|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
155718407|NCT02891174|562063450|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
155718408|NCT02891174|562063451|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
155718409|NCT02891174|562063450|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
155718410|NCT02891174|562063451|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
155718411|NCT04607668|562063456|FG000|Overall Study|Death|49|||
155718412|NCT04607668|562063457|FG001|Overall Study|Death|26|||
155718413|NCT04607668|562063456|FG000|Overall Study|Lost to Follow-up|3|||
155718414|NCT04607668|562063457|FG001|Overall Study|Lost to Follow-up|4|||
155718415|NCT04607668|562063456|FG000|Overall Study|Study terminated by Sponsor|92|||
155718416|NCT04607668|562063457|FG001|Overall Study|Study terminated by Sponsor|114|||
155718417|NCT04607668|562063456|FG000|Overall Study|Withdrawal by Subject|12|||
155718418|NCT04607668|562063457|FG001|Overall Study|Withdrawal by Subject|11|||
155718419|NCT04607668|562063456|FG000|Overall Study|Other, unspecified|8|||
155718420|NCT04607668|562063457|FG001|Overall Study|Other, unspecified|7|||
155718421|NCT02250326|562063458|FG000|Treatment|Death|1|||
155718422|NCT02250326|562063459|FG001|Treatment|Death|13|||
155718423|NCT02250326|562063460|FG002|Treatment|Death|2|||
155718424|NCT02250326|562063458|FG000|Treatment|Adverse Event|8|||
155718425|NCT02250326|562063459|FG001|Treatment|Adverse Event|8|||
155718426|NCT02250326|562063460|FG002|Treatment|Adverse Event|9|||
155718427|NCT02250326|562063458|FG000|Treatment|Progressive Disease|42|||
155718428|NCT02250326|562063459|FG001|Treatment|Progressive Disease|40|||
155718429|NCT02250326|562063460|FG002|Treatment|Progressive Disease|47|||
155718430|NCT02250326|562063458|FG000|Treatment|Symptomatic Deterioration|9|||
155718431|NCT02250326|562063459|FG001|Treatment|Symptomatic Deterioration|4|||
155718432|NCT02250326|562063460|FG002|Treatment|Symptomatic Deterioration|10|||
155186340|NCT01397201|560122751|FG000|Overall Study|Not treated|0|||
155718433|NCT02250326|562063458|FG000|Treatment|Withdrawal by Subject|11|||
155718434|NCT02250326|562063459|FG001|Treatment|Withdrawal by Subject|6|||
155718435|NCT02250326|562063460|FG002|Treatment|Withdrawal by Subject|4|||
155718436|NCT02250326|562063458|FG000|Treatment|Other reasons|8|||
155718437|NCT02250326|562063459|FG001|Treatment|Other reasons|7|||
155718438|NCT02250326|562063460|FG002|Treatment|Other reasons|7|||
155718439|NCT02250326|562063458|FG000|Extension Period|Progressive Disease|0|||
155718440|NCT02250326|562063459|FG001|Extension Period|Progressive Disease|2|||
155718441|NCT02250326|562063460|FG002|Extension Period|Progressive Disease|0|||
155718442|NCT02250326|562063458|FG000|Extension Period|Withdrawal by Subject|0|||
155718443|NCT02250326|562063459|FG001|Extension Period|Withdrawal by Subject|1|||
155718444|NCT02250326|562063460|FG002|Extension Period|Withdrawal by Subject|0|||
155718445|NCT02250326|562063458|FG000|Extension Period|Withdrawal by investigator|0|||
155718446|NCT02250326|562063459|FG001|Extension Period|Withdrawal by investigator|1|||
155718447|NCT02250326|562063460|FG002|Extension Period|Withdrawal by investigator|0|||
155718448|NCT01693029|562063461|FG000|Overall Study|Withdrawal by Subject|15|||
155718449|NCT01693029|562063462|FG001|Overall Study|Withdrawal by Subject|22|||
155718450|NCT01693029|562063461|FG000|Overall Study|Kidney transplantation|7|||
155718451|NCT01693029|562063462|FG001|Overall Study|Kidney transplantation|7|||
155718452|NCT01693029|562063461|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
155718453|NCT01693029|562063462|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
155718454|NCT01693029|562063461|FG000|Overall Study|Protocol Violation|6|||
155718455|NCT01693029|562063462|FG001|Overall Study|Protocol Violation|7|||
155718456|NCT01693029|562063461|FG000|Overall Study|Change in dialysis modality|2|||
155718457|NCT01693029|562063462|FG001|Overall Study|Change in dialysis modality|1|||
155718458|NCT01693029|562063461|FG000|Overall Study|Physician Decision|0|||
155718459|NCT01693029|562063462|FG001|Overall Study|Physician Decision|2|||
155718460|NCT01693029|562063461|FG000|Overall Study|Lost to Follow-up|0|||
155718461|NCT01693029|562063462|FG001|Overall Study|Lost to Follow-up|1|||
155718462|NCT01693029|562063461|FG000|Overall Study|Adverse Event|1|||
155718463|NCT01693029|562063462|FG001|Overall Study|Adverse Event|6|||
155718464|NCT01693029|562063461|FG000|Overall Study|Death|5|||
155718465|NCT01693029|562063462|FG001|Overall Study|Death|8|||
155718466|NCT01693029|562063461|FG000|Overall Study|Non-compliance|2|||
155718467|NCT01693029|562063462|FG001|Overall Study|Non-compliance|1|||
155718468|NCT05801991|562063463|FG000|Overall Study|Lost to Follow-up|1|||
155718469|NCT05801991|562063464|FG001|Overall Study|Lost to Follow-up|0|||
155718470|NCT01451723|562063465|FG000|Overall Study|study halted|6|||
155718471|NCT01451723|562063466|FG001|Overall Study|study halted|5|||
155718472|NCT00833040|562063467|FG000|Overall Study|Adverse Event|0|||
155718473|NCT00833040|562063468|FG001|Overall Study|Adverse Event|0|||
155718474|NCT00833040|562063469|FG002|Overall Study|Adverse Event|0|||
155718475|NCT00833040|562063470|FG003|Overall Study|Adverse Event|0|||
155718476|NCT00833040|562063471|FG004|Overall Study|Adverse Event|0|||
155718477|NCT00833040|562063472|FG005|Overall Study|Adverse Event|1|||
155718478|NCT03489863|562063474|FG000|Overall Study|Withdrawal by Subject|0|||
155718479|NCT03489863|562063475|FG001|Overall Study|Withdrawal by Subject|1|||
155718480|NCT05196828|562063476|FG000|Overall Study|Withdrawal by Subject|2|||
155718481|NCT05196828|562063477|FG001|Overall Study|Withdrawal by Subject|0|||
155186341|NCT01397201|560122752|FG001|Overall Study|Not treated|0|||
155718482|NCT05196828|562063476|FG000|Overall Study|Lost to Follow-up|0|||
155718483|NCT05196828|562063477|FG001|Overall Study|Lost to Follow-up|4|||
155718484|NCT05196828|562063476|FG000|Overall Study|Adverse Event|1|||
155718485|NCT05196828|562063477|FG001|Overall Study|Adverse Event|0|||
155718486|NCT01096316|562063478|FG000|Overall Study|Lost to Follow-up|15|||
155718487|NCT01096316|562063479|FG001|Overall Study|Lost to Follow-up|9|||
155718488|NCT02763644|562063480|FG000|Overall Study|Patient/guardian decision|1|||
155718489|NCT02763644|562063481|FG001|Overall Study|Patient/guardian decision|0|||
155718490|NCT02763644|562063480|FG000|Overall Study|Death|1|||
155718491|NCT02763644|562063481|FG001|Overall Study|Death|1|||
155718492|NCT02763644|562063480|FG000|Overall Study|Adverse Event|1|||
155718493|NCT02763644|562063481|FG001|Overall Study|Adverse Event|1|||
155718494|NCT02648204|562063482|FG000|Overall Study|Withdrawal by Subject|12|||
155186342|NCT01397201|560122753|FG002|Overall Study|Not treated|1|||
155186343|NCT01397201|560122754|FG003|Overall Study|Not treated|0|||
155186344|NCT01397201|560122755|FG004|Overall Study|Not treated|0|||
155186345|NCT01397201|560122751|FG000|Overall Study|Not yet defined|3|||
155186346|NCT01397201|560122752|FG001|Overall Study|Not yet defined|6|||
155186347|NCT01397201|560122753|FG002|Overall Study|Not yet defined|5|||
155186348|NCT01397201|560122754|FG003|Overall Study|Not yet defined|5|||
155186349|NCT01397201|560122755|FG004|Overall Study|Not yet defined|4|||
155186350|NCT01397201|560122751|FG000|Overall Study|Adverse Event|2|||
155186351|NCT01397201|560122752|FG001|Overall Study|Adverse Event|0|||
155186352|NCT01397201|560122753|FG002|Overall Study|Adverse Event|0|||
155186353|NCT01397201|560122754|FG003|Overall Study|Adverse Event|0|||
155186354|NCT01397201|560122755|FG004|Overall Study|Adverse Event|0|||
155186355|NCT00851630|560122757|FG000|Overall Study|Death|2|||
155186356|NCT00851630|560122758|FG001|Overall Study|Death|1|||
155186357|NCT00851630|560122757|FG000|Overall Study|Clinical failure|0|||
155186358|NCT00851630|560122758|FG001|Overall Study|Clinical failure|1|||
155186359|NCT00401531|560122759|FG000|Overall Study|Adverse Event|2|||
155186360|NCT00401531|560122760|FG001|Overall Study|Adverse Event|0|||
155186361|NCT00401531|560122759|FG000|Overall Study|Protocol Violation|3|||
155186362|NCT00401531|560122760|FG001|Overall Study|Protocol Violation|7|||
155186363|NCT00401531|560122759|FG000|Overall Study|Lost to Follow-up|1|||
155186364|NCT00401531|560122760|FG001|Overall Study|Lost to Follow-up|1|||
155186365|NCT00401531|560122759|FG000|Overall Study|Withdrawal by Subject|3|||
155186366|NCT00401531|560122760|FG001|Overall Study|Withdrawal by Subject|2|||
155186367|NCT01614600|560122763|FG000|Overall Study|Unacceptable fit|1|||
155186368|NCT01614600|560122763|FG000|Overall Study|Discomfort|1|||
155186369|NCT01614600|560122763|FG000|Overall Study|Unable to remove lens at the end of day|1|||
155186370|NCT01614600|560122763|FG000|Overall Study|Protocol deviation|1|||
155186371|NCT02437513|560122764|FG000|Overall Study|Withdrawal by Subject|2|||
155186372|NCT03956056|560122767|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
155186373|NCT03956056|560122767|FG000|Overall Study|Lack of Efficacy|1|||
155186374|NCT03403374|560122768|FG000|Overall Study|Lost to Follow-up|1|||
155186375|NCT01092507|560122772|FG000|Overall Study|Withdrawal by Subject|2|||
155186376|NCT01092507|560122773|FG001|Overall Study|Withdrawal by Subject|0|||
155186377|NCT04629508|560122776|FG000|Overall Study|Adverse Event|1|||
155186378|NCT04629508|560122776|FG000|Overall Study|Death|2|||
155718495|NCT02648204|562063483|FG001|Overall Study|Withdrawal by Subject|8|||
155718496|NCT02648204|562063484|FG002|Overall Study|Withdrawal by Subject|2|||
155718497|NCT02648204|562063485|FG003|Overall Study|Withdrawal by Subject|6|||
155718498|NCT02648204|562063482|FG000|Overall Study|Lost to Follow-up|5|||
155718499|NCT02648204|562063483|FG001|Overall Study|Lost to Follow-up|8|||
155718500|NCT02648204|562063484|FG002|Overall Study|Lost to Follow-up|4|||
155718501|NCT02648204|562063485|FG003|Overall Study|Lost to Follow-up|6|||
155718502|NCT02648204|562063482|FG000|Overall Study|Missing follow-up information|4|||
155718503|NCT02648204|562063483|FG001|Overall Study|Missing follow-up information|4|||
155718504|NCT02648204|562063484|FG002|Overall Study|Missing follow-up information|4|||
155718505|NCT02648204|562063485|FG003|Overall Study|Missing follow-up information|2|||
155718506|NCT02648204|562063482|FG000|Overall Study|Death|1|||
155718507|NCT02648204|562063483|FG001|Overall Study|Death|1|||
155718508|NCT02648204|562063484|FG002|Overall Study|Death|2|||
155718509|NCT02648204|562063485|FG003|Overall Study|Death|2|||
155718510|NCT02648204|562063482|FG000|Overall Study|Adverse Event|0|||
155186379|NCT04629508|560122776|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
155186380|NCT04073368|560122777|FG000|Overall Study|Adverse Event|2|||
155186381|NCT04073368|560122778|FG001|Overall Study|Adverse Event|0|||
155718511|NCT02648204|562063483|FG001|Overall Study|Adverse Event|0|||
155186382|NCT04073368|560122779|FG002|Overall Study|Adverse Event|1|||
155186383|NCT04073368|560122780|FG003|Overall Study|Adverse Event|1|||
155186384|NCT04073368|560122777|FG000|Overall Study|Withdrawal by Subject|2|||
155186385|NCT04073368|560122778|FG001|Overall Study|Withdrawal by Subject|2|||
155718512|NCT02648204|562063484|FG002|Overall Study|Adverse Event|1|||
155186386|NCT04073368|560122779|FG002|Overall Study|Withdrawal by Subject|1|||
155186387|NCT04073368|560122780|FG003|Overall Study|Withdrawal by Subject|1|||
155186388|NCT04073368|560122777|FG000|Overall Study|Lost to Follow-up|1|||
155186389|NCT04073368|560122778|FG001|Overall Study|Lost to Follow-up|1|||
155186390|NCT04073368|560122779|FG002|Overall Study|Lost to Follow-up|1|||
155186391|NCT04073368|560122780|FG003|Overall Study|Lost to Follow-up|0|||
155186392|NCT04073368|560122777|FG000|Overall Study|Protocol Violation|0|||
155186393|NCT04073368|560122778|FG001|Overall Study|Protocol Violation|1|||
155186394|NCT04073368|560122779|FG002|Overall Study|Protocol Violation|0|||
155186395|NCT04073368|560122780|FG003|Overall Study|Protocol Violation|0|||
155718513|NCT02648204|562063485|FG003|Overall Study|Adverse Event|0|||
155186396|NCT04073368|560122777|FG000|Overall Study|Subject noncompliance|7|||
155186397|NCT04073368|560122778|FG001|Overall Study|Subject noncompliance|4|||
155718514|NCT06418152|562063486|FG000|Overall Study|Frequent DBS setting changes|1|||
155718515|NCT06418152|562063486|FG000|Overall Study|Withdrawal by Subject|2|||
155718516|NCT02314052|562063491|FG000|Cycle One|Adverse Event|0|||
155718517|NCT02314052|562063492|FG001|Cycle One|Adverse Event|0|||
155718518|NCT02314052|562063493|FG002|Cycle One|Adverse Event|0|||
155186398|NCT04073368|560122779|FG002|Overall Study|Subject noncompliance|0|||
155186399|NCT04073368|560122780|FG003|Overall Study|Subject noncompliance|0|||
155186400|NCT00736879|560122783|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155186401|NCT00736879|560122784|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155186402|NCT00736879|560122785|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155186403|NCT00736879|560122786|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155186404|NCT00736879|560122783|FG000|Double Blind Treatment Period|Adverse Event|0|||
155186405|NCT00736879|560122784|FG001|Double Blind Treatment Period|Adverse Event|1|||
155186406|NCT00736879|560122785|FG002|Double Blind Treatment Period|Adverse Event|1|||
155186407|NCT00736879|560122786|FG003|Double Blind Treatment Period|Adverse Event|0|||
155186408|NCT00736879|560122783|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
155186409|NCT00736879|560122784|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
155186410|NCT00736879|560122785|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
155186411|NCT00736879|560122786|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
155186412|NCT00736879|560122783|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155186413|NCT00736879|560122784|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155186414|NCT00736879|560122785|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
155186415|NCT00736879|560122786|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
155186416|NCT00736879|560122783|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
155186417|NCT00736879|560122784|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
155186418|NCT00736879|560122785|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
155186419|NCT00736879|560122786|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
155186420|NCT00736879|560122783|FG000|Double Blind Treatment Period|No longer met criteria|0|||
155186421|NCT00736879|560122784|FG001|Double Blind Treatment Period|No longer met criteria|1|||
155186422|NCT00736879|560122785|FG002|Double Blind Treatment Period|No longer met criteria|0|||
155186423|NCT00736879|560122786|FG003|Double Blind Treatment Period|No longer met criteria|0|||
155186424|NCT00736879|560122783|FG000|Double Blind Treatment Period|non-specified|0|||
155186425|NCT00736879|560122784|FG001|Double Blind Treatment Period|non-specified|1|||
155186426|NCT00736879|560122785|FG002|Double Blind Treatment Period|non-specified|0|||
155718519|NCT02314052|562063494|FG003|Cycle One|Adverse Event|1|||
155718520|NCT02314052|562063495|FG004|Cycle One|Adverse Event|0|||
155186427|NCT00736879|560122786|FG003|Double Blind Treatment Period|non-specified|0|||
155186428|NCT00736879|560122783|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186429|NCT00736879|560122784|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
155186430|NCT00736879|560122785|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186431|NCT00736879|560122786|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186432|NCT00736879|560122783|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
155186433|NCT00736879|560122784|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
155186434|NCT00736879|560122785|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
155186435|NCT00736879|560122786|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
155186436|NCT00735254|560122787|FG000|Overall Study|Protocol Violation|1|||
155718521|NCT02314052|562063496|FG005|Cycle One|Adverse Event|0|||
155718522|NCT02422498|562063497|FG000|Overall Study|Inevaluable|4|||
155718523|NCT02653326|562063498|FG000|Overall Study|Lost to Follow-up|10|||
155718524|NCT02653326|562063499|FG001|Overall Study|Lost to Follow-up|7|||
155718525|NCT01045460|562063503|FG000|Overall Study|Physician Decision|3|||
155718526|NCT01045460|562063504|FG001|Overall Study|Physician Decision|2|||
155718527|NCT01045460|562063503|FG000|Overall Study|Lost to Follow-up|0|||
155718528|NCT01045460|562063504|FG001|Overall Study|Lost to Follow-up|1|||
155718529|NCT01045460|562063503|FG000|Overall Study|Lack of Efficacy|3|||
155718530|NCT01045460|562063504|FG001|Overall Study|Lack of Efficacy|0|||
155718531|NCT00097500|562063505|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
155718532|NCT00097500|562063506|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
155718533|NCT00097500|562063505|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
155718534|NCT00097500|562063506|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
155718535|NCT00097500|562063505|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
155718536|NCT00097500|562063506|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
155718537|NCT00097500|562063505|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155718538|NCT00097500|562063506|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
155718539|NCT00097500|562063505|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
155186437|NCT00735254|560122788|FG001|Overall Study|Protocol Violation|1|||
155186438|NCT00735254|560122789|FG002|Overall Study|Protocol Violation|1|||
155186439|NCT00735254|560122790|FG003|Overall Study|Protocol Violation|0|||
155186440|NCT01031381|560122791|FG000|Overall Study|Physician Decision|3|||
155186441|NCT01031381|560122791|FG000|Overall Study|Withdrawal by Subject|6|||
155186442|NCT00147251|560122792|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
155718540|NCT00097500|562063506|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
155718541|NCT00097500|562063505|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
155718542|NCT00097500|562063506|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
155718543|NCT00097500|562063505|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
155718544|NCT00097500|562063506|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
155718545|NCT00524485|562063509|FG000|Overall Study|Withdrawal by Subject|5|||
155718546|NCT00642356|562063513|FG000|Overall Study|Adverse Event|1|||
155718547|NCT00642356|562063514|FG001|Overall Study|Adverse Event|0|||
155718548|NCT00642356|562063513|FG000|Overall Study|Protocol Violation|0|||
155718549|NCT00642356|562063514|FG001|Overall Study|Protocol Violation|3|||
155718550|NCT00642356|562063513|FG000|Overall Study|Lack of Efficacy|1|||
155718551|NCT00642356|562063514|FG001|Overall Study|Lack of Efficacy|0|||
155718552|NCT00005906|562063517|FG000|Overall Study|Lack of Efficacy|3|||
155718553|NCT04551989|562063518|FG000|Overall Study|Adverse Event|4|||
155718554|NCT04551989|562063518|FG000|Overall Study|Protocol Violation|3|||
155718555|NCT04551989|562063518|FG000|Overall Study|Lost to Follow-up|1|||
155718556|NCT04551989|562063518|FG000|Overall Study|Physician Decision|3|||
155718557|NCT04201431|562063519|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
155718558|NCT04201431|562063520|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
155718559|NCT04201431|562063521|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
155718560|NCT02694744|562063524|FG000|Overall Study|Adverse Event|2|||
155718561|NCT02694744|562063525|FG001|Overall Study|Adverse Event|1|||
155718562|NCT02694744|562063524|FG000|Overall Study|Withdrawal by Subject|2|||
155718563|NCT02694744|562063525|FG001|Overall Study|Withdrawal by Subject|1|||
155718564|NCT02694744|562063524|FG000|Overall Study|Physician Decision|1|||
155718565|NCT02694744|562063525|FG001|Overall Study|Physician Decision|2|||
155718566|NCT02694744|562063524|FG000|Overall Study|Lost to Follow-up|1|||
155718567|NCT02694744|562063525|FG001|Overall Study|Lost to Follow-up|0|||
155718568|NCT02694744|562063524|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
155718569|NCT02694744|562063525|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
155718570|NCT00686777|562063528|FG000|Overall Study|Adverse Event|2|||
155718571|NCT00686777|562063528|FG000|Overall Study|Pregnancy|1|||
155718572|NCT00686777|562063528|FG000|Overall Study|Withdrawal by Subject|2|||
155718573|NCT00686777|562063528|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
155718574|NCT00686777|562063528|FG000|Overall Study|No Visit|1|||
155718575|NCT00667888|562063529|FG000|Overall Study|Death|1|||
155718576|NCT00667888|562063530|FG001|Overall Study|Death|1|||
155718577|NCT00667888|562063529|FG000|Overall Study|Withdrawal by Subject|6|||
155718578|NCT00667888|562063530|FG001|Overall Study|Withdrawal by Subject|3|||
155718579|NCT00667888|562063529|FG000|Overall Study|Proceed with other treatment|3|||
155718580|NCT00667888|562063530|FG001|Overall Study|Proceed with other treatment|3|||
155718581|NCT00667888|562063529|FG000|Overall Study|Ineligible after SIM|0|||
155718582|NCT00667888|562063530|FG001|Overall Study|Ineligible after SIM|2|||
155718583|NCT01945021|562063531|FG000|Overall Study|Adverse Event|1|||
155718584|NCT01945021|562063531|FG000|Overall Study|Withdrawal of consent|12|||
155718585|NCT01945021|562063531|FG000|Overall Study|Lost to Follow-up|5|||
155718586|NCT01945021|562063531|FG000|Overall Study|Death|65|||
155718587|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
155718588|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
155718589|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Disease progression|75|||
155718590|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Disease progression|59|||
155718591|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Adverse Event|16|||
155718592|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Adverse Event|16|||
155718593|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Death|2|||
155718594|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Death|3|||
155718595|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
155718596|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
155718597|NCT00883779|562063532|FG000|Primary Study Treatment Phase|Other|3|||
155718598|NCT00883779|562063533|FG001|Primary Study Treatment Phase|Other|0|||
155718599|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Adverse Event|2|||
155718600|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Adverse Event|3|||
155718601|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Death|1|||
155718602|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Death|3|||
155718603|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
155718604|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
155718605|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
155718606|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
155718607|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Disease progression|103|||
155718608|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Disease progression|122|||
155718609|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Other|3|||
155718610|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Other|0|||
155718611|NCT00883779|562063532|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
155718612|NCT00883779|562063533|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
155718613|NCT00883779|562063532|FG000|Off-study Phase|Death|185|||
155718614|NCT00883779|562063533|FG001|Off-study Phase|Death|174|||
155718615|NCT00883779|562063532|FG000|Off-study Phase|Refused treatment|1|||
155718616|NCT00883779|562063533|FG001|Off-study Phase|Refused treatment|1|||
155718617|NCT00883779|562063532|FG000|Off-study Phase|Failure to return|5|||
155718618|NCT00883779|562063533|FG001|Off-study Phase|Failure to return|6|||
155718619|NCT00883779|562063532|FG000|Off-study Phase|Other|18|||
155718620|NCT00883779|562063533|FG001|Off-study Phase|Other|21|||
155718621|NCT03915717|562063540|FG000|Overall Study|EchoMark Not Implanted|6|||
155718622|NCT03550378|562063541|FG000|Overall Study|Death|0|||
155718623|NCT03550378|562063542|FG001|Overall Study|Death|1|||
155718624|NCT00626275|562063543|FG000|Part A - Treatment Period 1|Adverse Event|1|||
155718625|NCT00626275|562063544|FG001|Part A - Treatment Period 1|Adverse Event|0|||
155718626|NCT00626275|562063545|FG002|Part A - Treatment Period 1|Adverse Event|0|||
155718627|NCT00626275|562063546|FG003|Part A - Treatment Period 1|Adverse Event|0|||
155718628|NCT00626275|562063547|FG004|Part A - Treatment Period 1|Adverse Event|0|||
155718629|NCT00626275|562063548|FG005|Part A - Treatment Period 1|Adverse Event|0|||
155718630|NCT00626275|562063549|FG006|Part A - Treatment Period 1|Adverse Event|0|||
155718631|NCT00626275|562063550|FG007|Part A - Treatment Period 1|Adverse Event|0|||
155718632|NCT00626275|562063543|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718633|NCT00626275|562063544|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718634|NCT00626275|562063545|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
155718635|NCT00626275|562063546|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718636|NCT00626275|562063547|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718637|NCT00626275|562063548|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718638|NCT00626275|562063549|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718639|NCT00626275|562063550|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155718640|NCT00626275|562063543|FG000|Part B|Lost to Follow-up|0|||
155718641|NCT00626275|562063544|FG001|Part B|Lost to Follow-up|0|||
155718642|NCT00626275|562063545|FG002|Part B|Lost to Follow-up|0|||
155718643|NCT00626275|562063546|FG003|Part B|Lost to Follow-up|0|||
155718644|NCT00626275|562063547|FG004|Part B|Lost to Follow-up|0|||
155718645|NCT00626275|562063548|FG005|Part B|Lost to Follow-up|0|||
155718646|NCT00626275|562063549|FG006|Part B|Lost to Follow-up|1|||
155718647|NCT00626275|562063550|FG007|Part B|Lost to Follow-up|0|||
155718648|NCT00626275|562063543|FG000|Part B|Withdrawal by Subject|0|||
155718649|NCT00626275|562063544|FG001|Part B|Withdrawal by Subject|0|||
155718650|NCT00626275|562063545|FG002|Part B|Withdrawal by Subject|0|||
155718651|NCT00626275|562063546|FG003|Part B|Withdrawal by Subject|0|||
155718652|NCT00626275|562063547|FG004|Part B|Withdrawal by Subject|0|||
155718653|NCT00626275|562063548|FG005|Part B|Withdrawal by Subject|0|||
155718654|NCT00626275|562063549|FG006|Part B|Withdrawal by Subject|0|||
155718655|NCT00626275|562063550|FG007|Part B|Withdrawal by Subject|1|||
155718656|NCT01362348|562063551|FG000|Overall Study|Protocol-defined stopping criteria|9|||
155718657|NCT01362348|562063551|FG000|Overall Study|Study closed/terminated|5|||
155718658|NCT00399516|562063552|FG000|Overall Study|Lost to Follow-up|2|||
155718659|NCT03409796|562064960|FG000|Overall Study|Adverse Event|2|||
155718660|NCT03409796|562064961|FG001|Overall Study|Adverse Event|0|||
155718661|NCT03409796|562064960|FG000|Overall Study|Other|0|||
155718662|NCT03409796|562064961|FG001|Overall Study|Other|1|||
155718663|NCT01908426|562064963|FG000|Overall Study|Adverse Event|98|||
155718664|NCT01908426|562064964|FG001|Overall Study|Adverse Event|11|||
155718665|NCT01908426|562064963|FG000|Overall Study|Clinical Deterioration|72|||
155718666|NCT01908426|562064964|FG001|Overall Study|Clinical Deterioration|38|||
155718667|NCT01908426|562064963|FG000|Overall Study|Lack of Efficacy|3|||
155718668|NCT01908426|562064964|FG001|Overall Study|Lack of Efficacy|0|||
155718669|NCT01908426|562064963|FG000|Overall Study|Lost to Follow-up|0|||
155718670|NCT01908426|562064964|FG001|Overall Study|Lost to Follow-up|1|||
155718671|NCT01908426|562064963|FG000|Overall Study|Physician Decision|3|||
155718672|NCT01908426|562064964|FG001|Overall Study|Physician Decision|3|||
155718673|NCT01908426|562064963|FG000|Overall Study|Withdrawal by Subject|11|||
155718674|NCT01908426|562064964|FG001|Overall Study|Withdrawal by Subject|6|||
155718675|NCT01908426|562064963|FG000|Overall Study|Progressive Disease|206|||
155718676|NCT01908426|562064964|FG001|Overall Study|Progressive Disease|152|||
155718677|NCT01908426|562064963|FG000|Overall Study|Protocol Violation|1|||
155718678|NCT01908426|562064964|FG001|Overall Study|Protocol Violation|0|||
155718679|NCT01908426|562064963|FG000|Overall Study|No Study Treatment Given|3|||
155718680|NCT01908426|562064964|FG001|Overall Study|No Study Treatment Given|0|||
155718681|NCT01419236|562064969|FG000|Overall Study|Adverse Event|1|||
155718682|NCT01419236|562064970|FG001|Overall Study|Adverse Event|0|||
155718683|NCT01419236|562064969|FG000|Overall Study|Lack of Efficacy|0|||
155718684|NCT01419236|562064970|FG001|Overall Study|Lack of Efficacy|1|||
155718685|NCT01419236|562064969|FG000|Overall Study|Lost to Follow-up|1|||
155718686|NCT01419236|562064970|FG001|Overall Study|Lost to Follow-up|0|||
155718687|NCT01419236|562064969|FG000|Overall Study|Physician Decision|1|||
155718688|NCT01419236|562064970|FG001|Overall Study|Physician Decision|0|||
155718689|NCT01419236|562064969|FG000|Overall Study|Withdrawal by Subject|1|||
155718690|NCT01419236|562064970|FG001|Overall Study|Withdrawal by Subject|4|||
155718691|NCT01419236|562064969|FG000|Overall Study|Entry Criteria Not Met|1|||
155718692|NCT01419236|562064970|FG001|Overall Study|Entry Criteria Not Met|0|||
155718693|NCT02173769|562064971|FG000|Overall Study|Protocol Violation|4|||
155718694|NCT01838694|562064983|FG000|Overall Study|Adverse Event|0|||
155718695|NCT01838694|562064984|FG001|Overall Study|Adverse Event|1|||
155718696|NCT02356159|562064986|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155718697|NCT02356159|562064987|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155718698|NCT02356159|562064988|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155718699|NCT02356159|562064989|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155718700|NCT02356159|562064990|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155718701|NCT02356159|562064991|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
155718702|NCT02529852|562064992|FG000|Overall Study|Withdrawal by Subject|2|||
155718703|NCT03206216|562064993|FG000|Overall Study|Withdrawal by Subject|0|||
155718704|NCT03206216|562064994|FG001|Overall Study|Withdrawal by Subject|1|||
155718705|NCT01582061|562064995|FG000|Overall Study|Lack of Efficacy|3|||
155718706|NCT01582061|562064996|FG001|Overall Study|Lack of Efficacy|23|||
155718707|NCT01582061|562064995|FG000|Overall Study|Adverse Event|12|||
155718708|NCT01582061|562064996|FG001|Overall Study|Adverse Event|8|||
155718709|NCT01582061|562064995|FG000|Overall Study|Withdrawal by Subject|10|||
155718710|NCT01582061|562064996|FG001|Overall Study|Withdrawal by Subject|4|||
155718711|NCT01582061|562064995|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155718712|NCT01582061|562064996|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155718713|NCT01582061|562064995|FG000|Overall Study|Death|0|||
155718714|NCT01582061|562064996|FG001|Overall Study|Death|1|||
155718715|NCT01582061|562064995|FG000|Overall Study|condition no longer requires study drug|1|||
155718716|NCT01582061|562064996|FG001|Overall Study|condition no longer requires study drug|0|||
155718717|NCT01582061|562064995|FG000|Overall Study|Lost to Follow-up|1|||
155718718|NCT01582061|562064996|FG001|Overall Study|Lost to Follow-up|0|||
155718719|NCT04664153|562064997|FG000|Overall Study|Lack of Efficacy|0|||
155718720|NCT04664153|562064998|FG001|Overall Study|Lack of Efficacy|0|||
155718721|NCT04664153|562064999|FG002|Overall Study|Lack of Efficacy|1|||
155718722|NCT04664153|562065000|FG003|Overall Study|Lack of Efficacy|0|||
155718723|NCT04664153|562064997|FG000|Overall Study|Physician Decision|0|||
155718724|NCT04664153|562064998|FG001|Overall Study|Physician Decision|0|||
155718725|NCT04664153|562064999|FG002|Overall Study|Physician Decision|1|||
155718726|NCT04664153|562065000|FG003|Overall Study|Physician Decision|0|||
155718727|NCT04664153|562064997|FG000|Overall Study|Withdrawal by Subject|3|||
155718728|NCT04664153|562064998|FG001|Overall Study|Withdrawal by Subject|2|||
155718729|NCT04664153|562064999|FG002|Overall Study|Withdrawal by Subject|1|||
155718730|NCT04664153|562065000|FG003|Overall Study|Withdrawal by Subject|2|||
155718731|NCT04664153|562064997|FG000|Overall Study|Other|0|||
155718732|NCT04664153|562064998|FG001|Overall Study|Other|1|||
155718733|NCT04664153|562064999|FG002|Overall Study|Other|0|||
155718734|NCT04664153|562065000|FG003|Overall Study|Other|0|||
155718735|NCT04664153|562064997|FG000|Overall Study|Adverse Event|4|||
155718736|NCT04664153|562064998|FG001|Overall Study|Adverse Event|0|||
155718737|NCT04664153|562064999|FG002|Overall Study|Adverse Event|1|||
155718738|NCT04664153|562065000|FG003|Overall Study|Adverse Event|0|||
155718739|NCT01600885|562065004|FG000|First Period|Adverse Event|1|||
155718740|NCT01600885|562065005|FG001|First Period|Adverse Event|1|||
155718741|NCT01600885|562065004|FG000|First Period|moved out of area|1|||
155718742|NCT01600885|562065005|FG001|First Period|moved out of area|0|||
155718743|NCT00088530|562065008|FG000|Overall Study|Progressive/Relapsed Disease|28|||
155718744|NCT00088530|562065009|FG001|Overall Study|Progressive/Relapsed Disease|39|||
155718745|NCT00088530|562065008|FG000|Overall Study|Adverse Event|15|||
155718746|NCT00088530|562065009|FG001|Overall Study|Adverse Event|9|||
155718747|NCT00088530|562065008|FG000|Overall Study|Withdrawal by Subject|2|||
155718748|NCT00088530|562065009|FG001|Overall Study|Withdrawal by Subject|5|||
155718749|NCT00088530|562065008|FG000|Overall Study|Lost to Follow-up|2|||
155718750|NCT00088530|562065009|FG001|Overall Study|Lost to Follow-up|0|||
155718751|NCT00088530|562065008|FG000|Overall Study|Physician Decision|2|||
155718752|NCT00088530|562065009|FG001|Overall Study|Physician Decision|0|||
155718753|NCT00088530|562065008|FG000|Overall Study|Sponsor decision|0|||
155718754|NCT00088530|562065009|FG001|Overall Study|Sponsor decision|1|||
155718755|NCT00088530|562065008|FG000|Overall Study|Patient never treated|1|||
155718756|NCT00088530|562065009|FG001|Overall Study|Patient never treated|0|||
155718757|NCT00300755|562065010|FG000|Overall Study|Adverse Event|1|||
155718758|NCT00300755|562065011|FG001|Overall Study|Adverse Event|2|||
155718759|NCT00300755|562065012|FG002|Overall Study|Adverse Event|1|||
155718760|NCT00300755|562065010|FG000|Overall Study|Withdrawal by Subject|0|||
155718761|NCT00300755|562065011|FG001|Overall Study|Withdrawal by Subject|2|||
155718762|NCT00300755|562065012|FG002|Overall Study|Withdrawal by Subject|0|||
155718763|NCT00300755|562065010|FG000|Overall Study|Protocol Violation|0|||
155718764|NCT00300755|562065011|FG001|Overall Study|Protocol Violation|0|||
155718765|NCT00300755|562065012|FG002|Overall Study|Protocol Violation|1|||
155718766|NCT04571944|562065013|FG000|Overall Study|Death|1|||
155718767|NCT04571944|562065014|FG001|Overall Study|Death|0|||
155718768|NCT04571944|562065013|FG000|Overall Study|Withdrawal by Subject|3|||
155718769|NCT04571944|562065014|FG001|Overall Study|Withdrawal by Subject|0|||
155718770|NCT04571944|562065013|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
155718771|NCT04571944|562065014|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
155718772|NCT02163902|562065015|FG000|Overall Study|Subject's Request|3|||
155718773|NCT02163902|562065016|FG001|Overall Study|Subject's Request|4|||
155718774|NCT02163902|562065015|FG000|Overall Study|Lost to Follow-up|6|||
155718775|NCT02163902|562065016|FG001|Overall Study|Lost to Follow-up|7|||
155718776|NCT02163902|562065015|FG000|Overall Study|Administrative Decision|2|||
155718777|NCT02163902|562065016|FG001|Overall Study|Administrative Decision|2|||
155718778|NCT03119259|562065017|FG000|Overall Study|Withdrawn as no longer eligible|1|||
155718779|NCT03119259|562065018|FG001|Overall Study|Withdrawn as no longer eligible|0|||
155718780|NCT03119259|562065017|FG000|Overall Study|Withdrawal by Subject|4|||
155718781|NCT03119259|562065018|FG001|Overall Study|Withdrawal by Subject|2|||
155718782|NCT03119259|562065017|FG000|Overall Study|Lost to Follow-up|0|||
155718783|NCT03119259|562065018|FG001|Overall Study|Lost to Follow-up|1|||
155718784|NCT02525471|562065019|FG000|Overall Study|Screen Failure|6|||
155718785|NCT02525471|562065019|FG000|Overall Study|Withdrawal by Subject|4|||
155718786|NCT02525471|562065019|FG000|Overall Study|Death|1|||
155718787|NCT00867165|562065021|FG000|Overall Study|Adverse Event|3|||
155718788|NCT00867165|562065022|FG001|Overall Study|Adverse Event|0|||
155186443|NCT00147251|560122793|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
155186444|NCT06400979|560122794|FG000|Overall Study|Lost to Follow-up|29|||
155186445|NCT06400979|560122794|FG000|Overall Study|Withdrawal by Subject|1|||
155718789|NCT00867165|562065021|FG000|Overall Study|Withdrawal by Subject|1|||
155718790|NCT00867165|562065022|FG001|Overall Study|Withdrawal by Subject|0|||
155718791|NCT00539981|562065023|FG000|Overall Study|Adverse events (AE)|3|||
155718792|NCT00539981|562065024|FG001|Overall Study|Adverse events (AE)|3|||
155718793|NCT00539981|562065023|FG000|Overall Study|Lost to Follow-up|260|||
155718794|NCT00539981|562065024|FG001|Overall Study|Lost to Follow-up|251|||
155718795|NCT00539981|562065023|FG000|Overall Study|Withdrew consent|22|||
155718796|NCT00539981|562065024|FG001|Overall Study|Withdrew consent|14|||
155718797|NCT00539981|562065023|FG000|Overall Study|Death|1|||
155718798|NCT00539981|562065024|FG001|Overall Study|Death|1|||
155718799|NCT00539981|562065023|FG000|Overall Study|Other reason-unspecified|9|||
155718800|NCT00539981|562065024|FG001|Overall Study|Other reason-unspecified|13|||
155718801|NCT01759420|562065027|FG000|Overall Study|Screen failure|5|||
155718802|NCT01759420|562065027|FG000|Overall Study|Inaccurate EKG machine readings|1|||
155718803|NCT01129622|562065030|FG000|Overall Study|Withdrawal by Subject|2|||
155718804|NCT02051764|562065031|FG000|Overall Study|Study terminated by sponsor|0|||
155718805|NCT02051764|562065032|FG001|Overall Study|Study terminated by sponsor|7|||
155718806|NCT00591006|562065033|FG000|Overall Study|Withdrawal by Subject|0|||
155718807|NCT00591006|562065034|FG001|Overall Study|Withdrawal by Subject|0|||
155718808|NCT00591006|562065035|FG002|Overall Study|Withdrawal by Subject|0|||
155718809|NCT00591006|562065036|FG003|Overall Study|Withdrawal by Subject|0|||
155718810|NCT00591006|562065037|FG004|Overall Study|Withdrawal by Subject|0|||
155718811|NCT00591006|562065038|FG005|Overall Study|Withdrawal by Subject|0|||
155718812|NCT00591006|562065039|FG006|Overall Study|Withdrawal by Subject|0|||
155718813|NCT00591006|562065040|FG007|Overall Study|Withdrawal by Subject|0|||
155718814|NCT00591006|562065041|FG008|Overall Study|Withdrawal by Subject|0|||
155718815|NCT00591006|562065042|FG009|Overall Study|Withdrawal by Subject|0|||
155718816|NCT00591006|562065043|FG010|Overall Study|Withdrawal by Subject|0|||
155718817|NCT00591006|562065044|FG011|Overall Study|Withdrawal by Subject|0|||
155718818|NCT00591006|562065045|FG012|Overall Study|Withdrawal by Subject|0|||
155718819|NCT00591006|562065046|FG013|Overall Study|Withdrawal by Subject|0|||
155718820|NCT00591006|562065047|FG014|Overall Study|Withdrawal by Subject|0|||
155718821|NCT00591006|562065048|FG015|Overall Study|Withdrawal by Subject|1|||
155718822|NCT00591006|562065049|FG016|Overall Study|Withdrawal by Subject|0|||
155718823|NCT00591006|562065050|FG017|Overall Study|Withdrawal by Subject|0|||
155718824|NCT00591006|562065051|FG018|Overall Study|Withdrawal by Subject|0|||
155718825|NCT00591006|562065052|FG019|Overall Study|Withdrawal by Subject|0|||
155718826|NCT00591006|562065053|FG020|Overall Study|Withdrawal by Subject|0|||
155718827|NCT00591006|562065054|FG021|Overall Study|Withdrawal by Subject|0|||
155718828|NCT00591006|562065055|FG022|Overall Study|Withdrawal by Subject|0|||
155718829|NCT00591006|562065056|FG023|Overall Study|Withdrawal by Subject|1|||
155718830|NCT00591006|562065033|FG000|Overall Study|Adverse Event|0|||
155718831|NCT00591006|562065034|FG001|Overall Study|Adverse Event|0|||
155718832|NCT00591006|562065035|FG002|Overall Study|Adverse Event|0|||
155718833|NCT00591006|562065036|FG003|Overall Study|Adverse Event|0|||
155718834|NCT00591006|562065037|FG004|Overall Study|Adverse Event|0|||
155718835|NCT00591006|562065038|FG005|Overall Study|Adverse Event|0|||
155718836|NCT00591006|562065039|FG006|Overall Study|Adverse Event|0|||
155718837|NCT00591006|562065040|FG007|Overall Study|Adverse Event|0|||
155718838|NCT00591006|562065041|FG008|Overall Study|Adverse Event|0|||
155718839|NCT00591006|562065042|FG009|Overall Study|Adverse Event|0|||
155718840|NCT00591006|562065043|FG010|Overall Study|Adverse Event|0|||
155718841|NCT00591006|562065044|FG011|Overall Study|Adverse Event|0|||
155718842|NCT00591006|562065045|FG012|Overall Study|Adverse Event|0|||
155718843|NCT00591006|562065046|FG013|Overall Study|Adverse Event|0|||
155718844|NCT00591006|562065047|FG014|Overall Study|Adverse Event|0|||
155718845|NCT00591006|562065048|FG015|Overall Study|Adverse Event|0|||
155718846|NCT00591006|562065049|FG016|Overall Study|Adverse Event|0|||
155718847|NCT00591006|562065050|FG017|Overall Study|Adverse Event|0|||
155718848|NCT00591006|562065051|FG018|Overall Study|Adverse Event|0|||
155718849|NCT00591006|562065052|FG019|Overall Study|Adverse Event|0|||
155718850|NCT00591006|562065053|FG020|Overall Study|Adverse Event|0|||
155718851|NCT00591006|562065054|FG021|Overall Study|Adverse Event|0|||
155718852|NCT00591006|562065055|FG022|Overall Study|Adverse Event|1|||
155718853|NCT00591006|562065056|FG023|Overall Study|Adverse Event|0|||
155718854|NCT03071263|562065057|FG000|Overall Study|Adverse Event|1|||
155718855|NCT03071263|562065058|FG001|Overall Study|Adverse Event|3|||
155718856|NCT03071263|562065057|FG000|Overall Study|Withdrawal by Subject|1|||
155718857|NCT03071263|562065058|FG001|Overall Study|Withdrawal by Subject|3|||
155718858|NCT03071263|562065057|FG000|Overall Study|Physician Decision|1|||
155718859|NCT03071263|562065058|FG001|Overall Study|Physician Decision|0|||
155718860|NCT03071263|562065057|FG000|Overall Study|Participant moved to another city|0|||
155718861|NCT03071263|562065058|FG001|Overall Study|Participant moved to another city|1|||
155718862|NCT03289208|562065062|FG000|Overall Study|Adverse Event|1|||
155718863|NCT03289208|562065063|FG001|Overall Study|Adverse Event|0|||
155718864|NCT03289208|562065064|FG002|Overall Study|Adverse Event|0|||
155718865|NCT00647296|562065066|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155718866|NCT00647296|562065067|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155718867|NCT00647296|562065068|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155718868|NCT00647296|562065069|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
155718869|NCT00647296|562065066|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
155718870|NCT00647296|562065067|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
155718871|NCT00647296|562065068|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
155718872|NCT00647296|562065069|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
155718873|NCT00647296|562065066|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155718874|NCT00647296|562065067|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
155718875|NCT00647296|562065068|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155718876|NCT00647296|562065069|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155718877|NCT00647296|562065066|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
155718878|NCT00647296|562065067|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155718879|NCT00647296|562065068|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155718880|NCT00647296|562065069|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155718881|NCT00647296|562065066|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
155718882|NCT00647296|562065067|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155718883|NCT00647296|562065068|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155718884|NCT00647296|562065069|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155718885|NCT00647296|562065066|FG000|Part 2: 4-week Placebo Washout|Death|3|||
155718886|NCT00647296|562065067|FG001|Part 2: 4-week Placebo Washout|Death|0|||
155718887|NCT00647296|562065068|FG002|Part 2: 4-week Placebo Washout|Death|0|||
155718888|NCT00647296|562065069|FG003|Part 2: 4-week Placebo Washout|Death|0|||
155718889|NCT00647296|562065066|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
155718890|NCT00647296|562065067|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
155718891|NCT00647296|562065068|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
155718892|NCT00647296|562065069|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
155718893|NCT00647296|562065066|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
155718894|NCT00647296|562065067|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
155718895|NCT00647296|562065068|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
155718896|NCT00647296|562065069|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
155718897|NCT00647296|562065066|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155718898|NCT00647296|562065067|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
155718899|NCT00647296|562065068|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155718900|NCT00647296|562065069|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155718901|NCT00647296|562065066|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
155718902|NCT00647296|562065067|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
155718903|NCT00647296|562065068|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
155718904|NCT00647296|562065069|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
155718905|NCT00647296|562065066|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
155718906|NCT00647296|562065067|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
155718907|NCT00647296|562065068|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
155718908|NCT00647296|562065069|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
155718909|NCT00871871|562065070|FG000|Part I|Adverse Event|0|||
155718910|NCT00871871|562065071|FG001|Part I|Adverse Event|2|||
155718911|NCT00871871|562065072|FG002|Part I|Adverse Event|0|||
155186446|NCT02694523|560122795|FG000|Part A|Adverse Event|7|||
155718912|NCT00871871|562065073|FG003|Part I|Adverse Event|0|||
155718913|NCT00871871|562065070|FG000|Part I|Withdrawal by Subject|3|||
155718914|NCT00871871|562065071|FG001|Part I|Withdrawal by Subject|0|||
155718915|NCT00871871|562065072|FG002|Part I|Withdrawal by Subject|0|||
155718916|NCT00871871|562065073|FG003|Part I|Withdrawal by Subject|0|||
155718917|NCT00871871|562065070|FG000|Part I|Laboratory abnormality|0|||
155718918|NCT00871871|562065071|FG001|Part I|Laboratory abnormality|1|||
155718919|NCT00871871|562065072|FG002|Part I|Laboratory abnormality|0|||
155718920|NCT00871871|562065073|FG003|Part I|Laboratory abnormality|0|||
155718921|NCT00871871|562065070|FG000|Part II|Lack of Efficacy|0|||
155718922|NCT00871871|562065071|FG001|Part II|Lack of Efficacy|0|||
155718923|NCT00871871|562065072|FG002|Part II|Lack of Efficacy|1|||
155718924|NCT00871871|562065073|FG003|Part II|Lack of Efficacy|0|||
155718925|NCT00871871|562065070|FG000|Part II|Withdrawal by Subject|0|||
155718926|NCT00871871|562065071|FG001|Part II|Withdrawal by Subject|0|||
155718927|NCT00871871|562065072|FG002|Part II|Withdrawal by Subject|2|||
155718928|NCT00871871|562065073|FG003|Part II|Withdrawal by Subject|1|||
155718929|NCT00871871|562065070|FG000|Part II|Adverse Event|0|||
155718930|NCT00871871|562065071|FG001|Part II|Adverse Event|0|||
155718931|NCT00871871|562065072|FG002|Part II|Adverse Event|1|||
155718932|NCT00871871|562065073|FG003|Part II|Adverse Event|2|||
155718933|NCT00871871|562065070|FG000|Part II|Protocol Violation|0|||
155718934|NCT00871871|562065071|FG001|Part II|Protocol Violation|0|||
155718935|NCT00871871|562065072|FG002|Part II|Protocol Violation|0|||
155718936|NCT00871871|562065073|FG003|Part II|Protocol Violation|1|||
155718937|NCT02354235|562065074|FG000|Overall Study|Adverse Event|2|||
155718938|NCT02354235|562065075|FG001|Overall Study|Adverse Event|2|||
155718939|NCT02354235|562065074|FG000|Overall Study|Physician Decision|0|||
155718940|NCT02354235|562065075|FG001|Overall Study|Physician Decision|1|||
155718941|NCT02354235|562065074|FG000|Overall Study|Withdrawal by Subject|1|||
155718942|NCT02354235|562065075|FG001|Overall Study|Withdrawal by Subject|3|||
155718943|NCT02354235|562065074|FG000|Overall Study|Conflict with the stopping criteria|0|||
155718944|NCT02354235|562065075|FG001|Overall Study|Conflict with the stopping criteria|1|||
155718945|NCT03069352|562065076|FG000|Overall Study|Ongoing|12|||
155718946|NCT03069352|562065077|FG001|Overall Study|Ongoing|40|||
155718947|NCT02621424|562065078|FG000|Overall Study|Withdrawal by Subject|1|||
155718948|NCT02621424|562065079|FG001|Overall Study|Withdrawal by Subject|2|||
155718949|NCT05148234|562065081|FG000|Phase I|Ineligible|0|||
155718950|NCT05148234|562065082|FG001|Phase I|Ineligible|0|||
155718951|NCT05148234|562065083|FG002|Phase I|Ineligible|0|||
155718952|NCT05148234|562065084|FG003|Phase I|Ineligible|0|||
155718953|NCT05148234|562065085|FG004|Phase I|Ineligible|0|||
155718954|NCT05148234|562065086|FG005|Phase I|Ineligible|0|||
155718955|NCT05148234|562065087|FG006|Phase I|Ineligible|0|||
155718956|NCT05148234|562065088|FG007|Phase I|Ineligible|1|||
155718957|NCT05148234|562065081|FG000|Phase I|Company closed the trial.|0|||
155718958|NCT05148234|562065082|FG001|Phase I|Company closed the trial.|1|||
155718959|NCT05148234|562065083|FG002|Phase I|Company closed the trial.|0|||
155718960|NCT05148234|562065084|FG003|Phase I|Company closed the trial.|0|||
155718961|NCT05148234|562065085|FG004|Phase I|Company closed the trial.|0|||
155718962|NCT05148234|562065086|FG005|Phase I|Company closed the trial.|0|||
155718963|NCT05148234|562065087|FG006|Phase I|Company closed the trial.|0|||
155718964|NCT05148234|562065088|FG007|Phase I|Company closed the trial.|0|||
155718965|NCT04750642|562065090|FG000|Overall Study|Adverse Event|1|||
155718966|NCT04750642|562065091|FG001|Overall Study|Adverse Event|0|||
155718967|NCT04750642|562065090|FG000|Overall Study|Withdrawal by Subject|0|||
155718968|NCT04750642|562065091|FG001|Overall Study|Withdrawal by Subject|1|||
155718969|NCT04750642|562065090|FG000|Overall Study|Protocol Violation|0|||
155718970|NCT04750642|562065091|FG001|Overall Study|Protocol Violation|1|||
155718971|NCT01650194|562065093|FG000|Overall Study|Progressive Disease (PD)|35|||
155718972|NCT01650194|562065093|FG000|Overall Study|Withdrawal by Subject|2|||
155186447|NCT02694523|560122796|FG001|Part A|Adverse Event|3|||
155186448|NCT02694523|560122797|FG002|Part A|Adverse Event|0|||
155186449|NCT02694523|560122798|FG003|Part A|Adverse Event|0|||
155186450|NCT02694523|560122799|FG004|Part A|Adverse Event|0|||
155186451|NCT02694523|560122800|FG005|Part A|Adverse Event|0|||
155186452|NCT02694523|560122801|FG006|Part A|Adverse Event|0|||
155186453|NCT02694523|560122795|FG000|Part A|Protocol Violation|1|||
155186454|NCT02694523|560122796|FG001|Part A|Protocol Violation|0|||
155186455|NCT02694523|560122797|FG002|Part A|Protocol Violation|0|||
155186456|NCT02694523|560122798|FG003|Part A|Protocol Violation|0|||
155186457|NCT02694523|560122799|FG004|Part A|Protocol Violation|0|||
155186458|NCT02694523|560122800|FG005|Part A|Protocol Violation|0|||
155186459|NCT02694523|560122801|FG006|Part A|Protocol Violation|0|||
155186460|NCT02694523|560122795|FG000|Part A|Lost to Follow-up|1|||
155186461|NCT02694523|560122796|FG001|Part A|Lost to Follow-up|2|||
155718973|NCT01650194|562065093|FG000|Overall Study|Miscellaneous|10|||
155718974|NCT04158583|562065098|FG000|Overall Study|Withdrawal by Subject|1|||
155718975|NCT04158583|562065099|FG001|Overall Study|Withdrawal by Subject|1|||
155718976|NCT04158583|562065100|FG002|Overall Study|Withdrawal by Subject|0|||
155718977|NCT04158583|562065101|FG003|Overall Study|Withdrawal by Subject|0|||
155718978|NCT04158583|562065102|FG004|Overall Study|Withdrawal by Subject|1|||
155718979|NCT04158583|562065103|FG005|Overall Study|Withdrawal by Subject|0|||
155718980|NCT04158583|562065104|FG006|Overall Study|Withdrawal by Subject|0|||
155718981|NCT04158583|562065105|FG007|Overall Study|Withdrawal by Subject|0|||
155718982|NCT04158583|562065106|FG008|Overall Study|Withdrawal by Subject|2|||
155718983|NCT04158583|562065107|FG009|Overall Study|Withdrawal by Subject|0|||
155718984|NCT04158583|562065098|FG000|Overall Study|Study Terminated by Sponsor|0|||
155718985|NCT04158583|562065099|FG001|Overall Study|Study Terminated by Sponsor|0|||
155718986|NCT04158583|562065100|FG002|Overall Study|Study Terminated by Sponsor|0|||
155718987|NCT04158583|562065101|FG003|Overall Study|Study Terminated by Sponsor|1|||
155718988|NCT04158583|562065102|FG004|Overall Study|Study Terminated by Sponsor|0|||
155718989|NCT04158583|562065103|FG005|Overall Study|Study Terminated by Sponsor|0|||
155718990|NCT04158583|562065104|FG006|Overall Study|Study Terminated by Sponsor|0|||
155718991|NCT04158583|562065105|FG007|Overall Study|Study Terminated by Sponsor|0|||
155718992|NCT04158583|562065106|FG008|Overall Study|Study Terminated by Sponsor|0|||
155718993|NCT04158583|562065107|FG009|Overall Study|Study Terminated by Sponsor|0|||
155718994|NCT04158583|562065098|FG000|Overall Study|Progressive Disease|1|||
155718995|NCT04158583|562065099|FG001|Overall Study|Progressive Disease|0|||
155718996|NCT04158583|562065100|FG002|Overall Study|Progressive Disease|3|||
155718997|NCT04158583|562065101|FG003|Overall Study|Progressive Disease|5|||
155718998|NCT04158583|562065102|FG004|Overall Study|Progressive Disease|0|||
155718999|NCT04158583|562065103|FG005|Overall Study|Progressive Disease|1|||
155719000|NCT04158583|562065104|FG006|Overall Study|Progressive Disease|6|||
155719001|NCT04158583|562065105|FG007|Overall Study|Progressive Disease|2|||
155719002|NCT04158583|562065106|FG008|Overall Study|Progressive Disease|1|||
155719003|NCT04158583|562065107|FG009|Overall Study|Progressive Disease|2|||
155719004|NCT04158583|562065098|FG000|Overall Study|Lost to Follow-up|0|||
155719005|NCT04158583|562065099|FG001|Overall Study|Lost to Follow-up|0|||
155719006|NCT04158583|562065100|FG002|Overall Study|Lost to Follow-up|1|||
155719007|NCT04158583|562065101|FG003|Overall Study|Lost to Follow-up|1|||
155719008|NCT04158583|562065102|FG004|Overall Study|Lost to Follow-up|1|||
155719009|NCT04158583|562065103|FG005|Overall Study|Lost to Follow-up|0|||
155719010|NCT04158583|562065104|FG006|Overall Study|Lost to Follow-up|0|||
155719011|NCT04158583|562065105|FG007|Overall Study|Lost to Follow-up|0|||
155719012|NCT04158583|562065106|FG008|Overall Study|Lost to Follow-up|0|||
155719013|NCT04158583|562065107|FG009|Overall Study|Lost to Follow-up|0|||
155719014|NCT04158583|562065098|FG000|Overall Study|Due To Patient Status|0|||
155719015|NCT04158583|562065099|FG001|Overall Study|Due To Patient Status|0|||
155719016|NCT04158583|562065100|FG002|Overall Study|Due To Patient Status|0|||
155719017|NCT04158583|562065101|FG003|Overall Study|Due To Patient Status|0|||
155719018|NCT04158583|562065102|FG004|Overall Study|Due To Patient Status|0|||
155719019|NCT04158583|562065103|FG005|Overall Study|Due To Patient Status|0|||
155719020|NCT04158583|562065104|FG006|Overall Study|Due To Patient Status|0|||
155719021|NCT04158583|562065105|FG007|Overall Study|Due To Patient Status|0|||
155719022|NCT04158583|562065106|FG008|Overall Study|Due To Patient Status|1|||
155186462|NCT02694523|560122797|FG002|Part A|Lost to Follow-up|0|||
155186463|NCT02694523|560122798|FG003|Part A|Lost to Follow-up|0|||
155186464|NCT02694523|560122799|FG004|Part A|Lost to Follow-up|0|||
155186465|NCT02694523|560122800|FG005|Part A|Lost to Follow-up|0|||
155186466|NCT02694523|560122801|FG006|Part A|Lost to Follow-up|0|||
155186467|NCT02694523|560122795|FG000|Part A|Withdrawal by Subject|3|||
155719023|NCT04158583|562065107|FG009|Overall Study|Due To Patient Status|0|||
155719024|NCT04158583|562065098|FG000|Overall Study|Death|3|||
155719025|NCT04158583|562065099|FG001|Overall Study|Death|4|||
155719026|NCT04158583|562065100|FG002|Overall Study|Death|2|||
155719027|NCT04158583|562065101|FG003|Overall Study|Death|2|||
155719028|NCT04158583|562065102|FG004|Overall Study|Death|4|||
155719029|NCT04158583|562065103|FG005|Overall Study|Death|3|||
155719030|NCT04158583|562065104|FG006|Overall Study|Death|5|||
155719031|NCT04158583|562065105|FG007|Overall Study|Death|2|||
155719032|NCT04158583|562065106|FG008|Overall Study|Death|0|||
155719033|NCT04158583|562065107|FG009|Overall Study|Death|1|||
155186468|NCT02694523|560122796|FG001|Part A|Withdrawal by Subject|1|||
155186469|NCT02694523|560122797|FG002|Part A|Withdrawal by Subject|0|||
155186470|NCT02694523|560122798|FG003|Part A|Withdrawal by Subject|0|||
155719034|NCT04158583|562065098|FG000|Overall Study|Clinical Progression Disease|0|||
155719035|NCT04158583|562065099|FG001|Overall Study|Clinical Progression Disease|0|||
155719036|NCT04158583|562065100|FG002|Overall Study|Clinical Progression Disease|0|||
155719037|NCT04158583|562065101|FG003|Overall Study|Clinical Progression Disease|1|||
155719038|NCT04158583|562065102|FG004|Overall Study|Clinical Progression Disease|0|||
155719039|NCT04158583|562065103|FG005|Overall Study|Clinical Progression Disease|0|||
155719040|NCT04158583|562065104|FG006|Overall Study|Clinical Progression Disease|0|||
155719041|NCT04158583|562065105|FG007|Overall Study|Clinical Progression Disease|0|||
155719042|NCT04158583|562065106|FG008|Overall Study|Clinical Progression Disease|0|||
155186471|NCT02694523|560122799|FG004|Part A|Withdrawal by Subject|0|||
155186472|NCT02694523|560122800|FG005|Part A|Withdrawal by Subject|0|||
155719043|NCT04158583|562065107|FG009|Overall Study|Clinical Progression Disease|0|||
155719044|NCT04158583|562065098|FG000|Overall Study|Clinical Progression|0|||
155719045|NCT04158583|562065099|FG001|Overall Study|Clinical Progression|0|||
155186473|NCT02694523|560122801|FG006|Part A|Withdrawal by Subject|0|||
155719046|NCT04158583|562065100|FG002|Overall Study|Clinical Progression|0|||
155719047|NCT04158583|562065101|FG003|Overall Study|Clinical Progression|0|||
155719048|NCT04158583|562065102|FG004|Overall Study|Clinical Progression|1|||
155719049|NCT04158583|562065103|FG005|Overall Study|Clinical Progression|0|||
155719050|NCT04158583|562065104|FG006|Overall Study|Clinical Progression|2|||
155719051|NCT04158583|562065105|FG007|Overall Study|Clinical Progression|0|||
155719052|NCT04158583|562065106|FG008|Overall Study|Clinical Progression|0|||
155719053|NCT04158583|562065107|FG009|Overall Study|Clinical Progression|0|||
155719054|NCT04158583|562065098|FG000|Overall Study|Clinical Deterioration|0|||
155719055|NCT04158583|562065099|FG001|Overall Study|Clinical Deterioration|0|||
155719056|NCT04158583|562065100|FG002|Overall Study|Clinical Deterioration|0|||
155719057|NCT04158583|562065101|FG003|Overall Study|Clinical Deterioration|1|||
155719058|NCT04158583|562065102|FG004|Overall Study|Clinical Deterioration|0|||
155719059|NCT04158583|562065103|FG005|Overall Study|Clinical Deterioration|0|||
155719060|NCT04158583|562065104|FG006|Overall Study|Clinical Deterioration|0|||
155719061|NCT04158583|562065105|FG007|Overall Study|Clinical Deterioration|0|||
155719062|NCT04158583|562065106|FG008|Overall Study|Clinical Deterioration|0|||
155719063|NCT04158583|562065107|FG009|Overall Study|Clinical Deterioration|1|||
155719064|NCT03224130|562067179|FG000|Overall Study|consent issue|0|||
155719065|NCT03224130|562067180|FG001|Overall Study|consent issue|1|||
155719066|NCT04124939|562067185|FG000|Overall Study|Lost to Follow-up|1|||
155719067|NCT04124939|562067186|FG001|Overall Study|Lost to Follow-up|3|||
155719068|NCT02210000|562067187|FG000|Overall Study|Study Terminated|11|||
155719069|NCT02210000|562067188|FG001|Overall Study|Study Terminated|12|||
155719070|NCT02210000|562067187|FG000|Overall Study|Withdrawal by Subject|7|||
155719071|NCT02210000|562067188|FG001|Overall Study|Withdrawal by Subject|1|||
155719072|NCT02210000|562067187|FG000|Overall Study|Adverse Event|1|||
155719073|NCT02210000|562067188|FG001|Overall Study|Adverse Event|5|||
155719074|NCT02210000|562067187|FG000|Overall Study|Lost to Follow-up|0|||
155719075|NCT02210000|562067188|FG001|Overall Study|Lost to Follow-up|2|||
155719076|NCT02210000|562067187|FG000|Overall Study|Physician Decision|0|||
155719077|NCT02210000|562067188|FG001|Overall Study|Physician Decision|1|||
155719078|NCT00308139|562067189|FG000|Overall Study|Adverse Event|20|||
155719079|NCT00308139|562067190|FG001|Overall Study|Adverse Event|14|||
155719080|NCT00308139|562067189|FG000|Overall Study|Lost to Follow-up|13|||
155719081|NCT00308139|562067190|FG001|Overall Study|Lost to Follow-up|8|||
155719082|NCT00308139|562067189|FG000|Overall Study|Protocol Violation|3|||
155719083|NCT00308139|562067190|FG001|Overall Study|Protocol Violation|2|||
155719084|NCT00308139|562067189|FG000|Overall Study|Withdrawal of Consent|40|||
155719085|NCT00308139|562067190|FG001|Overall Study|Withdrawal of Consent|42|||
155719086|NCT00308139|562067189|FG000|Overall Study|Investigator Decision|11|||
155719087|NCT00308139|562067190|FG001|Overall Study|Investigator Decision|10|||
155719088|NCT00308139|562067189|FG000|Overall Study|Loss of Glucose Control|5|||
155719089|NCT00308139|562067190|FG001|Overall Study|Loss of Glucose Control|7|||
155719090|NCT00308139|562067189|FG000|Overall Study|Administrative|1|||
155719091|NCT00308139|562067190|FG001|Overall Study|Administrative|4|||
155719092|NCT00308139|562067189|FG000|Overall Study|Other|1|||
155719093|NCT00308139|562067190|FG001|Overall Study|Other|0|||
155719094|NCT01751061|562067199|FG000|Overall Study|Death|1|||
155719095|NCT01751061|562067200|FG001|Overall Study|Death|0|||
155719096|NCT01751061|562067199|FG000|Overall Study|patient death|5|||
155719097|NCT01751061|562067200|FG001|Overall Study|patient death|0|||
155719098|NCT01751061|562067199|FG000|Overall Study|Lost to Follow-up|40|||
155719099|NCT01751061|562067200|FG001|Overall Study|Lost to Follow-up|25|||
155719100|NCT01751061|562067199|FG000|Overall Study|patient regained decisional capacity|4|||
155719101|NCT01751061|562067200|FG001|Overall Study|patient regained decisional capacity|8|||
155719102|NCT01751061|562067199|FG000|Overall Study|Withdrawal by Subject|4|||
155719103|NCT01751061|562067200|FG001|Overall Study|Withdrawal by Subject|1|||
155719104|NCT01751061|562067199|FG000|Overall Study|Physician Decision|2|||
155719105|NCT01751061|562067200|FG001|Overall Study|Physician Decision|0|||
155719106|NCT00768989|562067205|FG000|Prior to Week 24|Withdrawal by Subject|1|||
155719107|NCT00768989|562067206|FG001|Prior to Week 24|Withdrawal by Subject|0|||
155719108|NCT00768989|562067205|FG000|Prior to Week 24|Adverse Event|3|||
155719109|NCT00768989|562067206|FG001|Prior to Week 24|Adverse Event|0|||
155719110|NCT00768989|562067205|FG000|Prior to Week 24|Lost to Follow-up|0|||
155186474|NCT02694523|560122795|FG000|Part A|Other|1|||
155186475|NCT02694523|560122796|FG001|Part A|Other|1|||
155719111|NCT00768989|562067206|FG001|Prior to Week 24|Lost to Follow-up|1|||
155719112|NCT00768989|562067205|FG000|Prior to Week 24|Protocol Violation|0|||
155719113|NCT00768989|562067206|FG001|Prior to Week 24|Protocol Violation|2|||
155719114|NCT00768989|562067205|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
155719115|NCT00768989|562067206|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
155719116|NCT00768989|562067205|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
155719117|NCT00768989|562067206|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
155719118|NCT00768989|562067205|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
155719119|NCT00768989|562067206|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
155719120|NCT00768989|562067205|FG000|On or After Week 36|Lack of Efficacy|1|||
155186476|NCT02694523|560122797|FG002|Part A|Other|0|||
155719121|NCT00768989|562067206|FG001|On or After Week 36|Lack of Efficacy|0|||
155719122|NCT00768989|562067205|FG000|On or After Week 36|Adverse Event|0|||
155719123|NCT00768989|562067206|FG001|On or After Week 36|Adverse Event|1|||
155719124|NCT00768989|562067205|FG000|On or After Week 36|Lost to Follow-up|1|||
155719125|NCT00768989|562067206|FG001|On or After Week 36|Lost to Follow-up|0|||
155719126|NCT00768989|562067205|FG000|On or After Week 36|Poor Compliance|1|||
155719127|NCT00768989|562067206|FG001|On or After Week 36|Poor Compliance|0|||
155719128|NCT00768989|562067205|FG000|On or After Week 36|Protocol Violation|1|||
155719129|NCT00768989|562067206|FG001|On or After Week 36|Protocol Violation|0|||
155719130|NCT00768989|562067205|FG000|On or After Week 36|Did not attend termination visit|2|||
155719131|NCT00768989|562067206|FG001|On or After Week 36|Did not attend termination visit|0|||
155719132|NCT00768989|562067205|FG000|On or After Week 36|Sponsor Termination|45|||
155719133|NCT00768989|562067206|FG001|On or After Week 36|Sponsor Termination|26|||
155719134|NCT02153086|562067207|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
155719135|NCT02153086|562067207|FG000|Overall Study|Other|2|||
155719136|NCT00791388|562067208|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155719137|NCT00791388|562067209|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
155186477|NCT02694523|560122798|FG003|Part A|Other|0|||
155186478|NCT02694523|560122799|FG004|Part A|Other|0|||
155186479|NCT02694523|560122800|FG005|Part A|Other|0|||
155186480|NCT02694523|560122801|FG006|Part A|Other|0|||
155186481|NCT02694523|560122795|FG000|Part B|Adverse Event|0|||
155186482|NCT02694523|560122796|FG001|Part B|Adverse Event|0|||
155719138|NCT00791388|562067210|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155719139|NCT00791388|562067211|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155719140|NCT00791388|562067212|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155719141|NCT00791388|562067208|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
155719142|NCT00791388|562067209|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155719143|NCT00791388|562067210|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155719144|NCT00791388|562067211|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155719145|NCT00791388|562067212|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155719146|NCT00791388|562067208|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155719147|NCT00791388|562067209|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155719148|NCT00791388|562067210|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155719149|NCT00791388|562067211|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155719150|NCT00791388|562067212|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
155719151|NCT01194830|562067213|FG000|Overall Study|Adverse Event|3|||
155719152|NCT01194830|562067214|FG001|Overall Study|Adverse Event|2|||
155719153|NCT01194830|562067213|FG000|Overall Study|Protocol Violation|5|||
155719154|NCT01194830|562067214|FG001|Overall Study|Protocol Violation|4|||
155719155|NCT01194830|562067213|FG000|Overall Study|Lost to Follow-up|9|||
155719156|NCT01194830|562067214|FG001|Overall Study|Lost to Follow-up|7|||
155186483|NCT02694523|560122797|FG002|Part B|Adverse Event|7|||
155186484|NCT02694523|560122798|FG003|Part B|Adverse Event|1|||
155186485|NCT02694523|560122799|FG004|Part B|Adverse Event|1|||
155186486|NCT02694523|560122800|FG005|Part B|Adverse Event|2|||
155186487|NCT02694523|560122801|FG006|Part B|Adverse Event|0|||
155186488|NCT02694523|560122795|FG000|Part B|Protocol Violation|0|||
155186489|NCT02694523|560122796|FG001|Part B|Protocol Violation|0|||
155186490|NCT02694523|560122797|FG002|Part B|Protocol Violation|1|||
155186491|NCT02694523|560122798|FG003|Part B|Protocol Violation|0|||
155186492|NCT02694523|560122799|FG004|Part B|Protocol Violation|0|||
155186493|NCT02694523|560122800|FG005|Part B|Protocol Violation|0|||
155186494|NCT02694523|560122801|FG006|Part B|Protocol Violation|0|||
155186495|NCT02694523|560122795|FG000|Part B|Lost to Follow-up|0|||
155186496|NCT02694523|560122796|FG001|Part B|Lost to Follow-up|0|||
155719157|NCT01194830|562067213|FG000|Overall Study|Withdrawal by Subject|2|||
155719158|NCT01194830|562067214|FG001|Overall Study|Withdrawal by Subject|1|||
155719159|NCT01194830|562067213|FG000|Overall Study|Lack of Efficacy|1|||
155719160|NCT01194830|562067214|FG001|Overall Study|Lack of Efficacy|1|||
155719161|NCT01194830|562067213|FG000|Overall Study|Non-compliance issues|4|||
155719162|NCT01194830|562067214|FG001|Overall Study|Non-compliance issues|4|||
155186497|NCT02694523|560122797|FG002|Part B|Lost to Follow-up|2|||
155186498|NCT02694523|560122798|FG003|Part B|Lost to Follow-up|3|||
155186499|NCT02694523|560122799|FG004|Part B|Lost to Follow-up|2|||
155719163|NCT01194830|562067213|FG000|Overall Study|Other Reason|12|||
155719164|NCT01194830|562067214|FG001|Overall Study|Other Reason|8|||
155719165|NCT03115359|562067215|FG000|Overall Study|Withdrawal by Subject|29|||
155719166|NCT03115359|562067216|FG001|Overall Study|Withdrawal by Subject|39|||
155186500|NCT02694523|560122800|FG005|Part B|Lost to Follow-up|0|||
155186501|NCT02694523|560122801|FG006|Part B|Lost to Follow-up|1|||
155186502|NCT02694523|560122795|FG000|Part B|Withdrawal by Subject|0|||
155186503|NCT02694523|560122796|FG001|Part B|Withdrawal by Subject|0|||
155186504|NCT02694523|560122797|FG002|Part B|Withdrawal by Subject|9|||
155186505|NCT02694523|560122798|FG003|Part B|Withdrawal by Subject|0|||
155186506|NCT02694523|560122799|FG004|Part B|Withdrawal by Subject|1|||
155186507|NCT02694523|560122800|FG005|Part B|Withdrawal by Subject|3|||
155719167|NCT03115359|562067215|FG000|Overall Study|Scheduling conflict|25|||
155719168|NCT03115359|562067216|FG001|Overall Study|Scheduling conflict|23|||
155719169|NCT03115359|562067215|FG000|Overall Study|Personal reasons including health|12|||
155719170|NCT03115359|562067216|FG001|Overall Study|Personal reasons including health|9|||
155719171|NCT03115359|562067215|FG000|Overall Study|Transportation barriers|3|||
155719172|NCT03115359|562067216|FG001|Overall Study|Transportation barriers|0|||
155719173|NCT03115359|562067215|FG000|Overall Study|No longer interested|5|||
155719174|NCT03115359|562067216|FG001|Overall Study|No longer interested|4|||
155719175|NCT03115359|562067215|FG000|Overall Study|No reason provided|45|||
155719176|NCT03115359|562067216|FG001|Overall Study|No reason provided|47|||
155719177|NCT01317472|562067217|FG000|Overall Study|Withdrawal by Subject|1|||
155719178|NCT01317472|562067218|FG001|Overall Study|Withdrawal by Subject|0|||
155719179|NCT01317472|562067217|FG000|Overall Study|Unrelated hospitalization|1|||
155719180|NCT01317472|562067218|FG001|Overall Study|Unrelated hospitalization|0|||
155719181|NCT01815918|562067219|FG000|Overall Study|Patient samples not analyzable|3|||
155719182|NCT01815918|562067220|FG001|Overall Study|Patient samples not analyzable|4|||
155719183|NCT01815918|562067219|FG000|Overall Study|Lack of Efficacy|15|||
155719184|NCT01815918|562067220|FG001|Overall Study|Lack of Efficacy|15|||
155719185|NCT02412306|562067232|FG000|Overall Study|Lost to Follow-up|0|||
155719186|NCT02412306|562067233|FG001|Overall Study|Lost to Follow-up|1|||
155719187|NCT02412306|562067234|FG002|Overall Study|Lost to Follow-up|0|||
155719188|NCT02412306|562067235|FG003|Overall Study|Lost to Follow-up|0|||
155719189|NCT02412306|562067236|FG004|Overall Study|Lost to Follow-up|0|||
155719190|NCT02412306|562067232|FG000|Overall Study|Withdrawal by Subject|0|||
155719191|NCT02412306|562067233|FG001|Overall Study|Withdrawal by Subject|0|||
155719192|NCT02412306|562067234|FG002|Overall Study|Withdrawal by Subject|1|||
155719193|NCT02412306|562067235|FG003|Overall Study|Withdrawal by Subject|0|||
155719194|NCT02412306|562067236|FG004|Overall Study|Withdrawal by Subject|0|||
155719195|NCT02412306|562067232|FG000|Overall Study|Death|5|||
155719196|NCT02412306|562067233|FG001|Overall Study|Death|7|||
155719197|NCT02412306|562067234|FG002|Overall Study|Death|15|||
155719198|NCT02412306|562067235|FG003|Overall Study|Death|0|||
155719199|NCT02412306|562067236|FG004|Overall Study|Death|2|||
155719200|NCT00443040|562067242|FG000|Overall Study|Withdrawal by Subject|1|||
155719201|NCT00443040|562067243|FG001|Overall Study|Withdrawal by Subject|0|||
155719202|NCT00443040|562067244|FG002|Overall Study|Withdrawal by Subject|0|||
155719203|NCT00443040|562067242|FG000|Overall Study|Converted to an open laparotomy|3|||
155719204|NCT00443040|562067243|FG001|Overall Study|Converted to an open laparotomy|0|||
155719205|NCT00443040|562067244|FG002|Overall Study|Converted to an open laparotomy|1|||
155719206|NCT00866177|562067245|FG000|Overall Study|Withdrawal by Subject|1|||
155719207|NCT00866177|562067245|FG000|Overall Study|Not Treated|151|||
155719208|NCT00435409|562067247|FG000|Overall Study|Protocol Violation|1|||
155719209|NCT00435409|562067248|FG001|Overall Study|Protocol Violation|2|||
155719210|NCT00435409|562067249|FG002|Overall Study|Protocol Violation|0|||
155719211|NCT00435409|562067247|FG000|Overall Study|Lost to Follow-up|1|||
155719212|NCT00435409|562067248|FG001|Overall Study|Lost to Follow-up|2|||
155719213|NCT00435409|562067249|FG002|Overall Study|Lost to Follow-up|0|||
155719214|NCT00435409|562067247|FG000|Overall Study|Death|8|||
155719215|NCT00435409|562067248|FG001|Overall Study|Death|6|||
155719216|NCT00435409|562067249|FG002|Overall Study|Death|6|||
155719217|NCT00435409|562067247|FG000|Overall Study|Objective progression or relapse|158|||
155719218|NCT00435409|562067248|FG001|Overall Study|Objective progression or relapse|93|||
155719219|NCT00435409|562067249|FG002|Overall Study|Objective progression or relapse|58|||
155719220|NCT00435409|562067247|FG000|Overall Study|Global deterioration of health status|0|||
155719221|NCT00435409|562067248|FG001|Overall Study|Global deterioration of health status|0|||
155719222|NCT00435409|562067249|FG002|Overall Study|Global deterioration of health status|4|||
155719223|NCT00435409|562067247|FG000|Overall Study|Withdrawal by Subject|8|||
155719224|NCT00435409|562067248|FG001|Overall Study|Withdrawal by Subject|7|||
155719225|NCT00435409|562067249|FG002|Overall Study|Withdrawal by Subject|1|||
155719226|NCT00435409|562067247|FG000|Overall Study|Other|45|||
155719227|NCT00435409|562067248|FG001|Overall Study|Other|30|||
155719228|NCT00435409|562067249|FG002|Overall Study|Other|1|||
155719229|NCT00435409|562067247|FG000|Overall Study|Adverse Event|0|||
155719230|NCT00435409|562067248|FG001|Overall Study|Adverse Event|0|||
155719231|NCT00435409|562067249|FG002|Overall Study|Adverse Event|8|||
155719232|NCT00435409|562067247|FG000|Overall Study|Sponsor decision|0|||
155719233|NCT00435409|562067248|FG001|Overall Study|Sponsor decision|3|||
155719234|NCT00435409|562067249|FG002|Overall Study|Sponsor decision|0|||
155719235|NCT00117637|562067254|FG000|First Intervention (Period 1)|Adverse Event|11|||
155719236|NCT00117637|562067255|FG001|First Intervention (Period 1)|Adverse Event|16|||
155719237|NCT00117637|562067254|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
155719238|NCT00117637|562067255|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
155719239|NCT00117637|562067254|FG000|First Intervention (Period 1)|Protocol Violation|1|||
155719240|NCT00117637|562067255|FG001|First Intervention (Period 1)|Protocol Violation|0|||
155719241|NCT00117637|562067254|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
155719242|NCT00117637|562067255|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
155719243|NCT00117637|562067254|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
155719244|NCT00117637|562067255|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
155719245|NCT00117637|562067254|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
155719246|NCT00117637|562067255|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
155719247|NCT00117637|562067254|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
155719248|NCT00117637|562067255|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
155719249|NCT00117637|562067254|FG000|First Intervention (Period 1)|reason not reported|0|||
155719250|NCT00117637|562067255|FG001|First Intervention (Period 1)|reason not reported|1|||
155719251|NCT00117637|562067254|FG000|Second Intervention (Period 2)|Adverse Event|0|||
155719252|NCT00117637|562067255|FG001|Second Intervention (Period 2)|Adverse Event|9|||
155719253|NCT00117637|562067254|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
155719254|NCT00117637|562067255|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
155719255|NCT00117637|562067254|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
155719256|NCT00117637|562067255|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
155719257|NCT00117637|562067254|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
155719258|NCT00117637|562067255|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
155719259|NCT00117637|562067254|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
155719260|NCT00117637|562067255|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
155719261|NCT00117637|562067254|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
155719262|NCT00117637|562067255|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
155719263|NCT00117637|562067254|FG000|Second Intervention (Period 2)|reason not reported|1|||
155719264|NCT00117637|562067255|FG001|Second Intervention (Period 2)|reason not reported|0|||
155719265|NCT02914639|562067262|FG000|Overall Study|Withdrawal by Subject|0|||
155719266|NCT02914639|562067263|FG001|Overall Study|Withdrawal by Subject|2|||
155719267|NCT00189540|562067265|FG000|Overall Study|Withdrawal by Subject|3|||
155719268|NCT00189540|562067266|FG001|Overall Study|Withdrawal by Subject|0|||
155719269|NCT00189540|562067265|FG000|Overall Study|Death|4|||
155719270|NCT00189540|562067266|FG001|Overall Study|Death|1|||
155719271|NCT00062439|562067267|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
155719272|NCT00062439|562067267|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
155719273|NCT00062439|562067267|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
155719274|NCT00062439|562067267|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
155719275|NCT00062439|562067267|FG000|Post Chemoradiation Assessment|Death|1|||
155719276|NCT00062439|562067267|FG000|Post Chemoradiation Assessment|Disease progression|2|||
155719277|NCT00062439|562067267|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
155719278|NCT00062439|562067267|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
155719279|NCT00062439|562067267|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
155719280|NCT00062439|562067267|FG000|Surgery|Physician Decision|4|||
155719281|NCT00062439|562067267|FG000|Surgery|Death|1|||
155719282|NCT00062439|562067267|FG000|Surgery|Adverse Event|2|||
155719283|NCT00062439|562067267|FG000|Consolidation Chemotherapy|Adverse Event|2|||
155719284|NCT01924845|562067268|FG000|Overall Study|Adverse Event|3|||
155719285|NCT01924845|562067268|FG000|Overall Study|Withdrawal by Subject|2|||
155719286|NCT01924845|562067268|FG000|Overall Study|Protocol Violation|1|||
155719287|NCT01903356|562067269|FG000|Overall Study|Lost to Follow-up|7|||
155719288|NCT01903356|562067269|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
155719289|NCT01903356|562067269|FG000|Overall Study|Violated the dosage and administration|3|||
155719290|NCT00286442|562067270|FG000|Overall Study|Hyperglycemic Rescue|19|||
155719291|NCT00286442|562067271|FG001|Overall Study|Hyperglycemic Rescue|17|||
155719292|NCT00286442|562067272|FG002|Overall Study|Hyperglycemic Rescue|25|||
155719293|NCT00286442|562067270|FG000|Overall Study|Adverse Event|7|||
155719294|NCT00286442|562067271|FG001|Overall Study|Adverse Event|6|||
155719295|NCT00286442|562067272|FG002|Overall Study|Adverse Event|1|||
155719296|NCT00286442|562067270|FG000|Overall Study|Protocol Violation|2|||
155719297|NCT00286442|562067271|FG001|Overall Study|Protocol Violation|4|||
155719298|NCT00286442|562067272|FG002|Overall Study|Protocol Violation|2|||
155719299|NCT00286442|562067270|FG000|Overall Study|Lost to Follow-up|5|||
155719300|NCT00286442|562067271|FG001|Overall Study|Lost to Follow-up|2|||
155719301|NCT00286442|562067272|FG002|Overall Study|Lost to Follow-up|1|||
155719302|NCT00286442|562067270|FG000|Overall Study|Physician Decision|1|||
155719303|NCT00286442|562067271|FG001|Overall Study|Physician Decision|1|||
155719304|NCT00286442|562067272|FG002|Overall Study|Physician Decision|1|||
155719305|NCT00286442|562067270|FG000|Overall Study|Administrative Error|1|||
155719306|NCT00286442|562067271|FG001|Overall Study|Administrative Error|1|||
155719307|NCT00286442|562067272|FG002|Overall Study|Administrative Error|0|||
155719308|NCT00286442|562067270|FG000|Overall Study|Withdrawal by Subject|2|||
155719309|NCT00286442|562067271|FG001|Overall Study|Withdrawal by Subject|14|||
155719310|NCT00286442|562067272|FG002|Overall Study|Withdrawal by Subject|2|||
155719311|NCT02140047|562067273|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155719312|NCT02140047|562067274|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155719313|NCT02140047|562067275|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155719314|NCT02174731|562067276|FG000|Overall Study|Participant decision|67|||
155719315|NCT02174731|562067277|FG001|Overall Study|Participant decision|64|||
155719316|NCT02174731|562067276|FG000|Overall Study|Incorrect enrolment before randomization|0|||
155719317|NCT02174731|562067277|FG001|Overall Study|Incorrect enrolment before randomization|1|||
155719318|NCT02174731|562067276|FG000|Overall Study|Missing|2|||
155719319|NCT02174731|562067277|FG001|Overall Study|Missing|0|||
155719320|NCT00079040|562067278|FG000|Overall Study|Withdrew before treatment|1|||
155719321|NCT00079040|562067278|FG000|Overall Study|Ineligible|1|||
155719322|NCT00325897|562067279|FG000|Overall Study|Lost to Follow-up|12|||
155719323|NCT00325897|562067280|FG001|Overall Study|Lost to Follow-up|13|||
155719324|NCT04079296|562067281|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155719325|NCT04079296|562067282|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155719326|NCT04079296|562067283|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155719327|NCT04079296|562067284|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
155719328|NCT04079296|562067285|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
155719329|NCT04079296|562067281|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155719330|NCT04079296|562067282|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155719331|NCT04079296|562067283|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155719332|NCT04079296|562067284|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
155719333|NCT04079296|562067285|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
155719334|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155719335|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155719336|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155719337|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155719338|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
155719339|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155719340|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155719341|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155719342|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155719343|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
155719344|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155719345|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155719346|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155719347|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
155719348|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155719349|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155719350|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155719351|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155719352|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
155719353|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
155719354|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155719355|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155186508|NCT02694523|560122801|FG006|Part B|Withdrawal by Subject|0|||
155186509|NCT02694523|560122795|FG000|Part B|Other|0|||
155186510|NCT02694523|560122796|FG001|Part B|Other|0|||
155186511|NCT02694523|560122797|FG002|Part B|Other|1|||
155186512|NCT02694523|560122798|FG003|Part B|Other|0|||
155186513|NCT02694523|560122799|FG004|Part B|Other|0|||
155186514|NCT02694523|560122800|FG005|Part B|Other|0|||
155186515|NCT02694523|560122801|FG006|Part B|Other|1|||
155186516|NCT01367119|560122806|FG000|Overall Study|Adverse Event|1|||
155186517|NCT01367119|560122807|FG001|Overall Study|Adverse Event|0|||
155186518|NCT01367119|560122806|FG000|Overall Study|Withdrawal by Subject|1|||
155186519|NCT01367119|560122807|FG001|Overall Study|Withdrawal by Subject|1|||
155186520|NCT01028378|560122812|FG000|Overall Study|Lost to Follow-up|12|||
155186521|NCT01028378|560122812|FG000|Overall Study|Withdrawal by Subject|1|||
155186522|NCT01028378|560122812|FG000|Overall Study|Adminstrative Reasons|4|||
155719356|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155719357|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
155719358|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
155186523|NCT00064298|560122813|FG000|Overall Study|Withdrawal by Subject|2|||
155186524|NCT00064298|560122814|FG001|Overall Study|Withdrawal by Subject|1|||
155186525|NCT00064298|560122813|FG000|Overall Study|Lost to Follow-up|2|||
155186526|NCT00064298|560122814|FG001|Overall Study|Lost to Follow-up|2|||
155719359|NCT04079296|562067281|FG000|Dose Expansion Phase (168 Days)|Death|0|||
155719360|NCT04079296|562067282|FG001|Dose Expansion Phase (168 Days)|Death|0|||
155719361|NCT04079296|562067283|FG002|Dose Expansion Phase (168 Days)|Death|0|||
155719362|NCT04079296|562067284|FG003|Dose Expansion Phase (168 Days)|Death|1|||
155719363|NCT04079296|562067285|FG004|Dose Expansion Phase (168 Days)|Death|0|||
155719364|NCT00467740|562067286|FG000|Overall Study|Adverse Event|0|||
155719365|NCT00467740|562067287|FG001|Overall Study|Adverse Event|0|||
155719366|NCT00467740|562067288|FG002|Overall Study|Adverse Event|1|||
155719367|NCT00467740|562067289|FG003|Overall Study|Adverse Event|0|||
155719368|NCT00467740|562067290|FG004|Overall Study|Adverse Event|0|||
155719369|NCT00467740|562067286|FG000|Overall Study|Protocol Violation|0|||
155719370|NCT00467740|562067287|FG001|Overall Study|Protocol Violation|0|||
155719371|NCT00467740|562067288|FG002|Overall Study|Protocol Violation|1|||
155719372|NCT00467740|562067289|FG003|Overall Study|Protocol Violation|0|||
155719373|NCT00467740|562067290|FG004|Overall Study|Protocol Violation|0|||
155719374|NCT00467740|562067286|FG000|Overall Study|Lost to Follow-up|0|||
155719375|NCT00467740|562067287|FG001|Overall Study|Lost to Follow-up|1|||
155719376|NCT00467740|562067288|FG002|Overall Study|Lost to Follow-up|0|||
155719377|NCT00467740|562067289|FG003|Overall Study|Lost to Follow-up|0|||
155719378|NCT00467740|562067290|FG004|Overall Study|Lost to Follow-up|0|||
155719379|NCT00467740|562067286|FG000|Overall Study|Withdrawal by Subject|1|||
155719380|NCT00467740|562067287|FG001|Overall Study|Withdrawal by Subject|1|||
155719381|NCT00467740|562067288|FG002|Overall Study|Withdrawal by Subject|0|||
155719382|NCT00467740|562067289|FG003|Overall Study|Withdrawal by Subject|1|||
155719383|NCT00467740|562067290|FG004|Overall Study|Withdrawal by Subject|0|||
155719384|NCT00467740|562067286|FG000|Overall Study|Lack of Efficacy|0|||
155719385|NCT00467740|562067287|FG001|Overall Study|Lack of Efficacy|1|||
155719386|NCT00467740|562067288|FG002|Overall Study|Lack of Efficacy|0|||
155719387|NCT00467740|562067289|FG003|Overall Study|Lack of Efficacy|0|||
155719388|NCT00467740|562067290|FG004|Overall Study|Lack of Efficacy|0|||
155719389|NCT02903160|562067291|FG000|Overall Study|Adverse Event|2|||
155719390|NCT02903160|562067291|FG000|Overall Study|Death|1|||
155719391|NCT02903160|562067291|FG000|Overall Study|Lost to Follow-up|2|||
155719392|NCT02903160|562067291|FG000|Overall Study|Withdrawal by Subject|1|||
155719393|NCT02903160|562067291|FG000|Overall Study|Medical Insurance Barriers|1|||
155719394|NCT01664910|562067294|FG000|Overall Study|Adverse Event|0|||
155719395|NCT01664910|562067295|FG001|Overall Study|Adverse Event|0|||
155719396|NCT01664910|562067296|FG002|Overall Study|Adverse Event|1|||
155719397|NCT02240485|562067297|FG000|3 Months Post-admission|Lost to Follow-up|1|||
155719398|NCT02240485|562067298|FG001|3 Months Post-admission|Lost to Follow-up|5|||
155719399|NCT02240485|562067297|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
155719400|NCT02240485|562067298|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
155719401|NCT02240485|562067297|FG000|9 Months Post-admission|Lost to Follow-up|3|||
155186527|NCT00064298|560122813|FG000|Overall Study|Death|0|||
155186528|NCT00064298|560122814|FG001|Overall Study|Death|1|||
155186529|NCT00064298|560122813|FG000|Overall Study|Disease Progression|2|||
155186530|NCT00064298|560122814|FG001|Overall Study|Disease Progression|1|||
155186531|NCT02017171|560122815|FG000|Overall Study|Death|10|||
155186532|NCT02017171|560122816|FG001|Overall Study|Death|4|||
155186533|NCT02017171|560122815|FG000|Overall Study|Withdrawal by Subject|23|||
155186534|NCT02017171|560122816|FG001|Overall Study|Withdrawal by Subject|17|||
155186535|NCT02017171|560122815|FG000|Overall Study|Lost to Follow-up|21|||
155186536|NCT02017171|560122816|FG001|Overall Study|Lost to Follow-up|20|||
155186537|NCT02017171|560122815|FG000|Overall Study|ESKD|6|||
155186538|NCT02017171|560122816|FG001|Overall Study|ESKD|2|||
155186539|NCT02017171|560122815|FG000|Overall Study|Miscellaneous|2|||
155186540|NCT02017171|560122816|FG001|Overall Study|Miscellaneous|3|||
155186541|NCT02220998|560122817|FG000|Overall Study|Randomized but Never Treated|1|||
155186542|NCT02220998|560122818|FG001|Overall Study|Randomized but Never Treated|2|||
155186543|NCT02220998|560122817|FG000|Overall Study|Death|2|||
155186544|NCT02220998|560122818|FG001|Overall Study|Death|0|||
155186545|NCT02220998|560122817|FG000|Overall Study|Lack of Efficacy|0|||
155186546|NCT02220998|560122818|FG001|Overall Study|Lack of Efficacy|5|||
155186547|NCT02220998|560122817|FG000|Overall Study|Lost to Follow-up|4|||
155186548|NCT02220998|560122818|FG001|Overall Study|Lost to Follow-up|4|||
155186549|NCT03309046|560122819|FG000|Overall Study|Withdrawal by Subject|4|||
155719402|NCT02240485|562067298|FG001|9 Months Post-admission|Lost to Follow-up|1|||
155719403|NCT02240485|562067297|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
155719404|NCT02240485|562067298|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
155719405|NCT02240485|562067297|FG000|18 Months Post-admission|Lost to Follow-up|1|||
155719406|NCT02240485|562067298|FG001|18 Months Post-admission|Lost to Follow-up|1|||
155719407|NCT02240485|562067297|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
155719408|NCT02240485|562067298|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
155719409|NCT01919229|562067302|FG000|Overall Study|Subject/guardian decision|0|||
155186550|NCT03309046|560122820|FG001|Overall Study|Withdrawal by Subject|17|||
155186551|NCT02280473|560122822|FG000|Overall Study|Adverse Event|1|||
155186552|NCT02280473|560122823|FG001|Overall Study|Adverse Event|1|||
155186553|NCT02280473|560122822|FG000|Overall Study|Lack of Efficacy|0|||
155186554|NCT02280473|560122823|FG001|Overall Study|Lack of Efficacy|1|||
155719410|NCT01919229|562067303|FG001|Overall Study|Subject/guardian decision|0|||
155719411|NCT01919229|562067304|FG002|Overall Study|Subject/guardian decision|1|||
155719412|NCT01632020|562067305|FG000|Overall Study|Withdrawal by Subject|1|||
155719413|NCT01632020|562067306|FG001|Overall Study|Withdrawal by Subject|0|||
155719414|NCT01632020|562067305|FG000|Overall Study|Adverse Event|1|||
155719415|NCT01632020|562067306|FG001|Overall Study|Adverse Event|0|||
155719416|NCT00549640|562067308|FG000|Overall Study|Withdrawal by Subject|6|||
155719417|NCT00549640|562067309|FG001|Overall Study|Withdrawal by Subject|12|||
155719418|NCT00549640|562067308|FG000|Overall Study|Adverse Event|5|||
155719419|NCT00549640|562067309|FG001|Overall Study|Adverse Event|0|||
155719420|NCT00549640|562067308|FG000|Overall Study|Lost to Follow-up|7|||
155719421|NCT00549640|562067309|FG001|Overall Study|Lost to Follow-up|4|||
155719422|NCT04999839|562067314|FG000|Overall Study|Adverse Event|1|||
155719423|NCT04999839|562067315|FG001|Overall Study|Adverse Event|1|||
155719424|NCT04999839|562067316|FG002|Overall Study|Adverse Event|1|||
155719425|NCT04999839|562067317|FG003|Overall Study|Adverse Event|1|||
155719426|NCT04999839|562067318|FG004|Overall Study|Adverse Event|1|||
155719427|NCT04999839|562067314|FG000|Overall Study|Lost to Follow-up|2|||
155719428|NCT04999839|562067315|FG001|Overall Study|Lost to Follow-up|0|||
155719429|NCT04999839|562067316|FG002|Overall Study|Lost to Follow-up|2|||
155719430|NCT04999839|562067317|FG003|Overall Study|Lost to Follow-up|4|||
155719431|NCT04999839|562067318|FG004|Overall Study|Lost to Follow-up|1|||
155719432|NCT04999839|562067314|FG000|Overall Study|Withdrawal by Subject|6|||
155719433|NCT04999839|562067315|FG001|Overall Study|Withdrawal by Subject|5|||
155719434|NCT04999839|562067316|FG002|Overall Study|Withdrawal by Subject|3|||
155719435|NCT04999839|562067317|FG003|Overall Study|Withdrawal by Subject|2|||
155719436|NCT04999839|562067318|FG004|Overall Study|Withdrawal by Subject|2|||
155719437|NCT04999839|562067314|FG000|Overall Study|Lack of Efficacy|0|||
155719438|NCT04999839|562067315|FG001|Overall Study|Lack of Efficacy|1|||
155719439|NCT04999839|562067316|FG002|Overall Study|Lack of Efficacy|0|||
155719440|NCT04999839|562067317|FG003|Overall Study|Lack of Efficacy|0|||
155719441|NCT04999839|562067318|FG004|Overall Study|Lack of Efficacy|0|||
155719442|NCT04999839|562067314|FG000|Overall Study|Physician Decision|0|||
155719443|NCT04999839|562067315|FG001|Overall Study|Physician Decision|0|||
155719444|NCT04999839|562067316|FG002|Overall Study|Physician Decision|0|||
155719445|NCT04999839|562067317|FG003|Overall Study|Physician Decision|0|||
155719446|NCT04999839|562067318|FG004|Overall Study|Physician Decision|1|||
155719447|NCT04999839|562067314|FG000|Overall Study|Sponsor request|0|||
155719448|NCT04999839|562067315|FG001|Overall Study|Sponsor request|1|||
155719449|NCT04999839|562067316|FG002|Overall Study|Sponsor request|0|||
155719450|NCT04999839|562067317|FG003|Overall Study|Sponsor request|0|||
155719451|NCT04999839|562067318|FG004|Overall Study|Sponsor request|0|||
155719452|NCT04999839|562067314|FG000|Overall Study|Other|0|||
155719453|NCT04999839|562067315|FG001|Overall Study|Other|0|||
155719454|NCT04999839|562067316|FG002|Overall Study|Other|1|||
155719455|NCT04999839|562067317|FG003|Overall Study|Other|0|||
155719456|NCT04999839|562067318|FG004|Overall Study|Other|0|||
155719457|NCT02734693|562067319|FG000|Overall Study|Adverse Event|1|||
155719458|NCT02734693|562067320|FG001|Overall Study|Adverse Event|3|||
155719459|NCT02734693|562067321|FG002|Overall Study|Adverse Event|3|||
155719460|NCT02734693|562067319|FG000|Overall Study|Lack of Efficacy|1|||
155719461|NCT02734693|562067320|FG001|Overall Study|Lack of Efficacy|0|||
155719462|NCT02734693|562067321|FG002|Overall Study|Lack of Efficacy|0|||
155719463|NCT02734693|562067319|FG000|Overall Study|Lost to Follow-up|2|||
155719464|NCT02734693|562067320|FG001|Overall Study|Lost to Follow-up|0|||
155719465|NCT02734693|562067321|FG002|Overall Study|Lost to Follow-up|0|||
155719466|NCT02734693|562067319|FG000|Overall Study|Protocol Violation|1|||
155719467|NCT02734693|562067320|FG001|Overall Study|Protocol Violation|0|||
155719468|NCT02734693|562067321|FG002|Overall Study|Protocol Violation|0|||
155186555|NCT02280473|560122822|FG000|Overall Study|Lost to Follow-up|0|||
155186556|NCT02280473|560122823|FG001|Overall Study|Lost to Follow-up|1|||
155186557|NCT01539317|560122824|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
155186558|NCT01539317|560122825|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
155186559|NCT02393690|560122826|FG000|Overall Study|Ineligible|0|||
155719469|NCT02734693|562067319|FG000|Overall Study|Withdrawal by Subject|1|||
155719470|NCT02734693|562067320|FG001|Overall Study|Withdrawal by Subject|0|||
155719471|NCT02734693|562067321|FG002|Overall Study|Withdrawal by Subject|0|||
155719472|NCT03261336|562067322|FG000|Overall Study|Adverse Event|1|||
155719473|NCT00292942|562067324|FG000|Overall Study|Withdrawal by Subject|0|||
155719474|NCT00292942|562067325|FG001|Overall Study|Withdrawal by Subject|0|||
155186560|NCT02393690|560122827|FG001|Overall Study|Ineligible|1|||
155719475|NCT00292942|562067326|FG002|Overall Study|Withdrawal by Subject|1|||
155186561|NCT00591266|560122828|FG000|Overall Study|Adverse Event|2|||
155719476|NCT00292942|562067327|FG003|Overall Study|Withdrawal by Subject|0|||
155719477|NCT00292942|562067324|FG000|Overall Study|Adverse Event|0|||
155186562|NCT00591266|560122829|FG001|Overall Study|Adverse Event|2|||
155719478|NCT00292942|562067325|FG001|Overall Study|Adverse Event|0|||
155719479|NCT00292942|562067326|FG002|Overall Study|Adverse Event|0|||
155719480|NCT00292942|562067327|FG003|Overall Study|Adverse Event|1|||
155719481|NCT00644358|562067328|FG000|Overall Study|Adverse Event|124|||
155719482|NCT00644358|562067328|FG000|Overall Study|Lost to Follow-up|105|||
155719483|NCT00644358|562067328|FG000|Overall Study|Consent Withdrawal|64|||
155719484|NCT00644358|562067328|FG000|Overall Study|Lack of Effectiveness|39|||
155719485|NCT00644358|562067328|FG000|Overall Study|Protocol Violation|5|||
155719486|NCT00644358|562067328|FG000|Overall Study|Noncompliance|14|||
155719487|NCT00644358|562067328|FG000|Overall Study|Other Unspecified|11|||
155719488|NCT04264442|562067335|FG000|Overall Study|Lack of Efficacy|6|||
155719489|NCT04264442|562067335|FG000|Overall Study|Lost to Follow-up|2|||
155719490|NCT04264442|562067335|FG000|Overall Study|Sponsor Decision|23|||
155719491|NCT04264442|562067335|FG000|Overall Study|Withdrawal by Subject|11|||
155719492|NCT04264442|562067335|FG000|Overall Study|Study Termination|5|||
155719493|NCT01290523|562067336|FG000|Overall Study|Death|3|||
155719494|NCT00740220|562069019|FG000|Overall Study|screen failures (non-COPD patients)|9|||
155719495|NCT00633477|562069020|FG000|Overall Study|Death|1|||
155719496|NCT00633477|562069021|FG001|Overall Study|Death|0|||
155719497|NCT00633477|562069020|FG000|Overall Study|Randomized but not treated|1|||
155719498|NCT00633477|562069021|FG001|Overall Study|Randomized but not treated|0|||
155719499|NCT00770653|562069025|FG000|Overall Study|Adverse Event|13|||
155719500|NCT00770653|562069026|FG001|Overall Study|Adverse Event|5|||
155719501|NCT00770653|562069025|FG000|Overall Study|Protocol Violation|8|||
155719502|NCT00770653|562069026|FG001|Overall Study|Protocol Violation|6|||
155719503|NCT00770653|562069025|FG000|Overall Study|Withdrawal by Subject|4|||
155719504|NCT00770653|562069026|FG001|Overall Study|Withdrawal by Subject|7|||
155719505|NCT00770653|562069025|FG000|Overall Study|Lack of Compliance|1|||
155719506|NCT00770653|562069026|FG001|Overall Study|Lack of Compliance|4|||
155719507|NCT00770653|562069025|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
155719508|NCT00770653|562069026|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
155719509|NCT00770653|562069025|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
155719510|NCT00770653|562069026|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
155719511|NCT00770653|562069025|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
155719512|NCT00770653|562069026|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
155719513|NCT00770653|562069025|FG000|Overall Study|Lost to Follow-up|1|||
155719514|NCT00770653|562069026|FG001|Overall Study|Lost to Follow-up|2|||
155719515|NCT00770653|562069025|FG000|Overall Study|Physician Decision|1|||
155719516|NCT00770653|562069026|FG001|Overall Study|Physician Decision|0|||
155719517|NCT04906499|562069032|FG000|Overall Study|Lack of time|1|||
155719518|NCT00644423|562069034|FG000|Overall Study|Lost to Follow-up|1|||
155719519|NCT00644423|562069035|FG001|Overall Study|Lost to Follow-up|1|||
155719520|NCT03525444|562069036|FG000|Overall Study|Adverse Event|0|||
155719521|NCT03525444|562069037|FG001|Overall Study|Adverse Event|1|||
155719522|NCT03525444|562069036|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155719523|NCT03525444|562069037|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155719524|NCT03525444|562069036|FG000|Overall Study|Other|0|||
155719525|NCT03525444|562069037|FG001|Overall Study|Other|1|||
155719526|NCT00262860|562069040|FG000|Overall Study|Adverse Event|2|||
155719527|NCT00878501|562069041|FG000|Overall Study|Adverse Event|11|||
155719528|NCT00878501|562069042|FG001|Overall Study|Adverse Event|3|||
155719529|NCT00878501|562069043|FG002|Overall Study|Adverse Event|3|||
155719530|NCT00878501|562069041|FG000|Overall Study|Lack of Efficacy|2|||
155186563|NCT00591266|560122830|FG002|Overall Study|Adverse Event|3|||
155186564|NCT00591266|560122828|FG000|Overall Study|Lost to Follow-up|0|||
155186565|NCT00591266|560122829|FG001|Overall Study|Lost to Follow-up|1|||
155186566|NCT00591266|560122830|FG002|Overall Study|Lost to Follow-up|0|||
155186567|NCT00591266|560122828|FG000|Overall Study|Protocol Violation|0|||
155186568|NCT00591266|560122829|FG001|Overall Study|Protocol Violation|0|||
155186569|NCT00591266|560122830|FG002|Overall Study|Protocol Violation|1|||
155186570|NCT00591266|560122828|FG000|Overall Study|Withdrawal by Subject|6|||
155719531|NCT00878501|562069042|FG001|Overall Study|Lack of Efficacy|1|||
155719532|NCT00878501|562069043|FG002|Overall Study|Lack of Efficacy|0|||
155719533|NCT00878501|562069041|FG000|Overall Study|Withdrawal by Subject|2|||
155719534|NCT00878501|562069042|FG001|Overall Study|Withdrawal by Subject|1|||
155719535|NCT00878501|562069043|FG002|Overall Study|Withdrawal by Subject|2|||
155719536|NCT00878501|562069041|FG000|Overall Study|Protocol Violation|0|||
155719537|NCT00878501|562069042|FG001|Overall Study|Protocol Violation|0|||
155719538|NCT00878501|562069043|FG002|Overall Study|Protocol Violation|1|||
155719539|NCT00878501|562069041|FG000|Overall Study|Incorrect enrolment|1|||
155719540|NCT00878501|562069042|FG001|Overall Study|Incorrect enrolment|2|||
155719541|NCT00878501|562069043|FG002|Overall Study|Incorrect enrolment|0|||
155719542|NCT00878501|562069041|FG000|Overall Study|Intake of prohibited concom. medication|0|||
155719543|NCT00878501|562069042|FG001|Overall Study|Intake of prohibited concom. medication|0|||
155719544|NCT00878501|562069043|FG002|Overall Study|Intake of prohibited concom. medication|1|||
155719545|NCT00878501|562069041|FG000|Overall Study|Mis-randomisation of patient|1|||
155719546|NCT00878501|562069042|FG001|Overall Study|Mis-randomisation of patient|0|||
155719547|NCT00878501|562069043|FG002|Overall Study|Mis-randomisation of patient|0|||
155186571|NCT00591266|560122829|FG001|Overall Study|Withdrawal by Subject|2|||
155186572|NCT00591266|560122830|FG002|Overall Study|Withdrawal by Subject|5|||
155719548|NCT00878501|562069041|FG000|Overall Study|Administrative|0|||
155719549|NCT00878501|562069042|FG001|Overall Study|Administrative|0|||
155719550|NCT00878501|562069043|FG002|Overall Study|Administrative|1|||
155719551|NCT04416204|562069044|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155719552|NCT04416204|562069045|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
155719553|NCT04416204|562069046|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155719554|NCT04416204|562069047|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155719555|NCT01959503|562069051|FG000|Overall Study|Death|2|||
155719556|NCT01959503|562069052|FG001|Overall Study|Death|1|||
155719557|NCT01959503|562069051|FG000|Overall Study|Randomized but not treated|1|||
155719558|NCT01959503|562069052|FG001|Overall Study|Randomized but not treated|1|||
155719559|NCT03598036|562069056|FG000|Overall Study|Withdrawal by Subject|1|||
155719560|NCT03598036|562069057|FG001|Overall Study|Withdrawal by Subject|0|||
155719561|NCT03585660|562069064|FG000|Overall Study|operator error|1|||
155719562|NCT03585660|562069064|FG000|Overall Study|technical error|2|||
155719563|NCT03585660|562069064|FG000|Overall Study|hip prosthesis|2|||
155719564|NCT03585660|562069064|FG000|Overall Study|did not undergo biopsy|8|||
155719565|NCT03585660|562069064|FG000|Overall Study|scanner problem|2|||
155719566|NCT05635461|562069065|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155719567|NCT05635461|562069066|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155719568|NCT05635461|562069067|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155719569|NCT05635461|562069068|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155719570|NCT05635461|562069069|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
155719571|NCT05635461|562069070|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155719572|NCT05635461|562069065|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155719573|NCT05635461|562069066|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
155719574|NCT05635461|562069067|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155719575|NCT05635461|562069068|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155719576|NCT05635461|562069069|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155719577|NCT05635461|562069070|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155719578|NCT05635461|562069065|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155719579|NCT05635461|562069066|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155719580|NCT05635461|562069067|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155719581|NCT05635461|562069068|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
155719582|NCT05635461|562069069|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155719583|NCT05635461|562069070|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155719584|NCT03661723|562069071|FG000|Overall Study|Disease Progression|4|||
155719585|NCT03661723|562069072|FG001|Overall Study|Disease Progression|24|||
155719586|NCT03661723|562069073|FG002|Overall Study|Disease Progression|4|||
155719587|NCT03661723|562069074|FG003|Overall Study|Disease Progression|19|||
155719588|NCT03661723|562069071|FG000|Overall Study|Withdrawal by Subject|1|||
155719589|NCT03661723|562069072|FG001|Overall Study|Withdrawal by Subject|0|||
155719590|NCT03661723|562069073|FG002|Overall Study|Withdrawal by Subject|2|||
155719591|NCT03661723|562069074|FG003|Overall Study|Withdrawal by Subject|4|||
155719592|NCT03661723|562069071|FG000|Overall Study|Physician Decision|1|||
155719593|NCT03661723|562069072|FG001|Overall Study|Physician Decision|0|||
155719594|NCT03661723|562069073|FG002|Overall Study|Physician Decision|0|||
155719595|NCT03661723|562069074|FG003|Overall Study|Physician Decision|0|||
155719596|NCT03661723|562069071|FG000|Overall Study|Clinical Deterioration|0|||
155719597|NCT03661723|562069072|FG001|Overall Study|Clinical Deterioration|0|||
155719598|NCT03661723|562069073|FG002|Overall Study|Clinical Deterioration|0|||
155719599|NCT03661723|562069074|FG003|Overall Study|Clinical Deterioration|1|||
155719600|NCT04750824|562069080|FG000|Overall Study|Toxicity/intolerability|3|||
155719601|NCT04750824|562069081|FG001|Overall Study|Toxicity/intolerability|1|||
155719602|NCT04750824|562069080|FG000|Overall Study|Death|1|||
155719603|NCT04750824|562069081|FG001|Overall Study|Death|3|||
155719604|NCT04750824|562069080|FG000|Overall Study|Scheduled duration of therapy complete|1|||
155186573|NCT00591266|560122828|FG000|Overall Study|Lack of Efficacy|0|||
155186574|NCT00591266|560122829|FG001|Overall Study|Lack of Efficacy|2|||
155186575|NCT00591266|560122830|FG002|Overall Study|Lack of Efficacy|0|||
155186576|NCT00591266|560122828|FG000|Overall Study|Other|1|||
155186577|NCT00591266|560122829|FG001|Overall Study|Other|4|||
155186578|NCT00591266|560122830|FG002|Overall Study|Other|5|||
155186579|NCT05298306|560122831|FG000|Overall Study|Physician Decision|0|||
155186580|NCT05298306|560122832|FG001|Overall Study|Physician Decision|0|||
155719605|NCT04750824|562069081|FG001|Overall Study|Scheduled duration of therapy complete|9|||
155719606|NCT04750824|562069080|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
155719607|NCT04750824|562069081|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
155719608|NCT00807911|562069082|FG000|Overall Study|Withdrawal by Subject|12|||
155186581|NCT05298306|560122833|FG002|Overall Study|Physician Decision|0|||
155186582|NCT05298306|560122834|FG003|Overall Study|Physician Decision|1|||
155186583|NCT05298306|560122835|FG004|Overall Study|Physician Decision|0|||
155719609|NCT00807911|562069083|FG001|Overall Study|Withdrawal by Subject|10|||
155719610|NCT00807911|562069082|FG000|Overall Study|Ineligible|0|||
155719611|NCT00807911|562069083|FG001|Overall Study|Ineligible|4|||
155719612|NCT03192176|562069088|FG000|Overall Study|Adverse Event|1|||
155719613|NCT03192176|562069089|FG001|Overall Study|Adverse Event|0|||
155186584|NCT05298306|560122836|FG005|Overall Study|Physician Decision|0|||
155719614|NCT03192176|562069090|FG002|Overall Study|Adverse Event|4|||
155719615|NCT03192176|562069091|FG003|Overall Study|Adverse Event|5|||
155719616|NCT03192176|562069092|FG004|Overall Study|Adverse Event|3|||
155719617|NCT03192176|562069093|FG005|Overall Study|Adverse Event|2|||
155719618|NCT03192176|562069094|FG006|Overall Study|Adverse Event|3|||
155719619|NCT03192176|562069095|FG007|Overall Study|Adverse Event|3|||
155719620|NCT03192176|562069088|FG000|Overall Study|Lost to Follow-up|0|||
155719621|NCT03192176|562069089|FG001|Overall Study|Lost to Follow-up|0|||
155719622|NCT03192176|562069090|FG002|Overall Study|Lost to Follow-up|1|||
155719623|NCT03192176|562069091|FG003|Overall Study|Lost to Follow-up|2|||
155719624|NCT03192176|562069092|FG004|Overall Study|Lost to Follow-up|3|||
155719625|NCT03192176|562069093|FG005|Overall Study|Lost to Follow-up|1|||
155719626|NCT03192176|562069094|FG006|Overall Study|Lost to Follow-up|1|||
155719627|NCT03192176|562069095|FG007|Overall Study|Lost to Follow-up|1|||
155719628|NCT03192176|562069088|FG000|Overall Study|Physician Decision|1|||
155719629|NCT03192176|562069089|FG001|Overall Study|Physician Decision|0|||
155719630|NCT03192176|562069090|FG002|Overall Study|Physician Decision|0|||
155719631|NCT03192176|562069091|FG003|Overall Study|Physician Decision|0|||
155719632|NCT03192176|562069092|FG004|Overall Study|Physician Decision|0|||
155719633|NCT03192176|562069093|FG005|Overall Study|Physician Decision|2|||
155719634|NCT03192176|562069094|FG006|Overall Study|Physician Decision|1|||
155719635|NCT03192176|562069095|FG007|Overall Study|Physician Decision|0|||
155719636|NCT03192176|562069088|FG000|Overall Study|Protocol Deviation|1|||
155719637|NCT03192176|562069089|FG001|Overall Study|Protocol Deviation|1|||
155719638|NCT03192176|562069090|FG002|Overall Study|Protocol Deviation|0|||
155719639|NCT03192176|562069091|FG003|Overall Study|Protocol Deviation|0|||
155719640|NCT03192176|562069092|FG004|Overall Study|Protocol Deviation|2|||
155719641|NCT03192176|562069093|FG005|Overall Study|Protocol Deviation|0|||
155719642|NCT03192176|562069094|FG006|Overall Study|Protocol Deviation|0|||
155719643|NCT03192176|562069095|FG007|Overall Study|Protocol Deviation|0|||
155719644|NCT03192176|562069088|FG000|Overall Study|Withdrawal by Subject|3|||
155719645|NCT03192176|562069089|FG001|Overall Study|Withdrawal by Subject|4|||
155719646|NCT03192176|562069090|FG002|Overall Study|Withdrawal by Subject|0|||
155719647|NCT03192176|562069091|FG003|Overall Study|Withdrawal by Subject|4|||
155719648|NCT03192176|562069092|FG004|Overall Study|Withdrawal by Subject|3|||
155719649|NCT03192176|562069093|FG005|Overall Study|Withdrawal by Subject|4|||
155719650|NCT03192176|562069094|FG006|Overall Study|Withdrawal by Subject|4|||
155719651|NCT03192176|562069095|FG007|Overall Study|Withdrawal by Subject|2|||
155719652|NCT03192176|562069088|FG000|Overall Study|Miscellaneous|1|||
155719653|NCT03192176|562069089|FG001|Overall Study|Miscellaneous|0|||
155719654|NCT03192176|562069090|FG002|Overall Study|Miscellaneous|1|||
155719655|NCT03192176|562069091|FG003|Overall Study|Miscellaneous|1|||
155719656|NCT03192176|562069092|FG004|Overall Study|Miscellaneous|1|||
155719657|NCT03192176|562069093|FG005|Overall Study|Miscellaneous|2|||
155719658|NCT03192176|562069094|FG006|Overall Study|Miscellaneous|0|||
155719659|NCT03192176|562069095|FG007|Overall Study|Miscellaneous|1|||
155719660|NCT03562195|562069098|FG000|Overall Study|Adverse Event|0|||
155719661|NCT03562195|562069099|FG001|Overall Study|Adverse Event|6|||
155719662|NCT03562195|562069098|FG000|Overall Study|Lack of Efficacy|0|||
155719663|NCT03562195|562069099|FG001|Overall Study|Lack of Efficacy|5|||
155719664|NCT03562195|562069098|FG000|Overall Study|Protocol Violation|0|||
155719665|NCT03562195|562069099|FG001|Overall Study|Protocol Violation|1|||
155719666|NCT03562195|562069098|FG000|Overall Study|Lost to Follow-up|0|||
155719667|NCT03562195|562069099|FG001|Overall Study|Lost to Follow-up|1|||
155719668|NCT03562195|562069098|FG000|Overall Study|Physician Decision|1|||
155719669|NCT03562195|562069099|FG001|Overall Study|Physician Decision|0|||
155719670|NCT03562195|562069098|FG000|Overall Study|Withdrawal by Subject|3|||
155719671|NCT03562195|562069099|FG001|Overall Study|Withdrawal by Subject|0|||
155719672|NCT00836589|562069100|FG000|Overall Study|Lost to Follow-up|246|||
155719673|NCT00836589|562069100|FG000|Overall Study|Death|429|||
155719674|NCT00836589|562069100|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
155719675|NCT00614575|562069101|FG000|Overall Study|Adverse Event|106|||
155719676|NCT00614575|562069101|FG000|Overall Study|Lost to Follow-up|55|||
155719677|NCT00614575|562069101|FG000|Overall Study|Lack of Efficacy|14|||
155719678|NCT00614575|562069101|FG000|Overall Study|Withdrawal by Subject|6|||
155719679|NCT00614575|562069101|FG000|Overall Study|Death|3|||
155719680|NCT00614575|562069101|FG000|Overall Study|Physician Decision|2|||
155719681|NCT00614575|562069101|FG000|Overall Study|No data were collected.|18|||
155719682|NCT00614575|562069101|FG000|Overall Study|Irregularly enrolled patients|23|||
155719683|NCT00614575|562069101|FG000|Overall Study|No treatment|1|||
155719684|NCT01018030|562069102|FG000|Overall Study|Adverse Event|10|||
155719685|NCT01018030|562069103|FG001|Overall Study|Adverse Event|5|||
155719686|NCT01018030|562069104|FG002|Overall Study|Adverse Event|5|||
155719687|NCT01018030|562069102|FG000|Overall Study|Withdrawal by Subject|2|||
155719688|NCT01018030|562069103|FG001|Overall Study|Withdrawal by Subject|2|||
155719689|NCT01018030|562069104|FG002|Overall Study|Withdrawal by Subject|4|||
155719690|NCT01018030|562069102|FG000|Overall Study|Lost to Follow-up|2|||
155719691|NCT01018030|562069103|FG001|Overall Study|Lost to Follow-up|0|||
155719692|NCT01018030|562069104|FG002|Overall Study|Lost to Follow-up|3|||
155719693|NCT01018030|562069102|FG000|Overall Study|Protocol Violation|2|||
155719694|NCT01018030|562069103|FG001|Overall Study|Protocol Violation|1|||
155719695|NCT01018030|562069104|FG002|Overall Study|Protocol Violation|0|||
155719696|NCT01018030|562069102|FG000|Overall Study|Physician Decision|1|||
155719697|NCT01018030|562069103|FG001|Overall Study|Physician Decision|0|||
155719698|NCT01018030|562069104|FG002|Overall Study|Physician Decision|1|||
155719699|NCT01018030|562069102|FG000|Overall Study|Lack of Efficacy|1|||
155719700|NCT01018030|562069103|FG001|Overall Study|Lack of Efficacy|0|||
155719701|NCT01018030|562069104|FG002|Overall Study|Lack of Efficacy|0|||
155719702|NCT01018030|562069102|FG000|Overall Study|Did Not Receive Study Drug|1|||
155719703|NCT01018030|562069103|FG001|Overall Study|Did Not Receive Study Drug|3|||
155719704|NCT01018030|562069104|FG002|Overall Study|Did Not Receive Study Drug|0|||
155719705|NCT00436332|562069108|FG000|Overall Study|Adverse Event|9|||
155719706|NCT00436332|562069108|FG000|Overall Study|Withdrawal by Subject|2|||
155719707|NCT00436332|562069108|FG000|Overall Study|Progression|59|||
155719708|NCT00436332|562069108|FG000|Overall Study|Death|2|||
155719709|NCT00436332|562069108|FG000|Overall Study|Not Protocol Specified|6|||
155719710|NCT00436332|562069108|FG000|Overall Study|Ineligible|2|||
155719711|NCT00436332|562069108|FG000|Overall Study|Never Received Treatment|3|||
155719712|NCT00472108|562069109|FG000|Overall Study|Lost to Follow-up|0|||
155719713|NCT00472108|562069110|FG001|Overall Study|Lost to Follow-up|1|||
155719714|NCT03582215|562069111|FG000|Overall Study|Adverse Event|1|||
155719715|NCT03582215|562069112|FG001|Overall Study|Adverse Event|0|||
155719716|NCT03582215|562069113|FG002|Overall Study|Adverse Event|0|||
155719717|NCT03582215|562069114|FG003|Overall Study|Adverse Event|0|||
155719718|NCT03582215|562069115|FG004|Overall Study|Adverse Event|0|||
155719719|NCT03582215|562069116|FG005|Overall Study|Adverse Event|0|||
155719720|NCT03582215|562069117|FG006|Overall Study|Adverse Event|2|||
155719721|NCT03582215|562069118|FG007|Overall Study|Adverse Event|2|||
155719722|NCT01791244|562069119|FG000|Overall Study|Adverse Event|5|||
155719723|NCT01791244|562069120|FG001|Overall Study|Adverse Event|7|||
155719724|NCT01791244|562069119|FG000|Overall Study|Insufficient clinical response|10|||
155719725|NCT01791244|562069120|FG001|Overall Study|Insufficient clinical response|10|||
155719726|NCT01791244|562069119|FG000|Overall Study|Laboratory Abnormality|0|||
155719727|NCT01791244|562069120|FG001|Overall Study|Laboratory Abnormality|1|||
155719728|NCT00703014|562069123|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
155719729|NCT00703014|562069124|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
155719730|NCT00703014|562069125|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155719731|NCT00703014|562069126|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155719732|NCT00703014|562069123|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155719733|NCT00703014|562069124|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155719734|NCT00703014|562069125|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
155719735|NCT00703014|562069126|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
155719736|NCT04949191|562069127|FG000|Overall Study|Non-compliance with Study Drug|1|||
155719737|NCT04949191|562069128|FG001|Overall Study|Non-compliance with Study Drug|0|||
155719738|NCT04949191|562069129|FG002|Overall Study|Non-compliance with Study Drug|0|||
155719739|NCT04949191|562069130|FG003|Overall Study|Non-compliance with Study Drug|0|||
155719740|NCT04949191|562069127|FG000|Overall Study|Progressive Disease|0|||
155719741|NCT04949191|562069128|FG001|Overall Study|Progressive Disease|1|||
155719742|NCT04949191|562069129|FG002|Overall Study|Progressive Disease|0|||
155719743|NCT04949191|562069130|FG003|Overall Study|Progressive Disease|0|||
155719744|NCT04949191|562069127|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155719745|NCT04949191|562069128|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
155719746|NCT04949191|562069129|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155719747|NCT04949191|562069130|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155719748|NCT04949191|562069127|FG000|Overall Study|Sponsor Terminated Study|0|||
155719749|NCT04949191|562069128|FG001|Overall Study|Sponsor Terminated Study|0|||
155719750|NCT04949191|562069129|FG002|Overall Study|Sponsor Terminated Study|1|||
155719751|NCT04949191|562069130|FG003|Overall Study|Sponsor Terminated Study|1|||
155719752|NCT05121766|562069131|FG000|Overall Study|Covid reinfection|3|||
155719753|NCT05121766|562069132|FG001|Overall Study|Covid reinfection|0|||
155719754|NCT05121766|562069131|FG000|Overall Study|Withdrawal by Subject|3|||
155719755|NCT05121766|562069132|FG001|Overall Study|Withdrawal by Subject|1|||
155719756|NCT05121766|562069131|FG000|Overall Study|Adverse Event|2|||
155719757|NCT05121766|562069132|FG001|Overall Study|Adverse Event|4|||
155719758|NCT05121766|562069131|FG000|Overall Study|Lost to Follow-up|0|||
155719759|NCT05121766|562069132|FG001|Overall Study|Lost to Follow-up|1|||
155719760|NCT00730158|562069133|FG000|Overall Study|Withdrawal by Subject|1|||
155719761|NCT00730158|562069134|FG001|Overall Study|Withdrawal by Subject|1|||
155719762|NCT03535974|562069135|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
155719763|NCT03535974|562069136|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
155719764|NCT03535974|562069137|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
155719765|NCT03535974|562069135|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
155719766|NCT03535974|562069136|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
155719767|NCT03535974|562069137|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
155719768|NCT04059549|562069138|FG000|Overall Study|Withdrawal by Subject|2|||
155719769|NCT04059549|562069139|FG001|Overall Study|Withdrawal by Subject|0|||
155719770|NCT02678351|562069141|FG000|Overall Study|Withdrawal by Subject|1|||
155719771|NCT01011673|562069142|FG000|Randomized|Secondary headache|2|||
155719772|NCT01011673|562069143|FG001|Randomized|Secondary headache|1|||
155719773|NCT01011673|562069142|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
155719774|NCT01011673|562069143|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
155719775|NCT00651924|562069144|FG000|Overall Study|Withdrawal by PI|0|||
155719776|NCT00651924|562069145|FG001|Overall Study|Withdrawal by PI|2|||
155719777|NCT00651924|562069144|FG000|Overall Study|Withdrawal by Subject|0|||
155719778|NCT00651924|562069145|FG001|Overall Study|Withdrawal by Subject|5|||
155719779|NCT00960063|562069146|FG000|Overall Study|Adverse Event|1|||
155719780|NCT00960063|562069147|FG001|Overall Study|Adverse Event|0|||
155719781|NCT00960063|562069148|FG002|Overall Study|Adverse Event|0|||
155719782|NCT00960063|562069146|FG000|Overall Study|Progression of Disease|0|||
155719783|NCT00960063|562069147|FG001|Overall Study|Progression of Disease|0|||
155719784|NCT00960063|562069148|FG002|Overall Study|Progression of Disease|3|||
155719785|NCT05083351|562069151|FG000|Overall Study|Adverse Event|3|||
155719786|NCT05083351|562069151|FG000|Overall Study|Did not meet data inclusion criteria|8|||
155719787|NCT05083351|562069151|FG000|Overall Study|Did not meet eligibility criteria|19|||
155719788|NCT05083351|562069151|FG000|Overall Study|Study Staff Decision|19|||
155719789|NCT01611792|562069152|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
155719790|NCT01611792|562069153|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
155719791|NCT01611792|562069152|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
155719792|NCT01611792|562069153|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
155719793|NCT00584415|562069157|FG000|Overall Study|Adverse Event|7|||
155719794|NCT00556894|562069158|FG000|Overall Study|Adverse Event|2|||
155719795|NCT00556894|562069159|FG001|Overall Study|Adverse Event|3|||
155719796|NCT00556894|562069160|FG002|Overall Study|Adverse Event|3|||
155719797|NCT00556894|562069158|FG000|Overall Study|Death|1|||
155719798|NCT00556894|562069159|FG001|Overall Study|Death|0|||
155719799|NCT00556894|562069160|FG002|Overall Study|Death|0|||
155719800|NCT00556894|562069158|FG000|Overall Study|regulatory decision in Bulgaria|10|||
155719801|NCT00556894|562069159|FG001|Overall Study|regulatory decision in Bulgaria|14|||
155719802|NCT00556894|562069160|FG002|Overall Study|regulatory decision in Bulgaria|13|||
155719803|NCT00556894|562069158|FG000|Overall Study|Change in therapy|2|||
155719804|NCT00556894|562069159|FG001|Overall Study|Change in therapy|1|||
155719805|NCT00556894|562069160|FG002|Overall Study|Change in therapy|2|||
155719806|NCT00556894|562069158|FG000|Overall Study|Withdrawal by Subject|1|||
155719807|NCT00556894|562069159|FG001|Overall Study|Withdrawal by Subject|1|||
155719808|NCT00556894|562069160|FG002|Overall Study|Withdrawal by Subject|1|||
155719809|NCT03883581|562069161|FG000|Overall Study|Withdrawal by Subject|4|||
155719810|NCT05190120|562069165|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155719811|NCT05190120|562069166|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155719812|NCT05190120|562069167|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155719813|NCT05190120|562069168|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
155719814|NCT05190120|562069165|FG000|Overall Study|Lost to Follow-up|5|||
155186585|NCT03497676|560122837|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186586|NCT03497676|560122838|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
155186587|NCT03497676|560122839|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186588|NCT03497676|560122840|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186589|NCT03497676|560122837|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
155186590|NCT03497676|560122838|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
155186591|NCT03497676|560122839|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
155186592|NCT03497676|560122840|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
155186593|NCT03497676|560122837|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
155186594|NCT03497676|560122838|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
155186595|NCT03497676|560122839|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
155186596|NCT03497676|560122840|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
155186597|NCT03497676|560122837|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186598|NCT03497676|560122838|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
155186599|NCT03497676|560122839|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186600|NCT03497676|560122840|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186601|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186602|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186603|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
155186604|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186605|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186606|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186607|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
155186608|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186609|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186610|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186611|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
155186612|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186613|NCT03497676|560122837|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155186614|NCT03497676|560122838|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155719815|NCT05190120|562069166|FG001|Overall Study|Lost to Follow-up|0|||
155719816|NCT05190120|562069167|FG002|Overall Study|Lost to Follow-up|2|||
155719817|NCT05190120|562069168|FG003|Overall Study|Lost to Follow-up|3|||
155186615|NCT03497676|560122839|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
155719818|NCT03062358|562069169|FG000|Overall Study|Death|269|||
155719819|NCT03062358|562069170|FG001|Overall Study|Death|145|||
155719820|NCT03062358|562069169|FG000|Overall Study|Withdrawal by Subject|2|||
155719821|NCT03062358|562069170|FG001|Overall Study|Withdrawal by Subject|1|||
155719822|NCT03062358|562069169|FG000|Overall Study|Sponsor Decision|29|||
155719823|NCT03062358|562069170|FG001|Overall Study|Sponsor Decision|7|||
155719824|NCT05893862|562069171|FG000|Overall Study|Physician Decision|0|||
155719825|NCT05893862|562069172|FG001|Overall Study|Physician Decision|1|||
155719826|NCT05893862|562069173|FG002|Overall Study|Physician Decision|0|||
155719827|NCT05893862|562069174|FG003|Overall Study|Physician Decision|0|||
155719828|NCT05893862|562069175|FG004|Overall Study|Physician Decision|1|||
155719829|NCT05893862|562069176|FG005|Overall Study|Physician Decision|0|||
155719830|NCT05893862|562069171|FG000|Overall Study|Withdrawal by Subject|1|||
155719831|NCT05893862|562069172|FG001|Overall Study|Withdrawal by Subject|7|||
155719832|NCT05893862|562069173|FG002|Overall Study|Withdrawal by Subject|1|||
155719833|NCT05893862|562069174|FG003|Overall Study|Withdrawal by Subject|3|||
155719834|NCT05893862|562069175|FG004|Overall Study|Withdrawal by Subject|3|||
155719835|NCT05893862|562069176|FG005|Overall Study|Withdrawal by Subject|2|||
155719836|NCT05893862|562069171|FG000|Overall Study|Adverse Event|1|||
155719837|NCT05893862|562069172|FG001|Overall Study|Adverse Event|4|||
155719838|NCT05893862|562069173|FG002|Overall Study|Adverse Event|2|||
155719839|NCT05893862|562069174|FG003|Overall Study|Adverse Event|2|||
155719840|NCT05893862|562069175|FG004|Overall Study|Adverse Event|1|||
155719841|NCT05893862|562069176|FG005|Overall Study|Adverse Event|0|||
155719842|NCT01400698|562069177|FG000|Overall Study|Lost to Follow-up|2|||
155719843|NCT01400698|562069178|FG001|Overall Study|Lost to Follow-up|5|||
155719844|NCT01400698|562069179|FG002|Overall Study|Lost to Follow-up|2|||
155719845|NCT01400698|562069180|FG003|Overall Study|Lost to Follow-up|1|||
155719846|NCT01400698|562069181|FG004|Overall Study|Lost to Follow-up|4|||
155719847|NCT01400698|562069182|FG005|Overall Study|Lost to Follow-up|3|||
155719848|NCT01400698|562069177|FG000|Overall Study|Withdrawal by Subject|8|||
155719849|NCT01400698|562069178|FG001|Overall Study|Withdrawal by Subject|2|||
155719850|NCT01400698|562069179|FG002|Overall Study|Withdrawal by Subject|0|||
155719851|NCT01400698|562069180|FG003|Overall Study|Withdrawal by Subject|4|||
155719852|NCT01400698|562069181|FG004|Overall Study|Withdrawal by Subject|1|||
155719853|NCT01400698|562069182|FG005|Overall Study|Withdrawal by Subject|3|||
155719854|NCT01400698|562069177|FG000|Overall Study|Protocol Violation|0|||
155719855|NCT01400698|562069178|FG001|Overall Study|Protocol Violation|1|||
155719856|NCT01400698|562069179|FG002|Overall Study|Protocol Violation|0|||
155719857|NCT01400698|562069180|FG003|Overall Study|Protocol Violation|0|||
155719858|NCT01400698|562069181|FG004|Overall Study|Protocol Violation|1|||
155719859|NCT01400698|562069182|FG005|Overall Study|Protocol Violation|0|||
155719860|NCT01400698|562069177|FG000|Overall Study|Non-compliance|0|||
155719861|NCT01400698|562069178|FG001|Overall Study|Non-compliance|1|||
155719862|NCT01400698|562069179|FG002|Overall Study|Non-compliance|0|||
155719863|NCT01400698|562069180|FG003|Overall Study|Non-compliance|1|||
155719864|NCT01400698|562069181|FG004|Overall Study|Non-compliance|0|||
155719865|NCT01400698|562069182|FG005|Overall Study|Non-compliance|0|||
155719866|NCT01400698|562069177|FG000|Overall Study|Adverse Event|1|||
155719867|NCT01400698|562069178|FG001|Overall Study|Adverse Event|0|||
155719868|NCT01400698|562069179|FG002|Overall Study|Adverse Event|0|||
155719869|NCT01400698|562069180|FG003|Overall Study|Adverse Event|0|||
155719870|NCT01400698|562069181|FG004|Overall Study|Adverse Event|0|||
155719871|NCT01400698|562069182|FG005|Overall Study|Adverse Event|0|||
155719872|NCT01400698|562069177|FG000|Overall Study|Other|4|||
155719873|NCT01400698|562069178|FG001|Overall Study|Other|2|||
155719874|NCT01400698|562069179|FG002|Overall Study|Other|0|||
155719875|NCT01400698|562069180|FG003|Overall Study|Other|2|||
155719876|NCT01400698|562069181|FG004|Overall Study|Other|1|||
155719877|NCT01400698|562069182|FG005|Overall Study|Other|0|||
155719878|NCT01602224|562071483|FG000|Overall Study|Adverse Event|0|||
155719879|NCT01602224|562071484|FG001|Overall Study|Adverse Event|1|||
155719880|NCT01602224|562071485|FG002|Overall Study|Adverse Event|0|||
155719881|NCT01602224|562071483|FG000|Overall Study|Investigator Decison|1|||
155719882|NCT01602224|562071484|FG001|Overall Study|Investigator Decison|0|||
155719883|NCT01602224|562071485|FG002|Overall Study|Investigator Decison|0|||
155186616|NCT03497676|560122840|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155186617|NCT00237185|560122841|FG000|Core|Adverse Event|3|||
155186618|NCT00237185|560122842|FG001|Core|Adverse Event|4|||
155186619|NCT00237185|560122841|FG000|Core|Abnormal laboratory value|0|||
155186620|NCT00237185|560122842|FG001|Core|Abnormal laboratory value|4|||
155186621|NCT00237185|560122841|FG000|Core|Abnormal test procedure results|1|||
155186622|NCT00237185|560122842|FG001|Core|Abnormal test procedure results|0|||
155186623|NCT00237185|560122841|FG000|Core|Lack of Efficacy|30|||
155186624|NCT00237185|560122842|FG001|Core|Lack of Efficacy|23|||
155186625|NCT00237185|560122841|FG000|Core|Protocol Violation|1|||
155186626|NCT00237185|560122842|FG001|Core|Protocol Violation|1|||
155186627|NCT00237185|560122841|FG000|Core|Withdrawal by Subject|4|||
155186628|NCT00237185|560122842|FG001|Core|Withdrawal by Subject|4|||
155186629|NCT00237185|560122841|FG000|Core|Administrative problems|0|||
155186630|NCT00237185|560122842|FG001|Core|Administrative problems|1|||
155186631|NCT00237185|560122841|FG000|Core|Death|4|||
155186632|NCT00237185|560122842|FG001|Core|Death|0|||
155186633|NCT00237185|560122841|FG000|Core|Determined ineligible post randomization|1|||
155186634|NCT00237185|560122842|FG001|Core|Determined ineligible post randomization|0|||
155186635|NCT00237185|560122841|FG000|Extension|Adverse Event|1|||
155186636|NCT00237185|560122842|FG001|Extension|Adverse Event|0|||
155186637|NCT00237185|560122841|FG000|Extension|Abnormal laboratory value|0|||
155186638|NCT00237185|560122842|FG001|Extension|Abnormal laboratory value|1|||
155186639|NCT00237185|560122841|FG000|Extension|Lack of Efficacy|9|||
155719884|NCT01602224|562071483|FG000|Overall Study|Lost to Follow-up|0|||
155719885|NCT01602224|562071484|FG001|Overall Study|Lost to Follow-up|0|||
155719886|NCT01602224|562071485|FG002|Overall Study|Lost to Follow-up|1|||
155719887|NCT01602224|562071483|FG000|Overall Study|Protocol Violation|0|||
155719888|NCT01602224|562071484|FG001|Overall Study|Protocol Violation|1|||
155719889|NCT01602224|562071485|FG002|Overall Study|Protocol Violation|0|||
155719890|NCT01602224|562071483|FG000|Overall Study|Sponsor Decision|2|||
155719891|NCT01602224|562071484|FG001|Overall Study|Sponsor Decision|3|||
155719892|NCT01602224|562071485|FG002|Overall Study|Sponsor Decision|2|||
155186640|NCT00237185|560122842|FG001|Extension|Lack of Efficacy|14|||
155186641|NCT00237185|560122841|FG000|Extension|Condition no longer required study drug|0|||
155719893|NCT01602224|562071483|FG000|Overall Study|Withdrawal by Subject|5|||
155719894|NCT01602224|562071484|FG001|Overall Study|Withdrawal by Subject|3|||
155719895|NCT01602224|562071485|FG002|Overall Study|Withdrawal by Subject|3|||
155719896|NCT03346434|562071486|FG000|Overall Study|Randomized in Error|0|||
155719897|NCT03346434|562071487|FG001|Overall Study|Randomized in Error|0|||
155719898|NCT03346434|562071488|FG002|Overall Study|Randomized in Error|0|||
155719899|NCT03346434|562071489|FG003|Overall Study|Randomized in Error|0|||
155719900|NCT03346434|562071490|FG004|Overall Study|Randomized in Error|1|||
155719901|NCT03346434|562071491|FG005|Overall Study|Randomized in Error|0|||
155719902|NCT03346434|562071486|FG000|Overall Study|Withdrawal by Subject|0|||
155719903|NCT03346434|562071487|FG001|Overall Study|Withdrawal by Subject|0|||
155719904|NCT03346434|562071488|FG002|Overall Study|Withdrawal by Subject|1|||
155719905|NCT03346434|562071489|FG003|Overall Study|Withdrawal by Subject|0|||
155719906|NCT03346434|562071490|FG004|Overall Study|Withdrawal by Subject|1|||
155719907|NCT03346434|562071491|FG005|Overall Study|Withdrawal by Subject|0|||
155719908|NCT03346434|562071486|FG000|Overall Study|Lost to Follow-up|0|||
155719909|NCT03346434|562071487|FG001|Overall Study|Lost to Follow-up|0|||
155719910|NCT03346434|562071488|FG002|Overall Study|Lost to Follow-up|0|||
155719911|NCT03346434|562071489|FG003|Overall Study|Lost to Follow-up|0|||
155719912|NCT03346434|562071490|FG004|Overall Study|Lost to Follow-up|1|||
155719913|NCT03346434|562071491|FG005|Overall Study|Lost to Follow-up|1|||
155719914|NCT03346434|562071486|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155719915|NCT03346434|562071487|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155719916|NCT03346434|562071488|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155719917|NCT03346434|562071489|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155719918|NCT03346434|562071490|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
155719919|NCT03346434|562071491|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
155719920|NCT02741128|562071493|FG000|Overall Study|Protocol Violation|4|||
155719921|NCT02741128|562071494|FG001|Overall Study|Protocol Violation|1|||
155719922|NCT02741128|562071493|FG000|Overall Study|Withdrawal by Subject|2|||
155719923|NCT02741128|562071494|FG001|Overall Study|Withdrawal by Subject|0|||
155719924|NCT02741128|562071493|FG000|Overall Study|Lost to Follow-up|1|||
155719925|NCT02741128|562071494|FG001|Overall Study|Lost to Follow-up|0|||
155719926|NCT02081677|562071495|FG000|Overall Study|Adverse Event|0|||
155719927|NCT02081677|562071496|FG001|Overall Study|Adverse Event|0|||
155719928|NCT02081677|562071497|FG002|Overall Study|Adverse Event|1|||
155719929|NCT02081677|562071498|FG003|Overall Study|Adverse Event|0|||
155719930|NCT02081677|562071495|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155719931|NCT02081677|562071496|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155719932|NCT02081677|562071497|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
155719933|NCT02081677|562071498|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155719934|NCT02081677|562071495|FG000|Overall Study|Not comfortable with lens care system|1|||
155719935|NCT02081677|562071496|FG001|Overall Study|Not comfortable with lens care system|0|||
155719936|NCT02081677|562071497|FG002|Overall Study|Not comfortable with lens care system|0|||
155719937|NCT02081677|562071498|FG003|Overall Study|Not comfortable with lens care system|0|||
155719938|NCT02081677|562071495|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155719939|NCT02081677|562071496|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155719940|NCT02081677|562071497|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
155719941|NCT02081677|562071498|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
155719942|NCT01419769|562071499|FG000|Overall Study|Did not receive the AXIOS stent|3|||
155719943|NCT01419769|562071499|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
155719944|NCT00812708|562071502|FG000|Overall Study|Device could not be implanted|2|||
155719945|NCT00812708|562071502|FG000|Overall Study|Lack of medical insurance|1|||
155719946|NCT00812708|562071502|FG000|Overall Study|Switched to another study|1|||
155719947|NCT00812708|562071502|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
155719948|NCT00812708|562071502|FG000|Overall Study|Signed consent but later withdrew|3|||
155719949|NCT04235140|562071506|FG000|Overall Study|Adverse Event|2|||
155719950|NCT04235140|562071506|FG000|Overall Study|Lost to Follow-up|1|||
155719951|NCT04235140|562071506|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
155719952|NCT04235140|562071506|FG000|Overall Study|Commercial drug is available for participants|7|||
155719953|NCT02587520|562071507|FG000|Overall Study|Protocol Violation|2|||
155719954|NCT02587520|562071508|FG001|Overall Study|Protocol Violation|0|||
155719955|NCT02587520|562071509|FG002|Overall Study|Protocol Violation|0|||
155719956|NCT02587520|562071510|FG003|Overall Study|Protocol Violation|2|||
155719957|NCT02587520|562071511|FG004|Overall Study|Protocol Violation|0|||
155719958|NCT02587520|562071512|FG005|Overall Study|Protocol Violation|1|||
155719959|NCT02587520|562071513|FG006|Overall Study|Protocol Violation|1|||
155186642|NCT00237185|560122842|FG001|Extension|Condition no longer required study drug|1|||
155719960|NCT02587520|562071514|FG007|Overall Study|Protocol Violation|1|||
155719961|NCT02587520|562071515|FG008|Overall Study|Protocol Violation|3|||
155719962|NCT02587520|562071516|FG009|Overall Study|Protocol Violation|3|||
155719963|NCT02587520|562071517|FG010|Overall Study|Protocol Violation|1|||
155719964|NCT02587520|562071518|FG011|Overall Study|Protocol Violation|2|||
155719965|NCT02587520|562071519|FG012|Overall Study|Protocol Violation|0|||
155186643|NCT00237185|560122841|FG000|Extension|Withdrawal by Subject|3|||
155719966|NCT02587520|562071520|FG013|Overall Study|Protocol Violation|0|||
155719967|NCT02587520|562071521|FG014|Overall Study|Protocol Violation|0|||
155719968|NCT02587520|562071522|FG015|Overall Study|Protocol Violation|0|||
155719969|NCT02587520|562071523|FG016|Overall Study|Protocol Violation|0|||
155719970|NCT02587520|562071524|FG017|Overall Study|Protocol Violation|0|||
155719971|NCT02587520|562071507|FG000|Overall Study|Adverse Event|0|||
155719972|NCT02587520|562071508|FG001|Overall Study|Adverse Event|0|||
155719973|NCT02587520|562071509|FG002|Overall Study|Adverse Event|0|||
155719974|NCT02587520|562071510|FG003|Overall Study|Adverse Event|0|||
155719975|NCT02587520|562071511|FG004|Overall Study|Adverse Event|0|||
155719976|NCT02587520|562071512|FG005|Overall Study|Adverse Event|0|||
155719977|NCT02587520|562071513|FG006|Overall Study|Adverse Event|0|||
155719978|NCT02587520|562071514|FG007|Overall Study|Adverse Event|0|||
155719979|NCT02587520|562071515|FG008|Overall Study|Adverse Event|0|||
155719980|NCT02587520|562071516|FG009|Overall Study|Adverse Event|0|||
155719981|NCT02587520|562071517|FG010|Overall Study|Adverse Event|0|||
155719982|NCT02587520|562071518|FG011|Overall Study|Adverse Event|1|||
155719983|NCT02587520|562071519|FG012|Overall Study|Adverse Event|0|||
155719984|NCT02587520|562071520|FG013|Overall Study|Adverse Event|0|||
155719985|NCT02587520|562071521|FG014|Overall Study|Adverse Event|0|||
155719986|NCT02587520|562071522|FG015|Overall Study|Adverse Event|0|||
155719987|NCT02587520|562071523|FG016|Overall Study|Adverse Event|0|||
155719988|NCT02587520|562071524|FG017|Overall Study|Adverse Event|0|||
155719989|NCT02587520|562071507|FG000|Overall Study|Withdrawal by Subject|0|||
155719990|NCT02587520|562071508|FG001|Overall Study|Withdrawal by Subject|0|||
155719991|NCT02587520|562071509|FG002|Overall Study|Withdrawal by Subject|1|||
155719992|NCT02587520|562071510|FG003|Overall Study|Withdrawal by Subject|1|||
155186644|NCT00237185|560122842|FG001|Extension|Withdrawal by Subject|2|||
155186645|NCT00237185|560122841|FG000|Extension|Lost to Follow-up|1|||
155186646|NCT00237185|560122842|FG001|Extension|Lost to Follow-up|0|||
155186647|NCT00237185|560122841|FG000|Extension|Administrative problems|1|||
155186648|NCT00237185|560122842|FG001|Extension|Administrative problems|0|||
155186649|NCT00237185|560122841|FG000|Extension|Death|1|||
155186650|NCT00237185|560122842|FG001|Extension|Death|1|||
155186651|NCT00910988|560122849|FG000|Overall Study|Lost to Follow-up|2|||
155186652|NCT00910988|560122850|FG001|Overall Study|Lost to Follow-up|4|||
155186653|NCT00910988|560122851|FG002|Overall Study|Lost to Follow-up|3|||
155186654|NCT00910988|560122852|FG003|Overall Study|Lost to Follow-up|0|||
155186655|NCT03911843|560122857|FG000|Overall Study|Adverse Event|2|||
155186656|NCT03911843|560122858|FG001|Overall Study|Adverse Event|0|||
155186657|NCT03911843|560122857|FG000|Overall Study|Protocol Violation|2|||
155186658|NCT03911843|560122858|FG001|Overall Study|Protocol Violation|0|||
155186659|NCT03911843|560122857|FG000|Overall Study|Lost to Follow-up|0|||
155186660|NCT03911843|560122858|FG001|Overall Study|Lost to Follow-up|1|||
155186661|NCT02819518|560122859|FG000|Overall Study|Death|9|||
155186662|NCT02819518|560122860|FG001|Overall Study|Death|12|||
155186663|NCT02819518|560122861|FG002|Overall Study|Death|9|||
155186664|NCT02819518|560122862|FG003|Overall Study|Death|475|||
155186665|NCT02819518|560122863|FG004|Overall Study|Death|244|||
155186666|NCT02819518|560122859|FG000|Overall Study|Withdrawal by Subject|0|||
155186667|NCT02819518|560122860|FG001|Overall Study|Withdrawal by Subject|0|||
155186668|NCT02819518|560122861|FG002|Overall Study|Withdrawal by Subject|0|||
155186669|NCT02819518|560122862|FG003|Overall Study|Withdrawal by Subject|25|||
155186670|NCT02819518|560122863|FG004|Overall Study|Withdrawal by Subject|8|||
155186671|NCT02819518|560122859|FG000|Overall Study|Lost to Follow-up|0|||
155186672|NCT02819518|560122860|FG001|Overall Study|Lost to Follow-up|0|||
155186673|NCT02819518|560122861|FG002|Overall Study|Lost to Follow-up|0|||
155186674|NCT02819518|560122862|FG003|Overall Study|Lost to Follow-up|0|||
155186675|NCT02819518|560122863|FG004|Overall Study|Lost to Follow-up|1|||
155186676|NCT02819518|560122859|FG000|Overall Study|Sponsor Decision|1|||
155186677|NCT02819518|560122860|FG001|Overall Study|Sponsor Decision|1|||
155186678|NCT02819518|560122861|FG002|Overall Study|Sponsor Decision|0|||
155186679|NCT02819518|560122862|FG003|Overall Study|Sponsor Decision|34|||
155186680|NCT02819518|560122863|FG004|Overall Study|Sponsor Decision|17|||
155186681|NCT02819518|560122859|FG000|Overall Study|Transferred to extension study|1|||
155719993|NCT02587520|562071511|FG004|Overall Study|Withdrawal by Subject|0|||
155719994|NCT02587520|562071512|FG005|Overall Study|Withdrawal by Subject|1|||
155186682|NCT02819518|560122860|FG001|Overall Study|Transferred to extension study|1|||
155186683|NCT02819518|560122861|FG002|Overall Study|Transferred to extension study|1|||
155186684|NCT02819518|560122862|FG003|Overall Study|Transferred to extension study|32|||
155186685|NCT02819518|560122863|FG004|Overall Study|Transferred to extension study|11|||
155186686|NCT00880165|560122864|FG000|Overall Study|Withdrawal by Subject|27|||
155719995|NCT02587520|562071513|FG006|Overall Study|Withdrawal by Subject|1|||
155719996|NCT02587520|562071514|FG007|Overall Study|Withdrawal by Subject|0|||
155719997|NCT02587520|562071515|FG008|Overall Study|Withdrawal by Subject|0|||
155719998|NCT02587520|562071516|FG009|Overall Study|Withdrawal by Subject|0|||
155186687|NCT00880165|560122865|FG001|Overall Study|Withdrawal by Subject|23|||
155186688|NCT00880165|560122864|FG000|Overall Study|Not diagnosed with OSA|14|||
155186689|NCT00880165|560122865|FG001|Overall Study|Not diagnosed with OSA|8|||
155186690|NCT00880165|560122864|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
155186691|NCT00880165|560122865|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
155186692|NCT00880165|560122864|FG000|Overall Study|Lost to follow|9|||
155186693|NCT00880165|560122865|FG001|Overall Study|Lost to follow|15|||
155186694|NCT01758289|560122866|FG000|Overall Study|Premature Study Termination|44|||
155186695|NCT01758289|560122866|FG000|Overall Study|Adverse Event|9|||
155186696|NCT00395538|560122871|FG000|Overall Study|Did not re-consent to revised protocol|1|||
155186697|NCT00395538|560122872|FG001|Overall Study|Did not re-consent to revised protocol|10|||
155186698|NCT00395538|560122873|FG002|Overall Study|Did not re-consent to revised protocol|0|||
155186699|NCT00395538|560122871|FG000|Overall Study|FDA partial hold on PTH|0|||
155186700|NCT00395538|560122872|FG001|Overall Study|FDA partial hold on PTH|0|||
155186701|NCT00395538|560122873|FG002|Overall Study|FDA partial hold on PTH|11|||
155186702|NCT00395538|560122871|FG000|Overall Study|Failed screening|0|||
155186703|NCT00395538|560122872|FG001|Overall Study|Failed screening|0|||
155186704|NCT00395538|560122873|FG002|Overall Study|Failed screening|4|||
155186705|NCT00395538|560122871|FG000|Overall Study|Switch to Natpara|0|||
155186706|NCT00395538|560122872|FG001|Overall Study|Switch to Natpara|0|||
155186707|NCT00395538|560122873|FG002|Overall Study|Switch to Natpara|3|||
155186708|NCT00395538|560122871|FG000|Overall Study|Adverse Event|1|||
155186709|NCT00395538|560122872|FG001|Overall Study|Adverse Event|0|||
155186710|NCT00395538|560122873|FG002|Overall Study|Adverse Event|2|||
155186711|NCT00395538|560122871|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
155186712|NCT00395538|560122872|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
155186713|NCT00395538|560122873|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
155186714|NCT00395538|560122871|FG000|Overall Study|Non-compliance with study protocol|0|||
155186715|NCT00395538|560122872|FG001|Overall Study|Non-compliance with study protocol|1|||
155186716|NCT00395538|560122873|FG002|Overall Study|Non-compliance with study protocol|0|||
155186717|NCT00395538|560122871|FG000|Overall Study|PTH resistance|0|||
155186718|NCT00395538|560122872|FG001|Overall Study|PTH resistance|0|||
155186719|NCT00395538|560122873|FG002|Overall Study|PTH resistance|1|||
155186720|NCT00395538|560122871|FG000|Overall Study|Pregnancy|1|||
155186721|NCT00395538|560122872|FG001|Overall Study|Pregnancy|0|||
155186722|NCT00395538|560122873|FG002|Overall Study|Pregnancy|0|||
155186723|NCT00395538|560122871|FG000|Overall Study|Partial recovery of parathyroid function|0|||
155186724|NCT00395538|560122872|FG001|Overall Study|Partial recovery of parathyroid function|0|||
155186725|NCT00395538|560122873|FG002|Overall Study|Partial recovery of parathyroid function|1|||
155186726|NCT00395538|560122871|FG000|Overall Study|Participant elected to discontinue|0|||
155186727|NCT00395538|560122872|FG001|Overall Study|Participant elected to discontinue|0|||
155186728|NCT00395538|560122873|FG002|Overall Study|Participant elected to discontinue|1|||
155186729|NCT04669535|560122880|FG000|Overall Study|Death|1|||
155186730|NCT04669535|560122881|FG001|Overall Study|Death|1|||
155186731|NCT04669535|560122882|FG002|Overall Study|Death|0|||
155186732|NCT04669535|560122883|FG003|Overall Study|Death|0|||
155186733|NCT05169567|560122885|FG000|Overall Study|On study treatment|116|||
155186734|NCT05169567|560122886|FG001|Overall Study|On study treatment|128|||
155186735|NCT05169567|560122885|FG000|Overall Study|Lost to Follow-up|1|||
155186736|NCT05169567|560122886|FG001|Overall Study|Lost to Follow-up|0|||
155186737|NCT05169567|560122885|FG000|Overall Study|Withdrawal by Subject|25|||
155186738|NCT05169567|560122886|FG001|Overall Study|Withdrawal by Subject|21|||
155186739|NCT02211638|560122887|FG000|Overall Study|Case Report Forms Uncollected|291|||
155186740|NCT02211638|560122887|FG000|Overall Study|Protocol Violation|692|||
155186741|NCT04041700|560122890|FG000|Overall Study|Pregnancy|1|||
155186742|NCT04041700|560122890|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
155719999|NCT02587520|562071517|FG010|Overall Study|Withdrawal by Subject|0|||
155720000|NCT02587520|562071518|FG011|Overall Study|Withdrawal by Subject|0|||
155720001|NCT02587520|562071519|FG012|Overall Study|Withdrawal by Subject|0|||
155720002|NCT02587520|562071520|FG013|Overall Study|Withdrawal by Subject|1|||
155720003|NCT02587520|562071521|FG014|Overall Study|Withdrawal by Subject|0|||
155720004|NCT02587520|562071522|FG015|Overall Study|Withdrawal by Subject|0|||
155720005|NCT02587520|562071523|FG016|Overall Study|Withdrawal by Subject|0|||
155186743|NCT02775903|560122891|FG000|Overall Study|Death|7|||
155186744|NCT02775903|560122892|FG001|Overall Study|Death|11|||
155186745|NCT02775903|560122893|FG002|Overall Study|Death|12|||
155186746|NCT02775903|560122894|FG003|Overall Study|Death|11|||
155186747|NCT02775903|560122891|FG000|Overall Study|Adverse Event|0|||
155186748|NCT02775903|560122892|FG001|Overall Study|Adverse Event|1|||
155186749|NCT02775903|560122893|FG002|Overall Study|Adverse Event|12|||
155186750|NCT02775903|560122894|FG003|Overall Study|Adverse Event|3|||
155186751|NCT02775903|560122891|FG000|Overall Study|Progressive disease|15|||
155186752|NCT02775903|560122892|FG001|Overall Study|Progressive disease|14|||
155186753|NCT02775903|560122893|FG002|Overall Study|Progressive disease|30|||
155186754|NCT02775903|560122894|FG003|Overall Study|Progressive disease|20|||
155186755|NCT02775903|560122891|FG000|Overall Study|Lack of Efficacy|2|||
155186756|NCT02775903|560122892|FG001|Overall Study|Lack of Efficacy|2|||
155720006|NCT02587520|562071524|FG017|Overall Study|Withdrawal by Subject|0|||
155186757|NCT02775903|560122893|FG002|Overall Study|Lack of Efficacy|2|||
155186758|NCT02775903|560122894|FG003|Overall Study|Lack of Efficacy|6|||
155186759|NCT02775903|560122891|FG000|Overall Study|Withdrawal by Subject|7|||
155186760|NCT02775903|560122892|FG001|Overall Study|Withdrawal by Subject|5|||
155186761|NCT02775903|560122893|FG002|Overall Study|Withdrawal by Subject|5|||
155186762|NCT02775903|560122894|FG003|Overall Study|Withdrawal by Subject|8|||
155186763|NCT02775903|560122891|FG000|Overall Study|Other reasons|7|||
155186764|NCT02775903|560122892|FG001|Overall Study|Other reasons|8|||
155186765|NCT02775903|560122893|FG002|Overall Study|Other reasons|2|||
155186766|NCT02775903|560122894|FG003|Overall Study|Other reasons|12|||
155186767|NCT00458536|560122897|FG000|Overall Study|Disease progression prior to treatment|7|||
155186768|NCT00458536|560122897|FG000|Overall Study|Unable to make vaccine|3|||
155186769|NCT00458536|560122897|FG000|Overall Study|No measurable disease after surgery|2|||
155186770|NCT00458536|560122897|FG000|Overall Study|Did not have renal cell carcinoma|2|||
155186771|NCT00458536|560122897|FG000|Overall Study|Patient did not have surgery|1|||
155186772|NCT00458536|560122897|FG000|Overall Study|Ineligible due to toxicity|1|||
155186773|NCT00458536|560122897|FG000|Overall Study|Withdrawal by Subject|1|||
155186774|NCT00458536|560122897|FG000|Overall Study|Progressive disease during treatment|2|||
155186775|NCT03120624|560122900|FG000|Overall Study|Withdrawal by Subject|0|||
155186776|NCT03120624|560122901|FG001|Overall Study|Withdrawal by Subject|1|||
155186777|NCT03120624|560122902|FG002|Overall Study|Withdrawal by Subject|0|||
155186778|NCT03120624|560122903|FG003|Overall Study|Withdrawal by Subject|0|||
155186779|NCT03120624|560122904|FG004|Overall Study|Withdrawal by Subject|0|||
155186780|NCT03120624|560122905|FG005|Overall Study|Withdrawal by Subject|0|||
155186781|NCT03120624|560122906|FG006|Overall Study|Withdrawal by Subject|0|||
155186782|NCT03120624|560122907|FG007|Overall Study|Withdrawal by Subject|0|||
155186783|NCT00215683|560124563|FG000|Overall Study|Adverse Event|15|||
155186784|NCT00215683|560124564|FG001|Overall Study|Adverse Event|16|||
155186785|NCT00215683|560124565|FG002|Overall Study|Adverse Event|15|||
155186786|NCT00215683|560124563|FG000|Overall Study|Lack of Efficacy|5|||
155186787|NCT00215683|560124564|FG001|Overall Study|Lack of Efficacy|1|||
155186788|NCT00215683|560124565|FG002|Overall Study|Lack of Efficacy|2|||
155186789|NCT00215683|560124563|FG000|Overall Study|Lost to Follow-up|0|||
155186790|NCT00215683|560124564|FG001|Overall Study|Lost to Follow-up|2|||
155186791|NCT00215683|560124565|FG002|Overall Study|Lost to Follow-up|1|||
155186792|NCT00215683|560124563|FG000|Overall Study|Withdrawal by Subject|9|||
155186793|NCT00215683|560124564|FG001|Overall Study|Withdrawal by Subject|4|||
155186794|NCT00215683|560124565|FG002|Overall Study|Withdrawal by Subject|13|||
155186795|NCT00215683|560124563|FG000|Overall Study|Physician Decision|0|||
155186796|NCT00215683|560124564|FG001|Overall Study|Physician Decision|0|||
155186797|NCT00215683|560124565|FG002|Overall Study|Physician Decision|1|||
155186798|NCT00215683|560124563|FG000|Overall Study|Difficult to attend visits|0|||
155186799|NCT00215683|560124564|FG001|Overall Study|Difficult to attend visits|1|||
155186800|NCT00215683|560124565|FG002|Overall Study|Difficult to attend visits|0|||
155186801|NCT00215683|560124563|FG000|Overall Study|No study drug available|0|||
155186802|NCT00215683|560124564|FG001|Overall Study|No study drug available|1|||
155186803|NCT00215683|560124565|FG002|Overall Study|No study drug available|0|||
155186804|NCT00215683|560124563|FG000|Overall Study|Intermittent therapy required|0|||
155186805|NCT00215683|560124564|FG001|Overall Study|Intermittent therapy required|1|||
155186806|NCT00215683|560124565|FG002|Overall Study|Intermittent therapy required|0|||
155186807|NCT02171065|560124566|FG000|Overall Study|Withdrawal by Subject|1|||
155186808|NCT02171065|560124567|FG001|Overall Study|Withdrawal by Subject|0|||
155186809|NCT02171065|560124568|FG002|Overall Study|Withdrawal by Subject|0|||
155186810|NCT02171065|560124566|FG000|Overall Study|Lost to Follow-up|0|||
155186811|NCT02171065|560124567|FG001|Overall Study|Lost to Follow-up|0|||
155186812|NCT02171065|560124568|FG002|Overall Study|Lost to Follow-up|1|||
155186813|NCT00674973|560124569|FG000|Overall Study|Insufficient Therapeutic Response|77|||
155186814|NCT00674973|560124570|FG001|Overall Study|Insufficient Therapeutic Response|72|||
155186815|NCT00674973|560124569|FG000|Overall Study|Refused Treatment|1|||
155186816|NCT00674973|560124570|FG001|Overall Study|Refused Treatment|5|||
155186817|NCT00674973|560124569|FG000|Overall Study|Failure to Return|1|||
155186818|NCT00674973|560124570|FG001|Overall Study|Failure to Return|0|||
155186819|NCT00674973|560124569|FG000|Overall Study|Adverse Event|2|||
155186820|NCT00674973|560124570|FG001|Overall Study|Adverse Event|9|||
155186821|NCT00674973|560124569|FG000|Overall Study|Death|19|||
155186822|NCT00674973|560124570|FG001|Overall Study|Death|15|||
155186823|NCT00674973|560124569|FG000|Overall Study|Protocol Violation|0|||
155186824|NCT00674973|560124570|FG001|Overall Study|Protocol Violation|1|||
155186825|NCT00084838|560124573|FG000|Overall Study|Death|1|||
155186826|NCT00084838|560124573|FG000|Overall Study|Adverse Event|2|||
155186827|NCT00084838|560124573|FG000|Overall Study|Withdrawal by Subject|1|||
155186828|NCT00084838|560124573|FG000|Overall Study|Progressive Disease|4|||
155186829|NCT00084838|560124573|FG000|Overall Study|Pt Non-Compliance|1|||
155186830|NCT00084838|560124573|FG000|Overall Study|Ineligible|4|||
155186831|NCT00518687|560124574|FG000|Overall Study|Adverse Event|201|||
155186832|NCT00518687|560124575|FG001|Overall Study|Adverse Event|177|||
155186833|NCT00518687|560124574|FG000|Overall Study|Lost to Follow-up|144|||
155186834|NCT00518687|560124575|FG001|Overall Study|Lost to Follow-up|155|||
155186835|NCT00518687|560124574|FG000|Overall Study|Physician Decision|42|||
155186836|NCT00518687|560124575|FG001|Overall Study|Physician Decision|48|||
155186837|NCT00518687|560124574|FG000|Overall Study|Progressive disease|2|||
155186838|NCT00518687|560124575|FG001|Overall Study|Progressive disease|2|||
155186839|NCT00518687|560124574|FG000|Overall Study|Protocol Violation|8|||
155186840|NCT00518687|560124575|FG001|Overall Study|Protocol Violation|10|||
155186841|NCT00518687|560124574|FG000|Overall Study|Study terminated by sponsor|930|||
155186842|NCT00518687|560124575|FG001|Overall Study|Study terminated by sponsor|918|||
155186843|NCT00518687|560124574|FG000|Overall Study|Withdrawal by Subject|110|||
155186844|NCT00518687|560124575|FG001|Overall Study|Withdrawal by Subject|110|||
155186845|NCT02231918|560124578|FG000|Overall Study|Withdrawal by Subject|0|||
155186846|NCT02231918|560124579|FG001|Overall Study|Withdrawal by Subject|1|||
155186847|NCT02231918|560124580|FG002|Overall Study|Withdrawal by Subject|0|||
155186848|NCT02231918|560124578|FG000|Overall Study|Adverse Event|0|||
155186849|NCT02231918|560124579|FG001|Overall Study|Adverse Event|0|||
155186850|NCT02231918|560124580|FG002|Overall Study|Adverse Event|1|||
155186851|NCT02395666|560124581|FG000|Overall Study|Physician Decision|3|||
155186852|NCT02395666|560124582|FG001|Overall Study|Physician Decision|0|||
155186853|NCT02395666|560124581|FG000|Overall Study|Lost to Follow-up|1|||
155186854|NCT02395666|560124582|FG001|Overall Study|Lost to Follow-up|0|||
155186855|NCT02395666|560124581|FG000|Overall Study|Withdrawal by Subject|2|||
155186856|NCT02395666|560124582|FG001|Overall Study|Withdrawal by Subject|1|||
155186857|NCT00145600|560124587|FG000|Overall Study|Death|1|||
155186858|NCT00145600|560124588|FG001|Overall Study|Death|2|||
155186859|NCT00145600|560124589|FG002|Overall Study|Death|2|||
155186860|NCT00145600|560124590|FG003|Overall Study|Death|6|||
155186861|NCT00145600|560124587|FG000|Overall Study|Ineligible|3|||
155186862|NCT00145600|560124588|FG001|Overall Study|Ineligible|0|||
155186863|NCT00145600|560124589|FG002|Overall Study|Ineligible|1|||
155186864|NCT00145600|560124590|FG003|Overall Study|Ineligible|5|||
155186865|NCT00145600|560124587|FG000|Overall Study|Lost to Follow-up|2|||
155186866|NCT00145600|560124588|FG001|Overall Study|Lost to Follow-up|6|||
155186867|NCT00145600|560124589|FG002|Overall Study|Lost to Follow-up|2|||
155186868|NCT00145600|560124590|FG003|Overall Study|Lost to Follow-up|4|||
155186869|NCT00145600|560124587|FG000|Overall Study|Noncompliance|1|||
155186870|NCT00145600|560124588|FG001|Overall Study|Noncompliance|0|||
155186871|NCT00145600|560124589|FG002|Overall Study|Noncompliance|0|||
155186872|NCT00145600|560124590|FG003|Overall Study|Noncompliance|0|||
155186873|NCT00145600|560124587|FG000|Overall Study|Withdrawal by Subject|1|||
155186874|NCT00145600|560124588|FG001|Overall Study|Withdrawal by Subject|2|||
155186875|NCT00145600|560124589|FG002|Overall Study|Withdrawal by Subject|0|||
155186876|NCT00145600|560124590|FG003|Overall Study|Withdrawal by Subject|1|||
155186877|NCT04087213|560124591|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
155186878|NCT04087213|560124591|FG000|In-Facility Introduction|Adverse Event|1|||
155186879|NCT04087213|560124591|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
155186880|NCT04087213|560124591|FG000|Assisted Evaluable Period|Personal reasons|3|||
155186881|NCT04087213|560124591|FG000|Transition Period B|Renal Transplantation|1|||
155186882|NCT01272661|560124604|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
155186883|NCT01272661|560124605|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
155186884|NCT01272661|560124606|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
155186885|NCT00750880|560124607|FG000|Overall Study|Adverse Event|76|||
155186886|NCT00750880|560124607|FG000|Overall Study|Death|4|||
155186887|NCT00750880|560124607|FG000|Overall Study|Lack of Efficacy|46|||
155186888|NCT00750880|560124607|FG000|Overall Study|Lost to Follow-up|10|||
155186889|NCT00750880|560124607|FG000|Overall Study|Protocol Violation|15|||
155186890|NCT00750880|560124607|FG000|Overall Study|Withdrawal by Subject|33|||
155186891|NCT00750880|560124607|FG000|Overall Study|Physician Decision|20|||
155186892|NCT00750880|560124607|FG000|Overall Study|Administrative|11|||
155186893|NCT00573248|560124608|FG000|Overall Study|scheduling conflicts|15|||
155186894|NCT00573248|560124609|FG001|Overall Study|scheduling conflicts|11|||
155186895|NCT04505540|560124610|FG000|Baseline|Protocol Violation|10|||
155720007|NCT02587520|562071507|FG000|Overall Study|Lost to Follow-up|0|||
155720008|NCT02587520|562071508|FG001|Overall Study|Lost to Follow-up|2|||
155720009|NCT02587520|562071509|FG002|Overall Study|Lost to Follow-up|0|||
155720010|NCT02587520|562071510|FG003|Overall Study|Lost to Follow-up|2|||
155720011|NCT02587520|562071511|FG004|Overall Study|Lost to Follow-up|0|||
155186896|NCT04505540|560124610|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
155186897|NCT04505540|560124610|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
155186898|NCT04505540|560124610|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
155186899|NCT04505540|560124610|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
155186900|NCT04505540|560124610|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
155186901|NCT04505540|560124610|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
155186902|NCT04505540|560124610|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
155186903|NCT04505540|560124610|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
155186904|NCT04505540|560124610|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
155186905|NCT04505540|560124610|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
155186906|NCT04505540|560124610|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
155720012|NCT02587520|562071512|FG005|Overall Study|Lost to Follow-up|1|||
155720013|NCT02587520|562071513|FG006|Overall Study|Lost to Follow-up|1|||
155186907|NCT04505540|560124610|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
155186908|NCT02057393|560124613|FG000|Overall Study|Withdrawal by Subject|1|||
155186909|NCT02057393|560124613|FG000|Overall Study|Patient did not meet criteria|1|||
155186910|NCT03180684|560124614|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
155186911|NCT03180684|560124615|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
155186912|NCT03180684|560124614|FG000|Overall Study|Physician Decision|1|||
155186913|NCT03180684|560124615|FG001|Overall Study|Physician Decision|0|||
155186914|NCT03180684|560124614|FG000|Overall Study|Lost to Follow-up|1|||
155186915|NCT03180684|560124615|FG001|Overall Study|Lost to Follow-up|0|||
155186916|NCT03180684|560124614|FG000|Overall Study|Progressive Disease|1|||
155186917|NCT03180684|560124615|FG001|Overall Study|Progressive Disease|0|||
155186918|NCT01130103|560124618|FG000|Randomized Treatment|Adverse Event|1|||
155186919|NCT01130103|560124619|FG001|Randomized Treatment|Adverse Event|1|||
155186920|NCT01130103|560124618|FG000|Randomized Treatment|Lost to Follow-up|1|||
155186921|NCT01130103|560124619|FG001|Randomized Treatment|Lost to Follow-up|0|||
155186922|NCT01130103|560124618|FG000|Randomized Treatment|Protocol Violation|3|||
155186923|NCT01130103|560124619|FG001|Randomized Treatment|Protocol Violation|2|||
155186924|NCT01130103|560124618|FG000|Randomized Treatment|Withdrawal by Subject|1|||
155186925|NCT01130103|560124619|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155186926|NCT01130103|560124618|FG000|Maintenance Treatment|Lack of Efficacy|0|||
155186927|NCT01130103|560124619|FG001|Maintenance Treatment|Lack of Efficacy|1|||
155186928|NCT01130103|560124618|FG000|Maintenance Treatment|Lost to Follow-up|1|||
155186929|NCT01130103|560124619|FG001|Maintenance Treatment|Lost to Follow-up|1|||
155186930|NCT01130103|560124618|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
155186931|NCT01130103|560124619|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
155186932|NCT03614975|560124620|FG000|Overall Study|Physician Decision|7|||
155186933|NCT03614975|560124621|FG001|Overall Study|Physician Decision|5|||
155186934|NCT03614975|560124620|FG000|Overall Study|Withdrawal by Subject|2|||
155186935|NCT03614975|560124621|FG001|Overall Study|Withdrawal by Subject|2|||
155186936|NCT03614975|560124620|FG000|Overall Study|Specimens not in lab batch shipment|1|||
155186937|NCT03614975|560124621|FG001|Overall Study|Specimens not in lab batch shipment|1|||
155186938|NCT01390220|560124624|FG000|Test Dose Phase|Adverse Event|17|||
155186939|NCT01390220|560124625|FG001|Test Dose Phase|Adverse Event|0|||
155186940|NCT01390220|560124626|FG002|Test Dose Phase|Adverse Event|0|||
155186941|NCT01390220|560124624|FG000|Test Dose Phase|Withdrawal by Subject|8|||
155186942|NCT01390220|560124625|FG001|Test Dose Phase|Withdrawal by Subject|0|||
155186943|NCT01390220|560124626|FG002|Test Dose Phase|Withdrawal by Subject|0|||
155186944|NCT01390220|560124624|FG000|Test Dose Phase|Lost to Follow-up|2|||
155186945|NCT01390220|560124625|FG001|Test Dose Phase|Lost to Follow-up|0|||
155186946|NCT01390220|560124626|FG002|Test Dose Phase|Lost to Follow-up|0|||
155186947|NCT01390220|560124624|FG000|Test Dose Phase|Protocol Violation|8|||
155186948|NCT01390220|560124625|FG001|Test Dose Phase|Protocol Violation|0|||
155186949|NCT01390220|560124626|FG002|Test Dose Phase|Protocol Violation|0|||
155186950|NCT01390220|560124624|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
155186951|NCT01390220|560124625|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
155186952|NCT01390220|560124626|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
155186953|NCT01390220|560124624|FG000|Test Dose Phase|Study/Site closure|6|||
155186954|NCT01390220|560124625|FG001|Test Dose Phase|Study/Site closure|0|||
155186955|NCT01390220|560124626|FG002|Test Dose Phase|Study/Site closure|0|||
155186956|NCT01390220|560124624|FG000|Test Dose Phase|Caregiver no longer available|5|||
155186957|NCT01390220|560124625|FG001|Test Dose Phase|Caregiver no longer available|0|||
155186958|NCT01390220|560124626|FG002|Test Dose Phase|Caregiver no longer available|0|||
155186959|NCT01390220|560124624|FG000|Test Dose Phase|Noncompliance|2|||
155186960|NCT01390220|560124625|FG001|Test Dose Phase|Noncompliance|0|||
155186961|NCT01390220|560124626|FG002|Test Dose Phase|Noncompliance|0|||
155186962|NCT01390220|560124624|FG000|Test Dose Phase|Logistical|6|||
155186963|NCT01390220|560124625|FG001|Test Dose Phase|Logistical|0|||
155186964|NCT01390220|560124626|FG002|Test Dose Phase|Logistical|0|||
155720014|NCT02587520|562071514|FG007|Overall Study|Lost to Follow-up|1|||
155720015|NCT02587520|562071515|FG008|Overall Study|Lost to Follow-up|0|||
155720016|NCT02587520|562071516|FG009|Overall Study|Lost to Follow-up|2|||
155720017|NCT02587520|562071517|FG010|Overall Study|Lost to Follow-up|2|||
155720018|NCT02587520|562071518|FG011|Overall Study|Lost to Follow-up|1|||
155720019|NCT02587520|562071519|FG012|Overall Study|Lost to Follow-up|0|||
155720020|NCT02587520|562071520|FG013|Overall Study|Lost to Follow-up|0|||
155186965|NCT01390220|560124624|FG000|Comparative Phase|Withdrawal by Subject|0|||
155186966|NCT01390220|560124625|FG001|Comparative Phase|Withdrawal by Subject|1|||
155186967|NCT01390220|560124626|FG002|Comparative Phase|Withdrawal by Subject|0|||
155186968|NCT00249288|560124627|FG000|Overall Study|Lost to Follow-up|3|||
155186969|NCT00249288|560124628|FG001|Overall Study|Lost to Follow-up|3|||
155186970|NCT00249288|560124627|FG000|Overall Study|Withdrawal by Subject|2|||
155186971|NCT00249288|560124628|FG001|Overall Study|Withdrawal by Subject|2|||
155186972|NCT03059446|560124629|FG000|Overall Study|Adverse Event|11|||
155186973|NCT03059446|560124629|FG000|Overall Study|Withdrawal of Consent|16|||
155720021|NCT02587520|562071521|FG014|Overall Study|Lost to Follow-up|0|||
155720022|NCT02587520|562071522|FG015|Overall Study|Lost to Follow-up|0|||
155186974|NCT03059446|560124629|FG000|Overall Study|Lost to Follow-up|3|||
155186975|NCT03059446|560124629|FG000|Overall Study|Protocol Violation|1|||
155186976|NCT03059446|560124629|FG000|Overall Study|Study Terminated by Sponsor|131|||
155186977|NCT03059446|560124629|FG000|Overall Study|Reason not Specified|5|||
155186978|NCT00136604|560124630|FG000|Overall Study|Lost to Follow-up|1|||
155186979|NCT00136604|560124631|FG001|Overall Study|Lost to Follow-up|0|||
155186980|NCT00136604|560124632|FG002|Overall Study|Lost to Follow-up|0|||
155186981|NCT00136604|560124633|FG003|Overall Study|Lost to Follow-up|0|||
155186982|NCT00136604|560124634|FG004|Overall Study|Lost to Follow-up|1|||
155186983|NCT00136604|560124630|FG000|Overall Study|Migrated/moved from study area|0|||
155186984|NCT00136604|560124631|FG001|Overall Study|Migrated/moved from study area|1|||
155186985|NCT00136604|560124632|FG002|Overall Study|Migrated/moved from study area|0|||
155186986|NCT00136604|560124633|FG003|Overall Study|Migrated/moved from study area|0|||
155186987|NCT00136604|560124634|FG004|Overall Study|Migrated/moved from study area|0|||
155186988|NCT03091777|560124635|FG000|Overall Study|Pregnancy|2|||
155186989|NCT03091777|560124636|FG001|Overall Study|Pregnancy|1|||
155186990|NCT03091777|560124637|FG002|Overall Study|Pregnancy|0|||
155186991|NCT03091777|560124635|FG000|Overall Study|Adverse Event|2|||
155186992|NCT03091777|560124636|FG001|Overall Study|Adverse Event|1|||
155186993|NCT03091777|560124637|FG002|Overall Study|Adverse Event|4|||
155186994|NCT03091777|560124635|FG000|Overall Study|Withdrawal by Subject|4|||
155186995|NCT03091777|560124636|FG001|Overall Study|Withdrawal by Subject|2|||
155186996|NCT03091777|560124637|FG002|Overall Study|Withdrawal by Subject|6|||
155186997|NCT03091777|560124635|FG000|Overall Study|Protocol Violation|2|||
155186998|NCT03091777|560124636|FG001|Overall Study|Protocol Violation|1|||
155186999|NCT03091777|560124637|FG002|Overall Study|Protocol Violation|1|||
155187000|NCT03091777|560124635|FG000|Overall Study|Lost to Follow-up|12|||
155187001|NCT03091777|560124636|FG001|Overall Study|Lost to Follow-up|14|||
155187002|NCT03091777|560124637|FG002|Overall Study|Lost to Follow-up|7|||
155187003|NCT03091777|560124635|FG000|Overall Study|Lack of Efficacy|0|||
155187004|NCT03091777|560124636|FG001|Overall Study|Lack of Efficacy|0|||
155187005|NCT03091777|560124637|FG002|Overall Study|Lack of Efficacy|5|||
155187006|NCT03091777|560124635|FG000|Overall Study|Noncompliance with study drug|2|||
155187007|NCT03091777|560124636|FG001|Overall Study|Noncompliance with study drug|3|||
155187008|NCT03091777|560124637|FG002|Overall Study|Noncompliance with study drug|1|||
155187009|NCT03091777|560124635|FG000|Overall Study|Physician Decision|1|||
155187010|NCT03091777|560124636|FG001|Overall Study|Physician Decision|0|||
155187011|NCT03091777|560124637|FG002|Overall Study|Physician Decision|1|||
155187012|NCT03091777|560124635|FG000|Overall Study|Abnormal Laboratory Value|7|||
155187013|NCT03091777|560124636|FG001|Overall Study|Abnormal Laboratory Value|11|||
155187014|NCT03091777|560124637|FG002|Overall Study|Abnormal Laboratory Value|12|||
155187015|NCT02536833|560124638|FG000|Overall Study|Discontinued Before Treatment|0|||
155187016|NCT02536833|560124639|FG001|Overall Study|Discontinued Before Treatment|0|||
155187017|NCT02536833|560124640|FG002|Overall Study|Discontinued Before Treatment|1|||
155187018|NCT02536833|560124641|FG003|Overall Study|Discontinued Before Treatment|2|||
155187019|NCT02536833|560124638|FG000|Overall Study|Adverse Event|1|||
155187020|NCT02536833|560124639|FG001|Overall Study|Adverse Event|3|||
155187021|NCT02536833|560124640|FG002|Overall Study|Adverse Event|4|||
155187022|NCT02536833|560124641|FG003|Overall Study|Adverse Event|1|||
155187023|NCT02536833|560124638|FG000|Overall Study|Lost to Follow-up|2|||
155187024|NCT02536833|560124639|FG001|Overall Study|Lost to Follow-up|1|||
155187025|NCT02536833|560124640|FG002|Overall Study|Lost to Follow-up|2|||
155187026|NCT02536833|560124641|FG003|Overall Study|Lost to Follow-up|2|||
155187027|NCT02536833|560124638|FG000|Overall Study|Physician Decision|0|||
155187028|NCT02536833|560124639|FG001|Overall Study|Physician Decision|0|||
155187029|NCT02536833|560124640|FG002|Overall Study|Physician Decision|0|||
155187030|NCT02536833|560124641|FG003|Overall Study|Physician Decision|1|||
155187031|NCT02536833|560124638|FG000|Overall Study|Site Terminated by Sponsor|2|||
155187032|NCT02536833|560124639|FG001|Overall Study|Site Terminated by Sponsor|2|||
155187033|NCT02536833|560124640|FG002|Overall Study|Site Terminated by Sponsor|2|||
155187034|NCT02536833|560124641|FG003|Overall Study|Site Terminated by Sponsor|2|||
155187035|NCT02536833|560124638|FG000|Overall Study|Subject Non-Compliance|0|||
155187036|NCT02536833|560124639|FG001|Overall Study|Subject Non-Compliance|1|||
155187037|NCT02536833|560124640|FG002|Overall Study|Subject Non-Compliance|1|||
155187038|NCT02536833|560124641|FG003|Overall Study|Subject Non-Compliance|0|||
155187039|NCT02536833|560124638|FG000|Overall Study|Withdrawal by Subject|4|||
155187040|NCT02536833|560124639|FG001|Overall Study|Withdrawal by Subject|3|||
155187041|NCT02536833|560124640|FG002|Overall Study|Withdrawal by Subject|5|||
155187042|NCT02536833|560124641|FG003|Overall Study|Withdrawal by Subject|11|||
155187043|NCT00089674|560124643|FG000|Overall Study|Physician Decision|4|||
155187044|NCT00089674|560124644|FG001|Overall Study|Physician Decision|2|||
155187045|NCT00089674|560124643|FG000|Overall Study|Adverse Event|23|||
155187046|NCT00089674|560124644|FG001|Overall Study|Adverse Event|29|||
155187047|NCT00089674|560124643|FG000|Overall Study|Withdrawal by Subject|143|||
155187048|NCT00089674|560124644|FG001|Overall Study|Withdrawal by Subject|127|||
155187049|NCT00089674|560124643|FG000|Overall Study|Death|43|||
155187050|NCT00089674|560124644|FG001|Overall Study|Death|43|||
155187051|NCT00089674|560124643|FG000|Overall Study|Disease progression|21|||
155187052|NCT00089674|560124644|FG001|Overall Study|Disease progression|23|||
155187053|NCT00089674|560124643|FG000|Overall Study|Ineligibility determined|8|||
155187054|NCT00089674|560124644|FG001|Overall Study|Ineligibility determined|10|||
155187055|NCT00089674|560124643|FG000|Overall Study|Lost to Follow-up|21|||
155187056|NCT00089674|560124644|FG001|Overall Study|Lost to Follow-up|17|||
155187057|NCT00089674|560124643|FG000|Overall Study|Noncompliance|7|||
155187058|NCT00089674|560124644|FG001|Overall Study|Noncompliance|3|||
155187059|NCT00089674|560124643|FG000|Overall Study|Other|5|||
155187060|NCT00089674|560124644|FG001|Overall Study|Other|9|||
155187061|NCT00089674|560124643|FG000|Overall Study|Requirement for alternative therapy|14|||
155187062|NCT00089674|560124644|FG001|Overall Study|Requirement for alternative therapy|4|||
155187063|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
155187064|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
155187065|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
155187066|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
155187067|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
155187068|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
155187069|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187070|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187071|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
155187072|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
155187073|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187074|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187075|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
155187076|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187077|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187078|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187079|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
155187080|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
155187081|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187082|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
155187083|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187084|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187085|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187086|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187087|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
155187088|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
155187089|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
155187090|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
155187091|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
155187092|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
155187093|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
155187094|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187095|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
155187096|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187097|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187098|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187099|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187100|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155720023|NCT02587520|562071523|FG016|Overall Study|Lost to Follow-up|0|||
155720024|NCT02587520|562071524|FG017|Overall Study|Lost to Follow-up|0|||
155720025|NCT00672555|562071525|FG000|Overall Study|Lost to Follow-up|4|||
155720026|NCT00672555|562071525|FG000|Overall Study|Did not want to answer questionnaire|2|||
155720027|NCT04516746|562071528|FG000|Overall Study|Randomized but not Treated|51|||
155720028|NCT04516746|562071529|FG001|Overall Study|Randomized but not Treated|19|||
155720029|NCT04516746|562071528|FG000|Overall Study|Adverse Event|0|||
155187101|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
155187102|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187103|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187104|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187105|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
155187106|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187107|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155720030|NCT04516746|562071529|FG001|Overall Study|Adverse Event|1|||
155187108|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187109|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187110|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155720031|NCT04516746|562071528|FG000|Overall Study|Death|62|||
155720032|NCT04516746|562071529|FG001|Overall Study|Death|32|||
155720033|NCT04516746|562071528|FG000|Overall Study|Lost to Follow-up|3431|||
155720034|NCT04516746|562071529|FG001|Overall Study|Lost to Follow-up|1831|||
155720035|NCT04516746|562071528|FG000|Overall Study|Withdrawal by Subject|1946|||
155720036|NCT04516746|562071529|FG001|Overall Study|Withdrawal by Subject|1696|||
155720037|NCT04516746|562071528|FG000|Overall Study|Physician Decision|10|||
155720038|NCT04516746|562071529|FG001|Overall Study|Physician Decision|8|||
155720039|NCT04516746|562071528|FG000|Overall Study|Other|35|||
155720040|NCT04516746|562071529|FG001|Overall Study|Other|16|||
155720041|NCT00446849|562071531|FG000|Acute Phase|Lack of Efficacy|64|||
155720042|NCT00446849|562071531|FG000|Acute Phase|Protocol Violation|10|||
155720043|NCT00446849|562071531|FG000|Acute Phase|Consent withdrawn|4|||
155720044|NCT00446849|562071531|FG000|Acute Phase|Lost to Follow-up|2|||
155720045|NCT00446849|562071531|FG000|Acute Phase|Physician Decision|1|||
155720046|NCT00446849|562071531|FG000|Acute Phase|noncompliance|1|||
155720047|NCT00446849|562071531|FG000|Maintenance Phase|Lack of Efficacy|40|||
155720048|NCT00446849|562071531|FG000|Maintenance Phase|Protocol Violation|7|||
155720049|NCT00446849|562071531|FG000|Maintenance Phase|Adverse Event|6|||
155720050|NCT00446849|562071531|FG000|Maintenance Phase|Consent withdrawn|5|||
155720051|NCT00446849|562071531|FG000|Maintenance Phase|Lost to Follow-up|3|||
155720052|NCT00446849|562071531|FG000|Maintenance Phase|Pregnancy|1|||
155720053|NCT00446849|562071531|FG000|Maintenance Phase|noncompliance|2|||
155720054|NCT00446849|562071531|FG000|Maintenance Phase|prohibited medication use|2|||
155720055|NCT00446849|562071531|FG000|Maintenance Phase|antibiotic use|1|||
155720056|NCT00446849|562071531|FG000|Maintenance Phase|study closure|1|||
155720057|NCT00446849|562071531|FG000|Maintenance Phase|hydrocodone use|1|||
155720058|NCT00446849|562071531|FG000|Maintenance Phase|concomitant medication use|1|||
155720059|NCT05546476|562071535|FG000|Period 1: Part A|Adverse Event|2|||
155720060|NCT05546476|562071536|FG001|Period 1: Part A|Adverse Event|0|||
155720061|NCT05546476|562071537|FG002|Period 1: Part A|Adverse Event|0|||
155720062|NCT05546476|562071538|FG003|Period 1: Part A|Adverse Event|1|||
155720063|NCT05546476|562071535|FG000|Period 1: Part A|Death|4|||
155720064|NCT05546476|562071536|FG001|Period 1: Part A|Death|4|||
155720065|NCT05546476|562071537|FG002|Period 1: Part A|Death|5|||
155720066|NCT05546476|562071538|FG003|Period 1: Part A|Death|6|||
155720067|NCT05546476|562071535|FG000|Period 1: Part A|Lack of Efficacy|0|||
155720068|NCT05546476|562071536|FG001|Period 1: Part A|Lack of Efficacy|0|||
155720069|NCT05546476|562071537|FG002|Period 1: Part A|Lack of Efficacy|0|||
155720070|NCT05546476|562071538|FG003|Period 1: Part A|Lack of Efficacy|1|||
155720071|NCT05546476|562071535|FG000|Period 1: Part A|Lost to Follow-up|0|||
155720072|NCT05546476|562071536|FG001|Period 1: Part A|Lost to Follow-up|0|||
155720073|NCT05546476|562071537|FG002|Period 1: Part A|Lost to Follow-up|0|||
155720074|NCT05546476|562071538|FG003|Period 1: Part A|Lost to Follow-up|1|||
155720075|NCT05546476|562071535|FG000|Period 1: Part A|Physician Decision|1|||
155720076|NCT05546476|562071536|FG001|Period 1: Part A|Physician Decision|0|||
155720077|NCT05546476|562071537|FG002|Period 1: Part A|Physician Decision|0|||
155720078|NCT05546476|562071538|FG003|Period 1: Part A|Physician Decision|0|||
155720079|NCT05546476|562071535|FG000|Period 1: Part A|Progressive disease|3|||
155720080|NCT05546476|562071536|FG001|Period 1: Part A|Progressive disease|5|||
155720081|NCT05546476|562071537|FG002|Period 1: Part A|Progressive disease|0|||
155720082|NCT05546476|562071538|FG003|Period 1: Part A|Progressive disease|1|||
155720083|NCT05546476|562071535|FG000|Period 1: Part A|Withdrawal by Subject|1|||
155720084|NCT05546476|562071536|FG001|Period 1: Part A|Withdrawal by Subject|1|||
155720085|NCT05546476|562071537|FG002|Period 1: Part A|Withdrawal by Subject|1|||
155720086|NCT05546476|562071538|FG003|Period 1: Part A|Withdrawal by Subject|2|||
155720087|NCT05546476|562071535|FG000|Period 1: Part A|Global deterioration of health status|2|||
155720088|NCT05546476|562071536|FG001|Period 1: Part A|Global deterioration of health status|2|||
155720089|NCT05546476|562071537|FG002|Period 1: Part A|Global deterioration of health status|1|||
155720090|NCT05546476|562071538|FG003|Period 1: Part A|Global deterioration of health status|4|||
155720091|NCT05546476|562071535|FG000|Period 1: Part A|Other: Unspecified|0|||
155720092|NCT05546476|562071536|FG001|Period 1: Part A|Other: Unspecified|2|||
155720093|NCT05546476|562071537|FG002|Period 1: Part A|Other: Unspecified|0|||
155720094|NCT05546476|562071538|FG003|Period 1: Part A|Other: Unspecified|0|||
155720095|NCT05546476|562071535|FG000|Period 2: Part B|Ongoing|26|||
155720096|NCT05546476|562071536|FG001|Period 2: Part B|Ongoing|27|||
155720097|NCT05546476|562071537|FG002|Period 2: Part B|Ongoing|35|||
155720098|NCT05546476|562071538|FG003|Period 2: Part B|Ongoing|29|||
155720099|NCT04890652|562071548|FG000|Overall Study|Withdrawal by Subject|2|||
155720100|NCT01706458|562071550|FG000|Overall Study|Physician Decision|3|||
155720101|NCT01706458|562071551|FG001|Overall Study|Physician Decision|4|||
155720102|NCT02766023|562071553|FG000|Overall Study|Lost to Follow-up|23|||
155720103|NCT02766023|562071554|FG001|Overall Study|Lost to Follow-up|11|||
155720104|NCT02766023|562071553|FG000|Overall Study|Pregnancy|1|||
155720105|NCT02766023|562071554|FG001|Overall Study|Pregnancy|0|||
155720106|NCT02766023|562071553|FG000|Overall Study|Adverse Event|1|||
155720107|NCT02766023|562071554|FG001|Overall Study|Adverse Event|0|||
155720108|NCT02766023|562071553|FG000|Overall Study|Withdrawal by Subject|4|||
155187111|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
155187112|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187113|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
155187114|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
155187115|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187116|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187117|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
155187118|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187119|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187120|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187121|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187122|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187123|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
155187124|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
155187125|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
155187126|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
155187127|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
155187128|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
155187129|NCT01982331|560124651|FG000|Received Vaccination 2|Adverse Event|1|||
155187130|NCT01982331|560124652|FG001|Received Vaccination 2|Adverse Event|2|||
155187131|NCT01982331|560124651|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155187132|NCT01982331|560124652|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
155187133|NCT01982331|560124651|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
155187134|NCT01982331|560124652|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
155187135|NCT03488927|560124653|FG000|Overall Study|Withdrawal by Subject|44|||
155187136|NCT03488927|560124654|FG001|Overall Study|Withdrawal by Subject|118|||
155187137|NCT03488927|560124655|FG002|Overall Study|Withdrawal by Subject|217|||
155187138|NCT02204007|560124657|FG000|Overall Study|Surgery Canceled|1|||
155187139|NCT02204007|560124658|FG001|Overall Study|Surgery Canceled|1|||
155187140|NCT02766465|560124659|FG000|Overall Study|Withdrawal by Subject|0|||
155187141|NCT02766465|560124660|FG001|Overall Study|Withdrawal by Subject|10|||
155187142|NCT01907100|560124661|FG000|Overall Study|PD based on modified RECIST criteria|31|||
155187143|NCT01907100|560124662|FG001|Overall Study|PD based on modified RECIST criteria|32|||
155187144|NCT01907100|560124663|FG002|Overall Study|PD based on modified RECIST criteria|95|||
155187145|NCT01907100|560124664|FG003|Overall Study|PD based on modified RECIST criteria|92|||
155187146|NCT01907100|560124661|FG000|Overall Study|Withdrawal by Subject|2|||
155187147|NCT01907100|560124662|FG001|Overall Study|Withdrawal by Subject|5|||
155187148|NCT01907100|560124663|FG002|Overall Study|Withdrawal by Subject|10|||
155187149|NCT01907100|560124664|FG003|Overall Study|Withdrawal by Subject|13|||
155187150|NCT01907100|560124661|FG000|Overall Study|Protocol Violation|0|||
155187151|NCT01907100|560124662|FG001|Overall Study|Protocol Violation|0|||
155187152|NCT01907100|560124663|FG002|Overall Study|Protocol Violation|1|||
155187153|NCT01907100|560124664|FG003|Overall Study|Protocol Violation|1|||
155187154|NCT01907100|560124661|FG000|Overall Study|Lost to Follow-up|0|||
155187155|NCT01907100|560124662|FG001|Overall Study|Lost to Follow-up|0|||
155187156|NCT01907100|560124663|FG002|Overall Study|Lost to Follow-up|0|||
155187157|NCT01907100|560124664|FG003|Overall Study|Lost to Follow-up|1|||
155187158|NCT01907100|560124661|FG000|Overall Study|Not treated|2|||
155187159|NCT01907100|560124662|FG001|Overall Study|Not treated|0|||
155187160|NCT01907100|560124663|FG002|Overall Study|Not treated|1|||
155187161|NCT01907100|560124664|FG003|Overall Study|Not treated|2|||
155720109|NCT02766023|562071554|FG001|Overall Study|Withdrawal by Subject|5|||
155187162|NCT01907100|560124661|FG000|Overall Study|Other than reasons specified|1|||
155187163|NCT01907100|560124662|FG001|Overall Study|Other than reasons specified|0|||
155187164|NCT01907100|560124663|FG002|Overall Study|Other than reasons specified|10|||
155187165|NCT01907100|560124664|FG003|Overall Study|Other than reasons specified|6|||
155720110|NCT02766023|562071553|FG000|Overall Study|Physician Decision|1|||
155720111|NCT02766023|562071554|FG001|Overall Study|Physician Decision|0|||
155720112|NCT02766023|562071553|FG000|Overall Study|Not Eligible at Enrollment|0|||
155720113|NCT02766023|562071554|FG001|Overall Study|Not Eligible at Enrollment|1|||
155720114|NCT02384551|562071558|FG000|Overall Study|Lost to Follow-up|13|||
155187166|NCT01907100|560124661|FG000|Overall Study|Adverse event (AE)|6|||
155187167|NCT01907100|560124662|FG001|Overall Study|Adverse event (AE)|3|||
155187168|NCT01907100|560124663|FG002|Overall Study|Adverse event (AE)|22|||
155187169|NCT01907100|560124664|FG003|Overall Study|Adverse event (AE)|23|||
155187170|NCT01907100|560124661|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
155187171|NCT01907100|560124662|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
155187172|NCT01907100|560124663|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
155187173|NCT01907100|560124664|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
155720115|NCT02384551|562071559|FG001|Overall Study|Lost to Follow-up|14|||
155720116|NCT02384551|562071560|FG002|Overall Study|Lost to Follow-up|14|||
155720117|NCT02384551|562071561|FG003|Overall Study|Lost to Follow-up|14|||
155187174|NCT00667602|560124665|FG000|Overall Study|Withdrawal by Subject|4|||
155187175|NCT00667602|560124666|FG001|Overall Study|Withdrawal by Subject|9|||
155187176|NCT00667602|560124667|FG002|Overall Study|Withdrawal by Subject|10|||
155187177|NCT00667602|560124665|FG000|Overall Study|Lost to Follow-up|4|||
155187178|NCT00667602|560124666|FG001|Overall Study|Lost to Follow-up|5|||
155187179|NCT00667602|560124667|FG002|Overall Study|Lost to Follow-up|6|||
155187180|NCT00667602|560124665|FG000|Overall Study|Administrative reason|0|||
155187181|NCT00667602|560124666|FG001|Overall Study|Administrative reason|0|||
155187182|NCT00667602|560124667|FG002|Overall Study|Administrative reason|2|||
155187183|NCT00667602|560124665|FG000|Overall Study|Protocol Violation|0|||
155187184|NCT00667602|560124666|FG001|Overall Study|Protocol Violation|1|||
155187185|NCT00667602|560124667|FG002|Overall Study|Protocol Violation|0|||
155187186|NCT02301988|560124669|FG000|Overall Study|Withdrawal by Subject|2|||
155187187|NCT02301988|560124670|FG001|Overall Study|Withdrawal by Subject|1|||
155187188|NCT02301988|560124669|FG000|Overall Study|Physician Decision|2|||
155187189|NCT02301988|560124670|FG001|Overall Study|Physician Decision|2|||
155187190|NCT02301988|560124669|FG000|Overall Study|Unknown Reason|1|||
155187191|NCT02301988|560124670|FG001|Overall Study|Unknown Reason|3|||
155187192|NCT02301988|560124669|FG000|Overall Study|Lack of Efficacy|3|||
155187193|NCT02301988|560124670|FG001|Overall Study|Lack of Efficacy|2|||
155187194|NCT02301988|560124669|FG000|Overall Study|Death|1|||
155187195|NCT02301988|560124670|FG001|Overall Study|Death|0|||
155187196|NCT02301988|560124669|FG000|Overall Study|Adverse Event|1|||
155187197|NCT02301988|560124670|FG001|Overall Study|Adverse Event|1|||
155187198|NCT02891161|560124673|FG000|Study Treatment|Disease Progression|2|||
155187199|NCT02891161|560124674|FG001|Study Treatment|Disease Progression|4|||
155187200|NCT02891161|560124673|FG000|Study Treatment|AE/Side Effects/Complications|1|||
155187201|NCT02891161|560124674|FG001|Study Treatment|AE/Side Effects/Complications|5|||
155187202|NCT02891161|560124673|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
155187203|NCT02891161|560124674|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
155187204|NCT02891161|560124673|FG000|Follow up|Death|4|||
155187205|NCT02891161|560124674|FG001|Follow up|Death|8|||
155187206|NCT02891161|560124673|FG000|Follow up|Refused to Follow up|0|||
155187207|NCT02891161|560124674|FG001|Follow up|Refused to Follow up|2|||
155720118|NCT04349891|562071562|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
155720119|NCT04349891|562071563|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
155720120|NCT04349891|562071562|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
155720121|NCT04349891|562071563|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
155720122|NCT04349891|562071562|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
155720123|NCT04349891|562071563|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
155720124|NCT04349891|562071562|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
155720125|NCT04349891|562071563|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
155720126|NCT03532542|562071568|FG000|Overall Study|Death|1|||
155187208|NCT02891161|560124673|FG000|Follow up|Symptomatic deterioration|0|||
155187209|NCT02891161|560124674|FG001|Follow up|Symptomatic deterioration|1|||
155187210|NCT02891161|560124673|FG000|Follow up|Study terminated|0|||
155187211|NCT02891161|560124674|FG001|Follow up|Study terminated|6|||
155187212|NCT01931202|560124676|FG000|Overall Study|Withdrawal by Subject|0|||
155187213|NCT01931202|560124677|FG001|Overall Study|Withdrawal by Subject|0|||
155187214|NCT01931202|560124678|FG002|Overall Study|Withdrawal by Subject|2|||
155187215|NCT01931202|560124676|FG000|Overall Study|Lost to Follow-up|0|||
155187216|NCT01931202|560124677|FG001|Overall Study|Lost to Follow-up|5|||
155187217|NCT01931202|560124678|FG002|Overall Study|Lost to Follow-up|2|||
155187218|NCT01074047|560124679|FG000|Treatment Phase|Adverse Event|89|||
155187219|NCT01074047|560124680|FG001|Treatment Phase|Adverse Event|66|||
155720127|NCT03532542|562071569|FG001|Overall Study|Death|0|||
155720128|NCT03532542|562071568|FG000|Overall Study|Study Terminated by Sponsor|41|||
155720129|NCT03532542|562071569|FG001|Overall Study|Study Terminated by Sponsor|65|||
155187220|NCT01074047|560124679|FG000|Treatment Phase|Disease Progression|16|||
155720130|NCT03532542|562071568|FG000|Overall Study|Withdrawal by Subject|6|||
155720131|NCT03532542|562071569|FG001|Overall Study|Withdrawal by Subject|5|||
155720132|NCT00772538|562071583|FG000|Overall Study|Adverse Event|6|||
155187221|NCT01074047|560124680|FG001|Treatment Phase|Disease Progression|21|||
155187222|NCT01074047|560124679|FG000|Treatment Phase|Withdrawal by Subject|27|||
155187223|NCT01074047|560124680|FG001|Treatment Phase|Withdrawal by Subject|48|||
155187224|NCT01074047|560124679|FG000|Treatment Phase|Death|53|||
155187225|NCT01074047|560124680|FG001|Treatment Phase|Death|58|||
155187226|NCT01074047|560124679|FG000|Treatment Phase|Lost to Follow-up|0|||
155187227|NCT01074047|560124680|FG001|Treatment Phase|Lost to Follow-up|1|||
155187228|NCT01074047|560124679|FG000|Treatment Phase|Protocol Violation|0|||
155720133|NCT00772538|562071584|FG001|Overall Study|Adverse Event|6|||
155720134|NCT00772538|562071583|FG000|Overall Study|Protocol Violation|3|||
155720135|NCT00772538|562071584|FG001|Overall Study|Protocol Violation|3|||
155720136|NCT00772538|562071583|FG000|Overall Study|Lost to Follow-up|1|||
155720137|NCT00772538|562071584|FG001|Overall Study|Lost to Follow-up|1|||
155187229|NCT01074047|560124680|FG001|Treatment Phase|Protocol Violation|1|||
155187230|NCT01074047|560124679|FG000|Treatment Phase|Miscellaneous|32|||
155187231|NCT01074047|560124680|FG001|Treatment Phase|Miscellaneous|39|||
155720138|NCT00772538|562071583|FG000|Overall Study|Withdrawal by Subject|3|||
155720139|NCT00772538|562071584|FG001|Overall Study|Withdrawal by Subject|8|||
155720140|NCT00772538|562071583|FG000|Overall Study|Lack of Efficacy|0|||
155720141|NCT00772538|562071584|FG001|Overall Study|Lack of Efficacy|1|||
155720142|NCT00772538|562071583|FG000|Overall Study|Other|7|||
155720143|NCT00772538|562071584|FG001|Overall Study|Other|7|||
155720144|NCT00001832|562071585|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
155187232|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
155187233|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
155187234|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
155187235|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
155187236|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Death|116|||
155187237|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Death|124|||
155187238|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
155187239|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
155187240|NCT01074047|560124679|FG000|Extension Phase|Physician Decision|1|||
155187241|NCT01074047|560124680|FG001|Extension Phase|Physician Decision|0|||
155187242|NCT01074047|560124679|FG000|Extension Phase|Adverse Event|5|||
155187243|NCT01074047|560124680|FG001|Extension Phase|Adverse Event|0|||
155187244|NCT01074047|560124679|FG000|Extension Phase|Disease Progression|9|||
155187245|NCT01074047|560124680|FG001|Extension Phase|Disease Progression|0|||
155187246|NCT01074047|560124679|FG000|Extension Phase|Withdrawal by Subject|2|||
155187247|NCT01074047|560124680|FG001|Extension Phase|Withdrawal by Subject|0|||
155187248|NCT01074047|560124679|FG000|Extension Phase|Death|5|||
155187249|NCT01074047|560124680|FG001|Extension Phase|Death|0|||
155187250|NCT01876810|560124681|FG000|Overall Study|Physician Decision|0|||
155187251|NCT01876810|560124682|FG001|Overall Study|Physician Decision|1|||
155187252|NCT01857583|560124685|FG000|Overall Study|Adverse Event|0|||
155187253|NCT01857583|560124686|FG001|Overall Study|Adverse Event|0|||
155187254|NCT01857583|560124687|FG002|Overall Study|Adverse Event|1|||
155187255|NCT01857583|560124688|FG003|Overall Study|Adverse Event|1|||
155187256|NCT01857583|560124685|FG000|Overall Study|Death|0|||
155187257|NCT01857583|560124686|FG001|Overall Study|Death|1|||
155187258|NCT01857583|560124687|FG002|Overall Study|Death|1|||
155187259|NCT01857583|560124688|FG003|Overall Study|Death|0|||
155187260|NCT01857583|560124685|FG000|Overall Study|Physician Decision|0|||
155187261|NCT01857583|560124686|FG001|Overall Study|Physician Decision|0|||
155187262|NCT01857583|560124687|FG002|Overall Study|Physician Decision|0|||
155187263|NCT01857583|560124688|FG003|Overall Study|Physician Decision|1|||
155187264|NCT01857583|560124685|FG000|Overall Study|Withdrawal by Subject|1|||
155187265|NCT01857583|560124686|FG001|Overall Study|Withdrawal by Subject|0|||
155187266|NCT01857583|560124687|FG002|Overall Study|Withdrawal by Subject|1|||
155187267|NCT01857583|560124688|FG003|Overall Study|Withdrawal by Subject|2|||
155187268|NCT04382755|560124689|FG000|Overall Study|Withdrawal by Subject|1|||
155187269|NCT04382755|560124690|FG001|Overall Study|Withdrawal by Subject|0|||
155187270|NCT04382755|560124689|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
155187271|NCT04382755|560124690|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
155187272|NCT04382755|560124689|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
155187273|NCT04382755|560124690|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
155187274|NCT04571515|560124691|FG000|Overall Study|Physician Decision|0|||
155187275|NCT04571515|560124692|FG001|Overall Study|Physician Decision|0|||
155187276|NCT04571515|560124693|FG002|Overall Study|Physician Decision|0|||
155187277|NCT04571515|560124694|FG003|Overall Study|Physician Decision|0|||
155720145|NCT00001832|562071586|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
155720146|NCT00001832|562071587|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
155720147|NCT00001832|562071588|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
155720148|NCT00001832|562071589|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
155720149|NCT00001832|562071590|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
155187278|NCT04571515|560124695|FG004|Overall Study|Physician Decision|1|||
155187279|NCT04571515|560124691|FG000|Overall Study|Withdrawal by Subject|0|||
155187280|NCT04571515|560124692|FG001|Overall Study|Withdrawal by Subject|0|||
155187281|NCT04571515|560124693|FG002|Overall Study|Withdrawal by Subject|0|||
155187282|NCT04571515|560124694|FG003|Overall Study|Withdrawal by Subject|0|||
155187283|NCT04571515|560124695|FG004|Overall Study|Withdrawal by Subject|1|||
155187284|NCT04571515|560124691|FG000|Overall Study|insufficient pain|1|||
155187285|NCT04571515|560124692|FG001|Overall Study|insufficient pain|0|||
155187286|NCT04571515|560124693|FG002|Overall Study|insufficient pain|0|||
155187287|NCT04571515|560124694|FG003|Overall Study|insufficient pain|0|||
155187288|NCT04571515|560124695|FG004|Overall Study|insufficient pain|1|||
155187289|NCT01104701|560126223|FG000|Overall Study|Withdrawal by Subject|0|||
155187290|NCT01104701|560126224|FG001|Overall Study|Withdrawal by Subject|1|||
155187291|NCT01104701|560126225|FG002|Overall Study|Withdrawal by Subject|2|||
155187292|NCT01104701|560126226|FG003|Overall Study|Withdrawal by Subject|1|||
155187293|NCT01104701|560126223|FG000|Overall Study|Adverse Event|0|||
155187294|NCT01104701|560126224|FG001|Overall Study|Adverse Event|0|||
155720150|NCT00001832|562071591|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
155187295|NCT01104701|560126225|FG002|Overall Study|Adverse Event|0|||
155187296|NCT01104701|560126226|FG003|Overall Study|Adverse Event|1|||
155187297|NCT01104701|560126223|FG000|Overall Study|Physician Decision|0|||
155187298|NCT01104701|560126224|FG001|Overall Study|Physician Decision|2|||
155187299|NCT01104701|560126225|FG002|Overall Study|Physician Decision|0|||
155187300|NCT01104701|560126226|FG003|Overall Study|Physician Decision|0|||
155187301|NCT00423722|560126227|FG000|Overall Study|Death|4|||
155187302|NCT00423722|560126228|FG001|Overall Study|Death|4|||
155187303|NCT00423722|560126227|FG000|Overall Study|Declined to participate|2|||
155187304|NCT00423722|560126228|FG001|Overall Study|Declined to participate|3|||
155187305|NCT00423722|560126227|FG000|Overall Study|Unable to complete questionnaires|4|||
155187306|NCT00423722|560126228|FG001|Overall Study|Unable to complete questionnaires|4|||
155187307|NCT00423722|560126227|FG000|Overall Study|Withdrawal by Subject|4|||
155187308|NCT00423722|560126228|FG001|Overall Study|Withdrawal by Subject|2|||
155187309|NCT02598960|560126229|FG000|Treatment Period|Disease Progression|4|||
155187310|NCT02598960|560126230|FG001|Treatment Period|Disease Progression|4|||
155187311|NCT02598960|560126231|FG002|Treatment Period|Disease Progression|4|||
155187312|NCT02598960|560126232|FG003|Treatment Period|Disease Progression|6|||
155720151|NCT00001832|562071592|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
155720152|NCT00001832|562071593|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
155720153|NCT00001832|562071594|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
155720154|NCT00001832|562071595|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
155720155|NCT00001832|562071596|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
155720156|NCT00001832|562071597|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
155720157|NCT00001832|562071598|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
155720158|NCT00001832|562071599|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
155720159|NCT00001832|562071585|FG000|Treatment Period|Death during treatment|0|||
155720160|NCT00001832|562071586|FG001|Treatment Period|Death during treatment|0|||
155720161|NCT00001832|562071587|FG002|Treatment Period|Death during treatment|0|||
155720162|NCT00001832|562071588|FG003|Treatment Period|Death during treatment|0|||
155720163|NCT00001832|562071589|FG004|Treatment Period|Death during treatment|0|||
155720164|NCT00001832|562071590|FG005|Treatment Period|Death during treatment|1|||
155720165|NCT00001832|562071591|FG006|Treatment Period|Death during treatment|0|||
155720166|NCT00001832|562071592|FG007|Treatment Period|Death during treatment|0|||
155720167|NCT00001832|562071593|FG008|Treatment Period|Death during treatment|0|||
155720168|NCT00001832|562071594|FG009|Treatment Period|Death during treatment|0|||
155720169|NCT00001832|562071595|FG010|Treatment Period|Death during treatment|0|||
155720170|NCT00001832|562071596|FG011|Treatment Period|Death during treatment|0|||
155720171|NCT00001832|562071597|FG012|Treatment Period|Death during treatment|0|||
155720172|NCT00001832|562071598|FG013|Treatment Period|Death during treatment|0|||
155720173|NCT00001832|562071599|FG014|Treatment Period|Death during treatment|0|||
155720174|NCT00001832|562071585|FG000|Treatment Period|Not treated|0|||
155720175|NCT00001832|562071586|FG001|Treatment Period|Not treated|0|||
155720176|NCT00001832|562071587|FG002|Treatment Period|Not treated|0|||
155720177|NCT00001832|562071588|FG003|Treatment Period|Not treated|0|||
155720178|NCT00001832|562071589|FG004|Treatment Period|Not treated|0|||
155720179|NCT00001832|562071590|FG005|Treatment Period|Not treated|0|||
155720180|NCT00001832|562071591|FG006|Treatment Period|Not treated|0|||
155720181|NCT00001832|562071592|FG007|Treatment Period|Not treated|1|||
155720182|NCT00001832|562071593|FG008|Treatment Period|Not treated|0|||
155720183|NCT00001832|562071594|FG009|Treatment Period|Not treated|0|||
155720184|NCT00001832|562071595|FG010|Treatment Period|Not treated|0|||
155720185|NCT00001832|562071596|FG011|Treatment Period|Not treated|0|||
155720186|NCT00001832|562071597|FG012|Treatment Period|Not treated|0|||
155720187|NCT00001832|562071598|FG013|Treatment Period|Not treated|0|||
155720188|NCT00001832|562071599|FG014|Treatment Period|Not treated|0|||
155720189|NCT00713609|562071600|FG000|Overall Study|Adverse Event|2|||
155720190|NCT00713609|562071601|FG001|Overall Study|Adverse Event|0|||
155720191|NCT00713609|562071602|FG002|Overall Study|Adverse Event|2|||
155720192|NCT00713609|562071603|FG003|Overall Study|Adverse Event|2|||
155720193|NCT00713609|562071604|FG004|Overall Study|Adverse Event|3|||
155720194|NCT00713609|562071605|FG005|Overall Study|Adverse Event|1|||
155720195|NCT00713609|562071600|FG000|Overall Study|Lost to Follow-up|5|||
155720196|NCT00713609|562071601|FG001|Overall Study|Lost to Follow-up|7|||
155720197|NCT00713609|562071602|FG002|Overall Study|Lost to Follow-up|5|||
155720198|NCT00713609|562071603|FG003|Overall Study|Lost to Follow-up|5|||
155720199|NCT00713609|562071604|FG004|Overall Study|Lost to Follow-up|7|||
155720200|NCT00713609|562071605|FG005|Overall Study|Lost to Follow-up|0|||
155720201|NCT00713609|562071600|FG000|Overall Study|Lack of Efficacy|1|||
155720202|NCT00713609|562071601|FG001|Overall Study|Lack of Efficacy|3|||
155720203|NCT00713609|562071602|FG002|Overall Study|Lack of Efficacy|0|||
155720204|NCT00713609|562071603|FG003|Overall Study|Lack of Efficacy|0|||
155720205|NCT00713609|562071604|FG004|Overall Study|Lack of Efficacy|1|||
155720206|NCT00713609|562071605|FG005|Overall Study|Lack of Efficacy|0|||
155720207|NCT00713609|562071600|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
155187313|NCT02598960|560126233|FG004|Treatment Period|Disease Progression|8|||
155187314|NCT02598960|560126234|FG005|Treatment Period|Disease Progression|2|||
155187315|NCT02598960|560126235|FG006|Treatment Period|Disease Progression|2|||
155187316|NCT02598960|560126236|FG007|Treatment Period|Disease Progression|3|||
155187317|NCT02598960|560126237|FG008|Treatment Period|Disease Progression|7|||
155187318|NCT02598960|560126238|FG009|Treatment Period|Disease Progression|9|||
155187319|NCT02598960|560126239|FG010|Treatment Period|Disease Progression|7|||
155187320|NCT02598960|560126240|FG011|Treatment Period|Disease Progression|143|||
155187321|NCT02598960|560126241|FG012|Treatment Period|Disease Progression|23|||
155187322|NCT02598960|560126229|FG000|Treatment Period|Study drug toxicity|0|||
155187323|NCT02598960|560126230|FG001|Treatment Period|Study drug toxicity|0|||
155187324|NCT02598960|560126231|FG002|Treatment Period|Study drug toxicity|0|||
155187325|NCT02598960|560126232|FG003|Treatment Period|Study drug toxicity|0|||
155187326|NCT02598960|560126233|FG004|Treatment Period|Study drug toxicity|0|||
155187327|NCT02598960|560126234|FG005|Treatment Period|Study drug toxicity|0|||
155187328|NCT02598960|560126235|FG006|Treatment Period|Study drug toxicity|0|||
155187329|NCT02598960|560126236|FG007|Treatment Period|Study drug toxicity|0|||
155187330|NCT02598960|560126237|FG008|Treatment Period|Study drug toxicity|0|||
155187331|NCT02598960|560126238|FG009|Treatment Period|Study drug toxicity|1|||
155187332|NCT02598960|560126239|FG010|Treatment Period|Study drug toxicity|0|||
155187333|NCT02598960|560126240|FG011|Treatment Period|Study drug toxicity|3|||
155187334|NCT02598960|560126241|FG012|Treatment Period|Study drug toxicity|0|||
155187335|NCT02598960|560126229|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
155187336|NCT02598960|560126230|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
155187337|NCT02598960|560126231|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
155187338|NCT02598960|560126232|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
155187339|NCT02598960|560126233|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
155187340|NCT02598960|560126234|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
155187341|NCT02598960|560126235|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
155187342|NCT02598960|560126236|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
155187343|NCT02598960|560126237|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
155187344|NCT02598960|560126238|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
155187345|NCT02598960|560126239|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
155187346|NCT02598960|560126240|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
155187347|NCT02598960|560126241|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
155187348|NCT02598960|560126229|FG000|Treatment Period|participant request to discontinue|0|||
155187349|NCT02598960|560126230|FG001|Treatment Period|participant request to discontinue|1|||
155187350|NCT02598960|560126231|FG002|Treatment Period|participant request to discontinue|0|||
155187351|NCT02598960|560126232|FG003|Treatment Period|participant request to discontinue|0|||
155187352|NCT02598960|560126233|FG004|Treatment Period|participant request to discontinue|1|||
155187353|NCT02598960|560126234|FG005|Treatment Period|participant request to discontinue|0|||
155187354|NCT02598960|560126235|FG006|Treatment Period|participant request to discontinue|0|||
155187355|NCT02598960|560126236|FG007|Treatment Period|participant request to discontinue|0|||
155187356|NCT02598960|560126237|FG008|Treatment Period|participant request to discontinue|0|||
155187357|NCT02598960|560126238|FG009|Treatment Period|participant request to discontinue|0|||
155187358|NCT02598960|560126239|FG010|Treatment Period|participant request to discontinue|1|||
155187359|NCT02598960|560126240|FG011|Treatment Period|participant request to discontinue|4|||
155187360|NCT02598960|560126241|FG012|Treatment Period|participant request to discontinue|0|||
155187361|NCT02598960|560126229|FG000|Treatment Period|participant withdrew consent|0|||
155187362|NCT02598960|560126230|FG001|Treatment Period|participant withdrew consent|0|||
155187363|NCT02598960|560126231|FG002|Treatment Period|participant withdrew consent|0|||
155187364|NCT02598960|560126232|FG003|Treatment Period|participant withdrew consent|0|||
155187365|NCT02598960|560126233|FG004|Treatment Period|participant withdrew consent|0|||
155187366|NCT02598960|560126234|FG005|Treatment Period|participant withdrew consent|0|||
155187367|NCT02598960|560126235|FG006|Treatment Period|participant withdrew consent|0|||
155187368|NCT02598960|560126236|FG007|Treatment Period|participant withdrew consent|0|||
155187369|NCT02598960|560126237|FG008|Treatment Period|participant withdrew consent|0|||
155187370|NCT02598960|560126238|FG009|Treatment Period|participant withdrew consent|0|||
155187371|NCT02598960|560126239|FG010|Treatment Period|participant withdrew consent|0|||
155187372|NCT02598960|560126240|FG011|Treatment Period|participant withdrew consent|3|||
155187373|NCT02598960|560126241|FG012|Treatment Period|participant withdrew consent|0|||
155187374|NCT02598960|560126229|FG000|Treatment Period|No longer meets study criteria|0|||
155187375|NCT02598960|560126230|FG001|Treatment Period|No longer meets study criteria|0|||
155187376|NCT02598960|560126231|FG002|Treatment Period|No longer meets study criteria|0|||
155187377|NCT02598960|560126232|FG003|Treatment Period|No longer meets study criteria|0|||
155187378|NCT02598960|560126233|FG004|Treatment Period|No longer meets study criteria|0|||
155187379|NCT02598960|560126234|FG005|Treatment Period|No longer meets study criteria|0|||
155187380|NCT02598960|560126235|FG006|Treatment Period|No longer meets study criteria|0|||
155187381|NCT02598960|560126236|FG007|Treatment Period|No longer meets study criteria|0|||
155187382|NCT02598960|560126237|FG008|Treatment Period|No longer meets study criteria|0|||
155187383|NCT02598960|560126238|FG009|Treatment Period|No longer meets study criteria|0|||
155187384|NCT02598960|560126239|FG010|Treatment Period|No longer meets study criteria|0|||
155187385|NCT02598960|560126240|FG011|Treatment Period|No longer meets study criteria|1|||
155187386|NCT02598960|560126241|FG012|Treatment Period|No longer meets study criteria|0|||
155187387|NCT02598960|560126229|FG000|Treatment Period|Other Reasons|0|||
155187388|NCT02598960|560126230|FG001|Treatment Period|Other Reasons|0|||
155187389|NCT02598960|560126231|FG002|Treatment Period|Other Reasons|0|||
155187390|NCT02598960|560126232|FG003|Treatment Period|Other Reasons|0|||
155187391|NCT02598960|560126233|FG004|Treatment Period|Other Reasons|0|||
155187392|NCT02598960|560126234|FG005|Treatment Period|Other Reasons|0|||
155187393|NCT02598960|560126235|FG006|Treatment Period|Other Reasons|0|||
155187394|NCT02598960|560126236|FG007|Treatment Period|Other Reasons|0|||
155187395|NCT02598960|560126237|FG008|Treatment Period|Other Reasons|0|||
155187396|NCT02598960|560126238|FG009|Treatment Period|Other Reasons|0|||
155187397|NCT02598960|560126239|FG010|Treatment Period|Other Reasons|0|||
155187398|NCT02598960|560126240|FG011|Treatment Period|Other Reasons|0|||
155187399|NCT02598960|560126241|FG012|Treatment Period|Other Reasons|1|||
155187400|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|Death|1|||
155187401|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|Death|0|||
155187402|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|Death|0|||
155187403|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|Death|0|||
155187404|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|Death|0|||
155187405|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|Death|0|||
155720208|NCT00713609|562071601|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
155720209|NCT00713609|562071602|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
155720210|NCT00713609|562071603|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
155720211|NCT00713609|562071604|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
155720212|NCT00713609|562071605|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
155720213|NCT00713609|562071600|FG000|Overall Study|Withdrawal by Subject|6|||
155720214|NCT00713609|562071601|FG001|Overall Study|Withdrawal by Subject|1|||
155720215|NCT00713609|562071602|FG002|Overall Study|Withdrawal by Subject|5|||
155720216|NCT00713609|562071603|FG003|Overall Study|Withdrawal by Subject|1|||
155720217|NCT00713609|562071604|FG004|Overall Study|Withdrawal by Subject|5|||
155720218|NCT00713609|562071605|FG005|Overall Study|Withdrawal by Subject|7|||
155720219|NCT00713609|562071600|FG000|Overall Study|Protocol Violation|6|||
155720220|NCT00713609|562071601|FG001|Overall Study|Protocol Violation|3|||
155720221|NCT00713609|562071602|FG002|Overall Study|Protocol Violation|1|||
155720222|NCT00713609|562071603|FG003|Overall Study|Protocol Violation|1|||
155720223|NCT00713609|562071604|FG004|Overall Study|Protocol Violation|2|||
155720224|NCT00713609|562071605|FG005|Overall Study|Protocol Violation|0|||
155720225|NCT04529083|562071606|FG000|Overall Study|Withdrawal by Subject|3|||
155187406|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|Death|0|||
155187407|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|Death|0|||
155187408|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|Death|0|||
155187409|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|Death|1|||
155187410|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|Death|0|||
155187411|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|Death|11|||
155187412|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|Death|2|||
155187413|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187414|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187415|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187416|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187417|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187418|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187419|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187420|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187421|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187422|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187423|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187424|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
155187425|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187426|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
155187427|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
155187428|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
155187429|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
155187430|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
155187431|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
155187432|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
155187433|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
155720226|NCT04196686|562071611|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
155720227|NCT04196686|562071612|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
155187434|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
155187435|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
155187436|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
155187437|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
155187438|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
155187439|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187440|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187441|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187442|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187443|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187444|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187445|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187446|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187447|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187448|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187449|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187450|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
155187451|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187452|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
155187453|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
155187454|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
155187455|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
155187456|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
155187457|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
155187458|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
155187459|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
155187460|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
155187461|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
155187462|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
155187463|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
155187464|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
155187465|NCT00595465|560126244|FG000|Overall Study|Adverse Event|4|||
155187466|NCT00595465|560126245|FG001|Overall Study|Adverse Event|3|||
155187467|NCT00595465|560126246|FG002|Overall Study|Adverse Event|3|||
155187468|NCT00595465|560126244|FG000|Overall Study|Pregnancy|0|||
155187469|NCT00595465|560126245|FG001|Overall Study|Pregnancy|0|||
155187470|NCT00595465|560126246|FG002|Overall Study|Pregnancy|1|||
155187471|NCT00595465|560126244|FG000|Overall Study|Protocol Violation|2|||
155187472|NCT00595465|560126245|FG001|Overall Study|Protocol Violation|1|||
155187473|NCT00595465|560126246|FG002|Overall Study|Protocol Violation|0|||
155187474|NCT00595465|560126244|FG000|Overall Study|Lost to Follow-up|0|||
155187475|NCT00595465|560126245|FG001|Overall Study|Lost to Follow-up|0|||
155187476|NCT00595465|560126246|FG002|Overall Study|Lost to Follow-up|2|||
155187477|NCT00595465|560126244|FG000|Overall Study|administrative reason|0|||
155187478|NCT00595465|560126245|FG001|Overall Study|administrative reason|0|||
155187479|NCT00595465|560126246|FG002|Overall Study|administrative reason|1|||
155187480|NCT00107783|560126247|FG000|Overall Study|Adverse Event|0|||
155187481|NCT00107783|560126248|FG001|Overall Study|Adverse Event|2|||
155187482|NCT00107783|560126247|FG000|Overall Study|Death|0|||
155187483|NCT00107783|560126248|FG001|Overall Study|Death|1|||
155187484|NCT00107783|560126247|FG000|Overall Study|Withdrawal by Subject|2|||
155187485|NCT00107783|560126248|FG001|Overall Study|Withdrawal by Subject|0|||
155187486|NCT00107783|560126247|FG000|Overall Study|Second hip replacement|1|||
155187487|NCT00107783|560126248|FG001|Overall Study|Second hip replacement|1|||
155187488|NCT00422097|560126249|FG000|Dose Level 2|Still on treatment|0|||
155187489|NCT00422097|560126250|FG001|Dose Level 2|Still on treatment|1|||
155187490|NCT00422097|560126251|FG002|Dose Level 2|Still on treatment|0|||
155720228|NCT03780452|562071613|FG000|Overall Study|Screening failure|2|||
155720229|NCT01292486|562071616|FG000|Overall Study|Protocol Violation|2|||
155720230|NCT01292486|562071616|FG000|Overall Study|Did not meet screening criteria|2|||
155720231|NCT01292486|562071616|FG000|Overall Study|Adverse Event|1|||
155720232|NCT01292486|562071616|FG000|Overall Study|Physician Decision|1|||
155187491|NCT00422097|560126252|FG003|Dose Level 2|Still on treatment|0|||
155187492|NCT00422097|560126253|FG004|Dose Level 2|Still on treatment|0|||
155187493|NCT00422097|560126254|FG005|Dose Level 2|Still on treatment|0|||
155187494|NCT00422097|560126255|FG006|Dose Level 2|Still on treatment|0|||
155187495|NCT00422097|560126256|FG007|Dose Level 2|Still on treatment|0|||
155187496|NCT02360995|560126257|FG000|Overall Study|Lost to Follow-up|2|||
155187497|NCT02360995|560126258|FG001|Overall Study|Lost to Follow-up|0|||
155720233|NCT00087152|562071617|FG000|Overall Study|Ineligible|6|||
155187498|NCT02360995|560126259|FG002|Overall Study|Lost to Follow-up|2|||
155187499|NCT02360995|560126257|FG000|Overall Study|Withdrawal by Subject|0|||
155187500|NCT02360995|560126258|FG001|Overall Study|Withdrawal by Subject|1|||
155187501|NCT02360995|560126259|FG002|Overall Study|Withdrawal by Subject|0|||
155187502|NCT00331864|560126267|FG000|Overall Study|Adverse Event|30|||
155187503|NCT00331864|560126268|FG001|Overall Study|Adverse Event|1|||
155187504|NCT00331864|560126267|FG000|Overall Study|Lack of Efficacy|4|||
155187505|NCT00331864|560126268|FG001|Overall Study|Lack of Efficacy|0|||
155187506|NCT00331864|560126267|FG000|Overall Study|Protocol Violation|3|||
155187507|NCT00331864|560126268|FG001|Overall Study|Protocol Violation|0|||
155187508|NCT00331864|560126267|FG000|Overall Study|Withdrawal by Subject|10|||
155187509|NCT00331864|560126268|FG001|Overall Study|Withdrawal by Subject|0|||
155187510|NCT00331864|560126267|FG000|Overall Study|Lost to Follow-up|4|||
155187511|NCT00331864|560126268|FG001|Overall Study|Lost to Follow-up|3|||
155187512|NCT00331864|560126267|FG000|Overall Study|Administrative Problems|1|||
155187513|NCT00331864|560126268|FG001|Overall Study|Administrative Problems|0|||
155187514|NCT00331864|560126267|FG000|Overall Study|Death|6|||
155187515|NCT00331864|560126268|FG001|Overall Study|Death|0|||
155187516|NCT00137631|560126269|FG000|Overall Study|Lost to Follow-up|37|||
155187517|NCT00137631|560126270|FG001|Overall Study|Lost to Follow-up|41|||
155187518|NCT00085709|560126273|FG000|Overall Study|Adverse Event|8|||
155187519|NCT00085709|560126274|FG001|Overall Study|Adverse Event|0|||
155187520|NCT00085709|560126273|FG000|Overall Study|Death|8|||
155187521|NCT00085709|560126274|FG001|Overall Study|Death|2|||
155187522|NCT00085709|560126273|FG000|Overall Study|Refusal unrelated to adverse events|1|||
155187523|NCT00085709|560126274|FG001|Overall Study|Refusal unrelated to adverse events|2|||
155187524|NCT00085709|560126273|FG000|Overall Study|Progression|3|||
155187525|NCT00085709|560126274|FG001|Overall Study|Progression|4|||
155187526|NCT00085709|560126273|FG000|Overall Study|Not protocol specified|12|||
155187527|NCT00085709|560126274|FG001|Overall Study|Not protocol specified|22|||
155187528|NCT00085709|560126273|FG000|Overall Study|Not eligible|19|||
155187529|NCT00085709|560126274|FG001|Overall Study|Not eligible|19|||
155187530|NCT00085709|560126273|FG000|Overall Study|Withdrawal by Subject|2|||
155187531|NCT00085709|560126274|FG001|Overall Study|Withdrawal by Subject|1|||
155187532|NCT01409434|560126275|FG000|Overall Study|Protocol Violation|4|||
155187533|NCT00293215|560126276|FG000|Overall Study|Progressive disease|3|||
155187534|NCT00293215|560126277|FG001|Overall Study|Progressive disease|1|||
155187535|NCT00293215|560126276|FG000|Overall Study|Adverse Event|2|||
155187536|NCT00293215|560126277|FG001|Overall Study|Adverse Event|2|||
155187537|NCT01229371|560126278|FG000|Overall Study|Withdrawal by Subject|0|||
155187538|NCT01229371|560126279|FG001|Overall Study|Withdrawal by Subject|1|||
155187539|NCT01229371|560126280|FG002|Overall Study|Withdrawal by Subject|0|||
155187540|NCT01229371|560126281|FG003|Overall Study|Withdrawal by Subject|0|||
155187541|NCT02213042|560126282|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
155187542|NCT02213042|560126283|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
155187543|NCT02213042|560126284|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
155187544|NCT02213042|560126282|FG000|Overall Study|Adverse Event|2|||
155187545|NCT02213042|560126283|FG001|Overall Study|Adverse Event|1|||
155187546|NCT02213042|560126284|FG002|Overall Study|Adverse Event|0|||
155187547|NCT02213042|560126282|FG000|Overall Study|Withdrawal by Subject|0|||
155187548|NCT02213042|560126283|FG001|Overall Study|Withdrawal by Subject|1|||
155187549|NCT02213042|560126284|FG002|Overall Study|Withdrawal by Subject|1|||
155187550|NCT02213042|560126282|FG000|Overall Study|Protocol Violation|1|||
155187551|NCT02213042|560126283|FG001|Overall Study|Protocol Violation|0|||
155187552|NCT02213042|560126284|FG002|Overall Study|Protocol Violation|0|||
155720234|NCT00265564|562071625|FG000|Overall Study|Lost to Follow-up|5|||
155720235|NCT00265564|562071626|FG001|Overall Study|Lost to Follow-up|7|||
155187553|NCT02213042|560126282|FG000|Overall Study|Investigator discretion|0|||
155187554|NCT02213042|560126283|FG001|Overall Study|Investigator discretion|0|||
155187555|NCT02213042|560126284|FG002|Overall Study|Investigator discretion|1|||
155187556|NCT04622735|560126285|FG000|Overall Study|Lost to Follow-up|1|||
155187557|NCT04622735|560126286|FG001|Overall Study|Lost to Follow-up|2|||
155187558|NCT04622735|560126287|FG002|Overall Study|Lost to Follow-up|1|||
155187559|NCT04622735|560126285|FG000|Overall Study|Adverse Event|0|||
155187560|NCT04622735|560126286|FG001|Overall Study|Adverse Event|0|||
155187561|NCT04622735|560126287|FG002|Overall Study|Adverse Event|1|||
155187562|NCT04622735|560126285|FG000|Overall Study|Protocol Violation|1|||
155187563|NCT04622735|560126286|FG001|Overall Study|Protocol Violation|0|||
155187564|NCT04622735|560126287|FG002|Overall Study|Protocol Violation|0|||
155187565|NCT02007512|560126289|FG000|Double Blind Treatment Period|Adverse Event|4|||
155187566|NCT02007512|560126290|FG001|Double Blind Treatment Period|Adverse Event|6|||
155187567|NCT02007512|560126291|FG002|Double Blind Treatment Period|Adverse Event|2|||
155187568|NCT02007512|560126292|FG003|Double Blind Treatment Period|Adverse Event|2|||
155187569|NCT02007512|560126289|FG000|Double Blind Treatment Period|Death|1|||
155187570|NCT02007512|560126290|FG001|Double Blind Treatment Period|Death|0|||
155720236|NCT00265564|562071625|FG000|Overall Study|met exclusion criteria|5|||
155187571|NCT02007512|560126291|FG002|Double Blind Treatment Period|Death|0|||
155187572|NCT02007512|560126292|FG003|Double Blind Treatment Period|Death|0|||
155187573|NCT02007512|560126289|FG000|Double Blind Treatment Period|Disease progression|51|||
155187574|NCT02007512|560126290|FG001|Double Blind Treatment Period|Disease progression|50|||
155187575|NCT02007512|560126291|FG002|Double Blind Treatment Period|Disease progression|57|||
155187576|NCT02007512|560126292|FG003|Double Blind Treatment Period|Disease progression|52|||
155187577|NCT02007512|560126289|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187578|NCT02007512|560126290|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187579|NCT02007512|560126291|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187580|NCT02007512|560126292|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187581|NCT02007512|560126289|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155187582|NCT02007512|560126290|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155187583|NCT02007512|560126291|FG002|Double Blind Treatment Period|Protocol Violation|0|||
155187584|NCT02007512|560126292|FG003|Double Blind Treatment Period|Protocol Violation|1|||
155187585|NCT02007512|560126289|FG000|Double Blind Treatment Period|Other|2|||
155187586|NCT02007512|560126290|FG001|Double Blind Treatment Period|Other|1|||
155187587|NCT02007512|560126291|FG002|Double Blind Treatment Period|Other|1|||
155187588|NCT02007512|560126292|FG003|Double Blind Treatment Period|Other|2|||
155187589|NCT02007512|560126289|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
155187590|NCT02007512|560126290|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
155187591|NCT02007512|560126291|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
155187592|NCT02007512|560126292|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
155187593|NCT02007512|560126289|FG000|Open Label Treatment Period|Adverse Event|1|||
155187594|NCT02007512|560126290|FG001|Open Label Treatment Period|Adverse Event|0|||
155187595|NCT02007512|560126291|FG002|Open Label Treatment Period|Adverse Event|0|||
155187596|NCT02007512|560126292|FG003|Open Label Treatment Period|Adverse Event|0|||
155187597|NCT02007512|560126289|FG000|Open Label Treatment Period|Other|1|||
155187598|NCT02007512|560126290|FG001|Open Label Treatment Period|Other|1|||
155187599|NCT02007512|560126291|FG002|Open Label Treatment Period|Other|0|||
155187600|NCT02007512|560126292|FG003|Open Label Treatment Period|Other|0|||
155187601|NCT02007512|560126289|FG000|Open Label Treatment Period|Disease progression|23|||
155187602|NCT02007512|560126290|FG001|Open Label Treatment Period|Disease progression|11|||
155187603|NCT02007512|560126291|FG002|Open Label Treatment Period|Disease progression|0|||
155187604|NCT02007512|560126292|FG003|Open Label Treatment Period|Disease progression|0|||
155187605|NCT03960554|560126299|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
155187606|NCT03960554|560126300|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
155187607|NCT02545075|560126303|FG000|Randomization|Lost to Follow-up|0|||
155187608|NCT02545075|560126304|FG001|Randomization|Lost to Follow-up|1|||
155187609|NCT02545075|560126303|FG000|Randomization|Withdrawal by Subject|0|||
155187610|NCT02545075|560126304|FG001|Randomization|Withdrawal by Subject|6|||
155187611|NCT02545075|560126303|FG000|Treatment|Disease progression|71|||
155187612|NCT02545075|560126304|FG001|Treatment|Disease progression|32|||
155187613|NCT02545075|560126303|FG000|Treatment|Participant dicontinued study treatment|7|||
155187614|NCT02545075|560126304|FG001|Treatment|Participant dicontinued study treatment|9|||
155187615|NCT02545075|560126303|FG000|Treatment|Withdrawal by Subject|1|||
155187616|NCT02545075|560126304|FG001|Treatment|Withdrawal by Subject|0|||
155187617|NCT02545075|560126303|FG000|Treatment|Adverse event not related to study drug|1|||
155187618|NCT02545075|560126304|FG001|Treatment|Adverse event not related to study drug|0|||
155187619|NCT02545075|560126303|FG000|Treatment|Death|1|||
155187620|NCT02545075|560126304|FG001|Treatment|Death|0|||
155187621|NCT02545075|560126303|FG000|Treatment|Participant drug toxicity|1|||
155187622|NCT02545075|560126304|FG001|Treatment|Participant drug toxicity|0|||
155187623|NCT02545075|560126303|FG000|Treatment|Completed treatment|40|||
155187624|NCT02545075|560126304|FG001|Treatment|Completed treatment|12|||
155187625|NCT02180165|560126308|FG000|Overall Study|Not Treated|0|||
155187626|NCT02180165|560126309|FG001|Overall Study|Not Treated|0|||
155187627|NCT02180165|560126310|FG002|Overall Study|Not Treated|1|||
155187628|NCT02180165|560126311|FG003|Overall Study|Not Treated|0|||
155187629|NCT02180165|560126308|FG000|Overall Study|Adverse Event|7|||
155187630|NCT02180165|560126309|FG001|Overall Study|Adverse Event|0|||
155187631|NCT02180165|560126310|FG002|Overall Study|Adverse Event|18|||
155187632|NCT02180165|560126311|FG003|Overall Study|Adverse Event|3|||
155187633|NCT02180165|560126308|FG000|Overall Study|Lack of Efficacy|0|||
155187634|NCT02180165|560126309|FG001|Overall Study|Lack of Efficacy|1|||
155187635|NCT02180165|560126310|FG002|Overall Study|Lack of Efficacy|3|||
155187636|NCT02180165|560126311|FG003|Overall Study|Lack of Efficacy|2|||
155187637|NCT02180165|560126308|FG000|Overall Study|Physician Decision|1|||
155187638|NCT02180165|560126309|FG001|Overall Study|Physician Decision|0|||
155720237|NCT00265564|562071626|FG001|Overall Study|met exclusion criteria|2|||
155187639|NCT02180165|560126310|FG002|Overall Study|Physician Decision|5|||
155187640|NCT02180165|560126311|FG003|Overall Study|Physician Decision|0|||
155187641|NCT02180165|560126308|FG000|Overall Study|Withdrawal by Subject|3|||
155187642|NCT02180165|560126309|FG001|Overall Study|Withdrawal by Subject|0|||
155720238|NCT01553084|562071631|FG000|Overall Study|Withdrawal by Subject|15|||
155187643|NCT02180165|560126310|FG002|Overall Study|Withdrawal by Subject|2|||
155187644|NCT02180165|560126311|FG003|Overall Study|Withdrawal by Subject|1|||
155187645|NCT00267189|560126312|FG000|Overall Study|Patient withdrew consent|1|||
155187646|NCT00267189|560126313|FG001|Overall Study|Patient withdrew consent|1|||
155187647|NCT00267189|560126312|FG000|Overall Study|Death|1|||
155187648|NCT00267189|560126313|FG001|Overall Study|Death|0|||
155187649|NCT00267189|560126312|FG000|Overall Study|Missing|3|||
155187650|NCT00267189|560126313|FG001|Overall Study|Missing|0|||
155187651|NCT00751621|560126314|FG000|Overall Study|Adverse Event|1|||
155187652|NCT00751621|560126314|FG000|Overall Study|Withdrawal by Subject|1|||
155187653|NCT00751621|560126314|FG000|Overall Study|Subject moved to another country|1|||
155187654|NCT00751621|560126314|FG000|Overall Study|Poor adherence to asthma treatment|1|||
155187655|NCT01086423|560126316|FG000|Overall Study|Protocol Violation|0|||
155187656|NCT01086423|560126317|FG001|Overall Study|Protocol Violation|0|||
155187657|NCT01086423|560126318|FG002|Overall Study|Protocol Violation|1|||
155187658|NCT01086423|560126316|FG000|Overall Study|Migrated/moved from study area|2|||
155187659|NCT01086423|560126317|FG001|Overall Study|Migrated/moved from study area|0|||
155187660|NCT01086423|560126318|FG002|Overall Study|Migrated/moved from study area|4|||
155187661|NCT01086423|560126316|FG000|Overall Study|Adverse event, fatal|1|||
155187662|NCT01086423|560126317|FG001|Overall Study|Adverse event, fatal|1|||
155187663|NCT01086423|560126318|FG002|Overall Study|Adverse event, fatal|0|||
155187664|NCT01086423|560126316|FG000|Overall Study|Adverse event, non-fatal|2|||
155187665|NCT01086423|560126317|FG001|Overall Study|Adverse event, non-fatal|1|||
155187666|NCT01086423|560126318|FG002|Overall Study|Adverse event, non-fatal|0|||
155187667|NCT01086423|560126316|FG000|Overall Study|Withdrawal by Subject|5|||
155187668|NCT01086423|560126317|FG001|Overall Study|Withdrawal by Subject|1|||
155187669|NCT01086423|560126318|FG002|Overall Study|Withdrawal by Subject|3|||
155187670|NCT01086423|560126316|FG000|Overall Study|Lost to Follow-up|0|||
155187671|NCT01086423|560126317|FG001|Overall Study|Lost to Follow-up|0|||
155187672|NCT01086423|560126318|FG002|Overall Study|Lost to Follow-up|1|||
155187673|NCT00925990|560126320|FG000|Overall Study|Adverse Event|1|||
155187674|NCT00925990|560126321|FG001|Overall Study|Adverse Event|3|||
155187675|NCT00925990|560126320|FG000|Overall Study|Withdrawal by Subject|2|||
155187676|NCT00925990|560126321|FG001|Overall Study|Withdrawal by Subject|2|||
155187677|NCT00925990|560126320|FG000|Overall Study|Lost to Follow-up|1|||
155187678|NCT00925990|560126321|FG001|Overall Study|Lost to Follow-up|3|||
155187679|NCT00925990|560126320|FG000|Overall Study|Physician Decision|1|||
155187680|NCT00925990|560126321|FG001|Overall Study|Physician Decision|1|||
155187681|NCT00925990|560126320|FG000|Overall Study|moved out of state, missed medication|0|||
155187682|NCT00925990|560126321|FG001|Overall Study|moved out of state, missed medication|2|||
155187683|NCT05342532|560126324|FG000|Overall Study|Adverse Event|5|||
155187684|NCT05342532|560126325|FG001|Overall Study|Adverse Event|20|||
155187685|NCT05342532|560126324|FG000|Overall Study|Lost to Follow-up|10|||
155187686|NCT05342532|560126325|FG001|Overall Study|Lost to Follow-up|15|||
155187687|NCT04508140|560126327|FG000|Overall Study|Adverse Event|2|||
155187688|NCT04508140|560126328|FG001|Overall Study|Adverse Event|2|||
155187689|NCT04508140|560126327|FG000|Overall Study|Withdrawal by Subject|0|||
155187690|NCT04508140|560126328|FG001|Overall Study|Withdrawal by Subject|2|||
155187691|NCT04508140|560126327|FG000|Overall Study|progressive disease|9|||
155187692|NCT04508140|560126328|FG001|Overall Study|progressive disease|3|||
155187693|NCT00450385|560126329|FG000|Overall Study|Death|3|||
155187694|NCT00450385|560126329|FG000|Overall Study|Protocol Violation|1|||
155187695|NCT00450385|560126329|FG000|Overall Study|Withdrawal by Subject|2|||
155187696|NCT00450385|560126329|FG000|Overall Study|Lack of Efficacy|2|||
155187697|NCT00450385|560126329|FG000|Overall Study|Adverse Event|1|||
155187698|NCT00450385|560126329|FG000|Overall Study|Physician Decision|1|||
155187699|NCT00450385|560126329|FG000|Overall Study|Other|3|||
155187700|NCT02314143|560126330|FG000|Overall Study|Adverse Event|0|||
155187701|NCT02314143|560126331|FG001|Overall Study|Adverse Event|6|||
155187702|NCT02314143|560126332|FG002|Overall Study|Adverse Event|4|||
155187703|NCT02314143|560126330|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
155187704|NCT02314143|560126331|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
155187705|NCT02314143|560126332|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
155187706|NCT02314143|560126330|FG000|Overall Study|Physician Decision|2|||
155187707|NCT02314143|560126331|FG001|Overall Study|Physician Decision|1|||
155187708|NCT02314143|560126332|FG002|Overall Study|Physician Decision|0|||
155187709|NCT02314143|560126330|FG000|Overall Study|Withdrawal by Subject|1|||
155187710|NCT02314143|560126331|FG001|Overall Study|Withdrawal by Subject|0|||
155187711|NCT02314143|560126332|FG002|Overall Study|Withdrawal by Subject|1|||
155187712|NCT01528215|560126333|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
155187713|NCT01528215|560126334|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
155187714|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
155187715|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
155187716|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
155187717|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
155187718|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
155187719|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
155187720|NCT01476644|560126335|FG000|Overall Study|Death|5|||
155187721|NCT01476644|560126335|FG000|Overall Study|moved to another state|2|||
155187722|NCT01476644|560126335|FG000|Overall Study|Lost to Follow-up|19|||
155187723|NCT01476644|560126335|FG000|Overall Study|Withdrawal by Subject|13|||
155187724|NCT00586066|560126336|FG000|Overall Study|Lost to Follow-up|6|||
155187725|NCT00586066|560126337|FG001|Overall Study|Lost to Follow-up|3|||
155187726|NCT00586066|560126336|FG000|Overall Study|Lack of Efficacy|5|||
155187727|NCT00586066|560126337|FG001|Overall Study|Lack of Efficacy|3|||
155187728|NCT00586066|560126336|FG000|Overall Study|Adverse Event|2|||
155187729|NCT00586066|560126337|FG001|Overall Study|Adverse Event|2|||
155187730|NCT00586066|560126336|FG000|Overall Study|Physician Decision|1|||
155187731|NCT00586066|560126337|FG001|Overall Study|Physician Decision|0|||
155187732|NCT00586066|560126336|FG000|Overall Study|Withdrawal of consent|4|||
155187733|NCT00586066|560126337|FG001|Overall Study|Withdrawal of consent|2|||
155187734|NCT02676466|560126339|FG000|Overall Study|Death|0|||
155187735|NCT02676466|560126340|FG001|Overall Study|Death|2|||
155187736|NCT02676466|560126341|FG002|Overall Study|Death|1|||
155187737|NCT02676466|560126342|FG003|Overall Study|Death|0|||
155187738|NCT02676466|560126343|FG004|Overall Study|Death|0|||
155187739|NCT02676466|560126344|FG005|Overall Study|Death|0|||
155187740|NCT02676466|560126345|FG006|Overall Study|Death|0|||
155187741|NCT02676466|560126346|FG007|Overall Study|Death|0|||
155187742|NCT02676466|560126339|FG000|Overall Study|Withdrawal by Subject|4|||
155187743|NCT02676466|560126340|FG001|Overall Study|Withdrawal by Subject|3|||
155187744|NCT02676466|560126341|FG002|Overall Study|Withdrawal by Subject|1|||
155187745|NCT02676466|560126342|FG003|Overall Study|Withdrawal by Subject|0|||
155187746|NCT02676466|560126343|FG004|Overall Study|Withdrawal by Subject|3|||
155187747|NCT02676466|560126344|FG005|Overall Study|Withdrawal by Subject|1|||
155187748|NCT02676466|560126345|FG006|Overall Study|Withdrawal by Subject|1|||
155187749|NCT02676466|560126346|FG007|Overall Study|Withdrawal by Subject|1|||
155187750|NCT01090973|560126353|FG000|Overall Study|Disease progression|1|||
155187751|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
155187752|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
155187753|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
155187754|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
155187755|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
155187756|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
155187757|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
155187758|NCT00445978|560126354|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
155187759|NCT00445978|560126354|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
155187760|NCT00843726|560126355|FG000|Overall Study|Death|1|||
155187761|NCT00843726|560126356|FG001|Overall Study|Death|0|||
155187762|NCT00843726|560126355|FG000|Overall Study|Withdrawal by Subject|0|||
155187763|NCT00843726|560126356|FG001|Overall Study|Withdrawal by Subject|1|||
155187764|NCT00760084|560126365|FG000|Overall Study|Physician Decision|5|||
155187765|NCT00760084|560126365|FG000|Overall Study|Withdrawal by Subject|2|||
155187766|NCT00760084|560126365|FG000|Overall Study|Progressive Disease|3|||
155187767|NCT02567552|560126366|FG000|Overall Study|Adverse Event|0|||
155187768|NCT02567552|560126367|FG001|Overall Study|Adverse Event|1|||
155187769|NCT00171054|560126369|FG000|Overall Study|Protocol Violation|1|||
155187770|NCT00171054|560126370|FG001|Overall Study|Protocol Violation|2|||
155187771|NCT00171054|560126369|FG000|Overall Study|Patient withdrew consent|1|||
155187772|NCT00171054|560126370|FG001|Overall Study|Patient withdrew consent|0|||
155187773|NCT00171054|560126369|FG000|Overall Study|Lost to Follow-up|0|||
155187774|NCT00171054|560126370|FG001|Overall Study|Lost to Follow-up|1|||
155187775|NCT00171054|560126369|FG000|Overall Study|Adverse Event|8|||
155187776|NCT00171054|560126370|FG001|Overall Study|Adverse Event|8|||
155187777|NCT00171054|560126369|FG000|Overall Study|Condition no longer required study drug|0|||
155187778|NCT00171054|560126370|FG001|Overall Study|Condition no longer required study drug|1|||
155187779|NCT00285207|560126381|FG000|Overall Study|Lost to Follow-up|3|||
155187780|NCT00285207|560126382|FG001|Overall Study|Lost to Follow-up|2|||
155187781|NCT00285207|560126381|FG000|Overall Study|Withdrawal by Subject|5|||
155187782|NCT00285207|560126382|FG001|Overall Study|Withdrawal by Subject|2|||
155187783|NCT00285207|560126381|FG000|Overall Study|Pregnancy|1|||
155720239|NCT01553084|562071632|FG001|Overall Study|Withdrawal by Subject|13|||
155720240|NCT01553084|562071633|FG002|Overall Study|Withdrawal by Subject|35|||
155720241|NCT04698343|562071634|FG000|Overall Study|Withdrawal by Subject|6|||
155187784|NCT00285207|560126382|FG001|Overall Study|Pregnancy|1|||
155720242|NCT04698343|562071634|FG000|Overall Study|Physician Decision|2|||
155187785|NCT00285207|560126381|FG000|Overall Study|non-compliance|0|||
155187786|NCT00285207|560126382|FG001|Overall Study|non-compliance|1|||
155187787|NCT03552965|560126383|FG000|Overall Study|Death|1|||
155187788|NCT03552965|560126384|FG001|Overall Study|Death|1|||
155187789|NCT03552965|560126383|FG000|Overall Study|Lost to Follow-up|1|||
155187790|NCT03552965|560126384|FG001|Overall Study|Lost to Follow-up|1|||
155187791|NCT03552965|560126383|FG000|Overall Study|Physician Decision|1|||
155187792|NCT03552965|560126384|FG001|Overall Study|Physician Decision|1|||
155187793|NCT03552965|560126383|FG000|Overall Study|Withdrawal by Subject|0|||
155187794|NCT03552965|560126384|FG001|Overall Study|Withdrawal by Subject|2|||
155187795|NCT03552965|560126383|FG000|Overall Study|Continuation not in patient best interest|1|||
155187796|NCT03552965|560126384|FG001|Overall Study|Continuation not in patient best interest|0|||
155187797|NCT03552965|560126383|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
155187798|NCT03552965|560126384|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
155187799|NCT02160782|560127932|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
155187800|NCT02160782|560127933|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
155187801|NCT02160782|560127934|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
155187802|NCT02160782|560127935|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
155187803|NCT02160782|560127936|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
155187804|NCT02160782|560127932|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187805|NCT02160782|560127933|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187806|NCT02160782|560127934|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187807|NCT02160782|560127935|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
155187808|NCT02160782|560127936|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187809|NCT02160782|560127932|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187810|NCT02160782|560127933|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187811|NCT02160782|560127934|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187812|NCT02160782|560127935|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
155187813|NCT02160782|560127936|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187814|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187815|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187816|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187817|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187818|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
155187819|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187820|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187821|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187822|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187823|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
155187824|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187825|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187826|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187827|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187828|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
155187829|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187830|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187831|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187832|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187833|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
155187834|NCT01846104|560127940|FG000|Overall Study|Withdrawal by Subject|1|||
155187835|NCT00398411|560127941|FG000|Overall Study|Death|0|||
155187836|NCT00398411|560127942|FG001|Overall Study|Death|1|||
155187837|NCT03061097|560127945|FG000|Overall Study|Withdrawal by Subject|0|||
155187838|NCT03061097|560127946|FG001|Overall Study|Withdrawal by Subject|3|||
155187839|NCT02611960|560127953|FG000|Overall Study|Adverse Event|7|||
155187840|NCT02611960|560127954|FG001|Overall Study|Adverse Event|8|||
155187841|NCT02611960|560127953|FG000|Overall Study|Death|98|||
155187842|NCT02611960|560127954|FG001|Overall Study|Death|92|||
155187843|NCT02611960|560127953|FG000|Overall Study|Withdrawal by Subject|1|||
155187844|NCT02611960|560127954|FG001|Overall Study|Withdrawal by Subject|5|||
155187845|NCT02611960|560127953|FG000|Overall Study|Sponsor Decision|11|||
155187846|NCT02611960|560127954|FG001|Overall Study|Sponsor Decision|11|||
155187847|NCT04131556|560127965|FG000|Overall Study|Adverse Event|1|||
155187848|NCT04131556|560127965|FG000|Overall Study|Withdrawal by Subject|1|||
155187849|NCT03026088|560127968|FG000|Overall Study|Study termination|20|||
155187850|NCT00761579|560127969|FG000|Overall Study|Adverse Event|10|||
155187851|NCT00761579|560127969|FG000|Overall Study|Death|2|||
155187852|NCT00761579|560127969|FG000|Overall Study|Lack of Efficacy|21|||
155187853|NCT00761579|560127969|FG000|Overall Study|Lost to Follow-up|16|||
155187854|NCT00761579|560127969|FG000|Overall Study|Pregnancy|1|||
155187855|NCT00761579|560127969|FG000|Overall Study|Withdrawal by Subject|34|||
155187856|NCT00761579|560127969|FG000|Overall Study|Lack of compliance|2|||
155187857|NCT00761579|560127969|FG000|Overall Study|Protocol deviation|1|||
155720243|NCT04698343|562071634|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
155720244|NCT04698343|562071634|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
155720245|NCT04698343|562071634|FG000|Overall Study|Personal reasons|3|||
155187858|NCT00761579|560127969|FG000|Overall Study|Drug overdose|1|||
155187859|NCT00761579|560127969|FG000|Overall Study|Aggravation of depression|1|||
155187860|NCT00761579|560127969|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
155187861|NCT00761579|560127969|FG000|Overall Study|Lost survey form|1|||
155187862|NCT00761579|560127969|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
155187863|NCT03611010|560127970|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
155187864|NCT03611010|560127971|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187865|NCT03611010|560127972|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187866|NCT03611010|560127973|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187867|NCT00950911|560127975|FG000|Overall Study|Adverse Event|0|||
155187868|NCT00950911|560127976|FG001|Overall Study|Adverse Event|2|||
155187869|NCT00950911|560127975|FG000|Overall Study|Death|4|||
155187870|NCT00950911|560127976|FG001|Overall Study|Death|6|||
155187871|NCT00950911|560127975|FG000|Overall Study|Disease progression|2|||
155187872|NCT00950911|560127976|FG001|Overall Study|Disease progression|2|||
155187873|NCT00950911|560127975|FG000|Overall Study|Consent withdrawn|1|||
155187874|NCT00950911|560127976|FG001|Overall Study|Consent withdrawn|3|||
155187875|NCT00950911|560127975|FG000|Overall Study|Administrative decision|3|||
155187876|NCT00950911|560127976|FG001|Overall Study|Administrative decision|1|||
155187877|NCT00950911|560127975|FG000|Overall Study|Ineligibility determined|1|||
155187878|NCT00950911|560127976|FG001|Overall Study|Ineligibility determined|0|||
155187879|NCT00950911|560127975|FG000|Overall Study|Noncompliance|1|||
155187880|NCT00950911|560127976|FG001|Overall Study|Noncompliance|0|||
155187881|NCT00950911|560127975|FG000|Overall Study|Poor performance status|0|||
155187882|NCT00950911|560127976|FG001|Overall Study|Poor performance status|1|||
155187883|NCT02600351|560127977|FG000|Overall Study|Lack of Efficacy|3|||
155187884|NCT02600351|560127978|FG001|Overall Study|Lack of Efficacy|0|||
155187885|NCT02600351|560127979|FG002|Overall Study|Lack of Efficacy|5|||
155187886|NCT02600351|560127980|FG003|Overall Study|Lack of Efficacy|2|||
155187887|NCT02600351|560127977|FG000|Overall Study|Lost to Follow-up|1|||
155187888|NCT02600351|560127978|FG001|Overall Study|Lost to Follow-up|0|||
155187889|NCT02600351|560127979|FG002|Overall Study|Lost to Follow-up|0|||
155187890|NCT02600351|560127980|FG003|Overall Study|Lost to Follow-up|0|||
155187891|NCT02600351|560127977|FG000|Overall Study|Randomized but Not Treated|1|||
155187892|NCT02600351|560127978|FG001|Overall Study|Randomized but Not Treated|0|||
155187893|NCT02600351|560127979|FG002|Overall Study|Randomized but Not Treated|1|||
155187894|NCT02600351|560127980|FG003|Overall Study|Randomized but Not Treated|3|||
155187895|NCT02063880|560127981|FG000|Overall Study|Death|21|||
155187896|NCT02063880|560127982|FG001|Overall Study|Death|18|||
155187897|NCT02063880|560127981|FG000|Overall Study|Lost to Follow-up|7|||
155187898|NCT02063880|560127982|FG001|Overall Study|Lost to Follow-up|7|||
155187899|NCT02063880|560127981|FG000|Overall Study|Ineligible|0|||
155187900|NCT02063880|560127982|FG001|Overall Study|Ineligible|2|||
155187901|NCT02106910|560127983|FG000|Overall Study|Lost to Follow-up|1|||
155187902|NCT02106910|560127984|FG001|Overall Study|Lost to Follow-up|1|||
155187903|NCT00567593|560127987|FG000|Overall Study|Adverse Event|1|||
155187904|NCT00567593|560127987|FG000|Overall Study|Physician Decision|1|||
155187905|NCT02476422|560127988|FG000|Overall Study|Subject/guardian decision|0|||
155187906|NCT02476422|560127989|FG001|Overall Study|Subject/guardian decision|1|||
155187907|NCT01859143|560127990|FG000|Overall Study|Lost to Follow-up|2|||
155187908|NCT01859143|560127991|FG001|Overall Study|Lost to Follow-up|0|||
155187909|NCT02413372|560127995|FG000|Treatment|Lost to Follow-up|0|||
155187910|NCT02413372|560127996|FG001|Treatment|Lost to Follow-up|2|||
155187911|NCT02413372|560127997|FG002|Treatment|Lost to Follow-up|1|||
155187912|NCT02413372|560127995|FG000|Treatment|Withdrawal by Subject|1|||
155187913|NCT02413372|560127996|FG001|Treatment|Withdrawal by Subject|0|||
155187914|NCT02413372|560127997|FG002|Treatment|Withdrawal by Subject|0|||
155187915|NCT02413372|560127995|FG000|Follow-up|Lost to Follow-up|1|||
155187916|NCT02413372|560127996|FG001|Follow-up|Lost to Follow-up|1|||
155187917|NCT02413372|560127997|FG002|Follow-up|Lost to Follow-up|0|||
155187918|NCT02413372|560127995|FG000|Follow-up|Subject Withdrew Consent|1|||
155187919|NCT02413372|560127996|FG001|Follow-up|Subject Withdrew Consent|0|||
155187920|NCT02413372|560127997|FG002|Follow-up|Subject Withdrew Consent|1|||
155187921|NCT02413372|560127995|FG000|Follow-up|Subject unable to return for visit|0|||
155187922|NCT02413372|560127996|FG001|Follow-up|Subject unable to return for visit|0|||
155187923|NCT02413372|560127997|FG002|Follow-up|Subject unable to return for visit|1|||
155187924|NCT00760214|560128005|FG000|Overall Study|Adverse Event|8|||
155187925|NCT00760214|560128006|FG001|Overall Study|Adverse Event|9|||
155187926|NCT00760214|560128007|FG002|Overall Study|Adverse Event|12|||
155187927|NCT00760214|560128005|FG000|Overall Study|Protocol Violation|3|||
155187928|NCT00760214|560128006|FG001|Overall Study|Protocol Violation|0|||
155187929|NCT00760214|560128007|FG002|Overall Study|Protocol Violation|3|||
155187930|NCT00760214|560128005|FG000|Overall Study|Lost to Follow-up|0|||
155187931|NCT00760214|560128006|FG001|Overall Study|Lost to Follow-up|0|||
155187932|NCT00760214|560128007|FG002|Overall Study|Lost to Follow-up|1|||
155187933|NCT00760214|560128005|FG000|Overall Study|Withdrawal by Subject|12|||
155187934|NCT00760214|560128006|FG001|Overall Study|Withdrawal by Subject|14|||
155187935|NCT00760214|560128007|FG002|Overall Study|Withdrawal by Subject|13|||
155187936|NCT00760214|560128005|FG000|Overall Study|Lack of Efficacy|3|||
155720246|NCT04698343|562071634|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
155720247|NCT02756338|562071638|FG000|Overall Study|Withdrawn by Investigator|1|||
155720248|NCT02756338|562071638|FG000|Overall Study|Device Replaced with Pacemaker|4|||
155720249|NCT01339689|562071641|FG000|Overall Study|Adverse Event|1|||
155187937|NCT00760214|560128006|FG001|Overall Study|Lack of Efficacy|2|||
155187938|NCT00760214|560128007|FG002|Overall Study|Lack of Efficacy|4|||
155187939|NCT00760214|560128005|FG000|Overall Study|Pregnancy|0|||
155187940|NCT00760214|560128006|FG001|Overall Study|Pregnancy|0|||
155187941|NCT00760214|560128007|FG002|Overall Study|Pregnancy|1|||
155187942|NCT00760214|560128005|FG000|Overall Study|Physician Decision|1|||
155187943|NCT00760214|560128006|FG001|Overall Study|Physician Decision|1|||
155187944|NCT00760214|560128007|FG002|Overall Study|Physician Decision|1|||
155187945|NCT00760214|560128005|FG000|Overall Study|Other|3|||
155187946|NCT00760214|560128006|FG001|Overall Study|Other|4|||
155187947|NCT00760214|560128007|FG002|Overall Study|Other|6|||
155187948|NCT00700570|560128008|FG000|Overall Study|Adverse Event|2|||
155187949|NCT00700570|560128009|FG001|Overall Study|Adverse Event|6|||
155187950|NCT00700570|560128008|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
155187951|NCT00700570|560128009|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
155187952|NCT00700570|560128008|FG000|Overall Study|Disease Progression|8|||
155187953|NCT00700570|560128009|FG001|Overall Study|Disease Progression|11|||
155187954|NCT00700570|560128008|FG000|Overall Study|Withdrawal by Subject|1|||
155187955|NCT00700570|560128009|FG001|Overall Study|Withdrawal by Subject|6|||
155187956|NCT01134315|560128010|FG000|Overall Study|Adverse Event|1|||
155187957|NCT01134315|560128011|FG001|Overall Study|Adverse Event|2|||
155187958|NCT01134315|560128010|FG000|Overall Study|Other Reason|8|||
155187959|NCT01134315|560128011|FG001|Overall Study|Other Reason|17|||
155187960|NCT04587271|560128012|FG000|Overall Study|Lost to Follow-up|2|||
155187961|NCT04587271|560128013|FG001|Overall Study|Lost to Follow-up|2|||
155187962|NCT04587271|560128014|FG002|Overall Study|Lost to Follow-up|0|||
155187963|NCT04587271|560128015|FG003|Overall Study|Lost to Follow-up|2|||
155187964|NCT04587271|560128016|FG004|Overall Study|Lost to Follow-up|2|||
155187965|NCT04587271|560128017|FG005|Overall Study|Lost to Follow-up|0|||
155187966|NCT04587271|560128012|FG000|Overall Study|Caregiver brought child to visits|0|||
155187967|NCT04587271|560128013|FG001|Overall Study|Caregiver brought child to visits|0|||
155187968|NCT04587271|560128014|FG002|Overall Study|Caregiver brought child to visits|0|||
155187969|NCT04587271|560128015|FG003|Overall Study|Caregiver brought child to visits|1|||
155187970|NCT04587271|560128016|FG004|Overall Study|Caregiver brought child to visits|0|||
155187971|NCT04587271|560128017|FG005|Overall Study|Caregiver brought child to visits|0|||
155187972|NCT02360111|560128018|FG000|Overall Study|Death|2|||
155187973|NCT01933217|560128019|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
155187974|NCT01933217|560128020|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
155187975|NCT01933217|560128019|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
155187976|NCT01933217|560128020|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
155187977|NCT03923738|560128024|FG000|Period 1|Adverse Event|1|||
155187978|NCT03923738|560128024|FG000|Period 1|Withdrawal by Subject|1|||
155187979|NCT05246397|560128025|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
155187980|NCT03875768|560128026|FG000|Overall Study|Lost to Follow-up|16|||
155187981|NCT03875768|560128027|FG001|Overall Study|Lost to Follow-up|13|||
155187982|NCT03875768|560128026|FG000|Overall Study|Withdrawal by Subject|10|||
155187983|NCT03875768|560128027|FG001|Overall Study|Withdrawal by Subject|21|||
155187984|NCT03875768|560128026|FG000|Overall Study|Did not complete assessment|21|||
155187985|NCT03875768|560128027|FG001|Overall Study|Did not complete assessment|12|||
155187986|NCT03875768|560128026|FG000|Overall Study|Became ineligible|1|||
155187987|NCT03875768|560128027|FG001|Overall Study|Became ineligible|0|||
155187988|NCT01925274|560128028|FG000|Overall Study|Death|1|||
155187989|NCT01925274|560128029|FG001|Overall Study|Death|0|||
155187990|NCT01925274|560128030|FG002|Overall Study|Death|0|||
155187991|NCT01925274|560128028|FG000|Overall Study|Lost to Follow-up|0|||
155187992|NCT01925274|560128029|FG001|Overall Study|Lost to Follow-up|1|||
155187993|NCT01925274|560128030|FG002|Overall Study|Lost to Follow-up|0|||
155187994|NCT01925274|560128028|FG000|Overall Study|Withdrawal by Subject|1|||
155187995|NCT01925274|560128029|FG001|Overall Study|Withdrawal by Subject|2|||
155187996|NCT01925274|560128030|FG002|Overall Study|Withdrawal by Subject|0|||
155187997|NCT01925274|560128028|FG000|Overall Study|Study terminated by sponsor|4|||
155187998|NCT01925274|560128029|FG001|Overall Study|Study terminated by sponsor|0|||
155187999|NCT01925274|560128030|FG002|Overall Study|Study terminated by sponsor|0|||
155188000|NCT01925274|560128028|FG000|Overall Study|Protocol amendment|1|||
155188001|NCT01925274|560128029|FG001|Overall Study|Protocol amendment|3|||
155188002|NCT01925274|560128030|FG002|Overall Study|Protocol amendment|6|||
155188003|NCT04327674|560128032|FG000|Overall Study|Protocol Violation|19|||
155188004|NCT00723398|560128037|FG000|Overall Study|Withdrawal by Subject|2|||
155188005|NCT00723398|560128038|FG001|Overall Study|Withdrawal by Subject|6|||
155188006|NCT00723398|560128039|FG002|Overall Study|Withdrawal by Subject|4|||
155188007|NCT00723398|560128040|FG003|Overall Study|Withdrawal by Subject|4|||
155188008|NCT00723398|560128041|FG004|Overall Study|Withdrawal by Subject|4|||
155188009|NCT00723398|560128037|FG000|Overall Study|Protocol Violation|2|||
155188010|NCT00723398|560128038|FG001|Overall Study|Protocol Violation|1|||
155188011|NCT00723398|560128039|FG002|Overall Study|Protocol Violation|5|||
155188012|NCT00723398|560128040|FG003|Overall Study|Protocol Violation|0|||
155188013|NCT00723398|560128041|FG004|Overall Study|Protocol Violation|0|||
155188014|NCT00723398|560128037|FG000|Overall Study|Physician Decision|2|||
155188015|NCT00723398|560128038|FG001|Overall Study|Physician Decision|2|||
155188016|NCT00723398|560128039|FG002|Overall Study|Physician Decision|5|||
155188017|NCT00723398|560128040|FG003|Overall Study|Physician Decision|0|||
155188018|NCT00723398|560128041|FG004|Overall Study|Physician Decision|1|||
155188019|NCT00723398|560128037|FG000|Overall Study|Adverse Event|0|||
155188020|NCT00723398|560128038|FG001|Overall Study|Adverse Event|5|||
155188021|NCT00723398|560128039|FG002|Overall Study|Adverse Event|3|||
155188022|NCT00723398|560128040|FG003|Overall Study|Adverse Event|1|||
155188023|NCT00723398|560128041|FG004|Overall Study|Adverse Event|4|||
155188024|NCT00723398|560128037|FG000|Overall Study|Lost to Follow-up|0|||
155188025|NCT00723398|560128038|FG001|Overall Study|Lost to Follow-up|1|||
155188026|NCT00723398|560128039|FG002|Overall Study|Lost to Follow-up|0|||
155188027|NCT00723398|560128040|FG003|Overall Study|Lost to Follow-up|0|||
155188028|NCT00723398|560128041|FG004|Overall Study|Lost to Follow-up|0|||
155188029|NCT01225887|560128048|FG000|Overall Study|Ineligible:required test not done|2|||
155188030|NCT01225887|560128048|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
155188031|NCT01225887|560128048|FG000|Overall Study|Ineligible:inadequate pathology|2|||
155188032|NCT01400815|560128051|FG000|Overall Study|Adverse Event|3|||
155188033|NCT01400815|560128052|FG001|Overall Study|Adverse Event|0|||
155188034|NCT01400815|560128051|FG000|Overall Study|Death|0|||
155188035|NCT01400815|560128052|FG001|Overall Study|Death|1|||
155188036|NCT01400815|560128051|FG000|Overall Study|Lost to Follow-up|18|||
155188037|NCT01400815|560128052|FG001|Overall Study|Lost to Follow-up|11|||
155188038|NCT01400815|560128051|FG000|Overall Study|Protocol Violation|0|||
155188039|NCT01400815|560128052|FG001|Overall Study|Protocol Violation|1|||
155188040|NCT01400815|560128051|FG000|Overall Study|Physician Decision|1|||
155188041|NCT01400815|560128052|FG001|Overall Study|Physician Decision|0|||
155188042|NCT01400815|560128051|FG000|Overall Study|Withdrawal by Subject|15|||
155188043|NCT01400815|560128052|FG001|Overall Study|Withdrawal by Subject|8|||
155188044|NCT01400815|560128051|FG000|Overall Study|Subject in jail|1|||
155188045|NCT01400815|560128052|FG001|Overall Study|Subject in jail|0|||
155188046|NCT01123850|560128053|FG000|Overall Study|Slow enrollment|45|||
155188047|NCT01822678|560128061|FG000|Overall Study|Withdrawal by Subject|5|||
155188048|NCT01822678|560128062|FG001|Overall Study|Withdrawal by Subject|4|||
155188049|NCT01822678|560128063|FG002|Overall Study|Withdrawal by Subject|4|||
155188050|NCT01822678|560128061|FG000|Overall Study|Adverse Event|4|||
155188051|NCT01822678|560128062|FG001|Overall Study|Adverse Event|3|||
155188052|NCT01822678|560128063|FG002|Overall Study|Adverse Event|1|||
155188053|NCT01822678|560128061|FG000|Overall Study|Lack of Efficacy|3|||
155188054|NCT01822678|560128062|FG001|Overall Study|Lack of Efficacy|6|||
155188055|NCT01822678|560128063|FG002|Overall Study|Lack of Efficacy|5|||
155188056|NCT01822678|560128061|FG000|Overall Study|Lost to Follow-up|0|||
155188057|NCT01822678|560128062|FG001|Overall Study|Lost to Follow-up|2|||
155188058|NCT01822678|560128063|FG002|Overall Study|Lost to Follow-up|1|||
155188059|NCT01437878|560128069|FG000|Overall Study|Withdrawal by Subject|1|||
155188060|NCT01437878|560128070|FG001|Overall Study|Withdrawal by Subject|0|||
155188061|NCT01369615|560128072|FG000|Overall Study|Withdrawal by Subject|0|||
155188062|NCT01369615|560128073|FG001|Overall Study|Withdrawal by Subject|1|||
155188063|NCT01369615|560128072|FG000|Overall Study|Lost to Follow-up|0|||
155188064|NCT01369615|560128073|FG001|Overall Study|Lost to Follow-up|1|||
155188065|NCT04263454|560128074|FG000|Overall Study|Adverse Event|0|||
155188066|NCT04263454|560128075|FG001|Overall Study|Adverse Event|2|||
155188067|NCT04263454|560128074|FG000|Overall Study|Physician Decision|3|||
155188068|NCT04263454|560128075|FG001|Overall Study|Physician Decision|5|||
155188069|NCT04263454|560128074|FG000|Overall Study|Poor Data Quality|0|||
155188070|NCT04263454|560128075|FG001|Overall Study|Poor Data Quality|1|||
155188071|NCT00986479|560128076|FG000|Period 1|Improved mood|1|||
155188072|NCT00986479|560128077|FG001|Period 1|Improved mood|0|||
155188073|NCT00986479|560128076|FG000|Period 1|Administrative reasons|1|||
155188074|NCT00986479|560128077|FG001|Period 1|Administrative reasons|0|||
155188075|NCT01721070|560128078|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
155188076|NCT02035475|560128079|FG000|Overall Study|Withdrawal by Subject|4|||
155188077|NCT02035475|560128079|FG000|Overall Study|Physician Decision|1|||
155188078|NCT02035475|560128079|FG000|Overall Study|Equipment Error|1|||
155188079|NCT01460368|560128080|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188080|NCT01460368|560128081|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188081|NCT01460368|560128082|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188082|NCT01460368|560128083|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188083|NCT01460368|560128084|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
155188084|NCT01460368|560128085|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188085|NCT01460368|560128086|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188086|NCT01460368|560128080|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188087|NCT01460368|560128081|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
155720250|NCT01339689|562071642|FG001|Overall Study|Adverse Event|2|||
155188088|NCT01460368|560128082|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188089|NCT01460368|560128083|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188090|NCT01460368|560128084|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188091|NCT01460368|560128085|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188092|NCT01460368|560128086|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
155188093|NCT01460368|560128080|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188094|NCT01460368|560128081|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
155188095|NCT01460368|560128082|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188096|NCT01460368|560128083|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188097|NCT01460368|560128084|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188098|NCT01460368|560128085|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188099|NCT01460368|560128086|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188100|NCT01460368|560128080|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188101|NCT01460368|560128081|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188102|NCT01460368|560128082|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
155188103|NCT01460368|560128083|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188104|NCT01460368|560128084|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188105|NCT01460368|560128085|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188106|NCT01460368|560128086|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188107|NCT01460368|560128080|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188108|NCT01460368|560128081|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188109|NCT01460368|560128082|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188110|NCT01460368|560128083|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188111|NCT01460368|560128084|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188112|NCT01460368|560128085|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188113|NCT01460368|560128086|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188114|NCT02322021|560128087|FG000|Core Phase|Adverse Event|1|||
155188115|NCT02322021|560128088|FG001|Core Phase|Adverse Event|3|||
155188116|NCT02322021|560128089|FG002|Core Phase|Adverse Event|4|||
155188117|NCT02322021|560128090|FG003|Core Phase|Adverse Event|2|||
155188118|NCT02322021|560128091|FG004|Core Phase|Adverse Event|0|||
155188119|NCT02322021|560128087|FG000|Core Phase|Participant Choice|4|||
155188120|NCT02322021|560128088|FG001|Core Phase|Participant Choice|5|||
155188121|NCT02322021|560128089|FG002|Core Phase|Participant Choice|4|||
155188122|NCT02322021|560128090|FG003|Core Phase|Participant Choice|2|||
155188123|NCT02322021|560128091|FG004|Core Phase|Participant Choice|0|||
155188124|NCT02322021|560128087|FG000|Core Phase|Lost to Follow-up|0|||
155188125|NCT02322021|560128088|FG001|Core Phase|Lost to Follow-up|0|||
155188126|NCT02322021|560128089|FG002|Core Phase|Lost to Follow-up|0|||
155188127|NCT02322021|560128090|FG003|Core Phase|Lost to Follow-up|1|||
155188128|NCT02322021|560128091|FG004|Core Phase|Lost to Follow-up|0|||
155188129|NCT02322021|560128087|FG000|Core Phase|Other|0|||
155188130|NCT02322021|560128088|FG001|Core Phase|Other|0|||
155188131|NCT02322021|560128089|FG002|Core Phase|Other|1|||
155188132|NCT02322021|560128090|FG003|Core Phase|Other|0|||
155188133|NCT02322021|560128091|FG004|Core Phase|Other|0|||
155188134|NCT02322021|560128087|FG000|Extension Phase|Adverse Event|0|||
155188135|NCT02322021|560128088|FG001|Extension Phase|Adverse Event|0|||
155188136|NCT02322021|560128089|FG002|Extension Phase|Adverse Event|0|||
155188137|NCT02322021|560128090|FG003|Extension Phase|Adverse Event|0|||
155188138|NCT02322021|560128091|FG004|Extension Phase|Adverse Event|3|||
155188139|NCT02322021|560128087|FG000|Extension Phase|Participant Choice|0|||
155188140|NCT02322021|560128088|FG001|Extension Phase|Participant Choice|0|||
155188141|NCT02322021|560128089|FG002|Extension Phase|Participant Choice|0|||
155188142|NCT02322021|560128090|FG003|Extension Phase|Participant Choice|0|||
155188143|NCT02322021|560128091|FG004|Extension Phase|Participant Choice|6|||
155188144|NCT02322021|560128087|FG000|Extension Phase|Other|0|||
155188145|NCT02322021|560128088|FG001|Extension Phase|Other|0|||
155188146|NCT02322021|560128089|FG002|Extension Phase|Other|0|||
155188147|NCT02322021|560128090|FG003|Extension Phase|Other|0|||
155188148|NCT02322021|560128091|FG004|Extension Phase|Other|3|||
155188149|NCT02322021|560128087|FG000|Extension Phase|Lost to Follow-up|0|||
155188150|NCT02322021|560128088|FG001|Extension Phase|Lost to Follow-up|0|||
155188151|NCT02322021|560128089|FG002|Extension Phase|Lost to Follow-up|0|||
155188152|NCT02322021|560128090|FG003|Extension Phase|Lost to Follow-up|0|||
155188153|NCT02322021|560128091|FG004|Extension Phase|Lost to Follow-up|1|||
155188154|NCT02322021|560128087|FG000|Extension Phase|Study terminated by sponsor|0|||
155188155|NCT02322021|560128088|FG001|Extension Phase|Study terminated by sponsor|0|||
155188156|NCT02322021|560128089|FG002|Extension Phase|Study terminated by sponsor|0|||
155188157|NCT02322021|560128090|FG003|Extension Phase|Study terminated by sponsor|0|||
155188158|NCT02322021|560128091|FG004|Extension Phase|Study terminated by sponsor|28|||
155188159|NCT02047227|560128092|FG000|Overall Study|Adverse Event|2|||
155188160|NCT02047227|560128093|FG001|Overall Study|Adverse Event|4|||
155188161|NCT02047227|560128092|FG000|Overall Study|Lost to Follow-up|0|||
155188162|NCT02047227|560128093|FG001|Overall Study|Lost to Follow-up|3|||
155188163|NCT02047227|560128092|FG000|Overall Study|Protocol Violation|1|||
155188164|NCT02047227|560128093|FG001|Overall Study|Protocol Violation|0|||
155188165|NCT02047227|560128092|FG000|Overall Study|Spontaneous pregnancy|1|||
155188166|NCT02047227|560128093|FG001|Overall Study|Spontaneous pregnancy|0|||
155188167|NCT02047227|560128092|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
155188168|NCT02047227|560128093|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
155188169|NCT02047227|560128092|FG000|Overall Study|No oocytes retrieved|21|||
155188170|NCT02047227|560128093|FG001|Overall Study|No oocytes retrieved|20|||
155188171|NCT02047227|560128092|FG000|Overall Study|No fertilization|61|||
155188172|NCT02047227|560128093|FG001|Overall Study|No fertilization|51|||
155188173|NCT02047227|560128092|FG000|Overall Study|Intention to freeze all embryos|1|||
155188174|NCT02047227|560128093|FG001|Overall Study|Intention to freeze all embryos|0|||
155188175|NCT02047227|560128092|FG000|Overall Study|All embryos discarded|12|||
155188176|NCT02047227|560128093|FG001|Overall Study|All embryos discarded|11|||
155188177|NCT02047227|560128092|FG000|Overall Study|Other|10|||
155188178|NCT02047227|560128093|FG001|Overall Study|Other|9|||
155188179|NCT02001181|560128100|FG000|Overall Study|Adverse Event|0|||
155188180|NCT02001181|560128101|FG001|Overall Study|Adverse Event|2|||
155188181|NCT02001181|560128100|FG000|Overall Study|Lost to Follow-up|1|||
155188182|NCT02001181|560128101|FG001|Overall Study|Lost to Follow-up|0|||
155188183|NCT02001181|560128100|FG000|Overall Study|Withdrawal by Subject|0|||
155188184|NCT02001181|560128101|FG001|Overall Study|Withdrawal by Subject|1|||
155188185|NCT02435069|560128106|FG000|Dose Response - First Intervention|Adverse Event|0|||
155188186|NCT02435069|560128107|FG001|Dose Response - First Intervention|Adverse Event|1|||
155188187|NCT02435069|560128108|FG002|Dose Response - First Intervention|Adverse Event|1|||
155188188|NCT02435069|560128109|FG003|Dose Response - First Intervention|Adverse Event|0|||
155188189|NCT02435069|560128110|FG004|Dose Response - First Intervention|Adverse Event|0|||
155188190|NCT02435069|560128106|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188191|NCT02435069|560128107|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188192|NCT02435069|560128108|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188193|NCT02435069|560128109|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188194|NCT02435069|560128110|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
155188195|NCT03112590|560128111|FG000|Overall Study|Adverse Event|0|||
155188196|NCT03112590|560128112|FG001|Overall Study|Adverse Event|1|||
155188197|NCT03112590|560128113|FG002|Overall Study|Adverse Event|0|||
155188198|NCT02059005|560128116|FG000|Overall Study|Death|1|||
155188199|NCT02059005|560128117|FG001|Overall Study|Death|3|||
155188200|NCT02059005|560128116|FG000|Overall Study|Lost to Follow-up|19|||
155188201|NCT02059005|560128117|FG001|Overall Study|Lost to Follow-up|19|||
155188202|NCT02059005|560128116|FG000|Overall Study|Incarceration|0|||
155188203|NCT02059005|560128117|FG001|Overall Study|Incarceration|1|||
155188204|NCT02059005|560128116|FG000|Overall Study|Inpatient|0|||
155188205|NCT02059005|560128117|FG001|Overall Study|Inpatient|1|||
155188206|NCT00739596|560128122|FG000|Overall Study|Adverse Event|12|||
155188207|NCT00739596|560128123|FG001|Overall Study|Adverse Event|6|||
155188208|NCT00739596|560128122|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155188209|NCT00739596|560128123|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155188210|NCT00739596|560128122|FG000|Overall Study|Patient Withdrew Consent|8|||
155188211|NCT00739596|560128123|FG001|Overall Study|Patient Withdrew Consent|8|||
155188212|NCT00739596|560128122|FG000|Overall Study|Lost to Follow-up|0|||
155188213|NCT00739596|560128123|FG001|Overall Study|Lost to Follow-up|2|||
155188214|NCT00739596|560128122|FG000|Overall Study|Protocol Deviation|1|||
155188215|NCT00739596|560128123|FG001|Overall Study|Protocol Deviation|1|||
155188216|NCT00908011|560128124|FG000|Overall Study|Withdrawal by Subject|2|||
155188217|NCT00908011|560128125|FG001|Overall Study|Withdrawal by Subject|2|||
155188218|NCT02520661|560128126|FG000|Overall Study|Lost to Follow-up|7|||
155188219|NCT02520661|560128127|FG001|Overall Study|Lost to Follow-up|3|||
155188220|NCT02520661|560128126|FG000|Overall Study|Admitted from ED|49|||
155188221|NCT02520661|560128127|FG001|Overall Study|Admitted from ED|48|||
155188222|NCT02520661|560128126|FG000|Overall Study|ED greater than 24 hours|29|||
155188223|NCT02520661|560128127|FG001|Overall Study|ED greater than 24 hours|38|||
155188224|NCT02520661|560128126|FG000|Overall Study|other ineligibility|14|||
155188225|NCT02520661|560128127|FG001|Overall Study|other ineligibility|22|||
155720251|NCT01339689|562071641|FG000|Overall Study|Lost to Follow-up|9|||
155720252|NCT01339689|562071642|FG001|Overall Study|Lost to Follow-up|3|||
155188226|NCT02520661|560128126|FG000|Overall Study|Withdrawal by Subject|7|||
155188227|NCT02520661|560128127|FG001|Overall Study|Withdrawal by Subject|16|||
155188228|NCT00891462|560129240|FG000|Overall Study|Withdrawal by Subject|9|||
155188229|NCT00891462|560129241|FG001|Overall Study|Withdrawal by Subject|6|||
155188230|NCT00891462|560129242|FG002|Overall Study|Withdrawal by Subject|7|||
155188231|NCT00891462|560129240|FG000|Overall Study|Adverse Event|7|||
155188232|NCT00891462|560129241|FG001|Overall Study|Adverse Event|8|||
155188233|NCT00891462|560129242|FG002|Overall Study|Adverse Event|7|||
155720253|NCT01339689|562071641|FG000|Overall Study|Withdrawal by Subject|3|||
155188234|NCT00891462|560129240|FG000|Overall Study|Lack of Efficacy|10|||
155188235|NCT00891462|560129241|FG001|Overall Study|Lack of Efficacy|5|||
155188236|NCT00891462|560129242|FG002|Overall Study|Lack of Efficacy|1|||
155188237|NCT00891462|560129240|FG000|Overall Study|COPD exacerbation|7|||
155188238|NCT00891462|560129241|FG001|Overall Study|COPD exacerbation|4|||
155188239|NCT00891462|560129242|FG002|Overall Study|COPD exacerbation|1|||
155188240|NCT00891462|560129240|FG000|Overall Study|Other Reason|2|||
155188241|NCT00891462|560129241|FG001|Overall Study|Other Reason|5|||
155188242|NCT00891462|560129242|FG002|Overall Study|Other Reason|3|||
155188243|NCT00891462|560129240|FG000|Overall Study|Protocol Violation|2|||
155188244|NCT00891462|560129241|FG001|Overall Study|Protocol Violation|1|||
155188245|NCT00891462|560129242|FG002|Overall Study|Protocol Violation|3|||
155188246|NCT00891462|560129240|FG000|Overall Study|Inclusion/exclusion criteria|0|||
155188247|NCT00891462|560129241|FG001|Overall Study|Inclusion/exclusion criteria|2|||
155188248|NCT00891462|560129242|FG002|Overall Study|Inclusion/exclusion criteria|2|||
155188249|NCT00891462|560129240|FG000|Overall Study|Lost to Follow-up|0|||
155188250|NCT00891462|560129241|FG001|Overall Study|Lost to Follow-up|2|||
155188251|NCT00891462|560129242|FG002|Overall Study|Lost to Follow-up|0|||
155188252|NCT01083485|560129243|FG000|Overall Study|Adverse Event|0|||
155188253|NCT01083485|560129244|FG001|Overall Study|Adverse Event|1|||
155188254|NCT01083485|560129243|FG000|Overall Study|Protocol Violation|1|||
155188255|NCT01083485|560129244|FG001|Overall Study|Protocol Violation|0|||
155188256|NCT01083485|560129243|FG000|Overall Study|Withdrawal by Subject|5|||
155188257|NCT01083485|560129244|FG001|Overall Study|Withdrawal by Subject|2|||
155188258|NCT01083485|560129243|FG000|Overall Study|Other|1|||
155188259|NCT01083485|560129244|FG001|Overall Study|Other|0|||
155188260|NCT05108922|560129245|FG000|Overall Study|Adverse Event|2|||
155188261|NCT05108922|560129246|FG001|Overall Study|Adverse Event|3|||
155188262|NCT05108922|560129245|FG000|Overall Study|Lost to Follow-up|2|||
155188263|NCT05108922|560129246|FG001|Overall Study|Lost to Follow-up|1|||
155188264|NCT05108922|560129245|FG000|Overall Study|Inadvertent enrollment|0|||
155188265|NCT05108922|560129246|FG001|Overall Study|Inadvertent enrollment|1|||
155188266|NCT05108922|560129245|FG000|Overall Study|Physician Decision|2|||
155188267|NCT05108922|560129246|FG001|Overall Study|Physician Decision|3|||
155188268|NCT05108922|560129245|FG000|Overall Study|Protocol deviation|1|||
155188269|NCT05108922|560129246|FG001|Overall Study|Protocol deviation|0|||
155188270|NCT05108922|560129245|FG000|Overall Study|Screen failure|1|||
155188271|NCT05108922|560129246|FG001|Overall Study|Screen failure|0|||
155188272|NCT05108922|560129245|FG000|Overall Study|Withdrawal by Subject|11|||
155188273|NCT05108922|560129246|FG001|Overall Study|Withdrawal by Subject|8|||
155188274|NCT05036369|560129247|FG000|Overall Study|Run In non compliance|1|||
155188275|NCT05036369|560129248|FG001|Overall Study|Run In non compliance|2|||
155188276|NCT05036369|560129247|FG000|Overall Study|Change in eligibility criteria|0|||
155188277|NCT05036369|560129248|FG001|Overall Study|Change in eligibility criteria|1|||
155188278|NCT02095223|560129250|FG000|Overall Study|Withdrawal by Subject|1|||
155188279|NCT02095223|560129251|FG001|Overall Study|Withdrawal by Subject|0|||
155188280|NCT01397162|560129252|FG000|Overall Study|Adverse Event|4|||
155188281|NCT01397162|560129253|FG001|Overall Study|Adverse Event|0|||
155188282|NCT01397162|560129254|FG002|Overall Study|Adverse Event|0|||
155188283|NCT01397162|560129255|FG003|Overall Study|Adverse Event|0|||
155188284|NCT01397162|560129256|FG004|Overall Study|Adverse Event|0|||
155188285|NCT01397162|560129252|FG000|Overall Study|Not yet defined|3|||
155188286|NCT01397162|560129253|FG001|Overall Study|Not yet defined|4|||
155188287|NCT01397162|560129254|FG002|Overall Study|Not yet defined|3|||
155188288|NCT01397162|560129255|FG003|Overall Study|Not yet defined|5|||
155188289|NCT01397162|560129256|FG004|Overall Study|Not yet defined|3|||
155188290|NCT01507298|560129261|FG000|Overall Study|Protocol Violation|0|||
155188291|NCT01507298|560129262|FG001|Overall Study|Protocol Violation|6|||
155188292|NCT03906461|560129263|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
155188293|NCT03906461|560129263|FG000|Completed 12-month Follow-up|Missed Visit|6|||
155188294|NCT01920555|560129264|FG000|Overall Study|Physician Decision|1|||
155188295|NCT01920555|560129265|FG001|Overall Study|Physician Decision|2|||
155188296|NCT01920555|560129266|FG002|Overall Study|Physician Decision|1|||
155188297|NCT01920555|560129267|FG003|Overall Study|Physician Decision|2|||
155188298|NCT01920555|560129268|FG004|Overall Study|Physician Decision|0|||
155188299|NCT01920555|560129264|FG000|Overall Study|Lack of Efficacy|2|||
155720254|NCT01339689|562071642|FG001|Overall Study|Withdrawal by Subject|0|||
155720255|NCT01339689|562071641|FG000|Overall Study|Noncompliance|1|||
155720256|NCT01339689|562071642|FG001|Overall Study|Noncompliance|0|||
155720257|NCT01339689|562071641|FG000|Overall Study|Relocated out of area|0|||
155188300|NCT01920555|560129265|FG001|Overall Study|Lack of Efficacy|0|||
155188301|NCT01920555|560129266|FG002|Overall Study|Lack of Efficacy|0|||
155188302|NCT01920555|560129267|FG003|Overall Study|Lack of Efficacy|0|||
155188303|NCT01920555|560129268|FG004|Overall Study|Lack of Efficacy|0|||
155188304|NCT01920555|560129264|FG000|Overall Study|Travel Difficulties|1|||
155188305|NCT01920555|560129265|FG001|Overall Study|Travel Difficulties|1|||
155188306|NCT01920555|560129266|FG002|Overall Study|Travel Difficulties|0|||
155188307|NCT01920555|560129267|FG003|Overall Study|Travel Difficulties|0|||
155188308|NCT01920555|560129268|FG004|Overall Study|Travel Difficulties|1|||
155188309|NCT01920555|560129264|FG000|Overall Study|Lost to Follow-up|0|||
155188310|NCT01920555|560129265|FG001|Overall Study|Lost to Follow-up|1|||
155188311|NCT01920555|560129266|FG002|Overall Study|Lost to Follow-up|0|||
155188312|NCT01920555|560129267|FG003|Overall Study|Lost to Follow-up|1|||
155188313|NCT01920555|560129268|FG004|Overall Study|Lost to Follow-up|0|||
155188314|NCT01795638|560129271|FG000|Overall Study|Death|0|||
155188315|NCT01795638|560129272|FG001|Overall Study|Death|3|||
155188316|NCT01795638|560129271|FG000|Overall Study|transferred to quaternary hospital|2|||
155188317|NCT01795638|560129272|FG001|Overall Study|transferred to quaternary hospital|3|||
155188318|NCT01795638|560129271|FG000|Overall Study|Protocol Violation|3|||
155188319|NCT01795638|560129272|FG001|Overall Study|Protocol Violation|0|||
155188320|NCT01795638|560129271|FG000|Overall Study|discharged from hospital|7|||
155188321|NCT01795638|560129272|FG001|Overall Study|discharged from hospital|5|||
155188322|NCT01795638|560129271|FG000|Overall Study|Withdrawal by Subject|1|||
155188323|NCT01795638|560129272|FG001|Overall Study|Withdrawal by Subject|0|||
155188324|NCT00611533|560129273|FG000|First Intervention (6 Weeks)|Never started study|0|||
155188325|NCT00611533|560129274|FG001|First Intervention (6 Weeks)|Never started study|1|||
155188326|NCT00611533|560129273|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
155188327|NCT00611533|560129274|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155188328|NCT00611533|560129273|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155188329|NCT00611533|560129274|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
155188330|NCT01954342|560129278|FG000|Overall Study|Missing data from 13-16week study visit|0|||
155188331|NCT01954342|560129279|FG001|Overall Study|Missing data from 13-16week study visit|0|||
155188332|NCT01954342|560129280|FG002|Overall Study|Missing data from 13-16week study visit|0|||
155188333|NCT01954342|560129281|FG003|Overall Study|Missing data from 13-16week study visit|1|||
155188334|NCT01954342|560129278|FG000|Overall Study|Miscarriage|0|||
155188335|NCT01954342|560129279|FG001|Overall Study|Miscarriage|0|||
155188336|NCT01954342|560129280|FG002|Overall Study|Miscarriage|0|||
155188337|NCT01954342|560129281|FG003|Overall Study|Miscarriage|3|||
155188338|NCT01954342|560129278|FG000|Overall Study|Lost to Follow-up|0|||
155188339|NCT01954342|560129279|FG001|Overall Study|Lost to Follow-up|0|||
155188340|NCT01954342|560129280|FG002|Overall Study|Lost to Follow-up|0|||
155188341|NCT01954342|560129281|FG003|Overall Study|Lost to Follow-up|5|||
155188342|NCT01954342|560129278|FG000|Overall Study|Preterm delivery|0|||
155188343|NCT01954342|560129279|FG001|Overall Study|Preterm delivery|0|||
155188344|NCT01954342|560129280|FG002|Overall Study|Preterm delivery|0|||
155188345|NCT01954342|560129281|FG003|Overall Study|Preterm delivery|3|||
155188346|NCT01954342|560129278|FG000|Overall Study|Pre-eclampsia|0|||
155188347|NCT01954342|560129279|FG001|Overall Study|Pre-eclampsia|0|||
155188348|NCT01954342|560129280|FG002|Overall Study|Pre-eclampsia|0|||
155188349|NCT01954342|560129281|FG003|Overall Study|Pre-eclampsia|4|||
155188350|NCT01954342|560129278|FG000|Overall Study|Unreliable Data|0|||
155188351|NCT01954342|560129279|FG001|Overall Study|Unreliable Data|0|||
155188352|NCT01954342|560129280|FG002|Overall Study|Unreliable Data|0|||
155188353|NCT01954342|560129281|FG003|Overall Study|Unreliable Data|2|||
155188354|NCT00984568|560129284|FG000|Overall Study|Withdrawal by Subject|1|||
155188355|NCT00984568|560129285|FG001|Overall Study|Withdrawal by Subject|2|||
155188356|NCT00984568|560129284|FG000|Overall Study|Lack of Efficacy|2|||
155188357|NCT00984568|560129285|FG001|Overall Study|Lack of Efficacy|0|||
155188358|NCT00984568|560129284|FG000|Overall Study|Adverse Event|2|||
155188359|NCT00984568|560129285|FG001|Overall Study|Adverse Event|0|||
155188360|NCT00984568|560129284|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
155188361|NCT00984568|560129285|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
155188362|NCT00984568|560129284|FG000|Overall Study|Lost to Follow-up|0|||
155188363|NCT00984568|560129285|FG001|Overall Study|Lost to Follow-up|1|||
155188364|NCT00984568|560129284|FG000|Overall Study|Opportunistic Infection|1|||
155188365|NCT00984568|560129285|FG001|Overall Study|Opportunistic Infection|0|||
155188366|NCT00984568|560129284|FG000|Overall Study|Unknown Reason|1|||
155188367|NCT00984568|560129285|FG001|Overall Study|Unknown Reason|3|||
155188368|NCT02310321|560129292|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
155188369|NCT02310321|560129293|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188370|NCT02310321|560129294|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188371|NCT02310321|560129292|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
155720258|NCT01339689|562071642|FG001|Overall Study|Relocated out of area|1|||
155720259|NCT01339689|562071641|FG000|Overall Study|Other|2|||
155188372|NCT02310321|560129293|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188373|NCT02310321|560129294|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188374|NCT02310321|560129292|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
155188375|NCT02310321|560129293|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188376|NCT02310321|560129294|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188377|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
155188378|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
155188379|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
155188380|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155720260|NCT01339689|562071642|FG001|Overall Study|Other|2|||
155188381|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
155720261|NCT01339689|562071641|FG000|Overall Study|multiple reasons|1|||
155188382|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188383|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
155188384|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
155188385|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
155188386|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
155188387|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
155188388|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
155188389|NCT02310321|560129292|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
155188390|NCT02310321|560129293|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
155188391|NCT02310321|560129294|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
155188392|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
155188393|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
155188394|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
155188395|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
155188396|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
155188397|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
155188398|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
155188399|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
155188400|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
155188401|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
155188402|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
155188403|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
155188404|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
155188405|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
155188406|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
155188407|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
155188408|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
155188409|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
155188410|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
155188411|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
155188412|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
155188413|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
155188414|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
155188415|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
155188416|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
155188417|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
155188418|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
155188419|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
155188420|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
155188421|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
155188422|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
155188423|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
155188424|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
155188425|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
155188426|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
155188427|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
155188428|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
155188429|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
155188430|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
155188431|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
155188432|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
155188433|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
155188434|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
155188435|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
155188436|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
155188437|NCT04950166|560129295|FG000|Overall Study|Withdrawal by Subject|1|||
155188438|NCT05896748|560129296|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
155188439|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
155188440|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
155720262|NCT01339689|562071642|FG001|Overall Study|multiple reasons|1|||
155188441|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
155188442|NCT05896748|560129296|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
155188443|NCT00857415|560129299|FG000|Overall Study|Image acquisition failure|2|||
155188444|NCT00857415|560129300|FG001|Overall Study|Image acquisition failure|0|||
155188445|NCT00857415|560129299|FG000|Overall Study|Invalid image or not imaged|3|||
155188446|NCT00857415|560129300|FG001|Overall Study|Invalid image or not imaged|0|||
155188447|NCT00857415|560129299|FG000|Overall Study|Subject still living at end of study|110|||
155188448|NCT00857415|560129300|FG001|Overall Study|Subject still living at end of study|0|||
155188449|NCT00857415|560129299|FG000|Overall Study|Deceased with no autopsy|2|||
155188450|NCT00857415|560129300|FG001|Overall Study|Deceased with no autopsy|0|||
155188451|NCT00764504|560129301|FG000|Overall Study|Death|12|||
155188452|NCT00764504|560129302|FG001|Overall Study|Death|6|||
155188453|NCT00764504|560129303|FG002|Overall Study|Death|13|||
155188454|NCT00764504|560129301|FG000|Overall Study|Revision of Device|12|||
155188455|NCT00764504|560129302|FG001|Overall Study|Revision of Device|23|||
155188456|NCT00764504|560129303|FG002|Overall Study|Revision of Device|14|||
155188457|NCT00764504|560129301|FG000|Overall Study|Physician Decision|1|||
155188458|NCT00764504|560129302|FG001|Overall Study|Physician Decision|0|||
155188459|NCT00764504|560129303|FG002|Overall Study|Physician Decision|0|||
155188460|NCT00764504|560129301|FG000|Overall Study|Withdrawal by Subject|1|||
155188461|NCT00764504|560129302|FG001|Overall Study|Withdrawal by Subject|7|||
155188462|NCT00764504|560129303|FG002|Overall Study|Withdrawal by Subject|4|||
155188463|NCT00764504|560129301|FG000|Overall Study|Lost to Follow-up|40|||
155188464|NCT00764504|560129302|FG001|Overall Study|Lost to Follow-up|34|||
155188465|NCT00764504|560129303|FG002|Overall Study|Lost to Follow-up|72|||
155188466|NCT02456103|560129304|FG000|Overall Study|Study Closure|207|||
155188467|NCT02456103|560129304|FG000|Overall Study|Physician Decision|1|||
155188468|NCT02456103|560129304|FG000|Overall Study|Required prohibited medications|5|||
155188469|NCT02456103|560129304|FG000|Overall Study|Protocol Violation|1|||
155188470|NCT02456103|560129304|FG000|Overall Study|Adverse Event|5|||
155188471|NCT02456103|560129304|FG000|Overall Study|Abnormal Laboratory Value|2|||
155188472|NCT02456103|560129304|FG000|Overall Study|Lost to Follow-up|1|||
155188473|NCT02456103|560129304|FG000|Overall Study|Withdrawal by Subject|24|||
155188474|NCT04795622|560129305|FG000|Overall Study|Adverse Event|1|||
155188475|NCT04795622|560129306|FG001|Overall Study|Adverse Event|0|||
155188476|NCT04795622|560129305|FG000|Overall Study|Withdrawal by Subject|3|||
155188477|NCT04795622|560129306|FG001|Overall Study|Withdrawal by Subject|3|||
155188478|NCT04795622|560129305|FG000|Overall Study|Protocol Violation|0|||
155188479|NCT04795622|560129306|FG001|Overall Study|Protocol Violation|2|||
155188480|NCT04795622|560129305|FG000|Overall Study|Lost to Follow-up|2|||
155188481|NCT04795622|560129306|FG001|Overall Study|Lost to Follow-up|3|||
155188482|NCT04795622|560129305|FG000|Overall Study|Other|7|||
155188483|NCT04795622|560129306|FG001|Overall Study|Other|8|||
155188484|NCT01070043|560129307|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
155188485|NCT01070043|560129308|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
155188486|NCT01070043|560129309|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
155188487|NCT01070043|560129307|FG000|Double-Blind Treatment|Adverse Event|0|||
155188488|NCT01070043|560129308|FG001|Double-Blind Treatment|Adverse Event|0|||
155188489|NCT01070043|560129309|FG002|Double-Blind Treatment|Adverse Event|2|||
155188490|NCT01610271|560129310|FG000|Overall Study|Surgery not complete|0|||
155188491|NCT01610271|560129311|FG001|Overall Study|Surgery not complete|1|||
155188492|NCT01610271|560129310|FG000|Overall Study|Prosthesis not implanted|2|||
155188493|NCT01610271|560129311|FG001|Overall Study|Prosthesis not implanted|3|||
155188494|NCT01638819|560129312|FG000|Overall Study|Lost to Follow-up|1|||
155188495|NCT01638819|560129313|FG001|Overall Study|Lost to Follow-up|0|||
155188496|NCT00471146|560129316|FG000|Overall Study|Adverse Event|32|||
155188497|NCT00471146|560129317|FG001|Overall Study|Adverse Event|33|||
155188498|NCT00471146|560129316|FG000|Overall Study|Withdrawal by Subject|14|||
155188499|NCT00471146|560129317|FG001|Overall Study|Withdrawal by Subject|11|||
155720263|NCT01046565|562071643|FG000|Overall Study|Adverse Event|2|||
155720264|NCT01046565|562071643|FG000|Overall Study|Withdrawal by Subject|7|||
155720265|NCT03740048|562071644|FG000|Overall Study|Withdrawal by Subject|1|||
155720266|NCT03740048|562071645|FG001|Overall Study|Withdrawal by Subject|1|||
155720267|NCT03740048|562071644|FG000|Overall Study|Death|1|||
155720268|NCT03740048|562071645|FG001|Overall Study|Death|6|||
155720269|NCT03740048|562071644|FG000|Overall Study|Switched to thrice-weekly HD|2|||
155720270|NCT03740048|562071645|FG001|Overall Study|Switched to thrice-weekly HD|0|||
155720271|NCT03740048|562071644|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
155720272|NCT03740048|562071645|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
155720273|NCT03740048|562071644|FG000|Overall Study|Lost to Follow-up|0|||
155720274|NCT03740048|562071645|FG001|Overall Study|Lost to Follow-up|1|||
155720275|NCT03740048|562071644|FG000|Overall Study|Non-compliance with HD|0|||
155720276|NCT03740048|562071645|FG001|Overall Study|Non-compliance with HD|1|||
155720277|NCT01069484|562071646|FG000|Overall Study|Death-in-near-family|1|||
155720278|NCT01069484|562071647|FG001|Overall Study|Death-in-near-family|0|||
155720279|NCT01069484|562071646|FG000|Overall Study|No specific reason|8|||
155720280|NCT01069484|562071647|FG001|Overall Study|No specific reason|2|||
155720281|NCT01069484|562071646|FG000|Overall Study|Illness mother or child|3|||
155188500|NCT00471146|560129316|FG000|Overall Study|Death|11|||
155720282|NCT01069484|562071647|FG001|Overall Study|Illness mother or child|1|||
155188501|NCT00471146|560129317|FG001|Overall Study|Death|12|||
155188502|NCT00471146|560129316|FG000|Overall Study|Lost to Follow-up|4|||
155188503|NCT00471146|560129317|FG001|Overall Study|Lost to Follow-up|2|||
155188504|NCT00471146|560129316|FG000|Overall Study|Protocol Violation|2|||
155188505|NCT00471146|560129317|FG001|Overall Study|Protocol Violation|2|||
155188506|NCT00471146|560129316|FG000|Overall Study|Objective progression or relapse|84|||
155188507|NCT00471146|560129317|FG001|Overall Study|Objective progression or relapse|87|||
155188508|NCT00471146|560129316|FG000|Overall Study|Global deterioration of health status|12|||
155188509|NCT00471146|560129317|FG001|Overall Study|Global deterioration of health status|14|||
155188510|NCT00471146|560129316|FG000|Overall Study|Randomized but not treated|9|||
155188511|NCT00471146|560129317|FG001|Overall Study|Randomized but not treated|8|||
155188512|NCT00471146|560129316|FG000|Overall Study|Other|4|||
155188513|NCT00471146|560129317|FG001|Overall Study|Other|5|||
155188514|NCT00467610|560129320|FG000|Overall Study|Withdrawal by Subject|1|||
155188515|NCT01385371|560129321|FG000|Overall Study|Adverse Event|54|||
155188516|NCT01385371|560129322|FG001|Overall Study|Adverse Event|19|||
155188517|NCT01385371|560129321|FG000|Overall Study|Lost to Follow-up|16|||
155188518|NCT01385371|560129322|FG001|Overall Study|Lost to Follow-up|16|||
155188519|NCT01385371|560129321|FG000|Overall Study|Withdrawal by Subject|52|||
155188520|NCT01385371|560129322|FG001|Overall Study|Withdrawal by Subject|39|||
155188521|NCT01385371|560129321|FG000|Overall Study|Protocol Violation|25|||
155188522|NCT01385371|560129322|FG001|Overall Study|Protocol Violation|21|||
155188523|NCT01385371|560129321|FG000|Overall Study|Administrative|2|||
155188524|NCT01385371|560129322|FG001|Overall Study|Administrative|2|||
155188525|NCT02436681|560129325|FG000|Overall Study|Lost to Follow-up|10|||
155188526|NCT02436681|560129325|FG000|Overall Study|Withdrawal by Subject|2|||
155188527|NCT02436681|560129325|FG000|Overall Study|Death|2|||
155188528|NCT02030938|560129328|FG000|Overall Study|Lost to Follow-up|4|||
155188529|NCT02030938|560129328|FG000|Overall Study|Withdrawal by Subject|1|||
155188530|NCT05430022|560129330|FG000|Overall Study|Withdrawal by Subject|4|||
155188531|NCT05430022|560129331|FG001|Overall Study|Withdrawal by Subject|4|||
155188532|NCT05521906|560129332|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
155188533|NCT05521906|560129333|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
155188534|NCT01828320|560129347|FG000|Overall Study|Lost to Follow-up|1|||
155188535|NCT01828320|560129348|FG001|Overall Study|Lost to Follow-up|3|||
155188536|NCT01828320|560129347|FG000|Overall Study|Withdrawal by Subject|7|||
155188537|NCT01828320|560129348|FG001|Overall Study|Withdrawal by Subject|2|||
155188538|NCT04493333|560131446|FG000|Overall Study|Withdrawal by Subject|1|||
155188539|NCT04493333|560131447|FG001|Overall Study|Withdrawal by Subject|1|||
155188540|NCT04493333|560131446|FG000|Overall Study|Ineligible|0|||
155188541|NCT04493333|560131447|FG001|Overall Study|Ineligible|1|||
155188542|NCT04493333|560131446|FG000|Overall Study|Noncompliance|2|||
155188543|NCT04493333|560131447|FG001|Overall Study|Noncompliance|1|||
155188544|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
155188545|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
155188546|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
155188547|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
155188548|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
155188549|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
155188550|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
155188551|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
155188552|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
155188553|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
155188554|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
155188555|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
155188556|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
155188557|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
155188558|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
155188559|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
155188560|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
155188561|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
155188562|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
155720283|NCT00758771|562071648|FG000|Overall Study|Withdrawal by Subject|1|||
155720284|NCT00758771|562071649|FG001|Overall Study|Withdrawal by Subject|1|||
155720285|NCT00758771|562071648|FG000|Overall Study|Did not meet eligibility criteria|2|||
155720286|NCT00758771|562071649|FG001|Overall Study|Did not meet eligibility criteria|4|||
155720287|NCT00528957|562071650|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
155720288|NCT00528957|562071651|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
155720289|NCT00528957|562071650|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
155720290|NCT00528957|562071651|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
155720291|NCT00528957|562071650|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
155720292|NCT00528957|562071651|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
155188563|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
155188564|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
155188565|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
155188566|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
155720293|NCT00528957|562071650|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
155720294|NCT00528957|562071651|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
155720295|NCT00528957|562071650|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
155720296|NCT00528957|562071651|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
155720297|NCT00528957|562071650|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
155720298|NCT00528957|562071651|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
155720299|NCT00528957|562071650|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
155720300|NCT00528957|562071651|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
155720301|NCT00528957|562071650|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
155720302|NCT00528957|562071651|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
155720303|NCT00528957|562071650|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
155720304|NCT00528957|562071651|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
155720305|NCT00528957|562071650|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
155720306|NCT00528957|562071651|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
155720307|NCT00528957|562071650|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
155720308|NCT00528957|562071651|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
155720309|NCT00528957|562071650|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
155720310|NCT00528957|562071651|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
155720311|NCT00528957|562071650|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
155720312|NCT00528957|562071651|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
155720313|NCT00528957|562071650|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
155720314|NCT00528957|562071651|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
155720315|NCT00528957|562071650|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
155720316|NCT00528957|562071651|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
155720317|NCT00528957|562071650|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
155720318|NCT00528957|562071651|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
155720319|NCT01323582|562071652|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
155720320|NCT01323582|562071653|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
155720321|NCT01323582|562071652|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
155720322|NCT01323582|562071653|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
155720323|NCT01323582|562071652|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
155720324|NCT01323582|562071653|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
155720325|NCT00083889|562071658|FG000|Overall Study|Adverse Event|76|||
155720326|NCT00083889|562071659|FG001|Overall Study|Adverse Event|86|||
155720327|NCT00083889|562071658|FG000|Overall Study|Protocol Violation|2|||
155720328|NCT00083889|562071659|FG001|Overall Study|Protocol Violation|2|||
155720329|NCT00083889|562071658|FG000|Overall Study|Withdrawal by Subject|22|||
155720330|NCT00083889|562071659|FG001|Overall Study|Withdrawal by Subject|24|||
155720331|NCT00083889|562071658|FG000|Overall Study|Lack of Efficacy|240|||
155720332|NCT00083889|562071659|FG001|Overall Study|Lack of Efficacy|219|||
155720333|NCT00083889|562071658|FG000|Overall Study|Decision of sponsor|32|||
155720334|NCT00083889|562071659|FG001|Overall Study|Decision of sponsor|4|||
155720335|NCT00083889|562071658|FG000|Overall Study|Randomized: did not take study drug|0|||
155720336|NCT00083889|562071659|FG001|Overall Study|Randomized: did not take study drug|15|||
155720337|NCT00083889|562071658|FG000|Overall Study|Completed on marketed sunitinub|3|||
155720338|NCT00083889|562071659|FG001|Overall Study|Completed on marketed sunitinub|0|||
155720339|NCT00083889|562071658|FG000|Overall Study|Crossover to SU011248|0|||
155720340|NCT00083889|562071659|FG001|Overall Study|Crossover to SU011248|25|||
155720341|NCT00960375|562071660|FG000|Overall Study|Lost to Follow-up|20|||
155720342|NCT00960375|562071661|FG001|Overall Study|Lost to Follow-up|22|||
155720343|NCT03473236|562071662|FG000|Overall Study|Withdrawal by Subject|0|||
155720344|NCT03473236|562071663|FG001|Overall Study|Withdrawal by Subject|0|||
155720345|NCT03473236|562071664|FG002|Overall Study|Withdrawal by Subject|0|||
155720346|NCT03473236|562071665|FG003|Overall Study|Withdrawal by Subject|0|||
155720347|NCT03473236|562071666|FG004|Overall Study|Withdrawal by Subject|0|||
155720348|NCT03473236|562071667|FG005|Overall Study|Withdrawal by Subject|1|||
155720349|NCT03473236|562071668|FG006|Overall Study|Withdrawal by Subject|0|||
155720350|NCT03473236|562071669|FG007|Overall Study|Withdrawal by Subject|0|||
155720351|NCT03473236|562071670|FG008|Overall Study|Withdrawal by Subject|1|||
155720352|NCT03473236|562071671|FG009|Overall Study|Withdrawal by Subject|0|||
155720353|NCT03353675|562071679|FG000|Overall Study|Adverse Event|4|||
155188567|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
155188568|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
155188569|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
155188570|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
155188571|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
155188572|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
155188573|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
155188574|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
155188575|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
155188576|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
155188577|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
155188578|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
155188579|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
155188580|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
155188581|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
155188582|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
155188583|NCT01854658|560131456|FG000|Overall Study|Protocol Violation|6|||
155188584|NCT01854658|560131457|FG001|Overall Study|Protocol Violation|2|||
155188585|NCT01854658|560131458|FG002|Overall Study|Protocol Violation|2|||
155188586|NCT01854658|560131459|FG003|Overall Study|Protocol Violation|1|||
155188587|NCT01854658|560131456|FG000|Overall Study|Physician Decision|7|||
155188588|NCT01854658|560131457|FG001|Overall Study|Physician Decision|5|||
155188589|NCT01854658|560131458|FG002|Overall Study|Physician Decision|2|||
155188590|NCT01854658|560131459|FG003|Overall Study|Physician Decision|4|||
155188591|NCT01854658|560131456|FG000|Overall Study|Lost to Follow-up|8|||
155188592|NCT01854658|560131457|FG001|Overall Study|Lost to Follow-up|9|||
155188593|NCT01854658|560131458|FG002|Overall Study|Lost to Follow-up|8|||
155188594|NCT01854658|560131459|FG003|Overall Study|Lost to Follow-up|4|||
155188595|NCT01854658|560131456|FG000|Overall Study|Withdrawal by Subject|28|||
155188596|NCT01854658|560131457|FG001|Overall Study|Withdrawal by Subject|21|||
155188597|NCT01854658|560131458|FG002|Overall Study|Withdrawal by Subject|29|||
155188598|NCT01854658|560131459|FG003|Overall Study|Withdrawal by Subject|15|||
155188599|NCT01854658|560131456|FG000|Overall Study|Protocol-specified criteria|15|||
155188600|NCT01854658|560131457|FG001|Overall Study|Protocol-specified criteria|15|||
155188601|NCT01854658|560131458|FG002|Overall Study|Protocol-specified criteria|10|||
155188602|NCT01854658|560131459|FG003|Overall Study|Protocol-specified criteria|7|||
155188603|NCT01854658|560131456|FG000|Overall Study|Lack of Efficacy|3|||
155188604|NCT01854658|560131457|FG001|Overall Study|Lack of Efficacy|8|||
155188605|NCT01854658|560131458|FG002|Overall Study|Lack of Efficacy|4|||
155188606|NCT01854658|560131459|FG003|Overall Study|Lack of Efficacy|7|||
155188607|NCT01854658|560131456|FG000|Overall Study|Adverse Event|21|||
155188608|NCT01854658|560131457|FG001|Overall Study|Adverse Event|14|||
155188609|NCT01854658|560131458|FG002|Overall Study|Adverse Event|23|||
155188610|NCT01854658|560131459|FG003|Overall Study|Adverse Event|19|||
155188611|NCT01854658|560131456|FG000|Overall Study|Administrative reasons|5|||
155188612|NCT01854658|560131457|FG001|Overall Study|Administrative reasons|1|||
155188613|NCT01854658|560131458|FG002|Overall Study|Administrative reasons|2|||
155188614|NCT01854658|560131459|FG003|Overall Study|Administrative reasons|2|||
155188615|NCT00426231|560131460|FG000|Overall Study|Withdrawal by Subject|9|||
155188616|NCT00426231|560131461|FG001|Overall Study|Withdrawal by Subject|12|||
155188617|NCT02367131|560131462|FG000|Overall Study|Adverse Event|64|||
155188618|NCT02367131|560131462|FG000|Overall Study|No visit since the first visit|3|||
155188619|NCT02367131|560131462|FG000|Overall Study|Request by patient|53|||
155188620|NCT02367131|560131462|FG000|Overall Study|Improvement/remission|2|||
155188621|NCT02367131|560131462|FG000|Overall Study|No change/progressive disease|78|||
155188622|NCT02367131|560131462|FG000|Overall Study|Other than stated above|20|||
155188623|NCT02367131|560131462|FG000|Overall Study|Not treated|2|||
155188624|NCT02572388|560131463|FG000|Overall Study|Withdrawal by Subject|1|||
155188625|NCT02572388|560131464|FG001|Overall Study|Withdrawal by Subject|1|||
155188626|NCT02572388|560131465|FG002|Overall Study|Withdrawal by Subject|2|||
155188627|NCT02572388|560131466|FG003|Overall Study|Withdrawal by Subject|2|||
155188628|NCT01051466|560131467|FG000|Overall Study|Adverse Event|1|||
155188629|NCT01051466|560131468|FG001|Overall Study|Adverse Event|0|||
155188630|NCT01051466|560131467|FG000|Overall Study|Lost to Follow-up|1|||
155188631|NCT01051466|560131468|FG001|Overall Study|Lost to Follow-up|1|||
155188632|NCT01051466|560131467|FG000|Overall Study|Withdrawal by Subject|5|||
155188633|NCT01051466|560131468|FG001|Overall Study|Withdrawal by Subject|1|||
155188634|NCT01051466|560131467|FG000|Overall Study|Entry Criteria Not Met|0|||
155188635|NCT01051466|560131468|FG001|Overall Study|Entry Criteria Not Met|3|||
155188636|NCT01051466|560131467|FG000|Overall Study|Physician Decision|1|||
155188637|NCT01051466|560131468|FG001|Overall Study|Physician Decision|0|||
155720354|NCT00402168|562071680|FG000|Randomized|Lost to Follow-up|1|||
155188638|NCT02570074|560131469|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
155188639|NCT02570074|560131470|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
155188640|NCT05061966|560131473|FG000|Overall Study|Lost to Follow-up|13|||
155188641|NCT05061966|560131474|FG001|Overall Study|Lost to Follow-up|13|||
155188642|NCT02923427|560131475|FG000|Overall Study|convert to laparatomy|2|||
155188643|NCT02923427|560131476|FG001|Overall Study|convert to laparatomy|2|||
155188644|NCT02923427|560131475|FG000|Overall Study|destaturation|1|||
155188645|NCT02923427|560131476|FG001|Overall Study|destaturation|0|||
155188646|NCT02923427|560131475|FG000|Overall Study|can not replace LMA|1|||
155188647|NCT02923427|560131476|FG001|Overall Study|can not replace LMA|0|||
155188648|NCT01325623|560131477|FG000|Overall Study|Withdrawal by Subject|3|||
155188649|NCT01539642|560131483|FG000|Overall Study|Lack of Efficacy|20|||
155188650|NCT01539642|560131484|FG001|Overall Study|Lack of Efficacy|18|||
155188651|NCT01539642|560131483|FG000|Overall Study|Patient ready for early discharge|8|||
155188652|NCT01539642|560131484|FG001|Overall Study|Patient ready for early discharge|7|||
155188653|NCT01539642|560131483|FG000|Overall Study|Adverse Event|6|||
155188654|NCT01539642|560131484|FG001|Overall Study|Adverse Event|4|||
155188655|NCT01539642|560131483|FG000|Overall Study|Withdrawal by Subject|2|||
155188656|NCT01539642|560131484|FG001|Overall Study|Withdrawal by Subject|2|||
155188657|NCT00598702|560131485|FG000|Overall Study|Other|0|||
155188658|NCT00598702|560131486|FG001|Overall Study|Other|2|||
155188659|NCT00598702|560131487|FG002|Overall Study|Other|0|||
155188660|NCT00598702|560131488|FG003|Overall Study|Other|0|||
155188661|NCT00598702|560131489|FG004|Overall Study|Other|0|||
155188662|NCT00598702|560131490|FG005|Overall Study|Other|1|||
155188663|NCT00598702|560131491|FG006|Overall Study|Other|0|||
155188664|NCT00598702|560131492|FG007|Overall Study|Other|0|||
155188665|NCT00598702|560131485|FG000|Overall Study|Early discharge from hospital|0|||
155188666|NCT00598702|560131486|FG001|Overall Study|Early discharge from hospital|0|||
155188667|NCT00598702|560131487|FG002|Overall Study|Early discharge from hospital|2|||
155188668|NCT00598702|560131488|FG003|Overall Study|Early discharge from hospital|5|||
155188669|NCT00598702|560131489|FG004|Overall Study|Early discharge from hospital|0|||
155188670|NCT00598702|560131490|FG005|Overall Study|Early discharge from hospital|10|||
155188671|NCT00598702|560131491|FG006|Overall Study|Early discharge from hospital|1|||
155188672|NCT00598702|560131492|FG007|Overall Study|Early discharge from hospital|0|||
155188673|NCT00598702|560131485|FG000|Overall Study|Adverse Event|0|||
155188674|NCT00598702|560131486|FG001|Overall Study|Adverse Event|0|||
155188675|NCT00598702|560131487|FG002|Overall Study|Adverse Event|0|||
155188676|NCT00598702|560131488|FG003|Overall Study|Adverse Event|1|||
155188677|NCT00598702|560131489|FG004|Overall Study|Adverse Event|0|||
155188678|NCT00598702|560131490|FG005|Overall Study|Adverse Event|0|||
155188679|NCT00598702|560131491|FG006|Overall Study|Adverse Event|0|||
155188680|NCT00598702|560131492|FG007|Overall Study|Adverse Event|0|||
155188681|NCT00598702|560131485|FG000|Overall Study|Withdrawal by Subject|0|||
155188682|NCT00598702|560131486|FG001|Overall Study|Withdrawal by Subject|0|||
155188683|NCT00598702|560131487|FG002|Overall Study|Withdrawal by Subject|0|||
155188684|NCT00598702|560131488|FG003|Overall Study|Withdrawal by Subject|1|||
155188685|NCT00598702|560131489|FG004|Overall Study|Withdrawal by Subject|1|||
155188686|NCT00598702|560131490|FG005|Overall Study|Withdrawal by Subject|0|||
155188687|NCT00598702|560131491|FG006|Overall Study|Withdrawal by Subject|0|||
155188688|NCT00598702|560131492|FG007|Overall Study|Withdrawal by Subject|0|||
155188689|NCT00598702|560131485|FG000|Overall Study|Physician Decision|0|||
155188690|NCT00598702|560131486|FG001|Overall Study|Physician Decision|0|||
155188691|NCT00598702|560131487|FG002|Overall Study|Physician Decision|0|||
155188692|NCT00598702|560131488|FG003|Overall Study|Physician Decision|0|||
155188693|NCT00598702|560131489|FG004|Overall Study|Physician Decision|1|||
155188694|NCT00598702|560131490|FG005|Overall Study|Physician Decision|0|||
155188695|NCT00598702|560131491|FG006|Overall Study|Physician Decision|0|||
155188696|NCT00598702|560131492|FG007|Overall Study|Physician Decision|0|||
155188697|NCT00598702|560131485|FG000|Overall Study|Dose limiting toxicity|0|||
155188698|NCT00598702|560131486|FG001|Overall Study|Dose limiting toxicity|0|||
155188699|NCT00598702|560131487|FG002|Overall Study|Dose limiting toxicity|0|||
155188700|NCT00598702|560131488|FG003|Overall Study|Dose limiting toxicity|1|||
155188701|NCT00598702|560131489|FG004|Overall Study|Dose limiting toxicity|1|||
155188702|NCT00598702|560131490|FG005|Overall Study|Dose limiting toxicity|1|||
155188703|NCT00598702|560131491|FG006|Overall Study|Dose limiting toxicity|0|||
155188704|NCT00598702|560131492|FG007|Overall Study|Dose limiting toxicity|0|||
155188705|NCT02556203|560131493|FG000|Overall Study|Withdrawal by Subject|21|||
155188706|NCT02556203|560131494|FG001|Overall Study|Withdrawal by Subject|21|||
155188707|NCT02556203|560131493|FG000|Overall Study|Lost to Follow-up|5|||
155188708|NCT02556203|560131494|FG001|Overall Study|Lost to Follow-up|5|||
155188709|NCT02556203|560131493|FG000|Overall Study|Adverse Event|1|||
155188710|NCT02556203|560131494|FG001|Overall Study|Adverse Event|0|||
155188711|NCT02943460|560131501|FG000|Blinded Study Phase|Adverse Event|3|||
155188712|NCT02943460|560131502|FG001|Blinded Study Phase|Adverse Event|0|||
155188713|NCT02943460|560131503|FG002|Blinded Study Phase|Adverse Event|0|||
155188714|NCT02943460|560131501|FG000|Blinded Study Phase|Withdrew Consent|0|||
155188715|NCT02943460|560131502|FG001|Blinded Study Phase|Withdrew Consent|1|||
155188716|NCT02943460|560131503|FG002|Blinded Study Phase|Withdrew Consent|0|||
155188717|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
155188718|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
155188719|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
155188720|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
155720355|NCT00402168|562071681|FG001|Randomized|Lost to Follow-up|0|||
155188721|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
155188722|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
155188723|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
155188724|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
155188725|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
155188726|NCT04171765|560131504|FG000|Overall Study|Adverse Event|2|||
155188727|NCT04171765|560131505|FG001|Overall Study|Adverse Event|0|||
155188728|NCT04171765|560131506|FG002|Overall Study|Adverse Event|1|||
155188729|NCT04171765|560131507|FG003|Overall Study|Adverse Event|0|||
155188730|NCT04171765|560131504|FG000|Overall Study|Lost to Follow-up|0|||
155188731|NCT04171765|560131505|FG001|Overall Study|Lost to Follow-up|2|||
155188732|NCT04171765|560131506|FG002|Overall Study|Lost to Follow-up|2|||
155188733|NCT04171765|560131507|FG003|Overall Study|Lost to Follow-up|2|||
155188734|NCT04171765|560131504|FG000|Overall Study|Week 58 visit missed|0|||
155188735|NCT04171765|560131505|FG001|Overall Study|Week 58 visit missed|0|||
155188736|NCT04171765|560131506|FG002|Overall Study|Week 58 visit missed|1|||
155188737|NCT04171765|560131507|FG003|Overall Study|Week 58 visit missed|0|||
155188738|NCT04171765|560131504|FG000|Overall Study|Study terminated by sponsor|2|||
155188739|NCT04171765|560131505|FG001|Overall Study|Study terminated by sponsor|0|||
155188740|NCT04171765|560131506|FG002|Overall Study|Study terminated by sponsor|0|||
155188741|NCT04171765|560131507|FG003|Overall Study|Study terminated by sponsor|0|||
155188742|NCT04171765|560131504|FG000|Overall Study|Withdrawal by Subject|1|||
155188743|NCT04171765|560131505|FG001|Overall Study|Withdrawal by Subject|0|||
155188744|NCT04171765|560131506|FG002|Overall Study|Withdrawal by Subject|0|||
155188745|NCT04171765|560131507|FG003|Overall Study|Withdrawal by Subject|3|||
155188746|NCT00809354|560131511|FG000|Overall Study|Adverse Event|32|||
155188747|NCT00809354|560131512|FG001|Overall Study|Adverse Event|45|||
155188748|NCT00809354|560131513|FG002|Overall Study|Adverse Event|37|||
155720356|NCT00402168|562071680|FG000|Randomized|Withdrawal by Subject|0|||
155720357|NCT00402168|562071681|FG001|Randomized|Withdrawal by Subject|1|||
155720358|NCT00402168|562071680|FG000|Treatment (up to 12 Months)|Death|0|||
155720359|NCT00402168|562071681|FG001|Treatment (up to 12 Months)|Death|1|||
155720360|NCT00402168|562071680|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
155720361|NCT00402168|562071681|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
155720362|NCT00402168|562071680|FG000|Treatment (up to 12 Months)|non-specified|0|||
155188749|NCT00809354|560131514|FG003|Overall Study|Adverse Event|53|||
155188750|NCT00809354|560131515|FG004|Overall Study|Adverse Event|26|||
155188751|NCT00809354|560131516|FG005|Overall Study|Adverse Event|33|||
155188752|NCT00809354|560131517|FG006|Overall Study|Adverse Event|44|||
155188753|NCT00809354|560131518|FG007|Overall Study|Adverse Event|40|||
155188754|NCT00809354|560131519|FG008|Overall Study|Adverse Event|46|||
155188755|NCT00809354|560131520|FG009|Overall Study|Adverse Event|26|||
155188756|NCT00809354|560131511|FG000|Overall Study|Lack of Efficacy|23|||
155188757|NCT00809354|560131512|FG001|Overall Study|Lack of Efficacy|23|||
155188758|NCT00809354|560131513|FG002|Overall Study|Lack of Efficacy|22|||
155188759|NCT00809354|560131514|FG003|Overall Study|Lack of Efficacy|15|||
155188760|NCT00809354|560131515|FG004|Overall Study|Lack of Efficacy|40|||
155188761|NCT00809354|560131516|FG005|Overall Study|Lack of Efficacy|19|||
155188762|NCT00809354|560131517|FG006|Overall Study|Lack of Efficacy|21|||
155188763|NCT00809354|560131518|FG007|Overall Study|Lack of Efficacy|15|||
155188764|NCT00809354|560131519|FG008|Overall Study|Lack of Efficacy|18|||
155188765|NCT00809354|560131520|FG009|Overall Study|Lack of Efficacy|38|||
155188766|NCT00809354|560131511|FG000|Overall Study|Lost to Follow-up|10|||
155188767|NCT00809354|560131512|FG001|Overall Study|Lost to Follow-up|11|||
155188768|NCT00809354|560131513|FG002|Overall Study|Lost to Follow-up|8|||
155188769|NCT00809354|560131514|FG003|Overall Study|Lost to Follow-up|13|||
155188770|NCT00809354|560131515|FG004|Overall Study|Lost to Follow-up|6|||
155188771|NCT00809354|560131516|FG005|Overall Study|Lost to Follow-up|2|||
155188772|NCT00809354|560131517|FG006|Overall Study|Lost to Follow-up|0|||
155188773|NCT00809354|560131518|FG007|Overall Study|Lost to Follow-up|5|||
155188774|NCT00809354|560131519|FG008|Overall Study|Lost to Follow-up|4|||
155188775|NCT00809354|560131520|FG009|Overall Study|Lost to Follow-up|0|||
155188776|NCT00809354|560131511|FG000|Overall Study|Protocol Violation|7|||
155188777|NCT00809354|560131512|FG001|Overall Study|Protocol Violation|14|||
155188778|NCT00809354|560131513|FG002|Overall Study|Protocol Violation|14|||
155188779|NCT00809354|560131514|FG003|Overall Study|Protocol Violation|12|||
155188780|NCT00809354|560131515|FG004|Overall Study|Protocol Violation|14|||
155188781|NCT00809354|560131516|FG005|Overall Study|Protocol Violation|6|||
155188782|NCT00809354|560131517|FG006|Overall Study|Protocol Violation|4|||
155188783|NCT00809354|560131518|FG007|Overall Study|Protocol Violation|6|||
155188784|NCT00809354|560131519|FG008|Overall Study|Protocol Violation|9|||
155188785|NCT00809354|560131520|FG009|Overall Study|Protocol Violation|3|||
155188786|NCT00809354|560131511|FG000|Overall Study|Withdrawal by Subject|32|||
155188787|NCT00809354|560131512|FG001|Overall Study|Withdrawal by Subject|27|||
155188788|NCT00809354|560131513|FG002|Overall Study|Withdrawal by Subject|31|||
155188789|NCT00809354|560131514|FG003|Overall Study|Withdrawal by Subject|33|||
155720363|NCT00402168|562071681|FG001|Treatment (up to 12 Months)|non-specified|1|||
155188790|NCT00809354|560131515|FG004|Overall Study|Withdrawal by Subject|34|||
155188791|NCT00809354|560131516|FG005|Overall Study|Withdrawal by Subject|29|||
155188792|NCT00809354|560131517|FG006|Overall Study|Withdrawal by Subject|27|||
155188793|NCT00809354|560131518|FG007|Overall Study|Withdrawal by Subject|19|||
155188794|NCT00809354|560131519|FG008|Overall Study|Withdrawal by Subject|18|||
155188795|NCT00809354|560131520|FG009|Overall Study|Withdrawal by Subject|20|||
155188796|NCT00809354|560131511|FG000|Overall Study|Other|10|||
155188797|NCT00809354|560131512|FG001|Overall Study|Other|2|||
155188798|NCT00809354|560131513|FG002|Overall Study|Other|7|||
155188799|NCT00809354|560131514|FG003|Overall Study|Other|10|||
155188800|NCT00809354|560131515|FG004|Overall Study|Other|5|||
155188801|NCT00809354|560131516|FG005|Overall Study|Other|3|||
155188802|NCT00809354|560131517|FG006|Overall Study|Other|2|||
155188803|NCT00809354|560131518|FG007|Overall Study|Other|3|||
155188804|NCT00809354|560131519|FG008|Overall Study|Other|4|||
155188805|NCT00809354|560131520|FG009|Overall Study|Other|3|||
155188806|NCT00809354|560131511|FG000|Overall Study|Study terminated by sponsor|138|||
155188807|NCT00809354|560131512|FG001|Overall Study|Study terminated by sponsor|134|||
155188808|NCT00809354|560131513|FG002|Overall Study|Study terminated by sponsor|129|||
155188809|NCT00809354|560131514|FG003|Overall Study|Study terminated by sponsor|120|||
155188810|NCT00809354|560131515|FG004|Overall Study|Study terminated by sponsor|126|||
155188811|NCT00809354|560131516|FG005|Overall Study|Study terminated by sponsor|133|||
155188812|NCT00809354|560131517|FG006|Overall Study|Study terminated by sponsor|124|||
155188813|NCT00809354|560131518|FG007|Overall Study|Study terminated by sponsor|148|||
155188814|NCT00809354|560131519|FG008|Overall Study|Study terminated by sponsor|127|||
155188815|NCT00809354|560131520|FG009|Overall Study|Study terminated by sponsor|135|||
155188816|NCT00809354|560131511|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155188817|NCT00809354|560131512|FG001|Overall Study|Withdrawn due to pregnancy|1|||
155188818|NCT00809354|560131513|FG002|Overall Study|Withdrawn due to pregnancy|0|||
155188819|NCT00809354|560131514|FG003|Overall Study|Withdrawn due to pregnancy|0|||
155188820|NCT00809354|560131515|FG004|Overall Study|Withdrawn due to pregnancy|0|||
155188821|NCT00809354|560131516|FG005|Overall Study|Withdrawn due to pregnancy|0|||
155188822|NCT00809354|560131517|FG006|Overall Study|Withdrawn due to pregnancy|0|||
155188823|NCT00809354|560131518|FG007|Overall Study|Withdrawn due to pregnancy|0|||
155188824|NCT00809354|560131519|FG008|Overall Study|Withdrawn due to pregnancy|0|||
155188825|NCT00809354|560131520|FG009|Overall Study|Withdrawn due to pregnancy|0|||
155188826|NCT00809354|560131511|FG000|Overall Study|Randomized but not Treated|3|||
155188827|NCT00809354|560131512|FG001|Overall Study|Randomized but not Treated|1|||
155188828|NCT00809354|560131513|FG002|Overall Study|Randomized but not Treated|6|||
155188829|NCT00809354|560131514|FG003|Overall Study|Randomized but not Treated|0|||
155188830|NCT00809354|560131515|FG004|Overall Study|Randomized but not Treated|5|||
155188831|NCT00809354|560131516|FG005|Overall Study|Randomized but not Treated|0|||
155188832|NCT00809354|560131517|FG006|Overall Study|Randomized but not Treated|1|||
155188833|NCT00809354|560131518|FG007|Overall Study|Randomized but not Treated|1|||
155188834|NCT00809354|560131519|FG008|Overall Study|Randomized but not Treated|2|||
155188835|NCT00809354|560131520|FG009|Overall Study|Randomized but not Treated|1|||
155188836|NCT00809354|560131511|FG000|Overall Study|Death|0|||
155188837|NCT00809354|560131512|FG001|Overall Study|Death|0|||
155188838|NCT00809354|560131513|FG002|Overall Study|Death|0|||
155188839|NCT00809354|560131514|FG003|Overall Study|Death|0|||
155188840|NCT00809354|560131515|FG004|Overall Study|Death|0|||
155188841|NCT00809354|560131516|FG005|Overall Study|Death|0|||
155188842|NCT00809354|560131517|FG006|Overall Study|Death|0|||
155188843|NCT00809354|560131518|FG007|Overall Study|Death|1|||
155188844|NCT00809354|560131519|FG008|Overall Study|Death|0|||
155188845|NCT00809354|560131520|FG009|Overall Study|Death|0|||
155188846|NCT04137224|560131527|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
155188847|NCT04137224|560131528|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
155188848|NCT04137224|560131527|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
155188849|NCT04137224|560131528|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
155188850|NCT04137224|560131527|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
155188851|NCT04137224|560131528|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
155188852|NCT00566501|560131529|FG000|Overall Study|Adverse Event|68|||
155188853|NCT00566501|560131530|FG001|Overall Study|Adverse Event|59|||
155188854|NCT00566501|560131529|FG000|Overall Study|Medication Non-compliance|5|||
155188855|NCT00566501|560131530|FG001|Overall Study|Medication Non-compliance|0|||
155188856|NCT00566501|560131529|FG000|Overall Study|Protocol Violation|2|||
155188857|NCT00566501|560131530|FG001|Overall Study|Protocol Violation|2|||
155188858|NCT00566501|560131529|FG000|Overall Study|Request of Investigator or Sponsor|6|||
155720364|NCT00402168|562071680|FG000|Long Term (LT)|Adverse Event|1|||
155720365|NCT00402168|562071681|FG001|Long Term (LT)|Adverse Event|5|||
155188859|NCT00566501|560131530|FG001|Overall Study|Request of Investigator or Sponsor|7|||
155188860|NCT00566501|560131529|FG000|Overall Study|Withdrawal by Subject|33|||
155188861|NCT00566501|560131530|FG001|Overall Study|Withdrawal by Subject|30|||
155188862|NCT00566501|560131529|FG000|Overall Study|Lack of Efficacy|8|||
155188863|NCT00566501|560131530|FG001|Overall Study|Lack of Efficacy|3|||
155188864|NCT00566501|560131529|FG000|Overall Study|Other|25|||
155188865|NCT00566501|560131530|FG001|Overall Study|Other|21|||
155188866|NCT01368432|560131533|FG000|Overall Study|Lost to Follow-up|0|||
155188867|NCT01368432|560131534|FG001|Overall Study|Lost to Follow-up|1|||
155188868|NCT00437320|560131537|FG000|Overall Study|Participant request|2|||
155188869|NCT00437320|560131538|FG001|Overall Study|Participant request|1|||
155188870|NCT00437320|560131539|FG002|Overall Study|Participant request|4|||
155188871|NCT02791594|560131540|FG000|Overall Study|Physician Decision|2|||
155188872|NCT01698905|560131542|FG000|Overall Study|Adverse Event|4|||
155188873|NCT01698905|560131542|FG000|Overall Study|Physician Decision|2|||
155188874|NCT01698905|560131542|FG000|Overall Study|Pregnancy|1|||
155188875|NCT01698905|560131542|FG000|Overall Study|Protocol Violation|1|||
155188876|NCT01698905|560131542|FG000|Overall Study|Subject/guardian decision|2|||
155188877|NCT01698905|560131542|FG000|Overall Study|Death|1|||
155188878|NCT02448810|560131543|FG000|Overall Study|Adverse Event|0|||
155188879|NCT02448810|560131544|FG001|Overall Study|Adverse Event|0|||
155188880|NCT02448810|560131545|FG002|Overall Study|Adverse Event|1|||
155188881|NCT02448810|560131546|FG003|Overall Study|Adverse Event|0|||
155188882|NCT02448810|560131547|FG004|Overall Study|Adverse Event|0|||
155188883|NCT02448810|560131548|FG005|Overall Study|Adverse Event|0|||
155188884|NCT02448810|560131549|FG006|Overall Study|Adverse Event|0|||
155188885|NCT02448810|560131550|FG007|Overall Study|Adverse Event|0|||
155188886|NCT02448810|560131543|FG000|Overall Study|Withdrawal by Subject|0|||
155188887|NCT02448810|560131544|FG001|Overall Study|Withdrawal by Subject|0|||
155188888|NCT02448810|560131545|FG002|Overall Study|Withdrawal by Subject|1|||
155188889|NCT02448810|560131546|FG003|Overall Study|Withdrawal by Subject|0|||
155188890|NCT02448810|560131547|FG004|Overall Study|Withdrawal by Subject|3|||
155188891|NCT02448810|560131548|FG005|Overall Study|Withdrawal by Subject|5|||
155188892|NCT02448810|560131549|FG006|Overall Study|Withdrawal by Subject|0|||
155188893|NCT02448810|560131550|FG007|Overall Study|Withdrawal by Subject|2|||
155188894|NCT02448810|560131543|FG000|Overall Study|Other (study terminated by sponsor)|0|||
155188895|NCT02448810|560131544|FG001|Overall Study|Other (study terminated by sponsor)|0|||
155188896|NCT02448810|560131545|FG002|Overall Study|Other (study terminated by sponsor)|0|||
155188897|NCT02448810|560131546|FG003|Overall Study|Other (study terminated by sponsor)|0|||
155188898|NCT02448810|560131547|FG004|Overall Study|Other (study terminated by sponsor)|4|||
155188899|NCT02448810|560131548|FG005|Overall Study|Other (study terminated by sponsor)|2|||
155188900|NCT02448810|560131549|FG006|Overall Study|Other (study terminated by sponsor)|2|||
155188901|NCT02448810|560131550|FG007|Overall Study|Other (study terminated by sponsor)|1|||
155188902|NCT02448810|560131543|FG000|Overall Study|Death|1|||
155188903|NCT02448810|560131544|FG001|Overall Study|Death|0|||
155188904|NCT02448810|560131545|FG002|Overall Study|Death|1|||
155188905|NCT02448810|560131546|FG003|Overall Study|Death|0|||
155188906|NCT02448810|560131547|FG004|Overall Study|Death|1|||
155188907|NCT02448810|560131548|FG005|Overall Study|Death|0|||
155720366|NCT00402168|562071680|FG000|Long Term (LT)|Withdrawal by Subject|4|||
155720367|NCT00402168|562071681|FG001|Long Term (LT)|Withdrawal by Subject|7|||
155188908|NCT02448810|560131549|FG006|Overall Study|Death|0|||
155188909|NCT02448810|560131550|FG007|Overall Study|Death|0|||
155188910|NCT02448810|560131543|FG000|Overall Study|Other (Progressive disease)|2|||
155188911|NCT02448810|560131544|FG001|Overall Study|Other (Progressive disease)|2|||
155188912|NCT02448810|560131545|FG002|Overall Study|Other (Progressive disease)|0|||
155188913|NCT02448810|560131546|FG003|Overall Study|Other (Progressive disease)|3|||
155188914|NCT02448810|560131547|FG004|Overall Study|Other (Progressive disease)|23|||
155188915|NCT02448810|560131548|FG005|Overall Study|Other (Progressive disease)|9|||
155188916|NCT02448810|560131549|FG006|Overall Study|Other (Progressive disease)|14|||
155188917|NCT02448810|560131550|FG007|Overall Study|Other (Progressive disease)|5|||
155188918|NCT02448810|560131543|FG000|Overall Study|Lost to Follow-up|0|||
155188919|NCT02448810|560131544|FG001|Overall Study|Lost to Follow-up|1|||
155188920|NCT02448810|560131545|FG002|Overall Study|Lost to Follow-up|0|||
155188921|NCT02448810|560131546|FG003|Overall Study|Lost to Follow-up|0|||
155188922|NCT02448810|560131547|FG004|Overall Study|Lost to Follow-up|0|||
155188923|NCT02448810|560131548|FG005|Overall Study|Lost to Follow-up|0|||
155188924|NCT02448810|560131549|FG006|Overall Study|Lost to Follow-up|0|||
155188925|NCT02448810|560131550|FG007|Overall Study|Lost to Follow-up|0|||
155188926|NCT02448810|560131543|FG000|Overall Study|Other (unspecified)|0|||
155188927|NCT02448810|560131544|FG001|Overall Study|Other (unspecified)|0|||
155188928|NCT02448810|560131545|FG002|Overall Study|Other (unspecified)|0|||
155188929|NCT02448810|560131546|FG003|Overall Study|Other (unspecified)|0|||
155188930|NCT02448810|560131547|FG004|Overall Study|Other (unspecified)|0|||
155188931|NCT02448810|560131548|FG005|Overall Study|Other (unspecified)|0|||
155188932|NCT02448810|560131549|FG006|Overall Study|Other (unspecified)|2|||
155188933|NCT02448810|560131550|FG007|Overall Study|Other (unspecified)|0|||
155720368|NCT00402168|562071680|FG000|Long Term (LT)|Pregnancy|0|||
155188934|NCT00470847|560131553|FG000|Overall Study|Pt still receiving treatment|1|||
155188935|NCT00568685|560131559|FG000|Overall Study|Adverse Event|2|||
155188936|NCT00568685|560131560|FG001|Overall Study|Adverse Event|3|||
155188937|NCT00568685|560131561|FG002|Overall Study|Adverse Event|3|||
155188938|NCT00568685|560131559|FG000|Overall Study|Withdrawal by Subject|7|||
155188939|NCT00568685|560131560|FG001|Overall Study|Withdrawal by Subject|2|||
155188940|NCT00568685|560131561|FG002|Overall Study|Withdrawal by Subject|2|||
155188941|NCT00568685|560131559|FG000|Overall Study|Protocol Violation|1|||
155188942|NCT00568685|560131560|FG001|Overall Study|Protocol Violation|0|||
155188943|NCT00568685|560131561|FG002|Overall Study|Protocol Violation|0|||
155188944|NCT00923936|560131564|FG000|Overall Study|progressive disease on study|2|||
155188945|NCT00923936|560131565|FG001|Overall Study|progressive disease on study|1|||
155188946|NCT00923936|560131564|FG000|Overall Study|Adverse Event|2|||
155188947|NCT00923936|560131565|FG001|Overall Study|Adverse Event|1|||
155188948|NCT00923936|560131564|FG000|Overall Study|Lost to follow up|2|||
155188949|NCT00923936|560131565|FG001|Overall Study|Lost to follow up|0|||
155188950|NCT00923936|560131564|FG000|Overall Study|Continuing in follow up period|2|||
155188951|NCT00923936|560131565|FG001|Overall Study|Continuing in follow up period|1|||
155188952|NCT03538431|560131566|FG000|Overall Study|Physician Decision|0|||
155188953|NCT03538431|560131567|FG001|Overall Study|Physician Decision|1|||
155188954|NCT03538431|560131566|FG000|Overall Study|Withdrawal by Subject|1|||
155188955|NCT03538431|560131567|FG001|Overall Study|Withdrawal by Subject|0|||
155188956|NCT05394350|560131568|FG000|Overall Study|Death|2|||
155188957|NCT05394350|560131569|FG001|Overall Study|Death|2|||
155188958|NCT05394350|560131570|FG002|Overall Study|Death|4|||
155188959|NCT05394350|560131571|FG003|Overall Study|Death|0|||
155188960|NCT05394350|560131572|FG004|Overall Study|Death|1|||
155188961|NCT05394350|560131573|FG005|Overall Study|Death|0|||
155188962|NCT05394350|560131568|FG000|Overall Study|Study terminated by sponsor|1|||
155188963|NCT05394350|560131569|FG001|Overall Study|Study terminated by sponsor|1|||
155188964|NCT05394350|560131570|FG002|Overall Study|Study terminated by sponsor|7|||
155188965|NCT05394350|560131571|FG003|Overall Study|Study terminated by sponsor|3|||
155188966|NCT05394350|560131572|FG004|Overall Study|Study terminated by sponsor|2|||
155188967|NCT05394350|560131573|FG005|Overall Study|Study terminated by sponsor|4|||
155188968|NCT01231347|560131576|FG000|Overall Study|Full Consent withdrawn|19|||
155188969|NCT01231347|560131577|FG001|Overall Study|Full Consent withdrawn|19|||
155188970|NCT01231347|560131578|FG002|Overall Study|Full Consent withdrawn|11|||
155188971|NCT01231347|560131576|FG000|Overall Study|Lost to Follow-up|4|||
155188972|NCT01231347|560131577|FG001|Overall Study|Lost to Follow-up|2|||
155188973|NCT01231347|560131578|FG002|Overall Study|Lost to Follow-up|2|||
155188974|NCT01231347|560131576|FG000|Overall Study|Death|202|||
155188975|NCT01231347|560131577|FG001|Overall Study|Death|210|||
155188976|NCT01231347|560131578|FG002|Overall Study|Death|101|||
155188977|NCT01231347|560131576|FG000|Overall Study|other event|7|||
155188978|NCT01231347|560131577|FG001|Overall Study|other event|9|||
155720369|NCT00402168|562071681|FG001|Long Term (LT)|Pregnancy|1|||
155720370|NCT00402168|562071680|FG000|Long Term (LT)|Lost to Follow-up|1|||
155720371|NCT00402168|562071681|FG001|Long Term (LT)|Lost to Follow-up|0|||
155188979|NCT01231347|560131578|FG002|Overall Study|other event|3|||
155188980|NCT01626495|560131591|FG000|Overall Study|Adverse Event|3|||
155188981|NCT01626495|560131591|FG000|Overall Study|Disease progression|27|||
155188982|NCT01626495|560131591|FG000|Overall Study|Withdrawal by Subject|1|||
155188983|NCT01626495|560131591|FG000|Overall Study|Administrative problem|1|||
155188984|NCT01626495|560131591|FG000|Overall Study|Death|2|||
155188985|NCT01626495|560131591|FG000|Overall Study|Physician Decision|1|||
155188986|NCT01626495|560131591|FG000|Overall Study|New cancer therapy|16|||
155188987|NCT01626495|560131591|FG000|Overall Study|Manufacturing failure|1|||
155188988|NCT02979197|560131596|FG000|Overall Study|Adverse Event|4|||
155188989|NCT02979197|560131597|FG001|Overall Study|Adverse Event|2|||
155188990|NCT02979197|560131598|FG002|Overall Study|Adverse Event|0|||
155188991|NCT02979197|560131596|FG000|Overall Study|Protocol Violation|0|||
155188992|NCT02979197|560131597|FG001|Overall Study|Protocol Violation|1|||
155188993|NCT02979197|560131598|FG002|Overall Study|Protocol Violation|0|||
155188994|NCT02979197|560131596|FG000|Overall Study|Subject unable to commit to study dates|0|||
155188995|NCT02979197|560131597|FG001|Overall Study|Subject unable to commit to study dates|1|||
155188996|NCT02979197|560131598|FG002|Overall Study|Subject unable to commit to study dates|0|||
155188997|NCT03643159|560131599|FG000|Overall Study|Adverse Event|1|||
155188998|NCT03643159|560131599|FG000|Overall Study|Withdrawal by Subject|1|||
155188999|NCT03438383|560131600|FG000|Overall Study|Protocol Violation|9|||
155720372|NCT00402168|562071680|FG000|Long Term (LT)|Death|4|||
155720373|NCT00402168|562071681|FG001|Long Term (LT)|Death|0|||
155720374|NCT00402168|562071680|FG000|Long Term (LT)|Lack of Efficacy|0|||
155189000|NCT03438383|560131601|FG001|Overall Study|Protocol Violation|3|||
155189001|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
155189002|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
155189003|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
155189004|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
155189005|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Death|2|||
155720375|NCT00402168|562071681|FG001|Long Term (LT)|Lack of Efficacy|2|||
155189006|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Death|2|||
155189007|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
155189008|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
155189009|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
155189010|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
155189011|NCT01528033|560131602|FG000|Follow Up|No data available|46|||
155189012|NCT01528033|560131603|FG001|Follow Up|No data available|44|||
155189013|NCT03954132|560131604|FG000|Overall Study|Adverse Event|2|||
155189014|NCT03954132|560131605|FG001|Overall Study|Adverse Event|0|||
155189015|NCT03954132|560131604|FG000|Overall Study|Patient's wish|5|||
155189016|NCT03954132|560131605|FG001|Overall Study|Patient's wish|0|||
155189017|NCT03954132|560131604|FG000|Overall Study|Lost to Follow-up|10|||
155720376|NCT00402168|562071680|FG000|Long Term (LT)|non-specified|1|||
155189018|NCT03954132|560131605|FG001|Overall Study|Lost to Follow-up|0|||
155189019|NCT03954132|560131604|FG000|Overall Study|Screening failure|0|||
155189020|NCT03954132|560131605|FG001|Overall Study|Screening failure|1|||
155189021|NCT03954132|560131604|FG000|Overall Study|No registration after Visit 1|5|||
155189022|NCT03954132|560131605|FG001|Overall Study|No registration after Visit 1|2|||
155189023|NCT03954132|560131604|FG000|Overall Study|Other reason than listed|2|||
155189024|NCT03954132|560131605|FG001|Overall Study|Other reason than listed|2|||
155189025|NCT03954132|560131604|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
155189026|NCT03954132|560131605|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
155189027|NCT03954132|560131604|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
155189028|NCT03954132|560131605|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
155189029|NCT01414608|560131608|FG000|Overall Study|Ineligible|5|||
155189030|NCT01414608|560131609|FG001|Overall Study|Ineligible|2|||
155189031|NCT05156073|560131610|FG000|Overall Study|Patient canceled appointment with PCP|1|||
155189032|NCT00973349|560131611|FG000|Overall Study|Adverse Event|0|||
155189033|NCT00973349|560131612|FG001|Overall Study|Adverse Event|0|||
155189034|NCT00973349|560131613|FG002|Overall Study|Adverse Event|0|||
155189035|NCT00973349|560131614|FG003|Overall Study|Adverse Event|0|||
155189036|NCT00973349|560131615|FG004|Overall Study|Adverse Event|1|||
155189037|NCT00973349|560131616|FG005|Overall Study|Adverse Event|0|||
155189038|NCT00973349|560131617|FG006|Overall Study|Adverse Event|0|||
155189039|NCT00973349|560131618|FG007|Overall Study|Adverse Event|0|||
155189040|NCT00973349|560131619|FG008|Overall Study|Adverse Event|1|||
155189041|NCT00973349|560131620|FG009|Overall Study|Adverse Event|0|||
155189042|NCT00973349|560131621|FG010|Overall Study|Adverse Event|0|||
155189043|NCT00973349|560131622|FG011|Overall Study|Adverse Event|0|||
155189044|NCT00973349|560131623|FG012|Overall Study|Adverse Event|0|||
155189045|NCT00973349|560131624|FG013|Overall Study|Adverse Event|0|||
155189046|NCT00973349|560131625|FG014|Overall Study|Adverse Event|1|||
155189047|NCT00973349|560131626|FG015|Overall Study|Adverse Event|0|||
155189048|NCT00973349|560131611|FG000|Overall Study|Withdrawal by Subject|1|||
155189049|NCT00973349|560131612|FG001|Overall Study|Withdrawal by Subject|2|||
155189050|NCT00973349|560131613|FG002|Overall Study|Withdrawal by Subject|2|||
155189051|NCT00973349|560131614|FG003|Overall Study|Withdrawal by Subject|3|||
155189052|NCT00973349|560131615|FG004|Overall Study|Withdrawal by Subject|2|||
155189053|NCT00973349|560131616|FG005|Overall Study|Withdrawal by Subject|0|||
155189054|NCT00973349|560131617|FG006|Overall Study|Withdrawal by Subject|2|||
155189055|NCT00973349|560131618|FG007|Overall Study|Withdrawal by Subject|2|||
155189056|NCT00973349|560131619|FG008|Overall Study|Withdrawal by Subject|0|||
155189057|NCT00973349|560131620|FG009|Overall Study|Withdrawal by Subject|2|||
155189058|NCT00973349|560131621|FG010|Overall Study|Withdrawal by Subject|0|||
155189059|NCT00973349|560131622|FG011|Overall Study|Withdrawal by Subject|1|||
155189060|NCT00973349|560131623|FG012|Overall Study|Withdrawal by Subject|0|||
155189061|NCT00973349|560131624|FG013|Overall Study|Withdrawal by Subject|0|||
155189062|NCT00973349|560131625|FG014|Overall Study|Withdrawal by Subject|0|||
155189063|NCT00973349|560131626|FG015|Overall Study|Withdrawal by Subject|0|||
155189064|NCT00973349|560131611|FG000|Overall Study|Lost to Follow-up|3|||
155189065|NCT00973349|560131612|FG001|Overall Study|Lost to Follow-up|1|||
155189066|NCT00973349|560131613|FG002|Overall Study|Lost to Follow-up|2|||
155189067|NCT00973349|560131614|FG003|Overall Study|Lost to Follow-up|2|||
155189068|NCT00973349|560131615|FG004|Overall Study|Lost to Follow-up|1|||
155189069|NCT00973349|560131616|FG005|Overall Study|Lost to Follow-up|3|||
155189070|NCT00973349|560131617|FG006|Overall Study|Lost to Follow-up|0|||
155189071|NCT00973349|560131618|FG007|Overall Study|Lost to Follow-up|1|||
155189072|NCT00973349|560131619|FG008|Overall Study|Lost to Follow-up|2|||
155189073|NCT00973349|560131620|FG009|Overall Study|Lost to Follow-up|1|||
155189074|NCT00973349|560131621|FG010|Overall Study|Lost to Follow-up|0|||
155189075|NCT00973349|560131622|FG011|Overall Study|Lost to Follow-up|1|||
155189076|NCT00973349|560131623|FG012|Overall Study|Lost to Follow-up|0|||
155189077|NCT00973349|560131624|FG013|Overall Study|Lost to Follow-up|0|||
155189078|NCT00973349|560131625|FG014|Overall Study|Lost to Follow-up|0|||
155720377|NCT00402168|562071681|FG001|Long Term (LT)|non-specified|2|||
155720378|NCT00402168|562071680|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
155720379|NCT00402168|562071681|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
155720380|NCT00402168|562071680|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
155720381|NCT00402168|562071681|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
155720382|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
155720383|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
155720384|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
155189079|NCT00973349|560131626|FG015|Overall Study|Lost to Follow-up|1|||
155189080|NCT00973349|560131611|FG000|Overall Study|Inappropriate enrolment|0|||
155189081|NCT00973349|560131612|FG001|Overall Study|Inappropriate enrolment|0|||
155189082|NCT00973349|560131613|FG002|Overall Study|Inappropriate enrolment|1|||
155189083|NCT00973349|560131614|FG003|Overall Study|Inappropriate enrolment|0|||
155189084|NCT00973349|560131615|FG004|Overall Study|Inappropriate enrolment|0|||
155189085|NCT00973349|560131616|FG005|Overall Study|Inappropriate enrolment|0|||
155189086|NCT00973349|560131617|FG006|Overall Study|Inappropriate enrolment|0|||
155189087|NCT00973349|560131618|FG007|Overall Study|Inappropriate enrolment|0|||
155189088|NCT00973349|560131619|FG008|Overall Study|Inappropriate enrolment|0|||
155189089|NCT00973349|560131620|FG009|Overall Study|Inappropriate enrolment|2|||
155189090|NCT00973349|560131621|FG010|Overall Study|Inappropriate enrolment|0|||
155189091|NCT00973349|560131622|FG011|Overall Study|Inappropriate enrolment|0|||
155189092|NCT00973349|560131623|FG012|Overall Study|Inappropriate enrolment|1|||
155189093|NCT00973349|560131624|FG013|Overall Study|Inappropriate enrolment|0|||
155189094|NCT00973349|560131625|FG014|Overall Study|Inappropriate enrolment|1|||
155189095|NCT00973349|560131626|FG015|Overall Study|Inappropriate enrolment|1|||
155189096|NCT00973349|560131611|FG000|Overall Study|Protocol Violation|0|||
155189097|NCT00973349|560131612|FG001|Overall Study|Protocol Violation|0|||
155189098|NCT00973349|560131613|FG002|Overall Study|Protocol Violation|0|||
155189099|NCT00973349|560131614|FG003|Overall Study|Protocol Violation|0|||
155189100|NCT00973349|560131615|FG004|Overall Study|Protocol Violation|0|||
155189101|NCT00973349|560131616|FG005|Overall Study|Protocol Violation|0|||
155189102|NCT00973349|560131617|FG006|Overall Study|Protocol Violation|0|||
155189103|NCT00973349|560131618|FG007|Overall Study|Protocol Violation|0|||
155189104|NCT00973349|560131619|FG008|Overall Study|Protocol Violation|1|||
155189105|NCT00973349|560131620|FG009|Overall Study|Protocol Violation|0|||
155189106|NCT00973349|560131621|FG010|Overall Study|Protocol Violation|0|||
155189107|NCT00973349|560131622|FG011|Overall Study|Protocol Violation|0|||
155189108|NCT00973349|560131623|FG012|Overall Study|Protocol Violation|0|||
155189109|NCT00973349|560131624|FG013|Overall Study|Protocol Violation|0|||
155189110|NCT00973349|560131625|FG014|Overall Study|Protocol Violation|0|||
155189111|NCT00973349|560131626|FG015|Overall Study|Protocol Violation|0|||
155189112|NCT00973349|560131611|FG000|Overall Study|Unable to classify|0|||
155189113|NCT00973349|560131612|FG001|Overall Study|Unable to classify|0|||
155189114|NCT00973349|560131613|FG002|Overall Study|Unable to classify|0|||
155189115|NCT00973349|560131614|FG003|Overall Study|Unable to classify|0|||
155189116|NCT00973349|560131615|FG004|Overall Study|Unable to classify|1|||
155189117|NCT00973349|560131616|FG005|Overall Study|Unable to classify|1|||
155189118|NCT00973349|560131617|FG006|Overall Study|Unable to classify|0|||
155189119|NCT00973349|560131618|FG007|Overall Study|Unable to classify|0|||
155189120|NCT00973349|560131619|FG008|Overall Study|Unable to classify|0|||
155189121|NCT00973349|560131620|FG009|Overall Study|Unable to classify|1|||
155189122|NCT00973349|560131621|FG010|Overall Study|Unable to classify|0|||
155189123|NCT00973349|560131622|FG011|Overall Study|Unable to classify|0|||
155189124|NCT00973349|560131623|FG012|Overall Study|Unable to classify|0|||
155189125|NCT00973349|560131624|FG013|Overall Study|Unable to classify|0|||
155720385|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
155720386|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
155720387|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
155720388|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
155720389|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
155720390|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
155720391|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
155720392|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
155720393|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
155720394|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
155720395|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
155720396|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
155189126|NCT00973349|560131625|FG014|Overall Study|Unable to classify|0|||
155189127|NCT00973349|560131626|FG015|Overall Study|Unable to classify|0|||
155189128|NCT03635788|560131627|FG000|Step 1|Death|1|||
155189129|NCT03635788|560131628|FG001|Step 1|Death|0|||
155189130|NCT03635788|560131629|FG002|Step 1|Death|0|||
155189131|NCT03635788|560131627|FG000|Step 1|Lost to Follow-up|31|||
155189132|NCT03635788|560131628|FG001|Step 1|Lost to Follow-up|0|||
155189133|NCT03635788|560131629|FG002|Step 1|Lost to Follow-up|0|||
155189134|NCT03635788|560131627|FG000|Step 1|Pregnancy|1|||
155189135|NCT03635788|560131628|FG001|Step 1|Pregnancy|0|||
155189136|NCT03635788|560131629|FG002|Step 1|Pregnancy|0|||
155189137|NCT03635788|560131627|FG000|Step 1|Protocol Violation|8|||
155189138|NCT03635788|560131628|FG001|Step 1|Protocol Violation|0|||
155189139|NCT03635788|560131629|FG002|Step 1|Protocol Violation|0|||
155189140|NCT03635788|560131627|FG000|Step 1|Withdrawal by Subject|13|||
155189141|NCT03635788|560131628|FG001|Step 1|Withdrawal by Subject|0|||
155491121|NCT03205046|561223473|FG001|Overall Study|Study terminated by sponsor|1|||
155189142|NCT03635788|560131629|FG002|Step 1|Withdrawal by Subject|0|||
155189143|NCT03635788|560131627|FG000|Step 1|Other reasons|12|||
155189144|NCT03635788|560131628|FG001|Step 1|Other reasons|0|||
155189145|NCT03635788|560131629|FG002|Step 1|Other reasons|0|||
155189146|NCT03635788|560131627|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
155189147|NCT03635788|560131628|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
155189148|NCT03635788|560131629|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
155189149|NCT03635788|560131627|FG000|Step 2|Lost to Follow-up|0|||
155189150|NCT03635788|560131628|FG001|Step 2|Lost to Follow-up|8|||
155189151|NCT03635788|560131629|FG002|Step 2|Lost to Follow-up|15|||
155189152|NCT03635788|560131627|FG000|Step 2|Withdrawal by Subject|0|||
155189153|NCT03635788|560131628|FG001|Step 2|Withdrawal by Subject|6|||
155189154|NCT03635788|560131629|FG002|Step 2|Withdrawal by Subject|6|||
155189155|NCT03635788|560131627|FG000|Step 2|Death|0|||
155189156|NCT03635788|560131628|FG001|Step 2|Death|2|||
155189157|NCT03635788|560131629|FG002|Step 2|Death|0|||
155189158|NCT03635788|560131627|FG000|Step 2|Incarceration|0|||
155189159|NCT03635788|560131628|FG001|Step 2|Incarceration|2|||
155189160|NCT03635788|560131629|FG002|Step 2|Incarceration|0|||
155189161|NCT03635788|560131627|FG000|Step 2|Non-Compliance With Study Requirements|0|||
155189162|NCT03635788|560131628|FG001|Step 2|Non-Compliance With Study Requirements|1|||
155189163|NCT03635788|560131629|FG002|Step 2|Non-Compliance With Study Requirements|1|||
155189164|NCT03635788|560131627|FG000|Step 2|Confounding Medical Condition|0|||
155189165|NCT03635788|560131628|FG001|Step 2|Confounding Medical Condition|0|||
155189166|NCT03635788|560131629|FG002|Step 2|Confounding Medical Condition|1|||
155189167|NCT03635788|560131627|FG000|Step 2|Out Of State With No Plan To Return|0|||
155189168|NCT03635788|560131628|FG001|Step 2|Out Of State With No Plan To Return|1|||
155189169|NCT03635788|560131629|FG002|Step 2|Out Of State With No Plan To Return|0|||
155189170|NCT03635788|560131627|FG000|Step 2|Switched To Injectables|0|||
155189171|NCT03635788|560131628|FG001|Step 2|Switched To Injectables|0|||
155189172|NCT03635788|560131629|FG002|Step 2|Switched To Injectables|1|||
155189173|NCT03635788|560131627|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
155189174|NCT03635788|560131628|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
155189175|NCT03635788|560131629|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
155189176|NCT02452697|560131632|FG000|Overall Study|Physician Decision|4|||
155189177|NCT02452697|560131633|FG001|Overall Study|Physician Decision|4|||
155189178|NCT02452697|560131634|FG002|Overall Study|Physician Decision|3|||
155189179|NCT02452697|560131635|FG003|Overall Study|Physician Decision|2|||
155189180|NCT02452697|560131632|FG000|Overall Study|Withdrawal by Subject|1|||
155189181|NCT02452697|560131633|FG001|Overall Study|Withdrawal by Subject|0|||
155189182|NCT02452697|560131634|FG002|Overall Study|Withdrawal by Subject|0|||
155189183|NCT02452697|560131635|FG003|Overall Study|Withdrawal by Subject|0|||
155189184|NCT02452697|560131632|FG000|Overall Study|still in follow-up|2|||
155189185|NCT02452697|560131633|FG001|Overall Study|still in follow-up|2|||
155189186|NCT02452697|560131634|FG002|Overall Study|still in follow-up|1|||
155189187|NCT02452697|560131635|FG003|Overall Study|still in follow-up|3|||
155189188|NCT05098938|560131636|FG000|Overall Study|Adverse Event|4|||
155189189|NCT05098938|560131637|FG001|Overall Study|Adverse Event|3|||
155189190|NCT05098938|560131636|FG000|Overall Study|inclusion/exclusion criteria change|11|||
155189191|NCT05098938|560131637|FG001|Overall Study|inclusion/exclusion criteria change|5|||
155189192|NCT05098938|560131636|FG000|Overall Study|lack of compliance|26|||
155189193|NCT05098938|560131637|FG001|Overall Study|lack of compliance|19|||
155189194|NCT05098938|560131636|FG000|Overall Study|Lost to Follow-up|37|||
155189195|NCT05098938|560131637|FG001|Overall Study|Lost to Follow-up|40|||
155189196|NCT05098938|560131636|FG000|Overall Study|Lost in treatment period|17|||
155189197|NCT05098938|560131637|FG001|Overall Study|Lost in treatment period|13|||
155189198|NCT05098938|560131636|FG000|Overall Study|Met an exclusion criterion|0|||
155189199|NCT05098938|560131637|FG001|Overall Study|Met an exclusion criterion|3|||
155189200|NCT05098938|560131636|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
155189201|NCT05098938|560131637|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
155189202|NCT05098938|560131636|FG000|Overall Study|Physician Decision|25|||
155189203|NCT05098938|560131637|FG001|Overall Study|Physician Decision|32|||
155189204|NCT05098938|560131636|FG000|Overall Study|Run in failure in treatment phase|1|||
155189205|NCT05098938|560131637|FG001|Overall Study|Run in failure in treatment phase|1|||
155189206|NCT05098938|560131636|FG000|Overall Study|Withdrawal by Subject|0|||
155189207|NCT05098938|560131637|FG001|Overall Study|Withdrawal by Subject|3|||
155189208|NCT05098938|560131636|FG000|Overall Study|Run-in Failure in early study|505|||
155189209|NCT05098938|560131637|FG001|Overall Study|Run-in Failure in early study|514|||
155189210|NCT05098938|560131636|FG000|Overall Study|IMP delivery missed|1|||
155189211|NCT05098938|560131637|FG001|Overall Study|IMP delivery missed|5|||
155189212|NCT05098938|560131636|FG000|Overall Study|6 months visit was missed|2|||
155189213|NCT05098938|560131637|FG001|Overall Study|6 months visit was missed|0|||
155189214|NCT05098938|560131636|FG000|Overall Study|fit for use was not completed within window|3|||
155189215|NCT05098938|560131637|FG001|Overall Study|fit for use was not completed within window|0|||
155189216|NCT05098938|560131636|FG000|Overall Study|V2 visit was not completed within window|0|||
155189217|NCT05098938|560131637|FG001|Overall Study|V2 visit was not completed within window|1|||
155189218|NCT05098938|560131636|FG000|Overall Study|exclusionary medication use|1|||
155189219|NCT05098938|560131637|FG001|Overall Study|exclusionary medication use|2|||
155189220|NCT05098938|560131636|FG000|Overall Study|change in medication|1|||
155189221|NCT05098938|560131637|FG001|Overall Study|change in medication|0|||
155189222|NCT05098938|560131636|FG000|Overall Study|treatment failure|2|||
155189223|NCT05098938|560131637|FG001|Overall Study|treatment failure|1|||
155189224|NCT03803683|560131638|FG000|Overall Study|Lost to Follow-up|41|||
155189225|NCT03803683|560131639|FG001|Overall Study|Lost to Follow-up|18|||
155189226|NCT03803683|560131640|FG002|Overall Study|Lost to Follow-up|12|||
155189227|NCT03803683|560131638|FG000|Overall Study|Withdrawal by Subject|9|||
155189228|NCT03803683|560131639|FG001|Overall Study|Withdrawal by Subject|1|||
155189229|NCT03803683|560131640|FG002|Overall Study|Withdrawal by Subject|4|||
155189230|NCT00492050|560131641|FG000|Overall Study|Adverse Event|1|||
155189231|NCT00492050|560131641|FG000|Overall Study|Lack of Efficacy|1|||
155189232|NCT00492050|560131641|FG000|Overall Study|Withdrawal by Subject|3|||
155189233|NCT00492050|560131641|FG000|Overall Study|Unable to collect SCT|2|||
155189234|NCT00492050|560131641|FG000|Overall Study|Progressive Disease|2|||
155189235|NCT02206048|560133414|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
155189236|NCT02925923|560133415|FG000|Overall Study|blood samples hemolyzed|0|||
155189237|NCT02925923|560133416|FG001|Overall Study|blood samples hemolyzed|2|||
155189238|NCT00866788|560133420|FG000|Overall Study|Adverse Event|0|||
155189239|NCT00866788|560133421|FG001|Overall Study|Adverse Event|2|||
155189240|NCT00866788|560133422|FG002|Overall Study|Adverse Event|0|||
155189241|NCT00866788|560133423|FG003|Overall Study|Adverse Event|1|||
155189242|NCT00866788|560133420|FG000|Overall Study|Lost to Follow-up|1|||
155189243|NCT00866788|560133421|FG001|Overall Study|Lost to Follow-up|1|||
155189244|NCT00866788|560133422|FG002|Overall Study|Lost to Follow-up|0|||
155189245|NCT00866788|560133423|FG003|Overall Study|Lost to Follow-up|2|||
155189246|NCT00866788|560133420|FG000|Overall Study|Withdrawal by Subject|2|||
155189247|NCT00866788|560133421|FG001|Overall Study|Withdrawal by Subject|1|||
155189248|NCT00866788|560133422|FG002|Overall Study|Withdrawal by Subject|0|||
155189249|NCT00866788|560133423|FG003|Overall Study|Withdrawal by Subject|1|||
155189250|NCT00866788|560133420|FG000|Overall Study|Pregnancy|0|||
155189251|NCT00866788|560133421|FG001|Overall Study|Pregnancy|1|||
155189252|NCT00866788|560133422|FG002|Overall Study|Pregnancy|0|||
155189253|NCT00866788|560133423|FG003|Overall Study|Pregnancy|0|||
155189254|NCT00866788|560133420|FG000|Overall Study|Disease progression|3|||
155189255|NCT00866788|560133421|FG001|Overall Study|Disease progression|1|||
155189256|NCT00866788|560133422|FG002|Overall Study|Disease progression|1|||
155189257|NCT00866788|560133423|FG003|Overall Study|Disease progression|0|||
155189258|NCT00866788|560133420|FG000|Overall Study|Physician Decision|0|||
155189259|NCT00866788|560133421|FG001|Overall Study|Physician Decision|0|||
155189260|NCT00866788|560133422|FG002|Overall Study|Physician Decision|1|||
155189261|NCT00866788|560133423|FG003|Overall Study|Physician Decision|1|||
155189262|NCT02339285|560133424|FG000|Overall Study|Withdrawal by Subject|0|||
155189263|NCT02339285|560133425|FG001|Overall Study|Withdrawal by Subject|1|||
155189264|NCT02339285|560133426|FG002|Overall Study|Withdrawal by Subject|1|||
155189265|NCT02339285|560133424|FG000|Overall Study|Lost to Follow-up|1|||
155189266|NCT02339285|560133425|FG001|Overall Study|Lost to Follow-up|1|||
155189267|NCT02339285|560133426|FG002|Overall Study|Lost to Follow-up|1|||
155189268|NCT02339285|560133424|FG000|Overall Study|Protocol Deviation|0|||
155189269|NCT02339285|560133425|FG001|Overall Study|Protocol Deviation|1|||
155189270|NCT02339285|560133426|FG002|Overall Study|Protocol Deviation|0|||
155189271|NCT00282412|560133427|FG000|Overall Study|Death|2|||
155189272|NCT03911713|560133428|FG000|Overall Study|Lost to Follow-up|0|||
155189273|NCT03911713|560133429|FG001|Overall Study|Lost to Follow-up|2|||
155189274|NCT03911713|560133430|FG002|Overall Study|Lost to Follow-up|0|||
155189275|NCT03911713|560133431|FG003|Overall Study|Lost to Follow-up|0|||
155189276|NCT03911713|560133432|FG004|Overall Study|Lost to Follow-up|0|||
155189277|NCT03911713|560133428|FG000|Overall Study|Other|0|||
155189278|NCT03911713|560133429|FG001|Overall Study|Other|0|||
155189279|NCT03911713|560133430|FG002|Overall Study|Other|0|||
155189280|NCT03911713|560133431|FG003|Overall Study|Other|1|||
155189281|NCT03911713|560133432|FG004|Overall Study|Other|0|||
155189282|NCT03911713|560133428|FG000|Overall Study|Randomized, Never Dosed|1|||
155189283|NCT03911713|560133429|FG001|Overall Study|Randomized, Never Dosed|0|||
155189284|NCT03911713|560133430|FG002|Overall Study|Randomized, Never Dosed|0|||
155189285|NCT03911713|560133431|FG003|Overall Study|Randomized, Never Dosed|1|||
155189286|NCT03911713|560133432|FG004|Overall Study|Randomized, Never Dosed|0|||
155189287|NCT00108433|560133434|FG000|Overall Study|Lack of Efficacy|1|||
155189288|NCT00108433|560133435|FG001|Overall Study|Lack of Efficacy|2|||
155189289|NCT00108433|560133434|FG000|Overall Study|Death|3|||
155189290|NCT00108433|560133435|FG001|Overall Study|Death|0|||
155189291|NCT00108433|560133434|FG000|Overall Study|Adverse Event|3|||
155189292|NCT00108433|560133435|FG001|Overall Study|Adverse Event|1|||
155189293|NCT00108433|560133434|FG000|Overall Study|Other|14|||
155189294|NCT00108433|560133435|FG001|Overall Study|Other|14|||
155189295|NCT02203071|560133436|FG000|Overall Study|Lost to Follow-up|3|||
155189296|NCT02203071|560133437|FG001|Overall Study|Lost to Follow-up|1|||
155189297|NCT01193660|560133438|FG000|Overall Study|Withdrawal by Subject|2|||
155189298|NCT01193660|560133439|FG001|Overall Study|Withdrawal by Subject|3|||
155189299|NCT01193660|560133440|FG002|Overall Study|Withdrawal by Subject|1|||
155189300|NCT01193660|560133438|FG000|Overall Study|Death|1|||
155189301|NCT01193660|560133439|FG001|Overall Study|Death|0|||
155189302|NCT01193660|560133440|FG002|Overall Study|Death|0|||
155189303|NCT01193660|560133438|FG000|Overall Study|Physician Decision|1|||
155189304|NCT01193660|560133439|FG001|Overall Study|Physician Decision|0|||
155189305|NCT01193660|560133440|FG002|Overall Study|Physician Decision|1|||
155720397|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
155189306|NCT00195273|560133441|FG000|Overall Study|Adverse Event|9|||
155189307|NCT00195273|560133442|FG001|Overall Study|Adverse Event|9|||
155189308|NCT00195273|560133441|FG000|Overall Study|Protocol deviation|0|||
155189309|NCT00195273|560133442|FG001|Overall Study|Protocol deviation|1|||
155189310|NCT00195273|560133441|FG000|Overall Study|Lack of Efficacy|3|||
155189311|NCT00195273|560133442|FG001|Overall Study|Lack of Efficacy|1|||
155189312|NCT00195273|560133441|FG000|Overall Study|Procedural complications|9|||
155189313|NCT00195273|560133442|FG001|Overall Study|Procedural complications|3|||
155189314|NCT02595970|560133443|FG000|Overall Study|Withdrawal by Subject|2|||
155189315|NCT02595970|560133443|FG000|Overall Study|Physician Decision|2|||
155189316|NCT02595970|560133443|FG000|Overall Study|Protocol Violation|4|||
155189317|NCT02595970|560133443|FG000|Overall Study|Adverse Event|5|||
155189318|NCT02595970|560133443|FG000|Overall Study|Lack of Efficacy|7|||
155189319|NCT01886716|560133444|FG000|Week 1|Lost to Follow-up|0|||
155189320|NCT01886716|560133445|FG001|Week 1|Lost to Follow-up|0|||
155189321|NCT01886716|560133446|FG002|Week 1|Lost to Follow-up|2|||
155189322|NCT01886716|560133447|FG003|Week 1|Lost to Follow-up|2|||
155189323|NCT01886716|560133444|FG000|Week 2|Lost to Follow-up|3|||
155189324|NCT01886716|560133445|FG001|Week 2|Lost to Follow-up|2|||
155189325|NCT01886716|560133446|FG002|Week 2|Lost to Follow-up|1|||
155189326|NCT01886716|560133447|FG003|Week 2|Lost to Follow-up|3|||
155189327|NCT01886716|560133444|FG000|Week 3|Lost to Follow-up|1|||
155189328|NCT01886716|560133445|FG001|Week 3|Lost to Follow-up|1|||
155189329|NCT01886716|560133446|FG002|Week 3|Lost to Follow-up|0|||
155189330|NCT01886716|560133447|FG003|Week 3|Lost to Follow-up|1|||
155189331|NCT00810108|560133454|FG000|Overall Study|Withdrawal by Subject|1|||
155189332|NCT00810108|560133455|FG001|Overall Study|Withdrawal by Subject|0|||
155189333|NCT03793556|560133463|FG000|Overall Study|Withdrawal by Subject|12|||
155189334|NCT03793556|560133464|FG001|Overall Study|Withdrawal by Subject|1|||
155189335|NCT03793556|560133463|FG000|Overall Study|Lost to Follow-up|1|||
155189336|NCT03793556|560133464|FG001|Overall Study|Lost to Follow-up|1|||
155189337|NCT04416633|560133465|FG000|Overall Study|Death|1|||
155189338|NCT04416633|560133465|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
155189339|NCT04416633|560133465|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
155189340|NCT04416633|560133465|FG000|Overall Study|Adverse Event|6|||
155189341|NCT04416633|560133465|FG000|Overall Study|Withdrawal by Subject|6|||
155189342|NCT00785928|560133466|FG000|Treatment Phase|Adverse Event|1|||
155189343|NCT00785928|560133467|FG001|Treatment Phase|Adverse Event|1|||
155189344|NCT00785928|560133468|FG002|Treatment Phase|Adverse Event|2|||
155189345|NCT00785928|560133469|FG003|Treatment Phase|Adverse Event|0|||
155189346|NCT00785928|560133470|FG004|Treatment Phase|Adverse Event|0|||
155189347|NCT00785928|560133471|FG005|Treatment Phase|Adverse Event|0|||
155189348|NCT00785928|560133472|FG006|Treatment Phase|Adverse Event|2|||
155189349|NCT00785928|560133466|FG000|Treatment Phase|Inadequate Response|0|||
155189350|NCT00785928|560133467|FG001|Treatment Phase|Inadequate Response|1|||
155189351|NCT00785928|560133468|FG002|Treatment Phase|Inadequate Response|0|||
155189352|NCT00785928|560133469|FG003|Treatment Phase|Inadequate Response|0|||
155189353|NCT00785928|560133470|FG004|Treatment Phase|Inadequate Response|0|||
155189354|NCT00785928|560133471|FG005|Treatment Phase|Inadequate Response|0|||
155189355|NCT00785928|560133472|FG006|Treatment Phase|Inadequate Response|0|||
155189356|NCT00785928|560133466|FG000|Treatment Phase|Lack of Efficacy|0|||
155189357|NCT00785928|560133467|FG001|Treatment Phase|Lack of Efficacy|1|||
155189358|NCT00785928|560133468|FG002|Treatment Phase|Lack of Efficacy|1|||
155189359|NCT00785928|560133469|FG003|Treatment Phase|Lack of Efficacy|0|||
155189360|NCT00785928|560133470|FG004|Treatment Phase|Lack of Efficacy|0|||
155189361|NCT00785928|560133471|FG005|Treatment Phase|Lack of Efficacy|0|||
155189362|NCT00785928|560133472|FG006|Treatment Phase|Lack of Efficacy|0|||
155189363|NCT00785928|560133466|FG000|Treatment Phase|Physician Decision|0|||
155189364|NCT00785928|560133467|FG001|Treatment Phase|Physician Decision|0|||
155720398|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
155720399|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
155720400|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
155720401|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
155720402|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
155189365|NCT00785928|560133468|FG002|Treatment Phase|Physician Decision|0|||
155189366|NCT00785928|560133469|FG003|Treatment Phase|Physician Decision|0|||
155189367|NCT00785928|560133470|FG004|Treatment Phase|Physician Decision|1|||
155189368|NCT00785928|560133471|FG005|Treatment Phase|Physician Decision|0|||
155189369|NCT00785928|560133472|FG006|Treatment Phase|Physician Decision|0|||
155189370|NCT00785928|560133466|FG000|Treatment Phase|Sponsor Decision|1|||
155189371|NCT00785928|560133467|FG001|Treatment Phase|Sponsor Decision|0|||
155720403|NCT00550407|562071682|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
155189372|NCT00785928|560133468|FG002|Treatment Phase|Sponsor Decision|0|||
155189373|NCT00785928|560133469|FG003|Treatment Phase|Sponsor Decision|0|||
155189374|NCT00785928|560133470|FG004|Treatment Phase|Sponsor Decision|0|||
155189375|NCT00785928|560133471|FG005|Treatment Phase|Sponsor Decision|0|||
155189376|NCT00785928|560133472|FG006|Treatment Phase|Sponsor Decision|1|||
155189377|NCT00785928|560133466|FG000|Treatment Phase|Withdrawal by Subject|1|||
155189378|NCT00785928|560133467|FG001|Treatment Phase|Withdrawal by Subject|2|||
155189379|NCT00785928|560133468|FG002|Treatment Phase|Withdrawal by Subject|0|||
155189380|NCT00785928|560133469|FG003|Treatment Phase|Withdrawal by Subject|0|||
155189381|NCT00785928|560133470|FG004|Treatment Phase|Withdrawal by Subject|1|||
155189382|NCT00785928|560133471|FG005|Treatment Phase|Withdrawal by Subject|0|||
155189383|NCT00785928|560133472|FG006|Treatment Phase|Withdrawal by Subject|0|||
155189384|NCT05021081|560133474|FG000|Phase 2|Subject enrolled in error|1|||
155189385|NCT05021081|560133475|FG001|Phase 2|Subject enrolled in error|1|||
155189386|NCT05021081|560133476|FG002|Phase 2|Subject enrolled in error|0|||
155189387|NCT01461980|560133477|FG000|Overall Study|Other|9|||
155189388|NCT01461980|560133478|FG001|Overall Study|Other|8|||
155189389|NCT01461980|560133479|FG002|Overall Study|Other|6|||
155189390|NCT01461980|560133477|FG000|Overall Study|Medication error|7|||
155189391|NCT01461980|560133478|FG001|Overall Study|Medication error|5|||
155189392|NCT01461980|560133479|FG002|Overall Study|Medication error|6|||
155189393|NCT01461980|560133477|FG000|Overall Study|Adverse Event|12|||
155189394|NCT01461980|560133478|FG001|Overall Study|Adverse Event|5|||
155189395|NCT01461980|560133479|FG002|Overall Study|Adverse Event|6|||
155189396|NCT01461980|560133477|FG000|Overall Study|Protocol Violation|12|||
155189397|NCT01461980|560133478|FG001|Overall Study|Protocol Violation|19|||
155189398|NCT01461980|560133479|FG002|Overall Study|Protocol Violation|16|||
155189399|NCT01461980|560133477|FG000|Overall Study|No longer meets eligibility criteria|18|||
155189400|NCT01461980|560133478|FG001|Overall Study|No longer meets eligibility criteria|9|||
155189401|NCT01461980|560133479|FG002|Overall Study|No longer meets eligibility criteria|19|||
155189402|NCT01461980|560133477|FG000|Overall Study|Lost to Follow-up|52|||
155189403|NCT01461980|560133478|FG001|Overall Study|Lost to Follow-up|53|||
155189404|NCT01461980|560133479|FG002|Overall Study|Lost to Follow-up|51|||
155189405|NCT01461980|560133477|FG000|Overall Study|No longer willing to participate|52|||
155189406|NCT01461980|560133478|FG001|Overall Study|No longer willing to participate|38|||
155189407|NCT01461980|560133479|FG002|Overall Study|No longer willing to participate|54|||
155189408|NCT01461980|560133477|FG000|Overall Study|Randomized but not vaccinated|4|||
155189409|NCT01461980|560133478|FG001|Overall Study|Randomized but not vaccinated|8|||
155189410|NCT01461980|560133479|FG002|Overall Study|Randomized but not vaccinated|7|||
155189411|NCT00122109|560133480|FG000|Overall Study|Did not meet criteria|6|||
155189412|NCT00122109|560133481|FG001|Overall Study|Did not meet criteria|7|||
155189413|NCT00100178|560133482|FG000|Overall Study|Lost to Follow-up|0|||
155189414|NCT00100178|560133483|FG001|Overall Study|Lost to Follow-up|6|||
155189415|NCT00100178|560133484|FG002|Overall Study|Lost to Follow-up|5|||
155189416|NCT00100178|560133482|FG000|Overall Study|Adverse Event|2|||
155189417|NCT00100178|560133483|FG001|Overall Study|Adverse Event|2|||
155189418|NCT00100178|560133484|FG002|Overall Study|Adverse Event|1|||
155189419|NCT00100178|560133482|FG000|Overall Study|Withdrawal by Subject|1|||
155189420|NCT00100178|560133483|FG001|Overall Study|Withdrawal by Subject|1|||
155189421|NCT00100178|560133484|FG002|Overall Study|Withdrawal by Subject|1|||
155189422|NCT00100178|560133482|FG000|Overall Study|Physician Decision|6|||
155189423|NCT00100178|560133483|FG001|Overall Study|Physician Decision|1|||
155189424|NCT00100178|560133484|FG002|Overall Study|Physician Decision|3|||
155189425|NCT01439568|560133487|FG000|Overall Study|Lost to Follow-up|1|||
155189426|NCT01439568|560133488|FG001|Overall Study|Lost to Follow-up|0|||
155189427|NCT01439568|560133487|FG000|Overall Study|Withdrawal by Subject|2|||
155189428|NCT01439568|560133488|FG001|Overall Study|Withdrawal by Subject|2|||
155189429|NCT03161093|560133491|FG000|Overall Study|Protocol Violation|11|||
155189430|NCT03161093|560133492|FG001|Overall Study|Protocol Violation|14|||
155189431|NCT03161093|560133493|FG002|Overall Study|Protocol Violation|6|||
155189432|NCT03161093|560133494|FG003|Overall Study|Protocol Violation|13|||
155189433|NCT03161093|560133495|FG004|Overall Study|Protocol Violation|1|||
155189434|NCT03161093|560133496|FG005|Overall Study|Protocol Violation|0|||
155189435|NCT03161093|560133491|FG000|Overall Study|Adverse Event|5|||
155189436|NCT03161093|560133492|FG001|Overall Study|Adverse Event|21|||
155189437|NCT03161093|560133493|FG002|Overall Study|Adverse Event|16|||
155189438|NCT03161093|560133494|FG003|Overall Study|Adverse Event|35|||
155189439|NCT03161093|560133495|FG004|Overall Study|Adverse Event|2|||
155189440|NCT03161093|560133496|FG005|Overall Study|Adverse Event|1|||
155189441|NCT03161093|560133491|FG000|Overall Study|Lack of Efficacy|9|||
155189442|NCT03161093|560133492|FG001|Overall Study|Lack of Efficacy|13|||
155189443|NCT03161093|560133493|FG002|Overall Study|Lack of Efficacy|9|||
155189444|NCT03161093|560133494|FG003|Overall Study|Lack of Efficacy|24|||
155189445|NCT03161093|560133495|FG004|Overall Study|Lack of Efficacy|4|||
155189446|NCT03161093|560133496|FG005|Overall Study|Lack of Efficacy|1|||
155189447|NCT03161093|560133491|FG000|Overall Study|Physician Decision|0|||
155189448|NCT03161093|560133492|FG001|Overall Study|Physician Decision|1|||
155189449|NCT03161093|560133493|FG002|Overall Study|Physician Decision|0|||
155189450|NCT03161093|560133494|FG003|Overall Study|Physician Decision|2|||
155189451|NCT03161093|560133495|FG004|Overall Study|Physician Decision|17|||
155189452|NCT03161093|560133496|FG005|Overall Study|Physician Decision|15|||
155189453|NCT03161093|560133491|FG000|Overall Study|Withdrawal by Subject|24|||
155189454|NCT03161093|560133492|FG001|Overall Study|Withdrawal by Subject|73|||
155189455|NCT03161093|560133493|FG002|Overall Study|Withdrawal by Subject|44|||
155189456|NCT03161093|560133494|FG003|Overall Study|Withdrawal by Subject|97|||
155189457|NCT03161093|560133495|FG004|Overall Study|Withdrawal by Subject|11|||
155189458|NCT03161093|560133496|FG005|Overall Study|Withdrawal by Subject|10|||
155189459|NCT03161093|560133491|FG000|Overall Study|Lost to Follow-up|3|||
155189460|NCT03161093|560133492|FG001|Overall Study|Lost to Follow-up|12|||
155189461|NCT03161093|560133493|FG002|Overall Study|Lost to Follow-up|4|||
155189462|NCT03161093|560133494|FG003|Overall Study|Lost to Follow-up|7|||
155189463|NCT03161093|560133495|FG004|Overall Study|Lost to Follow-up|8|||
155189464|NCT03161093|560133496|FG005|Overall Study|Lost to Follow-up|13|||
155189465|NCT03161093|560133491|FG000|Overall Study|Death|3|||
155189466|NCT03161093|560133492|FG001|Overall Study|Death|9|||
155189467|NCT03161093|560133493|FG002|Overall Study|Death|7|||
155189468|NCT03161093|560133494|FG003|Overall Study|Death|9|||
155189469|NCT03161093|560133495|FG004|Overall Study|Death|0|||
155189470|NCT03161093|560133496|FG005|Overall Study|Death|0|||
155189471|NCT03161093|560133491|FG000|Overall Study|Unknown - Not reported|0|||
155189472|NCT03161093|560133492|FG001|Overall Study|Unknown - Not reported|1|||
155189473|NCT03161093|560133493|FG002|Overall Study|Unknown - Not reported|0|||
155189474|NCT03161093|560133494|FG003|Overall Study|Unknown - Not reported|0|||
155189475|NCT03161093|560133495|FG004|Overall Study|Unknown - Not reported|0|||
155189476|NCT03161093|560133496|FG005|Overall Study|Unknown - Not reported|1|||
155189477|NCT01649804|560133504|FG000|Overall Study|Administrative/Other|8|||
155189478|NCT03719586|560133505|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
155189479|NCT03719586|560133506|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
155189480|NCT03719586|560133507|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
155189481|NCT03719586|560133508|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
155189482|NCT01199731|560133509|FG000|Overall Study|Adverse Event|0|||
155189483|NCT01199731|560133510|FG001|Overall Study|Adverse Event|1|||
155189484|NCT01199731|560133511|FG002|Overall Study|Adverse Event|0|||
155189485|NCT01199731|560133509|FG000|Overall Study|Study closed/terminated|7|||
155189486|NCT01199731|560133510|FG001|Overall Study|Study closed/terminated|9|||
155189487|NCT01199731|560133511|FG002|Overall Study|Study closed/terminated|7|||
155189488|NCT01199731|560133509|FG000|Overall Study|Lost to Follow-up|0|||
155189489|NCT01199731|560133510|FG001|Overall Study|Lost to Follow-up|0|||
155189490|NCT01199731|560133511|FG002|Overall Study|Lost to Follow-up|2|||
155189491|NCT01199731|560133509|FG000|Overall Study|Physician Decision|0|||
155189492|NCT01199731|560133510|FG001|Overall Study|Physician Decision|1|||
155189493|NCT01199731|560133511|FG002|Overall Study|Physician Decision|1|||
155189494|NCT01199731|560133509|FG000|Overall Study|Withdrawal by Subject|2|||
155189495|NCT01199731|560133510|FG001|Overall Study|Withdrawal by Subject|0|||
155189496|NCT01199731|560133511|FG002|Overall Study|Withdrawal by Subject|0|||
155189497|NCT01465191|560133512|FG000|Overall Study|Protocol Violation|6|||
155189498|NCT01465191|560133513|FG001|Overall Study|Protocol Violation|3|||
155189499|NCT01465191|560133514|FG002|Overall Study|Protocol Violation|3|||
155189500|NCT01465191|560133512|FG000|Overall Study|Lost to Follow-up|3|||
155189501|NCT01465191|560133513|FG001|Overall Study|Lost to Follow-up|6|||
155189502|NCT01465191|560133514|FG002|Overall Study|Lost to Follow-up|4|||
155189503|NCT00943124|560133515|FG000|Period 1|Withdrawal by Subject|1|||
155189504|NCT00943124|560133516|FG001|Period 1|Withdrawal by Subject|1|||
155189505|NCT00943124|560133515|FG000|Period 1|Did Not Follow Study Procedures|1|||
155189506|NCT00943124|560133516|FG001|Period 1|Did Not Follow Study Procedures|0|||
155189507|NCT00943124|560133515|FG000|Period 1|Personal Reasons|0|||
155189508|NCT00943124|560133516|FG001|Period 1|Personal Reasons|1|||
155189509|NCT02992132|560133517|FG000|Overall Study|Adverse Event|4|||
155189510|NCT02992132|560133518|FG001|Overall Study|Adverse Event|1|||
155720404|NCT00550407|562071683|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
155720405|NCT00550407|562071684|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
155720406|NCT00550407|562071682|FG000|26-Week Randomized Phase|Adverse Event|0|||
155720407|NCT00550407|562071683|FG001|26-Week Randomized Phase|Adverse Event|5|||
155720408|NCT00550407|562071684|FG002|26-Week Randomized Phase|Adverse Event|2|||
155720409|NCT00550407|562071682|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
155189511|NCT02992132|560133519|FG002|Overall Study|Adverse Event|3|||
155189512|NCT02992132|560133517|FG000|Overall Study|Lack of Efficacy|2|||
155189513|NCT02992132|560133518|FG001|Overall Study|Lack of Efficacy|0|||
155189514|NCT02992132|560133519|FG002|Overall Study|Lack of Efficacy|0|||
155189515|NCT02992132|560133517|FG000|Overall Study|Non-compliance with study drug|2|||
155189516|NCT02992132|560133518|FG001|Overall Study|Non-compliance with study drug|0|||
155189517|NCT02992132|560133519|FG002|Overall Study|Non-compliance with study drug|0|||
155189518|NCT02992132|560133517|FG000|Overall Study|Progressive disease|1|||
155189519|NCT02992132|560133518|FG001|Overall Study|Progressive disease|0|||
155189520|NCT02992132|560133519|FG002|Overall Study|Progressive disease|0|||
155189521|NCT02992132|560133517|FG000|Overall Study|Protocol Violation|2|||
155189522|NCT02992132|560133518|FG001|Overall Study|Protocol Violation|2|||
155189523|NCT02992132|560133519|FG002|Overall Study|Protocol Violation|0|||
155189524|NCT02992132|560133517|FG000|Overall Study|Caregiver withdrew consent|2|||
155189525|NCT02992132|560133518|FG001|Overall Study|Caregiver withdrew consent|3|||
155189526|NCT02992132|560133519|FG002|Overall Study|Caregiver withdrew consent|2|||
155189527|NCT02992132|560133517|FG000|Overall Study|Withdrawal by Subject|0|||
155189528|NCT02992132|560133518|FG001|Overall Study|Withdrawal by Subject|2|||
155189529|NCT02992132|560133519|FG002|Overall Study|Withdrawal by Subject|1|||
155189530|NCT02992132|560133517|FG000|Overall Study|Physician Decision|0|||
155189531|NCT02992132|560133518|FG001|Overall Study|Physician Decision|0|||
155189532|NCT02992132|560133519|FG002|Overall Study|Physician Decision|1|||
155189533|NCT00381381|560133532|FG000|Overall Study|Adverse Event|3|||
155189534|NCT00381381|560133532|FG000|Overall Study|Lost to Follow-up|52|||
155189535|NCT00381381|560133532|FG000|Overall Study|Withdrawal by Subject|9|||
155189536|NCT01916967|560133533|FG000|Overall Study|Adverse Event|0|||
155189537|NCT01916967|560133534|FG001|Overall Study|Adverse Event|0|||
155189538|NCT01916967|560133535|FG002|Overall Study|Adverse Event|2|||
155189539|NCT01916967|560133533|FG000|Overall Study|Lack of Efficacy|0|||
155189540|NCT01916967|560133534|FG001|Overall Study|Lack of Efficacy|0|||
155189541|NCT01916967|560133535|FG002|Overall Study|Lack of Efficacy|6|||
155189542|NCT01916967|560133533|FG000|Overall Study|Physician Decision|0|||
155189543|NCT01916967|560133534|FG001|Overall Study|Physician Decision|0|||
155189544|NCT01916967|560133535|FG002|Overall Study|Physician Decision|1|||
155189545|NCT01916967|560133533|FG000|Overall Study|Protocol Violation|0|||
155189546|NCT01916967|560133534|FG001|Overall Study|Protocol Violation|1|||
155189547|NCT01916967|560133535|FG002|Overall Study|Protocol Violation|0|||
155189548|NCT03799211|560133538|FG000|Overall Study|Lost to Follow-up|2|||
155189549|NCT03799211|560133539|FG001|Overall Study|Lost to Follow-up|13|||
155189550|NCT03799211|560133538|FG000|Overall Study|Withdrawal by Subject|2|||
155189551|NCT03799211|560133539|FG001|Overall Study|Withdrawal by Subject|0|||
155189552|NCT00764491|560133540|FG000|Overall Study|Lost to Follow-up|35|||
155189553|NCT00764491|560133541|FG001|Overall Study|Lost to Follow-up|17|||
155189554|NCT00620464|560133542|FG000|Overall Study|Adverse Event|15|||
155189555|NCT00620464|560133543|FG001|Overall Study|Adverse Event|17|||
155189556|NCT00620464|560133542|FG000|Overall Study|Lost to Follow-up|1|||
155189557|NCT00620464|560133543|FG001|Overall Study|Lost to Follow-up|1|||
155189558|NCT00620464|560133542|FG000|Overall Study|Planning Pregnancy|1|||
155189559|NCT00620464|560133543|FG001|Overall Study|Planning Pregnancy|4|||
155189560|NCT00620464|560133542|FG000|Overall Study|Personal|2|||
155189561|NCT00620464|560133543|FG001|Overall Study|Personal|2|||
155189562|NCT00620464|560133542|FG000|Overall Study|Used prohibited medication|1|||
155189563|NCT00620464|560133543|FG001|Overall Study|Used prohibited medication|0|||
155189564|NCT02027376|560133544|FG000|Overall Study|Death|1|||
155189565|NCT02027376|560133545|FG001|Overall Study|Death|0|||
155189566|NCT02027376|560133546|FG002|Overall Study|Death|0|||
155189567|NCT00932737|560133549|FG000|Overall Study|Not treated in second episode|1|||
155189568|NCT00932737|560133550|FG001|Overall Study|Not treated in second episode|0|||
155189569|NCT00932737|560133549|FG000|Overall Study|Adverse Event|0|||
155189570|NCT00932737|560133550|FG001|Overall Study|Adverse Event|1|||
155189571|NCT02949700|560133551|FG000|Phase I|Withdrawal by Subject|1|||
155189572|NCT02949700|560133552|FG001|Phase I|Withdrawal by Subject|1|||
155189573|NCT02949700|560133553|FG002|Phase I|Withdrawal by Subject|0|||
155189574|NCT02949700|560133554|FG003|Phase I|Withdrawal by Subject|0|||
155189575|NCT02949700|560133551|FG000|Phase I|Protocol Violation|1|||
155189576|NCT02949700|560133552|FG001|Phase I|Protocol Violation|0|||
155189577|NCT02949700|560133553|FG002|Phase I|Protocol Violation|0|||
155189578|NCT02949700|560133554|FG003|Phase I|Protocol Violation|0|||
155189579|NCT02949700|560133551|FG000|Phase II|Withdrawal by Subject|0|||
155189580|NCT02949700|560133552|FG001|Phase II|Withdrawal by Subject|0|||
155189581|NCT02949700|560133553|FG002|Phase II|Withdrawal by Subject|0|||
155189582|NCT02949700|560133554|FG003|Phase II|Withdrawal by Subject|2|||
155720410|NCT00550407|562071683|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
155720411|NCT00550407|562071684|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
155189583|NCT02949700|560133551|FG000|Phase II|Protocol Violation|0|||
155189584|NCT02949700|560133552|FG001|Phase II|Protocol Violation|0|||
155189585|NCT02949700|560133553|FG002|Phase II|Protocol Violation|1|||
155189586|NCT02949700|560133554|FG003|Phase II|Protocol Violation|3|||
155189587|NCT02898116|560133559|FG000|Overall Study|Adverse Event|1|||
155189588|NCT02898116|560133559|FG000|Overall Study|Progressive disease|1|||
155189589|NCT05597020|560133563|FG000|Washout|Forbidden medication|2|||
155189590|NCT05597020|560133564|FG001|Washout|Forbidden medication|0|||
155189591|NCT05597020|560133563|FG000|Treatment Period II|Advice from primary care physician|1|||
155189592|NCT05597020|560133564|FG001|Treatment Period II|Advice from primary care physician|0|||
155189593|NCT05597020|560133563|FG000|Treatment Period II|Subject lost investigational product|1|||
155189594|NCT05597020|560133564|FG001|Treatment Period II|Subject lost investigational product|0|||
155189595|NCT05597020|560133563|FG000|Treatment Period II|Private reasons|0|||
155189596|NCT05597020|560133564|FG001|Treatment Period II|Private reasons|1|||
155189597|NCT01015131|560133565|FG000|Overall Study|Physician Decision|1|||
155189598|NCT01015131|560133565|FG000|Overall Study|Protocol Violation|1|||
155189599|NCT01015131|560133565|FG000|Overall Study|Withdrawal by Subject|2|||
155189600|NCT01015131|560133565|FG000|Overall Study|Other Protocol Specified Criteria|4|||
155189601|NCT00560885|560133566|FG000|Overall Study|Death|7|||
155189602|NCT00560885|560133566|FG000|Overall Study|Withdrawal by Subject|1|||
155189603|NCT02887859|560133567|FG000|Overall Study|Ongoing|6|||
155189604|NCT02887859|560133567|FG000|Overall Study|Adverse Event|7|||
155189605|NCT02887859|560133567|FG000|Overall Study|Death|1|||
155189606|NCT02887859|560133567|FG000|Overall Study|Physician Decision|1|||
155189607|NCT01554397|560133568|FG000|Overall Study|Withdrawal by Subject|1|||
155189608|NCT01554397|560133569|FG001|Overall Study|Withdrawal by Subject|0|||
155189609|NCT01554397|560133568|FG000|Overall Study|Ineligible|7|||
155189610|NCT01554397|560133569|FG001|Overall Study|Ineligible|0|||
155189611|NCT03148275|560133570|FG000|Overall Study|Death|6|||
155189612|NCT03148275|560133570|FG000|Overall Study|Adverse Event|3|||
155189613|NCT03148275|560133570|FG000|Overall Study|Liver transplant|2|||
155189614|NCT03148275|560133570|FG000|Overall Study|Patient decision|5|||
155189615|NCT03148275|560133570|FG000|Overall Study|transition to commercial drug|1|||
155189616|NCT03148275|560133570|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
155189617|NCT00257608|560135522|FG000|Chemotherapy Phase|Adverse Event|138|||
155189618|NCT00257608|560135523|FG001|Chemotherapy Phase|Adverse Event|0|||
155189619|NCT00257608|560135524|FG002|Chemotherapy Phase|Adverse Event|0|||
155189620|NCT00257608|560135522|FG000|Chemotherapy Phase|Disease progression|139|||
155189621|NCT00257608|560135523|FG001|Chemotherapy Phase|Disease progression|0|||
155189622|NCT00257608|560135524|FG002|Chemotherapy Phase|Disease progression|0|||
155189623|NCT00257608|560135522|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
155189624|NCT00257608|560135523|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189625|NCT00257608|560135524|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189626|NCT00257608|560135522|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
155189627|NCT00257608|560135523|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189628|NCT00257608|560135524|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189629|NCT00257608|560135522|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
155189630|NCT00257608|560135523|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
155189631|NCT00257608|560135524|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
155189632|NCT00257608|560135522|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
155189633|NCT00257608|560135523|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189634|NCT00257608|560135524|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189635|NCT00257608|560135522|FG000|Chemotherapy Phase|Physician Decision|28|||
155189636|NCT00257608|560135523|FG001|Chemotherapy Phase|Physician Decision|0|||
155189637|NCT00257608|560135524|FG002|Chemotherapy Phase|Physician Decision|0|||
155189638|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Adverse Event|0|||
155189639|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Adverse Event|34|||
155189640|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Adverse Event|38|||
155189641|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Disease progression|0|||
155189642|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Disease progression|204|||
155189643|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Disease progression|168|||
155189644|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189645|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
155189646|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
155189647|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189648|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
155189649|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
155189650|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
155189651|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
155189652|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
155189653|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189654|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189655|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
155189656|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
155189657|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
155189658|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
155189659|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Physician Decision|0|||
155189660|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Physician Decision|8|||
155189661|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Physician Decision|11|||
155189662|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
155189663|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
155189664|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
155189665|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Not treated|0|||
155189666|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Not treated|4|||
155189667|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Not treated|7|||
155189668|NCT03673046|560135525|FG000|Overall Study|Adverse Event|1|||
155189669|NCT03673046|560135526|FG001|Overall Study|Adverse Event|1|||
155189670|NCT03673046|560135525|FG000|Overall Study|Withdrawal by Subject|8|||
155189671|NCT03673046|560135526|FG001|Overall Study|Withdrawal by Subject|2|||
155189672|NCT03817879|560135527|FG000|Overall Study|Drop out|5|||
155189673|NCT03817879|560135528|FG001|Overall Study|Drop out|12|||
155189674|NCT03817879|560135527|FG000|Overall Study|Withdrawal by Subject|0|||
155189675|NCT03817879|560135528|FG001|Overall Study|Withdrawal by Subject|1|||
155189676|NCT03693300|560135529|FG000|Overall Study|Withdrawal by Subject|6|||
155189677|NCT03693300|560135530|FG001|Overall Study|Withdrawal by Subject|0|||
155189678|NCT03693300|560135529|FG000|Overall Study|Death|50|||
155189679|NCT03693300|560135530|FG001|Overall Study|Death|2|||
155189680|NCT03693300|560135529|FG000|Overall Study|Lost to Follow-up|2|||
155189681|NCT03693300|560135530|FG001|Overall Study|Lost to Follow-up|0|||
155189682|NCT00537238|560135531|FG000|Overall Study|Death|1|||
155189683|NCT00537238|560135532|FG001|Overall Study|Death|2|||
155189684|NCT00537238|560135531|FG000|Overall Study|Adverse Event|31|||
155189685|NCT00537238|560135532|FG001|Overall Study|Adverse Event|22|||
155189686|NCT00537238|560135531|FG000|Overall Study|Lack of Efficacy|20|||
155189687|NCT00537238|560135532|FG001|Overall Study|Lack of Efficacy|21|||
155189688|NCT00537238|560135531|FG000|Overall Study|Lost to Follow-up|12|||
155189689|NCT00537238|560135532|FG001|Overall Study|Lost to Follow-up|8|||
155189690|NCT00537238|560135531|FG000|Overall Study|Withdrawal by Subject|51|||
155189691|NCT00537238|560135532|FG001|Overall Study|Withdrawal by Subject|47|||
155189692|NCT00537238|560135531|FG000|Overall Study|Protocol Violation|15|||
155189693|NCT00537238|560135532|FG001|Overall Study|Protocol Violation|19|||
155189694|NCT00537238|560135531|FG000|Overall Study|Does not meet entrance criteria|0|||
155189695|NCT00537238|560135532|FG001|Overall Study|Does not meet entrance criteria|2|||
155189696|NCT00537238|560135531|FG000|Overall Study|Other|44|||
155189697|NCT00537238|560135532|FG001|Overall Study|Other|52|||
155189698|NCT00697073|560135533|FG000|Overall Study|Withdrawal by Subject|2|||
155189699|NCT00697073|560135533|FG000|Overall Study|Pregnancy|1|||
155189700|NCT00697073|560135533|FG000|Overall Study|non compliance and other|6|||
155189701|NCT03265665|560135538|FG000|24-week Data Collection|Withdrawal by Subject|2|||
155189702|NCT03265665|560135539|FG001|24-week Data Collection|Withdrawal by Subject|2|||
155189703|NCT03265665|560135538|FG000|24-week Data Collection|Lost to Follow-up|4|||
155189704|NCT03265665|560135539|FG001|24-week Data Collection|Lost to Follow-up|5|||
155189705|NCT03265665|560135538|FG000|36-week Data Collection|Lost to Follow-up|6|||
155189706|NCT03265665|560135539|FG001|36-week Data Collection|Lost to Follow-up|8|||
155189707|NCT01845818|560135542|FG000|Overall Study|Withdrawal by Subject|0|||
155189708|NCT01845818|560135543|FG001|Overall Study|Withdrawal by Subject|1|||
155189709|NCT01845818|560135542|FG000|Overall Study|Lost to Follow-up|7|||
155189710|NCT01845818|560135543|FG001|Overall Study|Lost to Follow-up|5|||
155189711|NCT01845818|560135542|FG000|Overall Study|Administrative Reasons|3|||
155189712|NCT01845818|560135543|FG001|Overall Study|Administrative Reasons|1|||
155189713|NCT01845818|560135542|FG000|Overall Study|Serious Adverse Event|1|||
155189714|NCT01845818|560135543|FG001|Overall Study|Serious Adverse Event|1|||
155189715|NCT01845818|560135542|FG000|Overall Study|Other|25|||
155189716|NCT01845818|560135543|FG001|Overall Study|Other|8|||
155189717|NCT01845818|560135542|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
155189718|NCT01845818|560135543|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
155189719|NCT01845818|560135542|FG000|Overall Study|No Follow-Up Data Available|4|||
155189720|NCT01845818|560135543|FG001|Overall Study|No Follow-Up Data Available|1|||
155189721|NCT01680965|560135544|FG000|Overall Study|Death|0|||
155189722|NCT01680965|560135545|FG001|Overall Study|Death|0|||
155189723|NCT01680965|560135546|FG002|Overall Study|Death|0|||
155189724|NCT01680965|560135547|FG003|Overall Study|Death|6|||
155189725|NCT04806503|560135552|FG000|Overall Study|Lost to Follow-up|0|||
155189726|NCT04806503|560135553|FG001|Overall Study|Lost to Follow-up|0|||
155189727|NCT04806503|560135554|FG002|Overall Study|Lost to Follow-up|1|||
155189728|NCT04806503|560135555|FG003|Overall Study|Lost to Follow-up|0|||
155189729|NCT04806503|560135556|FG004|Overall Study|Lost to Follow-up|0|||
155189730|NCT04806503|560135552|FG000|Overall Study|Withdrawal by Subject|1|||
155189731|NCT04806503|560135553|FG001|Overall Study|Withdrawal by Subject|0|||
155189732|NCT04806503|560135554|FG002|Overall Study|Withdrawal by Subject|1|||
155189733|NCT04806503|560135555|FG003|Overall Study|Withdrawal by Subject|1|||
155189734|NCT04806503|560135556|FG004|Overall Study|Withdrawal by Subject|1|||
155189735|NCT04806503|560135552|FG000|Overall Study|Adverse Event|1|||
155189736|NCT04806503|560135553|FG001|Overall Study|Adverse Event|1|||
155189737|NCT04806503|560135554|FG002|Overall Study|Adverse Event|0|||
155189738|NCT04806503|560135555|FG003|Overall Study|Adverse Event|1|||
155189739|NCT04806503|560135556|FG004|Overall Study|Adverse Event|0|||
155189740|NCT03589469|560135557|FG000|Overall Study|Withdrawal by Subject|8|||
155720412|NCT00550407|562071682|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
155189741|NCT03589469|560135557|FG000|Overall Study|Physician Decision|20|||
155189742|NCT03589469|560135557|FG000|Overall Study|Death|97|||
155189743|NCT03589469|560135557|FG000|Overall Study|Lost to Follow-up|8|||
155189744|NCT03589469|560135557|FG000|Overall Study|Miscellaneous|1|||
155189745|NCT00231842|560135565|FG000|Overall Study|Withdrawal by Subject|3|||
155189746|NCT00231842|560135565|FG000|Overall Study|Did not complete the last 3 cycle|8|||
155189747|NCT02422303|560135566|FG000|Overall Study|Lost to Follow-up|1|||
155189748|NCT02422303|560135567|FG001|Overall Study|Lost to Follow-up|1|||
155189749|NCT00850343|560135568|FG000|Overall Study|Withdrawal by Subject|11|||
155189750|NCT00850343|560135569|FG001|Overall Study|Withdrawal by Subject|0|||
155189751|NCT00850343|560135570|FG002|Overall Study|Withdrawal by Subject|3|||
155189752|NCT00850343|560135571|FG003|Overall Study|Withdrawal by Subject|2|||
155189753|NCT00850343|560135568|FG000|Overall Study|Adverse Event|15|||
155189754|NCT00850343|560135569|FG001|Overall Study|Adverse Event|2|||
155189755|NCT00850343|560135570|FG002|Overall Study|Adverse Event|6|||
155189756|NCT00850343|560135571|FG003|Overall Study|Adverse Event|6|||
155189757|NCT00850343|560135568|FG000|Overall Study|Pregnancy|0|||
155189758|NCT00850343|560135569|FG001|Overall Study|Pregnancy|0|||
155189759|NCT00850343|560135570|FG002|Overall Study|Pregnancy|0|||
155189760|NCT00850343|560135571|FG003|Overall Study|Pregnancy|1|||
155189761|NCT00850343|560135568|FG000|Overall Study|Lack of Efficacy|17|||
155189762|NCT00850343|560135569|FG001|Overall Study|Lack of Efficacy|0|||
155189763|NCT00850343|560135570|FG002|Overall Study|Lack of Efficacy|3|||
155189764|NCT00850343|560135571|FG003|Overall Study|Lack of Efficacy|2|||
155189765|NCT00850343|560135568|FG000|Overall Study|Non-compliance with Study Procedures|1|||
155189766|NCT00850343|560135569|FG001|Overall Study|Non-compliance with Study Procedures|0|||
155189767|NCT00850343|560135570|FG002|Overall Study|Non-compliance with Study Procedures|1|||
155189768|NCT00850343|560135571|FG003|Overall Study|Non-compliance with Study Procedures|1|||
155189769|NCT00850343|560135568|FG000|Overall Study|Physician Decision|2|||
155189770|NCT00850343|560135569|FG001|Overall Study|Physician Decision|1|||
155189771|NCT00850343|560135570|FG002|Overall Study|Physician Decision|1|||
155189772|NCT00850343|560135571|FG003|Overall Study|Physician Decision|1|||
155189773|NCT00639678|560135572|FG000|Overall Study|Withdrawal by Subject|3|||
155189774|NCT00639678|560135573|FG001|Overall Study|Withdrawal by Subject|0|||
155189775|NCT00639678|560135574|FG002|Overall Study|Withdrawal by Subject|4|||
155189776|NCT00639678|560135575|FG003|Overall Study|Withdrawal by Subject|0|||
155189777|NCT00639678|560135572|FG000|Overall Study|Lost to Follow-up|1|||
155189778|NCT00639678|560135573|FG001|Overall Study|Lost to Follow-up|0|||
155189779|NCT00639678|560135574|FG002|Overall Study|Lost to Follow-up|6|||
155189780|NCT00639678|560135575|FG003|Overall Study|Lost to Follow-up|0|||
155189781|NCT00639678|560135572|FG000|Overall Study|Adverse Event|0|||
155189782|NCT00639678|560135573|FG001|Overall Study|Adverse Event|1|||
155189783|NCT00639678|560135574|FG002|Overall Study|Adverse Event|0|||
155189784|NCT00639678|560135575|FG003|Overall Study|Adverse Event|0|||
155189785|NCT00639678|560135572|FG000|Overall Study|Lack of Compliance|0|||
155189786|NCT00639678|560135573|FG001|Overall Study|Lack of Compliance|0|||
155189787|NCT00639678|560135574|FG002|Overall Study|Lack of Compliance|1|||
155189788|NCT00639678|560135575|FG003|Overall Study|Lack of Compliance|0|||
155189789|NCT01973569|560135576|FG000|Overall Study|Adverse Event|9|||
155189790|NCT01973569|560135577|FG001|Overall Study|Adverse Event|2|||
155189791|NCT01973569|560135578|FG002|Overall Study|Adverse Event|4|||
155189792|NCT01973569|560135576|FG000|Overall Study|Protocol Violation|2|||
155189793|NCT01973569|560135577|FG001|Overall Study|Protocol Violation|1|||
155189794|NCT01973569|560135578|FG002|Overall Study|Protocol Violation|3|||
155189795|NCT01973569|560135576|FG000|Overall Study|Withdrawal by Subject|7|||
155189796|NCT01973569|560135577|FG001|Overall Study|Withdrawal by Subject|5|||
155189797|NCT01973569|560135578|FG002|Overall Study|Withdrawal by Subject|2|||
155189798|NCT01973569|560135576|FG000|Overall Study|Invasive dental treatment|3|||
155189799|NCT01973569|560135577|FG001|Overall Study|Invasive dental treatment|5|||
155189800|NCT01973569|560135578|FG002|Overall Study|Invasive dental treatment|6|||
155189801|NCT01973569|560135576|FG000|Overall Study|Prohibited concomitant d|1|||
155189802|NCT01973569|560135577|FG001|Overall Study|Prohibited concomitant d|5|||
155189803|NCT01973569|560135578|FG002|Overall Study|Prohibited concomitant d|0|||
155189804|NCT01973569|560135576|FG000|Overall Study|Disease progression|0|||
155189805|NCT01973569|560135577|FG001|Overall Study|Disease progression|3|||
155189806|NCT01973569|560135578|FG002|Overall Study|Disease progression|0|||
155720413|NCT00550407|562071683|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
155720414|NCT00550407|562071684|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
155720415|NCT00550407|562071682|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
155720416|NCT00550407|562071683|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
155720417|NCT00550407|562071684|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
155720418|NCT02370420|562071685|FG000|Overall Study|Physician Decision|3|||
155720419|NCT02370420|562071686|FG001|Overall Study|Physician Decision|3|||
155720420|NCT02370420|562071685|FG000|Overall Study|Lost to Follow-up|11|||
155720421|NCT02370420|562071686|FG001|Overall Study|Lost to Follow-up|9|||
155189807|NCT01973569|560135576|FG000|Overall Study|Other|1|||
155189808|NCT01973569|560135577|FG001|Overall Study|Other|1|||
155189809|NCT01973569|560135578|FG002|Overall Study|Other|0|||
155189810|NCT01973569|560135576|FG000|Overall Study|Did not receive study drug|6|||
155189811|NCT01973569|560135577|FG001|Overall Study|Did not receive study drug|3|||
155189812|NCT01973569|560135578|FG002|Overall Study|Did not receive study drug|3|||
155189813|NCT00371826|560135579|FG000|Core Phase (12 Months)|Adverse Event|15|||
155189814|NCT00371826|560135580|FG001|Core Phase (12 Months)|Adverse Event|4|||
155189815|NCT00371826|560135581|FG002|Core Phase (12 Months)|Adverse Event|9|||
155189816|NCT00371826|560135579|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
155720422|NCT02919761|562071691|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
155189817|NCT00371826|560135580|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
155189818|NCT00371826|560135581|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
155189819|NCT00371826|560135579|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
155189820|NCT00371826|560135580|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
155189821|NCT00371826|560135581|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
155189822|NCT00371826|560135579|FG000|Core Phase (12 Months)|Protocol Violation|1|||
155189823|NCT00371826|560135580|FG001|Core Phase (12 Months)|Protocol Violation|0|||
155189824|NCT00371826|560135581|FG002|Core Phase (12 Months)|Protocol Violation|1|||
155189825|NCT00371826|560135579|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
155189826|NCT00371826|560135580|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
155189827|NCT00371826|560135581|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
155189828|NCT00371826|560135579|FG000|Core Phase (12 Months)|Administrative problems|1|||
155189829|NCT00371826|560135580|FG001|Core Phase (12 Months)|Administrative problems|0|||
155189830|NCT00371826|560135581|FG002|Core Phase (12 Months)|Administrative problems|8|||
155189831|NCT00371826|560135579|FG000|Core Phase (12 Months)|Graft Loss|0|||
155189832|NCT00371826|560135580|FG001|Core Phase (12 Months)|Graft Loss|1|||
155189833|NCT00371826|560135581|FG002|Core Phase (12 Months)|Graft Loss|0|||
155189834|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Adverse Event|4|||
155189835|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Adverse Event|5|||
155189836|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Adverse Event|0|||
155189837|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
155189838|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
155189839|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
155189840|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
155189841|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
155189842|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
155189843|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
155189844|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
155189845|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
155189846|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Administrative problems|0|||
155189847|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Administrative problems|0|||
155189848|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Administrative problems|2|||
155189849|NCT02436304|560135582|FG000|Overall Study|Lost to Follow-up|0|||
155189850|NCT02436304|560135583|FG001|Overall Study|Lost to Follow-up|1|||
155189851|NCT02436304|560135584|FG002|Overall Study|Lost to Follow-up|0|||
155189852|NCT02436304|560135582|FG000|Overall Study|Withdrawal by Subject|0|||
155189853|NCT02436304|560135583|FG001|Overall Study|Withdrawal by Subject|1|||
155189854|NCT02436304|560135584|FG002|Overall Study|Withdrawal by Subject|0|||
155189855|NCT02436304|560135582|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
155189856|NCT02436304|560135583|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
155189857|NCT02436304|560135584|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
155189858|NCT01675427|560135593|FG000|Overall Study|Withdrawal by Subject|7|||
155189859|NCT01675427|560135593|FG000|Overall Study|Participant Refused Sample Collection|18|||
155189860|NCT01675427|560135593|FG000|Overall Study|Sample not Collected by Mistake|2|||
155189861|NCT01675427|560135593|FG000|Overall Study|Lost to Follow-up|5|||
155189862|NCT01675427|560135593|FG000|Overall Study|Other|2|||
155189863|NCT00369122|560135597|FG000|Overall Study|Ineligible|10|||
155189864|NCT00369122|560135597|FG000|Overall Study|No protocol treatment|1|||
155189865|NCT00408629|560135600|FG000|Overall Study|Adverse Event|13|||
155189866|NCT00408629|560135601|FG001|Overall Study|Adverse Event|27|||
155189867|NCT00408629|560135600|FG000|Overall Study|Withdrawal by Subject|8|||
155189868|NCT00408629|560135601|FG001|Overall Study|Withdrawal by Subject|4|||
155189869|NCT00408629|560135600|FG000|Overall Study|Lost to Follow-up|1|||
155189870|NCT00408629|560135601|FG001|Overall Study|Lost to Follow-up|1|||
155189871|NCT00408629|560135600|FG000|Overall Study|Lack of Efficacy|63|||
155189872|NCT00408629|560135601|FG001|Overall Study|Lack of Efficacy|73|||
155189873|NCT00408629|560135600|FG000|Overall Study|Protocol Violation|1|||
155189874|NCT00408629|560135601|FG001|Overall Study|Protocol Violation|5|||
155189875|NCT00408629|560135600|FG000|Overall Study|Miscellaneous|11|||
155189876|NCT00408629|560135601|FG001|Overall Study|Miscellaneous|15|||
155189877|NCT03633617|560135602|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
155189878|NCT03633617|560135603|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
155189879|NCT03633617|560135604|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189880|NCT03633617|560135605|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189881|NCT03633617|560135606|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189882|NCT03633617|560135607|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189883|NCT03633617|560135608|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189884|NCT03633617|560135609|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189885|NCT03633617|560135610|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189886|NCT03633617|560135611|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189887|NCT03633617|560135612|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189888|NCT03633617|560135602|FG000|Part A|Unconfirmed early termination visit|1|||
155189889|NCT03633617|560135603|FG001|Part A|Unconfirmed early termination visit|0|||
155189890|NCT03633617|560135604|FG002|Part A|Unconfirmed early termination visit|0|||
155189891|NCT03633617|560135605|FG003|Part A|Unconfirmed early termination visit|0|||
155189892|NCT03633617|560135606|FG004|Part A|Unconfirmed early termination visit|0|||
155189893|NCT03633617|560135607|FG005|Part A|Unconfirmed early termination visit|0|||
155189894|NCT03633617|560135608|FG006|Part A|Unconfirmed early termination visit|0|||
155720423|NCT02919761|562071692|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
155720424|NCT02919761|562071693|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
155720425|NCT02919761|562071691|FG000|Part 1: Open Label|Adverse Event|1|||
155189895|NCT03633617|560135609|FG007|Part A|Unconfirmed early termination visit|0|||
155189896|NCT03633617|560135610|FG008|Part A|Unconfirmed early termination visit|0|||
155189897|NCT03633617|560135611|FG009|Part A|Unconfirmed early termination visit|0|||
155189898|NCT03633617|560135612|FG010|Part A|Unconfirmed early termination visit|0|||
155189899|NCT03633617|560135602|FG000|Part A|Adverse Event|0|||
155189900|NCT03633617|560135603|FG001|Part A|Adverse Event|1|||
155189901|NCT03633617|560135604|FG002|Part A|Adverse Event|0|||
155189902|NCT03633617|560135605|FG003|Part A|Adverse Event|0|||
155189903|NCT03633617|560135606|FG004|Part A|Adverse Event|0|||
155189904|NCT03633617|560135607|FG005|Part A|Adverse Event|0|||
155189905|NCT03633617|560135608|FG006|Part A|Adverse Event|0|||
155189906|NCT03633617|560135609|FG007|Part A|Adverse Event|0|||
155189907|NCT03633617|560135610|FG008|Part A|Adverse Event|0|||
155189908|NCT03633617|560135611|FG009|Part A|Adverse Event|0|||
155189909|NCT03633617|560135612|FG010|Part A|Adverse Event|0|||
155189910|NCT03633617|560135602|FG000|Part A|Pregnancy|1|||
155189911|NCT03633617|560135603|FG001|Part A|Pregnancy|0|||
155189912|NCT03633617|560135604|FG002|Part A|Pregnancy|0|||
155189913|NCT03633617|560135605|FG003|Part A|Pregnancy|0|||
155189914|NCT03633617|560135606|FG004|Part A|Pregnancy|0|||
155189915|NCT03633617|560135607|FG005|Part A|Pregnancy|0|||
155189916|NCT03633617|560135608|FG006|Part A|Pregnancy|0|||
155189917|NCT03633617|560135609|FG007|Part A|Pregnancy|0|||
155189918|NCT03633617|560135610|FG008|Part A|Pregnancy|0|||
155189919|NCT03633617|560135611|FG009|Part A|Pregnancy|0|||
155189920|NCT03633617|560135612|FG010|Part A|Pregnancy|0|||
155189921|NCT03633617|560135602|FG000|Part A|Withdrawal by Subject|0|||
155189922|NCT03633617|560135603|FG001|Part A|Withdrawal by Subject|1|||
155189923|NCT03633617|560135604|FG002|Part A|Withdrawal by Subject|0|||
155189924|NCT03633617|560135605|FG003|Part A|Withdrawal by Subject|0|||
155189925|NCT03633617|560135606|FG004|Part A|Withdrawal by Subject|0|||
155189926|NCT03633617|560135607|FG005|Part A|Withdrawal by Subject|0|||
155189927|NCT03633617|560135608|FG006|Part A|Withdrawal by Subject|0|||
155189928|NCT03633617|560135609|FG007|Part A|Withdrawal by Subject|0|||
155189929|NCT03633617|560135610|FG008|Part A|Withdrawal by Subject|0|||
155189930|NCT03633617|560135611|FG009|Part A|Withdrawal by Subject|0|||
155189931|NCT03633617|560135612|FG010|Part A|Withdrawal by Subject|0|||
155189932|NCT03633617|560135602|FG000|Part B|Adverse Event|0|||
155189933|NCT03633617|560135603|FG001|Part B|Adverse Event|0|||
155189934|NCT03633617|560135604|FG002|Part B|Adverse Event|2|||
155189935|NCT03633617|560135605|FG003|Part B|Adverse Event|2|||
155189936|NCT03633617|560135606|FG004|Part B|Adverse Event|1|||
155189937|NCT03633617|560135607|FG005|Part B|Adverse Event|0|||
155189938|NCT03633617|560135608|FG006|Part B|Adverse Event|0|||
155189939|NCT03633617|560135609|FG007|Part B|Adverse Event|0|||
155189940|NCT03633617|560135610|FG008|Part B|Adverse Event|0|||
155189941|NCT03633617|560135611|FG009|Part B|Adverse Event|0|||
155189942|NCT03633617|560135612|FG010|Part B|Adverse Event|0|||
155189943|NCT03633617|560135602|FG000|Part B|Withdrawal by Subject|0|||
155189944|NCT03633617|560135603|FG001|Part B|Withdrawal by Subject|0|||
155189945|NCT03633617|560135604|FG002|Part B|Withdrawal by Subject|1|||
155189946|NCT03633617|560135605|FG003|Part B|Withdrawal by Subject|0|||
155189947|NCT03633617|560135606|FG004|Part B|Withdrawal by Subject|2|||
155189948|NCT03633617|560135607|FG005|Part B|Withdrawal by Subject|0|||
155189949|NCT03633617|560135608|FG006|Part B|Withdrawal by Subject|0|||
155720426|NCT02919761|562071692|FG001|Part 1: Open Label|Adverse Event|0|||
155189950|NCT03633617|560135609|FG007|Part B|Withdrawal by Subject|0|||
155189951|NCT03633617|560135610|FG008|Part B|Withdrawal by Subject|0|||
155189952|NCT03633617|560135611|FG009|Part B|Withdrawal by Subject|0|||
155189953|NCT03633617|560135612|FG010|Part B|Withdrawal by Subject|0|||
155189954|NCT03633617|560135602|FG000|Part B|Lost to Follow-up|0|||
155189955|NCT03633617|560135603|FG001|Part B|Lost to Follow-up|0|||
155189956|NCT03633617|560135604|FG002|Part B|Lost to Follow-up|0|||
155189957|NCT03633617|560135605|FG003|Part B|Lost to Follow-up|0|||
155189958|NCT03633617|560135606|FG004|Part B|Lost to Follow-up|1|||
155189959|NCT03633617|560135607|FG005|Part B|Lost to Follow-up|0|||
155189960|NCT03633617|560135608|FG006|Part B|Lost to Follow-up|0|||
155189961|NCT03633617|560135609|FG007|Part B|Lost to Follow-up|0|||
155189962|NCT03633617|560135610|FG008|Part B|Lost to Follow-up|0|||
155189963|NCT03633617|560135611|FG009|Part B|Lost to Follow-up|0|||
155189964|NCT03633617|560135612|FG010|Part B|Lost to Follow-up|0|||
155189965|NCT03633617|560135602|FG000|Part B|Physician Decision|0|||
155189966|NCT03633617|560135603|FG001|Part B|Physician Decision|0|||
155189967|NCT03633617|560135604|FG002|Part B|Physician Decision|0|||
155189968|NCT03633617|560135605|FG003|Part B|Physician Decision|0|||
155189969|NCT03633617|560135606|FG004|Part B|Physician Decision|1|||
155189970|NCT03633617|560135607|FG005|Part B|Physician Decision|0|||
155189971|NCT03633617|560135608|FG006|Part B|Physician Decision|0|||
155189972|NCT03633617|560135609|FG007|Part B|Physician Decision|0|||
155189973|NCT03633617|560135610|FG008|Part B|Physician Decision|0|||
155189974|NCT03633617|560135611|FG009|Part B|Physician Decision|0|||
155189975|NCT03633617|560135612|FG010|Part B|Physician Decision|0|||
155189976|NCT03633617|560135602|FG000|Part B|COVID-19 Restrictions|0|||
155189977|NCT03633617|560135603|FG001|Part B|COVID-19 Restrictions|0|||
155189978|NCT03633617|560135604|FG002|Part B|COVID-19 Restrictions|1|||
155189979|NCT03633617|560135605|FG003|Part B|COVID-19 Restrictions|0|||
155189980|NCT03633617|560135606|FG004|Part B|COVID-19 Restrictions|0|||
155189981|NCT03633617|560135607|FG005|Part B|COVID-19 Restrictions|0|||
155189982|NCT03633617|560135608|FG006|Part B|COVID-19 Restrictions|0|||
155189983|NCT03633617|560135609|FG007|Part B|COVID-19 Restrictions|0|||
155189984|NCT03633617|560135610|FG008|Part B|COVID-19 Restrictions|0|||
155189985|NCT03633617|560135611|FG009|Part B|COVID-19 Restrictions|0|||
155189986|NCT03633617|560135612|FG010|Part B|COVID-19 Restrictions|0|||
155189987|NCT03633617|560135602|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189988|NCT03633617|560135603|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189989|NCT03633617|560135604|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
155189990|NCT03633617|560135605|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189991|NCT03633617|560135606|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189992|NCT03633617|560135607|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189993|NCT03633617|560135608|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189994|NCT03633617|560135609|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189995|NCT03633617|560135610|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189996|NCT03633617|560135611|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189997|NCT03633617|560135612|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189998|NCT03633617|560135602|FG000|Part C (& Follow-up)|Adverse Event|0|||
155189999|NCT03633617|560135603|FG001|Part C (& Follow-up)|Adverse Event|0|||
155190000|NCT03633617|560135604|FG002|Part C (& Follow-up)|Adverse Event|0|||
155190001|NCT03633617|560135605|FG003|Part C (& Follow-up)|Adverse Event|0|||
155190002|NCT03633617|560135606|FG004|Part C (& Follow-up)|Adverse Event|0|||
155190003|NCT03633617|560135607|FG005|Part C (& Follow-up)|Adverse Event|1|||
155190004|NCT03633617|560135608|FG006|Part C (& Follow-up)|Adverse Event|0|||
155190005|NCT03633617|560135609|FG007|Part C (& Follow-up)|Adverse Event|1|||
155190006|NCT03633617|560135610|FG008|Part C (& Follow-up)|Adverse Event|0|||
155190007|NCT03633617|560135611|FG009|Part C (& Follow-up)|Adverse Event|0|||
155190008|NCT03633617|560135612|FG010|Part C (& Follow-up)|Adverse Event|0|||
155190009|NCT03633617|560135602|FG000|Part C (& Follow-up)|Pregnancy|0|||
155190010|NCT03633617|560135603|FG001|Part C (& Follow-up)|Pregnancy|0|||
155190011|NCT03633617|560135604|FG002|Part C (& Follow-up)|Pregnancy|0|||
155190012|NCT03633617|560135605|FG003|Part C (& Follow-up)|Pregnancy|0|||
155190013|NCT03633617|560135606|FG004|Part C (& Follow-up)|Pregnancy|0|||
155190014|NCT03633617|560135607|FG005|Part C (& Follow-up)|Pregnancy|0|||
155190015|NCT03633617|560135608|FG006|Part C (& Follow-up)|Pregnancy|0|||
155190016|NCT03633617|560135609|FG007|Part C (& Follow-up)|Pregnancy|0|||
155190017|NCT03633617|560135610|FG008|Part C (& Follow-up)|Pregnancy|0|||
155190018|NCT03633617|560135611|FG009|Part C (& Follow-up)|Pregnancy|1|||
155190019|NCT03633617|560135612|FG010|Part C (& Follow-up)|Pregnancy|0|||
155190020|NCT03633617|560135602|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190021|NCT03633617|560135603|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190022|NCT03633617|560135604|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
155720427|NCT02919761|562071693|FG002|Part 1: Open Label|Adverse Event|0|||
155720428|NCT02919761|562071691|FG000|Part 1: Open Label|Lost to Follow-up|1|||
155720429|NCT02919761|562071692|FG001|Part 1: Open Label|Lost to Follow-up|0|||
155190023|NCT03633617|560135605|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190024|NCT03633617|560135606|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190025|NCT03633617|560135607|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
155190026|NCT03633617|560135608|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
155190027|NCT03633617|560135609|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190028|NCT03633617|560135610|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
155190029|NCT03633617|560135611|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
155190030|NCT03633617|560135612|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
155190031|NCT03633617|560135602|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
155190032|NCT03633617|560135603|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
155720430|NCT02919761|562071693|FG002|Part 1: Open Label|Lost to Follow-up|0|||
155190033|NCT03633617|560135604|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
155190034|NCT03633617|560135605|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
155190035|NCT03633617|560135606|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
155190036|NCT03633617|560135607|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
155190037|NCT03633617|560135608|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
155190038|NCT03633617|560135609|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
155190039|NCT03633617|560135610|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
155190040|NCT03633617|560135611|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
155190041|NCT03633617|560135612|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
155190042|NCT03633617|560135602|FG000|Part C (& Follow-up)|Physician Decision|0|||
155190043|NCT03633617|560135603|FG001|Part C (& Follow-up)|Physician Decision|0|||
155190044|NCT03633617|560135604|FG002|Part C (& Follow-up)|Physician Decision|0|||
155190045|NCT03633617|560135605|FG003|Part C (& Follow-up)|Physician Decision|0|||
155190046|NCT03633617|560135606|FG004|Part C (& Follow-up)|Physician Decision|0|||
155190047|NCT03633617|560135607|FG005|Part C (& Follow-up)|Physician Decision|0|||
155190048|NCT03633617|560135608|FG006|Part C (& Follow-up)|Physician Decision|0|||
155190049|NCT03633617|560135609|FG007|Part C (& Follow-up)|Physician Decision|1|||
155190050|NCT03633617|560135610|FG008|Part C (& Follow-up)|Physician Decision|0|||
155190051|NCT03633617|560135611|FG009|Part C (& Follow-up)|Physician Decision|0|||
155720431|NCT02919761|562071691|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
155720432|NCT02919761|562071692|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
155720433|NCT02919761|562071693|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
155720434|NCT02919761|562071691|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
155720435|NCT02919761|562071692|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
155720436|NCT02919761|562071693|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
155720437|NCT02919761|562071691|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
155720438|NCT02919761|562071692|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
155720439|NCT02919761|562071693|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
155720440|NCT02919761|562071691|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
155720441|NCT02919761|562071692|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
155720442|NCT02919761|562071693|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
155720443|NCT02919761|562071691|FG000|Part 1: Open Label|Termination by Sponsor|1|||
155720444|NCT02919761|562071692|FG001|Part 1: Open Label|Termination by Sponsor|0|||
155720445|NCT02919761|562071693|FG002|Part 1: Open Label|Termination by Sponsor|0|||
155720446|NCT02919761|562071691|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
155720447|NCT02919761|562071692|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
155720448|NCT02919761|562071693|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
155720449|NCT02919761|562071691|FG000|Part 2: Double-blind|Adverse Event|0|||
155720450|NCT02919761|562071692|FG001|Part 2: Double-blind|Adverse Event|1|||
155720451|NCT02919761|562071693|FG002|Part 2: Double-blind|Adverse Event|0|||
155720452|NCT02919761|562071691|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
155720453|NCT02919761|562071692|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
155720454|NCT02919761|562071693|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
155720455|NCT02919761|562071691|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
155720456|NCT02919761|562071692|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
155720457|NCT02919761|562071693|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
155720458|NCT02919761|562071691|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
155720459|NCT02919761|562071692|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
155720460|NCT02919761|562071693|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
155720461|NCT02919761|562071691|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
155720462|NCT02919761|562071692|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
155720463|NCT02919761|562071693|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
155720464|NCT02919761|562071691|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
155720465|NCT02919761|562071692|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
155720466|NCT02919761|562071693|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
155720467|NCT02919761|562071691|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
155190052|NCT03633617|560135612|FG010|Part C (& Follow-up)|Physician Decision|1|||
155190053|NCT03633617|560135602|FG000|Part C (& Follow-up)|COVID-19 related|0|||
155190054|NCT03633617|560135603|FG001|Part C (& Follow-up)|COVID-19 related|0|||
155720468|NCT02919761|562071692|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
155190055|NCT03633617|560135604|FG002|Part C (& Follow-up)|COVID-19 related|0|||
155190056|NCT03633617|560135605|FG003|Part C (& Follow-up)|COVID-19 related|0|||
155190057|NCT03633617|560135606|FG004|Part C (& Follow-up)|COVID-19 related|0|||
155190058|NCT03633617|560135607|FG005|Part C (& Follow-up)|COVID-19 related|1|||
155190059|NCT03633617|560135608|FG006|Part C (& Follow-up)|COVID-19 related|0|||
155720469|NCT02919761|562071693|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
155720470|NCT00410956|562071694|FG000|Overall Study|Adverse Event|1|||
155720471|NCT00410956|562071694|FG000|Overall Study|Death|2|||
155720472|NCT00410956|562071694|FG000|Overall Study|Lack of Efficacy|10|||
155190060|NCT03633617|560135609|FG007|Part C (& Follow-up)|COVID-19 related|0|||
155190061|NCT03633617|560135610|FG008|Part C (& Follow-up)|COVID-19 related|0|||
155190062|NCT03633617|560135611|FG009|Part C (& Follow-up)|COVID-19 related|0|||
155190063|NCT03633617|560135612|FG010|Part C (& Follow-up)|COVID-19 related|0|||
155190064|NCT03633617|560135602|FG000|Part C (& Follow-up)|Protocol Violation|0|||
155190065|NCT03633617|560135603|FG001|Part C (& Follow-up)|Protocol Violation|0|||
155720473|NCT00410956|562071694|FG000|Overall Study|Physician Decision|6|||
155720474|NCT03760029|562073459|FG000|Overall Study|Death|1|||
155190066|NCT03633617|560135604|FG002|Part C (& Follow-up)|Protocol Violation|0|||
155190067|NCT03633617|560135605|FG003|Part C (& Follow-up)|Protocol Violation|0|||
155190068|NCT03633617|560135606|FG004|Part C (& Follow-up)|Protocol Violation|0|||
155190069|NCT03633617|560135607|FG005|Part C (& Follow-up)|Protocol Violation|0|||
155190070|NCT03633617|560135608|FG006|Part C (& Follow-up)|Protocol Violation|0|||
155190071|NCT03633617|560135609|FG007|Part C (& Follow-up)|Protocol Violation|0|||
155190072|NCT03633617|560135610|FG008|Part C (& Follow-up)|Protocol Violation|0|||
155190073|NCT03633617|560135611|FG009|Part C (& Follow-up)|Protocol Violation|3|||
155190074|NCT03633617|560135612|FG010|Part C (& Follow-up)|Protocol Violation|1|||
155190075|NCT03633617|560135602|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
155190076|NCT03633617|560135603|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
155190077|NCT03633617|560135604|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
155190078|NCT03633617|560135605|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
155190079|NCT03633617|560135606|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
155190080|NCT03633617|560135607|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
155190081|NCT03633617|560135608|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
155190082|NCT03633617|560135609|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
155190083|NCT03633617|560135610|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
155190084|NCT03633617|560135611|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
155190085|NCT03633617|560135612|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
155190086|NCT02477839|560135613|FG000|Overall Study|Adverse Event|0|||
155190087|NCT02477839|560135614|FG001|Overall Study|Adverse Event|1|||
155190088|NCT02477839|560135613|FG000|Overall Study|Protocol Violation|0|||
155190089|NCT02477839|560135614|FG001|Overall Study|Protocol Violation|2|||
155190090|NCT02477839|560135613|FG000|Overall Study|Withdrawal by Subject|3|||
155190091|NCT02477839|560135614|FG001|Overall Study|Withdrawal by Subject|3|||
155190092|NCT02477839|560135613|FG000|Overall Study|Participant had PGS during V6|0|||
155190093|NCT02477839|560135614|FG001|Overall Study|Participant had PGS during V6|1|||
155190094|NCT02477839|560135613|FG000|Overall Study|Parents decided to stop medication|0|||
155190095|NCT02477839|560135614|FG001|Overall Study|Parents decided to stop medication|1|||
155190096|NCT02477839|560135613|FG000|Overall Study|Lack of tolerability|0|||
155190097|NCT02477839|560135614|FG001|Overall Study|Lack of tolerability|1|||
155190098|NCT02477839|560135613|FG000|Overall Study|Exclusion criterion|0|||
155190099|NCT02477839|560135614|FG001|Overall Study|Exclusion criterion|1|||
155190100|NCT01578330|560135615|FG000|Overall Study|Adverse Event|2|||
155190101|NCT01578330|560135615|FG000|Overall Study|Protocol Violation|5|||
155190102|NCT01050543|560135616|FG000|Overall Study|Withdrawal by Subject|0|||
155190103|NCT01050543|560135617|FG001|Overall Study|Withdrawal by Subject|2|||
155190104|NCT01050543|560135616|FG000|Overall Study|Protocol Violation|0|||
155190105|NCT01050543|560135617|FG001|Overall Study|Protocol Violation|1|||
155190106|NCT01050543|560135616|FG000|Overall Study|Administrative|4|||
155190107|NCT01050543|560135617|FG001|Overall Study|Administrative|1|||
155190108|NCT03053271|560135618|FG000|Overall Study|Did not meet randomization criteria|3|||
155190109|NCT03053271|560135618|FG000|Overall Study|Withdrawal by Subject|1|||
155190110|NCT00580970|560135619|FG000|Pre-treatment|Non-compliance|1|||
155190111|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Non-compliance|6|||
155190112|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
155190113|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Physician Decision|4|||
155190114|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
155190115|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Death|1|||
155190116|NCT00570765|560135622|FG000|DB Phase|Withdrawal by Subject|1|||
155190117|NCT00570765|560135623|FG001|DB Phase|Withdrawal by Subject|0|||
155190118|NCT00570765|560135624|FG002|DB Phase|Withdrawal by Subject|0|||
155190119|NCT00570765|560135625|FG003|DB Phase|Withdrawal by Subject|0|||
155190120|NCT00570765|560135622|FG000|DB Phase|Protocol Violation|0|||
155190121|NCT00570765|560135623|FG001|DB Phase|Protocol Violation|1|||
155190122|NCT00570765|560135624|FG002|DB Phase|Protocol Violation|0|||
155190123|NCT00570765|560135625|FG003|DB Phase|Protocol Violation|0|||
155190124|NCT00570765|560135622|FG000|DB Phase|Adverse Event|3|||
155190125|NCT00570765|560135623|FG001|DB Phase|Adverse Event|6|||
155190126|NCT00570765|560135624|FG002|DB Phase|Adverse Event|0|||
155190127|NCT00570765|560135625|FG003|DB Phase|Adverse Event|0|||
155190128|NCT00570765|560135622|FG000|DB Phase|Did Not Receive Study Drug|0|||
155190129|NCT00570765|560135623|FG001|DB Phase|Did Not Receive Study Drug|0|||
155190130|NCT00570765|560135624|FG002|DB Phase|Did Not Receive Study Drug|1|||
155190131|NCT00570765|560135625|FG003|DB Phase|Did Not Receive Study Drug|0|||
155190132|NCT00570765|560135622|FG000|LTSE Phase|Withdrawal by Subject|0|||
155190133|NCT00570765|560135623|FG001|LTSE Phase|Withdrawal by Subject|0|||
155190134|NCT00570765|560135624|FG002|LTSE Phase|Withdrawal by Subject|0|||
155190135|NCT00570765|560135625|FG003|LTSE Phase|Withdrawal by Subject|1|||
155190136|NCT00570765|560135622|FG000|LTSE Phase|Adverse Event|0|||
155190137|NCT00570765|560135623|FG001|LTSE Phase|Adverse Event|0|||
155190138|NCT00570765|560135624|FG002|LTSE Phase|Adverse Event|0|||
155190139|NCT00570765|560135625|FG003|LTSE Phase|Adverse Event|7|||
155190140|NCT00570765|560135622|FG000|LTSE Phase|Physician Decision|0|||
155190141|NCT00570765|560135623|FG001|LTSE Phase|Physician Decision|0|||
155190142|NCT00570765|560135624|FG002|LTSE Phase|Physician Decision|0|||
155190143|NCT00570765|560135625|FG003|LTSE Phase|Physician Decision|4|||
155190144|NCT01669928|560135626|FG000|First Intervention|Withdrawal by Subject|3|||
155190145|NCT01669928|560135627|FG001|First Intervention|Withdrawal by Subject|5|||
155190146|NCT00057876|560135630|FG000|Overall Study|Adverse Event|8|||
155190147|NCT00057876|560135631|FG001|Overall Study|Adverse Event|8|||
155190148|NCT00057876|560135630|FG000|Overall Study|Death|2|||
155190149|NCT00057876|560135631|FG001|Overall Study|Death|1|||
155190150|NCT00057876|560135630|FG000|Overall Study|Withdrawal by Subject|5|||
155190151|NCT00057876|560135631|FG001|Overall Study|Withdrawal by Subject|6|||
155190152|NCT00057876|560135630|FG000|Overall Study|Lack of Efficacy|10|||
155190153|NCT00057876|560135631|FG001|Overall Study|Lack of Efficacy|8|||
155190154|NCT00057876|560135630|FG000|Overall Study|Ineligible|1|||
155190155|NCT00057876|560135631|FG001|Overall Study|Ineligible|2|||
155190156|NCT00057876|560135630|FG000|Overall Study|other reason|2|||
155190157|NCT00057876|560135631|FG001|Overall Study|other reason|2|||
155190158|NCT00057876|560135630|FG000|Overall Study|other complicating disease|1|||
155190159|NCT00057876|560135631|FG001|Overall Study|other complicating disease|0|||
155190160|NCT02758171|560135632|FG000|Wash-out|Withdrawal by Subject|1|||
155190161|NCT02758171|560135633|FG001|Wash-out|Withdrawal by Subject|0|||
155190162|NCT02758171|560135632|FG000|Wash-out|Other reason|1|||
155190163|NCT02758171|560135633|FG001|Wash-out|Other reason|0|||
155190164|NCT05085730|560135639|FG000|Overall Study|Withdrawal by Subject|4|||
155190165|NCT05085730|560135639|FG000|Overall Study|Physician Decision|1|||
155190166|NCT05447897|560135640|FG000|Overall Study|Did not participate in survey|2|||
155190167|NCT04010539|560135641|FG000|Overall Study|Withdrawal by Subject|4|||
155190168|NCT04010539|560135642|FG001|Overall Study|Withdrawal by Subject|1|||
155190169|NCT04010539|560135641|FG000|Overall Study|Physician Decision|0|||
155190170|NCT04010539|560135642|FG001|Overall Study|Physician Decision|2|||
155190171|NCT04010539|560135641|FG000|Overall Study|Lost to Follow-up|10|||
155190172|NCT04010539|560135642|FG001|Overall Study|Lost to Follow-up|14|||
155190173|NCT04010539|560135641|FG000|Overall Study|Adverse Event|3|||
155190174|NCT04010539|560135642|FG001|Overall Study|Adverse Event|0|||
155190175|NCT04010539|560135641|FG000|Overall Study|Participant Did Not Receive IP|0|||
155190176|NCT04010539|560135642|FG001|Overall Study|Participant Did Not Receive IP|1|||
155190177|NCT04010539|560135641|FG000|Overall Study|Protocol Deviation|0|||
155190178|NCT04010539|560135642|FG001|Overall Study|Protocol Deviation|1|||
155190179|NCT04010539|560135641|FG000|Overall Study|Randomized in Error/ Mistake|2|||
155190180|NCT04010539|560135642|FG001|Overall Study|Randomized in Error/ Mistake|0|||
155190181|NCT04010539|560135641|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
155190182|NCT04010539|560135642|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
155190183|NCT02038452|560135643|FG000|Overall Study|Withdrawal by Subject|7|||
155190184|NCT02038452|560135644|FG001|Overall Study|Withdrawal by Subject|9|||
155190185|NCT02038452|560135643|FG000|Overall Study|Lost to Follow-up|31|||
155720475|NCT03760029|562073460|FG001|Overall Study|Death|0|||
155720476|NCT03760029|562073461|FG002|Overall Study|Death|0|||
155720477|NCT03760029|562073459|FG000|Overall Study|Lost to Follow-up|0|||
155720478|NCT03760029|562073460|FG001|Overall Study|Lost to Follow-up|2|||
155720479|NCT03760029|562073461|FG002|Overall Study|Lost to Follow-up|1|||
155720480|NCT03760029|562073459|FG000|Overall Study|Withdrawal by Subject|1|||
155720481|NCT03760029|562073460|FG001|Overall Study|Withdrawal by Subject|4|||
155720482|NCT03760029|562073461|FG002|Overall Study|Withdrawal by Subject|1|||
155720483|NCT03760029|562073459|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155720484|NCT03760029|562073460|FG001|Overall Study|Withdrawal by parent/guardian|4|||
155720485|NCT03760029|562073461|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155720486|NCT03760029|562073459|FG000|Overall Study|Other|2|||
155720487|NCT03760029|562073460|FG001|Overall Study|Other|1|||
155190186|NCT02038452|560135644|FG001|Overall Study|Lost to Follow-up|28|||
155190187|NCT03139279|560135645|FG000|Overall Study|Physician Decision|2|||
155190188|NCT03139279|560135646|FG001|Overall Study|Physician Decision|0|||
155190189|NCT03139279|560135645|FG000|Overall Study|Protocol Violation|5|||
155190190|NCT03139279|560135646|FG001|Overall Study|Protocol Violation|4|||
155190191|NCT03139279|560135645|FG000|Overall Study|Withdrawal by Subject|0|||
155190192|NCT03139279|560135646|FG001|Overall Study|Withdrawal by Subject|2|||
155190193|NCT01565642|560135649|FG000|Overall Study|Withdrawal by Subject|2|||
155720488|NCT03760029|562073461|FG002|Overall Study|Other|0|||
155720489|NCT03305666|562073464|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
155190194|NCT01565642|560135650|FG001|Overall Study|Withdrawal by Subject|1|||
155190195|NCT01934972|560135651|FG000|Overall Study|Withdrawal by Subject|9|||
155190196|NCT01934972|560135652|FG001|Overall Study|Withdrawal by Subject|6|||
155190197|NCT01278160|560135653|FG000|Overall Study|Adverse Event|1|||
155190198|NCT01278160|560135654|FG001|Overall Study|Adverse Event|1|||
155190199|NCT01278160|560135653|FG000|Overall Study|Lost to Follow-up|0|||
155190200|NCT01278160|560135654|FG001|Overall Study|Lost to Follow-up|1|||
155190201|NCT01278160|560135653|FG000|Overall Study|Withdrawal by Subject|3|||
155190202|NCT01278160|560135654|FG001|Overall Study|Withdrawal by Subject|2|||
155190203|NCT01278160|560135653|FG000|Overall Study|Unclassified|1|||
155190204|NCT01278160|560135654|FG001|Overall Study|Unclassified|2|||
155190205|NCT00304239|560135656|FG000|Overall Study|Protocol Deviations/Violations|15|||
155190206|NCT00304239|560135657|FG001|Overall Study|Protocol Deviations/Violations|0|||
155190207|NCT00304239|560135656|FG000|Overall Study|Adverse Event|2|||
155190208|NCT00304239|560135657|FG001|Overall Study|Adverse Event|0|||
155190209|NCT01631812|560135658|FG000|Overall Study|Adverse Event|25|||
155190210|NCT01631812|560135658|FG000|Overall Study|Lack of Efficacy|5|||
155190211|NCT01631812|560135658|FG000|Overall Study|Withdrawal by Subject|4|||
155190212|NCT01631812|560135658|FG000|Overall Study|Physician Decision|3|||
155190213|NCT02718300|560135661|FG000|Overall Study|Death|4|||
155190214|NCT02718300|560135662|FG001|Overall Study|Death|5|||
155190215|NCT02718300|560135663|FG002|Overall Study|Death|17|||
155190216|NCT02718300|560135661|FG000|Overall Study|Lost to Follow-up|1|||
155190217|NCT02718300|560135662|FG001|Overall Study|Lost to Follow-up|0|||
155190218|NCT02718300|560135663|FG002|Overall Study|Lost to Follow-up|2|||
155190219|NCT02718300|560135661|FG000|Overall Study|Physician Decision|1|||
155190220|NCT02718300|560135662|FG001|Overall Study|Physician Decision|0|||
155190221|NCT02718300|560135663|FG002|Overall Study|Physician Decision|2|||
155190222|NCT02718300|560135661|FG000|Overall Study|Study Terminated by Sponsor|6|||
155190223|NCT02718300|560135662|FG001|Overall Study|Study Terminated by Sponsor|3|||
155190224|NCT02718300|560135663|FG002|Overall Study|Study Terminated by Sponsor|4|||
155190225|NCT02718300|560135661|FG000|Overall Study|Withdrawal by Subject|0|||
155190226|NCT02718300|560135662|FG001|Overall Study|Withdrawal by Subject|4|||
155190227|NCT02718300|560135663|FG002|Overall Study|Withdrawal by Subject|3|||
155720490|NCT03305666|562073465|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
155720491|NCT01001221|562073466|FG000|Overall Study|Adverse Event|1|||
155720492|NCT01001221|562073467|FG001|Overall Study|Adverse Event|2|||
155720493|NCT01001221|562073468|FG002|Overall Study|Adverse Event|0|||
155720494|NCT01001221|562073469|FG003|Overall Study|Adverse Event|2|||
155720495|NCT01001221|562073470|FG004|Overall Study|Adverse Event|0|||
155720496|NCT01001221|562073466|FG000|Overall Study|Disease progression|3|||
155190228|NCT02718300|560135661|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
155190229|NCT02718300|560135662|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
155190230|NCT02718300|560135663|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
155190231|NCT01858376|560137195|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
155190232|NCT03894046|560137199|FG000|Overall Study|Protocol Violation|1|||
155190233|NCT03894046|560137200|FG001|Overall Study|Protocol Violation|0|||
155190234|NCT03894046|560137201|FG002|Overall Study|Protocol Violation|0|||
155190235|NCT03894046|560137199|FG000|Overall Study|Adverse Event|0|||
155190236|NCT03894046|560137200|FG001|Overall Study|Adverse Event|1|||
155190237|NCT03894046|560137201|FG002|Overall Study|Adverse Event|0|||
155190238|NCT03894046|560137199|FG000|Overall Study|Withdrawal by Subject|2|||
155190239|NCT03894046|560137200|FG001|Overall Study|Withdrawal by Subject|3|||
155190240|NCT03894046|560137201|FG002|Overall Study|Withdrawal by Subject|1|||
155190241|NCT03894046|560137199|FG000|Overall Study|Death|15|||
155190242|NCT03894046|560137200|FG001|Overall Study|Death|21|||
155190243|NCT03894046|560137201|FG002|Overall Study|Death|4|||
155190244|NCT03894046|560137199|FG000|Overall Study|No growth of ABC|2|||
155190245|NCT03894046|560137200|FG001|Overall Study|No growth of ABC|1|||
155190246|NCT03894046|560137201|FG002|Overall Study|No growth of ABC|0|||
155190247|NCT03894046|560137199|FG000|Overall Study|Physician Decision|1|||
155190248|NCT03894046|560137200|FG001|Overall Study|Physician Decision|1|||
155190249|NCT03894046|560137201|FG002|Overall Study|Physician Decision|1|||
155190250|NCT03894046|560137199|FG000|Overall Study|Prohibited concomitant medication|1|||
155190251|NCT03894046|560137200|FG001|Overall Study|Prohibited concomitant medication|0|||
155190252|NCT03894046|560137201|FG002|Overall Study|Prohibited concomitant medication|0|||
155190253|NCT03894046|560137199|FG000|Overall Study|Transferred to other arm/group|1|||
155190254|NCT03894046|560137200|FG001|Overall Study|Transferred to other arm/group|1|||
155190255|NCT03894046|560137201|FG002|Overall Study|Transferred to other arm/group|0|||
155190256|NCT02202837|560137207|FG000|Overall Study|Enbrel treatment discontinued|36|||
155190257|NCT02202837|560137208|FG001|Overall Study|Enbrel treatment discontinued|4|||
155190258|NCT02202837|560137207|FG000|Overall Study|Other|10|||
155190259|NCT02202837|560137208|FG001|Overall Study|Other|0|||
155190260|NCT02202837|560137207|FG000|Overall Study|Lost to Follow-up|7|||
155190261|NCT02202837|560137208|FG001|Overall Study|Lost to Follow-up|1|||
155720497|NCT01001221|562073467|FG001|Overall Study|Disease progression|2|||
155190262|NCT01890746|560137213|FG000|Overall Study|Death|39|||
155190263|NCT01890746|560137214|FG001|Overall Study|Death|30|||
155190264|NCT01890746|560137213|FG000|Overall Study|Adverse Event|1|||
155190265|NCT01890746|560137214|FG001|Overall Study|Adverse Event|0|||
155190266|NCT01890746|560137213|FG000|Overall Study|Lost to Follow-up|4|||
155190267|NCT01890746|560137214|FG001|Overall Study|Lost to Follow-up|1|||
155190268|NCT01890746|560137213|FG000|Overall Study|Physician Decision|3|||
155190269|NCT01890746|560137214|FG001|Overall Study|Physician Decision|2|||
155190270|NCT01890746|560137213|FG000|Overall Study|Withdrawal by Subject|5|||
155190271|NCT01890746|560137214|FG001|Overall Study|Withdrawal by Subject|8|||
155190272|NCT03257371|560137217|FG000|Overall Study|Lost to Follow-up|1|||
155190273|NCT01031706|560137219|FG000|Overall Study|Adverse Event|1|||
155190274|NCT01031706|560137220|FG001|Overall Study|Adverse Event|0|||
155190275|NCT01031706|560137219|FG000|Overall Study|Withdrawal by Subject|1|||
155190276|NCT01031706|560137220|FG001|Overall Study|Withdrawal by Subject|1|||
155190277|NCT02124161|560137221|FG000|Overall Study|Other unspecified|0|||
155190278|NCT02124161|560137222|FG001|Overall Study|Other unspecified|1|||
155190279|NCT02124161|560137221|FG000|Overall Study|Death|1|||
155190280|NCT02124161|560137222|FG001|Overall Study|Death|0|||
155190281|NCT02124161|560137221|FG000|Overall Study|Protocol Violation|2|||
155190282|NCT02124161|560137222|FG001|Overall Study|Protocol Violation|1|||
155190283|NCT02124161|560137221|FG000|Overall Study|Withdrawal by Subject|1|||
155190284|NCT02124161|560137222|FG001|Overall Study|Withdrawal by Subject|2|||
155190285|NCT02124161|560137221|FG000|Overall Study|Adverse Event|2|||
155190286|NCT02124161|560137222|FG001|Overall Study|Adverse Event|0|||
155190287|NCT02124161|560137221|FG000|Overall Study|Does not meet entrance criteria|2|||
155190288|NCT02124161|560137222|FG001|Overall Study|Does not meet entrance criteria|3|||
155190289|NCT02124161|560137221|FG000|Overall Study|No longer meets eligibility criteria|5|||
155190290|NCT02124161|560137222|FG001|Overall Study|No longer meets eligibility criteria|4|||
155190291|NCT02124161|560137221|FG000|Overall Study|Lost to Follow-up|3|||
155190292|NCT02124161|560137222|FG001|Overall Study|Lost to Follow-up|4|||
155190293|NCT02517866|560137223|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155190294|NCT02517866|560137224|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155190295|NCT02517866|560137225|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155190296|NCT02517866|560137223|FG000|Overall Study|Significant Protocol Deviation|4|||
155190297|NCT02517866|560137224|FG001|Overall Study|Significant Protocol Deviation|1|||
155190298|NCT02517866|560137225|FG002|Overall Study|Significant Protocol Deviation|0|||
155190299|NCT02517866|560137223|FG000|Overall Study|Lost to Follow-up|1|||
155190300|NCT02517866|560137224|FG001|Overall Study|Lost to Follow-up|0|||
155190301|NCT02517866|560137225|FG002|Overall Study|Lost to Follow-up|0|||
155190302|NCT02517866|560137223|FG000|Overall Study|Voluntary Withdrawal|2|||
155190303|NCT02517866|560137224|FG001|Overall Study|Voluntary Withdrawal|2|||
155190304|NCT02517866|560137225|FG002|Overall Study|Voluntary Withdrawal|0|||
155190305|NCT02517866|560137223|FG000|Overall Study|Investigator Decision|2|||
155190306|NCT02517866|560137224|FG001|Overall Study|Investigator Decision|1|||
155190307|NCT02517866|560137225|FG002|Overall Study|Investigator Decision|0|||
155190308|NCT02517866|560137223|FG000|Overall Study|Reason not specified|2|||
155190309|NCT02517866|560137224|FG001|Overall Study|Reason not specified|0|||
155190310|NCT02517866|560137225|FG002|Overall Study|Reason not specified|0|||
155190311|NCT03114488|560137226|FG000|Time Period 2|Withdrawal by Subject|1|||
155190312|NCT03114488|560137227|FG001|Time Period 2|Withdrawal by Subject|3|||
155190313|NCT03711266|560137229|FG000|Overall Study|Lost to Follow-up|10|||
155190314|NCT03387683|560137230|FG000|Overall Study|In receipt of disallowed medication|1|||
155190315|NCT03387683|560137231|FG001|Overall Study|In receipt of disallowed medication|0|||
155190316|NCT03387683|560137230|FG000|Overall Study|Did not receive treatment|1|||
155190317|NCT03387683|560137231|FG001|Overall Study|Did not receive treatment|0|||
155190318|NCT01646073|560137232|FG000|Period A (12 Weeks)|Adverse Event|0|||
155190319|NCT01646073|560137233|FG001|Period A (12 Weeks)|Adverse Event|2|||
155190320|NCT01646073|560137232|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
155190321|NCT01646073|560137233|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
155190322|NCT01646073|560137232|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
155190323|NCT01646073|560137233|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
155190324|NCT01646073|560137232|FG000|Period A (12 Weeks)|Protocol Violation|0|||
155190325|NCT01646073|560137233|FG001|Period A (12 Weeks)|Protocol Violation|1|||
155190326|NCT01646073|560137232|FG000|Period A (12 Weeks)|Other|0|||
155190327|NCT01646073|560137233|FG001|Period A (12 Weeks)|Other|1|||
155190328|NCT01646073|560137232|FG000|Period B (12 Weeks)|Adverse Event|0|||
155190329|NCT01646073|560137233|FG001|Period B (12 Weeks)|Adverse Event|7|||
155190330|NCT01646073|560137232|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
155190331|NCT01646073|560137233|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
155190332|NCT01646073|560137232|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
155190333|NCT01646073|560137233|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
155190334|NCT01393301|560137236|FG000|Overall Study|Lost to Follow-up|5|||
155190335|NCT01393301|560137237|FG001|Overall Study|Lost to Follow-up|3|||
155190336|NCT01393301|560137236|FG000|Overall Study|Withdrawal by Subject|2|||
155190337|NCT01393301|560137237|FG001|Overall Study|Withdrawal by Subject|0|||
155190338|NCT01393301|560137236|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
155190339|NCT01393301|560137237|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
155190340|NCT00853073|560137238|FG000|Overall Study|Withdrawal by Subject|3|||
155190341|NCT00853073|560137239|FG001|Overall Study|Withdrawal by Subject|2|||
155190342|NCT01999114|560137240|FG000|Overall Study|Adverse Event|8|||
155190343|NCT01999114|560137241|FG001|Overall Study|Adverse Event|7|||
155190344|NCT01999114|560137242|FG002|Overall Study|Adverse Event|2|||
155190345|NCT01999114|560137243|FG003|Overall Study|Adverse Event|2|||
155190346|NCT01999114|560137244|FG004|Overall Study|Adverse Event|1|||
155190347|NCT01999114|560137240|FG000|Overall Study|Withdrawal by Subject|0|||
155190348|NCT01999114|560137241|FG001|Overall Study|Withdrawal by Subject|0|||
155190349|NCT01999114|560137242|FG002|Overall Study|Withdrawal by Subject|1|||
155190350|NCT01999114|560137243|FG003|Overall Study|Withdrawal by Subject|0|||
155190351|NCT01999114|560137244|FG004|Overall Study|Withdrawal by Subject|1|||
155190352|NCT01999114|560137240|FG000|Overall Study|Lost to Follow-up|0|||
155190353|NCT01999114|560137241|FG001|Overall Study|Lost to Follow-up|0|||
155190354|NCT01999114|560137242|FG002|Overall Study|Lost to Follow-up|1|||
155190355|NCT01999114|560137243|FG003|Overall Study|Lost to Follow-up|0|||
155190356|NCT01999114|560137244|FG004|Overall Study|Lost to Follow-up|0|||
155190357|NCT01999114|560137240|FG000|Overall Study|Administrative|0|||
155190358|NCT01999114|560137241|FG001|Overall Study|Administrative|0|||
155190359|NCT01999114|560137242|FG002|Overall Study|Administrative|1|||
155190360|NCT01999114|560137243|FG003|Overall Study|Administrative|1|||
155190361|NCT01999114|560137244|FG004|Overall Study|Administrative|2|||
155190362|NCT03342963|560137245|FG000|Overall Study|Adverse Event|1|||
155190363|NCT03342963|560137246|FG001|Overall Study|Adverse Event|2|||
155190364|NCT03342963|560137247|FG002|Overall Study|Adverse Event|0|||
155190365|NCT03342963|560137248|FG003|Overall Study|Adverse Event|0|||
155190366|NCT03342963|560137245|FG000|Overall Study|Withdrawal by Subject|1|||
155190367|NCT03342963|560137246|FG001|Overall Study|Withdrawal by Subject|0|||
155190368|NCT03342963|560137247|FG002|Overall Study|Withdrawal by Subject|0|||
155190369|NCT03342963|560137248|FG003|Overall Study|Withdrawal by Subject|0|||
155190370|NCT01008150|560137249|FG000|Overall Study|did not receive study drug|1|||
155190371|NCT01008150|560137250|FG001|Overall Study|did not receive study drug|1|||
155190372|NCT01008150|560137251|FG002|Overall Study|did not receive study drug|1|||
155190373|NCT01008150|560137252|FG003|Overall Study|did not receive study drug|0|||
155190374|NCT01309165|560137253|FG000|Overall Study|Lost to Follow-up|4|||
155190375|NCT01309165|560137254|FG001|Overall Study|Lost to Follow-up|3|||
155190376|NCT01309165|560137253|FG000|Overall Study|Return to work|1|||
155190377|NCT01309165|560137254|FG001|Overall Study|Return to work|2|||
155190378|NCT01309165|560137253|FG000|Overall Study|Left country|0|||
155190379|NCT01309165|560137254|FG001|Overall Study|Left country|1|||
155190380|NCT01309165|560137253|FG000|Overall Study|No transportation|0|||
155190381|NCT01309165|560137254|FG001|Overall Study|No transportation|1|||
155190382|NCT01309165|560137253|FG000|Overall Study|Admitted to hospital for second stroke|1|||
155190383|NCT01309165|560137254|FG001|Overall Study|Admitted to hospital for second stroke|0|||
155190384|NCT01497275|560137255|FG000|Overall Study|Death|1|||
155190385|NCT01497275|560137255|FG000|Overall Study|Adverse Event|1|||
155190386|NCT01950169|560137256|FG000|Overall Study|Withdrawal by Subject|2|||
155190387|NCT01950169|560137257|FG001|Overall Study|Withdrawal by Subject|8|||
155190388|NCT01950169|560137258|FG002|Overall Study|Withdrawal by Subject|1|||
155190389|NCT01950169|560137256|FG000|Overall Study|Death|1|||
155190390|NCT01950169|560137257|FG001|Overall Study|Death|0|||
155190391|NCT01950169|560137258|FG002|Overall Study|Death|0|||
155190392|NCT01938573|560137259|FG000|Overall Study|Lack of Efficacy|1|||
155190393|NCT01938573|560137260|FG001|Overall Study|Lack of Efficacy|0|||
155190394|NCT01938573|560137259|FG000|Overall Study|Operation at other hospital|1|||
155190395|NCT01938573|560137260|FG001|Overall Study|Operation at other hospital|0|||
155190396|NCT01739309|560137265|FG000|Overall Study|Adverse Event|1|||
155190397|NCT01739309|560137265|FG000|Overall Study|Withdrawal by Subject|1|||
155190398|NCT04553679|560137266|FG000|Overall Study|Withdrawal by Subject|2|||
155190399|NCT04553679|560137267|FG001|Overall Study|Withdrawal by Subject|0|||
155190400|NCT04553679|560137266|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
155190401|NCT04553679|560137267|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
155190402|NCT00178633|560137268|FG000|Overall Study|Lost to Follow-up|6|||
155190403|NCT03845543|560137269|FG000|Overall Study|Death|25|||
155190404|NCT03845543|560137269|FG000|Overall Study|Withdrawal by Subject|2|||
155190405|NCT03845543|560137269|FG000|Overall Study|Lost to Follow-up|12|||
155190406|NCT03845543|560137269|FG000|Overall Study|Adverse Event|17|||
155190407|NCT02028871|560137272|FG000|Overall Study|Positive urine drug screen|1|||
155190408|NCT02028871|560137273|FG001|Overall Study|Positive urine drug screen|1|||
155190409|NCT02028871|560137272|FG000|Overall Study|Withdrawal by Subject|1|||
155190410|NCT02028871|560137273|FG001|Overall Study|Withdrawal by Subject|2|||
155190411|NCT02028871|560137272|FG000|Overall Study|IV placement difficulty|1|||
155190412|NCT02028871|560137273|FG001|Overall Study|IV placement difficulty|0|||
155190413|NCT02028871|560137272|FG000|Overall Study|Current Illness|1|||
155720498|NCT01001221|562073468|FG002|Overall Study|Disease progression|2|||
155720499|NCT01001221|562073469|FG003|Overall Study|Disease progression|4|||
155720500|NCT01001221|562073470|FG004|Overall Study|Disease progression|0|||
155190414|NCT02028871|560137273|FG001|Overall Study|Current Illness|0|||
155190415|NCT02633501|560137276|FG000|Overall Study|Adverse Event|0|||
155190416|NCT02633501|560137277|FG001|Overall Study|Adverse Event|0|||
155190417|NCT02633501|560137278|FG002|Overall Study|Adverse Event|1|||
155190418|NCT02633501|560137279|FG003|Overall Study|Adverse Event|0|||
155190419|NCT02633501|560137280|FG004|Overall Study|Adverse Event|1|||
155190420|NCT02633501|560137281|FG005|Overall Study|Adverse Event|1|||
155190421|NCT02633501|560137276|FG000|Overall Study|Withdrawal by Subject|2|||
155190422|NCT02633501|560137277|FG001|Overall Study|Withdrawal by Subject|1|||
155190423|NCT02633501|560137278|FG002|Overall Study|Withdrawal by Subject|2|||
155720501|NCT01001221|562073466|FG000|Overall Study|Other|1|||
155190424|NCT02633501|560137279|FG003|Overall Study|Withdrawal by Subject|2|||
155190425|NCT02633501|560137280|FG004|Overall Study|Withdrawal by Subject|1|||
155190426|NCT02633501|560137281|FG005|Overall Study|Withdrawal by Subject|3|||
155190427|NCT02633501|560137276|FG000|Overall Study|Various other reasons|0|||
155190428|NCT02633501|560137277|FG001|Overall Study|Various other reasons|2|||
155190429|NCT02633501|560137278|FG002|Overall Study|Various other reasons|4|||
155190430|NCT02633501|560137279|FG003|Overall Study|Various other reasons|1|||
155190431|NCT02633501|560137280|FG004|Overall Study|Various other reasons|7|||
155190432|NCT02633501|560137281|FG005|Overall Study|Various other reasons|11|||
155190433|NCT02633501|560137276|FG000|Overall Study|Lost to Follow-up|0|||
155190434|NCT02633501|560137277|FG001|Overall Study|Lost to Follow-up|0|||
155190435|NCT02633501|560137278|FG002|Overall Study|Lost to Follow-up|0|||
155190436|NCT02633501|560137279|FG003|Overall Study|Lost to Follow-up|1|||
155190437|NCT02633501|560137280|FG004|Overall Study|Lost to Follow-up|2|||
155190438|NCT02633501|560137281|FG005|Overall Study|Lost to Follow-up|0|||
155190439|NCT01104155|560137286|FG000|Overall Study|Adverse Event|15|||
155190440|NCT01104155|560137287|FG001|Overall Study|Adverse Event|8|||
155190441|NCT01104155|560137286|FG000|Overall Study|Participant choice|6|||
155190442|NCT01104155|560137287|FG001|Overall Study|Participant choice|5|||
155190443|NCT01104155|560137286|FG000|Overall Study|Withdrawal of consent|1|||
155190444|NCT01104155|560137287|FG001|Overall Study|Withdrawal of consent|1|||
155190445|NCT01104155|560137286|FG000|Overall Study|Other|3|||
155190446|NCT01104155|560137287|FG001|Overall Study|Other|4|||
155190447|NCT01484132|560137293|FG000|Overall Study|Lost to Follow-up|8|||
155190448|NCT01484132|560137293|FG000|Overall Study|Difficulty with time commitment|2|||
155190449|NCT01484132|560137293|FG000|Overall Study|Ineligible|1|||
155190450|NCT01484132|560137293|FG000|Overall Study|No pre-treatment urine sample collected|1|||
155190451|NCT01484132|560137293|FG000|Overall Study|No post-treatment urine sample collected|10|||
155190452|NCT01912963|560137294|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
155190453|NCT01912963|560137295|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
155190454|NCT01912963|560137296|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
155190455|NCT01912963|560137294|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
155190456|NCT01912963|560137295|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
155190457|NCT01912963|560137296|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
155190458|NCT01912963|560137294|FG000|Overall Study|Adverse Event|0|||
155190459|NCT01912963|560137295|FG001|Overall Study|Adverse Event|1|||
155190460|NCT01912963|560137296|FG002|Overall Study|Adverse Event|1|||
155190461|NCT01912963|560137294|FG000|Overall Study|Withdrawal by Subject|0|||
155190462|NCT01912963|560137295|FG001|Overall Study|Withdrawal by Subject|1|||
155190463|NCT01912963|560137296|FG002|Overall Study|Withdrawal by Subject|0|||
155190464|NCT01912963|560137294|FG000|Overall Study|Sought treatment locally|0|||
155190465|NCT01912963|560137295|FG001|Overall Study|Sought treatment locally|1|||
155190466|NCT01912963|560137296|FG002|Overall Study|Sought treatment locally|0|||
155190467|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Adverse Event|10|||
155190468|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Adverse Event|0|||
155190469|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
155190470|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
155190471|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
155190472|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
155190473|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
155190474|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
155190475|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
155190476|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
155190477|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Other than specified|3|||
155190478|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Other than specified|1|||
155190479|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
155190480|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
155190481|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
155190482|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
155190483|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
155190484|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
155190485|NCT01336569|560137300|FG000|Overall Study|Lost to Follow-up|4|||
155720502|NCT01001221|562073467|FG001|Overall Study|Other|1|||
155720503|NCT01001221|562073468|FG002|Overall Study|Other|0|||
155190486|NCT02963935|560137301|FG000|Overall Study|Adverse Event|12|||
155190487|NCT02963935|560137302|FG001|Overall Study|Adverse Event|6|||
155190488|NCT02963935|560137301|FG000|Overall Study|Protocol Violation|2|||
155190489|NCT02963935|560137302|FG001|Overall Study|Protocol Violation|1|||
155190490|NCT02963935|560137301|FG000|Overall Study|Lack of Efficacy|0|||
155190491|NCT02963935|560137302|FG001|Overall Study|Lack of Efficacy|2|||
155720504|NCT01001221|562073469|FG003|Overall Study|Other|0|||
155190492|NCT02963935|560137301|FG000|Overall Study|Lost to Follow-up|1|||
155720505|NCT01001221|562073470|FG004|Overall Study|Other|0|||
155720506|NCT01001221|562073466|FG000|Overall Study|Not treated; protocol exclusion|0|||
155190493|NCT02963935|560137302|FG001|Overall Study|Lost to Follow-up|6|||
155190494|NCT02963935|560137301|FG000|Overall Study|Unclassified|13|||
155190495|NCT02963935|560137302|FG001|Overall Study|Unclassified|22|||
155190496|NCT02337738|560137303|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
155190497|NCT02337738|560137304|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
155190498|NCT02337738|560137305|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
155190499|NCT02337738|560137303|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155190500|NCT02337738|560137304|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
155190501|NCT02337738|560137305|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
155190502|NCT02337738|560137303|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
155190503|NCT02337738|560137304|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
155190504|NCT02337738|560137305|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
155190505|NCT02337738|560137303|FG000|Overall Study|Voluntary Withdrawal|10|||
155720507|NCT01001221|562073467|FG001|Overall Study|Not treated; protocol exclusion|0|||
155720508|NCT01001221|562073468|FG002|Overall Study|Not treated; protocol exclusion|1|||
155720509|NCT01001221|562073469|FG003|Overall Study|Not treated; protocol exclusion|0|||
155720510|NCT01001221|562073470|FG004|Overall Study|Not treated; protocol exclusion|0|||
155720511|NCT02388269|562073471|FG000|Overall Study|Adverse Event|2|||
155720512|NCT02388269|562073472|FG001|Overall Study|Adverse Event|0|||
155720513|NCT02388269|562073473|FG002|Overall Study|Adverse Event|0|||
155720514|NCT02388269|562073471|FG000|Overall Study|Withdrawal by Subject|1|||
155720515|NCT02388269|562073472|FG001|Overall Study|Withdrawal by Subject|2|||
155720516|NCT02388269|562073473|FG002|Overall Study|Withdrawal by Subject|0|||
155720517|NCT02388269|562073471|FG000|Overall Study|less than 50% stimulations|1|||
155720518|NCT02388269|562073472|FG001|Overall Study|less than 50% stimulations|0|||
155720519|NCT02388269|562073473|FG002|Overall Study|less than 50% stimulations|0|||
155720520|NCT02388269|562073471|FG000|Overall Study|no diary data|3|||
155720521|NCT02388269|562073472|FG001|Overall Study|no diary data|0|||
155720522|NCT02388269|562073473|FG002|Overall Study|no diary data|0|||
155720523|NCT02388269|562073471|FG000|Overall Study|Protocol Violation|2|||
155720524|NCT02388269|562073472|FG001|Overall Study|Protocol Violation|0|||
155720525|NCT02388269|562073473|FG002|Overall Study|Protocol Violation|0|||
155720526|NCT02388269|562073471|FG000|Overall Study|Screen Failure|0|||
155720527|NCT02388269|562073472|FG001|Overall Study|Screen Failure|0|||
155720528|NCT02388269|562073473|FG002|Overall Study|Screen Failure|10|||
155720529|NCT03882021|562073474|FG000|Enrollment|Procedure aborted/cancelled|2|||
155720530|NCT03882021|562073474|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
155720531|NCT03882021|562073474|FG000|Enrollment to 3-Month|Death|1|||
155720532|NCT03882021|562073474|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
155720533|NCT03882021|562073474|FG000|Enrollment to 3-Month|Missed Visit|4|||
155720534|NCT03882021|562073474|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
155720535|NCT03882021|562073474|FG000|6-Month to 12-Month Visit|Death|1|||
155720536|NCT03882021|562073474|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
155720537|NCT02542865|562073476|FG000|Overall Study|Identified as screen failure|1|||
155720538|NCT02542865|562073477|FG001|Overall Study|Identified as screen failure|0|||
155720539|NCT02542865|562073476|FG000|Overall Study|Withdrawal by Subject|16|||
155720540|NCT02542865|562073477|FG001|Overall Study|Withdrawal by Subject|0|||
155720541|NCT01469221|562073478|FG000|Double Blind Phase|Protocol Violation|1|||
155720542|NCT01469221|562073479|FG001|Double Blind Phase|Protocol Violation|0|||
155720543|NCT01469221|562073480|FG002|Double Blind Phase|Protocol Violation|0|||
155720544|NCT01469221|562073478|FG000|Double Blind Phase|Physician Decision|1|||
155190506|NCT02337738|560137304|FG001|Overall Study|Voluntary Withdrawal|5|||
155190507|NCT02337738|560137305|FG002|Overall Study|Voluntary Withdrawal|2|||
155190508|NCT02337738|560137303|FG000|Overall Study|Lack of Efficacy|2|||
155190509|NCT02337738|560137304|FG001|Overall Study|Lack of Efficacy|4|||
155720545|NCT01469221|562073479|FG001|Double Blind Phase|Physician Decision|1|||
155720546|NCT01469221|562073480|FG002|Double Blind Phase|Physician Decision|0|||
155720547|NCT01469221|562073478|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
155720548|NCT01469221|562073479|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
155720549|NCT01469221|562073480|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
155720550|NCT00659061|562073481|FG000|Overall Study|Migration due to political unrest|21|||
155720551|NCT00659061|562073482|FG001|Overall Study|Migration due to political unrest|15|||
155720552|NCT00475670|562073491|FG000|Overall Study|Death|0|||
155720553|NCT00475670|562073492|FG001|Overall Study|Death|1|||
155720554|NCT00475670|562073491|FG000|Overall Study|Lack of Efficacy|3|||
155720555|NCT00475670|562073492|FG001|Overall Study|Lack of Efficacy|34|||
155720556|NCT00475670|562073491|FG000|Overall Study|Refused treatment|0|||
155190510|NCT02337738|560137305|FG002|Overall Study|Lack of Efficacy|0|||
155190511|NCT02337738|560137303|FG000|Overall Study|Investigator's Judgment|1|||
155720557|NCT00475670|562073492|FG001|Overall Study|Refused treatment|2|||
155720558|NCT00475670|562073491|FG000|Overall Study|Failure to Return|0|||
155720559|NCT00475670|562073492|FG001|Overall Study|Failure to Return|1|||
155720560|NCT00475670|562073491|FG000|Overall Study|Other|0|||
155720561|NCT00475670|562073492|FG001|Overall Study|Other|3|||
155720562|NCT02004236|562073493|FG000|Overall Study|Lack of Efficacy|0|||
155720563|NCT02004236|562073494|FG001|Overall Study|Lack of Efficacy|0|||
155720564|NCT02004236|562073495|FG002|Overall Study|Lack of Efficacy|16|||
155190512|NCT02337738|560137304|FG001|Overall Study|Investigator's Judgment|1|||
155190513|NCT02337738|560137305|FG002|Overall Study|Investigator's Judgment|3|||
155190514|NCT03911154|560137306|FG000|Overall Study|Withdrawal by Subject|1|||
155190515|NCT00406354|560137307|FG000|All Randomized Patients|Protocol Violation|0|||
155190516|NCT00406354|560137308|FG001|All Randomized Patients|Protocol Violation|0|||
155190517|NCT00406354|560137309|FG002|All Randomized Patients|Protocol Violation|1|||
155190518|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
155190519|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
155190520|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
155190521|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Adverse Event|6|||
155190522|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Adverse Event|2|||
155190523|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Adverse Event|1|||
155190524|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
155190525|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
155190526|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
155190527|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
155190528|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
155190529|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
155190530|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Physician Decision|0|||
155190531|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Physician Decision|0|||
155190532|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Physician Decision|1|||
155190533|NCT00292318|560137314|FG000|Overall Study|Study terminated by officials|2|||
155190534|NCT00292318|560137315|FG001|Overall Study|Study terminated by officials|1|||
155190535|NCT01822496|560137316|FG000|Overall Study|Protocol Violation|2|||
155190536|NCT01822496|560137317|FG001|Overall Study|Protocol Violation|2|||
155190537|NCT01822496|560137318|FG002|Overall Study|Protocol Violation|0|||
155190538|NCT01822496|560137319|FG003|Overall Study|Protocol Violation|1|||
155190539|NCT01822496|560137316|FG000|Overall Study|Withdrawal by Subject|0|||
155190540|NCT01822496|560137317|FG001|Overall Study|Withdrawal by Subject|0|||
155190541|NCT01822496|560137318|FG002|Overall Study|Withdrawal by Subject|0|||
155190542|NCT01822496|560137319|FG003|Overall Study|Withdrawal by Subject|3|||
155190543|NCT02906332|560137324|FG000|Overall Study|Withdrawal by Subject|1|||
155190544|NCT03945266|560137328|FG000|Overall Study|Withdrawal by Subject|1|||
155190545|NCT03945266|560137329|FG001|Overall Study|Withdrawal by Subject|0|||
155190546|NCT03945266|560137328|FG000|Overall Study|Miscarriage|0|||
155190547|NCT03945266|560137329|FG001|Overall Study|Miscarriage|2|||
155190548|NCT03945266|560137328|FG000|Overall Study|Lost to Follow-up|1|||
155190549|NCT03945266|560137329|FG001|Overall Study|Lost to Follow-up|0|||
155190550|NCT02130024|560137342|FG000|Overall Study|Adverse Event|10|||
155190551|NCT02130024|560137343|FG001|Overall Study|Adverse Event|11|||
155190552|NCT02130024|560137342|FG000|Overall Study|Death|2|||
155190553|NCT02130024|560137343|FG001|Overall Study|Death|2|||
155190554|NCT02130024|560137342|FG000|Overall Study|Lost to Follow-up|1|||
155190555|NCT02130024|560137343|FG001|Overall Study|Lost to Follow-up|1|||
155190556|NCT02130024|560137342|FG000|Overall Study|Physician Decision|1|||
155720565|NCT01168349|562073496|FG000|Overall Study|Death|157|||
155720566|NCT01168349|562073496|FG000|Overall Study|Lost to Follow-up|34|||
155720567|NCT01168349|562073496|FG000|Overall Study|Withdrawal by Subject|9|||
155720568|NCT01168349|562073496|FG000|Overall Study|Kidney transplantation|3|||
155720569|NCT01168349|562073496|FG000|Overall Study|Other|22|||
155720570|NCT01168349|562073496|FG000|Overall Study|Protocol Violation|76|||
155720571|NCT03259230|562073498|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
155720572|NCT03259230|562073499|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
155720573|NCT01033240|562073500|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
155720574|NCT01033240|562073501|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
155720575|NCT01033240|562073502|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
155720576|NCT01033240|562073500|FG000|Overall Study|Death|2|||
155720577|NCT01033240|562073501|FG001|Overall Study|Death|0|||
155720578|NCT01033240|562073502|FG002|Overall Study|Death|0|||
155720579|NCT01033240|562073500|FG000|Overall Study|Withdrew Consent|2|||
155720580|NCT01033240|562073501|FG001|Overall Study|Withdrew Consent|9|||
155720581|NCT01033240|562073502|FG002|Overall Study|Withdrew Consent|2|||
155720582|NCT01033240|562073500|FG000|Overall Study|Disease Progression|35|||
155720583|NCT01033240|562073501|FG001|Overall Study|Disease Progression|32|||
155720584|NCT01033240|562073502|FG002|Overall Study|Disease Progression|41|||
155720585|NCT01033240|562073500|FG000|Overall Study|Investigator Discretion|0|||
155720586|NCT01033240|562073501|FG001|Overall Study|Investigator Discretion|0|||
155190557|NCT02130024|560137343|FG001|Overall Study|Physician Decision|3|||
155190558|NCT02130024|560137342|FG000|Overall Study|Protocol Deviation|4|||
155190559|NCT02130024|560137343|FG001|Overall Study|Protocol Deviation|0|||
155190560|NCT02130024|560137342|FG000|Overall Study|Site Administration Problems|1|||
155190561|NCT02130024|560137343|FG001|Overall Study|Site Administration Problems|0|||
155190562|NCT02130024|560137342|FG000|Overall Study|Subject Withdrew Consent|6|||
155190563|NCT02130024|560137343|FG001|Overall Study|Subject Withdrew Consent|14|||
155190564|NCT02024555|560137344|FG000|Overall Study|Lost to Follow-up|1|||
155190565|NCT02024555|560137345|FG001|Overall Study|Lost to Follow-up|1|||
155190566|NCT02024555|560137344|FG000|Overall Study|Withdrawal by Subject|5|||
155190567|NCT02024555|560137345|FG001|Overall Study|Withdrawal by Subject|1|||
155190568|NCT05736224|560137346|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
155190569|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
155190570|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190571|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190572|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190573|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190574|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190575|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190576|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
155190577|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190578|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190579|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190580|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190581|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190582|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190583|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
155190584|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190585|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190586|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190587|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190588|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190589|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190590|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
155190591|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190592|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190593|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190594|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190595|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190596|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190597|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
155190598|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190599|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190600|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190601|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190602|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190603|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190604|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
155190605|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190606|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190607|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190608|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190609|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190610|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190611|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
155190612|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190613|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190614|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190615|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190616|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190617|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190618|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
155190619|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190620|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190621|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190622|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190623|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190624|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190625|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
155190626|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190627|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190628|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190629|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190630|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190631|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190632|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
155190633|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190634|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190635|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190636|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190637|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190638|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190639|NCT04526509|560137347|FG000|Enrolled|Study Terminated by Sponsor|0|||
155190640|NCT04526509|560137348|FG001|Enrolled|Study Terminated by Sponsor|0|||
155190641|NCT04526509|560137349|FG002|Enrolled|Study Terminated by Sponsor|0|||
155190642|NCT04526509|560137350|FG003|Enrolled|Study Terminated by Sponsor|0|||
155190643|NCT04526509|560137351|FG004|Enrolled|Study Terminated by Sponsor|0|||
155190644|NCT04526509|560137352|FG005|Enrolled|Study Terminated by Sponsor|0|||
155190645|NCT04526509|560137353|FG006|Enrolled|Study Terminated by Sponsor|1|||
155190646|NCT04526509|560137347|FG000|Enrolled|Death prior to lymphodepletion|0|||
155190647|NCT04526509|560137348|FG001|Enrolled|Death prior to lymphodepletion|0|||
155190648|NCT04526509|560137349|FG002|Enrolled|Death prior to lymphodepletion|0|||
155190649|NCT04526509|560137350|FG003|Enrolled|Death prior to lymphodepletion|1|||
155190650|NCT04526509|560137351|FG004|Enrolled|Death prior to lymphodepletion|0|||
155190651|NCT04526509|560137352|FG005|Enrolled|Death prior to lymphodepletion|0|||
155190652|NCT04526509|560137353|FG006|Enrolled|Death prior to lymphodepletion|0|||
155190653|NCT04526509|560137347|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190654|NCT04526509|560137348|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190655|NCT04526509|560137349|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190656|NCT04526509|560137350|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
155190657|NCT04526509|560137351|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190658|NCT04526509|560137352|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190659|NCT04526509|560137353|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190660|NCT04526509|560137347|FG000|Enrolled|Physician Decision|0|||
155190661|NCT04526509|560137348|FG001|Enrolled|Physician Decision|1|||
155190662|NCT04526509|560137349|FG002|Enrolled|Physician Decision|0|||
155190663|NCT04526509|560137350|FG003|Enrolled|Physician Decision|0|||
155190664|NCT04526509|560137351|FG004|Enrolled|Physician Decision|0|||
155190665|NCT04526509|560137352|FG005|Enrolled|Physician Decision|0|||
155190666|NCT04526509|560137353|FG006|Enrolled|Physician Decision|0|||
155190667|NCT01896050|560138895|FG000|Overall Study|Adverse Event|37|||
155190668|NCT01896050|560138896|FG001|Overall Study|Adverse Event|2|||
155190669|NCT01896050|560138895|FG000|Overall Study|Death|1|||
155190670|NCT01896050|560138896|FG001|Overall Study|Death|0|||
155190671|NCT00392015|560138898|FG000|Overall Study|Lost to Follow-up|2|||
155190672|NCT00392015|560138899|FG001|Overall Study|Lost to Follow-up|0|||
155190673|NCT00392015|560138900|FG002|Overall Study|Lost to Follow-up|2|||
155190674|NCT00392015|560138901|FG003|Overall Study|Lost to Follow-up|1|||
155190675|NCT00392015|560138902|FG004|Overall Study|Lost to Follow-up|1|||
155190676|NCT00392015|560138903|FG005|Overall Study|Lost to Follow-up|0|||
155190677|NCT00392015|560138898|FG000|Overall Study|Withdrawal by Subject|0|||
155190678|NCT00392015|560138899|FG001|Overall Study|Withdrawal by Subject|0|||
155190679|NCT00392015|560138900|FG002|Overall Study|Withdrawal by Subject|2|||
155190680|NCT00392015|560138901|FG003|Overall Study|Withdrawal by Subject|0|||
155190681|NCT00392015|560138902|FG004|Overall Study|Withdrawal by Subject|0|||
155190682|NCT00392015|560138903|FG005|Overall Study|Withdrawal by Subject|0|||
155190683|NCT00392015|560138898|FG000|Overall Study|Adverse Event|0|||
155190684|NCT00392015|560138899|FG001|Overall Study|Adverse Event|0|||
155190685|NCT00392015|560138900|FG002|Overall Study|Adverse Event|0|||
155190686|NCT00392015|560138901|FG003|Overall Study|Adverse Event|0|||
155190687|NCT00392015|560138902|FG004|Overall Study|Adverse Event|1|||
155190688|NCT00392015|560138903|FG005|Overall Study|Adverse Event|0|||
155190689|NCT00392015|560138898|FG000|Overall Study|Previous trial recipient|0|||
155190690|NCT00392015|560138899|FG001|Overall Study|Previous trial recipient|0|||
155190691|NCT00392015|560138900|FG002|Overall Study|Previous trial recipient|0|||
155190692|NCT00392015|560138901|FG003|Overall Study|Previous trial recipient|0|||
155190693|NCT00392015|560138902|FG004|Overall Study|Previous trial recipient|1|||
155190694|NCT00392015|560138903|FG005|Overall Study|Previous trial recipient|0|||
155190695|NCT02742441|560138904|FG000|Overall Study|Lost to Follow-up|4|||
155190696|NCT02742441|560138905|FG001|Overall Study|Lost to Follow-up|4|||
155190697|NCT02742441|560138904|FG000|Overall Study|Withdrawal by Subject|2|||
155190698|NCT02742441|560138905|FG001|Overall Study|Withdrawal by Subject|2|||
155190699|NCT02742441|560138904|FG000|Overall Study|Adverse Event|0|||
155190700|NCT02742441|560138905|FG001|Overall Study|Adverse Event|2|||
155190701|NCT01824342|560138907|FG000|Overall Study|Withdrawal by Subject|0|||
155190702|NCT01824342|560138908|FG001|Overall Study|Withdrawal by Subject|3|||
155190703|NCT01824342|560138907|FG000|Overall Study|Adverse Event|1|||
155190704|NCT01824342|560138908|FG001|Overall Study|Adverse Event|1|||
155190705|NCT01824342|560138907|FG000|Overall Study|Disease Progression|1|||
155190706|NCT01824342|560138908|FG001|Overall Study|Disease Progression|1|||
155190707|NCT01824342|560138907|FG000|Overall Study|Physician Decision|5|||
155190708|NCT01824342|560138908|FG001|Overall Study|Physician Decision|0|||
155190709|NCT01824342|560138907|FG000|Overall Study|Death|2|||
155190710|NCT01824342|560138908|FG001|Overall Study|Death|0|||
155190711|NCT04195906|560138911|FG000|Part 1|Adverse Event|3|||
155190712|NCT04195906|560138912|FG001|Part 1|Adverse Event|7|||
155190713|NCT04195906|560138911|FG000|Part 1|Withdrawal by Subject|0|||
155190714|NCT04195906|560138912|FG001|Part 1|Withdrawal by Subject|1|||
155190715|NCT04195906|560138911|FG000|Part 2|Adverse Event|1|||
155190716|NCT04195906|560138912|FG001|Part 2|Adverse Event|1|||
155190717|NCT04195906|560138911|FG000|Part 2|Withdrawal by Subject|0|||
155190718|NCT04195906|560138912|FG001|Part 2|Withdrawal by Subject|3|||
155190719|NCT04195906|560138911|FG000|Part 2|Other|1|||
155190720|NCT04195906|560138912|FG001|Part 2|Other|3|||
155190721|NCT02486302|560138913|FG000|Overall Study|Discontinued prematurely|410|||
155190722|NCT02486302|560138913|FG000|Overall Study|Documentation not completed|255|||
155190723|NCT02486302|560138913|FG000|Overall Study|Excluded due to legal reasons|8|||
155190724|NCT02486302|560138913|FG000|Overall Study|Not treated|3|||
155190725|NCT01871142|560138914|FG000|Overall Study|Adverse Event|1|||
155190726|NCT00734474|560138917|FG000|Overall Study|Entry Criteria Not Met|0|||
155190727|NCT00734474|560138918|FG001|Overall Study|Entry Criteria Not Met|0|||
155190728|NCT00734474|560138919|FG002|Overall Study|Entry Criteria Not Met|5|||
155190729|NCT00734474|560138920|FG003|Overall Study|Entry Criteria Not Met|0|||
155720587|NCT01033240|562073502|FG002|Overall Study|Investigator Discretion|2|||
155720588|NCT01033240|562073500|FG000|Overall Study|Other|0|||
155190730|NCT00734474|560138921|FG004|Overall Study|Entry Criteria Not Met|3|||
155190731|NCT00734474|560138922|FG005|Overall Study|Entry Criteria Not Met|1|||
155190732|NCT00734474|560138923|FG006|Overall Study|Entry Criteria Not Met|0|||
155190733|NCT00734474|560138924|FG007|Overall Study|Entry Criteria Not Met|1|||
155190734|NCT00734474|560138925|FG008|Overall Study|Entry Criteria Not Met|1|||
155190735|NCT00734474|560138917|FG000|Overall Study|Lost to Follow-up|1|||
155190736|NCT00734474|560138918|FG001|Overall Study|Lost to Follow-up|0|||
155190737|NCT00734474|560138919|FG002|Overall Study|Lost to Follow-up|13|||
155190738|NCT00734474|560138920|FG003|Overall Study|Lost to Follow-up|0|||
155190739|NCT00734474|560138921|FG004|Overall Study|Lost to Follow-up|11|||
155190740|NCT00734474|560138922|FG005|Overall Study|Lost to Follow-up|1|||
155190741|NCT00734474|560138923|FG006|Overall Study|Lost to Follow-up|0|||
155190742|NCT00734474|560138924|FG007|Overall Study|Lost to Follow-up|9|||
155190743|NCT00734474|560138925|FG008|Overall Study|Lost to Follow-up|4|||
155190744|NCT00734474|560138917|FG000|Overall Study|Withdrawal by Subject|2|||
155190745|NCT00734474|560138918|FG001|Overall Study|Withdrawal by Subject|1|||
155190746|NCT00734474|560138919|FG002|Overall Study|Withdrawal by Subject|18|||
155190747|NCT00734474|560138920|FG003|Overall Study|Withdrawal by Subject|0|||
155190748|NCT00734474|560138921|FG004|Overall Study|Withdrawal by Subject|24|||
155190749|NCT00734474|560138922|FG005|Overall Study|Withdrawal by Subject|2|||
155190750|NCT00734474|560138923|FG006|Overall Study|Withdrawal by Subject|0|||
155190751|NCT00734474|560138924|FG007|Overall Study|Withdrawal by Subject|36|||
155190752|NCT00734474|560138925|FG008|Overall Study|Withdrawal by Subject|21|||
155190753|NCT00734474|560138917|FG000|Overall Study|Physician Decision|0|||
155190754|NCT00734474|560138918|FG001|Overall Study|Physician Decision|0|||
155190755|NCT00734474|560138919|FG002|Overall Study|Physician Decision|4|||
155190756|NCT00734474|560138920|FG003|Overall Study|Physician Decision|1|||
155190757|NCT00734474|560138921|FG004|Overall Study|Physician Decision|11|||
155190758|NCT00734474|560138922|FG005|Overall Study|Physician Decision|0|||
155190759|NCT00734474|560138923|FG006|Overall Study|Physician Decision|0|||
155190760|NCT00734474|560138924|FG007|Overall Study|Physician Decision|9|||
155190761|NCT00734474|560138925|FG008|Overall Study|Physician Decision|9|||
155190762|NCT00734474|560138917|FG000|Overall Study|Adverse Event|4|||
155190763|NCT00734474|560138918|FG001|Overall Study|Adverse Event|4|||
155190764|NCT00734474|560138919|FG002|Overall Study|Adverse Event|63|||
155190765|NCT00734474|560138920|FG003|Overall Study|Adverse Event|1|||
155190766|NCT00734474|560138921|FG004|Overall Study|Adverse Event|64|||
155190767|NCT00734474|560138922|FG005|Overall Study|Adverse Event|0|||
155190768|NCT00734474|560138923|FG006|Overall Study|Adverse Event|1|||
155190769|NCT00734474|560138924|FG007|Overall Study|Adverse Event|65|||
155190770|NCT00734474|560138925|FG008|Overall Study|Adverse Event|39|||
155190771|NCT00734474|560138917|FG000|Overall Study|Protocol Violation|0|||
155190772|NCT00734474|560138918|FG001|Overall Study|Protocol Violation|0|||
155190773|NCT00734474|560138919|FG002|Overall Study|Protocol Violation|4|||
155190774|NCT00734474|560138920|FG003|Overall Study|Protocol Violation|0|||
155190775|NCT00734474|560138921|FG004|Overall Study|Protocol Violation|3|||
155190776|NCT00734474|560138922|FG005|Overall Study|Protocol Violation|0|||
155190777|NCT00734474|560138923|FG006|Overall Study|Protocol Violation|0|||
155190778|NCT00734474|560138924|FG007|Overall Study|Protocol Violation|3|||
155190779|NCT00734474|560138925|FG008|Overall Study|Protocol Violation|1|||
155190780|NCT00734474|560138917|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
155190781|NCT00734474|560138918|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
155190782|NCT00734474|560138919|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190783|NCT00734474|560138920|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
155190784|NCT00734474|560138921|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190785|NCT00734474|560138922|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
155190786|NCT00734474|560138923|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
155190787|NCT00734474|560138924|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190788|NCT00734474|560138925|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190789|NCT00734474|560138917|FG000|Overall Study|Sponsor Decision|0|||
155190790|NCT00734474|560138918|FG001|Overall Study|Sponsor Decision|0|||
155190791|NCT00734474|560138919|FG002|Overall Study|Sponsor Decision|0|||
155190792|NCT00734474|560138920|FG003|Overall Study|Sponsor Decision|0|||
155190793|NCT00734474|560138921|FG004|Overall Study|Sponsor Decision|2|||
155190794|NCT00734474|560138922|FG005|Overall Study|Sponsor Decision|0|||
155190795|NCT00734474|560138923|FG006|Overall Study|Sponsor Decision|0|||
155190796|NCT00734474|560138924|FG007|Overall Study|Sponsor Decision|0|||
155190797|NCT00734474|560138925|FG008|Overall Study|Sponsor Decision|0|||
155190798|NCT00734474|560138917|FG000|Overall Study|Death|0|||
155190799|NCT00734474|560138918|FG001|Overall Study|Death|0|||
155190800|NCT00734474|560138919|FG002|Overall Study|Death|1|||
155190801|NCT00734474|560138920|FG003|Overall Study|Death|0|||
155190802|NCT00734474|560138921|FG004|Overall Study|Death|0|||
155190803|NCT00734474|560138922|FG005|Overall Study|Death|0|||
155190804|NCT00734474|560138923|FG006|Overall Study|Death|0|||
155190805|NCT00734474|560138924|FG007|Overall Study|Death|2|||
155190806|NCT00734474|560138925|FG008|Overall Study|Death|1|||
155190807|NCT00734474|560138917|FG000|Overall Study|Lack of Efficacy|0|||
155190808|NCT00734474|560138918|FG001|Overall Study|Lack of Efficacy|0|||
155190809|NCT00734474|560138919|FG002|Overall Study|Lack of Efficacy|4|||
155720589|NCT01033240|562073501|FG001|Overall Study|Other|1|||
155720590|NCT01033240|562073502|FG002|Overall Study|Other|2|||
155190810|NCT00734474|560138920|FG003|Overall Study|Lack of Efficacy|0|||
155190811|NCT00734474|560138921|FG004|Overall Study|Lack of Efficacy|0|||
155190812|NCT00734474|560138922|FG005|Overall Study|Lack of Efficacy|0|||
155190813|NCT00734474|560138923|FG006|Overall Study|Lack of Efficacy|0|||
155190814|NCT00734474|560138924|FG007|Overall Study|Lack of Efficacy|4|||
155190815|NCT00734474|560138925|FG008|Overall Study|Lack of Efficacy|6|||
155190816|NCT02104752|560138926|FG000|Overall Study|Withdrawal by Subject|1|||
155190817|NCT02104752|560138927|FG001|Overall Study|Withdrawal by Subject|0|||
155190818|NCT02104752|560138926|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
155190819|NCT02104752|560138927|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
155190820|NCT02899299|560138928|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
155190821|NCT02899299|560138929|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
155190822|NCT02899299|560138928|FG000|Pre-treatment|Participant withdrew consent|1|||
155190823|NCT02899299|560138929|FG001|Pre-treatment|Participant withdrew consent|11|||
155190824|NCT02899299|560138928|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
155190825|NCT02899299|560138929|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
155190826|NCT02899299|560138928|FG000|Pre-treatment|Not reported|0|||
155190827|NCT02899299|560138929|FG001|Pre-treatment|Not reported|1|||
155190828|NCT02899299|560138928|FG000|Treatment|Disease Progression|182|||
155190829|NCT02899299|560138929|FG001|Treatment|Disease Progression|43|||
155190830|NCT02899299|560138928|FG000|Treatment|Study Drug Toxicity|60|||
155190831|NCT02899299|560138929|FG001|Treatment|Study Drug Toxicity|24|||
155190832|NCT02899299|560138928|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
155190833|NCT02899299|560138929|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
155190834|NCT02899299|560138928|FG000|Treatment|Participant request to discontinue Study treatment|4|||
155190835|NCT02899299|560138929|FG001|Treatment|Participant request to discontinue Study treatment|10|||
155190836|NCT02899299|560138928|FG000|Treatment|Participant withdrew consent|6|||
155190837|NCT02899299|560138929|FG001|Treatment|Participant withdrew consent|3|||
155190838|NCT02899299|560138928|FG000|Treatment|Lost to Follow-up|0|||
155190839|NCT02899299|560138929|FG001|Treatment|Lost to Follow-up|2|||
155190840|NCT02899299|560138928|FG000|Treatment|Maximum Clinical Benefit|11|||
155190841|NCT02899299|560138929|FG001|Treatment|Maximum Clinical Benefit|2|||
155190842|NCT02899299|560138928|FG000|Treatment|Poor/Non-compliance|1|||
155190843|NCT02899299|560138929|FG001|Treatment|Poor/Non-compliance|0|||
155190844|NCT02899299|560138928|FG000|Treatment|Participant no longer meets Study criteria|4|||
155190845|NCT02899299|560138929|FG001|Treatment|Participant no longer meets Study criteria|0|||
155190846|NCT02899299|560138928|FG000|Treatment|Administrative reason by Sponsor|2|||
155190847|NCT02899299|560138929|FG001|Treatment|Administrative reason by Sponsor|0|||
155190848|NCT02899299|560138928|FG000|Treatment|Other reasons|12|||
155190849|NCT02899299|560138929|FG001|Treatment|Other reasons|2|||
155190850|NCT02899299|560138928|FG000|Treatment|Not reported|7|||
155190851|NCT02899299|560138929|FG001|Treatment|Not reported|0|||
155190852|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
155190853|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
155190854|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
155190855|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
155190856|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
155190857|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
155190858|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
155190859|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
155190860|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
155190861|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
155190862|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
155190863|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
155190864|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
155190865|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
155190866|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
155190867|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
155190868|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
155190869|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
155190870|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
155190871|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
155190872|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
155190873|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
155190874|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
155190875|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
155190876|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
155190877|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
155190878|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
155190879|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
155190880|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
155190881|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
155190882|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
155190883|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190884|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190885|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190886|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190887|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
155190888|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
155190889|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
155190890|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
155720591|NCT02913482|562073503|FG000|Overall Study|Death|0|||
155190891|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
155190892|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
155190893|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
155190894|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
155190895|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
155190896|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
155190897|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
155190898|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
155190899|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
155190900|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
155190901|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
155190902|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
155190903|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
155190904|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
155190905|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
155190906|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
155190907|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
155190908|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
155190909|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
155190910|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
155190911|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
155190912|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
155190913|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
155190914|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
155190915|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
155190916|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
155190917|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
155190918|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
155190919|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
155190920|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
155190921|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
155190922|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
155190923|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190924|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190925|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190926|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190927|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
155190928|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
155190929|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
155190930|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
155190931|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
155190932|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190933|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
155190934|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190935|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190936|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190937|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190938|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
155190939|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
155190940|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190941|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190942|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
155190943|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190944|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190945|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190946|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190947|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190948|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190949|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190950|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
155190951|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
155190952|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
155190953|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190954|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190955|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
155190956|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190957|NCT00428792|560138936|FG000|Overall Study|Lack of Efficacy|1|||
155190958|NCT00428792|560138937|FG001|Overall Study|Lack of Efficacy|3|||
155190959|NCT00428792|560138936|FG000|Overall Study|Lost to Follow-up|0|||
155190960|NCT00428792|560138937|FG001|Overall Study|Lost to Follow-up|1|||
155190961|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Death|1|||
155190962|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Death|1|||
155190963|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Death|0|||
155190964|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Death|0|||
155190965|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
155190966|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190967|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190968|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190969|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
155190970|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
155190971|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
155190972|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
155190973|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
155190974|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
155190975|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
155190976|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
155190977|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
155190978|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
155190979|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
155190980|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
155190981|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Other|1|||
155190982|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Other|0|||
155190983|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Other|0|||
155190984|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Other|0|||
155190985|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190986|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190987|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190988|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
155190989|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
155190990|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
155190991|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
155190992|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
155190993|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
155190994|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
155190995|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
155190996|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
155190997|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Other|0|||
155190998|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Other|0|||
155190999|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Other|0|||
155191000|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Other|1|||
155191001|NCT03615326|560138945|FG000|Overall Study|Death|266|||
155191002|NCT03615326|560138946|FG001|Overall Study|Death|286|||
155191003|NCT03615326|560138947|FG002|Overall Study|Death|14|||
155191004|NCT03615326|560138948|FG003|Overall Study|Death|17|||
155191005|NCT03615326|560138945|FG000|Overall Study|Lost to Follow-up|0|||
155191006|NCT03615326|560138946|FG001|Overall Study|Lost to Follow-up|1|||
155191007|NCT03615326|560138947|FG002|Overall Study|Lost to Follow-up|0|||
155191008|NCT03615326|560138948|FG003|Overall Study|Lost to Follow-up|0|||
155191009|NCT03615326|560138945|FG000|Overall Study|Withdrawal by Subject|1|||
155191010|NCT03615326|560138946|FG001|Overall Study|Withdrawal by Subject|3|||
155191011|NCT03615326|560138947|FG002|Overall Study|Withdrawal by Subject|0|||
155191012|NCT03615326|560138948|FG003|Overall Study|Withdrawal by Subject|0|||
155191013|NCT03615326|560138945|FG000|Overall Study|Participants Ongoing|83|||
155191014|NCT03615326|560138946|FG001|Overall Study|Participants Ongoing|58|||
155191015|NCT03615326|560138947|FG002|Overall Study|Participants Ongoing|6|||
155191016|NCT03615326|560138948|FG003|Overall Study|Participants Ongoing|3|||
155191017|NCT02651467|560138960|FG000|Overall Study|Withdrawal by Subject|0|||
155191018|NCT02651467|560138961|FG001|Overall Study|Withdrawal by Subject|0|||
155191019|NCT02651467|560138962|FG002|Overall Study|Withdrawal by Subject|2|||
155191020|NCT02651467|560138960|FG000|Overall Study|Other (Not specified)|1|||
155191021|NCT02651467|560138961|FG001|Overall Study|Other (Not specified)|0|||
155191022|NCT02651467|560138962|FG002|Overall Study|Other (Not specified)|2|||
155191023|NCT00004635|560138963|FG000|Period One|refused|2|||
155191024|NCT00004635|560138964|FG001|Period One|refused|1|||
155191025|NCT00004635|560138963|FG000|Period One|Withdrawal by Subject|1|||
155191026|NCT00004635|560138964|FG001|Period One|Withdrawal by Subject|1|||
155191027|NCT00004635|560138963|FG000|Period One|Protocol Violation|1|||
155720592|NCT02913482|562073504|FG001|Overall Study|Death|2|||
155720593|NCT02913482|562073505|FG002|Overall Study|Death|2|||
155191028|NCT00004635|560138964|FG001|Period One|Protocol Violation|0|||
155191029|NCT00004635|560138963|FG000|Period One|PSA did not go <5 ng/mL|1|||
155191030|NCT00004635|560138964|FG001|Period One|PSA did not go <5 ng/mL|0|||
155191031|NCT00004635|560138963|FG000|Period One|second malignancy|1|||
155191032|NCT00004635|560138964|FG001|Period One|second malignancy|0|||
155191033|NCT00004635|560138963|FG000|Period One|progressed|0|||
155191034|NCT00004635|560138964|FG001|Period One|progressed|2|||
155191035|NCT00004635|560138963|FG000|Period One|health problem|0|||
155191036|NCT00004635|560138964|FG001|Period One|health problem|1|||
155191037|NCT00004635|560138963|FG000|Period One|discrepancy in data entry|0|||
155191038|NCT00004635|560138964|FG001|Period One|discrepancy in data entry|1|||
155191039|NCT00004635|560138963|FG000|Period Two|progression|2|||
155191040|NCT00004635|560138964|FG001|Period Two|progression|3|||
155191041|NCT00004635|560138963|FG000|Period Two|Adverse Event|1|||
155191042|NCT00004635|560138964|FG001|Period Two|Adverse Event|0|||
155191043|NCT00004635|560138963|FG000|Period Two|refused|0|||
155191044|NCT00004635|560138964|FG001|Period Two|refused|2|||
155191045|NCT00004635|560138963|FG000|Period Two|health problem|1|||
155191046|NCT00004635|560138964|FG001|Period Two|health problem|1|||
155191047|NCT00004635|560138963|FG000|Period Two|travel issues|0|||
155191048|NCT00004635|560138964|FG001|Period Two|travel issues|1|||
155191049|NCT00004635|560138963|FG000|Period Two|secondary malignancy|1|||
155191050|NCT00004635|560138964|FG001|Period Two|secondary malignancy|1|||
155191051|NCT00004635|560138963|FG000|Period Two|Lost to Follow-up|1|||
155191052|NCT00004635|560138964|FG001|Period Two|Lost to Follow-up|0|||
155191053|NCT00004635|560138963|FG000|Period Two|discrepancy in data entry|0|||
155191054|NCT00004635|560138964|FG001|Period Two|discrepancy in data entry|1|||
155191055|NCT00191906|560138965|FG000|Study Period II|Adverse Event|0|||
155191056|NCT00191906|560138966|FG001|Study Period II|Adverse Event|1|||
155191057|NCT00191906|560138967|FG002|Study Period II|Adverse Event|0|||
155191058|NCT00191906|560138968|FG003|Study Period II|Adverse Event|0|||
155191059|NCT00191906|560138965|FG000|Study Period II|Withdrawal by Subject|0|||
155191060|NCT00191906|560138966|FG001|Study Period II|Withdrawal by Subject|3|||
155191061|NCT00191906|560138967|FG002|Study Period II|Withdrawal by Subject|0|||
155191062|NCT00191906|560138968|FG003|Study Period II|Withdrawal by Subject|0|||
155191063|NCT00191906|560138965|FG000|Study Period II|Parent/Caregiver Decision|0|||
155191064|NCT00191906|560138966|FG001|Study Period II|Parent/Caregiver Decision|1|||
155191065|NCT00191906|560138967|FG002|Study Period II|Parent/Caregiver Decision|0|||
155191066|NCT00191906|560138968|FG003|Study Period II|Parent/Caregiver Decision|0|||
155191067|NCT00191906|560138965|FG000|Study Period II|Entry Criteria Exclusion|0|||
155191068|NCT00191906|560138966|FG001|Study Period II|Entry Criteria Exclusion|0|||
155191069|NCT00191906|560138967|FG002|Study Period II|Entry Criteria Exclusion|1|||
155191070|NCT00191906|560138968|FG003|Study Period II|Entry Criteria Exclusion|0|||
155191071|NCT00191906|560138965|FG000|Study Period III|Adverse Event|1|||
155191072|NCT00191906|560138966|FG001|Study Period III|Adverse Event|0|||
155191073|NCT00191906|560138967|FG002|Study Period III|Adverse Event|0|||
155191074|NCT00191906|560138968|FG003|Study Period III|Adverse Event|0|||
155191075|NCT00191906|560138965|FG000|Study Period III|Lost to Follow-up|0|||
155191076|NCT00191906|560138966|FG001|Study Period III|Lost to Follow-up|1|||
155191077|NCT00191906|560138967|FG002|Study Period III|Lost to Follow-up|0|||
155191078|NCT00191906|560138968|FG003|Study Period III|Lost to Follow-up|0|||
155191079|NCT00191906|560138965|FG000|Study Period III|Parent/Caregiver Decision|1|||
155191080|NCT00191906|560138966|FG001|Study Period III|Parent/Caregiver Decision|0|||
155191081|NCT00191906|560138967|FG002|Study Period III|Parent/Caregiver Decision|0|||
155191082|NCT00191906|560138968|FG003|Study Period III|Parent/Caregiver Decision|0|||
155191083|NCT00191906|560138965|FG000|Study Period III|Lack of Efficacy|3|||
155191084|NCT00191906|560138966|FG001|Study Period III|Lack of Efficacy|3|||
155191085|NCT00191906|560138967|FG002|Study Period III|Lack of Efficacy|0|||
155191086|NCT00191906|560138968|FG003|Study Period III|Lack of Efficacy|0|||
155191087|NCT00573937|560138969|FG000|Overall Study|Study Terminated|0|||
155191088|NCT00573937|560138970|FG001|Overall Study|Study Terminated|1|||
155191089|NCT00333801|560138971|FG000|Overall Study|Moved to another state|5|||
155191090|NCT00333801|560138972|FG001|Overall Study|Moved to another state|3|||
155191091|NCT00333801|560138971|FG000|Overall Study|Lost to Follow-up|2|||
155191092|NCT00333801|560138972|FG001|Overall Study|Lost to Follow-up|0|||
155191093|NCT00333801|560138971|FG000|Overall Study|Incarcerated|1|||
155191094|NCT00333801|560138972|FG001|Overall Study|Incarcerated|2|||
155191095|NCT00333801|560138971|FG000|Overall Study|Withdrawal by Subject|0|||
155191096|NCT00333801|560138972|FG001|Overall Study|Withdrawal by Subject|1|||
155720594|NCT02913482|562073503|FG000|Overall Study|Progressive Disease|1|||
155191097|NCT00777205|560138973|FG000|Overall Study|Lost to Follow-up|25|||
155191098|NCT00777205|560138974|FG001|Overall Study|Lost to Follow-up|9|||
155191099|NCT00777205|560138973|FG000|Overall Study|Withdrawal by Subject|6|||
155191100|NCT00777205|560138974|FG001|Overall Study|Withdrawal by Subject|4|||
155191101|NCT00777205|560138973|FG000|Overall Study|Death|0|||
155191102|NCT00777205|560138974|FG001|Overall Study|Death|2|||
155191103|NCT00777205|560138973|FG000|Overall Study|Protocol Violation|0|||
155191104|NCT00777205|560138974|FG001|Overall Study|Protocol Violation|56|||
155191105|NCT00631696|560138977|FG000|Overall Study|Entered, not randomized to treatment|1|||
155191106|NCT00631696|560138978|FG001|Overall Study|Entered, not randomized to treatment|1|||
155191107|NCT00631696|560138977|FG000|Overall Study|Discontinued after database release date|1|||
155720595|NCT02913482|562073504|FG001|Overall Study|Progressive Disease|1|||
155191108|NCT00631696|560138978|FG001|Overall Study|Discontinued after database release date|0|||
155191109|NCT00631696|560138977|FG000|Overall Study|Follow up after database release date|1|||
155191110|NCT00631696|560138978|FG001|Overall Study|Follow up after database release date|0|||
155191111|NCT00631696|560138977|FG000|Overall Study|Lost to Follow-up|7|||
155191112|NCT00631696|560138978|FG001|Overall Study|Lost to Follow-up|10|||
155191113|NCT00631696|560138977|FG000|Overall Study|Withdrawal by Subject|2|||
155191114|NCT00631696|560138978|FG001|Overall Study|Withdrawal by Subject|9|||
155191115|NCT00631696|560138977|FG000|Overall Study|Other|8|||
155191116|NCT00631696|560138978|FG001|Overall Study|Other|8|||
155720596|NCT02913482|562073505|FG002|Overall Study|Progressive Disease|1|||
155720597|NCT02913482|562073503|FG000|Overall Study|Reason not specified|0|||
155720598|NCT02913482|562073504|FG001|Overall Study|Reason not specified|0|||
155720599|NCT02913482|562073505|FG002|Overall Study|Reason not specified|1|||
155720600|NCT02913482|562073503|FG000|Overall Study|Withdrawal by Subject|0|||
155720601|NCT02913482|562073504|FG001|Overall Study|Withdrawal by Subject|1|||
155720602|NCT02913482|562073505|FG002|Overall Study|Withdrawal by Subject|1|||
155720603|NCT05468814|562073506|FG000|Overall Study|Lost to Follow-up|5|||
155720604|NCT05468814|562073507|FG001|Overall Study|Lost to Follow-up|6|||
155720605|NCT04716426|562073509|FG000|Overall Study|Vaccination|1|||
155720606|NCT04716426|562073510|FG001|Overall Study|Vaccination|1|||
155720607|NCT04716426|562073509|FG000|Overall Study|Contamination|1|||
155720608|NCT04716426|562073510|FG001|Overall Study|Contamination|0|||
155720609|NCT01650558|562073515|FG000|Overall Study|Migration out of study area|61|||
155720610|NCT01650558|562073516|FG001|Overall Study|Migration out of study area|71|||
155191117|NCT00631696|560138977|FG000|Overall Study|Protocol Violation|9|||
155191118|NCT00631696|560138978|FG001|Overall Study|Protocol Violation|9|||
155191119|NCT00631696|560138977|FG000|Overall Study|Study terminated by sponsor|3|||
155191120|NCT00631696|560138978|FG001|Overall Study|Study terminated by sponsor|3|||
155191121|NCT00631696|560138977|FG000|Overall Study|Adverse Event|5|||
155191122|NCT00631696|560138978|FG001|Overall Study|Adverse Event|0|||
155191123|NCT01134731|560138979|FG000|Overall Study|Adverse Event|3|||
155191124|NCT01134731|560138980|FG001|Overall Study|Adverse Event|2|||
155191125|NCT01134731|560138981|FG002|Overall Study|Adverse Event|1|||
155191126|NCT01134731|560138979|FG000|Overall Study|Physician Decision|2|||
155191127|NCT01134731|560138980|FG001|Overall Study|Physician Decision|2|||
155191128|NCT01134731|560138981|FG002|Overall Study|Physician Decision|2|||
155191129|NCT01134731|560138979|FG000|Overall Study|Lack of Efficacy|0|||
155191130|NCT01134731|560138980|FG001|Overall Study|Lack of Efficacy|0|||
155191131|NCT01134731|560138981|FG002|Overall Study|Lack of Efficacy|1|||
155191132|NCT01134731|560138979|FG000|Overall Study|Withdrawal by Subject|3|||
155191133|NCT01134731|560138980|FG001|Overall Study|Withdrawal by Subject|3|||
155191134|NCT01134731|560138981|FG002|Overall Study|Withdrawal by Subject|1|||
155191135|NCT01134731|560138979|FG000|Overall Study|Lost to Follow-up|5|||
155191136|NCT01134731|560138980|FG001|Overall Study|Lost to Follow-up|4|||
155191137|NCT01134731|560138981|FG002|Overall Study|Lost to Follow-up|3|||
155191138|NCT05095454|560138982|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
155191139|NCT05095454|560138983|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
155191140|NCT00679055|560138984|FG000|Overall Study|Adverse Event|0|||
155191141|NCT00679055|560138985|FG001|Overall Study|Adverse Event|1|||
155191142|NCT00679055|560138984|FG000|Overall Study|Other|0|||
155191143|NCT00679055|560138985|FG001|Overall Study|Other|3|||
155191144|NCT00679055|560138984|FG000|Overall Study|Study Terminated|2|||
155191145|NCT00679055|560138985|FG001|Overall Study|Study Terminated|1|||
155191146|NCT00629772|560138986|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
155191147|NCT00629772|560138987|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
155191148|NCT00629772|560138986|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
155191149|NCT00629772|560138987|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
155191150|NCT03840174|560138988|FG000|Overall Study|Withdrawal by Subject|1|||
155191151|NCT03840174|560138989|FG001|Overall Study|Withdrawal by Subject|0|||
155191152|NCT03840174|560138990|FG002|Overall Study|Withdrawal by Subject|0|||
155720611|NCT01650558|562073517|FG002|Overall Study|Migration out of study area|56|||
155191153|NCT03840174|560138991|FG003|Overall Study|Withdrawal by Subject|0|||
155191154|NCT02410551|560138992|FG000|Overall Study|Adverse Event|1|||
155191155|NCT02410551|560138992|FG000|Overall Study|Withdrawal by Subject|1|||
155191156|NCT02410551|560138992|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
155191157|NCT01069627|560139000|FG000|Overall Study|Disease progression|7|||
155191158|NCT01069627|560139000|FG000|Overall Study|Adverse Event|12|||
155191159|NCT01069627|560139000|FG000|Overall Study|Protocol Violation|1|||
155191160|NCT04209348|560139001|FG000|Overall Study|Lost to Follow-up|1|||
155191161|NCT04209348|560139002|FG001|Overall Study|Lost to Follow-up|0|||
155191162|NCT02149875|560139008|FG000|Overall Study|Lost to Follow-up|3|||
155191163|NCT02149875|560139009|FG001|Overall Study|Lost to Follow-up|4|||
155191164|NCT02149875|560139010|FG002|Overall Study|Lost to Follow-up|5|||
155720612|NCT01650558|562073515|FG000|Overall Study|Lost to Follow-up|10|||
155720613|NCT01650558|562073516|FG001|Overall Study|Lost to Follow-up|13|||
155720614|NCT01650558|562073517|FG002|Overall Study|Lost to Follow-up|6|||
155720615|NCT01650558|562073515|FG000|Overall Study|Death|10|||
155191165|NCT02149875|560139008|FG000|Overall Study|Withdrawal by Subject|3|||
155191166|NCT02149875|560139009|FG001|Overall Study|Withdrawal by Subject|2|||
155191167|NCT02149875|560139010|FG002|Overall Study|Withdrawal by Subject|2|||
155191168|NCT02149875|560139008|FG000|Overall Study|Physician Decision|1|||
155191169|NCT02149875|560139009|FG001|Overall Study|Physician Decision|2|||
155191170|NCT02149875|560139010|FG002|Overall Study|Physician Decision|2|||
155191171|NCT02955797|560139014|FG000|Overall Study|Protocol Violation|1|||
155191172|NCT02955797|560139015|FG001|Overall Study|Protocol Violation|0|||
155191173|NCT02955797|560139016|FG002|Overall Study|Protocol Violation|0|||
155191174|NCT02955797|560139017|FG003|Overall Study|Protocol Violation|1|||
155191175|NCT02955797|560139014|FG000|Overall Study|Withdrawal by Subject|2|||
155191176|NCT02955797|560139015|FG001|Overall Study|Withdrawal by Subject|2|||
155191177|NCT02955797|560139016|FG002|Overall Study|Withdrawal by Subject|0|||
155191178|NCT02955797|560139017|FG003|Overall Study|Withdrawal by Subject|1|||
155191179|NCT02955797|560139014|FG000|Overall Study|Lost to Follow-up|0|||
155191180|NCT02955797|560139015|FG001|Overall Study|Lost to Follow-up|1|||
155191181|NCT02955797|560139016|FG002|Overall Study|Lost to Follow-up|0|||
155191182|NCT02955797|560139017|FG003|Overall Study|Lost to Follow-up|0|||
155191183|NCT03131453|560139018|FG000|Overall Study|Study terminated by Sponsor|424|||
155191184|NCT03131453|560139019|FG001|Overall Study|Study terminated by Sponsor|222|||
155191185|NCT03131453|560139020|FG002|Overall Study|Study terminated by Sponsor|438|||
155191186|NCT03131453|560139018|FG000|Overall Study|Withdrawal by Subject|18|||
155191187|NCT03131453|560139019|FG001|Overall Study|Withdrawal by Subject|7|||
155191188|NCT03131453|560139020|FG002|Overall Study|Withdrawal by Subject|13|||
155191189|NCT03131453|560139018|FG000|Overall Study|Adverse Event|10|||
155191190|NCT03131453|560139019|FG001|Overall Study|Adverse Event|3|||
155191191|NCT03131453|560139020|FG002|Overall Study|Adverse Event|3|||
155191192|NCT03131453|560139018|FG000|Overall Study|Lost to Follow-up|1|||
155191193|NCT03131453|560139019|FG001|Overall Study|Lost to Follow-up|0|||
155191194|NCT03131453|560139020|FG002|Overall Study|Lost to Follow-up|1|||
155191195|NCT03131453|560139018|FG000|Overall Study|Physician Decision|1|||
155191196|NCT03131453|560139019|FG001|Overall Study|Physician Decision|0|||
155191197|NCT03131453|560139020|FG002|Overall Study|Physician Decision|1|||
155191198|NCT03131453|560139018|FG000|Overall Study|Non-compliance with study treatment|1|||
155191199|NCT03131453|560139019|FG001|Overall Study|Non-compliance with study treatment|0|||
155191200|NCT03131453|560139020|FG002|Overall Study|Non-compliance with study treatment|0|||
155191201|NCT03131453|560139018|FG000|Overall Study|Technical problems|1|||
155191202|NCT03131453|560139019|FG001|Overall Study|Technical problems|0|||
155191203|NCT03131453|560139020|FG002|Overall Study|Technical problems|0|||
155191204|NCT03131453|560139018|FG000|Overall Study|Protocol deviation|0|||
155191205|NCT03131453|560139019|FG001|Overall Study|Protocol deviation|1|||
155191206|NCT03131453|560139020|FG002|Overall Study|Protocol deviation|0|||
155191207|NCT02081183|560139021|FG000|Overall Study|Lost to Follow-up|0|||
155191208|NCT02081183|560139022|FG001|Overall Study|Lost to Follow-up|1|||
155191209|NCT02081183|560139021|FG000|Overall Study|Protocol Violation|1|||
155720616|NCT01650558|562073516|FG001|Overall Study|Death|6|||
155720617|NCT01650558|562073517|FG002|Overall Study|Death|8|||
155720618|NCT01650558|562073515|FG000|Overall Study|Withdrawal by Subject|1|||
155720619|NCT01650558|562073516|FG001|Overall Study|Withdrawal by Subject|1|||
155720620|NCT01650558|562073517|FG002|Overall Study|Withdrawal by Subject|3|||
155720621|NCT01650558|562073515|FG000|Overall Study|Non-compliant participant|1|||
155720622|NCT01650558|562073516|FG001|Overall Study|Non-compliant participant|0|||
155720623|NCT01650558|562073517|FG002|Overall Study|Non-compliant participant|2|||
155720624|NCT01650558|562073515|FG000|Overall Study|Physician Decision|0|||
155720625|NCT01650558|562073516|FG001|Overall Study|Physician Decision|1|||
155720626|NCT01650558|562073517|FG002|Overall Study|Physician Decision|0|||
155720627|NCT02960217|562073518|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
155720628|NCT02960217|562073519|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
155720629|NCT02960217|562073518|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
155720630|NCT02960217|562073519|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
155720631|NCT02960217|562073518|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
155720632|NCT02960217|562073519|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
155720633|NCT02960217|562073518|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
155720634|NCT02960217|562073519|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
155720635|NCT02960217|562073518|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
155191210|NCT02081183|560139022|FG001|Overall Study|Protocol Violation|0|||
155191211|NCT02081183|560139021|FG000|Overall Study|Other|3|||
155191212|NCT02081183|560139022|FG001|Overall Study|Other|3|||
155720636|NCT02960217|562073519|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
155720637|NCT02960217|562073518|FG000|Open-Label Extension Phase|Adverse Event|1|||
155191213|NCT00543543|560139023|FG000|Base Study|Adverse Event|1|||
155191214|NCT00543543|560139024|FG001|Base Study|Adverse Event|11|||
155720638|NCT02960217|562073519|FG001|Open-Label Extension Phase|Adverse Event|0|||
155191215|NCT00543543|560139025|FG002|Base Study|Adverse Event|0|||
155191216|NCT00543543|560139026|FG003|Base Study|Adverse Event|5|||
155191217|NCT00543543|560139023|FG000|Base Study|Lost to Follow-up|12|||
155191218|NCT00543543|560139024|FG001|Base Study|Lost to Follow-up|749|||
155191219|NCT00543543|560139025|FG002|Base Study|Lost to Follow-up|9|||
155191220|NCT00543543|560139026|FG003|Base Study|Lost to Follow-up|701|||
155191221|NCT00543543|560139023|FG000|Base Study|Physician Decision|0|||
155191222|NCT00543543|560139024|FG001|Base Study|Physician Decision|4|||
155191223|NCT00543543|560139025|FG002|Base Study|Physician Decision|0|||
155191224|NCT00543543|560139026|FG003|Base Study|Physician Decision|7|||
155191225|NCT00543543|560139023|FG000|Base Study|Protocol Violation|0|||
155191226|NCT00543543|560139024|FG001|Base Study|Protocol Violation|6|||
155191227|NCT00543543|560139025|FG002|Base Study|Protocol Violation|0|||
155191228|NCT00543543|560139026|FG003|Base Study|Protocol Violation|6|||
155191229|NCT00543543|560139023|FG000|Base Study|Withdrawal by Subject|7|||
155191230|NCT00543543|560139024|FG001|Base Study|Withdrawal by Subject|482|||
155191231|NCT00543543|560139025|FG002|Base Study|Withdrawal by Subject|5|||
155191232|NCT00543543|560139026|FG003|Base Study|Withdrawal by Subject|503|||
155191233|NCT00543543|560139023|FG000|Extension Study|Adverse Event|0|||
155191234|NCT00543543|560139024|FG001|Extension Study|Adverse Event|0|||
155191235|NCT00543543|560139025|FG002|Extension Study|Adverse Event|0|||
155191236|NCT00543543|560139026|FG003|Extension Study|Adverse Event|5|||
155191237|NCT00543543|560139023|FG000|Extension Study|Lost to Follow-up|0|||
155191238|NCT00543543|560139024|FG001|Extension Study|Lost to Follow-up|0|||
155191239|NCT00543543|560139025|FG002|Extension Study|Lost to Follow-up|0|||
155191240|NCT00543543|560139026|FG003|Extension Study|Lost to Follow-up|77|||
155191241|NCT00543543|560139023|FG000|Extension Study|Physician Decision|0|||
155191242|NCT00543543|560139024|FG001|Extension Study|Physician Decision|0|||
155191243|NCT00543543|560139025|FG002|Extension Study|Physician Decision|0|||
155191244|NCT00543543|560139026|FG003|Extension Study|Physician Decision|7|||
155191245|NCT00543543|560139023|FG000|Extension Study|Pregnancy|0|||
155191246|NCT00543543|560139024|FG001|Extension Study|Pregnancy|0|||
155191247|NCT00543543|560139025|FG002|Extension Study|Pregnancy|0|||
155191248|NCT00543543|560139026|FG003|Extension Study|Pregnancy|6|||
155191249|NCT00543543|560139023|FG000|Extension Study|Protocol Violation|0|||
155191250|NCT00543543|560139024|FG001|Extension Study|Protocol Violation|0|||
155191251|NCT00543543|560139025|FG002|Extension Study|Protocol Violation|0|||
155191252|NCT00543543|560139026|FG003|Extension Study|Protocol Violation|11|||
155191253|NCT00543543|560139023|FG000|Extension Study|Withdrawal by Subject|0|||
155191254|NCT00543543|560139024|FG001|Extension Study|Withdrawal by Subject|0|||
155191255|NCT00543543|560139025|FG002|Extension Study|Withdrawal by Subject|0|||
155191256|NCT00543543|560139026|FG003|Extension Study|Withdrawal by Subject|120|||
155191257|NCT04308304|560139027|FG000|Overall Study|Withdrawal by Subject|4|||
155191258|NCT04308304|560139028|FG001|Overall Study|Withdrawal by Subject|0|||
155191259|NCT04308304|560139027|FG000|Overall Study|Protocol Violation|1|||
155191260|NCT04308304|560139028|FG001|Overall Study|Protocol Violation|0|||
155191261|NCT00945555|560139029|FG000|Overall Study|Referred to another hospital|5|||
155191262|NCT00945555|560139029|FG000|Overall Study|Worsening condition, intensive care unit|1|||
155191263|NCT00945555|560139029|FG000|Overall Study|Withdrawal by Subject|2|||
155191264|NCT00945555|560139029|FG000|Overall Study|Participant continued treatment at home|1|||
155191265|NCT00945555|560139029|FG000|Overall Study|Death|18|||
155191266|NCT00945555|560139029|FG000|Overall Study|Other|1|||
155191267|NCT04502979|560139031|FG000|Overall Study|Lost to Follow-up|1|||
155191268|NCT04502979|560139032|FG001|Overall Study|Lost to Follow-up|3|||
155191269|NCT04502979|560139031|FG000|Overall Study|Withdrawal by Subject|2|||
155191270|NCT04502979|560139032|FG001|Overall Study|Withdrawal by Subject|1|||
155720639|NCT02960217|562073518|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
155720640|NCT02960217|562073519|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
155720641|NCT02960217|562073518|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
155720642|NCT02960217|562073519|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
155720643|NCT02960217|562073518|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
155720644|NCT02960217|562073519|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
155720645|NCT00918385|562073520|FG000|Monotherapy|Adverse Event|1|||
155720646|NCT00918385|562073521|FG001|Monotherapy|Adverse Event|6|||
155720647|NCT00918385|562073520|FG000|Monotherapy|Complicating illness|1|||
155720648|NCT00918385|562073521|FG001|Monotherapy|Complicating illness|0|||
155720649|NCT00918385|562073520|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
155720650|NCT00918385|562073521|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
155191271|NCT00165984|560139036|FG000|Overall Study|Death|15|||
155191272|NCT01686828|560139037|FG000|Overall Study|Physician Decision|1|||
155191273|NCT01686828|560139038|FG001|Overall Study|Physician Decision|0|||
155191274|NCT01686828|560139039|FG002|Overall Study|Physician Decision|0|||
155191275|NCT01686828|560139040|FG003|Overall Study|Physician Decision|0|||
155191276|NCT01686828|560139037|FG000|Overall Study|New Job|0|||
155191277|NCT01686828|560139038|FG001|Overall Study|New Job|1|||
155720651|NCT00918385|562073520|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
155191278|NCT01686828|560139039|FG002|Overall Study|New Job|0|||
155191279|NCT01686828|560139040|FG003|Overall Study|New Job|0|||
155191280|NCT01686828|560139037|FG000|Overall Study|Weight Loss|0|||
155191281|NCT01686828|560139038|FG001|Overall Study|Weight Loss|0|||
155191282|NCT01686828|560139039|FG002|Overall Study|Weight Loss|1|||
155191283|NCT01686828|560139040|FG003|Overall Study|Weight Loss|0|||
155720652|NCT00918385|562073521|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
155720653|NCT00918385|562073520|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
155720654|NCT00918385|562073521|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
155720655|NCT00918385|562073520|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
155720656|NCT00918385|562073521|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
155720657|NCT01476722|562073523|FG000|Overall Study|Adverse Event|1|||
155720658|NCT00625131|562073528|FG000|Overall Study|Lost to Follow-up|3|||
155720659|NCT00625131|562073529|FG001|Overall Study|Lost to Follow-up|2|||
155720660|NCT00625131|562073530|FG002|Overall Study|Lost to Follow-up|0|||
155191284|NCT01736124|560139041|FG000|Post-intervention Assessment|Death|2|||
155191285|NCT01736124|560139042|FG001|Post-intervention Assessment|Death|2|||
155191286|NCT01736124|560139041|FG000|Post-intervention Assessment|lost computer access|1|||
155191287|NCT01736124|560139042|FG001|Post-intervention Assessment|lost computer access|1|||
155191288|NCT01736124|560139041|FG000|Post-intervention Assessment|Moved away|3|||
155191289|NCT01736124|560139042|FG001|Post-intervention Assessment|Moved away|1|||
155191290|NCT01736124|560139041|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
155191291|NCT01736124|560139042|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
155191292|NCT01736124|560139041|FG000|Post-intervention Assessment|Illness|3|||
155191293|NCT01736124|560139042|FG001|Post-intervention Assessment|Illness|2|||
155191294|NCT01736124|560139041|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
155191295|NCT01736124|560139042|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
155191296|NCT01736124|560139041|FG000|Post-intervention Assessment|Temporarily away|3|||
155191297|NCT01736124|560139042|FG001|Post-intervention Assessment|Temporarily away|1|||
155191298|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
155191299|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
155191300|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
155191301|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
155191302|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
155191303|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
155191304|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
155191305|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
155191306|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
155191307|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
155191308|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
155191309|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
155191310|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
155191311|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
155191312|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
155191313|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
155191314|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
155191315|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
155191316|NCT02734433|560139043|FG000|Overall Study|Disease progression|1|||
155191317|NCT02734433|560139044|FG001|Overall Study|Disease progression|5|||
155191318|NCT02734433|560139043|FG000|Overall Study|Clinical progression|0|||
155191319|NCT02734433|560139044|FG001|Overall Study|Clinical progression|1|||
155191320|NCT02734433|560139043|FG000|Overall Study|Withdrawal by Subject|1|||
155191321|NCT02734433|560139044|FG001|Overall Study|Withdrawal by Subject|2|||
155191322|NCT03698331|560139045|FG000|Overall Study|Adverse Event|2|||
155191323|NCT03698331|560139046|FG001|Overall Study|Adverse Event|3|||
155191324|NCT03698331|560139045|FG000|Overall Study|Withdrawal by Subject|1|||
155191325|NCT03698331|560139046|FG001|Overall Study|Withdrawal by Subject|1|||
155191326|NCT03698331|560139045|FG000|Overall Study|Lost to Follow-up|0|||
155191327|NCT03698331|560139046|FG001|Overall Study|Lost to Follow-up|2|||
155191328|NCT03698331|560139045|FG000|Overall Study|Non-compliance with study drug|1|||
155191329|NCT03698331|560139046|FG001|Overall Study|Non-compliance with study drug|0|||
155191330|NCT02719327|560139062|FG000|Overall Study|Withdrawal by Subject|11|||
155191331|NCT02719327|560139063|FG001|Overall Study|Withdrawal by Subject|8|||
155191332|NCT04063384|560140713|FG000|Overall Study|placebo manipulation issue|1|||
155191333|NCT04063384|560140714|FG001|Overall Study|placebo manipulation issue|2|||
155191334|NCT04063384|560140715|FG002|Overall Study|placebo manipulation issue|1|||
155191335|NCT04063384|560140716|FG003|Overall Study|placebo manipulation issue|1|||
155191336|NCT01926015|560140720|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155191337|NCT01926015|560140721|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155191338|NCT01926015|560140720|FG000|Overall Study|Randomized not treated|2|||
155191339|NCT01926015|560140721|FG001|Overall Study|Randomized not treated|0|||
155191340|NCT01364649|560140722|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
155191341|NCT01364649|560140723|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
155191342|NCT01364649|560140722|FG000|Overall Study|Lack of Efficacy|6|||
155191343|NCT01364649|560140723|FG001|Overall Study|Lack of Efficacy|0|||
155191344|NCT01364649|560140722|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
155191345|NCT01364649|560140723|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
155191346|NCT01364649|560140722|FG000|Overall Study|Protocol Deviations|4|||
155191347|NCT01364649|560140723|FG001|Overall Study|Protocol Deviations|8|||
155720661|NCT00625131|562073528|FG000|Overall Study|Withdrawal by Subject|1|||
155720662|NCT00625131|562073529|FG001|Overall Study|Withdrawal by Subject|0|||
155720663|NCT00625131|562073530|FG002|Overall Study|Withdrawal by Subject|5|||
155191348|NCT01364649|560140722|FG000|Overall Study|Withdrawal of Consent|9|||
155191349|NCT01364649|560140723|FG001|Overall Study|Withdrawal of Consent|7|||
155191350|NCT01364649|560140722|FG000|Overall Study|Lost to Follow-up|12|||
155191351|NCT01364649|560140723|FG001|Overall Study|Lost to Follow-up|13|||
155191352|NCT01364649|560140722|FG000|Overall Study|Other|4|||
155191353|NCT01364649|560140723|FG001|Overall Study|Other|1|||
155191354|NCT02468232|560140726|FG000|Core Part of Study|Adverse Event|0|||
155191355|NCT02468232|560140727|FG001|Core Part of Study|Adverse Event|1|||
155191356|NCT02468232|560140728|FG002|Core Part of Study|Adverse Event|0|||
155191357|NCT02468232|560140729|FG003|Core Part of Study|Adverse Event|0|||
155191358|NCT02468232|560140726|FG000|Core Part of Study|Death|20|||
155191359|NCT02468232|560140727|FG001|Core Part of Study|Death|17|||
155191360|NCT02468232|560140728|FG002|Core Part of Study|Death|0|||
155191361|NCT02468232|560140729|FG003|Core Part of Study|Death|0|||
155191362|NCT02468232|560140726|FG000|Core Part of Study|Technical Problems|1|||
155191363|NCT02468232|560140727|FG001|Core Part of Study|Technical Problems|1|||
155191364|NCT02468232|560140728|FG002|Core Part of Study|Technical Problems|0|||
155191365|NCT02468232|560140729|FG003|Core Part of Study|Technical Problems|0|||
155191366|NCT02468232|560140726|FG000|OLE Part of Study|Adverse Event|0|||
155191367|NCT02468232|560140727|FG001|OLE Part of Study|Adverse Event|0|||
155191368|NCT02468232|560140728|FG002|OLE Part of Study|Adverse Event|4|||
155191369|NCT02468232|560140729|FG003|OLE Part of Study|Adverse Event|5|||
155191370|NCT02468232|560140726|FG000|OLE Part of Study|Death|0|||
155191371|NCT02468232|560140727|FG001|OLE Part of Study|Death|0|||
155191372|NCT02468232|560140728|FG002|OLE Part of Study|Death|4|||
155191373|NCT02468232|560140729|FG003|OLE Part of Study|Death|2|||
155191374|NCT02468232|560140726|FG000|OLE Part of Study|Physician Decision|0|||
155191375|NCT02468232|560140727|FG001|OLE Part of Study|Physician Decision|0|||
155191376|NCT02468232|560140728|FG002|OLE Part of Study|Physician Decision|4|||
155191377|NCT02468232|560140729|FG003|OLE Part of Study|Physician Decision|0|||
155191378|NCT02468232|560140726|FG000|OLE Part of Study|Subject/Guardian decision|0|||
155191379|NCT02468232|560140727|FG001|OLE Part of Study|Subject/Guardian decision|0|||
155191380|NCT02468232|560140728|FG002|OLE Part of Study|Subject/Guardian decision|2|||
155191381|NCT02468232|560140729|FG003|OLE Part of Study|Subject/Guardian decision|5|||
155191382|NCT01826604|560140730|FG000|Overall Study|Lost to Follow-up|8|||
155191383|NCT01826604|560140731|FG001|Overall Study|Lost to Follow-up|9|||
155191384|NCT04540497|560140734|FG000|Overall Study|Adverse Event|0|||
155191385|NCT04540497|560140735|FG001|Overall Study|Adverse Event|2|||
155191386|NCT04540497|560140734|FG000|Overall Study|Lost to Follow-up|1|||
155191387|NCT04540497|560140735|FG001|Overall Study|Lost to Follow-up|0|||
155191388|NCT04540497|560140734|FG000|Overall Study|Withdrawal by Subject|1|||
155191389|NCT04540497|560140735|FG001|Overall Study|Withdrawal by Subject|1|||
155720664|NCT00918281|562073533|FG000|Overall Study|Physician Decision|29|||
155191390|NCT04540497|560140734|FG000|Overall Study|Miscellaneous|2|||
155191391|NCT04540497|560140735|FG001|Overall Study|Miscellaneous|1|||
155191392|NCT05274815|560140736|FG000|Overall Study|Adverse Event|1|||
155191393|NCT05274815|560140736|FG000|Overall Study|Death|2|||
155191394|NCT05274815|560140736|FG000|Overall Study|Lost to Follow-up|4|||
155191395|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
155191396|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
155191397|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
155191398|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
155191399|NCT05274815|560140736|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
155191400|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
155191401|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
155191402|NCT05274815|560140736|FG000|Overall Study|Withdrawal by Subject|11|||
155191403|NCT06132659|560140737|FG000|Overall Study|Lost to Follow-up|0|||
155191404|NCT06132659|560140738|FG001|Overall Study|Lost to Follow-up|1|||
155191405|NCT06132659|560140739|FG002|Overall Study|Lost to Follow-up|0|||
155191406|NCT03914326|560140740|FG000|Overall Study|Withdrawal by Subject|27|||
155191407|NCT03914326|560140741|FG001|Overall Study|Withdrawal by Subject|34|||
155191408|NCT03914326|560140740|FG000|Overall Study|Lost to Follow-up|43|||
155191409|NCT03914326|560140741|FG001|Overall Study|Lost to Follow-up|51|||
155191410|NCT03914326|560140740|FG000|Overall Study|Randomised more than once|0|||
155191411|NCT03914326|560140741|FG001|Overall Study|Randomised more than once|1|||
155191412|NCT04798781|560140742|FG000|Overall Study|Withdrawal by Subject|1|||
155191413|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
155191414|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
155191415|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
155191416|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
155191417|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
155191418|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
155191419|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
155191420|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
155191421|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
155191422|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
155191423|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
155191424|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
155191425|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
155191426|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
155191427|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
155191428|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
155191429|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
155191430|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
155191431|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
155191432|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
155191433|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
155191434|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
155191435|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
155191436|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
155191437|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Death|2|||
155191438|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Death|1|||
155191439|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Death|0|||
155191440|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Death|0|||
155191441|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
155191442|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191443|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191444|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191445|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155191446|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155191447|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
155191448|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
155191449|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
155191450|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
155191451|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
155191452|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
155191453|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
155191454|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
155191455|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
155191456|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
155191457|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
155191458|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
155191459|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
155191460|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
155191461|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
155191462|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
155191463|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
155191464|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
155191465|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
155191466|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
155191467|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
155191468|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
155191469|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
155191470|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
155191471|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
155191472|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
155191473|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191474|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191475|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
155191476|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191477|NCT03198078|560140750|FG000|Overall Study|Adverse Event|0|||
155191478|NCT03198078|560140751|FG001|Overall Study|Adverse Event|1|||
155191479|NCT03198078|560140752|FG002|Overall Study|Adverse Event|2|||
155191480|NCT03198078|560140750|FG000|Overall Study|Lack of Efficacy|0|||
155191481|NCT03198078|560140751|FG001|Overall Study|Lack of Efficacy|0|||
155191482|NCT03198078|560140752|FG002|Overall Study|Lack of Efficacy|3|||
155191483|NCT03198078|560140750|FG000|Overall Study|Lost to Follow-up|1|||
155191484|NCT03198078|560140751|FG001|Overall Study|Lost to Follow-up|0|||
155191485|NCT03198078|560140752|FG002|Overall Study|Lost to Follow-up|0|||
155191486|NCT03198078|560140750|FG000|Overall Study|Pregnancy|0|||
155191487|NCT03198078|560140751|FG001|Overall Study|Pregnancy|1|||
155191488|NCT03198078|560140752|FG002|Overall Study|Pregnancy|0|||
155191489|NCT03198078|560140750|FG000|Overall Study|Withdrawal by Subject|1|||
155191490|NCT03198078|560140751|FG001|Overall Study|Withdrawal by Subject|0|||
155191491|NCT03198078|560140752|FG002|Overall Study|Withdrawal by Subject|2|||
155191492|NCT03198078|560140750|FG000|Overall Study|Withdrawal by Caregiver|1|||
155191493|NCT03198078|560140751|FG001|Overall Study|Withdrawal by Caregiver|3|||
155191494|NCT03198078|560140752|FG002|Overall Study|Withdrawal by Caregiver|5|||
155191495|NCT01676727|560140753|FG000|Overall Study|Death|18|||
155720665|NCT02978417|562073535|FG000|Overall Study|Lost to Follow-up|2|||
155720666|NCT02978417|562073536|FG001|Overall Study|Lost to Follow-up|2|||
155720667|NCT02675907|562073539|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
155720668|NCT02675907|562073540|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
155720669|NCT02675907|562073539|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
155720670|NCT02675907|562073540|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
155720671|NCT02675907|562073539|FG000|Study Overall|Lack of Efficacy|1|||
155191496|NCT01676727|560140753|FG000|Overall Study|Withdrawal by Subject|6|||
155191497|NCT01676727|560140753|FG000|Overall Study|Screening failure|5|||
155191498|NCT01676727|560140753|FG000|Overall Study|Not willing to attend 1-year visit|2|||
155191499|NCT01676727|560140753|FG000|Overall Study|Valve explanted|1|||
155191500|NCT00722423|560140755|FG000|Overall Study|Protocol Violation|0|||
155191501|NCT00722423|560140756|FG001|Overall Study|Protocol Violation|1|||
155191502|NCT00737438|560140759|FG000|Overall Study|Withdrawal by Subject|2|||
155191503|NCT00737438|560140759|FG000|Overall Study|Patient ineligible|1|||
155191504|NCT05469113|560140760|FG000|Period 2|Adverse Event|0|||
155191505|NCT05469113|560140761|FG001|Period 2|Adverse Event|3|||
155191506|NCT03755791|560140763|FG000|Overall Study|Did not receive any study treatment|3|||
155191507|NCT03755791|560140764|FG001|Overall Study|Did not receive any study treatment|0|||
155191508|NCT03755791|560140765|FG002|Overall Study|Did not receive any study treatment|10|||
155191509|NCT03755791|560140763|FG000|Overall Study|Radiographic progression|204|||
155191510|NCT03755791|560140764|FG001|Overall Study|Radiographic progression|92|||
155191511|NCT03755791|560140765|FG002|Overall Study|Radiographic progression|115|||
155191512|NCT03755791|560140763|FG000|Overall Study|Adverse Event|140|||
155720672|NCT02675907|562073540|FG001|Study Overall|Lack of Efficacy|0|||
155191513|NCT03755791|560140764|FG001|Overall Study|Adverse Event|60|||
155191514|NCT03755791|560140765|FG002|Overall Study|Adverse Event|51|||
155191515|NCT03755791|560140763|FG000|Overall Study|Lack of Efficacy|12|||
155191516|NCT03755791|560140764|FG001|Overall Study|Lack of Efficacy|6|||
155191517|NCT03755791|560140765|FG002|Overall Study|Lack of Efficacy|6|||
155191518|NCT03755791|560140763|FG000|Overall Study|Withdrawal by Subject|26|||
155191519|NCT03755791|560140764|FG001|Overall Study|Withdrawal by Subject|23|||
155191520|NCT03755791|560140765|FG002|Overall Study|Withdrawal by Subject|24|||
155191521|NCT03755791|560140763|FG000|Overall Study|Sponsor decision,|41|||
155191522|NCT03755791|560140764|FG001|Overall Study|Sponsor decision,|5|||
155191523|NCT03755791|560140765|FG002|Overall Study|Sponsor decision,|7|||
155191524|NCT03755791|560140763|FG000|Overall Study|Lost to Follow-up|1|||
155191525|NCT03755791|560140764|FG001|Overall Study|Lost to Follow-up|0|||
155191526|NCT03755791|560140765|FG002|Overall Study|Lost to Follow-up|2|||
155191527|NCT03755791|560140763|FG000|Overall Study|Protocol Violation|0|||
155191528|NCT03755791|560140764|FG001|Overall Study|Protocol Violation|0|||
155191529|NCT03755791|560140765|FG002|Overall Study|Protocol Violation|2|||
155191530|NCT03755791|560140763|FG000|Overall Study|Other than specified|5|||
155191531|NCT03755791|560140764|FG001|Overall Study|Other than specified|2|||
155191532|NCT03755791|560140765|FG002|Overall Study|Other than specified|0|||
155191533|NCT01986140|560140766|FG000|Overall Study|Withdrawal by Subject|31|||
155191534|NCT01986140|560140767|FG001|Overall Study|Withdrawal by Subject|25|||
155191535|NCT01986140|560140766|FG000|Overall Study|alternative treatment|1|||
155191536|NCT01986140|560140767|FG001|Overall Study|alternative treatment|1|||
155191537|NCT01986140|560140766|FG000|Overall Study|found not eligible|3|||
155191538|NCT01986140|560140767|FG001|Overall Study|found not eligible|0|||
155191539|NCT01986140|560140766|FG000|Overall Study|Adverse Event|0|||
155191540|NCT01986140|560140767|FG001|Overall Study|Adverse Event|1|||
155191541|NCT01986140|560140766|FG000|Overall Study|progression disease|0|||
155191542|NCT01986140|560140767|FG001|Overall Study|progression disease|1|||
155191543|NCT00464269|560140774|FG000|Overall Study|Lack of Efficacy|1|||
155191544|NCT00464269|560140775|FG001|Overall Study|Lack of Efficacy|0|||
155191545|NCT00464269|560140776|FG002|Overall Study|Lack of Efficacy|0|||
155191546|NCT00464269|560140777|FG003|Overall Study|Lack of Efficacy|0|||
155191547|NCT00464269|560140774|FG000|Overall Study|Lost to Follow-up|0|||
155720673|NCT02675907|562073539|FG000|Study Overall|Withdrawal by Subject|2|||
155191548|NCT00464269|560140775|FG001|Overall Study|Lost to Follow-up|4|||
155191549|NCT00464269|560140776|FG002|Overall Study|Lost to Follow-up|0|||
155191550|NCT00464269|560140777|FG003|Overall Study|Lost to Follow-up|1|||
155191551|NCT00464269|560140774|FG000|Overall Study|Withdrawal by Subject|0|||
155191552|NCT00464269|560140775|FG001|Overall Study|Withdrawal by Subject|2|||
155191553|NCT00464269|560140776|FG002|Overall Study|Withdrawal by Subject|1|||
155191554|NCT00464269|560140777|FG003|Overall Study|Withdrawal by Subject|1|||
155191555|NCT00464269|560140774|FG000|Overall Study|Other reason|3|||
155191556|NCT00464269|560140775|FG001|Overall Study|Other reason|3|||
155191557|NCT00464269|560140776|FG002|Overall Study|Other reason|1|||
155191558|NCT00464269|560140777|FG003|Overall Study|Other reason|1|||
155191559|NCT00464269|560140774|FG000|Overall Study|AE, serious fatal|0|||
155191560|NCT00464269|560140775|FG001|Overall Study|AE, serious fatal|0|||
155191561|NCT00464269|560140776|FG002|Overall Study|AE, serious fatal|1|||
155191562|NCT00464269|560140777|FG003|Overall Study|AE, serious fatal|1|||
155191563|NCT00464269|560140774|FG000|Overall Study|SAE, non-fatal|0|||
155191564|NCT00464269|560140775|FG001|Overall Study|SAE, non-fatal|0|||
155191565|NCT00464269|560140776|FG002|Overall Study|SAE, non-fatal|0|||
155191566|NCT00464269|560140777|FG003|Overall Study|SAE, non-fatal|1|||
155191567|NCT00464269|560140774|FG000|Overall Study|AE, non-serious non-fatal|2|||
155191568|NCT00464269|560140775|FG001|Overall Study|AE, non-serious non-fatal|8|||
155191569|NCT00464269|560140776|FG002|Overall Study|AE, non-serious non-fatal|3|||
155191570|NCT00464269|560140777|FG003|Overall Study|AE, non-serious non-fatal|4|||
155191571|NCT00464269|560140774|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191572|NCT00464269|560140775|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191573|NCT00464269|560140776|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
155191574|NCT00464269|560140777|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191575|NCT05055128|560140778|FG000|Overall Study|Adverse Event|0|||
155191576|NCT05055128|560140779|FG001|Overall Study|Adverse Event|0|||
155191577|NCT05055128|560140780|FG002|Overall Study|Adverse Event|0|||
155191578|NCT05055128|560140781|FG003|Overall Study|Adverse Event|1|||
155191579|NCT05055128|560140782|FG004|Overall Study|Adverse Event|1|||
155191580|NCT05055128|560140778|FG000|Overall Study|Protocol Violation|0|||
155191581|NCT05055128|560140779|FG001|Overall Study|Protocol Violation|0|||
155191582|NCT05055128|560140780|FG002|Overall Study|Protocol Violation|0|||
155191583|NCT05055128|560140781|FG003|Overall Study|Protocol Violation|1|||
155191584|NCT05055128|560140782|FG004|Overall Study|Protocol Violation|0|||
155191585|NCT05055128|560140778|FG000|Overall Study|Withdrawal by Subject|5|||
155191586|NCT05055128|560140779|FG001|Overall Study|Withdrawal by Subject|2|||
155191587|NCT05055128|560140780|FG002|Overall Study|Withdrawal by Subject|2|||
155191588|NCT05055128|560140781|FG003|Overall Study|Withdrawal by Subject|4|||
155191589|NCT05055128|560140782|FG004|Overall Study|Withdrawal by Subject|2|||
155191590|NCT05055128|560140778|FG000|Overall Study|Randomized By Mistake|0|||
155191591|NCT05055128|560140779|FG001|Overall Study|Randomized By Mistake|1|||
155191592|NCT05055128|560140780|FG002|Overall Study|Randomized By Mistake|0|||
155191593|NCT05055128|560140781|FG003|Overall Study|Randomized By Mistake|0|||
155191594|NCT05055128|560140782|FG004|Overall Study|Randomized By Mistake|0|||
155191595|NCT05055128|560140778|FG000|Overall Study|Other|1|||
155191596|NCT05055128|560140779|FG001|Overall Study|Other|0|||
155191597|NCT05055128|560140780|FG002|Overall Study|Other|0|||
155191598|NCT05055128|560140781|FG003|Overall Study|Other|0|||
155191599|NCT05055128|560140782|FG004|Overall Study|Other|0|||
155191600|NCT00747461|560140789|FG000|Overall Study|study terminated by sponsor|5|||
155191601|NCT04176705|560140791|FG000|Overall Study|Withdrawal by Subject|4|||
155191602|NCT04176705|560140792|FG001|Overall Study|Withdrawal by Subject|4|||
155191603|NCT04176705|560140791|FG000|Overall Study|Death|1|||
155191604|NCT04176705|560140792|FG001|Overall Study|Death|1|||
155191605|NCT04176705|560140791|FG000|Overall Study|Lost to Follow-up|3|||
155191606|NCT04176705|560140792|FG001|Overall Study|Lost to Follow-up|3|||
155191607|NCT04916769|560140795|FG000|Period 1|Physician Decision|0|||
155191608|NCT04916769|560140796|FG001|Period 1|Physician Decision|0|||
155191609|NCT04916769|560140797|FG002|Period 1|Physician Decision|0|||
155191610|NCT04916769|560140798|FG003|Period 1|Physician Decision|0|||
155191611|NCT04916769|560140799|FG004|Period 1|Physician Decision|0|||
155191612|NCT04916769|560140800|FG005|Period 1|Physician Decision|1|||
155191613|NCT04916769|560140795|FG000|Period 2|Physician Decision|0|||
155191614|NCT04916769|560140796|FG001|Period 2|Physician Decision|1|||
155191615|NCT04916769|560140797|FG002|Period 2|Physician Decision|0|||
155191616|NCT04916769|560140798|FG003|Period 2|Physician Decision|0|||
155191617|NCT04916769|560140799|FG004|Period 2|Physician Decision|0|||
155191618|NCT04916769|560140800|FG005|Period 2|Physician Decision|0|||
155191619|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
155191620|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
155191621|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
155191622|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
155191623|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
155191624|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
155191625|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
155191626|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
155191627|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
155191628|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
155191629|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
155191630|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
155191631|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Other|1|||
155191632|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Other|3|||
155191633|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Other|9|||
155191634|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
155191635|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
155191636|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
155191637|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
155191638|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
155191639|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
155191640|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
155191641|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
155191642|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
155191643|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
155191644|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
155191645|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
155191646|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
155191647|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
155191648|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
155191649|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
155191650|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
155191651|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
155191652|NCT03805646|560140804|FG000|Overall Study|Death|40|||
155191653|NCT03805646|560140805|FG001|Overall Study|Death|49|||
155191654|NCT03805646|560140804|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
155191655|NCT03805646|560140805|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
155191656|NCT04686786|560140807|FG000|Overall Study|Adverse Event|9|||
155191657|NCT04686786|560140807|FG000|Overall Study|Death|1|||
155191658|NCT04686786|560140807|FG000|Overall Study|Lack of Efficacy|25|||
155191659|NCT04686786|560140807|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155191660|NCT04686786|560140807|FG000|Overall Study|Study Terminated by Sponsor|14|||
155191661|NCT04686786|560140807|FG000|Overall Study|Withdrawal by Subject|15|||
155191662|NCT04686786|560140807|FG000|Overall Study|Other than specified|1|||
155191663|NCT05628103|560140808|FG000|Overall Study|Adverse Event|7|||
155191664|NCT05628103|560140808|FG000|Overall Study|Withdrawal by Subject|3|||
155191665|NCT05628103|560140808|FG000|Overall Study|Lost to Follow-up|3|||
155191666|NCT05628103|560140808|FG000|Overall Study|Lack of Efficacy|1|||
155191667|NCT05628103|560140808|FG000|Overall Study|Non-Compliance With Study Drug|4|||
155191668|NCT04840888|560140809|FG000|Period 1|Withdrawal by Subject|0|||
155191669|NCT04840888|560140810|FG001|Period 1|Withdrawal by Subject|0|||
155191670|NCT04840888|560140811|FG002|Period 1|Withdrawal by Subject|0|||
155191671|NCT04840888|560140812|FG003|Period 1|Withdrawal by Subject|0|||
155191672|NCT04840888|560140813|FG004|Period 1|Withdrawal by Subject|1|||
155191673|NCT04840888|560140814|FG005|Period 1|Withdrawal by Subject|0|||
155191674|NCT04840888|560140809|FG000|Period 1|Adverse Event|0|||
155191675|NCT04840888|560140810|FG001|Period 1|Adverse Event|0|||
155191676|NCT04840888|560140811|FG002|Period 1|Adverse Event|1|||
155191677|NCT04840888|560140812|FG003|Period 1|Adverse Event|1|||
155191678|NCT04840888|560140813|FG004|Period 1|Adverse Event|10|||
155191679|NCT04840888|560140814|FG005|Period 1|Adverse Event|1|||
155191680|NCT04340193|560140816|FG000|Overall Study|Other reason|0|||
155191681|NCT04340193|560140817|FG001|Overall Study|Other reason|0|||
155191682|NCT04340193|560140818|FG002|Overall Study|Other reason|1|||
155191683|NCT04340193|560140816|FG000|Overall Study|Disease recurrence|0|||
155191684|NCT04340193|560140817|FG001|Overall Study|Disease recurrence|1|||
155191685|NCT04340193|560140818|FG002|Overall Study|Disease recurrence|0|||
155191686|NCT04340193|560140816|FG000|Overall Study|Study drug toxicity|1|||
155191687|NCT04340193|560140817|FG001|Overall Study|Study drug toxicity|0|||
155191688|NCT04340193|560140818|FG002|Overall Study|Study drug toxicity|0|||
155191689|NCT04340193|560140816|FG000|Overall Study|Disease progression|1|||
155720674|NCT02675907|562073540|FG001|Study Overall|Withdrawal by Subject|2|||
155720675|NCT02675907|562073539|FG000|Study Overall|Lost to Follow-up|0|||
155720676|NCT02675907|562073540|FG001|Study Overall|Lost to Follow-up|2|||
155720677|NCT03416868|562073544|FG000|Overall Study|Withdrawal by Subject|2|||
155720678|NCT03416868|562073544|FG000|Overall Study|Lost to Follow-up|1|||
155720679|NCT00004563|562073556|FG000|Overall Study|Withdrawal by Subject|20|||
155191690|NCT04340193|560140817|FG001|Overall Study|Disease progression|2|||
155191691|NCT04340193|560140818|FG002|Overall Study|Disease progression|3|||
155191692|NCT04340193|560140816|FG000|Overall Study|Administrative reasons by sponsor|0|||
155191693|NCT04340193|560140817|FG001|Overall Study|Administrative reasons by sponsor|1|||
155191694|NCT04340193|560140818|FG002|Overall Study|Administrative reasons by sponsor|0|||
155191695|NCT04340193|560140816|FG000|Overall Study|Adverse Event|1|||
155191696|NCT04340193|560140817|FG001|Overall Study|Adverse Event|1|||
155191697|NCT04340193|560140818|FG002|Overall Study|Adverse Event|0|||
155191698|NCT03924869|560140819|FG000|Overall Study|Death|73|||
155191699|NCT03924869|560140820|FG001|Overall Study|Death|62|||
155720680|NCT00004563|562073557|FG001|Overall Study|Withdrawal by Subject|16|||
155191700|NCT03924869|560140819|FG000|Overall Study|Lost to Follow-up|3|||
155191701|NCT03924869|560140820|FG001|Overall Study|Lost to Follow-up|0|||
155191702|NCT03924869|560140819|FG000|Overall Study|Physician Decision|0|||
155191703|NCT03924869|560140820|FG001|Overall Study|Physician Decision|3|||
155191704|NCT03924869|560140819|FG000|Overall Study|Withdrawal by Subject|7|||
155191705|NCT03924869|560140820|FG001|Overall Study|Withdrawal by Subject|3|||
155191706|NCT03924869|560140819|FG000|Overall Study|Study Terminated By Sponsor|144|||
155191707|NCT03924869|560140820|FG001|Overall Study|Study Terminated By Sponsor|153|||
155720681|NCT00004563|562073556|FG000|Overall Study|Lack of Efficacy|3|||
155720682|NCT00004563|562073557|FG001|Overall Study|Lack of Efficacy|5|||
155720683|NCT00004563|562073556|FG000|Overall Study|Death|2|||
155191708|NCT04026711|560140825|FG000|Overall Study|Withdrawal by Subject|1|||
155191709|NCT04026711|560140826|FG001|Overall Study|Withdrawal by Subject|0|||
155191710|NCT04026711|560140825|FG000|Overall Study|mental health crisis|1|||
155191711|NCT04026711|560140826|FG001|Overall Study|mental health crisis|0|||
155191712|NCT04823650|560140827|FG000|Overall Study|Withdrawal by Subject|0|||
155191713|NCT04823650|560140828|FG001|Overall Study|Withdrawal by Subject|0|||
155191714|NCT04823650|560140829|FG002|Overall Study|Withdrawal by Subject|0|||
155191715|NCT04823650|560140830|FG003|Overall Study|Withdrawal by Subject|0|||
155191716|NCT04823650|560140831|FG004|Overall Study|Withdrawal by Subject|1|||
155191717|NCT04823650|560140832|FG005|Overall Study|Withdrawal by Subject|0|||
155191718|NCT04246372|560142245|FG000|Overall Study|Adverse Event|1|||
155191719|NCT04246372|560142245|FG000|Overall Study|Withdrawal by Subject|1|||
155191720|NCT04246372|560142245|FG000|Overall Study|Protocol Violation|2|||
155191721|NCT04246372|560142245|FG000|Overall Study|Physician Decision|1|||
155191722|NCT01314703|560142247|FG000|Overall Study|screen failure and closed enrollment|8|||
155191723|NCT02281773|560142253|FG000|Overall Study|Adverse Event|6|||
155191724|NCT02281773|560142254|FG001|Overall Study|Adverse Event|1|||
155191725|NCT02281773|560142255|FG002|Overall Study|Adverse Event|4|||
155191726|NCT02281773|560142256|FG003|Overall Study|Adverse Event|8|||
155191727|NCT02281773|560142257|FG004|Overall Study|Adverse Event|9|||
155191728|NCT02281773|560142253|FG000|Overall Study|Protocol Violation|1|||
155191729|NCT02281773|560142254|FG001|Overall Study|Protocol Violation|0|||
155191730|NCT02281773|560142255|FG002|Overall Study|Protocol Violation|0|||
155191731|NCT02281773|560142256|FG003|Overall Study|Protocol Violation|2|||
155191732|NCT02281773|560142257|FG004|Overall Study|Protocol Violation|2|||
155191733|NCT02281773|560142253|FG000|Overall Study|Lost to Follow-up|2|||
155191734|NCT02281773|560142254|FG001|Overall Study|Lost to Follow-up|2|||
155191735|NCT02281773|560142255|FG002|Overall Study|Lost to Follow-up|6|||
155191736|NCT02281773|560142256|FG003|Overall Study|Lost to Follow-up|2|||
155191737|NCT02281773|560142257|FG004|Overall Study|Lost to Follow-up|10|||
155191738|NCT02281773|560142253|FG000|Overall Study|Withdrawal by Subject|2|||
155191739|NCT02281773|560142254|FG001|Overall Study|Withdrawal by Subject|8|||
155191740|NCT02281773|560142255|FG002|Overall Study|Withdrawal by Subject|6|||
155191741|NCT02281773|560142256|FG003|Overall Study|Withdrawal by Subject|6|||
155191742|NCT02281773|560142257|FG004|Overall Study|Withdrawal by Subject|8|||
155191743|NCT02281773|560142253|FG000|Overall Study|Other Reason|0|||
155191744|NCT02281773|560142254|FG001|Overall Study|Other Reason|4|||
155191745|NCT02281773|560142255|FG002|Overall Study|Other Reason|2|||
155191746|NCT02281773|560142256|FG003|Overall Study|Other Reason|3|||
155191747|NCT02281773|560142257|FG004|Overall Study|Other Reason|1|||
155191748|NCT00385762|560142259|FG000|Overall Study|Adverse Event|1|||
155191749|NCT00385762|560142259|FG000|Overall Study|Lost to Follow-up|1|||
155191750|NCT03323502|560142263|FG000|Overall Study|Resident could not be linked to CMS data|594|||
155191751|NCT03323502|560142264|FG001|Overall Study|Resident could not be linked to CMS data|435|||
155191752|NCT03323502|560142263|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
155191753|NCT03323502|560142264|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
155191754|NCT03323502|560142263|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
155191755|NCT03323502|560142264|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
155191756|NCT03323502|560142263|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
155191757|NCT03323502|560142264|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
155191758|NCT03323502|560142263|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
155191759|NCT03323502|560142264|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
155191760|NCT03794583|560142265|FG000|Overall Study|Death|8|||
155191761|NCT03794583|560142265|FG000|Overall Study|Study Terminated by Sponsor|24|||
155191762|NCT03794583|560142265|FG000|Overall Study|Withdrawal by Subject|9|||
155191763|NCT02497612|560142267|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
155191764|NCT02497612|560142268|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
155191765|NCT02497612|560142269|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
155191766|NCT02497612|560142270|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
155191767|NCT02497612|560142267|FG000|Overall Study|Participant's request|2|||
155191768|NCT02497612|560142268|FG001|Overall Study|Participant's request|3|||
155191769|NCT02497612|560142269|FG002|Overall Study|Participant's request|4|||
155191770|NCT02497612|560142270|FG003|Overall Study|Participant's request|1|||
155191771|NCT02497612|560142267|FG000|Overall Study|Investigator's judgement|1|||
155191772|NCT02497612|560142268|FG001|Overall Study|Investigator's judgement|0|||
155191773|NCT02497612|560142269|FG002|Overall Study|Investigator's judgement|0|||
155191774|NCT02497612|560142270|FG003|Overall Study|Investigator's judgement|2|||
155191775|NCT02497612|560142267|FG000|Overall Study|Adverse Event|3|||
155191776|NCT02497612|560142268|FG001|Overall Study|Adverse Event|1|||
155191777|NCT02497612|560142269|FG002|Overall Study|Adverse Event|4|||
155191778|NCT02497612|560142270|FG003|Overall Study|Adverse Event|1|||
155191779|NCT02497612|560142267|FG000|Overall Study|Lost to Follow-up|1|||
155191780|NCT02497612|560142268|FG001|Overall Study|Lost to Follow-up|1|||
155191781|NCT02497612|560142269|FG002|Overall Study|Lost to Follow-up|0|||
155191782|NCT02497612|560142270|FG003|Overall Study|Lost to Follow-up|1|||
155191783|NCT02497612|560142267|FG000|Overall Study|Other unspecified|1|||
155191784|NCT02497612|560142268|FG001|Overall Study|Other unspecified|1|||
155191785|NCT02497612|560142269|FG002|Overall Study|Other unspecified|2|||
155191786|NCT02497612|560142270|FG003|Overall Study|Other unspecified|0|||
155191787|NCT02497612|560142267|FG000|Overall Study|Not eligible|1|||
155191788|NCT02497612|560142268|FG001|Overall Study|Not eligible|0|||
155191789|NCT02497612|560142269|FG002|Overall Study|Not eligible|0|||
155191790|NCT02497612|560142270|FG003|Overall Study|Not eligible|1|||
155191791|NCT02699697|560142271|FG000|Overall Study|Death|18|||
155191792|NCT02699697|560142272|FG001|Overall Study|Death|15|||
155191793|NCT02699697|560142271|FG000|Overall Study|Physician Decision|0|||
155191794|NCT02699697|560142272|FG001|Overall Study|Physician Decision|1|||
155191795|NCT02699697|560142271|FG000|Overall Study|Lost to Follow-up|2|||
155191796|NCT02699697|560142272|FG001|Overall Study|Lost to Follow-up|3|||
155191797|NCT02699697|560142271|FG000|Overall Study|Refused to follow up|1|||
155191798|NCT02699697|560142272|FG001|Overall Study|Refused to follow up|1|||
155191799|NCT02699697|560142271|FG000|Overall Study|Entered hospice care|5|||
155191800|NCT02699697|560142272|FG001|Overall Study|Entered hospice care|2|||
155191801|NCT02699697|560142271|FG000|Overall Study|Missing reason for discontinuation|6|||
155191802|NCT02699697|560142272|FG001|Overall Study|Missing reason for discontinuation|5|||
155191803|NCT00902668|560142273|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
155191804|NCT00615108|560142274|FG000|Overall Study|Adverse Event|122|||
155191805|NCT00615108|560142274|FG000|Overall Study|Other|370|||
155191806|NCT00615108|560142274|FG000|Overall Study|Lost to Follow-up|15|||
155191807|NCT01914757|560142275|FG000|Overall Study|Severe non-compliance to protocol|3|||
155191808|NCT01914757|560142276|FG001|Overall Study|Severe non-compliance to protocol|1|||
155191809|NCT01914757|560142277|FG002|Overall Study|Severe non-compliance to protocol|2|||
155191810|NCT01914757|560142275|FG000|Overall Study|Lost to Follow-up|5|||
155191811|NCT01914757|560142276|FG001|Overall Study|Lost to Follow-up|8|||
155191812|NCT01914757|560142277|FG002|Overall Study|Lost to Follow-up|6|||
155191813|NCT01914757|560142275|FG000|Overall Study|Withdrawal by Subject|15|||
155191814|NCT01914757|560142276|FG001|Overall Study|Withdrawal by Subject|27|||
155191815|NCT01914757|560142277|FG002|Overall Study|Withdrawal by Subject|19|||
155191816|NCT01914757|560142275|FG000|Overall Study|Death|2|||
155191817|NCT01914757|560142276|FG001|Overall Study|Death|2|||
155191818|NCT01914757|560142277|FG002|Overall Study|Death|1|||
155191819|NCT01914757|560142275|FG000|Overall Study|Adverse Event|4|||
155191820|NCT01914757|560142276|FG001|Overall Study|Adverse Event|3|||
155191821|NCT01914757|560142277|FG002|Overall Study|Adverse Event|4|||
155191822|NCT01914757|560142275|FG000|Overall Study|Study specific withdrawal criteria|0|||
155191823|NCT01914757|560142276|FG001|Overall Study|Study specific withdrawal criteria|1|||
155191824|NCT01914757|560142277|FG002|Overall Study|Study specific withdrawal criteria|0|||
155191825|NCT01914757|560142275|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155191826|NCT01914757|560142276|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155191827|NCT01914757|560142277|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
155191828|NCT01914757|560142275|FG000|Overall Study|Other reasons|5|||
155191829|NCT01914757|560142276|FG001|Overall Study|Other reasons|9|||
155191830|NCT01914757|560142277|FG002|Overall Study|Other reasons|4|||
155191831|NCT02476201|560142278|FG000|Overall Study|Unable to program MPP|9|||
155191832|NCT02476201|560142278|FG000|Overall Study|Study echo not performed|5|||
155191833|NCT02476201|560142278|FG000|Overall Study|Adverse Event|4|||
155191834|NCT02476201|560142278|FG000|Overall Study|Death|2|||
155191835|NCT02476201|560142278|FG000|Overall Study|Lost to Follow-up|2|||
155191836|NCT02476201|560142278|FG000|Overall Study|MPP programmed to OFF|2|||
155191837|NCT02476201|560142278|FG000|Overall Study|Withdrawal by Subject|1|||
155191838|NCT02476201|560142278|FG000|Overall Study|Unsuccessful implant|1|||
155191839|NCT00694707|560142287|FG000|Overall Study|Did Not Receive Treatment|0|||
155191840|NCT00694707|560142288|FG001|Overall Study|Did Not Receive Treatment|0|||
155191841|NCT00694707|560142289|FG002|Overall Study|Did Not Receive Treatment|1|||
155191842|NCT00694707|560142290|FG003|Overall Study|Did Not Receive Treatment|1|||
155191843|NCT00694707|560142291|FG004|Overall Study|Did Not Receive Treatment|1|||
155191844|NCT00694707|560142287|FG000|Overall Study|Adverse Event|22|||
155191845|NCT00694707|560142288|FG001|Overall Study|Adverse Event|14|||
155191846|NCT00694707|560142289|FG002|Overall Study|Adverse Event|8|||
155191847|NCT00694707|560142290|FG003|Overall Study|Adverse Event|12|||
155191848|NCT00694707|560142291|FG004|Overall Study|Adverse Event|13|||
155191849|NCT00694707|560142287|FG000|Overall Study|Insufficient Therapeutic Response|33|||
155191850|NCT00694707|560142288|FG001|Overall Study|Insufficient Therapeutic Response|18|||
155191851|NCT00694707|560142289|FG002|Overall Study|Insufficient Therapeutic Response|17|||
155191852|NCT00694707|560142290|FG003|Overall Study|Insufficient Therapeutic Response|15|||
155191853|NCT00694707|560142291|FG004|Overall Study|Insufficient Therapeutic Response|10|||
155191854|NCT00694707|560142287|FG000|Overall Study|Protocol Violation|1|||
155191855|NCT00694707|560142288|FG001|Overall Study|Protocol Violation|2|||
155191856|NCT00694707|560142289|FG002|Overall Study|Protocol Violation|1|||
155191857|NCT00694707|560142290|FG003|Overall Study|Protocol Violation|3|||
155191858|NCT00694707|560142291|FG004|Overall Study|Protocol Violation|1|||
155191859|NCT00694707|560142287|FG000|Overall Study|Withdrawal of Consent|14|||
155191860|NCT00694707|560142288|FG001|Overall Study|Withdrawal of Consent|18|||
155191861|NCT00694707|560142289|FG002|Overall Study|Withdrawal of Consent|22|||
155191862|NCT00694707|560142290|FG003|Overall Study|Withdrawal of Consent|16|||
155191863|NCT00694707|560142291|FG004|Overall Study|Withdrawal of Consent|15|||
155191864|NCT00694707|560142287|FG000|Overall Study|Lost to Follow-up|0|||
155191865|NCT00694707|560142288|FG001|Overall Study|Lost to Follow-up|1|||
155191866|NCT00694707|560142289|FG002|Overall Study|Lost to Follow-up|2|||
155191867|NCT00694707|560142290|FG003|Overall Study|Lost to Follow-up|0|||
155191868|NCT00694707|560142291|FG004|Overall Study|Lost to Follow-up|0|||
155191869|NCT00694707|560142287|FG000|Overall Study|Jeopardizing Parole Status|1|||
155191870|NCT00694707|560142288|FG001|Overall Study|Jeopardizing Parole Status|0|||
155191871|NCT00694707|560142289|FG002|Overall Study|Jeopardizing Parole Status|0|||
155191872|NCT00694707|560142290|FG003|Overall Study|Jeopardizing Parole Status|0|||
155191873|NCT00694707|560142291|FG004|Overall Study|Jeopardizing Parole Status|0|||
155720684|NCT00004563|562073557|FG001|Overall Study|Death|3|||
155720685|NCT04258423|562073564|FG000|Overall Study|Study Closure|2|||
155720686|NCT04258423|562073565|FG001|Overall Study|Study Closure|2|||
155720687|NCT01352117|562075257|FG000|Overall Study|Death|15|||
155720688|NCT01352117|562075258|FG001|Overall Study|Death|16|||
155720689|NCT01352117|562075257|FG000|Overall Study|Withdrawal by Subject|1|||
155720690|NCT01352117|562075258|FG001|Overall Study|Withdrawal by Subject|0|||
155720691|NCT01352117|562075257|FG000|Overall Study|Lost to Follow-up|2|||
155720692|NCT01352117|562075258|FG001|Overall Study|Lost to Follow-up|7|||
155720693|NCT01352117|562075257|FG000|Overall Study|Non-adherent to study requirements|1|||
155720694|NCT01352117|562075258|FG001|Overall Study|Non-adherent to study requirements|1|||
155720695|NCT01352117|562075257|FG000|Overall Study|Did not initiate study treatment|1|||
155720696|NCT01352117|562075258|FG001|Overall Study|Did not initiate study treatment|0|||
155720697|NCT01352117|562075257|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
155720698|NCT01352117|562075258|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
155191874|NCT00694707|560142287|FG000|Overall Study|Death in the Family|1|||
155191875|NCT00694707|560142288|FG001|Overall Study|Death in the Family|0|||
155191876|NCT00694707|560142289|FG002|Overall Study|Death in the Family|0|||
155191877|NCT00694707|560142290|FG003|Overall Study|Death in the Family|0|||
155191878|NCT00694707|560142291|FG004|Overall Study|Death in the Family|0|||
155191879|NCT00694707|560142287|FG000|Overall Study|Arrest by Police|0|||
155191880|NCT00694707|560142288|FG001|Overall Study|Arrest by Police|1|||
155191881|NCT00694707|560142289|FG002|Overall Study|Arrest by Police|0|||
155191882|NCT00694707|560142290|FG003|Overall Study|Arrest by Police|0|||
155191883|NCT00694707|560142291|FG004|Overall Study|Arrest by Police|0|||
155191884|NCT00694707|560142287|FG000|Overall Study|Administrative Reasons|0|||
155191885|NCT00694707|560142288|FG001|Overall Study|Administrative Reasons|1|||
155191886|NCT00694707|560142289|FG002|Overall Study|Administrative Reasons|0|||
155191887|NCT00694707|560142290|FG003|Overall Study|Administrative Reasons|2|||
155191888|NCT00694707|560142291|FG004|Overall Study|Administrative Reasons|0|||
155191889|NCT00694707|560142287|FG000|Overall Study|Notification of Past Head Injury|0|||
155191890|NCT00694707|560142288|FG001|Overall Study|Notification of Past Head Injury|0|||
155191891|NCT00694707|560142289|FG002|Overall Study|Notification of Past Head Injury|0|||
155191892|NCT00694707|560142290|FG003|Overall Study|Notification of Past Head Injury|1|||
155191893|NCT00694707|560142291|FG004|Overall Study|Notification of Past Head Injury|0|||
155191894|NCT04810481|560142295|FG000|Overall Study|Disqualified data sets|10|||
155191895|NCT04810481|560142296|FG001|Overall Study|Disqualified data sets|28|||
155191896|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
155720699|NCT01766050|562075259|FG000|Overall Study|Adverse Event|1|||
155720700|NCT01766050|562075259|FG000|Overall Study|Lost to Follow-up|1|||
155720701|NCT01766050|562075259|FG000|Overall Study|Withdrawal by Subject|2|||
155720702|NCT00385671|562075261|FG000|Overall Study|Adverse Event|14|||
155191897|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
155191898|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
155191899|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
155191900|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
155191901|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
155191902|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
155191903|NCT00369707|560142299|FG000|Follow up for 2 Years After Treatment|Death|1|||
155191904|NCT00369707|560142299|FG000|Follow up for 2 Years After Treatment|Other|2|||
155191905|NCT04102098|560142301|FG000|Main Study Period|Ongoing in study|302|||
155191906|NCT04102098|560142302|FG001|Main Study Period|Ongoing in study|291|||
155191907|NCT04102098|560142301|FG000|Main Study Period|Death|20|||
155191908|NCT04102098|560142302|FG001|Main Study Period|Death|27|||
155191909|NCT04102098|560142301|FG000|Main Study Period|Lost to Follow-up|1|||
155191910|NCT04102098|560142302|FG001|Main Study Period|Lost to Follow-up|1|||
155191911|NCT04102098|560142301|FG000|Main Study Period|Physician Decision|0|||
155191912|NCT04102098|560142302|FG001|Main Study Period|Physician Decision|1|||
155191913|NCT04102098|560142301|FG000|Main Study Period|Withdrawal by Subject|11|||
155191914|NCT04102098|560142302|FG001|Main Study Period|Withdrawal by Subject|14|||
155191915|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
155191916|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
155191917|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Death|11|||
155191918|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Death|0|||
155191919|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
155191920|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
155191921|NCT01254292|560142310|FG000|Comparative Phase|Adverse Event|25|||
155191922|NCT01254292|560142311|FG001|Comparative Phase|Adverse Event|25|||
155191923|NCT01254292|560142310|FG000|Comparative Phase|Lost to Follow-up|3|||
155191924|NCT01254292|560142311|FG001|Comparative Phase|Lost to Follow-up|21|||
155191925|NCT01254292|560142310|FG000|Comparative Phase|Pregnancy|2|||
155191926|NCT01254292|560142311|FG001|Comparative Phase|Pregnancy|6|||
155191927|NCT01254292|560142310|FG000|Comparative Phase|Withdrawal by Subject|20|||
155191928|NCT01254292|560142311|FG001|Comparative Phase|Withdrawal by Subject|21|||
155191929|NCT01254292|560142310|FG000|Comparative Phase|Protocol Violation|1|||
155191930|NCT01254292|560142311|FG001|Comparative Phase|Protocol Violation|2|||
155191931|NCT01254292|560142310|FG000|Comparative Phase|Wish for pregnancy|4|||
155191932|NCT01254292|560142311|FG001|Comparative Phase|Wish for pregnancy|6|||
155191933|NCT01254292|560142310|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
155191934|NCT01254292|560142311|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
155191935|NCT01254292|560142310|FG000|LCS12 Extension Phase|Adverse Event|9|||
155191936|NCT01254292|560142311|FG001|LCS12 Extension Phase|Adverse Event|0|||
155191937|NCT01254292|560142310|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
155191938|NCT01254292|560142311|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
155191939|NCT01254292|560142310|FG000|LCS12 Extension Phase|Other unknown|4|||
155191940|NCT01254292|560142311|FG001|LCS12 Extension Phase|Other unknown|0|||
155191941|NCT01254292|560142310|FG000|LCS12 Extension Phase|Pregnancy|2|||
155191942|NCT01254292|560142311|FG001|LCS12 Extension Phase|Pregnancy|0|||
155191943|NCT01254292|560142310|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
155191944|NCT01254292|560142311|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
155191945|NCT02083081|560142312|FG000|Overall Study|Lost to Follow-up|31|||
155191946|NCT02083081|560142313|FG001|Overall Study|Lost to Follow-up|9|||
155191947|NCT01230710|560142316|FG000|Overall Study|Disease Progression|41|||
155191948|NCT01230710|560142316|FG000|Overall Study|Lost to Follow-up|3|||
155191949|NCT01230710|560142316|FG000|Overall Study|Death|4|||
155191950|NCT01230710|560142316|FG000|Overall Study|Withdrawal of Consent|1|||
155191951|NCT02905149|560142317|FG000|Overall Study|Lost to Follow-up|2|||
155191952|NCT02905149|560142318|FG001|Overall Study|Lost to Follow-up|0|||
155191953|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
155191954|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
155191955|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Physician Decision|1|||
155191956|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Physician Decision|0|||
155191957|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
155191958|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
155191959|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
155191960|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
155191961|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Adverse Event|15|||
155191962|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Adverse Event|0|||
155191963|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
155191964|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
155191965|NCT03277690|560142319|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
155191966|NCT03277690|560142320|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
155191967|NCT00747812|560142321|FG000|Overall Study|Research Site Staff Relocation|5|||
155720703|NCT00385671|562075262|FG001|Overall Study|Adverse Event|27|||
155191968|NCT00747812|560142322|FG001|Overall Study|Research Site Staff Relocation|3|||
155191969|NCT03109847|560142323|FG000|Overall Study|Withdrawal by Subject|1|||
155191970|NCT03109847|560142324|FG001|Overall Study|Withdrawal by Subject|0|||
155191971|NCT00299182|560142325|FG000|Overall Study|Withdrawal by Subject|0|||
155191972|NCT00299182|560142326|FG001|Overall Study|Withdrawal by Subject|0|||
155191973|NCT00299182|560142327|FG002|Overall Study|Withdrawal by Subject|1|||
155191974|NCT00299182|560142328|FG003|Overall Study|Withdrawal by Subject|0|||
155191975|NCT00299182|560142329|FG004|Overall Study|Withdrawal by Subject|1|||
155191976|NCT00299182|560142330|FG005|Overall Study|Withdrawal by Subject|2|||
155191977|NCT00299182|560142331|FG006|Overall Study|Withdrawal by Subject|0|||
155191978|NCT00299182|560142325|FG000|Overall Study|Chemotherapy Changed|0|||
155191979|NCT00299182|560142326|FG001|Overall Study|Chemotherapy Changed|0|||
155191980|NCT00299182|560142327|FG002|Overall Study|Chemotherapy Changed|1|||
155191981|NCT00299182|560142328|FG003|Overall Study|Chemotherapy Changed|0|||
155191982|NCT00299182|560142329|FG004|Overall Study|Chemotherapy Changed|1|||
155191983|NCT00299182|560142330|FG005|Overall Study|Chemotherapy Changed|0|||
155191984|NCT00299182|560142331|FG006|Overall Study|Chemotherapy Changed|1|||
155191985|NCT00299182|560142325|FG000|Overall Study|Adverse Event|0|||
155191986|NCT00299182|560142326|FG001|Overall Study|Adverse Event|0|||
155191987|NCT00299182|560142327|FG002|Overall Study|Adverse Event|0|||
155191988|NCT00299182|560142328|FG003|Overall Study|Adverse Event|0|||
155191989|NCT00299182|560142329|FG004|Overall Study|Adverse Event|0|||
155191990|NCT00299182|560142330|FG005|Overall Study|Adverse Event|1|||
155191991|NCT00299182|560142331|FG006|Overall Study|Adverse Event|0|||
155191992|NCT00299182|560142325|FG000|Overall Study|Not Eligible|0|||
155191993|NCT00299182|560142326|FG001|Overall Study|Not Eligible|0|||
155191994|NCT00299182|560142327|FG002|Overall Study|Not Eligible|0|||
155191995|NCT00299182|560142328|FG003|Overall Study|Not Eligible|0|||
155191996|NCT00299182|560142329|FG004|Overall Study|Not Eligible|1|||
155191997|NCT00299182|560142330|FG005|Overall Study|Not Eligible|0|||
155191998|NCT00299182|560142331|FG006|Overall Study|Not Eligible|0|||
155191999|NCT00771316|560142332|FG000|Overall Study|Adverse Event|0|||
155192000|NCT00771316|560142333|FG001|Overall Study|Adverse Event|1|||
155192001|NCT00771316|560142332|FG000|Overall Study|Patient withdrew consent|1|||
155192002|NCT00771316|560142333|FG001|Overall Study|Patient withdrew consent|0|||
155192003|NCT00771316|560142332|FG000|Overall Study|Discontinued due to early termination|1|||
155192004|NCT00771316|560142333|FG001|Overall Study|Discontinued due to early termination|0|||
155192005|NCT04068610|560142337|FG000|Overall Study|Death|4|||
155192006|NCT04068610|560142338|FG001|Overall Study|Death|8|||
155192007|NCT04068610|560142339|FG002|Overall Study|Death|13|||
155192008|NCT04068610|560142337|FG000|Overall Study|Lost to Follow-up|0|||
155192009|NCT04068610|560142338|FG001|Overall Study|Lost to Follow-up|2|||
155192010|NCT04068610|560142339|FG002|Overall Study|Lost to Follow-up|0|||
155192011|NCT04068610|560142337|FG000|Overall Study|Withdrawal by Subject|0|||
155192012|NCT04068610|560142338|FG001|Overall Study|Withdrawal by Subject|4|||
155192013|NCT04068610|560142339|FG002|Overall Study|Withdrawal by Subject|2|||
155192014|NCT04068610|560142337|FG000|Overall Study|Other|3|||
155192015|NCT04068610|560142338|FG001|Overall Study|Other|12|||
155192016|NCT04068610|560142339|FG002|Overall Study|Other|11|||
155192017|NCT05535972|560142340|FG000|Overall Study|Withdrawal by Subject|31|||
155192018|NCT05535972|560142340|FG000|Overall Study|Lost to Follow-up|5|||
155192019|NCT05535972|560142340|FG000|Overall Study|Adverse Event|6|||
155192020|NCT05535972|560142340|FG000|Overall Study|Protocol Deviation|2|||
155192021|NCT02649894|560142342|FG000|Overall Study|Adverse Event|1|||
155192022|NCT02649894|560142343|FG001|Overall Study|Adverse Event|0|||
155192023|NCT02649894|560142342|FG000|Overall Study|Physician Decision|0|||
155192024|NCT02649894|560142343|FG001|Overall Study|Physician Decision|1|||
155192025|NCT02649894|560142342|FG000|Overall Study|Withdrawal by Subject|5|||
155192026|NCT02649894|560142343|FG001|Overall Study|Withdrawal by Subject|2|||
155192027|NCT02649894|560142342|FG000|Overall Study|Lost to Follow-up|2|||
155192028|NCT02649894|560142343|FG001|Overall Study|Lost to Follow-up|1|||
155192029|NCT02649894|560142342|FG000|Overall Study|Death|30|||
155192030|NCT02649894|560142343|FG001|Overall Study|Death|7|||
155192031|NCT02649894|560142342|FG000|Overall Study|Other, not specified|6|||
155192032|NCT02649894|560142343|FG001|Overall Study|Other, not specified|0|||
155192033|NCT04590963|560142344|FG000|Overall Study|Death|118|||
155192034|NCT04590963|560142345|FG001|Overall Study|Death|59|||
155192035|NCT04590963|560142344|FG000|Overall Study|Lost to Follow-up|1|||
155192036|NCT04590963|560142345|FG001|Overall Study|Lost to Follow-up|1|||
155192037|NCT04590963|560142344|FG000|Overall Study|Progressive disease|0|||
155192038|NCT04590963|560142345|FG001|Overall Study|Progressive disease|1|||
155192039|NCT04590963|560142344|FG000|Overall Study|Study terminated by sponsor|103|||
155192040|NCT04590963|560142345|FG001|Overall Study|Study terminated by sponsor|50|||
155192041|NCT04590963|560142344|FG000|Overall Study|Withdrawal by Subject|15|||
155192042|NCT04590963|560142345|FG001|Overall Study|Withdrawal by Subject|8|||
155192043|NCT04590963|560142344|FG000|Overall Study|Ongoing at data cut-off|9|||
155192044|NCT04590963|560142345|FG001|Overall Study|Ongoing at data cut-off|4|||
155192045|NCT04590963|560142344|FG000|Overall Study|Screen failure|1|||
155192046|NCT04590963|560142345|FG001|Overall Study|Screen failure|0|||
155192047|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Death|1|||
155192048|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Death|4|||
155192049|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Death|4|||
155192050|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Death|1|||
155192051|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Death|6|||
155192052|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Death|0|||
155192053|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
155192054|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192055|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
155192056|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192057|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192058|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
155192059|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192060|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
155192061|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192062|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
155192063|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192064|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192065|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Other|1|||
155192066|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Other|0|||
155192067|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Other|0|||
155192068|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Other|0|||
155192069|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Other|0|||
155192070|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Other|0|||
155192071|NCT04430738|560142348|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192072|NCT04430738|560142349|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192073|NCT04430738|560142350|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192074|NCT04430738|560142351|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192075|NCT04430738|560142352|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192076|NCT04430738|560142353|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
155192077|NCT04430738|560142348|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192078|NCT04430738|560142349|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192079|NCT04430738|560142350|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192080|NCT04430738|560142351|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192081|NCT04430738|560142352|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192082|NCT04430738|560142353|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
155192083|NCT02628769|560142355|FG000|First Intervention|Adverse Event|1|||
155192084|NCT02628769|560142356|FG001|First Intervention|Adverse Event|0|||
155192085|NCT02628769|560142355|FG000|First Intervention|Withdrawal by Subject|0|||
155192086|NCT02628769|560142356|FG001|First Intervention|Withdrawal by Subject|1|||
155192087|NCT02628769|560142355|FG000|Second Intervention|Adverse Event|2|||
155192088|NCT02628769|560142356|FG001|Second Intervention|Adverse Event|0|||
155192089|NCT02628769|560142355|FG000|Second Intervention|Physician Decision|0|||
155192090|NCT02628769|560142356|FG001|Second Intervention|Physician Decision|1|||
155192091|NCT01467583|560142357|FG000|Overall Study|Death|1|||
155192092|NCT01467583|560142358|FG001|Overall Study|Death|1|||
155192093|NCT01467583|560142359|FG002|Overall Study|Death|0|||
155192094|NCT01467583|560142357|FG000|Overall Study|Withdrawal by Subject|1|||
155192095|NCT01467583|560142358|FG001|Overall Study|Withdrawal by Subject|0|||
155192096|NCT01467583|560142359|FG002|Overall Study|Withdrawal by Subject|0|||
155192097|NCT01467583|560142357|FG000|Overall Study|Protocol Violation|0|||
155192098|NCT01467583|560142358|FG001|Overall Study|Protocol Violation|0|||
155192099|NCT01467583|560142359|FG002|Overall Study|Protocol Violation|2|||
155192100|NCT00309985|560142361|FG000|Overall Study|Disease progression|12|||
155192101|NCT00309985|560142362|FG001|Overall Study|Disease progression|0|||
155192102|NCT00309985|560142361|FG000|Overall Study|Adverse Event|30|||
155192103|NCT00309985|560142362|FG001|Overall Study|Adverse Event|0|||
155192104|NCT00309985|560142361|FG000|Overall Study|Death|2|||
155192105|NCT00309985|560142362|FG001|Overall Study|Death|0|||
155192106|NCT00309985|560142361|FG000|Overall Study|Withdrawal by Subject|5|||
155192107|NCT00309985|560142362|FG001|Overall Study|Withdrawal by Subject|1|||
155192108|NCT00309985|560142361|FG000|Overall Study|Physician Decision|3|||
155192109|NCT00309985|560142362|FG001|Overall Study|Physician Decision|0|||
155192110|NCT00309985|560142361|FG000|Overall Study|Never started treatment|7|||
155192111|NCT00309985|560142362|FG001|Overall Study|Never started treatment|0|||
155192112|NCT00309985|560142361|FG000|Overall Study|Complicating disease|1|||
155192113|NCT00309985|560142362|FG001|Overall Study|Complicating disease|0|||
155192114|NCT00309985|560142361|FG000|Overall Study|Non-compliance|1|||
155192115|NCT00309985|560142362|FG001|Overall Study|Non-compliance|0|||
155192116|NCT00309985|560142361|FG000|Overall Study|Chemotherapy discontinued only|1|||
155192117|NCT00309985|560142362|FG001|Overall Study|Chemotherapy discontinued only|0|||
155192118|NCT04941456|560142363|FG000|Overall Study|Withdrawal by Subject|1|||
155192119|NCT04941456|560142364|FG001|Overall Study|Withdrawal by Subject|0|||
155192120|NCT04941456|560142363|FG000|Overall Study|Protocol Violation|1|||
155192121|NCT04941456|560142364|FG001|Overall Study|Protocol Violation|0|||
155192122|NCT02296684|560142365|FG000|Overall Study|Withdrawal by Subject|0|||
155192123|NCT02296684|560142366|FG001|Overall Study|Withdrawal by Subject|1|||
155192124|NCT02296684|560142367|FG002|Overall Study|Withdrawal by Subject|1|||
155192125|NCT02296684|560142365|FG000|Overall Study|Death|2|||
155192126|NCT02296684|560142366|FG001|Overall Study|Death|0|||
155192127|NCT02296684|560142367|FG002|Overall Study|Death|0|||
155192128|NCT05171777|560142368|FG000|Treatment Crossover Period|Adverse Event|9|||
155192129|NCT05171777|560142369|FG001|Treatment Crossover Period|Adverse Event|6|||
155192130|NCT05171777|560142370|FG002|Treatment Crossover Period|Adverse Event|0|||
155192131|NCT05171777|560142371|FG003|Treatment Crossover Period|Adverse Event|0|||
155192132|NCT05171777|560142368|FG000|Treatment Crossover Period|Death|5|||
155192133|NCT05171777|560142369|FG001|Treatment Crossover Period|Death|5|||
155192134|NCT05171777|560142370|FG002|Treatment Crossover Period|Death|0|||
155192135|NCT05171777|560142371|FG003|Treatment Crossover Period|Death|0|||
155192136|NCT05171777|560142368|FG000|Treatment Crossover Period|Disease Relapse|1|||
155192137|NCT05171777|560142369|FG001|Treatment Crossover Period|Disease Relapse|0|||
155192138|NCT05171777|560142370|FG002|Treatment Crossover Period|Disease Relapse|0|||
155192139|NCT05171777|560142371|FG003|Treatment Crossover Period|Disease Relapse|0|||
155192140|NCT05171777|560142368|FG000|Treatment Crossover Period|Reason not Specified|1|||
155192141|NCT05171777|560142369|FG001|Treatment Crossover Period|Reason not Specified|1|||
155192142|NCT05171777|560142370|FG002|Treatment Crossover Period|Reason not Specified|0|||
155192143|NCT05171777|560142371|FG003|Treatment Crossover Period|Reason not Specified|0|||
155192144|NCT05171777|560142368|FG000|Treatment Crossover Period|Physician Decision|0|||
155192145|NCT05171777|560142369|FG001|Treatment Crossover Period|Physician Decision|1|||
155192146|NCT05171777|560142370|FG002|Treatment Crossover Period|Physician Decision|0|||
155192147|NCT05171777|560142371|FG003|Treatment Crossover Period|Physician Decision|0|||
155192148|NCT05171777|560142368|FG000|Treatment Crossover Period|Progressive Disease|14|||
155192149|NCT05171777|560142369|FG001|Treatment Crossover Period|Progressive Disease|10|||
155192150|NCT05171777|560142370|FG002|Treatment Crossover Period|Progressive Disease|0|||
155192151|NCT05171777|560142371|FG003|Treatment Crossover Period|Progressive Disease|0|||
155192152|NCT05171777|560142368|FG000|Treatment Crossover Period|Protocol Violation|0|||
155192153|NCT05171777|560142369|FG001|Treatment Crossover Period|Protocol Violation|2|||
155192154|NCT05171777|560142370|FG002|Treatment Crossover Period|Protocol Violation|0|||
155192155|NCT05171777|560142371|FG003|Treatment Crossover Period|Protocol Violation|0|||
155192156|NCT05171777|560142368|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192157|NCT05171777|560142369|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
155192158|NCT05171777|560142370|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192159|NCT05171777|560142371|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192160|NCT05171777|560142368|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
155192161|NCT05171777|560142369|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
155192162|NCT05171777|560142370|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
155192163|NCT05171777|560142371|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
155192164|NCT05171777|560142368|FG000|Treatment Continuation Period|Adverse Event|0|||
155192165|NCT05171777|560142369|FG001|Treatment Continuation Period|Adverse Event|0|||
155192166|NCT05171777|560142370|FG002|Treatment Continuation Period|Adverse Event|3|||
155192167|NCT05171777|560142371|FG003|Treatment Continuation Period|Adverse Event|6|||
155192168|NCT05171777|560142368|FG000|Treatment Continuation Period|Death|0|||
155192169|NCT05171777|560142369|FG001|Treatment Continuation Period|Death|0|||
155192170|NCT05171777|560142370|FG002|Treatment Continuation Period|Death|1|||
155192171|NCT05171777|560142371|FG003|Treatment Continuation Period|Death|3|||
155192172|NCT05171777|560142368|FG000|Treatment Continuation Period|Disease Relapse|0|||
155192173|NCT05171777|560142369|FG001|Treatment Continuation Period|Disease Relapse|0|||
155192174|NCT05171777|560142370|FG002|Treatment Continuation Period|Disease Relapse|1|||
155192175|NCT05171777|560142371|FG003|Treatment Continuation Period|Disease Relapse|0|||
155192176|NCT05171777|560142368|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
155192177|NCT05171777|560142369|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
155192178|NCT05171777|560142370|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
155192179|NCT05171777|560142371|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
155192180|NCT05171777|560142368|FG000|Treatment Continuation Period|Physician Decision|0|||
155192181|NCT05171777|560142369|FG001|Treatment Continuation Period|Physician Decision|0|||
155192182|NCT05171777|560142370|FG002|Treatment Continuation Period|Physician Decision|0|||
155192183|NCT05171777|560142371|FG003|Treatment Continuation Period|Physician Decision|4|||
155192184|NCT05171777|560142368|FG000|Treatment Continuation Period|Progressive Disease|0|||
155192185|NCT05171777|560142369|FG001|Treatment Continuation Period|Progressive Disease|0|||
155192186|NCT05171777|560142370|FG002|Treatment Continuation Period|Progressive Disease|6|||
155192187|NCT05171777|560142371|FG003|Treatment Continuation Period|Progressive Disease|20|||
155192188|NCT05171777|560142368|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
155192189|NCT05171777|560142369|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
155192190|NCT05171777|560142370|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
155192191|NCT05171777|560142371|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
155192192|NCT05171777|560142368|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192193|NCT05171777|560142369|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192194|NCT05171777|560142370|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192195|NCT05171777|560142371|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
155192196|NCT05171777|560142368|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
155192197|NCT05171777|560142369|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
155192198|NCT05171777|560142370|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
155192199|NCT05171777|560142371|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
155192200|NCT02364713|560142372|FG000|Overall Study|Ineligible|2|||
155192201|NCT02364713|560142373|FG001|Overall Study|Ineligible|2|||
155192202|NCT05741528|560142376|FG000|Overall Study|Withdrawal by Subject|11|||
155192203|NCT05741528|560142376|FG000|Overall Study|Lost to Follow-up|3|||
155192204|NCT05741528|560142376|FG000|Overall Study|Adverse Event|2|||
155192205|NCT05741528|560142376|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155192206|NCT05741528|560142376|FG000|Overall Study|Reason Not Specified|1|||
155192207|NCT05938920|560142379|FG000|Overall Study|Adverse Event|1|||
155192208|NCT05938920|560142380|FG001|Overall Study|Adverse Event|3|||
155192209|NCT05938920|560142381|FG002|Overall Study|Adverse Event|2|||
155192210|NCT05938920|560142382|FG003|Overall Study|Adverse Event|1|||
155192211|NCT05938920|560142379|FG000|Overall Study|Death|0|||
155192212|NCT05938920|560142380|FG001|Overall Study|Death|1|||
155192213|NCT05938920|560142381|FG002|Overall Study|Death|0|||
155192214|NCT05938920|560142382|FG003|Overall Study|Death|0|||
155192215|NCT05938920|560142379|FG000|Overall Study|Lost to Follow-up|0|||
155192216|NCT05938920|560142380|FG001|Overall Study|Lost to Follow-up|0|||
155192217|NCT05938920|560142381|FG002|Overall Study|Lost to Follow-up|1|||
155192218|NCT05938920|560142382|FG003|Overall Study|Lost to Follow-up|0|||
155192219|NCT05938920|560142379|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
155192220|NCT05938920|560142380|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192221|NCT05938920|560142381|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192222|NCT05938920|560142382|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192223|NCT05938920|560142379|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192224|NCT05938920|560142380|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192225|NCT05938920|560142381|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
155192226|NCT05938920|560142382|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192227|NCT05938920|560142379|FG000|Overall Study|Participant Refused to Come In|0|||
155192228|NCT05938920|560142380|FG001|Overall Study|Participant Refused to Come In|0|||
155192229|NCT05938920|560142381|FG002|Overall Study|Participant Refused to Come In|1|||
155192230|NCT05938920|560142382|FG003|Overall Study|Participant Refused to Come In|0|||
155192231|NCT01251861|560142383|FG000|Overall Study|Disease progression|6|||
155192232|NCT01251861|560142384|FG001|Overall Study|Disease progression|6|||
155192233|NCT01251861|560142383|FG000|Overall Study|Adverse Event|2|||
155192234|NCT01251861|560142384|FG001|Overall Study|Adverse Event|17|||
155192235|NCT01251861|560142383|FG000|Overall Study|Withdrawal by Subject|2|||
155192236|NCT01251861|560142384|FG001|Overall Study|Withdrawal by Subject|2|||
155192237|NCT01251861|560142383|FG000|Overall Study|Alternative therapy|1|||
155192238|NCT01251861|560142384|FG001|Overall Study|Alternative therapy|0|||
155192239|NCT01251861|560142383|FG000|Overall Study|Other complicating disease|0|||
155192240|NCT01251861|560142384|FG001|Overall Study|Other complicating disease|1|||
155192241|NCT01251861|560142383|FG000|Overall Study|Physician Decision|1|||
155192242|NCT01251861|560142384|FG001|Overall Study|Physician Decision|0|||
155192243|NCT01251861|560142383|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
155192244|NCT01251861|560142384|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
155192245|NCT01251861|560142383|FG000|Overall Study|Other|1|||
155192246|NCT01251861|560142384|FG001|Overall Study|Other|0|||
155192247|NCT01251861|560142383|FG000|Overall Study|Never started therapy|4|||
155192248|NCT01251861|560142384|FG001|Overall Study|Never started therapy|1|||
155192249|NCT01251861|560142383|FG000|Overall Study|Potential interaction of drugs|0|||
155192250|NCT01251861|560142384|FG001|Overall Study|Potential interaction of drugs|1|||
155192251|NCT05439941|560143755|FG000|Overall Study|Lack of Efficacy|8|||
155192252|NCT05439941|560143756|FG001|Overall Study|Lack of Efficacy|5|||
155192253|NCT05439941|560143757|FG002|Overall Study|Lack of Efficacy|3|||
155192254|NCT05439941|560143755|FG000|Overall Study|Treatment Failure|0|||
155192255|NCT05439941|560143756|FG001|Overall Study|Treatment Failure|1|||
155192256|NCT05439941|560143757|FG002|Overall Study|Treatment Failure|0|||
155192257|NCT05439941|560143755|FG000|Overall Study|Adverse Event|1|||
155192258|NCT05439941|560143756|FG001|Overall Study|Adverse Event|3|||
155192259|NCT05439941|560143757|FG002|Overall Study|Adverse Event|0|||
155192260|NCT05439941|560143755|FG000|Overall Study|Adverse Event - Parent Study|1|||
155192261|NCT05439941|560143756|FG001|Overall Study|Adverse Event - Parent Study|0|||
155192262|NCT05439941|560143757|FG002|Overall Study|Adverse Event - Parent Study|0|||
155192263|NCT05439941|560143755|FG000|Overall Study|Pregnancy|1|||
155192264|NCT05439941|560143756|FG001|Overall Study|Pregnancy|0|||
155192265|NCT05439941|560143757|FG002|Overall Study|Pregnancy|0|||
155192266|NCT05439941|560143755|FG000|Overall Study|Withdrawal by Subject|9|||
155192267|NCT05439941|560143756|FG001|Overall Study|Withdrawal by Subject|6|||
155192268|NCT05439941|560143757|FG002|Overall Study|Withdrawal by Subject|10|||
155192269|NCT05439941|560143755|FG000|Overall Study|Non-Compliance|1|||
155192270|NCT05439941|560143756|FG001|Overall Study|Non-Compliance|1|||
155192271|NCT05439941|560143757|FG002|Overall Study|Non-Compliance|1|||
155192272|NCT05439941|560143755|FG000|Overall Study|Lost to Follow-up|2|||
155192273|NCT05439941|560143756|FG001|Overall Study|Lost to Follow-up|2|||
155192274|NCT05439941|560143757|FG002|Overall Study|Lost to Follow-up|0|||
155192275|NCT05439941|560143755|FG000|Overall Study|Physician Decision|1|||
155192276|NCT05439941|560143756|FG001|Overall Study|Physician Decision|0|||
155192277|NCT05439941|560143757|FG002|Overall Study|Physician Decision|0|||
155192278|NCT05439941|560143755|FG000|Overall Study|Trial Termination by Sponsor|78|||
155192279|NCT05439941|560143756|FG001|Overall Study|Trial Termination by Sponsor|83|||
155192280|NCT05439941|560143757|FG002|Overall Study|Trial Termination by Sponsor|65|||
155192281|NCT05439941|560143755|FG000|Overall Study|Other than Reasons Listed|2|||
155192282|NCT05439941|560143756|FG001|Overall Study|Other than Reasons Listed|1|||
155192283|NCT05439941|560143757|FG002|Overall Study|Other than Reasons Listed|0|||
155192284|NCT00573183|560143758|FG000|Overall Study|Lost to Follow-up|52|||
155192285|NCT00573183|560143759|FG001|Overall Study|Lost to Follow-up|50|||
155192286|NCT00573183|560143758|FG000|Overall Study|Withdrawal by Subject|8|||
155192287|NCT00573183|560143759|FG001|Overall Study|Withdrawal by Subject|2|||
155192288|NCT00573183|560143758|FG000|Overall Study|Death|0|||
155192289|NCT00573183|560143759|FG001|Overall Study|Death|1|||
155192290|NCT00573183|560143758|FG000|Overall Study|Adverse Event|2|||
155192291|NCT00573183|560143759|FG001|Overall Study|Adverse Event|0|||
155192292|NCT00573183|560143758|FG000|Overall Study|Incarceration|5|||
155192293|NCT00573183|560143759|FG001|Overall Study|Incarceration|8|||
155192294|NCT00573183|560143758|FG000|Overall Study|Other|5|||
155192295|NCT00573183|560143759|FG001|Overall Study|Other|2|||
155192296|NCT02362035|560143760|FG000|Overall Study|Death|67|||
155192297|NCT02362035|560143760|FG000|Overall Study|Lost to Follow-up|3|||
155192298|NCT02362035|560143760|FG000|Overall Study|Adverse Event|1|||
155192299|NCT02362035|560143760|FG000|Overall Study|Physician Decision|1|||
155192300|NCT02362035|560143760|FG000|Overall Study|Subject started another cancer therapy|10|||
155192301|NCT02362035|560143760|FG000|Overall Study|Study terminated by sponsor|45|||
155192302|NCT02362035|560143760|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
155192303|NCT02362035|560143760|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
155192304|NCT02362035|560143760|FG000|Overall Study|Disease progression|11|||
155192305|NCT02362035|560143760|FG000|Overall Study|Withdrawal by Subject|20|||
155192306|NCT01797731|560143763|FG000|Overall Study|Didn't have proper radiographs required|3|||
155192307|NCT01797731|560143764|FG001|Overall Study|Didn't have proper radiographs required|3|||
155192308|NCT01189604|560143770|FG000|Overall Study|Impossible to visit|0|||
155192309|NCT01189604|560143771|FG001|Overall Study|Impossible to visit|0|||
155192310|NCT01189604|560143772|FG002|Overall Study|Impossible to visit|0|||
155192311|NCT01189604|560143773|FG003|Overall Study|Impossible to visit|0|||
155192312|NCT01189604|560143774|FG004|Overall Study|Impossible to visit|0|||
155192313|NCT01189604|560143775|FG005|Overall Study|Impossible to visit|1|||
155192314|NCT01189604|560143776|FG006|Overall Study|Impossible to visit|0|||
155192315|NCT01189604|560143770|FG000|Overall Study|Adverse Event|0|||
155192316|NCT01189604|560143771|FG001|Overall Study|Adverse Event|1|||
155192317|NCT01189604|560143772|FG002|Overall Study|Adverse Event|0|||
155192318|NCT01189604|560143773|FG003|Overall Study|Adverse Event|0|||
155192319|NCT01189604|560143774|FG004|Overall Study|Adverse Event|2|||
155192320|NCT01189604|560143775|FG005|Overall Study|Adverse Event|0|||
155192321|NCT01189604|560143776|FG006|Overall Study|Adverse Event|1|||
155192322|NCT01189604|560143770|FG000|Overall Study|Withdrawal by Subject|1|||
155192323|NCT01189604|560143771|FG001|Overall Study|Withdrawal by Subject|0|||
155192324|NCT01189604|560143772|FG002|Overall Study|Withdrawal by Subject|0|||
155192325|NCT01189604|560143773|FG003|Overall Study|Withdrawal by Subject|0|||
155192326|NCT01189604|560143774|FG004|Overall Study|Withdrawal by Subject|0|||
155192327|NCT01189604|560143775|FG005|Overall Study|Withdrawal by Subject|0|||
155192328|NCT01189604|560143776|FG006|Overall Study|Withdrawal by Subject|0|||
155192329|NCT00986830|560143777|FG000|Overall Study|Death|1|||
155192330|NCT00986830|560143777|FG000|Overall Study|Lost to Follow-up|1|||
155192331|NCT00986830|560143777|FG000|Overall Study|Lack of Efficacy|1|||
155192332|NCT00986830|560143777|FG000|Overall Study|Unable to access sinus with device|5|||
155192333|NCT01495975|560143778|FG000|Overall Study|Lost to Follow-up|1|||
155192334|NCT01495975|560143779|FG001|Overall Study|Lost to Follow-up|0|||
155192335|NCT00808483|560143780|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
155192336|NCT00808483|560143781|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
155192337|NCT00808483|560143780|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
155192338|NCT00808483|560143781|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
155192339|NCT00808483|560143780|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
155192340|NCT00808483|560143781|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
155192341|NCT02038881|560143782|FG000|Overall Study|Withdrawal by Subject|0|||
155192342|NCT02038881|560143783|FG001|Overall Study|Withdrawal by Subject|0|||
155192343|NCT02038881|560143784|FG002|Overall Study|Withdrawal by Subject|1|||
155192344|NCT02038881|560143782|FG000|Overall Study|Lost to Follow-up|2|||
155192345|NCT02038881|560143783|FG001|Overall Study|Lost to Follow-up|0|||
155192346|NCT02038881|560143784|FG002|Overall Study|Lost to Follow-up|0|||
155192347|NCT02038881|560143782|FG000|Overall Study|incarcerated|1|||
155192348|NCT02038881|560143783|FG001|Overall Study|incarcerated|0|||
155192349|NCT02038881|560143784|FG002|Overall Study|incarcerated|0|||
155192350|NCT00333840|560143785|FG000|First-line Treatment Period|Adverse Event|38|||
155192351|NCT00333840|560143786|FG001|First-line Treatment Period|Adverse Event|37|||
155192352|NCT00333840|560143787|FG002|First-line Treatment Period|Adverse Event|0|||
155192353|NCT00333840|560143788|FG003|First-line Treatment Period|Adverse Event|0|||
155192354|NCT00333840|560143785|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
155192355|NCT00333840|560143786|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
155192356|NCT00333840|560143787|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
155192357|NCT00333840|560143788|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
155192358|NCT00333840|560143785|FG000|First-line Treatment Period|Abnormal procedure|2|||
155192359|NCT00333840|560143786|FG001|First-line Treatment Period|Abnormal procedure|0|||
155192360|NCT00333840|560143787|FG002|First-line Treatment Period|Abnormal procedure|0|||
155192361|NCT00333840|560143788|FG003|First-line Treatment Period|Abnormal procedure|0|||
155192362|NCT00333840|560143785|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
155192363|NCT00333840|560143786|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
155192364|NCT00333840|560143787|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192365|NCT00333840|560143788|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192366|NCT00333840|560143785|FG000|First-line Treatment Period|No longer required study drug|21|||
155192367|NCT00333840|560143786|FG001|First-line Treatment Period|No longer required study drug|8|||
155192368|NCT00333840|560143787|FG002|First-line Treatment Period|No longer required study drug|0|||
155192369|NCT00333840|560143788|FG003|First-line Treatment Period|No longer required study drug|0|||
155192370|NCT00333840|560143785|FG000|First-line Treatment Period|Protocol Violation|17|||
155192371|NCT00333840|560143786|FG001|First-line Treatment Period|Protocol Violation|17|||
155192372|NCT00333840|560143787|FG002|First-line Treatment Period|Protocol Violation|0|||
155192373|NCT00333840|560143788|FG003|First-line Treatment Period|Protocol Violation|0|||
155192374|NCT00333840|560143785|FG000|First-line Treatment Period|Subject withdrew consent|57|||
155192375|NCT00333840|560143786|FG001|First-line Treatment Period|Subject withdrew consent|77|||
155192376|NCT00333840|560143787|FG002|First-line Treatment Period|Subject withdrew consent|0|||
155192377|NCT00333840|560143788|FG003|First-line Treatment Period|Subject withdrew consent|0|||
155192378|NCT00333840|560143785|FG000|First-line Treatment Period|Lost to Follow-up|15|||
155192379|NCT00333840|560143786|FG001|First-line Treatment Period|Lost to Follow-up|6|||
155192380|NCT00333840|560143787|FG002|First-line Treatment Period|Lost to Follow-up|0|||
155192381|NCT00333840|560143788|FG003|First-line Treatment Period|Lost to Follow-up|0|||
155192382|NCT00333840|560143785|FG000|First-line Treatment Period|Administrative problems|12|||
155192383|NCT00333840|560143786|FG001|First-line Treatment Period|Administrative problems|6|||
155192384|NCT00333840|560143787|FG002|First-line Treatment Period|Administrative problems|0|||
155192385|NCT00333840|560143788|FG003|First-line Treatment Period|Administrative problems|0|||
155192386|NCT00333840|560143785|FG000|First-line Treatment Period|Death|19|||
155192387|NCT00333840|560143786|FG001|First-line Treatment Period|Death|2|||
155192388|NCT00333840|560143787|FG002|First-line Treatment Period|Death|0|||
155192389|NCT00333840|560143788|FG003|First-line Treatment Period|Death|0|||
155192390|NCT00333840|560143785|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
155192391|NCT00333840|560143786|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
155192392|NCT00333840|560143787|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
155192393|NCT00333840|560143788|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
155192394|NCT00333840|560143785|FG000|Second-line Treatment Period|Adverse Event|0|||
155192395|NCT00333840|560143786|FG001|Second-line Treatment Period|Adverse Event|0|||
155192396|NCT00333840|560143787|FG002|Second-line Treatment Period|Adverse Event|3|||
155192397|NCT00333840|560143788|FG003|Second-line Treatment Period|Adverse Event|34|||
155192398|NCT00333840|560143785|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192399|NCT00333840|560143786|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192400|NCT00333840|560143787|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192401|NCT00333840|560143788|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
155192402|NCT00333840|560143785|FG000|Second-line Treatment Period|Abnormal procedure|0|||
155192403|NCT00333840|560143786|FG001|Second-line Treatment Period|Abnormal procedure|0|||
155192404|NCT00333840|560143787|FG002|Second-line Treatment Period|Abnormal procedure|0|||
155192405|NCT00333840|560143788|FG003|Second-line Treatment Period|Abnormal procedure|1|||
155192406|NCT00333840|560143785|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192407|NCT00333840|560143786|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192408|NCT00333840|560143787|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
155192409|NCT00333840|560143788|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
155192410|NCT00333840|560143785|FG000|Second-line Treatment Period|No longer required study drug|0|||
155192411|NCT00333840|560143786|FG001|Second-line Treatment Period|No longer required study drug|0|||
155192412|NCT00333840|560143787|FG002|Second-line Treatment Period|No longer required study drug|1|||
155720704|NCT00385671|562075263|FG002|Overall Study|Adverse Event|18|||
155192413|NCT00333840|560143788|FG003|Second-line Treatment Period|No longer required study drug|14|||
155192414|NCT00333840|560143785|FG000|Second-line Treatment Period|Protocol Violation|0|||
155192415|NCT00333840|560143786|FG001|Second-line Treatment Period|Protocol Violation|0|||
155192416|NCT00333840|560143787|FG002|Second-line Treatment Period|Protocol Violation|1|||
155720705|NCT00385671|562075261|FG000|Overall Study|Lack of Efficacy|5|||
155192417|NCT00333840|560143788|FG003|Second-line Treatment Period|Protocol Violation|10|||
155192418|NCT00333840|560143785|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
155192419|NCT00333840|560143786|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
155192420|NCT00333840|560143787|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
155192421|NCT00333840|560143788|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
155192422|NCT00333840|560143785|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
155192423|NCT00333840|560143786|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
155192424|NCT00333840|560143787|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
155192425|NCT00333840|560143788|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
155192426|NCT00333840|560143785|FG000|Second-line Treatment Period|Administrative problems|0|||
155192427|NCT00333840|560143786|FG001|Second-line Treatment Period|Administrative problems|0|||
155192428|NCT00333840|560143787|FG002|Second-line Treatment Period|Administrative problems|0|||
155192429|NCT00333840|560143788|FG003|Second-line Treatment Period|Administrative problems|7|||
155192430|NCT00333840|560143785|FG000|Second-line Treatment Period|Death|0|||
155192431|NCT00333840|560143786|FG001|Second-line Treatment Period|Death|0|||
155192432|NCT00333840|560143787|FG002|Second-line Treatment Period|Death|0|||
155192433|NCT00333840|560143788|FG003|Second-line Treatment Period|Death|9|||
155192434|NCT02357979|560143789|FG000|Overall Study|Lost to Follow-up|5|||
155192435|NCT02357979|560143790|FG001|Overall Study|Lost to Follow-up|5|||
155192436|NCT03945214|560143791|FG000|Overall Study|Lost to Follow-up|3|||
155192437|NCT03945214|560143792|FG001|Overall Study|Lost to Follow-up|4|||
155192438|NCT03945214|560143793|FG002|Overall Study|Lost to Follow-up|7|||
155192439|NCT03945214|560143794|FG003|Overall Study|Lost to Follow-up|4|||
155192440|NCT03449901|560143806|FG000|Overall Study|Progression|57|||
155192441|NCT03449901|560143807|FG001|Overall Study|Progression|12|||
155192442|NCT03449901|560143806|FG000|Overall Study|Adverse Event|3|||
155192443|NCT03449901|560143807|FG001|Overall Study|Adverse Event|0|||
155192444|NCT03449901|560143806|FG000|Overall Study|Death|6|||
155192445|NCT03449901|560143807|FG001|Overall Study|Death|2|||
155192446|NCT03449901|560143806|FG000|Overall Study|Withdrawal by Subject|12|||
155192447|NCT03449901|560143807|FG001|Overall Study|Withdrawal by Subject|1|||
155192448|NCT03449901|560143806|FG000|Overall Study|Physician Decision|1|||
155192449|NCT03449901|560143807|FG001|Overall Study|Physician Decision|0|||
155192450|NCT03449901|560143806|FG000|Overall Study|Patient elected for surgical intervention|1|||
155192451|NCT03449901|560143807|FG001|Overall Study|Patient elected for surgical intervention|0|||
155192452|NCT03449901|560143806|FG000|Overall Study|Patient off for other complicating disease|1|||
155192453|NCT03449901|560143807|FG001|Overall Study|Patient off for other complicating disease|0|||
155192454|NCT03150173|560143808|FG000|Overall Study|Lost to Follow-up|13|||
155192455|NCT03150173|560143809|FG001|Overall Study|Lost to Follow-up|5|||
155192456|NCT04041375|560143815|FG000|Intervention Phase|Withdrawal by Subject|2|||
155192457|NCT04041375|560143816|FG001|Intervention Phase|Withdrawal by Subject|2|||
155192458|NCT04041375|560143815|FG000|Follow-up Phase|Death|2|||
155192459|NCT04041375|560143816|FG001|Follow-up Phase|Death|0|||
155192460|NCT04041375|560143815|FG000|Follow-up Phase|Lost to Follow-up|2|||
155192461|NCT04041375|560143816|FG001|Follow-up Phase|Lost to Follow-up|1|||
155192462|NCT04041375|560143815|FG000|Follow-up Phase|Too ill|3|||
155192463|NCT04041375|560143816|FG001|Follow-up Phase|Too ill|0|||
155192464|NCT02404220|560143822|FG000|Overall Study|Adverse Event|0|||
155192465|NCT02404220|560143823|FG001|Overall Study|Adverse Event|0|||
155192466|NCT02404220|560143824|FG002|Overall Study|Adverse Event|1|||
155192467|NCT02404220|560143825|FG003|Overall Study|Adverse Event|0|||
155192468|NCT02404220|560143822|FG000|Overall Study|Death|5|||
155192469|NCT02404220|560143823|FG001|Overall Study|Death|5|||
155192470|NCT02404220|560143824|FG002|Overall Study|Death|3|||
155192471|NCT02404220|560143825|FG003|Overall Study|Death|8|||
155192472|NCT02404220|560143822|FG000|Overall Study|Progressive Disease|0|||
155192473|NCT02404220|560143823|FG001|Overall Study|Progressive Disease|0|||
155192474|NCT02404220|560143824|FG002|Overall Study|Progressive Disease|1|||
155192475|NCT02404220|560143825|FG003|Overall Study|Progressive Disease|1|||
155192476|NCT02404220|560143822|FG000|Overall Study|Study Terminated by Sponsor|0|||
155192477|NCT02404220|560143823|FG001|Overall Study|Study Terminated by Sponsor|0|||
155720706|NCT00385671|562075262|FG001|Overall Study|Lack of Efficacy|9|||
155720707|NCT00385671|562075263|FG002|Overall Study|Lack of Efficacy|5|||
155720708|NCT00385671|562075261|FG000|Overall Study|Lost to Follow-up|6|||
155720709|NCT00385671|562075262|FG001|Overall Study|Lost to Follow-up|6|||
155192478|NCT02404220|560143824|FG002|Overall Study|Study Terminated by Sponsor|2|||
155491122|NCT01023815|561223474|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
155720710|NCT00385671|562075263|FG002|Overall Study|Lost to Follow-up|5|||
155192479|NCT02404220|560143825|FG003|Overall Study|Study Terminated by Sponsor|1|||
155192480|NCT02404220|560143822|FG000|Overall Study|Withdrawal by Subject|0|||
155192481|NCT02404220|560143823|FG001|Overall Study|Withdrawal by Subject|1|||
155192482|NCT02404220|560143824|FG002|Overall Study|Withdrawal by Subject|0|||
155192483|NCT02404220|560143825|FG003|Overall Study|Withdrawal by Subject|0|||
155192484|NCT02404220|560143822|FG000|Overall Study|Enrolled but Never Treated|0|||
155192485|NCT02404220|560143823|FG001|Overall Study|Enrolled but Never Treated|2|||
155192486|NCT02404220|560143824|FG002|Overall Study|Enrolled but Never Treated|0|||
155720711|NCT00385671|562075261|FG000|Overall Study|Physician Decision|2|||
155192487|NCT02404220|560143825|FG003|Overall Study|Enrolled but Never Treated|0|||
155192488|NCT01708161|560143828|FG000|Overall Study|Adverse Event|1|||
155192489|NCT01708161|560143829|FG001|Overall Study|Adverse Event|3|||
155192490|NCT01708161|560143830|FG002|Overall Study|Adverse Event|4|||
155192491|NCT01708161|560143831|FG003|Overall Study|Adverse Event|2|||
155192492|NCT01708161|560143832|FG004|Overall Study|Adverse Event|3|||
155192493|NCT01708161|560143833|FG005|Overall Study|Adverse Event|0|||
155192494|NCT01708161|560143828|FG000|Overall Study|Death|0|||
155192495|NCT01708161|560143829|FG001|Overall Study|Death|0|||
155192496|NCT01708161|560143830|FG002|Overall Study|Death|0|||
155192497|NCT01708161|560143831|FG003|Overall Study|Death|1|||
155192498|NCT01708161|560143832|FG004|Overall Study|Death|0|||
155192499|NCT01708161|560143833|FG005|Overall Study|Death|1|||
155192500|NCT01708161|560143828|FG000|Overall Study|Withdrawal by Subject|0|||
155192501|NCT01708161|560143829|FG001|Overall Study|Withdrawal by Subject|1|||
155720712|NCT00385671|562075262|FG001|Overall Study|Physician Decision|1|||
155720713|NCT00385671|562075263|FG002|Overall Study|Physician Decision|2|||
155720714|NCT00385671|562075261|FG000|Overall Study|Protocol Violation|5|||
155720715|NCT00385671|562075262|FG001|Overall Study|Protocol Violation|2|||
155720716|NCT00385671|562075263|FG002|Overall Study|Protocol Violation|1|||
155720717|NCT00385671|562075261|FG000|Overall Study|Sponsor Decision|2|||
155720718|NCT00385671|562075262|FG001|Overall Study|Sponsor Decision|2|||
155720719|NCT00385671|562075263|FG002|Overall Study|Sponsor Decision|1|||
155720720|NCT00385671|562075261|FG000|Overall Study|Withdrawal by Subject|4|||
155720721|NCT00385671|562075262|FG001|Overall Study|Withdrawal by Subject|4|||
155720722|NCT00385671|562075263|FG002|Overall Study|Withdrawal by Subject|4|||
155720723|NCT01021020|562075271|FG000|Period I|Protocol Violation|1|||
155192502|NCT01708161|560143830|FG002|Overall Study|Withdrawal by Subject|1|||
155192503|NCT01708161|560143831|FG003|Overall Study|Withdrawal by Subject|0|||
155192504|NCT01708161|560143832|FG004|Overall Study|Withdrawal by Subject|0|||
155192505|NCT01708161|560143833|FG005|Overall Study|Withdrawal by Subject|0|||
155192506|NCT01708161|560143828|FG000|Overall Study|Administrative problems|0|||
155192507|NCT01708161|560143829|FG001|Overall Study|Administrative problems|1|||
155192508|NCT01708161|560143830|FG002|Overall Study|Administrative problems|0|||
155192509|NCT01708161|560143831|FG003|Overall Study|Administrative problems|0|||
155192510|NCT01708161|560143832|FG004|Overall Study|Administrative problems|0|||
155192511|NCT01708161|560143833|FG005|Overall Study|Administrative problems|0|||
155192512|NCT01708161|560143828|FG000|Overall Study|Disease progression|3|||
155192513|NCT01708161|560143829|FG001|Overall Study|Disease progression|5|||
155192514|NCT01708161|560143830|FG002|Overall Study|Disease progression|5|||
155192515|NCT01708161|560143831|FG003|Overall Study|Disease progression|13|||
155192516|NCT01708161|560143832|FG004|Overall Study|Disease progression|3|||
155192517|NCT01708161|560143833|FG005|Overall Study|Disease progression|0|||
155192518|NCT01672736|560143837|FG000|Overall Study|Available drug expired on 31 May 16|3|||
155192519|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
155192520|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
155192521|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
155192522|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
155192523|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
155192524|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
155192525|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
155192526|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
155192527|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
155192528|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
155192529|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
155192530|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
155720724|NCT01021020|562075271|FG000|Period I|Withdrawal by Subject|1|||
155720725|NCT01021020|562075271|FG000|14 Day Washout Period A|Physician Decision|1|||
155720726|NCT00755183|562075272|FG000|Overall Study|Adverse Event|5|||
155192531|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
155720727|NCT00755183|562075273|FG001|Overall Study|Adverse Event|2|||
155720728|NCT00755183|562075272|FG000|Overall Study|Protocol Violation|0|||
155720729|NCT00755183|562075273|FG001|Overall Study|Protocol Violation|1|||
155720730|NCT00755183|562075272|FG000|Overall Study|Withdrawal by Subject|0|||
155720731|NCT00755183|562075273|FG001|Overall Study|Withdrawal by Subject|2|||
155192532|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
155192533|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
155192534|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
155192535|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
155192536|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
155192537|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
155192538|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
155192539|NCT02853344|560143840|FG000|Overall Study|Lost to Follow-up|1|||
155192540|NCT02853344|560143841|FG001|Overall Study|Lost to Follow-up|1|||
155720732|NCT00755183|562075272|FG000|Overall Study|Administrative|2|||
155192541|NCT02853344|560143840|FG000|Overall Study|Withdrawal by Subject|2|||
155192542|NCT02853344|560143841|FG001|Overall Study|Withdrawal by Subject|4|||
155192543|NCT02853344|560143840|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
155192544|NCT02853344|560143841|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
155192545|NCT02853344|560143840|FG000|Overall Study|Death|70|||
155192546|NCT02853344|560143841|FG001|Overall Study|Death|112|||
155192547|NCT04251273|560143842|FG000|Overall Study|Lost to Follow-up|331|||
155192548|NCT04251273|560143843|FG001|Overall Study|Lost to Follow-up|290|||
155192549|NCT00810693|560143844|FG000|Treatment Period|Adverse Event|8|||
155192550|NCT00810693|560143845|FG001|Treatment Period|Adverse Event|1|||
155192551|NCT00810693|560143846|FG002|Treatment Period|Adverse Event|7|||
155192552|NCT00810693|560143844|FG000|Treatment Period|Death|0|||
155192553|NCT00810693|560143845|FG001|Treatment Period|Death|1|||
155192554|NCT00810693|560143846|FG002|Treatment Period|Death|2|||
155192555|NCT00810693|560143844|FG000|Treatment Period|Lack of Efficacy|0|||
155192556|NCT00810693|560143845|FG001|Treatment Period|Lack of Efficacy|0|||
155192557|NCT00810693|560143846|FG002|Treatment Period|Lack of Efficacy|1|||
155192558|NCT00810693|560143844|FG000|Treatment Period|Lost to Follow-up|1|||
155192559|NCT00810693|560143845|FG001|Treatment Period|Lost to Follow-up|0|||
155192560|NCT00810693|560143846|FG002|Treatment Period|Lost to Follow-up|0|||
155192561|NCT00810693|560143844|FG000|Treatment Period|Non-compliance|1|||
155192562|NCT00810693|560143845|FG001|Treatment Period|Non-compliance|0|||
155192563|NCT00810693|560143846|FG002|Treatment Period|Non-compliance|0|||
155192564|NCT00810693|560143844|FG000|Treatment Period|Protocol Violation|1|||
155192565|NCT00810693|560143845|FG001|Treatment Period|Protocol Violation|2|||
155192566|NCT00810693|560143846|FG002|Treatment Period|Protocol Violation|2|||
155192567|NCT00810693|560143844|FG000|Treatment Period|Withdrawal by Subject|6|||
155192568|NCT00810693|560143845|FG001|Treatment Period|Withdrawal by Subject|2|||
155192569|NCT00810693|560143846|FG002|Treatment Period|Withdrawal by Subject|3|||
155192570|NCT00810693|560143844|FG000|Treatment Period|Not treated|0|||
155192571|NCT00810693|560143845|FG001|Treatment Period|Not treated|1|||
155192572|NCT00810693|560143846|FG002|Treatment Period|Not treated|1|||
155192573|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Adverse Event|3|||
155192574|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Adverse Event|1|||
155192575|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Adverse Event|1|||
155192576|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Death|2|||
155192577|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Death|0|||
155192578|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Death|1|||
155192579|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
155192580|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
155192581|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
155192582|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
155192583|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
155192584|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
155192585|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
155192586|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
155192587|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
155192588|NCT00936611|560143851|FG000|Overall Study|Progressive Disease|3|||
155192589|NCT00936611|560143851|FG000|Overall Study|New Systemic Therapy|22|||
155192590|NCT00936611|560143851|FG000|Overall Study|Lost to Follow-up|1|||
155192591|NCT00936611|560143851|FG000|Overall Study|Withdrawal by Subject|2|||
155192592|NCT00936611|560143851|FG000|Overall Study|Still on Follow-up|1|||
155192593|NCT00936611|560143851|FG000|Overall Study|Still on Active Therapy|7|||
155192594|NCT00936611|560143851|FG000|Overall Study|Ineligible for Study Drug|3|||
155192595|NCT02282358|560143854|FG000|Overall Study|Nonevaluable|1|||
155192596|NCT01898208|560143855|FG000|Overall Study|Positive blood culture|17|||
155192597|NCT01898208|560143856|FG001|Overall Study|Positive blood culture|23|||
155192598|NCT01898208|560143857|FG002|Overall Study|Positive blood culture|15|||
155192599|NCT01898208|560143855|FG000|Overall Study|Death/comfort care within 24 hours|10|||
155192600|NCT01898208|560143856|FG001|Overall Study|Death/comfort care within 24 hours|9|||
155192601|NCT01898208|560143857|FG002|Overall Study|Death/comfort care within 24 hours|8|||
155192602|NCT01898208|560143855|FG000|Overall Study|Negative Gram Stain|6|||
155192603|NCT01898208|560143856|FG001|Overall Study|Negative Gram Stain|9|||
155720733|NCT00755183|562075273|FG001|Overall Study|Administrative|1|||
155720734|NCT03547518|562075278|FG000|Overall Study|Lost to Follow-up|2|||
155720735|NCT03547518|562075279|FG001|Overall Study|Lost to Follow-up|0|||
155192604|NCT01898208|560143857|FG002|Overall Study|Negative Gram Stain|6|||
155192605|NCT01898208|560143855|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
155192606|NCT01898208|560143856|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
155192607|NCT01898208|560143857|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
155192608|NCT01898208|560143855|FG000|Overall Study|System/Technical Error|1|||
155192609|NCT01898208|560143856|FG001|Overall Study|System/Technical Error|2|||
155192610|NCT01898208|560143857|FG002|Overall Study|System/Technical Error|3|||
155192611|NCT01898208|560143855|FG000|Overall Study|Lost to Follow-up|3|||
155192612|NCT01898208|560143856|FG001|Overall Study|Lost to Follow-up|1|||
155192613|NCT01898208|560143857|FG002|Overall Study|Lost to Follow-up|1|||
155192614|NCT02155881|560143858|FG000|Overall Study|Withdrawal by Subject|0|||
155192615|NCT02155881|560143859|FG001|Overall Study|Withdrawal by Subject|2|||
155192616|NCT02155881|560143858|FG000|Overall Study|Inappropriately randomized|2|||
155192617|NCT02155881|560143859|FG001|Overall Study|Inappropriately randomized|2|||
155192618|NCT00961649|560143860|FG000|Overall Study|Adverse Event|4|||
155192619|NCT00961649|560143861|FG001|Overall Study|Adverse Event|0|||
155192620|NCT00961649|560143862|FG002|Overall Study|Adverse Event|0|||
155192621|NCT00961649|560143863|FG003|Overall Study|Adverse Event|2|||
155192622|NCT00961649|560143860|FG000|Overall Study|Inadequate control of IOP|0|||
155192623|NCT00961649|560143861|FG001|Overall Study|Inadequate control of IOP|0|||
155192624|NCT00961649|560143862|FG002|Overall Study|Inadequate control of IOP|0|||
155192625|NCT00961649|560143863|FG003|Overall Study|Inadequate control of IOP|1|||
155192626|NCT00961649|560143860|FG000|Overall Study|Patient has travel plans during holidays|0|||
155192627|NCT00961649|560143861|FG001|Overall Study|Patient has travel plans during holidays|0|||
155192628|NCT00961649|560143862|FG002|Overall Study|Patient has travel plans during holidays|1|||
155192629|NCT00961649|560143863|FG003|Overall Study|Patient has travel plans during holidays|0|||
155192630|NCT00961649|560143860|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
155192631|NCT00961649|560143861|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
155192632|NCT00961649|560143862|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
155192633|NCT00961649|560143863|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
155192634|NCT00961649|560143860|FG000|Overall Study|Study terminated by sponsor|4|||
155192635|NCT00961649|560143861|FG001|Overall Study|Study terminated by sponsor|4|||
155720736|NCT04742556|562075283|FG000|Overall Study|Withdrawal by Subject|0|||
155720737|NCT04742556|562075284|FG001|Overall Study|Withdrawal by Subject|1|||
155720738|NCT04742556|562075285|FG002|Overall Study|Withdrawal by Subject|0|||
155720739|NCT04742556|562075283|FG000|Overall Study|Adverse Event|0|||
155192636|NCT00961649|560143862|FG002|Overall Study|Study terminated by sponsor|4|||
155192637|NCT00961649|560143863|FG003|Overall Study|Study terminated by sponsor|1|||
155192638|NCT04043728|560143864|FG000|Overall Study|Lost to Follow-up|1|||
155192639|NCT04043728|560143865|FG001|Overall Study|Lost to Follow-up|2|||
155192640|NCT04043728|560143866|FG002|Overall Study|Lost to Follow-up|0|||
155192641|NCT03841448|560143867|FG000|Double-blind Treatment (DBT) Period|Death|1|||
155192642|NCT03841448|560143868|FG001|Double-blind Treatment (DBT) Period|Death|1|||
155192643|NCT03841448|560143869|FG002|Double-blind Treatment (DBT) Period|Death|0|||
155192644|NCT03841448|560143870|FG003|Double-blind Treatment (DBT) Period|Death|0|||
155192645|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155192646|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155192647|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
155192648|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
155192649|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Death|0|||
155192650|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Death|0|||
155192651|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Death|0|||
155192652|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Death|1|||
155192653|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
155192654|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
155192655|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
155192656|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
155192657|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
155192658|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
155192659|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
155192660|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
155192661|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
155192662|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
155192663|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
155192664|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
155192665|NCT00586625|560143871|FG000|Overall Study|Adverse Event|6|||
155192666|NCT00586625|560143872|FG001|Overall Study|Adverse Event|6|||
155192667|NCT00586625|560143871|FG000|Overall Study|Protocol Violation|3|||
155192668|NCT00586625|560143872|FG001|Overall Study|Protocol Violation|0|||
155192669|NCT00586625|560143871|FG000|Overall Study|Withdrawal by Subject|32|||
155192670|NCT00586625|560143872|FG001|Overall Study|Withdrawal by Subject|10|||
155720740|NCT04742556|562075284|FG001|Overall Study|Adverse Event|0|||
155720741|NCT04742556|562075285|FG002|Overall Study|Adverse Event|2|||
155192671|NCT00586625|560143871|FG000|Overall Study|Subject non-compliance|0|||
155192672|NCT00586625|560143872|FG001|Overall Study|Subject non-compliance|1|||
155192673|NCT00586625|560143871|FG000|Overall Study|Subject unable to return for visit|2|||
155192674|NCT00586625|560143872|FG001|Overall Study|Subject unable to return for visit|0|||
155192675|NCT03594994|560143873|FG000|Overall Study|Adverse Event|1|||
155192676|NCT03594994|560143874|FG001|Overall Study|Adverse Event|0|||
155720742|NCT04742556|562075283|FG000|Overall Study|Clinical disease progression|0|||
155192677|NCT03594994|560143873|FG000|Overall Study|Withdrawal by Subject|0|||
155192678|NCT03594994|560143874|FG001|Overall Study|Withdrawal by Subject|1|||
155192679|NCT04452344|560143877|FG000|Overall Study|Withdrawal by Subject|3|||
155720743|NCT04742556|562075284|FG001|Overall Study|Clinical disease progression|1|||
155720744|NCT04742556|562075285|FG002|Overall Study|Clinical disease progression|2|||
155720745|NCT04742556|562075283|FG000|Overall Study|Objective disease progression|3|||
155720746|NCT04742556|562075284|FG001|Overall Study|Objective disease progression|2|||
155720747|NCT04742556|562075285|FG002|Overall Study|Objective disease progression|4|||
155720748|NCT04247347|562075286|FG000|Overall Study|Withdrawal by Subject|2|||
155720749|NCT04247347|562075287|FG001|Overall Study|Withdrawal by Subject|3|||
155720750|NCT04247347|562075288|FG002|Overall Study|Withdrawal by Subject|3|||
155720751|NCT04247347|562075286|FG000|Overall Study|Lost to Follow-up|1|||
155720752|NCT04247347|562075287|FG001|Overall Study|Lost to Follow-up|1|||
155720753|NCT04247347|562075288|FG002|Overall Study|Lost to Follow-up|1|||
155720754|NCT03035032|562075289|FG000|Overall Study|Adverse Event|2|||
155720755|NCT03035032|562075289|FG000|Overall Study|Death|9|||
155720756|NCT03035032|562075289|FG000|Overall Study|Lost to Follow-up|1|||
155192680|NCT04452344|560143878|FG001|Overall Study|Withdrawal by Subject|6|||
155192681|NCT04452344|560143877|FG000|Overall Study|Adverse Event|1|||
155192682|NCT04452344|560143878|FG001|Overall Study|Adverse Event|2|||
155192683|NCT04452344|560143877|FG000|Overall Study|Lost to Follow-up|2|||
155192684|NCT04452344|560143878|FG001|Overall Study|Lost to Follow-up|2|||
155192685|NCT04452344|560143877|FG000|Overall Study|No Post-Op Visit|6|||
155192686|NCT04452344|560143878|FG001|Overall Study|No Post-Op Visit|7|||
155192687|NCT03350620|560143880|FG000|Stage 2|Adverse Event|0|||
155192688|NCT03350620|560143881|FG001|Stage 2|Adverse Event|1|||
155192689|NCT03350620|560143882|FG002|Stage 2|Adverse Event|1|||
155192690|NCT03350620|560143880|FG000|Stage 2|Lack of Efficacy|0|||
155192691|NCT03350620|560143881|FG001|Stage 2|Lack of Efficacy|2|||
155192692|NCT03350620|560143882|FG002|Stage 2|Lack of Efficacy|0|||
155192693|NCT03350620|560143880|FG000|Stage 2|Lost to Follow-up|1|||
155192694|NCT03350620|560143881|FG001|Stage 2|Lost to Follow-up|2|||
155192695|NCT03350620|560143882|FG002|Stage 2|Lost to Follow-up|2|||
155192696|NCT03350620|560143880|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
155192697|NCT03350620|560143881|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
155192698|NCT03350620|560143882|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
155192699|NCT03001882|560143885|FG000|Overall Study|Death|1|||
155192700|NCT03001882|560143886|FG001|Overall Study|Death|0|||
155192701|NCT03001882|560143887|FG002|Overall Study|Death|0|||
155192702|NCT03001882|560143888|FG003|Overall Study|Death|3|||
155192703|NCT03001882|560143885|FG000|Overall Study|Participant withdrew consent|0|||
155192704|NCT03001882|560143886|FG001|Overall Study|Participant withdrew consent|1|||
155192705|NCT03001882|560143887|FG002|Overall Study|Participant withdrew consent|0|||
155192706|NCT03001882|560143888|FG003|Overall Study|Participant withdrew consent|5|||
155192707|NCT03001882|560143885|FG000|Overall Study|Other reasons|1|||
155192708|NCT03001882|560143886|FG001|Overall Study|Other reasons|2|||
155192709|NCT03001882|560143887|FG002|Overall Study|Other reasons|0|||
155192710|NCT03001882|560143888|FG003|Overall Study|Other reasons|5|||
155192711|NCT03001882|560143885|FG000|Overall Study|Administrative reason by sponsor|0|||
155192712|NCT03001882|560143886|FG001|Overall Study|Administrative reason by sponsor|0|||
155192713|NCT03001882|560143887|FG002|Overall Study|Administrative reason by sponsor|0|||
155192714|NCT03001882|560143888|FG003|Overall Study|Administrative reason by sponsor|1|||
155192715|NCT03001882|560143885|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155192716|NCT03001882|560143886|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
155192717|NCT03001882|560143887|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155192718|NCT03001882|560143888|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
155192719|NCT03001882|560143885|FG000|Overall Study|Not reported|0|||
155192720|NCT03001882|560143886|FG001|Overall Study|Not reported|0|||
155192721|NCT03001882|560143887|FG002|Overall Study|Not reported|0|||
155192722|NCT03001882|560143888|FG003|Overall Study|Not reported|6|||
155192723|NCT03001882|560143885|FG000|Overall Study|Maximum clinical benefit|2|||
155192724|NCT03001882|560143886|FG001|Overall Study|Maximum clinical benefit|3|||
155192725|NCT03001882|560143887|FG002|Overall Study|Maximum clinical benefit|0|||
155192726|NCT03001882|560143888|FG003|Overall Study|Maximum clinical benefit|10|||
155192727|NCT03001882|560143885|FG000|Overall Study|AE unrelated to study drug|3|||
155192728|NCT03001882|560143886|FG001|Overall Study|AE unrelated to study drug|3|||
155192729|NCT03001882|560143887|FG002|Overall Study|AE unrelated to study drug|0|||
155192730|NCT03001882|560143888|FG003|Overall Study|AE unrelated to study drug|11|||
155192731|NCT03001882|560143885|FG000|Overall Study|Study Drug Toxicity|8|||
155192732|NCT03001882|560143886|FG001|Overall Study|Study Drug Toxicity|5|||
155192733|NCT03001882|560143887|FG002|Overall Study|Study Drug Toxicity|0|||
155192734|NCT03001882|560143888|FG003|Overall Study|Study Drug Toxicity|37|||
155192735|NCT03001882|560143885|FG000|Overall Study|Disease progression|16|||
155192736|NCT03001882|560143886|FG001|Overall Study|Disease progression|14|||
155192737|NCT03001882|560143887|FG002|Overall Study|Disease progression|1|||
155192738|NCT03001882|560143888|FG003|Overall Study|Disease progression|90|||
155192739|NCT03507400|560143889|FG000|Overall Study|discontinued|5|||
155192740|NCT03507400|560143890|FG001|Overall Study|discontinued|1|||
155192741|NCT03507400|560143889|FG000|Overall Study|Lost to Follow-up|8|||
155192742|NCT03507400|560143890|FG001|Overall Study|Lost to Follow-up|6|||
155192743|NCT03507400|560143889|FG000|Overall Study|Protocol Violation|0|||
155192744|NCT03507400|560143890|FG001|Overall Study|Protocol Violation|1|||
155192745|NCT01555983|560143891|FG000|Overall Study|Withdrawal by Subject|1|||
155192746|NCT01555983|560143892|FG001|Overall Study|Withdrawal by Subject|0|||
155192747|NCT01555983|560143893|FG002|Overall Study|Withdrawal by Subject|0|||
155192748|NCT01555983|560143894|FG003|Overall Study|Withdrawal by Subject|0|||
155192749|NCT01555983|560143895|FG004|Overall Study|Withdrawal by Subject|1|||
155192750|NCT01555983|560143896|FG005|Overall Study|Withdrawal by Subject|1|||
155192751|NCT04102189|560143900|FG000|Overall Study|Withdrawal by Subject|1|||
155192752|NCT04102189|560143901|FG001|Overall Study|Withdrawal by Subject|2|||
155192753|NCT04102189|560143900|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155192754|NCT04102189|560143901|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155192755|NCT04102189|560143900|FG000|Overall Study|Lost to Follow-up|1|||
155192756|NCT04102189|560143901|FG001|Overall Study|Lost to Follow-up|0|||
155192757|NCT01950390|560143902|FG000|Overall Study|Never started treatment|3|||
155192758|NCT01950390|560143903|FG001|Overall Study|Never started treatment|2|||
155192759|NCT01950390|560143902|FG000|Overall Study|Disease progression|45|||
155192760|NCT01950390|560143903|FG001|Overall Study|Disease progression|52|||
155192761|NCT01950390|560143902|FG000|Overall Study|Adverse Event|22|||
155192762|NCT01950390|560143903|FG001|Overall Study|Adverse Event|16|||
155192763|NCT01950390|560143902|FG000|Overall Study|Death|5|||
155192764|NCT01950390|560143903|FG001|Overall Study|Death|3|||
155192765|NCT01950390|560143902|FG000|Overall Study|Withdrawal by Subject|5|||
155192766|NCT01950390|560143903|FG001|Overall Study|Withdrawal by Subject|1|||
155192767|NCT01950390|560143902|FG000|Overall Study|Alternative therapy|0|||
155192768|NCT01950390|560143903|FG001|Overall Study|Alternative therapy|3|||
155192769|NCT01950390|560143902|FG000|Overall Study|Complicating disease|1|||
155192770|NCT01950390|560143903|FG001|Overall Study|Complicating disease|0|||
155192771|NCT01950390|560143902|FG000|Overall Study|On treatment|1|||
155192772|NCT01950390|560143903|FG001|Overall Study|On treatment|0|||
155192773|NCT01950390|560143902|FG000|Overall Study|Symptomatic deterioration|2|||
155192774|NCT01950390|560143903|FG001|Overall Study|Symptomatic deterioration|1|||
155192775|NCT01950390|560143902|FG000|Overall Study|Physician Decision|0|||
155192776|NCT01950390|560143903|FG001|Overall Study|Physician Decision|4|||
155192777|NCT01950390|560143902|FG000|Overall Study|Lack of clinical benefit|0|||
155192778|NCT01950390|560143903|FG001|Overall Study|Lack of clinical benefit|1|||
155192779|NCT01950390|560143902|FG000|Overall Study|Maintained PR and moved to observation only|0|||
155192780|NCT01950390|560143903|FG001|Overall Study|Maintained PR and moved to observation only|1|||
155192781|NCT00717093|560145418|FG000|Overall Study|Adverse Event|19|||
155192782|NCT00717093|560145419|FG001|Overall Study|Adverse Event|9|||
155192783|NCT00717093|560145418|FG000|Overall Study|Lack of Efficacy|3|||
155192784|NCT00717093|560145419|FG001|Overall Study|Lack of Efficacy|13|||
155192785|NCT00717093|560145418|FG000|Overall Study|Lost to Follow-up|9|||
155192786|NCT00717093|560145419|FG001|Overall Study|Lost to Follow-up|6|||
155192787|NCT00717093|560145418|FG000|Overall Study|Withdrawal by Subject|12|||
155192788|NCT00717093|560145419|FG001|Overall Study|Withdrawal by Subject|19|||
155192789|NCT00717093|560145418|FG000|Overall Study|Other|0|||
155192790|NCT00717093|560145419|FG001|Overall Study|Other|1|||
155192791|NCT00717093|560145418|FG000|Overall Study|Randomized but not treated|1|||
155192792|NCT00717093|560145419|FG001|Overall Study|Randomized but not treated|0|||
155192793|NCT01543698|560145424|FG000|Phase 1b|Disease progression|2|||
155192794|NCT01543698|560145425|FG001|Phase 1b|Disease progression|4|||
155192795|NCT01543698|560145426|FG002|Phase 1b|Disease progression|3|||
155192796|NCT01543698|560145427|FG003|Phase 1b|Disease progression|2|||
155192797|NCT01543698|560145428|FG004|Phase 1b|Disease progression|10|||
155192798|NCT01543698|560145429|FG005|Phase 1b|Disease progression|6|||
155192799|NCT01543698|560145430|FG006|Phase 1b|Disease progression|5|||
155192800|NCT01543698|560145431|FG007|Phase 1b|Disease progression|3|||
155192801|NCT01543698|560145432|FG008|Phase 1b|Disease progression|4|||
155192802|NCT01543698|560145433|FG009|Phase 1b|Disease progression|5|||
155192803|NCT01543698|560145434|FG010|Phase 1b|Disease progression|1|||
155192804|NCT01543698|560145435|FG011|Phase 1b|Disease progression|0|||
155192805|NCT01543698|560145436|FG012|Phase 1b|Disease progression|0|||
155192806|NCT01543698|560145437|FG013|Phase 1b|Disease progression|0|||
155192807|NCT01543698|560145438|FG014|Phase 1b|Disease progression|0|||
155192808|NCT01543698|560145424|FG000|Phase 1b|Death|0|||
155192809|NCT01543698|560145425|FG001|Phase 1b|Death|0|||
155192810|NCT01543698|560145426|FG002|Phase 1b|Death|1|||
155192811|NCT01543698|560145427|FG003|Phase 1b|Death|1|||
155192812|NCT01543698|560145428|FG004|Phase 1b|Death|0|||
155192813|NCT01543698|560145429|FG005|Phase 1b|Death|0|||
155192814|NCT01543698|560145430|FG006|Phase 1b|Death|0|||
155192815|NCT01543698|560145431|FG007|Phase 1b|Death|0|||
155192816|NCT01543698|560145432|FG008|Phase 1b|Death|0|||
155192817|NCT01543698|560145433|FG009|Phase 1b|Death|0|||
155192818|NCT01543698|560145434|FG010|Phase 1b|Death|1|||
155192819|NCT01543698|560145435|FG011|Phase 1b|Death|0|||
155192820|NCT01543698|560145436|FG012|Phase 1b|Death|0|||
155720757|NCT03035032|562075289|FG000|Overall Study|Progressive Disease|22|||
155192821|NCT01543698|560145437|FG013|Phase 1b|Death|0|||
155720758|NCT03035032|562075289|FG000|Overall Study|Protocol Violation|2|||
155192822|NCT01543698|560145438|FG014|Phase 1b|Death|0|||
155192823|NCT01543698|560145424|FG000|Phase 1b|Withdrawal by Subject|0|||
155192824|NCT01543698|560145425|FG001|Phase 1b|Withdrawal by Subject|1|||
155192825|NCT01543698|560145426|FG002|Phase 1b|Withdrawal by Subject|0|||
155192826|NCT01543698|560145427|FG003|Phase 1b|Withdrawal by Subject|1|||
155192827|NCT01543698|560145428|FG004|Phase 1b|Withdrawal by Subject|0|||
155192828|NCT01543698|560145429|FG005|Phase 1b|Withdrawal by Subject|0|||
155192829|NCT01543698|560145430|FG006|Phase 1b|Withdrawal by Subject|1|||
155192830|NCT01543698|560145431|FG007|Phase 1b|Withdrawal by Subject|0|||
155192831|NCT01543698|560145432|FG008|Phase 1b|Withdrawal by Subject|0|||
155192832|NCT01543698|560145433|FG009|Phase 1b|Withdrawal by Subject|0|||
155192833|NCT01543698|560145434|FG010|Phase 1b|Withdrawal by Subject|0|||
155192834|NCT01543698|560145435|FG011|Phase 1b|Withdrawal by Subject|0|||
155192835|NCT01543698|560145436|FG012|Phase 1b|Withdrawal by Subject|0|||
155192836|NCT01543698|560145437|FG013|Phase 1b|Withdrawal by Subject|0|||
155192837|NCT01543698|560145438|FG014|Phase 1b|Withdrawal by Subject|0|||
155192838|NCT01543698|560145424|FG000|Phase 1b|Adverse Event|1|||
155192839|NCT01543698|560145425|FG001|Phase 1b|Adverse Event|0|||
155192840|NCT01543698|560145426|FG002|Phase 1b|Adverse Event|0|||
155192841|NCT01543698|560145427|FG003|Phase 1b|Adverse Event|1|||
155192842|NCT01543698|560145428|FG004|Phase 1b|Adverse Event|2|||
155192843|NCT01543698|560145429|FG005|Phase 1b|Adverse Event|2|||
155192844|NCT01543698|560145430|FG006|Phase 1b|Adverse Event|0|||
155192845|NCT01543698|560145431|FG007|Phase 1b|Adverse Event|0|||
155192846|NCT01543698|560145432|FG008|Phase 1b|Adverse Event|1|||
155192847|NCT01543698|560145433|FG009|Phase 1b|Adverse Event|1|||
155192848|NCT01543698|560145434|FG010|Phase 1b|Adverse Event|2|||
155192849|NCT01543698|560145435|FG011|Phase 1b|Adverse Event|0|||
155192850|NCT01543698|560145436|FG012|Phase 1b|Adverse Event|0|||
155192851|NCT01543698|560145437|FG013|Phase 1b|Adverse Event|0|||
155192852|NCT01543698|560145438|FG014|Phase 1b|Adverse Event|0|||
155192853|NCT01543698|560145424|FG000|Phase 1b|Administrative problems|1|||
155192854|NCT01543698|560145425|FG001|Phase 1b|Administrative problems|0|||
155192855|NCT01543698|560145426|FG002|Phase 1b|Administrative problems|0|||
155192856|NCT01543698|560145427|FG003|Phase 1b|Administrative problems|0|||
155192857|NCT01543698|560145428|FG004|Phase 1b|Administrative problems|1|||
155192858|NCT01543698|560145429|FG005|Phase 1b|Administrative problems|0|||
155192859|NCT01543698|560145430|FG006|Phase 1b|Administrative problems|0|||
155192860|NCT01543698|560145431|FG007|Phase 1b|Administrative problems|1|||
155192861|NCT01543698|560145432|FG008|Phase 1b|Administrative problems|0|||
155192862|NCT01543698|560145433|FG009|Phase 1b|Administrative problems|0|||
155192863|NCT01543698|560145434|FG010|Phase 1b|Administrative problems|2|||
155192864|NCT01543698|560145435|FG011|Phase 1b|Administrative problems|0|||
155192865|NCT01543698|560145436|FG012|Phase 1b|Administrative problems|0|||
155192866|NCT01543698|560145437|FG013|Phase 1b|Administrative problems|0|||
155192867|NCT01543698|560145438|FG014|Phase 1b|Administrative problems|0|||
155192868|NCT01543698|560145424|FG000|Phase 1b|Protocol Violation|2|||
155192869|NCT01543698|560145425|FG001|Phase 1b|Protocol Violation|0|||
155192870|NCT01543698|560145426|FG002|Phase 1b|Protocol Violation|0|||
155192871|NCT01543698|560145427|FG003|Phase 1b|Protocol Violation|0|||
155192872|NCT01543698|560145428|FG004|Phase 1b|Protocol Violation|0|||
155192873|NCT01543698|560145429|FG005|Phase 1b|Protocol Violation|0|||
155192874|NCT01543698|560145430|FG006|Phase 1b|Protocol Violation|0|||
155192875|NCT01543698|560145431|FG007|Phase 1b|Protocol Violation|0|||
155192876|NCT01543698|560145432|FG008|Phase 1b|Protocol Violation|0|||
155192877|NCT01543698|560145433|FG009|Phase 1b|Protocol Violation|0|||
155192878|NCT01543698|560145434|FG010|Phase 1b|Protocol Violation|0|||
155192879|NCT01543698|560145435|FG011|Phase 1b|Protocol Violation|0|||
155192880|NCT01543698|560145436|FG012|Phase 1b|Protocol Violation|0|||
155192881|NCT01543698|560145437|FG013|Phase 1b|Protocol Violation|0|||
155192882|NCT01543698|560145438|FG014|Phase 1b|Protocol Violation|0|||
155192883|NCT01543698|560145424|FG000|Phase 2|Protocol Violation|0|||
155192884|NCT01543698|560145425|FG001|Phase 2|Protocol Violation|0|||
155192885|NCT01543698|560145426|FG002|Phase 2|Protocol Violation|0|||
155720759|NCT03035032|562075289|FG000|Overall Study|Withdrawal by Subject|2|||
155720760|NCT03035032|562075289|FG000|Overall Study|Physician Decision|5|||
155720761|NCT02923726|562075292|FG000|Overall Study|Death|196|||
155720762|NCT02923726|562075293|FG001|Overall Study|Death|175|||
155720763|NCT02923726|562075292|FG000|Overall Study|Withdrawal by Subject|337|||
155720764|NCT02923726|562075293|FG001|Overall Study|Withdrawal by Subject|307|||
155720765|NCT02399215|562075297|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
155720766|NCT02399215|562075297|FG000|Overall Study|Withdrawal by Subject|1|||
155720767|NCT01089504|562075298|FG000|Overall Study|Lost to Follow-up|1|||
155720768|NCT01089504|562075299|FG001|Overall Study|Lost to Follow-up|1|||
155720769|NCT01089504|562075298|FG000|Overall Study|Withdrawal by Subject|2|||
155720770|NCT01089504|562075299|FG001|Overall Study|Withdrawal by Subject|0|||
155720771|NCT00914849|562075303|FG000|Overall Study|Withdrawal by Subject|1|||
155192886|NCT01543698|560145427|FG003|Phase 2|Protocol Violation|0|||
155192887|NCT01543698|560145428|FG004|Phase 2|Protocol Violation|0|||
155192888|NCT01543698|560145429|FG005|Phase 2|Protocol Violation|0|||
155192889|NCT01543698|560145430|FG006|Phase 2|Protocol Violation|0|||
155192890|NCT01543698|560145431|FG007|Phase 2|Protocol Violation|0|||
155192891|NCT01543698|560145432|FG008|Phase 2|Protocol Violation|0|||
155192892|NCT01543698|560145433|FG009|Phase 2|Protocol Violation|0|||
155192893|NCT01543698|560145434|FG010|Phase 2|Protocol Violation|0|||
155192894|NCT01543698|560145435|FG011|Phase 2|Protocol Violation|0|||
155192895|NCT01543698|560145436|FG012|Phase 2|Protocol Violation|1|||
155192896|NCT01543698|560145437|FG013|Phase 2|Protocol Violation|0|||
155192897|NCT01543698|560145438|FG014|Phase 2|Protocol Violation|0|||
155192898|NCT01543698|560145424|FG000|Phase 2|Disease progression|0|||
155192899|NCT01543698|560145425|FG001|Phase 2|Disease progression|0|||
155192900|NCT01543698|560145426|FG002|Phase 2|Disease progression|0|||
155192901|NCT01543698|560145427|FG003|Phase 2|Disease progression|0|||
155192902|NCT01543698|560145428|FG004|Phase 2|Disease progression|0|||
155192903|NCT01543698|560145429|FG005|Phase 2|Disease progression|0|||
155192904|NCT01543698|560145430|FG006|Phase 2|Disease progression|0|||
155192905|NCT01543698|560145431|FG007|Phase 2|Disease progression|0|||
155192906|NCT01543698|560145432|FG008|Phase 2|Disease progression|0|||
155192907|NCT01543698|560145433|FG009|Phase 2|Disease progression|0|||
155192908|NCT01543698|560145434|FG010|Phase 2|Disease progression|0|||
155192909|NCT01543698|560145435|FG011|Phase 2|Disease progression|10|||
155192910|NCT01543698|560145436|FG012|Phase 2|Disease progression|21|||
155192911|NCT01543698|560145437|FG013|Phase 2|Disease progression|30|||
155192912|NCT01543698|560145438|FG014|Phase 2|Disease progression|25|||
155192913|NCT01543698|560145424|FG000|Phase 2|Death|0|||
155192914|NCT01543698|560145425|FG001|Phase 2|Death|0|||
155192915|NCT01543698|560145426|FG002|Phase 2|Death|0|||
155192916|NCT01543698|560145427|FG003|Phase 2|Death|0|||
155192917|NCT01543698|560145428|FG004|Phase 2|Death|0|||
155192918|NCT01543698|560145429|FG005|Phase 2|Death|0|||
155192919|NCT01543698|560145430|FG006|Phase 2|Death|0|||
155192920|NCT01543698|560145431|FG007|Phase 2|Death|0|||
155192921|NCT01543698|560145432|FG008|Phase 2|Death|0|||
155192922|NCT01543698|560145433|FG009|Phase 2|Death|0|||
155192923|NCT01543698|560145434|FG010|Phase 2|Death|0|||
155192924|NCT01543698|560145435|FG011|Phase 2|Death|0|||
155192925|NCT01543698|560145436|FG012|Phase 2|Death|1|||
155192926|NCT01543698|560145437|FG013|Phase 2|Death|1|||
155192927|NCT01543698|560145438|FG014|Phase 2|Death|1|||
155192928|NCT01543698|560145424|FG000|Phase 2|Administrative problems|0|||
155192929|NCT01543698|560145425|FG001|Phase 2|Administrative problems|0|||
155192930|NCT01543698|560145426|FG002|Phase 2|Administrative problems|0|||
155192931|NCT01543698|560145427|FG003|Phase 2|Administrative problems|0|||
155192932|NCT01543698|560145428|FG004|Phase 2|Administrative problems|0|||
155192933|NCT01543698|560145429|FG005|Phase 2|Administrative problems|0|||
155192934|NCT01543698|560145430|FG006|Phase 2|Administrative problems|0|||
155192935|NCT01543698|560145431|FG007|Phase 2|Administrative problems|0|||
155192936|NCT01543698|560145432|FG008|Phase 2|Administrative problems|0|||
155192937|NCT01543698|560145433|FG009|Phase 2|Administrative problems|0|||
155192938|NCT01543698|560145434|FG010|Phase 2|Administrative problems|0|||
155192939|NCT01543698|560145435|FG011|Phase 2|Administrative problems|0|||
155192940|NCT01543698|560145436|FG012|Phase 2|Administrative problems|0|||
155192941|NCT01543698|560145437|FG013|Phase 2|Administrative problems|3|||
155192942|NCT01543698|560145438|FG014|Phase 2|Administrative problems|1|||
155192943|NCT01543698|560145424|FG000|Phase 2|Withdrawal by Subject|0|||
155192944|NCT01543698|560145425|FG001|Phase 2|Withdrawal by Subject|0|||
155192945|NCT01543698|560145426|FG002|Phase 2|Withdrawal by Subject|0|||
155192946|NCT01543698|560145427|FG003|Phase 2|Withdrawal by Subject|0|||
155192947|NCT01543698|560145428|FG004|Phase 2|Withdrawal by Subject|0|||
155192948|NCT01543698|560145429|FG005|Phase 2|Withdrawal by Subject|0|||
155192949|NCT01543698|560145430|FG006|Phase 2|Withdrawal by Subject|0|||
155192950|NCT01543698|560145431|FG007|Phase 2|Withdrawal by Subject|0|||
155192951|NCT01543698|560145432|FG008|Phase 2|Withdrawal by Subject|0|||
155192952|NCT01543698|560145433|FG009|Phase 2|Withdrawal by Subject|0|||
155192953|NCT01543698|560145434|FG010|Phase 2|Withdrawal by Subject|0|||
155192954|NCT01543698|560145435|FG011|Phase 2|Withdrawal by Subject|0|||
155192955|NCT01543698|560145436|FG012|Phase 2|Withdrawal by Subject|0|||
155192956|NCT01543698|560145437|FG013|Phase 2|Withdrawal by Subject|3|||
155192957|NCT01543698|560145438|FG014|Phase 2|Withdrawal by Subject|1|||
155192958|NCT01543698|560145424|FG000|Phase 2|Adverse Event|0|||
155192959|NCT01543698|560145425|FG001|Phase 2|Adverse Event|0|||
155192960|NCT01543698|560145426|FG002|Phase 2|Adverse Event|0|||
155192961|NCT01543698|560145427|FG003|Phase 2|Adverse Event|0|||
155192962|NCT01543698|560145428|FG004|Phase 2|Adverse Event|0|||
155192963|NCT01543698|560145429|FG005|Phase 2|Adverse Event|0|||
155192964|NCT01543698|560145430|FG006|Phase 2|Adverse Event|0|||
155192965|NCT01543698|560145431|FG007|Phase 2|Adverse Event|0|||
155192966|NCT01543698|560145432|FG008|Phase 2|Adverse Event|0|||
155192967|NCT01543698|560145433|FG009|Phase 2|Adverse Event|0|||
155192968|NCT01543698|560145434|FG010|Phase 2|Adverse Event|0|||
155192969|NCT01543698|560145435|FG011|Phase 2|Adverse Event|1|||
155192970|NCT01543698|560145436|FG012|Phase 2|Adverse Event|3|||
155192971|NCT01543698|560145437|FG013|Phase 2|Adverse Event|5|||
155192972|NCT01543698|560145438|FG014|Phase 2|Adverse Event|14|||
155192973|NCT00217620|560145439|FG000|Overall Study|Adverse Event|2|||
155192974|NCT00217620|560145439|FG000|Overall Study|Progression|31|||
155192975|NCT00217620|560145439|FG000|Overall Study|Not Protocol Specified|4|||
155192976|NCT00217620|560145439|FG000|Overall Study|Ineligible|13|||
155192977|NCT00217620|560145439|FG000|Overall Study|Never received treatment|1|||
155192978|NCT01863953|560145454|FG000|Overall Study|Adverse Event|0|||
155192979|NCT01863953|560145455|FG001|Overall Study|Adverse Event|0|||
155192980|NCT01863953|560145456|FG002|Overall Study|Adverse Event|1|||
155192981|NCT02008318|560145459|FG000|Overall Study|Adverse Event|4|||
155192982|NCT02008318|560145460|FG001|Overall Study|Adverse Event|0|||
155192983|NCT02008318|560145459|FG000|Overall Study|Physician Decision|2|||
155192984|NCT02008318|560145460|FG001|Overall Study|Physician Decision|0|||
155192985|NCT02008318|560145459|FG000|Overall Study|Progressive Disease|2|||
155192986|NCT02008318|560145460|FG001|Overall Study|Progressive Disease|0|||
155192987|NCT02008318|560145459|FG000|Overall Study|Protocol Violation|1|||
155192988|NCT02008318|560145460|FG001|Overall Study|Protocol Violation|1|||
155720772|NCT00914849|562075304|FG001|Overall Study|Withdrawal by Subject|0|||
155720773|NCT00914849|562075303|FG000|Overall Study|Not eligible|0|||
155720774|NCT00914849|562075304|FG001|Overall Study|Not eligible|1|||
155720775|NCT05106959|562075305|FG000|Overall Study|Lost to Follow-up|1|||
155720776|NCT03448406|562075306|FG000|Overall Study|Noncompliance of scheduled visits|1|||
155720777|NCT03448406|562075307|FG001|Overall Study|Noncompliance of scheduled visits|2|||
155720778|NCT03448406|562075306|FG000|Overall Study|Withdrawal by Subject|1|||
155720779|NCT03448406|562075307|FG001|Overall Study|Withdrawal by Subject|2|||
155720780|NCT03448406|562075306|FG000|Overall Study|Protocol Violation|1|||
155720781|NCT03448406|562075307|FG001|Overall Study|Protocol Violation|0|||
155720782|NCT03448406|562075306|FG000|Overall Study|Adverse Event|8|||
155720783|NCT03448406|562075307|FG001|Overall Study|Adverse Event|9|||
155720784|NCT04602390|562075309|FG000|Overall Study|Withdrawal by Subject|0|||
155720785|NCT04602390|562075310|FG001|Overall Study|Withdrawal by Subject|0|||
155720786|NCT04602390|562075311|FG002|Overall Study|Withdrawal by Subject|0|||
155720787|NCT04602390|562075312|FG003|Overall Study|Withdrawal by Subject|0|||
155720788|NCT04602390|562075313|FG004|Overall Study|Withdrawal by Subject|1|||
155720789|NCT04602390|562075314|FG005|Overall Study|Withdrawal by Subject|0|||
155720790|NCT04602390|562075309|FG000|Overall Study|Adverse Event|0|||
155720791|NCT04602390|562075310|FG001|Overall Study|Adverse Event|0|||
155720792|NCT04602390|562075311|FG002|Overall Study|Adverse Event|0|||
155720793|NCT04602390|562075312|FG003|Overall Study|Adverse Event|0|||
155720794|NCT04602390|562075313|FG004|Overall Study|Adverse Event|0|||
155720795|NCT04602390|562075314|FG005|Overall Study|Adverse Event|1|||
155720796|NCT01546857|562075315|FG000|Overall Study|Withdrawal by Subject|2|||
155720797|NCT01546857|562075316|FG001|Overall Study|Withdrawal by Subject|3|||
155720798|NCT01176032|562075317|FG000|Overall Study|Adverse Event|1|||
155720799|NCT01176032|562075318|FG001|Overall Study|Adverse Event|0|||
155720800|NCT01176032|562075317|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155720801|NCT01176032|562075318|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155720802|NCT01176032|562075317|FG000|Overall Study|Protocol Violation|1|||
155720803|NCT01176032|562075318|FG001|Overall Study|Protocol Violation|0|||
155720804|NCT01176032|562075317|FG000|Overall Study|Informed consent withdrawn|3|||
155720805|NCT01176032|562075318|FG001|Overall Study|Informed consent withdrawn|0|||
155720806|NCT01176032|562075317|FG000|Overall Study|Other|1|||
155720807|NCT01176032|562075318|FG001|Overall Study|Other|0|||
155720808|NCT01277744|562075326|FG000|Overall Study|Physician Decision|2|||
155720809|NCT02358473|562075328|FG000|Overall Study|Disease Progession|6|||
155720810|NCT02358473|562075328|FG000|Overall Study|Adverse Event|3|||
155720811|NCT02358473|562075328|FG000|Overall Study|Withdrawal by Subject|2|||
155720812|NCT02358473|562075328|FG000|Overall Study|Physician Decision|2|||
155720813|NCT04038359|562075346|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
155720814|NCT04038359|562075347|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
155720815|NCT04038359|562075346|FG000|Overall Study|Death|8|||
155720816|NCT04038359|562075347|FG001|Overall Study|Death|7|||
155720817|NCT04038359|562075346|FG000|Overall Study|Lost to Follow-up|3|||
155720818|NCT04038359|562075347|FG001|Overall Study|Lost to Follow-up|0|||
155720819|NCT04038359|562075346|FG000|Overall Study|Participant Moved|1|||
155720820|NCT04038359|562075347|FG001|Overall Study|Participant Moved|0|||
155720821|NCT04038359|562075346|FG000|Overall Study|Withdrawal by Subject|4|||
155720822|NCT04038359|562075347|FG001|Overall Study|Withdrawal by Subject|3|||
155720823|NCT04038359|562075346|FG000|Overall Study|Physician Decision|3|||
155720824|NCT04038359|562075347|FG001|Overall Study|Physician Decision|2|||
155720825|NCT04038359|562075346|FG000|Overall Study|Adverse Event|0|||
155720826|NCT04038359|562075347|FG001|Overall Study|Adverse Event|2|||
155720827|NCT04038359|562075346|FG000|Overall Study|Progressive Disease|0|||
155720828|NCT04038359|562075347|FG001|Overall Study|Progressive Disease|1|||
155720829|NCT03624881|562075352|FG000|Overall Study|Screen Failure|14|||
155720830|NCT03624881|562075353|FG001|Overall Study|Screen Failure|0|||
155720831|NCT03624881|562075352|FG000|Overall Study|No Catheter Inserted|6|||
155720832|NCT03624881|562075353|FG001|Overall Study|No Catheter Inserted|1|||
155720833|NCT03624881|562075352|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
155720834|NCT03624881|562075353|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
155720835|NCT03624881|562075352|FG000|Overall Study|Death|2|||
155720836|NCT03624881|562075353|FG001|Overall Study|Death|0|||
155720837|NCT03624881|562075352|FG000|Overall Study|Lost to Follow-up|10|||
155720838|NCT03624881|562075353|FG001|Overall Study|Lost to Follow-up|4|||
155720839|NCT03624881|562075352|FG000|Overall Study|Withdrawal by Subject|12|||
155720840|NCT03624881|562075353|FG001|Overall Study|Withdrawal by Subject|1|||
155720841|NCT00168844|562075354|FG000|Overall Study|Adverse Event|31|||
155720842|NCT00168844|562075355|FG001|Overall Study|Adverse Event|32|||
155720843|NCT00168844|562075356|FG002|Overall Study|Adverse Event|48|||
155720844|NCT00168844|562075354|FG000|Overall Study|Lost to Follow-up|4|||
155720845|NCT00168844|562075355|FG001|Overall Study|Lost to Follow-up|5|||
155720846|NCT00168844|562075356|FG002|Overall Study|Lost to Follow-up|11|||
155720847|NCT00168844|562075354|FG000|Overall Study|Withdrawal by Subject|12|||
155720848|NCT00168844|562075355|FG001|Overall Study|Withdrawal by Subject|9|||
155720849|NCT00168844|562075356|FG002|Overall Study|Withdrawal by Subject|19|||
155720850|NCT00168844|562075354|FG000|Overall Study|Protocol Violation|2|||
155720851|NCT00168844|562075355|FG001|Overall Study|Protocol Violation|2|||
155720852|NCT00168844|562075356|FG002|Overall Study|Protocol Violation|4|||
155720853|NCT00168844|562075354|FG000|Overall Study|Other|6|||
155720854|NCT00168844|562075355|FG001|Overall Study|Other|7|||
155720855|NCT00168844|562075356|FG002|Overall Study|Other|9|||
155720856|NCT03557970|562075359|FG000|Overall Study|Study closure|1|||
155720857|NCT03557970|562075360|FG001|Overall Study|Study closure|0|||
155720858|NCT03557970|562075359|FG000|Overall Study|Physician Decision|0|||
155720859|NCT03557970|562075360|FG001|Overall Study|Physician Decision|1|||
155720860|NCT03557970|562075359|FG000|Overall Study|Death|0|||
155720861|NCT03557970|562075360|FG001|Overall Study|Death|1|||
155720862|NCT00112736|562075361|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
155720863|NCT00112736|562075362|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
155720864|NCT02138890|562075363|FG000|Overall Study|Adverse Event|1|||
155720865|NCT02138890|562075364|FG001|Overall Study|Adverse Event|0|||
155720866|NCT03019406|562075365|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
155720867|NCT03019406|562075366|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
155720868|NCT03019406|562075367|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
155720869|NCT03019406|562075368|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
155720870|NCT01446159|562075369|FG000|Overall Study|Withdrawal by Subject|1|||
155720871|NCT01446159|562075370|FG001|Overall Study|Withdrawal by Subject|0|||
155720872|NCT01446159|562075371|FG002|Overall Study|Withdrawal by Subject|14|||
155720873|NCT01446159|562075372|FG003|Overall Study|Withdrawal by Subject|11|||
155720874|NCT01446159|562075369|FG000|Overall Study|Lost to Follow-up|0|||
155720875|NCT01446159|562075370|FG001|Overall Study|Lost to Follow-up|0|||
155720876|NCT01446159|562075371|FG002|Overall Study|Lost to Follow-up|1|||
155720877|NCT01446159|562075372|FG003|Overall Study|Lost to Follow-up|2|||
155720878|NCT01446159|562075369|FG000|Overall Study|Death|2|||
155720879|NCT01446159|562075370|FG001|Overall Study|Death|3|||
155720880|NCT01446159|562075371|FG002|Overall Study|Death|43|||
155720881|NCT01446159|562075372|FG003|Overall Study|Death|36|||
155720882|NCT01446159|562075369|FG000|Overall Study|Other|0|||
155720883|NCT01446159|562075370|FG001|Overall Study|Other|0|||
155720884|NCT01446159|562075371|FG002|Overall Study|Other|13|||
155720885|NCT01446159|562075372|FG003|Overall Study|Other|13|||
155720886|NCT03668873|562075375|FG000|Overall Study|Lost to Follow-up|6|||
155720887|NCT03668873|562075376|FG001|Overall Study|Lost to Follow-up|3|||
155720888|NCT03155724|562075380|FG000|Overall Study|Death|3|||
155720889|NCT03155724|562075380|FG000|Overall Study|Physician Decision|1|||
155720890|NCT03155724|562075380|FG000|Overall Study|Study closure|7|||
155720891|NCT00849940|562075381|FG000|Overall Study|Physician Decision|4|||
155720892|NCT03309020|562075386|FG000|Overall Study|Death|1|||
155720893|NCT03309020|562075387|FG001|Overall Study|Death|0|||
155720894|NCT03309020|562075386|FG000|Overall Study|Did not undergo surgery|2|||
155720895|NCT03309020|562075387|FG001|Overall Study|Did not undergo surgery|1|||
155720896|NCT00601835|562075391|FG000|Overall Study|Withdrawal by Subject|9|||
155720897|NCT00601835|562075392|FG001|Overall Study|Withdrawal by Subject|6|||
155720898|NCT00601835|562075391|FG000|Overall Study|Physician Decision|1|||
155720899|NCT00601835|562075392|FG001|Overall Study|Physician Decision|0|||
155192989|NCT02008318|560145459|FG000|Overall Study|Withdrawal by Subject|3|||
155192990|NCT02008318|560145460|FG001|Overall Study|Withdrawal by Subject|0|||
155192991|NCT02336373|560145463|FG000|Overall Study|Protocol closed early|4|||
155192992|NCT02336373|560145463|FG000|Overall Study|Physician Decision|14|||
155192993|NCT03270644|560145466|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
155192994|NCT03270644|560145466|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
155192995|NCT00354614|560145471|FG000|Overall Study|Lack of Efficacy|28|||
155192996|NCT03650556|560145472|FG000|Overall Study|Death|2|||
155192997|NCT03650556|560145472|FG000|Overall Study|Withdrawal by Subject|20|||
155192998|NCT03650556|560145472|FG000|Overall Study|Physician Decision|2|||
155192999|NCT03650556|560145472|FG000|Overall Study|Lost to Follow-up|8|||
155193000|NCT03650556|560145472|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
155193001|NCT03650556|560145472|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
155193002|NCT00463580|560145473|FG000|Overall Study|Lost to Follow-up|1|||
155193003|NCT00463580|560145474|FG001|Overall Study|Lost to Follow-up|0|||
155193004|NCT00463580|560145473|FG000|Overall Study|Schedule conflict|2|||
155193005|NCT00463580|560145474|FG001|Overall Study|Schedule conflict|0|||
155193006|NCT00463580|560145473|FG000|Overall Study|Medical/psychiatric complications|0|||
155193007|NCT00463580|560145474|FG001|Overall Study|Medical/psychiatric complications|2|||
155193008|NCT01788046|560145475|FG000|Overall Study|Withdrawal by Subject|12|||
155193009|NCT01788046|560145476|FG001|Overall Study|Withdrawal by Subject|12|||
155193010|NCT01788046|560145475|FG000|Overall Study|Lost to Follow-up|12|||
155193011|NCT01788046|560145476|FG001|Overall Study|Lost to Follow-up|19|||
155193012|NCT01788046|560145475|FG000|Overall Study|Death|7|||
155193013|NCT01788046|560145476|FG001|Overall Study|Death|5|||
155193014|NCT01788046|560145475|FG000|Overall Study|Protocol Specified Criteria|25|||
155193015|NCT01788046|560145476|FG001|Overall Study|Protocol Specified Criteria|1|||
155193016|NCT01147640|560145480|FG000|Overall Study|Adverse Event|2|||
155193017|NCT01147640|560145481|FG001|Overall Study|Adverse Event|0|||
155193018|NCT01147640|560145480|FG000|Overall Study|Physician Decision|1|||
155193019|NCT01147640|560145481|FG001|Overall Study|Physician Decision|0|||
155193020|NCT01147640|560145480|FG000|Overall Study|Withdrawal by Subject|1|||
155193021|NCT01147640|560145481|FG001|Overall Study|Withdrawal by Subject|0|||
155193022|NCT01147640|560145480|FG000|Overall Study|Lost to Follow-up|0|||
155193023|NCT01147640|560145481|FG001|Overall Study|Lost to Follow-up|1|||
155193024|NCT01147640|560145480|FG000|Overall Study|Didn't meet eligibility criteria|1|||
155193025|NCT01147640|560145481|FG001|Overall Study|Didn't meet eligibility criteria|0|||
155193026|NCT01604408|560145482|FG000|Treatment Period 1|Protocol Violation|0|||
155193027|NCT01604408|560145483|FG001|Treatment Period 1|Protocol Violation|1|||
155193028|NCT01604408|560145482|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155193029|NCT01604408|560145483|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155193030|NCT01604408|560145482|FG000|Treatment Period 2|Protocol Violation|1|||
155193031|NCT01604408|560145483|FG001|Treatment Period 2|Protocol Violation|0|||
155193032|NCT01604408|560145482|FG000|Treatment Period 2|Adverse Event|0|||
155193033|NCT01604408|560145483|FG001|Treatment Period 2|Adverse Event|1|||
155193034|NCT01604408|560145482|FG000|Treatment Period 3|Protocol Violation|1|||
155193035|NCT01604408|560145483|FG001|Treatment Period 3|Protocol Violation|1|||
155193036|NCT01604408|560145482|FG000|Treatment Period 3|Adverse Event|0|||
155193037|NCT01604408|560145483|FG001|Treatment Period 3|Adverse Event|3|||
155720900|NCT00601835|562075391|FG000|Overall Study|Lost to Follow-up|37|||
155193038|NCT01604408|560145482|FG000|Treatment Period 3|Withdrawal by Subject|3|||
155193039|NCT01604408|560145483|FG001|Treatment Period 3|Withdrawal by Subject|1|||
155193040|NCT01604408|560145482|FG000|Treatment Period 3|Sponsor Decision|1|||
155193041|NCT01604408|560145483|FG001|Treatment Period 3|Sponsor Decision|0|||
155193042|NCT01604408|560145482|FG000|Treatment Period 4|Death|1|||
155193043|NCT01604408|560145483|FG001|Treatment Period 4|Death|0|||
155193044|NCT01604408|560145482|FG000|Treatment Period 4|Withdrawal by Subject|2|||
155193045|NCT01604408|560145483|FG001|Treatment Period 4|Withdrawal by Subject|1|||
155193046|NCT01604408|560145482|FG000|Treatment Period 4|Adverse Event|0|||
155193047|NCT01604408|560145483|FG001|Treatment Period 4|Adverse Event|1|||
155193048|NCT01604408|560145482|FG000|Treatment Period 5|Adverse Event|4|||
155193049|NCT01604408|560145483|FG001|Treatment Period 5|Adverse Event|0|||
155193050|NCT01604408|560145482|FG000|Treatment Period 6|Lost to Follow-up|0|||
155193051|NCT01604408|560145483|FG001|Treatment Period 6|Lost to Follow-up|1|||
155193052|NCT01604408|560145482|FG000|Treatment Period 6|Adverse Event|2|||
155193053|NCT01604408|560145483|FG001|Treatment Period 6|Adverse Event|0|||
155720901|NCT00601835|562075392|FG001|Overall Study|Lost to Follow-up|5|||
155720902|NCT00601835|562075391|FG000|Overall Study|Adverse Event|1|||
155720903|NCT00601835|562075392|FG001|Overall Study|Adverse Event|1|||
155193054|NCT01604408|560145482|FG000|Treatment Period 6|Sponsor decision|0|||
155193055|NCT01604408|560145483|FG001|Treatment Period 6|Sponsor decision|1|||
155193056|NCT01604408|560145482|FG000|Observation Period|Adverse Event|1|||
155193057|NCT01604408|560145483|FG001|Observation Period|Adverse Event|1|||
155193058|NCT01604408|560145482|FG000|Observation Period|Withdrawal by Subject|0|||
155720904|NCT00601835|562075391|FG000|Overall Study|Relocate|12|||
155193059|NCT01604408|560145483|FG001|Observation Period|Withdrawal by Subject|2|||
155193060|NCT00917501|560145484|FG000|Overall Study|Lost to Follow-up|4|||
155720905|NCT00601835|562075392|FG001|Overall Study|Relocate|2|||
155720906|NCT00880620|562075393|FG000|Overall Study|Adverse Event|4|||
155720907|NCT00880620|562075394|FG001|Overall Study|Adverse Event|5|||
155720908|NCT00880620|562075395|FG002|Overall Study|Adverse Event|15|||
155720909|NCT00880620|562075396|FG003|Overall Study|Adverse Event|15|||
155720910|NCT00880620|562075393|FG000|Overall Study|Death|0|||
155720911|NCT00880620|562075394|FG001|Overall Study|Death|0|||
155720912|NCT00880620|562075395|FG002|Overall Study|Death|1|||
155720913|NCT00880620|562075396|FG003|Overall Study|Death|0|||
155720914|NCT00880620|562075393|FG000|Overall Study|Lack of Efficacy|12|||
155720915|NCT00880620|562075394|FG001|Overall Study|Lack of Efficacy|4|||
155720916|NCT00880620|562075395|FG002|Overall Study|Lack of Efficacy|0|||
155720917|NCT00880620|562075396|FG003|Overall Study|Lack of Efficacy|1|||
155720918|NCT00880620|562075393|FG000|Overall Study|Lost to Follow-up|0|||
155720919|NCT00880620|562075394|FG001|Overall Study|Lost to Follow-up|1|||
155720920|NCT00880620|562075395|FG002|Overall Study|Lost to Follow-up|1|||
155720921|NCT00880620|562075396|FG003|Overall Study|Lost to Follow-up|0|||
155720922|NCT00880620|562075393|FG000|Overall Study|Protocol Violation|0|||
155720923|NCT00880620|562075394|FG001|Overall Study|Protocol Violation|1|||
155720924|NCT00880620|562075395|FG002|Overall Study|Protocol Violation|0|||
155720925|NCT00880620|562075396|FG003|Overall Study|Protocol Violation|2|||
155720926|NCT00880620|562075393|FG000|Overall Study|Withdrawal by Subject|4|||
155720927|NCT00880620|562075394|FG001|Overall Study|Withdrawal by Subject|3|||
155720928|NCT00880620|562075395|FG002|Overall Study|Withdrawal by Subject|1|||
155720929|NCT00880620|562075396|FG003|Overall Study|Withdrawal by Subject|3|||
155720930|NCT00880620|562075393|FG000|Overall Study|Noncompliance|0|||
155720931|NCT00880620|562075394|FG001|Overall Study|Noncompliance|0|||
155720932|NCT00880620|562075395|FG002|Overall Study|Noncompliance|1|||
155720933|NCT00880620|562075396|FG003|Overall Study|Noncompliance|1|||
155720934|NCT00880620|562075393|FG000|Overall Study|Other|1|||
155720935|NCT00880620|562075394|FG001|Overall Study|Other|1|||
155720936|NCT00880620|562075395|FG002|Overall Study|Other|2|||
155720937|NCT00880620|562075396|FG003|Overall Study|Other|2|||
155720938|NCT00880698|562075399|FG000|Overall Study|Death|0|||
155720939|NCT00880698|562075400|FG001|Overall Study|Death|0|||
155720940|NCT00880698|562075401|FG002|Overall Study|Death|1|||
155720941|NCT00880698|562075402|FG003|Overall Study|Death|2|||
155720942|NCT00880698|562075399|FG000|Overall Study|Lost to Follow-up|1|||
155720943|NCT00880698|562075400|FG001|Overall Study|Lost to Follow-up|3|||
155720944|NCT00880698|562075401|FG002|Overall Study|Lost to Follow-up|0|||
155720945|NCT00880698|562075402|FG003|Overall Study|Lost to Follow-up|1|||
155720946|NCT04972162|562075405|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
155720947|NCT04972162|562075406|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
155720948|NCT02994108|562077676|FG000|Intervention Messages|Withdrawal by Subject|2|||
155720949|NCT02994108|562077677|FG001|Intervention Messages|Withdrawal by Subject|0|||
155720950|NCT02994108|562077676|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
155720951|NCT02994108|562077677|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
155720952|NCT02994108|562077676|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
155720953|NCT02994108|562077677|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
155720954|NCT02994108|562077676|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
155720955|NCT02994108|562077677|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
155720956|NCT00089297|562077678|FG000|Overall Study|Adverse Event|9|||
155720957|NCT00089297|562077678|FG000|Overall Study|Death|1|||
155720958|NCT00089297|562077678|FG000|Overall Study|Withdrawal by Subject|12|||
155720959|NCT00089297|562077678|FG000|Overall Study|Disease progression|2|||
155720960|NCT00089297|562077678|FG000|Overall Study|Ineligible|11|||
155720961|NCT00089297|562077678|FG000|Overall Study|Secondary malignancy|1|||
155720962|NCT00089297|562077678|FG000|Overall Study|IRB approval not ready|1|||
155720963|NCT00089297|562077678|FG000|Overall Study|Non-compliance|1|||
155720964|NCT00904969|562077679|FG000|Overall Study|Lost to Follow-up|4|||
155720965|NCT00904969|562077679|FG000|Overall Study|Withdrawal by Subject|3|||
155720966|NCT00904969|562077679|FG000|Overall Study|Additional Treatments|11|||
155720967|NCT00904969|562077679|FG000|Overall Study|Case Aborted; Subject Exited|1|||
155720968|NCT01097668|562077680|FG000|Overall Study|Withdrawal by Subject|1|||
155720969|NCT01097668|562077681|FG001|Overall Study|Withdrawal by Subject|2|||
155720970|NCT01097668|562077680|FG000|Overall Study|Lost to Follow-up|1|||
155720971|NCT01097668|562077681|FG001|Overall Study|Lost to Follow-up|0|||
155720972|NCT01295814|562077689|FG000|Overall Study|Lack of Efficacy|0|||
155720973|NCT01295814|562077690|FG001|Overall Study|Lack of Efficacy|2|||
155720974|NCT01295814|562077689|FG000|Overall Study|Withdrawal by Subject|2|||
155720975|NCT01295814|562077690|FG001|Overall Study|Withdrawal by Subject|0|||
155720976|NCT04515771|562077692|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
155720977|NCT04515771|562077693|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
155720978|NCT04515771|562077692|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
155720979|NCT04515771|562077693|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
155720980|NCT04515771|562077692|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
155720981|NCT04515771|562077693|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
155720982|NCT00948246|562077696|FG000|Overall Study|Lost to Follow-up|11|||
155720983|NCT00948246|562077696|FG000|Overall Study|Adverse Event|11|||
155720984|NCT00948246|562077696|FG000|Overall Study|Death|1|||
155193061|NCT00917501|560145485|FG001|Overall Study|Lost to Follow-up|1|||
155193062|NCT00917501|560145484|FG000|Overall Study|Withdrawal by Subject|3|||
155193063|NCT00917501|560145485|FG001|Overall Study|Withdrawal by Subject|1|||
155193064|NCT00917501|560145484|FG000|Overall Study|Lack of Efficacy|1|||
155193065|NCT00917501|560145485|FG001|Overall Study|Lack of Efficacy|2|||
155193066|NCT00917501|560145484|FG000|Overall Study|trouble swollowing capsules|0|||
155193067|NCT00917501|560145485|FG001|Overall Study|trouble swollowing capsules|1|||
155193068|NCT01453725|560145488|FG000|Overall Study|Adverse Event|3|||
155193069|NCT01453725|560145489|FG001|Overall Study|Adverse Event|3|||
155193070|NCT01453725|560145488|FG000|Overall Study|Lost to Follow-up|4|||
155193071|NCT01453725|560145489|FG001|Overall Study|Lost to Follow-up|0|||
155193072|NCT01453725|560145488|FG000|Overall Study|Non-compliance With Protocol|1|||
155193073|NCT01453725|560145489|FG001|Overall Study|Non-compliance With Protocol|2|||
155193074|NCT01453725|560145488|FG000|Overall Study|Protocol Violation|1|||
155193075|NCT01453725|560145489|FG001|Overall Study|Protocol Violation|0|||
155193076|NCT01453725|560145488|FG000|Overall Study|Withdrawal by Subject|2|||
155193077|NCT01453725|560145489|FG001|Overall Study|Withdrawal by Subject|3|||
155193078|NCT01453725|560145488|FG000|Overall Study|Pregnancy Wish|0|||
155193079|NCT01453725|560145489|FG001|Overall Study|Pregnancy Wish|2|||
155193080|NCT01453725|560145488|FG000|Overall Study|Pregnancy|1|||
155193081|NCT01453725|560145489|FG001|Overall Study|Pregnancy|0|||
155193082|NCT01453725|560145488|FG000|Overall Study|Physician Decision|1|||
155193083|NCT01453725|560145489|FG001|Overall Study|Physician Decision|1|||
155193084|NCT01436396|560145490|FG000|Overall Study|Protocol Violation|7|||
155193085|NCT01436396|560145491|FG001|Overall Study|Protocol Violation|5|||
155193086|NCT01436396|560145490|FG000|Overall Study|Adverse Event|1|||
155193087|NCT01436396|560145491|FG001|Overall Study|Adverse Event|2|||
155193088|NCT01436396|560145490|FG000|Overall Study|Withdrawal by Subject|19|||
155193089|NCT01436396|560145491|FG001|Overall Study|Withdrawal by Subject|29|||
155193090|NCT01436396|560145490|FG000|Overall Study|Serious adverse event|2|||
155193091|NCT01436396|560145491|FG001|Overall Study|Serious adverse event|3|||
155193092|NCT01436396|560145490|FG000|Overall Study|Lost to Follow-up|3|||
155193093|NCT01436396|560145491|FG001|Overall Study|Lost to Follow-up|3|||
155193094|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
155193095|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
155193096|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
155193097|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
155193098|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
155193099|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
155193100|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
155193101|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
155193102|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
155193103|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
155193104|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
155193105|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
155193106|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
155193107|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
155193108|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
155193109|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
155193110|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
155193111|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
155193112|NCT00216476|560145497|FG000|Overall Study|Withdrawal by Subject|59|||
155193113|NCT00216476|560145498|FG001|Overall Study|Withdrawal by Subject|72|||
155193114|NCT00216476|560145499|FG002|Overall Study|Withdrawal by Subject|9|||
155193115|NCT00216476|560145497|FG000|Overall Study|Lost to Follow-up|10|||
155193116|NCT00216476|560145498|FG001|Overall Study|Lost to Follow-up|9|||
155193117|NCT00216476|560145499|FG002|Overall Study|Lost to Follow-up|1|||
155193118|NCT00216476|560145497|FG000|Overall Study|Adverse Event|6|||
155193119|NCT00216476|560145498|FG001|Overall Study|Adverse Event|10|||
155193120|NCT00216476|560145499|FG002|Overall Study|Adverse Event|1|||
155193121|NCT00216476|560145497|FG000|Overall Study|Lack of Efficacy|4|||
155193122|NCT00216476|560145498|FG001|Overall Study|Lack of Efficacy|3|||
155193123|NCT00216476|560145499|FG002|Overall Study|Lack of Efficacy|0|||
155193124|NCT00216476|560145497|FG000|Overall Study|Death|2|||
155193125|NCT00216476|560145498|FG001|Overall Study|Death|0|||
155720985|NCT00948246|562077696|FG000|Overall Study|Withdrawal by Subject|1|||
155193126|NCT00216476|560145499|FG002|Overall Study|Death|0|||
155193127|NCT00216476|560145497|FG000|Overall Study|Pregnancy|0|||
155193128|NCT00216476|560145498|FG001|Overall Study|Pregnancy|1|||
155193129|NCT00216476|560145499|FG002|Overall Study|Pregnancy|1|||
155193130|NCT00216476|560145497|FG000|Overall Study|Other|0|||
155193131|NCT00216476|560145498|FG001|Overall Study|Other|0|||
155193132|NCT00216476|560145499|FG002|Overall Study|Other|1|||
155193133|NCT00216476|560145497|FG000|Overall Study|Refuses Injection|11|||
155193134|NCT00216476|560145498|FG001|Overall Study|Refuses Injection|0|||
155193135|NCT00216476|560145499|FG002|Overall Study|Refuses Injection|0|||
155193136|NCT00216476|560145497|FG000|Overall Study|No Further Need for Treatment|3|||
155193137|NCT00216476|560145498|FG001|Overall Study|No Further Need for Treatment|4|||
155193138|NCT00216476|560145499|FG002|Overall Study|No Further Need for Treatment|1|||
155193139|NCT00216476|560145497|FG000|Overall Study|Non-compliance|0|||
155193140|NCT00216476|560145498|FG001|Overall Study|Non-compliance|4|||
155193141|NCT00216476|560145499|FG002|Overall Study|Non-compliance|1|||
155193142|NCT00216476|560145497|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
155193143|NCT00216476|560145498|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
155193144|NCT00216476|560145499|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
155193145|NCT00216476|560145497|FG000|Overall Study|Administrative Reasons|1|||
155193146|NCT00216476|560145498|FG001|Overall Study|Administrative Reasons|1|||
155193147|NCT00216476|560145499|FG002|Overall Study|Administrative Reasons|0|||
155193148|NCT00216476|560145497|FG000|Overall Study|Protocol Deviation|5|||
155193149|NCT00216476|560145498|FG001|Overall Study|Protocol Deviation|1|||
155193150|NCT00216476|560145499|FG002|Overall Study|Protocol Deviation|0|||
155193151|NCT00216476|560145497|FG000|Overall Study|Patient Moved|2|||
155193152|NCT00216476|560145498|FG001|Overall Study|Patient Moved|2|||
155193153|NCT00216476|560145499|FG002|Overall Study|Patient Moved|0|||
155193154|NCT02191137|560145502|FG000|Treatment|Death|4|||
155193155|NCT02191137|560145502|FG000|Treatment|Withdrawal by Subject|3|||
155193156|NCT02191137|560145502|FG000|Treatment|Adverse Event|2|||
155193157|NCT02191137|560145502|FG000|Treatment|Other|1|||
155193158|NCT02191137|560145502|FG000|Follow-up|Lost to Follow-up|2|||
155193159|NCT02191137|560145502|FG000|Follow-up|Ongoing/unknown|2|||
155193160|NCT02191137|560145502|FG000|Follow-up|Adverse Event|1|||
155193161|NCT00538291|560145503|FG000|Overall Study|Adverse Event|2|||
155193162|NCT00538291|560145503|FG000|Overall Study|Withdrawal by Subject|1|||
155193163|NCT01904058|560145506|FG000|Overall Study|Adverse Event|2|||
155193164|NCT01904058|560145507|FG001|Overall Study|Adverse Event|0|||
155193165|NCT01904058|560145508|FG002|Overall Study|Adverse Event|0|||
155193166|NCT01904058|560145509|FG003|Overall Study|Adverse Event|0|||
155193167|NCT01904058|560145506|FG000|Overall Study|Withdrawal by Subject|1|||
155193168|NCT01904058|560145507|FG001|Overall Study|Withdrawal by Subject|0|||
155193169|NCT01904058|560145508|FG002|Overall Study|Withdrawal by Subject|1|||
155193170|NCT01904058|560145509|FG003|Overall Study|Withdrawal by Subject|0|||
155193171|NCT01904058|560145506|FG000|Overall Study|Pregnancy|0|||
155193172|NCT01904058|560145507|FG001|Overall Study|Pregnancy|0|||
155193173|NCT01904058|560145508|FG002|Overall Study|Pregnancy|0|||
155193174|NCT01904058|560145509|FG003|Overall Study|Pregnancy|1|||
155193175|NCT03096483|560145510|FG000|Overall Study|Withdrawal by site|1|||
155193176|NCT02046733|560145513|FG000|Overall Study|never initiated 'treatment visits'|6|||
155193177|NCT02046733|560145514|FG001|Overall Study|never initiated 'treatment visits'|0|||
155193178|NCT03605212|560145515|FG000|Treatment Period|Adverse Event|1|||
155193179|NCT03605212|560145516|FG001|Treatment Period|Adverse Event|0|||
155193180|NCT03605212|560145517|FG002|Treatment Period|Adverse Event|0|||
155193181|NCT03605212|560145518|FG003|Treatment Period|Adverse Event|0|||
155193182|NCT03605212|560145519|FG004|Treatment Period|Adverse Event|0|||
155193183|NCT03605212|560145515|FG000|Treatment Period|Physician Decision|0|||
155193184|NCT03605212|560145516|FG001|Treatment Period|Physician Decision|0|||
155193185|NCT03605212|560145517|FG002|Treatment Period|Physician Decision|0|||
155193186|NCT03605212|560145518|FG003|Treatment Period|Physician Decision|0|||
155193187|NCT03605212|560145519|FG004|Treatment Period|Physician Decision|1|||
155193188|NCT01756053|560145520|FG000|Period 1 (10 Days)|Protocol Violation|1|||
155193189|NCT01756053|560145521|FG001|Period 1 (10 Days)|Protocol Violation|1|||
155193190|NCT01756053|560145520|FG000|Period 2 (10 Days)|Protocol Violation|0|||
155193191|NCT01756053|560145521|FG001|Period 2 (10 Days)|Protocol Violation|2|||
155193192|NCT00285818|560145522|FG000|Overall Study|Withdrawal by Subject|3|||
155193193|NCT00285818|560145523|FG001|Overall Study|Withdrawal by Subject|2|||
155193194|NCT00285818|560145522|FG000|Overall Study|Lost to Follow-up|1|||
155193195|NCT00285818|560145523|FG001|Overall Study|Lost to Follow-up|0|||
155193196|NCT04674644|560145524|FG000|Overall Study|with missing data|37|||
155193197|NCT01024231|560145526|FG000|Overall Study|Other Reasons|1|||
155193198|NCT01024231|560145527|FG001|Overall Study|Other Reasons|2|||
155193199|NCT01024231|560145528|FG002|Overall Study|Other Reasons|0|||
155193200|NCT01024231|560145529|FG003|Overall Study|Other Reasons|0|||
155193201|NCT01024231|560145530|FG004|Overall Study|Other Reasons|2|||
155193202|NCT01024231|560145531|FG005|Overall Study|Other Reasons|0|||
155193203|NCT01024231|560145532|FG006|Overall Study|Other Reasons|1|||
155193204|NCT01024231|560145526|FG000|Overall Study|Maximum Clinical Benefit|1|||
155193205|NCT01024231|560145527|FG001|Overall Study|Maximum Clinical Benefit|2|||
155193206|NCT01024231|560145528|FG002|Overall Study|Maximum Clinical Benefit|0|||
155193207|NCT01024231|560145529|FG003|Overall Study|Maximum Clinical Benefit|1|||
155193208|NCT01024231|560145530|FG004|Overall Study|Maximum Clinical Benefit|1|||
155193209|NCT01024231|560145531|FG005|Overall Study|Maximum Clinical Benefit|0|||
155193210|NCT01024231|560145532|FG006|Overall Study|Maximum Clinical Benefit|0|||
155193211|NCT01024231|560145526|FG000|Overall Study|Disease Progression|3|||
155193212|NCT01024231|560145527|FG001|Overall Study|Disease Progression|1|||
155193213|NCT01024231|560145528|FG002|Overall Study|Disease Progression|3|||
155193214|NCT01024231|560145529|FG003|Overall Study|Disease Progression|0|||
155193215|NCT01024231|560145530|FG004|Overall Study|Disease Progression|4|||
155193216|NCT01024231|560145531|FG005|Overall Study|Disease Progression|11|||
155193217|NCT01024231|560145532|FG006|Overall Study|Disease Progression|6|||
155193218|NCT01024231|560145526|FG000|Overall Study|AE unrelated to Study Drug|0|||
155193219|NCT01024231|560145527|FG001|Overall Study|AE unrelated to Study Drug|1|||
155193220|NCT01024231|560145528|FG002|Overall Study|AE unrelated to Study Drug|0|||
155193221|NCT01024231|560145529|FG003|Overall Study|AE unrelated to Study Drug|0|||
155193222|NCT01024231|560145530|FG004|Overall Study|AE unrelated to Study Drug|0|||
155193223|NCT01024231|560145531|FG005|Overall Study|AE unrelated to Study Drug|0|||
155193224|NCT01024231|560145532|FG006|Overall Study|AE unrelated to Study Drug|0|||
155193225|NCT01024231|560145526|FG000|Overall Study|No longer meets criteria|0|||
155193226|NCT01024231|560145527|FG001|Overall Study|No longer meets criteria|0|||
155193227|NCT01024231|560145528|FG002|Overall Study|No longer meets criteria|0|||
155193228|NCT01024231|560145529|FG003|Overall Study|No longer meets criteria|0|||
155193229|NCT01024231|560145530|FG004|Overall Study|No longer meets criteria|1|||
155193230|NCT01024231|560145531|FG005|Overall Study|No longer meets criteria|0|||
155193231|NCT01024231|560145532|FG006|Overall Study|No longer meets criteria|1|||
155193232|NCT01024231|560145526|FG000|Overall Study|Study Drug Toxicity|1|||
155193233|NCT01024231|560145527|FG001|Overall Study|Study Drug Toxicity|6|||
155193234|NCT01024231|560145528|FG002|Overall Study|Study Drug Toxicity|6|||
155193235|NCT01024231|560145529|FG003|Overall Study|Study Drug Toxicity|4|||
155193236|NCT01024231|560145530|FG004|Overall Study|Study Drug Toxicity|2|||
155193237|NCT01024231|560145531|FG005|Overall Study|Study Drug Toxicity|0|||
155193238|NCT01024231|560145532|FG006|Overall Study|Study Drug Toxicity|7|||
155193239|NCT01024231|560145526|FG000|Overall Study|Death|6|||
155193240|NCT01024231|560145527|FG001|Overall Study|Death|2|||
155193241|NCT01024231|560145528|FG002|Overall Study|Death|1|||
155193242|NCT01024231|560145529|FG003|Overall Study|Death|0|||
155193243|NCT01024231|560145530|FG004|Overall Study|Death|4|||
155193244|NCT01024231|560145531|FG005|Overall Study|Death|3|||
155193245|NCT01024231|560145532|FG006|Overall Study|Death|5|||
155193246|NCT01024231|560145526|FG000|Overall Study|Lost to Follow-up|0|||
155193247|NCT01024231|560145527|FG001|Overall Study|Lost to Follow-up|0|||
155193248|NCT01024231|560145528|FG002|Overall Study|Lost to Follow-up|0|||
155193249|NCT01024231|560145529|FG003|Overall Study|Lost to Follow-up|0|||
155193250|NCT01024231|560145530|FG004|Overall Study|Lost to Follow-up|0|||
155193251|NCT01024231|560145531|FG005|Overall Study|Lost to Follow-up|0|||
155193252|NCT01024231|560145532|FG006|Overall Study|Lost to Follow-up|1|||
155193253|NCT01024231|560145526|FG000|Overall Study|Withdrew Consent|0|||
155193254|NCT01024231|560145527|FG001|Overall Study|Withdrew Consent|1|||
155193255|NCT01024231|560145528|FG002|Overall Study|Withdrew Consent|0|||
155193256|NCT01024231|560145529|FG003|Overall Study|Withdrew Consent|0|||
155193257|NCT01024231|560145530|FG004|Overall Study|Withdrew Consent|0|||
155193258|NCT01024231|560145531|FG005|Overall Study|Withdrew Consent|0|||
155193259|NCT01024231|560145532|FG006|Overall Study|Withdrew Consent|0|||
155193260|NCT01024231|560145526|FG000|Overall Study|Continuing on Treatment|0|||
155193261|NCT01024231|560145527|FG001|Overall Study|Continuing on Treatment|0|||
155193262|NCT01024231|560145528|FG002|Overall Study|Continuing on Treatment|0|||
155193263|NCT01024231|560145529|FG003|Overall Study|Continuing on Treatment|0|||
155193264|NCT01024231|560145530|FG004|Overall Study|Continuing on Treatment|3|||
155193265|NCT01024231|560145531|FG005|Overall Study|Continuing on Treatment|2|||
155193266|NCT01024231|560145532|FG006|Overall Study|Continuing on Treatment|0|||
155193267|NCT01268150|560145533|FG000|Treatment Phase|Progression of disease|18|||
155193268|NCT01268150|560145533|FG000|Treatment Phase|Adverse Event|3|||
155193269|NCT01268150|560145533|FG000|Treatment Phase|Withdrawal by Subject|3|||
155193270|NCT01268150|560145533|FG000|Treatment Phase|Other|4|||
155193271|NCT01268150|560145533|FG000|Extension Phase|Adverse Event|3|||
155193272|NCT01268150|560145533|FG000|Extension Phase|Disease progression|18|||
155193273|NCT01268150|560145533|FG000|Extension Phase|Other|6|||
155193274|NCT00395733|560145534|FG000|Period 2|Withdrawal by Subject|1|||
155193275|NCT00395733|560145535|FG001|Period 2|Withdrawal by Subject|2|||
155193276|NCT00395733|560145534|FG000|Period 2|Protocol Violation|0|||
155193277|NCT00395733|560145535|FG001|Period 2|Protocol Violation|1|||
155193278|NCT00395733|560145534|FG000|Period 2|Adverse Event|0|||
155193279|NCT00395733|560145535|FG001|Period 2|Adverse Event|2|||
155193280|NCT00395733|560145534|FG000|Period 2|Technical problems|1|||
155193281|NCT00395733|560145535|FG001|Period 2|Technical problems|0|||
155193282|NCT01147172|560145537|FG000|Overall Study|Withdrawal by Subject|2|||
155193283|NCT01147172|560145537|FG000|Overall Study|Lost to Follow-up|2|||
155193284|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
155193285|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
155193286|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Death|1|||
155193287|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Death|0|||
155193288|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
155193289|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
155193290|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
155193291|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
155193292|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
155193293|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
155193294|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
155193295|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
155193296|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
155193297|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
155193298|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
155193299|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
155193300|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
155193301|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
155193302|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
155193303|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
155193304|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
155193305|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
155193306|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
155193307|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
155193308|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
155193309|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
155193310|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
155193311|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
155193312|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
155193313|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
155193314|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
155193315|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
155193316|NCT04357782|560145545|FG000|Overall Study|Discharged from hospital|1|||
155193317|NCT04357782|560145546|FG001|Overall Study|Discharged from hospital|0|||
155193318|NCT04357782|560145545|FG000|Overall Study|Death|0|||
155193319|NCT04357782|560145546|FG001|Overall Study|Death|2|||
155193320|NCT01786148|560145547|FG000|Overall Study|Lost to Follow-up|21|||
155193321|NCT01786148|560145548|FG001|Overall Study|Lost to Follow-up|13|||
155193322|NCT01786148|560145547|FG000|Overall Study|Death|0|||
155193323|NCT01786148|560145548|FG001|Overall Study|Death|1|||
155193324|NCT01786148|560145547|FG000|Overall Study|Withdrawal by Subject|0|||
155193325|NCT01786148|560145548|FG001|Overall Study|Withdrawal by Subject|7|||
155193326|NCT01786148|560145547|FG000|Overall Study|Incarceration|1|||
155193327|NCT01786148|560145548|FG001|Overall Study|Incarceration|1|||
155193328|NCT00072176|560145550|FG000|Overall Study|Withdrawal by Subject|1|||
155193329|NCT00072176|560145551|FG001|Overall Study|Withdrawal by Subject|0|||
155193330|NCT00072176|560145550|FG000|Overall Study|Protocol Violation|0|||
155193331|NCT00072176|560145551|FG001|Overall Study|Protocol Violation|1|||
155193332|NCT04128371|560145554|FG000|Overall Study|Lack of Efficacy|1|||
155193333|NCT02840721|560145556|FG000|Treatment Period|Adverse Event|1|||
155193334|NCT02840721|560145556|FG000|Follow-Up|Lack of Efficacy|1|||
155193335|NCT02840721|560145556|FG000|Follow-Up|Withdrawal by Subject|4|||
155193336|NCT02840721|560145556|FG000|Follow-Up|Withdrawal of Consent|2|||
155720986|NCT00148317|562077697|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
155720987|NCT00148317|562077697|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
155720988|NCT00148317|562077697|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
155720989|NCT04199351|562077700|FG000|Overall Study|Decision by sponsor|0|||
155720990|NCT04199351|562077701|FG001|Overall Study|Decision by sponsor|0|||
155720991|NCT04199351|562077702|FG002|Overall Study|Decision by sponsor|0|||
155720992|NCT04199351|562077703|FG003|Overall Study|Decision by sponsor|2|||
155720993|NCT04199351|562077704|FG004|Overall Study|Decision by sponsor|0|||
155720994|NCT04199351|562077705|FG005|Overall Study|Decision by sponsor|0|||
155720995|NCT04199351|562077706|FG006|Overall Study|Decision by sponsor|0|||
155720996|NCT04199351|562077707|FG007|Overall Study|Decision by sponsor|0|||
155720997|NCT04199351|562077708|FG008|Overall Study|Decision by sponsor|0|||
155720998|NCT04199351|562077709|FG009|Overall Study|Decision by sponsor|6|||
155720999|NCT04199351|562077700|FG000|Overall Study|Lost to Follow-up|0|||
155193337|NCT05274165|560145559|FG000|Overall Study|Withdrawal by Subject|3|||
155193338|NCT05274165|560145560|FG001|Overall Study|Withdrawal by Subject|3|||
155193339|NCT03672643|560145562|FG000|Overall Study|Adverse Event|3|||
155193340|NCT03672643|560145562|FG000|Overall Study|Death|2|||
155193341|NCT03672643|560145562|FG000|Overall Study|Withdrawal by Subject|1|||
155193342|NCT03672643|560145562|FG000|Overall Study|Progressive disease|11|||
155721000|NCT04199351|562077701|FG001|Overall Study|Lost to Follow-up|0|||
155721001|NCT04199351|562077702|FG002|Overall Study|Lost to Follow-up|1|||
155721002|NCT04199351|562077703|FG003|Overall Study|Lost to Follow-up|0|||
155721003|NCT04199351|562077704|FG004|Overall Study|Lost to Follow-up|0|||
155721004|NCT04199351|562077705|FG005|Overall Study|Lost to Follow-up|1|||
155721005|NCT04199351|562077706|FG006|Overall Study|Lost to Follow-up|0|||
155721006|NCT04199351|562077707|FG007|Overall Study|Lost to Follow-up|0|||
155721007|NCT04199351|562077708|FG008|Overall Study|Lost to Follow-up|0|||
155721008|NCT04199351|562077709|FG009|Overall Study|Lost to Follow-up|0|||
155721009|NCT04199351|562077700|FG000|Overall Study|Withdrawal by Subject|0|||
155721010|NCT04199351|562077701|FG001|Overall Study|Withdrawal by Subject|1|||
155721011|NCT04199351|562077702|FG002|Overall Study|Withdrawal by Subject|0|||
155721012|NCT04199351|562077703|FG003|Overall Study|Withdrawal by Subject|0|||
155721013|NCT04199351|562077704|FG004|Overall Study|Withdrawal by Subject|1|||
155721014|NCT04199351|562077705|FG005|Overall Study|Withdrawal by Subject|4|||
155721015|NCT04199351|562077706|FG006|Overall Study|Withdrawal by Subject|2|||
155721016|NCT04199351|562077707|FG007|Overall Study|Withdrawal by Subject|0|||
155721017|NCT04199351|562077708|FG008|Overall Study|Withdrawal by Subject|3|||
155721018|NCT04199351|562077709|FG009|Overall Study|Withdrawal by Subject|0|||
155193343|NCT03672643|560145562|FG000|Overall Study|Global deterioration of health status|1|||
155193344|NCT03672643|560145562|FG000|Overall Study|Refused further treatment|7|||
155193345|NCT03672643|560145562|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
155193346|NCT05985395|560145563|FG000|Overall Study|Physician Decision|2|||
155193347|NCT05985395|560145564|FG001|Overall Study|Physician Decision|1|||
155193348|NCT05985395|560145563|FG000|Overall Study|Withdrawal by Subject|1|||
155193349|NCT05985395|560145564|FG001|Overall Study|Withdrawal by Subject|0|||
155193350|NCT03774082|560145565|FG000|Overall Study|Death|6|||
155193351|NCT03774082|560145566|FG001|Overall Study|Death|3|||
155193352|NCT03774082|560145567|FG002|Overall Study|Death|2|||
155193353|NCT03774082|560145565|FG000|Overall Study|Subject decision|0|||
155193354|NCT03774082|560145566|FG001|Overall Study|Subject decision|3|||
155193355|NCT03774082|560145567|FG002|Overall Study|Subject decision|0|||
155193356|NCT03774082|560145565|FG000|Overall Study|Lost to Follow-up|2|||
155193357|NCT03774082|560145566|FG001|Overall Study|Lost to Follow-up|0|||
155193358|NCT03774082|560145567|FG002|Overall Study|Lost to Follow-up|0|||
155193359|NCT03774082|560145565|FG000|Overall Study|Guardian decision|0|||
155193360|NCT03774082|560145566|FG001|Overall Study|Guardian decision|0|||
155193361|NCT03774082|560145567|FG002|Overall Study|Guardian decision|1|||
155193362|NCT03774082|560145565|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
155193363|NCT03774082|560145566|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
155193364|NCT03774082|560145567|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
155193365|NCT00150709|560147388|FG000|Overall Study|Protocol Violation|7|||
155193366|NCT00150709|560147389|FG001|Overall Study|Protocol Violation|8|||
155193367|NCT00150709|560147390|FG002|Overall Study|Protocol Violation|3|||
155193368|NCT00150709|560147391|FG003|Overall Study|Protocol Violation|1|||
155193369|NCT00150709|560147388|FG000|Overall Study|Adverse Event|8|||
155193370|NCT00150709|560147389|FG001|Overall Study|Adverse Event|2|||
155193371|NCT00150709|560147390|FG002|Overall Study|Adverse Event|2|||
155193372|NCT00150709|560147391|FG003|Overall Study|Adverse Event|3|||
155193373|NCT00150709|560147388|FG000|Overall Study|Lack of Efficacy|6|||
155193374|NCT00150709|560147389|FG001|Overall Study|Lack of Efficacy|11|||
155193375|NCT00150709|560147390|FG002|Overall Study|Lack of Efficacy|9|||
155193376|NCT00150709|560147391|FG003|Overall Study|Lack of Efficacy|0|||
155193377|NCT00150709|560147388|FG000|Overall Study|Withdrawal by Subject|7|||
155193378|NCT00150709|560147389|FG001|Overall Study|Withdrawal by Subject|10|||
155193379|NCT00150709|560147390|FG002|Overall Study|Withdrawal by Subject|5|||
155193380|NCT00150709|560147391|FG003|Overall Study|Withdrawal by Subject|0|||
155193381|NCT00150709|560147388|FG000|Overall Study|Lost to Follow-up|3|||
155193382|NCT00150709|560147389|FG001|Overall Study|Lost to Follow-up|2|||
155193383|NCT00150709|560147390|FG002|Overall Study|Lost to Follow-up|0|||
155193384|NCT00150709|560147391|FG003|Overall Study|Lost to Follow-up|0|||
155193385|NCT00150709|560147388|FG000|Overall Study|Sponsor decision|0|||
155193386|NCT00150709|560147389|FG001|Overall Study|Sponsor decision|0|||
155193387|NCT00150709|560147390|FG002|Overall Study|Sponsor decision|0|||
155193388|NCT00150709|560147391|FG003|Overall Study|Sponsor decision|1|||
155193389|NCT00150709|560147388|FG000|Overall Study|Site/Investigator discontinued the study|5|||
155193390|NCT00150709|560147389|FG001|Overall Study|Site/Investigator discontinued the study|5|||
155721019|NCT03623243|562077712|FG000|Overall Study|Adverse Event|15|||
155193391|NCT00150709|560147390|FG002|Overall Study|Site/Investigator discontinued the study|2|||
155193392|NCT00150709|560147391|FG003|Overall Study|Site/Investigator discontinued the study|0|||
155193393|NCT00150709|560147388|FG000|Overall Study|Decision of parent(s)|1|||
155193394|NCT00150709|560147389|FG001|Overall Study|Decision of parent(s)|2|||
155721020|NCT03623243|562077712|FG000|Overall Study|Guardian Decision|1|||
155721021|NCT03623243|562077712|FG000|Overall Study|New Therapy for Study Indication|1|||
155721022|NCT03623243|562077712|FG000|Overall Study|Protocol Deviation|3|||
155721023|NCT03623243|562077712|FG000|Overall Study|Physician Decision|4|||
155193395|NCT00150709|560147390|FG002|Overall Study|Decision of parent(s)|0|||
155193396|NCT00150709|560147391|FG003|Overall Study|Decision of parent(s)|0|||
155193397|NCT00150709|560147388|FG000|Overall Study|Decision of parent(s) and investigator|3|||
155721024|NCT03623243|562077712|FG000|Overall Study|Patient Decision|15|||
155721025|NCT00979901|562077713|FG000|Overall Study|Adverse Event|1|||
155721026|NCT00979901|562077714|FG001|Overall Study|Adverse Event|3|||
155721027|NCT00979901|562077715|FG002|Overall Study|Adverse Event|9|||
155193398|NCT00150709|560147389|FG001|Overall Study|Decision of parent(s) and investigator|0|||
155193399|NCT00150709|560147390|FG002|Overall Study|Decision of parent(s) and investigator|0|||
155193400|NCT00150709|560147391|FG003|Overall Study|Decision of parent(s) and investigator|0|||
155193401|NCT00150709|560147388|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
155193402|NCT00150709|560147389|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
155193403|NCT00150709|560147390|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
155193404|NCT00150709|560147391|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
155193405|NCT00150709|560147388|FG000|Overall Study|Investigator decision|1|||
155193406|NCT00150709|560147389|FG001|Overall Study|Investigator decision|0|||
155193407|NCT00150709|560147390|FG002|Overall Study|Investigator decision|0|||
155193408|NCT00150709|560147391|FG003|Overall Study|Investigator decision|1|||
155193409|NCT00150709|560147388|FG000|Overall Study|Subject relocated|2|||
155193410|NCT00150709|560147389|FG001|Overall Study|Subject relocated|2|||
155193411|NCT00150709|560147390|FG002|Overall Study|Subject relocated|1|||
155193412|NCT00150709|560147391|FG003|Overall Study|Subject relocated|0|||
155193413|NCT00150709|560147388|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
155193414|NCT00150709|560147389|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
155193415|NCT00150709|560147390|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
155193416|NCT00150709|560147391|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
155193417|NCT00150709|560147388|FG000|Overall Study|Convenience|0|||
155193418|NCT00150709|560147389|FG001|Overall Study|Convenience|1|||
155193419|NCT00150709|560147390|FG002|Overall Study|Convenience|0|||
155193420|NCT00150709|560147391|FG003|Overall Study|Convenience|0|||
155193421|NCT00150709|560147388|FG000|Overall Study|Subject entered new drug study|0|||
155193422|NCT00150709|560147389|FG001|Overall Study|Subject entered new drug study|1|||
155193423|NCT00150709|560147390|FG002|Overall Study|Subject entered new drug study|0|||
155193424|NCT00150709|560147391|FG003|Overall Study|Subject entered new drug study|0|||
155193425|NCT00150709|560147388|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
155193426|NCT00150709|560147389|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
155193427|NCT00150709|560147390|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
155193428|NCT00150709|560147391|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
155193429|NCT00150709|560147388|FG000|Overall Study|Lack of ease of swallowing|0|||
155193430|NCT00150709|560147389|FG001|Overall Study|Lack of ease of swallowing|1|||
155193431|NCT00150709|560147390|FG002|Overall Study|Lack of ease of swallowing|0|||
155193432|NCT00150709|560147391|FG003|Overall Study|Lack of ease of swallowing|0|||
155193433|NCT00316719|560147392|FG000|Overall Study|Adverse Event|0|||
155193434|NCT00316719|560147393|FG001|Overall Study|Adverse Event|6|||
155193435|NCT00316719|560147392|FG000|Overall Study|Consent withdrawn|2|||
155193436|NCT00316719|560147393|FG001|Overall Study|Consent withdrawn|0|||
155193437|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Adverse Event|16|||
155193438|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Adverse Event|17|||
155193439|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Adverse Event|13|||
155193440|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Adverse Event|18|||
155193441|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Adverse Event|0|||
155193442|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Adverse Event|0|||
155193443|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Adverse Event|0|||
155193444|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Adverse Event|0|||
155193445|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
155193446|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
155193447|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
155193448|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
155193449|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193450|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193451|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193452|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193453|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
155193454|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
155193455|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
155193456|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
155193457|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
155193458|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
155193459|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
155193460|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
155193461|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
155193462|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
155193463|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
155193464|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
155193465|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193466|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193467|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193468|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193469|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
155193470|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193471|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
155193472|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
155193473|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155721028|NCT00979901|562077716|FG003|Overall Study|Adverse Event|2|||
155721029|NCT00979901|562077713|FG000|Overall Study|Lack of Efficacy|8|||
155721030|NCT00979901|562077714|FG001|Overall Study|Lack of Efficacy|4|||
155721031|NCT00979901|562077715|FG002|Overall Study|Lack of Efficacy|9|||
155721032|NCT00979901|562077716|FG003|Overall Study|Lack of Efficacy|0|||
155721033|NCT00979901|562077713|FG000|Overall Study|Lost to Follow-up|1|||
155193474|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193475|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193476|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193477|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
155193478|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
155193479|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
155193480|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
155193481|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
155193482|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
155193483|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
155193484|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
155193485|NCT02975336|560147394|FG000|LTE (104 Weeks)|Adverse Event|0|||
155193486|NCT02975336|560147395|FG001|LTE (104 Weeks)|Adverse Event|0|||
155193487|NCT02975336|560147396|FG002|LTE (104 Weeks)|Adverse Event|0|||
155193488|NCT02975336|560147397|FG003|LTE (104 Weeks)|Adverse Event|0|||
155193489|NCT02975336|560147398|FG004|LTE (104 Weeks)|Adverse Event|7|||
155193490|NCT02975336|560147399|FG005|LTE (104 Weeks)|Adverse Event|4|||
155193491|NCT02975336|560147400|FG006|LTE (104 Weeks)|Adverse Event|2|||
155193492|NCT02975336|560147401|FG007|LTE (104 Weeks)|Adverse Event|0|||
155193493|NCT02975336|560147394|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
155193494|NCT02975336|560147395|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
155193495|NCT02975336|560147396|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
155193496|NCT02975336|560147397|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
155193497|NCT02975336|560147398|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
155193498|NCT02975336|560147399|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
155193499|NCT02975336|560147400|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
155193500|NCT02975336|560147401|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
155193501|NCT02975336|560147394|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
155193502|NCT02975336|560147395|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
155193503|NCT02975336|560147396|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
155193504|NCT02975336|560147397|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
155193505|NCT02975336|560147398|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
155193506|NCT02975336|560147399|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
155193507|NCT02975336|560147400|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
155193508|NCT02975336|560147401|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
155193509|NCT02975336|560147394|FG000|LTE (104 Weeks)|Other|0|||
155193510|NCT02975336|560147395|FG001|LTE (104 Weeks)|Other|0|||
155193511|NCT02975336|560147396|FG002|LTE (104 Weeks)|Other|0|||
155193512|NCT02975336|560147397|FG003|LTE (104 Weeks)|Other|0|||
155193513|NCT02975336|560147398|FG004|LTE (104 Weeks)|Other|55|||
155193514|NCT02975336|560147399|FG005|LTE (104 Weeks)|Other|63|||
155193515|NCT02975336|560147400|FG006|LTE (104 Weeks)|Other|76|||
155193516|NCT02975336|560147401|FG007|LTE (104 Weeks)|Other|72|||
155193517|NCT02024529|560147407|FG000|Overall Study|Withdrawal by Subject|11|||
155193518|NCT02024529|560147408|FG001|Overall Study|Withdrawal by Subject|21|||
155193519|NCT02024529|560147407|FG000|Overall Study|Lost to Follow-up|2|||
155193520|NCT02024529|560147408|FG001|Overall Study|Lost to Follow-up|4|||
155193521|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
155193522|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193523|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193524|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193525|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193526|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193527|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193528|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
155193529|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155721034|NCT00979901|562077714|FG001|Overall Study|Lost to Follow-up|1|||
155721035|NCT00979901|562077715|FG002|Overall Study|Lost to Follow-up|2|||
155721036|NCT00979901|562077716|FG003|Overall Study|Lost to Follow-up|0|||
155193530|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193531|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193532|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193533|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193534|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193535|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193536|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193537|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
155721037|NCT00979901|562077713|FG000|Overall Study|Protocol Violation|2|||
155721038|NCT00979901|562077714|FG001|Overall Study|Protocol Violation|2|||
155193538|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193539|NCT02642029|560147409|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
155193540|NCT02642029|560147410|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
155193541|NCT02642029|560147411|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
155193542|NCT02642029|560147412|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
155193543|NCT02642029|560147413|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
155193544|NCT02642029|560147414|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
155193545|NCT02642029|560147409|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
155193546|NCT02642029|560147410|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193547|NCT02642029|560147411|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193548|NCT02642029|560147412|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193549|NCT02642029|560147413|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193550|NCT02642029|560147414|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193551|NCT02642029|560147409|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
155193552|NCT02642029|560147410|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193553|NCT02642029|560147411|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193554|NCT02642029|560147412|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193555|NCT02642029|560147413|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193556|NCT02642029|560147414|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193557|NCT00691301|560147417|FG000|Overall Study|Adverse Event|10|||
155193558|NCT00691301|560147417|FG000|Overall Study|Death|2|||
155193559|NCT00691301|560147417|FG000|Overall Study|Lack of Efficacy|32|||
155193560|NCT00691301|560147417|FG000|Overall Study|Withdrawal by Subject|4|||
155193561|NCT00691301|560147417|FG000|Overall Study|Concurrent illness|2|||
155193562|NCT00691301|560147417|FG000|Overall Study|other reason|3|||
155193563|NCT00691301|560147417|FG000|Overall Study|Did not initiate study treatment|1|||
155193564|NCT01823146|560147418|FG000|Overall Study|Withdrawal by Subject|0|||
155193565|NCT01823146|560147419|FG001|Overall Study|Withdrawal by Subject|1|||
155193566|NCT01823146|560147418|FG000|Overall Study|Lost to Follow-up|2|||
155193567|NCT01823146|560147419|FG001|Overall Study|Lost to Follow-up|1|||
155193568|NCT00736944|560147420|FG000|Induction|Death|1|||
155193569|NCT00736944|560147420|FG000|Definitive Treatment|Physician Decision|1|||
155193570|NCT01426438|560147421|FG000|Overall Study|Lost to Follow-up|1|||
155193571|NCT01426438|560147422|FG001|Overall Study|Lost to Follow-up|3|||
155193572|NCT01426438|560147421|FG000|Overall Study|Off study Treatment|9|||
155193573|NCT01426438|560147422|FG001|Overall Study|Off study Treatment|3|||
155193574|NCT01426438|560147421|FG000|Overall Study|Poor scan quality|3|||
155193575|NCT01426438|560147422|FG001|Overall Study|Poor scan quality|2|||
155193576|NCT01426438|560147421|FG000|Overall Study|Missed Scan|2|||
155193577|NCT01426438|560147422|FG001|Overall Study|Missed Scan|2|||
155193578|NCT00091442|560147423|FG000|Overall Study|Progressive Disease|220|||
155193579|NCT00091442|560147424|FG001|Overall Study|Progressive Disease|189|||
155193580|NCT00091442|560147423|FG000|Overall Study|Physician Decision|61|||
155193581|NCT00091442|560147424|FG001|Overall Study|Physician Decision|58|||
155193582|NCT00091442|560147423|FG000|Overall Study|Withdrawal by Subject|38|||
155193583|NCT00091442|560147424|FG001|Overall Study|Withdrawal by Subject|46|||
155193584|NCT00091442|560147423|FG000|Overall Study|Adverse Event|29|||
155193585|NCT00091442|560147424|FG001|Overall Study|Adverse Event|48|||
155193586|NCT00091442|560147423|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
155193587|NCT00091442|560147424|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
155193588|NCT00091442|560147423|FG000|Overall Study|Death|9|||
155193589|NCT00091442|560147424|FG001|Overall Study|Death|7|||
155193590|NCT00091442|560147423|FG000|Overall Study|Lost to Follow-up|1|||
155193591|NCT00091442|560147424|FG001|Overall Study|Lost to Follow-up|3|||
155193592|NCT00091442|560147423|FG000|Overall Study|Other|2|||
155193593|NCT00091442|560147424|FG001|Overall Study|Other|6|||
155193594|NCT00845858|560147425|FG000|Overall Study|Withdrawal by Subject|5|||
155193595|NCT00845858|560147426|FG001|Overall Study|Withdrawal by Subject|1|||
155721039|NCT00979901|562077715|FG002|Overall Study|Protocol Violation|7|||
155721040|NCT00979901|562077716|FG003|Overall Study|Protocol Violation|1|||
155721041|NCT00979901|562077713|FG000|Overall Study|Withdrawal by Subject|2|||
155193596|NCT00845858|560147427|FG002|Overall Study|Withdrawal by Subject|1|||
155193597|NCT00845858|560147425|FG000|Overall Study|Adverse Event|3|||
155193598|NCT00845858|560147426|FG001|Overall Study|Adverse Event|8|||
155193599|NCT00845858|560147427|FG002|Overall Study|Adverse Event|4|||
155193600|NCT00845858|560147425|FG000|Overall Study|Protocol Violation|0|||
155193601|NCT00845858|560147426|FG001|Overall Study|Protocol Violation|0|||
155193602|NCT00845858|560147427|FG002|Overall Study|Protocol Violation|1|||
155193603|NCT00845858|560147425|FG000|Overall Study|not eligible|0|||
155193604|NCT00845858|560147426|FG001|Overall Study|not eligible|3|||
155193605|NCT00845858|560147427|FG002|Overall Study|not eligible|2|||
155193606|NCT03725852|560147433|FG000|Overall Study|Death|1|||
155193607|NCT03725852|560147434|FG001|Overall Study|Death|0|||
155193608|NCT03725852|560147433|FG000|Overall Study|Withdrawal by Subject|1|||
155193609|NCT03725852|560147434|FG001|Overall Study|Withdrawal by Subject|0|||
155193610|NCT03725852|560147433|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
155721042|NCT00979901|562077714|FG001|Overall Study|Withdrawal by Subject|1|||
155721043|NCT00979901|562077715|FG002|Overall Study|Withdrawal by Subject|1|||
155721044|NCT00979901|562077716|FG003|Overall Study|Withdrawal by Subject|1|||
155721045|NCT00979901|562077713|FG000|Overall Study|Noncompliance|1|||
155721046|NCT00979901|562077714|FG001|Overall Study|Noncompliance|0|||
155193611|NCT03725852|560147434|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
155193612|NCT02808650|560147439|FG000|Overall Study|Death|0|||
155193613|NCT02808650|560147440|FG001|Overall Study|Death|0|||
155193614|NCT02808650|560147441|FG002|Overall Study|Death|0|||
155193615|NCT02808650|560147442|FG003|Overall Study|Death|0|||
155193616|NCT02808650|560147443|FG004|Overall Study|Death|1|||
155721047|NCT00979901|562077715|FG002|Overall Study|Noncompliance|0|||
155721048|NCT00979901|562077716|FG003|Overall Study|Noncompliance|0|||
155721049|NCT00979901|562077713|FG000|Overall Study|out-of-state|1|||
155721050|NCT00979901|562077714|FG001|Overall Study|out-of-state|0|||
155721051|NCT00979901|562077715|FG002|Overall Study|out-of-state|0|||
155721052|NCT00979901|562077716|FG003|Overall Study|out-of-state|0|||
155721053|NCT00979901|562077713|FG000|Overall Study|vacation|1|||
155721054|NCT00979901|562077714|FG001|Overall Study|vacation|0|||
155721055|NCT00979901|562077715|FG002|Overall Study|vacation|0|||
155721056|NCT00979901|562077716|FG003|Overall Study|vacation|0|||
155721057|NCT00979901|562077713|FG000|Overall Study|elevated lab values pre-randomization|1|||
155721058|NCT00979901|562077714|FG001|Overall Study|elevated lab values pre-randomization|0|||
155193617|NCT02808650|560147439|FG000|Overall Study|Lack of Efficacy|5|||
155193618|NCT02808650|560147440|FG001|Overall Study|Lack of Efficacy|5|||
155193619|NCT02808650|560147441|FG002|Overall Study|Lack of Efficacy|6|||
155193620|NCT02808650|560147442|FG003|Overall Study|Lack of Efficacy|5|||
155721059|NCT00979901|562077715|FG002|Overall Study|elevated lab values pre-randomization|0|||
155721060|NCT00979901|562077716|FG003|Overall Study|elevated lab values pre-randomization|0|||
155721061|NCT00979901|562077713|FG000|Overall Study|Discontinued in Error|0|||
155721062|NCT00979901|562077714|FG001|Overall Study|Discontinued in Error|1|||
155721063|NCT00979901|562077715|FG002|Overall Study|Discontinued in Error|0|||
155193621|NCT02808650|560147443|FG004|Overall Study|Lack of Efficacy|4|||
155193622|NCT02808650|560147439|FG000|Overall Study|Physician Decision|1|||
155193623|NCT02808650|560147440|FG001|Overall Study|Physician Decision|1|||
155193624|NCT02808650|560147441|FG002|Overall Study|Physician Decision|0|||
155193625|NCT02808650|560147442|FG003|Overall Study|Physician Decision|0|||
155193626|NCT02808650|560147443|FG004|Overall Study|Physician Decision|0|||
155193627|NCT02808650|560147439|FG000|Overall Study|Withdrawal by Subject|0|||
155193628|NCT02808650|560147440|FG001|Overall Study|Withdrawal by Subject|0|||
155193629|NCT02808650|560147441|FG002|Overall Study|Withdrawal by Subject|0|||
155193630|NCT02808650|560147442|FG003|Overall Study|Withdrawal by Subject|1|||
155193631|NCT02808650|560147443|FG004|Overall Study|Withdrawal by Subject|1|||
155193632|NCT00669396|560147450|FG000|Overall Study|Lost to Follow-up|10|||
155193633|NCT00669396|560147451|FG001|Overall Study|Lost to Follow-up|12|||
155193634|NCT01262573|560147452|FG000|Overall Study|Withdrawal by Subject|0|||
155193635|NCT01262573|560147453|FG001|Overall Study|Withdrawal by Subject|1|||
155193636|NCT04402060|560147454|FG000|Overall Study|Death|1|||
155193637|NCT04402060|560147455|FG001|Overall Study|Death|12|||
155193638|NCT04402060|560147456|FG002|Overall Study|Death|7|||
155193639|NCT04402060|560147454|FG000|Overall Study|Adverse Event|0|||
155193640|NCT04402060|560147455|FG001|Overall Study|Adverse Event|0|||
155193641|NCT04402060|560147456|FG002|Overall Study|Adverse Event|1|||
155193642|NCT04402060|560147454|FG000|Overall Study|Withdrawal by Subject|0|||
155193643|NCT04402060|560147455|FG001|Overall Study|Withdrawal by Subject|1|||
155193644|NCT04402060|560147456|FG002|Overall Study|Withdrawal by Subject|2|||
155193645|NCT04402060|560147454|FG000|Overall Study|Sponsor Request|0|||
155193646|NCT04402060|560147455|FG001|Overall Study|Sponsor Request|2|||
155193647|NCT04402060|560147456|FG002|Overall Study|Sponsor Request|0|||
155193648|NCT04402060|560147454|FG000|Overall Study|Physician Decision|0|||
155193649|NCT04402060|560147455|FG001|Overall Study|Physician Decision|0|||
155193650|NCT04402060|560147456|FG002|Overall Study|Physician Decision|1|||
155193651|NCT04402060|560147454|FG000|Overall Study|Other|0|||
155193652|NCT04402060|560147455|FG001|Overall Study|Other|1|||
155193653|NCT04402060|560147456|FG002|Overall Study|Other|0|||
155193654|NCT00331422|560147457|FG000|Overall Study|Did not receive entire study regimen|5|||
155193655|NCT02345226|560147458|FG000|Double-Blind Phase|Adverse Event|5|||
155193656|NCT02345226|560147459|FG001|Double-Blind Phase|Adverse Event|6|||
155193657|NCT02345226|560147458|FG000|Double-Blind Phase|Death|3|||
155193658|NCT02345226|560147459|FG001|Double-Blind Phase|Death|0|||
155193659|NCT02345226|560147458|FG000|Double-Blind Phase|Pregnancy|0|||
155193660|NCT02345226|560147459|FG001|Double-Blind Phase|Pregnancy|1|||
155193661|NCT02345226|560147458|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155193662|NCT02345226|560147459|FG001|Double-Blind Phase|Lack of Efficacy|0|||
155193663|NCT02345226|560147458|FG000|Double-Blind Phase|Investigator's Discretion|4|||
155193664|NCT02345226|560147459|FG001|Double-Blind Phase|Investigator's Discretion|3|||
155193665|NCT02345226|560147458|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155193666|NCT02345226|560147459|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
155193667|NCT02345226|560147458|FG000|Double-Blind Phase|Withdrew Consent|41|||
155193668|NCT02345226|560147459|FG001|Double-Blind Phase|Withdrew Consent|39|||
155193669|NCT02345226|560147458|FG000|Double-Blind Phase|Lost to Follow-up|12|||
155193670|NCT02345226|560147459|FG001|Double-Blind Phase|Lost to Follow-up|16|||
155193671|NCT02345226|560147458|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
155193672|NCT02345226|560147459|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
155193673|NCT02345226|560147458|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155193674|NCT02345226|560147459|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
155193675|NCT01033851|560147462|FG000|Overall Study|Withdrawal by Subject|3|||
155193676|NCT01033851|560147463|FG001|Overall Study|Withdrawal by Subject|7|||
155193677|NCT00066729|560147464|FG000|Overall Study|Lost to Follow-up|1|||
155193678|NCT00066729|560147464|FG000|Overall Study|Disease progression|1|||
155193679|NCT02349542|560147467|FG000|Overall Study|Withdrawal by Subject|5|||
155193680|NCT02215096|560147468|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
155193681|NCT02215096|560147469|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193682|NCT02215096|560147470|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193683|NCT02215096|560147471|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193684|NCT02215096|560147472|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193685|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193686|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193687|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193688|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193689|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
155193690|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193691|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193692|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193693|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
155193694|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193695|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
155721064|NCT00979901|562077716|FG003|Overall Study|Discontinued in Error|0|||
155721065|NCT00979901|562077713|FG000|Overall Study|Left Country|0|||
155721066|NCT00979901|562077714|FG001|Overall Study|Left Country|0|||
155721067|NCT00979901|562077715|FG002|Overall Study|Left Country|1|||
155721068|NCT00979901|562077716|FG003|Overall Study|Left Country|0|||
155721069|NCT00979901|562077713|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
155721070|NCT00979901|562077714|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
155721071|NCT00979901|562077715|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
155721072|NCT00979901|562077716|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
155721073|NCT03924622|562077717|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
155721074|NCT03924622|562077718|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155721075|NCT03924622|562077719|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155721076|NCT03924622|562077720|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
155721077|NCT03924622|562077721|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155721078|NCT03924622|562077722|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155721079|NCT00248625|562077723|FG000|Overall Study|Withdrawal by Subject|0|||
155721080|NCT00248625|562077724|FG001|Overall Study|Withdrawal by Subject|2|||
155721081|NCT03284710|562077727|FG000|Overall Study|Withdrawal by Subject|1|||
155721082|NCT03284710|562077728|FG001|Overall Study|Withdrawal by Subject|0|||
155721083|NCT03284710|562077729|FG002|Overall Study|Withdrawal by Subject|1|||
155721084|NCT03284710|562077730|FG003|Overall Study|Withdrawal by Subject|6|||
155721085|NCT03284710|562077727|FG000|Overall Study|Lost to Follow-up|3|||
155721086|NCT03284710|562077728|FG001|Overall Study|Lost to Follow-up|3|||
155721087|NCT03284710|562077729|FG002|Overall Study|Lost to Follow-up|1|||
155721088|NCT03284710|562077730|FG003|Overall Study|Lost to Follow-up|0|||
155721089|NCT03284710|562077727|FG000|Overall Study|Physician Decision|1|||
155721090|NCT03284710|562077728|FG001|Overall Study|Physician Decision|0|||
155721091|NCT03284710|562077729|FG002|Overall Study|Physician Decision|0|||
155721092|NCT03284710|562077730|FG003|Overall Study|Physician Decision|0|||
155721093|NCT03284710|562077727|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155721094|NCT03284710|562077728|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155721095|NCT03284710|562077729|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155721096|NCT03284710|562077730|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155721097|NCT03284710|562077727|FG000|Overall Study|HIV Infection|0|||
155721098|NCT03284710|562077728|FG001|Overall Study|HIV Infection|2|||
155721099|NCT03284710|562077729|FG002|Overall Study|HIV Infection|2|||
155721100|NCT03284710|562077730|FG003|Overall Study|HIV Infection|1|||
155721101|NCT02814916|562077734|FG000|Overall Study|Withdrawal of consent|0|||
155721102|NCT02814916|562077735|FG001|Overall Study|Withdrawal of consent|2|||
155721103|NCT02814916|562077736|FG002|Overall Study|Withdrawal of consent|0|||
155721104|NCT02814916|562077734|FG000|Overall Study|Lost to Follow-up|0|||
155721105|NCT02814916|562077735|FG001|Overall Study|Lost to Follow-up|1|||
155721106|NCT02814916|562077736|FG002|Overall Study|Lost to Follow-up|0|||
155721107|NCT02814916|562077734|FG000|Overall Study|Other, not specified|0|||
155721108|NCT02814916|562077735|FG001|Overall Study|Other, not specified|1|||
155721109|NCT02814916|562077736|FG002|Overall Study|Other, not specified|0|||
155721110|NCT00286468|562077741|FG000|Overall Study|Hyperglycemic Rescue|28|||
155721111|NCT00286468|562077742|FG001|Overall Study|Hyperglycemic Rescue|30|||
155721112|NCT00286468|562077743|FG002|Overall Study|Hyperglycemic Rescue|31|||
155721113|NCT00286468|562077741|FG000|Overall Study|Adverse Event|2|||
155721114|NCT00286468|562077742|FG001|Overall Study|Adverse Event|6|||
155721115|NCT00286468|562077743|FG002|Overall Study|Adverse Event|4|||
155721116|NCT00286468|562077741|FG000|Overall Study|Protocol Violation|0|||
155721117|NCT00286468|562077742|FG001|Overall Study|Protocol Violation|3|||
155721118|NCT00286468|562077743|FG002|Overall Study|Protocol Violation|1|||
155721119|NCT00286468|562077741|FG000|Overall Study|Lost to Follow-up|1|||
155721120|NCT00286468|562077742|FG001|Overall Study|Lost to Follow-up|1|||
155721121|NCT00286468|562077743|FG002|Overall Study|Lost to Follow-up|2|||
155721122|NCT00286468|562077741|FG000|Overall Study|Withdrawal by Subject|3|||
155721123|NCT00286468|562077742|FG001|Overall Study|Withdrawal by Subject|8|||
155193696|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
155193697|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
155193698|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
155193699|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
155193700|NCT01011738|560147473|FG000|Overall Study|Death|12|||
155193701|NCT01011738|560147474|FG001|Overall Study|Death|3|||
155193702|NCT01011738|560147475|FG002|Overall Study|Death|0|||
155193703|NCT01011738|560147473|FG000|Overall Study|Unknown reasons|312|||
155193704|NCT01011738|560147474|FG001|Overall Study|Unknown reasons|291|||
155193705|NCT01011738|560147475|FG002|Overall Study|Unknown reasons|17|||
155193706|NCT03896165|560147478|FG000|Overall Study|Withdrawal by Subject|2|||
155193707|NCT03181893|560147479|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193708|NCT03181893|560147480|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
155193709|NCT03181893|560147481|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193710|NCT03181893|560147482|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193711|NCT03181893|560147483|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193712|NCT03181893|560147484|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193713|NCT03181893|560147485|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193714|NCT03181893|560147486|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193715|NCT03181893|560147487|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193716|NCT03181893|560147488|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193717|NCT03181893|560147489|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193718|NCT03181893|560147479|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
155193719|NCT03181893|560147480|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
155193720|NCT03181893|560147481|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193721|NCT03181893|560147482|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193722|NCT03181893|560147483|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193723|NCT03181893|560147484|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193724|NCT03181893|560147485|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193725|NCT03181893|560147486|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193726|NCT03181893|560147487|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193727|NCT03181893|560147488|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193728|NCT03181893|560147489|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193729|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193730|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193731|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193732|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193733|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193734|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193735|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193736|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
155193737|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
155193738|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193739|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193740|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193741|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193742|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193743|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193744|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193745|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193746|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193747|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193748|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193749|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
155193750|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193751|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193752|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193753|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193754|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193755|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193756|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193757|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193758|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193759|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193760|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193761|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
155193762|NCT02158975|560147490|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
155193763|NCT04815031|560147495|FG000|Overall Study|No adverse event information (missing information)|33|||
155193764|NCT03021304|560147496|FG000|Overall Study|Lack of Efficacy|1|||
155193765|NCT00423514|560147504|FG000|Overall Study|Ineligible|1|||
155193766|NCT00423514|560147505|FG001|Overall Study|Ineligible|0|||
155193767|NCT01361568|560147506|FG000|Overall Study|Adverse Event|0|||
155193768|NCT01361568|560147507|FG001|Overall Study|Adverse Event|0|||
155193769|NCT01361568|560147508|FG002|Overall Study|Adverse Event|0|||
155193770|NCT01361568|560147509|FG003|Overall Study|Adverse Event|0|||
155193771|NCT01361568|560147510|FG004|Overall Study|Adverse Event|1|||
155193772|NCT01361568|560147511|FG005|Overall Study|Adverse Event|0|||
155193773|NCT01361568|560147506|FG000|Overall Study|Physician Decision|0|||
155193774|NCT01361568|560147507|FG001|Overall Study|Physician Decision|0|||
155193775|NCT01361568|560147508|FG002|Overall Study|Physician Decision|0|||
155193776|NCT01361568|560147509|FG003|Overall Study|Physician Decision|0|||
155193777|NCT01361568|560147510|FG004|Overall Study|Physician Decision|0|||
155193778|NCT01361568|560147511|FG005|Overall Study|Physician Decision|1|||
155193779|NCT01361568|560147506|FG000|Overall Study|Withdrawal by Subject|2|||
155193780|NCT01361568|560147507|FG001|Overall Study|Withdrawal by Subject|1|||
155193781|NCT01361568|560147508|FG002|Overall Study|Withdrawal by Subject|0|||
155193782|NCT01361568|560147509|FG003|Overall Study|Withdrawal by Subject|0|||
155193783|NCT01361568|560147510|FG004|Overall Study|Withdrawal by Subject|0|||
155193784|NCT01361568|560147511|FG005|Overall Study|Withdrawal by Subject|1|||
155193785|NCT02728596|560147512|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155193786|NCT02728596|560147513|FG001|Overall Study|Refusal unrelated to adverse event|6|||
155193787|NCT02728596|560147514|FG002|Overall Study|Refusal unrelated to adverse event|7|||
155193788|NCT02728596|560147515|FG003|Overall Study|Refusal unrelated to adverse event|7|||
155193789|NCT02728596|560147512|FG000|Overall Study|Death|44|||
155193790|NCT02728596|560147513|FG001|Overall Study|Death|42|||
155193791|NCT02728596|560147514|FG002|Overall Study|Death|123|||
155193792|NCT02728596|560147515|FG003|Overall Study|Death|68|||
155193793|NCT03439657|560147516|FG000|Overall Study|Adverse Event|2|||
155193794|NCT03439657|560147517|FG001|Overall Study|Adverse Event|3|||
155193795|NCT03439657|560147516|FG000|Overall Study|Lost to Follow-up|1|||
155193796|NCT03439657|560147517|FG001|Overall Study|Lost to Follow-up|0|||
155193797|NCT03439657|560147516|FG000|Overall Study|Protocol Violation|1|||
155193798|NCT03439657|560147517|FG001|Overall Study|Protocol Violation|1|||
155193799|NCT03439657|560147516|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
155193800|NCT03439657|560147517|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
155193801|NCT00667875|560147520|FG000|Overall Study|Adverse Event|0|||
155193802|NCT00667875|560147521|FG001|Overall Study|Adverse Event|2|||
155193803|NCT00667875|560147522|FG002|Overall Study|Adverse Event|6|||
155193804|NCT00667875|560147520|FG000|Overall Study|Withdrawal by Subject|10|||
155193805|NCT00667875|560147521|FG001|Overall Study|Withdrawal by Subject|9|||
155193806|NCT00667875|560147522|FG002|Overall Study|Withdrawal by Subject|7|||
155193807|NCT03553927|560147523|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
155193808|NCT03553927|560147524|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
155193809|NCT03553927|560147523|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
155193810|NCT03553927|560147524|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
155193811|NCT01441180|560147525|FG000|Overall Study|Lost to Follow-up|1|||
155193812|NCT01441180|560147526|FG001|Overall Study|Lost to Follow-up|1|||
155193813|NCT01441180|560147527|FG002|Overall Study|Lost to Follow-up|1|||
155193814|NCT01441180|560147525|FG000|Overall Study|Discontinued|0|||
155193815|NCT01441180|560147526|FG001|Overall Study|Discontinued|0|||
155193816|NCT01441180|560147527|FG002|Overall Study|Discontinued|2|||
155193817|NCT01558739|560147528|FG000|Overall Study|Adverse Event|7|||
155193818|NCT01558739|560147528|FG000|Overall Study|Withdrawal by Subject|2|||
155193819|NCT01558739|560147528|FG000|Overall Study|Death|3|||
155193820|NCT01558739|560147528|FG000|Overall Study|Disease Progression|4|||
155193821|NCT01558739|560147528|FG000|Overall Study|Protocol Violation|1|||
155193822|NCT00142298|560147531|FG000|Overall Study|Adverse Event|10|||
155193823|NCT00142298|560147532|FG001|Overall Study|Adverse Event|10|||
155193824|NCT00142298|560147533|FG002|Overall Study|Adverse Event|1|||
155193825|NCT00142298|560147534|FG003|Overall Study|Adverse Event|5|||
155193826|NCT00142298|560147535|FG004|Overall Study|Adverse Event|2|||
155193827|NCT00142298|560147536|FG005|Overall Study|Adverse Event|2|||
155193828|NCT00142298|560147537|FG006|Overall Study|Adverse Event|0|||
155193829|NCT00142298|560147538|FG007|Overall Study|Adverse Event|0|||
155193830|NCT00142298|560147539|FG008|Overall Study|Adverse Event|0|||
155193831|NCT00142298|560147540|FG009|Overall Study|Adverse Event|0|||
155193832|NCT00142298|560147531|FG000|Overall Study|Clinical disease progression|1|||
155193833|NCT00142298|560147532|FG001|Overall Study|Clinical disease progression|0|||
155193834|NCT00142298|560147533|FG002|Overall Study|Clinical disease progression|0|||
155193835|NCT00142298|560147534|FG003|Overall Study|Clinical disease progression|0|||
155193836|NCT00142298|560147535|FG004|Overall Study|Clinical disease progression|0|||
155193837|NCT00142298|560147536|FG005|Overall Study|Clinical disease progression|0|||
155193838|NCT00142298|560147537|FG006|Overall Study|Clinical disease progression|0|||
155193839|NCT00142298|560147538|FG007|Overall Study|Clinical disease progression|0|||
155193840|NCT00142298|560147539|FG008|Overall Study|Clinical disease progression|0|||
155193841|NCT00142298|560147540|FG009|Overall Study|Clinical disease progression|0|||
155193842|NCT00142298|560147531|FG000|Overall Study|Death|1|||
155193843|NCT00142298|560147532|FG001|Overall Study|Death|1|||
155193844|NCT00142298|560147533|FG002|Overall Study|Death|1|||
155193845|NCT00142298|560147534|FG003|Overall Study|Death|0|||
155193846|NCT00142298|560147535|FG004|Overall Study|Death|0|||
155193847|NCT00142298|560147536|FG005|Overall Study|Death|6|||
155193848|NCT00142298|560147537|FG006|Overall Study|Death|0|||
155193849|NCT00142298|560147538|FG007|Overall Study|Death|0|||
155193850|NCT00142298|560147539|FG008|Overall Study|Death|0|||
155193851|NCT00142298|560147540|FG009|Overall Study|Death|0|||
155193852|NCT00142298|560147531|FG000|Overall Study|Lack of Efficacy|44|||
155193853|NCT00142298|560147532|FG001|Overall Study|Lack of Efficacy|62|||
155193854|NCT00142298|560147533|FG002|Overall Study|Lack of Efficacy|9|||
155193855|NCT00142298|560147534|FG003|Overall Study|Lack of Efficacy|12|||
155193856|NCT00142298|560147535|FG004|Overall Study|Lack of Efficacy|1|||
155193857|NCT00142298|560147536|FG005|Overall Study|Lack of Efficacy|0|||
155193858|NCT00142298|560147537|FG006|Overall Study|Lack of Efficacy|0|||
155193859|NCT00142298|560147538|FG007|Overall Study|Lack of Efficacy|1|||
155193860|NCT00142298|560147539|FG008|Overall Study|Lack of Efficacy|0|||
155193861|NCT00142298|560147540|FG009|Overall Study|Lack of Efficacy|0|||
155193862|NCT00142298|560147531|FG000|Overall Study|Non-compliance|15|||
155193863|NCT00142298|560147532|FG001|Overall Study|Non-compliance|13|||
155193864|NCT00142298|560147533|FG002|Overall Study|Non-compliance|0|||
155193865|NCT00142298|560147534|FG003|Overall Study|Non-compliance|6|||
155193866|NCT00142298|560147535|FG004|Overall Study|Non-compliance|1|||
155193867|NCT00142298|560147536|FG005|Overall Study|Non-compliance|0|||
155193868|NCT00142298|560147537|FG006|Overall Study|Non-compliance|0|||
155193869|NCT00142298|560147538|FG007|Overall Study|Non-compliance|3|||
155193870|NCT00142298|560147539|FG008|Overall Study|Non-compliance|3|||
155193871|NCT00142298|560147540|FG009|Overall Study|Non-compliance|0|||
155193872|NCT00142298|560147531|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
155193873|NCT00142298|560147532|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
155193874|NCT00142298|560147533|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
155193875|NCT00142298|560147534|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
155193876|NCT00142298|560147535|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
155193877|NCT00142298|560147536|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
155193878|NCT00142298|560147537|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
155193879|NCT00142298|560147538|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
155193880|NCT00142298|560147539|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
155193881|NCT00142298|560147540|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
155193882|NCT00142298|560147531|FG000|Overall Study|Pregnancy|4|||
155193883|NCT00142298|560147532|FG001|Overall Study|Pregnancy|4|||
155193884|NCT00142298|560147533|FG002|Overall Study|Pregnancy|2|||
155193885|NCT00142298|560147534|FG003|Overall Study|Pregnancy|3|||
155193886|NCT00142298|560147535|FG004|Overall Study|Pregnancy|0|||
155193887|NCT00142298|560147536|FG005|Overall Study|Pregnancy|0|||
155193888|NCT00142298|560147537|FG006|Overall Study|Pregnancy|0|||
155193889|NCT00142298|560147538|FG007|Overall Study|Pregnancy|0|||
155193890|NCT00142298|560147539|FG008|Overall Study|Pregnancy|1|||
155193891|NCT00142298|560147540|FG009|Overall Study|Pregnancy|0|||
155193892|NCT00142298|560147531|FG000|Overall Study|Virologic breakthrough|19|||
155193893|NCT00142298|560147532|FG001|Overall Study|Virologic breakthrough|23|||
155193894|NCT00142298|560147533|FG002|Overall Study|Virologic breakthrough|9|||
155193895|NCT00142298|560147534|FG003|Overall Study|Virologic breakthrough|7|||
155193896|NCT00142298|560147535|FG004|Overall Study|Virologic breakthrough|2|||
155193897|NCT00142298|560147536|FG005|Overall Study|Virologic breakthrough|3|||
155193898|NCT00142298|560147537|FG006|Overall Study|Virologic breakthrough|3|||
155193899|NCT00142298|560147538|FG007|Overall Study|Virologic breakthrough|0|||
155193900|NCT00142298|560147539|FG008|Overall Study|Virologic breakthrough|0|||
155193901|NCT00142298|560147540|FG009|Overall Study|Virologic breakthrough|0|||
155193902|NCT00142298|560147531|FG000|Overall Study|Other- not specified|0|||
155193903|NCT00142298|560147532|FG001|Overall Study|Other- not specified|3|||
155193904|NCT00142298|560147533|FG002|Overall Study|Other- not specified|0|||
155193905|NCT00142298|560147534|FG003|Overall Study|Other- not specified|1|||
155193906|NCT00142298|560147535|FG004|Overall Study|Other- not specified|0|||
155193907|NCT00142298|560147536|FG005|Overall Study|Other- not specified|0|||
155193908|NCT00142298|560147537|FG006|Overall Study|Other- not specified|0|||
155193909|NCT00142298|560147538|FG007|Overall Study|Other- not specified|0|||
155193910|NCT00142298|560147539|FG008|Overall Study|Other- not specified|0|||
155193911|NCT00142298|560147540|FG009|Overall Study|Other- not specified|0|||
155193912|NCT00142298|560147531|FG000|Overall Study|Lost to Follow-up|0|||
155193913|NCT00142298|560147532|FG001|Overall Study|Lost to Follow-up|0|||
155193914|NCT00142298|560147533|FG002|Overall Study|Lost to Follow-up|0|||
155193915|NCT00142298|560147534|FG003|Overall Study|Lost to Follow-up|0|||
155193916|NCT00142298|560147535|FG004|Overall Study|Lost to Follow-up|0|||
155193917|NCT00142298|560147536|FG005|Overall Study|Lost to Follow-up|0|||
155193918|NCT00142298|560147537|FG006|Overall Study|Lost to Follow-up|2|||
155193919|NCT00142298|560147538|FG007|Overall Study|Lost to Follow-up|0|||
155193920|NCT00142298|560147539|FG008|Overall Study|Lost to Follow-up|0|||
155193921|NCT00142298|560147540|FG009|Overall Study|Lost to Follow-up|0|||
155193922|NCT00142298|560147531|FG000|Overall Study|Treatment Failure|0|||
155193923|NCT00142298|560147532|FG001|Overall Study|Treatment Failure|0|||
155193924|NCT00142298|560147533|FG002|Overall Study|Treatment Failure|0|||
155193925|NCT00142298|560147534|FG003|Overall Study|Treatment Failure|0|||
155193926|NCT00142298|560147535|FG004|Overall Study|Treatment Failure|0|||
155193927|NCT00142298|560147536|FG005|Overall Study|Treatment Failure|2|||
155193928|NCT00142298|560147537|FG006|Overall Study|Treatment Failure|2|||
155193929|NCT00142298|560147538|FG007|Overall Study|Treatment Failure|0|||
155193930|NCT00142298|560147539|FG008|Overall Study|Treatment Failure|0|||
155193931|NCT00142298|560147540|FG009|Overall Study|Treatment Failure|0|||
155193932|NCT02423772|560147542|FG000|Overall Study|Lost to Follow-up|3|||
155193933|NCT02423772|560147543|FG001|Overall Study|Lost to Follow-up|3|||
155193934|NCT02423772|560147542|FG000|Overall Study|Did not begin intervention|2|||
155193935|NCT02423772|560147543|FG001|Overall Study|Did not begin intervention|5|||
155193936|NCT01386008|560147544|FG000|Overall Study|exited w/o incident /study discontinued|17|||
155193937|NCT01386008|560147544|FG000|Overall Study|Adverse Event|3|||
155193938|NCT04449861|560147545|FG000|Overall Study|Withdrawal by Subject|4|||
155193939|NCT04449861|560147545|FG000|Overall Study|Lost to Follow-up|5|||
155193940|NCT04449861|560147545|FG000|Overall Study|Death|112|||
155193941|NCT05268055|560147546|FG000|Overall Study|Lost to Follow-up|68|||
155193942|NCT05268055|560147547|FG001|Overall Study|Lost to Follow-up|68|||
155193943|NCT05268055|560147546|FG000|Overall Study|Withdrawal by Subject|12|||
155193944|NCT05268055|560147547|FG001|Overall Study|Withdrawal by Subject|8|||
155193945|NCT00531934|560149457|FG000|Overall Study|Adverse Event|4|||
155193946|NCT00531934|560149458|FG001|Overall Study|Adverse Event|8|||
155193947|NCT00531934|560149457|FG000|Overall Study|Progression|52|||
155193948|NCT00531934|560149458|FG001|Overall Study|Progression|42|||
155193949|NCT00531934|560149457|FG000|Overall Study|Death|7|||
155193950|NCT00531934|560149458|FG001|Overall Study|Death|10|||
155193951|NCT00531934|560149457|FG000|Overall Study|Withdrawal by Subject|1|||
155193952|NCT00531934|560149458|FG001|Overall Study|Withdrawal by Subject|1|||
155193953|NCT00531934|560149457|FG000|Overall Study|Other|2|||
155193954|NCT00531934|560149458|FG001|Overall Study|Other|2|||
155193955|NCT01816074|560149459|FG000|Phase 1|Time commitment issues|0|||
155193956|NCT01816074|560149460|FG001|Phase 1|Time commitment issues|0|||
155193957|NCT01816074|560149461|FG002|Phase 1|Time commitment issues|1|||
155193958|NCT01816074|560149462|FG003|Phase 1|Time commitment issues|0|||
155193959|NCT01816074|560149459|FG000|Phase 2|Time commitment Issues|0|||
155193960|NCT01816074|560149460|FG001|Phase 2|Time commitment Issues|2|||
155193961|NCT01816074|560149461|FG002|Phase 2|Time commitment Issues|0|||
155193962|NCT01816074|560149462|FG003|Phase 2|Time commitment Issues|0|||
155193963|NCT01816074|560149459|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
155193964|NCT01816074|560149460|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193965|NCT01816074|560149461|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193966|NCT01816074|560149462|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193967|NCT01816074|560149459|FG000|Phase 2|Physician Decision|0|||
155193968|NCT01816074|560149460|FG001|Phase 2|Physician Decision|0|||
155193969|NCT01816074|560149461|FG002|Phase 2|Physician Decision|0|||
155193970|NCT01816074|560149462|FG003|Phase 2|Physician Decision|1|||
155193971|NCT01816074|560149459|FG000|Phase 2|Withdrawal by Subject|1|||
155193972|NCT01816074|560149460|FG001|Phase 2|Withdrawal by Subject|0|||
155193973|NCT01816074|560149461|FG002|Phase 2|Withdrawal by Subject|0|||
155193974|NCT01816074|560149462|FG003|Phase 2|Withdrawal by Subject|0|||
155193975|NCT03355365|560149463|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
155193976|NCT03355365|560149464|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
155193977|NCT03355365|560149463|FG000|Year 1, First Intervention|Protocol Violation|1|||
155193978|NCT03355365|560149464|FG001|Year 1, First Intervention|Protocol Violation|0|||
155193979|NCT03355365|560149463|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
155193980|NCT03355365|560149464|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
155193981|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
155193982|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
155193983|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
155193984|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
155193985|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|severe COVID|0|||
155193986|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|severe COVID|1|||
155193987|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
155193988|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
155193989|NCT01303861|560149470|FG000|Overall Study|Lost to Follow-up|34|||
155193990|NCT01303861|560149471|FG001|Overall Study|Lost to Follow-up|14|||
155193991|NCT01303861|560149472|FG002|Overall Study|Lost to Follow-up|27|||
155193992|NCT01303861|560149473|FG003|Overall Study|Lost to Follow-up|31|||
155193993|NCT01303861|560149470|FG000|Overall Study|Lack of Efficacy|3|||
155193994|NCT01303861|560149471|FG001|Overall Study|Lack of Efficacy|2|||
155193995|NCT01303861|560149472|FG002|Overall Study|Lack of Efficacy|1|||
155193996|NCT01303861|560149473|FG003|Overall Study|Lack of Efficacy|0|||
155193997|NCT01303861|560149470|FG000|Overall Study|Withdrawal by Subject|16|||
155193998|NCT01303861|560149471|FG001|Overall Study|Withdrawal by Subject|8|||
155193999|NCT01303861|560149472|FG002|Overall Study|Withdrawal by Subject|8|||
155194000|NCT01303861|560149473|FG003|Overall Study|Withdrawal by Subject|23|||
155194001|NCT01303861|560149470|FG000|Overall Study|Adverse Event|4|||
155194002|NCT01303861|560149471|FG001|Overall Study|Adverse Event|1|||
155194003|NCT01303861|560149472|FG002|Overall Study|Adverse Event|0|||
155194004|NCT01303861|560149473|FG003|Overall Study|Adverse Event|5|||
155194005|NCT01303861|560149470|FG000|Overall Study|Pregnancy|1|||
155194006|NCT01303861|560149471|FG001|Overall Study|Pregnancy|0|||
155194007|NCT01303861|560149472|FG002|Overall Study|Pregnancy|0|||
155194008|NCT01303861|560149473|FG003|Overall Study|Pregnancy|0|||
155194009|NCT00676338|560149476|FG000|Overall Study|Adverse Event|6|||
155194010|NCT00676338|560149477|FG001|Overall Study|Adverse Event|6|||
155194011|NCT00676338|560149478|FG002|Overall Study|Adverse Event|5|||
155194012|NCT00676338|560149479|FG003|Overall Study|Adverse Event|1|||
155194013|NCT00676338|560149476|FG000|Overall Study|Lost to Follow-up|4|||
155194014|NCT00676338|560149477|FG001|Overall Study|Lost to Follow-up|1|||
155194015|NCT00676338|560149478|FG002|Overall Study|Lost to Follow-up|3|||
155194016|NCT00676338|560149479|FG003|Overall Study|Lost to Follow-up|4|||
155194017|NCT00676338|560149476|FG000|Overall Study|Physician Decision|3|||
155194018|NCT00676338|560149477|FG001|Overall Study|Physician Decision|3|||
155194019|NCT00676338|560149478|FG002|Overall Study|Physician Decision|2|||
155194020|NCT00676338|560149479|FG003|Overall Study|Physician Decision|3|||
155194021|NCT00676338|560149476|FG000|Overall Study|Protocol Violation|5|||
155194022|NCT00676338|560149477|FG001|Overall Study|Protocol Violation|9|||
155194023|NCT00676338|560149478|FG002|Overall Study|Protocol Violation|2|||
155194024|NCT00676338|560149479|FG003|Overall Study|Protocol Violation|5|||
155194025|NCT00676338|560149476|FG000|Overall Study|Withdrawal by Subject|17|||
155194026|NCT00676338|560149477|FG001|Overall Study|Withdrawal by Subject|9|||
155194027|NCT00676338|560149478|FG002|Overall Study|Withdrawal by Subject|12|||
155194028|NCT00676338|560149479|FG003|Overall Study|Withdrawal by Subject|6|||
155194029|NCT00676338|560149476|FG000|Overall Study|Entry Criteria Not Met|0|||
155194030|NCT00676338|560149477|FG001|Overall Study|Entry Criteria Not Met|2|||
155194031|NCT00676338|560149478|FG002|Overall Study|Entry Criteria Not Met|1|||
155194032|NCT00676338|560149479|FG003|Overall Study|Entry Criteria Not Met|1|||
155194033|NCT00676338|560149476|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194034|NCT00676338|560149477|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194035|NCT00676338|560149478|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
155194036|NCT00676338|560149479|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194037|NCT02122458|560149480|FG000|Overall Study|Withdrawal by Subject|0|||
155194038|NCT02122458|560149481|FG001|Overall Study|Withdrawal by Subject|0|||
155194039|NCT02122458|560149482|FG002|Overall Study|Withdrawal by Subject|0|||
155194040|NCT02122458|560149483|FG003|Overall Study|Withdrawal by Subject|4|||
155194041|NCT02122458|560149484|FG004|Overall Study|Withdrawal by Subject|4|||
155194042|NCT02122458|560149485|FG005|Overall Study|Withdrawal by Subject|4|||
155194043|NCT02122458|560149486|FG006|Overall Study|Withdrawal by Subject|0|||
155194044|NCT02122458|560149480|FG000|Overall Study|Lost to Follow-up|1|||
155194045|NCT02122458|560149481|FG001|Overall Study|Lost to Follow-up|3|||
155194046|NCT02122458|560149482|FG002|Overall Study|Lost to Follow-up|0|||
155194047|NCT02122458|560149483|FG003|Overall Study|Lost to Follow-up|7|||
155194048|NCT02122458|560149484|FG004|Overall Study|Lost to Follow-up|5|||
155194049|NCT02122458|560149485|FG005|Overall Study|Lost to Follow-up|15|||
155194050|NCT02122458|560149486|FG006|Overall Study|Lost to Follow-up|1|||
155194051|NCT02122458|560149480|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
155194052|NCT02122458|560149481|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194053|NCT02122458|560149482|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194054|NCT02122458|560149483|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194055|NCT02122458|560149484|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194056|NCT02122458|560149485|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194057|NCT02122458|560149486|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194058|NCT02122458|560149480|FG000|Overall Study|Adverse Event|1|||
155194059|NCT02122458|560149481|FG001|Overall Study|Adverse Event|0|||
155194060|NCT02122458|560149482|FG002|Overall Study|Adverse Event|0|||
155194061|NCT02122458|560149483|FG003|Overall Study|Adverse Event|0|||
155194062|NCT02122458|560149484|FG004|Overall Study|Adverse Event|0|||
155194063|NCT02122458|560149485|FG005|Overall Study|Adverse Event|0|||
155194064|NCT02122458|560149486|FG006|Overall Study|Adverse Event|0|||
155194065|NCT02122458|560149480|FG000|Overall Study|Experimental Error|0|||
155194066|NCT02122458|560149481|FG001|Overall Study|Experimental Error|0|||
155194067|NCT02122458|560149482|FG002|Overall Study|Experimental Error|0|||
155194068|NCT02122458|560149483|FG003|Overall Study|Experimental Error|0|||
155194069|NCT02122458|560149484|FG004|Overall Study|Experimental Error|3|||
155194070|NCT02122458|560149485|FG005|Overall Study|Experimental Error|0|||
155194071|NCT02122458|560149486|FG006|Overall Study|Experimental Error|0|||
155194072|NCT02122458|560149480|FG000|Overall Study|Deployed or Moved|0|||
155194073|NCT02122458|560149481|FG001|Overall Study|Deployed or Moved|0|||
155194074|NCT02122458|560149482|FG002|Overall Study|Deployed or Moved|0|||
155194075|NCT02122458|560149483|FG003|Overall Study|Deployed or Moved|0|||
155194076|NCT02122458|560149484|FG004|Overall Study|Deployed or Moved|1|||
155194077|NCT02122458|560149485|FG005|Overall Study|Deployed or Moved|0|||
155194078|NCT02122458|560149486|FG006|Overall Study|Deployed or Moved|0|||
155194079|NCT02122458|560149480|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194080|NCT02122458|560149481|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
155194081|NCT02122458|560149482|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194082|NCT02122458|560149483|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
155194083|NCT02122458|560149484|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
155194084|NCT02122458|560149485|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
155194085|NCT02122458|560149486|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194086|NCT02122458|560149480|FG000|Overall Study|Noncompliance|0|||
155194087|NCT02122458|560149481|FG001|Overall Study|Noncompliance|1|||
155194088|NCT02122458|560149482|FG002|Overall Study|Noncompliance|0|||
155194089|NCT02122458|560149483|FG003|Overall Study|Noncompliance|0|||
155194090|NCT02122458|560149484|FG004|Overall Study|Noncompliance|0|||
155194091|NCT02122458|560149485|FG005|Overall Study|Noncompliance|0|||
155194092|NCT02122458|560149486|FG006|Overall Study|Noncompliance|0|||
155194093|NCT00412542|560149487|FG000|Overall Study|Withdrawal by Subject|0|||
155194094|NCT00412542|560149488|FG001|Overall Study|Withdrawal by Subject|2|||
155194095|NCT00412542|560149487|FG000|Overall Study|Not Eligible|0|||
155194096|NCT00412542|560149488|FG001|Overall Study|Not Eligible|1|||
155194097|NCT02833350|560149489|FG000|Overall Study|Adverse Event|0|||
155194098|NCT02833350|560149490|FG001|Overall Study|Adverse Event|3|||
155194099|NCT02833350|560149491|FG002|Overall Study|Adverse Event|4|||
155194100|NCT02833350|560149492|FG003|Overall Study|Adverse Event|4|||
155194101|NCT02833350|560149493|FG004|Overall Study|Adverse Event|1|||
155194102|NCT02833350|560149494|FG005|Overall Study|Adverse Event|0|||
155194103|NCT02833350|560149495|FG006|Overall Study|Adverse Event|1|||
155194104|NCT02833350|560149489|FG000|Overall Study|Death|0|||
155194105|NCT02833350|560149490|FG001|Overall Study|Death|0|||
155194106|NCT02833350|560149491|FG002|Overall Study|Death|1|||
155194107|NCT02833350|560149492|FG003|Overall Study|Death|0|||
155194108|NCT02833350|560149493|FG004|Overall Study|Death|0|||
155194109|NCT02833350|560149494|FG005|Overall Study|Death|0|||
155194110|NCT02833350|560149495|FG006|Overall Study|Death|0|||
155194111|NCT02833350|560149489|FG000|Overall Study|Lack of Efficacy|0|||
155194112|NCT02833350|560149490|FG001|Overall Study|Lack of Efficacy|2|||
155194113|NCT02833350|560149491|FG002|Overall Study|Lack of Efficacy|1|||
155194114|NCT02833350|560149492|FG003|Overall Study|Lack of Efficacy|4|||
155194115|NCT02833350|560149493|FG004|Overall Study|Lack of Efficacy|0|||
155194116|NCT02833350|560149494|FG005|Overall Study|Lack of Efficacy|1|||
155194117|NCT02833350|560149495|FG006|Overall Study|Lack of Efficacy|1|||
155194118|NCT02833350|560149489|FG000|Overall Study|Lost to Follow-up|0|||
155194119|NCT02833350|560149490|FG001|Overall Study|Lost to Follow-up|1|||
155194120|NCT02833350|560149491|FG002|Overall Study|Lost to Follow-up|0|||
155194121|NCT02833350|560149492|FG003|Overall Study|Lost to Follow-up|0|||
155194122|NCT02833350|560149493|FG004|Overall Study|Lost to Follow-up|0|||
155194123|NCT02833350|560149494|FG005|Overall Study|Lost to Follow-up|0|||
155194124|NCT02833350|560149495|FG006|Overall Study|Lost to Follow-up|1|||
155194125|NCT02833350|560149489|FG000|Overall Study|Withdrawal by Subject|3|||
155194126|NCT02833350|560149490|FG001|Overall Study|Withdrawal by Subject|3|||
155194127|NCT02833350|560149491|FG002|Overall Study|Withdrawal by Subject|2|||
155194128|NCT02833350|560149492|FG003|Overall Study|Withdrawal by Subject|0|||
155194129|NCT02833350|560149493|FG004|Overall Study|Withdrawal by Subject|2|||
155194130|NCT02833350|560149494|FG005|Overall Study|Withdrawal by Subject|0|||
155194131|NCT02833350|560149495|FG006|Overall Study|Withdrawal by Subject|2|||
155194132|NCT01500031|560149496|FG000|Overall Study|Death|1|||
155194133|NCT01500031|560149496|FG000|Overall Study|Withdrawal by Subject|4|||
155194134|NCT01856907|560149499|FG000|Overall Study|Pregnancy|0|||
155194135|NCT01856907|560149500|FG001|Overall Study|Pregnancy|1|||
155194136|NCT01856907|560149501|FG002|Overall Study|Pregnancy|0|||
155194137|NCT01856907|560149499|FG000|Overall Study|Pregnancy|0|||
155194138|NCT01856907|560149500|FG001|Overall Study|Pregnancy|1|||
155194139|NCT01856907|560149501|FG002|Overall Study|Pregnancy|0|||
155194140|NCT01856907|560149499|FG000|Overall Study|Withdrawal by Subject|0|||
155194141|NCT01856907|560149500|FG001|Overall Study|Withdrawal by Subject|1|||
155194142|NCT01856907|560149501|FG002|Overall Study|Withdrawal by Subject|0|||
155194143|NCT00075218|560149502|FG000|Double-Blind Treatment|Adverse Event|23|||
155194144|NCT00075218|560149503|FG001|Double-Blind Treatment|Adverse Event|4|||
155194145|NCT00075218|560149504|FG002|Double-Blind Treatment|Adverse Event|0|||
155194146|NCT00075218|560149502|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
155194147|NCT00075218|560149503|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
155194148|NCT00075218|560149504|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
155194149|NCT00075218|560149502|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
155194150|NCT00075218|560149503|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
155194151|NCT00075218|560149504|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
155194152|NCT00075218|560149502|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
155194153|NCT00075218|560149503|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
155194154|NCT00075218|560149504|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
155194155|NCT00075218|560149502|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
155194156|NCT00075218|560149503|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
155194157|NCT00075218|560149504|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
155194158|NCT00075218|560149502|FG000|Double-Blind Treatment|No study medication taken|2|||
155194159|NCT00075218|560149503|FG001|Double-Blind Treatment|No study medication taken|0|||
155194160|NCT00075218|560149504|FG002|Double-Blind Treatment|No study medication taken|0|||
155194161|NCT00075218|560149502|FG000|Open-Label Treatment|Lack of Efficacy|0|||
155194162|NCT00075218|560149503|FG001|Open-Label Treatment|Lack of Efficacy|0|||
155194163|NCT00075218|560149504|FG002|Open-Label Treatment|Lack of Efficacy|174|||
155194164|NCT00075218|560149502|FG000|Open-Label Treatment|Adverse Event|0|||
155194165|NCT00075218|560149503|FG001|Open-Label Treatment|Adverse Event|0|||
155194166|NCT00075218|560149504|FG002|Open-Label Treatment|Adverse Event|51|||
155194167|NCT00075218|560149502|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
155194168|NCT00075218|560149503|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155194169|NCT00075218|560149504|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
155194170|NCT00075218|560149502|FG000|Open-Label Treatment|Decision of Sponsor|0|||
155194171|NCT00075218|560149503|FG001|Open-Label Treatment|Decision of Sponsor|0|||
155194172|NCT00075218|560149504|FG002|Open-Label Treatment|Decision of Sponsor|8|||
155194173|NCT00075218|560149502|FG000|Open-Label Treatment|Protocol Violation|0|||
155194174|NCT00075218|560149503|FG001|Open-Label Treatment|Protocol Violation|0|||
155194175|NCT00075218|560149504|FG002|Open-Label Treatment|Protocol Violation|1|||
155194176|NCT00075218|560149502|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
155194177|NCT00075218|560149503|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
155194178|NCT00075218|560149504|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
155194179|NCT03643575|560149505|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
155194180|NCT03643575|560149506|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
155194181|NCT03643575|560149507|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
155194182|NCT03643575|560149508|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
155194183|NCT03643575|560149509|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
155194184|NCT03643575|560149510|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
155194185|NCT03643575|560149505|FG000|Washout: 7 Days|Adverse Event|1|||
155194186|NCT03643575|560149506|FG001|Washout: 7 Days|Adverse Event|0|||
155194187|NCT03643575|560149507|FG002|Washout: 7 Days|Adverse Event|0|||
155194188|NCT03643575|560149508|FG003|Washout: 7 Days|Adverse Event|0|||
155194189|NCT03643575|560149509|FG004|Washout: 7 Days|Adverse Event|0|||
155194190|NCT03643575|560149510|FG005|Washout: 7 Days|Adverse Event|0|||
155194191|NCT03643575|560149505|FG000|Washout: 7 Days|Non compliance check in|0|||
155194192|NCT03643575|560149506|FG001|Washout: 7 Days|Non compliance check in|1|||
155194193|NCT03643575|560149507|FG002|Washout: 7 Days|Non compliance check in|0|||
155194194|NCT03643575|560149508|FG003|Washout: 7 Days|Non compliance check in|0|||
155194195|NCT03643575|560149509|FG004|Washout: 7 Days|Non compliance check in|0|||
155194196|NCT03643575|560149510|FG005|Washout: 7 Days|Non compliance check in|0|||
155194197|NCT00850070|560149511|FG000|Overall Study|Lack of Efficacy|1|||
155194198|NCT00850070|560149512|FG001|Overall Study|Lack of Efficacy|1|||
155194199|NCT00850070|560149511|FG000|Overall Study|Adverse Event|2|||
155194200|NCT00850070|560149512|FG001|Overall Study|Adverse Event|0|||
155194201|NCT01522248|560149513|FG000|Overall Study|Lost to Follow-up|1|||
155194202|NCT01522248|560149514|FG001|Overall Study|Lost to Follow-up|0|||
155194203|NCT01332331|560149515|FG000|Overall Study|Lost to Follow-up|0|||
155194204|NCT01332331|560149516|FG001|Overall Study|Lost to Follow-up|1|||
155194205|NCT01332331|560149515|FG000|Overall Study|Adverse Event|1|||
155194206|NCT01332331|560149516|FG001|Overall Study|Adverse Event|1|||
155194207|NCT01332331|560149515|FG000|Overall Study|Physician Decision|1|||
155194208|NCT01332331|560149516|FG001|Overall Study|Physician Decision|0|||
155194209|NCT01696695|560149517|FG000|Overall Study|Disease progression|373|||
155194210|NCT01696695|560149517|FG000|Overall Study|Death|29|||
155194211|NCT01696695|560149517|FG000|Overall Study|Adverse Event|74|||
155194212|NCT01696695|560149517|FG000|Overall Study|Withdrawal by Subject|92|||
155194213|NCT01696695|560149517|FG000|Overall Study|Lost to Follow-up|48|||
155194214|NCT01696695|560149517|FG000|Overall Study|Other|74|||
155194215|NCT01696695|560149517|FG000|Overall Study|Major Protocol Violation|192|||
155194216|NCT04515394|560149526|FG000|Overall Study|Participant did not receive treatment|1|||
155194217|NCT00199875|560149527|FG000|Overall Study|Withdrawal by Subject|0|||
155194218|NCT00199875|560149528|FG001|Overall Study|Withdrawal by Subject|0|||
155194219|NCT00199875|560149529|FG002|Overall Study|Withdrawal by Subject|0|||
155194220|NCT00199875|560149530|FG003|Overall Study|Withdrawal by Subject|0|||
155194221|NCT00199875|560149531|FG004|Overall Study|Withdrawal by Subject|1|||
155194222|NCT03469934|560149533|FG000|Overall Study|Withdrawal by Subject|0|||
155194223|NCT03469934|560149534|FG001|Overall Study|Withdrawal by Subject|1|||
155194224|NCT01013350|560149537|FG000|Overall Study|Lost to Follow-up|15|||
155194225|NCT01013350|560149538|FG001|Overall Study|Lost to Follow-up|95|||
155194226|NCT01013350|560149537|FG000|Overall Study|Adverse Event|0|||
155194227|NCT01013350|560149538|FG001|Overall Study|Adverse Event|1|||
155194228|NCT01013350|560149537|FG000|Overall Study|Physician Decision|4|||
155194229|NCT01013350|560149538|FG001|Overall Study|Physician Decision|20|||
155194230|NCT01013350|560149537|FG000|Overall Study|Withdrawal by Subject|15|||
155194231|NCT01013350|560149538|FG001|Overall Study|Withdrawal by Subject|38|||
155194232|NCT01013350|560149537|FG000|Overall Study|Death|3|||
155194233|NCT01013350|560149538|FG001|Overall Study|Death|5|||
155194234|NCT01013350|560149537|FG000|Overall Study|Participant entered interventional study|0|||
155194235|NCT01013350|560149538|FG001|Overall Study|Participant entered interventional study|8|||
155194236|NCT01013350|560149537|FG000|Overall Study|Other|1|||
155194237|NCT01013350|560149538|FG001|Overall Study|Other|25|||
155194238|NCT02913612|560149545|FG000|Overall Study|Lost to Follow-up|6|||
155194239|NCT02913612|560149546|FG001|Overall Study|Lost to Follow-up|5|||
155194240|NCT02913612|560149547|FG002|Overall Study|Lost to Follow-up|2|||
155194241|NCT02913612|560149548|FG003|Overall Study|Lost to Follow-up|0|||
155194242|NCT02913612|560149545|FG000|Overall Study|Physician Decision|1|||
155194243|NCT02913612|560149546|FG001|Overall Study|Physician Decision|4|||
155194244|NCT02913612|560149547|FG002|Overall Study|Physician Decision|1|||
155194245|NCT02913612|560149548|FG003|Overall Study|Physician Decision|0|||
155194246|NCT02913612|560149545|FG000|Overall Study|Withdrawal by Subject|2|||
155194247|NCT02913612|560149546|FG001|Overall Study|Withdrawal by Subject|4|||
155194248|NCT02913612|560149547|FG002|Overall Study|Withdrawal by Subject|0|||
155194249|NCT02913612|560149548|FG003|Overall Study|Withdrawal by Subject|0|||
155194250|NCT02913612|560149545|FG000|Overall Study|Hemangioma resolved|1|||
155194251|NCT02913612|560149546|FG001|Overall Study|Hemangioma resolved|0|||
155194252|NCT02913612|560149547|FG002|Overall Study|Hemangioma resolved|0|||
155194253|NCT02913612|560149548|FG003|Overall Study|Hemangioma resolved|0|||
155194254|NCT02913612|560149545|FG000|Overall Study|Local IRB decision|1|||
155194255|NCT02913612|560149546|FG001|Overall Study|Local IRB decision|0|||
155194256|NCT02913612|560149547|FG002|Overall Study|Local IRB decision|0|||
155194257|NCT02913612|560149548|FG003|Overall Study|Local IRB decision|0|||
155194258|NCT02913612|560149545|FG000|Overall Study|Study drug non-compliance|1|||
155194259|NCT02913612|560149546|FG001|Overall Study|Study drug non-compliance|1|||
155194260|NCT02913612|560149547|FG002|Overall Study|Study drug non-compliance|0|||
155194261|NCT02913612|560149548|FG003|Overall Study|Study drug non-compliance|0|||
155194262|NCT02913612|560149545|FG000|Overall Study|Insurance issues|0|||
155194263|NCT02913612|560149546|FG001|Overall Study|Insurance issues|1|||
155194264|NCT02913612|560149547|FG002|Overall Study|Insurance issues|0|||
155194265|NCT02913612|560149548|FG003|Overall Study|Insurance issues|0|||
155194266|NCT02913612|560149545|FG000|Overall Study|Needed to treat second hemangioma|0|||
155194267|NCT02913612|560149546|FG001|Overall Study|Needed to treat second hemangioma|1|||
155194268|NCT02913612|560149547|FG002|Overall Study|Needed to treat second hemangioma|0|||
155194269|NCT02913612|560149548|FG003|Overall Study|Needed to treat second hemangioma|0|||
155194270|NCT02913612|560149545|FG000|Overall Study|Study completion criteria not met|0|||
155194271|NCT02913612|560149546|FG001|Overall Study|Study completion criteria not met|1|||
155194272|NCT02913612|560149547|FG002|Overall Study|Study completion criteria not met|0|||
155194273|NCT02913612|560149548|FG003|Overall Study|Study completion criteria not met|0|||
155194274|NCT02913612|560149545|FG000|Overall Study|Ineligible|0|||
155194275|NCT02913612|560149546|FG001|Overall Study|Ineligible|1|||
155194276|NCT02913612|560149547|FG002|Overall Study|Ineligible|0|||
155194277|NCT02913612|560149548|FG003|Overall Study|Ineligible|0|||
155194278|NCT02507973|560149549|FG000|Overall Study|Adverse Event|1|||
155194279|NCT01927627|560149553|FG000|Overall Study|Adverse Event|3|||
155194280|NCT01927627|560149553|FG000|Overall Study|Lack of Efficacy|1|||
155194281|NCT01927627|560149553|FG000|Overall Study|Financial Concerns|1|||
155194282|NCT01710046|560149554|FG000|Overall Study|Lost to Follow-up|1|||
155194283|NCT01710046|560149555|FG001|Overall Study|Lost to Follow-up|0|||
155194284|NCT03386474|560149560|FG000|Overall Study|Death|1|||
155194285|NCT03386474|560149561|FG001|Overall Study|Death|0|||
155194286|NCT03386474|560149560|FG000|Overall Study|Adverse Event|0|||
155194287|NCT03386474|560149561|FG001|Overall Study|Adverse Event|1|||
155194288|NCT02711345|560149566|FG000|Overall Study|Adverse Event|0|||
155194289|NCT02711345|560149567|FG001|Overall Study|Adverse Event|0|||
155194290|NCT02711345|560149568|FG002|Overall Study|Adverse Event|0|||
155194291|NCT02711345|560149569|FG003|Overall Study|Adverse Event|1|||
155194292|NCT02711345|560149570|FG004|Overall Study|Adverse Event|1|||
155194293|NCT02711345|560149571|FG005|Overall Study|Adverse Event|2|||
155194294|NCT02711345|560149572|FG006|Overall Study|Adverse Event|1|||
155194295|NCT02711345|560149573|FG007|Overall Study|Adverse Event|0|||
155194296|NCT02711345|560149574|FG008|Overall Study|Adverse Event|0|||
155194297|NCT02711345|560149575|FG009|Overall Study|Adverse Event|2|||
155194298|NCT02711345|560149566|FG000|Overall Study|Physician Decision|0|||
155194299|NCT02711345|560149567|FG001|Overall Study|Physician Decision|0|||
155194300|NCT02711345|560149568|FG002|Overall Study|Physician Decision|1|||
155194301|NCT02711345|560149569|FG003|Overall Study|Physician Decision|0|||
155194302|NCT02711345|560149570|FG004|Overall Study|Physician Decision|0|||
155194303|NCT02711345|560149571|FG005|Overall Study|Physician Decision|0|||
155194304|NCT02711345|560149572|FG006|Overall Study|Physician Decision|0|||
155194305|NCT02711345|560149573|FG007|Overall Study|Physician Decision|0|||
155194306|NCT02711345|560149574|FG008|Overall Study|Physician Decision|1|||
155194307|NCT02711345|560149575|FG009|Overall Study|Physician Decision|0|||
155194308|NCT02711345|560149566|FG000|Overall Study|Progressive disease|1|||
155194309|NCT02711345|560149567|FG001|Overall Study|Progressive disease|3|||
155194310|NCT02711345|560149568|FG002|Overall Study|Progressive disease|5|||
155194311|NCT02711345|560149569|FG003|Overall Study|Progressive disease|3|||
155194312|NCT02711345|560149570|FG004|Overall Study|Progressive disease|7|||
155194313|NCT02711345|560149571|FG005|Overall Study|Progressive disease|2|||
155194314|NCT02711345|560149572|FG006|Overall Study|Progressive disease|8|||
155194315|NCT02711345|560149573|FG007|Overall Study|Progressive disease|4|||
155194316|NCT02711345|560149574|FG008|Overall Study|Progressive disease|5|||
155194317|NCT02711345|560149575|FG009|Overall Study|Progressive disease|6|||
155194318|NCT02711345|560149566|FG000|Overall Study|Subject/guardian decision|0|||
155194319|NCT02711345|560149567|FG001|Overall Study|Subject/guardian decision|0|||
155194320|NCT02711345|560149568|FG002|Overall Study|Subject/guardian decision|0|||
155194321|NCT02711345|560149569|FG003|Overall Study|Subject/guardian decision|0|||
155194322|NCT02711345|560149570|FG004|Overall Study|Subject/guardian decision|0|||
155194323|NCT02711345|560149571|FG005|Overall Study|Subject/guardian decision|2|||
155194324|NCT02711345|560149572|FG006|Overall Study|Subject/guardian decision|3|||
155194325|NCT02711345|560149573|FG007|Overall Study|Subject/guardian decision|1|||
155194326|NCT02711345|560149574|FG008|Overall Study|Subject/guardian decision|0|||
155194327|NCT02711345|560149575|FG009|Overall Study|Subject/guardian decision|4|||
155194328|NCT02711345|560149566|FG000|Overall Study|Death|1|||
155194329|NCT02711345|560149567|FG001|Overall Study|Death|0|||
155194330|NCT02711345|560149568|FG002|Overall Study|Death|0|||
155194331|NCT02711345|560149569|FG003|Overall Study|Death|0|||
155194332|NCT02711345|560149570|FG004|Overall Study|Death|0|||
155194333|NCT02711345|560149571|FG005|Overall Study|Death|0|||
155194334|NCT02711345|560149572|FG006|Overall Study|Death|0|||
155194335|NCT02711345|560149573|FG007|Overall Study|Death|1|||
155194336|NCT02711345|560149574|FG008|Overall Study|Death|0|||
155194337|NCT02711345|560149575|FG009|Overall Study|Death|0|||
155194338|NCT03780543|560149576|FG000|Overall Study|Adverse Event|1|||
155194339|NCT03780543|560149577|FG001|Overall Study|Adverse Event|0|||
155194340|NCT03780543|560149578|FG002|Overall Study|Adverse Event|2|||
155194341|NCT03780543|560149576|FG000|Overall Study|Lost to Follow-up|2|||
155194342|NCT03780543|560149577|FG001|Overall Study|Lost to Follow-up|0|||
155194343|NCT03780543|560149578|FG002|Overall Study|Lost to Follow-up|1|||
155194344|NCT03780543|560149576|FG000|Overall Study|Study terminated by Sponsor|8|||
155194345|NCT03780543|560149577|FG001|Overall Study|Study terminated by Sponsor|7|||
155194346|NCT03780543|560149578|FG002|Overall Study|Study terminated by Sponsor|13|||
155194347|NCT03780543|560149576|FG000|Overall Study|Withdrawal by Subject|1|||
155194348|NCT03780543|560149577|FG001|Overall Study|Withdrawal by Subject|8|||
155194349|NCT03780543|560149578|FG002|Overall Study|Withdrawal by Subject|1|||
155194350|NCT03780543|560149576|FG000|Overall Study|Noncompliance with study drug|1|||
155194351|NCT03780543|560149577|FG001|Overall Study|Noncompliance with study drug|0|||
155194352|NCT03780543|560149578|FG002|Overall Study|Noncompliance with study drug|0|||
155194353|NCT00338104|560149581|FG000|Overall Study|Protocol Violation|2|||
155194354|NCT00338104|560149582|FG001|Overall Study|Protocol Violation|1|||
155194355|NCT00338104|560149583|FG002|Overall Study|Protocol Violation|3|||
155194356|NCT02362269|560149584|FG000|Overall Study|Moved|1|||
155194357|NCT02362269|560149585|FG001|Overall Study|Moved|0|||
155194358|NCT02362269|560149584|FG000|Overall Study|Lost to Follow-up|0|||
155194359|NCT02362269|560149585|FG001|Overall Study|Lost to Follow-up|6|||
155194360|NCT01163266|560149586|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
155194361|NCT01163266|560149587|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
155194362|NCT01163266|560149588|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
155194363|NCT01163266|560149586|FG000|Overall Study|Lack of Efficacy|1|||
155194364|NCT01163266|560149587|FG001|Overall Study|Lack of Efficacy|3|||
155194365|NCT01163266|560149588|FG002|Overall Study|Lack of Efficacy|1|||
155194366|NCT01163266|560149586|FG000|Overall Study|Noncompliance with Study Drug|0|||
155194367|NCT01163266|560149587|FG001|Overall Study|Noncompliance with Study Drug|2|||
155194368|NCT01163266|560149588|FG002|Overall Study|Noncompliance with Study Drug|0|||
155194369|NCT01163266|560149586|FG000|Overall Study|Protocol Deviations|2|||
155194370|NCT01163266|560149587|FG001|Overall Study|Protocol Deviations|2|||
155194371|NCT01163266|560149588|FG002|Overall Study|Protocol Deviations|5|||
155194372|NCT01163266|560149586|FG000|Overall Study|Withdrawal of Consent|5|||
155194373|NCT01163266|560149587|FG001|Overall Study|Withdrawal of Consent|7|||
155194374|NCT01163266|560149588|FG002|Overall Study|Withdrawal of Consent|3|||
155194375|NCT01163266|560149586|FG000|Overall Study|Lost to Follow-up|7|||
155194376|NCT01163266|560149587|FG001|Overall Study|Lost to Follow-up|7|||
155194377|NCT01163266|560149588|FG002|Overall Study|Lost to Follow-up|10|||
155194378|NCT01163266|560149586|FG000|Overall Study|Other|1|||
155194379|NCT01163266|560149587|FG001|Overall Study|Other|1|||
155194380|NCT01163266|560149588|FG002|Overall Study|Other|2|||
155194381|NCT02586064|560149589|FG000|Overall Study|Other Obligations|6|||
155194382|NCT02586064|560149590|FG001|Overall Study|Other Obligations|6|||
155194383|NCT02586064|560149589|FG000|Overall Study|Other|3|||
155194384|NCT02586064|560149590|FG001|Overall Study|Other|7|||
155194385|NCT02586064|560149589|FG000|Overall Study|Never Started|3|||
155194386|NCT02586064|560149590|FG001|Overall Study|Never Started|3|||
155194387|NCT02586064|560149589|FG000|Overall Study|Lost Interest|1|||
155194388|NCT02586064|560149590|FG001|Overall Study|Lost Interest|4|||
155194389|NCT02586064|560149589|FG000|Overall Study|Miscellaneous Life Issues|0|||
155194390|NCT02586064|560149590|FG001|Overall Study|Miscellaneous Life Issues|5|||
155194391|NCT02586064|560149589|FG000|Overall Study|Infrequent Attendance|2|||
155194392|NCT02586064|560149590|FG001|Overall Study|Infrequent Attendance|1|||
155194393|NCT02586064|560149589|FG000|Overall Study|Timed Out|2|||
155194394|NCT02586064|560149590|FG001|Overall Study|Timed Out|0|||
155194395|NCT02586064|560149589|FG000|Overall Study|AUD relapse|0|||
155194396|NCT02586064|560149590|FG001|Overall Study|AUD relapse|2|||
155194397|NCT02586064|560149589|FG000|Overall Study|Legal Issue|1|||
155194398|NCT02586064|560149590|FG001|Overall Study|Legal Issue|0|||
155194399|NCT02919696|560149591|FG000|Overall Study|Adverse Event|1|||
155194400|NCT02919696|560149592|FG001|Overall Study|Adverse Event|2|||
155194401|NCT02919696|560149591|FG000|Overall Study|Withdrawal by Subject|2|||
155194402|NCT02919696|560149592|FG001|Overall Study|Withdrawal by Subject|1|||
155194403|NCT02919696|560149591|FG000|Overall Study|Sponsor Decision|1|||
155194404|NCT02919696|560149592|FG001|Overall Study|Sponsor Decision|1|||
155194405|NCT02919696|560149591|FG000|Overall Study|Never Treated|0|||
155194406|NCT02919696|560149592|FG001|Overall Study|Never Treated|1|||
155194407|NCT00397215|560149593|FG000|Month 0 (Day 0)|Adverse Event|0|||
155194408|NCT00397215|560149594|FG001|Month 0 (Day 0)|Adverse Event|1|||
155194409|NCT00397215|560149595|FG002|Month 0 (Day 0)|Adverse Event|0|||
155194410|NCT00397215|560149596|FG003|Month 0 (Day 0)|Adverse Event|0|||
155194411|NCT00397215|560149593|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194412|NCT00397215|560149594|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194413|NCT00397215|560149595|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194414|NCT00397215|560149596|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
155194415|NCT00397215|560149593|FG000|Month 0 (Day 0)|Other|4|||
155194416|NCT00397215|560149594|FG001|Month 0 (Day 0)|Other|1|||
155194417|NCT00397215|560149595|FG002|Month 0 (Day 0)|Other|3|||
155194418|NCT00397215|560149596|FG003|Month 0 (Day 0)|Other|3|||
155194419|NCT00397215|560149593|FG000|Month 6 (Day 180)|Adverse Event|0|||
155194420|NCT00397215|560149594|FG001|Month 6 (Day 180)|Adverse Event|3|||
155194421|NCT00397215|560149595|FG002|Month 6 (Day 180)|Adverse Event|2|||
155194422|NCT00397215|560149596|FG003|Month 6 (Day 180)|Adverse Event|0|||
155194423|NCT00397215|560149593|FG000|Month 6 (Day 180)|Other|2|||
155194424|NCT00397215|560149594|FG001|Month 6 (Day 180)|Other|0|||
155194425|NCT00397215|560149595|FG002|Month 6 (Day 180)|Other|3|||
155194426|NCT00397215|560149596|FG003|Month 6 (Day 180)|Other|0|||
155194427|NCT00484094|560149597|FG000|Overall Study|Discontinued|39|||
155194428|NCT00484094|560149597|FG000|Overall Study|Other|3|||
155194429|NCT04032652|560149598|FG000|Overall Study|The study was terminated and the PI has|1|||
155194430|NCT04032652|560149599|FG001|Overall Study|The study was terminated and the PI has|1|||
155194431|NCT00761631|560149601|FG000|Overall Study|Parent/legal guardian request|8|||
155194432|NCT00761631|560149602|FG001|Overall Study|Parent/legal guardian request|3|||
155194433|NCT00761631|560149603|FG002|Overall Study|Parent/legal guardian request|8|||
155194434|NCT00761631|560149604|FG003|Overall Study|Parent/legal guardian request|0|||
155194435|NCT00761631|560149605|FG004|Overall Study|Parent/legal guardian request|5|||
155194436|NCT00761631|560149606|FG005|Overall Study|Parent/legal guardian request|0|||
155194437|NCT00761631|560149601|FG000|Overall Study|Lost to Follow-up|2|||
155194438|NCT00761631|560149602|FG001|Overall Study|Lost to Follow-up|4|||
155194439|NCT00761631|560149603|FG002|Overall Study|Lost to Follow-up|7|||
155194440|NCT00761631|560149604|FG003|Overall Study|Lost to Follow-up|1|||
155194441|NCT00761631|560149605|FG004|Overall Study|Lost to Follow-up|6|||
155194442|NCT00761631|560149606|FG005|Overall Study|Lost to Follow-up|1|||
155194443|NCT00761631|560149601|FG000|Overall Study|Protocol Violation|2|||
155194444|NCT00761631|560149602|FG001|Overall Study|Protocol Violation|0|||
155194445|NCT00761631|560149603|FG002|Overall Study|Protocol Violation|0|||
155194446|NCT00761631|560149604|FG003|Overall Study|Protocol Violation|1|||
155194447|NCT00761631|560149605|FG004|Overall Study|Protocol Violation|5|||
155194448|NCT00761631|560149606|FG005|Overall Study|Protocol Violation|1|||
155194449|NCT00761631|560149601|FG000|Overall Study|Randomized, not treated|1|||
155194450|NCT00761631|560149602|FG001|Overall Study|Randomized, not treated|0|||
155194451|NCT00761631|560149603|FG002|Overall Study|Randomized, not treated|0|||
155194452|NCT00761631|560149604|FG003|Overall Study|Randomized, not treated|0|||
155194453|NCT00761631|560149605|FG004|Overall Study|Randomized, not treated|0|||
155194454|NCT00761631|560149606|FG005|Overall Study|Randomized, not treated|0|||
155194455|NCT00761631|560149601|FG000|Overall Study|Failed to return|1|||
155194456|NCT00761631|560149602|FG001|Overall Study|Failed to return|0|||
155194457|NCT00761631|560149603|FG002|Overall Study|Failed to return|1|||
155194458|NCT00761631|560149604|FG003|Overall Study|Failed to return|1|||
155194459|NCT00761631|560149605|FG004|Overall Study|Failed to return|5|||
155194460|NCT00761631|560149606|FG005|Overall Study|Failed to return|2|||
155194461|NCT00761631|560149601|FG000|Overall Study|Physician Decision|1|||
155194462|NCT00761631|560149602|FG001|Overall Study|Physician Decision|0|||
155194463|NCT00761631|560149603|FG002|Overall Study|Physician Decision|0|||
155194464|NCT00761631|560149604|FG003|Overall Study|Physician Decision|0|||
155194465|NCT00761631|560149605|FG004|Overall Study|Physician Decision|0|||
155194466|NCT00761631|560149606|FG005|Overall Study|Physician Decision|0|||
155194467|NCT00761631|560149601|FG000|Overall Study|Other|0|||
155194468|NCT00761631|560149602|FG001|Overall Study|Other|0|||
155194469|NCT00761631|560149603|FG002|Overall Study|Other|0|||
155194470|NCT00761631|560149604|FG003|Overall Study|Other|0|||
155194471|NCT00761631|560149605|FG004|Overall Study|Other|1|||
155194472|NCT00761631|560149606|FG005|Overall Study|Other|1|||
155194473|NCT01999868|560149607|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
155194474|NCT01999868|560149608|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
155194475|NCT01999868|560149609|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
155194476|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
155194477|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
155194478|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
155194479|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
155194480|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
155194481|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
155194482|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
155194483|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
155194484|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
155194485|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
155194486|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
155194487|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
155194488|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
155194489|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
155194490|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
155194491|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
155194492|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
155194493|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
155194494|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
155194495|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
155194496|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
155194497|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
155194498|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
155194499|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
155194500|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
155194501|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
155194502|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
155194503|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
155194504|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
155194505|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
155194506|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
155194507|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
155194508|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
155194509|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
155194510|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
155194511|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
155194512|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
155194513|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
155194514|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
155194515|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
155194516|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
155194517|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
155194518|NCT00289016|560149614|FG000|Overall Study|Disease Progression|29|||
155194519|NCT00289016|560149614|FG000|Overall Study|Death|2|||
155194520|NCT00289016|560149614|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
155194521|NCT00289016|560149614|FG000|Overall Study|Withdrawal by Subject|2|||
155194522|NCT00289016|560149614|FG000|Overall Study|Adverse Event|1|||
155194523|NCT00289016|560149614|FG000|Overall Study|Other|1|||
155194524|NCT00319501|560149615|FG000|Double-blind Period|Withdrawal by Subject|0|||
155194525|NCT00319501|560149616|FG001|Double-blind Period|Withdrawal by Subject|3|||
155194526|NCT00319501|560149615|FG000|Double-blind Period|Sponsor Request|1|||
155194527|NCT00319501|560149616|FG001|Double-blind Period|Sponsor Request|0|||
155194528|NCT00319501|560149615|FG000|Double-blind Period|Did not receive treatment|42|||
155194529|NCT00319501|560149616|FG001|Double-blind Period|Did not receive treatment|29|||
155194530|NCT00319501|560149615|FG000|Open-label Period|Adverse Event|5|||
155194531|NCT00319501|560149616|FG001|Open-label Period|Adverse Event|0|||
155194532|NCT00319501|560149615|FG000|Open-label Period|Protocol Violation|6|||
155194533|NCT00319501|560149616|FG001|Open-label Period|Protocol Violation|0|||
155194534|NCT00319501|560149615|FG000|Open-label Period|Withdrawal by Subject|38|||
155194535|NCT00319501|560149616|FG001|Open-label Period|Withdrawal by Subject|0|||
155194536|NCT00319501|560149615|FG000|Open-label Period|Principal Investigator decision|6|||
155194537|NCT00319501|560149616|FG001|Open-label Period|Principal Investigator decision|0|||
155194538|NCT00319501|560149615|FG000|Open-label Period|Sponsor request|12|||
155194539|NCT00319501|560149616|FG001|Open-label Period|Sponsor request|0|||
155194540|NCT00319501|560149615|FG000|Open-label Period|Lost to Follow-up|5|||
155194541|NCT00319501|560149616|FG001|Open-label Period|Lost to Follow-up|0|||
155194542|NCT00319501|560149615|FG000|Open-label Period|Did not receive treatment|33|||
155194543|NCT00319501|560149616|FG001|Open-label Period|Did not receive treatment|0|||
155194544|NCT00319501|560149615|FG000|Open-label Period|Other|11|||
155194545|NCT00319501|560149616|FG001|Open-label Period|Other|0|||
155194546|NCT00319501|560149615|FG000|Open-label Extension Period|Adverse Event|2|||
155194547|NCT00319501|560149616|FG001|Open-label Extension Period|Adverse Event|0|||
155194548|NCT00319501|560149615|FG000|Open-label Extension Period|Did not receive treatment|18|||
155194549|NCT00319501|560149616|FG001|Open-label Extension Period|Did not receive treatment|0|||
155194550|NCT00319501|560149615|FG000|Open-label Extension Period|Other|1|||
155194551|NCT00319501|560149616|FG001|Open-label Extension Period|Other|0|||
155194552|NCT00319501|560149615|FG000|Open-label Extension Period|Principal investigator decision|2|||
155194553|NCT00319501|560149616|FG001|Open-label Extension Period|Principal investigator decision|0|||
155194554|NCT00319501|560149615|FG000|Open-label Extension Period|Sponsor request|26|||
155194555|NCT00319501|560149616|FG001|Open-label Extension Period|Sponsor request|0|||
155194556|NCT00319501|560149615|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
155194557|NCT00319501|560149616|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155194558|NCT02612129|560149617|FG000|Single Dose Treatment Period|Screening Failure|1|||
155194559|NCT02612129|560149618|FG001|Single Dose Treatment Period|Screening Failure|0|||
155194560|NCT02612129|560149619|FG002|Single Dose Treatment Period|Screening Failure|0|||
155194561|NCT02612129|560149617|FG000|Continuous Treatment Period|Early Escape|0|||
155194562|NCT02612129|560149618|FG001|Continuous Treatment Period|Early Escape|2|||
155194563|NCT02612129|560149619|FG002|Continuous Treatment Period|Early Escape|0|||
155194564|NCT02612129|560149617|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
155194565|NCT02612129|560149618|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
155194566|NCT02612129|560149619|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
155194567|NCT02612129|560149617|FG000|Continuous Treatment Period|Safety Reasons|0|||
155194568|NCT02612129|560149618|FG001|Continuous Treatment Period|Safety Reasons|3|||
155194569|NCT02612129|560149619|FG002|Continuous Treatment Period|Safety Reasons|0|||
155194570|NCT02612129|560149617|FG000|Continuous Treatment Period|Death|0|||
155194571|NCT02612129|560149618|FG001|Continuous Treatment Period|Death|1|||
155194572|NCT02612129|560149619|FG002|Continuous Treatment Period|Death|0|||
155194573|NCT02612129|560149617|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
155194574|NCT02612129|560149618|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
155194575|NCT02612129|560149619|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
155194576|NCT02557295|560149620|FG000|Overall Study|Withdrawal by Subject|9|||
155194577|NCT02557295|560149621|FG001|Overall Study|Withdrawal by Subject|2|||
155194578|NCT02557295|560149622|FG002|Overall Study|Withdrawal by Subject|4|||
155194579|NCT02557295|560149623|FG003|Overall Study|Withdrawal by Subject|0|||
155194580|NCT02557295|560149624|FG004|Overall Study|Withdrawal by Subject|0|||
155194581|NCT02557295|560149625|FG005|Overall Study|Withdrawal by Subject|0|||
155194582|NCT02557295|560149626|FG006|Overall Study|Withdrawal by Subject|15|||
155194583|NCT02557295|560149627|FG007|Overall Study|Withdrawal by Subject|1|||
155194584|NCT02557295|560149628|FG008|Overall Study|Withdrawal by Subject|3|||
155194585|NCT02557295|560149620|FG000|Overall Study|Disease Progression|0|||
155194586|NCT02557295|560149621|FG001|Overall Study|Disease Progression|0|||
155194587|NCT02557295|560149622|FG002|Overall Study|Disease Progression|0|||
155194588|NCT02557295|560149623|FG003|Overall Study|Disease Progression|0|||
155194589|NCT02557295|560149624|FG004|Overall Study|Disease Progression|0|||
155194590|NCT02557295|560149625|FG005|Overall Study|Disease Progression|0|||
155194591|NCT02557295|560149626|FG006|Overall Study|Disease Progression|1|||
155194592|NCT02557295|560149627|FG007|Overall Study|Disease Progression|0|||
155194593|NCT02557295|560149628|FG008|Overall Study|Disease Progression|0|||
155194594|NCT02557295|560149620|FG000|Overall Study|Lack of Efficacy|24|||
155194595|NCT02557295|560149621|FG001|Overall Study|Lack of Efficacy|1|||
155194596|NCT02557295|560149622|FG002|Overall Study|Lack of Efficacy|3|||
155194597|NCT02557295|560149623|FG003|Overall Study|Lack of Efficacy|0|||
155194598|NCT02557295|560149624|FG004|Overall Study|Lack of Efficacy|0|||
155194599|NCT02557295|560149625|FG005|Overall Study|Lack of Efficacy|0|||
155194600|NCT02557295|560149626|FG006|Overall Study|Lack of Efficacy|12|||
155194601|NCT02557295|560149627|FG007|Overall Study|Lack of Efficacy|1|||
155194602|NCT02557295|560149628|FG008|Overall Study|Lack of Efficacy|0|||
155194603|NCT02557295|560149620|FG000|Overall Study|Adverse Event|16|||
155194604|NCT02557295|560149621|FG001|Overall Study|Adverse Event|2|||
155194605|NCT02557295|560149622|FG002|Overall Study|Adverse Event|3|||
155194606|NCT02557295|560149623|FG003|Overall Study|Adverse Event|0|||
155194607|NCT02557295|560149624|FG004|Overall Study|Adverse Event|0|||
155194608|NCT02557295|560149625|FG005|Overall Study|Adverse Event|0|||
155194609|NCT02557295|560149626|FG006|Overall Study|Adverse Event|2|||
155194610|NCT02557295|560149627|FG007|Overall Study|Adverse Event|1|||
155194611|NCT02557295|560149628|FG008|Overall Study|Adverse Event|1|||
155194612|NCT02557295|560149620|FG000|Overall Study|Lost to Follow-up|4|||
155194613|NCT02557295|560149621|FG001|Overall Study|Lost to Follow-up|0|||
155194614|NCT02557295|560149622|FG002|Overall Study|Lost to Follow-up|0|||
155194615|NCT02557295|560149623|FG003|Overall Study|Lost to Follow-up|0|||
155194616|NCT02557295|560149624|FG004|Overall Study|Lost to Follow-up|0|||
155194617|NCT02557295|560149625|FG005|Overall Study|Lost to Follow-up|0|||
155194618|NCT02557295|560149626|FG006|Overall Study|Lost to Follow-up|9|||
155194619|NCT02557295|560149627|FG007|Overall Study|Lost to Follow-up|0|||
155194620|NCT02557295|560149628|FG008|Overall Study|Lost to Follow-up|0|||
155194621|NCT02557295|560149620|FG000|Overall Study|Study Close|54|||
155194622|NCT02557295|560149621|FG001|Overall Study|Study Close|3|||
155194623|NCT02557295|560149622|FG002|Overall Study|Study Close|5|||
155194624|NCT02557295|560149623|FG003|Overall Study|Study Close|3|||
155194625|NCT02557295|560149624|FG004|Overall Study|Study Close|0|||
155194626|NCT02557295|560149625|FG005|Overall Study|Study Close|0|||
155194627|NCT02557295|560149626|FG006|Overall Study|Study Close|37|||
155194628|NCT02557295|560149627|FG007|Overall Study|Study Close|3|||
155194629|NCT02557295|560149628|FG008|Overall Study|Study Close|19|||
155194630|NCT02557295|560149620|FG000|Overall Study|except for study close|4|||
155194631|NCT02557295|560149621|FG001|Overall Study|except for study close|0|||
155194632|NCT02557295|560149622|FG002|Overall Study|except for study close|0|||
155194633|NCT02557295|560149623|FG003|Overall Study|except for study close|0|||
155194634|NCT02557295|560149624|FG004|Overall Study|except for study close|0|||
155194635|NCT02557295|560149625|FG005|Overall Study|except for study close|0|||
155194636|NCT02557295|560149626|FG006|Overall Study|except for study close|5|||
155194637|NCT02557295|560149627|FG007|Overall Study|except for study close|1|||
155194638|NCT02557295|560149628|FG008|Overall Study|except for study close|0|||
155194639|NCT01066000|560149629|FG000|Overall Study|Protocol Violation|4|||
155194640|NCT01066000|560149629|FG000|Overall Study|Death|3|||
155194641|NCT01066000|560149629|FG000|Overall Study|Withdrawal by Subject|1|||
155194642|NCT01066000|560149629|FG000|Overall Study|Adverse Event|1|||
155194643|NCT01067976|560149630|FG000|Overall Study|Study drug never administered|20|||
155194644|NCT01067976|560149630|FG000|Overall Study|Study prematurely discontinued|2|||
155194645|NCT00566111|560149631|FG000|Overall Study|Adverse Event|0|||
155194646|NCT00566111|560149632|FG001|Overall Study|Adverse Event|2|||
155194647|NCT00976677|560149633|FG000|Overall Study|Adverse Event|1|||
155194648|NCT00976677|560149634|FG001|Overall Study|Adverse Event|0|||
155194649|NCT00976677|560149633|FG000|Overall Study|Withdrawal by Subject|0|||
155194650|NCT00976677|560149634|FG001|Overall Study|Withdrawal by Subject|2|||
155194651|NCT00976677|560149633|FG000|Overall Study|Disease progression|1|||
155194652|NCT00976677|560149634|FG001|Overall Study|Disease progression|1|||
155194653|NCT00976677|560149633|FG000|Overall Study|Trial unblinded|2|||
155194654|NCT00976677|560149634|FG001|Overall Study|Trial unblinded|2|||
155194655|NCT00976677|560149633|FG000|Overall Study|Unknown/Missing|1|||
155194656|NCT00976677|560149634|FG001|Overall Study|Unknown/Missing|0|||
155194657|NCT04092582|560151166|FG000|Overall Study|Death|1|||
155194658|NCT04092582|560151167|FG001|Overall Study|Death|1|||
155194659|NCT04092582|560151166|FG000|Overall Study|Withdrawal by Subject|4|||
155194660|NCT04092582|560151167|FG001|Overall Study|Withdrawal by Subject|1|||
155194661|NCT04092582|560151166|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
155194662|NCT04092582|560151167|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
155194663|NCT01313858|560151170|FG000|Overall Study|Premature Treatment Termination|251|||
155194664|NCT01313858|560151171|FG001|Overall Study|Premature Treatment Termination|219|||
155194665|NCT01313858|560151172|FG002|Overall Study|Premature Treatment Termination|191|||
155194666|NCT01313858|560151170|FG000|Overall Study|Lost to Follow-up|35|||
155194667|NCT01313858|560151171|FG001|Overall Study|Lost to Follow-up|51|||
155194668|NCT01313858|560151172|FG002|Overall Study|Lost to Follow-up|47|||
155194669|NCT03689530|560151174|FG000|Overall Study|Withdrawal by Subject|53|||
155194670|NCT03689530|560151175|FG001|Overall Study|Withdrawal by Subject|16|||
155194671|NCT01392443|560151176|FG000|Overall Study|Disease progression|30|||
155194672|NCT01392443|560151176|FG000|Overall Study|Adverse Event|24|||
155194673|NCT01392443|560151176|FG000|Overall Study|Death|7|||
155194674|NCT01392443|560151176|FG000|Overall Study|Withdrawal by Subject|5|||
155194675|NCT01392443|560151176|FG000|Overall Study|Lost to Follow-up|1|||
155194676|NCT01392443|560151176|FG000|Overall Study|Protocol Violation|1|||
155194677|NCT01977794|560151177|FG000|Overall Study|Adverse Event|2|||
155194678|NCT01977794|560151178|FG001|Overall Study|Adverse Event|2|||
155194679|NCT01977794|560151177|FG000|Overall Study|Lost to Follow-up|2|||
155194680|NCT01977794|560151178|FG001|Overall Study|Lost to Follow-up|1|||
155194681|NCT01977794|560151177|FG000|Overall Study|Protocol Violation|1|||
155194682|NCT01977794|560151178|FG001|Overall Study|Protocol Violation|0|||
155194683|NCT01977794|560151177|FG000|Overall Study|Death|1|||
155194684|NCT01977794|560151178|FG001|Overall Study|Death|1|||
155194685|NCT01977794|560151177|FG000|Overall Study|Withdrew consent|2|||
155194686|NCT01977794|560151178|FG001|Overall Study|Withdrew consent|1|||
155194687|NCT01977794|560151177|FG000|Overall Study|Other|0|||
155194688|NCT01977794|560151178|FG001|Overall Study|Other|1|||
155194689|NCT00491075|560151181|FG000|Overall Study|Withdrawal by Subject|1|||
155194690|NCT00491075|560151181|FG000|Overall Study|Physician Decision|1|||
155194691|NCT01603355|560151182|FG000|Overall Study|Lack of Efficacy|2|||
155194692|NCT00246753|560151185|FG000|Overall Study|Withdrawal by Subject|2|||
155194693|NCT00246753|560151185|FG000|Overall Study|Physician Decision|2|||
155194694|NCT00246753|560151185|FG000|Overall Study|Adverse Event|2|||
155194695|NCT00246753|560151185|FG000|Overall Study|Unacceptable toxicity|2|||
155194696|NCT01868503|560151197|FG000|Overall Study|Withdrawal by Subject|1|||
155194697|NCT01868503|560151197|FG000|Overall Study|Protocol Violation|1|||
155194698|NCT03917459|560151200|FG000|Overall Study|Adverse Event|1|||
155194699|NCT03917459|560151201|FG001|Overall Study|Adverse Event|0|||
155194700|NCT03917459|560151200|FG000|Overall Study|Withdrawal by Subject|0|||
155194701|NCT03917459|560151201|FG001|Overall Study|Withdrawal by Subject|1|||
155194702|NCT00131508|560151204|FG000|Overall Study|Disease progression|0|||
155194703|NCT00131508|560151205|FG001|Overall Study|Disease progression|2|||
155194704|NCT00131508|560151204|FG000|Overall Study|Non-Compliance|2|||
155194705|NCT00131508|560151205|FG001|Overall Study|Non-Compliance|4|||
155194706|NCT00131508|560151204|FG000|Overall Study|Withdrawal by Subject|1|||
155194707|NCT00131508|560151205|FG001|Overall Study|Withdrawal by Subject|2|||
155194708|NCT01691898|560151216|FG000|Overall Study|Death|34|||
155194709|NCT01691898|560151217|FG001|Overall Study|Death|32|||
155194710|NCT01691898|560151218|FG002|Overall Study|Death|6|||
155194711|NCT01691898|560151219|FG003|Overall Study|Death|3|||
155194712|NCT01691898|560151220|FG004|Overall Study|Death|8|||
155194713|NCT01691898|560151221|FG005|Overall Study|Death|31|||
155194714|NCT01691898|560151216|FG000|Overall Study|Adverse Event|0|||
155194715|NCT01691898|560151217|FG001|Overall Study|Adverse Event|1|||
155194716|NCT01691898|560151218|FG002|Overall Study|Adverse Event|0|||
155194717|NCT01691898|560151219|FG003|Overall Study|Adverse Event|1|||
155194718|NCT01691898|560151220|FG004|Overall Study|Adverse Event|1|||
155194719|NCT01691898|560151221|FG005|Overall Study|Adverse Event|0|||
155194720|NCT01691898|560151216|FG000|Overall Study|Progression of Disease|1|||
155194721|NCT01691898|560151217|FG001|Overall Study|Progression of Disease|2|||
155194722|NCT01691898|560151218|FG002|Overall Study|Progression of Disease|1|||
155194723|NCT01691898|560151219|FG003|Overall Study|Progression of Disease|0|||
155194724|NCT01691898|560151220|FG004|Overall Study|Progression of Disease|0|||
155194725|NCT01691898|560151221|FG005|Overall Study|Progression of Disease|1|||
155194726|NCT01691898|560151216|FG000|Overall Study|Lost to Follow-up|3|||
155194727|NCT01691898|560151217|FG001|Overall Study|Lost to Follow-up|1|||
155194728|NCT01691898|560151218|FG002|Overall Study|Lost to Follow-up|0|||
155194729|NCT01691898|560151219|FG003|Overall Study|Lost to Follow-up|0|||
155194730|NCT01691898|560151220|FG004|Overall Study|Lost to Follow-up|1|||
155194731|NCT01691898|560151221|FG005|Overall Study|Lost to Follow-up|0|||
155194732|NCT01691898|560151216|FG000|Overall Study|Withdrawal by Subject|9|||
155194733|NCT01691898|560151217|FG001|Overall Study|Withdrawal by Subject|8|||
155194734|NCT01691898|560151218|FG002|Overall Study|Withdrawal by Subject|2|||
155194735|NCT01691898|560151219|FG003|Overall Study|Withdrawal by Subject|1|||
155194736|NCT01691898|560151220|FG004|Overall Study|Withdrawal by Subject|3|||
155194737|NCT01691898|560151221|FG005|Overall Study|Withdrawal by Subject|3|||
155194738|NCT01691898|560151216|FG000|Overall Study|Non-Compliance|0|||
155194739|NCT01691898|560151217|FG001|Overall Study|Non-Compliance|0|||
155194740|NCT01691898|560151218|FG002|Overall Study|Non-Compliance|0|||
155194741|NCT01691898|560151219|FG003|Overall Study|Non-Compliance|0|||
155194742|NCT01691898|560151220|FG004|Overall Study|Non-Compliance|1|||
155194743|NCT01691898|560151221|FG005|Overall Study|Non-Compliance|0|||
155194744|NCT02019277|560151222|FG000|Overall Study|Withdrawal by Subject|3|||
155194745|NCT02019277|560151222|FG000|Overall Study|Death|7|||
155194746|NCT02019277|560151222|FG000|Overall Study|Did no Cooperate|1|||
155194747|NCT02019277|560151222|FG000|Overall Study|Adverse Event|1|||
155194748|NCT04738734|560151223|FG000|Overall Study|Withdrawal by Subject|2|||
155194749|NCT04738734|560151224|FG001|Overall Study|Withdrawal by Subject|4|||
155194750|NCT04738734|560151223|FG000|Overall Study|Lost to Follow-up|5|||
155194751|NCT04738734|560151224|FG001|Overall Study|Lost to Follow-up|2|||
155194752|NCT04738734|560151223|FG000|Overall Study|Physician Decision|0|||
155194753|NCT04738734|560151224|FG001|Overall Study|Physician Decision|1|||
155194754|NCT04738734|560151223|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
155194755|NCT04738734|560151224|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
155194756|NCT04093414|560151225|FG000|3 Month Follow up|Physician Decision|0|||
155194757|NCT04093414|560151226|FG001|3 Month Follow up|Physician Decision|1|||
155194758|NCT04093414|560151225|FG000|6month Follow up|Physician Decision|1|||
155194759|NCT04093414|560151226|FG001|6month Follow up|Physician Decision|3|||
155194760|NCT04889222|560151227|FG000|Overall Study|Did not meet eligibility criteria|8|||
155194761|NCT04889222|560151227|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
155194762|NCT04889222|560151227|FG000|Overall Study|Did not proceed due to time constraints|5|||
155194763|NCT02639546|560151228|FG000|Overall Study|Death|2|||
155194764|NCT02639546|560151229|FG001|Overall Study|Death|2|||
155194765|NCT02639546|560151230|FG002|Overall Study|Death|1|||
155194766|NCT02639546|560151231|FG003|Overall Study|Death|2|||
155194767|NCT02639546|560151232|FG004|Overall Study|Death|2|||
155194768|NCT02639546|560151233|FG005|Overall Study|Death|2|||
155194769|NCT02639546|560151234|FG006|Overall Study|Death|0|||
155194770|NCT02639546|560151235|FG007|Overall Study|Death|0|||
155194771|NCT02639546|560151228|FG000|Overall Study|Lost to Follow-up|0|||
155194772|NCT02639546|560151229|FG001|Overall Study|Lost to Follow-up|0|||
155194773|NCT02639546|560151230|FG002|Overall Study|Lost to Follow-up|1|||
155194774|NCT02639546|560151231|FG003|Overall Study|Lost to Follow-up|0|||
155194775|NCT02639546|560151232|FG004|Overall Study|Lost to Follow-up|1|||
155194776|NCT02639546|560151233|FG005|Overall Study|Lost to Follow-up|1|||
155194777|NCT02639546|560151234|FG006|Overall Study|Lost to Follow-up|0|||
155194778|NCT02639546|560151235|FG007|Overall Study|Lost to Follow-up|1|||
155194779|NCT02639546|560151228|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
155194780|NCT02639546|560151229|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
155194781|NCT02639546|560151230|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
155194782|NCT02639546|560151231|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
155194783|NCT02639546|560151232|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
155194784|NCT02639546|560151233|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
155194785|NCT02639546|560151234|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
155194786|NCT02639546|560151235|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
155194787|NCT02639546|560151228|FG000|Overall Study|Study Terminated By Sponsor|0|||
155194788|NCT02639546|560151229|FG001|Overall Study|Study Terminated By Sponsor|2|||
155194789|NCT02639546|560151230|FG002|Overall Study|Study Terminated By Sponsor|3|||
155194790|NCT02639546|560151231|FG003|Overall Study|Study Terminated By Sponsor|4|||
155194791|NCT02639546|560151232|FG004|Overall Study|Study Terminated By Sponsor|4|||
155194792|NCT02639546|560151233|FG005|Overall Study|Study Terminated By Sponsor|3|||
155194793|NCT02639546|560151234|FG006|Overall Study|Study Terminated By Sponsor|3|||
155194794|NCT02639546|560151235|FG007|Overall Study|Study Terminated By Sponsor|9|||
155194795|NCT02639546|560151228|FG000|Overall Study|Withdrawal by Subject|2|||
155194796|NCT02639546|560151229|FG001|Overall Study|Withdrawal by Subject|2|||
155194797|NCT02639546|560151230|FG002|Overall Study|Withdrawal by Subject|1|||
155194798|NCT02639546|560151231|FG003|Overall Study|Withdrawal by Subject|0|||
155194799|NCT02639546|560151232|FG004|Overall Study|Withdrawal by Subject|0|||
155194800|NCT02639546|560151233|FG005|Overall Study|Withdrawal by Subject|1|||
155194801|NCT02639546|560151234|FG006|Overall Study|Withdrawal by Subject|2|||
155194802|NCT02639546|560151235|FG007|Overall Study|Withdrawal by Subject|1|||
155194803|NCT00113087|560151236|FG000|Overall Study|Death or Transplant|14|||
155194804|NCT00113087|560151237|FG001|Overall Study|Death or Transplant|16|||
155194805|NCT00113087|560151236|FG000|Overall Study|Family or MD withdrew subject|10|||
155194806|NCT00113087|560151237|FG001|Overall Study|Family or MD withdrew subject|5|||
155194807|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155194808|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155194809|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155194810|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155194811|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155194812|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155194813|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
155194814|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
155194815|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
155194816|NCT03452228|560151238|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155194817|NCT03452228|560151239|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155194818|NCT03452228|560151240|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155194819|NCT04295772|560151244|FG000|Overall Study|Protocol Violation|1|||
155194820|NCT04295772|560151245|FG001|Overall Study|Protocol Violation|0|||
155194821|NCT04295772|560151244|FG000|Overall Study|Ongoing for safety monitoring|14|||
155194822|NCT04295772|560151245|FG001|Overall Study|Ongoing for safety monitoring|1|||
155194823|NCT04295772|560151244|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
155194824|NCT04295772|560151245|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
155194825|NCT00968864|560151246|FG000|Overall Study|Protocol exception/ not evaluable|1|||
155194826|NCT01967173|560151247|FG000|Overall Study|Lost to Follow-up|5|||
155194827|NCT01967173|560151248|FG001|Overall Study|Lost to Follow-up|3|||
155194828|NCT01967173|560151249|FG002|Overall Study|Lost to Follow-up|2|||
155194829|NCT01967173|560151250|FG003|Overall Study|Lost to Follow-up|4|||
155194830|NCT01967173|560151251|FG004|Overall Study|Lost to Follow-up|8|||
155194831|NCT01967173|560151252|FG005|Overall Study|Lost to Follow-up|12|||
155194832|NCT01967173|560151253|FG006|Overall Study|Lost to Follow-up|6|||
155194833|NCT01967173|560151254|FG007|Overall Study|Lost to Follow-up|8|||
155194834|NCT01967173|560151247|FG000|Overall Study|Physician Decision|2|||
155194835|NCT01967173|560151248|FG001|Overall Study|Physician Decision|0|||
155194836|NCT01967173|560151249|FG002|Overall Study|Physician Decision|2|||
155194837|NCT01967173|560151250|FG003|Overall Study|Physician Decision|1|||
155194838|NCT01967173|560151251|FG004|Overall Study|Physician Decision|1|||
155194839|NCT01967173|560151252|FG005|Overall Study|Physician Decision|1|||
155194840|NCT01967173|560151253|FG006|Overall Study|Physician Decision|1|||
155194841|NCT01967173|560151254|FG007|Overall Study|Physician Decision|0|||
155194842|NCT01967173|560151247|FG000|Overall Study|Lack of Efficacy|2|||
155194843|NCT01967173|560151248|FG001|Overall Study|Lack of Efficacy|0|||
155194844|NCT01967173|560151249|FG002|Overall Study|Lack of Efficacy|2|||
155194845|NCT01967173|560151250|FG003|Overall Study|Lack of Efficacy|2|||
155194846|NCT01967173|560151251|FG004|Overall Study|Lack of Efficacy|0|||
155194847|NCT01967173|560151252|FG005|Overall Study|Lack of Efficacy|1|||
155194848|NCT01967173|560151253|FG006|Overall Study|Lack of Efficacy|0|||
155194849|NCT01967173|560151254|FG007|Overall Study|Lack of Efficacy|2|||
155194850|NCT01967173|560151247|FG000|Overall Study|Pregnancy|0|||
155194851|NCT01967173|560151248|FG001|Overall Study|Pregnancy|0|||
155194852|NCT01967173|560151249|FG002|Overall Study|Pregnancy|0|||
155194853|NCT01967173|560151250|FG003|Overall Study|Pregnancy|0|||
155194854|NCT01967173|560151251|FG004|Overall Study|Pregnancy|0|||
155194855|NCT01967173|560151252|FG005|Overall Study|Pregnancy|0|||
155194856|NCT01967173|560151253|FG006|Overall Study|Pregnancy|1|||
155194857|NCT01967173|560151254|FG007|Overall Study|Pregnancy|1|||
155194858|NCT01967173|560151247|FG000|Overall Study|Adverse Event|0|||
155194859|NCT01967173|560151248|FG001|Overall Study|Adverse Event|0|||
155194860|NCT01967173|560151249|FG002|Overall Study|Adverse Event|0|||
155194861|NCT01967173|560151250|FG003|Overall Study|Adverse Event|0|||
155194862|NCT01967173|560151251|FG004|Overall Study|Adverse Event|0|||
155194863|NCT01967173|560151252|FG005|Overall Study|Adverse Event|0|||
155194864|NCT01967173|560151253|FG006|Overall Study|Adverse Event|0|||
155194865|NCT01967173|560151254|FG007|Overall Study|Adverse Event|1|||
155194866|NCT01967173|560151247|FG000|Overall Study|Withdrawal by Subject|15|||
155194867|NCT01967173|560151248|FG001|Overall Study|Withdrawal by Subject|14|||
155194868|NCT01967173|560151249|FG002|Overall Study|Withdrawal by Subject|10|||
155194869|NCT01967173|560151250|FG003|Overall Study|Withdrawal by Subject|7|||
155194870|NCT01967173|560151251|FG004|Overall Study|Withdrawal by Subject|8|||
155194871|NCT01967173|560151252|FG005|Overall Study|Withdrawal by Subject|9|||
155194872|NCT01967173|560151253|FG006|Overall Study|Withdrawal by Subject|10|||
155194873|NCT01967173|560151254|FG007|Overall Study|Withdrawal by Subject|12|||
155194874|NCT03666624|560151256|FG000|Overall Study|participant grieving over recent death of parent|1|||
155194875|NCT03666624|560151257|FG001|Overall Study|participant grieving over recent death of parent|0|||
155194876|NCT01254630|560151259|FG000|Overall Study|Adverse Event|36|||
155194877|NCT01254630|560151260|FG001|Overall Study|Adverse Event|15|||
155194878|NCT01254630|560151261|FG002|Overall Study|Adverse Event|40|||
155194879|NCT01254630|560151262|FG003|Overall Study|Adverse Event|8|||
155194880|NCT01254630|560151259|FG000|Overall Study|Death|461|||
155194881|NCT01254630|560151260|FG001|Overall Study|Death|151|||
155194882|NCT01254630|560151261|FG002|Overall Study|Death|478|||
155194883|NCT01254630|560151262|FG003|Overall Study|Death|139|||
155194884|NCT01254630|560151259|FG000|Overall Study|Lost to Follow-up|80|||
155194885|NCT01254630|560151260|FG001|Overall Study|Lost to Follow-up|26|||
155194886|NCT01254630|560151261|FG002|Overall Study|Lost to Follow-up|89|||
155194887|NCT01254630|560151262|FG003|Overall Study|Lost to Follow-up|32|||
155194888|NCT01254630|560151259|FG000|Overall Study|Physician Decision|24|||
155194889|NCT01254630|560151260|FG001|Overall Study|Physician Decision|8|||
155194890|NCT01254630|560151261|FG002|Overall Study|Physician Decision|16|||
155194891|NCT01254630|560151262|FG003|Overall Study|Physician Decision|7|||
155194892|NCT01254630|560151259|FG000|Overall Study|Withdrawal by Subject|201|||
155194893|NCT01254630|560151260|FG001|Overall Study|Withdrawal by Subject|94|||
155194894|NCT01254630|560151261|FG002|Overall Study|Withdrawal by Subject|188|||
155194895|NCT01254630|560151262|FG003|Overall Study|Withdrawal by Subject|89|||
155194896|NCT01254630|560151259|FG000|Overall Study|Study terminated by sponsor|0|||
155194897|NCT01254630|560151260|FG001|Overall Study|Study terminated by sponsor|994|||
155194898|NCT01254630|560151261|FG002|Overall Study|Study terminated by sponsor|0|||
155194899|NCT01254630|560151262|FG003|Overall Study|Study terminated by sponsor|1010|||
155194900|NCT01254630|560151259|FG000|Overall Study|Status not recorded|0|||
155194901|NCT01254630|560151260|FG001|Overall Study|Status not recorded|0|||
155194902|NCT01254630|560151261|FG002|Overall Study|Status not recorded|1|||
155194903|NCT01254630|560151262|FG003|Overall Study|Status not recorded|0|||
155194904|NCT02959983|560151263|FG000|Overall Study|Protocol Violation|0|||
155194905|NCT02959983|560151264|FG001|Overall Study|Protocol Violation|1|||
155194906|NCT02959983|560151263|FG000|Overall Study|Lack of Efficacy|0|||
155194907|NCT02959983|560151264|FG001|Overall Study|Lack of Efficacy|1|||
155194908|NCT02959983|560151263|FG000|Overall Study|Lost to Follow-up|12|||
155194909|NCT02959983|560151264|FG001|Overall Study|Lost to Follow-up|9|||
155194910|NCT02959983|560151263|FG000|Overall Study|Other|1|||
155194911|NCT02959983|560151264|FG001|Overall Study|Other|1|||
155194912|NCT02959983|560151263|FG000|Overall Study|Physician Decision|1|||
155194913|NCT02959983|560151264|FG001|Overall Study|Physician Decision|0|||
155194914|NCT02959983|560151263|FG000|Overall Study|Adverse Event|5|||
155194915|NCT02959983|560151264|FG001|Overall Study|Adverse Event|1|||
155194916|NCT02959983|560151263|FG000|Overall Study|Withdrawal by Subject|7|||
155194917|NCT02959983|560151264|FG001|Overall Study|Withdrawal by Subject|12|||
155194918|NCT03308786|560151269|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
155194919|NCT01193842|560151276|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194920|NCT01193842|560151277|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
155194921|NCT01193842|560151278|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194922|NCT01193842|560151279|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194923|NCT01193842|560151280|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194924|NCT01193842|560151276|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
155194925|NCT01193842|560151277|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194926|NCT01193842|560151278|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194927|NCT01193842|560151279|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194928|NCT01193842|560151280|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194929|NCT01193842|560151276|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194930|NCT01193842|560151277|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194931|NCT01193842|560151278|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
155194932|NCT01193842|560151279|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194933|NCT01193842|560151280|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194934|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Death|0|||
155194935|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Death|0|||
155194936|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Death|0|||
155194937|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Death|1|||
155194938|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Death|1|||
155194939|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Adverse Event|0|||
155194940|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Adverse Event|0|||
155194941|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Adverse Event|0|||
155194942|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Adverse Event|5|||
155194943|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Adverse Event|3|||
155194944|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194945|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194946|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194947|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
155194948|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
155194949|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Ineligible|0|||
155194950|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Ineligible|0|||
155194951|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Ineligible|0|||
155194952|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Ineligible|0|||
155194953|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Ineligible|1|||
155194954|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194955|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194956|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194957|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
155194958|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
155194959|NCT02484690|560151282|FG000|Overall Study|Adverse Event|1|||
155194960|NCT02484690|560151283|FG001|Overall Study|Adverse Event|3|||
155194961|NCT02484690|560151284|FG002|Overall Study|Adverse Event|0|||
155194962|NCT02484690|560151285|FG003|Overall Study|Adverse Event|0|||
155194963|NCT02484690|560151286|FG004|Overall Study|Adverse Event|5|||
155194964|NCT02484690|560151282|FG000|Overall Study|Death|0|||
155194965|NCT02484690|560151283|FG001|Overall Study|Death|0|||
155194966|NCT02484690|560151284|FG002|Overall Study|Death|0|||
155194967|NCT02484690|560151285|FG003|Overall Study|Death|0|||
155194968|NCT02484690|560151286|FG004|Overall Study|Death|1|||
155194969|NCT02484690|560151282|FG000|Overall Study|Withdrawal by Subject|1|||
155194970|NCT02484690|560151283|FG001|Overall Study|Withdrawal by Subject|3|||
155194971|NCT02484690|560151284|FG002|Overall Study|Withdrawal by Subject|1|||
155194972|NCT02484690|560151285|FG003|Overall Study|Withdrawal by Subject|2|||
155194973|NCT02484690|560151286|FG004|Overall Study|Withdrawal by Subject|0|||
155194974|NCT02484690|560151282|FG000|Overall Study|Physician Decision|2|||
155194975|NCT02484690|560151283|FG001|Overall Study|Physician Decision|0|||
155194976|NCT02484690|560151284|FG002|Overall Study|Physician Decision|1|||
155194977|NCT02484690|560151285|FG003|Overall Study|Physician Decision|0|||
155194978|NCT02484690|560151286|FG004|Overall Study|Physician Decision|0|||
155194979|NCT02484690|560151282|FG000|Overall Study|Lost to Follow-up|0|||
155194980|NCT02484690|560151283|FG001|Overall Study|Lost to Follow-up|0|||
155194981|NCT02484690|560151284|FG002|Overall Study|Lost to Follow-up|1|||
155194982|NCT02484690|560151285|FG003|Overall Study|Lost to Follow-up|0|||
155194983|NCT02484690|560151286|FG004|Overall Study|Lost to Follow-up|0|||
155194984|NCT01757535|560151287|FG000|Overall Study|Disease Relapse|151|||
155194985|NCT01757535|560151288|FG001|Overall Study|Disease Relapse|181|||
155194986|NCT01757535|560151287|FG000|Overall Study|Other Reasons|28|||
155194987|NCT01757535|560151288|FG001|Overall Study|Other Reasons|27|||
155194988|NCT01757535|560151287|FG000|Overall Study|Adverse Event|31|||
155194989|NCT01757535|560151288|FG001|Overall Study|Adverse Event|11|||
155194990|NCT01757535|560151287|FG000|Overall Study|Withdrew Consent|19|||
155194991|NCT01757535|560151288|FG001|Overall Study|Withdrew Consent|13|||
155194992|NCT01757535|560151287|FG000|Overall Study|Physician Decision|7|||
155194993|NCT01757535|560151288|FG001|Overall Study|Physician Decision|0|||
155194994|NCT01757535|560151287|FG000|Overall Study|Death|2|||
155194995|NCT01757535|560151288|FG001|Overall Study|Death|2|||
155194996|NCT00589290|560151289|FG000|Overall Study|Withdrawal by Subject|1|||
155194997|NCT03487549|560151294|FG000|Overall Study|Protocol Violation|0|||
155194998|NCT03487549|560151295|FG001|Overall Study|Protocol Violation|1|||
155194999|NCT03487549|560151294|FG000|Overall Study|Lost to Follow-up|2|||
155195000|NCT03487549|560151295|FG001|Overall Study|Lost to Follow-up|1|||
155195001|NCT03487549|560151294|FG000|Overall Study|Withdrawal by Subject|2|||
155195002|NCT03487549|560151295|FG001|Overall Study|Withdrawal by Subject|0|||
155195003|NCT02323113|560152796|FG000|Overall Study|Adverse Event|3|||
155195004|NCT02323113|560152797|FG001|Overall Study|Adverse Event|3|||
155195005|NCT02323113|560152798|FG002|Overall Study|Adverse Event|2|||
155195006|NCT02323113|560152799|FG003|Overall Study|Adverse Event|5|||
155195007|NCT02323113|560152800|FG004|Overall Study|Adverse Event|8|||
155195008|NCT02323113|560152801|FG005|Overall Study|Adverse Event|3|||
155195009|NCT02323113|560152802|FG006|Overall Study|Adverse Event|6|||
155195010|NCT02323113|560152803|FG007|Overall Study|Adverse Event|0|||
155195011|NCT02323113|560152796|FG000|Overall Study|Progressive Disease|0|||
155195012|NCT02323113|560152797|FG001|Overall Study|Progressive Disease|1|||
155195013|NCT02323113|560152798|FG002|Overall Study|Progressive Disease|1|||
155195014|NCT02323113|560152799|FG003|Overall Study|Progressive Disease|0|||
155195015|NCT02323113|560152800|FG004|Overall Study|Progressive Disease|0|||
155195016|NCT02323113|560152801|FG005|Overall Study|Progressive Disease|3|||
155195017|NCT02323113|560152802|FG006|Overall Study|Progressive Disease|0|||
155195018|NCT02323113|560152803|FG007|Overall Study|Progressive Disease|0|||
155195019|NCT02323113|560152796|FG000|Overall Study|Symptomatic Deterioration|0|||
155195020|NCT02323113|560152797|FG001|Overall Study|Symptomatic Deterioration|0|||
155195021|NCT02323113|560152798|FG002|Overall Study|Symptomatic Deterioration|1|||
155195022|NCT02323113|560152799|FG003|Overall Study|Symptomatic Deterioration|0|||
155195023|NCT02323113|560152800|FG004|Overall Study|Symptomatic Deterioration|1|||
155195024|NCT02323113|560152801|FG005|Overall Study|Symptomatic Deterioration|0|||
155195025|NCT02323113|560152802|FG006|Overall Study|Symptomatic Deterioration|0|||
155195026|NCT02323113|560152803|FG007|Overall Study|Symptomatic Deterioration|0|||
155195027|NCT02323113|560152796|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
155195028|NCT02323113|560152797|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
155195029|NCT02323113|560152798|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195030|NCT02323113|560152799|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195031|NCT02323113|560152800|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195032|NCT02323113|560152801|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
155195033|NCT02323113|560152802|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195034|NCT02323113|560152803|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195035|NCT02323113|560152796|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195036|NCT02323113|560152797|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
155195037|NCT02323113|560152798|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195038|NCT02323113|560152799|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195039|NCT02323113|560152800|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195040|NCT02323113|560152801|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195041|NCT02323113|560152802|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195042|NCT02323113|560152803|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195043|NCT02280304|560152806|FG000|Overall Study|Lost to Follow-up|7|||
155195044|NCT02280304|560152807|FG001|Overall Study|Lost to Follow-up|8|||
155195045|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
155195046|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
155195047|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
155195048|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
155195049|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
155195050|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
155195051|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
155195052|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
155195053|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
155195054|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195055|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195056|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195057|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195058|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195059|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195060|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195061|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
155195062|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195063|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195064|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195065|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195066|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195067|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195068|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195069|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
155195070|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195071|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195072|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195073|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195074|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195075|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195076|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195077|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
155195078|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195079|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195080|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195081|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195082|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195083|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195084|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195085|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
155195086|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195087|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195088|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195089|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195090|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195091|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195092|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195093|NCT00533897|560152813|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195094|NCT00533897|560152814|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
155195095|NCT00533897|560152815|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
155195096|NCT00533897|560152816|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195097|NCT00533897|560152817|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195098|NCT00533897|560152818|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195099|NCT00533897|560152819|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195100|NCT00533897|560152820|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195101|NCT00533897|560152813|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195102|NCT00533897|560152814|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195103|NCT00533897|560152815|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
155195104|NCT00533897|560152816|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195105|NCT00533897|560152817|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195106|NCT00533897|560152818|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195107|NCT00533897|560152819|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195108|NCT00533897|560152820|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195109|NCT00533897|560152813|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195110|NCT00533897|560152814|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195111|NCT00533897|560152815|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195112|NCT00533897|560152816|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195113|NCT00533897|560152817|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195114|NCT00533897|560152818|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
155195115|NCT00533897|560152819|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195116|NCT00533897|560152820|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195117|NCT00533897|560152813|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195118|NCT00533897|560152814|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195119|NCT00533897|560152815|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195120|NCT00533897|560152816|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195121|NCT00533897|560152817|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195122|NCT00533897|560152818|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
155195123|NCT00533897|560152819|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195124|NCT00533897|560152820|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195125|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195126|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195127|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195128|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195129|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195130|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195131|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
155195132|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
155195133|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Death|0|||
155195134|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Death|0|||
155195135|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Death|0|||
155195136|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Death|0|||
155195137|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Death|0|||
155195138|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Death|0|||
155195139|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Death|1|||
155195140|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Death|3|||
155195141|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195142|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195143|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195144|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195145|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195146|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195147|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
155195148|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
155195149|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195150|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195151|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195152|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195153|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195154|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195155|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
155195156|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195157|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Adverse Event|0|||
155195158|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Adverse Event|0|||
155195159|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Adverse Event|0|||
155195160|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Adverse Event|0|||
155195161|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Adverse Event|0|||
155195162|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Adverse Event|0|||
155195163|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Adverse Event|2|||
155195164|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Adverse Event|5|||
155195165|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Pregnancy|0|||
155195166|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Pregnancy|0|||
155195167|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Pregnancy|0|||
155195168|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Pregnancy|0|||
155195169|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Pregnancy|0|||
155195170|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Pregnancy|0|||
155195171|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Pregnancy|0|||
155195172|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Pregnancy|2|||
155195173|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195174|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195175|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195176|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195177|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195178|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195179|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
155195180|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
155195181|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Other|0|||
155195182|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Other|0|||
155195183|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Other|0|||
155195184|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Other|0|||
155195185|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Other|0|||
155195186|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Other|0|||
155195187|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Other|1|||
155195188|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Other|6|||
155195189|NCT01546207|560152834|FG000|Overall Study|Death|1|||
155195190|NCT01626456|560152835|FG000|Overall Study|Withdrawal by Subject|21|||
155195191|NCT01626456|560152836|FG001|Overall Study|Withdrawal by Subject|46|||
155195192|NCT01626456|560152835|FG000|Overall Study|Adverse Event|2|||
155195193|NCT01626456|560152836|FG001|Overall Study|Adverse Event|27|||
155195194|NCT01626456|560152835|FG000|Overall Study|Lost to Follow-up|2|||
155195195|NCT01626456|560152836|FG001|Overall Study|Lost to Follow-up|27|||
155195196|NCT01626456|560152835|FG000|Overall Study|Lack of Efficacy|6|||
155195197|NCT01626456|560152836|FG001|Overall Study|Lack of Efficacy|7|||
155195198|NCT01626456|560152835|FG000|Overall Study|Physician Decision|1|||
155195199|NCT01626456|560152836|FG001|Overall Study|Physician Decision|4|||
155195200|NCT01626456|560152835|FG000|Overall Study|Protocol Violation|1|||
155195201|NCT01626456|560152836|FG001|Overall Study|Protocol Violation|1|||
155195202|NCT01626456|560152835|FG000|Overall Study|Site Closure|2|||
155195203|NCT01626456|560152836|FG001|Overall Study|Site Closure|3|||
155195204|NCT01626456|560152835|FG000|Overall Study|Incarceration|0|||
155195205|NCT01626456|560152836|FG001|Overall Study|Incarceration|2|||
155195206|NCT00713323|560152837|FG000|Overall Study|Adverse Event|75|||
155195207|NCT00713323|560152837|FG000|Overall Study|Withdrawal by Subject|15|||
155195208|NCT00713323|560152837|FG000|Overall Study|Lost to Follow-up|11|||
155195209|NCT00713323|560152837|FG000|Overall Study|Lack of Efficacy|36|||
155195210|NCT00713323|560152837|FG000|Overall Study|Low creatine clearance at screening|1|||
155195211|NCT00713323|560152837|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
155195212|NCT00713323|560152837|FG000|Overall Study|Surgery cured allodynic pain|1|||
155195213|NCT00713323|560152837|FG000|Overall Study|Pain free|1|||
155195214|NCT00713323|560152837|FG000|Overall Study|Non-compliance|1|||
155195215|NCT00713323|560152837|FG000|Overall Study|Pain resolved|1|||
155195216|NCT00713323|560152837|FG000|Overall Study|Subject travelling to USA|1|||
155195217|NCT00713323|560152837|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
155195218|NCT00713323|560152837|FG000|Overall Study|Treatment that may interact with Sativex|1|||
155195219|NCT00506662|560152838|FG000|Overall Study|Adverse Event|0|||
155195220|NCT00506662|560152839|FG001|Overall Study|Adverse Event|2|||
155195221|NCT00506662|560152838|FG000|Overall Study|Lack of Efficacy|1|||
155195222|NCT00506662|560152839|FG001|Overall Study|Lack of Efficacy|0|||
155195223|NCT00506662|560152838|FG000|Overall Study|Protocol Violation|2|||
155195224|NCT00506662|560152839|FG001|Overall Study|Protocol Violation|4|||
155195225|NCT00506662|560152838|FG000|Overall Study|Trial terminated|10|||
155195226|NCT00506662|560152839|FG001|Overall Study|Trial terminated|16|||
155195227|NCT00506662|560152838|FG000|Overall Study|Not recorded|4|||
155195228|NCT00506662|560152839|FG001|Overall Study|Not recorded|6|||
155195229|NCT03019185|560152844|FG000|Overall Study|Lost to Follow-up|3|||
155195230|NCT03019185|560152845|FG001|Overall Study|Lost to Follow-up|0|||
155195231|NCT03019185|560152846|FG002|Overall Study|Lost to Follow-up|2|||
155195232|NCT03019185|560152844|FG000|Overall Study|Withdrawal by Subject|1|||
155195233|NCT03019185|560152845|FG001|Overall Study|Withdrawal by Subject|1|||
155195234|NCT03019185|560152846|FG002|Overall Study|Withdrawal by Subject|0|||
155195235|NCT03019185|560152844|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
155195236|NCT03019185|560152845|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
155195237|NCT03019185|560152846|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
155195238|NCT03019185|560152844|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
155195239|NCT03019185|560152845|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
155195240|NCT03019185|560152846|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
155195241|NCT02764333|560152847|FG000|Overall Study|Ineligible|1|||
155195242|NCT03626168|560152848|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155195243|NCT03626168|560152849|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155195244|NCT03626168|560152848|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
155195245|NCT03626168|560152849|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
155195246|NCT03626168|560152848|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155195247|NCT03626168|560152849|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
155195248|NCT01772160|560152850|FG000|Overall Study|Death|3|||
155195249|NCT01772160|560152850|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
155195250|NCT01772160|560152850|FG000|Overall Study|Consent withdrawal|3|||
155195251|NCT01772160|560152850|FG000|Overall Study|Migrated / moved from the study area|4|||
155195252|NCT01772160|560152850|FG000|Overall Study|Lost to Follow-up|30|||
155195253|NCT01772160|560152850|FG000|Overall Study|Other|5|||
155195254|NCT00071396|560152851|FG000|Overall Study|Withdrawal by Subject|1|||
155195255|NCT00071396|560152851|FG000|Overall Study|Physician Decision|2|||
155195256|NCT01032174|560152852|FG000|Overall Study|Adverse Event|0|||
155195257|NCT01032174|560152853|FG001|Overall Study|Adverse Event|1|||
155195258|NCT00386607|560152854|FG000|Core|Adverse Event|40|||
155195259|NCT00386607|560152855|FG001|Core|Adverse Event|0|||
155195260|NCT00386607|560152854|FG000|Core|Abnormal laboratory value(s)|3|||
155195261|NCT00386607|560152855|FG001|Core|Abnormal laboratory value(s)|0|||
155195262|NCT00386607|560152854|FG000|Core|Unsatisfactory therapeutic effect|23|||
155195263|NCT00386607|560152855|FG001|Core|Unsatisfactory therapeutic effect|0|||
155195264|NCT00386607|560152854|FG000|Core|Condition no longer requires study drug|4|||
155195265|NCT00386607|560152855|FG001|Core|Condition no longer requires study drug|0|||
155195266|NCT00386607|560152854|FG000|Core|Patient withdrew consent|15|||
155195267|NCT00386607|560152855|FG001|Core|Patient withdrew consent|0|||
155195268|NCT00386607|560152854|FG000|Core|Lost to Follow-up|23|||
155195269|NCT00386607|560152855|FG001|Core|Lost to Follow-up|0|||
155195270|NCT00386607|560152854|FG000|Core|Administrative problems|1|||
155195271|NCT00386607|560152855|FG001|Core|Administrative problems|0|||
155195272|NCT00386607|560152854|FG000|Core|Protocol Deviation|6|||
155195273|NCT00386607|560152855|FG001|Core|Protocol Deviation|0|||
155195274|NCT00386607|560152854|FG000|Extension|Adverse Event|0|||
155195275|NCT00386607|560152855|FG001|Extension|Adverse Event|6|||
155195276|NCT00386607|560152854|FG000|Extension|Abnormal laboratory value(s)|0|||
155195277|NCT00386607|560152855|FG001|Extension|Abnormal laboratory value(s)|1|||
155195278|NCT00386607|560152854|FG000|Extension|Administrative problems|0|||
155195279|NCT00386607|560152855|FG001|Extension|Administrative problems|1|||
155195280|NCT00386607|560152854|FG000|Extension|Lost to Follow-up|0|||
155195281|NCT00386607|560152855|FG001|Extension|Lost to Follow-up|3|||
155195282|NCT00386607|560152854|FG000|Extension|Patient withdrew consent|0|||
155195283|NCT00386607|560152855|FG001|Extension|Patient withdrew consent|5|||
155195284|NCT00386607|560152854|FG000|Extension|Unsatisfactory therapeutic effect|0|||
155195285|NCT00386607|560152855|FG001|Extension|Unsatisfactory therapeutic effect|1|||
155195286|NCT02761733|560152856|FG000|Overall Study|Death|3|||
155195287|NCT02761733|560152857|FG001|Overall Study|Death|5|||
155195288|NCT02761733|560152858|FG002|Overall Study|Death|1|||
155195289|NCT02761733|560152859|FG003|Overall Study|Death|1|||
155195290|NCT02761733|560152856|FG000|Overall Study|Lost to Follow-up|6|||
155195291|NCT02761733|560152857|FG001|Overall Study|Lost to Follow-up|7|||
155195292|NCT02761733|560152858|FG002|Overall Study|Lost to Follow-up|0|||
155195293|NCT02761733|560152859|FG003|Overall Study|Lost to Follow-up|3|||
155195294|NCT02761733|560152856|FG000|Overall Study|Physician Decision|4|||
155195295|NCT02761733|560152857|FG001|Overall Study|Physician Decision|0|||
155195296|NCT02761733|560152858|FG002|Overall Study|Physician Decision|0|||
155195297|NCT02761733|560152859|FG003|Overall Study|Physician Decision|0|||
155195298|NCT02761733|560152856|FG000|Overall Study|Withdrawal by Subject|2|||
155195299|NCT02761733|560152857|FG001|Overall Study|Withdrawal by Subject|0|||
155195300|NCT02761733|560152858|FG002|Overall Study|Withdrawal by Subject|0|||
155195301|NCT02761733|560152859|FG003|Overall Study|Withdrawal by Subject|0|||
155195302|NCT02761733|560152856|FG000|Overall Study|Discharged from Study Site|10|||
155195303|NCT02761733|560152857|FG001|Overall Study|Discharged from Study Site|9|||
155195304|NCT02761733|560152858|FG002|Overall Study|Discharged from Study Site|25|||
155195305|NCT02761733|560152859|FG003|Overall Study|Discharged from Study Site|11|||
155195306|NCT02761733|560152856|FG000|Overall Study|Cognitive Impairment|5|||
155195307|NCT02761733|560152857|FG001|Overall Study|Cognitive Impairment|0|||
155195308|NCT02761733|560152858|FG002|Overall Study|Cognitive Impairment|1|||
155195309|NCT02761733|560152859|FG003|Overall Study|Cognitive Impairment|0|||
155195310|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
155195311|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195312|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
155195313|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195314|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195315|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195316|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195317|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195318|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195319|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195320|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
155195321|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195322|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195323|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195324|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195325|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195326|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195327|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
155195328|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195329|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195330|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195331|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195332|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195333|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195334|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Adverse Event|1|||
155195335|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Adverse Event|0|||
155195336|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Adverse Event|0|||
155195337|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Adverse Event|1|||
155195338|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Adverse Event|1|||
155195339|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Adverse Event|0|||
155195340|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Adverse Event|2|||
155195341|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Adverse Event|1|||
155195342|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Death|0|||
155195343|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Death|0|||
155195344|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Death|0|||
155195345|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Death|1|||
155195346|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Death|0|||
155195347|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Death|1|||
155195348|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Death|0|||
155195349|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Death|3|||
155195350|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195351|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195352|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195353|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
155195354|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195355|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195356|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195357|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195358|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
155195359|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
155195360|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
155195361|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
155195362|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
155195363|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
155195364|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
155195365|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
155195366|NCT01297920|560152872|FG000|Overall Study|Adverse Event|42|||
155195367|NCT01297920|560152873|FG001|Overall Study|Adverse Event|10|||
155195368|NCT01297920|560152874|FG002|Overall Study|Adverse Event|38|||
155195369|NCT01297920|560152872|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
155195370|NCT01297920|560152873|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
155195371|NCT01297920|560152874|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
155195372|NCT01297920|560152872|FG000|Overall Study|Noncompliance|1|||
155195373|NCT01297920|560152873|FG001|Overall Study|Noncompliance|0|||
155195374|NCT01297920|560152874|FG002|Overall Study|Noncompliance|0|||
155195375|NCT01297920|560152872|FG000|Overall Study|Protocol Violation|1|||
155195376|NCT01297920|560152873|FG001|Overall Study|Protocol Violation|3|||
155195377|NCT01297920|560152874|FG002|Overall Study|Protocol Violation|0|||
155195378|NCT01297920|560152872|FG000|Overall Study|Inadequate Control of IOP|7|||
155195379|NCT01297920|560152873|FG001|Overall Study|Inadequate Control of IOP|9|||
155195380|NCT01297920|560152874|FG002|Overall Study|Inadequate Control of IOP|17|||
155195381|NCT01297920|560152872|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
155195382|NCT01297920|560152873|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
155195383|NCT01297920|560152874|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
155195384|NCT03212690|560152875|FG000|Overall Study|Protocol Violation|1|||
155195385|NCT00474760|560152876|FG000|Overall Study|Death|0|||
155195386|NCT00474760|560152877|FG001|Overall Study|Death|0|||
155195387|NCT00474760|560152878|FG002|Overall Study|Death|0|||
155195388|NCT00474760|560152879|FG003|Overall Study|Death|0|||
155195389|NCT00474760|560152880|FG004|Overall Study|Death|2|||
155195390|NCT00474760|560152881|FG005|Overall Study|Death|0|||
155195391|NCT00474760|560152882|FG006|Overall Study|Death|0|||
155195392|NCT00474760|560152876|FG000|Overall Study|Adverse Event|0|||
155195393|NCT00474760|560152877|FG001|Overall Study|Adverse Event|0|||
155195394|NCT00474760|560152878|FG002|Overall Study|Adverse Event|0|||
155195395|NCT00474760|560152879|FG003|Overall Study|Adverse Event|0|||
155195396|NCT00474760|560152880|FG004|Overall Study|Adverse Event|1|||
155195397|NCT00474760|560152881|FG005|Overall Study|Adverse Event|7|||
155195398|NCT00474760|560152882|FG006|Overall Study|Adverse Event|0|||
155195399|NCT00474760|560152876|FG000|Overall Study|Laboratory abnormality|0|||
155195400|NCT00474760|560152877|FG001|Overall Study|Laboratory abnormality|0|||
155195401|NCT00474760|560152878|FG002|Overall Study|Laboratory abnormality|0|||
155195402|NCT00474760|560152879|FG003|Overall Study|Laboratory abnormality|0|||
155195403|NCT00474760|560152880|FG004|Overall Study|Laboratory abnormality|0|||
155195404|NCT00474760|560152881|FG005|Overall Study|Laboratory abnormality|1|||
155195405|NCT00474760|560152882|FG006|Overall Study|Laboratory abnormality|0|||
155195406|NCT00474760|560152876|FG000|Overall Study|Withdrawal by Subject|0|||
155195407|NCT00474760|560152877|FG001|Overall Study|Withdrawal by Subject|0|||
155195408|NCT00474760|560152878|FG002|Overall Study|Withdrawal by Subject|0|||
155195409|NCT00474760|560152879|FG003|Overall Study|Withdrawal by Subject|1|||
155195410|NCT00474760|560152880|FG004|Overall Study|Withdrawal by Subject|0|||
155195411|NCT00474760|560152881|FG005|Overall Study|Withdrawal by Subject|1|||
155195412|NCT00474760|560152882|FG006|Overall Study|Withdrawal by Subject|1|||
155195413|NCT00474760|560152876|FG000|Overall Study|Other|0|||
155195414|NCT00474760|560152877|FG001|Overall Study|Other|1|||
155195415|NCT00474760|560152878|FG002|Overall Study|Other|0|||
155195416|NCT00474760|560152879|FG003|Overall Study|Other|0|||
155195417|NCT00474760|560152880|FG004|Overall Study|Other|1|||
155195418|NCT00474760|560152881|FG005|Overall Study|Other|0|||
155195419|NCT00474760|560152882|FG006|Overall Study|Other|0|||
155195420|NCT00474760|560152876|FG000|Overall Study|Progressive disease|3|||
155195421|NCT00474760|560152877|FG001|Overall Study|Progressive disease|2|||
155195422|NCT00474760|560152878|FG002|Overall Study|Progressive disease|3|||
155195423|NCT00474760|560152879|FG003|Overall Study|Progressive disease|2|||
155195424|NCT00474760|560152880|FG004|Overall Study|Progressive disease|8|||
155195425|NCT00474760|560152881|FG005|Overall Study|Progressive disease|20|||
155195426|NCT00474760|560152882|FG006|Overall Study|Progressive disease|7|||
155195427|NCT00474760|560152876|FG000|Overall Study|Terminated by sponsor|0|||
155195428|NCT00474760|560152877|FG001|Overall Study|Terminated by sponsor|0|||
155195429|NCT00474760|560152878|FG002|Overall Study|Terminated by sponsor|0|||
155195430|NCT00474760|560152879|FG003|Overall Study|Terminated by sponsor|0|||
155195431|NCT00474760|560152880|FG004|Overall Study|Terminated by sponsor|0|||
155195432|NCT00474760|560152881|FG005|Overall Study|Terminated by sponsor|0|||
155195433|NCT00474760|560152882|FG006|Overall Study|Terminated by sponsor|2|||
155195434|NCT03608254|560152883|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
155195435|NCT03608254|560152883|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
155195436|NCT03000569|560152885|FG000|Overall Study|Withdrawal by Subject|1|||
155195437|NCT03000569|560152886|FG001|Overall Study|Withdrawal by Subject|0|||
155195438|NCT01346969|560152887|FG000|Overall Study|Withdrawal by Subject|0|||
155195439|NCT01346969|560152888|FG001|Overall Study|Withdrawal by Subject|0|||
155195440|NCT01346969|560152889|FG002|Overall Study|Withdrawal by Subject|1|||
155195441|NCT01346969|560152890|FG003|Overall Study|Withdrawal by Subject|0|||
155195442|NCT01346969|560152887|FG000|Overall Study|Lost to Follow-up|1|||
155195443|NCT01346969|560152888|FG001|Overall Study|Lost to Follow-up|0|||
155195444|NCT01346969|560152889|FG002|Overall Study|Lost to Follow-up|2|||
155195445|NCT01346969|560152890|FG003|Overall Study|Lost to Follow-up|0|||
155195446|NCT01346969|560152887|FG000|Overall Study|Physician Decision|0|||
155195447|NCT01346969|560152888|FG001|Overall Study|Physician Decision|0|||
155195448|NCT01346969|560152889|FG002|Overall Study|Physician Decision|0|||
155195449|NCT01346969|560152890|FG003|Overall Study|Physician Decision|1|||
155195450|NCT01346969|560152887|FG000|Overall Study|Randomized but not treated|1|||
155195451|NCT01346969|560152888|FG001|Overall Study|Randomized but not treated|0|||
155195452|NCT01346969|560152889|FG002|Overall Study|Randomized but not treated|0|||
155195453|NCT01346969|560152890|FG003|Overall Study|Randomized but not treated|0|||
155195454|NCT03540030|560152893|FG000|Overall Study|Withdrawal by Subject|2|||
155195455|NCT03540030|560152894|FG001|Overall Study|Withdrawal by Subject|1|||
155195456|NCT03540030|560152893|FG000|Overall Study|screen fail|7|||
155195457|NCT03540030|560152894|FG001|Overall Study|screen fail|1|||
155195458|NCT03540030|560152893|FG000|Overall Study|never had surgery after signing consent|9|||
155195459|NCT03540030|560152894|FG001|Overall Study|never had surgery after signing consent|1|||
155195460|NCT04122534|560152895|FG000|Overall Study|Lost to Follow-up|4|||
155195461|NCT02128932|560152903|FG000|Overall Study|Withdrawal by Subject|11|||
155195462|NCT02128932|560152904|FG001|Overall Study|Withdrawal by Subject|7|||
155195463|NCT02128932|560152905|FG002|Overall Study|Withdrawal by Subject|8|||
155195464|NCT02128932|560152903|FG000|Overall Study|Death|2|||
155195465|NCT02128932|560152904|FG001|Overall Study|Death|0|||
155195466|NCT02128932|560152905|FG002|Overall Study|Death|2|||
155195467|NCT02128932|560152903|FG000|Overall Study|Lost to Follow-up|2|||
155195468|NCT02128932|560152904|FG001|Overall Study|Lost to Follow-up|1|||
155195469|NCT02128932|560152905|FG002|Overall Study|Lost to Follow-up|1|||
155195470|NCT02128932|560152903|FG000|Overall Study|No reason for withdrawal|12|||
155195471|NCT02128932|560152904|FG001|Overall Study|No reason for withdrawal|11|||
155195472|NCT02128932|560152905|FG002|Overall Study|No reason for withdrawal|7|||
155195473|NCT03685123|560152910|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
155195474|NCT03685123|560152911|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
155195475|NCT03685123|560152912|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
155195476|NCT03685123|560152910|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
155195477|NCT03685123|560152911|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
155195478|NCT03685123|560152912|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
155195479|NCT03685123|560152910|FG000|Weight Loss Phase|Lost to Follow-up|1|||
155195480|NCT03685123|560152911|FG001|Weight Loss Phase|Lost to Follow-up|0|||
155195481|NCT03685123|560152912|FG002|Weight Loss Phase|Lost to Follow-up|0|||
155195482|NCT03685123|560152910|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
155195483|NCT03685123|560152911|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
155195484|NCT03685123|560152912|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
155195485|NCT03685123|560152910|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
155195486|NCT03685123|560152911|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
155195487|NCT03685123|560152912|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
155195488|NCT03685123|560152910|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
155195489|NCT03685123|560152911|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
155195490|NCT03685123|560152912|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
155195491|NCT02020577|560152913|FG000|Overall Study|Progressive disease|3|||
155195492|NCT02020577|560152914|FG001|Overall Study|Progressive disease|38|||
155195493|NCT02020577|560152913|FG000|Overall Study|Other AE or clinical progression|0|||
155195494|NCT02020577|560152914|FG001|Overall Study|Other AE or clinical progression|15|||
155195495|NCT02020577|560152913|FG000|Overall Study|Withdrawal by Subject|0|||
155195496|NCT02020577|560152914|FG001|Overall Study|Withdrawal by Subject|1|||
155195497|NCT02020577|560152913|FG000|Overall Study|Other than stated above|0|||
155195498|NCT02020577|560152914|FG001|Overall Study|Other than stated above|1|||
155195499|NCT01893203|560152915|FG000|Overall Study|Withdrawal by Subject|1|||
155195500|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
155195501|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
155195502|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
155195503|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
155195504|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195505|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195506|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195507|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195508|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195509|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195510|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195511|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195512|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
155195513|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
155195514|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
155195515|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195516|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195517|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195518|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195519|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195520|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195521|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195522|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195523|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195524|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
155195525|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
155195526|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195527|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195528|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195529|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195530|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195531|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195532|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195533|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195534|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195535|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195536|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
155195537|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
155195538|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
155195539|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
155195540|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
155195541|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
155195542|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
155195543|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
155195544|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
155195545|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
155195546|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
155195547|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
155195548|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195549|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195550|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195551|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195552|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195553|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
155195554|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195555|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195556|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195557|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195558|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
155195559|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
155195560|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195561|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195562|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195563|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195564|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195565|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
155195566|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
155195567|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
155195568|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195569|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195570|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195571|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195572|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195573|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195574|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195575|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195576|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195577|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
155195578|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195579|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195580|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195581|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195582|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195583|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195584|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
155195585|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
155195586|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
155195587|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
155195588|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
155195589|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
155195590|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
155195591|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
155195592|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
155195593|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
155195594|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
155195595|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
155195596|NCT02663908|560152928|FG000|Overall Study|Withdrawal by Subject|8|||
155195597|NCT02663908|560152929|FG001|Overall Study|Withdrawal by Subject|5|||
155195598|NCT02663908|560152928|FG000|Overall Study|Lost to Follow-up|1|||
155195599|NCT02663908|560152929|FG001|Overall Study|Lost to Follow-up|5|||
155195600|NCT02663908|560152928|FG000|Overall Study|Adverse Event|13|||
155195601|NCT02663908|560152929|FG001|Overall Study|Adverse Event|11|||
155195602|NCT02663908|560152928|FG000|Overall Study|Protocol Violation|1|||
155195603|NCT02663908|560152929|FG001|Overall Study|Protocol Violation|2|||
155195604|NCT02663908|560152928|FG000|Overall Study|Lack of therapeutic response|2|||
155195605|NCT02663908|560152929|FG001|Overall Study|Lack of therapeutic response|0|||
155195606|NCT02663908|560152928|FG000|Overall Study|COVID-19|1|||
155195607|NCT02663908|560152929|FG001|Overall Study|COVID-19|0|||
155195608|NCT02663908|560152928|FG000|Overall Study|Site closed|1|||
155195609|NCT02663908|560152929|FG001|Overall Study|Site closed|0|||
155195610|NCT02663908|560152928|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
155195611|NCT02663908|560152929|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
155195612|NCT02663908|560152928|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
155195613|NCT02663908|560152929|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
155195614|NCT02663908|560152928|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
155195615|NCT02663908|560152929|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
155195616|NCT02663908|560152928|FG000|Overall Study|Death|1|||
155195617|NCT02663908|560152929|FG001|Overall Study|Death|0|||
155195618|NCT02663908|560152928|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
155195619|NCT02663908|560152929|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
155195620|NCT02663908|560152928|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
155195621|NCT02663908|560152929|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
155195622|NCT00370071|560152930|FG000|Overall Study|Withdrawal by Subject|2|||
155195623|NCT02004522|560152931|FG000|Overall Study|Adverse Event|55|||
155195624|NCT02004522|560152932|FG001|Overall Study|Adverse Event|6|||
155195625|NCT02004522|560152931|FG000|Overall Study|Withdrawal by Subject|13|||
155195626|NCT02004522|560152932|FG001|Overall Study|Withdrawal by Subject|7|||
155195627|NCT02004522|560152931|FG000|Overall Study|Death|12|||
155195628|NCT02004522|560152932|FG001|Overall Study|Death|3|||
155195629|NCT02004522|560152931|FG000|Overall Study|Physician Decision|3|||
155195630|NCT02004522|560152932|FG001|Overall Study|Physician Decision|4|||
155195631|NCT02004522|560152931|FG000|Overall Study|Protocol Violation|1|||
155195632|NCT02004522|560152932|FG001|Overall Study|Protocol Violation|0|||
155195633|NCT02004522|560152931|FG000|Overall Study|Other is reason listed by PI|4|||
155195634|NCT02004522|560152932|FG001|Overall Study|Other is reason listed by PI|1|||
155195635|NCT02004522|560152931|FG000|Overall Study|Never Dosed|2|||
155195636|NCT02004522|560152932|FG001|Overall Study|Never Dosed|4|||
155195637|NCT02004522|560152931|FG000|Overall Study|Disease Progression|35|||
155195638|NCT02004522|560152932|FG001|Overall Study|Disease Progression|31|||
155195639|NCT02004522|560152931|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
155195640|NCT02004522|560152932|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
155195641|NCT01787331|560152934|FG000|Overall Study|Physician Decision|1|||
155195642|NCT01787331|560152934|FG000|Overall Study|Withdrawal by Subject|1|||
155195643|NCT00450255|560152935|FG000|Overall Study|Prior RFA ablation of liver|1|||
155195644|NCT01402011|560152938|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
155195645|NCT01402011|560152939|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
155195646|NCT01402011|560152940|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
155195647|NCT01402011|560152938|FG000|Active Treatment Period|Withdrawal by Subject|1|||
155195648|NCT01402011|560152939|FG001|Active Treatment Period|Withdrawal by Subject|3|||
155195649|NCT01402011|560152940|FG002|Active Treatment Period|Withdrawal by Subject|0|||
155195650|NCT01402011|560152938|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
155195651|NCT01402011|560152939|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
155195652|NCT01402011|560152940|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
155195653|NCT01759511|560152942|FG000|Overall Study|Adverse Event|4|||
155195654|NCT01759511|560152942|FG000|Overall Study|Death|2|||
155195655|NCT01759511|560152942|FG000|Overall Study|Lack of Efficacy|2|||
155195656|NCT01759511|560152942|FG000|Overall Study|Physician Decision|1|||
155195657|NCT01759511|560152942|FG000|Overall Study|Progressive Disease|5|||
155195658|NCT01759511|560152942|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
155195659|NCT01759511|560152942|FG000|Overall Study|Study Terminated by Sponsor|13|||
155195660|NCT01759511|560152942|FG000|Overall Study|Withdrawal by Subject|3|||
155195661|NCT02569671|560152943|FG000|Overall Study|Lost to Follow-up|2|||
155195662|NCT02569671|560152944|FG001|Overall Study|Lost to Follow-up|1|||
155195663|NCT02569671|560152943|FG000|Overall Study|Withdrawal by Subject|1|||
155195664|NCT02569671|560152944|FG001|Overall Study|Withdrawal by Subject|3|||
155195665|NCT05154578|560154464|FG000|Overall Study|Withdrawal by Subject|2|||
155195666|NCT05154578|560154465|FG001|Overall Study|Withdrawal by Subject|3|||
155195667|NCT05154578|560154466|FG002|Overall Study|Withdrawal by Subject|2|||
155195668|NCT05154578|560154467|FG003|Overall Study|Withdrawal by Subject|4|||
155195669|NCT05154578|560154468|FG004|Overall Study|Withdrawal by Subject|0|||
155195670|NCT05154578|560154464|FG000|Overall Study|Lost to Follow-up|0|||
155195671|NCT05154578|560154465|FG001|Overall Study|Lost to Follow-up|1|||
155195672|NCT05154578|560154466|FG002|Overall Study|Lost to Follow-up|0|||
155195673|NCT05154578|560154467|FG003|Overall Study|Lost to Follow-up|3|||
155195674|NCT05154578|560154468|FG004|Overall Study|Lost to Follow-up|0|||
155195675|NCT05154578|560154464|FG000|Overall Study|Adverse Event|0|||
155195676|NCT05154578|560154465|FG001|Overall Study|Adverse Event|0|||
155195677|NCT05154578|560154466|FG002|Overall Study|Adverse Event|0|||
155195678|NCT05154578|560154467|FG003|Overall Study|Adverse Event|1|||
155195679|NCT05154578|560154468|FG004|Overall Study|Adverse Event|0|||
155195680|NCT05154578|560154464|FG000|Overall Study|Relocated to another province|0|||
155195681|NCT05154578|560154465|FG001|Overall Study|Relocated to another province|0|||
155195682|NCT05154578|560154466|FG002|Overall Study|Relocated to another province|1|||
155195683|NCT05154578|560154467|FG003|Overall Study|Relocated to another province|0|||
155195684|NCT05154578|560154468|FG004|Overall Study|Relocated to another province|1|||
155195685|NCT05154578|560154464|FG000|Overall Study|Baby loss|0|||
155195686|NCT05154578|560154465|FG001|Overall Study|Baby loss|1|||
155195687|NCT05154578|560154466|FG002|Overall Study|Baby loss|0|||
155195688|NCT05154578|560154467|FG003|Overall Study|Baby loss|0|||
155195689|NCT05154578|560154468|FG004|Overall Study|Baby loss|0|||
155195690|NCT04622306|560154474|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195691|NCT04622306|560154475|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195692|NCT04622306|560154476|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
155195693|NCT04622306|560154477|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
155195694|NCT04622306|560154478|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195695|NCT04622306|560154479|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
155195696|NCT04622306|560154474|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195697|NCT04622306|560154475|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195698|NCT04622306|560154476|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
155195699|NCT04622306|560154477|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
155195700|NCT04622306|560154478|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195701|NCT04622306|560154479|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195702|NCT01200524|560154480|FG000|Overall Study|Withdrawal by Subject|1|||
155195703|NCT01200524|560154481|FG001|Overall Study|Withdrawal by Subject|1|||
155195704|NCT01200524|560154482|FG002|Overall Study|Withdrawal by Subject|3|||
155195705|NCT01200524|560154480|FG000|Overall Study|Adverse Event|1|||
155195706|NCT01200524|560154481|FG001|Overall Study|Adverse Event|0|||
155195707|NCT01200524|560154482|FG002|Overall Study|Adverse Event|0|||
155195708|NCT01200524|560154480|FG000|Overall Study|Non availability of study nurse|0|||
155195709|NCT01200524|560154481|FG001|Overall Study|Non availability of study nurse|0|||
155195710|NCT01200524|560154482|FG002|Overall Study|Non availability of study nurse|1|||
155195711|NCT00491764|560154485|FG000|Overall Study|Adverse Event|1|||
155195712|NCT00491764|560154486|FG001|Overall Study|Adverse Event|2|||
155195713|NCT00491764|560154487|FG002|Overall Study|Adverse Event|4|||
155195714|NCT00491764|560154488|FG003|Overall Study|Adverse Event|4|||
155195715|NCT00491764|560154489|FG004|Overall Study|Adverse Event|0|||
155195716|NCT00491764|560154490|FG005|Overall Study|Adverse Event|1|||
155195717|NCT00491764|560154485|FG000|Overall Study|Lost to Follow-up|0|||
155195718|NCT00491764|560154486|FG001|Overall Study|Lost to Follow-up|1|||
155195719|NCT00491764|560154487|FG002|Overall Study|Lost to Follow-up|0|||
155195720|NCT00491764|560154488|FG003|Overall Study|Lost to Follow-up|1|||
155195721|NCT00491764|560154489|FG004|Overall Study|Lost to Follow-up|0|||
155195722|NCT00491764|560154490|FG005|Overall Study|Lost to Follow-up|3|||
155195723|NCT00491764|560154485|FG000|Overall Study|Withdrawal by Subject|2|||
155195724|NCT00491764|560154486|FG001|Overall Study|Withdrawal by Subject|3|||
155195725|NCT00491764|560154487|FG002|Overall Study|Withdrawal by Subject|1|||
155195726|NCT00491764|560154488|FG003|Overall Study|Withdrawal by Subject|2|||
155195727|NCT00491764|560154489|FG004|Overall Study|Withdrawal by Subject|2|||
155195728|NCT00491764|560154490|FG005|Overall Study|Withdrawal by Subject|4|||
155195729|NCT00491764|560154485|FG000|Overall Study|Non Compliance with the Protocol|1|||
155195730|NCT00491764|560154486|FG001|Overall Study|Non Compliance with the Protocol|0|||
155195731|NCT00491764|560154487|FG002|Overall Study|Non Compliance with the Protocol|0|||
155195732|NCT00491764|560154488|FG003|Overall Study|Non Compliance with the Protocol|0|||
155195733|NCT00491764|560154489|FG004|Overall Study|Non Compliance with the Protocol|0|||
155195734|NCT00491764|560154490|FG005|Overall Study|Non Compliance with the Protocol|0|||
155195735|NCT00491764|560154485|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
155195736|NCT00491764|560154486|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
155195737|NCT00491764|560154487|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
155195738|NCT00491764|560154488|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
155195739|NCT00491764|560154489|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
155195740|NCT00491764|560154490|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
155195741|NCT00491764|560154485|FG000|Overall Study|Administrative|1|||
155195742|NCT00491764|560154486|FG001|Overall Study|Administrative|0|||
155195743|NCT00491764|560154487|FG002|Overall Study|Administrative|2|||
155195744|NCT00491764|560154488|FG003|Overall Study|Administrative|1|||
155195745|NCT00491764|560154489|FG004|Overall Study|Administrative|0|||
155195746|NCT00491764|560154490|FG005|Overall Study|Administrative|0|||
155195747|NCT00894166|560154491|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
155195748|NCT00894166|560154492|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
155195749|NCT00894166|560154493|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
155195750|NCT00894166|560154494|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
155195751|NCT00894166|560154495|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
155195752|NCT00894166|560154496|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
155195753|NCT00894166|560154497|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
155195754|NCT00894166|560154498|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
155195755|NCT00894166|560154491|FG000|Overall Study|Death|0|||
155195756|NCT00894166|560154492|FG001|Overall Study|Death|0|||
155195757|NCT00894166|560154493|FG002|Overall Study|Death|0|||
155195758|NCT00894166|560154494|FG003|Overall Study|Death|1|||
155195759|NCT00894166|560154495|FG004|Overall Study|Death|0|||
155195760|NCT00894166|560154496|FG005|Overall Study|Death|0|||
155195761|NCT00894166|560154497|FG006|Overall Study|Death|0|||
155195762|NCT00894166|560154498|FG007|Overall Study|Death|0|||
155195763|NCT05350410|560154499|FG000|Overall Study|Withdrawal by Subject|1|||
155195764|NCT01601132|560154500|FG000|Overall Study|Patient withdrew consent|1|||
155195765|NCT01601132|560154500|FG000|Overall Study|Protocol deviation|1|||
155195766|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Adverse Event|3|||
155195767|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Adverse Event|0|||
155195768|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
155195769|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
155195770|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
155195771|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
155195772|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Physician Decision|0|||
155195773|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Physician Decision|2|||
155195774|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
155195775|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
155195776|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
155195777|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
155195778|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
155195779|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
155195780|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
155195781|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
155195782|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
155195783|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
155195784|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
155195785|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
155195786|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
155195787|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
155195788|NCT00142935|560154511|FG000|Overall Study|Other reason|1|||
155195789|NCT00142935|560154512|FG001|Overall Study|Other reason|1|||
155195790|NCT00142935|560154513|FG002|Overall Study|Other reason|1|||
155195791|NCT00142935|560154511|FG000|Overall Study|Lost to Follow-up|2|||
155195792|NCT00142935|560154512|FG001|Overall Study|Lost to Follow-up|5|||
155195793|NCT00142935|560154513|FG002|Overall Study|Lost to Follow-up|5|||
155195794|NCT00142935|560154511|FG000|Overall Study|Death|0|||
155195795|NCT00142935|560154512|FG001|Overall Study|Death|2|||
155195796|NCT00142935|560154513|FG002|Overall Study|Death|1|||
155195797|NCT01330030|560154514|FG000|Overall Study|Lost to Follow-up|16|||
155195798|NCT01330030|560154515|FG001|Overall Study|Lost to Follow-up|17|||
155195799|NCT05047770|560154516|FG000|Overall Study|Withdrawal by Subject|15|||
155195800|NCT05047770|560154517|FG001|Overall Study|Withdrawal by Subject|10|||
155195801|NCT05047770|560154518|FG002|Overall Study|Withdrawal by Subject|6|||
155195802|NCT05047770|560154519|FG003|Overall Study|Withdrawal by Subject|12|||
155195803|NCT05047770|560154516|FG000|Overall Study|Lost to Follow-up|7|||
155195804|NCT05047770|560154517|FG001|Overall Study|Lost to Follow-up|5|||
155195805|NCT05047770|560154518|FG002|Overall Study|Lost to Follow-up|12|||
155195806|NCT05047770|560154519|FG003|Overall Study|Lost to Follow-up|13|||
155195807|NCT05047770|560154516|FG000|Overall Study|Other|1|||
155195808|NCT05047770|560154517|FG001|Overall Study|Other|0|||
155195809|NCT05047770|560154518|FG002|Overall Study|Other|1|||
155195810|NCT05047770|560154519|FG003|Overall Study|Other|0|||
155195811|NCT01952145|560154520|FG000|Overall Study|Protocol Violation|2|||
155195812|NCT01952145|560154521|FG001|Overall Study|Protocol Violation|1|||
155195813|NCT01952145|560154520|FG000|Overall Study|Death|0|||
155195814|NCT01952145|560154521|FG001|Overall Study|Death|1|||
155195815|NCT01952145|560154520|FG000|Overall Study|Adverse Event|9|||
155195816|NCT01952145|560154521|FG001|Overall Study|Adverse Event|0|||
155195817|NCT01952145|560154520|FG000|Overall Study|Withdrawal Criteria|16|||
155195818|NCT01952145|560154521|FG001|Overall Study|Withdrawal Criteria|11|||
155195819|NCT01952145|560154520|FG000|Overall Study|Unclassified|1|||
155195820|NCT01952145|560154521|FG001|Overall Study|Unclassified|1|||
155195821|NCT04138810|560154522|FG000|Overall Study|Withdrawal by Subject|0|||
155195822|NCT04138810|560154523|FG001|Overall Study|Withdrawal by Subject|1|||
155195823|NCT04138810|560154522|FG000|Overall Study|Subject cancelled surgery|1|||
155195824|NCT04138810|560154523|FG001|Overall Study|Subject cancelled surgery|0|||
155195825|NCT05224141|560154530|FG000|Overall Study|Ongoing|75|||
155195826|NCT05224141|560154531|FG001|Overall Study|Ongoing|88|||
155195827|NCT05224141|560154530|FG000|Overall Study|Withdrawal by Subject|2|||
155195828|NCT05224141|560154531|FG001|Overall Study|Withdrawal by Subject|4|||
155195829|NCT05224141|560154530|FG000|Overall Study|Death|153|||
155195830|NCT05224141|560154531|FG001|Overall Study|Death|138|||
155195831|NCT04545060|560154537|FG000|Overall Study|Adverse Event|0|||
155195832|NCT04545060|560154538|FG001|Overall Study|Adverse Event|1|||
155195833|NCT04545060|560154537|FG000|Overall Study|Death|0|||
155195834|NCT04545060|560154538|FG001|Overall Study|Death|5|||
155195835|NCT04545060|560154537|FG000|Overall Study|Lost to Follow-up|10|||
155195836|NCT04545060|560154538|FG001|Overall Study|Lost to Follow-up|13|||
155195837|NCT04545060|560154537|FG000|Overall Study|Physician Decision|3|||
155195838|NCT04545060|560154538|FG001|Overall Study|Physician Decision|0|||
155195839|NCT04545060|560154537|FG000|Overall Study|Withdrawal by Subject|17|||
155195840|NCT04545060|560154538|FG001|Overall Study|Withdrawal by Subject|22|||
155195841|NCT00619177|560154539|FG000|Overall Study|Adverse Event|18|||
155195842|NCT00619177|560154539|FG000|Overall Study|Lost to Follow-up|2|||
155195843|NCT00619177|560154539|FG000|Overall Study|Lack of Efficacy|1|||
155195844|NCT00619177|560154539|FG000|Overall Study|Missing termination information|481|||
155195845|NCT00619177|560154539|FG000|Overall Study|Not specified reasons|6|||
155195846|NCT02435147|560154541|FG000|Overall Study|non-evaluable DXA scan|11|||
155195847|NCT02939079|560154542|FG000|Overall Study|Adverse Event|2|||
155195848|NCT02939079|560154543|FG001|Overall Study|Adverse Event|1|||
155195849|NCT02939079|560154542|FG000|Overall Study|Lost to Follow-up|0|||
155195850|NCT02939079|560154543|FG001|Overall Study|Lost to Follow-up|2|||
155195851|NCT02939079|560154542|FG000|Overall Study|Protocol Violation|1|||
155195852|NCT02939079|560154543|FG001|Overall Study|Protocol Violation|0|||
155195853|NCT02939079|560154542|FG000|Overall Study|Withdrawal by Subject|0|||
155195854|NCT02939079|560154543|FG001|Overall Study|Withdrawal by Subject|1|||
155195855|NCT02939079|560154542|FG000|Overall Study|relapse during the study|1|||
155195856|NCT02939079|560154543|FG001|Overall Study|relapse during the study|1|||
155195857|NCT01609231|560154544|FG000|Overall Study|Adverse Event|1|||
155195858|NCT01609231|560154545|FG001|Overall Study|Adverse Event|3|||
155195859|NCT01609231|560154544|FG000|Overall Study|Physician Decision|1|||
155195860|NCT01609231|560154545|FG001|Overall Study|Physician Decision|0|||
155195861|NCT01609231|560154544|FG000|Overall Study|Withdrawal by Subject|1|||
155195862|NCT01609231|560154545|FG001|Overall Study|Withdrawal by Subject|0|||
155195863|NCT01180647|560154546|FG000|Overall Study|Lost to Follow-up|5|||
155195864|NCT01180647|560154547|FG001|Overall Study|Lost to Follow-up|6|||
155195865|NCT04545554|560154558|FG000|Overall Study|Withdrawal by Subject|0|||
155195866|NCT04545554|560154559|FG001|Overall Study|Withdrawal by Subject|0|||
155195867|NCT04545554|560154560|FG002|Overall Study|Withdrawal by Subject|0|||
155195868|NCT04545554|560154561|FG003|Overall Study|Withdrawal by Subject|1|||
155195869|NCT04545554|560154562|FG004|Overall Study|Withdrawal by Subject|0|||
155195870|NCT04545554|560154563|FG005|Overall Study|Withdrawal by Subject|0|||
155195871|NCT02478372|560154564|FG000|Overall Study|Protocol Violation|12|||
155195872|NCT02478372|560154565|FG001|Overall Study|Protocol Violation|8|||
155195873|NCT02478372|560154564|FG000|Overall Study|Lost to Follow-up|1|||
155195874|NCT02478372|560154565|FG001|Overall Study|Lost to Follow-up|4|||
155195875|NCT02478372|560154564|FG000|Overall Study|Death|0|||
155195876|NCT02478372|560154565|FG001|Overall Study|Death|2|||
155195877|NCT00116428|560154566|FG000|Overall Study|Withdrawal by Subject|2|||
155195878|NCT00116428|560154567|FG001|Overall Study|Withdrawal by Subject|5|||
155195879|NCT00116428|560154566|FG000|Overall Study|Did not meet inclusion criteria|1|||
155195880|NCT00116428|560154567|FG001|Overall Study|Did not meet inclusion criteria|0|||
155195881|NCT00788073|560154569|FG000|STX209 Then Placebo|Adverse Event|1|||
155195882|NCT00788073|560154570|FG001|STX209 Then Placebo|Adverse Event|0|||
155195883|NCT00788073|560154569|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
155195884|NCT00788073|560154570|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
155195885|NCT00788073|560154569|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
155195886|NCT00788073|560154570|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
155195887|NCT00788073|560154569|FG000|STX209 Then Placebo|unable to return due to travel|0|||
155195888|NCT00788073|560154570|FG001|STX209 Then Placebo|unable to return due to travel|1|||
155195889|NCT00788073|560154569|FG000|Placebo Then STX209|Adverse Event|2|||
155195890|NCT00788073|560154570|FG001|Placebo Then STX209|Adverse Event|0|||
155195891|NCT00788073|560154569|FG000|Placebo Then STX209|Protocol Violation|0|||
155195892|NCT00788073|560154570|FG001|Placebo Then STX209|Protocol Violation|1|||
155195893|NCT00910273|560154571|FG000|Overall Study|Lack of Efficacy|6|||
155195894|NCT00910273|560154572|FG001|Overall Study|Lack of Efficacy|9|||
155195895|NCT00910273|560154571|FG000|Overall Study|Adverse Event|1|||
155195896|NCT00910273|560154572|FG001|Overall Study|Adverse Event|1|||
155195897|NCT00910273|560154571|FG000|Overall Study|Withdrawal by Subject|1|||
155195898|NCT00910273|560154572|FG001|Overall Study|Withdrawal by Subject|0|||
155195899|NCT00910273|560154571|FG000|Overall Study|Discontinuation of study by sponsor|8|||
155195900|NCT00910273|560154572|FG001|Overall Study|Discontinuation of study by sponsor|2|||
155195901|NCT00910273|560154571|FG000|Overall Study|Protocol Violation|1|||
155195902|NCT00910273|560154572|FG001|Overall Study|Protocol Violation|0|||
155195903|NCT00910273|560154571|FG000|Overall Study|Lost to Follow-up|1|||
155195904|NCT00910273|560154572|FG001|Overall Study|Lost to Follow-up|1|||
155195905|NCT00660673|560154573|FG000|Overall Study|Adverse Event|84|||
155195906|NCT00660673|560154573|FG000|Overall Study|Lack of Efficacy|7|||
155195907|NCT00660673|560154573|FG000|Overall Study|Withdrawal by Subject|22|||
155195908|NCT00660673|560154573|FG000|Overall Study|Administrative|2|||
155195909|NCT00660673|560154573|FG000|Overall Study|Protocol Violation|2|||
155195910|NCT00579098|560154578|FG000|Overall Study|Lost to Follow-up|2|||
155195911|NCT00579098|560154579|FG001|Overall Study|Lost to Follow-up|0|||
155195912|NCT00579098|560154578|FG000|Overall Study|Adverse Event|2|||
155195913|NCT00579098|560154579|FG001|Overall Study|Adverse Event|3|||
155195914|NCT00579098|560154578|FG000|Overall Study|Withdrawal by Subject|2|||
155195915|NCT00579098|560154579|FG001|Overall Study|Withdrawal by Subject|3|||
155195916|NCT00579098|560154578|FG000|Overall Study|AF returned after ablation|3|||
155195917|NCT00579098|560154579|FG001|Overall Study|AF returned after ablation|2|||
155195918|NCT01254331|560154585|FG000|Initial Phase|Adverse Event|3|||
155195919|NCT01254331|560154585|FG000|Initial Phase|Withdrawal by Subject|1|||
155195920|NCT01254331|560154585|FG000|Initial Phase|Pregnancy|1|||
155195921|NCT01254331|560154585|FG000|Extension Phase|Lack of Efficacy|1|||
155195922|NCT01254331|560154585|FG000|Extension Phase|Lost to Follow-up|3|||
155195923|NCT00633750|560154586|FG000|Overall Study|Adverse Event|2|||
155195924|NCT00633750|560154586|FG000|Overall Study|Withdrawal by Subject|3|||
155195925|NCT01903031|560154587|FG000|Overall Study|Not Able to Attend Clinic|1|||
155195926|NCT01903031|560154588|FG001|Overall Study|Not Able to Attend Clinic|1|||
155195927|NCT01903031|560154589|FG002|Overall Study|Not Able to Attend Clinic|0|||
155195928|NCT01903031|560154587|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
155195929|NCT01903031|560154588|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
155195930|NCT01903031|560154589|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
155195931|NCT01903031|560154587|FG000|Overall Study|Adverse Event|0|||
155195932|NCT01903031|560154588|FG001|Overall Study|Adverse Event|1|||
155195933|NCT01903031|560154589|FG002|Overall Study|Adverse Event|0|||
155195934|NCT01903031|560154587|FG000|Overall Study|Withdrawal by Subject|0|||
155195935|NCT01903031|560154588|FG001|Overall Study|Withdrawal by Subject|1|||
155195936|NCT01903031|560154589|FG002|Overall Study|Withdrawal by Subject|1|||
155195937|NCT01903031|560154587|FG000|Overall Study|Protocol Violation|0|||
155195938|NCT01903031|560154588|FG001|Overall Study|Protocol Violation|0|||
155195939|NCT01903031|560154589|FG002|Overall Study|Protocol Violation|2|||
155195940|NCT01903031|560154587|FG000|Overall Study|Lost to Follow-up|0|||
155195941|NCT01903031|560154588|FG001|Overall Study|Lost to Follow-up|0|||
155195942|NCT01903031|560154589|FG002|Overall Study|Lost to Follow-up|1|||
155195943|NCT01903031|560154587|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
155195944|NCT01903031|560154588|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
155195945|NCT01903031|560154589|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
155195946|NCT05213481|560154590|FG000|Overall Study|Adverse Event|3|||
155195947|NCT05213481|560154590|FG000|Overall Study|Lost to Follow-up|1|||
155195948|NCT00569270|560154591|FG000|Period: First Intervention|Protocol Violation|0|||
155195949|NCT00569270|560154592|FG001|Period: First Intervention|Protocol Violation|1|||
155195950|NCT00447005|560154594|FG000|Overall Study|Adverse Event|1|||
155195951|NCT00447005|560154594|FG000|Overall Study|Lack of Efficacy|11|||
155195952|NCT00492531|560154595|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
155195953|NCT00492531|560154596|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
155195954|NCT00400764|560154601|FG000|Phase Ib|Adverse Event|1|||
155195955|NCT00400764|560154602|FG001|Phase Ib|Adverse Event|0|||
155195956|NCT00400764|560154603|FG002|Phase Ib|Adverse Event|0|||
155195957|NCT00400764|560154604|FG003|Phase Ib|Adverse Event|0|||
155195958|NCT00400764|560154605|FG004|Phase Ib|Adverse Event|0|||
155195959|NCT00400764|560154601|FG000|Phase Ib|Death|1|||
155195960|NCT00400764|560154602|FG001|Phase Ib|Death|0|||
155195961|NCT00400764|560154603|FG002|Phase Ib|Death|0|||
155195962|NCT00400764|560154604|FG003|Phase Ib|Death|0|||
155195963|NCT00400764|560154605|FG004|Phase Ib|Death|0|||
155195964|NCT00400764|560154601|FG000|Phase Ib|Disease Progression|4|||
155195965|NCT00400764|560154602|FG001|Phase Ib|Disease Progression|4|||
155195966|NCT00400764|560154603|FG002|Phase Ib|Disease Progression|0|||
155195967|NCT00400764|560154604|FG003|Phase Ib|Disease Progression|0|||
155195968|NCT00400764|560154605|FG004|Phase Ib|Disease Progression|0|||
155195969|NCT00400764|560154601|FG000|Phase II|Death|0|||
155195970|NCT00400764|560154602|FG001|Phase II|Death|0|||
155195971|NCT00400764|560154603|FG002|Phase II|Death|1|||
155195972|NCT00400764|560154604|FG003|Phase II|Death|2|||
155195973|NCT00400764|560154605|FG004|Phase II|Death|0|||
155195974|NCT00400764|560154601|FG000|Phase II|Lost to Follow-up|0|||
155195975|NCT00400764|560154602|FG001|Phase II|Lost to Follow-up|0|||
155195976|NCT00400764|560154603|FG002|Phase II|Lost to Follow-up|1|||
155195977|NCT00400764|560154604|FG003|Phase II|Lost to Follow-up|0|||
155195978|NCT00400764|560154605|FG004|Phase II|Lost to Follow-up|0|||
155195979|NCT00400764|560154601|FG000|Phase II|Physician Decision|0|||
155195980|NCT00400764|560154602|FG001|Phase II|Physician Decision|0|||
155195981|NCT00400764|560154603|FG002|Phase II|Physician Decision|1|||
155195982|NCT00400764|560154604|FG003|Phase II|Physician Decision|1|||
155195983|NCT00400764|560154605|FG004|Phase II|Physician Decision|0|||
155195984|NCT00400764|560154601|FG000|Phase II|Sponsor's decision to terminate|0|||
155195985|NCT00400764|560154602|FG001|Phase II|Sponsor's decision to terminate|0|||
155195986|NCT00400764|560154603|FG002|Phase II|Sponsor's decision to terminate|18|||
155195987|NCT00400764|560154604|FG003|Phase II|Sponsor's decision to terminate|22|||
155195988|NCT00400764|560154605|FG004|Phase II|Sponsor's decision to terminate|11|||
155195989|NCT00400764|560154601|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
155195990|NCT00400764|560154602|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
155195991|NCT00400764|560154603|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
155195992|NCT00400764|560154604|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
155195993|NCT00400764|560154605|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
155195994|NCT00400764|560154601|FG000|Phase II|Withdrawal by Subject|0|||
155195995|NCT00400764|560154602|FG001|Phase II|Withdrawal by Subject|0|||
155195996|NCT00400764|560154603|FG002|Phase II|Withdrawal by Subject|1|||
155195997|NCT00400764|560154604|FG003|Phase II|Withdrawal by Subject|1|||
155195998|NCT00400764|560154605|FG004|Phase II|Withdrawal by Subject|0|||
155195999|NCT03113071|560154608|FG000|Overall Study|Withdrawal by Subject|1|||
155196000|NCT03113071|560154609|FG001|Overall Study|Withdrawal by Subject|0|||
155196001|NCT02764697|560154610|FG000|Overall Study|Lack of Efficacy|3|||
155196002|NCT00302107|560154611|FG000|Overall Study|Lost to Follow-up|6|||
155196003|NCT00302107|560154612|FG001|Overall Study|Lost to Follow-up|5|||
155196004|NCT00302107|560154611|FG000|Overall Study|Protocol Violation|1|||
155196005|NCT00302107|560154612|FG001|Overall Study|Protocol Violation|0|||
155196006|NCT00302107|560154611|FG000|Overall Study|Relocation|0|||
155196007|NCT00302107|560154612|FG001|Overall Study|Relocation|1|||
155196008|NCT00302107|560154611|FG000|Overall Study|Withdrawal by Subject|0|||
155196009|NCT00302107|560154612|FG001|Overall Study|Withdrawal by Subject|3|||
155196010|NCT00302107|560154611|FG000|Overall Study|Adverse Event|1|||
155196011|NCT00302107|560154612|FG001|Overall Study|Adverse Event|0|||
155196012|NCT00437983|560154613|FG000|Overall Study|Adverse Event|6|||
155196013|NCT00437983|560154614|FG001|Overall Study|Adverse Event|6|||
155196014|NCT00437983|560154613|FG000|Overall Study|Protocol Violation|2|||
155196015|NCT00437983|560154614|FG001|Overall Study|Protocol Violation|1|||
155196016|NCT00437983|560154613|FG000|Overall Study|Withdrawal by Subject|5|||
155196017|NCT00437983|560154614|FG001|Overall Study|Withdrawal by Subject|6|||
155196018|NCT00621959|560154615|FG000|Overall Study|Adverse Event|4|||
155196019|NCT00621959|560154616|FG001|Overall Study|Adverse Event|2|||
155196020|NCT00621959|560154615|FG000|Overall Study|Lack of Efficacy|1|||
155196021|NCT00621959|560154616|FG001|Overall Study|Lack of Efficacy|1|||
155196022|NCT00621959|560154615|FG000|Overall Study|Lost to Follow-up|0|||
155196023|NCT00621959|560154616|FG001|Overall Study|Lost to Follow-up|2|||
155196024|NCT00621959|560154615|FG000|Overall Study|Withdrawal by Subject|1|||
155196025|NCT00621959|560154616|FG001|Overall Study|Withdrawal by Subject|1|||
155196026|NCT00621959|560154615|FG000|Overall Study|Other|1|||
155196027|NCT00621959|560154616|FG001|Overall Study|Other|3|||
155196028|NCT01790932|560154617|FG000|Overall Study|Disease Progression|41|||
155196029|NCT01790932|560154617|FG000|Overall Study|Adverse Event|7|||
155196030|NCT01790932|560154617|FG000|Overall Study|Physician Decision|1|||
155196031|NCT01790932|560154617|FG000|Overall Study|Withdrawal by Subject|1|||
155196032|NCT03360747|560154620|FG000|Overall Study|Voluntary Withdrawal|1|||
155196033|NCT06238362|560154623|FG000|Overall Study|Insufficient total sleep time|1|||
155196034|NCT06238362|560154624|FG001|Overall Study|Insufficient total sleep time|0|||
155196035|NCT06238362|560154623|FG000|Overall Study|Inadequate signal quality|1|||
155196036|NCT06238362|560154624|FG001|Overall Study|Inadequate signal quality|0|||
155196037|NCT03730012|560154625|FG000|Overall Study|Adverse Event|0|||
155196038|NCT03730012|560154626|FG001|Overall Study|Adverse Event|1|||
155196039|NCT03730012|560154625|FG000|Overall Study|Lack of Efficacy|1|||
155196040|NCT03730012|560154626|FG001|Overall Study|Lack of Efficacy|5|||
155196041|NCT03730012|560154625|FG000|Overall Study|Withdrawal by Subject|0|||
155196042|NCT03730012|560154626|FG001|Overall Study|Withdrawal by Subject|1|||
155196043|NCT03730012|560154625|FG000|Overall Study|Miscellaneous|2|||
155196044|NCT03730012|560154626|FG001|Overall Study|Miscellaneous|1|||
155196045|NCT01798004|560156062|FG000|Overall Study|Death|2|||
155196046|NCT01798004|560156062|FG000|Overall Study|Lack of Efficacy|8|||
155196047|NCT01798004|560156062|FG000|Overall Study|Physician Decision|25|||
155196048|NCT01798004|560156062|FG000|Overall Study|Withdrawal by Subject|4|||
155196049|NCT01798004|560156062|FG000|Overall Study|Ineligible|4|||
155196050|NCT01798004|560156062|FG000|Overall Study|Patient/parent refusal|7|||
155196051|NCT01798004|560156062|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
155196052|NCT01798004|560156062|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
155196053|NCT03320057|560156063|FG000|Overall Study|Lost to Follow-up|4|||
155196054|NCT03320057|560156064|FG001|Overall Study|Lost to Follow-up|17|||
155196055|NCT03320057|560156063|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
155196056|NCT03320057|560156064|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
155196057|NCT06956170|560156065|FG000|Overall Study|Death|2|||
155196058|NCT06956170|560156066|FG001|Overall Study|Death|1|||
155196059|NCT06956170|560156065|FG000|Overall Study|Withdrawal by Subject|1|||
155196060|NCT06956170|560156066|FG001|Overall Study|Withdrawal by Subject|0|||
155196061|NCT06956170|560156065|FG000|Overall Study|Ongoing|7|||
155196062|NCT06956170|560156066|FG001|Overall Study|Ongoing|10|||
155196063|NCT01516437|560156067|FG000|Overall Study|Reason not specified|0|||
155196064|NCT01516437|560156068|FG001|Overall Study|Reason not specified|0|||
155196065|NCT01516437|560156069|FG002|Overall Study|Reason not specified|1|||
155196066|NCT01516437|560156070|FG003|Overall Study|Reason not specified|1|||
155196067|NCT00403234|560156071|FG000|Overall Study|Withdrawal by Subject|0|||
155196068|NCT00403234|560156072|FG001|Overall Study|Withdrawal by Subject|1|||
155196069|NCT00403234|560156073|FG002|Overall Study|Withdrawal by Subject|0|||
155196070|NCT00403234|560156074|FG003|Overall Study|Withdrawal by Subject|0|||
155196071|NCT00403234|560156071|FG000|Overall Study|Adverse Event|1|||
155196072|NCT00403234|560156072|FG001|Overall Study|Adverse Event|0|||
155196073|NCT00403234|560156073|FG002|Overall Study|Adverse Event|1|||
155196074|NCT00403234|560156074|FG003|Overall Study|Adverse Event|0|||
155196075|NCT00825682|560156075|FG000|Overall Study|personal reasons/ inconvenience|13|||
155196076|NCT00825682|560156076|FG001|Overall Study|personal reasons/ inconvenience|5|||
155196077|NCT04805541|560156081|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
155196078|NCT04015336|560156083|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
155196079|NCT03228433|560156084|FG000|Overall Study|Lost to Follow-up|1|||
155196080|NCT03228433|560156085|FG001|Overall Study|Lost to Follow-up|0|||
155196081|NCT03228433|560156086|FG002|Overall Study|Lost to Follow-up|0|||
155196082|NCT03228433|560156087|FG003|Overall Study|Lost to Follow-up|0|||
155196083|NCT03228433|560156088|FG004|Overall Study|Lost to Follow-up|0|||
155196084|NCT03228433|560156089|FG005|Overall Study|Lost to Follow-up|0|||
155196085|NCT03228433|560156084|FG000|Overall Study|Positive alcohol test|0|||
155196086|NCT03228433|560156085|FG001|Overall Study|Positive alcohol test|0|||
155196087|NCT03228433|560156086|FG002|Overall Study|Positive alcohol test|0|||
155196088|NCT03228433|560156087|FG003|Overall Study|Positive alcohol test|1|||
155196089|NCT03228433|560156088|FG004|Overall Study|Positive alcohol test|0|||
155196090|NCT03228433|560156089|FG005|Overall Study|Positive alcohol test|0|||
155196091|NCT00129272|560156098|FG000|Overall Study|Lost to Follow-up|12|||
155196092|NCT00129272|560156099|FG001|Overall Study|Lost to Follow-up|11|||
155196093|NCT00129272|560156098|FG000|Overall Study|Withdrawal by Subject|5|||
155196094|NCT00129272|560156099|FG001|Overall Study|Withdrawal by Subject|11|||
155196095|NCT02601027|560156103|FG000|Registration to Surgery|Withdrawal by Subject|20|||
155196096|NCT02601027|560156104|FG001|Registration to Surgery|Withdrawal by Subject|10|||
155196097|NCT01419626|560156107|FG000|Overall Study|Protocol Violation|3|||
155196098|NCT01419626|560156108|FG001|Overall Study|Protocol Violation|2|||
155196099|NCT01419626|560156109|FG002|Overall Study|Protocol Violation|2|||
155196100|NCT01419626|560156107|FG000|Overall Study|Withdrawal by Subject|1|||
155196101|NCT01419626|560156108|FG001|Overall Study|Withdrawal by Subject|0|||
155196102|NCT01419626|560156109|FG002|Overall Study|Withdrawal by Subject|0|||
155196103|NCT01419626|560156107|FG000|Overall Study|Lost to Follow-up|0|||
155196104|NCT01419626|560156108|FG001|Overall Study|Lost to Follow-up|1|||
155196105|NCT01419626|560156109|FG002|Overall Study|Lost to Follow-up|1|||
155196106|NCT01365052|560156110|FG000|Overall Study|Adverse Event|4|||
155196107|NCT01365052|560156111|FG001|Overall Study|Adverse Event|4|||
155196108|NCT01146912|560156112|FG000|Overall Study|Already received influenza vaccination|817|||
155196109|NCT01146912|560156113|FG001|Overall Study|Already received influenza vaccination|822|||
155196110|NCT01146912|560156114|FG002|Overall Study|Already received influenza vaccination|13|||
155196111|NCT01146912|560156115|FG003|Overall Study|Already received influenza vaccination|15|||
155196112|NCT01146912|560156116|FG004|Overall Study|Already received influenza vaccination|41|||
155196113|NCT01146912|560156117|FG005|Overall Study|Already received influenza vaccination|61|||
155196114|NCT01146912|560156118|FG006|Overall Study|Already received influenza vaccination|56|||
155196115|NCT01146912|560156119|FG007|Overall Study|Already received influenza vaccination|0|||
155196116|NCT01146912|560156112|FG000|Overall Study|< 14 weeks gestational age|0|||
155196117|NCT01146912|560156113|FG001|Overall Study|< 14 weeks gestational age|0|||
155196118|NCT01146912|560156114|FG002|Overall Study|< 14 weeks gestational age|3|||
155196119|NCT01146912|560156115|FG003|Overall Study|< 14 weeks gestational age|2|||
155196120|NCT01146912|560156116|FG004|Overall Study|< 14 weeks gestational age|0|||
155196121|NCT01146912|560156117|FG005|Overall Study|< 14 weeks gestational age|0|||
155196122|NCT01146912|560156118|FG006|Overall Study|< 14 weeks gestational age|0|||
155196123|NCT01146912|560156119|FG007|Overall Study|< 14 weeks gestational age|0|||
155196124|NCT01146912|560156112|FG000|Overall Study|Duplicate patient|0|||
155196125|NCT01146912|560156113|FG001|Overall Study|Duplicate patient|0|||
155196126|NCT01146912|560156114|FG002|Overall Study|Duplicate patient|1|||
155196127|NCT01146912|560156115|FG003|Overall Study|Duplicate patient|0|||
155196128|NCT01146912|560156116|FG004|Overall Study|Duplicate patient|0|||
155196129|NCT01146912|560156117|FG005|Overall Study|Duplicate patient|0|||
155196130|NCT01146912|560156118|FG006|Overall Study|Duplicate patient|0|||
155196131|NCT01146912|560156119|FG007|Overall Study|Duplicate patient|0|||
155196132|NCT02980783|560156120|FG000|Overall Study|Lost to Follow-up|1|||
155196133|NCT00880542|560156121|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
155196134|NCT00880542|560156121|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
155196135|NCT00880542|560156121|FG000|REP: Surgical Resection|progressive disease|1|||
155196136|NCT00074984|560156122|FG000|Overall Study|Death|1|||
155196137|NCT00074984|560156123|FG001|Overall Study|Death|2|||
155196138|NCT00074984|560156122|FG000|Overall Study|Withdrawal by Subject|2|||
155196139|NCT00074984|560156123|FG001|Overall Study|Withdrawal by Subject|3|||
155196140|NCT00074984|560156122|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
155196141|NCT00074984|560156123|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
155196142|NCT04289623|560156124|FG000|Wave 1 Emails|Email was not delivered|268|||
155196143|NCT04289623|560156125|FG001|Wave 1 Emails|Email was not delivered|257|||
155196144|NCT04289623|560156126|FG002|Wave 1 Emails|Email was not delivered|0|||
155196145|NCT04289623|560156127|FG003|Wave 1 Emails|Email was not delivered|0|||
155196146|NCT04289623|560156128|FG004|Wave 1 Emails|Email was not delivered|0|||
155196147|NCT04289623|560156129|FG005|Wave 1 Emails|Email was not delivered|0|||
155196148|NCT03758443|560156130|FG000|Induction Period|Adverse Event|2|||
155196149|NCT03758443|560156131|FG001|Induction Period|Adverse Event|4|||
155196150|NCT03758443|560156132|FG002|Induction Period|Adverse Event|2|||
155196151|NCT03758443|560156133|FG003|Induction Period|Adverse Event|3|||
155196152|NCT03758443|560156130|FG000|Induction Period|Physician Decision|1|||
155196153|NCT03758443|560156131|FG001|Induction Period|Physician Decision|1|||
155196154|NCT03758443|560156132|FG002|Induction Period|Physician Decision|3|||
155196155|NCT03758443|560156133|FG003|Induction Period|Physician Decision|0|||
155196156|NCT03758443|560156130|FG000|Induction Period|Protocol Violation|0|||
155196157|NCT03758443|560156131|FG001|Induction Period|Protocol Violation|0|||
155196158|NCT03758443|560156132|FG002|Induction Period|Protocol Violation|0|||
155196159|NCT03758443|560156133|FG003|Induction Period|Protocol Violation|1|||
155196160|NCT03758443|560156130|FG000|Induction Period|Withdrawal by Subject|3|||
155196161|NCT03758443|560156131|FG001|Induction Period|Withdrawal by Subject|2|||
155196162|NCT03758443|560156132|FG002|Induction Period|Withdrawal by Subject|2|||
155196163|NCT03758443|560156133|FG003|Induction Period|Withdrawal by Subject|4|||
155196164|NCT03758443|560156130|FG000|Extended Induction Period|Adverse Event|1|||
155196165|NCT03758443|560156131|FG001|Extended Induction Period|Adverse Event|1|||
155196166|NCT03758443|560156132|FG002|Extended Induction Period|Adverse Event|0|||
155196167|NCT03758443|560156133|FG003|Extended Induction Period|Adverse Event|1|||
155196168|NCT03758443|560156130|FG000|Extended Induction Period|Lost to Follow-up|1|||
155196169|NCT03758443|560156131|FG001|Extended Induction Period|Lost to Follow-up|0|||
155196170|NCT03758443|560156132|FG002|Extended Induction Period|Lost to Follow-up|0|||
155196171|NCT03758443|560156133|FG003|Extended Induction Period|Lost to Follow-up|0|||
155196172|NCT03758443|560156130|FG000|Extended Induction Period|Physician Decision|2|||
155196173|NCT03758443|560156131|FG001|Extended Induction Period|Physician Decision|1|||
155196174|NCT03758443|560156132|FG002|Extended Induction Period|Physician Decision|2|||
155196175|NCT03758443|560156133|FG003|Extended Induction Period|Physician Decision|2|||
155196176|NCT03758443|560156130|FG000|Extended Induction Period|Protocol Violation|0|||
155196177|NCT03758443|560156131|FG001|Extended Induction Period|Protocol Violation|0|||
155196178|NCT03758443|560156132|FG002|Extended Induction Period|Protocol Violation|0|||
155196179|NCT03758443|560156133|FG003|Extended Induction Period|Protocol Violation|1|||
155196180|NCT03758443|560156130|FG000|Extended Induction Period|Withdrawal by Subject|8|||
155196181|NCT03758443|560156131|FG001|Extended Induction Period|Withdrawal by Subject|1|||
155196182|NCT03758443|560156132|FG002|Extended Induction Period|Withdrawal by Subject|7|||
155196183|NCT03758443|560156133|FG003|Extended Induction Period|Withdrawal by Subject|3|||
155196184|NCT03758443|560156130|FG000|Extended Induction Period|Miscellaneous|1|||
155196185|NCT03758443|560156131|FG001|Extended Induction Period|Miscellaneous|0|||
155196186|NCT03758443|560156132|FG002|Extended Induction Period|Miscellaneous|0|||
155196187|NCT03758443|560156133|FG003|Extended Induction Period|Miscellaneous|0|||
155196188|NCT03758443|560156130|FG000|Maintenance Period|Adverse Event|1|||
155196189|NCT03758443|560156131|FG001|Maintenance Period|Adverse Event|2|||
155196190|NCT03758443|560156132|FG002|Maintenance Period|Adverse Event|0|||
155196191|NCT03758443|560156133|FG003|Maintenance Period|Adverse Event|0|||
155196192|NCT03758443|560156130|FG000|Maintenance Period|Lost to Follow-up|0|||
155196193|NCT03758443|560156131|FG001|Maintenance Period|Lost to Follow-up|0|||
155196194|NCT03758443|560156132|FG002|Maintenance Period|Lost to Follow-up|0|||
155196195|NCT03758443|560156133|FG003|Maintenance Period|Lost to Follow-up|1|||
155196196|NCT03758443|560156130|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
155196197|NCT03758443|560156131|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
155196198|NCT03758443|560156132|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
155196199|NCT03758443|560156133|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
155196200|NCT03758443|560156130|FG000|Maintenance Period|Protocol Violation|0|||
155196201|NCT03758443|560156131|FG001|Maintenance Period|Protocol Violation|1|||
155196202|NCT03758443|560156132|FG002|Maintenance Period|Protocol Violation|0|||
155196203|NCT03758443|560156133|FG003|Maintenance Period|Protocol Violation|0|||
155196204|NCT03758443|560156130|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
155196205|NCT03758443|560156131|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
155196206|NCT03758443|560156132|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
155196207|NCT03758443|560156133|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
155196208|NCT03758443|560156130|FG000|Maintenance Period|Withdrawal by Subject|1|||
155196209|NCT03758443|560156131|FG001|Maintenance Period|Withdrawal by Subject|0|||
155196210|NCT03758443|560156132|FG002|Maintenance Period|Withdrawal by Subject|1|||
155196211|NCT03758443|560156133|FG003|Maintenance Period|Withdrawal by Subject|1|||
155196212|NCT03758443|560156130|FG000|Maintenance Period|Miscellaneous|0|||
155196213|NCT03758443|560156131|FG001|Maintenance Period|Miscellaneous|0|||
155196214|NCT03758443|560156132|FG002|Maintenance Period|Miscellaneous|1|||
155196215|NCT03758443|560156133|FG003|Maintenance Period|Miscellaneous|0|||
155196216|NCT03080454|560156134|FG000|Baseline|Adverse Event|2|||
155196217|NCT03080454|560156134|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
155196218|NCT03080454|560156134|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
155196219|NCT02202980|560156135|FG000|Overall Study|Lack of Efficacy|1|||
155196220|NCT02202980|560156136|FG001|Overall Study|Lack of Efficacy|0|||
155196221|NCT02202980|560156137|FG002|Overall Study|Lack of Efficacy|7|||
155196222|NCT02202980|560156138|FG003|Overall Study|Lack of Efficacy|0|||
155196223|NCT02202980|560156139|FG004|Overall Study|Lack of Efficacy|3|||
155196224|NCT02202980|560156140|FG005|Overall Study|Lack of Efficacy|1|||
155196225|NCT02202980|560156141|FG006|Overall Study|Lack of Efficacy|11|||
155196226|NCT02202980|560156142|FG007|Overall Study|Lack of Efficacy|2|||
155196227|NCT02202980|560156143|FG008|Overall Study|Lack of Efficacy|2|||
155196228|NCT02202980|560156144|FG009|Overall Study|Lack of Efficacy|0|||
155196229|NCT02202980|560156145|FG010|Overall Study|Lack of Efficacy|0|||
155196230|NCT02202980|560156146|FG011|Overall Study|Lack of Efficacy|3|||
155196231|NCT02202980|560156147|FG012|Overall Study|Lack of Efficacy|10|||
155196232|NCT02202980|560156148|FG013|Overall Study|Lack of Efficacy|0|||
155196233|NCT02202980|560156135|FG000|Overall Study|Protocol Violation|0|||
155196234|NCT02202980|560156136|FG001|Overall Study|Protocol Violation|0|||
155196235|NCT02202980|560156137|FG002|Overall Study|Protocol Violation|0|||
155196236|NCT02202980|560156138|FG003|Overall Study|Protocol Violation|3|||
155196237|NCT02202980|560156139|FG004|Overall Study|Protocol Violation|3|||
155196238|NCT02202980|560156140|FG005|Overall Study|Protocol Violation|0|||
155196239|NCT02202980|560156141|FG006|Overall Study|Protocol Violation|0|||
155196240|NCT02202980|560156142|FG007|Overall Study|Protocol Violation|0|||
155196241|NCT02202980|560156143|FG008|Overall Study|Protocol Violation|0|||
155196242|NCT02202980|560156144|FG009|Overall Study|Protocol Violation|0|||
155196243|NCT02202980|560156145|FG010|Overall Study|Protocol Violation|0|||
155196244|NCT02202980|560156146|FG011|Overall Study|Protocol Violation|0|||
155196245|NCT02202980|560156147|FG012|Overall Study|Protocol Violation|0|||
155196246|NCT02202980|560156148|FG013|Overall Study|Protocol Violation|0|||
155196247|NCT02202980|560156135|FG000|Overall Study|Lost to Follow-up|0|||
155196248|NCT02202980|560156136|FG001|Overall Study|Lost to Follow-up|1|||
155196249|NCT02202980|560156137|FG002|Overall Study|Lost to Follow-up|1|||
155196250|NCT02202980|560156138|FG003|Overall Study|Lost to Follow-up|1|||
155196251|NCT02202980|560156139|FG004|Overall Study|Lost to Follow-up|0|||
155196252|NCT02202980|560156140|FG005|Overall Study|Lost to Follow-up|0|||
155196253|NCT02202980|560156141|FG006|Overall Study|Lost to Follow-up|0|||
155196254|NCT02202980|560156142|FG007|Overall Study|Lost to Follow-up|1|||
155196255|NCT02202980|560156143|FG008|Overall Study|Lost to Follow-up|1|||
155196256|NCT02202980|560156144|FG009|Overall Study|Lost to Follow-up|0|||
155196257|NCT02202980|560156145|FG010|Overall Study|Lost to Follow-up|0|||
155196258|NCT02202980|560156146|FG011|Overall Study|Lost to Follow-up|0|||
155196259|NCT02202980|560156147|FG012|Overall Study|Lost to Follow-up|1|||
155196260|NCT02202980|560156148|FG013|Overall Study|Lost to Follow-up|0|||
155196261|NCT02202980|560156135|FG000|Overall Study|Withdrew Consent|0|||
155196262|NCT02202980|560156136|FG001|Overall Study|Withdrew Consent|1|||
155196263|NCT02202980|560156137|FG002|Overall Study|Withdrew Consent|2|||
155196264|NCT02202980|560156138|FG003|Overall Study|Withdrew Consent|0|||
155196265|NCT02202980|560156139|FG004|Overall Study|Withdrew Consent|0|||
155196266|NCT02202980|560156140|FG005|Overall Study|Withdrew Consent|0|||
155196267|NCT02202980|560156141|FG006|Overall Study|Withdrew Consent|0|||
155196268|NCT02202980|560156142|FG007|Overall Study|Withdrew Consent|0|||
155196269|NCT02202980|560156143|FG008|Overall Study|Withdrew Consent|1|||
155196270|NCT02202980|560156144|FG009|Overall Study|Withdrew Consent|0|||
155196271|NCT02202980|560156145|FG010|Overall Study|Withdrew Consent|0|||
155196272|NCT02202980|560156146|FG011|Overall Study|Withdrew Consent|0|||
155196273|NCT02202980|560156147|FG012|Overall Study|Withdrew Consent|0|||
155196274|NCT02202980|560156148|FG013|Overall Study|Withdrew Consent|0|||
155196275|NCT00696800|560156152|FG000|Overall Study|Adverse Event|16|||
155196276|NCT00696800|560156153|FG001|Overall Study|Adverse Event|3|||
155196277|NCT00696800|560156152|FG000|Overall Study|Insufficient compliance with medication|2|||
155196278|NCT00696800|560156153|FG001|Overall Study|Insufficient compliance with medication|1|||
155196279|NCT00696800|560156152|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
155196280|NCT00696800|560156153|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
155196281|NCT00696800|560156152|FG000|Overall Study|Insufficient ovarian response|4|||
155196282|NCT00696800|560156153|FG001|Overall Study|Insufficient ovarian response|1|||
155196283|NCT00696800|560156152|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
155196284|NCT00696800|560156153|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
155196285|NCT00696800|560156152|FG000|Overall Study|Too high ovarian response|6|||
155196286|NCT00696800|560156153|FG001|Overall Study|Too high ovarian response|1|||
155196287|NCT00696800|560156152|FG000|Overall Study|No/too few/bad quality oocytes|4|||
155196288|NCT00696800|560156153|FG001|Overall Study|No/too few/bad quality oocytes|3|||
155196289|NCT00696800|560156152|FG000|Overall Study|No/abnormal fertilization|11|||
155196290|NCT00696800|560156153|FG001|Overall Study|No/abnormal fertilization|13|||
155196291|NCT00696800|560156152|FG000|Overall Study|No/too few/bad quality embryos|24|||
155196292|NCT00696800|560156153|FG001|Overall Study|No/too few/bad quality embryos|18|||
155196293|NCT00696800|560156152|FG000|Overall Study|Other Reasons|5|||
155196294|NCT00696800|560156153|FG001|Overall Study|Other Reasons|3|||
155196295|NCT00696800|560156152|FG000|Overall Study|Not treated|1|||
155196296|NCT00696800|560156153|FG001|Overall Study|Not treated|2|||
155196297|NCT01540838|560156154|FG000|Overall Study|Open nasogastric tube|9|||
155196298|NCT01540838|560156155|FG001|Overall Study|Open nasogastric tube|7|||
155196299|NCT01540838|560156154|FG000|Overall Study|Treatment doses missing|8|||
155196300|NCT01540838|560156155|FG001|Overall Study|Treatment doses missing|12|||
155196301|NCT01540838|560156154|FG000|Overall Study|Additional antibiotic treatment|1|||
155196302|NCT01540838|560156155|FG001|Overall Study|Additional antibiotic treatment|2|||
155196303|NCT01540838|560156154|FG000|Overall Study|Died before treatment initiation|1|||
155196304|NCT01540838|560156155|FG001|Overall Study|Died before treatment initiation|1|||
155196305|NCT01540838|560156154|FG000|Overall Study|Not BM. Other treatment|3|||
155196306|NCT01540838|560156155|FG001|Overall Study|Not BM. Other treatment|1|||
155196307|NCT02130570|560156156|FG000|Overall Study|Death|3|||
155196308|NCT02130570|560156157|FG001|Overall Study|Death|5|||
155196309|NCT02130570|560156156|FG000|Overall Study|Withdrawal by Subject|6|||
155196310|NCT02130570|560156157|FG001|Overall Study|Withdrawal by Subject|3|||
155196311|NCT02130570|560156156|FG000|Overall Study|Part of practice that discontinued study|0|||
155196312|NCT02130570|560156157|FG001|Overall Study|Part of practice that discontinued study|5|||
155196313|NCT00413244|560156163|FG000|Overall Study|Withdrawal by Subject|10|||
155196314|NCT00413244|560156164|FG001|Overall Study|Withdrawal by Subject|1|||
155196315|NCT01058655|560156166|FG000|Overall Study|Withdrawal by Subject|1|||
155196316|NCT01058655|560156167|FG001|Overall Study|Withdrawal by Subject|0|||
155196317|NCT01058655|560156168|FG002|Overall Study|Withdrawal by Subject|3|||
155196318|NCT01058655|560156169|FG003|Overall Study|Withdrawal by Subject|4|||
155196319|NCT01058655|560156166|FG000|Overall Study|Prolonged Treatment Delay|0|||
155196320|NCT01058655|560156167|FG001|Overall Study|Prolonged Treatment Delay|0|||
155196321|NCT01058655|560156168|FG002|Overall Study|Prolonged Treatment Delay|0|||
155196322|NCT01058655|560156169|FG003|Overall Study|Prolonged Treatment Delay|2|||
155196323|NCT01058655|560156166|FG000|Overall Study|Symptomatic Deterioration|0|||
155196324|NCT01058655|560156167|FG001|Overall Study|Symptomatic Deterioration|0|||
155196325|NCT01058655|560156168|FG002|Overall Study|Symptomatic Deterioration|0|||
155196326|NCT01058655|560156169|FG003|Overall Study|Symptomatic Deterioration|1|||
155196327|NCT01058655|560156166|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
155196328|NCT01058655|560156167|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
155196329|NCT01058655|560156168|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
155196330|NCT01058655|560156169|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
155196331|NCT01058655|560156166|FG000|Overall Study|Death|0|||
155196332|NCT01058655|560156167|FG001|Overall Study|Death|1|||
155196333|NCT01058655|560156168|FG002|Overall Study|Death|1|||
155196334|NCT01058655|560156169|FG003|Overall Study|Death|0|||
155196335|NCT01058655|560156166|FG000|Overall Study|Disease Progression|1|||
155196336|NCT01058655|560156167|FG001|Overall Study|Disease Progression|2|||
155196337|NCT01058655|560156168|FG002|Overall Study|Disease Progression|4|||
155196338|NCT01058655|560156169|FG003|Overall Study|Disease Progression|24|||
155196339|NCT01058655|560156166|FG000|Overall Study|Other|0|||
155196340|NCT01058655|560156167|FG001|Overall Study|Other|0|||
155196341|NCT01058655|560156168|FG002|Overall Study|Other|0|||
155196342|NCT01058655|560156169|FG003|Overall Study|Other|4|||
155196343|NCT02635776|560156173|FG000|Overall Study|Physician Decision|1|||
155196344|NCT02635776|560156174|FG001|Overall Study|Physician Decision|0|||
155196345|NCT02635776|560156173|FG000|Overall Study|Adverse Event|51|||
155196346|NCT02635776|560156174|FG001|Overall Study|Adverse Event|3|||
155196347|NCT02635776|560156173|FG000|Overall Study|Withdrawal by Subject|41|||
155196348|NCT02635776|560156174|FG001|Overall Study|Withdrawal by Subject|7|||
155196349|NCT02635776|560156173|FG000|Overall Study|Lost to Follow-up|4|||
155196350|NCT02635776|560156174|FG001|Overall Study|Lost to Follow-up|0|||
155196351|NCT02635776|560156173|FG000|Overall Study|Other reasons|5|||
155196352|NCT02635776|560156174|FG001|Overall Study|Other reasons|1|||
155196353|NCT03208127|560156175|FG000|Overall Study|Death|1|||
155196354|NCT01811225|560156176|FG000|Treatment Period 1|Adverse Event|2|||
155196355|NCT01811225|560156177|FG001|Treatment Period 1|Adverse Event|3|||
155196356|NCT01811225|560156176|FG000|Treatment Period 1|Lost to Follow-up|12|||
155196357|NCT01811225|560156177|FG001|Treatment Period 1|Lost to Follow-up|8|||
155196358|NCT01811225|560156176|FG000|Treatment Period 1|transporation|1|||
155196359|NCT01811225|560156177|FG001|Treatment Period 1|transporation|0|||
155196360|NCT01811225|560156176|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
155196361|NCT01811225|560156177|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
155196362|NCT01811225|560156176|FG000|Treatment Period 2|Lost to Follow-up|1|||
155196363|NCT01811225|560156177|FG001|Treatment Period 2|Lost to Follow-up|2|||
155196364|NCT01811225|560156176|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
155196365|NCT01811225|560156177|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
155196366|NCT00287365|560156178|FG000|Overall Study|sample not acquired|13|||
155196367|NCT02298023|560156179|FG000|Overall Study|Withdrawal by Subject|1|||
155196368|NCT02298023|560156180|FG001|Overall Study|Withdrawal by Subject|0|||
155196369|NCT02298023|560156181|FG002|Overall Study|Withdrawal by Subject|0|||
155196370|NCT01612858|560156183|FG000|Overall Study|Withdrawal by Subject|5|||
155196371|NCT01612858|560156184|FG001|Overall Study|Withdrawal by Subject|1|||
155196372|NCT03113916|560156185|FG000|Overall Study|Withdrawal by Subject|9|||
155196373|NCT03113916|560156186|FG001|Overall Study|Withdrawal by Subject|7|||
155196374|NCT03113916|560156185|FG000|Overall Study|Pregnancy|1|||
155196375|NCT03113916|560156186|FG001|Overall Study|Pregnancy|3|||
155196376|NCT03113916|560156185|FG000|Overall Study|Lost to Follow-up|1|||
155196377|NCT03113916|560156186|FG001|Overall Study|Lost to Follow-up|2|||
155196378|NCT01758523|560156188|FG000|Overall Study|Adverse Event|2|||
155196379|NCT01758523|560156189|FG001|Overall Study|Adverse Event|1|||
155196380|NCT01758523|560156188|FG000|Overall Study|Lack of Efficacy|4|||
155196381|NCT01758523|560156189|FG001|Overall Study|Lack of Efficacy|2|||
155196382|NCT01758523|560156188|FG000|Overall Study|Lost to Follow-up|3|||
155196383|NCT01758523|560156189|FG001|Overall Study|Lost to Follow-up|4|||
155196384|NCT01758523|560156188|FG000|Overall Study|Withdrawal by Subject|12|||
155196385|NCT01758523|560156189|FG001|Overall Study|Withdrawal by Subject|7|||
155196386|NCT00722800|560156190|FG000|Overall Study|Withdrawal by Subject|1|||
155196387|NCT00722800|560156191|FG001|Overall Study|Withdrawal by Subject|0|||
155196388|NCT00722800|560156190|FG000|Overall Study|Physician Decision|1|||
155196389|NCT00722800|560156191|FG001|Overall Study|Physician Decision|0|||
155196390|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
155196391|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
155196392|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196393|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196394|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196395|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
155196396|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
155196397|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196398|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196399|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196400|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
155196401|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
155196402|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196403|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196404|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196405|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155196406|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155196407|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
155196408|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
155196409|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
155196410|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196411|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196412|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196413|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
155196414|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196415|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
155196416|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
155196417|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
155196418|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
155196419|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
155196420|NCT01449539|560156197|FG000|Overall Study|Withdrawal by Subject|3|||
155196421|NCT01449539|560156197|FG000|Overall Study|Toxicity not study related|1|||
155196422|NCT01387789|560156198|FG000|Overall Study|Adverse Event|5|||
155196423|NCT01387789|560156198|FG000|Overall Study|Lack of Efficacy|2|||
155196424|NCT01387789|560156198|FG000|Overall Study|Lost to Follow-up|1|||
155196425|NCT00913380|560156201|FG000|Clinical Outcomes|Lost to Follow-up|6|||
155196426|NCT00913380|560156202|FG001|Clinical Outcomes|Lost to Follow-up|6|||
155196427|NCT01788228|560156203|FG000|Overall Study|Migrated/moved from study area|1|||
155196428|NCT01788228|560156204|FG001|Overall Study|Migrated/moved from study area|0|||
155196429|NCT02187744|560156205|FG000|Study|Participant refused further follow-up|1|||
155196430|NCT02187744|560156206|FG001|Study|Participant refused further follow-up|0|||
155196431|NCT02187744|560156205|FG000|Study|Other|2|||
155196432|NCT02187744|560156206|FG001|Study|Other|1|||
155196433|NCT02187744|560156205|FG000|Study|Lost to Follow-up|0|||
155196434|NCT02187744|560156206|FG001|Study|Lost to Follow-up|2|||
155196435|NCT02187744|560156205|FG000|Study|Related adverse event, not serious|0|||
155196436|NCT02187744|560156206|FG001|Study|Related adverse event, not serious|2|||
155196437|NCT02187744|560156205|FG000|Study|Death|1|||
155196438|NCT02187744|560156206|FG001|Study|Death|0|||
155196439|NCT02187744|560156205|FG000|Study|Related adverse event, serious non-fatal|0|||
155196440|NCT02187744|560156206|FG001|Study|Related adverse event, serious non-fatal|1|||
155196441|NCT02187744|560156205|FG000|Treatment|Death|1|||
155196442|NCT02187744|560156206|FG001|Treatment|Death|0|||
155196443|NCT02187744|560156205|FG000|Treatment|Related adverse event, serious non-fatal|0|||
155196444|NCT02187744|560156206|FG001|Treatment|Related adverse event, serious non-fatal|1|||
155196445|NCT02187744|560156205|FG000|Treatment|Related adverse event, not serious|0|||
155196446|NCT02187744|560156206|FG001|Treatment|Related adverse event, not serious|2|||
155196447|NCT02187744|560156205|FG000|Treatment|Lost to Follow-up|0|||
155196448|NCT02187744|560156206|FG001|Treatment|Lost to Follow-up|1|||
155196449|NCT02187744|560156205|FG000|Treatment|Other|2|||
155196450|NCT02187744|560156206|FG001|Treatment|Other|0|||
155196451|NCT02187744|560156205|FG000|Treatment|Participant refused continued treatment|1|||
155196452|NCT02187744|560156206|FG001|Treatment|Participant refused continued treatment|1|||
155196453|NCT01602120|560156210|FG000|Overall Study|Adverse Event|3|||
155196454|NCT01602120|560156211|FG001|Overall Study|Adverse Event|6|||
155196455|NCT01602120|560156212|FG002|Overall Study|Adverse Event|0|||
155196456|NCT01602120|560156213|FG003|Overall Study|Adverse Event|2|||
155196457|NCT01602120|560156210|FG000|Overall Study|Death|0|||
155196458|NCT01602120|560156211|FG001|Overall Study|Death|4|||
155196459|NCT01602120|560156212|FG002|Overall Study|Death|0|||
155196460|NCT01602120|560156213|FG003|Overall Study|Death|0|||
155196461|NCT01602120|560156210|FG000|Overall Study|Lost to Follow-up|0|||
155196462|NCT01602120|560156211|FG001|Overall Study|Lost to Follow-up|1|||
155196463|NCT01602120|560156212|FG002|Overall Study|Lost to Follow-up|0|||
155196464|NCT01602120|560156213|FG003|Overall Study|Lost to Follow-up|1|||
155196465|NCT01602120|560156210|FG000|Overall Study|Protocol Violation|1|||
155196466|NCT01602120|560156211|FG001|Overall Study|Protocol Violation|1|||
155196467|NCT01602120|560156212|FG002|Overall Study|Protocol Violation|0|||
155196468|NCT01602120|560156213|FG003|Overall Study|Protocol Violation|0|||
155196469|NCT01602120|560156210|FG000|Overall Study|Non-compliance|0|||
155196470|NCT01602120|560156211|FG001|Overall Study|Non-compliance|3|||
155196471|NCT01602120|560156212|FG002|Overall Study|Non-compliance|0|||
155196472|NCT01602120|560156213|FG003|Overall Study|Non-compliance|1|||
155196473|NCT01602120|560156210|FG000|Overall Study|Withdrawal by Subject|8|||
155196474|NCT01602120|560156211|FG001|Overall Study|Withdrawal by Subject|17|||
155196475|NCT01602120|560156212|FG002|Overall Study|Withdrawal by Subject|0|||
155196476|NCT01602120|560156213|FG003|Overall Study|Withdrawal by Subject|3|||
155196477|NCT01602120|560156210|FG000|Overall Study|Study Terminated by Sponsor|12|||
155196478|NCT01602120|560156211|FG001|Overall Study|Study Terminated by Sponsor|24|||
155196479|NCT01602120|560156212|FG002|Overall Study|Study Terminated by Sponsor|17|||
155196480|NCT01602120|560156213|FG003|Overall Study|Study Terminated by Sponsor|44|||
155196481|NCT01602120|560156210|FG000|Overall Study|Physician Decision|2|||
155196482|NCT01602120|560156211|FG001|Overall Study|Physician Decision|3|||
155196483|NCT01602120|560156212|FG002|Overall Study|Physician Decision|0|||
155196484|NCT01602120|560156213|FG003|Overall Study|Physician Decision|0|||
155196485|NCT01602120|560156210|FG000|Overall Study|Unspecified Reason|3|||
155196486|NCT01602120|560156211|FG001|Overall Study|Unspecified Reason|1|||
155196487|NCT01602120|560156212|FG002|Overall Study|Unspecified Reason|0|||
155196488|NCT01602120|560156213|FG003|Overall Study|Unspecified Reason|2|||
155196489|NCT01187433|560156222|FG000|Overall Study|Protocol Violation|6|||
155196490|NCT01187433|560156223|FG001|Overall Study|Protocol Violation|2|||
155196491|NCT01187433|560156222|FG000|Overall Study|Withdrawal by Subject|5|||
155196492|NCT01187433|560156223|FG001|Overall Study|Withdrawal by Subject|2|||
155196493|NCT04223973|560156226|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
155196494|NCT04223973|560156227|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
155196495|NCT04223973|560156226|FG000|Overall Study|Adverse Event|4|||
155196496|NCT04223973|560156227|FG001|Overall Study|Adverse Event|0|||
155196497|NCT04223973|560156226|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
155196498|NCT04223973|560156227|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
155196499|NCT04223973|560156226|FG000|Overall Study|Physician Decision|1|||
155196500|NCT04223973|560156227|FG001|Overall Study|Physician Decision|1|||
155196501|NCT04223973|560156226|FG000|Overall Study|Withdrawal by Subject|0|||
155196502|NCT04223973|560156227|FG001|Overall Study|Withdrawal by Subject|1|||
155196503|NCT00594659|560156230|FG000|Overall Study|Lost to Follow-up|13|||
155196504|NCT00594659|560156231|FG001|Overall Study|Lost to Follow-up|9|||
155196505|NCT00594659|560156232|FG002|Overall Study|Lost to Follow-up|7|||
155196506|NCT04439201|560156240|FG000|Overall Study|Ineligible|2|||
155196507|NCT04439201|560156240|FG000|Overall Study|Never start protocol therapy|1|||
155196508|NCT04439201|560156240|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
155196509|NCT04439201|560156240|FG000|Overall Study|Mutation status not confirmed|4|||
155196510|NCT04439201|560156240|FG000|Overall Study|Adverse Event|1|||
155196511|NCT04439201|560156240|FG000|Overall Study|Death|7|||
155196512|NCT04439201|560156240|FG000|Overall Study|Withdrawal by Subject|2|||
155196513|NCT04439201|560156240|FG000|Overall Study|Disease progression|20|||
155196514|NCT04439201|560156240|FG000|Overall Study|Alternative therapy|1|||
155196515|NCT04439201|560156240|FG000|Overall Study|Physician Decision|1|||
155196516|NCT05136690|560156241|FG000|Period 1|Withdrawal by Subject|0|||
155196517|NCT05136690|560156242|FG001|Period 1|Withdrawal by Subject|1|||
155196518|NCT05136690|560156241|FG000|Period 2|Lost to Follow-up|0|||
155196519|NCT05136690|560156242|FG001|Period 2|Lost to Follow-up|3|||
155196520|NCT05136690|560156241|FG000|Period 2|Withdrawal by Subject|0|||
155196521|NCT05136690|560156242|FG001|Period 2|Withdrawal by Subject|1|||
155196522|NCT01995825|560158324|FG000|Overall Study|Withdrawal by Subject|1|||
155196523|NCT01995825|560158325|FG001|Overall Study|Withdrawal by Subject|0|||
155196524|NCT01367002|560158326|FG000|Overall Study|Withdrawal by Subject|1|||
155196525|NCT01367002|560158327|FG001|Overall Study|Withdrawal by Subject|0|||
155196526|NCT01367002|560158326|FG000|Overall Study|Physician Decision|0|||
155196527|NCT01367002|560158327|FG001|Overall Study|Physician Decision|2|||
155196528|NCT00560105|560158330|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
155196529|NCT00560105|560158331|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
155196530|NCT02400333|560158332|FG000|Overall Study|Withdrawal by Subject|0|||
155196531|NCT02400333|560158333|FG001|Overall Study|Withdrawal by Subject|1|||
155196532|NCT02400333|560158334|FG002|Overall Study|Withdrawal by Subject|0|||
155196533|NCT02400333|560158335|FG003|Overall Study|Withdrawal by Subject|1|||
155196534|NCT02400333|560158332|FG000|Overall Study|Protocol Violation|1|||
155196535|NCT02400333|560158333|FG001|Overall Study|Protocol Violation|0|||
155196536|NCT02400333|560158334|FG002|Overall Study|Protocol Violation|2|||
155196537|NCT02400333|560158335|FG003|Overall Study|Protocol Violation|1|||
155196538|NCT03281577|560158337|FG000|Overall Study|Adverse Event|0|||
155196539|NCT03281577|560158338|FG001|Overall Study|Adverse Event|0|||
155196540|NCT03281577|560158339|FG002|Overall Study|Adverse Event|0|||
155196541|NCT03281577|560158340|FG003|Overall Study|Adverse Event|1|||
155196542|NCT03281577|560158337|FG000|Overall Study|Withdrawal by Subject|1|||
155196543|NCT03281577|560158338|FG001|Overall Study|Withdrawal by Subject|0|||
155196544|NCT03281577|560158339|FG002|Overall Study|Withdrawal by Subject|0|||
155196545|NCT03281577|560158340|FG003|Overall Study|Withdrawal by Subject|0|||
155196546|NCT01687998|560158345|FG000|Overall Study|Withdrawal by Subject|49|||
155196547|NCT01687998|560158346|FG001|Overall Study|Withdrawal by Subject|51|||
155196548|NCT01687998|560158345|FG000|Overall Study|Known to be Alive at Study End|54|||
155196549|NCT01687998|560158346|FG001|Overall Study|Known to be Alive at Study End|62|||
155196550|NCT01687998|560158345|FG000|Overall Study|Lost to Follow-up|9|||
155196551|NCT01687998|560158346|FG001|Overall Study|Lost to Follow-up|7|||
155196552|NCT00443261|560158347|FG000|Overall Study|Death|1|||
155196553|NCT01550289|560158348|FG000|Overall Study|Protocol Violation|1|||
155196554|NCT01550289|560158349|FG001|Overall Study|Protocol Violation|0|||
155196555|NCT01550289|560158348|FG000|Overall Study|Lost to Follow-up|1|||
155196556|NCT01550289|560158349|FG001|Overall Study|Lost to Follow-up|1|||
155196557|NCT01550289|560158348|FG000|Overall Study|Withdrawal by Subject|11|||
155196558|NCT01550289|560158349|FG001|Overall Study|Withdrawal by Subject|3|||
155196559|NCT00739674|560158350|FG000|Overall Study|Screening failures|19|||
155196560|NCT00739674|560158351|FG001|Overall Study|Screening failures|17|||
155196561|NCT00739674|560158350|FG000|Overall Study|Site 212 removal|19|||
155196562|NCT00739674|560158351|FG001|Overall Study|Site 212 removal|13|||
155196563|NCT00739674|560158350|FG000|Overall Study|No follow-up data|33|||
155196564|NCT00739674|560158351|FG001|Overall Study|No follow-up data|18|||
155196565|NCT00739674|560158350|FG000|Overall Study|Dietician consultation >30 days|1|||
155196566|NCT00739674|560158351|FG001|Overall Study|Dietician consultation >30 days|9|||
155196567|NCT00739674|560158350|FG000|Overall Study|Adverse Event|22|||
155196568|NCT00739674|560158351|FG001|Overall Study|Adverse Event|13|||
155196569|NCT00739674|560158350|FG000|Overall Study|Death|1|||
155196570|NCT00739674|560158351|FG001|Overall Study|Death|0|||
155196571|NCT00739674|560158350|FG000|Overall Study|Lack of Efficacy|1|||
155196572|NCT00739674|560158351|FG001|Overall Study|Lack of Efficacy|0|||
155196573|NCT00739674|560158350|FG000|Overall Study|Lost to Follow-up|52|||
155196574|NCT00739674|560158351|FG001|Overall Study|Lost to Follow-up|30|||
155196575|NCT00739674|560158350|FG000|Overall Study|Protocol Violation|5|||
155196576|NCT00739674|560158351|FG001|Overall Study|Protocol Violation|5|||
155196577|NCT00739674|560158350|FG000|Overall Study|Withdrawal by Subject|9|||
155196578|NCT00739674|560158351|FG001|Overall Study|Withdrawal by Subject|9|||
155196579|NCT00739674|560158350|FG000|Overall Study|Reason missing|2|||
155196580|NCT00739674|560158351|FG001|Overall Study|Reason missing|0|||
155196581|NCT00739674|560158350|FG000|Overall Study|Clinic closed|6|||
155196582|NCT00739674|560158351|FG001|Overall Study|Clinic closed|4|||
155196583|NCT00739674|560158350|FG000|Overall Study|Patient moved|3|||
155196584|NCT00739674|560158351|FG001|Overall Study|Patient moved|2|||
155196585|NCT00739674|560158350|FG000|Overall Study|Non compliant|4|||
155196586|NCT00739674|560158351|FG001|Overall Study|Non compliant|0|||
155196587|NCT00739674|560158350|FG000|Overall Study|Unable to attend visit|3|||
155196588|NCT00739674|560158351|FG001|Overall Study|Unable to attend visit|1|||
155196589|NCT00739674|560158350|FG000|Overall Study|Home monitoring off meds|1|||
155196590|NCT00739674|560158351|FG001|Overall Study|Home monitoring off meds|0|||
155196591|NCT00739674|560158350|FG000|Overall Study|Erectile dysfunction|0|||
155196592|NCT00739674|560158351|FG001|Overall Study|Erectile dysfunction|1|||
155196593|NCT00354744|560158352|FG000|Overall Study|Adverse Event|2|||
155196594|NCT00354744|560158352|FG000|Overall Study|Death|2|||
155196595|NCT00354744|560158352|FG000|Overall Study|Lack of Efficacy|11|||
155196596|NCT00354744|560158352|FG000|Overall Study|Lost to Follow-up|2|||
155196597|NCT00354744|560158352|FG000|Overall Study|Physician Decision|11|||
155196598|NCT00354744|560158352|FG000|Overall Study|Withdrawal by Subject|14|||
155196599|NCT00541931|560158356|FG000|Overall Study|Adverse Event|1|||
155196600|NCT00541931|560158357|FG001|Overall Study|Adverse Event|0|||
155196601|NCT00541931|560158356|FG000|Overall Study|Lost to Follow-up|3|||
155196602|NCT00541931|560158357|FG001|Overall Study|Lost to Follow-up|3|||
155196603|NCT00541931|560158356|FG000|Overall Study|Withdrawal by Subject|1|||
155196604|NCT00541931|560158357|FG001|Overall Study|Withdrawal by Subject|0|||
155196605|NCT00541931|560158356|FG000|Overall Study|Transportation Issue|0|||
155196606|NCT00541931|560158357|FG001|Overall Study|Transportation Issue|1|||
155196607|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
155196608|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
155196609|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Progression|3|||
155196610|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
155196611|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Death|2|||
155196612|NCT00064337|560158358|FG000|Transplant|Adverse Event|9|||
155196613|NCT00064337|560158358|FG000|Transplant|Not protocol-specified|5|||
155196614|NCT00064337|560158358|FG000|Transplant|Death|3|||
155196615|NCT00064337|560158358|FG000|Transplant|Patient Refusal|2|||
155196616|NCT00064337|560158358|FG000|Transplant|Progression|2|||
155196617|NCT00064337|560158358|FG000|Maintenance|Adverse Event|3|||
155196618|NCT00064337|560158358|FG000|Maintenance|Progression|2|||
155196619|NCT00064337|560158358|FG000|Maintenance|On treatment at time of analysis|2|||
155196620|NCT00064337|560158358|FG000|Maintenance|Not protocol-specified|2|||
155196621|NCT00064337|560158358|FG000|Maintenance|Death|1|||
155196622|NCT00617851|560158361|FG000|Overall Study|Death|0|||
155196623|NCT00617851|560158362|FG001|Overall Study|Death|0|||
155196624|NCT00617851|560158363|FG002|Overall Study|Death|0|||
155196625|NCT00617851|560158364|FG003|Overall Study|Death|1|||
155196626|NCT00617851|560158361|FG000|Overall Study|Withdrawal by Subject|14|||
155196627|NCT00617851|560158362|FG001|Overall Study|Withdrawal by Subject|7|||
155196628|NCT00617851|560158363|FG002|Overall Study|Withdrawal by Subject|12|||
155196629|NCT00617851|560158364|FG003|Overall Study|Withdrawal by Subject|4|||
155196630|NCT00617851|560158361|FG000|Overall Study|Lost to Follow-up|27|||
155196631|NCT00617851|560158362|FG001|Overall Study|Lost to Follow-up|29|||
155196632|NCT00617851|560158363|FG002|Overall Study|Lost to Follow-up|31|||
155196633|NCT00617851|560158364|FG003|Overall Study|Lost to Follow-up|19|||
155196634|NCT00617851|560158361|FG000|Overall Study|Inappropriate Enrollment|5|||
155196635|NCT00617851|560158362|FG001|Overall Study|Inappropriate Enrollment|4|||
155196636|NCT00617851|560158363|FG002|Overall Study|Inappropriate Enrollment|1|||
155196637|NCT00617851|560158364|FG003|Overall Study|Inappropriate Enrollment|1|||
155196638|NCT00617851|560158361|FG000|Overall Study|Unable to classify|1|||
155196639|NCT00617851|560158362|FG001|Overall Study|Unable to classify|0|||
155196640|NCT00617851|560158363|FG002|Overall Study|Unable to classify|1|||
155196641|NCT00617851|560158364|FG003|Overall Study|Unable to classify|0|||
155196642|NCT03750955|560158371|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
155196643|NCT03750955|560158372|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
155196644|NCT03750955|560158371|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
155196645|NCT03750955|560158372|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
155196646|NCT00697788|560158375|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196647|NCT00697788|560158376|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
155196648|NCT00697788|560158377|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196649|NCT00697788|560158378|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196650|NCT00697788|560158379|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196651|NCT00697788|560158380|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196652|NCT00697788|560158381|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196653|NCT00697788|560158382|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196654|NCT00697788|560158375|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196655|NCT00697788|560158376|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196656|NCT00697788|560158377|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196657|NCT00697788|560158378|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196658|NCT00697788|560158379|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
155196659|NCT00697788|560158380|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196660|NCT00697788|560158381|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196661|NCT00697788|560158382|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196662|NCT01180985|560158384|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
155196663|NCT01180985|560158385|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
155196664|NCT00705289|560158386|FG000|Overall Study|Subject or treating physician's choice|131|||
155196665|NCT01030536|560158387|FG000|Overall Study|Withdrawal by Subject|0|||
155196666|NCT01030536|560158388|FG001|Overall Study|Withdrawal by Subject|0|||
155196667|NCT01030536|560158389|FG002|Overall Study|Withdrawal by Subject|1|||
155196668|NCT01030536|560158390|FG003|Overall Study|Withdrawal by Subject|0|||
155196669|NCT01030536|560158391|FG004|Overall Study|Withdrawal by Subject|0|||
155196670|NCT01030536|560158387|FG000|Overall Study|undefined|1|||
155196671|NCT01030536|560158388|FG001|Overall Study|undefined|0|||
155196672|NCT01030536|560158389|FG002|Overall Study|undefined|1|||
155196673|NCT01030536|560158390|FG003|Overall Study|undefined|1|||
155196674|NCT01030536|560158391|FG004|Overall Study|undefined|0|||
155196675|NCT01030536|560158387|FG000|Overall Study|Adverse Event|0|||
155196676|NCT01030536|560158388|FG001|Overall Study|Adverse Event|3|||
155196677|NCT01030536|560158389|FG002|Overall Study|Adverse Event|1|||
155196678|NCT01030536|560158390|FG003|Overall Study|Adverse Event|0|||
155196679|NCT01030536|560158391|FG004|Overall Study|Adverse Event|1|||
155196680|NCT01030536|560158387|FG000|Overall Study|Progressive disease|6|||
155196681|NCT01030536|560158388|FG001|Overall Study|Progressive disease|2|||
155196682|NCT01030536|560158389|FG002|Overall Study|Progressive disease|3|||
155196683|NCT01030536|560158390|FG003|Overall Study|Progressive disease|2|||
155196684|NCT01030536|560158391|FG004|Overall Study|Progressive disease|0|||
155196685|NCT01030536|560158387|FG000|Overall Study|Death|0|||
155196686|NCT01030536|560158388|FG001|Overall Study|Death|1|||
155196687|NCT01030536|560158389|FG002|Overall Study|Death|0|||
155196688|NCT01030536|560158390|FG003|Overall Study|Death|0|||
155196689|NCT01030536|560158391|FG004|Overall Study|Death|0|||
155196690|NCT02763462|560158394|FG000|Overall Study|Protocol Violation|6|||
155196691|NCT00675948|560158395|FG000|Overall Study|Adverse Event|23|||
155196692|NCT00675948|560158396|FG001|Overall Study|Adverse Event|1|||
155196693|NCT00675948|560158395|FG000|Overall Study|Lack of Efficacy|3|||
155196694|NCT00675948|560158396|FG001|Overall Study|Lack of Efficacy|0|||
155196695|NCT00675948|560158395|FG000|Overall Study|Withdrawal by Subject|7|||
155196696|NCT00675948|560158396|FG001|Overall Study|Withdrawal by Subject|0|||
155196697|NCT00675948|560158395|FG000|Overall Study|Lost to Follow-up|2|||
155196698|NCT00675948|560158396|FG001|Overall Study|Lost to Follow-up|0|||
155196699|NCT00675948|560158395|FG000|Overall Study|Protocol Violation|1|||
155196700|NCT00675948|560158396|FG001|Overall Study|Protocol Violation|0|||
155196701|NCT00675948|560158395|FG000|Overall Study|Pain under control|1|||
155196702|NCT00675948|560158396|FG001|Overall Study|Pain under control|0|||
155196703|NCT00675948|560158395|FG000|Overall Study|Sponsor decision|0|||
155196704|NCT00675948|560158396|FG001|Overall Study|Sponsor decision|1|||
155196705|NCT00675948|560158395|FG000|Overall Study|Patient died|1|||
155196706|NCT00675948|560158396|FG001|Overall Study|Patient died|0|||
155196707|NCT00675948|560158395|FG000|Overall Study|Patient unable to comply with diaries|1|||
155196708|NCT00675948|560158396|FG001|Overall Study|Patient unable to comply with diaries|0|||
155196709|NCT00675948|560158395|FG000|Overall Study|Patient feels unable to take medication|0|||
155196710|NCT00675948|560158396|FG001|Overall Study|Patient feels unable to take medication|1|||
155196711|NCT02100514|560158398|FG000|Treatment Period|Adverse Event|0|||
155196712|NCT02100514|560158399|FG001|Treatment Period|Adverse Event|5|||
155196713|NCT02100514|560158400|FG002|Treatment Period|Adverse Event|0|||
155196714|NCT02100514|560158401|FG003|Treatment Period|Adverse Event|0|||
155196715|NCT02100514|560158402|FG004|Treatment Period|Adverse Event|0|||
155196716|NCT02100514|560158398|FG000|Treatment Period|Death|2|||
155196717|NCT02100514|560158399|FG001|Treatment Period|Death|2|||
155196718|NCT02100514|560158400|FG002|Treatment Period|Death|0|||
155196719|NCT02100514|560158401|FG003|Treatment Period|Death|0|||
155196720|NCT02100514|560158402|FG004|Treatment Period|Death|0|||
155196721|NCT02100514|560158398|FG000|Treatment Period|Lost to Follow-up|5|||
155196722|NCT02100514|560158399|FG001|Treatment Period|Lost to Follow-up|17|||
155196723|NCT02100514|560158400|FG002|Treatment Period|Lost to Follow-up|0|||
155196724|NCT02100514|560158401|FG003|Treatment Period|Lost to Follow-up|0|||
155196725|NCT02100514|560158402|FG004|Treatment Period|Lost to Follow-up|0|||
155196726|NCT02100514|560158398|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196727|NCT02100514|560158399|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
155196728|NCT02100514|560158400|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196729|NCT02100514|560158401|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196730|NCT02100514|560158402|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196731|NCT02100514|560158398|FG000|Treatment Period|Protocol Violation|1|||
155196732|NCT02100514|560158399|FG001|Treatment Period|Protocol Violation|1|||
155196733|NCT02100514|560158400|FG002|Treatment Period|Protocol Violation|0|||
155196734|NCT02100514|560158401|FG003|Treatment Period|Protocol Violation|0|||
155196735|NCT02100514|560158402|FG004|Treatment Period|Protocol Violation|0|||
155196736|NCT02100514|560158398|FG000|Treatment Period|Withdrawal by Subject|12|||
155196737|NCT02100514|560158399|FG001|Treatment Period|Withdrawal by Subject|37|||
155196738|NCT02100514|560158400|FG002|Treatment Period|Withdrawal by Subject|0|||
155196739|NCT02100514|560158401|FG003|Treatment Period|Withdrawal by Subject|0|||
155196740|NCT02100514|560158402|FG004|Treatment Period|Withdrawal by Subject|0|||
155196741|NCT02100514|560158398|FG000|Treatment Period|Other|9|||
155196742|NCT02100514|560158399|FG001|Treatment Period|Other|11|||
155196743|NCT02100514|560158400|FG002|Treatment Period|Other|0|||
155196744|NCT02100514|560158401|FG003|Treatment Period|Other|0|||
155196745|NCT02100514|560158402|FG004|Treatment Period|Other|0|||
155196746|NCT02100514|560158398|FG000|Extension Period|Withdrew consent|0|||
155196747|NCT02100514|560158399|FG001|Extension Period|Withdrew consent|0|||
155196748|NCT02100514|560158400|FG002|Extension Period|Withdrew consent|2|||
155196749|NCT02100514|560158401|FG003|Extension Period|Withdrew consent|0|||
155196750|NCT02100514|560158402|FG004|Extension Period|Withdrew consent|0|||
155196751|NCT02248701|560158405|FG000|Overall Study|Withdrawal by Subject|2|||
155196752|NCT02248701|560158406|FG001|Overall Study|Withdrawal by Subject|1|||
155196753|NCT02248701|560158405|FG000|Overall Study|Physician Decision|0|||
155196754|NCT02248701|560158406|FG001|Overall Study|Physician Decision|1|||
155196755|NCT02248701|560158405|FG000|Overall Study|Adverse Event|1|||
155196756|NCT02248701|560158406|FG001|Overall Study|Adverse Event|0|||
155196757|NCT02248701|560158405|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
155196758|NCT02248701|560158406|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
155196759|NCT00319553|560158409|FG000|Overall Study|Protocol Violation|1|||
155196760|NCT00319553|560158410|FG001|Overall Study|Protocol Violation|2|||
155196761|NCT00319553|560158409|FG000|Overall Study|Lost to Follow-up|2|||
155196762|NCT00319553|560158410|FG001|Overall Study|Lost to Follow-up|1|||
155196763|NCT00319553|560158409|FG000|Overall Study|Withdrawal by Subject|1|||
155196764|NCT00319553|560158410|FG001|Overall Study|Withdrawal by Subject|1|||
155196765|NCT01896102|560158411|FG000|Overall Study|Death|1|||
155196766|NCT01896102|560158411|FG000|Overall Study|Participant to receive allogenic transplant|2|||
155196767|NCT00762385|560158414|FG000|First Intervention|Lens Issue|1|||
155196768|NCT00762385|560158415|FG001|First Intervention|Lens Issue|1|||
155196769|NCT00762385|560158414|FG000|First Intervention|Lost to Follow-up|0|||
155196770|NCT00762385|560158415|FG001|First Intervention|Lost to Follow-up|2|||
155196771|NCT00762385|560158414|FG000|First Intervention|Ineligible|1|||
155196772|NCT00762385|560158415|FG001|First Intervention|Ineligible|0|||
155196773|NCT00762385|560158414|FG000|First Intervention|Protocol Violation|0|||
155196774|NCT00762385|560158415|FG001|First Intervention|Protocol Violation|1|||
155196775|NCT00762385|560158414|FG000|Second Intervention|Protocol Violation|3|||
155196776|NCT00762385|560158415|FG001|Second Intervention|Protocol Violation|3|||
155196777|NCT00591344|560158417|FG000|Overall Study|Transportation issues|1|||
155196778|NCT00591344|560158418|FG001|Overall Study|Transportation issues|0|||
155196779|NCT00591344|560158417|FG000|Overall Study|Moved out of state|1|||
155196780|NCT00591344|560158418|FG001|Overall Study|Moved out of state|0|||
155196781|NCT00591344|560158417|FG000|Overall Study|Medical complications|1|||
155196782|NCT00591344|560158418|FG001|Overall Study|Medical complications|3|||
155196783|NCT00591344|560158417|FG000|Overall Study|Underwent DBS|2|||
155196784|NCT00591344|560158418|FG001|Overall Study|Underwent DBS|2|||
155196785|NCT00591344|560158417|FG000|Overall Study|Death|0|||
155196786|NCT00591344|560158418|FG001|Overall Study|Death|1|||
155196787|NCT00591344|560158417|FG000|Overall Study|Lost to Follow-up|0|||
155196788|NCT00591344|560158418|FG001|Overall Study|Lost to Follow-up|1|||
155196789|NCT00591344|560158417|FG000|Overall Study|Did not want to come off medication|0|||
155196790|NCT00591344|560158418|FG001|Overall Study|Did not want to come off medication|1|||
155196791|NCT03863197|560158419|FG000|Overall Study|Lost to Follow-up|2|||
155196792|NCT03863197|560158420|FG001|Overall Study|Lost to Follow-up|3|||
155196793|NCT03863197|560158419|FG000|Overall Study|Withdrawal by Subject|4|||
155196794|NCT03863197|560158420|FG001|Overall Study|Withdrawal by Subject|0|||
155196795|NCT03863197|560158419|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
155196796|NCT03863197|560158420|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
155196797|NCT01065597|560158421|FG000|Overall Study|Adverse Event|1|||
155196798|NCT01781975|560158422|FG000|Overall Study|Death|1|||
155196799|NCT01781975|560158423|FG001|Overall Study|Death|0|||
155196800|NCT01781975|560158422|FG000|Overall Study|Withdrawal by Subject|1|||
155196801|NCT01781975|560158423|FG001|Overall Study|Withdrawal by Subject|1|||
155196802|NCT01622231|560158424|FG000|Overall Study|Physician Decision|1|||
155196803|NCT01622231|560158424|FG000|Overall Study|Withdrawal by Subject|1|||
155196804|NCT02329080|560158425|FG000|Overall Study|Adverse Event|1|||
155196805|NCT02329080|560158425|FG000|Overall Study|Death|4|||
155196806|NCT02329080|560158425|FG000|Overall Study|Lack of Efficacy|22|||
155196807|NCT02329080|560158425|FG000|Overall Study|Lost to Follow-up|1|||
155196808|NCT02329080|560158425|FG000|Overall Study|Physician Decision|2|||
155196809|NCT02329080|560158425|FG000|Overall Study|Partial response|4|||
155196810|NCT02329080|560158425|FG000|Overall Study|Complete response|4|||
155196811|NCT00973674|560158428|FG000|Overall Study|Protocol Violation|2|||
155196812|NCT00973674|560158429|FG001|Overall Study|Protocol Violation|0|||
155196813|NCT03082261|560158436|FG000|Overall Study|Death|4|||
155196814|NCT03082261|560158436|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
155196815|NCT03082261|560158436|FG000|Overall Study|Insurance denial|1|||
155196816|NCT03082261|560158436|FG000|Overall Study|Peripheral lead added|1|||
155196817|NCT03082261|560158436|FG000|Overall Study|Withdrawal by Subject|40|||
155196818|NCT03082261|560158436|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
155196819|NCT03082261|560158436|FG000|Overall Study|Subject implanted with device other than study device|1|||
155196820|NCT03082261|560158436|FG000|Overall Study|Lost to Follow-up|14|||
155196821|NCT03082261|560158436|FG000|Overall Study|Subject moved to a different state|1|||
155196822|NCT03082261|560158436|FG000|Overall Study|Subject non-compliance|2|||
155196823|NCT03082261|560158436|FG000|Overall Study|Subject participation terminated by investigator|9|||
155196824|NCT03082261|560158436|FG000|Overall Study|Subject participation terminated by sponsor|4|||
155196825|NCT03082261|560158436|FG000|Overall Study|System explant|19|||
155196826|NCT03082261|560158436|FG000|Overall Study|Unable to place lead(s)|2|||
155196827|NCT03082261|560158436|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
155196828|NCT00839852|560158437|FG000|Overall Study|Adverse Event|10|||
155196829|NCT00839852|560158437|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155196830|NCT00839852|560158437|FG000|Overall Study|Protocol Violation|9|||
155196831|NCT00839852|560158437|FG000|Overall Study|Withdrawal of Consent|16|||
155196832|NCT00839852|560158437|FG000|Overall Study|Lost to Follow-up|7|||
155196833|NCT00839852|560158437|FG000|Overall Study|Lack of Compliance While in Jail|1|||
155196834|NCT00839852|560158437|FG000|Overall Study|Pregnancy|1|||
155196835|NCT00494299|560158442|FG000|Overall Study|Adverse Event|93|||
155196836|NCT00494299|560158443|FG001|Overall Study|Adverse Event|13|||
155196837|NCT00494299|560158442|FG000|Overall Study|Lost to Follow-up|1|||
155196838|NCT00494299|560158443|FG001|Overall Study|Lost to Follow-up|0|||
155196839|NCT00494299|560158442|FG000|Overall Study|Physician Decision|0|||
155196840|NCT00494299|560158443|FG001|Overall Study|Physician Decision|2|||
155196841|NCT00494299|560158442|FG000|Overall Study|Protocol Violation|1|||
155196842|NCT00494299|560158443|FG001|Overall Study|Protocol Violation|2|||
155196843|NCT00494299|560158442|FG000|Overall Study|Withdrawal by Subject|8|||
155196844|NCT00494299|560158443|FG001|Overall Study|Withdrawal by Subject|3|||
155196845|NCT00494299|560158442|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
155196846|NCT00494299|560158443|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
155196847|NCT00494299|560158442|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
155196848|NCT00494299|560158443|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
155196849|NCT00494299|560158442|FG000|Overall Study|Site Closed by Sponsor|6|||
155196850|NCT00494299|560158443|FG001|Overall Study|Site Closed by Sponsor|0|||
155196851|NCT00494299|560158442|FG000|Overall Study|Protocol Driven Decision Point|11|||
155196852|NCT00494299|560158443|FG001|Overall Study|Protocol Driven Decision Point|22|||
155196853|NCT01281137|560158445|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
155196854|NCT01281137|560158446|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
155196855|NCT01281137|560158445|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
155196856|NCT01281137|560158446|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
155491238|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
155196857|NCT01281137|560158445|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
155196858|NCT01281137|560158446|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
155196859|NCT01281137|560158445|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
155196860|NCT01281137|560158446|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
155196861|NCT01281137|560158445|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
155196862|NCT01281137|560158446|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
155196863|NCT02846324|560158449|FG000|Overall Study|Other|1|||
155196864|NCT02846324|560158450|FG001|Overall Study|Other|0|||
155196865|NCT02846324|560158451|FG002|Overall Study|Other|0|||
155196866|NCT02846324|560158452|FG003|Overall Study|Other|0|||
155196867|NCT02846324|560158449|FG000|Overall Study|Withdrawal by Subject|1|||
155196868|NCT02846324|560158450|FG001|Overall Study|Withdrawal by Subject|0|||
155196869|NCT02846324|560158451|FG002|Overall Study|Withdrawal by Subject|4|||
155196870|NCT02846324|560158452|FG003|Overall Study|Withdrawal by Subject|0|||
155196871|NCT03822182|560158457|FG000|Overall Study|Protocol Violation|0|||
155196872|NCT03822182|560158458|FG001|Overall Study|Protocol Violation|1|||
155196873|NCT03822182|560158459|FG002|Overall Study|Protocol Violation|1|||
155196874|NCT00810355|560158460|FG000|Overall Study|Lost to Follow-up|13|||
155196875|NCT00810355|560158461|FG001|Overall Study|Lost to Follow-up|17|||
155196876|NCT00810355|560158462|FG002|Overall Study|Lost to Follow-up|11|||
155196877|NCT00810355|560158460|FG000|Overall Study|Withdrawal by Subject|1|||
155196878|NCT00810355|560158461|FG001|Overall Study|Withdrawal by Subject|0|||
155196879|NCT00810355|560158462|FG002|Overall Study|Withdrawal by Subject|0|||
155196880|NCT02130297|560158469|FG000|Overall Study|Lost to Follow-up|4|||
155196881|NCT00347360|560158480|FG000|Overall Study|Adverse Event|1|||
155196882|NCT00347360|560158481|FG001|Overall Study|Adverse Event|2|||
155196883|NCT00347360|560158482|FG002|Overall Study|Adverse Event|0|||
155196884|NCT00347360|560158483|FG003|Overall Study|Adverse Event|4|||
155196885|NCT00347360|560158484|FG004|Overall Study|Adverse Event|1|||
155196886|NCT00347360|560158485|FG005|Overall Study|Adverse Event|2|||
155196887|NCT00347360|560158486|FG006|Overall Study|Adverse Event|2|||
155196888|NCT00347360|560158487|FG007|Overall Study|Adverse Event|0|||
155196889|NCT00347360|560158488|FG008|Overall Study|Adverse Event|2|||
155196890|NCT00347360|560158489|FG009|Overall Study|Adverse Event|3|||
155196891|NCT00347360|560158490|FG010|Overall Study|Adverse Event|3|||
155196892|NCT00347360|560158491|FG011|Overall Study|Adverse Event|1|||
155196893|NCT00347360|560158492|FG012|Overall Study|Adverse Event|3|||
155196894|NCT00347360|560158493|FG013|Overall Study|Adverse Event|2|||
155196895|NCT00347360|560158494|FG014|Overall Study|Adverse Event|2|||
155196896|NCT00347360|560158480|FG000|Overall Study|Lost to Follow-up|0|||
155196897|NCT00347360|560158481|FG001|Overall Study|Lost to Follow-up|0|||
155196898|NCT00347360|560158482|FG002|Overall Study|Lost to Follow-up|0|||
155196899|NCT00347360|560158483|FG003|Overall Study|Lost to Follow-up|2|||
155196900|NCT00347360|560158484|FG004|Overall Study|Lost to Follow-up|1|||
155196901|NCT00347360|560158485|FG005|Overall Study|Lost to Follow-up|1|||
155196902|NCT00347360|560158486|FG006|Overall Study|Lost to Follow-up|0|||
155196903|NCT00347360|560158487|FG007|Overall Study|Lost to Follow-up|1|||
155196904|NCT00347360|560158488|FG008|Overall Study|Lost to Follow-up|1|||
155196905|NCT00347360|560158489|FG009|Overall Study|Lost to Follow-up|2|||
155196906|NCT00347360|560158490|FG010|Overall Study|Lost to Follow-up|0|||
155196907|NCT00347360|560158491|FG011|Overall Study|Lost to Follow-up|0|||
155196908|NCT00347360|560158492|FG012|Overall Study|Lost to Follow-up|1|||
155196909|NCT00347360|560158493|FG013|Overall Study|Lost to Follow-up|0|||
155196910|NCT00347360|560158494|FG014|Overall Study|Lost to Follow-up|0|||
155196911|NCT00347360|560158480|FG000|Overall Study|Protocol Violation|2|||
155196912|NCT00347360|560158481|FG001|Overall Study|Protocol Violation|3|||
155196913|NCT00347360|560158482|FG002|Overall Study|Protocol Violation|1|||
155196914|NCT00347360|560158483|FG003|Overall Study|Protocol Violation|2|||
155196915|NCT00347360|560158484|FG004|Overall Study|Protocol Violation|1|||
155196916|NCT00347360|560158485|FG005|Overall Study|Protocol Violation|2|||
155196917|NCT00347360|560158486|FG006|Overall Study|Protocol Violation|0|||
155196918|NCT00347360|560158487|FG007|Overall Study|Protocol Violation|0|||
155196919|NCT00347360|560158488|FG008|Overall Study|Protocol Violation|1|||
155196920|NCT00347360|560158489|FG009|Overall Study|Protocol Violation|2|||
155196921|NCT00347360|560158490|FG010|Overall Study|Protocol Violation|0|||
155196922|NCT00347360|560158491|FG011|Overall Study|Protocol Violation|0|||
155196923|NCT00347360|560158492|FG012|Overall Study|Protocol Violation|0|||
155196924|NCT00347360|560158493|FG013|Overall Study|Protocol Violation|1|||
155196925|NCT00347360|560158494|FG014|Overall Study|Protocol Violation|0|||
155196926|NCT00347360|560158480|FG000|Overall Study|Withdrawal by Subject|0|||
155196927|NCT00347360|560158481|FG001|Overall Study|Withdrawal by Subject|1|||
155196928|NCT00347360|560158482|FG002|Overall Study|Withdrawal by Subject|2|||
155196929|NCT00347360|560158483|FG003|Overall Study|Withdrawal by Subject|4|||
155196930|NCT00347360|560158484|FG004|Overall Study|Withdrawal by Subject|1|||
155196931|NCT00347360|560158485|FG005|Overall Study|Withdrawal by Subject|2|||
155196932|NCT00347360|560158486|FG006|Overall Study|Withdrawal by Subject|1|||
155196933|NCT00347360|560158487|FG007|Overall Study|Withdrawal by Subject|1|||
155196934|NCT00347360|560158488|FG008|Overall Study|Withdrawal by Subject|1|||
155196935|NCT00347360|560158489|FG009|Overall Study|Withdrawal by Subject|1|||
155196936|NCT00347360|560158490|FG010|Overall Study|Withdrawal by Subject|0|||
155196937|NCT00347360|560158491|FG011|Overall Study|Withdrawal by Subject|3|||
155196938|NCT00347360|560158492|FG012|Overall Study|Withdrawal by Subject|4|||
155196939|NCT00347360|560158493|FG013|Overall Study|Withdrawal by Subject|2|||
155196940|NCT00347360|560158494|FG014|Overall Study|Withdrawal by Subject|1|||
155196941|NCT00347360|560158480|FG000|Overall Study|Lack of Efficacy|1|||
155196942|NCT00347360|560158481|FG001|Overall Study|Lack of Efficacy|1|||
155196943|NCT00347360|560158482|FG002|Overall Study|Lack of Efficacy|3|||
155196944|NCT00347360|560158483|FG003|Overall Study|Lack of Efficacy|1|||
155196945|NCT00347360|560158484|FG004|Overall Study|Lack of Efficacy|0|||
155196946|NCT00347360|560158485|FG005|Overall Study|Lack of Efficacy|1|||
155196947|NCT00347360|560158486|FG006|Overall Study|Lack of Efficacy|0|||
155196948|NCT00347360|560158487|FG007|Overall Study|Lack of Efficacy|1|||
155196949|NCT00347360|560158488|FG008|Overall Study|Lack of Efficacy|1|||
155196950|NCT00347360|560158489|FG009|Overall Study|Lack of Efficacy|0|||
155196951|NCT00347360|560158490|FG010|Overall Study|Lack of Efficacy|0|||
155196952|NCT00347360|560158491|FG011|Overall Study|Lack of Efficacy|0|||
155196953|NCT00347360|560158492|FG012|Overall Study|Lack of Efficacy|0|||
155196954|NCT00347360|560158493|FG013|Overall Study|Lack of Efficacy|0|||
155196955|NCT00347360|560158494|FG014|Overall Study|Lack of Efficacy|0|||
155196956|NCT00347360|560158480|FG000|Overall Study|Reason not listed/blank|1|||
155196957|NCT00347360|560158481|FG001|Overall Study|Reason not listed/blank|0|||
155196958|NCT00347360|560158482|FG002|Overall Study|Reason not listed/blank|0|||
155196959|NCT00347360|560158483|FG003|Overall Study|Reason not listed/blank|0|||
155196960|NCT00347360|560158484|FG004|Overall Study|Reason not listed/blank|0|||
155196961|NCT00347360|560158485|FG005|Overall Study|Reason not listed/blank|0|||
155196962|NCT00347360|560158486|FG006|Overall Study|Reason not listed/blank|1|||
155196963|NCT00347360|560158487|FG007|Overall Study|Reason not listed/blank|0|||
155196964|NCT00347360|560158488|FG008|Overall Study|Reason not listed/blank|0|||
155196965|NCT00347360|560158489|FG009|Overall Study|Reason not listed/blank|0|||
155196966|NCT00347360|560158490|FG010|Overall Study|Reason not listed/blank|0|||
155196967|NCT00347360|560158491|FG011|Overall Study|Reason not listed/blank|0|||
155196968|NCT00347360|560158492|FG012|Overall Study|Reason not listed/blank|0|||
155196969|NCT00347360|560158493|FG013|Overall Study|Reason not listed/blank|1|||
155196970|NCT00347360|560158494|FG014|Overall Study|Reason not listed/blank|0|||
155196971|NCT00347360|560158480|FG000|Overall Study|Per sponsors instruction|0|||
155196972|NCT00347360|560158481|FG001|Overall Study|Per sponsors instruction|1|||
155196973|NCT00347360|560158482|FG002|Overall Study|Per sponsors instruction|0|||
155196974|NCT00347360|560158483|FG003|Overall Study|Per sponsors instruction|0|||
155196975|NCT00347360|560158484|FG004|Overall Study|Per sponsors instruction|0|||
155196976|NCT00347360|560158485|FG005|Overall Study|Per sponsors instruction|0|||
155196977|NCT00347360|560158486|FG006|Overall Study|Per sponsors instruction|0|||
155196978|NCT00347360|560158487|FG007|Overall Study|Per sponsors instruction|0|||
155196979|NCT00347360|560158488|FG008|Overall Study|Per sponsors instruction|0|||
155196980|NCT00347360|560158489|FG009|Overall Study|Per sponsors instruction|0|||
155196981|NCT00347360|560158490|FG010|Overall Study|Per sponsors instruction|0|||
155196982|NCT00347360|560158491|FG011|Overall Study|Per sponsors instruction|0|||
155196983|NCT00347360|560158492|FG012|Overall Study|Per sponsors instruction|0|||
155196984|NCT00347360|560158493|FG013|Overall Study|Per sponsors instruction|0|||
155196985|NCT00347360|560158494|FG014|Overall Study|Per sponsors instruction|0|||
155196986|NCT00347360|560158480|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
155196987|NCT00347360|560158481|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
155196988|NCT00347360|560158482|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
155196989|NCT00347360|560158483|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
155196990|NCT00347360|560158484|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
155196991|NCT00347360|560158485|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
155196992|NCT00347360|560158486|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
155196993|NCT00347360|560158487|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
155196994|NCT00347360|560158488|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
155196995|NCT00347360|560158489|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
155196996|NCT00347360|560158490|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
155196997|NCT00347360|560158491|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
155196998|NCT00347360|560158492|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
155196999|NCT00347360|560158493|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
155197000|NCT00347360|560158494|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
155197001|NCT00347360|560158480|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
155197002|NCT00347360|560158481|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
155197003|NCT00347360|560158482|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
155197004|NCT00347360|560158483|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
155197005|NCT00347360|560158484|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
155197006|NCT00347360|560158485|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
155197007|NCT00347360|560158486|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
155197008|NCT00347360|560158487|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
155197009|NCT00347360|560158488|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
155197010|NCT00347360|560158489|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
155197011|NCT00347360|560158490|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
155197012|NCT00347360|560158491|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
155197013|NCT00347360|560158492|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
155197014|NCT00347360|560158493|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
155197015|NCT00347360|560158494|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
155197016|NCT00347360|560158480|FG000|Overall Study|Abnormal lab values|0|||
155197017|NCT00347360|560158481|FG001|Overall Study|Abnormal lab values|0|||
155197018|NCT00347360|560158482|FG002|Overall Study|Abnormal lab values|0|||
155197019|NCT00347360|560158483|FG003|Overall Study|Abnormal lab values|0|||
155197020|NCT00347360|560158484|FG004|Overall Study|Abnormal lab values|0|||
155197021|NCT00347360|560158485|FG005|Overall Study|Abnormal lab values|0|||
155197022|NCT00347360|560158486|FG006|Overall Study|Abnormal lab values|1|||
155197023|NCT00347360|560158487|FG007|Overall Study|Abnormal lab values|0|||
155197024|NCT00347360|560158488|FG008|Overall Study|Abnormal lab values|0|||
155197025|NCT00347360|560158489|FG009|Overall Study|Abnormal lab values|0|||
155197026|NCT00347360|560158490|FG010|Overall Study|Abnormal lab values|0|||
155197027|NCT00347360|560158491|FG011|Overall Study|Abnormal lab values|0|||
155197028|NCT00347360|560158492|FG012|Overall Study|Abnormal lab values|0|||
155197029|NCT00347360|560158493|FG013|Overall Study|Abnormal lab values|0|||
155197030|NCT00347360|560158494|FG014|Overall Study|Abnormal lab values|0|||
155197031|NCT00347360|560158480|FG000|Overall Study|PI recommended early withdrawal|0|||
155197032|NCT00347360|560158481|FG001|Overall Study|PI recommended early withdrawal|0|||
155197033|NCT00347360|560158482|FG002|Overall Study|PI recommended early withdrawal|0|||
155197034|NCT00347360|560158483|FG003|Overall Study|PI recommended early withdrawal|0|||
155197035|NCT00347360|560158484|FG004|Overall Study|PI recommended early withdrawal|0|||
155197036|NCT00347360|560158485|FG005|Overall Study|PI recommended early withdrawal|0|||
155197037|NCT00347360|560158486|FG006|Overall Study|PI recommended early withdrawal|0|||
155197038|NCT00347360|560158487|FG007|Overall Study|PI recommended early withdrawal|0|||
155197039|NCT00347360|560158488|FG008|Overall Study|PI recommended early withdrawal|0|||
155197040|NCT00347360|560158489|FG009|Overall Study|PI recommended early withdrawal|1|||
155197041|NCT00347360|560158490|FG010|Overall Study|PI recommended early withdrawal|0|||
155197042|NCT00347360|560158491|FG011|Overall Study|PI recommended early withdrawal|0|||
155197043|NCT00347360|560158492|FG012|Overall Study|PI recommended early withdrawal|0|||
155197044|NCT00347360|560158493|FG013|Overall Study|PI recommended early withdrawal|0|||
155197045|NCT00347360|560158494|FG014|Overall Study|PI recommended early withdrawal|0|||
155197046|NCT00347360|560158480|FG000|Overall Study|Did not meet criteria before ABPM|0|||
155197047|NCT00347360|560158481|FG001|Overall Study|Did not meet criteria before ABPM|0|||
155197048|NCT00347360|560158482|FG002|Overall Study|Did not meet criteria before ABPM|0|||
155197049|NCT00347360|560158483|FG003|Overall Study|Did not meet criteria before ABPM|0|||
155197050|NCT00347360|560158484|FG004|Overall Study|Did not meet criteria before ABPM|0|||
155197051|NCT00347360|560158485|FG005|Overall Study|Did not meet criteria before ABPM|0|||
155197052|NCT00347360|560158486|FG006|Overall Study|Did not meet criteria before ABPM|0|||
155197053|NCT00347360|560158487|FG007|Overall Study|Did not meet criteria before ABPM|0|||
155197054|NCT00347360|560158488|FG008|Overall Study|Did not meet criteria before ABPM|0|||
155197055|NCT00347360|560158489|FG009|Overall Study|Did not meet criteria before ABPM|0|||
155197056|NCT00347360|560158490|FG010|Overall Study|Did not meet criteria before ABPM|1|||
155197057|NCT00347360|560158491|FG011|Overall Study|Did not meet criteria before ABPM|0|||
155197058|NCT00347360|560158492|FG012|Overall Study|Did not meet criteria before ABPM|0|||
155197059|NCT00347360|560158493|FG013|Overall Study|Did not meet criteria before ABPM|0|||
155197060|NCT00347360|560158494|FG014|Overall Study|Did not meet criteria before ABPM|0|||
155197061|NCT00347360|560158480|FG000|Overall Study|Randomized in error|0|||
155197062|NCT00347360|560158481|FG001|Overall Study|Randomized in error|0|||
155197063|NCT00347360|560158482|FG002|Overall Study|Randomized in error|0|||
155197064|NCT00347360|560158483|FG003|Overall Study|Randomized in error|0|||
155197065|NCT00347360|560158484|FG004|Overall Study|Randomized in error|0|||
155197066|NCT00347360|560158485|FG005|Overall Study|Randomized in error|0|||
155197067|NCT00347360|560158486|FG006|Overall Study|Randomized in error|0|||
155197068|NCT00347360|560158487|FG007|Overall Study|Randomized in error|0|||
155197069|NCT00347360|560158488|FG008|Overall Study|Randomized in error|0|||
155197070|NCT00347360|560158489|FG009|Overall Study|Randomized in error|0|||
155197071|NCT00347360|560158490|FG010|Overall Study|Randomized in error|0|||
155197072|NCT00347360|560158491|FG011|Overall Study|Randomized in error|1|||
155197073|NCT00347360|560158492|FG012|Overall Study|Randomized in error|0|||
155197074|NCT00347360|560158493|FG013|Overall Study|Randomized in error|0|||
155197075|NCT00347360|560158494|FG014|Overall Study|Randomized in error|0|||
155197076|NCT00347360|560158480|FG000|Overall Study|Failed inclusion criteria #4|0|||
155197077|NCT00347360|560158481|FG001|Overall Study|Failed inclusion criteria #4|0|||
155197078|NCT00347360|560158482|FG002|Overall Study|Failed inclusion criteria #4|0|||
155197079|NCT00347360|560158483|FG003|Overall Study|Failed inclusion criteria #4|0|||
155197080|NCT00347360|560158484|FG004|Overall Study|Failed inclusion criteria #4|0|||
155197081|NCT00347360|560158485|FG005|Overall Study|Failed inclusion criteria #4|0|||
155197082|NCT00347360|560158486|FG006|Overall Study|Failed inclusion criteria #4|0|||
155197083|NCT00347360|560158487|FG007|Overall Study|Failed inclusion criteria #4|0|||
155197084|NCT00347360|560158488|FG008|Overall Study|Failed inclusion criteria #4|0|||
155197085|NCT00347360|560158489|FG009|Overall Study|Failed inclusion criteria #4|0|||
155197086|NCT00347360|560158490|FG010|Overall Study|Failed inclusion criteria #4|0|||
155197087|NCT00347360|560158491|FG011|Overall Study|Failed inclusion criteria #4|1|||
155197088|NCT00347360|560158492|FG012|Overall Study|Failed inclusion criteria #4|0|||
155197089|NCT00347360|560158493|FG013|Overall Study|Failed inclusion criteria #4|0|||
155197090|NCT00347360|560158494|FG014|Overall Study|Failed inclusion criteria #4|0|||
155197091|NCT00347360|560158480|FG000|Overall Study|Prolonged duration between visits|0|||
155197092|NCT00347360|560158481|FG001|Overall Study|Prolonged duration between visits|0|||
155197093|NCT00347360|560158482|FG002|Overall Study|Prolonged duration between visits|0|||
155197094|NCT00347360|560158483|FG003|Overall Study|Prolonged duration between visits|0|||
155197095|NCT00347360|560158484|FG004|Overall Study|Prolonged duration between visits|0|||
155197096|NCT00347360|560158485|FG005|Overall Study|Prolonged duration between visits|0|||
155197097|NCT00347360|560158486|FG006|Overall Study|Prolonged duration between visits|0|||
155197098|NCT00347360|560158487|FG007|Overall Study|Prolonged duration between visits|0|||
155197099|NCT00347360|560158488|FG008|Overall Study|Prolonged duration between visits|0|||
155197100|NCT00347360|560158489|FG009|Overall Study|Prolonged duration between visits|0|||
155197101|NCT00347360|560158490|FG010|Overall Study|Prolonged duration between visits|0|||
155197102|NCT00347360|560158491|FG011|Overall Study|Prolonged duration between visits|0|||
155197103|NCT00347360|560158492|FG012|Overall Study|Prolonged duration between visits|1|||
155197104|NCT00347360|560158493|FG013|Overall Study|Prolonged duration between visits|0|||
155197105|NCT00347360|560158494|FG014|Overall Study|Prolonged duration between visits|0|||
155197106|NCT00347360|560158480|FG000|Overall Study|Subject left town, ran out of study drug|0|||
155197107|NCT00347360|560158481|FG001|Overall Study|Subject left town, ran out of study drug|0|||
155197108|NCT00347360|560158482|FG002|Overall Study|Subject left town, ran out of study drug|0|||
155197109|NCT00347360|560158483|FG003|Overall Study|Subject left town, ran out of study drug|0|||
155197110|NCT00347360|560158484|FG004|Overall Study|Subject left town, ran out of study drug|0|||
155197111|NCT00347360|560158485|FG005|Overall Study|Subject left town, ran out of study drug|0|||
155197112|NCT00347360|560158486|FG006|Overall Study|Subject left town, ran out of study drug|0|||
155197113|NCT00347360|560158487|FG007|Overall Study|Subject left town, ran out of study drug|0|||
155197114|NCT00347360|560158488|FG008|Overall Study|Subject left town, ran out of study drug|0|||
155197115|NCT00347360|560158489|FG009|Overall Study|Subject left town, ran out of study drug|0|||
155197116|NCT00347360|560158490|FG010|Overall Study|Subject left town, ran out of study drug|0|||
155197117|NCT00347360|560158491|FG011|Overall Study|Subject left town, ran out of study drug|0|||
155197118|NCT00347360|560158492|FG012|Overall Study|Subject left town, ran out of study drug|0|||
155197119|NCT00347360|560158493|FG013|Overall Study|Subject left town, ran out of study drug|1|||
155197120|NCT00347360|560158494|FG014|Overall Study|Subject left town, ran out of study drug|0|||
155197121|NCT00347360|560158480|FG000|Overall Study|Subject refuse to sign updated consent|0|||
155197122|NCT00347360|560158481|FG001|Overall Study|Subject refuse to sign updated consent|0|||
155197123|NCT00347360|560158482|FG002|Overall Study|Subject refuse to sign updated consent|0|||
155197124|NCT00347360|560158483|FG003|Overall Study|Subject refuse to sign updated consent|0|||
155197125|NCT00347360|560158484|FG004|Overall Study|Subject refuse to sign updated consent|0|||
155197126|NCT00347360|560158485|FG005|Overall Study|Subject refuse to sign updated consent|0|||
155197127|NCT00347360|560158486|FG006|Overall Study|Subject refuse to sign updated consent|0|||
155197128|NCT00347360|560158487|FG007|Overall Study|Subject refuse to sign updated consent|0|||
155197129|NCT00347360|560158488|FG008|Overall Study|Subject refuse to sign updated consent|0|||
155197130|NCT00347360|560158489|FG009|Overall Study|Subject refuse to sign updated consent|0|||
155197131|NCT00347360|560158490|FG010|Overall Study|Subject refuse to sign updated consent|0|||
155197132|NCT00347360|560158491|FG011|Overall Study|Subject refuse to sign updated consent|0|||
155197133|NCT00347360|560158492|FG012|Overall Study|Subject refuse to sign updated consent|0|||
155197134|NCT00347360|560158493|FG013|Overall Study|Subject refuse to sign updated consent|0|||
155197135|NCT00347360|560158494|FG014|Overall Study|Subject refuse to sign updated consent|1|||
155197136|NCT00347360|560158480|FG000|Overall Study|Visits conflicted with new job|0|||
155197137|NCT00347360|560158481|FG001|Overall Study|Visits conflicted with new job|0|||
155197138|NCT00347360|560158482|FG002|Overall Study|Visits conflicted with new job|0|||
155197139|NCT00347360|560158483|FG003|Overall Study|Visits conflicted with new job|0|||
155197140|NCT00347360|560158484|FG004|Overall Study|Visits conflicted with new job|0|||
155197141|NCT00347360|560158485|FG005|Overall Study|Visits conflicted with new job|0|||
155197142|NCT00347360|560158486|FG006|Overall Study|Visits conflicted with new job|1|||
155197143|NCT00347360|560158487|FG007|Overall Study|Visits conflicted with new job|0|||
155197144|NCT00347360|560158488|FG008|Overall Study|Visits conflicted with new job|0|||
155197145|NCT00347360|560158489|FG009|Overall Study|Visits conflicted with new job|0|||
155197146|NCT00347360|560158490|FG010|Overall Study|Visits conflicted with new job|0|||
155197147|NCT00347360|560158491|FG011|Overall Study|Visits conflicted with new job|0|||
155197148|NCT00347360|560158492|FG012|Overall Study|Visits conflicted with new job|0|||
155197149|NCT00347360|560158493|FG013|Overall Study|Visits conflicted with new job|0|||
155197150|NCT00347360|560158494|FG014|Overall Study|Visits conflicted with new job|0|||
155197151|NCT01972568|560158499|FG000|Overall Study|Other events|3|||
155197152|NCT01972568|560158500|FG001|Overall Study|Other events|0|||
155197153|NCT01972568|560158501|FG002|Overall Study|Other events|0|||
155197154|NCT01972568|560158499|FG000|Overall Study|Lack of Efficacy|0|||
155197155|NCT01972568|560158500|FG001|Overall Study|Lack of Efficacy|1|||
155197156|NCT01972568|560158501|FG002|Overall Study|Lack of Efficacy|2|||
155197157|NCT01972568|560158499|FG000|Overall Study|Protocol Violation|1|||
155197158|NCT01972568|560158500|FG001|Overall Study|Protocol Violation|2|||
155197159|NCT01972568|560158501|FG002|Overall Study|Protocol Violation|2|||
155197160|NCT01972568|560158499|FG000|Overall Study|Withdrawal by Subject|6|||
155197161|NCT01972568|560158500|FG001|Overall Study|Withdrawal by Subject|3|||
155197162|NCT01972568|560158501|FG002|Overall Study|Withdrawal by Subject|7|||
155197163|NCT01972568|560158499|FG000|Overall Study|Lost to Follow-up|1|||
155197164|NCT01972568|560158500|FG001|Overall Study|Lost to Follow-up|0|||
155197165|NCT01972568|560158501|FG002|Overall Study|Lost to Follow-up|0|||
155197166|NCT01972568|560158499|FG000|Overall Study|Adverse Event|5|||
155197167|NCT01972568|560158500|FG001|Overall Study|Adverse Event|6|||
155197168|NCT01972568|560158501|FG002|Overall Study|Adverse Event|5|||
155197169|NCT02059408|560158504|FG000|Overall Study|Did not get tested|0|||
155197170|NCT02059408|560158505|FG001|Overall Study|Did not get tested|330|||
155197171|NCT02059408|560158506|FG002|Overall Study|Did not get tested|358|||
155197172|NCT00508755|560158507|FG000|Overall Study|Withdrawal by Subject|1|||
155197173|NCT00957580|560158508|FG000|Overall Study|Ongoing at data cut-off|0|||
155197174|NCT00957580|560158509|FG001|Overall Study|Ongoing at data cut-off|1|||
155197175|NCT00957580|560158510|FG002|Overall Study|Ongoing at data cut-off|0|||
155197176|NCT00957580|560158508|FG000|Overall Study|Enrolled but not treated|0|||
155197177|NCT00957580|560158509|FG001|Overall Study|Enrolled but not treated|1|||
155197178|NCT00957580|560158510|FG002|Overall Study|Enrolled but not treated|0|||
155197179|NCT00945893|560158511|FG000|Overall Study|Lost to Follow-up|2|||
155197180|NCT00945893|560158512|FG001|Overall Study|Lost to Follow-up|8|||
155197181|NCT00945893|560158511|FG000|Overall Study|Withdrawal of consent|1|||
155197182|NCT00945893|560158512|FG001|Overall Study|Withdrawal of consent|2|||
155197183|NCT04502433|560158513|FG000|Overall Study|Death|2|||
155197184|NCT04502433|560158514|FG001|Overall Study|Death|4|||
155197185|NCT04502433|560158513|FG000|Overall Study|Lost to Follow-up|1|||
155197186|NCT04502433|560158514|FG001|Overall Study|Lost to Follow-up|0|||
155197187|NCT04502433|560158513|FG000|Overall Study|Physician Decision|0|||
155197188|NCT04502433|560158514|FG001|Overall Study|Physician Decision|1|||
155197189|NCT01999179|560158522|FG000|Overall Study|Adverse Event|1|||
155197190|NCT01999179|560158522|FG000|Overall Study|Lost to Follow-up|1|||
155197191|NCT01999179|560158522|FG000|Overall Study|Change in Therapy|3|||
155197192|NCT01999179|560158522|FG000|Overall Study|New catheter|2|||
155197193|NCT00300274|560158526|FG000|Overall Study|Withdrawal by Subject|12|||
155197194|NCT00300274|560158527|FG001|Overall Study|Withdrawal by Subject|3|||
155197195|NCT00300274|560158528|FG002|Overall Study|Withdrawal by Subject|14|||
155197196|NCT00300274|560158526|FG000|Overall Study|Lost to Follow-up|3|||
155197197|NCT00300274|560158527|FG001|Overall Study|Lost to Follow-up|4|||
155197198|NCT00300274|560158528|FG002|Overall Study|Lost to Follow-up|5|||
155197199|NCT00300274|560158526|FG000|Overall Study|Death|31|||
155197200|NCT00300274|560158527|FG001|Overall Study|Death|20|||
155197201|NCT00300274|560158528|FG002|Overall Study|Death|25|||
155197202|NCT00300274|560158526|FG000|Overall Study|Re-transplant|0|||
155197203|NCT00300274|560158527|FG001|Overall Study|Re-transplant|0|||
155197204|NCT00300274|560158528|FG002|Overall Study|Re-transplant|1|||
155197205|NCT00242216|560158529|FG000|Overall Study|Lost to Follow-up|12|||
155197206|NCT00242216|560158530|FG001|Overall Study|Lost to Follow-up|17|||
155197207|NCT00242216|560158529|FG000|Overall Study|Death|4|||
155197208|NCT00242216|560158530|FG001|Overall Study|Death|2|||
155197209|NCT00242216|560158529|FG000|Overall Study|Lack of Efficacy|1|||
155197210|NCT00242216|560158530|FG001|Overall Study|Lack of Efficacy|2|||
155197211|NCT00242216|560158529|FG000|Overall Study|no medicaiton dispensed|1|||
155197212|NCT00242216|560158530|FG001|Overall Study|no medicaiton dispensed|1|||
155197213|NCT01663532|560159686|FG000|Overall Study|Lost to Follow-up|9|||
155197214|NCT01663532|560159687|FG001|Overall Study|Lost to Follow-up|10|||
155197215|NCT01663532|560159686|FG000|Overall Study|Adverse Event|7|||
155197216|NCT01663532|560159687|FG001|Overall Study|Adverse Event|13|||
155197217|NCT01663532|560159686|FG000|Overall Study|Met Withdrawal Criteria|7|||
155197218|NCT01663532|560159687|FG001|Overall Study|Met Withdrawal Criteria|6|||
155197219|NCT01663532|560159686|FG000|Overall Study|Physician Decision|1|||
155197220|NCT01663532|560159687|FG001|Overall Study|Physician Decision|1|||
155197221|NCT01663532|560159686|FG000|Overall Study|Withdrawal by Subject|35|||
155197222|NCT01663532|560159687|FG001|Overall Study|Withdrawal by Subject|17|||
155197223|NCT01663532|560159686|FG000|Overall Study|Lack of Efficacy|15|||
155197224|NCT01663532|560159687|FG001|Overall Study|Lack of Efficacy|60|||
155197225|NCT03539081|560159693|FG000|Overall Study|Withdrawal by Subject|2|||
155197226|NCT03539081|560159694|FG001|Overall Study|Withdrawal by Subject|3|||
155197227|NCT03539081|560159695|FG002|Overall Study|Withdrawal by Subject|0|||
155197228|NCT03539081|560159693|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
155197229|NCT03539081|560159694|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
155197230|NCT03539081|560159695|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
155197231|NCT02025621|560159696|FG000|Overall Study|Withdrawal by Subject|1|||
155197232|NCT02025621|560159697|FG001|Overall Study|Withdrawal by Subject|0|||
155197233|NCT02025621|560159696|FG000|Overall Study|Death|0|||
155197234|NCT02025621|560159697|FG001|Overall Study|Death|1|||
155197235|NCT02025621|560159696|FG000|Overall Study|No longer eligible|10|||
155197236|NCT02025621|560159697|FG001|Overall Study|No longer eligible|15|||
155197237|NCT02025621|560159696|FG000|Overall Study|Surgery initiated before infusion|3|||
155197238|NCT02025621|560159697|FG001|Overall Study|Surgery initiated before infusion|3|||
155197239|NCT01897454|560159701|FG000|Overall Study|Withdrawal by Subject|1|||
155197240|NCT01560403|560159704|FG000|Overall Study|Lost to Follow-up|0|||
155197241|NCT01560403|560159705|FG001|Overall Study|Lost to Follow-up|1|||
155197242|NCT00983437|560159707|FG000|Overall Study|Adverse Event|9|||
155197243|NCT00983437|560159707|FG000|Overall Study|Lack of Efficacy|1|||
155197244|NCT00983437|560159707|FG000|Overall Study|Withdrawal by Subject|8|||
155197245|NCT00983437|560159707|FG000|Overall Study|Noncompliance to Study Procedures|1|||
155197246|NCT00983437|560159707|FG000|Overall Study|Lost to Follow-up|2|||
155197247|NCT00983437|560159707|FG000|Overall Study|Other Reason|26|||
155197248|NCT00094172|560159708|FG000|Overall Study|Adverse Event|0|||
155197249|NCT00094172|560159709|FG001|Overall Study|Adverse Event|1|||
155197250|NCT00094172|560159708|FG000|Overall Study|Lost to Follow-up|2|||
155197251|NCT00094172|560159709|FG001|Overall Study|Lost to Follow-up|0|||
155197252|NCT00094172|560159708|FG000|Overall Study|Protocol Violation|0|||
155197253|NCT00094172|560159709|FG001|Overall Study|Protocol Violation|1|||
155197254|NCT00094172|560159708|FG000|Overall Study|Withdrawal by Subject|10|||
155197255|NCT00094172|560159709|FG001|Overall Study|Withdrawal by Subject|5|||
155197256|NCT00094172|560159708|FG000|Overall Study|Primary endpoint met.|1|||
155197257|NCT00094172|560159709|FG001|Overall Study|Primary endpoint met.|0|||
155197258|NCT00094172|560159708|FG000|Overall Study|Started other MS therapy due to disease|1|||
155197259|NCT00094172|560159709|FG001|Overall Study|Started other MS therapy due to disease|0|||
155197260|NCT01020981|560159710|FG000|Overall Study|Did not return mailed survey|74|||
155197261|NCT01020981|560159711|FG001|Overall Study|Did not return mailed survey|58|||
155197262|NCT01020981|560159710|FG000|Overall Study|Survey returned undeliverable|8|||
155197263|NCT01020981|560159711|FG001|Overall Study|Survey returned undeliverable|32|||
155197264|NCT01020981|560159710|FG000|Overall Study|Participant declined to complete survey|2|||
155197265|NCT01020981|560159711|FG001|Overall Study|Participant declined to complete survey|0|||
155197266|NCT00289133|560159716|FG000|Overall Study|Non-study device implanted|12|||
155197267|NCT00289133|560159717|FG001|Overall Study|Non-study device implanted|0|||
155197268|NCT00289133|560159716|FG000|Overall Study|Protocol Violation|32|||
155197269|NCT00289133|560159717|FG001|Overall Study|Protocol Violation|38|||
155197270|NCT00289133|560159716|FG000|Overall Study|Withdrawal by Subject|9|||
155197271|NCT00289133|560159717|FG001|Overall Study|Withdrawal by Subject|10|||
155197272|NCT00289133|560159716|FG000|Overall Study|Death|5|||
155197273|NCT00289133|560159717|FG001|Overall Study|Death|10|||
155197274|NCT00289133|560159716|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
155197275|NCT00289133|560159717|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
155197276|NCT00289133|560159716|FG000|Overall Study|Physician Decision|41|||
155197277|NCT00289133|560159717|FG001|Overall Study|Physician Decision|45|||
155197278|NCT00289133|560159716|FG000|Overall Study|Revision|8|||
155197279|NCT00289133|560159717|FG001|Overall Study|Revision|6|||
155197280|NCT00289133|560159716|FG000|Overall Study|Lost to Follow-up|92|||
155197281|NCT00289133|560159717|FG001|Overall Study|Lost to Follow-up|115|||
155197282|NCT03372096|560159722|FG000|Overall Study|Study Closed|8|||
155197283|NCT01397890|560159723|FG000|Overall Study|Withdrawal by Subject|7|||
155197284|NCT01397890|560159724|FG001|Overall Study|Withdrawal by Subject|11|||
155197285|NCT01397890|560159723|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
155197286|NCT01397890|560159724|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
155197287|NCT01397890|560159723|FG000|Overall Study|Death|2|||
155197288|NCT01397890|560159724|FG001|Overall Study|Death|3|||
155197289|NCT01397890|560159723|FG000|Overall Study|Lost to Follow-up|1|||
155197290|NCT01397890|560159724|FG001|Overall Study|Lost to Follow-up|4|||
155197291|NCT01397890|560159723|FG000|Overall Study|Condition under Investigation Worsened|1|||
155197292|NCT01397890|560159724|FG001|Overall Study|Condition under Investigation Worsened|3|||
155197293|NCT01397890|560159723|FG000|Overall Study|Adverse Event|1|||
155197294|NCT01397890|560159724|FG001|Overall Study|Adverse Event|2|||
155197295|NCT01397890|560159723|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
155197296|NCT01397890|560159724|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
155197297|NCT01397890|560159723|FG000|Overall Study|Others|2|||
155197298|NCT01397890|560159724|FG001|Overall Study|Others|1|||
155197299|NCT03094169|560159725|FG000|Overall Study|Lack of Efficacy|0|||
155197300|NCT03094169|560159726|FG001|Overall Study|Lack of Efficacy|0|||
155197301|NCT03094169|560159727|FG002|Overall Study|Lack of Efficacy|0|||
155197302|NCT03094169|560159728|FG003|Overall Study|Lack of Efficacy|0|||
155197303|NCT03094169|560159729|FG004|Overall Study|Lack of Efficacy|0|||
155197304|NCT03094169|560159730|FG005|Overall Study|Lack of Efficacy|0|||
155197305|NCT03094169|560159731|FG006|Overall Study|Lack of Efficacy|0|||
155197306|NCT03094169|560159732|FG007|Overall Study|Lack of Efficacy|21|||
155197307|NCT03094169|560159725|FG000|Overall Study|Adverse Event|0|||
155197308|NCT03094169|560159726|FG001|Overall Study|Adverse Event|0|||
155197309|NCT03094169|560159727|FG002|Overall Study|Adverse Event|0|||
155197310|NCT03094169|560159728|FG003|Overall Study|Adverse Event|0|||
155197311|NCT03094169|560159729|FG004|Overall Study|Adverse Event|0|||
155197312|NCT03094169|560159730|FG005|Overall Study|Adverse Event|0|||
155197313|NCT03094169|560159731|FG006|Overall Study|Adverse Event|0|||
155197314|NCT03094169|560159732|FG007|Overall Study|Adverse Event|2|||
155197315|NCT03094169|560159725|FG000|Overall Study|Withdrawal by Subject|0|||
155197316|NCT03094169|560159726|FG001|Overall Study|Withdrawal by Subject|0|||
155197317|NCT03094169|560159727|FG002|Overall Study|Withdrawal by Subject|0|||
155197318|NCT03094169|560159728|FG003|Overall Study|Withdrawal by Subject|0|||
155197319|NCT03094169|560159729|FG004|Overall Study|Withdrawal by Subject|0|||
155197320|NCT03094169|560159730|FG005|Overall Study|Withdrawal by Subject|0|||
155197321|NCT03094169|560159731|FG006|Overall Study|Withdrawal by Subject|1|||
155197322|NCT03094169|560159732|FG007|Overall Study|Withdrawal by Subject|1|||
155197323|NCT03094169|560159725|FG000|Overall Study|Trial Termination|0|||
155197324|NCT03094169|560159726|FG001|Overall Study|Trial Termination|0|||
155197325|NCT03094169|560159727|FG002|Overall Study|Trial Termination|0|||
155197326|NCT03094169|560159728|FG003|Overall Study|Trial Termination|0|||
155197327|NCT03094169|560159729|FG004|Overall Study|Trial Termination|0|||
155197328|NCT03094169|560159730|FG005|Overall Study|Trial Termination|0|||
155197329|NCT03094169|560159731|FG006|Overall Study|Trial Termination|0|||
155197330|NCT03094169|560159732|FG007|Overall Study|Trial Termination|1|||
155197331|NCT04645953|560159733|FG000|Overall Study|Lost to Follow-up|2|||
155197332|NCT04645953|560159734|FG001|Overall Study|Lost to Follow-up|1|||
155197333|NCT04645953|560159735|FG002|Overall Study|Lost to Follow-up|1|||
155197334|NCT04645953|560159733|FG000|Overall Study|Withdrawal by Subject|0|||
155197335|NCT04645953|560159734|FG001|Overall Study|Withdrawal by Subject|1|||
155197336|NCT04645953|560159735|FG002|Overall Study|Withdrawal by Subject|0|||
155197337|NCT04645953|560159733|FG000|Overall Study|Physician Decision|0|||
155197338|NCT04645953|560159734|FG001|Overall Study|Physician Decision|1|||
155197339|NCT04645953|560159735|FG002|Overall Study|Physician Decision|0|||
155197340|NCT04645953|560159733|FG000|Overall Study|Discontinued Prior to Dosing|0|||
155197341|NCT04645953|560159734|FG001|Overall Study|Discontinued Prior to Dosing|0|||
155197342|NCT04645953|560159735|FG002|Overall Study|Discontinued Prior to Dosing|2|||
155197343|NCT04613375|560159736|FG000|Overall Study|Death|198|||
155197344|NCT04613375|560159736|FG000|Overall Study|Withdrawal by Subject|3|||
155197345|NCT00434954|560159737|FG000|Overall Study|Adverse Event|17|||
155197346|NCT00434954|560159738|FG001|Overall Study|Adverse Event|2|||
155197347|NCT00434954|560159737|FG000|Overall Study|Entry criteria not met|14|||
155197348|NCT00434954|560159738|FG001|Overall Study|Entry criteria not met|16|||
155197349|NCT00434954|560159737|FG000|Overall Study|Lost to Follow-up|0|||
155197350|NCT00434954|560159738|FG001|Overall Study|Lost to Follow-up|1|||
155197351|NCT00434954|560159737|FG000|Overall Study|Physician Decision|6|||
155197352|NCT00434954|560159738|FG001|Overall Study|Physician Decision|3|||
155197353|NCT00434954|560159737|FG000|Overall Study|Protocol Violation|36|||
155197354|NCT00434954|560159738|FG001|Overall Study|Protocol Violation|27|||
155197355|NCT00434954|560159737|FG000|Overall Study|Sponsor decision|1|||
155197356|NCT00434954|560159738|FG001|Overall Study|Sponsor decision|0|||
155197357|NCT00434954|560159737|FG000|Overall Study|Subject decision|8|||
155197358|NCT00434954|560159738|FG001|Overall Study|Subject decision|22|||
155197359|NCT01145625|560159739|FG000|Overall Study|Lost to Follow-up|8|||
155197360|NCT01145625|560159740|FG001|Overall Study|Lost to Follow-up|9|||
155197361|NCT01145625|560159739|FG000|Overall Study|Adverse Event|6|||
155197362|NCT01145625|560159740|FG001|Overall Study|Adverse Event|4|||
155197363|NCT01145625|560159739|FG000|Overall Study|Protocol Violation|3|||
155197364|NCT01145625|560159740|FG001|Overall Study|Protocol Violation|1|||
155197365|NCT01145625|560159739|FG000|Overall Study|Withdrawal by Subject|7|||
155197366|NCT01145625|560159740|FG001|Overall Study|Withdrawal by Subject|16|||
155197367|NCT01145625|560159739|FG000|Overall Study|Pregnancy|0|||
155197368|NCT01145625|560159740|FG001|Overall Study|Pregnancy|1|||
155197369|NCT01751178|560159741|FG000|Overall Study|Adverse Event|2|||
155197370|NCT01751178|560159742|FG001|Overall Study|Adverse Event|0|||
155197371|NCT01751178|560159743|FG002|Overall Study|Adverse Event|0|||
155197372|NCT01751178|560159741|FG000|Overall Study|Other Reason (unknown)|1|||
155197373|NCT01751178|560159742|FG001|Overall Study|Other Reason (unknown)|0|||
155197374|NCT01751178|560159743|FG002|Overall Study|Other Reason (unknown)|2|||
155197375|NCT00885846|560159744|FG000|Overall Study|Withdrawal by Subject|2|||
155197376|NCT00885846|560159745|FG001|Overall Study|Withdrawal by Subject|5|||
155197377|NCT00885846|560159746|FG002|Overall Study|Withdrawal by Subject|2|||
155197378|NCT02747875|560159749|FG000|Overall Study|Physician Decision|1|||
155197379|NCT02747875|560159750|FG001|Overall Study|Physician Decision|0|||
155197380|NCT02747875|560159749|FG000|Overall Study|Adverse Event|0|||
155197381|NCT02747875|560159750|FG001|Overall Study|Adverse Event|1|||
155197382|NCT00493025|560159753|FG000|Overall Study|Physician Decision|19|||
155197383|NCT01986907|560159755|FG000|Overall Study|Adverse Event|11|||
155197384|NCT01986907|560159755|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
155197385|NCT01986907|560159755|FG000|Overall Study|Protocol Violation|4|||
155197386|NCT01986907|560159755|FG000|Overall Study|Withdrawal by Subject|76|||
155197387|NCT01986907|560159755|FG000|Overall Study|Lost to Follow-up|38|||
155197388|NCT01986907|560159755|FG000|Overall Study|Death|9|||
155197389|NCT03800173|560159757|FG000|Overall Study|Lost to Follow-up|0|||
155197390|NCT03800173|560159758|FG001|Overall Study|Lost to Follow-up|0|||
155197391|NCT03800173|560159759|FG002|Overall Study|Lost to Follow-up|0|||
155197392|NCT03800173|560159760|FG003|Overall Study|Lost to Follow-up|0|||
155197393|NCT03800173|560159761|FG004|Overall Study|Lost to Follow-up|1|||
155197394|NCT01313312|560159762|FG000|Overall Study|Adverse Event|5|||
155197395|NCT01313312|560159762|FG000|Overall Study|Withdrawal by Subject|18|||
155197396|NCT01313312|560159762|FG000|Overall Study|Lack of Efficacy|3|||
155197397|NCT01313312|560159762|FG000|Overall Study|Investigator Decision|1|||
155197398|NCT01313312|560159762|FG000|Overall Study|Observational Phase|1|||
155197399|NCT01313312|560159762|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
155197400|NCT01313312|560159762|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
155197401|NCT02716805|560159768|FG000|Overall Study|Progressive disease|2|||
155197402|NCT02716805|560159769|FG001|Overall Study|Progressive disease|0|||
155197403|NCT02716805|560159770|FG002|Overall Study|Progressive disease|0|||
155197404|NCT02716805|560159771|FG003|Overall Study|Progressive disease|0|||
155197405|NCT00066365|560159772|FG000|Overall Study|Adverse Event|1|||
155197406|NCT00066365|560159773|FG001|Overall Study|Adverse Event|0|||
155197407|NCT00066365|560159772|FG000|Overall Study|Lack of Efficacy|15|||
155197408|NCT00066365|560159773|FG001|Overall Study|Lack of Efficacy|12|||
155197409|NCT00066365|560159772|FG000|Overall Study|Physician Decision|1|||
155197410|NCT00066365|560159773|FG001|Overall Study|Physician Decision|0|||
155197411|NCT00066365|560159772|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
155197412|NCT00066365|560159773|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
155197413|NCT00066365|560159772|FG000|Overall Study|Ineligible|4|||
155197414|NCT00066365|560159773|FG001|Overall Study|Ineligible|2|||
155197415|NCT00467857|560159776|FG000|Overall Study|Adverse Event|1|||
155197416|NCT00467857|560159777|FG001|Overall Study|Adverse Event|0|||
155197417|NCT00467857|560159776|FG000|Overall Study|Withdrew consent|2|||
155197418|NCT00467857|560159777|FG001|Overall Study|Withdrew consent|0|||
155197419|NCT00467857|560159776|FG000|Overall Study|Death|0|||
155197420|NCT00467857|560159777|FG001|Overall Study|Death|1|||
155197421|NCT00467857|560159776|FG000|Overall Study|Discharged from court service|0|||
155197422|NCT00467857|560159777|FG001|Overall Study|Discharged from court service|1|||
155197423|NCT00467857|560159776|FG000|Overall Study|Emergency care required|0|||
155197424|NCT00467857|560159777|FG001|Overall Study|Emergency care required|1|||
155197425|NCT00467857|560159776|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
155197426|NCT00467857|560159777|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
155197427|NCT00467857|560159776|FG000|Overall Study|Discontinuation reason missing|0|||
155197428|NCT00467857|560159777|FG001|Overall Study|Discontinuation reason missing|3|||
155197429|NCT00516074|560159781|FG000|Overall Study|Adverse Event|0|||
155197430|NCT00516074|560159782|FG001|Overall Study|Adverse Event|1|||
155197431|NCT00516074|560159781|FG000|Overall Study|Subject Decision|4|||
155197432|NCT00516074|560159782|FG001|Overall Study|Subject Decision|2|||
155197433|NCT00516074|560159781|FG000|Overall Study|Loss of Glucose Control|2|||
155197434|NCT00516074|560159782|FG001|Overall Study|Loss of Glucose Control|0|||
155197435|NCT00369824|560159784|FG000|Overall Study|Adverse Event|0|||
155197436|NCT00369824|560159785|FG001|Overall Study|Adverse Event|2|||
155197437|NCT00369824|560159786|FG002|Overall Study|Adverse Event|0|||
155197438|NCT00369824|560159787|FG003|Overall Study|Adverse Event|0|||
155197439|NCT00369824|560159788|FG004|Overall Study|Adverse Event|1|||
155197440|NCT00369824|560159789|FG005|Overall Study|Adverse Event|0|||
155197441|NCT00369824|560159784|FG000|Overall Study|Protocol Violation|0|||
155197442|NCT00369824|560159785|FG001|Overall Study|Protocol Violation|1|||
155197443|NCT00369824|560159786|FG002|Overall Study|Protocol Violation|0|||
155197444|NCT00369824|560159787|FG003|Overall Study|Protocol Violation|1|||
155197445|NCT00369824|560159788|FG004|Overall Study|Protocol Violation|1|||
155197446|NCT00369824|560159789|FG005|Overall Study|Protocol Violation|0|||
155197447|NCT00369824|560159784|FG000|Overall Study|Withdrawal by Subject|9|||
155197448|NCT00369824|560159785|FG001|Overall Study|Withdrawal by Subject|5|||
155197449|NCT00369824|560159786|FG002|Overall Study|Withdrawal by Subject|5|||
155197450|NCT00369824|560159787|FG003|Overall Study|Withdrawal by Subject|4|||
155197451|NCT00369824|560159788|FG004|Overall Study|Withdrawal by Subject|6|||
155197452|NCT00369824|560159789|FG005|Overall Study|Withdrawal by Subject|2|||
155197453|NCT00369824|560159784|FG000|Overall Study|Lost to Follow-up|6|||
155197454|NCT00369824|560159785|FG001|Overall Study|Lost to Follow-up|11|||
155197455|NCT00369824|560159786|FG002|Overall Study|Lost to Follow-up|7|||
155197456|NCT00369824|560159787|FG003|Overall Study|Lost to Follow-up|8|||
155197457|NCT00369824|560159788|FG004|Overall Study|Lost to Follow-up|9|||
155197458|NCT00369824|560159789|FG005|Overall Study|Lost to Follow-up|6|||
155197459|NCT00369824|560159784|FG000|Overall Study|Other|0|||
155197460|NCT00369824|560159785|FG001|Overall Study|Other|0|||
155197461|NCT00369824|560159786|FG002|Overall Study|Other|0|||
155197462|NCT00369824|560159787|FG003|Overall Study|Other|2|||
155197463|NCT00369824|560159788|FG004|Overall Study|Other|1|||
155197464|NCT00369824|560159789|FG005|Overall Study|Other|3|||
155197465|NCT01484275|560159793|FG000|Overall Study|Study terminated by sponsor|28|||
155197466|NCT01484275|560159794|FG001|Overall Study|Study terminated by sponsor|32|||
155197467|NCT01484275|560159793|FG000|Overall Study|Other|10|||
155197468|NCT01484275|560159794|FG001|Overall Study|Other|0|||
155197469|NCT01484275|560159793|FG000|Overall Study|Death|3|||
155197470|NCT01484275|560159794|FG001|Overall Study|Death|4|||
155197471|NCT01484275|560159793|FG000|Overall Study|Withdrawal by Subject|1|||
155197472|NCT01484275|560159794|FG001|Overall Study|Withdrawal by Subject|5|||
155197473|NCT01484275|560159793|FG000|Overall Study|Lost to Follow-up|1|||
155197474|NCT01484275|560159794|FG001|Overall Study|Lost to Follow-up|1|||
155197475|NCT00003487|560159795|FG000|Overall Study|Not evaluable|2|||
155197476|NCT04154930|560159798|FG000|Overall Study|Withdrawal by Subject|15|||
155197477|NCT04154930|560159799|FG001|Overall Study|Withdrawal by Subject|6|||
155197478|NCT04154930|560159798|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
155197479|NCT04154930|560159799|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
155197480|NCT04154930|560159798|FG000|Overall Study|Lost to Follow-up|14|||
155197481|NCT04154930|560159799|FG001|Overall Study|Lost to Follow-up|6|||
155197482|NCT04154930|560159798|FG000|Overall Study|Other|6|||
155197483|NCT04154930|560159799|FG001|Overall Study|Other|0|||
155197484|NCT00657358|560159800|FG000|Overall Study|Lack of Efficacy|6|||
155197485|NCT04203797|560159808|FG000|Overall Study|Adverse Event|1|||
155197486|NCT04203797|560159809|FG001|Overall Study|Adverse Event|0|||
155197487|NCT04203797|560159808|FG000|Overall Study|Did not complete End of Study follow-up|1|||
155197488|NCT04203797|560159809|FG001|Overall Study|Did not complete End of Study follow-up|0|||
155197489|NCT00678080|560159810|FG000|Overall Study|Physician Decision|2|||
155197490|NCT00678080|560159811|FG001|Overall Study|Physician Decision|0|||
155197491|NCT00678080|560159810|FG000|Overall Study|Lost to Follow-up|1|||
155197492|NCT00678080|560159811|FG001|Overall Study|Lost to Follow-up|0|||
155197493|NCT00678080|560159810|FG000|Overall Study|Withdrawal by Subject|0|||
155197494|NCT00678080|560159811|FG001|Overall Study|Withdrawal by Subject|1|||
155197495|NCT01453361|560159812|FG000|Overall Study|Disease Progression|6|||
155197496|NCT01453361|560159812|FG000|Overall Study|Screen-Failures|10|||
155197497|NCT01752985|560159813|FG000|Treatment Period|Subject request to discontinue treatment|1|||
155197498|NCT01752985|560159814|FG001|Treatment Period|Subject request to discontinue treatment|0|||
155197499|NCT01752985|560159815|FG002|Treatment Period|Subject request to discontinue treatment|1|||
155197500|NCT01752985|560159813|FG000|Treatment Period|Subject no longer meets study criteria|0|||
155197501|NCT01752985|560159814|FG001|Treatment Period|Subject no longer meets study criteria|1|||
155197502|NCT01752985|560159815|FG002|Treatment Period|Subject no longer meets study criteria|1|||
155197503|NCT01752985|560159813|FG000|Treatment Period|Adverse Event|2|||
155197504|NCT01752985|560159814|FG001|Treatment Period|Adverse Event|1|||
155197505|NCT01752985|560159815|FG002|Treatment Period|Adverse Event|2|||
155197506|NCT01752985|560159813|FG000|Treatment Period|Withdrawal by Subject|1|||
155197507|NCT01752985|560159814|FG001|Treatment Period|Withdrawal by Subject|1|||
155197508|NCT01752985|560159815|FG002|Treatment Period|Withdrawal by Subject|0|||
155197509|NCT01752985|560159813|FG000|Treatment Period|Lost to Follow-up|0|||
155197510|NCT01752985|560159814|FG001|Treatment Period|Lost to Follow-up|0|||
155197511|NCT01752985|560159815|FG002|Treatment Period|Lost to Follow-up|1|||
155197512|NCT01385566|560161652|FG000|Overall Study|Lost to Follow-up|1|||
155197513|NCT01385566|560161653|FG001|Overall Study|Lost to Follow-up|0|||
155197514|NCT01385566|560161654|FG002|Overall Study|Lost to Follow-up|0|||
155197515|NCT01385566|560161655|FG003|Overall Study|Lost to Follow-up|0|||
155197516|NCT01385566|560161656|FG004|Overall Study|Lost to Follow-up|0|||
155197517|NCT01385566|560161657|FG005|Overall Study|Lost to Follow-up|0|||
155197518|NCT01385566|560161652|FG000|Overall Study|Withdrawal by Subject|0|||
155197519|NCT01385566|560161653|FG001|Overall Study|Withdrawal by Subject|0|||
155197520|NCT01385566|560161654|FG002|Overall Study|Withdrawal by Subject|0|||
155197521|NCT01385566|560161655|FG003|Overall Study|Withdrawal by Subject|1|||
155197522|NCT01385566|560161656|FG004|Overall Study|Withdrawal by Subject|0|||
155197523|NCT01385566|560161657|FG005|Overall Study|Withdrawal by Subject|0|||
155197524|NCT00967668|560161658|FG000|Overall Study|Withdrawal by Subject|13|||
155197525|NCT00967668|560161659|FG001|Overall Study|Withdrawal by Subject|8|||
155197526|NCT00967668|560161660|FG002|Overall Study|Withdrawal by Subject|8|||
155197527|NCT00967668|560161658|FG000|Overall Study|Death|0|||
155197528|NCT00967668|560161659|FG001|Overall Study|Death|2|||
155197529|NCT00967668|560161660|FG002|Overall Study|Death|4|||
155197530|NCT00967668|560161658|FG000|Overall Study|Removed due to behavior|1|||
155197531|NCT00967668|560161659|FG001|Overall Study|Removed due to behavior|1|||
155197532|NCT00967668|560161660|FG002|Overall Study|Removed due to behavior|2|||
155197533|NCT00967668|560161658|FG000|Overall Study|Refused Year 2|11|||
155197534|NCT00967668|560161659|FG001|Overall Study|Refused Year 2|6|||
155197535|NCT00967668|560161660|FG002|Overall Study|Refused Year 2|4|||
155197536|NCT00967668|560161658|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
155197537|NCT00967668|560161659|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
155197538|NCT00967668|560161660|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
155197539|NCT00967668|560161658|FG000|Overall Study|Lost to Follow-up|15|||
155197540|NCT00967668|560161659|FG001|Overall Study|Lost to Follow-up|9|||
155197541|NCT00967668|560161660|FG002|Overall Study|Lost to Follow-up|16|||
155197542|NCT00967668|560161658|FG000|Overall Study|Refused 12-mo assessment|3|||
155197543|NCT00967668|560161659|FG001|Overall Study|Refused 12-mo assessment|1|||
155197544|NCT00967668|560161660|FG002|Overall Study|Refused 12-mo assessment|9|||
155197545|NCT00967668|560161658|FG000|Overall Study|Pregnancy|1|||
155197546|NCT00967668|560161659|FG001|Overall Study|Pregnancy|0|||
155197547|NCT00967668|560161660|FG002|Overall Study|Pregnancy|0|||
155197548|NCT02468674|560161663|FG000|Overall Study|Adverse Event|0|||
155197549|NCT02468674|560161664|FG001|Overall Study|Adverse Event|0|||
155197550|NCT02468674|560161665|FG002|Overall Study|Adverse Event|0|||
155197551|NCT02468674|560161666|FG003|Overall Study|Adverse Event|1|||
155197552|NCT02468674|560161667|FG004|Overall Study|Adverse Event|0|||
155197553|NCT02468674|560161668|FG005|Overall Study|Adverse Event|1|||
155197554|NCT02468674|560161669|FG006|Overall Study|Adverse Event|0|||
155197555|NCT02468674|560161670|FG007|Overall Study|Adverse Event|0|||
155197556|NCT02468674|560161671|FG008|Overall Study|Adverse Event|0|||
155197557|NCT02468674|560161663|FG000|Overall Study|Lost to Follow-up|1|||
155197558|NCT02468674|560161664|FG001|Overall Study|Lost to Follow-up|0|||
155197559|NCT02468674|560161665|FG002|Overall Study|Lost to Follow-up|0|||
155197560|NCT02468674|560161666|FG003|Overall Study|Lost to Follow-up|0|||
155197561|NCT02468674|560161667|FG004|Overall Study|Lost to Follow-up|0|||
155197562|NCT02468674|560161668|FG005|Overall Study|Lost to Follow-up|0|||
155197563|NCT02468674|560161669|FG006|Overall Study|Lost to Follow-up|0|||
155197564|NCT02468674|560161670|FG007|Overall Study|Lost to Follow-up|1|||
155197565|NCT02468674|560161671|FG008|Overall Study|Lost to Follow-up|1|||
155197566|NCT02468674|560161663|FG000|Overall Study|Physician Decision|0|||
155197567|NCT02468674|560161664|FG001|Overall Study|Physician Decision|0|||
155197568|NCT02468674|560161665|FG002|Overall Study|Physician Decision|0|||
155197569|NCT02468674|560161666|FG003|Overall Study|Physician Decision|0|||
155197570|NCT02468674|560161667|FG004|Overall Study|Physician Decision|0|||
155197571|NCT02468674|560161668|FG005|Overall Study|Physician Decision|0|||
155197572|NCT02468674|560161669|FG006|Overall Study|Physician Decision|1|||
155197573|NCT02468674|560161670|FG007|Overall Study|Physician Decision|0|||
155197574|NCT02468674|560161671|FG008|Overall Study|Physician Decision|0|||
155197575|NCT02468674|560161663|FG000|Overall Study|Patient/Guardian Decision|0|||
155197576|NCT02468674|560161664|FG001|Overall Study|Patient/Guardian Decision|0|||
155197577|NCT02468674|560161665|FG002|Overall Study|Patient/Guardian Decision|0|||
155197578|NCT02468674|560161666|FG003|Overall Study|Patient/Guardian Decision|0|||
155197579|NCT02468674|560161667|FG004|Overall Study|Patient/Guardian Decision|1|||
155197580|NCT02468674|560161668|FG005|Overall Study|Patient/Guardian Decision|0|||
155197581|NCT02468674|560161669|FG006|Overall Study|Patient/Guardian Decision|0|||
155197582|NCT02468674|560161670|FG007|Overall Study|Patient/Guardian Decision|2|||
155197583|NCT02468674|560161671|FG008|Overall Study|Patient/Guardian Decision|1|||
155197584|NCT02468674|560161663|FG000|Overall Study|Protocol Deviation|0|||
155197585|NCT02468674|560161664|FG001|Overall Study|Protocol Deviation|0|||
155197586|NCT02468674|560161665|FG002|Overall Study|Protocol Deviation|0|||
155197587|NCT02468674|560161666|FG003|Overall Study|Protocol Deviation|0|||
155197588|NCT02468674|560161667|FG004|Overall Study|Protocol Deviation|0|||
155197589|NCT02468674|560161668|FG005|Overall Study|Protocol Deviation|0|||
155197590|NCT02468674|560161669|FG006|Overall Study|Protocol Deviation|0|||
155197591|NCT02468674|560161670|FG007|Overall Study|Protocol Deviation|1|||
155197592|NCT02468674|560161671|FG008|Overall Study|Protocol Deviation|1|||
155197593|NCT01644565|560161674|FG000|Overall Study|Undisclosed Medical History|1|||
155197594|NCT01644565|560161675|FG001|Overall Study|Undisclosed Medical History|0|||
155197595|NCT01644565|560161676|FG002|Overall Study|Undisclosed Medical History|0|||
155197596|NCT01644565|560161677|FG003|Overall Study|Undisclosed Medical History|0|||
155197597|NCT01644565|560161678|FG004|Overall Study|Undisclosed Medical History|0|||
155197598|NCT01644565|560161679|FG005|Overall Study|Undisclosed Medical History|0|||
155197599|NCT01644565|560161680|FG006|Overall Study|Undisclosed Medical History|0|||
155197600|NCT01644565|560161681|FG007|Overall Study|Undisclosed Medical History|0|||
155197601|NCT01644565|560161682|FG008|Overall Study|Undisclosed Medical History|0|||
155197602|NCT01644565|560161674|FG000|Overall Study|Lost to Follow-up|0|||
155197603|NCT01644565|560161675|FG001|Overall Study|Lost to Follow-up|0|||
155197604|NCT01644565|560161676|FG002|Overall Study|Lost to Follow-up|0|||
155197605|NCT01644565|560161677|FG003|Overall Study|Lost to Follow-up|1|||
155197606|NCT01644565|560161678|FG004|Overall Study|Lost to Follow-up|0|||
155197607|NCT01644565|560161679|FG005|Overall Study|Lost to Follow-up|0|||
155197608|NCT01644565|560161680|FG006|Overall Study|Lost to Follow-up|0|||
155197609|NCT01644565|560161681|FG007|Overall Study|Lost to Follow-up|2|||
155197610|NCT01644565|560161682|FG008|Overall Study|Lost to Follow-up|0|||
155197611|NCT01644565|560161674|FG000|Overall Study|Family emergency|0|||
155197612|NCT01644565|560161675|FG001|Overall Study|Family emergency|0|||
155197613|NCT01644565|560161676|FG002|Overall Study|Family emergency|0|||
155197614|NCT01644565|560161677|FG003|Overall Study|Family emergency|0|||
155197615|NCT01644565|560161678|FG004|Overall Study|Family emergency|1|||
155197616|NCT01644565|560161679|FG005|Overall Study|Family emergency|0|||
155197617|NCT01644565|560161680|FG006|Overall Study|Family emergency|0|||
155197618|NCT01644565|560161681|FG007|Overall Study|Family emergency|0|||
155197619|NCT01644565|560161682|FG008|Overall Study|Family emergency|0|||
155197620|NCT01644565|560161674|FG000|Overall Study|Relocation|0|||
155197621|NCT01644565|560161675|FG001|Overall Study|Relocation|0|||
155197622|NCT01644565|560161676|FG002|Overall Study|Relocation|0|||
155197623|NCT01644565|560161677|FG003|Overall Study|Relocation|0|||
155197624|NCT01644565|560161678|FG004|Overall Study|Relocation|0|||
155197625|NCT01644565|560161679|FG005|Overall Study|Relocation|0|||
155197626|NCT01644565|560161680|FG006|Overall Study|Relocation|0|||
155197627|NCT01644565|560161681|FG007|Overall Study|Relocation|0|||
155197628|NCT01644565|560161682|FG008|Overall Study|Relocation|1|||
155197629|NCT02195583|560161685|FG000|Overall Study|Lost to Follow-up|1|||
155197630|NCT02195583|560161685|FG000|Overall Study|Withdrawal by Subject|4|||
155197631|NCT02195583|560161685|FG000|Overall Study|Adverse Event|2|||
155197632|NCT02195583|560161685|FG000|Overall Study|Other Reason|2|||
155197633|NCT00040365|560161688|FG000|Overall Study|Death|1|||
155197634|NCT00040365|560161688|FG000|Overall Study|Progressive disease|7|||
155197635|NCT00040365|560161688|FG000|Overall Study|Lost to Follow-up|3|||
155197636|NCT00680017|560161689|FG000|Overall Study|Adverse Event|13|||
155197637|NCT00680017|560161690|FG001|Overall Study|Adverse Event|7|||
155197638|NCT00680017|560161689|FG000|Overall Study|Withdrawal by Subject|2|||
155197639|NCT00680017|560161690|FG001|Overall Study|Withdrawal by Subject|5|||
155197640|NCT00680017|560161689|FG000|Overall Study|Lost to Follow-up|2|||
155197641|NCT00680017|560161690|FG001|Overall Study|Lost to Follow-up|0|||
155197642|NCT02555683|560161694|FG000|Overall Study|Physician Decision|1|||
155197643|NCT02555683|560161695|FG001|Overall Study|Physician Decision|0|||
155197644|NCT02555683|560161696|FG002|Overall Study|Physician Decision|2|||
155197645|NCT02555683|560161694|FG000|Overall Study|Lost to Follow-up|2|||
155197646|NCT02555683|560161695|FG001|Overall Study|Lost to Follow-up|1|||
155197647|NCT02555683|560161696|FG002|Overall Study|Lost to Follow-up|2|||
155197648|NCT02555683|560161694|FG000|Overall Study|Technical Problems|1|||
155197649|NCT02555683|560161695|FG001|Overall Study|Technical Problems|1|||
155197650|NCT02555683|560161696|FG002|Overall Study|Technical Problems|0|||
155197651|NCT02555683|560161694|FG000|Overall Study|Protocol deviation|0|||
155197652|NCT02555683|560161695|FG001|Overall Study|Protocol deviation|1|||
155197653|NCT02555683|560161696|FG002|Overall Study|Protocol deviation|0|||
155197654|NCT02555683|560161694|FG000|Overall Study|Lack of Efficacy|2|||
155197655|NCT02555683|560161695|FG001|Overall Study|Lack of Efficacy|0|||
155197656|NCT02555683|560161696|FG002|Overall Study|Lack of Efficacy|0|||
155197657|NCT02555683|560161694|FG000|Overall Study|Death|0|||
155197658|NCT02555683|560161695|FG001|Overall Study|Death|1|||
155197659|NCT02555683|560161696|FG002|Overall Study|Death|2|||
155197660|NCT02555683|560161694|FG000|Overall Study|Adverse Event|1|||
155197661|NCT02555683|560161695|FG001|Overall Study|Adverse Event|0|||
155197662|NCT02555683|560161696|FG002|Overall Study|Adverse Event|1|||
155197663|NCT02555683|560161694|FG000|Overall Study|Subject/guardian decision|12|||
155197664|NCT02555683|560161695|FG001|Overall Study|Subject/guardian decision|12|||
155197665|NCT02555683|560161696|FG002|Overall Study|Subject/guardian decision|22|||
155197666|NCT02555683|560161694|FG000|Overall Study|Death post Treatment/safety period|0|||
155197667|NCT02555683|560161695|FG001|Overall Study|Death post Treatment/safety period|1|||
155197668|NCT02555683|560161696|FG002|Overall Study|Death post Treatment/safety period|0|||
155197669|NCT01947582|560161701|FG000|Overall Study|Withdrawal by Subject|1|||
155197670|NCT02279420|560161702|FG000|Overall Study|Lost to Follow-up|23|||
155197671|NCT00612040|560161703|FG000|Overall Study|Adverse Event|0|||
155197672|NCT00612040|560161704|FG001|Overall Study|Adverse Event|2|||
155197673|NCT00612040|560161705|FG002|Overall Study|Adverse Event|1|||
155197674|NCT00612040|560161703|FG000|Overall Study|Protocol Violation|1|||
155197675|NCT00612040|560161704|FG001|Overall Study|Protocol Violation|2|||
155197676|NCT00612040|560161705|FG002|Overall Study|Protocol Violation|1|||
155197677|NCT00612040|560161703|FG000|Overall Study|Lack of Efficacy|2|||
155197678|NCT00612040|560161704|FG001|Overall Study|Lack of Efficacy|1|||
155197679|NCT00612040|560161705|FG002|Overall Study|Lack of Efficacy|0|||
155197680|NCT00612040|560161703|FG000|Overall Study|Unclassified|2|||
155197681|NCT00612040|560161704|FG001|Overall Study|Unclassified|2|||
155197682|NCT00612040|560161705|FG002|Overall Study|Unclassified|5|||
155197683|NCT02835820|560161706|FG000|Overall Study|Baseline Screen Failure|0|||
155197684|NCT02835820|560161707|FG001|Overall Study|Baseline Screen Failure|3|||
155197685|NCT02924571|560161716|FG000|Overall Study|Lost to Follow-up|1|||
155197686|NCT02924571|560161717|FG001|Overall Study|Lost to Follow-up|1|||
155197687|NCT02924571|560161718|FG002|Overall Study|Lost to Follow-up|0|||
155197688|NCT00002651|560161722|FG000|Induction|Adverse Event|44|||
155197689|NCT00002651|560161723|FG001|Induction|Adverse Event|0|||
155197690|NCT00002651|560161724|FG002|Induction|Adverse Event|0|||
155197691|NCT00002651|560161722|FG000|Induction|Refusal unrelated to adverse event|50|||
155197692|NCT00002651|560161723|FG001|Induction|Refusal unrelated to adverse event|0|||
155197693|NCT00002651|560161724|FG002|Induction|Refusal unrelated to adverse event|0|||
155197694|NCT00002651|560161722|FG000|Induction|Progression/relapse|274|||
155197695|NCT00002651|560161723|FG001|Induction|Progression/relapse|0|||
155197696|NCT00002651|560161724|FG002|Induction|Progression/relapse|0|||
155197697|NCT00002651|560161722|FG000|Induction|Death|62|||
155197698|NCT00002651|560161723|FG001|Induction|Death|0|||
155197699|NCT00002651|560161724|FG002|Induction|Death|0|||
155197700|NCT00002651|560161722|FG000|Induction|Other|823|||
155197701|NCT00002651|560161723|FG001|Induction|Other|0|||
155197702|NCT00002651|560161724|FG002|Induction|Other|0|||
155197703|NCT00002651|560161722|FG000|Induction|not eligible|90|||
155197704|NCT00002651|560161723|FG001|Induction|not eligible|0|||
155197705|NCT00002651|560161724|FG002|Induction|not eligible|0|||
155197706|NCT00002651|560161722|FG000|Consolidation and Randomization|Adverse Event|0|||
155197707|NCT00002651|560161723|FG001|Consolidation and Randomization|Adverse Event|36|||
155197708|NCT00002651|560161724|FG002|Consolidation and Randomization|Adverse Event|14|||
155197709|NCT00002651|560161722|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
155197710|NCT00002651|560161723|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
155197711|NCT00002651|560161724|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
155197712|NCT00002651|560161722|FG000|Consolidation and Randomization|Progression/relapse|0|||
155197713|NCT00002651|560161723|FG001|Consolidation and Randomization|Progression/relapse|295|||
155197714|NCT00002651|560161724|FG002|Consolidation and Randomization|Progression/relapse|298|||
155197715|NCT00002651|560161722|FG000|Consolidation and Randomization|Death|0|||
155197716|NCT00002651|560161723|FG001|Consolidation and Randomization|Death|38|||
155197717|NCT00002651|560161724|FG002|Consolidation and Randomization|Death|48|||
155197718|NCT00002651|560161722|FG000|Consolidation and Randomization|Other|0|||
155197719|NCT00002651|560161723|FG001|Consolidation and Randomization|Other|314|||
155197720|NCT00002651|560161724|FG002|Consolidation and Randomization|Other|313|||
155197721|NCT00002651|560161722|FG000|Consolidation and Randomization|not eligible|0|||
155197722|NCT00002651|560161723|FG001|Consolidation and Randomization|not eligible|102|||
155197723|NCT00002651|560161724|FG002|Consolidation and Randomization|not eligible|112|||
155197724|NCT01705730|560161725|FG000|Overall Study|Lack of Efficacy|1|||
155197725|NCT01705730|560161725|FG000|Overall Study|Adverse Event|3|||
155197726|NCT01705730|560161725|FG000|Overall Study|Lost to Follow-up|1|||
155197727|NCT01705730|560161725|FG000|Overall Study|Reason not Specified|4|||
155197728|NCT01773733|560161726|FG000|Overall Study|Adverse Event|3286|||
155197729|NCT01773733|560161727|FG001|Overall Study|Adverse Event|540|||
155197730|NCT01773733|560161726|FG000|Overall Study|Pregnancy|28|||
155197731|NCT01773733|560161727|FG001|Overall Study|Pregnancy|0|||
155197732|NCT01773733|560161726|FG000|Overall Study|Other different categories of not compl|55415|||
155197733|NCT01773733|560161727|FG001|Overall Study|Other different categories of not compl|7781|||
155197734|NCT03345914|560161729|FG000|Overall Study|Transition to another study at week 16|80|||
155197735|NCT03345914|560161730|FG001|Overall Study|Transition to another study at week 16|86|||
155197736|NCT03345914|560161731|FG002|Overall Study|Transition to another study at week 16|78|||
155197737|NCT03345914|560161729|FG000|Overall Study|Transition to OLE during follow-up|37|||
155197738|NCT03345914|560161730|FG001|Overall Study|Transition to OLE during follow-up|33|||
155197739|NCT03345914|560161731|FG002|Overall Study|Transition to OLE during follow-up|39|||
155197740|NCT03345914|560161729|FG000|Overall Study|Physician Decision|0|||
155197741|NCT03345914|560161730|FG001|Overall Study|Physician Decision|1|||
155197742|NCT03345914|560161731|FG002|Overall Study|Physician Decision|1|||
155197743|NCT03345914|560161729|FG000|Overall Study|Withdrawal by Subject|5|||
155197744|NCT03345914|560161730|FG001|Overall Study|Withdrawal by Subject|1|||
155197745|NCT03345914|560161731|FG002|Overall Study|Withdrawal by Subject|2|||
155197746|NCT03345914|560161729|FG000|Overall Study|Other|1|||
155197747|NCT03345914|560161730|FG001|Overall Study|Other|1|||
155197748|NCT03345914|560161731|FG002|Overall Study|Other|1|||
155197749|NCT03345914|560161729|FG000|Overall Study|Ongoing|0|||
155197750|NCT03345914|560161730|FG001|Overall Study|Ongoing|0|||
155197751|NCT03345914|560161731|FG002|Overall Study|Ongoing|1|||
155197752|NCT03576495|560161741|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
155197753|NCT03576495|560161742|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
155197754|NCT02628938|560161745|FG000|Overall Study|Did not attend the follow up recall|2|||
155197755|NCT02628938|560161746|FG001|Overall Study|Did not attend the follow up recall|2|||
155197756|NCT02628938|560161747|FG002|Overall Study|Did not attend the follow up recall|1|||
155197757|NCT02628938|560161745|FG000|Overall Study|Failure to comply with the instructions|3|||
155197758|NCT02628938|560161746|FG001|Overall Study|Failure to comply with the instructions|0|||
155197759|NCT02628938|560161747|FG002|Overall Study|Failure to comply with the instructions|3|||
155197760|NCT02058693|560161748|FG000|Phase 1|Withdrawal by Subject|3|||
155197761|NCT02058693|560161749|FG001|Phase 1|Withdrawal by Subject|2|||
155197762|NCT02058693|560161748|FG000|Phase 1|Adverse Event|0|||
155197763|NCT02058693|560161749|FG001|Phase 1|Adverse Event|1|||
155197764|NCT02058693|560161748|FG000|Phase 1|Lack of Efficacy|1|||
155197765|NCT02058693|560161749|FG001|Phase 1|Lack of Efficacy|0|||
155197766|NCT02058693|560161748|FG000|Phase 1|Physician Decision|1|||
155197767|NCT02058693|560161749|FG001|Phase 1|Physician Decision|1|||
155197768|NCT02058693|560161748|FG000|Phase 2|Withdrawal by Subject|0|||
155197769|NCT02058693|560161749|FG001|Phase 2|Withdrawal by Subject|2|||
155197770|NCT00843856|560161750|FG000|Overall Study|Lost to Follow-up|1|||
155197771|NCT00843856|560161751|FG001|Overall Study|Lost to Follow-up|2|||
155197772|NCT03855228|560161752|FG000|Overall Study|Adverse Event|2|||
155197773|NCT03855228|560161753|FG001|Overall Study|Adverse Event|4|||
155197774|NCT03855228|560161754|FG002|Overall Study|Adverse Event|4|||
155197775|NCT03855228|560161755|FG003|Overall Study|Adverse Event|8|||
155197776|NCT03855228|560161752|FG000|Overall Study|Treatment Failure|1|||
155197777|NCT03855228|560161753|FG001|Overall Study|Treatment Failure|2|||
155197778|NCT03855228|560161754|FG002|Overall Study|Treatment Failure|1|||
155197779|NCT03855228|560161755|FG003|Overall Study|Treatment Failure|8|||
155197780|NCT03855228|560161752|FG000|Overall Study|Lost to Follow-up|0|||
155197781|NCT03855228|560161753|FG001|Overall Study|Lost to Follow-up|0|||
155197782|NCT03855228|560161754|FG002|Overall Study|Lost to Follow-up|0|||
155197783|NCT03855228|560161755|FG003|Overall Study|Lost to Follow-up|1|||
155197784|NCT03855228|560161752|FG000|Overall Study|Protocol Violation|0|||
155197785|NCT03855228|560161753|FG001|Overall Study|Protocol Violation|1|||
155197786|NCT03855228|560161754|FG002|Overall Study|Protocol Violation|2|||
155197787|NCT03855228|560161755|FG003|Overall Study|Protocol Violation|1|||
155197788|NCT03855228|560161752|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
155197789|NCT03855228|560161753|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
155197790|NCT03855228|560161754|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
155197791|NCT03855228|560161755|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
155197792|NCT02993757|560161756|FG000|Overall Study|Non compliance with the protocol|155|||
155197793|NCT02993757|560161757|FG001|Overall Study|Non compliance with the protocol|170|||
155197794|NCT02993757|560161756|FG000|Overall Study|Lost to Follow-up|1|||
155197795|NCT02993757|560161757|FG001|Overall Study|Lost to Follow-up|0|||
155197796|NCT02993757|560161756|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
155197797|NCT02993757|560161757|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
155197798|NCT00190671|560161761|FG000|Overall Study|Satisfactory Response|4|||
155197799|NCT00190671|560161762|FG001|Overall Study|Satisfactory Response|7|||
155197800|NCT00190671|560161761|FG000|Overall Study|Lack of Efficacy|19|||
155197801|NCT00190671|560161762|FG001|Overall Study|Lack of Efficacy|24|||
155197802|NCT00190671|560161761|FG000|Overall Study|Death from Study Disease|1|||
155197803|NCT00190671|560161762|FG001|Overall Study|Death from Study Disease|1|||
155197804|NCT00190671|560161761|FG000|Overall Study|Adverse Event|3|||
155197805|NCT00190671|560161762|FG001|Overall Study|Adverse Event|2|||
155197806|NCT00190671|560161761|FG000|Overall Study|Clinical Relapse|0|||
155197807|NCT00190671|560161762|FG001|Overall Study|Clinical Relapse|1|||
155197808|NCT00190671|560161761|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
155197809|NCT00190671|560161762|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
155197810|NCT00190671|560161761|FG000|Overall Study|Death from Other Causes|0|||
155197811|NCT00190671|560161762|FG001|Overall Study|Death from Other Causes|2|||
155197812|NCT00190671|560161761|FG000|Overall Study|Protocol Violation|0|||
155197813|NCT00190671|560161762|FG001|Overall Study|Protocol Violation|1|||
155197814|NCT00190671|560161761|FG000|Overall Study|Withdrawal by Subject|0|||
155197815|NCT00190671|560161762|FG001|Overall Study|Withdrawal by Subject|2|||
155197816|NCT02699593|560161763|FG000|Period 1|Unsatisfactory Visual Response|0|||
155197817|NCT02699593|560161764|FG001|Period 1|Unsatisfactory Visual Response|1|||
155197818|NCT02699593|560161763|FG000|Period 1|Torn Contact Len|4|||
155197819|NCT02699593|560161764|FG001|Period 1|Torn Contact Len|3|||
155197820|NCT02699593|560161763|FG000|Period 1|Protocol Violation|0|||
155197821|NCT02699593|560161764|FG001|Period 1|Protocol Violation|1|||
155197822|NCT02699593|560161763|FG000|Period 1|Withdrawal by Subject|0|||
155197823|NCT02699593|560161764|FG001|Period 1|Withdrawal by Subject|1|||
155197824|NCT02699593|560161763|FG000|Period 1|Adverse Event|1|||
155197825|NCT02699593|560161764|FG001|Period 1|Adverse Event|1|||
155197826|NCT02699593|560161763|FG000|Period 2|Adverse Event|1|||
155197827|NCT02699593|560161764|FG001|Period 2|Adverse Event|1|||
155197828|NCT02699593|560161763|FG000|Period 2|Lost Contact Lens|0|||
155197829|NCT02699593|560161764|FG001|Period 2|Lost Contact Lens|1|||
155197830|NCT02699593|560161763|FG000|Period 2|Torn Contact Lens|1|||
155197831|NCT02699593|560161764|FG001|Period 2|Torn Contact Lens|0|||
155197832|NCT01681472|560161765|FG000|Overall Study|Adverse Event|0|||
155197833|NCT01681472|560161766|FG001|Overall Study|Adverse Event|1|||
155197834|NCT01681472|560161767|FG002|Overall Study|Adverse Event|0|||
155197835|NCT01681472|560161768|FG003|Overall Study|Adverse Event|0|||
155197836|NCT02369016|560161769|FG000|Overall Study|AE associated with clinical disease progression|2|||
155197837|NCT02369016|560161770|FG001|Overall Study|AE associated with clinical disease progression|1|||
155197838|NCT02369016|560161769|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
155197839|NCT02369016|560161770|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
155197840|NCT02369016|560161769|FG000|Overall Study|Progressive disease - clinical progression|1|||
155197841|NCT02369016|560161770|FG001|Overall Study|Progressive disease - clinical progression|4|||
155197842|NCT02369016|560161769|FG000|Overall Study|withdrawal by patient|4|||
155197843|NCT02369016|560161770|FG001|Overall Study|withdrawal by patient|0|||
155197844|NCT02369016|560161769|FG000|Overall Study|Progressive disease - radiological progression|6|||
155197845|NCT02369016|560161770|FG001|Overall Study|Progressive disease - radiological progression|2|||
155197846|NCT02229383|560161771|FG000|Overall Study|Adverse Event|7|||
155197847|NCT02229383|560161772|FG001|Overall Study|Adverse Event|4|||
155197848|NCT02229383|560161771|FG000|Overall Study|Death|0|||
155197849|NCT02229383|560161772|FG001|Overall Study|Death|1|||
155197850|NCT02229383|560161771|FG000|Overall Study|Lost to Follow-up|5|||
155197851|NCT02229383|560161772|FG001|Overall Study|Lost to Follow-up|3|||
155197852|NCT02229383|560161771|FG000|Overall Study|Withdrawal by Subject|4|||
155197853|NCT02229383|560161772|FG001|Overall Study|Withdrawal by Subject|6|||
155197854|NCT02229383|560161771|FG000|Overall Study|Did not receive treatment|1|||
155197855|NCT02229383|560161772|FG001|Overall Study|Did not receive treatment|0|||
155197856|NCT02229383|560161771|FG000|Overall Study|Other|3|||
155197857|NCT02229383|560161772|FG001|Overall Study|Other|8|||
155197858|NCT01696071|560161780|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
155197859|NCT01696071|560161781|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
155197860|NCT00672646|560161788|FG000|Overall Study|Lost to Follow-up|0|||
155197861|NCT00672646|560161789|FG001|Overall Study|Lost to Follow-up|1|||
155197862|NCT00672646|560161790|FG002|Overall Study|Lost to Follow-up|2|||
155197863|NCT00672646|560161788|FG000|Overall Study|Withdrawal by Subject|0|||
155197864|NCT00672646|560161789|FG001|Overall Study|Withdrawal by Subject|0|||
155197865|NCT00672646|560161790|FG002|Overall Study|Withdrawal by Subject|1|||
155197866|NCT00289783|560161791|FG000|Primary Phase|Adverse Event|10|||
155197867|NCT00289783|560161792|FG001|Primary Phase|Adverse Event|1|||
155197868|NCT00289783|560161791|FG000|Primary Phase|Protocol Violation|27|||
155197869|NCT00289783|560161792|FG001|Primary Phase|Protocol Violation|6|||
155197870|NCT00289783|560161791|FG000|Primary Phase|Withdrawal by Subject|93|||
155197871|NCT00289783|560161792|FG001|Primary Phase|Withdrawal by Subject|40|||
155197872|NCT00289783|560161791|FG000|Primary Phase|Lost to Follow-up|60|||
155197873|NCT00289783|560161792|FG001|Primary Phase|Lost to Follow-up|14|||
155197874|NCT00289783|560161791|FG000|Primary Phase|Migration from the study area|26|||
155197875|NCT00289783|560161792|FG001|Primary Phase|Migration from the study area|10|||
155197876|NCT00289783|560161791|FG000|Primary Phase|Other|32|||
155197877|NCT00289783|560161792|FG001|Primary Phase|Other|12|||
155197878|NCT00289783|560161791|FG000|Fourth Dose Phase|Adverse Event|1|||
155197879|NCT00289783|560161792|FG001|Fourth Dose Phase|Adverse Event|0|||
155197880|NCT00289783|560161791|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
155197881|NCT00289783|560161792|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
155197882|NCT00289783|560161791|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
155197883|NCT00289783|560161792|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
155197884|NCT00289783|560161791|FG000|Fourth Dose Phase|Migration from the study area|1|||
155197885|NCT00289783|560161792|FG001|Fourth Dose Phase|Migration from the study area|1|||
155197886|NCT00289783|560161791|FG000|Fourth Dose Phase|Other|22|||
155197887|NCT00289783|560161792|FG001|Fourth Dose Phase|Other|10|||
155197888|NCT03298867|560161804|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
155197889|NCT03298867|560161805|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
155197890|NCT03298867|560161804|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
155197891|NCT03298867|560161805|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
155197892|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
155197893|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
155197894|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
155197895|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
155197896|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
155197897|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
155197898|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
155197899|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
155197900|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
155197901|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
155197902|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
155197903|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
155197904|NCT03298867|560161804|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
155197905|NCT03298867|560161805|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
155197906|NCT01594281|560163757|FG000|Interventional Core Phase|Protocol Deviation|1|||
155197907|NCT01594281|560163758|FG001|Interventional Core Phase|Protocol Deviation|0|||
155197908|NCT01594281|560163759|FG002|Interventional Core Phase|Protocol Deviation|0|||
155197909|NCT01594281|560163757|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
155197910|NCT01594281|560163758|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
155197911|NCT01594281|560163759|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
155197912|NCT01594281|560163757|FG000|Interventional Core Phase|Death|1|||
155197913|NCT01594281|560163758|FG001|Interventional Core Phase|Death|1|||
155197914|NCT01594281|560163759|FG002|Interventional Core Phase|Death|2|||
155197915|NCT01594281|560163757|FG000|Interventional Core Phase|Lost to Follow-up|1|||
155197916|NCT01594281|560163758|FG001|Interventional Core Phase|Lost to Follow-up|4|||
155197917|NCT01594281|560163759|FG002|Interventional Core Phase|Lost to Follow-up|1|||
155197918|NCT01594281|560163757|FG000|Interventional Core Phase|Adverse Event|4|||
155197919|NCT01594281|560163758|FG001|Interventional Core Phase|Adverse Event|4|||
155197920|NCT01594281|560163759|FG002|Interventional Core Phase|Adverse Event|4|||
155197921|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
155197922|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
155197923|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
155197924|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
155197925|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
155197926|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
155197927|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
155197928|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
155197929|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
155197930|NCT01871532|560163760|FG000|Overall Study|Withdrawal by Subject|1|||
155197931|NCT01871532|560163761|FG001|Overall Study|Withdrawal by Subject|2|||
155197932|NCT00283400|560163762|FG000|Overall Study|Withdrawal by Subject|1|||
155197933|NCT00283400|560163763|FG001|Overall Study|Withdrawal by Subject|1|||
155197934|NCT00283400|560163764|FG002|Overall Study|Withdrawal by Subject|0|||
155197935|NCT00283400|560163765|FG003|Overall Study|Withdrawal by Subject|0|||
155197936|NCT00283400|560163762|FG000|Overall Study|Death|1|||
155197937|NCT00283400|560163763|FG001|Overall Study|Death|0|||
155197938|NCT00283400|560163764|FG002|Overall Study|Death|1|||
155197939|NCT00283400|560163765|FG003|Overall Study|Death|0|||
155197940|NCT01673867|560163767|FG000|Randomization|Adverse event unrelated to study drug|1|||
155197941|NCT01673867|560163768|FG001|Randomization|Adverse event unrelated to study drug|0|||
155197942|NCT01673867|560163767|FG000|Randomization|Participant request to discontinue study treatment|0|||
155197943|NCT01673867|560163768|FG001|Randomization|Participant request to discontinue study treatment|4|||
155197944|NCT01673867|560163767|FG000|Randomization|Withdrawal by participant|0|||
155197945|NCT01673867|560163768|FG001|Randomization|Withdrawal by participant|12|||
155197946|NCT01673867|560163767|FG000|Randomization|Lost to Follow-up|0|||
155197947|NCT01673867|560163768|FG001|Randomization|Lost to Follow-up|1|||
155197948|NCT01673867|560163767|FG000|Randomization|Participant no longer meets study criteria|4|||
155197949|NCT01673867|560163768|FG001|Randomization|Participant no longer meets study criteria|5|||
155197950|NCT01673867|560163767|FG000|Treatment|Disease Progression|208|||
155197951|NCT01673867|560163768|FG001|Treatment|Disease Progression|178|||
155197952|NCT01673867|560163767|FG000|Treatment|Study Drug Toxicity|23|||
155197953|NCT01673867|560163768|FG001|Treatment|Study Drug Toxicity|43|||
155197954|NCT01673867|560163767|FG000|Treatment|Death|2|||
155197955|NCT01673867|560163768|FG001|Treatment|Death|3|||
155197956|NCT01673867|560163767|FG000|Treatment|Adverse event unrelated to study drug|23|||
155197957|NCT01673867|560163768|FG001|Treatment|Adverse event unrelated to study drug|10|||
155197958|NCT01673867|560163767|FG000|Treatment|Participant request to discontinue study treatment|7|||
155197959|NCT01673867|560163768|FG001|Treatment|Participant request to discontinue study treatment|17|||
155197960|NCT01673867|560163767|FG000|Treatment|Withdrawal by participant|5|||
155197961|NCT01673867|560163768|FG001|Treatment|Withdrawal by participant|5|||
155197962|NCT01673867|560163767|FG000|Treatment|Maximum clinical benefit|1|||
155197963|NCT01673867|560163768|FG001|Treatment|Maximum clinical benefit|10|||
155197964|NCT01673867|560163767|FG000|Treatment|Participant no longer meets study criteria|2|||
155197965|NCT01673867|560163768|FG001|Treatment|Participant no longer meets study criteria|0|||
155197966|NCT01673867|560163767|FG000|Treatment|Administrative reason by sponsor|3|||
155197967|NCT01673867|560163768|FG001|Treatment|Administrative reason by sponsor|0|||
155197968|NCT01673867|560163767|FG000|Treatment|Other reason|11|||
155197969|NCT01673867|560163768|FG001|Treatment|Other reason|2|||
155197970|NCT02550106|560163771|FG000|Overall Study|Adverse Event|1|||
155197971|NCT02550106|560163771|FG000|Overall Study|Lack of Efficacy|3|||
155197972|NCT02550106|560163771|FG000|Overall Study|Protocol Violation|6|||
155197973|NCT02550106|560163771|FG000|Overall Study|Withdrawal by Subject|2|||
155197974|NCT04019288|560163772|FG000|Overall Study|Death|1|||
155197975|NCT04019288|560163773|FG001|Overall Study|Death|0|||
155197976|NCT04019288|560163774|FG002|Overall Study|Death|0|||
155197977|NCT03166735|560163775|FG000|Overall Study|Not Treated|1|||
155197978|NCT03166735|560163776|FG001|Overall Study|Not Treated|0|||
155197979|NCT03166735|560163777|FG002|Overall Study|Not Treated|0|||
155197980|NCT03166735|560163778|FG003|Overall Study|Not Treated|0|||
155197981|NCT03166735|560163779|FG004|Overall Study|Not Treated|0|||
155197982|NCT03166735|560163775|FG000|Overall Study|follow-up not completed as planned|0|||
155197983|NCT03166735|560163776|FG001|Overall Study|follow-up not completed as planned|1|||
155197984|NCT03166735|560163777|FG002|Overall Study|follow-up not completed as planned|1|||
155197985|NCT03166735|560163778|FG003|Overall Study|follow-up not completed as planned|0|||
155197986|NCT03166735|560163779|FG004|Overall Study|follow-up not completed as planned|1|||
155197987|NCT03166735|560163775|FG000|Overall Study|Withdrawal by Subject|0|||
155197988|NCT03166735|560163776|FG001|Overall Study|Withdrawal by Subject|0|||
155197989|NCT03166735|560163777|FG002|Overall Study|Withdrawal by Subject|1|||
155197990|NCT03166735|560163778|FG003|Overall Study|Withdrawal by Subject|1|||
155197991|NCT03166735|560163779|FG004|Overall Study|Withdrawal by Subject|2|||
155197992|NCT03166735|560163775|FG000|Overall Study|Lost to Follow-up|0|||
155197993|NCT03166735|560163776|FG001|Overall Study|Lost to Follow-up|2|||
155197994|NCT03166735|560163777|FG002|Overall Study|Lost to Follow-up|1|||
155197995|NCT03166735|560163778|FG003|Overall Study|Lost to Follow-up|0|||
155197996|NCT03166735|560163779|FG004|Overall Study|Lost to Follow-up|1|||
155197997|NCT01543958|560163780|FG000|Overall Study|Loss to follow-up|3|||
155197998|NCT01543958|560163780|FG000|Overall Study|ART initiation|1|||
155197999|NCT00926328|560163785|FG000|Overall Study|Lost to Follow-up|12|||
155198000|NCT00926328|560163786|FG001|Overall Study|Lost to Follow-up|14|||
155198001|NCT03486223|560163789|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
155198002|NCT03486223|560163790|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
155198003|NCT01819831|560163791|FG000|Overall Study|Withdrawal by Subject|1|||
155198004|NCT03535844|560163794|FG000|Overall Study|Withdrawal by Subject|0|||
155198005|NCT03535844|560163795|FG001|Overall Study|Withdrawal by Subject|1|||
155198006|NCT01153347|560163798|FG000|Overall Study|Withdrawal by Subject|7|||
155198007|NCT01153347|560163799|FG001|Overall Study|Withdrawal by Subject|7|||
155198008|NCT01153347|560163800|FG002|Overall Study|Withdrawal by Subject|7|||
155198009|NCT01153347|560163801|FG003|Overall Study|Withdrawal by Subject|7|||
155198010|NCT01153347|560163798|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155198011|NCT01153347|560163799|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155198012|NCT01153347|560163800|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
155198013|NCT01153347|560163801|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155198014|NCT01153347|560163798|FG000|Overall Study|Adverse Event|3|||
155198015|NCT01153347|560163799|FG001|Overall Study|Adverse Event|9|||
155198016|NCT01153347|560163800|FG002|Overall Study|Adverse Event|21|||
155198017|NCT01153347|560163801|FG003|Overall Study|Adverse Event|7|||
155198018|NCT01153347|560163798|FG000|Overall Study|Severe non-compliance to protocol|6|||
155198019|NCT01153347|560163799|FG001|Overall Study|Severe non-compliance to protocol|7|||
155198020|NCT01153347|560163800|FG002|Overall Study|Severe non-compliance to protocol|4|||
155198021|NCT01153347|560163801|FG003|Overall Study|Severe non-compliance to protocol|3|||
155198022|NCT01153347|560163798|FG000|Overall Study|Condition under investigation worsened|1|||
155198023|NCT01153347|560163799|FG001|Overall Study|Condition under investigation worsened|1|||
155198024|NCT01153347|560163800|FG002|Overall Study|Condition under investigation worsened|0|||
155198025|NCT01153347|560163801|FG003|Overall Study|Condition under investigation worsened|0|||
155198026|NCT01153347|560163798|FG000|Overall Study|Lack of Efficacy|2|||
155198027|NCT01153347|560163799|FG001|Overall Study|Lack of Efficacy|2|||
155198028|NCT01153347|560163800|FG002|Overall Study|Lack of Efficacy|0|||
155198029|NCT01153347|560163801|FG003|Overall Study|Lack of Efficacy|4|||
155198030|NCT01153347|560163798|FG000|Overall Study|Study-specific withdrawal criteria|4|||
155198031|NCT01153347|560163799|FG001|Overall Study|Study-specific withdrawal criteria|3|||
155198032|NCT01153347|560163800|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155198033|NCT01153347|560163801|FG003|Overall Study|Study-specific withdrawal criteria|2|||
155198034|NCT01153347|560163798|FG000|Overall Study|Lost to Follow-up|4|||
155198035|NCT01153347|560163799|FG001|Overall Study|Lost to Follow-up|9|||
155198036|NCT01153347|560163800|FG002|Overall Study|Lost to Follow-up|11|||
155198037|NCT01153347|560163801|FG003|Overall Study|Lost to Follow-up|8|||
155198038|NCT01153347|560163798|FG000|Overall Study|Other|5|||
155198039|NCT01153347|560163799|FG001|Overall Study|Other|5|||
155198040|NCT01153347|560163800|FG002|Overall Study|Other|4|||
155198041|NCT01153347|560163801|FG003|Overall Study|Other|0|||
155198042|NCT01153347|560163798|FG000|Overall Study|Death|1|||
155198043|NCT01153347|560163799|FG001|Overall Study|Death|0|||
155198044|NCT01153347|560163800|FG002|Overall Study|Death|0|||
155198045|NCT01153347|560163801|FG003|Overall Study|Death|0|||
155198046|NCT00297830|560163802|FG000|6 Month Visit|Death|1|||
155198047|NCT00297830|560163803|FG001|6 Month Visit|Death|0|||
155198048|NCT00297830|560163804|FG002|6 Month Visit|Death|2|||
155198049|NCT00297830|560163802|FG000|6 Month Visit|Withdrawal by Subject|2|||
155198050|NCT00297830|560163803|FG001|6 Month Visit|Withdrawal by Subject|1|||
155198051|NCT00297830|560163804|FG002|6 Month Visit|Withdrawal by Subject|1|||
155198052|NCT00297830|560163802|FG000|6 Month Visit|Adverse Event|0|||
155198053|NCT00297830|560163803|FG001|6 Month Visit|Adverse Event|1|||
155198054|NCT00297830|560163804|FG002|6 Month Visit|Adverse Event|0|||
155198055|NCT00297830|560163802|FG000|12 Month Visit|Lost to Follow-up|1|||
155198056|NCT00297830|560163803|FG001|12 Month Visit|Lost to Follow-up|0|||
155198057|NCT00297830|560163804|FG002|12 Month Visit|Lost to Follow-up|0|||
155198058|NCT00297830|560163802|FG000|12 Month Visit|Adverse Event|0|||
155198059|NCT00297830|560163803|FG001|12 Month Visit|Adverse Event|3|||
155198060|NCT00297830|560163804|FG002|12 Month Visit|Adverse Event|0|||
155198061|NCT00297830|560163802|FG000|12 Month Visit|Withdrawal by Subject|0|||
155198062|NCT00297830|560163803|FG001|12 Month Visit|Withdrawal by Subject|3|||
155198063|NCT00297830|560163804|FG002|12 Month Visit|Withdrawal by Subject|0|||
155198064|NCT00003473|560163807|FG000|Overall Study|Three patients were not evaluable.|3|||
155198065|NCT04401423|560163808|FG000|Overall Study|Withdrawal by Subject|3|||
155198066|NCT04401423|560163809|FG001|Overall Study|Withdrawal by Subject|1|||
155198067|NCT04401423|560163808|FG000|Overall Study|Physician Decision|2|||
155198068|NCT04401423|560163809|FG001|Overall Study|Physician Decision|1|||
155198069|NCT00827502|560163810|FG000|Overall Study|randomized but not treated|11|||
155198070|NCT00827502|560163810|FG000|Overall Study|Adverse Event|1|||
155198071|NCT00827502|560163810|FG000|Overall Study|Lost to Follow-up|4|||
155198072|NCT00827502|560163810|FG000|Overall Study|Withdrawal by Subject|5|||
155198073|NCT05096221|560163811|FG000|Part 2|Physician Decision|0|||
155198074|NCT05096221|560163812|FG001|Part 2|Physician Decision|1|||
155198075|NCT02478632|560163816|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
155198076|NCT02478632|560163817|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
155198077|NCT02478632|560163816|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
155198078|NCT02478632|560163817|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
155198079|NCT02478632|560163816|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
155198080|NCT02478632|560163817|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
155198081|NCT01086033|560163818|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
155198082|NCT01086033|560163818|FG000|Overall Study|Lost to Follow-up|86|||
155198083|NCT01086033|560163818|FG000|Overall Study|Adverse Event|42|||
155198084|NCT01086033|560163818|FG000|Overall Study|Withdrawal by Subject|41|||
155198085|NCT01086033|560163818|FG000|Overall Study|Other|14|||
155198086|NCT01086033|560163818|FG000|Overall Study|Other|13|||
155198087|NCT01086033|560163818|FG000|Overall Study|AE and Withdrew Consent|5|||
155198088|NCT01086033|560163818|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
155198089|NCT01086033|560163818|FG000|Overall Study|Withdrew consent and Other Reason|4|||
155198090|NCT01086033|560163818|FG000|Overall Study|AE and Lack of Efficacy|4|||
155198091|NCT01086033|560163818|FG000|Overall Study|Death|1|||
155198092|NCT01086033|560163818|FG000|Overall Study|AE and Lost to Follow-up|1|||
155198093|NCT01086033|560163818|FG000|Overall Study|AE and Other Reason|1|||
155198094|NCT01086033|560163818|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
155198095|NCT02193867|560163820|FG000|Overall Study|Death|2|||
155198096|NCT02193867|560163820|FG000|Overall Study|Sponsor Study Termination|2|||
155198097|NCT03741062|560163823|FG000|Overall Study|Protocol Violation|1|||
155198098|NCT03741062|560163824|FG001|Overall Study|Protocol Violation|0|||
155198099|NCT03417219|560163827|FG000|Overall Study|Lost to Follow-up|0|||
155198100|NCT03417219|560163828|FG001|Overall Study|Lost to Follow-up|3|||
155198101|NCT00762229|560163830|FG000|Overall Study|Lost to Follow-up|1|||
155198102|NCT00762229|560163831|FG001|Overall Study|Lost to Follow-up|1|||
155198103|NCT00762229|560163830|FG000|Overall Study|did not recveive intervention|0|||
155198104|NCT00762229|560163831|FG001|Overall Study|did not recveive intervention|1|||
155198105|NCT02609828|560163832|FG000|Overall Study|Adverse Event|8|||
155198106|NCT02609828|560163833|FG001|Overall Study|Adverse Event|1|||
155198107|NCT02609828|560163834|FG002|Overall Study|Adverse Event|0|||
155198108|NCT02609828|560163835|FG003|Overall Study|Adverse Event|6|||
155198109|NCT02609828|560163832|FG000|Overall Study|Death|15|||
155198110|NCT02609828|560163833|FG001|Overall Study|Death|1|||
155198111|NCT02609828|560163834|FG002|Overall Study|Death|1|||
155198112|NCT02609828|560163835|FG003|Overall Study|Death|19|||
155198113|NCT02609828|560163832|FG000|Overall Study|Insufficient clinical response|2|||
155198114|NCT02609828|560163833|FG001|Overall Study|Insufficient clinical response|1|||
155198115|NCT02609828|560163834|FG002|Overall Study|Insufficient clinical response|0|||
155198116|NCT02609828|560163835|FG003|Overall Study|Insufficient clinical response|0|||
155198117|NCT02609828|560163832|FG000|Overall Study|Lost to Follow-up|0|||
155198118|NCT02609828|560163833|FG001|Overall Study|Lost to Follow-up|0|||
155198119|NCT02609828|560163834|FG002|Overall Study|Lost to Follow-up|0|||
155198120|NCT02609828|560163835|FG003|Overall Study|Lost to Follow-up|1|||
155198121|NCT02609828|560163832|FG000|Overall Study|Protocol Violation|2|||
155198122|NCT02609828|560163833|FG001|Overall Study|Protocol Violation|0|||
155198123|NCT02609828|560163834|FG002|Overall Study|Protocol Violation|0|||
155198124|NCT02609828|560163835|FG003|Overall Study|Protocol Violation|1|||
155198125|NCT02609828|560163832|FG000|Overall Study|Withdrawal by Subject|12|||
155198126|NCT02609828|560163833|FG001|Overall Study|Withdrawal by Subject|1|||
155198127|NCT02609828|560163834|FG002|Overall Study|Withdrawal by Subject|0|||
155198128|NCT02609828|560163835|FG003|Overall Study|Withdrawal by Subject|10|||
155198129|NCT02609828|560163832|FG000|Overall Study|Other|3|||
155198130|NCT02609828|560163833|FG001|Overall Study|Other|0|||
155198131|NCT02609828|560163834|FG002|Overall Study|Other|0|||
155198132|NCT02609828|560163835|FG003|Overall Study|Other|6|||
155198133|NCT02609828|560163832|FG000|Overall Study|Randomized but not treated|1|||
155198134|NCT02609828|560163833|FG001|Overall Study|Randomized but not treated|0|||
155198135|NCT02609828|560163834|FG002|Overall Study|Randomized but not treated|0|||
155198136|NCT02609828|560163835|FG003|Overall Study|Randomized but not treated|0|||
155198137|NCT01281865|560163836|FG000|Overall Study|Adverse Event|1|||
155198138|NCT01281865|560163837|FG001|Overall Study|Adverse Event|1|||
155198139|NCT01281865|560163836|FG000|Overall Study|Withdrawal by Subject|1|||
155198140|NCT01281865|560163837|FG001|Overall Study|Withdrawal by Subject|0|||
155198141|NCT01281865|560163836|FG000|Overall Study|Lack of Efficacy|1|||
155198142|NCT01281865|560163837|FG001|Overall Study|Lack of Efficacy|0|||
155198143|NCT03478657|560163838|FG000|Overall Study|Withdrawal by Subject|0|||
155198144|NCT03478657|560163839|FG001|Overall Study|Withdrawal by Subject|1|||
155198145|NCT03733470|560163842|FG000|Overall Study|PI Decision|1|||
155198146|NCT03733470|560163843|FG001|Overall Study|PI Decision|1|||
155198147|NCT01786668|560163845|FG000|Overall Study|Adverse Event|0|||
155198148|NCT01786668|560163846|FG001|Overall Study|Adverse Event|1|||
155198149|NCT01786668|560163847|FG002|Overall Study|Adverse Event|1|||
155198150|NCT01786668|560163848|FG003|Overall Study|Adverse Event|2|||
155198151|NCT01786668|560163845|FG000|Overall Study|Withdrawal by Subject|0|||
155198152|NCT01786668|560163846|FG001|Overall Study|Withdrawal by Subject|0|||
155198153|NCT01786668|560163847|FG002|Overall Study|Withdrawal by Subject|3|||
155198154|NCT01786668|560163848|FG003|Overall Study|Withdrawal by Subject|1|||
155198155|NCT01786668|560163845|FG000|Overall Study|Pregnancy|0|||
155198156|NCT01786668|560163846|FG001|Overall Study|Pregnancy|0|||
155198157|NCT01786668|560163847|FG002|Overall Study|Pregnancy|0|||
155198158|NCT01786668|560163848|FG003|Overall Study|Pregnancy|1|||
155198159|NCT01786668|560163845|FG000|Overall Study|Lost to Follow-up|1|||
155198160|NCT01786668|560163846|FG001|Overall Study|Lost to Follow-up|0|||
155198161|NCT01786668|560163847|FG002|Overall Study|Lost to Follow-up|1|||
155198162|NCT01786668|560163848|FG003|Overall Study|Lost to Follow-up|0|||
155198163|NCT01776840|560163855|FG000|Overall Study|Lost to Follow-up|12|||
155198164|NCT01776840|560163856|FG001|Overall Study|Lost to Follow-up|7|||
155198165|NCT01776840|560163855|FG000|Overall Study|Withdrawal by Subject|32|||
155198166|NCT01776840|560163856|FG001|Overall Study|Withdrawal by Subject|48|||
155198167|NCT01776840|560163855|FG000|Overall Study|Sponsor decision|89|||
155198168|NCT01776840|560163856|FG001|Overall Study|Sponsor decision|87|||
155198169|NCT03641339|560163857|FG000|Overall Study|Physician Decision|1|||
155198170|NCT03641339|560163858|FG001|Overall Study|Physician Decision|0|||
155198171|NCT03641339|560163859|FG002|Overall Study|Physician Decision|0|||
155198172|NCT03641339|560163860|FG003|Overall Study|Physician Decision|0|||
155198173|NCT03641339|560163861|FG004|Overall Study|Physician Decision|0|||
155198174|NCT03641339|560163862|FG005|Overall Study|Physician Decision|0|||
155198175|NCT03641339|560163857|FG000|Overall Study|Withdrawal by Subject|0|||
155198176|NCT03641339|560163858|FG001|Overall Study|Withdrawal by Subject|2|||
155198177|NCT03641339|560163859|FG002|Overall Study|Withdrawal by Subject|0|||
155198178|NCT03641339|560163860|FG003|Overall Study|Withdrawal by Subject|2|||
155198179|NCT03641339|560163861|FG004|Overall Study|Withdrawal by Subject|0|||
155198180|NCT03641339|560163862|FG005|Overall Study|Withdrawal by Subject|1|||
155198181|NCT05338216|560163864|FG000|Overall Study|Withdrawal by Subject|1|||
155198182|NCT05338216|560163865|FG001|Overall Study|Withdrawal by Subject|1|||
155198183|NCT04457336|560163866|FG000|Period 2: Part A|Withdrawal by Subject|0|||
155198184|NCT04457336|560163867|FG001|Period 2: Part A|Withdrawal by Subject|1|||
155198185|NCT04457336|560163868|FG002|Period 2: Part A|Withdrawal by Subject|1|||
155198186|NCT04457336|560163869|FG003|Period 2: Part A|Withdrawal by Subject|1|||
155198187|NCT04457336|560163870|FG004|Period 2: Part A|Withdrawal by Subject|0|||
155198188|NCT04457336|560163871|FG005|Period 2: Part A|Withdrawal by Subject|0|||
155198189|NCT04457336|560163872|FG006|Period 2: Part A|Withdrawal by Subject|0|||
155198190|NCT04457336|560163873|FG007|Period 2: Part A|Withdrawal by Subject|0|||
155198191|NCT04457336|560163866|FG000|Period 2: Part A|Adverse Event|0|||
155198192|NCT04457336|560163867|FG001|Period 2: Part A|Adverse Event|0|||
155198193|NCT04457336|560163868|FG002|Period 2: Part A|Adverse Event|1|||
155198194|NCT04457336|560163869|FG003|Period 2: Part A|Adverse Event|1|||
155198195|NCT04457336|560163870|FG004|Period 2: Part A|Adverse Event|0|||
155198196|NCT04457336|560163871|FG005|Period 2: Part A|Adverse Event|0|||
155198197|NCT04457336|560163872|FG006|Period 2: Part A|Adverse Event|0|||
155198198|NCT04457336|560163873|FG007|Period 2: Part A|Adverse Event|0|||
155198199|NCT04457336|560163866|FG000|Period 2: Part A|Study Terminated|0|||
155198200|NCT04457336|560163867|FG001|Period 2: Part A|Study Terminated|0|||
155198201|NCT04457336|560163868|FG002|Period 2: Part A|Study Terminated|1|||
155198202|NCT04457336|560163869|FG003|Period 2: Part A|Study Terminated|0|||
155198203|NCT04457336|560163870|FG004|Period 2: Part A|Study Terminated|0|||
155198204|NCT04457336|560163871|FG005|Period 2: Part A|Study Terminated|0|||
155198205|NCT04457336|560163872|FG006|Period 2: Part A|Study Terminated|0|||
155198206|NCT04457336|560163873|FG007|Period 2: Part A|Study Terminated|0|||
155198207|NCT04457336|560163866|FG000|Period 2: Part A|Protocol Violation|0|||
155198208|NCT04457336|560163867|FG001|Period 2: Part A|Protocol Violation|1|||
155198209|NCT04457336|560163868|FG002|Period 2: Part A|Protocol Violation|0|||
155198210|NCT04457336|560163869|FG003|Period 2: Part A|Protocol Violation|0|||
155198211|NCT04457336|560163870|FG004|Period 2: Part A|Protocol Violation|0|||
155198212|NCT04457336|560163871|FG005|Period 2: Part A|Protocol Violation|0|||
155198213|NCT04457336|560163872|FG006|Period 2: Part A|Protocol Violation|0|||
155198214|NCT04457336|560163873|FG007|Period 2: Part A|Protocol Violation|0|||
155198215|NCT04457336|560163866|FG000|Period 2: Part A|Lost to Follow-up|0|||
155198216|NCT04457336|560163867|FG001|Period 2: Part A|Lost to Follow-up|1|||
155198217|NCT04457336|560163868|FG002|Period 2: Part A|Lost to Follow-up|0|||
155198218|NCT04457336|560163869|FG003|Period 2: Part A|Lost to Follow-up|0|||
155198219|NCT04457336|560163870|FG004|Period 2: Part A|Lost to Follow-up|0|||
155198220|NCT04457336|560163871|FG005|Period 2: Part A|Lost to Follow-up|0|||
155198221|NCT04457336|560163872|FG006|Period 2: Part A|Lost to Follow-up|0|||
155198222|NCT04457336|560163873|FG007|Period 2: Part A|Lost to Follow-up|0|||
155198223|NCT04457336|560163866|FG000|Period 2: Part A|Other|0|||
155198224|NCT04457336|560163867|FG001|Period 2: Part A|Other|1|||
155198225|NCT04457336|560163868|FG002|Period 2: Part A|Other|0|||
155198226|NCT04457336|560163869|FG003|Period 2: Part A|Other|0|||
155198227|NCT04457336|560163870|FG004|Period 2: Part A|Other|0|||
155198228|NCT04457336|560163871|FG005|Period 2: Part A|Other|0|||
155198229|NCT04457336|560163872|FG006|Period 2: Part A|Other|0|||
155198230|NCT04457336|560163873|FG007|Period 2: Part A|Other|0|||
155198231|NCT04457336|560163866|FG000|Period 2: Part A|Physician Decision|0|||
155198232|NCT04457336|560163867|FG001|Period 2: Part A|Physician Decision|0|||
155198233|NCT04457336|560163868|FG002|Period 2: Part A|Physician Decision|0|||
155198234|NCT04457336|560163869|FG003|Period 2: Part A|Physician Decision|1|||
155198235|NCT04457336|560163870|FG004|Period 2: Part A|Physician Decision|0|||
155198236|NCT04457336|560163871|FG005|Period 2: Part A|Physician Decision|0|||
155198237|NCT04457336|560163872|FG006|Period 2: Part A|Physician Decision|0|||
155198238|NCT04457336|560163873|FG007|Period 2: Part A|Physician Decision|0|||
155198239|NCT04457336|560163866|FG000|Period 3: Part B|Study Terminated|0|||
155198240|NCT04457336|560163867|FG001|Period 3: Part B|Study Terminated|0|||
155198241|NCT04457336|560163868|FG002|Period 3: Part B|Study Terminated|0|||
155198242|NCT04457336|560163869|FG003|Period 3: Part B|Study Terminated|0|||
155198243|NCT04457336|560163870|FG004|Period 3: Part B|Study Terminated|1|||
155198244|NCT04457336|560163871|FG005|Period 3: Part B|Study Terminated|10|||
155198245|NCT04457336|560163872|FG006|Period 3: Part B|Study Terminated|13|||
155198246|NCT04457336|560163873|FG007|Period 3: Part B|Study Terminated|0|||
155198247|NCT04457336|560163866|FG000|Period 3: Part B|Withdrawal by Subject|0|||
155198248|NCT04457336|560163867|FG001|Period 3: Part B|Withdrawal by Subject|0|||
155198249|NCT04457336|560163868|FG002|Period 3: Part B|Withdrawal by Subject|0|||
155198250|NCT04457336|560163869|FG003|Period 3: Part B|Withdrawal by Subject|0|||
155198251|NCT04457336|560163870|FG004|Period 3: Part B|Withdrawal by Subject|0|||
155198252|NCT04457336|560163871|FG005|Period 3: Part B|Withdrawal by Subject|1|||
155198253|NCT04457336|560163872|FG006|Period 3: Part B|Withdrawal by Subject|2|||
155198254|NCT04457336|560163873|FG007|Period 3: Part B|Withdrawal by Subject|0|||
155198255|NCT04457336|560163866|FG000|Period 4: Part C|Study Terminated|0|||
155198256|NCT04457336|560163867|FG001|Period 4: Part C|Study Terminated|0|||
155198257|NCT04457336|560163868|FG002|Period 4: Part C|Study Terminated|0|||
155198258|NCT04457336|560163869|FG003|Period 4: Part C|Study Terminated|0|||
155198259|NCT04457336|560163870|FG004|Period 4: Part C|Study Terminated|0|||
155198260|NCT04457336|560163871|FG005|Period 4: Part C|Study Terminated|0|||
155198261|NCT04457336|560163872|FG006|Period 4: Part C|Study Terminated|0|||
155198262|NCT04457336|560163873|FG007|Period 4: Part C|Study Terminated|30|||
155198263|NCT04457336|560163866|FG000|Period 4: Part C|Adverse Event|0|||
155198264|NCT04457336|560163867|FG001|Period 4: Part C|Adverse Event|0|||
155198265|NCT04457336|560163868|FG002|Period 4: Part C|Adverse Event|0|||
155198266|NCT04457336|560163869|FG003|Period 4: Part C|Adverse Event|0|||
155198267|NCT04457336|560163870|FG004|Period 4: Part C|Adverse Event|0|||
155198268|NCT04457336|560163871|FG005|Period 4: Part C|Adverse Event|0|||
155198269|NCT04457336|560163872|FG006|Period 4: Part C|Adverse Event|0|||
155198270|NCT04457336|560163873|FG007|Period 4: Part C|Adverse Event|2|||
155198271|NCT04457336|560163866|FG000|Period 4: Part C|Site Terminated|0|||
155198272|NCT04457336|560163867|FG001|Period 4: Part C|Site Terminated|0|||
155198273|NCT04457336|560163868|FG002|Period 4: Part C|Site Terminated|0|||
155198274|NCT04457336|560163869|FG003|Period 4: Part C|Site Terminated|0|||
155198275|NCT04457336|560163870|FG004|Period 4: Part C|Site Terminated|0|||
155198276|NCT04457336|560163871|FG005|Period 4: Part C|Site Terminated|0|||
155198277|NCT04457336|560163872|FG006|Period 4: Part C|Site Terminated|0|||
155198278|NCT04457336|560163873|FG007|Period 4: Part C|Site Terminated|1|||
155198279|NCT04457336|560163866|FG000|Period 4: Part C|Other|0|||
155198280|NCT04457336|560163867|FG001|Period 4: Part C|Other|0|||
155198281|NCT04457336|560163868|FG002|Period 4: Part C|Other|0|||
155198282|NCT04457336|560163869|FG003|Period 4: Part C|Other|0|||
155198283|NCT04457336|560163870|FG004|Period 4: Part C|Other|0|||
155198284|NCT04457336|560163871|FG005|Period 4: Part C|Other|0|||
155198285|NCT04457336|560163872|FG006|Period 4: Part C|Other|0|||
155198286|NCT04457336|560163873|FG007|Period 4: Part C|Other|2|||
155198287|NCT04457336|560163866|FG000|Period 4: Part C|Withdrawal by Subject|0|||
155198288|NCT04457336|560163867|FG001|Period 4: Part C|Withdrawal by Subject|0|||
155198289|NCT04457336|560163868|FG002|Period 4: Part C|Withdrawal by Subject|0|||
155198290|NCT04457336|560163869|FG003|Period 4: Part C|Withdrawal by Subject|0|||
155198291|NCT04457336|560163870|FG004|Period 4: Part C|Withdrawal by Subject|0|||
155198292|NCT04457336|560163871|FG005|Period 4: Part C|Withdrawal by Subject|0|||
155198293|NCT04457336|560163872|FG006|Period 4: Part C|Withdrawal by Subject|0|||
155198294|NCT04457336|560163873|FG007|Period 4: Part C|Withdrawal by Subject|3|||
155198295|NCT05379231|560163874|FG000|Home Visit|Withdrawal by Subject|2|||
155198296|NCT05379231|560163874|FG000|In-lab Visit|Withdrawal by Subject|2|||
155198297|NCT02693119|560163881|FG000|Open-Label Period|Withdrawal by Subject|0|||
155198298|NCT02693119|560163882|FG001|Open-Label Period|Withdrawal by Subject|1|||
155198299|NCT01719783|560163883|FG000|Dose 2|Physician Decision|1|||
155198300|NCT01719783|560163884|FG001|Dose 2|Physician Decision|0|||
155198301|NCT02319837|560163885|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
155198302|NCT02319837|560163886|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
155198303|NCT02319837|560163887|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
155198304|NCT02319837|560163885|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
155198305|NCT02319837|560163886|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
155198306|NCT02319837|560163887|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
155198307|NCT02319837|560163885|FG000|Study Treatment Phase|Adverse Event|73|||
155198308|NCT02319837|560163886|FG001|Study Treatment Phase|Adverse Event|36|||
155198309|NCT02319837|560163887|FG002|Study Treatment Phase|Adverse Event|63|||
155198310|NCT02319837|560163885|FG000|Study Treatment Phase|Development of castration resistance|0|||
155198311|NCT02319837|560163886|FG001|Study Treatment Phase|Development of castration resistance|2|||
155198312|NCT02319837|560163887|FG002|Study Treatment Phase|Development of castration resistance|0|||
155198313|NCT02319837|560163885|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
155198314|NCT02319837|560163886|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
155198315|NCT02319837|560163887|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
155198316|NCT02319837|560163885|FG000|Study Treatment Phase|Protocol Violation|2|||
155198317|NCT02319837|560163886|FG001|Study Treatment Phase|Protocol Violation|2|||
155198318|NCT02319837|560163887|FG002|Study Treatment Phase|Protocol Violation|1|||
155198319|NCT02319837|560163885|FG000|Study Treatment Phase|Lost to Follow-up|0|||
155198320|NCT02319837|560163886|FG001|Study Treatment Phase|Lost to Follow-up|1|||
155198321|NCT02319837|560163887|FG002|Study Treatment Phase|Lost to Follow-up|0|||
155198322|NCT02319837|560163885|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
155198323|NCT02319837|560163886|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
155198324|NCT02319837|560163887|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
155198325|NCT02319837|560163885|FG000|Study Treatment Phase|Other|0|||
155198326|NCT02319837|560163886|FG001|Study Treatment Phase|Other|1|||
155198327|NCT02319837|560163887|FG002|Study Treatment Phase|Other|0|||
155198328|NCT02319837|560163885|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
155198329|NCT02319837|560163886|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
155198330|NCT02319837|560163887|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
155198331|NCT02319837|560163885|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
155198332|NCT02319837|560163886|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
155198333|NCT02319837|560163887|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
155198334|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
155198335|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
155198336|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
155198337|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
155198338|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
155198339|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
155198340|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
155198341|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
155198342|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
155198343|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
155198344|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
155198345|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
155198346|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Death|33|||
155198347|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Death|54|||
155198348|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Death|42|||
155198349|NCT00753766|560163888|FG000|Overall Study|Physician Decision|1|||
155198350|NCT00753766|560163889|FG001|Overall Study|Physician Decision|0|||
155198351|NCT01206166|560163891|FG000|Overall Study|No evaluable data|2|||
155198352|NCT01206166|560163892|FG001|Overall Study|No evaluable data|3|||
155198353|NCT00932126|560163893|FG000|Overall Study|Adverse Event|0|||
155198354|NCT00932126|560163894|FG001|Overall Study|Adverse Event|0|||
155198355|NCT00932126|560163895|FG002|Overall Study|Adverse Event|0|||
155198356|NCT00932126|560163896|FG003|Overall Study|Adverse Event|0|||
155198357|NCT00932126|560163897|FG004|Overall Study|Adverse Event|0|||
155198358|NCT00932126|560163898|FG005|Overall Study|Adverse Event|0|||
155198359|NCT00932126|560163899|FG006|Overall Study|Adverse Event|1|||
155198360|NCT00932126|560163900|FG007|Overall Study|Adverse Event|2|||
155198361|NCT00932126|560163893|FG000|Overall Study|Protocol Violation|0|||
155198362|NCT00932126|560163894|FG001|Overall Study|Protocol Violation|0|||
155198363|NCT00932126|560163895|FG002|Overall Study|Protocol Violation|0|||
155198364|NCT00932126|560163896|FG003|Overall Study|Protocol Violation|0|||
155198365|NCT00932126|560163897|FG004|Overall Study|Protocol Violation|1|||
155198366|NCT00932126|560163898|FG005|Overall Study|Protocol Violation|0|||
155198367|NCT00932126|560163899|FG006|Overall Study|Protocol Violation|0|||
155198368|NCT00932126|560163900|FG007|Overall Study|Protocol Violation|0|||
155198369|NCT00932126|560163893|FG000|Overall Study|Withdrawal by Subject|0|||
155198370|NCT00932126|560163894|FG001|Overall Study|Withdrawal by Subject|0|||
155198371|NCT00932126|560163895|FG002|Overall Study|Withdrawal by Subject|1|||
155198372|NCT00932126|560163896|FG003|Overall Study|Withdrawal by Subject|0|||
155198373|NCT00932126|560163897|FG004|Overall Study|Withdrawal by Subject|0|||
155198374|NCT00932126|560163898|FG005|Overall Study|Withdrawal by Subject|0|||
155198375|NCT00932126|560163899|FG006|Overall Study|Withdrawal by Subject|0|||
155198376|NCT00932126|560163900|FG007|Overall Study|Withdrawal by Subject|1|||
155198377|NCT00932126|560163893|FG000|Overall Study|Objective progression or relapse|3|||
155198378|NCT00932126|560163894|FG001|Overall Study|Objective progression or relapse|3|||
155198379|NCT00932126|560163895|FG002|Overall Study|Objective progression or relapse|2|||
155198380|NCT00932126|560163896|FG003|Overall Study|Objective progression or relapse|3|||
155198381|NCT00932126|560163897|FG004|Overall Study|Objective progression or relapse|3|||
155198382|NCT00932126|560163898|FG005|Overall Study|Objective progression or relapse|3|||
155198383|NCT00932126|560163899|FG006|Overall Study|Objective progression or relapse|3|||
155198384|NCT00932126|560163900|FG007|Overall Study|Objective progression or relapse|5|||
155198385|NCT00932126|560163893|FG000|Overall Study|Other|0|||
155198386|NCT00932126|560163894|FG001|Overall Study|Other|0|||
155198387|NCT00932126|560163895|FG002|Overall Study|Other|0|||
155198388|NCT00932126|560163896|FG003|Overall Study|Other|0|||
155198389|NCT00932126|560163897|FG004|Overall Study|Other|1|||
155198390|NCT00932126|560163898|FG005|Overall Study|Other|0|||
155198391|NCT00932126|560163899|FG006|Overall Study|Other|1|||
155198392|NCT00932126|560163900|FG007|Overall Study|Other|2|||
155198393|NCT05306977|560163904|FG000|Overall Study|Withdrawal by Subject|1|||
155198394|NCT00415168|560163905|FG000|Overall Study|Death|26|||
155198395|NCT00415168|560163905|FG000|Overall Study|Lost to Follow-up|3|||
155198396|NCT00415168|560163905|FG000|Overall Study|Physician Decision|13|||
155198397|NCT00415168|560163905|FG000|Overall Study|Sponsor Decision|4|||
155198398|NCT00415168|560163905|FG000|Overall Study|Withdrawal by Subject|6|||
155198399|NCT00241358|560163906|FG000|Overall Study|Determined to be not ineligible|0|||
155198400|NCT00241358|560163907|FG001|Overall Study|Determined to be not ineligible|1|||
155198401|NCT00241358|560163908|FG002|Overall Study|Determined to be not ineligible|1|||
155198402|NCT01611155|560163909|FG000|Overall Study|Adverse Event|1|||
155198403|NCT01611155|560163910|FG001|Overall Study|Adverse Event|1|||
155198404|NCT01611155|560163909|FG000|Overall Study|Refused further treatment|6|||
155198405|NCT01611155|560163910|FG001|Overall Study|Refused further treatment|4|||
155198406|NCT01611155|560163909|FG000|Overall Study|Disease progression|1|||
155198407|NCT01611155|560163910|FG001|Overall Study|Disease progression|0|||
155198408|NCT01611155|560163909|FG000|Overall Study|Withdrawal by Subject|1|||
155198409|NCT01611155|560163910|FG001|Overall Study|Withdrawal by Subject|0|||
155198410|NCT01611155|560163909|FG000|Overall Study|Alternative treatment|0|||
155198411|NCT01611155|560163910|FG001|Overall Study|Alternative treatment|1|||
155198412|NCT01611155|560163909|FG000|Overall Study|Ineligible patient|0|||
155198413|NCT01611155|560163910|FG001|Overall Study|Ineligible patient|1|||
155198414|NCT00087607|560163917|FG000|Overall Study|Adverse Event|14|||
155198415|NCT00087607|560163918|FG001|Overall Study|Adverse Event|24|||
155198416|NCT00087607|560163917|FG000|Overall Study|Death|0|||
155198417|NCT00087607|560163918|FG001|Overall Study|Death|1|||
155198418|NCT00087607|560163917|FG000|Overall Study|Insufficient Therapeutic Response|53|||
155198419|NCT00087607|560163918|FG001|Overall Study|Insufficient Therapeutic Response|42|||
155198420|NCT00087607|560163917|FG000|Overall Study|Failure to return|21|||
155198421|NCT00087607|560163918|FG001|Overall Study|Failure to return|17|||
155198422|NCT00087607|560163917|FG000|Overall Study|Withdrew Consent|12|||
155198423|NCT00087607|560163918|FG001|Overall Study|Withdrew Consent|16|||
155198424|NCT00087607|560163917|FG000|Overall Study|Administrative|12|||
155198425|NCT00087607|560163918|FG001|Overall Study|Administrative|12|||
155198426|NCT00087607|560163917|FG000|Overall Study|Refused Treatment|5|||
155198427|NCT00087607|560163918|FG001|Overall Study|Refused Treatment|7|||
155198428|NCT00087607|560163917|FG000|Overall Study|Other Protocol Violation|5|||
155198429|NCT00087607|560163918|FG001|Overall Study|Other Protocol Violation|2|||
155198430|NCT00087607|560163917|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155198431|NCT00087607|560163918|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155198432|NCT02015754|560163919|FG000|Overall Study|Disease progression|5|||
155198433|NCT02015754|560163919|FG000|Overall Study|Change in treatment modality|5|||
155198434|NCT02015754|560163919|FG000|Overall Study|Lost to Follow-up|1|||
155198435|NCT06934993|560163934|FG000|Overall Study|Withdrawal by Subject|29|||
155198436|NCT06934993|560163934|FG000|Overall Study|elevated postoperative creatinine level|11|||
155198437|NCT06934993|560163934|FG000|Overall Study|Death|3|||
155198438|NCT03749447|560164968|FG000|Overall Study|Adverse Event|11|||
155198439|NCT03749447|560164969|FG001|Overall Study|Adverse Event|3|||
155198440|NCT03749447|560164968|FG000|Overall Study|Death|1|||
155198441|NCT03749447|560164969|FG001|Overall Study|Death|1|||
155198442|NCT03749447|560164968|FG000|Overall Study|Lost to Follow-up|2|||
155198443|NCT03749447|560164969|FG001|Overall Study|Lost to Follow-up|2|||
155198444|NCT03749447|560164968|FG000|Overall Study|Reason Not Specified|0|||
155198445|NCT03749447|560164969|FG001|Overall Study|Reason Not Specified|3|||
155198446|NCT03749447|560164968|FG000|Overall Study|Physician Decision|4|||
155198447|NCT03749447|560164969|FG001|Overall Study|Physician Decision|3|||
155198448|NCT03749447|560164968|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
155198449|NCT03749447|560164969|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
155198450|NCT03749447|560164968|FG000|Overall Study|Study Terminated By Sponsor|112|||
155198451|NCT03749447|560164969|FG001|Overall Study|Study Terminated By Sponsor|105|||
155198452|NCT03749447|560164968|FG000|Overall Study|Withdrawal by Subject|12|||
155198453|NCT03749447|560164969|FG001|Overall Study|Withdrawal by Subject|6|||
155198454|NCT03749447|560164968|FG000|Overall Study|Non-compliance With Study Drug|0|||
155198455|NCT03749447|560164969|FG001|Overall Study|Non-compliance With Study Drug|1|||
155198456|NCT00259649|560164971|FG000|Overall Study|Lost to Follow-up|7|||
155198457|NCT00259649|560164971|FG000|Overall Study|irregular menses|3|||
155198458|NCT00745823|560164972|FG000|Overall Study|Adverse Event|5|||
155198459|NCT00745823|560164973|FG001|Overall Study|Adverse Event|3|||
155198460|NCT00745823|560164972|FG000|Overall Study|Lack of Efficacy|20|||
155198461|NCT00745823|560164973|FG001|Overall Study|Lack of Efficacy|6|||
155198462|NCT00745823|560164972|FG000|Overall Study|Lost to Follow-up|10|||
155198463|NCT00745823|560164973|FG001|Overall Study|Lost to Follow-up|11|||
155198464|NCT00745823|560164972|FG000|Overall Study|Physician Decision|10|||
155198465|NCT00745823|560164973|FG001|Overall Study|Physician Decision|5|||
155198466|NCT00745823|560164972|FG000|Overall Study|Pregnancy|0|||
155198467|NCT00745823|560164973|FG001|Overall Study|Pregnancy|4|||
155198468|NCT00745823|560164972|FG000|Overall Study|Withdrawal by Subject|14|||
155198487|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
155198488|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
155198489|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
155198490|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
155198491|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
155198492|NCT04218695|560164978|FG000|Overall Study|Adverse Event|1|||
155198493|NCT04218695|560164979|FG001|Overall Study|Adverse Event|0|||
155198494|NCT01890473|560164980|FG000|Overall Study|Lost to Follow-up|1|||
155198495|NCT01890473|560164981|FG001|Overall Study|Lost to Follow-up|0|||
155198496|NCT01890473|560164980|FG000|Overall Study|Poor/non-compliance|1|||
155198497|NCT01890473|560164981|FG001|Overall Study|Poor/non-compliance|0|||
155198498|NCT01945281|560164982|FG000|Overall Study|Adverse Event|1|||
155198499|NCT01945281|560164983|FG001|Overall Study|Adverse Event|0|||
155198500|NCT01945281|560164982|FG000|Overall Study|Death|3|||
155198501|NCT01945281|560164983|FG001|Overall Study|Death|3|||
155198502|NCT01945281|560164982|FG000|Overall Study|Physician Decision|1|||
155198503|NCT01945281|560164983|FG001|Overall Study|Physician Decision|1|||
155198504|NCT01945281|560164982|FG000|Overall Study|Technical Problems|1|||
155198505|NCT01945281|560164983|FG001|Overall Study|Technical Problems|0|||
155198506|NCT00934089|560164984|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
155198507|NCT00934089|560164985|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
155198508|NCT00934089|560164984|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
155198509|NCT00934089|560164985|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
155198510|NCT00799383|560164986|FG000|Overall Study|Protocol Violation|1|||
155198511|NCT00799383|560164987|FG001|Overall Study|Protocol Violation|1|||
155198512|NCT00799383|560164986|FG000|Overall Study|Adverse Event|0|||
155198513|NCT00799383|560164987|FG001|Overall Study|Adverse Event|1|||
155198514|NCT00799383|560164986|FG000|Overall Study|Lost to Follow-up|1|||
155198515|NCT00799383|560164987|FG001|Overall Study|Lost to Follow-up|2|||
155198516|NCT00799383|560164986|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
155198517|NCT00799383|560164987|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
155198518|NCT00799383|560164986|FG000|Overall Study|Withdrawal by Subject|0|||
155198519|NCT00799383|560164987|FG001|Overall Study|Withdrawal by Subject|1|||
155198520|NCT00726986|560164988|FG000|Induction Phase|Adverse Event|4|||
155198521|NCT00726986|560164988|FG000|Induction Phase|Withdrawal by Subject|2|||
155198522|NCT00726986|560164988|FG000|Induction Phase|Death|2|||
155198523|NCT00726986|560164988|FG000|Induction Phase|Lack of Efficacy|5|||
155198524|NCT00726986|560164988|FG000|Induction Phase|Secondary Disease|2|||
155198525|NCT00726986|560164988|FG000|Maintenance Phase|Adverse Event|1|||
155198526|NCT00726986|560164988|FG000|Maintenance Phase|Lack of Efficacy|2|||
155198527|NCT01513343|560164992|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
155198528|NCT01513343|560164993|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
155198529|NCT01513343|560164992|FG000|Post Data Collection|Dropped/withdrew from study|7|||
155198530|NCT01513343|560164993|FG001|Post Data Collection|Dropped/withdrew from study|1|||
155198531|NCT01513343|560164992|FG000|Post Data Collection|Lost to Follow-up|10|||
155198532|NCT01513343|560164993|FG001|Post Data Collection|Lost to Follow-up|23|||
155198533|NCT01513343|560164992|FG000|6-month Follow-up|Lost to Follow-up|28|||
155198534|NCT01513343|560164993|FG001|6-month Follow-up|Lost to Follow-up|17|||
155198535|NCT01513343|560164992|FG000|12-month Follow-up|Lost to Follow-up|10|||
155198536|NCT01513343|560164993|FG001|12-month Follow-up|Lost to Follow-up|3|||
155198537|NCT01434667|560164994|FG000|Overall Study|Lost to Follow-up|5|||
155198538|NCT01434667|560164995|FG001|Overall Study|Lost to Follow-up|10|||
155198539|NCT02034110|560165000|FG000|Overall Study|Physician Decision|0|||
155198540|NCT02034110|560165001|FG001|Overall Study|Physician Decision|0|||
155198541|NCT02034110|560165002|FG002|Overall Study|Physician Decision|0|||
155198542|NCT02034110|560165003|FG003|Overall Study|Physician Decision|0|||
155198543|NCT02034110|560165004|FG004|Overall Study|Physician Decision|2|||
155198544|NCT02034110|560165005|FG005|Overall Study|Physician Decision|0|||
155198545|NCT02034110|560165006|FG006|Overall Study|Physician Decision|1|||
155198546|NCT02034110|560165007|FG007|Overall Study|Physician Decision|0|||
155198547|NCT02034110|560165000|FG000|Overall Study|Lost to Follow-up|1|||
155198548|NCT02034110|560165001|FG001|Overall Study|Lost to Follow-up|0|||
155198549|NCT02034110|560165002|FG002|Overall Study|Lost to Follow-up|0|||
155198550|NCT02034110|560165003|FG003|Overall Study|Lost to Follow-up|0|||
155198551|NCT02034110|560165004|FG004|Overall Study|Lost to Follow-up|1|||
155198552|NCT02034110|560165005|FG005|Overall Study|Lost to Follow-up|0|||
155198553|NCT02034110|560165006|FG006|Overall Study|Lost to Follow-up|1|||
155198554|NCT02034110|560165007|FG007|Overall Study|Lost to Follow-up|0|||
155198555|NCT02034110|560165000|FG000|Overall Study|Withdrawal by Subject|5|||
155198556|NCT02034110|560165001|FG001|Overall Study|Withdrawal by Subject|7|||
155198557|NCT02034110|560165002|FG002|Overall Study|Withdrawal by Subject|0|||
155198558|NCT02034110|560165003|FG003|Overall Study|Withdrawal by Subject|3|||
155198559|NCT02034110|560165004|FG004|Overall Study|Withdrawal by Subject|7|||
155198560|NCT02034110|560165005|FG005|Overall Study|Withdrawal by Subject|0|||
155198561|NCT02034110|560165006|FG006|Overall Study|Withdrawal by Subject|3|||
155198562|NCT02034110|560165007|FG007|Overall Study|Withdrawal by Subject|1|||
155198563|NCT02034110|560165000|FG000|Overall Study|Study closed by sponsor|6|||
155198564|NCT02034110|560165001|FG001|Overall Study|Study closed by sponsor|2|||
155198565|NCT02034110|560165002|FG002|Overall Study|Study closed by sponsor|0|||
155198566|NCT02034110|560165003|FG003|Overall Study|Study closed by sponsor|6|||
155198567|NCT02034110|560165004|FG004|Overall Study|Study closed by sponsor|7|||
155198568|NCT02034110|560165005|FG005|Overall Study|Study closed by sponsor|0|||
155198569|NCT02034110|560165006|FG006|Overall Study|Study closed by sponsor|42|||
155198570|NCT02034110|560165007|FG007|Overall Study|Study closed by sponsor|0|||
155198571|NCT02587234|560165008|FG000|Overall Study|Withdrawal by Subject|1|||
155198572|NCT02587234|560165009|FG001|Overall Study|Withdrawal by Subject|1|||
155198573|NCT02587234|560165008|FG000|Overall Study|Lost to Follow-up|0|||
155198574|NCT02587234|560165009|FG001|Overall Study|Lost to Follow-up|2|||
155198575|NCT02165215|560165010|FG000|Induction Phase|Adverse Event|1|||
155198576|NCT02165215|560165011|FG001|Induction Phase|Adverse Event|0|||
155198577|NCT02165215|560165012|FG002|Induction Phase|Adverse Event|0|||
155198578|NCT02165215|560165010|FG000|Induction Phase|Withdrawal by Subject|10|||
155198579|NCT02165215|560165011|FG001|Induction Phase|Withdrawal by Subject|0|||
155198580|NCT02165215|560165012|FG002|Induction Phase|Withdrawal by Subject|0|||
155198581|NCT02165215|560165010|FG000|Induction Phase|Protocol Violation|1|||
155198582|NCT02165215|560165011|FG001|Induction Phase|Protocol Violation|0|||
155198583|NCT02165215|560165012|FG002|Induction Phase|Protocol Violation|0|||
155198584|NCT02165215|560165010|FG000|Induction Phase|Physician Decision|1|||
155198585|NCT02165215|560165011|FG001|Induction Phase|Physician Decision|0|||
155198586|NCT02165215|560165012|FG002|Induction Phase|Physician Decision|0|||
155198587|NCT02165215|560165010|FG000|Induction Phase|Lack of Efficacy|2|||
155198588|NCT02165215|560165011|FG001|Induction Phase|Lack of Efficacy|0|||
155198589|NCT02165215|560165012|FG002|Induction Phase|Lack of Efficacy|0|||
155198590|NCT02165215|560165010|FG000|Induction Phase|Non-Compliance|2|||
155198591|NCT02165215|560165011|FG001|Induction Phase|Non-Compliance|0|||
155198592|NCT02165215|560165012|FG002|Induction Phase|Non-Compliance|0|||
155198593|NCT02165215|560165010|FG000|Induction Phase|Lost to Follow-up|6|||
155198594|NCT02165215|560165011|FG001|Induction Phase|Lost to Follow-up|0|||
155198595|NCT02165215|560165012|FG002|Induction Phase|Lost to Follow-up|0|||
155198596|NCT02165215|560165010|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155198597|NCT02165215|560165011|FG001|Maintenance Phase|Withdrawal by Subject|7|||
155198598|NCT02165215|560165012|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155198599|NCT02165215|560165010|FG000|Maintenance Phase|Multiple reasons|0|||
155198600|NCT02165215|560165011|FG001|Maintenance Phase|Multiple reasons|2|||
155198601|NCT02165215|560165012|FG002|Maintenance Phase|Multiple reasons|1|||
155198602|NCT02165215|560165010|FG000|Maintenance Phase|Lost to Follow-up|0|||
155198603|NCT02165215|560165011|FG001|Maintenance Phase|Lost to Follow-up|2|||
155198604|NCT02165215|560165012|FG002|Maintenance Phase|Lost to Follow-up|0|||
155198605|NCT02165215|560165010|FG000|Maintenance Phase|Adverse Event|0|||
155198606|NCT02165215|560165011|FG001|Maintenance Phase|Adverse Event|1|||
155198607|NCT02165215|560165012|FG002|Maintenance Phase|Adverse Event|1|||
155198608|NCT05074667|560165013|FG000|Overall Study|Death|1|||
155198609|NCT05074667|560165013|FG000|Overall Study|Withdrawal by Subject|4|||
155198610|NCT05074667|560165013|FG000|Overall Study|Lost to Follow-up|10|||
155198611|NCT04678661|560165014|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
155198612|NCT04678661|560165015|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
155198613|NCT04678661|560165014|FG000|Overall Study|Protocol Violation|2|||
155198614|NCT04678661|560165015|FG001|Overall Study|Protocol Violation|0|||
155198615|NCT04678661|560165014|FG000|Overall Study|Withdrawal by Subject|1|||
155198616|NCT04678661|560165015|FG001|Overall Study|Withdrawal by Subject|0|||
155198617|NCT04678661|560165014|FG000|Overall Study|Lost to Follow-up|2|||
155198618|NCT04678661|560165015|FG001|Overall Study|Lost to Follow-up|0|||
155198619|NCT04678661|560165014|FG000|Overall Study|Death|2|||
155198620|NCT04678661|560165015|FG001|Overall Study|Death|0|||
155198621|NCT01867424|560165016|FG000|Overall Study|Patient noncompliance|2|||
155198622|NCT01867424|560165017|FG001|Overall Study|Patient noncompliance|1|||
155198623|NCT00864721|560165018|FG000|Overall Study|Patient request|11|||
155198624|NCT00864721|560165018|FG000|Overall Study|Hospitalized|1|||
155198625|NCT00864721|560165018|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
155198626|NCT00864721|560165018|FG000|Overall Study|Adverse Event|21|||
155198627|NCT01921387|560165019|FG000|Overall Study|Adverse Event|1|||
155198628|NCT00261807|560165020|FG000|Overall Study|Lost to Follow-up|2|||
155198629|NCT00261807|560165020|FG000|Overall Study|Adverse Event|2|||
155198630|NCT00261807|560165020|FG000|Overall Study|Death|1|||
155198631|NCT00261807|560165020|FG000|Overall Study|Protocol Violation|2|||
155198632|NCT01706146|560165021|FG000|Overall Study|Withdrawal by Subject|1|||
155198633|NCT01706146|560165021|FG000|Overall Study|Adverse Event|3|||
155198634|NCT01706146|560165021|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
155198635|NCT02582983|560165022|FG000|Overall Study|Death|3|||
155198636|NCT02582983|560165022|FG000|Overall Study|Withdrawal by Subject|2|||
155198637|NCT02582983|560165022|FG000|Overall Study|Adverse Event|1|||
155198638|NCT02527161|560165023|FG000|Overall Study|Failed MRI|52|||
155198639|NCT02527161|560165023|FG000|Overall Study|Withdrawal by Subject|19|||
155198640|NCT02527161|560165023|FG000|Overall Study|Delay in or unfit for surgery|16|||
155198641|NCT02527161|560165023|FG000|Overall Study|MRI contraindication|6|||
155198642|NCT02527161|560165023|FG000|Overall Study|Consent violation|4|||
155198643|NCT02527161|560165023|FG000|Overall Study|Only Recruited to Part A|27|||
155198644|NCT02527161|560165023|FG000|Overall Study|Physician Decision|1|||
155198645|NCT02527161|560165023|FG000|Overall Study|Adverse Event|1|||
155198646|NCT02527161|560165023|FG000|Overall Study|Lost to Follow-up|6|||
155198647|NCT02021331|560165026|FG000|Overall Study|Adverse Event|0|||
155198648|NCT02021331|560165027|FG001|Overall Study|Adverse Event|2|||
155198649|NCT01081678|560165029|FG000|Overall Study|Ineligibility Determined|0|||
155198650|NCT01081678|560165030|FG001|Overall Study|Ineligibility Determined|0|||
155198651|NCT01081678|560165031|FG002|Overall Study|Ineligibility Determined|1|||
155198652|NCT01081678|560165032|FG003|Overall Study|Ineligibility Determined|1|||
155198653|NCT01081678|560165029|FG000|Overall Study|Noncompliance|3|||
155198654|NCT01081678|560165030|FG001|Overall Study|Noncompliance|4|||
155198655|NCT01081678|560165031|FG002|Overall Study|Noncompliance|5|||
155198656|NCT01081678|560165032|FG003|Overall Study|Noncompliance|2|||
155198657|NCT01081678|560165029|FG000|Overall Study|Adverse Event|2|||
155198658|NCT01081678|560165030|FG001|Overall Study|Adverse Event|1|||
155198659|NCT01081678|560165031|FG002|Overall Study|Adverse Event|2|||
155198660|NCT01081678|560165032|FG003|Overall Study|Adverse Event|2|||
155198661|NCT01081678|560165029|FG000|Overall Study|Withdrawal by Subject|15|||
155198662|NCT01081678|560165030|FG001|Overall Study|Withdrawal by Subject|7|||
155198663|NCT01081678|560165031|FG002|Overall Study|Withdrawal by Subject|17|||
155198664|NCT01081678|560165032|FG003|Overall Study|Withdrawal by Subject|14|||
155198665|NCT01081678|560165029|FG000|Overall Study|Administrative Decision|1|||
155198666|NCT01081678|560165030|FG001|Overall Study|Administrative Decision|0|||
155198667|NCT01081678|560165031|FG002|Overall Study|Administrative Decision|0|||
155198668|NCT01081678|560165032|FG003|Overall Study|Administrative Decision|1|||
155198669|NCT01081678|560165029|FG000|Overall Study|Lost to Follow-up|4|||
155198670|NCT01081678|560165030|FG001|Overall Study|Lost to Follow-up|1|||
155198671|NCT01081678|560165031|FG002|Overall Study|Lost to Follow-up|4|||
155198672|NCT01081678|560165032|FG003|Overall Study|Lost to Follow-up|3|||
155198673|NCT01081678|560165029|FG000|Overall Study|Death|2|||
155198674|NCT01081678|560165030|FG001|Overall Study|Death|2|||
155198675|NCT01081678|560165031|FG002|Overall Study|Death|2|||
155198676|NCT01081678|560165032|FG003|Overall Study|Death|6|||
155198677|NCT01081678|560165029|FG000|Overall Study|Other|0|||
155198678|NCT01081678|560165030|FG001|Overall Study|Other|1|||
155198679|NCT01081678|560165031|FG002|Overall Study|Other|0|||
155198680|NCT01081678|560165032|FG003|Overall Study|Other|0|||
155198681|NCT02589405|560165036|FG000|Overall Study|Adverse Event|3|||
155198682|NCT02589405|560165036|FG000|Overall Study|Withdrawal by Subject|1|||
155198683|NCT00446251|560165039|FG000|Overall Study|On-study Transplants|2|||
155198684|NCT00446251|560165039|FG000|Overall Study|Rituximab Infusion Reaction|2|||
155198685|NCT00446251|560165039|FG000|Overall Study|Lost to Follow-up|1|||
155198686|NCT00939640|560165050|FG000|Overall Study|Physician Decision|1|||
155198687|NCT00590135|560165053|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
155198688|NCT00306189|560165056|FG000|Overall Study|Physician Decision|0|||
155198689|NCT00306189|560165057|FG001|Overall Study|Physician Decision|0|||
155198690|NCT00306189|560165058|FG002|Overall Study|Physician Decision|0|||
155198691|NCT00306189|560165059|FG003|Overall Study|Physician Decision|1|||
155198692|NCT00306189|560165056|FG000|Overall Study|Adverse Event|3|||
155198693|NCT00306189|560165057|FG001|Overall Study|Adverse Event|3|||
155198694|NCT00306189|560165058|FG002|Overall Study|Adverse Event|2|||
155198695|NCT00306189|560165059|FG003|Overall Study|Adverse Event|2|||
155198696|NCT00306189|560165056|FG000|Overall Study|Withdrawal by Subject|4|||
155198697|NCT00306189|560165057|FG001|Overall Study|Withdrawal by Subject|2|||
155198698|NCT00306189|560165058|FG002|Overall Study|Withdrawal by Subject|8|||
155198699|NCT00306189|560165059|FG003|Overall Study|Withdrawal by Subject|1|||
155198700|NCT00306189|560165056|FG000|Overall Study|Ineligibility determined|1|||
155198701|NCT00306189|560165057|FG001|Overall Study|Ineligibility determined|1|||
155198702|NCT00306189|560165058|FG002|Overall Study|Ineligibility determined|1|||
155198703|NCT00306189|560165059|FG003|Overall Study|Ineligibility determined|1|||
155198704|NCT00306189|560165056|FG000|Overall Study|Other|1|||
155198705|NCT00306189|560165057|FG001|Overall Study|Other|0|||
155198706|NCT00306189|560165058|FG002|Overall Study|Other|0|||
155198707|NCT00306189|560165059|FG003|Overall Study|Other|0|||
155198708|NCT05248867|560165060|FG000|Double-blind Period|Lost to Follow-up|0|||
155198709|NCT05248867|560165061|FG001|Double-blind Period|Lost to Follow-up|3|||
155198710|NCT05248867|560165062|FG002|Double-blind Period|Lost to Follow-up|0|||
155198711|NCT05248867|560165063|FG003|Double-blind Period|Lost to Follow-up|0|||
155198712|NCT05248867|560165064|FG004|Double-blind Period|Lost to Follow-up|0|||
155198713|NCT05248867|560165065|FG005|Double-blind Period|Lost to Follow-up|0|||
155198714|NCT05248867|560165060|FG000|Double-blind Period|Withdrawal by Subject|5|||
155198715|NCT05248867|560165061|FG001|Double-blind Period|Withdrawal by Subject|14|||
155198716|NCT05248867|560165062|FG002|Double-blind Period|Withdrawal by Subject|0|||
155198717|NCT05248867|560165063|FG003|Double-blind Period|Withdrawal by Subject|0|||
155198718|NCT05248867|560165064|FG004|Double-blind Period|Withdrawal by Subject|0|||
155198719|NCT05248867|560165065|FG005|Double-blind Period|Withdrawal by Subject|0|||
155198720|NCT05248867|560165060|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198721|NCT05248867|560165061|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
155198722|NCT05248867|560165062|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198723|NCT05248867|560165063|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198724|NCT05248867|560165064|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198725|NCT05248867|560165065|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198726|NCT05248867|560165060|FG000|Double-blind Period|Other, not specified|3|||
155198727|NCT05248867|560165061|FG001|Double-blind Period|Other, not specified|8|||
155198728|NCT05248867|560165062|FG002|Double-blind Period|Other, not specified|0|||
155198729|NCT05248867|560165063|FG003|Double-blind Period|Other, not specified|0|||
155198730|NCT05248867|560165064|FG004|Double-blind Period|Other, not specified|0|||
155198731|NCT05248867|560165065|FG005|Double-blind Period|Other, not specified|0|||
155198732|NCT05248867|560165060|FG000|Open-label Period|Withdrawal by Subject|0|||
155198733|NCT05248867|560165061|FG001|Open-label Period|Withdrawal by Subject|0|||
155198734|NCT05248867|560165062|FG002|Open-label Period|Withdrawal by Subject|3|||
155198735|NCT05248867|560165063|FG003|Open-label Period|Withdrawal by Subject|1|||
155198736|NCT05248867|560165064|FG004|Open-label Period|Withdrawal by Subject|7|||
155198737|NCT05248867|560165065|FG005|Open-label Period|Withdrawal by Subject|9|||
155198738|NCT05248867|560165060|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198739|NCT05248867|560165061|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198740|NCT05248867|560165062|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198741|NCT05248867|560165063|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
155198742|NCT05248867|560165064|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198743|NCT05248867|560165065|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198744|NCT05248867|560165060|FG000|Open-label Period|Lost to Follow-up|0|||
155198745|NCT05248867|560165061|FG001|Open-label Period|Lost to Follow-up|0|||
155198746|NCT05248867|560165062|FG002|Open-label Period|Lost to Follow-up|0|||
155198747|NCT05248867|560165063|FG003|Open-label Period|Lost to Follow-up|0|||
155198748|NCT05248867|560165064|FG004|Open-label Period|Lost to Follow-up|5|||
155198749|NCT05248867|560165065|FG005|Open-label Period|Lost to Follow-up|2|||
155198750|NCT05248867|560165060|FG000|Open-label Period|COVID-19 Infection|0|||
155198751|NCT05248867|560165061|FG001|Open-label Period|COVID-19 Infection|0|||
155198752|NCT05248867|560165062|FG002|Open-label Period|COVID-19 Infection|0|||
155198753|NCT05248867|560165063|FG003|Open-label Period|COVID-19 Infection|0|||
155198754|NCT05248867|560165064|FG004|Open-label Period|COVID-19 Infection|1|||
155198755|NCT05248867|560165065|FG005|Open-label Period|COVID-19 Infection|0|||
155198756|NCT05248867|560165060|FG000|Open-label Period|Other, not specified|0|||
155198757|NCT05248867|560165061|FG001|Open-label Period|Other, not specified|0|||
155198758|NCT05248867|560165062|FG002|Open-label Period|Other, not specified|0|||
155198759|NCT05248867|560165063|FG003|Open-label Period|Other, not specified|0|||
155198760|NCT05248867|560165064|FG004|Open-label Period|Other, not specified|4|||
155198761|NCT05248867|560165065|FG005|Open-label Period|Other, not specified|0|||
155198762|NCT03128411|560165066|FG000|Treatment Phase|Adverse Event|21|||
155198763|NCT03128411|560165066|FG000|Treatment Phase|Physician Decision|1|||
155198764|NCT03128411|560165066|FG000|Treatment Phase|Other|2|||
155198765|NCT03128411|560165066|FG000|Long Term Follow-up Phase|Death|2|||
155198766|NCT05147428|560165071|FG000|Overall Study|Removed prior to mailing|289|||
155198767|NCT05147428|560165072|FG001|Overall Study|Removed prior to mailing|306|||
155198768|NCT05147428|560165073|FG002|Overall Study|Removed prior to mailing|270|||
155198769|NCT05147428|560165071|FG000|Overall Study|Died or disenrolled during blackout period|239|||
155198770|NCT05147428|560165072|FG001|Overall Study|Died or disenrolled during blackout period|278|||
155198771|NCT05147428|560165073|FG002|Overall Study|Died or disenrolled during blackout period|273|||
155198772|NCT03128047|560165074|FG000|Overall Study|Withdrawal by Subject|1|||
155198773|NCT00688753|560166474|FG000|Overall Study|Disease progression|55|||
155198774|NCT00688753|560166474|FG000|Overall Study|Missing|1|||
155198775|NCT00688753|560166474|FG000|Overall Study|Death|9|||
155198776|NCT00688753|560166474|FG000|Overall Study|Withdrawal by Subject|3|||
155198777|NCT00688753|560166474|FG000|Overall Study|Adverse Event|20|||
155198778|NCT00688753|560166474|FG000|Overall Study|Protocol Violation|1|||
155198779|NCT00688753|560166474|FG000|Overall Study|Lost to Follow-up|3|||
155198780|NCT05996718|560166476|FG000|Overall Study|Lost to Follow-up|3|||
155198781|NCT01218113|560166477|FG000|Overall Study|Withdrawal by Subject|1|||
155198782|NCT01218113|560166478|FG001|Overall Study|Withdrawal by Subject|0|||
155198783|NCT01218113|560166479|FG002|Overall Study|Withdrawal by Subject|1|||
155198784|NCT01218113|560166477|FG000|Overall Study|Lost to Follow-up|4|||
155198785|NCT01218113|560166478|FG001|Overall Study|Lost to Follow-up|1|||
155198786|NCT01218113|560166479|FG002|Overall Study|Lost to Follow-up|4|||
155198787|NCT01218113|560166477|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
155198788|NCT01218113|560166478|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
155198789|NCT01218113|560166479|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
155198790|NCT01713686|560166480|FG000|Overall Study|Lost to Follow-up|9|||
155198791|NCT01713686|560166480|FG000|Overall Study|Withdrawal by Subject|6|||
155198792|NCT03187197|560166481|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
155198793|NCT03187197|560166482|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
155198794|NCT03187197|560166483|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
155198795|NCT03187197|560166481|FG000|Overall Study|Withdrawal by Subject|8|||
155198796|NCT03187197|560166482|FG001|Overall Study|Withdrawal by Subject|63|||
155198797|NCT03187197|560166483|FG002|Overall Study|Withdrawal by Subject|4|||
155198798|NCT03187197|560166481|FG000|Overall Study|Lost to Follow-up|1|||
155198799|NCT03187197|560166482|FG001|Overall Study|Lost to Follow-up|60|||
155198800|NCT03187197|560166483|FG002|Overall Study|Lost to Follow-up|7|||
155198801|NCT03187197|560166481|FG000|Overall Study|Adverse Event|6|||
155198802|NCT03187197|560166482|FG001|Overall Study|Adverse Event|29|||
155198803|NCT03187197|560166483|FG002|Overall Study|Adverse Event|0|||
155198804|NCT03187197|560166481|FG000|Overall Study|Death|0|||
155198805|NCT03187197|560166482|FG001|Overall Study|Death|11|||
155198806|NCT03187197|560166483|FG002|Overall Study|Death|0|||
155198807|NCT03187197|560166481|FG000|Overall Study|Administrative problem|1|||
155198808|NCT03187197|560166482|FG001|Overall Study|Administrative problem|1|||
155198809|NCT03187197|560166483|FG002|Overall Study|Administrative problem|0|||
155198810|NCT03187197|560166481|FG000|Overall Study|Reason not listed|2|||
155198811|NCT03187197|560166482|FG001|Overall Study|Reason not listed|54|||
155198812|NCT03187197|560166483|FG002|Overall Study|Reason not listed|1|||
155198813|NCT03187197|560166481|FG000|Overall Study|Missing|1|||
155198814|NCT03187197|560166482|FG001|Overall Study|Missing|32|||
155198815|NCT03187197|560166483|FG002|Overall Study|Missing|3|||
155198816|NCT03187197|560166481|FG000|Overall Study|Status missing|2|||
155198817|NCT03187197|560166482|FG001|Overall Study|Status missing|33|||
155198818|NCT03187197|560166483|FG002|Overall Study|Status missing|3|||
155198819|NCT03187197|560166481|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
155198820|NCT03187197|560166482|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
155198821|NCT03187197|560166483|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
155198822|NCT02385045|560166484|FG000|Overall Study|Endoscopy could not be completed|4|||
155198823|NCT00115739|560166485|FG000|Overall Study|Lost to Follow-up|3|||
155198824|NCT02955602|560166498|FG000|Overall Study|Adverse Event|0|||
155198825|NCT02955602|560166499|FG001|Overall Study|Adverse Event|3|||
155198826|NCT02955602|560166500|FG002|Overall Study|Adverse Event|0|||
155198827|NCT02955602|560166498|FG000|Overall Study|Withdrawal of informed consent|1|||
155198828|NCT02955602|560166499|FG001|Overall Study|Withdrawal of informed consent|3|||
155198829|NCT02955602|560166500|FG002|Overall Study|Withdrawal of informed consent|2|||
155198830|NCT02955602|560166498|FG000|Overall Study|Lost to Follow-up|0|||
155198831|NCT02955602|560166499|FG001|Overall Study|Lost to Follow-up|0|||
155198832|NCT02955602|560166500|FG002|Overall Study|Lost to Follow-up|1|||
155198833|NCT02955602|560166498|FG000|Overall Study|Other|0|||
155198834|NCT02955602|560166499|FG001|Overall Study|Other|1|||
155198835|NCT02955602|560166500|FG002|Overall Study|Other|3|||
155198836|NCT02980601|560166503|FG000|Overall Study|Lost to Follow-up|2|||
155198837|NCT02980601|560166504|FG001|Overall Study|Lost to Follow-up|2|||
155198838|NCT02980601|560166503|FG000|Overall Study|Death|0|||
155198839|NCT02980601|560166504|FG001|Overall Study|Death|1|||
155198840|NCT02980601|560166503|FG000|Overall Study|Graft loss|1|||
155198841|NCT02980601|560166504|FG001|Overall Study|Graft loss|0|||
155198842|NCT02980601|560166503|FG000|Overall Study|Failed to sign consent|2|||
155198843|NCT02980601|560166504|FG001|Overall Study|Failed to sign consent|0|||
155198844|NCT01575769|560166505|FG000|Overall Study|Adverse Event|1|||
155198845|NCT01575769|560166505|FG000|Overall Study|Study terminated by sponsor|40|||
155198846|NCT01709513|560166506|FG000|Overall Study|Randomized but not treated|0|||
155198847|NCT01709513|560166507|FG001|Overall Study|Randomized but not treated|1|||
155198848|NCT01709513|560166508|FG002|Overall Study|Randomized but not treated|0|||
155198849|NCT01709513|560166506|FG000|Overall Study|Adverse Event|16|||
155198850|NCT01709513|560166507|FG001|Overall Study|Adverse Event|31|||
155198851|NCT01709513|560166508|FG002|Overall Study|Adverse Event|23|||
155198852|NCT01709513|560166506|FG000|Overall Study|Poor compliance to protocol|2|||
155198853|NCT01709513|560166507|FG001|Overall Study|Poor compliance to protocol|0|||
155198854|NCT01709513|560166508|FG002|Overall Study|Poor compliance to protocol|0|||
155198855|NCT01709513|560166506|FG000|Overall Study|Other|3|||
155198856|NCT01709513|560166507|FG001|Overall Study|Other|11|||
155198857|NCT01709513|560166508|FG002|Overall Study|Other|7|||
155198858|NCT01034631|560166509|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
155198859|NCT01034631|560166510|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
155198860|NCT01034631|560166511|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
155198861|NCT01034631|560166509|FG000|Phase II|Not Evaluable per protocol|0|||
155198862|NCT01034631|560166510|FG001|Phase II|Not Evaluable per protocol|0|||
155198863|NCT01034631|560166511|FG002|Phase II|Not Evaluable per protocol|2|||
155198864|NCT01034631|560166509|FG000|Phase II|Determined Ineligible per protocol|0|||
155198865|NCT01034631|560166510|FG001|Phase II|Determined Ineligible per protocol|1|||
155198866|NCT01034631|560166511|FG002|Phase II|Determined Ineligible per protocol|0|||
155198867|NCT01193530|560166512|FG000|Overall Study|Withdrawal by Subject|2|||
155198868|NCT01193530|560166513|FG001|Overall Study|Withdrawal by Subject|2|||
155198869|NCT01193530|560166512|FG000|Overall Study|Began Contraindicated Therapy|1|||
155198870|NCT01193530|560166513|FG001|Overall Study|Began Contraindicated Therapy|0|||
155198871|NCT01193530|560166512|FG000|Overall Study|Lost Light Box|0|||
155198872|NCT01193530|560166513|FG001|Overall Study|Lost Light Box|1|||
155198873|NCT01193530|560166512|FG000|Overall Study|Returned home - out of state|0|||
155198874|NCT01193530|560166513|FG001|Overall Study|Returned home - out of state|1|||
155198875|NCT01193530|560166512|FG000|Overall Study|Non-Compliance|0|||
155198876|NCT01193530|560166513|FG001|Overall Study|Non-Compliance|1|||
155198877|NCT01877265|560166521|FG000|Treatment Period 1|Sponsor Decision|0|||
155198878|NCT01877265|560166522|FG001|Treatment Period 1|Sponsor Decision|0|||
155198879|NCT01877265|560166523|FG002|Treatment Period 1|Sponsor Decision|1|||
155198880|NCT01877265|560166524|FG003|Treatment Period 1|Sponsor Decision|0|||
155198881|NCT01877265|560166525|FG004|Treatment Period 1|Sponsor Decision|0|||
155198882|NCT01877265|560166526|FG005|Treatment Period 1|Sponsor Decision|0|||
155198883|NCT01877265|560166521|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198884|NCT01877265|560166522|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198885|NCT01877265|560166523|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198886|NCT01877265|560166524|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198887|NCT01877265|560166525|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198888|NCT01877265|560166526|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
155198889|NCT01877265|560166521|FG000|Treatment Period 3|Lost to Follow-up|1|||
155198890|NCT01877265|560166522|FG001|Treatment Period 3|Lost to Follow-up|0|||
155198891|NCT01877265|560166523|FG002|Treatment Period 3|Lost to Follow-up|0|||
155198892|NCT01877265|560166524|FG003|Treatment Period 3|Lost to Follow-up|0|||
155198893|NCT01877265|560166525|FG004|Treatment Period 3|Lost to Follow-up|0|||
155198894|NCT01877265|560166526|FG005|Treatment Period 3|Lost to Follow-up|0|||
155198895|NCT03039283|560166533|FG000|Overall Study|Protocol Violation|2|||
155198896|NCT01619423|560166543|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
155198897|NCT01619423|560166544|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
155198898|NCT01619423|560166545|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
155198899|NCT01619423|560166546|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
155198900|NCT02590003|560166554|FG000|Overall Study|Death|1|||
155198901|NCT02590003|560166555|FG001|Overall Study|Death|2|||
155198902|NCT02264639|560166556|FG000|Overall Study|Death (after completing single-dose phase)|1|||
155198903|NCT02264639|560166557|FG001|Overall Study|Death (after completing single-dose phase)|0|||
155198904|NCT02264639|560166558|FG002|Overall Study|Death (after completing single-dose phase)|0|||
155198905|NCT02264639|560166559|FG003|Overall Study|Death (after completing single-dose phase)|0|||
155198906|NCT02264639|560166560|FG004|Overall Study|Death (after completing single-dose phase)|0|||
155198907|NCT02264639|560166556|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
155198908|NCT02264639|560166557|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198909|NCT02264639|560166558|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198910|NCT02264639|560166559|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198911|NCT02264639|560166560|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198912|NCT02264639|560166556|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198913|NCT02264639|560166557|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198914|NCT02264639|560166558|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
155198915|NCT02264639|560166559|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198916|NCT02264639|560166560|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198917|NCT02264639|560166556|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198918|NCT02264639|560166557|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198919|NCT02264639|560166558|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198920|NCT02264639|560166559|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198921|NCT02264639|560166560|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
155198922|NCT01416272|560166562|FG000|Overall Study|Unacceptable distance visual acuity|2|||
155198923|NCT01416272|560166562|FG000|Overall Study|Lost to Follow-up|1|||
155198924|NCT01416272|560166562|FG000|Overall Study|Study related complaints|1|||
155198925|NCT01350492|560166563|FG000|Intervention|Lost to Follow-up|2|||
155198926|NCT01350492|560166564|FG001|Intervention|Lost to Follow-up|5|||
155198927|NCT01350492|560166563|FG000|Intervention|Withdrawal by Subject|3|||
155198928|NCT01350492|560166564|FG001|Intervention|Withdrawal by Subject|1|||
155198929|NCT01350492|560166563|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
155198930|NCT01350492|560166564|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
155198931|NCT01350492|560166563|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
155198932|NCT01350492|560166564|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
155198933|NCT00702689|560166565|FG000|Overall Study|Withdrawal by Subject|4|||
155198934|NCT00702689|560166565|FG000|Overall Study|Recurrent malignancy|1|||
155198935|NCT00702689|560166565|FG000|Overall Study|Adverse Event|1|||
155198936|NCT02805972|560166568|FG000|Washout Period|Lost to Follow-up|3|||
155198937|NCT02805972|560166569|FG001|Washout Period|Lost to Follow-up|0|||
155198938|NCT00239590|560166571|FG000|Randomized|Lost to Follow-up|0|||
155198939|NCT00239590|560166572|FG001|Randomized|Lost to Follow-up|1|||
155198940|NCT00239590|560166571|FG000|Randomized|Withdrawal by Subject|0|||
155198941|NCT00239590|560166572|FG001|Randomized|Withdrawal by Subject|1|||
155198942|NCT00239590|560166571|FG000|Completed Study Protocol|Adverse Event|1|||
155198943|NCT00239590|560166572|FG001|Completed Study Protocol|Adverse Event|1|||
155198944|NCT00239590|560166571|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
155198945|NCT00239590|560166572|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
155198946|NCT02121522|560166573|FG000|Overall Study|Adverse Event|1|||
155198947|NCT00892047|560166579|FG000|Overall Study|Adverse Event|2|||
155198948|NCT00892047|560166580|FG001|Overall Study|Adverse Event|2|||
155198949|NCT00892047|560166579|FG000|Overall Study|subject burden|2|||
155198950|NCT00892047|560166580|FG001|Overall Study|subject burden|3|||
155198951|NCT00892047|560166579|FG000|Overall Study|Lack of Efficacy|0|||
155198952|NCT00892047|560166580|FG001|Overall Study|Lack of Efficacy|2|||
155198953|NCT01443078|560166581|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
155198954|NCT01443078|560166581|FG000|Overall Study|Withdrawal by Subject|1|||
155198955|NCT01443078|560166581|FG000|Overall Study|Patient had brain mets|1|||
155198956|NCT02106975|560166588|FG000|Overall Study|Death|25|||
155198957|NCT02106975|560166589|FG001|Overall Study|Death|39|||
155198958|NCT03546062|560166590|FG000|Overall Study|Adverse Event|6|||
155198959|NCT03546062|560166591|FG001|Overall Study|Adverse Event|5|||
155198960|NCT03546062|560166592|FG002|Overall Study|Adverse Event|8|||
155198961|NCT00806351|560166593|FG000|Overall Study|Death|5|||
155198962|NCT00806351|560166594|FG001|Overall Study|Death|4|||
155198963|NCT00259610|560166595|FG000|Overall Study|Withdrawal by Subject|33|||
155198964|NCT00259610|560166596|FG001|Overall Study|Withdrawal by Subject|25|||
155198965|NCT00259610|560166597|FG002|Overall Study|Withdrawal by Subject|29|||
155198966|NCT00259610|560166598|FG003|Overall Study|Withdrawal by Subject|19|||
155198967|NCT00259610|560166595|FG000|Overall Study|Lost to Follow-up|19|||
155198968|NCT00259610|560166596|FG001|Overall Study|Lost to Follow-up|8|||
155198969|NCT00259610|560166597|FG002|Overall Study|Lost to Follow-up|18|||
155198970|NCT00259610|560166598|FG003|Overall Study|Lost to Follow-up|15|||
155198971|NCT00259610|560166595|FG000|Overall Study|Physician Decision|6|||
155198972|NCT00259610|560166596|FG001|Overall Study|Physician Decision|4|||
155198973|NCT00259610|560166597|FG002|Overall Study|Physician Decision|7|||
155198974|NCT00259610|560166598|FG003|Overall Study|Physician Decision|2|||
155198975|NCT00259610|560166595|FG000|Overall Study|Death|1|||
155198976|NCT00259610|560166596|FG001|Overall Study|Death|1|||
155198977|NCT00259610|560166597|FG002|Overall Study|Death|2|||
155198978|NCT00259610|560166598|FG003|Overall Study|Death|0|||
155198979|NCT00259610|560166595|FG000|Overall Study|non medical reason|6|||
155198980|NCT00259610|560166596|FG001|Overall Study|non medical reason|2|||
155198981|NCT00259610|560166597|FG002|Overall Study|non medical reason|10|||
155198982|NCT00259610|560166598|FG003|Overall Study|non medical reason|3|||
155198983|NCT00259610|560166595|FG000|Overall Study|Adverse Event|3|||
155198984|NCT00259610|560166596|FG001|Overall Study|Adverse Event|4|||
155198985|NCT00259610|560166597|FG002|Overall Study|Adverse Event|5|||
155198986|NCT00259610|560166598|FG003|Overall Study|Adverse Event|2|||
155198987|NCT00259610|560166595|FG000|Overall Study|Serious Adverse Event|8|||
155198988|NCT00259610|560166596|FG001|Overall Study|Serious Adverse Event|2|||
155198989|NCT00259610|560166597|FG002|Overall Study|Serious Adverse Event|2|||
155198990|NCT00259610|560166598|FG003|Overall Study|Serious Adverse Event|2|||
155198991|NCT01201785|560166602|FG000|Overall Study|Lost to Follow-up|16|||
155198992|NCT02151110|560166603|FG000|Overall Study|Withdrawal by Subject|0|||
155198993|NCT02151110|560166604|FG001|Overall Study|Withdrawal by Subject|0|||
155198994|NCT02151110|560166605|FG002|Overall Study|Withdrawal by Subject|0|||
155198995|NCT02151110|560166606|FG003|Overall Study|Withdrawal by Subject|0|||
155198996|NCT02151110|560166607|FG004|Overall Study|Withdrawal by Subject|0|||
155198997|NCT02151110|560166608|FG005|Overall Study|Withdrawal by Subject|0|||
155198998|NCT02151110|560166609|FG006|Overall Study|Withdrawal by Subject|0|||
155198999|NCT02151110|560166610|FG007|Overall Study|Withdrawal by Subject|1|||
155199000|NCT02151110|560166603|FG000|Overall Study|Lost to Follow-up|0|||
155199001|NCT02151110|560166604|FG001|Overall Study|Lost to Follow-up|0|||
155199002|NCT02151110|560166605|FG002|Overall Study|Lost to Follow-up|0|||
155199003|NCT02151110|560166606|FG003|Overall Study|Lost to Follow-up|0|||
155199004|NCT02151110|560166607|FG004|Overall Study|Lost to Follow-up|0|||
155199005|NCT02151110|560166608|FG005|Overall Study|Lost to Follow-up|0|||
155199006|NCT02151110|560166609|FG006|Overall Study|Lost to Follow-up|0|||
155199007|NCT02151110|560166610|FG007|Overall Study|Lost to Follow-up|2|||
155199008|NCT01064310|560166611|FG000|Period 1|Adverse Event|7|||
155199009|NCT01064310|560166612|FG001|Period 1|Adverse Event|10|||
155199010|NCT01064310|560166613|FG002|Period 1|Adverse Event|0|||
155199011|NCT01064310|560166611|FG000|Period 1|Physician Decision|1|||
155199012|NCT01064310|560166612|FG001|Period 1|Physician Decision|0|||
155199013|NCT01064310|560166613|FG002|Period 1|Physician Decision|0|||
155199014|NCT01064310|560166611|FG000|Period 1|Withdrawal by Subject|2|||
155199015|NCT01064310|560166612|FG001|Period 1|Withdrawal by Subject|2|||
155199016|NCT01064310|560166613|FG002|Period 1|Withdrawal by Subject|0|||
155199017|NCT01064310|560166611|FG000|Period 1|Lack of Efficacy|3|||
155199018|NCT01064310|560166612|FG001|Period 1|Lack of Efficacy|5|||
155199019|NCT01064310|560166613|FG002|Period 1|Lack of Efficacy|0|||
155199020|NCT01064310|560166611|FG000|Period 1|Entered Open-label Period|1|||
155199021|NCT01064310|560166612|FG001|Period 1|Entered Open-label Period|1|||
155199022|NCT01064310|560166613|FG002|Period 1|Entered Open-label Period|0|||
155199023|NCT01064310|560166611|FG000|Period 2|Adverse Event|2|||
155199024|NCT01064310|560166612|FG001|Period 2|Adverse Event|1|||
155199025|NCT01064310|560166613|FG002|Period 2|Adverse Event|0|||
155199026|NCT01064310|560166611|FG000|Period 2|Physician Decision|0|||
155199027|NCT01064310|560166612|FG001|Period 2|Physician Decision|1|||
155199028|NCT01064310|560166613|FG002|Period 2|Physician Decision|0|||
155199029|NCT01064310|560166611|FG000|Period 2|Entered Open-label Period|1|||
155199030|NCT01064310|560166612|FG001|Period 2|Entered Open-label Period|0|||
155199031|NCT01064310|560166613|FG002|Period 2|Entered Open-label Period|0|||
155199032|NCT01064310|560166611|FG000|Period 2|Lack of Efficacy|1|||
155199033|NCT01064310|560166612|FG001|Period 2|Lack of Efficacy|4|||
155199034|NCT01064310|560166613|FG002|Period 2|Lack of Efficacy|0|||
155199035|NCT01064310|560166611|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
155199036|NCT01064310|560166612|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
155199037|NCT01064310|560166613|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
155199038|NCT01064310|560166611|FG000|Open Label Pazopinib|Adverse Event|0|||
155199039|NCT01064310|560166612|FG001|Open Label Pazopinib|Adverse Event|0|||
155199040|NCT01064310|560166613|FG002|Open Label Pazopinib|Adverse Event|12|||
155199041|NCT01064310|560166611|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
155199042|NCT01064310|560166612|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
155199043|NCT01064310|560166613|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
155199044|NCT01064310|560166611|FG000|Open Label Pazopinib|Physician Decision|0|||
155199045|NCT01064310|560166612|FG001|Open Label Pazopinib|Physician Decision|0|||
155199046|NCT01064310|560166613|FG002|Open Label Pazopinib|Physician Decision|20|||
155199047|NCT00001880|560166614|FG000|Overall Study|Death|14|||
155199048|NCT02639065|560166615|FG000|Study Treatment|Disease Progression|13|||
155199049|NCT02639065|560166615|FG000|Study Treatment|Adverse Event|9|||
155199050|NCT02639065|560166615|FG000|Study Treatment|Withdrawal by Subject|1|||
155199051|NCT02639065|560166615|FG000|Follow up|Subject refused to follow up|1|||
155199052|NCT02639065|560166615|FG000|Follow up|Symptomatic Deterioration|2|||
155199053|NCT02639065|560166615|FG000|Follow up|Death|2|||
155199054|NCT02639065|560166615|FG000|Follow up|Study Terminated|1|||
155199055|NCT02639065|560166615|FG000|Follow up|Disease Progression|3|||
155199056|NCT00873015|560166616|FG000|Overall Study|Withdrawal by Subject|0|||
155199057|NCT00873015|560166617|FG001|Overall Study|Withdrawal by Subject|1|||
155199058|NCT00873015|560166618|FG002|Overall Study|Withdrawal by Subject|0|||
155199059|NCT00873015|560166619|FG003|Overall Study|Withdrawal by Subject|0|||
155199060|NCT00345839|560166620|FG000|Overall Study|Withdrawal by Subject|91|||
155199061|NCT00345839|560166621|FG001|Overall Study|Withdrawal by Subject|98|||
155199062|NCT00345839|560166620|FG000|Overall Study|Lost to Follow-up|58|||
155199063|NCT00345839|560166621|FG001|Overall Study|Lost to Follow-up|61|||
155199064|NCT00660699|560166627|FG000|Overall Study|Withdrawal by Subject|2|||
155199065|NCT00599924|560168416|FG000|Overall Study|Lack of Efficacy|3|||
155199066|NCT00599924|560168417|FG001|Overall Study|Lack of Efficacy|5|||
155199067|NCT00599924|560168418|FG002|Overall Study|Lack of Efficacy|1|||
155199068|NCT00599924|560168419|FG003|Overall Study|Lack of Efficacy|2|||
155199069|NCT00599924|560168420|FG004|Overall Study|Lack of Efficacy|3|||
155199070|NCT00599924|560168421|FG005|Overall Study|Lack of Efficacy|2|||
155199071|NCT00599924|560168422|FG006|Overall Study|Lack of Efficacy|0|||
155199072|NCT00599924|560168416|FG000|Overall Study|Adverse Event|0|||
155199073|NCT00599924|560168417|FG001|Overall Study|Adverse Event|0|||
155199074|NCT00599924|560168418|FG002|Overall Study|Adverse Event|0|||
155199075|NCT00599924|560168419|FG003|Overall Study|Adverse Event|2|||
155199076|NCT00599924|560168420|FG004|Overall Study|Adverse Event|0|||
155199077|NCT00599924|560168421|FG005|Overall Study|Adverse Event|0|||
155199078|NCT00599924|560168422|FG006|Overall Study|Adverse Event|2|||
155199079|NCT00599924|560168416|FG000|Overall Study|Death|0|||
155199080|NCT00599924|560168417|FG001|Overall Study|Death|0|||
155199081|NCT00599924|560168418|FG002|Overall Study|Death|0|||
155199082|NCT00599924|560168419|FG003|Overall Study|Death|2|||
155199083|NCT00599924|560168420|FG004|Overall Study|Death|0|||
155199084|NCT00599924|560168421|FG005|Overall Study|Death|2|||
155199085|NCT00599924|560168422|FG006|Overall Study|Death|1|||
155199086|NCT00599924|560168416|FG000|Overall Study|Protocol Violation|0|||
155199087|NCT00599924|560168417|FG001|Overall Study|Protocol Violation|0|||
155199088|NCT00599924|560168418|FG002|Overall Study|Protocol Violation|0|||
155199089|NCT00599924|560168419|FG003|Overall Study|Protocol Violation|1|||
155199090|NCT00599924|560168420|FG004|Overall Study|Protocol Violation|0|||
155199091|NCT00599924|560168421|FG005|Overall Study|Protocol Violation|0|||
155199092|NCT00599924|560168422|FG006|Overall Study|Protocol Violation|0|||
155199093|NCT00599924|560168416|FG000|Overall Study|Withdrawal by Subject|0|||
155199094|NCT00599924|560168417|FG001|Overall Study|Withdrawal by Subject|0|||
155199095|NCT00599924|560168418|FG002|Overall Study|Withdrawal by Subject|1|||
155199096|NCT00599924|560168419|FG003|Overall Study|Withdrawal by Subject|0|||
155199097|NCT00599924|560168420|FG004|Overall Study|Withdrawal by Subject|1|||
155199098|NCT00599924|560168421|FG005|Overall Study|Withdrawal by Subject|0|||
155199099|NCT00599924|560168422|FG006|Overall Study|Withdrawal by Subject|0|||
155199100|NCT00599924|560168416|FG000|Overall Study|Other|0|||
155199101|NCT00599924|560168417|FG001|Overall Study|Other|0|||
155199102|NCT00599924|560168418|FG002|Overall Study|Other|0|||
155199103|NCT00599924|560168419|FG003|Overall Study|Other|1|||
155199104|NCT00599924|560168420|FG004|Overall Study|Other|2|||
155199105|NCT00599924|560168421|FG005|Overall Study|Other|0|||
155199106|NCT00599924|560168422|FG006|Overall Study|Other|2|||
155199107|NCT01806298|560168423|FG000|Overall Study|Adverse Event|3|||
155199108|NCT01806298|560168423|FG000|Overall Study|Protocol Non-compliance|1|||
155199109|NCT01806298|560168423|FG000|Overall Study|Withdrawal by Subject|1|||
155199110|NCT01806298|560168423|FG000|Overall Study|Other|5|||
155199111|NCT00592384|560168424|FG000|Overall Study|Withdrawal by Subject|5|||
155199112|NCT00592384|560168425|FG001|Overall Study|Withdrawal by Subject|6|||
155199113|NCT00590720|560168430|FG000|Overall Study|Lost to Follow-up|1|||
155199114|NCT00590720|560168431|FG001|Overall Study|Lost to Follow-up|0|||
155199115|NCT00590720|560168430|FG000|Overall Study|Withdrawal by Subject|0|||
155199116|NCT00590720|560168431|FG001|Overall Study|Withdrawal by Subject|1|||
155199117|NCT00867568|560168435|FG000|Overall Study|Lack of Efficacy|10|||
155199118|NCT00867568|560168435|FG000|Overall Study|Adverse Event|4|||
155199119|NCT00867568|560168435|FG000|Overall Study|Withdrawal by Subject|1|||
155199120|NCT01056653|560168436|FG000|Overall Study|Lost to Follow-up|0|||
155199121|NCT01056653|560168437|FG001|Overall Study|Lost to Follow-up|0|||
155199122|NCT01056653|560168438|FG002|Overall Study|Lost to Follow-up|2|||
155199123|NCT03639935|560168439|FG000|Overall Study|Death|3|||
155199124|NCT03639935|560168439|FG000|Overall Study|Adverse Event|1|||
155199125|NCT06333613|560168441|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
155199126|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
155199127|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
155199128|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
155199129|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
155199130|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199131|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199132|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199133|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199134|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199135|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199136|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199137|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
155199138|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
155199139|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
155199140|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
155199141|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199142|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199143|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199144|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199145|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199146|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199147|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199148|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
155199149|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
155199150|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
155199151|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
155199152|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199153|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199154|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199155|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199156|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199157|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199158|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199159|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199160|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199161|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199162|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
155199163|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199164|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199165|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199166|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199167|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199168|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199169|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199170|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
155199171|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
155199172|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
155199173|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
155199174|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199175|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199176|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199177|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199178|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199179|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199180|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199181|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
155199182|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
155199183|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
155199184|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
155199185|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199186|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199187|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199188|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199189|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199190|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199191|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199192|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
155199193|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
155199194|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
155199195|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
155199196|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199197|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199198|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199199|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199200|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199201|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199202|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199203|NCT01847274|560168442|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199204|NCT01847274|560168443|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199205|NCT01847274|560168444|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199206|NCT01847274|560168445|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199207|NCT01847274|560168446|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199208|NCT01847274|560168447|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
155199209|NCT01847274|560168448|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199210|NCT01847274|560168449|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199211|NCT01847274|560168450|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199212|NCT01847274|560168451|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199213|NCT01847274|560168452|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199214|NCT01847274|560168442|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199215|NCT01847274|560168443|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199216|NCT01847274|560168444|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199217|NCT01847274|560168445|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199218|NCT01847274|560168446|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
155199219|NCT01847274|560168447|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199220|NCT01847274|560168448|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199221|NCT01847274|560168449|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199222|NCT01847274|560168450|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199223|NCT01847274|560168451|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199224|NCT01847274|560168452|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199225|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199226|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199227|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199228|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199229|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199230|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199231|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
155199232|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199233|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199234|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199235|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199236|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199237|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199238|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199239|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199240|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199241|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199242|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
155199243|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199244|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199245|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199246|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199247|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199248|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199249|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199250|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199251|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199252|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199253|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
155199254|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199255|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199256|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199257|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199258|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199259|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199260|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199261|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199262|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199263|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199264|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199265|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
155199266|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
155199267|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
155199268|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
155199269|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199270|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199271|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199272|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199273|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199274|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199275|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199276|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
155199277|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199278|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
155199279|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199280|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199281|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199282|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199283|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199284|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199285|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199286|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199287|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
155199288|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199289|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
155199290|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
155199291|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199292|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199293|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199294|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199295|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199296|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199297|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199298|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199299|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199300|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
155199301|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199302|NCT03727230|560168453|FG000|Overall Study|Lost to Follow-up|12|||
155199303|NCT02059395|560168456|FG000|Overall Study|Lost to Follow-up|2|||
155199304|NCT02059395|560168457|FG001|Overall Study|Lost to Follow-up|4|||
155199305|NCT05209360|560168458|FG000|Overall Study|Withdrawal by Subject|0|||
155199306|NCT05209360|560168459|FG001|Overall Study|Withdrawal by Subject|0|||
155199307|NCT05209360|560168460|FG002|Overall Study|Withdrawal by Subject|1|||
155199308|NCT05209360|560168461|FG003|Overall Study|Withdrawal by Subject|0|||
155199309|NCT05209360|560168462|FG004|Overall Study|Withdrawal by Subject|0|||
155199310|NCT05209360|560168463|FG005|Overall Study|Withdrawal by Subject|0|||
155199311|NCT00134082|560168464|FG000|Overall Study|Adverse Event|2|||
155199312|NCT00134082|560168464|FG000|Overall Study|Death|1|||
155199313|NCT00724932|560168467|FG000|Overall Study|Lost to Follow-up|1|||
155199314|NCT00724932|560168468|FG001|Overall Study|Lost to Follow-up|0|||
155199315|NCT00724932|560168467|FG000|Overall Study|Not treated|4|||
155199316|NCT00724932|560168468|FG001|Overall Study|Not treated|3|||
155199317|NCT02849678|560168469|FG000|Overall Study|Protocol Violation|3|||
155199318|NCT02849678|560168470|FG001|Overall Study|Protocol Violation|6|||
155199319|NCT00289991|560168472|FG000|Overall Study|Death|35|||
155199320|NCT00289991|560168473|FG001|Overall Study|Death|38|||
155199321|NCT00289991|560168472|FG000|Overall Study|Adverse Event|15|||
155199322|NCT00289991|560168473|FG001|Overall Study|Adverse Event|13|||
155199323|NCT00289991|560168472|FG000|Overall Study|Failure of prophylaxis|1|||
155199324|NCT00289991|560168473|FG001|Overall Study|Failure of prophylaxis|1|||
155199325|NCT00289991|560168472|FG000|Overall Study|Fungal breakthrough infection|0|||
155199326|NCT00289991|560168473|FG001|Overall Study|Fungal breakthrough infection|1|||
155199327|NCT00289991|560168472|FG000|Overall Study|Lost to Follow-up|0|||
155199328|NCT00289991|560168473|FG001|Overall Study|Lost to Follow-up|1|||
155199329|NCT00289991|560168472|FG000|Overall Study|Withdrawal by Subject|2|||
155199330|NCT00289991|560168473|FG001|Overall Study|Withdrawal by Subject|12|||
155199331|NCT00289991|560168472|FG000|Overall Study|Other|5|||
155199332|NCT00289991|560168473|FG001|Overall Study|Other|14|||
155199333|NCT02340975|560168476|FG000|Overall Study|Death|6|||
155199334|NCT02340975|560168477|FG001|Overall Study|Death|23|||
155199335|NCT02340975|560168478|FG002|Overall Study|Death|21|||
155199336|NCT02340975|560168479|FG003|Overall Study|Death|7|||
155199337|NCT02340975|560168480|FG004|Overall Study|Death|21|||
155199338|NCT02340975|560168481|FG005|Overall Study|Death|13|||
155199339|NCT02340975|560168476|FG000|Overall Study|Lost to Follow-up|0|||
155199340|NCT02340975|560168477|FG001|Overall Study|Lost to Follow-up|0|||
155199341|NCT02340975|560168478|FG002|Overall Study|Lost to Follow-up|0|||
155199342|NCT02340975|560168479|FG003|Overall Study|Lost to Follow-up|0|||
155199343|NCT02340975|560168480|FG004|Overall Study|Lost to Follow-up|2|||
155199344|NCT02340975|560168481|FG005|Overall Study|Lost to Follow-up|0|||
155199345|NCT02340975|560168476|FG000|Overall Study|Withdrawal by Subject|0|||
155199346|NCT02340975|560168477|FG001|Overall Study|Withdrawal by Subject|0|||
155199347|NCT02340975|560168478|FG002|Overall Study|Withdrawal by Subject|3|||
155199348|NCT02340975|560168479|FG003|Overall Study|Withdrawal by Subject|3|||
155199349|NCT02340975|560168480|FG004|Overall Study|Withdrawal by Subject|2|||
155199350|NCT02340975|560168481|FG005|Overall Study|Withdrawal by Subject|0|||
155199351|NCT02340975|560168476|FG000|Overall Study|Other|0|||
155199352|NCT02340975|560168477|FG001|Overall Study|Other|4|||
155199353|NCT02340975|560168478|FG002|Overall Study|Other|0|||
155199354|NCT02340975|560168479|FG003|Overall Study|Other|2|||
155199355|NCT02340975|560168480|FG004|Overall Study|Other|0|||
155199356|NCT02340975|560168481|FG005|Overall Study|Other|6|||
155199357|NCT01007812|560168482|FG000|Period 1, One Week|Lost to Follow-up|0|||
155199358|NCT01007812|560168483|FG001|Period 1, One Week|Lost to Follow-up|1|||
155199359|NCT01007812|560168482|FG000|Period 1, One Week|Discomfort|1|||
155199360|NCT01007812|560168483|FG001|Period 1, One Week|Discomfort|0|||
155199361|NCT01091974|560168484|FG000|Overall Study|Did not start intervention|3|||
155199362|NCT01091974|560168485|FG001|Overall Study|Did not start intervention|1|||
155199363|NCT01091974|560168486|FG002|Overall Study|Did not start intervention|3|||
155199364|NCT01091974|560168487|FG003|Overall Study|Did not start intervention|1|||
155199365|NCT01091974|560168484|FG000|Overall Study|resumed sleep medication|0|||
155199366|NCT01091974|560168485|FG001|Overall Study|resumed sleep medication|0|||
155199367|NCT01091974|560168486|FG002|Overall Study|resumed sleep medication|1|||
155199368|NCT01091974|560168487|FG003|Overall Study|resumed sleep medication|2|||
155199369|NCT01091974|560168484|FG000|Overall Study|Withdrawal by Subject|1|||
155199370|NCT01091974|560168485|FG001|Overall Study|Withdrawal by Subject|3|||
155199371|NCT01091974|560168486|FG002|Overall Study|Withdrawal by Subject|2|||
155199372|NCT01091974|560168487|FG003|Overall Study|Withdrawal by Subject|2|||
155199373|NCT01091974|560168484|FG000|Overall Study|side-effects|1|||
155199374|NCT01091974|560168485|FG001|Overall Study|side-effects|1|||
155199375|NCT01091974|560168486|FG002|Overall Study|side-effects|0|||
155199376|NCT01091974|560168487|FG003|Overall Study|side-effects|2|||
155199377|NCT04891978|560168488|FG000|Baseline|Protocol Violation|2|||
155199378|NCT04891978|560168489|FG001|Baseline|Protocol Violation|1|||
155199379|NCT04891978|560168490|FG002|Baseline|Protocol Violation|0|||
155199380|NCT04891978|560168488|FG000|Baseline|Missing AIRQ|1|||
155199381|NCT04891978|560168489|FG001|Baseline|Missing AIRQ|0|||
155199382|NCT04891978|560168490|FG002|Baseline|Missing AIRQ|0|||
155199383|NCT04891978|560168488|FG000|Baseline|Did not attend a baseline visit|0|||
155199384|NCT04891978|560168489|FG001|Baseline|Did not attend a baseline visit|0|||
155199385|NCT04891978|560168490|FG002|Baseline|Did not attend a baseline visit|9|||
155199386|NCT03948581|560168491|FG000|Overall Study|Lost to Follow-up|0|||
155199387|NCT03948581|560168492|FG001|Overall Study|Lost to Follow-up|1|||
155199388|NCT03068455|560168493|FG000|Pre-treatment Period|Disease progression|0|||
155199389|NCT03068455|560168494|FG001|Pre-treatment Period|Disease progression|1|||
155199390|NCT03068455|560168493|FG000|Pre-treatment Period|Participant withdrew consent|1|||
155199391|NCT03068455|560168494|FG001|Pre-treatment Period|Participant withdrew consent|1|||
155199392|NCT03068455|560168493|FG000|Pre-treatment Period|Poor/non-compliance|0|||
155199393|NCT03068455|560168494|FG001|Pre-treatment Period|Poor/non-compliance|1|||
155199394|NCT03068455|560168493|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
155199395|NCT03068455|560168494|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
155199396|NCT03068455|560168493|FG000|Pre-treatment Period|Not reported|2|||
155199397|NCT03068455|560168494|FG001|Pre-treatment Period|Not reported|1|||
155199398|NCT03068455|560168493|FG000|Treatment Period|Disease progression|166|||
155199399|NCT03068455|560168494|FG001|Treatment Period|Disease progression|208|||
155199400|NCT03068455|560168493|FG000|Treatment Period|Study drug toxicity|317|||
155199401|NCT03068455|560168494|FG001|Treatment Period|Study drug toxicity|104|||
155199402|NCT03068455|560168493|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
155199403|NCT03068455|560168494|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
155199404|NCT03068455|560168493|FG000|Treatment Period|Participant request to stop therapy|33|||
155199405|NCT03068455|560168494|FG001|Treatment Period|Participant request to stop therapy|20|||
155199406|NCT03068455|560168493|FG000|Treatment Period|Participant withdrew consent|5|||
155199407|NCT03068455|560168494|FG001|Treatment Period|Participant withdrew consent|10|||
155199408|NCT03068455|560168493|FG000|Treatment Period|Poor/non-compliance|3|||
155199409|NCT03068455|560168494|FG001|Treatment Period|Poor/non-compliance|0|||
155199410|NCT03068455|560168493|FG000|Treatment Period|Participant no longer meets study criteria|1|||
155199411|NCT03068455|560168494|FG001|Treatment Period|Participant no longer meets study criteria|3|||
155199412|NCT03068455|560168493|FG000|Treatment Period|Other reasons|12|||
155199413|NCT03068455|560168494|FG001|Treatment Period|Other reasons|4|||
155199414|NCT03330288|560168500|FG000|Overall Study|Other reason|1|||
155199415|NCT03330288|560168501|FG001|Overall Study|Other reason|1|||
155199416|NCT03330288|560168500|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
155199417|NCT03330288|560168501|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
155199418|NCT03330288|560168500|FG000|Overall Study|Adverse Event|1|||
155199419|NCT03330288|560168501|FG001|Overall Study|Adverse Event|0|||
155199420|NCT03330288|560168500|FG000|Overall Study|Withdrawal by Subject|1|||
155199421|NCT03330288|560168501|FG001|Overall Study|Withdrawal by Subject|0|||
155199422|NCT03330288|560168500|FG000|Overall Study|Lost to Follow-up|26|||
155199423|NCT03330288|560168501|FG001|Overall Study|Lost to Follow-up|7|||
155199424|NCT01235689|560168510|FG000|Overall Study|Adverse Event|12|||
155199425|NCT01235689|560168511|FG001|Overall Study|Adverse Event|16|||
155199426|NCT01235689|560168510|FG000|Overall Study|Lack of Efficacy|12|||
155199427|NCT01235689|560168511|FG001|Overall Study|Lack of Efficacy|5|||
155199428|NCT01235689|560168510|FG000|Overall Study|Withdrawal by Subject|3|||
155199429|NCT01235689|560168511|FG001|Overall Study|Withdrawal by Subject|4|||
155199430|NCT01235689|560168510|FG000|Overall Study|Lost to Follow-up|1|||
155199431|NCT01235689|560168511|FG001|Overall Study|Lost to Follow-up|2|||
155199432|NCT01235689|560168510|FG000|Overall Study|Miscellaneous|1|||
155199433|NCT01235689|560168511|FG001|Overall Study|Miscellaneous|5|||
155199434|NCT02217878|560168516|FG000|Overall Study|required morphine due to chest pain|1|||
155199435|NCT02217878|560168517|FG001|Overall Study|required morphine due to chest pain|2|||
155199436|NCT02217878|560168516|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
155199437|NCT02217878|560168517|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
155199438|NCT01390649|560168518|FG000|Overall Study|Physician Decision|1|||
155199439|NCT00389597|560168519|FG000|Overall Study|Lost to Follow-up|8|||
155199440|NCT00389597|560168520|FG001|Overall Study|Lost to Follow-up|6|||
155199441|NCT00389597|560168521|FG002|Overall Study|Lost to Follow-up|4|||
155199442|NCT00389597|560168522|FG003|Overall Study|Lost to Follow-up|6|||
155199443|NCT00005044|560168523|FG000|Overall Study|Protocol Violation|37|||
155199444|NCT00005044|560168524|FG001|Overall Study|Protocol Violation|46|||
155199445|NCT00005044|560168523|FG000|Overall Study|Withdrawal by Subject|1|||
155199446|NCT00005044|560168524|FG001|Overall Study|Withdrawal by Subject|5|||
155199447|NCT00005044|560168523|FG000|Overall Study|No protocol treatment|0|||
155199448|NCT00005044|560168524|FG001|Overall Study|No protocol treatment|1|||
155199449|NCT00181155|560168525|FG000|Overall Study|Physician Decision|1|||
155199450|NCT00181155|560168526|FG001|Overall Study|Physician Decision|0|||
155199451|NCT00181155|560168525|FG000|Overall Study|Withdrawal by Subject|1|||
155199452|NCT00181155|560168526|FG001|Overall Study|Withdrawal by Subject|0|||
155199453|NCT02572401|560168527|FG000|Overall Study|Lost to Follow-up|5|||
155199454|NCT02572401|560168528|FG001|Overall Study|Lost to Follow-up|8|||
155199455|NCT02572401|560168529|FG002|Overall Study|Lost to Follow-up|9|||
155199456|NCT02572401|560168530|FG003|Overall Study|Lost to Follow-up|9|||
155199457|NCT02572401|560168527|FG000|Overall Study|Death|0|||
155199458|NCT02572401|560168528|FG001|Overall Study|Death|0|||
155199459|NCT02572401|560168529|FG002|Overall Study|Death|0|||
155199460|NCT02572401|560168530|FG003|Overall Study|Death|1|||
155199461|NCT01548287|560168531|FG000|Screening|No reason provided|0|||
155199462|NCT01548287|560168532|FG001|Screening|No reason provided|0|||
155199463|NCT01548287|560168533|FG002|Screening|No reason provided|0|||
155199464|NCT01548287|560168534|FG003|Screening|No reason provided|0|||
155199465|NCT01548287|560168535|FG004|Screening|No reason provided|9|||
155199466|NCT01548287|560168531|FG000|Screening|Did not meet eligibility criteria|0|||
155199467|NCT01548287|560168532|FG001|Screening|Did not meet eligibility criteria|0|||
155199468|NCT01548287|560168533|FG002|Screening|Did not meet eligibility criteria|0|||
155199469|NCT01548287|560168534|FG003|Screening|Did not meet eligibility criteria|0|||
155199470|NCT01548287|560168535|FG004|Screening|Did not meet eligibility criteria|74|||
155199471|NCT01548287|560168531|FG000|Randomized Period|Did not meet inclusion criteria|0|||
155199472|NCT01548287|560168532|FG001|Randomized Period|Did not meet inclusion criteria|0|||
155199473|NCT01548287|560168533|FG002|Randomized Period|Did not meet inclusion criteria|2|||
155199474|NCT01548287|560168534|FG003|Randomized Period|Did not meet inclusion criteria|0|||
155199475|NCT01548287|560168535|FG004|Randomized Period|Did not meet inclusion criteria|0|||
155199476|NCT01548287|560168531|FG000|Randomized Period|Adverse Event|0|||
155199477|NCT01548287|560168532|FG001|Randomized Period|Adverse Event|2|||
155199478|NCT01548287|560168533|FG002|Randomized Period|Adverse Event|5|||
155199479|NCT01548287|560168534|FG003|Randomized Period|Adverse Event|0|||
155199480|NCT01548287|560168535|FG004|Randomized Period|Adverse Event|0|||
155199481|NCT01768286|560168540|FG000|Overall Study|Randomized But Not Treated|0|||
155199482|NCT01768286|560168541|FG001|Overall Study|Randomized But Not Treated|0|||
155199483|NCT01768286|560168542|FG002|Overall Study|Randomized But Not Treated|1|||
155199484|NCT01768286|560168543|FG003|Overall Study|Randomized But Not Treated|0|||
155199485|NCT01768286|560168540|FG000|Overall Study|Lack of Efficacy|7|||
155199486|NCT01768286|560168541|FG001|Overall Study|Lack of Efficacy|4|||
155199487|NCT01768286|560168542|FG002|Overall Study|Lack of Efficacy|0|||
155199488|NCT01768286|560168543|FG003|Overall Study|Lack of Efficacy|1|||
155199489|NCT01768286|560168540|FG000|Overall Study|Withdrew Consent|0|||
155199490|NCT01768286|560168541|FG001|Overall Study|Withdrew Consent|0|||
155199491|NCT01768286|560168542|FG002|Overall Study|Withdrew Consent|1|||
155199492|NCT01768286|560168543|FG003|Overall Study|Withdrew Consent|0|||
155199493|NCT02083965|560168544|FG000|Treatment Period|Other|1|||
155199494|NCT02083965|560168545|FG001|Treatment Period|Other|0|||
155199495|NCT00868608|560168547|FG000|Overall Study|Withdrawal by Subject|3|||
155199496|NCT00868608|560168548|FG001|Overall Study|Withdrawal by Subject|1|||
155199497|NCT00868608|560168549|FG002|Overall Study|Withdrawal by Subject|0|||
155199498|NCT00868608|560168547|FG000|Overall Study|Lost to Follow-up|3|||
155199499|NCT00868608|560168548|FG001|Overall Study|Lost to Follow-up|0|||
155199500|NCT00868608|560168549|FG002|Overall Study|Lost to Follow-up|1|||
155199501|NCT00868608|560168547|FG000|Overall Study|Death|16|||
155199502|NCT00868608|560168548|FG001|Overall Study|Death|2|||
155199503|NCT00868608|560168549|FG002|Overall Study|Death|4|||
155199504|NCT00868608|560168547|FG000|Overall Study|Other - Unspecified|1|||
155199505|NCT00868608|560168548|FG001|Overall Study|Other - Unspecified|0|||
155199506|NCT00868608|560168549|FG002|Overall Study|Other - Unspecified|0|||
155199507|NCT00674362|560168551|FG000|Double Blind|Adverse Event|6|||
155199508|NCT00674362|560168552|FG001|Double Blind|Adverse Event|6|||
155199509|NCT00674362|560168551|FG000|Double Blind|Lack of Efficacy|2|||
155199510|NCT00674362|560168552|FG001|Double Blind|Lack of Efficacy|6|||
155199511|NCT00674362|560168551|FG000|Double Blind|Loss of efficacy|0|||
155199512|NCT00674362|560168552|FG001|Double Blind|Loss of efficacy|1|||
155199513|NCT00674362|560168551|FG000|Double Blind|Withdrawal by Subject|4|||
155199514|NCT00674362|560168552|FG001|Double Blind|Withdrawal by Subject|3|||
155199515|NCT00674362|560168551|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
155199516|NCT00674362|560168552|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
155199517|NCT00674362|560168551|FG000|Double Blind|Other: Surgery|0|||
155199518|NCT00674362|560168552|FG001|Double Blind|Other: Surgery|1|||
155199519|NCT00674362|560168551|FG000|Open Label|Adverse Event|1|||
155199520|NCT00674362|560168552|FG001|Open Label|Adverse Event|0|||
155199521|NCT00674362|560168551|FG000|Open Label|Other: Subject moved to extension study|1|||
155199522|NCT00674362|560168552|FG001|Open Label|Other: Subject moved to extension study|0|||
155199523|NCT00939770|560168555|FG000|Overall Study|Adverse Event|1|||
155199524|NCT00939770|560168556|FG001|Overall Study|Adverse Event|1|||
155199525|NCT00939770|560168557|FG002|Overall Study|Adverse Event|0|||
155199526|NCT00939770|560168558|FG003|Overall Study|Adverse Event|0|||
155199527|NCT00939770|560168559|FG004|Overall Study|Adverse Event|6|||
155199528|NCT00939770|560168560|FG005|Overall Study|Adverse Event|2|||
155199529|NCT00939770|560168561|FG006|Overall Study|Adverse Event|1|||
155199530|NCT00939770|560168562|FG007|Overall Study|Adverse Event|1|||
155199531|NCT00939770|560168555|FG000|Overall Study|Lack of Efficacy|4|||
155199532|NCT00939770|560168556|FG001|Overall Study|Lack of Efficacy|6|||
155199533|NCT00939770|560168557|FG002|Overall Study|Lack of Efficacy|13|||
155199534|NCT00939770|560168558|FG003|Overall Study|Lack of Efficacy|9|||
155199535|NCT00939770|560168559|FG004|Overall Study|Lack of Efficacy|16|||
155199536|NCT00939770|560168560|FG005|Overall Study|Lack of Efficacy|8|||
155199537|NCT00939770|560168561|FG006|Overall Study|Lack of Efficacy|11|||
155199538|NCT00939770|560168562|FG007|Overall Study|Lack of Efficacy|1|||
155199539|NCT00939770|560168555|FG000|Overall Study|Lost to Follow-up|0|||
155199540|NCT00939770|560168556|FG001|Overall Study|Lost to Follow-up|0|||
155199541|NCT00939770|560168557|FG002|Overall Study|Lost to Follow-up|0|||
155199542|NCT00939770|560168558|FG003|Overall Study|Lost to Follow-up|0|||
155199543|NCT00939770|560168559|FG004|Overall Study|Lost to Follow-up|1|||
155199544|NCT00939770|560168560|FG005|Overall Study|Lost to Follow-up|0|||
155199545|NCT00939770|560168561|FG006|Overall Study|Lost to Follow-up|0|||
155199546|NCT00939770|560168562|FG007|Overall Study|Lost to Follow-up|0|||
155199547|NCT00939770|560168555|FG000|Overall Study|Physician Decision|0|||
155199548|NCT00939770|560168556|FG001|Overall Study|Physician Decision|0|||
155199549|NCT00939770|560168557|FG002|Overall Study|Physician Decision|2|||
155199550|NCT00939770|560168558|FG003|Overall Study|Physician Decision|0|||
155199551|NCT00939770|560168559|FG004|Overall Study|Physician Decision|7|||
155199552|NCT00939770|560168560|FG005|Overall Study|Physician Decision|1|||
155199553|NCT00939770|560168561|FG006|Overall Study|Physician Decision|0|||
155199554|NCT00939770|560168562|FG007|Overall Study|Physician Decision|6|||
155199555|NCT00939770|560168555|FG000|Overall Study|Protocol Violation|0|||
155199556|NCT00939770|560168556|FG001|Overall Study|Protocol Violation|0|||
155199557|NCT00939770|560168557|FG002|Overall Study|Protocol Violation|0|||
155199558|NCT00939770|560168558|FG003|Overall Study|Protocol Violation|0|||
155199559|NCT00939770|560168559|FG004|Overall Study|Protocol Violation|1|||
155199560|NCT00939770|560168560|FG005|Overall Study|Protocol Violation|0|||
155199561|NCT00939770|560168561|FG006|Overall Study|Protocol Violation|0|||
155199562|NCT00939770|560168562|FG007|Overall Study|Protocol Violation|0|||
155199563|NCT00939770|560168555|FG000|Overall Study|Withdrawal by Subject|0|||
155199564|NCT00939770|560168556|FG001|Overall Study|Withdrawal by Subject|1|||
155199565|NCT00939770|560168557|FG002|Overall Study|Withdrawal by Subject|5|||
155199566|NCT00939770|560168558|FG003|Overall Study|Withdrawal by Subject|2|||
155199567|NCT00939770|560168559|FG004|Overall Study|Withdrawal by Subject|6|||
155199568|NCT00939770|560168560|FG005|Overall Study|Withdrawal by Subject|0|||
155199569|NCT00939770|560168561|FG006|Overall Study|Withdrawal by Subject|2|||
155199570|NCT00939770|560168562|FG007|Overall Study|Withdrawal by Subject|2|||
155199571|NCT04066023|560168563|FG000|Overall Study|Adverse Event|0|||
155199572|NCT04066023|560168564|FG001|Overall Study|Adverse Event|0|||
155199573|NCT04066023|560168565|FG002|Overall Study|Adverse Event|1|||
155199574|NCT04066023|560168563|FG000|Overall Study|Sponsor decision|3|||
155199575|NCT04066023|560168564|FG001|Overall Study|Sponsor decision|6|||
155199576|NCT04066023|560168565|FG002|Overall Study|Sponsor decision|2|||
155199577|NCT04066023|560168563|FG000|Overall Study|Physician Decision|0|||
155199578|NCT04066023|560168564|FG001|Overall Study|Physician Decision|0|||
155199579|NCT04066023|560168565|FG002|Overall Study|Physician Decision|1|||
155199580|NCT04066023|560168563|FG000|Overall Study|Lost to Follow-up|0|||
155199581|NCT04066023|560168564|FG001|Overall Study|Lost to Follow-up|1|||
155199582|NCT04066023|560168565|FG002|Overall Study|Lost to Follow-up|1|||
155199583|NCT04066023|560168563|FG000|Overall Study|Noncompliance|0|||
155199584|NCT04066023|560168564|FG001|Overall Study|Noncompliance|1|||
155199585|NCT04066023|560168565|FG002|Overall Study|Noncompliance|1|||
155199586|NCT04665856|560168566|FG000|Overall Study|Site Terminated by Sponsor|1|||
155199587|NCT04665856|560168567|FG001|Overall Study|Site Terminated by Sponsor|0|||
155199588|NCT04665856|560168566|FG000|Overall Study|Withdrawal by Subject|2|||
155199589|NCT04665856|560168567|FG001|Overall Study|Withdrawal by Subject|0|||
155199590|NCT04665856|560168566|FG000|Overall Study|Lost to Follow-up|3|||
155199591|NCT04665856|560168567|FG001|Overall Study|Lost to Follow-up|2|||
155199592|NCT04665856|560168566|FG000|Overall Study|Death|39|||
155199593|NCT04665856|560168567|FG001|Overall Study|Death|44|||
155199594|NCT04665856|560168566|FG000|Overall Study|Ongoing in study|17|||
155199595|NCT04665856|560168567|FG001|Overall Study|Ongoing in study|15|||
155199596|NCT03386448|560168568|FG000|Overall Study|Adverse Event|0|||
155199597|NCT03386448|560168569|FG001|Overall Study|Adverse Event|2|||
155199598|NCT03338010|560168570|FG000|Overall Study|Withdrawal by Subject|14|||
155199599|NCT03338010|560168571|FG001|Overall Study|Withdrawal by Subject|8|||
155199600|NCT03338010|560168570|FG000|Overall Study|Lost to Follow-up|4|||
155199601|NCT03338010|560168571|FG001|Overall Study|Lost to Follow-up|2|||
155199602|NCT03338010|560168570|FG000|Overall Study|Adverse Event|3|||
155199603|NCT03338010|560168571|FG001|Overall Study|Adverse Event|2|||
155199604|NCT03338010|560168570|FG000|Overall Study|Physician Decision|2|||
155199605|NCT03338010|560168571|FG001|Overall Study|Physician Decision|2|||
155199606|NCT03338010|560168570|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155199607|NCT03338010|560168571|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155199608|NCT03338010|560168570|FG000|Overall Study|Protocol Violation|0|||
155199609|NCT03338010|560168571|FG001|Overall Study|Protocol Violation|1|||
155199610|NCT01146665|560168572|FG000|Overall Study|Withdrawal by Subject|10|||
155199611|NCT01146665|560168573|FG001|Overall Study|Withdrawal by Subject|16|||
155199612|NCT02538029|560168575|FG000|Overall Study|unable to complete cognitive assessments|1|||
155199613|NCT02538029|560168576|FG001|Overall Study|unable to complete cognitive assessments|0|||
155199614|NCT02538029|560168577|FG002|Overall Study|unable to complete cognitive assessments|1|||
155199615|NCT00481078|560168581|FG000|Overall Study|Progression of disease|11|||
155199616|NCT00481078|560168582|FG001|Overall Study|Progression of disease|11|||
155199617|NCT00481078|560168581|FG000|Overall Study|Adverse Event|15|||
155199618|NCT00481078|560168582|FG001|Overall Study|Adverse Event|3|||
155199619|NCT00481078|560168581|FG000|Overall Study|Death|5|||
155199620|NCT00481078|560168582|FG001|Overall Study|Death|3|||
155199621|NCT00481078|560168581|FG000|Overall Study|Intercurrent illness|1|||
155199622|NCT00481078|560168582|FG001|Overall Study|Intercurrent illness|0|||
155199623|NCT00481078|560168581|FG000|Overall Study|Withdrawal by Subject|7|||
155199624|NCT00481078|560168582|FG001|Overall Study|Withdrawal by Subject|1|||
155199625|NCT00481078|560168581|FG000|Overall Study|Information not available|1|||
155199626|NCT00481078|560168582|FG001|Overall Study|Information not available|0|||
155199627|NCT00481078|560168581|FG000|Overall Study|Received other treatment|2|||
155199628|NCT00481078|560168582|FG001|Overall Study|Received other treatment|1|||
155199629|NCT00481078|560168581|FG000|Overall Study|Brain metastasis|0|||
155199630|NCT00481078|560168582|FG001|Overall Study|Brain metastasis|1|||
155199631|NCT03192462|560170432|FG000|Overall Study|Death|13|||
155199632|NCT03192462|560170433|FG001|Overall Study|Death|11|||
155199633|NCT03192462|560170434|FG002|Overall Study|Death|10|||
155199634|NCT03192462|560170432|FG000|Overall Study|Lost to Follow-up|0|||
155199635|NCT03192462|560170433|FG001|Overall Study|Lost to Follow-up|1|||
155199636|NCT03192462|560170434|FG002|Overall Study|Lost to Follow-up|0|||
155199637|NCT02200211|560170438|FG000|Overall Study|Lost to Follow-up|7|||
155199638|NCT02200211|560170439|FG001|Overall Study|Lost to Follow-up|7|||
155199639|NCT02200211|560170440|FG002|Overall Study|Lost to Follow-up|1|||
155199640|NCT02200211|560170441|FG003|Overall Study|Lost to Follow-up|2|||
155199641|NCT02200211|560170438|FG000|Overall Study|Withdrawal by Subject|1|||
155199642|NCT02200211|560170439|FG001|Overall Study|Withdrawal by Subject|0|||
155199643|NCT02200211|560170440|FG002|Overall Study|Withdrawal by Subject|0|||
155199644|NCT02200211|560170441|FG003|Overall Study|Withdrawal by Subject|0|||
155199645|NCT00381485|560170442|FG000|Open-Label Run-In Period|Adverse Event|9|||
155199646|NCT00381485|560170443|FG001|Open-Label Run-In Period|Adverse Event|0|||
155199647|NCT00381485|560170444|FG002|Open-Label Run-In Period|Adverse Event|0|||
155199648|NCT00381485|560170445|FG003|Open-Label Run-In Period|Adverse Event|0|||
155199649|NCT00381485|560170442|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
155199650|NCT00381485|560170443|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199651|NCT00381485|560170444|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199652|NCT00381485|560170445|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199653|NCT00381485|560170442|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
155199654|NCT00381485|560170443|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199655|NCT00381485|560170444|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199656|NCT00381485|560170445|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199657|NCT00381485|560170442|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
155199658|NCT00381485|560170443|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199659|NCT00381485|560170444|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199660|NCT00381485|560170445|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199661|NCT00381485|560170442|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
155199662|NCT00381485|560170443|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
155199663|NCT00381485|560170444|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
155199664|NCT00381485|560170445|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
155199665|NCT00381485|560170442|FG000|Open-Label Run-In Period|Treatment failure|1|||
155199666|NCT00381485|560170443|FG001|Open-Label Run-In Period|Treatment failure|0|||
155199667|NCT00381485|560170444|FG002|Open-Label Run-In Period|Treatment failure|0|||
155199668|NCT00381485|560170445|FG003|Open-Label Run-In Period|Treatment failure|0|||
155199669|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155199670|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155199671|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Adverse Event|2|||
155199672|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Adverse Event|5|||
155199673|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155199674|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
155199675|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
155199676|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
155199677|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155199678|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155199679|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
155199680|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
155199681|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
155199682|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
155199683|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
155199684|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
155199685|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
155199686|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155199687|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
155199688|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155199689|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
155199690|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
155199691|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
155199692|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
155199693|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199694|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199695|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199696|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
155199697|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Administrative|0|||
155199698|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Administrative|1|||
155199699|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Administrative|0|||
155199700|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Administrative|1|||
155199701|NCT01235351|560170446|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
155199702|NCT01235351|560170447|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
155199703|NCT00126191|560170450|FG000|Overall Study|Physician Decision|0|||
155199704|NCT00126191|560170451|FG001|Overall Study|Physician Decision|1|||
155199705|NCT00126191|560170450|FG000|Overall Study|Death|0|||
155199706|NCT00126191|560170451|FG001|Overall Study|Death|1|||
155199707|NCT00307294|560170452|FG000|Overall Study|Withdrawal by Subject|1|||
155199708|NCT01433991|560170461|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
155199709|NCT01433991|560170462|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199710|NCT01433991|560170463|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199711|NCT01433991|560170464|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199712|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
155199713|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
155199714|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
155199715|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
155199716|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199717|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199718|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199719|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
155199720|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199721|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199722|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199723|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
155199724|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
155199725|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
155199726|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
155199727|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
155199728|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
155199729|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199730|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199731|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199732|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199733|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199734|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
155199735|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199736|NCT00290888|560170467|FG000|Overall Study|Physician Decision|3|||
155199737|NCT00290888|560170468|FG001|Overall Study|Physician Decision|1|||
155199738|NCT01473836|560170471|FG000|Overall Study|Adverse Event|4|||
155199739|NCT01473836|560170471|FG000|Overall Study|Lack of Efficacy|1|||
155199740|NCT01473836|560170471|FG000|Overall Study|Does not meet entrance criteria|1|||
155199741|NCT03068130|560170474|FG000|Overall Study|Adverse Event|19|||
155199742|NCT03068130|560170474|FG000|Overall Study|Death|14|||
155199743|NCT03068130|560170474|FG000|Overall Study|Lost to Follow-up|4|||
155199744|NCT03068130|560170474|FG000|Overall Study|Withdrawal by Subject|26|||
155199745|NCT03068130|560170474|FG000|Overall Study|Administrative Reasons|3|||
155199746|NCT03068130|560170474|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
155199747|NCT03068130|560170474|FG000|Overall Study|Study terminated by sponsor|194|||
155199748|NCT01001377|560170475|FG000|Overall Study|Ineligibility determined|2|||
155199749|NCT01001377|560170476|FG001|Overall Study|Ineligibility determined|0|||
155199750|NCT01001377|560170475|FG000|Overall Study|Withdrawal by Subject|19|||
155199751|NCT01001377|560170476|FG001|Overall Study|Withdrawal by Subject|20|||
155199752|NCT01001377|560170475|FG000|Overall Study|Lost to Follow-up|14|||
155199753|NCT01001377|560170476|FG001|Overall Study|Lost to Follow-up|17|||
155199754|NCT01001377|560170475|FG000|Overall Study|Death|391|||
155199755|NCT01001377|560170476|FG001|Overall Study|Death|384|||
155199756|NCT00964860|560170479|FG000|Overall Study|Withdrawal by Subject|0|||
155199757|NCT00964860|560170480|FG001|Overall Study|Withdrawal by Subject|1|||
155199758|NCT03570697|560170483|FG000|Overall Study|Lost to Follow-up|0|||
155199759|NCT03570697|560170484|FG001|Overall Study|Lost to Follow-up|1|||
155199760|NCT03570697|560170483|FG000|Overall Study|Death|2|||
155199761|NCT03570697|560170484|FG001|Overall Study|Death|0|||
155199762|NCT03570697|560170483|FG000|Overall Study|Withdrawal by Subject|4|||
155199763|NCT03570697|560170484|FG001|Overall Study|Withdrawal by Subject|2|||
155199764|NCT01849783|560170485|FG000|Overall Study|Adverse Event|5|||
155199765|NCT01849783|560170485|FG000|Overall Study|Death|2|||
155199766|NCT01849783|560170485|FG000|Overall Study|Physician Decision|1|||
155199767|NCT01849783|560170485|FG000|Overall Study|Withdrawal by Subject|1|||
155199768|NCT01849783|560170485|FG000|Overall Study|Unable to comply|2|||
155199769|NCT01849783|560170485|FG000|Overall Study|Disease progression|11|||
155199770|NCT01876420|560170488|FG000|Overall Study|Missed 30 day visit|1|||
155199771|NCT03173313|560170489|FG000|Overall Study|Lost to Follow-up|2|||
155199772|NCT03173313|560170490|FG001|Overall Study|Lost to Follow-up|3|||
155199773|NCT03173313|560170489|FG000|Overall Study|Withdrawal by Subject|0|||
155199774|NCT03173313|560170490|FG001|Overall Study|Withdrawal by Subject|1|||
155199775|NCT03173313|560170489|FG000|Overall Study|Death|5|||
155199776|NCT03173313|560170490|FG001|Overall Study|Death|0|||
155199777|NCT03173313|560170489|FG000|Overall Study|Physician Decision|1|||
155199778|NCT03173313|560170490|FG001|Overall Study|Physician Decision|0|||
155199779|NCT03173313|560170489|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
155199780|NCT03173313|560170490|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
155199781|NCT03173313|560170489|FG000|Overall Study|Bone Fracture|1|||
155199782|NCT03173313|560170490|FG001|Overall Study|Bone Fracture|0|||
155199783|NCT03095612|560170496|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199784|NCT03095612|560170497|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
155199785|NCT03095612|560170498|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199786|NCT03095612|560170499|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199787|NCT03095612|560170500|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199788|NCT03095612|560170501|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199789|NCT03095612|560170502|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199790|NCT04447794|560170503|FG000|Overall Study|Lost to Follow-up|2|||
155199791|NCT04447794|560170504|FG001|Overall Study|Lost to Follow-up|3|||
155199792|NCT04447794|560170505|FG002|Overall Study|Lost to Follow-up|8|||
155199793|NCT04447794|560170503|FG000|Overall Study|Withdrawal by Subject|1|||
155199794|NCT04447794|560170504|FG001|Overall Study|Withdrawal by Subject|1|||
155199795|NCT04447794|560170505|FG002|Overall Study|Withdrawal by Subject|0|||
155199796|NCT01042678|560170506|FG000|Overall Study|Physician Decision|1|||
155199797|NCT01042678|560170507|FG001|Overall Study|Physician Decision|0|||
155199798|NCT01042678|560170508|FG002|Overall Study|Physician Decision|0|||
155199799|NCT01042678|560170509|FG003|Overall Study|Physician Decision|0|||
155199800|NCT01042678|560170510|FG004|Overall Study|Physician Decision|0|||
155199801|NCT01042678|560170511|FG005|Overall Study|Physician Decision|0|||
155199802|NCT00205881|560170516|FG000|Overall Study|Withdrawal by Subject|16|||
155199803|NCT04203498|560170519|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
155199804|NCT04203498|560170520|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
155199805|NCT04203498|560170519|FG000|Overall Study|Withdrawal of patient consent|7|||
155199806|NCT04203498|560170520|FG001|Overall Study|Withdrawal of patient consent|2|||
155199807|NCT04203498|560170519|FG000|Overall Study|Adverse Event|4|||
155199808|NCT04203498|560170520|FG001|Overall Study|Adverse Event|1|||
155199809|NCT04203498|560170519|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
155199810|NCT04203498|560170520|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
155199811|NCT04203498|560170519|FG000|Overall Study|Did not receive IMP|2|||
155199812|NCT04203498|560170520|FG001|Overall Study|Did not receive IMP|0|||
155199813|NCT00781274|560170521|FG000|Overall Study|Withdrawal by Subject|2|||
155199814|NCT02762578|560170524|FG000|Overall Study|Adverse Event|1|||
155199815|NCT02762578|560170525|FG001|Overall Study|Adverse Event|6|||
155199816|NCT02762578|560170524|FG000|Overall Study|Protocol Violation|4|||
155199817|NCT02762578|560170525|FG001|Overall Study|Protocol Violation|2|||
155199818|NCT02762578|560170524|FG000|Overall Study|Withdrawal by Subject|4|||
155199819|NCT02762578|560170525|FG001|Overall Study|Withdrawal by Subject|2|||
155199820|NCT02762578|560170524|FG000|Overall Study|Unclassified|6|||
155199821|NCT02762578|560170525|FG001|Overall Study|Unclassified|0|||
155199822|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199823|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199824|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199825|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
155199826|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199827|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199828|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199829|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199830|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199831|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
155199832|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199833|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199834|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199835|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199836|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199837|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
155199838|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199839|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199840|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
155199841|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199842|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199843|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199844|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199845|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199846|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Other|0|||
155199847|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Other|0|||
155199848|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Other|1|||
155199849|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Other|1|||
155199850|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Other|2|||
155199851|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Other|0|||
155199852|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Other|0|||
155199853|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Other|0|||
155199854|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199855|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199856|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199857|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199858|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
155199859|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199860|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199861|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199862|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199863|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
155199864|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199865|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
155199866|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
155199867|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
155199868|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199869|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
155199870|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199871|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199872|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199873|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199874|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199875|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199876|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199877|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199878|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199879|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
155199880|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199881|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199882|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199883|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199884|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199885|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199886|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Other|0|||
155199887|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Other|1|||
155199888|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Other|1|||
155199889|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Other|0|||
155199890|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Other|0|||
155199891|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Other|0|||
155199892|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Other|0|||
155199893|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Other|0|||
155199894|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199895|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199896|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199897|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199898|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199899|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199900|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
155199901|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199902|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199903|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199904|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199905|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199906|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199907|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199908|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
155199909|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199910|NCT00282984|560170534|FG000|Overall Study|Death|2|||
155199911|NCT00282984|560170535|FG001|Overall Study|Death|5|||
155199912|NCT00282984|560170534|FG000|Overall Study|Adverse Event|8|||
155199913|NCT00282984|560170535|FG001|Overall Study|Adverse Event|5|||
155199914|NCT00282984|560170534|FG000|Overall Study|Lack of Efficacy|0|||
155199915|NCT00282984|560170535|FG001|Overall Study|Lack of Efficacy|2|||
155199916|NCT00282984|560170534|FG000|Overall Study|Lost to Follow-up|14|||
155199917|NCT00282984|560170535|FG001|Overall Study|Lost to Follow-up|10|||
155199918|NCT00282984|560170534|FG000|Overall Study|Withdrawal by Participant|22|||
155199919|NCT00282984|560170535|FG001|Overall Study|Withdrawal by Participant|34|||
155199920|NCT00282984|560170534|FG000|Overall Study|Participant stopped study medication|2|||
155199921|NCT00282984|560170535|FG001|Overall Study|Participant stopped study medication|2|||
155199922|NCT00282984|560170534|FG000|Overall Study|Participant only allowed phone follow-up|0|||
155199923|NCT00282984|560170535|FG001|Overall Study|Participant only allowed phone follow-up|1|||
155199924|NCT00282984|560170534|FG000|Overall Study|Participant used antipsychosis meds|0|||
155199925|NCT00282984|560170535|FG001|Overall Study|Participant used antipsychosis meds|1|||
155199926|NCT00282984|560170534|FG000|Overall Study|lack of motivation|1|||
155199927|NCT00282984|560170535|FG001|Overall Study|lack of motivation|0|||
155199928|NCT00282984|560170534|FG000|Overall Study|in prison|0|||
155199929|NCT00282984|560170535|FG001|Overall Study|in prison|1|||
155199930|NCT00282984|560170534|FG000|Overall Study|Protocol Violation|2|||
155199931|NCT00282984|560170535|FG001|Overall Study|Protocol Violation|0|||
155199932|NCT00911547|560170536|FG000|Overall Study|Adverse Event|8|||
155199933|NCT00911547|560170537|FG001|Overall Study|Adverse Event|27|||
155199934|NCT00911547|560170538|FG002|Overall Study|Adverse Event|11|||
155199935|NCT00911547|560170539|FG003|Overall Study|Adverse Event|6|||
155199936|NCT00911547|560170536|FG000|Overall Study|Lost to Follow-up|0|||
155199937|NCT00911547|560170537|FG001|Overall Study|Lost to Follow-up|0|||
155199938|NCT00911547|560170538|FG002|Overall Study|Lost to Follow-up|2|||
155199939|NCT00911547|560170539|FG003|Overall Study|Lost to Follow-up|1|||
155199940|NCT00911547|560170536|FG000|Overall Study|Protocol Violation|0|||
155199941|NCT00911547|560170537|FG001|Overall Study|Protocol Violation|5|||
155199942|NCT00911547|560170538|FG002|Overall Study|Protocol Violation|5|||
155199943|NCT00911547|560170539|FG003|Overall Study|Protocol Violation|1|||
155199944|NCT00911547|560170536|FG000|Overall Study|Withdrawal by Subject|3|||
155199945|NCT00911547|560170537|FG001|Overall Study|Withdrawal by Subject|10|||
155199946|NCT00911547|560170538|FG002|Overall Study|Withdrawal by Subject|4|||
155199947|NCT00911547|560170539|FG003|Overall Study|Withdrawal by Subject|8|||
155199948|NCT00457301|560170540|FG000|Overall Study|Withdrawal by Subject|3|||
155199949|NCT00457301|560170541|FG001|Overall Study|Withdrawal by Subject|3|||
155199950|NCT00457301|560170540|FG000|Overall Study|Censored out of the study|15|||
155199951|NCT00457301|560170541|FG001|Overall Study|Censored out of the study|14|||
155199952|NCT00457301|560170540|FG000|Overall Study|Death|5|||
155199953|NCT00457301|560170541|FG001|Overall Study|Death|7|||
155199954|NCT00191269|560170542|FG000|Overall Study|Protocol Violation|0|||
155199955|NCT00191269|560170543|FG001|Overall Study|Protocol Violation|2|||
155199956|NCT00191269|560170542|FG000|Overall Study|Adverse Event|1|||
155199957|NCT00191269|560170543|FG001|Overall Study|Adverse Event|4|||
155199958|NCT00191269|560170542|FG000|Overall Study|Progression of Disease|4|||
155199959|NCT00191269|560170543|FG001|Overall Study|Progression of Disease|42|||
155199960|NCT00191269|560170542|FG000|Overall Study|Lack of Efficacy|1|||
155199961|NCT00191269|560170543|FG001|Overall Study|Lack of Efficacy|5|||
155199962|NCT00191269|560170542|FG000|Overall Study|Withdrawal by Subject|0|||
155199963|NCT00191269|560170543|FG001|Overall Study|Withdrawal by Subject|1|||
155199964|NCT00191269|560170542|FG000|Overall Study|Pathologic Aggrevation|0|||
155199965|NCT00191269|560170543|FG001|Overall Study|Pathologic Aggrevation|1|||
155199966|NCT00191269|560170542|FG000|Overall Study|Physician Decision|0|||
155199967|NCT00191269|560170543|FG001|Overall Study|Physician Decision|3|||
155199968|NCT03344796|560170548|FG000|Overall Study|Lost to Follow-up|0|||
155199969|NCT03344796|560170549|FG001|Overall Study|Lost to Follow-up|0|||
155199970|NCT03344796|560170550|FG002|Overall Study|Lost to Follow-up|0|||
155199971|NCT03344796|560170551|FG003|Overall Study|Lost to Follow-up|0|||
155199972|NCT03344796|560170552|FG004|Overall Study|Lost to Follow-up|0|||
155199973|NCT03344796|560170553|FG005|Overall Study|Lost to Follow-up|2|||
155199974|NCT02564796|560170560|FG000|Overall Study|Physician Decision|2|||
155199975|NCT02564796|560170561|FG001|Overall Study|Physician Decision|2|||
155199976|NCT00293033|560170562|FG000|Open-label Titration Period|Adverse Event|10|||
155199977|NCT00293033|560170562|FG000|Open-label Titration Period|Death|3|||
155199978|NCT00293033|560170562|FG000|Open-label Titration Period|Lack of Efficacy|5|||
155199979|NCT00293033|560170562|FG000|Open-label Titration Period|Protocol Violation|2|||
155199980|NCT00293033|560170562|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
155199981|NCT00293033|560170562|FG000|Open-label Titration Period|Noncompliance and other|27|||
155199982|NCT00293033|560170562|FG000|Double-blind Treatment Period|Adverse Event|3|||
155199983|NCT00293033|560170562|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
155199984|NCT00293033|560170562|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
155199985|NCT00293033|560170562|FG000|Double-blind Treatment Period|Noncompliance|4|||
155199986|NCT03583697|560170563|FG000|Overall Study|Withdrawal by Subject|0|||
155199987|NCT03583697|560170564|FG001|Overall Study|Withdrawal by Subject|0|||
155199988|NCT03583697|560170565|FG002|Overall Study|Withdrawal by Subject|1|||
155199989|NCT03583697|560170563|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
155199990|NCT03583697|560170564|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
155199991|NCT03583697|560170565|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
155199992|NCT00453063|560170566|FG000|Overall Study|Adverse Event|1|||
155199993|NCT00453063|560170567|FG001|Overall Study|Adverse Event|2|||
155199994|NCT00453063|560170566|FG000|Overall Study|Withdrawal by Subject|1|||
155199995|NCT00453063|560170567|FG001|Overall Study|Withdrawal by Subject|1|||
155199996|NCT00453063|560170566|FG000|Overall Study|Protocol Violation|1|||
155199997|NCT00453063|560170567|FG001|Overall Study|Protocol Violation|0|||
155199998|NCT00114530|560170569|FG000|Overall Study|Death|3|||
155199999|NCT00114530|560170570|FG001|Overall Study|Death|11|||
155200000|NCT00114530|560170569|FG000|Overall Study|Lost to Follow-up|1|||
155200001|NCT00114530|560170570|FG001|Overall Study|Lost to Follow-up|1|||
155200002|NCT00114530|560170569|FG000|Overall Study|Physician Decision|1|||
155200003|NCT00114530|560170570|FG001|Overall Study|Physician Decision|1|||
155200004|NCT00114530|560170569|FG000|Overall Study|Withdrawal by Subject|2|||
155200005|NCT00114530|560170570|FG001|Overall Study|Withdrawal by Subject|6|||
155200006|NCT00114530|560170569|FG000|Overall Study|Breast Cancer|1|||
155200007|NCT00114530|560170570|FG001|Overall Study|Breast Cancer|0|||
155200008|NCT00114530|560170569|FG000|Overall Study|Subject decision after endpoint failure|0|||
155200009|NCT00114530|560170570|FG001|Overall Study|Subject decision after endpoint failure|1|||
155200010|NCT00114530|560170569|FG000|Overall Study|Ineligible|1|||
155200011|NCT00114530|560170570|FG001|Overall Study|Ineligible|0|||
155200012|NCT00365508|560170573|FG000|Overall Study|Lost to Follow-up|139|||
155200013|NCT00365508|560170574|FG001|Overall Study|Lost to Follow-up|154|||
155200014|NCT03724032|560170575|FG000|Overall Study|Physician Decision|1|||
155200015|NCT03724032|560170576|FG001|Overall Study|Physician Decision|0|||
155200016|NCT03724032|560170577|FG002|Overall Study|Physician Decision|0|||
155200017|NCT03724032|560170575|FG000|Overall Study|Protocol Violation|2|||
155200018|NCT03724032|560170576|FG001|Overall Study|Protocol Violation|2|||
155200019|NCT03724032|560170577|FG002|Overall Study|Protocol Violation|1|||
155200020|NCT00404235|560170579|FG000|Overall Study|Withdrawal by Subject|1|||
155200021|NCT00404235|560170580|FG001|Overall Study|Withdrawal by Subject|2|||
155200022|NCT00743483|560170581|FG000|Baseline Period|Physician Decision|1|||
155200023|NCT00743483|560170581|FG000|Treatment Period|Adverse Event|1|||
155200024|NCT00873912|560170582|FG000|Overall Study|Withdrawal by Subject|1|||
155200025|NCT00873912|560170583|FG001|Overall Study|Withdrawal by Subject|0|||
155200026|NCT00873912|560170582|FG000|Overall Study|Lost to Follow-up|2|||
155200027|NCT00873912|560170583|FG001|Overall Study|Lost to Follow-up|0|||
155200028|NCT01785069|560170586|FG000|Overall Study|Implanted with nonstudy device|1|||
155200029|NCT01785069|560170587|FG001|Overall Study|Implanted with nonstudy device|2|||
155200030|NCT01785069|560170588|FG002|Overall Study|Implanted with nonstudy device|1|||
155200031|NCT01785069|560170589|FG003|Overall Study|Implanted with nonstudy device|0|||
155200032|NCT01785069|560170586|FG000|Overall Study|Death|0|||
155200033|NCT01785069|560170587|FG001|Overall Study|Death|0|||
155200034|NCT01785069|560170588|FG002|Overall Study|Death|2|||
155200035|NCT01785069|560170589|FG003|Overall Study|Death|0|||
155200036|NCT01785069|560170586|FG000|Overall Study|Subject choice|2|||
155200037|NCT01785069|560170587|FG001|Overall Study|Subject choice|2|||
155200038|NCT01785069|560170588|FG002|Overall Study|Subject choice|0|||
155200039|NCT01785069|560170589|FG003|Overall Study|Subject choice|1|||
155200040|NCT01785069|560170586|FG000|Overall Study|Lost to Follow-up|1|||
155200041|NCT01785069|560170587|FG001|Overall Study|Lost to Follow-up|2|||
155200042|NCT01785069|560170588|FG002|Overall Study|Lost to Follow-up|4|||
155200043|NCT01785069|560170589|FG003|Overall Study|Lost to Follow-up|1|||
155200044|NCT01785069|560170586|FG000|Overall Study|Reason not Specified|1|||
155200045|NCT01785069|560170587|FG001|Overall Study|Reason not Specified|2|||
155200046|NCT01785069|560170588|FG002|Overall Study|Reason not Specified|1|||
155200047|NCT01785069|560170589|FG003|Overall Study|Reason not Specified|4|||
155200048|NCT01785069|560170586|FG000|Overall Study|Not evaluable|7|||
155200049|NCT01785069|560170587|FG001|Overall Study|Not evaluable|4|||
155200050|NCT01785069|560170588|FG002|Overall Study|Not evaluable|5|||
155200051|NCT01785069|560170589|FG003|Overall Study|Not evaluable|8|||
155200052|NCT01088997|560170592|FG000|Overall Study|Physician Decision|1|||
155200053|NCT01088997|560170593|FG001|Overall Study|Physician Decision|1|||
155200054|NCT01088997|560170592|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
155200055|NCT01088997|560170593|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
155200056|NCT01088997|560170592|FG000|Overall Study|Excluded prior to receiving drug|1|||
155200057|NCT01088997|560170593|FG001|Overall Study|Excluded prior to receiving drug|1|||
155200058|NCT05570500|560170598|FG000|Overall Study|Lost to Follow-up|7|||
155200059|NCT05570500|560170599|FG001|Overall Study|Lost to Follow-up|5|||
155200060|NCT01095731|560170600|FG000|Overall Study|Protocol Violation|1|||
155200061|NCT01095731|560170601|FG001|Overall Study|Protocol Violation|1|||
155200062|NCT01095731|560170600|FG000|Overall Study|Withdrawal by Subject|0|||
155200063|NCT01095731|560170601|FG001|Overall Study|Withdrawal by Subject|1|||
155200064|NCT02302807|560170604|FG000|Overall Study|Withdrawal by Subject|28|||
155200065|NCT02302807|560170605|FG001|Overall Study|Withdrawal by Subject|11|||
155200066|NCT02302807|560170604|FG000|Overall Study|Lost to Follow-up|4|||
155200067|NCT02302807|560170605|FG001|Overall Study|Lost to Follow-up|6|||
155200068|NCT02302807|560170604|FG000|Overall Study|Death|397|||
155200069|NCT02302807|560170605|FG001|Overall Study|Death|385|||
155200070|NCT02302807|560170604|FG000|Overall Study|Study Terminated By Sponsor|35|||
155200071|NCT02302807|560170605|FG001|Overall Study|Study Terminated By Sponsor|64|||
155200072|NCT02302807|560170604|FG000|Overall Study|Physician Decision|0|||
155200073|NCT02302807|560170605|FG001|Overall Study|Physician Decision|1|||
155200074|NCT04840615|560172359|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
155200075|NCT04840615|560172360|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
155200076|NCT04840615|560172361|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
155200077|NCT01749137|560172366|FG000|Overall Study|Adverse Event|4|||
155200078|NCT01749137|560172367|FG001|Overall Study|Adverse Event|4|||
155200079|NCT01749137|560172366|FG000|Overall Study|Lost to Follow-up|2|||
155200080|NCT01749137|560172367|FG001|Overall Study|Lost to Follow-up|3|||
155200081|NCT01749137|560172366|FG000|Overall Study|Physician Decision|1|||
155200082|NCT01749137|560172367|FG001|Overall Study|Physician Decision|0|||
155200083|NCT01749137|560172366|FG000|Overall Study|Withdrawal by Subject|8|||
155200084|NCT01749137|560172367|FG001|Overall Study|Withdrawal by Subject|4|||
155200085|NCT00621985|560172372|FG000|Dexamethasone Admission|Adverse Event|1|||
155200086|NCT00980057|560172378|FG000|Overall Study|Death|13|||
155200087|NCT00980057|560172379|FG001|Overall Study|Death|3|||
155200088|NCT00980057|560172378|FG000|Overall Study|Adverse Event|0|||
155200089|NCT00980057|560172379|FG001|Overall Study|Adverse Event|1|||
155200090|NCT00980057|560172378|FG000|Overall Study|Physician Decision|4|||
155200091|NCT00980057|560172379|FG001|Overall Study|Physician Decision|0|||
155200092|NCT00980057|560172378|FG000|Overall Study|Lost to Follow-up|1|||
155200093|NCT00980057|560172379|FG001|Overall Study|Lost to Follow-up|0|||
155200094|NCT00980057|560172378|FG000|Overall Study|Withdrawal by Subject|1|||
155200095|NCT00980057|560172379|FG001|Overall Study|Withdrawal by Subject|1|||
155200096|NCT00691015|560172383|FG000|Overall Study|Refused further treatment|1|||
155200097|NCT04160195|560172386|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
155200098|NCT04160195|560172387|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
155200099|NCT03766581|560172390|FG000|Randomization|Other reasons|2|||
155200100|NCT03766581|560172391|FG001|Randomization|Other reasons|1|||
155200101|NCT03766581|560172392|FG002|Randomization|Other reasons|0|||
155200102|NCT03766581|560172393|FG003|Randomization|Other reasons|1|||
155200103|NCT03766581|560172394|FG004|Randomization|Other reasons|0|||
155200104|NCT03766581|560172395|FG005|Randomization|Other reasons|0|||
155200105|NCT03766581|560172396|FG006|Randomization|Other reasons|0|||
155200106|NCT03766581|560172397|FG007|Randomization|Other reasons|0|||
155200107|NCT03766581|560172390|FG000|Randomization|Participant no longer meets study criteria|5|||
155200108|NCT03766581|560172391|FG001|Randomization|Participant no longer meets study criteria|3|||
155200109|NCT03766581|560172392|FG002|Randomization|Participant no longer meets study criteria|4|||
155200110|NCT03766581|560172393|FG003|Randomization|Participant no longer meets study criteria|0|||
155200111|NCT03766581|560172394|FG004|Randomization|Participant no longer meets study criteria|2|||
155200112|NCT03766581|560172395|FG005|Randomization|Participant no longer meets study criteria|3|||
155200113|NCT03766581|560172396|FG006|Randomization|Participant no longer meets study criteria|0|||
155200114|NCT03766581|560172397|FG007|Randomization|Participant no longer meets study criteria|1|||
155200115|NCT03766581|560172390|FG000|Randomization|Participant request to discontinue study treatment|1|||
155200116|NCT03766581|560172391|FG001|Randomization|Participant request to discontinue study treatment|0|||
155200117|NCT03766581|560172392|FG002|Randomization|Participant request to discontinue study treatment|0|||
155200118|NCT03766581|560172393|FG003|Randomization|Participant request to discontinue study treatment|0|||
155200119|NCT03766581|560172394|FG004|Randomization|Participant request to discontinue study treatment|1|||
155200120|NCT03766581|560172395|FG005|Randomization|Participant request to discontinue study treatment|2|||
155200121|NCT03766581|560172396|FG006|Randomization|Participant request to discontinue study treatment|0|||
155200122|NCT03766581|560172397|FG007|Randomization|Participant request to discontinue study treatment|0|||
155200123|NCT03766581|560172390|FG000|Randomization|Participant withdrew consent|1|||
155200124|NCT03766581|560172391|FG001|Randomization|Participant withdrew consent|0|||
155200125|NCT03766581|560172392|FG002|Randomization|Participant withdrew consent|1|||
155200126|NCT03766581|560172393|FG003|Randomization|Participant withdrew consent|2|||
155200127|NCT03766581|560172394|FG004|Randomization|Participant withdrew consent|1|||
155200128|NCT03766581|560172395|FG005|Randomization|Participant withdrew consent|1|||
155200129|NCT03766581|560172396|FG006|Randomization|Participant withdrew consent|0|||
155200130|NCT03766581|560172397|FG007|Randomization|Participant withdrew consent|0|||
155200131|NCT03766581|560172390|FG000|Treatment|Adverse Event|82|||
155200132|NCT03766581|560172391|FG001|Treatment|Adverse Event|44|||
155200133|NCT03766581|560172392|FG002|Treatment|Adverse Event|47|||
155200134|NCT03766581|560172393|FG003|Treatment|Adverse Event|46|||
155200135|NCT03766581|560172394|FG004|Treatment|Adverse Event|50|||
155200136|NCT03766581|560172395|FG005|Treatment|Adverse Event|77|||
155200137|NCT03766581|560172396|FG006|Treatment|Adverse Event|5|||
155200138|NCT03766581|560172397|FG007|Treatment|Adverse Event|2|||
155200139|NCT03766581|560172390|FG000|Treatment|Participant request to discontinue treatment|34|||
155200140|NCT03766581|560172391|FG001|Treatment|Participant request to discontinue treatment|6|||
155200141|NCT03766581|560172392|FG002|Treatment|Participant request to discontinue treatment|10|||
155200142|NCT03766581|560172393|FG003|Treatment|Participant request to discontinue treatment|10|||
155200143|NCT03766581|560172394|FG004|Treatment|Participant request to discontinue treatment|14|||
155200144|NCT03766581|560172395|FG005|Treatment|Participant request to discontinue treatment|15|||
155200145|NCT03766581|560172396|FG006|Treatment|Participant request to discontinue treatment|0|||
155200146|NCT03766581|560172397|FG007|Treatment|Participant request to discontinue treatment|1|||
155200147|NCT03766581|560172390|FG000|Treatment|Participant withdrew consent|11|||
155200148|NCT03766581|560172391|FG001|Treatment|Participant withdrew consent|4|||
155200149|NCT03766581|560172392|FG002|Treatment|Participant withdrew consent|5|||
155200150|NCT03766581|560172393|FG003|Treatment|Participant withdrew consent|5|||
155200151|NCT03766581|560172394|FG004|Treatment|Participant withdrew consent|4|||
155200152|NCT03766581|560172395|FG005|Treatment|Participant withdrew consent|4|||
155200153|NCT03766581|560172396|FG006|Treatment|Participant withdrew consent|0|||
155200154|NCT03766581|560172397|FG007|Treatment|Participant withdrew consent|0|||
155200155|NCT03766581|560172390|FG000|Treatment|Death|1|||
155200156|NCT03766581|560172391|FG001|Treatment|Death|0|||
155200157|NCT03766581|560172392|FG002|Treatment|Death|0|||
155200158|NCT03766581|560172393|FG003|Treatment|Death|0|||
155200159|NCT03766581|560172394|FG004|Treatment|Death|0|||
155200160|NCT03766581|560172395|FG005|Treatment|Death|0|||
155200161|NCT03766581|560172396|FG006|Treatment|Death|0|||
155200162|NCT03766581|560172397|FG007|Treatment|Death|0|||
155200163|NCT03766581|560172390|FG000|Treatment|Lost to Follow-up|1|||
155200164|NCT03766581|560172391|FG001|Treatment|Lost to Follow-up|0|||
155200165|NCT03766581|560172392|FG002|Treatment|Lost to Follow-up|0|||
155200166|NCT03766581|560172393|FG003|Treatment|Lost to Follow-up|1|||
155200167|NCT03766581|560172394|FG004|Treatment|Lost to Follow-up|0|||
155200168|NCT03766581|560172395|FG005|Treatment|Lost to Follow-up|0|||
155200169|NCT03766581|560172396|FG006|Treatment|Lost to Follow-up|0|||
155200170|NCT03766581|560172397|FG007|Treatment|Lost to Follow-up|0|||
155200171|NCT03766581|560172390|FG000|Treatment|Poor/Non compliance|2|||
155200172|NCT03766581|560172391|FG001|Treatment|Poor/Non compliance|2|||
155200173|NCT03766581|560172392|FG002|Treatment|Poor/Non compliance|1|||
155200174|NCT03766581|560172393|FG003|Treatment|Poor/Non compliance|1|||
155200175|NCT03766581|560172394|FG004|Treatment|Poor/Non compliance|1|||
155200176|NCT03766581|560172395|FG005|Treatment|Poor/Non compliance|1|||
155200177|NCT03766581|560172396|FG006|Treatment|Poor/Non compliance|0|||
155200178|NCT03766581|560172397|FG007|Treatment|Poor/Non compliance|0|||
155200179|NCT03766581|560172390|FG000|Treatment|Participant no longer meets study criteria|9|||
155200180|NCT03766581|560172391|FG001|Treatment|Participant no longer meets study criteria|1|||
155200181|NCT03766581|560172392|FG002|Treatment|Participant no longer meets study criteria|5|||
155200182|NCT03766581|560172393|FG003|Treatment|Participant no longer meets study criteria|4|||
155200183|NCT03766581|560172394|FG004|Treatment|Participant no longer meets study criteria|4|||
155200184|NCT03766581|560172395|FG005|Treatment|Participant no longer meets study criteria|4|||
155200185|NCT03766581|560172396|FG006|Treatment|Participant no longer meets study criteria|2|||
155200186|NCT03766581|560172397|FG007|Treatment|Participant no longer meets study criteria|0|||
155200187|NCT03766581|560172390|FG000|Treatment|Other reasons|13|||
155200188|NCT03766581|560172391|FG001|Treatment|Other reasons|8|||
155200189|NCT03766581|560172392|FG002|Treatment|Other reasons|3|||
155200190|NCT03766581|560172393|FG003|Treatment|Other reasons|7|||
155200191|NCT03766581|560172394|FG004|Treatment|Other reasons|3|||
155200192|NCT03766581|560172395|FG005|Treatment|Other reasons|3|||
155200193|NCT03766581|560172396|FG006|Treatment|Other reasons|0|||
155200194|NCT03766581|560172397|FG007|Treatment|Other reasons|0|||
155200195|NCT02732119|560172398|FG000|Phase I|Adverse Event|1|||
155200196|NCT02732119|560172399|FG001|Phase I|Adverse Event|3|||
155200197|NCT02732119|560172400|FG002|Phase I|Adverse Event|1|||
155200198|NCT02732119|560172401|FG003|Phase I|Adverse Event|0|||
155200199|NCT02732119|560172402|FG004|Phase I|Adverse Event|0|||
155200200|NCT02732119|560172398|FG000|Phase I|Progressive disease|7|||
155200201|NCT02732119|560172399|FG001|Phase I|Progressive disease|3|||
155200202|NCT02732119|560172400|FG002|Phase I|Progressive disease|2|||
155200203|NCT02732119|560172401|FG003|Phase I|Progressive disease|0|||
155200204|NCT02732119|560172402|FG004|Phase I|Progressive disease|0|||
155200205|NCT02732119|560172398|FG000|Phase I|Protocol deviation|0|||
155200206|NCT02732119|560172399|FG001|Phase I|Protocol deviation|1|||
155200207|NCT02732119|560172400|FG002|Phase I|Protocol deviation|0|||
155200208|NCT02732119|560172401|FG003|Phase I|Protocol deviation|0|||
155200209|NCT02732119|560172402|FG004|Phase I|Protocol deviation|0|||
155200210|NCT02732119|560172398|FG000|Phase I|Physician Decision|0|||
155200211|NCT02732119|560172399|FG001|Phase I|Physician Decision|3|||
155200212|NCT02732119|560172400|FG002|Phase I|Physician Decision|4|||
155200213|NCT02732119|560172401|FG003|Phase I|Physician Decision|0|||
155200214|NCT02732119|560172402|FG004|Phase I|Physician Decision|0|||
155200215|NCT02732119|560172398|FG000|Phase II|Adverse Event|0|||
155200216|NCT02732119|560172399|FG001|Phase II|Adverse Event|0|||
155200217|NCT02732119|560172400|FG002|Phase II|Adverse Event|0|||
155200218|NCT02732119|560172401|FG003|Phase II|Adverse Event|3|||
155200219|NCT02732119|560172402|FG004|Phase II|Adverse Event|3|||
155200220|NCT02732119|560172398|FG000|Phase II|Death|0|||
155200221|NCT02732119|560172399|FG001|Phase II|Death|0|||
155200222|NCT02732119|560172400|FG002|Phase II|Death|0|||
155200223|NCT02732119|560172401|FG003|Phase II|Death|1|||
155200224|NCT02732119|560172402|FG004|Phase II|Death|0|||
155200225|NCT02732119|560172398|FG000|Phase II|Progressive dissease|0|||
155200226|NCT02732119|560172399|FG001|Phase II|Progressive dissease|0|||
155200227|NCT02732119|560172400|FG002|Phase II|Progressive dissease|0|||
155200228|NCT02732119|560172401|FG003|Phase II|Progressive dissease|30|||
155200229|NCT02732119|560172402|FG004|Phase II|Progressive dissease|23|||
155200230|NCT02732119|560172398|FG000|Phase II|Study terminated by sponsor|0|||
155200231|NCT02732119|560172399|FG001|Phase II|Study terminated by sponsor|0|||
155200232|NCT02732119|560172400|FG002|Phase II|Study terminated by sponsor|0|||
155200233|NCT02732119|560172401|FG003|Phase II|Study terminated by sponsor|2|||
155200234|NCT02732119|560172402|FG004|Phase II|Study terminated by sponsor|2|||
155200235|NCT02732119|560172398|FG000|Phase II|Other|0|||
155200236|NCT02732119|560172399|FG001|Phase II|Other|0|||
155200237|NCT02732119|560172400|FG002|Phase II|Other|0|||
155200238|NCT02732119|560172401|FG003|Phase II|Other|2|||
155200239|NCT02732119|560172402|FG004|Phase II|Other|0|||
155200240|NCT02732119|560172398|FG000|Phase II|Physician Decision|0|||
155200241|NCT02732119|560172399|FG001|Phase II|Physician Decision|0|||
155200242|NCT02732119|560172400|FG002|Phase II|Physician Decision|0|||
155200243|NCT02732119|560172401|FG003|Phase II|Physician Decision|8|||
155200244|NCT02732119|560172402|FG004|Phase II|Physician Decision|5|||
155200245|NCT05275400|560172403|FG000|Treatment Period|Adverse Event|7|||
155200246|NCT05275400|560172404|FG001|Treatment Period|Adverse Event|1|||
155200247|NCT05275400|560172403|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
155200248|NCT05275400|560172404|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
155200249|NCT05275400|560172403|FG000|Treatment Period|Death|5|||
155200250|NCT05275400|560172404|FG001|Treatment Period|Death|2|||
155200251|NCT05275400|560172403|FG000|Treatment Period|Protocol Violation|1|||
155200252|NCT05275400|560172404|FG001|Treatment Period|Protocol Violation|0|||
155200253|NCT05275400|560172403|FG000|Treatment Period|Physician Decision|5|||
155200254|NCT05275400|560172404|FG001|Treatment Period|Physician Decision|4|||
155200255|NCT05275400|560172403|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
155200256|NCT05275400|560172404|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
155200257|NCT05275400|560172403|FG000|Treatment Period|Withdrawal by Subject|30|||
155200258|NCT05275400|560172404|FG001|Treatment Period|Withdrawal by Subject|12|||
155200259|NCT05275400|560172403|FG000|Treatment Period|Lost to Follow-up|1|||
155200260|NCT05275400|560172404|FG001|Treatment Period|Lost to Follow-up|5|||
155200261|NCT05275400|560172403|FG000|Treatment Period|Lack of Efficacy|1|||
155200262|NCT05275400|560172404|FG001|Treatment Period|Lack of Efficacy|0|||
155200263|NCT05275400|560172403|FG000|Treatment Period|Sponsor Decision|1|||
155200264|NCT05275400|560172404|FG001|Treatment Period|Sponsor Decision|0|||
155200265|NCT05275400|560172403|FG000|Follow-Up Period|Death|2|||
155200266|NCT05275400|560172404|FG001|Follow-Up Period|Death|0|||
155200267|NCT05275400|560172403|FG000|Follow-Up Period|Protocol Violation|1|||
155200268|NCT05275400|560172404|FG001|Follow-Up Period|Protocol Violation|0|||
155200269|NCT05275400|560172403|FG000|Follow-Up Period|Withdrawal by Subject|3|||
155200270|NCT05275400|560172404|FG001|Follow-Up Period|Withdrawal by Subject|0|||
155200271|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Physician Decision|0|||
155200272|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Physician Decision|1|||
155200273|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Physician Decision|0|||
155200274|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
155200275|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
155200276|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
155200277|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
155200278|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
155200279|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
155200280|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Other|4|||
155200281|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Other|4|||
155200282|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Other|0|||
155200283|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
155200284|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
155200285|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
155200286|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Screen Failure|0|||
155200287|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Screen Failure|0|||
155200288|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Screen Failure|1|||
155200289|NCT02585960|560172405|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
155200290|NCT02585960|560172406|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
155200291|NCT02585960|560172407|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
155200292|NCT02585960|560172405|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
155200293|NCT02585960|560172406|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
155200294|NCT02585960|560172407|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
155200295|NCT01651039|560172409|FG000|Overall Study|Non-evaluables|5|||
155200296|NCT01651039|560172409|FG000|Overall Study|Physician Decision|2|||
155200297|NCT01651039|560172409|FG000|Overall Study|Withdrawal by Subject|1|||
155200298|NCT01651039|560172409|FG000|Overall Study|Progressive Disease|22|||
155200299|NCT04377620|560172411|FG000|Overall Study|Death|42|||
155200300|NCT04377620|560172412|FG001|Overall Study|Death|48|||
155200301|NCT04377620|560172413|FG002|Overall Study|Death|36|||
155200302|NCT04377620|560172411|FG000|Overall Study|Withdrawal by Subject|0|||
155200303|NCT04377620|560172412|FG001|Overall Study|Withdrawal by Subject|2|||
155200304|NCT04377620|560172413|FG002|Overall Study|Withdrawal by Subject|0|||
155200305|NCT04930965|560172414|FG000|Overall Study|Lost to Follow-up|7|||
155200306|NCT04930965|560172415|FG001|Overall Study|Lost to Follow-up|5|||
155200307|NCT00288054|560172416|FG000|Overall Study|Protocol Violation|2|||
155200308|NCT00288054|560172416|FG000|Overall Study|Lack of Efficacy|16|||
155200309|NCT00288054|560172416|FG000|Overall Study|Adverse Event|3|||
155200310|NCT00288054|560172416|FG000|Overall Study|Withdrawal by Subject|1|||
155200311|NCT00288054|560172416|FG000|Overall Study|Not protocol specified|2|||
155200312|NCT00444912|560172424|FG000|Overall Study|Death|1|||
155200313|NCT00444912|560172425|FG001|Overall Study|Death|2|||
155200314|NCT00444912|560172424|FG000|Overall Study|Lost to Follow-up|1|||
155200315|NCT00444912|560172425|FG001|Overall Study|Lost to Follow-up|0|||
155200316|NCT00444912|560172424|FG000|Overall Study|Participant Failed Mobilization|1|||
155200317|NCT00444912|560172425|FG001|Overall Study|Participant Failed Mobilization|0|||
155200318|NCT01606007|560172426|FG000|Overall Study|Reason 'Other' in the protocol|0|||
155200319|NCT01606007|560172427|FG001|Overall Study|Reason 'Other' in the protocol|1|||
155200320|NCT01606007|560172428|FG002|Overall Study|Reason 'Other' in the protocol|1|||
155200321|NCT01606007|560172426|FG000|Overall Study|Pregnancy|0|||
155200322|NCT01606007|560172427|FG001|Overall Study|Pregnancy|1|||
155200323|NCT01606007|560172428|FG002|Overall Study|Pregnancy|1|||
155200324|NCT01606007|560172426|FG000|Overall Study|Withdrawal by Subject|8|||
155200325|NCT01606007|560172427|FG001|Overall Study|Withdrawal by Subject|6|||
155200326|NCT01606007|560172428|FG002|Overall Study|Withdrawal by Subject|1|||
155200327|NCT01606007|560172426|FG000|Overall Study|Adverse Event|0|||
155200328|NCT01606007|560172427|FG001|Overall Study|Adverse Event|1|||
155200329|NCT01606007|560172428|FG002|Overall Study|Adverse Event|1|||
155200330|NCT01606007|560172426|FG000|Overall Study|discontinue study treatment|0|||
155200331|NCT01606007|560172427|FG001|Overall Study|discontinue study treatment|2|||
155200332|NCT01606007|560172428|FG002|Overall Study|discontinue study treatment|1|||
155200333|NCT01606007|560172426|FG000|Overall Study|Lost to Follow-up|6|||
155200334|NCT01606007|560172427|FG001|Overall Study|Lost to Follow-up|8|||
155200335|NCT01606007|560172428|FG002|Overall Study|Lost to Follow-up|5|||
155200336|NCT01606007|560172426|FG000|Overall Study|Poor/Non-compliance|1|||
155200337|NCT01606007|560172427|FG001|Overall Study|Poor/Non-compliance|0|||
155200338|NCT01606007|560172428|FG002|Overall Study|Poor/Non-compliance|0|||
155200339|NCT03758066|560172429|FG000|Overall Study|Lost to Follow-up|14|||
155200340|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
155200341|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
155200342|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
155200343|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
155200344|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
155200345|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200346|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
155200347|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
155200348|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200349|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200350|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
155200351|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
155200352|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
155200353|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
155200354|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
155200355|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
155200356|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
155200357|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
155200358|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
155200359|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
155200360|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200361|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200362|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
155200363|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200364|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200365|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200366|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200367|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
155200368|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200369|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200370|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
155200371|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200372|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200373|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200374|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200375|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200376|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
155200377|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200378|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200379|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200380|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200381|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
155200382|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200383|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200384|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
155200385|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200386|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200387|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
155200388|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200389|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200390|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
155200391|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
155200392|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
155200393|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
155200394|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
155200395|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200396|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
155200397|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200398|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200399|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200400|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200401|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200402|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200403|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
155200404|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200405|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200406|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200407|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
155200408|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200409|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200410|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Change of location|0|||
155200411|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Change of location|0|||
155200412|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Change of location|0|||
155200413|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Change of location|1|||
155200414|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Change of location|0|||
155200415|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
155200416|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
155200417|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
155200418|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
155200419|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
155200420|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200421|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200422|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200423|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200424|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
155200425|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
155200426|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200427|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200428|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200429|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200430|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
155200431|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
155200432|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
155200433|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
155200434|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
155200435|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
155200436|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
155200437|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
155200438|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
155200439|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
155200440|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
155200441|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
155200442|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
155200443|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
155200444|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
155200445|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Death|0|||
155200446|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Death|1|||
155200447|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Death|0|||
155200448|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Death|1|||
155200449|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Death|0|||
155200450|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Change of location|1|||
155200451|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Change of location|1|||
155200452|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Change of location|0|||
155200453|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Change of location|1|||
155200454|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Change of location|0|||
155200455|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200456|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200457|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
155200458|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200459|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200460|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200461|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200462|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
155200463|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200464|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200465|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200466|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200467|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
155200468|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200469|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200470|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200471|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200472|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200473|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200474|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
155200475|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
155200476|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200477|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200478|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200479|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200480|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200481|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200482|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200483|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
155200484|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200485|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200486|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
155200487|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
155200488|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200489|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200490|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
155200491|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
155200492|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200493|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200494|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200495|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200496|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
155200497|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200498|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200499|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200500|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
155200501|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
155200502|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
155200503|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
155200504|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
155200505|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Missing|0|||
155200506|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Missing|0|||
155200507|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Missing|2|||
155200508|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Missing|0|||
155200509|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Missing|0|||
155200510|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200511|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200512|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200513|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200514|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
155200515|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200516|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200517|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
155200518|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200519|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200520|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
155200521|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
155200522|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
155200523|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
155200524|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
155200525|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200526|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200527|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
155200528|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200529|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200530|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200531|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200532|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200533|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
155200534|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200535|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
155200536|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200537|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200538|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200539|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200540|NCT01496807|560172439|FG000|Overall Study|Progressive Disease|21|||
155200541|NCT01496807|560172439|FG000|Overall Study|Participant preference/toxicity|8|||
155200542|NCT01496807|560172439|FG000|Overall Study|Change in diagnosis|1|||
155200543|NCT00963937|560172445|FG000|Overall Study|Protocol Violation|1|||
155200544|NCT00963937|560172446|FG001|Overall Study|Protocol Violation|1|||
155200545|NCT00963937|560172447|FG002|Overall Study|Protocol Violation|0|||
155200546|NCT00963937|560172445|FG000|Overall Study|Physician Decision|18|||
155200547|NCT00963937|560172446|FG001|Overall Study|Physician Decision|10|||
155200548|NCT00963937|560172447|FG002|Overall Study|Physician Decision|4|||
155200549|NCT00334958|560172448|FG000|Overall Study|Medication Noncompliance|0|||
155200550|NCT00334958|560172449|FG001|Overall Study|Medication Noncompliance|3|||
155200551|NCT00334958|560172448|FG000|Overall Study|Protocol Violation|2|||
155200552|NCT00334958|560172449|FG001|Overall Study|Protocol Violation|2|||
155200553|NCT00334958|560172448|FG000|Overall Study|Request of the investigator or sponsor|0|||
155200554|NCT00334958|560172449|FG001|Overall Study|Request of the investigator or sponsor|1|||
155200555|NCT00334958|560172448|FG000|Overall Study|Withdrawal by Subject|7|||
155200556|NCT00334958|560172449|FG001|Overall Study|Withdrawal by Subject|4|||
155200557|NCT00334958|560172448|FG000|Overall Study|Adverse Event|27|||
155200558|NCT00334958|560172449|FG001|Overall Study|Adverse Event|12|||
155200559|NCT00334958|560172448|FG000|Overall Study|Other|1|||
155200560|NCT00334958|560172449|FG001|Overall Study|Other|2|||
155200561|NCT03988088|560172450|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200562|NCT03988088|560172451|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
155200563|NCT03988088|560172452|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200564|NCT03988088|560172453|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200565|NCT03988088|560172450|FG000|Open-Label Addendum|Lost to Follow-up|0|||
155200566|NCT03988088|560172451|FG001|Open-Label Addendum|Lost to Follow-up|0|||
155200567|NCT03988088|560172452|FG002|Open-Label Addendum|Lost to Follow-up|1|||
155200568|NCT03988088|560172453|FG003|Open-Label Addendum|Lost to Follow-up|0|||
155200569|NCT02935842|560172456|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
155200570|NCT02935842|560172457|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200571|NCT02935842|560172458|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200572|NCT02935842|560172459|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200573|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
155200574|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
155200575|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
155200576|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
155200577|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
155200578|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
155200579|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
155200580|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
155200581|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200582|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200583|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200584|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
155200585|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200586|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200587|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
155200588|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200589|NCT00923156|560172469|FG000|Overall Study|Adverse Event|0|||
155200590|NCT00923156|560172470|FG001|Overall Study|Adverse Event|2|||
155200591|NCT00923156|560172471|FG002|Overall Study|Adverse Event|1|||
155200592|NCT00923156|560172469|FG000|Overall Study|Abnormal laboratory values|0|||
155200593|NCT00923156|560172470|FG001|Overall Study|Abnormal laboratory values|0|||
155200594|NCT00923156|560172471|FG002|Overall Study|Abnormal laboratory values|1|||
155200595|NCT00923156|560172469|FG000|Overall Study|Withdrawal by Subject|0|||
155200596|NCT00923156|560172470|FG001|Overall Study|Withdrawal by Subject|1|||
155200597|NCT00923156|560172471|FG002|Overall Study|Withdrawal by Subject|0|||
155200598|NCT00923156|560172469|FG000|Overall Study|Death|0|||
155200599|NCT00923156|560172470|FG001|Overall Study|Death|1|||
155200600|NCT00923156|560172471|FG002|Overall Study|Death|0|||
155200601|NCT00923156|560172469|FG000|Overall Study|Lack of Efficacy|0|||
155200602|NCT00923156|560172470|FG001|Overall Study|Lack of Efficacy|0|||
155200603|NCT00923156|560172471|FG002|Overall Study|Lack of Efficacy|1|||
155200604|NCT01201850|560172474|FG000|Overall Study|Tumor progression|4|||
155200605|NCT03137537|560172475|FG000|Overall Study|Adverse Event|0|||
155200606|NCT03137537|560172476|FG001|Overall Study|Adverse Event|1|||
155200607|NCT01552694|560172477|FG000|Overall Study|Lost to Follow-up|0|||
155200608|NCT01552694|560172478|FG001|Overall Study|Lost to Follow-up|1|||
155200609|NCT01552694|560172477|FG000|Overall Study|Protocol Violation|0|||
155200610|NCT01552694|560172478|FG001|Overall Study|Protocol Violation|1|||
155200611|NCT00191139|560172480|FG000|Overall Study|Adverse Event|2|||
155200612|NCT00191139|560172481|FG001|Overall Study|Adverse Event|6|||
155200613|NCT00191139|560172480|FG000|Overall Study|Death|2|||
155200614|NCT00191139|560172481|FG001|Overall Study|Death|0|||
155200615|NCT00191139|560172480|FG000|Overall Study|Withdrawal by Subject|0|||
155200616|NCT00191139|560172481|FG001|Overall Study|Withdrawal by Subject|3|||
155200617|NCT00191139|560172480|FG000|Overall Study|Disease Progression|0|||
155200618|NCT00191139|560172481|FG001|Overall Study|Disease Progression|1|||
155200619|NCT00191139|560172480|FG000|Overall Study|Other|1|||
155200620|NCT00191139|560172481|FG001|Overall Study|Other|2|||
155200621|NCT00816595|560172484|FG000|Overall Study|Withdrawal by Subject|2|||
155200622|NCT00816595|560172485|FG001|Overall Study|Withdrawal by Subject|0|||
155200623|NCT00751933|560172486|FG000|Overall Study|Withdrawal by Subject|0|||
155200624|NCT00751933|560172487|FG001|Overall Study|Withdrawal by Subject|1|||
155200625|NCT00751933|560172488|FG002|Overall Study|Withdrawal by Subject|0|||
155200626|NCT00751933|560172489|FG003|Overall Study|Withdrawal by Subject|0|||
155200627|NCT00751933|560172486|FG000|Overall Study|Physician Decision|0|||
155200628|NCT00751933|560172487|FG001|Overall Study|Physician Decision|0|||
155200629|NCT00751933|560172488|FG002|Overall Study|Physician Decision|1|||
155200630|NCT00751933|560172489|FG003|Overall Study|Physician Decision|1|||
155200631|NCT01817530|560172490|FG000|Overall Study|Exclusionary Medication Received|0|||
155200632|NCT01817530|560172491|FG001|Overall Study|Exclusionary Medication Received|0|||
155200633|NCT01817530|560172492|FG002|Overall Study|Exclusionary Medication Received|0|||
155200634|NCT01817530|560172493|FG003|Overall Study|Exclusionary Medication Received|0|||
155200635|NCT01817530|560172494|FG004|Overall Study|Exclusionary Medication Received|1|||
155200636|NCT01817530|560172495|FG005|Overall Study|Exclusionary Medication Received|0|||
155200637|NCT01817530|560172496|FG006|Overall Study|Exclusionary Medication Received|0|||
155200638|NCT01817530|560172497|FG007|Overall Study|Exclusionary Medication Received|0|||
155200639|NCT01817530|560172490|FG000|Overall Study|Adverse Event|6|||
155200640|NCT01817530|560172491|FG001|Overall Study|Adverse Event|3|||
155200641|NCT01817530|560172492|FG002|Overall Study|Adverse Event|2|||
155200642|NCT01817530|560172493|FG003|Overall Study|Adverse Event|5|||
155200643|NCT01817530|560172494|FG004|Overall Study|Adverse Event|0|||
155200644|NCT01817530|560172495|FG005|Overall Study|Adverse Event|10|||
155200645|NCT01817530|560172496|FG006|Overall Study|Adverse Event|5|||
155200646|NCT01817530|560172497|FG007|Overall Study|Adverse Event|8|||
155200647|NCT01817530|560172490|FG000|Overall Study|Subject Noncompliant|3|||
155200648|NCT01817530|560172491|FG001|Overall Study|Subject Noncompliant|1|||
155200649|NCT01817530|560172492|FG002|Overall Study|Subject Noncompliant|0|||
155200650|NCT01817530|560172493|FG003|Overall Study|Subject Noncompliant|4|||
155200651|NCT01817530|560172494|FG004|Overall Study|Subject Noncompliant|0|||
155200652|NCT01817530|560172495|FG005|Overall Study|Subject Noncompliant|1|||
155200653|NCT01817530|560172496|FG006|Overall Study|Subject Noncompliant|1|||
155200654|NCT01817530|560172497|FG007|Overall Study|Subject Noncompliant|1|||
155200655|NCT01817530|560172490|FG000|Overall Study|Lack of Efficacy|1|||
155200656|NCT01817530|560172491|FG001|Overall Study|Lack of Efficacy|0|||
155200657|NCT01817530|560172492|FG002|Overall Study|Lack of Efficacy|0|||
155200658|NCT01817530|560172493|FG003|Overall Study|Lack of Efficacy|0|||
155200659|NCT01817530|560172494|FG004|Overall Study|Lack of Efficacy|0|||
155200660|NCT01817530|560172495|FG005|Overall Study|Lack of Efficacy|1|||
155200661|NCT01817530|560172496|FG006|Overall Study|Lack of Efficacy|0|||
155200662|NCT01817530|560172497|FG007|Overall Study|Lack of Efficacy|1|||
155200663|NCT01817530|560172490|FG000|Overall Study|Pregnancy|0|||
155200664|NCT01817530|560172491|FG001|Overall Study|Pregnancy|0|||
155200665|NCT01817530|560172492|FG002|Overall Study|Pregnancy|0|||
155200666|NCT01817530|560172493|FG003|Overall Study|Pregnancy|0|||
155200667|NCT01817530|560172494|FG004|Overall Study|Pregnancy|0|||
155200668|NCT01817530|560172495|FG005|Overall Study|Pregnancy|1|||
155200669|NCT01817530|560172496|FG006|Overall Study|Pregnancy|0|||
155200670|NCT01817530|560172497|FG007|Overall Study|Pregnancy|0|||
155200671|NCT01817530|560172490|FG000|Overall Study|Other|0|||
155200672|NCT01817530|560172491|FG001|Overall Study|Other|1|||
155200673|NCT01817530|560172492|FG002|Overall Study|Other|0|||
155200674|NCT01817530|560172493|FG003|Overall Study|Other|0|||
155200675|NCT01817530|560172494|FG004|Overall Study|Other|1|||
155200676|NCT01817530|560172495|FG005|Overall Study|Other|0|||
155491239|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Disease Progression|1|||
155200677|NCT01817530|560172496|FG006|Overall Study|Other|5|||
155200678|NCT01817530|560172497|FG007|Overall Study|Other|0|||
155200679|NCT01817530|560172490|FG000|Overall Study|Surgery or Invasive Intervention|1|||
155200680|NCT01817530|560172491|FG001|Overall Study|Surgery or Invasive Intervention|0|||
155200681|NCT01817530|560172492|FG002|Overall Study|Surgery or Invasive Intervention|0|||
155200682|NCT01817530|560172493|FG003|Overall Study|Surgery or Invasive Intervention|0|||
155200683|NCT01817530|560172494|FG004|Overall Study|Surgery or Invasive Intervention|1|||
155200684|NCT01817530|560172495|FG005|Overall Study|Surgery or Invasive Intervention|1|||
155200685|NCT01817530|560172496|FG006|Overall Study|Surgery or Invasive Intervention|1|||
155200686|NCT01817530|560172497|FG007|Overall Study|Surgery or Invasive Intervention|0|||
155200687|NCT01817530|560172490|FG000|Overall Study|Consent Withdrawn by Subject|3|||
155200688|NCT01817530|560172491|FG001|Overall Study|Consent Withdrawn by Subject|4|||
155200689|NCT01817530|560172492|FG002|Overall Study|Consent Withdrawn by Subject|7|||
155200690|NCT01817530|560172493|FG003|Overall Study|Consent Withdrawn by Subject|3|||
155200691|NCT01817530|560172494|FG004|Overall Study|Consent Withdrawn by Subject|5|||
155200692|NCT01817530|560172495|FG005|Overall Study|Consent Withdrawn by Subject|3|||
155200693|NCT01817530|560172496|FG006|Overall Study|Consent Withdrawn by Subject|3|||
155200694|NCT01817530|560172497|FG007|Overall Study|Consent Withdrawn by Subject|10|||
155200695|NCT01817530|560172490|FG000|Overall Study|Lost to Follow-up|1|||
155200696|NCT01817530|560172491|FG001|Overall Study|Lost to Follow-up|4|||
155200697|NCT01817530|560172492|FG002|Overall Study|Lost to Follow-up|2|||
155200698|NCT01817530|560172493|FG003|Overall Study|Lost to Follow-up|1|||
155200699|NCT01817530|560172494|FG004|Overall Study|Lost to Follow-up|3|||
155200700|NCT01817530|560172495|FG005|Overall Study|Lost to Follow-up|2|||
155200701|NCT01817530|560172496|FG006|Overall Study|Lost to Follow-up|8|||
155200702|NCT01817530|560172497|FG007|Overall Study|Lost to Follow-up|4|||
155200703|NCT03846804|560172498|FG000|Overall Study|Refused blood draw|1|||
155200704|NCT03846804|560172498|FG000|Overall Study|Protocol Violation|1|||
155200705|NCT00566995|560172499|FG000|Overall Study|Toxicity|4|||
155200706|NCT00566995|560172499|FG000|Overall Study|Withdrew consent|3|||
155200707|NCT00679432|560172500|FG000|Overall Study|Adverse Event|5|||
155200708|NCT00679432|560172501|FG001|Overall Study|Adverse Event|6|||
155200709|NCT00679432|560172502|FG002|Overall Study|Adverse Event|10|||
155200710|NCT00679432|560172503|FG003|Overall Study|Adverse Event|7|||
155200711|NCT00679432|560172500|FG000|Overall Study|Protocol Violation|1|||
155200712|NCT00679432|560172501|FG001|Overall Study|Protocol Violation|1|||
155200713|NCT00679432|560172502|FG002|Overall Study|Protocol Violation|2|||
155200714|NCT00679432|560172503|FG003|Overall Study|Protocol Violation|1|||
155200715|NCT00679432|560172500|FG000|Overall Study|Withdrawal by Subject|8|||
155200716|NCT00679432|560172501|FG001|Overall Study|Withdrawal by Subject|11|||
155200717|NCT00679432|560172502|FG002|Overall Study|Withdrawal by Subject|10|||
155200718|NCT00679432|560172503|FG003|Overall Study|Withdrawal by Subject|9|||
155200719|NCT00679432|560172500|FG000|Overall Study|Lost to Follow-up|1|||
155200720|NCT00679432|560172501|FG001|Overall Study|Lost to Follow-up|5|||
155200721|NCT00679432|560172502|FG002|Overall Study|Lost to Follow-up|4|||
155200722|NCT00679432|560172503|FG003|Overall Study|Lost to Follow-up|2|||
155200723|NCT00679432|560172500|FG000|Overall Study|Physician Decision|3|||
155200724|NCT00679432|560172501|FG001|Overall Study|Physician Decision|2|||
155200725|NCT00679432|560172502|FG002|Overall Study|Physician Decision|2|||
155200726|NCT00679432|560172503|FG003|Overall Study|Physician Decision|2|||
155200727|NCT00679432|560172500|FG000|Overall Study|Sponsor decision|1|||
155200728|NCT00679432|560172501|FG001|Overall Study|Sponsor decision|0|||
155200729|NCT00679432|560172502|FG002|Overall Study|Sponsor decision|0|||
155200730|NCT00679432|560172503|FG003|Overall Study|Sponsor decision|0|||
155200731|NCT00679432|560172500|FG000|Overall Study|Lack of Efficacy|13|||
155200732|NCT00679432|560172501|FG001|Overall Study|Lack of Efficacy|9|||
155200733|NCT00679432|560172502|FG002|Overall Study|Lack of Efficacy|14|||
155200734|NCT00679432|560172503|FG003|Overall Study|Lack of Efficacy|8|||
155200735|NCT00679432|560172500|FG000|Overall Study|Infectious colitis, normal histology|5|||
155200736|NCT00679432|560172501|FG001|Overall Study|Infectious colitis, normal histology|4|||
155200737|NCT00679432|560172502|FG002|Overall Study|Infectious colitis, normal histology|8|||
155200738|NCT00679432|560172503|FG003|Overall Study|Infectious colitis, normal histology|3|||
155200739|NCT00679432|560172500|FG000|Overall Study|Randomization error, return to prior Rx|0|||
155200740|NCT00679432|560172501|FG001|Overall Study|Randomization error, return to prior Rx|0|||
155200741|NCT00679432|560172502|FG002|Overall Study|Randomization error, return to prior Rx|3|||
155200742|NCT00679432|560172503|FG003|Overall Study|Randomization error, return to prior Rx|0|||
155200743|NCT00824720|560172504|FG000|Overall Study|failed plug insertion|3|||
155200744|NCT00824720|560172505|FG001|Overall Study|failed plug insertion|1|||
155200745|NCT00824720|560172506|FG002|Overall Study|failed plug insertion|0|||
155200746|NCT00824720|560172504|FG000|Overall Study|Protocol Violation|0|||
155200747|NCT00824720|560172505|FG001|Overall Study|Protocol Violation|0|||
155200748|NCT00824720|560172506|FG002|Overall Study|Protocol Violation|1|||
155200749|NCT01558271|560172507|FG000|Overall Study|Adverse Event|6|||
155200750|NCT01558271|560172508|FG001|Overall Study|Adverse Event|3|||
155200751|NCT01558271|560172509|FG002|Overall Study|Adverse Event|4|||
155200752|NCT01558271|560172507|FG000|Overall Study|Lost to Follow-up|1|||
155200753|NCT01558271|560172508|FG001|Overall Study|Lost to Follow-up|0|||
155200754|NCT01558271|560172509|FG002|Overall Study|Lost to Follow-up|0|||
155200755|NCT01558271|560172507|FG000|Overall Study|Protocol Violation|1|||
155200756|NCT01558271|560172508|FG001|Overall Study|Protocol Violation|0|||
155200757|NCT01558271|560172509|FG002|Overall Study|Protocol Violation|0|||
155200758|NCT01558271|560172507|FG000|Overall Study|Withdrawal by Subject|10|||
155200759|NCT01558271|560172508|FG001|Overall Study|Withdrawal by Subject|6|||
155200760|NCT01558271|560172509|FG002|Overall Study|Withdrawal by Subject|12|||
155200761|NCT01558271|560172507|FG000|Overall Study|Physician Decision|0|||
155200762|NCT01558271|560172508|FG001|Overall Study|Physician Decision|2|||
155200763|NCT01558271|560172509|FG002|Overall Study|Physician Decision|1|||
155200764|NCT02339584|560172510|FG000|Overall Study|Adverse Event|11|||
155200765|NCT02339584|560172511|FG001|Overall Study|Adverse Event|7|||
155200766|NCT02339584|560172510|FG000|Overall Study|Lack of Efficacy|0|||
155200767|NCT02339584|560172511|FG001|Overall Study|Lack of Efficacy|1|||
155200768|NCT02339584|560172510|FG000|Overall Study|Physician Decision|1|||
155200769|NCT02339584|560172511|FG001|Overall Study|Physician Decision|2|||
155200770|NCT02339584|560172510|FG000|Overall Study|Protocol Violation|1|||
155200771|NCT02339584|560172511|FG001|Overall Study|Protocol Violation|1|||
155200772|NCT02339584|560172510|FG000|Overall Study|Withdrawal by Subject|2|||
155200773|NCT02339584|560172511|FG001|Overall Study|Withdrawal by Subject|4|||
155200774|NCT02610725|560172512|FG000|Overall Study|Lost to Follow-up|197|||
155200775|NCT02610725|560172512|FG000|Overall Study|self-reported contraindication|9|||
155200776|NCT04094883|560172513|FG000|Overall Study|Withdrawal by Subject|1|||
155200777|NCT01084083|560172514|FG000|Overall Study|Adverse Event|5|||
155200778|NCT01084083|560172514|FG000|Overall Study|Death|1|||
155200779|NCT01084083|560172514|FG000|Overall Study|Withdrawal by Subject|2|||
155200780|NCT01084083|560172514|FG000|Overall Study|Complicating disease|1|||
155200781|NCT01084083|560172514|FG000|Overall Study|Other|2|||
155200782|NCT01084083|560172514|FG000|Overall Study|Never started assigned therapy|1|||
155200783|NCT00228384|560172515|FG000|Overall Study|Death|9|||
155200784|NCT00228384|560172516|FG001|Overall Study|Death|3|||
155200785|NCT00228384|560172515|FG000|Overall Study|Lost to Follow-up|6|||
155200786|NCT00228384|560172516|FG001|Overall Study|Lost to Follow-up|10|||
155200787|NCT00228384|560172515|FG000|Overall Study|Surgical Intervention (bypass)|5|||
155200788|NCT00228384|560172516|FG001|Overall Study|Surgical Intervention (bypass)|5|||
155200789|NCT00228384|560172515|FG000|Overall Study|Withdrawal by Subject|9|||
155200790|NCT00228384|560172516|FG001|Overall Study|Withdrawal by Subject|10|||
155200791|NCT00228384|560172515|FG000|Overall Study|Physician Decision|0|||
155200792|NCT00228384|560172516|FG001|Overall Study|Physician Decision|1|||
155200793|NCT01466153|560172520|FG000|Overall Study|Disease Progression|2|||
155200794|NCT01466153|560172521|FG001|Overall Study|Disease Progression|2|||
155200795|NCT01466153|560172522|FG002|Overall Study|Disease Progression|0|||
155200796|NCT01466153|560172520|FG000|Overall Study|Adverse Event|14|||
155200797|NCT01466153|560172521|FG001|Overall Study|Adverse Event|13|||
155200798|NCT01466153|560172522|FG002|Overall Study|Adverse Event|17|||
155200799|NCT01466153|560172520|FG000|Overall Study|Withdrawal of Consent|2|||
155200800|NCT01466153|560172521|FG001|Overall Study|Withdrawal of Consent|0|||
155200801|NCT01466153|560172522|FG002|Overall Study|Withdrawal of Consent|0|||
155200802|NCT01466153|560172520|FG000|Overall Study|Investigator Discretion|3|||
155200803|NCT01466153|560172521|FG001|Overall Study|Investigator Discretion|2|||
155200804|NCT01466153|560172522|FG002|Overall Study|Investigator Discretion|2|||
155200805|NCT01466153|560172520|FG000|Overall Study|Randomized-Not Treated|2|||
155200806|NCT01466153|560172521|FG001|Overall Study|Randomized-Not Treated|3|||
155200807|NCT01466153|560172522|FG002|Overall Study|Randomized-Not Treated|4|||
155200808|NCT01466153|560172520|FG000|Overall Study|Other-Unspecified|6|||
155200809|NCT01466153|560172521|FG001|Overall Study|Other-Unspecified|4|||
155200810|NCT01466153|560172522|FG002|Overall Study|Other-Unspecified|2|||
155200811|NCT05695209|560172523|FG000|3-months|Withdrawal by Subject|2|||
155200812|NCT05695209|560172524|FG001|3-months|Withdrawal by Subject|0|||
155200813|NCT05695209|560172523|FG000|3-months|Unable to contact for 3-month data collection|0|||
155200814|NCT05695209|560172524|FG001|3-months|Unable to contact for 3-month data collection|1|||
155200815|NCT05695209|560172523|FG000|6-months|Lost to Follow-up|1|||
155200816|NCT05695209|560172524|FG001|6-months|Lost to Follow-up|1|||
155200817|NCT04362072|560172527|FG000|Treatment|Adverse Event|1|||
155200818|NCT04362072|560172527|FG000|Treatment|Death|9|||
155200819|NCT04362072|560172527|FG000|Treatment|Physician Decision|2|||
155200820|NCT04362072|560172527|FG000|Treatment|Progressive disease|27|||
155200821|NCT04362072|560172527|FG000|Treatment|Withdrawal by Subject|4|||
155200822|NCT04362072|560172527|FG000|Treatment|Global deterioration of health status|1|||
155200823|NCT04362072|560172527|FG000|Treatment|Switched to commercial Lorlatinib|13|||
155200824|NCT04362072|560172527|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
155200825|NCT04362072|560172527|FG000|Treatment|Other|3|||
155200826|NCT04362072|560172527|FG000|Follow up|Death|2|||
155200827|NCT04362072|560172527|FG000|Follow up|Other|2|||
155200828|NCT01133522|560172528|FG000|Overall Study|Withdrawal by Subject|0|||
155200829|NCT01133522|560172529|FG001|Overall Study|Withdrawal by Subject|1|||
155200830|NCT01133522|560172530|FG002|Overall Study|Withdrawal by Subject|0|||
155200831|NCT01133522|560172531|FG003|Overall Study|Withdrawal by Subject|1|||
155200832|NCT01133522|560172532|FG004|Overall Study|Withdrawal by Subject|0|||
155200833|NCT01133522|560172533|FG005|Overall Study|Withdrawal by Subject|0|||
155200834|NCT01133522|560172534|FG006|Overall Study|Withdrawal by Subject|0|||
155200835|NCT01133522|560172535|FG007|Overall Study|Withdrawal by Subject|0|||
155200836|NCT01133522|560172536|FG008|Overall Study|Withdrawal by Subject|0|||
155200837|NCT01133522|560172537|FG009|Overall Study|Withdrawal by Subject|0|||
155200838|NCT01133522|560172528|FG000|Overall Study|Physician Decision|0|||
155200839|NCT01133522|560172529|FG001|Overall Study|Physician Decision|0|||
155200840|NCT01133522|560172530|FG002|Overall Study|Physician Decision|0|||
155200841|NCT01133522|560172531|FG003|Overall Study|Physician Decision|0|||
155200842|NCT01133522|560172532|FG004|Overall Study|Physician Decision|1|||
155200843|NCT01133522|560172533|FG005|Overall Study|Physician Decision|0|||
155200844|NCT01133522|560172534|FG006|Overall Study|Physician Decision|0|||
155200845|NCT01133522|560172535|FG007|Overall Study|Physician Decision|0|||
155200846|NCT01133522|560172536|FG008|Overall Study|Physician Decision|0|||
155200847|NCT01133522|560172537|FG009|Overall Study|Physician Decision|0|||
155200848|NCT04731363|560172543|FG000|Overall Study|Could not obtain samples|0|||
155200849|NCT04731363|560172544|FG001|Overall Study|Could not obtain samples|1|||
155200850|NCT04731363|560172545|FG002|Overall Study|Could not obtain samples|0|||
155200851|NCT04731363|560172546|FG003|Overall Study|Could not obtain samples|0|||
155200852|NCT04731363|560172543|FG000|Overall Study|Physician Decision|0|||
155200853|NCT04731363|560172544|FG001|Overall Study|Physician Decision|1|||
155200854|NCT04731363|560172545|FG002|Overall Study|Physician Decision|0|||
155200855|NCT04731363|560172546|FG003|Overall Study|Physician Decision|0|||
155200856|NCT01918774|560174553|FG000|Overall Study|Lost prior to first CBTw session|4|||
155200857|NCT01918774|560174553|FG000|Overall Study|Lost to Follow-up|1|||
155200858|NCT01606800|560174554|FG000|Overall Study|Adverse Event|3|||
155200859|NCT01606800|560174555|FG001|Overall Study|Adverse Event|1|||
155200860|NCT01606800|560174554|FG000|Overall Study|Participant withdrew consent|0|||
155200861|NCT01606800|560174555|FG001|Overall Study|Participant withdrew consent|1|||
155200862|NCT01606800|560174554|FG000|Overall Study|Missing completion status|2|||
155200863|NCT01606800|560174555|FG001|Overall Study|Missing completion status|0|||
155200864|NCT00717197|560174561|FG000|Overall Study|Unable to purchase study drug|5|||
155200865|NCT00717197|560174561|FG000|Overall Study|Tumor Progression|1|||
155200866|NCT00717197|560174561|FG000|Overall Study|Physician Decision|1|||
155200867|NCT00982137|560174562|FG000|Overall Study|Lost to Follow-up|0|||
155200868|NCT00982137|560174563|FG001|Overall Study|Lost to Follow-up|0|||
155200869|NCT00982137|560174564|FG002|Overall Study|Lost to Follow-up|0|||
155200870|NCT00982137|560174565|FG003|Overall Study|Lost to Follow-up|1|||
155200871|NCT00982137|560174562|FG000|Overall Study|Withdrawal by Subject|0|||
155200872|NCT00982137|560174563|FG001|Overall Study|Withdrawal by Subject|1|||
155200873|NCT00982137|560174564|FG002|Overall Study|Withdrawal by Subject|0|||
155200874|NCT00982137|560174565|FG003|Overall Study|Withdrawal by Subject|0|||
155200875|NCT01898806|560174568|FG000|Overall Study|Withdrawal by Subject|2|||
155200876|NCT01898806|560174568|FG000|Overall Study|Physician Decision|1|||
155200877|NCT03003390|560174569|FG000|Overall Study|Physician Decision|2|||
155200878|NCT03003390|560174570|FG001|Overall Study|Physician Decision|0|||
155200879|NCT03003390|560174569|FG000|Overall Study|Parent refused intervention|2|||
155200880|NCT03003390|560174570|FG001|Overall Study|Parent refused intervention|0|||
155200881|NCT03000439|560174589|FG000|Open Label Part 1|Adverse Event|6|||
155200882|NCT03000439|560174590|FG001|Open Label Part 1|Adverse Event|0|||
155200883|NCT03000439|560174591|FG002|Open Label Part 1|Adverse Event|0|||
155200884|NCT03000439|560174592|FG003|Open Label Part 1|Adverse Event|0|||
155200885|NCT03000439|560174589|FG000|Open Label Part 1|Other|2|||
155200886|NCT03000439|560174590|FG001|Open Label Part 1|Other|0|||
155200887|NCT03000439|560174591|FG002|Open Label Part 1|Other|0|||
155200888|NCT03000439|560174592|FG003|Open Label Part 1|Other|0|||
155200889|NCT03000439|560174589|FG000|Open Label Part 1|Insufficient clinical response|16|||
155200890|NCT03000439|560174590|FG001|Open Label Part 1|Insufficient clinical response|0|||
155200891|NCT03000439|560174591|FG002|Open Label Part 1|Insufficient clinical response|0|||
155200892|NCT03000439|560174592|FG003|Open Label Part 1|Insufficient clinical response|0|||
155200893|NCT03000439|560174589|FG000|Open Label Part 2|Other|0|||
155200894|NCT03000439|560174590|FG001|Open Label Part 2|Other|5|||
155200895|NCT03000439|560174591|FG002|Open Label Part 2|Other|0|||
155200896|NCT03000439|560174592|FG003|Open Label Part 2|Other|0|||
155200897|NCT03000439|560174589|FG000|Open Label Part 2|Insufficient clinical response|0|||
155200898|NCT03000439|560174590|FG001|Open Label Part 2|Insufficient clinical response|12|||
155200899|NCT03000439|560174591|FG002|Open Label Part 2|Insufficient clinical response|0|||
155200900|NCT03000439|560174592|FG003|Open Label Part 2|Insufficient clinical response|0|||
155200901|NCT03000439|560174589|FG000|Double Blind Phase|Adverse Event|0|||
155200902|NCT03000439|560174590|FG001|Double Blind Phase|Adverse Event|0|||
155200903|NCT03000439|560174591|FG002|Double Blind Phase|Adverse Event|2|||
155200904|NCT03000439|560174592|FG003|Double Blind Phase|Adverse Event|1|||
155200905|NCT03000439|560174589|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200906|NCT03000439|560174590|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200907|NCT03000439|560174591|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
155200908|NCT03000439|560174592|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200909|NCT03000439|560174589|FG000|Double Blind Phase|Other|0|||
155200910|NCT03000439|560174590|FG001|Double Blind Phase|Other|0|||
155200911|NCT03000439|560174591|FG002|Double Blind Phase|Other|10|||
155200912|NCT03000439|560174592|FG003|Double Blind Phase|Other|11|||
155200913|NCT03000439|560174589|FG000|Double Blind Phase|Insufficient clinical response|0|||
155200914|NCT03000439|560174590|FG001|Double Blind Phase|Insufficient clinical response|0|||
155200915|NCT03000439|560174591|FG002|Double Blind Phase|Insufficient clinical response|0|||
155200916|NCT03000439|560174592|FG003|Double Blind Phase|Insufficient clinical response|2|||
155200917|NCT02370160|560174593|FG000|Overall Study|Death|3|||
155200918|NCT02370160|560174594|FG001|Overall Study|Death|4|||
155200919|NCT02370160|560174595|FG002|Overall Study|Death|1|||
155200920|NCT02501473|560174598|FG000|Overall Study|Study Terminated|2|||
155200921|NCT02501473|560174599|FG001|Overall Study|Study Terminated|3|||
155200922|NCT02501473|560174600|FG002|Overall Study|Study Terminated|7|||
155200923|NCT02501473|560174601|FG003|Overall Study|Study Terminated|9|||
155200924|NCT02501473|560174602|FG004|Overall Study|Study Terminated|2|||
155200925|NCT02501473|560174603|FG005|Overall Study|Study Terminated|10|||
155200926|NCT02501473|560174604|FG006|Overall Study|Study Terminated|1|||
155200927|NCT02501473|560174605|FG007|Overall Study|Study Terminated|0|||
155200928|NCT02501473|560174598|FG000|Overall Study|Withdrawal by Subject|0|||
155200929|NCT02501473|560174599|FG001|Overall Study|Withdrawal by Subject|0|||
155200930|NCT02501473|560174600|FG002|Overall Study|Withdrawal by Subject|3|||
155200931|NCT02501473|560174601|FG003|Overall Study|Withdrawal by Subject|3|||
155200932|NCT02501473|560174602|FG004|Overall Study|Withdrawal by Subject|2|||
155200933|NCT02501473|560174603|FG005|Overall Study|Withdrawal by Subject|2|||
155200934|NCT02501473|560174604|FG006|Overall Study|Withdrawal by Subject|0|||
155200935|NCT02501473|560174605|FG007|Overall Study|Withdrawal by Subject|0|||
155200936|NCT02501473|560174598|FG000|Overall Study|Death|0|||
155200937|NCT02501473|560174599|FG001|Overall Study|Death|0|||
155200938|NCT02501473|560174600|FG002|Overall Study|Death|1|||
155200939|NCT02501473|560174601|FG003|Overall Study|Death|1|||
155200940|NCT02501473|560174602|FG004|Overall Study|Death|0|||
155200941|NCT02501473|560174603|FG005|Overall Study|Death|1|||
155200942|NCT02501473|560174604|FG006|Overall Study|Death|0|||
155200943|NCT02501473|560174605|FG007|Overall Study|Death|0|||
155200944|NCT02501473|560174598|FG000|Overall Study|Lost to Follow-up|1|||
155200945|NCT02501473|560174599|FG001|Overall Study|Lost to Follow-up|0|||
155200946|NCT02501473|560174600|FG002|Overall Study|Lost to Follow-up|1|||
155200947|NCT02501473|560174601|FG003|Overall Study|Lost to Follow-up|0|||
155200948|NCT02501473|560174602|FG004|Overall Study|Lost to Follow-up|0|||
155200949|NCT02501473|560174603|FG005|Overall Study|Lost to Follow-up|1|||
155200950|NCT02501473|560174604|FG006|Overall Study|Lost to Follow-up|0|||
155200951|NCT02501473|560174605|FG007|Overall Study|Lost to Follow-up|0|||
155200952|NCT02501473|560174598|FG000|Overall Study|Reason not specified|0|||
155200953|NCT02501473|560174599|FG001|Overall Study|Reason not specified|0|||
155200954|NCT02501473|560174600|FG002|Overall Study|Reason not specified|1|||
155200955|NCT02501473|560174601|FG003|Overall Study|Reason not specified|1|||
155200956|NCT02501473|560174602|FG004|Overall Study|Reason not specified|0|||
155200957|NCT02501473|560174603|FG005|Overall Study|Reason not specified|0|||
155200958|NCT02501473|560174604|FG006|Overall Study|Reason not specified|0|||
155200959|NCT02501473|560174605|FG007|Overall Study|Reason not specified|0|||
155200960|NCT01581931|560174606|FG000|Washout|Adverse Event|0|||
155200961|NCT01581931|560174607|FG001|Washout|Adverse Event|1|||
155200962|NCT02954237|560174612|FG000|Overall Study|Withdrawal by Subject|25|||
155200963|NCT02954237|560174612|FG000|Overall Study|Missed visit|16|||
155200964|NCT02954237|560174612|FG000|Overall Study|Death|2|||
155200965|NCT00674700|560174613|FG000|Year 1|Adverse Event|17|||
155200966|NCT00674700|560174614|FG001|Year 1|Adverse Event|20|||
155200967|NCT00674700|560174615|FG002|Year 1|Adverse Event|5|||
155200968|NCT00674700|560174613|FG000|Year 1|Withdrawal by Subject|7|||
155200969|NCT00674700|560174614|FG001|Year 1|Withdrawal by Subject|7|||
155200970|NCT00674700|560174615|FG002|Year 1|Withdrawal by Subject|6|||
155200971|NCT00674700|560174613|FG000|Year 1|Any other reason not above-mentioned|7|||
155200972|NCT00674700|560174614|FG001|Year 1|Any other reason not above-mentioned|7|||
155200973|NCT00674700|560174615|FG002|Year 1|Any other reason not above-mentioned|6|||
155200974|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
155200975|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
155200976|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
155200977|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
155200978|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
155200979|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
155200980|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
155200981|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
155200982|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
155200983|NCT00395304|560174616|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155200984|NCT00395304|560174617|FG001|Treatment Period 1|Withdrawal by Subject|3|||
155200985|NCT00395304|560174618|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155200986|NCT00395304|560174619|FG003|Treatment Period 1|Withdrawal by Subject|2|||
155200987|NCT00395304|560174620|FG004|Treatment Period 1|Withdrawal by Subject|1|||
155200988|NCT00395304|560174621|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155200989|NCT00395304|560174616|FG000|Treatment Period 1|Lost to Follow-up|1|||
155200990|NCT00395304|560174617|FG001|Treatment Period 1|Lost to Follow-up|0|||
155200991|NCT00395304|560174618|FG002|Treatment Period 1|Lost to Follow-up|0|||
155200992|NCT00395304|560174619|FG003|Treatment Period 1|Lost to Follow-up|1|||
155200993|NCT00395304|560174620|FG004|Treatment Period 1|Lost to Follow-up|0|||
155200994|NCT00395304|560174621|FG005|Treatment Period 1|Lost to Follow-up|1|||
155200995|NCT00395304|560174616|FG000|Treatment Period 1|Physician Decision|0|||
155200996|NCT00395304|560174617|FG001|Treatment Period 1|Physician Decision|1|||
155200997|NCT00395304|560174618|FG002|Treatment Period 1|Physician Decision|0|||
155200998|NCT00395304|560174619|FG003|Treatment Period 1|Physician Decision|0|||
155200999|NCT00395304|560174620|FG004|Treatment Period 1|Physician Decision|0|||
155201000|NCT00395304|560174621|FG005|Treatment Period 1|Physician Decision|0|||
155201001|NCT00395304|560174616|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155201002|NCT00395304|560174617|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155201003|NCT00395304|560174618|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155201004|NCT00395304|560174619|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155201005|NCT00395304|560174620|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155201006|NCT00395304|560174621|FG005|Treatment Period 2|Withdrawal by Subject|2|||
155201007|NCT00395304|560174616|FG000|Treatment Period 2|Lost to Follow-up|0|||
155201008|NCT00395304|560174617|FG001|Treatment Period 2|Lost to Follow-up|3|||
155201009|NCT00395304|560174618|FG002|Treatment Period 2|Lost to Follow-up|0|||
155201010|NCT00395304|560174619|FG003|Treatment Period 2|Lost to Follow-up|0|||
155201011|NCT00395304|560174620|FG004|Treatment Period 2|Lost to Follow-up|0|||
155201012|NCT00395304|560174621|FG005|Treatment Period 2|Lost to Follow-up|0|||
155201013|NCT00395304|560174616|FG000|Treatment Period 2|Physician Decision|0|||
155201014|NCT00395304|560174617|FG001|Treatment Period 2|Physician Decision|0|||
155201015|NCT00395304|560174618|FG002|Treatment Period 2|Physician Decision|1|||
155201016|NCT00395304|560174619|FG003|Treatment Period 2|Physician Decision|0|||
155201017|NCT00395304|560174620|FG004|Treatment Period 2|Physician Decision|0|||
155201018|NCT00395304|560174621|FG005|Treatment Period 2|Physician Decision|0|||
155201019|NCT00395304|560174616|FG000|Treatment Period 2|Other|0|||
155201020|NCT00395304|560174617|FG001|Treatment Period 2|Other|1|||
155201021|NCT00395304|560174618|FG002|Treatment Period 2|Other|0|||
155201022|NCT00395304|560174619|FG003|Treatment Period 2|Other|0|||
155201023|NCT00395304|560174620|FG004|Treatment Period 2|Other|0|||
155201024|NCT00395304|560174621|FG005|Treatment Period 2|Other|0|||
155201025|NCT00395304|560174616|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155201026|NCT00395304|560174617|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155201027|NCT00395304|560174618|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155201028|NCT00395304|560174619|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155201029|NCT00395304|560174620|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155201030|NCT00395304|560174621|FG005|Treatment Period 3|Withdrawal by Subject|1|||
155201031|NCT00395304|560174616|FG000|Treatment Period 3|Lost to Follow-up|1|||
155201032|NCT00395304|560174617|FG001|Treatment Period 3|Lost to Follow-up|1|||
155201033|NCT00395304|560174618|FG002|Treatment Period 3|Lost to Follow-up|0|||
155201034|NCT00395304|560174619|FG003|Treatment Period 3|Lost to Follow-up|0|||
155201035|NCT00395304|560174620|FG004|Treatment Period 3|Lost to Follow-up|0|||
155201036|NCT00395304|560174621|FG005|Treatment Period 3|Lost to Follow-up|0|||
155201037|NCT00395304|560174616|FG000|Treatment Period 3|Physician Decision|0|||
155201038|NCT00395304|560174617|FG001|Treatment Period 3|Physician Decision|1|||
155201039|NCT00395304|560174618|FG002|Treatment Period 3|Physician Decision|0|||
155201040|NCT00395304|560174619|FG003|Treatment Period 3|Physician Decision|0|||
155201041|NCT00395304|560174620|FG004|Treatment Period 3|Physician Decision|0|||
155201042|NCT00395304|560174621|FG005|Treatment Period 3|Physician Decision|0|||
155201043|NCT00395304|560174616|FG000|Treatment Period 3|Other|0|||
155201044|NCT00395304|560174617|FG001|Treatment Period 3|Other|0|||
155201045|NCT00395304|560174618|FG002|Treatment Period 3|Other|0|||
155201046|NCT00395304|560174619|FG003|Treatment Period 3|Other|1|||
155201047|NCT00395304|560174620|FG004|Treatment Period 3|Other|0|||
155201048|NCT00395304|560174621|FG005|Treatment Period 3|Other|0|||
155201049|NCT03130257|560174622|FG000|Overall Study|Withdrawal by Subject|1|||
155201050|NCT03130257|560174623|FG001|Overall Study|Withdrawal by Subject|0|||
155201051|NCT03130257|560174624|FG002|Overall Study|Withdrawal by Subject|2|||
155201052|NCT03600818|560174625|FG000|Overall Study|Adverse Event|4|||
155201053|NCT03600818|560174626|FG001|Overall Study|Adverse Event|7|||
155201054|NCT03600818|560174625|FG000|Overall Study|Lack of Efficacy|9|||
155201055|NCT03600818|560174626|FG001|Overall Study|Lack of Efficacy|4|||
155201056|NCT03600818|560174625|FG000|Overall Study|Withdrawal by Subject|4|||
155201057|NCT03600818|560174626|FG001|Overall Study|Withdrawal by Subject|3|||
155201058|NCT03600818|560174625|FG000|Overall Study|Other-unspecified|5|||
155201059|NCT03600818|560174626|FG001|Overall Study|Other-unspecified|3|||
155201060|NCT03600818|560174625|FG000|Overall Study|Randomized and not treated|0|||
155201061|NCT03600818|560174626|FG001|Overall Study|Randomized and not treated|1|||
155201062|NCT01488370|560174629|FG000|Overall Study|Protocol Violation|0|||
155201063|NCT01488370|560174630|FG001|Overall Study|Protocol Violation|1|||
155201064|NCT01488370|560174631|FG002|Overall Study|Protocol Violation|1|||
155201065|NCT04189081|560174633|FG000|Overall Study|Lost to Follow-up|1|||
155201066|NCT04189081|560174634|FG001|Overall Study|Lost to Follow-up|0|||
155201067|NCT04189081|560174635|FG002|Overall Study|Lost to Follow-up|0|||
155201068|NCT04189081|560174633|FG000|Overall Study|Withdrawal by Subject|0|||
155201069|NCT04189081|560174634|FG001|Overall Study|Withdrawal by Subject|0|||
155201070|NCT04189081|560174635|FG002|Overall Study|Withdrawal by Subject|1|||
155201071|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
155201072|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
155201073|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
155201074|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
155201075|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
155201076|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
155201077|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
155201078|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
155201079|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
155201080|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
155201081|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
155201082|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
155201083|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
155201084|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
155201085|NCT00044083|560174636|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
155201086|NCT00044083|560174637|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
155201087|NCT00044083|560174636|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
155201088|NCT00044083|560174637|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
155201089|NCT00044083|560174636|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
155201090|NCT00044083|560174637|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
155201091|NCT00851747|560174644|FG000|Overall Study|Physician Decision|6|||
155201092|NCT00851747|560174645|FG001|Overall Study|Physician Decision|6|||
155201093|NCT00851747|560174646|FG002|Overall Study|Physician Decision|6|||
155201094|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
155201095|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
155201096|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
155201097|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
155201098|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
155201099|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
155201100|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
155201101|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
155201102|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
155201103|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
155201104|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
155201105|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
155201106|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
155201107|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
155201108|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
155201109|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Other|1|||
155201110|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Other|1|||
155201111|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Other|0|||
155201112|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
155201113|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
155201114|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
155201115|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
155201116|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
155201117|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
155201118|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
155201119|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
155201120|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
155201121|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
155201122|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
155201123|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
155201124|NCT02228460|560174654|FG000|Overall Study|Adverse Event|1|||
155201125|NCT02228460|560174654|FG000|Overall Study|Lost to Follow-up|1|||
155201126|NCT01243892|560174655|FG000|Overall Study|Did not meet eligibility criteria|2|||
155201127|NCT01243892|560174656|FG001|Overall Study|Did not meet eligibility criteria|0|||
155201128|NCT00119106|560174657|FG000|Overall Study|HIV infected at baseline|179|||
155201129|NCT00119106|560174658|FG001|Overall Study|HIV infected at baseline|178|||
155201130|NCT01866293|560174659|FG000|Overall Study|Adverse Event|2|||
155201131|NCT01010061|560174660|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
155201132|NCT01010061|560174661|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
155201133|NCT01010061|560174660|FG000|Overall Study|Disease Progression|2|||
155201134|NCT01010061|560174661|FG001|Overall Study|Disease Progression|8|||
155201135|NCT01010061|560174660|FG000|Overall Study|Withdrew Consent|5|||
155201136|NCT01010061|560174661|FG001|Overall Study|Withdrew Consent|1|||
155201137|NCT01010061|560174660|FG000|Overall Study|Death|3|||
155201138|NCT01010061|560174661|FG001|Overall Study|Death|6|||
155201139|NCT01010061|560174660|FG000|Overall Study|Administrative/Other|0|||
155201140|NCT01010061|560174661|FG001|Overall Study|Administrative/Other|1|||
155201141|NCT01010061|560174660|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
155201142|NCT01010061|560174661|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155201143|NCT01010061|560174660|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155201144|NCT01010061|560174661|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155201145|NCT01010061|560174660|FG000|Overall Study|Violation of Selection Criteria|0|||
155201146|NCT01010061|560174661|FG001|Overall Study|Violation of Selection Criteria|1|||
155201147|NCT01010061|560174660|FG000|Overall Study|Did Not Receive Treatment|2|||
155201148|NCT01010061|560174661|FG001|Overall Study|Did Not Receive Treatment|2|||
155201149|NCT03066804|560174662|FG000|Overall Study|Physician Decision|0|||
155201150|NCT03066804|560174663|FG001|Overall Study|Physician Decision|4|||
155201151|NCT03066804|560174662|FG000|Overall Study|Death|23|||
155201152|NCT03066804|560174663|FG001|Overall Study|Death|17|||
155201153|NCT03066804|560174662|FG000|Overall Study|Withdrawal by Subject|19|||
155201154|NCT03066804|560174663|FG001|Overall Study|Withdrawal by Subject|25|||
155201155|NCT03066804|560174662|FG000|Overall Study|Lost to Follow-up|2|||
155201156|NCT03066804|560174663|FG001|Overall Study|Lost to Follow-up|0|||
155201157|NCT03066804|560174662|FG000|Overall Study|Adverse Event|2|||
155201158|NCT03066804|560174663|FG001|Overall Study|Adverse Event|3|||
155201159|NCT03066804|560174662|FG000|Overall Study|Technical problems|5|||
155201160|NCT03066804|560174663|FG001|Overall Study|Technical problems|1|||
155201161|NCT03470441|560174667|FG000|Overall Study|Death|0|||
155201162|NCT03470441|560174668|FG001|Overall Study|Death|1|||
155201163|NCT03470441|560174669|FG002|Overall Study|Death|1|||
155201164|NCT03470441|560174670|FG003|Overall Study|Death|0|||
155201165|NCT03470441|560174667|FG000|Overall Study|Adverse Event|0|||
155201166|NCT03470441|560174668|FG001|Overall Study|Adverse Event|0|||
155201167|NCT03470441|560174669|FG002|Overall Study|Adverse Event|0|||
155201168|NCT03470441|560174670|FG003|Overall Study|Adverse Event|1|||
155201169|NCT03470441|560174667|FG000|Overall Study|Withdrawal by Subject|1|||
155201170|NCT03470441|560174668|FG001|Overall Study|Withdrawal by Subject|4|||
155201171|NCT03470441|560174669|FG002|Overall Study|Withdrawal by Subject|1|||
155201172|NCT03470441|560174670|FG003|Overall Study|Withdrawal by Subject|3|||
155201173|NCT03982368|560174671|FG000|Overall Study|Adverse Event|6|||
155201174|NCT03982368|560174672|FG001|Overall Study|Adverse Event|4|||
155201175|NCT03982368|560174673|FG002|Overall Study|Adverse Event|3|||
155201176|NCT03982368|560174671|FG000|Overall Study|Lost to Follow-up|2|||
155201177|NCT03982368|560174672|FG001|Overall Study|Lost to Follow-up|1|||
155201178|NCT03982368|560174673|FG002|Overall Study|Lost to Follow-up|0|||
155201179|NCT03982368|560174671|FG000|Overall Study|Withdrawal by Subject|1|||
155201180|NCT03982368|560174672|FG001|Overall Study|Withdrawal by Subject|2|||
155201181|NCT03982368|560174673|FG002|Overall Study|Withdrawal by Subject|0|||
155201182|NCT03982368|560174671|FG000|Overall Study|unknow|4|||
155201183|NCT03982368|560174672|FG001|Overall Study|unknow|0|||
155201184|NCT03982368|560174673|FG002|Overall Study|unknow|2|||
155201185|NCT00518284|560174674|FG000|Overall Study|Adverse Event|0|||
155201186|NCT00518284|560174675|FG001|Overall Study|Adverse Event|1|||
155201187|NCT00518284|560174676|FG002|Overall Study|Adverse Event|0|||
155201188|NCT00518284|560174677|FG003|Overall Study|Adverse Event|0|||
155201189|NCT00518284|560174674|FG000|Overall Study|Study Termination|0|||
155201190|NCT00518284|560174675|FG001|Overall Study|Study Termination|2|||
155201191|NCT00518284|560174676|FG002|Overall Study|Study Termination|1|||
155201192|NCT00518284|560174677|FG003|Overall Study|Study Termination|2|||
155201193|NCT03768414|560174678|FG000|Overall Study|Adverse Event or side effects|72|||
155201194|NCT03768414|560174679|FG001|Overall Study|Adverse Event or side effects|28|||
155201195|NCT03768414|560174678|FG000|Overall Study|Refusal unrelated to adverse event|33|||
155201196|NCT03768414|560174679|FG001|Overall Study|Refusal unrelated to adverse event|33|||
155201197|NCT03768414|560174678|FG000|Overall Study|Progression/relapse|132|||
155201198|NCT03768414|560174679|FG001|Overall Study|Progression/relapse|60|||
155201199|NCT03768414|560174678|FG000|Overall Study|Death|9|||
155201200|NCT03768414|560174679|FG001|Overall Study|Death|6|||
155201201|NCT03768414|560174678|FG000|Overall Study|Other - not protocol specified|45|||
155201202|NCT03768414|560174679|FG001|Overall Study|Other - not protocol specified|18|||
155201203|NCT03768414|560174678|FG000|Overall Study|Reason under review|3|||
155201204|NCT03768414|560174679|FG001|Overall Study|Reason under review|2|||
155201205|NCT02571777|560174681|FG000|Overall Study|Subject/guardian decision|34|||
155201206|NCT02571777|560174682|FG001|Overall Study|Subject/guardian decision|26|||
155201207|NCT02571777|560174683|FG002|Overall Study|Subject/guardian decision|26|||
155201208|NCT02571777|560174684|FG003|Overall Study|Subject/guardian decision|25|||
155201209|NCT02571777|560174685|FG004|Overall Study|Subject/guardian decision|27|||
155201210|NCT02571777|560174681|FG000|Overall Study|Protocol Deviation|2|||
155201211|NCT02571777|560174682|FG001|Overall Study|Protocol Deviation|3|||
155201212|NCT02571777|560174683|FG002|Overall Study|Protocol Deviation|4|||
155201213|NCT02571777|560174684|FG003|Overall Study|Protocol Deviation|8|||
155201214|NCT02571777|560174685|FG004|Overall Study|Protocol Deviation|4|||
155201215|NCT02571777|560174681|FG000|Overall Study|Death|1|||
155201216|NCT02571777|560174682|FG001|Overall Study|Death|1|||
155201217|NCT02571777|560174683|FG002|Overall Study|Death|4|||
155201218|NCT02571777|560174684|FG003|Overall Study|Death|0|||
155201219|NCT02571777|560174685|FG004|Overall Study|Death|0|||
155201220|NCT02571777|560174681|FG000|Overall Study|Lost to Follow-up|1|||
155201221|NCT02571777|560174682|FG001|Overall Study|Lost to Follow-up|1|||
155201222|NCT02571777|560174683|FG002|Overall Study|Lost to Follow-up|2|||
155201223|NCT02571777|560174684|FG003|Overall Study|Lost to Follow-up|0|||
155201224|NCT02571777|560174685|FG004|Overall Study|Lost to Follow-up|1|||
155201225|NCT02571777|560174681|FG000|Overall Study|Physician Decision|1|||
155201226|NCT02571777|560174682|FG001|Overall Study|Physician Decision|7|||
155201227|NCT02571777|560174683|FG002|Overall Study|Physician Decision|5|||
155201228|NCT02571777|560174684|FG003|Overall Study|Physician Decision|2|||
155201229|NCT02571777|560174685|FG004|Overall Study|Physician Decision|4|||
155201230|NCT02571777|560174681|FG000|Overall Study|Pregnancy|0|||
155201231|NCT02571777|560174682|FG001|Overall Study|Pregnancy|0|||
155201232|NCT02571777|560174683|FG002|Overall Study|Pregnancy|0|||
155201233|NCT02571777|560174684|FG003|Overall Study|Pregnancy|2|||
155201234|NCT02571777|560174685|FG004|Overall Study|Pregnancy|0|||
155201235|NCT03706079|560174686|FG000|Predecessor Study|Death|0|||
155201236|NCT03706079|560174687|FG001|Predecessor Study|Death|2|||
155201237|NCT03706079|560174688|FG002|Predecessor Study|Death|0|||
155201238|NCT03706079|560174689|FG003|Predecessor Study|Death|1|||
155201239|NCT03706079|560174690|FG004|Predecessor Study|Death|0|||
155201240|NCT03706079|560174691|FG005|Predecessor Study|Death|0|||
155201241|NCT03706079|560174686|FG000|Predecessor Study|Lost to Follow-up|5|||
155201242|NCT03706079|560174687|FG001|Predecessor Study|Lost to Follow-up|2|||
155201243|NCT03706079|560174688|FG002|Predecessor Study|Lost to Follow-up|0|||
155201244|NCT03706079|560174689|FG003|Predecessor Study|Lost to Follow-up|0|||
155201245|NCT03706079|560174690|FG004|Predecessor Study|Lost to Follow-up|1|||
155201246|NCT03706079|560174691|FG005|Predecessor Study|Lost to Follow-up|0|||
155201247|NCT03706079|560174686|FG000|Predecessor Study|Withdrawal by Subject|8|||
155201248|NCT03706079|560174687|FG001|Predecessor Study|Withdrawal by Subject|15|||
155201249|NCT03706079|560174688|FG002|Predecessor Study|Withdrawal by Subject|0|||
155201250|NCT03706079|560174689|FG003|Predecessor Study|Withdrawal by Subject|5|||
155201251|NCT03706079|560174690|FG004|Predecessor Study|Withdrawal by Subject|2|||
155201252|NCT03706079|560174691|FG005|Predecessor Study|Withdrawal by Subject|0|||
155201253|NCT03706079|560174686|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
155201254|NCT03706079|560174687|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
155201255|NCT03706079|560174688|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201256|NCT03706079|560174689|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201257|NCT03706079|560174690|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201258|NCT03706079|560174691|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201259|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201260|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201261|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201262|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201263|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201264|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
155201265|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
155201266|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201267|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
155201268|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201269|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201270|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201271|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
155201272|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201273|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201274|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201275|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201276|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201277|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201278|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201279|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201280|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
155201281|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201282|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
155201283|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
155201284|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201285|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201286|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
155201287|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201288|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
155201289|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Death|8|||
155201290|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Death|2|||
155491240|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Disease Progression|0|||
155201291|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Death|2|||
155201292|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Death|1|||
155201293|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Death|0|||
155201294|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Death|0|||
155201295|NCT00329238|560174692|FG000|Overall Study|Adverse Event|147|||
155201296|NCT00329238|560174693|FG001|Overall Study|Adverse Event|129|||
155201297|NCT00329238|560174692|FG000|Overall Study|Protocol Violation|23|||
155201298|NCT00329238|560174693|FG001|Overall Study|Protocol Violation|34|||
155201299|NCT00329238|560174692|FG000|Overall Study|Lost to Follow-up|2|||
155201300|NCT00329238|560174693|FG001|Overall Study|Lost to Follow-up|6|||
155201301|NCT00329238|560174692|FG000|Overall Study|Withdrawal by Subject|64|||
155201302|NCT00329238|560174693|FG001|Overall Study|Withdrawal by Subject|58|||
155201303|NCT00329238|560174692|FG000|Overall Study|Other reason (not specified)|40|||
155201304|NCT00329238|560174693|FG001|Overall Study|Other reason (not specified)|54|||
155201305|NCT00801632|560174694|FG000|Overall Study|Re-transplant|1|||
155201306|NCT00915278|560174702|FG000|Overall Study|Death|1|||
155201307|NCT00915278|560174703|FG001|Overall Study|Death|0|||
155201308|NCT00915278|560174704|FG002|Overall Study|Death|0|||
155201309|NCT00915278|560174705|FG003|Overall Study|Death|0|||
155201310|NCT00915278|560174706|FG004|Overall Study|Death|0|||
155201311|NCT00915278|560174707|FG005|Overall Study|Death|0|||
155201312|NCT00915278|560174702|FG000|Overall Study|Lost to Follow-up|0|||
155201313|NCT00915278|560174703|FG001|Overall Study|Lost to Follow-up|1|||
155201314|NCT00915278|560174704|FG002|Overall Study|Lost to Follow-up|0|||
155201315|NCT00915278|560174705|FG003|Overall Study|Lost to Follow-up|0|||
155201316|NCT00915278|560174706|FG004|Overall Study|Lost to Follow-up|0|||
155201317|NCT00915278|560174707|FG005|Overall Study|Lost to Follow-up|0|||
155201318|NCT00915278|560174702|FG000|Overall Study|Withdrawal by Subject|0|||
155201319|NCT00915278|560174703|FG001|Overall Study|Withdrawal by Subject|1|||
155201320|NCT00915278|560174704|FG002|Overall Study|Withdrawal by Subject|0|||
155201321|NCT00915278|560174705|FG003|Overall Study|Withdrawal by Subject|0|||
155201322|NCT00915278|560174706|FG004|Overall Study|Withdrawal by Subject|1|||
155201323|NCT00915278|560174707|FG005|Overall Study|Withdrawal by Subject|4|||
155201324|NCT00915278|560174702|FG000|Overall Study|Adverse Event|4|||
155201325|NCT00915278|560174703|FG001|Overall Study|Adverse Event|1|||
155201326|NCT00915278|560174704|FG002|Overall Study|Adverse Event|0|||
155201327|NCT00915278|560174705|FG003|Overall Study|Adverse Event|0|||
155201328|NCT00915278|560174706|FG004|Overall Study|Adverse Event|0|||
155201329|NCT00915278|560174707|FG005|Overall Study|Adverse Event|0|||
155201330|NCT00915278|560174702|FG000|Overall Study|Progressive disease/clinical progression|0|||
155201331|NCT00915278|560174703|FG001|Overall Study|Progressive disease/clinical progression|0|||
155201332|NCT00915278|560174704|FG002|Overall Study|Progressive disease/clinical progression|0|||
155201333|NCT00915278|560174705|FG003|Overall Study|Progressive disease/clinical progression|3|||
155201334|NCT00915278|560174706|FG004|Overall Study|Progressive disease/clinical progression|1|||
155201335|NCT00915278|560174707|FG005|Overall Study|Progressive disease/clinical progression|2|||
155201336|NCT00915278|560174702|FG000|Overall Study|Infusion related AEs|0|||
155201337|NCT00915278|560174703|FG001|Overall Study|Infusion related AEs|0|||
155201338|NCT00915278|560174704|FG002|Overall Study|Infusion related AEs|0|||
155201339|NCT00915278|560174705|FG003|Overall Study|Infusion related AEs|0|||
155201340|NCT00915278|560174706|FG004|Overall Study|Infusion related AEs|0|||
155201341|NCT00915278|560174707|FG005|Overall Study|Infusion related AEs|2|||
155201342|NCT00915278|560174702|FG000|Overall Study|Admission to hospice|0|||
155201343|NCT00915278|560174703|FG001|Overall Study|Admission to hospice|0|||
155201344|NCT00915278|560174704|FG002|Overall Study|Admission to hospice|1|||
155201345|NCT00915278|560174705|FG003|Overall Study|Admission to hospice|0|||
155201346|NCT00915278|560174706|FG004|Overall Study|Admission to hospice|0|||
155201347|NCT00915278|560174707|FG005|Overall Study|Admission to hospice|0|||
155201348|NCT01702961|560174708|FG000|Overall Study|Additional treatment|3|||
155201349|NCT01702961|560174708|FG000|Overall Study|Progressive disease|5|||
155201350|NCT01702961|560174708|FG000|Overall Study|Relapse|20|||
155201351|NCT01702961|560174708|FG000|Overall Study|Death|6|||
155201352|NCT01702961|560174708|FG000|Overall Study|Lost to Follow-up|2|||
155201353|NCT01702961|560174708|FG000|Overall Study|Ongoing|11|||
155201354|NCT02465515|560174709|FG000|Overall Study|Investigator site closed|4|||
155201355|NCT02465515|560174710|FG001|Overall Study|Investigator site closed|5|||
155201356|NCT02465515|560174709|FG000|Overall Study|Withdrawal by Subject|74|||
155201357|NCT02465515|560174710|FG001|Overall Study|Withdrawal by Subject|43|||
155201358|NCT02465515|560174709|FG000|Overall Study|Physician Decision|8|||
155201359|NCT02465515|560174710|FG001|Overall Study|Physician Decision|12|||
155201360|NCT02465515|560174709|FG000|Overall Study|Lost to Follow-up|68|||
155201361|NCT02465515|560174710|FG001|Overall Study|Lost to Follow-up|51|||
155201362|NCT01273597|560174711|FG000|Overall Study|Adverse Event|5|||
155201363|NCT01273597|560174711|FG000|Overall Study|Underwent Kidney Transplantation|2|||
155201364|NCT01273597|560174711|FG000|Overall Study|Reason Not Reported|1|||
155201365|NCT01594762|560174712|FG000|Overall Study|Withdrawal by Subject|1|||
155201366|NCT01594762|560174713|FG001|Overall Study|Withdrawal by Subject|0|||
155201367|NCT01594762|560174712|FG000|Overall Study|Lost to Follow-up|10|||
155201368|NCT01594762|560174713|FG001|Overall Study|Lost to Follow-up|10|||
155201369|NCT03288129|560174717|FG000|Overall Study|Adverse Event|10|||
155201370|NCT03288129|560174717|FG000|Overall Study|Lost to Follow-up|3|||
155201371|NCT03288129|560174717|FG000|Overall Study|Withdrawal by Subject|3|||
155201372|NCT03288129|560174717|FG000|Overall Study|Withdrawal of consent/assent|1|||
155201373|NCT03288129|560174717|FG000|Overall Study|Other|5|||
155201374|NCT02777333|560174718|FG000|Overall Study|Withdrawal by Subject|0|||
155201375|NCT02777333|560174719|FG001|Overall Study|Withdrawal by Subject|1|||
155201376|NCT02777333|560174718|FG000|Overall Study|Lost to Follow-up|0|||
155201377|NCT02777333|560174719|FG001|Overall Study|Lost to Follow-up|1|||
155201378|NCT01980940|560174720|FG000|Overall Study|Protocol Violation|0|||
155201379|NCT01980940|560174721|FG001|Overall Study|Protocol Violation|0|||
155201380|NCT01980940|560174722|FG002|Overall Study|Protocol Violation|0|||
155201381|NCT01980940|560174723|FG003|Overall Study|Protocol Violation|0|||
155201382|NCT01980940|560174724|FG004|Overall Study|Protocol Violation|0|||
155201383|NCT01980940|560174725|FG005|Overall Study|Protocol Violation|2|||
155201384|NCT01980940|560174726|FG006|Overall Study|Protocol Violation|0|||
155201385|NCT01980940|560174727|FG007|Overall Study|Protocol Violation|0|||
155201386|NCT00837811|560174728|FG000|Overall Study|Adverse Event|4|||
155201387|NCT00837811|560174729|FG001|Overall Study|Adverse Event|6|||
155201388|NCT00837811|560174730|FG002|Overall Study|Adverse Event|0|||
155201389|NCT00837811|560174728|FG000|Overall Study|Death|1|||
155201390|NCT00837811|560174729|FG001|Overall Study|Death|1|||
155201391|NCT00837811|560174730|FG002|Overall Study|Death|0|||
155201392|NCT00837811|560174728|FG000|Overall Study|Lack of Efficacy|0|||
155201393|NCT00837811|560174729|FG001|Overall Study|Lack of Efficacy|11|||
155201394|NCT00837811|560174730|FG002|Overall Study|Lack of Efficacy|0|||
155201395|NCT00837811|560174728|FG000|Overall Study|Lost to Follow-up|1|||
155201396|NCT00837811|560174729|FG001|Overall Study|Lost to Follow-up|3|||
155201397|NCT00837811|560174730|FG002|Overall Study|Lost to Follow-up|0|||
155201398|NCT00837811|560174728|FG000|Overall Study|Physician Decision|0|||
155201399|NCT00837811|560174729|FG001|Overall Study|Physician Decision|2|||
155201400|NCT00837811|560174730|FG002|Overall Study|Physician Decision|1|||
155201401|NCT00837811|560174728|FG000|Overall Study|Withdrawal by Subject|1|||
155201402|NCT00837811|560174729|FG001|Overall Study|Withdrawal by Subject|9|||
155201403|NCT00837811|560174730|FG002|Overall Study|Withdrawal by Subject|0|||
155201404|NCT00837811|560174728|FG000|Overall Study|Sponsor Decision|0|||
155201405|NCT00837811|560174729|FG001|Overall Study|Sponsor Decision|2|||
155201406|NCT00837811|560174730|FG002|Overall Study|Sponsor Decision|0|||
155201407|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
155201408|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
155201409|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
155201410|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
155201411|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
155201412|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
155201413|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
155201414|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
155201415|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
155201416|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
155201417|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
155201418|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
155201419|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
155201420|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
155201421|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
155201422|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
155201423|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
155201424|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
155201425|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
155201426|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
155201427|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
155201428|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
155201429|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
155201430|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
155201431|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
155201432|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
155201433|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
155201434|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
155201435|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
155201436|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
155201437|NCT01648101|560176617|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
155201438|NCT01648101|560176618|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
155201439|NCT01648101|560176619|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
155201440|NCT02469298|560176620|FG000|Overall Study|Protocol Violation|0|||
155201441|NCT02469298|560176621|FG001|Overall Study|Protocol Violation|1|||
155201442|NCT02469298|560176622|FG002|Overall Study|Protocol Violation|1|||
155201443|NCT02469298|560176623|FG003|Overall Study|Protocol Violation|0|||
155201444|NCT02469298|560176620|FG000|Overall Study|Lost to Follow-up|1|||
155201445|NCT02469298|560176621|FG001|Overall Study|Lost to Follow-up|0|||
155201446|NCT02469298|560176622|FG002|Overall Study|Lost to Follow-up|1|||
155201447|NCT02469298|560176623|FG003|Overall Study|Lost to Follow-up|0|||
155201448|NCT02469298|560176620|FG000|Overall Study|Physician Decision|0|||
155201449|NCT02469298|560176621|FG001|Overall Study|Physician Decision|0|||
155201450|NCT02469298|560176622|FG002|Overall Study|Physician Decision|0|||
155201451|NCT02469298|560176623|FG003|Overall Study|Physician Decision|1|||
155201452|NCT02469298|560176620|FG000|Overall Study|Withdrawal by Subject|0|||
155201453|NCT02469298|560176621|FG001|Overall Study|Withdrawal by Subject|0|||
155201454|NCT02469298|560176622|FG002|Overall Study|Withdrawal by Subject|0|||
155201455|NCT02469298|560176623|FG003|Overall Study|Withdrawal by Subject|1|||
155201456|NCT03797014|560176628|FG000|Overall Study|Withdrawal by Subject|1|||
155201457|NCT03797014|560176628|FG000|Overall Study|Lost to Follow-up|1|||
155201458|NCT03797014|560176628|FG000|Overall Study|Protocol Violation|1|||
155201459|NCT03305575|560176633|FG000|Overall Study|Physician Decision|1|||
155201460|NCT03305575|560176634|FG001|Overall Study|Physician Decision|0|||
155201461|NCT01389817|560176635|FG000|Overall Study|Physician Decision|1|||
155201462|NCT01389817|560176636|FG001|Overall Study|Physician Decision|0|||
155201463|NCT01389817|560176635|FG000|Overall Study|Lost to Follow-up|1|||
155201464|NCT01389817|560176636|FG001|Overall Study|Lost to Follow-up|0|||
155201465|NCT01389817|560176635|FG000|Overall Study|Withdrawal by Subject|2|||
155201466|NCT01389817|560176636|FG001|Overall Study|Withdrawal by Subject|0|||
155201467|NCT00105469|560176637|FG000|Overall Study|Adverse Event|9|||
155201468|NCT00105469|560176638|FG001|Overall Study|Adverse Event|8|||
155201469|NCT00105469|560176637|FG000|Overall Study|Protocol Violation|4|||
155201470|NCT00105469|560176638|FG001|Overall Study|Protocol Violation|0|||
155201471|NCT00105469|560176637|FG000|Overall Study|Withdrawal by Subject|2|||
155201472|NCT00105469|560176638|FG001|Overall Study|Withdrawal by Subject|3|||
155201473|NCT00105469|560176637|FG000|Overall Study|Lost to Follow-up|1|||
155201474|NCT00105469|560176638|FG001|Overall Study|Lost to Follow-up|0|||
155201475|NCT00105469|560176637|FG000|Overall Study|Lack of Efficacy|2|||
155201476|NCT00105469|560176638|FG001|Overall Study|Lack of Efficacy|0|||
155201477|NCT00105469|560176637|FG000|Overall Study|Other Reason|4|||
155201478|NCT00105469|560176638|FG001|Overall Study|Other Reason|0|||
155201479|NCT04980040|560176639|FG000|Overall Study|Violated the Inclusion Criteria|260|||
155201480|NCT04980040|560176639|FG000|Overall Study|Violated the Administration & Dosage|225|||
155201481|NCT04980040|560176639|FG000|Overall Study|Lost to Safety-Follow-up|4|||
155201482|NCT04980040|560176639|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
155201483|NCT01408485|560176640|FG000|Overall Study|Withdrawal by Subject|21|||
155201484|NCT01508650|560176641|FG000|Overall Study|Lost to Follow-up|0|||
155201485|NCT01508650|560176642|FG001|Overall Study|Lost to Follow-up|3|||
155201486|NCT02064894|560176643|FG000|Overall Study|Withdrawal by Subject|43|||
155201487|NCT02064894|560176644|FG001|Overall Study|Withdrawal by Subject|102|||
155201488|NCT02064894|560176645|FG002|Overall Study|Withdrawal by Subject|115|||
155201489|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
155201490|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
155201491|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201492|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201493|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201494|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201495|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201496|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201497|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
155201498|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
155201499|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201500|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201501|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201502|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201503|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201504|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201505|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
155201506|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
155201507|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201508|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201509|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201510|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201511|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201512|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201513|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201514|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
155201515|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201516|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201517|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201518|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201519|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201520|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201521|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
155201522|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
155201523|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201524|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201525|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201526|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201527|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201528|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201529|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
155201530|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201531|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201532|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201533|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201534|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201535|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201536|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201537|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
155201538|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
155201539|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201540|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201541|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201542|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201543|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201544|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201545|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
155201546|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
155201547|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201548|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201549|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201550|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201551|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201552|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201553|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201554|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201555|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
155201556|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201557|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201558|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201559|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201560|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
155201561|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201562|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201563|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
155201564|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201565|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201566|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201567|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201568|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
155201569|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201570|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201571|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
155201572|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201573|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201574|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201575|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201576|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
155201577|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201578|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201579|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
155201580|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201581|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201582|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201583|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201584|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
155201585|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201586|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201587|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
155201588|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201589|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201590|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201591|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201592|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201593|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201594|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201595|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
155201596|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201597|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201598|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201599|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201600|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
155201601|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201602|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201603|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201604|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201605|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201606|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201607|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201608|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
155201609|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201610|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201611|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201612|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201613|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201614|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
155201615|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201616|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201617|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201618|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201619|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201620|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201621|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
155201622|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201623|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
155201624|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201625|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201626|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201627|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201628|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201629|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
155201630|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201631|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201632|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
155201633|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201634|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201635|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201636|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201637|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
155201638|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201639|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201640|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
155201641|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201642|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201643|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201644|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
155201645|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201646|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
155201647|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201648|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201649|NCT00160693|560176654|FG000|Overall Study|Adverse Event|97|||
155201650|NCT00160693|560176654|FG000|Overall Study|Lack of Efficacy|30|||
155201651|NCT00160693|560176654|FG000|Overall Study|Protocol Violation|24|||
155201652|NCT00160693|560176654|FG000|Overall Study|Lost to Follow-up|15|||
155201653|NCT00160693|560176654|FG000|Overall Study|Withdrawal by Subject|54|||
155201654|NCT00160693|560176654|FG000|Overall Study|Study terminated by sponsor|15|||
155201655|NCT03716024|560176655|FG000|Overall Study|Randomized, not Treated|7|||
155201656|NCT03716024|560176656|FG001|Overall Study|Randomized, not Treated|8|||
155201657|NCT03716024|560176655|FG000|Overall Study|Adverse Event|1|||
155201658|NCT03716024|560176656|FG001|Overall Study|Adverse Event|2|||
155201659|NCT03716024|560176655|FG000|Overall Study|Treatment Failure|1|||
155201660|NCT03716024|560176656|FG001|Overall Study|Treatment Failure|0|||
155201661|NCT03716024|560176655|FG000|Overall Study|Lost to Follow-up|2|||
155201662|NCT03716024|560176656|FG001|Overall Study|Lost to Follow-up|6|||
155201663|NCT03716024|560176655|FG000|Overall Study|Withdrawal by Subject|0|||
155201664|NCT03716024|560176656|FG001|Overall Study|Withdrawal by Subject|1|||
155201665|NCT03716024|560176655|FG000|Overall Study|Missing Reason|0|||
155201666|NCT03716024|560176656|FG001|Overall Study|Missing Reason|1|||
155201667|NCT04343261|560176657|FG000|Overall Study|Adverse Event|1|||
155201668|NCT04343261|560176657|FG000|Overall Study|received inadequate amount of antibodies|7|||
155201669|NCT05988619|560176658|FG000|Overall Study|Lost to Follow-up|1|||
155201670|NCT05988619|560176659|FG001|Overall Study|Lost to Follow-up|4|||
155201671|NCT05988619|560176658|FG000|Overall Study|Withdrawal by Subject|2|||
155201672|NCT05988619|560176659|FG001|Overall Study|Withdrawal by Subject|9|||
155201673|NCT00587054|560176662|FG000|Overall Study|Patient not treated|9|||
155201674|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Death|0|||
155201675|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Death|0|||
155201676|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Death|0|||
155201677|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Death|0|||
155201678|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Death|1|||
155201679|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Death|0|||
155201680|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Death|0|||
155201681|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Death|0|||
155201682|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
155201683|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
155201684|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
155201685|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
155201686|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
155201687|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
155201688|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
155201689|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
155201690|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
155201691|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201692|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201693|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
155201694|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201695|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
155201696|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201697|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201698|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
155201699|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
155201700|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
155201701|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
155201702|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
155201703|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
155201704|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
155201705|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
155201706|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
155201707|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201708|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201709|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
155201710|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
155201711|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201712|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
155201713|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
155201714|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
155201715|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201716|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201717|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
155201718|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
155201719|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
155201720|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201721|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201722|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
155201723|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201724|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201725|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201726|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201727|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201728|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201729|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201730|NCT00726232|560176664|FG000|Expansion Phase|Death|0|||
155201731|NCT00726232|560176665|FG001|Expansion Phase|Death|0|||
155201732|NCT00726232|560176666|FG002|Expansion Phase|Death|0|||
155201733|NCT00726232|560176667|FG003|Expansion Phase|Death|0|||
155201734|NCT00726232|560176668|FG004|Expansion Phase|Death|0|||
155201735|NCT00726232|560176669|FG005|Expansion Phase|Death|0|||
155201736|NCT00726232|560176670|FG006|Expansion Phase|Death|0|||
155201737|NCT00726232|560176671|FG007|Expansion Phase|Death|1|||
155201738|NCT00726232|560176664|FG000|Expansion Phase|Adverse Event|0|||
155201739|NCT00726232|560176665|FG001|Expansion Phase|Adverse Event|0|||
155201740|NCT00726232|560176666|FG002|Expansion Phase|Adverse Event|0|||
155201741|NCT00726232|560176667|FG003|Expansion Phase|Adverse Event|0|||
155201742|NCT00726232|560176668|FG004|Expansion Phase|Adverse Event|0|||
155201743|NCT00726232|560176669|FG005|Expansion Phase|Adverse Event|0|||
155201744|NCT00726232|560176670|FG006|Expansion Phase|Adverse Event|6|||
155201745|NCT00726232|560176671|FG007|Expansion Phase|Adverse Event|11|||
155201746|NCT00726232|560176664|FG000|Expansion Phase|Withdrawal by Subject|0|||
155201747|NCT00726232|560176665|FG001|Expansion Phase|Withdrawal by Subject|0|||
155201748|NCT00726232|560176666|FG002|Expansion Phase|Withdrawal by Subject|0|||
155201749|NCT00726232|560176667|FG003|Expansion Phase|Withdrawal by Subject|0|||
155201750|NCT00726232|560176668|FG004|Expansion Phase|Withdrawal by Subject|0|||
155201751|NCT00726232|560176669|FG005|Expansion Phase|Withdrawal by Subject|0|||
155201752|NCT00726232|560176670|FG006|Expansion Phase|Withdrawal by Subject|2|||
155201753|NCT00726232|560176671|FG007|Expansion Phase|Withdrawal by Subject|3|||
155201754|NCT00726232|560176664|FG000|Expansion Phase|Disease progression|0|||
155201755|NCT00726232|560176665|FG001|Expansion Phase|Disease progression|0|||
155201756|NCT00726232|560176666|FG002|Expansion Phase|Disease progression|0|||
155201757|NCT00726232|560176667|FG003|Expansion Phase|Disease progression|0|||
155201758|NCT00726232|560176668|FG004|Expansion Phase|Disease progression|0|||
155201759|NCT00726232|560176669|FG005|Expansion Phase|Disease progression|0|||
155201760|NCT00726232|560176670|FG006|Expansion Phase|Disease progression|4|||
155201761|NCT00726232|560176671|FG007|Expansion Phase|Disease progression|0|||
155201762|NCT00726232|560176664|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
155201763|NCT00726232|560176665|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
155201764|NCT00726232|560176666|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
155201765|NCT00726232|560176667|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
155201766|NCT00726232|560176668|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
155201767|NCT00726232|560176669|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
155201768|NCT00726232|560176670|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
155201769|NCT00726232|560176671|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
155201770|NCT00726232|560176664|FG000|Expansion Phase|Per Investigator: lack of response|0|||
155201771|NCT00726232|560176665|FG001|Expansion Phase|Per Investigator: lack of response|0|||
155201772|NCT00726232|560176666|FG002|Expansion Phase|Per Investigator: lack of response|0|||
155201773|NCT00726232|560176667|FG003|Expansion Phase|Per Investigator: lack of response|0|||
155201774|NCT00726232|560176668|FG004|Expansion Phase|Per Investigator: lack of response|0|||
155201775|NCT00726232|560176669|FG005|Expansion Phase|Per Investigator: lack of response|0|||
155201776|NCT00726232|560176670|FG006|Expansion Phase|Per Investigator: lack of response|1|||
155201777|NCT00726232|560176671|FG007|Expansion Phase|Per Investigator: lack of response|7|||
155201778|NCT00726232|560176664|FG000|Expansion Phase|Unspecified reason|0|||
155201779|NCT00726232|560176665|FG001|Expansion Phase|Unspecified reason|0|||
155201780|NCT00726232|560176666|FG002|Expansion Phase|Unspecified reason|0|||
155201781|NCT00726232|560176667|FG003|Expansion Phase|Unspecified reason|0|||
155201782|NCT00726232|560176668|FG004|Expansion Phase|Unspecified reason|0|||
155201783|NCT00726232|560176669|FG005|Expansion Phase|Unspecified reason|0|||
155201784|NCT00726232|560176670|FG006|Expansion Phase|Unspecified reason|1|||
155201785|NCT00726232|560176671|FG007|Expansion Phase|Unspecified reason|0|||
155201786|NCT00709761|560176672|FG000|Overall Study|Withdrawal by Subject|8|||
155201787|NCT00709761|560176672|FG000|Overall Study|study closed/terminated|17|||
155201788|NCT00709761|560176672|FG000|Overall Study|Lost to Follow-up|2|||
155201789|NCT03478930|560176673|FG000|Overall Study|Adverse Event|0|||
155201790|NCT03478930|560176674|FG001|Overall Study|Adverse Event|1|||
155201791|NCT03478930|560176673|FG000|Overall Study|Lack of Efficacy|3|||
155201792|NCT03478930|560176674|FG001|Overall Study|Lack of Efficacy|3|||
155201793|NCT03478930|560176673|FG000|Overall Study|Withdrawal by Subject|6|||
155201794|NCT03478930|560176674|FG001|Overall Study|Withdrawal by Subject|5|||
155201795|NCT00553644|560176677|FG000|Overall Study|Adverse Event|17|||
155201796|NCT00553644|560176677|FG000|Overall Study|Withdrawal by Subject|4|||
155201797|NCT00553644|560176677|FG000|Overall Study|Physician Decision|1|||
155201798|NCT00553644|560176677|FG000|Overall Study|Alternative therapy|6|||
155201799|NCT00705484|560176678|FG000|Overall Study|Adverse Event|28|||
155201800|NCT00705484|560176679|FG001|Overall Study|Adverse Event|27|||
155201801|NCT00705484|560176678|FG000|Overall Study|Lost to Follow-up|169|||
155201802|NCT00705484|560176679|FG001|Overall Study|Lost to Follow-up|250|||
155201803|NCT00705484|560176678|FG000|Overall Study|Withdrawal by Subject|96|||
155201804|NCT00705484|560176679|FG001|Overall Study|Withdrawal by Subject|72|||
155201805|NCT00705484|560176678|FG000|Overall Study|Administrative|89|||
155201806|NCT00705484|560176679|FG001|Overall Study|Administrative|59|||
155201807|NCT02197247|560176680|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
155201808|NCT02197247|560176680|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
155201809|NCT02197247|560176680|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
155201810|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
155201811|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
155201812|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
155201813|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
155201814|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
155201815|NCT03851705|560176686|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
155201816|NCT03851705|560176687|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201817|NCT03851705|560176688|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201818|NCT03851705|560176689|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201819|NCT03851705|560176686|FG000|Part 1: Double-Blind Period|Other reason|1|||
155201820|NCT03851705|560176687|FG001|Part 1: Double-Blind Period|Other reason|0|||
155201821|NCT03851705|560176688|FG002|Part 1: Double-Blind Period|Other reason|0|||
155201822|NCT03851705|560176689|FG003|Part 1: Double-Blind Period|Other reason|0|||
155201823|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Other reason|0|||
155201824|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Other reason|0|||
155201825|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Other reason|0|||
155201826|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Other reason|1|||
155201827|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Death|0|||
155201828|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Death|0|||
155201829|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Death|3|||
155201830|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Death|0|||
155201831|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201832|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201833|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
155201834|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201835|NCT04431453|560176690|FG000|Overall Study|Withdrew Consent|0|||
155201836|NCT04431453|560176691|FG001|Overall Study|Withdrew Consent|1|||
155201837|NCT04431453|560176692|FG002|Overall Study|Withdrew Consent|0|||
155201838|NCT04431453|560176693|FG003|Overall Study|Withdrew Consent|2|||
155201839|NCT04431453|560176694|FG004|Overall Study|Withdrew Consent|0|||
155201840|NCT04431453|560176695|FG005|Overall Study|Withdrew Consent|0|||
155201841|NCT04431453|560176696|FG006|Overall Study|Withdrew Consent|0|||
155201842|NCT04431453|560176697|FG007|Overall Study|Withdrew Consent|0|||
155201843|NCT04431453|560176690|FG000|Overall Study|Death|1|||
155201844|NCT04431453|560176691|FG001|Overall Study|Death|0|||
155201845|NCT04431453|560176692|FG002|Overall Study|Death|0|||
155201846|NCT04431453|560176693|FG003|Overall Study|Death|0|||
155201847|NCT04431453|560176694|FG004|Overall Study|Death|0|||
155201848|NCT04431453|560176695|FG005|Overall Study|Death|0|||
155201849|NCT04431453|560176696|FG006|Overall Study|Death|0|||
155201850|NCT04431453|560176697|FG007|Overall Study|Death|1|||
155201851|NCT04431453|560176690|FG000|Overall Study|Lost to Follow-up|0|||
155201852|NCT04431453|560176691|FG001|Overall Study|Lost to Follow-up|0|||
155201853|NCT04431453|560176692|FG002|Overall Study|Lost to Follow-up|1|||
155201854|NCT04431453|560176693|FG003|Overall Study|Lost to Follow-up|1|||
155201855|NCT04431453|560176694|FG004|Overall Study|Lost to Follow-up|0|||
155201856|NCT04431453|560176695|FG005|Overall Study|Lost to Follow-up|0|||
155201857|NCT04431453|560176696|FG006|Overall Study|Lost to Follow-up|0|||
155201858|NCT04431453|560176697|FG007|Overall Study|Lost to Follow-up|0|||
155201859|NCT04431453|560176690|FG000|Overall Study|Enrolled but Never Treated|0|||
155201860|NCT04431453|560176691|FG001|Overall Study|Enrolled but Never Treated|0|||
155201861|NCT04431453|560176692|FG002|Overall Study|Enrolled but Never Treated|0|||
155201862|NCT04431453|560176693|FG003|Overall Study|Enrolled but Never Treated|0|||
155201863|NCT04431453|560176694|FG004|Overall Study|Enrolled but Never Treated|1|||
155201864|NCT04431453|560176695|FG005|Overall Study|Enrolled but Never Treated|0|||
155201865|NCT04431453|560176696|FG006|Overall Study|Enrolled but Never Treated|0|||
155201866|NCT04431453|560176697|FG007|Overall Study|Enrolled but Never Treated|0|||
155201867|NCT00622401|560176698|FG000|Overall Study|Disease progression prior to treatment|3|||
155201868|NCT00622401|560176699|FG001|Overall Study|Disease progression prior to treatment|2|||
155201869|NCT00622401|560176700|FG002|Overall Study|Disease progression prior to treatment|0|||
155201870|NCT03087643|560176708|FG000|Overall Study|Withdrawal by Subject|2|||
155201871|NCT03087643|560176709|FG001|Overall Study|Withdrawal by Subject|4|||
155201872|NCT03087643|560176708|FG000|Overall Study|Death|2|||
155201873|NCT03087643|560176709|FG001|Overall Study|Death|2|||
155201874|NCT02083783|560176710|FG000|Overall Study|Withdrawal by Subject|1|||
155201875|NCT02083783|560176711|FG001|Overall Study|Withdrawal by Subject|0|||
155201876|NCT02021773|560176717|FG000|Overall Study|Adverse Event|1|||
155201877|NCT02021773|560176718|FG001|Overall Study|Adverse Event|4|||
155201878|NCT02021773|560176719|FG002|Overall Study|Adverse Event|3|||
155201879|NCT02021773|560176717|FG000|Overall Study|Lack of Efficacy|2|||
155201880|NCT02021773|560176718|FG001|Overall Study|Lack of Efficacy|2|||
155201881|NCT02021773|560176719|FG002|Overall Study|Lack of Efficacy|2|||
155201882|NCT02021773|560176717|FG000|Overall Study|Protocol Violation|2|||
155201883|NCT02021773|560176718|FG001|Overall Study|Protocol Violation|3|||
155201884|NCT02021773|560176719|FG002|Overall Study|Protocol Violation|1|||
155201885|NCT02021773|560176717|FG000|Overall Study|Withdrawal by Subject|3|||
155201886|NCT02021773|560176718|FG001|Overall Study|Withdrawal by Subject|4|||
155201887|NCT02021773|560176719|FG002|Overall Study|Withdrawal by Subject|5|||
155201888|NCT02021773|560176717|FG000|Overall Study|Lost to Follow-up|1|||
155201889|NCT02021773|560176718|FG001|Overall Study|Lost to Follow-up|3|||
155201890|NCT02021773|560176719|FG002|Overall Study|Lost to Follow-up|0|||
155201891|NCT02021773|560176717|FG000|Overall Study|Reason not specified|3|||
155201892|NCT02021773|560176718|FG001|Overall Study|Reason not specified|0|||
155201893|NCT02021773|560176719|FG002|Overall Study|Reason not specified|0|||
155201894|NCT00530946|560176720|FG000|Overall Study|Adverse Event|1|||
155201895|NCT00530946|560176721|FG001|Overall Study|Adverse Event|2|||
155201896|NCT00530946|560176722|FG002|Overall Study|Adverse Event|1|||
155201897|NCT00530946|560176723|FG003|Overall Study|Adverse Event|1|||
155201898|NCT00530946|560176720|FG000|Overall Study|Protocol Violation|0|||
155201899|NCT00530946|560176721|FG001|Overall Study|Protocol Violation|0|||
155201900|NCT00530946|560176722|FG002|Overall Study|Protocol Violation|0|||
155201901|NCT00530946|560176723|FG003|Overall Study|Protocol Violation|1|||
155201902|NCT00530946|560176720|FG000|Overall Study|Noncompliance|1|||
155201903|NCT00530946|560176721|FG001|Overall Study|Noncompliance|0|||
155201904|NCT00530946|560176722|FG002|Overall Study|Noncompliance|0|||
155201905|NCT00530946|560176723|FG003|Overall Study|Noncompliance|0|||
155201906|NCT01534962|560176724|FG000|Overall Study|Randomized but did not start treatment|2|||
155201907|NCT01534962|560176725|FG001|Overall Study|Randomized but did not start treatment|0|||
155201908|NCT01534962|560176726|FG002|Overall Study|Randomized but did not start treatment|0|||
155201909|NCT01534962|560176727|FG003|Overall Study|Randomized but did not start treatment|1|||
155201910|NCT01534962|560176724|FG000|Overall Study|Discontinued at AF recurrence|35|||
155201911|NCT01534962|560176725|FG001|Overall Study|Discontinued at AF recurrence|26|||
155201912|NCT01534962|560176726|FG002|Overall Study|Discontinued at AF recurrence|24|||
155201913|NCT01534962|560176727|FG003|Overall Study|Discontinued at AF recurrence|31|||
155201914|NCT02243696|560176728|FG000|Overall Study|Death|282|||
155201915|NCT02243696|560176728|FG000|Overall Study|Withdrawal by Subject|79|||
155201916|NCT02243696|560176728|FG000|Overall Study|Lost to Follow-up|57|||
155201917|NCT02243696|560176728|FG000|Overall Study|Subject No Longer has Study System|42|||
155201918|NCT02243696|560176728|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
155201919|NCT02243696|560176728|FG000|Overall Study|Study Terminated for EP PASSION|961|||
155201920|NCT00622284|560176729|FG000|Overall Study|Lack of Efficacy|45|||
155201921|NCT00622284|560176730|FG001|Overall Study|Lack of Efficacy|15|||
155201922|NCT00622284|560176729|FG000|Overall Study|Adverse Event|61|||
155201923|NCT00622284|560176730|FG001|Overall Study|Adverse Event|90|||
155201924|NCT00622284|560176729|FG000|Overall Study|Protocol Violation|12|||
155201925|NCT00622284|560176730|FG001|Overall Study|Protocol Violation|5|||
155201926|NCT00622284|560176729|FG000|Overall Study|Lost to Follow-up|11|||
155201927|NCT00622284|560176730|FG001|Overall Study|Lost to Follow-up|13|||
155201928|NCT00622284|560176729|FG000|Overall Study|Withdrawal by Subject|27|||
155201929|NCT00622284|560176730|FG001|Overall Study|Withdrawal by Subject|24|||
155201930|NCT00622284|560176729|FG000|Overall Study|Other reason (not specified)|33|||
155201931|NCT00622284|560176730|FG001|Overall Study|Other reason (not specified)|24|||
155201932|NCT04545385|560176731|FG000|Overall Study|Withdrawal by Subject|2|||
155201933|NCT04545385|560176732|FG001|Overall Study|Withdrawal by Subject|0|||
155201934|NCT04545385|560176731|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
155201935|NCT04545385|560176732|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
155201936|NCT04545385|560176731|FG000|Overall Study|Study termination|10|||
155201937|NCT04545385|560176732|FG001|Overall Study|Study termination|10|||
155201938|NCT04545385|560176731|FG000|Overall Study|Sponsor decision|2|||
155201939|NCT04545385|560176732|FG001|Overall Study|Sponsor decision|2|||
155201940|NCT04545385|560176731|FG000|Overall Study|Other than specified|1|||
155201941|NCT04545385|560176732|FG001|Overall Study|Other than specified|0|||
155201942|NCT02412618|560176735|FG000|Overall Study|Withdrawal by Subject|1|||
155201943|NCT02412618|560176736|FG001|Overall Study|Withdrawal by Subject|1|||
155201944|NCT02412618|560176735|FG000|Overall Study|Expulsion|1|||
155201945|NCT02412618|560176736|FG001|Overall Study|Expulsion|1|||
155201946|NCT02094677|560176743|FG000|Overall Study|Screening|3|||
155201947|NCT02094677|560176744|FG001|Overall Study|Screening|1|||
155201948|NCT03408483|560176745|FG000|Overall Study|Physician Decision|3|||
155201949|NCT03408483|560176746|FG001|Overall Study|Physician Decision|3|||
155201950|NCT03408483|560176745|FG000|Overall Study|Lost to Follow-up|3|||
155201951|NCT03408483|560176746|FG001|Overall Study|Lost to Follow-up|0|||
155201952|NCT05399641|560176747|FG000|Overall Study|Adverse Event|0|||
155201953|NCT05399641|560176748|FG001|Overall Study|Adverse Event|1|||
155201954|NCT05399641|560176749|FG002|Overall Study|Adverse Event|1|||
155201955|NCT05399641|560176747|FG000|Overall Study|Lost to Follow-up|1|||
155201956|NCT05399641|560176748|FG001|Overall Study|Lost to Follow-up|2|||
155201957|NCT05399641|560176749|FG002|Overall Study|Lost to Follow-up|2|||
155201958|NCT05399641|560176747|FG000|Overall Study|Physician Decision|1|||
155201959|NCT05399641|560176748|FG001|Overall Study|Physician Decision|3|||
155201960|NCT05399641|560176749|FG002|Overall Study|Physician Decision|3|||
155201961|NCT05399641|560176747|FG000|Overall Study|Withdrawal by Subject|4|||
155201962|NCT05399641|560176748|FG001|Overall Study|Withdrawal by Subject|11|||
155201963|NCT05399641|560176749|FG002|Overall Study|Withdrawal by Subject|7|||
155201964|NCT05399641|560176747|FG000|Overall Study|Reason not defined|3|||
155201965|NCT05399641|560176748|FG001|Overall Study|Reason not defined|5|||
155201966|NCT05399641|560176749|FG002|Overall Study|Reason not defined|6|||
155201967|NCT00478231|560176750|FG000|Overall Study|Death|7|||
155201968|NCT00478231|560176750|FG000|Overall Study|Lack of Efficacy|47|||
155201969|NCT00478231|560176750|FG000|Overall Study|Lost to Follow-up|7|||
155201970|NCT00478231|560176750|FG000|Overall Study|Withdrawal by Subject|6|||
155201971|NCT00478231|560176750|FG000|Overall Study|Other|9|||
155201972|NCT00478231|560176750|FG000|Overall Study|Adverse Event|5|||
155201973|NCT00478231|560176750|FG000|Overall Study|Randomized, not treated|3|||
155201974|NCT00602797|560176753|FG000|Overall Study|Adverse Event|1|||
155201975|NCT00629707|560176756|FG000|Overall Study|Withdrawal by Subject|0|||
155201976|NCT00629707|560176757|FG001|Overall Study|Withdrawal by Subject|1|||
155201977|NCT00629707|560176756|FG000|Overall Study|Physician Decision|0|||
155201978|NCT00629707|560176757|FG001|Overall Study|Physician Decision|1|||
155201979|NCT02657369|560176758|FG000|Overall Study|Death|27|||
155201980|NCT02657369|560176758|FG000|Overall Study|Study terminated by sponsor|7|||
155201981|NCT02605824|560176759|FG000|Overall Study|Physician Decision|1|||
155201982|NCT02605824|560176760|FG001|Overall Study|Physician Decision|0|||
155201983|NCT04875195|560176761|FG000|Overall Study|Death|9|||
155201984|NCT04875195|560176762|FG001|Overall Study|Death|3|||
155201985|NCT04875195|560176761|FG000|Overall Study|Withdrawal by Subject|2|||
155201986|NCT04875195|560176762|FG001|Overall Study|Withdrawal by Subject|1|||
155201987|NCT04875195|560176761|FG000|Overall Study|Ongoing in study|49|||
155201988|NCT04875195|560176762|FG001|Overall Study|Ongoing in study|2|||
155201989|NCT00826943|560176765|FG000|Overall Study|Withdrawal by Subject|0|||
155201990|NCT00826943|560176766|FG001|Overall Study|Withdrawal by Subject|0|||
155201991|NCT00826943|560176767|FG002|Overall Study|Withdrawal by Subject|0|||
155201992|NCT00826943|560176768|FG003|Overall Study|Withdrawal by Subject|0|||
155201993|NCT00826943|560176769|FG004|Overall Study|Withdrawal by Subject|1|||
155201994|NCT00826943|560176770|FG005|Overall Study|Withdrawal by Subject|0|||
155201995|NCT03715530|560176771|FG000|Overall Study|Lost to Follow-up|3|||
155201996|NCT03715530|560176772|FG001|Overall Study|Lost to Follow-up|1|||
155201997|NCT03715530|560176773|FG002|Overall Study|Lost to Follow-up|2|||
155201998|NCT03547583|560176774|FG000|Overall Study|Adverse Event|16|||
155201999|NCT03547583|560176775|FG001|Overall Study|Adverse Event|11|||
155202000|NCT03547583|560176776|FG002|Overall Study|Adverse Event|10|||
155202001|NCT03547583|560176774|FG000|Overall Study|Death|11|||
155202002|NCT03547583|560176775|FG001|Overall Study|Death|7|||
155202003|NCT03547583|560176776|FG002|Overall Study|Death|4|||
155202004|NCT03547583|560176774|FG000|Overall Study|Lost to Follow-up|1|||
155202005|NCT03547583|560176775|FG001|Overall Study|Lost to Follow-up|0|||
155202006|NCT03547583|560176776|FG002|Overall Study|Lost to Follow-up|0|||
155202007|NCT03547583|560176774|FG000|Overall Study|Non-compliance with study drug|0|||
155202008|NCT03547583|560176775|FG001|Overall Study|Non-compliance with study drug|0|||
155202009|NCT03547583|560176776|FG002|Overall Study|Non-compliance with study drug|1|||
155202010|NCT03547583|560176774|FG000|Overall Study|Physician Decision|1|||
155202011|NCT03547583|560176775|FG001|Overall Study|Physician Decision|0|||
155202012|NCT03547583|560176776|FG002|Overall Study|Physician Decision|3|||
155202013|NCT03547583|560176774|FG000|Overall Study|Protocol Violation|2|||
155202014|NCT03547583|560176775|FG001|Overall Study|Protocol Violation|1|||
155202015|NCT03547583|560176776|FG002|Overall Study|Protocol Violation|1|||
155202016|NCT03547583|560176774|FG000|Overall Study|Withdrawal by Subject|12|||
155202017|NCT03547583|560176775|FG001|Overall Study|Withdrawal by Subject|19|||
155202018|NCT03547583|560176776|FG002|Overall Study|Withdrawal by Subject|10|||
155202019|NCT03547583|560176774|FG000|Overall Study|Other|2|||
155202020|NCT03547583|560176775|FG001|Overall Study|Other|2|||
155202021|NCT03547583|560176776|FG002|Overall Study|Other|3|||
155202022|NCT01744197|560176777|FG000|Overall Study|Received 1 patch|2|||
155202023|NCT01744197|560176778|FG001|Overall Study|Received 1 patch|1|||
155202024|NCT01744197|560176777|FG000|Overall Study|No patch received|2|||
155202025|NCT01744197|560176778|FG001|Overall Study|No patch received|2|||
155202026|NCT04706091|560176779|FG000|Treatment 2|Withdrawal by Subject|1|||
155202027|NCT04706091|560176780|FG001|Treatment 2|Withdrawal by Subject|0|||
155202028|NCT03329573|560176781|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202029|NCT03329573|560176782|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
155202030|NCT03329573|560176783|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202031|NCT03329573|560176784|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202032|NCT03329573|560176781|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155202033|NCT03329573|560176782|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
155202034|NCT03329573|560176783|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155202035|NCT03329573|560176784|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155202036|NCT03329573|560176781|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
155202037|NCT03329573|560176782|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202038|NCT03329573|560176783|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202039|NCT03329573|560176784|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202040|NCT03329573|560176781|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202041|NCT03329573|560176782|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
155202042|NCT03329573|560176783|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202043|NCT03329573|560176784|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202044|NCT02166905|560176787|FG000|Overall Study|Withdrawal by Subject|1|||
155202045|NCT02166905|560176788|FG001|Overall Study|Withdrawal by Subject|0|||
155202046|NCT02166905|560176789|FG002|Overall Study|Withdrawal by Subject|0|||
155202047|NCT02166905|560176790|FG003|Overall Study|Withdrawal by Subject|0|||
155202048|NCT05243641|560176792|FG000|Overall Study|Adverse Event|3|||
155202049|NCT05243641|560176793|FG001|Overall Study|Adverse Event|0|||
155202050|NCT05243641|560176794|FG002|Overall Study|Adverse Event|0|||
155202051|NCT05243641|560176795|FG003|Overall Study|Adverse Event|1|||
155202052|NCT05243641|560176796|FG004|Overall Study|Adverse Event|0|||
155202053|NCT05243641|560176797|FG005|Overall Study|Adverse Event|0|||
155202054|NCT05243641|560176792|FG000|Overall Study|Disease progression|4|||
155202055|NCT05243641|560176793|FG001|Overall Study|Disease progression|0|||
155202056|NCT05243641|560176794|FG002|Overall Study|Disease progression|0|||
155202057|NCT05243641|560176795|FG003|Overall Study|Disease progression|2|||
155202058|NCT05243641|560176796|FG004|Overall Study|Disease progression|0|||
155202059|NCT05243641|560176797|FG005|Overall Study|Disease progression|0|||
155202060|NCT05372419|560176801|FG000|Overall Study|Protocol Deviation|1|||
155202061|NCT05372419|560176801|FG000|Overall Study|Withdrawal by Subject|5|||
155202062|NCT05372419|560176801|FG000|Overall Study|Lost to Follow-up|7|||
155202063|NCT04997304|560176802|FG000|Overall Study|Lost to Follow-up|11|||
155202064|NCT04997304|560176802|FG000|Overall Study|Death|1|||
155202065|NCT04997304|560176802|FG000|Overall Study|Withdrawal by Subject|14|||
155202066|NCT03311724|560178957|FG000|Overall Study|Physician Decision|0|||
155202067|NCT03311724|560178958|FG001|Overall Study|Physician Decision|0|||
155202068|NCT03311724|560178959|FG002|Overall Study|Physician Decision|0|||
155202069|NCT03311724|560178960|FG003|Overall Study|Physician Decision|1|||
155202070|NCT03311724|560178957|FG000|Overall Study|Protocol Violation|1|||
155202071|NCT03311724|560178958|FG001|Overall Study|Protocol Violation|0|||
155202072|NCT03311724|560178959|FG002|Overall Study|Protocol Violation|1|||
155202073|NCT03311724|560178960|FG003|Overall Study|Protocol Violation|0|||
155202074|NCT03311724|560178957|FG000|Overall Study|Withdrawal by Subject|1|||
155202075|NCT03311724|560178958|FG001|Overall Study|Withdrawal by Subject|1|||
155202076|NCT03311724|560178959|FG002|Overall Study|Withdrawal by Subject|0|||
155202077|NCT03311724|560178960|FG003|Overall Study|Withdrawal by Subject|0|||
155202078|NCT03311724|560178957|FG000|Overall Study|Lost to Follow-up|1|||
155202079|NCT03311724|560178958|FG001|Overall Study|Lost to Follow-up|0|||
155202080|NCT03311724|560178959|FG002|Overall Study|Lost to Follow-up|0|||
155202081|NCT03311724|560178960|FG003|Overall Study|Lost to Follow-up|0|||
155202082|NCT03311724|560178957|FG000|Overall Study|Sponsor Decision|0|||
155202083|NCT03311724|560178958|FG001|Overall Study|Sponsor Decision|0|||
155202084|NCT03311724|560178959|FG002|Overall Study|Sponsor Decision|1|||
155202085|NCT03311724|560178960|FG003|Overall Study|Sponsor Decision|0|||
155202086|NCT01970397|560178963|FG000|Overall Study|Adverse Event|0|||
155202087|NCT01970397|560178964|FG001|Overall Study|Adverse Event|1|||
155202088|NCT01970397|560178963|FG000|Overall Study|Lost to Follow-up|0|||
155202089|NCT01970397|560178964|FG001|Overall Study|Lost to Follow-up|1|||
155202090|NCT01970397|560178963|FG000|Overall Study|Personal Reasons|1|||
155202091|NCT01970397|560178964|FG001|Overall Study|Personal Reasons|2|||
155202092|NCT01970397|560178963|FG000|Overall Study|Protocol Violation|1|||
155202093|NCT01970397|560178964|FG001|Overall Study|Protocol Violation|1|||
155202094|NCT01471171|560178970|FG000|Treatment Period 1|Adverse Event|4|||
155202095|NCT01471171|560178971|FG001|Treatment Period 1|Adverse Event|1|||
155202096|NCT01471171|560178970|FG000|Treatment Period 2|Adverse Event|1|||
155202097|NCT01471171|560178971|FG001|Treatment Period 2|Adverse Event|0|||
155202098|NCT00407797|560178972|FG000|Overall Study|Lost to Follow-up|2|||
155202099|NCT00407797|560178972|FG000|Overall Study|Adverse Event|6|||
155202100|NCT00407797|560178972|FG000|Overall Study|Other|7|||
155202101|NCT00407797|560178972|FG000|Overall Study|Withdrawal by Subject|3|||
155202102|NCT01812174|560178973|FG000|Overall Study|Death|1|||
155202103|NCT01812174|560178974|FG001|Overall Study|Death|0|||
155202104|NCT01812174|560178973|FG000|Overall Study|Protocol Violation|2|||
155202105|NCT01812174|560178974|FG001|Overall Study|Protocol Violation|0|||
155202106|NCT00555971|560178975|FG000|Overall Study|Adverse Event|1|||
155202107|NCT00555971|560178976|FG001|Overall Study|Adverse Event|1|||
155202108|NCT05469178|560178977|FG000|Overall Study|Death|1|||
155202109|NCT05469178|560178978|FG001|Overall Study|Death|1|||
155202110|NCT05469178|560178979|FG002|Overall Study|Death|3|||
155202111|NCT05469178|560178980|FG003|Overall Study|Death|6|||
155202112|NCT05469178|560178977|FG000|Overall Study|Lack of Efficacy|2|||
155202113|NCT05469178|560178978|FG001|Overall Study|Lack of Efficacy|2|||
155202114|NCT05469178|560178979|FG002|Overall Study|Lack of Efficacy|1|||
155202115|NCT05469178|560178980|FG003|Overall Study|Lack of Efficacy|10|||
155202116|NCT05393895|560178981|FG000|Overall Study|Adverse Event|2|||
155202117|NCT05393895|560178982|FG001|Overall Study|Adverse Event|3|||
155202118|NCT05393895|560178981|FG000|Overall Study|Lost to Follow-up|4|||
155202119|NCT05393895|560178982|FG001|Overall Study|Lost to Follow-up|3|||
155202120|NCT05393895|560178981|FG000|Overall Study|Protocol Violation|1|||
155202121|NCT05393895|560178982|FG001|Overall Study|Protocol Violation|0|||
155202122|NCT05393895|560178981|FG000|Overall Study|Withdrawal by Subject|1|||
155202123|NCT05393895|560178982|FG001|Overall Study|Withdrawal by Subject|4|||
155202124|NCT01203098|560178987|FG000|Overall Study|Adverse Event|3|||
155202125|NCT01203098|560178988|FG001|Overall Study|Adverse Event|1|||
155202126|NCT01203098|560178989|FG002|Overall Study|Adverse Event|7|||
155202127|NCT01203098|560178987|FG000|Overall Study|Lost to Follow-up|0|||
155202128|NCT01203098|560178988|FG001|Overall Study|Lost to Follow-up|0|||
155202129|NCT01203098|560178989|FG002|Overall Study|Lost to Follow-up|1|||
155202130|NCT01203098|560178987|FG000|Overall Study|Physician Decision|2|||
155202131|NCT01203098|560178988|FG001|Overall Study|Physician Decision|2|||
155202132|NCT01203098|560178989|FG002|Overall Study|Physician Decision|0|||
155202133|NCT01203098|560178987|FG000|Overall Study|Withdrawal by Subject|1|||
155202134|NCT01203098|560178988|FG001|Overall Study|Withdrawal by Subject|1|||
155202135|NCT01203098|560178989|FG002|Overall Study|Withdrawal by Subject|3|||
155202136|NCT00621582|560178997|FG000|Overall Study|Adverse Event|7|||
155202137|NCT00621582|560178997|FG000|Overall Study|Protocol Violation|57|||
155202138|NCT00621582|560178997|FG000|Overall Study|Lost to Follow-up|24|||
155202139|NCT00621582|560178997|FG000|Overall Study|issues not identified by investigators|18|||
155202140|NCT03617185|560178998|FG000|Baseline|Lost to Follow-up|0|||
155202141|NCT03617185|560178999|FG001|Baseline|Lost to Follow-up|2|||
155202142|NCT03617185|560179000|FG002|Baseline|Lost to Follow-up|1|||
155202143|NCT03617185|560179001|FG003|Baseline|Lost to Follow-up|1|||
155202144|NCT03617185|560178998|FG000|Baseline|Withdrawal by Subject|0|||
155202145|NCT03617185|560178999|FG001|Baseline|Withdrawal by Subject|1|||
155202146|NCT03617185|560179000|FG002|Baseline|Withdrawal by Subject|0|||
155202147|NCT03617185|560179001|FG003|Baseline|Withdrawal by Subject|1|||
155202148|NCT03617185|560178998|FG000|Baseline|Driving Distance/Travel|0|||
155202149|NCT03617185|560178999|FG001|Baseline|Driving Distance/Travel|0|||
155202150|NCT03617185|560179000|FG002|Baseline|Driving Distance/Travel|2|||
155202151|NCT03617185|560179001|FG003|Baseline|Driving Distance/Travel|0|||
155202152|NCT03617185|560178998|FG000|Baseline|Family Obligations|0|||
155202153|NCT03617185|560178999|FG001|Baseline|Family Obligations|0|||
155202154|NCT03617185|560179000|FG002|Baseline|Family Obligations|0|||
155202155|NCT03617185|560179001|FG003|Baseline|Family Obligations|1|||
155202156|NCT03617185|560178998|FG000|3 Months|Lost to Follow-up|4|||
155202157|NCT03617185|560178999|FG001|3 Months|Lost to Follow-up|1|||
155202158|NCT03617185|560179000|FG002|3 Months|Lost to Follow-up|0|||
155202159|NCT03617185|560179001|FG003|3 Months|Lost to Follow-up|2|||
155202160|NCT03617185|560178998|FG000|3 Months|Withdrawal by Subject|1|||
155202161|NCT03617185|560178999|FG001|3 Months|Withdrawal by Subject|3|||
155202162|NCT03617185|560179000|FG002|3 Months|Withdrawal by Subject|0|||
155202163|NCT03617185|560179001|FG003|3 Months|Withdrawal by Subject|0|||
155202164|NCT03617185|560178998|FG000|3 Months|Driving Distance/Travel|1|||
155202165|NCT03617185|560178999|FG001|3 Months|Driving Distance/Travel|0|||
155202166|NCT03617185|560179000|FG002|3 Months|Driving Distance/Travel|0|||
155202167|NCT03617185|560179001|FG003|3 Months|Driving Distance/Travel|0|||
155202168|NCT03617185|560178998|FG000|3 Months|Family Obligations|0|||
155202169|NCT03617185|560178999|FG001|3 Months|Family Obligations|0|||
155202170|NCT03617185|560179000|FG002|3 Months|Family Obligations|0|||
155202171|NCT03617185|560179001|FG003|3 Months|Family Obligations|1|||
155202172|NCT03617185|560178998|FG000|12 Months|Lost to Follow-up|3|||
155202173|NCT03617185|560178999|FG001|12 Months|Lost to Follow-up|1|||
155202174|NCT03617185|560179000|FG002|12 Months|Lost to Follow-up|3|||
155202175|NCT03617185|560179001|FG003|12 Months|Lost to Follow-up|0|||
155202176|NCT03617185|560178998|FG000|12 Months|Withdrawal by Subject|0|||
155202177|NCT03617185|560178999|FG001|12 Months|Withdrawal by Subject|0|||
155202178|NCT03617185|560179000|FG002|12 Months|Withdrawal by Subject|0|||
155202179|NCT03617185|560179001|FG003|12 Months|Withdrawal by Subject|1|||
155202180|NCT03617185|560178998|FG000|12 Months|Driving Distance/Travel|0|||
155202181|NCT03617185|560178999|FG001|12 Months|Driving Distance/Travel|0|||
155202182|NCT03617185|560179000|FG002|12 Months|Driving Distance/Travel|1|||
155202183|NCT03617185|560179001|FG003|12 Months|Driving Distance/Travel|0|||
155202184|NCT01387932|560179003|FG000|Randomized and Treated|Physician Decision|3|||
155202185|NCT01387932|560179004|FG001|Randomized and Treated|Physician Decision|2|||
155202186|NCT01387932|560179003|FG000|Randomized and Treated|Withdrawal by Subject|4|||
155202187|NCT01387932|560179004|FG001|Randomized and Treated|Withdrawal by Subject|2|||
155202188|NCT01387932|560179003|FG000|Survival Follow-up|Liver Transplant|24|||
155202189|NCT01387932|560179004|FG001|Survival Follow-up|Liver Transplant|28|||
155202190|NCT01387932|560179003|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
155202191|NCT01387932|560179004|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
155202192|NCT01387932|560179003|FG000|Survival Follow-up|Withdrawal by Subject|2|||
155202193|NCT01387932|560179004|FG001|Survival Follow-up|Withdrawal by Subject|4|||
155202194|NCT01387932|560179003|FG000|Survival Follow-up|Lost to Follow-up|6|||
155202195|NCT01387932|560179004|FG001|Survival Follow-up|Lost to Follow-up|5|||
155202196|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
155202197|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
155202198|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
155202199|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
155202200|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
155202201|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
155202202|NCT01964430|560179005|FG000|Treatment Period|Adverse Event|71|||
155202203|NCT01964430|560179006|FG001|Treatment Period|Adverse Event|37|||
155202204|NCT01964430|560179005|FG000|Treatment Period|Withdrawal by Subject|36|||
155202205|NCT01964430|560179006|FG001|Treatment Period|Withdrawal by Subject|27|||
155202206|NCT01964430|560179005|FG000|Treatment Period|Death|1|||
155202207|NCT01964430|560179006|FG001|Treatment Period|Death|3|||
155202208|NCT01964430|560179005|FG000|Treatment Period|Protocol Deviation|0|||
155202209|NCT01964430|560179006|FG001|Treatment Period|Protocol Deviation|1|||
155202210|NCT01964430|560179005|FG000|Treatment Period|Physician Decision|5|||
155202211|NCT01964430|560179006|FG001|Treatment Period|Physician Decision|4|||
155202212|NCT01964430|560179005|FG000|Treatment Period|Disease Relapse|28|||
155202213|NCT01964430|560179006|FG001|Treatment Period|Disease Relapse|38|||
155202214|NCT01964430|560179005|FG000|Treatment Period|Other reasons|1|||
155202215|NCT01964430|560179006|FG001|Treatment Period|Other reasons|3|||
155202216|NCT02591290|560179007|FG000|Overall Study|Withdrawal by Subject|2|||
155202217|NCT02571075|560179008|FG000|Overall Study|Lost to Follow-up|20|||
155202218|NCT02571075|560179009|FG001|Overall Study|Lost to Follow-up|24|||
155202219|NCT02197520|560179015|FG000|Period 1|Withdrawal by Subject|1|||
155202220|NCT02197520|560179016|FG001|Period 1|Withdrawal by Subject|0|||
155202221|NCT02197520|560179015|FG000|Period 2|Adverse Event|0|||
155202222|NCT02197520|560179016|FG001|Period 2|Adverse Event|2|||
155202223|NCT02197520|560179015|FG000|Period 2|Withdrawal by Subject|1|||
155202224|NCT02197520|560179016|FG001|Period 2|Withdrawal by Subject|0|||
155202225|NCT00913497|560179017|FG000|Overall Study|Adverse Event|1|||
155202226|NCT00913497|560179017|FG000|Overall Study|Withdrawal by Subject|2|||
155202227|NCT01306942|560179018|FG000|Phase I|Adverse Event|2|||
155202228|NCT01306942|560179019|FG001|Phase I|Adverse Event|2|||
155202229|NCT01306942|560179020|FG002|Phase I|Adverse Event|0|||
155202230|NCT01306942|560179021|FG003|Phase I|Adverse Event|0|||
155202231|NCT01306942|560179018|FG000|Phase I|Physician Decision|3|||
155202232|NCT01306942|560179019|FG001|Phase I|Physician Decision|1|||
155202233|NCT01306942|560179020|FG002|Phase I|Physician Decision|0|||
155202234|NCT01306942|560179021|FG003|Phase I|Physician Decision|0|||
155202235|NCT01306942|560179018|FG000|Phase II|Adverse Event|0|||
155202236|NCT01306942|560179019|FG001|Phase II|Adverse Event|0|||
155202237|NCT01306942|560179020|FG002|Phase II|Adverse Event|0|||
155202238|NCT01306942|560179021|FG003|Phase II|Adverse Event|6|||
155202239|NCT01306942|560179018|FG000|Phase II|Physician Decision|2|||
155202240|NCT01306942|560179019|FG001|Phase II|Physician Decision|0|||
155202241|NCT01306942|560179020|FG002|Phase II|Physician Decision|0|||
155202242|NCT01306942|560179021|FG003|Phase II|Physician Decision|5|||
155202243|NCT01306942|560179018|FG000|Phase II|Withdrawal by Subject|0|||
155202244|NCT01306942|560179019|FG001|Phase II|Withdrawal by Subject|0|||
155202245|NCT01306942|560179020|FG002|Phase II|Withdrawal by Subject|0|||
155202246|NCT01306942|560179021|FG003|Phase II|Withdrawal by Subject|2|||
155202247|NCT01306942|560179018|FG000|Phase II|Death|0|||
155202248|NCT01306942|560179019|FG001|Phase II|Death|0|||
155202249|NCT01306942|560179020|FG002|Phase II|Death|0|||
155202250|NCT01306942|560179021|FG003|Phase II|Death|1|||
155202251|NCT01306942|560179018|FG000|Phase II|Not finished treatment|0|||
155202252|NCT01306942|560179019|FG001|Phase II|Not finished treatment|0|||
155202253|NCT01306942|560179020|FG002|Phase II|Not finished treatment|0|||
155202254|NCT01306942|560179021|FG003|Phase II|Not finished treatment|1|||
155202255|NCT01306942|560179018|FG000|Phase II|Protocol Violation|0|||
155202256|NCT01306942|560179019|FG001|Phase II|Protocol Violation|0|||
155202257|NCT01306942|560179020|FG002|Phase II|Protocol Violation|0|||
155202258|NCT01306942|560179021|FG003|Phase II|Protocol Violation|1|||
155202259|NCT03190915|560179022|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
155202260|NCT03190915|560179022|FG000|Overall Study|Progressive Disease|3|||
155202261|NCT03385564|560179023|FG000|Overall Study|Adverse Event|0|||
155202262|NCT03385564|560179024|FG001|Overall Study|Adverse Event|0|||
155202263|NCT03385564|560179025|FG002|Overall Study|Adverse Event|3|||
155202264|NCT03385564|560179026|FG003|Overall Study|Adverse Event|3|||
155202265|NCT03385564|560179023|FG000|Overall Study|Other than listed|0|||
155202266|NCT03385564|560179024|FG001|Overall Study|Other than listed|0|||
155202267|NCT03385564|560179025|FG002|Overall Study|Other than listed|0|||
155202268|NCT03385564|560179026|FG003|Overall Study|Other than listed|5|||
155202269|NCT03385564|560179023|FG000|Overall Study|Withdrawal by Subject|0|||
155202270|NCT03385564|560179024|FG001|Overall Study|Withdrawal by Subject|1|||
155202271|NCT03385564|560179025|FG002|Overall Study|Withdrawal by Subject|1|||
155202272|NCT03385564|560179026|FG003|Overall Study|Withdrawal by Subject|0|||
155202273|NCT03385564|560179023|FG000|Overall Study|Lack of Efficacy|0|||
155202274|NCT03385564|560179024|FG001|Overall Study|Lack of Efficacy|0|||
155202275|NCT03385564|560179025|FG002|Overall Study|Lack of Efficacy|0|||
155202276|NCT03385564|560179026|FG003|Overall Study|Lack of Efficacy|1|||
155202277|NCT03385564|560179023|FG000|Overall Study|Death|0|||
155202278|NCT03385564|560179024|FG001|Overall Study|Death|0|||
155202279|NCT03385564|560179025|FG002|Overall Study|Death|1|||
155202280|NCT03385564|560179026|FG003|Overall Study|Death|0|||
155202281|NCT01546883|560179033|FG000|Overall Study|Withdrawal by Subject|3|||
155202282|NCT01546883|560179033|FG000|Overall Study|Adverse Event|4|||
155202283|NCT01546883|560179033|FG000|Overall Study|Lost to Follow-up|2|||
155202284|NCT01546883|560179033|FG000|Overall Study|early closure of study|2|||
155202285|NCT01546883|560179033|FG000|Overall Study|other unrelated illness|1|||
155202286|NCT02256631|560179034|FG000|Overall Study|Lost to Follow-up|1|||
155202287|NCT02256631|560179035|FG001|Overall Study|Lost to Follow-up|1|||
155202288|NCT02256631|560179036|FG002|Overall Study|Lost to Follow-up|0|||
155202289|NCT02256631|560179037|FG003|Overall Study|Lost to Follow-up|2|||
155202290|NCT02256631|560179038|FG004|Overall Study|Lost to Follow-up|0|||
155202291|NCT02256631|560179039|FG005|Overall Study|Lost to Follow-up|4|||
155202292|NCT02256631|560179040|FG006|Overall Study|Lost to Follow-up|1|||
155202293|NCT02256631|560179034|FG000|Overall Study|Withdrawal by Subject|0|||
155202294|NCT02256631|560179035|FG001|Overall Study|Withdrawal by Subject|0|||
155202295|NCT02256631|560179036|FG002|Overall Study|Withdrawal by Subject|0|||
155202296|NCT02256631|560179037|FG003|Overall Study|Withdrawal by Subject|1|||
155202297|NCT02256631|560179038|FG004|Overall Study|Withdrawal by Subject|1|||
155202298|NCT02256631|560179039|FG005|Overall Study|Withdrawal by Subject|0|||
155202299|NCT02256631|560179040|FG006|Overall Study|Withdrawal by Subject|1|||
155202300|NCT02256631|560179034|FG000|Overall Study|Unable to get to clinic|0|||
155202301|NCT02256631|560179035|FG001|Overall Study|Unable to get to clinic|2|||
155202302|NCT02256631|560179036|FG002|Overall Study|Unable to get to clinic|0|||
155202303|NCT02256631|560179037|FG003|Overall Study|Unable to get to clinic|1|||
155202304|NCT02256631|560179038|FG004|Overall Study|Unable to get to clinic|0|||
155202305|NCT02256631|560179039|FG005|Overall Study|Unable to get to clinic|1|||
155202306|NCT02256631|560179040|FG006|Overall Study|Unable to get to clinic|2|||
155202307|NCT01427972|560179041|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202308|NCT01427972|560179042|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202309|NCT01427972|560179043|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202310|NCT01427972|560179044|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202311|NCT01427972|560179045|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202312|NCT01427972|560179046|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202313|NCT01427972|560179047|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202314|NCT01427972|560179048|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
155202315|NCT01427972|560179049|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202316|NCT01427972|560179050|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202317|NCT01427972|560179051|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202318|NCT01427972|560179052|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202319|NCT01427972|560179041|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202320|NCT01427972|560179042|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202321|NCT01427972|560179043|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202322|NCT01427972|560179044|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202323|NCT01427972|560179045|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202324|NCT01427972|560179046|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
155202325|NCT01427972|560179047|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202326|NCT01427972|560179048|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202327|NCT01427972|560179049|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202328|NCT01427972|560179050|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202329|NCT01427972|560179051|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202330|NCT01427972|560179052|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202331|NCT01427972|560179041|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202332|NCT01427972|560179042|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
155202333|NCT01427972|560179043|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202334|NCT01427972|560179044|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202335|NCT01427972|560179045|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202336|NCT01427972|560179046|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202337|NCT01427972|560179047|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202338|NCT01427972|560179048|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202339|NCT01427972|560179049|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202340|NCT01427972|560179050|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202341|NCT01427972|560179051|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202342|NCT01427972|560179052|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202343|NCT01128842|560179060|FG000|Overall Study|Adverse Event|1|||
155202344|NCT01128842|560179060|FG000|Overall Study|Disease Progression|6|||
155202345|NCT03322631|560179061|FG000|Overall Study|Withdrawal by Subject|0|||
155202346|NCT03322631|560179062|FG001|Overall Study|Withdrawal by Subject|1|||
155202347|NCT03322631|560179063|FG002|Overall Study|Withdrawal by Subject|0|||
155202348|NCT03322631|560179064|FG003|Overall Study|Withdrawal by Subject|0|||
155202349|NCT03322631|560179061|FG000|Overall Study|Adverse Event|0|||
155202350|NCT03322631|560179062|FG001|Overall Study|Adverse Event|0|||
155202351|NCT03322631|560179063|FG002|Overall Study|Adverse Event|1|||
155202352|NCT03322631|560179064|FG003|Overall Study|Adverse Event|0|||
155202353|NCT02378961|560179066|FG000|Overall Study|Lack of Efficacy|4|||
155202354|NCT02378961|560179067|FG001|Overall Study|Lack of Efficacy|2|||
155202355|NCT02378961|560179068|FG002|Overall Study|Lack of Efficacy|0|||
155202356|NCT02378961|560179069|FG003|Overall Study|Lack of Efficacy|1|||
155202357|NCT02378961|560179066|FG000|Overall Study|Death|0|||
155202358|NCT02378961|560179067|FG001|Overall Study|Death|0|||
155202359|NCT02378961|560179068|FG002|Overall Study|Death|1|||
155202360|NCT02378961|560179069|FG003|Overall Study|Death|0|||
155202361|NCT04528732|560179070|FG000|Overall Study|Death|1|||
155202362|NCT04528732|560179071|FG001|Overall Study|Death|0|||
155202363|NCT04528732|560179072|FG002|Overall Study|Death|1|||
155202364|NCT04528732|560179070|FG000|Overall Study|Lost to Follow-up|0|||
155202365|NCT04528732|560179071|FG001|Overall Study|Lost to Follow-up|1|||
155202366|NCT04528732|560179072|FG002|Overall Study|Lost to Follow-up|2|||
155202367|NCT01253408|560179073|FG000|Overall Study|Adverse Event|0|||
155202368|NCT01253408|560179074|FG001|Overall Study|Adverse Event|1|||
155202369|NCT01253408|560179075|FG002|Overall Study|Adverse Event|0|||
155202370|NCT01300650|560179076|FG000|Overall Study|Adverse Event|1|||
155202371|NCT02784431|560179082|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
155202372|NCT02784431|560179082|FG000|Overall Study|Early Study Termination|19|||
155202373|NCT00361569|560179083|FG000|Overall Study|Protocol Violation|3|||
155202374|NCT00361569|560179084|FG001|Overall Study|Protocol Violation|2|||
155202375|NCT00361569|560179085|FG002|Overall Study|Protocol Violation|4|||
155202376|NCT00361569|560179086|FG003|Overall Study|Protocol Violation|2|||
155202377|NCT00361569|560179083|FG000|Overall Study|Withdrawal by Subject|2|||
155202378|NCT00361569|560179084|FG001|Overall Study|Withdrawal by Subject|1|||
155202379|NCT00361569|560179085|FG002|Overall Study|Withdrawal by Subject|9|||
155202380|NCT00361569|560179086|FG003|Overall Study|Withdrawal by Subject|14|||
155202381|NCT00361569|560179083|FG000|Overall Study|Adverse Event|3|||
155202382|NCT00361569|560179084|FG001|Overall Study|Adverse Event|5|||
155202383|NCT00361569|560179085|FG002|Overall Study|Adverse Event|2|||
155202384|NCT00361569|560179086|FG003|Overall Study|Adverse Event|2|||
155202385|NCT00361569|560179083|FG000|Overall Study|Lost to Follow-up|2|||
155202386|NCT00361569|560179084|FG001|Overall Study|Lost to Follow-up|3|||
155202387|NCT00361569|560179085|FG002|Overall Study|Lost to Follow-up|3|||
155202388|NCT00361569|560179086|FG003|Overall Study|Lost to Follow-up|2|||
155202389|NCT00361569|560179083|FG000|Overall Study|Not specified by investigator|2|||
155202390|NCT00361569|560179084|FG001|Overall Study|Not specified by investigator|0|||
155202391|NCT00361569|560179085|FG002|Overall Study|Not specified by investigator|0|||
155202392|NCT00361569|560179086|FG003|Overall Study|Not specified by investigator|1|||
155202393|NCT00074152|560179087|FG000|Overall Study|Death|21|||
155202394|NCT00074152|560179088|FG001|Overall Study|Death|9|||
155202395|NCT00074152|560179087|FG000|Overall Study|Lack of Efficacy|34|||
155202396|NCT00074152|560179088|FG001|Overall Study|Lack of Efficacy|24|||
155202397|NCT01446289|560179089|FG000|Overall Study|Withdrawal by Subject|1|||
155202398|NCT01446289|560179090|FG001|Overall Study|Withdrawal by Subject|0|||
155202399|NCT01446289|560179091|FG002|Overall Study|Withdrawal by Subject|1|||
155202400|NCT01446289|560179092|FG003|Overall Study|Withdrawal by Subject|0|||
155202401|NCT03307967|560179093|FG000|Overall Study|Lost to Follow-up|4|||
155202402|NCT02915016|560179094|FG000|Overall Study|Lost to Follow-up|4|||
155202403|NCT02915016|560179095|FG001|Overall Study|Lost to Follow-up|2|||
155202404|NCT02915016|560179096|FG002|Overall Study|Lost to Follow-up|5|||
155202405|NCT02915016|560179097|FG003|Overall Study|Lost to Follow-up|3|||
155202406|NCT02915016|560179098|FG004|Overall Study|Lost to Follow-up|5|||
155202407|NCT02915016|560179099|FG005|Overall Study|Lost to Follow-up|2|||
155202408|NCT02915016|560179100|FG006|Overall Study|Lost to Follow-up|8|||
155202409|NCT02915016|560179101|FG007|Overall Study|Lost to Follow-up|2|||
155202410|NCT02915016|560179094|FG000|Overall Study|Physician Decision|0|||
155202411|NCT02915016|560179095|FG001|Overall Study|Physician Decision|0|||
155202412|NCT02915016|560179096|FG002|Overall Study|Physician Decision|1|||
155202413|NCT02915016|560179097|FG003|Overall Study|Physician Decision|0|||
155202414|NCT02915016|560179098|FG004|Overall Study|Physician Decision|0|||
155202415|NCT02915016|560179099|FG005|Overall Study|Physician Decision|1|||
155202416|NCT02915016|560179100|FG006|Overall Study|Physician Decision|2|||
155202417|NCT02915016|560179101|FG007|Overall Study|Physician Decision|0|||
155202418|NCT02915016|560179094|FG000|Overall Study|Withdrawal by Subject|2|||
155202419|NCT02915016|560179095|FG001|Overall Study|Withdrawal by Subject|0|||
155202420|NCT02915016|560179096|FG002|Overall Study|Withdrawal by Subject|1|||
155202421|NCT02915016|560179097|FG003|Overall Study|Withdrawal by Subject|0|||
155202422|NCT02915016|560179098|FG004|Overall Study|Withdrawal by Subject|1|||
155202423|NCT02915016|560179099|FG005|Overall Study|Withdrawal by Subject|3|||
155202424|NCT02915016|560179100|FG006|Overall Study|Withdrawal by Subject|1|||
155202425|NCT02915016|560179101|FG007|Overall Study|Withdrawal by Subject|1|||
155202426|NCT02915016|560179094|FG000|Overall Study|Elected not to continue|0|||
155202427|NCT02915016|560179095|FG001|Overall Study|Elected not to continue|0|||
155202428|NCT02915016|560179096|FG002|Overall Study|Elected not to continue|0|||
155202429|NCT02915016|560179097|FG003|Overall Study|Elected not to continue|1|||
155202430|NCT02915016|560179098|FG004|Overall Study|Elected not to continue|0|||
155202431|NCT02915016|560179099|FG005|Overall Study|Elected not to continue|0|||
155202432|NCT02915016|560179100|FG006|Overall Study|Elected not to continue|1|||
155202433|NCT02915016|560179101|FG007|Overall Study|Elected not to continue|0|||
155202434|NCT02915016|560179094|FG000|Overall Study|HIV infection|1|||
155202435|NCT02915016|560179095|FG001|Overall Study|HIV infection|1|||
155202436|NCT02915016|560179096|FG002|Overall Study|HIV infection|1|||
155202437|NCT02915016|560179097|FG003|Overall Study|HIV infection|0|||
155202438|NCT02915016|560179098|FG004|Overall Study|HIV infection|1|||
155202439|NCT02915016|560179099|FG005|Overall Study|HIV infection|0|||
155202440|NCT02915016|560179100|FG006|Overall Study|HIV infection|0|||
155202441|NCT02915016|560179101|FG007|Overall Study|HIV infection|0|||
155202442|NCT02915016|560179094|FG000|Overall Study|Participant unable to adhere|0|||
155202443|NCT02915016|560179095|FG001|Overall Study|Participant unable to adhere|0|||
155202444|NCT02915016|560179096|FG002|Overall Study|Participant unable to adhere|0|||
155202445|NCT02915016|560179097|FG003|Overall Study|Participant unable to adhere|0|||
155202446|NCT02915016|560179098|FG004|Overall Study|Participant unable to adhere|0|||
155202447|NCT02915016|560179099|FG005|Overall Study|Participant unable to adhere|0|||
155202448|NCT02915016|560179100|FG006|Overall Study|Participant unable to adhere|0|||
155202449|NCT02915016|560179101|FG007|Overall Study|Participant unable to adhere|1|||
155202450|NCT02578316|560179102|FG000|Extension Phase|Progression of disease|6|||
155202451|NCT02617628|560179103|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
155202452|NCT02617628|560179104|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
155202453|NCT03278873|560179108|FG000|Overall Study|Withdrawal by Subject|0|||
155202454|NCT03278873|560179109|FG001|Overall Study|Withdrawal by Subject|1|||
155202455|NCT03278873|560179110|FG002|Overall Study|Withdrawal by Subject|0|||
155202456|NCT03278873|560179111|FG003|Overall Study|Withdrawal by Subject|0|||
155202457|NCT03278873|560179108|FG000|Overall Study|Sponsor's decision|0|||
155202458|NCT03278873|560179109|FG001|Overall Study|Sponsor's decision|1|||
155202459|NCT03278873|560179110|FG002|Overall Study|Sponsor's decision|0|||
155202460|NCT03278873|560179111|FG003|Overall Study|Sponsor's decision|0|||
155202461|NCT03278873|560179108|FG000|Overall Study|Early Termination|2|||
155202462|NCT03278873|560179109|FG001|Overall Study|Early Termination|6|||
155202463|NCT03278873|560179110|FG002|Overall Study|Early Termination|0|||
155202464|NCT03278873|560179111|FG003|Overall Study|Early Termination|4|||
155202465|NCT03278873|560179108|FG000|Overall Study|Lost to Follow-up|0|||
155202466|NCT03278873|560179109|FG001|Overall Study|Lost to Follow-up|0|||
155202467|NCT03278873|560179110|FG002|Overall Study|Lost to Follow-up|2|||
155202468|NCT03278873|560179111|FG003|Overall Study|Lost to Follow-up|0|||
155202469|NCT03278873|560179108|FG000|Overall Study|The patient decided to withdraw via email|1|||
155202470|NCT03278873|560179109|FG001|Overall Study|The patient decided to withdraw via email|0|||
155202471|NCT03278873|560179110|FG002|Overall Study|The patient decided to withdraw via email|0|||
155202472|NCT03278873|560179111|FG003|Overall Study|The patient decided to withdraw via email|0|||
155202473|NCT03278873|560179108|FG000|Overall Study|The patient was unresponsive to contact|0|||
155202474|NCT03278873|560179109|FG001|Overall Study|The patient was unresponsive to contact|0|||
155202475|NCT03278873|560179110|FG002|Overall Study|The patient was unresponsive to contact|0|||
155202476|NCT03278873|560179111|FG003|Overall Study|The patient was unresponsive to contact|4|||
155202477|NCT03278873|560179108|FG000|Overall Study|The patient wished to participate no longer|0|||
155202478|NCT03278873|560179109|FG001|Overall Study|The patient wished to participate no longer|1|||
155202479|NCT03278873|560179110|FG002|Overall Study|The patient wished to participate no longer|0|||
155202480|NCT03278873|560179111|FG003|Overall Study|The patient wished to participate no longer|0|||
155202481|NCT03278873|560179108|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202482|NCT03278873|560179109|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202483|NCT03278873|560179110|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
155202484|NCT03278873|560179111|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202485|NCT04518306|560179127|FG000|Double-Blind Period|Run in failure|0|||
155202486|NCT04518306|560179128|FG001|Double-Blind Period|Run in failure|0|||
155202487|NCT04518306|560179129|FG002|Double-Blind Period|Run in failure|1|||
155202488|NCT04518306|560179127|FG000|Double-Blind Period|Adverse Event|0|||
155202489|NCT04518306|560179128|FG001|Double-Blind Period|Adverse Event|2|||
155202490|NCT04518306|560179129|FG002|Double-Blind Period|Adverse Event|2|||
155202491|NCT04518306|560179127|FG000|Double-Blind Period|Lost to Follow-up|1|||
155202492|NCT04518306|560179128|FG001|Double-Blind Period|Lost to Follow-up|2|||
155202493|NCT04518306|560179129|FG002|Double-Blind Period|Lost to Follow-up|2|||
155202494|NCT04518306|560179127|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
155202495|NCT04518306|560179128|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
155202496|NCT04518306|560179129|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
155202497|NCT04518306|560179127|FG000|Double-Blind Period|Other|0|||
155202498|NCT04518306|560179128|FG001|Double-Blind Period|Other|2|||
155202499|NCT04518306|560179129|FG002|Double-Blind Period|Other|0|||
155202500|NCT04518306|560179127|FG000|Double-Blind Period|Missing|0|||
155202501|NCT04518306|560179128|FG001|Double-Blind Period|Missing|1|||
155202502|NCT04518306|560179129|FG002|Double-Blind Period|Missing|0|||
155202503|NCT03268954|560179130|FG000|Overall Study|Withdrawal by Subject|27|||
155202504|NCT03268954|560179131|FG001|Overall Study|Withdrawal by Subject|17|||
155202505|NCT03268954|560179130|FG000|Overall Study|Lost to Follow-up|2|||
155202506|NCT03268954|560179131|FG001|Overall Study|Lost to Follow-up|3|||
155202507|NCT03268954|560179130|FG000|Overall Study|Reason Not Specified|3|||
155202508|NCT03268954|560179131|FG001|Overall Study|Reason Not Specified|8|||
155202509|NCT05358444|560179134|FG000|Overall Study|Withdrawal by Subject|0|||
155202510|NCT05358444|560179135|FG001|Overall Study|Withdrawal by Subject|1|||
155202511|NCT05358444|560179134|FG000|Overall Study|Lost to Follow-up|0|||
155202512|NCT05358444|560179135|FG001|Overall Study|Lost to Follow-up|3|||
155202513|NCT02801331|560179136|FG000|Overall Study|Transferred to another hospital|8|||
155202514|NCT02801331|560179137|FG001|Overall Study|Transferred to another hospital|7|||
155202515|NCT02801331|560179136|FG000|Overall Study|Withdrawal by Subject|0|||
155202516|NCT02801331|560179137|FG001|Overall Study|Withdrawal by Subject|4|||
155202517|NCT02801331|560179136|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
155202518|NCT02801331|560179137|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
155202519|NCT02443987|560179138|FG000|Overall Study|Bladder injury|1|||
155202520|NCT02443987|560179139|FG001|Overall Study|Bladder injury|1|||
155202521|NCT02443987|560179138|FG000|Overall Study|Other|0|||
155202522|NCT02443987|560179139|FG001|Overall Study|Other|1|||
155202523|NCT04698187|560179145|FG000|Overall Study|Withdrawal by Subject|7|||
155202524|NCT04698187|560179145|FG000|Overall Study|Death|21|||
155202525|NCT04698187|560179145|FG000|Overall Study|Sponsor Decision|15|||
155202526|NCT04698187|560179145|FG000|Overall Study|In-transit Disease|1|||
155202527|NCT03820986|560179146|FG000|Overall Study|Death|201|||
155202528|NCT03820986|560179147|FG001|Overall Study|Death|175|||
155202529|NCT03820986|560179146|FG000|Overall Study|Lost to Follow-up|1|||
155202530|NCT03820986|560179147|FG001|Overall Study|Lost to Follow-up|1|||
155202531|NCT03820986|560179146|FG000|Overall Study|Physician Decision|1|||
155202532|NCT03820986|560179147|FG001|Overall Study|Physician Decision|0|||
155202533|NCT03820986|560179146|FG000|Overall Study|Sponsor Decision|122|||
155202534|NCT03820986|560179147|FG001|Overall Study|Sponsor Decision|160|||
155202535|NCT03820986|560179146|FG000|Overall Study|Withdrawal by Subject|9|||
155202536|NCT03820986|560179147|FG001|Overall Study|Withdrawal by Subject|4|||
155202537|NCT03069378|560179148|FG000|Overall Study|Withdrawal by Subject|1|||
155202538|NCT02993146|560179149|FG000|Overall Study|Withdrawal by Subject|0|||
155202539|NCT02993146|560179150|FG001|Overall Study|Withdrawal by Subject|0|||
155202540|NCT02993146|560179151|FG002|Overall Study|Withdrawal by Subject|1|||
155202541|NCT02993146|560179152|FG003|Overall Study|Withdrawal by Subject|1|||
155202542|NCT01397708|560179153|FG000|Overall Study|Withdrawal by Subject|0|||
155202543|NCT01397708|560179154|FG001|Overall Study|Withdrawal by Subject|0|||
155202544|NCT01397708|560179155|FG002|Overall Study|Withdrawal by Subject|1|||
155202545|NCT01397708|560179156|FG003|Overall Study|Withdrawal by Subject|0|||
155202546|NCT01397708|560179157|FG004|Overall Study|Withdrawal by Subject|0|||
155202547|NCT01397708|560179158|FG005|Overall Study|Withdrawal by Subject|0|||
155202548|NCT01397708|560179159|FG006|Overall Study|Withdrawal by Subject|0|||
155202549|NCT01397708|560179160|FG007|Overall Study|Withdrawal by Subject|1|||
155202550|NCT01397708|560179153|FG000|Overall Study|Death|0|||
155202551|NCT01397708|560179154|FG001|Overall Study|Death|0|||
155202552|NCT01397708|560179155|FG002|Overall Study|Death|1|||
155202553|NCT01397708|560179156|FG003|Overall Study|Death|1|||
155202554|NCT01397708|560179157|FG004|Overall Study|Death|0|||
155202555|NCT01397708|560179158|FG005|Overall Study|Death|0|||
155202556|NCT01397708|560179159|FG006|Overall Study|Death|0|||
155202557|NCT01397708|560179160|FG007|Overall Study|Death|0|||
155202558|NCT01397708|560179153|FG000|Overall Study|Lost to Follow-up|0|||
155202559|NCT01397708|560179154|FG001|Overall Study|Lost to Follow-up|0|||
155202560|NCT01397708|560179155|FG002|Overall Study|Lost to Follow-up|0|||
155202561|NCT01397708|560179156|FG003|Overall Study|Lost to Follow-up|0|||
155202562|NCT01397708|560179157|FG004|Overall Study|Lost to Follow-up|1|||
155202563|NCT01397708|560179158|FG005|Overall Study|Lost to Follow-up|0|||
155202564|NCT01397708|560179159|FG006|Overall Study|Lost to Follow-up|0|||
155202565|NCT01397708|560179160|FG007|Overall Study|Lost to Follow-up|0|||
155202566|NCT01397708|560179153|FG000|Overall Study|Other|0|||
155202567|NCT01397708|560179154|FG001|Overall Study|Other|0|||
155202568|NCT01397708|560179155|FG002|Overall Study|Other|0|||
155202569|NCT01397708|560179156|FG003|Overall Study|Other|0|||
155202570|NCT01397708|560179157|FG004|Overall Study|Other|0|||
155202571|NCT01397708|560179158|FG005|Overall Study|Other|0|||
155202572|NCT01397708|560179159|FG006|Overall Study|Other|1|||
155202573|NCT01397708|560179160|FG007|Overall Study|Other|0|||
155202574|NCT04524689|560179163|FG000|Overall Study|Withdrawal by Subject|1|||
155202575|NCT04524689|560179164|FG001|Overall Study|Withdrawal by Subject|1|||
155202576|NCT04524689|560179165|FG002|Overall Study|Withdrawal by Subject|0|||
155202577|NCT04524689|560179166|FG003|Overall Study|Withdrawal by Subject|0|||
155202578|NCT04524689|560179167|FG004|Overall Study|Withdrawal by Subject|2|||
155202579|NCT04524689|560179168|FG005|Overall Study|Withdrawal by Subject|0|||
155202580|NCT04524689|560179163|FG000|Overall Study|Study terminated by Sponsor|6|||
155202581|NCT04524689|560179164|FG001|Overall Study|Study terminated by Sponsor|0|||
155202582|NCT04524689|560179165|FG002|Overall Study|Study terminated by Sponsor|1|||
155202583|NCT04524689|560179166|FG003|Overall Study|Study terminated by Sponsor|0|||
155202584|NCT04524689|560179167|FG004|Overall Study|Study terminated by Sponsor|4|||
155202585|NCT04524689|560179168|FG005|Overall Study|Study terminated by Sponsor|0|||
155202586|NCT04524689|560179163|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
155202587|NCT04524689|560179164|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
155202588|NCT04524689|560179165|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
155202589|NCT04524689|560179166|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
155202590|NCT04524689|560179167|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
155202591|NCT04524689|560179168|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
155202592|NCT04487730|560180744|FG000|Overall Study|Withdrawal by Subject|3|||
155202593|NCT04487730|560180745|FG001|Overall Study|Withdrawal by Subject|1|||
155202594|NCT04487730|560180744|FG000|Overall Study|Lost to Follow-up|0|||
155202595|NCT04487730|560180745|FG001|Overall Study|Lost to Follow-up|1|||
155202596|NCT04487730|560180744|FG000|Overall Study|Physician Decision|0|||
155202597|NCT04487730|560180745|FG001|Overall Study|Physician Decision|1|||
155202598|NCT00907777|560180746|FG000|Overall Study|Withdrawal by Subject|0|||
155202599|NCT00907777|560180747|FG001|Overall Study|Withdrawal by Subject|1|||
155202600|NCT03364023|560180750|FG000|Overall Study|Lost to Follow-up|3|||
155202601|NCT03364023|560180750|FG000|Overall Study|Death|14|||
155202602|NCT02820753|560180757|FG000|2 Month|Withdrawal by Subject|3|||
155202603|NCT02820753|560180758|FG001|2 Month|Withdrawal by Subject|3|||
155202604|NCT02820753|560180757|FG000|2 Month|Lost to Follow-up|24|||
155202605|NCT02820753|560180758|FG001|2 Month|Lost to Follow-up|26|||
155202606|NCT02820753|560180757|FG000|2 Month|Stopped per NIH Hold|51|||
155202607|NCT02820753|560180758|FG001|2 Month|Stopped per NIH Hold|13|||
155202608|NCT02820753|560180757|FG000|6 Month|Withdrawal by Subject|2|||
155202609|NCT02820753|560180758|FG001|6 Month|Withdrawal by Subject|2|||
155202610|NCT02820753|560180757|FG000|6 Month|Lost to Follow-up|20|||
155202611|NCT02820753|560180758|FG001|6 Month|Lost to Follow-up|27|||
155202612|NCT02820753|560180757|FG000|6 Month|Stopped per NIH Hold|81|||
155202613|NCT02820753|560180758|FG001|6 Month|Stopped per NIH Hold|81|||
155202614|NCT02820753|560180757|FG000|6 Month|Death|0|||
155202615|NCT02820753|560180758|FG001|6 Month|Death|1|||
155202616|NCT01397084|560180759|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155202617|NCT01397084|560180759|FG000|Overall Study|Protocol Violation|2|||
155202618|NCT01397084|560180759|FG000|Overall Study|Adverse Event|2|||
155202619|NCT01397084|560180759|FG000|Overall Study|Withdrawal by Subject|1|||
155202620|NCT01397084|560180759|FG000|Overall Study|Lost to Follow-up|1|||
155202621|NCT01397084|560180759|FG000|Overall Study|Used other proton pump inhibitor|1|||
155202622|NCT02155608|560180763|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
155202623|NCT02155608|560180764|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
155202624|NCT02155608|560180763|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
155202625|NCT02155608|560180764|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
155202626|NCT00684593|560180765|FG000|Overall Study|Adverse Event|0|||
155202627|NCT00684593|560180766|FG001|Overall Study|Adverse Event|2|||
155202628|NCT01751867|560180767|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
155202629|NCT01751867|560180768|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
155202630|NCT01751867|560180767|FG000|Overall Study|Diease Progression|4|||
155202631|NCT01751867|560180768|FG001|Overall Study|Diease Progression|18|||
155202632|NCT01751867|560180767|FG000|Overall Study|Adverse Event|8|||
155202633|NCT01751867|560180768|FG001|Overall Study|Adverse Event|15|||
155202634|NCT01751867|560180767|FG000|Overall Study|Poor Compliance|0|||
155202635|NCT01751867|560180768|FG001|Overall Study|Poor Compliance|5|||
155202636|NCT01751867|560180767|FG000|Overall Study|Withdrawal by Subject|3|||
155202637|NCT01751867|560180768|FG001|Overall Study|Withdrawal by Subject|1|||
155202638|NCT01751867|560180767|FG000|Overall Study|Physician Decision|4|||
155202639|NCT01751867|560180768|FG001|Overall Study|Physician Decision|7|||
155202640|NCT01751867|560180767|FG000|Overall Study|Protocol Violation|0|||
155202641|NCT01751867|560180768|FG001|Overall Study|Protocol Violation|2|||
155202642|NCT01751867|560180767|FG000|Overall Study|Death|0|||
155202643|NCT01751867|560180768|FG001|Overall Study|Death|5|||
155202644|NCT01751867|560180767|FG000|Overall Study|Other|11|||
155202645|NCT01751867|560180768|FG001|Overall Study|Other|37|||
155202646|NCT01751867|560180767|FG000|Overall Study|Randomized but not treated.|2|||
155202647|NCT01751867|560180768|FG001|Overall Study|Randomized but not treated.|1|||
155202648|NCT04932096|560180769|FG000|Overall Study|Withdrawal by Subject|1|||
155202649|NCT04932096|560180770|FG001|Overall Study|Withdrawal by Subject|1|||
155202650|NCT04932096|560180769|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
155202651|NCT04932096|560180770|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
155202652|NCT01396148|560180771|FG000|Overall Study|Patient Decision|1|||
155202653|NCT00224042|560180778|FG000|Overall Study|Adverse Event|2|||
155202654|NCT00224042|560180779|FG001|Overall Study|Adverse Event|1|||
155202655|NCT00224042|560180778|FG000|Overall Study|Protocol Violation|0|||
155202656|NCT00224042|560180779|FG001|Overall Study|Protocol Violation|1|||
155202657|NCT00224042|560180778|FG000|Overall Study|Physician Decision|0|||
155202658|NCT00224042|560180779|FG001|Overall Study|Physician Decision|1|||
155202659|NCT00224042|560180778|FG000|Overall Study|Did not meet lab incusion criteria|2|||
155202660|NCT00224042|560180779|FG001|Overall Study|Did not meet lab incusion criteria|3|||
155202661|NCT00224042|560180778|FG000|Overall Study|Other|2|||
155202662|NCT00224042|560180779|FG001|Overall Study|Other|0|||
155202663|NCT00840450|560180780|FG000|Overall Study|Adverse Event|1|||
155202664|NCT00840450|560180780|FG000|Overall Study|Lack of Efficacy|2|||
155202665|NCT03052725|560180783|FG000|Overall Study|Adverse Event|2|||
155202666|NCT03052725|560180784|FG001|Overall Study|Adverse Event|0|||
155202667|NCT03052725|560180783|FG000|Overall Study|Withdrawal by Subject|3|||
155202668|NCT03052725|560180784|FG001|Overall Study|Withdrawal by Subject|4|||
155202669|NCT03052725|560180783|FG000|Overall Study|Pregnancy|0|||
155202670|NCT03052725|560180784|FG001|Overall Study|Pregnancy|1|||
155202671|NCT03052725|560180783|FG000|Overall Study|Site closure|0|||
155202672|NCT03052725|560180784|FG001|Overall Study|Site closure|1|||
155202673|NCT03052725|560180783|FG000|Overall Study|Study terminated by sponsor|143|||
155202674|NCT03052725|560180784|FG001|Overall Study|Study terminated by sponsor|144|||
155202675|NCT01976338|560180789|FG000|Overall Study|Physician Decision|0|||
155202676|NCT01976338|560180790|FG001|Overall Study|Physician Decision|1|||
155202677|NCT01976338|560180789|FG000|Overall Study|Lost to Follow-up|3|||
155202678|NCT01976338|560180790|FG001|Overall Study|Lost to Follow-up|0|||
155202679|NCT01976338|560180789|FG000|Overall Study|Withdrawal by Subject|5|||
155202680|NCT01976338|560180790|FG001|Overall Study|Withdrawal by Subject|2|||
155202681|NCT01976338|560180789|FG000|Overall Study|Adverse Event|5|||
155202682|NCT01976338|560180790|FG001|Overall Study|Adverse Event|1|||
155202683|NCT04213079|560180791|FG000|Overall Study|Lost to Follow-up|0|||
155202684|NCT04213079|560180792|FG001|Overall Study|Lost to Follow-up|2|||
155202685|NCT00520936|560180794|FG000|Overall Study|Physician Decision|0|||
155202686|NCT00520936|560180795|FG001|Overall Study|Physician Decision|2|||
155202687|NCT00520936|560180796|FG002|Overall Study|Physician Decision|1|||
155202688|NCT00520936|560180797|FG003|Overall Study|Physician Decision|0|||
155202689|NCT00520936|560180798|FG004|Overall Study|Physician Decision|0|||
155202690|NCT00520936|560180799|FG005|Overall Study|Physician Decision|0|||
155202691|NCT00520936|560180800|FG006|Overall Study|Physician Decision|0|||
155202692|NCT00520936|560180801|FG007|Overall Study|Physician Decision|0|||
155202693|NCT00520936|560180794|FG000|Overall Study|Withdrawal by Subject|0|||
155202694|NCT00520936|560180795|FG001|Overall Study|Withdrawal by Subject|0|||
155202695|NCT00520936|560180796|FG002|Overall Study|Withdrawal by Subject|0|||
155202696|NCT00520936|560180797|FG003|Overall Study|Withdrawal by Subject|0|||
155202697|NCT00520936|560180798|FG004|Overall Study|Withdrawal by Subject|0|||
155202698|NCT00520936|560180799|FG005|Overall Study|Withdrawal by Subject|0|||
155202699|NCT00520936|560180800|FG006|Overall Study|Withdrawal by Subject|0|||
155202700|NCT00520936|560180801|FG007|Overall Study|Withdrawal by Subject|1|||
155202701|NCT00520936|560180794|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
155202702|NCT00520936|560180795|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
155202703|NCT00520936|560180796|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
155202704|NCT00520936|560180797|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
155202705|NCT00520936|560180798|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
155202706|NCT00520936|560180799|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
155202707|NCT00520936|560180800|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
155202708|NCT00520936|560180801|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
155202709|NCT00520936|560180794|FG000|Overall Study|Death|0|||
155202710|NCT00520936|560180795|FG001|Overall Study|Death|0|||
155202711|NCT00520936|560180796|FG002|Overall Study|Death|0|||
155202712|NCT00520936|560180797|FG003|Overall Study|Death|0|||
155202713|NCT00520936|560180798|FG004|Overall Study|Death|0|||
155202714|NCT00520936|560180799|FG005|Overall Study|Death|0|||
155202715|NCT00520936|560180800|FG006|Overall Study|Death|1|||
155202716|NCT00520936|560180801|FG007|Overall Study|Death|0|||
155202717|NCT00520936|560180794|FG000|Overall Study|Protocol Violation|0|||
155202718|NCT00520936|560180795|FG001|Overall Study|Protocol Violation|1|||
155202719|NCT00520936|560180796|FG002|Overall Study|Protocol Violation|1|||
155202720|NCT00520936|560180797|FG003|Overall Study|Protocol Violation|0|||
155202721|NCT00520936|560180798|FG004|Overall Study|Protocol Violation|1|||
155202722|NCT00520936|560180799|FG005|Overall Study|Protocol Violation|0|||
155202723|NCT00520936|560180800|FG006|Overall Study|Protocol Violation|1|||
155202724|NCT00520936|560180801|FG007|Overall Study|Protocol Violation|0|||
155202725|NCT01061177|560180809|FG000|Overall Study|Adverse Event|117|||
155202726|NCT01061177|560180809|FG000|Overall Study|Withdrawal by Subject|27|||
155202727|NCT01061177|560180809|FG000|Overall Study|Disease progression|17|||
155202728|NCT01061177|560180809|FG000|Overall Study|Protocol Violation|11|||
155202729|NCT01061177|560180809|FG000|Overall Study|Lost to Follow-up|9|||
155202730|NCT01061177|560180809|FG000|Overall Study|New cancer therapy|9|||
155202731|NCT01061177|560180809|FG000|Overall Study|Abnormal laboratory values|6|||
155202732|NCT01061177|560180809|FG000|Overall Study|Abnormal test procedure results|4|||
155202733|NCT01061177|560180809|FG000|Overall Study|Administratie problems|4|||
155202734|NCT01061177|560180809|FG000|Overall Study|Death|4|||
155202735|NCT03984994|560180810|FG000|Overall Study|Withdrawal by Subject|2|||
155202736|NCT03984994|560180811|FG001|Overall Study|Withdrawal by Subject|1|||
155202737|NCT03010176|560180812|FG000|Overall Study|Death|21|||
155202738|NCT03010176|560180813|FG001|Overall Study|Death|35|||
155202739|NCT03010176|560180814|FG002|Overall Study|Death|19|||
155202740|NCT03010176|560180815|FG003|Overall Study|Death|19|||
155202741|NCT03010176|560180816|FG004|Overall Study|Death|14|||
155202742|NCT03010176|560180817|FG005|Overall Study|Death|0|||
155202743|NCT03010176|560180812|FG000|Overall Study|Lost to Follow-up|0|||
155202744|NCT03010176|560180813|FG001|Overall Study|Lost to Follow-up|0|||
155202745|NCT03010176|560180814|FG002|Overall Study|Lost to Follow-up|0|||
155202746|NCT03010176|560180815|FG003|Overall Study|Lost to Follow-up|0|||
155202747|NCT03010176|560180816|FG004|Overall Study|Lost to Follow-up|1|||
155202748|NCT03010176|560180817|FG005|Overall Study|Lost to Follow-up|0|||
155202749|NCT03010176|560180812|FG000|Overall Study|Physician Decision|0|||
155202750|NCT03010176|560180813|FG001|Overall Study|Physician Decision|4|||
155202751|NCT03010176|560180814|FG002|Overall Study|Physician Decision|0|||
155202752|NCT03010176|560180815|FG003|Overall Study|Physician Decision|1|||
155202753|NCT03010176|560180816|FG004|Overall Study|Physician Decision|0|||
155202754|NCT03010176|560180817|FG005|Overall Study|Physician Decision|0|||
155202755|NCT03010176|560180812|FG000|Overall Study|Sponsor Decision|0|||
155202756|NCT03010176|560180813|FG001|Overall Study|Sponsor Decision|4|||
155202757|NCT03010176|560180814|FG002|Overall Study|Sponsor Decision|4|||
155202758|NCT03010176|560180815|FG003|Overall Study|Sponsor Decision|1|||
155202759|NCT03010176|560180816|FG004|Overall Study|Sponsor Decision|6|||
155202760|NCT03010176|560180817|FG005|Overall Study|Sponsor Decision|0|||
155202761|NCT03010176|560180812|FG000|Overall Study|Withdrawal by Subject|11|||
155202762|NCT03010176|560180813|FG001|Overall Study|Withdrawal by Subject|9|||
155202763|NCT03010176|560180814|FG002|Overall Study|Withdrawal by Subject|3|||
155202764|NCT03010176|560180815|FG003|Overall Study|Withdrawal by Subject|0|||
155202765|NCT03010176|560180816|FG004|Overall Study|Withdrawal by Subject|4|||
155202766|NCT03010176|560180817|FG005|Overall Study|Withdrawal by Subject|0|||
155202767|NCT04220866|560180818|FG000|Overall Study|Death|4|||
155202768|NCT04220866|560180819|FG001|Overall Study|Death|5|||
155202769|NCT04220866|560180818|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
155202770|NCT04220866|560180819|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
155202771|NCT04220866|560180818|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
155202772|NCT04220866|560180819|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
155202773|NCT04220866|560180818|FG000|Overall Study|Withdrawal by Subject|0|||
155202774|NCT04220866|560180819|FG001|Overall Study|Withdrawal by Subject|1|||
155202775|NCT03897465|560180825|FG000|Overall Study|Lost to Follow-up|2|||
155202776|NCT03897465|560180826|FG001|Overall Study|Lost to Follow-up|1|||
155202777|NCT03897465|560180825|FG000|Overall Study|Adverse Event|2|||
155202778|NCT03897465|560180826|FG001|Overall Study|Adverse Event|0|||
155202779|NCT03897465|560180825|FG000|Overall Study|complete healing by V2|1|||
155202780|NCT03897465|560180826|FG001|Overall Study|complete healing by V2|0|||
155202781|NCT03897465|560180825|FG000|Overall Study|occurence of exclusion criterion|1|||
155202782|NCT03897465|560180826|FG001|Overall Study|occurence of exclusion criterion|1|||
155202783|NCT03897465|560180825|FG000|Overall Study|Other|1|||
155202784|NCT03897465|560180826|FG001|Overall Study|Other|0|||
155202785|NCT00521014|560180827|FG000|Overall Study|Inevaluable, not treated|1|||
155202786|NCT02864498|560180828|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
155202787|NCT02864498|560180829|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
155202788|NCT02864498|560180830|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
155202789|NCT02864498|560180828|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
155202790|NCT02864498|560180829|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
155202791|NCT02864498|560180830|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
155202792|NCT02864498|560180828|FG000|Overall Study|Investigator Discretion|0|||
155202793|NCT02864498|560180829|FG001|Overall Study|Investigator Discretion|2|||
155202794|NCT02864498|560180830|FG002|Overall Study|Investigator Discretion|1|||
155202795|NCT02864498|560180828|FG000|Overall Study|Lost to Follow-up|8|||
155202796|NCT02864498|560180829|FG001|Overall Study|Lost to Follow-up|6|||
155202797|NCT02864498|560180830|FG002|Overall Study|Lost to Follow-up|3|||
155202798|NCT02864498|560180828|FG000|Overall Study|Lack of Efficacy|5|||
155202799|NCT02864498|560180829|FG001|Overall Study|Lack of Efficacy|3|||
155202800|NCT02864498|560180830|FG002|Overall Study|Lack of Efficacy|3|||
155202801|NCT02864498|560180828|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
155202802|NCT02864498|560180829|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
155202803|NCT02864498|560180830|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
155202804|NCT02864498|560180828|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
155202805|NCT02864498|560180829|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
155202806|NCT02864498|560180830|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
155202807|NCT02864498|560180828|FG000|Overall Study|Subject moved out of the country.|0|||
155202808|NCT02864498|560180829|FG001|Overall Study|Subject moved out of the country.|0|||
155202809|NCT02864498|560180830|FG002|Overall Study|Subject moved out of the country.|1|||
155202810|NCT03132220|560180832|FG000|Overall Study|Lost to Follow-up|17|||
155202811|NCT03132220|560180833|FG001|Overall Study|Lost to Follow-up|8|||
155202812|NCT03132220|560180832|FG000|Overall Study|Withdrawal by Subject|1|||
155202813|NCT03132220|560180833|FG001|Overall Study|Withdrawal by Subject|4|||
155202814|NCT00601458|560180834|FG000|Overall Study|Dosing Error|1|||
155202815|NCT00601458|560180835|FG001|Overall Study|Dosing Error|0|||
155202816|NCT00601458|560180836|FG002|Overall Study|Dosing Error|0|||
155202817|NCT00601458|560180834|FG000|Overall Study|Incomplete Data|0|||
155202818|NCT00601458|560180835|FG001|Overall Study|Incomplete Data|2|||
155202819|NCT00601458|560180836|FG002|Overall Study|Incomplete Data|0|||
155202820|NCT00601458|560180834|FG000|Overall Study|Protocol Violation|3|||
155202821|NCT00601458|560180835|FG001|Overall Study|Protocol Violation|2|||
155202822|NCT00601458|560180836|FG002|Overall Study|Protocol Violation|1|||
155202823|NCT00601458|560180834|FG000|Overall Study|Early Termination|0|||
155202824|NCT00601458|560180835|FG001|Overall Study|Early Termination|1|||
155202825|NCT00601458|560180836|FG002|Overall Study|Early Termination|1|||
155202826|NCT00370032|560180837|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
155202827|NCT00370032|560180838|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
155202828|NCT00370032|560180837|FG000|Washout Period|Withdrawal by Subject|0|||
155202829|NCT00370032|560180838|FG001|Washout Period|Withdrawal by Subject|1|||
155202830|NCT00370032|560180837|FG000|Washout Period|Lost to Follow-up|0|||
155202831|NCT00370032|560180838|FG001|Washout Period|Lost to Follow-up|1|||
155202832|NCT00370032|560180837|FG000|Washout Period|Adverse Event|1|||
155202833|NCT00370032|560180838|FG001|Washout Period|Adverse Event|0|||
155202834|NCT00370032|560180837|FG000|Follow-up Period|Withdrawal by Subject|1|||
155202835|NCT00370032|560180838|FG001|Follow-up Period|Withdrawal by Subject|0|||
155202836|NCT00518986|560180839|FG000|Overall Study|Adverse Event|12|||
155202837|NCT00518986|560180840|FG001|Overall Study|Adverse Event|7|||
155202838|NCT00518986|560180839|FG000|Overall Study|Lack of Efficacy|0|||
155202839|NCT00518986|560180840|FG001|Overall Study|Lack of Efficacy|2|||
155202840|NCT00518986|560180839|FG000|Overall Study|Lost to Follow-up|3|||
155202841|NCT00518986|560180840|FG001|Overall Study|Lost to Follow-up|2|||
155202842|NCT00518986|560180839|FG000|Overall Study|Physician Decision|0|||
155202843|NCT00518986|560180840|FG001|Overall Study|Physician Decision|3|||
155202844|NCT00518986|560180839|FG000|Overall Study|Protocol Violation|5|||
155202845|NCT00518986|560180840|FG001|Overall Study|Protocol Violation|7|||
155202846|NCT00518986|560180839|FG000|Overall Study|Withdrawal by Subject|4|||
155202847|NCT00518986|560180840|FG001|Overall Study|Withdrawal by Subject|4|||
155202848|NCT00518986|560180839|FG000|Overall Study|Non-Specific|2|||
155202849|NCT00518986|560180840|FG001|Overall Study|Non-Specific|1|||
155202850|NCT00968513|560180841|FG000|Overall Study|Death|4|||
155202851|NCT00968513|560180842|FG001|Overall Study|Death|10|||
155202852|NCT00968513|560180843|FG002|Overall Study|Death|15|||
155202853|NCT01328431|560180844|FG000|Baseline|Protocol Violation|0|||
155202854|NCT01328431|560180845|FG001|Baseline|Protocol Violation|2|||
155202855|NCT01328431|560180844|FG000|1 Month (1M)|Lost to Follow-up|55|||
155202856|NCT01328431|560180845|FG001|1 Month (1M)|Lost to Follow-up|58|||
155202857|NCT01328431|560180844|FG000|3 Month (3M)|Death|2|||
155202858|NCT01328431|560180845|FG001|3 Month (3M)|Death|2|||
155202859|NCT01328431|560180844|FG000|3 Month (3M)|Lost to Follow-up|75|||
155202860|NCT01328431|560180845|FG001|3 Month (3M)|Lost to Follow-up|70|||
155202861|NCT01328431|560180844|FG000|12 Month (12M)|Death|2|||
155202862|NCT01328431|560180845|FG001|12 Month (12M)|Death|6|||
155202863|NCT01328431|560180844|FG000|12 Month (12M)|Lost to Follow-up|82|||
155202864|NCT01328431|560180845|FG001|12 Month (12M)|Lost to Follow-up|91|||
155202865|NCT05466682|560180849|FG000|Overall Study|Withdrawal by Subject|0|||
155202866|NCT05466682|560180850|FG001|Overall Study|Withdrawal by Subject|2|||
155202867|NCT05466682|560180849|FG000|Overall Study|Lost to Follow-up|2|||
155202868|NCT05466682|560180850|FG001|Overall Study|Lost to Follow-up|1|||
155202869|NCT02801396|560180851|FG000|Period 1|Withdrawal by Subject|0|||
155202870|NCT02801396|560180852|FG001|Period 1|Withdrawal by Subject|0|||
155202871|NCT02801396|560180853|FG002|Period 1|Withdrawal by Subject|0|||
155202872|NCT02801396|560180854|FG003|Period 1|Withdrawal by Subject|0|||
155202873|NCT02801396|560180855|FG004|Period 1|Withdrawal by Subject|1|||
155202874|NCT02801396|560180856|FG005|Period 1|Withdrawal by Subject|0|||
155202875|NCT03208244|560180857|FG000|Overall Study|Death|1|||
155202876|NCT04967443|560180864|FG000|Open Label Treatment|Death|1|||
155202877|NCT04967443|560180865|FG001|Open Label Treatment|Death|0|||
155202878|NCT04967443|560180866|FG002|Open Label Treatment|Death|0|||
155202879|NCT04967443|560180867|FG003|Open Label Treatment|Death|0|||
155202880|NCT04967443|560180868|FG004|Open Label Treatment|Death|0|||
155202881|NCT04967443|560180869|FG005|Open Label Treatment|Death|0|||
155202882|NCT04967443|560180870|FG006|Open Label Treatment|Death|0|||
155202883|NCT04967443|560180871|FG007|Open Label Treatment|Death|0|||
155202884|NCT04967443|560180864|FG000|Open Label Treatment|Lost to Follow-up|0|||
155202885|NCT04967443|560180865|FG001|Open Label Treatment|Lost to Follow-up|0|||
155202886|NCT04967443|560180866|FG002|Open Label Treatment|Lost to Follow-up|1|||
155202887|NCT04967443|560180867|FG003|Open Label Treatment|Lost to Follow-up|0|||
155202888|NCT04967443|560180868|FG004|Open Label Treatment|Lost to Follow-up|0|||
155202889|NCT04967443|560180869|FG005|Open Label Treatment|Lost to Follow-up|0|||
155202890|NCT04967443|560180870|FG006|Open Label Treatment|Lost to Follow-up|0|||
155202891|NCT04967443|560180871|FG007|Open Label Treatment|Lost to Follow-up|0|||
155202892|NCT04967443|560180864|FG000|Open Label Treatment|Withdrawal by Subject|0|||
155202893|NCT04967443|560180865|FG001|Open Label Treatment|Withdrawal by Subject|1|||
155202894|NCT04967443|560180866|FG002|Open Label Treatment|Withdrawal by Subject|0|||
155202895|NCT04967443|560180867|FG003|Open Label Treatment|Withdrawal by Subject|1|||
155202896|NCT04967443|560180868|FG004|Open Label Treatment|Withdrawal by Subject|0|||
155202897|NCT04967443|560180869|FG005|Open Label Treatment|Withdrawal by Subject|1|||
155202898|NCT04967443|560180870|FG006|Open Label Treatment|Withdrawal by Subject|2|||
155202899|NCT04967443|560180871|FG007|Open Label Treatment|Withdrawal by Subject|3|||
155202900|NCT04967443|560180864|FG000|Follow-Up|Death|1|||
155202901|NCT04967443|560180865|FG001|Follow-Up|Death|0|||
155202902|NCT04967443|560180866|FG002|Follow-Up|Death|0|||
155202903|NCT04967443|560180867|FG003|Follow-Up|Death|0|||
155202904|NCT04967443|560180868|FG004|Follow-Up|Death|0|||
155202905|NCT04967443|560180869|FG005|Follow-Up|Death|0|||
155202906|NCT04967443|560180870|FG006|Follow-Up|Death|0|||
155202907|NCT04967443|560180871|FG007|Follow-Up|Death|0|||
155202908|NCT04967443|560180864|FG000|Follow-Up|Lost to Follow-up|0|||
155202909|NCT04967443|560180865|FG001|Follow-Up|Lost to Follow-up|0|||
155202910|NCT04967443|560180866|FG002|Follow-Up|Lost to Follow-up|1|||
155202911|NCT04967443|560180867|FG003|Follow-Up|Lost to Follow-up|1|||
155202912|NCT04967443|560180868|FG004|Follow-Up|Lost to Follow-up|0|||
155202913|NCT04967443|560180869|FG005|Follow-Up|Lost to Follow-up|0|||
155202914|NCT04967443|560180870|FG006|Follow-Up|Lost to Follow-up|0|||
155202915|NCT04967443|560180871|FG007|Follow-Up|Lost to Follow-up|0|||
155202916|NCT04967443|560180864|FG000|Follow-Up|Withdrawal by Subject|0|||
155202917|NCT04967443|560180865|FG001|Follow-Up|Withdrawal by Subject|1|||
155202918|NCT04967443|560180866|FG002|Follow-Up|Withdrawal by Subject|0|||
155202919|NCT04967443|560180867|FG003|Follow-Up|Withdrawal by Subject|1|||
155202920|NCT04967443|560180868|FG004|Follow-Up|Withdrawal by Subject|0|||
155202921|NCT04967443|560180869|FG005|Follow-Up|Withdrawal by Subject|1|||
155202922|NCT04967443|560180870|FG006|Follow-Up|Withdrawal by Subject|2|||
155202923|NCT04967443|560180871|FG007|Follow-Up|Withdrawal by Subject|3|||
155202924|NCT02405780|560180872|FG000|Period I|Adverse Event|8|||
155202925|NCT02405780|560180873|FG001|Period I|Adverse Event|0|||
155202926|NCT02405780|560180874|FG002|Period I|Adverse Event|3|||
155202927|NCT02405780|560180875|FG003|Period I|Adverse Event|7|||
155202928|NCT02405780|560180872|FG000|Period I|Medical reasons|1|||
155202929|NCT02405780|560180873|FG001|Period I|Medical reasons|1|||
155202930|NCT02405780|560180874|FG002|Period I|Medical reasons|0|||
155202931|NCT02405780|560180875|FG003|Period I|Medical reasons|1|||
155202932|NCT02405780|560180872|FG000|Period I|Screening Failure|1|||
155202933|NCT02405780|560180873|FG001|Period I|Screening Failure|0|||
155202934|NCT02405780|560180874|FG002|Period I|Screening Failure|1|||
155202935|NCT02405780|560180875|FG003|Period I|Screening Failure|0|||
155202936|NCT02405780|560180872|FG000|Period I|Withdrawal by Subject|9|||
155202937|NCT02405780|560180873|FG001|Period I|Withdrawal by Subject|1|||
155202938|NCT02405780|560180874|FG002|Period I|Withdrawal by Subject|3|||
155202939|NCT02405780|560180875|FG003|Period I|Withdrawal by Subject|4|||
155202940|NCT02405780|560180872|FG000|Period I|Non-compliance with study procedures|8|||
155202941|NCT02405780|560180873|FG001|Period I|Non-compliance with study procedures|6|||
155202942|NCT02405780|560180874|FG002|Period I|Non-compliance with study procedures|8|||
155202943|NCT02405780|560180875|FG003|Period I|Non-compliance with study procedures|11|||
155202944|NCT02405780|560180872|FG000|Period II|Adverse Event|3|||
155202945|NCT02405780|560180873|FG001|Period II|Adverse Event|5|||
155202946|NCT02405780|560180874|FG002|Period II|Adverse Event|4|||
155202947|NCT02405780|560180875|FG003|Period II|Adverse Event|11|||
155202948|NCT02405780|560180872|FG000|Period II|Medical reason|0|||
155202949|NCT02405780|560180873|FG001|Period II|Medical reason|1|||
155202950|NCT02405780|560180874|FG002|Period II|Medical reason|0|||
155202951|NCT02405780|560180875|FG003|Period II|Medical reason|0|||
155202952|NCT02405780|560180872|FG000|Period II|Pregnancy|0|||
155202953|NCT02405780|560180873|FG001|Period II|Pregnancy|0|||
155202954|NCT02405780|560180874|FG002|Period II|Pregnancy|1|||
155202955|NCT02405780|560180875|FG003|Period II|Pregnancy|0|||
155202956|NCT02405780|560180872|FG000|Period II|Withdrawal by Subject|7|||
155202957|NCT02405780|560180873|FG001|Period II|Withdrawal by Subject|4|||
155202958|NCT02405780|560180874|FG002|Period II|Withdrawal by Subject|0|||
155202959|NCT02405780|560180875|FG003|Period II|Withdrawal by Subject|3|||
155202960|NCT02405780|560180872|FG000|Period II|Non-compliance with study procedures|5|||
155202961|NCT02405780|560180873|FG001|Period II|Non-compliance with study procedures|2|||
155202962|NCT02405780|560180874|FG002|Period II|Non-compliance with study procedures|7|||
155202963|NCT02405780|560180875|FG003|Period II|Non-compliance with study procedures|4|||
155202964|NCT01654536|560180876|FG000|Overall Study|Lost to Follow-up|5|||
155202965|NCT01654536|560180877|FG001|Overall Study|Lost to Follow-up|5|||
155202966|NCT01654536|560180876|FG000|Overall Study|Physician Decision|12|||
155202967|NCT01654536|560180877|FG001|Overall Study|Physician Decision|8|||
155202968|NCT01654536|560180876|FG000|Overall Study|Withdrawal by Subject|27|||
155202969|NCT01654536|560180877|FG001|Overall Study|Withdrawal by Subject|25|||
155202970|NCT00668707|560180878|FG000|Overall Study|Cancer Recurrence|58|||
155202971|NCT00668707|560180879|FG001|Overall Study|Cancer Recurrence|58|||
155202972|NCT00668707|560180878|FG000|Overall Study|Withdrawal by Subject|117|||
155202973|NCT00668707|560180879|FG001|Overall Study|Withdrawal by Subject|100|||
155202974|NCT00668707|560180878|FG000|Overall Study|Lost to Follow-up|3|||
155202975|NCT00668707|560180879|FG001|Overall Study|Lost to Follow-up|6|||
155202976|NCT00668707|560180878|FG000|Overall Study|Protocol Violation|10|||
155202977|NCT00668707|560180879|FG001|Overall Study|Protocol Violation|12|||
155202978|NCT00668707|560180878|FG000|Overall Study|Death|11|||
155202979|NCT00668707|560180879|FG001|Overall Study|Death|4|||
155202980|NCT04502693|560180880|FG000|Overall Study|Adverse Event|7|||
155202981|NCT04502693|560180881|FG001|Overall Study|Adverse Event|6|||
155202982|NCT04502693|560180882|FG002|Overall Study|Adverse Event|11|||
155202983|NCT04502693|560180883|FG003|Overall Study|Adverse Event|1|||
155202984|NCT04502693|560180880|FG000|Overall Study|Lost to Follow-up|32|||
155202985|NCT04502693|560180881|FG001|Overall Study|Lost to Follow-up|36|||
155202986|NCT04502693|560180882|FG002|Overall Study|Lost to Follow-up|69|||
155202987|NCT04502693|560180883|FG003|Overall Study|Lost to Follow-up|4|||
155202988|NCT04502693|560180880|FG000|Overall Study|Protocol Violation|8|||
155202989|NCT04502693|560180881|FG001|Overall Study|Protocol Violation|8|||
155202990|NCT04502693|560180882|FG002|Overall Study|Protocol Violation|16|||
155202991|NCT04502693|560180883|FG003|Overall Study|Protocol Violation|1|||
155202992|NCT04502693|560180880|FG000|Overall Study|Withdrawal by Subject|46|||
155202993|NCT04502693|560180881|FG001|Overall Study|Withdrawal by Subject|38|||
155202994|NCT04502693|560180882|FG002|Overall Study|Withdrawal by Subject|54|||
155202995|NCT04502693|560180883|FG003|Overall Study|Withdrawal by Subject|7|||
155202996|NCT04502693|560180880|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
155202997|NCT04502693|560180881|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
155202998|NCT04502693|560180882|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
155202999|NCT04502693|560180883|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155203000|NCT04502693|560180880|FG000|Overall Study|Other|1|||
155203001|NCT04502693|560180881|FG001|Overall Study|Other|0|||
155203002|NCT04502693|560180882|FG002|Overall Study|Other|1|||
155203003|NCT04502693|560180883|FG003|Overall Study|Other|1|||
155203004|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
155203005|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
155203006|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
155203007|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
155203008|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
155203009|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
155203010|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
155203011|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
155203012|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
155203013|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
155203014|NCT03943147|560180884|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
155203015|NCT03943147|560180885|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
155203016|NCT00968201|560180888|FG000|Base Study - (Period II)|Adverse Event|8|||
155203017|NCT00968201|560180889|FG001|Base Study - (Period II)|Adverse Event|0|||
155203018|NCT00968201|560180890|FG002|Base Study - (Period II)|Adverse Event|16|||
155203019|NCT00968201|560180888|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
155203020|NCT00968201|560180889|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
155203021|NCT00968201|560180890|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
155203022|NCT00968201|560180888|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
155203023|NCT00968201|560180889|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
155203024|NCT00968201|560180890|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
155203025|NCT00968201|560180888|FG000|Base Study - (Period II)|Protocol Violation|12|||
155203026|NCT00968201|560180889|FG001|Base Study - (Period II)|Protocol Violation|0|||
155203027|NCT00968201|560180890|FG002|Base Study - (Period II)|Protocol Violation|12|||
155203028|NCT00968201|560180888|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
155203029|NCT00968201|560180889|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
155203030|NCT00968201|560180890|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
155203031|NCT00968201|560180888|FG000|Base Study - (Period II)|Site Error|0|||
155203032|NCT00968201|560180889|FG001|Base Study - (Period II)|Site Error|0|||
155203033|NCT00968201|560180890|FG002|Base Study - (Period II)|Site Error|1|||
155203034|NCT00968201|560180888|FG000|Extension Study - (Period III)|Adverse Event|0|||
155203035|NCT00968201|560180889|FG001|Extension Study - (Period III)|Adverse Event|5|||
155203036|NCT00968201|560180890|FG002|Extension Study - (Period III)|Adverse Event|22|||
155203037|NCT00968201|560180888|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
155203038|NCT00968201|560180889|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
155203039|NCT00968201|560180890|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
155203040|NCT00968201|560180888|FG000|Extension Study - (Period III)|Protocol Violation|0|||
155203041|NCT00968201|560180889|FG001|Extension Study - (Period III)|Protocol Violation|17|||
155203042|NCT00968201|560180890|FG002|Extension Study - (Period III)|Protocol Violation|14|||
155203043|NCT00968201|560180888|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
155203044|NCT00968201|560180889|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
155203045|NCT00968201|560180890|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
155203046|NCT00968201|560180888|FG000|Extension Study - (Period III)|Patient Relocated|0|||
155203047|NCT00968201|560180889|FG001|Extension Study - (Period III)|Patient Relocated|1|||
155203048|NCT00968201|560180890|FG002|Extension Study - (Period III)|Patient Relocated|1|||
155203049|NCT00968201|560180888|FG000|Extension Study - (Period III)|Noncompliance|0|||
155203050|NCT00968201|560180889|FG001|Extension Study - (Period III)|Noncompliance|0|||
155203051|NCT00968201|560180890|FG002|Extension Study - (Period III)|Noncompliance|3|||
155203052|NCT00968201|560180888|FG000|Extension Study - (Period III)|Other|0|||
155203053|NCT00968201|560180889|FG001|Extension Study - (Period III)|Other|0|||
155203054|NCT00968201|560180890|FG002|Extension Study - (Period III)|Other|2|||
155203055|NCT00968201|560180888|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
155203056|NCT00968201|560180889|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
155203057|NCT00968201|560180890|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
155203058|NCT01382212|560180892|FG000|Overall Study|Kidney transplant|1|||
155203059|NCT01382212|560180892|FG000|Overall Study|Withdrew consent|1|||
155203060|NCT01949506|560180900|FG000|Overall Study|Physician Decision|1|||
155203061|NCT02513394|560180901|FG000|Overall Study|Withdrawal by Subject|11|||
155203062|NCT02513394|560180902|FG001|Overall Study|Withdrawal by Subject|23|||
155203063|NCT02513394|560180901|FG000|Overall Study|Ineligible|1|||
155203064|NCT02513394|560180902|FG001|Overall Study|Ineligible|0|||
155203065|NCT00612690|560182672|FG000|Overall Study|Lost to Follow-up|72|||
155203066|NCT00612690|560182673|FG001|Overall Study|Lost to Follow-up|98|||
155203067|NCT00612690|560182672|FG000|Overall Study|Withdrawal by Subject|32|||
155203068|NCT00612690|560182673|FG001|Overall Study|Withdrawal by Subject|20|||
155203069|NCT00612690|560182672|FG000|Overall Study|Withdrawal by Site|11|||
155203070|NCT00612690|560182673|FG001|Overall Study|Withdrawal by Site|0|||
155203071|NCT01664533|560182674|FG000|Overall Study|Death|42|||
155203072|NCT01664533|560182674|FG000|Overall Study|Lost to Follow-up|3|||
155203073|NCT01664533|560182674|FG000|Overall Study|Study termination|9|||
155203074|NCT01664533|560182674|FG000|Overall Study|Protocol Violation|3|||
155203075|NCT00844831|560182676|FG000|Overall Study|Withdrawal by Subject|4|||
155203076|NCT00844831|560182676|FG000|Overall Study|Adverse Event|1|||
155203077|NCT00844831|560182676|FG000|Overall Study|Physician Decision|1|||
155203078|NCT05255068|560182677|FG000|Overall Study|Lost to Follow-up|0|||
155203079|NCT05255068|560182678|FG001|Overall Study|Lost to Follow-up|1|||
155203080|NCT03156543|560182680|FG000|Overall Study|Withdrawal by Subject|1|||
155203081|NCT03156543|560182681|FG001|Overall Study|Withdrawal by Subject|0|||
155203082|NCT02674529|560182682|FG000|Overall Study|Lost to Follow-up|1|||
155203083|NCT02674529|560182683|FG001|Overall Study|Lost to Follow-up|2|||
155203084|NCT02674529|560182682|FG000|Overall Study|Withdrawal by Subject|2|||
155203085|NCT02674529|560182683|FG001|Overall Study|Withdrawal by Subject|1|||
155203086|NCT02674529|560182682|FG000|Overall Study|Physician Decision|0|||
155203087|NCT02674529|560182683|FG001|Overall Study|Physician Decision|1|||
155203088|NCT02674529|560182682|FG000|Overall Study|Protocol Violation|0|||
155203089|NCT02674529|560182683|FG001|Overall Study|Protocol Violation|1|||
155203090|NCT02891850|560182684|FG000|Overall Study|Adverse Event|3|||
155203091|NCT02891850|560182685|FG001|Overall Study|Adverse Event|0|||
155203092|NCT02891850|560182684|FG000|Overall Study|Death|0|||
155203093|NCT02891850|560182685|FG001|Overall Study|Death|4|||
155203094|NCT02891850|560182684|FG000|Overall Study|Physician Decision|1|||
155203095|NCT02891850|560182685|FG001|Overall Study|Physician Decision|0|||
155203096|NCT02891850|560182684|FG000|Overall Study|Pregnancy|1|||
155203097|NCT02891850|560182685|FG001|Overall Study|Pregnancy|0|||
155203098|NCT02891850|560182684|FG000|Overall Study|Withdrawal by Subject|2|||
155203099|NCT02891850|560182685|FG001|Overall Study|Withdrawal by Subject|3|||
155203100|NCT02397278|560182693|FG000|Overall Study|Withdrawal by Subject|0|||
155203101|NCT02397278|560182694|FG001|Overall Study|Withdrawal by Subject|2|||
155203102|NCT02397278|560182693|FG000|Overall Study|Deemed ineligible following surgery|1|||
155203103|NCT02397278|560182694|FG001|Overall Study|Deemed ineligible following surgery|1|||
155203104|NCT02871297|560182702|FG000|Overall Study|Adverse Event|34|||
155203105|NCT02871297|560182702|FG000|Overall Study|Lack of Efficacy|10|||
155203106|NCT02871297|560182702|FG000|Overall Study|Non-compliance with study drug|15|||
155203107|NCT02871297|560182702|FG000|Overall Study|Protocol Violation|3|||
155203108|NCT02871297|560182702|FG000|Overall Study|Withdrawal by Subject|20|||
155203109|NCT02871297|560182702|FG000|Overall Study|Lost to Follow-up|13|||
155203110|NCT02871297|560182702|FG000|Overall Study|Rolled over to 13546A|2|||
155203111|NCT02871297|560182702|FG000|Overall Study|Other than specified|39|||
155203112|NCT02966028|560182706|FG000|Overall Study|Adverse Event|7|||
155203113|NCT02966028|560182707|FG001|Overall Study|Adverse Event|13|||
155203114|NCT02966028|560182708|FG002|Overall Study|Adverse Event|10|||
155203115|NCT02966028|560182706|FG000|Overall Study|Physician Decision|1|||
155203116|NCT02966028|560182707|FG001|Overall Study|Physician Decision|0|||
155203117|NCT02966028|560182708|FG002|Overall Study|Physician Decision|2|||
155203118|NCT02966028|560182706|FG000|Overall Study|Withdrawal by Subject|7|||
155203119|NCT02966028|560182707|FG001|Overall Study|Withdrawal by Subject|5|||
155203120|NCT02966028|560182708|FG002|Overall Study|Withdrawal by Subject|5|||
155203121|NCT02966028|560182706|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
155203122|NCT02966028|560182707|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
155203123|NCT02966028|560182708|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
155203124|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
155203125|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
155203126|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
155203127|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203128|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203129|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203130|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203131|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
155203132|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
155203133|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
155203134|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203135|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203136|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203137|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203138|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
155203139|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203140|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203141|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203142|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203143|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203144|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203145|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203146|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203147|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
155203148|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203149|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203150|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203151|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203152|NCT04115839|560182709|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203153|NCT04115839|560182710|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203154|NCT04115839|560182711|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203155|NCT04115839|560182712|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
155203156|NCT04115839|560182713|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
155203157|NCT04115839|560182714|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
155203158|NCT04115839|560182715|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
155203159|NCT04115839|560182709|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203160|NCT04115839|560182710|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203161|NCT04115839|560182711|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203162|NCT04115839|560182712|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
155203163|NCT04115839|560182713|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
155203164|NCT04115839|560182714|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203165|NCT04115839|560182715|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203166|NCT03808545|560182716|FG000|Overall Study|Withdrawal by Subject|1|||
155203167|NCT03808545|560182717|FG001|Overall Study|Withdrawal by Subject|1|||
155203168|NCT02161731|560182718|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
155203169|NCT02161731|560182719|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
155203170|NCT02161731|560182718|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
155203171|NCT02161731|560182719|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
155203172|NCT00790023|560182724|FG000|Overall Study|Adverse Event|2|||
155203173|NCT00790023|560182725|FG001|Overall Study|Adverse Event|1|||
155203174|NCT00790023|560182726|FG002|Overall Study|Adverse Event|4|||
155203175|NCT00790023|560182724|FG000|Overall Study|Protocol Violation|2|||
155203176|NCT00790023|560182725|FG001|Overall Study|Protocol Violation|4|||
155203177|NCT00790023|560182726|FG002|Overall Study|Protocol Violation|2|||
155203178|NCT00790023|560182724|FG000|Overall Study|Withdrawal by Subject|2|||
155203179|NCT00790023|560182725|FG001|Overall Study|Withdrawal by Subject|0|||
155203180|NCT00790023|560182726|FG002|Overall Study|Withdrawal by Subject|6|||
155203181|NCT00790023|560182724|FG000|Overall Study|Lost to Follow-up|0|||
155203182|NCT00790023|560182725|FG001|Overall Study|Lost to Follow-up|0|||
155203183|NCT00790023|560182726|FG002|Overall Study|Lost to Follow-up|1|||
155203184|NCT00790023|560182724|FG000|Overall Study|Other|5|||
155203185|NCT00790023|560182725|FG001|Overall Study|Other|5|||
155203186|NCT00790023|560182726|FG002|Overall Study|Other|8|||
155203187|NCT00573469|560182727|FG000|Overall Study|Adverse Event|1|||
155203188|NCT00573469|560182728|FG001|Overall Study|Adverse Event|1|||
155203189|NCT00573469|560182729|FG002|Overall Study|Adverse Event|1|||
155203190|NCT00573469|560182727|FG000|Overall Study|Withdrawal by Subject|0|||
155203191|NCT00573469|560182728|FG001|Overall Study|Withdrawal by Subject|2|||
155203192|NCT00573469|560182729|FG002|Overall Study|Withdrawal by Subject|0|||
155203193|NCT00573469|560182727|FG000|Overall Study|Other|5|||
155203194|NCT00573469|560182728|FG001|Overall Study|Other|1|||
155203195|NCT00573469|560182729|FG002|Overall Study|Other|3|||
155203196|NCT01338792|560182730|FG000|Overall Study|Adverse Event|2|||
155203197|NCT01338792|560182730|FG000|Overall Study|Death|1|||
155203198|NCT01338792|560182730|FG000|Overall Study|Withdrawal by Subject|1|||
155203199|NCT00004978|560182731|FG000|Overall Study|Death|107|||
155203200|NCT00004978|560182732|FG001|Overall Study|Death|116|||
155203201|NCT00004978|560182731|FG000|Overall Study|Lost to Follow-up|101|||
155203202|NCT00004978|560182732|FG001|Overall Study|Lost to Follow-up|108|||
155203203|NCT00004978|560182731|FG000|Overall Study|Withdrawal by Subject|17|||
155203204|NCT00004978|560182732|FG001|Overall Study|Withdrawal by Subject|26|||
155203205|NCT00004978|560182731|FG000|Overall Study|site closure - not in analysis cohort|19|||
155203206|NCT00004978|560182732|FG001|Overall Study|site closure - not in analysis cohort|20|||
155203207|NCT01652703|560182736|FG000|Overall Study|Withdrawal by Subject|0|||
155203208|NCT01652703|560182737|FG001|Overall Study|Withdrawal by Subject|1|||
155203209|NCT01652703|560182738|FG002|Overall Study|Withdrawal by Subject|3|||
155203210|NCT01652703|560182739|FG003|Overall Study|Withdrawal by Subject|1|||
155203211|NCT01652703|560182740|FG004|Overall Study|Withdrawal by Subject|0|||
155203212|NCT01652703|560182741|FG005|Overall Study|Withdrawal by Subject|1|||
155203213|NCT01652703|560182736|FG000|Overall Study|Other|0|||
155203214|NCT01652703|560182737|FG001|Overall Study|Other|0|||
155203215|NCT01652703|560182738|FG002|Overall Study|Other|0|||
155203216|NCT01652703|560182739|FG003|Overall Study|Other|1|||
155203217|NCT01652703|560182740|FG004|Overall Study|Other|1|||
155203218|NCT01652703|560182741|FG005|Overall Study|Other|1|||
155203219|NCT00062374|560182743|FG000|Overall Study|Not treated|12|||
155203220|NCT02151591|560182744|FG000|Overall Study|Lost to Follow-up|6|||
155203221|NCT02151591|560182745|FG001|Overall Study|Lost to Follow-up|3|||
155203222|NCT03555591|560182748|FG000|Overall Study|Protocol Violation|77|||
155203223|NCT03633695|560182749|FG000|Overall Study|Lost to Follow-up|4|||
155203224|NCT03633695|560182750|FG001|Overall Study|Lost to Follow-up|5|||
155203225|NCT03633695|560182749|FG000|Overall Study|Discontinued|8|||
155203226|NCT03633695|560182750|FG001|Overall Study|Discontinued|4|||
155203227|NCT01532414|560182751|FG000|Overall Study|Lost to Follow-up|3|||
155203228|NCT01532414|560182752|FG001|Overall Study|Lost to Follow-up|0|||
155203229|NCT01532414|560182753|FG002|Overall Study|Lost to Follow-up|1|||
155203230|NCT01532414|560182751|FG000|Overall Study|Withdrawal by Subject|3|||
155203231|NCT01532414|560182752|FG001|Overall Study|Withdrawal by Subject|0|||
155203232|NCT01532414|560182753|FG002|Overall Study|Withdrawal by Subject|0|||
155203233|NCT01532414|560182751|FG000|Overall Study|No V6 semen sample|0|||
155203234|NCT01532414|560182752|FG001|Overall Study|No V6 semen sample|1|||
155203235|NCT01532414|560182753|FG002|Overall Study|No V6 semen sample|0|||
155203236|NCT01532414|560182751|FG000|Overall Study|Adverse Event|0|||
155203237|NCT01532414|560182752|FG001|Overall Study|Adverse Event|1|||
155203238|NCT01532414|560182753|FG002|Overall Study|Adverse Event|1|||
155203239|NCT01532414|560182751|FG000|Overall Study|Unable to complete 24 hour PK|0|||
155203240|NCT01532414|560182752|FG001|Overall Study|Unable to complete 24 hour PK|0|||
155203241|NCT01532414|560182753|FG002|Overall Study|Unable to complete 24 hour PK|1|||
155203242|NCT01532414|560182751|FG000|Overall Study|Withdrawn by sponsor|1|||
155203243|NCT01532414|560182752|FG001|Overall Study|Withdrawn by sponsor|0|||
155203244|NCT01532414|560182753|FG002|Overall Study|Withdrawn by sponsor|0|||
155203245|NCT02380677|560182763|FG000|Overall Study|Adverse Event|0|||
155203246|NCT02380677|560182764|FG001|Overall Study|Adverse Event|0|||
155203247|NCT02380677|560182765|FG002|Overall Study|Adverse Event|0|||
155203248|NCT02380677|560182766|FG003|Overall Study|Adverse Event|1|||
155203249|NCT02380677|560182767|FG004|Overall Study|Adverse Event|1|||
155203250|NCT02380677|560182768|FG005|Overall Study|Adverse Event|4|||
155203251|NCT02380677|560182769|FG006|Overall Study|Adverse Event|2|||
155203252|NCT02380677|560182770|FG007|Overall Study|Adverse Event|2|||
155203253|NCT02380677|560182771|FG008|Overall Study|Adverse Event|2|||
155203254|NCT02380677|560182772|FG009|Overall Study|Adverse Event|1|||
155203255|NCT02380677|560182773|FG010|Overall Study|Adverse Event|2|||
155203256|NCT02380677|560182774|FG011|Overall Study|Adverse Event|1|||
155203257|NCT02380677|560182763|FG000|Overall Study|Physician Decision|1|||
155203258|NCT02380677|560182764|FG001|Overall Study|Physician Decision|0|||
155203259|NCT02380677|560182765|FG002|Overall Study|Physician Decision|1|||
155203260|NCT02380677|560182766|FG003|Overall Study|Physician Decision|1|||
155203261|NCT02380677|560182767|FG004|Overall Study|Physician Decision|0|||
155203262|NCT02380677|560182768|FG005|Overall Study|Physician Decision|0|||
155203263|NCT02380677|560182769|FG006|Overall Study|Physician Decision|0|||
155203264|NCT02380677|560182770|FG007|Overall Study|Physician Decision|0|||
155203265|NCT02380677|560182771|FG008|Overall Study|Physician Decision|0|||
155203266|NCT02380677|560182772|FG009|Overall Study|Physician Decision|0|||
155203267|NCT02380677|560182773|FG010|Overall Study|Physician Decision|0|||
155203268|NCT02380677|560182774|FG011|Overall Study|Physician Decision|0|||
155203269|NCT02380677|560182763|FG000|Overall Study|Lack of Efficacy|0|||
155203270|NCT02380677|560182764|FG001|Overall Study|Lack of Efficacy|1|||
155203271|NCT02380677|560182765|FG002|Overall Study|Lack of Efficacy|2|||
155203272|NCT02380677|560182766|FG003|Overall Study|Lack of Efficacy|0|||
155203273|NCT02380677|560182767|FG004|Overall Study|Lack of Efficacy|4|||
155203274|NCT02380677|560182768|FG005|Overall Study|Lack of Efficacy|1|||
155203275|NCT02380677|560182769|FG006|Overall Study|Lack of Efficacy|1|||
155203276|NCT02380677|560182770|FG007|Overall Study|Lack of Efficacy|2|||
155203277|NCT02380677|560182771|FG008|Overall Study|Lack of Efficacy|2|||
155203278|NCT02380677|560182772|FG009|Overall Study|Lack of Efficacy|0|||
155203279|NCT02380677|560182773|FG010|Overall Study|Lack of Efficacy|2|||
155203280|NCT02380677|560182774|FG011|Overall Study|Lack of Efficacy|1|||
155203281|NCT02380677|560182763|FG000|Overall Study|Withdrawal by Subject|0|||
155203282|NCT02380677|560182764|FG001|Overall Study|Withdrawal by Subject|0|||
155203283|NCT02380677|560182765|FG002|Overall Study|Withdrawal by Subject|0|||
155203284|NCT02380677|560182766|FG003|Overall Study|Withdrawal by Subject|0|||
155203285|NCT02380677|560182767|FG004|Overall Study|Withdrawal by Subject|0|||
155203286|NCT02380677|560182768|FG005|Overall Study|Withdrawal by Subject|0|||
155203287|NCT02380677|560182769|FG006|Overall Study|Withdrawal by Subject|0|||
155203288|NCT02380677|560182770|FG007|Overall Study|Withdrawal by Subject|0|||
155203289|NCT02380677|560182771|FG008|Overall Study|Withdrawal by Subject|0|||
155203290|NCT02380677|560182772|FG009|Overall Study|Withdrawal by Subject|1|||
155203291|NCT02380677|560182773|FG010|Overall Study|Withdrawal by Subject|0|||
155203292|NCT02380677|560182774|FG011|Overall Study|Withdrawal by Subject|3|||
155203293|NCT02380677|560182763|FG000|Overall Study|Other|0|||
155203294|NCT02380677|560182764|FG001|Overall Study|Other|0|||
155203295|NCT02380677|560182765|FG002|Overall Study|Other|0|||
155203296|NCT02380677|560182766|FG003|Overall Study|Other|1|||
155203297|NCT02380677|560182767|FG004|Overall Study|Other|1|||
155203298|NCT02380677|560182768|FG005|Overall Study|Other|1|||
155203299|NCT02380677|560182769|FG006|Overall Study|Other|0|||
155203300|NCT02380677|560182770|FG007|Overall Study|Other|0|||
155203301|NCT02380677|560182771|FG008|Overall Study|Other|0|||
155203302|NCT02380677|560182772|FG009|Overall Study|Other|0|||
155203303|NCT02380677|560182773|FG010|Overall Study|Other|0|||
155203304|NCT02380677|560182774|FG011|Overall Study|Other|0|||
155203305|NCT02599129|560182780|FG000|Overall Study|Lack of Efficacy|2|||
155203306|NCT02599129|560182781|FG001|Overall Study|Lack of Efficacy|2|||
155203307|NCT02599129|560182780|FG000|Overall Study|Lost to Follow-up|1|||
155203308|NCT02599129|560182781|FG001|Overall Study|Lost to Follow-up|0|||
155203309|NCT02599129|560182780|FG000|Overall Study|Withdrawal by Subject|2|||
155203310|NCT02599129|560182781|FG001|Overall Study|Withdrawal by Subject|1|||
155203311|NCT00617773|560182782|FG000|Overall Study|Physician Decision|1|||
155203312|NCT00617773|560182782|FG000|Overall Study|Lack of compliance with the protocol|1|||
155203313|NCT00617773|560182782|FG000|Overall Study|Withdrawal by Subject|1|||
155203314|NCT00617773|560182782|FG000|Overall Study|Death|1|||
155203315|NCT00617773|560182782|FG000|Overall Study|Progressive disease|19|||
155203316|NCT00617773|560182782|FG000|Overall Study|Protocol Violation|1|||
155203317|NCT01029795|560182783|FG000|Overall Study|Entry Criteria Not Met|2|||
155203318|NCT01029795|560182784|FG001|Overall Study|Entry Criteria Not Met|1|||
155203319|NCT01029795|560182783|FG000|Overall Study|Physician Decision|2|||
155203320|NCT01029795|560182784|FG001|Overall Study|Physician Decision|1|||
155203321|NCT01029795|560182783|FG000|Overall Study|Sponsor Decision|11|||
155203322|NCT01029795|560182784|FG001|Overall Study|Sponsor Decision|17|||
155203323|NCT01029795|560182783|FG000|Overall Study|Withdrawal by Subject|1|||
155203324|NCT01029795|560182784|FG001|Overall Study|Withdrawal by Subject|3|||
155203325|NCT01342796|560182785|FG000|Overall Study|Withdrawal by Subject|2|||
155203326|NCT01342796|560182786|FG001|Overall Study|Withdrawal by Subject|0|||
155203327|NCT01342796|560182785|FG000|Overall Study|Lost to Follow-up|0|||
155203328|NCT01342796|560182786|FG001|Overall Study|Lost to Follow-up|3|||
155203329|NCT01342796|560182785|FG000|Overall Study|Inappropriate enrollment|1|||
155203330|NCT01342796|560182786|FG001|Overall Study|Inappropriate enrollment|0|||
155203331|NCT03217175|560182787|FG000|Overall Study|Physician Decision|4|||
155203332|NCT03217175|560182788|FG001|Overall Study|Physician Decision|1|||
155203333|NCT05526716|560182795|FG000|Overall Study|Death|1|||
155203334|NCT05526716|560182796|FG001|Overall Study|Death|2|||
155203335|NCT05526716|560182795|FG000|Overall Study|Lost to Follow-up|17|||
155203336|NCT05526716|560182796|FG001|Overall Study|Lost to Follow-up|15|||
155203337|NCT05526716|560182795|FG000|Overall Study|Physician Decision|0|||
155203338|NCT05526716|560182796|FG001|Overall Study|Physician Decision|1|||
155203339|NCT05526716|560182795|FG000|Overall Study|Randomized by mistake without study treatment|0|||
155203340|NCT05526716|560182796|FG001|Overall Study|Randomized by mistake without study treatment|1|||
155203341|NCT05526716|560182795|FG000|Overall Study|Withdrawal by Subject|12|||
155203342|NCT05526716|560182796|FG001|Overall Study|Withdrawal by Subject|12|||
155203343|NCT05526716|560182795|FG000|Overall Study|Not reported|0|||
155203344|NCT05526716|560182796|FG001|Overall Study|Not reported|2|||
155203345|NCT04182763|560182803|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203346|NCT04182763|560182804|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203347|NCT04182763|560182805|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203348|NCT04182763|560182806|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
155203349|NCT04182763|560182807|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203350|NCT04182763|560182803|FG000|Double-Blind Period, initial 6 months|Death|0|||
155203351|NCT04182763|560182804|FG001|Double-Blind Period, initial 6 months|Death|1|||
155203352|NCT04182763|560182805|FG002|Double-Blind Period, initial 6 months|Death|0|||
155203353|NCT04182763|560182806|FG003|Double-Blind Period, initial 6 months|Death|0|||
155203354|NCT04182763|560182807|FG004|Double-Blind Period, initial 6 months|Death|0|||
155203355|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Death|3|||
155203356|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Death|2|||
155203357|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Death|2|||
155203358|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Death|0|||
155203359|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Death|1|||
155203360|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
155203361|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
155203362|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
155203363|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
155203364|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
155203365|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203366|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
155203367|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203368|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203369|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
155203370|NCT03616600|560182808|FG000|Overall Study|Withdrawal by Subject|1|||
155203371|NCT03616600|560182809|FG001|Overall Study|Withdrawal by Subject|0|||
155203372|NCT03858309|560182812|FG000|Overall Study|Withdrawal by Subject|2|||
155203373|NCT03858309|560182813|FG001|Overall Study|Withdrawal by Subject|3|||
155203374|NCT00730132|560182819|FG000|Overall Study|Protocol Violation|154|||
155203375|NCT00730132|560182819|FG000|Overall Study|Death|1|||
155203376|NCT02002091|560182824|FG000|Screening|Lost to Follow-up|10|||
155203377|NCT02002091|560182825|FG001|Screening|Lost to Follow-up|12|||
155203378|NCT02002091|560182824|FG000|Screening|Death|3|||
155203379|NCT02002091|560182825|FG001|Screening|Death|2|||
155203380|NCT00390468|560182833|FG000|Overall Study|Protocol Violation|2|||
155203381|NCT00390468|560182833|FG000|Overall Study|Lack of Efficacy|1|||
155203382|NCT03736447|560182835|FG000|Overall Study|Adverse Event|5|||
155203383|NCT03736447|560182836|FG001|Overall Study|Adverse Event|1|||
155203384|NCT03736447|560182835|FG000|Overall Study|Withdrawal by Subject|5|||
155203385|NCT03736447|560182836|FG001|Overall Study|Withdrawal by Subject|1|||
155203386|NCT03736447|560182835|FG000|Overall Study|Lost to Follow-up|1|||
155203387|NCT03736447|560182836|FG001|Overall Study|Lost to Follow-up|0|||
155203388|NCT03736447|560182835|FG000|Overall Study|Physician Decision|1|||
155203389|NCT03736447|560182836|FG001|Overall Study|Physician Decision|0|||
155203390|NCT03736447|560182835|FG000|Overall Study|Continued commitment to study treatment|3|||
155203391|NCT03736447|560182836|FG001|Overall Study|Continued commitment to study treatment|0|||
155203392|NCT03736447|560182835|FG000|Overall Study|Taste aversion to study product|0|||
155203393|NCT03736447|560182836|FG001|Overall Study|Taste aversion to study product|1|||
155203394|NCT02619175|560182837|FG000|Overall Study|Withdrawal by Subject|1|||
155203395|NCT02619175|560182838|FG001|Overall Study|Withdrawal by Subject|0|||
155203396|NCT02619175|560182837|FG000|Overall Study|foot pain|1|||
155203397|NCT02619175|560182838|FG001|Overall Study|foot pain|0|||
155203398|NCT02695329|560182840|FG000|Overall Study|Adverse Event|1|||
155203399|NCT02695329|560182841|FG001|Overall Study|Adverse Event|0|||
155203400|NCT02695329|560182840|FG000|Overall Study|Poor X-ray quality for measurement|4|||
155203401|NCT02695329|560182841|FG001|Overall Study|Poor X-ray quality for measurement|5|||
155203402|NCT00393029|560182842|FG000|Overall Study|Not treated|0|||
155203403|NCT00393029|560182843|FG001|Overall Study|Not treated|1|||
155203404|NCT00382252|560182844|FG000|Overall Study|Death|4|||
155203405|NCT00382252|560182844|FG000|Overall Study|Protocol Violation|8|||
155203406|NCT00382252|560182844|FG000|Overall Study|Not treated by RFA|1|||
155203407|NCT03338998|560182846|FG000|Treatment Period|Withdrawal by Subject|1|||
155203408|NCT03338998|560182847|FG001|Treatment Period|Withdrawal by Subject|1|||
155203409|NCT03338998|560182846|FG000|Treatment Period|Adverse Event|0|||
155203410|NCT03338998|560182847|FG001|Treatment Period|Adverse Event|2|||
155203411|NCT03338998|560182846|FG000|Treatment Period|Protocol deviation|1|||
155203412|NCT03338998|560182847|FG001|Treatment Period|Protocol deviation|0|||
155203413|NCT03338998|560182846|FG000|Treatment Period|Physician Decision|2|||
155203414|NCT03338998|560182847|FG001|Treatment Period|Physician Decision|0|||
155203415|NCT03338998|560182846|FG000|Treatment Period|Subject failed swallow test|4|||
155203416|NCT03338998|560182847|FG001|Treatment Period|Subject failed swallow test|0|||
155203417|NCT03338998|560182846|FG000|Safety Follow-Up Period|Adverse Event|0|||
155203418|NCT03338998|560182847|FG001|Safety Follow-Up Period|Adverse Event|1|||
155203419|NCT03338998|560182846|FG000|Safety Follow-Up Period|Protocol deviation|1|||
155203420|NCT03338998|560182847|FG001|Safety Follow-Up Period|Protocol deviation|0|||
155203421|NCT03338998|560182846|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
155203422|NCT03338998|560182847|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
155203423|NCT00039130|560182848|FG000|Overall Study|Adverse Event|11|||
155203424|NCT00039130|560182848|FG000|Overall Study|Death|9|||
155203425|NCT00039130|560182848|FG000|Overall Study|Withdrawal by Subject|3|||
155203426|NCT00039130|560182848|FG000|Overall Study|Progression|2|||
155203427|NCT00039130|560182848|FG000|Overall Study|Subsequent treatment|2|||
155203428|NCT00039130|560182848|FG000|Overall Study|Physician Decision|3|||
155203429|NCT02612727|560182849|FG000|Overall Study|Parent request|4|||
155203430|NCT02612727|560182850|FG001|Overall Study|Parent request|1|||
155203431|NCT02612727|560182849|FG000|Overall Study|Needed treatment incompatible with PT|1|||
155203432|NCT02612727|560182850|FG001|Overall Study|Needed treatment incompatible with PT|1|||
155203433|NCT02612727|560182849|FG000|Overall Study|Direct hyperbilirubinemia|0|||
155203434|NCT02612727|560182850|FG001|Overall Study|Direct hyperbilirubinemia|2|||
155203435|NCT01063868|560182851|FG000|Overall Study|Adverse Event|9|||
155203436|NCT01063868|560182852|FG001|Overall Study|Adverse Event|7|||
155203437|NCT01063868|560182851|FG000|Overall Study|Withdrawal by Subject|3|||
155203438|NCT01063868|560182852|FG001|Overall Study|Withdrawal by Subject|1|||
155203439|NCT01063868|560182851|FG000|Overall Study|Study Terminated By Sponsor|23|||
155203440|NCT01063868|560182852|FG001|Overall Study|Study Terminated By Sponsor|4|||
155203441|NCT03199274|560182853|FG000|Overall Study|Withdrawal by Subject|4|||
155203442|NCT03199274|560182854|FG001|Overall Study|Withdrawal by Subject|0|||
155203443|NCT03199274|560182853|FG000|Overall Study|Lost to Follow-up|0|||
155203444|NCT03199274|560182854|FG001|Overall Study|Lost to Follow-up|1|||
155203445|NCT03199274|560182853|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
155203446|NCT03199274|560182854|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
155203447|NCT05766423|560182855|FG000|Overall Study|Withdrawal by Subject|1|||
155203448|NCT05766423|560182856|FG001|Overall Study|Withdrawal by Subject|0|||
155203449|NCT05766423|560182855|FG000|Overall Study|Consented, not scheduled|3|||
155203450|NCT05766423|560182856|FG001|Overall Study|Consented, not scheduled|5|||
155203451|NCT00540514|560184491|FG000|Overall Study|Still on treatment|3|||
155203452|NCT00540514|560184492|FG001|Overall Study|Still on treatment|0|||
155203453|NCT00540514|560184491|FG000|Overall Study|Unacceptable Toxicity|61|||
155203454|NCT00540514|560184492|FG001|Overall Study|Unacceptable Toxicity|62|||
155203455|NCT00540514|560184491|FG000|Overall Study|Adverse Event|20|||
155203456|NCT00540514|560184492|FG001|Overall Study|Adverse Event|24|||
155203457|NCT00540514|560184491|FG000|Overall Study|Physician Decision|86|||
155203458|NCT00540514|560184492|FG001|Overall Study|Physician Decision|99|||
155203459|NCT00540514|560184491|FG000|Overall Study|Protocol Deviation|3|||
155203460|NCT00540514|560184492|FG001|Overall Study|Protocol Deviation|4|||
155203461|NCT00540514|560184491|FG000|Overall Study|Lost to Follow-up|1|||
155203462|NCT00540514|560184492|FG001|Overall Study|Lost to Follow-up|1|||
155203463|NCT00540514|560184491|FG000|Overall Study|Withdrawal by Subject|65|||
155203464|NCT00540514|560184492|FG001|Overall Study|Withdrawal by Subject|67|||
155203465|NCT00540514|560184491|FG000|Overall Study|Excluded prior to treatment|7|||
155203466|NCT00540514|560184492|FG001|Overall Study|Excluded prior to treatment|7|||
155203467|NCT00540514|560184491|FG000|Overall Study|Paclitaxel not available|0|||
155203468|NCT00540514|560184492|FG001|Overall Study|Paclitaxel not available|2|||
155203469|NCT00638378|560184493|FG000|Overall Study|Death|2|||
155203470|NCT00638378|560184493|FG000|Overall Study|Adverse Event|1|||
155203471|NCT00638378|560184493|FG000|Overall Study|Disease progression|15|||
155203472|NCT00638378|560184493|FG000|Overall Study|Physician Decision|4|||
155203473|NCT03291808|560184494|FG000|Overall Study|Lost to Follow-up|6|||
155203474|NCT03291808|560184494|FG000|Overall Study|Research burden|4|||
155203475|NCT01892293|560184497|FG000|Overall Study|Apheresed but not treated|4|||
155203476|NCT03602482|560184502|FG000|Overall Study|Withdrawal by Subject|6|||
155203477|NCT03602482|560184503|FG001|Overall Study|Withdrawal by Subject|7|||
155203478|NCT03602482|560184504|FG002|Overall Study|Withdrawal by Subject|0|||
155203479|NCT03602482|560184505|FG003|Overall Study|Withdrawal by Subject|0|||
155203480|NCT02601469|560184508|FG000|Overall Study|Enrolled in Error|1|||
155203481|NCT02601469|560184509|FG001|Overall Study|Enrolled in Error|0|||
155203482|NCT00618072|560184510|FG000|Overall Study|Lost to Follow-up|2|||
155203483|NCT00618072|560184511|FG001|Overall Study|Lost to Follow-up|0|||
155203484|NCT00618072|560184512|FG002|Overall Study|Lost to Follow-up|3|||
155203485|NCT00618072|560184510|FG000|Overall Study|Physician Decision|0|||
155203486|NCT00618072|560184511|FG001|Overall Study|Physician Decision|1|||
155203487|NCT00618072|560184512|FG002|Overall Study|Physician Decision|1|||
155203488|NCT05035550|560184515|FG000|Overall Study|Withdrawal by Subject|3|||
155203489|NCT05035550|560184516|FG001|Overall Study|Withdrawal by Subject|0|||
155203490|NCT00429273|560184517|FG000|Overall Study|Lost to Follow-up|1|||
155203491|NCT00429273|560184518|FG001|Overall Study|Lost to Follow-up|2|||
155203492|NCT00429273|560184519|FG002|Overall Study|Lost to Follow-up|2|||
155203493|NCT00429273|560184517|FG000|Overall Study|Physician Decision|6|||
155203494|NCT00429273|560184518|FG001|Overall Study|Physician Decision|5|||
155203495|NCT00429273|560184519|FG002|Overall Study|Physician Decision|5|||
155203496|NCT00429273|560184517|FG000|Overall Study|Adverse Event|1|||
155203497|NCT00429273|560184518|FG001|Overall Study|Adverse Event|1|||
155203498|NCT00429273|560184519|FG002|Overall Study|Adverse Event|2|||
155203499|NCT01438957|560184520|FG000|Overall Study|Physician Decision|1|||
155203500|NCT01438957|560184521|FG001|Overall Study|Physician Decision|1|||
155203501|NCT01438957|560184522|FG002|Overall Study|Physician Decision|0|||
155203502|NCT01438957|560184523|FG003|Overall Study|Physician Decision|1|||
155203503|NCT01438957|560184524|FG004|Overall Study|Physician Decision|0|||
155203504|NCT00617123|560184526|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
155203505|NCT00617123|560184527|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
155203506|NCT00617123|560184526|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
155203507|NCT00617123|560184527|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
155203508|NCT00617123|560184526|FG000|Referral Screening Period|Adverse Event|0|||
155203509|NCT00617123|560184527|FG001|Referral Screening Period|Adverse Event|1|||
155203510|NCT00617123|560184526|FG000|Study Treatment Period|Withdrawal by Subject|8|||
155203511|NCT00617123|560184527|FG001|Study Treatment Period|Withdrawal by Subject|12|||
155203512|NCT00617123|560184526|FG000|Study Treatment Period|Adverse Event|7|||
155203513|NCT00617123|560184527|FG001|Study Treatment Period|Adverse Event|3|||
155203514|NCT00617123|560184526|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
155203515|NCT00617123|560184527|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
155203516|NCT00617123|560184526|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
155203517|NCT00617123|560184527|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
155203518|NCT00777608|560184531|FG000|Overall Study|Lost to Follow-up|1|||
155203519|NCT00777608|560184532|FG001|Overall Study|Lost to Follow-up|1|||
155203520|NCT00777608|560184531|FG000|Overall Study|Withdrawal by Subject|1|||
155203521|NCT00777608|560184532|FG001|Overall Study|Withdrawal by Subject|3|||
155203522|NCT00777608|560184531|FG000|Overall Study|Protocol Violation|1|||
155203523|NCT00777608|560184532|FG001|Overall Study|Protocol Violation|0|||
155203524|NCT00777608|560184531|FG000|Overall Study|Investigator Decision|1|||
155203525|NCT00777608|560184532|FG001|Overall Study|Investigator Decision|2|||
155203526|NCT02853604|560184535|FG000|Overall Study|Withdrawal by Subject|12|||
155203527|NCT02853604|560184536|FG001|Overall Study|Withdrawal by Subject|35|||
155203528|NCT02853604|560184535|FG000|Overall Study|Lost to Follow-up|4|||
155203529|NCT02853604|560184536|FG001|Overall Study|Lost to Follow-up|8|||
155203530|NCT02853604|560184535|FG000|Overall Study|Death|1|||
155203531|NCT02853604|560184536|FG001|Overall Study|Death|5|||
155203532|NCT02853604|560184535|FG000|Overall Study|Miscellaneous|11|||
155203533|NCT02853604|560184536|FG001|Overall Study|Miscellaneous|2|||
155203534|NCT02853604|560184535|FG000|Overall Study|Progressive Disease|0|||
155203535|NCT02853604|560184536|FG001|Overall Study|Progressive Disease|2|||
155203536|NCT00727025|560184537|FG000|Overall Study|Physician Decision|23|||
155203537|NCT01539538|560184539|FG000|Overall Study|Adverse Event|13|||
155203538|NCT01539538|560184540|FG001|Overall Study|Adverse Event|18|||
155203539|NCT01539538|560184539|FG000|Overall Study|Lack of Efficacy|13|||
155203540|NCT01539538|560184540|FG001|Overall Study|Lack of Efficacy|16|||
155203541|NCT01539538|560184539|FG000|Overall Study|Withdrawal by Subject|2|||
155203542|NCT01539538|560184540|FG001|Overall Study|Withdrawal by Subject|3|||
155203543|NCT01539538|560184539|FG000|Overall Study|PCA no longer required or PCA problem|3|||
155203544|NCT01539538|560184540|FG001|Overall Study|PCA no longer required or PCA problem|7|||
155203545|NCT00847379|560184541|FG000|Overall Study|Study terminated by Sponsor|59|||
155203546|NCT00847379|560184542|FG001|Overall Study|Study terminated by Sponsor|57|||
155203547|NCT00847379|560184543|FG002|Overall Study|Study terminated by Sponsor|57|||
155203548|NCT00378378|560184544|FG000|Overall Study|Withdrawal by Subject|0|||
155203549|NCT00378378|560184545|FG001|Overall Study|Withdrawal by Subject|1|||
155203550|NCT00378378|560184546|FG002|Overall Study|Withdrawal by Subject|0|||
155203551|NCT00378378|560184544|FG000|Overall Study|Treatment Failure|0|||
155203552|NCT00378378|560184545|FG001|Overall Study|Treatment Failure|0|||
155203553|NCT00378378|560184546|FG002|Overall Study|Treatment Failure|1|||
155203554|NCT00378378|560184544|FG000|Overall Study|Non-compliance with protocol|0|||
155203555|NCT00378378|560184545|FG001|Overall Study|Non-compliance with protocol|0|||
155203556|NCT00378378|560184546|FG002|Overall Study|Non-compliance with protocol|1|||
155203557|NCT00982878|560184559|FG000|Overall Study|Physician Decision|1|||
155203558|NCT01854710|560184560|FG000|Overall Study|Withdrawal by Subject|2|||
155203559|NCT01854710|560184561|FG001|Overall Study|Withdrawal by Subject|1|||
155203560|NCT01854710|560184562|FG002|Overall Study|Withdrawal by Subject|0|||
155203561|NCT01854710|560184563|FG003|Overall Study|Withdrawal by Subject|0|||
155203562|NCT01854710|560184564|FG004|Overall Study|Withdrawal by Subject|0|||
155203563|NCT01854710|560184565|FG005|Overall Study|Withdrawal by Subject|0|||
155203564|NCT01854710|560184560|FG000|Overall Study|CRI procedural error|2|||
155203565|NCT01854710|560184561|FG001|Overall Study|CRI procedural error|2|||
155203566|NCT01854710|560184562|FG002|Overall Study|CRI procedural error|2|||
155203567|NCT01854710|560184563|FG003|Overall Study|CRI procedural error|2|||
155203568|NCT01854710|560184564|FG004|Overall Study|CRI procedural error|2|||
155203569|NCT01854710|560184565|FG005|Overall Study|CRI procedural error|2|||
155203570|NCT01336764|560184570|FG000|Overall Study|Withdrawal by Subject|5|||
155203571|NCT01336764|560184571|FG001|Overall Study|Withdrawal by Subject|5|||
155203572|NCT01626391|560184572|FG000|Overall Study|Physician Decision|1|||
155203573|NCT01626391|560184573|FG001|Overall Study|Physician Decision|0|||
155203574|NCT01626391|560184572|FG000|Overall Study|Withdrawal by Subject|1|||
155203575|NCT01626391|560184573|FG001|Overall Study|Withdrawal by Subject|0|||
155203576|NCT05683249|560184574|FG000|Overall Study|Adverse Event|3|||
155203577|NCT05683249|560184575|FG001|Overall Study|Adverse Event|1|||
155203578|NCT05683249|560184574|FG000|Overall Study|Lack of Efficacy|0|||
155203579|NCT05683249|560184575|FG001|Overall Study|Lack of Efficacy|2|||
155203580|NCT05683249|560184574|FG000|Overall Study|Lost to Follow-up|6|||
155203581|NCT05683249|560184575|FG001|Overall Study|Lost to Follow-up|5|||
155203582|NCT05683249|560184574|FG000|Overall Study|Non-compliance with Study Drug|2|||
155203583|NCT05683249|560184575|FG001|Overall Study|Non-compliance with Study Drug|0|||
155203584|NCT05683249|560184574|FG000|Overall Study|Protocol Violation|6|||
155203585|NCT05683249|560184575|FG001|Overall Study|Protocol Violation|3|||
155203586|NCT05683249|560184574|FG000|Overall Study|Withdrawal by Subject|9|||
155203587|NCT05683249|560184575|FG001|Overall Study|Withdrawal by Subject|8|||
155203588|NCT05683249|560184574|FG000|Overall Study|Other|0|||
155203589|NCT05683249|560184575|FG001|Overall Study|Other|2|||
155203590|NCT01930123|560184576|FG000|Overall Study|Adverse Event|1|||
155203591|NCT01930123|560184577|FG001|Overall Study|Adverse Event|0|||
155203592|NCT01930123|560184576|FG000|Overall Study|Physician Decision|21|||
155203593|NCT01930123|560184577|FG001|Overall Study|Physician Decision|8|||
155203594|NCT01930123|560184576|FG000|Overall Study|Withdrawal by Subject|1|||
155203595|NCT01930123|560184577|FG001|Overall Study|Withdrawal by Subject|0|||
155203596|NCT03310021|560184581|FG000|Overall Study|Withdrawal by Subject|0|||
155203597|NCT03310021|560184582|FG001|Overall Study|Withdrawal by Subject|0|||
155203598|NCT03310021|560184583|FG002|Overall Study|Withdrawal by Subject|0|||
155203599|NCT03310021|560184584|FG003|Overall Study|Withdrawal by Subject|0|||
155203600|NCT03310021|560184585|FG004|Overall Study|Withdrawal by Subject|0|||
155203601|NCT03310021|560184586|FG005|Overall Study|Withdrawal by Subject|0|||
155203602|NCT03310021|560184587|FG006|Overall Study|Withdrawal by Subject|1|||
155203603|NCT03310021|560184588|FG007|Overall Study|Withdrawal by Subject|0|||
155203604|NCT03310021|560184589|FG008|Overall Study|Withdrawal by Subject|0|||
155203605|NCT03310021|560184590|FG009|Overall Study|Withdrawal by Subject|0|||
155203606|NCT03310021|560184591|FG010|Overall Study|Withdrawal by Subject|0|||
155203607|NCT03310021|560184592|FG011|Overall Study|Withdrawal by Subject|0|||
155203608|NCT03310021|560184593|FG012|Overall Study|Withdrawal by Subject|0|||
155203609|NCT03310021|560184594|FG013|Overall Study|Withdrawal by Subject|0|||
155203610|NCT03310021|560184595|FG014|Overall Study|Withdrawal by Subject|0|||
155203611|NCT03310021|560184596|FG015|Overall Study|Withdrawal by Subject|0|||
155203612|NCT03310021|560184597|FG016|Overall Study|Withdrawal by Subject|0|||
155203613|NCT03310021|560184598|FG017|Overall Study|Withdrawal by Subject|0|||
155203614|NCT03310021|560184599|FG018|Overall Study|Withdrawal by Subject|0|||
155203615|NCT03310021|560184600|FG019|Overall Study|Withdrawal by Subject|0|||
155203616|NCT03310021|560184581|FG000|Overall Study|Lost to Follow-up|0|||
155203617|NCT03310021|560184582|FG001|Overall Study|Lost to Follow-up|0|||
155203618|NCT03310021|560184583|FG002|Overall Study|Lost to Follow-up|0|||
155203619|NCT03310021|560184584|FG003|Overall Study|Lost to Follow-up|0|||
155203620|NCT03310021|560184585|FG004|Overall Study|Lost to Follow-up|0|||
155203621|NCT03310021|560184586|FG005|Overall Study|Lost to Follow-up|0|||
155203622|NCT03310021|560184587|FG006|Overall Study|Lost to Follow-up|0|||
155203623|NCT03310021|560184588|FG007|Overall Study|Lost to Follow-up|0|||
155203624|NCT03310021|560184589|FG008|Overall Study|Lost to Follow-up|0|||
155203625|NCT03310021|560184590|FG009|Overall Study|Lost to Follow-up|0|||
155203626|NCT03310021|560184591|FG010|Overall Study|Lost to Follow-up|1|||
155203627|NCT03310021|560184592|FG011|Overall Study|Lost to Follow-up|0|||
155203628|NCT03310021|560184593|FG012|Overall Study|Lost to Follow-up|0|||
155203629|NCT03310021|560184594|FG013|Overall Study|Lost to Follow-up|0|||
155203630|NCT03310021|560184595|FG014|Overall Study|Lost to Follow-up|0|||
155203631|NCT03310021|560184596|FG015|Overall Study|Lost to Follow-up|0|||
155203632|NCT03310021|560184597|FG016|Overall Study|Lost to Follow-up|0|||
155203633|NCT03310021|560184598|FG017|Overall Study|Lost to Follow-up|0|||
155203634|NCT03310021|560184599|FG018|Overall Study|Lost to Follow-up|0|||
155203635|NCT03310021|560184600|FG019|Overall Study|Lost to Follow-up|0|||
155203636|NCT00702923|560184603|FG000|Overall Study|Adverse Event|1|||
155203637|NCT01233258|560184604|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203638|NCT01233258|560184605|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203639|NCT01233258|560184606|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203640|NCT01233258|560184607|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
155203641|NCT01233258|560184608|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203642|NCT01233258|560184609|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
155203643|NCT01233258|560184604|FG000|First Intervention (6 Months)|Protocol Violation|0|||
155203644|NCT01233258|560184605|FG001|First Intervention (6 Months)|Protocol Violation|0|||
155203645|NCT01233258|560184606|FG002|First Intervention (6 Months)|Protocol Violation|1|||
155203646|NCT01233258|560184607|FG003|First Intervention (6 Months)|Protocol Violation|0|||
155203647|NCT01233258|560184608|FG004|First Intervention (6 Months)|Protocol Violation|0|||
155203648|NCT01233258|560184609|FG005|First Intervention (6 Months)|Protocol Violation|0|||
155203649|NCT01233258|560184604|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
155203650|NCT01233258|560184605|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203651|NCT01233258|560184606|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203652|NCT01233258|560184607|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203653|NCT01233258|560184608|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203654|NCT01233258|560184609|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203655|NCT02795832|560184613|FG000|Overall Study|Adverse Event|0|||
155203656|NCT02795832|560184614|FG001|Overall Study|Adverse Event|0|||
155203657|NCT02795832|560184615|FG002|Overall Study|Adverse Event|0|||
155203658|NCT02795832|560184616|FG003|Overall Study|Adverse Event|0|||
155203659|NCT02795832|560184617|FG004|Overall Study|Adverse Event|0|||
155203660|NCT02795832|560184618|FG005|Overall Study|Adverse Event|3|||
155203661|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
155203662|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
155203663|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
155203664|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Other|2|||
155203665|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Other|0|||
155203666|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Other|0|||
155203667|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Death|1|||
155203668|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Death|0|||
155203669|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Death|0|||
155203670|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
155203671|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
155203672|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
155203673|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Death|3|||
155203674|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Death|2|||
155203675|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Death|4|||
155203676|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
155203677|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
155203678|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
155203679|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
155203680|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
155203681|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
155203682|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Other|5|||
155203683|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Other|4|||
155203684|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Other|2|||
155203685|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
155203686|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
155203687|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
155203688|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
155203689|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
155203690|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
155203691|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
155203692|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
155203693|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
155203694|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
155203695|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
155203696|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
155203697|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Death|3|||
155203698|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Death|0|||
155203699|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Death|0|||
155203700|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
155203701|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
155203702|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
155203703|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Other|2|||
155203704|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Other|0|||
155203705|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Other|1|||
155203706|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
155203707|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
155203708|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
155203709|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
155203710|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
155203711|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
155203712|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Death|0|||
155203713|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Death|2|||
155203714|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Death|1|||
155203715|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
155203716|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
155203717|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
155203718|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
155203719|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
155203720|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
155203721|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
155203722|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
155203723|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
155203724|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Other|0|||
155203725|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Other|1|||
155203726|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Other|1|||
155203727|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
155203728|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
155203729|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
155203730|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
155203731|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
155203732|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
155203733|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
155203734|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
155203735|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
155203736|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
155203737|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
155203738|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
155203739|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
155203740|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
155203741|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
155203742|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
155203743|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
155203744|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
155203745|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
155203746|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
155203747|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
155203748|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
155203749|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
155203750|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
155203751|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
155203752|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
155203753|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
155203754|NCT01348165|560184623|FG000|Overall Study|Adverse Event|0|||
155203755|NCT01348165|560184624|FG001|Overall Study|Adverse Event|0|||
155203756|NCT01348165|560184625|FG002|Overall Study|Adverse Event|0|||
155203757|NCT01348165|560184626|FG003|Overall Study|Adverse Event|0|||
155203758|NCT01348165|560184627|FG004|Overall Study|Adverse Event|0|||
155203759|NCT01348165|560184628|FG005|Overall Study|Adverse Event|0|||
155203760|NCT01348165|560184629|FG006|Overall Study|Adverse Event|1|||
155203761|NCT04659161|560184630|FG000|Overall Study|Adverse Event|10|||
155203762|NCT04659161|560184631|FG001|Overall Study|Adverse Event|6|||
155203763|NCT04659161|560184630|FG000|Overall Study|Withdrawal by Subject|13|||
155203764|NCT04659161|560184631|FG001|Overall Study|Withdrawal by Subject|12|||
155203765|NCT04659161|560184630|FG000|Overall Study|Other|9|||
155203766|NCT04659161|560184631|FG001|Overall Study|Other|8|||
155203767|NCT01929343|560184633|FG000|Overall Study|Physician Decision|0|||
155203768|NCT01929343|560184634|FG001|Overall Study|Physician Decision|2|||
155203769|NCT01929343|560184635|FG002|Overall Study|Physician Decision|0|||
155203770|NCT01929343|560184633|FG000|Overall Study|Withdrawal by Subject|1|||
155203771|NCT01929343|560184634|FG001|Overall Study|Withdrawal by Subject|0|||
155203772|NCT01929343|560184635|FG002|Overall Study|Withdrawal by Subject|0|||
155203773|NCT02197130|560184638|FG000|Overall Study|Adverse Event|13|||
155203774|NCT02197130|560184639|FG001|Overall Study|Adverse Event|4|||
155203775|NCT02197130|560184640|FG002|Overall Study|Adverse Event|23|||
155203776|NCT02197130|560184638|FG000|Overall Study|Death|0|||
155203777|NCT02197130|560184639|FG001|Overall Study|Death|1|||
155203778|NCT02197130|560184640|FG002|Overall Study|Death|0|||
155203779|NCT02197130|560184638|FG000|Overall Study|Lost to Follow-up|2|||
155203780|NCT02197130|560184639|FG001|Overall Study|Lost to Follow-up|0|||
155203781|NCT02197130|560184640|FG002|Overall Study|Lost to Follow-up|1|||
155203782|NCT02197130|560184638|FG000|Overall Study|Does not meet entrance criteria|0|||
155203783|NCT02197130|560184639|FG001|Overall Study|Does not meet entrance criteria|0|||
155203784|NCT02197130|560184640|FG002|Overall Study|Does not meet entrance criteria|1|||
155203785|NCT02197130|560184638|FG000|Overall Study|Withdrawal by Subject|0|||
155203786|NCT02197130|560184639|FG001|Overall Study|Withdrawal by Subject|3|||
155203787|NCT02197130|560184640|FG002|Overall Study|Withdrawal by Subject|4|||
155203788|NCT02197130|560184638|FG000|Overall Study|Other|1|||
155203789|NCT02197130|560184639|FG001|Overall Study|Other|0|||
155203790|NCT02197130|560184640|FG002|Overall Study|Other|3|||
155203791|NCT03648983|560184643|FG000|Overall Study|Study was terminated due to PI departure|95|||
155203792|NCT01269463|560184646|FG000|First Intervention|Withdrawal by Subject|1|||
155203793|NCT01269463|560184647|FG001|First Intervention|Withdrawal by Subject|0|||
155203794|NCT01269463|560184646|FG000|First Intervention|Adverse Event|1|||
155203795|NCT01269463|560184647|FG001|First Intervention|Adverse Event|0|||
155203796|NCT01269463|560184646|FG000|First Intervention|Lack of Efficacy|0|||
155203797|NCT01269463|560184647|FG001|First Intervention|Lack of Efficacy|1|||
155203798|NCT01269463|560184646|FG000|First Intervention|Physician Decision|0|||
155203799|NCT01269463|560184647|FG001|First Intervention|Physician Decision|1|||
155203800|NCT04404361|560184649|FG000|Overall Study|Death|12|||
155203801|NCT04404361|560184650|FG001|Overall Study|Death|12|||
155203802|NCT04404361|560184649|FG000|Overall Study|Withdrawal by Subject|13|||
155203803|NCT04404361|560184650|FG001|Overall Study|Withdrawal by Subject|5|||
155203804|NCT04404361|560184649|FG000|Overall Study|Lost to Follow-up|6|||
155203805|NCT04404361|560184650|FG001|Overall Study|Lost to Follow-up|3|||
155203806|NCT04404361|560184649|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
155203807|NCT04404361|560184650|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
155203808|NCT00558558|560184651|FG000|Overall Study|Unable to swallow|1|||
155203809|NCT00558558|560184651|FG000|Overall Study|Withdrawal by Subject|1|||
155203810|NCT00558558|560184651|FG000|Overall Study|Lack of Efficacy|4|||
155203811|NCT02549937|560184653|FG000|Overall Study|Death|0|||
155203812|NCT02549937|560184654|FG001|Overall Study|Death|1|||
155203813|NCT02549937|560184655|FG002|Overall Study|Death|0|||
155203814|NCT02549937|560184656|FG003|Overall Study|Death|1|||
155203815|NCT02549937|560184657|FG004|Overall Study|Death|0|||
155203816|NCT02549937|560184658|FG005|Overall Study|Death|8|||
155203817|NCT02549937|560184659|FG006|Overall Study|Death|0|||
155203818|NCT02549937|560184660|FG007|Overall Study|Death|0|||
155203819|NCT02549937|560184661|FG008|Overall Study|Death|19|||
155203820|NCT02549937|560184653|FG000|Overall Study|No follow up required|3|||
155203821|NCT02549937|560184654|FG001|Overall Study|No follow up required|6|||
155203822|NCT02549937|560184655|FG002|Overall Study|No follow up required|3|||
155203823|NCT02549937|560184656|FG003|Overall Study|No follow up required|8|||
155203824|NCT02549937|560184657|FG004|Overall Study|No follow up required|12|||
155203825|NCT02549937|560184658|FG005|Overall Study|No follow up required|21|||
155203826|NCT02549937|560184659|FG006|Overall Study|No follow up required|9|||
155203827|NCT02549937|560184660|FG007|Overall Study|No follow up required|11|||
155203828|NCT02549937|560184661|FG008|Overall Study|No follow up required|0|||
155203829|NCT02549937|560184653|FG000|Overall Study|Other|0|||
155203830|NCT02549937|560184654|FG001|Overall Study|Other|0|||
155203831|NCT02549937|560184655|FG002|Overall Study|Other|0|||
155203832|NCT02549937|560184656|FG003|Overall Study|Other|0|||
155203833|NCT02549937|560184657|FG004|Overall Study|Other|1|||
155203834|NCT02549937|560184658|FG005|Overall Study|Other|0|||
155203835|NCT02549937|560184659|FG006|Overall Study|Other|3|||
155203836|NCT02549937|560184660|FG007|Overall Study|Other|2|||
155203837|NCT02549937|560184661|FG008|Overall Study|Other|3|||
155203838|NCT02549937|560184653|FG000|Overall Study|Lost to Follow-up|0|||
155203839|NCT02549937|560184654|FG001|Overall Study|Lost to Follow-up|0|||
155203840|NCT02549937|560184655|FG002|Overall Study|Lost to Follow-up|0|||
155203841|NCT02549937|560184656|FG003|Overall Study|Lost to Follow-up|0|||
155203842|NCT02549937|560184657|FG004|Overall Study|Lost to Follow-up|0|||
155203843|NCT02549937|560184658|FG005|Overall Study|Lost to Follow-up|0|||
155203844|NCT02549937|560184659|FG006|Overall Study|Lost to Follow-up|0|||
155203845|NCT02549937|560184660|FG007|Overall Study|Lost to Follow-up|0|||
155203846|NCT02549937|560184661|FG008|Overall Study|Lost to Follow-up|3|||
155203847|NCT02549937|560184653|FG000|Overall Study|Withdrawal by Subject|0|||
155203848|NCT02549937|560184654|FG001|Overall Study|Withdrawal by Subject|0|||
155203849|NCT02549937|560184655|FG002|Overall Study|Withdrawal by Subject|0|||
155203850|NCT02549937|560184656|FG003|Overall Study|Withdrawal by Subject|0|||
155203851|NCT02549937|560184657|FG004|Overall Study|Withdrawal by Subject|0|||
155203852|NCT02549937|560184658|FG005|Overall Study|Withdrawal by Subject|1|||
155203853|NCT02549937|560184659|FG006|Overall Study|Withdrawal by Subject|4|||
155203854|NCT02549937|560184660|FG007|Overall Study|Withdrawal by Subject|3|||
155203855|NCT02549937|560184661|FG008|Overall Study|Withdrawal by Subject|2|||
155203856|NCT02549937|560184653|FG000|Overall Study|Sponsor Decision|0|||
155203857|NCT02549937|560184654|FG001|Overall Study|Sponsor Decision|0|||
155203858|NCT02549937|560184655|FG002|Overall Study|Sponsor Decision|0|||
155203859|NCT02549937|560184656|FG003|Overall Study|Sponsor Decision|0|||
155203860|NCT02549937|560184657|FG004|Overall Study|Sponsor Decision|0|||
155203861|NCT02549937|560184658|FG005|Overall Study|Sponsor Decision|0|||
155203862|NCT02549937|560184659|FG006|Overall Study|Sponsor Decision|0|||
155203863|NCT02549937|560184660|FG007|Overall Study|Sponsor Decision|0|||
155203864|NCT02549937|560184661|FG008|Overall Study|Sponsor Decision|6|||
155203865|NCT05330702|560184664|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
155203866|NCT05330702|560184665|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
155203867|NCT05330702|560184666|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
155203868|NCT01411774|560186074|FG000|Overall Study|Withdrawal by Subject|0|||
155203869|NCT01411774|560186075|FG001|Overall Study|Withdrawal by Subject|3|||
155203870|NCT00056316|560186076|FG000|Overall Study|Withdrawal by Subject|2|||
155203871|NCT00056316|560186077|FG001|Overall Study|Withdrawal by Subject|2|||
155203872|NCT00056316|560186076|FG000|Overall Study|Death/NH placement of pt|1|||
155203873|NCT00056316|560186077|FG001|Overall Study|Death/NH placement of pt|1|||
155203874|NCT01315678|560186080|FG000|Overall Study|Withdrawal by Subject|7|||
155203875|NCT01315678|560186081|FG001|Overall Study|Withdrawal by Subject|3|||
155203876|NCT01315678|560186080|FG000|Overall Study|Adverse Event|3|||
155203877|NCT01315678|560186081|FG001|Overall Study|Adverse Event|1|||
155203878|NCT01315678|560186080|FG000|Overall Study|Lost to Follow-up|1|||
155203879|NCT01315678|560186081|FG001|Overall Study|Lost to Follow-up|0|||
155203880|NCT01315678|560186080|FG000|Overall Study|similar reason to those listed above|3|||
155203881|NCT01315678|560186081|FG001|Overall Study|similar reason to those listed above|2|||
155203882|NCT00331682|560186090|FG000|Overall Study|Adverse Event|1|||
155203883|NCT02468414|560186091|FG000|Overall Study|Early Study Termination by Sponsor|1|||
155203884|NCT02468414|560186092|FG001|Overall Study|Early Study Termination by Sponsor|0|||
155203885|NCT02468414|560186091|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
155203886|NCT02468414|560186092|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
155203887|NCT02468414|560186091|FG000|Overall Study|Screen Failure|1|||
155203888|NCT02468414|560186092|FG001|Overall Study|Screen Failure|0|||
155203889|NCT03292588|560186093|FG000|Overall Study|Death|1|||
155203890|NCT03292588|560186094|FG001|Overall Study|Death|0|||
155203891|NCT03292588|560186093|FG000|Overall Study|Lost to Follow-up|12|||
155203892|NCT03292588|560186094|FG001|Overall Study|Lost to Follow-up|16|||
155203893|NCT03292588|560186093|FG000|Overall Study|Physician Decision|0|||
155203894|NCT03292588|560186094|FG001|Overall Study|Physician Decision|1|||
155203895|NCT03292588|560186093|FG000|Overall Study|Withdrawal by Subject|4|||
155203896|NCT03292588|560186094|FG001|Overall Study|Withdrawal by Subject|4|||
155203897|NCT03292588|560186093|FG000|Overall Study|Move out of town|1|||
155203898|NCT03292588|560186094|FG001|Overall Study|Move out of town|0|||
155203899|NCT03292588|560186093|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
155203900|NCT03292588|560186094|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
155203901|NCT00187486|560186095|FG000|Overall Study|Protocol Violation|1|||
155203902|NCT00543140|560186096|FG000|Overall Study|Lost to Follow-up|33|||
155203903|NCT00543140|560186096|FG000|Overall Study|Withdrawal by Subject|13|||
155203904|NCT00543140|560186096|FG000|Overall Study|Protocol Violation|10|||
155203905|NCT00543140|560186096|FG000|Overall Study|Insufficient weight loss|10|||
155203906|NCT00543140|560186096|FG000|Overall Study|SAE leading to explant of SAGB|3|||
155203907|NCT00543140|560186096|FG000|Overall Study|Death|1|||
155203908|NCT00543140|560186096|FG000|Overall Study|Subject moved|1|||
155203909|NCT00543140|560186096|FG000|Overall Study|Conversion to different procedure|1|||
155203910|NCT02483520|560186097|FG000|Overall Study|Lost to Follow-up|3|||
155203911|NCT02483520|560186098|FG001|Overall Study|Lost to Follow-up|4|||
155203912|NCT02483520|560186097|FG000|Overall Study|Withdrawal by Subject|4|||
155203913|NCT02483520|560186098|FG001|Overall Study|Withdrawal by Subject|14|||
155203914|NCT02483520|560186097|FG000|Overall Study|Hospitalized|2|||
155203915|NCT02483520|560186098|FG001|Overall Study|Hospitalized|3|||
155203916|NCT02483520|560186097|FG000|Overall Study|Moved to LTC|2|||
155203917|NCT02483520|560186098|FG001|Overall Study|Moved to LTC|3|||
155203918|NCT01104493|560186105|FG000|Overall Study|Lost to Follow-up|0|||
155203919|NCT01104493|560186106|FG001|Overall Study|Lost to Follow-up|2|||
155203920|NCT02511184|560186107|FG000|Overall Study|Death|1|||
155203921|NCT02511184|560186108|FG001|Overall Study|Death|0|||
155203922|NCT02511184|560186107|FG000|Overall Study|Lost to Follow-up|0|||
155203923|NCT02511184|560186108|FG001|Overall Study|Lost to Follow-up|1|||
155203924|NCT02511184|560186107|FG000|Overall Study|Study terminated by sponsor|1|||
155203925|NCT02511184|560186108|FG001|Overall Study|Study terminated by sponsor|5|||
155203926|NCT02511184|560186107|FG000|Overall Study|Withdrawal by Subject|0|||
155203927|NCT02511184|560186108|FG001|Overall Study|Withdrawal by Subject|1|||
155203928|NCT00133952|560186113|FG000|Overall Study|Adverse Event|1|||
155203929|NCT00133952|560186114|FG001|Overall Study|Adverse Event|2|||
155203930|NCT00133952|560186113|FG000|Overall Study|Death|3|||
155203931|NCT00133952|560186114|FG001|Overall Study|Death|2|||
155203932|NCT00133952|560186113|FG000|Overall Study|Lost to Follow-up|9|||
155203933|NCT00133952|560186114|FG001|Overall Study|Lost to Follow-up|14|||
155203934|NCT00133952|560186113|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
155203935|NCT00133952|560186114|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
155203936|NCT00133952|560186113|FG000|Overall Study|Protocol Violation|1|||
155203937|NCT00133952|560186114|FG001|Overall Study|Protocol Violation|1|||
155203938|NCT00133952|560186113|FG000|Overall Study|Withdrawal by Subject|20|||
155203939|NCT00133952|560186114|FG001|Overall Study|Withdrawal by Subject|4|||
155203940|NCT00133952|560186113|FG000|Overall Study|Physician Decision|4|||
155203941|NCT00133952|560186114|FG001|Overall Study|Physician Decision|3|||
155203942|NCT00133952|560186113|FG000|Overall Study|Sponsor Decision|0|||
155203943|NCT00133952|560186114|FG001|Overall Study|Sponsor Decision|1|||
155203944|NCT02170298|560186117|FG000|Overall Study|Withdrawal by Subject|0|||
155203945|NCT02170298|560186118|FG001|Overall Study|Withdrawal by Subject|1|||
155203946|NCT02170298|560186117|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
155203947|NCT02170298|560186118|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
155203948|NCT00003499|560186131|FG000|Overall Study|Not evaluable|8|||
155203949|NCT01256008|560186136|FG000|Overall Study|Lost to Follow-up|6|||
155203950|NCT01256008|560186137|FG001|Overall Study|Lost to Follow-up|4|||
155203951|NCT01256008|560186138|FG002|Overall Study|Lost to Follow-up|11|||
155203952|NCT01256008|560186136|FG000|Overall Study|Withdrawal by Subject|2|||
155203953|NCT01256008|560186137|FG001|Overall Study|Withdrawal by Subject|3|||
155203954|NCT01256008|560186138|FG002|Overall Study|Withdrawal by Subject|10|||
155203955|NCT01402492|560186141|FG000|Overall Study|Withdrawal by Subject|17|||
155203956|NCT01402492|560186142|FG001|Overall Study|Withdrawal by Subject|11|||
155203957|NCT01402492|560186143|FG002|Overall Study|Withdrawal by Subject|11|||
155203958|NCT01402492|560186141|FG000|Overall Study|Adverse Event|2|||
155203959|NCT01402492|560186142|FG001|Overall Study|Adverse Event|3|||
155203960|NCT01402492|560186143|FG002|Overall Study|Adverse Event|4|||
155203961|NCT01402492|560186141|FG000|Overall Study|Physician Decision|0|||
155203962|NCT01402492|560186142|FG001|Overall Study|Physician Decision|3|||
155203963|NCT01402492|560186143|FG002|Overall Study|Physician Decision|0|||
155203964|NCT01402492|560186141|FG000|Overall Study|Incarcerated (N=3)|2|||
155203965|NCT01402492|560186142|FG001|Overall Study|Incarcerated (N=3)|0|||
155203966|NCT01402492|560186143|FG002|Overall Study|Incarcerated (N=3)|1|||
155203967|NCT02573311|560186146|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
155203968|NCT02573311|560186147|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
155203969|NCT02573311|560186146|FG000|Disposition for Part 2|Physician Decision|25|||
155203970|NCT02573311|560186147|FG001|Disposition for Part 2|Physician Decision|7|||
155203971|NCT02573311|560186146|FG000|Disposition for Part 2|Adverse Event|36|||
155203972|NCT02573311|560186147|FG001|Disposition for Part 2|Adverse Event|5|||
155203973|NCT02573311|560186146|FG000|Disposition for Part 2|Lost to Follow-up|76|||
155203974|NCT02573311|560186147|FG001|Disposition for Part 2|Lost to Follow-up|7|||
155203975|NCT02573311|560186146|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
155203976|NCT02573311|560186147|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
155203977|NCT02573311|560186146|FG000|Disposition for Part 2|Investigator decision|0|||
155203978|NCT02573311|560186147|FG001|Disposition for Part 2|Investigator decision|1|||
155203979|NCT02573311|560186146|FG000|Disposition for Part 2|Other than specified above|13|||
155203980|NCT02573311|560186147|FG001|Disposition for Part 2|Other than specified above|3|||
155203981|NCT04862585|560186149|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
155203982|NCT04862585|560186150|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
155203983|NCT04862585|560186149|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
155203984|NCT04862585|560186150|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
155203985|NCT04862585|560186149|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
155203986|NCT04862585|560186150|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
155203987|NCT04862585|560186149|FG000|Overall Study|one withdrew without providing a reason|0|||
155203988|NCT04862585|560186150|FG001|Overall Study|one withdrew without providing a reason|1|||
155203989|NCT05537883|560186153|FG000|Overall Study|revisional surgery|4|||
155203990|NCT05537883|560186154|FG001|Overall Study|revisional surgery|2|||
155203991|NCT05537883|560186153|FG000|Overall Study|surgeries were cancelled|0|||
155203992|NCT05537883|560186154|FG001|Overall Study|surgeries were cancelled|2|||
155203993|NCT05537883|560186153|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
155203994|NCT05537883|560186154|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
155203995|NCT02296320|560186156|FG000|Overall Study|Withdrawal by Subject|4|||
155203996|NCT02296320|560186157|FG001|Overall Study|Withdrawal by Subject|0|||
155203997|NCT02296320|560186158|FG002|Overall Study|Withdrawal by Subject|2|||
155203998|NCT02296320|560186156|FG000|Overall Study|Death|24|||
155203999|NCT02296320|560186157|FG001|Overall Study|Death|3|||
155204000|NCT02296320|560186158|FG002|Overall Study|Death|27|||
155204001|NCT02296320|560186156|FG000|Overall Study|Lost to Follow-up|5|||
155204002|NCT02296320|560186157|FG001|Overall Study|Lost to Follow-up|2|||
155204003|NCT02296320|560186158|FG002|Overall Study|Lost to Follow-up|7|||
155204004|NCT02296320|560186156|FG000|Overall Study|Not treated|2|||
155204005|NCT02296320|560186157|FG001|Overall Study|Not treated|0|||
155204006|NCT02296320|560186158|FG002|Overall Study|Not treated|0|||
155204007|NCT02296320|560186156|FG000|Overall Study|Not - specified|0|||
155204008|NCT02296320|560186157|FG001|Overall Study|Not - specified|0|||
155204009|NCT02296320|560186158|FG002|Overall Study|Not - specified|1|||
155204010|NCT05229406|560186162|FG000|Overall Study|Withdrawal by Subject|1|||
155204011|NCT05229406|560186163|FG001|Overall Study|Withdrawal by Subject|2|||
155204012|NCT00040664|560186164|FG000|Overall Study|Adverse Event|12|||
155204013|NCT00040664|560186165|FG001|Overall Study|Adverse Event|3|||
155204014|NCT00040664|560186166|FG002|Overall Study|Adverse Event|2|||
155204015|NCT00040664|560186167|FG003|Overall Study|Adverse Event|7|||
155204016|NCT00040664|560186164|FG000|Overall Study|Lack of Efficacy|9|||
155204017|NCT00040664|560186165|FG001|Overall Study|Lack of Efficacy|2|||
155204018|NCT00040664|560186166|FG002|Overall Study|Lack of Efficacy|3|||
155204019|NCT00040664|560186167|FG003|Overall Study|Lack of Efficacy|4|||
155204020|NCT00040664|560186164|FG000|Overall Study|Insufficient CD4 response|1|||
155204021|NCT00040664|560186165|FG001|Overall Study|Insufficient CD4 response|0|||
155204022|NCT00040664|560186166|FG002|Overall Study|Insufficient CD4 response|1|||
155204023|NCT00040664|560186167|FG003|Overall Study|Insufficient CD4 response|0|||
155204024|NCT00040664|560186164|FG000|Overall Study|Lost to Follow-up|4|||
155204025|NCT00040664|560186165|FG001|Overall Study|Lost to Follow-up|2|||
155204026|NCT00040664|560186166|FG002|Overall Study|Lost to Follow-up|0|||
155204027|NCT00040664|560186167|FG003|Overall Study|Lost to Follow-up|2|||
155204028|NCT00040664|560186164|FG000|Overall Study|Protocol Violation|2|||
155204029|NCT00040664|560186165|FG001|Overall Study|Protocol Violation|1|||
155204030|NCT00040664|560186166|FG002|Overall Study|Protocol Violation|0|||
155204031|NCT00040664|560186167|FG003|Overall Study|Protocol Violation|1|||
155204032|NCT00040664|560186164|FG000|Overall Study|Withdrawal by Subject|7|||
155204033|NCT00040664|560186165|FG001|Overall Study|Withdrawal by Subject|0|||
155204034|NCT00040664|560186166|FG002|Overall Study|Withdrawal by Subject|3|||
155204035|NCT00040664|560186167|FG003|Overall Study|Withdrawal by Subject|4|||
155204036|NCT00040664|560186164|FG000|Overall Study|Pregnancy|3|||
155204037|NCT00040664|560186165|FG001|Overall Study|Pregnancy|0|||
155204038|NCT00040664|560186166|FG002|Overall Study|Pregnancy|0|||
155204039|NCT00040664|560186167|FG003|Overall Study|Pregnancy|3|||
155204040|NCT00040664|560186164|FG000|Overall Study|Medication adherence/compliance problems|8|||
155204041|NCT00040664|560186165|FG001|Overall Study|Medication adherence/compliance problems|2|||
155204042|NCT00040664|560186166|FG002|Overall Study|Medication adherence/compliance problems|1|||
155204043|NCT00040664|560186167|FG003|Overall Study|Medication adherence/compliance problems|5|||
155204044|NCT00040664|560186164|FG000|Overall Study|Poor taste|2|||
155204045|NCT00040664|560186165|FG001|Overall Study|Poor taste|0|||
155204046|NCT00040664|560186166|FG002|Overall Study|Poor taste|2|||
155204047|NCT00040664|560186167|FG003|Overall Study|Poor taste|0|||
155204048|NCT00040664|560186164|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
155204049|NCT00040664|560186165|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
155204050|NCT00040664|560186166|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
155204051|NCT00040664|560186167|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
155204052|NCT00040664|560186164|FG000|Overall Study|Change of formulation|2|||
155204053|NCT00040664|560186165|FG001|Overall Study|Change of formulation|2|||
155204054|NCT00040664|560186166|FG002|Overall Study|Change of formulation|0|||
155204055|NCT00040664|560186167|FG003|Overall Study|Change of formulation|0|||
155204056|NCT00040664|560186164|FG000|Overall Study|Non-viability of oral suspension|1|||
155204057|NCT00040664|560186165|FG001|Overall Study|Non-viability of oral suspension|0|||
155204058|NCT00040664|560186166|FG002|Overall Study|Non-viability of oral suspension|1|||
155204059|NCT00040664|560186167|FG003|Overall Study|Non-viability of oral suspension|0|||
155204060|NCT01709162|560186168|FG000|Overall Study|Disease progression|3|||
155204061|NCT01709162|560186169|FG001|Overall Study|Disease progression|3|||
155204062|NCT01709162|560186168|FG000|Overall Study|Study drug toxicity|2|||
155204063|NCT01709162|560186169|FG001|Overall Study|Study drug toxicity|0|||
155204064|NCT01709162|560186168|FG000|Overall Study|Administrative reason by sponsor|0|||
155204065|NCT01709162|560186169|FG001|Overall Study|Administrative reason by sponsor|1|||
155204066|NCT01709162|560186168|FG000|Overall Study|Other|1|||
155204067|NCT01709162|560186169|FG001|Overall Study|Other|0|||
155204068|NCT01709162|560186168|FG000|Overall Study|Withdrawal by Subject|0|||
155204069|NCT01709162|560186169|FG001|Overall Study|Withdrawal by Subject|1|||
155204070|NCT03953820|560186171|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
155204071|NCT03953820|560186172|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
155204072|NCT03953820|560186173|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
155204073|NCT03953820|560186171|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
155204074|NCT03953820|560186172|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
155204075|NCT03953820|560186173|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
155204076|NCT01049308|560186174|FG000|Pill Counts|Withdrawal by Subject|83|||
155204077|NCT03845985|560186175|FG000|Overall Study|Lost to Follow-up|2|||
155204078|NCT03845985|560186176|FG001|Overall Study|Lost to Follow-up|1|||
155204079|NCT03845985|560186175|FG000|Overall Study|Physician Decision|1|||
155204080|NCT03845985|560186176|FG001|Overall Study|Physician Decision|0|||
155204081|NCT03845985|560186175|FG000|Overall Study|Withdrawal by Subject|4|||
155204082|NCT03845985|560186176|FG001|Overall Study|Withdrawal by Subject|1|||
155204083|NCT01318993|560186177|FG000|Overall Study|Adverse Event|53|||
155204084|NCT01318993|560186177|FG000|Overall Study|Lack of Efficacy|121|||
155204085|NCT01318993|560186177|FG000|Overall Study|Protocol Violation|3|||
155204086|NCT01318993|560186177|FG000|Overall Study|Protocol based stopping criteria|6|||
155204087|NCT01318993|560186177|FG000|Overall Study|Study closed or terminated|174|||
155204088|NCT01318993|560186177|FG000|Overall Study|Lost to Follow-up|4|||
155204089|NCT01318993|560186177|FG000|Overall Study|Physician Decision|13|||
155204090|NCT01318993|560186177|FG000|Overall Study|Withdrawal by Subject|24|||
155204091|NCT03334539|560186178|FG000|Overall Study|Adverse Event|3|||
155204092|NCT03334539|560186179|FG001|Overall Study|Adverse Event|5|||
155204093|NCT03334539|560186180|FG002|Overall Study|Adverse Event|0|||
155204094|NCT03334539|560186178|FG000|Overall Study|Withdrawal by Subject|0|||
155204095|NCT03334539|560186179|FG001|Overall Study|Withdrawal by Subject|1|||
155204096|NCT03334539|560186180|FG002|Overall Study|Withdrawal by Subject|1|||
155204097|NCT03334539|560186178|FG000|Overall Study|Administrative Reasons|1|||
155204098|NCT03334539|560186179|FG001|Overall Study|Administrative Reasons|0|||
155204099|NCT03334539|560186180|FG002|Overall Study|Administrative Reasons|0|||
155204100|NCT03334539|560186178|FG000|Overall Study|Hypertension Not Controlled|0|||
155204101|NCT03334539|560186179|FG001|Overall Study|Hypertension Not Controlled|1|||
155204102|NCT03334539|560186180|FG002|Overall Study|Hypertension Not Controlled|0|||
155204103|NCT04974697|560186184|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
155204104|NCT04974697|560186184|FG000|Overall Study|Lens discomfort|1|||
155204105|NCT03706456|560186185|FG000|Overall Study|Adverse Event|1|||
155204106|NCT03706456|560186185|FG000|Overall Study|Lack of Efficacy|2|||
155204107|NCT01845831|560186187|FG000|Inpatient Phase|Withdrawal by Subject|1|||
155204108|NCT01845831|560186188|FG001|Inpatient Phase|Withdrawal by Subject|1|||
155204109|NCT01845831|560186189|FG002|Inpatient Phase|Withdrawal by Subject|0|||
155204110|NCT01845831|560186190|FG003|Inpatient Phase|Withdrawal by Subject|0|||
155204111|NCT01845831|560186191|FG004|Inpatient Phase|Withdrawal by Subject|0|||
155204112|NCT00221403|560186192|FG000|Overall Study|Protocol Violation|1|||
155204113|NCT00221403|560186193|FG001|Overall Study|Protocol Violation|0|||
155204114|NCT00221403|560186194|FG002|Overall Study|Protocol Violation|0|||
155204115|NCT00221403|560186192|FG000|Overall Study|Physician Decision|1|||
155204116|NCT00221403|560186193|FG001|Overall Study|Physician Decision|0|||
155204117|NCT00221403|560186194|FG002|Overall Study|Physician Decision|0|||
155204118|NCT00221403|560186192|FG000|Overall Study|Withdrawal by Subject|0|||
155204119|NCT00221403|560186193|FG001|Overall Study|Withdrawal by Subject|3|||
155204120|NCT00221403|560186194|FG002|Overall Study|Withdrawal by Subject|0|||
155204121|NCT00221403|560186192|FG000|Overall Study|Lack of Efficacy|0|||
155204122|NCT00221403|560186193|FG001|Overall Study|Lack of Efficacy|1|||
155204123|NCT00221403|560186194|FG002|Overall Study|Lack of Efficacy|0|||
155204124|NCT00221403|560186192|FG000|Overall Study|Adverse Event|0|||
155204125|NCT00221403|560186193|FG001|Overall Study|Adverse Event|1|||
155204126|NCT00221403|560186194|FG002|Overall Study|Adverse Event|0|||
155204127|NCT00279305|560186201|FG000|Overall Study|Pregnancy|1|||
155204128|NCT00279305|560186202|FG001|Overall Study|Pregnancy|0|||
155204129|NCT00279305|560186201|FG000|Overall Study|Withdrawal by Subject|2|||
155204130|NCT00279305|560186202|FG001|Overall Study|Withdrawal by Subject|0|||
155204131|NCT00279305|560186201|FG000|Overall Study|Dificulting establishing IV|1|||
155204132|NCT00279305|560186202|FG001|Overall Study|Dificulting establishing IV|0|||
155204133|NCT00279305|560186201|FG000|Overall Study|FDA Safety Alert|4|||
155204134|NCT00279305|560186202|FG001|Overall Study|FDA Safety Alert|1|||
155204135|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204136|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
155204137|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204138|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204139|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204140|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204141|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204142|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204143|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204144|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204145|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204146|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204147|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
155204148|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
155204149|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
155204150|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
155204151|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
155204152|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
155204153|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
155204154|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
155204155|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
155204156|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
155204157|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
155204158|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
155204159|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
155204160|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
155204161|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
155204162|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
155204163|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
155204164|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
155204165|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
155204166|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
155204167|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
155204168|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
155204169|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
155204170|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
155204171|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204172|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204173|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204174|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204175|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
155204176|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204177|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204178|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204179|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204180|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204181|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
155204182|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204183|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
155204184|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
155204185|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
155204186|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
155204187|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
155204188|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
155204189|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
155204190|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
155204191|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
155204192|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
155204193|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
155204194|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
155204195|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
155204196|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
155204197|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
155204198|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
155204199|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
155204200|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
155204201|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
155204202|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
155204203|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
155204204|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
155204205|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
155204206|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
155204207|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Death|0|||
155204208|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Death|0|||
155204209|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Death|0|||
155204210|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Death|0|||
155204211|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Death|1|||
155204212|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Death|1|||
155204213|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Death|3|||
155204214|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Death|1|||
155204215|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Death|1|||
155204216|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Death|5|||
155204217|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Death|2|||
155204218|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Death|2|||
155204219|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Other|0|||
155204220|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Other|0|||
155204221|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Other|0|||
155204222|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Other|0|||
155204223|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Other|10|||
155204224|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Other|3|||
155204225|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Other|2|||
155204226|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Other|0|||
155204227|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Other|10|||
155204228|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Other|5|||
155204229|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Other|1|||
155204230|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Other|7|||
155204231|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204232|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204233|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204234|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204235|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
155204236|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204237|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204238|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204239|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204240|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204241|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204242|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204243|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204244|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204245|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204246|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204247|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
155204248|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204249|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204250|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204251|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204252|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204253|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204254|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204255|NCT01638546|560186225|FG000|Overall Study|Adverse Event|1|||
155204256|NCT01638546|560186226|FG001|Overall Study|Adverse Event|3|||
155204257|NCT04292743|560186229|FG000|Overall Study|Physician Decision|1|||
155204258|NCT04292743|560186230|FG001|Overall Study|Physician Decision|3|||
155204259|NCT04292743|560186231|FG002|Overall Study|Physician Decision|0|||
155204260|NCT04292743|560186232|FG003|Overall Study|Physician Decision|0|||
155204261|NCT04292743|560186229|FG000|Overall Study|Withdrawal by Subject|0|||
155204262|NCT04292743|560186230|FG001|Overall Study|Withdrawal by Subject|5|||
155204263|NCT04292743|560186231|FG002|Overall Study|Withdrawal by Subject|0|||
155204264|NCT04292743|560186232|FG003|Overall Study|Withdrawal by Subject|0|||
155204265|NCT04292743|560186229|FG000|Overall Study|Death|0|||
155204266|NCT04292743|560186230|FG001|Overall Study|Death|1|||
155204267|NCT04292743|560186231|FG002|Overall Study|Death|0|||
155204268|NCT04292743|560186232|FG003|Overall Study|Death|0|||
155204269|NCT04292743|560186229|FG000|Overall Study|Progression of Disease|2|||
155204270|NCT04292743|560186230|FG001|Overall Study|Progression of Disease|5|||
155204271|NCT04292743|560186231|FG002|Overall Study|Progression of Disease|0|||
155204272|NCT04292743|560186232|FG003|Overall Study|Progression of Disease|0|||
155204273|NCT04292743|560186229|FG000|Overall Study|No Treatment per protocol|0|||
155204274|NCT04292743|560186230|FG001|Overall Study|No Treatment per protocol|2|||
155204275|NCT04292743|560186231|FG002|Overall Study|No Treatment per protocol|0|||
155204276|NCT04292743|560186232|FG003|Overall Study|No Treatment per protocol|0|||
155204277|NCT02881554|560186233|FG000|Overall Study|Withdrawal by Subject|2|||
155204278|NCT02881554|560186234|FG001|Overall Study|Withdrawal by Subject|0|||
155204279|NCT00684307|560188270|FG000|Overall Study|Adverse Event|11|||
155204280|NCT00684307|560188271|FG001|Overall Study|Adverse Event|6|||
155204281|NCT00684307|560188272|FG002|Overall Study|Adverse Event|15|||
155204282|NCT00684307|560188273|FG003|Overall Study|Adverse Event|16|||
155204283|NCT00684307|560188274|FG004|Overall Study|Adverse Event|8|||
155204284|NCT00684307|560188270|FG000|Overall Study|Development of increasing Liver Function|0|||
155204285|NCT00684307|560188271|FG001|Overall Study|Development of increasing Liver Function|2|||
155204286|NCT00684307|560188272|FG002|Overall Study|Development of increasing Liver Function|0|||
155204287|NCT00684307|560188273|FG003|Overall Study|Development of increasing Liver Function|1|||
155204288|NCT00684307|560188274|FG004|Overall Study|Development of increasing Liver Function|0|||
155204289|NCT00684307|560188270|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
155204290|NCT00684307|560188271|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
155204291|NCT00684307|560188272|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
155204292|NCT00684307|560188273|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
155204293|NCT00684307|560188274|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
155204294|NCT00684307|560188270|FG000|Overall Study|Incorrect enrolment or randomization|4|||
155204295|NCT00684307|560188271|FG001|Overall Study|Incorrect enrolment or randomization|0|||
155204296|NCT00684307|560188272|FG002|Overall Study|Incorrect enrolment or randomization|0|||
155204297|NCT00684307|560188273|FG003|Overall Study|Incorrect enrolment or randomization|0|||
155204298|NCT00684307|560188274|FG004|Overall Study|Incorrect enrolment or randomization|0|||
155204299|NCT00684307|560188270|FG000|Overall Study|Interupted IP for more than 7 days|0|||
155204300|NCT00684307|560188271|FG001|Overall Study|Interupted IP for more than 7 days|4|||
155204301|NCT00684307|560188272|FG002|Overall Study|Interupted IP for more than 7 days|1|||
155204302|NCT00684307|560188273|FG003|Overall Study|Interupted IP for more than 7 days|3|||
155204303|NCT00684307|560188274|FG004|Overall Study|Interupted IP for more than 7 days|3|||
155204304|NCT00684307|560188270|FG000|Overall Study|Severe non compliance to protocol|1|||
155204305|NCT00684307|560188271|FG001|Overall Study|Severe non compliance to protocol|0|||
155204306|NCT00684307|560188272|FG002|Overall Study|Severe non compliance to protocol|0|||
155204307|NCT00684307|560188273|FG003|Overall Study|Severe non compliance to protocol|1|||
155204308|NCT00684307|560188274|FG004|Overall Study|Severe non compliance to protocol|2|||
155204309|NCT00684307|560188270|FG000|Overall Study|Participant not willing to continue|7|||
155204310|NCT00684307|560188271|FG001|Overall Study|Participant not willing to continue|10|||
155204311|NCT00684307|560188272|FG002|Overall Study|Participant not willing to continue|11|||
155204312|NCT00684307|560188273|FG003|Overall Study|Participant not willing to continue|5|||
155204313|NCT00684307|560188274|FG004|Overall Study|Participant not willing to continue|8|||
155204314|NCT00684307|560188270|FG000|Overall Study|Criteria from the CSR|0|||
155204315|NCT00684307|560188271|FG001|Overall Study|Criteria from the CSR|0|||
155204316|NCT00684307|560188272|FG002|Overall Study|Criteria from the CSR|1|||
155204317|NCT00684307|560188273|FG003|Overall Study|Criteria from the CSR|3|||
155204318|NCT00684307|560188274|FG004|Overall Study|Criteria from the CSR|3|||
155204319|NCT00759031|560188275|FG000|First Intervention (1 Day)|Physician Decision|1|||
155204320|NCT00759031|560188276|FG001|First Intervention (1 Day)|Physician Decision|0|||
155204321|NCT00759031|560188275|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155204322|NCT00759031|560188276|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155204323|NCT00759031|560188275|FG000|First Intervention (1 Day)|Screening failure|1|||
155204324|NCT00759031|560188276|FG001|First Intervention (1 Day)|Screening failure|0|||
155204325|NCT04532164|560188277|FG000|Overall Study|Adverse Event|1|||
155204326|NCT04532164|560188277|FG000|Overall Study|Protocol Violation|5|||
155204327|NCT04532164|560188277|FG000|Overall Study|Lost to Follow-up|1|||
155204328|NCT04532164|560188277|FG000|Overall Study|Found to be Ineligible|3|||
155204329|NCT04532164|560188277|FG000|Overall Study|Withdrawal by Subject|14|||
155204330|NCT04492618|560188278|FG000|Overall Study|Withdrawal by Subject|1|||
155204331|NCT03489720|560188279|FG000|Overall Study|Withdrawal by Subject|2|||
155204332|NCT03489720|560188280|FG001|Overall Study|Withdrawal by Subject|0|||
155204333|NCT01806545|560188281|FG000|Overall Study|Adverse Event|2|||
155204334|NCT01806545|560188282|FG001|Overall Study|Adverse Event|3|||
155204335|NCT01806545|560188281|FG000|Overall Study|Lost to Follow-up|1|||
155204336|NCT01806545|560188282|FG001|Overall Study|Lost to Follow-up|0|||
155204337|NCT01806545|560188281|FG000|Overall Study|Withdrawal by Subject|3|||
155204338|NCT01806545|560188282|FG001|Overall Study|Withdrawal by Subject|2|||
155204339|NCT00884312|560188285|FG000|Overall Study|Non-fatal Progressive Disease|0|||
155204340|NCT00884312|560188286|FG001|Overall Study|Non-fatal Progressive Disease|8|||
155204341|NCT00884312|560188285|FG000|Overall Study|Fatal Progressive Disease|0|||
155204342|NCT00884312|560188286|FG001|Overall Study|Fatal Progressive Disease|1|||
155204343|NCT00884312|560188285|FG000|Overall Study|Non-fatal Adverse Event|1|||
155204344|NCT00884312|560188286|FG001|Overall Study|Non-fatal Adverse Event|0|||
155204345|NCT00884312|560188285|FG000|Overall Study|Fatal Adverse Event|1|||
155204346|NCT00884312|560188286|FG001|Overall Study|Fatal Adverse Event|4|||
155204347|NCT00884312|560188285|FG000|Overall Study|Withdrawal by Subject|0|||
155204348|NCT00884312|560188286|FG001|Overall Study|Withdrawal by Subject|6|||
155204349|NCT00884312|560188285|FG000|Overall Study|Physician Decision|0|||
155204350|NCT00884312|560188286|FG001|Overall Study|Physician Decision|1|||
155204351|NCT00884312|560188285|FG000|Overall Study|Other|0|||
155204352|NCT00884312|560188286|FG001|Overall Study|Other|4|||
155204353|NCT00884312|560188285|FG000|Overall Study|Did Not Receive Study Drug|0|||
155204354|NCT00884312|560188286|FG001|Overall Study|Did Not Receive Study Drug|1|||
155204355|NCT03902574|560188287|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
155204356|NCT03902574|560188288|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
155204357|NCT03902574|560188289|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
155204358|NCT03521934|560188297|FG000|Overall Study|Death|65|||
155204359|NCT03521934|560188298|FG001|Overall Study|Death|73|||
155204360|NCT03521934|560188297|FG000|Overall Study|Withdrawal by Subject|18|||
155204361|NCT03521934|560188298|FG001|Overall Study|Withdrawal by Subject|23|||
155204362|NCT03521934|560188297|FG000|Overall Study|Site Terminated by Sponsor|39|||
155204363|NCT03521934|560188298|FG001|Overall Study|Site Terminated by Sponsor|35|||
155204364|NCT03521934|560188297|FG000|Overall Study|Study Terminated by Sponsor|483|||
155204365|NCT03521934|560188298|FG001|Overall Study|Study Terminated by Sponsor|477|||
155204366|NCT03521934|560188297|FG000|Overall Study|Reason not Specified|3|||
155204367|NCT03521934|560188298|FG001|Overall Study|Reason not Specified|6|||
155204368|NCT05048784|560188299|FG000|Period 1|Adverse Event|3|||
155204369|NCT05048784|560188300|FG001|Period 1|Adverse Event|1|||
155204370|NCT05048784|560188301|FG002|Period 1|Adverse Event|0|||
155204371|NCT05048784|560188302|FG003|Period 1|Adverse Event|0|||
155204372|NCT05048784|560188299|FG000|Period 2|Lost to Follow-up|0|||
155204373|NCT05048784|560188300|FG001|Period 2|Lost to Follow-up|1|||
155204374|NCT05048784|560188301|FG002|Period 2|Lost to Follow-up|0|||
155204375|NCT05048784|560188302|FG003|Period 2|Lost to Follow-up|0|||
155204376|NCT02101060|560188305|FG000|Overall Study|Adverse Event|1|||
155204377|NCT02101060|560188306|FG001|Overall Study|Adverse Event|0|||
155204378|NCT02101060|560188305|FG000|Overall Study|Withdrawal by Subject|1|||
155204379|NCT02101060|560188306|FG001|Overall Study|Withdrawal by Subject|1|||
155204380|NCT02101060|560188305|FG000|Overall Study|Lost to Follow-up|3|||
155204381|NCT02101060|560188306|FG001|Overall Study|Lost to Follow-up|3|||
155204382|NCT02269241|560188307|FG000|Overall Study|Lost to Follow-up|269|||
155204383|NCT02269241|560188307|FG000|Overall Study|Withdrawal by Subject|155|||
155204384|NCT02269241|560188307|FG000|Overall Study|Protocol Violation|1|||
155204385|NCT02269241|560188307|FG000|Overall Study|Physician Decision|7|||
155204386|NCT02269241|560188307|FG000|Overall Study|Pregnancy|15|||
155204387|NCT02269241|560188307|FG000|Overall Study|Wish for pregnancy|5|||
155204388|NCT02269241|560188307|FG000|Overall Study|Development of an exclusion criteria|16|||
155204389|NCT02269241|560188307|FG000|Overall Study|Adverse Event|113|||
155204390|NCT02269241|560188307|FG000|Overall Study|At the specific request of the sponsor|20|||
155204391|NCT02269241|560188307|FG000|Overall Study|Several reasons not classified|53|||
155204392|NCT02269241|560188307|FG000|Overall Study|Screening failures|546|||
155204393|NCT03020160|560188308|FG000|Overall Study|Withdrawal by Subject|1|||
155204394|NCT03020160|560188309|FG001|Overall Study|Withdrawal by Subject|0|||
155204395|NCT02270957|560188310|FG000|Overall Study|Lack of Efficacy|2|||
155204396|NCT02270957|560188311|FG001|Overall Study|Lack of Efficacy|4|||
155204397|NCT02270957|560188310|FG000|Overall Study|Adverse Event|2|||
155204398|NCT02270957|560188311|FG001|Overall Study|Adverse Event|0|||
155204399|NCT00284050|560188315|FG000|Overall Study|Adverse Event|1|||
155204400|NCT00284050|560188316|FG001|Overall Study|Adverse Event|1|||
155204401|NCT00284050|560188317|FG002|Overall Study|Adverse Event|1|||
155204402|NCT00284050|560188315|FG000|Overall Study|Lack of Efficacy|0|||
155204403|NCT00284050|560188316|FG001|Overall Study|Lack of Efficacy|1|||
155204404|NCT00284050|560188317|FG002|Overall Study|Lack of Efficacy|3|||
155204405|NCT00284050|560188315|FG000|Overall Study|Protocol Violation|0|||
155204406|NCT00284050|560188316|FG001|Overall Study|Protocol Violation|1|||
155204407|NCT00284050|560188317|FG002|Overall Study|Protocol Violation|2|||
155204408|NCT00284050|560188315|FG000|Overall Study|Withdrawal by Subject|2|||
155204409|NCT00284050|560188316|FG001|Overall Study|Withdrawal by Subject|2|||
155204410|NCT00284050|560188317|FG002|Overall Study|Withdrawal by Subject|2|||
155204411|NCT00284050|560188315|FG000|Overall Study|Lost to Follow-up|1|||
155204412|NCT00284050|560188316|FG001|Overall Study|Lost to Follow-up|0|||
155204413|NCT00284050|560188317|FG002|Overall Study|Lost to Follow-up|1|||
155204414|NCT00284050|560188315|FG000|Overall Study|Death|1|||
155204415|NCT00284050|560188316|FG001|Overall Study|Death|0|||
155204416|NCT00284050|560188317|FG002|Overall Study|Death|0|||
155204417|NCT00166114|560188321|FG000|Overall Study|Protocol Violation|2|||
155204418|NCT00166114|560188322|FG001|Overall Study|Protocol Violation|1|||
155204419|NCT00166114|560188321|FG000|Overall Study|Withdrawal by Subject|10|||
155204420|NCT00166114|560188322|FG001|Overall Study|Withdrawal by Subject|4|||
155204421|NCT00166114|560188321|FG000|Overall Study|Adverse Event|2|||
155204422|NCT00166114|560188322|FG001|Overall Study|Adverse Event|1|||
155204423|NCT00545168|560188329|FG000|Overall Study|Lost to Follow-up|5|||
155204424|NCT00545168|560188330|FG001|Overall Study|Lost to Follow-up|5|||
155204425|NCT00545168|560188331|FG002|Overall Study|Lost to Follow-up|5|||
155204426|NCT00545168|560188329|FG000|Overall Study|Withdrawal by Subject|9|||
155204427|NCT00545168|560188330|FG001|Overall Study|Withdrawal by Subject|0|||
155204428|NCT00545168|560188331|FG002|Overall Study|Withdrawal by Subject|13|||
155204429|NCT00545168|560188329|FG000|Overall Study|Protocol Violation|1|||
155204430|NCT00545168|560188330|FG001|Overall Study|Protocol Violation|0|||
155204431|NCT00545168|560188331|FG002|Overall Study|Protocol Violation|1|||
155204432|NCT00545168|560188329|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
155204433|NCT00545168|560188330|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
155204434|NCT00545168|560188331|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
155204435|NCT01218204|560188332|FG000|Part B Washout|Adverse Event|0|||
155204436|NCT01218204|560188333|FG001|Part B Washout|Adverse Event|1|||
155204437|NCT01218204|560188334|FG002|Part B Washout|Adverse Event|0|||
155204438|NCT01218204|560188335|FG003|Part B Washout|Adverse Event|0|||
155204439|NCT01218204|560188332|FG000|Part B Washout|Lost to Follow-up|0|||
155204440|NCT01218204|560188333|FG001|Part B Washout|Lost to Follow-up|2|||
155204441|NCT01218204|560188334|FG002|Part B Washout|Lost to Follow-up|0|||
155204442|NCT01218204|560188335|FG003|Part B Washout|Lost to Follow-up|0|||
155204443|NCT01218204|560188332|FG000|Part B Washout|Physician Decision|0|||
155204444|NCT01218204|560188333|FG001|Part B Washout|Physician Decision|14|||
155204445|NCT01218204|560188334|FG002|Part B Washout|Physician Decision|0|||
155204446|NCT01218204|560188335|FG003|Part B Washout|Physician Decision|0|||
155204447|NCT01218204|560188332|FG000|Part B Washout|Withdrawal by Subject|0|||
155204448|NCT01218204|560188333|FG001|Part B Washout|Withdrawal by Subject|14|||
155204449|NCT01218204|560188334|FG002|Part B Washout|Withdrawal by Subject|0|||
155204450|NCT01218204|560188335|FG003|Part B Washout|Withdrawal by Subject|0|||
155204451|NCT01218204|560188332|FG000|Part B Washout|Reached defined stopping criteria|0|||
155204452|NCT01218204|560188333|FG001|Part B Washout|Reached defined stopping criteria|2|||
155204453|NCT01218204|560188334|FG002|Part B Washout|Reached defined stopping criteria|0|||
155204454|NCT01218204|560188335|FG003|Part B Washout|Reached defined stopping criteria|0|||
155204455|NCT01218204|560188332|FG000|Part B Washout|Did not meet continuation criteria|0|||
155204456|NCT01218204|560188333|FG001|Part B Washout|Did not meet continuation criteria|112|||
155204457|NCT01218204|560188334|FG002|Part B Washout|Did not meet continuation criteria|0|||
155204458|NCT01218204|560188335|FG003|Part B Washout|Did not meet continuation criteria|0|||
155204459|NCT01218204|560188332|FG000|Part B Run-in|Adverse Event|0|||
155204460|NCT01218204|560188333|FG001|Part B Run-in|Adverse Event|0|||
155204461|NCT01218204|560188334|FG002|Part B Run-in|Adverse Event|1|||
155204462|NCT01218204|560188335|FG003|Part B Run-in|Adverse Event|0|||
155204463|NCT01218204|560188332|FG000|Part B Run-in|Protocol Violation|0|||
155204464|NCT01218204|560188333|FG001|Part B Run-in|Protocol Violation|0|||
155204465|NCT01218204|560188334|FG002|Part B Run-in|Protocol Violation|2|||
155204466|NCT01218204|560188335|FG003|Part B Run-in|Protocol Violation|0|||
155204467|NCT01218204|560188332|FG000|Part B Run-in|Withdrawal by Subject|0|||
155204468|NCT01218204|560188333|FG001|Part B Run-in|Withdrawal by Subject|0|||
155204469|NCT01218204|560188334|FG002|Part B Run-in|Withdrawal by Subject|3|||
155204470|NCT01218204|560188335|FG003|Part B Run-in|Withdrawal by Subject|0|||
155204471|NCT01218204|560188332|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
155204472|NCT01218204|560188333|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
155204473|NCT01218204|560188334|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
155204474|NCT01218204|560188335|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
155204475|NCT01218204|560188332|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204476|NCT01218204|560188333|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204477|NCT01218204|560188334|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204478|NCT01218204|560188335|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
155204479|NCT04390191|560188338|FG000|Overall Study|Withdrawal by Subject|1|||
155204480|NCT04390191|560188339|FG001|Overall Study|Withdrawal by Subject|0|||
155204481|NCT03978832|560188340|FG000|Overall Study|Adverse Event|1|||
155204482|NCT03978832|560188340|FG000|Overall Study|Lost to Follow-up|1|||
155204483|NCT03978832|560188340|FG000|Overall Study|Withdrawal by Subject|6|||
155204484|NCT03978832|560188340|FG000|Overall Study|Physician Decision|2|||
155204485|NCT03978832|560188340|FG000|Overall Study|did not pass screening criteria|44|||
155204486|NCT02244606|560188341|FG000|Overall Study|Adverse Event|0|||
155204487|NCT02244606|560188342|FG001|Overall Study|Adverse Event|1|||
155204488|NCT02244606|560188343|FG002|Overall Study|Adverse Event|1|||
155204489|NCT02244606|560188344|FG003|Overall Study|Adverse Event|0|||
155204490|NCT02244606|560188341|FG000|Overall Study|Lost to Follow-up|2|||
155204491|NCT02244606|560188342|FG001|Overall Study|Lost to Follow-up|2|||
155204492|NCT02244606|560188343|FG002|Overall Study|Lost to Follow-up|1|||
155204493|NCT02244606|560188344|FG003|Overall Study|Lost to Follow-up|0|||
155204494|NCT02244606|560188341|FG000|Overall Study|Protocol Violation|0|||
155204495|NCT02244606|560188342|FG001|Overall Study|Protocol Violation|0|||
155204496|NCT02244606|560188343|FG002|Overall Study|Protocol Violation|0|||
155204497|NCT02244606|560188344|FG003|Overall Study|Protocol Violation|1|||
155204498|NCT02244606|560188341|FG000|Overall Study|Withdrawal by Subject|1|||
155204499|NCT02244606|560188342|FG001|Overall Study|Withdrawal by Subject|1|||
155204500|NCT02244606|560188343|FG002|Overall Study|Withdrawal by Subject|0|||
155204501|NCT02244606|560188344|FG003|Overall Study|Withdrawal by Subject|0|||
155204502|NCT02244606|560188341|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
155204503|NCT02244606|560188342|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
155204504|NCT02244606|560188343|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
155204505|NCT02244606|560188344|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
155204506|NCT04605484|560188349|FG000|Overall Study|Lost to Follow-up|0|||
155204507|NCT04605484|560188350|FG001|Overall Study|Lost to Follow-up|1|||
155204508|NCT04605484|560188351|FG002|Overall Study|Lost to Follow-up|1|||
155204509|NCT04605484|560188349|FG000|Overall Study|Other|0|||
155204510|NCT04605484|560188350|FG001|Overall Study|Other|1|||
155204511|NCT04605484|560188351|FG002|Overall Study|Other|0|||
155204512|NCT04171531|560188352|FG000|Overall Study|Lost to Follow-up|4|||
155204513|NCT04171531|560188353|FG001|Overall Study|Lost to Follow-up|5|||
155204514|NCT04171531|560188352|FG000|Overall Study|Consent only through 6 months|1|||
155204515|NCT04171531|560188353|FG001|Overall Study|Consent only through 6 months|1|||
155204516|NCT04171531|560188352|FG000|Overall Study|Insurance did not cover procedure|0|||
155204517|NCT04171531|560188353|FG001|Overall Study|Insurance did not cover procedure|1|||
155204518|NCT04171531|560188352|FG000|Overall Study|Physician Decision|0|||
155204519|NCT04171531|560188353|FG001|Overall Study|Physician Decision|3|||
155204520|NCT04171531|560188352|FG000|Overall Study|Withdrawal by Subject|1|||
155204521|NCT04171531|560188353|FG001|Overall Study|Withdrawal by Subject|5|||
155204522|NCT03366337|560188355|FG000|Overall Study|Lost to Follow-up|1|||
155204523|NCT03366337|560188356|FG001|Overall Study|Lost to Follow-up|0|||
155204524|NCT03366337|560188357|FG002|Overall Study|Lost to Follow-up|1|||
155204525|NCT03366337|560188358|FG003|Overall Study|Lost to Follow-up|0|||
155204526|NCT03366337|560188355|FG000|Overall Study|Withdrawal by Subject|2|||
155204527|NCT03366337|560188356|FG001|Overall Study|Withdrawal by Subject|0|||
155204528|NCT03366337|560188357|FG002|Overall Study|Withdrawal by Subject|1|||
155204529|NCT03366337|560188358|FG003|Overall Study|Withdrawal by Subject|1|||
155204530|NCT05288062|560188359|FG000|Overall Study|Ineligible|0|||
155204531|NCT05288062|560188360|FG001|Overall Study|Ineligible|0|||
155204532|NCT05288062|560188361|FG002|Overall Study|Ineligible|1|||
155204533|NCT05288062|560188362|FG003|Overall Study|Ineligible|0|||
155204534|NCT05288062|560188359|FG000|Overall Study|Withdrawal by Subject|0|||
155204535|NCT05288062|560188360|FG001|Overall Study|Withdrawal by Subject|0|||
155204536|NCT05288062|560188361|FG002|Overall Study|Withdrawal by Subject|1|||
155204537|NCT05288062|560188362|FG003|Overall Study|Withdrawal by Subject|0|||
155204538|NCT02099708|560188363|FG000|Overall Study|Data Not Available|30|||
155204539|NCT02099708|560188363|FG000|Overall Study|Lost to Follow-up|141|||
155204540|NCT02099708|560188363|FG000|Overall Study|Other|29|||
155204541|NCT01658072|560188372|FG000|Overall Study|Protocol Violation|4|||
155204542|NCT01658072|560188373|FG001|Overall Study|Protocol Violation|2|||
155204543|NCT00799422|560188378|FG000|First Week of Wear|Lost to Follow-up|0|||
155204544|NCT00799422|560188379|FG001|First Week of Wear|Lost to Follow-up|0|||
155204545|NCT00799422|560188380|FG002|First Week of Wear|Lost to Follow-up|1|||
155204546|NCT00799422|560188381|FG003|First Week of Wear|Lost to Follow-up|0|||
155204547|NCT00799422|560188382|FG004|First Week of Wear|Lost to Follow-up|0|||
155204548|NCT00799422|560188383|FG005|First Week of Wear|Lost to Follow-up|0|||
155204549|NCT00799422|560188378|FG000|First Week of Wear|Adverse Event|0|||
155204550|NCT00799422|560188379|FG001|First Week of Wear|Adverse Event|0|||
155204551|NCT00799422|560188380|FG002|First Week of Wear|Adverse Event|0|||
155204552|NCT00799422|560188381|FG003|First Week of Wear|Adverse Event|1|||
155204553|NCT00799422|560188382|FG004|First Week of Wear|Adverse Event|0|||
155204554|NCT00799422|560188383|FG005|First Week of Wear|Adverse Event|0|||
155204555|NCT00880009|560188384|FG000|Overall Study|Study terminated by sponsor|14|||
155204556|NCT00880009|560188384|FG000|Overall Study|Withdrawal by Subject|1|||
155204557|NCT00880009|560188384|FG000|Overall Study|Protocol Violation|1|||
155204558|NCT04584645|560188386|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
155204559|NCT04584645|560188387|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
155204560|NCT03708328|560188396|FG000|Overall Study|Death|3|||
155204561|NCT03708328|560188397|FG001|Overall Study|Death|3|||
155204562|NCT03708328|560188398|FG002|Overall Study|Death|4|||
155204563|NCT03708328|560188399|FG003|Overall Study|Death|2|||
155204564|NCT03708328|560188400|FG004|Overall Study|Death|2|||
155204565|NCT03708328|560188401|FG005|Overall Study|Death|13|||
155204566|NCT03708328|560188402|FG006|Overall Study|Death|26|||
155204567|NCT03708328|560188403|FG007|Overall Study|Death|18|||
155204568|NCT03708328|560188404|FG008|Overall Study|Death|13|||
155204569|NCT03708328|560188405|FG009|Overall Study|Death|8|||
155204570|NCT03708328|560188396|FG000|Overall Study|Lost to Follow-up|0|||
155204571|NCT03708328|560188397|FG001|Overall Study|Lost to Follow-up|1|||
155204572|NCT03708328|560188398|FG002|Overall Study|Lost to Follow-up|0|||
155204573|NCT03708328|560188399|FG003|Overall Study|Lost to Follow-up|1|||
155204574|NCT03708328|560188400|FG004|Overall Study|Lost to Follow-up|0|||
155204575|NCT03708328|560188401|FG005|Overall Study|Lost to Follow-up|3|||
155204576|NCT03708328|560188402|FG006|Overall Study|Lost to Follow-up|3|||
155204577|NCT03708328|560188403|FG007|Overall Study|Lost to Follow-up|0|||
155204578|NCT03708328|560188404|FG008|Overall Study|Lost to Follow-up|0|||
155204579|NCT03708328|560188405|FG009|Overall Study|Lost to Follow-up|1|||
155204580|NCT03708328|560188396|FG000|Overall Study|Physician Decision|0|||
155204581|NCT03708328|560188397|FG001|Overall Study|Physician Decision|0|||
155204582|NCT03708328|560188398|FG002|Overall Study|Physician Decision|0|||
155204583|NCT03708328|560188399|FG003|Overall Study|Physician Decision|0|||
155204584|NCT03708328|560188400|FG004|Overall Study|Physician Decision|0|||
155204585|NCT03708328|560188401|FG005|Overall Study|Physician Decision|1|||
155204586|NCT03708328|560188402|FG006|Overall Study|Physician Decision|0|||
155204587|NCT03708328|560188403|FG007|Overall Study|Physician Decision|0|||
155204588|NCT03708328|560188404|FG008|Overall Study|Physician Decision|0|||
155204589|NCT03708328|560188405|FG009|Overall Study|Physician Decision|0|||
155204590|NCT03708328|560188396|FG000|Overall Study|Withdrawal by Subject|0|||
155204591|NCT03708328|560188397|FG001|Overall Study|Withdrawal by Subject|0|||
155204592|NCT03708328|560188398|FG002|Overall Study|Withdrawal by Subject|0|||
155204593|NCT03708328|560188399|FG003|Overall Study|Withdrawal by Subject|0|||
155204594|NCT03708328|560188400|FG004|Overall Study|Withdrawal by Subject|1|||
155204595|NCT03708328|560188401|FG005|Overall Study|Withdrawal by Subject|0|||
155204596|NCT03708328|560188402|FG006|Overall Study|Withdrawal by Subject|2|||
155204597|NCT03708328|560188403|FG007|Overall Study|Withdrawal by Subject|4|||
155204598|NCT03708328|560188404|FG008|Overall Study|Withdrawal by Subject|1|||
155204599|NCT03708328|560188405|FG009|Overall Study|Withdrawal by Subject|5|||
155204600|NCT03708328|560188396|FG000|Overall Study|Study Closed Locally|0|||
155204601|NCT03708328|560188397|FG001|Overall Study|Study Closed Locally|0|||
155204602|NCT03708328|560188398|FG002|Overall Study|Study Closed Locally|0|||
155204603|NCT03708328|560188399|FG003|Overall Study|Study Closed Locally|0|||
155204604|NCT03708328|560188400|FG004|Overall Study|Study Closed Locally|0|||
155204605|NCT03708328|560188401|FG005|Overall Study|Study Closed Locally|0|||
155204606|NCT03708328|560188402|FG006|Overall Study|Study Closed Locally|0|||
155204607|NCT03708328|560188403|FG007|Overall Study|Study Closed Locally|1|||
155204608|NCT03708328|560188404|FG008|Overall Study|Study Closed Locally|0|||
155204609|NCT03708328|560188405|FG009|Overall Study|Study Closed Locally|0|||
155204610|NCT03708328|560188396|FG000|Overall Study|Study Ended By Sponsor|0|||
155204611|NCT03708328|560188397|FG001|Overall Study|Study Ended By Sponsor|0|||
155204612|NCT03708328|560188398|FG002|Overall Study|Study Ended By Sponsor|0|||
155204613|NCT03708328|560188399|FG003|Overall Study|Study Ended By Sponsor|0|||
155204614|NCT03708328|560188400|FG004|Overall Study|Study Ended By Sponsor|0|||
155204615|NCT03708328|560188401|FG005|Overall Study|Study Ended By Sponsor|1|||
155204616|NCT03708328|560188402|FG006|Overall Study|Study Ended By Sponsor|0|||
155204617|NCT03708328|560188403|FG007|Overall Study|Study Ended By Sponsor|1|||
155204618|NCT03708328|560188404|FG008|Overall Study|Study Ended By Sponsor|0|||
155204619|NCT03708328|560188405|FG009|Overall Study|Study Ended By Sponsor|0|||
155204620|NCT03708328|560188396|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204621|NCT03708328|560188397|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204622|NCT03708328|560188398|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204623|NCT03708328|560188399|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204624|NCT03708328|560188400|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204625|NCT03708328|560188401|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204626|NCT03708328|560188402|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204627|NCT03708328|560188403|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204628|NCT03708328|560188404|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
155204629|NCT03708328|560188405|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204630|NCT04523220|560188406|FG000|Main Treatment Period|Physician Decision|1|||
155204631|NCT04523220|560188407|FG001|Main Treatment Period|Physician Decision|1|||
155204632|NCT04523220|560188408|FG002|Main Treatment Period|Physician Decision|0|||
155204633|NCT04523220|560188406|FG000|Main Treatment Period|Other|5|||
155204634|NCT04523220|560188407|FG001|Main Treatment Period|Other|2|||
155204635|NCT04523220|560188408|FG002|Main Treatment Period|Other|4|||
155204636|NCT04523220|560188406|FG000|Main Treatment Period|Subject Decision|5|||
155204637|NCT04523220|560188407|FG001|Main Treatment Period|Subject Decision|7|||
155204638|NCT04523220|560188408|FG002|Main Treatment Period|Subject Decision|3|||
155204639|NCT04523220|560188406|FG000|Main Treatment Period|Death|5|||
155204640|NCT04523220|560188407|FG001|Main Treatment Period|Death|11|||
155204641|NCT04523220|560188408|FG002|Main Treatment Period|Death|4|||
155204642|NCT04523220|560188406|FG000|Main Treatment Period|Adverse Event|11|||
155204643|NCT04523220|560188407|FG001|Main Treatment Period|Adverse Event|9|||
155204644|NCT04523220|560188408|FG002|Main Treatment Period|Adverse Event|9|||
155204645|NCT04523220|560188406|FG000|Main Treatment Period|Withdrawal by Subject|3|||
155204646|NCT04523220|560188407|FG001|Main Treatment Period|Withdrawal by Subject|3|||
155204647|NCT04523220|560188408|FG002|Main Treatment Period|Withdrawal by Subject|4|||
155204648|NCT04523220|560188406|FG000|Main Treatment Period|Study drug never adminstered|10|||
155204649|NCT04523220|560188407|FG001|Main Treatment Period|Study drug never adminstered|3|||
155204650|NCT04523220|560188408|FG002|Main Treatment Period|Study drug never adminstered|5|||
155204651|NCT04523220|560188406|FG000|Extension Treatment Period|Physician Decision|1|||
155204652|NCT04523220|560188407|FG001|Extension Treatment Period|Physician Decision|0|||
155204653|NCT04523220|560188408|FG002|Extension Treatment Period|Physician Decision|3|||
155204654|NCT04523220|560188406|FG000|Extension Treatment Period|Other|2|||
155204655|NCT04523220|560188407|FG001|Extension Treatment Period|Other|6|||
155204656|NCT04523220|560188408|FG002|Extension Treatment Period|Other|6|||
155204657|NCT04523220|560188406|FG000|Extension Treatment Period|Subject Decision|5|||
155204658|NCT04523220|560188407|FG001|Extension Treatment Period|Subject Decision|2|||
155204659|NCT04523220|560188408|FG002|Extension Treatment Period|Subject Decision|4|||
155204660|NCT04523220|560188406|FG000|Extension Treatment Period|Death|6|||
155204661|NCT04523220|560188407|FG001|Extension Treatment Period|Death|4|||
155204662|NCT04523220|560188408|FG002|Extension Treatment Period|Death|7|||
155204663|NCT04523220|560188406|FG000|Extension Treatment Period|Adverse Event|6|||
155204664|NCT04523220|560188407|FG001|Extension Treatment Period|Adverse Event|7|||
155204665|NCT04523220|560188408|FG002|Extension Treatment Period|Adverse Event|9|||
155204666|NCT04523220|560188406|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155204667|NCT04523220|560188407|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
155204668|NCT04523220|560188408|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
155204669|NCT04523220|560188406|FG000|Extension Treatment Period|Study drug never administered|0|||
155204670|NCT04523220|560188407|FG001|Extension Treatment Period|Study drug never administered|1|||
155204671|NCT04523220|560188408|FG002|Extension Treatment Period|Study drug never administered|0|||
155204672|NCT02010775|560188409|FG000|Overall Study|Adverse Event|0|||
155204673|NCT02010775|560188410|FG001|Overall Study|Adverse Event|0|||
155204674|NCT02010775|560188411|FG002|Overall Study|Adverse Event|0|||
155204675|NCT02010775|560188412|FG003|Overall Study|Adverse Event|0|||
155204676|NCT02010775|560188413|FG004|Overall Study|Adverse Event|1|||
155204677|NCT02010775|560188409|FG000|Overall Study|Pregnancy|0|||
155204678|NCT02010775|560188410|FG001|Overall Study|Pregnancy|0|||
155204679|NCT02010775|560188411|FG002|Overall Study|Pregnancy|2|||
155204680|NCT02010775|560188412|FG003|Overall Study|Pregnancy|0|||
155204681|NCT02010775|560188413|FG004|Overall Study|Pregnancy|0|||
155204682|NCT02010775|560188409|FG000|Overall Study|Lost to Follow-up|2|||
155204683|NCT02010775|560188410|FG001|Overall Study|Lost to Follow-up|0|||
155204684|NCT02010775|560188411|FG002|Overall Study|Lost to Follow-up|0|||
155204685|NCT02010775|560188412|FG003|Overall Study|Lost to Follow-up|1|||
155204686|NCT02010775|560188413|FG004|Overall Study|Lost to Follow-up|1|||
155204687|NCT02010775|560188409|FG000|Overall Study|Personal Reasons|3|||
155204688|NCT02010775|560188410|FG001|Overall Study|Personal Reasons|3|||
155204689|NCT02010775|560188411|FG002|Overall Study|Personal Reasons|1|||
155204690|NCT02010775|560188412|FG003|Overall Study|Personal Reasons|2|||
155204691|NCT02010775|560188413|FG004|Overall Study|Personal Reasons|4|||
155204692|NCT02006719|560188414|FG000|Overall Study|Withdrawal by Subject|10|||
155204693|NCT02006719|560188415|FG001|Overall Study|Withdrawal by Subject|2|||
155204694|NCT02006719|560188414|FG000|Overall Study|Lost to Follow-up|5|||
155204695|NCT02006719|560188415|FG001|Overall Study|Lost to Follow-up|1|||
155204696|NCT02006719|560188414|FG000|Overall Study|Protocol Violation|2|||
155204697|NCT02006719|560188415|FG001|Overall Study|Protocol Violation|0|||
155204698|NCT02006719|560188414|FG000|Overall Study|Adverse Event|1|||
155204699|NCT02006719|560188415|FG001|Overall Study|Adverse Event|1|||
155204700|NCT02006719|560188414|FG000|Overall Study|Other/Unknown|0|||
155204701|NCT02006719|560188415|FG001|Overall Study|Other/Unknown|1|||
155204702|NCT02439138|560188417|FG000|Overall Study|Adverse Event|1|||
155204703|NCT02439138|560188417|FG000|Overall Study|PI decision to terminate the study|2|||
155204704|NCT02615145|560188422|FG000|Overall Study|Did Not Start Treatment|0|||
155204705|NCT02615145|560188423|FG001|Overall Study|Did Not Start Treatment|0|||
155204706|NCT02615145|560188424|FG002|Overall Study|Did Not Start Treatment|1|||
155204707|NCT02615145|560188425|FG003|Overall Study|Did Not Start Treatment|1|||
155204708|NCT02615145|560188422|FG000|Overall Study|Failure to Return|20|||
155204709|NCT02615145|560188423|FG001|Overall Study|Failure to Return|10|||
155204710|NCT02615145|560188424|FG002|Overall Study|Failure to Return|7|||
155204711|NCT02615145|560188425|FG003|Overall Study|Failure to Return|0|||
155204712|NCT02615145|560188422|FG000|Overall Study|Death|2|||
155204713|NCT02615145|560188423|FG001|Overall Study|Death|3|||
155204714|NCT02615145|560188424|FG002|Overall Study|Death|0|||
155204715|NCT02615145|560188425|FG003|Overall Study|Death|0|||
155204716|NCT02615145|560188422|FG000|Overall Study|Other, Not Specified|5|||
155204717|NCT02615145|560188423|FG001|Overall Study|Other, Not Specified|2|||
155204718|NCT02615145|560188424|FG002|Overall Study|Other, Not Specified|0|||
155204719|NCT02615145|560188425|FG003|Overall Study|Other, Not Specified|0|||
155204720|NCT00006237|560188426|FG000|Overall Study|Adverse Event|39|||
155204721|NCT00006237|560188427|FG001|Overall Study|Adverse Event|29|||
155204722|NCT00006237|560188426|FG000|Overall Study|Death|1|||
155204723|NCT00006237|560188427|FG001|Overall Study|Death|0|||
155204724|NCT00006237|560188426|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
155204725|NCT00006237|560188427|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
155204726|NCT00006237|560188426|FG000|Overall Study|Progression/relapse|54|||
155204727|NCT00006237|560188427|FG001|Overall Study|Progression/relapse|2|||
155204728|NCT00006237|560188426|FG000|Overall Study|Not eligible|9|||
155204729|NCT00006237|560188427|FG001|Overall Study|Not eligible|20|||
155204730|NCT00006237|560188426|FG000|Overall Study|Withdrawal by Subject|0|||
155204731|NCT00006237|560188427|FG001|Overall Study|Withdrawal by Subject|1|||
155204732|NCT00006237|560188426|FG000|Overall Study|Not protocol specified|14|||
155204733|NCT00006237|560188427|FG001|Overall Study|Not protocol specified|5|||
155204734|NCT03727347|560188428|FG000|Overall Study|Withdrawal by Subject|2|||
155204735|NCT03727347|560188428|FG000|Overall Study|Lost to Follow-up|1|||
155204736|NCT01846416|560188433|FG000|Treatment Phase|Death|2|||
155204737|NCT01846416|560188434|FG001|Treatment Phase|Death|9|||
155204738|NCT01846416|560188435|FG002|Treatment Phase|Death|1|||
155204739|NCT01846416|560188433|FG000|Treatment Phase|Withdrawal by Subject|2|||
155204740|NCT01846416|560188434|FG001|Treatment Phase|Withdrawal by Subject|4|||
155204741|NCT01846416|560188435|FG002|Treatment Phase|Withdrawal by Subject|2|||
155204742|NCT01846416|560188433|FG000|Treatment Phase|Other|1|||
155204743|NCT01846416|560188434|FG001|Treatment Phase|Other|5|||
155204744|NCT01846416|560188435|FG002|Treatment Phase|Other|1|||
155204745|NCT01846416|560188433|FG000|Treatment Phase|Physician Decision|1|||
155204746|NCT01846416|560188434|FG001|Treatment Phase|Physician Decision|2|||
155204747|NCT01846416|560188435|FG002|Treatment Phase|Physician Decision|0|||
155204748|NCT01846416|560188433|FG000|Treatment Phase|Adverse Event|3|||
155204749|NCT01846416|560188434|FG001|Treatment Phase|Adverse Event|4|||
155204750|NCT01846416|560188435|FG002|Treatment Phase|Adverse Event|0|||
155204751|NCT01846416|560188433|FG000|Treatment Phase|Non-compliance|0|||
155204752|NCT01846416|560188434|FG001|Treatment Phase|Non-compliance|2|||
155204753|NCT01846416|560188435|FG002|Treatment Phase|Non-compliance|0|||
155204754|NCT01846416|560188433|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
155204755|NCT01846416|560188434|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
155204756|NCT01846416|560188435|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
155204757|NCT01846416|560188433|FG000|Treatment Phase|Progressive Disease|21|||
155204758|NCT01846416|560188434|FG001|Treatment Phase|Progressive Disease|63|||
155204759|NCT01846416|560188435|FG002|Treatment Phase|Progressive Disease|9|||
155204760|NCT01846416|560188433|FG000|Survival Follow-up|Death|21|||
155204761|NCT01846416|560188434|FG001|Survival Follow-up|Death|62|||
155204762|NCT01846416|560188435|FG002|Survival Follow-up|Death|9|||
155204763|NCT01846416|560188433|FG000|Survival Follow-up|Lost to Follow-up|0|||
155204764|NCT01846416|560188434|FG001|Survival Follow-up|Lost to Follow-up|2|||
155204765|NCT01846416|560188435|FG002|Survival Follow-up|Lost to Follow-up|2|||
155204766|NCT01846416|560188433|FG000|Survival Follow-up|Withdrawal by Subject|2|||
155204767|NCT01846416|560188434|FG001|Survival Follow-up|Withdrawal by Subject|7|||
155204768|NCT01846416|560188435|FG002|Survival Follow-up|Withdrawal by Subject|0|||
155204769|NCT01846416|560188433|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
155204770|NCT01846416|560188434|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
155204771|NCT01846416|560188435|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
155204772|NCT01846416|560188433|FG000|Survival Follow-up|Other|3|||
155204773|NCT01846416|560188434|FG001|Survival Follow-up|Other|1|||
155204774|NCT01846416|560188435|FG002|Survival Follow-up|Other|1|||
155204775|NCT02144012|560188438|FG000|Overall Study|Adverse Event|1|||
155204776|NCT02144012|560188439|FG001|Overall Study|Adverse Event|0|||
155204777|NCT02144012|560188438|FG000|Overall Study|Death|1|||
155204778|NCT02144012|560188439|FG001|Overall Study|Death|0|||
155204779|NCT02144012|560188438|FG000|Overall Study|Withdrawal by Subject|11|||
155204780|NCT02144012|560188439|FG001|Overall Study|Withdrawal by Subject|3|||
155204781|NCT02144012|560188438|FG000|Overall Study|Study Terminated by Sponsor|18|||
155204782|NCT02144012|560188439|FG001|Overall Study|Study Terminated by Sponsor|12|||
155204783|NCT02144012|560188438|FG000|Overall Study|Other|3|||
155204784|NCT02144012|560188439|FG001|Overall Study|Other|0|||
155204785|NCT00317356|560188440|FG000|Overall Study|Adverse Event|0|||
155204786|NCT00317356|560188441|FG001|Overall Study|Adverse Event|0|||
155204787|NCT00317356|560188442|FG002|Overall Study|Adverse Event|1|||
155204788|NCT00317356|560188443|FG003|Overall Study|Adverse Event|0|||
155204789|NCT00317356|560188440|FG000|Overall Study|Lack of Efficacy|1|||
155204790|NCT00317356|560188441|FG001|Overall Study|Lack of Efficacy|1|||
155204791|NCT00317356|560188442|FG002|Overall Study|Lack of Efficacy|0|||
155204792|NCT00317356|560188443|FG003|Overall Study|Lack of Efficacy|3|||
155204793|NCT00317356|560188440|FG000|Overall Study|Physician Decision|0|||
155204794|NCT00317356|560188441|FG001|Overall Study|Physician Decision|1|||
155204795|NCT00317356|560188442|FG002|Overall Study|Physician Decision|0|||
155204796|NCT00317356|560188443|FG003|Overall Study|Physician Decision|0|||
155204797|NCT00598832|560188444|FG000|Overall Study|Lack of Efficacy|3|||
155204798|NCT00598832|560188445|FG001|Overall Study|Lack of Efficacy|7|||
155204799|NCT00598832|560188444|FG000|Overall Study|Adverse Event|6|||
155204800|NCT00598832|560188445|FG001|Overall Study|Adverse Event|2|||
155204801|NCT00598832|560188444|FG000|Overall Study|Withdrawal by Subject|25|||
155204802|NCT00598832|560188445|FG001|Overall Study|Withdrawal by Subject|36|||
155204803|NCT00598832|560188444|FG000|Overall Study|Protocol Violation|0|||
155204804|NCT00598832|560188445|FG001|Overall Study|Protocol Violation|2|||
155204805|NCT00598832|560188444|FG000|Overall Study|Lost to Follow-up|24|||
155204806|NCT00598832|560188445|FG001|Overall Study|Lost to Follow-up|29|||
155204807|NCT00598832|560188444|FG000|Overall Study|Pregnancy|2|||
155204808|NCT00598832|560188445|FG001|Overall Study|Pregnancy|2|||
155204809|NCT00598832|560188444|FG000|Overall Study|Physician Decision|1|||
155204810|NCT00598832|560188445|FG001|Overall Study|Physician Decision|4|||
155204811|NCT00598832|560188444|FG000|Overall Study|Non compliance|1|||
155204812|NCT00598832|560188445|FG001|Overall Study|Non compliance|0|||
155204813|NCT02142959|560188446|FG000|Overall Study|Adverse Event|1|||
155204814|NCT02142959|560188447|FG001|Overall Study|Adverse Event|0|||
155204815|NCT02142959|560188448|FG002|Overall Study|Adverse Event|0|||
155204816|NCT02142959|560188446|FG000|Overall Study|Death|0|||
155204817|NCT02142959|560188447|FG001|Overall Study|Death|1|||
155204818|NCT02142959|560188448|FG002|Overall Study|Death|0|||
155204819|NCT02142959|560188446|FG000|Overall Study|Withdrawal by Subject|3|||
155204820|NCT02142959|560188447|FG001|Overall Study|Withdrawal by Subject|1|||
155204821|NCT02142959|560188448|FG002|Overall Study|Withdrawal by Subject|3|||
155204822|NCT02142959|560188446|FG000|Overall Study|Administrative Reasons|1|||
155204823|NCT02142959|560188447|FG001|Overall Study|Administrative Reasons|0|||
155204824|NCT02142959|560188448|FG002|Overall Study|Administrative Reasons|1|||
155204825|NCT02142959|560188446|FG000|Overall Study|Missing|0|||
155204826|NCT02142959|560188447|FG001|Overall Study|Missing|1|||
155204827|NCT02142959|560188448|FG002|Overall Study|Missing|0|||
155204828|NCT02142959|560188446|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
155204829|NCT02142959|560188447|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
155204830|NCT02142959|560188448|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
155204831|NCT02142959|560188446|FG000|Overall Study|Patient didn't complete end of study visit|0|||
155204832|NCT02142959|560188447|FG001|Overall Study|Patient didn't complete end of study visit|0|||
155204833|NCT02142959|560188448|FG002|Overall Study|Patient didn't complete end of study visit|1|||
155204834|NCT01943292|560190234|FG000|Overall Study|Withdrawal by Subject|1|||
155204835|NCT01943292|560190235|FG001|Overall Study|Withdrawal by Subject|0|||
155204836|NCT01943292|560190236|FG002|Overall Study|Withdrawal by Subject|0|||
155204837|NCT00911820|560190237|FG000|Overall Study|RECIST progression|12|||
155204838|NCT00911820|560190238|FG001|Overall Study|RECIST progression|8|||
155204839|NCT00911820|560190237|FG000|Overall Study|Adverse Event|8|||
155204840|NCT00911820|560190238|FG001|Overall Study|Adverse Event|8|||
155204841|NCT00911820|560190237|FG000|Overall Study|Clinical Progression|7|||
155204842|NCT00911820|560190238|FG001|Overall Study|Clinical Progression|5|||
155204843|NCT00911820|560190237|FG000|Overall Study|Physician Decision|5|||
155204844|NCT00911820|560190238|FG001|Overall Study|Physician Decision|9|||
155204845|NCT00911820|560190237|FG000|Overall Study|Decline in Performance Status|4|||
155204846|NCT00911820|560190238|FG001|Overall Study|Decline in Performance Status|2|||
155204847|NCT00911820|560190237|FG000|Overall Study|Withdrawal by Subject|3|||
155204848|NCT00911820|560190238|FG001|Overall Study|Withdrawal by Subject|4|||
155204849|NCT00911820|560190237|FG000|Overall Study|Death|1|||
155204850|NCT00911820|560190238|FG001|Overall Study|Death|2|||
155204851|NCT00911820|560190237|FG000|Overall Study|Pursue surgery|1|||
155204852|NCT00911820|560190238|FG001|Overall Study|Pursue surgery|1|||
155204853|NCT00911820|560190237|FG000|Overall Study|Pursue Radiation|1|||
155204854|NCT00911820|560190238|FG001|Overall Study|Pursue Radiation|0|||
155204855|NCT00911820|560190237|FG000|Overall Study|Still on Therapy|2|||
155204856|NCT00911820|560190238|FG001|Overall Study|Still on Therapy|2|||
155204857|NCT00911820|560190237|FG000|Overall Study|Pathology Not Confirmed|1|||
155204858|NCT00911820|560190238|FG001|Overall Study|Pathology Not Confirmed|0|||
155204859|NCT00911820|560190237|FG000|Overall Study|Withdraw before Receive Treatment|0|||
155204860|NCT00911820|560190238|FG001|Overall Study|Withdraw before Receive Treatment|2|||
155204861|NCT00996216|560190239|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
155204862|NCT00996216|560190239|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
155204863|NCT00996216|560190239|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
155204864|NCT00963547|560190248|FG000|Overall Study|Adverse Event|0|||
155204865|NCT00963547|560190249|FG001|Overall Study|Adverse Event|1|||
155204866|NCT00963547|560190250|FG002|Overall Study|Adverse Event|0|||
155204867|NCT00963547|560190251|FG003|Overall Study|Adverse Event|1|||
155204868|NCT00963547|560190252|FG004|Overall Study|Adverse Event|0|||
155204869|NCT00963547|560190253|FG005|Overall Study|Adverse Event|0|||
155204870|NCT00963547|560190254|FG006|Overall Study|Adverse Event|0|||
155204871|NCT00963547|560190248|FG000|Overall Study|Physician Decision|1|||
155204872|NCT00963547|560190249|FG001|Overall Study|Physician Decision|1|||
155204873|NCT00963547|560190250|FG002|Overall Study|Physician Decision|0|||
155204874|NCT00963547|560190251|FG003|Overall Study|Physician Decision|0|||
155204875|NCT00963547|560190252|FG004|Overall Study|Physician Decision|0|||
155204876|NCT00963547|560190253|FG005|Overall Study|Physician Decision|0|||
155204877|NCT00963547|560190254|FG006|Overall Study|Physician Decision|0|||
155204878|NCT00963547|560190248|FG000|Overall Study|Progressive Disease|3|||
155204879|NCT00963547|560190249|FG001|Overall Study|Progressive Disease|8|||
155204880|NCT00963547|560190250|FG002|Overall Study|Progressive Disease|9|||
155204881|NCT00963547|560190251|FG003|Overall Study|Progressive Disease|5|||
155204882|NCT00963547|560190252|FG004|Overall Study|Progressive Disease|0|||
155204883|NCT00963547|560190253|FG005|Overall Study|Progressive Disease|0|||
155204884|NCT00963547|560190254|FG006|Overall Study|Progressive Disease|0|||
155204885|NCT00963547|560190248|FG000|Overall Study|Withdrawal by Subject|0|||
155204886|NCT00963547|560190249|FG001|Overall Study|Withdrawal by Subject|0|||
155204887|NCT00963547|560190250|FG002|Overall Study|Withdrawal by Subject|3|||
155204888|NCT00963547|560190251|FG003|Overall Study|Withdrawal by Subject|0|||
155204889|NCT00963547|560190252|FG004|Overall Study|Withdrawal by Subject|0|||
155204890|NCT00963547|560190253|FG005|Overall Study|Withdrawal by Subject|0|||
155204891|NCT00963547|560190254|FG006|Overall Study|Withdrawal by Subject|0|||
155204892|NCT00963547|560190248|FG000|Overall Study|Reason Unknown|0|||
155204893|NCT00963547|560190249|FG001|Overall Study|Reason Unknown|1|||
155204894|NCT00963547|560190250|FG002|Overall Study|Reason Unknown|0|||
155204895|NCT00963547|560190251|FG003|Overall Study|Reason Unknown|0|||
155204896|NCT00963547|560190252|FG004|Overall Study|Reason Unknown|0|||
155204897|NCT00963547|560190253|FG005|Overall Study|Reason Unknown|0|||
155204898|NCT00963547|560190254|FG006|Overall Study|Reason Unknown|0|||
155204899|NCT03761277|560190258|FG000|Enrollment to Implant|Screen Failure|17|||
155204900|NCT03761277|560190258|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
155204901|NCT03761277|560190258|FG000|Enrollment to Implant|Physician Decision|2|||
155204902|NCT03761277|560190258|FG000|Enrollment to Implant|Site Closure|3|||
155204903|NCT03761277|560190258|FG000|Enrollment to Implant|Sponsor Request|2|||
155204904|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Adverse Event|2|||
155204905|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Death|1|||
155204906|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Site Closure|2|||
155204907|NCT03761277|560190258|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
155204908|NCT03761277|560190258|FG000|6 Months to 12 Months|Physician Decision|2|||
155204909|NCT03761277|560190258|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
155204910|NCT00903695|560190259|FG000|Overall Study|medical exclusion after 1st testing|1|||
155204911|NCT00903695|560190260|FG001|Overall Study|medical exclusion after 1st testing|0|||
155204912|NCT00903695|560190259|FG000|Overall Study|lung cancer|1|||
155204913|NCT00903695|560190260|FG001|Overall Study|lung cancer|0|||
155204914|NCT02430311|560190262|FG000|Part A|Adverse Event|0|||
155204915|NCT02430311|560190263|FG001|Part A|Adverse Event|1|||
155204916|NCT02430311|560190262|FG000|Part A|Withdrawal by Subject|1|||
155204917|NCT02430311|560190263|FG001|Part A|Withdrawal by Subject|0|||
155204918|NCT02430311|560190262|FG000|Part B|Meet study-specific withdrawal criteria|6|||
155204919|NCT02430311|560190263|FG001|Part B|Meet study-specific withdrawal criteria|6|||
155204920|NCT02430311|560190262|FG000|Part B|Withdrawal by Subject|2|||
155204921|NCT02430311|560190263|FG001|Part B|Withdrawal by Subject|2|||
155204922|NCT02430311|560190262|FG000|Part B|Adverse Event|1|||
155204923|NCT02430311|560190263|FG001|Part B|Adverse Event|0|||
155204924|NCT02430311|560190262|FG000|Part B|Death|1|||
155204925|NCT02430311|560190263|FG001|Part B|Death|0|||
155204926|NCT00578812|560190264|FG000|Overall Study|Not treated|6|||
155204927|NCT00578812|560190265|FG001|Overall Study|Not treated|7|||
155204928|NCT00309387|560190267|FG000|Overall Study|Death|72|||
155204929|NCT00309387|560190268|FG001|Overall Study|Death|73|||
155204930|NCT00309387|560190267|FG000|Overall Study|Lost to Follow-up|70|||
155204931|NCT00309387|560190268|FG001|Overall Study|Lost to Follow-up|86|||
155204932|NCT01599234|560190279|FG000|Overall Study|Adverse Event|9|||
155204933|NCT01599234|560190280|FG001|Overall Study|Adverse Event|5|||
155204934|NCT01599234|560190279|FG000|Overall Study|Withdrawal by Subject|2|||
155204935|NCT01599234|560190280|FG001|Overall Study|Withdrawal by Subject|1|||
155204936|NCT01599234|560190279|FG000|Overall Study|Lost to Follow-up|1|||
155204937|NCT01599234|560190280|FG001|Overall Study|Lost to Follow-up|2|||
155204938|NCT01599234|560190279|FG000|Overall Study|Lack of Efficacy|2|||
155204939|NCT01599234|560190280|FG001|Overall Study|Lack of Efficacy|4|||
155204940|NCT01599234|560190279|FG000|Overall Study|Unable to operate spray|1|||
155204941|NCT01599234|560190280|FG001|Overall Study|Unable to operate spray|0|||
155204942|NCT01599234|560190279|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
155204943|NCT01599234|560190280|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
155204944|NCT01599234|560190279|FG000|Overall Study|Death|1|||
155204945|NCT01599234|560190280|FG001|Overall Study|Death|0|||
155204946|NCT01599234|560190279|FG000|Overall Study|Patient would not stop driving|1|||
155204947|NCT01599234|560190280|FG001|Overall Study|Patient would not stop driving|0|||
155204948|NCT01599234|560190279|FG000|Overall Study|Contra-indication discovered|0|||
155204949|NCT01599234|560190280|FG001|Overall Study|Contra-indication discovered|1|||
155204950|NCT01599234|560190279|FG000|Overall Study|Pregnancy|0|||
155204951|NCT01599234|560190280|FG001|Overall Study|Pregnancy|1|||
155204952|NCT02041286|560190283|FG000|Overall Study|Adverse Event|1|||
155204953|NCT01349790|560190290|FG000|Overall Study|Investigator Judgement|3|||
155204954|NCT01349790|560190290|FG000|Overall Study|Death|2|||
155204955|NCT01349790|560190290|FG000|Overall Study|Withdrawal by Patient|2|||
155204956|NCT01349790|560190290|FG000|Overall Study|Adverse Event|1|||
155204957|NCT01349790|560190290|FG000|Overall Study|Lost to Follow-up|1|||
155204958|NCT02495168|560190291|FG000|Overall Study|Other than Specified|18|||
155204959|NCT02495168|560190292|FG001|Overall Study|Other than Specified|22|||
155204960|NCT02495168|560190293|FG002|Overall Study|Other than Specified|5|||
155204961|NCT02495168|560190291|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
155204962|NCT02495168|560190292|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
155204963|NCT02495168|560190293|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
155204964|NCT02495168|560190291|FG000|Overall Study|Physician Decision|1|||
155204965|NCT02495168|560190292|FG001|Overall Study|Physician Decision|1|||
155204966|NCT02495168|560190293|FG002|Overall Study|Physician Decision|0|||
155204967|NCT02495168|560190291|FG000|Overall Study|Lost to Follow-up|10|||
155204968|NCT02495168|560190292|FG001|Overall Study|Lost to Follow-up|6|||
155204969|NCT02495168|560190293|FG002|Overall Study|Lost to Follow-up|1|||
155204970|NCT02495168|560190291|FG000|Overall Study|Withdrawal by Subject|1|||
155204971|NCT02495168|560190292|FG001|Overall Study|Withdrawal by Subject|4|||
155204972|NCT02495168|560190293|FG002|Overall Study|Withdrawal by Subject|2|||
155204973|NCT02495168|560190291|FG000|Overall Study|Protocol Violation|0|||
155204974|NCT02495168|560190292|FG001|Overall Study|Protocol Violation|10|||
155204975|NCT02495168|560190293|FG002|Overall Study|Protocol Violation|1|||
155204976|NCT02495168|560190291|FG000|Overall Study|Adverse Event|4|||
155204977|NCT02495168|560190292|FG001|Overall Study|Adverse Event|8|||
155204978|NCT02495168|560190293|FG002|Overall Study|Adverse Event|3|||
155204979|NCT02495168|560190291|FG000|Overall Study|Lack of Efficacy|0|||
155204980|NCT02495168|560190292|FG001|Overall Study|Lack of Efficacy|0|||
155204981|NCT02495168|560190293|FG002|Overall Study|Lack of Efficacy|3|||
155204982|NCT04166435|560190296|FG000|Overall Study|2 patients ineligible for response|2|||
155204983|NCT03462082|560190297|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204984|NCT03462082|560190298|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204985|NCT03462082|560190299|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204986|NCT03462082|560190300|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204987|NCT03462082|560190301|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204988|NCT03462082|560190302|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204989|NCT03462082|560190303|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
155204990|NCT03462082|560190304|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
155204991|NCT00127660|560190309|FG000|Overall Study|Protocol Violation|3|||
155204992|NCT00127660|560190310|FG001|Overall Study|Protocol Violation|3|||
155204993|NCT00127660|560190311|FG002|Overall Study|Protocol Violation|5|||
155204994|NCT00127660|560190312|FG003|Overall Study|Protocol Violation|0|||
155204995|NCT01833520|560190313|FG000|Overall Study|Lack of Efficacy|3|||
155204996|NCT01833520|560190314|FG001|Overall Study|Lack of Efficacy|3|||
155204997|NCT01833520|560190315|FG002|Overall Study|Lack of Efficacy|8|||
155204998|NCT01833520|560190316|FG003|Overall Study|Lack of Efficacy|3|||
155204999|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
155205000|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
155205001|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
155205002|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
155205003|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
155205004|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
155205005|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Death|3|||
155205006|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Death|2|||
155205007|NCT00489541|560190321|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
155205008|NCT00489541|560190322|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
155205009|NCT00489541|560190321|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
155205010|NCT00489541|560190322|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
155205011|NCT05131646|560190323|FG000|Overall Study|Withdrawal by Subject|1|||
155205012|NCT05131646|560190324|FG001|Overall Study|Withdrawal by Subject|0|||
155205013|NCT05131646|560190325|FG002|Overall Study|Withdrawal by Subject|0|||
155205014|NCT00003479|560190332|FG000|Overall Study|Not evaluable|3|||
155205015|NCT02128113|560190334|FG000|Overall Study|Withdrawal by Subject|3|||
155205016|NCT02128113|560190335|FG001|Overall Study|Withdrawal by Subject|1|||
155205017|NCT02128113|560190336|FG002|Overall Study|Withdrawal by Subject|0|||
155205018|NCT02128113|560190334|FG000|Overall Study|Protocol Violation|0|||
155205019|NCT02128113|560190335|FG001|Overall Study|Protocol Violation|1|||
155205020|NCT02128113|560190336|FG002|Overall Study|Protocol Violation|0|||
155205021|NCT02128113|560190334|FG000|Overall Study|Surgery cancelled|0|||
155205022|NCT02128113|560190335|FG001|Overall Study|Surgery cancelled|1|||
155205023|NCT02128113|560190336|FG002|Overall Study|Surgery cancelled|0|||
155205024|NCT02128113|560190334|FG000|Overall Study|Adverse Event|0|||
155205025|NCT02128113|560190335|FG001|Overall Study|Adverse Event|0|||
155205026|NCT02128113|560190336|FG002|Overall Study|Adverse Event|1|||
155205027|NCT00299104|560190337|FG000|Treatment Period|Adverse Event|14|||
155205028|NCT00299104|560190338|FG001|Treatment Period|Adverse Event|9|||
155205029|NCT00299104|560190339|FG002|Treatment Period|Adverse Event|7|||
155205030|NCT00299104|560190337|FG000|Treatment Period|Death|1|||
155205031|NCT00299104|560190338|FG001|Treatment Period|Death|1|||
155205032|NCT00299104|560190339|FG002|Treatment Period|Death|1|||
155205033|NCT00299104|560190337|FG000|Treatment Period|Insufficient therapeutic response|34|||
155205034|NCT00299104|560190338|FG001|Treatment Period|Insufficient therapeutic response|13|||
155205035|NCT00299104|560190339|FG002|Treatment Period|Insufficient therapeutic response|8|||
155205036|NCT00299104|560190337|FG000|Treatment Period|Failure to return|9|||
155205037|NCT00299104|560190338|FG001|Treatment Period|Failure to return|8|||
155205038|NCT00299104|560190339|FG002|Treatment Period|Failure to return|8|||
155205039|NCT00299104|560190337|FG000|Treatment Period|Violation of selection criteria|1|||
155205040|NCT00299104|560190338|FG001|Treatment Period|Violation of selection criteria|2|||
155205041|NCT00299104|560190339|FG002|Treatment Period|Violation of selection criteria|0|||
155205042|NCT00299104|560190337|FG000|Treatment Period|Protocol Violation|1|||
155205043|NCT00299104|560190338|FG001|Treatment Period|Protocol Violation|1|||
155205044|NCT00299104|560190339|FG002|Treatment Period|Protocol Violation|0|||
155205045|NCT00299104|560190337|FG000|Treatment Period|Refused treatment|9|||
155205046|NCT00299104|560190338|FG001|Treatment Period|Refused treatment|2|||
155205047|NCT00299104|560190339|FG002|Treatment Period|Refused treatment|2|||
155205048|NCT00299104|560190337|FG000|Treatment Period|Withdrew consent|14|||
155205049|NCT00299104|560190338|FG001|Treatment Period|Withdrew consent|19|||
155205050|NCT00299104|560190339|FG002|Treatment Period|Withdrew consent|9|||
155205051|NCT00299104|560190337|FG000|Treatment Period|Administrative reasons|106|||
155205052|NCT00299104|560190338|FG001|Treatment Period|Administrative reasons|120|||
155205053|NCT00299104|560190339|FG002|Treatment Period|Administrative reasons|137|||
155205054|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Death|3|||
155205055|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Death|2|||
155205056|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Death|1|||
155205057|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
155205058|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
155205059|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
155205060|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
155205061|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
155205062|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
155205063|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
155205064|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
155205065|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
155205066|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
155205067|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
155205068|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
155205069|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205070|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205071|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205072|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
155205073|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
155205074|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
155205075|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
155205076|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
155205077|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
155205078|NCT02969369|560190341|FG000|Study|Adverse Event|1|||
155205079|NCT02969369|560190342|FG001|Study|Adverse Event|6|||
155205080|NCT02969369|560190341|FG000|Study|Lack of Efficacy|0|||
155205081|NCT02969369|560190342|FG001|Study|Lack of Efficacy|1|||
155205082|NCT02969369|560190341|FG000|Study|Lost to Follow-up|0|||
155205083|NCT02969369|560190342|FG001|Study|Lost to Follow-up|1|||
155205084|NCT02969369|560190341|FG000|Study|Withdrawal by Subject|3|||
155205085|NCT02969369|560190342|FG001|Study|Withdrawal by Subject|5|||
155205086|NCT02969369|560190341|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
155205087|NCT02969369|560190342|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
155205088|NCT02969369|560190341|FG000|Double-blind Period|Adverse Event|1|||
155205089|NCT02969369|560190342|FG001|Double-blind Period|Adverse Event|5|||
155205090|NCT02969369|560190341|FG000|Double-blind Period|Lost to Follow-up|0|||
155205091|NCT02969369|560190342|FG001|Double-blind Period|Lost to Follow-up|1|||
155205092|NCT02969369|560190341|FG000|Double-blind Period|Withdrawal by Subject|2|||
155205093|NCT02969369|560190342|FG001|Double-blind Period|Withdrawal by Subject|3|||
155205094|NCT02969369|560190341|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
155205095|NCT02969369|560190342|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
155205096|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
155205097|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
155205098|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
155205099|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
155205100|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
155205101|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
155205102|NCT01484197|560190350|FG000|Treatment Period 1|Adverse Event|1|||
155205103|NCT01484197|560190351|FG001|Treatment Period 1|Adverse Event|0|||
155205104|NCT01484197|560190352|FG002|Treatment Period 1|Adverse Event|0|||
155205105|NCT01484197|560190353|FG003|Treatment Period 1|Adverse Event|0|||
155205106|NCT01484197|560190350|FG000|Treatment Period 2|Subject withdrew consent|0|||
155205107|NCT01484197|560190351|FG001|Treatment Period 2|Subject withdrew consent|0|||
155205108|NCT01484197|560190352|FG002|Treatment Period 2|Subject withdrew consent|0|||
155205109|NCT01484197|560190353|FG003|Treatment Period 2|Subject withdrew consent|1|||
155205110|NCT01727297|560190354|FG000|Overall Study|Death|13|||
155205111|NCT01727297|560190355|FG001|Overall Study|Death|0|||
155205112|NCT01727297|560190354|FG000|Overall Study|Protocol Violation|1|||
155205113|NCT01727297|560190355|FG001|Overall Study|Protocol Violation|10|||
155205114|NCT01727297|560190354|FG000|Overall Study|Adverse Event|3|||
155205115|NCT01727297|560190355|FG001|Overall Study|Adverse Event|1|||
155205116|NCT01727297|560190354|FG000|Overall Study|Lost to Follow-up|11|||
155205117|NCT01727297|560190355|FG001|Overall Study|Lost to Follow-up|0|||
155205118|NCT01727297|560190354|FG000|Overall Study|Withdrawal by Subject|26|||
155205119|NCT01727297|560190355|FG001|Overall Study|Withdrawal by Subject|27|||
155205120|NCT01727297|560190354|FG000|Overall Study|Physician Decision|19|||
155205121|NCT01727297|560190355|FG001|Overall Study|Physician Decision|5|||
155205122|NCT01727297|560190354|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
155205123|NCT01727297|560190355|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
155205124|NCT02042183|560190356|FG000|Overall Study|Physician Decision|7|||
155205125|NCT02042183|560190357|FG001|Overall Study|Physician Decision|2|||
155205126|NCT02042183|560190356|FG000|Overall Study|Lack of Efficacy|4|||
155205127|NCT02042183|560190357|FG001|Overall Study|Lack of Efficacy|3|||
155205128|NCT02042183|560190356|FG000|Overall Study|Non-compliance with Study Drug|2|||
155205129|NCT02042183|560190357|FG001|Overall Study|Non-compliance with Study Drug|3|||
155205130|NCT02042183|560190356|FG000|Overall Study|Adverse Event|17|||
155205131|NCT02042183|560190357|FG001|Overall Study|Adverse Event|6|||
155205132|NCT02042183|560190356|FG000|Overall Study|Other|3|||
155205133|NCT02042183|560190357|FG001|Overall Study|Other|3|||
155205134|NCT02042183|560190356|FG000|Overall Study|Withdrawal by Subject|21|||
155205135|NCT02042183|560190357|FG001|Overall Study|Withdrawal by Subject|16|||
155205136|NCT02042183|560190356|FG000|Overall Study|Site Terminated by Sponsor|2|||
155205137|NCT02042183|560190357|FG001|Overall Study|Site Terminated by Sponsor|1|||
155205138|NCT02042183|560190356|FG000|Overall Study|Lost to Follow-up|9|||
155205139|NCT02042183|560190357|FG001|Overall Study|Lost to Follow-up|2|||
155205140|NCT01192516|560190358|FG000|Overall Study|Lost to Follow-up|7|||
155205141|NCT01192516|560190359|FG001|Overall Study|Lost to Follow-up|10|||
155205142|NCT01192516|560190360|FG002|Overall Study|Lost to Follow-up|7|||
155205143|NCT01192516|560190358|FG000|Overall Study|Withdrawal by Subject|4|||
155205144|NCT01192516|560190359|FG001|Overall Study|Withdrawal by Subject|4|||
155205145|NCT01192516|560190360|FG002|Overall Study|Withdrawal by Subject|1|||
155205146|NCT01192516|560190358|FG000|Overall Study|started new treatment|5|||
155205147|NCT01192516|560190359|FG001|Overall Study|started new treatment|1|||
155205148|NCT01192516|560190360|FG002|Overall Study|started new treatment|0|||
155205149|NCT01192516|560190358|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
155205150|NCT01192516|560190359|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
155205151|NCT01192516|560190360|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
155205152|NCT02321800|560190368|FG000|Overall Study|Withdrawal by Subject|3|||
155205153|NCT02321800|560190369|FG001|Overall Study|Withdrawal by Subject|3|||
155205154|NCT02321800|560190368|FG000|Overall Study|Death|1|||
155205155|NCT02321800|560190369|FG001|Overall Study|Death|0|||
155205156|NCT02321800|560190368|FG000|Overall Study|Protocol Violation|1|||
155205157|NCT02321800|560190369|FG001|Overall Study|Protocol Violation|0|||
155205158|NCT02321800|560190368|FG000|Overall Study|Lost to Follow-up|10|||
155205159|NCT02321800|560190369|FG001|Overall Study|Lost to Follow-up|4|||
155205160|NCT02321800|560190368|FG000|Overall Study|Adverse Event|2|||
155205161|NCT02321800|560190369|FG001|Overall Study|Adverse Event|3|||
155205162|NCT02321800|560190368|FG000|Overall Study|Other, Miscellaneous|3|||
155205163|NCT02321800|560190369|FG001|Overall Study|Other, Miscellaneous|1|||
155205164|NCT01051323|560190370|FG000|Overall Study|Discontinuation of treatment|103|||
155205165|NCT01051323|560190370|FG000|Overall Study|Transplantation|28|||
155205166|NCT01051323|560190370|FG000|Overall Study|Dialysis dependency|22|||
155205167|NCT01051323|560190370|FG000|Overall Study|Withdrawal by Subject|13|||
155205168|NCT01051323|560190370|FG000|Overall Study|Lost to Follow-up|31|||
155205169|NCT01051323|560190370|FG000|Overall Study|Death|129|||
155205170|NCT01051323|560190370|FG000|Overall Study|Hospitalization|28|||
155205171|NCT01051323|560190370|FG000|Overall Study|Other|148|||
155205172|NCT01051323|560190370|FG000|Overall Study|Missing|37|||
155205173|NCT03926169|560190372|FG000|Period A|Adverse Event|2|||
155205174|NCT03926169|560190373|FG001|Period A|Adverse Event|2|||
155205175|NCT03926169|560190374|FG002|Period A|Adverse Event|1|||
155205176|NCT03926169|560190372|FG000|Period A|Withdrawal by Subject|2|||
155205177|NCT03926169|560190373|FG001|Period A|Withdrawal by Subject|2|||
155205178|NCT03926169|560190374|FG002|Period A|Withdrawal by Subject|2|||
155205179|NCT03926169|560190372|FG000|Period A|Lost to Follow-up|3|||
155205180|NCT03926169|560190373|FG001|Period A|Lost to Follow-up|1|||
155205181|NCT03926169|560190374|FG002|Period A|Lost to Follow-up|0|||
155205182|NCT03926169|560190372|FG000|Period A|Lack of Efficacy|0|||
155205183|NCT03926169|560190373|FG001|Period A|Lack of Efficacy|2|||
155205184|NCT03926169|560190374|FG002|Period A|Lack of Efficacy|2|||
155205185|NCT03926169|560190372|FG000|Period A|COVID-19 Infection|0|||
155205186|NCT03926169|560190373|FG001|Period A|COVID-19 Infection|1|||
155205187|NCT03926169|560190374|FG002|Period A|COVID-19 Infection|0|||
155205188|NCT03926169|560190372|FG000|Period A|COVID-19 Logistical Restrictions|0|||
155205189|NCT03926169|560190373|FG001|Period A|COVID-19 Logistical Restrictions|2|||
155205190|NCT03926169|560190374|FG002|Period A|COVID-19 Logistical Restrictions|1|||
155205191|NCT03926169|560190372|FG000|Period A|Other, Not Specified|1|||
155205192|NCT03926169|560190373|FG001|Period A|Other, Not Specified|0|||
155205193|NCT03926169|560190374|FG002|Period A|Other, Not Specified|0|||
155205194|NCT03926169|560190372|FG000|Period B|Adverse Event|3|||
155205195|NCT03926169|560190373|FG001|Period B|Adverse Event|1|||
155205196|NCT03926169|560190374|FG002|Period B|Adverse Event|1|||
155205197|NCT03926169|560190372|FG000|Period B|Withdrawal by Subject|1|||
155205198|NCT03926169|560190373|FG001|Period B|Withdrawal by Subject|3|||
155205199|NCT03926169|560190374|FG002|Period B|Withdrawal by Subject|0|||
155205200|NCT03926169|560190372|FG000|Period B|Lack of Efficacy|3|||
155205201|NCT03926169|560190373|FG001|Period B|Lack of Efficacy|1|||
155205202|NCT03926169|560190374|FG002|Period B|Lack of Efficacy|1|||
155205203|NCT03926169|560190372|FG000|Period B|Lost to Follow-up|1|||
155205204|NCT03926169|560190373|FG001|Period B|Lost to Follow-up|1|||
155205205|NCT03926169|560190374|FG002|Period B|Lost to Follow-up|4|||
155205206|NCT03926169|560190372|FG000|Period B|Other, Not Specified|62|||
155205207|NCT03926169|560190373|FG001|Period B|Other, Not Specified|57|||
155205208|NCT03926169|560190374|FG002|Period B|Other, Not Specified|65|||
155205209|NCT03302234|560190375|FG000|Overall Study|Death|191|||
155205210|NCT03302234|560190376|FG001|Overall Study|Death|192|||
155205211|NCT03302234|560190375|FG000|Overall Study|Withdrawal by Subject|2|||
155205212|NCT03302234|560190376|FG001|Overall Study|Withdrawal by Subject|2|||
155205213|NCT03302234|560190375|FG000|Overall Study|Sponsor Decision|90|||
155205214|NCT03302234|560190376|FG001|Overall Study|Sponsor Decision|89|||
155205215|NCT03302234|560190375|FG000|Overall Study|Laryngeal carcinoma|0|||
155205216|NCT03302234|560190376|FG001|Overall Study|Laryngeal carcinoma|1|||
155205217|NCT03302234|560190375|FG000|Overall Study|Not Reported|1|||
155205218|NCT03302234|560190376|FG001|Overall Study|Not Reported|0|||
155205219|NCT04112784|560190377|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
155205220|NCT04112784|560190377|FG000|Overall Study|Screen Failures|4|||
155205221|NCT02030041|560190379|FG000|Overall Study|Withdrawal by Subject|2|||
155205222|NCT02030041|560190380|FG001|Overall Study|Withdrawal by Subject|2|||
155205223|NCT02030041|560190381|FG002|Overall Study|Withdrawal by Subject|1|||
155205224|NCT00833794|560190382|FG000|Open-label Phase|Adverse Event|225|||
155205225|NCT00833794|560190383|FG001|Open-label Phase|Adverse Event|0|||
155205226|NCT00833794|560190382|FG000|Open-label Phase|Lack of Efficacy|28|||
155205227|NCT00833794|560190383|FG001|Open-label Phase|Lack of Efficacy|0|||
155205228|NCT00833794|560190382|FG000|Open-label Phase|Withdrawal by Subject|48|||
155205229|NCT00833794|560190383|FG001|Open-label Phase|Withdrawal by Subject|0|||
155205230|NCT00833794|560190382|FG000|Open-label Phase|Physician Decision|20|||
155205231|NCT00833794|560190383|FG001|Open-label Phase|Physician Decision|0|||
155205232|NCT00833794|560190382|FG000|Open-label Phase|Administrative reason|1|||
155205233|NCT00833794|560190383|FG001|Open-label Phase|Administrative reason|0|||
155205234|NCT00833794|560190382|FG000|Open-label Phase|Protocol Violation|47|||
155205235|NCT00833794|560190383|FG001|Open-label Phase|Protocol Violation|0|||
155205236|NCT00833794|560190382|FG000|Open-label Phase|Did not complete wash-out period|12|||
155205237|NCT00833794|560190383|FG001|Open-label Phase|Did not complete wash-out period|0|||
155205238|NCT00833794|560190382|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
155205239|NCT00833794|560190383|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
155205240|NCT00833794|560190382|FG000|Double-blind Phase|Adverse Event|44|||
155205241|NCT00833794|560190383|FG001|Double-blind Phase|Adverse Event|11|||
155205242|NCT00833794|560190382|FG000|Double-blind Phase|Lack of Efficacy|34|||
155205243|NCT00833794|560190383|FG001|Double-blind Phase|Lack of Efficacy|22|||
155205244|NCT00833794|560190382|FG000|Double-blind Phase|Withdrawal by Subject|23|||
155205245|NCT00833794|560190383|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155205246|NCT00833794|560190382|FG000|Double-blind Phase|Physician Decision|4|||
155205247|NCT00833794|560190383|FG001|Double-blind Phase|Physician Decision|7|||
155205248|NCT00833794|560190382|FG000|Double-blind Phase|Administrative reason|1|||
155205249|NCT00833794|560190383|FG001|Double-blind Phase|Administrative reason|3|||
155205250|NCT01866930|560190387|FG000|Treatment Period|Other|1|||
155205251|NCT01866930|560190388|FG001|Treatment Period|Other|0|||
155205252|NCT01866930|560190387|FG000|Treatment Period|Death|0|||
155205253|NCT01866930|560190388|FG001|Treatment Period|Death|2|||
155205254|NCT01866930|560190387|FG000|Treatment Period|Poor/non compliance|0|||
155205255|NCT01866930|560190388|FG001|Treatment Period|Poor/non compliance|2|||
155205256|NCT01866930|560190387|FG000|Treatment Period|No longer meets study criteria|0|||
155205257|NCT01866930|560190388|FG001|Treatment Period|No longer meets study criteria|1|||
155205258|NCT01866930|560190387|FG000|Treatment Period|Withdrawal by Subject|2|||
155205259|NCT01866930|560190388|FG001|Treatment Period|Withdrawal by Subject|8|||
155205260|NCT01866930|560190387|FG000|Treatment Period|Lack of Efficacy|1|||
155205261|NCT01866930|560190388|FG001|Treatment Period|Lack of Efficacy|9|||
155205262|NCT01866930|560190387|FG000|Treatment Period|Adverse Event|4|||
155205263|NCT01866930|560190388|FG001|Treatment Period|Adverse Event|12|||
155205264|NCT01866930|560190387|FG000|Treatment Period|Lost to Follow-up|1|||
155205265|NCT01866930|560190388|FG001|Treatment Period|Lost to Follow-up|1|||
155205266|NCT01866930|560190387|FG000|Follow-up Period|Lost to Follow-up|1|||
155205267|NCT01866930|560190388|FG001|Follow-up Period|Lost to Follow-up|1|||
155205268|NCT01866930|560190387|FG000|Follow-up Period|Other|1|||
155205269|NCT01866930|560190388|FG001|Follow-up Period|Other|5|||
155205270|NCT01866930|560190387|FG000|Follow-up Period|No longer required per protocol|1|||
155205271|NCT01866930|560190388|FG001|Follow-up Period|No longer required per protocol|0|||
155205272|NCT01866930|560190387|FG000|Follow-up Period|Withdrawal by Subject|3|||
155205273|NCT01866930|560190388|FG001|Follow-up Period|Withdrawal by Subject|3|||
155205274|NCT00519831|560190391|FG000|Overall Study|Adverse Event|3|||
155205275|NCT02854631|560190392|FG000|Overall Study|Adverse Event|1|||
155205276|NCT02854631|560190393|FG001|Overall Study|Adverse Event|2|||
155205277|NCT02854631|560190392|FG000|Overall Study|Withdrew Consent|3|||
155205278|NCT02854631|560190393|FG001|Overall Study|Withdrew Consent|2|||
155205279|NCT02854631|560190392|FG000|Overall Study|Investigator's Discretion|2|||
155205280|NCT02854631|560190393|FG001|Overall Study|Investigator's Discretion|0|||
155205281|NCT02854631|560190392|FG000|Overall Study|Death|12|||
155205282|NCT02854631|560190393|FG001|Overall Study|Death|8|||
155205283|NCT02854631|560190392|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
155205284|NCT02854631|560190393|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
155205285|NCT02854631|560190392|FG000|Overall Study|Protocol Violation|0|||
155205286|NCT02854631|560190393|FG001|Overall Study|Protocol Violation|1|||
155205287|NCT02854631|560190392|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
155205288|NCT02854631|560190393|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
155205289|NCT02854631|560190392|FG000|Overall Study|Lost to Follow-up|4|||
155205290|NCT02854631|560190393|FG001|Overall Study|Lost to Follow-up|2|||
155205291|NCT02862171|560190394|FG000|Overall Study|Death|1|||
155205292|NCT02862171|560190394|FG000|Overall Study|Lost to Follow-up|13|||
155205293|NCT02862171|560190394|FG000|Overall Study|Withdrawal by Subject|57|||
155205294|NCT02862171|560190394|FG000|Overall Study|Non-compliance|4|||
155205295|NCT02862171|560190394|FG000|Overall Study|HIV-1 seroconversion|18|||
155205296|NCT03930797|560190395|FG000|Overall Study|Lost to Follow-up|3|||
155205297|NCT03930797|560190396|FG001|Overall Study|Lost to Follow-up|10|||
155205298|NCT00662012|560190397|FG000|Overall Study|Lost to Follow-up|85|||
155205299|NCT00662012|560190397|FG000|Overall Study|Death|1|||
155205300|NCT00662012|560190397|FG000|Overall Study|Withdrawal by Subject|1|||
155205301|NCT00753415|560190398|FG000|Part A|Disease progression|1|||
155205302|NCT00753415|560190399|FG001|Part A|Disease progression|0|||
155205303|NCT00753415|560190400|FG002|Part A|Disease progression|1|||
155205304|NCT00753415|560190401|FG003|Part A|Disease progression|2|||
155205305|NCT00753415|560190402|FG004|Part A|Disease progression|0|||
155205306|NCT00753415|560190403|FG005|Part A|Disease progression|0|||
155205307|NCT00753415|560190404|FG006|Part A|Disease progression|0|||
155205308|NCT00753415|560190405|FG007|Part A|Disease progression|0|||
155205309|NCT00753415|560190406|FG008|Part A|Disease progression|0|||
155205310|NCT00753415|560190407|FG009|Part A|Disease progression|0|||
155205311|NCT00753415|560190398|FG000|Part A|Withdrawal by Subject|0|||
155205312|NCT00753415|560190399|FG001|Part A|Withdrawal by Subject|0|||
155205313|NCT00753415|560190400|FG002|Part A|Withdrawal by Subject|1|||
155205314|NCT00753415|560190401|FG003|Part A|Withdrawal by Subject|0|||
155205315|NCT00753415|560190402|FG004|Part A|Withdrawal by Subject|0|||
155205316|NCT00753415|560190403|FG005|Part A|Withdrawal by Subject|0|||
155205317|NCT00753415|560190404|FG006|Part A|Withdrawal by Subject|0|||
155205318|NCT00753415|560190405|FG007|Part A|Withdrawal by Subject|0|||
155205319|NCT00753415|560190406|FG008|Part A|Withdrawal by Subject|0|||
155205320|NCT00753415|560190407|FG009|Part A|Withdrawal by Subject|0|||
155205321|NCT00753415|560190398|FG000|Part B|Lost to Follow-up|0|||
155205322|NCT00753415|560190399|FG001|Part B|Lost to Follow-up|0|||
155205323|NCT00753415|560190400|FG002|Part B|Lost to Follow-up|0|||
155205324|NCT00753415|560190401|FG003|Part B|Lost to Follow-up|0|||
155205325|NCT00753415|560190402|FG004|Part B|Lost to Follow-up|0|||
155205326|NCT00753415|560190403|FG005|Part B|Lost to Follow-up|0|||
155205327|NCT00753415|560190404|FG006|Part B|Lost to Follow-up|0|||
155205328|NCT00753415|560190405|FG007|Part B|Lost to Follow-up|1|||
155205329|NCT00753415|560190406|FG008|Part B|Lost to Follow-up|1|||
155205330|NCT00753415|560190407|FG009|Part B|Lost to Follow-up|0|||
155205331|NCT00753415|560190398|FG000|Part B|Disease progression|0|||
155205332|NCT00753415|560190399|FG001|Part B|Disease progression|0|||
155205333|NCT00753415|560190400|FG002|Part B|Disease progression|0|||
155205334|NCT00753415|560190401|FG003|Part B|Disease progression|0|||
155205335|NCT00753415|560190402|FG004|Part B|Disease progression|0|||
155205336|NCT00753415|560190403|FG005|Part B|Disease progression|0|||
155205337|NCT00753415|560190404|FG006|Part B|Disease progression|0|||
155205338|NCT00753415|560190405|FG007|Part B|Disease progression|0|||
155205339|NCT00753415|560190406|FG008|Part B|Disease progression|2|||
155205340|NCT00753415|560190407|FG009|Part B|Disease progression|1|||
155205341|NCT02700815|560192094|FG000|Overall Study|Adverse Event|0|||
155205342|NCT02700815|560192095|FG001|Overall Study|Adverse Event|6|||
155205343|NCT02700815|560192096|FG002|Overall Study|Adverse Event|2|||
155205344|NCT02700815|560192097|FG003|Overall Study|Adverse Event|3|||
155205345|NCT02700815|560192094|FG000|Overall Study|Lack of Efficacy|0|||
155205346|NCT02700815|560192095|FG001|Overall Study|Lack of Efficacy|0|||
155205347|NCT02700815|560192096|FG002|Overall Study|Lack of Efficacy|1|||
155205348|NCT02700815|560192097|FG003|Overall Study|Lack of Efficacy|2|||
155205349|NCT02700815|560192094|FG000|Overall Study|Lost to Follow-up|1|||
155205350|NCT02700815|560192095|FG001|Overall Study|Lost to Follow-up|0|||
155205351|NCT02700815|560192096|FG002|Overall Study|Lost to Follow-up|0|||
155205352|NCT02700815|560192097|FG003|Overall Study|Lost to Follow-up|1|||
155205353|NCT02700815|560192094|FG000|Overall Study|Refusal to continue medication|0|||
155205354|NCT02700815|560192095|FG001|Overall Study|Refusal to continue medication|1|||
155205355|NCT02700815|560192096|FG002|Overall Study|Refusal to continue medication|0|||
155205356|NCT02700815|560192097|FG003|Overall Study|Refusal to continue medication|1|||
155205357|NCT02700815|560192094|FG000|Overall Study|Withdrawal by Subject|0|||
155205358|NCT02700815|560192095|FG001|Overall Study|Withdrawal by Subject|0|||
155205359|NCT02700815|560192096|FG002|Overall Study|Withdrawal by Subject|1|||
155205360|NCT02700815|560192097|FG003|Overall Study|Withdrawal by Subject|0|||
155205361|NCT02324569|560192103|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155205362|NCT02324569|560192104|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
155205363|NCT02324569|560192103|FG000|Overall Study|Voluntary Withdrawal|3|||
155205364|NCT02324569|560192104|FG001|Overall Study|Voluntary Withdrawal|6|||
155205365|NCT02324569|560192103|FG000|Overall Study|Lack of Efficacy|2|||
155205366|NCT02324569|560192104|FG001|Overall Study|Lack of Efficacy|3|||
155205367|NCT02324569|560192103|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
155205368|NCT02324569|560192104|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
155205369|NCT02324569|560192103|FG000|Overall Study|Inconvenient Schedule|2|||
155205370|NCT02324569|560192104|FG001|Overall Study|Inconvenient Schedule|0|||
155205371|NCT00085631|560192109|FG000|Overall Study|Missing Data|4|||
155205372|NCT00085631|560192110|FG001|Overall Study|Missing Data|11|||
155205373|NCT00085631|560192111|FG002|Overall Study|Missing Data|7|||
155205374|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
155205375|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
155205376|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
155205377|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
155205378|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Unclassified|0|||
155205379|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Unclassified|2|||
155205380|NCT01513473|560192112|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
155205381|NCT01513473|560192113|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
155205382|NCT01513473|560192112|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
155205383|NCT01513473|560192113|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
155205384|NCT00743340|560192118|FG000|Overall Study|Study medication non-compliance|1|||
155205385|NCT00743340|560192118|FG000|Overall Study|Lost to Follow-up|1|||
155205386|NCT00743340|560192118|FG000|Overall Study|Withdrawal from the Study|5|||
155205387|NCT00743340|560192118|FG000|Overall Study|Protocol Violation|1|||
155205388|NCT00743340|560192118|FG000|Overall Study|Virologic failure|8|||
155205389|NCT00743340|560192118|FG000|Overall Study|Pregnancy|1|||
155205390|NCT00743340|560192118|FG000|Overall Study|Rolled over to other Gilead Study|23|||
155205391|NCT00743340|560192118|FG000|Overall Study|Participant Relocated|1|||
155205392|NCT01425281|560192119|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
155205393|NCT01425281|560192120|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
155205394|NCT01425281|560192119|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
155205395|NCT01425281|560192120|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
155205396|NCT01425281|560192119|FG000|At 180-day Clinical Follow-up|Death|0|||
155205397|NCT01425281|560192120|FG001|At 180-day Clinical Follow-up|Death|1|||
155205398|NCT01425281|560192119|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
155205399|NCT01425281|560192120|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
155205400|NCT01425281|560192119|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
155205401|NCT01425281|560192120|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
155205402|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
155205403|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
155205404|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Death|2|||
155205405|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Death|0|||
155205406|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
155205407|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
155205408|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
155205409|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
155205410|NCT01425281|560192119|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
155205411|NCT01425281|560192120|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
155205412|NCT01425281|560192119|FG000|At 3-year Clinical Follow-up|Death|2|||
155205413|NCT01425281|560192120|FG001|At 3-year Clinical Follow-up|Death|3|||
155205414|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Death|7|||
155205415|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Death|3|||
155205416|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
155205417|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
155205418|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
155205419|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
155205420|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
155205421|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
155205422|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
155205423|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
155205424|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Death|2|||
155205425|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Death|0|||
155205426|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
155205427|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
155205428|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
155205429|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
155205430|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
155205431|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
155205432|NCT03266107|560192121|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
155205433|NCT03266107|560192121|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
155205434|NCT03266107|560192121|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
155205435|NCT03266107|560192121|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
155205436|NCT02548650|560192122|FG000|Triple Therapy|Adverse Event|1|||
155205437|NCT02548650|560192123|FG001|Triple Therapy|Adverse Event|0|||
155205438|NCT02548650|560192122|FG000|Triple Therapy|Withdrawal by Subject|0|||
155205439|NCT02548650|560192123|FG001|Triple Therapy|Withdrawal by Subject|4|||
155205440|NCT02548650|560192122|FG000|Double Therapy|Adverse Event|1|||
155205441|NCT02548650|560192123|FG001|Double Therapy|Adverse Event|1|||
155205442|NCT02548650|560192122|FG000|Double Therapy|Withdrawal by Subject|0|||
155205443|NCT02548650|560192123|FG001|Double Therapy|Withdrawal by Subject|1|||
155205444|NCT01191801|560192124|FG000|Overall Study|Death|36|||
155205445|NCT01191801|560192125|FG001|Overall Study|Death|12|||
155205446|NCT01191801|560192124|FG000|Overall Study|Lack of Efficacy|176|||
155205447|NCT01191801|560192125|FG001|Overall Study|Lack of Efficacy|258|||
155205448|NCT01191801|560192124|FG000|Overall Study|Adverse Event|9|||
155205449|NCT01191801|560192125|FG001|Overall Study|Adverse Event|8|||
155205450|NCT01191801|560192124|FG000|Overall Study|Protocol Violation|2|||
155205451|NCT01191801|560192125|FG001|Overall Study|Protocol Violation|4|||
155205452|NCT01191801|560192124|FG000|Overall Study|Physician Decision|47|||
155205453|NCT01191801|560192125|FG001|Overall Study|Physician Decision|24|||
155205454|NCT01191801|560192124|FG000|Overall Study|Withdrawal by Subject|1|||
155205455|NCT01191801|560192125|FG001|Overall Study|Withdrawal by Subject|4|||
155205456|NCT01191801|560192124|FG000|Overall Study|Not Provided|45|||
155205457|NCT01191801|560192125|FG001|Overall Study|Not Provided|27|||
155205458|NCT00814164|560192126|FG000|Overall Study|Progression|7|||
155205459|NCT00814164|560192126|FG000|Overall Study|not stated|7|||
155491241|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
155205460|NCT00814164|560192126|FG000|Overall Study|Death|5|||
155205461|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
155205462|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
155205463|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
155205464|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
155205465|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
155205466|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
155205467|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
155205468|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
155205469|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
155205470|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
155205471|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
155205472|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
155205473|NCT01169493|560192136|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205474|NCT01169493|560192137|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
155205475|NCT01169493|560192138|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
155205476|NCT01169493|560192139|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205477|NCT01169493|560192140|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205478|NCT01169493|560192141|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
155205479|NCT01169493|560192136|FG000|Period 3 (6 Months)|Adverse Event|0|||
155205480|NCT01169493|560192137|FG001|Period 3 (6 Months)|Adverse Event|1|||
155205481|NCT01169493|560192138|FG002|Period 3 (6 Months)|Adverse Event|0|||
155205482|NCT01169493|560192139|FG003|Period 3 (6 Months)|Adverse Event|0|||
155205483|NCT01169493|560192140|FG004|Period 3 (6 Months)|Adverse Event|0|||
155205484|NCT01169493|560192141|FG005|Period 3 (6 Months)|Adverse Event|0|||
155205485|NCT01169493|560192136|FG000|Period 3 (6 Months)|Physician Decision|0|||
155205486|NCT01169493|560192137|FG001|Period 3 (6 Months)|Physician Decision|1|||
155205487|NCT01169493|560192138|FG002|Period 3 (6 Months)|Physician Decision|1|||
155205488|NCT01169493|560192139|FG003|Period 3 (6 Months)|Physician Decision|0|||
155205489|NCT01169493|560192140|FG004|Period 3 (6 Months)|Physician Decision|0|||
155205490|NCT01169493|560192141|FG005|Period 3 (6 Months)|Physician Decision|0|||
155205491|NCT05228132|560192142|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
155205492|NCT05228132|560192142|FG000|Overall Study|Adverse Event|3|||
155205493|NCT05228132|560192142|FG000|Overall Study|Lost to Follow-up|1|||
155205494|NCT05228132|560192142|FG000|Overall Study|Arteriovenous-fistula mature|1|||
155205495|NCT02627144|560192145|FG000|Overall Study|Serious adverse event|32|||
155205496|NCT02627144|560192145|FG000|Overall Study|Cancer progression|171|||
155205497|NCT02627144|560192145|FG000|Overall Study|Death from cancer|20|||
155205498|NCT02627144|560192145|FG000|Overall Study|Death from other cause|8|||
155205499|NCT02627144|560192145|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
155205500|NCT02627144|560192145|FG000|Overall Study|Administrative reasons|65|||
155205501|NCT02627144|560192145|FG000|Overall Study|Lost to Follow-up|8|||
155205502|NCT02627144|560192145|FG000|Overall Study|Enrolled, not treated|6|||
155205503|NCT02627144|560192145|FG000|Overall Study|Other|17|||
155205504|NCT02651922|560192151|FG000|Overall Study|due to exclusion criteria|2|||
155205505|NCT03018704|560192154|FG000|Overall Study|Lost to Follow-up|1|||
155205506|NCT03018704|560192155|FG001|Overall Study|Lost to Follow-up|1|||
155205507|NCT00642460|560192156|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205508|NCT00642460|560192157|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
155205509|NCT00642460|560192158|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
155205510|NCT00642460|560192159|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205511|NCT00642460|560192160|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205512|NCT00642460|560192161|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205513|NCT00642460|560192156|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
155205514|NCT00642460|560192157|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205515|NCT00642460|560192158|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205516|NCT00642460|560192159|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205517|NCT00642460|560192160|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205518|NCT00642460|560192161|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205519|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
155205520|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
155205521|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205522|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205523|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205524|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205525|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Death|0|||
155205526|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Death|1|||
155205527|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Death|0|||
155205528|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Death|2|||
155205529|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Death|0|||
155205530|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Death|0|||
155205531|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
155205532|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
155205533|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205534|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205535|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205536|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205537|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
155205538|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
155205539|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205540|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205541|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205542|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205543|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205544|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
155205545|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205546|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205547|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205548|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205549|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205550|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205551|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205552|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
155205553|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205554|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205555|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205556|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205557|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205558|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205559|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
155205560|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
155205561|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205562|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205563|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205564|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205565|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
155205566|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
155205567|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205568|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205569|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205570|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205571|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
155205572|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
155205573|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205574|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205575|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205576|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205577|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
155205578|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
155205579|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Other|0|||
155205580|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Other|0|||
155205581|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Other|0|||
155205582|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Other|0|||
155205583|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Other|2|||
155205584|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Other|2|||
155205585|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Death|0|||
155205586|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Death|0|||
155205587|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Death|0|||
155205588|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Death|0|||
155205589|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Death|0|||
155205590|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Death|3|||
155205591|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205592|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205593|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205594|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205595|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205596|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
155205597|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205598|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205599|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205600|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205601|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
155205602|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
155205603|NCT04448171|560192162|FG000|Overall Study|Procedure Cancelled|1|||
155205604|NCT04448171|560192163|FG001|Overall Study|Procedure Cancelled|0|||
155205605|NCT04448171|560192162|FG000|Overall Study|Protocol Violation|1|||
155205606|NCT04448171|560192163|FG001|Overall Study|Protocol Violation|0|||
155205607|NCT01025752|560192172|FG000|Overall Study|Lost to Follow-up|7|||
155205608|NCT01025752|560192173|FG001|Overall Study|Lost to Follow-up|10|||
155205609|NCT01025752|560192172|FG000|Overall Study|Physician Decision|1|||
155205610|NCT01025752|560192173|FG001|Overall Study|Physician Decision|3|||
155205611|NCT00211809|560192174|FG000|Overall Study|Lack of Efficacy|1|||
155205612|NCT00211809|560192174|FG000|Overall Study|Lost to Follow-up|2|||
155205613|NCT00211809|560192174|FG000|Overall Study|Pregnancy|1|||
155205614|NCT00211809|560192174|FG000|Overall Study|side effects|2|||
155205615|NCT00023764|560192175|FG000|Overall Study|Other|1|||
155205616|NCT00023764|560192175|FG000|Overall Study|Adverse Event|4|||
155205617|NCT00023764|560192175|FG000|Overall Study|Withdrawal by Subject|1|||
155205618|NCT00023764|560192175|FG000|Overall Study|Progression of disease|6|||
155205619|NCT00023764|560192175|FG000|Overall Study|patient received other treatment|1|||
155205620|NCT00023764|560192175|FG000|Overall Study|delay in obtaining staging images|1|||
155205621|NCT01537393|560192176|FG000|Overall Study|Exclude prior to study|32|||
155205622|NCT01537393|560192177|FG001|Overall Study|Exclude prior to study|44|||
155205623|NCT01537393|560192176|FG000|Overall Study|Death|20|||
155205624|NCT01537393|560192177|FG001|Overall Study|Death|32|||
155205625|NCT01537393|560192176|FG000|Overall Study|Withdrawal by Subject|18|||
155205626|NCT01537393|560192177|FG001|Overall Study|Withdrawal by Subject|17|||
155205627|NCT01537393|560192176|FG000|Overall Study|Lost to Follow-up|53|||
155205628|NCT01537393|560192177|FG001|Overall Study|Lost to Follow-up|48|||
155205629|NCT01537393|560192176|FG000|Overall Study|Failure - Regrafted|28|||
155205630|NCT01537393|560192177|FG001|Overall Study|Failure - Regrafted|43|||
155205631|NCT01537393|560192176|FG000|Overall Study|Failure - Not regrafted|2|||
155205632|NCT01537393|560192177|FG001|Overall Study|Failure - Not regrafted|6|||
155205633|NCT01537393|560192176|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
155205634|NCT01537393|560192177|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
155205635|NCT01697566|560192181|FG000|Overall Study|Withdrawal by Subject|0|||
155205636|NCT01697566|560192182|FG001|Overall Study|Withdrawal by Subject|0|||
155205637|NCT01697566|560192183|FG002|Overall Study|Withdrawal by Subject|1|||
155205638|NCT01697566|560192184|FG003|Overall Study|Withdrawal by Subject|1|||
155205639|NCT01697566|560192181|FG000|Overall Study|Final biopsy not obtained|0|||
155205640|NCT01697566|560192182|FG001|Overall Study|Final biopsy not obtained|0|||
155205641|NCT01697566|560192183|FG002|Overall Study|Final biopsy not obtained|1|||
155205642|NCT01697566|560192184|FG003|Overall Study|Final biopsy not obtained|0|||
155205643|NCT00459953|560192186|FG000|Overall Study|not analyzed-household member in study|1|||
155205644|NCT00459953|560192187|FG001|Overall Study|not analyzed-household member in study|1|||
155205645|NCT01447433|560192188|FG000|Overall Study|Lost to Follow-up|0|||
155205646|NCT01447433|560192189|FG001|Overall Study|Lost to Follow-up|2|||
155205647|NCT01447433|560192188|FG000|Overall Study|Withdrawal by Subject|3|||
155205648|NCT01447433|560192189|FG001|Overall Study|Withdrawal by Subject|3|||
155205649|NCT01447433|560192188|FG000|Overall Study|Protocol Violation|1|||
155205650|NCT01447433|560192189|FG001|Overall Study|Protocol Violation|1|||
155205651|NCT00036270|560192190|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
155205652|NCT00036270|560192191|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
155205653|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
155205654|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
155205655|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
155205656|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
155205657|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
155205658|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
155205659|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Other|277|||
155205660|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Other|288|||
155205661|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
155205662|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
155205663|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
155205664|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
155205665|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
155205666|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
155205667|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
155205668|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
155205669|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
155205670|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
155205671|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
155205672|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
155205673|NCT00496470|560192192|FG000|Overall Study|Adverse Event|8|||
155205674|NCT00496470|560192193|FG001|Overall Study|Adverse Event|10|||
155205675|NCT00496470|560192192|FG000|Overall Study|Withdrawal by Subject|5|||
155205676|NCT00496470|560192193|FG001|Overall Study|Withdrawal by Subject|12|||
155205677|NCT00496470|560192192|FG000|Overall Study|Incorrectly enrolled|13|||
155205678|NCT00496470|560192193|FG001|Overall Study|Incorrectly enrolled|5|||
155205679|NCT00496470|560192192|FG000|Overall Study|Other reason|0|||
155205680|NCT00496470|560192193|FG001|Overall Study|Other reason|2|||
155205681|NCT02516163|560192194|FG000|Overall Study|Withdrawal by Subject|1|||
155205682|NCT02516163|560192194|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
155205683|NCT02516163|560192194|FG000|Overall Study|Unfit/delay in surgery|3|||
155205684|NCT02516163|560192194|FG000|Overall Study|Use of incorrect measurement technique|5|||
155205685|NCT02516163|560192194|FG000|Overall Study|Data not recorded|2|||
155205686|NCT02516163|560192194|FG000|Overall Study|MRI contraindication exclusion|6|||
155205687|NCT01217814|560192195|FG000|Overall Study|Adverse Event|1|||
155205688|NCT01217814|560192196|FG001|Overall Study|Adverse Event|1|||
155205689|NCT01217814|560192197|FG002|Overall Study|Adverse Event|0|||
155205690|NCT01217814|560192195|FG000|Overall Study|Lack of Efficacy|0|||
155205691|NCT01217814|560192196|FG001|Overall Study|Lack of Efficacy|0|||
155205692|NCT01217814|560192197|FG002|Overall Study|Lack of Efficacy|1|||
155205693|NCT01370356|560192198|FG000|Overall Study|Death|1|||
155205694|NCT01370356|560192199|FG001|Overall Study|Death|0|||
155205695|NCT01370356|560192198|FG000|Overall Study|Lack of Efficacy|6|||
155205696|NCT01370356|560192199|FG001|Overall Study|Lack of Efficacy|28|||
155205697|NCT01370356|560192198|FG000|Overall Study|Lost to Follow-up|76|||
155205698|NCT01370356|560192199|FG001|Overall Study|Lost to Follow-up|81|||
155205699|NCT01370356|560192198|FG000|Overall Study|Withdrawal by Subject|54|||
155205700|NCT01370356|560192199|FG001|Overall Study|Withdrawal by Subject|59|||
155205701|NCT01370356|560192198|FG000|Overall Study|Reason not specified|39|||
155205702|NCT01370356|560192199|FG001|Overall Study|Reason not specified|43|||
155205703|NCT01370356|560192198|FG000|Overall Study|Protocol Violation|3|||
155205704|NCT01370356|560192199|FG001|Overall Study|Protocol Violation|3|||
155205705|NCT01370356|560192198|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
155205706|NCT01370356|560192199|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
155205707|NCT01370356|560192198|FG000|Overall Study|AE Not Related to Study Drug|1|||
155205708|NCT01370356|560192199|FG001|Overall Study|AE Not Related to Study Drug|4|||
155205709|NCT00729651|560192202|FG000|Overall Study|Withdrawal by Subject|5|||
155205710|NCT00729651|560192203|FG001|Overall Study|Withdrawal by Subject|6|||
155205711|NCT00729651|560192202|FG000|Overall Study|Lost to Follow-up|5|||
155205712|NCT00729651|560192203|FG001|Overall Study|Lost to Follow-up|4|||
155205713|NCT00729651|560192202|FG000|Overall Study|Protocol Violation|0|||
155205714|NCT00729651|560192203|FG001|Overall Study|Protocol Violation|1|||
155205715|NCT00729651|560192202|FG000|Overall Study|Adverse Event|7|||
155205716|NCT00729651|560192203|FG001|Overall Study|Adverse Event|3|||
155205717|NCT00729651|560192202|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
155205718|NCT00729651|560192203|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
155205719|NCT00729651|560192202|FG000|Overall Study|Subject's private reason|2|||
155205720|NCT00729651|560192203|FG001|Overall Study|Subject's private reason|0|||
155205721|NCT01874054|560192204|FG000|Overall Study|Withdrawal by Subject|3|||
155205722|NCT01874054|560192204|FG000|Overall Study|Study Termination by Sponsor|42|||
155205723|NCT01874054|560192204|FG000|Overall Study|Lost to Follow-up|5|||
155205724|NCT01874054|560192204|FG000|Overall Study|Death|5|||
155205725|NCT01844518|560192208|FG000|Overall Study|Adverse Event|7|||
155205726|NCT01844518|560192209|FG001|Overall Study|Adverse Event|1|||
155205727|NCT01844518|560192208|FG000|Overall Study|Lack of Efficacy|17|||
155205728|NCT01844518|560192209|FG001|Overall Study|Lack of Efficacy|5|||
155205729|NCT01844518|560192208|FG000|Overall Study|Participant's request to discontinue|4|||
155205730|NCT01844518|560192209|FG001|Overall Study|Participant's request to discontinue|1|||
155205731|NCT01844518|560192208|FG000|Overall Study|Poor/Non-compliance|1|||
155205732|NCT01844518|560192209|FG001|Overall Study|Poor/Non-compliance|0|||
155205733|NCT01844518|560192208|FG000|Overall Study|No Longer Met Study Criteria|2|||
155205734|NCT01844518|560192209|FG001|Overall Study|No Longer Met Study Criteria|0|||
155205735|NCT01844518|560192208|FG000|Overall Study|Withdrawal by Subject|9|||
155205736|NCT01844518|560192209|FG001|Overall Study|Withdrawal by Subject|0|||
155205737|NCT01844518|560192208|FG000|Overall Study|Pregnancy|1|||
155205738|NCT01844518|560192209|FG001|Overall Study|Pregnancy|0|||
155205739|NCT01217801|560192210|FG000|Period 1|Protocol Violation|1|||
155205740|NCT01217801|560192211|FG001|Period 1|Protocol Violation|1|||
155205741|NCT01217801|560192210|FG000|Period 1|Withdrawal by Subject|0|||
155205742|NCT01217801|560192211|FG001|Period 1|Withdrawal by Subject|1|||
155205743|NCT00291577|560192212|FG000|Overall Study|Adverse Event|1|||
155205744|NCT00291577|560192212|FG000|Overall Study|Other|4|||
155205745|NCT00291577|560192212|FG000|Overall Study|Withdrawal by Subject|2|||
155205746|NCT00291577|560192212|FG000|Overall Study|Lack of Efficacy|14|||
155205747|NCT01197560|560192215|FG000|Overall Study|Adverse Event|6|||
155205748|NCT01197560|560192216|FG001|Overall Study|Adverse Event|8|||
155205749|NCT01197560|560192215|FG000|Overall Study|Death|3|||
155205750|NCT01197560|560192216|FG001|Overall Study|Death|5|||
155205751|NCT01197560|560192215|FG000|Overall Study|Withdrawal by Subject|1|||
155205752|NCT01197560|560192216|FG001|Overall Study|Withdrawal by Subject|1|||
155205753|NCT01197560|560192215|FG000|Overall Study|Disease progression|40|||
155205754|NCT01197560|560192216|FG001|Overall Study|Disease progression|35|||
155205755|NCT01197560|560192215|FG000|Overall Study|Miscellaneous|4|||
155205756|NCT01197560|560192216|FG001|Overall Study|Miscellaneous|3|||
155205757|NCT01197560|560192215|FG000|Overall Study|Missing|0|||
155205758|NCT01197560|560192216|FG001|Overall Study|Missing|1|||
155205759|NCT00621153|560192221|FG000|Overall Study|Safety Reason|8|||
155205760|NCT00621153|560192222|FG001|Overall Study|Safety Reason|7|||
155205761|NCT00621153|560192221|FG000|Overall Study|Adverse Event|3|||
155205762|NCT00621153|560192222|FG001|Overall Study|Adverse Event|2|||
155205763|NCT00621153|560192221|FG000|Overall Study|Lost to Follow-up|5|||
155205764|NCT00621153|560192222|FG001|Overall Study|Lost to Follow-up|1|||
155205765|NCT00621153|560192221|FG000|Overall Study|Withdrawal by Subject|4|||
155205766|NCT00621153|560192222|FG001|Overall Study|Withdrawal by Subject|5|||
155205767|NCT04212650|560192223|FG000|Overall Study|Withdrawal by Subject|1|||
155205768|NCT04212650|560192224|FG001|Overall Study|Withdrawal by Subject|0|||
155205769|NCT00357968|560192229|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
155205770|NCT00357968|560192230|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
155205771|NCT00357968|560192229|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
155205772|NCT00357968|560192230|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
155205773|NCT00679302|560192232|FG000|Overall Study|Lost to Follow-up|8|||
155205774|NCT00679302|560192233|FG001|Overall Study|Lost to Follow-up|4|||
155205775|NCT03547687|560192234|FG000|Overall Study|Withdrawal by Subject|1|||
155205776|NCT03547687|560192234|FG000|Overall Study|Death|1|||
155205777|NCT04656691|560192237|FG000|Overall Study|Adverse Event|1|||
155205778|NCT02846779|560192240|FG000|Overall Study|Lost Enrollment|83|||
155205779|NCT02846779|560192241|FG001|Overall Study|Lost Enrollment|82|||
155205780|NCT02846779|560192242|FG002|Overall Study|Lost Enrollment|86|||
155205781|NCT02846779|560192240|FG000|Overall Study|Less than 31 days of follow-up|56|||
155205782|NCT02846779|560192241|FG001|Overall Study|Less than 31 days of follow-up|45|||
155205783|NCT02846779|560192242|FG002|Overall Study|Less than 31 days of follow-up|52|||
155205784|NCT01753856|560192245|FG000|Overall Study|Adverse Event|1|||
155205785|NCT01753856|560192246|FG001|Overall Study|Adverse Event|0|||
155205786|NCT01753856|560192245|FG000|Overall Study|Withdrawal by Subject|0|||
155205787|NCT01753856|560192246|FG001|Overall Study|Withdrawal by Subject|2|||
155205788|NCT01753856|560192245|FG000|Overall Study|Sponsor Decision|2|||
155205789|NCT01753856|560192246|FG001|Overall Study|Sponsor Decision|0|||
155205790|NCT00887978|560192247|FG000|Overall Study|Adverse Event|18|||
155205791|NCT00887978|560192248|FG001|Overall Study|Adverse Event|5|||
155205792|NCT00887978|560192247|FG000|Overall Study|Clinical Worsening|4|||
155205793|NCT00887978|560192248|FG001|Overall Study|Clinical Worsening|4|||
155205794|NCT00887978|560192247|FG000|Overall Study|Death|2|||
155205795|NCT00887978|560192248|FG001|Overall Study|Death|3|||
155205796|NCT00887978|560192247|FG000|Overall Study|Withdrawal by Subject|1|||
155205797|NCT00887978|560192248|FG001|Overall Study|Withdrawal by Subject|2|||
155205798|NCT00887978|560192247|FG000|Overall Study|Lost to Follow-up|0|||
155205799|NCT00887978|560192248|FG001|Overall Study|Lost to Follow-up|1|||
155205800|NCT05980182|560192249|FG000|Overall Study|Lost to Follow-up|10|||
155205801|NCT01955733|560194425|FG000|Period 1|Lost to Follow-up|1|||
155205802|NCT01955733|560194426|FG001|Period 1|Lost to Follow-up|0|||
155205803|NCT01955733|560194427|FG002|Period 1|Lost to Follow-up|0|||
155205804|NCT01955733|560194425|FG000|Period 2|Adverse Event|1|||
155205805|NCT01955733|560194426|FG001|Period 2|Adverse Event|0|||
155205806|NCT01955733|560194427|FG002|Period 2|Adverse Event|0|||
155205807|NCT01955733|560194425|FG000|Period 2|Physician Decision|0|||
155205808|NCT01955733|560194426|FG001|Period 2|Physician Decision|0|||
155205809|NCT01955733|560194427|FG002|Period 2|Physician Decision|1|||
155205810|NCT01955733|560194425|FG000|Period 2|Withdrawal by Subject|1|||
155205811|NCT01955733|560194426|FG001|Period 2|Withdrawal by Subject|3|||
155205812|NCT01955733|560194427|FG002|Period 2|Withdrawal by Subject|2|||
155205813|NCT01955733|560194425|FG000|Period 2|Study terminated by sponsor|8|||
155205814|NCT01955733|560194426|FG001|Period 2|Study terminated by sponsor|14|||
155205815|NCT01955733|560194427|FG002|Period 2|Study terminated by sponsor|16|||
155205816|NCT01955733|560194425|FG000|Period 2|Lost to Follow-up|2|||
155205817|NCT01955733|560194426|FG001|Period 2|Lost to Follow-up|0|||
155205818|NCT01955733|560194427|FG002|Period 2|Lost to Follow-up|0|||
155205819|NCT01955733|560194425|FG000|Period 2|Other not defined above|0|||
155205820|NCT01955733|560194426|FG001|Period 2|Other not defined above|2|||
155205821|NCT01955733|560194427|FG002|Period 2|Other not defined above|2|||
155205822|NCT02239978|560194430|FG000|Overall Study|Withdrawal by Subject|2|||
155205823|NCT02239978|560194431|FG001|Overall Study|Withdrawal by Subject|0|||
155205824|NCT01852110|560194439|FG000|Overall Study|Adverse Event|12|||
155205825|NCT01852110|560194440|FG001|Overall Study|Adverse Event|5|||
155205826|NCT01852110|560194441|FG002|Overall Study|Adverse Event|0|||
155205827|NCT01852110|560194442|FG003|Overall Study|Adverse Event|0|||
155205828|NCT01852110|560194443|FG004|Overall Study|Adverse Event|0|||
155205829|NCT01852110|560194444|FG005|Overall Study|Adverse Event|0|||
155205830|NCT01852110|560194439|FG000|Overall Study|Lost to Follow-up|1|||
155205831|NCT01852110|560194440|FG001|Overall Study|Lost to Follow-up|3|||
155205832|NCT01852110|560194441|FG002|Overall Study|Lost to Follow-up|0|||
155205833|NCT01852110|560194442|FG003|Overall Study|Lost to Follow-up|0|||
155205834|NCT01852110|560194443|FG004|Overall Study|Lost to Follow-up|0|||
155205835|NCT01852110|560194444|FG005|Overall Study|Lost to Follow-up|0|||
155205836|NCT01852110|560194439|FG000|Overall Study|Non-compliance with Study Drug|2|||
155205837|NCT01852110|560194440|FG001|Overall Study|Non-compliance with Study Drug|1|||
155205838|NCT01852110|560194441|FG002|Overall Study|Non-compliance with Study Drug|0|||
155205839|NCT01852110|560194442|FG003|Overall Study|Non-compliance with Study Drug|0|||
155205840|NCT01852110|560194443|FG004|Overall Study|Non-compliance with Study Drug|0|||
155205841|NCT01852110|560194444|FG005|Overall Study|Non-compliance with Study Drug|0|||
155205842|NCT01852110|560194439|FG000|Overall Study|Physician Decision|1|||
155205843|NCT01852110|560194440|FG001|Overall Study|Physician Decision|0|||
155205844|NCT01852110|560194441|FG002|Overall Study|Physician Decision|0|||
155205845|NCT01852110|560194442|FG003|Overall Study|Physician Decision|0|||
155205846|NCT01852110|560194443|FG004|Overall Study|Physician Decision|0|||
155205847|NCT01852110|560194444|FG005|Overall Study|Physician Decision|0|||
155205848|NCT01852110|560194439|FG000|Overall Study|Protocol Violation|0|||
155205849|NCT01852110|560194440|FG001|Overall Study|Protocol Violation|1|||
155205850|NCT01852110|560194441|FG002|Overall Study|Protocol Violation|0|||
155205851|NCT01852110|560194442|FG003|Overall Study|Protocol Violation|0|||
155205852|NCT01852110|560194443|FG004|Overall Study|Protocol Violation|0|||
155205853|NCT01852110|560194444|FG005|Overall Study|Protocol Violation|0|||
155205854|NCT01852110|560194439|FG000|Overall Study|Study Terminated by Sponsor|30|||
155205855|NCT01852110|560194440|FG001|Overall Study|Study Terminated by Sponsor|32|||
155205856|NCT01852110|560194441|FG002|Overall Study|Study Terminated by Sponsor|0|||
155205857|NCT01852110|560194442|FG003|Overall Study|Study Terminated by Sponsor|0|||
155205858|NCT01852110|560194443|FG004|Overall Study|Study Terminated by Sponsor|0|||
155205859|NCT01852110|560194444|FG005|Overall Study|Study Terminated by Sponsor|0|||
155205860|NCT01852110|560194439|FG000|Overall Study|Withdrawal by Subject|4|||
155205861|NCT01852110|560194440|FG001|Overall Study|Withdrawal by Subject|4|||
155205862|NCT01852110|560194441|FG002|Overall Study|Withdrawal by Subject|0|||
155205863|NCT01852110|560194442|FG003|Overall Study|Withdrawal by Subject|0|||
155205864|NCT01852110|560194443|FG004|Overall Study|Withdrawal by Subject|0|||
155205865|NCT01852110|560194444|FG005|Overall Study|Withdrawal by Subject|0|||
155205866|NCT01549860|560194450|FG000|Overall Study|Withdrawal by Subject|1|||
155205867|NCT01549860|560194451|FG001|Overall Study|Withdrawal by Subject|0|||
155205868|NCT01549860|560194450|FG000|Overall Study|Physician Decision|1|||
155205869|NCT01549860|560194451|FG001|Overall Study|Physician Decision|1|||
155205870|NCT01366521|560194452|FG000|Overall Study|Adverse Event|1|||
155205871|NCT01366521|560194453|FG001|Overall Study|Adverse Event|0|||
155205872|NCT01366521|560194454|FG002|Overall Study|Adverse Event|0|||
155205873|NCT01366521|560194455|FG003|Overall Study|Adverse Event|0|||
155205874|NCT01366521|560194452|FG000|Overall Study|Protocol Violation|0|||
155205875|NCT01366521|560194453|FG001|Overall Study|Protocol Violation|0|||
155205876|NCT01366521|560194454|FG002|Overall Study|Protocol Violation|1|||
155205877|NCT01366521|560194455|FG003|Overall Study|Protocol Violation|0|||
155205878|NCT01366521|560194452|FG000|Overall Study|Physician Decision|0|||
155205879|NCT01366521|560194453|FG001|Overall Study|Physician Decision|0|||
155205880|NCT01366521|560194454|FG002|Overall Study|Physician Decision|1|||
155205881|NCT01366521|560194455|FG003|Overall Study|Physician Decision|0|||
155205882|NCT01366521|560194452|FG000|Overall Study|Withdrawal by Subject|0|||
155205883|NCT01366521|560194453|FG001|Overall Study|Withdrawal by Subject|1|||
155205884|NCT01366521|560194454|FG002|Overall Study|Withdrawal by Subject|0|||
155205885|NCT01366521|560194455|FG003|Overall Study|Withdrawal by Subject|0|||
155205886|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155205887|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
155205888|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205889|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205890|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205891|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205892|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205893|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205894|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205895|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205896|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205897|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
155205898|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
155205899|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
155205900|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
155205901|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155205902|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155205903|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155205904|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155205905|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
155205906|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
155205907|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
155205908|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
155205909|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
155205910|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
155205911|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
155205912|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
155205913|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
155205914|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
155205915|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
155205916|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
155205917|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
155205918|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
155205919|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205920|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205921|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205922|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205923|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205924|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205925|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205926|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205927|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205928|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205929|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205930|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205931|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205932|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205933|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205934|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205935|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
155205936|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205937|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
155205938|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205939|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205940|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205941|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205942|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205943|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205944|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205945|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
155205946|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205947|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
155205948|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
155205949|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
155205950|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205951|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
155205952|NCT02485301|560194468|FG000|Overall Study|Serious Adverse Events|2|||
155205953|NCT02485301|560194469|FG001|Overall Study|Serious Adverse Events|1|||
155205954|NCT02485301|560194468|FG000|Overall Study|Protocol Violation|0|||
155205955|NCT02485301|560194469|FG001|Overall Study|Protocol Violation|1|||
155205956|NCT02485301|560194468|FG000|Overall Study|Withdrawal by Subject|6|||
155205957|NCT02485301|560194469|FG001|Overall Study|Withdrawal by Subject|7|||
155205958|NCT02485301|560194468|FG000|Overall Study|Migrated/moved from study area|10|||
155205959|NCT02485301|560194469|FG001|Overall Study|Migrated/moved from study area|19|||
155205960|NCT02485301|560194468|FG000|Overall Study|Lost to Follow-up|17|||
155205961|NCT02485301|560194469|FG001|Overall Study|Lost to Follow-up|17|||
155205962|NCT02485301|560194468|FG000|Overall Study|Other|3|||
155205963|NCT02485301|560194469|FG001|Overall Study|Other|4|||
155205964|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205965|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205966|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205967|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205968|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205969|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205970|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
155205971|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205972|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205973|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205974|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205975|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205976|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205977|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
155205978|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205979|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205980|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205981|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205982|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205983|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205984|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
155205985|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205986|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205987|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205988|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205989|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205990|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205991|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
155205992|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
155205993|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
155205994|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
155205995|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
155205996|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
155205997|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
155205998|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
155205999|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
155206000|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
155206001|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
155206002|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
155206003|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
155206004|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
155206005|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
155206006|NCT01059825|560194470|FG000|Treatment Period|Lost to Follow-up|2|||
155206007|NCT01059825|560194471|FG001|Treatment Period|Lost to Follow-up|1|||
155206008|NCT01059825|560194472|FG002|Treatment Period|Lost to Follow-up|0|||
155206009|NCT01059825|560194473|FG003|Treatment Period|Lost to Follow-up|1|||
155206010|NCT01059825|560194474|FG004|Treatment Period|Lost to Follow-up|2|||
155206011|NCT01059825|560194475|FG005|Treatment Period|Lost to Follow-up|0|||
155206012|NCT01059825|560194476|FG006|Treatment Period|Lost to Follow-up|0|||
155206013|NCT01059825|560194470|FG000|Treatment Period|Withdrawal by Subject|3|||
155206014|NCT01059825|560194471|FG001|Treatment Period|Withdrawal by Subject|0|||
155206015|NCT01059825|560194472|FG002|Treatment Period|Withdrawal by Subject|1|||
155206016|NCT01059825|560194473|FG003|Treatment Period|Withdrawal by Subject|5|||
155206017|NCT01059825|560194474|FG004|Treatment Period|Withdrawal by Subject|4|||
155206018|NCT01059825|560194475|FG005|Treatment Period|Withdrawal by Subject|1|||
155206019|NCT01059825|560194476|FG006|Treatment Period|Withdrawal by Subject|0|||
155206020|NCT01059825|560194470|FG000|Treatment Period|Other reason not specified|1|||
155206021|NCT01059825|560194471|FG001|Treatment Period|Other reason not specified|2|||
155206022|NCT01059825|560194472|FG002|Treatment Period|Other reason not specified|1|||
155206023|NCT01059825|560194473|FG003|Treatment Period|Other reason not specified|2|||
155206024|NCT01059825|560194474|FG004|Treatment Period|Other reason not specified|0|||
155206025|NCT01059825|560194475|FG005|Treatment Period|Other reason not specified|0|||
155206026|NCT01059825|560194476|FG006|Treatment Period|Other reason not specified|0|||
155206027|NCT01059825|560194470|FG000|Treatment Period|Protocol Violation|0|||
155206028|NCT01059825|560194471|FG001|Treatment Period|Protocol Violation|0|||
155206029|NCT01059825|560194472|FG002|Treatment Period|Protocol Violation|1|||
155206030|NCT01059825|560194473|FG003|Treatment Period|Protocol Violation|1|||
155206031|NCT01059825|560194474|FG004|Treatment Period|Protocol Violation|1|||
155206032|NCT01059825|560194475|FG005|Treatment Period|Protocol Violation|1|||
155206033|NCT01059825|560194476|FG006|Treatment Period|Protocol Violation|0|||
155206034|NCT01059825|560194470|FG000|Treatment Period|Adverse event related to study drug|1|||
155206035|NCT01059825|560194471|FG001|Treatment Period|Adverse event related to study drug|0|||
155206036|NCT01059825|560194472|FG002|Treatment Period|Adverse event related to study drug|1|||
155206037|NCT01059825|560194473|FG003|Treatment Period|Adverse event related to study drug|1|||
155206038|NCT01059825|560194474|FG004|Treatment Period|Adverse event related to study drug|0|||
155206039|NCT01059825|560194475|FG005|Treatment Period|Adverse event related to study drug|0|||
155206040|NCT01059825|560194476|FG006|Treatment Period|Adverse event related to study drug|0|||
155206041|NCT01059825|560194470|FG000|Treatment Period|Insufficient clinical response|3|||
155206042|NCT01059825|560194471|FG001|Treatment Period|Insufficient clinical response|0|||
155206043|NCT01059825|560194472|FG002|Treatment Period|Insufficient clinical response|0|||
155206044|NCT01059825|560194473|FG003|Treatment Period|Insufficient clinical response|0|||
155206045|NCT01059825|560194474|FG004|Treatment Period|Insufficient clinical response|0|||
155206046|NCT01059825|560194475|FG005|Treatment Period|Insufficient clinical response|0|||
155206047|NCT01059825|560194476|FG006|Treatment Period|Insufficient clinical response|0|||
155206048|NCT01059825|560194470|FG000|Treatment Period|Adverse event not related to study drug|0|||
155206049|NCT01059825|560194471|FG001|Treatment Period|Adverse event not related to study drug|1|||
155206050|NCT01059825|560194472|FG002|Treatment Period|Adverse event not related to study drug|2|||
155206051|NCT01059825|560194473|FG003|Treatment Period|Adverse event not related to study drug|1|||
155206052|NCT01059825|560194474|FG004|Treatment Period|Adverse event not related to study drug|1|||
155206053|NCT01059825|560194475|FG005|Treatment Period|Adverse event not related to study drug|1|||
155206054|NCT01059825|560194476|FG006|Treatment Period|Adverse event not related to study drug|0|||
155206055|NCT00105482|560194477|FG000|Overall Study|Adverse Event|1|||
155206056|NCT00105482|560194478|FG001|Overall Study|Adverse Event|1|||
155206057|NCT00105482|560194477|FG000|Overall Study|Lost to Follow-up|26|||
155206058|NCT00105482|560194478|FG001|Overall Study|Lost to Follow-up|17|||
155206059|NCT00105482|560194477|FG000|Overall Study|Withdrawal by Subject|0|||
155206060|NCT00105482|560194478|FG001|Overall Study|Withdrawal by Subject|1|||
155206061|NCT00105482|560194477|FG000|Overall Study|Lost Interest|29|||
155206062|NCT00105482|560194478|FG001|Overall Study|Lost Interest|32|||
155206063|NCT00105482|560194477|FG000|Overall Study|Scheduling Conflict|2|||
155206064|NCT00105482|560194478|FG001|Overall Study|Scheduling Conflict|3|||
155206065|NCT00105482|560194477|FG000|Overall Study|Withdrawn by PI|1|||
155206066|NCT00105482|560194478|FG001|Overall Study|Withdrawn by PI|1|||
155206067|NCT02708121|560194479|FG000|Overall Study|Withdrawn by Study Team|1|||
155206068|NCT02708121|560194480|FG001|Overall Study|Withdrawn by Study Team|1|||
155206069|NCT02708121|560194479|FG000|Overall Study|Withdrawal by Subject|0|||
155206070|NCT02708121|560194480|FG001|Overall Study|Withdrawal by Subject|4|||
155206071|NCT01749514|560194483|FG000|Overall Study|Lost to Follow-up|0|||
155206072|NCT01749514|560194484|FG001|Overall Study|Lost to Follow-up|0|||
155206073|NCT01749514|560194485|FG002|Overall Study|Lost to Follow-up|0|||
155206074|NCT01749514|560194486|FG003|Overall Study|Lost to Follow-up|0|||
155206075|NCT01749514|560194487|FG004|Overall Study|Lost to Follow-up|0|||
155206076|NCT01749514|560194488|FG005|Overall Study|Lost to Follow-up|0|||
155206077|NCT01749514|560194489|FG006|Overall Study|Lost to Follow-up|0|||
155206078|NCT01749514|560194490|FG007|Overall Study|Lost to Follow-up|1|||
155206079|NCT01749514|560194483|FG000|Overall Study|Withdrawal by Subject|0|||
155206080|NCT01749514|560194484|FG001|Overall Study|Withdrawal by Subject|0|||
155206081|NCT01749514|560194485|FG002|Overall Study|Withdrawal by Subject|0|||
155206082|NCT01749514|560194486|FG003|Overall Study|Withdrawal by Subject|0|||
155206083|NCT01749514|560194487|FG004|Overall Study|Withdrawal by Subject|0|||
155206084|NCT01749514|560194488|FG005|Overall Study|Withdrawal by Subject|1|||
155206085|NCT01749514|560194489|FG006|Overall Study|Withdrawal by Subject|0|||
155206086|NCT01749514|560194490|FG007|Overall Study|Withdrawal by Subject|1|||
155206087|NCT01749514|560194483|FG000|Overall Study|Not Reported|0|||
155206088|NCT01749514|560194484|FG001|Overall Study|Not Reported|0|||
155206089|NCT01749514|560194485|FG002|Overall Study|Not Reported|0|||
155206090|NCT01749514|560194486|FG003|Overall Study|Not Reported|0|||
155206091|NCT01749514|560194487|FG004|Overall Study|Not Reported|0|||
155206092|NCT01749514|560194488|FG005|Overall Study|Not Reported|0|||
155206093|NCT01749514|560194489|FG006|Overall Study|Not Reported|0|||
155206094|NCT01749514|560194490|FG007|Overall Study|Not Reported|5|||
155206095|NCT02551731|560194491|FG000|Overall Study|Withdrawal by Subject|2|||
155206096|NCT01750242|560194492|FG000|Overall Study|Unreadable Images|3|||
155206097|NCT03765918|560194498|FG000|Overall Study|Death|109|||
155206098|NCT03765918|560194499|FG001|Overall Study|Death|127|||
155206099|NCT03765918|560194498|FG000|Overall Study|Lost to Follow-up|2|||
155206100|NCT03765918|560194499|FG001|Overall Study|Lost to Follow-up|3|||
155206101|NCT03765918|560194498|FG000|Overall Study|Withdrawal by Subject|12|||
155206102|NCT03765918|560194499|FG001|Overall Study|Withdrawal by Subject|16|||
155206103|NCT03765918|560194498|FG000|Overall Study|Participants Ongoing|240|||
155206104|NCT03765918|560194499|FG001|Overall Study|Participants Ongoing|205|||
155206105|NCT04202965|560194500|FG000|Overall Study|Adverse Event|3|||
155206106|NCT04202965|560194500|FG000|Overall Study|Did not meet inclusion criteria|1|||
155206107|NCT00299975|560194503|FG000|Overall Study|Adverse Event|1|||
155206108|NCT00299975|560194504|FG001|Overall Study|Adverse Event|0|||
155206109|NCT00299975|560194505|FG002|Overall Study|Adverse Event|2|||
155206110|NCT00299975|560194503|FG000|Overall Study|Pregnancy|0|||
155206111|NCT00299975|560194504|FG001|Overall Study|Pregnancy|0|||
155206112|NCT00299975|560194505|FG002|Overall Study|Pregnancy|1|||
155206113|NCT00299975|560194503|FG000|Overall Study|Lack of Efficacy|1|||
155206114|NCT00299975|560194504|FG001|Overall Study|Lack of Efficacy|0|||
155206115|NCT00299975|560194505|FG002|Overall Study|Lack of Efficacy|1|||
155206116|NCT00299975|560194503|FG000|Overall Study|Lost to Follow-up|1|||
155206117|NCT00299975|560194504|FG001|Overall Study|Lost to Follow-up|0|||
155206118|NCT00299975|560194505|FG002|Overall Study|Lost to Follow-up|0|||
155206119|NCT00299975|560194503|FG000|Overall Study|Withdrawal by Subject|0|||
155206120|NCT00299975|560194504|FG001|Overall Study|Withdrawal by Subject|1|||
155206121|NCT00299975|560194505|FG002|Overall Study|Withdrawal by Subject|3|||
155206122|NCT00299975|560194503|FG000|Overall Study|Physician Decision|0|||
155206123|NCT00299975|560194504|FG001|Overall Study|Physician Decision|0|||
155206124|NCT00299975|560194505|FG002|Overall Study|Physician Decision|1|||
155206125|NCT03167411|560194507|FG000|Overall Study|Adverse Event|0|||
155206126|NCT03167411|560194508|FG001|Overall Study|Adverse Event|1|||
155206127|NCT01578187|560194509|FG000|Usability Phase|Withdrawal by Subject|1|||
155206128|NCT01218243|560194510|FG000|Overall Study|Lack of Efficacy|1|||
155206129|NCT01218243|560194511|FG001|Overall Study|Lack of Efficacy|1|||
155206130|NCT01218243|560194510|FG000|Overall Study|Lost to Follow-up|3|||
155206131|NCT01218243|560194511|FG001|Overall Study|Lost to Follow-up|3|||
155206132|NCT01218243|560194510|FG000|Overall Study|Protocol Violation|5|||
155206133|NCT01218243|560194511|FG001|Overall Study|Protocol Violation|10|||
155206134|NCT01637272|560194513|FG000|Overall Study|Adverse Event|6|||
155206135|NCT01637272|560194513|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155206136|NCT01637272|560194513|FG000|Overall Study|Withdrawal by Subject|3|||
155206137|NCT01637272|560194513|FG000|Overall Study|Lost to Follow-up|2|||
155206138|NCT01637272|560194513|FG000|Overall Study|completed core, did not enter ext. phase|4|||
155206139|NCT01637272|560194513|FG000|Overall Study|Administrative problems|1|||
155206140|NCT01637272|560194513|FG000|Overall Study|Protocol Violation|2|||
155206141|NCT01496612|560194514|FG000|1st Intervention|Adverse Event|1|||
155206142|NCT01496612|560194515|FG001|1st Intervention|Adverse Event|0|||
155206143|NCT01496612|560194514|FG000|1st Intervention|Withdrawal by Subject|1|||
155206144|NCT01496612|560194515|FG001|1st Intervention|Withdrawal by Subject|0|||
155206145|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
155206146|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
155206147|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
155206148|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
155206149|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
155206150|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
155206151|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
155206152|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
155206153|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
155206154|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
155206155|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
155206156|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
155206157|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
155206158|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
155206159|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
155206160|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
155206161|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
155206162|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
155206163|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
155206164|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
155206165|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
155206166|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
155206167|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
155206168|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
155206169|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
155206170|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
155206171|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
155206172|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206173|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206174|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206175|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206176|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206177|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206178|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206179|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206180|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206181|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206182|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206183|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206184|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206185|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206186|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206187|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206188|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206189|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206190|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206191|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206192|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206193|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206194|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206195|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206196|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206197|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
155206198|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
155206199|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206200|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206201|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206202|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206203|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206204|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206205|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206206|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206207|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206208|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206209|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206210|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206211|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206212|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206213|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206214|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206215|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206216|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206217|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206218|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206219|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206220|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206221|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206222|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206223|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
155206224|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
155206225|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206226|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206227|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206228|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206229|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206230|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206231|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206232|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206233|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206234|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206235|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206236|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206237|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206238|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206239|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206240|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206241|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206242|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206243|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206244|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206245|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206246|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206247|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206248|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206249|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206250|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
155206251|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206252|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206253|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206254|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206255|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206256|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206257|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206258|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206259|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206260|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206261|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206262|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206263|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206264|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206265|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206266|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206267|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206268|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206269|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206270|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206271|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206272|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206273|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206274|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206275|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206276|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206277|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
155206278|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
155206279|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206280|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
155206281|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206282|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206283|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206284|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206285|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206286|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206287|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206288|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206289|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206290|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206291|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206292|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206293|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206294|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206295|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206296|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206297|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206298|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206299|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206300|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206301|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Death|0|||
155206302|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Death|0|||
155206303|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Death|1|||
155206304|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Death|0|||
155206305|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Death|0|||
155206306|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Death|0|||
155206307|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Death|0|||
155206308|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Death|0|||
155206309|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Death|0|||
155206310|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Death|0|||
155206311|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Death|0|||
155206312|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Death|0|||
155206313|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Death|0|||
155206314|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Death|0|||
155206315|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Death|0|||
155206316|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Death|0|||
155206317|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Death|0|||
155206318|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Death|0|||
155206319|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Death|0|||
155206320|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Death|0|||
155206321|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Death|0|||
155206322|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Death|0|||
155206323|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Death|0|||
155206324|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Death|0|||
155206325|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Death|0|||
155206326|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Death|0|||
155206327|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206328|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206329|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
155206330|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
155206331|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
155206332|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
155206333|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
155206334|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206335|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206336|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206337|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206338|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206339|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206340|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206341|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206342|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206343|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206344|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206345|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206346|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206347|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206348|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206349|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206350|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206351|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206352|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206353|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206354|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206355|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
155206356|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206357|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206358|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206359|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206360|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206361|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206362|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206363|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206364|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206365|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206366|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206367|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206368|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206369|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206370|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206371|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206372|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206373|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206374|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206375|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206376|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206377|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206378|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206379|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206380|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206381|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
155206382|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206383|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206384|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206385|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206386|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206387|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206388|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206389|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206390|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206391|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206392|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206393|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206394|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206395|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206396|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206397|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206398|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206399|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206400|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206401|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206402|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206403|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206404|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206405|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206406|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206407|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
155206408|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206409|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206410|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206411|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206412|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206413|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206414|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206415|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206416|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206417|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206418|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206419|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206420|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206421|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206422|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206423|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206424|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206425|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206426|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206427|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206428|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206429|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206430|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206431|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206432|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206433|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206434|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206435|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
155206436|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
155206437|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
155206438|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206439|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206440|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206441|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206442|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206443|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206444|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206445|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206446|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206447|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206448|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206449|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206450|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206451|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206452|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206453|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206454|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206455|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206456|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206457|NCT03129100|560194520|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206458|NCT03129100|560194521|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206459|NCT03129100|560194522|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206460|NCT03129100|560194523|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206461|NCT03129100|560194524|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206462|NCT03129100|560194525|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206463|NCT03129100|560194526|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206464|NCT03129100|560194527|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206465|NCT03129100|560194528|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206466|NCT03129100|560194529|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
155206467|NCT03129100|560194530|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206468|NCT03129100|560194531|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206469|NCT03129100|560194532|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206470|NCT03129100|560194533|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206471|NCT03129100|560194534|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206472|NCT03129100|560194535|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206473|NCT03129100|560194536|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206474|NCT03129100|560194537|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206475|NCT03129100|560194538|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206476|NCT03129100|560194539|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206477|NCT03129100|560194540|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206478|NCT03129100|560194541|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206479|NCT03129100|560194542|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206480|NCT03129100|560194543|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206481|NCT03129100|560194544|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206482|NCT03129100|560194545|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206483|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206484|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206485|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206486|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206487|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206488|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206489|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206490|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206491|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206492|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206493|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206494|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
155206495|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206496|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206497|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206498|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206499|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206500|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206501|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206502|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206503|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206504|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206505|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206506|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206507|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206508|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206509|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206510|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206511|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206512|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206513|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206514|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206515|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206516|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206517|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206518|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206519|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206520|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
155206521|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
155206522|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
155206523|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
155206524|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206525|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206526|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206527|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206528|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206529|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206530|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206531|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206532|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206533|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206534|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206535|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206536|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206537|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206538|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206539|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206540|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206541|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206542|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206543|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206544|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206545|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206546|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206547|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206548|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206549|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206550|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206551|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206552|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206553|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206554|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206555|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206556|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206557|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206558|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206559|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206560|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206561|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206562|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206563|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206564|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206565|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206566|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206567|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206568|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206569|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206570|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206571|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206572|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206573|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206574|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206575|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206576|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
155206577|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206578|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206579|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206580|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206581|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206582|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206583|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206584|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206585|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206586|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206587|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206588|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206589|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206590|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206591|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206592|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206593|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206594|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206595|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206596|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206597|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206598|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206599|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
155206600|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206601|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
155206602|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
155206603|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206604|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206605|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206606|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206607|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206608|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206609|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206610|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206611|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206612|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206613|NCT03129100|560194520|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206614|NCT03129100|560194521|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206615|NCT03129100|560194522|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206616|NCT03129100|560194523|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206617|NCT03129100|560194524|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206618|NCT03129100|560194525|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206619|NCT03129100|560194526|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206620|NCT03129100|560194527|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206621|NCT03129100|560194528|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206622|NCT03129100|560194529|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206623|NCT03129100|560194530|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206624|NCT03129100|560194531|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206625|NCT03129100|560194532|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206626|NCT03129100|560194533|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206627|NCT03129100|560194534|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206628|NCT03129100|560194535|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206629|NCT03129100|560194536|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206630|NCT03129100|560194537|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
155206631|NCT03129100|560194538|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206632|NCT03129100|560194539|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
155206633|NCT03129100|560194540|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206634|NCT03129100|560194541|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206635|NCT03129100|560194542|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206636|NCT03129100|560194543|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206637|NCT03129100|560194544|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206638|NCT03129100|560194545|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206639|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206640|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206641|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206642|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206643|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206644|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206645|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206646|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206647|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206648|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206649|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206650|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206651|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206652|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206653|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206654|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206655|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206656|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206657|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206658|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206659|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
155206660|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206661|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206662|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206663|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206664|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206665|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
155206666|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
155206667|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
155206668|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
155206669|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
155206670|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
155206671|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
155206672|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
155206673|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
155206674|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
155206675|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
155206676|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
155206677|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
155206678|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
155206679|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
155206680|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
155206681|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
155206682|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
155206683|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
155206684|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
155206685|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
155206686|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
155206687|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
155206688|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
155206689|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
155206690|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
155206691|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206692|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206693|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206694|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206695|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206696|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206697|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206698|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206699|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206700|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206701|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206702|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206703|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206704|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206705|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206706|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206707|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206708|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206709|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206710|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206711|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
155206712|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206713|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206714|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206715|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206716|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206717|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
155206718|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
155206719|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
155206720|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
155206721|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
155206722|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
155206723|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
155206724|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
155206725|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
155206726|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
155206727|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
155206728|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
155206729|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
155206730|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
155206731|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
155206732|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
155206733|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
155206734|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
155206735|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
155206736|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
155206737|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
155206738|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
155206739|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
155206740|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
155206741|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
155206742|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
155206743|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206744|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206745|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206746|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206747|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206748|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206749|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206750|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206751|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206752|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206753|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206754|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206755|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206756|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206757|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206758|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206759|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206760|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206761|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206762|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206763|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206764|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206765|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206766|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206767|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
155206768|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
155206769|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206770|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206771|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206772|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206773|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206774|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206775|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206776|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206777|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206778|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206779|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206780|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206781|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206782|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206783|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206784|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206785|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206786|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206787|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206788|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206789|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206790|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206791|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206792|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
155206793|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
155206794|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
155206795|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206796|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206797|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206798|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206799|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206800|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206801|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206802|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206803|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206804|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206805|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206806|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206807|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206808|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206809|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206810|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206811|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206812|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206813|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206814|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206815|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206816|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206817|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206818|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206819|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
155206820|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206821|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206822|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206823|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206824|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206825|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206826|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206827|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206828|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206829|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206830|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206831|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206832|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206833|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206834|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206835|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206836|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206837|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206838|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206839|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206840|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206841|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206842|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206843|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206844|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206845|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206846|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
155206847|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
155206848|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
155206849|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
155206850|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
155206851|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
155206852|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
155206853|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
155206854|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
155206855|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
155206856|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
155206857|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
155206858|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
155206859|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
155206860|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
155206861|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
155206862|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
155206863|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
155206864|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
155206865|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
155206866|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
155206867|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
155206868|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
155206869|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
155206870|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
155206871|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
155206872|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
155206873|NCT01587001|560194546|FG000|Overall Study|Lost to Follow-up|2|||
155206874|NCT01587001|560194547|FG001|Overall Study|Lost to Follow-up|0|||
155206875|NCT01587001|560194546|FG000|Overall Study|Insufficient samples to complete testing|4|||
155206876|NCT01587001|560194547|FG001|Overall Study|Insufficient samples to complete testing|1|||
155206877|NCT02756013|560194548|FG000|Overall Study|Adverse Event|1|||
155206878|NCT02756013|560194548|FG000|Overall Study|Hypersensitivity|1|||
155206879|NCT00571948|560194549|FG000|Overall Study|Lost to Follow-up|2|||
155206880|NCT00571948|560194550|FG001|Overall Study|Lost to Follow-up|0|||
155206881|NCT00571948|560194549|FG000|Overall Study|Withdrawal by Subject|1|||
155206882|NCT00571948|560194550|FG001|Overall Study|Withdrawal by Subject|2|||
155206883|NCT00571948|560194549|FG000|Overall Study|Protocol Violation|3|||
155206884|NCT00571948|560194550|FG001|Overall Study|Protocol Violation|3|||
155206885|NCT00571948|560194549|FG000|Overall Study|infant refused study meal|3|||
155206886|NCT00571948|560194550|FG001|Overall Study|infant refused study meal|4|||
155206887|NCT00571948|560194549|FG000|Overall Study|Parent were afraid of blood colection|2|||
155206888|NCT00571948|560194550|FG001|Overall Study|Parent were afraid of blood colection|5|||
155206889|NCT01032837|560194551|FG000|Overall Study|Adverse event/internal illness|0|||
155206890|NCT01032837|560194552|FG001|Overall Study|Adverse event/internal illness|1|||
155206891|NCT01032837|560194553|FG002|Overall Study|Adverse event/internal illness|0|||
155206892|NCT01032837|560194554|FG003|Overall Study|Adverse event/internal illness|1|||
155206893|NCT01032837|560194551|FG000|Overall Study|Withdrew consent|0|||
155206894|NCT01032837|560194552|FG001|Overall Study|Withdrew consent|2|||
155206895|NCT01032837|560194553|FG002|Overall Study|Withdrew consent|0|||
155206896|NCT01032837|560194554|FG003|Overall Study|Withdrew consent|1|||
155206897|NCT01032837|560194551|FG000|Overall Study|Failed to return|0|||
155206898|NCT01032837|560194552|FG001|Overall Study|Failed to return|0|||
155206899|NCT01032837|560194553|FG002|Overall Study|Failed to return|1|||
155206900|NCT01032837|560194554|FG003|Overall Study|Failed to return|0|||
155206901|NCT01032837|560194551|FG000|Overall Study|Refused treatment|0|||
155206902|NCT01032837|560194552|FG001|Overall Study|Refused treatment|0|||
155206903|NCT01032837|560194553|FG002|Overall Study|Refused treatment|0|||
155206904|NCT01032837|560194554|FG003|Overall Study|Refused treatment|1|||
155206905|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
155206906|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
155206907|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206908|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206909|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206910|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206911|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
155206912|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
155206913|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206914|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206915|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206916|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206917|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
155206918|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
155206919|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206920|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206921|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206922|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206923|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
155206924|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
155206925|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206926|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206927|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206928|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206929|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
155206930|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
155206931|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206932|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206933|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206934|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206935|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206936|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
155206937|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206938|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206939|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206940|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206941|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Other|0|||
155206942|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Other|1|||
155206943|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Other|0|||
155206944|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Other|0|||
155206945|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Other|0|||
155206946|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Other|0|||
155206947|NCT00843024|560194555|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
155206948|NCT00843024|560194556|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
155206949|NCT00843024|560194557|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
155206950|NCT00843024|560194558|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
155206951|NCT00843024|560194559|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
155206952|NCT00843024|560194560|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
155206953|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155206954|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
155206955|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
155206956|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206957|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206958|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206959|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206960|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206961|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206962|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155206963|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206964|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
155206965|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155206966|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
155206967|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
155206968|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
155206969|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
155206970|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
155206971|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Physician Decision|0|||
155206972|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Physician Decision|0|||
155206973|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Physician Decision|0|||
155206974|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Physician Decision|3|||
155206975|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Physician Decision|1|||
155206976|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Physician Decision|1|||
155206977|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155206978|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155206979|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155206980|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Adverse Event|0|||
155206981|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Adverse Event|1|||
155206982|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Adverse Event|1|||
155206983|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206984|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206985|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206986|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206987|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
155206988|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206989|NCT05201703|560194561|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
155206990|NCT05201703|560194562|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
155206991|NCT05201703|560194561|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
155206992|NCT05201703|560194562|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
155206993|NCT01487200|560194563|FG000|Overall Study|Withdrawal by Subject|0|||
155206994|NCT01487200|560194564|FG001|Overall Study|Withdrawal by Subject|1|||
155206995|NCT01487200|560194565|FG002|Overall Study|Withdrawal by Subject|0|||
155206996|NCT01487200|560194566|FG003|Overall Study|Withdrawal by Subject|0|||
155206997|NCT00496054|560194571|FG000|Overall Study|Adverse Event|1|||
155206998|NCT00496054|560194571|FG000|Overall Study|Lost to Follow-up|7|||
155206999|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207000|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207001|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207002|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207003|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207004|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207005|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207006|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207007|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207008|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207009|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207010|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207011|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207012|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207013|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207014|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
155207015|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
155207016|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
155207017|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207018|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207019|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207020|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207021|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207022|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207023|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207024|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207025|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207026|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207027|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207028|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207029|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207030|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207031|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207032|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
155207033|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207034|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207035|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207036|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207037|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207038|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207039|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207040|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207041|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207042|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207043|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207044|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207045|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
155207046|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207047|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207048|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207049|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207050|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207051|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207052|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207053|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207054|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207055|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207056|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207057|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207058|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207059|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207060|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207061|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207062|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207063|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
155207064|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207065|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207066|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207067|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207068|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207069|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207070|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207071|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207072|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207073|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207074|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207075|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207076|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207077|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
155207078|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207079|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207080|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207081|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207082|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207083|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207084|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207085|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207086|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207087|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207088|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207089|NCT01737697|560194572|FG000|Subacute Phase|Adverse Event|0|||
155207090|NCT01737697|560194573|FG001|Subacute Phase|Adverse Event|0|||
155207091|NCT01737697|560194574|FG002|Subacute Phase|Adverse Event|0|||
155207092|NCT01737697|560194575|FG003|Subacute Phase|Adverse Event|0|||
155207093|NCT01737697|560194576|FG004|Subacute Phase|Adverse Event|0|||
155207094|NCT01737697|560194577|FG005|Subacute Phase|Adverse Event|1|||
155207095|NCT01737697|560194578|FG006|Subacute Phase|Adverse Event|1|||
155207096|NCT01737697|560194579|FG007|Subacute Phase|Adverse Event|1|||
155207097|NCT01737697|560194580|FG008|Subacute Phase|Adverse Event|1|||
155207098|NCT01737697|560194581|FG009|Subacute Phase|Adverse Event|1|||
155207099|NCT01737697|560194582|FG010|Subacute Phase|Adverse Event|4|||
155207100|NCT01737697|560194583|FG011|Subacute Phase|Adverse Event|1|||
155207101|NCT01737697|560194584|FG012|Subacute Phase|Adverse Event|1|||
155207102|NCT01737697|560194585|FG013|Subacute Phase|Adverse Event|0|||
155207103|NCT01737697|560194586|FG014|Subacute Phase|Adverse Event|0|||
155207104|NCT01737697|560194572|FG000|Subacute Phase|Withdrawal by Subject|0|||
155207105|NCT01737697|560194573|FG001|Subacute Phase|Withdrawal by Subject|0|||
155207106|NCT01737697|560194574|FG002|Subacute Phase|Withdrawal by Subject|0|||
155207107|NCT01737697|560194575|FG003|Subacute Phase|Withdrawal by Subject|0|||
155207108|NCT01737697|560194576|FG004|Subacute Phase|Withdrawal by Subject|0|||
155207109|NCT01737697|560194577|FG005|Subacute Phase|Withdrawal by Subject|1|||
155207110|NCT01737697|560194578|FG006|Subacute Phase|Withdrawal by Subject|0|||
155207111|NCT01737697|560194579|FG007|Subacute Phase|Withdrawal by Subject|2|||
155207112|NCT01737697|560194580|FG008|Subacute Phase|Withdrawal by Subject|0|||
155207113|NCT01737697|560194581|FG009|Subacute Phase|Withdrawal by Subject|1|||
155207114|NCT01737697|560194582|FG010|Subacute Phase|Withdrawal by Subject|0|||
155207115|NCT01737697|560194583|FG011|Subacute Phase|Withdrawal by Subject|1|||
155207116|NCT01737697|560194584|FG012|Subacute Phase|Withdrawal by Subject|1|||
155207117|NCT01737697|560194585|FG013|Subacute Phase|Withdrawal by Subject|1|||
155207118|NCT01737697|560194586|FG014|Subacute Phase|Withdrawal by Subject|0|||
155207119|NCT01737697|560194572|FG000|Subacute Phase|Lost to Follow-up|0|||
155207120|NCT01737697|560194573|FG001|Subacute Phase|Lost to Follow-up|0|||
155207121|NCT01737697|560194574|FG002|Subacute Phase|Lost to Follow-up|0|||
155207122|NCT01737697|560194575|FG003|Subacute Phase|Lost to Follow-up|0|||
155207123|NCT01737697|560194576|FG004|Subacute Phase|Lost to Follow-up|0|||
155207124|NCT01737697|560194577|FG005|Subacute Phase|Lost to Follow-up|0|||
155207125|NCT01737697|560194578|FG006|Subacute Phase|Lost to Follow-up|0|||
155207126|NCT01737697|560194579|FG007|Subacute Phase|Lost to Follow-up|0|||
155207127|NCT01737697|560194580|FG008|Subacute Phase|Lost to Follow-up|0|||
155207128|NCT01737697|560194581|FG009|Subacute Phase|Lost to Follow-up|0|||
155207129|NCT01737697|560194582|FG010|Subacute Phase|Lost to Follow-up|0|||
155207130|NCT01737697|560194583|FG011|Subacute Phase|Lost to Follow-up|0|||
155207131|NCT01737697|560194584|FG012|Subacute Phase|Lost to Follow-up|0|||
155207132|NCT01737697|560194585|FG013|Subacute Phase|Lost to Follow-up|0|||
155207133|NCT01737697|560194586|FG014|Subacute Phase|Lost to Follow-up|1|||
155207134|NCT01737697|560194572|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
155207135|NCT01737697|560194573|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
155207136|NCT01737697|560194574|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
155207137|NCT01737697|560194575|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
155207138|NCT01737697|560194576|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
155207139|NCT01737697|560194577|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
155207140|NCT01737697|560194578|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
155207141|NCT01737697|560194579|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
155207142|NCT01737697|560194580|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
155207143|NCT01737697|560194581|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
155207144|NCT01737697|560194582|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
155207145|NCT01737697|560194583|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
155207146|NCT01737697|560194584|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
155207147|NCT01737697|560194585|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
155207148|NCT01737697|560194586|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
155207149|NCT01737697|560194572|FG000|Subacute Phase|Protocol Violation|0|||
155207150|NCT01737697|560194573|FG001|Subacute Phase|Protocol Violation|0|||
155207151|NCT01737697|560194574|FG002|Subacute Phase|Protocol Violation|0|||
155207152|NCT01737697|560194575|FG003|Subacute Phase|Protocol Violation|0|||
155207153|NCT01737697|560194576|FG004|Subacute Phase|Protocol Violation|0|||
155207154|NCT01737697|560194577|FG005|Subacute Phase|Protocol Violation|1|||
155207155|NCT01737697|560194578|FG006|Subacute Phase|Protocol Violation|0|||
155207156|NCT01737697|560194579|FG007|Subacute Phase|Protocol Violation|0|||
155207157|NCT01737697|560194580|FG008|Subacute Phase|Protocol Violation|0|||
155207158|NCT01737697|560194581|FG009|Subacute Phase|Protocol Violation|0|||
155207159|NCT01737697|560194582|FG010|Subacute Phase|Protocol Violation|1|||
155207160|NCT01737697|560194583|FG011|Subacute Phase|Protocol Violation|0|||
155207161|NCT01737697|560194584|FG012|Subacute Phase|Protocol Violation|0|||
155207162|NCT01737697|560194585|FG013|Subacute Phase|Protocol Violation|0|||
155207163|NCT01737697|560194586|FG014|Subacute Phase|Protocol Violation|0|||
155207164|NCT01737697|560194572|FG000|Subacute Phase|Physician Decision|0|||
155207165|NCT01737697|560194573|FG001|Subacute Phase|Physician Decision|0|||
155207166|NCT01737697|560194574|FG002|Subacute Phase|Physician Decision|0|||
155207167|NCT01737697|560194575|FG003|Subacute Phase|Physician Decision|0|||
155207168|NCT01737697|560194576|FG004|Subacute Phase|Physician Decision|0|||
155207169|NCT01737697|560194577|FG005|Subacute Phase|Physician Decision|0|||
155207170|NCT01737697|560194578|FG006|Subacute Phase|Physician Decision|0|||
155207171|NCT01737697|560194579|FG007|Subacute Phase|Physician Decision|0|||
155207172|NCT01737697|560194580|FG008|Subacute Phase|Physician Decision|1|||
155207173|NCT01737697|560194581|FG009|Subacute Phase|Physician Decision|0|||
155207174|NCT01737697|560194582|FG010|Subacute Phase|Physician Decision|0|||
155207175|NCT01737697|560194583|FG011|Subacute Phase|Physician Decision|0|||
155207176|NCT01737697|560194584|FG012|Subacute Phase|Physician Decision|0|||
155207177|NCT01737697|560194585|FG013|Subacute Phase|Physician Decision|0|||
155207178|NCT01737697|560194586|FG014|Subacute Phase|Physician Decision|0|||
155207179|NCT01737697|560194572|FG000|Subacute Phase|Death|0|||
155207180|NCT01737697|560194573|FG001|Subacute Phase|Death|0|||
155207181|NCT01737697|560194574|FG002|Subacute Phase|Death|0|||
155207182|NCT01737697|560194575|FG003|Subacute Phase|Death|0|||
155207183|NCT01737697|560194576|FG004|Subacute Phase|Death|0|||
155207184|NCT01737697|560194577|FG005|Subacute Phase|Death|0|||
155207185|NCT01737697|560194578|FG006|Subacute Phase|Death|0|||
155207186|NCT01737697|560194579|FG007|Subacute Phase|Death|0|||
155207187|NCT01737697|560194580|FG008|Subacute Phase|Death|0|||
155207188|NCT01737697|560194581|FG009|Subacute Phase|Death|0|||
155207189|NCT01737697|560194582|FG010|Subacute Phase|Death|1|||
155207190|NCT01737697|560194583|FG011|Subacute Phase|Death|0|||
155207191|NCT01737697|560194584|FG012|Subacute Phase|Death|0|||
155207192|NCT01737697|560194585|FG013|Subacute Phase|Death|0|||
155207193|NCT01737697|560194586|FG014|Subacute Phase|Death|0|||
155207194|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
155207195|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
155207196|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
155207197|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207198|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207199|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207200|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207201|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207202|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207203|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207204|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207205|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
155207206|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207207|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
155207208|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207209|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207210|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207211|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207212|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207213|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207214|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207215|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207216|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
155207217|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
155207218|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
155207219|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207220|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207221|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207222|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207223|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207224|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207225|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207226|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207227|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
155207228|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
155207229|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207230|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207231|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207232|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207233|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207234|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207235|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207236|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207237|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207238|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
155207239|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
155207240|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
155207241|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207242|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207243|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207244|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207245|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207246|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207247|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207248|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207249|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207250|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
155207251|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
155207252|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207253|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207254|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207255|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207256|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207257|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207258|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207259|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207260|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207261|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
155207262|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207263|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207264|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207265|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207266|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207267|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207268|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207269|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207270|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207271|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207272|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207273|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207274|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207275|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
155207276|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
155207277|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207278|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207279|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207280|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207281|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207282|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207283|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207284|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207285|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207286|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207287|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
155207288|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207289|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207290|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207291|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207292|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207293|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207294|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207295|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207296|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
155207297|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
155207298|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
155207299|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207300|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207301|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207302|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207303|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207304|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207305|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207306|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207307|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
155207308|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
155207309|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
155207310|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207311|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207312|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207313|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207314|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207315|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207316|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207317|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207318|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
155207319|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207320|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
155207321|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207322|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207323|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207324|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207325|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207326|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207327|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207328|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207329|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
155207330|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207331|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207332|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207333|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207334|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207335|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207336|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207337|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207338|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207339|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207340|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207341|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207342|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207343|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
155207344|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
155207345|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
155207346|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
155207347|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207348|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207349|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207350|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207351|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207352|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207353|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207354|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207355|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
155207356|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207357|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207358|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207359|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207360|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207361|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207362|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207363|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207364|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207365|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
155207366|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
155207367|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
155207368|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
155207369|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207370|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207371|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207372|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207373|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207374|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207375|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207376|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
155207377|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
155207378|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207379|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
155207380|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207381|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207382|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207383|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207384|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207385|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207386|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207387|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207388|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
155207389|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207390|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207391|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207392|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207393|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207394|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207395|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207396|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207397|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207398|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207399|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
155207400|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
155207401|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207402|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207403|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207404|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207405|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207406|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207407|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207408|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207409|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207410|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207411|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
155207412|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207413|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207414|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207415|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207416|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207417|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207418|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207419|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207420|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207421|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
155207422|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207423|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207424|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207425|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207426|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207427|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207428|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207429|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207430|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207431|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
155207432|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207433|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207434|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207435|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207436|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207437|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207438|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207439|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207440|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207441|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207442|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207443|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207444|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
155207445|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207446|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
155207447|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207448|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207449|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207450|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207451|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207452|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207453|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207454|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207455|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
155207456|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207457|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
155207458|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207459|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207460|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207461|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207462|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207463|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207464|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207465|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207466|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
155207467|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207468|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
155207469|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207470|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207471|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207472|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207473|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207474|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207475|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207476|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207477|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
155207478|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207479|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
155207480|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
155207481|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
155207482|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
155207483|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
155207484|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
155207485|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
155207486|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
155207487|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
155207488|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
155207489|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
155207490|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
155207491|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
155207492|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
155207493|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
155207494|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
155207495|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
155207496|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
155207497|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
155207498|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
155207499|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
155207500|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
155207501|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
155207502|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207503|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207504|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207505|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207506|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207507|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207508|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207509|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207510|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207511|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207512|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
155207513|NCT01950741|560194602|FG000|Overall Study|Lost to Follow-up|1|||
155207514|NCT01950741|560194602|FG000|Overall Study|Death|1|||
155207515|NCT01950741|560194602|FG000|Overall Study|Withdrawal by Subject|1|||
155207516|NCT00471328|560194607|FG000|Core Phase|Adverse Event|18|||
155207517|NCT00471328|560194608|FG001|Core Phase|Adverse Event|6|||
155207518|NCT00471328|560194607|FG000|Core Phase|Death|8|||
155207519|NCT00471328|560194608|FG001|Core Phase|Death|4|||
155207520|NCT00471328|560194607|FG000|Core Phase|Withdrawal by Subject|2|||
155207521|NCT00471328|560194608|FG001|Core Phase|Withdrawal by Subject|2|||
155207522|NCT00471328|560194607|FG000|Core Phase|Abnormal laboratory value|1|||
155207523|NCT00471328|560194608|FG001|Core Phase|Abnormal laboratory value|0|||
155207524|NCT00471328|560194607|FG000|Core Phase|Disease Progression|78|||
155207525|NCT00471328|560194608|FG001|Core Phase|Disease Progression|53|||
155207526|NCT00471328|560194607|FG000|Core Phase|Administrative Problem|0|||
155207527|NCT00471328|560194608|FG001|Core Phase|Administrative Problem|1|||
155207528|NCT00471328|560194607|FG000|Core Phase|Protocol Deviation|0|||
155207529|NCT00471328|560194608|FG001|Core Phase|Protocol Deviation|1|||
155207530|NCT00471328|560194607|FG000|Extension Phase|Adverse Event|3|||
155207531|NCT00471328|560194608|FG001|Extension Phase|Adverse Event|12|||
155207532|NCT00471328|560194607|FG000|Extension Phase|Withdrawal by Subject|0|||
155207533|NCT00471328|560194608|FG001|Extension Phase|Withdrawal by Subject|2|||
155207534|NCT00471328|560194607|FG000|Extension Phase|Death|1|||
155207535|NCT00471328|560194608|FG001|Extension Phase|Death|7|||
155207536|NCT00471328|560194607|FG000|Extension Phase|Protocol Deviation|3|||
155207537|NCT00471328|560194608|FG001|Extension Phase|Protocol Deviation|1|||
155207538|NCT00471328|560194607|FG000|Extension Phase|Treatment duration as per protocol|0|||
155207539|NCT00471328|560194608|FG001|Extension Phase|Treatment duration as per protocol|1|||
155207540|NCT00471328|560194607|FG000|Extension Phase|Disease Progression|32|||
155207541|NCT00471328|560194608|FG001|Extension Phase|Disease Progression|44|||
155207542|NCT00471328|560194607|FG000|Extension Phase|New cancer Therapy|1|||
155207543|NCT00471328|560194608|FG001|Extension Phase|New cancer Therapy|0|||
155207544|NCT00471328|560194607|FG000|Extension Phase|Administrative Problem|1|||
155207545|NCT00471328|560194608|FG001|Extension Phase|Administrative Problem|0|||
155207546|NCT04051008|560194609|FG000|Overall Study|Withdrawal by Subject|2|||
155207547|NCT04051008|560194610|FG001|Overall Study|Withdrawal by Subject|0|||
155207548|NCT04051008|560194611|FG002|Overall Study|Withdrawal by Subject|1|||
155207549|NCT02233647|560194612|FG000|Overall Study|Adverse Event|1|||
155207550|NCT00458211|560194616|FG000|Overall Study|Lack of Efficacy|12|||
155207551|NCT00458211|560194616|FG000|Overall Study|Withdrawal by Subject|2|||
155207552|NCT00458211|560194616|FG000|Overall Study|Protocol Violation|2|||
155207553|NCT04342897|560194617|FG000|Overall Study|Death|7|||
155207554|NCT04342897|560194618|FG001|Overall Study|Death|4|||
155207555|NCT04342897|560194617|FG000|Overall Study|Lost to Follow-up|6|||
155207556|NCT04342897|560194618|FG001|Overall Study|Lost to Follow-up|6|||
155207557|NCT04342897|560194617|FG000|Overall Study|Withdrawal by Subject|1|||
155207558|NCT04342897|560194618|FG001|Overall Study|Withdrawal by Subject|2|||
155207559|NCT04600921|560194628|FG000|Overall Study|Withdrawal by Subject|3|||
155207560|NCT04600921|560194629|FG001|Overall Study|Withdrawal by Subject|5|||
155207561|NCT04600921|560194628|FG000|Overall Study|Death|0|||
155207562|NCT04600921|560194629|FG001|Overall Study|Death|1|||
155207563|NCT05425745|560194633|FG000|Overall Study|Withdrawal of Consent|3|||
155207564|NCT05425745|560194634|FG001|Overall Study|Withdrawal of Consent|3|||
155207565|NCT05425745|560194633|FG000|Overall Study|Death|2|||
155207566|NCT05425745|560194634|FG001|Overall Study|Death|3|||
155207567|NCT05425745|560194633|FG000|Overall Study|Lost to Follow-up|1|||
155207568|NCT05425745|560194634|FG001|Overall Study|Lost to Follow-up|2|||
155207569|NCT05425745|560194633|FG000|Overall Study|Adverse Event|0|||
155207570|NCT05425745|560194634|FG001|Overall Study|Adverse Event|1|||
155207571|NCT05425745|560194633|FG000|Overall Study|Did not return for end of study visit|0|||
155207572|NCT05425745|560194634|FG001|Overall Study|Did not return for end of study visit|1|||
155207573|NCT05425745|560194633|FG000|Overall Study|End of study visit completed by phone|1|||
155207574|NCT05425745|560194634|FG001|Overall Study|End of study visit completed by phone|0|||
155207575|NCT05425745|560194633|FG000|Overall Study|Subject decision|1|||
155207576|NCT05425745|560194634|FG001|Overall Study|Subject decision|0|||
155207577|NCT00524368|560196330|FG000|Overall Study|Adverse Event|10|||
155207578|NCT00524368|560196331|FG001|Overall Study|Adverse Event|12|||
155207579|NCT00524368|560196330|FG000|Overall Study|Lost to Follow-up|9|||
155207580|NCT00524368|560196331|FG001|Overall Study|Lost to Follow-up|13|||
155207581|NCT00524368|560196330|FG000|Overall Study|Withdrawal by Subject|4|||
155207582|NCT00524368|560196331|FG001|Overall Study|Withdrawal by Subject|5|||
155207583|NCT00524368|560196330|FG000|Overall Study|Non-compliant|8|||
155207584|NCT00524368|560196331|FG001|Overall Study|Non-compliant|9|||
155207585|NCT00524368|560196330|FG000|Overall Study|Reached a Virologic Endpoint|3|||
155207586|NCT00524368|560196331|FG001|Overall Study|Reached a Virologic Endpoint|2|||
155207587|NCT00524368|560196330|FG000|Overall Study|Sponsor's Decision|2|||
155207588|NCT00524368|560196331|FG001|Overall Study|Sponsor's Decision|0|||
155207589|NCT00524368|560196330|FG000|Overall Study|Ineligible to Continue the study|2|||
155207590|NCT00524368|560196331|FG001|Overall Study|Ineligible to Continue the study|5|||
155207591|NCT00524368|560196330|FG000|Overall Study|Other|3|||
155207592|NCT00524368|560196331|FG001|Overall Study|Other|2|||
155207593|NCT04023526|560196332|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
155207594|NCT04023526|560196333|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
155207595|NCT04023526|560196332|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
155207596|NCT04023526|560196333|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
155207597|NCT00793403|560196340|FG000|Overall Study|Other|73|||
155207598|NCT00842712|560196343|FG000|Safety Run-in Part|Adverse Event|0|||
155207599|NCT00842712|560196344|FG001|Safety Run-in Part|Adverse Event|1|||
155207600|NCT00842712|560196345|FG002|Safety Run-in Part|Adverse Event|0|||
155207601|NCT00842712|560196346|FG003|Safety Run-in Part|Adverse Event|0|||
155207602|NCT00842712|560196347|FG004|Safety Run-in Part|Adverse Event|0|||
155207603|NCT00842712|560196348|FG005|Safety Run-in Part|Adverse Event|0|||
155207604|NCT00842712|560196349|FG006|Safety Run-in Part|Adverse Event|0|||
155207605|NCT00842712|560196343|FG000|Safety Run-in Part|Progressive disease|3|||
155207606|NCT00842712|560196344|FG001|Safety Run-in Part|Progressive disease|1|||
155207607|NCT00842712|560196345|FG002|Safety Run-in Part|Progressive disease|0|||
155207608|NCT00842712|560196346|FG003|Safety Run-in Part|Progressive disease|1|||
155207609|NCT00842712|560196347|FG004|Safety Run-in Part|Progressive disease|0|||
155207610|NCT00842712|560196348|FG005|Safety Run-in Part|Progressive disease|0|||
155207611|NCT00842712|560196349|FG006|Safety Run-in Part|Progressive disease|0|||
155207612|NCT00842712|560196343|FG000|Randomized Part|Randomized but not treated|0|||
155207613|NCT00842712|560196344|FG001|Randomized Part|Randomized but not treated|0|||
155207614|NCT00842712|560196345|FG002|Randomized Part|Randomized but not treated|0|||
155207615|NCT00842712|560196346|FG003|Randomized Part|Randomized but not treated|0|||
155207616|NCT00842712|560196347|FG004|Randomized Part|Randomized but not treated|0|||
155207617|NCT00842712|560196348|FG005|Randomized Part|Randomized but not treated|1|||
155207618|NCT00842712|560196349|FG006|Randomized Part|Randomized but not treated|4|||
155207619|NCT00842712|560196343|FG000|Randomized Part|Ongoing at cut-off date|0|||
155207620|NCT00842712|560196344|FG001|Randomized Part|Ongoing at cut-off date|0|||
155207621|NCT00842712|560196345|FG002|Randomized Part|Ongoing at cut-off date|0|||
155207622|NCT00842712|560196346|FG003|Randomized Part|Ongoing at cut-off date|0|||
155207623|NCT00842712|560196347|FG004|Randomized Part|Ongoing at cut-off date|0|||
155207624|NCT00842712|560196348|FG005|Randomized Part|Ongoing at cut-off date|0|||
155207625|NCT00842712|560196349|FG006|Randomized Part|Ongoing at cut-off date|2|||
155207626|NCT00410046|560196350|FG000|Overall Study|Adverse Event|3|||
155207627|NCT00410046|560196350|FG000|Overall Study|Withdrawal by Subject|1|||
155207628|NCT00410046|560196350|FG000|Overall Study|Lost to Follow-up|1|||
155207629|NCT02141282|560196358|FG000|Overall Study|Adverse event, not related to progression|8|||
155207630|NCT02141282|560196359|FG001|Overall Study|Adverse event, not related to progression|1|||
155207631|NCT02141282|560196360|FG002|Overall Study|Adverse event, not related to progression|3|||
155207632|NCT02141282|560196361|FG003|Overall Study|Adverse event, not related to progression|1|||
155207633|NCT02141282|560196358|FG000|Overall Study|Adverse event, related to progression|1|||
155207634|NCT02141282|560196359|FG001|Overall Study|Adverse event, related to progression|0|||
155207635|NCT02141282|560196360|FG002|Overall Study|Adverse event, related to progression|2|||
155207636|NCT02141282|560196361|FG003|Overall Study|Adverse event, related to progression|0|||
155207637|NCT02141282|560196358|FG000|Overall Study|COVID-19 infection|1|||
155207638|NCT02141282|560196359|FG001|Overall Study|COVID-19 infection|0|||
155207639|NCT02141282|560196360|FG002|Overall Study|COVID-19 infection|0|||
155207640|NCT02141282|560196361|FG003|Overall Study|COVID-19 infection|0|||
155207641|NCT02141282|560196358|FG000|Overall Study|Lost to Follow-up|0|||
155207642|NCT02141282|560196359|FG001|Overall Study|Lost to Follow-up|0|||
155207643|NCT02141282|560196360|FG002|Overall Study|Lost to Follow-up|4|||
155207644|NCT02141282|560196361|FG003|Overall Study|Lost to Follow-up|2|||
155207645|NCT02141282|560196358|FG000|Overall Study|Other, not specified|14|||
155207646|NCT02141282|560196359|FG001|Overall Study|Other, not specified|11|||
155207647|NCT02141282|560196360|FG002|Overall Study|Other, not specified|23|||
155207648|NCT02141282|560196361|FG003|Overall Study|Other, not specified|9|||
155207649|NCT02141282|560196358|FG000|Overall Study|Progressive disease, Richter's|4|||
155207650|NCT02141282|560196359|FG001|Overall Study|Progressive disease, Richter's|1|||
155207651|NCT02141282|560196360|FG002|Overall Study|Progressive disease, Richter's|1|||
155207652|NCT02141282|560196361|FG003|Overall Study|Progressive disease, Richter's|1|||
155207653|NCT02141282|560196358|FG000|Overall Study|Progressive disease per protocol|12|||
155207654|NCT02141282|560196359|FG001|Overall Study|Progressive disease per protocol|7|||
155207655|NCT02141282|560196360|FG002|Overall Study|Progressive disease per protocol|9|||
155207656|NCT02141282|560196361|FG003|Overall Study|Progressive disease per protocol|2|||
155207657|NCT02141282|560196358|FG000|Overall Study|Stem cell transplant|1|||
155207658|NCT02141282|560196359|FG001|Overall Study|Stem cell transplant|0|||
155207659|NCT02141282|560196360|FG002|Overall Study|Stem cell transplant|1|||
155207660|NCT02141282|560196361|FG003|Overall Study|Stem cell transplant|0|||
155207661|NCT02141282|560196358|FG000|Overall Study|Study terminated by Sponsor|0|||
155207662|NCT02141282|560196359|FG001|Overall Study|Study terminated by Sponsor|1|||
155207663|NCT02141282|560196360|FG002|Overall Study|Study terminated by Sponsor|0|||
155207664|NCT02141282|560196361|FG003|Overall Study|Study terminated by Sponsor|0|||
155207665|NCT02141282|560196358|FG000|Overall Study|Subject non-compliance|0|||
155207666|NCT02141282|560196359|FG001|Overall Study|Subject non-compliance|0|||
155207667|NCT02141282|560196360|FG002|Overall Study|Subject non-compliance|1|||
155207668|NCT02141282|560196361|FG003|Overall Study|Subject non-compliance|0|||
155207669|NCT02141282|560196358|FG000|Overall Study|Withdrew consent|2|||
155207670|NCT02141282|560196359|FG001|Overall Study|Withdrew consent|0|||
155207671|NCT02141282|560196360|FG002|Overall Study|Withdrew consent|4|||
155207672|NCT02141282|560196361|FG003|Overall Study|Withdrew consent|0|||
155207673|NCT03312933|560196362|FG000|Overall Study|Protocol Violation|15|||
155207674|NCT03312933|560196362|FG000|Overall Study|Lost to Follow-up|36|||
155207675|NCT03312933|560196362|FG000|Overall Study|Withdrawal by Subject|3|||
155207676|NCT01752907|560196364|FG000|Overall Study|Withdrawal by Subject|4|||
155207677|NCT01752907|560196365|FG001|Overall Study|Withdrawal by Subject|10|||
155207678|NCT01752907|560196364|FG000|Overall Study|Lost to Follow-up|2|||
155207679|NCT01752907|560196365|FG001|Overall Study|Lost to Follow-up|1|||
155207680|NCT01752907|560196364|FG000|Overall Study|Decision by Sponsor|6|||
155207681|NCT01752907|560196365|FG001|Overall Study|Decision by Sponsor|9|||
155207682|NCT03098550|560196366|FG000|Overall Study|Disease Progression|30|||
155207683|NCT03098550|560196367|FG001|Overall Study|Disease Progression|19|||
155207684|NCT03098550|560196368|FG002|Overall Study|Disease Progression|41|||
155207685|NCT03098550|560196366|FG000|Overall Study|Study Drug Toxicity|2|||
155207686|NCT03098550|560196367|FG001|Overall Study|Study Drug Toxicity|1|||
155207687|NCT03098550|560196368|FG002|Overall Study|Study Drug Toxicity|0|||
155207688|NCT03098550|560196366|FG000|Overall Study|Death|1|||
155207689|NCT03098550|560196367|FG001|Overall Study|Death|0|||
155207690|NCT03098550|560196368|FG002|Overall Study|Death|0|||
155207691|NCT03098550|560196366|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
155207692|NCT03098550|560196367|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
155207693|NCT03098550|560196368|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
155207694|NCT03098550|560196366|FG000|Overall Study|Administrative reason by sponsor|0|||
155207695|NCT03098550|560196367|FG001|Overall Study|Administrative reason by sponsor|0|||
155207696|NCT03098550|560196368|FG002|Overall Study|Administrative reason by sponsor|1|||
155207697|NCT03098550|560196366|FG000|Overall Study|Other reasons|2|||
155207698|NCT03098550|560196367|FG001|Overall Study|Other reasons|0|||
155491242|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
155207699|NCT03098550|560196368|FG002|Overall Study|Other reasons|0|||
155207700|NCT01384760|560196369|FG000|Overall Study|Lost to Follow-up|0|||
155207701|NCT01384760|560196370|FG001|Overall Study|Lost to Follow-up|6|||
155207702|NCT01384760|560196369|FG000|Overall Study|Protocol Violation|16|||
155207703|NCT01384760|560196370|FG001|Overall Study|Protocol Violation|0|||
155207704|NCT00630396|560196371|FG000|Overall Study|Death|4|||
155207705|NCT00630396|560196371|FG000|Overall Study|Lost to Follow-up|3|||
155207706|NCT02990910|560196375|FG000|Overall Study|Lack of Efficacy|6|||
155207707|NCT02990910|560196376|FG001|Overall Study|Lack of Efficacy|10|||
155207708|NCT02989194|560196386|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
155207709|NCT02989194|560196387|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
155207710|NCT02989194|560196388|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
155207711|NCT02989194|560196386|FG000|Overall Study|Lost to Follow-up|0|||
155207712|NCT02989194|560196387|FG001|Overall Study|Lost to Follow-up|1|||
155207713|NCT02989194|560196388|FG002|Overall Study|Lost to Follow-up|0|||
155207714|NCT02989194|560196386|FG000|Overall Study|Withdrawal by Subject|0|||
155207715|NCT02989194|560196387|FG001|Overall Study|Withdrawal by Subject|1|||
155207716|NCT02989194|560196388|FG002|Overall Study|Withdrawal by Subject|0|||
155207717|NCT00482612|560196389|FG000|In-treatment Period|No study medication administered|0|||
155207718|NCT00482612|560196390|FG001|In-treatment Period|No study medication administered|0|||
155207719|NCT00482612|560196391|FG002|In-treatment Period|No study medication administered|1|||
155207720|NCT00482612|560196392|FG003|In-treatment Period|No study medication administered|0|||
155207721|NCT00482612|560196389|FG000|Follow-up Period|Other|4|||
155207722|NCT00482612|560196390|FG001|Follow-up Period|Other|2|||
155207723|NCT00482612|560196391|FG002|Follow-up Period|Other|1|||
155207724|NCT00482612|560196392|FG003|Follow-up Period|Other|2|||
155207725|NCT00482612|560196389|FG000|Follow-up Period|Lack of compliance|0|||
155207726|NCT00482612|560196390|FG001|Follow-up Period|Lack of compliance|0|||
155207727|NCT00482612|560196391|FG002|Follow-up Period|Lack of compliance|1|||
155207728|NCT00482612|560196392|FG003|Follow-up Period|Lack of compliance|0|||
155207729|NCT00482612|560196389|FG000|Follow-up Period|Lost to Follow-up|0|||
155207730|NCT00482612|560196390|FG001|Follow-up Period|Lost to Follow-up|4|||
155207731|NCT00482612|560196391|FG002|Follow-up Period|Lost to Follow-up|2|||
155207732|NCT00482612|560196392|FG003|Follow-up Period|Lost to Follow-up|1|||
155207733|NCT00482612|560196389|FG000|Follow-up Period|Adverse Event|4|||
155207734|NCT00482612|560196390|FG001|Follow-up Period|Adverse Event|7|||
155207735|NCT00482612|560196391|FG002|Follow-up Period|Adverse Event|9|||
155207736|NCT00482612|560196392|FG003|Follow-up Period|Adverse Event|0|||
155207737|NCT00482612|560196389|FG000|Follow-up Period|Lack of Efficacy|2|||
155207738|NCT00482612|560196390|FG001|Follow-up Period|Lack of Efficacy|0|||
155207739|NCT00482612|560196391|FG002|Follow-up Period|Lack of Efficacy|1|||
155207740|NCT00482612|560196392|FG003|Follow-up Period|Lack of Efficacy|0|||
155207741|NCT00482612|560196389|FG000|Follow-up Period|Withdrawal by Subject|3|||
155207742|NCT00482612|560196390|FG001|Follow-up Period|Withdrawal by Subject|5|||
155207743|NCT00482612|560196391|FG002|Follow-up Period|Withdrawal by Subject|7|||
155207744|NCT00482612|560196392|FG003|Follow-up Period|Withdrawal by Subject|2|||
155207745|NCT00482612|560196389|FG000|Follow-up Period|Reasons not related to trial|1|||
155207746|NCT00482612|560196390|FG001|Follow-up Period|Reasons not related to trial|0|||
155207747|NCT00482612|560196391|FG002|Follow-up Period|Reasons not related to trial|1|||
155207748|NCT00482612|560196392|FG003|Follow-up Period|Reasons not related to trial|3|||
155207749|NCT03506815|560196393|FG000|Overall Study|Adverse Event|8|||
155207750|NCT03506815|560196394|FG001|Overall Study|Adverse Event|0|||
155207751|NCT03506815|560196393|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
155207752|NCT03506815|560196394|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
155207753|NCT03506815|560196393|FG000|Overall Study|Protocol Violation|1|||
155207754|NCT03506815|560196394|FG001|Overall Study|Protocol Violation|0|||
155207755|NCT03506815|560196393|FG000|Overall Study|Elective Surgery|1|||
155207756|NCT03506815|560196394|FG001|Overall Study|Elective Surgery|0|||
155207757|NCT04160091|560196395|FG000|Overall Study|Terminated by Sponsor|7|||
155207758|NCT04160091|560196396|FG001|Overall Study|Terminated by Sponsor|3|||
155207759|NCT04160091|560196397|FG002|Overall Study|Terminated by Sponsor|5|||
155207760|NCT04160091|560196398|FG003|Overall Study|Terminated by Sponsor|2|||
155207761|NCT04160091|560196395|FG000|Overall Study|Noncompliance|0|||
155207762|NCT04160091|560196396|FG001|Overall Study|Noncompliance|0|||
155207763|NCT04160091|560196397|FG002|Overall Study|Noncompliance|0|||
155207764|NCT04160091|560196398|FG003|Overall Study|Noncompliance|1|||
155207765|NCT04160091|560196395|FG000|Overall Study|Withdrawal by Subject|0|||
155207766|NCT04160091|560196396|FG001|Overall Study|Withdrawal by Subject|0|||
155207767|NCT04160091|560196397|FG002|Overall Study|Withdrawal by Subject|0|||
155207768|NCT04160091|560196398|FG003|Overall Study|Withdrawal by Subject|1|||
155207769|NCT00381095|560196402|FG000|Overall Study|Death|3|||
155207770|NCT00381095|560196403|FG001|Overall Study|Death|4|||
155207771|NCT00381095|560196402|FG000|Overall Study|Lack of Efficacy|2|||
155207772|NCT00381095|560196403|FG001|Overall Study|Lack of Efficacy|4|||
155207773|NCT00381095|560196402|FG000|Overall Study|Other|2|||
155207774|NCT00381095|560196403|FG001|Overall Study|Other|2|||
155207775|NCT00381095|560196402|FG000|Overall Study|Protocol Violation|1|||
155207776|NCT00381095|560196403|FG001|Overall Study|Protocol Violation|1|||
155207777|NCT00381095|560196402|FG000|Overall Study|Withdrawal by Subject|3|||
155207778|NCT00381095|560196403|FG001|Overall Study|Withdrawal by Subject|3|||
155207779|NCT00381095|560196402|FG000|Overall Study|Adverse Event|2|||
155207780|NCT00381095|560196403|FG001|Overall Study|Adverse Event|7|||
155207781|NCT00856284|560196410|FG000|Overall Study|Hyperglycemic rescue|231|||
155207782|NCT00856284|560196411|FG001|Overall Study|Hyperglycemic rescue|201|||
155207783|NCT00856284|560196412|FG002|Overall Study|Hyperglycemic rescue|235|||
155207784|NCT00856284|560196410|FG000|Overall Study|Adverse Event|60|||
155207785|NCT00856284|560196411|FG001|Overall Study|Adverse Event|74|||
155207786|NCT00856284|560196412|FG002|Overall Study|Adverse Event|82|||
155207787|NCT00856284|560196410|FG000|Overall Study|Major protocol deviation|24|||
155207788|NCT00856284|560196411|FG001|Overall Study|Major protocol deviation|16|||
155207789|NCT00856284|560196412|FG002|Overall Study|Major protocol deviation|15|||
155207790|NCT00856284|560196410|FG000|Overall Study|Lost to Follow-up|20|||
155207791|NCT00856284|560196411|FG001|Overall Study|Lost to Follow-up|22|||
155207792|NCT00856284|560196412|FG002|Overall Study|Lost to Follow-up|28|||
155207793|NCT00856284|560196410|FG000|Overall Study|Voluntary withdrawal|48|||
155207794|NCT00856284|560196411|FG001|Overall Study|Voluntary withdrawal|52|||
155207795|NCT00856284|560196412|FG002|Overall Study|Voluntary withdrawal|62|||
155207796|NCT00856284|560196410|FG000|Overall Study|Pregnancy|1|||
155207797|NCT00856284|560196411|FG001|Overall Study|Pregnancy|2|||
155207798|NCT00856284|560196412|FG002|Overall Study|Pregnancy|0|||
155207799|NCT00856284|560196410|FG000|Overall Study|Investigator discretion|9|||
155207800|NCT00856284|560196411|FG001|Overall Study|Investigator discretion|8|||
155207801|NCT00856284|560196412|FG002|Overall Study|Investigator discretion|10|||
155207802|NCT00856284|560196410|FG000|Overall Study|Other|15|||
155207803|NCT00856284|560196411|FG001|Overall Study|Other|17|||
155207804|NCT00856284|560196412|FG002|Overall Study|Other|14|||
155207805|NCT00856284|560196410|FG000|Overall Study|Randomized in error|0|||
155207806|NCT00856284|560196411|FG001|Overall Study|Randomized in error|0|||
155207807|NCT00856284|560196412|FG002|Overall Study|Randomized in error|1|||
155207808|NCT01327885|560196417|FG000|Overall Study|Disease progression-according to RECIST|173|||
155207809|NCT01327885|560196418|FG001|Overall Study|Disease progression-according to RECIST|165|||
155207810|NCT01327885|560196417|FG000|Overall Study|Clinical progression|24|||
155207811|NCT01327885|560196418|FG001|Overall Study|Clinical progression|27|||
155207812|NCT01327885|560196417|FG000|Overall Study|Adverse Event|14|||
155207813|NCT01327885|560196418|FG001|Overall Study|Adverse Event|10|||
155207814|NCT01327885|560196417|FG000|Overall Study|Subject choice|5|||
155207815|NCT01327885|560196418|FG001|Overall Study|Subject choice|10|||
155207816|NCT01327885|560196417|FG000|Overall Study|Other|8|||
155207817|NCT01327885|560196418|FG001|Overall Study|Other|6|||
155207818|NCT01327885|560196417|FG000|Overall Study|Withdrawal of consent from study|3|||
155207819|NCT01327885|560196418|FG001|Overall Study|Withdrawal of consent from study|4|||
155207820|NCT01327885|560196417|FG000|Overall Study|Not treated|1|||
155207821|NCT01327885|560196418|FG001|Overall Study|Not treated|1|||
155207822|NCT01327885|560196417|FG000|Overall Study|Administrative decision|0|||
155207823|NCT01327885|560196418|FG001|Overall Study|Administrative decision|1|||
155207824|NCT04271605|560196421|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
155207825|NCT03138889|560196423|FG000|Overall Study|Withdrawal by Subject|5|||
155207826|NCT03138889|560196424|FG001|Overall Study|Withdrawal by Subject|5|||
155207827|NCT03138889|560196425|FG002|Overall Study|Withdrawal by Subject|0|||
155207828|NCT03138889|560196426|FG003|Overall Study|Withdrawal by Subject|2|||
155207829|NCT03138889|560196427|FG004|Overall Study|Withdrawal by Subject|1|||
155207830|NCT03138889|560196428|FG005|Overall Study|Withdrawal by Subject|3|||
155207831|NCT03138889|560196429|FG006|Overall Study|Withdrawal by Subject|0|||
155207832|NCT03138889|560196430|FG007|Overall Study|Withdrawal by Subject|1|||
155207833|NCT00411645|560196431|FG000|Overall Study|Consent Withdrawn|13|||
155207834|NCT00411645|560196432|FG001|Overall Study|Consent Withdrawn|22|||
155207835|NCT00411645|560196431|FG000|Overall Study|Death|56|||
155207836|NCT00411645|560196432|FG001|Overall Study|Death|135|||
155207837|NCT00411645|560196431|FG000|Overall Study|Investigator/Sponsor Decision|10|||
155207838|NCT00411645|560196432|FG001|Overall Study|Investigator/Sponsor Decision|7|||
155207839|NCT00411645|560196431|FG000|Overall Study|Lost to Follow-up|2|||
155207840|NCT00411645|560196432|FG001|Overall Study|Lost to Follow-up|0|||
155207841|NCT04016285|560196433|FG000|Overall Study|Did not progress to surgery|2|||
155207842|NCT04016285|560196434|FG001|Overall Study|Did not progress to surgery|5|||
155207843|NCT04016285|560196433|FG000|Overall Study|Failed to collect outcome data|5|||
155207844|NCT04016285|560196434|FG001|Overall Study|Failed to collect outcome data|3|||
155207845|NCT01987505|560196435|FG000|Overall Study|Other|9|||
155207846|NCT01987505|560196435|FG000|Overall Study|Withdrawal by Subject|2|||
155207847|NCT01987505|560196435|FG000|Overall Study|Other Reason|2|||
155207848|NCT01987505|560196435|FG000|Overall Study|Lost to Follow-up|15|||
155207849|NCT01987505|560196435|FG000|Overall Study|Investigator Decision|2|||
155207850|NCT01987505|560196435|FG000|Overall Study|Death|4|||
155207851|NCT03042533|560196437|FG000|Overall Study|MD left program|1|||
155207852|NCT03042533|560196438|FG001|Overall Study|MD left program|4|||
155207853|NCT03042533|560196439|FG002|Overall Study|MD left program|1|||
155207854|NCT02794883|560196442|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
155207855|NCT02794883|560196443|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
155207856|NCT02794883|560196444|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
155207857|NCT02794883|560196442|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
155207858|NCT02794883|560196443|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
155207859|NCT02794883|560196444|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
155207860|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
155207861|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
155207862|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
155207863|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
155207864|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
155207865|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
155207866|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
155207867|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
155207868|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
155207869|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
155207870|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
155207871|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
155207872|NCT02794883|560196442|FG000|Follow-up Period (up to 2 Years)|Death|12|||
155207873|NCT02794883|560196443|FG001|Follow-up Period (up to 2 Years)|Death|10|||
155207874|NCT02794883|560196444|FG002|Follow-up Period (up to 2 Years)|Death|10|||
155207875|NCT01366209|560196447|FG000|Overall Study|Adverse Event|6|||
155207876|NCT01366209|560196448|FG001|Overall Study|Adverse Event|7|||
155207877|NCT01366209|560196447|FG000|Overall Study|Withdrawal by Subject|4|||
155207878|NCT01366209|560196448|FG001|Overall Study|Withdrawal by Subject|4|||
155207879|NCT01366209|560196447|FG000|Overall Study|Death|12|||
155207880|NCT01366209|560196448|FG001|Overall Study|Death|19|||
155207881|NCT01366209|560196447|FG000|Overall Study|Lung transplantation|6|||
155207882|NCT01366209|560196448|FG001|Overall Study|Lung transplantation|1|||
155207883|NCT01366209|560196447|FG000|Overall Study|Lost to Follow-up|2|||
155207884|NCT01366209|560196448|FG001|Overall Study|Lost to Follow-up|1|||
155207885|NCT01366209|560196447|FG000|Overall Study|Physician Decision|1|||
155207886|NCT01366209|560196448|FG001|Overall Study|Physician Decision|0|||
155207887|NCT01366209|560196447|FG000|Overall Study|Sponsors decision|0|||
155207888|NCT01366209|560196448|FG001|Overall Study|Sponsors decision|1|||
155207889|NCT01366209|560196447|FG000|Overall Study|Withdrew consent|4|||
155207890|NCT01366209|560196448|FG001|Overall Study|Withdrew consent|3|||
155207891|NCT01053221|560196449|FG000|Overall Study|The study was closed prematurely|5|||
155207892|NCT01053221|560196450|FG001|Overall Study|The study was closed prematurely|9|||
155207893|NCT02266225|560196451|FG000|Overall Study|Lost to Follow-up|2|||
155207894|NCT02266225|560196451|FG000|Overall Study|Death|1|||
155207895|NCT02266225|560196451|FG000|Overall Study|Withdrawal by Subject|13|||
155491243|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
155491244|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
155491245|NCT04419558|561223493|FG000|DB Period (48 Weeks)|Participant Decision|4|||
155491246|NCT04419558|561223494|FG001|DB Period (48 Weeks)|Participant Decision|3|||
155491247|NCT04419558|561223493|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
155491248|NCT04419558|561223494|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
155491249|NCT04419558|561223493|FG000|OLE Period (48 Weeks)|Death|4|||
155491250|NCT04419558|561223494|FG001|OLE Period (48 Weeks)|Death|6|||
155491251|NCT04419558|561223493|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
155491252|NCT04419558|561223494|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
155491253|NCT04419558|561223493|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
155491254|NCT04419558|561223494|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
155491255|NCT03522506|561223495|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155491256|NCT03522506|561223496|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155491257|NCT03522506|561223497|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155491258|NCT03522506|561223498|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155491259|NCT03522506|561223495|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155491260|NCT03522506|561223496|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155491261|NCT03522506|561223497|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155491262|NCT03522506|561223498|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
155491263|NCT03480243|561223499|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
155491264|NCT03480243|561223499|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
155491265|NCT04410991|561223513|FG000|Overall Study|Poor compliance to protocol|5|||
155491266|NCT04410991|561223514|FG001|Overall Study|Poor compliance to protocol|4|||
155207896|NCT00420927|560196452|FG000|Period 1|Adverse Event|19|||
155207897|NCT00420927|560196453|FG001|Period 1|Adverse Event|15|||
155207898|NCT00420927|560196454|FG002|Period 1|Adverse Event|0|||
155491267|NCT04410991|561223513|FG000|Overall Study|Withdrawal by Subject|59|||
155491268|NCT04410991|561223514|FG001|Overall Study|Withdrawal by Subject|55|||
155491269|NCT04410991|561223513|FG000|Overall Study|Other|10|||
155491270|NCT04410991|561223514|FG001|Overall Study|Other|4|||
155207899|NCT00420927|560196455|FG003|Period 1|Adverse Event|0|||
155207900|NCT00420927|560196456|FG004|Period 1|Adverse Event|0|||
155207901|NCT00420927|560196457|FG005|Period 1|Adverse Event|0|||
155207902|NCT00420927|560196458|FG006|Period 1|Adverse Event|0|||
155207903|NCT00420927|560196452|FG000|Period 1|Withdrawal by Subject|7|||
155207904|NCT00420927|560196453|FG001|Period 1|Withdrawal by Subject|12|||
155207905|NCT00420927|560196454|FG002|Period 1|Withdrawal by Subject|0|||
155207906|NCT00420927|560196455|FG003|Period 1|Withdrawal by Subject|0|||
155207907|NCT00420927|560196456|FG004|Period 1|Withdrawal by Subject|0|||
155207908|NCT00420927|560196457|FG005|Period 1|Withdrawal by Subject|0|||
155207909|NCT00420927|560196458|FG006|Period 1|Withdrawal by Subject|0|||
155207910|NCT00420927|560196452|FG000|Period 1|Lost to Follow-up|8|||
155207911|NCT00420927|560196453|FG001|Period 1|Lost to Follow-up|6|||
155207912|NCT00420927|560196454|FG002|Period 1|Lost to Follow-up|0|||
155207913|NCT00420927|560196455|FG003|Period 1|Lost to Follow-up|0|||
155207914|NCT00420927|560196456|FG004|Period 1|Lost to Follow-up|0|||
155207915|NCT00420927|560196457|FG005|Period 1|Lost to Follow-up|0|||
155207916|NCT00420927|560196458|FG006|Period 1|Lost to Follow-up|0|||
155207917|NCT00420927|560196452|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
155207918|NCT00420927|560196453|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
155207919|NCT00420927|560196454|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207920|NCT00420927|560196455|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207921|NCT00420927|560196456|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207922|NCT00420927|560196457|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207923|NCT00420927|560196458|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207924|NCT00420927|560196452|FG000|Period 1|Death|2|||
155207925|NCT00420927|560196453|FG001|Period 1|Death|0|||
155207926|NCT00420927|560196454|FG002|Period 1|Death|0|||
155207927|NCT00420927|560196455|FG003|Period 1|Death|0|||
155207928|NCT00420927|560196456|FG004|Period 1|Death|0|||
155207929|NCT00420927|560196457|FG005|Period 1|Death|0|||
155207930|NCT00420927|560196458|FG006|Period 1|Death|0|||
155207931|NCT00420927|560196452|FG000|Period 1|Subject moved/relocated|0|||
155207932|NCT00420927|560196453|FG001|Period 1|Subject moved/relocated|2|||
155207933|NCT00420927|560196454|FG002|Period 1|Subject moved/relocated|0|||
155207934|NCT00420927|560196455|FG003|Period 1|Subject moved/relocated|0|||
155207935|NCT00420927|560196456|FG004|Period 1|Subject moved/relocated|0|||
155207936|NCT00420927|560196457|FG005|Period 1|Subject moved/relocated|0|||
155207937|NCT00420927|560196458|FG006|Period 1|Subject moved/relocated|0|||
155207938|NCT00420927|560196452|FG000|Period 1|Noncompliant with study drug|1|||
155207939|NCT00420927|560196453|FG001|Period 1|Noncompliant with study drug|1|||
155207940|NCT00420927|560196454|FG002|Period 1|Noncompliant with study drug|0|||
155207941|NCT00420927|560196455|FG003|Period 1|Noncompliant with study drug|0|||
155207942|NCT00420927|560196456|FG004|Period 1|Noncompliant with study drug|0|||
155207943|NCT00420927|560196457|FG005|Period 1|Noncompliant with study drug|0|||
155207944|NCT00420927|560196458|FG006|Period 1|Noncompliant with study drug|0|||
155207945|NCT00420927|560196452|FG000|Period 1|Randomization error|1|||
155207946|NCT00420927|560196453|FG001|Period 1|Randomization error|0|||
155207947|NCT00420927|560196454|FG002|Period 1|Randomization error|0|||
155207948|NCT00420927|560196455|FG003|Period 1|Randomization error|0|||
155207949|NCT00420927|560196456|FG004|Period 1|Randomization error|0|||
155207950|NCT00420927|560196457|FG005|Period 1|Randomization error|0|||
155207951|NCT00420927|560196458|FG006|Period 1|Randomization error|0|||
155207952|NCT00420927|560196452|FG000|Period 1|Suspected tuberculosis/positive test|1|||
155207953|NCT00420927|560196453|FG001|Period 1|Suspected tuberculosis/positive test|1|||
155207954|NCT00420927|560196454|FG002|Period 1|Suspected tuberculosis/positive test|0|||
155207955|NCT00420927|560196455|FG003|Period 1|Suspected tuberculosis/positive test|0|||
155207956|NCT00420927|560196456|FG004|Period 1|Suspected tuberculosis/positive test|0|||
155207957|NCT00420927|560196457|FG005|Period 1|Suspected tuberculosis/positive test|0|||
155207958|NCT00420927|560196458|FG006|Period 1|Suspected tuberculosis/positive test|0|||
155207959|NCT00420927|560196452|FG000|Period 1|Study site closure|0|||
155207960|NCT00420927|560196453|FG001|Period 1|Study site closure|1|||
155207961|NCT00420927|560196454|FG002|Period 1|Study site closure|0|||
155207962|NCT00420927|560196455|FG003|Period 1|Study site closure|0|||
155207963|NCT00420927|560196456|FG004|Period 1|Study site closure|0|||
155207964|NCT00420927|560196457|FG005|Period 1|Study site closure|0|||
155207965|NCT00420927|560196458|FG006|Period 1|Study site closure|0|||
155207966|NCT00420927|560196452|FG000|Period 1|Subject received new diagnosis|0|||
155207967|NCT00420927|560196453|FG001|Period 1|Subject received new diagnosis|2|||
155207968|NCT00420927|560196454|FG002|Period 1|Subject received new diagnosis|0|||
155207969|NCT00420927|560196455|FG003|Period 1|Subject received new diagnosis|0|||
155207970|NCT00420927|560196456|FG004|Period 1|Subject received new diagnosis|0|||
155207971|NCT00420927|560196457|FG005|Period 1|Subject received new diagnosis|0|||
155207972|NCT00420927|560196458|FG006|Period 1|Subject received new diagnosis|0|||
155207973|NCT00420927|560196452|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
155207974|NCT00420927|560196453|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
155207975|NCT00420927|560196454|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
155207976|NCT00420927|560196455|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
155207977|NCT00420927|560196456|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
155207978|NCT00420927|560196457|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
155207979|NCT00420927|560196458|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
155207980|NCT00420927|560196452|FG000|Period 1|Failed to meet entry criteria|8|||
155207981|NCT00420927|560196453|FG001|Period 1|Failed to meet entry criteria|7|||
155207982|NCT00420927|560196454|FG002|Period 1|Failed to meet entry criteria|0|||
155207983|NCT00420927|560196455|FG003|Period 1|Failed to meet entry criteria|0|||
155207984|NCT00420927|560196456|FG004|Period 1|Failed to meet entry criteria|0|||
155207985|NCT00420927|560196457|FG005|Period 1|Failed to meet entry criteria|0|||
155207986|NCT00420927|560196458|FG006|Period 1|Failed to meet entry criteria|0|||
155207987|NCT00420927|560196452|FG000|Period 1|Took prohibited medication|1|||
155207988|NCT00420927|560196453|FG001|Period 1|Took prohibited medication|3|||
155207989|NCT00420927|560196454|FG002|Period 1|Took prohibited medication|0|||
155207990|NCT00420927|560196455|FG003|Period 1|Took prohibited medication|0|||
155207991|NCT00420927|560196456|FG004|Period 1|Took prohibited medication|0|||
155207992|NCT00420927|560196457|FG005|Period 1|Took prohibited medication|0|||
155207993|NCT00420927|560196458|FG006|Period 1|Took prohibited medication|0|||
155207994|NCT00420927|560196452|FG000|Period 2|Adverse Event|0|||
155207995|NCT00420927|560196453|FG001|Period 2|Adverse Event|0|||
155207996|NCT00420927|560196454|FG002|Period 2|Adverse Event|7|||
155207997|NCT00420927|560196455|FG003|Period 2|Adverse Event|3|||
155207998|NCT00420927|560196456|FG004|Period 2|Adverse Event|17|||
155207999|NCT00420927|560196457|FG005|Period 2|Adverse Event|6|||
155208000|NCT00420927|560196458|FG006|Period 2|Adverse Event|20|||
155208001|NCT00420927|560196452|FG000|Period 2|Withdrawal by Subject|0|||
155208002|NCT00420927|560196453|FG001|Period 2|Withdrawal by Subject|0|||
155208003|NCT00420927|560196454|FG002|Period 2|Withdrawal by Subject|1|||
155208004|NCT00420927|560196455|FG003|Period 2|Withdrawal by Subject|3|||
155208005|NCT00420927|560196456|FG004|Period 2|Withdrawal by Subject|11|||
155208006|NCT00420927|560196457|FG005|Period 2|Withdrawal by Subject|2|||
155208007|NCT00420927|560196458|FG006|Period 2|Withdrawal by Subject|12|||
155208008|NCT00420927|560196452|FG000|Period 2|Lost to Follow-up|0|||
155208009|NCT00420927|560196453|FG001|Period 2|Lost to Follow-up|0|||
155208010|NCT00420927|560196454|FG002|Period 2|Lost to Follow-up|2|||
155208011|NCT00420927|560196455|FG003|Period 2|Lost to Follow-up|2|||
155208012|NCT00420927|560196456|FG004|Period 2|Lost to Follow-up|6|||
155208013|NCT00420927|560196457|FG005|Period 2|Lost to Follow-up|3|||
155208014|NCT00420927|560196458|FG006|Period 2|Lost to Follow-up|9|||
155208015|NCT00420927|560196452|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
155208016|NCT00420927|560196453|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
155208017|NCT00420927|560196454|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
155208018|NCT00420927|560196455|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
155208019|NCT00420927|560196456|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
155208020|NCT00420927|560196457|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
155208021|NCT00420927|560196458|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
155208022|NCT00420927|560196452|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
155208023|NCT00420927|560196453|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
155208024|NCT00420927|560196454|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
155208025|NCT00420927|560196455|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
155208026|NCT00420927|560196456|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
155208027|NCT00420927|560196457|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
155208028|NCT00420927|560196458|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
155208029|NCT00420927|560196452|FG000|Period 2|Subject unable to find transportation|0|||
155208030|NCT00420927|560196453|FG001|Period 2|Subject unable to find transportation|0|||
155208031|NCT00420927|560196454|FG002|Period 2|Subject unable to find transportation|0|||
155208032|NCT00420927|560196455|FG003|Period 2|Subject unable to find transportation|0|||
155208033|NCT00420927|560196456|FG004|Period 2|Subject unable to find transportation|0|||
155208034|NCT00420927|560196457|FG005|Period 2|Subject unable to find transportation|0|||
155208035|NCT00420927|560196458|FG006|Period 2|Subject unable to find transportation|1|||
155208036|NCT00420927|560196452|FG000|Period 2|Physician Decision|0|||
155208037|NCT00420927|560196453|FG001|Period 2|Physician Decision|0|||
155208038|NCT00420927|560196454|FG002|Period 2|Physician Decision|0|||
155208039|NCT00420927|560196455|FG003|Period 2|Physician Decision|0|||
155208040|NCT00420927|560196456|FG004|Period 2|Physician Decision|1|||
155208041|NCT00420927|560196457|FG005|Period 2|Physician Decision|1|||
155208042|NCT00420927|560196458|FG006|Period 2|Physician Decision|0|||
155208043|NCT00420927|560196452|FG000|Period 2|Sponsor decision|0|||
155208044|NCT00420927|560196453|FG001|Period 2|Sponsor decision|0|||
155208045|NCT00420927|560196454|FG002|Period 2|Sponsor decision|1|||
155208046|NCT00420927|560196455|FG003|Period 2|Sponsor decision|0|||
155208047|NCT00420927|560196456|FG004|Period 2|Sponsor decision|0|||
155208048|NCT00420927|560196457|FG005|Period 2|Sponsor decision|0|||
155208049|NCT00420927|560196458|FG006|Period 2|Sponsor decision|1|||
155208050|NCT00420927|560196452|FG000|Period 2|Randomization error|0|||
155208051|NCT00420927|560196453|FG001|Period 2|Randomization error|0|||
155208052|NCT00420927|560196454|FG002|Period 2|Randomization error|0|||
155208053|NCT00420927|560196455|FG003|Period 2|Randomization error|0|||
155208054|NCT00420927|560196456|FG004|Period 2|Randomization error|1|||
155208055|NCT00420927|560196457|FG005|Period 2|Randomization error|1|||
155208056|NCT00420927|560196458|FG006|Period 2|Randomization error|0|||
155208057|NCT00420927|560196452|FG000|Period 2|Noncompliant with study drug|0|||
155208058|NCT00420927|560196453|FG001|Period 2|Noncompliant with study drug|0|||
155208059|NCT00420927|560196454|FG002|Period 2|Noncompliant with study drug|0|||
155208060|NCT00420927|560196455|FG003|Period 2|Noncompliant with study drug|1|||
155208061|NCT00420927|560196456|FG004|Period 2|Noncompliant with study drug|0|||
155208062|NCT00420927|560196457|FG005|Period 2|Noncompliant with study drug|0|||
155208063|NCT00420927|560196458|FG006|Period 2|Noncompliant with study drug|2|||
155208064|NCT00420927|560196452|FG000|Period 2|Methotrexate intolerance|0|||
155208065|NCT00420927|560196453|FG001|Period 2|Methotrexate intolerance|0|||
155208066|NCT00420927|560196454|FG002|Period 2|Methotrexate intolerance|0|||
155208067|NCT00420927|560196455|FG003|Period 2|Methotrexate intolerance|0|||
155208068|NCT00420927|560196456|FG004|Period 2|Methotrexate intolerance|0|||
155208069|NCT00420927|560196457|FG005|Period 2|Methotrexate intolerance|0|||
155208070|NCT00420927|560196458|FG006|Period 2|Methotrexate intolerance|1|||
155208071|NCT00420927|560196452|FG000|Period 2|Took prohibited medication|0|||
155208072|NCT00420927|560196453|FG001|Period 2|Took prohibited medication|0|||
155208073|NCT00420927|560196454|FG002|Period 2|Took prohibited medication|0|||
155208074|NCT00420927|560196455|FG003|Period 2|Took prohibited medication|0|||
155208075|NCT00420927|560196456|FG004|Period 2|Took prohibited medication|1|||
155208076|NCT00420927|560196457|FG005|Period 2|Took prohibited medication|0|||
155208077|NCT00420927|560196458|FG006|Period 2|Took prohibited medication|0|||
155208078|NCT00320411|560196459|FG000|Overall Study|No investigational product admin.|4|||
155208079|NCT02088047|560196462|FG000|Overall Study|Withdrawal by Subject|1|||
155208080|NCT02088047|560196463|FG001|Overall Study|Withdrawal by Subject|0|||
155208081|NCT01417234|560196464|FG000|Overall Study|Subject non-compliant|3|||
155208082|NCT02268084|560196466|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
155208083|NCT02268084|560196467|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
155208084|NCT02268084|560196466|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
155208085|NCT02268084|560196467|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
155208086|NCT05227027|560196468|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
155208087|NCT05227027|560196469|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
155208088|NCT00855920|560196470|FG000|Overall Study|Protocol Violation|0|||
155208089|NCT00855920|560196471|FG001|Overall Study|Protocol Violation|0|||
155208090|NCT00855920|560196472|FG002|Overall Study|Protocol Violation|2|||
155208091|NCT00855920|560196470|FG000|Overall Study|Adverse Event|2|||
155208092|NCT00855920|560196471|FG001|Overall Study|Adverse Event|1|||
155208093|NCT00855920|560196472|FG002|Overall Study|Adverse Event|1|||
155208094|NCT00855920|560196470|FG000|Overall Study|Lack of Efficacy|2|||
155208095|NCT00855920|560196471|FG001|Overall Study|Lack of Efficacy|2|||
155208096|NCT00855920|560196472|FG002|Overall Study|Lack of Efficacy|2|||
155208097|NCT00855920|560196470|FG000|Overall Study|Withdrawal by Subject|2|||
155208098|NCT00855920|560196471|FG001|Overall Study|Withdrawal by Subject|3|||
155208099|NCT00855920|560196472|FG002|Overall Study|Withdrawal by Subject|2|||
155208100|NCT00855920|560196470|FG000|Overall Study|Lost to Follow-up|1|||
155208101|NCT00855920|560196471|FG001|Overall Study|Lost to Follow-up|0|||
155208102|NCT00855920|560196472|FG002|Overall Study|Lost to Follow-up|2|||
155208103|NCT00855920|560196470|FG000|Overall Study|Death|0|||
155208104|NCT00855920|560196471|FG001|Overall Study|Death|1|||
155208105|NCT00855920|560196472|FG002|Overall Study|Death|0|||
155208106|NCT00855920|560196470|FG000|Overall Study|Decision by the sponsor|0|||
155208107|NCT00855920|560196471|FG001|Overall Study|Decision by the sponsor|1|||
155208108|NCT00855920|560196472|FG002|Overall Study|Decision by the sponsor|1|||
155208109|NCT00855920|560196470|FG000|Overall Study|Other than specified above|1|||
155208110|NCT00855920|560196471|FG001|Overall Study|Other than specified above|1|||
155208111|NCT00855920|560196472|FG002|Overall Study|Other than specified above|1|||
155208112|NCT00211510|560196473|FG000|Overall Study|Physician Decision|3|||
155208113|NCT00211510|560196474|FG001|Overall Study|Physician Decision|1|||
155208114|NCT00211510|560196473|FG000|Overall Study|Withdrawal by Subject|3|||
155208115|NCT00211510|560196474|FG001|Overall Study|Withdrawal by Subject|1|||
155208116|NCT02216591|560196475|FG000|Overall Study|Lost to Follow-up|0|||
155208117|NCT02216591|560196476|FG001|Overall Study|Lost to Follow-up|1|||
155208118|NCT02837783|560196478|FG000|Overall Study|Adverse Event|1|||
155208119|NCT02837783|560196479|FG001|Overall Study|Adverse Event|0|||
155208120|NCT02837783|560196478|FG000|Overall Study|Other, Not Specified|1|||
155208121|NCT02837783|560196479|FG001|Overall Study|Other, Not Specified|2|||
155208122|NCT01962896|560196480|FG000|Overall Study|Lack of Efficacy|4|||
155208123|NCT03200860|560196481|FG000|Overall Study|Withdrawal by Subject|1|||
155208124|NCT03200860|560196482|FG001|Overall Study|Withdrawal by Subject|0|||
155208125|NCT00844896|560196483|FG000|Overall Study|Lost to Follow-up|12|||
155208126|NCT00844896|560196484|FG001|Overall Study|Lost to Follow-up|16|||
155208127|NCT00844896|560196483|FG000|Overall Study|Parents did not have time to complete|0|||
155208128|NCT00844896|560196484|FG001|Overall Study|Parents did not have time to complete|1|||
155208129|NCT02634320|560196485|FG000|Overall Study|Adverse Event|2|||
155208130|NCT02634320|560196485|FG000|Overall Study|Lost to Follow-up|3|||
155208131|NCT02634320|560196485|FG000|Overall Study|Moved out of area|2|||
155208132|NCT02634320|560196485|FG000|Overall Study|Out of window for study visits|1|||
155208133|NCT02634320|560196485|FG000|Overall Study|Protocol Violation|1|||
155208134|NCT02634320|560196485|FG000|Overall Study|Withdrawal by Subject|5|||
155208135|NCT02634320|560196485|FG000|Overall Study|Lack of Efficacy|2|||
155208136|NCT00838578|560196486|FG000|Overall Study|Protocol Violation|2|||
155208137|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
155208138|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
155208139|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
155208140|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
155208141|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
155208142|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Adverse Event|1|||
155208143|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Adverse Event|1|||
155208144|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Adverse Event|1|||
155208145|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Adverse Event|0|||
155208146|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Adverse Event|0|||
155208147|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208148|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
155208149|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208150|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208151|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208152|NCT03919799|560196487|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208153|NCT03919799|560196488|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
155208154|NCT03919799|560196489|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208155|NCT03919799|560196490|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208156|NCT03919799|560196491|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208157|NCT03919799|560196487|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
155208158|NCT03919799|560196488|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
155208159|NCT03919799|560196489|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
155208160|NCT03919799|560196490|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
155208161|NCT03919799|560196491|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
155208162|NCT00646776|560196494|FG000|Overall Study|Adverse Event|1|||
155208163|NCT00646776|560196495|FG001|Overall Study|Adverse Event|9|||
155208164|NCT00646776|560196494|FG000|Overall Study|Investigator discretion|0|||
155208165|NCT00646776|560196495|FG001|Overall Study|Investigator discretion|4|||
155208166|NCT00439244|560196497|FG000|Overall Study|Adverse Event|5|||
155208167|NCT00439244|560196498|FG001|Overall Study|Adverse Event|2|||
155208168|NCT00439244|560196499|FG002|Overall Study|Adverse Event|3|||
155208169|NCT00439244|560196497|FG000|Overall Study|Withdrawal by Subject|3|||
155208170|NCT00439244|560196498|FG001|Overall Study|Withdrawal by Subject|1|||
155208171|NCT00439244|560196499|FG002|Overall Study|Withdrawal by Subject|2|||
155208172|NCT00439244|560196497|FG000|Overall Study|Lost to Follow-up|2|||
155208173|NCT00439244|560196498|FG001|Overall Study|Lost to Follow-up|1|||
155208174|NCT00439244|560196499|FG002|Overall Study|Lost to Follow-up|2|||
155208175|NCT00439244|560196497|FG000|Overall Study|Death|0|||
155208176|NCT00439244|560196498|FG001|Overall Study|Death|1|||
155208177|NCT00439244|560196499|FG002|Overall Study|Death|0|||
155208178|NCT00439244|560196497|FG000|Overall Study|Protocol Violation|0|||
155208179|NCT00439244|560196498|FG001|Overall Study|Protocol Violation|1|||
155208180|NCT00439244|560196499|FG002|Overall Study|Protocol Violation|0|||
155208181|NCT00439244|560196497|FG000|Overall Study|Administrative problems|1|||
155208182|NCT00439244|560196498|FG001|Overall Study|Administrative problems|0|||
155208183|NCT00439244|560196499|FG002|Overall Study|Administrative problems|0|||
155208184|NCT02762266|560198045|FG000|Overall Study|Physician Decision|2|||
155208185|NCT02762266|560198046|FG001|Overall Study|Physician Decision|0|||
155208186|NCT02961751|560198057|FG000|Overall Study|Lost to Follow-up|11|||
155208187|NCT02961751|560198057|FG000|Overall Study|Physician Decision|2|||
155208188|NCT02961751|560198057|FG000|Overall Study|Not Eligible at Enrollment|1|||
155208189|NCT02961751|560198057|FG000|Overall Study|Protocol Violation|1|||
155208190|NCT02373202|560198059|FG000|Overall Study|Adverse Event|2|||
155208191|NCT02373202|560198060|FG001|Overall Study|Adverse Event|5|||
155208192|NCT02373202|560198061|FG002|Overall Study|Adverse Event|2|||
155208193|NCT02373202|560198062|FG003|Overall Study|Adverse Event|1|||
155208194|NCT02373202|560198059|FG000|Overall Study|Lack of Efficacy|0|||
155208195|NCT02373202|560198060|FG001|Overall Study|Lack of Efficacy|0|||
155208196|NCT02373202|560198061|FG002|Overall Study|Lack of Efficacy|1|||
155208197|NCT02373202|560198062|FG003|Overall Study|Lack of Efficacy|0|||
155208198|NCT02373202|560198059|FG000|Overall Study|Other|0|||
155208199|NCT02373202|560198060|FG001|Overall Study|Other|1|||
155208200|NCT02373202|560198061|FG002|Overall Study|Other|0|||
155208201|NCT02373202|560198062|FG003|Overall Study|Other|0|||
155208202|NCT03010254|560198063|FG000|Overall Study|Adverse Event|0|||
155208203|NCT03010254|560198064|FG001|Overall Study|Adverse Event|1|||
155208204|NCT03010254|560198063|FG000|Overall Study|Lost to Follow-up|4|||
155208205|NCT03010254|560198064|FG001|Overall Study|Lost to Follow-up|0|||
155208206|NCT03010254|560198063|FG000|Overall Study|Withdrawal by Subject|1|||
155208207|NCT03010254|560198064|FG001|Overall Study|Withdrawal by Subject|1|||
155208208|NCT03010254|560198063|FG000|Overall Study|Other|2|||
155208209|NCT03010254|560198064|FG001|Overall Study|Other|3|||
155208210|NCT03909295|560198068|FG000|Overall Study|Adverse Event|2|||
155208211|NCT03909295|560198068|FG000|Overall Study|Study terminated by sponsor|50|||
155208212|NCT00848081|560198072|FG000|Overall Study|Adverse Event|6|||
155208213|NCT00848081|560198073|FG001|Overall Study|Adverse Event|7|||
155208214|NCT00848081|560198072|FG000|Overall Study|Protocol Violation|8|||
155208215|NCT00848081|560198073|FG001|Overall Study|Protocol Violation|5|||
155208216|NCT00848081|560198072|FG000|Overall Study|Lost to Follow-up|1|||
155208217|NCT00848081|560198073|FG001|Overall Study|Lost to Follow-up|0|||
155208218|NCT00848081|560198072|FG000|Overall Study|Physician Decision|0|||
155208219|NCT00848081|560198073|FG001|Overall Study|Physician Decision|3|||
155208220|NCT00848081|560198072|FG000|Overall Study|Withdrawal by Subject|5|||
155208221|NCT00848081|560198073|FG001|Overall Study|Withdrawal by Subject|3|||
155208222|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208223|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208224|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208225|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208226|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
155208227|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
155208228|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208229|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208230|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208231|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208232|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Other|1|||
155208233|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Other|1|||
155208234|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Other|0|||
155208235|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Other|0|||
155208236|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Other|0|||
155208237|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208238|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208239|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208240|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
155208241|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
155208242|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208243|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208244|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208245|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
155208246|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208247|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208248|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208249|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208250|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
155208251|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208252|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
155208253|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208254|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208255|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
155208256|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208257|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Other|0|||
155208258|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Other|1|||
155208259|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Other|1|||
155208260|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Other|0|||
155208261|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Other|0|||
155208262|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
155208263|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
155208264|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
155208265|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
155208266|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
155208267|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208268|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208269|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208270|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
155208271|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208272|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208273|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208274|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208275|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
155208276|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208277|NCT02064868|560198085|FG000|Overall Study|Lost to Follow-up|14|||
155208278|NCT02064868|560198086|FG001|Overall Study|Lost to Follow-up|8|||
155208279|NCT02064868|560198085|FG000|Overall Study|Physician Decision|1|||
155208280|NCT02064868|560198086|FG001|Overall Study|Physician Decision|0|||
155208281|NCT02064868|560198085|FG000|Overall Study|Withdrawal by Subject|14|||
155208282|NCT02064868|560198086|FG001|Overall Study|Withdrawal by Subject|3|||
155208283|NCT02064868|560198085|FG000|Overall Study|Technical Problems or Missing|5|||
155208284|NCT02064868|560198086|FG001|Overall Study|Technical Problems or Missing|2|||
155208285|NCT03342690|560198097|FG000|Overall Study|Missing Information|9|||
155208286|NCT03342690|560198097|FG000|Overall Study|Protocol Violation|16|||
155208287|NCT02289690|560198098|FG000|Overall Study|Adverse Event Related to Progression|0|||
155208288|NCT02289690|560198099|FG001|Overall Study|Adverse Event Related to Progression|1|||
155208289|NCT02289690|560198100|FG002|Overall Study|Adverse Event Related to Progression|1|||
155208290|NCT02289690|560198101|FG003|Overall Study|Adverse Event Related to Progression|0|||
155208291|NCT02289690|560198102|FG004|Overall Study|Adverse Event Related to Progression|1|||
155208292|NCT02289690|560198103|FG005|Overall Study|Adverse Event Related to Progression|0|||
155208293|NCT02289690|560198104|FG006|Overall Study|Adverse Event Related to Progression|1|||
155208294|NCT02289690|560198105|FG007|Overall Study|Adverse Event Related to Progression|0|||
155208295|NCT02289690|560198106|FG008|Overall Study|Adverse Event Related to Progression|0|||
155208296|NCT02289690|560198107|FG009|Overall Study|Adverse Event Related to Progression|0|||
155208297|NCT02289690|560198098|FG000|Overall Study|Withdrawal by Subject|1|||
155208298|NCT02289690|560198099|FG001|Overall Study|Withdrawal by Subject|0|||
155208299|NCT02289690|560198100|FG002|Overall Study|Withdrawal by Subject|0|||
155208300|NCT02289690|560198101|FG003|Overall Study|Withdrawal by Subject|0|||
155208301|NCT02289690|560198102|FG004|Overall Study|Withdrawal by Subject|1|||
155208302|NCT02289690|560198103|FG005|Overall Study|Withdrawal by Subject|1|||
155208303|NCT02289690|560198104|FG006|Overall Study|Withdrawal by Subject|0|||
155208304|NCT02289690|560198105|FG007|Overall Study|Withdrawal by Subject|0|||
155208305|NCT02289690|560198106|FG008|Overall Study|Withdrawal by Subject|4|||
155208306|NCT02289690|560198107|FG009|Overall Study|Withdrawal by Subject|2|||
155208307|NCT02289690|560198098|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
155208308|NCT02289690|560198099|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
155208309|NCT02289690|560198100|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
155208310|NCT02289690|560198101|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
155208311|NCT02289690|560198102|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
155208312|NCT02289690|560198103|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
155208313|NCT02289690|560198104|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
155208314|NCT02289690|560198105|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
155208315|NCT02289690|560198106|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
155208316|NCT02289690|560198107|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
155208317|NCT02289690|560198098|FG000|Overall Study|Lost to Follow-up|0|||
155208318|NCT02289690|560198099|FG001|Overall Study|Lost to Follow-up|0|||
155208319|NCT02289690|560198100|FG002|Overall Study|Lost to Follow-up|0|||
155208320|NCT02289690|560198101|FG003|Overall Study|Lost to Follow-up|0|||
155208321|NCT02289690|560198102|FG004|Overall Study|Lost to Follow-up|0|||
155208322|NCT02289690|560198103|FG005|Overall Study|Lost to Follow-up|0|||
155208323|NCT02289690|560198104|FG006|Overall Study|Lost to Follow-up|0|||
155208324|NCT02289690|560198105|FG007|Overall Study|Lost to Follow-up|1|||
155208325|NCT02289690|560198106|FG008|Overall Study|Lost to Follow-up|0|||
155208326|NCT02289690|560198107|FG009|Overall Study|Lost to Follow-up|2|||
155208327|NCT02289690|560198098|FG000|Overall Study|Death|0|||
155208328|NCT02289690|560198099|FG001|Overall Study|Death|0|||
155208329|NCT02289690|560198100|FG002|Overall Study|Death|0|||
155208330|NCT02289690|560198101|FG003|Overall Study|Death|0|||
155208331|NCT02289690|560198102|FG004|Overall Study|Death|0|||
155208332|NCT02289690|560198103|FG005|Overall Study|Death|0|||
155208333|NCT02289690|560198104|FG006|Overall Study|Death|0|||
155208334|NCT02289690|560198105|FG007|Overall Study|Death|49|||
155208335|NCT02289690|560198106|FG008|Overall Study|Death|45|||
155208336|NCT02289690|560198107|FG009|Overall Study|Death|41|||
155208337|NCT02289690|560198098|FG000|Overall Study|Sponsor Discontinued Study|0|||
155208338|NCT02289690|560198099|FG001|Overall Study|Sponsor Discontinued Study|0|||
155208339|NCT02289690|560198100|FG002|Overall Study|Sponsor Discontinued Study|0|||
155208340|NCT02289690|560198101|FG003|Overall Study|Sponsor Discontinued Study|0|||
155208341|NCT02289690|560198102|FG004|Overall Study|Sponsor Discontinued Study|0|||
155208342|NCT02289690|560198103|FG005|Overall Study|Sponsor Discontinued Study|0|||
155208343|NCT02289690|560198104|FG006|Overall Study|Sponsor Discontinued Study|0|||
155208344|NCT02289690|560198105|FG007|Overall Study|Sponsor Discontinued Study|9|||
155208345|NCT02289690|560198106|FG008|Overall Study|Sponsor Discontinued Study|7|||
155208346|NCT02289690|560198107|FG009|Overall Study|Sponsor Discontinued Study|15|||
155208347|NCT02289690|560198098|FG000|Overall Study|Other|0|||
155208348|NCT02289690|560198099|FG001|Overall Study|Other|0|||
155208349|NCT02289690|560198100|FG002|Overall Study|Other|0|||
155208350|NCT02289690|560198101|FG003|Overall Study|Other|1|||
155208351|NCT02289690|560198102|FG004|Overall Study|Other|1|||
155208352|NCT02289690|560198103|FG005|Overall Study|Other|0|||
155208353|NCT02289690|560198104|FG006|Overall Study|Other|1|||
155208354|NCT02289690|560198105|FG007|Overall Study|Other|2|||
155208355|NCT02289690|560198106|FG008|Overall Study|Other|3|||
155208356|NCT02289690|560198107|FG009|Overall Study|Other|1|||
155208357|NCT02573350|560198110|FG000|Overall Study|Lost to Follow-up|2|||
155208358|NCT02573350|560198111|FG001|Overall Study|Lost to Follow-up|1|||
155208359|NCT02573350|560198110|FG000|Overall Study|Adverse Event|3|||
155208360|NCT02573350|560198111|FG001|Overall Study|Adverse Event|4|||
155208361|NCT02573350|560198110|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
155208362|NCT02573350|560198111|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
155208363|NCT02573350|560198110|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
155208364|NCT02573350|560198111|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
155208365|NCT02573350|560198110|FG000|Overall Study|Subject withdrew consent to participate|6|||
155208366|NCT02573350|560198111|FG001|Overall Study|Subject withdrew consent to participate|1|||
155208367|NCT02573350|560198110|FG000|Overall Study|Protocol Deviation|1|||
155208368|NCT02573350|560198111|FG001|Overall Study|Protocol Deviation|1|||
155208369|NCT02743520|560198112|FG000|Overall Study|Withdrawal by Subject|1|||
155208370|NCT03247530|560198113|FG000|Overall Study|Withdrawal by caregiver|19|||
155208371|NCT03247530|560198114|FG001|Overall Study|Withdrawal by caregiver|8|||
155208372|NCT03247530|560198115|FG002|Overall Study|Withdrawal by caregiver|10|||
155208373|NCT03247530|560198113|FG000|Overall Study|Lost to Follow-up|3|||
155208374|NCT03247530|560198114|FG001|Overall Study|Lost to Follow-up|9|||
155208375|NCT03247530|560198115|FG002|Overall Study|Lost to Follow-up|6|||
155208376|NCT03247530|560198113|FG000|Overall Study|Adverse Event|2|||
155208377|NCT03247530|560198114|FG001|Overall Study|Adverse Event|5|||
155208378|NCT03247530|560198115|FG002|Overall Study|Adverse Event|2|||
155208379|NCT03247530|560198113|FG000|Overall Study|Failure to follow procedure|1|||
155208380|NCT03247530|560198114|FG001|Overall Study|Failure to follow procedure|1|||
155208381|NCT03247530|560198115|FG002|Overall Study|Failure to follow procedure|1|||
155208382|NCT03247530|560198113|FG000|Overall Study|Withdrawal by Subject|1|||
155208383|NCT03247530|560198114|FG001|Overall Study|Withdrawal by Subject|1|||
155208384|NCT03247530|560198115|FG002|Overall Study|Withdrawal by Subject|0|||
155208385|NCT03247530|560198113|FG000|Overall Study|Study medication misuse|0|||
155208386|NCT03247530|560198114|FG001|Overall Study|Study medication misuse|1|||
155208387|NCT03247530|560198115|FG002|Overall Study|Study medication misuse|0|||
155208388|NCT03247530|560198113|FG000|Overall Study|Other, multiple categories|1|||
155208389|NCT03247530|560198114|FG001|Overall Study|Other, multiple categories|3|||
155208390|NCT03247530|560198115|FG002|Overall Study|Other, multiple categories|1|||
155208391|NCT02509156|560198117|FG000|Randomized Phase|Death|1|||
155208392|NCT02509156|560198118|FG001|Randomized Phase|Death|0|||
155208393|NCT02509156|560198117|FG000|Randomized Phase|Withdrawal by Subject|1|||
155208394|NCT02509156|560198118|FG001|Randomized Phase|Withdrawal by Subject|1|||
155208395|NCT02547649|560198120|FG000|Overall Study|Lost to Follow-up|3|||
155208396|NCT02547649|560198121|FG001|Overall Study|Lost to Follow-up|1|||
155208397|NCT02547649|560198122|FG002|Overall Study|Lost to Follow-up|1|||
155208398|NCT02547649|560198120|FG000|Overall Study|Not vaccinated|0|||
155208399|NCT02547649|560198121|FG001|Overall Study|Not vaccinated|0|||
155208400|NCT02547649|560198122|FG002|Overall Study|Not vaccinated|1|||
155208401|NCT02547649|560198120|FG000|Overall Study|Withdrawal by Subject|0|||
155208402|NCT02547649|560198121|FG001|Overall Study|Withdrawal by Subject|4|||
155208403|NCT02547649|560198122|FG002|Overall Study|Withdrawal by Subject|2|||
155208404|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Left Oranization|1|||
155208405|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Left Oranization|1|||
155208406|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
155208407|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
155208408|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
155208409|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
155208410|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
155208411|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
155208412|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
155208413|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
155208414|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Left organization|0|||
155208415|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Left organization|1|||
155208416|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
155208417|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
155208418|NCT01111149|560198130|FG000|Overall Study|Protocol Violation|1|||
155208419|NCT01111149|560198131|FG001|Overall Study|Protocol Violation|1|||
155208420|NCT01111149|560198132|FG002|Overall Study|Protocol Violation|2|||
155208421|NCT01111149|560198130|FG000|Overall Study|Withdrawal by Subject|1|||
155208422|NCT01111149|560198131|FG001|Overall Study|Withdrawal by Subject|0|||
155208423|NCT01111149|560198132|FG002|Overall Study|Withdrawal by Subject|2|||
155208424|NCT00006903|560198135|FG000|Overall Study|Still receiving treatment|0|||
155208425|NCT00006903|560198136|FG001|Overall Study|Still receiving treatment|0|||
155208426|NCT00006903|560198137|FG002|Overall Study|Still receiving treatment|1|||
155208427|NCT00006903|560198135|FG000|Overall Study|Refused further treatment|0|||
155208428|NCT00006903|560198136|FG001|Overall Study|Refused further treatment|2|||
155208429|NCT00006903|560198137|FG002|Overall Study|Refused further treatment|1|||
155208430|NCT00006903|560198135|FG000|Overall Study|Adverse Event|0|||
155208431|NCT00006903|560198136|FG001|Overall Study|Adverse Event|0|||
155208432|NCT00006903|560198137|FG002|Overall Study|Adverse Event|1|||
155208433|NCT00006903|560198135|FG000|Overall Study|Death|0|||
155208434|NCT00006903|560198136|FG001|Overall Study|Death|1|||
155208435|NCT00006903|560198137|FG002|Overall Study|Death|0|||
155208436|NCT00006903|560198135|FG000|Overall Study|Patient never treated|0|||
155208437|NCT00006903|560198136|FG001|Overall Study|Patient never treated|0|||
155208438|NCT00006903|560198137|FG002|Overall Study|Patient never treated|1|||
155208439|NCT00006903|560198135|FG000|Overall Study|Ineligible|10|||
155208440|NCT00006903|560198136|FG001|Overall Study|Ineligible|1|||
155208441|NCT00006903|560198137|FG002|Overall Study|Ineligible|2|||
155208442|NCT01909674|560198138|FG000|Overall Study|Withdrawal by Subject|5|||
155208443|NCT01909674|560198139|FG001|Overall Study|Withdrawal by Subject|2|||
155208444|NCT01906008|560198144|FG000|Overall Study|Lost to Follow-up|2|||
155208445|NCT01906008|560198145|FG001|Overall Study|Lost to Follow-up|0|||
155208446|NCT01906008|560198144|FG000|Overall Study|Oxaliplatin toxicity|2|||
155208447|NCT01906008|560198145|FG001|Overall Study|Oxaliplatin toxicity|0|||
155208448|NCT01906008|560198144|FG000|Overall Study|Protocol Violation|0|||
155208449|NCT01906008|560198145|FG001|Overall Study|Protocol Violation|1|||
155208450|NCT01906008|560198144|FG000|Overall Study|Withdrawal by Subject|1|||
155208451|NCT01906008|560198145|FG001|Overall Study|Withdrawal by Subject|5|||
155208452|NCT01906008|560198144|FG000|Overall Study|Did not start study med|3|||
155208453|NCT01906008|560198145|FG001|Overall Study|Did not start study med|4|||
155208454|NCT01906008|560198144|FG000|Overall Study|Oxaliplatin stops|10|||
155208455|NCT01906008|560198145|FG001|Overall Study|Oxaliplatin stops|8|||
155208456|NCT01906008|560198144|FG000|Overall Study|Hospice|1|||
155208457|NCT01906008|560198145|FG001|Overall Study|Hospice|0|||
155208458|NCT01906008|560198144|FG000|Overall Study|Physician Decision|3|||
155208459|NCT01906008|560198145|FG001|Overall Study|Physician Decision|3|||
155208460|NCT01906008|560198144|FG000|Overall Study|Lack of compliance of study med|5|||
155208461|NCT01906008|560198145|FG001|Overall Study|Lack of compliance of study med|3|||
155208462|NCT01906008|560198144|FG000|Overall Study|Adverse Event|0|||
155208463|NCT01906008|560198145|FG001|Overall Study|Adverse Event|3|||
155208464|NCT01465997|560198146|FG000|Overall Study|Adverse Event|12|||
155208465|NCT01465997|560198147|FG001|Overall Study|Adverse Event|22|||
155208466|NCT01465997|560198146|FG000|Overall Study|Lack of Efficacy|13|||
155208467|NCT01465997|560198147|FG001|Overall Study|Lack of Efficacy|1|||
155208468|NCT01465997|560198146|FG000|Overall Study|Protocol Violation|1|||
155208469|NCT01465997|560198147|FG001|Overall Study|Protocol Violation|4|||
155208470|NCT01465997|560198146|FG000|Overall Study|Lost to Follow-up|6|||
155208471|NCT01465997|560198147|FG001|Overall Study|Lost to Follow-up|9|||
155208472|NCT01465997|560198146|FG000|Overall Study|Withdrawal by Subject|32|||
155208473|NCT01465997|560198147|FG001|Overall Study|Withdrawal by Subject|35|||
155208474|NCT01465997|560198146|FG000|Overall Study|investigator's decision|1|||
155208475|NCT01465997|560198147|FG001|Overall Study|investigator's decision|1|||
155208476|NCT01465997|560198146|FG000|Overall Study|Death|0|||
155208477|NCT01465997|560198147|FG001|Overall Study|Death|1|||
155208478|NCT01465997|560198146|FG000|Overall Study|sponsor's decision|1|||
155208479|NCT01465997|560198147|FG001|Overall Study|sponsor's decision|1|||
155208480|NCT01465997|560198146|FG000|Overall Study|subject withdrew consent|1|||
155208481|NCT01465997|560198147|FG001|Overall Study|subject withdrew consent|0|||
155208482|NCT01465997|560198146|FG000|Overall Study|local lab unblinded site|1|||
155208483|NCT01465997|560198147|FG001|Overall Study|local lab unblinded site|0|||
155208484|NCT01465997|560198146|FG000|Overall Study|withdrew before follow-up|0|||
155208485|NCT01465997|560198147|FG001|Overall Study|withdrew before follow-up|13|||
155208486|NCT01465997|560198146|FG000|Overall Study|decision by site staff|0|||
155208487|NCT01465997|560198147|FG001|Overall Study|decision by site staff|1|||
155208488|NCT01465997|560198146|FG000|Overall Study|subject left participation SP0993|0|||
155208489|NCT01465997|560198147|FG001|Overall Study|subject left participation SP0993|1|||
155208490|NCT00660309|560198148|FG000|Overall Study|Adverse Event|2|||
155208491|NCT00660309|560198149|FG001|Overall Study|Adverse Event|0|||
155208492|NCT00660309|560198148|FG000|Overall Study|Withdrawal by Subject|0|||
155208493|NCT00660309|560198149|FG001|Overall Study|Withdrawal by Subject|3|||
155208494|NCT01666782|560198154|FG000|Overall Study|Received 2 doses of vaccine|0|||
155208495|NCT01666782|560198155|FG001|Overall Study|Received 2 doses of vaccine|1|||
155208496|NCT01666782|560198154|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
155208497|NCT01666782|560198155|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
155208498|NCT04786990|560198156|FG000|Overall Study|Withdrawal by Subject|1|||
155208499|NCT04786990|560198156|FG000|Overall Study|Adverse Event|1|||
155208500|NCT04786990|560198156|FG000|Overall Study|Lost to Follow-up|1|||
155208501|NCT04786990|560198156|FG000|Overall Study|Noncompliance|1|||
155208502|NCT04786990|560198156|FG000|Overall Study|Unable to complete site visits|1|||
155208503|NCT04786990|560198156|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
155208504|NCT02007109|560198157|FG000|Overall Study|Diary not returned or excluded|102|||
155208505|NCT02007109|560198157|FG000|Overall Study|Excluded - Age<7yo|9|||
155208506|NCT00687323|560198158|FG000|Overall Study|Death|25|||
155208507|NCT00687323|560198158|FG000|Overall Study|Withdrawal by Subject|1|||
155208508|NCT00687323|560198158|FG000|Overall Study|Excluded from efficacy evaluations|6|||
155208509|NCT00687323|560198158|FG000|Overall Study|Screen failure|148|||
155208510|NCT03031678|560198164|FG000|Overall Study|Study closed prior to completion|1|||
155208511|NCT04557371|560198165|FG000|Overall Study|Covid-19-related|0|||
155208512|NCT04557371|560198166|FG001|Overall Study|Covid-19-related|1|||
155208513|NCT04557371|560198167|FG002|Overall Study|Covid-19-related|0|||
155208514|NCT04557371|560198165|FG000|Overall Study|Withdrawal by Subject|0|||
155208515|NCT04557371|560198166|FG001|Overall Study|Withdrawal by Subject|1|||
155208516|NCT04557371|560198167|FG002|Overall Study|Withdrawal by Subject|0|||
155208517|NCT04557371|560198165|FG000|Overall Study|Adverse Event|1|||
155208518|NCT04557371|560198166|FG001|Overall Study|Adverse Event|0|||
155208519|NCT04557371|560198167|FG002|Overall Study|Adverse Event|0|||
155208520|NCT01482884|560198170|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
155208521|NCT01482884|560198171|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
155208522|NCT01482884|560198170|FG000|Overall Study|Protocol Violation|1|||
155208523|NCT01482884|560198171|FG001|Overall Study|Protocol Violation|0|||
155208524|NCT01482884|560198170|FG000|Overall Study|Lost to Follow-up|2|||
155208525|NCT01482884|560198171|FG001|Overall Study|Lost to Follow-up|2|||
155208526|NCT01482884|560198170|FG000|Overall Study|Lack of Efficacy|0|||
155208527|NCT01482884|560198171|FG001|Overall Study|Lack of Efficacy|1|||
155208528|NCT01482884|560198170|FG000|Overall Study|Adverse Event|2|||
155208529|NCT01482884|560198171|FG001|Overall Study|Adverse Event|1|||
155208530|NCT01482884|560198170|FG000|Overall Study|Withdrawal by Subject|8|||
155208531|NCT01482884|560198171|FG001|Overall Study|Withdrawal by Subject|13|||
155208532|NCT05353985|560198178|FG000|Overall Study|Adverse Event|5|||
155208533|NCT05353985|560198179|FG001|Overall Study|Adverse Event|7|||
155208534|NCT05353985|560198178|FG000|Overall Study|Lost to Follow-up|1|||
155208535|NCT05353985|560198179|FG001|Overall Study|Lost to Follow-up|1|||
155208536|NCT05353985|560198178|FG000|Overall Study|Protocol Violation|1|||
155208537|NCT05353985|560198179|FG001|Overall Study|Protocol Violation|0|||
155208538|NCT05353985|560198178|FG000|Overall Study|Withdrawal by Subject|13|||
155208539|NCT05353985|560198179|FG001|Overall Study|Withdrawal by Subject|17|||
155208540|NCT05353985|560198178|FG000|Overall Study|Reason Not Specified|1|||
155208541|NCT05353985|560198179|FG001|Overall Study|Reason Not Specified|0|||
155208542|NCT05353985|560198178|FG000|Overall Study|Randomized in Error & Not Treated|0|||
155208543|NCT05353985|560198179|FG001|Overall Study|Randomized in Error & Not Treated|1|||
155208544|NCT04419714|560198180|FG000|Overall Study|Technical Fault|5|||
155208545|NCT04419714|560198180|FG000|Overall Study|Protocol Deviation|2|||
155208546|NCT04419714|560198180|FG000|Overall Study|Withdrawal by Subject|1|||
155208547|NCT02057406|560199621|FG000|Overall Study|Physician Decision|0|||
155208548|NCT02057406|560199622|FG001|Overall Study|Physician Decision|0|||
155208549|NCT02057406|560199623|FG002|Overall Study|Physician Decision|2|||
155208550|NCT02057406|560199621|FG000|Overall Study|Withdrawal by Subject|0|||
155208551|NCT02057406|560199622|FG001|Overall Study|Withdrawal by Subject|2|||
155208552|NCT02057406|560199623|FG002|Overall Study|Withdrawal by Subject|0|||
155208553|NCT02057406|560199621|FG000|Overall Study|Lost to Follow-up|0|||
155208554|NCT02057406|560199622|FG001|Overall Study|Lost to Follow-up|0|||
155208555|NCT02057406|560199623|FG002|Overall Study|Lost to Follow-up|1|||
155208556|NCT02057406|560199621|FG000|Overall Study|Death|1|||
155208557|NCT02057406|560199622|FG001|Overall Study|Death|0|||
155208558|NCT02057406|560199623|FG002|Overall Study|Death|0|||
155208559|NCT02057406|560199621|FG000|Overall Study|Protocol Violation|0|||
155208560|NCT02057406|560199622|FG001|Overall Study|Protocol Violation|1|||
155208561|NCT02057406|560199623|FG002|Overall Study|Protocol Violation|0|||
155208562|NCT02057406|560199621|FG000|Overall Study|Patient transportation issues|0|||
155208563|NCT02057406|560199622|FG001|Overall Study|Patient transportation issues|0|||
155208564|NCT02057406|560199623|FG002|Overall Study|Patient transportation issues|1|||
155208565|NCT02692716|560199624|FG000|Overall Study|Lost to Follow-up|2|||
155208566|NCT02692716|560199625|FG001|Overall Study|Lost to Follow-up|5|||
155208567|NCT02692716|560199624|FG000|Overall Study|Withdrawal by Subject|3|||
155208568|NCT02692716|560199625|FG001|Overall Study|Withdrawal by Subject|1|||
155208569|NCT03562481|560199630|FG000|First Intervention|Lost to Follow-up|1|||
155208570|NCT03562481|560199631|FG001|First Intervention|Lost to Follow-up|0|||
155208571|NCT03654651|560199633|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155208572|NCT03654651|560199634|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155208573|NCT01401283|560199635|FG000|Overall Study|surgery cancelled|5|||
155208574|NCT01401283|560199636|FG001|Overall Study|surgery cancelled|8|||
155208575|NCT01401283|560199635|FG000|Overall Study|preoperative arrhythmia|5|||
155208576|NCT01401283|560199636|FG001|Overall Study|preoperative arrhythmia|0|||
155208577|NCT01401283|560199635|FG000|Overall Study|no central venous access|0|||
155208578|NCT01401283|560199636|FG001|Overall Study|no central venous access|1|||
155208579|NCT01401283|560199635|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
155208580|NCT01401283|560199636|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
155208581|NCT02433483|560199637|FG000|Overall Study|Unacceptable toxicity|1|||
155208582|NCT02433483|560199637|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
155208583|NCT03824912|560199638|FG000|Overall Study|Lost to Follow-up|18|||
155208584|NCT03824912|560199639|FG001|Overall Study|Lost to Follow-up|15|||
155208585|NCT03824912|560199640|FG002|Overall Study|Lost to Follow-up|8|||
155208586|NCT03824912|560199638|FG000|Overall Study|Negative Baseline Culture Result|118|||
155208587|NCT03824912|560199639|FG001|Overall Study|Negative Baseline Culture Result|112|||
155208588|NCT03824912|560199640|FG002|Overall Study|Negative Baseline Culture Result|57|||
155208589|NCT03824912|560199638|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155208590|NCT03824912|560199639|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155208591|NCT03824912|560199640|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155208592|NCT03824912|560199638|FG000|Overall Study|Protocol Violation|1|||
155208593|NCT03824912|560199639|FG001|Overall Study|Protocol Violation|4|||
155208594|NCT03824912|560199640|FG002|Overall Study|Protocol Violation|1|||
155208595|NCT03824912|560199638|FG000|Overall Study|Withdrawal by Subject|3|||
155208596|NCT03824912|560199639|FG001|Overall Study|Withdrawal by Subject|2|||
155208597|NCT03824912|560199640|FG002|Overall Study|Withdrawal by Subject|1|||
155208598|NCT03824912|560199638|FG000|Overall Study|Participation in another study|0|||
155208599|NCT03824912|560199639|FG001|Overall Study|Participation in another study|1|||
155208600|NCT03824912|560199640|FG002|Overall Study|Participation in another study|0|||
155208601|NCT01414114|560199646|FG000|Overall Study|Adverse Event|2|||
155208602|NCT01414114|560199646|FG000|Overall Study|Withdrawal by Subject|1|||
155208603|NCT01414114|560199646|FG000|Overall Study|Other|2|||
155208604|NCT05620563|560199651|FG000|Overall Study|Adverse Event|3|||
155208605|NCT05620563|560199652|FG001|Overall Study|Adverse Event|1|||
155208606|NCT05620563|560199651|FG000|Overall Study|Lost to Follow-up|0|||
155208607|NCT05620563|560199652|FG001|Overall Study|Lost to Follow-up|2|||
155208608|NCT05620563|560199651|FG000|Overall Study|Protocol Deviation|1|||
155208609|NCT05620563|560199652|FG001|Overall Study|Protocol Deviation|2|||
155208610|NCT05620563|560199651|FG000|Overall Study|Withdrawal by Subject|3|||
155208611|NCT05620563|560199652|FG001|Overall Study|Withdrawal by Subject|3|||
155208612|NCT05620563|560199651|FG000|Overall Study|Physician Decision|0|||
155208613|NCT05620563|560199652|FG001|Overall Study|Physician Decision|1|||
155208614|NCT02085785|560199658|FG000|Overall Study|Withdrawal by Subject|2|||
155208615|NCT02085785|560199659|FG001|Overall Study|Withdrawal by Subject|1|||
155208616|NCT02085785|560199658|FG000|Overall Study|Lost to Follow-up|0|||
155208617|NCT02085785|560199659|FG001|Overall Study|Lost to Follow-up|1|||
155208618|NCT00779467|560199660|FG000|Overall Study|Lack of Efficacy|11|||
155208619|NCT00779467|560199661|FG001|Overall Study|Lack of Efficacy|2|||
155208620|NCT00779467|560199662|FG002|Overall Study|Lack of Efficacy|6|||
155208621|NCT00779467|560199663|FG003|Overall Study|Lack of Efficacy|11|||
155208622|NCT00779467|560199660|FG000|Overall Study|failed inclusion criteria|3|||
155208623|NCT00779467|560199661|FG001|Overall Study|failed inclusion criteria|3|||
155208624|NCT00779467|560199662|FG002|Overall Study|failed inclusion criteria|1|||
155208625|NCT00779467|560199663|FG003|Overall Study|failed inclusion criteria|2|||
155208626|NCT00779467|560199660|FG000|Overall Study|missing data|1|||
155208627|NCT00779467|560199661|FG001|Overall Study|missing data|0|||
155208628|NCT00779467|560199662|FG002|Overall Study|missing data|1|||
155491271|NCT03282123|561223515|FG000|Overall Study|Withdrawal by Subject|5|||
155491272|NCT00764465|561223516|FG000|Overall Study|Adverse Event|2|||
155491273|NCT00764465|561223517|FG001|Overall Study|Adverse Event|0|||
155491274|NCT00764465|561223518|FG002|Overall Study|Adverse Event|0|||
155491275|NCT00764465|561223519|FG003|Overall Study|Adverse Event|1|||
155491276|NCT00764465|561223520|FG004|Overall Study|Adverse Event|1|||
155491277|NCT00764465|561223521|FG005|Overall Study|Adverse Event|1|||
155491278|NCT00764465|561223516|FG000|Overall Study|Withdrawal by Subject|0|||
155491279|NCT00764465|561223517|FG001|Overall Study|Withdrawal by Subject|1|||
155491280|NCT00764465|561223518|FG002|Overall Study|Withdrawal by Subject|1|||
155491281|NCT00764465|561223519|FG003|Overall Study|Withdrawal by Subject|0|||
155491282|NCT00764465|561223520|FG004|Overall Study|Withdrawal by Subject|0|||
155491283|NCT00764465|561223521|FG005|Overall Study|Withdrawal by Subject|0|||
155491284|NCT01195662|561223522|FG000|Double Blind Treatment Period|Adverse Event|4|||
155491285|NCT01195662|561223523|FG001|Double Blind Treatment Period|Adverse Event|1|||
155491286|NCT01195662|561223524|FG002|Double Blind Treatment Period|Adverse Event|2|||
155491287|NCT01195662|561223522|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
155491288|NCT01195662|561223523|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
155491289|NCT01195662|561223524|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
155491290|NCT01195662|561223522|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
155491291|NCT01195662|561223523|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
155491292|NCT01195662|561223524|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
155491293|NCT01195662|561223522|FG000|Double Blind Treatment Period|Administrative reason|2|||
155491294|NCT01195662|561223523|FG001|Double Blind Treatment Period|Administrative reason|1|||
155491295|NCT01195662|561223524|FG002|Double Blind Treatment Period|Administrative reason|1|||
155491296|NCT01195662|561223522|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
155491297|NCT01195662|561223523|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
155491298|NCT01195662|561223524|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
155491299|NCT01195662|561223522|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
155491300|NCT01195662|561223523|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
155491301|NCT01195662|561223524|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
155491302|NCT01195662|561223522|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
155491303|NCT01195662|561223523|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155208629|NCT00779467|560199663|FG003|Overall Study|missing data|4|||
155208630|NCT00779467|560199660|FG000|Overall Study|technical issue|0|||
155208631|NCT00779467|560199661|FG001|Overall Study|technical issue|0|||
155208632|NCT00779467|560199662|FG002|Overall Study|technical issue|2|||
155208633|NCT00779467|560199663|FG003|Overall Study|technical issue|1|||
155208634|NCT00779467|560199660|FG000|Overall Study|unavailable research staff|0|||
155208635|NCT00779467|560199661|FG001|Overall Study|unavailable research staff|0|||
155208636|NCT00779467|560199662|FG002|Overall Study|unavailable research staff|0|||
155208637|NCT00779467|560199663|FG003|Overall Study|unavailable research staff|1|||
155208638|NCT00644995|560199664|FG000|Overall Study|Lost to Follow-up|1|||
155208639|NCT00644995|560199665|FG001|Overall Study|Lost to Follow-up|4|||
155208640|NCT00644995|560199664|FG000|Overall Study|Refused|1|||
155208641|NCT00644995|560199665|FG001|Overall Study|Refused|0|||
155208642|NCT00865124|560199672|FG000|Overall Study|Physician Decision|2|||
155208643|NCT00865124|560199673|FG001|Overall Study|Physician Decision|1|||
155208644|NCT00865124|560199674|FG002|Overall Study|Physician Decision|0|||
155208645|NCT00865124|560199672|FG000|Overall Study|Withdrawn consent|2|||
155208646|NCT00865124|560199673|FG001|Overall Study|Withdrawn consent|0|||
155208647|NCT00865124|560199674|FG002|Overall Study|Withdrawn consent|0|||
155208648|NCT01678911|560199682|FG000|Second Intervention|Lost to Follow-up|2|||
155208649|NCT01678911|560199683|FG001|Second Intervention|Lost to Follow-up|0|||
155208650|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
155208651|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
155208652|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
155208653|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
155208654|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
155208655|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
155208656|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
155208657|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
155208658|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Patient Request|1|||
155208659|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Patient Request|0|||
155208660|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
155208661|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
155208662|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Other|1|||
155208663|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Other|0|||
155208664|NCT04649060|560199684|FG000|Crossover (Arm B)|Adverse Event|0|||
155208665|NCT04649060|560199685|FG001|Crossover (Arm B)|Adverse Event|1|||
155208666|NCT04649060|560199684|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
155208667|NCT04649060|560199685|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
155208668|NCT02117648|560199686|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
155491304|NCT01195662|561223524|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155491305|NCT01195662|561223522|FG000|Double Blind Treatment Period|Non-specified|3|||
155491306|NCT01195662|561223523|FG001|Double Blind Treatment Period|Non-specified|0|||
155491307|NCT01195662|561223524|FG002|Double Blind Treatment Period|Non-specified|0|||
155491308|NCT01195662|561223522|FG000|Double Blind Treatment Period|Missing disposition information|0|||
155491309|NCT01195662|561223523|FG001|Double Blind Treatment Period|Missing disposition information|1|||
155491310|NCT01195662|561223524|FG002|Double Blind Treatment Period|Missing disposition information|1|||
155491311|NCT01195662|561223522|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
155491312|NCT01195662|561223523|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
155491313|NCT01195662|561223524|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
155491314|NCT01195662|561223522|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
155491315|NCT01195662|561223523|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
155491316|NCT01195662|561223524|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
155491317|NCT03457701|561223525|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
155491318|NCT03457701|561223526|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
155491319|NCT03457701|561223525|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
155491320|NCT03457701|561223526|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
155491321|NCT03329404|561223527|FG000|Overall Study|The study was suspended.|1|||
155491322|NCT03329404|561223528|FG001|Overall Study|The study was suspended.|4|||
155491323|NCT01250418|561223529|FG000|Overall Study|monitor data failure|1|||
155491324|NCT01250418|561223530|FG001|Overall Study|monitor data failure|1|||
155491325|NCT01298323|561223533|FG000|Overall Study|Adverse Event|2|||
155491326|NCT01298323|561223534|FG001|Overall Study|Adverse Event|4|||
155491327|NCT01298323|561223533|FG000|Overall Study|Death|11|||
155491328|NCT01298323|561223534|FG001|Overall Study|Death|16|||
155208669|NCT02117648|560199686|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
155208670|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
155208671|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
155208672|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
155208673|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
155208674|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
155208675|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
155491329|NCT01298323|561223533|FG000|Overall Study|Lost to Follow-up|1|||
155208676|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
155208677|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
155208678|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
155208679|NCT00171730|560199688|FG000|Overall Study|Adverse Event|3|||
155208680|NCT00171730|560199688|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155208681|NCT00171730|560199688|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
155208682|NCT00171730|560199688|FG000|Overall Study|Withdrawal by Subject|3|||
155208683|NCT05025241|560199689|FG000|Screening|Failed Screening|5|||
155208684|NCT05025241|560199689|FG000|Treatment and Follow Up|Adverse Event|3|||
155208685|NCT02670837|560199690|FG000|Overall Study|Death|2|||
155208686|NCT02670837|560199691|FG001|Overall Study|Death|0|||
155208687|NCT02670837|560199692|FG002|Overall Study|Death|0|||
155208688|NCT01985867|560199693|FG000|Overall Study|Lost to Follow-up|3|||
155208689|NCT01985867|560199694|FG001|Overall Study|Lost to Follow-up|4|||
155208690|NCT01985867|560199693|FG000|Overall Study|Adverse Event|3|||
155208691|NCT01985867|560199694|FG001|Overall Study|Adverse Event|2|||
155208692|NCT01985867|560199693|FG000|Overall Study|Lack of Efficacy|1|||
155208693|NCT01985867|560199694|FG001|Overall Study|Lack of Efficacy|0|||
155208694|NCT02220205|560199695|FG000|Overall Study|Withdrawal by Subject|1|||
155208695|NCT02220205|560199696|FG001|Overall Study|Withdrawal by Subject|0|||
155208696|NCT02557646|560199699|FG000|Overall Study|Adverse Event|40|||
155208697|NCT02557646|560199699|FG000|Overall Study|Death|1|||
155208698|NCT02557646|560199699|FG000|Overall Study|Lack of Efficacy|186|||
155208699|NCT02557646|560199699|FG000|Overall Study|Withdrawal by Subject|18|||
155208700|NCT02557646|560199699|FG000|Overall Study|Lost to Follow-up|17|||
155208701|NCT02557646|560199699|FG000|Overall Study|Other|14|||
155208702|NCT00137046|560199700|FG000|Overall Study|Death|2|||
155208703|NCT00137046|560199701|FG001|Overall Study|Death|1|||
155208704|NCT00137046|560199700|FG000|Overall Study|Adverse Event|16|||
155208705|NCT00137046|560199701|FG001|Overall Study|Adverse Event|5|||
155208706|NCT00137046|560199700|FG000|Overall Study|Laboratory Abnormality|2|||
155208707|NCT00137046|560199701|FG001|Overall Study|Laboratory Abnormality|0|||
155208708|NCT00137046|560199700|FG000|Overall Study|Lack of Efficacy|13|||
155208709|NCT00137046|560199701|FG001|Overall Study|Lack of Efficacy|1|||
155208710|NCT00137046|560199700|FG000|Overall Study|Lost to Follow-up|8|||
155208711|NCT00137046|560199701|FG001|Overall Study|Lost to Follow-up|24|||
155208712|NCT00137046|560199700|FG000|Overall Study|Other|23|||
155208713|NCT00137046|560199701|FG001|Overall Study|Other|19|||
155208714|NCT00137046|560199700|FG000|Overall Study|Withdrawal by Subject|33|||
155208715|NCT00137046|560199701|FG001|Overall Study|Withdrawal by Subject|42|||
155208716|NCT00137046|560199700|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
155208717|NCT00137046|560199701|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
155208718|NCT00137046|560199700|FG000|Overall Study|Withdrew prior to study treatment|1|||
155208719|NCT00137046|560199701|FG001|Overall Study|Withdrew prior to study treatment|1|||
155208720|NCT02532972|560199702|FG000|Overall Study|Withdrawal by Subject|1|||
155208721|NCT03552198|560199705|FG000|Overall Study|Lost to Follow-up|42|||
155208722|NCT03552198|560199706|FG001|Overall Study|Lost to Follow-up|48|||
155208723|NCT03552198|560199707|FG002|Overall Study|Lost to Follow-up|15|||
155208724|NCT03552198|560199708|FG003|Overall Study|Lost to Follow-up|19|||
155208725|NCT03552198|560199705|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
155208726|NCT03552198|560199706|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
155208727|NCT03552198|560199707|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
155208728|NCT03552198|560199708|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
155208729|NCT03552198|560199705|FG000|Overall Study|Did not receive air alerts|1|||
155208730|NCT03552198|560199706|FG001|Overall Study|Did not receive air alerts|0|||
155208731|NCT03552198|560199707|FG002|Overall Study|Did not receive air alerts|0|||
155208732|NCT03552198|560199708|FG003|Overall Study|Did not receive air alerts|1|||
155208733|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155208734|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155208735|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155208736|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
155208737|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155208738|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155208739|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
155208740|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
155208741|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Other|1|||
155208742|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Other|4|||
155208743|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Other|3|||
155208744|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Other|6|||
155208745|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
155208746|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
155208747|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
155208748|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
155208749|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
155208750|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
155208751|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
155208752|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
155208753|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155208754|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155208755|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155208756|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
155208757|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208758|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208759|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208760|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
155208761|NCT03334448|560199718|FG000|Washout|Personal Reason|0|||
155208762|NCT03334448|560199719|FG001|Washout|Personal Reason|1|||
155208763|NCT03334448|560199720|FG002|Washout|Personal Reason|0|||
155208764|NCT03334448|560199721|FG003|Washout|Personal Reason|0|||
155208765|NCT03334448|560199718|FG000|Washout|Protocol Violation|0|||
155208766|NCT03334448|560199719|FG001|Washout|Protocol Violation|0|||
155208767|NCT03334448|560199720|FG002|Washout|Protocol Violation|0|||
155208768|NCT03334448|560199721|FG003|Washout|Protocol Violation|1|||
155208769|NCT06149247|560199722|FG000|Overall Study|Adverse Event|0|||
155208770|NCT06149247|560199723|FG001|Overall Study|Adverse Event|1|||
155208771|NCT01365910|560199729|FG000|Overall Study|Withdrawal by Subject|7|||
155208772|NCT01365910|560199729|FG000|Overall Study|disease progression|18|||
155208773|NCT01365910|560199729|FG000|Overall Study|Adverse Event|3|||
155208774|NCT01365910|560199729|FG000|Overall Study|other complicating disease|1|||
155208775|NCT01365910|560199729|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
155208776|NCT00371137|560199730|FG000|Overall Study|Adverse Event|20|||
155208777|NCT00371137|560199731|FG001|Overall Study|Adverse Event|35|||
155208778|NCT00371137|560199732|FG002|Overall Study|Adverse Event|42|||
155208779|NCT00371137|560199730|FG000|Overall Study|Withdrawal by Subject|11|||
155208780|NCT00371137|560199731|FG001|Overall Study|Withdrawal by Subject|10|||
155208781|NCT00371137|560199732|FG002|Overall Study|Withdrawal by Subject|15|||
155208782|NCT00371137|560199730|FG000|Overall Study|Lost to Follow-up|6|||
155208783|NCT00371137|560199731|FG001|Overall Study|Lost to Follow-up|3|||
155208784|NCT00371137|560199732|FG002|Overall Study|Lost to Follow-up|5|||
155208785|NCT00371137|560199730|FG000|Overall Study|Lack of Efficacy|30|||
155208786|NCT00371137|560199731|FG001|Overall Study|Lack of Efficacy|12|||
155208787|NCT00371137|560199732|FG002|Overall Study|Lack of Efficacy|13|||
155208788|NCT00371137|560199730|FG000|Overall Study|Sponsor Decision|2|||
155208789|NCT00371137|560199731|FG001|Overall Study|Sponsor Decision|1|||
155208790|NCT00371137|560199732|FG002|Overall Study|Sponsor Decision|2|||
155208791|NCT00371137|560199730|FG000|Overall Study|Physician Decision|1|||
155208792|NCT00371137|560199731|FG001|Overall Study|Physician Decision|1|||
155208793|NCT00371137|560199732|FG002|Overall Study|Physician Decision|1|||
155208794|NCT00371137|560199730|FG000|Overall Study|Protocol Violation|2|||
155208795|NCT00371137|560199731|FG001|Overall Study|Protocol Violation|1|||
155208796|NCT00371137|560199732|FG002|Overall Study|Protocol Violation|1|||
155208797|NCT02013791|560199733|FG000|Period 1|Lost to Follow-up|0|||
155208798|NCT02013791|560199734|FG001|Period 1|Lost to Follow-up|0|||
155208799|NCT02013791|560199735|FG002|Period 1|Lost to Follow-up|0|||
155208800|NCT02013791|560199736|FG003|Period 1|Lost to Follow-up|1|||
155208801|NCT02013791|560199737|FG004|Period 1|Lost to Follow-up|0|||
155208802|NCT02013791|560199738|FG005|Period 1|Lost to Follow-up|0|||
155208803|NCT02013791|560199739|FG006|Period 1|Lost to Follow-up|1|||
155208804|NCT02013791|560199740|FG007|Period 1|Lost to Follow-up|1|||
155208805|NCT02013791|560199741|FG008|Period 1|Lost to Follow-up|0|||
155208806|NCT02013791|560199733|FG000|Period 1|Other Miscellaneous Reasons|0|||
155208807|NCT02013791|560199734|FG001|Period 1|Other Miscellaneous Reasons|2|||
155208808|NCT02013791|560199735|FG002|Period 1|Other Miscellaneous Reasons|0|||
155208809|NCT02013791|560199736|FG003|Period 1|Other Miscellaneous Reasons|0|||
155208810|NCT02013791|560199737|FG004|Period 1|Other Miscellaneous Reasons|0|||
155208811|NCT02013791|560199738|FG005|Period 1|Other Miscellaneous Reasons|0|||
155208812|NCT02013791|560199739|FG006|Period 1|Other Miscellaneous Reasons|0|||
155208813|NCT02013791|560199740|FG007|Period 1|Other Miscellaneous Reasons|0|||
155208814|NCT02013791|560199741|FG008|Period 1|Other Miscellaneous Reasons|0|||
155208815|NCT01782222|560199755|FG000|Overall Study|Adverse Event|4|||
155208816|NCT01782222|560199756|FG001|Overall Study|Adverse Event|5|||
155208817|NCT01782222|560199757|FG002|Overall Study|Adverse Event|3|||
155208818|NCT01782222|560199755|FG000|Overall Study|Lack of Efficacy|2|||
155208819|NCT01782222|560199756|FG001|Overall Study|Lack of Efficacy|1|||
155208820|NCT01782222|560199757|FG002|Overall Study|Lack of Efficacy|0|||
155208821|NCT01782222|560199755|FG000|Overall Study|Protocol Violation|1|||
155208822|NCT01782222|560199756|FG001|Overall Study|Protocol Violation|0|||
155208823|NCT01782222|560199757|FG002|Overall Study|Protocol Violation|0|||
155208824|NCT01782222|560199755|FG000|Overall Study|Withdrawal by Subject|1|||
155208825|NCT01782222|560199756|FG001|Overall Study|Withdrawal by Subject|4|||
155208826|NCT01782222|560199757|FG002|Overall Study|Withdrawal by Subject|1|||
155208827|NCT01782222|560199755|FG000|Overall Study|Moved to other state|0|||
155208828|NCT01782222|560199756|FG001|Overall Study|Moved to other state|1|||
155208829|NCT01782222|560199757|FG002|Overall Study|Moved to other state|0|||
155208830|NCT01756898|560199761|FG000|Overall Study|Adverse Event|7|||
155208831|NCT01756898|560199762|FG001|Overall Study|Adverse Event|1|||
155208832|NCT01756898|560199763|FG002|Overall Study|Adverse Event|0|||
155208833|NCT01756898|560199764|FG003|Overall Study|Adverse Event|0|||
155208834|NCT01756898|560199761|FG000|Overall Study|Lack of Efficacy|4|||
155208835|NCT01756898|560199762|FG001|Overall Study|Lack of Efficacy|7|||
155208836|NCT01756898|560199763|FG002|Overall Study|Lack of Efficacy|6|||
155208837|NCT01756898|560199764|FG003|Overall Study|Lack of Efficacy|6|||
155208838|NCT01756898|560199761|FG000|Overall Study|Lost to Follow-up|2|||
155208839|NCT01756898|560199762|FG001|Overall Study|Lost to Follow-up|4|||
155208840|NCT01756898|560199763|FG002|Overall Study|Lost to Follow-up|2|||
155208841|NCT01756898|560199764|FG003|Overall Study|Lost to Follow-up|3|||
155208842|NCT01756898|560199761|FG000|Overall Study|Protocol Violation|1|||
155208843|NCT01756898|560199762|FG001|Overall Study|Protocol Violation|2|||
155208844|NCT01756898|560199763|FG002|Overall Study|Protocol Violation|2|||
155208845|NCT01756898|560199764|FG003|Overall Study|Protocol Violation|1|||
155208846|NCT01756898|560199761|FG000|Overall Study|Withdrew Consent|5|||
155208847|NCT01756898|560199762|FG001|Overall Study|Withdrew Consent|3|||
155208848|NCT01756898|560199763|FG002|Overall Study|Withdrew Consent|5|||
155208849|NCT01756898|560199764|FG003|Overall Study|Withdrew Consent|6|||
155208850|NCT01756898|560199761|FG000|Overall Study|Other|0|||
155208851|NCT01756898|560199762|FG001|Overall Study|Other|2|||
155208852|NCT01756898|560199763|FG002|Overall Study|Other|2|||
155208853|NCT01756898|560199764|FG003|Overall Study|Other|0|||
155208854|NCT01500694|560199765|FG000|Overall Study|Adverse Event|4|||
155208855|NCT01500694|560199766|FG001|Overall Study|Adverse Event|3|||
155208856|NCT01500694|560199765|FG000|Overall Study|Protocol Violation|0|||
155208857|NCT01500694|560199766|FG001|Overall Study|Protocol Violation|1|||
155208858|NCT01500694|560199765|FG000|Overall Study|Withdrawal by Subject|23|||
155208859|NCT01500694|560199766|FG001|Overall Study|Withdrawal by Subject|14|||
155208860|NCT01500694|560199765|FG000|Overall Study|Lost to Follow-up|2|||
155208861|NCT01500694|560199766|FG001|Overall Study|Lost to Follow-up|3|||
155208862|NCT01500694|560199765|FG000|Overall Study|Lack of Efficacy|14|||
155208863|NCT01500694|560199766|FG001|Overall Study|Lack of Efficacy|5|||
155208864|NCT01500694|560199765|FG000|Overall Study|Other|9|||
155208865|NCT01500694|560199766|FG001|Overall Study|Other|3|||
155208866|NCT01691781|560199767|FG000|Overall Study|Withdrawal by Subject|4|||
155208867|NCT01691781|560199768|FG001|Overall Study|Withdrawal by Subject|3|||
155208868|NCT01691781|560199767|FG000|Overall Study|Physician Decision|1|||
155208869|NCT01691781|560199768|FG001|Overall Study|Physician Decision|1|||
155208870|NCT01691781|560199767|FG000|Overall Study|Protocol Violation|2|||
155208871|NCT01691781|560199768|FG001|Overall Study|Protocol Violation|2|||
155208872|NCT01691781|560199767|FG000|Overall Study|Adverse Event|0|||
155208873|NCT01691781|560199768|FG001|Overall Study|Adverse Event|1|||
155208874|NCT03978520|560199769|FG000|Overall Study|Adverse Event|2|||
155208875|NCT03978520|560199770|FG001|Overall Study|Adverse Event|5|||
155208876|NCT03978520|560199771|FG002|Overall Study|Adverse Event|3|||
155208877|NCT03978520|560199772|FG003|Overall Study|Adverse Event|5|||
155208878|NCT03978520|560199773|FG004|Overall Study|Adverse Event|6|||
155208879|NCT03978520|560199769|FG000|Overall Study|Withdrawal by Subject|10|||
155208880|NCT03978520|560199770|FG001|Overall Study|Withdrawal by Subject|4|||
155208881|NCT03978520|560199771|FG002|Overall Study|Withdrawal by Subject|5|||
155208882|NCT03978520|560199772|FG003|Overall Study|Withdrawal by Subject|6|||
155208883|NCT03978520|560199773|FG004|Overall Study|Withdrawal by Subject|5|||
155208884|NCT03978520|560199769|FG000|Overall Study|Lost to Follow-up|2|||
155208885|NCT03978520|560199770|FG001|Overall Study|Lost to Follow-up|2|||
155208886|NCT03978520|560199771|FG002|Overall Study|Lost to Follow-up|2|||
155208887|NCT03978520|560199772|FG003|Overall Study|Lost to Follow-up|0|||
155208888|NCT03978520|560199773|FG004|Overall Study|Lost to Follow-up|1|||
155208889|NCT03978520|560199769|FG000|Overall Study|COVID-19 infection|0|||
155208890|NCT03978520|560199770|FG001|Overall Study|COVID-19 infection|1|||
155208891|NCT03978520|560199771|FG002|Overall Study|COVID-19 infection|0|||
155208892|NCT03978520|560199772|FG003|Overall Study|COVID-19 infection|0|||
155208893|NCT03978520|560199773|FG004|Overall Study|COVID-19 infection|0|||
155208894|NCT03978520|560199769|FG000|Overall Study|Other, not specified|9|||
155208895|NCT03978520|560199770|FG001|Overall Study|Other, not specified|4|||
155208896|NCT03978520|560199771|FG002|Overall Study|Other, not specified|1|||
155208897|NCT03978520|560199772|FG003|Overall Study|Other, not specified|1|||
155208898|NCT03978520|560199773|FG004|Overall Study|Other, not specified|2|||
155208899|NCT03978520|560199769|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208900|NCT03978520|560199770|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208901|NCT03978520|560199771|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208902|NCT03978520|560199772|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
155208903|NCT03978520|560199773|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
155208904|NCT01918085|560199776|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
155208905|NCT01918085|560199777|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
155208906|NCT02132130|560199784|FG000|Overall Study|Lost to Follow-up|0|||
155208907|NCT02132130|560199785|FG001|Overall Study|Lost to Follow-up|2|||
155208908|NCT02132130|560199786|FG002|Overall Study|Lost to Follow-up|0|||
155208909|NCT02132130|560199787|FG003|Overall Study|Lost to Follow-up|0|||
155208910|NCT02132130|560199784|FG000|Overall Study|Withdrawal by Subject|0|||
155208911|NCT02132130|560199785|FG001|Overall Study|Withdrawal by Subject|0|||
155208912|NCT02132130|560199786|FG002|Overall Study|Withdrawal by Subject|0|||
155208913|NCT02132130|560199787|FG003|Overall Study|Withdrawal by Subject|1|||
155208914|NCT02760069|560199788|FG000|Overall Study|Withdrawal by Subject|0|||
155208915|NCT02760069|560199789|FG001|Overall Study|Withdrawal by Subject|1|||
155208916|NCT02760069|560199790|FG002|Overall Study|Withdrawal by Subject|1|||
155208917|NCT00600483|560199795|FG000|Overall Study|Lost to Follow-up|26|||
155208918|NCT00600483|560199796|FG001|Overall Study|Lost to Follow-up|47|||
155208919|NCT00600483|560199795|FG000|Overall Study|Randomized but not treated|10|||
155208920|NCT00600483|560199796|FG001|Overall Study|Randomized but not treated|0|||
155208921|NCT02547454|560199805|FG000|Overall Study|Due to hemodialysis|53|||
155208922|NCT02547454|560199805|FG000|Overall Study|Due to transplantation|1|||
155208923|NCT02547454|560199805|FG000|Overall Study|Due to no further need to treat|4|||
155208924|NCT02547454|560199805|FG000|Overall Study|Death|38|||
155208925|NCT02547454|560199805|FG000|Overall Study|Lost to Follow-up|26|||
155208926|NCT02547454|560199805|FG000|Overall Study|Other|39|||
155208927|NCT02547454|560199805|FG000|Overall Study|No data|11|||
155208928|NCT03655691|560199808|FG000|Overall Study|Adverse Event|0|||
155208929|NCT03655691|560199809|FG001|Overall Study|Adverse Event|0|||
155208930|NCT03655691|560199810|FG002|Overall Study|Adverse Event|1|||
155208931|NCT03655691|560199808|FG000|Overall Study|Lost to Follow-up|1|||
155208932|NCT03655691|560199809|FG001|Overall Study|Lost to Follow-up|1|||
155208933|NCT03655691|560199810|FG002|Overall Study|Lost to Follow-up|2|||
155208934|NCT03655691|560199808|FG000|Overall Study|Protocol Violation|0|||
155208935|NCT03655691|560199809|FG001|Overall Study|Protocol Violation|1|||
155208936|NCT03655691|560199810|FG002|Overall Study|Protocol Violation|0|||
155208937|NCT03655691|560199808|FG000|Overall Study|Withdrawal by Subject|1|||
155208938|NCT03655691|560199809|FG001|Overall Study|Withdrawal by Subject|1|||
155208939|NCT03655691|560199810|FG002|Overall Study|Withdrawal by Subject|0|||
155208940|NCT03694821|560199813|FG000|Overall Study|Study terminated|4|||
155208941|NCT03694821|560199814|FG001|Overall Study|Study terminated|8|||
155208942|NCT03694821|560199815|FG002|Overall Study|Study terminated|4|||
155208943|NCT04221009|560201918|FG000|Overall Study|Withdrawal by Subject|4|||
155208944|NCT00793598|560201919|FG000|Overall Study|Patient Request|0|||
155208945|NCT00793598|560201920|FG001|Overall Study|Patient Request|1|||
155208946|NCT00793598|560201921|FG002|Overall Study|Patient Request|0|||
155208947|NCT00793598|560201922|FG003|Overall Study|Patient Request|0|||
155208948|NCT00793598|560201923|FG004|Overall Study|Patient Request|0|||
155208949|NCT00793598|560201924|FG005|Overall Study|Patient Request|0|||
155208950|NCT00793598|560201925|FG006|Overall Study|Patient Request|0|||
155208951|NCT00793598|560201926|FG007|Overall Study|Patient Request|0|||
155208952|NCT00793598|560201919|FG000|Overall Study|Protocol Violation|0|||
155208953|NCT00793598|560201920|FG001|Overall Study|Protocol Violation|0|||
155208954|NCT00793598|560201921|FG002|Overall Study|Protocol Violation|0|||
155208955|NCT00793598|560201922|FG003|Overall Study|Protocol Violation|0|||
155208956|NCT00793598|560201923|FG004|Overall Study|Protocol Violation|0|||
155208957|NCT00793598|560201924|FG005|Overall Study|Protocol Violation|0|||
155208958|NCT00793598|560201925|FG006|Overall Study|Protocol Violation|0|||
155208959|NCT00793598|560201926|FG007|Overall Study|Protocol Violation|1|||
155208960|NCT00793598|560201919|FG000|Overall Study|Subject not dosed|0|||
155208961|NCT00793598|560201920|FG001|Overall Study|Subject not dosed|0|||
155208962|NCT00793598|560201921|FG002|Overall Study|Subject not dosed|0|||
155208963|NCT00793598|560201922|FG003|Overall Study|Subject not dosed|0|||
155208964|NCT00793598|560201923|FG004|Overall Study|Subject not dosed|0|||
155208965|NCT00793598|560201924|FG005|Overall Study|Subject not dosed|1|||
155208966|NCT00793598|560201925|FG006|Overall Study|Subject not dosed|0|||
155208967|NCT00793598|560201926|FG007|Overall Study|Subject not dosed|0|||
155208968|NCT02154490|560201927|FG000|Overall Study|No tissue submitted|23|||
155208969|NCT02154490|560201927|FG000|Overall Study|No biomarker results|167|||
155208970|NCT02154490|560201927|FG000|Overall Study|Not assigned to a sub-study|270|||
155208971|NCT02154490|560201927|FG000|Overall Study|Did not register to a sub-study|749|||
155208972|NCT01404325|560201928|FG000|Overall Study|Lost to Follow-up|1|||
155208973|NCT01404325|560201929|FG001|Overall Study|Lost to Follow-up|0|||
155208974|NCT01404325|560201928|FG000|Overall Study|Death|2|||
155208975|NCT01404325|560201929|FG001|Overall Study|Death|0|||
155208976|NCT01404325|560201928|FG000|Overall Study|Graft loss/Retransplantation|1|||
155208977|NCT01404325|560201929|FG001|Overall Study|Graft loss/Retransplantation|0|||
155208978|NCT01404325|560201928|FG000|Overall Study|non-specified reason|0|||
155208979|NCT01404325|560201929|FG001|Overall Study|non-specified reason|2|||
155208980|NCT00660023|560201932|FG000|Overall Study|Adverse Event|2|||
155208981|NCT00660023|560201932|FG000|Overall Study|Death|8|||
155208982|NCT00660023|560201932|FG000|Overall Study|Blood Transfusion|5|||
155208983|NCT00660023|560201932|FG000|Overall Study|Renal Transplantation|3|||
155208984|NCT00660023|560201932|FG000|Overall Study|Withdrawal by Subject|1|||
155208985|NCT00660023|560201932|FG000|Overall Study|Missed Pregnancy Test|1|||
155208986|NCT00660023|560201932|FG000|Overall Study|Other Screening Failure|9|||
155208987|NCT04180488|560201934|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208988|NCT04180488|560201935|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
155208989|NCT04180488|560201936|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
155208990|NCT04180488|560201937|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
155208991|NCT04180488|560201938|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208992|NCT04180488|560201939|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208993|NCT04180488|560201934|FG000|Overall Study|Withdrawal by Subject|8|||
155208994|NCT04180488|560201935|FG001|Overall Study|Withdrawal by Subject|4|||
155208995|NCT04180488|560201936|FG002|Overall Study|Withdrawal by Subject|5|||
155208996|NCT04180488|560201937|FG003|Overall Study|Withdrawal by Subject|2|||
155208997|NCT04180488|560201938|FG004|Overall Study|Withdrawal by Subject|8|||
155208998|NCT04180488|560201939|FG005|Overall Study|Withdrawal by Subject|6|||
155208999|NCT04180488|560201934|FG000|Overall Study|Adverse Event|3|||
155209000|NCT04180488|560201935|FG001|Overall Study|Adverse Event|2|||
155209001|NCT04180488|560201936|FG002|Overall Study|Adverse Event|0|||
155209002|NCT04180488|560201937|FG003|Overall Study|Adverse Event|0|||
155209003|NCT04180488|560201938|FG004|Overall Study|Adverse Event|0|||
155209004|NCT04180488|560201939|FG005|Overall Study|Adverse Event|0|||
155209005|NCT04180488|560201934|FG000|Overall Study|Poor compliance to protocol|0|||
155209006|NCT04180488|560201935|FG001|Overall Study|Poor compliance to protocol|0|||
155209007|NCT04180488|560201936|FG002|Overall Study|Poor compliance to protocol|1|||
155209008|NCT04180488|560201937|FG003|Overall Study|Poor compliance to protocol|0|||
155209009|NCT04180488|560201938|FG004|Overall Study|Poor compliance to protocol|0|||
155209010|NCT04180488|560201939|FG005|Overall Study|Poor compliance to protocol|0|||
155209011|NCT00464087|560201945|FG000|Overall Study|No PCI per inclusion criteria|0|||
155209012|NCT00464087|560201946|FG001|Overall Study|No PCI per inclusion criteria|0|||
155209013|NCT00464087|560201947|FG002|Overall Study|No PCI per inclusion criteria|29|||
155209014|NCT00418314|560201949|FG000|Overall Study|Withdrawal by Subject|1|||
155209015|NCT00418314|560201950|FG001|Overall Study|Withdrawal by Subject|2|||
155209016|NCT01224431|560201951|FG000|Overall Study|not randomized|0|||
155209017|NCT01224431|560201952|FG001|Overall Study|not randomized|4|||
155209018|NCT01224431|560201951|FG000|Overall Study|no video record|0|||
155209019|NCT01224431|560201952|FG001|Overall Study|no video record|1|||
155209020|NCT00549302|560201955|FG000|Double-Blind|Death|2|||
155209021|NCT00549302|560201956|FG001|Double-Blind|Death|9|||
155209022|NCT00549302|560201957|FG002|Double-Blind|Death|0|||
155209023|NCT00549302|560201955|FG000|Double-Blind|Adverse Event|3|||
155209024|NCT00549302|560201956|FG001|Double-Blind|Adverse Event|16|||
155209025|NCT00549302|560201957|FG002|Double-Blind|Adverse Event|0|||
155209026|NCT00549302|560201955|FG000|Double-Blind|Withdrawal by Subject|3|||
155209027|NCT00549302|560201956|FG001|Double-Blind|Withdrawal by Subject|8|||
155209028|NCT00549302|560201957|FG002|Double-Blind|Withdrawal by Subject|0|||
155209029|NCT00549302|560201955|FG000|Double-Blind|Investigator Decision|1|||
155209030|NCT00549302|560201956|FG001|Double-Blind|Investigator Decision|5|||
155209031|NCT00549302|560201957|FG002|Double-Blind|Investigator Decision|0|||
155209032|NCT00549302|560201955|FG000|Double-Blind|Sponsor Decision|0|||
155209033|NCT00549302|560201956|FG001|Double-Blind|Sponsor Decision|1|||
155209034|NCT00549302|560201957|FG002|Double-Blind|Sponsor Decision|0|||
155209035|NCT00549302|560201955|FG000|Double-Blind|Lost to Follow-up|1|||
155209036|NCT00549302|560201956|FG001|Double-Blind|Lost to Follow-up|2|||
155209037|NCT00549302|560201957|FG002|Double-Blind|Lost to Follow-up|0|||
155209038|NCT00549302|560201955|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
155209039|NCT00549302|560201956|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
155209040|NCT00549302|560201957|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
155209041|NCT00549302|560201955|FG000|Double-Blind|New condition or starts new therapy|0|||
155209042|NCT00549302|560201956|FG001|Double-Blind|New condition or starts new therapy|2|||
155209043|NCT00549302|560201957|FG002|Double-Blind|New condition or starts new therapy|0|||
155209044|NCT00549302|560201955|FG000|Open-Label|Adverse Event|0|||
155209045|NCT00549302|560201956|FG001|Open-Label|Adverse Event|0|||
155209046|NCT00549302|560201957|FG002|Open-Label|Adverse Event|11|||
155209047|NCT00549302|560201955|FG000|Open-Label|Death|0|||
155209048|NCT00549302|560201956|FG001|Open-Label|Death|0|||
155209049|NCT00549302|560201957|FG002|Open-Label|Death|40|||
155209050|NCT00549302|560201955|FG000|Open-Label|Investigator Decision|0|||
155209051|NCT00549302|560201956|FG001|Open-Label|Investigator Decision|0|||
155209052|NCT00549302|560201957|FG002|Open-Label|Investigator Decision|5|||
155209053|NCT00549302|560201955|FG000|Open-Label|Lost to Follow-up|0|||
155209054|NCT00549302|560201956|FG001|Open-Label|Lost to Follow-up|0|||
155209055|NCT00549302|560201957|FG002|Open-Label|Lost to Follow-up|2|||
155209056|NCT00549302|560201955|FG000|Open-Label|Other|0|||
155209057|NCT00549302|560201956|FG001|Open-Label|Other|0|||
155209058|NCT00549302|560201957|FG002|Open-Label|Other|3|||
155209059|NCT00549302|560201955|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
155209060|NCT00549302|560201956|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
155209061|NCT00549302|560201957|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
155209062|NCT00549302|560201955|FG000|Open-Label|Withdrawal by Subject|0|||
155209063|NCT00549302|560201956|FG001|Open-Label|Withdrawal by Subject|0|||
155209064|NCT00549302|560201957|FG002|Open-Label|Withdrawal by Subject|6|||
155209065|NCT03585504|560201958|FG000|Overall Study|Lost to Follow-up|26|||
155209066|NCT03585504|560201959|FG001|Overall Study|Lost to Follow-up|29|||
155209067|NCT03590041|560201960|FG000|Overall Study|Protocol Violation|4|||
155209068|NCT03590041|560201961|FG001|Overall Study|Protocol Violation|3|||
155209069|NCT03590041|560201960|FG000|Overall Study|No session data recorded|14|||
155209070|NCT03590041|560201961|FG001|Overall Study|No session data recorded|2|||
155209071|NCT02692703|560201962|FG000|Overall Study|Lost to Follow-up|1|||
155209072|NCT02692703|560201962|FG000|Overall Study|Other|1|||
155209073|NCT04626297|560201963|FG000|Overall Study|Adverse Event|5|||
155209074|NCT04626297|560201964|FG001|Overall Study|Adverse Event|3|||
155209075|NCT04626297|560201963|FG000|Overall Study|Lost to Follow-up|7|||
155209076|NCT04626297|560201964|FG001|Overall Study|Lost to Follow-up|3|||
155209077|NCT04626297|560201963|FG000|Overall Study|Protocol Violation|5|||
155209078|NCT04626297|560201964|FG001|Overall Study|Protocol Violation|1|||
155209079|NCT04626297|560201963|FG000|Overall Study|Withdrawal by Subject|20|||
155209080|NCT04626297|560201964|FG001|Overall Study|Withdrawal by Subject|6|||
155209081|NCT04626297|560201963|FG000|Overall Study|Sponsor decision|2|||
155209082|NCT04626297|560201964|FG001|Overall Study|Sponsor decision|1|||
155209083|NCT04118166|560201965|FG000|Overall Study|Adverse Event|1|||
155209084|NCT03303079|560201969|FG000|Overall Study|Adverse Event|0|||
155209085|NCT03303079|560201970|FG001|Overall Study|Adverse Event|1|||
155209086|NCT03303079|560201971|FG002|Overall Study|Adverse Event|3|||
155209087|NCT03303079|560201969|FG000|Overall Study|Protocol Violation|5|||
155209088|NCT03303079|560201970|FG001|Overall Study|Protocol Violation|4|||
155209089|NCT03303079|560201971|FG002|Overall Study|Protocol Violation|7|||
155209090|NCT03303079|560201969|FG000|Overall Study|Withdrawal by Subject|2|||
155209091|NCT03303079|560201970|FG001|Overall Study|Withdrawal by Subject|4|||
155209092|NCT03303079|560201971|FG002|Overall Study|Withdrawal by Subject|2|||
155209093|NCT03303079|560201969|FG000|Overall Study|Other than specified|0|||
155209094|NCT03303079|560201970|FG001|Overall Study|Other than specified|2|||
155209095|NCT03303079|560201971|FG002|Overall Study|Other than specified|0|||
155209096|NCT01829191|560201972|FG000|Overall Study|Relocation|0|||
155209097|NCT01829191|560201973|FG001|Overall Study|Relocation|1|||
155209098|NCT01829191|560201972|FG000|Overall Study|Lens discomfort|0|||
155209099|NCT01829191|560201973|FG001|Overall Study|Lens discomfort|3|||
155209100|NCT01829191|560201972|FG000|Overall Study|Lens handling difficulty|1|||
155209101|NCT01829191|560201973|FG001|Overall Study|Lens handling difficulty|4|||
155209102|NCT01829191|560201972|FG000|Overall Study|Protocol Violation|4|||
155209103|NCT01829191|560201973|FG001|Overall Study|Protocol Violation|1|||
155209104|NCT01829191|560201972|FG000|Overall Study|Withdrawal by Subject|2|||
155209105|NCT01829191|560201973|FG001|Overall Study|Withdrawal by Subject|3|||
155209106|NCT01829191|560201972|FG000|Overall Study|Lost to Follow-up|0|||
155209107|NCT01829191|560201973|FG001|Overall Study|Lost to Follow-up|1|||
155209108|NCT01829191|560201972|FG000|Overall Study|Subject was fit for ortho - k|0|||
155209109|NCT01829191|560201973|FG001|Overall Study|Subject was fit for ortho - k|1|||
155209110|NCT01276353|560201974|FG000|Double-blind|Adverse Event|2|||
155209111|NCT01276353|560201975|FG001|Double-blind|Adverse Event|0|||
155209112|NCT01276353|560201974|FG000|Double-blind|Withdrawal by Subject|1|||
155209113|NCT01276353|560201975|FG001|Double-blind|Withdrawal by Subject|0|||
155209114|NCT01276353|560201974|FG000|Extension|Adverse Event|2|||
155209115|NCT01276353|560201975|FG001|Extension|Adverse Event|5|||
155209116|NCT01276353|560201974|FG000|Extension|Withdrawal by Subject|1|||
155209117|NCT01276353|560201975|FG001|Extension|Withdrawal by Subject|2|||
155209118|NCT01276353|560201974|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
155209119|NCT01276353|560201975|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
155209120|NCT01276353|560201974|FG000|Extension|Physician Decision|1|||
155209121|NCT01276353|560201975|FG001|Extension|Physician Decision|0|||
155209122|NCT01276353|560201974|FG000|Extension|Prohibited concomitant medications|0|||
155209123|NCT01276353|560201975|FG001|Extension|Prohibited concomitant medications|1|||
155209124|NCT02205814|560201980|FG000|Overall Study|Lost to Follow-up|0|||
155209125|NCT02205814|560201981|FG001|Overall Study|Lost to Follow-up|0|||
155209126|NCT02205814|560201982|FG002|Overall Study|Lost to Follow-up|0|||
155209127|NCT02205814|560201983|FG003|Overall Study|Lost to Follow-up|1|||
155209128|NCT02205814|560201980|FG000|Overall Study|Lack of Efficacy|1|||
155209129|NCT02205814|560201981|FG001|Overall Study|Lack of Efficacy|0|||
155209130|NCT02205814|560201982|FG002|Overall Study|Lack of Efficacy|1|||
155209131|NCT02205814|560201983|FG003|Overall Study|Lack of Efficacy|1|||
155209132|NCT02205814|560201980|FG000|Overall Study|Physician Decision|0|||
155209133|NCT02205814|560201981|FG001|Overall Study|Physician Decision|0|||
155209134|NCT02205814|560201982|FG002|Overall Study|Physician Decision|1|||
155209135|NCT02205814|560201983|FG003|Overall Study|Physician Decision|0|||
155209136|NCT02205814|560201980|FG000|Overall Study|Protocol Violation|1|||
155209137|NCT02205814|560201981|FG001|Overall Study|Protocol Violation|0|||
155209138|NCT02205814|560201982|FG002|Overall Study|Protocol Violation|0|||
155209139|NCT02205814|560201983|FG003|Overall Study|Protocol Violation|1|||
155209140|NCT02205814|560201980|FG000|Overall Study|Withdrawal by Subject|0|||
155209141|NCT02205814|560201981|FG001|Overall Study|Withdrawal by Subject|1|||
155209142|NCT02205814|560201982|FG002|Overall Study|Withdrawal by Subject|2|||
155209143|NCT02205814|560201983|FG003|Overall Study|Withdrawal by Subject|1|||
155209144|NCT02205814|560201980|FG000|Overall Study|not compliant with study procedures|0|||
155209145|NCT02205814|560201981|FG001|Overall Study|not compliant with study procedures|0|||
155209146|NCT02205814|560201982|FG002|Overall Study|not compliant with study procedures|1|||
155209147|NCT02205814|560201983|FG003|Overall Study|not compliant with study procedures|0|||
155209148|NCT01426373|560201984|FG000|Overall Study|Adverse Event|6|||
155209149|NCT01426373|560201984|FG000|Overall Study|Lost to Follow-up|14|||
155209150|NCT01426373|560201984|FG000|Overall Study|Participant Convenience|10|||
155209151|NCT01426373|560201984|FG000|Overall Study|Miscellaneous Reasons|4|||
155209152|NCT02246660|560201985|FG000|Overall Study|Withdrawal by Subject|0|||
155209153|NCT02246660|560201986|FG001|Overall Study|Withdrawal by Subject|1|||
155209154|NCT02246660|560201987|FG002|Overall Study|Withdrawal by Subject|0|||
155209155|NCT02246660|560201985|FG000|Overall Study|Death|0|||
155209156|NCT02246660|560201986|FG001|Overall Study|Death|0|||
155209157|NCT02246660|560201987|FG002|Overall Study|Death|1|||
155209158|NCT00726661|560201988|FG000|Overall Study|Lost to Follow-up|36|||
155209159|NCT00726661|560201989|FG001|Overall Study|Lost to Follow-up|11|||
155209160|NCT00726661|560201988|FG000|Overall Study|Withdrawal by Subject|17|||
155209161|NCT00726661|560201989|FG001|Overall Study|Withdrawal by Subject|13|||
155209162|NCT00726661|560201988|FG000|Overall Study|Trial terminated by sponsor|214|||
155209163|NCT00726661|560201989|FG001|Overall Study|Trial terminated by sponsor|187|||
155209164|NCT00726661|560201988|FG000|Overall Study|Death|475|||
155209165|NCT00726661|560201989|FG001|Overall Study|Death|159|||
155209166|NCT00726661|560201988|FG000|Overall Study|Physician Decision|25|||
155209167|NCT00726661|560201989|FG001|Overall Study|Physician Decision|13|||
155209168|NCT00726661|560201988|FG000|Overall Study|Other|47|||
155209169|NCT00726661|560201989|FG001|Overall Study|Other|35|||
155209170|NCT00587639|560201992|FG000|Overall Study|Withdrawal by Subject|1|||
155209171|NCT01574326|560201993|FG000|Overall Study|Randomized but not treated|0|||
155209172|NCT01574326|560201994|FG001|Overall Study|Randomized but not treated|1|||
155209173|NCT01574326|560201993|FG000|Overall Study|Withdrawal by Participant|2|||
155209174|NCT01574326|560201994|FG001|Overall Study|Withdrawal by Participant|4|||
155209175|NCT01574326|560201993|FG000|Overall Study|Physician Decision|5|||
155209176|NCT01574326|560201994|FG001|Overall Study|Physician Decision|3|||
155209177|NCT01574326|560201993|FG000|Overall Study|Adverse Event|1|||
155209178|NCT01574326|560201994|FG001|Overall Study|Adverse Event|3|||
155209179|NCT01574326|560201993|FG000|Overall Study|Other: Mainly kidney transplant|8|||
155209180|NCT01574326|560201994|FG001|Overall Study|Other: Mainly kidney transplant|8|||
155209181|NCT00005937|560202004|FG000|Overall Study|Lack of Efficacy|5|||
155209182|NCT01288469|560202005|FG000|Overall Study|Adverse Event|4|||
155209183|NCT01288469|560202006|FG001|Overall Study|Adverse Event|1|||
155209184|NCT01288469|560202007|FG002|Overall Study|Adverse Event|1|||
155209185|NCT01288469|560202005|FG000|Overall Study|Poor compliance to protocol|0|||
155209186|NCT01288469|560202006|FG001|Overall Study|Poor compliance to protocol|1|||
155209187|NCT01288469|560202007|FG002|Overall Study|Poor compliance to protocol|0|||
155209188|NCT01288469|560202005|FG000|Overall Study|Participant Moved|1|||
155209189|NCT01288469|560202006|FG001|Overall Study|Participant Moved|0|||
155209190|NCT01288469|560202007|FG002|Overall Study|Participant Moved|0|||
155209191|NCT01288469|560202005|FG000|Overall Study|Consent withdrawn by subject|1|||
155209192|NCT01288469|560202006|FG001|Overall Study|Consent withdrawn by subject|1|||
155209193|NCT01288469|560202007|FG002|Overall Study|Consent withdrawn by subject|1|||
155209194|NCT01288469|560202005|FG000|Overall Study|Exclusion criteria finally met|1|||
155209195|NCT01288469|560202006|FG001|Overall Study|Exclusion criteria finally met|0|||
155209196|NCT01288469|560202007|FG002|Overall Study|Exclusion criteria finally met|0|||
155209197|NCT00582166|560202011|FG000|Overall Study|Death|1|||
155209198|NCT00582166|560202011|FG000|Overall Study|Ineligible pathology|1|||
155209199|NCT01606436|560202014|FG000|Overall Study|Withdrawal by Subject|0|||
155209200|NCT01606436|560202015|FG001|Overall Study|Withdrawal by Subject|0|||
155209201|NCT01606436|560202016|FG002|Overall Study|Withdrawal by Subject|1|||
155209202|NCT01606436|560202017|FG003|Overall Study|Withdrawal by Subject|1|||
155209203|NCT01606436|560202018|FG004|Overall Study|Withdrawal by Subject|1|||
155209204|NCT01606436|560202019|FG005|Overall Study|Withdrawal by Subject|0|||
155209205|NCT01606436|560202014|FG000|Overall Study|Adverse Event|0|||
155209206|NCT01606436|560202015|FG001|Overall Study|Adverse Event|0|||
155209207|NCT01606436|560202016|FG002|Overall Study|Adverse Event|1|||
155209208|NCT01606436|560202017|FG003|Overall Study|Adverse Event|0|||
155209209|NCT01606436|560202018|FG004|Overall Study|Adverse Event|0|||
155209210|NCT01606436|560202019|FG005|Overall Study|Adverse Event|0|||
155209211|NCT01606436|560202014|FG000|Overall Study|Sponsor Decision|0|||
155209212|NCT01606436|560202015|FG001|Overall Study|Sponsor Decision|0|||
155209213|NCT01606436|560202016|FG002|Overall Study|Sponsor Decision|0|||
155209214|NCT01606436|560202017|FG003|Overall Study|Sponsor Decision|1|||
155209215|NCT01606436|560202018|FG004|Overall Study|Sponsor Decision|0|||
155209216|NCT01606436|560202019|FG005|Overall Study|Sponsor Decision|0|||
155209217|NCT02859454|560202020|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
155209218|NCT04294472|560202021|FG000|Overall Study|Adverse Event|0|||
155209219|NCT04294472|560202022|FG001|Overall Study|Adverse Event|1|||
155209220|NCT04294472|560202023|FG002|Overall Study|Adverse Event|1|||
155209221|NCT04294472|560202021|FG000|Overall Study|Randomized but not treated|0|||
155209222|NCT04294472|560202022|FG001|Overall Study|Randomized but not treated|1|||
155209223|NCT04294472|560202023|FG002|Overall Study|Randomized but not treated|1|||
155209224|NCT00110149|560202024|FG000|Overall Study|Physician Decision|3|||
155209225|NCT02452398|560202025|FG000|Overall Study|Adverse Event|1|||
155209226|NCT02452398|560202025|FG000|Overall Study|Lost to Follow-up|28|||
155209227|NCT02452398|560202025|FG000|Overall Study|Physician Decision|2|||
155209228|NCT02452398|560202025|FG000|Overall Study|Withdrawal by Subject|6|||
155209229|NCT02452398|560202025|FG000|Overall Study|Moved away|4|||
155209230|NCT03944954|560202028|FG000|Overall Study|Withdrawal by Subject|22|||
155209231|NCT03944954|560202029|FG001|Overall Study|Withdrawal by Subject|4|||
155491330|NCT01298323|561223534|FG001|Overall Study|Lost to Follow-up|0|||
155491331|NCT01298323|561223533|FG000|Overall Study|Withdrawal by Subject|6|||
155491332|NCT01298323|561223534|FG001|Overall Study|Withdrawal by Subject|3|||
155491333|NCT01298323|561223533|FG000|Overall Study|Protocol Violation|1|||
155491334|NCT01298323|561223534|FG001|Overall Study|Protocol Violation|0|||
155491335|NCT01298323|561223533|FG000|Overall Study|Other|10|||
155491336|NCT01298323|561223534|FG001|Overall Study|Other|9|||
155491337|NCT01298323|561223533|FG000|Overall Study|Ongoing|55|||
155491338|NCT01298323|561223534|FG001|Overall Study|Ongoing|55|||
155491339|NCT01298323|561223533|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155491340|NCT01298323|561223534|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155491341|NCT01761565|561223535|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
155491342|NCT02161380|561223536|FG000|Overall Study|Lost to Follow-up|0|||
155491343|NCT02161380|561223537|FG001|Overall Study|Lost to Follow-up|1|||
155491344|NCT02161380|561223538|FG002|Overall Study|Lost to Follow-up|0|||
155491345|NCT02161380|561223539|FG003|Overall Study|Lost to Follow-up|0|||
155491346|NCT04409262|561223541|FG000|Overall Study|Adverse Event|0|||
155491347|NCT04409262|561223542|FG001|Overall Study|Adverse Event|2|||
155491348|NCT04409262|561223541|FG000|Overall Study|Death|55|||
155491349|NCT04409262|561223542|FG001|Overall Study|Death|97|||
155491350|NCT04409262|561223541|FG000|Overall Study|Lost to Follow-up|12|||
155491351|NCT04409262|561223542|FG001|Overall Study|Lost to Follow-up|23|||
155491352|NCT04409262|561223541|FG000|Overall Study|Lack of Staff|0|||
155491353|NCT04409262|561223542|FG001|Overall Study|Lack of Staff|1|||
155491354|NCT04409262|561223541|FG000|Overall Study|Protocol Violation|3|||
155491355|NCT04409262|561223542|FG001|Overall Study|Protocol Violation|1|||
155491356|NCT04409262|561223541|FG000|Overall Study|Withdrawal by Subject|5|||
155491357|NCT04409262|561223542|FG001|Overall Study|Withdrawal by Subject|10|||
155491358|NCT00948896|561223545|FG000|Randomization to 24 Months of Age|Death|1|||
155491359|NCT00948896|561223546|FG001|Randomization to 24 Months of Age|Death|0|||
155491360|NCT00948896|561223547|FG002|Randomization to 24 Months of Age|Death|0|||
155491361|NCT00948896|561223548|FG003|Randomization to 24 Months of Age|Death|0|||
155491362|NCT00948896|561223549|FG004|Randomization to 24 Months of Age|Death|2|||
155491363|NCT00948896|561223550|FG005|Randomization to 24 Months of Age|Death|1|||
155491364|NCT00948896|561223551|FG006|Randomization to 24 Months of Age|Death|2|||
155491365|NCT00948896|561223552|FG007|Randomization to 24 Months of Age|Death|1|||
155491366|NCT00948896|561223545|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
155491367|NCT00948896|561223546|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
155491368|NCT00948896|561223547|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
155491369|NCT00948896|561223548|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
155491370|NCT00948896|561223549|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
155491371|NCT00948896|561223550|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
155491372|NCT00948896|561223551|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
155491373|NCT00948896|561223552|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
155491374|NCT00948896|561223545|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
155491375|NCT00948896|561223546|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
155491376|NCT00948896|561223547|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
155491377|NCT00948896|561223548|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
155491378|NCT00948896|561223549|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
155491379|NCT00948896|561223550|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
155491380|NCT00948896|561223551|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
155491381|NCT00948896|561223552|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
155491382|NCT00948896|561223545|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
155491383|NCT00948896|561223546|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
155491384|NCT00948896|561223547|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
155491385|NCT00948896|561223548|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
155491386|NCT00948896|561223549|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
155491387|NCT00948896|561223550|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
155491388|NCT00948896|561223551|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
155491389|NCT00948896|561223552|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
155491390|NCT00948896|561223545|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
155209232|NCT03944954|560202028|FG000|Overall Study|Lost to Follow-up|18|||
155209233|NCT03944954|560202029|FG001|Overall Study|Lost to Follow-up|0|||
155209234|NCT03944954|560202028|FG000|Overall Study|Failed Medical Screening|7|||
155209235|NCT03944954|560202029|FG001|Overall Study|Failed Medical Screening|0|||
155209236|NCT00748033|560202030|FG000|Overall Study|Adverse Event|0|||
155209237|NCT00748033|560202031|FG001|Overall Study|Adverse Event|1|||
155209238|NCT01018186|560202032|FG000|2-week Run-in Period|Protocol Violation|1|||
155209239|NCT01018186|560202033|FG001|2-week Run-in Period|Protocol Violation|0|||
155209240|NCT01018186|560202034|FG002|2-week Run-in Period|Protocol Violation|0|||
155209241|NCT01018186|560202035|FG003|2-week Run-in Period|Protocol Violation|0|||
155209242|NCT01018186|560202032|FG000|2-week Run-in Period|Lost to Follow-up|2|||
155209243|NCT01018186|560202033|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155209244|NCT01018186|560202034|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155209245|NCT01018186|560202035|FG003|2-week Run-in Period|Lost to Follow-up|0|||
155209246|NCT01018186|560202032|FG000|2-week Run-in Period|Physician Decision|3|||
155209247|NCT01018186|560202033|FG001|2-week Run-in Period|Physician Decision|0|||
155209248|NCT01018186|560202034|FG002|2-week Run-in Period|Physician Decision|0|||
155209249|NCT01018186|560202035|FG003|2-week Run-in Period|Physician Decision|0|||
155209250|NCT01018186|560202032|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
155209251|NCT01018186|560202033|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155209252|NCT01018186|560202034|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155209253|NCT01018186|560202035|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
155209254|NCT01018186|560202032|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
155209255|NCT01018186|560202033|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209256|NCT01018186|560202034|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209257|NCT01018186|560202035|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209258|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
155209259|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
155209260|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
155209261|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
155209262|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
155209263|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
155209264|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
155209265|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
155209266|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
155209267|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
155209268|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
155209269|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
155209270|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
155209271|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
155209272|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
155209273|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
155209274|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
155209275|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
155209276|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
155209277|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
155209278|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
155209279|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
155209280|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
155209281|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
155209282|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155209283|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
155209284|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
155209285|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
155209286|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209287|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
155209288|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209289|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209290|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209291|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209292|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
155209293|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
155209294|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
155209295|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
155209296|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
155209297|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
155209298|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
155209299|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209300|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
155209301|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209302|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
155209303|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209304|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209305|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209306|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209307|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209308|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
155209309|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209310|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209311|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
155209312|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209313|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209314|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209315|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209316|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
155209317|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209318|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209319|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
155209320|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209321|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
155209322|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209323|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209324|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209325|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
155209326|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209327|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209328|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209329|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209330|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209331|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209332|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209333|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
155209334|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209335|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209336|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209337|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209338|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209339|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
155209340|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209341|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209342|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209343|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209344|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209345|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
155209346|NCT04102020|560202046|FG000|Overall Study|Adverse Event|1|||
155209347|NCT04102020|560202047|FG001|Overall Study|Adverse Event|0|||
155209348|NCT04102020|560202048|FG002|Overall Study|Adverse Event|0|||
155209349|NCT04102020|560202049|FG003|Overall Study|Adverse Event|1|||
155209350|NCT04102020|560202050|FG004|Overall Study|Adverse Event|0|||
155209351|NCT04102020|560202046|FG000|Overall Study|Withdrawal by Subject|0|||
155209352|NCT04102020|560202047|FG001|Overall Study|Withdrawal by Subject|1|||
155209353|NCT04102020|560202048|FG002|Overall Study|Withdrawal by Subject|1|||
155209354|NCT04102020|560202049|FG003|Overall Study|Withdrawal by Subject|1|||
155209355|NCT04102020|560202050|FG004|Overall Study|Withdrawal by Subject|1|||
155209356|NCT04102020|560202046|FG000|Overall Study|Death|1|||
155209357|NCT04102020|560202047|FG001|Overall Study|Death|4|||
155209358|NCT04102020|560202048|FG002|Overall Study|Death|1|||
155209359|NCT04102020|560202049|FG003|Overall Study|Death|1|||
155209360|NCT04102020|560202050|FG004|Overall Study|Death|0|||
155209361|NCT04102020|560202046|FG000|Overall Study|Physician Decision|1|||
155209362|NCT04102020|560202047|FG001|Overall Study|Physician Decision|2|||
155209363|NCT04102020|560202048|FG002|Overall Study|Physician Decision|2|||
155209364|NCT04102020|560202049|FG003|Overall Study|Physician Decision|0|||
155209365|NCT04102020|560202050|FG004|Overall Study|Physician Decision|1|||
155209366|NCT04102020|560202046|FG000|Overall Study|COVID-19 Infection|1|||
155209367|NCT04102020|560202047|FG001|Overall Study|COVID-19 Infection|0|||
155209368|NCT04102020|560202048|FG002|Overall Study|COVID-19 Infection|0|||
155209369|NCT04102020|560202049|FG003|Overall Study|COVID-19 Infection|0|||
155209370|NCT04102020|560202050|FG004|Overall Study|COVID-19 Infection|0|||
155209371|NCT04102020|560202046|FG000|Overall Study|Not disclosed|5|||
155209372|NCT04102020|560202047|FG001|Overall Study|Not disclosed|3|||
155209373|NCT04102020|560202048|FG002|Overall Study|Not disclosed|8|||
155209374|NCT04102020|560202049|FG003|Overall Study|Not disclosed|0|||
155209375|NCT04102020|560202050|FG004|Overall Study|Not disclosed|1|||
155209376|NCT04102020|560202046|FG000|Overall Study|MIssing|1|||
155209377|NCT04102020|560202047|FG001|Overall Study|MIssing|0|||
155209378|NCT04102020|560202048|FG002|Overall Study|MIssing|1|||
155209379|NCT04102020|560202049|FG003|Overall Study|MIssing|1|||
155209380|NCT04102020|560202050|FG004|Overall Study|MIssing|1|||
155209381|NCT04102020|560202046|FG000|Overall Study|Continuing in ongoing study|13|||
155209382|NCT04102020|560202047|FG001|Overall Study|Continuing in ongoing study|13|||
155209383|NCT04102020|560202048|FG002|Overall Study|Continuing in ongoing study|7|||
155209384|NCT04102020|560202049|FG003|Overall Study|Continuing in ongoing study|26|||
155209385|NCT04102020|560202050|FG004|Overall Study|Continuing in ongoing study|12|||
155209386|NCT05109442|560202051|FG000|Overall Study|Withdrawal by Subject|0|||
155209387|NCT05109442|560202052|FG001|Overall Study|Withdrawal by Subject|0|||
155209388|NCT05109442|560202053|FG002|Overall Study|Withdrawal by Subject|1|||
155209389|NCT05109442|560202054|FG003|Overall Study|Withdrawal by Subject|0|||
155209390|NCT05109442|560202055|FG004|Overall Study|Withdrawal by Subject|0|||
155209391|NCT05109442|560202056|FG005|Overall Study|Withdrawal by Subject|0|||
155209392|NCT05109442|560202051|FG000|Overall Study|Adverse Event|0|||
155209393|NCT05109442|560202052|FG001|Overall Study|Adverse Event|1|||
155209394|NCT05109442|560202053|FG002|Overall Study|Adverse Event|5|||
155209395|NCT05109442|560202054|FG003|Overall Study|Adverse Event|0|||
155209396|NCT05109442|560202055|FG004|Overall Study|Adverse Event|0|||
155209397|NCT05109442|560202056|FG005|Overall Study|Adverse Event|2|||
155209398|NCT05109442|560202051|FG000|Overall Study|Death|0|||
155209399|NCT05109442|560202052|FG001|Overall Study|Death|0|||
155209400|NCT05109442|560202053|FG002|Overall Study|Death|4|||
155209401|NCT05109442|560202054|FG003|Overall Study|Death|0|||
155209402|NCT05109442|560202055|FG004|Overall Study|Death|0|||
155209403|NCT05109442|560202056|FG005|Overall Study|Death|1|||
155209404|NCT05109442|560202051|FG000|Overall Study|Physician Decision|1|||
155209405|NCT05109442|560202052|FG001|Overall Study|Physician Decision|0|||
155209406|NCT05109442|560202053|FG002|Overall Study|Physician Decision|1|||
155209407|NCT05109442|560202054|FG003|Overall Study|Physician Decision|0|||
155209408|NCT05109442|560202055|FG004|Overall Study|Physician Decision|0|||
155209409|NCT05109442|560202056|FG005|Overall Study|Physician Decision|2|||
155209410|NCT05109442|560202051|FG000|Overall Study|Other than listed|0|||
155209411|NCT05109442|560202052|FG001|Overall Study|Other than listed|0|||
155209412|NCT05109442|560202053|FG002|Overall Study|Other than listed|9|||
155209413|NCT05109442|560202054|FG003|Overall Study|Other than listed|2|||
155209414|NCT05109442|560202055|FG004|Overall Study|Other than listed|0|||
155209415|NCT05109442|560202056|FG005|Overall Study|Other than listed|8|||
155209416|NCT05109442|560202051|FG000|Overall Study|Lack of Efficacy|3|||
155209417|NCT05109442|560202052|FG001|Overall Study|Lack of Efficacy|5|||
155209418|NCT05109442|560202053|FG002|Overall Study|Lack of Efficacy|29|||
155209419|NCT05109442|560202054|FG003|Overall Study|Lack of Efficacy|10|||
155209420|NCT05109442|560202055|FG004|Overall Study|Lack of Efficacy|11|||
155209421|NCT05109442|560202056|FG005|Overall Study|Lack of Efficacy|17|||
155209422|NCT04853225|560202061|FG000|Overall Study|Withdrawal by Subject|81|||
155209423|NCT04853225|560202062|FG001|Overall Study|Withdrawal by Subject|4|||
155209424|NCT04853225|560202063|FG002|Overall Study|Withdrawal by Subject|1|||
155209425|NCT04853225|560202061|FG000|Overall Study|Physician Decision|12|||
155209426|NCT04853225|560202062|FG001|Overall Study|Physician Decision|4|||
155209427|NCT04853225|560202063|FG002|Overall Study|Physician Decision|1|||
155209428|NCT04853225|560202061|FG000|Overall Study|Lost to Follow-up|50|||
155209429|NCT04853225|560202062|FG001|Overall Study|Lost to Follow-up|0|||
155209430|NCT04853225|560202063|FG002|Overall Study|Lost to Follow-up|0|||
155209431|NCT04853225|560202061|FG000|Overall Study|Other|102|||
155209432|NCT04853225|560202062|FG001|Overall Study|Other|11|||
155209433|NCT04853225|560202063|FG002|Overall Study|Other|5|||
155209434|NCT04853225|560202061|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
155209435|NCT04853225|560202062|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
155209436|NCT04853225|560202063|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
155209437|NCT04853225|560202061|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
155209438|NCT04853225|560202062|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
155209439|NCT04853225|560202063|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
155209440|NCT03918447|560202064|FG000|Overall Study|Death|1|||
155209441|NCT03918447|560202065|FG001|Overall Study|Death|0|||
155209442|NCT03918447|560202064|FG000|Overall Study|Lost to Follow-up|13|||
155209443|NCT03918447|560202065|FG001|Overall Study|Lost to Follow-up|6|||
155209444|NCT03918447|560202064|FG000|Overall Study|Withdrawal by Subject|19|||
155209445|NCT03918447|560202065|FG001|Overall Study|Withdrawal by Subject|17|||
155209446|NCT03918447|560202064|FG000|Overall Study|Study Terminated by Sponsor|195|||
155209447|NCT03918447|560202065|FG001|Overall Study|Study Terminated by Sponsor|197|||
155209448|NCT03918447|560202064|FG000|Overall Study|Reason not Specified|0|||
155209449|NCT03918447|560202065|FG001|Overall Study|Reason not Specified|1|||
155209450|NCT03278613|560202066|FG000|Overall Study|Lost to Follow-up|3|||
155209451|NCT03278613|560202067|FG001|Overall Study|Lost to Follow-up|1|||
155209452|NCT01405456|560202068|FG000|Overall Study|Lost to Follow-up|2|||
155209453|NCT01405456|560202069|FG001|Overall Study|Lost to Follow-up|1|||
155209454|NCT01405456|560202068|FG000|Overall Study|Physician Decision|1|||
155209455|NCT01405456|560202069|FG001|Overall Study|Physician Decision|0|||
155209456|NCT05475236|560202070|FG000|Overall Study|Withdrawal by Subject|0|||
155209457|NCT05475236|560202071|FG001|Overall Study|Withdrawal by Subject|1|||
155209458|NCT01774968|560202072|FG000|Overall Study|Adverse Event|4|||
155209459|NCT01774968|560202073|FG001|Overall Study|Adverse Event|4|||
155209460|NCT01774968|560202072|FG000|Overall Study|Death|0|||
155209461|NCT01774968|560202073|FG001|Overall Study|Death|1|||
155209462|NCT01774968|560202072|FG000|Overall Study|Lost to Follow-up|1|||
155209463|NCT01774968|560202073|FG001|Overall Study|Lost to Follow-up|3|||
155209464|NCT01774968|560202072|FG000|Overall Study|Physician Decision|5|||
155209465|NCT01774968|560202073|FG001|Overall Study|Physician Decision|1|||
155209466|NCT01774968|560202072|FG000|Overall Study|Protocol Violation|14|||
155209467|NCT01774968|560202073|FG001|Overall Study|Protocol Violation|13|||
155209468|NCT01774968|560202072|FG000|Overall Study|Sponsor Decision|0|||
155209469|NCT01774968|560202073|FG001|Overall Study|Sponsor Decision|2|||
155209470|NCT01774968|560202072|FG000|Overall Study|Withdrawal by Subject|6|||
155209471|NCT01774968|560202073|FG001|Overall Study|Withdrawal by Subject|11|||
155209472|NCT05355805|560202076|FG000|Overall Study|Lost to Follow-up|6|||
155209473|NCT05355805|560202077|FG001|Overall Study|Lost to Follow-up|11|||
155209474|NCT05355805|560202078|FG002|Overall Study|Lost to Follow-up|10|||
155209475|NCT05355805|560202079|FG003|Overall Study|Lost to Follow-up|6|||
155209476|NCT05355805|560202076|FG000|Overall Study|Decision by Sponsor|0|||
155209477|NCT05355805|560202077|FG001|Overall Study|Decision by Sponsor|0|||
155209478|NCT05355805|560202078|FG002|Overall Study|Decision by Sponsor|1|||
155209479|NCT05355805|560202079|FG003|Overall Study|Decision by Sponsor|0|||
155209480|NCT05355805|560202076|FG000|Overall Study|Withdrawal by Subject|7|||
155209481|NCT05355805|560202077|FG001|Overall Study|Withdrawal by Subject|14|||
155209482|NCT05355805|560202078|FG002|Overall Study|Withdrawal by Subject|15|||
155209483|NCT05355805|560202079|FG003|Overall Study|Withdrawal by Subject|13|||
155209484|NCT04847557|560202081|FG000|Overall Study|Adverse Event|1|||
155209485|NCT04847557|560202082|FG001|Overall Study|Adverse Event|0|||
155209486|NCT04847557|560202081|FG000|Overall Study|Death|19|||
155209487|NCT04847557|560202082|FG001|Overall Study|Death|15|||
155209488|NCT04847557|560202081|FG000|Overall Study|Lost to Follow-up|3|||
155209489|NCT04847557|560202082|FG001|Overall Study|Lost to Follow-up|6|||
155209490|NCT04847557|560202081|FG000|Overall Study|Physician Decision|1|||
155209491|NCT04847557|560202082|FG001|Overall Study|Physician Decision|0|||
155209492|NCT04847557|560202081|FG000|Overall Study|Protocol Violation|0|||
155209493|NCT04847557|560202082|FG001|Overall Study|Protocol Violation|1|||
155209494|NCT04847557|560202081|FG000|Overall Study|Withdrawal by Subject|8|||
155209495|NCT04847557|560202082|FG001|Overall Study|Withdrawal by Subject|14|||
155209496|NCT01325584|560202083|FG000|Overall Study|Death|1|||
155209497|NCT01986855|560203506|FG000|Overall Study|Adverse Event|1|||
155209498|NCT01986855|560203507|FG001|Overall Study|Adverse Event|0|||
155209499|NCT01986855|560203508|FG002|Overall Study|Adverse Event|0|||
155209500|NCT01986855|560203506|FG000|Overall Study|Death|3|||
155209501|NCT01986855|560203507|FG001|Overall Study|Death|4|||
155209502|NCT01986855|560203508|FG002|Overall Study|Death|4|||
155209503|NCT01986855|560203506|FG000|Overall Study|Lost to Follow-up|2|||
155209504|NCT01986855|560203507|FG001|Overall Study|Lost to Follow-up|1|||
155209505|NCT01986855|560203508|FG002|Overall Study|Lost to Follow-up|0|||
155209506|NCT01986855|560203506|FG000|Overall Study|Screen Failure|0|||
155209507|NCT01986855|560203507|FG001|Overall Study|Screen Failure|1|||
155209508|NCT01986855|560203508|FG002|Overall Study|Screen Failure|0|||
155209509|NCT01986855|560203506|FG000|Overall Study|Participant Moved|0|||
155209510|NCT01986855|560203507|FG001|Overall Study|Participant Moved|0|||
155209511|NCT01986855|560203508|FG002|Overall Study|Participant Moved|2|||
155209512|NCT01986855|560203506|FG000|Overall Study|Withdrawal by Subject|7|||
155209513|NCT01986855|560203507|FG001|Overall Study|Withdrawal by Subject|8|||
155209514|NCT01986855|560203508|FG002|Overall Study|Withdrawal by Subject|5|||
155209515|NCT04317066|560203509|FG000|Overall Study|Sponsor decision|5|||
155209516|NCT04317066|560203509|FG000|Overall Study|Death|2|||
155209517|NCT02825992|560203513|FG000|Overall Study|Withdrawal by Subject|4|||
155209518|NCT02825992|560203513|FG000|Overall Study|Lost to Follow-up|2|||
155209519|NCT02825992|560203513|FG000|Overall Study|Procedure terminated|2|||
155209520|NCT02279173|560203517|FG000|Overall Study|Protocol-specified Criteria|67|||
155209521|NCT02279173|560203517|FG000|Overall Study|Withdrawal by Subject|20|||
155209522|NCT02279173|560203517|FG000|Overall Study|Decision by Sponsor|4|||
155209523|NCT02279173|560203517|FG000|Overall Study|Lost to Follow-up|3|||
155209524|NCT01164956|560203519|FG000|Overall Study|Side Effects|1|||
155209525|NCT01164956|560203520|FG001|Overall Study|Side Effects|0|||
155209526|NCT01164956|560203521|FG002|Overall Study|Side Effects|1|||
155209527|NCT00609492|560203522|FG000|Overall Study|Withdrawal by Subject|0|||
155209528|NCT00609492|560203523|FG001|Overall Study|Withdrawal by Subject|2|||
155209529|NCT00609492|560203524|FG002|Overall Study|Withdrawal by Subject|3|||
155209530|NCT00609492|560203522|FG000|Overall Study|Lost to Follow-up|1|||
155209531|NCT00609492|560203523|FG001|Overall Study|Lost to Follow-up|1|||
155209532|NCT00609492|560203524|FG002|Overall Study|Lost to Follow-up|4|||
155209533|NCT00720434|560203525|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209534|NCT00720434|560203526|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
155209535|NCT00720434|560203527|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209536|NCT00720434|560203528|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209537|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209538|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209539|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209540|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
155209541|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
155209542|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209543|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209544|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209545|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
155209546|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
155209547|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
155209548|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
155209549|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Other|4|||
155209550|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Other|3|||
155209551|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Other|3|||
155209552|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Other|2|||
155209553|NCT02425046|560203529|FG000|Overall Study|Lost to Follow-up|52|||
155209554|NCT02425046|560203530|FG001|Overall Study|Lost to Follow-up|50|||
155209555|NCT02425046|560203531|FG002|Overall Study|Lost to Follow-up|56|||
155209556|NCT02425046|560203529|FG000|Overall Study|Withdrawal by Subject|16|||
155209557|NCT02425046|560203530|FG001|Overall Study|Withdrawal by Subject|12|||
155209558|NCT02425046|560203531|FG002|Overall Study|Withdrawal by Subject|0|||
155209559|NCT02782780|560203532|FG000|Overall Study|dropped out after randomization.|7|||
155209560|NCT02782780|560203533|FG001|Overall Study|dropped out after randomization.|5|||
155209561|NCT02782780|560203532|FG000|Overall Study|Protocol Violation|0|||
155209562|NCT02782780|560203533|FG001|Overall Study|Protocol Violation|2|||
155209563|NCT01413191|560203534|FG000|Overall Study|Lost to Follow-up|5|||
155209564|NCT01413191|560203534|FG000|Overall Study|Disease Progression|5|||
155209565|NCT01413191|560203534|FG000|Overall Study|Death|1|||
155209566|NCT02904512|560203535|FG000|Overall Study|Withdrawal by Subject|1|||
155209567|NCT02904512|560203536|FG001|Overall Study|Withdrawal by Subject|0|||
155209568|NCT02904512|560203535|FG000|Overall Study|Transferred to ICU|1|||
155209569|NCT02904512|560203536|FG001|Overall Study|Transferred to ICU|0|||
155209570|NCT02904512|560203535|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
155209571|NCT02904512|560203536|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
155209572|NCT01963403|560203551|FG000|Overall Study|Lost to Follow-up|2|||
155209573|NCT01963403|560203552|FG001|Overall Study|Lost to Follow-up|3|||
155209574|NCT01963403|560203551|FG000|Overall Study|Implant removal|0|||
155209575|NCT01963403|560203552|FG001|Overall Study|Implant removal|1|||
155209576|NCT00589914|560203553|FG000|Overall Study|Adverse Event|19|||
155209577|NCT00589914|560203554|FG001|Overall Study|Adverse Event|10|||
155209578|NCT00589914|560203553|FG000|Overall Study|Death|2|||
155209579|NCT00589914|560203554|FG001|Overall Study|Death|0|||
155209580|NCT00589914|560203553|FG000|Overall Study|Lack of Efficacy|40|||
155209581|NCT00589914|560203554|FG001|Overall Study|Lack of Efficacy|43|||
155209582|NCT00589914|560203553|FG000|Overall Study|Lost to Follow-up|11|||
155209583|NCT00589914|560203554|FG001|Overall Study|Lost to Follow-up|18|||
155209584|NCT00589914|560203553|FG000|Overall Study|Pregnancy|1|||
155209585|NCT00589914|560203554|FG001|Overall Study|Pregnancy|0|||
155209586|NCT00589914|560203553|FG000|Overall Study|Withdrawal by Subject|55|||
155209587|NCT00589914|560203554|FG001|Overall Study|Withdrawal by Subject|49|||
155209588|NCT00589914|560203553|FG000|Overall Study|Other|22|||
155209589|NCT00589914|560203554|FG001|Overall Study|Other|17|||
155209590|NCT03519932|560203555|FG000|First Intervention|Adverse Event|1|||
155209591|NCT03519932|560203556|FG001|First Intervention|Adverse Event|3|||
155209592|NCT01979016|560203557|FG000|Overall Study|Withdrawal by Subject|2|||
155209593|NCT01979016|560203558|FG001|Overall Study|Withdrawal by Subject|0|||
155209594|NCT01979016|560203557|FG000|Overall Study|Adverse Event|0|||
155209595|NCT01979016|560203558|FG001|Overall Study|Adverse Event|1|||
155209596|NCT01442493|560203559|FG000|Overall Study|withdrawn from study|3|||
155209597|NCT01442493|560203560|FG001|Overall Study|withdrawn from study|2|||
155209598|NCT04326231|560203562|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
155209599|NCT00759954|560203563|FG000|Overall Study|Personal reason|1|||
155209600|NCT00759954|560203564|FG001|Overall Study|Personal reason|0|||
155209601|NCT00759954|560203563|FG000|Overall Study|Adverse Event|1|||
155209602|NCT00759954|560203564|FG001|Overall Study|Adverse Event|2|||
155209603|NCT00372112|560203566|FG000|Overall Study|Adverse Event|0|||
155209604|NCT00372112|560203567|FG001|Overall Study|Adverse Event|1|||
155209605|NCT00372112|560203568|FG002|Overall Study|Adverse Event|1|||
155209606|NCT00372112|560203569|FG003|Overall Study|Adverse Event|1|||
155209607|NCT00372112|560203566|FG000|Overall Study|Withdrawal by Subject|0|||
155209608|NCT00372112|560203567|FG001|Overall Study|Withdrawal by Subject|0|||
155209609|NCT00372112|560203568|FG002|Overall Study|Withdrawal by Subject|2|||
155209610|NCT00372112|560203569|FG003|Overall Study|Withdrawal by Subject|1|||
155209611|NCT00372112|560203566|FG000|Overall Study|Exacerbation|0|||
155209612|NCT00372112|560203567|FG001|Overall Study|Exacerbation|0|||
155209613|NCT00372112|560203568|FG002|Overall Study|Exacerbation|0|||
155209614|NCT00372112|560203569|FG003|Overall Study|Exacerbation|1|||
155209615|NCT00372112|560203566|FG000|Overall Study|PR >240 at Visit 3|0|||
155209616|NCT00372112|560203567|FG001|Overall Study|PR >240 at Visit 3|0|||
155209617|NCT00372112|560203568|FG002|Overall Study|PR >240 at Visit 3|0|||
155209618|NCT00372112|560203569|FG003|Overall Study|PR >240 at Visit 3|1|||
155209619|NCT00372112|560203566|FG000|Overall Study|Hepatitis B|1|||
155209620|NCT00372112|560203567|FG001|Overall Study|Hepatitis B|0|||
155209621|NCT00372112|560203568|FG002|Overall Study|Hepatitis B|0|||
155209622|NCT00372112|560203569|FG003|Overall Study|Hepatitis B|0|||
155209623|NCT00372112|560203566|FG000|Overall Study|Other-protocol violation|0|||
155209624|NCT00372112|560203567|FG001|Overall Study|Other-protocol violation|0|||
155209625|NCT00372112|560203568|FG002|Overall Study|Other-protocol violation|1|||
155209626|NCT00372112|560203569|FG003|Overall Study|Other-protocol violation|0|||
155209627|NCT02706691|560203570|FG000|Overall Study|Adverse Event|1|||
155209628|NCT02927431|560203571|FG000|Overall Study|Withdrawal by Subject|0|||
155209629|NCT02927431|560203572|FG001|Overall Study|Withdrawal by Subject|0|||
155209630|NCT02927431|560203573|FG002|Overall Study|Withdrawal by Subject|1|||
155209631|NCT01830972|560203574|FG000|Part II|Withdrawal by Subject|2|||
155209632|NCT01830972|560203575|FG001|Part II|Withdrawal by Subject|2|||
155209633|NCT01830972|560203574|FG000|Part III|Withdrawal by Subject|1|||
155209634|NCT01830972|560203575|FG001|Part III|Withdrawal by Subject|0|||
155209635|NCT01830972|560203574|FG000|Part III|Noncompliance|1|||
155209636|NCT01830972|560203575|FG001|Part III|Noncompliance|0|||
155209637|NCT01830972|560203574|FG000|Part IV|Withdrawal by Subject|2|||
155209638|NCT01830972|560203575|FG001|Part IV|Withdrawal by Subject|1|||
155209639|NCT01830972|560203574|FG000|Part IV|Non-Compliance|1|||
155209640|NCT01830972|560203575|FG001|Part IV|Non-Compliance|0|||
155209641|NCT00553514|560203576|FG000|Overall Study|Protocol deviation|0|||
155209642|NCT00553514|560203577|FG001|Overall Study|Protocol deviation|0|||
155209643|NCT00553514|560203578|FG002|Overall Study|Protocol deviation|0|||
155209644|NCT00553514|560203579|FG003|Overall Study|Protocol deviation|1|||
155209645|NCT00553514|560203580|FG004|Overall Study|Protocol deviation|0|||
155209646|NCT00553514|560203576|FG000|Overall Study|Lack of ovarian response|4|||
155209647|NCT00553514|560203577|FG001|Overall Study|Lack of ovarian response|5|||
155209648|NCT00553514|560203578|FG002|Overall Study|Lack of ovarian response|5|||
155209649|NCT00553514|560203579|FG003|Overall Study|Lack of ovarian response|5|||
155209650|NCT00553514|560203580|FG004|Overall Study|Lack of ovarian response|6|||
155209651|NCT00553514|560203576|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
155209652|NCT00553514|560203577|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209653|NCT00553514|560203578|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155209654|NCT00553514|560203579|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209655|NCT00553514|560203580|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209656|NCT00553514|560203576|FG000|Overall Study|Risk of multiple pregnancy|0|||
155209657|NCT00553514|560203577|FG001|Overall Study|Risk of multiple pregnancy|2|||
155209658|NCT00553514|560203578|FG002|Overall Study|Risk of multiple pregnancy|0|||
155209659|NCT00553514|560203579|FG003|Overall Study|Risk of multiple pregnancy|1|||
155209660|NCT00553514|560203580|FG004|Overall Study|Risk of multiple pregnancy|0|||
155209661|NCT00553514|560203576|FG000|Overall Study|Other|1|||
155209662|NCT00553514|560203577|FG001|Overall Study|Other|1|||
155209663|NCT00553514|560203578|FG002|Overall Study|Other|0|||
155209664|NCT00553514|560203579|FG003|Overall Study|Other|0|||
155209665|NCT00553514|560203580|FG004|Overall Study|Other|1|||
155209666|NCT00143403|560203582|FG000|Overall Study|Adverse Event|3|||
155209667|NCT00143403|560203583|FG001|Overall Study|Adverse Event|8|||
155209668|NCT00143403|560203582|FG000|Overall Study|Death|1|||
155209669|NCT00143403|560203583|FG001|Overall Study|Death|0|||
155209670|NCT00143403|560203582|FG000|Overall Study|Withdrawal by Subject|3|||
155209671|NCT00143403|560203583|FG001|Overall Study|Withdrawal by Subject|12|||
155209672|NCT00143403|560203582|FG000|Overall Study|Relapse|15|||
155209673|NCT00143403|560203583|FG001|Overall Study|Relapse|7|||
155209674|NCT00143403|560203582|FG000|Overall Study|Protocol Violation|2|||
155209675|NCT00143403|560203583|FG001|Overall Study|Protocol Violation|2|||
155209676|NCT00143403|560203582|FG000|Overall Study|specified by site|4|||
155209677|NCT00143403|560203583|FG001|Overall Study|specified by site|9|||
155209678|NCT00143403|560203582|FG000|Overall Study|Randomized Not Treated|7|||
155209679|NCT00143403|560203583|FG001|Overall Study|Randomized Not Treated|8|||
155209680|NCT03798483|560203588|FG000|Overall Study|Lost to Follow-up|2|||
155209681|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
155209682|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209683|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
155209684|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209685|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209686|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209687|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209688|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209689|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209690|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
155209691|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
155209692|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
155209693|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209694|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209695|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209696|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209697|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209698|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209699|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209700|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
155209701|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209702|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209703|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209704|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209705|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209706|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209707|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209708|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
155209709|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209710|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209711|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209712|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209713|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209714|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209715|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209716|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209717|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209718|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
155209719|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
155209720|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
155209721|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
155209722|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
155209723|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209724|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209725|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209726|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209727|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209728|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
155209729|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209730|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209731|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209732|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209733|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209734|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209735|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209736|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
155209737|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
155209738|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
155209739|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
155209740|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
155209741|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209742|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209743|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209744|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209745|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209746|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209747|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209748|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209749|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209750|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209751|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209752|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209753|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209754|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209755|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209756|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209757|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209758|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209759|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
155209760|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209761|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209762|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209763|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209764|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209765|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
155209766|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209767|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209768|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
155209769|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209770|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209771|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
155209772|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
155209773|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
155209774|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
155209775|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
155209776|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
155209777|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
155209778|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
155209779|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
155209780|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209781|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209782|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209783|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209784|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209785|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209786|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209787|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
155209788|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
155209789|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209790|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209791|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209792|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209793|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209794|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209795|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209796|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
155209797|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
155209798|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209799|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209800|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209801|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209802|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209803|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209804|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209805|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
155209806|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209807|NCT02725710|560203598|FG000|Overall Study|Lost to Follow-up|1|||
155209808|NCT02725710|560203599|FG001|Overall Study|Lost to Follow-up|0|||
155209809|NCT01858389|560203602|FG000|Overall Study|Death|1|||
155209810|NCT01858389|560203603|FG001|Overall Study|Death|3|||
155209811|NCT01858389|560203602|FG000|Overall Study|Study terminated by sponsor|0|||
155209812|NCT01858389|560203603|FG001|Overall Study|Study terminated by sponsor|2|||
155209813|NCT01858389|560203602|FG000|Overall Study|Withdrawal by Subject|0|||
155209814|NCT01858389|560203603|FG001|Overall Study|Withdrawal by Subject|1|||
155209815|NCT01858389|560203602|FG000|Overall Study|Progressive disease|10|||
155491391|NCT00948896|561223546|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
155209816|NCT01858389|560203603|FG001|Overall Study|Progressive disease|11|||
155209817|NCT01858389|560203602|FG000|Overall Study|Other|2|||
155209818|NCT01858389|560203603|FG001|Overall Study|Other|4|||
155209819|NCT01858389|560203602|FG000|Overall Study|Adverse Event|3|||
155209820|NCT01858389|560203603|FG001|Overall Study|Adverse Event|1|||
155209821|NCT01858389|560203602|FG000|Overall Study|Did not receive treatment|0|||
155209822|NCT01858389|560203603|FG001|Overall Study|Did not receive treatment|3|||
155209823|NCT03572062|560203604|FG000|Overall Study|Adverse Event|0|||
155209824|NCT03572062|560203605|FG001|Overall Study|Adverse Event|0|||
155209825|NCT03572062|560203606|FG002|Overall Study|Adverse Event|0|||
155209826|NCT03572062|560203607|FG003|Overall Study|Adverse Event|0|||
155209827|NCT03572062|560203608|FG004|Overall Study|Adverse Event|0|||
155209828|NCT03572062|560203609|FG005|Overall Study|Adverse Event|0|||
155209829|NCT03572062|560203610|FG006|Overall Study|Adverse Event|0|||
155209830|NCT03572062|560203611|FG007|Overall Study|Adverse Event|0|||
155209831|NCT03572062|560203612|FG008|Overall Study|Adverse Event|1|||
155209832|NCT03572062|560203613|FG009|Overall Study|Adverse Event|3|||
155209833|NCT03572062|560203604|FG000|Overall Study|Death|0|||
155209834|NCT03572062|560203605|FG001|Overall Study|Death|0|||
155209835|NCT03572062|560203606|FG002|Overall Study|Death|0|||
155209836|NCT03572062|560203607|FG003|Overall Study|Death|0|||
155209837|NCT03572062|560203608|FG004|Overall Study|Death|0|||
155209838|NCT03572062|560203609|FG005|Overall Study|Death|1|||
155209839|NCT03572062|560203610|FG006|Overall Study|Death|0|||
155209840|NCT03572062|560203611|FG007|Overall Study|Death|0|||
155209841|NCT03572062|560203612|FG008|Overall Study|Death|0|||
155209842|NCT03572062|560203613|FG009|Overall Study|Death|0|||
155209843|NCT03572062|560203604|FG000|Overall Study|Lost to Follow-up|0|||
155209844|NCT03572062|560203605|FG001|Overall Study|Lost to Follow-up|0|||
155209845|NCT03572062|560203606|FG002|Overall Study|Lost to Follow-up|0|||
155209846|NCT03572062|560203607|FG003|Overall Study|Lost to Follow-up|0|||
155209847|NCT03572062|560203608|FG004|Overall Study|Lost to Follow-up|0|||
155209848|NCT03572062|560203609|FG005|Overall Study|Lost to Follow-up|1|||
155209849|NCT03572062|560203610|FG006|Overall Study|Lost to Follow-up|1|||
155209850|NCT03572062|560203611|FG007|Overall Study|Lost to Follow-up|0|||
155209851|NCT03572062|560203612|FG008|Overall Study|Lost to Follow-up|0|||
155209852|NCT03572062|560203613|FG009|Overall Study|Lost to Follow-up|0|||
155209853|NCT03572062|560203604|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209854|NCT03572062|560203605|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209855|NCT03572062|560203606|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209856|NCT03572062|560203607|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209857|NCT03572062|560203608|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209858|NCT03572062|560203609|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209859|NCT03572062|560203610|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209860|NCT03572062|560203611|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209861|NCT03572062|560203612|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
155209862|NCT03572062|560203613|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209863|NCT03572062|560203604|FG000|Overall Study|Study Terminated By Sponsor|0|||
155209864|NCT03572062|560203605|FG001|Overall Study|Study Terminated By Sponsor|0|||
155209865|NCT03572062|560203606|FG002|Overall Study|Study Terminated By Sponsor|0|||
155209866|NCT03572062|560203607|FG003|Overall Study|Study Terminated By Sponsor|0|||
155209867|NCT03572062|560203608|FG004|Overall Study|Study Terminated By Sponsor|0|||
155209868|NCT03572062|560203609|FG005|Overall Study|Study Terminated By Sponsor|0|||
155209869|NCT03572062|560203610|FG006|Overall Study|Study Terminated By Sponsor|0|||
155209870|NCT03572062|560203611|FG007|Overall Study|Study Terminated By Sponsor|0|||
155209871|NCT03572062|560203612|FG008|Overall Study|Study Terminated By Sponsor|29|||
155209872|NCT03572062|560203613|FG009|Overall Study|Study Terminated By Sponsor|27|||
155209873|NCT03572062|560203604|FG000|Overall Study|Physician Decision|0|||
155209874|NCT03572062|560203605|FG001|Overall Study|Physician Decision|0|||
155209875|NCT03572062|560203606|FG002|Overall Study|Physician Decision|0|||
155209876|NCT03572062|560203607|FG003|Overall Study|Physician Decision|0|||
155209877|NCT03572062|560203608|FG004|Overall Study|Physician Decision|0|||
155209878|NCT03572062|560203609|FG005|Overall Study|Physician Decision|0|||
155209879|NCT03572062|560203610|FG006|Overall Study|Physician Decision|0|||
155209880|NCT03572062|560203611|FG007|Overall Study|Physician Decision|0|||
155209881|NCT03572062|560203612|FG008|Overall Study|Physician Decision|1|||
155209882|NCT03572062|560203613|FG009|Overall Study|Physician Decision|0|||
155209883|NCT03572062|560203604|FG000|Overall Study|Withdrawal by Subject|0|||
155209884|NCT03572062|560203605|FG001|Overall Study|Withdrawal by Subject|0|||
155209885|NCT03572062|560203606|FG002|Overall Study|Withdrawal by Subject|0|||
155209886|NCT03572062|560203607|FG003|Overall Study|Withdrawal by Subject|0|||
155209887|NCT03572062|560203608|FG004|Overall Study|Withdrawal by Subject|0|||
155209888|NCT03572062|560203609|FG005|Overall Study|Withdrawal by Subject|0|||
155209889|NCT03572062|560203610|FG006|Overall Study|Withdrawal by Subject|0|||
155209890|NCT03572062|560203611|FG007|Overall Study|Withdrawal by Subject|0|||
155209891|NCT03572062|560203612|FG008|Overall Study|Withdrawal by Subject|0|||
155209892|NCT03572062|560203613|FG009|Overall Study|Withdrawal by Subject|1|||
155209893|NCT03572062|560203604|FG000|Overall Study|Randomized But Not Treated|0|||
155209894|NCT03572062|560203605|FG001|Overall Study|Randomized But Not Treated|0|||
155209895|NCT03572062|560203606|FG002|Overall Study|Randomized But Not Treated|0|||
155209896|NCT03572062|560203607|FG003|Overall Study|Randomized But Not Treated|0|||
155209897|NCT03572062|560203608|FG004|Overall Study|Randomized But Not Treated|1|||
155209898|NCT03572062|560203609|FG005|Overall Study|Randomized But Not Treated|2|||
155209899|NCT03572062|560203610|FG006|Overall Study|Randomized But Not Treated|0|||
155209900|NCT03572062|560203611|FG007|Overall Study|Randomized But Not Treated|1|||
155209901|NCT03572062|560203612|FG008|Overall Study|Randomized But Not Treated|0|||
155209902|NCT03572062|560203613|FG009|Overall Study|Randomized But Not Treated|0|||
155209903|NCT01605877|560203614|FG000|Overall Study|Withdrawal by Subject|1|||
155209904|NCT00580606|560203626|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
155209905|NCT00580606|560203627|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
155209906|NCT00580606|560203626|FG000|Open Label (OL)|Withdrawal by Subject|4|||
155209907|NCT00580606|560203627|FG001|Open Label (OL)|Withdrawal by Subject|6|||
155209908|NCT00580606|560203626|FG000|Open Label (OL)|Dosing Symptoms|0|||
155209909|NCT00580606|560203627|FG001|Open Label (OL)|Dosing Symptoms|1|||
155209910|NCT00580606|560203626|FG000|Open Label (OL)|Lost to Follow-up|0|||
155209911|NCT00580606|560203627|FG001|Open Label (OL)|Lost to Follow-up|1|||
155209912|NCT00580606|560203626|FG000|Open Label (OL)|Pregnancy|0|||
155209913|NCT00580606|560203627|FG001|Open Label (OL)|Pregnancy|1|||
155209914|NCT00580606|560203626|FG000|Open Label (OL)|Non-compliance|2|||
155209915|NCT00580606|560203627|FG001|Open Label (OL)|Non-compliance|0|||
155209916|NCT00580606|560203626|FG000|Open Label (OL)|Physician Decision|1|||
155209917|NCT00580606|560203627|FG001|Open Label (OL)|Physician Decision|1|||
155209918|NCT00580606|560203626|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
155209919|NCT00580606|560203627|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
155209920|NCT03064451|560203629|FG000|Overall Study|Lost to Follow-up|1|||
155209921|NCT03064451|560203629|FG000|Overall Study|Mapping Failure|4|||
155209922|NCT03064451|560203629|FG000|Overall Study|Exited prior to procedure|8|||
155209923|NCT03064451|560203629|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
155209924|NCT00750204|560203632|FG000|Overall Study|study halted prematurely|1|||
155209925|NCT00750204|560203633|FG001|Overall Study|study halted prematurely|1|||
155209926|NCT01428453|560203634|FG000|Overall Study|Adverse Event|2|||
155209927|NCT01428453|560203635|FG001|Overall Study|Adverse Event|7|||
155209928|NCT01428453|560203634|FG000|Overall Study|Protocol Violation|1|||
155209929|NCT01428453|560203635|FG001|Overall Study|Protocol Violation|0|||
155209930|NCT01428453|560203634|FG000|Overall Study|Lost to Follow-up|0|||
155209931|NCT01428453|560203635|FG001|Overall Study|Lost to Follow-up|1|||
155209932|NCT01428453|560203634|FG000|Overall Study|Withdrawal by Subject|3|||
155209933|NCT01428453|560203635|FG001|Overall Study|Withdrawal by Subject|1|||
155209934|NCT01996709|560203636|FG000|Overall Study|Withdrawal by Subject|1|||
155209935|NCT01996709|560203637|FG001|Overall Study|Withdrawal by Subject|0|||
155209936|NCT01996709|560203636|FG000|Overall Study|Lost to Follow-up|3|||
155209937|NCT01996709|560203637|FG001|Overall Study|Lost to Follow-up|0|||
155209938|NCT01996709|560203636|FG000|Overall Study|Subject Non-Compliant|1|||
155209939|NCT01996709|560203637|FG001|Overall Study|Subject Non-Compliant|0|||
155209940|NCT01996709|560203636|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155209941|NCT01996709|560203637|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
155209942|NCT00477971|560203638|FG000|Overall Study|Disease progression|6|||
155209943|NCT00477971|560203639|FG001|Overall Study|Disease progression|0|||
155209944|NCT00477971|560203638|FG000|Overall Study|Withdrawal by Subject|3|||
155209945|NCT00477971|560203639|FG001|Overall Study|Withdrawal by Subject|1|||
155209946|NCT00477971|560203638|FG000|Overall Study|Adverse Event|3|||
155209947|NCT00477971|560203639|FG001|Overall Study|Adverse Event|0|||
155209948|NCT00477971|560203638|FG000|Overall Study|Death|2|||
155209949|NCT00477971|560203639|FG001|Overall Study|Death|4|||
155209950|NCT00477971|560203638|FG000|Overall Study|Alternative treatment|3|||
155209951|NCT00477971|560203639|FG001|Overall Study|Alternative treatment|1|||
155209952|NCT02167893|560203640|FG000|Overall Study|Investigator transferred|85|||
155209953|NCT02167893|560203640|FG000|Overall Study|Investigator health reasons|10|||
155209954|NCT02167893|560203640|FG000|Overall Study|Case report forms not collected|68|||
155209955|NCT01438424|560205308|FG000|Overall Study|Continuing treatment|29|||
155209956|NCT01438424|560205308|FG000|Overall Study|Minimal virologic response|95|||
155209957|NCT01438424|560205308|FG000|Overall Study|Not identified|55|||
155209958|NCT01438424|560205308|FG000|Overall Study|Withdrawal by Subject|104|||
155209959|NCT01438424|560205308|FG000|Overall Study|Progression of chronic hepatitis B|22|||
155209960|NCT01438424|560205308|FG000|Overall Study|Death|22|||
155209961|NCT01438424|560205308|FG000|Overall Study|Adverse Event|17|||
155209962|NCT01438424|560205308|FG000|Overall Study|Lost to Follow-up|17|||
155209963|NCT01438424|560205308|FG000|Overall Study|Abnormal laboratory test result|14|||
155209964|NCT01438424|560205308|FG000|Overall Study|Need for drug prohibited by protocol|14|||
155209965|NCT01438424|560205308|FG000|Overall Study|Pregnancy|7|||
155209966|NCT01438424|560205308|FG000|Overall Study|No longer met inclusion criteria|1|||
155209967|NCT01438424|560205308|FG000|Overall Study|Participant noncompliance|20|||
155209968|NCT02927080|560205309|FG000|Overall Study|Withdrawal by Subject|0|||
155209969|NCT02927080|560205310|FG001|Overall Study|Withdrawal by Subject|0|||
155209970|NCT02927080|560205311|FG002|Overall Study|Withdrawal by Subject|0|||
155209971|NCT02927080|560205312|FG003|Overall Study|Withdrawal by Subject|0|||
155209972|NCT02927080|560205313|FG004|Overall Study|Withdrawal by Subject|1|||
155209973|NCT02927080|560205314|FG005|Overall Study|Withdrawal by Subject|0|||
155209974|NCT02927080|560205315|FG006|Overall Study|Withdrawal by Subject|1|||
155209975|NCT02927080|560205316|FG007|Overall Study|Withdrawal by Subject|1|||
155209976|NCT02927080|560205317|FG008|Overall Study|Withdrawal by Subject|0|||
155209977|NCT02927080|560205318|FG009|Overall Study|Withdrawal by Subject|2|||
155209978|NCT02927080|560205309|FG000|Overall Study|Willingness to comply with protocol|0|||
155209979|NCT02927080|560205310|FG001|Overall Study|Willingness to comply with protocol|0|||
155209980|NCT02927080|560205311|FG002|Overall Study|Willingness to comply with protocol|0|||
155209981|NCT02927080|560205312|FG003|Overall Study|Willingness to comply with protocol|0|||
155209982|NCT02927080|560205313|FG004|Overall Study|Willingness to comply with protocol|0|||
155209983|NCT02927080|560205314|FG005|Overall Study|Willingness to comply with protocol|0|||
155209984|NCT02927080|560205315|FG006|Overall Study|Willingness to comply with protocol|0|||
155209985|NCT02927080|560205316|FG007|Overall Study|Willingness to comply with protocol|0|||
155209986|NCT02927080|560205317|FG008|Overall Study|Willingness to comply with protocol|0|||
155209987|NCT02927080|560205318|FG009|Overall Study|Willingness to comply with protocol|1|||
155209988|NCT02927080|560205309|FG000|Overall Study|Study terminated by Sponsor|0|||
155209989|NCT02927080|560205310|FG001|Overall Study|Study terminated by Sponsor|0|||
155209990|NCT02927080|560205311|FG002|Overall Study|Study terminated by Sponsor|0|||
155209991|NCT02927080|560205312|FG003|Overall Study|Study terminated by Sponsor|0|||
155209992|NCT02927080|560205313|FG004|Overall Study|Study terminated by Sponsor|0|||
155209993|NCT02927080|560205314|FG005|Overall Study|Study terminated by Sponsor|0|||
155209994|NCT02927080|560205315|FG006|Overall Study|Study terminated by Sponsor|6|||
155209995|NCT02927080|560205316|FG007|Overall Study|Study terminated by Sponsor|7|||
155209996|NCT02927080|560205317|FG008|Overall Study|Study terminated by Sponsor|2|||
155209997|NCT02927080|560205318|FG009|Overall Study|Study terminated by Sponsor|3|||
155209998|NCT02927080|560205309|FG000|Overall Study|Adverse Event|0|||
155209999|NCT02927080|560205310|FG001|Overall Study|Adverse Event|1|||
155210000|NCT02927080|560205311|FG002|Overall Study|Adverse Event|0|||
155210001|NCT02927080|560205312|FG003|Overall Study|Adverse Event|0|||
155210002|NCT02927080|560205313|FG004|Overall Study|Adverse Event|0|||
155210003|NCT02927080|560205314|FG005|Overall Study|Adverse Event|0|||
155210004|NCT02927080|560205315|FG006|Overall Study|Adverse Event|0|||
155210005|NCT02927080|560205316|FG007|Overall Study|Adverse Event|1|||
155210006|NCT02927080|560205317|FG008|Overall Study|Adverse Event|0|||
155210007|NCT02927080|560205318|FG009|Overall Study|Adverse Event|1|||
155210008|NCT02927080|560205309|FG000|Overall Study|Other|0|||
155210009|NCT02927080|560205310|FG001|Overall Study|Other|0|||
155210010|NCT02927080|560205311|FG002|Overall Study|Other|0|||
155210011|NCT02927080|560205312|FG003|Overall Study|Other|0|||
155210012|NCT02927080|560205313|FG004|Overall Study|Other|0|||
155210013|NCT02927080|560205314|FG005|Overall Study|Other|0|||
155210014|NCT02927080|560205315|FG006|Overall Study|Other|1|||
155210015|NCT02927080|560205316|FG007|Overall Study|Other|0|||
155210016|NCT02927080|560205317|FG008|Overall Study|Other|1|||
155210017|NCT02927080|560205318|FG009|Overall Study|Other|0|||
155210018|NCT01411228|560205319|FG000|Overall Study|Lost to Follow-up|0|||
155210019|NCT01411228|560205320|FG001|Overall Study|Lost to Follow-up|0|||
155210020|NCT01411228|560205321|FG002|Overall Study|Lost to Follow-up|1|||
155210021|NCT01411228|560205319|FG000|Overall Study|Withdrawal by Subject|1|||
155210022|NCT01411228|560205320|FG001|Overall Study|Withdrawal by Subject|0|||
155210023|NCT01411228|560205321|FG002|Overall Study|Withdrawal by Subject|0|||
155210024|NCT00664742|560205322|FG000|Overall Study|Withdrawn due to adverse events|3|||
155210025|NCT00664742|560205322|FG000|Overall Study|Withdrawal by Subject|31|||
155210026|NCT00664742|560205322|FG000|Overall Study|Lost to Follow-up|92|||
155210027|NCT02670083|560205323|FG000|Overall Study|Adverse Event|16|||
155210028|NCT02670083|560205324|FG001|Overall Study|Adverse Event|13|||
155210029|NCT02670083|560205323|FG000|Overall Study|Death|4|||
155210030|NCT02670083|560205324|FG001|Overall Study|Death|6|||
155210031|NCT02670083|560205323|FG000|Overall Study|Lost to Follow-up|2|||
155210032|NCT02670083|560205324|FG001|Overall Study|Lost to Follow-up|2|||
155210033|NCT02670083|560205323|FG000|Overall Study|Multiple Reasons|9|||
155210034|NCT02670083|560205324|FG001|Overall Study|Multiple Reasons|9|||
155210035|NCT02670083|560205323|FG000|Overall Study|Physician Decision|0|||
155210036|NCT02670083|560205324|FG001|Overall Study|Physician Decision|2|||
155210037|NCT02670083|560205323|FG000|Overall Study|Study Terminated By Sponsor|257|||
155210038|NCT02670083|560205324|FG001|Overall Study|Study Terminated By Sponsor|254|||
155210039|NCT02670083|560205323|FG000|Overall Study|Symptomatic Deterioration|0|||
155210040|NCT02670083|560205324|FG001|Overall Study|Symptomatic Deterioration|2|||
155210041|NCT02670083|560205323|FG000|Overall Study|Withdrawal by Subject|32|||
155210042|NCT02670083|560205324|FG001|Overall Study|Withdrawal by Subject|31|||
155210043|NCT02670083|560205323|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155210044|NCT02670083|560205324|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155210045|NCT03045328|560205328|FG000|Overall Study|Withdrawal by Subject|2|||
155210046|NCT02564042|560205329|FG000|Overall Study|Adverse Event|4|||
155210047|NCT02564042|560205330|FG001|Overall Study|Adverse Event|4|||
155210048|NCT02564042|560205331|FG002|Overall Study|Adverse Event|3|||
155210049|NCT02564042|560205332|FG003|Overall Study|Adverse Event|0|||
155210050|NCT02564042|560205333|FG004|Overall Study|Adverse Event|0|||
155210051|NCT02564042|560205334|FG005|Overall Study|Adverse Event|1|||
155210052|NCT02564042|560205329|FG000|Overall Study|Lost to Follow-up|1|||
155210053|NCT02564042|560205330|FG001|Overall Study|Lost to Follow-up|1|||
155210054|NCT02564042|560205331|FG002|Overall Study|Lost to Follow-up|1|||
155210055|NCT02564042|560205332|FG003|Overall Study|Lost to Follow-up|0|||
155210056|NCT02564042|560205333|FG004|Overall Study|Lost to Follow-up|1|||
155210057|NCT02564042|560205334|FG005|Overall Study|Lost to Follow-up|1|||
155210058|NCT02564042|560205329|FG000|Overall Study|Physician Decision|1|||
155210059|NCT02564042|560205330|FG001|Overall Study|Physician Decision|0|||
155210060|NCT02564042|560205331|FG002|Overall Study|Physician Decision|0|||
155210061|NCT02564042|560205332|FG003|Overall Study|Physician Decision|1|||
155210062|NCT02564042|560205333|FG004|Overall Study|Physician Decision|0|||
155210063|NCT02564042|560205334|FG005|Overall Study|Physician Decision|0|||
155210064|NCT02564042|560205329|FG000|Overall Study|Withdrawal by Subject|5|||
155210065|NCT02564042|560205330|FG001|Overall Study|Withdrawal by Subject|3|||
155210066|NCT02564042|560205331|FG002|Overall Study|Withdrawal by Subject|2|||
155210067|NCT02564042|560205332|FG003|Overall Study|Withdrawal by Subject|2|||
155210068|NCT02564042|560205333|FG004|Overall Study|Withdrawal by Subject|10|||
155210069|NCT02564042|560205334|FG005|Overall Study|Withdrawal by Subject|12|||
155210070|NCT01356966|560205335|FG000|Overall Study|Withdrawal by Subject|1|||
155210071|NCT01356966|560205336|FG001|Overall Study|Withdrawal by Subject|2|||
155210072|NCT01356966|560205335|FG000|Overall Study|Physician Decision|1|||
155210073|NCT01356966|560205336|FG001|Overall Study|Physician Decision|0|||
155210074|NCT02743806|560205337|FG000|Overall Study|Adverse Event|9|||
155210075|NCT02743806|560205337|FG000|Overall Study|Lost to Follow-up|8|||
155210076|NCT02743806|560205337|FG000|Overall Study|Voluntary Withdrawal|54|||
155210077|NCT02743806|560205337|FG000|Overall Study|Study Termination|65|||
155210078|NCT02743806|560205337|FG000|Overall Study|Pregnancy|6|||
155210079|NCT02743806|560205337|FG000|Overall Study|No Longer Clinically Benefiting|27|||
155210080|NCT02743806|560205337|FG000|Overall Study|Reason Not Specified|12|||
155210081|NCT00849381|560205339|FG000|Overall Study|Adverse Event|1|||
155210082|NCT00849381|560205339|FG000|Overall Study|Lost to Follow-up|129|||
155210083|NCT00849381|560205339|FG000|Overall Study|Protocol Violation|5|||
155210084|NCT00849381|560205339|FG000|Overall Study|Withdrawal by Subject|6|||
155210085|NCT00849381|560205339|FG000|Overall Study|Other|4|||
155210086|NCT04429061|560205343|FG000|Overall Study|Lost to Follow-up|62|||
155210087|NCT04429061|560205344|FG001|Overall Study|Lost to Follow-up|87|||
155210088|NCT04429061|560205343|FG000|Overall Study|Withdrawal by Subject|3|||
155210089|NCT04429061|560205344|FG001|Overall Study|Withdrawal by Subject|4|||
155210090|NCT02618434|560205349|FG000|Overall Study|Withdrawal by Subject|0|||
155210091|NCT02618434|560205350|FG001|Overall Study|Withdrawal by Subject|2|||
155210092|NCT02618434|560205351|FG002|Overall Study|Withdrawal by Subject|3|||
155210093|NCT02618434|560205349|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
155210094|NCT02618434|560205350|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155210095|NCT02618434|560205351|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
155210096|NCT02618434|560205349|FG000|Overall Study|Lost to Follow-up|3|||
155210097|NCT02618434|560205350|FG001|Overall Study|Lost to Follow-up|1|||
155210098|NCT02618434|560205351|FG002|Overall Study|Lost to Follow-up|3|||
155210099|NCT02618434|560205349|FG000|Overall Study|Adverse Event|1|||
155210100|NCT02618434|560205350|FG001|Overall Study|Adverse Event|0|||
155210101|NCT02618434|560205351|FG002|Overall Study|Adverse Event|12|||
155210102|NCT02618434|560205349|FG000|Overall Study|Physician Decision|0|||
155210103|NCT02618434|560205350|FG001|Overall Study|Physician Decision|1|||
155210104|NCT02618434|560205351|FG002|Overall Study|Physician Decision|0|||
155210105|NCT02618434|560205349|FG000|Overall Study|Protocol Violation|0|||
155210106|NCT02618434|560205350|FG001|Overall Study|Protocol Violation|0|||
155210107|NCT02618434|560205351|FG002|Overall Study|Protocol Violation|1|||
155210108|NCT02618434|560205349|FG000|Overall Study|Other, Multiple categories|1|||
155210109|NCT02618434|560205350|FG001|Overall Study|Other, Multiple categories|1|||
155210110|NCT02618434|560205351|FG002|Overall Study|Other, Multiple categories|1|||
155210111|NCT02289898|560205357|FG000|Overall Study|Death|5|||
155210112|NCT02289898|560205358|FG001|Overall Study|Death|4|||
155210113|NCT02289898|560205359|FG002|Overall Study|Death|3|||
155210114|NCT02289898|560205357|FG000|Overall Study|Physician Decision|2|||
155210115|NCT02289898|560205358|FG001|Overall Study|Physician Decision|5|||
155210116|NCT02289898|560205359|FG002|Overall Study|Physician Decision|2|||
155210117|NCT02289898|560205357|FG000|Overall Study|Withdrawal by Subject|0|||
155210118|NCT02289898|560205358|FG001|Overall Study|Withdrawal by Subject|4|||
155210119|NCT02289898|560205359|FG002|Overall Study|Withdrawal by Subject|1|||
155210120|NCT02289898|560205357|FG000|Overall Study|Adverse Event|3|||
155210121|NCT02289898|560205358|FG001|Overall Study|Adverse Event|5|||
155210122|NCT02289898|560205359|FG002|Overall Study|Adverse Event|5|||
155210123|NCT02289898|560205357|FG000|Overall Study|Disease progression|34|||
155210124|NCT02289898|560205358|FG001|Overall Study|Disease progression|28|||
155210125|NCT02289898|560205359|FG002|Overall Study|Disease progression|34|||
155210126|NCT02289898|560205357|FG000|Overall Study|Use of another anticancer therapy|0|||
155210127|NCT02289898|560205358|FG001|Overall Study|Use of another anticancer therapy|0|||
155210128|NCT02289898|560205359|FG002|Overall Study|Use of another anticancer therapy|1|||
155210129|NCT02289898|560205357|FG000|Overall Study|Other|8|||
155210130|NCT02289898|560205358|FG001|Overall Study|Other|7|||
155210131|NCT02289898|560205359|FG002|Overall Study|Other|10|||
155210132|NCT00885105|560205360|FG000|Overall Study|Withdrawal by Subject|0|||
155210133|NCT00885105|560205361|FG001|Overall Study|Withdrawal by Subject|8|||
155210134|NCT00885105|560205360|FG000|Overall Study|Adverse Event|1|||
155210135|NCT00885105|560205361|FG001|Overall Study|Adverse Event|0|||
155210136|NCT00885105|560205360|FG000|Overall Study|Protocol Violation|0|||
155210137|NCT00885105|560205361|FG001|Overall Study|Protocol Violation|2|||
155210138|NCT02254486|560205362|FG000|Overall Study|Adverse Event|1|||
155210139|NCT02254486|560205363|FG001|Overall Study|Adverse Event|1|||
155210140|NCT02254486|560205362|FG000|Overall Study|Lack of Efficacy|1|||
155210141|NCT02254486|560205363|FG001|Overall Study|Lack of Efficacy|0|||
155210142|NCT02254486|560205362|FG000|Overall Study|Lost to Follow-up|2|||
155210143|NCT02254486|560205363|FG001|Overall Study|Lost to Follow-up|4|||
155210144|NCT02254486|560205362|FG000|Overall Study|Protocol Violation|1|||
155210145|NCT02254486|560205363|FG001|Overall Study|Protocol Violation|2|||
155210146|NCT02254486|560205362|FG000|Overall Study|Withdrawal by Subject|17|||
155210147|NCT02254486|560205363|FG001|Overall Study|Withdrawal by Subject|15|||
155210148|NCT02254486|560205362|FG000|Overall Study|GFR<60mL/min|16|||
155210149|NCT02254486|560205363|FG001|Overall Study|GFR<60mL/min|21|||
155210150|NCT02254486|560205362|FG000|Overall Study|Various|12|||
155210151|NCT02254486|560205363|FG001|Overall Study|Various|12|||
155210152|NCT01350414|560205364|FG000|Overall Study|Lost to Follow-up|13|||
155210153|NCT01350414|560205364|FG000|Overall Study|Withdrawal by Subject|4|||
155210154|NCT01350414|560205364|FG000|Overall Study|Physician Decision|2|||
155210155|NCT00267046|560205370|FG000|Overall Study|Disease progression|4|||
155210156|NCT00267046|560205371|FG001|Overall Study|Disease progression|2|||
155210157|NCT00267046|560205370|FG000|Overall Study|Chemotoxicity|2|||
155210158|NCT00267046|560205371|FG001|Overall Study|Chemotoxicity|0|||
155210159|NCT00267046|560205370|FG000|Overall Study|Open-label palifermin|2|||
155210160|NCT00267046|560205371|FG001|Overall Study|Open-label palifermin|7|||
155210161|NCT00267046|560205370|FG000|Overall Study|Surgery|3|||
155210162|NCT00267046|560205371|FG001|Overall Study|Surgery|1|||
155210163|NCT00267046|560205370|FG000|Overall Study|Withdrawal by Subject|1|||
155210164|NCT00267046|560205371|FG001|Overall Study|Withdrawal by Subject|0|||
155210165|NCT00267046|560205370|FG000|Overall Study|Radiation|0|||
155210166|NCT00267046|560205371|FG001|Overall Study|Radiation|1|||
155210167|NCT00460408|560205372|FG000|Overall Study|Adverse Event|1|||
155210168|NCT00460408|560205373|FG001|Overall Study|Adverse Event|0|||
155210169|NCT00460408|560205374|FG002|Overall Study|Adverse Event|0|||
155210170|NCT00460408|560205375|FG003|Overall Study|Adverse Event|0|||
155210171|NCT00460408|560205372|FG000|Overall Study|Death|7|||
155210172|NCT00460408|560205373|FG001|Overall Study|Death|0|||
155210173|NCT00460408|560205374|FG002|Overall Study|Death|0|||
155210174|NCT00460408|560205375|FG003|Overall Study|Death|0|||
155210175|NCT00460408|560205372|FG000|Overall Study|Lost to Follow-up|11|||
155210176|NCT00460408|560205373|FG001|Overall Study|Lost to Follow-up|0|||
155210177|NCT00460408|560205374|FG002|Overall Study|Lost to Follow-up|1|||
155210178|NCT00460408|560205375|FG003|Overall Study|Lost to Follow-up|0|||
155210179|NCT00460408|560205372|FG000|Overall Study|Withdrawal by Subject|31|||
155210180|NCT00460408|560205373|FG001|Overall Study|Withdrawal by Subject|0|||
155210181|NCT00460408|560205374|FG002|Overall Study|Withdrawal by Subject|0|||
155210182|NCT00460408|560205375|FG003|Overall Study|Withdrawal by Subject|0|||
155210183|NCT00460408|560205372|FG000|Overall Study|Insufficient clinical response|5|||
155210184|NCT00460408|560205373|FG001|Overall Study|Insufficient clinical response|1|||
155210185|NCT00460408|560205374|FG002|Overall Study|Insufficient clinical response|5|||
155210186|NCT00460408|560205375|FG003|Overall Study|Insufficient clinical response|0|||
155210187|NCT00460408|560205372|FG000|Overall Study|Other|12|||
155210188|NCT00460408|560205373|FG001|Overall Study|Other|2|||
155210189|NCT00460408|560205374|FG002|Overall Study|Other|0|||
155210190|NCT00460408|560205375|FG003|Overall Study|Other|0|||
155210191|NCT00103142|560205376|FG000|Overall Study|Adverse Event|1|||
155210192|NCT00103142|560205377|FG001|Overall Study|Adverse Event|0|||
155210193|NCT00103142|560205376|FG000|Overall Study|Progression of disease|2|||
155210194|NCT00103142|560205377|FG001|Overall Study|Progression of disease|1|||
155210195|NCT04983264|560205381|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
155210196|NCT04983264|560205382|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
155210197|NCT04983264|560205383|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
155210198|NCT04983264|560205381|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
155210199|NCT04983264|560205382|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
155210200|NCT04983264|560205383|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
155210201|NCT00938639|560205384|FG000|Overall Study|Moved away from study area|0|||
155210202|NCT00938639|560205385|FG001|Overall Study|Moved away from study area|1|||
155210203|NCT00938639|560205384|FG000|Overall Study|Lost to Follow-up|1|||
155210204|NCT00938639|560205385|FG001|Overall Study|Lost to Follow-up|2|||
155210205|NCT00938639|560205384|FG000|Overall Study|Family issues|1|||
155210206|NCT00938639|560205385|FG001|Overall Study|Family issues|1|||
155210207|NCT00938639|560205384|FG000|Overall Study|Participant noncompliance|1|||
155210208|NCT00938639|560205385|FG001|Overall Study|Participant noncompliance|0|||
155210209|NCT00010374|560205390|FG000|Overall Study|False positive phrenic nerve test|1|||
155210210|NCT01741701|560205396|FG000|Overall Study|Adverse Event|5|||
155210211|NCT01741701|560205397|FG001|Overall Study|Adverse Event|1|||
155210212|NCT01741701|560205396|FG000|Overall Study|Withdrawal by Subject|0|||
155210213|NCT01741701|560205397|FG001|Overall Study|Withdrawal by Subject|1|||
155210214|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
155210215|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
155210216|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
155210217|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
155210218|NCT03033394|560205404|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
155210219|NCT00356369|560205405|FG000|Active Phase|Withdrawal by Subject|2|||
155210220|NCT00356369|560205406|FG001|Active Phase|Withdrawal by Subject|1|||
155210221|NCT00673465|560205410|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210222|NCT00673465|560205411|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210223|NCT00673465|560205412|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210224|NCT00673465|560205413|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210225|NCT00673465|560205414|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
155210226|NCT00673465|560205415|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
155210227|NCT00673465|560205416|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210228|NCT00673465|560205417|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210229|NCT00673465|560205418|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210230|NCT00673465|560205419|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210231|NCT00673465|560205420|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210232|NCT00673465|560205421|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210233|NCT00673465|560205410|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210234|NCT00673465|560205411|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210235|NCT00673465|560205412|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210236|NCT00673465|560205413|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210237|NCT00673465|560205414|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
155210238|NCT00673465|560205415|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210239|NCT00673465|560205416|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210240|NCT00673465|560205417|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210241|NCT00673465|560205418|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210242|NCT00673465|560205419|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210243|NCT00673465|560205420|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210244|NCT00673465|560205421|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210245|NCT04952402|560205422|FG000|Overall Study|Lost to Follow-up|1|||
155210246|NCT04952402|560205423|FG001|Overall Study|Lost to Follow-up|3|||
155210247|NCT04952402|560205422|FG000|Overall Study|Lack Of Venous Access|0|||
155210248|NCT04952402|560205423|FG001|Overall Study|Lack Of Venous Access|1|||
155210249|NCT01919723|560205426|FG000|Overall Study|Blood Samples Hemolyzed|2|||
155210250|NCT01919723|560205427|FG001|Overall Study|Blood Samples Hemolyzed|2|||
155210251|NCT04502589|560205428|FG000|Overall Study|Physician Decision|1|||
155210252|NCT04502589|560205429|FG001|Overall Study|Physician Decision|0|||
155210253|NCT01574612|560205430|FG000|Overall Study|Adverse Event|3|||
155210254|NCT01574612|560205430|FG000|Overall Study|non compliant with drug|2|||
155210255|NCT01574612|560205430|FG000|Overall Study|Withdrawal by Subject|1|||
155210256|NCT01574612|560205430|FG000|Overall Study|Lost to Follow-up|2|||
155210257|NCT01683383|560205431|FG000|Overall Study|Infant was not transported|1|||
155210258|NCT01683383|560205432|FG001|Overall Study|Infant was not transported|0|||
155210259|NCT02496611|560205433|FG000|Overall Study|Lost to Follow-up|2|||
155210260|NCT02496611|560205434|FG001|Overall Study|Lost to Follow-up|1|||
155210261|NCT02496611|560205433|FG000|Overall Study|Withdrawal by Subject|5|||
155210262|NCT02496611|560205434|FG001|Overall Study|Withdrawal by Subject|2|||
155210263|NCT02850965|560205435|FG000|Overall Study|Other than listed|3|||
155210264|NCT02850965|560205436|FG001|Overall Study|Other than listed|4|||
155210265|NCT02850965|560205435|FG000|Overall Study|Protocol Violation|0|||
155210266|NCT02850965|560205436|FG001|Overall Study|Protocol Violation|2|||
155210267|NCT02850965|560205435|FG000|Overall Study|Lost to Follow-up|5|||
155210268|NCT02850965|560205436|FG001|Overall Study|Lost to Follow-up|3|||
155210269|NCT02850965|560205435|FG000|Overall Study|Lack of Efficacy|4|||
155210270|NCT02850965|560205436|FG001|Overall Study|Lack of Efficacy|8|||
155210271|NCT02850965|560205435|FG000|Overall Study|Adverse Event|3|||
155210272|NCT02850965|560205436|FG001|Overall Study|Adverse Event|2|||
155210273|NCT02850965|560205435|FG000|Overall Study|Withdrawal by Subject|3|||
155210274|NCT02850965|560205436|FG001|Overall Study|Withdrawal by Subject|4|||
155210275|NCT02850965|560205435|FG000|Overall Study|Physician Decision|0|||
155210276|NCT02850965|560205436|FG001|Overall Study|Physician Decision|1|||
155210277|NCT02850965|560205435|FG000|Overall Study|Randomized but not treated|0|||
155210278|NCT02850965|560205436|FG001|Overall Study|Randomized but not treated|1|||
155210279|NCT00536198|560205437|FG000|Overall Study|Lost to Follow-up|15|||
155210280|NCT00536198|560205438|FG001|Overall Study|Lost to Follow-up|14|||
155210281|NCT00536198|560205437|FG000|Overall Study|Withdrawal by Subject|16|||
155210282|NCT00536198|560205438|FG001|Overall Study|Withdrawal by Subject|12|||
155210283|NCT00536198|560205437|FG000|Overall Study|Adverse Event|2|||
155210284|NCT00536198|560205438|FG001|Overall Study|Adverse Event|2|||
155210285|NCT00536198|560205437|FG000|Overall Study|Rescue|3|||
155210286|NCT00536198|560205438|FG001|Overall Study|Rescue|9|||
155210287|NCT00536198|560205437|FG000|Overall Study|Pregnancy|1|||
155210288|NCT00536198|560205438|FG001|Overall Study|Pregnancy|1|||
155210289|NCT00536198|560205437|FG000|Overall Study|Protocol Violation|0|||
155210290|NCT00536198|560205438|FG001|Overall Study|Protocol Violation|1|||
155210291|NCT02643082|560205439|FG000|Period 1|Adverse Event|1|||
155210292|NCT02643082|560205440|FG001|Period 1|Adverse Event|0|||
155210293|NCT00276744|560205441|FG000|PART A|Reason unknown|98|||
155210294|NCT02860169|560205442|FG000|Part A|Withdrawal by Subject|1|||
155210295|NCT02860169|560205442|FG000|Part A|Other (Screening failure)|6|||
155210296|NCT02860169|560205442|FG000|Part A|Other (Survey not completed)|3|||
155210297|NCT02860169|560205442|FG000|Part A|Other (did not completed consent)|1|||
155210298|NCT02860169|560205442|FG000|Part B|Other (Screening failure)|10|||
155210299|NCT02860169|560205442|FG000|Part B|Withdrawal by Subject|1|||
155210300|NCT02860169|560205442|FG000|Part C|Other (Screening failure)|1|||
155210301|NCT00165776|560205444|FG000|Overall Study|Lack of Efficacy|0|||
155210302|NCT00165776|560205445|FG001|Overall Study|Lack of Efficacy|0|||
155210303|NCT00165776|560205446|FG002|Overall Study|Lack of Efficacy|0|||
155210304|NCT00165776|560205447|FG003|Overall Study|Lack of Efficacy|1|||
155210305|NCT00165776|560205444|FG000|Overall Study|Withdrawal by Subject|4|||
155210306|NCT00165776|560205445|FG001|Overall Study|Withdrawal by Subject|1|||
155210307|NCT00165776|560205446|FG002|Overall Study|Withdrawal by Subject|2|||
155210308|NCT00165776|560205447|FG003|Overall Study|Withdrawal by Subject|0|||
155210309|NCT00165776|560205444|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
155210310|NCT00165776|560205445|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
155210311|NCT00165776|560205446|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
155210312|NCT00165776|560205447|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
155210313|NCT03310775|560205453|FG000|Overall Study|Lost to Follow-up|2|||
155210314|NCT03310775|560205454|FG001|Overall Study|Lost to Follow-up|3|||
155210315|NCT03310775|560205453|FG000|Overall Study|aggravation of depression|0|||
155210316|NCT03310775|560205454|FG001|Overall Study|aggravation of depression|1|||
155491392|NCT00948896|561223547|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
155491393|NCT00948896|561223548|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
155491394|NCT00948896|561223549|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
155491395|NCT00948896|561223550|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
155491396|NCT00948896|561223551|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
155491397|NCT00948896|561223552|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
155491398|NCT00948896|561223545|FG000|24 Months of Age to 36 Months of Age|Death|0|||
155491399|NCT00948896|561223546|FG001|24 Months of Age to 36 Months of Age|Death|2|||
155491400|NCT00948896|561223547|FG002|24 Months of Age to 36 Months of Age|Death|2|||
155491401|NCT00948896|561223548|FG003|24 Months of Age to 36 Months of Age|Death|0|||
155491402|NCT00948896|561223549|FG004|24 Months of Age to 36 Months of Age|Death|0|||
155491403|NCT00948896|561223550|FG005|24 Months of Age to 36 Months of Age|Death|1|||
155491404|NCT00948896|561223551|FG006|24 Months of Age to 36 Months of Age|Death|0|||
155491405|NCT00948896|561223552|FG007|24 Months of Age to 36 Months of Age|Death|0|||
155491406|NCT00948896|561223545|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
155491407|NCT00948896|561223546|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
155491408|NCT00948896|561223547|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
155491409|NCT00948896|561223548|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
155491410|NCT00948896|561223549|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
155491411|NCT00948896|561223550|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
155491412|NCT00948896|561223551|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
155491413|NCT00948896|561223552|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
155491414|NCT00948896|561223545|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
155491415|NCT00948896|561223546|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
155491416|NCT00948896|561223547|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
155491417|NCT00948896|561223548|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
155491418|NCT00948896|561223549|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
155491419|NCT00948896|561223550|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
155491420|NCT00948896|561223551|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
155491421|NCT00948896|561223552|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
155491422|NCT00948896|561223545|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155491423|NCT00948896|561223546|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155491424|NCT00948896|561223547|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
155210317|NCT02066233|560207754|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
155210318|NCT02066233|560207755|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
155210319|NCT02772081|560207756|FG000|Overall Study|Physician Decision|1|||
155210320|NCT02772081|560207757|FG001|Overall Study|Physician Decision|1|||
155210321|NCT02772081|560207756|FG000|Overall Study|Death|1|||
155210322|NCT02772081|560207757|FG001|Overall Study|Death|1|||
155210323|NCT02598076|560207761|FG000|Overall Study|Lost to Follow-up|2|||
155210324|NCT02598076|560207762|FG001|Overall Study|Lost to Follow-up|3|||
155210325|NCT01828281|560207763|FG000|Overall Study|Withdrawal by Subject|1|||
155210326|NCT01828281|560207764|FG001|Overall Study|Withdrawal by Subject|0|||
155210327|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
155210328|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
155210329|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
155210330|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
155210331|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
155210332|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
155210333|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
155210334|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
155210335|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
155210336|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
155210337|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
155210338|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
155210339|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
155210340|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
155210341|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
155210342|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
155210343|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
155210344|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
155210345|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
155210346|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
155210347|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
155210348|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
155210349|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
155210350|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
155210351|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
155210352|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
155210353|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
155210354|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
155210355|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
155210356|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
155210357|NCT02709785|560207772|FG000|Overall Study|Withdrawal by Subject|1|||
155210358|NCT02709785|560207773|FG001|Overall Study|Withdrawal by Subject|2|||
155210359|NCT02709785|560207774|FG002|Overall Study|Withdrawal by Subject|1|||
155210360|NCT01961323|560207775|FG000|Overall Study|Withdrawal by Subject|7|||
155210361|NCT01961323|560207775|FG000|Overall Study|Lost to Follow-up|8|||
155210362|NCT01961323|560207775|FG000|Overall Study|screen failure|34|||
155210363|NCT03315208|560207776|FG000|Overall Study|Lost to Follow-up|11|||
155210364|NCT03315208|560207777|FG001|Overall Study|Lost to Follow-up|6|||
155210365|NCT03315208|560207776|FG000|Overall Study|Withdrawal by Subject|2|||
155210366|NCT03315208|560207777|FG001|Overall Study|Withdrawal by Subject|0|||
155210367|NCT02875860|560207780|FG000|Overall Study|Withdrawal by Subject|0|||
155210368|NCT02875860|560207781|FG001|Overall Study|Withdrawal by Subject|1|||
155210369|NCT02320149|560207788|FG000|Overall Study|Adverse Event|3|||
155210370|NCT02320149|560207789|FG001|Overall Study|Adverse Event|7|||
155210371|NCT02320149|560207788|FG000|Overall Study|Withdrawal of Consent|28|||
155210372|NCT02320149|560207789|FG001|Overall Study|Withdrawal of Consent|32|||
155210373|NCT02320149|560207788|FG000|Overall Study|Lost to Follow-up|21|||
155210374|NCT02320149|560207789|FG001|Overall Study|Lost to Follow-up|34|||
155210375|NCT02320149|560207788|FG000|Overall Study|Protocol Violation|2|||
155210376|NCT02320149|560207789|FG001|Overall Study|Protocol Violation|1|||
155210377|NCT02320149|560207788|FG000|Overall Study|Noncompliance with Study Treatment|7|||
155210378|NCT02320149|560207789|FG001|Overall Study|Noncompliance with Study Treatment|2|||
155210379|NCT02320149|560207788|FG000|Overall Study|Lack of Efficacy|0|||
155210380|NCT02320149|560207789|FG001|Overall Study|Lack of Efficacy|1|||
155210381|NCT02320149|560207788|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155210382|NCT02320149|560207789|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155210383|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
155210384|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
155210385|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
155210386|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
155210387|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Physician Decision|0|||
155491425|NCT00948896|561223548|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155210388|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Physician Decision|1|||
155210389|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Physician Decision|0|||
155210390|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Physician Decision|0|||
155210391|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Other|1|||
155210392|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Other|0|||
155210393|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Other|0|||
155210394|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Other|0|||
155210395|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
155210396|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
155210397|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
155210398|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
155210399|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210400|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210401|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
155210402|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210403|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
155210404|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
155210405|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
155210406|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
155210407|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
155210408|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
155210409|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
155210410|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
155210411|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Other|0|||
155210412|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Other|0|||
155210413|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Other|1|||
155210414|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Other|2|||
155210415|NCT06133348|560207797|FG000|Overall Study|Death|3|||
155210416|NCT06133348|560207797|FG000|Overall Study|Lost to Follow-up|1|||
155210417|NCT06133348|560207797|FG000|Overall Study|Physician Decision|1|||
155210418|NCT06133348|560207797|FG000|Overall Study|Withdrawal by Subject|5|||
155210419|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
155210420|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
155210421|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
155210422|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
155210423|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
155210424|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
155210425|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
155210426|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
155210427|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
155210428|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
155210429|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
155210430|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210431|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
155210432|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210433|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210434|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
155210435|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
155210436|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
155210437|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
155210438|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
155210439|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210440|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
155210441|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
155210442|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210443|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210444|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
155210445|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210446|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
155210447|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210448|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210449|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
155210450|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
155210451|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
155210452|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
155210453|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
155210454|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
155210455|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
155210456|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
155210457|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
155210458|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
155210459|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
155210460|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
155210461|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
155210462|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
155210463|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
155210464|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
155210465|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
155210466|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
155210467|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
155210468|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
155210469|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
155210470|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
155210471|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
155210472|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
155210473|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
155210474|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
155210475|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210476|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210477|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210478|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
155210479|NCT01996982|560207803|FG000|Overall Study|PI/team left institution|7|||
155210480|NCT01195415|560207824|FG000|Overall Study|No repeat biopsy due to progression|2|||
155210481|NCT00533845|560207825|FG000|Overall Study|Physician Decision|1|||
155210482|NCT00533845|560207826|FG001|Overall Study|Physician Decision|0|||
155210483|NCT01442675|560207831|FG000|Overall Study|Protocol Violation|6|||
155210484|NCT01442675|560207831|FG000|Overall Study|Lost to Follow-up|2|||
155210485|NCT01442675|560207831|FG000|Overall Study|Withdrawal by Subject|4|||
155210486|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
155210487|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
155210488|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
155210489|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
155210490|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
155210491|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
155210492|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210493|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
155210494|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210495|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210496|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Death|2|||
155210497|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Death|1|||
155210498|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Death|4|||
155210499|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Death|0|||
155210500|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Death|0|||
155210501|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
155210502|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
155210503|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
155210504|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
155210505|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
155210506|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Other Reason|1|||
155210507|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Other Reason|3|||
155210508|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Other Reason|2|||
155210509|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Other Reason|0|||
155210510|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Other Reason|0|||
155210511|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Never treated|2|||
155210512|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Never treated|3|||
155210513|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Never treated|1|||
155210514|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Never treated|0|||
155210515|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Never treated|4|||
155210516|NCT00555321|560207832|FG000|Long-term Extension Phase|Adverse Event|2|||
155210517|NCT00555321|560207833|FG001|Long-term Extension Phase|Adverse Event|5|||
155210518|NCT00555321|560207834|FG002|Long-term Extension Phase|Adverse Event|2|||
155210519|NCT00555321|560207835|FG003|Long-term Extension Phase|Adverse Event|1|||
155210520|NCT00555321|560207836|FG004|Long-term Extension Phase|Adverse Event|0|||
155210521|NCT00555321|560207832|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
155210522|NCT00555321|560207833|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
155210523|NCT00555321|560207834|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
155210524|NCT00555321|560207835|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
155210525|NCT00555321|560207836|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
155210526|NCT00555321|560207832|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
155210527|NCT00555321|560207833|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
155210528|NCT00555321|560207834|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
155210529|NCT00555321|560207835|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
155210530|NCT00555321|560207836|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
155210531|NCT00555321|560207832|FG000|Long-term Extension Phase|Death|2|||
155210532|NCT00555321|560207833|FG001|Long-term Extension Phase|Death|0|||
155210533|NCT00555321|560207834|FG002|Long-term Extension Phase|Death|0|||
155210534|NCT00555321|560207835|FG003|Long-term Extension Phase|Death|3|||
155210535|NCT00555321|560207836|FG004|Long-term Extension Phase|Death|0|||
155210536|NCT00555321|560207832|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210537|NCT00555321|560207833|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210538|NCT00555321|560207834|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210539|NCT00555321|560207835|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210540|NCT00555321|560207836|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
155210541|NCT00555321|560207832|FG000|Long-term Extension Phase|Other Reason|1|||
155210542|NCT00555321|560207833|FG001|Long-term Extension Phase|Other Reason|0|||
155210543|NCT00555321|560207834|FG002|Long-term Extension Phase|Other Reason|2|||
155210544|NCT00555321|560207835|FG003|Long-term Extension Phase|Other Reason|0|||
155210545|NCT00555321|560207836|FG004|Long-term Extension Phase|Other Reason|0|||
155210546|NCT00160251|560207837|FG000|Prior to Amendment 2|Adverse Event|2|||
155210547|NCT00160251|560207838|FG001|Prior to Amendment 2|Adverse Event|1|||
155210548|NCT00160251|560207839|FG002|Prior to Amendment 2|Adverse Event|3|||
155210549|NCT00160251|560207840|FG003|Prior to Amendment 2|Adverse Event|1|||
155210550|NCT00160251|560207841|FG004|Prior to Amendment 2|Adverse Event|1|||
155210551|NCT00160251|560207842|FG005|Prior to Amendment 2|Adverse Event|1|||
155210552|NCT00160251|560207843|FG006|Prior to Amendment 2|Adverse Event|1|||
155210553|NCT00160251|560207844|FG007|Prior to Amendment 2|Adverse Event|0|||
155210554|NCT00160251|560207837|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
155210555|NCT00160251|560207838|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
155210556|NCT00160251|560207839|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
155210557|NCT00160251|560207840|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
155210558|NCT00160251|560207841|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
155210559|NCT00160251|560207842|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
155210560|NCT00160251|560207843|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
155210561|NCT00160251|560207844|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
155210562|NCT00160251|560207837|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
155210563|NCT00160251|560207838|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
155210564|NCT00160251|560207839|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
155210565|NCT00160251|560207840|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
155210566|NCT00160251|560207841|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
155210567|NCT00160251|560207842|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
155210568|NCT00160251|560207843|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
155210569|NCT00160251|560207844|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
155210570|NCT00160251|560207837|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
155210571|NCT00160251|560207838|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
155210572|NCT00160251|560207839|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
155210573|NCT00160251|560207840|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
155210574|NCT00160251|560207841|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
155210575|NCT00160251|560207842|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
155210576|NCT00160251|560207843|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
155210577|NCT00160251|560207844|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
155210578|NCT00160251|560207837|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
155210579|NCT00160251|560207838|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
155210580|NCT00160251|560207839|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
155210581|NCT00160251|560207840|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
155210582|NCT00160251|560207841|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
155210583|NCT00160251|560207842|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
155210584|NCT00160251|560207843|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
155210585|NCT00160251|560207844|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
155210586|NCT00160251|560207837|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
155210587|NCT00160251|560207838|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
155210588|NCT00160251|560207839|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
155210589|NCT00160251|560207840|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
155210590|NCT00160251|560207841|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
155210591|NCT00160251|560207842|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
155210592|NCT00160251|560207843|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
155210593|NCT00160251|560207844|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
155210594|NCT00160251|560207837|FG000|Post-amendment 2|Adverse Event|0|||
155210595|NCT00160251|560207838|FG001|Post-amendment 2|Adverse Event|0|||
155210596|NCT00160251|560207839|FG002|Post-amendment 2|Adverse Event|0|||
155210597|NCT00160251|560207840|FG003|Post-amendment 2|Adverse Event|0|||
155210598|NCT00160251|560207841|FG004|Post-amendment 2|Adverse Event|0|||
155210599|NCT00160251|560207842|FG005|Post-amendment 2|Adverse Event|0|||
155210600|NCT00160251|560207843|FG006|Post-amendment 2|Adverse Event|0|||
155210601|NCT00160251|560207844|FG007|Post-amendment 2|Adverse Event|20|||
155210602|NCT00160251|560207837|FG000|Post-amendment 2|Lack of Efficacy|0|||
155210603|NCT00160251|560207838|FG001|Post-amendment 2|Lack of Efficacy|0|||
155210604|NCT00160251|560207839|FG002|Post-amendment 2|Lack of Efficacy|0|||
155210605|NCT00160251|560207840|FG003|Post-amendment 2|Lack of Efficacy|0|||
155210606|NCT00160251|560207841|FG004|Post-amendment 2|Lack of Efficacy|0|||
155210607|NCT00160251|560207842|FG005|Post-amendment 2|Lack of Efficacy|0|||
155210608|NCT00160251|560207843|FG006|Post-amendment 2|Lack of Efficacy|0|||
155210609|NCT00160251|560207844|FG007|Post-amendment 2|Lack of Efficacy|24|||
155210610|NCT00160251|560207837|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210611|NCT00160251|560207838|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210612|NCT00160251|560207839|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210613|NCT00160251|560207840|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210614|NCT00160251|560207841|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210615|NCT00160251|560207842|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210616|NCT00160251|560207843|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210617|NCT00160251|560207844|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
155210618|NCT00563381|560207846|FG000|Overall Study|Adverse Event|264|||
155210619|NCT00563381|560207847|FG001|Overall Study|Adverse Event|292|||
155210620|NCT00563381|560207846|FG000|Overall Study|Protocol Violation|66|||
155210621|NCT00563381|560207847|FG001|Overall Study|Protocol Violation|74|||
155210622|NCT00563381|560207846|FG000|Overall Study|Lost to Follow-up|7|||
155210623|NCT00563381|560207847|FG001|Overall Study|Lost to Follow-up|15|||
155210624|NCT00563381|560207846|FG000|Overall Study|Withdrawal by Subject|192|||
155210625|NCT00563381|560207847|FG001|Overall Study|Withdrawal by Subject|209|||
155210626|NCT00563381|560207846|FG000|Overall Study|Lack of Efficacy|32|||
155210627|NCT00563381|560207847|FG001|Overall Study|Lack of Efficacy|24|||
155210628|NCT00563381|560207846|FG000|Overall Study|Individual different reasons|24|||
155210629|NCT00563381|560207847|FG001|Overall Study|Individual different reasons|34|||
155210630|NCT02407704|560207850|FG000|Overall Study|Lost to Follow-up|0|||
155210631|NCT02407704|560207851|FG001|Overall Study|Lost to Follow-up|0|||
155210632|NCT02407704|560207852|FG002|Overall Study|Lost to Follow-up|0|||
155210633|NCT02407704|560207853|FG003|Overall Study|Lost to Follow-up|2|||
155210634|NCT02407704|560207850|FG000|Overall Study|Protocol Violation|0|||
155210635|NCT02407704|560207851|FG001|Overall Study|Protocol Violation|0|||
155210636|NCT02407704|560207852|FG002|Overall Study|Protocol Violation|0|||
155210637|NCT02407704|560207853|FG003|Overall Study|Protocol Violation|1|||
155210638|NCT02407704|560207850|FG000|Overall Study|Withdrawal by Subject|0|||
155210639|NCT02407704|560207851|FG001|Overall Study|Withdrawal by Subject|0|||
155210640|NCT02407704|560207852|FG002|Overall Study|Withdrawal by Subject|1|||
155210641|NCT02407704|560207853|FG003|Overall Study|Withdrawal by Subject|0|||
155210642|NCT01957644|560207854|FG000|Overall Study|Adverse Event|4|||
155210643|NCT01957644|560207855|FG001|Overall Study|Adverse Event|2|||
155210644|NCT01957644|560207856|FG002|Overall Study|Adverse Event|0|||
155210645|NCT01957644|560207857|FG003|Overall Study|Adverse Event|0|||
155210646|NCT01957644|560207858|FG004|Overall Study|Adverse Event|1|||
155210647|NCT01957644|560207854|FG000|Overall Study|Progressive disease / relapse|0|||
155210648|NCT01957644|560207855|FG001|Overall Study|Progressive disease / relapse|1|||
155210649|NCT01957644|560207856|FG002|Overall Study|Progressive disease / relapse|0|||
155210650|NCT01957644|560207857|FG003|Overall Study|Progressive disease / relapse|1|||
155210651|NCT01957644|560207858|FG004|Overall Study|Progressive disease / relapse|0|||
155210652|NCT01957644|560207854|FG000|Overall Study|Other reason|1|||
155210653|NCT01957644|560207855|FG001|Overall Study|Other reason|2|||
155210654|NCT01957644|560207856|FG002|Overall Study|Other reason|1|||
155210655|NCT01957644|560207857|FG003|Overall Study|Other reason|1|||
155210656|NCT01957644|560207858|FG004|Overall Study|Other reason|0|||
155210657|NCT01957644|560207854|FG000|Overall Study|Withdrawal by Subject|1|||
155210658|NCT01957644|560207855|FG001|Overall Study|Withdrawal by Subject|0|||
155210659|NCT01957644|560207856|FG002|Overall Study|Withdrawal by Subject|0|||
155210660|NCT01957644|560207857|FG003|Overall Study|Withdrawal by Subject|0|||
155210661|NCT01957644|560207858|FG004|Overall Study|Withdrawal by Subject|0|||
155210662|NCT01957644|560207854|FG000|Overall Study|Protocol Violation|0|||
155210663|NCT01957644|560207855|FG001|Overall Study|Protocol Violation|1|||
155210664|NCT01957644|560207856|FG002|Overall Study|Protocol Violation|0|||
155210665|NCT01957644|560207857|FG003|Overall Study|Protocol Violation|0|||
155210666|NCT01957644|560207858|FG004|Overall Study|Protocol Violation|0|||
155210667|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
155210668|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
155210669|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
155210670|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
155210671|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
155210672|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
155491426|NCT00948896|561223549|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155210673|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
155210674|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
155210675|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
155210676|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
155210677|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
155210678|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
155210679|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
155210680|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
155210681|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
155210682|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
155210683|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
155210684|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
155210685|NCT04044716|560207861|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
155210686|NCT04044716|560207862|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
155210687|NCT04044716|560207863|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
155210688|NCT04044716|560207861|FG000|Overall Study|Lost to Follow-up|2|||
155210689|NCT04044716|560207862|FG001|Overall Study|Lost to Follow-up|3|||
155210690|NCT04044716|560207863|FG002|Overall Study|Lost to Follow-up|0|||
155210691|NCT03235154|560207866|FG000|Overall Study|Withdrawal by Subject|1|||
155210692|NCT03235154|560207866|FG000|Overall Study|Adverse Event|1|||
155210693|NCT03235154|560207866|FG000|Overall Study|Lost to Follow-up|2|||
155210694|NCT01922089|560207871|FG000|Overall Study|Adverse Event|18|||
155210695|NCT01922089|560207872|FG001|Overall Study|Adverse Event|13|||
155210696|NCT01922089|560207871|FG000|Overall Study|Protocol Deviation|10|||
155210697|NCT01922089|560207872|FG001|Overall Study|Protocol Deviation|7|||
155210698|NCT01922089|560207871|FG000|Overall Study|Withdrawal by Subject|3|||
155210699|NCT01922089|560207872|FG001|Overall Study|Withdrawal by Subject|4|||
155210700|NCT01922089|560207871|FG000|Overall Study|administrative problems|4|||
155210701|NCT01922089|560207872|FG001|Overall Study|administrative problems|1|||
155210702|NCT01922089|560207871|FG000|Overall Study|Physician Decision|2|||
155210703|NCT01922089|560207872|FG001|Overall Study|Physician Decision|3|||
155210704|NCT01922089|560207871|FG000|Overall Study|Death|2|||
155210705|NCT01922089|560207872|FG001|Overall Study|Death|1|||
155210706|NCT01922089|560207871|FG000|Overall Study|Lost to Follow-up|0|||
155210707|NCT01922089|560207872|FG001|Overall Study|Lost to Follow-up|1|||
155210708|NCT02326025|560207874|FG000|Overall Study|Adverse Event|3|||
155210709|NCT02326025|560207875|FG001|Overall Study|Adverse Event|0|||
155210710|NCT02326025|560207874|FG000|Overall Study|Physician Decision|1|||
155210711|NCT02326025|560207875|FG001|Overall Study|Physician Decision|2|||
155210712|NCT02326025|560207874|FG000|Overall Study|Physician and Participant Decision|1|||
155210713|NCT02326025|560207875|FG001|Overall Study|Physician and Participant Decision|0|||
155210714|NCT02326025|560207874|FG000|Overall Study|Withdrawal by Subject|0|||
155210715|NCT02326025|560207875|FG001|Overall Study|Withdrawal by Subject|2|||
155210716|NCT02326025|560207874|FG000|Overall Study|Protocol Violation|0|||
155210717|NCT02326025|560207875|FG001|Overall Study|Protocol Violation|1|||
155210718|NCT00881712|560207876|FG000|Overall Study|Death|1|||
155210719|NCT00881712|560207877|FG001|Overall Study|Death|0|||
155210720|NCT00881712|560207878|FG002|Overall Study|Death|0|||
155210721|NCT00881712|560207876|FG000|Overall Study|Withdrawal by Subject|1|||
155210722|NCT00881712|560207877|FG001|Overall Study|Withdrawal by Subject|0|||
155210723|NCT00881712|560207878|FG002|Overall Study|Withdrawal by Subject|0|||
155210724|NCT01324999|560207879|FG000|Overall Study|Adverse Event|3|||
155210725|NCT01324999|560207879|FG000|Overall Study|Withdrawal by Subject|2|||
155210726|NCT02505867|560207884|FG000|Overall Study|Lack of Efficacy|6|||
155210727|NCT02505867|560207885|FG001|Overall Study|Lack of Efficacy|6|||
155210728|NCT03681405|560207886|FG000|Overall Study|Found to be ineligible after randomized|1|||
155210729|NCT03681405|560207887|FG001|Overall Study|Found to be ineligible after randomized|0|||
155210730|NCT01714635|560207895|FG000|Overall Study|Discontinued|1|||
155210731|NCT01714635|560207896|FG001|Overall Study|Discontinued|0|||
155210732|NCT01714635|560207897|FG002|Overall Study|Discontinued|2|||
155210733|NCT01714635|560207895|FG000|Overall Study|Missed 6-month exam|1|||
155210734|NCT01714635|560207896|FG001|Overall Study|Missed 6-month exam|0|||
155210735|NCT01714635|560207897|FG002|Overall Study|Missed 6-month exam|0|||
155210736|NCT01129960|560207898|FG000|Overall Study|Withdrawal by Subject|3|||
155210737|NCT01129960|560207899|FG001|Overall Study|Withdrawal by Subject|0|||
155210738|NCT01129960|560207900|FG002|Overall Study|Withdrawal by Subject|3|||
155210739|NCT01129960|560207901|FG003|Overall Study|Withdrawal by Subject|2|||
155210740|NCT01129960|560207898|FG000|Overall Study|Lack of Efficacy|1|||
155210741|NCT01129960|560207899|FG001|Overall Study|Lack of Efficacy|1|||
155210742|NCT01129960|560207900|FG002|Overall Study|Lack of Efficacy|1|||
155210743|NCT01129960|560207901|FG003|Overall Study|Lack of Efficacy|1|||
155210744|NCT01129960|560207898|FG000|Overall Study|Adverse Event|23|||
155210745|NCT01129960|560207899|FG001|Overall Study|Adverse Event|16|||
155210746|NCT01129960|560207900|FG002|Overall Study|Adverse Event|16|||
155210747|NCT01129960|560207901|FG003|Overall Study|Adverse Event|7|||
155210748|NCT01129960|560207898|FG000|Overall Study|Protocol Violation|1|||
155210749|NCT01129960|560207899|FG001|Overall Study|Protocol Violation|2|||
155210750|NCT01129960|560207900|FG002|Overall Study|Protocol Violation|3|||
155210751|NCT01129960|560207901|FG003|Overall Study|Protocol Violation|0|||
155210752|NCT01129960|560207898|FG000|Overall Study|Lost to Follow-up|0|||
155210753|NCT01129960|560207899|FG001|Overall Study|Lost to Follow-up|2|||
155210754|NCT01129960|560207900|FG002|Overall Study|Lost to Follow-up|3|||
155210755|NCT01129960|560207901|FG003|Overall Study|Lost to Follow-up|3|||
155210756|NCT01129960|560207898|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
155210757|NCT01129960|560207899|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
155210758|NCT01129960|560207900|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
155210759|NCT01129960|560207901|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
155210760|NCT01129960|560207898|FG000|Overall Study|Physician Decision|1|||
155210761|NCT01129960|560207899|FG001|Overall Study|Physician Decision|0|||
155210762|NCT01129960|560207900|FG002|Overall Study|Physician Decision|0|||
155210763|NCT01129960|560207901|FG003|Overall Study|Physician Decision|0|||
155210764|NCT01129960|560207898|FG000|Overall Study|Pregnancy|1|||
155210765|NCT01129960|560207899|FG001|Overall Study|Pregnancy|0|||
155210766|NCT01129960|560207900|FG002|Overall Study|Pregnancy|0|||
155210767|NCT01129960|560207901|FG003|Overall Study|Pregnancy|0|||
155210768|NCT00230607|560207902|FG000|Overall Study|Other|3|||
155210769|NCT01835587|560207903|FG000|Overall Study|Disease Recurrence or Relapse|0|||
155210770|NCT01835587|560207904|FG001|Overall Study|Disease Recurrence or Relapse|3|||
155210771|NCT01835587|560207905|FG002|Overall Study|Disease Recurrence or Relapse|0|||
155210772|NCT01835587|560207906|FG003|Overall Study|Disease Recurrence or Relapse|3|||
155210773|NCT01835587|560207903|FG000|Overall Study|Withdrawal by Subject|2|||
155210774|NCT01835587|560207904|FG001|Overall Study|Withdrawal by Subject|0|||
155210775|NCT01835587|560207905|FG002|Overall Study|Withdrawal by Subject|0|||
155210776|NCT01835587|560207906|FG003|Overall Study|Withdrawal by Subject|3|||
155210777|NCT01835587|560207903|FG000|Overall Study|Adverse Event|0|||
155210778|NCT01835587|560207904|FG001|Overall Study|Adverse Event|0|||
155210779|NCT01835587|560207905|FG002|Overall Study|Adverse Event|2|||
155210780|NCT01835587|560207906|FG003|Overall Study|Adverse Event|2|||
155210781|NCT01835587|560207903|FG000|Overall Study|Death|0|||
155210782|NCT01835587|560207904|FG001|Overall Study|Death|0|||
155210783|NCT01835587|560207905|FG002|Overall Study|Death|0|||
155210784|NCT01835587|560207906|FG003|Overall Study|Death|1|||
155210785|NCT01835587|560207903|FG000|Overall Study|Miscellaneous|0|||
155210786|NCT01835587|560207904|FG001|Overall Study|Miscellaneous|1|||
155210787|NCT01835587|560207905|FG002|Overall Study|Miscellaneous|0|||
155210788|NCT01835587|560207906|FG003|Overall Study|Miscellaneous|0|||
155210789|NCT00126568|560207909|FG000|Overall Study|Death|2|||
155210790|NCT03358290|560207910|FG000|Overall Study|Study discontinued by Sponsor|0|||
155210791|NCT03358290|560207911|FG001|Overall Study|Study discontinued by Sponsor|1|||
155210792|NCT03358290|560207912|FG002|Overall Study|Study discontinued by Sponsor|1|||
155210793|NCT03358290|560207913|FG003|Overall Study|Study discontinued by Sponsor|0|||
155210794|NCT03358290|560207914|FG004|Overall Study|Study discontinued by Sponsor|0|||
155210795|NCT03358290|560207910|FG000|Overall Study|Adverse Event|0|||
155210796|NCT03358290|560207911|FG001|Overall Study|Adverse Event|0|||
155210797|NCT03358290|560207912|FG002|Overall Study|Adverse Event|1|||
155210798|NCT03358290|560207913|FG003|Overall Study|Adverse Event|2|||
155210799|NCT03358290|560207914|FG004|Overall Study|Adverse Event|0|||
155210800|NCT03358290|560207910|FG000|Overall Study|Withdrawal by Subject|0|||
155210801|NCT03358290|560207911|FG001|Overall Study|Withdrawal by Subject|0|||
155210802|NCT03358290|560207912|FG002|Overall Study|Withdrawal by Subject|0|||
155210803|NCT03358290|560207913|FG003|Overall Study|Withdrawal by Subject|0|||
155210804|NCT03358290|560207914|FG004|Overall Study|Withdrawal by Subject|1|||
155210805|NCT00203996|560207915|FG000|Overall Study|Lost to Follow-up|0|||
155210806|NCT00203996|560207916|FG001|Overall Study|Lost to Follow-up|0|||
155210807|NCT00203996|560207917|FG002|Overall Study|Lost to Follow-up|0|||
155210808|NCT00203996|560207918|FG003|Overall Study|Lost to Follow-up|1|||
155210809|NCT00203996|560207919|FG004|Overall Study|Lost to Follow-up|0|||
155210810|NCT00203996|560207920|FG005|Overall Study|Lost to Follow-up|0|||
155210811|NCT00203996|560207921|FG006|Overall Study|Lost to Follow-up|0|||
155210812|NCT00203996|560207922|FG007|Overall Study|Lost to Follow-up|0|||
155210813|NCT00203996|560207923|FG008|Overall Study|Lost to Follow-up|0|||
155210814|NCT00203996|560207924|FG009|Overall Study|Lost to Follow-up|0|||
155210815|NCT00203996|560207915|FG000|Overall Study|Protocol Violation|0|||
155210816|NCT00203996|560207916|FG001|Overall Study|Protocol Violation|0|||
155210817|NCT00203996|560207917|FG002|Overall Study|Protocol Violation|0|||
155210818|NCT00203996|560207918|FG003|Overall Study|Protocol Violation|6|||
155210819|NCT00203996|560207919|FG004|Overall Study|Protocol Violation|1|||
155210820|NCT00203996|560207920|FG005|Overall Study|Protocol Violation|0|||
155210821|NCT00203996|560207921|FG006|Overall Study|Protocol Violation|0|||
155210822|NCT00203996|560207922|FG007|Overall Study|Protocol Violation|0|||
155210823|NCT00203996|560207923|FG008|Overall Study|Protocol Violation|0|||
155210824|NCT00203996|560207924|FG009|Overall Study|Protocol Violation|0|||
155210825|NCT00203996|560207915|FG000|Overall Study|Physician Decision|0|||
155210826|NCT00203996|560207916|FG001|Overall Study|Physician Decision|0|||
155210827|NCT00203996|560207917|FG002|Overall Study|Physician Decision|0|||
155210828|NCT00203996|560207918|FG003|Overall Study|Physician Decision|2|||
155210829|NCT00203996|560207919|FG004|Overall Study|Physician Decision|0|||
155210830|NCT00203996|560207920|FG005|Overall Study|Physician Decision|0|||
155210831|NCT00203996|560207921|FG006|Overall Study|Physician Decision|0|||
155210832|NCT00203996|560207922|FG007|Overall Study|Physician Decision|0|||
155210833|NCT00203996|560207923|FG008|Overall Study|Physician Decision|0|||
155210834|NCT00203996|560207924|FG009|Overall Study|Physician Decision|1|||
155210835|NCT00203996|560207915|FG000|Overall Study|CPAP machine malfunction|0|||
155210836|NCT00203996|560207916|FG001|Overall Study|CPAP machine malfunction|0|||
155210837|NCT00203996|560207917|FG002|Overall Study|CPAP machine malfunction|0|||
155210838|NCT00203996|560207918|FG003|Overall Study|CPAP machine malfunction|1|||
155210839|NCT00203996|560207919|FG004|Overall Study|CPAP machine malfunction|0|||
155210840|NCT00203996|560207920|FG005|Overall Study|CPAP machine malfunction|0|||
155210841|NCT00203996|560207921|FG006|Overall Study|CPAP machine malfunction|0|||
155210842|NCT00203996|560207922|FG007|Overall Study|CPAP machine malfunction|0|||
155210843|NCT00203996|560207923|FG008|Overall Study|CPAP machine malfunction|0|||
155210844|NCT00203996|560207924|FG009|Overall Study|CPAP machine malfunction|0|||
155210845|NCT00203996|560207915|FG000|Overall Study|Scheduling issue|0|||
155210846|NCT00203996|560207916|FG001|Overall Study|Scheduling issue|0|||
155210847|NCT00203996|560207917|FG002|Overall Study|Scheduling issue|0|||
155210848|NCT00203996|560207918|FG003|Overall Study|Scheduling issue|0|||
155210849|NCT00203996|560207919|FG004|Overall Study|Scheduling issue|0|||
155210850|NCT00203996|560207920|FG005|Overall Study|Scheduling issue|0|||
155210851|NCT00203996|560207921|FG006|Overall Study|Scheduling issue|0|||
155210852|NCT00203996|560207922|FG007|Overall Study|Scheduling issue|2|||
155210853|NCT00203996|560207923|FG008|Overall Study|Scheduling issue|0|||
155210854|NCT00203996|560207924|FG009|Overall Study|Scheduling issue|0|||
155210855|NCT00897104|560207925|FG000|Overall Study|Lost to Follow-up|12|||
155210856|NCT00897104|560207926|FG001|Overall Study|Lost to Follow-up|17|||
155210857|NCT00897104|560207927|FG002|Overall Study|Lost to Follow-up|2|||
155210858|NCT00897104|560207925|FG000|Overall Study|Pregnancy|0|||
155210859|NCT00897104|560207926|FG001|Overall Study|Pregnancy|1|||
155210860|NCT00897104|560207927|FG002|Overall Study|Pregnancy|0|||
155210861|NCT00897104|560207925|FG000|Overall Study|Protocol Violation|0|||
155210862|NCT00897104|560207926|FG001|Overall Study|Protocol Violation|1|||
155210863|NCT00897104|560207927|FG002|Overall Study|Protocol Violation|0|||
155210864|NCT00897104|560207925|FG000|Overall Study|Withdrawal by Subject|23|||
155210865|NCT00897104|560207926|FG001|Overall Study|Withdrawal by Subject|27|||
155210866|NCT00897104|560207927|FG002|Overall Study|Withdrawal by Subject|3|||
155210867|NCT00897104|560207925|FG000|Overall Study|Abnormal Prestudy Labs|2|||
155210868|NCT00897104|560207926|FG001|Overall Study|Abnormal Prestudy Labs|0|||
155210869|NCT00897104|560207927|FG002|Overall Study|Abnormal Prestudy Labs|0|||
155210870|NCT00897104|560207925|FG000|Overall Study|Abnormal Baseline ECG|2|||
155210871|NCT00897104|560207926|FG001|Overall Study|Abnormal Baseline ECG|2|||
155210872|NCT00897104|560207927|FG002|Overall Study|Abnormal Baseline ECG|0|||
155210873|NCT00897104|560207925|FG000|Overall Study|Need for Concom. Med.|0|||
155210874|NCT00897104|560207926|FG001|Overall Study|Need for Concom. Med.|1|||
155210875|NCT00897104|560207927|FG002|Overall Study|Need for Concom. Med.|1|||
155210876|NCT00897104|560207925|FG000|Overall Study|Lack of Migraine Attack|20|||
155210877|NCT00897104|560207926|FG001|Overall Study|Lack of Migraine Attack|22|||
155210878|NCT00897104|560207927|FG002|Overall Study|Lack of Migraine Attack|1|||
155210879|NCT00897104|560207925|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155210880|NCT00897104|560207926|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155210881|NCT00897104|560207927|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155210882|NCT00897104|560207925|FG000|Overall Study|Other|3|||
155210883|NCT00897104|560207926|FG001|Overall Study|Other|0|||
155210884|NCT00897104|560207927|FG002|Overall Study|Other|0|||
155210885|NCT00897104|560207925|FG000|Overall Study|Protocol Violation|1|||
155210886|NCT00897104|560207926|FG001|Overall Study|Protocol Violation|0|||
155210887|NCT00897104|560207927|FG002|Overall Study|Protocol Violation|0|||
155210888|NCT00897104|560207925|FG000|Overall Study|Withdrawal by Subject|0|||
155210889|NCT00897104|560207926|FG001|Overall Study|Withdrawal by Subject|0|||
155210890|NCT00897104|560207927|FG002|Overall Study|Withdrawal by Subject|1|||
155210891|NCT00434330|560207928|FG000|Overall Study|Adverse Event|0|||
155210892|NCT00434330|560207929|FG001|Overall Study|Adverse Event|0|||
155210893|NCT00434330|560207930|FG002|Overall Study|Adverse Event|1|||
155210894|NCT00434330|560207931|FG003|Overall Study|Adverse Event|0|||
155210895|NCT00434330|560207932|FG004|Overall Study|Adverse Event|0|||
155210896|NCT00434330|560207933|FG005|Overall Study|Adverse Event|0|||
155210897|NCT00434330|560207928|FG000|Overall Study|Death|1|||
155210898|NCT00434330|560207929|FG001|Overall Study|Death|0|||
155210899|NCT00434330|560207930|FG002|Overall Study|Death|0|||
155210900|NCT00434330|560207931|FG003|Overall Study|Death|0|||
155210901|NCT00434330|560207932|FG004|Overall Study|Death|1|||
155210902|NCT00434330|560207933|FG005|Overall Study|Death|1|||
155210903|NCT00434330|560207928|FG000|Overall Study|Withdrawal by Subject|0|||
155210904|NCT00434330|560207929|FG001|Overall Study|Withdrawal by Subject|0|||
155210905|NCT00434330|560207930|FG002|Overall Study|Withdrawal by Subject|1|||
155210906|NCT00434330|560207931|FG003|Overall Study|Withdrawal by Subject|1|||
155210907|NCT00434330|560207932|FG004|Overall Study|Withdrawal by Subject|0|||
155210908|NCT00434330|560207933|FG005|Overall Study|Withdrawal by Subject|0|||
155210909|NCT00434330|560207928|FG000|Overall Study|Renal transplant|0|||
155210910|NCT00434330|560207929|FG001|Overall Study|Renal transplant|0|||
155210911|NCT00434330|560207930|FG002|Overall Study|Renal transplant|0|||
155210912|NCT00434330|560207931|FG003|Overall Study|Renal transplant|1|||
155210913|NCT00434330|560207932|FG004|Overall Study|Renal transplant|0|||
155210914|NCT00434330|560207933|FG005|Overall Study|Renal transplant|0|||
155210915|NCT00434330|560207928|FG000|Overall Study|Subject Not Compliant With Study|0|||
155210916|NCT00434330|560207929|FG001|Overall Study|Subject Not Compliant With Study|0|||
155210917|NCT00434330|560207930|FG002|Overall Study|Subject Not Compliant With Study|1|||
155210918|NCT00434330|560207931|FG003|Overall Study|Subject Not Compliant With Study|0|||
155210919|NCT00434330|560207932|FG004|Overall Study|Subject Not Compliant With Study|0|||
155210920|NCT00434330|560207933|FG005|Overall Study|Subject Not Compliant With Study|0|||
155210921|NCT03789318|560207936|FG000|Overall Study|Adverse Event|0|||
155210922|NCT03789318|560207937|FG001|Overall Study|Adverse Event|0|||
155210923|NCT03789318|560207938|FG002|Overall Study|Adverse Event|1|||
155210924|NCT03789318|560207939|FG003|Overall Study|Adverse Event|1|||
155210925|NCT03789318|560207940|FG004|Overall Study|Adverse Event|0|||
155210926|NCT03789318|560207936|FG000|Overall Study|Lost to Follow-up|0|||
155210927|NCT03789318|560207937|FG001|Overall Study|Lost to Follow-up|0|||
155210928|NCT03789318|560207938|FG002|Overall Study|Lost to Follow-up|1|||
155210929|NCT03789318|560207939|FG003|Overall Study|Lost to Follow-up|0|||
155210930|NCT03789318|560207940|FG004|Overall Study|Lost to Follow-up|0|||
155210931|NCT03789318|560207936|FG000|Overall Study|Withdrawal by Subject|0|||
155210932|NCT03789318|560207937|FG001|Overall Study|Withdrawal by Subject|0|||
155210933|NCT03789318|560207938|FG002|Overall Study|Withdrawal by Subject|1|||
155210934|NCT03789318|560207939|FG003|Overall Study|Withdrawal by Subject|0|||
155210935|NCT03789318|560207940|FG004|Overall Study|Withdrawal by Subject|0|||
155210936|NCT00850564|560207941|FG000|Overall Study|Withdrawal by Subject|2|||
155210937|NCT01937559|560207942|FG000|Overall Study|Physician Decision|3|||
155210938|NCT01937559|560207943|FG001|Overall Study|Physician Decision|3|||
155210939|NCT01937559|560207944|FG002|Overall Study|Physician Decision|0|||
155210940|NCT01937559|560207942|FG000|Overall Study|Withdrawal by Subject|6|||
155210941|NCT01937559|560207943|FG001|Overall Study|Withdrawal by Subject|4|||
155210942|NCT01937559|560207944|FG002|Overall Study|Withdrawal by Subject|0|||
155210943|NCT01937559|560207942|FG000|Overall Study|screen fail|2|||
155210944|NCT01937559|560207943|FG001|Overall Study|screen fail|4|||
155210945|NCT01937559|560207944|FG002|Overall Study|screen fail|0|||
155210946|NCT00531232|560210012|FG000|Overall Study|Investigator decision|0|||
155210947|NCT00531232|560210013|FG001|Overall Study|Investigator decision|0|||
155210948|NCT00531232|560210014|FG002|Overall Study|Investigator decision|4|||
155210949|NCT00531232|560210012|FG000|Overall Study|Participants refused further treatment|0|||
155210950|NCT00531232|560210013|FG001|Overall Study|Participants refused further treatment|1|||
155210951|NCT00531232|560210014|FG002|Overall Study|Participants refused further treatment|2|||
155210952|NCT00531232|560210012|FG000|Overall Study|Adverse events (AEs)|1|||
155210953|NCT00531232|560210013|FG001|Overall Study|Adverse events (AEs)|2|||
155210954|NCT00531232|560210014|FG002|Overall Study|Adverse events (AEs)|2|||
155210955|NCT00531232|560210012|FG000|Overall Study|Treatment failure|1|||
155210956|NCT00531232|560210013|FG001|Overall Study|Treatment failure|3|||
155210957|NCT00531232|560210014|FG002|Overall Study|Treatment failure|7|||
155210958|NCT00531232|560210012|FG000|Overall Study|Disease recurrence|0|||
155210959|NCT00531232|560210013|FG001|Overall Study|Disease recurrence|0|||
155210960|NCT00531232|560210014|FG002|Overall Study|Disease recurrence|1|||
155210961|NCT00531232|560210012|FG000|Overall Study|Deceased|2|||
155210962|NCT00531232|560210013|FG001|Overall Study|Deceased|2|||
155210963|NCT00531232|560210014|FG002|Overall Study|Deceased|2|||
155210964|NCT00531232|560210012|FG000|Overall Study|Withdrawal by Subject|0|||
155210965|NCT00531232|560210013|FG001|Overall Study|Withdrawal by Subject|1|||
155210966|NCT00531232|560210014|FG002|Overall Study|Withdrawal by Subject|2|||
155210967|NCT00531232|560210012|FG000|Overall Study|Other|0|||
155210968|NCT00531232|560210013|FG001|Overall Study|Other|0|||
155210969|NCT00531232|560210014|FG002|Overall Study|Other|5|||
155210970|NCT00397982|560210015|FG000|Overall Study|Withdrawal by Subject|1|||
155210971|NCT00397982|560210015|FG000|Overall Study|Adverse Event|1|||
155210972|NCT00397982|560210015|FG000|Overall Study|noncompliance|1|||
155210973|NCT00397982|560210015|FG000|Overall Study|Unrelated health issues|1|||
155210974|NCT04232124|560210016|FG000|Overall Study|Lost to Follow-up|3|||
155210975|NCT02345850|560210019|FG000|Overall Study|Not transplanted|10|||
155210976|NCT02345850|560210020|FG001|Overall Study|Not transplanted|5|||
155210977|NCT02345850|560210021|FG002|Overall Study|Not transplanted|4|||
155210978|NCT02345850|560210019|FG000|Overall Study|Lost to Follow-up|2|||
155210979|NCT02345850|560210020|FG001|Overall Study|Lost to Follow-up|3|||
155210980|NCT02345850|560210021|FG002|Overall Study|Lost to Follow-up|2|||
155210981|NCT02345850|560210019|FG000|Overall Study|Withdrawal by Subject|1|||
155210982|NCT02345850|560210020|FG001|Overall Study|Withdrawal by Subject|0|||
155210983|NCT02345850|560210021|FG002|Overall Study|Withdrawal by Subject|0|||
155210984|NCT02392247|560210022|FG000|Overall Study|Withdrawal by Subject|1|||
155210985|NCT02392247|560210022|FG000|Overall Study|Surgery cancelled; no data|1|||
155210986|NCT01991067|560210023|FG000|Overall Study|Lost to Follow-up|6|||
155210987|NCT01991067|560210024|FG001|Overall Study|Lost to Follow-up|5|||
155210988|NCT00224055|560210026|FG000|Overall Study|Adverse Event|9|||
155210989|NCT00224055|560210027|FG001|Overall Study|Adverse Event|3|||
155210990|NCT00224055|560210026|FG000|Overall Study|Lost to Follow-up|1|||
155210991|NCT00224055|560210027|FG001|Overall Study|Lost to Follow-up|2|||
155210992|NCT00224055|560210026|FG000|Overall Study|Protocol Violation|1|||
155210993|NCT00224055|560210027|FG001|Overall Study|Protocol Violation|1|||
155210994|NCT00224055|560210026|FG000|Overall Study|Inclusion Violation|3|||
155210995|NCT00224055|560210027|FG001|Overall Study|Inclusion Violation|6|||
155210996|NCT00224055|560210026|FG000|Overall Study|Withdrawal by Subject|0|||
155210997|NCT00224055|560210027|FG001|Overall Study|Withdrawal by Subject|2|||
155210998|NCT00224055|560210026|FG000|Overall Study|Other|1|||
155210999|NCT00224055|560210027|FG001|Overall Study|Other|0|||
155211000|NCT00407563|560210030|FG000|Overall Study|Patient continues on treatment|1|||
155211001|NCT02014597|560210031|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
155211002|NCT02014597|560210032|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
155211003|NCT00754624|560210033|FG000|Overall Study|Adverse Event|16|||
155211004|NCT00754624|560210033|FG000|Overall Study|Death|1|||
155211005|NCT00754624|560210033|FG000|Overall Study|Physician Decision|8|||
155211006|NCT00754624|560210033|FG000|Overall Study|Protocol Violation|1|||
155211007|NCT00754624|560210033|FG000|Overall Study|Withdrawal by Subject|28|||
155211008|NCT00754624|560210033|FG000|Overall Study|Various|12|||
155211009|NCT00754624|560210033|FG000|Overall Study|Lost to Follow-up|3|||
155211010|NCT04067544|560210034|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
155211011|NCT00967798|560210035|FG000|Overall Study|Withdrawal by Subject|5|||
155211012|NCT00967798|560210036|FG001|Overall Study|Withdrawal by Subject|2|||
155211013|NCT00967798|560210035|FG000|Overall Study|Lost to Follow-up|4|||
155211014|NCT00967798|560210036|FG001|Overall Study|Lost to Follow-up|1|||
155211015|NCT00592839|560210046|FG000|Overall Study|Withdrawal by Subject|1|||
155211016|NCT00592839|560210047|FG001|Overall Study|Withdrawal by Subject|1|||
155211017|NCT00592839|560210048|FG002|Overall Study|Withdrawal by Subject|3|||
155211018|NCT00592839|560210046|FG000|Overall Study|Protocol Violation|1|||
155211019|NCT00592839|560210047|FG001|Overall Study|Protocol Violation|1|||
155211020|NCT00592839|560210048|FG002|Overall Study|Protocol Violation|2|||
155211021|NCT00592839|560210046|FG000|Overall Study|Adverse Event|0|||
155211022|NCT00592839|560210047|FG001|Overall Study|Adverse Event|1|||
155211023|NCT00592839|560210048|FG002|Overall Study|Adverse Event|0|||
155211024|NCT00592839|560210046|FG000|Overall Study|Lost to Follow-up|0|||
155211025|NCT00592839|560210047|FG001|Overall Study|Lost to Follow-up|1|||
155211026|NCT00592839|560210048|FG002|Overall Study|Lost to Follow-up|1|||
155211027|NCT02282020|560210049|FG000|Overall Study|Objective Disease Progression|128|||
155211028|NCT02282020|560210050|FG001|Overall Study|Objective Disease Progression|30|||
155211029|NCT02282020|560210049|FG000|Overall Study|Adverse Event|18|||
155211030|NCT02282020|560210050|FG001|Overall Study|Adverse Event|15|||
155211031|NCT02282020|560210049|FG000|Overall Study|Withdrawal by Subject|7|||
155211032|NCT02282020|560210050|FG001|Overall Study|Withdrawal by Subject|10|||
155211033|NCT02282020|560210049|FG000|Overall Study|Miscellaneous|5|||
155211034|NCT02282020|560210050|FG001|Overall Study|Miscellaneous|19|||
155211035|NCT02282020|560210049|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
155211036|NCT02282020|560210050|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
155211037|NCT02282020|560210049|FG000|Overall Study|Developed Discontinuation Criteria|0|||
155211038|NCT02282020|560210050|FG001|Overall Study|Developed Discontinuation Criteria|2|||
155211039|NCT02282020|560210049|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
155211040|NCT02282020|560210050|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
155211041|NCT01500629|560210051|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
155211042|NCT01500629|560210052|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
155211043|NCT00249444|560210053|FG000|Overall Study|Lost to Follow-up|2|||
155211044|NCT00249444|560210054|FG001|Overall Study|Lost to Follow-up|2|||
155211045|NCT00249444|560210053|FG000|Overall Study|non-compliant|9|||
155211046|NCT00249444|560210054|FG001|Overall Study|non-compliant|11|||
155211047|NCT00249444|560210053|FG000|Overall Study|Adverse Event|1|||
155211048|NCT00249444|560210054|FG001|Overall Study|Adverse Event|1|||
155211049|NCT00249444|560210053|FG000|Overall Study|life event|0|||
155211050|NCT00249444|560210054|FG001|Overall Study|life event|1|||
155211051|NCT01499667|560210055|FG000|Overall Study|administrative problems|4|||
155211052|NCT01499667|560210056|FG001|Overall Study|administrative problems|5|||
155211053|NCT01499667|560210057|FG002|Overall Study|administrative problems|5|||
155211054|NCT01499667|560210055|FG000|Overall Study|Protocol Violation|1|||
155211055|NCT01499667|560210056|FG001|Overall Study|Protocol Violation|3|||
155211056|NCT01499667|560210057|FG002|Overall Study|Protocol Violation|2|||
155211057|NCT01499667|560210055|FG000|Overall Study|Adverse Event|0|||
155211058|NCT01499667|560210056|FG001|Overall Study|Adverse Event|2|||
155211059|NCT01499667|560210057|FG002|Overall Study|Adverse Event|2|||
155211060|NCT01499667|560210055|FG000|Overall Study|Withdrawal by Subject|2|||
155211061|NCT01499667|560210056|FG001|Overall Study|Withdrawal by Subject|1|||
155211062|NCT01499667|560210057|FG002|Overall Study|Withdrawal by Subject|1|||
155211063|NCT01499667|560210055|FG000|Overall Study|Lack of Efficacy|2|||
155211064|NCT01499667|560210056|FG001|Overall Study|Lack of Efficacy|0|||
155211065|NCT01499667|560210057|FG002|Overall Study|Lack of Efficacy|0|||
155211066|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Death|3|||
155211067|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Death|3|||
155211068|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Death|0|||
155211069|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Death|0|||
155211070|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
155211071|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
155211072|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
155211073|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
155211074|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
155211075|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
155211076|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
155211077|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
155211078|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
155211079|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
155211080|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
155211081|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
155211082|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
155211083|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
155211084|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
155211085|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
155211086|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211087|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
155211088|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211089|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211090|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
155211091|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
155211092|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
155211093|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
155211094|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Other|6|||
155211095|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Other|3|||
155211096|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Other|0|||
155211097|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Other|0|||
155211098|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
155211099|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
155211100|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
155211101|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
155211102|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Adverse Event|0|||
155211103|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Adverse Event|0|||
155211104|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Adverse Event|6|||
155211105|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Adverse Event|8|||
155211106|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Death|0|||
155211107|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Death|0|||
155211108|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Death|7|||
155211109|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Death|4|||
155211110|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211111|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211112|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211113|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
155211114|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
155211115|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
155211116|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
155211117|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
155211118|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155211119|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155211120|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
155211121|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
155211122|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211123|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211124|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211125|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
155211126|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Physician Decision|0|||
155211127|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Physician Decision|0|||
155211128|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Physician Decision|8|||
155211129|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Physician Decision|5|||
155211130|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Other|0|||
155211131|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Other|0|||
155211132|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Other|9|||
155211133|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Other|9|||
155211134|NCT00142584|560210064|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
155211135|NCT00142584|560210065|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
155211136|NCT00142584|560210064|FG000|Overall Study|Withdrawal by Subject|30|||
155211137|NCT00142584|560210065|FG001|Overall Study|Withdrawal by Subject|16|||
155211138|NCT00142584|560210064|FG000|Overall Study|Lost to Follow-up|22|||
155211139|NCT00142584|560210065|FG001|Overall Study|Lost to Follow-up|12|||
155211140|NCT00142584|560210064|FG000|Overall Study|Adverse Event|14|||
155211141|NCT00142584|560210065|FG001|Overall Study|Adverse Event|5|||
155211142|NCT00142584|560210064|FG000|Overall Study|Protocol Violation|4|||
155211143|NCT00142584|560210065|FG001|Overall Study|Protocol Violation|7|||
155211144|NCT00142584|560210064|FG000|Overall Study|Treatment Failure|2|||
155211145|NCT00142584|560210065|FG001|Overall Study|Treatment Failure|0|||
155211146|NCT03070782|560210066|FG000|Overall Study|Adverse Event|3|||
155211147|NCT03070782|560210067|FG001|Overall Study|Adverse Event|0|||
155211148|NCT03070782|560210068|FG002|Overall Study|Adverse Event|3|||
155211149|NCT03070782|560210069|FG003|Overall Study|Adverse Event|1|||
155211150|NCT03070782|560210070|FG004|Overall Study|Adverse Event|6|||
155211151|NCT03070782|560210071|FG005|Overall Study|Adverse Event|2|||
155211152|NCT03070782|560210066|FG000|Overall Study|Withdrawal by Subject|2|||
155211153|NCT03070782|560210067|FG001|Overall Study|Withdrawal by Subject|1|||
155211154|NCT03070782|560210068|FG002|Overall Study|Withdrawal by Subject|1|||
155211155|NCT03070782|560210069|FG003|Overall Study|Withdrawal by Subject|0|||
155211156|NCT03070782|560210070|FG004|Overall Study|Withdrawal by Subject|4|||
155211157|NCT03070782|560210071|FG005|Overall Study|Withdrawal by Subject|3|||
155211158|NCT03070782|560210066|FG000|Overall Study|Reason Not Specified|2|||
155211159|NCT03070782|560210067|FG001|Overall Study|Reason Not Specified|0|||
155211160|NCT03070782|560210068|FG002|Overall Study|Reason Not Specified|0|||
155211161|NCT03070782|560210069|FG003|Overall Study|Reason Not Specified|1|||
155211162|NCT03070782|560210070|FG004|Overall Study|Reason Not Specified|2|||
155211163|NCT03070782|560210071|FG005|Overall Study|Reason Not Specified|1|||
155211164|NCT03070782|560210066|FG000|Overall Study|Ineligibility|0|||
155211165|NCT03070782|560210067|FG001|Overall Study|Ineligibility|0|||
155211166|NCT03070782|560210068|FG002|Overall Study|Ineligibility|0|||
155211167|NCT03070782|560210069|FG003|Overall Study|Ineligibility|1|||
155211168|NCT03070782|560210070|FG004|Overall Study|Ineligibility|0|||
155211169|NCT03070782|560210071|FG005|Overall Study|Ineligibility|1|||
155211170|NCT03070782|560210066|FG000|Overall Study|Pregnancy|0|||
155211171|NCT03070782|560210067|FG001|Overall Study|Pregnancy|0|||
155211172|NCT03070782|560210068|FG002|Overall Study|Pregnancy|0|||
155211173|NCT03070782|560210069|FG003|Overall Study|Pregnancy|1|||
155211174|NCT03070782|560210070|FG004|Overall Study|Pregnancy|0|||
155211175|NCT03070782|560210071|FG005|Overall Study|Pregnancy|0|||
155211176|NCT03070782|560210066|FG000|Overall Study|Investigator Judgement|0|||
155211177|NCT03070782|560210067|FG001|Overall Study|Investigator Judgement|0|||
155211178|NCT03070782|560210068|FG002|Overall Study|Investigator Judgement|0|||
155211179|NCT03070782|560210069|FG003|Overall Study|Investigator Judgement|1|||
155211180|NCT03070782|560210070|FG004|Overall Study|Investigator Judgement|0|||
155211181|NCT03070782|560210071|FG005|Overall Study|Investigator Judgement|0|||
155211182|NCT02288559|560210072|FG000|Overall Study|Adverse Event|1|||
155211183|NCT02288559|560210073|FG001|Overall Study|Adverse Event|1|||
155211184|NCT02288559|560210074|FG002|Overall Study|Adverse Event|5|||
155211185|NCT02288559|560210075|FG003|Overall Study|Adverse Event|0|||
155211186|NCT02288559|560210072|FG000|Overall Study|Death|0|||
155211187|NCT02288559|560210073|FG001|Overall Study|Death|0|||
155211188|NCT02288559|560210074|FG002|Overall Study|Death|1|||
155211189|NCT02288559|560210075|FG003|Overall Study|Death|0|||
155211190|NCT02288559|560210072|FG000|Overall Study|Lost to Follow-up|0|||
155211191|NCT02288559|560210073|FG001|Overall Study|Lost to Follow-up|0|||
155211192|NCT02288559|560210074|FG002|Overall Study|Lost to Follow-up|0|||
155211193|NCT02288559|560210075|FG003|Overall Study|Lost to Follow-up|1|||
155211194|NCT02288559|560210072|FG000|Overall Study|Withdrawal by Subject|0|||
155211195|NCT02288559|560210073|FG001|Overall Study|Withdrawal by Subject|0|||
155211196|NCT02288559|560210074|FG002|Overall Study|Withdrawal by Subject|2|||
155211197|NCT02288559|560210075|FG003|Overall Study|Withdrawal by Subject|1|||
155211198|NCT02288559|560210072|FG000|Overall Study|Reason Not Specified|0|||
155211199|NCT02288559|560210073|FG001|Overall Study|Reason Not Specified|0|||
155211200|NCT02288559|560210074|FG002|Overall Study|Reason Not Specified|3|||
155211201|NCT02288559|560210075|FG003|Overall Study|Reason Not Specified|0|||
155211202|NCT00558025|560210076|FG000|Overall Study|Adverse Event|1|||
155211203|NCT00558025|560210077|FG001|Overall Study|Adverse Event|1|||
155211204|NCT00558025|560210076|FG000|Overall Study|Withdrawal by Subject|2|||
155211205|NCT00558025|560210077|FG001|Overall Study|Withdrawal by Subject|2|||
155211206|NCT00558025|560210076|FG000|Overall Study|Protocol Violation|1|||
155211207|NCT00558025|560210077|FG001|Overall Study|Protocol Violation|0|||
155211208|NCT00449540|560210078|FG000|Pretreatment Phase|No migraine experienced|66|||
155211209|NCT00449540|560210079|FG001|Pretreatment Phase|No migraine experienced|0|||
155211210|NCT00449540|560210080|FG002|Pretreatment Phase|No migraine experienced|0|||
155211211|NCT00449540|560210078|FG000|Treatment Phase|did not experience or treat migraine|0|||
155211212|NCT00449540|560210079|FG001|Treatment Phase|did not experience or treat migraine|20|||
155211213|NCT00449540|560210080|FG002|Treatment Phase|did not experience or treat migraine|17|||
155211214|NCT01881776|560210081|FG000|Overall Study|Lost to Follow-up|1|||
155211215|NCT01881776|560210082|FG001|Overall Study|Lost to Follow-up|2|||
155211216|NCT01881776|560210083|FG002|Overall Study|Lost to Follow-up|1|||
155211217|NCT01881776|560210081|FG000|Overall Study|Protocol Violation|0|||
155211218|NCT01881776|560210082|FG001|Overall Study|Protocol Violation|2|||
155211219|NCT01881776|560210083|FG002|Overall Study|Protocol Violation|1|||
155211220|NCT00022633|560210084|FG000|Overall Study|Adverse Event|11|||
155211221|NCT00022633|560210085|FG001|Overall Study|Adverse Event|1|||
155211222|NCT00022633|560210084|FG000|Overall Study|Refusal unrelated to adverse event|1|||
155211223|NCT00022633|560210085|FG001|Overall Study|Refusal unrelated to adverse event|0|||
155211224|NCT00022633|560210084|FG000|Overall Study|Progression/relapse|9|||
155211225|NCT00022633|560210085|FG001|Overall Study|Progression/relapse|2|||
155211226|NCT00022633|560210084|FG000|Overall Study|Death|4|||
155211227|NCT00022633|560210085|FG001|Overall Study|Death|0|||
155211228|NCT00022633|560210084|FG000|Overall Study|Other - not protocol specified|3|||
155211229|NCT00022633|560210085|FG001|Overall Study|Other - not protocol specified|2|||
155211230|NCT00022633|560210084|FG000|Overall Study|Ineligible|4|||
155211231|NCT00022633|560210085|FG001|Overall Study|Ineligible|0|||
155211232|NCT02036294|560210100|FG000|Overall Study|Death|7|||
155211233|NCT02036294|560210101|FG001|Overall Study|Death|8|||
155211234|NCT02036294|560210100|FG000|Overall Study|Withdrawal by Subject|2|||
155211235|NCT02036294|560210101|FG001|Overall Study|Withdrawal by Subject|3|||
155211236|NCT02393547|560210102|FG000|Overall Study|Adverse Event|2|||
155211237|NCT02393547|560210102|FG000|Overall Study|Withdrawal by Subject|3|||
155211238|NCT02393547|560210102|FG000|Overall Study|Lost to Follow-up|1|||
155211239|NCT00514540|560210103|FG000|First-Line Chemo|Withdrawal by Subject|1|||
155211240|NCT00514540|560210103|FG000|First-Line Chemo|Protocol Violation|7|||
155211241|NCT00514540|560210103|FG000|Second-Line|Physician/Patient Decision|31|||
155211242|NCT00752232|560210120|FG000|Overall Study|Protocol Violation|0|||
155211243|NCT00752232|560210121|FG001|Overall Study|Protocol Violation|0|||
155211244|NCT00752232|560210122|FG002|Overall Study|Protocol Violation|0|||
155211245|NCT00752232|560210123|FG003|Overall Study|Protocol Violation|0|||
155211246|NCT00752232|560210124|FG004|Overall Study|Protocol Violation|0|||
155211247|NCT00752232|560210125|FG005|Overall Study|Protocol Violation|1|||
155211248|NCT00752232|560210126|FG006|Overall Study|Protocol Violation|0|||
155211249|NCT00752232|560210120|FG000|Overall Study|Caregiver request|2|||
155211250|NCT00752232|560210121|FG001|Overall Study|Caregiver request|0|||
155211251|NCT00752232|560210122|FG002|Overall Study|Caregiver request|0|||
155211252|NCT00752232|560210123|FG003|Overall Study|Caregiver request|0|||
155211253|NCT00752232|560210124|FG004|Overall Study|Caregiver request|1|||
155211254|NCT00752232|560210125|FG005|Overall Study|Caregiver request|0|||
155211255|NCT00752232|560210126|FG006|Overall Study|Caregiver request|0|||
155211256|NCT00752232|560210120|FG000|Overall Study|Investigator request|0|||
155211257|NCT00752232|560210121|FG001|Overall Study|Investigator request|0|||
155211258|NCT00752232|560210122|FG002|Overall Study|Investigator request|0|||
155211259|NCT00752232|560210123|FG003|Overall Study|Investigator request|0|||
155211260|NCT00752232|560210124|FG004|Overall Study|Investigator request|1|||
155211261|NCT00752232|560210125|FG005|Overall Study|Investigator request|0|||
155211262|NCT00752232|560210126|FG006|Overall Study|Investigator request|0|||
155211263|NCT00752232|560210120|FG000|Overall Study|Subject request|0|||
155211264|NCT00752232|560210121|FG001|Overall Study|Subject request|0|||
155211265|NCT00752232|560210122|FG002|Overall Study|Subject request|1|||
155211266|NCT00752232|560210123|FG003|Overall Study|Subject request|0|||
155211267|NCT00752232|560210124|FG004|Overall Study|Subject request|0|||
155211268|NCT00752232|560210125|FG005|Overall Study|Subject request|0|||
155211269|NCT00752232|560210126|FG006|Overall Study|Subject request|0|||
155211270|NCT00752232|560210120|FG000|Overall Study|Group home admission|0|||
155211271|NCT00752232|560210121|FG001|Overall Study|Group home admission|0|||
155211272|NCT00752232|560210122|FG002|Overall Study|Group home admission|0|||
155211273|NCT00752232|560210123|FG003|Overall Study|Group home admission|1|||
155211274|NCT00752232|560210124|FG004|Overall Study|Group home admission|0|||
155211275|NCT00752232|560210125|FG005|Overall Study|Group home admission|0|||
155211276|NCT00752232|560210126|FG006|Overall Study|Group home admission|0|||
155211277|NCT00752232|560210120|FG000|Overall Study|Caregiver could not attend the subject|0|||
155211278|NCT00752232|560210121|FG001|Overall Study|Caregiver could not attend the subject|0|||
155211279|NCT00752232|560210122|FG002|Overall Study|Caregiver could not attend the subject|0|||
155211280|NCT00752232|560210123|FG003|Overall Study|Caregiver could not attend the subject|0|||
155211281|NCT00752232|560210124|FG004|Overall Study|Caregiver could not attend the subject|1|||
155211282|NCT00752232|560210125|FG005|Overall Study|Caregiver could not attend the subject|0|||
155211283|NCT00752232|560210126|FG006|Overall Study|Caregiver could not attend the subject|0|||
155211284|NCT02788357|560210134|FG000|Overall Study|Lost to Follow-up|3|||
155211285|NCT02788357|560210135|FG001|Overall Study|Lost to Follow-up|0|||
155211286|NCT02170051|560210136|FG000|Overall Study|Withdrawal by Subject|10|||
155211287|NCT02170051|560210137|FG001|Overall Study|Withdrawal by Subject|10|||
155211288|NCT02170051|560210136|FG000|Overall Study|Lost to Follow-up|1|||
155211289|NCT02170051|560210137|FG001|Overall Study|Lost to Follow-up|3|||
155211290|NCT03672747|560210140|FG000|Overall Study|Lost to Follow-up|1|||
155211291|NCT03672747|560210141|FG001|Overall Study|Lost to Follow-up|1|||
155211292|NCT03672747|560210142|FG002|Overall Study|Lost to Follow-up|2|||
155211293|NCT03672747|560210143|FG003|Overall Study|Lost to Follow-up|2|||
155211294|NCT03672747|560210144|FG004|Overall Study|Lost to Follow-up|2|||
155211295|NCT03672747|560210145|FG005|Overall Study|Lost to Follow-up|1|||
155211296|NCT00071513|560210152|FG000|Intervention Component|Withdrawal by Subject|2|||
155211297|NCT00071513|560210153|FG001|Intervention Component|Withdrawal by Subject|3|||
155211298|NCT00071513|560210152|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
155211299|NCT00071513|560210153|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
155211300|NCT01648205|560210154|FG000|Placebo|Pregnancy|1|||
155211301|NCT01648205|560210154|FG000|Placebo|Withdrawal by Subject|1|||
155211302|NCT01648205|560210154|FG000|Placebo|Protocol Violation|2|||
155211303|NCT01648205|560210154|FG000|Ranolazine|Death|1|||
155211304|NCT01648205|560210154|FG000|Ranolazine|Withdrawal by Subject|1|||
155211305|NCT01648205|560210154|FG000|Ranolazine|Protocol Violation|3|||
155211306|NCT01958008|560210155|FG000|Overall Study|Worsening of disease under study|0|||
155211307|NCT01958008|560210156|FG001|Overall Study|Worsening of disease under study|0|||
155211308|NCT01958008|560210157|FG002|Overall Study|Worsening of disease under study|1|||
155211309|NCT01958008|560210158|FG003|Overall Study|Worsening of disease under study|0|||
155211310|NCT01958008|560210155|FG000|Overall Study|Other adverse event|1|||
155211311|NCT01958008|560210156|FG001|Overall Study|Other adverse event|0|||
155211312|NCT01958008|560210157|FG002|Overall Study|Other adverse event|0|||
155211313|NCT01958008|560210158|FG003|Overall Study|Other adverse event|0|||
155211314|NCT01634360|560210159|FG000|Overall Study|Adverse Event|10|||
155211315|NCT01634360|560210160|FG001|Overall Study|Adverse Event|34|||
155211316|NCT01634360|560210159|FG000|Overall Study|subject withdrew consent|13|||
155211317|NCT01634360|560210160|FG001|Overall Study|subject withdrew consent|23|||
155211318|NCT01634360|560210159|FG000|Overall Study|Protocol Violation|1|||
155211319|NCT01634360|560210160|FG001|Overall Study|Protocol Violation|1|||
155211320|NCT01634360|560210159|FG000|Overall Study|Lack of Efficacy|4|||
155211321|NCT01634360|560210160|FG001|Overall Study|Lack of Efficacy|14|||
155211322|NCT01634360|560210159|FG000|Overall Study|Other|3|||
155211323|NCT01634360|560210160|FG001|Overall Study|Other|20|||
155211324|NCT01634360|560210159|FG000|Overall Study|Study termination by sponsor|18|||
155211325|NCT01634360|560210160|FG001|Overall Study|Study termination by sponsor|44|||
155211326|NCT03667924|560210161|FG000|Baseline Completed|Lost to Follow-up|0|||
155211327|NCT03667924|560210162|FG001|Baseline Completed|Lost to Follow-up|2|||
155211328|NCT03667924|560210163|FG002|Baseline Completed|Lost to Follow-up|0|||
155211329|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
155211330|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
155211331|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
155211332|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
155211333|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
155211334|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
155211335|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
155211336|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
155211337|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
155211338|NCT03667924|560210161|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
155211339|NCT03667924|560210162|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
155211340|NCT03667924|560210163|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
155211341|NCT03667924|560210161|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
155211342|NCT03667924|560210162|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
155211343|NCT03667924|560210163|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
155211344|NCT03667924|560210161|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
155211345|NCT03667924|560210162|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
155211346|NCT03667924|560210163|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
155211347|NCT02260921|560210170|FG000|Overall Study|Adverse Event|1|||
155211348|NCT02260921|560210171|FG001|Overall Study|Adverse Event|0|||
155211349|NCT02260921|560210170|FG000|Overall Study|Lost to Follow-up|4|||
155211350|NCT02260921|560210171|FG001|Overall Study|Lost to Follow-up|3|||
155211351|NCT02260921|560210170|FG000|Overall Study|Withdraw Consent|4|||
155211352|NCT02260921|560210171|FG001|Overall Study|Withdraw Consent|1|||
155211353|NCT02260921|560210170|FG000|Overall Study|Death|1|||
155211354|NCT02260921|560210171|FG001|Overall Study|Death|0|||
155211355|NCT02260921|560210170|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
155211356|NCT02260921|560210171|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
155211357|NCT01244425|560210172|FG000|Overall Study|Withdrawal by Subject|2|||
155211358|NCT01244425|560210173|FG001|Overall Study|Withdrawal by Subject|2|||
155211359|NCT01244425|560210172|FG000|Overall Study|Adverse Event|1|||
155211360|NCT01244425|560210173|FG001|Overall Study|Adverse Event|1|||
155211361|NCT02743871|560210174|FG000|Overall Study|Lost to Follow-up|0|||
155211362|NCT02743871|560210175|FG001|Overall Study|Lost to Follow-up|0|||
155211363|NCT02743871|560210176|FG002|Overall Study|Lost to Follow-up|0|||
155211364|NCT02743871|560210177|FG003|Overall Study|Lost to Follow-up|1|||
155211365|NCT02743871|560210178|FG004|Overall Study|Lost to Follow-up|0|||
155211366|NCT02743871|560210179|FG005|Overall Study|Lost to Follow-up|0|||
155211367|NCT02743871|560210180|FG006|Overall Study|Lost to Follow-up|1|||
155211368|NCT02743871|560210181|FG007|Overall Study|Lost to Follow-up|0|||
155211369|NCT02743871|560210182|FG008|Overall Study|Lost to Follow-up|0|||
155211370|NCT02743871|560210183|FG009|Overall Study|Lost to Follow-up|0|||
155211371|NCT02743871|560210184|FG010|Overall Study|Lost to Follow-up|0|||
155211372|NCT02743871|560210185|FG011|Overall Study|Lost to Follow-up|2|||
155211373|NCT02743871|560210186|FG012|Overall Study|Lost to Follow-up|0|||
155211374|NCT02743871|560210187|FG013|Overall Study|Lost to Follow-up|0|||
155211375|NCT02743871|560210174|FG000|Overall Study|Withdrawal by Subject|0|||
155211376|NCT02743871|560210175|FG001|Overall Study|Withdrawal by Subject|0|||
155211377|NCT02743871|560210176|FG002|Overall Study|Withdrawal by Subject|0|||
155211378|NCT02743871|560210177|FG003|Overall Study|Withdrawal by Subject|0|||
155211379|NCT02743871|560210178|FG004|Overall Study|Withdrawal by Subject|0|||
155211380|NCT02743871|560210179|FG005|Overall Study|Withdrawal by Subject|0|||
155211381|NCT02743871|560210180|FG006|Overall Study|Withdrawal by Subject|0|||
155211382|NCT02743871|560210181|FG007|Overall Study|Withdrawal by Subject|0|||
155211383|NCT02743871|560210182|FG008|Overall Study|Withdrawal by Subject|0|||
155211384|NCT02743871|560210183|FG009|Overall Study|Withdrawal by Subject|0|||
155211385|NCT02743871|560210184|FG010|Overall Study|Withdrawal by Subject|1|||
155211386|NCT02743871|560210185|FG011|Overall Study|Withdrawal by Subject|0|||
155211387|NCT02743871|560210186|FG012|Overall Study|Withdrawal by Subject|12|||
155211388|NCT02743871|560210187|FG013|Overall Study|Withdrawal by Subject|6|||
155211389|NCT02743871|560210174|FG000|Overall Study|Adverse Event|1|||
155211390|NCT02743871|560210175|FG001|Overall Study|Adverse Event|0|||
155211391|NCT02743871|560210176|FG002|Overall Study|Adverse Event|0|||
155211392|NCT02743871|560210177|FG003|Overall Study|Adverse Event|0|||
155211393|NCT02743871|560210178|FG004|Overall Study|Adverse Event|0|||
155211394|NCT02743871|560210179|FG005|Overall Study|Adverse Event|0|||
155211395|NCT02743871|560210180|FG006|Overall Study|Adverse Event|0|||
155211396|NCT02743871|560210181|FG007|Overall Study|Adverse Event|0|||
155211397|NCT02743871|560210182|FG008|Overall Study|Adverse Event|0|||
155211398|NCT02743871|560210183|FG009|Overall Study|Adverse Event|0|||
155211399|NCT02743871|560210184|FG010|Overall Study|Adverse Event|0|||
155211400|NCT02743871|560210185|FG011|Overall Study|Adverse Event|0|||
155211401|NCT02743871|560210186|FG012|Overall Study|Adverse Event|0|||
155211402|NCT02743871|560210187|FG013|Overall Study|Adverse Event|0|||
155211403|NCT02743871|560210174|FG000|Overall Study|Other|0|||
155211404|NCT02743871|560210175|FG001|Overall Study|Other|0|||
155211405|NCT02743871|560210176|FG002|Overall Study|Other|0|||
155211406|NCT02743871|560210177|FG003|Overall Study|Other|0|||
155211407|NCT02743871|560210178|FG004|Overall Study|Other|0|||
155211408|NCT02743871|560210179|FG005|Overall Study|Other|0|||
155211409|NCT02743871|560210180|FG006|Overall Study|Other|0|||
155211410|NCT02743871|560210181|FG007|Overall Study|Other|0|||
155211411|NCT02743871|560210182|FG008|Overall Study|Other|0|||
155211412|NCT02743871|560210183|FG009|Overall Study|Other|0|||
155211413|NCT02743871|560210184|FG010|Overall Study|Other|0|||
155211414|NCT02743871|560210185|FG011|Overall Study|Other|1|||
155211415|NCT02743871|560210186|FG012|Overall Study|Other|1|||
155211416|NCT02743871|560210187|FG013|Overall Study|Other|1|||
155211417|NCT02743871|560210174|FG000|Overall Study|Protocol Violation|0|||
155211418|NCT02743871|560210175|FG001|Overall Study|Protocol Violation|0|||
155211419|NCT02743871|560210176|FG002|Overall Study|Protocol Violation|0|||
155211420|NCT02743871|560210177|FG003|Overall Study|Protocol Violation|0|||
155211421|NCT02743871|560210178|FG004|Overall Study|Protocol Violation|0|||
155211422|NCT02743871|560210179|FG005|Overall Study|Protocol Violation|0|||
155211423|NCT02743871|560210180|FG006|Overall Study|Protocol Violation|0|||
155211424|NCT02743871|560210181|FG007|Overall Study|Protocol Violation|0|||
155211425|NCT02743871|560210182|FG008|Overall Study|Protocol Violation|0|||
155211426|NCT02743871|560210183|FG009|Overall Study|Protocol Violation|0|||
155211427|NCT02743871|560210184|FG010|Overall Study|Protocol Violation|0|||
155211428|NCT02743871|560210185|FG011|Overall Study|Protocol Violation|0|||
155211429|NCT02743871|560210186|FG012|Overall Study|Protocol Violation|2|||
155211430|NCT02743871|560210187|FG013|Overall Study|Protocol Violation|0|||
155211431|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
155211432|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
155211433|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
155211434|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
155211435|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Death|7|||
155211436|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Death|5|||
155211437|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
155211438|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
155211439|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
155211440|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
155211441|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
155211442|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
155211443|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
155211444|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
155211445|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
155211446|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
155211447|NCT03032705|560210190|FG000|Overall Study|Lost to Follow-up|16|||
155211448|NCT03032705|560210191|FG001|Overall Study|Lost to Follow-up|17|||
155211449|NCT03032705|560210190|FG000|Overall Study|did not quality|6|||
155211450|NCT03032705|560210191|FG001|Overall Study|did not quality|6|||
155211451|NCT04818840|560210194|FG000|Overall Study|Lost to Follow-up|0|||
155211452|NCT04818840|560210195|FG001|Overall Study|Lost to Follow-up|5|||
155211453|NCT04818840|560210194|FG000|Overall Study|Physician Decision|1|||
155211454|NCT04818840|560210195|FG001|Overall Study|Physician Decision|0|||
155211455|NCT04818840|560210194|FG000|Overall Study|Site Terminated by Sponsor|0|||
155211456|NCT04818840|560210195|FG001|Overall Study|Site Terminated by Sponsor|3|||
155211457|NCT04818840|560210194|FG000|Overall Study|Study Terminated by Sponsor|43|||
155211458|NCT04818840|560210195|FG001|Overall Study|Study Terminated by Sponsor|7|||
155211459|NCT04818840|560210194|FG000|Overall Study|Withdrawal by Subject|0|||
155211460|NCT04818840|560210195|FG001|Overall Study|Withdrawal by Subject|1|||
155211461|NCT00733408|560212256|FG000|Overall Study|Adverse Event|4|||
155211462|NCT01134783|560212258|FG000|Overall Study|Pregnancy|16|||
155211463|NCT01134783|560212259|FG001|Overall Study|Pregnancy|8|||
155211464|NCT01134783|560212258|FG000|Overall Study|Withdrawal by Subject|15|||
155211465|NCT01134783|560212259|FG001|Overall Study|Withdrawal by Subject|9|||
155211466|NCT01134783|560212258|FG000|Overall Study|Lost to Follow-up|5|||
155211467|NCT01134783|560212259|FG001|Overall Study|Lost to Follow-up|20|||
155211468|NCT02329730|560212266|FG000|Overall Study|Protocol Violation|0|||
155211469|NCT02329730|560212267|FG001|Overall Study|Protocol Violation|0|||
155211470|NCT02329730|560212268|FG002|Overall Study|Protocol Violation|0|||
155211471|NCT02329730|560212269|FG003|Overall Study|Protocol Violation|0|||
155211472|NCT02329730|560212270|FG004|Overall Study|Protocol Violation|2|||
155211473|NCT02329730|560212271|FG005|Overall Study|Protocol Violation|2|||
155211474|NCT02329730|560212272|FG006|Overall Study|Protocol Violation|0|||
155211475|NCT02329730|560212273|FG007|Overall Study|Protocol Violation|0|||
155211476|NCT02329730|560212274|FG008|Overall Study|Protocol Violation|0|||
155211477|NCT02329730|560212275|FG009|Overall Study|Protocol Violation|0|||
155211478|NCT02329730|560212276|FG010|Overall Study|Protocol Violation|0|||
155211479|NCT02329730|560212277|FG011|Overall Study|Protocol Violation|0|||
155211480|NCT02329730|560212266|FG000|Overall Study|Withdrawal by Subject|0|||
155211481|NCT02329730|560212267|FG001|Overall Study|Withdrawal by Subject|0|||
155211482|NCT02329730|560212268|FG002|Overall Study|Withdrawal by Subject|0|||
155211483|NCT02329730|560212269|FG003|Overall Study|Withdrawal by Subject|0|||
155211484|NCT02329730|560212270|FG004|Overall Study|Withdrawal by Subject|1|||
155211485|NCT02329730|560212271|FG005|Overall Study|Withdrawal by Subject|0|||
155211486|NCT02329730|560212272|FG006|Overall Study|Withdrawal by Subject|1|||
155211487|NCT02329730|560212273|FG007|Overall Study|Withdrawal by Subject|1|||
155211488|NCT02329730|560212274|FG008|Overall Study|Withdrawal by Subject|1|||
155211489|NCT02329730|560212275|FG009|Overall Study|Withdrawal by Subject|1|||
155211490|NCT02329730|560212276|FG010|Overall Study|Withdrawal by Subject|0|||
155211491|NCT02329730|560212277|FG011|Overall Study|Withdrawal by Subject|0|||
155211492|NCT00463346|560212282|FG000|Overall Study|Withdrawal by Subject|3|||
155211493|NCT00463346|560212283|FG001|Overall Study|Withdrawal by Subject|3|||
155211494|NCT03641651|560212285|FG000|Overall Study|organizational issues at one study site|1|||
155211495|NCT00951665|560212287|FG000|Phase 1b|Adverse Event|2|||
155211496|NCT00951665|560212288|FG001|Phase 1b|Adverse Event|1|||
155211497|NCT00951665|560212289|FG002|Phase 1b|Adverse Event|0|||
155211498|NCT00951665|560212290|FG003|Phase 1b|Adverse Event|1|||
155211499|NCT00951665|560212291|FG004|Phase 1b|Adverse Event|0|||
155211500|NCT00951665|560212292|FG005|Phase 1b|Adverse Event|0|||
155211501|NCT00951665|560212287|FG000|Phase 1b|Death|1|||
155211502|NCT00951665|560212288|FG001|Phase 1b|Death|0|||
155211503|NCT00951665|560212289|FG002|Phase 1b|Death|2|||
155211504|NCT00951665|560212290|FG003|Phase 1b|Death|0|||
155211505|NCT00951665|560212291|FG004|Phase 1b|Death|0|||
155211506|NCT00951665|560212292|FG005|Phase 1b|Death|0|||
155211507|NCT00951665|560212287|FG000|Phase 1b|Physician Decision|4|||
155211508|NCT00951665|560212288|FG001|Phase 1b|Physician Decision|0|||
155211509|NCT00951665|560212289|FG002|Phase 1b|Physician Decision|1|||
155211510|NCT00951665|560212290|FG003|Phase 1b|Physician Decision|0|||
155211511|NCT00951665|560212291|FG004|Phase 1b|Physician Decision|0|||
155211512|NCT00951665|560212292|FG005|Phase 1b|Physician Decision|0|||
155211513|NCT00951665|560212287|FG000|Phase 1b|Withdrawal by Subject|0|||
155211514|NCT00951665|560212288|FG001|Phase 1b|Withdrawal by Subject|1|||
155211515|NCT00951665|560212289|FG002|Phase 1b|Withdrawal by Subject|0|||
155211516|NCT00951665|560212290|FG003|Phase 1b|Withdrawal by Subject|0|||
155211517|NCT00951665|560212291|FG004|Phase 1b|Withdrawal by Subject|0|||
155211518|NCT00951665|560212292|FG005|Phase 1b|Withdrawal by Subject|0|||
155211519|NCT00951665|560212287|FG000|Phase 1b|Disease Progression|13|||
155211520|NCT00951665|560212288|FG001|Phase 1b|Disease Progression|2|||
155211521|NCT00951665|560212289|FG002|Phase 1b|Disease Progression|14|||
155211522|NCT00951665|560212290|FG003|Phase 1b|Disease Progression|0|||
155211523|NCT00951665|560212291|FG004|Phase 1b|Disease Progression|0|||
155211524|NCT00951665|560212292|FG005|Phase 1b|Disease Progression|0|||
155211525|NCT00951665|560212287|FG000|Phase 1b|Protocol Violation|2|||
155211526|NCT00951665|560212288|FG001|Phase 1b|Protocol Violation|0|||
155211527|NCT00951665|560212289|FG002|Phase 1b|Protocol Violation|0|||
155211528|NCT00951665|560212290|FG003|Phase 1b|Protocol Violation|0|||
155211529|NCT00951665|560212291|FG004|Phase 1b|Protocol Violation|0|||
155211530|NCT00951665|560212292|FG005|Phase 1b|Protocol Violation|0|||
155211531|NCT00951665|560212287|FG000|Phase 2a|Adverse Event|0|||
155211532|NCT00951665|560212288|FG001|Phase 2a|Adverse Event|0|||
155211533|NCT00951665|560212289|FG002|Phase 2a|Adverse Event|0|||
155211534|NCT00951665|560212290|FG003|Phase 2a|Adverse Event|0|||
155211535|NCT00951665|560212291|FG004|Phase 2a|Adverse Event|2|||
155211536|NCT00951665|560212292|FG005|Phase 2a|Adverse Event|0|||
155211537|NCT00951665|560212287|FG000|Phase 2a|Death|0|||
155211538|NCT00951665|560212288|FG001|Phase 2a|Death|0|||
155211539|NCT00951665|560212289|FG002|Phase 2a|Death|0|||
155211540|NCT00951665|560212290|FG003|Phase 2a|Death|0|||
155211541|NCT00951665|560212291|FG004|Phase 2a|Death|1|||
155211542|NCT00951665|560212292|FG005|Phase 2a|Death|1|||
155211543|NCT00951665|560212287|FG000|Phase 2a|Lost to Follow-up|0|||
155211544|NCT00951665|560212288|FG001|Phase 2a|Lost to Follow-up|0|||
155211545|NCT00951665|560212289|FG002|Phase 2a|Lost to Follow-up|0|||
155211546|NCT00951665|560212290|FG003|Phase 2a|Lost to Follow-up|0|||
155211547|NCT00951665|560212291|FG004|Phase 2a|Lost to Follow-up|1|||
155211548|NCT00951665|560212292|FG005|Phase 2a|Lost to Follow-up|0|||
155211549|NCT00951665|560212287|FG000|Phase 2a|Physician Decision|0|||
155211550|NCT00951665|560212288|FG001|Phase 2a|Physician Decision|0|||
155211551|NCT00951665|560212289|FG002|Phase 2a|Physician Decision|0|||
155211552|NCT00951665|560212290|FG003|Phase 2a|Physician Decision|0|||
155211553|NCT00951665|560212291|FG004|Phase 2a|Physician Decision|0|||
155211554|NCT00951665|560212292|FG005|Phase 2a|Physician Decision|1|||
155211555|NCT00951665|560212287|FG000|Phase 2a|Withdrawal by Subject|0|||
155211556|NCT00951665|560212288|FG001|Phase 2a|Withdrawal by Subject|0|||
155211557|NCT00951665|560212289|FG002|Phase 2a|Withdrawal by Subject|0|||
155211558|NCT00951665|560212290|FG003|Phase 2a|Withdrawal by Subject|0|||
155211559|NCT00951665|560212291|FG004|Phase 2a|Withdrawal by Subject|2|||
155211560|NCT00951665|560212292|FG005|Phase 2a|Withdrawal by Subject|0|||
155211561|NCT00951665|560212287|FG000|Phase 2a|Disease Progression|0|||
155211562|NCT00951665|560212288|FG001|Phase 2a|Disease Progression|0|||
155211563|NCT00951665|560212289|FG002|Phase 2a|Disease Progression|0|||
155211564|NCT00951665|560212290|FG003|Phase 2a|Disease Progression|0|||
155211565|NCT00951665|560212291|FG004|Phase 2a|Disease Progression|6|||
155211566|NCT00951665|560212292|FG005|Phase 2a|Disease Progression|5|||
155211567|NCT02068443|560212293|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155211568|NCT02068443|560212294|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
155211569|NCT02068443|560212295|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
155211570|NCT02068443|560212293|FG000|Overall Study|Voluntary Withdrawal|4|||
155211571|NCT02068443|560212294|FG001|Overall Study|Voluntary Withdrawal|0|||
155211572|NCT02068443|560212295|FG002|Overall Study|Voluntary Withdrawal|1|||
155211573|NCT02068443|560212293|FG000|Overall Study|Lack of Efficacy|2|||
155211574|NCT02068443|560212294|FG001|Overall Study|Lack of Efficacy|1|||
155211575|NCT02068443|560212295|FG002|Overall Study|Lack of Efficacy|0|||
155211576|NCT02068443|560212293|FG000|Overall Study|Other Reason Not Specified|1|||
155211577|NCT02068443|560212294|FG001|Overall Study|Other Reason Not Specified|0|||
155211578|NCT02068443|560212295|FG002|Overall Study|Other Reason Not Specified|0|||
155211579|NCT00127712|560212296|FG000|Overall Study|Adverse Event|3|||
155211580|NCT00127712|560212297|FG001|Overall Study|Adverse Event|0|||
155211581|NCT00127712|560212296|FG000|Overall Study|Lack of GI access to continue|2|||
155211582|NCT00127712|560212297|FG001|Overall Study|Lack of GI access to continue|0|||
155211583|NCT02450903|560212300|FG000|Overall Study|Adverse Event|3|||
155211584|NCT02450903|560212300|FG000|Overall Study|Progressive disease|15|||
155211585|NCT02450903|560212300|FG000|Overall Study|Switched to commercial drug|1|||
155211586|NCT02450903|560212300|FG000|Overall Study|Subject/guardian decision|1|||
155211587|NCT05126901|560212301|FG000|Overall Study|Withdrawal by Subject|1|||
155211588|NCT05126901|560212302|FG001|Overall Study|Withdrawal by Subject|1|||
155211589|NCT05126901|560212303|FG002|Overall Study|Withdrawal by Subject|4|||
155211590|NCT05126901|560212301|FG000|Overall Study|Adverse Event|0|||
155211591|NCT05126901|560212302|FG001|Overall Study|Adverse Event|0|||
155211592|NCT05126901|560212303|FG002|Overall Study|Adverse Event|1|||
155211593|NCT05126901|560212301|FG000|Overall Study|Lost to Follow-up|0|||
155211594|NCT05126901|560212302|FG001|Overall Study|Lost to Follow-up|2|||
155211595|NCT05126901|560212303|FG002|Overall Study|Lost to Follow-up|0|||
155491427|NCT00948896|561223550|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
155211596|NCT01320085|560212304|FG000|Overall Study|Disease Progression|26|||
155211597|NCT01320085|560212305|FG001|Overall Study|Disease Progression|93|||
155211598|NCT01320085|560212306|FG002|Overall Study|Disease Progression|17|||
155211599|NCT01320085|560212304|FG000|Overall Study|Adverse Event|12|||
155211600|NCT01320085|560212305|FG001|Overall Study|Adverse Event|20|||
155211601|NCT01320085|560212306|FG002|Overall Study|Adverse Event|5|||
155211602|NCT01320085|560212304|FG000|Overall Study|Withdrawal by Subject|2|||
155211603|NCT01320085|560212305|FG001|Overall Study|Withdrawal by Subject|4|||
155211604|NCT01320085|560212306|FG002|Overall Study|Withdrawal by Subject|1|||
155211605|NCT01320085|560212304|FG000|Overall Study|Protocol Deviation|1|||
155211606|NCT01320085|560212305|FG001|Overall Study|Protocol Deviation|0|||
155211607|NCT01320085|560212306|FG002|Overall Study|Protocol Deviation|1|||
155211608|NCT01320085|560212304|FG000|Overall Study|Administrative problems|0|||
155211609|NCT01320085|560212305|FG001|Overall Study|Administrative problems|0|||
155211610|NCT01320085|560212306|FG002|Overall Study|Administrative problems|1|||
155211611|NCT01409564|560212307|FG000|Overall Study|low medication compliance|4|||
155211612|NCT01409564|560212308|FG001|Overall Study|low medication compliance|3|||
155211613|NCT01409564|560212307|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
155211614|NCT01409564|560212308|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
155211615|NCT05040386|560212309|FG000|Overall Study|Withdrawal by Subject|1|||
155211616|NCT05040386|560212310|FG001|Overall Study|Withdrawal by Subject|0|||
155211617|NCT05040386|560212311|FG002|Overall Study|Withdrawal by Subject|1|||
155211618|NCT05040386|560212312|FG003|Overall Study|Withdrawal by Subject|0|||
155211619|NCT05040386|560212309|FG000|Overall Study|Lost to Follow-up|0|||
155211620|NCT05040386|560212310|FG001|Overall Study|Lost to Follow-up|0|||
155211621|NCT05040386|560212311|FG002|Overall Study|Lost to Follow-up|1|||
155211622|NCT05040386|560212312|FG003|Overall Study|Lost to Follow-up|0|||
155211623|NCT01702454|560212313|FG000|Overall Study|Consent withdrawal|0|||
155211624|NCT01702454|560212314|FG001|Overall Study|Consent withdrawal|1|||
155211625|NCT01702454|560212313|FG000|Overall Study|Migrated/moved from study area|0|||
155211626|NCT01702454|560212314|FG001|Overall Study|Migrated/moved from study area|1|||
155211627|NCT01702454|560212313|FG000|Overall Study|Lost to Follow-up|3|||
155211628|NCT01702454|560212314|FG001|Overall Study|Lost to Follow-up|6|||
155211629|NCT00710710|560212315|FG000|Overall Study|Consent withdrawn|2|||
155211630|NCT00710710|560212316|FG001|Overall Study|Consent withdrawn|2|||
155211631|NCT00710710|560212315|FG000|Overall Study|Protocol Violation|0|||
155211632|NCT00710710|560212316|FG001|Overall Study|Protocol Violation|1|||
155211633|NCT00710710|560212315|FG000|Overall Study|Adverse Event|3|||
155211634|NCT00710710|560212316|FG001|Overall Study|Adverse Event|3|||
155211635|NCT00710710|560212315|FG000|Overall Study|Progressive disease|40|||
155211636|NCT00710710|560212316|FG001|Overall Study|Progressive disease|38|||
155211637|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211638|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211639|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211640|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
155211641|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
155211642|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
155211643|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
155211644|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
155211645|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211646|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
155211647|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211648|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211649|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211650|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
155211651|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211652|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211653|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
155211654|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
155211655|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
155211656|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
155211657|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
155211658|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
155211659|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
155211660|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
155211661|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211662|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
155211663|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211664|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211665|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
155211666|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
155211667|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
155211668|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
155211669|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211670|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
155211671|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211672|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211673|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
155211674|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
155211675|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
155211676|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
155211677|NCT00715078|560212321|FG000|Overall Study|Death|29|||
155211678|NCT00715078|560212322|FG001|Overall Study|Death|36|||
155211679|NCT00715078|560212323|FG002|Overall Study|Death|36|||
155211680|NCT00715078|560212321|FG000|Overall Study|Withdrawal by Subject|1|||
155211681|NCT00715078|560212322|FG001|Overall Study|Withdrawal by Subject|0|||
155211682|NCT00715078|560212323|FG002|Overall Study|Withdrawal by Subject|1|||
155211683|NCT00715078|560212321|FG000|Overall Study|Unable to start due to disease prog.|0|||
155211684|NCT00715078|560212322|FG001|Overall Study|Unable to start due to disease prog.|0|||
155211685|NCT00715078|560212323|FG002|Overall Study|Unable to start due to disease prog.|1|||
155211686|NCT01313767|560212324|FG000|Overall Study|Adverse Event|1|||
155211687|NCT01313767|560212325|FG001|Overall Study|Adverse Event|0|||
155211688|NCT01313767|560212324|FG000|Overall Study|Lost to Follow-up|1|||
155211689|NCT01313767|560212325|FG001|Overall Study|Lost to Follow-up|0|||
155211690|NCT01313767|560212324|FG000|Overall Study|Withdrawal by Subject|2|||
155211691|NCT01313767|560212325|FG001|Overall Study|Withdrawal by Subject|1|||
155211692|NCT01313767|560212324|FG000|Overall Study|Protocol Violation|3|||
155211693|NCT01313767|560212325|FG001|Overall Study|Protocol Violation|1|||
155211694|NCT00157950|560212326|FG000|Overall Study|Death|1|||
155211695|NCT00157950|560212327|FG001|Overall Study|Death|0|||
155211696|NCT02673489|560212328|FG000|Treatment Period|Lost to Follow-up|3|||
155211697|NCT02673489|560212329|FG001|Treatment Period|Lost to Follow-up|0|||
155211698|NCT02673489|560212328|FG000|Treatment Period|Participant request to discontinue|1|||
155211699|NCT02673489|560212329|FG001|Treatment Period|Participant request to discontinue|1|||
155211700|NCT02673489|560212328|FG000|Treatment Period|Participant moved to another province|1|||
155211701|NCT02673489|560212329|FG001|Treatment Period|Participant moved to another province|0|||
155211702|NCT02673489|560212328|FG000|Treatment Period|Participant was incarcerated|0|||
155211703|NCT02673489|560212329|FG001|Treatment Period|Participant was incarcerated|1|||
155211704|NCT02673489|560212328|FG000|Treatment Period|Adverse Event|0|||
155211705|NCT02673489|560212329|FG001|Treatment Period|Adverse Event|1|||
155211706|NCT02673489|560212328|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
155211707|NCT02673489|560212329|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
155211708|NCT02673489|560212328|FG000|Follow Up Period|Unable to return for follow-up|0|||
155211709|NCT02673489|560212329|FG001|Follow Up Period|Unable to return for follow-up|1|||
155211710|NCT00759863|560212330|FG000|Overall Study|Death, moved, or lost contact|20|||
155211711|NCT00759863|560212331|FG001|Overall Study|Death, moved, or lost contact|18|||
155211712|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
155211713|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
155211714|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
155211715|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
155211716|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
155211717|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
155211718|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
155211719|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
155211720|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
155211721|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
155211722|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
155211723|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
155211724|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
155211725|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155211726|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155211727|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
155211728|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
155211729|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
155211730|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
155211731|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
155211732|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155211733|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
155211734|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
155211735|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155491428|NCT00948896|561223551|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155211736|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155211737|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
155211738|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
155211739|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
155211740|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
155211741|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
155211742|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
155211743|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
155211744|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
155211745|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
155211746|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
155211747|NCT02506153|560212338|FG000|Overall Study|Adverse Event|359|||
155211748|NCT02506153|560212339|FG001|Overall Study|Adverse Event|114|||
155211749|NCT02506153|560212338|FG000|Overall Study|Refused unrelated to adverse event|127|||
155211750|NCT02506153|560212339|FG001|Overall Study|Refused unrelated to adverse event|18|||
155211751|NCT02506153|560212338|FG000|Overall Study|Progression/relapse|91|||
155211752|NCT02506153|560212339|FG001|Overall Study|Progression/relapse|136|||
155211753|NCT02506153|560212338|FG000|Overall Study|Death|2|||
155211754|NCT02506153|560212339|FG001|Overall Study|Death|1|||
155211755|NCT02506153|560212338|FG000|Overall Study|Other - not protocol specified|23|||
155211756|NCT02506153|560212339|FG001|Overall Study|Other - not protocol specified|12|||
155211757|NCT00311623|560212342|FG000|Overall Study|Physician Decision|0|||
155211758|NCT00311623|560212343|FG001|Overall Study|Physician Decision|0|||
155211759|NCT00311623|560212344|FG002|Overall Study|Physician Decision|2|||
155211760|NCT03103919|560212345|FG000|Overall Study|Adverse Event|2|||
155211761|NCT03103919|560212346|FG001|Overall Study|Adverse Event|2|||
155211762|NCT03998189|560212347|FG000|Overall Study|Lack of Efficacy|0|||
155211763|NCT03998189|560212348|FG001|Overall Study|Lack of Efficacy|1|||
155211764|NCT01402544|560212349|FG000|Overall Study|Withdrawal by Subject|6|||
155211765|NCT04876274|560212352|FG000|Overall Study|Lost to Follow-up|9|||
155211766|NCT04876274|560212353|FG001|Overall Study|Lost to Follow-up|12|||
155211767|NCT03454893|560212354|FG000|Overall Study|Study Terminated by the Sponsor|5|||
155211768|NCT03454893|560212354|FG000|Overall Study|Did not pass screening|4|||
155211769|NCT01986985|560212355|FG000|Overall Study|Withdrawal by Subject|4|||
155211770|NCT01986985|560212355|FG000|Overall Study|Scan not completed due to malfunction|3|||
155211771|NCT01083576|560212356|FG000|Overall Study|Treatment Failure|6|||
155211772|NCT01083576|560212357|FG001|Overall Study|Treatment Failure|1|||
155211773|NCT03527966|560212358|FG000|Overall Study|Lost to Follow-up|3|||
155211774|NCT03527966|560212359|FG001|Overall Study|Lost to Follow-up|0|||
155211775|NCT01948050|560212360|FG000|Overall Study|Withdrawal by Subject|0|||
155211776|NCT01948050|560212361|FG001|Overall Study|Withdrawal by Subject|1|||
155211777|NCT02005445|560212362|FG000|Overall Study|Dual study enrollment|0|||
155211778|NCT02005445|560212363|FG001|Overall Study|Dual study enrollment|1|||
155211779|NCT00333866|560212366|FG000|Overall Study|Adverse Event|23|||
155211780|NCT00333866|560212367|FG001|Overall Study|Adverse Event|37|||
155211781|NCT00333866|560212368|FG002|Overall Study|Adverse Event|38|||
155211782|NCT00333866|560212369|FG003|Overall Study|Adverse Event|47|||
155211783|NCT00333866|560212366|FG000|Overall Study|Other|3|||
155211784|NCT00333866|560212367|FG001|Overall Study|Other|2|||
155211785|NCT00333866|560212368|FG002|Overall Study|Other|2|||
155211786|NCT00333866|560212369|FG003|Overall Study|Other|2|||
155211787|NCT00333866|560212366|FG000|Overall Study|Lack of Efficacy|8|||
155211788|NCT00333866|560212367|FG001|Overall Study|Lack of Efficacy|6|||
155211789|NCT00333866|560212368|FG002|Overall Study|Lack of Efficacy|3|||
155211790|NCT00333866|560212369|FG003|Overall Study|Lack of Efficacy|5|||
155211791|NCT00333866|560212366|FG000|Overall Study|Lost to Follow-up|1|||
155211792|NCT00333866|560212367|FG001|Overall Study|Lost to Follow-up|2|||
155211793|NCT00333866|560212368|FG002|Overall Study|Lost to Follow-up|2|||
155211794|NCT00333866|560212369|FG003|Overall Study|Lost to Follow-up|2|||
155211795|NCT00333866|560212366|FG000|Overall Study|Withdrawal by Subject|8|||
155211796|NCT00333866|560212367|FG001|Overall Study|Withdrawal by Subject|14|||
155211797|NCT00333866|560212368|FG002|Overall Study|Withdrawal by Subject|4|||
155211798|NCT00333866|560212369|FG003|Overall Study|Withdrawal by Subject|9|||
155211799|NCT00333866|560212366|FG000|Overall Study|Randomized but not Treated|5|||
155211800|NCT00333866|560212367|FG001|Overall Study|Randomized but not Treated|3|||
155211801|NCT00333866|560212368|FG002|Overall Study|Randomized but not Treated|2|||
155211802|NCT00333866|560212369|FG003|Overall Study|Randomized but not Treated|1|||
155211803|NCT06073119|560212370|FG000|Overall Study|Adverse Event|1|||
155211804|NCT06073119|560212371|FG001|Overall Study|Adverse Event|3|||
155211805|NCT06073119|560212372|FG002|Overall Study|Adverse Event|0|||
155211806|NCT06073119|560212373|FG003|Overall Study|Adverse Event|0|||
155211807|NCT06073119|560212374|FG004|Overall Study|Adverse Event|1|||
155211808|NCT06073119|560212375|FG005|Overall Study|Adverse Event|0|||
155211809|NCT06073119|560212370|FG000|Overall Study|Non-compliance with study schedule|1|||
155211810|NCT06073119|560212371|FG001|Overall Study|Non-compliance with study schedule|0|||
155211811|NCT06073119|560212372|FG002|Overall Study|Non-compliance with study schedule|0|||
155211812|NCT06073119|560212373|FG003|Overall Study|Non-compliance with study schedule|0|||
155211813|NCT06073119|560212374|FG004|Overall Study|Non-compliance with study schedule|1|||
155211814|NCT06073119|560212375|FG005|Overall Study|Non-compliance with study schedule|0|||
155211815|NCT06073119|560212370|FG000|Overall Study|Withdrawal by Subject|4|||
155211816|NCT06073119|560212371|FG001|Overall Study|Withdrawal by Subject|4|||
155211817|NCT06073119|560212372|FG002|Overall Study|Withdrawal by Subject|3|||
155211818|NCT06073119|560212373|FG003|Overall Study|Withdrawal by Subject|5|||
155211819|NCT06073119|560212374|FG004|Overall Study|Withdrawal by Subject|3|||
155211820|NCT06073119|560212375|FG005|Overall Study|Withdrawal by Subject|1|||
155211821|NCT06073119|560212370|FG000|Overall Study|Other|2|||
155211822|NCT06073119|560212371|FG001|Overall Study|Other|4|||
155211823|NCT06073119|560212372|FG002|Overall Study|Other|1|||
155211824|NCT06073119|560212373|FG003|Overall Study|Other|0|||
155211825|NCT06073119|560212374|FG004|Overall Study|Other|1|||
155211826|NCT06073119|560212375|FG005|Overall Study|Other|0|||
155211827|NCT05185089|560212376|FG000|First Intervention (4 weeks)|Adverse Event|0|||
155211828|NCT05185089|560212377|FG001|First Intervention (4 weeks)|Adverse Event|0|||
155211829|NCT05185089|560212378|FG002|First Intervention (4 weeks)|Adverse Event|0|||
155211830|NCT05185089|560212379|FG003|First Intervention (4 weeks)|Adverse Event|1|||
155211831|NCT05185089|560212376|FG000|Second Intervention (4 weeks)|Death|0|||
155211832|NCT05185089|560212377|FG001|Second Intervention (4 weeks)|Death|1|||
155211833|NCT05185089|560212378|FG002|Second Intervention (4 weeks)|Death|0|||
155211834|NCT05185089|560212379|FG003|Second Intervention (4 weeks)|Death|0|||
155211835|NCT05185089|560212376|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
155211836|NCT05185089|560212377|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
155211837|NCT05185089|560212378|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
155211838|NCT05185089|560212379|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
155211839|NCT04997161|560212380|FG000|Overall Study|Study terminated by sponsor|3|||
155211840|NCT00667368|560212381|FG000|Overall Study|Lost to Follow-up|176|||
155211841|NCT00667368|560212382|FG001|Overall Study|Lost to Follow-up|155|||
155211842|NCT00667368|560212381|FG000|Overall Study|Discontinued early|24|||
155211843|NCT00667368|560212382|FG001|Overall Study|Discontinued early|17|||
155211844|NCT02730455|560212383|FG000|Overall Study|Death|5|||
155211845|NCT02730455|560212384|FG001|Overall Study|Death|6|||
155211846|NCT02730455|560212385|FG002|Overall Study|Death|4|||
155211847|NCT02730455|560212383|FG000|Overall Study|Consent withdrawn|2|||
155211848|NCT02730455|560212384|FG001|Overall Study|Consent withdrawn|4|||
155211849|NCT02730455|560212385|FG002|Overall Study|Consent withdrawn|1|||
155211850|NCT02730455|560212383|FG000|Overall Study|Lost to Follow-up|3|||
155211851|NCT02730455|560212384|FG001|Overall Study|Lost to Follow-up|1|||
155211852|NCT02730455|560212385|FG002|Overall Study|Lost to Follow-up|4|||
155211853|NCT02730455|560212383|FG000|Overall Study|Other|1|||
155211854|NCT02730455|560212384|FG001|Overall Study|Other|1|||
155211855|NCT02730455|560212385|FG002|Overall Study|Other|2|||
155211856|NCT02730455|560212383|FG000|Overall Study|Other|2|||
155211857|NCT02730455|560212384|FG001|Overall Study|Other|2|||
155211858|NCT02730455|560212385|FG002|Overall Study|Other|0|||
155211859|NCT02733367|560212386|FG000|Overall Study|Withdrawal by Subject|6|||
155211860|NCT01348347|560212387|FG000|Overall Study|Withdrawal by Subject|1|||
155211861|NCT01348347|560212388|FG001|Overall Study|Withdrawal by Subject|1|||
155211862|NCT01348347|560212389|FG002|Overall Study|Withdrawal by Subject|1|||
155211863|NCT01348347|560212387|FG000|Overall Study|Progressive disease|2|||
155211864|NCT01348347|560212388|FG001|Overall Study|Progressive disease|5|||
155211865|NCT01348347|560212389|FG002|Overall Study|Progressive disease|5|||
155211866|NCT03049280|560212396|FG000|Overall Study|Physician Decision|1|||
155211867|NCT00996307|560212397|FG000|Overall Study|Adverse Event|0|||
155211868|NCT00996307|560212398|FG001|Overall Study|Adverse Event|1|||
155211869|NCT00996307|560212399|FG002|Overall Study|Adverse Event|0|||
155211870|NCT00996307|560212400|FG003|Overall Study|Adverse Event|0|||
155211871|NCT00996307|560212397|FG000|Overall Study|Withdrawal by Subject|3|||
155211872|NCT00996307|560212398|FG001|Overall Study|Withdrawal by Subject|2|||
155211873|NCT00996307|560212399|FG002|Overall Study|Withdrawal by Subject|5|||
155211874|NCT00996307|560212400|FG003|Overall Study|Withdrawal by Subject|5|||
155211875|NCT00996307|560212397|FG000|Overall Study|Lost to Follow-up|13|||
155211876|NCT00996307|560212398|FG001|Overall Study|Lost to Follow-up|13|||
155211877|NCT00996307|560212399|FG002|Overall Study|Lost to Follow-up|7|||
155211878|NCT00996307|560212400|FG003|Overall Study|Lost to Follow-up|15|||
155211879|NCT00996307|560212397|FG000|Overall Study|Administrative reason|0|||
155211880|NCT00996307|560212398|FG001|Overall Study|Administrative reason|1|||
155211881|NCT00996307|560212399|FG002|Overall Study|Administrative reason|0|||
155211882|NCT00996307|560212400|FG003|Overall Study|Administrative reason|0|||
155211883|NCT00996307|560212397|FG000|Overall Study|Unable to classify|4|||
155211884|NCT00996307|560212398|FG001|Overall Study|Unable to classify|0|||
155211885|NCT00996307|560212399|FG002|Overall Study|Unable to classify|2|||
155211886|NCT00996307|560212400|FG003|Overall Study|Unable to classify|1|||
155211887|NCT00001723|560212401|FG000|Overall Study|Lack of Efficacy|6|||
155211888|NCT00001723|560212402|FG001|Overall Study|Lack of Efficacy|7|||
155211889|NCT00001723|560212401|FG000|Overall Study|Lack of family interest|4|||
155211890|NCT00001723|560212402|FG001|Overall Study|Lack of family interest|5|||
155211891|NCT00001723|560212401|FG000|Overall Study|Lost to Follow-up|2|||
155211892|NCT00001723|560212402|FG001|Overall Study|Lost to Follow-up|2|||
155211893|NCT00001723|560212401|FG000|Overall Study|medication intolerance|1|||
155211894|NCT00001723|560212402|FG001|Overall Study|medication intolerance|2|||
155211895|NCT01867021|560212403|FG000|Overall Study|Adverse Event|0|||
155211896|NCT01867021|560212404|FG001|Overall Study|Adverse Event|1|||
155211897|NCT01867021|560212403|FG000|Overall Study|Not Eligible|0|||
155211898|NCT01867021|560212404|FG001|Overall Study|Not Eligible|1|||
155211899|NCT01867021|560212403|FG000|Overall Study|Death|1|||
155211900|NCT01867021|560212404|FG001|Overall Study|Death|0|||
155211901|NCT01867021|560212403|FG000|Overall Study|Lost to Follow-up|0|||
155211902|NCT01867021|560212404|FG001|Overall Study|Lost to Follow-up|2|||
155211903|NCT01867021|560212403|FG000|Overall Study|Withdrawal by Subject|1|||
155211904|NCT01867021|560212404|FG001|Overall Study|Withdrawal by Subject|6|||
155211905|NCT00640601|560212405|FG000|Overall Study|Adverse Event|43|||
155211906|NCT00640601|560212405|FG000|Overall Study|Withdrawal by Subject|20|||
155211907|NCT00640601|560212405|FG000|Overall Study|Protocol Violation|6|||
155211908|NCT00640601|560212405|FG000|Overall Study|Lack of Efficacy|16|||
155211909|NCT00640601|560212405|FG000|Overall Study|Lost to Follow-up|9|||
155211910|NCT00640601|560212405|FG000|Overall Study|Physician Decision|8|||
155211911|NCT00640601|560212405|FG000|Overall Study|treatment naive, combination therapy|10|||
155211912|NCT01862874|560212406|FG000|Overall Study|Randomized not treated|1|||
155211913|NCT01862874|560212407|FG001|Overall Study|Randomized not treated|0|||
155211914|NCT01862874|560212406|FG000|Overall Study|Adverse Event|0|||
155211915|NCT01862874|560212407|FG001|Overall Study|Adverse Event|3|||
155211916|NCT01862874|560212406|FG000|Overall Study|Lost to Follow-up|26|||
155211917|NCT01862874|560212407|FG001|Overall Study|Lost to Follow-up|29|||
155211918|NCT01862874|560212406|FG000|Overall Study|Physician Decision|5|||
155211919|NCT01862874|560212407|FG001|Overall Study|Physician Decision|3|||
155211920|NCT01862874|560212406|FG000|Overall Study|Withdrawn by parent/guardian|1|||
155211921|NCT01862874|560212407|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155211922|NCT01862874|560212406|FG000|Overall Study|Withdrawal by Subject|46|||
155211923|NCT01862874|560212407|FG001|Overall Study|Withdrawal by Subject|40|||
155211924|NCT01862874|560212406|FG000|Overall Study|Death|0|||
155211925|NCT01862874|560212407|FG001|Overall Study|Death|1|||
155211926|NCT03198234|560212408|FG000|Overall Study|Relapse of primary disease|0|||
155211927|NCT03198234|560212409|FG001|Overall Study|Relapse of primary disease|1|||
155211928|NCT03198234|560212410|FG002|Overall Study|Relapse of primary disease|0|||
155211929|NCT04285879|560212411|FG000|Overall Study|Lost to Follow-up|1|||
155211930|NCT04285879|560212412|FG001|Overall Study|Lost to Follow-up|8|||
155211931|NCT04285879|560212411|FG000|Overall Study|medical/surgical exclusion|16|||
155211932|NCT04285879|560212412|FG001|Overall Study|medical/surgical exclusion|0|||
155211933|NCT03228537|560212415|FG000|Neoadjuvant|Adverse Event|2|||
155211934|NCT03228537|560212415|FG000|Neoadjuvant|Progression/Relapse|4|||
155211935|NCT03228537|560212415|FG000|Neoadjuvant|Death|1|||
155211936|NCT03228537|560212415|FG000|Surgery|Death|1|||
155211937|NCT03228537|560212415|FG000|Surgery|Other - Not Protocol Specified|2|||
155211938|NCT03228537|560212415|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
155211939|NCT03228537|560212415|FG000|Maintenance|Progression/Relapse|10|||
155211940|NCT01927367|560212416|FG000|Overall Study|Withdrawal by Subject|7|||
155211941|NCT01927367|560212417|FG001|Overall Study|Withdrawal by Subject|4|||
155211942|NCT01927367|560212416|FG000|Overall Study|No baseline data|0|||
155211943|NCT01927367|560212417|FG001|Overall Study|No baseline data|1|||
155211944|NCT02622321|560212418|FG000|Overall Study|Withdrawal by Subject|2|||
155211945|NCT02622321|560212419|FG001|Overall Study|Withdrawal by Subject|0|||
155211946|NCT02622321|560212420|FG002|Overall Study|Withdrawal by Subject|0|||
155211947|NCT02622321|560212421|FG003|Overall Study|Withdrawal by Subject|0|||
155211948|NCT02622321|560212418|FG000|Overall Study|Death|0|||
155211949|NCT02622321|560212419|FG001|Overall Study|Death|0|||
155211950|NCT02622321|560212420|FG002|Overall Study|Death|1|||
155211951|NCT02622321|560212421|FG003|Overall Study|Death|0|||
155211952|NCT02622321|560212418|FG000|Overall Study|Physician Decision|1|||
155211953|NCT02622321|560212419|FG001|Overall Study|Physician Decision|0|||
155211954|NCT02622321|560212420|FG002|Overall Study|Physician Decision|0|||
155211955|NCT02622321|560212421|FG003|Overall Study|Physician Decision|0|||
155211956|NCT00241280|560212424|FG000|Overall Study|Adverse Event|2|||
155211957|NCT00241280|560212425|FG001|Overall Study|Adverse Event|6|||
155211958|NCT00241280|560212424|FG000|Overall Study|Discomfort|11|||
155211959|NCT00241280|560212425|FG001|Overall Study|Discomfort|16|||
155211960|NCT00241280|560212424|FG000|Overall Study|Pregnancy|1|||
155211961|NCT00241280|560212425|FG001|Overall Study|Pregnancy|5|||
155211962|NCT00241280|560212424|FG000|Overall Study|Lost to Follow-up|5|||
155211963|NCT00241280|560212425|FG001|Overall Study|Lost to Follow-up|8|||
155211964|NCT00241280|560212424|FG000|Overall Study|Withdrawal by Subject|7|||
155211965|NCT00241280|560212425|FG001|Overall Study|Withdrawal by Subject|4|||
155211966|NCT00241280|560212424|FG000|Overall Study|Protocol Violation|4|||
155211967|NCT00241280|560212425|FG001|Overall Study|Protocol Violation|10|||
155211968|NCT00241280|560212424|FG000|Overall Study|Relocation|4|||
155211969|NCT00241280|560212425|FG001|Overall Study|Relocation|4|||
155211970|NCT00241280|560212424|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
155211971|NCT00241280|560212425|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
155211972|NCT00241280|560212424|FG000|Overall Study|Unsatisfactory Visual Response|1|||
155211973|NCT00241280|560212425|FG001|Overall Study|Unsatisfactory Visual Response|1|||
155211974|NCT00241280|560212424|FG000|Overall Study|Diabetic|1|||
155211975|NCT00241280|560212425|FG001|Overall Study|Diabetic|0|||
155211976|NCT00241280|560212424|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
155211977|NCT00241280|560212425|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
155211978|NCT00241280|560212424|FG000|Overall Study|Dispensed incorrect test article|1|||
155211979|NCT00241280|560212425|FG001|Overall Study|Dispensed incorrect test article|2|||
155211980|NCT00241280|560212424|FG000|Overall Study|Unacceptable Fit|0|||
155211981|NCT00241280|560212425|FG001|Overall Study|Unacceptable Fit|1|||
155211982|NCT00241280|560212424|FG000|Overall Study|Scheduling Conflict|0|||
155211983|NCT00241280|560212425|FG001|Overall Study|Scheduling Conflict|2|||
155211984|NCT00241280|560212424|FG000|Overall Study|History of Ocular Surgery|0|||
155211985|NCT00241280|560212425|FG001|Overall Study|History of Ocular Surgery|1|||
155211986|NCT00241280|560212424|FG000|Overall Study|Coating on Lens|1|||
155211987|NCT00241280|560212425|FG001|Overall Study|Coating on Lens|0|||
155211988|NCT00241280|560212424|FG000|Overall Study|Excessive Dryness|0|||
155211989|NCT00241280|560212425|FG001|Overall Study|Excessive Dryness|1|||
155211990|NCT00965718|560212426|FG000|Overall Study|Withdrawal by Subject|4|||
155211991|NCT01414855|560212428|FG000|Overall Study|Death|17|||
155211992|NCT01414855|560212428|FG000|Overall Study|Lost to Follow-up|5|||
155211993|NCT01414855|560212428|FG000|Overall Study|Withdrawal by Subject|7|||
155211994|NCT01572909|560214212|FG000|Overall Study|Adverse Event|7|||
155211995|NCT01572909|560214213|FG001|Overall Study|Adverse Event|2|||
155211996|NCT01572909|560214212|FG000|Overall Study|Death|3|||
155211997|NCT01572909|560214213|FG001|Overall Study|Death|1|||
155211998|NCT01572909|560214212|FG000|Overall Study|Lost to Follow-up|8|||
155211999|NCT01572909|560214213|FG001|Overall Study|Lost to Follow-up|7|||
155212000|NCT01572909|560214212|FG000|Overall Study|Physician Decision|1|||
155212001|NCT01572909|560214213|FG001|Overall Study|Physician Decision|1|||
155212002|NCT01572909|560214212|FG000|Overall Study|Technical Issues|1|||
155212003|NCT01572909|560214213|FG001|Overall Study|Technical Issues|0|||
155212004|NCT01572909|560214212|FG000|Overall Study|Withdrawal by Subject|12|||
155212005|NCT01572909|560214213|FG001|Overall Study|Withdrawal by Subject|11|||
155212006|NCT01572909|560214212|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
155212007|NCT01572909|560214213|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
155212008|NCT04779489|560214214|FG000|Overall Study|Physician Decision|1|||
155212009|NCT02723084|560214216|FG000|Overall Study|Withdrawal by Subject|1|||
155212010|NCT02723084|560214217|FG001|Overall Study|Withdrawal by Subject|1|||
155212011|NCT02723084|560214216|FG000|Overall Study|Lost to Follow-up|3|||
155212012|NCT02723084|560214217|FG001|Overall Study|Lost to Follow-up|0|||
155212013|NCT05024058|560214220|FG000|Treatment|Study terminated by sponsor|5|||
155212014|NCT05024058|560214221|FG001|Treatment|Study terminated by sponsor|6|||
155212015|NCT05024058|560214222|FG002|Treatment|Study terminated by sponsor|4|||
155212016|NCT05024058|560214223|FG003|Treatment|Study terminated by sponsor|2|||
155212017|NCT05024058|560214224|FG004|Treatment|Study terminated by sponsor|3|||
155212018|NCT05024058|560214225|FG005|Treatment|Study terminated by sponsor|3|||
155212019|NCT05024058|560214226|FG006|Treatment|Study terminated by sponsor|1|||
155212020|NCT05024058|560214227|FG007|Treatment|Study terminated by sponsor|3|||
155212021|NCT05024058|560214228|FG008|Treatment|Study terminated by sponsor|6|||
155212022|NCT05024058|560214229|FG009|Treatment|Study terminated by sponsor|6|||
155212023|NCT05024058|560214220|FG000|Follow-up|Withdrawal by Subject|1|||
155212024|NCT05024058|560214221|FG001|Follow-up|Withdrawal by Subject|0|||
155212025|NCT05024058|560214222|FG002|Follow-up|Withdrawal by Subject|1|||
155212026|NCT05024058|560214223|FG003|Follow-up|Withdrawal by Subject|0|||
155212027|NCT05024058|560214224|FG004|Follow-up|Withdrawal by Subject|0|||
155212028|NCT05024058|560214225|FG005|Follow-up|Withdrawal by Subject|0|||
155212029|NCT05024058|560214226|FG006|Follow-up|Withdrawal by Subject|0|||
155212030|NCT05024058|560214227|FG007|Follow-up|Withdrawal by Subject|1|||
155212031|NCT05024058|560214228|FG008|Follow-up|Withdrawal by Subject|0|||
155212032|NCT05024058|560214229|FG009|Follow-up|Withdrawal by Subject|1|||
155212033|NCT03055260|560214233|FG000|Overall Study|Withdrawal by Subject|1|||
155212034|NCT03055260|560214234|FG001|Overall Study|Withdrawal by Subject|0|||
155212035|NCT00931762|560214235|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
155212036|NCT00931762|560214235|FG000|Overall Study|Administrative Problems|5|||
155212037|NCT00931762|560214235|FG000|Overall Study|Death|1|||
155212038|NCT00931762|560214235|FG000|Overall Study|Disease Progression|3|||
155212039|NCT00931762|560214235|FG000|Overall Study|Adverse Event (s)|11|||
155212040|NCT00931762|560214235|FG000|Overall Study|Subject withdrew consent|13|||
155212041|NCT00225251|560214238|FG000|Overall Study|Withdrawal by Subject|1|||
155212042|NCT00225251|560214239|FG001|Overall Study|Withdrawal by Subject|1|||
155212043|NCT02664441|560214240|FG000|Randomization|Withdrawal by Subject|0|||
155212044|NCT02664441|560214241|FG001|Randomization|Withdrawal by Subject|1|||
155212045|NCT02664441|560214240|FG000|36-week Randomized Trial|Adverse Event|2|||
155212046|NCT02664441|560214241|FG001|36-week Randomized Trial|Adverse Event|0|||
155212047|NCT02664441|560214240|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
155212048|NCT02664441|560214241|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
155212049|NCT02664441|560214240|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
155212050|NCT02664441|560214241|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
155212051|NCT02664441|560214240|FG000|18-week Open Label Extension|Adverse Event|1|||
155212052|NCT02664441|560214241|FG001|18-week Open Label Extension|Adverse Event|0|||
155212053|NCT02664441|560214240|FG000|18-week Open Label Extension|Physician Decision|1|||
155212054|NCT02664441|560214241|FG001|18-week Open Label Extension|Physician Decision|0|||
155212055|NCT02664441|560214240|FG000|18-week Open Label Extension|Death|1|||
155212056|NCT02664441|560214241|FG001|18-week Open Label Extension|Death|0|||
155212057|NCT02664441|560214240|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
155212058|NCT02664441|560214241|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
155212059|NCT01529346|560214246|FG000|Overall Study|Lost to Follow-up|2|||
155212060|NCT01529346|560214247|FG001|Overall Study|Lost to Follow-up|0|||
155212061|NCT01529346|560214248|FG002|Overall Study|Lost to Follow-up|1|||
155212062|NCT01529346|560214249|FG003|Overall Study|Lost to Follow-up|0|||
155212063|NCT01529346|560214250|FG004|Overall Study|Lost to Follow-up|0|||
155212064|NCT01529346|560214246|FG000|Overall Study|Other|0|||
155212065|NCT01529346|560214247|FG001|Overall Study|Other|1|||
155212066|NCT01529346|560214248|FG002|Overall Study|Other|1|||
155212067|NCT01529346|560214249|FG003|Overall Study|Other|0|||
155212068|NCT01529346|560214250|FG004|Overall Study|Other|0|||
155212069|NCT02892760|560214251|FG000|Overall Study|Withdrawal by Subject|3|||
155212070|NCT00386776|560214258|FG000|Overall Study|Withdrawal by Subject|8|||
155212071|NCT00588848|560214259|FG000|Overall Study|Physician Decision|0|||
155212072|NCT00588848|560214260|FG001|Overall Study|Physician Decision|3|||
155212073|NCT00082355|560214261|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
155212074|NCT00082355|560214261|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
155212075|NCT00082355|560214261|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
155212076|NCT02335489|560214262|FG000|Overall Study|Sponsor terminated study|4|||
155212077|NCT02335489|560214262|FG000|Overall Study|Lost to Follow-up|1|||
155212078|NCT02335489|560214262|FG000|Overall Study|Withdrawal by Subject|2|||
155212079|NCT02335489|560214262|FG000|Overall Study|Physician Decision|2|||
155212080|NCT02335489|560214262|FG000|Overall Study|Lack of Efficacy|1|||
155212081|NCT00412854|560214269|FG000|Overall Study|Withdrawn due to adverse events|1|||
155212082|NCT00412854|560214270|FG001|Overall Study|Withdrawn due to adverse events|5|||
155212083|NCT00412854|560214269|FG000|Overall Study|Withdrawn for other reasons|13|||
155212084|NCT00412854|560214270|FG001|Overall Study|Withdrawn for other reasons|11|||
155212085|NCT00531050|560214272|FG000|Part 1: Period 1|Adverse Event|0|||
155212086|NCT00531050|560214273|FG001|Part 1: Period 1|Adverse Event|1|||
155212087|NCT00531050|560214274|FG002|Part 1: Period 1|Adverse Event|0|||
155212088|NCT00531050|560214275|FG003|Part 1: Period 1|Adverse Event|0|||
155212089|NCT00531050|560214276|FG004|Part 1: Period 1|Adverse Event|0|||
155212090|NCT00531050|560214277|FG005|Part 1: Period 1|Adverse Event|0|||
155212091|NCT00531050|560214272|FG000|Part 1: Period 1|Protocol Deviation|0|||
155212092|NCT00531050|560214273|FG001|Part 1: Period 1|Protocol Deviation|0|||
155212093|NCT00531050|560214274|FG002|Part 1: Period 1|Protocol Deviation|0|||
155212094|NCT00531050|560214275|FG003|Part 1: Period 1|Protocol Deviation|1|||
155212095|NCT00531050|560214276|FG004|Part 1: Period 1|Protocol Deviation|0|||
155212096|NCT00531050|560214277|FG005|Part 1: Period 1|Protocol Deviation|0|||
155212097|NCT00531050|560214272|FG000|Part 1: Period 3|Adverse Event|1|||
155212098|NCT00531050|560214273|FG001|Part 1: Period 3|Adverse Event|0|||
155212099|NCT00531050|560214274|FG002|Part 1: Period 3|Adverse Event|0|||
155212100|NCT00531050|560214275|FG003|Part 1: Period 3|Adverse Event|0|||
155212101|NCT00531050|560214276|FG004|Part 1: Period 3|Adverse Event|0|||
155212102|NCT00531050|560214277|FG005|Part 1: Period 3|Adverse Event|0|||
155212103|NCT00531050|560214272|FG000|Part 2: Period 1|Adverse Event|0|||
155212104|NCT00531050|560214273|FG001|Part 2: Period 1|Adverse Event|0|||
155212105|NCT00531050|560214274|FG002|Part 2: Period 1|Adverse Event|0|||
155212106|NCT00531050|560214275|FG003|Part 2: Period 1|Adverse Event|0|||
155212107|NCT00531050|560214276|FG004|Part 2: Period 1|Adverse Event|0|||
155212108|NCT00531050|560214277|FG005|Part 2: Period 1|Adverse Event|1|||
155212109|NCT00531050|560214272|FG000|Part 2: Period 3|Abnormal test procedure|1|||
155212110|NCT00531050|560214273|FG001|Part 2: Period 3|Abnormal test procedure|0|||
155212111|NCT00531050|560214274|FG002|Part 2: Period 3|Abnormal test procedure|0|||
155212112|NCT00531050|560214275|FG003|Part 2: Period 3|Abnormal test procedure|0|||
155212113|NCT00531050|560214276|FG004|Part 2: Period 3|Abnormal test procedure|0|||
155212114|NCT00531050|560214277|FG005|Part 2: Period 3|Abnormal test procedure|1|||
155212115|NCT02233309|560214279|FG000|Overall Study|Physician Decision|5|||
155212116|NCT00799487|560214284|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
155212117|NCT00799487|560214285|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
155212118|NCT00799487|560214286|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
155212119|NCT00799487|560214284|FG000|Dose Adjustment Period|Adverse Event|2|||
155212120|NCT00799487|560214285|FG001|Dose Adjustment Period|Adverse Event|0|||
155212121|NCT00799487|560214286|FG002|Dose Adjustment Period|Adverse Event|0|||
155212122|NCT00799487|560214284|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
155212123|NCT00799487|560214285|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
155212124|NCT00799487|560214286|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
155212125|NCT00799487|560214284|FG000|Dose Adjustment Period|Investigator Discretion|2|||
155212126|NCT00799487|560214285|FG001|Dose Adjustment Period|Investigator Discretion|0|||
155212127|NCT00799487|560214286|FG002|Dose Adjustment Period|Investigator Discretion|0|||
155212128|NCT00799487|560214284|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
155212129|NCT00799487|560214285|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
155212130|NCT00799487|560214286|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
155212131|NCT00799487|560214284|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
155212132|NCT00799487|560214285|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
155212133|NCT00799487|560214286|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
155212134|NCT00799487|560214284|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
155212135|NCT00799487|560214285|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
155212136|NCT00799487|560214286|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
155212137|NCT00799487|560214284|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
155212138|NCT00799487|560214285|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
155212139|NCT00799487|560214286|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
155212140|NCT00799487|560214284|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
155212141|NCT00799487|560214285|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
155212142|NCT00799487|560214286|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
155212143|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
155212144|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
155212145|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
155212146|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
155212147|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
155212148|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
155212149|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
155212150|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
155212151|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
155212152|NCT00232817|560214287|FG000|Overall Study|Protocol Violation|2|||
155212153|NCT00232817|560214288|FG001|Overall Study|Protocol Violation|1|||
155212154|NCT01484873|560214289|FG000|Overall Study|Withdrawal by Subject|2|||
155212155|NCT01549392|560214290|FG000|Overall Study|Withdrawal by Subject|1|||
155212156|NCT01549392|560214291|FG001|Overall Study|Withdrawal by Subject|0|||
155212157|NCT00227903|560214292|FG000|Overall Study|Withdrawal by Subject|2|||
155212158|NCT00227903|560214293|FG001|Overall Study|Withdrawal by Subject|5|||
155212159|NCT00227903|560214292|FG000|Overall Study|Subject moved out of area|1|||
155212160|NCT00227903|560214293|FG001|Overall Study|Subject moved out of area|2|||
155212161|NCT00227903|560214292|FG000|Overall Study|Lost to Follow-up|1|||
155212162|NCT00227903|560214293|FG001|Overall Study|Lost to Follow-up|3|||
155212163|NCT00227903|560214292|FG000|Overall Study|Miscarriage|1|||
155212164|NCT00227903|560214293|FG001|Overall Study|Miscarriage|0|||
155212165|NCT04273217|560214294|FG000|Overall Study|Lost to Follow-up|0|||
155212166|NCT04273217|560214295|FG001|Overall Study|Lost to Follow-up|0|||
155212167|NCT04273217|560214296|FG002|Overall Study|Lost to Follow-up|0|||
155212168|NCT04273217|560214297|FG003|Overall Study|Lost to Follow-up|0|||
155212169|NCT04273217|560214298|FG004|Overall Study|Lost to Follow-up|0|||
155212170|NCT04273217|560214299|FG005|Overall Study|Lost to Follow-up|1|||
155212171|NCT04273217|560214294|FG000|Overall Study|Participant non-compliance|0|||
155212172|NCT04273217|560214295|FG001|Overall Study|Participant non-compliance|0|||
155212173|NCT04273217|560214296|FG002|Overall Study|Participant non-compliance|0|||
155212174|NCT04273217|560214297|FG003|Overall Study|Participant non-compliance|0|||
155212175|NCT04273217|560214298|FG004|Overall Study|Participant non-compliance|1|||
155212176|NCT04273217|560214299|FG005|Overall Study|Participant non-compliance|0|||
155212177|NCT04273217|560214294|FG000|Overall Study|Positive urine drug screen|1|||
155212178|NCT04273217|560214295|FG001|Overall Study|Positive urine drug screen|0|||
155212179|NCT04273217|560214296|FG002|Overall Study|Positive urine drug screen|1|||
155212180|NCT04273217|560214297|FG003|Overall Study|Positive urine drug screen|0|||
155212181|NCT04273217|560214298|FG004|Overall Study|Positive urine drug screen|0|||
155212182|NCT04273217|560214299|FG005|Overall Study|Positive urine drug screen|1|||
155212183|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
155212184|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
155212185|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
155212186|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
155212187|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
155212188|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
155212189|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212190|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212191|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212192|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
155212193|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212194|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
155212195|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
155212196|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
155212197|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
155212198|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
155212199|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
155212200|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
155212201|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212202|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212203|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212204|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212205|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
155212206|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
155212207|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212208|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
155212209|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
155212210|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212211|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212212|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
155212213|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
155212214|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
155212215|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
155212216|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
155212217|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
155212218|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
155212219|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212220|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212221|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212222|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
155212223|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
155212224|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212225|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
155212226|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
155212227|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
155212228|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
155212229|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
155212230|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
155212231|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212232|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212233|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212234|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212235|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212236|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
155212237|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212238|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212239|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212240|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
155212241|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
155212242|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
155212243|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212244|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212245|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
155212246|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212247|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212248|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212249|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212250|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212251|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212252|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
155212253|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212254|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
155212255|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212256|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212257|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212258|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212259|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212260|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
155212261|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212262|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212263|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
155212264|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212265|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212266|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212267|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
155212268|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
155212269|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
155212270|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212271|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212272|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212273|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Other|0|||
155212274|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Other|1|||
155212275|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Other|0|||
155212276|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Other|2|||
155212277|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Other|1|||
155212278|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Other|0|||
155212279|NCT00460031|560214310|FG000|Overall Study|Adverse Event|5|||
155212280|NCT00460031|560214310|FG000|Overall Study|Withdrawal by Subject|5|||
155212281|NCT00460031|560214310|FG000|Overall Study|Death|1|||
155212282|NCT04532099|560214311|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
155212283|NCT04532099|560214312|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
155212284|NCT04532099|560214313|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
155212285|NCT05492942|560214318|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
155212286|NCT05492942|560214319|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
155212287|NCT05492942|560214320|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
155212288|NCT05492942|560214321|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
155212289|NCT01907815|560214322|FG000|Overall Study|Withdrawal by Subject|1|||
155212290|NCT01907815|560214323|FG001|Overall Study|Withdrawal by Subject|0|||
155212291|NCT01712490|560214327|FG000|Overall Study|Ongoing|601|||
155212292|NCT01712490|560214328|FG001|Overall Study|Ongoing|586|||
155212293|NCT01712490|560214327|FG000|Overall Study|Other|11|||
155212294|NCT01712490|560214328|FG001|Overall Study|Other|11|||
155212295|NCT01712490|560214327|FG000|Overall Study|Withdrawal by Subject|36|||
155212296|NCT01712490|560214328|FG001|Overall Study|Withdrawal by Subject|44|||
155212297|NCT01712490|560214327|FG000|Overall Study|Lost to Follow-up|16|||
155212298|NCT01712490|560214328|FG001|Overall Study|Lost to Follow-up|29|||
155212299|NCT02056340|560214334|FG000|Overall Study|Lost to Follow-up|5|||
155212300|NCT02056340|560214335|FG001|Overall Study|Lost to Follow-up|5|||
155212301|NCT02056340|560214334|FG000|Overall Study|Withdrawal by Subject|2|||
155212302|NCT02056340|560214335|FG001|Overall Study|Withdrawal by Subject|6|||
155212303|NCT01782495|560214336|FG000|Overall Study|Adverse Event|0|||
155212304|NCT01782495|560214337|FG001|Overall Study|Adverse Event|0|||
155212305|NCT01782495|560214338|FG002|Overall Study|Adverse Event|0|||
155212306|NCT01782495|560214339|FG003|Overall Study|Adverse Event|0|||
155212307|NCT01782495|560214340|FG004|Overall Study|Adverse Event|0|||
155212308|NCT01782495|560214341|FG005|Overall Study|Adverse Event|0|||
155212309|NCT01782495|560214342|FG006|Overall Study|Adverse Event|0|||
155212310|NCT01782495|560214343|FG007|Overall Study|Adverse Event|2|||
155212311|NCT01782495|560214344|FG008|Overall Study|Adverse Event|0|||
155212312|NCT01782495|560214345|FG009|Overall Study|Adverse Event|0|||
155212313|NCT01782495|560214346|FG010|Overall Study|Adverse Event|0|||
155212314|NCT01782495|560214336|FG000|Overall Study|Withdrew Consent|0|||
155212315|NCT01782495|560214337|FG001|Overall Study|Withdrew Consent|1|||
155212316|NCT01782495|560214338|FG002|Overall Study|Withdrew Consent|0|||
155212317|NCT01782495|560214339|FG003|Overall Study|Withdrew Consent|0|||
155212318|NCT01782495|560214340|FG004|Overall Study|Withdrew Consent|0|||
155212319|NCT01782495|560214341|FG005|Overall Study|Withdrew Consent|0|||
155212320|NCT01782495|560214342|FG006|Overall Study|Withdrew Consent|0|||
155212321|NCT01782495|560214343|FG007|Overall Study|Withdrew Consent|1|||
155212322|NCT01782495|560214344|FG008|Overall Study|Withdrew Consent|0|||
155212323|NCT01782495|560214345|FG009|Overall Study|Withdrew Consent|0|||
155212324|NCT01782495|560214346|FG010|Overall Study|Withdrew Consent|0|||
155212325|NCT02848651|560214348|FG000|Overall Study|Death|85|||
155212326|NCT02848651|560214348|FG000|Overall Study|Lost to Follow-up|1|||
155212327|NCT02848651|560214348|FG000|Overall Study|Non-Compliance|1|||
155212328|NCT02848651|560214348|FG000|Overall Study|Symptomatic Deterioration|1|||
155212329|NCT02848651|560214348|FG000|Overall Study|Physician Decision|4|||
155212330|NCT02848651|560214348|FG000|Overall Study|Withdrawal by Subject|14|||
155212331|NCT02480114|560214353|FG000|Overall Study|Not completing surveys|3|||
155212332|NCT02480114|560214354|FG001|Overall Study|Not completing surveys|2|||
155212333|NCT02480114|560214353|FG000|Overall Study|Withdrawal by Subject|2|||
155212334|NCT02480114|560214354|FG001|Overall Study|Withdrawal by Subject|4|||
155212335|NCT02480114|560214353|FG000|Overall Study|Disease progression|3|||
155212336|NCT02480114|560214354|FG001|Overall Study|Disease progression|0|||
155212337|NCT02480114|560214353|FG000|Overall Study|Improper completion of survey|1|||
155212338|NCT02480114|560214354|FG001|Overall Study|Improper completion of survey|1|||
155212339|NCT02480114|560214353|FG000|Overall Study|Not eligible|0|||
155212340|NCT02480114|560214354|FG001|Overall Study|Not eligible|1|||
155212341|NCT01535053|560214355|FG000|Overall Study|Ineligible|1|||
155212342|NCT01535053|560214356|FG001|Overall Study|Ineligible|2|||
155212343|NCT01031069|560214357|FG000|Overall Study|Serious Adverse Event|0|||
155212344|NCT01031069|560214358|FG001|Overall Study|Serious Adverse Event|1|||
155212345|NCT01031069|560214359|FG002|Overall Study|Serious Adverse Event|0|||
155212346|NCT01031069|560214360|FG003|Overall Study|Serious Adverse Event|0|||
155212347|NCT01031069|560214357|FG000|Overall Study|Withdrawal by Subject|2|||
155212348|NCT01031069|560214358|FG001|Overall Study|Withdrawal by Subject|3|||
155212349|NCT01031069|560214359|FG002|Overall Study|Withdrawal by Subject|18|||
155212350|NCT01031069|560214360|FG003|Overall Study|Withdrawal by Subject|18|||
155212351|NCT01031069|560214357|FG000|Overall Study|Migrated/moved from study area|1|||
155212352|NCT01031069|560214358|FG001|Overall Study|Migrated/moved from study area|2|||
155212353|NCT01031069|560214359|FG002|Overall Study|Migrated/moved from study area|1|||
155212354|NCT01031069|560214360|FG003|Overall Study|Migrated/moved from study area|1|||
155212355|NCT01031069|560214357|FG000|Overall Study|Lost to Follow-up|9|||
155212356|NCT01031069|560214358|FG001|Overall Study|Lost to Follow-up|5|||
155212357|NCT01031069|560214359|FG002|Overall Study|Lost to Follow-up|21|||
155212358|NCT01031069|560214360|FG003|Overall Study|Lost to Follow-up|15|||
155212359|NCT01031069|560214357|FG000|Overall Study|Other|0|||
155212360|NCT01031069|560214358|FG001|Overall Study|Other|0|||
155212361|NCT01031069|560214359|FG002|Overall Study|Other|1|||
155212362|NCT01031069|560214360|FG003|Overall Study|Other|0|||
155212363|NCT00512707|560214361|FG000|Overall Study|Lost to Follow-up|5|||
155212364|NCT00512707|560214362|FG001|Overall Study|Lost to Follow-up|11|||
155212365|NCT00512707|560214361|FG000|Overall Study|Developed skin irritation|2|||
155212366|NCT00512707|560214362|FG001|Overall Study|Developed skin irritation|1|||
155212367|NCT00512707|560214361|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
155212368|NCT00512707|560214362|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
155212369|NCT00512707|560214361|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
155212370|NCT00512707|560214362|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
155212371|NCT01317160|560214363|FG000|Overall Study|Incorrect inclusion|1|||
155212372|NCT01317160|560214364|FG001|Overall Study|Incorrect inclusion|1|||
155212373|NCT01317160|560214363|FG000|Overall Study|Lost to Follow-up|3|||
155212374|NCT01317160|560214364|FG001|Overall Study|Lost to Follow-up|3|||
155212375|NCT01317160|560214363|FG000|Overall Study|Withdrawal by Subject|0|||
155212376|NCT01317160|560214364|FG001|Overall Study|Withdrawal by Subject|2|||
155212377|NCT04405037|560214366|FG000|Overall Study|Withdrawal by Subject|1|||
155212378|NCT04405037|560214367|FG001|Overall Study|Withdrawal by Subject|0|||
155212379|NCT04405037|560214366|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
155212380|NCT04405037|560214367|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
155212381|NCT01853826|560216000|FG000|Overall Study|Patients who switched to commercial drug|11|||
155212382|NCT01853826|560216000|FG000|Overall Study|Patient refused to continue medication|21|||
155212383|NCT01853826|560216000|FG000|Overall Study|Lost to Follow-up|2|||
155212384|NCT01853826|560216000|FG000|Overall Study|Non-compliant with protocol|4|||
155212385|NCT01853826|560216000|FG000|Overall Study|Other adverse events (AE)|62|||
155212386|NCT01853826|560216000|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
155212387|NCT01853826|560216000|FG000|Overall Study|Progressive disease|342|||
155212388|NCT01853826|560216000|FG000|Overall Study|Other than listed|13|||
155212389|NCT01853826|560216000|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
155212390|NCT03653637|560216001|FG000|Overall Study|Death|1|||
155212391|NCT03653637|560216002|FG001|Overall Study|Death|3|||
155212392|NCT03653637|560216001|FG000|Overall Study|Lost to Follow-up|29|||
155212393|NCT03653637|560216002|FG001|Overall Study|Lost to Follow-up|30|||
155212394|NCT03653637|560216001|FG000|Overall Study|Physician Decision|1|||
155212395|NCT03653637|560216002|FG001|Overall Study|Physician Decision|1|||
155212396|NCT03653637|560216001|FG000|Overall Study|Withdrawal by Subject|7|||
155212397|NCT03653637|560216002|FG001|Overall Study|Withdrawal by Subject|4|||
155212398|NCT05661942|560216003|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
155212399|NCT05661942|560216004|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
155212400|NCT01287897|560216013|FG000|Overall Study|Adverse Event|5|||
155212401|NCT01287897|560216014|FG001|Overall Study|Adverse Event|3|||
155212402|NCT01287897|560216015|FG002|Overall Study|Adverse Event|6|||
155212403|NCT01287897|560216016|FG003|Overall Study|Adverse Event|4|||
155212404|NCT01287897|560216013|FG000|Overall Study|Lack of Efficacy|2|||
155212405|NCT01287897|560216014|FG001|Overall Study|Lack of Efficacy|0|||
155212406|NCT01287897|560216015|FG002|Overall Study|Lack of Efficacy|0|||
155212407|NCT01287897|560216016|FG003|Overall Study|Lack of Efficacy|0|||
155212408|NCT01287897|560216013|FG000|Overall Study|Protocol Violation|1|||
155212409|NCT01287897|560216014|FG001|Overall Study|Protocol Violation|1|||
155212410|NCT01287897|560216015|FG002|Overall Study|Protocol Violation|0|||
155212411|NCT01287897|560216016|FG003|Overall Study|Protocol Violation|1|||
155212412|NCT01287897|560216013|FG000|Overall Study|Lost to Follow-up|0|||
155212413|NCT01287897|560216014|FG001|Overall Study|Lost to Follow-up|0|||
155212414|NCT01287897|560216015|FG002|Overall Study|Lost to Follow-up|2|||
155212415|NCT01287897|560216016|FG003|Overall Study|Lost to Follow-up|0|||
155212416|NCT01287897|560216013|FG000|Overall Study|Withdrawal by Subject|1|||
155212417|NCT01287897|560216014|FG001|Overall Study|Withdrawal by Subject|5|||
155212418|NCT01287897|560216015|FG002|Overall Study|Withdrawal by Subject|3|||
155212419|NCT01287897|560216016|FG003|Overall Study|Withdrawal by Subject|2|||
155212420|NCT01287897|560216013|FG000|Overall Study|Not consented properly|0|||
155212421|NCT01287897|560216014|FG001|Overall Study|Not consented properly|1|||
155212422|NCT01287897|560216015|FG002|Overall Study|Not consented properly|0|||
155212423|NCT01287897|560216016|FG003|Overall Study|Not consented properly|0|||
155212424|NCT01287897|560216013|FG000|Overall Study|Not meeting entrance criteria|1|||
155212425|NCT01287897|560216014|FG001|Overall Study|Not meeting entrance criteria|1|||
155212426|NCT01287897|560216015|FG002|Overall Study|Not meeting entrance criteria|0|||
155212427|NCT01287897|560216016|FG003|Overall Study|Not meeting entrance criteria|0|||
155212428|NCT01287897|560216013|FG000|Overall Study|Other|1|||
155212429|NCT01287897|560216014|FG001|Overall Study|Other|0|||
155212430|NCT01287897|560216015|FG002|Overall Study|Other|1|||
155212431|NCT01287897|560216016|FG003|Overall Study|Other|0|||
155212432|NCT02902965|560216017|FG000|Overall Study|Withdrawal by Subject|10|||
155212433|NCT03263442|560216018|FG000|Inpatient Phase|Death|1|||
155212434|NCT03263442|560216019|FG001|Inpatient Phase|Death|0|||
155212435|NCT03263442|560216018|FG000|Inpatient Phase|Withdrawal by Subject|1|||
155212436|NCT03263442|560216019|FG001|Inpatient Phase|Withdrawal by Subject|0|||
155212437|NCT03263442|560216018|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
155212438|NCT03263442|560216019|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
155212439|NCT03263442|560216018|FG000|1-month Follow-Up|Lost to Follow-up|1|||
155212440|NCT03263442|560216019|FG001|1-month Follow-Up|Lost to Follow-up|0|||
155212441|NCT03263442|560216018|FG000|3-month Follow-Up|Lost to Follow-up|1|||
155212442|NCT03263442|560216019|FG001|3-month Follow-Up|Lost to Follow-up|3|||
155212443|NCT03263442|560216018|FG000|6-month Follow-Up|Lost to Follow-up|2|||
155212444|NCT03263442|560216019|FG001|6-month Follow-Up|Lost to Follow-up|2|||
155212445|NCT02436889|560216020|FG000|Overall Study|No improvement in symptoms|1|||
155212446|NCT02436889|560216021|FG001|Overall Study|No improvement in symptoms|0|||
155212447|NCT02436889|560216020|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
155212448|NCT02436889|560216021|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
155212449|NCT01084174|560216022|FG000|Overall Study|gastrointestinal symptoms|1|||
155212450|NCT01084174|560216023|FG001|Overall Study|gastrointestinal symptoms|1|||
155212451|NCT01084174|560216022|FG000|Overall Study|Eosinophilic esophagitis|0|||
155212452|NCT01084174|560216023|FG001|Overall Study|Eosinophilic esophagitis|1|||
155212453|NCT01084174|560216022|FG000|Overall Study|Anaphylaxis|0|||
155212454|NCT01084174|560216023|FG001|Overall Study|Anaphylaxis|1|||
155212455|NCT01084174|560216022|FG000|Overall Study|Participant noncompliance|0|||
155212456|NCT01084174|560216023|FG001|Overall Study|Participant noncompliance|1|||
155212457|NCT00708643|560216024|FG000|Overall Study|Adverse Event|0|||
155212458|NCT00708643|560216025|FG001|Overall Study|Adverse Event|1|||
155212459|NCT01946425|560216027|FG000|Overall Study|Protocol Violation|1|||
155212460|NCT01946425|560216028|FG001|Overall Study|Protocol Violation|0|||
155212461|NCT01946425|560216027|FG000|Overall Study|Withdrawal by Subject|1|||
155212462|NCT01946425|560216028|FG001|Overall Study|Withdrawal by Subject|0|||
155212463|NCT05682326|560216034|FG000|Overall Study|Withdrawal by Subject|1|||
155212464|NCT05682326|560216035|FG001|Overall Study|Withdrawal by Subject|0|||
155212465|NCT03414424|560216036|FG000|Overall Study|Screened out after consent|0|||
155212466|NCT03414424|560216037|FG001|Overall Study|Screened out after consent|2|||
155212467|NCT03414424|560216036|FG000|Overall Study|Lost to Follow-up|0|||
155212468|NCT03414424|560216037|FG001|Overall Study|Lost to Follow-up|1|||
155212469|NCT01506479|560216042|FG000|Overall Study|Lost to Follow-up|1|||
155212470|NCT01506479|560216043|FG001|Overall Study|Lost to Follow-up|2|||
155212471|NCT01506479|560216044|FG002|Overall Study|Lost to Follow-up|2|||
155212472|NCT01506479|560216042|FG000|Overall Study|Withdrawal by Subject|1|||
155212473|NCT01506479|560216043|FG001|Overall Study|Withdrawal by Subject|2|||
155212474|NCT01506479|560216044|FG002|Overall Study|Withdrawal by Subject|1|||
155212475|NCT01506479|560216042|FG000|Overall Study|Missing assessment|1|||
155212476|NCT01506479|560216043|FG001|Overall Study|Missing assessment|0|||
155212477|NCT01506479|560216044|FG002|Overall Study|Missing assessment|0|||
155212478|NCT01506479|560216042|FG000|Overall Study|Adverse Event|0|||
155212479|NCT01506479|560216043|FG001|Overall Study|Adverse Event|1|||
155212480|NCT01506479|560216044|FG002|Overall Study|Adverse Event|0|||
155212481|NCT01846507|560216045|FG000|Overall Study|Lost to Follow-up|4|||
155212482|NCT01846507|560216045|FG000|Overall Study|Protocol Violation|1|||
155212483|NCT01846507|560216045|FG000|Overall Study|Missing data|2|||
155212484|NCT01314443|560216046|FG000|Overall Study|Withdrawal by Subject|2|||
155212485|NCT01314443|560216047|FG001|Overall Study|Withdrawal by Subject|1|||
155212486|NCT01314443|560216048|FG002|Overall Study|Withdrawal by Subject|1|||
155212487|NCT01314443|560216049|FG003|Overall Study|Withdrawal by Subject|1|||
155212488|NCT01314443|560216046|FG000|Overall Study|Protocol Violation|2|||
155212489|NCT01314443|560216047|FG001|Overall Study|Protocol Violation|2|||
155212490|NCT01314443|560216048|FG002|Overall Study|Protocol Violation|1|||
155212491|NCT01314443|560216049|FG003|Overall Study|Protocol Violation|1|||
155212492|NCT04545866|560216051|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
155212493|NCT04545866|560216052|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
155212494|NCT04545866|560216051|FG000|Overall Study|Withdrawal by Physician|1|||
155212495|NCT04545866|560216052|FG001|Overall Study|Withdrawal by Physician|0|||
155212496|NCT05247866|560216053|FG000|Overall Study|Adverse Event|2|||
155212497|NCT05247866|560216053|FG000|Overall Study|Lack of Efficacy|1|||
155212498|NCT05247866|560216053|FG000|Overall Study|Protocol Violation|1|||
155212499|NCT05247866|560216053|FG000|Overall Study|Withdrawal by Subject|3|||
155212500|NCT04463719|560216058|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
155212501|NCT04463719|560216059|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
155212502|NCT04463719|560216060|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
155212503|NCT04577118|560216061|FG000|Overall Study|Withdrawal by Subject|4|||
155212504|NCT00810407|560216062|FG000|Overall Study|Protocol Violation|3|||
155212505|NCT00810407|560216062|FG000|Overall Study|No Visit After First Day of Treatment|3|||
155212506|NCT02746874|560216063|FG000|Overall Study|Withdrawal by Subject|0|||
155212507|NCT02746874|560216064|FG001|Overall Study|Withdrawal by Subject|1|||
155212508|NCT02746874|560216063|FG000|Overall Study|Surgery Date Changed|0|||
155212509|NCT02746874|560216064|FG001|Overall Study|Surgery Date Changed|2|||
155212510|NCT00487747|560216065|FG000|Overall Study|Adverse Event|1|||
155212511|NCT00487747|560216065|FG000|Overall Study|Lost to Follow-up|9|||
155212512|NCT00487747|560216065|FG000|Overall Study|Lack of Efficacy|1|||
155212513|NCT00276159|560216066|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
155212514|NCT01359449|560216069|FG000|Overall Study|Lost to Follow-up|1|||
155212515|NCT01359449|560216070|FG001|Overall Study|Lost to Follow-up|0|||
155212516|NCT01359449|560216069|FG000|Overall Study|Protocol Violation|0|||
155212517|NCT01359449|560216070|FG001|Overall Study|Protocol Violation|2|||
155212518|NCT01359449|560216069|FG000|Overall Study|Withdrawal by Subject|3|||
155212519|NCT01359449|560216070|FG001|Overall Study|Withdrawal by Subject|2|||
155212520|NCT02979522|560216077|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
155212521|NCT02979522|560216078|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
155212522|NCT02979522|560216077|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
155212523|NCT02979522|560216078|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
155212524|NCT02485574|560216081|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
155212525|NCT01408914|560216082|FG000|Overall Study|Could not complete tx in protocol period|5|||
155212526|NCT01408914|560216083|FG001|Overall Study|Could not complete tx in protocol period|5|||
155212527|NCT01408914|560216084|FG002|Overall Study|Could not complete tx in protocol period|6|||
155212528|NCT01408914|560216082|FG000|Overall Study|Lost to Follow-up|4|||
155212529|NCT01408914|560216083|FG001|Overall Study|Lost to Follow-up|1|||
155212530|NCT01408914|560216084|FG002|Overall Study|Lost to Follow-up|2|||
155212531|NCT01408914|560216082|FG000|Overall Study|Physician Decision|1|||
155212532|NCT01408914|560216083|FG001|Overall Study|Physician Decision|1|||
155212533|NCT01408914|560216084|FG002|Overall Study|Physician Decision|0|||
155212534|NCT01408914|560216082|FG000|Overall Study|Withdrawal by Subject|1|||
155212535|NCT01408914|560216083|FG001|Overall Study|Withdrawal by Subject|0|||
155212536|NCT01408914|560216084|FG002|Overall Study|Withdrawal by Subject|1|||
155212537|NCT01408914|560216082|FG000|Overall Study|Moved out of study jurisdiction|1|||
155212538|NCT01408914|560216083|FG001|Overall Study|Moved out of study jurisdiction|1|||
155212539|NCT01408914|560216084|FG002|Overall Study|Moved out of study jurisdiction|0|||
155212540|NCT01408914|560216082|FG000|Overall Study|Late exclusion|0|||
155212541|NCT01408914|560216083|FG001|Overall Study|Late exclusion|3|||
155212542|NCT01408914|560216084|FG002|Overall Study|Late exclusion|3|||
155212543|NCT01408914|560216082|FG000|Overall Study|Change in local TB/HIV norms|0|||
155212544|NCT01408914|560216083|FG001|Overall Study|Change in local TB/HIV norms|1|||
155212545|NCT01408914|560216084|FG002|Overall Study|Change in local TB/HIV norms|1|||
155212546|NCT00191789|560216087|FG000|Overall Study|Adverse Event|5|||
155212547|NCT00191789|560216087|FG000|Overall Study|Patient: Satisfactory Response|5|||
155212548|NCT00191789|560216087|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
155212549|NCT00191789|560216087|FG000|Overall Study|Withdrawal by Subject|4|||
155212550|NCT00191789|560216087|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
155212551|NCT00191789|560216087|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
155212552|NCT00191789|560216087|FG000|Overall Study|Death - Not Study-Drug Related|1|||
155212553|NCT05582889|560216088|FG000|Overall Study|Health event|3|||
155212554|NCT05582889|560216089|FG001|Overall Study|Health event|2|||
155212555|NCT05582889|560216088|FG000|Overall Study|Lost to Follow-up|2|||
155212556|NCT05582889|560216089|FG001|Overall Study|Lost to Follow-up|4|||
155212557|NCT06112756|560216090|FG000|Overall Study|Withdrawal by Subject|0|||
155212558|NCT06112756|560216091|FG001|Overall Study|Withdrawal by Subject|2|||
155212559|NCT06112756|560216090|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
155212560|NCT06112756|560216091|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
155212561|NCT06112756|560216090|FG000|Overall Study|Adverse Event|2|||
155212562|NCT06112756|560216091|FG001|Overall Study|Adverse Event|2|||
155212563|NCT04551092|560216092|FG000|Overall Study|Lost to Follow-up|7|||
155212564|NCT04551092|560216092|FG000|Overall Study|Withdrawal by Subject|4|||
155212565|NCT03060629|560216095|FG000|Overall Study|Death|4|||
155212566|NCT03060629|560216096|FG001|Overall Study|Death|5|||
155212567|NCT03060629|560216095|FG000|Overall Study|Withdrawal by Subject|50|||
155212568|NCT03060629|560216096|FG001|Overall Study|Withdrawal by Subject|35|||
155212569|NCT03060629|560216095|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
155212570|NCT03060629|560216096|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
155212571|NCT03060629|560216095|FG000|Overall Study|Participant Relocate|15|||
155212572|NCT03060629|560216096|FG001|Overall Study|Participant Relocate|15|||
155212573|NCT03060629|560216095|FG000|Overall Study|Unable to Contact Participant|34|||
155212574|NCT03060629|560216096|FG001|Overall Study|Unable to Contact Participant|23|||
155212575|NCT03060629|560216095|FG000|Overall Study|Investigator Decision|7|||
155212576|NCT03060629|560216096|FG001|Overall Study|Investigator Decision|7|||
155212577|NCT03060629|560216095|FG000|Overall Study|Study Terminated by Sponsor|1100|||
155212578|NCT03060629|560216096|FG001|Overall Study|Study Terminated by Sponsor|1123|||
155212579|NCT03060629|560216095|FG000|Overall Study|Other|4|||
155212580|NCT03060629|560216096|FG001|Overall Study|Other|4|||
155212581|NCT00867009|560216102|FG000|Induction Period|Nonserious Adverse Event|5|||
155212582|NCT00867009|560216102|FG000|Induction Period|Serious Adverse Event|10|||
155212583|NCT00867009|560216102|FG000|Induction Period|Death due to serious adverse event|6|||
155212584|NCT00867009|560216102|FG000|Induction Period|Death due to Study Disease|4|||
155212585|NCT00867009|560216102|FG000|Induction Period|Protocol Violation|1|||
155212586|NCT00867009|560216102|FG000|Induction Period|Withdrawal by Subject|8|||
155212587|NCT00867009|560216102|FG000|Induction Period|Physician Decision|3|||
155212588|NCT00867009|560216102|FG000|Induction Period|Progressive Disease (PD)|25|||
155212589|NCT00867009|560216102|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
155212590|NCT03266094|560216103|FG000|Overall Study|Lost to Follow-up|1|||
155212591|NCT03266094|560216103|FG000|Overall Study|Withdrawal by Subject|1|||
155212592|NCT04140292|560216112|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
155212593|NCT04140292|560216113|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
155212594|NCT00396591|560216114|FG000|Overall Study|Disease Progression|13|||
155212595|NCT00396591|560216114|FG000|Overall Study|Adverse Event|2|||
155212596|NCT00396591|560216114|FG000|Overall Study|Participant request|1|||
155212597|NCT03036072|560216120|FG000|Overall Study|Death|0|||
155212598|NCT03036072|560216121|FG001|Overall Study|Death|1|||
155212599|NCT03036072|560216120|FG000|Overall Study|Withdrawal by Subject|0|||
155212600|NCT03036072|560216121|FG001|Overall Study|Withdrawal by Subject|1|||
155212601|NCT03036072|560216120|FG000|Overall Study|Physician Decision|0|||
155212602|NCT03036072|560216121|FG001|Overall Study|Physician Decision|1|||
155212603|NCT00680043|560216122|FG000|Overall Study|Withdrawal by Subject|1|||
155212604|NCT00680043|560216123|FG001|Overall Study|Withdrawal by Subject|0|||
155212605|NCT00680043|560216124|FG002|Overall Study|Withdrawal by Subject|0|||
155212606|NCT00680043|560216122|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
155212607|NCT00680043|560216123|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
155212608|NCT00680043|560216124|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
155212609|NCT00680043|560216122|FG000|Overall Study|Renal Transplant|1|||
155212610|NCT00680043|560216123|FG001|Overall Study|Renal Transplant|0|||
155212611|NCT00680043|560216124|FG002|Overall Study|Renal Transplant|4|||
155212612|NCT02484729|560216125|FG000|Overall Study|Failure of IntelliCap Error|0|||
155212613|NCT02484729|560216126|FG001|Overall Study|Failure of IntelliCap Error|0|||
155212614|NCT02484729|560216127|FG002|Overall Study|Failure of IntelliCap Error|0|||
155212615|NCT02484729|560216128|FG003|Overall Study|Failure of IntelliCap Error|0|||
155212616|NCT02484729|560216129|FG004|Overall Study|Failure of IntelliCap Error|0|||
155212617|NCT02484729|560216130|FG005|Overall Study|Failure of IntelliCap Error|0|||
155212618|NCT02484729|560216131|FG006|Overall Study|Failure of IntelliCap Error|0|||
155212619|NCT02484729|560216132|FG007|Overall Study|Failure of IntelliCap Error|0|||
155212620|NCT02484729|560216133|FG008|Overall Study|Failure of IntelliCap Error|0|||
155212621|NCT02484729|560216134|FG009|Overall Study|Failure of IntelliCap Error|1|||
155212622|NCT00662363|560216135|FG000|Overall Study|Withdrawal by Subject|6|||
155212623|NCT00662363|560216136|FG001|Overall Study|Withdrawal by Subject|5|||
155212624|NCT00662363|560216135|FG000|Overall Study|Adverse Event|0|||
155212625|NCT00662363|560216136|FG001|Overall Study|Adverse Event|3|||
155212626|NCT00662363|560216135|FG000|Overall Study|Discharged early from rehab|4|||
155212627|NCT00662363|560216136|FG001|Overall Study|Discharged early from rehab|1|||
155212628|NCT00662363|560216135|FG000|Overall Study|Protocol Violation|1|||
155212629|NCT00662363|560216136|FG001|Overall Study|Protocol Violation|1|||
155212630|NCT05119569|560216137|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
155212631|NCT05119569|560216138|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
155212632|NCT05119569|560216139|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155212633|NCT05119569|560216140|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155212634|NCT05119569|560216137|FG000|Double Blind Treatment Phase|Adverse Event|6|||
155212635|NCT05119569|560216138|FG001|Double Blind Treatment Phase|Adverse Event|0|||
155212636|NCT05119569|560216139|FG002|Double Blind Treatment Phase|Adverse Event|0|||
155212637|NCT05119569|560216140|FG003|Double Blind Treatment Phase|Adverse Event|0|||
155212638|NCT05119569|560216137|FG000|Open Label Extension Phase|Ongoing in the study|0|||
155212639|NCT05119569|560216138|FG001|Open Label Extension Phase|Ongoing in the study|0|||
155212640|NCT05119569|560216139|FG002|Open Label Extension Phase|Ongoing in the study|65|||
155212641|NCT05119569|560216140|FG003|Open Label Extension Phase|Ongoing in the study|34|||
155212642|NCT03334903|560216141|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
155212643|NCT03334903|560216142|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
155212644|NCT03334903|560216141|FG000|Overall Study|Protocol Violation|1|||
155212645|NCT03334903|560216142|FG001|Overall Study|Protocol Violation|3|||
155212646|NCT03334903|560216141|FG000|Overall Study|Surgery postponed|1|||
155212647|NCT03334903|560216142|FG001|Overall Study|Surgery postponed|0|||
155212648|NCT03334903|560216141|FG000|Overall Study|Adverse Event|1|||
155212649|NCT03334903|560216142|FG001|Overall Study|Adverse Event|1|||
155212650|NCT03334903|560216141|FG000|Overall Study|Withdrawal by Subject|0|||
155212651|NCT03334903|560216142|FG001|Overall Study|Withdrawal by Subject|1|||
155212652|NCT02081690|560217447|FG000|Overall Study|Death|3|||
155212653|NCT02081690|560217447|FG000|Overall Study|Physician Decision|3|||
155212654|NCT02081690|560217447|FG000|Overall Study|Withdrawal by Subject|1|||
155212655|NCT01463878|560217451|FG000|Overall Study|no longer met criteria for tube feed|2|||
155212656|NCT01463878|560217452|FG001|Overall Study|no longer met criteria for tube feed|2|||
155212657|NCT01034462|560217453|FG000|Overall Study|Adverse Event|7|||
155212658|NCT01034462|560217454|FG001|Overall Study|Adverse Event|17|||
155212659|NCT01034462|560217453|FG000|Overall Study|Lack of Efficacy|4|||
155212660|NCT01034462|560217454|FG001|Overall Study|Lack of Efficacy|4|||
155212661|NCT01034462|560217453|FG000|Overall Study|Protocol Violation|10|||
155212662|NCT01034462|560217454|FG001|Overall Study|Protocol Violation|7|||
155212663|NCT01034462|560217453|FG000|Overall Study|Withdrawal by Subject|9|||
155212664|NCT01034462|560217454|FG001|Overall Study|Withdrawal by Subject|8|||
155212665|NCT01034462|560217453|FG000|Overall Study|Lost to Follow-up|14|||
155212666|NCT01034462|560217454|FG001|Overall Study|Lost to Follow-up|16|||
155212667|NCT01034462|560217453|FG000|Overall Study|Other reasons|1|||
155212668|NCT01034462|560217454|FG001|Overall Study|Other reasons|2|||
155212669|NCT01594125|560217455|FG000|Overall Study|Withdrawal by Subject|1|||
155212670|NCT01594125|560217456|FG001|Overall Study|Withdrawal by Subject|0|||
155212671|NCT01594125|560217457|FG002|Overall Study|Withdrawal by Subject|0|||
155212672|NCT01594125|560217458|FG003|Overall Study|Withdrawal by Subject|1|||
155212673|NCT01594125|560217459|FG004|Overall Study|Withdrawal by Subject|0|||
155212674|NCT01594125|560217455|FG000|Overall Study|Progressive Disease|3|||
155212675|NCT01594125|560217456|FG001|Overall Study|Progressive Disease|12|||
155212676|NCT01594125|560217457|FG002|Overall Study|Progressive Disease|3|||
155212677|NCT01594125|560217458|FG003|Overall Study|Progressive Disease|3|||
155212678|NCT01594125|560217459|FG004|Overall Study|Progressive Disease|7|||
155212679|NCT01475331|560217462|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
155212680|NCT01475331|560217463|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
155212681|NCT01475331|560217462|FG000|Overall Study|excessive main duct communication|1|||
155212682|NCT01475331|560217463|FG001|Overall Study|excessive main duct communication|1|||
155212683|NCT01475331|560217462|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
155212684|NCT01475331|560217463|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
155212685|NCT01475331|560217462|FG000|Overall Study|Sign of malignancy during the procedure|2|||
155212686|NCT01475331|560217463|FG001|Overall Study|Sign of malignancy during the procedure|0|||
155212687|NCT01475331|560217462|FG000|Overall Study|cyst found to be prohibitively small|0|||
155212688|NCT01475331|560217463|FG001|Overall Study|cyst found to be prohibitively small|1|||
155212689|NCT00462761|560217464|FG000|Overall Study|Adverse Event|6|||
155212690|NCT00462761|560217464|FG000|Overall Study|Withdrawal by Subject|9|||
155212691|NCT00462761|560217464|FG000|Overall Study|Physician Decision|5|||
155212692|NCT00462761|560217464|FG000|Overall Study|Disease progression|43|||
155212693|NCT00462761|560217464|FG000|Overall Study|Death|12|||
155212694|NCT00462761|560217464|FG000|Overall Study|Other|1|||
155212695|NCT02877082|560217465|FG000|Overall Study|Trial was closed early|5|||
155212696|NCT01949051|560217466|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
155212697|NCT01949051|560217467|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212698|NCT01949051|560217468|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212699|NCT01949051|560217469|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
155212700|NCT01949051|560217470|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212701|NCT01949051|560217471|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212702|NCT01949051|560217466|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
155212703|NCT01949051|560217467|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212704|NCT01949051|560217468|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212705|NCT01949051|560217469|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212706|NCT01949051|560217470|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212707|NCT01949051|560217471|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212708|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212709|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212710|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212711|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212712|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212713|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
155212714|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212715|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
155212716|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212717|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212718|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212719|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212720|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212721|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212722|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
155212723|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212724|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212725|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212726|NCT01782859|560217472|FG000|Overall Study|Protocol Violation|6|||
155212727|NCT01782859|560217473|FG001|Overall Study|Protocol Violation|6|||
155212728|NCT01782859|560217472|FG000|Overall Study|Withdrawal by Subject|0|||
155212729|NCT01782859|560217473|FG001|Overall Study|Withdrawal by Subject|1|||
155212730|NCT02436356|560217474|FG000|Overall Study|Excluded by MRI Screening|0|||
155212731|NCT02436356|560217475|FG001|Overall Study|Excluded by MRI Screening|0|||
155212732|NCT02436356|560217476|FG002|Overall Study|Excluded by MRI Screening|2|||
155212733|NCT02436356|560217474|FG000|Overall Study|Lost to Follow-up|0|||
155212734|NCT02436356|560217475|FG001|Overall Study|Lost to Follow-up|1|||
155212735|NCT02436356|560217476|FG002|Overall Study|Lost to Follow-up|0|||
155212736|NCT02436356|560217474|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
155212737|NCT02436356|560217475|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
155212738|NCT02436356|560217476|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
155212739|NCT02436356|560217474|FG000|Overall Study|Excluded due to other medical conditions|3|||
155212740|NCT02436356|560217475|FG001|Overall Study|Excluded due to other medical conditions|0|||
155212741|NCT02436356|560217476|FG002|Overall Study|Excluded due to other medical conditions|0|||
155212742|NCT02436356|560217474|FG000|Overall Study|Withdrawal by Subject|1|||
155212743|NCT02436356|560217475|FG001|Overall Study|Withdrawal by Subject|0|||
155212744|NCT02436356|560217476|FG002|Overall Study|Withdrawal by Subject|0|||
155212745|NCT04483011|560217477|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155212746|NCT04483011|560217478|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
155212747|NCT00429104|560217481|FG000|Overall Study|Protocol Violation|1|||
155212748|NCT01896531|560217484|FG000|Overall Study|Death|57|||
155212749|NCT01896531|560217485|FG001|Overall Study|Death|59|||
155212750|NCT01896531|560217484|FG000|Overall Study|Lost to Follow-up|3|||
155212751|NCT01896531|560217485|FG001|Overall Study|Lost to Follow-up|0|||
155212752|NCT01896531|560217484|FG000|Overall Study|Non-compliance|0|||
155212753|NCT01896531|560217485|FG001|Overall Study|Non-compliance|1|||
155212754|NCT01896531|560217484|FG000|Overall Study|Study Ended by Sponsor|7|||
155212755|NCT01896531|560217485|FG001|Overall Study|Study Ended by Sponsor|20|||
155212756|NCT01896531|560217484|FG000|Overall Study|Withdrawal by Subject|3|||
155212757|NCT01896531|560217485|FG001|Overall Study|Withdrawal by Subject|2|||
155212758|NCT01896531|560217484|FG000|Overall Study|Death Prior to Treatment|1|||
155212759|NCT01896531|560217485|FG001|Overall Study|Death Prior to Treatment|0|||
155212760|NCT02956486|560217486|FG000|Core Phase|Adverse Event|51|||
155212761|NCT02956486|560217487|FG001|Core Phase|Adverse Event|88|||
155212762|NCT02956486|560217488|FG002|Core Phase|Adverse Event|0|||
155212763|NCT02956486|560217486|FG000|Core Phase|Lost to Follow-up|8|||
155212764|NCT02956486|560217487|FG001|Core Phase|Lost to Follow-up|6|||
155212765|NCT02956486|560217488|FG002|Core Phase|Lost to Follow-up|0|||
155212766|NCT02956486|560217486|FG000|Core Phase|Inadequate therapeutic effect|4|||
155212767|NCT02956486|560217487|FG001|Core Phase|Inadequate therapeutic effect|5|||
155212768|NCT02956486|560217488|FG002|Core Phase|Inadequate therapeutic effect|0|||
155212769|NCT02956486|560217486|FG000|Core Phase|Withdrawal by Subject|101|||
155212770|NCT02956486|560217487|FG001|Core Phase|Withdrawal by Subject|104|||
155212771|NCT02956486|560217488|FG002|Core Phase|Withdrawal by Subject|0|||
155212772|NCT02956486|560217486|FG000|Core Phase|Study terminated by sponsor|888|||
155212773|NCT02956486|560217487|FG001|Core Phase|Study terminated by sponsor|848|||
155212774|NCT02956486|560217488|FG002|Core Phase|Study terminated by sponsor|0|||
155212775|NCT02956486|560217486|FG000|Core Phase|Other|27|||
155212776|NCT02956486|560217487|FG001|Core Phase|Other|18|||
155212777|NCT02956486|560217488|FG002|Core Phase|Other|0|||
155212778|NCT02956486|560217486|FG000|Core Phase|Not treated|0|||
155212779|NCT02956486|560217487|FG001|Core Phase|Not treated|3|||
155212780|NCT02956486|560217488|FG002|Core Phase|Not treated|0|||
155212781|NCT02956486|560217486|FG000|Extension Phase|Adverse Event|0|||
155212782|NCT02956486|560217487|FG001|Extension Phase|Adverse Event|0|||
155212783|NCT02956486|560217488|FG002|Extension Phase|Adverse Event|2|||
155212784|NCT02956486|560217486|FG000|Extension Phase|Study terminated by sponsor|0|||
155212785|NCT02956486|560217487|FG001|Extension Phase|Study terminated by sponsor|0|||
155212786|NCT02956486|560217488|FG002|Extension Phase|Study terminated by sponsor|16|||
155212787|NCT02956486|560217486|FG000|Extension Phase|Not Treated|0|||
155212788|NCT02956486|560217487|FG001|Extension Phase|Not Treated|0|||
155212789|NCT02956486|560217488|FG002|Extension Phase|Not Treated|1|||
155212790|NCT00680745|560217489|FG000|Overall Study|Withdrawal by Subject|8|||
155212791|NCT00680745|560217490|FG001|Overall Study|Withdrawal by Subject|3|||
155212792|NCT00680745|560217491|FG002|Overall Study|Withdrawal by Subject|2|||
155212793|NCT00680745|560217492|FG003|Overall Study|Withdrawal by Subject|8|||
155212794|NCT00680745|560217489|FG000|Overall Study|Lost to Follow-up|0|||
155212795|NCT00680745|560217490|FG001|Overall Study|Lost to Follow-up|1|||
155212796|NCT00680745|560217491|FG002|Overall Study|Lost to Follow-up|1|||
155212797|NCT00680745|560217492|FG003|Overall Study|Lost to Follow-up|0|||
155212798|NCT00680745|560217489|FG000|Overall Study|Death|1|||
155212799|NCT00680745|560217490|FG001|Overall Study|Death|0|||
155212800|NCT00680745|560217491|FG002|Overall Study|Death|1|||
155212801|NCT00680745|560217492|FG003|Overall Study|Death|0|||
155212802|NCT00680745|560217489|FG000|Overall Study|Adverse Event|5|||
155212803|NCT00680745|560217490|FG001|Overall Study|Adverse Event|3|||
155212804|NCT00680745|560217491|FG002|Overall Study|Adverse Event|3|||
155212805|NCT00680745|560217492|FG003|Overall Study|Adverse Event|3|||
155212806|NCT00680745|560217489|FG000|Overall Study|Poor/Non-compliance|0|||
155212807|NCT00680745|560217490|FG001|Overall Study|Poor/Non-compliance|3|||
155212808|NCT00680745|560217491|FG002|Overall Study|Poor/Non-compliance|0|||
155212809|NCT00680745|560217492|FG003|Overall Study|Poor/Non-compliance|0|||
155212810|NCT00680745|560217489|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155212811|NCT00680745|560217490|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
155212812|NCT00680745|560217491|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
155212813|NCT00680745|560217492|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
155212814|NCT00680745|560217489|FG000|Overall Study|False Treatment|0|||
155212815|NCT00680745|560217490|FG001|Overall Study|False Treatment|1|||
155212816|NCT00680745|560217491|FG002|Overall Study|False Treatment|3|||
155212817|NCT00680745|560217492|FG003|Overall Study|False Treatment|0|||
155212818|NCT04851314|560217497|FG000|Overall Study|Unable to complete research set-up procedures|0|||
155212819|NCT04851314|560217498|FG001|Overall Study|Unable to complete research set-up procedures|2|||
155212820|NCT04851314|560217497|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
155212821|NCT04851314|560217498|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
155212822|NCT03171415|560217499|FG000|Overall Study|Lost to Follow-up|0|||
155212823|NCT03171415|560217500|FG001|Overall Study|Lost to Follow-up|0|||
155212824|NCT03171415|560217501|FG002|Overall Study|Lost to Follow-up|0|||
155212825|NCT03171415|560217502|FG003|Overall Study|Lost to Follow-up|0|||
155212826|NCT03171415|560217503|FG004|Overall Study|Lost to Follow-up|2|||
155212827|NCT01339429|560217504|FG000|Overall Study|Withdrawal by Subject|1|||
155212828|NCT01339429|560217504|FG000|Overall Study|Physician Decision|3|||
155212829|NCT01085591|560217505|FG000|Overall Study|Adverse Event|0|||
155212830|NCT01085591|560217506|FG001|Overall Study|Adverse Event|1|||
155212831|NCT01085591|560217507|FG002|Overall Study|Adverse Event|3|||
155212832|NCT01085591|560217505|FG000|Overall Study|Physician Decision|1|||
155212833|NCT01085591|560217506|FG001|Overall Study|Physician Decision|0|||
155212834|NCT01085591|560217507|FG002|Overall Study|Physician Decision|1|||
155212835|NCT01085591|560217505|FG000|Overall Study|Withdrawal by Subject|0|||
155212836|NCT01085591|560217506|FG001|Overall Study|Withdrawal by Subject|2|||
155212837|NCT01085591|560217507|FG002|Overall Study|Withdrawal by Subject|1|||
155212838|NCT01085591|560217505|FG000|Overall Study|Lost to Follow-up|0|||
155212839|NCT01085591|560217506|FG001|Overall Study|Lost to Follow-up|1|||
155212840|NCT01085591|560217507|FG002|Overall Study|Lost to Follow-up|1|||
155212841|NCT01085591|560217505|FG000|Overall Study|Protocol Violation|1|||
155212842|NCT01085591|560217506|FG001|Overall Study|Protocol Violation|1|||
155212843|NCT01085591|560217507|FG002|Overall Study|Protocol Violation|1|||
155212844|NCT01085591|560217505|FG000|Overall Study|Other|0|||
155212845|NCT01085591|560217506|FG001|Overall Study|Other|1|||
155212846|NCT01085591|560217507|FG002|Overall Study|Other|0|||
155212847|NCT01085591|560217505|FG000|Overall Study|Not Properly Consented|1|||
155212848|NCT01085591|560217506|FG001|Overall Study|Not Properly Consented|0|||
155212849|NCT01085591|560217507|FG002|Overall Study|Not Properly Consented|0|||
155212850|NCT00459667|560217510|FG000|Overall Study|Adverse Event|9|||
155212851|NCT00459667|560217511|FG001|Overall Study|Adverse Event|12|||
155212852|NCT00459667|560217512|FG002|Overall Study|Adverse Event|8|||
155212853|NCT00459667|560217510|FG000|Overall Study|Lost to Follow-up|5|||
155212854|NCT00459667|560217511|FG001|Overall Study|Lost to Follow-up|9|||
155212855|NCT00459667|560217512|FG002|Overall Study|Lost to Follow-up|3|||
155212856|NCT00459667|560217510|FG000|Overall Study|Pregnancy|1|||
155212857|NCT00459667|560217511|FG001|Overall Study|Pregnancy|1|||
155212858|NCT00459667|560217512|FG002|Overall Study|Pregnancy|1|||
155212859|NCT00459667|560217510|FG000|Overall Study|Protocol Violation|1|||
155212860|NCT00459667|560217511|FG001|Overall Study|Protocol Violation|0|||
155212861|NCT00459667|560217512|FG002|Overall Study|Protocol Violation|0|||
155212862|NCT00459667|560217510|FG000|Overall Study|Withdrawal by Subject|3|||
155212863|NCT00459667|560217511|FG001|Overall Study|Withdrawal by Subject|5|||
155212864|NCT00459667|560217512|FG002|Overall Study|Withdrawal by Subject|5|||
155212865|NCT00459667|560217510|FG000|Overall Study|Other disease modifying treatment|1|||
155212866|NCT00459667|560217511|FG001|Overall Study|Other disease modifying treatment|2|||
155212867|NCT00459667|560217512|FG002|Overall Study|Other disease modifying treatment|1|||
155212868|NCT00459667|560217510|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
155212869|NCT00459667|560217511|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
155212870|NCT00459667|560217512|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
155212871|NCT00459667|560217510|FG000|Overall Study|No treatment administered|6|||
155212872|NCT00459667|560217511|FG001|Overall Study|No treatment administered|3|||
155212873|NCT00459667|560217512|FG002|Overall Study|No treatment administered|1|||
155212874|NCT01013701|560217513|FG000|Overall Study|study prematurely terminated|7|||
155212875|NCT03241342|560217514|FG000|Overall Study|Adverse Event|5|||
155212876|NCT03241342|560217515|FG001|Overall Study|Adverse Event|8|||
155212877|NCT03241342|560217516|FG002|Overall Study|Adverse Event|4|||
155212878|NCT03241342|560217514|FG000|Overall Study|Lack of Efficacy|0|||
155212879|NCT03241342|560217515|FG001|Overall Study|Lack of Efficacy|0|||
155212880|NCT03241342|560217516|FG002|Overall Study|Lack of Efficacy|1|||
155212881|NCT03241342|560217514|FG000|Overall Study|noncompliance with study drug|2|||
155212882|NCT03241342|560217515|FG001|Overall Study|noncompliance with study drug|1|||
155212883|NCT03241342|560217516|FG002|Overall Study|noncompliance with study drug|1|||
155212884|NCT03241342|560217514|FG000|Overall Study|sponsor decision|0|||
155212885|NCT03241342|560217515|FG001|Overall Study|sponsor decision|1|||
155212886|NCT03241342|560217516|FG002|Overall Study|sponsor decision|2|||
155212887|NCT03241342|560217514|FG000|Overall Study|not reported|15|||
155212888|NCT03241342|560217515|FG001|Overall Study|not reported|21|||
155212889|NCT03241342|560217516|FG002|Overall Study|not reported|19|||
155212890|NCT00556712|560217518|FG000|Overall Study|Adverse Event|7|||
155212891|NCT00556712|560217519|FG001|Overall Study|Adverse Event|19|||
155212892|NCT00556712|560217518|FG000|Overall Study|Death|5|||
155212893|NCT00556712|560217519|FG001|Overall Study|Death|10|||
155212894|NCT00556712|560217518|FG000|Overall Study|Progressive Disease|383|||
155212895|NCT00556712|560217519|FG001|Overall Study|Progressive Disease|320|||
155212896|NCT00556712|560217518|FG000|Overall Study|Protocol Violation|3|||
155212897|NCT00556712|560217519|FG001|Overall Study|Protocol Violation|2|||
155212898|NCT00556712|560217518|FG000|Overall Study|Refused Treatment|17|||
155212899|NCT00556712|560217519|FG001|Overall Study|Refused Treatment|16|||
155212900|NCT00556712|560217518|FG000|Overall Study|Failure to Return|2|||
155212901|NCT00556712|560217519|FG001|Overall Study|Failure to Return|3|||
155212902|NCT00556712|560217518|FG000|Overall Study|Other|2|||
155212903|NCT00556712|560217519|FG001|Overall Study|Other|2|||
155212904|NCT00556712|560217518|FG000|Overall Study|Ongoing at Data Cutoff|32|||
155212905|NCT00556712|560217519|FG001|Overall Study|Ongoing at Data Cutoff|66|||
155212906|NCT01846611|560217522|FG000|Overall Study|Lost to Follow-up|4|||
155212907|NCT01846611|560217523|FG001|Overall Study|Lost to Follow-up|6|||
155212908|NCT01846611|560217522|FG000|Overall Study|Withdrawal by Subject|15|||
155212909|NCT01846611|560217523|FG001|Overall Study|Withdrawal by Subject|19|||
155212910|NCT01846611|560217522|FG000|Overall Study|Other|19|||
155212911|NCT01846611|560217523|FG001|Overall Study|Other|18|||
155212912|NCT00541034|560217524|FG000|Overall Study|Non-Compliance|3|||
155212913|NCT00847704|560217526|FG000|Overall Study|Withdrawal by Subject|1|||
155212914|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
155212915|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
155212916|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
155212917|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
155212918|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
155212919|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
155212920|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
155212921|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
155212922|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
155212923|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
155212924|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
155212925|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
155212926|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
155212927|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
155212928|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
155212929|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
155212930|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
155212931|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
155212932|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
155212933|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
155212934|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
155212935|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
155212936|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
155212937|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
155212938|NCT02289079|560217531|FG000|Overall Study|Physician Decision|2|||
155212939|NCT02289079|560217532|FG001|Overall Study|Physician Decision|0|||
155212940|NCT02289079|560217531|FG000|Overall Study|Lost to Follow-up|0|||
155212941|NCT02289079|560217532|FG001|Overall Study|Lost to Follow-up|1|||
155212942|NCT02671422|560217533|FG000|Overall Study|Lost to Follow-up|1|||
155212943|NCT02671422|560217533|FG000|Overall Study|Adverse Event|68|||
155212944|NCT02671422|560217533|FG000|Overall Study|Lack of Efficacy|1|||
155212945|NCT02671422|560217533|FG000|Overall Study|Lost to Follow-up|4|||
155212946|NCT02671422|560217533|FG000|Overall Study|Withdrawal by Subject|7|||
155212947|NCT02671422|560217533|FG000|Overall Study|Progressive Disease|156|||
155212948|NCT02671422|560217533|FG000|Overall Study|Worsening of Disease|4|||
155212949|NCT02671422|560217533|FG000|Overall Study|Sponsor decision|5|||
155212950|NCT02671422|560217533|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
155212951|NCT02671422|560217533|FG000|Overall Study|Not treated with Vargatef®|3|||
155212952|NCT02671422|560217533|FG000|Overall Study|Other not defined above|3|||
155212953|NCT02111850|560217534|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212954|NCT02111850|560217535|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212955|NCT02111850|560217536|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212956|NCT02111850|560217537|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212957|NCT02111850|560217538|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
155212958|NCT02111850|560217539|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212959|NCT02111850|560217540|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212960|NCT02111850|560217541|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212961|NCT02111850|560217542|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212962|NCT02111850|560217543|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212963|NCT02111850|560217544|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212964|NCT03061331|560217545|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
155212965|NCT03061331|560217546|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
155212966|NCT02625259|560217547|FG000|First Intervention (Day 1)|Other|0|||
155212967|NCT02625259|560217548|FG001|First Intervention (Day 1)|Other|0|||
155212968|NCT02625259|560217549|FG002|First Intervention (Day 1)|Other|1|||
155212969|NCT02625259|560217550|FG003|First Intervention (Day 1)|Other|0|||
155212970|NCT02625259|560217551|FG004|First Intervention (Day 1)|Other|0|||
155212971|NCT02625259|560217547|FG000|First Intervention (Day 1)|Adverse Event|2|||
155212972|NCT02625259|560217548|FG001|First Intervention (Day 1)|Adverse Event|1|||
155212973|NCT02625259|560217549|FG002|First Intervention (Day 1)|Adverse Event|0|||
155212974|NCT02625259|560217550|FG003|First Intervention (Day 1)|Adverse Event|0|||
155212975|NCT02625259|560217551|FG004|First Intervention (Day 1)|Adverse Event|0|||
155212976|NCT02625259|560217547|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212977|NCT02625259|560217548|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212978|NCT02625259|560217549|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212979|NCT02625259|560217550|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
155212980|NCT02625259|560217551|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212981|NCT01980875|560217552|FG000|Overall Study|Withdrew Consent|1|||
155212982|NCT01980875|560217553|FG001|Overall Study|Withdrew Consent|1|||
155212983|NCT01980875|560217554|FG002|Overall Study|Withdrew Consent|1|||
155212984|NCT01980875|560217552|FG000|Overall Study|Study Terminated by Sponsor|7|||
155212985|NCT01980875|560217553|FG001|Overall Study|Study Terminated by Sponsor|24|||
155212986|NCT01980875|560217554|FG002|Overall Study|Study Terminated by Sponsor|22|||
155212987|NCT01980875|560217552|FG000|Overall Study|Lost to Follow-up|0|||
155212988|NCT01980875|560217553|FG001|Overall Study|Lost to Follow-up|0|||
155212989|NCT01980875|560217554|FG002|Overall Study|Lost to Follow-up|1|||
155212990|NCT00513474|560217555|FG000|Overall Study|Death|6|||
155212991|NCT00513474|560217556|FG001|Overall Study|Death|9|||
155212992|NCT00513474|560217555|FG000|Overall Study|Participant Withdrew Consent|1|||
155212993|NCT00513474|560217556|FG001|Overall Study|Participant Withdrew Consent|0|||
155212994|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Adverse Event|82|||
155212995|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Death|6|||
155212996|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
155212997|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
155212998|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
155212999|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
155213000|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
155213001|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Other reasons|68|||
155213002|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
155213003|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
155213004|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
155213005|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
155213006|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
155213007|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
155213008|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
155213009|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
155213010|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
155213011|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
155213012|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
155213013|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
155213014|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
155213015|NCT01189812|560217558|FG000|Overall Study|Withdrawal by Subject|2|||
155213016|NCT01189812|560217559|FG001|Overall Study|Withdrawal by Subject|3|||
155213017|NCT01189812|560217558|FG000|Overall Study|Adverse Event|1|||
155213018|NCT01189812|560217559|FG001|Overall Study|Adverse Event|0|||
155213019|NCT01189812|560217558|FG000|Overall Study|Out of Window|4|||
155213020|NCT01189812|560217559|FG001|Overall Study|Out of Window|3|||
155213021|NCT01189812|560217558|FG000|Overall Study|Moved out of State|1|||
155213022|NCT01189812|560217559|FG001|Overall Study|Moved out of State|2|||
155213023|NCT01905657|560217560|FG000|Overall Study|Adverse Event|23|||
155213024|NCT01905657|560217561|FG001|Overall Study|Adverse Event|17|||
155213025|NCT01905657|560217562|FG002|Overall Study|Adverse Event|18|||
155213026|NCT01905657|560217560|FG000|Overall Study|Clinical Progression|103|||
155213027|NCT01905657|560217561|FG001|Overall Study|Clinical Progression|78|||
155213028|NCT01905657|560217562|FG002|Overall Study|Clinical Progression|59|||
155213029|NCT01905657|560217560|FG000|Overall Study|Death|40|||
155213030|NCT01905657|560217561|FG001|Overall Study|Death|43|||
155213031|NCT01905657|560217562|FG002|Overall Study|Death|47|||
155213032|NCT01905657|560217560|FG000|Overall Study|Excluded Medication|13|||
155213033|NCT01905657|560217561|FG001|Overall Study|Excluded Medication|16|||
155213034|NCT01905657|560217562|FG002|Overall Study|Excluded Medication|9|||
155213035|NCT01905657|560217560|FG000|Overall Study|Lost to Follow-up|1|||
155213036|NCT01905657|560217561|FG001|Overall Study|Lost to Follow-up|2|||
155213037|NCT01905657|560217562|FG002|Overall Study|Lost to Follow-up|1|||
155213038|NCT01905657|560217560|FG000|Overall Study|Physician Decision|5|||
155213039|NCT01905657|560217561|FG001|Overall Study|Physician Decision|8|||
155213040|NCT01905657|560217562|FG002|Overall Study|Physician Decision|12|||
155213041|NCT01905657|560217560|FG000|Overall Study|Protocol Violation|2|||
155213042|NCT01905657|560217561|FG001|Overall Study|Protocol Violation|1|||
155213043|NCT01905657|560217562|FG002|Overall Study|Protocol Violation|1|||
155213044|NCT01905657|560217560|FG000|Overall Study|Screen Failure|0|||
155213045|NCT01905657|560217561|FG001|Overall Study|Screen Failure|1|||
155213046|NCT01905657|560217562|FG002|Overall Study|Screen Failure|0|||
155213047|NCT01905657|560217560|FG000|Overall Study|Withdrawal by Subject|15|||
155213048|NCT01905657|560217561|FG001|Overall Study|Withdrawal by Subject|21|||
155213049|NCT01905657|560217562|FG002|Overall Study|Withdrawal by Subject|53|||
155213050|NCT01905657|560217560|FG000|Overall Study|Sponsor Decision|1|||
155213051|NCT01905657|560217561|FG001|Overall Study|Sponsor Decision|0|||
155213052|NCT01905657|560217562|FG002|Overall Study|Sponsor Decision|0|||
155213053|NCT04080297|560217564|FG000|Overall Study|Adverse Event|1|||
155213054|NCT04080297|560217565|FG001|Overall Study|Adverse Event|3|||
155213055|NCT04080297|560217564|FG000|Overall Study|concurrent illness|1|||
155213056|NCT04080297|560217565|FG001|Overall Study|concurrent illness|0|||
155213057|NCT05838742|560217567|FG000|Overall Study|Adverse Event|2|||
155213058|NCT05838742|560217568|FG001|Overall Study|Adverse Event|0|||
155213059|NCT05838742|560217569|FG002|Overall Study|Adverse Event|1|||
155213060|NCT05838742|560217570|FG003|Overall Study|Adverse Event|0|||
155213061|NCT05838742|560217571|FG004|Overall Study|Adverse Event|1|||
155213062|NCT05838742|560217567|FG000|Overall Study|Lost to Follow-up|1|||
155213063|NCT05838742|560217568|FG001|Overall Study|Lost to Follow-up|1|||
155213064|NCT05838742|560217569|FG002|Overall Study|Lost to Follow-up|1|||
155213065|NCT05838742|560217570|FG003|Overall Study|Lost to Follow-up|0|||
155213066|NCT05838742|560217571|FG004|Overall Study|Lost to Follow-up|0|||
155213067|NCT05838742|560217567|FG000|Overall Study|Physician Decision|0|||
155213068|NCT05838742|560217568|FG001|Overall Study|Physician Decision|0|||
155213069|NCT05838742|560217569|FG002|Overall Study|Physician Decision|0|||
155213070|NCT05838742|560217570|FG003|Overall Study|Physician Decision|0|||
155213071|NCT05838742|560217571|FG004|Overall Study|Physician Decision|1|||
155213072|NCT05838742|560217567|FG000|Overall Study|Withdrawal by Subject|8|||
155213073|NCT05838742|560217568|FG001|Overall Study|Withdrawal by Subject|3|||
155213074|NCT05838742|560217569|FG002|Overall Study|Withdrawal by Subject|3|||
155213075|NCT05838742|560217570|FG003|Overall Study|Withdrawal by Subject|1|||
155213076|NCT05838742|560217571|FG004|Overall Study|Withdrawal by Subject|4|||
155213077|NCT05838742|560217567|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
155213078|NCT05838742|560217568|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
155213079|NCT05838742|560217569|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
155213080|NCT05838742|560217570|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
155213081|NCT05838742|560217571|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
155213082|NCT05838742|560217567|FG000|Overall Study|Lack of Efficacy|0|||
155213083|NCT05838742|560217568|FG001|Overall Study|Lack of Efficacy|0|||
155213084|NCT05838742|560217569|FG002|Overall Study|Lack of Efficacy|0|||
155213085|NCT05838742|560217570|FG003|Overall Study|Lack of Efficacy|1|||
155213086|NCT05838742|560217571|FG004|Overall Study|Lack of Efficacy|0|||
155213087|NCT05838742|560217567|FG000|Overall Study|Randomized, not treated|2|||
155213088|NCT05838742|560217568|FG001|Overall Study|Randomized, not treated|1|||
155213089|NCT05838742|560217569|FG002|Overall Study|Randomized, not treated|0|||
155213090|NCT05838742|560217570|FG003|Overall Study|Randomized, not treated|1|||
155213091|NCT05838742|560217571|FG004|Overall Study|Randomized, not treated|0|||
155213092|NCT02623439|560217576|FG000|Overall Study|Withdrawal by Subject|1|||
155213093|NCT02623439|560217576|FG000|Overall Study|Screen Failure|1|||
155213094|NCT02200445|560217580|FG000|Overall Study|Lack of Efficacy|1|||
155213095|NCT02200445|560217581|FG001|Overall Study|Lack of Efficacy|2|||
155213096|NCT02200445|560217582|FG002|Overall Study|Lack of Efficacy|2|||
155213097|NCT02200445|560217580|FG000|Overall Study|Adverse Event|0|||
155213098|NCT02200445|560217581|FG001|Overall Study|Adverse Event|2|||
155213099|NCT02200445|560217582|FG002|Overall Study|Adverse Event|0|||
155213100|NCT04484142|560217583|FG000|Overall Study|Adverse Event|13|||
155213101|NCT04484142|560217583|FG000|Overall Study|Progressive Disease|87|||
155213102|NCT04484142|560217583|FG000|Overall Study|Clinical Progression|10|||
155213103|NCT04484142|560217583|FG000|Overall Study|Withdrawal by Subject|6|||
155213104|NCT04484142|560217583|FG000|Overall Study|Physician Decision|1|||
155213105|NCT03700671|560217584|FG000|Overall Study|Lack of Efficacy|1|||
155213106|NCT03700671|560217585|FG001|Overall Study|Lack of Efficacy|2|||
155213107|NCT05371509|560217586|FG000|Overall Study|Physician Decision|1|||
155213108|NCT05371509|560217587|FG001|Overall Study|Physician Decision|0|||
155213109|NCT03851302|560217594|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
155213110|NCT03851302|560217595|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
155213111|NCT03851302|560217596|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
155213112|NCT03851302|560217597|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
155213113|NCT03851302|560217598|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
155213114|NCT03851302|560217599|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
155213115|NCT03851302|560217594|FG000|Screening (1 Day)|Screened out|0|||
155213116|NCT03851302|560217595|FG001|Screening (1 Day)|Screened out|0|||
155213117|NCT03851302|560217596|FG002|Screening (1 Day)|Screened out|1|||
155213118|NCT03851302|560217597|FG003|Screening (1 Day)|Screened out|1|||
155213119|NCT03851302|560217598|FG004|Screening (1 Day)|Screened out|0|||
155213120|NCT03851302|560217599|FG005|Screening (1 Day)|Screened out|0|||
155213121|NCT03851302|560217594|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
155213122|NCT03851302|560217595|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213123|NCT03851302|560217596|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213124|NCT03851302|560217597|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213125|NCT03851302|560217598|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213126|NCT03851302|560217599|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213127|NCT03578367|560217600|FG000|Overall Study|Adverse Event|0|||
155213128|NCT03578367|560217601|FG001|Overall Study|Adverse Event|3|||
155213129|NCT03578367|560217602|FG002|Overall Study|Adverse Event|0|||
155213130|NCT03578367|560217603|FG003|Overall Study|Adverse Event|5|||
155213131|NCT03578367|560217600|FG000|Overall Study|Withdrawal by Subject|2|||
155213132|NCT03578367|560217601|FG001|Overall Study|Withdrawal by Subject|2|||
155213133|NCT03578367|560217602|FG002|Overall Study|Withdrawal by Subject|1|||
155213134|NCT03578367|560217603|FG003|Overall Study|Withdrawal by Subject|3|||
155213135|NCT03578367|560217600|FG000|Overall Study|Physician Decision|0|||
155213136|NCT03578367|560217601|FG001|Overall Study|Physician Decision|0|||
155213137|NCT03578367|560217602|FG002|Overall Study|Physician Decision|14|||
155213138|NCT03578367|560217603|FG003|Overall Study|Physician Decision|0|||
155213139|NCT03578367|560217600|FG000|Overall Study|Death|1|||
155213140|NCT03578367|560217601|FG001|Overall Study|Death|0|||
155213141|NCT03578367|560217602|FG002|Overall Study|Death|0|||
155213142|NCT03578367|560217603|FG003|Overall Study|Death|0|||
155213143|NCT03578367|560217600|FG000|Overall Study|Not treated|0|||
155213144|NCT03578367|560217601|FG001|Overall Study|Not treated|0|||
155213145|NCT03578367|560217602|FG002|Overall Study|Not treated|1|||
155213146|NCT03578367|560217603|FG003|Overall Study|Not treated|0|||
155213147|NCT00587561|560219372|FG000|Overall Study|Lost to Follow-up|6|||
155213148|NCT00587561|560219373|FG001|Overall Study|Lost to Follow-up|4|||
155213149|NCT00982488|560219374|FG000|Overall Study|Administrative reason by sponsor|81|||
155213150|NCT00982488|560219375|FG001|Overall Study|Administrative reason by sponsor|3|||
155213151|NCT00982488|560219376|FG002|Overall Study|Administrative reason by sponsor|11|||
155213152|NCT00982488|560219377|FG003|Overall Study|Administrative reason by sponsor|0|||
155213153|NCT00982488|560219378|FG004|Overall Study|Administrative reason by sponsor|0|||
155213154|NCT00982488|560219374|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155213155|NCT00982488|560219375|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155213156|NCT00982488|560219376|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155213157|NCT00982488|560219377|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155213158|NCT00982488|560219378|FG004|Overall Study|Adverse event unrelated to study drug|0|||
155213159|NCT00982488|560219374|FG000|Overall Study|Death|11|||
155213160|NCT00982488|560219375|FG001|Overall Study|Death|0|||
155213161|NCT00982488|560219376|FG002|Overall Study|Death|2|||
155213162|NCT00982488|560219377|FG003|Overall Study|Death|0|||
155213163|NCT00982488|560219378|FG004|Overall Study|Death|0|||
155213164|NCT00982488|560219374|FG000|Overall Study|Disease progression|30|||
155213165|NCT00982488|560219375|FG001|Overall Study|Disease progression|5|||
155213166|NCT00982488|560219376|FG002|Overall Study|Disease progression|10|||
155213167|NCT00982488|560219377|FG003|Overall Study|Disease progression|1|||
155213168|NCT00982488|560219378|FG004|Overall Study|Disease progression|1|||
155213169|NCT00982488|560219374|FG000|Overall Study|Lost to Follow-up|1|||
155213170|NCT00982488|560219375|FG001|Overall Study|Lost to Follow-up|0|||
155213171|NCT00982488|560219376|FG002|Overall Study|Lost to Follow-up|0|||
155213172|NCT00982488|560219377|FG003|Overall Study|Lost to Follow-up|0|||
155213173|NCT00982488|560219378|FG004|Overall Study|Lost to Follow-up|0|||
155213174|NCT00982488|560219374|FG000|Overall Study|Maximum clinical benefit|1|||
155213175|NCT00982488|560219375|FG001|Overall Study|Maximum clinical benefit|1|||
155213176|NCT00982488|560219376|FG002|Overall Study|Maximum clinical benefit|1|||
155213177|NCT00982488|560219377|FG003|Overall Study|Maximum clinical benefit|0|||
155213178|NCT00982488|560219378|FG004|Overall Study|Maximum clinical benefit|0|||
155213179|NCT00982488|560219374|FG000|Overall Study|Other|15|||
155213180|NCT00982488|560219375|FG001|Overall Study|Other|1|||
155213181|NCT00982488|560219376|FG002|Overall Study|Other|3|||
155213182|NCT00982488|560219377|FG003|Overall Study|Other|1|||
155213183|NCT00982488|560219378|FG004|Overall Study|Other|0|||
155213184|NCT00982488|560219374|FG000|Overall Study|Poor compliance/noncompliance|0|||
155213185|NCT00982488|560219375|FG001|Overall Study|Poor compliance/noncompliance|1|||
155213186|NCT00982488|560219376|FG002|Overall Study|Poor compliance/noncompliance|0|||
155213187|NCT00982488|560219377|FG003|Overall Study|Poor compliance/noncompliance|0|||
155213188|NCT00982488|560219378|FG004|Overall Study|Poor compliance/noncompliance|0|||
155213189|NCT00982488|560219374|FG000|Overall Study|Stem cell transplant|2|||
155213190|NCT00982488|560219375|FG001|Overall Study|Stem cell transplant|0|||
155213191|NCT00982488|560219376|FG002|Overall Study|Stem cell transplant|0|||
155213192|NCT00982488|560219377|FG003|Overall Study|Stem cell transplant|1|||
155213193|NCT00982488|560219378|FG004|Overall Study|Stem cell transplant|0|||
155213194|NCT00982488|560219374|FG000|Overall Study|Study drug toxicity|34|||
155213195|NCT00982488|560219375|FG001|Overall Study|Study drug toxicity|1|||
155213196|NCT00982488|560219376|FG002|Overall Study|Study drug toxicity|6|||
155213197|NCT00982488|560219377|FG003|Overall Study|Study drug toxicity|0|||
155213198|NCT00982488|560219378|FG004|Overall Study|Study drug toxicity|0|||
155213199|NCT00982488|560219374|FG000|Overall Study|Withdrawal by Subject|5|||
155213200|NCT00982488|560219375|FG001|Overall Study|Withdrawal by Subject|1|||
155213201|NCT00982488|560219376|FG002|Overall Study|Withdrawal by Subject|1|||
155213202|NCT00982488|560219377|FG003|Overall Study|Withdrawal by Subject|0|||
155213203|NCT00982488|560219378|FG004|Overall Study|Withdrawal by Subject|0|||
155213204|NCT04244786|560219379|FG000|Overall Study|Adverse Event|0|||
155213205|NCT04244786|560219380|FG001|Overall Study|Adverse Event|0|||
155213206|NCT04244786|560219381|FG002|Overall Study|Adverse Event|2|||
155213207|NCT04244786|560219379|FG000|Overall Study|Withdrawal by Subject|0|||
155213208|NCT04244786|560219380|FG001|Overall Study|Withdrawal by Subject|0|||
155213209|NCT04244786|560219381|FG002|Overall Study|Withdrawal by Subject|5|||
155213210|NCT01199289|560219382|FG000|Overall Study|Ineligibility determined|2|||
155213211|NCT01199289|560219383|FG001|Overall Study|Ineligibility determined|1|||
155213212|NCT01199289|560219384|FG002|Overall Study|Ineligibility determined|0|||
155213213|NCT01199289|560219385|FG003|Overall Study|Ineligibility determined|0|||
155213214|NCT01199289|560219382|FG000|Overall Study|Protocol Violation|1|||
155213215|NCT01199289|560219383|FG001|Overall Study|Protocol Violation|0|||
155213216|NCT01199289|560219384|FG002|Overall Study|Protocol Violation|0|||
155213217|NCT01199289|560219385|FG003|Overall Study|Protocol Violation|1|||
155213218|NCT01199289|560219382|FG000|Overall Study|Noncompliance|1|||
155213219|NCT01199289|560219383|FG001|Overall Study|Noncompliance|0|||
155213220|NCT01199289|560219384|FG002|Overall Study|Noncompliance|2|||
155213221|NCT01199289|560219385|FG003|Overall Study|Noncompliance|0|||
155213222|NCT01199289|560219382|FG000|Overall Study|Adverse Event|0|||
155213223|NCT01199289|560219383|FG001|Overall Study|Adverse Event|3|||
155213224|NCT01199289|560219384|FG002|Overall Study|Adverse Event|1|||
155213225|NCT01199289|560219385|FG003|Overall Study|Adverse Event|4|||
155213226|NCT01199289|560219382|FG000|Overall Study|Full consent withdrawn|2|||
155213227|NCT01199289|560219383|FG001|Overall Study|Full consent withdrawn|2|||
155213228|NCT01199289|560219384|FG002|Overall Study|Full consent withdrawn|2|||
155213229|NCT01199289|560219385|FG003|Overall Study|Full consent withdrawn|3|||
155213230|NCT01199289|560219382|FG000|Overall Study|Administrative decision|0|||
155213231|NCT01199289|560219383|FG001|Overall Study|Administrative decision|0|||
155213232|NCT01199289|560219384|FG002|Overall Study|Administrative decision|0|||
155213233|NCT01199289|560219385|FG003|Overall Study|Administrative decision|1|||
155213234|NCT01199289|560219382|FG000|Overall Study|Lost to Follow-up|0|||
155213235|NCT01199289|560219383|FG001|Overall Study|Lost to Follow-up|0|||
155213236|NCT01199289|560219384|FG002|Overall Study|Lost to Follow-up|0|||
155213237|NCT01199289|560219385|FG003|Overall Study|Lost to Follow-up|1|||
155213238|NCT01199289|560219382|FG000|Overall Study|Protocol-specified criteria|3|||
155213239|NCT01199289|560219383|FG001|Overall Study|Protocol-specified criteria|0|||
155213240|NCT01199289|560219384|FG002|Overall Study|Protocol-specified criteria|0|||
155213241|NCT01199289|560219385|FG003|Overall Study|Protocol-specified criteria|1|||
155213242|NCT01199289|560219382|FG000|Overall Study|Pregnancy|0|||
155213243|NCT01199289|560219383|FG001|Overall Study|Pregnancy|1|||
155213244|NCT01199289|560219384|FG002|Overall Study|Pregnancy|0|||
155213245|NCT01199289|560219385|FG003|Overall Study|Pregnancy|1|||
155213246|NCT00415909|560219387|FG000|Overall Study|Withdrawal by Subject|2|||
155213247|NCT00415909|560219387|FG000|Overall Study|Death|1|||
155213248|NCT02734810|560219388|FG000|Overall Study|Adverse Event|1|||
155213249|NCT02734810|560219389|FG001|Overall Study|Adverse Event|0|||
155213250|NCT02734810|560219388|FG000|Overall Study|Lack of Efficacy|1|||
155213251|NCT02734810|560219389|FG001|Overall Study|Lack of Efficacy|0|||
155213252|NCT02507505|560219391|FG000|Overall Study|Withdrawal by Subject|13|||
155213253|NCT02507505|560219392|FG001|Overall Study|Withdrawal by Subject|11|||
155213254|NCT02507505|560219391|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
155213255|NCT02507505|560219392|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
155213256|NCT02507505|560219391|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
155213257|NCT02507505|560219392|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
155213258|NCT02507505|560219391|FG000|Overall Study|Death before receipt of anesthesia|0|||
155213259|NCT02507505|560219392|FG001|Overall Study|Death before receipt of anesthesia|1|||
155213260|NCT00254540|560219393|FG000|Overall Study|Adverse Event|6|||
155213261|NCT00254540|560219394|FG001|Overall Study|Adverse Event|7|||
155213262|NCT00254540|560219393|FG000|Overall Study|Lack of Efficacy|13|||
155213263|NCT00254540|560219394|FG001|Overall Study|Lack of Efficacy|13|||
155213264|NCT00254540|560219393|FG000|Overall Study|Death|0|||
155213265|NCT00254540|560219394|FG001|Overall Study|Death|1|||
155213266|NCT00254540|560219393|FG000|Overall Study|Laboratory Test Abnormality|0|||
155213267|NCT00254540|560219394|FG001|Overall Study|Laboratory Test Abnormality|1|||
155213268|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
155213269|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
155213270|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
155213271|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155213272|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
155213273|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
155213274|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155213275|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155213276|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
155213277|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155213278|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
155213279|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155213280|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
155213281|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
155213282|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
155213283|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
155213284|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
155213285|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
155213286|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Death|4|||
155213287|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Death|1|||
155213288|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
155213289|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
155213290|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
155213291|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
155213292|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
155213293|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
155213294|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
155213295|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
155213296|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
155213297|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
155213298|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
155213299|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
155213300|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
155213301|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
155213302|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
155213303|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
155213304|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
155213305|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
155213306|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
155213307|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
155213308|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
155213309|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
155213310|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
155213311|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
155213312|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
155213313|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
155213314|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
155213315|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
155213316|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
155213317|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
155213318|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
155213319|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
155213320|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
155213321|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
155213322|NCT00503308|560219397|FG000|Overall Study|Protocol Violation|2|||
155213323|NCT00503308|560219398|FG001|Overall Study|Protocol Violation|1|||
155213324|NCT04481750|560219399|FG000|Period 1 (Fasted)|Adverse Event|0|||
155213325|NCT04481750|560219400|FG001|Period 1 (Fasted)|Adverse Event|0|||
155213326|NCT04481750|560219401|FG002|Period 1 (Fasted)|Adverse Event|1|||
155213327|NCT04481750|560219402|FG003|Period 1 (Fasted)|Adverse Event|0|||
155213328|NCT04481750|560219403|FG004|Period 1 (Fasted)|Adverse Event|0|||
155213329|NCT04481750|560219404|FG005|Period 1 (Fasted)|Adverse Event|0|||
155213330|NCT04481750|560219405|FG006|Period 1 (Fasted)|Adverse Event|0|||
155213331|NCT04481750|560219406|FG007|Period 1 (Fasted)|Adverse Event|0|||
155213332|NCT04481750|560219407|FG008|Period 1 (Fasted)|Adverse Event|0|||
155213333|NCT04481750|560219408|FG009|Period 1 (Fasted)|Adverse Event|0|||
155213334|NCT04481750|560219409|FG010|Period 1 (Fasted)|Adverse Event|0|||
155213335|NCT00475176|560219410|FG000|Overall Study|Adverse Event|2|||
155213336|NCT00475176|560219410|FG000|Overall Study|Withdrawal by Subject|1|||
155213337|NCT00475176|560219410|FG000|Overall Study|Protocol Violation|1|||
155213338|NCT01113801|560219413|FG000|Overall Study|Adverse Event|4|||
155213339|NCT01113801|560219414|FG001|Overall Study|Adverse Event|0|||
155213340|NCT01113801|560219415|FG002|Overall Study|Adverse Event|2|||
155213341|NCT01113801|560219416|FG003|Overall Study|Adverse Event|6|||
155213342|NCT01113801|560219413|FG000|Overall Study|Death|4|||
155213343|NCT01113801|560219414|FG001|Overall Study|Death|5|||
155213344|NCT01113801|560219415|FG002|Overall Study|Death|3|||
155213345|NCT01113801|560219416|FG003|Overall Study|Death|4|||
155213346|NCT01113801|560219413|FG000|Overall Study|Protocol Violation|0|||
155213347|NCT01113801|560219414|FG001|Overall Study|Protocol Violation|1|||
155213348|NCT01113801|560219415|FG002|Overall Study|Protocol Violation|0|||
155213349|NCT01113801|560219416|FG003|Overall Study|Protocol Violation|0|||
155213350|NCT01113801|560219413|FG000|Overall Study|Withdrawal by Subject|9|||
155213351|NCT01113801|560219414|FG001|Overall Study|Withdrawal by Subject|7|||
155213352|NCT01113801|560219415|FG002|Overall Study|Withdrawal by Subject|7|||
155213353|NCT01113801|560219416|FG003|Overall Study|Withdrawal by Subject|8|||
155213354|NCT01113801|560219413|FG000|Overall Study|Physician Decision|2|||
155213355|NCT01113801|560219414|FG001|Overall Study|Physician Decision|2|||
155213356|NCT01113801|560219415|FG002|Overall Study|Physician Decision|3|||
155213357|NCT01113801|560219416|FG003|Overall Study|Physician Decision|3|||
155213358|NCT01113801|560219413|FG000|Overall Study|Sponsor Decision|15|||
155213359|NCT01113801|560219414|FG001|Overall Study|Sponsor Decision|21|||
155213360|NCT01113801|560219415|FG002|Overall Study|Sponsor Decision|20|||
155213361|NCT01113801|560219416|FG003|Overall Study|Sponsor Decision|15|||
155213362|NCT01113801|560219413|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
155213363|NCT01113801|560219414|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
155213364|NCT01113801|560219415|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
155213365|NCT01113801|560219416|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
155213366|NCT03287804|560219417|FG000|Overall Study|Death|1|||
155213367|NCT03287804|560219417|FG000|Overall Study|Physician Decision|2|||
155213368|NCT03287804|560219417|FG000|Overall Study|Progressive disease|8|||
155213369|NCT03178773|560219428|FG000|Overall Study|Death|0|||
155213370|NCT03178773|560219429|FG001|Overall Study|Death|1|||
155213371|NCT03178773|560219428|FG000|Overall Study|Lost to Follow-up|29|||
155213372|NCT03178773|560219429|FG001|Overall Study|Lost to Follow-up|25|||
155213373|NCT03178773|560219428|FG000|Overall Study|Withdrawal by Subject|10|||
155213374|NCT03178773|560219429|FG001|Overall Study|Withdrawal by Subject|14|||
155213375|NCT00770289|560219430|FG000|Overall Study|Other|6|||
155213376|NCT02733991|560219431|FG000|Overall Study|Adverse Event|1|||
155213377|NCT02733991|560219432|FG001|Overall Study|Adverse Event|0|||
155213378|NCT02733991|560219431|FG000|Overall Study|Withdrawal by Subject|0|||
155213379|NCT02733991|560219432|FG001|Overall Study|Withdrawal by Subject|5|||
155213380|NCT02617511|560219438|FG000|Overall Study|Withdrawal by Subject|1|||
155213381|NCT02617511|560219439|FG001|Overall Study|Withdrawal by Subject|0|||
155213382|NCT00255047|560219440|FG000|Overall Study|Serious Adverse Events|2|||
155213383|NCT00255047|560219441|FG001|Overall Study|Serious Adverse Events|1|||
155213384|NCT00255047|560219442|FG002|Overall Study|Serious Adverse Events|2|||
155213385|NCT00255047|560219443|FG003|Overall Study|Serious Adverse Events|1|||
155213386|NCT00255047|560219440|FG000|Overall Study|Adverse Event|0|||
155213387|NCT00255047|560219441|FG001|Overall Study|Adverse Event|3|||
155213388|NCT00255047|560219442|FG002|Overall Study|Adverse Event|2|||
155213389|NCT00255047|560219443|FG003|Overall Study|Adverse Event|1|||
155213390|NCT00255047|560219440|FG000|Overall Study|Protocol Violation|13|||
155213391|NCT00255047|560219441|FG001|Overall Study|Protocol Violation|13|||
155213392|NCT00255047|560219442|FG002|Overall Study|Protocol Violation|16|||
155213393|NCT00255047|560219443|FG003|Overall Study|Protocol Violation|20|||
155213394|NCT00255047|560219440|FG000|Overall Study|Lost to Follow-up|9|||
155213395|NCT00255047|560219441|FG001|Overall Study|Lost to Follow-up|8|||
155213396|NCT00255047|560219442|FG002|Overall Study|Lost to Follow-up|5|||
155213397|NCT00255047|560219443|FG003|Overall Study|Lost to Follow-up|6|||
155213398|NCT00255047|560219440|FG000|Overall Study|Withdrawal by Subject|24|||
155213399|NCT00255047|560219441|FG001|Overall Study|Withdrawal by Subject|23|||
155213400|NCT00255047|560219442|FG002|Overall Study|Withdrawal by Subject|25|||
155213401|NCT00255047|560219443|FG003|Overall Study|Withdrawal by Subject|18|||
155213402|NCT00811473|560219444|FG000|Overall Study|Adverse Event|3|||
155213403|NCT00811473|560219445|FG001|Overall Study|Adverse Event|12|||
155213404|NCT00811473|560219444|FG000|Overall Study|Lost to Follow-up|5|||
155213405|NCT00811473|560219445|FG001|Overall Study|Lost to Follow-up|1|||
155213406|NCT00811473|560219444|FG000|Overall Study|Withdrawal by Subject|2|||
155213407|NCT00811473|560219445|FG001|Overall Study|Withdrawal by Subject|4|||
155213408|NCT00811473|560219444|FG000|Overall Study|Severe non-compliance to protocol|2|||
155213409|NCT00811473|560219445|FG001|Overall Study|Severe non-compliance to protocol|4|||
155213410|NCT00811473|560219444|FG000|Overall Study|Lack of therapeutic response|4|||
155213411|NCT00811473|560219445|FG001|Overall Study|Lack of therapeutic response|1|||
155213412|NCT00811473|560219444|FG000|Overall Study|Condition under investigation worsened|1|||
155213413|NCT00811473|560219445|FG001|Overall Study|Condition under investigation worsened|3|||
155213414|NCT00811473|560219444|FG000|Overall Study|Other 2|4|||
155213415|NCT00811473|560219445|FG001|Overall Study|Other 2|1|||
155213416|NCT00811473|560219444|FG000|Overall Study|Incorrect Enrollment|1|||
155213417|NCT00811473|560219445|FG001|Overall Study|Incorrect Enrollment|0|||
155213418|NCT00811473|560219444|FG000|Overall Study|Safety Reasons|1|||
155213419|NCT00811473|560219445|FG001|Overall Study|Safety Reasons|0|||
155213420|NCT01585194|560219455|FG000|Overall Study|Withdrawal by Subject|1|||
155213421|NCT01585194|560219455|FG000|Overall Study|Physician Decision|2|||
155213422|NCT01585194|560219455|FG000|Overall Study|Lack of insurance|1|||
155213423|NCT01119131|560219456|FG000|Overall Study|Adverse Event|1|||
155213424|NCT01119131|560219457|FG001|Overall Study|Adverse Event|1|||
155213425|NCT01119131|560219458|FG002|Overall Study|Adverse Event|1|||
155213426|NCT01119131|560219456|FG000|Overall Study|Non-Compliance|1|||
155213427|NCT01119131|560219457|FG001|Overall Study|Non-Compliance|0|||
155213428|NCT01119131|560219458|FG002|Overall Study|Non-Compliance|4|||
155213429|NCT01119131|560219456|FG000|Overall Study|Physician Decision|0|||
155213430|NCT01119131|560219457|FG001|Overall Study|Physician Decision|0|||
155213431|NCT01119131|560219458|FG002|Overall Study|Physician Decision|1|||
155213432|NCT00732615|560219459|FG000|Overall Study|Withdrawal by Subject|3|||
155213433|NCT00732615|560219460|FG001|Overall Study|Withdrawal by Subject|1|||
155213434|NCT00732615|560219459|FG000|Overall Study|Lost to Follow-up|0|||
155213435|NCT00732615|560219460|FG001|Overall Study|Lost to Follow-up|1|||
155213436|NCT00732615|560219459|FG000|Overall Study|Adverse Event|0|||
155213437|NCT00732615|560219460|FG001|Overall Study|Adverse Event|2|||
155213438|NCT00732615|560219459|FG000|Overall Study|Physician Decision|3|||
155213439|NCT00732615|560219460|FG001|Overall Study|Physician Decision|0|||
155213440|NCT00732615|560219459|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
155213441|NCT00732615|560219460|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
155213442|NCT00993291|560219461|FG000|Overall Study|Withdrawal by Subject|1|||
155213443|NCT00003492|560219462|FG000|Overall Study|Not evaluable|6|||
155213444|NCT01333059|560219463|FG000|Overall Study|Physician Decision|3|||
155213445|NCT01333059|560219464|FG001|Overall Study|Physician Decision|3|||
155213446|NCT01333059|560219463|FG000|Overall Study|Protocol Violation|3|||
155213447|NCT01333059|560219464|FG001|Overall Study|Protocol Violation|0|||
155213448|NCT03566823|560219465|FG000|Overall Study|Lack of Efficacy|0|||
155213449|NCT03566823|560219466|FG001|Overall Study|Lack of Efficacy|1|||
155213450|NCT03566823|560219467|FG002|Overall Study|Lack of Efficacy|0|||
155213451|NCT03566823|560219465|FG000|Overall Study|Withdrawal by Subject|1|||
155213452|NCT03566823|560219466|FG001|Overall Study|Withdrawal by Subject|2|||
155213453|NCT03566823|560219467|FG002|Overall Study|Withdrawal by Subject|0|||
155213454|NCT03566823|560219465|FG000|Overall Study|Adverse Event|1|||
155213455|NCT03566823|560219466|FG001|Overall Study|Adverse Event|0|||
155213456|NCT03566823|560219467|FG002|Overall Study|Adverse Event|2|||
155213457|NCT04446377|560219468|FG000|Overall Study|Withdrawal by Subject|6|||
155213458|NCT04446377|560219469|FG001|Overall Study|Withdrawal by Subject|1|||
155213459|NCT04446377|560219468|FG000|Overall Study|Physician Decision|1|||
155213460|NCT04446377|560219469|FG001|Overall Study|Physician Decision|1|||
155213461|NCT04446377|560219468|FG000|Overall Study|Lost to Follow-up|0|||
155213462|NCT04446377|560219469|FG001|Overall Study|Lost to Follow-up|2|||
155213463|NCT04446377|560219468|FG000|Overall Study|Not eligible|0|||
155213464|NCT04446377|560219469|FG001|Overall Study|Not eligible|1|||
155213465|NCT01414075|560219477|FG000|Overall Study|Adverse Event|1|||
155213466|NCT01414075|560219478|FG001|Overall Study|Adverse Event|0|||
155213467|NCT01414075|560219479|FG002|Overall Study|Adverse Event|1|||
155213468|NCT01414075|560219480|FG003|Overall Study|Adverse Event|0|||
155213469|NCT01414075|560219477|FG000|Overall Study|Death|1|||
155213470|NCT01414075|560219478|FG001|Overall Study|Death|0|||
155213471|NCT01414075|560219479|FG002|Overall Study|Death|0|||
155213472|NCT01414075|560219480|FG003|Overall Study|Death|1|||
155213473|NCT01414075|560219477|FG000|Overall Study|Withdrawal by Subject|0|||
155213474|NCT01414075|560219478|FG001|Overall Study|Withdrawal by Subject|0|||
155213475|NCT01414075|560219479|FG002|Overall Study|Withdrawal by Subject|0|||
155213476|NCT01414075|560219480|FG003|Overall Study|Withdrawal by Subject|1|||
155213477|NCT01414075|560219477|FG000|Overall Study|Other than specified|1|||
155213478|NCT01414075|560219478|FG001|Overall Study|Other than specified|0|||
155213479|NCT01414075|560219479|FG002|Overall Study|Other than specified|1|||
155213480|NCT01414075|560219480|FG003|Overall Study|Other than specified|0|||
155213481|NCT01187043|560219483|FG000|Overall Study|Adverse Event|0|||
155213482|NCT01187043|560219484|FG001|Overall Study|Adverse Event|0|||
155213483|NCT01187043|560219485|FG002|Overall Study|Adverse Event|0|||
155213484|NCT01187043|560219486|FG003|Overall Study|Adverse Event|0|||
155213485|NCT01187043|560219487|FG004|Overall Study|Adverse Event|1|||
155213486|NCT01187043|560219483|FG000|Overall Study|Unable to make scheduled visits|1|||
155213487|NCT01187043|560219484|FG001|Overall Study|Unable to make scheduled visits|0|||
155213488|NCT01187043|560219485|FG002|Overall Study|Unable to make scheduled visits|4|||
155213489|NCT01187043|560219486|FG003|Overall Study|Unable to make scheduled visits|0|||
155213490|NCT01187043|560219487|FG004|Overall Study|Unable to make scheduled visits|1|||
155213491|NCT04903626|560219488|FG000|Overall Study|Lost to Follow-up|6|||
155213492|NCT04903626|560219488|FG000|Overall Study|Withdrawal by Subject|1|||
155213493|NCT04903626|560219488|FG000|Overall Study|Other, Not Specified|1|||
155213494|NCT00573534|560219489|FG000|Overall Study|oppositional behavior|3|||
155213495|NCT03035409|560219490|FG000|Overall Study|Adverse Event|5|||
155213496|NCT03035409|560219490|FG000|Overall Study|Death|2|||
155213497|NCT03035409|560219490|FG000|Overall Study|Withdrawal by Subject|2|||
155213498|NCT03035409|560219490|FG000|Overall Study|Non compliance|4|||
155213499|NCT03035409|560219490|FG000|Overall Study|Patient was jittery|1|||
155213500|NCT03035409|560219490|FG000|Overall Study|Did not like Questionnaire|1|||
155213501|NCT03035409|560219490|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
155213502|NCT03035409|560219490|FG000|Overall Study|Did not like taking drugs|1|||
155213503|NCT00927784|560219495|FG000|Overall Study|Death|1|||
155213504|NCT00927784|560219496|FG001|Overall Study|Death|0|||
155213505|NCT00927784|560219495|FG000|Overall Study|Withdrawal by Subject|1|||
155213506|NCT00927784|560219496|FG001|Overall Study|Withdrawal by Subject|0|||
155213507|NCT02457910|560219497|FG000|Overall Study|Withdrawal by Subject|0|||
155213508|NCT02457910|560219498|FG001|Overall Study|Withdrawal by Subject|0|||
155213509|NCT02457910|560219499|FG002|Overall Study|Withdrawal by Subject|0|||
155213510|NCT02457910|560219500|FG003|Overall Study|Withdrawal by Subject|0|||
155213511|NCT02457910|560219501|FG004|Overall Study|Withdrawal by Subject|0|||
155213512|NCT02457910|560219502|FG005|Overall Study|Withdrawal by Subject|1|||
155213513|NCT02457910|560219497|FG000|Overall Study|Adverse Event|0|||
155213514|NCT02457910|560219498|FG001|Overall Study|Adverse Event|2|||
155213515|NCT02457910|560219499|FG002|Overall Study|Adverse Event|1|||
155213516|NCT02457910|560219500|FG003|Overall Study|Adverse Event|1|||
155213517|NCT02457910|560219501|FG004|Overall Study|Adverse Event|1|||
155213518|NCT02457910|560219502|FG005|Overall Study|Adverse Event|3|||
155213519|NCT02457910|560219497|FG000|Overall Study|Disease progression|3|||
155213520|NCT02457910|560219498|FG001|Overall Study|Disease progression|3|||
155213521|NCT02457910|560219499|FG002|Overall Study|Disease progression|1|||
155213522|NCT02457910|560219500|FG003|Overall Study|Disease progression|1|||
155213523|NCT02457910|560219501|FG004|Overall Study|Disease progression|4|||
155213524|NCT02457910|560219502|FG005|Overall Study|Disease progression|6|||
155213525|NCT02457910|560219497|FG000|Overall Study|Other complicating illness|0|||
155213526|NCT02457910|560219498|FG001|Overall Study|Other complicating illness|0|||
155213527|NCT02457910|560219499|FG002|Overall Study|Other complicating illness|0|||
155213528|NCT02457910|560219500|FG003|Overall Study|Other complicating illness|0|||
155213529|NCT02457910|560219501|FG004|Overall Study|Other complicating illness|0|||
155213530|NCT02457910|560219502|FG005|Overall Study|Other complicating illness|1|||
155213531|NCT02457910|560219497|FG000|Overall Study|Death|0|||
155213532|NCT02457910|560219498|FG001|Overall Study|Death|0|||
155213533|NCT02457910|560219499|FG002|Overall Study|Death|1|||
155213534|NCT02457910|560219500|FG003|Overall Study|Death|0|||
155213535|NCT02457910|560219501|FG004|Overall Study|Death|0|||
155213536|NCT02457910|560219502|FG005|Overall Study|Death|0|||
155213537|NCT00467259|560219503|FG000|Overall Study|Adverse Event|24|||
155213538|NCT00467259|560219504|FG001|Overall Study|Adverse Event|90|||
155213539|NCT00467259|560219503|FG000|Overall Study|Protocol Violation|1|||
155213540|NCT00467259|560219504|FG001|Overall Study|Protocol Violation|7|||
155213541|NCT00467259|560219503|FG000|Overall Study|Withdrawal by Subject|34|||
155213542|NCT00467259|560219504|FG001|Overall Study|Withdrawal by Subject|108|||
155213543|NCT00467259|560219503|FG000|Overall Study|Physician Decision|0|||
155213544|NCT00467259|560219504|FG001|Overall Study|Physician Decision|2|||
155213545|NCT00467259|560219503|FG000|Overall Study|Lost to Follow-up|14|||
155213546|NCT00467259|560219504|FG001|Overall Study|Lost to Follow-up|34|||
155213547|NCT00467259|560219503|FG000|Overall Study|Site Closed|2|||
155213548|NCT00467259|560219504|FG001|Overall Study|Site Closed|1|||
155213549|NCT06079320|560219508|FG000|Follow up Phase|Lost to Follow-up|1|||
155213550|NCT06079320|560219509|FG001|Follow up Phase|Lost to Follow-up|0|||
155213551|NCT01405742|560219510|FG000|Overall Study|Lost to Follow-up|1|||
155213552|NCT01405742|560219511|FG001|Overall Study|Lost to Follow-up|0|||
155213553|NCT04900220|560219512|FG000|Overall Study|Lost to Follow-up|1|||
155213554|NCT04900220|560219513|FG001|Overall Study|Lost to Follow-up|1|||
155213555|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
155213556|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
155213557|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
155213558|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
155213559|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
155213560|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
155213561|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
155213562|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
155213563|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
155213564|NCT02196558|560219514|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
155213565|NCT02196558|560219515|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
155213566|NCT02196558|560219516|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
155213567|NCT02196558|560219514|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213568|NCT02196558|560219515|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213569|NCT02196558|560219516|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213570|NCT03428360|560219517|FG000|Overall Study|Informed consent withdrawn|5|||
155213571|NCT03428360|560219517|FG000|Overall Study|Withdrawal by Subject|4|||
155213572|NCT03428360|560219517|FG000|Overall Study|Lost to Follow-up|5|||
155213573|NCT03428360|560219517|FG000|Overall Study|Physician Decision|2|||
155213574|NCT03428360|560219517|FG000|Overall Study|Informed consent withdrawn|5|||
155213575|NCT03428360|560219517|FG000|Overall Study|Study terminated by sponsor|10|||
155213576|NCT03428360|560219517|FG000|Overall Study|Non-compliant with study|1|||
155213577|NCT03428360|560219517|FG000|Overall Study|Non-compliant with study drug|3|||
155213578|NCT03428360|560219517|FG000|Overall Study|Death|3|||
155213579|NCT03428360|560219517|FG000|Overall Study|Adverse Event|1|||
155213580|NCT03428360|560219517|FG000|Overall Study|Not on antiepileptic drug|1|||
155213581|NCT02107482|560219521|FG000|Overall Study|inconveinence|2|||
155213582|NCT02107482|560219521|FG000|Overall Study|Lost to Follow-up|1|||
155213583|NCT02107482|560219521|FG000|Overall Study|Lack of Efficacy|1|||
155213584|NCT00576927|560219524|FG000|Clinical Assessment|Lack of Efficacy|24|||
155213585|NCT00576927|560219524|FG000|Clinical Assessment|Death|1|||
155213586|NCT00576927|560219524|FG000|Clinical Assessment|Withdrawal by Subject|10|||
155213587|NCT00576927|560219524|FG000|Clinical Assessment|Physician Decision|1|||
155213588|NCT00576927|560219524|FG000|Baseline|Physician Decision|9|||
155213589|NCT00576927|560219524|FG000|Baseline|Medication Change by PCP of subject|1|||
155213590|NCT00576927|560219524|FG000|Baseline|Withdrawal by Subject|3|||
155213591|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
155213592|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
155213593|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
155213594|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
155213595|NCT00576927|560219524|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
155213596|NCT03128892|560219525|FG000|Overall Study|Withdrawal by Subject|2|||
155213597|NCT03128892|560219525|FG000|Overall Study|Physician Decision|1|||
155213598|NCT01850524|560219528|FG000|Overall Study|Lost to Follow-up|5|||
155213599|NCT01850524|560219529|FG001|Overall Study|Lost to Follow-up|10|||
155213600|NCT01850524|560219528|FG000|Overall Study|Withdrawal by Subject|24|||
155213601|NCT01850524|560219529|FG001|Overall Study|Withdrawal by Subject|22|||
155213602|NCT01850524|560219528|FG000|Overall Study|Reason not Specified|142|||
155213603|NCT01850524|560219529|FG001|Overall Study|Reason not Specified|141|||
155213604|NCT00368355|560219530|FG000|Overall Study|Adverse Event|1|||
155213605|NCT00368355|560219531|FG001|Overall Study|Adverse Event|0|||
155213606|NCT00368355|560219530|FG000|Overall Study|Death|2|||
155213607|NCT00368355|560219531|FG001|Overall Study|Death|4|||
155213608|NCT00368355|560219530|FG000|Overall Study|Relapse|6|||
155213609|NCT00368355|560219531|FG001|Overall Study|Relapse|10|||
155213610|NCT00368355|560219530|FG000|Overall Study|Subsequent transplant|0|||
155213611|NCT00368355|560219531|FG001|Overall Study|Subsequent transplant|3|||
155213612|NCT00368355|560219530|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
155213613|NCT00368355|560219531|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
155213614|NCT03473808|560219541|FG000|Overall Study|Withdrawal by Subject|1|||
155213615|NCT04059094|560219544|FG000|Overall Study|Adverse Event|0|||
155213616|NCT04059094|560219545|FG001|Overall Study|Adverse Event|0|||
155213617|NCT04059094|560219546|FG002|Overall Study|Adverse Event|0|||
155213618|NCT04059094|560219547|FG003|Overall Study|Adverse Event|0|||
155213619|NCT04059094|560219548|FG004|Overall Study|Adverse Event|1|||
155213620|NCT04059094|560219544|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213621|NCT04059094|560219545|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
155213622|NCT04059094|560219546|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213623|NCT04059094|560219547|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213624|NCT04059094|560219548|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213625|NCT00883116|560219553|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155213626|NCT00883116|560219554|FG001|Overall Study|Adverse event unrelated to study drug|10|||
155213627|NCT00883116|560219553|FG000|Overall Study|Death|6|||
155213628|NCT00883116|560219554|FG001|Overall Study|Death|2|||
155213629|NCT00883116|560219553|FG000|Overall Study|Disease progression|130|||
155213630|NCT00883116|560219554|FG001|Overall Study|Disease progression|128|||
155213631|NCT00883116|560219553|FG000|Overall Study|Lost to Follow-up|0|||
155213632|NCT00883116|560219554|FG001|Overall Study|Lost to Follow-up|1|||
155213633|NCT00883116|560219553|FG000|Overall Study|Maximum clinical benefit|13|||
155213634|NCT00883116|560219554|FG001|Overall Study|Maximum clinical benefit|46|||
155213635|NCT00883116|560219553|FG000|Overall Study|Not identified|3|||
155213636|NCT00883116|560219554|FG001|Overall Study|Not identified|6|||
155213637|NCT00883116|560219553|FG000|Overall Study|Study drug toxicity|36|||
155213638|NCT00883116|560219554|FG001|Overall Study|Study drug toxicity|16|||
155213639|NCT00883116|560219553|FG000|Overall Study|Withdrawal by Subject|14|||
155213640|NCT00883116|560219554|FG001|Overall Study|Withdrawal by Subject|8|||
155213641|NCT00883116|560219553|FG000|Overall Study|No longer meets study criteria|2|||
155213642|NCT00883116|560219554|FG001|Overall Study|No longer meets study criteria|2|||
155213643|NCT01059799|560219557|FG000|Overall Study|Adverse Event|2|||
155213644|NCT01059799|560219558|FG001|Overall Study|Adverse Event|3|||
155213645|NCT01059799|560219557|FG000|Overall Study|Lack of Efficacy|1|||
155213646|NCT01059799|560219558|FG001|Overall Study|Lack of Efficacy|0|||
155213647|NCT01059799|560219557|FG000|Overall Study|Protocol Violation|3|||
155213648|NCT01059799|560219558|FG001|Overall Study|Protocol Violation|2|||
155213649|NCT01059799|560219557|FG000|Overall Study|Withdrawal criteria|13|||
155213650|NCT01059799|560219558|FG001|Overall Study|Withdrawal criteria|2|||
155213651|NCT01059799|560219557|FG000|Overall Study|Other|12|||
155213652|NCT01059799|560219558|FG001|Overall Study|Other|3|||
155213653|NCT04772755|560219562|FG000|Overall Study|Withdrawal by Subject|1|||
155213654|NCT04772755|560219563|FG001|Overall Study|Withdrawal by Subject|0|||
155213655|NCT04772755|560219562|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
155213656|NCT04772755|560219563|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
155213657|NCT03204981|560222007|FG000|Overall Study|Physician Decision|2|||
155213658|NCT03204981|560222007|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
155213659|NCT04203238|560222008|FG000|Overall Study|Withdrawal by Subject|1|||
155213660|NCT04203238|560222009|FG001|Overall Study|Withdrawal by Subject|1|||
155213661|NCT04203238|560222008|FG000|Overall Study|Covid-19|3|||
155213662|NCT04203238|560222009|FG001|Overall Study|Covid-19|0|||
155213663|NCT00001596|560222012|FG000|Overall Study|Death|1|||
155213664|NCT00001596|560222013|FG001|Overall Study|Death|0|||
155213665|NCT00001596|560222012|FG000|Overall Study|Withdrawal by Subject|3|||
155213666|NCT00001596|560222013|FG001|Overall Study|Withdrawal by Subject|1|||
155213667|NCT00001596|560222012|FG000|Overall Study|Study Termination|12|||
155213668|NCT00001596|560222013|FG001|Overall Study|Study Termination|9|||
155213669|NCT00001596|560222012|FG000|Overall Study|Adverse Event|1|||
155213670|NCT00001596|560222013|FG001|Overall Study|Adverse Event|0|||
155213671|NCT03274687|560222014|FG000|Overall Study|Protocol Violation|1|||
155213672|NCT03274687|560222015|FG001|Overall Study|Protocol Violation|1|||
155213673|NCT00180414|560222020|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
155213674|NCT00180414|560222021|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
155213675|NCT00613938|560222026|FG000|Overall Study|Withdrawal by Subject|2|||
155213676|NCT00613938|560222027|FG001|Overall Study|Withdrawal by Subject|4|||
155213677|NCT00613938|560222028|FG002|Overall Study|Withdrawal by Subject|9|||
155213678|NCT00613938|560222029|FG003|Overall Study|Withdrawal by Subject|9|||
155213679|NCT00613938|560222026|FG000|Overall Study|Adverse Event|1|||
155213680|NCT00613938|560222027|FG001|Overall Study|Adverse Event|4|||
155213681|NCT00613938|560222028|FG002|Overall Study|Adverse Event|8|||
155213682|NCT00613938|560222029|FG003|Overall Study|Adverse Event|5|||
155213683|NCT00613938|560222026|FG000|Overall Study|Lack of Efficacy|16|||
155213684|NCT00613938|560222027|FG001|Overall Study|Lack of Efficacy|18|||
155213685|NCT00613938|560222028|FG002|Overall Study|Lack of Efficacy|5|||
155213686|NCT00613938|560222029|FG003|Overall Study|Lack of Efficacy|9|||
155213687|NCT00613938|560222026|FG000|Overall Study|Other|1|||
155213688|NCT00613938|560222027|FG001|Overall Study|Other|2|||
155213689|NCT00613938|560222028|FG002|Overall Study|Other|1|||
155213690|NCT00613938|560222029|FG003|Overall Study|Other|3|||
155213691|NCT00623727|560222030|FG000|Double Blind (DB)|Adverse Event|1|||
155213692|NCT00623727|560222031|FG001|Double Blind (DB)|Adverse Event|3|||
155213693|NCT00623727|560222030|FG000|Double Blind (DB)|Physician Decision|0|||
155213694|NCT00623727|560222031|FG001|Double Blind (DB)|Physician Decision|1|||
155213695|NCT00623727|560222030|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
155213696|NCT00623727|560222031|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
155213697|NCT00623727|560222030|FG000|Double Blind (DB)|Lack of Efficacy|2|||
155213698|NCT00623727|560222031|FG001|Double Blind (DB)|Lack of Efficacy|2|||
155213699|NCT00623727|560222030|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
155213700|NCT00623727|560222031|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
155213701|NCT00623727|560222030|FG000|Double Blind (DB)|Lost to Follow-up|1|||
155213702|NCT00623727|560222031|FG001|Double Blind (DB)|Lost to Follow-up|1|||
155213703|NCT00623727|560222030|FG000|Double Blind (DB)|Protocol Violation|2|||
155213704|NCT00623727|560222031|FG001|Double Blind (DB)|Protocol Violation|2|||
155213705|NCT00623727|560222030|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
155213706|NCT00623727|560222031|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
155213707|NCT00623727|560222030|FG000|Open Label Follow-up|Study termination|0|||
155213708|NCT00623727|560222031|FG001|Open Label Follow-up|Study termination|6|||
155213709|NCT00623727|560222030|FG000|Open Label Follow-up|Participant convenience|0|||
155213710|NCT00623727|560222031|FG001|Open Label Follow-up|Participant convenience|1|||
155213711|NCT02636868|560222032|FG000|Overall Study|Death|0|||
155213712|NCT02636868|560222033|FG001|Overall Study|Death|1|||
155213713|NCT02636868|560222034|FG002|Overall Study|Death|2|||
155213714|NCT03220217|560222035|FG000|Overall Study|Withdrawal by Subject|0|||
155213715|NCT03220217|560222036|FG001|Overall Study|Withdrawal by Subject|1|||
155213716|NCT03220217|560222037|FG002|Overall Study|Withdrawal by Subject|0|||
155213717|NCT03220217|560222035|FG000|Overall Study|Subject Missed Procedure|0|||
155213718|NCT03220217|560222036|FG001|Overall Study|Subject Missed Procedure|0|||
155213719|NCT03220217|560222037|FG002|Overall Study|Subject Missed Procedure|1|||
155213720|NCT03025542|560222038|FG000|Overall Study|Adverse Event|0|||
155213721|NCT03025542|560222039|FG001|Overall Study|Adverse Event|2|||
155213722|NCT03025542|560222038|FG000|Overall Study|Lost to Follow-up|1|||
155213723|NCT03025542|560222039|FG001|Overall Study|Lost to Follow-up|0|||
155213724|NCT03025542|560222038|FG000|Overall Study|Withdrawal by Subject|1|||
155213725|NCT03025542|560222039|FG001|Overall Study|Withdrawal by Subject|0|||
155213726|NCT03745937|560222040|FG000|Overall Study|Withdrawal by Subject|0|||
155213727|NCT03745937|560222041|FG001|Overall Study|Withdrawal by Subject|0|||
155213728|NCT03745937|560222042|FG002|Overall Study|Withdrawal by Subject|0|||
155213729|NCT03745937|560222043|FG003|Overall Study|Withdrawal by Subject|1|||
155213730|NCT03745937|560222040|FG000|Overall Study|Not-specifed|0|||
155213731|NCT03745937|560222041|FG001|Overall Study|Not-specifed|1|||
155213732|NCT03745937|560222042|FG002|Overall Study|Not-specifed|0|||
155213733|NCT03745937|560222043|FG003|Overall Study|Not-specifed|1|||
155213734|NCT00501293|560222044|FG000|Optimization Period|Enrolled in error|1|||
155213735|NCT00501293|560222045|FG001|Optimization Period|Enrolled in error|0|||
155213736|NCT00501293|560222044|FG000|Maintenance Period|Withdrawal by Subject|14|||
155213737|NCT00501293|560222045|FG001|Maintenance Period|Withdrawal by Subject|13|||
155213738|NCT00501293|560222044|FG000|Maintenance Period|Lost to Follow-up|12|||
155213739|NCT00501293|560222045|FG001|Maintenance Period|Lost to Follow-up|7|||
155213740|NCT00501293|560222044|FG000|Maintenance Period|Adverse Event|6|||
155213741|NCT00501293|560222045|FG001|Maintenance Period|Adverse Event|6|||
155213742|NCT00501293|560222044|FG000|Maintenance Period|Protocol Violation|2|||
155213743|NCT00501293|560222045|FG001|Maintenance Period|Protocol Violation|1|||
155213744|NCT00501293|560222044|FG000|Maintenance Period|Lack of Efficacy|4|||
155213745|NCT00501293|560222045|FG001|Maintenance Period|Lack of Efficacy|1|||
155213746|NCT00501293|560222044|FG000|Maintenance Period|Noncompliant with study medication|5|||
155213747|NCT00501293|560222045|FG001|Maintenance Period|Noncompliant with study medication|0|||
155213748|NCT00501293|560222044|FG000|Maintenance Period|Went into rehabilitation|1|||
155213749|NCT00501293|560222045|FG001|Maintenance Period|Went into rehabilitation|0|||
155213750|NCT00501293|560222044|FG000|Maintenance Period|Would not wear patch|1|||
155213751|NCT00501293|560222045|FG001|Maintenance Period|Would not wear patch|0|||
155213752|NCT00501293|560222044|FG000|Maintenance Period|Application site reaction|1|||
155213753|NCT00501293|560222045|FG001|Maintenance Period|Application site reaction|0|||
155213754|NCT00488345|560222046|FG000|Overall Study|Adverse Event|0|||
155213755|NCT00488345|560222047|FG001|Overall Study|Adverse Event|1|||
155213756|NCT00488345|560222048|FG002|Overall Study|Adverse Event|1|||
155213757|NCT00488345|560222046|FG000|Overall Study|Unable to administer antibiotics at home|0|||
155213758|NCT00488345|560222047|FG001|Overall Study|Unable to administer antibiotics at home|1|||
155213759|NCT00488345|560222048|FG002|Overall Study|Unable to administer antibiotics at home|0|||
155213760|NCT00488345|560222046|FG000|Overall Study|Institutional Review Board review|0|||
155213761|NCT00488345|560222047|FG001|Overall Study|Institutional Review Board review|0|||
155213762|NCT00488345|560222048|FG002|Overall Study|Institutional Review Board review|1|||
155213763|NCT00488345|560222046|FG000|Overall Study|Surgical team recommendation|0|||
155213764|NCT00488345|560222047|FG001|Overall Study|Surgical team recommendation|1|||
155213765|NCT00488345|560222048|FG002|Overall Study|Surgical team recommendation|0|||
155213766|NCT00488345|560222046|FG000|Overall Study|Parent/legal guardian request|0|||
155213767|NCT00488345|560222047|FG001|Overall Study|Parent/legal guardian request|1|||
155213768|NCT00488345|560222048|FG002|Overall Study|Parent/legal guardian request|1|||
155213769|NCT00903617|560222051|FG000|Overall Study|Adverse Event|0|||
155213770|NCT00903617|560222052|FG001|Overall Study|Adverse Event|1|||
155213771|NCT00903617|560222053|FG002|Overall Study|Adverse Event|1|||
155213772|NCT00903617|560222054|FG003|Overall Study|Adverse Event|0|||
155213773|NCT00903617|560222051|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155213774|NCT00903617|560222052|FG001|Overall Study|Protocol-defined stopping criteria|2|||
155213775|NCT00903617|560222053|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155213776|NCT00903617|560222054|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155213777|NCT00903617|560222051|FG000|Overall Study|Lost to Follow-up|2|||
155213778|NCT00903617|560222052|FG001|Overall Study|Lost to Follow-up|0|||
155213779|NCT00903617|560222053|FG002|Overall Study|Lost to Follow-up|1|||
155213780|NCT00903617|560222054|FG003|Overall Study|Lost to Follow-up|1|||
155213781|NCT00903617|560222051|FG000|Overall Study|Withdrawal by Subject|1|||
155213782|NCT00903617|560222052|FG001|Overall Study|Withdrawal by Subject|2|||
155213783|NCT00903617|560222053|FG002|Overall Study|Withdrawal by Subject|3|||
155213784|NCT00903617|560222054|FG003|Overall Study|Withdrawal by Subject|0|||
155213785|NCT01104636|560222055|FG000|Overall Study|Lack of Efficacy|43|||
155213786|NCT01104636|560222055|FG000|Overall Study|Lost to Follow-up|24|||
155213787|NCT01104636|560222055|FG000|Overall Study|Withdrawal by Subject|4|||
155213788|NCT01104636|560222055|FG000|Overall Study|Other|43|||
155213789|NCT01104636|560222055|FG000|Overall Study|Study terminated by sponsor|1|||
155213790|NCT01104636|560222055|FG000|Overall Study|Pregnancy|2|||
155213791|NCT01104636|560222055|FG000|Overall Study|Adverse Event|40|||
155213792|NCT01104636|560222055|FG000|Overall Study|Ongoing|21|||
155213793|NCT01706003|560222056|FG000|Overall Study|Withdrawal by Subject|2|||
155213794|NCT01706003|560222057|FG001|Overall Study|Withdrawal by Subject|0|||
155213795|NCT01706003|560222056|FG000|Overall Study|Not scheduled|3|||
155213796|NCT01706003|560222057|FG001|Overall Study|Not scheduled|0|||
155213797|NCT01706003|560222056|FG000|Overall Study|Lost to Follow-up|6|||
155213798|NCT01706003|560222057|FG001|Overall Study|Lost to Follow-up|4|||
155213799|NCT03182829|560222060|FG000|Overall Study|Protocol Violation|12|||
155213800|NCT03182829|560222061|FG001|Overall Study|Protocol Violation|12|||
155213801|NCT03182829|560222060|FG000|Overall Study|Other|4|||
155213802|NCT03182829|560222061|FG001|Overall Study|Other|3|||
155213803|NCT03316131|560222062|FG000|Treatment Period 2|Protocol deviation|1|||
155213804|NCT03316131|560222063|FG001|Treatment Period 2|Protocol deviation|0|||
155213805|NCT05608005|560222064|FG000|Overall Study|Adverse Event|2|||
155213806|NCT05608005|560222065|FG001|Overall Study|Adverse Event|1|||
155213807|NCT05608005|560222066|FG002|Overall Study|Adverse Event|3|||
155213808|NCT05608005|560222064|FG000|Overall Study|Protocol Violation|2|||
155213809|NCT05608005|560222065|FG001|Overall Study|Protocol Violation|3|||
155213810|NCT05608005|560222066|FG002|Overall Study|Protocol Violation|0|||
155213811|NCT05608005|560222064|FG000|Overall Study|Withdrawal by Subject|10|||
155213812|NCT05608005|560222065|FG001|Overall Study|Withdrawal by Subject|12|||
155213813|NCT05608005|560222066|FG002|Overall Study|Withdrawal by Subject|4|||
155213814|NCT05608005|560222064|FG000|Overall Study|Lost to Follow-up|25|||
155213815|NCT05608005|560222065|FG001|Overall Study|Lost to Follow-up|27|||
155213816|NCT05608005|560222066|FG002|Overall Study|Lost to Follow-up|15|||
155213817|NCT05608005|560222064|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
155213818|NCT05608005|560222065|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
155213819|NCT05608005|560222066|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
155213820|NCT02259582|560222073|FG000|Overall Study|Physician Decision|0|||
155213821|NCT02259582|560222074|FG001|Overall Study|Physician Decision|1|||
155213822|NCT02259582|560222075|FG002|Overall Study|Physician Decision|0|||
155213823|NCT02259582|560222073|FG000|Overall Study|Death|0|||
155213824|NCT02259582|560222074|FG001|Overall Study|Death|0|||
155213825|NCT02259582|560222075|FG002|Overall Study|Death|1|||
155213826|NCT02259582|560222073|FG000|Overall Study|Adverse Event|1|||
155213827|NCT02259582|560222074|FG001|Overall Study|Adverse Event|0|||
155213828|NCT02259582|560222075|FG002|Overall Study|Adverse Event|1|||
155213829|NCT02259582|560222073|FG000|Overall Study|Withdrawal by Subject|0|||
155213830|NCT02259582|560222074|FG001|Overall Study|Withdrawal by Subject|0|||
155213831|NCT02259582|560222075|FG002|Overall Study|Withdrawal by Subject|1|||
155213832|NCT02259582|560222073|FG000|Overall Study|Disease progression|14|||
155213833|NCT02259582|560222074|FG001|Overall Study|Disease progression|15|||
155213834|NCT02259582|560222075|FG002|Overall Study|Disease progression|17|||
155213835|NCT02259582|560222073|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213836|NCT02259582|560222074|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213837|NCT02259582|560222075|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213838|NCT03518073|560222076|FG000|Overall Study|Adverse Event|2|||
155213839|NCT03518073|560222077|FG001|Overall Study|Adverse Event|4|||
155213840|NCT03518073|560222078|FG002|Overall Study|Adverse Event|2|||
155213841|NCT03518073|560222076|FG000|Overall Study|Death|2|||
155213842|NCT03518073|560222077|FG001|Overall Study|Death|1|||
155213843|NCT03518073|560222078|FG002|Overall Study|Death|3|||
155213844|NCT03518073|560222076|FG000|Overall Study|Lost to Follow-up|1|||
155213845|NCT03518073|560222077|FG001|Overall Study|Lost to Follow-up|0|||
155213846|NCT03518073|560222078|FG002|Overall Study|Lost to Follow-up|1|||
155213847|NCT03518073|560222076|FG000|Overall Study|Physician Decision|5|||
155213848|NCT03518073|560222077|FG001|Overall Study|Physician Decision|0|||
155213849|NCT03518073|560222078|FG002|Overall Study|Physician Decision|2|||
155213850|NCT03518073|560222076|FG000|Overall Study|Progressive disease|1|||
155213851|NCT03518073|560222077|FG001|Overall Study|Progressive disease|1|||
155213852|NCT03518073|560222078|FG002|Overall Study|Progressive disease|1|||
155213853|NCT03518073|560222076|FG000|Overall Study|Protocol Violation|1|||
155213854|NCT03518073|560222077|FG001|Overall Study|Protocol Violation|0|||
155213855|NCT03518073|560222078|FG002|Overall Study|Protocol Violation|0|||
155213856|NCT03518073|560222076|FG000|Overall Study|Withdrawal by Subject|30|||
155213857|NCT03518073|560222077|FG001|Overall Study|Withdrawal by Subject|34|||
155213858|NCT03518073|560222078|FG002|Overall Study|Withdrawal by Subject|29|||
155213859|NCT03518073|560222076|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155213860|NCT03518073|560222077|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
155213861|NCT03518073|560222078|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
155213862|NCT03518073|560222076|FG000|Overall Study|Covid-19|1|||
155213863|NCT03518073|560222077|FG001|Overall Study|Covid-19|2|||
155213864|NCT03518073|560222078|FG002|Overall Study|Covid-19|1|||
155213865|NCT03045081|560222079|FG000|Overall Study|Withdrawal by Subject|6|||
155213866|NCT03045081|560222080|FG001|Overall Study|Withdrawal by Subject|11|||
155213867|NCT01853046|560222081|FG000|Overall Study|Withdrawal by Subject|1|||
155213868|NCT01853046|560222082|FG001|Overall Study|Withdrawal by Subject|1|||
155213869|NCT01853046|560222081|FG000|Overall Study|Adverse Event|4|||
155213870|NCT01853046|560222082|FG001|Overall Study|Adverse Event|2|||
155213871|NCT01853046|560222081|FG000|Overall Study|Disease progression|13|||
155213872|NCT01853046|560222082|FG001|Overall Study|Disease progression|3|||
155213873|NCT03804879|560222083|FG000|Overall Study|Adverse Event|3|||
155213874|NCT03804879|560222084|FG001|Overall Study|Adverse Event|0|||
155213875|NCT03804879|560222083|FG000|Overall Study|Study Terminated By Sponsor|10|||
155213876|NCT03804879|560222084|FG001|Overall Study|Study Terminated By Sponsor|12|||
155213877|NCT03804879|560222083|FG000|Overall Study|Withdrawal by Subject|3|||
155213878|NCT03804879|560222084|FG001|Overall Study|Withdrawal by Subject|1|||
155213879|NCT00708162|560222085|FG000|Randomized Phase|Randomized but Not Treated|7|||
155213880|NCT00708162|560222086|FG001|Randomized Phase|Randomized but Not Treated|5|||
155213881|NCT00708162|560222085|FG000|Randomized Phase|Participant Noncompliance|40|||
155213882|NCT00708162|560222086|FG001|Randomized Phase|Participant Noncompliance|32|||
155213883|NCT00708162|560222085|FG000|Randomized Phase|Lost to Follow-up|34|||
155213884|NCT00708162|560222086|FG001|Randomized Phase|Lost to Follow-up|34|||
155213885|NCT00708162|560222085|FG000|Randomized Phase|Withdrew Consent|31|||
155213886|NCT00708162|560222086|FG001|Randomized Phase|Withdrew Consent|22|||
155213887|NCT00708162|560222085|FG000|Randomized Phase|Lack of Efficacy|14|||
155213888|NCT00708162|560222086|FG001|Randomized Phase|Lack of Efficacy|19|||
155213889|NCT00708162|560222085|FG000|Randomized Phase|Protocol Violation|10|||
155213890|NCT00708162|560222086|FG001|Randomized Phase|Protocol Violation|11|||
155213891|NCT00708162|560222085|FG000|Randomized Phase|Adverse Event|8|||
155213892|NCT00708162|560222086|FG001|Randomized Phase|Adverse Event|12|||
155213893|NCT00708162|560222085|FG000|Randomized Phase|Investigator's Discretion|7|||
155213894|NCT00708162|560222086|FG001|Randomized Phase|Investigator's Discretion|10|||
155213895|NCT00708162|560222085|FG000|Randomized Phase|Death|2|||
155213896|NCT00708162|560222086|FG001|Randomized Phase|Death|9|||
155213897|NCT00708162|560222085|FG000|Randomized Phase|Pregnancy|3|||
155213898|NCT00708162|560222086|FG001|Randomized Phase|Pregnancy|0|||
155213899|NCT00708162|560222085|FG000|Open-Label Phase|Lost to Follow-up|10|||
155213900|NCT00708162|560222086|FG001|Open-Label Phase|Lost to Follow-up|8|||
155213901|NCT00708162|560222085|FG000|Open-Label Phase|Withdrew Consent|12|||
155213902|NCT00708162|560222086|FG001|Open-Label Phase|Withdrew Consent|6|||
155213903|NCT00708162|560222085|FG000|Open-Label Phase|Participant Noncompliance|7|||
155213904|NCT00708162|560222086|FG001|Open-Label Phase|Participant Noncompliance|7|||
155213905|NCT00708162|560222085|FG000|Open-Label Phase|Lack of Efficacy|7|||
155213906|NCT00708162|560222086|FG001|Open-Label Phase|Lack of Efficacy|4|||
155213907|NCT00708162|560222085|FG000|Open-Label Phase|Investigator's Discretion|3|||
155213908|NCT00708162|560222086|FG001|Open-Label Phase|Investigator's Discretion|2|||
155213909|NCT00708162|560222085|FG000|Open-Label Phase|Death|3|||
155213910|NCT00708162|560222086|FG001|Open-Label Phase|Death|1|||
155213911|NCT00708162|560222085|FG000|Open-Label Phase|Adverse Event|1|||
155213912|NCT00708162|560222086|FG001|Open-Label Phase|Adverse Event|2|||
155213913|NCT00708162|560222085|FG000|Open-Label Phase|Other|1|||
155213914|NCT00708162|560222086|FG001|Open-Label Phase|Other|0|||
155213915|NCT02699554|560222088|FG000|Overall Study|Lost to Follow-up|9|||
155213916|NCT00788151|560222089|FG000|Overall Study|Other adverse event|0|||
155213917|NCT00788151|560222090|FG001|Overall Study|Other adverse event|2|||
155213918|NCT00788151|560222089|FG000|Overall Study|Protocol Violation|0|||
155213919|NCT00788151|560222090|FG001|Overall Study|Protocol Violation|1|||
155213920|NCT00788151|560222089|FG000|Overall Study|Withdrawal by Subject|13|||
155213921|NCT00788151|560222090|FG001|Overall Study|Withdrawal by Subject|6|||
155213922|NCT00788151|560222089|FG000|Overall Study|Enrolled but not treated|1|||
155213923|NCT00788151|560222090|FG001|Overall Study|Enrolled but not treated|1|||
155213924|NCT00503009|560222091|FG000|Overall Study|Protocol Violation|1|||
155213925|NCT00503009|560222092|FG001|Overall Study|Protocol Violation|0|||
155213926|NCT00503009|560222093|FG002|Overall Study|Protocol Violation|1|||
155213927|NCT00503009|560222091|FG000|Overall Study|Withdrawal by Subject|0|||
155213928|NCT00503009|560222092|FG001|Overall Study|Withdrawal by Subject|1|||
155213929|NCT00503009|560222093|FG002|Overall Study|Withdrawal by Subject|1|||
155213930|NCT00503009|560222091|FG000|Overall Study|Physician Decision|0|||
155213931|NCT00503009|560222092|FG001|Overall Study|Physician Decision|1|||
155213932|NCT00503009|560222093|FG002|Overall Study|Physician Decision|1|||
155213933|NCT02169739|560222096|FG000|Overall Study|Lost to Follow-up|0|||
155213934|NCT02169739|560222097|FG001|Overall Study|Lost to Follow-up|4|||
155213935|NCT03635957|560222098|FG000|Run-In Period|Lost to Follow-up|1|||
155213936|NCT03635957|560222098|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
155213937|NCT01710033|560222099|FG000|Stage 2|Adverse Event|0|||
155213938|NCT01710033|560222100|FG001|Stage 2|Adverse Event|0|||
155213939|NCT01710033|560222101|FG002|Stage 2|Adverse Event|0|||
155213940|NCT01710033|560222102|FG003|Stage 2|Adverse Event|0|||
155213941|NCT01710033|560222103|FG004|Stage 2|Adverse Event|1|||
155213942|NCT00100815|560222104|FG000|Overall Study|Progression|24|||
155213943|NCT00100815|560222104|FG000|Overall Study|Adverse Event|18|||
155213944|NCT00100815|560222104|FG000|Overall Study|Death|4|||
155213945|NCT00100815|560222104|FG000|Overall Study|Other|3|||
155213946|NCT01525550|560222111|FG000|Overall Study|Lost to Follow-up|8|||
155213947|NCT01525550|560222112|FG001|Overall Study|Lost to Follow-up|2|||
155213948|NCT01525550|560222111|FG000|Overall Study|Death|19|||
155213949|NCT01525550|560222112|FG001|Overall Study|Death|28|||
155213950|NCT01525550|560222111|FG000|Overall Study|Other|0|||
155213951|NCT01525550|560222112|FG001|Overall Study|Other|4|||
155213952|NCT01525550|560222111|FG000|Overall Study|Sponsor's Decision|30|||
155213953|NCT01525550|560222112|FG001|Overall Study|Sponsor's Decision|11|||
155213954|NCT01525550|560222111|FG000|Overall Study|Withdrawal by Subject|4|||
155213955|NCT01525550|560222112|FG001|Overall Study|Withdrawal by Subject|0|||
155213956|NCT02522286|560222114|FG000|Overall Study|Withdrawal by Subject|3|||
155213957|NCT02522286|560222115|FG001|Overall Study|Withdrawal by Subject|0|||
155213958|NCT02522286|560222116|FG002|Overall Study|Withdrawal by Subject|0|||
155213959|NCT02522286|560222117|FG003|Overall Study|Withdrawal by Subject|3|||
155213960|NCT01244906|560222118|FG000|Overall Study|Death|2|||
155213961|NCT01244906|560222118|FG000|Overall Study|Progression of disease post treatment|6|||
155213962|NCT03480750|560222121|FG000|Overall Study|Withdrawal by Subject|0|||
155213963|NCT03480750|560222122|FG001|Overall Study|Withdrawal by Subject|1|||
155213964|NCT03480750|560222123|FG002|Overall Study|Withdrawal by Subject|0|||
155213965|NCT03480750|560222124|FG003|Overall Study|Withdrawal by Subject|0|||
155213966|NCT03480750|560222125|FG004|Overall Study|Withdrawal by Subject|0|||
155213967|NCT03480750|560222126|FG005|Overall Study|Withdrawal by Subject|0|||
155213968|NCT03480750|560222121|FG000|Overall Study|The interruption in Trientine shippment|0|||
155213969|NCT03480750|560222122|FG001|Overall Study|The interruption in Trientine shippment|0|||
155213970|NCT03480750|560222123|FG002|Overall Study|The interruption in Trientine shippment|0|||
155213971|NCT03480750|560222124|FG003|Overall Study|The interruption in Trientine shippment|0|||
155213972|NCT03480750|560222125|FG004|Overall Study|The interruption in Trientine shippment|0|||
155213973|NCT03480750|560222126|FG005|Overall Study|The interruption in Trientine shippment|1|||
155213974|NCT00723892|560222127|FG000|Overall Study|Participant not tracked|33|||
155213975|NCT00723892|560222128|FG001|Overall Study|Participant not tracked|35|||
155213976|NCT00723892|560222127|FG000|Overall Study|Virological criterion|24|||
155213977|NCT00723892|560222128|FG001|Overall Study|Virological criterion|9|||
155213978|NCT00723892|560222127|FG000|Overall Study|Withdrawal by Subject|6|||
155213979|NCT00723892|560222128|FG001|Overall Study|Withdrawal by Subject|9|||
155213980|NCT00723892|560222127|FG000|Overall Study|End planned|11|||
155213981|NCT00723892|560222128|FG001|Overall Study|End planned|7|||
155213982|NCT00723892|560222127|FG000|Overall Study|Bad tolerance|5|||
155213983|NCT00723892|560222128|FG001|Overall Study|Bad tolerance|5|||
155213984|NCT00723892|560222127|FG000|Overall Study|Multiple reasons|17|||
155213985|NCT00723892|560222128|FG001|Overall Study|Multiple reasons|12|||
155213986|NCT00723892|560222127|FG000|Overall Study|Other|6|||
155213987|NCT00723892|560222128|FG001|Overall Study|Other|3|||
155213988|NCT00723892|560222127|FG000|Overall Study|Study end|1|||
155213989|NCT00723892|560222128|FG001|Overall Study|Study end|3|||
155213990|NCT00723892|560222127|FG000|Overall Study|Weight loss|1|||
155213991|NCT00723892|560222128|FG001|Overall Study|Weight loss|3|||
155213992|NCT00723892|560222127|FG000|Overall Study|Alcohol abuse|0|||
155213993|NCT00723892|560222128|FG001|Overall Study|Alcohol abuse|1|||
155213994|NCT00723892|560222127|FG000|Overall Study|Intercurrent infection|2|||
155213995|NCT00723892|560222128|FG001|Overall Study|Intercurrent infection|0|||
155213996|NCT00723892|560222127|FG000|Overall Study|Drug addiction|1|||
155213997|NCT00723892|560222128|FG001|Overall Study|Drug addiction|0|||
155213998|NCT02411292|560222129|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
155213999|NCT02411292|560222129|FG000|Overall Study|Death|2|||
155214000|NCT02411292|560222129|FG000|Overall Study|Lost to Follow-up|3|||
155214001|NCT03060447|560222130|FG000|Overall Study|Withdrawal by Subject|2|||
155214002|NCT03060447|560222131|FG001|Overall Study|Withdrawal by Subject|0|||
155214003|NCT02232425|560222132|FG000|Overall Study|Lost to Follow-up|6|||
155214004|NCT02232425|560222133|FG001|Overall Study|Lost to Follow-up|2|||
155214005|NCT02232425|560222132|FG000|Overall Study|Adverse Event|2|||
155214006|NCT02232425|560222133|FG001|Overall Study|Adverse Event|0|||
155214007|NCT02232425|560222132|FG000|Overall Study|Withdrawal by Subject|5|||
155214008|NCT02232425|560222133|FG001|Overall Study|Withdrawal by Subject|6|||
155214009|NCT02232425|560222132|FG000|Overall Study|Lack of Efficacy|1|||
155214010|NCT02232425|560222133|FG001|Overall Study|Lack of Efficacy|0|||
155214011|NCT01601626|560222136|FG000|Overall Study|Death|1|||
155214012|NCT01601626|560222137|FG001|Overall Study|Death|1|||
155214013|NCT01601626|560222138|FG002|Overall Study|Death|1|||
155214014|NCT01601626|560222136|FG000|Overall Study|Lost to Follow-up|1|||
155214015|NCT01601626|560222137|FG001|Overall Study|Lost to Follow-up|2|||
155214016|NCT01601626|560222138|FG002|Overall Study|Lost to Follow-up|0|||
155214017|NCT01601626|560222136|FG000|Overall Study|Unable to Get to Clinic|0|||
155214018|NCT01601626|560222137|FG001|Overall Study|Unable to Get to Clinic|1|||
155214019|NCT01601626|560222138|FG002|Overall Study|Unable to Get to Clinic|0|||
155214020|NCT01601626|560222136|FG000|Overall Study|Withdrawal by Subject|0|||
155214021|NCT01601626|560222137|FG001|Overall Study|Withdrawal by Subject|1|||
155214022|NCT01601626|560222138|FG002|Overall Study|Withdrawal by Subject|1|||
155214023|NCT01601626|560222136|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
155214024|NCT01601626|560222137|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
155214025|NCT01601626|560222138|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
155214026|NCT00498602|560222139|FG000|Overall Study|Death|0|||
155214027|NCT00498602|560222140|FG001|Overall Study|Death|0|||
155214028|NCT00498602|560222141|FG002|Overall Study|Death|0|||
155214029|NCT00498602|560222142|FG003|Overall Study|Death|0|||
155214030|NCT00498602|560222143|FG004|Overall Study|Death|0|||
155214031|NCT00498602|560222144|FG005|Overall Study|Death|1|||
155214032|NCT00498602|560222145|FG006|Overall Study|Death|0|||
155214033|NCT00498602|560222139|FG000|Overall Study|Lack of Efficacy|1|||
155214034|NCT00498602|560222140|FG001|Overall Study|Lack of Efficacy|0|||
155214035|NCT00498602|560222141|FG002|Overall Study|Lack of Efficacy|0|||
155214036|NCT00498602|560222142|FG003|Overall Study|Lack of Efficacy|0|||
155214037|NCT00498602|560222143|FG004|Overall Study|Lack of Efficacy|0|||
155214038|NCT00498602|560222144|FG005|Overall Study|Lack of Efficacy|0|||
155214039|NCT00498602|560222145|FG006|Overall Study|Lack of Efficacy|0|||
155214040|NCT00498602|560222139|FG000|Overall Study|Lost to Follow-up|0|||
155214041|NCT00498602|560222140|FG001|Overall Study|Lost to Follow-up|2|||
155214042|NCT00498602|560222141|FG002|Overall Study|Lost to Follow-up|0|||
155214043|NCT00498602|560222142|FG003|Overall Study|Lost to Follow-up|2|||
155214044|NCT00498602|560222143|FG004|Overall Study|Lost to Follow-up|0|||
155214045|NCT00498602|560222144|FG005|Overall Study|Lost to Follow-up|0|||
155214046|NCT00498602|560222145|FG006|Overall Study|Lost to Follow-up|0|||
155214047|NCT00498602|560222139|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155214048|NCT00498602|560222140|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214049|NCT00498602|560222141|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
155214050|NCT00498602|560222142|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
155214051|NCT00498602|560222143|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214052|NCT00498602|560222144|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155214053|NCT00498602|560222145|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214054|NCT00498602|560222139|FG000|Overall Study|AE not related to Study Drug|1|||
155214055|NCT00498602|560222140|FG001|Overall Study|AE not related to Study Drug|3|||
155214056|NCT00498602|560222141|FG002|Overall Study|AE not related to Study Drug|0|||
155214057|NCT00498602|560222142|FG003|Overall Study|AE not related to Study Drug|0|||
155214058|NCT00498602|560222143|FG004|Overall Study|AE not related to Study Drug|2|||
155214059|NCT00498602|560222144|FG005|Overall Study|AE not related to Study Drug|2|||
155214060|NCT00498602|560222145|FG006|Overall Study|AE not related to Study Drug|1|||
155214061|NCT00498602|560222139|FG000|Overall Study|Caregiver Request|2|||
155214062|NCT00498602|560222140|FG001|Overall Study|Caregiver Request|2|||
155214063|NCT00498602|560222141|FG002|Overall Study|Caregiver Request|2|||
155214064|NCT00498602|560222142|FG003|Overall Study|Caregiver Request|0|||
155214065|NCT00498602|560222143|FG004|Overall Study|Caregiver Request|1|||
155214066|NCT00498602|560222144|FG005|Overall Study|Caregiver Request|2|||
155214067|NCT00498602|560222145|FG006|Overall Study|Caregiver Request|0|||
155214068|NCT00498602|560222139|FG000|Overall Study|Investigator Request|0|||
155214069|NCT00498602|560222140|FG001|Overall Study|Investigator Request|0|||
155214070|NCT00498602|560222141|FG002|Overall Study|Investigator Request|1|||
155214071|NCT00498602|560222142|FG003|Overall Study|Investigator Request|0|||
155214072|NCT00498602|560222143|FG004|Overall Study|Investigator Request|0|||
155214073|NCT00498602|560222144|FG005|Overall Study|Investigator Request|0|||
155214074|NCT00498602|560222145|FG006|Overall Study|Investigator Request|0|||
155214075|NCT00498602|560222139|FG000|Overall Study|Subject Request|3|||
155214076|NCT00498602|560222140|FG001|Overall Study|Subject Request|0|||
155214077|NCT00498602|560222141|FG002|Overall Study|Subject Request|1|||
155214078|NCT00498602|560222142|FG003|Overall Study|Subject Request|1|||
155214079|NCT00498602|560222143|FG004|Overall Study|Subject Request|1|||
155214080|NCT00498602|560222144|FG005|Overall Study|Subject Request|4|||
155214081|NCT00498602|560222145|FG006|Overall Study|Subject Request|1|||
155214082|NCT00498602|560222139|FG000|Overall Study|Other|2|||
155214083|NCT00498602|560222140|FG001|Overall Study|Other|3|||
155214084|NCT00498602|560222141|FG002|Overall Study|Other|1|||
155214085|NCT00498602|560222142|FG003|Overall Study|Other|0|||
155214086|NCT00498602|560222143|FG004|Overall Study|Other|0|||
155214087|NCT00498602|560222144|FG005|Overall Study|Other|3|||
155214088|NCT00498602|560222145|FG006|Overall Study|Other|0|||
155214089|NCT02632552|560222146|FG000|Overall Study|Lost to Follow-up|14|||
155214090|NCT02632552|560222147|FG001|Overall Study|Lost to Follow-up|8|||
155214091|NCT02632552|560222146|FG000|Overall Study|Withdrawal by Subject|2|||
155214092|NCT02632552|560222147|FG001|Overall Study|Withdrawal by Subject|0|||
155214093|NCT02632552|560222146|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
155214094|NCT02632552|560222147|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
155214095|NCT02611778|560222148|FG000|Overall Study|Withdrawal by Subject|2|||
155214096|NCT02611778|560222149|FG001|Overall Study|Withdrawal by Subject|8|||
155214097|NCT02611778|560222148|FG000|Overall Study|Adverse Event|1|||
155214098|NCT02611778|560222149|FG001|Overall Study|Adverse Event|2|||
155214099|NCT02611778|560222148|FG000|Overall Study|Death|2|||
155214100|NCT02611778|560222149|FG001|Overall Study|Death|1|||
155214101|NCT02611778|560222148|FG000|Overall Study|Protocol Violation|1|||
155214102|NCT02611778|560222149|FG001|Overall Study|Protocol Violation|0|||
155214103|NCT02611778|560222148|FG000|Overall Study|Lost to Follow-up|3|||
155214104|NCT02611778|560222149|FG001|Overall Study|Lost to Follow-up|1|||
155214105|NCT02611778|560222148|FG000|Overall Study|Need for alternative treatment|1|||
155214106|NCT02611778|560222149|FG001|Overall Study|Need for alternative treatment|0|||
155214107|NCT02611778|560222148|FG000|Overall Study|Other Reason|2|||
155214108|NCT02611778|560222149|FG001|Overall Study|Other Reason|1|||
155214109|NCT03108027|560222150|FG000|Period 1|Subject/Guardian Decision|0|||
155214110|NCT03108027|560222151|FG001|Period 1|Subject/Guardian Decision|0|||
155214111|NCT03108027|560222152|FG002|Period 1|Subject/Guardian Decision|0|||
155214112|NCT03108027|560222153|FG003|Period 1|Subject/Guardian Decision|2|||
155214113|NCT03108027|560222154|FG004|Period 1|Subject/Guardian Decision|0|||
155214114|NCT03108027|560222155|FG005|Period 1|Subject/Guardian Decision|0|||
155214115|NCT03108027|560222150|FG000|Period 3|Adverse Event|0|||
155214116|NCT03108027|560222151|FG001|Period 3|Adverse Event|1|||
155214117|NCT03108027|560222152|FG002|Period 3|Adverse Event|0|||
155214118|NCT03108027|560222153|FG003|Period 3|Adverse Event|0|||
155214119|NCT03108027|560222154|FG004|Period 3|Adverse Event|0|||
155214120|NCT03108027|560222155|FG005|Period 3|Adverse Event|0|||
155214121|NCT02426892|560222156|FG000|Overall Study|Adverse Event|2|||
155214122|NCT02426892|560222156|FG000|Overall Study|Lack of Efficacy|17|||
155214123|NCT02426892|560222156|FG000|Overall Study|Withdrawal by Subject|1|||
155214124|NCT03402386|560222157|FG000|Overall Study|Adverse Event|3|||
155214125|NCT03402386|560222157|FG000|Overall Study|Physician Decision|1|||
155214126|NCT03402386|560222157|FG000|Overall Study|Difficult to control Hb|2|||
155214127|NCT00268996|560222158|FG000|Overall Study|Adverse Event|11|||
155214128|NCT00268996|560222159|FG001|Overall Study|Adverse Event|7|||
155214129|NCT00268996|560222158|FG000|Overall Study|Lost to Follow-up|3|||
155214130|NCT00268996|560222159|FG001|Overall Study|Lost to Follow-up|1|||
155214131|NCT00268996|560222158|FG000|Overall Study|Withdrawal by Subject|5|||
155214132|NCT00268996|560222159|FG001|Overall Study|Withdrawal by Subject|11|||
155214133|NCT00268996|560222158|FG000|Overall Study|Non-compliance|1|||
155214134|NCT00268996|560222159|FG001|Overall Study|Non-compliance|0|||
155214135|NCT00268996|560222158|FG000|Overall Study|Other|1|||
155214136|NCT00268996|560222159|FG001|Overall Study|Other|1|||
155214137|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
155214138|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214139|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214140|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214141|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214142|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
155214143|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214144|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214145|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
155214146|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
155214147|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
155214148|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
155214149|NCT02744391|560222164|FG000|Overall Study|Lost to Follow-up|9|||
155214150|NCT02744391|560222164|FG000|Overall Study|Physician Decision|2|||
155214151|NCT02744391|560222164|FG000|Overall Study|Withdrawal by Subject|3|||
155214152|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
155214153|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
155214154|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
155214155|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
155214156|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
155214157|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
155214158|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
155214159|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
155214160|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
155214161|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
155214162|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
155214163|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
155214164|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
155214165|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
155214166|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
155214167|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
155214168|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
155214169|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
155214170|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
155214171|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
155214172|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
155214173|NCT02554812|560222170|FG000|Overall Study|Adverse Event|2|||
155214174|NCT02554812|560222171|FG001|Overall Study|Adverse Event|5|||
155214175|NCT02554812|560222172|FG002|Overall Study|Adverse Event|3|||
155214176|NCT02554812|560222173|FG003|Overall Study|Adverse Event|0|||
155214177|NCT02554812|560222174|FG004|Overall Study|Adverse Event|5|||
155214178|NCT02554812|560222175|FG005|Overall Study|Adverse Event|0|||
155214179|NCT02554812|560222176|FG006|Overall Study|Adverse Event|1|||
155214180|NCT02554812|560222177|FG007|Overall Study|Adverse Event|6|||
155214181|NCT02554812|560222178|FG008|Overall Study|Adverse Event|2|||
155214182|NCT02554812|560222179|FG009|Overall Study|Adverse Event|2|||
155214183|NCT02554812|560222180|FG010|Overall Study|Adverse Event|1|||
155214184|NCT02554812|560222181|FG011|Overall Study|Adverse Event|2|||
155214185|NCT02554812|560222182|FG012|Overall Study|Adverse Event|0|||
155214186|NCT02554812|560222183|FG013|Overall Study|Adverse Event|3|||
155214187|NCT02554812|560222184|FG014|Overall Study|Adverse Event|2|||
155214188|NCT02554812|560222185|FG015|Overall Study|Adverse Event|1|||
155214189|NCT02554812|560222186|FG016|Overall Study|Adverse Event|0|||
155214190|NCT02554812|560222187|FG017|Overall Study|Adverse Event|1|||
155214191|NCT02554812|560222188|FG018|Overall Study|Adverse Event|0|||
155214192|NCT02554812|560222189|FG019|Overall Study|Adverse Event|0|||
155214193|NCT02554812|560222190|FG020|Overall Study|Adverse Event|0|||
155214194|NCT02554812|560222191|FG021|Overall Study|Adverse Event|2|||
155214195|NCT02554812|560222192|FG022|Overall Study|Adverse Event|1|||
155214196|NCT02554812|560222193|FG023|Overall Study|Adverse Event|1|||
155214197|NCT02554812|560222194|FG024|Overall Study|Adverse Event|1|||
155214198|NCT02554812|560222195|FG025|Overall Study|Adverse Event|2|||
155214199|NCT02554812|560222196|FG026|Overall Study|Adverse Event|1|||
155214200|NCT02554812|560222170|FG000|Overall Study|Death|1|||
155214201|NCT02554812|560222171|FG001|Overall Study|Death|2|||
155214202|NCT02554812|560222172|FG002|Overall Study|Death|2|||
155214203|NCT02554812|560222173|FG003|Overall Study|Death|2|||
155214204|NCT02554812|560222174|FG004|Overall Study|Death|0|||
155214205|NCT02554812|560222175|FG005|Overall Study|Death|1|||
155214206|NCT02554812|560222176|FG006|Overall Study|Death|1|||
155214207|NCT02554812|560222177|FG007|Overall Study|Death|1|||
155214208|NCT02554812|560222178|FG008|Overall Study|Death|0|||
155214209|NCT02554812|560222179|FG009|Overall Study|Death|0|||
155214210|NCT02554812|560222180|FG010|Overall Study|Death|0|||
155214211|NCT02554812|560222181|FG011|Overall Study|Death|0|||
155214212|NCT02554812|560222182|FG012|Overall Study|Death|0|||
155214213|NCT02554812|560222183|FG013|Overall Study|Death|0|||
155214214|NCT02554812|560222184|FG014|Overall Study|Death|1|||
155214215|NCT02554812|560222185|FG015|Overall Study|Death|1|||
155214216|NCT02554812|560222186|FG016|Overall Study|Death|1|||
155214217|NCT02554812|560222187|FG017|Overall Study|Death|0|||
155214218|NCT02554812|560222188|FG018|Overall Study|Death|1|||
155214219|NCT02554812|560222189|FG019|Overall Study|Death|2|||
155214220|NCT02554812|560222190|FG020|Overall Study|Death|0|||
155214221|NCT02554812|560222191|FG021|Overall Study|Death|1|||
155214222|NCT02554812|560222192|FG022|Overall Study|Death|1|||
155214223|NCT02554812|560222193|FG023|Overall Study|Death|0|||
155214224|NCT02554812|560222194|FG024|Overall Study|Death|0|||
155214225|NCT02554812|560222195|FG025|Overall Study|Death|0|||
155214226|NCT02554812|560222196|FG026|Overall Study|Death|0|||
155214227|NCT02554812|560222170|FG000|Overall Study|Lost to Follow-up|0|||
155214228|NCT02554812|560222171|FG001|Overall Study|Lost to Follow-up|1|||
155214229|NCT02554812|560222172|FG002|Overall Study|Lost to Follow-up|0|||
155214230|NCT02554812|560222173|FG003|Overall Study|Lost to Follow-up|0|||
155214231|NCT02554812|560222174|FG004|Overall Study|Lost to Follow-up|0|||
155214232|NCT02554812|560222175|FG005|Overall Study|Lost to Follow-up|0|||
155214233|NCT02554812|560222176|FG006|Overall Study|Lost to Follow-up|0|||
155214234|NCT02554812|560222177|FG007|Overall Study|Lost to Follow-up|0|||
155214235|NCT02554812|560222178|FG008|Overall Study|Lost to Follow-up|0|||
155214236|NCT02554812|560222179|FG009|Overall Study|Lost to Follow-up|0|||
155214237|NCT02554812|560222180|FG010|Overall Study|Lost to Follow-up|0|||
155214238|NCT02554812|560222181|FG011|Overall Study|Lost to Follow-up|0|||
155214239|NCT02554812|560222182|FG012|Overall Study|Lost to Follow-up|0|||
155214240|NCT02554812|560222183|FG013|Overall Study|Lost to Follow-up|0|||
155214241|NCT02554812|560222184|FG014|Overall Study|Lost to Follow-up|0|||
155214242|NCT02554812|560222185|FG015|Overall Study|Lost to Follow-up|0|||
155214243|NCT02554812|560222186|FG016|Overall Study|Lost to Follow-up|0|||
155214244|NCT02554812|560222187|FG017|Overall Study|Lost to Follow-up|0|||
155214245|NCT02554812|560222188|FG018|Overall Study|Lost to Follow-up|0|||
155214246|NCT02554812|560222189|FG019|Overall Study|Lost to Follow-up|0|||
155214247|NCT02554812|560222190|FG020|Overall Study|Lost to Follow-up|0|||
155214248|NCT02554812|560222191|FG021|Overall Study|Lost to Follow-up|0|||
155214249|NCT02554812|560222192|FG022|Overall Study|Lost to Follow-up|0|||
155214250|NCT02554812|560222193|FG023|Overall Study|Lost to Follow-up|0|||
155214251|NCT02554812|560222194|FG024|Overall Study|Lost to Follow-up|0|||
155214252|NCT02554812|560222195|FG025|Overall Study|Lost to Follow-up|0|||
155214253|NCT02554812|560222196|FG026|Overall Study|Lost to Follow-up|0|||
155214254|NCT02554812|560222170|FG000|Overall Study|Global deterioration of health status|4|||
155214255|NCT02554812|560222171|FG001|Overall Study|Global deterioration of health status|3|||
155214256|NCT02554812|560222172|FG002|Overall Study|Global deterioration of health status|3|||
155214257|NCT02554812|560222173|FG003|Overall Study|Global deterioration of health status|2|||
155214258|NCT02554812|560222174|FG004|Overall Study|Global deterioration of health status|5|||
155214259|NCT02554812|560222175|FG005|Overall Study|Global deterioration of health status|0|||
155214260|NCT02554812|560222176|FG006|Overall Study|Global deterioration of health status|2|||
155214261|NCT02554812|560222177|FG007|Overall Study|Global deterioration of health status|1|||
155214262|NCT02554812|560222178|FG008|Overall Study|Global deterioration of health status|1|||
155214263|NCT02554812|560222179|FG009|Overall Study|Global deterioration of health status|1|||
155214264|NCT02554812|560222180|FG010|Overall Study|Global deterioration of health status|2|||
155214265|NCT02554812|560222181|FG011|Overall Study|Global deterioration of health status|1|||
155214266|NCT02554812|560222182|FG012|Overall Study|Global deterioration of health status|0|||
155214267|NCT02554812|560222183|FG013|Overall Study|Global deterioration of health status|0|||
155214268|NCT02554812|560222184|FG014|Overall Study|Global deterioration of health status|0|||
155214269|NCT02554812|560222185|FG015|Overall Study|Global deterioration of health status|1|||
155214270|NCT02554812|560222186|FG016|Overall Study|Global deterioration of health status|0|||
155214271|NCT02554812|560222187|FG017|Overall Study|Global deterioration of health status|0|||
155214272|NCT02554812|560222188|FG018|Overall Study|Global deterioration of health status|0|||
155214273|NCT02554812|560222189|FG019|Overall Study|Global deterioration of health status|0|||
155214274|NCT02554812|560222190|FG020|Overall Study|Global deterioration of health status|0|||
155214275|NCT02554812|560222191|FG021|Overall Study|Global deterioration of health status|0|||
155214276|NCT02554812|560222192|FG022|Overall Study|Global deterioration of health status|0|||
155214277|NCT02554812|560222193|FG023|Overall Study|Global deterioration of health status|0|||
155214278|NCT02554812|560222194|FG024|Overall Study|Global deterioration of health status|0|||
155214279|NCT02554812|560222195|FG025|Overall Study|Global deterioration of health status|0|||
155214280|NCT02554812|560222196|FG026|Overall Study|Global deterioration of health status|0|||
155214281|NCT02554812|560222170|FG000|Overall Study|Progressive disease|20|||
155214282|NCT02554812|560222171|FG001|Overall Study|Progressive disease|16|||
155214283|NCT02554812|560222172|FG002|Overall Study|Progressive disease|19|||
155214284|NCT02554812|560222173|FG003|Overall Study|Progressive disease|18|||
155214285|NCT02554812|560222174|FG004|Overall Study|Progressive disease|21|||
155214286|NCT02554812|560222175|FG005|Overall Study|Progressive disease|15|||
155214287|NCT02554812|560222176|FG006|Overall Study|Progressive disease|6|||
155214288|NCT02554812|560222177|FG007|Overall Study|Progressive disease|13|||
155214289|NCT02554812|560222178|FG008|Overall Study|Progressive disease|6|||
155214290|NCT02554812|560222179|FG009|Overall Study|Progressive disease|6|||
155214291|NCT02554812|560222180|FG010|Overall Study|Progressive disease|8|||
155214292|NCT02554812|560222181|FG011|Overall Study|Progressive disease|8|||
155214293|NCT02554812|560222182|FG012|Overall Study|Progressive disease|6|||
155214294|NCT02554812|560222183|FG013|Overall Study|Progressive disease|10|||
155214295|NCT02554812|560222184|FG014|Overall Study|Progressive disease|20|||
155214296|NCT02554812|560222185|FG015|Overall Study|Progressive disease|6|||
155214297|NCT02554812|560222186|FG016|Overall Study|Progressive disease|3|||
155214298|NCT02554812|560222187|FG017|Overall Study|Progressive disease|3|||
155214299|NCT02554812|560222188|FG018|Overall Study|Progressive disease|11|||
155214300|NCT02554812|560222189|FG019|Overall Study|Progressive disease|7|||
155214301|NCT02554812|560222190|FG020|Overall Study|Progressive disease|11|||
155214302|NCT02554812|560222191|FG021|Overall Study|Progressive disease|6|||
155214303|NCT02554812|560222192|FG022|Overall Study|Progressive disease|9|||
155214304|NCT02554812|560222193|FG023|Overall Study|Progressive disease|9|||
155214305|NCT02554812|560222194|FG024|Overall Study|Progressive disease|4|||
155214306|NCT02554812|560222195|FG025|Overall Study|Progressive disease|5|||
155214307|NCT02554812|560222196|FG026|Overall Study|Progressive disease|5|||
155214308|NCT02554812|560222170|FG000|Overall Study|Other|0|||
155214309|NCT02554812|560222171|FG001|Overall Study|Other|0|||
155214310|NCT02554812|560222172|FG002|Overall Study|Other|2|||
155214311|NCT02554812|560222173|FG003|Overall Study|Other|3|||
155214312|NCT02554812|560222174|FG004|Overall Study|Other|2|||
155214313|NCT02554812|560222175|FG005|Overall Study|Other|1|||
155214314|NCT02554812|560222176|FG006|Overall Study|Other|0|||
155214315|NCT02554812|560222177|FG007|Overall Study|Other|0|||
155214316|NCT02554812|560222178|FG008|Overall Study|Other|1|||
155214317|NCT02554812|560222179|FG009|Overall Study|Other|1|||
155214318|NCT02554812|560222180|FG010|Overall Study|Other|0|||
155214319|NCT02554812|560222181|FG011|Overall Study|Other|0|||
155214320|NCT02554812|560222182|FG012|Overall Study|Other|1|||
155214321|NCT02554812|560222183|FG013|Overall Study|Other|0|||
155214322|NCT02554812|560222184|FG014|Overall Study|Other|1|||
155214323|NCT02554812|560222185|FG015|Overall Study|Other|0|||
155214324|NCT02554812|560222186|FG016|Overall Study|Other|0|||
155214325|NCT02554812|560222187|FG017|Overall Study|Other|0|||
155214326|NCT02554812|560222188|FG018|Overall Study|Other|0|||
155214327|NCT02554812|560222189|FG019|Overall Study|Other|0|||
155214328|NCT02554812|560222190|FG020|Overall Study|Other|0|||
155214329|NCT02554812|560222191|FG021|Overall Study|Other|2|||
155214330|NCT02554812|560222192|FG022|Overall Study|Other|0|||
155214331|NCT02554812|560222193|FG023|Overall Study|Other|0|||
155214332|NCT02554812|560222194|FG024|Overall Study|Other|0|||
155214333|NCT02554812|560222195|FG025|Overall Study|Other|0|||
155214334|NCT02554812|560222196|FG026|Overall Study|Other|0|||
155214335|NCT02554812|560222170|FG000|Overall Study|Withdrawal by Subject|1|||
155214336|NCT02554812|560222171|FG001|Overall Study|Withdrawal by Subject|0|||
155214337|NCT02554812|560222172|FG002|Overall Study|Withdrawal by Subject|0|||
155214338|NCT02554812|560222173|FG003|Overall Study|Withdrawal by Subject|2|||
155214339|NCT02554812|560222174|FG004|Overall Study|Withdrawal by Subject|2|||
155214340|NCT02554812|560222175|FG005|Overall Study|Withdrawal by Subject|3|||
155214341|NCT02554812|560222176|FG006|Overall Study|Withdrawal by Subject|0|||
155214342|NCT02554812|560222177|FG007|Overall Study|Withdrawal by Subject|0|||
155214343|NCT02554812|560222178|FG008|Overall Study|Withdrawal by Subject|1|||
155214344|NCT02554812|560222179|FG009|Overall Study|Withdrawal by Subject|1|||
155214345|NCT02554812|560222180|FG010|Overall Study|Withdrawal by Subject|0|||
155214346|NCT02554812|560222181|FG011|Overall Study|Withdrawal by Subject|1|||
155214347|NCT02554812|560222182|FG012|Overall Study|Withdrawal by Subject|1|||
155214348|NCT02554812|560222183|FG013|Overall Study|Withdrawal by Subject|1|||
155214349|NCT02554812|560222184|FG014|Overall Study|Withdrawal by Subject|1|||
155214350|NCT02554812|560222185|FG015|Overall Study|Withdrawal by Subject|1|||
155214351|NCT02554812|560222186|FG016|Overall Study|Withdrawal by Subject|3|||
155214352|NCT02554812|560222187|FG017|Overall Study|Withdrawal by Subject|1|||
155214353|NCT02554812|560222188|FG018|Overall Study|Withdrawal by Subject|0|||
155214354|NCT02554812|560222189|FG019|Overall Study|Withdrawal by Subject|2|||
155214355|NCT02554812|560222190|FG020|Overall Study|Withdrawal by Subject|0|||
155214356|NCT02554812|560222191|FG021|Overall Study|Withdrawal by Subject|1|||
155214357|NCT02554812|560222192|FG022|Overall Study|Withdrawal by Subject|0|||
155214358|NCT02554812|560222193|FG023|Overall Study|Withdrawal by Subject|1|||
155214359|NCT02554812|560222194|FG024|Overall Study|Withdrawal by Subject|0|||
155214360|NCT02554812|560222195|FG025|Overall Study|Withdrawal by Subject|0|||
155214361|NCT02554812|560222196|FG026|Overall Study|Withdrawal by Subject|1|||
155214362|NCT02554812|560222170|FG000|Overall Study|Physician Decision|1|||
155214363|NCT02554812|560222171|FG001|Overall Study|Physician Decision|0|||
155214364|NCT02554812|560222172|FG002|Overall Study|Physician Decision|0|||
155214365|NCT02554812|560222173|FG003|Overall Study|Physician Decision|1|||
155214366|NCT02554812|560222174|FG004|Overall Study|Physician Decision|0|||
155214367|NCT02554812|560222175|FG005|Overall Study|Physician Decision|1|||
155214368|NCT02554812|560222176|FG006|Overall Study|Physician Decision|0|||
155214369|NCT02554812|560222177|FG007|Overall Study|Physician Decision|0|||
155214370|NCT02554812|560222178|FG008|Overall Study|Physician Decision|0|||
155214371|NCT02554812|560222179|FG009|Overall Study|Physician Decision|0|||
155214372|NCT02554812|560222180|FG010|Overall Study|Physician Decision|1|||
155214373|NCT02554812|560222181|FG011|Overall Study|Physician Decision|0|||
155214374|NCT02554812|560222182|FG012|Overall Study|Physician Decision|0|||
155214375|NCT02554812|560222183|FG013|Overall Study|Physician Decision|0|||
155214376|NCT02554812|560222184|FG014|Overall Study|Physician Decision|0|||
155214377|NCT02554812|560222185|FG015|Overall Study|Physician Decision|0|||
155214378|NCT02554812|560222186|FG016|Overall Study|Physician Decision|1|||
155214379|NCT02554812|560222187|FG017|Overall Study|Physician Decision|1|||
155214380|NCT02554812|560222188|FG018|Overall Study|Physician Decision|0|||
155214381|NCT02554812|560222189|FG019|Overall Study|Physician Decision|1|||
155214382|NCT02554812|560222190|FG020|Overall Study|Physician Decision|1|||
155214383|NCT02554812|560222191|FG021|Overall Study|Physician Decision|0|||
155214384|NCT02554812|560222192|FG022|Overall Study|Physician Decision|1|||
155214385|NCT02554812|560222193|FG023|Overall Study|Physician Decision|0|||
155214386|NCT02554812|560222194|FG024|Overall Study|Physician Decision|0|||
155214387|NCT02554812|560222195|FG025|Overall Study|Physician Decision|0|||
155214388|NCT02554812|560222196|FG026|Overall Study|Physician Decision|0|||
155214389|NCT02554812|560222170|FG000|Overall Study|Study terminated by sponsor|0|||
155214390|NCT02554812|560222171|FG001|Overall Study|Study terminated by sponsor|0|||
155214391|NCT02554812|560222172|FG002|Overall Study|Study terminated by sponsor|0|||
155214392|NCT02554812|560222173|FG003|Overall Study|Study terminated by sponsor|0|||
155214393|NCT02554812|560222174|FG004|Overall Study|Study terminated by sponsor|0|||
155214394|NCT02554812|560222175|FG005|Overall Study|Study terminated by sponsor|0|||
155214395|NCT02554812|560222176|FG006|Overall Study|Study terminated by sponsor|0|||
155214396|NCT02554812|560222177|FG007|Overall Study|Study terminated by sponsor|0|||
155214397|NCT02554812|560222178|FG008|Overall Study|Study terminated by sponsor|0|||
155214398|NCT02554812|560222179|FG009|Overall Study|Study terminated by sponsor|0|||
155214399|NCT02554812|560222180|FG010|Overall Study|Study terminated by sponsor|0|||
155214400|NCT02554812|560222181|FG011|Overall Study|Study terminated by sponsor|0|||
155214401|NCT02554812|560222182|FG012|Overall Study|Study terminated by sponsor|0|||
155214402|NCT02554812|560222183|FG013|Overall Study|Study terminated by sponsor|0|||
155214403|NCT02554812|560222184|FG014|Overall Study|Study terminated by sponsor|0|||
155214404|NCT02554812|560222185|FG015|Overall Study|Study terminated by sponsor|0|||
155214405|NCT02554812|560222186|FG016|Overall Study|Study terminated by sponsor|0|||
155214406|NCT02554812|560222187|FG017|Overall Study|Study terminated by sponsor|0|||
155214407|NCT02554812|560222188|FG018|Overall Study|Study terminated by sponsor|0|||
155214408|NCT02554812|560222189|FG019|Overall Study|Study terminated by sponsor|0|||
155214409|NCT02554812|560222190|FG020|Overall Study|Study terminated by sponsor|0|||
155214410|NCT02554812|560222191|FG021|Overall Study|Study terminated by sponsor|0|||
155214411|NCT02554812|560222192|FG022|Overall Study|Study terminated by sponsor|0|||
155214412|NCT02554812|560222193|FG023|Overall Study|Study terminated by sponsor|0|||
155214413|NCT02554812|560222194|FG024|Overall Study|Study terminated by sponsor|1|||
155214414|NCT02554812|560222195|FG025|Overall Study|Study terminated by sponsor|0|||
155214415|NCT02554812|560222196|FG026|Overall Study|Study terminated by sponsor|0|||
155214416|NCT02554812|560222170|FG000|Overall Study|No longer meets eligibility criteria|0|||
155214417|NCT02554812|560222171|FG001|Overall Study|No longer meets eligibility criteria|1|||
155214418|NCT02554812|560222172|FG002|Overall Study|No longer meets eligibility criteria|0|||
155214419|NCT02554812|560222173|FG003|Overall Study|No longer meets eligibility criteria|0|||
155214420|NCT02554812|560222174|FG004|Overall Study|No longer meets eligibility criteria|0|||
155214421|NCT02554812|560222175|FG005|Overall Study|No longer meets eligibility criteria|0|||
155214422|NCT02554812|560222176|FG006|Overall Study|No longer meets eligibility criteria|0|||
155214423|NCT02554812|560222177|FG007|Overall Study|No longer meets eligibility criteria|0|||
155214424|NCT02554812|560222178|FG008|Overall Study|No longer meets eligibility criteria|0|||
155214425|NCT02554812|560222179|FG009|Overall Study|No longer meets eligibility criteria|0|||
155214426|NCT02554812|560222180|FG010|Overall Study|No longer meets eligibility criteria|0|||
155214427|NCT02554812|560222181|FG011|Overall Study|No longer meets eligibility criteria|0|||
155214428|NCT02554812|560222182|FG012|Overall Study|No longer meets eligibility criteria|0|||
155214429|NCT02554812|560222183|FG013|Overall Study|No longer meets eligibility criteria|0|||
155214430|NCT02554812|560222184|FG014|Overall Study|No longer meets eligibility criteria|0|||
155214431|NCT02554812|560222185|FG015|Overall Study|No longer meets eligibility criteria|0|||
155214432|NCT02554812|560222186|FG016|Overall Study|No longer meets eligibility criteria|0|||
155214433|NCT02554812|560222187|FG017|Overall Study|No longer meets eligibility criteria|0|||
155214434|NCT02554812|560222188|FG018|Overall Study|No longer meets eligibility criteria|0|||
155214435|NCT02554812|560222189|FG019|Overall Study|No longer meets eligibility criteria|0|||
155214436|NCT02554812|560222190|FG020|Overall Study|No longer meets eligibility criteria|0|||
155214437|NCT02554812|560222191|FG021|Overall Study|No longer meets eligibility criteria|0|||
155214438|NCT02554812|560222192|FG022|Overall Study|No longer meets eligibility criteria|0|||
155214439|NCT02554812|560222193|FG023|Overall Study|No longer meets eligibility criteria|0|||
155214440|NCT02554812|560222194|FG024|Overall Study|No longer meets eligibility criteria|0|||
155214441|NCT02554812|560222195|FG025|Overall Study|No longer meets eligibility criteria|0|||
155214442|NCT02554812|560222196|FG026|Overall Study|No longer meets eligibility criteria|0|||
155214443|NCT02879305|560222197|FG000|Overall Study|Investigator Site Closed|55|||
155214444|NCT02879305|560222198|FG001|Overall Study|Investigator Site Closed|57|||
155214445|NCT02879305|560222197|FG000|Overall Study|Withdrawal by Subject|44|||
155214446|NCT02879305|560222198|FG001|Overall Study|Withdrawal by Subject|42|||
155214447|NCT02879305|560222197|FG000|Overall Study|Lost to Follow-up|17|||
155214448|NCT02879305|560222198|FG001|Overall Study|Lost to Follow-up|12|||
155214449|NCT02879305|560222197|FG000|Overall Study|Other|1|||
155214450|NCT02879305|560222198|FG001|Overall Study|Other|0|||
155214451|NCT00936910|560224055|FG000|Overall Study|Lack of Efficacy|3|||
155214452|NCT03020407|560224057|FG000|Overall Study|Withdrawal by Subject|2|||
155214453|NCT03020407|560224058|FG001|Overall Study|Withdrawal by Subject|1|||
155214454|NCT03020407|560224057|FG000|Overall Study|Lost to Follow-up|2|||
155214455|NCT03020407|560224058|FG001|Overall Study|Lost to Follow-up|3|||
155214456|NCT03020407|560224057|FG000|Overall Study|Protocol Violation|0|||
155214457|NCT03020407|560224058|FG001|Overall Study|Protocol Violation|1|||
155214458|NCT01585428|560224059|FG000|Overall Study|Death during treatment|1|||
155214459|NCT01585428|560224060|FG001|Overall Study|Death during treatment|0|||
155214460|NCT02057198|560224061|FG000|Overall Study|Death|0|||
155214461|NCT02057198|560224062|FG001|Overall Study|Death|0|||
155214462|NCT02057198|560224063|FG002|Overall Study|Death|1|||
155214463|NCT02057198|560224061|FG000|Overall Study|Discharged early; lost to followup|0|||
155214464|NCT02057198|560224062|FG001|Overall Study|Discharged early; lost to followup|1|||
155214465|NCT02057198|560224063|FG002|Overall Study|Discharged early; lost to followup|0|||
155214466|NCT00065507|560224064|FG000|Overall Study|Death|16|||
155214467|NCT00065507|560224065|FG001|Overall Study|Death|17|||
155214468|NCT00065507|560224064|FG000|Overall Study|Adverse Event|4|||
155214469|NCT00065507|560224065|FG001|Overall Study|Adverse Event|3|||
155214470|NCT00065507|560224064|FG000|Overall Study|Lack of Efficacy|0|||
155214471|NCT00065507|560224065|FG001|Overall Study|Lack of Efficacy|6|||
155214472|NCT00065507|560224064|FG000|Overall Study|Poor/Non-compliance|3|||
155214473|NCT00065507|560224065|FG001|Overall Study|Poor/Non-compliance|2|||
155214474|NCT00065507|560224064|FG000|Overall Study|Lost to Follow-up|3|||
155214475|NCT00065507|560224065|FG001|Overall Study|Lost to Follow-up|0|||
155214476|NCT00065507|560224064|FG000|Overall Study|Subject Withdrew Consent|2|||
155214477|NCT00065507|560224065|FG001|Overall Study|Subject Withdrew Consent|1|||
155214478|NCT00065507|560224064|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
155214479|NCT00065507|560224065|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
155214480|NCT00350636|560224066|FG000|Overall Study|Adverse Event|19|||
155214481|NCT00350636|560224067|FG001|Overall Study|Adverse Event|13|||
155214482|NCT00350636|560224066|FG000|Overall Study|Protocol Violation|1|||
155214483|NCT00350636|560224067|FG001|Overall Study|Protocol Violation|3|||
155214484|NCT00350636|560224066|FG000|Overall Study|Withdrawal by Subject|13|||
155214485|NCT00350636|560224067|FG001|Overall Study|Withdrawal by Subject|17|||
155214486|NCT00350636|560224066|FG000|Overall Study|Lost to Follow-up|9|||
155214487|NCT00350636|560224067|FG001|Overall Study|Lost to Follow-up|8|||
155214488|NCT00350636|560224066|FG000|Overall Study|Physician Decision|0|||
155214489|NCT00350636|560224067|FG001|Overall Study|Physician Decision|2|||
155214490|NCT00350636|560224066|FG000|Overall Study|Other|1|||
155214491|NCT00350636|560224067|FG001|Overall Study|Other|2|||
155214492|NCT01647282|560224070|FG000|Overall Study|Physician Decision|7|||
155214493|NCT01647282|560224071|FG001|Overall Study|Physician Decision|5|||
155214494|NCT01042236|560224072|FG000|Treatment Period 1|Adverse Event|0|||
155214495|NCT01042236|560224073|FG001|Treatment Period 1|Adverse Event|1|||
155214496|NCT01042236|560224074|FG002|Treatment Period 1|Adverse Event|0|||
155214497|NCT01042236|560224075|FG003|Treatment Period 1|Adverse Event|0|||
155214498|NCT01042236|560224076|FG004|Treatment Period 1|Adverse Event|1|||
155214499|NCT01042236|560224077|FG005|Treatment Period 1|Adverse Event|0|||
155214500|NCT01042236|560224072|FG000|Treatment Period 3|Adverse Event|0|||
155214501|NCT01042236|560224073|FG001|Treatment Period 3|Adverse Event|0|||
155214502|NCT01042236|560224074|FG002|Treatment Period 3|Adverse Event|0|||
155214503|NCT01042236|560224075|FG003|Treatment Period 3|Adverse Event|1|||
155214504|NCT01042236|560224076|FG004|Treatment Period 3|Adverse Event|0|||
155214505|NCT01042236|560224077|FG005|Treatment Period 3|Adverse Event|0|||
155214506|NCT01042236|560224072|FG000|Treatment Period 3|Protocol Violation|0|||
155214507|NCT01042236|560224073|FG001|Treatment Period 3|Protocol Violation|0|||
155214508|NCT01042236|560224074|FG002|Treatment Period 3|Protocol Violation|0|||
155214509|NCT01042236|560224075|FG003|Treatment Period 3|Protocol Violation|1|||
155214510|NCT01042236|560224076|FG004|Treatment Period 3|Protocol Violation|0|||
155214511|NCT01042236|560224077|FG005|Treatment Period 3|Protocol Violation|0|||
155214512|NCT02345811|560224078|FG000|First Intervention|Withdrawal by Subject|1|||
155214513|NCT02345811|560224079|FG001|First Intervention|Withdrawal by Subject|1|||
155214514|NCT03683758|560224084|FG000|Overall Study|Non-study commitment conflict|1|||
155214515|NCT03683758|560224085|FG001|Overall Study|Non-study commitment conflict|3|||
155214516|NCT03683758|560224084|FG000|Overall Study|Illness preventing participation|1|||
155214517|NCT03683758|560224085|FG001|Overall Study|Illness preventing participation|0|||
155214518|NCT03683758|560224084|FG000|Overall Study|Adverse Event|1|||
155214519|NCT03683758|560224085|FG001|Overall Study|Adverse Event|0|||
155214520|NCT00453921|560224086|FG000|Overall Study|Withdrawal by Subject|1|||
155214521|NCT00453921|560224087|FG001|Overall Study|Withdrawal by Subject|1|||
155214522|NCT00453921|560224088|FG002|Overall Study|Withdrawal by Subject|1|||
155214523|NCT00453921|560224089|FG003|Overall Study|Withdrawal by Subject|1|||
155214524|NCT00453921|560224086|FG000|Overall Study|Lost to Follow-up|0|||
155214525|NCT00453921|560224087|FG001|Overall Study|Lost to Follow-up|0|||
155214526|NCT00453921|560224088|FG002|Overall Study|Lost to Follow-up|1|||
155214527|NCT00453921|560224089|FG003|Overall Study|Lost to Follow-up|0|||
155214528|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
155214529|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
155214530|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
155214531|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
155214532|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
155214533|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
155214534|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
155214535|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
155214536|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Other|4|||
155214537|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Other|1|||
155214538|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
155214539|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
155214540|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
155214541|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
155214542|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
155214543|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
155214544|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Death|1|||
155214545|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Death|0|||
155214546|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
155214547|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
155214548|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
155214549|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
155214550|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
155214551|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
155214552|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
155214553|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
155214554|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Other|1|||
155214555|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Other|0|||
155214556|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
155214557|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
155214558|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
155214559|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
155214560|NCT00174915|560224092|FG000|Overall Study|Lost to Follow-up|19|||
155214561|NCT00174915|560224093|FG001|Overall Study|Lost to Follow-up|17|||
155214562|NCT00174915|560224094|FG002|Overall Study|Lost to Follow-up|9|||
155214563|NCT00174915|560224095|FG003|Overall Study|Lost to Follow-up|17|||
155214564|NCT00174915|560224096|FG004|Overall Study|Lost to Follow-up|10|||
155214565|NCT00174915|560224092|FG000|Overall Study|Adverse Event|18|||
155214566|NCT00174915|560224093|FG001|Overall Study|Adverse Event|16|||
155214567|NCT00174915|560224094|FG002|Overall Study|Adverse Event|11|||
155214568|NCT00174915|560224095|FG003|Overall Study|Adverse Event|18|||
155214569|NCT00174915|560224096|FG004|Overall Study|Adverse Event|5|||
155214570|NCT00174915|560224092|FG000|Overall Study|Personal Reason(s)|16|||
155214571|NCT00174915|560224093|FG001|Overall Study|Personal Reason(s)|16|||
155214572|NCT00174915|560224094|FG002|Overall Study|Personal Reason(s)|9|||
155214573|NCT00174915|560224095|FG003|Overall Study|Personal Reason(s)|9|||
155214574|NCT00174915|560224096|FG004|Overall Study|Personal Reason(s)|9|||
155214575|NCT00174915|560224092|FG000|Overall Study|Other|15|||
155214576|NCT00174915|560224093|FG001|Overall Study|Other|8|||
155214577|NCT00174915|560224094|FG002|Overall Study|Other|6|||
155214578|NCT00174915|560224095|FG003|Overall Study|Other|5|||
155214579|NCT00174915|560224096|FG004|Overall Study|Other|3|||
155214580|NCT00174915|560224092|FG000|Overall Study|Gout Flare|13|||
155214581|NCT00174915|560224093|FG001|Overall Study|Gout Flare|6|||
155214582|NCT00174915|560224094|FG002|Overall Study|Gout Flare|8|||
155214583|NCT00174915|560224095|FG003|Overall Study|Gout Flare|1|||
155214584|NCT00174915|560224096|FG004|Overall Study|Gout Flare|0|||
155214585|NCT00174915|560224092|FG000|Overall Study|Protocol Violation|6|||
155214586|NCT00174915|560224093|FG001|Overall Study|Protocol Violation|3|||
155214587|NCT00174915|560224094|FG002|Overall Study|Protocol Violation|3|||
155214588|NCT00174915|560224095|FG003|Overall Study|Protocol Violation|6|||
155214589|NCT00174915|560224096|FG004|Overall Study|Protocol Violation|3|||
155214590|NCT00174915|560224092|FG000|Overall Study|Therapeutic Failure|6|||
155214591|NCT00174915|560224093|FG001|Overall Study|Therapeutic Failure|3|||
155214592|NCT00174915|560224094|FG002|Overall Study|Therapeutic Failure|2|||
155214593|NCT00174915|560224095|FG003|Overall Study|Therapeutic Failure|1|||
155214594|NCT00174915|560224096|FG004|Overall Study|Therapeutic Failure|3|||
155214595|NCT03045887|560224097|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
155214596|NCT03045887|560224098|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214597|NCT03045887|560224099|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214598|NCT03045887|560224100|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214599|NCT03045887|560224101|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214600|NCT03045887|560224102|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214601|NCT03045887|560224103|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214602|NCT03045887|560224104|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214603|NCT03045887|560224105|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214604|NCT03045887|560224106|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214605|NCT03045887|560224097|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214606|NCT03045887|560224098|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214607|NCT03045887|560224099|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214608|NCT03045887|560224100|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
155214609|NCT03045887|560224101|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214610|NCT03045887|560224102|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214611|NCT03045887|560224103|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214612|NCT03045887|560224104|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214613|NCT03045887|560224105|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214614|NCT03045887|560224106|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214615|NCT03045887|560224097|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
155214616|NCT03045887|560224098|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214617|NCT03045887|560224099|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214618|NCT03045887|560224100|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214619|NCT03045887|560224101|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214620|NCT03045887|560224102|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214621|NCT03045887|560224103|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214622|NCT03045887|560224104|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214623|NCT03045887|560224105|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214624|NCT03045887|560224106|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214625|NCT03045887|560224097|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214626|NCT03045887|560224098|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214627|NCT03045887|560224099|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
155214628|NCT03045887|560224100|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
155214629|NCT03045887|560224101|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214630|NCT03045887|560224102|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214631|NCT03045887|560224103|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214632|NCT03045887|560224104|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214633|NCT03045887|560224105|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214634|NCT03045887|560224106|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214635|NCT03045887|560224097|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214636|NCT03045887|560224098|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214637|NCT03045887|560224099|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214638|NCT03045887|560224100|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
155214639|NCT03045887|560224101|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214640|NCT03045887|560224102|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214641|NCT03045887|560224103|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214642|NCT03045887|560224104|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214643|NCT03045887|560224105|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214644|NCT03045887|560224106|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214645|NCT02132767|560224107|FG000|Overall Study|Death|3|||
155214646|NCT02132767|560224108|FG001|Overall Study|Death|2|||
155214647|NCT02132767|560224107|FG000|Overall Study|Withdrawal by Subject|10|||
155214648|NCT02132767|560224108|FG001|Overall Study|Withdrawal by Subject|9|||
155214649|NCT02132767|560224107|FG000|Overall Study|Lost to Follow-up|4|||
155214650|NCT02132767|560224108|FG001|Overall Study|Lost to Follow-up|4|||
155214651|NCT00546637|560224111|FG000|Overall Study|Adverse Event|46|||
155214652|NCT00546637|560224112|FG001|Overall Study|Adverse Event|20|||
155214653|NCT00546637|560224111|FG000|Overall Study|Lack of Efficacy|5|||
155214654|NCT00546637|560224112|FG001|Overall Study|Lack of Efficacy|5|||
155214655|NCT00546637|560224111|FG000|Overall Study|Lost to Follow-up|2|||
155214656|NCT00546637|560224112|FG001|Overall Study|Lost to Follow-up|2|||
155214657|NCT00546637|560224111|FG000|Overall Study|Other|10|||
155214658|NCT00546637|560224112|FG001|Overall Study|Other|12|||
155214659|NCT00546637|560224111|FG000|Overall Study|Withdrawal by Subject|7|||
155214660|NCT00546637|560224112|FG001|Overall Study|Withdrawal by Subject|9|||
155214661|NCT00546637|560224111|FG000|Overall Study|Randomized, but not treated|3|||
155214662|NCT00546637|560224112|FG001|Overall Study|Randomized, but not treated|1|||
155214663|NCT02968563|560224117|FG000|Overall Study|Adverse Event|0|||
155214664|NCT02968563|560224118|FG001|Overall Study|Adverse Event|6|||
155214665|NCT02968563|560224117|FG000|Overall Study|Death|1|||
155214666|NCT02968563|560224118|FG001|Overall Study|Death|1|||
155214667|NCT02968563|560224117|FG000|Overall Study|Lost to Follow-up|0|||
155214668|NCT02968563|560224118|FG001|Overall Study|Lost to Follow-up|1|||
155214669|NCT04008030|560224121|FG000|Pre-Treatment|Withdrawal by Subject|0|||
155214670|NCT04008030|560224122|FG001|Pre-Treatment|Withdrawal by Subject|0|||
155214671|NCT04008030|560224123|FG002|Pre-Treatment|Withdrawal by Subject|9|||
155214672|NCT04008030|560224121|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155214673|NCT04008030|560224122|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
155214674|NCT04008030|560224123|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
155214675|NCT04008030|560224121|FG000|Pre-Treatment|Other reasons|0|||
155214676|NCT04008030|560224122|FG001|Pre-Treatment|Other reasons|1|||
155214677|NCT04008030|560224123|FG002|Pre-Treatment|Other reasons|6|||
155214678|NCT04008030|560224121|FG000|Treatment|Withdrawal by Subject|1|||
155214679|NCT04008030|560224122|FG001|Treatment|Withdrawal by Subject|1|||
155214680|NCT04008030|560224123|FG002|Treatment|Withdrawal by Subject|1|||
155214681|NCT04008030|560224121|FG000|Treatment|Death|2|||
155214682|NCT04008030|560224122|FG001|Treatment|Death|4|||
155214683|NCT04008030|560224123|FG002|Treatment|Death|0|||
155214684|NCT04008030|560224121|FG000|Treatment|Pregnancy|0|||
155214685|NCT04008030|560224122|FG001|Treatment|Pregnancy|1|||
155214686|NCT04008030|560224123|FG002|Treatment|Pregnancy|0|||
155214687|NCT04008030|560224121|FG000|Treatment|Participant no longer meets study criteria|0|||
155214688|NCT04008030|560224122|FG001|Treatment|Participant no longer meets study criteria|1|||
155214689|NCT04008030|560224123|FG002|Treatment|Participant no longer meets study criteria|0|||
155214690|NCT04008030|560224121|FG000|Treatment|Other reasons|5|||
155214691|NCT04008030|560224122|FG001|Treatment|Other reasons|13|||
155214692|NCT04008030|560224123|FG002|Treatment|Other reasons|6|||
155214693|NCT04008030|560224121|FG000|Treatment|Disease Progression|137|||
155214694|NCT04008030|560224122|FG001|Treatment|Disease Progression|82|||
155214695|NCT04008030|560224123|FG002|Treatment|Disease Progression|85|||
155214696|NCT04008030|560224121|FG000|Treatment|Study drug toxicity|28|||
155214697|NCT04008030|560224122|FG001|Treatment|Study drug toxicity|48|||
155214698|NCT04008030|560224123|FG002|Treatment|Study drug toxicity|8|||
155214699|NCT04008030|560224121|FG000|Treatment|Adverse Event unrelated to study drug|28|||
155214700|NCT04008030|560224122|FG001|Treatment|Adverse Event unrelated to study drug|22|||
155214701|NCT04008030|560224123|FG002|Treatment|Adverse Event unrelated to study drug|6|||
155214702|NCT04008030|560224121|FG000|Treatment|Maximum Clinical Benefit|0|||
155214703|NCT04008030|560224122|FG001|Treatment|Maximum Clinical Benefit|1|||
155214704|NCT04008030|560224123|FG002|Treatment|Maximum Clinical Benefit|9|||
155214705|NCT04008030|560224121|FG000|Treatment|On-going treatment|13|||
155214706|NCT04008030|560224122|FG001|Treatment|On-going treatment|20|||
155214707|NCT04008030|560224123|FG002|Treatment|On-going treatment|0|||
155214708|NCT02574247|560224126|FG000|Overall Study|Withdrawal by Subject|1|||
155214709|NCT02574247|560224127|FG001|Overall Study|Withdrawal by Subject|0|||
155214710|NCT02574247|560224128|FG002|Overall Study|Withdrawal by Subject|0|||
155214711|NCT02574247|560224126|FG000|Overall Study|Did not meet inclusion criteria|4|||
155214712|NCT02574247|560224127|FG001|Overall Study|Did not meet inclusion criteria|3|||
155214713|NCT02574247|560224128|FG002|Overall Study|Did not meet inclusion criteria|5|||
155214714|NCT01382446|560224129|FG000|Overall Study|Withdrawal by Subject|0|||
155214715|NCT01382446|560224130|FG001|Overall Study|Withdrawal by Subject|1|||
155214716|NCT01382446|560224129|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
155214717|NCT01382446|560224130|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
155214718|NCT00422591|560224135|FG000|Overall Study|Physician Decision|4|||
155214719|NCT00422591|560224135|FG000|Overall Study|Withdrawal by Subject|2|||
155214720|NCT04210310|560224138|FG000|Overall Study|Lost to Follow-up|32|||
155214721|NCT04210310|560224139|FG001|Overall Study|Lost to Follow-up|1|||
155214722|NCT00495170|560224140|FG000|Overall Study|Lost to Follow-up|9|||
155214723|NCT00495170|560224140|FG000|Overall Study|Withdrawal by Subject|3|||
155214724|NCT00495170|560224140|FG000|Overall Study|Inappropriate staging|8|||
155214725|NCT04191499|560224141|FG000|Overall Study|Adverse Event|1|||
155214726|NCT04191499|560224142|FG001|Overall Study|Adverse Event|0|||
155214727|NCT04191499|560224141|FG000|Overall Study|Death|42|||
155214728|NCT04191499|560224142|FG001|Overall Study|Death|55|||
155214729|NCT04191499|560224141|FG000|Overall Study|Lost to Follow-up|4|||
155214730|NCT04191499|560224142|FG001|Overall Study|Lost to Follow-up|1|||
155214731|NCT04191499|560224141|FG000|Overall Study|Physician Decision|1|||
155214732|NCT04191499|560224142|FG001|Overall Study|Physician Decision|0|||
155214733|NCT04191499|560224141|FG000|Overall Study|Progressive Disease|1|||
155214734|NCT04191499|560224142|FG001|Overall Study|Progressive Disease|0|||
155214735|NCT04191499|560224141|FG000|Overall Study|Symptomatic Deterioration|1|||
155214736|NCT04191499|560224142|FG001|Overall Study|Symptomatic Deterioration|0|||
155214737|NCT04191499|560224141|FG000|Overall Study|Withdrawal by Subject|7|||
155214738|NCT04191499|560224142|FG001|Overall Study|Withdrawal by Subject|11|||
155214739|NCT04191499|560224141|FG000|Overall Study|Ongoing in the study|104|||
155214740|NCT04191499|560224142|FG001|Overall Study|Ongoing in the study|97|||
155214741|NCT01928329|560224143|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
155214742|NCT01928329|560224144|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
155214743|NCT01928329|560224143|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
155214744|NCT01928329|560224144|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
155214745|NCT01928329|560224143|FG000|Overall Study|Adverse Event|5|||
155214746|NCT01928329|560224144|FG001|Overall Study|Adverse Event|3|||
155214747|NCT01928329|560224143|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
155214748|NCT01928329|560224144|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
155214749|NCT01928329|560224143|FG000|Overall Study|Withdrawal by Subject|1|||
155214750|NCT01928329|560224144|FG001|Overall Study|Withdrawal by Subject|5|||
155214751|NCT01928329|560224143|FG000|Overall Study|Physician Decision|1|||
155214752|NCT01928329|560224144|FG001|Overall Study|Physician Decision|1|||
155214753|NCT00330616|560224145|FG000|Overall Study|Adverse Event|13|||
155214754|NCT00330616|560224145|FG000|Overall Study|Lack of Efficacy|1|||
155214755|NCT00330616|560224145|FG000|Overall Study|Lost to Follow-up|2|||
155214756|NCT00330616|560224145|FG000|Overall Study|Withdrawal by Subject|4|||
155214757|NCT00330616|560224145|FG000|Overall Study|Other|1|||
155214758|NCT02141997|560224150|FG000|Overall Study|Adverse Event|0|||
155214759|NCT02141997|560224151|FG001|Overall Study|Adverse Event|2|||
155214760|NCT02141997|560224152|FG002|Overall Study|Adverse Event|0|||
155214761|NCT02141997|560224153|FG003|Overall Study|Adverse Event|1|||
155214762|NCT02141997|560224150|FG000|Overall Study|Participant noncompliance|1|||
155214763|NCT02141997|560224151|FG001|Overall Study|Participant noncompliance|0|||
155214764|NCT02141997|560224152|FG002|Overall Study|Participant noncompliance|0|||
155214765|NCT02141997|560224153|FG003|Overall Study|Participant noncompliance|0|||
155214766|NCT02141997|560224150|FG000|Overall Study|Withdrew consent|1|||
155214767|NCT02141997|560224151|FG001|Overall Study|Withdrew consent|0|||
155214768|NCT02141997|560224152|FG002|Overall Study|Withdrew consent|3|||
155214769|NCT02141997|560224153|FG003|Overall Study|Withdrew consent|0|||
155214770|NCT02141997|560224150|FG000|Overall Study|Other|1|||
155214771|NCT02141997|560224151|FG001|Overall Study|Other|4|||
155214772|NCT02141997|560224152|FG002|Overall Study|Other|0|||
155214773|NCT02141997|560224153|FG003|Overall Study|Other|0|||
155214774|NCT03557151|560224163|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
155214775|NCT03557151|560224164|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
155214776|NCT03557151|560224163|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
155214777|NCT03557151|560224164|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
155214778|NCT03557151|560224163|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
155214779|NCT03557151|560224164|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
155214780|NCT00840294|560224165|FG000|Overall Study|Withdrawal by Subject|2|||
155214781|NCT00840294|560224166|FG001|Overall Study|Withdrawal by Subject|1|||
155214782|NCT00840294|560224165|FG000|Overall Study|Protocol Violation|1|||
155214783|NCT00840294|560224166|FG001|Overall Study|Protocol Violation|3|||
155214784|NCT00840294|560224165|FG000|Overall Study|Illness|0|||
155214785|NCT00840294|560224166|FG001|Overall Study|Illness|1|||
155214786|NCT02028065|560224173|FG000|Randomization Through Start Treatment|Not treated|1|||
155214787|NCT02028065|560224174|FG001|Randomization Through Start Treatment|Not treated|3|||
155214788|NCT02028065|560224175|FG002|Randomization Through Start Treatment|Not treated|3|||
155214789|NCT02028065|560224173|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
155214790|NCT02028065|560224174|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
155214791|NCT02028065|560224175|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
155214792|NCT02028065|560224173|FG000|Treatment Through Study Completion|Physician Decision|1|||
155214793|NCT02028065|560224174|FG001|Treatment Through Study Completion|Physician Decision|0|||
155214794|NCT02028065|560224175|FG002|Treatment Through Study Completion|Physician Decision|0|||
155214795|NCT02028065|560224173|FG000|Treatment Through Study Completion|Protocol Violation|1|||
155214796|NCT02028065|560224174|FG001|Treatment Through Study Completion|Protocol Violation|4|||
155214797|NCT02028065|560224175|FG002|Treatment Through Study Completion|Protocol Violation|0|||
155214798|NCT02028065|560224173|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
155214799|NCT02028065|560224174|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
155214800|NCT02028065|560224175|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
155214801|NCT02028065|560224173|FG000|Treatment Through Study Completion|Adverse Event|3|||
155214802|NCT02028065|560224174|FG001|Treatment Through Study Completion|Adverse Event|3|||
155214803|NCT02028065|560224175|FG002|Treatment Through Study Completion|Adverse Event|5|||
155214804|NCT04868890|560224176|FG000|Overall Study|Death|2|||
155214805|NCT04868890|560224177|FG001|Overall Study|Death|1|||
155214806|NCT04868890|560224176|FG000|Overall Study|Withdrawal by Subject|1|||
155214807|NCT04868890|560224177|FG001|Overall Study|Withdrawal by Subject|5|||
155214808|NCT02669433|560224180|FG000|Overall Study|Protocol Violation|0|||
155214809|NCT02669433|560224181|FG001|Overall Study|Protocol Violation|4|||
155214810|NCT02669433|560224182|FG002|Overall Study|Protocol Violation|1|||
155214811|NCT02669433|560224180|FG000|Overall Study|Disease Progression|1|||
155214812|NCT02669433|560224181|FG001|Overall Study|Disease Progression|0|||
155214813|NCT02669433|560224182|FG002|Overall Study|Disease Progression|0|||
155214814|NCT02669433|560224180|FG000|Overall Study|Physician Decision|1|||
155214815|NCT02669433|560224181|FG001|Overall Study|Physician Decision|1|||
155214816|NCT02669433|560224182|FG002|Overall Study|Physician Decision|0|||
155214817|NCT02669433|560224180|FG000|Overall Study|Adverse Event|6|||
155214818|NCT02669433|560224181|FG001|Overall Study|Adverse Event|7|||
155214819|NCT02669433|560224182|FG002|Overall Study|Adverse Event|10|||
155214820|NCT02669433|560224180|FG000|Overall Study|Sponsor Termination|1|||
155214821|NCT02669433|560224181|FG001|Overall Study|Sponsor Termination|0|||
155214822|NCT02669433|560224182|FG002|Overall Study|Sponsor Termination|1|||
155214823|NCT02669433|560224180|FG000|Overall Study|Withdrawal by Subject|5|||
155214824|NCT02669433|560224181|FG001|Overall Study|Withdrawal by Subject|1|||
155214825|NCT02669433|560224182|FG002|Overall Study|Withdrawal by Subject|0|||
155214826|NCT02669433|560224180|FG000|Overall Study|Withdrawal by Caregiver|1|||
155214827|NCT02669433|560224181|FG001|Overall Study|Withdrawal by Caregiver|0|||
155214828|NCT02669433|560224182|FG002|Overall Study|Withdrawal by Caregiver|2|||
155214829|NCT02669433|560224180|FG000|Overall Study|Death|0|||
155214830|NCT02669433|560224181|FG001|Overall Study|Death|1|||
155214831|NCT02669433|560224182|FG002|Overall Study|Death|1|||
155214832|NCT02157298|560224184|FG000|Overall Study|Adverse Event|1|||
155214833|NCT02157298|560224185|FG001|Overall Study|Adverse Event|0|||
155214834|NCT02157298|560224184|FG000|Overall Study|Subject no longer meets study criteria|1|||
155214835|NCT02157298|560224185|FG001|Overall Study|Subject no longer meets study criteria|2|||
155214836|NCT02157298|560224184|FG000|Overall Study|Poor/Non-compliance|1|||
155214837|NCT02157298|560224185|FG001|Overall Study|Poor/Non-compliance|0|||
155214838|NCT02157298|560224184|FG000|Overall Study|Withdrawal by Subject|1|||
155214839|NCT02157298|560224185|FG001|Overall Study|Withdrawal by Subject|0|||
155214840|NCT00818662|560224188|FG000|Overall Study|Adverse Event|5|||
155214841|NCT00818662|560224189|FG001|Overall Study|Adverse Event|14|||
155214842|NCT00818662|560224190|FG002|Overall Study|Adverse Event|4|||
155214843|NCT00818662|560224191|FG003|Overall Study|Adverse Event|3|||
155214844|NCT00818662|560224188|FG000|Overall Study|Withdrawal by Subject|5|||
155214845|NCT00818662|560224189|FG001|Overall Study|Withdrawal by Subject|4|||
155214846|NCT00818662|560224190|FG002|Overall Study|Withdrawal by Subject|2|||
155214847|NCT00818662|560224191|FG003|Overall Study|Withdrawal by Subject|2|||
155214848|NCT00818662|560224188|FG000|Overall Study|Death|1|||
155214849|NCT00818662|560224189|FG001|Overall Study|Death|3|||
155214850|NCT00818662|560224190|FG002|Overall Study|Death|0|||
155214851|NCT00818662|560224191|FG003|Overall Study|Death|0|||
155214852|NCT00818662|560224188|FG000|Overall Study|Physician Decision|1|||
155214853|NCT00818662|560224189|FG001|Overall Study|Physician Decision|0|||
155214854|NCT00818662|560224190|FG002|Overall Study|Physician Decision|0|||
155214855|NCT00818662|560224191|FG003|Overall Study|Physician Decision|0|||
155214856|NCT00818662|560224188|FG000|Overall Study|Lost to Follow-up|0|||
155214857|NCT00818662|560224189|FG001|Overall Study|Lost to Follow-up|0|||
155214858|NCT00818662|560224190|FG002|Overall Study|Lost to Follow-up|0|||
155214859|NCT00818662|560224191|FG003|Overall Study|Lost to Follow-up|1|||
155214860|NCT00818662|560224188|FG000|Overall Study|Unwilling or Unable to Participate|4|||
155214861|NCT00818662|560224189|FG001|Overall Study|Unwilling or Unable to Participate|6|||
155214862|NCT00818662|560224190|FG002|Overall Study|Unwilling or Unable to Participate|2|||
155214863|NCT00818662|560224191|FG003|Overall Study|Unwilling or Unable to Participate|4|||
155214864|NCT00818662|560224188|FG000|Overall Study|Protocol Violation|1|||
155214865|NCT00818662|560224189|FG001|Overall Study|Protocol Violation|1|||
155214866|NCT00818662|560224190|FG002|Overall Study|Protocol Violation|0|||
155214867|NCT00818662|560224191|FG003|Overall Study|Protocol Violation|0|||
155214868|NCT00818662|560224188|FG000|Overall Study|Requires a Prohibited Medication|1|||
155214869|NCT00818662|560224189|FG001|Overall Study|Requires a Prohibited Medication|0|||
155214870|NCT00818662|560224190|FG002|Overall Study|Requires a Prohibited Medication|0|||
155214871|NCT00818662|560224191|FG003|Overall Study|Requires a Prohibited Medication|0|||
155214872|NCT00818662|560224188|FG000|Overall Study|Safety Risk|1|||
155214873|NCT00818662|560224189|FG001|Overall Study|Safety Risk|1|||
155214874|NCT00818662|560224190|FG002|Overall Study|Safety Risk|0|||
155214875|NCT00818662|560224191|FG003|Overall Study|Safety Risk|1|||
155214876|NCT00818662|560224188|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
155214877|NCT00818662|560224189|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
155214878|NCT00818662|560224190|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
155214879|NCT00818662|560224191|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
155214880|NCT00818662|560224188|FG000|Overall Study|Participant's health declined|0|||
155214881|NCT00818662|560224189|FG001|Overall Study|Participant's health declined|0|||
155214882|NCT00818662|560224190|FG002|Overall Study|Participant's health declined|0|||
155214883|NCT00818662|560224191|FG003|Overall Study|Participant's health declined|1|||
155214884|NCT00818662|560224188|FG000|Overall Study|Caregiver to pursue other treatment|0|||
155214885|NCT00818662|560224189|FG001|Overall Study|Caregiver to pursue other treatment|1|||
155214886|NCT00818662|560224190|FG002|Overall Study|Caregiver to pursue other treatment|0|||
155214887|NCT00818662|560224191|FG003|Overall Study|Caregiver to pursue other treatment|0|||
155214888|NCT00818662|560224188|FG000|Overall Study|Moving out of state|0|||
155214889|NCT00818662|560224189|FG001|Overall Study|Moving out of state|0|||
155214890|NCT00818662|560224190|FG002|Overall Study|Moving out of state|0|||
155214891|NCT00818662|560224191|FG003|Overall Study|Moving out of state|1|||
155214892|NCT00818662|560224188|FG000|Overall Study|Declined move to another study site|1|||
155214893|NCT00818662|560224189|FG001|Overall Study|Declined move to another study site|0|||
155214894|NCT00818662|560224190|FG002|Overall Study|Declined move to another study site|0|||
155214895|NCT00818662|560224191|FG003|Overall Study|Declined move to another study site|0|||
155214896|NCT00818662|560224188|FG000|Overall Study|Change in living situation|0|||
155214897|NCT00818662|560224189|FG001|Overall Study|Change in living situation|0|||
155214898|NCT00818662|560224190|FG002|Overall Study|Change in living situation|0|||
155214899|NCT00818662|560224191|FG003|Overall Study|Change in living situation|1|||
155214900|NCT00818662|560224188|FG000|Overall Study|Study partner decision|0|||
155214901|NCT00818662|560224189|FG001|Overall Study|Study partner decision|0|||
155214902|NCT00818662|560224190|FG002|Overall Study|Study partner decision|0|||
155214903|NCT00818662|560224191|FG003|Overall Study|Study partner decision|1|||
155214904|NCT00818662|560224188|FG000|Overall Study|Admitted to long term nursing care|0|||
155214905|NCT00818662|560224189|FG001|Overall Study|Admitted to long term nursing care|1|||
155214906|NCT00818662|560224190|FG002|Overall Study|Admitted to long term nursing care|0|||
155214907|NCT00818662|560224191|FG003|Overall Study|Admitted to long term nursing care|0|||
155214908|NCT01722071|560224192|FG000|Overall Study|Protocol Violation|1|||
155214909|NCT01722071|560224193|FG001|Overall Study|Protocol Violation|0|||
155214910|NCT03021265|560224194|FG000|Overall Study|Adverse Event|29|||
155214911|NCT03021265|560224194|FG000|Overall Study|Lack of Efficacy|3|||
155214912|NCT03021265|560224194|FG000|Overall Study|Improved|17|||
155214913|NCT03021265|560224194|FG000|Overall Study|Lost to Follow-up|67|||
155214914|NCT03021265|560224194|FG000|Overall Study|No reason given|2|||
155214915|NCT03021265|560224194|FG000|Overall Study|No visit since the first visit|4|||
155214916|NCT01338493|560224195|FG000|Enrolled|Withdrawal by Subject|1|||
155214917|NCT01338493|560224195|FG000|Enrolled|Patient not implanted|4|||
155214918|NCT01338493|560224195|FG000|Discharge|Death|1|||
155214919|NCT01338493|560224195|FG000|Discharge|Missed visit|1|||
155214920|NCT01338493|560224195|FG000|6 Months Follow up|Lost to Follow-up|11|||
155214921|NCT01338493|560224195|FG000|6 Months Follow up|Missed visit|8|||
155214922|NCT01338493|560224195|FG000|12 Months Follow up|Lost to Follow-up|9|||
155214923|NCT01698801|560224196|FG000|Treatment Phase|Adverse Event|4|||
155214924|NCT01698801|560224196|FG000|Treatment Phase|Protocol Violation|1|||
155214925|NCT01698801|560224196|FG000|Treatment Phase|Other|4|||
155214926|NCT01698801|560224196|FG000|Treatment Phase|Withdrawal by Subject|1|||
155214927|NCT01698801|560224196|FG000|Treatment Phase|Disease progression|1|||
155214928|NCT01698801|560224196|FG000|Follow Up Phase|Withdrawal by Subject|1|||
155214929|NCT01698801|560224196|FG000|Follow Up Phase|Death|4|||
155214930|NCT01614067|560224197|FG000|Overall Study|Pregnancy|1|||
155214931|NCT01614067|560224198|FG001|Overall Study|Pregnancy|0|||
155214932|NCT01614067|560224197|FG000|Overall Study|Physician Decision|6|||
155214933|NCT01614067|560224198|FG001|Overall Study|Physician Decision|5|||
155214934|NCT01614067|560224197|FG000|Overall Study|Withdrawal by Subject|0|||
155214935|NCT01614067|560224198|FG001|Overall Study|Withdrawal by Subject|1|||
155214936|NCT01614067|560224197|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
155214937|NCT01614067|560224198|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
155214938|NCT02062879|560224199|FG000|Overall Study|Withdrawal by Subject|4|||
155214939|NCT02062879|560224200|FG001|Overall Study|Withdrawal by Subject|1|||
155214940|NCT00665847|560224203|FG000|Overall Study|Adverse Event|8|||
155214941|NCT00665847|560224203|FG000|Overall Study|Withdrawal by Subject|2|||
155214942|NCT00665847|560224203|FG000|Overall Study|Subject non-compliant|8|||
155214943|NCT00665847|560224203|FG000|Overall Study|Subject reached a virologic endpoint|4|||
155214944|NCT00665847|560224203|FG000|Overall Study|Resistance to TMC125|1|||
155214945|NCT00665847|560224203|FG000|Overall Study|Subject ineligible to continue the trial|1|||
155214946|NCT00665847|560224203|FG000|Overall Study|Switch to Commercial Medication|1|||
155214947|NCT00511667|560224209|FG000|Overall Study|Adverse Event|1|||
155214948|NCT00511667|560224210|FG001|Overall Study|Adverse Event|0|||
155214949|NCT00511667|560224209|FG000|Overall Study|Protocol Violation|1|||
155214950|NCT00511667|560224210|FG001|Overall Study|Protocol Violation|1|||
155214951|NCT00511667|560224209|FG000|Overall Study|Withdrawal by Subject|2|||
155214952|NCT00511667|560224210|FG001|Overall Study|Withdrawal by Subject|0|||
155214953|NCT00511667|560224209|FG000|Overall Study|Site terminated|6|||
155214954|NCT00511667|560224210|FG001|Overall Study|Site terminated|1|||
155214955|NCT00511667|560224209|FG000|Overall Study|Other|2|||
155214956|NCT00511667|560224210|FG001|Overall Study|Other|1|||
155214957|NCT00616655|560224211|FG000|Overall Study|Adverse Event|10|||
155214958|NCT00616655|560224212|FG001|Overall Study|Adverse Event|7|||
155214959|NCT00616655|560224213|FG002|Overall Study|Adverse Event|12|||
155214960|NCT00616655|560224211|FG000|Overall Study|Lack of Efficacy|5|||
155214961|NCT00616655|560224212|FG001|Overall Study|Lack of Efficacy|5|||
155214962|NCT00616655|560224213|FG002|Overall Study|Lack of Efficacy|5|||
155214963|NCT00616655|560224211|FG000|Overall Study|Lost to Follow-up|3|||
155214964|NCT00616655|560224212|FG001|Overall Study|Lost to Follow-up|12|||
155214965|NCT00616655|560224213|FG002|Overall Study|Lost to Follow-up|10|||
155214966|NCT00616655|560224211|FG000|Overall Study|Protocol Violation|2|||
155214967|NCT00616655|560224212|FG001|Overall Study|Protocol Violation|4|||
155214968|NCT00616655|560224213|FG002|Overall Study|Protocol Violation|3|||
155214969|NCT00616655|560224211|FG000|Overall Study|Withdrawal by Subject|9|||
155214970|NCT00616655|560224212|FG001|Overall Study|Withdrawal by Subject|7|||
155214971|NCT00616655|560224213|FG002|Overall Study|Withdrawal by Subject|11|||
155214972|NCT00616655|560224211|FG000|Overall Study|Does not meet in/ex criteria|0|||
155214973|NCT00616655|560224212|FG001|Overall Study|Does not meet in/ex criteria|0|||
155214974|NCT00616655|560224213|FG002|Overall Study|Does not meet in/ex criteria|2|||
155214975|NCT00616655|560224211|FG000|Overall Study|Other|6|||
155214976|NCT00616655|560224212|FG001|Overall Study|Other|6|||
155214977|NCT00616655|560224213|FG002|Overall Study|Other|5|||
155214978|NCT03761147|560224214|FG000|Overall Study|Withdrawal by Subject|6|||
155214979|NCT03761147|560224215|FG001|Overall Study|Withdrawal by Subject|1|||
155214980|NCT03761147|560224214|FG000|Overall Study|Adverse Event|1|||
155214981|NCT03761147|560224215|FG001|Overall Study|Adverse Event|3|||
155214982|NCT00309842|560224216|FG000|Overall Study|Lost to Follow-up|1|||
155214983|NCT03564145|560224217|FG000|Overall Study|Adverse Event|4|||
155214984|NCT03564145|560224217|FG000|Overall Study|Lost to Follow-up|21|||
155214985|NCT03564145|560224217|FG000|Overall Study|Protocol Violation|2|||
155214986|NCT03564145|560224217|FG000|Overall Study|Withdrawal by Subject|48|||
155214987|NCT03564145|560224217|FG000|Overall Study|Study Terminated by Sponsor|146|||
155214988|NCT03564145|560224217|FG000|Overall Study|Physician Decision|1|||
155214989|NCT03564145|560224217|FG000|Overall Study|Other Than Specified|1|||
155214990|NCT03564145|560224217|FG000|Overall Study|Pregnancy|1|||
155214991|NCT02045797|560224218|FG000|Overall Study|Adverse Event|3|||
155214992|NCT02045797|560224219|FG001|Overall Study|Adverse Event|1|||
155214993|NCT02045797|560224220|FG002|Overall Study|Adverse Event|0|||
155214994|NCT02045797|560224218|FG000|Overall Study|Lack of Efficacy|1|||
155214995|NCT02045797|560224219|FG001|Overall Study|Lack of Efficacy|0|||
155214996|NCT02045797|560224220|FG002|Overall Study|Lack of Efficacy|0|||
155214997|NCT02045797|560224218|FG000|Overall Study|Lost to Follow-up|2|||
155214998|NCT02045797|560224219|FG001|Overall Study|Lost to Follow-up|3|||
155214999|NCT02045797|560224220|FG002|Overall Study|Lost to Follow-up|1|||
155215000|NCT02045797|560224218|FG000|Overall Study|Physician Decision|0|||
155215001|NCT02045797|560224219|FG001|Overall Study|Physician Decision|1|||
155215002|NCT02045797|560224220|FG002|Overall Study|Physician Decision|0|||
155215003|NCT02045797|560224218|FG000|Overall Study|Withdrawal by Subject|1|||
155215004|NCT02045797|560224219|FG001|Overall Study|Withdrawal by Subject|2|||
155215005|NCT02045797|560224220|FG002|Overall Study|Withdrawal by Subject|0|||
155215006|NCT00670800|560225879|FG000|Overall Study|2 controls were insulin resistant|0|||
155215007|NCT00670800|560225880|FG001|Overall Study|2 controls were insulin resistant|2|||
155215008|NCT02355691|560225882|FG000|Overall Study|Loss of Research Personnel|7|||
155215009|NCT02355691|560225883|FG001|Overall Study|Loss of Research Personnel|9|||
155215010|NCT00778700|560225892|FG000|Overall Study|Adverse Event|6|||
155215011|NCT00778700|560225893|FG001|Overall Study|Adverse Event|1|||
155215012|NCT00778700|560225894|FG002|Overall Study|Adverse Event|3|||
155215013|NCT00778700|560225895|FG003|Overall Study|Adverse Event|5|||
155215014|NCT00778700|560225892|FG000|Overall Study|Protocol Violation|1|||
155215015|NCT00778700|560225893|FG001|Overall Study|Protocol Violation|1|||
155215016|NCT00778700|560225894|FG002|Overall Study|Protocol Violation|0|||
155215017|NCT00778700|560225895|FG003|Overall Study|Protocol Violation|0|||
155215018|NCT00778700|560225892|FG000|Overall Study|Subject Withdrew Consent|6|||
155215019|NCT00778700|560225893|FG001|Overall Study|Subject Withdrew Consent|4|||
155215020|NCT00778700|560225894|FG002|Overall Study|Subject Withdrew Consent|1|||
155215021|NCT00778700|560225895|FG003|Overall Study|Subject Withdrew Consent|4|||
155215022|NCT00778700|560225892|FG000|Overall Study|Lost to Follow-up|3|||
155215023|NCT00778700|560225893|FG001|Overall Study|Lost to Follow-up|1|||
155215024|NCT00778700|560225894|FG002|Overall Study|Lost to Follow-up|0|||
155215025|NCT00778700|560225895|FG003|Overall Study|Lost to Follow-up|1|||
155215026|NCT00778700|560225892|FG000|Overall Study|Reason not Specified|2|||
155215027|NCT00778700|560225893|FG001|Overall Study|Reason not Specified|0|||
155215028|NCT00778700|560225894|FG002|Overall Study|Reason not Specified|1|||
155215029|NCT00778700|560225895|FG003|Overall Study|Reason not Specified|3|||
155215030|NCT00778700|560225892|FG000|Overall Study|Other|0|||
155215031|NCT00778700|560225893|FG001|Overall Study|Other|0|||
155215032|NCT00778700|560225894|FG002|Overall Study|Other|1|||
155215033|NCT00778700|560225895|FG003|Overall Study|Other|0|||
155215034|NCT03227029|560225896|FG000|Overall Study|Child Wheezed (no treatment)|0|||
155215035|NCT03227029|560225897|FG001|Overall Study|Child Wheezed (no treatment)|1|||
155215036|NCT03227029|560225898|FG002|Overall Study|Child Wheezed (no treatment)|0|||
155215037|NCT03227029|560225896|FG000|Overall Study|No post RSV season visit due to COVID|3|||
155215038|NCT03227029|560225897|FG001|Overall Study|No post RSV season visit due to COVID|3|||
155215039|NCT03227029|560225898|FG002|Overall Study|No post RSV season visit due to COVID|2|||
155215040|NCT03227029|560225896|FG000|Overall Study|Not able to get to clinic|0|||
155215041|NCT03227029|560225897|FG001|Overall Study|Not able to get to clinic|0|||
155215042|NCT03227029|560225898|FG002|Overall Study|Not able to get to clinic|1|||
155215043|NCT03227029|560225896|FG000|Overall Study|Withdrawal by Subject|1|||
155215044|NCT03227029|560225897|FG001|Overall Study|Withdrawal by Subject|0|||
155215045|NCT03227029|560225898|FG002|Overall Study|Withdrawal by Subject|0|||
155215046|NCT03227029|560225896|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
155215047|NCT03227029|560225897|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
155215048|NCT03227029|560225898|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
155215049|NCT03274440|560225899|FG000|Overall Study|Time commitment too great|1|||
155215050|NCT03274440|560225900|FG001|Overall Study|Time commitment too great|0|||
155215051|NCT03274440|560225901|FG002|Overall Study|Time commitment too great|0|||
155215052|NCT03274440|560225902|FG003|Overall Study|Time commitment too great|1|||
155215053|NCT03274440|560225903|FG004|Overall Study|Time commitment too great|0|||
155215054|NCT03274440|560225904|FG005|Overall Study|Time commitment too great|0|||
155215055|NCT01291173|560225905|FG000|Overall Study|Adverse Event|0|||
155215056|NCT01291173|560225906|FG001|Overall Study|Adverse Event|3|||
155215057|NCT01291173|560225907|FG002|Overall Study|Adverse Event|1|||
155215058|NCT01291173|560225908|FG003|Overall Study|Adverse Event|3|||
155215059|NCT01291173|560225905|FG000|Overall Study|Protocol Violation|7|||
155215060|NCT01291173|560225906|FG001|Overall Study|Protocol Violation|2|||
155215061|NCT01291173|560225907|FG002|Overall Study|Protocol Violation|2|||
155215062|NCT01291173|560225908|FG003|Overall Study|Protocol Violation|5|||
155215063|NCT01291173|560225905|FG000|Overall Study|Withdrawal by Subject|6|||
155215064|NCT01291173|560225906|FG001|Overall Study|Withdrawal by Subject|4|||
155215065|NCT01291173|560225907|FG002|Overall Study|Withdrawal by Subject|4|||
155215066|NCT01291173|560225908|FG003|Overall Study|Withdrawal by Subject|2|||
155215067|NCT01291173|560225905|FG000|Overall Study|Lost to Follow-up|4|||
155215068|NCT01291173|560225906|FG001|Overall Study|Lost to Follow-up|6|||
155215069|NCT01291173|560225907|FG002|Overall Study|Lost to Follow-up|3|||
155215070|NCT01291173|560225908|FG003|Overall Study|Lost to Follow-up|2|||
155215071|NCT01291173|560225905|FG000|Overall Study|Unable to meet visit schedule|0|||
155215072|NCT01291173|560225906|FG001|Overall Study|Unable to meet visit schedule|0|||
155215073|NCT01291173|560225907|FG002|Overall Study|Unable to meet visit schedule|1|||
155215074|NCT01291173|560225908|FG003|Overall Study|Unable to meet visit schedule|0|||
155215075|NCT01291173|560225905|FG000|Overall Study|Lack of compliance|0|||
155215076|NCT01291173|560225906|FG001|Overall Study|Lack of compliance|0|||
155215077|NCT01291173|560225907|FG002|Overall Study|Lack of compliance|0|||
155215078|NCT01291173|560225908|FG003|Overall Study|Lack of compliance|1|||
155215079|NCT01291173|560225905|FG000|Overall Study|Subject was unblinded|0|||
155215080|NCT01291173|560225906|FG001|Overall Study|Subject was unblinded|0|||
155215081|NCT01291173|560225907|FG002|Overall Study|Subject was unblinded|1|||
155215082|NCT01291173|560225908|FG003|Overall Study|Subject was unblinded|0|||
155215083|NCT01291173|560225905|FG000|Overall Study|Excluded therapy|0|||
155215084|NCT01291173|560225906|FG001|Overall Study|Excluded therapy|0|||
155215085|NCT01291173|560225907|FG002|Overall Study|Excluded therapy|1|||
155215086|NCT01291173|560225908|FG003|Overall Study|Excluded therapy|0|||
155215087|NCT00450450|560225909|FG000|Overall Study|Death|1|||
155215088|NCT00450450|560225910|FG001|Overall Study|Death|3|||
155215089|NCT00450450|560225909|FG000|Overall Study|Relapse|2|||
155215090|NCT00450450|560225910|FG001|Overall Study|Relapse|0|||
155215091|NCT00450450|560225909|FG000|Overall Study|Missing Data|2|||
155215092|NCT00450450|560225910|FG001|Overall Study|Missing Data|0|||
155215093|NCT04984993|560225911|FG000|Overall Study|Withdrawal by Subject|8|||
155215094|NCT04984993|560225912|FG001|Overall Study|Withdrawal by Subject|2|||
155215095|NCT04984993|560225911|FG000|Overall Study|Lost to Follow-up|2|||
155215096|NCT04984993|560225912|FG001|Overall Study|Lost to Follow-up|2|||
155215097|NCT04984993|560225911|FG000|Overall Study|Both patients moved to another country|4|||
155215098|NCT04984993|560225912|FG001|Overall Study|Both patients moved to another country|0|||
155215099|NCT01110707|560225913|FG000|Overall Study|Protocol Violation|0|||
155215100|NCT01110707|560225914|FG001|Overall Study|Protocol Violation|3|||
155215101|NCT03318315|560225915|FG000|Overall Study|Lost to Follow-up|3|||
155215102|NCT03318315|560225916|FG001|Overall Study|Lost to Follow-up|2|||
155215103|NCT03318315|560225917|FG002|Overall Study|Lost to Follow-up|1|||
155215104|NCT03318315|560225915|FG000|Overall Study|Protocol Violation|1|||
155215105|NCT03318315|560225916|FG001|Overall Study|Protocol Violation|1|||
155215106|NCT03318315|560225917|FG002|Overall Study|Protocol Violation|1|||
155215107|NCT03318315|560225915|FG000|Overall Study|Withdrawal by Subject|0|||
155215108|NCT03318315|560225916|FG001|Overall Study|Withdrawal by Subject|0|||
155215109|NCT03318315|560225917|FG002|Overall Study|Withdrawal by Subject|2|||
155215110|NCT00674661|560225927|FG000|Overall Study|Other|5|||
155215111|NCT00674661|560225928|FG001|Overall Study|Other|7|||
155215112|NCT00674661|560225927|FG000|Overall Study|Lost to Follow-up|6|||
155215113|NCT00674661|560225928|FG001|Overall Study|Lost to Follow-up|3|||
155215114|NCT00674661|560225927|FG000|Overall Study|Withdrawal by Subject|0|||
155215115|NCT00674661|560225928|FG001|Overall Study|Withdrawal by Subject|5|||
155215116|NCT00003901|560225930|FG000|Overall Study|Adverse Event|1|||
155215117|NCT00003901|560225930|FG000|Overall Study|Withdrawal by Subject|1|||
155215118|NCT00003901|560225930|FG000|Overall Study|Ineligible|6|||
155215119|NCT00003901|560225930|FG000|Overall Study|CT Scan not within protocol requirement|2|||
155215120|NCT00003901|560225930|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
155215121|NCT00003901|560225930|FG000|Overall Study|Medical problems|6|||
155215122|NCT02659631|560225934|FG000|Overall Study|Lost to Follow-up|0|||
155215123|NCT02659631|560225935|FG001|Overall Study|Lost to Follow-up|0|||
155215124|NCT02659631|560225936|FG002|Overall Study|Lost to Follow-up|2|||
155215125|NCT02659631|560225937|FG003|Overall Study|Lost to Follow-up|0|||
155215126|NCT02659631|560225938|FG004|Overall Study|Lost to Follow-up|0|||
155215127|NCT02659631|560225939|FG005|Overall Study|Lost to Follow-up|1|||
155215128|NCT02659631|560225940|FG006|Overall Study|Lost to Follow-up|0|||
155215129|NCT02659631|560225941|FG007|Overall Study|Lost to Follow-up|0|||
155215130|NCT02659631|560225942|FG008|Overall Study|Lost to Follow-up|0|||
155215131|NCT02659631|560225943|FG009|Overall Study|Lost to Follow-up|0|||
155215132|NCT02659631|560225934|FG000|Overall Study|Withdrawal prior to treatment|0|||
155215133|NCT02659631|560225935|FG001|Overall Study|Withdrawal prior to treatment|0|||
155215134|NCT02659631|560225936|FG002|Overall Study|Withdrawal prior to treatment|0|||
155215135|NCT02659631|560225937|FG003|Overall Study|Withdrawal prior to treatment|0|||
155215136|NCT02659631|560225938|FG004|Overall Study|Withdrawal prior to treatment|1|||
155215137|NCT02659631|560225939|FG005|Overall Study|Withdrawal prior to treatment|0|||
155215138|NCT02659631|560225940|FG006|Overall Study|Withdrawal prior to treatment|0|||
155215139|NCT02659631|560225941|FG007|Overall Study|Withdrawal prior to treatment|0|||
155215140|NCT02659631|560225942|FG008|Overall Study|Withdrawal prior to treatment|0|||
155215141|NCT02659631|560225943|FG009|Overall Study|Withdrawal prior to treatment|0|||
155215142|NCT02659631|560225934|FG000|Overall Study|Participant refused further follow-up|0|||
155215143|NCT02659631|560225935|FG001|Overall Study|Participant refused further follow-up|0|||
155215144|NCT02659631|560225936|FG002|Overall Study|Participant refused further follow-up|0|||
155215145|NCT02659631|560225937|FG003|Overall Study|Participant refused further follow-up|1|||
155215146|NCT02659631|560225938|FG004|Overall Study|Participant refused further follow-up|0|||
155215147|NCT02659631|560225939|FG005|Overall Study|Participant refused further follow-up|0|||
155215148|NCT02659631|560225940|FG006|Overall Study|Participant refused further follow-up|0|||
155215149|NCT02659631|560225941|FG007|Overall Study|Participant refused further follow-up|0|||
155215150|NCT02659631|560225942|FG008|Overall Study|Participant refused further follow-up|1|||
155215151|NCT02659631|560225943|FG009|Overall Study|Participant refused further follow-up|0|||
155215152|NCT02659631|560225934|FG000|Overall Study|Death (follow-up phase)|1|||
155215153|NCT02659631|560225935|FG001|Overall Study|Death (follow-up phase)|2|||
155215154|NCT02659631|560225936|FG002|Overall Study|Death (follow-up phase)|1|||
155215155|NCT02659631|560225937|FG003|Overall Study|Death (follow-up phase)|1|||
155215156|NCT02659631|560225938|FG004|Overall Study|Death (follow-up phase)|3|||
155215157|NCT02659631|560225939|FG005|Overall Study|Death (follow-up phase)|2|||
155215158|NCT02659631|560225940|FG006|Overall Study|Death (follow-up phase)|0|||
155215159|NCT02659631|560225941|FG007|Overall Study|Death (follow-up phase)|3|||
155215160|NCT02659631|560225942|FG008|Overall Study|Death (follow-up phase)|1|||
155215161|NCT02659631|560225943|FG009|Overall Study|Death (follow-up phase)|0|||
155215162|NCT02659631|560225934|FG000|Overall Study|Death (treatment phase)|0|||
155215163|NCT02659631|560225935|FG001|Overall Study|Death (treatment phase)|0|||
155215164|NCT02659631|560225936|FG002|Overall Study|Death (treatment phase)|0|||
155215165|NCT02659631|560225937|FG003|Overall Study|Death (treatment phase)|0|||
155215166|NCT02659631|560225938|FG004|Overall Study|Death (treatment phase)|1|||
155215167|NCT02659631|560225939|FG005|Overall Study|Death (treatment phase)|0|||
155215168|NCT02659631|560225940|FG006|Overall Study|Death (treatment phase)|1|||
155215169|NCT02659631|560225941|FG007|Overall Study|Death (treatment phase)|0|||
155215170|NCT02659631|560225942|FG008|Overall Study|Death (treatment phase)|0|||
155215171|NCT02659631|560225943|FG009|Overall Study|Death (treatment phase)|0|||
155215172|NCT02377466|560225944|FG000|Overall Study|Other: Randomized and not treated|0|||
155215173|NCT02377466|560225945|FG001|Overall Study|Other: Randomized and not treated|2|||
155215174|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
155215175|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
155215176|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215177|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215178|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215179|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215180|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
155215181|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
155215182|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215183|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215184|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215185|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215186|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215187|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
155215188|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215189|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215190|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215191|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215192|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
155215193|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
155215194|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215195|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215196|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215197|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215198|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Other|1|||
155215199|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Other|2|||
155215200|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Other|0|||
155215201|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Other|0|||
155215202|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Other|0|||
155215203|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Other|0|||
155215204|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215205|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215206|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215207|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215208|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215209|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
155215210|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215211|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215212|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215213|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215214|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215215|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
155215216|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
155215217|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
155215218|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
155215219|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
155215220|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
155215221|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
155215222|NCT00451321|560225958|FG000|Overall Study|Lost to Follow-up|3|||
155215223|NCT00451321|560225959|FG001|Overall Study|Lost to Follow-up|3|||
155215224|NCT00451321|560225960|FG002|Overall Study|Lost to Follow-up|1|||
155215225|NCT00451321|560225961|FG003|Overall Study|Lost to Follow-up|3|||
155215226|NCT00451321|560225962|FG004|Overall Study|Lost to Follow-up|0|||
155215227|NCT00451321|560225963|FG005|Overall Study|Lost to Follow-up|1|||
155215228|NCT00451321|560225964|FG006|Overall Study|Lost to Follow-up|0|||
155215229|NCT00451321|560225965|FG007|Overall Study|Lost to Follow-up|0|||
155215230|NCT00451321|560225958|FG000|Overall Study|Withdrawal by Subject|3|||
155215231|NCT00451321|560225959|FG001|Overall Study|Withdrawal by Subject|1|||
155215232|NCT00451321|560225960|FG002|Overall Study|Withdrawal by Subject|0|||
155215233|NCT00451321|560225961|FG003|Overall Study|Withdrawal by Subject|4|||
155215234|NCT00451321|560225962|FG004|Overall Study|Withdrawal by Subject|0|||
155215235|NCT00451321|560225963|FG005|Overall Study|Withdrawal by Subject|0|||
155215236|NCT00451321|560225964|FG006|Overall Study|Withdrawal by Subject|0|||
155215237|NCT00451321|560225965|FG007|Overall Study|Withdrawal by Subject|0|||
155215238|NCT00451321|560225958|FG000|Overall Study|Study closed/terminated|1|||
155215239|NCT00451321|560225959|FG001|Overall Study|Study closed/terminated|1|||
155215240|NCT00451321|560225960|FG002|Overall Study|Study closed/terminated|17|||
155215241|NCT00451321|560225961|FG003|Overall Study|Study closed/terminated|5|||
155215242|NCT00451321|560225962|FG004|Overall Study|Study closed/terminated|7|||
155215243|NCT00451321|560225963|FG005|Overall Study|Study closed/terminated|7|||
155215244|NCT00451321|560225964|FG006|Overall Study|Study closed/terminated|5|||
155215245|NCT00451321|560225965|FG007|Overall Study|Study closed/terminated|3|||
155215246|NCT00451321|560225958|FG000|Overall Study|Sponsor decision to amend protocol|0|||
155215247|NCT00451321|560225959|FG001|Overall Study|Sponsor decision to amend protocol|0|||
155215248|NCT00451321|560225960|FG002|Overall Study|Sponsor decision to amend protocol|0|||
155215249|NCT00451321|560225961|FG003|Overall Study|Sponsor decision to amend protocol|0|||
155215250|NCT00451321|560225962|FG004|Overall Study|Sponsor decision to amend protocol|0|||
155215251|NCT00451321|560225963|FG005|Overall Study|Sponsor decision to amend protocol|1|||
155215252|NCT00451321|560225964|FG006|Overall Study|Sponsor decision to amend protocol|1|||
155215253|NCT00451321|560225965|FG007|Overall Study|Sponsor decision to amend protocol|3|||
155215254|NCT00597766|560225968|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
155215255|NCT00597766|560225969|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
155215256|NCT00597766|560225970|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
155215257|NCT00597766|560225968|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
155215258|NCT00597766|560225969|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
155215259|NCT00597766|560225970|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
155215260|NCT01528254|560225972|FG000|Overall Study|Administrative problems|96|||
155215261|NCT01528254|560225973|FG001|Overall Study|Administrative problems|94|||
155215262|NCT01528254|560225972|FG000|Overall Study|Adverse Event|28|||
155215263|NCT01528254|560225973|FG001|Overall Study|Adverse Event|44|||
155215264|NCT01528254|560225972|FG000|Overall Study|Lost to Follow-up|17|||
155215265|NCT01528254|560225973|FG001|Overall Study|Lost to Follow-up|24|||
155215266|NCT01528254|560225972|FG000|Overall Study|Death|13|||
155215267|NCT01528254|560225973|FG001|Overall Study|Death|9|||
155215268|NCT01528254|560225972|FG000|Overall Study|Protocol deviation|9|||
155215269|NCT01528254|560225973|FG001|Overall Study|Protocol deviation|19|||
155215270|NCT01528254|560225972|FG000|Overall Study|New therapy for study indication|8|||
155215271|NCT01528254|560225973|FG001|Overall Study|New therapy for study indication|6|||
155215272|NCT01528254|560225972|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155215273|NCT01528254|560225973|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155215274|NCT01528254|560225972|FG000|Overall Study|Withdrawal by Subject|5|||
155215275|NCT01528254|560225973|FG001|Overall Study|Withdrawal by Subject|4|||
155215276|NCT01528254|560225972|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155215277|NCT01528254|560225973|FG001|Overall Study|Abnormal laboratory value(s)|7|||
155215278|NCT01528254|560225972|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155215279|NCT01528254|560225973|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155215280|NCT01528254|560225972|FG000|Overall Study|No longer requires study drug|1|||
155215281|NCT01528254|560225973|FG001|Overall Study|No longer requires study drug|1|||
155215282|NCT01166763|560225974|FG000|Overall Study|Withdrawal by Subject|3|||
155215283|NCT01909479|560225975|FG000|From Baseline to Week 26|Adverse Event|3|||
155215284|NCT01909479|560225976|FG001|From Baseline to Week 26|Adverse Event|2|||
155215285|NCT01909479|560225975|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
155215286|NCT01909479|560225976|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
155215287|NCT01909479|560225975|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
155215288|NCT01909479|560225976|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
155215289|NCT01909479|560225975|FG000|26 - 52 Weeks|Adverse Event|0|||
155215290|NCT01909479|560225976|FG001|26 - 52 Weeks|Adverse Event|1|||
155215291|NCT01909479|560225975|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
155215292|NCT01909479|560225976|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
155215293|NCT01909479|560225975|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
155215294|NCT01909479|560225976|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
155215295|NCT01909479|560225975|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
155215296|NCT01909479|560225976|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
155215297|NCT01909479|560225975|FG000|52 Weeks to End of Study|Adverse Event|2|||
155215298|NCT01909479|560225976|FG001|52 Weeks to End of Study|Adverse Event|1|||
155215299|NCT01909479|560225975|FG000|52 Weeks to End of Study|Death|0|||
155215300|NCT01909479|560225976|FG001|52 Weeks to End of Study|Death|1|||
155215301|NCT01909479|560225975|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
155215302|NCT01909479|560225976|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
155215303|NCT01909479|560225975|FG000|52 Weeks to End of Study|Protocol Violation|1|||
155215304|NCT01909479|560225976|FG001|52 Weeks to End of Study|Protocol Violation|0|||
155215305|NCT01909479|560225975|FG000|52 Weeks to End of Study|Progressive disease|1|||
155215306|NCT01909479|560225976|FG001|52 Weeks to End of Study|Progressive disease|1|||
155215307|NCT01909479|560225975|FG000|52 Weeks to End of Study|Personal reasons|2|||
155215308|NCT01909479|560225976|FG001|52 Weeks to End of Study|Personal reasons|1|||
155215309|NCT01909479|560225975|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
155215310|NCT01909479|560225976|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
155215311|NCT01909479|560225975|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
155215312|NCT01909479|560225976|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
155215313|NCT01909479|560225975|FG000|52 Weeks to End of Study|Lack of contact|1|||
155215314|NCT01909479|560225976|FG001|52 Weeks to End of Study|Lack of contact|0|||
155215315|NCT01909479|560225975|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
155215316|NCT01909479|560225976|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
155215317|NCT01909479|560225975|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
155215318|NCT01909479|560225976|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
155215319|NCT02049957|560225977|FG000|Overall Study|Progressive Disease|5|||
155215320|NCT02049957|560225978|FG001|Overall Study|Progressive Disease|4|||
155215321|NCT02049957|560225979|FG002|Overall Study|Progressive Disease|2|||
155215322|NCT02049957|560225980|FG003|Overall Study|Progressive Disease|2|||
155215323|NCT02049957|560225981|FG004|Overall Study|Progressive Disease|6|||
155215324|NCT02049957|560225982|FG005|Overall Study|Progressive Disease|35|||
155215325|NCT02049957|560225983|FG006|Overall Study|Progressive Disease|7|||
155215326|NCT02049957|560225984|FG007|Overall Study|Progressive Disease|26|||
155215327|NCT02049957|560225985|FG008|Overall Study|Progressive Disease|6|||
155215328|NCT02049957|560225977|FG000|Overall Study|Adverse Event|1|||
155215329|NCT02049957|560225978|FG001|Overall Study|Adverse Event|1|||
155215330|NCT02049957|560225979|FG002|Overall Study|Adverse Event|1|||
155215331|NCT02049957|560225980|FG003|Overall Study|Adverse Event|0|||
155215332|NCT02049957|560225981|FG004|Overall Study|Adverse Event|0|||
155215333|NCT02049957|560225982|FG005|Overall Study|Adverse Event|5|||
155215334|NCT02049957|560225983|FG006|Overall Study|Adverse Event|0|||
155215335|NCT02049957|560225984|FG007|Overall Study|Adverse Event|6|||
155215336|NCT02049957|560225985|FG008|Overall Study|Adverse Event|1|||
155215337|NCT02049957|560225977|FG000|Overall Study|Study Terminated by Sponsor|0|||
155215338|NCT02049957|560225978|FG001|Overall Study|Study Terminated by Sponsor|1|||
155215339|NCT02049957|560225979|FG002|Overall Study|Study Terminated by Sponsor|0|||
155215340|NCT02049957|560225980|FG003|Overall Study|Study Terminated by Sponsor|0|||
155215341|NCT02049957|560225981|FG004|Overall Study|Study Terminated by Sponsor|0|||
155215342|NCT02049957|560225982|FG005|Overall Study|Study Terminated by Sponsor|0|||
155215343|NCT02049957|560225983|FG006|Overall Study|Study Terminated by Sponsor|1|||
155215344|NCT02049957|560225984|FG007|Overall Study|Study Terminated by Sponsor|0|||
155215345|NCT02049957|560225985|FG008|Overall Study|Study Terminated by Sponsor|0|||
155215346|NCT02049957|560225977|FG000|Overall Study|Withdrawal by Subject|0|||
155215347|NCT02049957|560225978|FG001|Overall Study|Withdrawal by Subject|0|||
155215348|NCT02049957|560225979|FG002|Overall Study|Withdrawal by Subject|0|||
155215349|NCT02049957|560225980|FG003|Overall Study|Withdrawal by Subject|1|||
155215350|NCT02049957|560225981|FG004|Overall Study|Withdrawal by Subject|0|||
155215351|NCT02049957|560225982|FG005|Overall Study|Withdrawal by Subject|2|||
155215352|NCT02049957|560225983|FG006|Overall Study|Withdrawal by Subject|0|||
155215353|NCT02049957|560225984|FG007|Overall Study|Withdrawal by Subject|3|||
155215354|NCT02049957|560225985|FG008|Overall Study|Withdrawal by Subject|1|||
155215355|NCT02049957|560225977|FG000|Overall Study|Physician Decision|0|||
155215356|NCT02049957|560225978|FG001|Overall Study|Physician Decision|0|||
155215357|NCT02049957|560225979|FG002|Overall Study|Physician Decision|0|||
155215358|NCT02049957|560225980|FG003|Overall Study|Physician Decision|0|||
155215359|NCT02049957|560225981|FG004|Overall Study|Physician Decision|0|||
155215360|NCT02049957|560225982|FG005|Overall Study|Physician Decision|1|||
155215361|NCT02049957|560225983|FG006|Overall Study|Physician Decision|0|||
155215362|NCT02049957|560225984|FG007|Overall Study|Physician Decision|0|||
155215363|NCT02049957|560225985|FG008|Overall Study|Physician Decision|0|||
155215364|NCT02810392|560225986|FG000|Overall Study|Subject too ill to continue|1|||
155215365|NCT02810392|560225987|FG001|Overall Study|Subject too ill to continue|0|||
155215366|NCT02810392|560225986|FG000|Overall Study|COVID 19 research restrictions|0|||
155215367|NCT02810392|560225987|FG001|Overall Study|COVID 19 research restrictions|1|||
155215368|NCT03715764|560225992|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
155215369|NCT03715764|560225993|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
155215370|NCT03715764|560225992|FG000|3 Month Follow-up|Lost to Follow-up|2|||
155215371|NCT03715764|560225993|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155215372|NCT03715764|560225992|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
155215373|NCT03715764|560225993|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
155215374|NCT03715764|560225992|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155215375|NCT03715764|560225993|FG001|6 Month Follow-up|Lost to Follow-up|0|||
155215376|NCT03715764|560225992|FG000|12 Month Follow-up|Lost to Follow-up|2|||
155215377|NCT03715764|560225993|FG001|12 Month Follow-up|Lost to Follow-up|3|||
155215378|NCT03715764|560225992|FG000|12 Month Follow-up|Pregnancy|0|||
155215379|NCT03715764|560225993|FG001|12 Month Follow-up|Pregnancy|1|||
155215380|NCT03715764|560225992|FG000|12 Month Follow-up|Surgery|2|||
155215381|NCT03715764|560225993|FG001|12 Month Follow-up|Surgery|0|||
155215382|NCT03715764|560225992|FG000|12 Month Follow-up|Wrong address|1|||
155215383|NCT03715764|560225993|FG001|12 Month Follow-up|Wrong address|0|||
155215384|NCT03715764|560225992|FG000|12 Month Follow-up|No symptoms|1|||
155215385|NCT03715764|560225993|FG001|12 Month Follow-up|No symptoms|0|||
155215386|NCT03715764|560225992|FG000|12 Month Follow-up|Changed primary care centre|0|||
155215387|NCT03715764|560225993|FG001|12 Month Follow-up|Changed primary care centre|1|||
155215388|NCT01361464|560225995|FG000|Overall Study|Death|1|||
155215389|NCT01361464|560225995|FG000|Overall Study|Withdrawal by Subject|2|||
155215390|NCT01106898|560225996|FG000|Overall Study|Adverse Event|6|||
155215391|NCT01705652|560225997|FG000|Overall Study|Adverse Event|1|||
155215392|NCT01705652|560225998|FG001|Overall Study|Adverse Event|0|||
155215393|NCT01705652|560225997|FG000|Overall Study|Withdrawal by Subject|1|||
155215394|NCT01705652|560225998|FG001|Overall Study|Withdrawal by Subject|2|||
155215395|NCT01705652|560225997|FG000|Overall Study|non-compliance|1|||
155215396|NCT01705652|560225998|FG001|Overall Study|non-compliance|1|||
155215397|NCT00656474|560225999|FG000|Overall Study|Other Reason|1|||
155215398|NCT02998840|560226003|FG000|Overall Study|Lost to Follow-up|1|||
155215399|NCT02998840|560226004|FG001|Overall Study|Lost to Follow-up|1|||
155215400|NCT02998840|560226005|FG002|Overall Study|Lost to Follow-up|2|||
155215401|NCT02998840|560226006|FG003|Overall Study|Lost to Follow-up|3|||
155215402|NCT02998840|560226003|FG000|Overall Study|Withdrawal by Subject|1|||
155215403|NCT02998840|560226004|FG001|Overall Study|Withdrawal by Subject|1|||
155215404|NCT02998840|560226005|FG002|Overall Study|Withdrawal by Subject|0|||
155215405|NCT02998840|560226006|FG003|Overall Study|Withdrawal by Subject|1|||
155215406|NCT02998840|560226003|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
155215407|NCT02998840|560226004|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
155215408|NCT02998840|560226005|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
155215409|NCT02998840|560226006|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
155215410|NCT01686633|560226007|FG000|Overall Study|Lack of Efficacy|33|||
155215411|NCT01686633|560226008|FG001|Overall Study|Lack of Efficacy|13|||
155215412|NCT01686633|560226009|FG002|Overall Study|Lack of Efficacy|11|||
155215413|NCT01686633|560226007|FG000|Overall Study|Withdrawal by Subject|8|||
155215414|NCT01686633|560226008|FG001|Overall Study|Withdrawal by Subject|8|||
155215415|NCT01686633|560226009|FG002|Overall Study|Withdrawal by Subject|5|||
155215416|NCT01686633|560226007|FG000|Overall Study|Physician Decision|3|||
155215417|NCT01686633|560226008|FG001|Overall Study|Physician Decision|4|||
155215418|NCT01686633|560226009|FG002|Overall Study|Physician Decision|4|||
155215419|NCT01686633|560226007|FG000|Overall Study|Adverse Event|4|||
155215420|NCT01686633|560226008|FG001|Overall Study|Adverse Event|3|||
155215421|NCT01686633|560226009|FG002|Overall Study|Adverse Event|3|||
155215422|NCT01686633|560226007|FG000|Overall Study|Protocol Violation|2|||
155215423|NCT01686633|560226008|FG001|Overall Study|Protocol Violation|3|||
155215424|NCT01686633|560226009|FG002|Overall Study|Protocol Violation|0|||
155215425|NCT01686633|560226007|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
155215426|NCT01686633|560226008|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
155215427|NCT01686633|560226009|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
155215428|NCT01686633|560226007|FG000|Overall Study|Lost to Follow-up|0|||
155215429|NCT01686633|560226008|FG001|Overall Study|Lost to Follow-up|1|||
155215430|NCT01686633|560226009|FG002|Overall Study|Lost to Follow-up|1|||
155215431|NCT00056407|560226010|FG000|Overall Study|Adverse Event|282|||
155215432|NCT00056407|560226011|FG001|Overall Study|Adverse Event|364|||
155215433|NCT00056407|560226010|FG000|Overall Study|Withdrawal by Subject|377|||
155215434|NCT00056407|560226011|FG001|Overall Study|Withdrawal by Subject|361|||
155215435|NCT00056407|560226010|FG000|Overall Study|Lost to Follow-up|123|||
155215436|NCT00056407|560226011|FG001|Overall Study|Lost to Follow-up|113|||
155215437|NCT00056407|560226010|FG000|Overall Study|Protocol Violation|104|||
155215438|NCT00056407|560226011|FG001|Overall Study|Protocol Violation|95|||
155215439|NCT00056407|560226010|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
155215440|NCT00056407|560226011|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
155215441|NCT00056407|560226010|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
155215442|NCT00056407|560226011|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
155215443|NCT00056407|560226010|FG000|Overall Study|Missing|25|||
155215444|NCT00056407|560226011|FG001|Overall Study|Missing|34|||
155215445|NCT03605303|560226012|FG000|Period 1|Study Terminated|2|||
155215446|NCT03605303|560226013|FG001|Period 1|Study Terminated|1|||
155215447|NCT01026792|560226014|FG000|Overall Study|Protocol Violation|1|||
155215448|NCT01472081|560226019|FG000|Overall Study|Continuing treatment at time of analysis|1|||
155215449|NCT01472081|560226020|FG001|Overall Study|Continuing treatment at time of analysis|4|||
155215450|NCT01472081|560226021|FG002|Overall Study|Continuing treatment at time of analysis|1|||
155215451|NCT01472081|560226022|FG003|Overall Study|Continuing treatment at time of analysis|8|||
155215452|NCT01472081|560226023|FG004|Overall Study|Continuing treatment at time of analysis|9|||
155215453|NCT01472081|560226024|FG005|Overall Study|Continuing treatment at time of analysis|0|||
155215454|NCT01472081|560226019|FG000|Overall Study|Disease Progression|4|||
155215455|NCT01472081|560226020|FG001|Overall Study|Disease Progression|10|||
155215456|NCT01472081|560226021|FG002|Overall Study|Disease Progression|12|||
155215457|NCT01472081|560226022|FG003|Overall Study|Disease Progression|31|||
155215458|NCT01472081|560226023|FG004|Overall Study|Disease Progression|22|||
155215459|NCT01472081|560226024|FG005|Overall Study|Disease Progression|3|||
155215460|NCT01472081|560226019|FG000|Overall Study|Study drug toxicity|2|||
155215461|NCT01472081|560226020|FG001|Overall Study|Study drug toxicity|9|||
155215462|NCT01472081|560226021|FG002|Overall Study|Study drug toxicity|4|||
155215463|NCT01472081|560226022|FG003|Overall Study|Study drug toxicity|6|||
155215464|NCT01472081|560226023|FG004|Overall Study|Study drug toxicity|13|||
155215465|NCT01472081|560226024|FG005|Overall Study|Study drug toxicity|2|||
155215466|NCT01472081|560226019|FG000|Overall Study|Death|0|||
155215467|NCT01472081|560226020|FG001|Overall Study|Death|0|||
155215468|NCT01472081|560226021|FG002|Overall Study|Death|0|||
155215469|NCT01472081|560226022|FG003|Overall Study|Death|0|||
155215470|NCT01472081|560226023|FG004|Overall Study|Death|1|||
155215471|NCT01472081|560226024|FG005|Overall Study|Death|0|||
155215472|NCT01472081|560226019|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155215473|NCT01472081|560226020|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155215474|NCT01472081|560226021|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155215475|NCT01472081|560226022|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
155215476|NCT01472081|560226023|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
155215477|NCT01472081|560226024|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
155215478|NCT01472081|560226019|FG000|Overall Study|Withdrawal by Subject|0|||
155215479|NCT01472081|560226020|FG001|Overall Study|Withdrawal by Subject|0|||
155215480|NCT01472081|560226021|FG002|Overall Study|Withdrawal by Subject|0|||
155215481|NCT01472081|560226022|FG003|Overall Study|Withdrawal by Subject|0|||
155215482|NCT01472081|560226023|FG004|Overall Study|Withdrawal by Subject|0|||
155215483|NCT01472081|560226024|FG005|Overall Study|Withdrawal by Subject|1|||
155215484|NCT01472081|560226019|FG000|Overall Study|Poor/non-compliance|0|||
155215485|NCT01472081|560226020|FG001|Overall Study|Poor/non-compliance|0|||
155215486|NCT01472081|560226021|FG002|Overall Study|Poor/non-compliance|1|||
155215487|NCT01472081|560226022|FG003|Overall Study|Poor/non-compliance|0|||
155215488|NCT01472081|560226023|FG004|Overall Study|Poor/non-compliance|1|||
155215489|NCT01472081|560226024|FG005|Overall Study|Poor/non-compliance|0|||
155215490|NCT01472081|560226019|FG000|Overall Study|No longer meets study criteria|0|||
155215491|NCT01472081|560226020|FG001|Overall Study|No longer meets study criteria|0|||
155215492|NCT01472081|560226021|FG002|Overall Study|No longer meets study criteria|1|||
155215493|NCT01472081|560226022|FG003|Overall Study|No longer meets study criteria|0|||
155215494|NCT01472081|560226023|FG004|Overall Study|No longer meets study criteria|0|||
155215495|NCT01472081|560226024|FG005|Overall Study|No longer meets study criteria|0|||
155215496|NCT01472081|560226019|FG000|Overall Study|Subject request to discontinue treatment|0|||
155215497|NCT01472081|560226020|FG001|Overall Study|Subject request to discontinue treatment|3|||
155215498|NCT01472081|560226021|FG002|Overall Study|Subject request to discontinue treatment|1|||
155215499|NCT01472081|560226022|FG003|Overall Study|Subject request to discontinue treatment|1|||
155215500|NCT01472081|560226023|FG004|Overall Study|Subject request to discontinue treatment|0|||
155215501|NCT01472081|560226024|FG005|Overall Study|Subject request to discontinue treatment|0|||
155215502|NCT04702997|560226025|FG000|Overall Study|Withdrawal by Subject|1|||
155215503|NCT04702997|560226026|FG001|Overall Study|Withdrawal by Subject|1|||
155215504|NCT01386554|560226029|FG000|Overall Study|Lost to Follow-up|0|||
155215505|NCT01386554|560226030|FG001|Overall Study|Lost to Follow-up|0|||
155215506|NCT01386554|560226031|FG002|Overall Study|Lost to Follow-up|1|||
155215507|NCT01386554|560226029|FG000|Overall Study|Adverse Event|2|||
155215508|NCT01386554|560226030|FG001|Overall Study|Adverse Event|5|||
155215509|NCT01386554|560226031|FG002|Overall Study|Adverse Event|2|||
155215510|NCT01386554|560226029|FG000|Overall Study|Progressive disease|1|||
155215511|NCT01386554|560226030|FG001|Overall Study|Progressive disease|2|||
155215512|NCT01386554|560226031|FG002|Overall Study|Progressive disease|2|||
155215513|NCT01386554|560226029|FG000|Overall Study|Administration of live vaccines|0|||
155215514|NCT01386554|560226030|FG001|Overall Study|Administration of live vaccines|1|||
155215515|NCT01386554|560226031|FG002|Overall Study|Administration of live vaccines|0|||
155215516|NCT01386554|560226029|FG000|Overall Study|Investigator discretion|0|||
155215517|NCT01386554|560226030|FG001|Overall Study|Investigator discretion|0|||
155215518|NCT01386554|560226031|FG002|Overall Study|Investigator discretion|1|||
155215519|NCT01386554|560226029|FG000|Overall Study|Reason not collected|0|||
155215520|NCT01386554|560226030|FG001|Overall Study|Reason not collected|1|||
155215521|NCT01386554|560226031|FG002|Overall Study|Reason not collected|0|||
155215522|NCT00353262|560226032|FG000|Overall Study|Adverse Event|8|||
155215523|NCT00353262|560226032|FG000|Overall Study|Withdrawal by Subject|2|||
155215524|NCT00353262|560226032|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155215525|NCT00353262|560226032|FG000|Overall Study|Progression|1|||
155215526|NCT00353262|560226032|FG000|Overall Study|Surgery|4|||
155215527|NCT00353262|560226032|FG000|Overall Study|Break from Chemotherapy|1|||
155215528|NCT05286307|560226033|FG000|Overall Study|Incomplete outcome assessments|2|||
155215529|NCT05286307|560226034|FG001|Overall Study|Incomplete outcome assessments|1|||
155215530|NCT05286307|560226033|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
155215531|NCT05286307|560226034|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
155215532|NCT05286307|560226033|FG000|Overall Study|Lost to follow up at 6 months|25|||
155215533|NCT05286307|560226034|FG001|Overall Study|Lost to follow up at 6 months|35|||
155215534|NCT05286307|560226033|FG000|Overall Study|Study medication not available|1|||
155215535|NCT05286307|560226034|FG001|Overall Study|Study medication not available|1|||
155215536|NCT02759471|560226035|FG000|Overall Study|discomfort|2|||
155215537|NCT01103284|560226038|FG000|Overall Study|Death|2|||
155215538|NCT01103284|560226039|FG001|Overall Study|Death|0|||
155215539|NCT01103284|560226038|FG000|Overall Study|Lost to Follow-up|9|||
155215540|NCT01103284|560226039|FG001|Overall Study|Lost to Follow-up|10|||
155215541|NCT01103284|560226038|FG000|Overall Study|Pregnancy|3|||
155215542|NCT01103284|560226039|FG001|Overall Study|Pregnancy|1|||
155215543|NCT01103284|560226038|FG000|Overall Study|Protocol Violation|12|||
155215544|NCT01103284|560226039|FG001|Overall Study|Protocol Violation|5|||
155215545|NCT01103284|560226038|FG000|Overall Study|Adverse Event|0|||
155215546|NCT01103284|560226039|FG001|Overall Study|Adverse Event|5|||
155215547|NCT01103284|560226038|FG000|Overall Study|Withdrawal by Subject|14|||
155215548|NCT01103284|560226039|FG001|Overall Study|Withdrawal by Subject|18|||
155215549|NCT01103284|560226038|FG000|Overall Study|Dermal Hypersensitivity|0|||
155215550|NCT01103284|560226039|FG001|Overall Study|Dermal Hypersensitivity|1|||
155215551|NCT01103284|560226038|FG000|Overall Study|Termination by the Sponsor|0|||
155215552|NCT01103284|560226039|FG001|Overall Study|Termination by the Sponsor|1|||
155215553|NCT01103284|560226038|FG000|Overall Study|Not described|2|||
155215554|NCT01103284|560226039|FG001|Overall Study|Not described|1|||
155215555|NCT01103284|560226038|FG000|Overall Study|Missing CRF entries for study completion|0|||
155215556|NCT01103284|560226039|FG001|Overall Study|Missing CRF entries for study completion|2|||
155215557|NCT01786629|560227204|FG000|Overall Study|Lack of Efficacy|0|||
155215558|NCT01786629|560227205|FG001|Overall Study|Lack of Efficacy|4|||
155215559|NCT01786629|560227204|FG000|Overall Study|Adverse Event|0|||
155215560|NCT01786629|560227205|FG001|Overall Study|Adverse Event|1|||
155215561|NCT00410761|560227206|FG000|Randomized Treatment Period|Adverse Event|34|||
155215562|NCT00410761|560227207|FG001|Randomized Treatment Period|Adverse Event|3|||
155215563|NCT00410761|560227206|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
155215564|NCT00410761|560227207|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
155215565|NCT00410761|560227206|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
155215566|NCT00410761|560227207|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
155215567|NCT00410761|560227206|FG000|Randomized Treatment Period|Other|69|||
155215568|NCT00410761|560227207|FG001|Randomized Treatment Period|Other|21|||
155215569|NCT00410761|560227206|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
155215570|NCT00410761|560227207|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
155215571|NCT00410761|560227206|FG000|Open-Label Treatment Period|Adverse Event|13|||
155215572|NCT00410761|560227207|FG001|Open-Label Treatment Period|Adverse Event|15|||
155215573|NCT00410761|560227206|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
155215574|NCT00410761|560227207|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
155215575|NCT00410761|560227206|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
155215576|NCT00410761|560227207|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
155215577|NCT00410761|560227206|FG000|Open-Label Treatment Period|Other|18|||
155215578|NCT00410761|560227207|FG001|Open-Label Treatment Period|Other|9|||
155215579|NCT00312494|560227210|FG000|Overall Study|Randomized; not treated with study drug|9|||
155215580|NCT00312494|560227211|FG001|Overall Study|Randomized; not treated with study drug|10|||
155215581|NCT00312494|560227212|FG002|Overall Study|Randomized; not treated with study drug|5|||
155215582|NCT00312494|560227210|FG000|Overall Study|Adverse Event|33|||
155215583|NCT00312494|560227211|FG001|Overall Study|Adverse Event|15|||
155215584|NCT00312494|560227212|FG002|Overall Study|Adverse Event|11|||
155215585|NCT00312494|560227210|FG000|Overall Study|Lack of Efficacy|4|||
155215586|NCT00312494|560227211|FG001|Overall Study|Lack of Efficacy|6|||
155215587|NCT00312494|560227212|FG002|Overall Study|Lack of Efficacy|8|||
155215588|NCT00312494|560227210|FG000|Overall Study|Laboratory abnormality|1|||
155215589|NCT00312494|560227211|FG001|Overall Study|Laboratory abnormality|0|||
155215590|NCT00312494|560227212|FG002|Overall Study|Laboratory abnormality|0|||
155215591|NCT00312494|560227210|FG000|Overall Study|Lost to Follow-up|8|||
155215592|NCT00312494|560227211|FG001|Overall Study|Lost to Follow-up|8|||
155215593|NCT00312494|560227212|FG002|Overall Study|Lost to Follow-up|8|||
155215594|NCT00312494|560227210|FG000|Overall Study|Withdrawal by Subject|6|||
155215595|NCT00312494|560227211|FG001|Overall Study|Withdrawal by Subject|9|||
155215596|NCT00312494|560227212|FG002|Overall Study|Withdrawal by Subject|10|||
155215597|NCT00312494|560227210|FG000|Overall Study|Other|10|||
155215598|NCT00312494|560227211|FG001|Overall Study|Other|10|||
155215599|NCT00312494|560227212|FG002|Overall Study|Other|1|||
155215600|NCT02642614|560227213|FG000|Overall Study|Adverse Event|1|||
155215601|NCT02642614|560227214|FG001|Overall Study|Adverse Event|1|||
155215602|NCT02642614|560227215|FG002|Overall Study|Adverse Event|2|||
155215603|NCT02642614|560227216|FG003|Overall Study|Adverse Event|2|||
155215604|NCT02642614|560227213|FG000|Overall Study|Lost to Follow-up|1|||
155215605|NCT02642614|560227214|FG001|Overall Study|Lost to Follow-up|0|||
155215606|NCT02642614|560227215|FG002|Overall Study|Lost to Follow-up|0|||
155215607|NCT02642614|560227216|FG003|Overall Study|Lost to Follow-up|0|||
155215608|NCT02642614|560227213|FG000|Overall Study|Withdrawal by Subject|1|||
155215609|NCT02642614|560227214|FG001|Overall Study|Withdrawal by Subject|1|||
155215610|NCT02642614|560227215|FG002|Overall Study|Withdrawal by Subject|0|||
155215611|NCT02642614|560227216|FG003|Overall Study|Withdrawal by Subject|0|||
155215612|NCT01349803|560227218|FG000|Overall Study|Adverse Event|0|||
155215613|NCT01349803|560227219|FG001|Overall Study|Adverse Event|0|||
155215614|NCT01349803|560227220|FG002|Overall Study|Adverse Event|0|||
155215615|NCT01349803|560227221|FG003|Overall Study|Adverse Event|2|||
155215616|NCT01349803|560227218|FG000|Overall Study|Withdrawal by Subject|1|||
155215617|NCT01349803|560227219|FG001|Overall Study|Withdrawal by Subject|0|||
155215618|NCT01349803|560227220|FG002|Overall Study|Withdrawal by Subject|0|||
155215619|NCT01349803|560227221|FG003|Overall Study|Withdrawal by Subject|0|||
155215620|NCT01349803|560227218|FG000|Overall Study|Protocol-specified criteria|0|||
155215621|NCT01349803|560227219|FG001|Overall Study|Protocol-specified criteria|1|||
155215622|NCT01349803|560227220|FG002|Overall Study|Protocol-specified criteria|3|||
155215623|NCT01349803|560227221|FG003|Overall Study|Protocol-specified criteria|0|||
155215624|NCT03232281|560227222|FG000|Overall Study|Adverse Event|1|||
155215625|NCT03232281|560227223|FG001|Overall Study|Adverse Event|1|||
155215626|NCT03232281|560227222|FG000|Overall Study|Withdrawal by Subject|5|||
155215627|NCT03232281|560227223|FG001|Overall Study|Withdrawal by Subject|4|||
155215628|NCT03232281|560227222|FG000|Overall Study|Protocol Deviation|1|||
155215629|NCT03232281|560227223|FG001|Overall Study|Protocol Deviation|1|||
155215630|NCT00605813|560227226|FG000|Overall Study|Protocol Violation|25|||
155215631|NCT01172847|560227227|FG000|Overall Study|Withdrawal by Subject|3|||
155215632|NCT01163279|560227228|FG000|Overall Study|Withdrawal by Subject|2|||
155215633|NCT01163279|560227229|FG001|Overall Study|Withdrawal by Subject|0|||
155215634|NCT00665353|560227234|FG000|Study Step 1|Adverse Event|1|||
155215635|NCT00665353|560227234|FG000|Study Step 1|Withdrawal by Subject|2|||
155215636|NCT00665353|560227234|FG000|Study Step 2|Lost to Follow-up|2|||
155215637|NCT00665353|560227234|FG000|Study Step 2|Lack of Efficacy|12|||
155215638|NCT00573755|560227235|FG000|Overall Study|Still receiving treatment|1|||
155215639|NCT00573755|560227236|FG001|Overall Study|Still receiving treatment|0|||
155215640|NCT03724812|560227237|FG000|Overall Study|Missed Visit|1|||
155215641|NCT03724812|560227237|FG000|Overall Study|Death|2|||
155215642|NCT03724812|560227237|FG000|Overall Study|Withdrawal by Subject|1|||
155215643|NCT01870583|560227242|FG000|Overall Study|Protocol Violation|0|||
155215644|NCT01870583|560227243|FG001|Overall Study|Protocol Violation|5|||
155215645|NCT01870583|560227244|FG002|Overall Study|Protocol Violation|3|||
155215646|NCT01870583|560227242|FG000|Overall Study|Lost to Follow-up|11|||
155215647|NCT01870583|560227243|FG001|Overall Study|Lost to Follow-up|13|||
155215648|NCT01870583|560227244|FG002|Overall Study|Lost to Follow-up|5|||
155215649|NCT00390858|560227245|FG000|Overall Study|Adverse Event|6|||
155215650|NCT00390858|560227246|FG001|Overall Study|Adverse Event|2|||
155215651|NCT00390858|560227245|FG000|Overall Study|Lack of Efficacy|0|||
155215652|NCT00390858|560227246|FG001|Overall Study|Lack of Efficacy|1|||
155215653|NCT00390858|560227245|FG000|Overall Study|Withdrawal by Subject|3|||
155215654|NCT00390858|560227246|FG001|Overall Study|Withdrawal by Subject|4|||
155215655|NCT02865187|560227253|FG000|Overall Study|Lost to Follow-up|12|||
155215656|NCT02865187|560227254|FG001|Overall Study|Lost to Follow-up|7|||
155215657|NCT02865187|560227253|FG000|Overall Study|Adverse Event|1|||
155215658|NCT02865187|560227254|FG001|Overall Study|Adverse Event|0|||
155215659|NCT04267133|560227255|FG000|Overall Study|Withdrawal by Subject|1|||
155215660|NCT04267133|560227255|FG000|Overall Study|Adverse Event|4|||
155215661|NCT02369341|560227256|FG000|Overall Study|Migrated/moved from study area|1|||
155215662|NCT02369341|560227257|FG001|Overall Study|Migrated/moved from study area|0|||
155215663|NCT00857220|560227265|FG000|Overall Study|Adverse Event|35|||
155215664|NCT00857220|560227265|FG000|Overall Study|Death|1|||
155215665|NCT00857220|560227265|FG000|Overall Study|Lack of Efficacy|11|||
155215666|NCT00857220|560227265|FG000|Overall Study|Lost to Follow-up|30|||
155215667|NCT00857220|560227265|FG000|Overall Study|Physician Decision|4|||
155215668|NCT00857220|560227265|FG000|Overall Study|Protocol Violation|16|||
155215669|NCT00857220|560227265|FG000|Overall Study|Withdrawal by Subject|67|||
155215670|NCT00857220|560227265|FG000|Overall Study|Clinical Hold|6|||
155215671|NCT00857220|560227265|FG000|Overall Study|Site Closed|5|||
155215672|NCT00857220|560227265|FG000|Overall Study|Miscellaneous|8|||
155215673|NCT02612428|560227266|FG000|VTL-308|Death|14|||
155215674|NCT02612428|560227267|FG001|VTL-308|Death|16|||
155215675|NCT02612428|560227266|FG000|VTL-308|Withdrawal by Subject|0|||
155215676|NCT02612428|560227267|FG001|VTL-308|Withdrawal by Subject|1|||
155215677|NCT02612428|560227266|FG000|VTL-308E|Death|9|||
155215678|NCT02612428|560227267|FG001|VTL-308E|Death|7|||
155215679|NCT02612428|560227266|FG000|VTL-308E|Lost to Follow-up|2|||
155215680|NCT02612428|560227267|FG001|VTL-308E|Lost to Follow-up|0|||
155215681|NCT00742001|560227268|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
155215682|NCT00742001|560227269|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
155215683|NCT00742001|560227270|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
155215684|NCT00137423|560227271|FG000|Overall Study|Adverse Event|7|||
155215685|NCT00137423|560227272|FG001|Overall Study|Adverse Event|9|||
155215686|NCT00137423|560227271|FG000|Overall Study|consent withdrawn|1|||
155215687|NCT00137423|560227272|FG001|Overall Study|consent withdrawn|1|||
155215688|NCT00137423|560227271|FG000|Overall Study|Lack of Efficacy|31|||
155215689|NCT00137423|560227272|FG001|Overall Study|Lack of Efficacy|33|||
155215690|NCT00137423|560227271|FG000|Overall Study|Death|0|||
155215691|NCT00137423|560227272|FG001|Overall Study|Death|1|||
155215692|NCT03187262|560227274|FG000|Induction|Lack of Efficacy|2|||
155215693|NCT03187262|560227274|FG000|Induction|Progressive Disease|4|||
155215694|NCT03187262|560227274|FG000|Consolidation|Progressive Disease|5|||
155215695|NCT00909389|560227278|FG000|Overall Study|Adverse Event|6|||
155215696|NCT00909389|560227278|FG000|Overall Study|Death|4|||
155215697|NCT00909389|560227278|FG000|Overall Study|Poor Compliance|16|||
155215698|NCT00909389|560227278|FG000|Overall Study|Lost to Follow-up|4|||
155215699|NCT00909389|560227278|FG000|Overall Study|No Information|103|||
155215700|NCT00737282|560227282|FG000|Overall Study|Study prematurely terminated|175|||
155215701|NCT02763189|560227283|FG000|Overall Study|Device failure|0|||
155215702|NCT02763189|560227284|FG001|Overall Study|Device failure|2|||
155215703|NCT00416078|560227287|FG000|Overall Study|Death|3|||
155215704|NCT00416078|560227288|FG001|Overall Study|Death|4|||
155215705|NCT00416078|560227287|FG000|Overall Study|Withdrawal by Subject|3|||
155215706|NCT00416078|560227288|FG001|Overall Study|Withdrawal by Subject|2|||
155215707|NCT00416078|560227287|FG000|Overall Study|Physician Decision|1|||
155215708|NCT00416078|560227288|FG001|Overall Study|Physician Decision|0|||
155215709|NCT00416078|560227287|FG000|Overall Study|Lost to Follow-up|4|||
155215710|NCT00416078|560227288|FG001|Overall Study|Lost to Follow-up|2|||
155215711|NCT02626520|560227302|FG000|Overall Study|Physician Decision|1|||
155215712|NCT02626520|560227303|FG001|Overall Study|Physician Decision|1|||
155215713|NCT02626520|560227302|FG000|Overall Study|Adverse Event|0|||
155215714|NCT02626520|560227303|FG001|Overall Study|Adverse Event|4|||
155215715|NCT02626520|560227302|FG000|Overall Study|Lack of Efficacy|0|||
155215716|NCT02626520|560227303|FG001|Overall Study|Lack of Efficacy|2|||
155215717|NCT02626520|560227302|FG000|Overall Study|Did not start protocol therapy|0|||
155215718|NCT02626520|560227303|FG001|Overall Study|Did not start protocol therapy|2|||
155215719|NCT02626520|560227302|FG000|Overall Study|Study terminated|0|||
155215720|NCT02626520|560227303|FG001|Overall Study|Study terminated|1|||
155215721|NCT00492115|560227304|FG000|Overall Study|Withdrawal by Subject|3|||
155215722|NCT00492115|560227305|FG001|Overall Study|Withdrawal by Subject|4|||
155215723|NCT03915496|560227308|FG000|Overall Study|Adverse Event|2|||
155215724|NCT03915496|560227309|FG001|Overall Study|Adverse Event|1|||
155215725|NCT03915496|560227310|FG002|Overall Study|Adverse Event|2|||
155215726|NCT02472795|560227311|FG000|Overall Study|Adverse Event|0|||
155215727|NCT02472795|560227312|FG001|Overall Study|Adverse Event|1|||
155215728|NCT02472795|560227313|FG002|Overall Study|Adverse Event|0|||
155215729|NCT02472795|560227314|FG003|Overall Study|Adverse Event|0|||
155215730|NCT02472795|560227315|FG004|Overall Study|Adverse Event|2|||
155215731|NCT02472795|560227311|FG000|Overall Study|Withdrawal by Subject|0|||
155215732|NCT02472795|560227312|FG001|Overall Study|Withdrawal by Subject|0|||
155215733|NCT02472795|560227313|FG002|Overall Study|Withdrawal by Subject|0|||
155215734|NCT02472795|560227314|FG003|Overall Study|Withdrawal by Subject|0|||
155215735|NCT02472795|560227315|FG004|Overall Study|Withdrawal by Subject|1|||
155215736|NCT04166513|560227316|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215737|NCT04166513|560227317|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
155215738|NCT04166513|560227318|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215739|NCT04166513|560227319|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215740|NCT04166513|560227316|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215741|NCT04166513|560227317|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215742|NCT04166513|560227318|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215743|NCT04166513|560227319|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
155215744|NCT04166513|560227316|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
155215745|NCT04166513|560227317|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
155215746|NCT04166513|560227318|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
155215747|NCT04166513|560227319|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
155215748|NCT04166513|560227316|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
155215749|NCT04166513|560227317|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
155215750|NCT04166513|560227318|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
155215751|NCT04166513|560227319|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
155215752|NCT04166513|560227316|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
155215753|NCT04166513|560227317|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
155215754|NCT04166513|560227318|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
155215755|NCT04166513|560227319|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
155215756|NCT04219891|560227321|FG000|Overall Study|Lost to Follow-up|3|||
155215757|NCT04219891|560227321|FG000|Overall Study|Withdrawal by Subject|2|||
155215758|NCT00597012|560227322|FG000|Overall Study|Death|1|||
155215759|NCT00597012|560227323|FG001|Overall Study|Death|1|||
155215760|NCT00597012|560227322|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
155215761|NCT00597012|560227323|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
155215762|NCT00597012|560227322|FG000|Overall Study|Withdrawal by Subject|7|||
155215763|NCT00597012|560227323|FG001|Overall Study|Withdrawal by Subject|4|||
155215764|NCT00597012|560227322|FG000|Overall Study|Ineligible|2|||
155215765|NCT00597012|560227323|FG001|Overall Study|Ineligible|0|||
155215766|NCT00597012|560227322|FG000|Overall Study|Lost to Follow-up|0|||
155215767|NCT00597012|560227323|FG001|Overall Study|Lost to Follow-up|2|||
155215768|NCT00696696|560229430|FG000|Overall Study|Adverse Event|5|||
155215769|NCT00696696|560229430|FG000|Overall Study|Withdrawal by Subject|8|||
155215770|NCT00696696|560229430|FG000|Overall Study|Physician Decision|2|||
155215771|NCT00696696|560229430|FG000|Overall Study|Death|3|||
155215772|NCT01485640|560229431|FG000|Overall Study|Adverse Event|10|||
155215773|NCT01485640|560229431|FG000|Overall Study|Lack of Efficacy|2|||
155215774|NCT01485640|560229431|FG000|Overall Study|Protocol Violation|1|||
155215775|NCT01485640|560229431|FG000|Overall Study|Withdrawal by Subject|14|||
155215776|NCT01485640|560229431|FG000|Overall Study|Terminated by Sponsor|95|||
155215777|NCT01851720|560229435|FG000|Overall Study|Lost to Follow-up|0|||
155215778|NCT01851720|560229436|FG001|Overall Study|Lost to Follow-up|1|||
155215779|NCT01394523|560229437|FG000|Overall Study|Unable to place block|1|||
155215780|NCT01394523|560229438|FG001|Overall Study|Unable to place block|0|||
155215781|NCT01394523|560229439|FG002|Overall Study|Unable to place block|0|||
155215782|NCT02389998|560229440|FG000|Overall Study|car accident|1|||
155215783|NCT02389998|560229441|FG001|Overall Study|car accident|0|||
155215784|NCT03525574|560229442|FG000|Overall Study|Adverse Event|15|||
155215785|NCT03525574|560229443|FG001|Overall Study|Adverse Event|0|||
155215786|NCT03525574|560229442|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
155215787|NCT03525574|560229443|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155215788|NCT03525574|560229442|FG000|Overall Study|Lost to Follow-up|4|||
155215789|NCT03525574|560229443|FG001|Overall Study|Lost to Follow-up|0|||
155215790|NCT03525574|560229442|FG000|Overall Study|Commercial drug is Available for participant|48|||
155215791|NCT03525574|560229443|FG001|Overall Study|Commercial drug is Available for participant|0|||
155215792|NCT03525574|560229442|FG000|Overall Study|Death|1|||
155215793|NCT03525574|560229443|FG001|Overall Study|Death|0|||
155215794|NCT03525574|560229442|FG000|Overall Study|Other non-compliance|2|||
155215795|NCT03525574|560229443|FG001|Overall Study|Other non-compliance|0|||
155215796|NCT03525574|560229442|FG000|Overall Study|Physician Decision|6|||
155215797|NCT03525574|560229443|FG001|Overall Study|Physician Decision|0|||
155215798|NCT03525574|560229442|FG000|Overall Study|Other|58|||
155215799|NCT03525574|560229443|FG001|Overall Study|Other|0|||
155215800|NCT03525574|560229442|FG000|Overall Study|Enrolled but never dosed|1|||
155215801|NCT03525574|560229443|FG001|Overall Study|Enrolled but never dosed|0|||
155215802|NCT03525574|560229442|FG000|Overall Study|Not enrolled in 105 study|0|||
155215803|NCT03525574|560229443|FG001|Overall Study|Not enrolled in 105 study|3|||
155215804|NCT04741074|560229446|FG000|Overall Study|Withdrawal by Subject|1|||
155215805|NCT04741074|560229447|FG001|Overall Study|Withdrawal by Subject|1|||
155215806|NCT04741074|560229446|FG000|Overall Study|Study terminated prematurely|1|||
155215807|NCT04741074|560229447|FG001|Overall Study|Study terminated prematurely|0|||
155215808|NCT01770379|560229448|FG000|Overall Study|Technical issues|1|||
155215809|NCT01770379|560229449|FG001|Overall Study|Technical issues|0|||
155215810|NCT01770379|560229450|FG002|Overall Study|Technical issues|0|||
155215811|NCT01770379|560229448|FG000|Overall Study|Withdrawal by Subject|7|||
155215812|NCT01770379|560229449|FG001|Overall Study|Withdrawal by Subject|10|||
155215813|NCT01770379|560229450|FG002|Overall Study|Withdrawal by Subject|7|||
155215814|NCT01770379|560229448|FG000|Overall Study|study terminated by sponsor|22|||
155215815|NCT01770379|560229449|FG001|Overall Study|study terminated by sponsor|23|||
155215816|NCT01770379|560229450|FG002|Overall Study|study terminated by sponsor|22|||
155215817|NCT01770379|560229448|FG000|Overall Study|Protocol Violation|0|||
155215818|NCT01770379|560229449|FG001|Overall Study|Protocol Violation|1|||
155215819|NCT01770379|560229450|FG002|Overall Study|Protocol Violation|1|||
155215820|NCT01770379|560229448|FG000|Overall Study|Physician Decision|0|||
155215821|NCT01770379|560229449|FG001|Overall Study|Physician Decision|1|||
155215822|NCT01770379|560229450|FG002|Overall Study|Physician Decision|2|||
155215823|NCT01770379|560229448|FG000|Overall Study|Lost to Follow-up|0|||
155215824|NCT01770379|560229449|FG001|Overall Study|Lost to Follow-up|0|||
155215825|NCT01770379|560229450|FG002|Overall Study|Lost to Follow-up|2|||
155215826|NCT01770379|560229448|FG000|Overall Study|Lack of Efficacy|8|||
155215827|NCT01770379|560229449|FG001|Overall Study|Lack of Efficacy|6|||
155215828|NCT01770379|560229450|FG002|Overall Study|Lack of Efficacy|6|||
155215829|NCT01770379|560229448|FG000|Overall Study|Adverse Event|1|||
155215830|NCT01770379|560229449|FG001|Overall Study|Adverse Event|3|||
155215831|NCT01770379|560229450|FG002|Overall Study|Adverse Event|2|||
155215832|NCT01074450|560229463|FG000|First Intervention|Emesis in Dosing Interval|0|||
155215833|NCT01074450|560229464|FG001|First Intervention|Emesis in Dosing Interval|2|||
155215834|NCT01074450|560229463|FG000|Second Intervention|Protocol Violation|1|||
155215835|NCT01074450|560229464|FG001|Second Intervention|Protocol Violation|0|||
155215836|NCT01074450|560229463|FG000|Second Intervention|Physician Decision|0|||
155215837|NCT01074450|560229464|FG001|Second Intervention|Physician Decision|1|||
155215838|NCT03226392|560229465|FG000|Overall Study|Protocol Deviation|1|||
155215839|NCT03226392|560229466|FG001|Overall Study|Protocol Deviation|0|||
155215840|NCT03226392|560229465|FG000|Overall Study|Physician Decision|1|||
155215841|NCT03226392|560229466|FG001|Overall Study|Physician Decision|0|||
155215842|NCT03226392|560229465|FG000|Overall Study|Lost to Follow-up|1|||
155215843|NCT03226392|560229466|FG001|Overall Study|Lost to Follow-up|0|||
155215844|NCT03226392|560229465|FG000|Overall Study|Adverse Event|1|||
155215845|NCT03226392|560229466|FG001|Overall Study|Adverse Event|0|||
155215846|NCT03226392|560229465|FG000|Overall Study|Technical Problems|0|||
155215847|NCT03226392|560229466|FG001|Overall Study|Technical Problems|2|||
155215848|NCT03226392|560229465|FG000|Overall Study|Subject/Guardian Decision|7|||
155215849|NCT03226392|560229466|FG001|Overall Study|Subject/Guardian Decision|6|||
155215850|NCT02728895|560229467|FG000|Overall Study|Other|1|||
155215851|NCT02728895|560229468|FG001|Overall Study|Other|2|||
155215852|NCT02728895|560229467|FG000|Overall Study|Withdrawal by Subject|0|||
155215853|NCT02728895|560229468|FG001|Overall Study|Withdrawal by Subject|3|||
155215854|NCT02769247|560229469|FG000|Overall Study|Withdrawal by Subject|1|||
155215855|NCT02769247|560229470|FG001|Overall Study|Withdrawal by Subject|0|||
155215856|NCT02769247|560229471|FG002|Overall Study|Withdrawal by Subject|0|||
155215857|NCT02769247|560229472|FG003|Overall Study|Withdrawal by Subject|1|||
155215858|NCT02769247|560229469|FG000|Overall Study|Protocol Violation|0|||
155215859|NCT02769247|560229470|FG001|Overall Study|Protocol Violation|0|||
155215860|NCT02769247|560229471|FG002|Overall Study|Protocol Violation|1|||
155215861|NCT02769247|560229472|FG003|Overall Study|Protocol Violation|0|||
155215862|NCT02769247|560229469|FG000|Overall Study|Physician Decision|1|||
155215863|NCT02769247|560229470|FG001|Overall Study|Physician Decision|0|||
155215864|NCT02769247|560229471|FG002|Overall Study|Physician Decision|0|||
155215865|NCT02769247|560229472|FG003|Overall Study|Physician Decision|0|||
155215866|NCT04788953|560229473|FG000|Overall Study|Adverse Event|1|||
155215867|NCT04788953|560229474|FG001|Overall Study|Adverse Event|1|||
155215868|NCT04788953|560229473|FG000|Overall Study|Withdrawal by Subject|1|||
155215869|NCT04788953|560229474|FG001|Overall Study|Withdrawal by Subject|0|||
155215870|NCT04788953|560229473|FG000|Overall Study|Protocol Violation|0|||
155215871|NCT04788953|560229474|FG001|Overall Study|Protocol Violation|1|||
155215872|NCT00937157|560229475|FG000|Overall Study|Pregnancy|1|||
155215873|NCT00937157|560229475|FG000|Overall Study|Lost to Follow-up|3|||
155215874|NCT00469092|560229476|FG000|Overall Study|Adverse Event|5|||
155215875|NCT00469092|560229477|FG001|Overall Study|Adverse Event|4|||
155215876|NCT00469092|560229476|FG000|Overall Study|Lack of Efficacy|1|||
155215877|NCT00469092|560229477|FG001|Overall Study|Lack of Efficacy|0|||
155215878|NCT00469092|560229476|FG000|Overall Study|Lost to Follow-up|1|||
155215879|NCT00469092|560229477|FG001|Overall Study|Lost to Follow-up|2|||
155215880|NCT00469092|560229476|FG000|Overall Study|Protocol Violation|3|||
155215881|NCT00469092|560229477|FG001|Overall Study|Protocol Violation|3|||
155215882|NCT00469092|560229476|FG000|Overall Study|Withdrawal by Subject|4|||
155215883|NCT00469092|560229477|FG001|Overall Study|Withdrawal by Subject|4|||
155215884|NCT00469092|560229476|FG000|Overall Study|Withdrawal Criteria|3|||
155215885|NCT00469092|560229477|FG001|Overall Study|Withdrawal Criteria|4|||
155215886|NCT00469092|560229476|FG000|Overall Study|Incorrectly Randomised|4|||
155215887|NCT00469092|560229477|FG001|Overall Study|Incorrectly Randomised|3|||
155215888|NCT00469092|560229476|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
155215889|NCT00469092|560229477|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
155215890|NCT00469092|560229476|FG000|Overall Study|Use of lipid lowering drug|1|||
155215891|NCT00469092|560229477|FG001|Overall Study|Use of lipid lowering drug|0|||
155215892|NCT00469092|560229476|FG000|Overall Study|Hypoglycaemic Episodes|1|||
155215893|NCT00469092|560229477|FG001|Overall Study|Hypoglycaemic Episodes|1|||
155215894|NCT00469092|560229476|FG000|Overall Study|Abnormal lab value|1|||
155215895|NCT00469092|560229477|FG001|Overall Study|Abnormal lab value|0|||
155215896|NCT00469092|560229476|FG000|Overall Study|Use of Corticosteroid|1|||
155215897|NCT00469092|560229477|FG001|Overall Study|Use of Corticosteroid|0|||
155215898|NCT01998737|560229485|FG000|Overall Study|Corrupted database|23|||
155215899|NCT01998737|560229486|FG001|Overall Study|Corrupted database|0|||
155215900|NCT02092662|560229487|FG000|Overall Study|Lost to Follow-up|13|||
155215901|NCT02092662|560229488|FG001|Overall Study|Lost to Follow-up|0|||
155215902|NCT02268864|560229489|FG000|Overall Study|Withdrawal by Subject|2|||
155215903|NCT02268864|560229490|FG001|Overall Study|Withdrawal by Subject|0|||
155215904|NCT02268864|560229491|FG002|Overall Study|Withdrawal by Subject|0|||
155215905|NCT02268864|560229489|FG000|Overall Study|Death|0|||
155215906|NCT02268864|560229490|FG001|Overall Study|Death|1|||
155215907|NCT02268864|560229491|FG002|Overall Study|Death|0|||
155215908|NCT05407675|560229492|FG000|Overall Study|Withdrawal by Subject|0|||
155215909|NCT05407675|560229493|FG001|Overall Study|Withdrawal by Subject|2|||
155215910|NCT05407675|560229494|FG002|Overall Study|Withdrawal by Subject|3|||
155215911|NCT05407675|560229495|FG003|Overall Study|Withdrawal by Subject|5|||
155215912|NCT05407675|560229496|FG004|Overall Study|Withdrawal by Subject|0|||
155215913|NCT05407675|560229497|FG005|Overall Study|Withdrawal by Subject|2|||
155215914|NCT05407675|560229498|FG006|Overall Study|Withdrawal by Subject|0|||
155215915|NCT05407675|560229499|FG007|Overall Study|Withdrawal by Subject|0|||
155215916|NCT05407675|560229500|FG008|Overall Study|Withdrawal by Subject|2|||
155215917|NCT05407675|560229501|FG009|Overall Study|Withdrawal by Subject|0|||
155215918|NCT05407675|560229502|FG010|Overall Study|Withdrawal by Subject|1|||
155215919|NCT05407675|560229503|FG011|Overall Study|Withdrawal by Subject|0|||
155215920|NCT05407675|560229504|FG012|Overall Study|Withdrawal by Subject|0|||
155215921|NCT05407675|560229492|FG000|Overall Study|Site terminated by sponsor|0|||
155215922|NCT05407675|560229493|FG001|Overall Study|Site terminated by sponsor|0|||
155215923|NCT05407675|560229494|FG002|Overall Study|Site terminated by sponsor|1|||
155215924|NCT05407675|560229495|FG003|Overall Study|Site terminated by sponsor|0|||
155215925|NCT05407675|560229496|FG004|Overall Study|Site terminated by sponsor|2|||
155215926|NCT05407675|560229497|FG005|Overall Study|Site terminated by sponsor|0|||
155215927|NCT05407675|560229498|FG006|Overall Study|Site terminated by sponsor|1|||
155215928|NCT05407675|560229499|FG007|Overall Study|Site terminated by sponsor|0|||
155215929|NCT05407675|560229500|FG008|Overall Study|Site terminated by sponsor|0|||
155215930|NCT05407675|560229501|FG009|Overall Study|Site terminated by sponsor|2|||
155215931|NCT05407675|560229502|FG010|Overall Study|Site terminated by sponsor|2|||
155215932|NCT05407675|560229503|FG011|Overall Study|Site terminated by sponsor|2|||
155215933|NCT05407675|560229504|FG012|Overall Study|Site terminated by sponsor|1|||
155215934|NCT05407675|560229492|FG000|Overall Study|Disease Progression|0|||
155215935|NCT05407675|560229493|FG001|Overall Study|Disease Progression|0|||
155215936|NCT05407675|560229494|FG002|Overall Study|Disease Progression|0|||
155215937|NCT05407675|560229495|FG003|Overall Study|Disease Progression|0|||
155215938|NCT05407675|560229496|FG004|Overall Study|Disease Progression|0|||
155215939|NCT05407675|560229497|FG005|Overall Study|Disease Progression|0|||
155215940|NCT05407675|560229498|FG006|Overall Study|Disease Progression|0|||
155215941|NCT05407675|560229499|FG007|Overall Study|Disease Progression|0|||
155215942|NCT05407675|560229500|FG008|Overall Study|Disease Progression|0|||
155215943|NCT05407675|560229501|FG009|Overall Study|Disease Progression|0|||
155215944|NCT05407675|560229502|FG010|Overall Study|Disease Progression|1|||
155215945|NCT05407675|560229503|FG011|Overall Study|Disease Progression|0|||
155215946|NCT05407675|560229504|FG012|Overall Study|Disease Progression|0|||
155215947|NCT05407675|560229492|FG000|Overall Study|Physician Decision|0|||
155215948|NCT05407675|560229493|FG001|Overall Study|Physician Decision|0|||
155215949|NCT05407675|560229494|FG002|Overall Study|Physician Decision|0|||
155215950|NCT05407675|560229495|FG003|Overall Study|Physician Decision|0|||
155215951|NCT05407675|560229496|FG004|Overall Study|Physician Decision|0|||
155215952|NCT05407675|560229497|FG005|Overall Study|Physician Decision|0|||
155215953|NCT05407675|560229498|FG006|Overall Study|Physician Decision|0|||
155215954|NCT05407675|560229499|FG007|Overall Study|Physician Decision|0|||
155215955|NCT05407675|560229500|FG008|Overall Study|Physician Decision|0|||
155215956|NCT05407675|560229501|FG009|Overall Study|Physician Decision|0|||
155215957|NCT05407675|560229502|FG010|Overall Study|Physician Decision|1|||
155215958|NCT05407675|560229503|FG011|Overall Study|Physician Decision|0|||
155215959|NCT05407675|560229504|FG012|Overall Study|Physician Decision|0|||
155215960|NCT05407675|560229492|FG000|Overall Study|Other reasons|0|||
155215961|NCT05407675|560229493|FG001|Overall Study|Other reasons|0|||
155215962|NCT05407675|560229494|FG002|Overall Study|Other reasons|0|||
155215963|NCT05407675|560229495|FG003|Overall Study|Other reasons|0|||
155215964|NCT05407675|560229496|FG004|Overall Study|Other reasons|0|||
155215965|NCT05407675|560229497|FG005|Overall Study|Other reasons|0|||
155215966|NCT05407675|560229498|FG006|Overall Study|Other reasons|0|||
155215967|NCT05407675|560229499|FG007|Overall Study|Other reasons|0|||
155215968|NCT05407675|560229500|FG008|Overall Study|Other reasons|1|||
155215969|NCT05407675|560229501|FG009|Overall Study|Other reasons|1|||
155215970|NCT05407675|560229502|FG010|Overall Study|Other reasons|1|||
155215971|NCT05407675|560229503|FG011|Overall Study|Other reasons|1|||
155215972|NCT05407675|560229504|FG012|Overall Study|Other reasons|0|||
155215973|NCT05407675|560229492|FG000|Overall Study|Death|3|||
155215974|NCT05407675|560229493|FG001|Overall Study|Death|4|||
155215975|NCT05407675|560229494|FG002|Overall Study|Death|3|||
155215976|NCT05407675|560229495|FG003|Overall Study|Death|6|||
155215977|NCT05407675|560229496|FG004|Overall Study|Death|0|||
155215978|NCT05407675|560229497|FG005|Overall Study|Death|2|||
155215979|NCT05407675|560229498|FG006|Overall Study|Death|4|||
155215980|NCT05407675|560229499|FG007|Overall Study|Death|2|||
155215981|NCT05407675|560229500|FG008|Overall Study|Death|2|||
155215982|NCT05407675|560229501|FG009|Overall Study|Death|4|||
155215983|NCT05407675|560229502|FG010|Overall Study|Death|2|||
155215984|NCT05407675|560229503|FG011|Overall Study|Death|1|||
155215985|NCT05407675|560229504|FG012|Overall Study|Death|0|||
155215986|NCT05407675|560229492|FG000|Overall Study|Adverse Event|0|||
155215987|NCT05407675|560229493|FG001|Overall Study|Adverse Event|0|||
155215988|NCT05407675|560229494|FG002|Overall Study|Adverse Event|0|||
155215989|NCT05407675|560229495|FG003|Overall Study|Adverse Event|0|||
155215990|NCT05407675|560229496|FG004|Overall Study|Adverse Event|1|||
155215991|NCT05407675|560229497|FG005|Overall Study|Adverse Event|0|||
155215992|NCT05407675|560229498|FG006|Overall Study|Adverse Event|0|||
155215993|NCT05407675|560229499|FG007|Overall Study|Adverse Event|0|||
155215994|NCT05407675|560229500|FG008|Overall Study|Adverse Event|0|||
155215995|NCT05407675|560229501|FG009|Overall Study|Adverse Event|0|||
155215996|NCT05407675|560229502|FG010|Overall Study|Adverse Event|0|||
155215997|NCT05407675|560229503|FG011|Overall Study|Adverse Event|1|||
155215998|NCT05407675|560229504|FG012|Overall Study|Adverse Event|0|||
155215999|NCT05407675|560229492|FG000|Overall Study|Ongoing Treatment|0|||
155216000|NCT05407675|560229493|FG001|Overall Study|Ongoing Treatment|0|||
155216001|NCT05407675|560229494|FG002|Overall Study|Ongoing Treatment|0|||
155216002|NCT05407675|560229495|FG003|Overall Study|Ongoing Treatment|0|||
155216003|NCT05407675|560229496|FG004|Overall Study|Ongoing Treatment|0|||
155216004|NCT05407675|560229497|FG005|Overall Study|Ongoing Treatment|0|||
155216005|NCT05407675|560229498|FG006|Overall Study|Ongoing Treatment|0|||
155216006|NCT05407675|560229499|FG007|Overall Study|Ongoing Treatment|0|||
155216007|NCT05407675|560229500|FG008|Overall Study|Ongoing Treatment|1|||
155216008|NCT05407675|560229501|FG009|Overall Study|Ongoing Treatment|0|||
155216009|NCT05407675|560229502|FG010|Overall Study|Ongoing Treatment|0|||
155216010|NCT05407675|560229503|FG011|Overall Study|Ongoing Treatment|0|||
155216011|NCT05407675|560229504|FG012|Overall Study|Ongoing Treatment|0|||
155216012|NCT01050257|560229505|FG000|Overall Study|Adverse Event|4|||
155216013|NCT01050257|560229506|FG001|Overall Study|Adverse Event|4|||
155216014|NCT01050257|560229507|FG002|Overall Study|Adverse Event|2|||
155216015|NCT01050257|560229505|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
155216016|NCT01050257|560229506|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
155216017|NCT01050257|560229507|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
155216018|NCT01050257|560229505|FG000|Overall Study|Withdrawal by Subject|0|||
155216019|NCT01050257|560229506|FG001|Overall Study|Withdrawal by Subject|3|||
155216020|NCT01050257|560229507|FG002|Overall Study|Withdrawal by Subject|0|||
155216021|NCT01050257|560229505|FG000|Overall Study|No reason specified|0|||
155216022|NCT01050257|560229506|FG001|Overall Study|No reason specified|0|||
155216023|NCT01050257|560229507|FG002|Overall Study|No reason specified|2|||
155216024|NCT01050257|560229505|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
155216025|NCT01050257|560229506|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
155216026|NCT01050257|560229507|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
155216027|NCT01050257|560229505|FG000|Overall Study|Violation criteria|0|||
155216028|NCT01050257|560229506|FG001|Overall Study|Violation criteria|1|||
155216029|NCT01050257|560229507|FG002|Overall Study|Violation criteria|0|||
155216030|NCT01050257|560229505|FG000|Overall Study|Failure to return|0|||
155216031|NCT01050257|560229506|FG001|Overall Study|Failure to return|2|||
155216032|NCT01050257|560229507|FG002|Overall Study|Failure to return|0|||
155216033|NCT01050257|560229505|FG000|Overall Study|Death|0|||
155216034|NCT01050257|560229506|FG001|Overall Study|Death|0|||
155216035|NCT01050257|560229507|FG002|Overall Study|Death|1|||
155216036|NCT00171223|560229508|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
155216037|NCT00171223|560229509|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
155216038|NCT00171223|560229510|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
155216039|NCT00171223|560229508|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
155216040|NCT00171223|560229509|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
155216041|NCT00171223|560229510|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
155216042|NCT00171223|560229508|FG000|Overall Study|Abnormal Procedure|1|||
155216043|NCT00171223|560229509|FG001|Overall Study|Abnormal Procedure|0|||
155216044|NCT00171223|560229510|FG002|Overall Study|Abnormal Procedure|0|||
155216045|NCT00171223|560229508|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
155216046|NCT00171223|560229509|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
155216047|NCT00171223|560229510|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
155216048|NCT00171223|560229508|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
155216049|NCT00171223|560229509|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
155216050|NCT00171223|560229510|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
155216051|NCT00171223|560229508|FG000|Overall Study|Protocol Violation|2|||
155216052|NCT00171223|560229509|FG001|Overall Study|Protocol Violation|2|||
155216053|NCT00171223|560229510|FG002|Overall Study|Protocol Violation|3|||
155216054|NCT00171223|560229508|FG000|Overall Study|Participant Withdrew Consent|12|||
155216055|NCT00171223|560229509|FG001|Overall Study|Participant Withdrew Consent|21|||
155216056|NCT00171223|560229510|FG002|Overall Study|Participant Withdrew Consent|15|||
155216057|NCT00171223|560229508|FG000|Overall Study|Lost to Follow-up|5|||
155216058|NCT00171223|560229509|FG001|Overall Study|Lost to Follow-up|2|||
155216059|NCT00171223|560229510|FG002|Overall Study|Lost to Follow-up|3|||
155216060|NCT00171223|560229508|FG000|Overall Study|Administrative Problems|4|||
155216061|NCT00171223|560229509|FG001|Overall Study|Administrative Problems|7|||
155216062|NCT00171223|560229510|FG002|Overall Study|Administrative Problems|6|||
155216063|NCT00171223|560229508|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
155216064|NCT00171223|560229509|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
155216065|NCT00171223|560229510|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
155216066|NCT00171223|560229508|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
155216067|NCT00171223|560229509|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
155216068|NCT00171223|560229510|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
155216069|NCT00278109|560229512|FG000|Overall Study|Adverse Event|3|||
155216070|NCT00278109|560229512|FG000|Overall Study|social circumstances|1|||
155216071|NCT02064166|560229513|FG000|Overall Study|Adverse Event|1|||
155216072|NCT02064166|560229514|FG001|Overall Study|Adverse Event|0|||
155216073|NCT04339296|560229515|FG000|Overall Study|Refuse to participate after allocation|1|||
155216074|NCT04339296|560229516|FG001|Overall Study|Refuse to participate after allocation|1|||
155216075|NCT04339296|560229515|FG000|Overall Study|Withdrew after completion of baseline|2|||
155216076|NCT04339296|560229516|FG001|Overall Study|Withdrew after completion of baseline|1|||
155216077|NCT04339296|560229515|FG000|Overall Study|Lost to Follow-up|0|||
155216078|NCT04339296|560229516|FG001|Overall Study|Lost to Follow-up|4|||
155216079|NCT04339296|560229515|FG000|Overall Study|Discontinued intervention|5|||
155216080|NCT04339296|560229516|FG001|Overall Study|Discontinued intervention|3|||
155216081|NCT00383149|560229520|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
155216082|NCT00383149|560229520|FG000|Overall Study|Death|2|||
155216083|NCT00383149|560229520|FG000|Overall Study|Disease Progression|38|||
155216084|NCT00383149|560229520|FG000|Overall Study|Lost to Follow-up|1|||
155216085|NCT00383149|560229520|FG000|Overall Study|Other|1|||
155216086|NCT00383149|560229520|FG000|Overall Study|Study Drug Toxicity|4|||
155216087|NCT00383149|560229520|FG000|Overall Study|Request to Discontinue Treatment|4|||
155216088|NCT00383149|560229520|FG000|Overall Study|Participant Withdrew Consent|1|||
155216089|NCT03721276|560229523|FG000|Overall Study|Lost to Follow-up|5|||
155216090|NCT03721276|560229524|FG001|Overall Study|Lost to Follow-up|3|||
155216091|NCT03721276|560229523|FG000|Overall Study|Adverse Event|0|||
155216092|NCT03721276|560229524|FG001|Overall Study|Adverse Event|1|||
155216093|NCT01340898|560229527|FG000|Primary Phase|Serious Adverse Events|0|||
155216094|NCT01340898|560229528|FG001|Primary Phase|Serious Adverse Events|0|||
155216095|NCT01340898|560229529|FG002|Primary Phase|Serious Adverse Events|1|||
155216096|NCT01340898|560229527|FG000|Primary Phase|Withdrawal by Subject|8|||
155216097|NCT01340898|560229528|FG001|Primary Phase|Withdrawal by Subject|7|||
155216098|NCT01340898|560229529|FG002|Primary Phase|Withdrawal by Subject|5|||
155216099|NCT01340898|560229527|FG000|Primary Phase|Migrated/moved from study area|4|||
155216100|NCT01340898|560229528|FG001|Primary Phase|Migrated/moved from study area|1|||
155216101|NCT01340898|560229529|FG002|Primary Phase|Migrated/moved from study area|0|||
155216102|NCT01340898|560229527|FG000|Primary Phase|Lost to Follow-up|4|||
155216103|NCT01340898|560229528|FG001|Primary Phase|Lost to Follow-up|1|||
155216104|NCT01340898|560229529|FG002|Primary Phase|Lost to Follow-up|0|||
155216105|NCT01340898|560229527|FG000|Booster Phase|Withdrawal by Subject|3|||
155216106|NCT01340898|560229528|FG001|Booster Phase|Withdrawal by Subject|0|||
155216107|NCT01340898|560229529|FG002|Booster Phase|Withdrawal by Subject|4|||
155216108|NCT01340898|560229527|FG000|Booster Phase|Migrated/moved from study area|3|||
155216109|NCT01340898|560229528|FG001|Booster Phase|Migrated/moved from study area|0|||
155216110|NCT01340898|560229529|FG002|Booster Phase|Migrated/moved from study area|0|||
155216111|NCT01340898|560229527|FG000|Booster Phase|Lost to Follow-up|4|||
155216112|NCT01340898|560229528|FG001|Booster Phase|Lost to Follow-up|2|||
155216113|NCT01340898|560229529|FG002|Booster Phase|Lost to Follow-up|3|||
155216114|NCT02375113|560229530|FG000|Overall Study|Undisclosed Reason(s).|1|||
155216115|NCT02375113|560229531|FG001|Overall Study|Undisclosed Reason(s).|1|||
155216116|NCT02375113|560229530|FG000|Overall Study|Poor adherence (<70%).|1|||
155216117|NCT02375113|560229531|FG001|Overall Study|Poor adherence (<70%).|0|||
155216118|NCT02375113|560229530|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
155216119|NCT02375113|560229531|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
155216120|NCT00969150|560229534|FG000|Overall Study|Adverse Event|4|||
155216121|NCT00969150|560229535|FG001|Overall Study|Adverse Event|14|||
155216122|NCT00969150|560229534|FG000|Overall Study|Lack of Efficacy|1|||
155216123|NCT00969150|560229535|FG001|Overall Study|Lack of Efficacy|1|||
155216124|NCT00969150|560229534|FG000|Overall Study|Protocol Violation|9|||
155216125|NCT00969150|560229535|FG001|Overall Study|Protocol Violation|12|||
155216126|NCT00969150|560229534|FG000|Overall Study|Withdrawal by Subject|13|||
155216127|NCT00969150|560229535|FG001|Overall Study|Withdrawal by Subject|9|||
155216128|NCT00969150|560229534|FG000|Overall Study|Lost to Follow-up|5|||
155216129|NCT00969150|560229535|FG001|Overall Study|Lost to Follow-up|4|||
155216130|NCT00969150|560229534|FG000|Overall Study|Other reasons|1|||
155216131|NCT00969150|560229535|FG001|Overall Study|Other reasons|0|||
155216132|NCT00461682|560229539|FG000|Overall Study|Protocol Violation|1|||
155216133|NCT04128267|560229545|FG000|Overall Study|Withdrawal by Subject|6|||
155216134|NCT04128267|560229545|FG000|Overall Study|Death|2|||
155216135|NCT04128267|560229545|FG000|Overall Study|Disease progression|1|||
155216136|NCT04128267|560229545|FG000|Overall Study|Participant had other medical issues|4|||
155216137|NCT04128267|560229545|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
155216138|NCT04501666|560229548|FG000|Overall Study|Physician Decision|0|||
155216139|NCT04501666|560229549|FG001|Overall Study|Physician Decision|1|||
155216140|NCT04501666|560229548|FG000|Overall Study|Adverse Event|12|||
155216141|NCT04501666|560229549|FG001|Overall Study|Adverse Event|4|||
155216142|NCT04501666|560229548|FG000|Overall Study|Subject's request|10|||
155216143|NCT04501666|560229549|FG001|Overall Study|Subject's request|6|||
155216144|NCT04501666|560229548|FG000|Overall Study|Protocol Deviation|2|||
155216145|NCT04501666|560229549|FG001|Overall Study|Protocol Deviation|1|||
155216146|NCT04501666|560229548|FG000|Overall Study|Other-- site permanently closing|0|||
155216147|NCT04501666|560229549|FG001|Overall Study|Other-- site permanently closing|1|||
155216148|NCT00642941|560229550|FG000|Overall Study|Physician Decision|3|||
155216149|NCT00642941|560229551|FG001|Overall Study|Physician Decision|1|||
155216150|NCT00642941|560229552|FG002|Overall Study|Physician Decision|0|||
155216151|NCT00642941|560229553|FG003|Overall Study|Physician Decision|0|||
155216152|NCT00642941|560229554|FG004|Overall Study|Physician Decision|0|||
155216153|NCT00642941|560229555|FG005|Overall Study|Physician Decision|0|||
155216154|NCT00642941|560229556|FG006|Overall Study|Physician Decision|1|||
155216155|NCT00642941|560229557|FG007|Overall Study|Physician Decision|0|||
155216156|NCT00642941|560229558|FG008|Overall Study|Physician Decision|0|||
155216157|NCT00642941|560229559|FG009|Overall Study|Physician Decision|1|||
155216158|NCT00642941|560229560|FG010|Overall Study|Physician Decision|0|||
155216159|NCT00642941|560229561|FG011|Overall Study|Physician Decision|1|||
155216160|NCT00642941|560229550|FG000|Overall Study|Death|4|||
155216161|NCT00642941|560229551|FG001|Overall Study|Death|0|||
155216162|NCT00642941|560229552|FG002|Overall Study|Death|1|||
155216163|NCT00642941|560229553|FG003|Overall Study|Death|1|||
155216164|NCT00642941|560229554|FG004|Overall Study|Death|2|||
155216165|NCT00642941|560229555|FG005|Overall Study|Death|1|||
155216166|NCT00642941|560229556|FG006|Overall Study|Death|0|||
155216167|NCT00642941|560229557|FG007|Overall Study|Death|0|||
155216168|NCT00642941|560229558|FG008|Overall Study|Death|0|||
155216169|NCT00642941|560229559|FG009|Overall Study|Death|0|||
155216170|NCT00642941|560229560|FG010|Overall Study|Death|0|||
155216171|NCT00642941|560229561|FG011|Overall Study|Death|1|||
155216172|NCT00642941|560229550|FG000|Overall Study|Study closed by Sponsor|0|||
155216173|NCT00642941|560229551|FG001|Overall Study|Study closed by Sponsor|1|||
155216174|NCT00642941|560229552|FG002|Overall Study|Study closed by Sponsor|0|||
155216175|NCT00642941|560229553|FG003|Overall Study|Study closed by Sponsor|0|||
155216176|NCT00642941|560229554|FG004|Overall Study|Study closed by Sponsor|0|||
155216177|NCT00642941|560229555|FG005|Overall Study|Study closed by Sponsor|0|||
155216178|NCT00642941|560229556|FG006|Overall Study|Study closed by Sponsor|0|||
155216179|NCT00642941|560229557|FG007|Overall Study|Study closed by Sponsor|0|||
155216180|NCT00642941|560229558|FG008|Overall Study|Study closed by Sponsor|0|||
155216181|NCT00642941|560229559|FG009|Overall Study|Study closed by Sponsor|0|||
155216182|NCT00642941|560229560|FG010|Overall Study|Study closed by Sponsor|0|||
155216183|NCT00642941|560229561|FG011|Overall Study|Study closed by Sponsor|0|||
155216184|NCT00642941|560229550|FG000|Overall Study|Withdrawal by Subject|1|||
155216185|NCT00642941|560229551|FG001|Overall Study|Withdrawal by Subject|0|||
155216186|NCT00642941|560229552|FG002|Overall Study|Withdrawal by Subject|0|||
155216187|NCT00642941|560229553|FG003|Overall Study|Withdrawal by Subject|2|||
155216188|NCT00642941|560229554|FG004|Overall Study|Withdrawal by Subject|0|||
155216189|NCT00642941|560229555|FG005|Overall Study|Withdrawal by Subject|0|||
155216190|NCT00642941|560229556|FG006|Overall Study|Withdrawal by Subject|2|||
155216191|NCT00642941|560229557|FG007|Overall Study|Withdrawal by Subject|0|||
155216192|NCT00642941|560229558|FG008|Overall Study|Withdrawal by Subject|1|||
155216193|NCT00642941|560229559|FG009|Overall Study|Withdrawal by Subject|0|||
155216194|NCT00642941|560229560|FG010|Overall Study|Withdrawal by Subject|0|||
155216195|NCT00642941|560229561|FG011|Overall Study|Withdrawal by Subject|1|||
155216196|NCT00642941|560229550|FG000|Overall Study|Protocol Violation|0|||
155216197|NCT00642941|560229551|FG001|Overall Study|Protocol Violation|0|||
155216198|NCT00642941|560229552|FG002|Overall Study|Protocol Violation|0|||
155216199|NCT00642941|560229553|FG003|Overall Study|Protocol Violation|0|||
155216200|NCT00642941|560229554|FG004|Overall Study|Protocol Violation|0|||
155216201|NCT00642941|560229555|FG005|Overall Study|Protocol Violation|0|||
155216202|NCT00642941|560229556|FG006|Overall Study|Protocol Violation|1|||
155216203|NCT00642941|560229557|FG007|Overall Study|Protocol Violation|0|||
155216204|NCT00642941|560229558|FG008|Overall Study|Protocol Violation|0|||
155216205|NCT00642941|560229559|FG009|Overall Study|Protocol Violation|0|||
155216206|NCT00642941|560229560|FG010|Overall Study|Protocol Violation|0|||
155216207|NCT00642941|560229561|FG011|Overall Study|Protocol Violation|0|||
155216208|NCT00642941|560229550|FG000|Overall Study|Adverse Event|1|||
155216209|NCT00642941|560229551|FG001|Overall Study|Adverse Event|1|||
155216210|NCT00642941|560229552|FG002|Overall Study|Adverse Event|0|||
155216211|NCT00642941|560229553|FG003|Overall Study|Adverse Event|0|||
155216212|NCT00642941|560229554|FG004|Overall Study|Adverse Event|0|||
155216213|NCT00642941|560229555|FG005|Overall Study|Adverse Event|0|||
155216214|NCT00642941|560229556|FG006|Overall Study|Adverse Event|1|||
155216215|NCT00642941|560229557|FG007|Overall Study|Adverse Event|1|||
155216216|NCT00642941|560229558|FG008|Overall Study|Adverse Event|0|||
155216217|NCT00642941|560229559|FG009|Overall Study|Adverse Event|1|||
155216218|NCT00642941|560229560|FG010|Overall Study|Adverse Event|0|||
155216219|NCT00642941|560229561|FG011|Overall Study|Adverse Event|0|||
155216220|NCT00642941|560229550|FG000|Overall Study|Other|1|||
155216221|NCT00642941|560229551|FG001|Overall Study|Other|1|||
155216222|NCT00642941|560229552|FG002|Overall Study|Other|1|||
155216223|NCT00642941|560229553|FG003|Overall Study|Other|1|||
155216224|NCT00642941|560229554|FG004|Overall Study|Other|0|||
155216225|NCT00642941|560229555|FG005|Overall Study|Other|1|||
155216226|NCT00642941|560229556|FG006|Overall Study|Other|0|||
155216227|NCT00642941|560229557|FG007|Overall Study|Other|1|||
155216228|NCT00642941|560229558|FG008|Overall Study|Other|0|||
155216229|NCT00642941|560229559|FG009|Overall Study|Other|0|||
155216230|NCT00642941|560229560|FG010|Overall Study|Other|0|||
155216231|NCT00642941|560229561|FG011|Overall Study|Other|1|||
155216232|NCT00642941|560229550|FG000|Overall Study|Disease progression|60|||
155216233|NCT00642941|560229551|FG001|Overall Study|Disease progression|50|||
155216234|NCT00642941|560229552|FG002|Overall Study|Disease progression|5|||
155216235|NCT00642941|560229553|FG003|Overall Study|Disease progression|36|||
155216236|NCT00642941|560229554|FG004|Overall Study|Disease progression|23|||
155216237|NCT00642941|560229555|FG005|Overall Study|Disease progression|39|||
155216238|NCT00642941|560229556|FG006|Overall Study|Disease progression|18|||
155216239|NCT00642941|560229557|FG007|Overall Study|Disease progression|12|||
155216240|NCT00642941|560229558|FG008|Overall Study|Disease progression|10|||
155216241|NCT00642941|560229559|FG009|Overall Study|Disease progression|7|||
155216242|NCT00642941|560229560|FG010|Overall Study|Disease progression|12|||
155216243|NCT00642941|560229561|FG011|Overall Study|Disease progression|7|||
155216244|NCT03051607|560229563|FG000|Overall Study|Adverse Event|66|||
155216245|NCT01505868|560229564|FG000|Overall Study|Withdrawal by Subject|1|||
155216246|NCT01505868|560229565|FG001|Overall Study|Withdrawal by Subject|0|||
155216247|NCT01505868|560229566|FG002|Overall Study|Withdrawal by Subject|0|||
155216248|NCT01505868|560229567|FG003|Overall Study|Withdrawal by Subject|0|||
155216249|NCT01505868|560229568|FG004|Overall Study|Withdrawal by Subject|0|||
155216250|NCT00553150|560229570|FG000|Overall Study|Withdrawal by Subject|0|||
155216251|NCT00553150|560229571|FG001|Overall Study|Withdrawal by Subject|0|||
155216252|NCT00553150|560229572|FG002|Overall Study|Withdrawal by Subject|0|||
155216253|NCT00553150|560229573|FG003|Overall Study|Withdrawal by Subject|2|||
155216254|NCT00553150|560229570|FG000|Overall Study|Protocol Violation|0|||
155216255|NCT00553150|560229571|FG001|Overall Study|Protocol Violation|0|||
155216256|NCT00553150|560229572|FG002|Overall Study|Protocol Violation|0|||
155216257|NCT00553150|560229573|FG003|Overall Study|Protocol Violation|1|||
155216258|NCT00553150|560229570|FG000|Overall Study|Ineligible|0|||
155216259|NCT00553150|560229571|FG001|Overall Study|Ineligible|0|||
155216260|NCT00553150|560229572|FG002|Overall Study|Ineligible|0|||
155216261|NCT00553150|560229573|FG003|Overall Study|Ineligible|1|||
155216262|NCT03251079|560229575|FG000|Overall Study|Withdrawal by Subject|1|||
155216263|NCT03204305|560229581|FG000|Overall Study|Lost to Follow-up|6|||
155216264|NCT03204305|560229582|FG001|Overall Study|Lost to Follow-up|4|||
155216265|NCT03204305|560229583|FG002|Overall Study|Lost to Follow-up|0|||
155216266|NCT03204305|560229584|FG003|Overall Study|Lost to Follow-up|0|||
155216267|NCT03204305|560229581|FG000|Overall Study|Physician Decision|1|||
155216268|NCT03204305|560229582|FG001|Overall Study|Physician Decision|0|||
155216269|NCT03204305|560229583|FG002|Overall Study|Physician Decision|0|||
155216270|NCT03204305|560229584|FG003|Overall Study|Physician Decision|0|||
155216271|NCT03204305|560229581|FG000|Overall Study|failure to place arterial line|2|||
155216272|NCT03204305|560229582|FG001|Overall Study|failure to place arterial line|1|||
155216273|NCT03204305|560229583|FG002|Overall Study|failure to place arterial line|0|||
155216274|NCT03204305|560229584|FG003|Overall Study|failure to place arterial line|0|||
155216275|NCT03204305|560229581|FG000|Overall Study|Withdrawal by Subject|2|||
155216276|NCT03204305|560229582|FG001|Overall Study|Withdrawal by Subject|0|||
155216277|NCT03204305|560229583|FG002|Overall Study|Withdrawal by Subject|0|||
155216278|NCT03204305|560229584|FG003|Overall Study|Withdrawal by Subject|0|||
155216279|NCT01603459|560229587|FG000|Overall Study|Adverse Event|5|||
155216280|NCT01603459|560229587|FG000|Overall Study|Withdrawal by Subject|5|||
155216281|NCT01603459|560229587|FG000|Overall Study|Lost to Follow-up|3|||
155216282|NCT01603459|560229587|FG000|Overall Study|Predefined discontinuation criteria|3|||
155216283|NCT01603459|560229587|FG000|Overall Study|Non-compliance|1|||
155216284|NCT01603459|560229587|FG000|Overall Study|Administrative reason|1|||
155216285|NCT00399360|560229589|FG000|Overall Study|Lost to Follow-up|2|||
155216286|NCT00399360|560229590|FG001|Overall Study|Lost to Follow-up|1|||
155216287|NCT00399360|560229591|FG002|Overall Study|Lost to Follow-up|2|||
155216288|NCT00399360|560229592|FG003|Overall Study|Lost to Follow-up|4|||
155216289|NCT00399360|560229589|FG000|Overall Study|Adverse Event|0|||
155216290|NCT00399360|560229590|FG001|Overall Study|Adverse Event|0|||
155216291|NCT00399360|560229591|FG002|Overall Study|Adverse Event|1|||
155216292|NCT00399360|560229592|FG003|Overall Study|Adverse Event|0|||
155216293|NCT00399360|560229589|FG000|Overall Study|Withdrawal by Subject|0|||
155216294|NCT00399360|560229590|FG001|Overall Study|Withdrawal by Subject|2|||
155216295|NCT00399360|560229591|FG002|Overall Study|Withdrawal by Subject|0|||
155216296|NCT00399360|560229592|FG003|Overall Study|Withdrawal by Subject|2|||
155216297|NCT00535223|560229593|FG000|Overall Study|Withdrawal by Subject|4|||
155216298|NCT00535223|560229594|FG001|Overall Study|Withdrawal by Subject|1|||
155216299|NCT01367158|560229598|FG000|Overall Study|Withdrew consent|0|||
155216300|NCT01367158|560229599|FG001|Overall Study|Withdrew consent|2|||
155216301|NCT01367158|560229600|FG002|Overall Study|Withdrew consent|1|||
155216302|NCT01367158|560229601|FG003|Overall Study|Withdrew consent|0|||
155216303|NCT01367158|560229602|FG004|Overall Study|Withdrew consent|2|||
155216304|NCT01367158|560229603|FG005|Overall Study|Withdrew consent|0|||
155216305|NCT01367158|560229604|FG006|Overall Study|Withdrew consent|0|||
155216306|NCT01367158|560229605|FG007|Overall Study|Withdrew consent|1|||
155216307|NCT01367158|560229606|FG008|Overall Study|Withdrew consent|0|||
155216308|NCT01367158|560229607|FG009|Overall Study|Withdrew consent|0|||
155216309|NCT01367158|560229608|FG010|Overall Study|Withdrew consent|0|||
155216310|NCT01367158|560229598|FG000|Overall Study|Lost to Follow-up|0|||
155216311|NCT01367158|560229599|FG001|Overall Study|Lost to Follow-up|0|||
155216312|NCT01367158|560229600|FG002|Overall Study|Lost to Follow-up|0|||
155216313|NCT01367158|560229601|FG003|Overall Study|Lost to Follow-up|1|||
155216314|NCT01367158|560229602|FG004|Overall Study|Lost to Follow-up|0|||
155216315|NCT01367158|560229603|FG005|Overall Study|Lost to Follow-up|2|||
155216316|NCT01367158|560229604|FG006|Overall Study|Lost to Follow-up|0|||
155216317|NCT01367158|560229605|FG007|Overall Study|Lost to Follow-up|1|||
155216318|NCT01367158|560229606|FG008|Overall Study|Lost to Follow-up|0|||
155216319|NCT01367158|560229607|FG009|Overall Study|Lost to Follow-up|0|||
155216320|NCT01367158|560229608|FG010|Overall Study|Lost to Follow-up|1|||
155216321|NCT01367158|560229598|FG000|Overall Study|Protocol Violation|0|||
155216322|NCT01367158|560229599|FG001|Overall Study|Protocol Violation|1|||
155216323|NCT01367158|560229600|FG002|Overall Study|Protocol Violation|0|||
155216324|NCT01367158|560229601|FG003|Overall Study|Protocol Violation|0|||
155216325|NCT01367158|560229602|FG004|Overall Study|Protocol Violation|0|||
155216326|NCT01367158|560229603|FG005|Overall Study|Protocol Violation|0|||
155216327|NCT01367158|560229604|FG006|Overall Study|Protocol Violation|0|||
155216328|NCT01367158|560229605|FG007|Overall Study|Protocol Violation|0|||
155216329|NCT01367158|560229606|FG008|Overall Study|Protocol Violation|0|||
155216330|NCT01367158|560229607|FG009|Overall Study|Protocol Violation|0|||
155216331|NCT01367158|560229608|FG010|Overall Study|Protocol Violation|0|||
155216332|NCT01765153|560229609|FG000|Training Phase 1|Format of intervention differed|1|||
155216333|NCT01765153|560229610|FG001|Training Phase 1|Format of intervention differed|0|||
155216334|NCT01765153|560229609|FG000|Training Phase 1|Poor participation in intervention|0|||
155216335|NCT01765153|560229610|FG001|Training Phase 1|Poor participation in intervention|1|||
155216336|NCT01765153|560229609|FG000|Rest Phase 1|Withdrawal by Subject|0|||
155216337|NCT01765153|560229610|FG001|Rest Phase 1|Withdrawal by Subject|1|||
155216338|NCT01765153|560229609|FG000|Training Phase 2|Withdrawal by Subject|0|||
155216339|NCT01765153|560229610|FG001|Training Phase 2|Withdrawal by Subject|1|||
155216340|NCT01765153|560229609|FG000|Rest Phase 2|Lost to Follow-up|2|||
155216341|NCT01765153|560229610|FG001|Rest Phase 2|Lost to Follow-up|1|||
155216342|NCT02663674|560229611|FG000|Overall Study|Lost to Follow-up|5|||
155216343|NCT02663674|560229612|FG001|Overall Study|Lost to Follow-up|4|||
155216344|NCT02663674|560229611|FG000|Overall Study|Withdrawal by Subject|1|||
155216345|NCT02663674|560229612|FG001|Overall Study|Withdrawal by Subject|4|||
155216346|NCT02663674|560229611|FG000|Overall Study|Physician Decision|1|||
155216347|NCT02663674|560229612|FG001|Overall Study|Physician Decision|1|||
155216348|NCT02663674|560229611|FG000|Overall Study|Other Event (Health Related)|0|||
155216349|NCT02663674|560229612|FG001|Overall Study|Other Event (Health Related)|1|||
155216350|NCT03712904|560230776|FG000|Overall Study|Death|0|||
155216351|NCT03712904|560230777|FG001|Overall Study|Death|1|||
155216352|NCT03712904|560230776|FG000|Overall Study|Withdrawal by Subject|0|||
155216353|NCT03712904|560230777|FG001|Overall Study|Withdrawal by Subject|1|||
155216354|NCT03712904|560230776|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
155216355|NCT03712904|560230777|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
155216356|NCT01852942|560230778|FG000|Overall Study|Physician Decision|1|||
155216357|NCT01852942|560230779|FG001|Overall Study|Physician Decision|0|||
155216358|NCT01852942|560230778|FG000|Overall Study|Death|1|||
155216359|NCT01852942|560230779|FG001|Overall Study|Death|1|||
155216360|NCT01852942|560230778|FG000|Overall Study|Withdrawal by Subject|2|||
155216361|NCT01852942|560230779|FG001|Overall Study|Withdrawal by Subject|3|||
155216362|NCT01852942|560230778|FG000|Overall Study|Lost to Follow-up|1|||
155216363|NCT01852942|560230779|FG001|Overall Study|Lost to Follow-up|2|||
155216364|NCT04708886|560230786|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
155216365|NCT04708886|560230786|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
155216366|NCT01729754|560230787|FG000|Part 1|Adverse Event|2|||
155216367|NCT01729754|560230788|FG001|Part 1|Adverse Event|0|||
155216368|NCT01729754|560230789|FG002|Part 1|Adverse Event|0|||
155216369|NCT01729754|560230790|FG003|Part 1|Adverse Event|1|||
155216370|NCT01729754|560230791|FG004|Part 1|Adverse Event|0|||
155216371|NCT01729754|560230792|FG005|Part 1|Adverse Event|0|||
155216372|NCT01729754|560230793|FG006|Part 1|Adverse Event|2|||
155216373|NCT01729754|560230794|FG007|Part 1|Adverse Event|0|||
155216374|NCT01729754|560230795|FG008|Part 1|Adverse Event|0|||
155216375|NCT01729754|560230796|FG009|Part 1|Adverse Event|5|||
155216376|NCT01729754|560230787|FG000|Part 1|Lack of Efficacy|1|||
155216377|NCT01729754|560230788|FG001|Part 1|Lack of Efficacy|0|||
155216378|NCT01729754|560230789|FG002|Part 1|Lack of Efficacy|0|||
155216379|NCT01729754|560230790|FG003|Part 1|Lack of Efficacy|0|||
155216380|NCT01729754|560230791|FG004|Part 1|Lack of Efficacy|0|||
155216381|NCT01729754|560230792|FG005|Part 1|Lack of Efficacy|0|||
155216382|NCT01729754|560230793|FG006|Part 1|Lack of Efficacy|2|||
155216383|NCT01729754|560230794|FG007|Part 1|Lack of Efficacy|0|||
155216384|NCT01729754|560230795|FG008|Part 1|Lack of Efficacy|0|||
155216385|NCT01729754|560230796|FG009|Part 1|Lack of Efficacy|0|||
155216386|NCT01729754|560230787|FG000|Part 1|Lost to Follow-up|1|||
155216387|NCT01729754|560230788|FG001|Part 1|Lost to Follow-up|0|||
155216388|NCT01729754|560230789|FG002|Part 1|Lost to Follow-up|0|||
155216389|NCT01729754|560230790|FG003|Part 1|Lost to Follow-up|2|||
155216390|NCT01729754|560230791|FG004|Part 1|Lost to Follow-up|0|||
155216391|NCT01729754|560230792|FG005|Part 1|Lost to Follow-up|0|||
155216392|NCT01729754|560230793|FG006|Part 1|Lost to Follow-up|3|||
155216393|NCT01729754|560230794|FG007|Part 1|Lost to Follow-up|0|||
155216394|NCT01729754|560230795|FG008|Part 1|Lost to Follow-up|0|||
155216395|NCT01729754|560230796|FG009|Part 1|Lost to Follow-up|3|||
155216396|NCT01729754|560230787|FG000|Part 1|Non-compliance with Study Drug|1|||
155216397|NCT01729754|560230788|FG001|Part 1|Non-compliance with Study Drug|0|||
155216398|NCT01729754|560230789|FG002|Part 1|Non-compliance with Study Drug|0|||
155216399|NCT01729754|560230790|FG003|Part 1|Non-compliance with Study Drug|0|||
155216400|NCT01729754|560230791|FG004|Part 1|Non-compliance with Study Drug|0|||
155216401|NCT01729754|560230792|FG005|Part 1|Non-compliance with Study Drug|0|||
155216402|NCT01729754|560230793|FG006|Part 1|Non-compliance with Study Drug|0|||
155216403|NCT01729754|560230794|FG007|Part 1|Non-compliance with Study Drug|0|||
155216404|NCT01729754|560230795|FG008|Part 1|Non-compliance with Study Drug|0|||
155216405|NCT01729754|560230796|FG009|Part 1|Non-compliance with Study Drug|0|||
155216406|NCT01729754|560230787|FG000|Part 1|Physician Decision|0|||
155216407|NCT01729754|560230788|FG001|Part 1|Physician Decision|0|||
155216408|NCT01729754|560230789|FG002|Part 1|Physician Decision|0|||
155216409|NCT01729754|560230790|FG003|Part 1|Physician Decision|0|||
155216410|NCT01729754|560230791|FG004|Part 1|Physician Decision|0|||
155216411|NCT01729754|560230792|FG005|Part 1|Physician Decision|0|||
155216412|NCT01729754|560230793|FG006|Part 1|Physician Decision|0|||
155216413|NCT01729754|560230794|FG007|Part 1|Physician Decision|0|||
155216414|NCT01729754|560230795|FG008|Part 1|Physician Decision|0|||
155216415|NCT01729754|560230796|FG009|Part 1|Physician Decision|4|||
155216416|NCT01729754|560230787|FG000|Part 1|Pregnancy|0|||
155216417|NCT01729754|560230788|FG001|Part 1|Pregnancy|0|||
155216418|NCT01729754|560230789|FG002|Part 1|Pregnancy|0|||
155216419|NCT01729754|560230790|FG003|Part 1|Pregnancy|1|||
155216420|NCT01729754|560230791|FG004|Part 1|Pregnancy|0|||
155216421|NCT01729754|560230792|FG005|Part 1|Pregnancy|0|||
155216422|NCT01729754|560230793|FG006|Part 1|Pregnancy|0|||
155216423|NCT01729754|560230794|FG007|Part 1|Pregnancy|0|||
155216424|NCT01729754|560230795|FG008|Part 1|Pregnancy|0|||
155216425|NCT01729754|560230796|FG009|Part 1|Pregnancy|1|||
155216426|NCT01729754|560230787|FG000|Part 1|Progressive Disease|0|||
155216427|NCT01729754|560230788|FG001|Part 1|Progressive Disease|0|||
155216428|NCT01729754|560230789|FG002|Part 1|Progressive Disease|0|||
155216429|NCT01729754|560230790|FG003|Part 1|Progressive Disease|0|||
155216430|NCT01729754|560230791|FG004|Part 1|Progressive Disease|0|||
155216431|NCT01729754|560230792|FG005|Part 1|Progressive Disease|0|||
155216432|NCT01729754|560230793|FG006|Part 1|Progressive Disease|0|||
155216433|NCT01729754|560230794|FG007|Part 1|Progressive Disease|0|||
155216434|NCT01729754|560230795|FG008|Part 1|Progressive Disease|0|||
155216435|NCT01729754|560230796|FG009|Part 1|Progressive Disease|1|||
155216436|NCT01729754|560230787|FG000|Part 1|Protocol Violation|2|||
155216437|NCT01729754|560230788|FG001|Part 1|Protocol Violation|0|||
155216438|NCT01729754|560230789|FG002|Part 1|Protocol Violation|0|||
155216439|NCT01729754|560230790|FG003|Part 1|Protocol Violation|1|||
155216440|NCT01729754|560230791|FG004|Part 1|Protocol Violation|0|||
155216441|NCT01729754|560230792|FG005|Part 1|Protocol Violation|0|||
155216442|NCT01729754|560230793|FG006|Part 1|Protocol Violation|1|||
155216443|NCT01729754|560230794|FG007|Part 1|Protocol Violation|0|||
155216444|NCT01729754|560230795|FG008|Part 1|Protocol Violation|0|||
155216445|NCT01729754|560230796|FG009|Part 1|Protocol Violation|0|||
155216446|NCT01729754|560230787|FG000|Part 1|Withdrawal by Subject|5|||
155216447|NCT01729754|560230788|FG001|Part 1|Withdrawal by Subject|0|||
155216448|NCT01729754|560230789|FG002|Part 1|Withdrawal by Subject|0|||
155216449|NCT01729754|560230790|FG003|Part 1|Withdrawal by Subject|7|||
155216450|NCT01729754|560230791|FG004|Part 1|Withdrawal by Subject|0|||
155216451|NCT01729754|560230792|FG005|Part 1|Withdrawal by Subject|0|||
155216452|NCT01729754|560230793|FG006|Part 1|Withdrawal by Subject|5|||
155216453|NCT01729754|560230794|FG007|Part 1|Withdrawal by Subject|0|||
155216454|NCT01729754|560230795|FG008|Part 1|Withdrawal by Subject|0|||
155216455|NCT01729754|560230796|FG009|Part 1|Withdrawal by Subject|6|||
155216456|NCT01729754|560230787|FG000|Part 1|Other Protocol Specified Criteria|2|||
155216457|NCT01729754|560230788|FG001|Part 1|Other Protocol Specified Criteria|0|||
155216458|NCT01729754|560230789|FG002|Part 1|Other Protocol Specified Criteria|0|||
155216459|NCT01729754|560230790|FG003|Part 1|Other Protocol Specified Criteria|0|||
155216460|NCT01729754|560230791|FG004|Part 1|Other Protocol Specified Criteria|0|||
155216461|NCT01729754|560230792|FG005|Part 1|Other Protocol Specified Criteria|0|||
155216462|NCT01729754|560230793|FG006|Part 1|Other Protocol Specified Criteria|1|||
155216463|NCT01729754|560230794|FG007|Part 1|Other Protocol Specified Criteria|0|||
155216464|NCT01729754|560230795|FG008|Part 1|Other Protocol Specified Criteria|0|||
155216465|NCT01729754|560230796|FG009|Part 1|Other Protocol Specified Criteria|4|||
155216466|NCT01729754|560230787|FG000|Part 2|Adverse Event|2|||
155216467|NCT01729754|560230788|FG001|Part 2|Adverse Event|0|||
155216468|NCT01729754|560230789|FG002|Part 2|Adverse Event|0|||
155216469|NCT01729754|560230790|FG003|Part 2|Adverse Event|0|||
155216470|NCT01729754|560230791|FG004|Part 2|Adverse Event|0|||
155216471|NCT01729754|560230792|FG005|Part 2|Adverse Event|0|||
155216472|NCT01729754|560230793|FG006|Part 2|Adverse Event|0|||
155216473|NCT01729754|560230794|FG007|Part 2|Adverse Event|0|||
155216474|NCT01729754|560230795|FG008|Part 2|Adverse Event|1|||
155216475|NCT01729754|560230796|FG009|Part 2|Adverse Event|2|||
155216476|NCT01729754|560230787|FG000|Part 2|Lack of Efficacy|0|||
155216477|NCT01729754|560230788|FG001|Part 2|Lack of Efficacy|0|||
155216478|NCT01729754|560230789|FG002|Part 2|Lack of Efficacy|0|||
155216479|NCT01729754|560230790|FG003|Part 2|Lack of Efficacy|0|||
155216480|NCT01729754|560230791|FG004|Part 2|Lack of Efficacy|0|||
155216481|NCT01729754|560230792|FG005|Part 2|Lack of Efficacy|0|||
155216482|NCT01729754|560230793|FG006|Part 2|Lack of Efficacy|0|||
155216483|NCT01729754|560230794|FG007|Part 2|Lack of Efficacy|0|||
155216484|NCT01729754|560230795|FG008|Part 2|Lack of Efficacy|2|||
155216485|NCT01729754|560230796|FG009|Part 2|Lack of Efficacy|2|||
155216486|NCT01729754|560230787|FG000|Part 2|Lost to Follow-up|0|||
155216487|NCT01729754|560230788|FG001|Part 2|Lost to Follow-up|0|||
155216488|NCT01729754|560230789|FG002|Part 2|Lost to Follow-up|0|||
155216489|NCT01729754|560230790|FG003|Part 2|Lost to Follow-up|2|||
155216490|NCT01729754|560230791|FG004|Part 2|Lost to Follow-up|0|||
155216491|NCT01729754|560230792|FG005|Part 2|Lost to Follow-up|0|||
155216492|NCT01729754|560230793|FG006|Part 2|Lost to Follow-up|0|||
155216493|NCT01729754|560230794|FG007|Part 2|Lost to Follow-up|1|||
155216494|NCT01729754|560230795|FG008|Part 2|Lost to Follow-up|0|||
155216495|NCT01729754|560230796|FG009|Part 2|Lost to Follow-up|2|||
155216496|NCT01729754|560230787|FG000|Part 2|Non-Compliance with Study Drug|0|||
155216497|NCT01729754|560230788|FG001|Part 2|Non-Compliance with Study Drug|0|||
155216498|NCT01729754|560230789|FG002|Part 2|Non-Compliance with Study Drug|0|||
155216499|NCT01729754|560230790|FG003|Part 2|Non-Compliance with Study Drug|0|||
155216500|NCT01729754|560230791|FG004|Part 2|Non-Compliance with Study Drug|0|||
155216501|NCT01729754|560230792|FG005|Part 2|Non-Compliance with Study Drug|0|||
155216502|NCT01729754|560230793|FG006|Part 2|Non-Compliance with Study Drug|0|||
155216503|NCT01729754|560230794|FG007|Part 2|Non-Compliance with Study Drug|0|||
155216504|NCT01729754|560230795|FG008|Part 2|Non-Compliance with Study Drug|0|||
155216505|NCT01729754|560230796|FG009|Part 2|Non-Compliance with Study Drug|1|||
155216506|NCT01729754|560230787|FG000|Part 2|Pregnancy|0|||
155216507|NCT01729754|560230788|FG001|Part 2|Pregnancy|0|||
155216508|NCT01729754|560230789|FG002|Part 2|Pregnancy|0|||
155216509|NCT01729754|560230790|FG003|Part 2|Pregnancy|1|||
155216510|NCT01729754|560230791|FG004|Part 2|Pregnancy|0|||
155216511|NCT01729754|560230792|FG005|Part 2|Pregnancy|0|||
155216512|NCT01729754|560230793|FG006|Part 2|Pregnancy|0|||
155216513|NCT01729754|560230794|FG007|Part 2|Pregnancy|0|||
155216514|NCT01729754|560230795|FG008|Part 2|Pregnancy|0|||
155216515|NCT01729754|560230796|FG009|Part 2|Pregnancy|1|||
155216516|NCT01729754|560230787|FG000|Part 2|Withdrawal by Subject|3|||
155216517|NCT01729754|560230788|FG001|Part 2|Withdrawal by Subject|0|||
155216518|NCT01729754|560230789|FG002|Part 2|Withdrawal by Subject|0|||
155216519|NCT01729754|560230790|FG003|Part 2|Withdrawal by Subject|2|||
155216520|NCT01729754|560230791|FG004|Part 2|Withdrawal by Subject|0|||
155216521|NCT01729754|560230792|FG005|Part 2|Withdrawal by Subject|0|||
155216522|NCT01729754|560230793|FG006|Part 2|Withdrawal by Subject|0|||
155216523|NCT01729754|560230794|FG007|Part 2|Withdrawal by Subject|1|||
155216524|NCT01729754|560230795|FG008|Part 2|Withdrawal by Subject|1|||
155216525|NCT01729754|560230796|FG009|Part 2|Withdrawal by Subject|4|||
155216526|NCT01729754|560230787|FG000|Part 2|Other Protocol Specified Criteria|1|||
155216527|NCT01729754|560230788|FG001|Part 2|Other Protocol Specified Criteria|0|||
155216528|NCT01729754|560230789|FG002|Part 2|Other Protocol Specified Criteria|0|||
155216529|NCT01729754|560230790|FG003|Part 2|Other Protocol Specified Criteria|0|||
155216530|NCT01729754|560230791|FG004|Part 2|Other Protocol Specified Criteria|0|||
155216531|NCT01729754|560230792|FG005|Part 2|Other Protocol Specified Criteria|0|||
155216532|NCT01729754|560230793|FG006|Part 2|Other Protocol Specified Criteria|0|||
155216533|NCT01729754|560230794|FG007|Part 2|Other Protocol Specified Criteria|1|||
155216534|NCT01729754|560230795|FG008|Part 2|Other Protocol Specified Criteria|0|||
155216535|NCT01729754|560230796|FG009|Part 2|Other Protocol Specified Criteria|0|||
155216536|NCT01729754|560230787|FG000|Part 3|Adverse Event|0|||
155216537|NCT01729754|560230788|FG001|Part 3|Adverse Event|0|||
155216538|NCT01729754|560230789|FG002|Part 3|Adverse Event|1|||
155216539|NCT01729754|560230790|FG003|Part 3|Adverse Event|0|||
155216540|NCT01729754|560230791|FG004|Part 3|Adverse Event|0|||
155216541|NCT01729754|560230792|FG005|Part 3|Adverse Event|5|||
155216542|NCT01729754|560230793|FG006|Part 3|Adverse Event|0|||
155216543|NCT01729754|560230794|FG007|Part 3|Adverse Event|0|||
155216544|NCT01729754|560230795|FG008|Part 3|Adverse Event|0|||
155216545|NCT01729754|560230796|FG009|Part 3|Adverse Event|3|||
155216546|NCT01729754|560230787|FG000|Part 3|Death|0|||
155216547|NCT01729754|560230788|FG001|Part 3|Death|0|||
155216548|NCT01729754|560230789|FG002|Part 3|Death|0|||
155216549|NCT01729754|560230790|FG003|Part 3|Death|0|||
155216550|NCT01729754|560230791|FG004|Part 3|Death|0|||
155216551|NCT01729754|560230792|FG005|Part 3|Death|2|||
155216552|NCT01729754|560230793|FG006|Part 3|Death|0|||
155216553|NCT01729754|560230794|FG007|Part 3|Death|0|||
155216554|NCT01729754|560230795|FG008|Part 3|Death|0|||
155216555|NCT01729754|560230796|FG009|Part 3|Death|0|||
155216556|NCT01729754|560230787|FG000|Part 3|Lack of Efficacy|0|||
155216557|NCT01729754|560230788|FG001|Part 3|Lack of Efficacy|0|||
155216558|NCT01729754|560230789|FG002|Part 3|Lack of Efficacy|0|||
155216559|NCT01729754|560230790|FG003|Part 3|Lack of Efficacy|0|||
155216560|NCT01729754|560230791|FG004|Part 3|Lack of Efficacy|2|||
155216561|NCT01729754|560230792|FG005|Part 3|Lack of Efficacy|0|||
155216562|NCT01729754|560230793|FG006|Part 3|Lack of Efficacy|0|||
155216563|NCT01729754|560230794|FG007|Part 3|Lack of Efficacy|0|||
155216564|NCT01729754|560230795|FG008|Part 3|Lack of Efficacy|0|||
155216565|NCT01729754|560230796|FG009|Part 3|Lack of Efficacy|4|||
155216566|NCT01729754|560230787|FG000|Part 3|Lost to Follow-up|0|||
155216567|NCT01729754|560230788|FG001|Part 3|Lost to Follow-up|1|||
155216568|NCT01729754|560230789|FG002|Part 3|Lost to Follow-up|2|||
155216569|NCT01729754|560230790|FG003|Part 3|Lost to Follow-up|0|||
155216570|NCT01729754|560230791|FG004|Part 3|Lost to Follow-up|0|||
155216571|NCT01729754|560230792|FG005|Part 3|Lost to Follow-up|3|||
155216572|NCT01729754|560230793|FG006|Part 3|Lost to Follow-up|0|||
155216573|NCT01729754|560230794|FG007|Part 3|Lost to Follow-up|0|||
155216574|NCT01729754|560230795|FG008|Part 3|Lost to Follow-up|1|||
155216575|NCT01729754|560230796|FG009|Part 3|Lost to Follow-up|0|||
155216576|NCT01729754|560230787|FG000|Part 3|Physician Decision|0|||
155216577|NCT01729754|560230788|FG001|Part 3|Physician Decision|0|||
155216578|NCT01729754|560230789|FG002|Part 3|Physician Decision|1|||
155216579|NCT01729754|560230790|FG003|Part 3|Physician Decision|0|||
155216580|NCT01729754|560230791|FG004|Part 3|Physician Decision|0|||
155216581|NCT01729754|560230792|FG005|Part 3|Physician Decision|0|||
155216582|NCT01729754|560230793|FG006|Part 3|Physician Decision|0|||
155216583|NCT01729754|560230794|FG007|Part 3|Physician Decision|0|||
155216584|NCT01729754|560230795|FG008|Part 3|Physician Decision|0|||
155216585|NCT01729754|560230796|FG009|Part 3|Physician Decision|0|||
155216586|NCT01729754|560230787|FG000|Part 3|Withdrawal by Subject|0|||
155216587|NCT01729754|560230788|FG001|Part 3|Withdrawal by Subject|4|||
155216588|NCT01729754|560230789|FG002|Part 3|Withdrawal by Subject|1|||
155216589|NCT01729754|560230790|FG003|Part 3|Withdrawal by Subject|0|||
155216590|NCT01729754|560230791|FG004|Part 3|Withdrawal by Subject|2|||
155216591|NCT01729754|560230792|FG005|Part 3|Withdrawal by Subject|1|||
155216592|NCT01729754|560230793|FG006|Part 3|Withdrawal by Subject|0|||
155216593|NCT01729754|560230794|FG007|Part 3|Withdrawal by Subject|2|||
155216594|NCT01729754|560230795|FG008|Part 3|Withdrawal by Subject|0|||
155216595|NCT01729754|560230796|FG009|Part 3|Withdrawal by Subject|0|||
155216596|NCT01729754|560230787|FG000|Part 3|Other Protocol Specified Criteria|0|||
155216597|NCT01729754|560230788|FG001|Part 3|Other Protocol Specified Criteria|0|||
155216598|NCT01729754|560230789|FG002|Part 3|Other Protocol Specified Criteria|0|||
155216599|NCT01729754|560230790|FG003|Part 3|Other Protocol Specified Criteria|0|||
155216600|NCT01729754|560230791|FG004|Part 3|Other Protocol Specified Criteria|0|||
155216601|NCT01729754|560230792|FG005|Part 3|Other Protocol Specified Criteria|2|||
155216602|NCT01729754|560230793|FG006|Part 3|Other Protocol Specified Criteria|0|||
155216603|NCT01729754|560230794|FG007|Part 3|Other Protocol Specified Criteria|1|||
155216604|NCT01729754|560230795|FG008|Part 3|Other Protocol Specified Criteria|0|||
155216605|NCT01729754|560230796|FG009|Part 3|Other Protocol Specified Criteria|0|||
155216606|NCT02489344|560230804|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
155216607|NCT02489344|560230804|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
155216608|NCT02489344|560230804|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
155216609|NCT02489344|560230804|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
155216610|NCT01132482|560230805|FG000|Overall Study|Adverse Event|1|||
155216611|NCT01132482|560230806|FG001|Overall Study|Adverse Event|0|||
155216612|NCT05333900|560230807|FG000|Overall Study|Protocol Violation|0|||
155216613|NCT05333900|560230808|FG001|Overall Study|Protocol Violation|1|||
155216614|NCT05333900|560230807|FG000|Overall Study|Withdrawal by Subject|0|||
155216615|NCT05333900|560230808|FG001|Overall Study|Withdrawal by Subject|1|||
155216616|NCT05333900|560230807|FG000|Overall Study|COVID-19 Pandemic|1|||
155216617|NCT05333900|560230808|FG001|Overall Study|COVID-19 Pandemic|1|||
155216618|NCT02024867|560230809|FG000|Overall Study|Protocol Violation|3|||
155216619|NCT02024867|560230810|FG001|Overall Study|Protocol Violation|3|||
155216620|NCT02024867|560230809|FG000|Overall Study|Lost to Follow-up|6|||
155216621|NCT02024867|560230810|FG001|Overall Study|Lost to Follow-up|4|||
155216622|NCT02150954|560230811|FG000|Overall Study|Protocol Violation|1|||
155216623|NCT02150954|560230812|FG001|Overall Study|Protocol Violation|0|||
155216624|NCT01086540|560230815|FG000|Overall Study|Death|3|||
155216625|NCT01086540|560230816|FG001|Overall Study|Death|1|||
155216626|NCT01086540|560230815|FG000|Overall Study|Physician Decision|2|||
155216627|NCT01086540|560230816|FG001|Overall Study|Physician Decision|1|||
155216628|NCT01086540|560230815|FG000|Overall Study|Addition of new therapy for PAH|1|||
155216629|NCT01086540|560230816|FG001|Overall Study|Addition of new therapy for PAH|0|||
155216630|NCT00227305|560230818|FG000|Overall Study|Adverse Event|40|||
155216631|NCT00227305|560230818|FG000|Overall Study|Withdrawal by Subject|42|||
155216632|NCT00227305|560230818|FG000|Overall Study|Lost to Follow-up|33|||
155216633|NCT00227305|560230818|FG000|Overall Study|Study specific discontinuation|13|||
155216634|NCT00227305|560230818|FG000|Overall Study|MOVED OUT OF AREA|3|||
155216635|NCT00227305|560230818|FG000|Overall Study|Lack of Efficacy|7|||
155216636|NCT00227305|560230818|FG000|Overall Study|Physician Decision|3|||
155216637|NCT00227305|560230818|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
155216638|NCT00227305|560230818|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
155216639|NCT00227305|560230818|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
155216640|NCT02707991|560230820|FG000|Overall Study|Protocol Violation|1|||
155216641|NCT02707991|560230821|FG001|Overall Study|Protocol Violation|0|||
155216642|NCT02707991|560230820|FG000|Overall Study|Became ineligible|0|||
155216643|NCT02707991|560230821|FG001|Overall Study|Became ineligible|1|||
155216644|NCT02580357|560230827|FG000|Overall Study|Lost to Follow-up|2|||
155216645|NCT02580357|560230828|FG001|Overall Study|Lost to Follow-up|0|||
155216646|NCT02580357|560230829|FG002|Overall Study|Lost to Follow-up|0|||
155216647|NCT02580357|560230827|FG000|Overall Study|Protocol Violation|1|||
155216648|NCT02580357|560230828|FG001|Overall Study|Protocol Violation|0|||
155216649|NCT02580357|560230829|FG002|Overall Study|Protocol Violation|0|||
155216650|NCT00619801|560230835|FG000|Overall Study|Lack of Efficacy|0|||
155216651|NCT00619801|560230836|FG001|Overall Study|Lack of Efficacy|1|||
155216652|NCT00619801|560230835|FG000|Overall Study|Withdrawal by Subject|1|||
155216653|NCT00619801|560230836|FG001|Overall Study|Withdrawal by Subject|1|||
155216654|NCT00619801|560230835|FG000|Overall Study|Loss of efficacy|0|||
155216655|NCT00619801|560230836|FG001|Overall Study|Loss of efficacy|1|||
155216656|NCT00450333|560230837|FG000|Overall Study|Study terminated|47|||
155216657|NCT00450333|560230838|FG001|Overall Study|Study terminated|54|||
155216658|NCT00450333|560230839|FG002|Overall Study|Study terminated|16|||
155216659|NCT00450333|560230840|FG003|Overall Study|Study terminated|21|||
155216660|NCT00450333|560230837|FG000|Overall Study|Adverse Event|1|||
155216661|NCT00450333|560230838|FG001|Overall Study|Adverse Event|7|||
155216662|NCT00450333|560230839|FG002|Overall Study|Adverse Event|2|||
155216663|NCT00450333|560230840|FG003|Overall Study|Adverse Event|2|||
155216664|NCT00450333|560230837|FG000|Overall Study|Protocol Violation|1|||
155216665|NCT00450333|560230838|FG001|Overall Study|Protocol Violation|0|||
155216666|NCT00450333|560230839|FG002|Overall Study|Protocol Violation|1|||
155216667|NCT00450333|560230840|FG003|Overall Study|Protocol Violation|0|||
155216668|NCT00450333|560230837|FG000|Overall Study|Withdrawal by Subject|1|||
155216669|NCT00450333|560230838|FG001|Overall Study|Withdrawal by Subject|0|||
155216670|NCT00450333|560230839|FG002|Overall Study|Withdrawal by Subject|3|||
155216671|NCT00450333|560230840|FG003|Overall Study|Withdrawal by Subject|0|||
155216672|NCT00450333|560230837|FG000|Overall Study|Kidney transplant|1|||
155216673|NCT00450333|560230838|FG001|Overall Study|Kidney transplant|0|||
155216674|NCT00450333|560230839|FG002|Overall Study|Kidney transplant|1|||
155216675|NCT00450333|560230840|FG003|Overall Study|Kidney transplant|3|||
155216676|NCT00450333|560230837|FG000|Overall Study|Death|3|||
155216677|NCT00450333|560230838|FG001|Overall Study|Death|2|||
155216678|NCT00450333|560230839|FG002|Overall Study|Death|2|||
155216679|NCT00450333|560230840|FG003|Overall Study|Death|2|||
155216680|NCT01214629|560230849|FG000|Overall Study|Progressive Disease|1|||
155216681|NCT01214629|560230850|FG001|Overall Study|Progressive Disease|1|||
155216682|NCT01214629|560230851|FG002|Overall Study|Progressive Disease|0|||
155216683|NCT01214629|560230852|FG003|Overall Study|Progressive Disease|1|||
155216684|NCT01214629|560230853|FG004|Overall Study|Progressive Disease|2|||
155216685|NCT01214629|560230854|FG005|Overall Study|Progressive Disease|3|||
155216686|NCT01214629|560230855|FG006|Overall Study|Progressive Disease|1|||
155216687|NCT01214629|560230856|FG007|Overall Study|Progressive Disease|1|||
155216688|NCT01214629|560230857|FG008|Overall Study|Progressive Disease|1|||
155216689|NCT01214629|560230858|FG009|Overall Study|Progressive Disease|5|||
155216690|NCT01214629|560230859|FG010|Overall Study|Progressive Disease|1|||
155216691|NCT01214629|560230849|FG000|Overall Study|Adverse Event|0|||
155216692|NCT01214629|560230850|FG001|Overall Study|Adverse Event|0|||
155216693|NCT01214629|560230851|FG002|Overall Study|Adverse Event|0|||
155216694|NCT01214629|560230852|FG003|Overall Study|Adverse Event|1|||
155216695|NCT01214629|560230853|FG004|Overall Study|Adverse Event|0|||
155216696|NCT01214629|560230854|FG005|Overall Study|Adverse Event|1|||
155216697|NCT01214629|560230855|FG006|Overall Study|Adverse Event|0|||
155216698|NCT01214629|560230856|FG007|Overall Study|Adverse Event|0|||
155216699|NCT01214629|560230857|FG008|Overall Study|Adverse Event|0|||
155216700|NCT01214629|560230858|FG009|Overall Study|Adverse Event|1|||
155216701|NCT01214629|560230859|FG010|Overall Study|Adverse Event|0|||
155216702|NCT01214629|560230849|FG000|Overall Study|Physician Decision|0|||
155216703|NCT01214629|560230850|FG001|Overall Study|Physician Decision|0|||
155216704|NCT01214629|560230851|FG002|Overall Study|Physician Decision|0|||
155216705|NCT01214629|560230852|FG003|Overall Study|Physician Decision|0|||
155216706|NCT01214629|560230853|FG004|Overall Study|Physician Decision|0|||
155216707|NCT01214629|560230854|FG005|Overall Study|Physician Decision|0|||
155216708|NCT01214629|560230855|FG006|Overall Study|Physician Decision|0|||
155216709|NCT01214629|560230856|FG007|Overall Study|Physician Decision|0|||
155216710|NCT01214629|560230857|FG008|Overall Study|Physician Decision|0|||
155216711|NCT01214629|560230858|FG009|Overall Study|Physician Decision|0|||
155216712|NCT01214629|560230859|FG010|Overall Study|Physician Decision|1|||
155216713|NCT01214629|560230849|FG000|Overall Study|Withdrawal by Subject|0|||
155216714|NCT01214629|560230850|FG001|Overall Study|Withdrawal by Subject|0|||
155216715|NCT01214629|560230851|FG002|Overall Study|Withdrawal by Subject|0|||
155216716|NCT01214629|560230852|FG003|Overall Study|Withdrawal by Subject|0|||
155216717|NCT01214629|560230853|FG004|Overall Study|Withdrawal by Subject|0|||
155216718|NCT01214629|560230854|FG005|Overall Study|Withdrawal by Subject|0|||
155216719|NCT01214629|560230855|FG006|Overall Study|Withdrawal by Subject|0|||
155216720|NCT01214629|560230856|FG007|Overall Study|Withdrawal by Subject|0|||
155216721|NCT01214629|560230857|FG008|Overall Study|Withdrawal by Subject|0|||
155216722|NCT01214629|560230858|FG009|Overall Study|Withdrawal by Subject|1|||
155216723|NCT01214629|560230859|FG010|Overall Study|Withdrawal by Subject|0|||
155216724|NCT00877383|560230862|FG000|Overall Study|Adverse Event|13|||
155216725|NCT00877383|560230863|FG001|Overall Study|Adverse Event|14|||
155216726|NCT00877383|560230862|FG000|Overall Study|Lost to Follow-up|5|||
155216727|NCT00877383|560230863|FG001|Overall Study|Lost to Follow-up|3|||
155216728|NCT00877383|560230862|FG000|Overall Study|Subject withdrew consent|3|||
155216729|NCT00877383|560230863|FG001|Overall Study|Subject withdrew consent|12|||
155216730|NCT00877383|560230862|FG000|Overall Study|Subject no longer requires study drug|2|||
155216731|NCT00877383|560230863|FG001|Overall Study|Subject no longer requires study drug|0|||
155216732|NCT00877383|560230862|FG000|Overall Study|Administrative problems|2|||
155216733|NCT00877383|560230863|FG001|Overall Study|Administrative problems|0|||
155216734|NCT00877383|560230862|FG000|Overall Study|Protocol deviation|2|||
155216735|NCT00877383|560230863|FG001|Overall Study|Protocol deviation|6|||
155216736|NCT00877383|560230862|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155216737|NCT00877383|560230863|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155216738|NCT00877383|560230862|FG000|Overall Study|Death|1|||
155216739|NCT00877383|560230863|FG001|Overall Study|Death|2|||
155216740|NCT00459108|560230864|FG000|Overall Study|Withdrawal by Subject|5|||
155216741|NCT00459108|560230864|FG000|Overall Study|Adverse Event|3|||
155216742|NCT00459108|560230864|FG000|Overall Study|Death|2|||
155216743|NCT00459108|560230864|FG000|Overall Study|Progression|1|||
155216744|NCT01829230|560230870|FG000|Overall Study|Protocol Violation|0|||
155216745|NCT01829230|560230871|FG001|Overall Study|Protocol Violation|2|||
155216746|NCT01829230|560230870|FG000|Overall Study|Withdrawal by Subject|0|||
155216747|NCT01829230|560230871|FG001|Overall Study|Withdrawal by Subject|1|||
155216748|NCT01829230|560230870|FG000|Overall Study|Lost to Follow-up|1|||
155216749|NCT01829230|560230871|FG001|Overall Study|Lost to Follow-up|1|||
155216750|NCT03855280|560230875|FG000|Treatment Phase|Adverse Event|1|||
155216751|NCT03855280|560230875|FG000|Treatment Phase|Withdrawal by Subject|1|||
155216752|NCT03855280|560230875|FG000|Continuation Phase|Protocol Violation|1|||
155216753|NCT03855280|560230875|FG000|Continuation Phase|Adverse Event|1|||
155216754|NCT03855280|560230875|FG000|Continuation Phase|Sponsor Concluded Study|1|||
155216755|NCT04568590|560232877|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
155216756|NCT01190254|560232879|FG000|Overall Study|Adverse Event|3|||
155216757|NCT01190254|560232880|FG001|Overall Study|Adverse Event|6|||
155216758|NCT01190254|560232881|FG002|Overall Study|Adverse Event|8|||
155216759|NCT01190254|560232879|FG000|Overall Study|Lack of Efficacy|7|||
155216760|NCT01190254|560232880|FG001|Overall Study|Lack of Efficacy|4|||
155216761|NCT01190254|560232881|FG002|Overall Study|Lack of Efficacy|5|||
155216762|NCT01190254|560232879|FG000|Overall Study|Lost to Follow-up|4|||
155216763|NCT01190254|560232880|FG001|Overall Study|Lost to Follow-up|2|||
155216764|NCT01190254|560232881|FG002|Overall Study|Lost to Follow-up|0|||
155216765|NCT01190254|560232879|FG000|Overall Study|Withdrawal by Subject|4|||
155216766|NCT01190254|560232880|FG001|Overall Study|Withdrawal by Subject|5|||
155216767|NCT01190254|560232881|FG002|Overall Study|Withdrawal by Subject|7|||
155216768|NCT01190254|560232879|FG000|Overall Study|Protocol Violation|2|||
155216769|NCT01190254|560232880|FG001|Overall Study|Protocol Violation|0|||
155216770|NCT01190254|560232881|FG002|Overall Study|Protocol Violation|2|||
155216771|NCT01190254|560232879|FG000|Overall Study|Did not meet protocol eligibility|1|||
155216772|NCT01190254|560232880|FG001|Overall Study|Did not meet protocol eligibility|0|||
155216773|NCT01190254|560232881|FG002|Overall Study|Did not meet protocol eligibility|0|||
155216774|NCT00773292|560232882|FG000|Treatment 48 Weeks|Adverse Event|1|||
155216775|NCT00773292|560232882|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
155216776|NCT04105998|560232883|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
155216777|NCT04105998|560232884|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
155216778|NCT02604212|560232885|FG000|Overall Study|Study Terminated by Sponsor|2|||
155216779|NCT02604212|560232886|FG001|Overall Study|Study Terminated by Sponsor|1|||
155216780|NCT02604212|560232887|FG002|Overall Study|Study Terminated by Sponsor|3|||
155216781|NCT02604212|560232888|FG003|Overall Study|Study Terminated by Sponsor|3|||
155216782|NCT02604212|560232885|FG000|Overall Study|Withdrawal by Subject|0|||
155216783|NCT02604212|560232886|FG001|Overall Study|Withdrawal by Subject|0|||
155216784|NCT02604212|560232887|FG002|Overall Study|Withdrawal by Subject|1|||
155216785|NCT02604212|560232888|FG003|Overall Study|Withdrawal by Subject|0|||
155216786|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216787|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
155216788|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216789|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216790|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216791|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216792|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216793|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216794|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
155216795|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
155216796|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216797|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216798|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
155216799|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
155216800|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
155216801|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
155216802|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
155216803|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
155216804|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
155216805|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
155216806|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
155216807|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216808|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
155216809|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216810|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216811|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216812|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
155216813|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216814|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
155216815|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
155216816|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
155216817|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
155216818|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
155216819|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
155216820|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
155216821|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216822|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216823|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216824|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216825|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216826|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
155216827|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216828|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216829|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216830|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216831|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216832|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216833|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216834|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
155216835|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216836|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216837|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216838|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216839|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216840|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216841|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
155216842|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
155216843|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
155216844|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
155216845|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
155216846|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
155216847|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
155216848|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
155216849|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216850|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216851|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
155216852|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
155216853|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216854|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216855|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
155216856|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216857|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
155216858|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
155216859|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216860|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216861|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216862|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216863|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
155216864|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216865|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216866|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216867|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216868|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216869|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
155216870|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216871|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
155216872|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
155216873|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
155216874|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216875|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216876|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
155216877|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
155216878|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216879|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
155216880|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216881|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216882|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216883|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
155216884|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216885|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216886|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
155216887|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216888|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216889|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216890|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216891|NCT04447755|560232898|FG000|Overall Study|Death|9|||
155216892|NCT04447755|560232899|FG001|Overall Study|Death|16|||
155216893|NCT04447755|560232900|FG002|Overall Study|Death|8|||
155216894|NCT04447755|560232901|FG003|Overall Study|Death|9|||
155216895|NCT04447755|560232902|FG004|Overall Study|Death|8|||
155216896|NCT04447755|560232903|FG005|Overall Study|Death|9|||
155216897|NCT04447755|560232904|FG006|Overall Study|Death|55|||
155216898|NCT04447755|560232898|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155216899|NCT04447755|560232899|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155216900|NCT04447755|560232900|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155216901|NCT04447755|560232901|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155216902|NCT04447755|560232902|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155216903|NCT04447755|560232903|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155216904|NCT04447755|560232904|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
155216905|NCT04447755|560232898|FG000|Overall Study|Sponsor Decision|0|||
155216906|NCT04447755|560232899|FG001|Overall Study|Sponsor Decision|0|||
155216907|NCT04447755|560232900|FG002|Overall Study|Sponsor Decision|0|||
155216908|NCT04447755|560232901|FG003|Overall Study|Sponsor Decision|0|||
155216909|NCT04447755|560232902|FG004|Overall Study|Sponsor Decision|1|||
155216910|NCT04447755|560232903|FG005|Overall Study|Sponsor Decision|0|||
155216911|NCT04447755|560232904|FG006|Overall Study|Sponsor Decision|10|||
155216912|NCT04447755|560232898|FG000|Overall Study|Lost to Follow-up|0|||
155216913|NCT04447755|560232899|FG001|Overall Study|Lost to Follow-up|0|||
155216914|NCT04447755|560232900|FG002|Overall Study|Lost to Follow-up|0|||
155216915|NCT04447755|560232901|FG003|Overall Study|Lost to Follow-up|0|||
155216916|NCT04447755|560232902|FG004|Overall Study|Lost to Follow-up|0|||
155216917|NCT04447755|560232903|FG005|Overall Study|Lost to Follow-up|0|||
155216918|NCT04447755|560232904|FG006|Overall Study|Lost to Follow-up|1|||
155216919|NCT00071760|560232905|FG000|Overall Study|Adverse Event|2|||
155216920|NCT00071760|560232906|FG001|Overall Study|Adverse Event|1|||
155216921|NCT00071760|560232905|FG000|Overall Study|Lost to Follow-up|0|||
155216922|NCT00071760|560232906|FG001|Overall Study|Lost to Follow-up|3|||
155216923|NCT00071760|560232905|FG000|Overall Study|Protocol Violation|1|||
155216924|NCT00071760|560232906|FG001|Overall Study|Protocol Violation|0|||
155216925|NCT00071760|560232905|FG000|Overall Study|Withdrawal by Subject|0|||
155216926|NCT00071760|560232906|FG001|Overall Study|Withdrawal by Subject|1|||
155216927|NCT00071760|560232905|FG000|Overall Study|Insufficient Viral Load Response|1|||
155216928|NCT00071760|560232906|FG001|Overall Study|Insufficient Viral Load Response|1|||
155216929|NCT00071760|560232905|FG000|Overall Study|Lack of availability of RTV|1|||
155216930|NCT00071760|560232906|FG001|Overall Study|Lack of availability of RTV|0|||
155216931|NCT00071760|560232905|FG000|Overall Study|Physician Decision|2|||
155216932|NCT00071760|560232906|FG001|Overall Study|Physician Decision|1|||
155216933|NCT00071760|560232905|FG000|Overall Study|Relocation|0|||
155216934|NCT00071760|560232906|FG001|Overall Study|Relocation|1|||
155216935|NCT02073279|560232907|FG000|Double-blind Period|Adverse Event|1|||
155216936|NCT02073279|560232908|FG001|Double-blind Period|Adverse Event|1|||
155216937|NCT02073279|560232907|FG000|Double-blind Period|Switched to another treatment|1|||
155216938|NCT02073279|560232908|FG001|Double-blind Period|Switched to another treatment|2|||
155216939|NCT02073279|560232907|FG000|Double-blind Period|Protocol Violation|0|||
155216940|NCT02073279|560232908|FG001|Double-blind Period|Protocol Violation|1|||
155216941|NCT02073279|560232907|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
155216942|NCT02073279|560232908|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
155216943|NCT02073279|560232907|FG000|Double-blind Period|Withdrawal by Subject|2|||
155216944|NCT02073279|560232908|FG001|Double-blind Period|Withdrawal by Subject|2|||
155216945|NCT02073279|560232907|FG000|Open-label Extension Period|Adverse Event|1|||
155216946|NCT02073279|560232908|FG001|Open-label Extension Period|Adverse Event|0|||
155216947|NCT02073279|560232907|FG000|Open-label Extension Period|Lack of Efficacy|1|||
155216948|NCT02073279|560232908|FG001|Open-label Extension Period|Lack of Efficacy|0|||
155216949|NCT02073279|560232907|FG000|Open-label Extension Period|Lost to Follow-up|0|||
155216950|NCT02073279|560232908|FG001|Open-label Extension Period|Lost to Follow-up|4|||
155216951|NCT02073279|560232907|FG000|Open-label Extension Period|Switched to another treatment|1|||
155216952|NCT02073279|560232908|FG001|Open-label Extension Period|Switched to another treatment|4|||
155216953|NCT02073279|560232907|FG000|Open-label Extension Period|Protocol Violation|0|||
155216954|NCT02073279|560232908|FG001|Open-label Extension Period|Protocol Violation|1|||
155216955|NCT02073279|560232907|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155216956|NCT02073279|560232908|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
155216957|NCT02073279|560232907|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
155216958|NCT02073279|560232908|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
155216959|NCT01994629|560232909|FG000|Overall Study|Withdrawal by Subject|1|||
155216960|NCT01994629|560232910|FG001|Overall Study|Withdrawal by Subject|0|||
155216961|NCT01994629|560232909|FG000|Overall Study|Lost to Follow-up|0|||
155216962|NCT01994629|560232910|FG001|Overall Study|Lost to Follow-up|3|||
155216963|NCT03338062|560232913|FG000|Overall Study|Alternative Therapy|1|||
155216964|NCT03338062|560232914|FG001|Overall Study|Alternative Therapy|0|||
155216965|NCT03424265|560232926|FG000|Overall Study|screening failure|1|||
155216966|NCT03424265|560232927|FG001|Overall Study|screening failure|0|||
155216967|NCT03424265|560232926|FG000|Overall Study|Withdrawal by Subject|0|||
155216968|NCT03424265|560232927|FG001|Overall Study|Withdrawal by Subject|2|||
155216969|NCT00453544|560232931|FG000|Overall Study|Withdrawal by Subject|1|||
155216970|NCT00453544|560232932|FG001|Overall Study|Withdrawal by Subject|0|||
155216971|NCT00453544|560232933|FG002|Overall Study|Withdrawal by Subject|0|||
155216972|NCT00453544|560232934|FG003|Overall Study|Withdrawal by Subject|0|||
155216973|NCT00453544|560232931|FG000|Overall Study|Primary outcome measure not completed|1|||
155216974|NCT00453544|560232932|FG001|Overall Study|Primary outcome measure not completed|1|||
155216975|NCT00453544|560232933|FG002|Overall Study|Primary outcome measure not completed|0|||
155216976|NCT00453544|560232934|FG003|Overall Study|Primary outcome measure not completed|1|||
155216977|NCT01558752|560232935|FG000|Overall Study|Physician Decision|2|||
155216978|NCT01558752|560232936|FG001|Overall Study|Physician Decision|0|||
155216979|NCT04340362|560232939|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
155216980|NCT00391274|560232943|FG000|Overall Study|Death Due to Study Disease|55|||
155216981|NCT00391274|560232944|FG001|Overall Study|Death Due to Study Disease|45|||
155491429|NCT00948896|561223552|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
155216982|NCT00391274|560232943|FG000|Overall Study|Lost to Follow-up|0|||
155216983|NCT00391274|560232944|FG001|Overall Study|Lost to Follow-up|3|||
155216984|NCT00391274|560232943|FG000|Overall Study|Physician Decision|4|||
155216985|NCT00391274|560232944|FG001|Overall Study|Physician Decision|2|||
155216986|NCT00391274|560232943|FG000|Overall Study|Withdrawal by Subject|0|||
155216987|NCT00391274|560232944|FG001|Overall Study|Withdrawal by Subject|3|||
155216988|NCT00391274|560232943|FG000|Overall Study|Death Due to Adverse Event|1|||
155216989|NCT00391274|560232944|FG001|Overall Study|Death Due to Adverse Event|3|||
155216990|NCT00391274|560232943|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
155216991|NCT00391274|560232944|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
155216992|NCT00391274|560232943|FG000|Overall Study|Death Not Study Related|0|||
155216993|NCT00391274|560232944|FG001|Overall Study|Death Not Study Related|1|||
155216994|NCT00894322|560232945|FG000|Overall Study|Withdrawal by Subject|1|||
155216995|NCT00894322|560232946|FG001|Overall Study|Withdrawal by Subject|0|||
155216996|NCT00894322|560232947|FG002|Overall Study|Withdrawal by Subject|0|||
155216997|NCT03338855|560232950|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
155216998|NCT03338855|560232951|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
155216999|NCT00975481|560232960|FG000|Second Intervention Period|Adverse Event|2|||
155217000|NCT00975481|560232961|FG001|Second Intervention Period|Adverse Event|1|||
155217001|NCT00975481|560232962|FG002|Second Intervention Period|Adverse Event|0|||
155217002|NCT00975481|560232963|FG003|Second Intervention Period|Adverse Event|0|||
155217003|NCT00975481|560232964|FG004|Second Intervention Period|Adverse Event|0|||
155217004|NCT00975481|560232965|FG005|Second Intervention Period|Adverse Event|0|||
155217005|NCT00975481|560232960|FG000|Second Intervention Period|Withdrawal by Subject|0|||
155217006|NCT00975481|560232961|FG001|Second Intervention Period|Withdrawal by Subject|0|||
155217007|NCT00975481|560232962|FG002|Second Intervention Period|Withdrawal by Subject|1|||
155217008|NCT00975481|560232963|FG003|Second Intervention Period|Withdrawal by Subject|0|||
155217009|NCT00975481|560232964|FG004|Second Intervention Period|Withdrawal by Subject|0|||
155217010|NCT00975481|560232965|FG005|Second Intervention Period|Withdrawal by Subject|0|||
155217011|NCT00975481|560232960|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
155217012|NCT00975481|560232961|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
155217013|NCT00975481|560232962|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
155217014|NCT00975481|560232963|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
155217015|NCT00975481|560232964|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
155217016|NCT00975481|560232965|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
155217017|NCT00975481|560232960|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
155217018|NCT00975481|560232961|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
155217019|NCT00975481|560232962|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
155217020|NCT00975481|560232963|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
155217021|NCT00975481|560232964|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
155217022|NCT00975481|560232965|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
155217023|NCT03559257|560232968|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
155217024|NCT03559257|560232969|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
155217025|NCT03559257|560232968|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155217026|NCT03559257|560232969|FG001|Double Blind Treatment Period|Protocol Violation|4|||
155217027|NCT03559257|560232968|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155217028|NCT03559257|560232969|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
155217029|NCT03559257|560232968|FG000|Double Blind Treatment Period|Adverse Event|0|||
155217030|NCT03559257|560232969|FG001|Double Blind Treatment Period|Adverse Event|1|||
155217031|NCT03559257|560232968|FG000|Double Blind Treatment Period|Screen Failure|0|||
155217032|NCT03559257|560232969|FG001|Double Blind Treatment Period|Screen Failure|1|||
155217033|NCT03559257|560232968|FG000|Open-label Treatment Period|Adverse Event|1|||
155217034|NCT03559257|560232969|FG001|Open-label Treatment Period|Adverse Event|4|||
155217035|NCT03559257|560232968|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
155217036|NCT03559257|560232969|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
155217037|NCT03559257|560232968|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
155217038|NCT03559257|560232969|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155217039|NCT03559257|560232968|FG000|Open-label Treatment Period|Protocol Violation|2|||
155217040|NCT03559257|560232969|FG001|Open-label Treatment Period|Protocol Violation|0|||
155217041|NCT03559257|560232968|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
155217042|NCT03559257|560232969|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155217043|NCT03559257|560232968|FG000|Open-label Treatment Period|Physician Decision|0|||
155217044|NCT03559257|560232969|FG001|Open-label Treatment Period|Physician Decision|1|||
155217045|NCT02738450|560232970|FG000|Overall Study|Withdrawal by Subject|0|||
155217046|NCT02738450|560232971|FG001|Overall Study|Withdrawal by Subject|2|||
155217047|NCT02738450|560232972|FG002|Overall Study|Withdrawal by Subject|0|||
155217048|NCT03630120|560232973|FG000|Overall Study|Disease progression|0|||
155217049|NCT03630120|560232974|FG001|Overall Study|Disease progression|1|||
155217050|NCT03630120|560232975|FG002|Overall Study|Disease progression|1|||
155217051|NCT03630120|560232976|FG003|Overall Study|Disease progression|1|||
155217052|NCT01519960|560232977|FG000|Overall Study|Withdrawal from the study|26|||
155491430|NCT00948896|561223545|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155217053|NCT01519960|560232978|FG001|Overall Study|Withdrawal from the study|22|||
155217054|NCT01519960|560232979|FG002|Overall Study|Withdrawal from the study|5|||
155217055|NCT01387347|560232980|FG000|Overall Study|Lost to Follow-up|2|||
155217056|NCT01387347|560232981|FG001|Overall Study|Lost to Follow-up|1|||
155217057|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
155217058|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
155217059|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
155217060|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
155217061|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
155217062|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
155217063|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
155217064|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
155217065|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
155217066|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
155217067|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
155217068|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
155217069|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
155217070|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
155217071|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
155217072|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Other|0|||
155217073|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Other|2|||
155217074|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Other|1|||
155217075|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
155217076|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
155217077|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
155217078|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
155217079|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
155217080|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
155217081|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
155217082|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
155217083|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
155217084|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
155217085|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
155217086|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
155217087|NCT01165554|560232988|FG000|Overall Study|Withdrawal by Subject|23|||
155217088|NCT02953314|560232991|FG000|Overall Study|Adverse Event|0|||
155217089|NCT02953314|560232992|FG001|Overall Study|Adverse Event|1|||
155217090|NCT02953314|560232991|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155217091|NCT02953314|560232992|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155217092|NCT02335099|560232993|FG000|Treatment|Withdrawal by Subject|1|||
155217093|NCT02335099|560232994|FG001|Treatment|Withdrawal by Subject|3|||
155217094|NCT02335099|560232993|FG000|Treatment|Lost to Follow-up|2|||
155217095|NCT02335099|560232994|FG001|Treatment|Lost to Follow-up|0|||
155217096|NCT02335099|560232993|FG000|Treatment|Death|1|||
155217097|NCT02335099|560232994|FG001|Treatment|Death|0|||
155217098|NCT02335099|560232993|FG000|Treatment|Adverse Event|1|||
155217099|NCT02335099|560232994|FG001|Treatment|Adverse Event|2|||
155217100|NCT02335099|560232993|FG000|Follow-up|Death|0|||
155217101|NCT02335099|560232994|FG001|Follow-up|Death|1|||
155217102|NCT01288287|560232995|FG000|Overall Study|Lost to Follow-up|8|||
155217103|NCT01288287|560232995|FG000|Overall Study|Withdrawal by Subject|4|||
155217104|NCT01288287|560232995|FG000|Overall Study|Lack of Efficacy|13|||
155217105|NCT01288287|560232995|FG000|Overall Study|Other Reason|13|||
155217106|NCT01288287|560232995|FG000|Overall Study|Unknown Reason|1|||
155217107|NCT01288287|560232995|FG000|Overall Study|Unknown Status|7|||
155217108|NCT01641692|560233001|FG000|Treatment Period 1|Adverse Event|1|||
155217109|NCT01641692|560233002|FG001|Treatment Period 1|Adverse Event|0|||
155217110|NCT01641692|560233003|FG002|Treatment Period 1|Adverse Event|0|||
155217111|NCT01641692|560233004|FG003|Treatment Period 1|Adverse Event|0|||
155217112|NCT01641692|560233005|FG004|Treatment Period 1|Adverse Event|0|||
155217113|NCT01641692|560233006|FG005|Treatment Period 1|Adverse Event|0|||
155217114|NCT01641692|560233007|FG006|Treatment Period 1|Adverse Event|0|||
155217115|NCT01641692|560233008|FG007|Treatment Period 1|Adverse Event|0|||
155217116|NCT01641692|560233001|FG000|Treatment Period 1|Lack of Efficacy|0|||
155217117|NCT01641692|560233002|FG001|Treatment Period 1|Lack of Efficacy|0|||
155217118|NCT01641692|560233003|FG002|Treatment Period 1|Lack of Efficacy|0|||
155217119|NCT01641692|560233004|FG003|Treatment Period 1|Lack of Efficacy|0|||
155217120|NCT01641692|560233005|FG004|Treatment Period 1|Lack of Efficacy|0|||
155217121|NCT01641692|560233006|FG005|Treatment Period 1|Lack of Efficacy|0|||
155217122|NCT01641692|560233007|FG006|Treatment Period 1|Lack of Efficacy|0|||
155217123|NCT01641692|560233008|FG007|Treatment Period 1|Lack of Efficacy|1|||
155217124|NCT01641692|560233001|FG000|Treatment Period 1|Protocol Violation|1|||
155217125|NCT01641692|560233002|FG001|Treatment Period 1|Protocol Violation|0|||
155217126|NCT01641692|560233003|FG002|Treatment Period 1|Protocol Violation|0|||
155217127|NCT01641692|560233004|FG003|Treatment Period 1|Protocol Violation|0|||
155217128|NCT01641692|560233005|FG004|Treatment Period 1|Protocol Violation|2|||
155217129|NCT01641692|560233006|FG005|Treatment Period 1|Protocol Violation|0|||
155217130|NCT01641692|560233007|FG006|Treatment Period 1|Protocol Violation|0|||
155217131|NCT01641692|560233008|FG007|Treatment Period 1|Protocol Violation|0|||
155217132|NCT01641692|560233001|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217133|NCT01641692|560233002|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217134|NCT01641692|560233003|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217135|NCT01641692|560233004|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217136|NCT01641692|560233005|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
155217137|NCT01641692|560233006|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217138|NCT01641692|560233007|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217139|NCT01641692|560233008|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
155217140|NCT01641692|560233001|FG000|Treatment Period 1|Lost to Follow-up|0|||
155217141|NCT01641692|560233002|FG001|Treatment Period 1|Lost to Follow-up|0|||
155217142|NCT01641692|560233003|FG002|Treatment Period 1|Lost to Follow-up|1|||
155217143|NCT01641692|560233004|FG003|Treatment Period 1|Lost to Follow-up|0|||
155217144|NCT01641692|560233005|FG004|Treatment Period 1|Lost to Follow-up|0|||
155217145|NCT01641692|560233006|FG005|Treatment Period 1|Lost to Follow-up|0|||
155217146|NCT01641692|560233007|FG006|Treatment Period 1|Lost to Follow-up|0|||
155217147|NCT01641692|560233008|FG007|Treatment Period 1|Lost to Follow-up|0|||
155217148|NCT01641692|560233001|FG000|Treatment Period 1|Physician Decision|0|||
155217149|NCT01641692|560233002|FG001|Treatment Period 1|Physician Decision|0|||
155217150|NCT01641692|560233003|FG002|Treatment Period 1|Physician Decision|0|||
155217151|NCT01641692|560233004|FG003|Treatment Period 1|Physician Decision|0|||
155217152|NCT01641692|560233005|FG004|Treatment Period 1|Physician Decision|1|||
155217153|NCT01641692|560233006|FG005|Treatment Period 1|Physician Decision|0|||
155217154|NCT01641692|560233007|FG006|Treatment Period 1|Physician Decision|0|||
155217155|NCT01641692|560233008|FG007|Treatment Period 1|Physician Decision|0|||
155217156|NCT01641692|560233001|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155217157|NCT01641692|560233002|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155217158|NCT01641692|560233003|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155217159|NCT01641692|560233004|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155217160|NCT01641692|560233005|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155217161|NCT01641692|560233006|FG005|Treatment Period 1|Withdrawal by Subject|2|||
155217162|NCT01641692|560233007|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155217163|NCT01641692|560233008|FG007|Treatment Period 1|Withdrawal by Subject|1|||
155217164|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
155217165|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217166|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217167|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217168|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217169|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217170|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217171|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217172|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217173|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217174|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217175|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217176|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217177|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217178|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155217179|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217180|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217181|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217182|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217183|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217184|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217185|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217186|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217187|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217188|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217189|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217190|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217191|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217192|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217193|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217194|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217195|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217196|NCT01641692|560233001|FG000|Treatment Period 2|Lack of Efficacy|1|||
155217197|NCT01641692|560233002|FG001|Treatment Period 2|Lack of Efficacy|0|||
155217198|NCT01641692|560233003|FG002|Treatment Period 2|Lack of Efficacy|0|||
155217199|NCT01641692|560233004|FG003|Treatment Period 2|Lack of Efficacy|0|||
155217200|NCT01641692|560233005|FG004|Treatment Period 2|Lack of Efficacy|0|||
155217201|NCT01641692|560233006|FG005|Treatment Period 2|Lack of Efficacy|0|||
155217202|NCT01641692|560233007|FG006|Treatment Period 2|Lack of Efficacy|0|||
155217203|NCT01641692|560233008|FG007|Treatment Period 2|Lack of Efficacy|0|||
155217204|NCT01641692|560233001|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
155217205|NCT01641692|560233002|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217206|NCT01641692|560233003|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217207|NCT01641692|560233004|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217208|NCT01641692|560233005|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217209|NCT01641692|560233006|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217210|NCT01641692|560233007|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217211|NCT01641692|560233008|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217212|NCT01641692|560233001|FG000|Treatment Period 2|Lost to Follow-up|0|||
155217213|NCT01641692|560233002|FG001|Treatment Period 2|Lost to Follow-up|0|||
155217214|NCT01641692|560233003|FG002|Treatment Period 2|Lost to Follow-up|0|||
155217215|NCT01641692|560233004|FG003|Treatment Period 2|Lost to Follow-up|0|||
155217216|NCT01641692|560233005|FG004|Treatment Period 2|Lost to Follow-up|0|||
155217217|NCT01641692|560233006|FG005|Treatment Period 2|Lost to Follow-up|1|||
155217218|NCT01641692|560233007|FG006|Treatment Period 2|Lost to Follow-up|0|||
155217219|NCT01641692|560233008|FG007|Treatment Period 2|Lost to Follow-up|0|||
155217220|NCT01641692|560233001|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155217221|NCT01641692|560233002|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155217222|NCT01641692|560233003|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155217223|NCT01641692|560233004|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155217224|NCT01641692|560233005|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155217225|NCT01641692|560233006|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155217226|NCT01641692|560233007|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155217227|NCT01641692|560233008|FG007|Treatment Period 2|Withdrawal by Subject|1|||
155217228|NCT01641692|560233001|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217229|NCT01641692|560233002|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217230|NCT01641692|560233003|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217231|NCT01641692|560233004|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217232|NCT01641692|560233005|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217233|NCT01641692|560233006|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217234|NCT01641692|560233007|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217235|NCT01641692|560233008|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217236|NCT01641692|560233001|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217237|NCT01641692|560233002|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217238|NCT01641692|560233003|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217239|NCT01641692|560233004|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217240|NCT01641692|560233005|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217241|NCT01641692|560233006|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217242|NCT01641692|560233007|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217243|NCT01641692|560233008|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217244|NCT01641692|560233001|FG000|Treatment Period 3|Adverse Event|0|||
155217245|NCT01641692|560233002|FG001|Treatment Period 3|Adverse Event|0|||
155217246|NCT01641692|560233003|FG002|Treatment Period 3|Adverse Event|0|||
155217247|NCT01641692|560233004|FG003|Treatment Period 3|Adverse Event|0|||
155217248|NCT01641692|560233005|FG004|Treatment Period 3|Adverse Event|0|||
155217249|NCT01641692|560233006|FG005|Treatment Period 3|Adverse Event|0|||
155217250|NCT01641692|560233007|FG006|Treatment Period 3|Adverse Event|1|||
155217251|NCT01641692|560233008|FG007|Treatment Period 3|Adverse Event|0|||
155217252|NCT01641692|560233001|FG000|Treatment Period 3|Protocol Violation|0|||
155217253|NCT01641692|560233002|FG001|Treatment Period 3|Protocol Violation|0|||
155217254|NCT01641692|560233003|FG002|Treatment Period 3|Protocol Violation|1|||
155217255|NCT01641692|560233004|FG003|Treatment Period 3|Protocol Violation|0|||
155217256|NCT01641692|560233005|FG004|Treatment Period 3|Protocol Violation|0|||
155217257|NCT01641692|560233006|FG005|Treatment Period 3|Protocol Violation|0|||
155217258|NCT01641692|560233007|FG006|Treatment Period 3|Protocol Violation|0|||
155217259|NCT01641692|560233008|FG007|Treatment Period 3|Protocol Violation|0|||
155217260|NCT01641692|560233001|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217261|NCT01641692|560233002|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217262|NCT01641692|560233003|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217263|NCT01641692|560233004|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217264|NCT01641692|560233005|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217265|NCT01641692|560233006|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217266|NCT01641692|560233007|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
155217267|NCT01641692|560233008|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217268|NCT01641692|560233001|FG000|Treatment Period 3|Lost to Follow-up|0|||
155217269|NCT01641692|560233002|FG001|Treatment Period 3|Lost to Follow-up|1|||
155217270|NCT01641692|560233003|FG002|Treatment Period 3|Lost to Follow-up|0|||
155217271|NCT01641692|560233004|FG003|Treatment Period 3|Lost to Follow-up|0|||
155217272|NCT01641692|560233005|FG004|Treatment Period 3|Lost to Follow-up|0|||
155217273|NCT01641692|560233006|FG005|Treatment Period 3|Lost to Follow-up|0|||
155217274|NCT01641692|560233007|FG006|Treatment Period 3|Lost to Follow-up|0|||
155217275|NCT01641692|560233008|FG007|Treatment Period 3|Lost to Follow-up|0|||
155217276|NCT01641692|560233001|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217277|NCT01641692|560233002|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217278|NCT01641692|560233003|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217279|NCT01641692|560233004|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217280|NCT01641692|560233005|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217281|NCT01641692|560233006|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
155217282|NCT01641692|560233007|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217283|NCT01641692|560233008|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217284|NCT01641692|560233001|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217285|NCT01641692|560233002|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217286|NCT01641692|560233003|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217287|NCT01641692|560233004|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217288|NCT01641692|560233005|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217289|NCT01641692|560233006|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217290|NCT01641692|560233007|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217291|NCT01641692|560233008|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217292|NCT04948450|560233014|FG000|Overall Study|Return home|1|||
155217293|NCT04948450|560233015|FG001|Overall Study|Return home|3|||
155217294|NCT00101907|560233019|FG000|Overall Study|Adverse Event|1|||
155217295|NCT00101907|560233020|FG001|Overall Study|Adverse Event|0|||
155217296|NCT00101907|560233021|FG002|Overall Study|Adverse Event|0|||
155217297|NCT00101907|560233022|FG003|Overall Study|Adverse Event|0|||
155217298|NCT00101907|560233023|FG004|Overall Study|Adverse Event|0|||
155217299|NCT00101907|560233024|FG005|Overall Study|Adverse Event|0|||
155217300|NCT00101907|560233019|FG000|Overall Study|Death|0|||
155217301|NCT00101907|560233020|FG001|Overall Study|Death|1|||
155217302|NCT00101907|560233021|FG002|Overall Study|Death|0|||
155217303|NCT00101907|560233022|FG003|Overall Study|Death|0|||
155217304|NCT00101907|560233023|FG004|Overall Study|Death|3|||
155217305|NCT00101907|560233024|FG005|Overall Study|Death|0|||
155217306|NCT00101907|560233019|FG000|Overall Study|Physician Decision|0|||
155217307|NCT00101907|560233020|FG001|Overall Study|Physician Decision|0|||
155217308|NCT00101907|560233021|FG002|Overall Study|Physician Decision|0|||
155217309|NCT00101907|560233022|FG003|Overall Study|Physician Decision|1|||
155217310|NCT00101907|560233023|FG004|Overall Study|Physician Decision|1|||
155217311|NCT00101907|560233024|FG005|Overall Study|Physician Decision|0|||
155217312|NCT00101907|560233019|FG000|Overall Study|Withdrawal by Subject|1|||
155217313|NCT00101907|560233020|FG001|Overall Study|Withdrawal by Subject|0|||
155217314|NCT00101907|560233021|FG002|Overall Study|Withdrawal by Subject|1|||
155217315|NCT00101907|560233022|FG003|Overall Study|Withdrawal by Subject|0|||
155217316|NCT00101907|560233023|FG004|Overall Study|Withdrawal by Subject|1|||
155217317|NCT00101907|560233024|FG005|Overall Study|Withdrawal by Subject|0|||
155217318|NCT00624052|560233025|FG000|Overall Study|Adverse Event|7|||
155217319|NCT00624052|560233026|FG001|Overall Study|Adverse Event|6|||
155217320|NCT00624052|560233027|FG002|Overall Study|Adverse Event|0|||
155217321|NCT00624052|560233028|FG003|Overall Study|Adverse Event|3|||
155217322|NCT00624052|560233025|FG000|Overall Study|Lack of Efficacy|1|||
155217323|NCT00624052|560233026|FG001|Overall Study|Lack of Efficacy|1|||
155217324|NCT00624052|560233027|FG002|Overall Study|Lack of Efficacy|0|||
155217325|NCT00624052|560233028|FG003|Overall Study|Lack of Efficacy|0|||
155217326|NCT00624052|560233025|FG000|Overall Study|Lost to Follow-up|2|||
155217327|NCT00624052|560233026|FG001|Overall Study|Lost to Follow-up|3|||
155217328|NCT00624052|560233027|FG002|Overall Study|Lost to Follow-up|1|||
155217329|NCT00624052|560233028|FG003|Overall Study|Lost to Follow-up|0|||
155217330|NCT00624052|560233025|FG000|Overall Study|Non compliant with the protocol|2|||
155217331|NCT00624052|560233026|FG001|Overall Study|Non compliant with the protocol|1|||
155217332|NCT00624052|560233027|FG002|Overall Study|Non compliant with the protocol|1|||
155217333|NCT00624052|560233028|FG003|Overall Study|Non compliant with the protocol|1|||
155217334|NCT00624052|560233025|FG000|Overall Study|Consent withdrawn|3|||
155217335|NCT00624052|560233026|FG001|Overall Study|Consent withdrawn|1|||
155217336|NCT00624052|560233027|FG002|Overall Study|Consent withdrawn|1|||
155217337|NCT00624052|560233028|FG003|Overall Study|Consent withdrawn|0|||
155217338|NCT00624052|560233025|FG000|Overall Study|Changed job/ran out if meds|0|||
155217339|NCT00624052|560233026|FG001|Overall Study|Changed job/ran out if meds|2|||
155217340|NCT00624052|560233027|FG002|Overall Study|Changed job/ran out if meds|0|||
155217341|NCT00624052|560233028|FG003|Overall Study|Changed job/ran out if meds|0|||
155217342|NCT03658538|560233031|FG000|Overall Study|Death|2|||
155217343|NCT03658538|560233032|FG001|Overall Study|Death|1|||
155217344|NCT03658538|560233031|FG000|Overall Study|Cancer diagnosis|1|||
155217345|NCT03658538|560233032|FG001|Overall Study|Cancer diagnosis|0|||
155217346|NCT03658538|560233031|FG000|Overall Study|Change residence|1|||
155217347|NCT03658538|560233032|FG001|Overall Study|Change residence|2|||
155217348|NCT03658538|560233031|FG000|Overall Study|Lost to Follow-up|3|||
155217349|NCT03658538|560233032|FG001|Overall Study|Lost to Follow-up|3|||
155217350|NCT03658538|560233031|FG000|Overall Study|Unblinded|2|||
155217351|NCT03658538|560233032|FG001|Overall Study|Unblinded|3|||
155217352|NCT03658538|560233031|FG000|Overall Study|Physician Decision|0|||
155217353|NCT03658538|560233032|FG001|Overall Study|Physician Decision|1|||
155217354|NCT03658538|560233031|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
155217355|NCT03658538|560233032|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
155217356|NCT03658538|560233031|FG000|Overall Study|Evicted from home|1|||
155217357|NCT03658538|560233032|FG001|Overall Study|Evicted from home|0|||
155217358|NCT00202644|560234501|FG000|Overall Study|Adverse Event|12|||
155217359|NCT00202644|560234502|FG001|Overall Study|Adverse Event|13|||
155217360|NCT00202644|560234501|FG000|Overall Study|Withdrawal by Subject|8|||
155217361|NCT00202644|560234502|FG001|Overall Study|Withdrawal by Subject|6|||
155217362|NCT00202644|560234501|FG000|Overall Study|Lack of Efficacy|6|||
155217363|NCT00202644|560234502|FG001|Overall Study|Lack of Efficacy|6|||
155217364|NCT00202644|560234501|FG000|Overall Study|Lost to Follow-up|0|||
155217365|NCT00202644|560234502|FG001|Overall Study|Lost to Follow-up|1|||
155217366|NCT00202644|560234501|FG000|Overall Study|Other|9|||
155217367|NCT00202644|560234502|FG001|Overall Study|Other|1|||
155217368|NCT02750592|560234503|FG000|Overall Study|Adverse Event|3|||
155217369|NCT02750592|560234503|FG000|Overall Study|Lack of Efficacy|2|||
155217370|NCT02981342|560234504|FG000|Overall Study|Adverse Event|0|||
155217371|NCT02981342|560234505|FG001|Overall Study|Adverse Event|0|||
155217372|NCT02981342|560234506|FG002|Overall Study|Adverse Event|0|||
155217373|NCT02981342|560234507|FG003|Overall Study|Adverse Event|1|||
155217374|NCT02981342|560234504|FG000|Overall Study|Death|0|||
155217375|NCT02981342|560234505|FG001|Overall Study|Death|9|||
155217376|NCT02981342|560234506|FG002|Overall Study|Death|9|||
155217377|NCT02981342|560234507|FG003|Overall Study|Death|4|||
155217378|NCT02981342|560234504|FG000|Overall Study|Withdrawal by Subject|0|||
155217379|NCT02981342|560234505|FG001|Overall Study|Withdrawal by Subject|0|||
155217380|NCT02981342|560234506|FG002|Overall Study|Withdrawal by Subject|3|||
155217381|NCT02981342|560234507|FG003|Overall Study|Withdrawal by Subject|1|||
155217382|NCT02981342|560234504|FG000|Overall Study|Study closed by sponsor|0|||
155217383|NCT02981342|560234505|FG001|Overall Study|Study closed by sponsor|0|||
155217384|NCT02981342|560234506|FG002|Overall Study|Study closed by sponsor|1|||
155217385|NCT02981342|560234507|FG003|Overall Study|Study closed by sponsor|1|||
155217386|NCT02981342|560234504|FG000|Overall Study|Randomized, Never Treated|0|||
155217387|NCT02981342|560234505|FG001|Overall Study|Randomized, Never Treated|1|||
155217388|NCT02981342|560234506|FG002|Overall Study|Randomized, Never Treated|0|||
155217389|NCT02981342|560234507|FG003|Overall Study|Randomized, Never Treated|7|||
155217390|NCT02981342|560234504|FG000|Overall Study|Lost to Follow-up|0|||
155217391|NCT02981342|560234505|FG001|Overall Study|Lost to Follow-up|1|||
155217392|NCT02981342|560234506|FG002|Overall Study|Lost to Follow-up|0|||
155217393|NCT02981342|560234507|FG003|Overall Study|Lost to Follow-up|0|||
155217394|NCT01372501|560234508|FG000|Overall Study|Adverse Event|4|||
155217395|NCT01372501|560234508|FG000|Overall Study|Device migration|1|||
155217396|NCT01277523|560234509|FG000|Overall Study|Adverse Event|1|||
155217397|NCT01277523|560234510|FG001|Overall Study|Adverse Event|0|||
155217398|NCT01277523|560234511|FG002|Overall Study|Adverse Event|0|||
155217399|NCT01277523|560234509|FG000|Overall Study|Protocol Violation|2|||
155217400|NCT01277523|560234510|FG001|Overall Study|Protocol Violation|0|||
155217401|NCT01277523|560234511|FG002|Overall Study|Protocol Violation|0|||
155217402|NCT01277523|560234509|FG000|Overall Study|Other Reason not Defined|0|||
155217403|NCT01277523|560234510|FG001|Overall Study|Other Reason not Defined|1|||
155217404|NCT01277523|560234511|FG002|Overall Study|Other Reason not Defined|0|||
155217405|NCT01859494|560234514|FG000|Overall Study|Adverse Event|1|||
155491431|NCT00948896|561223546|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155217406|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Death|3|||
155217407|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Death|2|||
155217408|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Death|4|||
155217409|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Death|3|||
155217410|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Death|0|||
155217411|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Death|0|||
155217412|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217413|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
155217414|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
155217415|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217416|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217417|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217418|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
155217419|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217420|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217421|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217422|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217423|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217424|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
155217425|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217426|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
155217427|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
155217428|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217429|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217430|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217431|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217432|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
155217433|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
155217434|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217435|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217436|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
155217437|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
155217438|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
155217439|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
155217440|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
155217441|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
155217442|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217443|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217444|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
155217445|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217446|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217447|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217448|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
155217449|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
155217450|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
155217451|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
155217452|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
155217453|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
155217454|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217455|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217456|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217457|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217458|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
155217459|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
155217460|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217461|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217462|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217463|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217464|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
155217465|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217466|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217467|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217468|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217469|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217470|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
155217471|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
155217472|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217473|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217474|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217475|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217476|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
155217477|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
155217478|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217479|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217480|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217481|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217482|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
155217483|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
155217484|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217485|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217486|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217487|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217488|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
155217489|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217490|NCT01912287|560234521|FG000|Overall Study|Ineligible|1|||
155217491|NCT01912287|560234522|FG001|Overall Study|Ineligible|0|||
155217492|NCT01912287|560234523|FG002|Overall Study|Ineligible|1|||
155217493|NCT01912287|560234521|FG000|Overall Study|No-show|0|||
155217494|NCT01912287|560234522|FG001|Overall Study|No-show|0|||
155217495|NCT01912287|560234523|FG002|Overall Study|No-show|1|||
155217496|NCT01912287|560234521|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
155217497|NCT01912287|560234522|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
155217498|NCT01912287|560234523|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
155217499|NCT01912287|560234521|FG000|Overall Study|Felt treatment no longer needed|0|||
155217500|NCT01912287|560234522|FG001|Overall Study|Felt treatment no longer needed|1|||
155217501|NCT01912287|560234523|FG002|Overall Study|Felt treatment no longer needed|0|||
155217502|NCT01912287|560234521|FG000|Overall Study|Life circumstances|4|||
155217503|NCT01912287|560234522|FG001|Overall Study|Life circumstances|2|||
155217504|NCT01912287|560234523|FG002|Overall Study|Life circumstances|0|||
155217505|NCT01912287|560234521|FG000|Overall Study|Lost Interest|1|||
155217506|NCT01912287|560234522|FG001|Overall Study|Lost Interest|0|||
155217507|NCT01912287|560234523|FG002|Overall Study|Lost Interest|0|||
155217508|NCT01912287|560234521|FG000|Overall Study|Uknown reason - subject drop out|5|||
155217509|NCT01912287|560234522|FG001|Overall Study|Uknown reason - subject drop out|7|||
155217510|NCT01912287|560234523|FG002|Overall Study|Uknown reason - subject drop out|3|||
155217511|NCT01912287|560234521|FG000|Overall Study|Missed Assesment|1|||
155217512|NCT01912287|560234522|FG001|Overall Study|Missed Assesment|1|||
155217513|NCT01912287|560234523|FG002|Overall Study|Missed Assesment|1|||
155217514|NCT01912287|560234521|FG000|Overall Study|Scheduling/change in availability|17|||
155217515|NCT01912287|560234522|FG001|Overall Study|Scheduling/change in availability|10|||
155217516|NCT01912287|560234523|FG002|Overall Study|Scheduling/change in availability|8|||
155217517|NCT02631850|560234524|FG000|Treatment Period|Lost to Follow-up|0|||
155217518|NCT02631850|560234525|FG001|Treatment Period|Lost to Follow-up|1|||
155217519|NCT02631850|560234526|FG002|Treatment Period|Lost to Follow-up|0|||
155217520|NCT02631850|560234527|FG003|Treatment Period|Lost to Follow-up|0|||
155217521|NCT02631850|560234524|FG000|Treatment Period|Protocol Violation|1|||
155217522|NCT02631850|560234525|FG001|Treatment Period|Protocol Violation|0|||
155217523|NCT02631850|560234526|FG002|Treatment Period|Protocol Violation|0|||
155217524|NCT02631850|560234527|FG003|Treatment Period|Protocol Violation|0|||
155217525|NCT02631850|560234524|FG000|Treatment Period|Withdrawal by Subject|0|||
155217526|NCT02631850|560234525|FG001|Treatment Period|Withdrawal by Subject|5|||
155217527|NCT02631850|560234526|FG002|Treatment Period|Withdrawal by Subject|2|||
155217528|NCT02631850|560234527|FG003|Treatment Period|Withdrawal by Subject|2|||
155217529|NCT02631850|560234524|FG000|Treatment Period|Adverse Event|1|||
155217530|NCT02631850|560234525|FG001|Treatment Period|Adverse Event|0|||
155217531|NCT02631850|560234526|FG002|Treatment Period|Adverse Event|2|||
155217532|NCT02631850|560234527|FG003|Treatment Period|Adverse Event|3|||
155217533|NCT02631850|560234524|FG000|Treatment Period|Family medical issue|1|||
155217534|NCT02631850|560234525|FG001|Treatment Period|Family medical issue|0|||
155217535|NCT02631850|560234526|FG002|Treatment Period|Family medical issue|0|||
155217536|NCT02631850|560234527|FG003|Treatment Period|Family medical issue|0|||
155217537|NCT02631850|560234524|FG000|6 Month Follow up|Lost to Follow-up|5|||
155217538|NCT02631850|560234525|FG001|6 Month Follow up|Lost to Follow-up|8|||
155217539|NCT02631850|560234526|FG002|6 Month Follow up|Lost to Follow-up|3|||
155217540|NCT02631850|560234527|FG003|6 Month Follow up|Lost to Follow-up|5|||
155217541|NCT02631850|560234524|FG000|6 Month Follow up|Withdrawal by Subject|1|||
155217542|NCT02631850|560234525|FG001|6 Month Follow up|Withdrawal by Subject|0|||
155217543|NCT02631850|560234526|FG002|6 Month Follow up|Withdrawal by Subject|0|||
155217544|NCT02631850|560234527|FG003|6 Month Follow up|Withdrawal by Subject|2|||
155217545|NCT02631850|560234524|FG000|6 Month Follow up|Adverse Event|1|||
155217546|NCT02631850|560234525|FG001|6 Month Follow up|Adverse Event|4|||
155217547|NCT02631850|560234526|FG002|6 Month Follow up|Adverse Event|1|||
155217548|NCT02631850|560234527|FG003|6 Month Follow up|Adverse Event|3|||
155217549|NCT02631850|560234524|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
155217550|NCT02631850|560234525|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
155217551|NCT02631850|560234526|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
155217552|NCT02631850|560234527|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
155217553|NCT01462084|560234528|FG000|Overall Study|Withdrawal by Subject|1|||
155217554|NCT01462084|560234529|FG001|Overall Study|Withdrawal by Subject|0|||
155217555|NCT01462084|560234528|FG000|Overall Study|Protocol Violation|1|||
155217556|NCT01462084|560234529|FG001|Overall Study|Protocol Violation|1|||
155217557|NCT02278263|560234530|FG000|Overall Study|Protocol Violation|7|||
155217558|NCT02278263|560234531|FG001|Overall Study|Protocol Violation|0|||
155217559|NCT02278263|560234532|FG002|Overall Study|Protocol Violation|9|||
155217560|NCT00326950|560234536|FG000|Overall Study|Progressive Disease|1|||
155217561|NCT01514760|560234537|FG000|Overall Study|Lost to Follow-up|2|||
155217562|NCT01266460|560234540|FG000|Overall Study|Adverse Event|3|||
155217563|NCT01266460|560234540|FG000|Overall Study|Withdrawal by Subject|5|||
155217564|NCT01266460|560234540|FG000|Overall Study|Disease Progression|18|||
155217565|NCT01266460|560234540|FG000|Overall Study|Not otherwise specified|8|||
155217566|NCT01132547|560234541|FG000|Overall Study|Withdrawal by Subject|3|||
155217567|NCT01132547|560234542|FG001|Overall Study|Withdrawal by Subject|1|||
155217568|NCT01132547|560234541|FG000|Overall Study|Death|1|||
155217569|NCT01132547|560234542|FG001|Overall Study|Death|0|||
155217570|NCT05811234|560234543|FG000|Overall Study|Loss of Effectiveness|2|||
155217571|NCT05811234|560234543|FG000|Overall Study|Adverse Event|4|||
155217572|NCT05811234|560234543|FG000|Overall Study|Pregnancy|1|||
155217573|NCT05811234|560234543|FG000|Overall Study|Disease progression|1|||
155217574|NCT05811234|560234543|FG000|Overall Study|Withdrawal by Subject|4|||
155217575|NCT05811234|560234543|FG000|Overall Study|Lost to Follow-up|13|||
155217576|NCT05811234|560234543|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
155217577|NCT02710045|560234544|FG000|Overall Study|Death|1|||
155217578|NCT02710045|560234545|FG001|Overall Study|Death|2|||
155217579|NCT02710045|560234546|FG002|Overall Study|Death|0|||
155217580|NCT02710045|560234544|FG000|Overall Study|Withdrawal by Subject|6|||
155217581|NCT02710045|560234545|FG001|Overall Study|Withdrawal by Subject|6|||
155217582|NCT02710045|560234546|FG002|Overall Study|Withdrawal by Subject|2|||
155217583|NCT02710045|560234544|FG000|Overall Study|Protocol Violation|1|||
155217584|NCT02710045|560234545|FG001|Overall Study|Protocol Violation|2|||
155217585|NCT02710045|560234546|FG002|Overall Study|Protocol Violation|3|||
155217586|NCT02710045|560234544|FG000|Overall Study|Lost to Follow-up|3|||
155217587|NCT02710045|560234545|FG001|Overall Study|Lost to Follow-up|6|||
155217588|NCT02710045|560234546|FG002|Overall Study|Lost to Follow-up|7|||
155217589|NCT02710045|560234544|FG000|Overall Study|Physician Decision|0|||
155217590|NCT02710045|560234545|FG001|Overall Study|Physician Decision|0|||
155217591|NCT02710045|560234546|FG002|Overall Study|Physician Decision|1|||
155217592|NCT02710045|560234544|FG000|Overall Study|Poor Attendance|0|||
155217593|NCT02710045|560234545|FG001|Overall Study|Poor Attendance|1|||
155217594|NCT02710045|560234546|FG002|Overall Study|Poor Attendance|0|||
155217595|NCT01275833|560234547|FG000|Overall Study|Study terminated|1|||
155217596|NCT01275833|560234548|FG001|Overall Study|Study terminated|1|||
155217597|NCT02118012|560234554|FG000|Overall Study|Adverse Event|0|||
155217598|NCT02118012|560234555|FG001|Overall Study|Adverse Event|1|||
155217599|NCT02118012|560234554|FG000|Overall Study|Physician Decision|0|||
155217600|NCT02118012|560234555|FG001|Overall Study|Physician Decision|1|||
155217601|NCT00483379|560234556|FG000|Treatment Period|Adverse Event|1|||
155217602|NCT00483379|560234557|FG001|Treatment Period|Adverse Event|0|||
155217603|NCT00483379|560234556|FG000|Treatment Period|Withdrawal by Subject|1|||
155217604|NCT00483379|560234557|FG001|Treatment Period|Withdrawal by Subject|0|||
155217605|NCT00536107|560234560|FG000|Overall Study|Death|5|||
155217606|NCT00536107|560234561|FG001|Overall Study|Death|1|||
155217607|NCT00536107|560234560|FG000|Overall Study|Incorrect enrolment|1|||
155217608|NCT00536107|560234561|FG001|Overall Study|Incorrect enrolment|0|||
155217609|NCT00536107|560234560|FG000|Overall Study|Withdrawal by Subject|0|||
155217610|NCT00536107|560234561|FG001|Overall Study|Withdrawal by Subject|1|||
155217611|NCT00536107|560234560|FG000|Overall Study|Study Termination|2|||
155217612|NCT00536107|560234561|FG001|Overall Study|Study Termination|4|||
155217613|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
155217614|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
155217615|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
155217616|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
155217617|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
155217618|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
155217619|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
155217620|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
155217621|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
155217622|NCT04519645|560234566|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
155217623|NCT04519645|560234567|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
155217624|NCT04519645|560234568|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
155217625|NCT04387435|560234575|FG000|Overall Study|Physician Decision|1|||
155217626|NCT03447990|560234583|FG000|Overall Study|Withdrawal by Subject|0|||
155217627|NCT03447990|560234584|FG001|Overall Study|Withdrawal by Subject|0|||
155217628|NCT03447990|560234585|FG002|Overall Study|Withdrawal by Subject|0|||
155217629|NCT03447990|560234586|FG003|Overall Study|Withdrawal by Subject|0|||
155217630|NCT03447990|560234587|FG004|Overall Study|Withdrawal by Subject|0|||
155217631|NCT03447990|560234588|FG005|Overall Study|Withdrawal by Subject|0|||
155217632|NCT03447990|560234589|FG006|Overall Study|Withdrawal by Subject|1|||
155217633|NCT00423150|560234590|FG000|Overall Study|Adverse Event|11|||
155217634|NCT00423150|560234590|FG000|Overall Study|Progression of disease being studied|69|||
155217635|NCT00423150|560234590|FG000|Overall Study|Withdrawal by Subject|1|||
155217636|NCT00423150|560234590|FG000|Overall Study|Non-compliance with protocol|1|||
155217637|NCT00423150|560234590|FG000|Overall Study|Administrative|4|||
155217638|NCT02951156|560234591|FG000|Overall Study|Death|3|||
155217639|NCT02951156|560234592|FG001|Overall Study|Death|8|||
155217640|NCT02951156|560234593|FG002|Overall Study|Death|5|||
155217641|NCT02951156|560234591|FG000|Overall Study|Progressive disease|1|||
155217642|NCT02951156|560234592|FG001|Overall Study|Progressive disease|0|||
155217643|NCT02951156|560234593|FG002|Overall Study|Progressive disease|1|||
155217644|NCT02951156|560234591|FG000|Overall Study|Withdrawal by Subject|0|||
155217645|NCT02951156|560234592|FG001|Overall Study|Withdrawal by Subject|0|||
155217646|NCT02951156|560234593|FG002|Overall Study|Withdrawal by Subject|1|||
155217647|NCT02951156|560234591|FG000|Overall Study|Study terminated by sponsor|0|||
155217648|NCT02951156|560234592|FG001|Overall Study|Study terminated by sponsor|0|||
155217649|NCT02951156|560234593|FG002|Overall Study|Study terminated by sponsor|1|||
155217650|NCT02951156|560234591|FG000|Overall Study|Other|5|||
155217651|NCT02951156|560234592|FG001|Overall Study|Other|1|||
155217652|NCT02951156|560234593|FG002|Overall Study|Other|2|||
155217653|NCT03519347|560234594|FG000|Interventional Crossover Period 1|Death|0|||
155217654|NCT03519347|560234595|FG001|Interventional Crossover Period 1|Death|0|||
155217655|NCT03519347|560234596|FG002|Interventional Crossover Period 1|Death|0|||
155217656|NCT03519347|560234597|FG003|Interventional Crossover Period 1|Death|1|||
155217657|NCT01092182|560234598|FG000|Overall Study|Death|0|||
155217658|NCT01092182|560234599|FG001|Overall Study|Death|5|||
155217659|NCT01092182|560234600|FG002|Overall Study|Death|3|||
155217660|NCT01092182|560234598|FG000|Overall Study|participant safety|1|||
155217661|NCT01092182|560234599|FG001|Overall Study|participant safety|2|||
155217662|NCT01092182|560234600|FG002|Overall Study|participant safety|0|||
155217663|NCT01092182|560234598|FG000|Overall Study|Physician Decision|0|||
155217664|NCT01092182|560234599|FG001|Overall Study|Physician Decision|6|||
155217665|NCT01092182|560234600|FG002|Overall Study|Physician Decision|0|||
155217666|NCT01092182|560234598|FG000|Overall Study|Did not meet criteria|0|||
155217667|NCT01092182|560234599|FG001|Overall Study|Did not meet criteria|0|||
155217668|NCT01092182|560234600|FG002|Overall Study|Did not meet criteria|25|||
155217669|NCT01092182|560234598|FG000|Overall Study|Non-compliance|0|||
155217670|NCT01092182|560234599|FG001|Overall Study|Non-compliance|3|||
155217671|NCT01092182|560234600|FG002|Overall Study|Non-compliance|0|||
155217672|NCT01092182|560234598|FG000|Overall Study|Participant refused follow-up|0|||
155217673|NCT01092182|560234599|FG001|Overall Study|Participant refused follow-up|2|||
155217674|NCT01092182|560234600|FG002|Overall Study|Participant refused follow-up|0|||
155217675|NCT02515045|560234601|FG000|Overall Study|Adverse Event|0|||
155217676|NCT02515045|560234602|FG001|Overall Study|Adverse Event|3|||
155217677|NCT02515045|560234603|FG002|Overall Study|Adverse Event|3|||
155217678|NCT02515045|560234601|FG000|Overall Study|Lost to Follow-up|0|||
155217679|NCT02515045|560234602|FG001|Overall Study|Lost to Follow-up|1|||
155217680|NCT02515045|560234603|FG002|Overall Study|Lost to Follow-up|1|||
155217681|NCT01474876|560234607|FG000|Overall Study|Adverse Event|11|||
155217682|NCT01474876|560234608|FG001|Overall Study|Adverse Event|5|||
155217683|NCT01474876|560234609|FG002|Overall Study|Adverse Event|0|||
155217684|NCT01474876|560234607|FG000|Overall Study|Serious Adverse Event|2|||
155217685|NCT01474876|560234608|FG001|Overall Study|Serious Adverse Event|3|||
155217686|NCT01474876|560234609|FG002|Overall Study|Serious Adverse Event|0|||
155217687|NCT01474876|560234607|FG000|Overall Study|Lost to Follow-up|5|||
155217688|NCT01474876|560234608|FG001|Overall Study|Lost to Follow-up|4|||
155217689|NCT01474876|560234609|FG002|Overall Study|Lost to Follow-up|0|||
155217690|NCT01474876|560234607|FG000|Overall Study|Investigator's decision|28|||
155217691|NCT01474876|560234608|FG001|Overall Study|Investigator's decision|6|||
155217692|NCT01474876|560234609|FG002|Overall Study|Investigator's decision|0|||
155217693|NCT01474876|560234607|FG000|Overall Study|Patient's request|19|||
155217694|NCT01474876|560234608|FG001|Overall Study|Patient's request|5|||
155217695|NCT01474876|560234609|FG002|Overall Study|Patient's request|0|||
155217696|NCT01474876|560234607|FG000|Overall Study|Investigator's decision and pt request|1|||
155217697|NCT01474876|560234608|FG001|Overall Study|Investigator's decision and pt request|0|||
155217698|NCT01474876|560234609|FG002|Overall Study|Investigator's decision and pt request|0|||
155217699|NCT02291055|560234610|FG000|Overall Study|Death|2|||
155217700|NCT02291055|560234611|FG001|Overall Study|Death|2|||
155217701|NCT02291055|560234612|FG002|Overall Study|Death|5|||
155217702|NCT02291055|560234613|FG003|Overall Study|Death|8|||
155217703|NCT02291055|560234614|FG004|Overall Study|Death|12|||
155217704|NCT02291055|560234610|FG000|Overall Study|Lost to Follow-up|0|||
155217705|NCT02291055|560234611|FG001|Overall Study|Lost to Follow-up|0|||
155217706|NCT02291055|560234612|FG002|Overall Study|Lost to Follow-up|0|||
155217707|NCT02291055|560234613|FG003|Overall Study|Lost to Follow-up|1|||
155217708|NCT02291055|560234614|FG004|Overall Study|Lost to Follow-up|2|||
155217709|NCT02291055|560234610|FG000|Overall Study|Withdrawal by Subject|3|||
155217710|NCT02291055|560234611|FG001|Overall Study|Withdrawal by Subject|1|||
155217711|NCT02291055|560234612|FG002|Overall Study|Withdrawal by Subject|1|||
155217712|NCT02291055|560234613|FG003|Overall Study|Withdrawal by Subject|5|||
155217713|NCT02291055|560234614|FG004|Overall Study|Withdrawal by Subject|10|||
155217714|NCT02291055|560234610|FG000|Overall Study|Progressive Disease|0|||
155217715|NCT02291055|560234611|FG001|Overall Study|Progressive Disease|0|||
155217716|NCT02291055|560234612|FG002|Overall Study|Progressive Disease|1|||
155217717|NCT02291055|560234613|FG003|Overall Study|Progressive Disease|4|||
155217718|NCT02291055|560234614|FG004|Overall Study|Progressive Disease|2|||
155217719|NCT02291055|560234610|FG000|Overall Study|Study Terminated by Sponsor|0|||
155217720|NCT02291055|560234611|FG001|Overall Study|Study Terminated by Sponsor|0|||
155217721|NCT02291055|560234612|FG002|Overall Study|Study Terminated by Sponsor|0|||
155217722|NCT02291055|560234613|FG003|Overall Study|Study Terminated by Sponsor|5|||
155217723|NCT02291055|560234614|FG004|Overall Study|Study Terminated by Sponsor|1|||
155217724|NCT02291055|560234610|FG000|Overall Study|Other|0|||
155217725|NCT02291055|560234611|FG001|Overall Study|Other|2|||
155217726|NCT02291055|560234612|FG002|Overall Study|Other|1|||
155217727|NCT02291055|560234613|FG003|Overall Study|Other|4|||
155217728|NCT02291055|560234614|FG004|Overall Study|Other|0|||
155217729|NCT01523886|560234617|FG000|Overall Study|surgery cancelled|0|||
155217730|NCT01523886|560234618|FG001|Overall Study|surgery cancelled|1|||
155217731|NCT03333044|560234622|FG000|Overall Study|Pregnancy|1|||
155217732|NCT03333044|560234623|FG001|Overall Study|Pregnancy|0|||
155217733|NCT03333044|560234624|FG002|Overall Study|Pregnancy|0|||
155217734|NCT03333044|560234622|FG000|Overall Study|Lost to Follow-up|0|||
155217735|NCT03333044|560234623|FG001|Overall Study|Lost to Follow-up|14|||
155217736|NCT03333044|560234624|FG002|Overall Study|Lost to Follow-up|6|||
155217737|NCT02921776|560234625|FG000|Overall Study|patient deterioration, fatigue|2|||
155217738|NCT02921776|560234626|FG001|Overall Study|patient deterioration, fatigue|6|||
155217739|NCT02921776|560234627|FG002|Overall Study|patient deterioration, fatigue|0|||
155217740|NCT02921776|560234628|FG003|Overall Study|patient deterioration, fatigue|0|||
155217741|NCT02921776|560234629|FG004|Overall Study|patient deterioration, fatigue|0|||
155217742|NCT02921776|560234630|FG005|Overall Study|patient deterioration, fatigue|0|||
155217743|NCT02921776|560234631|FG006|Overall Study|patient deterioration, fatigue|0|||
155217744|NCT02921776|560234632|FG007|Overall Study|patient deterioration, fatigue|0|||
155217745|NCT02921776|560234625|FG000|Overall Study|Withdrawal by Subject|0|||
155217746|NCT02921776|560234626|FG001|Overall Study|Withdrawal by Subject|2|||
155217747|NCT02921776|560234627|FG002|Overall Study|Withdrawal by Subject|0|||
155217748|NCT02921776|560234628|FG003|Overall Study|Withdrawal by Subject|1|||
155217749|NCT02921776|560234629|FG004|Overall Study|Withdrawal by Subject|1|||
155217750|NCT02921776|560234630|FG005|Overall Study|Withdrawal by Subject|0|||
155217751|NCT02921776|560234631|FG006|Overall Study|Withdrawal by Subject|8|||
155217752|NCT02921776|560234632|FG007|Overall Study|Withdrawal by Subject|1|||
155217753|NCT02921776|560234625|FG000|Overall Study|Death|0|||
155217754|NCT02921776|560234626|FG001|Overall Study|Death|0|||
155217755|NCT02921776|560234627|FG002|Overall Study|Death|0|||
155217756|NCT02921776|560234628|FG003|Overall Study|Death|2|||
155217757|NCT02921776|560234629|FG004|Overall Study|Death|0|||
155217758|NCT02921776|560234630|FG005|Overall Study|Death|0|||
155217759|NCT02921776|560234631|FG006|Overall Study|Death|0|||
155217760|NCT02921776|560234632|FG007|Overall Study|Death|0|||
155217761|NCT02921776|560234625|FG000|Overall Study|extubation or early discharge|0|||
155217762|NCT02921776|560234626|FG001|Overall Study|extubation or early discharge|0|||
155217763|NCT02921776|560234627|FG002|Overall Study|extubation or early discharge|0|||
155217764|NCT02921776|560234628|FG003|Overall Study|extubation or early discharge|5|||
155217765|NCT02921776|560234629|FG004|Overall Study|extubation or early discharge|5|||
155217766|NCT02921776|560234630|FG005|Overall Study|extubation or early discharge|0|||
155217767|NCT02921776|560234631|FG006|Overall Study|extubation or early discharge|0|||
155217768|NCT02921776|560234632|FG007|Overall Study|extubation or early discharge|0|||
155217769|NCT02921776|560234625|FG000|Overall Study|Lost to Follow-up|0|||
155217770|NCT02921776|560234626|FG001|Overall Study|Lost to Follow-up|0|||
155217771|NCT02921776|560234627|FG002|Overall Study|Lost to Follow-up|0|||
155217772|NCT02921776|560234628|FG003|Overall Study|Lost to Follow-up|0|||
155217773|NCT02921776|560234629|FG004|Overall Study|Lost to Follow-up|0|||
155217774|NCT02921776|560234630|FG005|Overall Study|Lost to Follow-up|2|||
155217775|NCT02921776|560234631|FG006|Overall Study|Lost to Follow-up|3|||
155217776|NCT02921776|560234632|FG007|Overall Study|Lost to Follow-up|6|||
155217777|NCT04537234|560234634|FG000|Overall Study|Withdrawal by Subject|2|||
155217778|NCT04537234|560234635|FG001|Overall Study|Withdrawal by Subject|0|||
155217779|NCT02070744|560234636|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217780|NCT02070744|560234637|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217781|NCT02070744|560234638|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217782|NCT02070744|560234639|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
155217783|NCT02070744|560234640|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217784|NCT02070744|560234636|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217785|NCT02070744|560234637|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217786|NCT02070744|560234638|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217787|NCT02070744|560234639|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217788|NCT02070744|560234640|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
155217789|NCT02070744|560234636|FG000|OLE Phase (48 Weeks)|Other|0|||
155217790|NCT02070744|560234637|FG001|OLE Phase (48 Weeks)|Other|0|||
155217791|NCT02070744|560234638|FG002|OLE Phase (48 Weeks)|Other|0|||
155217792|NCT02070744|560234639|FG003|OLE Phase (48 Weeks)|Other|0|||
155217793|NCT02070744|560234640|FG004|OLE Phase (48 Weeks)|Other|1|||
155217794|NCT07114198|560234641|FG000|Overall Study|Protocol Violation|1|||
155217795|NCT07114198|560234642|FG001|Overall Study|Protocol Violation|1|||
155217796|NCT04318080|560236778|FG000|Overall Study|Study closed by sponsor|10|||
155217797|NCT04318080|560236779|FG001|Overall Study|Study closed by sponsor|22|||
155217798|NCT04318080|560236778|FG000|Overall Study|Death|3|||
155217799|NCT04318080|560236779|FG001|Overall Study|Death|9|||
155217800|NCT04318080|560236778|FG000|Overall Study|Withdrawal by Subject|1|||
155217801|NCT04318080|560236779|FG001|Overall Study|Withdrawal by Subject|0|||
155217802|NCT04318080|560236778|FG000|Overall Study|Protocol Deviation|1|||
155217803|NCT04318080|560236779|FG001|Overall Study|Protocol Deviation|0|||
155217804|NCT06308822|560236780|FG000|Overall Study|Mutation Status Not Confirmed|17|||
155217805|NCT06308822|560236780|FG000|Overall Study|Adverse Event|1|||
155217806|NCT06308822|560236780|FG000|Overall Study|Death|5|||
155217807|NCT06308822|560236780|FG000|Overall Study|Disease progression|8|||
155217808|NCT06308822|560236780|FG000|Overall Study|Withdrawal by Subject|1|||
155217809|NCT06308822|560236780|FG000|Overall Study|Physician Decision|3|||
155217810|NCT02926924|560236781|FG000|Overall Study|withdrawal - reason unknown|0|||
155217811|NCT02926924|560236782|FG001|Overall Study|withdrawal - reason unknown|1|||
155217812|NCT04734652|560236793|FG000|Overall Study|Withdrawal by Subject|2|||
155217813|NCT04734652|560236794|FG001|Overall Study|Withdrawal by Subject|0|||
155217814|NCT04734652|560236793|FG000|Overall Study|Death|0|||
155217815|NCT04734652|560236794|FG001|Overall Study|Death|1|||
155217816|NCT01921179|560236795|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
155217817|NCT01921179|560236796|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
155217818|NCT01921179|560236795|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
155217819|NCT01921179|560236796|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
155217820|NCT02356783|560236797|FG000|Overall Study|Lost to Follow-up|1|||
155217821|NCT02356783|560236798|FG001|Overall Study|Lost to Follow-up|3|||
155217822|NCT02603809|560236799|FG000|Overall Study|Withdrawal by Subject|4|||
155217823|NCT02603809|560236800|FG001|Overall Study|Withdrawal by Subject|1|||
155217824|NCT02603809|560236801|FG002|Overall Study|Withdrawal by Subject|2|||
155217825|NCT02603809|560236802|FG003|Overall Study|Withdrawal by Subject|3|||
155217826|NCT02603809|560236803|FG004|Overall Study|Withdrawal by Subject|3|||
155217827|NCT02603809|560236804|FG005|Overall Study|Withdrawal by Subject|4|||
155217828|NCT02603809|560236799|FG000|Overall Study|Lost to Follow-up|2|||
155217829|NCT02603809|560236800|FG001|Overall Study|Lost to Follow-up|3|||
155217830|NCT02603809|560236801|FG002|Overall Study|Lost to Follow-up|1|||
155217831|NCT02603809|560236802|FG003|Overall Study|Lost to Follow-up|4|||
155217832|NCT02603809|560236803|FG004|Overall Study|Lost to Follow-up|2|||
155217833|NCT02603809|560236804|FG005|Overall Study|Lost to Follow-up|2|||
155217834|NCT02603809|560236799|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
155217835|NCT02603809|560236800|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
155217836|NCT02603809|560236801|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
155217837|NCT02603809|560236802|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
155217838|NCT02603809|560236803|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
155217839|NCT02603809|560236804|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
155217840|NCT02603809|560236799|FG000|Overall Study|Physician Decision|0|||
155217841|NCT02603809|560236800|FG001|Overall Study|Physician Decision|0|||
155217842|NCT02603809|560236801|FG002|Overall Study|Physician Decision|0|||
155217843|NCT02603809|560236802|FG003|Overall Study|Physician Decision|1|||
155217844|NCT02603809|560236803|FG004|Overall Study|Physician Decision|2|||
155217845|NCT02603809|560236804|FG005|Overall Study|Physician Decision|1|||
155217846|NCT02603809|560236799|FG000|Overall Study|Adverse Event|3|||
155217847|NCT02603809|560236800|FG001|Overall Study|Adverse Event|0|||
155217848|NCT02603809|560236801|FG002|Overall Study|Adverse Event|2|||
155217849|NCT02603809|560236802|FG003|Overall Study|Adverse Event|2|||
155217850|NCT02603809|560236803|FG004|Overall Study|Adverse Event|1|||
155217851|NCT02603809|560236804|FG005|Overall Study|Adverse Event|1|||
155217852|NCT02603809|560236799|FG000|Overall Study|Lack of Efficacy|0|||
155217853|NCT02603809|560236800|FG001|Overall Study|Lack of Efficacy|1|||
155217854|NCT02603809|560236801|FG002|Overall Study|Lack of Efficacy|0|||
155217855|NCT02603809|560236802|FG003|Overall Study|Lack of Efficacy|0|||
155217856|NCT02603809|560236803|FG004|Overall Study|Lack of Efficacy|0|||
155217857|NCT02603809|560236804|FG005|Overall Study|Lack of Efficacy|1|||
155217858|NCT04146545|560236805|FG000|Overall Study|deemed ineligible after randomization|1|||
155217859|NCT04146545|560236806|FG001|Overall Study|deemed ineligible after randomization|0|||
155217860|NCT00112502|560236807|FG000|Overall Study|Withdrawal by Subject|0|||
155217861|NCT00112502|560236808|FG001|Overall Study|Withdrawal by Subject|1|||
155217862|NCT00112502|560236809|FG002|Overall Study|Withdrawal by Subject|1|||
155217863|NCT00112502|560236810|FG003|Overall Study|Withdrawal by Subject|4|||
155217864|NCT00112502|560236811|FG004|Overall Study|Withdrawal by Subject|2|||
155217865|NCT00112502|560236812|FG005|Overall Study|Withdrawal by Subject|5|||
155217866|NCT00112502|560236813|FG006|Overall Study|Withdrawal by Subject|3|||
155217867|NCT00112502|560236814|FG007|Overall Study|Withdrawal by Subject|7|||
155217868|NCT00265343|560236815|FG000|Overall Study|Adverse Event|10|||
155217869|NCT00265343|560236816|FG001|Overall Study|Adverse Event|7|||
155217870|NCT00265343|560236815|FG000|Overall Study|Withdrawal by Subject|3|||
155217871|NCT00265343|560236816|FG001|Overall Study|Withdrawal by Subject|9|||
155217872|NCT00265343|560236815|FG000|Overall Study|Other|8|||
155217873|NCT00265343|560236816|FG001|Overall Study|Other|3|||
155217874|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
155217875|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217876|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217877|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217878|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217879|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217880|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217881|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217882|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217883|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217884|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
155217885|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217886|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217887|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217888|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217889|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217890|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217891|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217892|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
155217893|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
155217894|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
155217895|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
155217896|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
155217897|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
155217898|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
155217899|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
155217900|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
155217901|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
155217902|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217903|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217904|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217905|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217906|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217907|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217908|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217909|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217910|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217911|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217912|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217913|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217914|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217915|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
155217916|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217917|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217918|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217919|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217920|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217921|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217922|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
155217923|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
155217924|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217925|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217926|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217927|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217928|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217929|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217930|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217931|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
155217932|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
155217933|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
155217934|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217935|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217936|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217937|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217938|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217939|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217940|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217941|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
155217942|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
155217943|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217944|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217945|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217946|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217947|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217948|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217949|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217950|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217951|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
155217952|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217953|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217954|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217955|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217956|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217957|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217958|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217959|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217960|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217961|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217962|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
155217963|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217964|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217965|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217966|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217967|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217968|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217969|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217970|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
155217971|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217972|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
155217973|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217974|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217975|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217976|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217977|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217978|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217979|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
155217980|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217981|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
155217982|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217983|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217984|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217985|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217986|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217987|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217988|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
155217989|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
155217990|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
155217991|NCT01217060|560236830|FG000|Overall Study|Withdrawal by Subject|1|||
155217992|NCT01998633|560236848|FG000|Overall Study|Death|1|||
155217993|NCT00413192|560236849|FG000|Overall Study|Disease progression|26|||
155217994|NCT00413192|560236850|FG001|Overall Study|Disease progression|31|||
155217995|NCT00413192|560236851|FG002|Overall Study|Disease progression|16|||
155217996|NCT00413192|560236852|FG003|Overall Study|Disease progression|25|||
155217997|NCT00413192|560236849|FG000|Overall Study|Toxicity|3|||
155217998|NCT00413192|560236850|FG001|Overall Study|Toxicity|2|||
155217999|NCT00413192|560236851|FG002|Overall Study|Toxicity|2|||
155218000|NCT00413192|560236852|FG003|Overall Study|Toxicity|2|||
155218001|NCT00413192|560236849|FG000|Overall Study|Withdrawal by Subject|3|||
155218002|NCT00413192|560236850|FG001|Overall Study|Withdrawal by Subject|5|||
155218003|NCT00413192|560236851|FG002|Overall Study|Withdrawal by Subject|0|||
155218004|NCT00413192|560236852|FG003|Overall Study|Withdrawal by Subject|1|||
155218005|NCT00413192|560236849|FG000|Overall Study|Intercurrent illness|0|||
155218006|NCT00413192|560236850|FG001|Overall Study|Intercurrent illness|0|||
155218007|NCT00413192|560236851|FG002|Overall Study|Intercurrent illness|0|||
155218008|NCT00413192|560236852|FG003|Overall Study|Intercurrent illness|1|||
155218009|NCT00413192|560236849|FG000|Overall Study|Intercurrent death|0|||
155218010|NCT00413192|560236850|FG001|Overall Study|Intercurrent death|1|||
155218011|NCT00413192|560236851|FG002|Overall Study|Intercurrent death|0|||
155218012|NCT00413192|560236852|FG003|Overall Study|Intercurrent death|0|||
155218013|NCT00413192|560236849|FG000|Overall Study|Other|5|||
155218014|NCT00413192|560236850|FG001|Overall Study|Other|1|||
155218015|NCT00413192|560236851|FG002|Overall Study|Other|1|||
155218016|NCT00413192|560236852|FG003|Overall Study|Other|2|||
155218017|NCT00413192|560236849|FG000|Overall Study|Not treated|0|||
155218018|NCT00413192|560236850|FG001|Overall Study|Not treated|0|||
155218019|NCT00413192|560236851|FG002|Overall Study|Not treated|0|||
155218020|NCT00413192|560236852|FG003|Overall Study|Not treated|1|||
155218021|NCT03814746|560236853|FG000|Overall Study|Participant decision|9|||
155218022|NCT03814746|560236854|FG001|Overall Study|Participant decision|6|||
155218023|NCT03814746|560236855|FG002|Overall Study|Participant decision|15|||
155218024|NCT03814746|560236853|FG000|Overall Study|Physician Decision|2|||
155218025|NCT03814746|560236854|FG001|Overall Study|Physician Decision|2|||
155218026|NCT03814746|560236855|FG002|Overall Study|Physician Decision|4|||
155218027|NCT03814746|560236853|FG000|Overall Study|Death|2|||
155218028|NCT03814746|560236854|FG001|Overall Study|Death|2|||
155218029|NCT03814746|560236855|FG002|Overall Study|Death|2|||
155218030|NCT03814746|560236853|FG000|Overall Study|Adverse Event|2|||
155218031|NCT03814746|560236854|FG001|Overall Study|Adverse Event|2|||
155218032|NCT03814746|560236855|FG002|Overall Study|Adverse Event|1|||
155218033|NCT03814746|560236853|FG000|Overall Study|Lost to Follow-up|2|||
155218034|NCT03814746|560236854|FG001|Overall Study|Lost to Follow-up|1|||
155218035|NCT03814746|560236855|FG002|Overall Study|Lost to Follow-up|2|||
155218036|NCT03814746|560236853|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155218037|NCT03814746|560236854|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155218038|NCT03814746|560236855|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155218039|NCT03814746|560236853|FG000|Overall Study|Pregnancy|0|||
155218040|NCT03814746|560236854|FG001|Overall Study|Pregnancy|1|||
155218041|NCT03814746|560236855|FG002|Overall Study|Pregnancy|1|||
155218042|NCT03814746|560236853|FG000|Overall Study|Protocol Violation|1|||
155218043|NCT03814746|560236854|FG001|Overall Study|Protocol Violation|0|||
155218044|NCT03814746|560236855|FG002|Overall Study|Protocol Violation|0|||
155218045|NCT05089682|560236856|FG000|Overall Study|Withdrawal by Subject|2|||
155218046|NCT03992781|560236857|FG000|Overall Study|Lost to Follow-up|5|||
155218047|NCT03992781|560236857|FG000|Overall Study|Adverse Event|1|||
155218048|NCT03992781|560236857|FG000|Overall Study|Lack of Efficacy|5|||
155218049|NCT01996826|560236858|FG000|Overall Study|Lost to Follow-up|6|||
155218050|NCT01996826|560236859|FG001|Overall Study|Lost to Follow-up|2|||
155218051|NCT01996826|560236858|FG000|Overall Study|Physician Decision|1|||
155218052|NCT01996826|560236859|FG001|Overall Study|Physician Decision|1|||
155218053|NCT00695396|560236860|FG000|Overall Study|Study Closed Prematurely|5|||
155218054|NCT00695396|560236861|FG001|Overall Study|Study Closed Prematurely|6|||
155218055|NCT00695396|560236862|FG002|Overall Study|Study Closed Prematurely|8|||
155218056|NCT00695396|560236860|FG000|Overall Study|Withdrawal by Subject|2|||
155218057|NCT00695396|560236861|FG001|Overall Study|Withdrawal by Subject|2|||
155218058|NCT00695396|560236862|FG002|Overall Study|Withdrawal by Subject|0|||
155218059|NCT00518323|560236864|FG000|Overall Study|Lack of Efficacy|14|||
155218060|NCT00518323|560236865|FG001|Overall Study|Lack of Efficacy|2|||
155218061|NCT00518323|560236866|FG002|Overall Study|Lack of Efficacy|4|||
155218062|NCT00518323|560236867|FG003|Overall Study|Lack of Efficacy|20|||
155218063|NCT00518323|560236864|FG000|Overall Study|Withdrawal by Subject|1|||
155218064|NCT00518323|560236865|FG001|Overall Study|Withdrawal by Subject|2|||
155218065|NCT00518323|560236866|FG002|Overall Study|Withdrawal by Subject|4|||
155218066|NCT00518323|560236867|FG003|Overall Study|Withdrawal by Subject|2|||
155218067|NCT00518323|560236864|FG000|Overall Study|Lost to Follow-up|0|||
155218068|NCT00518323|560236865|FG001|Overall Study|Lost to Follow-up|2|||
155218069|NCT00518323|560236866|FG002|Overall Study|Lost to Follow-up|1|||
155218070|NCT00518323|560236867|FG003|Overall Study|Lost to Follow-up|3|||
155218071|NCT00518323|560236864|FG000|Overall Study|Adverse Event|1|||
155218072|NCT00518323|560236865|FG001|Overall Study|Adverse Event|1|||
155218073|NCT00518323|560236866|FG002|Overall Study|Adverse Event|1|||
155218074|NCT00518323|560236867|FG003|Overall Study|Adverse Event|0|||
155218075|NCT00518323|560236864|FG000|Overall Study|Prohibited medication and others|3|||
155218076|NCT00518323|560236865|FG001|Overall Study|Prohibited medication and others|1|||
155218077|NCT00518323|560236866|FG002|Overall Study|Prohibited medication and others|1|||
155218078|NCT00518323|560236867|FG003|Overall Study|Prohibited medication and others|0|||
155218079|NCT03164928|560236869|FG000|Overall Study|Lost to Follow-up|1|||
155218080|NCT03164928|560236870|FG001|Overall Study|Lost to Follow-up|0|||
155218081|NCT00772707|560236871|FG000|Overall Study|Withdrawn|3|||
155218082|NCT04499781|560236872|FG000|Overall Study|Lost to Follow-up|2|||
155218083|NCT04499781|560236873|FG001|Overall Study|Lost to Follow-up|3|||
155218084|NCT04499781|560236872|FG000|Overall Study|Withdrawal by Subject|2|||
155218085|NCT04499781|560236873|FG001|Overall Study|Withdrawal by Subject|0|||
155218086|NCT00371254|560236874|FG000|Overall Study|Disease progression|13|||
155218087|NCT00371254|560236875|FG001|Overall Study|Disease progression|13|||
155218088|NCT00371254|560236874|FG000|Overall Study|Study drug toxicity|3|||
155218089|NCT00371254|560236875|FG001|Overall Study|Study drug toxicity|5|||
155218090|NCT00371254|560236874|FG000|Overall Study|Subject request|5|||
155218091|NCT00371254|560236875|FG001|Overall Study|Subject request|0|||
155218092|NCT00371254|560236874|FG000|Overall Study|Investigator Decision|2|||
155218093|NCT00371254|560236875|FG001|Overall Study|Investigator Decision|0|||
155218094|NCT00371254|560236874|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155218095|NCT00371254|560236875|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155218096|NCT00371254|560236874|FG000|Overall Study|Lost to Follow-up|0|||
155218097|NCT00371254|560236875|FG001|Overall Study|Lost to Follow-up|1|||
155218098|NCT00371254|560236874|FG000|Overall Study|Withdrawal by Subject|0|||
155218099|NCT00371254|560236875|FG001|Overall Study|Withdrawal by Subject|1|||
155218100|NCT03329690|560236876|FG000|Overall Study|Progressive disease per RECIST|85|||
155218101|NCT03329690|560236877|FG001|Overall Study|Progressive disease per RECIST|44|||
155218102|NCT03329690|560236878|FG002|Overall Study|Progressive disease per RECIST|6|||
155218103|NCT03329690|560236879|FG003|Overall Study|Progressive disease per RECIST|16|||
155218104|NCT03329690|560236880|FG004|Overall Study|Progressive disease per RECIST|20|||
155218105|NCT03329690|560236876|FG000|Overall Study|Clinical progression|7|||
155218106|NCT03329690|560236877|FG001|Overall Study|Clinical progression|4|||
155218107|NCT03329690|560236878|FG002|Overall Study|Clinical progression|1|||
155218108|NCT03329690|560236879|FG003|Overall Study|Clinical progression|1|||
155218109|NCT03329690|560236880|FG004|Overall Study|Clinical progression|1|||
155218110|NCT03329690|560236876|FG000|Overall Study|Adverse Event|22|||
155218111|NCT03329690|560236877|FG001|Overall Study|Adverse Event|4|||
155218112|NCT03329690|560236878|FG002|Overall Study|Adverse Event|0|||
155218113|NCT03329690|560236879|FG003|Overall Study|Adverse Event|1|||
155218114|NCT03329690|560236880|FG004|Overall Study|Adverse Event|2|||
155218115|NCT03329690|560236876|FG000|Overall Study|Death|2|||
155218116|NCT03329690|560236877|FG001|Overall Study|Death|0|||
155218117|NCT03329690|560236878|FG002|Overall Study|Death|0|||
155218118|NCT03329690|560236879|FG003|Overall Study|Death|1|||
155218119|NCT03329690|560236880|FG004|Overall Study|Death|0|||
155218120|NCT03329690|560236876|FG000|Overall Study|Withdrawal by Subject|2|||
155218121|NCT03329690|560236877|FG001|Overall Study|Withdrawal by Subject|3|||
155218122|NCT03329690|560236878|FG002|Overall Study|Withdrawal by Subject|0|||
155218123|NCT03329690|560236879|FG003|Overall Study|Withdrawal by Subject|1|||
155218124|NCT03329690|560236880|FG004|Overall Study|Withdrawal by Subject|0|||
155218125|NCT03329690|560236876|FG000|Overall Study|Physician Decision|1|||
155218126|NCT03329690|560236877|FG001|Overall Study|Physician Decision|0|||
155218127|NCT03329690|560236878|FG002|Overall Study|Physician Decision|0|||
155218128|NCT03329690|560236879|FG003|Overall Study|Physician Decision|0|||
155218129|NCT03329690|560236880|FG004|Overall Study|Physician Decision|1|||
155218130|NCT03329690|560236876|FG000|Overall Study|Miscellaneous|6|||
155218131|NCT03329690|560236877|FG001|Overall Study|Miscellaneous|0|||
155218132|NCT03329690|560236878|FG002|Overall Study|Miscellaneous|0|||
155218133|NCT03329690|560236879|FG003|Overall Study|Miscellaneous|0|||
155218134|NCT03329690|560236880|FG004|Overall Study|Miscellaneous|0|||
155218135|NCT03329690|560236876|FG000|Overall Study|Did not receive treatment|1|||
155218136|NCT03329690|560236877|FG001|Overall Study|Did not receive treatment|0|||
155218137|NCT03329690|560236878|FG002|Overall Study|Did not receive treatment|0|||
155218138|NCT03329690|560236879|FG003|Overall Study|Did not receive treatment|1|||
155218139|NCT03329690|560236880|FG004|Overall Study|Did not receive treatment|0|||
155218140|NCT01817725|560236881|FG000|Overall Study|Withdrawal by Subject|1|||
155218141|NCT02337907|560236884|FG000|Overall Study|Other than listed|1|||
155218142|NCT02337907|560236885|FG001|Overall Study|Other than listed|0|||
155218143|NCT02337907|560236886|FG002|Overall Study|Other than listed|0|||
155218144|NCT02337907|560236887|FG003|Overall Study|Other than listed|1|||
155218145|NCT02337907|560236888|FG004|Overall Study|Other than listed|1|||
155218146|NCT02337907|560236889|FG005|Overall Study|Other than listed|0|||
155218147|NCT02337907|560236884|FG000|Overall Study|Withdrawal by Subject|2|||
155218148|NCT02337907|560236885|FG001|Overall Study|Withdrawal by Subject|3|||
155218149|NCT02337907|560236886|FG002|Overall Study|Withdrawal by Subject|0|||
155218150|NCT02337907|560236887|FG003|Overall Study|Withdrawal by Subject|2|||
155218151|NCT02337907|560236888|FG004|Overall Study|Withdrawal by Subject|5|||
155218152|NCT02337907|560236889|FG005|Overall Study|Withdrawal by Subject|0|||
155218153|NCT02337907|560236884|FG000|Overall Study|Lost to Follow-up|0|||
155218154|NCT02337907|560236885|FG001|Overall Study|Lost to Follow-up|0|||
155218155|NCT02337907|560236886|FG002|Overall Study|Lost to Follow-up|0|||
155218156|NCT02337907|560236887|FG003|Overall Study|Lost to Follow-up|0|||
155218157|NCT02337907|560236888|FG004|Overall Study|Lost to Follow-up|0|||
155218158|NCT02337907|560236889|FG005|Overall Study|Lost to Follow-up|1|||
155218159|NCT02337907|560236884|FG000|Overall Study|Adverse Event|1|||
155218160|NCT02337907|560236885|FG001|Overall Study|Adverse Event|1|||
155218161|NCT02337907|560236886|FG002|Overall Study|Adverse Event|1|||
155218162|NCT02337907|560236887|FG003|Overall Study|Adverse Event|1|||
155218163|NCT02337907|560236888|FG004|Overall Study|Adverse Event|4|||
155218164|NCT02337907|560236889|FG005|Overall Study|Adverse Event|0|||
155218165|NCT01679002|560236890|FG000|Overall Study|Adverse Event|1|||
155218166|NCT01679002|560236891|FG001|Overall Study|Adverse Event|1|||
155218167|NCT01679002|560236892|FG002|Overall Study|Adverse Event|0|||
155218168|NCT00613015|560236900|FG000|Overall Study|Lost to Follow-up|0|||
155218169|NCT00613015|560236901|FG001|Overall Study|Lost to Follow-up|1|||
155218170|NCT00613015|560236902|FG002|Overall Study|Lost to Follow-up|3|||
155218171|NCT00613015|560236903|FG003|Overall Study|Lost to Follow-up|3|||
155218172|NCT00613015|560236904|FG004|Overall Study|Lost to Follow-up|2|||
155218173|NCT00613015|560236905|FG005|Overall Study|Lost to Follow-up|3|||
155218174|NCT04327388|560236908|FG000|Overall Study|Adverse Event|17|||
155218175|NCT04327388|560236909|FG001|Overall Study|Adverse Event|18|||
155218176|NCT04327388|560236910|FG002|Overall Study|Adverse Event|9|||
155218177|NCT04327388|560236908|FG000|Overall Study|Other|1|||
155218178|NCT04327388|560236909|FG001|Overall Study|Other|2|||
155218179|NCT04327388|560236910|FG002|Overall Study|Other|0|||
155218180|NCT04327388|560236908|FG000|Overall Study|Randomized and not treated|2|||
155218181|NCT04327388|560236909|FG001|Overall Study|Randomized and not treated|0|||
155218182|NCT04327388|560236910|FG002|Overall Study|Randomized and not treated|2|||
155218183|NCT04829318|560236911|FG000|Overall Study|Adverse Event|6|||
155218184|NCT04829318|560236911|FG000|Overall Study|Death|1|||
155218185|NCT04829318|560236911|FG000|Overall Study|Lost to Follow-up|1|||
155218186|NCT04829318|560236911|FG000|Overall Study|Physician Decision|1|||
155218187|NCT04829318|560236911|FG000|Overall Study|Withdrawal by Subject|19|||
155218188|NCT04829318|560236911|FG000|Overall Study|Site terminated by sponsor|1|||
155218189|NCT04829318|560236911|FG000|Overall Study|Sponsor decision|5|||
155218190|NCT04829318|560236911|FG000|Overall Study|Other|1|||
155218191|NCT00728130|560236912|FG000|Overall Study|Withdrawal by Subject|1|||
155218192|NCT00728130|560236912|FG000|Overall Study|Paperwork not completed in time|1|||
155218193|NCT00728130|560236912|FG000|Overall Study|Physician Decision|1|||
155218194|NCT04053023|560236915|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
155218195|NCT04053023|560236916|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
155218196|NCT00455429|560236920|FG000|Overall Study|Study Terminated by Sponsor|0|||
155218197|NCT00455429|560236921|FG001|Overall Study|Study Terminated by Sponsor|0|||
155218198|NCT00455429|560236922|FG002|Overall Study|Study Terminated by Sponsor|0|||
155218199|NCT00455429|560236923|FG003|Overall Study|Study Terminated by Sponsor|3|||
155218200|NCT00455429|560236920|FG000|Overall Study|Lost to Follow-up|1|||
155218201|NCT00455429|560236921|FG001|Overall Study|Lost to Follow-up|0|||
155218202|NCT00455429|560236922|FG002|Overall Study|Lost to Follow-up|0|||
155218203|NCT00455429|560236923|FG003|Overall Study|Lost to Follow-up|3|||
155218204|NCT00455429|560236920|FG000|Overall Study|Withdrawal by Subject|0|||
155218205|NCT00455429|560236921|FG001|Overall Study|Withdrawal by Subject|1|||
155218206|NCT00455429|560236922|FG002|Overall Study|Withdrawal by Subject|1|||
155218207|NCT00455429|560236923|FG003|Overall Study|Withdrawal by Subject|0|||
155218208|NCT00455429|560236920|FG000|Overall Study|Lack of Efficacy|0|||
155218209|NCT00455429|560236921|FG001|Overall Study|Lack of Efficacy|1|||
155218210|NCT00455429|560236922|FG002|Overall Study|Lack of Efficacy|0|||
155218211|NCT00455429|560236923|FG003|Overall Study|Lack of Efficacy|1|||
155218212|NCT00455429|560236920|FG000|Overall Study|Adverse Event|0|||
155218213|NCT00455429|560236921|FG001|Overall Study|Adverse Event|1|||
155218214|NCT00455429|560236922|FG002|Overall Study|Adverse Event|0|||
155218215|NCT00455429|560236923|FG003|Overall Study|Adverse Event|3|||
155218216|NCT00455429|560236920|FG000|Overall Study|Randomly assigned but not treated|0|||
155218217|NCT00455429|560236921|FG001|Overall Study|Randomly assigned but not treated|0|||
155218218|NCT00455429|560236922|FG002|Overall Study|Randomly assigned but not treated|0|||
155218219|NCT00455429|560236923|FG003|Overall Study|Randomly assigned but not treated|2|||
155218220|NCT00455429|560236920|FG000|Overall Study|Personal Reason|1|||
155218221|NCT00455429|560236921|FG001|Overall Study|Personal Reason|0|||
155218222|NCT00455429|560236922|FG002|Overall Study|Personal Reason|0|||
155218223|NCT00455429|560236923|FG003|Overall Study|Personal Reason|0|||
155218224|NCT00455429|560236920|FG000|Overall Study|Non-compliance|0|||
155218225|NCT00455429|560236921|FG001|Overall Study|Non-compliance|0|||
155218226|NCT00455429|560236922|FG002|Overall Study|Non-compliance|0|||
155218227|NCT00455429|560236923|FG003|Overall Study|Non-compliance|1|||
155218228|NCT00455429|560236920|FG000|Overall Study|Other|0|||
155218229|NCT00455429|560236921|FG001|Overall Study|Other|2|||
155218230|NCT00455429|560236922|FG002|Overall Study|Other|0|||
155218231|NCT00455429|560236923|FG003|Overall Study|Other|1|||
155218232|NCT01412021|560236924|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
155218233|NCT01412021|560236924|FG000|Overall Study|Treatment Prior to Approval|3|||
155218234|NCT01412021|560236924|FG000|Overall Study|Transferred to Other Hospital|9|||
155218235|NCT00238121|560236925|FG000|Overall Study|Withdrawal by Subject|1|||
155218236|NCT00238121|560236926|FG001|Overall Study|Withdrawal by Subject|1|||
155218237|NCT00238121|560236925|FG000|Overall Study|Adverse Event|2|||
155218238|NCT00238121|560236926|FG001|Overall Study|Adverse Event|1|||
155218239|NCT03255382|560236927|FG000|Overall Study|Adverse Event|3|||
155218240|NCT03255382|560236928|FG001|Overall Study|Adverse Event|0|||
155218241|NCT03255382|560236927|FG000|Overall Study|Lost to Follow-up|2|||
155218242|NCT03255382|560236928|FG001|Overall Study|Lost to Follow-up|0|||
155218243|NCT03255382|560236927|FG000|Overall Study|Withdrawal by Subject|2|||
155218244|NCT03255382|560236928|FG001|Overall Study|Withdrawal by Subject|0|||
155218245|NCT03255382|560236927|FG000|Overall Study|Other|6|||
155218246|NCT03255382|560236928|FG001|Overall Study|Other|0|||
155218247|NCT01166178|560236929|FG000|Overall Study|Withdrawal by Subject|1|||
155218248|NCT01166178|560236930|FG001|Overall Study|Withdrawal by Subject|0|||
155218249|NCT01166178|560236929|FG000|Overall Study|Study was terminated|20|||
155218250|NCT01166178|560236930|FG001|Overall Study|Study was terminated|8|||
155218251|NCT00484939|560236931|FG000|Overall Study|Death|9|||
155218252|NCT00484939|560236932|FG001|Overall Study|Death|13|||
155218253|NCT00484939|560236931|FG000|Overall Study|Adverse Event|22|||
155218254|NCT00484939|560236932|FG001|Overall Study|Adverse Event|12|||
155218255|NCT00484939|560236931|FG000|Overall Study|Patient Withdrew Consent|19|||
155218256|NCT00484939|560236932|FG001|Overall Study|Patient Withdrew Consent|10|||
155218257|NCT00484939|560236931|FG000|Overall Study|Protocol Violation|3|||
155218258|NCT00484939|560236932|FG001|Overall Study|Protocol Violation|3|||
155218259|NCT00484939|560236931|FG000|Overall Study|Lost to Follow-up|0|||
155218260|NCT00484939|560236932|FG001|Overall Study|Lost to Follow-up|3|||
155218261|NCT00484939|560236931|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
155218262|NCT00484939|560236932|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
155218263|NCT00484939|560236931|FG000|Overall Study|Disease progression|67|||
155218264|NCT00484939|560236932|FG001|Overall Study|Disease progression|88|||
155218265|NCT00484939|560236931|FG000|Overall Study|Screen Failure|2|||
155218266|NCT00484939|560236932|FG001|Overall Study|Screen Failure|2|||
155218267|NCT00484939|560236931|FG000|Overall Study|Reason Not Specified|11|||
155218268|NCT00484939|560236932|FG001|Overall Study|Reason Not Specified|6|||
155218269|NCT02466555|560236933|FG000|Overall Study|Lost to Follow-up|2|||
155218270|NCT02113956|560236940|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
155218271|NCT02113956|560236941|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
155218272|NCT02113956|560236940|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
155218273|NCT02113956|560236941|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
155218274|NCT02113956|560236940|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
155218275|NCT02113956|560236941|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
155218276|NCT01499563|560236944|FG000|Overall Study|Withdrawal by Subject|10|||
155218277|NCT01499563|560236945|FG001|Overall Study|Withdrawal by Subject|11|||
155218278|NCT01499563|560236946|FG002|Overall Study|Withdrawal by Subject|7|||
155218279|NCT01499563|560236947|FG003|Overall Study|Withdrawal by Subject|8|||
155218280|NCT01499563|560236944|FG000|Overall Study|Physician Decision|2|||
155218281|NCT01499563|560236945|FG001|Overall Study|Physician Decision|1|||
155218282|NCT01499563|560236946|FG002|Overall Study|Physician Decision|3|||
155218283|NCT01499563|560236947|FG003|Overall Study|Physician Decision|0|||
155218284|NCT01499563|560236944|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
155218285|NCT01499563|560236945|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
155218286|NCT01499563|560236946|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
155218287|NCT01499563|560236947|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
155218288|NCT01499563|560236944|FG000|Overall Study|Adverse Event|2|||
155218289|NCT01499563|560236945|FG001|Overall Study|Adverse Event|0|||
155218290|NCT01499563|560236946|FG002|Overall Study|Adverse Event|1|||
155218291|NCT01499563|560236947|FG003|Overall Study|Adverse Event|3|||
155218292|NCT01499563|560236944|FG000|Overall Study|Lack of Efficacy|0|||
155218293|NCT01499563|560236945|FG001|Overall Study|Lack of Efficacy|1|||
155218294|NCT01499563|560236946|FG002|Overall Study|Lack of Efficacy|6|||
155218295|NCT01499563|560236947|FG003|Overall Study|Lack of Efficacy|3|||
155218296|NCT01499563|560236944|FG000|Overall Study|Other|8|||
155218297|NCT01499563|560236945|FG001|Overall Study|Other|6|||
155218298|NCT01499563|560236946|FG002|Overall Study|Other|6|||
155218299|NCT01499563|560236947|FG003|Overall Study|Other|4|||
155218300|NCT01239368|560239468|FG000|Overall Study|Principal investigator discretion|1|||
155218301|NCT01239368|560239469|FG001|Overall Study|Principal investigator discretion|0|||
155218302|NCT01239368|560239470|FG002|Overall Study|Principal investigator discretion|0|||
155218303|NCT01239368|560239471|FG003|Overall Study|Principal investigator discretion|0|||
155218304|NCT01239368|560239472|FG004|Overall Study|Principal investigator discretion|1|||
155218305|NCT01239368|560239473|FG005|Overall Study|Principal investigator discretion|2|||
155218306|NCT01239368|560239474|FG006|Overall Study|Principal investigator discretion|0|||
155218307|NCT01239368|560239475|FG007|Overall Study|Principal investigator discretion|0|||
155218308|NCT01239368|560239476|FG008|Overall Study|Principal investigator discretion|0|||
155218309|NCT01239368|560239477|FG009|Overall Study|Principal investigator discretion|1|||
155218310|NCT01239368|560239468|FG000|Overall Study|Disease progression on study|1|||
155218311|NCT01239368|560239469|FG001|Overall Study|Disease progression on study|1|||
155218312|NCT01239368|560239470|FG002|Overall Study|Disease progression on study|1|||
155218313|NCT01239368|560239471|FG003|Overall Study|Disease progression on study|1|||
155218314|NCT01239368|560239472|FG004|Overall Study|Disease progression on study|4|||
155218315|NCT01239368|560239473|FG005|Overall Study|Disease progression on study|2|||
155218316|NCT01239368|560239474|FG006|Overall Study|Disease progression on study|5|||
155218317|NCT01239368|560239475|FG007|Overall Study|Disease progression on study|0|||
155218318|NCT01239368|560239476|FG008|Overall Study|Disease progression on study|0|||
155218319|NCT01239368|560239477|FG009|Overall Study|Disease progression on study|2|||
155218320|NCT01239368|560239468|FG000|Overall Study|Refused further treatment|0|||
155218321|NCT01239368|560239469|FG001|Overall Study|Refused further treatment|0|||
155218322|NCT01239368|560239470|FG002|Overall Study|Refused further treatment|0|||
155218323|NCT01239368|560239471|FG003|Overall Study|Refused further treatment|0|||
155218324|NCT01239368|560239472|FG004|Overall Study|Refused further treatment|0|||
155218325|NCT01239368|560239473|FG005|Overall Study|Refused further treatment|0|||
155218326|NCT01239368|560239474|FG006|Overall Study|Refused further treatment|0|||
155218327|NCT01239368|560239475|FG007|Overall Study|Refused further treatment|0|||
155218328|NCT01239368|560239476|FG008|Overall Study|Refused further treatment|0|||
155218329|NCT01239368|560239477|FG009|Overall Study|Refused further treatment|1|||
155218330|NCT01239368|560239468|FG000|Overall Study|Death|0|||
155218331|NCT01239368|560239469|FG001|Overall Study|Death|0|||
155218332|NCT01239368|560239470|FG002|Overall Study|Death|0|||
155218333|NCT01239368|560239471|FG003|Overall Study|Death|0|||
155218334|NCT01239368|560239472|FG004|Overall Study|Death|0|||
155218335|NCT01239368|560239473|FG005|Overall Study|Death|0|||
155218336|NCT01239368|560239474|FG006|Overall Study|Death|1|||
155218337|NCT01239368|560239475|FG007|Overall Study|Death|0|||
155218338|NCT01239368|560239476|FG008|Overall Study|Death|0|||
155218339|NCT01239368|560239477|FG009|Overall Study|Death|0|||
155218340|NCT03181399|560239479|FG000|6 Months on Treatment|Protocol non-compliance|7|||
155218341|NCT03181399|560239479|FG000|6 Months on Treatment|Adverse Event|4|||
155218342|NCT03181399|560239479|FG000|6 Months on Treatment|Tried alternative treatment|2|||
155218343|NCT03181399|560239479|FG000|6 Months on Treatment|Lost to Follow-up|2|||
155218344|NCT03181399|560239479|FG000|6 Months on Treatment|Personal reasons|1|||
155218345|NCT03181399|560239479|FG000|3 Months Off-treatment|Parent unable to travel|1|||
155218346|NCT01536379|560239480|FG000|Overall Study|Adverse Event|1|||
155218347|NCT01536379|560239481|FG001|Overall Study|Adverse Event|2|||
155218348|NCT01536379|560239480|FG000|Overall Study|Withdrawal by Subject|1|||
155218349|NCT01536379|560239481|FG001|Overall Study|Withdrawal by Subject|1|||
155218350|NCT00939809|560239484|FG000|Overall Study|Adverse Event|2|||
155218351|NCT00939809|560239484|FG000|Overall Study|Death|1|||
155218352|NCT00380978|560239485|FG000|Overall Study|Refused allocated intervention|0|||
155218353|NCT00380978|560239486|FG001|Overall Study|Refused allocated intervention|6|||
155218354|NCT00380978|560239485|FG000|Overall Study|Wrong study envelope|0|||
155218355|NCT00380978|560239486|FG001|Overall Study|Wrong study envelope|2|||
155218356|NCT00380978|560239485|FG000|Overall Study|Allocation prior to analgesia request|1|||
155218357|NCT00380978|560239486|FG001|Overall Study|Allocation prior to analgesia request|2|||
155218358|NCT00380978|560239485|FG000|Overall Study|Parous patient|1|||
155218359|NCT00380978|560239486|FG001|Overall Study|Parous patient|0|||
155218360|NCT04729127|560239487|FG000|Overall Study|Suspended/Terminated EI Services|4|||
155218361|NCT04729127|560239488|FG001|Overall Study|Suspended/Terminated EI Services|0|||
155218362|NCT04729127|560239489|FG002|Overall Study|Suspended/Terminated EI Services|4|||
155218363|NCT04729127|560239490|FG003|Overall Study|Suspended/Terminated EI Services|6|||
155218364|NCT04729127|560239491|FG004|Overall Study|Suspended/Terminated EI Services|0|||
155218365|NCT04729127|560239492|FG005|Overall Study|Suspended/Terminated EI Services|6|||
155218366|NCT04729127|560239493|FG006|Overall Study|Suspended/Terminated EI Services|2|||
155218367|NCT04729127|560239494|FG007|Overall Study|Suspended/Terminated EI Services|0|||
155218368|NCT04729127|560239495|FG008|Overall Study|Suspended/Terminated EI Services|2|||
155218369|NCT04729127|560239487|FG000|Overall Study|Withdrawal by Subject|1|||
155218370|NCT04729127|560239488|FG001|Overall Study|Withdrawal by Subject|0|||
155218371|NCT04729127|560239489|FG002|Overall Study|Withdrawal by Subject|1|||
155218372|NCT04729127|560239490|FG003|Overall Study|Withdrawal by Subject|0|||
155218373|NCT04729127|560239491|FG004|Overall Study|Withdrawal by Subject|0|||
155218374|NCT04729127|560239492|FG005|Overall Study|Withdrawal by Subject|0|||
155218375|NCT04729127|560239493|FG006|Overall Study|Withdrawal by Subject|0|||
155218376|NCT04729127|560239494|FG007|Overall Study|Withdrawal by Subject|0|||
155218377|NCT04729127|560239495|FG008|Overall Study|Withdrawal by Subject|0|||
155218378|NCT04729127|560239487|FG000|Overall Study|Switched Agency/Setting|1|||
155218379|NCT04729127|560239488|FG001|Overall Study|Switched Agency/Setting|0|||
155218380|NCT04729127|560239489|FG002|Overall Study|Switched Agency/Setting|1|||
155218381|NCT04729127|560239490|FG003|Overall Study|Switched Agency/Setting|1|||
155218382|NCT04729127|560239491|FG004|Overall Study|Switched Agency/Setting|0|||
155218383|NCT04729127|560239492|FG005|Overall Study|Switched Agency/Setting|1|||
155218384|NCT04729127|560239493|FG006|Overall Study|Switched Agency/Setting|1|||
155218385|NCT04729127|560239494|FG007|Overall Study|Switched Agency/Setting|0|||
155218386|NCT04729127|560239495|FG008|Overall Study|Switched Agency/Setting|1|||
155218387|NCT02608268|560239498|FG000|Overall Study|Adverse Event|0|||
155218388|NCT02608268|560239499|FG001|Overall Study|Adverse Event|0|||
155218389|NCT02608268|560239500|FG002|Overall Study|Adverse Event|1|||
155218390|NCT02608268|560239501|FG003|Overall Study|Adverse Event|0|||
155218391|NCT02608268|560239502|FG004|Overall Study|Adverse Event|0|||
155218392|NCT02608268|560239503|FG005|Overall Study|Adverse Event|0|||
155218393|NCT02608268|560239504|FG006|Overall Study|Adverse Event|0|||
155218394|NCT02608268|560239505|FG007|Overall Study|Adverse Event|0|||
155218395|NCT02608268|560239506|FG008|Overall Study|Adverse Event|0|||
155218396|NCT02608268|560239507|FG009|Overall Study|Adverse Event|0|||
155218397|NCT02608268|560239508|FG010|Overall Study|Adverse Event|0|||
155218398|NCT02608268|560239509|FG011|Overall Study|Adverse Event|0|||
155218399|NCT02608268|560239510|FG012|Overall Study|Adverse Event|2|||
155218400|NCT02608268|560239511|FG013|Overall Study|Adverse Event|0|||
155218401|NCT02608268|560239512|FG014|Overall Study|Adverse Event|0|||
155218402|NCT02608268|560239513|FG015|Overall Study|Adverse Event|0|||
155218403|NCT02608268|560239514|FG016|Overall Study|Adverse Event|0|||
155218404|NCT02608268|560239515|FG017|Overall Study|Adverse Event|0|||
155218405|NCT02608268|560239516|FG018|Overall Study|Adverse Event|0|||
155218406|NCT02608268|560239517|FG019|Overall Study|Adverse Event|0|||
155218407|NCT02608268|560239518|FG020|Overall Study|Adverse Event|1|||
155218408|NCT02608268|560239519|FG021|Overall Study|Adverse Event|1|||
155218409|NCT02608268|560239520|FG022|Overall Study|Adverse Event|0|||
155218410|NCT02608268|560239521|FG023|Overall Study|Adverse Event|0|||
155218411|NCT02608268|560239522|FG024|Overall Study|Adverse Event|1|||
155218412|NCT02608268|560239523|FG025|Overall Study|Adverse Event|0|||
155218413|NCT02608268|560239524|FG026|Overall Study|Adverse Event|0|||
155218414|NCT02608268|560239525|FG027|Overall Study|Adverse Event|0|||
155218415|NCT02608268|560239526|FG028|Overall Study|Adverse Event|1|||
155218416|NCT02608268|560239527|FG029|Overall Study|Adverse Event|0|||
155218417|NCT02608268|560239498|FG000|Overall Study|Death|1|||
155218418|NCT02608268|560239499|FG001|Overall Study|Death|0|||
155218419|NCT02608268|560239500|FG002|Overall Study|Death|0|||
155218420|NCT02608268|560239501|FG003|Overall Study|Death|0|||
155218421|NCT02608268|560239502|FG004|Overall Study|Death|0|||
155218422|NCT02608268|560239503|FG005|Overall Study|Death|0|||
155218423|NCT02608268|560239504|FG006|Overall Study|Death|0|||
155218424|NCT02608268|560239505|FG007|Overall Study|Death|0|||
155218425|NCT02608268|560239506|FG008|Overall Study|Death|1|||
155218426|NCT02608268|560239507|FG009|Overall Study|Death|1|||
155218427|NCT02608268|560239508|FG010|Overall Study|Death|0|||
155218428|NCT02608268|560239509|FG011|Overall Study|Death|0|||
155218429|NCT02608268|560239510|FG012|Overall Study|Death|0|||
155218430|NCT02608268|560239511|FG013|Overall Study|Death|0|||
155218431|NCT02608268|560239512|FG014|Overall Study|Death|0|||
155218432|NCT02608268|560239513|FG015|Overall Study|Death|1|||
155218433|NCT02608268|560239514|FG016|Overall Study|Death|0|||
155218434|NCT02608268|560239515|FG017|Overall Study|Death|1|||
155218435|NCT02608268|560239516|FG018|Overall Study|Death|0|||
155218436|NCT02608268|560239517|FG019|Overall Study|Death|1|||
155218437|NCT02608268|560239518|FG020|Overall Study|Death|1|||
155218438|NCT02608268|560239519|FG021|Overall Study|Death|0|||
155218439|NCT02608268|560239520|FG022|Overall Study|Death|0|||
155218440|NCT02608268|560239521|FG023|Overall Study|Death|0|||
155218441|NCT02608268|560239522|FG024|Overall Study|Death|1|||
155218442|NCT02608268|560239523|FG025|Overall Study|Death|2|||
155218443|NCT02608268|560239524|FG026|Overall Study|Death|0|||
155218444|NCT02608268|560239525|FG027|Overall Study|Death|1|||
155218445|NCT02608268|560239526|FG028|Overall Study|Death|4|||
155218446|NCT02608268|560239527|FG029|Overall Study|Death|0|||
155218447|NCT02608268|560239498|FG000|Overall Study|Physician Decision|0|||
155218448|NCT02608268|560239499|FG001|Overall Study|Physician Decision|0|||
155218449|NCT02608268|560239500|FG002|Overall Study|Physician Decision|0|||
155218450|NCT02608268|560239501|FG003|Overall Study|Physician Decision|0|||
155218451|NCT02608268|560239502|FG004|Overall Study|Physician Decision|0|||
155218452|NCT02608268|560239503|FG005|Overall Study|Physician Decision|0|||
155218453|NCT02608268|560239504|FG006|Overall Study|Physician Decision|0|||
155218454|NCT02608268|560239505|FG007|Overall Study|Physician Decision|0|||
155218455|NCT02608268|560239506|FG008|Overall Study|Physician Decision|0|||
155218456|NCT02608268|560239507|FG009|Overall Study|Physician Decision|0|||
155218457|NCT02608268|560239508|FG010|Overall Study|Physician Decision|1|||
155218458|NCT02608268|560239509|FG011|Overall Study|Physician Decision|0|||
155218459|NCT02608268|560239510|FG012|Overall Study|Physician Decision|0|||
155218460|NCT02608268|560239511|FG013|Overall Study|Physician Decision|1|||
155218461|NCT02608268|560239512|FG014|Overall Study|Physician Decision|0|||
155218462|NCT02608268|560239513|FG015|Overall Study|Physician Decision|0|||
155218463|NCT02608268|560239514|FG016|Overall Study|Physician Decision|0|||
155218464|NCT02608268|560239515|FG017|Overall Study|Physician Decision|0|||
155218465|NCT02608268|560239516|FG018|Overall Study|Physician Decision|0|||
155218466|NCT02608268|560239517|FG019|Overall Study|Physician Decision|0|||
155218467|NCT02608268|560239518|FG020|Overall Study|Physician Decision|0|||
155218468|NCT02608268|560239519|FG021|Overall Study|Physician Decision|0|||
155218469|NCT02608268|560239520|FG022|Overall Study|Physician Decision|1|||
155218470|NCT02608268|560239521|FG023|Overall Study|Physician Decision|1|||
155218471|NCT02608268|560239522|FG024|Overall Study|Physician Decision|1|||
155218472|NCT02608268|560239523|FG025|Overall Study|Physician Decision|0|||
155218473|NCT02608268|560239524|FG026|Overall Study|Physician Decision|0|||
155218474|NCT02608268|560239525|FG027|Overall Study|Physician Decision|2|||
155218475|NCT02608268|560239526|FG028|Overall Study|Physician Decision|1|||
155218476|NCT02608268|560239527|FG029|Overall Study|Physician Decision|1|||
155218477|NCT02608268|560239498|FG000|Overall Study|Progressive disease|12|||
155218478|NCT02608268|560239499|FG001|Overall Study|Progressive disease|8|||
155218479|NCT02608268|560239500|FG002|Overall Study|Progressive disease|13|||
155218480|NCT02608268|560239501|FG003|Overall Study|Progressive disease|5|||
155218481|NCT02608268|560239502|FG004|Overall Study|Progressive disease|2|||
155218482|NCT02608268|560239503|FG005|Overall Study|Progressive disease|4|||
155218483|NCT02608268|560239504|FG006|Overall Study|Progressive disease|6|||
155218484|NCT02608268|560239505|FG007|Overall Study|Progressive disease|2|||
155218485|NCT02608268|560239506|FG008|Overall Study|Progressive disease|5|||
155218486|NCT02608268|560239507|FG009|Overall Study|Progressive disease|6|||
155218487|NCT02608268|560239508|FG010|Overall Study|Progressive disease|5|||
155218488|NCT02608268|560239509|FG011|Overall Study|Progressive disease|5|||
155218489|NCT02608268|560239510|FG012|Overall Study|Progressive disease|4|||
155218490|NCT02608268|560239511|FG013|Overall Study|Progressive disease|11|||
155218491|NCT02608268|560239512|FG014|Overall Study|Progressive disease|6|||
155218492|NCT02608268|560239513|FG015|Overall Study|Progressive disease|3|||
155218493|NCT02608268|560239514|FG016|Overall Study|Progressive disease|5|||
155218494|NCT02608268|560239515|FG017|Overall Study|Progressive disease|5|||
155218495|NCT02608268|560239516|FG018|Overall Study|Progressive disease|5|||
155218496|NCT02608268|560239517|FG019|Overall Study|Progressive disease|2|||
155218497|NCT02608268|560239518|FG020|Overall Study|Progressive disease|10|||
155218498|NCT02608268|560239519|FG021|Overall Study|Progressive disease|4|||
155218499|NCT02608268|560239520|FG022|Overall Study|Progressive disease|5|||
155218500|NCT02608268|560239521|FG023|Overall Study|Progressive disease|5|||
155218501|NCT02608268|560239522|FG024|Overall Study|Progressive disease|3|||
155218502|NCT02608268|560239523|FG025|Overall Study|Progressive disease|11|||
155218503|NCT02608268|560239524|FG026|Overall Study|Progressive disease|16|||
155218504|NCT02608268|560239525|FG027|Overall Study|Progressive disease|11|||
155218505|NCT02608268|560239526|FG028|Overall Study|Progressive disease|10|||
155218506|NCT02608268|560239527|FG029|Overall Study|Progressive disease|15|||
155218507|NCT02608268|560239498|FG000|Overall Study|Subject/guardian decision|1|||
155218508|NCT02608268|560239499|FG001|Overall Study|Subject/guardian decision|1|||
155218509|NCT02608268|560239500|FG002|Overall Study|Subject/guardian decision|2|||
155218510|NCT02608268|560239501|FG003|Overall Study|Subject/guardian decision|0|||
155218511|NCT02608268|560239502|FG004|Overall Study|Subject/guardian decision|0|||
155218512|NCT02608268|560239503|FG005|Overall Study|Subject/guardian decision|0|||
155218513|NCT02608268|560239504|FG006|Overall Study|Subject/guardian decision|0|||
155218514|NCT02608268|560239505|FG007|Overall Study|Subject/guardian decision|0|||
155218515|NCT02608268|560239506|FG008|Overall Study|Subject/guardian decision|2|||
155218516|NCT02608268|560239507|FG009|Overall Study|Subject/guardian decision|2|||
155218517|NCT02608268|560239508|FG010|Overall Study|Subject/guardian decision|0|||
155218518|NCT02608268|560239509|FG011|Overall Study|Subject/guardian decision|1|||
155218519|NCT02608268|560239510|FG012|Overall Study|Subject/guardian decision|0|||
155218520|NCT02608268|560239511|FG013|Overall Study|Subject/guardian decision|1|||
155218521|NCT02608268|560239512|FG014|Overall Study|Subject/guardian decision|0|||
155218522|NCT02608268|560239513|FG015|Overall Study|Subject/guardian decision|1|||
155218523|NCT02608268|560239514|FG016|Overall Study|Subject/guardian decision|0|||
155218524|NCT02608268|560239515|FG017|Overall Study|Subject/guardian decision|0|||
155218525|NCT02608268|560239516|FG018|Overall Study|Subject/guardian decision|1|||
155218526|NCT02608268|560239517|FG019|Overall Study|Subject/guardian decision|0|||
155218527|NCT02608268|560239518|FG020|Overall Study|Subject/guardian decision|0|||
155218528|NCT02608268|560239519|FG021|Overall Study|Subject/guardian decision|0|||
155218529|NCT02608268|560239520|FG022|Overall Study|Subject/guardian decision|1|||
155218530|NCT02608268|560239521|FG023|Overall Study|Subject/guardian decision|0|||
155218531|NCT02608268|560239522|FG024|Overall Study|Subject/guardian decision|0|||
155218532|NCT02608268|560239523|FG025|Overall Study|Subject/guardian decision|1|||
155218533|NCT02608268|560239524|FG026|Overall Study|Subject/guardian decision|1|||
155218534|NCT02608268|560239525|FG027|Overall Study|Subject/guardian decision|1|||
155218535|NCT02608268|560239526|FG028|Overall Study|Subject/guardian decision|1|||
155218536|NCT02608268|560239527|FG029|Overall Study|Subject/guardian decision|0|||
155218537|NCT04014075|560239528|FG000|Overall Study|Progressive Disease|53|||
155218538|NCT04014075|560239528|FG000|Overall Study|Adverse Event|15|||
155218539|NCT04014075|560239528|FG000|Overall Study|Clinical Progression|4|||
155218540|NCT04014075|560239528|FG000|Overall Study|Death|2|||
155218541|NCT04014075|560239528|FG000|Overall Study|Withdrawal by Subject|2|||
155218542|NCT04014075|560239528|FG000|Overall Study|Miscellaneous|2|||
155218543|NCT04014075|560239528|FG000|Overall Study|Physician Decision|1|||
155218544|NCT02584504|560239529|FG000|Double-blind Treatment|Participant withdrew consent|0|||
155218545|NCT02584504|560239530|FG001|Double-blind Treatment|Participant withdrew consent|0|||
155218546|NCT02584504|560239531|FG002|Double-blind Treatment|Participant withdrew consent|1|||
155218547|NCT02584504|560239529|FG000|Double-blind Treatment|Adverse Event|0|||
155218548|NCT02584504|560239530|FG001|Double-blind Treatment|Adverse Event|1|||
155218549|NCT02584504|560239531|FG002|Double-blind Treatment|Adverse Event|0|||
155218550|NCT02584504|560239529|FG000|Double-blind Treatment|Family Matter|0|||
155218551|NCT02584504|560239530|FG001|Double-blind Treatment|Family Matter|1|||
155218552|NCT02584504|560239531|FG002|Double-blind Treatment|Family Matter|0|||
155218553|NCT02584504|560239529|FG000|Open-label Treatment|Participant withdrew consent|0|||
155218554|NCT02584504|560239530|FG001|Open-label Treatment|Participant withdrew consent|0|||
155218555|NCT02584504|560239531|FG002|Open-label Treatment|Participant withdrew consent|4|||
155218556|NCT02584504|560239529|FG000|Open-label Treatment|Adverse Event|2|||
155218557|NCT02584504|560239530|FG001|Open-label Treatment|Adverse Event|2|||
155218558|NCT02584504|560239531|FG002|Open-label Treatment|Adverse Event|3|||
155218559|NCT02584504|560239529|FG000|Open-label Treatment|Physician Decision|0|||
155218560|NCT02584504|560239530|FG001|Open-label Treatment|Physician Decision|1|||
155218561|NCT02584504|560239531|FG002|Open-label Treatment|Physician Decision|0|||
155218562|NCT02584504|560239529|FG000|Open-label Treatment|Entered but not treated|0|||
155218563|NCT02584504|560239530|FG001|Open-label Treatment|Entered but not treated|1|||
155218564|NCT02584504|560239531|FG002|Open-label Treatment|Entered but not treated|1|||
155218565|NCT05172544|560239535|FG000|Overall Study|Withdrawal by Subject|1|||
155218566|NCT05172544|560239536|FG001|Overall Study|Withdrawal by Subject|0|||
155218567|NCT05172544|560239537|FG002|Overall Study|Withdrawal by Subject|0|||
155218568|NCT05172544|560239535|FG000|Overall Study|Physician Decision|0|||
155218569|NCT05172544|560239536|FG001|Overall Study|Physician Decision|0|||
155218570|NCT05172544|560239537|FG002|Overall Study|Physician Decision|1|||
155218571|NCT01179477|560239542|FG000|Overall Study|Death|542|||
155218572|NCT01179477|560239542|FG000|Overall Study|Unsuccessful implant|80|||
155218573|NCT01179477|560239542|FG000|Overall Study|Non-death withdrawal|438|||
155218574|NCT01179477|560239542|FG000|Overall Study|Did not complete final visit|27|||
155218575|NCT02221284|560239546|FG000|Overall Study|Case Report Forms Uncollected|56|||
155218576|NCT02221284|560239546|FG000|Overall Study|Protocol Deviation|5|||
155218577|NCT00529542|560239549|FG000|Overall Study|Withdrawal by Subject|1|||
155218578|NCT00529542|560239550|FG001|Overall Study|Withdrawal by Subject|0|||
155218579|NCT00529542|560239549|FG000|Overall Study|Lost to Follow-up|0|||
155218580|NCT00529542|560239550|FG001|Overall Study|Lost to Follow-up|1|||
155218581|NCT03839212|560239557|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
155218582|NCT00679263|560239562|FG000|Visit 2/Dose 1|Adverse Event|1|||
155218583|NCT00679263|560239563|FG001|Visit 2/Dose 1|Adverse Event|0|||
155218584|NCT00679263|560239564|FG002|Visit 2/Dose 1|Adverse Event|0|||
155218585|NCT00679263|560239562|FG000|Visit 2/Dose 1|subject not compliance|1|||
155218586|NCT00679263|560239563|FG001|Visit 2/Dose 1|subject not compliance|1|||
155218587|NCT00679263|560239564|FG002|Visit 2/Dose 1|subject not compliance|0|||
155218588|NCT05104567|560239566|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218589|NCT05104567|560239567|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
155218590|NCT05104567|560239568|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218591|NCT05104567|560239569|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218592|NCT05104567|560239570|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218593|NCT05104567|560239571|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218594|NCT05104567|560239572|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218595|NCT05104567|560239566|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
155218596|NCT05104567|560239567|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
155218597|NCT05104567|560239568|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
155218598|NCT05104567|560239569|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
155218599|NCT05104567|560239570|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
155218600|NCT05104567|560239571|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
155218601|NCT05104567|560239572|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
155218602|NCT05104567|560239566|FG000|Overall Study|Progressive disease|3|||
155218603|NCT05104567|560239567|FG001|Overall Study|Progressive disease|13|||
155218604|NCT05104567|560239568|FG002|Overall Study|Progressive disease|13|||
155218605|NCT05104567|560239569|FG003|Overall Study|Progressive disease|17|||
155218606|NCT05104567|560239570|FG004|Overall Study|Progressive disease|17|||
155218607|NCT05104567|560239571|FG005|Overall Study|Progressive disease|28|||
155218608|NCT05104567|560239572|FG006|Overall Study|Progressive disease|24|||
155218609|NCT05104567|560239566|FG000|Overall Study|Withdrawal by Subject|1|||
155218610|NCT05104567|560239567|FG001|Overall Study|Withdrawal by Subject|1|||
155218611|NCT05104567|560239568|FG002|Overall Study|Withdrawal by Subject|2|||
155218612|NCT05104567|560239569|FG003|Overall Study|Withdrawal by Subject|0|||
155218613|NCT05104567|560239570|FG004|Overall Study|Withdrawal by Subject|0|||
155218614|NCT05104567|560239571|FG005|Overall Study|Withdrawal by Subject|0|||
155218615|NCT05104567|560239572|FG006|Overall Study|Withdrawal by Subject|0|||
155218616|NCT05104567|560239566|FG000|Overall Study|Other|1|||
155218617|NCT05104567|560239567|FG001|Overall Study|Other|1|||
155218618|NCT05104567|560239568|FG002|Overall Study|Other|1|||
155218619|NCT05104567|560239569|FG003|Overall Study|Other|0|||
155218620|NCT05104567|560239570|FG004|Overall Study|Other|0|||
155218621|NCT05104567|560239571|FG005|Overall Study|Other|0|||
155218622|NCT05104567|560239572|FG006|Overall Study|Other|0|||
155218623|NCT01464346|560239576|FG000|Overall Study|Withdrawal by Subject|0|||
155218624|NCT01464346|560239577|FG001|Overall Study|Withdrawal by Subject|0|||
155218625|NCT01464346|560239578|FG002|Overall Study|Withdrawal by Subject|1|||
155218626|NCT00733746|560239579|FG000|Overall Study|Ineligible|5|||
155218627|NCT02295995|560239580|FG000|Overall Study|Lost to Follow-up|5|||
155218628|NCT02295995|560239581|FG001|Overall Study|Lost to Follow-up|1|||
155218629|NCT01173718|560239582|FG000|Overall Study|Death|17|||
155218630|NCT01173718|560239582|FG000|Overall Study|Abandonment of study graft|27|||
155218631|NCT01498458|560239584|FG000|Overall Study|Adverse Event|4|||
155218632|NCT01498458|560239584|FG000|Overall Study|Physician Decision|3|||
155218633|NCT02226003|560239585|FG000|Overall Study|Lost to Follow-up|2|||
155218634|NCT02226003|560239586|FG001|Overall Study|Lost to Follow-up|1|||
155218635|NCT02226003|560239587|FG002|Overall Study|Lost to Follow-up|3|||
155218636|NCT02226003|560239585|FG000|Overall Study|Withdrawal by Subject|0|||
155218637|NCT02226003|560239586|FG001|Overall Study|Withdrawal by Subject|0|||
155218638|NCT02226003|560239587|FG002|Overall Study|Withdrawal by Subject|3|||
155218639|NCT03279692|560239594|FG000|Overall Study|Withdrawal by Subject|1|||
155218640|NCT05198843|560239597|FG000|Overall Study|Lack of Efficacy|1|||
155218641|NCT02446990|560239598|FG000|Overall Study|Death|485|||
155218642|NCT02446990|560239599|FG001|Overall Study|Death|458|||
155218643|NCT02446990|560239598|FG000|Overall Study|Lost to Follow-up|3|||
155218644|NCT02446990|560239599|FG001|Overall Study|Lost to Follow-up|1|||
155218645|NCT02446990|560239598|FG000|Overall Study|Physician Decision|1|||
155218646|NCT02446990|560239599|FG001|Overall Study|Physician Decision|0|||
155218647|NCT02446990|560239598|FG000|Overall Study|Withdrawal by Subject|231|||
155218648|NCT02446990|560239599|FG001|Overall Study|Withdrawal by Subject|199|||
155218649|NCT01064401|560239600|FG000|Overall Study|Adverse Event|47|||
155218650|NCT01064401|560239601|FG001|Overall Study|Adverse Event|56|||
155218651|NCT01064401|560239600|FG000|Overall Study|Lack of Efficacy|46|||
155218652|NCT01064401|560239601|FG001|Overall Study|Lack of Efficacy|23|||
155218653|NCT01064401|560239600|FG000|Overall Study|Lost to Follow-up|12|||
155218654|NCT01064401|560239601|FG001|Overall Study|Lost to Follow-up|9|||
155218655|NCT01064401|560239600|FG000|Overall Study|Consent Withdrawn|98|||
155218656|NCT01064401|560239601|FG001|Overall Study|Consent Withdrawn|80|||
155218657|NCT01064401|560239600|FG000|Overall Study|Investigator Decision|4|||
155218658|NCT01064401|560239601|FG001|Overall Study|Investigator Decision|6|||
155218659|NCT01064401|560239600|FG000|Overall Study|Death|4|||
155218660|NCT01064401|560239601|FG001|Overall Study|Death|0|||
155218661|NCT01064401|560239600|FG000|Overall Study|Pregnancy|4|||
155218662|NCT01064401|560239601|FG001|Overall Study|Pregnancy|7|||
155218663|NCT01064401|560239600|FG000|Overall Study|Noncompliance|7|||
155218664|NCT01064401|560239601|FG001|Overall Study|Noncompliance|8|||
155218665|NCT01064401|560239600|FG000|Overall Study|Site Closure|4|||
155218666|NCT01064401|560239601|FG001|Overall Study|Site Closure|5|||
155218667|NCT01064401|560239600|FG000|Overall Study|Other|2|||
155218668|NCT01064401|560239601|FG001|Overall Study|Other|1|||
155218669|NCT03158051|560239602|FG000|Overall Study|Lost to Follow-up|41|||
155218670|NCT03158051|560239603|FG001|Overall Study|Lost to Follow-up|47|||
155218671|NCT03158051|560239602|FG000|Overall Study|Physician Decision|6|||
155218672|NCT03158051|560239603|FG001|Overall Study|Physician Decision|7|||
155218673|NCT03158051|560239602|FG000|Overall Study|Withdrawal by Subject|24|||
155218674|NCT03158051|560239603|FG001|Overall Study|Withdrawal by Subject|15|||
155218675|NCT03158051|560239602|FG000|Overall Study|Death|0|||
155218676|NCT03158051|560239603|FG001|Overall Study|Death|1|||
155218677|NCT02588833|560239604|FG000|Part 1|Withdrawal by Subject|1|||
155218678|NCT02588833|560239605|FG001|Part 1|Withdrawal by Subject|0|||
155218679|NCT02588833|560239604|FG000|Part 2A|Physician Decision|0|||
155218680|NCT02588833|560239605|FG001|Part 2A|Physician Decision|1|||
155218681|NCT02588833|560239604|FG000|Part 2A|Withdrawal by Subject|0|||
155218682|NCT02588833|560239605|FG001|Part 2A|Withdrawal by Subject|1|||
155218683|NCT02588833|560239604|FG000|Part 2B|Adverse Event|0|||
155218684|NCT02588833|560239605|FG001|Part 2B|Adverse Event|1|||
155218685|NCT02588833|560239604|FG000|Part 2C|Adverse Event|0|||
155218686|NCT02588833|560239605|FG001|Part 2C|Adverse Event|1|||
155218687|NCT02588833|560239604|FG000|Part 2C|Withdrawal by Subject|0|||
155218688|NCT02588833|560239605|FG001|Part 2C|Withdrawal by Subject|1|||
155218689|NCT02588833|560239604|FG000|Part 3 (Safety Follow-up)|Other|0|||
155218690|NCT02588833|560239605|FG001|Part 3 (Safety Follow-up)|Other|2|||
155218691|NCT02005250|560239606|FG000|Overall Study|Lost to Follow-up|15|||
155218692|NCT02005250|560239607|FG001|Overall Study|Lost to Follow-up|5|||
155218693|NCT02738151|560239608|FG000|Overall Study|Randomized but not treated|4|||
155218694|NCT02738151|560239609|FG001|Overall Study|Randomized but not treated|1|||
155218695|NCT02738151|560239608|FG000|Overall Study|Adverse Event|4|||
155218696|NCT02738151|560239609|FG001|Overall Study|Adverse Event|5|||
155218697|NCT02738151|560239608|FG000|Overall Study|Hypoglycemia|0|||
155218698|NCT02738151|560239609|FG001|Overall Study|Hypoglycemia|1|||
155218699|NCT02738151|560239608|FG000|Overall Study|Poor Compliance to Protocol|4|||
155218700|NCT02738151|560239609|FG001|Overall Study|Poor Compliance to Protocol|3|||
155218701|NCT02738151|560239608|FG000|Overall Study|Other than specified above|11|||
155218702|NCT02738151|560239609|FG001|Overall Study|Other than specified above|21|||
155218703|NCT03649711|560239615|FG000|Overall Study|Adverse Event|0|||
155218704|NCT03649711|560239616|FG001|Overall Study|Adverse Event|1|||
155218705|NCT03649711|560239617|FG002|Overall Study|Adverse Event|0|||
155218706|NCT03649711|560239615|FG000|Overall Study|Kidney Transplant|1|||
155218707|NCT03649711|560239616|FG001|Overall Study|Kidney Transplant|0|||
155218708|NCT03649711|560239617|FG002|Overall Study|Kidney Transplant|0|||
155218709|NCT04007094|560239622|FG000|Overall Study|Lost to Follow-up|1|||
155218710|NCT04007094|560239623|FG001|Overall Study|Lost to Follow-up|1|||
155218711|NCT04350788|560239639|FG000|Overall Study|Lost to Follow-up|6|||
155218712|NCT04350788|560239640|FG001|Overall Study|Lost to Follow-up|2|||
155218713|NCT04350788|560239639|FG000|Overall Study|Withdrawal by Subject|2|||
155218714|NCT04350788|560239640|FG001|Overall Study|Withdrawal by Subject|4|||
155218715|NCT04350788|560239639|FG000|Overall Study|Protocol Violation|4|||
155218716|NCT04350788|560239640|FG001|Overall Study|Protocol Violation|0|||
155218717|NCT01581307|560239641|FG000|Overall Study|Withdrawal by Subject|1|||
155218718|NCT00378209|560239646|FG000|Overall Study|Progressive disease|11|||
155218719|NCT00378209|560239646|FG000|Overall Study|Adverse Event|3|||
155218720|NCT00378209|560239646|FG000|Overall Study|Initiation of non-protocol therapy|3|||
155218721|NCT00378209|560239646|FG000|Overall Study|Physician Decision|3|||
155218722|NCT00378209|560239646|FG000|Overall Study|Death|1|||
155218723|NCT00378209|560239646|FG000|Overall Study|Treatment delay|1|||
155218724|NCT01894581|560239647|FG000|Overall Study|Withdrawal by Subject|2|||
155218725|NCT01894581|560239648|FG001|Overall Study|Withdrawal by Subject|3|||
155218726|NCT01894581|560239647|FG000|Overall Study|Screen Failure|3|||
155218727|NCT01894581|560239648|FG001|Overall Study|Screen Failure|4|||
155218728|NCT03795298|560239652|FG000|Overall Study|Death|34|||
155218729|NCT03795298|560239653|FG001|Overall Study|Death|29|||
155218730|NCT03795298|560239652|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
155218731|NCT03795298|560239653|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
155218732|NCT03795298|560239652|FG000|Overall Study|Lost to Follow-up|28|||
155218733|NCT03795298|560239653|FG001|Overall Study|Lost to Follow-up|17|||
155218734|NCT03795298|560239652|FG000|Overall Study|Physician Decision|5|||
155218735|NCT03795298|560239653|FG001|Overall Study|Physician Decision|4|||
155218736|NCT03795298|560239652|FG000|Overall Study|Withdrawal by Subject|43|||
155218737|NCT03795298|560239653|FG001|Overall Study|Withdrawal by Subject|28|||
155218738|NCT03795298|560239652|FG000|Overall Study|Reason not reported|7|||
155218739|NCT03795298|560239653|FG001|Overall Study|Reason not reported|9|||
155218740|NCT01252940|560239654|FG000|Main Study Phase|Randomized but not treated|4|||
155218741|NCT01252940|560239655|FG001|Main Study Phase|Randomized but not treated|2|||
155218742|NCT01252940|560239654|FG000|Main Study Phase|Adverse Event|3|||
155218743|NCT01252940|560239655|FG001|Main Study Phase|Adverse Event|1|||
155218744|NCT01252940|560239654|FG000|Main Study Phase|Lack of Efficacy|1|||
155218745|NCT01252940|560239655|FG001|Main Study Phase|Lack of Efficacy|0|||
155218746|NCT01252940|560239654|FG000|Main Study Phase|Lost to Follow-up|6|||
155218747|NCT01252940|560239655|FG001|Main Study Phase|Lost to Follow-up|1|||
155218748|NCT01252940|560239654|FG000|Main Study Phase|Physician Decision|1|||
155218749|NCT01252940|560239655|FG001|Main Study Phase|Physician Decision|0|||
155218750|NCT01252940|560239654|FG000|Main Study Phase|Protocol Violation|4|||
155218751|NCT01252940|560239655|FG001|Main Study Phase|Protocol Violation|2|||
155218752|NCT01252940|560239654|FG000|Main Study Phase|Withdrawal by Subject|6|||
155218753|NCT01252940|560239655|FG001|Main Study Phase|Withdrawal by Subject|5|||
155218754|NCT01252940|560239654|FG000|Main Study Phase|Subject Non-compliance|1|||
155218755|NCT01252940|560239655|FG001|Main Study Phase|Subject Non-compliance|1|||
155218756|NCT01252940|560239654|FG000|Extension Phase|Adverse Event|2|||
155218757|NCT01252940|560239655|FG001|Extension Phase|Adverse Event|1|||
155218758|NCT01252940|560239654|FG000|Extension Phase|Lack of Efficacy|1|||
155218759|NCT01252940|560239655|FG001|Extension Phase|Lack of Efficacy|0|||
155218760|NCT01252940|560239654|FG000|Extension Phase|Lost to Follow-up|5|||
155218761|NCT01252940|560239655|FG001|Extension Phase|Lost to Follow-up|0|||
155218762|NCT01252940|560239654|FG000|Extension Phase|Physician Decision|0|||
155218763|NCT01252940|560239655|FG001|Extension Phase|Physician Decision|1|||
155218764|NCT01252940|560239654|FG000|Extension Phase|Subject Non-compliance|1|||
155218765|NCT01252940|560239655|FG001|Extension Phase|Subject Non-compliance|0|||
155218766|NCT01252940|560239654|FG000|Extension Phase|Withdrawal by Subject|1|||
155218767|NCT01252940|560239655|FG001|Extension Phase|Withdrawal by Subject|1|||
155218768|NCT04199117|560239656|FG000|Overall Study|Withdrawal by Subject|3|||
155218769|NCT04199117|560239657|FG001|Overall Study|Withdrawal by Subject|0|||
155218770|NCT04199117|560239658|FG002|Overall Study|Withdrawal by Subject|0|||
155218771|NCT04199117|560239659|FG003|Overall Study|Withdrawal by Subject|1|||
155218772|NCT04199117|560239660|FG004|Overall Study|Withdrawal by Subject|1|||
155218773|NCT04199117|560239661|FG005|Overall Study|Withdrawal by Subject|0|||
155218774|NCT04199117|560239662|FG006|Overall Study|Withdrawal by Subject|0|||
155218775|NCT04199117|560239663|FG007|Overall Study|Withdrawal by Subject|2|||
155218776|NCT04199117|560239664|FG008|Overall Study|Withdrawal by Subject|0|||
155218777|NCT04199117|560239665|FG009|Overall Study|Withdrawal by Subject|0|||
155218778|NCT04199117|560239666|FG010|Overall Study|Withdrawal by Subject|1|||
155218779|NCT04199117|560239667|FG011|Overall Study|Withdrawal by Subject|1|||
155218780|NCT04199117|560239668|FG012|Overall Study|Withdrawal by Subject|2|||
155218781|NCT04199117|560239669|FG013|Overall Study|Withdrawal by Subject|1|||
155218782|NCT04199117|560239670|FG014|Overall Study|Withdrawal by Subject|1|||
155218783|NCT04199117|560239671|FG015|Overall Study|Withdrawal by Subject|1|||
155218784|NCT04199117|560239656|FG000|Overall Study|Death|1|||
155218785|NCT04199117|560239657|FG001|Overall Study|Death|1|||
155218786|NCT04199117|560239658|FG002|Overall Study|Death|0|||
155218787|NCT04199117|560239659|FG003|Overall Study|Death|0|||
155218788|NCT04199117|560239660|FG004|Overall Study|Death|0|||
155218789|NCT04199117|560239661|FG005|Overall Study|Death|0|||
155218790|NCT04199117|560239662|FG006|Overall Study|Death|0|||
155218791|NCT04199117|560239663|FG007|Overall Study|Death|0|||
155218792|NCT04199117|560239664|FG008|Overall Study|Death|0|||
155218793|NCT04199117|560239665|FG009|Overall Study|Death|0|||
155218794|NCT04199117|560239666|FG010|Overall Study|Death|0|||
155218795|NCT04199117|560239667|FG011|Overall Study|Death|1|||
155218796|NCT04199117|560239668|FG012|Overall Study|Death|0|||
155218797|NCT04199117|560239669|FG013|Overall Study|Death|1|||
155218798|NCT04199117|560239670|FG014|Overall Study|Death|0|||
155218799|NCT04199117|560239671|FG015|Overall Study|Death|0|||
155218800|NCT04199117|560239656|FG000|Overall Study|Withdrawal by PI|0|||
155218801|NCT04199117|560239657|FG001|Overall Study|Withdrawal by PI|0|||
155218802|NCT04199117|560239658|FG002|Overall Study|Withdrawal by PI|0|||
155218803|NCT04199117|560239659|FG003|Overall Study|Withdrawal by PI|0|||
155218804|NCT04199117|560239660|FG004|Overall Study|Withdrawal by PI|0|||
155218805|NCT04199117|560239661|FG005|Overall Study|Withdrawal by PI|0|||
155218806|NCT04199117|560239662|FG006|Overall Study|Withdrawal by PI|0|||
155218807|NCT04199117|560239663|FG007|Overall Study|Withdrawal by PI|0|||
155218808|NCT04199117|560239664|FG008|Overall Study|Withdrawal by PI|0|||
155218809|NCT04199117|560239665|FG009|Overall Study|Withdrawal by PI|0|||
155218810|NCT04199117|560239666|FG010|Overall Study|Withdrawal by PI|0|||
155218811|NCT04199117|560239667|FG011|Overall Study|Withdrawal by PI|0|||
155218812|NCT04199117|560239668|FG012|Overall Study|Withdrawal by PI|1|||
155218813|NCT04199117|560239669|FG013|Overall Study|Withdrawal by PI|0|||
155218814|NCT04199117|560239670|FG014|Overall Study|Withdrawal by PI|0|||
155218815|NCT04199117|560239671|FG015|Overall Study|Withdrawal by PI|0|||
155218816|NCT04383743|560239672|FG000|Overall Study|Withdrawal by Subject|1|||
155218817|NCT04383743|560239672|FG000|Overall Study|Adverse Event|1|||
155218818|NCT03482791|560239679|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
155218819|NCT03482791|560239680|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
155218820|NCT00296374|560239681|FG000|Overall Study|Adverse Event|14|||
155218821|NCT00296374|560239682|FG001|Overall Study|Adverse Event|10|||
155218822|NCT00296374|560239683|FG002|Overall Study|Adverse Event|7|||
155218823|NCT00296374|560239681|FG000|Overall Study|Withdrawal by Subject|3|||
155218824|NCT00296374|560239682|FG001|Overall Study|Withdrawal by Subject|5|||
155218825|NCT00296374|560239683|FG002|Overall Study|Withdrawal by Subject|11|||
155218826|NCT00296374|560239681|FG000|Overall Study|Incorrect enrollment|3|||
155218827|NCT00296374|560239682|FG001|Overall Study|Incorrect enrollment|3|||
155218828|NCT00296374|560239683|FG002|Overall Study|Incorrect enrollment|4|||
155218829|NCT00296374|560239681|FG000|Overall Study|Protocol Violation|1|||
155218830|NCT00296374|560239682|FG001|Overall Study|Protocol Violation|2|||
155218831|NCT00296374|560239683|FG002|Overall Study|Protocol Violation|3|||
155218832|NCT00296374|560239681|FG000|Overall Study|Lost to Follow-up|3|||
155218833|NCT00296374|560239682|FG001|Overall Study|Lost to Follow-up|1|||
155218834|NCT00296374|560239683|FG002|Overall Study|Lost to Follow-up|1|||
155218835|NCT00296374|560239681|FG000|Overall Study|Relocated to another state|1|||
155218836|NCT00296374|560239682|FG001|Overall Study|Relocated to another state|0|||
155218837|NCT00296374|560239683|FG002|Overall Study|Relocated to another state|0|||
155218838|NCT00296374|560239681|FG000|Overall Study|Stopped drug before end of study visit|0|||
155218839|NCT00296374|560239682|FG001|Overall Study|Stopped drug before end of study visit|1|||
155218840|NCT00296374|560239683|FG002|Overall Study|Stopped drug before end of study visit|0|||
155218841|NCT00296374|560239681|FG000|Overall Study|Nephrologist introduced ACE|0|||
155218842|NCT00296374|560239682|FG001|Overall Study|Nephrologist introduced ACE|1|||
155218843|NCT00296374|560239683|FG002|Overall Study|Nephrologist introduced ACE|0|||
155218844|NCT00296374|560239681|FG000|Overall Study|Pregnancy|0|||
155218845|NCT00296374|560239682|FG001|Overall Study|Pregnancy|0|||
155218846|NCT00296374|560239683|FG002|Overall Study|Pregnancy|2|||
155218847|NCT00296374|560239681|FG000|Overall Study|Other|0|||
155218848|NCT00296374|560239682|FG001|Overall Study|Other|0|||
155218849|NCT00296374|560239683|FG002|Overall Study|Other|1|||
155218850|NCT01721330|560239684|FG000|Overall Study|Withdrawal by Subject|0|||
155218851|NCT01721330|560239685|FG001|Overall Study|Withdrawal by Subject|1|||
155218852|NCT04709575|560241134|FG000|Overall Study|Withdrawal by Subject|6|||
155218853|NCT04709575|560241135|FG001|Overall Study|Withdrawal by Subject|2|||
155218854|NCT04709575|560241134|FG000|Overall Study|Lost to Follow-up|2|||
155218855|NCT04709575|560241135|FG001|Overall Study|Lost to Follow-up|2|||
155218856|NCT04709575|560241134|FG000|Overall Study|Adverse Event|1|||
155218857|NCT04709575|560241135|FG001|Overall Study|Adverse Event|0|||
155218858|NCT04709575|560241134|FG000|Overall Study|Protocol Violation|1|||
155218859|NCT04709575|560241135|FG001|Overall Study|Protocol Violation|1|||
155218860|NCT00542919|560241136|FG000|Overall Study|Adverse Event|1|||
155218861|NCT00542919|560241137|FG001|Overall Study|Adverse Event|5|||
155218862|NCT00542919|560241138|FG002|Overall Study|Adverse Event|1|||
155218863|NCT00542919|560241136|FG000|Overall Study|Withdrawal by Subject|1|||
155218864|NCT00542919|560241137|FG001|Overall Study|Withdrawal by Subject|0|||
155218865|NCT00542919|560241138|FG002|Overall Study|Withdrawal by Subject|3|||
155218866|NCT00542919|560241136|FG000|Overall Study|Physician Decision|2|||
155218867|NCT00542919|560241137|FG001|Overall Study|Physician Decision|2|||
155218868|NCT00542919|560241138|FG002|Overall Study|Physician Decision|1|||
155218869|NCT00542919|560241136|FG000|Overall Study|Sponsor Decision|1|||
155218870|NCT00542919|560241137|FG001|Overall Study|Sponsor Decision|0|||
155218871|NCT00542919|560241138|FG002|Overall Study|Sponsor Decision|0|||
155218872|NCT00542919|560241136|FG000|Overall Study|Lost to Follow-up|2|||
155218873|NCT00542919|560241137|FG001|Overall Study|Lost to Follow-up|0|||
155218874|NCT00542919|560241138|FG002|Overall Study|Lost to Follow-up|1|||
155218875|NCT02385266|560241139|FG000|Overall Study|Withdrawal by Subject|1|||
155218876|NCT02385266|560241140|FG001|Overall Study|Withdrawal by Subject|3|||
155218877|NCT02082210|560241147|FG000|Overall Study|Death|0|||
155218878|NCT02082210|560241148|FG001|Overall Study|Death|0|||
155218879|NCT02082210|560241149|FG002|Overall Study|Death|1|||
155218880|NCT02082210|560241150|FG003|Overall Study|Death|1|||
155218881|NCT02082210|560241151|FG004|Overall Study|Death|1|||
155218882|NCT02082210|560241152|FG005|Overall Study|Death|0|||
155218883|NCT02082210|560241147|FG000|Overall Study|Withdrawal by Subject|0|||
155218884|NCT02082210|560241148|FG001|Overall Study|Withdrawal by Subject|0|||
155218885|NCT02082210|560241149|FG002|Overall Study|Withdrawal by Subject|0|||
155218886|NCT02082210|560241150|FG003|Overall Study|Withdrawal by Subject|1|||
155218887|NCT02082210|560241151|FG004|Overall Study|Withdrawal by Subject|2|||
155218888|NCT02082210|560241152|FG005|Overall Study|Withdrawal by Subject|2|||
155218889|NCT02082210|560241147|FG000|Overall Study|Clinical Progression|0|||
155218890|NCT02082210|560241148|FG001|Overall Study|Clinical Progression|0|||
155218891|NCT02082210|560241149|FG002|Overall Study|Clinical Progression|0|||
155218892|NCT02082210|560241150|FG003|Overall Study|Clinical Progression|1|||
155218893|NCT02082210|560241151|FG004|Overall Study|Clinical Progression|0|||
155218894|NCT02082210|560241152|FG005|Overall Study|Clinical Progression|0|||
155218895|NCT02082210|560241147|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218896|NCT02082210|560241148|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218897|NCT02082210|560241149|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
155218898|NCT02082210|560241150|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
155218899|NCT02082210|560241151|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218900|NCT02082210|560241152|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218901|NCT02082210|560241147|FG000|Overall Study|Physician Decision|0|||
155218902|NCT02082210|560241148|FG001|Overall Study|Physician Decision|0|||
155218903|NCT02082210|560241149|FG002|Overall Study|Physician Decision|1|||
155218904|NCT02082210|560241150|FG003|Overall Study|Physician Decision|1|||
155218905|NCT02082210|560241151|FG004|Overall Study|Physician Decision|0|||
155218906|NCT02082210|560241152|FG005|Overall Study|Physician Decision|0|||
155218907|NCT04762680|560241153|FG000|Phase 2|Adverse Event|0|||
155218908|NCT04762680|560241154|FG001|Phase 2|Adverse Event|1|||
155218909|NCT04762680|560241155|FG002|Phase 2|Adverse Event|0|||
155218910|NCT04762680|560241156|FG003|Phase 2|Adverse Event|0|||
155218911|NCT04762680|560241157|FG004|Phase 2|Adverse Event|0|||
155218912|NCT04762680|560241158|FG005|Phase 2|Adverse Event|0|||
155218913|NCT04762680|560241159|FG006|Phase 2|Adverse Event|0|||
155218914|NCT04762680|560241160|FG007|Phase 2|Adverse Event|0|||
155218915|NCT04762680|560241161|FG008|Phase 2|Adverse Event|0|||
155218916|NCT04762680|560241162|FG009|Phase 2|Adverse Event|0|||
155218917|NCT04762680|560241163|FG010|Phase 2|Adverse Event|0|||
155218918|NCT04762680|560241164|FG011|Phase 2|Adverse Event|0|||
155218919|NCT04762680|560241165|FG012|Phase 2|Adverse Event|0|||
155218920|NCT04762680|560241166|FG013|Phase 2|Adverse Event|0|||
155218921|NCT04762680|560241167|FG014|Phase 2|Adverse Event|0|||
155218922|NCT04762680|560241168|FG015|Phase 2|Adverse Event|0|||
155218923|NCT04762680|560241169|FG016|Phase 2|Adverse Event|0|||
155218924|NCT04762680|560241170|FG017|Phase 2|Adverse Event|0|||
155218925|NCT04762680|560241171|FG018|Phase 2|Adverse Event|0|||
155218926|NCT04762680|560241172|FG019|Phase 2|Adverse Event|0|||
155218927|NCT04762680|560241173|FG020|Phase 2|Adverse Event|0|||
155218928|NCT04762680|560241174|FG021|Phase 2|Adverse Event|0|||
155218929|NCT04762680|560241153|FG000|Phase 2|Protocol Violation|5|||
155218930|NCT04762680|560241154|FG001|Phase 2|Protocol Violation|5|||
155218931|NCT04762680|560241155|FG002|Phase 2|Protocol Violation|1|||
155218932|NCT04762680|560241156|FG003|Phase 2|Protocol Violation|0|||
155218933|NCT04762680|560241157|FG004|Phase 2|Protocol Violation|0|||
155218934|NCT04762680|560241158|FG005|Phase 2|Protocol Violation|0|||
155218935|NCT04762680|560241159|FG006|Phase 2|Protocol Violation|0|||
155218936|NCT04762680|560241160|FG007|Phase 2|Protocol Violation|0|||
155218937|NCT04762680|560241161|FG008|Phase 2|Protocol Violation|0|||
155218938|NCT04762680|560241162|FG009|Phase 2|Protocol Violation|0|||
155218939|NCT04762680|560241163|FG010|Phase 2|Protocol Violation|0|||
155218940|NCT04762680|560241164|FG011|Phase 2|Protocol Violation|0|||
155218941|NCT04762680|560241165|FG012|Phase 2|Protocol Violation|0|||
155218942|NCT04762680|560241166|FG013|Phase 2|Protocol Violation|0|||
155218943|NCT04762680|560241167|FG014|Phase 2|Protocol Violation|0|||
155218944|NCT04762680|560241168|FG015|Phase 2|Protocol Violation|0|||
155218945|NCT04762680|560241169|FG016|Phase 2|Protocol Violation|0|||
155218946|NCT04762680|560241170|FG017|Phase 2|Protocol Violation|0|||
155218947|NCT04762680|560241171|FG018|Phase 2|Protocol Violation|0|||
155218948|NCT04762680|560241172|FG019|Phase 2|Protocol Violation|0|||
155218949|NCT04762680|560241173|FG020|Phase 2|Protocol Violation|0|||
155218950|NCT04762680|560241174|FG021|Phase 2|Protocol Violation|0|||
155218951|NCT04762680|560241153|FG000|Phase 2|Withdrawal by Subject|23|||
155218952|NCT04762680|560241154|FG001|Phase 2|Withdrawal by Subject|21|||
155218953|NCT04762680|560241155|FG002|Phase 2|Withdrawal by Subject|28|||
155218954|NCT04762680|560241156|FG003|Phase 2|Withdrawal by Subject|0|||
155218955|NCT04762680|560241157|FG004|Phase 2|Withdrawal by Subject|0|||
155218956|NCT04762680|560241158|FG005|Phase 2|Withdrawal by Subject|0|||
155218957|NCT04762680|560241159|FG006|Phase 2|Withdrawal by Subject|0|||
155218958|NCT04762680|560241160|FG007|Phase 2|Withdrawal by Subject|0|||
155218959|NCT04762680|560241161|FG008|Phase 2|Withdrawal by Subject|0|||
155218960|NCT04762680|560241162|FG009|Phase 2|Withdrawal by Subject|0|||
155218961|NCT04762680|560241163|FG010|Phase 2|Withdrawal by Subject|0|||
155218962|NCT04762680|560241164|FG011|Phase 2|Withdrawal by Subject|0|||
155218963|NCT04762680|560241165|FG012|Phase 2|Withdrawal by Subject|0|||
155218964|NCT04762680|560241166|FG013|Phase 2|Withdrawal by Subject|0|||
155218965|NCT04762680|560241167|FG014|Phase 2|Withdrawal by Subject|0|||
155218966|NCT04762680|560241168|FG015|Phase 2|Withdrawal by Subject|0|||
155218967|NCT04762680|560241169|FG016|Phase 2|Withdrawal by Subject|0|||
155218968|NCT04762680|560241170|FG017|Phase 2|Withdrawal by Subject|0|||
155218969|NCT04762680|560241171|FG018|Phase 2|Withdrawal by Subject|0|||
155218970|NCT04762680|560241172|FG019|Phase 2|Withdrawal by Subject|0|||
155218971|NCT04762680|560241173|FG020|Phase 2|Withdrawal by Subject|0|||
155218972|NCT04762680|560241174|FG021|Phase 2|Withdrawal by Subject|0|||
155218973|NCT04762680|560241153|FG000|Phase 2|Lost to Follow-up|14|||
155218974|NCT04762680|560241154|FG001|Phase 2|Lost to Follow-up|8|||
155218975|NCT04762680|560241155|FG002|Phase 2|Lost to Follow-up|9|||
155218976|NCT04762680|560241156|FG003|Phase 2|Lost to Follow-up|0|||
155218977|NCT04762680|560241157|FG004|Phase 2|Lost to Follow-up|0|||
155218978|NCT04762680|560241158|FG005|Phase 2|Lost to Follow-up|0|||
155218979|NCT04762680|560241159|FG006|Phase 2|Lost to Follow-up|0|||
155218980|NCT04762680|560241160|FG007|Phase 2|Lost to Follow-up|0|||
155218981|NCT04762680|560241161|FG008|Phase 2|Lost to Follow-up|0|||
155218982|NCT04762680|560241162|FG009|Phase 2|Lost to Follow-up|0|||
155218983|NCT04762680|560241163|FG010|Phase 2|Lost to Follow-up|0|||
155218984|NCT04762680|560241164|FG011|Phase 2|Lost to Follow-up|0|||
155218985|NCT04762680|560241165|FG012|Phase 2|Lost to Follow-up|0|||
155218986|NCT04762680|560241166|FG013|Phase 2|Lost to Follow-up|0|||
155218987|NCT04762680|560241167|FG014|Phase 2|Lost to Follow-up|0|||
155218988|NCT04762680|560241168|FG015|Phase 2|Lost to Follow-up|0|||
155218989|NCT04762680|560241169|FG016|Phase 2|Lost to Follow-up|0|||
155218990|NCT04762680|560241170|FG017|Phase 2|Lost to Follow-up|0|||
155218991|NCT04762680|560241171|FG018|Phase 2|Lost to Follow-up|0|||
155218992|NCT04762680|560241172|FG019|Phase 2|Lost to Follow-up|0|||
155218993|NCT04762680|560241173|FG020|Phase 2|Lost to Follow-up|0|||
155218994|NCT04762680|560241174|FG021|Phase 2|Lost to Follow-up|0|||
155218995|NCT04762680|560241153|FG000|Phase 3|Adverse Event|0|||
155218996|NCT04762680|560241154|FG001|Phase 3|Adverse Event|0|||
155218997|NCT04762680|560241155|FG002|Phase 3|Adverse Event|0|||
155218998|NCT04762680|560241156|FG003|Phase 3|Adverse Event|1|||
155218999|NCT04762680|560241157|FG004|Phase 3|Adverse Event|0|||
155219000|NCT04762680|560241158|FG005|Phase 3|Adverse Event|0|||
155219001|NCT04762680|560241159|FG006|Phase 3|Adverse Event|0|||
155219002|NCT04762680|560241160|FG007|Phase 3|Adverse Event|0|||
155219003|NCT04762680|560241161|FG008|Phase 3|Adverse Event|0|||
155219004|NCT04762680|560241162|FG009|Phase 3|Adverse Event|0|||
155219005|NCT04762680|560241163|FG010|Phase 3|Adverse Event|0|||
155219006|NCT04762680|560241164|FG011|Phase 3|Adverse Event|0|||
155219007|NCT04762680|560241165|FG012|Phase 3|Adverse Event|0|||
155219008|NCT04762680|560241166|FG013|Phase 3|Adverse Event|0|||
155219009|NCT04762680|560241167|FG014|Phase 3|Adverse Event|0|||
155219010|NCT04762680|560241168|FG015|Phase 3|Adverse Event|0|||
155219011|NCT04762680|560241169|FG016|Phase 3|Adverse Event|0|||
155219012|NCT04762680|560241170|FG017|Phase 3|Adverse Event|3|||
155219013|NCT04762680|560241171|FG018|Phase 3|Adverse Event|0|||
155219014|NCT04762680|560241172|FG019|Phase 3|Adverse Event|0|||
155219015|NCT04762680|560241173|FG020|Phase 3|Adverse Event|0|||
155219016|NCT04762680|560241174|FG021|Phase 3|Adverse Event|0|||
155219017|NCT04762680|560241153|FG000|Phase 3|Protocol Violation|0|||
155219018|NCT04762680|560241154|FG001|Phase 3|Protocol Violation|0|||
155219019|NCT04762680|560241155|FG002|Phase 3|Protocol Violation|0|||
155219020|NCT04762680|560241156|FG003|Phase 3|Protocol Violation|4|||
155219021|NCT04762680|560241157|FG004|Phase 3|Protocol Violation|1|||
155219022|NCT04762680|560241158|FG005|Phase 3|Protocol Violation|5|||
155219023|NCT04762680|560241159|FG006|Phase 3|Protocol Violation|1|||
155219024|NCT04762680|560241160|FG007|Phase 3|Protocol Violation|0|||
155219025|NCT04762680|560241161|FG008|Phase 3|Protocol Violation|0|||
155219026|NCT04762680|560241162|FG009|Phase 3|Protocol Violation|0|||
155219027|NCT04762680|560241163|FG010|Phase 3|Protocol Violation|0|||
155219028|NCT04762680|560241164|FG011|Phase 3|Protocol Violation|2|||
155219029|NCT04762680|560241165|FG012|Phase 3|Protocol Violation|3|||
155219030|NCT04762680|560241166|FG013|Phase 3|Protocol Violation|0|||
155219031|NCT04762680|560241167|FG014|Phase 3|Protocol Violation|0|||
155219032|NCT04762680|560241168|FG015|Phase 3|Protocol Violation|1|||
155219033|NCT04762680|560241169|FG016|Phase 3|Protocol Violation|0|||
155219034|NCT04762680|560241170|FG017|Phase 3|Protocol Violation|10|||
155219035|NCT04762680|560241171|FG018|Phase 3|Protocol Violation|0|||
155219036|NCT04762680|560241172|FG019|Phase 3|Protocol Violation|0|||
155219037|NCT04762680|560241173|FG020|Phase 3|Protocol Violation|0|||
155219038|NCT04762680|560241174|FG021|Phase 3|Protocol Violation|0|||
155219039|NCT04762680|560241153|FG000|Phase 3|Withdrawal by Subject|0|||
155219040|NCT04762680|560241154|FG001|Phase 3|Withdrawal by Subject|0|||
155219041|NCT04762680|560241155|FG002|Phase 3|Withdrawal by Subject|0|||
155219042|NCT04762680|560241156|FG003|Phase 3|Withdrawal by Subject|13|||
155219043|NCT04762680|560241157|FG004|Phase 3|Withdrawal by Subject|17|||
155219044|NCT04762680|560241158|FG005|Phase 3|Withdrawal by Subject|12|||
155219045|NCT04762680|560241159|FG006|Phase 3|Withdrawal by Subject|8|||
155219046|NCT04762680|560241160|FG007|Phase 3|Withdrawal by Subject|3|||
155219047|NCT04762680|560241161|FG008|Phase 3|Withdrawal by Subject|2|||
155219048|NCT04762680|560241162|FG009|Phase 3|Withdrawal by Subject|4|||
155219049|NCT04762680|560241163|FG010|Phase 3|Withdrawal by Subject|3|||
155219050|NCT04762680|560241164|FG011|Phase 3|Withdrawal by Subject|1|||
155219051|NCT04762680|560241165|FG012|Phase 3|Withdrawal by Subject|3|||
155219052|NCT04762680|560241166|FG013|Phase 3|Withdrawal by Subject|2|||
155219053|NCT04762680|560241167|FG014|Phase 3|Withdrawal by Subject|1|||
155219054|NCT04762680|560241168|FG015|Phase 3|Withdrawal by Subject|4|||
155219055|NCT04762680|560241169|FG016|Phase 3|Withdrawal by Subject|6|||
155219056|NCT04762680|560241170|FG017|Phase 3|Withdrawal by Subject|32|||
155219057|NCT04762680|560241171|FG018|Phase 3|Withdrawal by Subject|0|||
155219058|NCT04762680|560241172|FG019|Phase 3|Withdrawal by Subject|0|||
155219059|NCT04762680|560241173|FG020|Phase 3|Withdrawal by Subject|0|||
155219060|NCT04762680|560241174|FG021|Phase 3|Withdrawal by Subject|0|||
155219061|NCT04762680|560241153|FG000|Phase 3|Lost to Follow-up|0|||
155219062|NCT04762680|560241154|FG001|Phase 3|Lost to Follow-up|0|||
155219063|NCT04762680|560241155|FG002|Phase 3|Lost to Follow-up|0|||
155219064|NCT04762680|560241156|FG003|Phase 3|Lost to Follow-up|9|||
155219065|NCT04762680|560241157|FG004|Phase 3|Lost to Follow-up|22|||
155219066|NCT04762680|560241158|FG005|Phase 3|Lost to Follow-up|24|||
155219067|NCT04762680|560241159|FG006|Phase 3|Lost to Follow-up|2|||
155219068|NCT04762680|560241160|FG007|Phase 3|Lost to Follow-up|4|||
155219069|NCT04762680|560241161|FG008|Phase 3|Lost to Follow-up|6|||
155219070|NCT04762680|560241162|FG009|Phase 3|Lost to Follow-up|4|||
155219071|NCT04762680|560241163|FG010|Phase 3|Lost to Follow-up|3|||
155219072|NCT04762680|560241164|FG011|Phase 3|Lost to Follow-up|0|||
155219073|NCT04762680|560241165|FG012|Phase 3|Lost to Follow-up|5|||
155219074|NCT04762680|560241166|FG013|Phase 3|Lost to Follow-up|4|||
155219075|NCT04762680|560241167|FG014|Phase 3|Lost to Follow-up|6|||
155219076|NCT04762680|560241168|FG015|Phase 3|Lost to Follow-up|1|||
155219077|NCT04762680|560241169|FG016|Phase 3|Lost to Follow-up|1|||
155219078|NCT04762680|560241170|FG017|Phase 3|Lost to Follow-up|66|||
155219079|NCT04762680|560241171|FG018|Phase 3|Lost to Follow-up|0|||
155219080|NCT04762680|560241172|FG019|Phase 3|Lost to Follow-up|0|||
155219081|NCT04762680|560241173|FG020|Phase 3|Lost to Follow-up|0|||
155219082|NCT04762680|560241174|FG021|Phase 3|Lost to Follow-up|0|||
155219083|NCT04762680|560241153|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219084|NCT04762680|560241154|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219085|NCT04762680|560241155|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219086|NCT04762680|560241156|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219087|NCT04762680|560241157|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219088|NCT04762680|560241158|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219089|NCT04762680|560241159|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219090|NCT04762680|560241160|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219091|NCT04762680|560241161|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219092|NCT04762680|560241162|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219093|NCT04762680|560241163|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219094|NCT04762680|560241164|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219095|NCT04762680|560241165|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219096|NCT04762680|560241166|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219097|NCT04762680|560241167|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219098|NCT04762680|560241168|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219099|NCT04762680|560241169|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219100|NCT04762680|560241170|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219101|NCT04762680|560241171|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219102|NCT04762680|560241172|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219103|NCT04762680|560241173|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219104|NCT04762680|560241174|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
155219105|NCT04762680|560241153|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219106|NCT04762680|560241154|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219107|NCT04762680|560241155|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219108|NCT04762680|560241156|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219109|NCT04762680|560241157|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219110|NCT04762680|560241158|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219111|NCT04762680|560241159|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219112|NCT04762680|560241160|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219113|NCT04762680|560241161|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219114|NCT04762680|560241162|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219115|NCT04762680|560241163|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219116|NCT04762680|560241164|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219117|NCT04762680|560241165|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219118|NCT04762680|560241166|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219119|NCT04762680|560241167|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219120|NCT04762680|560241168|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219121|NCT04762680|560241169|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219122|NCT04762680|560241170|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219123|NCT04762680|560241171|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219124|NCT04762680|560241172|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
155219125|NCT04762680|560241173|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219126|NCT04762680|560241174|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219127|NCT03388138|560241175|FG000|Overall Study|Protocol Violation|1|||
155219128|NCT03388138|560241176|FG001|Overall Study|Protocol Violation|0|||
155219129|NCT01528072|560241177|FG000|Overall Study|Withdrawal by Subject|5|||
155219130|NCT01528072|560241177|FG000|Overall Study|Physician Decision|1|||
155219131|NCT01528072|560241177|FG000|Overall Study|Determined not eligible by AEAC|1|||
155219132|NCT01528072|560241177|FG000|Overall Study|Missed Visit|2|||
155219133|NCT01528072|560241177|FG000|Overall Study|Lost to Follow-up|5|||
155219134|NCT01528072|560241177|FG000|Overall Study|Explanted|2|||
155219135|NCT01528072|560241177|FG000|Overall Study|Site Closure|4|||
155219136|NCT01528072|560241177|FG000|Overall Study|Death|2|||
155219137|NCT01528072|560241177|FG000|Overall Study|Early Termination of Study|52|||
155219138|NCT02436759|560241193|FG000|Overall Study|Adverse Event|3|||
155219139|NCT02436759|560241194|FG001|Overall Study|Adverse Event|0|||
155219140|NCT02436759|560241193|FG000|Overall Study|Protocol Violation|1|||
155219141|NCT02436759|560241194|FG001|Overall Study|Protocol Violation|0|||
155219142|NCT02436759|560241193|FG000|Overall Study|Withdrawal by Subject|0|||
155219143|NCT02436759|560241194|FG001|Overall Study|Withdrawal by Subject|1|||
155219144|NCT01290666|560241196|FG000|Overall Study|Lost to Follow-up|11|||
155219145|NCT01290666|560241196|FG000|Overall Study|Withdrawal by Subject|23|||
155219146|NCT01290666|560241196|FG000|Overall Study|Early Termination of Study|4|||
155219147|NCT01652664|560241199|FG000|Overall Study|Treatment Failure|5|||
155219148|NCT01652664|560241200|FG001|Overall Study|Treatment Failure|1|||
155219149|NCT01652664|560241199|FG000|Overall Study|Inadequate IOP control|1|||
155219150|NCT01652664|560241200|FG001|Overall Study|Inadequate IOP control|0|||
155219151|NCT00297037|560241201|FG000|Overall Study|Withdrawal by Subject|2|||
155219152|NCT00297037|560241202|FG001|Overall Study|Withdrawal by Subject|0|||
155219153|NCT00581776|560241203|FG000|Overall Study|Disease progression or no response|3|||
155219154|NCT02357901|560241204|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
155219155|NCT02357901|560241205|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219156|NCT02357901|560241206|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219157|NCT02357901|560241207|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219158|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
155219159|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
155219160|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
155219161|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
155219162|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
155219163|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
155219164|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
155219165|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
155219166|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
155219167|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
155219168|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
155219169|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
155219170|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
155219171|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
155219172|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
155219173|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
155219174|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
155219175|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
155219176|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
155491432|NCT00948896|561223547|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155219177|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
155219178|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
155219179|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
155219180|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
155219181|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
155219182|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
155219183|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
155219184|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
155219185|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
155219186|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
155219187|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
155219188|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
155219189|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
155219190|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
155219191|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
155219192|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
155219193|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
155219194|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
155219195|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
155219196|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
155219197|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
155219198|NCT00491387|560241214|FG000|Overall Study|study terminated|20|||
155219199|NCT02418468|560241223|FG000|Overall Study|Adverse Event|1|||
155219200|NCT02418468|560241224|FG001|Overall Study|Adverse Event|0|||
155219201|NCT02418468|560241223|FG000|Overall Study|Withdrawal of informed consent|1|||
155219202|NCT02418468|560241224|FG001|Overall Study|Withdrawal of informed consent|1|||
155219203|NCT00909779|560241225|FG000|Overall Study|Adverse Event|53|||
155219204|NCT00909779|560241226|FG001|Overall Study|Adverse Event|55|||
155219205|NCT00909779|560241225|FG000|Overall Study|Lack of Efficacy|7|||
155219206|NCT00909779|560241226|FG001|Overall Study|Lack of Efficacy|4|||
155219207|NCT00909779|560241225|FG000|Overall Study|Lost to Follow-up|19|||
155219208|NCT00909779|560241226|FG001|Overall Study|Lost to Follow-up|15|||
155219209|NCT00909779|560241225|FG000|Overall Study|Physician Decision|8|||
155219210|NCT00909779|560241226|FG001|Overall Study|Physician Decision|2|||
155219211|NCT00909779|560241225|FG000|Overall Study|Protocol Violation|2|||
155219212|NCT00909779|560241226|FG001|Overall Study|Protocol Violation|5|||
155219213|NCT00909779|560241225|FG000|Overall Study|Withdrawal by Subject|116|||
155219214|NCT00909779|560241226|FG001|Overall Study|Withdrawal by Subject|80|||
155219215|NCT00909779|560241225|FG000|Overall Study|Site Ceasing Operation|2|||
155219216|NCT00909779|560241226|FG001|Overall Study|Site Ceasing Operation|2|||
155219217|NCT00909779|560241225|FG000|Overall Study|Medical Monitor Decision|1|||
155219218|NCT00909779|560241226|FG001|Overall Study|Medical Monitor Decision|0|||
155219219|NCT00909779|560241225|FG000|Overall Study|Noncompliance|1|||
155219220|NCT00909779|560241226|FG001|Overall Study|Noncompliance|1|||
155219221|NCT00909779|560241225|FG000|Overall Study|Randomized in error|1|||
155219222|NCT00909779|560241226|FG001|Overall Study|Randomized in error|1|||
155219223|NCT01592344|560241227|FG000|Overall Study|Adverse Event|1|||
155219224|NCT01592344|560241228|FG001|Overall Study|Adverse Event|1|||
155219225|NCT01592344|560241227|FG000|Overall Study|Lack of Efficacy|1|||
155219226|NCT01592344|560241228|FG001|Overall Study|Lack of Efficacy|0|||
155219227|NCT01592344|560241227|FG000|Overall Study|not available at primary outcome visit|2|||
155219228|NCT01592344|560241228|FG001|Overall Study|not available at primary outcome visit|4|||
155219229|NCT00099437|560241229|FG000|Overall Study|Lost to Follow-up|30|||
155219230|NCT00099437|560241230|FG001|Overall Study|Lost to Follow-up|33|||
155219231|NCT00099437|560241229|FG000|Overall Study|Death|293|||
155219232|NCT00099437|560241230|FG001|Overall Study|Death|261|||
155219233|NCT00099437|560241229|FG000|Overall Study|Withdrawal by Subject|6|||
155219234|NCT00099437|560241230|FG001|Overall Study|Withdrawal by Subject|10|||
155219235|NCT00099437|560241229|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
155219236|NCT00099437|560241230|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
155219237|NCT00949325|560241231|FG000|Overall Study|Adverse Event|0|||
155219238|NCT00949325|560241232|FG001|Overall Study|Adverse Event|2|||
155219239|NCT00949325|560241233|FG002|Overall Study|Adverse Event|0|||
155219240|NCT02809677|560241234|FG000|Overall Study|Withdrawal by Subject|8|||
155219241|NCT00730912|560241235|FG000|Overall Study|Discontinued|0|||
155219242|NCT00730912|560241236|FG001|Overall Study|Discontinued|0|||
155219243|NCT00730912|560241237|FG002|Overall Study|Discontinued|1|||
155219244|NCT03311659|560241238|FG000|Overall Study|Protocol Violation|1|||
155219245|NCT02205333|560241239|FG000|Overall Study|Death|5|||
155219246|NCT02205333|560241240|FG001|Overall Study|Death|6|||
155219247|NCT02205333|560241241|FG002|Overall Study|Death|2|||
155219248|NCT02205333|560241242|FG003|Overall Study|Death|6|||
155219249|NCT02205333|560241243|FG004|Overall Study|Death|5|||
155219250|NCT02205333|560241244|FG005|Overall Study|Death|3|||
155219251|NCT02205333|560241245|FG006|Overall Study|Death|3|||
155219252|NCT02205333|560241246|FG007|Overall Study|Death|2|||
155219253|NCT02205333|560241247|FG008|Overall Study|Death|0|||
155219254|NCT02205333|560241239|FG000|Overall Study|Withdrawal by Subject|1|||
155219255|NCT02205333|560241240|FG001|Overall Study|Withdrawal by Subject|0|||
155219256|NCT02205333|560241241|FG002|Overall Study|Withdrawal by Subject|0|||
155219257|NCT02205333|560241242|FG003|Overall Study|Withdrawal by Subject|1|||
155219258|NCT02205333|560241243|FG004|Overall Study|Withdrawal by Subject|0|||
155219259|NCT02205333|560241244|FG005|Overall Study|Withdrawal by Subject|0|||
155219260|NCT02205333|560241245|FG006|Overall Study|Withdrawal by Subject|2|||
155219261|NCT02205333|560241246|FG007|Overall Study|Withdrawal by Subject|0|||
155219262|NCT02205333|560241247|FG008|Overall Study|Withdrawal by Subject|0|||
155219263|NCT01176266|560241248|FG000|Overall Study|Death|6|||
155219264|NCT01176266|560241248|FG000|Overall Study|Withdrawal by Subject|3|||
155219265|NCT04351087|560241251|FG000|Overall Study|Lost to Follow-up|7|||
155219266|NCT04351087|560241252|FG001|Overall Study|Lost to Follow-up|3|||
155219267|NCT04351087|560241251|FG000|Overall Study|Withdrawal by Subject|3|||
155219268|NCT04351087|560241252|FG001|Overall Study|Withdrawal by Subject|4|||
155219269|NCT04351087|560241251|FG000|Overall Study|Lack of Efficacy|3|||
155219270|NCT04351087|560241252|FG001|Overall Study|Lack of Efficacy|2|||
155219271|NCT05517382|560241253|FG000|Overall Study|Lost to Follow-up|0|||
155219272|NCT05517382|560241254|FG001|Overall Study|Lost to Follow-up|1|||
155219273|NCT01374087|560241257|FG000|Overall Study|Adverse Event|1|||
155219274|NCT01374087|560241258|FG001|Overall Study|Adverse Event|0|||
155219275|NCT01374087|560241257|FG000|Overall Study|Disease progression|2|||
155219276|NCT01374087|560241258|FG001|Overall Study|Disease progression|2|||
155219277|NCT01374087|560241257|FG000|Overall Study|Study discontinued|13|||
155219278|NCT01374087|560241258|FG001|Overall Study|Study discontinued|13|||
155219279|NCT00271947|560241261|FG000|Overall Study|Lost to Follow-up|1|||
155219280|NCT01522365|560241264|FG000|Overall Study|Withdrawal by Subject|1|||
155219281|NCT01522365|560241265|FG001|Overall Study|Withdrawal by Subject|1|||
155219282|NCT01522365|560241264|FG000|Overall Study|Lost to Follow-up|1|||
155219283|NCT01522365|560241265|FG001|Overall Study|Lost to Follow-up|1|||
155219284|NCT00651755|560241266|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
155219285|NCT00651755|560241267|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
155219286|NCT00651755|560241266|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
155219287|NCT00651755|560241267|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
155219288|NCT01120756|560241268|FG000|Overall Study|Withdrawal by Subject|1|||
155219289|NCT01120756|560241269|FG001|Overall Study|Withdrawal by Subject|1|||
155219290|NCT00698581|560241270|FG000|Overall Study|Lack of Efficacy|23|||
155219291|NCT00698581|560241271|FG001|Overall Study|Lack of Efficacy|11|||
155219292|NCT00698581|560241270|FG000|Overall Study|Withdrawal by Subject|6|||
155219293|NCT00698581|560241271|FG001|Overall Study|Withdrawal by Subject|0|||
155219294|NCT00698581|560241270|FG000|Overall Study|Other reason|9|||
155219295|NCT00698581|560241271|FG001|Overall Study|Other reason|1|||
155219296|NCT00698581|560241270|FG000|Overall Study|SAE, non-fatal|1|||
155219297|NCT00698581|560241271|FG001|Overall Study|SAE, non-fatal|0|||
155219298|NCT00698581|560241270|FG000|Overall Study|AE, non-serious non-fatal|4|||
155219299|NCT00698581|560241271|FG001|Overall Study|AE, non-serious non-fatal|0|||
155219300|NCT00698581|560241270|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155219301|NCT00698581|560241271|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155219302|NCT00698581|560241270|FG000|Overall Study|AE of unknown type|1|||
155219303|NCT00698581|560241271|FG001|Overall Study|AE of unknown type|0|||
155219304|NCT03760146|560241272|FG000|Overall Study|Adverse Event|11|||
155219305|NCT03760146|560241273|FG001|Overall Study|Adverse Event|8|||
155219306|NCT03760146|560241274|FG002|Overall Study|Adverse Event|0|||
155219307|NCT03760146|560241275|FG003|Overall Study|Adverse Event|0|||
155219308|NCT03760146|560241276|FG004|Overall Study|Adverse Event|0|||
155219309|NCT03760146|560241277|FG005|Overall Study|Adverse Event|0|||
155219310|NCT03760146|560241272|FG000|Overall Study|Death|1|||
155219311|NCT03760146|560241273|FG001|Overall Study|Death|0|||
155219312|NCT03760146|560241274|FG002|Overall Study|Death|0|||
155219313|NCT03760146|560241275|FG003|Overall Study|Death|0|||
155219314|NCT03760146|560241276|FG004|Overall Study|Death|0|||
155219315|NCT03760146|560241277|FG005|Overall Study|Death|0|||
155219316|NCT03760146|560241272|FG000|Overall Study|Lost to Follow-up|41|||
155219317|NCT03760146|560241273|FG001|Overall Study|Lost to Follow-up|28|||
155219318|NCT03760146|560241274|FG002|Overall Study|Lost to Follow-up|9|||
155219319|NCT03760146|560241275|FG003|Overall Study|Lost to Follow-up|2|||
155219320|NCT03760146|560241276|FG004|Overall Study|Lost to Follow-up|14|||
155219321|NCT03760146|560241277|FG005|Overall Study|Lost to Follow-up|8|||
155219322|NCT03760146|560241272|FG000|Overall Study|No longer met eligibility criteria|3|||
155219323|NCT03760146|560241273|FG001|Overall Study|No longer met eligibility criteria|9|||
155219324|NCT03760146|560241274|FG002|Overall Study|No longer met eligibility criteria|0|||
155219325|NCT03760146|560241275|FG003|Overall Study|No longer met eligibility criteria|0|||
155219326|NCT03760146|560241276|FG004|Overall Study|No longer met eligibility criteria|1|||
155219327|NCT03760146|560241277|FG005|Overall Study|No longer met eligibility criteria|0|||
155219328|NCT03760146|560241272|FG000|Overall Study|Protocol Violation|21|||
155219329|NCT03760146|560241273|FG001|Overall Study|Protocol Violation|13|||
155219330|NCT03760146|560241274|FG002|Overall Study|Protocol Violation|1|||
155219331|NCT03760146|560241275|FG003|Overall Study|Protocol Violation|0|||
155219332|NCT03760146|560241276|FG004|Overall Study|Protocol Violation|1|||
155219333|NCT03760146|560241277|FG005|Overall Study|Protocol Violation|0|||
155219334|NCT03760146|560241272|FG000|Overall Study|Withdrawal by Subject|19|||
155219335|NCT03760146|560241273|FG001|Overall Study|Withdrawal by Subject|20|||
155219336|NCT03760146|560241274|FG002|Overall Study|Withdrawal by Subject|1|||
155219337|NCT03760146|560241275|FG003|Overall Study|Withdrawal by Subject|0|||
155219338|NCT03760146|560241276|FG004|Overall Study|Withdrawal by Subject|1|||
155219339|NCT03760146|560241277|FG005|Overall Study|Withdrawal by Subject|0|||
155219340|NCT00449644|560241278|FG000|Overall Study|Adverse Event|0|||
155219341|NCT00449644|560241279|FG001|Overall Study|Adverse Event|0|||
155219342|NCT00449644|560241280|FG002|Overall Study|Adverse Event|3|||
155219343|NCT00449644|560241281|FG003|Overall Study|Adverse Event|5|||
155219344|NCT00449644|560241278|FG000|Overall Study|Death|1|||
155219345|NCT00449644|560241279|FG001|Overall Study|Death|0|||
155219346|NCT00449644|560241280|FG002|Overall Study|Death|6|||
155219347|NCT00449644|560241281|FG003|Overall Study|Death|1|||
155219348|NCT00449644|560241278|FG000|Overall Study|Lost to Follow-up|1|||
155219349|NCT00449644|560241279|FG001|Overall Study|Lost to Follow-up|1|||
155219350|NCT00449644|560241280|FG002|Overall Study|Lost to Follow-up|5|||
155219351|NCT00449644|560241281|FG003|Overall Study|Lost to Follow-up|3|||
155219352|NCT00449644|560241278|FG000|Overall Study|Pregnancy|0|||
155219353|NCT00449644|560241279|FG001|Overall Study|Pregnancy|0|||
155219354|NCT00449644|560241280|FG002|Overall Study|Pregnancy|3|||
155219355|NCT00449644|560241281|FG003|Overall Study|Pregnancy|2|||
155219356|NCT00449644|560241278|FG000|Overall Study|Protocol Violation|4|||
155219357|NCT00449644|560241279|FG001|Overall Study|Protocol Violation|4|||
155219358|NCT00449644|560241280|FG002|Overall Study|Protocol Violation|3|||
155219359|NCT00449644|560241281|FG003|Overall Study|Protocol Violation|7|||
155219360|NCT00449644|560241278|FG000|Overall Study|Withdrawal by Subject|3|||
155219361|NCT00449644|560241279|FG001|Overall Study|Withdrawal by Subject|4|||
155219362|NCT00449644|560241280|FG002|Overall Study|Withdrawal by Subject|6|||
155219363|NCT00449644|560241281|FG003|Overall Study|Withdrawal by Subject|7|||
155219364|NCT00449644|560241278|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155219365|NCT00449644|560241279|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
155219366|NCT00449644|560241280|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
155219367|NCT00449644|560241281|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
155219368|NCT00449644|560241278|FG000|Overall Study|Other|1|||
155219369|NCT00449644|560241279|FG001|Overall Study|Other|4|||
155219370|NCT00449644|560241280|FG002|Overall Study|Other|1|||
155219371|NCT00449644|560241281|FG003|Overall Study|Other|0|||
155219372|NCT00449644|560241278|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
155219373|NCT00449644|560241279|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
155219374|NCT00449644|560241280|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
155219375|NCT00449644|560241281|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
155219376|NCT01816893|560241283|FG000|Washout Period|Withdrawal by Subject|2|||
155219377|NCT01816893|560241284|FG001|Washout Period|Withdrawal by Subject|0|||
155219378|NCT00858442|560242825|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
155219379|NCT00858442|560242826|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
155219380|NCT02016625|560242829|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
155219381|NCT02016625|560242830|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
155219382|NCT02016625|560242829|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
155219383|NCT02016625|560242830|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
155219384|NCT02016625|560242829|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
155219385|NCT02016625|560242830|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
155219386|NCT02155738|560242831|FG000|Overall Study|Missing critical information|1|||
155219387|NCT02155738|560242832|FG001|Overall Study|Missing critical information|0|||
155219388|NCT02155738|560242833|FG002|Overall Study|Missing critical information|0|||
155219389|NCT02155738|560242834|FG003|Overall Study|Missing critical information|1|||
155219390|NCT01254227|560242839|FG000|Overall Study|Withdrawal by Subject|6|||
155219391|NCT01254227|560242839|FG000|Overall Study|Lost to Follow-up|6|||
155219392|NCT01254227|560242839|FG000|Overall Study|Adverse Event|5|||
155219393|NCT01254227|560242839|FG000|Overall Study|Abnormal test procedure result|5|||
155219394|NCT01254227|560242839|FG000|Overall Study|Administrative problems|2|||
155219395|NCT01254227|560242839|FG000|Overall Study|Death|1|||
155219396|NCT01254227|560242839|FG000|Overall Study|Protocol deviation|1|||
155219397|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219398|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
155219399|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
155219400|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219401|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219402|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
155219403|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
155219404|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
155219405|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
155219406|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
155219407|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
155219408|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
155219409|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
155219410|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
155219411|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
155219412|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Other|1|||
155219413|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Other|1|||
155219414|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Other|0|||
155219415|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Other|0|||
155219416|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Other|0|||
155219417|NCT03970733|560242840|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219418|NCT03970733|560242841|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219419|NCT03970733|560242842|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219420|NCT03970733|560242843|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219421|NCT03970733|560242844|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
155219422|NCT02189473|560242848|FG000|Overall Study|Death|22|||
155219423|NCT02189473|560242849|FG001|Overall Study|Death|23|||
155219424|NCT02189473|560242848|FG000|Overall Study|Lost to Follow-up|1|||
155219425|NCT02189473|560242849|FG001|Overall Study|Lost to Follow-up|2|||
155219426|NCT02784821|560242850|FG000|Overall Study|Death|0|||
155219427|NCT02784821|560242851|FG001|Overall Study|Death|5|||
155219428|NCT02784821|560242852|FG002|Overall Study|Death|4|||
155219429|NCT02784821|560242853|FG003|Overall Study|Death|5|||
155219430|NCT01139450|560242854|FG000|Overall Study|Withdrawal by Subject|7|||
155219431|NCT01139450|560242855|FG001|Overall Study|Withdrawal by Subject|10|||
155219432|NCT01139450|560242856|FG002|Overall Study|Withdrawal by Subject|13|||
155219433|NCT01139450|560242854|FG000|Overall Study|Lack of Efficacy|3|||
155219434|NCT01139450|560242855|FG001|Overall Study|Lack of Efficacy|1|||
155219435|NCT01139450|560242856|FG002|Overall Study|Lack of Efficacy|8|||
155219436|NCT01139450|560242854|FG000|Overall Study|Protocol Violation|6|||
155219437|NCT01139450|560242855|FG001|Overall Study|Protocol Violation|5|||
155219438|NCT01139450|560242856|FG002|Overall Study|Protocol Violation|2|||
155219439|NCT01139450|560242854|FG000|Overall Study|Lost to Follow-up|9|||
155219440|NCT01139450|560242855|FG001|Overall Study|Lost to Follow-up|7|||
155219441|NCT01139450|560242856|FG002|Overall Study|Lost to Follow-up|11|||
155219442|NCT01139450|560242854|FG000|Overall Study|Administrative|0|||
155219443|NCT01139450|560242855|FG001|Overall Study|Administrative|0|||
155219444|NCT01139450|560242856|FG002|Overall Study|Administrative|1|||
155219445|NCT01139450|560242854|FG000|Overall Study|Adverse Event|2|||
155219446|NCT01139450|560242855|FG001|Overall Study|Adverse Event|2|||
155219447|NCT01139450|560242856|FG002|Overall Study|Adverse Event|3|||
155219448|NCT02794103|560242857|FG000|Overall Study|Loss to follow up due to high sedation|3|||
155219449|NCT04608500|560242858|FG000|Overall Study|Adverse Event|2|||
155219450|NCT04608500|560242859|FG001|Overall Study|Adverse Event|0|||
155219451|NCT04608500|560242858|FG000|Overall Study|Lost to Follow-up|15|||
155219452|NCT04608500|560242859|FG001|Overall Study|Lost to Follow-up|9|||
155219453|NCT04608500|560242858|FG000|Overall Study|Participant request|11|||
155219454|NCT04608500|560242859|FG001|Overall Study|Participant request|7|||
155219455|NCT04608500|560242858|FG000|Overall Study|Protocol Violation|1|||
155219456|NCT04608500|560242859|FG001|Overall Study|Protocol Violation|0|||
155219457|NCT04608500|560242858|FG000|Overall Study|Other|6|||
155219458|NCT04608500|560242859|FG001|Overall Study|Other|2|||
155219459|NCT01881230|560242866|FG000|Overall Study|Death|2|||
155219460|NCT01881230|560242867|FG001|Overall Study|Death|0|||
155219461|NCT01881230|560242868|FG002|Overall Study|Death|1|||
155219462|NCT01881230|560242866|FG000|Overall Study|Adverse Event|9|||
155219463|NCT01881230|560242867|FG001|Overall Study|Adverse Event|13|||
155219464|NCT01881230|560242868|FG002|Overall Study|Adverse Event|12|||
155219465|NCT01881230|560242866|FG000|Overall Study|Progressive Disease|31|||
155219466|NCT01881230|560242867|FG001|Overall Study|Progressive Disease|35|||
155219467|NCT01881230|560242868|FG002|Overall Study|Progressive Disease|36|||
155219468|NCT01881230|560242866|FG000|Overall Study|Symptomatic Deterioration|3|||
155219469|NCT01881230|560242867|FG001|Overall Study|Symptomatic Deterioration|3|||
155219470|NCT01881230|560242868|FG002|Overall Study|Symptomatic Deterioration|1|||
155219471|NCT01881230|560242866|FG000|Overall Study|Withdrawal by Subject|6|||
155219472|NCT01881230|560242867|FG001|Overall Study|Withdrawal by Subject|4|||
155219473|NCT01881230|560242868|FG002|Overall Study|Withdrawal by Subject|6|||
155219474|NCT01881230|560242866|FG000|Overall Study|Physician Decision|4|||
155219475|NCT01881230|560242867|FG001|Overall Study|Physician Decision|3|||
155219476|NCT01881230|560242868|FG002|Overall Study|Physician Decision|6|||
155219477|NCT01881230|560242866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155219478|NCT01881230|560242867|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155219479|NCT01881230|560242868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155219480|NCT01881230|560242866|FG000|Overall Study|Given Commercially Available Drug|0|||
155219481|NCT01881230|560242867|FG001|Overall Study|Given Commercially Available Drug|0|||
155219482|NCT01881230|560242868|FG002|Overall Study|Given Commercially Available Drug|2|||
155219483|NCT01881230|560242866|FG000|Overall Study|Protocol Violation|1|||
155219484|NCT01881230|560242867|FG001|Overall Study|Protocol Violation|1|||
155219485|NCT01881230|560242868|FG002|Overall Study|Protocol Violation|0|||
155219486|NCT01881230|560242866|FG000|Overall Study|Miscellaneous|3|||
155219487|NCT01881230|560242867|FG001|Overall Study|Miscellaneous|3|||
155219488|NCT01881230|560242868|FG002|Overall Study|Miscellaneous|0|||
155219489|NCT01881230|560242866|FG000|Overall Study|Untreated: Other|0|||
155219490|NCT01881230|560242867|FG001|Overall Study|Untreated: Other|0|||
155219491|NCT01881230|560242868|FG002|Overall Study|Untreated: Other|1|||
155219492|NCT01881230|560242866|FG000|Overall Study|Untreated: Death|0|||
155219493|NCT01881230|560242867|FG001|Overall Study|Untreated: Death|0|||
155219494|NCT01881230|560242868|FG002|Overall Study|Untreated: Death|1|||
155219495|NCT01881230|560242866|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
155219496|NCT01881230|560242867|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
155219497|NCT01881230|560242868|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
155219498|NCT05123222|560242869|FG000|Overall Study|Lost to Follow-up|2|||
155219499|NCT05123222|560242870|FG001|Overall Study|Lost to Follow-up|0|||
155219500|NCT05123222|560242871|FG002|Overall Study|Lost to Follow-up|0|||
155219501|NCT05123222|560242872|FG003|Overall Study|Lost to Follow-up|0|||
155219502|NCT05123222|560242869|FG000|Overall Study|Protocol Violation|0|||
155219503|NCT05123222|560242870|FG001|Overall Study|Protocol Violation|0|||
155219504|NCT05123222|560242871|FG002|Overall Study|Protocol Violation|1|||
155219505|NCT05123222|560242872|FG003|Overall Study|Protocol Violation|0|||
155219506|NCT00914810|560242875|FG000|Overall Study|Withdrawal by Subject|1|||
155219507|NCT00914810|560242876|FG001|Overall Study|Withdrawal by Subject|0|||
155219508|NCT00914810|560242875|FG000|Overall Study|Relocated out of state|1|||
155219509|NCT00914810|560242876|FG001|Overall Study|Relocated out of state|0|||
155219510|NCT00914810|560242875|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
155219511|NCT00914810|560242876|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
155219512|NCT02747420|560242877|FG000|Overall Study|Lost to Follow-up|4|||
155219513|NCT02747420|560242878|FG001|Overall Study|Lost to Follow-up|2|||
155219514|NCT02747420|560242877|FG000|Overall Study|Withdrawal by Subject|3|||
155219515|NCT02747420|560242878|FG001|Overall Study|Withdrawal by Subject|2|||
155219516|NCT04782856|560242879|FG000|Overall Study|Withdrawal by Subject|0|||
155219517|NCT04782856|560242880|FG001|Overall Study|Withdrawal by Subject|1|||
155219518|NCT02535741|560242881|FG000|Overall Study|Adverse Event|3|||
155219519|NCT02535741|560242881|FG000|Overall Study|Withdrawal by Subject|9|||
155219520|NCT02535741|560242881|FG000|Overall Study|Lost to Follow-up|10|||
155219521|NCT02535741|560242881|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
155219522|NCT02535741|560242881|FG000|Overall Study|Missing data|6|||
155219523|NCT01030523|560242882|FG000|Initial Study (5 Years)|Death|1|||
155219524|NCT01030523|560242883|FG001|Initial Study (5 Years)|Death|0|||
155219525|NCT01030523|560242882|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
155219526|NCT01030523|560242883|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
155219527|NCT01030523|560242882|FG000|Initial Study (5 Years)|Implant failure|1|||
155219528|NCT01030523|560242883|FG001|Initial Study (5 Years)|Implant failure|0|||
155219529|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
155219530|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
155219531|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
155219532|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
155219533|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
155219534|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
155219535|NCT00798369|560242886|FG000|Overall Study|Subject withdrew consent|0|||
155219536|NCT00798369|560242887|FG001|Overall Study|Subject withdrew consent|0|||
155219537|NCT00798369|560242888|FG002|Overall Study|Subject withdrew consent|1|||
155219538|NCT00798369|560242889|FG003|Overall Study|Subject withdrew consent|1|||
155219539|NCT00798369|560242890|FG004|Overall Study|Subject withdrew consent|0|||
155219540|NCT00798369|560242891|FG005|Overall Study|Subject withdrew consent|2|||
155219541|NCT00798369|560242886|FG000|Overall Study|Lost to Follow-up|1|||
155219542|NCT00798369|560242887|FG001|Overall Study|Lost to Follow-up|1|||
155219543|NCT00798369|560242888|FG002|Overall Study|Lost to Follow-up|1|||
155219544|NCT00798369|560242889|FG003|Overall Study|Lost to Follow-up|0|||
155219545|NCT00798369|560242890|FG004|Overall Study|Lost to Follow-up|1|||
155219546|NCT00798369|560242891|FG005|Overall Study|Lost to Follow-up|0|||
155219547|NCT00798369|560242886|FG000|Overall Study|Adminstrative problems|0|||
155219548|NCT00798369|560242887|FG001|Overall Study|Adminstrative problems|0|||
155219549|NCT00798369|560242888|FG002|Overall Study|Adminstrative problems|0|||
155219550|NCT00798369|560242889|FG003|Overall Study|Adminstrative problems|0|||
155219551|NCT00798369|560242890|FG004|Overall Study|Adminstrative problems|0|||
155219552|NCT00798369|560242891|FG005|Overall Study|Adminstrative problems|1|||
155219553|NCT04475588|560242892|FG000|Overall Study|Adverse Event|2|||
155219554|NCT04475588|560242893|FG001|Overall Study|Adverse Event|0|||
155219555|NCT03020823|560242894|FG000|Overall Study|Physician Decision|4|||
155219556|NCT03020823|560242894|FG000|Overall Study|Lack of Efficacy|4|||
155219557|NCT03020823|560242894|FG000|Overall Study|Adverse Event|2|||
155219558|NCT00588822|560242895|FG000|Overall Study|progression of disease|8|||
155219559|NCT01413360|560242899|FG000|Overall Study|Lost to Follow-up|2|||
155219560|NCT01413360|560242899|FG000|Overall Study|Adverse Event|1|||
155219561|NCT02246673|560242902|FG000|Overall Study|Sponsor Decision|1|||
155219562|NCT02246673|560242903|FG001|Overall Study|Sponsor Decision|0|||
155219563|NCT02246673|560242904|FG002|Overall Study|Sponsor Decision|0|||
155219564|NCT02246673|560242905|FG003|Overall Study|Sponsor Decision|0|||
155219565|NCT02246673|560242906|FG004|Overall Study|Sponsor Decision|0|||
155219566|NCT02246673|560242902|FG000|Overall Study|Withdrawal by Subject|0|||
155219567|NCT02246673|560242903|FG001|Overall Study|Withdrawal by Subject|0|||
155219568|NCT02246673|560242904|FG002|Overall Study|Withdrawal by Subject|0|||
155219569|NCT02246673|560242905|FG003|Overall Study|Withdrawal by Subject|0|||
155219570|NCT02246673|560242906|FG004|Overall Study|Withdrawal by Subject|1|||
155219571|NCT02246673|560242902|FG000|Overall Study|Lost to Follow-up|0|||
155219572|NCT02246673|560242903|FG001|Overall Study|Lost to Follow-up|0|||
155219573|NCT02246673|560242904|FG002|Overall Study|Lost to Follow-up|0|||
155219574|NCT02246673|560242905|FG003|Overall Study|Lost to Follow-up|1|||
155219575|NCT02246673|560242906|FG004|Overall Study|Lost to Follow-up|0|||
155219576|NCT02246673|560242902|FG000|Overall Study|Protocol Violation|0|||
155219577|NCT02246673|560242903|FG001|Overall Study|Protocol Violation|0|||
155219578|NCT02246673|560242904|FG002|Overall Study|Protocol Violation|0|||
155219579|NCT02246673|560242905|FG003|Overall Study|Protocol Violation|1|||
155219580|NCT02246673|560242906|FG004|Overall Study|Protocol Violation|0|||
155219581|NCT02914769|560242907|FG000|Overall Study|Protocol Violation|3|||
155219582|NCT02914769|560242908|FG001|Overall Study|Protocol Violation|2|||
155219583|NCT02914769|560242907|FG000|Overall Study|Withdrawal by Subject|0|||
155219584|NCT02914769|560242908|FG001|Overall Study|Withdrawal by Subject|1|||
155219585|NCT02410954|560242909|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
155219586|NCT02410954|560242910|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
155219587|NCT02410954|560242909|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
155219588|NCT02410954|560242910|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
155219589|NCT02738333|560242911|FG000|Overall Study|Death|1|||
155219590|NCT02738333|560242912|FG001|Overall Study|Death|0|||
155219591|NCT02738333|560242913|FG002|Overall Study|Death|0|||
155219592|NCT02738333|560242911|FG000|Overall Study|Lost to Follow-up|1|||
155219593|NCT02738333|560242912|FG001|Overall Study|Lost to Follow-up|0|||
155219594|NCT02738333|560242913|FG002|Overall Study|Lost to Follow-up|0|||
155219595|NCT05413369|560242914|FG000|Overall Study|Adverse Event|1|||
155219596|NCT05413369|560242915|FG001|Overall Study|Adverse Event|1|||
155219597|NCT05413369|560242914|FG000|Overall Study|Withdrawal by Subject|13|||
155219598|NCT05413369|560242915|FG001|Overall Study|Withdrawal by Subject|4|||
155219599|NCT05413369|560242914|FG000|Overall Study|Non-compliance with study schedule|2|||
155219600|NCT05413369|560242915|FG001|Overall Study|Non-compliance with study schedule|1|||
155219601|NCT05413369|560242914|FG000|Overall Study|Other|1|||
155219602|NCT05413369|560242915|FG001|Overall Study|Other|1|||
155219603|NCT03165110|560242916|FG000|Overall Study|Anroid phone software incompatibility|1|||
155219604|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
155219605|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
155219606|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
155219607|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
155219608|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
155219609|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
155219610|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
155219611|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
155219612|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
155219613|NCT02642432|560242927|FG000|Overall Study|Adverse Event|2|||
155219614|NCT02642432|560242927|FG000|Overall Study|Withdrew Consent|1|||
155219615|NCT02642432|560242927|FG000|Overall Study|Lost to Follow-up|2|||
155219616|NCT02642432|560242927|FG000|Overall Study|Other|3|||
155219617|NCT03999892|560242928|FG000|Overall Study|Lost to Follow-up|1|||
155219618|NCT01848756|560242929|FG000|Overall Study|Adverse Event|1|||
155219619|NCT01848756|560242929|FG000|Overall Study|Withdrawal by Subject|1|||
155219620|NCT01848756|560242929|FG000|Overall Study|Enrolled in Error|1|||
155219621|NCT03245008|560242930|FG000|Overall Study|Adverse Event|15|||
155219622|NCT03245008|560242931|FG001|Overall Study|Adverse Event|18|||
155219623|NCT03245008|560242932|FG002|Overall Study|Adverse Event|15|||
155219624|NCT03245008|560242933|FG003|Overall Study|Adverse Event|0|||
155219625|NCT03245008|560242934|FG004|Overall Study|Adverse Event|1|||
155219626|NCT03245008|560242930|FG000|Overall Study|Lack of Efficacy|0|||
155219627|NCT03245008|560242931|FG001|Overall Study|Lack of Efficacy|1|||
155219628|NCT03245008|560242932|FG002|Overall Study|Lack of Efficacy|0|||
155219629|NCT03245008|560242933|FG003|Overall Study|Lack of Efficacy|0|||
155219630|NCT03245008|560242934|FG004|Overall Study|Lack of Efficacy|0|||
155219631|NCT03245008|560242930|FG000|Overall Study|Lost to Follow-up|4|||
155219632|NCT03245008|560242931|FG001|Overall Study|Lost to Follow-up|1|||
155219633|NCT03245008|560242932|FG002|Overall Study|Lost to Follow-up|0|||
155219634|NCT03245008|560242933|FG003|Overall Study|Lost to Follow-up|0|||
155219635|NCT03245008|560242934|FG004|Overall Study|Lost to Follow-up|1|||
155219636|NCT03245008|560242930|FG000|Overall Study|Physician Decision|1|||
155219637|NCT03245008|560242931|FG001|Overall Study|Physician Decision|3|||
155219638|NCT03245008|560242932|FG002|Overall Study|Physician Decision|4|||
155219639|NCT03245008|560242933|FG003|Overall Study|Physician Decision|0|||
155219640|NCT03245008|560242934|FG004|Overall Study|Physician Decision|0|||
155219641|NCT03245008|560242930|FG000|Overall Study|Protocol Violation|0|||
155219642|NCT03245008|560242931|FG001|Overall Study|Protocol Violation|1|||
155219643|NCT03245008|560242932|FG002|Overall Study|Protocol Violation|0|||
155219644|NCT03245008|560242933|FG003|Overall Study|Protocol Violation|0|||
155219645|NCT03245008|560242934|FG004|Overall Study|Protocol Violation|0|||
155219646|NCT03245008|560242930|FG000|Overall Study|Withdrawal by Subject|20|||
155219647|NCT03245008|560242931|FG001|Overall Study|Withdrawal by Subject|19|||
155219648|NCT03245008|560242932|FG002|Overall Study|Withdrawal by Subject|11|||
155219649|NCT03245008|560242933|FG003|Overall Study|Withdrawal by Subject|0|||
155219650|NCT03245008|560242934|FG004|Overall Study|Withdrawal by Subject|0|||
155219651|NCT03245008|560242930|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219652|NCT03245008|560242931|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219653|NCT03245008|560242932|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219654|NCT03245008|560242933|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
155219655|NCT03245008|560242934|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
155219656|NCT03245008|560242930|FG000|Overall Study|Failure to meet randomization criteria|0|||
155219657|NCT03245008|560242931|FG001|Overall Study|Failure to meet randomization criteria|1|||
155219658|NCT03245008|560242932|FG002|Overall Study|Failure to meet randomization criteria|0|||
155219659|NCT03245008|560242933|FG003|Overall Study|Failure to meet randomization criteria|1|||
155219660|NCT03245008|560242934|FG004|Overall Study|Failure to meet randomization criteria|0|||
155219661|NCT02075658|560242935|FG000|Overall Study|Physician Decision|2|||
155219662|NCT02075658|560242936|FG001|Overall Study|Physician Decision|2|||
155219663|NCT01286012|560242937|FG000|Overall Study|Adverse Event|3|||
155219664|NCT01286012|560242938|FG001|Overall Study|Adverse Event|3|||
155219665|NCT01286012|560242937|FG000|Overall Study|Death|2|||
155219666|NCT01286012|560242938|FG001|Overall Study|Death|3|||
155219667|NCT01286012|560242937|FG000|Overall Study|Protocol Violation|1|||
155219668|NCT01286012|560242938|FG001|Overall Study|Protocol Violation|1|||
155219669|NCT01286012|560242937|FG000|Overall Study|Withdrawal by Subject|4|||
155219670|NCT01286012|560242938|FG001|Overall Study|Withdrawal by Subject|4|||
155219671|NCT01286012|560242937|FG000|Overall Study|Physician Decision|2|||
155219672|NCT01286012|560242938|FG001|Overall Study|Physician Decision|0|||
155219673|NCT01286012|560242937|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
155219674|NCT01286012|560242938|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
155219675|NCT04056195|560242941|FG000|Overall Study|Adverse Event|1|||
155219676|NCT04056195|560242942|FG001|Overall Study|Adverse Event|0|||
155219677|NCT04056195|560242943|FG002|Overall Study|Adverse Event|0|||
155219678|NCT04056195|560242941|FG000|Overall Study|Withdrawal by Subject|0|||
155219679|NCT04056195|560242942|FG001|Overall Study|Withdrawal by Subject|1|||
155219680|NCT04056195|560242943|FG002|Overall Study|Withdrawal by Subject|1|||
155219681|NCT04056195|560242941|FG000|Overall Study|Physician Decision|1|||
155219682|NCT04056195|560242942|FG001|Overall Study|Physician Decision|1|||
155219683|NCT04056195|560242943|FG002|Overall Study|Physician Decision|1|||
155219684|NCT02406651|560242944|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
155219685|NCT00718328|560242948|FG000|Overall Study|Lost to Follow-up|1|||
155219686|NCT00718328|560242949|FG001|Overall Study|Lost to Follow-up|0|||
155219687|NCT02865915|560242950|FG000|Overall Study|Pregnancy|1|||
155219688|NCT02865915|560242951|FG001|Overall Study|Pregnancy|0|||
155219689|NCT02865915|560242950|FG000|Overall Study|Withdrawal by Subject|1|||
155219690|NCT02865915|560242951|FG001|Overall Study|Withdrawal by Subject|1|||
155219691|NCT02865915|560242950|FG000|Overall Study|Adverse Event|0|||
155219692|NCT02865915|560242951|FG001|Overall Study|Adverse Event|4|||
155219693|NCT02865915|560242950|FG000|Overall Study|Lost to Follow-up|0|||
155219694|NCT02865915|560242951|FG001|Overall Study|Lost to Follow-up|1|||
155219695|NCT02865915|560242950|FG000|Overall Study|Protocol Violation|0|||
155219696|NCT02865915|560242951|FG001|Overall Study|Protocol Violation|1|||
155219697|NCT02865915|560242950|FG000|Overall Study|Study terminated by sponsor|23|||
155219698|NCT02865915|560242951|FG001|Overall Study|Study terminated by sponsor|18|||
155219699|NCT02865915|560242950|FG000|Overall Study|Dosing group discontinued|0|||
155219700|NCT02865915|560242951|FG001|Overall Study|Dosing group discontinued|5|||
155219701|NCT00663052|560242952|FG000|Overall Study|Adverse Event|6|||
155219702|NCT00663052|560242953|FG001|Overall Study|Adverse Event|3|||
155219703|NCT00663052|560242952|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
155219704|NCT00663052|560242953|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155219705|NCT00663052|560242952|FG000|Overall Study|Protocol Violation|1|||
155219706|NCT00663052|560242953|FG001|Overall Study|Protocol Violation|0|||
155219707|NCT00663052|560242952|FG000|Overall Study|Withdrawal by Subject|2|||
155219708|NCT00663052|560242953|FG001|Overall Study|Withdrawal by Subject|5|||
155219709|NCT00663052|560242952|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
155219710|NCT00663052|560242953|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
155219711|NCT00663052|560242952|FG000|Overall Study|Other|0|||
155219712|NCT00663052|560242953|FG001|Overall Study|Other|1|||
155219713|NCT01602380|560242956|FG000|Overall Study|Death|147|||
155219714|NCT01602380|560242957|FG001|Overall Study|Death|145|||
155219715|NCT01602380|560242956|FG000|Overall Study|Withdrawal by Subject|39|||
155219716|NCT01602380|560242957|FG001|Overall Study|Withdrawal by Subject|41|||
155219717|NCT01602380|560242956|FG000|Overall Study|Lost to Follow-up|15|||
155219718|NCT01602380|560242957|FG001|Overall Study|Lost to Follow-up|12|||
155219719|NCT01602380|560242956|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155219720|NCT01602380|560242957|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
155219721|NCT01602380|560242956|FG000|Overall Study|Other|2|||
155219722|NCT01602380|560242957|FG001|Overall Study|Other|0|||
155219723|NCT05760300|560242960|FG000|Overall Study|Adverse Event|0|||
155219724|NCT05760300|560242961|FG001|Overall Study|Adverse Event|0|||
155219725|NCT05760300|560242962|FG002|Overall Study|Adverse Event|1|||
155219726|NCT05760300|560242963|FG003|Overall Study|Adverse Event|0|||
155219727|NCT05760300|560242960|FG000|Overall Study|Participant Decision|1|||
155219728|NCT05760300|560242961|FG001|Overall Study|Participant Decision|0|||
155219729|NCT05760300|560242962|FG002|Overall Study|Participant Decision|0|||
155219730|NCT05760300|560242963|FG003|Overall Study|Participant Decision|0|||
155219731|NCT03313804|560242964|FG000|Treatment|Death|5|||
155219732|NCT03313804|560242964|FG000|Treatment|still on treatment|2|||
155219733|NCT03313804|560242964|FG000|Follow Up|still on follow up|3|||
155219734|NCT01502423|560242965|FG000|Overall Study|Withdrawal by Subject|0|||
155219735|NCT01502423|560242966|FG001|Overall Study|Withdrawal by Subject|1|||
155219736|NCT00567892|560242967|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219737|NCT00567892|560242968|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219738|NCT00567892|560242969|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
155219739|NCT00567892|560242970|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
155219740|NCT00567892|560242967|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219741|NCT00567892|560242968|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219742|NCT00567892|560242969|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219743|NCT00567892|560242970|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
155219744|NCT04814433|560242971|FG000|Overall Study|Survey not returned|4|||
155219745|NCT04814433|560242972|FG001|Overall Study|Survey not returned|8|||
155219746|NCT04814433|560242973|FG002|Overall Study|Survey not returned|4|||
155219747|NCT04814433|560242974|FG003|Overall Study|Survey not returned|5|||
155219748|NCT01545817|560244891|FG000|Pazopanib|Disease progression|51|||
155219749|NCT01545817|560244892|FG001|Pazopanib|Disease progression|0|||
155219750|NCT01545817|560244891|FG000|Pazopanib|Adverse Event|19|||
155219751|NCT01545817|560244892|FG001|Pazopanib|Adverse Event|0|||
155219752|NCT01545817|560244891|FG000|Pazopanib|Other reason|4|||
155219753|NCT01545817|560244892|FG001|Pazopanib|Other reason|0|||
155219754|NCT01545817|560244891|FG000|Everolimus|Other reason|0|||
155219755|NCT01545817|560244892|FG001|Everolimus|Other reason|7|||
155219756|NCT01545817|560244891|FG000|Everolimus|Disease progression|0|||
155219757|NCT01545817|560244892|FG001|Everolimus|Disease progression|25|||
155219758|NCT01545817|560244891|FG000|Everolimus|Adverse Event|0|||
155219759|NCT01545817|560244892|FG001|Everolimus|Adverse Event|6|||
155219760|NCT04439253|560244893|FG000|Overall Study|Adverse Event|1|||
155219761|NCT04439253|560244893|FG000|Overall Study|Disease progression|2|||
155219762|NCT04439253|560244893|FG000|Overall Study|Complicating disease|1|||
155219763|NCT03971695|560244894|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219764|NCT03971695|560244895|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219765|NCT03971695|560244896|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219766|NCT03971695|560244897|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
155219767|NCT03971695|560244898|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
155219768|NCT03971695|560244899|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219769|NCT03971695|560244900|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219770|NCT03971695|560244901|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219771|NCT03971695|560244902|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
155219772|NCT03971695|560244903|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219773|NCT03971695|560244904|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219774|NCT03971695|560244905|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219775|NCT03971695|560244906|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219776|NCT04447417|560244907|FG000|Overall Study|Withdrawal by Subject|1|||
155219777|NCT04447417|560244908|FG001|Overall Study|Withdrawal by Subject|0|||
155219778|NCT04447417|560244907|FG000|Overall Study|Failure to meet inclusion criteria|1|||
155219779|NCT04447417|560244908|FG001|Overall Study|Failure to meet inclusion criteria|0|||
155219780|NCT04447417|560244907|FG000|Overall Study|Lost to Follow-up|1|||
155219781|NCT04447417|560244908|FG001|Overall Study|Lost to Follow-up|0|||
155219782|NCT00702403|560244909|FG000|From Consent to Engraftment|Progressive leukemia|6|||
155219783|NCT00702403|560244909|FG000|From Consent to Engraftment|Critically ill|2|||
155219784|NCT00702403|560244909|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
155219785|NCT00702403|560244909|FG000|From Consent to Engraftment|Myocardial infarction|1|||
155219786|NCT00702403|560244909|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
155219787|NCT00702403|560244909|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
155219788|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
155219789|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
155219790|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Non-compliance|2|||
155219791|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
155219792|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
155219793|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Suicide|1|||
155219794|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
155219795|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
155219796|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
155219797|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
155219798|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
155219799|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
155219800|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
155219801|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
155219802|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
155219803|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
155219804|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
155219805|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
155219806|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
155219807|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
155219808|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
155219809|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
155219810|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
155219811|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
155219812|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
155219813|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
155219814|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
155219815|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
155219816|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
155219817|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
155219818|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
155219819|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
155219820|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
155219821|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
155219822|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
155219823|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
155219824|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
155219825|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
155219826|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
155219827|NCT01466348|560244919|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
155219828|NCT01466348|560244920|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
155219829|NCT00192504|560244923|FG000|Overall Study|Lost to Follow-up|1|||
155219830|NCT00192504|560244924|FG001|Overall Study|Lost to Follow-up|0|||
155219831|NCT00192504|560244925|FG002|Overall Study|Lost to Follow-up|0|||
155219832|NCT00192504|560244926|FG003|Overall Study|Lost to Follow-up|0|||
155219833|NCT00192504|560244923|FG000|Overall Study|Dosing window missed|0|||
155219834|NCT00192504|560244924|FG001|Overall Study|Dosing window missed|0|||
155219835|NCT00192504|560244925|FG002|Overall Study|Dosing window missed|1|||
155219836|NCT00192504|560244926|FG003|Overall Study|Dosing window missed|0|||
155219837|NCT03989440|560244927|FG000|Overall Study|COVID-19 travel restrictions|0|||
155219838|NCT03989440|560244928|FG001|Overall Study|COVID-19 travel restrictions|0|||
155219839|NCT03989440|560244929|FG002|Overall Study|COVID-19 travel restrictions|1|||
155219840|NCT03989440|560244930|FG003|Overall Study|COVID-19 travel restrictions|0|||
155219841|NCT03989440|560244931|FG004|Overall Study|COVID-19 travel restrictions|0|||
155219842|NCT03989440|560244932|FG005|Overall Study|COVID-19 travel restrictions|0|||
155219843|NCT03989440|560244927|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
155219844|NCT03989440|560244928|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
155219845|NCT03989440|560244929|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
155219846|NCT03989440|560244930|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
155219847|NCT03989440|560244931|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
155219848|NCT03989440|560244932|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
155219849|NCT01955161|560244935|FG000|Overall Study|Withdrawal before treatment|2|||
155219850|NCT01955161|560244936|FG001|Overall Study|Withdrawal before treatment|0|||
155219851|NCT01955161|560244937|FG002|Overall Study|Withdrawal before treatment|1|||
155219852|NCT01955161|560244935|FG000|Overall Study|Adverse Event|10|||
155219853|NCT01955161|560244936|FG001|Overall Study|Adverse Event|14|||
155219854|NCT01955161|560244937|FG002|Overall Study|Adverse Event|15|||
155219855|NCT01955161|560244935|FG000|Overall Study|Death|1|||
155219856|NCT01955161|560244936|FG001|Overall Study|Death|1|||
155219857|NCT01955161|560244937|FG002|Overall Study|Death|3|||
155219858|NCT01955161|560244935|FG000|Overall Study|Withdrawal by Subject|9|||
155219859|NCT01955161|560244936|FG001|Overall Study|Withdrawal by Subject|8|||
155219860|NCT01955161|560244937|FG002|Overall Study|Withdrawal by Subject|12|||
155219861|NCT01955161|560244935|FG000|Overall Study|Protocol Violation|2|||
155219862|NCT01955161|560244936|FG001|Overall Study|Protocol Violation|0|||
155219863|NCT01955161|560244937|FG002|Overall Study|Protocol Violation|0|||
155219864|NCT01955161|560244935|FG000|Overall Study|Other reason: physician decision|0|||
155219865|NCT01955161|560244936|FG001|Overall Study|Other reason: physician decision|1|||
155219866|NCT01955161|560244937|FG002|Overall Study|Other reason: physician decision|1|||
155219867|NCT01955161|560244935|FG000|Overall Study|Other reason: disallowed medication|1|||
155219868|NCT01955161|560244936|FG001|Overall Study|Other reason: disallowed medication|0|||
155219869|NCT01955161|560244937|FG002|Overall Study|Other reason: disallowed medication|1|||
155219870|NCT01955161|560244935|FG000|Overall Study|Other reason: caregiver unavailable|1|||
155219871|NCT01955161|560244936|FG001|Overall Study|Other reason: caregiver unavailable|0|||
155219872|NCT01955161|560244937|FG002|Overall Study|Other reason: caregiver unavailable|0|||
155219873|NCT01955161|560244935|FG000|Overall Study|Other reason: moved to nursing home|0|||
155219874|NCT01955161|560244936|FG001|Overall Study|Other reason: moved to nursing home|1|||
155219875|NCT01955161|560244937|FG002|Overall Study|Other reason: moved to nursing home|0|||
155219876|NCT01955161|560244935|FG000|Overall Study|Other reason: insufficient compliance|0|||
155219877|NCT01955161|560244936|FG001|Overall Study|Other reason: insufficient compliance|0|||
155219878|NCT01955161|560244937|FG002|Overall Study|Other reason: insufficient compliance|1|||
155219879|NCT01955161|560244935|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
155219880|NCT01955161|560244936|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
155219881|NCT01955161|560244937|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
155219882|NCT01955161|560244935|FG000|Overall Study|Other reason: patient's will|0|||
155219883|NCT01955161|560244936|FG001|Overall Study|Other reason: patient's will|0|||
155219884|NCT01955161|560244937|FG002|Overall Study|Other reason: patient's will|1|||
155219885|NCT05129488|560244943|FG000|Overall Study|Protocol Violation|3|||
155219886|NCT00706641|560244948|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
155219887|NCT00706641|560244948|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
155219888|NCT00706641|560244948|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
155219889|NCT01327300|560244949|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
155219890|NCT01327300|560244950|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
155219891|NCT03739112|560244951|FG000|Overall Study|Adverse Event|2|||
155219892|NCT03739112|560244952|FG001|Overall Study|Adverse Event|2|||
155219893|NCT03739112|560244951|FG000|Overall Study|Withdrawal by Subject|38|||
155219894|NCT03739112|560244952|FG001|Overall Study|Withdrawal by Subject|19|||
155219895|NCT03739112|560244951|FG000|Overall Study|Lost to Follow-up|31|||
155219896|NCT03739112|560244952|FG001|Overall Study|Lost to Follow-up|33|||
155219897|NCT03739112|560244951|FG000|Overall Study|Protocol Deviation|12|||
155219898|NCT03739112|560244952|FG001|Overall Study|Protocol Deviation|9|||
155219899|NCT03739112|560244951|FG000|Overall Study|Physician Decision|1|||
155219900|NCT03739112|560244952|FG001|Overall Study|Physician Decision|0|||
155219901|NCT03739112|560244951|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
155219902|NCT03739112|560244952|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
155219903|NCT03739112|560244951|FG000|Overall Study|Site went on hold|65|||
155219904|NCT03739112|560244952|FG001|Overall Study|Site went on hold|67|||
155219905|NCT03739112|560244951|FG000|Overall Study|Other than specified|8|||
155219906|NCT03739112|560244952|FG001|Overall Study|Other than specified|5|||
155219907|NCT03739112|560244951|FG000|Overall Study|Randomized but not vaccinated|31|||
155219908|NCT03739112|560244952|FG001|Overall Study|Randomized but not vaccinated|25|||
155219909|NCT04307446|560244954|FG000|Overall Study|Lost to Follow-up|2|||
155219910|NCT04307446|560244955|FG001|Overall Study|Lost to Follow-up|0|||
155219911|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
155219912|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
155219913|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
155219914|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
155219915|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
155219916|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
155219917|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
155219918|NCT01727141|560244959|FG000|Overall Study|Physician Decision|0|||
155219919|NCT01727141|560244960|FG001|Overall Study|Physician Decision|1|||
155219920|NCT01727141|560244961|FG002|Overall Study|Physician Decision|0|||
155219921|NCT01727141|560244962|FG003|Overall Study|Physician Decision|2|||
155219922|NCT01727141|560244959|FG000|Overall Study|Lost to Follow-up|0|||
155219923|NCT01727141|560244960|FG001|Overall Study|Lost to Follow-up|2|||
155219924|NCT01727141|560244961|FG002|Overall Study|Lost to Follow-up|0|||
155219925|NCT01727141|560244962|FG003|Overall Study|Lost to Follow-up|0|||
155219926|NCT01727141|560244959|FG000|Overall Study|Death|0|||
155219927|NCT01727141|560244960|FG001|Overall Study|Death|1|||
155219928|NCT01727141|560244961|FG002|Overall Study|Death|1|||
155219929|NCT01727141|560244962|FG003|Overall Study|Death|1|||
155219930|NCT01727141|560244959|FG000|Overall Study|Protocol deviation|1|||
155219931|NCT01727141|560244960|FG001|Overall Study|Protocol deviation|1|||
155219932|NCT01727141|560244961|FG002|Overall Study|Protocol deviation|0|||
155219933|NCT01727141|560244962|FG003|Overall Study|Protocol deviation|1|||
155219934|NCT01727141|560244959|FG000|Overall Study|Withdrawal by Subject|4|||
155219935|NCT01727141|560244960|FG001|Overall Study|Withdrawal by Subject|4|||
155219936|NCT01727141|560244961|FG002|Overall Study|Withdrawal by Subject|2|||
155219937|NCT01727141|560244962|FG003|Overall Study|Withdrawal by Subject|11|||
155219938|NCT02529137|560244963|FG000|Overall Study|Discontinuation for different reasons|8|||
155219939|NCT01660711|560244966|FG000|Overall Study|Adverse Event|7|||
155219940|NCT01660711|560244966|FG000|Overall Study|Withdrawal by Subject|1|||
155219941|NCT00952341|560244967|FG000|Cycle 1|Adverse Event|4|||
155219942|NCT00952341|560244968|FG001|Cycle 1|Adverse Event|1|||
155219943|NCT00952341|560244967|FG000|Cycle 1|Withdrawal by Subject|3|||
155219944|NCT00952341|560244968|FG001|Cycle 1|Withdrawal by Subject|8|||
155219945|NCT00952341|560244967|FG000|Cycle 1|Protocol Violation|2|||
155219946|NCT00952341|560244968|FG001|Cycle 1|Protocol Violation|1|||
155219947|NCT00952341|560244967|FG000|Cycle 1|Lost to Follow-up|11|||
155219948|NCT00952341|560244968|FG001|Cycle 1|Lost to Follow-up|2|||
155219949|NCT00952341|560244967|FG000|Cycle 1|Physician Decision|0|||
155219950|NCT00952341|560244968|FG001|Cycle 1|Physician Decision|1|||
155219951|NCT00952341|560244967|FG000|Cycle 2|Withdrawal by Subject|1|||
155219952|NCT00952341|560244968|FG001|Cycle 2|Withdrawal by Subject|1|||
155219953|NCT00952341|560244967|FG000|Cycle 2|Protocol Violation|1|||
155219954|NCT00952341|560244968|FG001|Cycle 2|Protocol Violation|0|||
155219955|NCT00952341|560244967|FG000|Cycle 2|Lost to Follow-up|6|||
155219956|NCT00952341|560244968|FG001|Cycle 2|Lost to Follow-up|9|||
155219957|NCT00952341|560244967|FG000|Cycle 2|Physician Decision|1|||
155219958|NCT00952341|560244968|FG001|Cycle 2|Physician Decision|1|||
155219959|NCT00952341|560244967|FG000|Cycle 2|Progressive Disease|0|||
155219960|NCT00952341|560244968|FG001|Cycle 2|Progressive Disease|1|||
155219961|NCT02066467|560244971|FG000|Overall Study|Did not undergo implant procedure|24|||
155219962|NCT02066467|560244971|FG000|Overall Study|Attempted to implant withoput success|43|||
155219963|NCT02066467|560244971|FG000|Overall Study|Consent ineligible|1|||
155219964|NCT02066467|560244971|FG000|Overall Study|Death|54|||
155219965|NCT02066467|560244971|FG000|Overall Study|Lost to Follow-up|51|||
155219966|NCT02066467|560244971|FG000|Overall Study|Adverse Event|20|||
155219967|NCT02066467|560244971|FG000|Overall Study|Withdrawal by Subject|16|||
155219968|NCT02066467|560244971|FG000|Overall Study|Physician Decision|2|||
155219969|NCT02066467|560244971|FG000|Overall Study|Not defined|4|||
155219970|NCT02759120|560244977|FG000|Overall Study|Death|34|||
155219971|NCT02759120|560244978|FG001|Overall Study|Death|36|||
155219972|NCT02759120|560244977|FG000|Overall Study|Lost to Follow-up|4|||
155219973|NCT02759120|560244978|FG001|Overall Study|Lost to Follow-up|7|||
155219974|NCT02759120|560244977|FG000|Overall Study|Physician Decision|3|||
155219975|NCT02759120|560244978|FG001|Overall Study|Physician Decision|0|||
155219976|NCT02759120|560244977|FG000|Overall Study|Withdrawal by Subject|28|||
155219977|NCT02759120|560244978|FG001|Overall Study|Withdrawal by Subject|15|||
155219978|NCT02759120|560244977|FG000|Overall Study|Moved out of area|3|||
155219979|NCT02759120|560244978|FG001|Overall Study|Moved out of area|4|||
155219980|NCT02759120|560244977|FG000|Overall Study|Lung transplant|3|||
155219981|NCT02759120|560244978|FG001|Overall Study|Lung transplant|5|||
155219982|NCT02759120|560244977|FG000|Overall Study|Other reason not completed|10|||
155219983|NCT02759120|560244978|FG001|Overall Study|Other reason not completed|12|||
155219984|NCT04461015|560244979|FG000|Overall Study|IV access lost during the study|0|||
155219985|NCT04461015|560244980|FG001|Overall Study|IV access lost during the study|1|||
155219986|NCT04461015|560244979|FG000|Overall Study|Withdrawal by Subject|0|||
155219987|NCT04461015|560244980|FG001|Overall Study|Withdrawal by Subject|1|||
155219988|NCT03538158|560244982|FG000|Overall Study|Lost to Follow-up|13|||
155219989|NCT03538158|560244983|FG001|Overall Study|Lost to Follow-up|7|||
155219990|NCT03538158|560244982|FG000|Overall Study|Withdrawal by Subject|2|||
155219991|NCT03538158|560244983|FG001|Overall Study|Withdrawal by Subject|1|||
155219992|NCT04356963|560244987|FG000|First Session|Withdrawal by Subject|1|||
155219993|NCT04356963|560244987|FG000|Second Session|Withdrawal by Subject|3|||
155219994|NCT04356963|560244987|FG000|Second Session|Lost to Follow-up|1|||
155219995|NCT04356963|560244987|FG000|Third Session|Lost to Follow-up|6|||
155219996|NCT04356963|560244987|FG000|Third Session|Withdrawal by Subject|1|||
155219997|NCT00791518|560244989|FG000|Overall Study|Protocol Violation|93|||
155219998|NCT04256785|560244996|FG000|Overall Study|Adverse Event|8|||
155219999|NCT04256785|560244997|FG001|Overall Study|Adverse Event|6|||
155220000|NCT04256785|560244996|FG000|Overall Study|Lack of Efficacy|3|||
155220001|NCT04256785|560244997|FG001|Overall Study|Lack of Efficacy|4|||
155220002|NCT04256785|560244996|FG000|Overall Study|Lost to Follow-up|7|||
155220003|NCT04256785|560244997|FG001|Overall Study|Lost to Follow-up|7|||
155220004|NCT04256785|560244996|FG000|Overall Study|Protocol Violation|1|||
155220005|NCT04256785|560244997|FG001|Overall Study|Protocol Violation|0|||
155220006|NCT04256785|560244996|FG000|Overall Study|Withdrawal by Subject|4|||
155220007|NCT04256785|560244997|FG001|Overall Study|Withdrawal by Subject|1|||
155220008|NCT04256785|560244996|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
155220009|NCT04256785|560244997|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
155220010|NCT00271609|560244999|FG000|Overall Study|Adverse Event|11|||
155220011|NCT00271609|560245000|FG001|Overall Study|Adverse Event|3|||
155220012|NCT00271609|560244999|FG000|Overall Study|Withdrawal by Subject|2|||
155220013|NCT00271609|560245000|FG001|Overall Study|Withdrawal by Subject|0|||
155220014|NCT03341533|560245001|FG000|Overall Study|Withdrawal by Subject|1|||
155220015|NCT03341533|560245002|FG001|Overall Study|Withdrawal by Subject|1|||
155220016|NCT03341533|560245001|FG000|Overall Study|Not eligible after randomization|2|||
155220017|NCT03341533|560245002|FG001|Overall Study|Not eligible after randomization|1|||
155220018|NCT00643682|560245003|FG000|Overall Study|did not keep appointment|522|||
155220019|NCT00643682|560245004|FG001|Overall Study|did not keep appointment|509|||
155220020|NCT03755414|560245006|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
155220021|NCT03755414|560245007|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
155220022|NCT03755414|560245008|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
155220023|NCT03755414|560245006|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
155220024|NCT03755414|560245007|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
155220025|NCT03755414|560245008|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
155220026|NCT03755414|560245006|FG000|Overall Study|Non-compliance|0|||
155220027|NCT03755414|560245007|FG001|Overall Study|Non-compliance|1|||
155220028|NCT03755414|560245008|FG002|Overall Study|Non-compliance|0|||
155220029|NCT02153112|560245009|FG000|Overall Study|Adverse Event|0|||
155220030|NCT02153112|560245010|FG001|Overall Study|Adverse Event|0|||
155220031|NCT02153112|560245011|FG002|Overall Study|Adverse Event|1|||
155220032|NCT02153112|560245012|FG003|Overall Study|Adverse Event|0|||
155220033|NCT02153112|560245013|FG004|Overall Study|Adverse Event|0|||
155220034|NCT02153112|560245014|FG005|Overall Study|Adverse Event|0|||
155220035|NCT02153112|560245015|FG006|Overall Study|Adverse Event|0|||
155220036|NCT02153112|560245016|FG007|Overall Study|Adverse Event|0|||
155220037|NCT02153112|560245017|FG008|Overall Study|Adverse Event|0|||
155220038|NCT02153112|560245018|FG009|Overall Study|Adverse Event|0|||
155220039|NCT02153112|560245009|FG000|Overall Study|Lost to Follow-up|1|||
155220040|NCT02153112|560245010|FG001|Overall Study|Lost to Follow-up|1|||
155220041|NCT02153112|560245011|FG002|Overall Study|Lost to Follow-up|0|||
155220042|NCT02153112|560245012|FG003|Overall Study|Lost to Follow-up|0|||
155220043|NCT02153112|560245013|FG004|Overall Study|Lost to Follow-up|2|||
155220044|NCT02153112|560245014|FG005|Overall Study|Lost to Follow-up|1|||
155220045|NCT02153112|560245015|FG006|Overall Study|Lost to Follow-up|1|||
155220046|NCT02153112|560245016|FG007|Overall Study|Lost to Follow-up|0|||
155220047|NCT02153112|560245017|FG008|Overall Study|Lost to Follow-up|1|||
155220048|NCT02153112|560245018|FG009|Overall Study|Lost to Follow-up|1|||
155220049|NCT02153112|560245009|FG000|Overall Study|Withdrawal by Subject|3|||
155220050|NCT02153112|560245010|FG001|Overall Study|Withdrawal by Subject|1|||
155220051|NCT02153112|560245011|FG002|Overall Study|Withdrawal by Subject|2|||
155220052|NCT02153112|560245012|FG003|Overall Study|Withdrawal by Subject|2|||
155220053|NCT02153112|560245013|FG004|Overall Study|Withdrawal by Subject|1|||
155220054|NCT02153112|560245014|FG005|Overall Study|Withdrawal by Subject|1|||
155220055|NCT02153112|560245015|FG006|Overall Study|Withdrawal by Subject|7|||
155220056|NCT02153112|560245016|FG007|Overall Study|Withdrawal by Subject|2|||
155220057|NCT02153112|560245017|FG008|Overall Study|Withdrawal by Subject|13|||
155220058|NCT02153112|560245018|FG009|Overall Study|Withdrawal by Subject|12|||
155220059|NCT02153112|560245009|FG000|Overall Study|Reason not Specified|0|||
155220060|NCT02153112|560245010|FG001|Overall Study|Reason not Specified|0|||
155220061|NCT02153112|560245011|FG002|Overall Study|Reason not Specified|0|||
155220062|NCT02153112|560245012|FG003|Overall Study|Reason not Specified|0|||
155220063|NCT02153112|560245013|FG004|Overall Study|Reason not Specified|0|||
155220064|NCT02153112|560245014|FG005|Overall Study|Reason not Specified|0|||
155220065|NCT02153112|560245015|FG006|Overall Study|Reason not Specified|0|||
155220066|NCT02153112|560245016|FG007|Overall Study|Reason not Specified|0|||
155220067|NCT02153112|560245017|FG008|Overall Study|Reason not Specified|1|||
155220068|NCT02153112|560245018|FG009|Overall Study|Reason not Specified|1|||
155220069|NCT01675128|560245021|FG000|Overall Study|Disease progression on study|1|||
155220070|NCT01675128|560245022|FG001|Overall Study|Disease progression on study|1|||
155220071|NCT01675128|560245023|FG002|Overall Study|Disease progression on study|1|||
155220072|NCT01675128|560245021|FG000|Overall Study|Refused further treatment|1|||
155220073|NCT01675128|560245022|FG001|Overall Study|Refused further treatment|0|||
155220074|NCT01675128|560245023|FG002|Overall Study|Refused further treatment|0|||
155220075|NCT01675128|560245021|FG000|Overall Study|Pulmonary complication; off study|0|||
155220076|NCT01675128|560245022|FG001|Overall Study|Pulmonary complication; off study|1|||
155220077|NCT01675128|560245023|FG002|Overall Study|Pulmonary complication; off study|0|||
155220078|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
155220079|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
155220080|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
155220081|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
155220082|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
155220083|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
155220084|NCT03526458|560245029|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
155220085|NCT03526458|560245030|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
155220086|NCT03526458|560245029|FG000|Overall Study|Stone passed, surgery cancelled|2|||
155220087|NCT03526458|560245030|FG001|Overall Study|Stone passed, surgery cancelled|1|||
155220088|NCT03526458|560245029|FG000|Overall Study|Withdrawal by Subject|1|||
155220089|NCT03526458|560245030|FG001|Overall Study|Withdrawal by Subject|0|||
155220090|NCT03526458|560245029|FG000|Overall Study|Physician Decision|2|||
155220091|NCT03526458|560245030|FG001|Overall Study|Physician Decision|1|||
155220092|NCT03526458|560245029|FG000|Overall Study|Lack of equipment|1|||
155220093|NCT03526458|560245030|FG001|Overall Study|Lack of equipment|1|||
155220094|NCT01782664|560245031|FG000|Overall Study|Adverse Event|2|||
155220095|NCT01782664|560245032|FG001|Overall Study|Adverse Event|2|||
155220096|NCT01782664|560245033|FG002|Overall Study|Adverse Event|2|||
155220097|NCT01782664|560245034|FG003|Overall Study|Adverse Event|2|||
155220098|NCT01782664|560245035|FG004|Overall Study|Adverse Event|0|||
155220099|NCT01782664|560245036|FG005|Overall Study|Adverse Event|0|||
155220100|NCT01782664|560245031|FG000|Overall Study|Lack of Efficacy|2|||
155220101|NCT01782664|560245032|FG001|Overall Study|Lack of Efficacy|0|||
155220102|NCT01782664|560245033|FG002|Overall Study|Lack of Efficacy|2|||
155220103|NCT01782664|560245034|FG003|Overall Study|Lack of Efficacy|2|||
155220104|NCT01782664|560245035|FG004|Overall Study|Lack of Efficacy|0|||
155220105|NCT01782664|560245036|FG005|Overall Study|Lack of Efficacy|0|||
155220106|NCT01782664|560245031|FG000|Overall Study|Protocol Violation|0|||
155220107|NCT01782664|560245032|FG001|Overall Study|Protocol Violation|1|||
155220108|NCT01782664|560245033|FG002|Overall Study|Protocol Violation|0|||
155220109|NCT01782664|560245034|FG003|Overall Study|Protocol Violation|1|||
155220110|NCT01782664|560245035|FG004|Overall Study|Protocol Violation|0|||
155220111|NCT01782664|560245036|FG005|Overall Study|Protocol Violation|0|||
155220112|NCT01782664|560245031|FG000|Overall Study|Withdrawal by Subject|2|||
155220113|NCT01782664|560245032|FG001|Overall Study|Withdrawal by Subject|2|||
155220114|NCT01782664|560245033|FG002|Overall Study|Withdrawal by Subject|0|||
155220115|NCT01782664|560245034|FG003|Overall Study|Withdrawal by Subject|0|||
155220116|NCT01782664|560245035|FG004|Overall Study|Withdrawal by Subject|0|||
155220117|NCT01782664|560245036|FG005|Overall Study|Withdrawal by Subject|0|||
155220118|NCT04170348|560245039|FG000|Overall Study|Lost to Follow-up|2|||
155220119|NCT04170348|560245040|FG001|Overall Study|Lost to Follow-up|2|||
155220120|NCT04170348|560245039|FG000|Overall Study|Withdrawal by Subject|1|||
155220121|NCT04170348|560245040|FG001|Overall Study|Withdrawal by Subject|5|||
155220122|NCT04170348|560245039|FG000|Overall Study|Non-adherence|1|||
155220123|NCT04170348|560245040|FG001|Overall Study|Non-adherence|1|||
155220124|NCT04170348|560245039|FG000|Overall Study|Adverse Event|1|||
155220125|NCT04170348|560245040|FG001|Overall Study|Adverse Event|0|||
155220126|NCT01082965|560245044|FG000|Overall Study|Protocol Violation|0|||
155220127|NCT01082965|560245045|FG001|Overall Study|Protocol Violation|1|||
155220128|NCT01082965|560245044|FG000|Overall Study|Other|1|||
155220129|NCT01082965|560245045|FG001|Overall Study|Other|1|||
155220130|NCT03642717|560245046|FG000|Overall Study|Lost to Follow-up|2|||
155220131|NCT03642717|560245046|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
155220132|NCT03642717|560245046|FG000|Overall Study|Taken study drug prior to contract date|3|||
155220133|NCT02587065|560245047|FG000|Overall Study|Adverse Event|14|||
155220134|NCT02587065|560245047|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
155220135|NCT02587065|560245047|FG000|Overall Study|Non-adherence to the Protocol|3|||
155220136|NCT02587065|560245047|FG000|Overall Study|Discontinuation of Study Medication|2|||
155220137|NCT02587065|560245047|FG000|Overall Study|Reason not Specified|3|||
155220138|NCT01559012|560245048|FG000|Overall Study|Withdrawal by Subject|0|||
155220139|NCT01559012|560245049|FG001|Overall Study|Withdrawal by Subject|1|||
155220140|NCT00302458|560245052|FG000|Overall Study|Lost to Follow-up|1|||
155220141|NCT00302458|560245052|FG000|Overall Study|Ineligible after screening|1|||
155220142|NCT00302458|560245052|FG000|Overall Study|Withdrawal by Subject|1|||
155220143|NCT00946712|560245053|FG000|Overall Study|Adverse Event|118|||
155220144|NCT00946712|560245054|FG001|Overall Study|Adverse Event|124|||
155220145|NCT00946712|560245053|FG000|Overall Study|Disease progression|308|||
155220146|NCT00946712|560245054|FG001|Overall Study|Disease progression|404|||
155220147|NCT00946712|560245053|FG000|Overall Study|Death|21|||
155220148|NCT00946712|560245054|FG001|Overall Study|Death|22|||
155220149|NCT00946712|560245053|FG000|Overall Study|No treatment given|25|||
155220150|NCT00946712|560245054|FG001|Overall Study|No treatment given|29|||
155220151|NCT00946712|560245053|FG000|Overall Study|Other reasons|61|||
155220152|NCT00946712|560245054|FG001|Overall Study|Other reasons|73|||
155220153|NCT00946712|560245053|FG000|Overall Study|On Treatment|0|||
155220154|NCT00946712|560245054|FG001|Overall Study|On Treatment|4|||
155220155|NCT00946712|560245053|FG000|Overall Study|Ineligible|14|||
155220156|NCT00946712|560245054|FG001|Overall Study|Ineligible|6|||
155220157|NCT02967692|560246458|FG000|Overall Study|Progressive disease|3|||
155220158|NCT02967692|560246459|FG001|Overall Study|Progressive disease|15|||
155220159|NCT02967692|560246460|FG002|Overall Study|Progressive disease|114|||
155220160|NCT02967692|560246461|FG003|Overall Study|Progressive disease|151|||
155220161|NCT02967692|560246458|FG000|Overall Study|Subject/guardian decision|1|||
155220162|NCT02967692|560246459|FG001|Overall Study|Subject/guardian decision|1|||
155220163|NCT02967692|560246460|FG002|Overall Study|Subject/guardian decision|14|||
155220164|NCT02967692|560246461|FG003|Overall Study|Subject/guardian decision|22|||
155220165|NCT02967692|560246458|FG000|Overall Study|Death|0|||
155220166|NCT02967692|560246459|FG001|Overall Study|Death|1|||
155220167|NCT02967692|560246460|FG002|Overall Study|Death|13|||
155220168|NCT02967692|560246461|FG003|Overall Study|Death|13|||
155220169|NCT02967692|560246458|FG000|Overall Study|Protocol deviation|1|||
155220170|NCT02967692|560246459|FG001|Overall Study|Protocol deviation|0|||
155220171|NCT02967692|560246460|FG002|Overall Study|Protocol deviation|1|||
155220172|NCT02967692|560246461|FG003|Overall Study|Protocol deviation|1|||
155220173|NCT02967692|560246458|FG000|Overall Study|Lost to Follow-up|0|||
155220174|NCT02967692|560246459|FG001|Overall Study|Lost to Follow-up|0|||
155220175|NCT02967692|560246460|FG002|Overall Study|Lost to Follow-up|1|||
155220176|NCT02967692|560246461|FG003|Overall Study|Lost to Follow-up|0|||
155220177|NCT02967692|560246458|FG000|Overall Study|Physician Decision|0|||
155220178|NCT02967692|560246459|FG001|Overall Study|Physician Decision|0|||
155220179|NCT02967692|560246460|FG002|Overall Study|Physician Decision|22|||
155220180|NCT02967692|560246461|FG003|Overall Study|Physician Decision|13|||
155220181|NCT02967692|560246458|FG000|Overall Study|Adverse Event|2|||
155220182|NCT02967692|560246459|FG001|Overall Study|Adverse Event|9|||
155220183|NCT02967692|560246460|FG002|Overall Study|Adverse Event|60|||
155220184|NCT02967692|560246461|FG003|Overall Study|Adverse Event|28|||
155220185|NCT02967692|560246458|FG000|Overall Study|Study terminated by sponsor|2|||
155220186|NCT02967692|560246459|FG001|Overall Study|Study terminated by sponsor|1|||
155220187|NCT02967692|560246460|FG002|Overall Study|Study terminated by sponsor|42|||
155220188|NCT02967692|560246461|FG003|Overall Study|Study terminated by sponsor|37|||
155220189|NCT02731729|560246468|FG000|Overall Study|Death|2|||
155220190|NCT02731729|560246469|FG001|Overall Study|Death|2|||
155220191|NCT02731729|560246468|FG000|Overall Study|Study terminated by Sponsor|6|||
155220192|NCT02731729|560246469|FG001|Overall Study|Study terminated by Sponsor|6|||
155220193|NCT02731729|560246468|FG000|Overall Study|Withdrawal by Subject|1|||
155220194|NCT02731729|560246469|FG001|Overall Study|Withdrawal by Subject|0|||
155220195|NCT01344447|560246470|FG000|Overall Study|Adverse Event|1|||
155220196|NCT01344447|560246470|FG000|Overall Study|Protocol Violation|1|||
155220197|NCT01344447|560246470|FG000|Overall Study|Withdrawal by Subject|1|||
155220198|NCT01344447|560246470|FG000|Overall Study|The contrast was not seen|1|||
155220199|NCT01344447|560246470|FG000|Overall Study|Physician Decision|1|||
155220200|NCT01344447|560246470|FG000|Overall Study|MRA unsuccessful|1|||
155220201|NCT01344447|560246470|FG000|Overall Study|Bolus tracking failed|1|||
155220202|NCT01344447|560246470|FG000|Overall Study|Error of power injector|1|||
155220203|NCT02063854|560246479|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
155220204|NCT02063854|560246480|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
155220205|NCT02063854|560246481|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
155220206|NCT02063854|560246482|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
155220207|NCT02063854|560246483|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
155220208|NCT02063854|560246484|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
155220209|NCT02063854|560246485|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
155220210|NCT02063854|560246479|FG000|Overall Study|Major Protocol Deviation|0|||
155220211|NCT02063854|560246480|FG001|Overall Study|Major Protocol Deviation|0|||
155220212|NCT02063854|560246481|FG002|Overall Study|Major Protocol Deviation|3|||
155220213|NCT02063854|560246482|FG003|Overall Study|Major Protocol Deviation|0|||
155220214|NCT02063854|560246483|FG004|Overall Study|Major Protocol Deviation|0|||
155220215|NCT02063854|560246484|FG005|Overall Study|Major Protocol Deviation|0|||
155220216|NCT02063854|560246485|FG006|Overall Study|Major Protocol Deviation|0|||
155220217|NCT02063854|560246479|FG000|Overall Study|Voluntary Withdrawal|2|||
155220218|NCT02063854|560246480|FG001|Overall Study|Voluntary Withdrawal|0|||
155220219|NCT02063854|560246481|FG002|Overall Study|Voluntary Withdrawal|8|||
155220220|NCT02063854|560246482|FG003|Overall Study|Voluntary Withdrawal|1|||
155220221|NCT02063854|560246483|FG004|Overall Study|Voluntary Withdrawal|3|||
155220222|NCT02063854|560246484|FG005|Overall Study|Voluntary Withdrawal|6|||
155220223|NCT02063854|560246485|FG006|Overall Study|Voluntary Withdrawal|1|||
155220224|NCT02063854|560246479|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
155220225|NCT02063854|560246480|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
155220226|NCT02063854|560246481|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
155220227|NCT02063854|560246482|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220228|NCT02063854|560246483|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220229|NCT02063854|560246484|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
155220230|NCT02063854|560246485|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220231|NCT02063854|560246479|FG000|Overall Study|Reason Not Specified|1|||
155220232|NCT02063854|560246480|FG001|Overall Study|Reason Not Specified|0|||
155220233|NCT02063854|560246481|FG002|Overall Study|Reason Not Specified|0|||
155220234|NCT02063854|560246482|FG003|Overall Study|Reason Not Specified|0|||
155220235|NCT02063854|560246483|FG004|Overall Study|Reason Not Specified|0|||
155220236|NCT02063854|560246484|FG005|Overall Study|Reason Not Specified|0|||
155220237|NCT02063854|560246485|FG006|Overall Study|Reason Not Specified|0|||
155220238|NCT02063854|560246479|FG000|Overall Study|Did Not Receive Study Drug|0|||
155220239|NCT02063854|560246480|FG001|Overall Study|Did Not Receive Study Drug|0|||
155220240|NCT02063854|560246481|FG002|Overall Study|Did Not Receive Study Drug|0|||
155220241|NCT02063854|560246482|FG003|Overall Study|Did Not Receive Study Drug|0|||
155220242|NCT02063854|560246483|FG004|Overall Study|Did Not Receive Study Drug|0|||
155220243|NCT02063854|560246484|FG005|Overall Study|Did Not Receive Study Drug|1|||
155220244|NCT02063854|560246485|FG006|Overall Study|Did Not Receive Study Drug|0|||
155220245|NCT02419742|560246488|FG000|Overall Study|Adverse Event|2|||
155220246|NCT02419742|560246489|FG001|Overall Study|Adverse Event|0|||
155220247|NCT02419742|560246488|FG000|Overall Study|Disease Progression|0|||
155220248|NCT02419742|560246489|FG001|Overall Study|Disease Progression|1|||
155220249|NCT02419742|560246488|FG000|Overall Study|Withdrew Consent|2|||
155220250|NCT02419742|560246489|FG001|Overall Study|Withdrew Consent|1|||
155220251|NCT02419742|560246488|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
155220252|NCT02419742|560246489|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
155220253|NCT02255981|560246492|FG000|Overall Study|Lost to Follow-up|3|||
155220254|NCT02255981|560246492|FG000|Overall Study|Withdrawal by Subject|1|||
155220255|NCT03425331|560246495|FG000|Overall Study|Withdrawal by Subject|1|||
155220256|NCT03425331|560246495|FG000|Overall Study|Death|1|||
155220257|NCT03425331|560246495|FG000|Overall Study|Adverse Event|1|||
155220258|NCT03425331|560246495|FG000|Overall Study|Disease Progression|2|||
155220259|NCT01454570|560246498|FG000|Overall Study|Withdrawal by Subject|2|||
155220260|NCT01454570|560246498|FG000|Overall Study|Screen Failure|7|||
155220261|NCT01852812|560246499|FG000|Overall Study|Adverse Event|0|||
155220262|NCT01852812|560246500|FG001|Overall Study|Adverse Event|0|||
155220263|NCT01852812|560246501|FG002|Overall Study|Adverse Event|1|||
155220264|NCT01852812|560246499|FG000|Overall Study|Non-compliance With Study Drug|0|||
155220265|NCT01852812|560246500|FG001|Overall Study|Non-compliance With Study Drug|1|||
155220266|NCT01852812|560246501|FG002|Overall Study|Non-compliance With Study Drug|0|||
155220267|NCT02488681|560246508|FG000|Overall Study|Implant unsuccessful|7|||
155220268|NCT00720057|560246509|FG000|Overall Study|Lost to Follow-up|0|||
155220269|NCT00720057|560246510|FG001|Overall Study|Lost to Follow-up|2|||
155220270|NCT00720057|560246509|FG000|Overall Study|Protocol Violation|1|||
155220271|NCT00720057|560246510|FG001|Overall Study|Protocol Violation|0|||
155220272|NCT00720057|560246509|FG000|Overall Study|Withdrawal by Subject|0|||
155220273|NCT00720057|560246510|FG001|Overall Study|Withdrawal by Subject|1|||
155220274|NCT04969224|560246513|FG000|Overall Study|Adverse Event|1|||
155220275|NCT04969224|560246513|FG000|Overall Study|Enrolled but never dosed|1|||
155220276|NCT01498952|560246514|FG000|Overall Study|Death|2|||
155220277|NCT01498952|560246515|FG001|Overall Study|Death|2|||
155220278|NCT01498952|560246516|FG002|Overall Study|Death|0|||
155220279|NCT01498952|560246517|FG003|Overall Study|Death|0|||
155220280|NCT01498952|560246518|FG004|Overall Study|Death|0|||
155220281|NCT05533632|560246519|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
155220282|NCT05533632|560246519|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
155220283|NCT05533632|560246519|FG000|Overall Study|Lost to Follow-up|1|||
155220284|NCT05533632|560246519|FG000|Overall Study|Withdrawal by Subject|4|||
155220285|NCT05533632|560246519|FG000|Overall Study|Adverse Event|4|||
155220286|NCT02726074|560246520|FG000|Overall Study|Withdrawal by Subject|4|||
155220287|NCT02726074|560246520|FG000|Overall Study|Adverse Event|14|||
155220288|NCT02726074|560246520|FG000|Overall Study|Protocol Violation|3|||
155220289|NCT02726074|560246520|FG000|Overall Study|Lost to Follow-up|2|||
155220290|NCT02726074|560246520|FG000|Overall Study|Others|3|||
155220291|NCT00579826|560246521|FG000|Overall Study|Withdrawal by Subject|5|||
155220292|NCT00579826|560246522|FG001|Overall Study|Withdrawal by Subject|3|||
155220293|NCT03054870|560246526|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
155220294|NCT03054870|560246526|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
155220295|NCT02009046|560246527|FG000|Overall Study|Lost to Follow-up|256|||
155220296|NCT02009046|560246528|FG001|Overall Study|Lost to Follow-up|206|||
155220297|NCT00973479|560246533|FG000|Overall Study|Lost to Follow-up|0|||
155220298|NCT00973479|560246534|FG001|Overall Study|Lost to Follow-up|3|||
155220299|NCT00973479|560246533|FG000|Overall Study|Death|2|||
155220300|NCT00973479|560246534|FG001|Overall Study|Death|2|||
155220301|NCT00973479|560246533|FG000|Overall Study|Withdrawal by Subject|15|||
155220302|NCT00973479|560246534|FG001|Overall Study|Withdrawal by Subject|16|||
155220303|NCT00973479|560246533|FG000|Overall Study|Lack of Efficacy|5|||
155220304|NCT00973479|560246534|FG001|Overall Study|Lack of Efficacy|7|||
155220305|NCT00973479|560246533|FG000|Overall Study|Adverse Event|12|||
155220306|NCT00973479|560246534|FG001|Overall Study|Adverse Event|32|||
155220307|NCT00973479|560246533|FG000|Overall Study|Protocol Violation|2|||
155220308|NCT00973479|560246534|FG001|Overall Study|Protocol Violation|2|||
155220309|NCT00973479|560246533|FG000|Overall Study|Other|1|||
155220310|NCT00973479|560246534|FG001|Overall Study|Other|7|||
155220311|NCT05075850|560246535|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
155220312|NCT01154218|560246536|FG000|Third Intervention Period|Adverse Event|0|||
155220313|NCT01154218|560246537|FG001|Third Intervention Period|Adverse Event|1|||
155220314|NCT01154218|560246538|FG002|Third Intervention Period|Adverse Event|0|||
155220315|NCT01154218|560246539|FG003|Third Intervention Period|Adverse Event|0|||
155220316|NCT01154218|560246536|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220317|NCT01154218|560246537|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220318|NCT01154218|560246538|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220319|NCT01154218|560246539|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
155220320|NCT01154218|560246536|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
155220321|NCT01154218|560246537|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
155220322|NCT01154218|560246538|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
155220323|NCT01154218|560246539|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
155220324|NCT01265849|560246540|FG000|Overall Study|Randomized//Treatment not initiated|1|||
155220325|NCT01265849|560246541|FG001|Overall Study|Randomized//Treatment not initiated|4|||
155220326|NCT01265849|560246542|FG002|Overall Study|Randomized//Treatment not initiated|0|||
155220327|NCT01265849|560246540|FG000|Overall Study|Physician Decision|1|||
155220328|NCT01265849|560246541|FG001|Overall Study|Physician Decision|2|||
155220329|NCT01265849|560246542|FG002|Overall Study|Physician Decision|0|||
155220330|NCT01265849|560246540|FG000|Overall Study|Lost to Follow-up|18|||
155220331|NCT01265849|560246541|FG001|Overall Study|Lost to Follow-up|15|||
155220332|NCT01265849|560246542|FG002|Overall Study|Lost to Follow-up|5|||
155220333|NCT01265849|560246540|FG000|Overall Study|Not otherwise specified|1|||
155220334|NCT01265849|560246541|FG001|Overall Study|Not otherwise specified|6|||
155220335|NCT01265849|560246542|FG002|Overall Study|Not otherwise specified|1|||
155220336|NCT01265849|560246540|FG000|Overall Study|Withdrawal by Subject|25|||
155220337|NCT01265849|560246541|FG001|Overall Study|Withdrawal by Subject|34|||
155220338|NCT01265849|560246542|FG002|Overall Study|Withdrawal by Subject|13|||
155220339|NCT00362115|560246543|FG000|Overall Study|Adverse Event|0|||
155220340|NCT00362115|560246544|FG001|Overall Study|Adverse Event|1|||
155220341|NCT00362115|560246545|FG002|Overall Study|Adverse Event|1|||
155220342|NCT00362115|560246546|FG003|Overall Study|Adverse Event|1|||
155220343|NCT00362115|560246547|FG004|Overall Study|Adverse Event|2|||
155220344|NCT00362115|560246548|FG005|Overall Study|Adverse Event|2|||
155220345|NCT00362115|560246549|FG006|Overall Study|Adverse Event|1|||
155220346|NCT00362115|560246543|FG000|Overall Study|Protocol Violation|0|||
155220347|NCT00362115|560246544|FG001|Overall Study|Protocol Violation|0|||
155220348|NCT00362115|560246545|FG002|Overall Study|Protocol Violation|0|||
155220349|NCT00362115|560246546|FG003|Overall Study|Protocol Violation|0|||
155220350|NCT00362115|560246547|FG004|Overall Study|Protocol Violation|0|||
155220351|NCT00362115|560246548|FG005|Overall Study|Protocol Violation|1|||
155220352|NCT00362115|560246549|FG006|Overall Study|Protocol Violation|0|||
155220353|NCT00362115|560246543|FG000|Overall Study|Lost to Follow-up|0|||
155220354|NCT00362115|560246544|FG001|Overall Study|Lost to Follow-up|1|||
155220355|NCT00362115|560246545|FG002|Overall Study|Lost to Follow-up|0|||
155220356|NCT00362115|560246546|FG003|Overall Study|Lost to Follow-up|0|||
155220357|NCT00362115|560246547|FG004|Overall Study|Lost to Follow-up|2|||
155220358|NCT00362115|560246548|FG005|Overall Study|Lost to Follow-up|0|||
155220359|NCT00362115|560246549|FG006|Overall Study|Lost to Follow-up|1|||
155220360|NCT00362115|560246543|FG000|Overall Study|Withdrawal by Subject|1|||
155220361|NCT00362115|560246544|FG001|Overall Study|Withdrawal by Subject|3|||
155220362|NCT00362115|560246545|FG002|Overall Study|Withdrawal by Subject|1|||
155220363|NCT00362115|560246546|FG003|Overall Study|Withdrawal by Subject|0|||
155220364|NCT00362115|560246547|FG004|Overall Study|Withdrawal by Subject|1|||
155220365|NCT00362115|560246548|FG005|Overall Study|Withdrawal by Subject|3|||
155220366|NCT00362115|560246549|FG006|Overall Study|Withdrawal by Subject|4|||
155220367|NCT00362115|560246543|FG000|Overall Study|Lack of Efficacy|1|||
155220368|NCT00362115|560246544|FG001|Overall Study|Lack of Efficacy|0|||
155220369|NCT00362115|560246545|FG002|Overall Study|Lack of Efficacy|5|||
155220370|NCT00362115|560246546|FG003|Overall Study|Lack of Efficacy|2|||
155220371|NCT00362115|560246547|FG004|Overall Study|Lack of Efficacy|2|||
155220372|NCT00362115|560246548|FG005|Overall Study|Lack of Efficacy|0|||
155220373|NCT00362115|560246549|FG006|Overall Study|Lack of Efficacy|3|||
155220374|NCT00362115|560246543|FG000|Overall Study|Physician Decision|0|||
155220375|NCT00362115|560246544|FG001|Overall Study|Physician Decision|0|||
155220376|NCT00362115|560246545|FG002|Overall Study|Physician Decision|0|||
155220377|NCT00362115|560246546|FG003|Overall Study|Physician Decision|0|||
155220378|NCT00362115|560246547|FG004|Overall Study|Physician Decision|0|||
155220379|NCT00362115|560246548|FG005|Overall Study|Physician Decision|0|||
155220380|NCT00362115|560246549|FG006|Overall Study|Physician Decision|3|||
155220381|NCT00362115|560246543|FG000|Overall Study|Other|0|||
155220382|NCT00362115|560246544|FG001|Overall Study|Other|1|||
155220383|NCT00362115|560246545|FG002|Overall Study|Other|0|||
155220384|NCT00362115|560246546|FG003|Overall Study|Other|1|||
155220385|NCT00362115|560246547|FG004|Overall Study|Other|0|||
155220386|NCT00362115|560246548|FG005|Overall Study|Other|1|||
155220387|NCT00362115|560246549|FG006|Overall Study|Other|0|||
155220388|NCT01170091|560246550|FG000|Overall Study|Missing efficacy evaluation|3|||
155220389|NCT01170091|560246550|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
155220390|NCT03194321|560246551|FG000|Overall Study|Withdrawal by Subject|1|||
155220391|NCT03194321|560246551|FG000|Overall Study|Lost to Follow-up|1|||
155220392|NCT03194321|560246551|FG000|Overall Study|Travel for Follow-up|1|||
155220393|NCT02188589|560246552|FG000|Overall Study|Withdrawal by Subject|5|||
155220394|NCT00003641|560246560|FG000|Overall Study|Withdrawal by Subject|0|||
155220395|NCT00003641|560246561|FG001|Overall Study|Withdrawal by Subject|100|||
155220396|NCT00003641|560246560|FG000|Overall Study|Adverse Event|0|||
155220397|NCT00003641|560246561|FG001|Overall Study|Adverse Event|38|||
155220398|NCT00003641|560246560|FG000|Overall Study|Disease progression|0|||
155220399|NCT00003641|560246561|FG001|Overall Study|Disease progression|2|||
155220400|NCT00003641|560246560|FG000|Overall Study|Unknown/missing|0|||
155220401|NCT00003641|560246561|FG001|Overall Study|Unknown/missing|22|||
155220402|NCT00003641|560246560|FG000|Overall Study|Should not receive interferon therapy|2|||
155220403|NCT00003641|560246561|FG001|Overall Study|Should not receive interferon therapy|0|||
155220404|NCT00003641|560246560|FG000|Overall Study|Never started interferon|567|||
155220405|NCT00003641|560246561|FG001|Overall Study|Never started interferon|12|||
155220406|NCT02154581|560246564|FG000|Overall Study|Lost to Follow-up|7|||
155220407|NCT02154581|560246565|FG001|Overall Study|Lost to Follow-up|8|||
155220408|NCT03886220|560246568|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
155220409|NCT03886220|560246569|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
155220410|NCT03886220|560246568|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
155220411|NCT03886220|560246569|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155220412|NCT03886220|560246568|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
155220413|NCT03886220|560246569|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155220414|NCT03082599|560246572|FG000|Overall Study|Lost to Follow-up|1|||
155220415|NCT03082599|560246573|FG001|Overall Study|Lost to Follow-up|0|||
155220416|NCT00832585|560246576|FG000|Overall Study|Withdrawal by Subject|1|||
155220417|NCT00832585|560246576|FG000|Overall Study|Lost to Follow-up|1|||
155220418|NCT04404855|560246577|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
155220419|NCT04404855|560246578|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
155220420|NCT00853723|560246581|FG000|Overall Study|Adverse Event|3|||
155220421|NCT00853723|560246582|FG001|Overall Study|Adverse Event|4|||
155220422|NCT00853723|560246583|FG002|Overall Study|Adverse Event|1|||
155220423|NCT00853723|560246581|FG000|Overall Study|Withdrawal by Subject|2|||
155220424|NCT00853723|560246582|FG001|Overall Study|Withdrawal by Subject|1|||
155220425|NCT00853723|560246583|FG002|Overall Study|Withdrawal by Subject|0|||
155220426|NCT00853723|560246581|FG000|Overall Study|Protocol Violation|1|||
155220427|NCT00853723|560246582|FG001|Overall Study|Protocol Violation|2|||
155220428|NCT00853723|560246583|FG002|Overall Study|Protocol Violation|1|||
155220429|NCT04248933|560246586|FG000|Overall Study|Lost to Follow-up|9|||
155220430|NCT04248933|560246586|FG000|Overall Study|Withdrawal by Subject|2|||
155220431|NCT00445965|560246587|FG000|Overall Study|Adverse Event|2|||
155220432|NCT00445965|560246587|FG000|Overall Study|Physician Decision|1|||
155220433|NCT00445965|560246587|FG000|Overall Study|Enrolled but not treated|1|||
155220434|NCT00445965|560246587|FG000|Overall Study|Removed due to progressive disease|29|||
155220435|NCT02447081|560246588|FG000|Overall Study|Death|161|||
155220436|NCT02447081|560246588|FG000|Overall Study|Lost to Follow-up|36|||
155220437|NCT02447081|560246588|FG000|Overall Study|Visit not completed|17|||
155220438|NCT02447081|560246588|FG000|Overall Study|unsuccessful implant procedure|10|||
155220439|NCT05778786|560246589|FG000|Period 1|COVID-19 Related|3|||
155220440|NCT05778786|560246590|FG001|Period 1|COVID-19 Related|3|||
155220441|NCT05778786|560246589|FG000|Period 1|Withdrew Consent during Study|1|||
155220442|NCT05778786|560246590|FG001|Period 1|Withdrew Consent during Study|0|||
155220443|NCT05778786|560246589|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
155220444|NCT05778786|560246590|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
155220445|NCT05778786|560246589|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
155220446|NCT05778786|560246590|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
155220447|NCT05497284|560246594|FG000|Overall Study|Adverse Event|1|||
155220448|NCT05497284|560246595|FG001|Overall Study|Adverse Event|0|||
155220449|NCT05497284|560246594|FG000|Overall Study|Physician Decision|0|||
155220450|NCT05497284|560246595|FG001|Overall Study|Physician Decision|1|||
155220451|NCT05497284|560246594|FG000|Overall Study|Study terminated by sponsor|7|||
155220452|NCT05497284|560246595|FG001|Overall Study|Study terminated by sponsor|4|||
155220453|NCT05497284|560246594|FG000|Overall Study|Subject Decision|0|||
155220454|NCT05497284|560246595|FG001|Overall Study|Subject Decision|1|||
155220455|NCT00066066|560248632|FG000|Overall Study|Lost to Follow-up|6|||
155220456|NCT00066066|560248633|FG001|Overall Study|Lost to Follow-up|4|||
155220457|NCT00066066|560248634|FG002|Overall Study|Lost to Follow-up|7|||
155220458|NCT00066066|560248635|FG003|Overall Study|Lost to Follow-up|4|||
155220459|NCT00066066|560248636|FG004|Overall Study|Lost to Follow-up|3|||
155220460|NCT00066066|560248637|FG005|Overall Study|Lost to Follow-up|5|||
155220461|NCT02515942|560248640|FG000|Overall Study|Adverse Event|5|||
155220462|NCT02515942|560248641|FG001|Overall Study|Adverse Event|0|||
155220463|NCT02515942|560248642|FG002|Overall Study|Adverse Event|0|||
155220464|NCT02515942|560248640|FG000|Overall Study|Death|0|||
155220465|NCT02515942|560248641|FG001|Overall Study|Death|0|||
155220466|NCT02515942|560248642|FG002|Overall Study|Death|1|||
155220467|NCT02515942|560248640|FG000|Overall Study|Lack of Efficacy|0|||
155220468|NCT02515942|560248641|FG001|Overall Study|Lack of Efficacy|0|||
155220469|NCT02515942|560248642|FG002|Overall Study|Lack of Efficacy|1|||
155220470|NCT02515942|560248640|FG000|Overall Study|Lost to Follow-up|2|||
155220471|NCT02515942|560248641|FG001|Overall Study|Lost to Follow-up|0|||
155220472|NCT02515942|560248642|FG002|Overall Study|Lost to Follow-up|0|||
155220473|NCT02515942|560248640|FG000|Overall Study|Withdrawal by Subject|0|||
155220474|NCT02515942|560248641|FG001|Overall Study|Withdrawal by Subject|3|||
155220475|NCT02515942|560248642|FG002|Overall Study|Withdrawal by Subject|2|||
155220476|NCT00697515|560248643|FG000|Dose Optimization Period|Adverse Event|4|||
155220477|NCT00697515|560248644|FG001|Dose Optimization Period|Adverse Event|0|||
155220478|NCT00697515|560248643|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
155220479|NCT00697515|560248644|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
155220480|NCT00697515|560248643|FG000|Dose Optimization Period|Lost to Follow-up|2|||
155220481|NCT00697515|560248644|FG001|Dose Optimization Period|Lost to Follow-up|0|||
155220482|NCT00697515|560248643|FG000|Dose Optimization Period|sponsor request|2|||
155220483|NCT00697515|560248644|FG001|Dose Optimization Period|sponsor request|0|||
155220484|NCT00697515|560248643|FG000|Dose Optimization Period|called to active duty|1|||
155220485|NCT00697515|560248644|FG001|Dose Optimization Period|called to active duty|0|||
155220486|NCT00697515|560248643|FG000|Dose Optimization Period|elevated QTc|1|||
155220487|NCT00697515|560248644|FG001|Dose Optimization Period|elevated QTc|0|||
155220488|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
155220489|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
155220490|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
155220491|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
155220492|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
155220493|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220494|NCT00697515|560248643|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220495|NCT00697515|560248644|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220496|NCT02603432|560248645|FG000|Overall Study|Adverse Event|1|||
155220497|NCT02603432|560248646|FG001|Overall Study|Adverse Event|0|||
155220498|NCT02603432|560248645|FG000|Overall Study|Death|221|||
155220499|NCT02603432|560248646|FG001|Overall Study|Death|242|||
155220500|NCT02603432|560248645|FG000|Overall Study|Lost to Follow-up|3|||
155220501|NCT02603432|560248646|FG001|Overall Study|Lost to Follow-up|9|||
155220502|NCT02603432|560248645|FG000|Overall Study|Progressive Disease|7|||
155220503|NCT02603432|560248646|FG001|Overall Study|Progressive Disease|5|||
155220504|NCT02603432|560248645|FG000|Overall Study|Withdrawal by Subject|12|||
155220505|NCT02603432|560248646|FG001|Overall Study|Withdrawal by Subject|18|||
155220506|NCT02603432|560248645|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
155220507|NCT02603432|560248646|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155220508|NCT02603432|560248645|FG000|Overall Study|Study terminated by sponsor|74|||
155220509|NCT02603432|560248646|FG001|Overall Study|Study terminated by sponsor|75|||
155220510|NCT02603432|560248645|FG000|Overall Study|Other|13|||
155220511|NCT02603432|560248646|FG001|Overall Study|Other|0|||
155220512|NCT00666757|560248647|FG000|Overall Study|Lost to Follow-up|39|||
155220513|NCT00666757|560248648|FG001|Overall Study|Lost to Follow-up|35|||
155220514|NCT00666757|560248647|FG000|Overall Study|Protocol Violation|23|||
155220515|NCT00666757|560248648|FG001|Overall Study|Protocol Violation|24|||
155220516|NCT00666757|560248647|FG000|Overall Study|Adverse Event|22|||
155220517|NCT00666757|560248648|FG001|Overall Study|Adverse Event|12|||
155220518|NCT00666757|560248647|FG000|Overall Study|Withdrawal by Subject|13|||
155220519|NCT00666757|560248648|FG001|Overall Study|Withdrawal by Subject|17|||
155220520|NCT00666757|560248647|FG000|Overall Study|Lack of Efficacy|3|||
155220521|NCT00666757|560248648|FG001|Overall Study|Lack of Efficacy|6|||
155220522|NCT00666757|560248647|FG000|Overall Study|Physician Decision|0|||
155220523|NCT00666757|560248648|FG001|Overall Study|Physician Decision|2|||
155220524|NCT00666757|560248647|FG000|Overall Study|Sponsor decision|0|||
155220525|NCT00666757|560248648|FG001|Overall Study|Sponsor decision|1|||
155220526|NCT05954052|560248649|FG000|Overall Study|Adverse Event|1|||
155220527|NCT01957462|560248650|FG000|Test Period 1|Withdrawal by Subject|1|||
155220528|NCT01957462|560248651|FG001|Test Period 1|Withdrawal by Subject|0|||
155220529|NCT01957462|560248650|FG000|Test Period 1|Adverse Event|1|||
155220530|NCT01957462|560248651|FG001|Test Period 1|Adverse Event|0|||
155220531|NCT01723163|560248654|FG000|Treatment Phase|Withdrawal by Subject|14|||
155220532|NCT01723163|560248655|FG001|Treatment Phase|Withdrawal by Subject|6|||
155220533|NCT01723163|560248654|FG000|Treatment Phase|Withdrawal by PI|5|||
155220534|NCT01723163|560248655|FG001|Treatment Phase|Withdrawal by PI|1|||
155220535|NCT01723163|560248654|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
155491433|NCT00948896|561223548|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
155220536|NCT01723163|560248655|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
155220537|NCT01723163|560248654|FG000|3-Month Follow-up|Unable to Contact|12|||
155220538|NCT01723163|560248655|FG001|3-Month Follow-up|Unable to Contact|19|||
155220539|NCT01723163|560248654|FG000|6-Month Follow-up|Death|1|||
155220540|NCT01723163|560248655|FG001|6-Month Follow-up|Death|0|||
155220541|NCT01723163|560248654|FG000|6-Month Follow-up|Unable to Contact|17|||
155220542|NCT01723163|560248655|FG001|6-Month Follow-up|Unable to Contact|15|||
155220543|NCT01723163|560248654|FG000|12-Month Follow-up|Death|1|||
155220544|NCT01723163|560248655|FG001|12-Month Follow-up|Death|0|||
155220545|NCT01723163|560248654|FG000|12-Month Follow-up|Unable to Contact|23|||
155220546|NCT01723163|560248655|FG001|12-Month Follow-up|Unable to Contact|28|||
155220547|NCT02510794|560248656|FG000|Overall Study|Adverse Event|0|||
155220548|NCT02510794|560248657|FG001|Overall Study|Adverse Event|1|||
155220549|NCT02510794|560248658|FG002|Overall Study|Adverse Event|0|||
155220550|NCT02510794|560248659|FG003|Overall Study|Adverse Event|0|||
155220551|NCT02510794|560248656|FG000|Overall Study|Death|1|||
155220552|NCT02510794|560248657|FG001|Overall Study|Death|2|||
155220553|NCT02510794|560248658|FG002|Overall Study|Death|1|||
155220554|NCT02510794|560248659|FG003|Overall Study|Death|1|||
155220555|NCT02510794|560248656|FG000|Overall Study|Lack of Efficacy|3|||
155220556|NCT02510794|560248657|FG001|Overall Study|Lack of Efficacy|1|||
155220557|NCT02510794|560248658|FG002|Overall Study|Lack of Efficacy|1|||
155220558|NCT02510794|560248659|FG003|Overall Study|Lack of Efficacy|0|||
155220559|NCT02510794|560248656|FG000|Overall Study|Participant moved out of the area|0|||
155220560|NCT02510794|560248657|FG001|Overall Study|Participant moved out of the area|0|||
155220561|NCT02510794|560248658|FG002|Overall Study|Participant moved out of the area|0|||
155220562|NCT02510794|560248659|FG003|Overall Study|Participant moved out of the area|1|||
155220563|NCT02510794|560248656|FG000|Overall Study|Physician Decision|3|||
155220564|NCT02510794|560248657|FG001|Overall Study|Physician Decision|0|||
155220565|NCT02510794|560248658|FG002|Overall Study|Physician Decision|0|||
155220566|NCT02510794|560248659|FG003|Overall Study|Physician Decision|0|||
155220567|NCT02510794|560248656|FG000|Overall Study|Protocol Violation|0|||
155220568|NCT02510794|560248657|FG001|Overall Study|Protocol Violation|0|||
155220569|NCT02510794|560248658|FG002|Overall Study|Protocol Violation|1|||
155220570|NCT02510794|560248659|FG003|Overall Study|Protocol Violation|0|||
155220571|NCT02510794|560248656|FG000|Overall Study|Withdrawal by Subject|1|||
155220572|NCT02510794|560248657|FG001|Overall Study|Withdrawal by Subject|2|||
155220573|NCT02510794|560248658|FG002|Overall Study|Withdrawal by Subject|4|||
155220574|NCT02510794|560248659|FG003|Overall Study|Withdrawal by Subject|3|||
155220575|NCT01649375|560248660|FG000|Up to Week 16|Adverse Event|2|||
155220576|NCT01649375|560248661|FG001|Up to Week 16|Adverse Event|5|||
155220577|NCT01649375|560248662|FG002|Up to Week 16|Adverse Event|4|||
155220578|NCT01649375|560248663|FG003|Up to Week 16|Adverse Event|0|||
155220579|NCT01649375|560248664|FG004|Up to Week 16|Adverse Event|0|||
155220580|NCT01649375|560248660|FG000|Up to Week 16|Lack of Efficacy|0|||
155220581|NCT01649375|560248661|FG001|Up to Week 16|Lack of Efficacy|0|||
155220582|NCT01649375|560248662|FG002|Up to Week 16|Lack of Efficacy|1|||
155220583|NCT01649375|560248663|FG003|Up to Week 16|Lack of Efficacy|0|||
155220584|NCT01649375|560248664|FG004|Up to Week 16|Lack of Efficacy|0|||
155220585|NCT01649375|560248660|FG000|Up to Week 16|Physician Decision|0|||
155220586|NCT01649375|560248661|FG001|Up to Week 16|Physician Decision|0|||
155220587|NCT01649375|560248662|FG002|Up to Week 16|Physician Decision|1|||
155220588|NCT01649375|560248663|FG003|Up to Week 16|Physician Decision|0|||
155220589|NCT01649375|560248664|FG004|Up to Week 16|Physician Decision|0|||
155220590|NCT01649375|560248660|FG000|Up to Week 16|Withdrawal by Subject|2|||
155220591|NCT01649375|560248661|FG001|Up to Week 16|Withdrawal by Subject|1|||
155220592|NCT01649375|560248662|FG002|Up to Week 16|Withdrawal by Subject|2|||
155220593|NCT01649375|560248663|FG003|Up to Week 16|Withdrawal by Subject|0|||
155220594|NCT01649375|560248664|FG004|Up to Week 16|Withdrawal by Subject|0|||
155220595|NCT01649375|560248660|FG000|Up to Week 16|Death|1|||
155220596|NCT01649375|560248661|FG001|Up to Week 16|Death|0|||
155220597|NCT01649375|560248662|FG002|Up to Week 16|Death|0|||
155220598|NCT01649375|560248663|FG003|Up to Week 16|Death|0|||
155220599|NCT01649375|560248664|FG004|Up to Week 16|Death|0|||
155220600|NCT01649375|560248660|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
155220601|NCT01649375|560248661|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
155220602|NCT01649375|560248662|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
155220603|NCT01649375|560248663|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
155220604|NCT01649375|560248664|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
155220605|NCT01649375|560248660|FG000|Week 16 up to Week 260|Non-compliance|0|||
155220606|NCT01649375|560248661|FG001|Week 16 up to Week 260|Non-compliance|1|||
155220607|NCT01649375|560248662|FG002|Week 16 up to Week 260|Non-compliance|0|||
155220608|NCT01649375|560248663|FG003|Week 16 up to Week 260|Non-compliance|1|||
155220609|NCT01649375|560248664|FG004|Week 16 up to Week 260|Non-compliance|0|||
155220610|NCT01649375|560248660|FG000|Week 16 up to Week 260|Physician Decision|0|||
155220611|NCT01649375|560248661|FG001|Week 16 up to Week 260|Physician Decision|2|||
155220612|NCT01649375|560248662|FG002|Week 16 up to Week 260|Physician Decision|0|||
155220613|NCT01649375|560248663|FG003|Week 16 up to Week 260|Physician Decision|0|||
155220614|NCT01649375|560248664|FG004|Week 16 up to Week 260|Physician Decision|0|||
155220615|NCT01649375|560248660|FG000|Week 16 up to Week 260|Technical issues|0|||
155220616|NCT01649375|560248661|FG001|Week 16 up to Week 260|Technical issues|1|||
155220617|NCT01649375|560248662|FG002|Week 16 up to Week 260|Technical issues|0|||
155220618|NCT01649375|560248663|FG003|Week 16 up to Week 260|Technical issues|1|||
155220619|NCT01649375|560248664|FG004|Week 16 up to Week 260|Technical issues|0|||
155220620|NCT01649375|560248660|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
155220621|NCT01649375|560248661|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
155220622|NCT01649375|560248662|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
155220623|NCT01649375|560248663|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
155220624|NCT01649375|560248664|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
155220625|NCT01649375|560248660|FG000|Week 16 up to Week 260|Death|1|||
155220626|NCT01649375|560248661|FG001|Week 16 up to Week 260|Death|1|||
155220627|NCT01649375|560248662|FG002|Week 16 up to Week 260|Death|0|||
155220628|NCT01649375|560248663|FG003|Week 16 up to Week 260|Death|0|||
155220629|NCT01649375|560248664|FG004|Week 16 up to Week 260|Death|0|||
155220630|NCT01649375|560248660|FG000|Week 16 up to Week 260|Adverse Event|5|||
155220631|NCT01649375|560248661|FG001|Week 16 up to Week 260|Adverse Event|2|||
155220632|NCT01649375|560248662|FG002|Week 16 up to Week 260|Adverse Event|0|||
155220633|NCT01649375|560248663|FG003|Week 16 up to Week 260|Adverse Event|3|||
155220634|NCT01649375|560248664|FG004|Week 16 up to Week 260|Adverse Event|2|||
155220635|NCT01856790|560248667|FG000|Closed Loop Control|Withdrawal by Subject|2|||
155220636|NCT01856790|560248667|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
155220637|NCT04091646|560248668|FG000|Overall Study|Adverse Event|2|||
155220638|NCT04091646|560248669|FG001|Overall Study|Adverse Event|1|||
155220639|NCT04091646|560248668|FG000|Overall Study|Lost to Follow-up|6|||
155220640|NCT04091646|560248669|FG001|Overall Study|Lost to Follow-up|2|||
155220641|NCT04091646|560248668|FG000|Overall Study|Protocol Violation|0|||
155220642|NCT04091646|560248669|FG001|Overall Study|Protocol Violation|1|||
155220643|NCT04091646|560248668|FG000|Overall Study|Withdrawal by Subject|4|||
155220644|NCT04091646|560248669|FG001|Overall Study|Withdrawal by Subject|1|||
155220645|NCT04091646|560248668|FG000|Overall Study|Participant Incarcerated|1|||
155220646|NCT04091646|560248669|FG001|Overall Study|Participant Incarcerated|0|||
155220647|NCT01921829|560248670|FG000|Overall Study|Withdrawal by Subject|0|||
155220648|NCT01921829|560248671|FG001|Overall Study|Withdrawal by Subject|1|||
155220649|NCT03102918|560248672|FG000|Overall Study|Protocol Violation|1|||
155220650|NCT03102918|560248673|FG001|Overall Study|Protocol Violation|0|||
155220651|NCT00539838|560248674|FG000|Overall Study|Fail to return|2|||
155220652|NCT00539838|560248675|FG001|Overall Study|Fail to return|0|||
155220653|NCT00539838|560248676|FG002|Overall Study|Fail to return|0|||
155220654|NCT00539838|560248674|FG000|Overall Study|Withdrawal by Subject|0|||
155220655|NCT00539838|560248675|FG001|Overall Study|Withdrawal by Subject|4|||
155220656|NCT00539838|560248676|FG002|Overall Study|Withdrawal by Subject|0|||
155220657|NCT00539838|560248674|FG000|Overall Study|Death|0|||
155220658|NCT00539838|560248675|FG001|Overall Study|Death|2|||
155220659|NCT00539838|560248676|FG002|Overall Study|Death|0|||
155220660|NCT00539838|560248674|FG000|Overall Study|Did not cooperate|1|||
155220661|NCT00539838|560248675|FG001|Overall Study|Did not cooperate|0|||
155220662|NCT00539838|560248676|FG002|Overall Study|Did not cooperate|1|||
155220663|NCT00539838|560248674|FG000|Overall Study|Administrative|4|||
155220664|NCT00539838|560248675|FG001|Overall Study|Administrative|0|||
155220665|NCT00539838|560248676|FG002|Overall Study|Administrative|8|||
155220666|NCT02658890|560248682|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220667|NCT02658890|560248683|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220668|NCT02658890|560248684|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220669|NCT02658890|560248685|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220670|NCT02658890|560248686|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220671|NCT02658890|560248687|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220672|NCT02658890|560248688|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220673|NCT02658890|560248689|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220674|NCT02658890|560248690|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220675|NCT02658890|560248691|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220676|NCT02658890|560248692|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220677|NCT02658890|560248693|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220678|NCT02658890|560248694|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220679|NCT02658890|560248695|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220680|NCT02658890|560248696|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220681|NCT02658890|560248697|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220682|NCT02658890|560248698|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220683|NCT02658890|560248699|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220684|NCT02658890|560248700|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220685|NCT02658890|560248701|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220686|NCT02658890|560248702|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220687|NCT02658890|560248703|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220688|NCT02658890|560248704|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220689|NCT02658890|560248705|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220690|NCT02658890|560248706|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220691|NCT02658890|560248707|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220692|NCT02658890|560248708|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220693|NCT02658890|560248682|FG000|Treatment Phase|Adverse Event|0|||
155220694|NCT02658890|560248683|FG001|Treatment Phase|Adverse Event|1|||
155220695|NCT02658890|560248684|FG002|Treatment Phase|Adverse Event|2|||
155220696|NCT02658890|560248685|FG003|Treatment Phase|Adverse Event|2|||
155220697|NCT02658890|560248686|FG004|Treatment Phase|Adverse Event|1|||
155220698|NCT02658890|560248687|FG005|Treatment Phase|Adverse Event|0|||
155220699|NCT02658890|560248688|FG006|Treatment Phase|Adverse Event|0|||
155220700|NCT02658890|560248689|FG007|Treatment Phase|Adverse Event|2|||
155220701|NCT02658890|560248690|FG008|Treatment Phase|Adverse Event|1|||
155220702|NCT02658890|560248691|FG009|Treatment Phase|Adverse Event|2|||
155220703|NCT02658890|560248692|FG010|Treatment Phase|Adverse Event|3|||
155220704|NCT02658890|560248693|FG011|Treatment Phase|Adverse Event|0|||
155220705|NCT02658890|560248694|FG012|Treatment Phase|Adverse Event|1|||
155220706|NCT02658890|560248695|FG013|Treatment Phase|Adverse Event|4|||
155220707|NCT02658890|560248696|FG014|Treatment Phase|Adverse Event|0|||
155220708|NCT02658890|560248697|FG015|Treatment Phase|Adverse Event|0|||
155220709|NCT02658890|560248698|FG016|Treatment Phase|Adverse Event|0|||
155220710|NCT02658890|560248699|FG017|Treatment Phase|Adverse Event|0|||
155220711|NCT02658890|560248700|FG018|Treatment Phase|Adverse Event|5|||
155220712|NCT02658890|560248701|FG019|Treatment Phase|Adverse Event|1|||
155220713|NCT02658890|560248702|FG020|Treatment Phase|Adverse Event|3|||
155220714|NCT02658890|560248703|FG021|Treatment Phase|Adverse Event|0|||
155220715|NCT02658890|560248704|FG022|Treatment Phase|Adverse Event|5|||
155220716|NCT02658890|560248705|FG023|Treatment Phase|Adverse Event|0|||
155220717|NCT02658890|560248706|FG024|Treatment Phase|Adverse Event|0|||
155220718|NCT02658890|560248707|FG025|Treatment Phase|Adverse Event|2|||
155220719|NCT02658890|560248708|FG026|Treatment Phase|Adverse Event|1|||
155220720|NCT02658890|560248682|FG000|Treatment Phase|Death|0|||
155220721|NCT02658890|560248683|FG001|Treatment Phase|Death|0|||
155220722|NCT02658890|560248684|FG002|Treatment Phase|Death|0|||
155220723|NCT02658890|560248685|FG003|Treatment Phase|Death|0|||
155220724|NCT02658890|560248686|FG004|Treatment Phase|Death|0|||
155220725|NCT02658890|560248687|FG005|Treatment Phase|Death|0|||
155220726|NCT02658890|560248688|FG006|Treatment Phase|Death|0|||
155220727|NCT02658890|560248689|FG007|Treatment Phase|Death|0|||
155220728|NCT02658890|560248690|FG008|Treatment Phase|Death|0|||
155220729|NCT02658890|560248691|FG009|Treatment Phase|Death|0|||
155220730|NCT02658890|560248692|FG010|Treatment Phase|Death|0|||
155220731|NCT02658890|560248693|FG011|Treatment Phase|Death|0|||
155220732|NCT02658890|560248694|FG012|Treatment Phase|Death|0|||
155220733|NCT02658890|560248695|FG013|Treatment Phase|Death|0|||
155220734|NCT02658890|560248696|FG014|Treatment Phase|Death|0|||
155220735|NCT02658890|560248697|FG015|Treatment Phase|Death|0|||
155220736|NCT02658890|560248698|FG016|Treatment Phase|Death|0|||
155220737|NCT02658890|560248699|FG017|Treatment Phase|Death|0|||
155220738|NCT02658890|560248700|FG018|Treatment Phase|Death|1|||
155220739|NCT02658890|560248701|FG019|Treatment Phase|Death|0|||
155220740|NCT02658890|560248702|FG020|Treatment Phase|Death|0|||
155220741|NCT02658890|560248703|FG021|Treatment Phase|Death|0|||
155220742|NCT02658890|560248704|FG022|Treatment Phase|Death|0|||
155220743|NCT02658890|560248705|FG023|Treatment Phase|Death|0|||
155220744|NCT02658890|560248706|FG024|Treatment Phase|Death|0|||
155220745|NCT02658890|560248707|FG025|Treatment Phase|Death|0|||
155220746|NCT02658890|560248708|FG026|Treatment Phase|Death|0|||
155220747|NCT02658890|560248682|FG000|Treatment Phase|Lost to Follow-up|0|||
155220748|NCT02658890|560248683|FG001|Treatment Phase|Lost to Follow-up|0|||
155220749|NCT02658890|560248684|FG002|Treatment Phase|Lost to Follow-up|0|||
155220750|NCT02658890|560248685|FG003|Treatment Phase|Lost to Follow-up|0|||
155220751|NCT02658890|560248686|FG004|Treatment Phase|Lost to Follow-up|0|||
155220752|NCT02658890|560248687|FG005|Treatment Phase|Lost to Follow-up|0|||
155220753|NCT02658890|560248688|FG006|Treatment Phase|Lost to Follow-up|1|||
155220754|NCT02658890|560248689|FG007|Treatment Phase|Lost to Follow-up|0|||
155220755|NCT02658890|560248690|FG008|Treatment Phase|Lost to Follow-up|0|||
155220756|NCT02658890|560248691|FG009|Treatment Phase|Lost to Follow-up|0|||
155220757|NCT02658890|560248692|FG010|Treatment Phase|Lost to Follow-up|0|||
155220758|NCT02658890|560248693|FG011|Treatment Phase|Lost to Follow-up|0|||
155220759|NCT02658890|560248694|FG012|Treatment Phase|Lost to Follow-up|0|||
155220760|NCT02658890|560248695|FG013|Treatment Phase|Lost to Follow-up|0|||
155220761|NCT02658890|560248696|FG014|Treatment Phase|Lost to Follow-up|0|||
155220762|NCT02658890|560248697|FG015|Treatment Phase|Lost to Follow-up|0|||
155220763|NCT02658890|560248698|FG016|Treatment Phase|Lost to Follow-up|0|||
155220764|NCT02658890|560248699|FG017|Treatment Phase|Lost to Follow-up|0|||
155220765|NCT02658890|560248700|FG018|Treatment Phase|Lost to Follow-up|0|||
155220766|NCT02658890|560248701|FG019|Treatment Phase|Lost to Follow-up|0|||
155220767|NCT02658890|560248702|FG020|Treatment Phase|Lost to Follow-up|0|||
155220768|NCT02658890|560248703|FG021|Treatment Phase|Lost to Follow-up|0|||
155220769|NCT02658890|560248704|FG022|Treatment Phase|Lost to Follow-up|0|||
155220770|NCT02658890|560248705|FG023|Treatment Phase|Lost to Follow-up|0|||
155220771|NCT02658890|560248706|FG024|Treatment Phase|Lost to Follow-up|0|||
155220772|NCT02658890|560248707|FG025|Treatment Phase|Lost to Follow-up|0|||
155220773|NCT02658890|560248708|FG026|Treatment Phase|Lost to Follow-up|0|||
155220774|NCT02658890|560248682|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
155220775|NCT02658890|560248683|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
155220776|NCT02658890|560248684|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
155220777|NCT02658890|560248685|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
155220778|NCT02658890|560248686|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
155220779|NCT02658890|560248687|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
155220780|NCT02658890|560248688|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
155220781|NCT02658890|560248689|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
155220782|NCT02658890|560248690|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
155220783|NCT02658890|560248691|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
155220784|NCT02658890|560248692|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
155220785|NCT02658890|560248693|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
155220786|NCT02658890|560248694|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
155220787|NCT02658890|560248695|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
155220788|NCT02658890|560248696|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
155220789|NCT02658890|560248697|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
155220790|NCT02658890|560248698|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
155220791|NCT02658890|560248699|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
155220792|NCT02658890|560248700|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
155220793|NCT02658890|560248701|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
155220794|NCT02658890|560248702|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
155220795|NCT02658890|560248703|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
155220796|NCT02658890|560248704|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
155220797|NCT02658890|560248705|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
155220798|NCT02658890|560248706|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
155220799|NCT02658890|560248707|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
155220800|NCT02658890|560248708|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
155220801|NCT02658890|560248682|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
155220802|NCT02658890|560248683|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
155220803|NCT02658890|560248684|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
155220804|NCT02658890|560248685|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
155220805|NCT02658890|560248686|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
155220806|NCT02658890|560248687|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
155220807|NCT02658890|560248688|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
155220808|NCT02658890|560248689|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
155220809|NCT02658890|560248690|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
155220810|NCT02658890|560248691|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
155220811|NCT02658890|560248692|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
155220812|NCT02658890|560248693|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
155220813|NCT02658890|560248694|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
155220814|NCT02658890|560248695|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
155220815|NCT02658890|560248696|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
155220816|NCT02658890|560248697|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
155220817|NCT02658890|560248698|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
155220818|NCT02658890|560248699|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
155220819|NCT02658890|560248700|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
155220820|NCT02658890|560248701|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
155220821|NCT02658890|560248702|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
155220822|NCT02658890|560248703|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
155220823|NCT02658890|560248704|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
155220824|NCT02658890|560248705|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
155220825|NCT02658890|560248706|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
155220826|NCT02658890|560248707|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
155220827|NCT02658890|560248708|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
155220828|NCT02658890|560248682|FG000|Treatment Phase|Other Reasons|0|||
155220829|NCT02658890|560248683|FG001|Treatment Phase|Other Reasons|0|||
155220830|NCT02658890|560248684|FG002|Treatment Phase|Other Reasons|0|||
155220831|NCT02658890|560248685|FG003|Treatment Phase|Other Reasons|0|||
155220832|NCT02658890|560248686|FG004|Treatment Phase|Other Reasons|0|||
155220833|NCT02658890|560248687|FG005|Treatment Phase|Other Reasons|0|||
155220834|NCT02658890|560248688|FG006|Treatment Phase|Other Reasons|1|||
155220835|NCT02658890|560248689|FG007|Treatment Phase|Other Reasons|0|||
155220836|NCT02658890|560248690|FG008|Treatment Phase|Other Reasons|1|||
155220837|NCT02658890|560248691|FG009|Treatment Phase|Other Reasons|0|||
155220838|NCT02658890|560248692|FG010|Treatment Phase|Other Reasons|0|||
155220839|NCT02658890|560248693|FG011|Treatment Phase|Other Reasons|0|||
155220840|NCT02658890|560248694|FG012|Treatment Phase|Other Reasons|0|||
155220841|NCT02658890|560248695|FG013|Treatment Phase|Other Reasons|2|||
155220842|NCT02658890|560248696|FG014|Treatment Phase|Other Reasons|0|||
155220843|NCT02658890|560248697|FG015|Treatment Phase|Other Reasons|0|||
155220844|NCT02658890|560248698|FG016|Treatment Phase|Other Reasons|0|||
155220845|NCT02658890|560248699|FG017|Treatment Phase|Other Reasons|0|||
155220846|NCT02658890|560248700|FG018|Treatment Phase|Other Reasons|1|||
155220847|NCT02658890|560248701|FG019|Treatment Phase|Other Reasons|0|||
155220848|NCT02658890|560248702|FG020|Treatment Phase|Other Reasons|0|||
155220849|NCT02658890|560248703|FG021|Treatment Phase|Other Reasons|0|||
155220850|NCT02658890|560248704|FG022|Treatment Phase|Other Reasons|0|||
155220851|NCT02658890|560248705|FG023|Treatment Phase|Other Reasons|0|||
155220852|NCT02658890|560248706|FG024|Treatment Phase|Other Reasons|1|||
155220853|NCT02658890|560248707|FG025|Treatment Phase|Other Reasons|0|||
155220854|NCT02658890|560248708|FG026|Treatment Phase|Other Reasons|1|||
155220855|NCT02658890|560248682|FG000|Treatment Phase|Progressive Disease|6|||
155220856|NCT02658890|560248683|FG001|Treatment Phase|Progressive Disease|7|||
155220857|NCT02658890|560248684|FG002|Treatment Phase|Progressive Disease|6|||
155220858|NCT02658890|560248685|FG003|Treatment Phase|Progressive Disease|12|||
155220859|NCT02658890|560248686|FG004|Treatment Phase|Progressive Disease|6|||
155220860|NCT02658890|560248687|FG005|Treatment Phase|Progressive Disease|18|||
155220861|NCT02658890|560248688|FG006|Treatment Phase|Progressive Disease|12|||
155220862|NCT02658890|560248689|FG007|Treatment Phase|Progressive Disease|19|||
155220863|NCT02658890|560248690|FG008|Treatment Phase|Progressive Disease|26|||
155220864|NCT02658890|560248691|FG009|Treatment Phase|Progressive Disease|8|||
155220865|NCT02658890|560248692|FG010|Treatment Phase|Progressive Disease|7|||
155220866|NCT02658890|560248693|FG011|Treatment Phase|Progressive Disease|9|||
155220867|NCT02658890|560248694|FG012|Treatment Phase|Progressive Disease|8|||
155220868|NCT02658890|560248695|FG013|Treatment Phase|Progressive Disease|29|||
155220869|NCT02658890|560248696|FG014|Treatment Phase|Progressive Disease|6|||
155220870|NCT02658890|560248697|FG015|Treatment Phase|Progressive Disease|2|||
155220871|NCT02658890|560248698|FG016|Treatment Phase|Progressive Disease|32|||
155220872|NCT02658890|560248699|FG017|Treatment Phase|Progressive Disease|14|||
155220873|NCT02658890|560248700|FG018|Treatment Phase|Progressive Disease|40|||
155220874|NCT02658890|560248701|FG019|Treatment Phase|Progressive Disease|32|||
155220875|NCT02658890|560248702|FG020|Treatment Phase|Progressive Disease|19|||
155220876|NCT02658890|560248703|FG021|Treatment Phase|Progressive Disease|30|||
155220877|NCT02658890|560248704|FG022|Treatment Phase|Progressive Disease|15|||
155220878|NCT02658890|560248705|FG023|Treatment Phase|Progressive Disease|0|||
155220879|NCT02658890|560248706|FG024|Treatment Phase|Progressive Disease|0|||
155220880|NCT02658890|560248707|FG025|Treatment Phase|Progressive Disease|14|||
155220881|NCT02658890|560248708|FG026|Treatment Phase|Progressive Disease|11|||
155220882|NCT02658890|560248682|FG000|Treatment Phase|Study Drug Toxicity|0|||
155220883|NCT02658890|560248683|FG001|Treatment Phase|Study Drug Toxicity|0|||
155220884|NCT02658890|560248684|FG002|Treatment Phase|Study Drug Toxicity|2|||
155220885|NCT02658890|560248685|FG003|Treatment Phase|Study Drug Toxicity|0|||
155220886|NCT02658890|560248686|FG004|Treatment Phase|Study Drug Toxicity|0|||
155220887|NCT02658890|560248687|FG005|Treatment Phase|Study Drug Toxicity|0|||
155220888|NCT02658890|560248688|FG006|Treatment Phase|Study Drug Toxicity|0|||
155220889|NCT02658890|560248689|FG007|Treatment Phase|Study Drug Toxicity|0|||
155220890|NCT02658890|560248690|FG008|Treatment Phase|Study Drug Toxicity|3|||
155220891|NCT02658890|560248691|FG009|Treatment Phase|Study Drug Toxicity|0|||
155220892|NCT02658890|560248692|FG010|Treatment Phase|Study Drug Toxicity|1|||
155220893|NCT02658890|560248693|FG011|Treatment Phase|Study Drug Toxicity|1|||
155220894|NCT02658890|560248694|FG012|Treatment Phase|Study Drug Toxicity|2|||
155220895|NCT02658890|560248695|FG013|Treatment Phase|Study Drug Toxicity|9|||
155220896|NCT02658890|560248696|FG014|Treatment Phase|Study Drug Toxicity|0|||
155220897|NCT02658890|560248697|FG015|Treatment Phase|Study Drug Toxicity|1|||
155220898|NCT02658890|560248698|FG016|Treatment Phase|Study Drug Toxicity|1|||
155220899|NCT02658890|560248699|FG017|Treatment Phase|Study Drug Toxicity|0|||
155220900|NCT02658890|560248700|FG018|Treatment Phase|Study Drug Toxicity|8|||
155220901|NCT02658890|560248701|FG019|Treatment Phase|Study Drug Toxicity|3|||
155220902|NCT02658890|560248702|FG020|Treatment Phase|Study Drug Toxicity|2|||
155220903|NCT02658890|560248703|FG021|Treatment Phase|Study Drug Toxicity|0|||
155220904|NCT02658890|560248704|FG022|Treatment Phase|Study Drug Toxicity|8|||
155220905|NCT02658890|560248705|FG023|Treatment Phase|Study Drug Toxicity|0|||
155220906|NCT02658890|560248706|FG024|Treatment Phase|Study Drug Toxicity|0|||
155220907|NCT02658890|560248707|FG025|Treatment Phase|Study Drug Toxicity|2|||
155220908|NCT02658890|560248708|FG026|Treatment Phase|Study Drug Toxicity|0|||
155220909|NCT02658890|560248682|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220910|NCT02658890|560248683|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220911|NCT02658890|560248684|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220912|NCT02658890|560248685|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220913|NCT02658890|560248686|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220914|NCT02658890|560248687|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220915|NCT02658890|560248688|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220916|NCT02658890|560248689|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220917|NCT02658890|560248690|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220918|NCT02658890|560248691|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220919|NCT02658890|560248692|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220920|NCT02658890|560248693|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220921|NCT02658890|560248694|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220922|NCT02658890|560248695|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220923|NCT02658890|560248696|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220924|NCT02658890|560248697|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220925|NCT02658890|560248698|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220926|NCT02658890|560248699|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220927|NCT02658890|560248700|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220928|NCT02658890|560248701|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220929|NCT02658890|560248702|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220930|NCT02658890|560248703|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220931|NCT02658890|560248704|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220932|NCT02658890|560248705|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220933|NCT02658890|560248706|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220934|NCT02658890|560248707|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220935|NCT02658890|560248708|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220936|NCT02658890|560248682|FG000|Treatment Phase|Withdrawal by Subject|0|||
155220937|NCT02658890|560248683|FG001|Treatment Phase|Withdrawal by Subject|1|||
155220938|NCT02658890|560248684|FG002|Treatment Phase|Withdrawal by Subject|0|||
155220939|NCT02658890|560248685|FG003|Treatment Phase|Withdrawal by Subject|0|||
155220940|NCT02658890|560248686|FG004|Treatment Phase|Withdrawal by Subject|0|||
155220941|NCT02658890|560248687|FG005|Treatment Phase|Withdrawal by Subject|0|||
155220942|NCT02658890|560248688|FG006|Treatment Phase|Withdrawal by Subject|1|||
155220943|NCT02658890|560248689|FG007|Treatment Phase|Withdrawal by Subject|0|||
155220944|NCT02658890|560248690|FG008|Treatment Phase|Withdrawal by Subject|0|||
155220945|NCT02658890|560248691|FG009|Treatment Phase|Withdrawal by Subject|1|||
155220946|NCT02658890|560248692|FG010|Treatment Phase|Withdrawal by Subject|0|||
155220947|NCT02658890|560248693|FG011|Treatment Phase|Withdrawal by Subject|0|||
155220948|NCT02658890|560248694|FG012|Treatment Phase|Withdrawal by Subject|1|||
155220949|NCT02658890|560248695|FG013|Treatment Phase|Withdrawal by Subject|3|||
155220950|NCT02658890|560248696|FG014|Treatment Phase|Withdrawal by Subject|0|||
155220951|NCT02658890|560248697|FG015|Treatment Phase|Withdrawal by Subject|0|||
155220952|NCT02658890|560248698|FG016|Treatment Phase|Withdrawal by Subject|1|||
155220953|NCT02658890|560248699|FG017|Treatment Phase|Withdrawal by Subject|0|||
155220954|NCT02658890|560248700|FG018|Treatment Phase|Withdrawal by Subject|4|||
155220955|NCT02658890|560248701|FG019|Treatment Phase|Withdrawal by Subject|3|||
155220956|NCT02658890|560248702|FG020|Treatment Phase|Withdrawal by Subject|0|||
155220957|NCT02658890|560248703|FG021|Treatment Phase|Withdrawal by Subject|4|||
155220958|NCT02658890|560248704|FG022|Treatment Phase|Withdrawal by Subject|1|||
155220959|NCT02658890|560248705|FG023|Treatment Phase|Withdrawal by Subject|1|||
155220960|NCT02658890|560248706|FG024|Treatment Phase|Withdrawal by Subject|0|||
155220961|NCT02658890|560248707|FG025|Treatment Phase|Withdrawal by Subject|0|||
155220962|NCT02658890|560248708|FG026|Treatment Phase|Withdrawal by Subject|0|||
155220963|NCT02474199|560248709|FG000|Overall Study|Lost to Follow-up|1|||
155220964|NCT02474199|560248710|FG001|Overall Study|Lost to Follow-up|0|||
155220965|NCT02474199|560248711|FG002|Overall Study|Lost to Follow-up|0|||
155220966|NCT02474199|560248712|FG003|Overall Study|Lost to Follow-up|0|||
155220967|NCT02474199|560248709|FG000|Overall Study|Withdrawal by Subject|1|||
155220968|NCT02474199|560248710|FG001|Overall Study|Withdrawal by Subject|2|||
155220969|NCT02474199|560248711|FG002|Overall Study|Withdrawal by Subject|0|||
155220970|NCT02474199|560248712|FG003|Overall Study|Withdrawal by Subject|1|||
155220971|NCT02474199|560248709|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220972|NCT02474199|560248710|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
155220973|NCT02474199|560248711|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220974|NCT02474199|560248712|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220975|NCT02474199|560248709|FG000|Overall Study|Did not meet eligibility criteria|0|||
155220976|NCT02474199|560248710|FG001|Overall Study|Did not meet eligibility criteria|0|||
155220977|NCT02474199|560248711|FG002|Overall Study|Did not meet eligibility criteria|2|||
155220978|NCT02474199|560248712|FG003|Overall Study|Did not meet eligibility criteria|2|||
155220979|NCT03090100|560248713|FG000|Overall Study|Adverse Event|9|||
155220980|NCT03090100|560248714|FG001|Overall Study|Adverse Event|11|||
155220981|NCT03090100|560248713|FG000|Overall Study|Pregnancy|1|||
155220982|NCT03090100|560248714|FG001|Overall Study|Pregnancy|1|||
155220983|NCT03090100|560248713|FG000|Overall Study|Lack of Efficacy|2|||
155220984|NCT03090100|560248714|FG001|Overall Study|Lack of Efficacy|7|||
155220985|NCT03090100|560248713|FG000|Overall Study|Lost to Follow-up|2|||
155220986|NCT03090100|560248714|FG001|Overall Study|Lost to Follow-up|2|||
155220987|NCT03090100|560248713|FG000|Overall Study|Withdrawal by Subject|7|||
155220988|NCT03090100|560248714|FG001|Overall Study|Withdrawal by Subject|19|||
155220989|NCT03090100|560248713|FG000|Overall Study|Protocol Violation|2|||
155220990|NCT03090100|560248714|FG001|Overall Study|Protocol Violation|6|||
155220991|NCT03090100|560248713|FG000|Overall Study|Non-compliance|2|||
155220992|NCT03090100|560248714|FG001|Overall Study|Non-compliance|0|||
155220993|NCT03090100|560248713|FG000|Overall Study|Other|2|||
155220994|NCT03090100|560248714|FG001|Overall Study|Other|2|||
155220995|NCT04765358|560248717|FG000|Overall Study|Withdrawal by Subject|1|||
155220996|NCT00159588|560248718|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
155220997|NCT00159588|560248719|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
155220998|NCT00159588|560248720|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
155220999|NCT03446040|560248721|FG000|Overall Study|Disease progression|3|||
155221000|NCT03446040|560248722|FG001|Overall Study|Disease progression|3|||
155221001|NCT03446040|560248723|FG002|Overall Study|Disease progression|3|||
155221002|NCT03446040|560248724|FG003|Overall Study|Disease progression|4|||
155221003|NCT03446040|560248725|FG004|Overall Study|Disease progression|4|||
155221004|NCT03446040|560248726|FG005|Overall Study|Disease progression|6|||
155221005|NCT03446040|560248727|FG006|Overall Study|Disease progression|3|||
155221006|NCT03446040|560248728|FG007|Overall Study|Disease progression|4|||
155221007|NCT03446040|560248729|FG008|Overall Study|Disease progression|2|||
155221008|NCT03446040|560248730|FG009|Overall Study|Disease progression|4|||
155221009|NCT03446040|560248731|FG010|Overall Study|Disease progression|9|||
155221010|NCT03446040|560248732|FG011|Overall Study|Disease progression|3|||
155221011|NCT03446040|560248733|FG012|Overall Study|Disease progression|7|||
155221012|NCT03446040|560248734|FG013|Overall Study|Disease progression|7|||
155221013|NCT03446040|560248721|FG000|Overall Study|Study drug toxicity|0|||
155221014|NCT03446040|560248722|FG001|Overall Study|Study drug toxicity|0|||
155221015|NCT03446040|560248723|FG002|Overall Study|Study drug toxicity|0|||
155221016|NCT03446040|560248724|FG003|Overall Study|Study drug toxicity|0|||
155221017|NCT03446040|560248725|FG004|Overall Study|Study drug toxicity|0|||
155221018|NCT03446040|560248726|FG005|Overall Study|Study drug toxicity|0|||
155221019|NCT03446040|560248727|FG006|Overall Study|Study drug toxicity|0|||
155221020|NCT03446040|560248728|FG007|Overall Study|Study drug toxicity|0|||
155221021|NCT03446040|560248729|FG008|Overall Study|Study drug toxicity|1|||
155221022|NCT03446040|560248730|FG009|Overall Study|Study drug toxicity|0|||
155221023|NCT03446040|560248731|FG010|Overall Study|Study drug toxicity|0|||
155221024|NCT03446040|560248732|FG011|Overall Study|Study drug toxicity|0|||
155221025|NCT03446040|560248733|FG012|Overall Study|Study drug toxicity|0|||
155221026|NCT03446040|560248734|FG013|Overall Study|Study drug toxicity|0|||
155221027|NCT03446040|560248721|FG000|Overall Study|Adverse Event|0|||
155221028|NCT03446040|560248722|FG001|Overall Study|Adverse Event|0|||
155221029|NCT03446040|560248723|FG002|Overall Study|Adverse Event|0|||
155221030|NCT03446040|560248724|FG003|Overall Study|Adverse Event|0|||
155221031|NCT03446040|560248725|FG004|Overall Study|Adverse Event|0|||
155221032|NCT03446040|560248726|FG005|Overall Study|Adverse Event|2|||
155221033|NCT03446040|560248727|FG006|Overall Study|Adverse Event|0|||
155221034|NCT03446040|560248728|FG007|Overall Study|Adverse Event|0|||
155221035|NCT03446040|560248729|FG008|Overall Study|Adverse Event|1|||
155221036|NCT03446040|560248730|FG009|Overall Study|Adverse Event|0|||
155221037|NCT03446040|560248731|FG010|Overall Study|Adverse Event|0|||
155221038|NCT03446040|560248732|FG011|Overall Study|Adverse Event|0|||
155221039|NCT03446040|560248733|FG012|Overall Study|Adverse Event|0|||
155221040|NCT03446040|560248734|FG013|Overall Study|Adverse Event|0|||
155221041|NCT03446040|560248721|FG000|Overall Study|Death|0|||
155221042|NCT03446040|560248722|FG001|Overall Study|Death|0|||
155221043|NCT03446040|560248723|FG002|Overall Study|Death|0|||
155221044|NCT03446040|560248724|FG003|Overall Study|Death|0|||
155221045|NCT03446040|560248725|FG004|Overall Study|Death|0|||
155221046|NCT03446040|560248726|FG005|Overall Study|Death|0|||
155221047|NCT03446040|560248727|FG006|Overall Study|Death|0|||
155221048|NCT03446040|560248728|FG007|Overall Study|Death|0|||
155221049|NCT03446040|560248729|FG008|Overall Study|Death|0|||
155221050|NCT03446040|560248730|FG009|Overall Study|Death|0|||
155221051|NCT03446040|560248731|FG010|Overall Study|Death|1|||
155221052|NCT03446040|560248732|FG011|Overall Study|Death|0|||
155221053|NCT03446040|560248733|FG012|Overall Study|Death|0|||
155221054|NCT03446040|560248734|FG013|Overall Study|Death|2|||
155221055|NCT03446040|560248721|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155221056|NCT03446040|560248722|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
155221057|NCT03446040|560248723|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155221058|NCT03446040|560248724|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
155221059|NCT03446040|560248725|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
155221060|NCT03446040|560248726|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
155221061|NCT03446040|560248727|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
155221062|NCT03446040|560248728|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
155221063|NCT03446040|560248729|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
155221064|NCT03446040|560248730|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
155221065|NCT03446040|560248731|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
155221066|NCT03446040|560248732|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
155221067|NCT03446040|560248733|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
155221068|NCT03446040|560248734|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
155221069|NCT03446040|560248721|FG000|Overall Study|Participant withdrew consent|0|||
155221070|NCT03446040|560248722|FG001|Overall Study|Participant withdrew consent|0|||
155221071|NCT03446040|560248723|FG002|Overall Study|Participant withdrew consent|0|||
155221072|NCT03446040|560248724|FG003|Overall Study|Participant withdrew consent|0|||
155221073|NCT03446040|560248725|FG004|Overall Study|Participant withdrew consent|0|||
155221074|NCT03446040|560248726|FG005|Overall Study|Participant withdrew consent|1|||
155221075|NCT03446040|560248727|FG006|Overall Study|Participant withdrew consent|0|||
155221076|NCT03446040|560248728|FG007|Overall Study|Participant withdrew consent|1|||
155221077|NCT03446040|560248729|FG008|Overall Study|Participant withdrew consent|0|||
155221078|NCT03446040|560248730|FG009|Overall Study|Participant withdrew consent|0|||
155221079|NCT03446040|560248731|FG010|Overall Study|Participant withdrew consent|0|||
155221080|NCT03446040|560248732|FG011|Overall Study|Participant withdrew consent|0|||
155221081|NCT03446040|560248733|FG012|Overall Study|Participant withdrew consent|0|||
155221082|NCT03446040|560248734|FG013|Overall Study|Participant withdrew consent|0|||
155221083|NCT03446040|560248721|FG000|Overall Study|Not reported|0|||
155221084|NCT03446040|560248722|FG001|Overall Study|Not reported|0|||
155221085|NCT03446040|560248723|FG002|Overall Study|Not reported|1|||
155221086|NCT03446040|560248724|FG003|Overall Study|Not reported|0|||
155221087|NCT03446040|560248725|FG004|Overall Study|Not reported|0|||
155221088|NCT03446040|560248726|FG005|Overall Study|Not reported|0|||
155221089|NCT03446040|560248727|FG006|Overall Study|Not reported|0|||
155221090|NCT03446040|560248728|FG007|Overall Study|Not reported|0|||
155221091|NCT03446040|560248729|FG008|Overall Study|Not reported|0|||
155221092|NCT03446040|560248730|FG009|Overall Study|Not reported|0|||
155221093|NCT03446040|560248731|FG010|Overall Study|Not reported|0|||
155221094|NCT03446040|560248732|FG011|Overall Study|Not reported|0|||
155221095|NCT03446040|560248733|FG012|Overall Study|Not reported|0|||
155221096|NCT03446040|560248734|FG013|Overall Study|Not reported|0|||
155221097|NCT00456521|560248735|FG000|Overall Study|Adverse Event|150|||
155221098|NCT00456521|560248736|FG001|Overall Study|Adverse Event|25|||
155221099|NCT00456521|560248735|FG000|Overall Study|Withdrawal by Subject|43|||
155221100|NCT00456521|560248736|FG001|Overall Study|Withdrawal by Subject|24|||
155221101|NCT00456521|560248735|FG000|Overall Study|Lost to Follow-up|22|||
155221102|NCT00456521|560248736|FG001|Overall Study|Lost to Follow-up|17|||
155221103|NCT00456521|560248735|FG000|Overall Study|Lack of Efficacy|3|||
155221104|NCT00456521|560248736|FG001|Overall Study|Lack of Efficacy|6|||
155221105|NCT00456521|560248735|FG000|Overall Study|Protocol Violation|4|||
155221106|NCT00456521|560248736|FG001|Overall Study|Protocol Violation|0|||
155221107|NCT00456521|560248735|FG000|Overall Study|Pregnancy|1|||
155221108|NCT00456521|560248736|FG001|Overall Study|Pregnancy|1|||
155221109|NCT00456521|560248735|FG000|Overall Study|Drug non-compliance, moved, other|26|||
155221110|NCT00456521|560248736|FG001|Overall Study|Drug non-compliance, moved, other|11|||
155221111|NCT01316276|560248737|FG000|Overall Study|Death|1|||
155221112|NCT01316276|560248737|FG000|Overall Study|Adverse Event|19|||
155221113|NCT01316276|560248737|FG000|Overall Study|Withdrawal of consent|24|||
155221114|NCT01316276|560248737|FG000|Overall Study|Lost to Follow-up|1|||
155221115|NCT01316276|560248737|FG000|Overall Study|Other|22|||
155221116|NCT00605475|560248738|FG000|Overall Study|Abnormal Laboratory Values|0|||
155221117|NCT00605475|560248739|FG001|Overall Study|Abnormal Laboratory Values|0|||
155221118|NCT00605475|560248740|FG002|Overall Study|Abnormal Laboratory Values|0|||
155221119|NCT00605475|560248741|FG003|Overall Study|Abnormal Laboratory Values|0|||
155221120|NCT00605475|560248742|FG004|Overall Study|Abnormal Laboratory Values|0|||
155221121|NCT00605475|560248743|FG005|Overall Study|Abnormal Laboratory Values|0|||
155221122|NCT00605475|560248744|FG006|Overall Study|Abnormal Laboratory Values|0|||
155221123|NCT00605475|560248745|FG007|Overall Study|Abnormal Laboratory Values|0|||
155221124|NCT00605475|560248746|FG008|Overall Study|Abnormal Laboratory Values|1|||
155221125|NCT00605475|560248747|FG009|Overall Study|Abnormal Laboratory Values|0|||
155221126|NCT00605475|560248738|FG000|Overall Study|Administrative problems|0|||
155221127|NCT00605475|560248739|FG001|Overall Study|Administrative problems|0|||
155221128|NCT00605475|560248740|FG002|Overall Study|Administrative problems|0|||
155221129|NCT00605475|560248741|FG003|Overall Study|Administrative problems|0|||
155221130|NCT00605475|560248742|FG004|Overall Study|Administrative problems|0|||
155221131|NCT00605475|560248743|FG005|Overall Study|Administrative problems|0|||
155221132|NCT00605475|560248744|FG006|Overall Study|Administrative problems|1|||
155221133|NCT00605475|560248745|FG007|Overall Study|Administrative problems|0|||
155221134|NCT00605475|560248746|FG008|Overall Study|Administrative problems|0|||
155221135|NCT00605475|560248747|FG009|Overall Study|Administrative problems|0|||
155221136|NCT00605475|560248738|FG000|Overall Study|Lost to Follow-up|0|||
155221137|NCT00605475|560248739|FG001|Overall Study|Lost to Follow-up|0|||
155221138|NCT00605475|560248740|FG002|Overall Study|Lost to Follow-up|0|||
155221139|NCT00605475|560248741|FG003|Overall Study|Lost to Follow-up|0|||
155221140|NCT00605475|560248742|FG004|Overall Study|Lost to Follow-up|0|||
155221141|NCT00605475|560248743|FG005|Overall Study|Lost to Follow-up|0|||
155221142|NCT00605475|560248744|FG006|Overall Study|Lost to Follow-up|0|||
155221143|NCT00605475|560248745|FG007|Overall Study|Lost to Follow-up|0|||
155221144|NCT00605475|560248746|FG008|Overall Study|Lost to Follow-up|1|||
155221145|NCT00605475|560248747|FG009|Overall Study|Lost to Follow-up|1|||
155221146|NCT00605475|560248738|FG000|Overall Study|Protocol Violation|0|||
155221147|NCT00605475|560248739|FG001|Overall Study|Protocol Violation|0|||
155221148|NCT00605475|560248740|FG002|Overall Study|Protocol Violation|0|||
155221149|NCT00605475|560248741|FG003|Overall Study|Protocol Violation|0|||
155221150|NCT00605475|560248742|FG004|Overall Study|Protocol Violation|1|||
155221151|NCT00605475|560248743|FG005|Overall Study|Protocol Violation|0|||
155221152|NCT00605475|560248744|FG006|Overall Study|Protocol Violation|0|||
155221153|NCT00605475|560248745|FG007|Overall Study|Protocol Violation|0|||
155221154|NCT00605475|560248746|FG008|Overall Study|Protocol Violation|0|||
155221155|NCT00605475|560248747|FG009|Overall Study|Protocol Violation|0|||
155221156|NCT00605475|560248738|FG000|Overall Study|Withdrawal by Subject|0|||
155221157|NCT00605475|560248739|FG001|Overall Study|Withdrawal by Subject|0|||
155221158|NCT00605475|560248740|FG002|Overall Study|Withdrawal by Subject|0|||
155221159|NCT00605475|560248741|FG003|Overall Study|Withdrawal by Subject|0|||
155221160|NCT00605475|560248742|FG004|Overall Study|Withdrawal by Subject|0|||
155221161|NCT00605475|560248743|FG005|Overall Study|Withdrawal by Subject|2|||
155221162|NCT00605475|560248744|FG006|Overall Study|Withdrawal by Subject|0|||
155221163|NCT00605475|560248745|FG007|Overall Study|Withdrawal by Subject|0|||
155221164|NCT00605475|560248746|FG008|Overall Study|Withdrawal by Subject|0|||
155221165|NCT00605475|560248747|FG009|Overall Study|Withdrawal by Subject|1|||
155221166|NCT02596854|560248748|FG000|Overall Study|Withdrawn|8|||
155221167|NCT00464568|560248755|FG000|Overall Study|Adverse Event|2|||
155221168|NCT00507442|560248756|FG000|Overall Study|Adverse Event|8|||
155221169|NCT00507442|560248757|FG001|Overall Study|Adverse Event|11|||
155221170|NCT00507442|560248758|FG002|Overall Study|Adverse Event|4|||
155221171|NCT00507442|560248759|FG003|Overall Study|Adverse Event|1|||
155221172|NCT00507442|560248756|FG000|Overall Study|Protocol Violation|0|||
155221173|NCT00507442|560248757|FG001|Overall Study|Protocol Violation|1|||
155221174|NCT00507442|560248758|FG002|Overall Study|Protocol Violation|0|||
155221175|NCT00507442|560248759|FG003|Overall Study|Protocol Violation|0|||
155221176|NCT00507442|560248756|FG000|Overall Study|Lost to Follow-up|0|||
155221177|NCT00507442|560248757|FG001|Overall Study|Lost to Follow-up|0|||
155221178|NCT00507442|560248758|FG002|Overall Study|Lost to Follow-up|1|||
155221179|NCT00507442|560248759|FG003|Overall Study|Lost to Follow-up|0|||
155221180|NCT00507442|560248756|FG000|Overall Study|Physician Decision|0|||
155221181|NCT00507442|560248757|FG001|Overall Study|Physician Decision|2|||
155221182|NCT00507442|560248758|FG002|Overall Study|Physician Decision|4|||
155221183|NCT00507442|560248759|FG003|Overall Study|Physician Decision|1|||
155221184|NCT00507442|560248756|FG000|Overall Study|Progressive Disease|2|||
155221185|NCT00507442|560248757|FG001|Overall Study|Progressive Disease|4|||
155221186|NCT00507442|560248758|FG002|Overall Study|Progressive Disease|2|||
155221187|NCT00507442|560248759|FG003|Overall Study|Progressive Disease|0|||
155221188|NCT00507442|560248756|FG000|Overall Study|Withdrawal by Subject|4|||
155221189|NCT00507442|560248757|FG001|Overall Study|Withdrawal by Subject|4|||
155221190|NCT00507442|560248758|FG002|Overall Study|Withdrawal by Subject|2|||
155221191|NCT00507442|560248759|FG003|Overall Study|Withdrawal by Subject|1|||
155221192|NCT00507442|560248756|FG000|Overall Study|Other|2|||
155221193|NCT00507442|560248757|FG001|Overall Study|Other|5|||
155221194|NCT00507442|560248758|FG002|Overall Study|Other|2|||
155221195|NCT00507442|560248759|FG003|Overall Study|Other|2|||
155221196|NCT03506373|560248762|FG000|Overall Study|Adverse Event|6|||
155221197|NCT03506373|560248762|FG000|Overall Study|Withdrawal by Subject|2|||
155221198|NCT03506373|560248762|FG000|Overall Study|Disease progression|5|||
155221199|NCT03506373|560248762|FG000|Overall Study|Other|3|||
155221200|NCT00107198|560248763|FG000|Overall Study|Lack of Efficacy|28|||
155221201|NCT00107198|560248763|FG000|Overall Study|Lost to Follow-up|12|||
155221202|NCT00107198|560248763|FG000|Overall Study|Protocol Violation|1|||
155221203|NCT00107198|560248763|FG000|Overall Study|Withdrawal by Subject|6|||
155221204|NCT00107198|560248763|FG000|Overall Study|Ineligible|5|||
155221205|NCT04649164|560248766|FG000|Overall Study|Withdrawal by Subject|1|||
155221206|NCT04649164|560248767|FG001|Overall Study|Withdrawal by Subject|1|||
155221207|NCT04649164|560248768|FG002|Overall Study|Withdrawal by Subject|2|||
155221208|NCT04649164|560248766|FG000|Overall Study|Participant's care recipient expired|0|||
155221209|NCT04649164|560248767|FG001|Overall Study|Participant's care recipient expired|0|||
155221210|NCT04649164|560248768|FG002|Overall Study|Participant's care recipient expired|2|||
155221211|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|5|||
155221212|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221213|NCT00304356|560248769|FG000|Nitazoxanide|number is 0|1|||
155221214|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221215|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221216|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221217|NCT04120974|560248770|FG000|Overall Study|Death|1|||
155221218|NCT04120974|560248770|FG000|Overall Study|Physician Decision|1|||
155221219|NCT04120974|560248770|FG000|Overall Study|Lost to Follow-up|6|||
155221220|NCT00741039|560248774|FG000|Overall Study|Patient non-compliance|2|||
155221221|NCT00741039|560248775|FG001|Overall Study|Patient non-compliance|0|||
155221222|NCT00768300|560248776|FG000|Overall Study|Randomized but not treated|1|||
155221223|NCT00768300|560248777|FG001|Overall Study|Randomized but not treated|1|||
155221224|NCT00768300|560248776|FG000|Overall Study|Adverse Event|10|||
155221225|NCT00768300|560248777|FG001|Overall Study|Adverse Event|2|||
155221226|NCT00768300|560248776|FG000|Overall Study|Protocol Violation|6|||
155221227|NCT00768300|560248777|FG001|Overall Study|Protocol Violation|1|||
155221228|NCT00768300|560248776|FG000|Overall Study|Withdrawal by Subject|13|||
155221229|NCT00768300|560248777|FG001|Overall Study|Withdrawal by Subject|7|||
155221230|NCT00768300|560248776|FG000|Overall Study|Physician Decision|2|||
155221231|NCT00768300|560248777|FG001|Overall Study|Physician Decision|3|||
155221232|NCT00768300|560248776|FG000|Overall Study|Study discontinued by Sponsor|271|||
155221233|NCT00768300|560248777|FG001|Overall Study|Study discontinued by Sponsor|140|||
155221234|NCT00768300|560248776|FG000|Overall Study|Death|21|||
155221235|NCT00768300|560248777|FG001|Overall Study|Death|5|||
155221236|NCT00768300|560248776|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
155221237|NCT00768300|560248777|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
155221238|NCT00768300|560248776|FG000|Overall Study|Screen failure following randomization|1|||
155221239|NCT00768300|560248777|FG001|Overall Study|Screen failure following randomization|0|||
155221240|NCT00768300|560248776|FG000|Overall Study|Received lung transplant|1|||
155221241|NCT00768300|560248777|FG001|Overall Study|Received lung transplant|1|||
155221242|NCT00768300|560248776|FG000|Overall Study|Lost to Follow-up|0|||
155221243|NCT00768300|560248777|FG001|Overall Study|Lost to Follow-up|1|||
155221244|NCT00768300|560248776|FG000|Overall Study|Began prohibited concomitant medication|0|||
155221245|NCT00768300|560248777|FG001|Overall Study|Began prohibited concomitant medication|1|||
155221246|NCT00768300|560248776|FG000|Overall Study|Treated but never dosed with Study drug|1|||
155221247|NCT00768300|560248777|FG001|Overall Study|Treated but never dosed with Study drug|0|||
155221248|NCT00768300|560248776|FG000|Overall Study|Missing data|1|||
155221249|NCT00768300|560248777|FG001|Overall Study|Missing data|0|||
155221250|NCT02068222|560248778|FG000|Overall Study|Lost to Follow-up|1|||
155221251|NCT00735878|560248779|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
155221252|NCT00735878|560248780|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
155221253|NCT00735878|560248781|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
155221254|NCT02867709|560248782|FG000|Treatment Period|Adverse Event|1|||
155221255|NCT02867709|560248783|FG001|Treatment Period|Adverse Event|1|||
155221256|NCT02867709|560248784|FG002|Treatment Period|Adverse Event|2|||
155221257|NCT02867709|560248782|FG000|Treatment Period|Withdrawal of Consent|7|||
155221258|NCT02867709|560248783|FG001|Treatment Period|Withdrawal of Consent|9|||
155221259|NCT02867709|560248784|FG002|Treatment Period|Withdrawal of Consent|8|||
155221260|NCT02867709|560248782|FG000|Treatment Period|Lost to Follow-up|17|||
155221261|NCT02867709|560248783|FG001|Treatment Period|Lost to Follow-up|20|||
155221262|NCT02867709|560248784|FG002|Treatment Period|Lost to Follow-up|20|||
155221263|NCT02867709|560248782|FG000|Treatment Period|Lack of Qualifying Event|42|||
155221264|NCT02867709|560248783|FG001|Treatment Period|Lack of Qualifying Event|55|||
155221265|NCT02867709|560248784|FG002|Treatment Period|Lack of Qualifying Event|42|||
155221266|NCT02867709|560248782|FG000|Treatment Period|Protocol Violation|3|||
155221267|NCT02867709|560248783|FG001|Treatment Period|Protocol Violation|2|||
155221268|NCT02867709|560248784|FG002|Treatment Period|Protocol Violation|3|||
155221269|NCT02867709|560248782|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
155221270|NCT02867709|560248783|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
155221271|NCT02867709|560248784|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
155221272|NCT02867709|560248782|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
155221273|NCT02867709|560248783|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
155221274|NCT02867709|560248784|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
155221275|NCT02867709|560248782|FG000|Safety Follow-up Period|Pregnancy|0|||
155221276|NCT02867709|560248783|FG001|Safety Follow-up Period|Pregnancy|1|||
155221277|NCT02867709|560248784|FG002|Safety Follow-up Period|Pregnancy|0|||
155221278|NCT02867709|560248782|FG000|Safety Follow-up Period|Protocol Violation|0|||
155221279|NCT02867709|560248783|FG001|Safety Follow-up Period|Protocol Violation|1|||
155221280|NCT02867709|560248784|FG002|Safety Follow-up Period|Protocol Violation|1|||
155221281|NCT03188094|560248790|FG000|Overall Study|Screen failure|1|||
155221282|NCT03188094|560248791|FG001|Overall Study|Screen failure|0|||
155221283|NCT03188094|560248792|FG002|Overall Study|Screen failure|0|||
155221284|NCT03188094|560248790|FG000|Overall Study|Pregnancy|3|||
155221285|NCT03188094|560248791|FG001|Overall Study|Pregnancy|0|||
155221286|NCT03188094|560248792|FG002|Overall Study|Pregnancy|0|||
155221287|NCT03188094|560248790|FG000|Overall Study|Ineligible|1|||
155221288|NCT03188094|560248791|FG001|Overall Study|Ineligible|0|||
155221289|NCT03188094|560248792|FG002|Overall Study|Ineligible|0|||
155221290|NCT03188094|560248790|FG000|Overall Study|Lost to Follow-up|0|||
155221291|NCT03188094|560248791|FG001|Overall Study|Lost to Follow-up|0|||
155221292|NCT03188094|560248792|FG002|Overall Study|Lost to Follow-up|17|||
155221293|NCT02946047|560248793|FG000|Overall Study|Adverse Event|1|||
155221294|NCT02946047|560248794|FG001|Overall Study|Adverse Event|0|||
155221295|NCT02946047|560248795|FG002|Overall Study|Adverse Event|0|||
155221296|NCT02946047|560248796|FG003|Overall Study|Adverse Event|0|||
155221297|NCT03615105|560248797|FG000|Overall Study|Protocol Violation|1|||
155221298|NCT03615105|560248798|FG001|Overall Study|Protocol Violation|0|||
155221299|NCT03615105|560248799|FG002|Overall Study|Protocol Violation|0|||
155221300|NCT03615105|560248797|FG000|Overall Study|Death|0|||
155221301|NCT03615105|560248798|FG001|Overall Study|Death|2|||
155221302|NCT03615105|560248799|FG002|Overall Study|Death|0|||
155221303|NCT05041322|560248800|FG000|Baseline|Withdrawal by Subject|1|||
155221304|NCT05041322|560248801|FG001|Baseline|Withdrawal by Subject|0|||
155221305|NCT05041322|560248800|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
155221306|NCT05041322|560248801|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
155221307|NCT05041322|560248800|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
155221308|NCT05041322|560248801|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
155221309|NCT04690751|560248803|FG000|Overall Study|Protocol Violation|0|||
155221310|NCT04690751|560248804|FG001|Overall Study|Protocol Violation|1|||
155221311|NCT04690751|560248805|FG002|Overall Study|Protocol Violation|0|||
155221312|NCT04690751|560248806|FG003|Overall Study|Protocol Violation|1|||
155221313|NCT04690751|560248807|FG004|Overall Study|Protocol Violation|2|||
155221314|NCT04690751|560248808|FG005|Overall Study|Protocol Violation|0|||
155221315|NCT04690751|560248803|FG000|Overall Study|Adverse Event|0|||
155221316|NCT04690751|560248804|FG001|Overall Study|Adverse Event|0|||
155221317|NCT04690751|560248805|FG002|Overall Study|Adverse Event|1|||
155221318|NCT04690751|560248806|FG003|Overall Study|Adverse Event|0|||
155221319|NCT04690751|560248807|FG004|Overall Study|Adverse Event|0|||
155221320|NCT04690751|560248808|FG005|Overall Study|Adverse Event|0|||
155221321|NCT04690751|560248803|FG000|Overall Study|Positive urine drug screen test|0|||
155221322|NCT04690751|560248804|FG001|Overall Study|Positive urine drug screen test|0|||
155221323|NCT04690751|560248805|FG002|Overall Study|Positive urine drug screen test|0|||
155221324|NCT04690751|560248806|FG003|Overall Study|Positive urine drug screen test|0|||
155221325|NCT04690751|560248807|FG004|Overall Study|Positive urine drug screen test|1|||
155221326|NCT04690751|560248808|FG005|Overall Study|Positive urine drug screen test|0|||
155221327|NCT01344161|560248809|FG000|Overall Study|Lost to Follow-up|4|||
155221328|NCT01344161|560248810|FG001|Overall Study|Lost to Follow-up|1|||
155221329|NCT01344161|560248809|FG000|Overall Study|Pregnancy|0|||
155221330|NCT01344161|560248810|FG001|Overall Study|Pregnancy|1|||
155221331|NCT01344161|560248809|FG000|Overall Study|Protocol Violation|1|||
155221332|NCT01344161|560248810|FG001|Overall Study|Protocol Violation|1|||
155221333|NCT04364620|560248811|FG000|Overall Study|Disease Progression|20|||
155221334|NCT04364620|560248811|FG000|Overall Study|Adverse Event|5|||
155221335|NCT04364620|560248811|FG000|Overall Study|Physician Decision|4|||
155221336|NCT04364620|560248811|FG000|Overall Study|Death|3|||
155221337|NCT04364620|560248811|FG000|Overall Study|Other|2|||
155221338|NCT04364620|560248811|FG000|Overall Study|Withdrawal by Subject|1|||
155221339|NCT01124604|560250340|FG000|Overall Study|Adverse Event|10|||
155221340|NCT01124604|560250341|FG001|Overall Study|Adverse Event|1|||
155221341|NCT01124604|560250340|FG000|Overall Study|Lack of Efficacy|1|||
155221342|NCT01124604|560250341|FG001|Overall Study|Lack of Efficacy|0|||
155221343|NCT01124604|560250340|FG000|Overall Study|Withdrawal by Subject|4|||
155221344|NCT01124604|560250341|FG001|Overall Study|Withdrawal by Subject|0|||
155221345|NCT01124604|560250340|FG000|Overall Study|Disease Progression|0|||
155221346|NCT01124604|560250341|FG001|Overall Study|Disease Progression|1|||
155221347|NCT00076011|560250342|FG000|Overall Study|Death|1|||
155221348|NCT00076011|560250342|FG000|Overall Study|Adverse Event|10|||
155221349|NCT00076011|560250342|FG000|Overall Study|Lack of Efficacy|25|||
155221350|NCT00076011|560250342|FG000|Overall Study|Withdrawal by Subject|1|||
155221351|NCT00076011|560250342|FG000|Overall Study|Study terminated by sponsor|3|||
155221352|NCT00076011|560250342|FG000|Overall Study|Other|11|||
155221353|NCT00076011|560250342|FG000|Overall Study|Ongoing|1|||
155221354|NCT06134817|560250343|FG000|Overall Study|Physician Departure - termination of study|1|||
155221355|NCT03406858|560250346|FG000|Overall Study|Failure to receive treatment drug.|1|||
155221356|NCT03406858|560250346|FG000|Overall Study|ineligible|1|||
155221357|NCT00405587|560250347|FG000|Overall Study|Death|0|||
155221358|NCT00405587|560250348|FG001|Overall Study|Death|0|||
155221359|NCT00405587|560250349|FG002|Overall Study|Death|0|||
155221360|NCT00405587|560250350|FG003|Overall Study|Death|1|||
155221361|NCT00405587|560250347|FG000|Overall Study|Disease Progression|22|||
155221362|NCT00405587|560250348|FG001|Overall Study|Disease Progression|23|||
155221363|NCT00405587|560250349|FG002|Overall Study|Disease Progression|21|||
155221364|NCT00405587|560250350|FG003|Overall Study|Disease Progression|17|||
155221365|NCT00405587|560250347|FG000|Overall Study|Physician Decision|3|||
155221366|NCT00405587|560250348|FG001|Overall Study|Physician Decision|2|||
155221367|NCT00405587|560250349|FG002|Overall Study|Physician Decision|0|||
155221368|NCT00405587|560250350|FG003|Overall Study|Physician Decision|0|||
155221369|NCT00405587|560250347|FG000|Overall Study|Adverse Event|1|||
155221370|NCT00405587|560250348|FG001|Overall Study|Adverse Event|0|||
155221371|NCT00405587|560250349|FG002|Overall Study|Adverse Event|0|||
155221372|NCT00405587|560250350|FG003|Overall Study|Adverse Event|0|||
155221373|NCT00405587|560250347|FG000|Overall Study|Lost to Follow-up|0|||
155221374|NCT00405587|560250348|FG001|Overall Study|Lost to Follow-up|1|||
155221375|NCT00405587|560250349|FG002|Overall Study|Lost to Follow-up|1|||
155221376|NCT00405587|560250350|FG003|Overall Study|Lost to Follow-up|0|||
155221377|NCT00405587|560250347|FG000|Overall Study|Radiation induced necrosis|0|||
155221378|NCT00405587|560250348|FG001|Overall Study|Radiation induced necrosis|1|||
155221379|NCT00405587|560250349|FG002|Overall Study|Radiation induced necrosis|0|||
155221380|NCT00405587|560250350|FG003|Overall Study|Radiation induced necrosis|0|||
155221381|NCT00405587|560250347|FG000|Overall Study|Withdrawal by Subject|0|||
155221382|NCT00405587|560250348|FG001|Overall Study|Withdrawal by Subject|0|||
155221383|NCT00405587|560250349|FG002|Overall Study|Withdrawal by Subject|0|||
155221384|NCT00405587|560250350|FG003|Overall Study|Withdrawal by Subject|2|||
155221385|NCT00405587|560250347|FG000|Overall Study|Participant not dosed|0|||
155221386|NCT00405587|560250348|FG001|Overall Study|Participant not dosed|1|||
155221387|NCT00405587|560250349|FG002|Overall Study|Participant not dosed|0|||
155221388|NCT00405587|560250350|FG003|Overall Study|Participant not dosed|0|||
155221389|NCT06027866|560250351|FG000|Overall Study|Withdrawal by Subject|2|||
155221390|NCT00930579|560250354|FG000|Overall Study|Withdrawal by Subject|1|||
155221391|NCT00930579|560250354|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
155221392|NCT02672423|560250355|FG000|Period 1|Adverse Event|0|||
155221393|NCT02672423|560250356|FG001|Period 1|Adverse Event|0|||
155221394|NCT02672423|560250357|FG002|Period 1|Adverse Event|0|||
155221395|NCT02672423|560250358|FG003|Period 1|Adverse Event|0|||
155221396|NCT02672423|560250359|FG004|Period 1|Adverse Event|1|||
155221397|NCT02672423|560250360|FG005|Period 1|Adverse Event|0|||
155221398|NCT02672423|560250361|FG006|Period 1|Adverse Event|0|||
155221399|NCT02672423|560250362|FG007|Period 1|Adverse Event|0|||
155221400|NCT02672423|560250363|FG008|Period 1|Adverse Event|0|||
155221401|NCT02672423|560250364|FG009|Period 1|Adverse Event|0|||
155221402|NCT02672423|560250355|FG000|Period 2|Withdrawal by Subject|0|||
155221403|NCT02672423|560250356|FG001|Period 2|Withdrawal by Subject|0|||
155221404|NCT02672423|560250357|FG002|Period 2|Withdrawal by Subject|1|||
155221405|NCT02672423|560250358|FG003|Period 2|Withdrawal by Subject|0|||
155221406|NCT02672423|560250359|FG004|Period 2|Withdrawal by Subject|0|||
155221407|NCT02672423|560250360|FG005|Period 2|Withdrawal by Subject|0|||
155221408|NCT02672423|560250361|FG006|Period 2|Withdrawal by Subject|0|||
155221409|NCT02672423|560250362|FG007|Period 2|Withdrawal by Subject|0|||
155221410|NCT02672423|560250363|FG008|Period 2|Withdrawal by Subject|0|||
155221411|NCT02672423|560250364|FG009|Period 2|Withdrawal by Subject|0|||
155221412|NCT02672423|560250355|FG000|Period 3|Withdrawal by Subject|0|||
155221413|NCT02672423|560250356|FG001|Period 3|Withdrawal by Subject|0|||
155221414|NCT02672423|560250357|FG002|Period 3|Withdrawal by Subject|0|||
155221415|NCT02672423|560250358|FG003|Period 3|Withdrawal by Subject|0|||
155221416|NCT02672423|560250359|FG004|Period 3|Withdrawal by Subject|0|||
155221417|NCT02672423|560250360|FG005|Period 3|Withdrawal by Subject|0|||
155221418|NCT02672423|560250361|FG006|Period 3|Withdrawal by Subject|0|||
155221419|NCT02672423|560250362|FG007|Period 3|Withdrawal by Subject|1|||
155221420|NCT02672423|560250363|FG008|Period 3|Withdrawal by Subject|0|||
155221421|NCT02672423|560250364|FG009|Period 3|Withdrawal by Subject|0|||
155221422|NCT02672423|560250355|FG000|Period 3|Physician Decision|0|||
155221423|NCT02672423|560250356|FG001|Period 3|Physician Decision|0|||
155221424|NCT02672423|560250357|FG002|Period 3|Physician Decision|0|||
155221425|NCT02672423|560250358|FG003|Period 3|Physician Decision|0|||
155221426|NCT02672423|560250359|FG004|Period 3|Physician Decision|0|||
155221427|NCT02672423|560250360|FG005|Period 3|Physician Decision|1|||
155221428|NCT02672423|560250361|FG006|Period 3|Physician Decision|0|||
155221429|NCT02672423|560250362|FG007|Period 3|Physician Decision|0|||
155221430|NCT02672423|560250363|FG008|Period 3|Physician Decision|0|||
155221431|NCT02672423|560250364|FG009|Period 3|Physician Decision|0|||
155221432|NCT01046682|560250369|FG000|Overall Study|Adverse Event|2|||
155221433|NCT01046682|560250370|FG001|Overall Study|Adverse Event|0|||
155221434|NCT05071183|560250371|FG000|Overall Study|Death|1|||
155221435|NCT05071183|560250372|FG001|Overall Study|Death|2|||
155221436|NCT05071183|560250373|FG002|Overall Study|Death|0|||
155221437|NCT05071183|560250371|FG000|Overall Study|Other Reasons|1|||
155221438|NCT05071183|560250372|FG001|Overall Study|Other Reasons|3|||
155221439|NCT05071183|560250373|FG002|Overall Study|Other Reasons|2|||
155221440|NCT02046148|560250374|FG000|Overall Study|Lost to Follow-up|1|||
155221441|NCT02046148|560250375|FG001|Overall Study|Lost to Follow-up|1|||
155221442|NCT02046148|560250374|FG000|Overall Study|Withdrawal by Subject|0|||
155221443|NCT02046148|560250375|FG001|Overall Study|Withdrawal by Subject|2|||
155221444|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
155221445|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
155221446|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
155221447|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
155221448|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
155221449|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
155221450|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
155221451|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
155221452|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
155221453|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Death|0|||
155221454|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Death|0|||
155221455|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Death|1|||
155221456|NCT00885755|560250383|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
155221457|NCT00885755|560250384|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
155221458|NCT00885755|560250385|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
155221459|NCT02939560|560250390|FG000|Overall Study|Withdrawal by Subject|2|||
155221460|NCT02939560|560250390|FG000|Overall Study|Protocol Violation|1|||
155221461|NCT03340025|560250393|FG000|Overall Study|Lost to Follow-up|2|||
155221462|NCT03340025|560250394|FG001|Overall Study|Lost to Follow-up|2|||
155221463|NCT02420691|560250395|FG000|Overall Study|Adverse Event|3|||
155221464|NCT02420691|560250395|FG000|Overall Study|Withdrawal by Subject|3|||
155221465|NCT00325754|560250396|FG000|Overall Study|Adverse Event|4|||
155221466|NCT00325754|560250397|FG001|Overall Study|Adverse Event|1|||
155221467|NCT01752855|560250407|FG000|Overall Study|Adverse Event|1|||
155221468|NCT01752855|560250408|FG001|Overall Study|Adverse Event|0|||
155221469|NCT01752855|560250407|FG000|Overall Study|Withdrew Consent|0|||
155221470|NCT01752855|560250408|FG001|Overall Study|Withdrew Consent|2|||
155221471|NCT01752855|560250407|FG000|Overall Study|Lack of Efficacy|0|||
155221472|NCT01752855|560250408|FG001|Overall Study|Lack of Efficacy|2|||
155221473|NCT02625090|560250409|FG000|Overall Study|Participant wants to be pregnant|2|||
155221474|NCT02625090|560250409|FG000|Overall Study|For the Promoter|1|||
155221475|NCT02625090|560250409|FG000|Overall Study|Sponsor's Decision|9|||
155221476|NCT02625090|560250409|FG000|Overall Study|Somnolence|1|||
155221477|NCT02625090|560250409|FG000|Overall Study|Study terminated by Sponsor|7|||
155221478|NCT02625090|560250409|FG000|Overall Study|Negative Benefit/Risk|1|||
155221479|NCT02625090|560250409|FG000|Overall Study|Protocol Deviation|2|||
155221480|NCT02625090|560250409|FG000|Overall Study|Lack of Efficacy|16|||
155221481|NCT02625090|560250409|FG000|Overall Study|Adverse Event|3|||
155221482|NCT02250443|560250410|FG000|Overall Study|Administrative problems|7|||
155221483|NCT02250443|560250410|FG000|Overall Study|Adverse Event|3|||
155221484|NCT03168464|560250411|FG000|Overall Study|Death|9|||
155221485|NCT03168464|560250411|FG000|Overall Study|Progression of disease|6|||
155221486|NCT01549964|560250414|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
155221487|NCT01549964|560250415|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
155221488|NCT01549964|560250416|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
155221489|NCT01549964|560250417|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
155221490|NCT01549964|560250414|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
155221491|NCT01549964|560250415|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
155221492|NCT01549964|560250416|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
155221493|NCT01549964|560250417|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
155221494|NCT01549964|560250414|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
155221495|NCT01549964|560250415|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221496|NCT01549964|560250416|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221497|NCT01549964|560250417|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221498|NCT01549964|560250414|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
155221499|NCT01549964|560250415|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
155221500|NCT01549964|560250416|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
155221501|NCT01549964|560250417|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
155221502|NCT01549964|560250414|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
155221503|NCT01549964|560250415|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
155221504|NCT01549964|560250416|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
155221505|NCT01549964|560250417|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
155221506|NCT01549964|560250414|FG000|24-Week Treatment Period|Other|1|||
155221507|NCT01549964|560250415|FG001|24-Week Treatment Period|Other|0|||
155221508|NCT01549964|560250416|FG002|24-Week Treatment Period|Other|1|||
155221509|NCT01549964|560250417|FG003|24-Week Treatment Period|Other|0|||
155221510|NCT01549964|560250414|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221511|NCT01549964|560250415|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221512|NCT01549964|560250416|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
155221513|NCT01549964|560250417|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221514|NCT01549964|560250414|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
155221515|NCT01549964|560250415|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
155221516|NCT01549964|560250416|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
155221517|NCT01549964|560250417|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
155221518|NCT01549964|560250414|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
155221519|NCT01549964|560250415|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
155221520|NCT01549964|560250416|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
155221521|NCT01549964|560250417|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
155221522|NCT01549964|560250414|FG000|80-Week Extension Period|Pregnancy|0|||
155221523|NCT01549964|560250415|FG001|80-Week Extension Period|Pregnancy|0|||
155221524|NCT01549964|560250416|FG002|80-Week Extension Period|Pregnancy|1|||
155221525|NCT01549964|560250417|FG003|80-Week Extension Period|Pregnancy|0|||
155221526|NCT01549964|560250414|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
155221527|NCT01549964|560250415|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
155221528|NCT01549964|560250416|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
155221529|NCT01549964|560250417|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
155221530|NCT01549964|560250414|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
155221531|NCT01549964|560250415|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
155221532|NCT01549964|560250416|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
155221533|NCT01549964|560250417|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
155221534|NCT01549964|560250414|FG000|80-Week Extension Period|Lost to Follow-up|1|||
155221535|NCT01549964|560250415|FG001|80-Week Extension Period|Lost to Follow-up|0|||
155221536|NCT01549964|560250416|FG002|80-Week Extension Period|Lost to Follow-up|2|||
155221537|NCT01549964|560250417|FG003|80-Week Extension Period|Lost to Follow-up|1|||
155221538|NCT01549964|560250414|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
155221539|NCT01549964|560250415|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
155221540|NCT01549964|560250416|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
155221541|NCT01549964|560250417|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
155221542|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
155221543|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
155221544|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
155221545|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
155221546|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
155221547|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
155221548|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
155221549|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
155221550|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
155221551|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
155221552|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
155221553|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
155221554|NCT00634088|560250418|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
155221555|NCT00634088|560250419|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
155221556|NCT00634088|560250420|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
155221557|NCT00634088|560250421|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
155221558|NCT00634088|560250418|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
155221559|NCT00634088|560250419|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
155221560|NCT00634088|560250420|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
155221561|NCT00634088|560250421|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
155221562|NCT00634088|560250418|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
155221563|NCT00634088|560250419|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
155221564|NCT00634088|560250420|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
155221565|NCT00634088|560250421|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
155221566|NCT02290821|560250424|FG000|Overall Study|Withdrawal by Subject|1|||
155221567|NCT02290821|560250425|FG001|Overall Study|Withdrawal by Subject|1|||
155221568|NCT02290821|560250424|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
155221569|NCT02290821|560250425|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
155221570|NCT02290821|560250424|FG000|Overall Study|Lost to Follow-up|3|||
155221571|NCT02290821|560250425|FG001|Overall Study|Lost to Follow-up|2|||
155221572|NCT02439320|560250430|FG000|Overall Study|Adverse Event|0|||
155221573|NCT02439320|560250431|FG001|Overall Study|Adverse Event|2|||
155221574|NCT02439320|560250432|FG002|Overall Study|Adverse Event|0|||
155221575|NCT02439320|560250430|FG000|Overall Study|Lost to Follow-up|37|||
155221576|NCT02439320|560250431|FG001|Overall Study|Lost to Follow-up|34|||
155221577|NCT02439320|560250432|FG002|Overall Study|Lost to Follow-up|42|||
155221578|NCT02439320|560250430|FG000|Overall Study|Death|0|||
155221579|NCT02439320|560250431|FG001|Overall Study|Death|1|||
155221580|NCT02439320|560250432|FG002|Overall Study|Death|0|||
155221581|NCT02439320|560250430|FG000|Overall Study|Noncompliance with Protocol|10|||
155221582|NCT02439320|560250431|FG001|Overall Study|Noncompliance with Protocol|11|||
155221583|NCT02439320|560250432|FG002|Overall Study|Noncompliance with Protocol|7|||
155221584|NCT02439320|560250430|FG000|Overall Study|Pregnancy|0|||
155221585|NCT02439320|560250431|FG001|Overall Study|Pregnancy|1|||
155221586|NCT02439320|560250432|FG002|Overall Study|Pregnancy|1|||
155491434|NCT00948896|561223549|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155491435|NCT00948896|561223550|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155221587|NCT02439320|560250430|FG000|Overall Study|Withdrawal by Subject|12|||
155221588|NCT02439320|560250431|FG001|Overall Study|Withdrawal by Subject|16|||
155221589|NCT02439320|560250432|FG002|Overall Study|Withdrawal by Subject|14|||
155221590|NCT02439320|560250430|FG000|Overall Study|Physician Decision|2|||
155221591|NCT02439320|560250431|FG001|Overall Study|Physician Decision|1|||
155221592|NCT02439320|560250432|FG002|Overall Study|Physician Decision|0|||
155221593|NCT02439320|560250430|FG000|Overall Study|Sponsor Request|0|||
155221594|NCT02439320|560250431|FG001|Overall Study|Sponsor Request|2|||
155221595|NCT02439320|560250432|FG002|Overall Study|Sponsor Request|1|||
155221596|NCT02439320|560250430|FG000|Overall Study|Randomization Failure|35|||
155221597|NCT02439320|560250431|FG001|Overall Study|Randomization Failure|46|||
155221598|NCT02439320|560250432|FG002|Overall Study|Randomization Failure|34|||
155221599|NCT01520363|560250437|FG000|Overall Study|Withdrawal by Subject|2|||
155221600|NCT01520363|560250438|FG001|Overall Study|Withdrawal by Subject|0|||
155221601|NCT04191382|560250443|FG000|Overall Study|Withdrawal by Subject|1|||
155221602|NCT04191382|560250444|FG001|Overall Study|Withdrawal by Subject|0|||
155221603|NCT04191382|560250445|FG002|Overall Study|Withdrawal by Subject|0|||
155221604|NCT00878709|560250450|FG000|Overall Study|Withdrawal by Subject|197|||
155221605|NCT00878709|560250451|FG001|Overall Study|Withdrawal by Subject|120|||
155221606|NCT00878709|560250450|FG000|Overall Study|Lost to Follow-up|35|||
155221607|NCT00878709|560250451|FG001|Overall Study|Lost to Follow-up|33|||
155221608|NCT00878709|560250450|FG000|Overall Study|Other Reasons|93|||
155221609|NCT00878709|560250451|FG001|Overall Study|Other Reasons|84|||
155221610|NCT02225743|560250452|FG000|Overall Study|Withdrawal by Subject|18|||
155221611|NCT00322842|560250455|FG000|Overall Study|Withdrawal by Subject|0|||
155221612|NCT00322842|560250456|FG001|Overall Study|Withdrawal by Subject|1|||
155221613|NCT00322842|560250455|FG000|Overall Study|Lost to Follow-up|0|||
155221614|NCT00322842|560250456|FG001|Overall Study|Lost to Follow-up|1|||
155221615|NCT00322842|560250455|FG000|Overall Study|Refused transplant|1|||
155221616|NCT00322842|560250456|FG001|Overall Study|Refused transplant|0|||
155221617|NCT00322842|560250455|FG000|Overall Study|Death|1|||
155221618|NCT00322842|560250456|FG001|Overall Study|Death|0|||
155221619|NCT00323492|560250457|FG000|Study Phase 1|Adverse Event|2|||
155221620|NCT00323492|560250458|FG001|Study Phase 1|Adverse Event|0|||
155221621|NCT00323492|560250459|FG002|Study Phase 1|Adverse Event|0|||
155221622|NCT00323492|560250457|FG000|Study Phase 2|Adverse Event|1|||
155221623|NCT00323492|560250458|FG001|Study Phase 2|Adverse Event|0|||
155221624|NCT00323492|560250459|FG002|Study Phase 2|Adverse Event|0|||
155221625|NCT00323492|560250457|FG000|Study Phase 2|Physician Decision|1|||
155221626|NCT00323492|560250458|FG001|Study Phase 2|Physician Decision|0|||
155221627|NCT00323492|560250459|FG002|Study Phase 2|Physician Decision|0|||
155221628|NCT00323492|560250457|FG000|Study Phase 2|Lost to Follow-up|1|||
155221629|NCT00323492|560250458|FG001|Study Phase 2|Lost to Follow-up|0|||
155221630|NCT00323492|560250459|FG002|Study Phase 2|Lost to Follow-up|0|||
155221631|NCT00323492|560250457|FG000|Study Phase 2|Withdrawal by Subject|0|||
155221632|NCT00323492|560250458|FG001|Study Phase 2|Withdrawal by Subject|1|||
155221633|NCT00323492|560250459|FG002|Study Phase 2|Withdrawal by Subject|0|||
155221634|NCT00323492|560250457|FG000|Study Phase 2|Noncompliance with study schedule|0|||
155221635|NCT00323492|560250458|FG001|Study Phase 2|Noncompliance with study schedule|0|||
155221636|NCT00323492|560250459|FG002|Study Phase 2|Noncompliance with study schedule|1|||
155221637|NCT00323492|560250457|FG000|Study Phase 2|Protocol Violation|1|||
155221638|NCT00323492|560250458|FG001|Study Phase 2|Protocol Violation|0|||
155221639|NCT00323492|560250459|FG002|Study Phase 2|Protocol Violation|0|||
155221640|NCT02486042|560250460|FG000|Overall Study|Physician Decision|1|||
155221641|NCT02486042|560250461|FG001|Overall Study|Physician Decision|7|||
155221642|NCT02486042|560250460|FG000|Overall Study|Hospital transfer|2|||
155221643|NCT02486042|560250461|FG001|Overall Study|Hospital transfer|2|||
155221644|NCT02486042|560250460|FG000|Overall Study|Withdrawal by Subject|0|||
155221645|NCT02486042|560250461|FG001|Overall Study|Withdrawal by Subject|2|||
155221646|NCT00281684|560250475|FG000|Overall Study|Lost to Follow-up|0|||
155221647|NCT00281684|560250476|FG001|Overall Study|Lost to Follow-up|0|||
155221648|NCT00281684|560250477|FG002|Overall Study|Lost to Follow-up|1|||
155221649|NCT00281684|560250478|FG003|Overall Study|Lost to Follow-up|0|||
155221650|NCT00281684|560250475|FG000|Overall Study|Withdrawal by Subject|1|||
155221651|NCT00281684|560250476|FG001|Overall Study|Withdrawal by Subject|0|||
155221652|NCT00281684|560250477|FG002|Overall Study|Withdrawal by Subject|0|||
155221653|NCT00281684|560250478|FG003|Overall Study|Withdrawal by Subject|0|||
155221654|NCT03979638|560250479|FG000|Period 1|Physician Decision|1|||
155221655|NCT03979638|560250480|FG001|Period 1|Physician Decision|1|||
155221656|NCT03979638|560250479|FG000|Period 1|Withdrawal by Subject|4|||
155221657|NCT03979638|560250480|FG001|Period 1|Withdrawal by Subject|3|||
155221658|NCT03979638|560250479|FG000|Period 1|Study terminated by Sponsor|1|||
155221659|NCT03979638|560250480|FG001|Period 1|Study terminated by Sponsor|3|||
155221660|NCT03979638|560250479|FG000|Period 1|Protocol Violation|1|||
155221661|NCT03979638|560250480|FG001|Period 1|Protocol Violation|0|||
155221662|NCT03979638|560250479|FG000|Period 2|Study terminated by Sponsor|1|||
155221663|NCT03979638|560250480|FG001|Period 2|Study terminated by Sponsor|1|||
155221664|NCT00578942|560250483|FG000|Overall Study|Lost to Follow-up|1|||
155221665|NCT03200899|560250484|FG000|Overall Study|Lost to Follow-up|10|||
155221666|NCT03200899|560250485|FG001|Overall Study|Lost to Follow-up|23|||
155221667|NCT01400516|560250494|FG000|Primary Trial|Withdrawal by Subject|0|||
155221668|NCT01400516|560250495|FG001|Primary Trial|Withdrawal by Subject|2|||
155221669|NCT00549562|560250496|FG000|Overall Study|Adverse Event|1|||
155221670|NCT00549562|560250496|FG000|Overall Study|Lack of Efficacy|1|||
155221671|NCT00699972|560252078|FG000|Overall Study|Adverse Event|7|||
155221672|NCT00699972|560252079|FG001|Overall Study|Adverse Event|9|||
155221673|NCT00699972|560252080|FG002|Overall Study|Adverse Event|24|||
155221674|NCT00699972|560252078|FG000|Overall Study|Lost to Follow-up|0|||
155221675|NCT00699972|560252079|FG001|Overall Study|Lost to Follow-up|2|||
155221676|NCT00699972|560252080|FG002|Overall Study|Lost to Follow-up|0|||
155221677|NCT00699972|560252078|FG000|Overall Study|Withdrawal by Subject|3|||
155221678|NCT00699972|560252079|FG001|Overall Study|Withdrawal by Subject|7|||
155221679|NCT00699972|560252080|FG002|Overall Study|Withdrawal by Subject|4|||
155221680|NCT00699972|560252078|FG000|Overall Study|Lack of Efficacy|2|||
155221681|NCT00699972|560252079|FG001|Overall Study|Lack of Efficacy|0|||
155221682|NCT00699972|560252080|FG002|Overall Study|Lack of Efficacy|2|||
155221683|NCT00699972|560252078|FG000|Overall Study|Administrative/Other|3|||
155221684|NCT00699972|560252079|FG001|Overall Study|Administrative/Other|1|||
155221685|NCT00699972|560252080|FG002|Overall Study|Administrative/Other|4|||
155221686|NCT00699972|560252078|FG000|Overall Study|Randomized, Not Treated|1|||
155221687|NCT00699972|560252079|FG001|Overall Study|Randomized, Not Treated|0|||
155221688|NCT00699972|560252080|FG002|Overall Study|Randomized, Not Treated|1|||
155221689|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
155221690|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
155221691|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
155221692|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
155221693|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
155221694|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
155221695|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
155221696|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
155221697|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
155221698|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
155221699|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
155221700|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
155221701|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
155221702|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
155221703|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
155221704|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
155221705|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
155221706|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
155221707|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
155221708|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
155221709|NCT01365507|560252092|FG000|Overall Study|Withdrawal Criteria|8|||
155221710|NCT01365507|560252093|FG001|Overall Study|Withdrawal Criteria|5|||
155221711|NCT01365507|560252092|FG000|Overall Study|Unclassified|1|||
155221712|NCT01365507|560252093|FG001|Overall Study|Unclassified|4|||
155221713|NCT02255500|560252096|FG000|Overall Study|Withdrawal by Subject|1|||
155221714|NCT02255500|560252097|FG001|Overall Study|Withdrawal by Subject|0|||
155221715|NCT01012622|560252098|FG000|Overall Study|Withdrawal by Subject|6|||
155221716|NCT01012622|560252098|FG000|Overall Study|Lost to Follow-up|5|||
155221717|NCT01012622|560252098|FG000|Overall Study|Adverse Event|7|||
155221718|NCT01012622|560252098|FG000|Overall Study|non-compliance with the drug|9|||
155221719|NCT01012622|560252098|FG000|Overall Study|Other|1|||
155221720|NCT01012622|560252098|FG000|Overall Study|screening failure|1|||
155221721|NCT01012622|560252098|FG000|Overall Study|withdrawal of consent by a parent|2|||
155221722|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
155221723|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
155221724|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
155221725|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
155221726|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
155221727|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
155221728|NCT03257631|560252102|FG000|Overall Study|Death|1|||
155221729|NCT03257631|560252103|FG001|Overall Study|Death|0|||
155221730|NCT03257631|560252104|FG002|Overall Study|Death|1|||
155221731|NCT03257631|560252105|FG003|Overall Study|Death|1|||
155221732|NCT03257631|560252102|FG000|Overall Study|Progressive Disease|10|||
155221733|NCT03257631|560252103|FG001|Overall Study|Progressive Disease|9|||
155221734|NCT03257631|560252104|FG002|Overall Study|Progressive Disease|17|||
155221735|NCT03257631|560252105|FG003|Overall Study|Progressive Disease|8|||
155221736|NCT03257631|560252102|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155221737|NCT03257631|560252103|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155221738|NCT03257631|560252104|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155221739|NCT03257631|560252105|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
155221740|NCT03257631|560252102|FG000|Overall Study|Adverse Event|0|||
155221741|NCT03257631|560252103|FG001|Overall Study|Adverse Event|0|||
155221742|NCT03257631|560252104|FG002|Overall Study|Adverse Event|2|||
155221743|NCT03257631|560252105|FG003|Overall Study|Adverse Event|0|||
155221744|NCT03509675|560252109|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
155221745|NCT03509675|560252110|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
155221746|NCT03509675|560252109|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
155221747|NCT03509675|560252110|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
155221748|NCT03509675|560252109|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
155221749|NCT03509675|560252110|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
155221750|NCT03509675|560252109|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
155221751|NCT03509675|560252110|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
155221752|NCT00902564|560252111|FG000|Overall Study|Withdrawal by Subject|2|||
155221753|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
155221754|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
155221755|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
155221756|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
155221757|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
155221758|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
155221759|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
155221760|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
155221761|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
155221762|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
155221763|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
155221764|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
155221765|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
155221766|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
155221767|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
155221768|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
155221769|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
155221770|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
155221771|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
155221772|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
155221773|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
155221774|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
155221775|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
155221776|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
155221777|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
155221778|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
155221779|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
155221780|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
155221781|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
155221782|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
155221783|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
155221784|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
155221785|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
155221786|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
155221787|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
155221788|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
155221789|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
155221790|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
155221791|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
155221792|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
155221793|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
155221794|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
155221795|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
155221796|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
155221797|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
155221798|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
155221799|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
155221800|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
155221801|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
155221802|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
155221803|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
155221804|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
155221805|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
155221806|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
155221807|NCT03336216|560252117|FG000|Randomization|Not reported|2|||
155221808|NCT03336216|560252118|FG001|Randomization|Not reported|0|||
155221809|NCT03336216|560252119|FG002|Randomization|Not reported|1|||
155221810|NCT03336216|560252120|FG003|Randomization|Not reported|0|||
155221811|NCT03336216|560252117|FG000|Randomization|Other reasons|1|||
155221812|NCT03336216|560252118|FG001|Randomization|Other reasons|1|||
155221813|NCT03336216|560252119|FG002|Randomization|Other reasons|1|||
155221814|NCT03336216|560252120|FG003|Randomization|Other reasons|0|||
155221815|NCT03336216|560252117|FG000|Randomization|Participant no longer meets study criteria|0|||
155221816|NCT03336216|560252118|FG001|Randomization|Participant no longer meets study criteria|2|||
155221817|NCT03336216|560252119|FG002|Randomization|Participant no longer meets study criteria|4|||
155221818|NCT03336216|560252120|FG003|Randomization|Participant no longer meets study criteria|1|||
155221819|NCT03336216|560252117|FG000|Randomization|Lost to Follow-up|1|||
155221820|NCT03336216|560252118|FG001|Randomization|Lost to Follow-up|0|||
155221821|NCT03336216|560252119|FG002|Randomization|Lost to Follow-up|0|||
155221822|NCT03336216|560252120|FG003|Randomization|Lost to Follow-up|0|||
155221823|NCT03336216|560252117|FG000|Randomization|Participant withdrew consent|9|||
155221824|NCT03336216|560252118|FG001|Randomization|Participant withdrew consent|1|||
155221825|NCT03336216|560252119|FG002|Randomization|Participant withdrew consent|0|||
155221826|NCT03336216|560252120|FG003|Randomization|Participant withdrew consent|0|||
155221827|NCT03336216|560252117|FG000|Randomization|Adverse Event|1|||
155221828|NCT03336216|560252118|FG001|Randomization|Adverse Event|1|||
155221829|NCT03336216|560252119|FG002|Randomization|Adverse Event|0|||
155221830|NCT03336216|560252120|FG003|Randomization|Adverse Event|0|||
155221831|NCT03336216|560252117|FG000|Treatment|Adverse Event|2|||
155221832|NCT03336216|560252118|FG001|Treatment|Adverse Event|3|||
155221833|NCT03336216|560252119|FG002|Treatment|Adverse Event|4|||
155221834|NCT03336216|560252120|FG003|Treatment|Adverse Event|4|||
155221835|NCT03336216|560252117|FG000|Treatment|Participant request to discontinue treatment|2|||
155221836|NCT03336216|560252118|FG001|Treatment|Participant request to discontinue treatment|1|||
155221837|NCT03336216|560252119|FG002|Treatment|Participant request to discontinue treatment|2|||
155221838|NCT03336216|560252120|FG003|Treatment|Participant request to discontinue treatment|2|||
155221839|NCT03336216|560252117|FG000|Treatment|Participant withdrew consent|7|||
155221840|NCT03336216|560252118|FG001|Treatment|Participant withdrew consent|2|||
155221841|NCT03336216|560252119|FG002|Treatment|Participant withdrew consent|3|||
155221842|NCT03336216|560252120|FG003|Treatment|Participant withdrew consent|2|||
155221843|NCT03336216|560252117|FG000|Treatment|Death|2|||
155221844|NCT03336216|560252118|FG001|Treatment|Death|3|||
155221845|NCT03336216|560252119|FG002|Treatment|Death|3|||
155221846|NCT03336216|560252120|FG003|Treatment|Death|4|||
155221847|NCT03336216|560252117|FG000|Treatment|Participant no longer meets study criteria|0|||
155221848|NCT03336216|560252118|FG001|Treatment|Participant no longer meets study criteria|1|||
155221849|NCT03336216|560252119|FG002|Treatment|Participant no longer meets study criteria|0|||
155221850|NCT03336216|560252120|FG003|Treatment|Participant no longer meets study criteria|0|||
155221851|NCT03336216|560252117|FG000|Treatment|Other reasons|2|||
155221852|NCT03336216|560252118|FG001|Treatment|Other reasons|0|||
155221853|NCT03336216|560252119|FG002|Treatment|Other reasons|0|||
155221854|NCT03336216|560252120|FG003|Treatment|Other reasons|3|||
155221855|NCT03336216|560252117|FG000|Treatment|Disease progression|23|||
155221856|NCT03336216|560252118|FG001|Treatment|Disease progression|34|||
155221857|NCT03336216|560252119|FG002|Treatment|Disease progression|33|||
155221858|NCT03336216|560252120|FG003|Treatment|Disease progression|26|||
155221859|NCT03336216|560252117|FG000|Treatment|Study drug toxicity|0|||
155221860|NCT03336216|560252118|FG001|Treatment|Study drug toxicity|3|||
155221861|NCT03336216|560252119|FG002|Treatment|Study drug toxicity|2|||
155221862|NCT03336216|560252120|FG003|Treatment|Study drug toxicity|0|||
155221863|NCT03336216|560252117|FG000|Treatment|Adverse Event unrelated to study drug|1|||
155221864|NCT03336216|560252118|FG001|Treatment|Adverse Event unrelated to study drug|1|||
155221865|NCT03336216|560252119|FG002|Treatment|Adverse Event unrelated to study drug|1|||
155221866|NCT03336216|560252120|FG003|Treatment|Adverse Event unrelated to study drug|0|||
155221867|NCT03336216|560252117|FG000|Treatment|Disease Recurrence|1|||
155221868|NCT03336216|560252118|FG001|Treatment|Disease Recurrence|0|||
155221869|NCT03336216|560252119|FG002|Treatment|Disease Recurrence|0|||
155221870|NCT03336216|560252120|FG003|Treatment|Disease Recurrence|0|||
155221871|NCT05620576|560252121|FG000|Overall Study|Adverse Event|1|||
155221872|NCT05620576|560252122|FG001|Overall Study|Adverse Event|1|||
155221873|NCT05620576|560252121|FG000|Overall Study|Lost to Follow-up|3|||
155221874|NCT05620576|560252122|FG001|Overall Study|Lost to Follow-up|1|||
155221875|NCT05620576|560252121|FG000|Overall Study|Physician Decision|0|||
155221876|NCT05620576|560252122|FG001|Overall Study|Physician Decision|1|||
155221877|NCT05620576|560252121|FG000|Overall Study|Protocol Deviation|1|||
155221878|NCT05620576|560252122|FG001|Overall Study|Protocol Deviation|1|||
155221879|NCT05620576|560252121|FG000|Overall Study|Withdrawal by Subject|2|||
155221880|NCT05620576|560252122|FG001|Overall Study|Withdrawal by Subject|3|||
155221881|NCT00922766|560252125|FG000|Overall Study|Death|3|||
155221882|NCT00922766|560252125|FG000|Overall Study|Withdrawal by Subject|2|||
155221883|NCT00922766|560252125|FG000|Overall Study|Other|1|||
155221884|NCT00922766|560252125|FG000|Overall Study|Adverse Event|1|||
155221885|NCT02622828|560252126|FG000|Overall Study|participant withdrew|3|||
155221886|NCT01231581|560252132|FG000|Overall Study|Lost to Follow-up|2|||
155221887|NCT01231581|560252133|FG001|Overall Study|Lost to Follow-up|2|||
155221888|NCT01231581|560252132|FG000|Overall Study|Withdrawal by Subject|6|||
155221889|NCT01231581|560252133|FG001|Overall Study|Withdrawal by Subject|9|||
155221890|NCT01231581|560252132|FG000|Overall Study|Study Closed/Terminated|6|||
155221891|NCT01231581|560252133|FG001|Overall Study|Study Closed/Terminated|5|||
155221892|NCT01231581|560252132|FG000|Overall Study|Death|65|||
155221893|NCT01231581|560252133|FG001|Overall Study|Death|64|||
155221894|NCT01231581|560252132|FG000|Overall Study|Ongoing|1|||
155221895|NCT01231581|560252133|FG001|Overall Study|Ongoing|0|||
155221896|NCT03616912|560252134|FG000|Overall Study|Adverse Event|17|||
155221897|NCT03616912|560252135|FG001|Overall Study|Adverse Event|21|||
155221898|NCT03616912|560252136|FG002|Overall Study|Adverse Event|9|||
155221899|NCT03616912|560252137|FG003|Overall Study|Adverse Event|0|||
155221900|NCT03616912|560252138|FG004|Overall Study|Adverse Event|0|||
155221901|NCT03616912|560252139|FG005|Overall Study|Adverse Event|0|||
155221902|NCT03616912|560252134|FG000|Overall Study|Death|1|||
155221903|NCT03616912|560252135|FG001|Overall Study|Death|1|||
155221904|NCT03616912|560252136|FG002|Overall Study|Death|0|||
155221905|NCT03616912|560252137|FG003|Overall Study|Death|0|||
155221906|NCT03616912|560252138|FG004|Overall Study|Death|0|||
155221907|NCT03616912|560252139|FG005|Overall Study|Death|0|||
155221908|NCT03616912|560252134|FG000|Overall Study|Lack of Efficacy|13|||
155221909|NCT03616912|560252135|FG001|Overall Study|Lack of Efficacy|6|||
155221910|NCT03616912|560252136|FG002|Overall Study|Lack of Efficacy|8|||
155221911|NCT03616912|560252137|FG003|Overall Study|Lack of Efficacy|4|||
155221912|NCT03616912|560252138|FG004|Overall Study|Lack of Efficacy|5|||
155221913|NCT03616912|560252139|FG005|Overall Study|Lack of Efficacy|1|||
155221914|NCT03616912|560252134|FG000|Overall Study|Lost to Follow-up|1|||
155221915|NCT03616912|560252135|FG001|Overall Study|Lost to Follow-up|2|||
155221916|NCT03616912|560252136|FG002|Overall Study|Lost to Follow-up|3|||
155221917|NCT03616912|560252137|FG003|Overall Study|Lost to Follow-up|0|||
155221918|NCT03616912|560252138|FG004|Overall Study|Lost to Follow-up|0|||
155221919|NCT03616912|560252139|FG005|Overall Study|Lost to Follow-up|0|||
155221920|NCT03616912|560252134|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
155221921|NCT03616912|560252135|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
155221922|NCT03616912|560252136|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
155221923|NCT03616912|560252137|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
155221924|NCT03616912|560252138|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
155221925|NCT03616912|560252139|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
155221926|NCT03616912|560252134|FG000|Overall Study|Withdrawal by Subject|12|||
155221927|NCT03616912|560252135|FG001|Overall Study|Withdrawal by Subject|12|||
155221928|NCT03616912|560252136|FG002|Overall Study|Withdrawal by Subject|15|||
155221929|NCT03616912|560252137|FG003|Overall Study|Withdrawal by Subject|2|||
155221930|NCT03616912|560252138|FG004|Overall Study|Withdrawal by Subject|0|||
155221931|NCT03616912|560252139|FG005|Overall Study|Withdrawal by Subject|2|||
155221932|NCT03616912|560252134|FG000|Overall Study|Study Terminated by Sponsor|0|||
155221933|NCT03616912|560252135|FG001|Overall Study|Study Terminated by Sponsor|0|||
155221934|NCT03616912|560252136|FG002|Overall Study|Study Terminated by Sponsor|0|||
155221935|NCT03616912|560252137|FG003|Overall Study|Study Terminated by Sponsor|10|||
155221936|NCT03616912|560252138|FG004|Overall Study|Study Terminated by Sponsor|9|||
155221937|NCT03616912|560252139|FG005|Overall Study|Study Terminated by Sponsor|11|||
155221938|NCT03616912|560252134|FG000|Overall Study|Protocol Deviation|1|||
155221939|NCT03616912|560252135|FG001|Overall Study|Protocol Deviation|1|||
155221940|NCT03616912|560252136|FG002|Overall Study|Protocol Deviation|0|||
155221941|NCT03616912|560252137|FG003|Overall Study|Protocol Deviation|0|||
155221942|NCT03616912|560252138|FG004|Overall Study|Protocol Deviation|0|||
155221943|NCT03616912|560252139|FG005|Overall Study|Protocol Deviation|0|||
155221944|NCT03616912|560252134|FG000|Overall Study|Pregnancy|1|||
155221945|NCT03616912|560252135|FG001|Overall Study|Pregnancy|0|||
155221946|NCT03616912|560252136|FG002|Overall Study|Pregnancy|4|||
155221947|NCT03616912|560252137|FG003|Overall Study|Pregnancy|0|||
155221948|NCT03616912|560252138|FG004|Overall Study|Pregnancy|0|||
155221949|NCT03616912|560252139|FG005|Overall Study|Pregnancy|0|||
155221950|NCT03616912|560252134|FG000|Overall Study|Protocol Violation|1|||
155221951|NCT03616912|560252135|FG001|Overall Study|Protocol Violation|0|||
155221952|NCT03616912|560252136|FG002|Overall Study|Protocol Violation|2|||
155221953|NCT03616912|560252137|FG003|Overall Study|Protocol Violation|0|||
155221954|NCT03616912|560252138|FG004|Overall Study|Protocol Violation|0|||
155221955|NCT03616912|560252139|FG005|Overall Study|Protocol Violation|0|||
155221956|NCT03616912|560252134|FG000|Overall Study|Physician Decision|2|||
155221957|NCT03616912|560252135|FG001|Overall Study|Physician Decision|0|||
155221958|NCT03616912|560252136|FG002|Overall Study|Physician Decision|0|||
155491436|NCT00948896|561223551|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155221959|NCT03616912|560252137|FG003|Overall Study|Physician Decision|0|||
155221960|NCT03616912|560252138|FG004|Overall Study|Physician Decision|1|||
155221961|NCT03616912|560252139|FG005|Overall Study|Physician Decision|0|||
155221962|NCT03616912|560252134|FG000|Overall Study|Randomized But Never Treated|0|||
155221963|NCT03616912|560252135|FG001|Overall Study|Randomized But Never Treated|2|||
155221964|NCT03616912|560252136|FG002|Overall Study|Randomized But Never Treated|0|||
155221965|NCT03616912|560252137|FG003|Overall Study|Randomized But Never Treated|0|||
155221966|NCT03616912|560252138|FG004|Overall Study|Randomized But Never Treated|0|||
155221967|NCT03616912|560252139|FG005|Overall Study|Randomized But Never Treated|0|||
155221968|NCT01859507|560252140|FG000|Overall Study|left the country|4|||
155221969|NCT01762943|560252142|FG000|Overall Study|Physician Decision|1|||
155221970|NCT01762943|560252143|FG001|Overall Study|Physician Decision|1|||
155221971|NCT01762943|560252142|FG000|Overall Study|Protocol Violation|1|||
155221972|NCT01762943|560252143|FG001|Overall Study|Protocol Violation|0|||
155221973|NCT01762943|560252142|FG000|Overall Study|Withdrawal by Subject|2|||
155221974|NCT01762943|560252143|FG001|Overall Study|Withdrawal by Subject|1|||
155221975|NCT02404311|560252144|FG000|Part A: Month 0-18|Death|2|||
155221976|NCT02404311|560252145|FG001|Part A: Month 0-18|Death|0|||
155221977|NCT02404311|560252146|FG002|Part A: Month 0-18|Death|0|||
155221978|NCT02404311|560252147|FG003|Part A: Month 0-18|Death|0|||
155221979|NCT02404311|560252148|FG004|Part A: Month 0-18|Death|0|||
155221980|NCT02404311|560252144|FG000|Part A: Month 0-18|Physician Decision|1|||
155221981|NCT02404311|560252145|FG001|Part A: Month 0-18|Physician Decision|0|||
155221982|NCT02404311|560252146|FG002|Part A: Month 0-18|Physician Decision|0|||
155221983|NCT02404311|560252147|FG003|Part A: Month 0-18|Physician Decision|0|||
155221984|NCT02404311|560252148|FG004|Part A: Month 0-18|Physician Decision|0|||
155221985|NCT02404311|560252144|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
155221986|NCT02404311|560252145|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
155221987|NCT02404311|560252146|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
155221988|NCT02404311|560252147|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
155221989|NCT02404311|560252148|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
155221990|NCT02404311|560252144|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
155221991|NCT02404311|560252145|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
155221992|NCT02404311|560252146|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
155221993|NCT02404311|560252147|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
155221994|NCT02404311|560252148|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
155221995|NCT02404311|560252144|FG000|Part A: Month 0-18|HIV Infection|6|||
155221996|NCT02404311|560252145|FG001|Part A: Month 0-18|HIV Infection|2|||
155221997|NCT02404311|560252146|FG002|Part A: Month 0-18|HIV Infection|0|||
155221998|NCT02404311|560252147|FG003|Part A: Month 0-18|HIV Infection|0|||
155221999|NCT02404311|560252148|FG004|Part A: Month 0-18|HIV Infection|0|||
155222000|NCT02404311|560252144|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
155222001|NCT02404311|560252145|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
155222002|NCT02404311|560252146|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
155222003|NCT02404311|560252147|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
155222004|NCT02404311|560252148|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
155222005|NCT03314584|560252156|FG000|Overall Study|Withdrawal by Subject|3|||
155222006|NCT03314584|560252157|FG001|Overall Study|Withdrawal by Subject|3|||
155222007|NCT03314584|560252156|FG000|Overall Study|Lost to Follow-up|4|||
155222008|NCT03314584|560252157|FG001|Overall Study|Lost to Follow-up|0|||
155222009|NCT02864251|560252159|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
155222010|NCT02864251|560252160|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
155222011|NCT02864251|560252161|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
155222012|NCT02864251|560252159|FG000|Pre-Treatment|Withdrawal by Participant|0|||
155222013|NCT02864251|560252160|FG001|Pre-Treatment|Withdrawal by Participant|0|||
155222014|NCT02864251|560252161|FG002|Pre-Treatment|Withdrawal by Participant|4|||
155222015|NCT02864251|560252159|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
155222016|NCT02864251|560252160|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
155222017|NCT02864251|560252161|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
155222018|NCT02864251|560252159|FG000|Pre-Treatment|Other Reasons|0|||
155222019|NCT02864251|560252160|FG001|Pre-Treatment|Other Reasons|1|||
155222020|NCT02864251|560252161|FG002|Pre-Treatment|Other Reasons|1|||
155222021|NCT02864251|560252159|FG000|Treatment|Disease Progression|109|||
155222022|NCT02864251|560252160|FG001|Treatment|Disease Progression|52|||
155222023|NCT02864251|560252161|FG002|Treatment|Disease Progression|101|||
155222024|NCT02864251|560252159|FG000|Treatment|Study Drug Toxicity|9|||
155222025|NCT02864251|560252160|FG001|Treatment|Study Drug Toxicity|4|||
155222026|NCT02864251|560252161|FG002|Treatment|Study Drug Toxicity|10|||
155222027|NCT02864251|560252159|FG000|Treatment|Death|0|||
155222028|NCT02864251|560252160|FG001|Treatment|Death|2|||
155222029|NCT02864251|560252161|FG002|Treatment|Death|3|||
155222030|NCT02864251|560252159|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
155222031|NCT02864251|560252160|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
155222032|NCT02864251|560252161|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
155222033|NCT02864251|560252159|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
155222034|NCT02864251|560252160|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
155222035|NCT02864251|560252161|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
155222036|NCT02864251|560252159|FG000|Treatment|Withdrawal by Participant|8|||
155222037|NCT02864251|560252160|FG001|Treatment|Withdrawal by Participant|5|||
155222038|NCT02864251|560252161|FG002|Treatment|Withdrawal by Participant|13|||
155222039|NCT02864251|560252159|FG000|Treatment|Maximum Clinical Benefit|1|||
155222040|NCT02864251|560252160|FG001|Treatment|Maximum Clinical Benefit|0|||
155222041|NCT02864251|560252161|FG002|Treatment|Maximum Clinical Benefit|1|||
155222042|NCT02864251|560252159|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
155222043|NCT02864251|560252160|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
155222044|NCT02864251|560252161|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
155222045|NCT02864251|560252159|FG000|Treatment|Other Reasons|1|||
155222046|NCT02864251|560252160|FG001|Treatment|Other Reasons|1|||
155222047|NCT02864251|560252161|FG002|Treatment|Other Reasons|4|||
155222048|NCT02864251|560252159|FG000|Treatment|Administrative Reason by Sponsor|1|||
155222049|NCT02864251|560252160|FG001|Treatment|Administrative Reason by Sponsor|0|||
155222050|NCT02864251|560252161|FG002|Treatment|Administrative Reason by Sponsor|0|||
155222051|NCT01480076|560252167|FG000|Overall Study|Run-in Failure|52|||
155222052|NCT01480076|560252167|FG000|Overall Study|Adverse Event|39|||
155222053|NCT01480076|560252167|FG000|Overall Study|Death|2|||
155222054|NCT01480076|560252167|FG000|Overall Study|Disease Progression|5|||
155222055|NCT01480076|560252167|FG000|Overall Study|Non-compliance With Study Protocol|15|||
155222056|NCT01480076|560252167|FG000|Overall Study|Withdrawal by Subject|105|||
155222057|NCT01480076|560252167|FG000|Overall Study|Lost to Follow-up|7|||
155222058|NCT01480076|560252167|FG000|Overall Study|Investigator Decision|13|||
155222059|NCT01480076|560252167|FG000|Overall Study|Other|52|||
155222060|NCT00704535|560252168|FG000|Overall Study|Adverse Event|2|||
155222061|NCT00704535|560252168|FG000|Overall Study|Death|2|||
155222062|NCT00704535|560252168|FG000|Overall Study|Lost to Follow-up|8|||
155222063|NCT00704535|560252168|FG000|Overall Study|Protocol Violation|10|||
155222064|NCT00704535|560252168|FG000|Overall Study|Completed status not on Case Report Form|124|||
155222065|NCT02503332|560252169|FG000|Overall Study|Adverse Event|17|||
155222066|NCT02503332|560252170|FG001|Overall Study|Adverse Event|5|||
155222067|NCT02503332|560252171|FG002|Overall Study|Adverse Event|3|||
155222068|NCT02503332|560252172|FG003|Overall Study|Adverse Event|1|||
155222069|NCT02503332|560252169|FG000|Overall Study|Investigator's Decision|5|||
155222070|NCT02503332|560252170|FG001|Overall Study|Investigator's Decision|1|||
155222071|NCT02503332|560252171|FG002|Overall Study|Investigator's Decision|0|||
155222072|NCT02503332|560252172|FG003|Overall Study|Investigator's Decision|0|||
155222073|NCT02503332|560252169|FG000|Overall Study|Sponsor's Decision|1|||
155222074|NCT02503332|560252170|FG001|Overall Study|Sponsor's Decision|0|||
155222075|NCT02503332|560252171|FG002|Overall Study|Sponsor's Decision|0|||
155222076|NCT02503332|560252172|FG003|Overall Study|Sponsor's Decision|1|||
155222077|NCT02503332|560252169|FG000|Overall Study|Subject Request|6|||
155222078|NCT02503332|560252170|FG001|Overall Study|Subject Request|5|||
155222079|NCT02503332|560252171|FG002|Overall Study|Subject Request|2|||
155222080|NCT02503332|560252172|FG003|Overall Study|Subject Request|1|||
155222081|NCT02503332|560252169|FG000|Overall Study|Death|0|||
155222082|NCT02503332|560252170|FG001|Overall Study|Death|2|||
155222083|NCT02503332|560252171|FG002|Overall Study|Death|2|||
155222084|NCT02503332|560252172|FG003|Overall Study|Death|0|||
155222085|NCT02503332|560252169|FG000|Overall Study|Other|5|||
155222086|NCT02503332|560252170|FG001|Overall Study|Other|6|||
155222087|NCT02503332|560252171|FG002|Overall Study|Other|1|||
155222088|NCT02503332|560252172|FG003|Overall Study|Other|1|||
155222089|NCT05694546|560252174|FG000|Overall Study|Lost to Follow-up|11|||
155222090|NCT02120950|560252175|FG000|Overall Study|Adverse Event|5|||
155222091|NCT02120950|560252176|FG001|Overall Study|Adverse Event|4|||
155222092|NCT02120950|560252177|FG002|Overall Study|Adverse Event|3|||
155222093|NCT02120950|560252175|FG000|Overall Study|Death|3|||
155222094|NCT02120950|560252176|FG001|Overall Study|Death|0|||
155222095|NCT02120950|560252177|FG002|Overall Study|Death|1|||
155222096|NCT02120950|560252175|FG000|Overall Study|Withdrawal by Subject|6|||
155222097|NCT02120950|560252176|FG001|Overall Study|Withdrawal by Subject|3|||
155222098|NCT02120950|560252177|FG002|Overall Study|Withdrawal by Subject|2|||
155222099|NCT02120950|560252175|FG000|Overall Study|Protocol Violation|1|||
155222100|NCT02120950|560252176|FG001|Overall Study|Protocol Violation|1|||
155222101|NCT02120950|560252177|FG002|Overall Study|Protocol Violation|7|||
155222102|NCT02120950|560252175|FG000|Overall Study|Other reasons|5|||
155222103|NCT02120950|560252176|FG001|Overall Study|Other reasons|4|||
155222104|NCT02120950|560252177|FG002|Overall Study|Other reasons|1|||
155222105|NCT02120950|560252175|FG000|Overall Study|Lost to Follow-up|0|||
155222106|NCT02120950|560252176|FG001|Overall Study|Lost to Follow-up|2|||
155222107|NCT02120950|560252177|FG002|Overall Study|Lost to Follow-up|1|||
155222108|NCT02424383|560252178|FG000|Overall Study|Withdrawal by Subject|32|||
155222109|NCT02424383|560252178|FG000|Overall Study|Death|170|||
155222110|NCT02424383|560252178|FG000|Overall Study|Sponsor's decision|3|||
155222111|NCT02424383|560252178|FG000|Overall Study|Investigator's decision|44|||
155222112|NCT02424383|560252178|FG000|Overall Study|Lost to Follow-up|81|||
155222113|NCT02424383|560252178|FG000|Overall Study|Other|7|||
155222114|NCT02424383|560252178|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
155222115|NCT02438722|560252182|FG000|Overall Study|Adverse Event|12|||
155222116|NCT02438722|560252183|FG001|Overall Study|Adverse Event|9|||
155222117|NCT02438722|560252182|FG000|Overall Study|Refusal unrelated to AE|2|||
155222118|NCT02438722|560252183|FG001|Overall Study|Refusal unrelated to AE|5|||
155222119|NCT02438722|560252182|FG000|Overall Study|Disease progression/relapse|46|||
155222120|NCT02438722|560252183|FG001|Overall Study|Disease progression/relapse|51|||
155222121|NCT02438722|560252182|FG000|Overall Study|Death|0|||
155222122|NCT02438722|560252183|FG001|Overall Study|Death|3|||
155222123|NCT02438722|560252182|FG000|Overall Study|Physician Decision|2|||
155222124|NCT02438722|560252183|FG001|Overall Study|Physician Decision|2|||
155222125|NCT02438722|560252182|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
155222126|NCT02438722|560252183|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
155222127|NCT02438722|560252182|FG000|Overall Study|Withdrawal by Subject|0|||
155222128|NCT02438722|560252183|FG001|Overall Study|Withdrawal by Subject|1|||
155222129|NCT02438722|560252182|FG000|Overall Study|On protocol treatment|15|||
155222130|NCT02438722|560252183|FG001|Overall Study|On protocol treatment|14|||
155222131|NCT02438722|560252182|FG000|Overall Study|Did not receive protocol treatment|5|||
155222132|NCT02438722|560252183|FG001|Overall Study|Did not receive protocol treatment|0|||
155222133|NCT03343483|560252184|FG000|Overall Study|Death|0|||
155222134|NCT03343483|560252185|FG001|Overall Study|Death|3|||
155222135|NCT03343483|560252184|FG000|Overall Study|Lost to Follow-up|9|||
155222136|NCT03343483|560252185|FG001|Overall Study|Lost to Follow-up|13|||
155222137|NCT03343483|560252184|FG000|Overall Study|Withdrawal by Subject|8|||
155222138|NCT03343483|560252185|FG001|Overall Study|Withdrawal by Subject|17|||
155222139|NCT01488097|560252188|FG000|Overall Study|Lost to Follow-up|1|||
155222140|NCT01577758|560252189|FG000|Dose Escalation Phase|Adverse Event|0|||
155222141|NCT01577758|560252190|FG001|Dose Escalation Phase|Adverse Event|0|||
155222142|NCT01577758|560252191|FG002|Dose Escalation Phase|Adverse Event|0|||
155222143|NCT01577758|560252192|FG003|Dose Escalation Phase|Adverse Event|0|||
155222144|NCT01577758|560252193|FG004|Dose Escalation Phase|Adverse Event|0|||
155222145|NCT01577758|560252194|FG005|Dose Escalation Phase|Adverse Event|2|||
155222146|NCT01577758|560252195|FG006|Dose Escalation Phase|Adverse Event|1|||
155222147|NCT01577758|560252196|FG007|Dose Escalation Phase|Adverse Event|0|||
155222148|NCT01577758|560252189|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222149|NCT01577758|560252190|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222150|NCT01577758|560252191|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222151|NCT01577758|560252192|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222152|NCT01577758|560252193|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222153|NCT01577758|560252194|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222154|NCT01577758|560252195|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222155|NCT01577758|560252196|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222156|NCT01577758|560252189|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155222157|NCT01577758|560252190|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155222158|NCT01577758|560252191|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155222159|NCT01577758|560252192|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155222160|NCT01577758|560252193|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
155222161|NCT01577758|560252194|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
155222162|NCT01577758|560252195|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
155222163|NCT01577758|560252196|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
155222164|NCT01577758|560252189|FG000|Dose Escalation Phase|Progression Disease|2|||
155222165|NCT01577758|560252190|FG001|Dose Escalation Phase|Progression Disease|2|||
155222166|NCT01577758|560252191|FG002|Dose Escalation Phase|Progression Disease|1|||
155222167|NCT01577758|560252192|FG003|Dose Escalation Phase|Progression Disease|2|||
155222168|NCT01577758|560252193|FG004|Dose Escalation Phase|Progression Disease|5|||
155222169|NCT01577758|560252194|FG005|Dose Escalation Phase|Progression Disease|0|||
155222170|NCT01577758|560252195|FG006|Dose Escalation Phase|Progression Disease|0|||
155222171|NCT01577758|560252196|FG007|Dose Escalation Phase|Progression Disease|0|||
155222172|NCT01577758|560252189|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222173|NCT01577758|560252190|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222174|NCT01577758|560252191|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222175|NCT01577758|560252192|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222176|NCT01577758|560252193|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222177|NCT01577758|560252194|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222178|NCT01577758|560252195|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222179|NCT01577758|560252196|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
155222180|NCT01577758|560252189|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222181|NCT01577758|560252190|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222182|NCT01577758|560252191|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222183|NCT01577758|560252192|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222184|NCT01577758|560252193|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222185|NCT01577758|560252194|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222186|NCT01577758|560252195|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222187|NCT01577758|560252196|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
155222188|NCT01577758|560252189|FG000|mCRC Expansion Phase|Progression Disease|0|||
155222189|NCT01577758|560252190|FG001|mCRC Expansion Phase|Progression Disease|0|||
155222190|NCT01577758|560252191|FG002|mCRC Expansion Phase|Progression Disease|0|||
155222191|NCT01577758|560252192|FG003|mCRC Expansion Phase|Progression Disease|0|||
155222192|NCT01577758|560252193|FG004|mCRC Expansion Phase|Progression Disease|0|||
155222193|NCT01577758|560252194|FG005|mCRC Expansion Phase|Progression Disease|0|||
155222194|NCT01577758|560252195|FG006|mCRC Expansion Phase|Progression Disease|0|||
155222195|NCT01577758|560252196|FG007|mCRC Expansion Phase|Progression Disease|19|||
155222196|NCT01293240|560252197|FG000|Overall Study|Noncompliance|2|||
155491437|NCT00948896|561223552|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
155222197|NCT00751348|560252201|FG000|Overall Study|Withdrawal by Subject|5|||
155222198|NCT00751348|560252202|FG001|Overall Study|Withdrawal by Subject|2|||
155222199|NCT00751348|560252201|FG000|Overall Study|Migration from study area|1|||
155222200|NCT00751348|560252202|FG001|Overall Study|Migration from study area|0|||
155222201|NCT02404350|560252208|FG000|Overall Study|Adverse Event|2|||
155222202|NCT02404350|560252209|FG001|Overall Study|Adverse Event|2|||
155222203|NCT02404350|560252210|FG002|Overall Study|Adverse Event|3|||
155222204|NCT02404350|560252211|FG003|Overall Study|Adverse Event|9|||
155222205|NCT02404350|560252208|FG000|Overall Study|Lack of Efficacy|3|||
155222206|NCT02404350|560252209|FG001|Overall Study|Lack of Efficacy|1|||
155222207|NCT02404350|560252210|FG002|Overall Study|Lack of Efficacy|0|||
155222208|NCT02404350|560252211|FG003|Overall Study|Lack of Efficacy|3|||
155222209|NCT02404350|560252208|FG000|Overall Study|Lost to Follow-up|2|||
155222210|NCT02404350|560252209|FG001|Overall Study|Lost to Follow-up|0|||
155222211|NCT02404350|560252210|FG002|Overall Study|Lost to Follow-up|0|||
155222212|NCT02404350|560252211|FG003|Overall Study|Lost to Follow-up|1|||
155222213|NCT02404350|560252208|FG000|Overall Study|Physician Decision|1|||
155222214|NCT02404350|560252209|FG001|Overall Study|Physician Decision|0|||
155222215|NCT02404350|560252210|FG002|Overall Study|Physician Decision|0|||
155222216|NCT02404350|560252211|FG003|Overall Study|Physician Decision|2|||
155222217|NCT02404350|560252208|FG000|Overall Study|Pregnancy|0|||
155222218|NCT02404350|560252209|FG001|Overall Study|Pregnancy|0|||
155222219|NCT02404350|560252210|FG002|Overall Study|Pregnancy|0|||
155222220|NCT02404350|560252211|FG003|Overall Study|Pregnancy|1|||
155222221|NCT02404350|560252208|FG000|Overall Study|Withdrawal by Subject|7|||
155222222|NCT02404350|560252209|FG001|Overall Study|Withdrawal by Subject|3|||
155222223|NCT02404350|560252210|FG002|Overall Study|Withdrawal by Subject|3|||
155222224|NCT02404350|560252211|FG003|Overall Study|Withdrawal by Subject|19|||
155222225|NCT02404350|560252208|FG000|Overall Study|Due to Non-compliance with treatment|0|||
155222226|NCT02404350|560252209|FG001|Overall Study|Due to Non-compliance with treatment|0|||
155222227|NCT02404350|560252210|FG002|Overall Study|Due to Non-compliance with treatment|0|||
155222228|NCT02404350|560252211|FG003|Overall Study|Due to Non-compliance with treatment|1|||
155222229|NCT02404350|560252208|FG000|Overall Study|Due to Technical problems|0|||
155222230|NCT02404350|560252209|FG001|Overall Study|Due to Technical problems|0|||
155222231|NCT02404350|560252210|FG002|Overall Study|Due to Technical problems|0|||
155222232|NCT02404350|560252211|FG003|Overall Study|Due to Technical problems|1|||
155222233|NCT05389657|560252212|FG000|Overall Study|Lost to Follow-up|7|||
155222234|NCT05389657|560252213|FG001|Overall Study|Lost to Follow-up|8|||
155222235|NCT05237206|560252215|FG000|Overall Study|screen failure-did not receive treatment|8|||
155222236|NCT05237206|560252215|FG000|Overall Study|did not receive treatment|3|||
155222237|NCT03261947|560252216|FG000|Overall Study|Death|10|||
155222238|NCT03261947|560252217|FG001|Overall Study|Death|13|||
155222239|NCT03261947|560252218|FG002|Overall Study|Death|17|||
155222240|NCT03261947|560252219|FG003|Overall Study|Death|12|||
155222241|NCT03261947|560252220|FG004|Overall Study|Death|8|||
155222242|NCT03261947|560252216|FG000|Overall Study|Lost to Follow-up|0|||
155222243|NCT03261947|560252217|FG001|Overall Study|Lost to Follow-up|0|||
155222244|NCT03261947|560252218|FG002|Overall Study|Lost to Follow-up|2|||
155222245|NCT03261947|560252219|FG003|Overall Study|Lost to Follow-up|1|||
155222246|NCT03261947|560252220|FG004|Overall Study|Lost to Follow-up|0|||
155222247|NCT03261947|560252216|FG000|Overall Study|Withdrawal by Subject|0|||
155222248|NCT03261947|560252217|FG001|Overall Study|Withdrawal by Subject|0|||
155222249|NCT03261947|560252218|FG002|Overall Study|Withdrawal by Subject|3|||
155222250|NCT03261947|560252219|FG003|Overall Study|Withdrawal by Subject|0|||
155222251|NCT03261947|560252220|FG004|Overall Study|Withdrawal by Subject|1|||
155222252|NCT03261947|560252216|FG000|Overall Study|Site Terminated by Sponsor|0|||
155222253|NCT03261947|560252217|FG001|Overall Study|Site Terminated by Sponsor|0|||
155222254|NCT03261947|560252218|FG002|Overall Study|Site Terminated by Sponsor|4|||
155222255|NCT03261947|560252219|FG003|Overall Study|Site Terminated by Sponsor|7|||
155222256|NCT03261947|560252220|FG004|Overall Study|Site Terminated by Sponsor|5|||
155222257|NCT03261947|560252216|FG000|Overall Study|Reason not Specified|2|||
155222258|NCT03261947|560252217|FG001|Overall Study|Reason not Specified|0|||
155222259|NCT03261947|560252218|FG002|Overall Study|Reason not Specified|4|||
155222260|NCT03261947|560252219|FG003|Overall Study|Reason not Specified|1|||
155222261|NCT03261947|560252220|FG004|Overall Study|Reason not Specified|3|||
155222262|NCT03969992|560252221|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
155222263|NCT03969992|560252222|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
155222264|NCT03969992|560252223|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
155222265|NCT03969992|560252221|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
155222266|NCT03969992|560252222|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
155222267|NCT03969992|560252223|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
155222268|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
155222269|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
155222270|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
155491438|NCT01590810|561223553|FG000|Overall Study|Physician Decision|0|||
155222271|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
155222272|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
155222273|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
155222274|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
155491439|NCT01590810|561223554|FG001|Overall Study|Physician Decision|1|||
155222275|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
155222276|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
155222277|NCT01476696|560252224|FG000|Overall Study|Sponsor decision|2|||
155222278|NCT01476696|560252225|FG001|Overall Study|Sponsor decision|1|||
155222279|NCT01476696|560252226|FG002|Overall Study|Sponsor decision|0|||
155222280|NCT01476696|560252224|FG000|Overall Study|Withdrawal by Subject|1|||
155222281|NCT01476696|560252225|FG001|Overall Study|Withdrawal by Subject|0|||
155222282|NCT01476696|560252226|FG002|Overall Study|Withdrawal by Subject|0|||
155222283|NCT03965962|560252234|FG000|Overall Study|Adverse Event|1|||
155222284|NCT03965962|560252235|FG001|Overall Study|Adverse Event|0|||
155222285|NCT03965962|560252236|FG002|Overall Study|Adverse Event|0|||
155222286|NCT03965962|560252237|FG003|Overall Study|Adverse Event|0|||
155222287|NCT03965962|560252234|FG000|Overall Study|Protocol Violation|21|||
155222288|NCT03965962|560252235|FG001|Overall Study|Protocol Violation|4|||
155222289|NCT03965962|560252236|FG002|Overall Study|Protocol Violation|10|||
155222290|NCT03965962|560252237|FG003|Overall Study|Protocol Violation|5|||
155222291|NCT03965962|560252234|FG000|Overall Study|Lost to Follow-up|0|||
155222292|NCT03965962|560252235|FG001|Overall Study|Lost to Follow-up|1|||
155222293|NCT03965962|560252236|FG002|Overall Study|Lost to Follow-up|0|||
155222294|NCT03965962|560252237|FG003|Overall Study|Lost to Follow-up|0|||
155222295|NCT03965962|560252234|FG000|Overall Study|Withdrawal by Subject|3|||
155222296|NCT03965962|560252235|FG001|Overall Study|Withdrawal by Subject|0|||
155222297|NCT03965962|560252236|FG002|Overall Study|Withdrawal by Subject|0|||
155222298|NCT03965962|560252237|FG003|Overall Study|Withdrawal by Subject|1|||
155222299|NCT02590939|560252238|FG000|Overall Study|Withdrawal by Subject|3|||
155222300|NCT02590939|560252239|FG001|Overall Study|Withdrawal by Subject|1|||
155222301|NCT02590939|560252238|FG000|Overall Study|Failed the nociceptive test|2|||
155222302|NCT02590939|560252239|FG001|Overall Study|Failed the nociceptive test|1|||
155222303|NCT00156533|560253510|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
155222304|NCT00156533|560253511|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
155222305|NCT00156533|560253512|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
155222306|NCT00156533|560253513|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
155222307|NCT00156533|560253510|FG000|Overall Study|Withdrawal by Subject|1|||
155222308|NCT00156533|560253511|FG001|Overall Study|Withdrawal by Subject|0|||
155222309|NCT00156533|560253512|FG002|Overall Study|Withdrawal by Subject|0|||
155222310|NCT00156533|560253513|FG003|Overall Study|Withdrawal by Subject|1|||
155222311|NCT00156533|560253510|FG000|Overall Study|Failed Screening|1|||
155222312|NCT00156533|560253511|FG001|Overall Study|Failed Screening|0|||
155222313|NCT00156533|560253512|FG002|Overall Study|Failed Screening|1|||
155222314|NCT00156533|560253513|FG003|Overall Study|Failed Screening|1|||
155222315|NCT03265249|560253516|FG000|Overall Study|Withdrawal by Subject|0|||
155222316|NCT03265249|560253517|FG001|Overall Study|Withdrawal by Subject|1|||
155222317|NCT01614990|560253518|FG000|Overall Study|Protocol Violation|1|||
155222318|NCT01614990|560253519|FG001|Overall Study|Protocol Violation|1|||
155222319|NCT04171414|560253531|FG000|Overall Study|Death|1|||
155222320|NCT04171414|560253531|FG000|Overall Study|Withdrawal by Subject|1|||
155222321|NCT02586493|560253534|FG000|Overall Study|Adverse Event|4|||
155222322|NCT02586493|560253534|FG000|Overall Study|Protocol Violation|6|||
155222323|NCT02586493|560253534|FG000|Overall Study|Lost to Follow-up|1|||
155222324|NCT02586493|560253534|FG000|Overall Study|Withdrawal by Subject|1|||
155222325|NCT04343521|560253547|FG000|Overall Study|Adverse Event|0|||
155222326|NCT04343521|560253548|FG001|Overall Study|Adverse Event|2|||
155222327|NCT04343521|560253547|FG000|Overall Study|Death|1|||
155222328|NCT04343521|560253548|FG001|Overall Study|Death|2|||
155222329|NCT04343521|560253547|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
155222330|NCT04343521|560253548|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
155222331|NCT04343521|560253547|FG000|Overall Study|Withdrawal by Subject|70|||
155222332|NCT04343521|560253548|FG001|Overall Study|Withdrawal by Subject|95|||
155222333|NCT04343521|560253547|FG000|Overall Study|Withdrawal by study team|6|||
155222334|NCT04343521|560253548|FG001|Overall Study|Withdrawal by study team|12|||
155222335|NCT02532647|560253551|FG000|Overall Study|Did not receive trial medication|1|||
155222336|NCT02532647|560253552|FG001|Overall Study|Did not receive trial medication|0|||
155222337|NCT02532647|560253553|FG002|Overall Study|Did not receive trial medication|1|||
155222338|NCT01505608|560253558|FG000|Phase I|Lack of Efficacy|0|||
155222339|NCT01505608|560253559|FG001|Phase I|Lack of Efficacy|4|||
155222340|NCT01505608|560253558|FG000|Phase I|Adverse Event|0|||
155222341|NCT01505608|560253559|FG001|Phase I|Adverse Event|1|||
155222342|NCT01505608|560253558|FG000|Phase I|Withdrawal by Subject|0|||
155222343|NCT01505608|560253559|FG001|Phase I|Withdrawal by Subject|1|||
155222344|NCT01505608|560253558|FG000|Phase II|Lack of Efficacy|2|||
155222345|NCT01505608|560253559|FG001|Phase II|Lack of Efficacy|1|||
155222346|NCT01505608|560253558|FG000|Phase II|Protocol Violation|0|||
155222347|NCT01505608|560253559|FG001|Phase II|Protocol Violation|1|||
155222348|NCT01251380|560253562|FG000|Overall Study|Other (Not otherwise specified)|12|||
155222349|NCT01251380|560253562|FG000|Overall Study|Withdrawal by Subject|6|||
155222350|NCT01251380|560253562|FG000|Overall Study|Lack of Efficacy|1|||
155222351|NCT01251380|560253562|FG000|Overall Study|Adverse Event|1|||
155222352|NCT01251380|560253562|FG000|Overall Study|Lost to Follow-up|2|||
155222353|NCT00600756|560253563|FG000|Analysis After 6 Months|Adverse Event|43|||
155222354|NCT00600756|560253564|FG001|Analysis After 6 Months|Adverse Event|33|||
155222355|NCT00600756|560253563|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
155222356|NCT00600756|560253564|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
155222357|NCT00600756|560253563|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
155222358|NCT00600756|560253564|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
155222359|NCT00600756|560253563|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
155222360|NCT00600756|560253564|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
155222361|NCT00600756|560253563|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
155222362|NCT00600756|560253564|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
155222363|NCT00600756|560253563|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
155222364|NCT00600756|560253564|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
155222365|NCT00600756|560253563|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
155222366|NCT00600756|560253564|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
155222367|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
155222368|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
155222369|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
155222370|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
155222371|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
155222372|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
155222373|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
155222374|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
155222375|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
155222376|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
155222377|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
155222378|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
155222379|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
155222380|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
155222381|NCT00768144|560253565|FG000|Overall Study|Adverse Event|13|||
155222382|NCT00768144|560253565|FG000|Overall Study|Progressive Disease|21|||
155222383|NCT00768144|560253565|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
155222384|NCT00768144|560253565|FG000|Overall Study|Pt Withdrew Consent|1|||
155222385|NCT01712854|560253566|FG000|Overall Study|Physician Decision|1|||
155222386|NCT01150123|560253567|FG000|Overall Study|Withdrawal by Subject|1|||
155222387|NCT01150123|560253568|FG001|Overall Study|Withdrawal by Subject|1|||
155222388|NCT01150123|560253569|FG002|Overall Study|Withdrawal by Subject|2|||
155222389|NCT01150123|560253570|FG003|Overall Study|Withdrawal by Subject|1|||
155222390|NCT01150123|560253571|FG004|Overall Study|Withdrawal by Subject|1|||
155222391|NCT01150123|560253572|FG005|Overall Study|Withdrawal by Subject|1|||
155222392|NCT01150123|560253573|FG006|Overall Study|Withdrawal by Subject|0|||
155222393|NCT01150123|560253574|FG007|Overall Study|Withdrawal by Subject|3|||
155222394|NCT01150123|560253575|FG008|Overall Study|Withdrawal by Subject|2|||
155222395|NCT01150123|560253576|FG009|Overall Study|Withdrawal by Subject|0|||
155222396|NCT01150123|560253577|FG010|Overall Study|Withdrawal by Subject|1|||
155222397|NCT01150123|560253578|FG011|Overall Study|Withdrawal by Subject|0|||
155222398|NCT01150123|560253579|FG012|Overall Study|Withdrawal by Subject|1|||
155222399|NCT01150123|560253580|FG013|Overall Study|Withdrawal by Subject|0|||
155222400|NCT01150123|560253581|FG014|Overall Study|Withdrawal by Subject|0|||
155222401|NCT01150123|560253582|FG015|Overall Study|Withdrawal by Subject|1|||
155222402|NCT01150123|560253583|FG016|Overall Study|Withdrawal by Subject|0|||
155222403|NCT01150123|560253584|FG017|Overall Study|Withdrawal by Subject|1|||
155222404|NCT01150123|560253567|FG000|Overall Study|Lost to Follow-up|2|||
155222405|NCT01150123|560253568|FG001|Overall Study|Lost to Follow-up|1|||
155222406|NCT01150123|560253569|FG002|Overall Study|Lost to Follow-up|2|||
155222407|NCT01150123|560253570|FG003|Overall Study|Lost to Follow-up|2|||
155222408|NCT01150123|560253571|FG004|Overall Study|Lost to Follow-up|2|||
155222409|NCT01150123|560253572|FG005|Overall Study|Lost to Follow-up|5|||
155222410|NCT01150123|560253573|FG006|Overall Study|Lost to Follow-up|0|||
155222411|NCT01150123|560253574|FG007|Overall Study|Lost to Follow-up|0|||
155222412|NCT01150123|560253575|FG008|Overall Study|Lost to Follow-up|3|||
155222413|NCT01150123|560253576|FG009|Overall Study|Lost to Follow-up|1|||
155222414|NCT01150123|560253577|FG010|Overall Study|Lost to Follow-up|1|||
155222415|NCT01150123|560253578|FG011|Overall Study|Lost to Follow-up|1|||
155222416|NCT01150123|560253579|FG012|Overall Study|Lost to Follow-up|2|||
155222417|NCT01150123|560253580|FG013|Overall Study|Lost to Follow-up|0|||
155222418|NCT01150123|560253581|FG014|Overall Study|Lost to Follow-up|0|||
155222419|NCT01150123|560253582|FG015|Overall Study|Lost to Follow-up|0|||
155222420|NCT01150123|560253583|FG016|Overall Study|Lost to Follow-up|0|||
155222421|NCT01150123|560253584|FG017|Overall Study|Lost to Follow-up|0|||
155222422|NCT02171260|560253585|FG000|Overall Study|Death|0|||
155222423|NCT02171260|560253586|FG001|Overall Study|Death|0|||
155222424|NCT02171260|560253587|FG002|Overall Study|Death|0|||
155222425|NCT02171260|560253588|FG003|Overall Study|Death|1|||
155222426|NCT02171260|560253585|FG000|Overall Study|Physician Decision|1|||
155222427|NCT02171260|560253586|FG001|Overall Study|Physician Decision|0|||
155222428|NCT02171260|560253587|FG002|Overall Study|Physician Decision|1|||
155222429|NCT02171260|560253588|FG003|Overall Study|Physician Decision|0|||
155222430|NCT02171260|560253585|FG000|Overall Study|Withdrawal by Subject|1|||
155222431|NCT02171260|560253586|FG001|Overall Study|Withdrawal by Subject|0|||
155222432|NCT02171260|560253587|FG002|Overall Study|Withdrawal by Subject|0|||
155222433|NCT02171260|560253588|FG003|Overall Study|Withdrawal by Subject|0|||
155222434|NCT02171260|560253585|FG000|Overall Study|Evidence of progressive disease|4|||
155222435|NCT02171260|560253586|FG001|Overall Study|Evidence of progressive disease|6|||
155222436|NCT02171260|560253587|FG002|Overall Study|Evidence of progressive disease|4|||
155222437|NCT02171260|560253588|FG003|Overall Study|Evidence of progressive disease|4|||
155222438|NCT01466387|560253591|FG000|Overall Study|Adverse Event|0|||
155222439|NCT01466387|560253592|FG001|Overall Study|Adverse Event|0|||
155222440|NCT01466387|560253593|FG002|Overall Study|Adverse Event|1|||
155222441|NCT01466387|560253594|FG003|Overall Study|Adverse Event|1|||
155222442|NCT01466387|560253595|FG004|Overall Study|Adverse Event|0|||
155222443|NCT01466387|560253596|FG005|Overall Study|Adverse Event|0|||
155222444|NCT01466387|560253591|FG000|Overall Study|Lost to Follow-up|0|||
155222445|NCT01466387|560253592|FG001|Overall Study|Lost to Follow-up|0|||
155222446|NCT01466387|560253593|FG002|Overall Study|Lost to Follow-up|0|||
155222447|NCT01466387|560253594|FG003|Overall Study|Lost to Follow-up|0|||
155222448|NCT01466387|560253595|FG004|Overall Study|Lost to Follow-up|0|||
155222449|NCT01466387|560253596|FG005|Overall Study|Lost to Follow-up|1|||
155222450|NCT01466387|560253591|FG000|Overall Study|Protocol Violation|1|||
155222451|NCT01466387|560253592|FG001|Overall Study|Protocol Violation|0|||
155222452|NCT01466387|560253593|FG002|Overall Study|Protocol Violation|0|||
155222453|NCT01466387|560253594|FG003|Overall Study|Protocol Violation|1|||
155222454|NCT01466387|560253595|FG004|Overall Study|Protocol Violation|0|||
155222455|NCT01466387|560253596|FG005|Overall Study|Protocol Violation|0|||
155222456|NCT01319877|560253597|FG000|Overall Study|Lost to Follow-up|100|||
155222457|NCT01319877|560253598|FG001|Overall Study|Lost to Follow-up|37|||
155222458|NCT01319877|560253597|FG000|Overall Study|Physician Decision|2|||
155222459|NCT01319877|560253598|FG001|Overall Study|Physician Decision|0|||
155222460|NCT01319877|560253597|FG000|Overall Study|Disease Progression|2|||
155222461|NCT01319877|560253598|FG001|Overall Study|Disease Progression|2|||
155222462|NCT01319877|560253597|FG000|Overall Study|Withdrawal by Subject|0|||
155222463|NCT01319877|560253598|FG001|Overall Study|Withdrawal by Subject|1|||
155222464|NCT01319877|560253597|FG000|Overall Study|Reason Not Specified|4|||
155222465|NCT01319877|560253598|FG001|Overall Study|Reason Not Specified|5|||
155222466|NCT02347189|560253601|FG000|Overall Study|No implant attempted of study device|9|||
155222467|NCT02347189|560253601|FG000|Overall Study|No primary outcome data available|2|||
155222468|NCT02677987|560253602|FG000|Overall Study|Withdrawal by Subject|3|||
155222469|NCT02677987|560253603|FG001|Overall Study|Withdrawal by Subject|0|||
155222470|NCT02677987|560253602|FG000|Overall Study|Lost to Follow-up|1|||
155222471|NCT02677987|560253603|FG001|Overall Study|Lost to Follow-up|0|||
155222472|NCT03320564|560253605|FG000|Overall Study|Protocol Violation|1|||
155222473|NCT00673179|560253606|FG000|Overall Study|Toxicity/Complications|3|||
155222474|NCT00673179|560253607|FG001|Overall Study|Toxicity/Complications|0|||
155222475|NCT00352846|560253608|FG000|Overall Study|Disease progression|0|||
155222476|NCT00352846|560253609|FG001|Overall Study|Disease progression|2|||
155222477|NCT00352846|560253608|FG000|Overall Study|Withdrawal by Subject|3|||
155222478|NCT00352846|560253609|FG001|Overall Study|Withdrawal by Subject|8|||
155222479|NCT00352846|560253608|FG000|Overall Study|Ineligible|3|||
155222480|NCT00352846|560253609|FG001|Overall Study|Ineligible|2|||
155222481|NCT00352846|560253608|FG000|Overall Study|Non-compliance|2|||
155222482|NCT00352846|560253609|FG001|Overall Study|Non-compliance|0|||
155222483|NCT00352846|560253608|FG000|Overall Study|Death|0|||
155222484|NCT00352846|560253609|FG001|Overall Study|Death|1|||
155222485|NCT01527682|560253610|FG000|Overall Study|Protocol Violation|8|||
155222486|NCT01531387|560253611|FG000|Overall Study|Early termination of study|11|||
155222487|NCT01531387|560253612|FG001|Overall Study|Early termination of study|11|||
155222488|NCT00600938|560253615|FG000|Core Study|Abnormal test procedure result(s)|3|||
155222489|NCT00600938|560253616|FG001|Core Study|Abnormal test procedure result(s)|2|||
155222490|NCT00600938|560253617|FG002|Core Study|Abnormal test procedure result(s)|0|||
155222491|NCT00600938|560253618|FG003|Core Study|Abnormal test procedure result(s)|0|||
155222492|NCT00600938|560253615|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
155222493|NCT00600938|560253616|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
155222494|NCT00600938|560253617|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
155491440|NCT01590810|561223555|FG002|Overall Study|Physician Decision|1|||
155222495|NCT00600938|560253618|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
155222496|NCT00600938|560253615|FG000|Core Study|Patient withdrew consent|7|||
155222497|NCT00600938|560253616|FG001|Core Study|Patient withdrew consent|12|||
155222498|NCT00600938|560253617|FG002|Core Study|Patient withdrew consent|0|||
155222499|NCT00600938|560253618|FG003|Core Study|Patient withdrew consent|0|||
155222500|NCT00600938|560253615|FG000|Core Study|Lost to Follow-up|3|||
155222501|NCT00600938|560253616|FG001|Core Study|Lost to Follow-up|2|||
155222502|NCT00600938|560253617|FG002|Core Study|Lost to Follow-up|0|||
155222503|NCT00600938|560253618|FG003|Core Study|Lost to Follow-up|0|||
155222504|NCT00600938|560253615|FG000|Core Study|Death|1|||
155222505|NCT00600938|560253616|FG001|Core Study|Death|1|||
155222506|NCT00600938|560253617|FG002|Core Study|Death|0|||
155222507|NCT00600938|560253618|FG003|Core Study|Death|0|||
155222508|NCT00600938|560253615|FG000|Core Study|Protocol Violation|1|||
155222509|NCT00600938|560253616|FG001|Core Study|Protocol Violation|2|||
155222510|NCT00600938|560253617|FG002|Core Study|Protocol Violation|0|||
155222511|NCT00600938|560253618|FG003|Core Study|Protocol Violation|0|||
155222512|NCT00600938|560253615|FG000|Extension Study|Adverse Event|1|||
155222513|NCT00600938|560253616|FG001|Extension Study|Adverse Event|0|||
155222514|NCT00600938|560253617|FG002|Extension Study|Adverse Event|2|||
155222515|NCT00600938|560253618|FG003|Extension Study|Adverse Event|0|||
155222516|NCT00600938|560253615|FG000|Extension Study|Abnormal test procedure results|0|||
155222517|NCT00600938|560253616|FG001|Extension Study|Abnormal test procedure results|1|||
155222518|NCT00600938|560253617|FG002|Extension Study|Abnormal test procedure results|1|||
155222519|NCT00600938|560253618|FG003|Extension Study|Abnormal test procedure results|1|||
155222520|NCT00600938|560253615|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
155222521|NCT00600938|560253616|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
155222522|NCT00600938|560253617|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
155222523|NCT00600938|560253618|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
155222524|NCT00600938|560253615|FG000|Extension Study|Withdrawal by Subject|2|||
155222525|NCT00600938|560253616|FG001|Extension Study|Withdrawal by Subject|2|||
155222526|NCT00600938|560253617|FG002|Extension Study|Withdrawal by Subject|3|||
155222527|NCT00600938|560253618|FG003|Extension Study|Withdrawal by Subject|0|||
155222528|NCT00600938|560253615|FG000|Extension Study|Lost to Follow-up|1|||
155222529|NCT00600938|560253616|FG001|Extension Study|Lost to Follow-up|1|||
155222530|NCT00600938|560253617|FG002|Extension Study|Lost to Follow-up|2|||
155222531|NCT00600938|560253618|FG003|Extension Study|Lost to Follow-up|0|||
155222532|NCT00600938|560253615|FG000|Extension Study|Death|1|||
155222533|NCT00600938|560253616|FG001|Extension Study|Death|0|||
155222534|NCT00600938|560253617|FG002|Extension Study|Death|0|||
155222535|NCT00600938|560253618|FG003|Extension Study|Death|0|||
155222536|NCT04220411|560253619|FG000|Overall Study|Adverse Event|0|||
155222537|NCT04220411|560253620|FG001|Overall Study|Adverse Event|0|||
155222538|NCT04220411|560253621|FG002|Overall Study|Adverse Event|0|||
155222539|NCT04220411|560253622|FG003|Overall Study|Adverse Event|1|||
155222540|NCT02680639|560253623|FG000|Screening Period|Screen Failure|7|||
155222541|NCT02680639|560253624|FG001|Screening Period|Screen Failure|0|||
155222542|NCT02680639|560253625|FG002|Screening Period|Screen Failure|0|||
155222543|NCT02678676|560253626|FG000|Overall Study|Death|619|||
155222544|NCT02678676|560253627|FG001|Overall Study|Death|649|||
155222545|NCT02678676|560253626|FG000|Overall Study|Withdrawal by Subject|13|||
155222546|NCT02678676|560253627|FG001|Overall Study|Withdrawal by Subject|5|||
155222547|NCT02678676|560253626|FG000|Overall Study|Lost to Follow-up|171|||
155222548|NCT02678676|560253627|FG001|Overall Study|Lost to Follow-up|151|||
155222549|NCT02678676|560253626|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
155222550|NCT02678676|560253627|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
155222551|NCT02496533|560253639|FG000|Overall Study|Lack of data on outcome|3|||
155222552|NCT02496533|560253640|FG001|Overall Study|Lack of data on outcome|0|||
155222553|NCT02496533|560253639|FG000|Overall Study|Patient did not complete all measures|0|||
155222554|NCT02496533|560253640|FG001|Overall Study|Patient did not complete all measures|4|||
155222555|NCT02496533|560253639|FG000|Overall Study|Late for radiologic testing|0|||
155222556|NCT02496533|560253640|FG001|Overall Study|Late for radiologic testing|2|||
155222557|NCT05756790|560253641|FG000|Overall Study|Withdrawal by Subject|1|||
155222558|NCT05756790|560253642|FG001|Overall Study|Withdrawal by Subject|1|||
155222559|NCT05756790|560253643|FG002|Overall Study|Withdrawal by Subject|1|||
155222560|NCT05756790|560253644|FG003|Overall Study|Withdrawal by Subject|1|||
155222561|NCT05756790|560253645|FG004|Overall Study|Withdrawal by Subject|0|||
155222562|NCT05756790|560253646|FG005|Overall Study|Withdrawal by Subject|0|||
155222563|NCT05756790|560253641|FG000|Overall Study|Protocol Violation|0|||
155222564|NCT05756790|560253642|FG001|Overall Study|Protocol Violation|0|||
155222565|NCT05756790|560253643|FG002|Overall Study|Protocol Violation|1|||
155222566|NCT05756790|560253644|FG003|Overall Study|Protocol Violation|1|||
155222567|NCT05756790|560253645|FG004|Overall Study|Protocol Violation|0|||
155222568|NCT05756790|560253646|FG005|Overall Study|Protocol Violation|0|||
155222569|NCT05756790|560253641|FG000|Overall Study|Ineligible|0|||
155222570|NCT05756790|560253642|FG001|Overall Study|Ineligible|0|||
155222571|NCT05756790|560253643|FG002|Overall Study|Ineligible|0|||
155222572|NCT05756790|560253644|FG003|Overall Study|Ineligible|0|||
155222573|NCT05756790|560253645|FG004|Overall Study|Ineligible|2|||
155222574|NCT05756790|560253646|FG005|Overall Study|Ineligible|2|||
155491441|NCT01590810|561223556|FG003|Overall Study|Physician Decision|0|||
155222575|NCT03256552|560254923|FG000|Overall Study|Protocol Violation|1|||
155222576|NCT03256552|560254923|FG000|Overall Study|Physician Decision|1|||
155222577|NCT03256552|560254923|FG000|Overall Study|Adverse Event|1|||
155222578|NCT03256552|560254923|FG000|Overall Study|Withdrawal by Subject|2|||
155222579|NCT02268409|560254928|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
155222580|NCT02268409|560254928|FG000|Overall Study|Death|1|||
155222581|NCT02268409|560254928|FG000|Overall Study|Lost to Follow-up|1|||
155222582|NCT02268409|560254928|FG000|Overall Study|Protocol Violation|3|||
155222583|NCT02268409|560254928|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
155222584|NCT02268409|560254928|FG000|Overall Study|Withdrawal by Subject|5|||
155222585|NCT00427635|560254929|FG000|Treatment Phase|Withdrawal by Subject|1|||
155222586|NCT00427635|560254930|FG001|Treatment Phase|Withdrawal by Subject|0|||
155222587|NCT00427635|560254929|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
155222588|NCT00427635|560254930|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
155222589|NCT00838201|560254933|FG000|Overall Study|Investigator decision, or other reasons|2|||
155222590|NCT00838201|560254934|FG001|Overall Study|Investigator decision, or other reasons|3|||
155222591|NCT00838201|560254933|FG000|Overall Study|Noncompliance|0|||
155222592|NCT00838201|560254934|FG001|Overall Study|Noncompliance|1|||
155222593|NCT00838201|560254933|FG000|Overall Study|Administrative decision|1|||
155222594|NCT00838201|560254934|FG001|Overall Study|Administrative decision|2|||
155222595|NCT00838201|560254933|FG000|Overall Study|Disease progression|3|||
155222596|NCT00838201|560254934|FG001|Overall Study|Disease progression|3|||
155222597|NCT00838201|560254933|FG000|Overall Study|Consent withdrawn|16|||
155222598|NCT00838201|560254934|FG001|Overall Study|Consent withdrawn|19|||
155222599|NCT00838201|560254933|FG000|Overall Study|Lost to Follow-up|4|||
155222600|NCT00838201|560254934|FG001|Overall Study|Lost to Follow-up|3|||
155222601|NCT00838201|560254933|FG000|Overall Study|Adverse Event|5|||
155222602|NCT00838201|560254934|FG001|Overall Study|Adverse Event|9|||
155222603|NCT00838201|560254933|FG000|Overall Study|Death|11|||
155222604|NCT00838201|560254934|FG001|Overall Study|Death|13|||
155222605|NCT00489853|560254935|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
155222606|NCT00489853|560254936|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
155222607|NCT00489853|560254937|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
155222608|NCT00489853|560254935|FG000|Wash-out Period 1|Adverse Event|0|||
155222609|NCT00489853|560254936|FG001|Wash-out Period 1|Adverse Event|1|||
155222610|NCT00489853|560254937|FG002|Wash-out Period 1|Adverse Event|1|||
155222611|NCT00489853|560254935|FG000|Wash-out Period 1|Protocol Violation|0|||
155222612|NCT00489853|560254936|FG001|Wash-out Period 1|Protocol Violation|1|||
155222613|NCT00489853|560254937|FG002|Wash-out Period 1|Protocol Violation|1|||
155222614|NCT00489853|560254935|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
155222615|NCT00489853|560254936|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
155222616|NCT00489853|560254937|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
155222617|NCT00489853|560254935|FG000|Wash-out Period 2|Adverse Event|1|||
155222618|NCT00489853|560254936|FG001|Wash-out Period 2|Adverse Event|1|||
155222619|NCT00489853|560254937|FG002|Wash-out Period 2|Adverse Event|0|||
155222620|NCT00489853|560254935|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
155222621|NCT00489853|560254936|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
155222622|NCT00489853|560254937|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
155222623|NCT00489853|560254935|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
155222624|NCT00489853|560254936|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
155222625|NCT00489853|560254937|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
155222626|NCT05083442|560254938|FG000|Overall Study|Lost to Follow-up|1|||
155222627|NCT05083442|560254939|FG001|Overall Study|Lost to Follow-up|0|||
155222628|NCT05083442|560254938|FG000|Overall Study|Lack of Efficacy|0|||
155222629|NCT05083442|560254939|FG001|Overall Study|Lack of Efficacy|1|||
155222630|NCT05083442|560254938|FG000|Overall Study|Withdrawal by Subject|1|||
155222631|NCT05083442|560254939|FG001|Overall Study|Withdrawal by Subject|3|||
155222632|NCT05083442|560254938|FG000|Overall Study|scheduling difficulties|1|||
155222633|NCT05083442|560254939|FG001|Overall Study|scheduling difficulties|2|||
155222634|NCT03873987|560254947|FG000|Overall Study|Adverse Event|1|||
155222635|NCT03873987|560254948|FG001|Overall Study|Adverse Event|0|||
155222636|NCT03873987|560254947|FG000|Overall Study|staff was unable to start a new IV line|1|||
155222637|NCT03873987|560254948|FG001|Overall Study|staff was unable to start a new IV line|0|||
155222638|NCT03873987|560254947|FG000|Overall Study|Lost to Follow-up|0|||
155222639|NCT03873987|560254948|FG001|Overall Study|Lost to Follow-up|1|||
155222640|NCT00004888|560254949|FG000|Overall Study|Adverse Event|5|||
155222641|NCT00004888|560254950|FG001|Overall Study|Adverse Event|10|||
155222642|NCT00004888|560254949|FG000|Overall Study|Withdrawal by Subject|0|||
155222643|NCT00004888|560254950|FG001|Overall Study|Withdrawal by Subject|3|||
155222644|NCT00004888|560254949|FG000|Overall Study|Physician Decision|1|||
155222645|NCT00004888|560254950|FG001|Overall Study|Physician Decision|1|||
155222646|NCT00004888|560254949|FG000|Overall Study|Progressive Disease|4|||
155222647|NCT00004888|560254950|FG001|Overall Study|Progressive Disease|9|||
155222648|NCT00004888|560254949|FG000|Overall Study|Death without progressive disease|0|||
155222649|NCT00004888|560254950|FG001|Overall Study|Death without progressive disease|1|||
155222650|NCT00004888|560254949|FG000|Overall Study|Toxic death|1|||
155222651|NCT00004888|560254950|FG001|Overall Study|Toxic death|0|||
155222652|NCT00136084|560254951|FG000|Overall Study|Death|12|||
155222653|NCT00136084|560254952|FG001|Overall Study|Death|5|||
155491442|NCT01590810|561223557|FG004|Overall Study|Physician Decision|0|||
155222654|NCT00136084|560254951|FG000|Overall Study|Unacceptable toxicity|8|||
155222655|NCT00136084|560254952|FG001|Overall Study|Unacceptable toxicity|11|||
155222656|NCT00136084|560254951|FG000|Overall Study|Relapse|20|||
155222657|NCT00136084|560254952|FG001|Overall Study|Relapse|23|||
155222658|NCT00136084|560254951|FG000|Overall Study|Lost to Follow-up|2|||
155222659|NCT00136084|560254952|FG001|Overall Study|Lost to Follow-up|0|||
155222660|NCT00136084|560254951|FG000|Overall Study|No Response|1|||
155222661|NCT00136084|560254952|FG001|Overall Study|No Response|2|||
155222662|NCT00136084|560254951|FG000|Overall Study|Withdrawal by Subject|5|||
155222663|NCT00136084|560254952|FG001|Overall Study|Withdrawal by Subject|1|||
155222664|NCT02579265|560254953|FG000|Overall Study|Weaned off earlier than 28 days|44|||
155222665|NCT02579265|560254954|FG001|Overall Study|Weaned off earlier than 28 days|43|||
155222666|NCT02579265|560254953|FG000|Overall Study|Adverse Event|2|||
155222667|NCT02579265|560254954|FG001|Overall Study|Adverse Event|0|||
155222668|NCT02579265|560254953|FG000|Overall Study|Any other reason not specified|0|||
155222669|NCT02579265|560254954|FG001|Overall Study|Any other reason not specified|2|||
155222670|NCT02579265|560254953|FG000|Overall Study|Withdrawal by Subject|2|||
155222671|NCT02579265|560254954|FG001|Overall Study|Withdrawal by Subject|0|||
155222672|NCT02579265|560254953|FG000|Overall Study|Physician Decision|1|||
155222673|NCT02579265|560254954|FG001|Overall Study|Physician Decision|0|||
155222674|NCT02579265|560254953|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
155222675|NCT02579265|560254954|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
155222676|NCT02174848|560254955|FG000|Overall Study|Adverse Event|2|||
155222677|NCT02174848|560254956|FG001|Overall Study|Adverse Event|1|||
155222678|NCT02174848|560254955|FG000|Overall Study|Withdrawal by Subject|3|||
155222679|NCT02174848|560254956|FG001|Overall Study|Withdrawal by Subject|3|||
155222680|NCT02174848|560254955|FG000|Overall Study|Lost to Follow-up|0|||
155222681|NCT02174848|560254956|FG001|Overall Study|Lost to Follow-up|1|||
155222682|NCT02174848|560254955|FG000|Overall Study|Worsening of disease|1|||
155222683|NCT02174848|560254956|FG001|Overall Study|Worsening of disease|1|||
155222684|NCT02174848|560254955|FG000|Overall Study|Unable to comply with study requirements|1|||
155222685|NCT02174848|560254956|FG001|Overall Study|Unable to comply with study requirements|0|||
155222686|NCT02520011|560254958|FG000|Overall Study|Adverse Event|0|||
155222687|NCT02520011|560254959|FG001|Overall Study|Adverse Event|1|||
155222688|NCT02520011|560254960|FG002|Overall Study|Adverse Event|2|||
155222689|NCT02520011|560254958|FG000|Overall Study|Death|0|||
155222690|NCT02520011|560254959|FG001|Overall Study|Death|8|||
155222691|NCT02520011|560254960|FG002|Overall Study|Death|1|||
155222692|NCT02520011|560254958|FG000|Overall Study|Lack of Efficacy|4|||
155222693|NCT02520011|560254959|FG001|Overall Study|Lack of Efficacy|26|||
155222694|NCT02520011|560254960|FG002|Overall Study|Lack of Efficacy|4|||
155222695|NCT02520011|560254958|FG000|Overall Study|Physician Decision|0|||
155222696|NCT02520011|560254959|FG001|Overall Study|Physician Decision|2|||
155222697|NCT02520011|560254960|FG002|Overall Study|Physician Decision|0|||
155222698|NCT02520011|560254958|FG000|Overall Study|Withdrawal by Subject|1|||
155222699|NCT02520011|560254959|FG001|Overall Study|Withdrawal by Subject|3|||
155222700|NCT02520011|560254960|FG002|Overall Study|Withdrawal by Subject|0|||
155222701|NCT02520011|560254958|FG000|Overall Study|Protocol Deviation|0|||
155222702|NCT02520011|560254959|FG001|Overall Study|Protocol Deviation|1|||
155222703|NCT02520011|560254960|FG002|Overall Study|Protocol Deviation|0|||
155222704|NCT02520011|560254958|FG000|Overall Study|Patient went to hospice|0|||
155222705|NCT02520011|560254959|FG001|Overall Study|Patient went to hospice|1|||
155222706|NCT02520011|560254960|FG002|Overall Study|Patient went to hospice|0|||
155222707|NCT02520011|560254958|FG000|Overall Study|Progressive disease following response|0|||
155222708|NCT02520011|560254959|FG001|Overall Study|Progressive disease following response|4|||
155222709|NCT02520011|560254960|FG002|Overall Study|Progressive disease following response|2|||
155222710|NCT00644969|560254961|FG000|Treatment Phase|Randomized, not treated|1|||
155222711|NCT00644969|560254962|FG001|Treatment Phase|Randomized, not treated|0|||
155222712|NCT00644969|560254961|FG000|Treatment Phase|Adverse Event|3|||
155222713|NCT00644969|560254962|FG001|Treatment Phase|Adverse Event|0|||
155222714|NCT00644969|560254961|FG000|Treatment Phase|Withdrawal by Subject|4|||
155222715|NCT00644969|560254962|FG001|Treatment Phase|Withdrawal by Subject|0|||
155222716|NCT00644969|560254961|FG000|Treatment Phase|Lost to Follow-up|2|||
155222717|NCT00644969|560254962|FG001|Treatment Phase|Lost to Follow-up|2|||
155222718|NCT00644969|560254961|FG000|Treatment Phase|Other|4|||
155222719|NCT00644969|560254962|FG001|Treatment Phase|Other|1|||
155222720|NCT00644969|560254961|FG000|Post Treatment Phase|Death|1|||
155222721|NCT00644969|560254962|FG001|Post Treatment Phase|Death|0|||
155222722|NCT00644969|560254961|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
155222723|NCT00644969|560254962|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
155222724|NCT00644969|560254961|FG000|Post Treatment Phase|Lost to Follow-up|4|||
155222725|NCT00644969|560254962|FG001|Post Treatment Phase|Lost to Follow-up|1|||
155222726|NCT00644969|560254961|FG000|Post Treatment Phase|Other|1|||
155222727|NCT00644969|560254962|FG001|Post Treatment Phase|Other|0|||
155222728|NCT02449239|560254963|FG000|Induction Phase|Lack of Efficacy|64|||
155222729|NCT02449239|560254963|FG000|Induction Phase|Adverse Event|1|||
155222730|NCT02449239|560254963|FG000|Induction Phase|Lost to Follow-up|1|||
155222731|NCT02449239|560254963|FG000|Induction Phase|Protocol Violation|1|||
155222732|NCT02449239|560254963|FG000|Induction Phase|Physician Decision|1|||
155222733|NCT02449239|560254963|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
155222734|NCT02449239|560254963|FG000|Induction Phase|Withdrawal by Subject|1|||
155222735|NCT02449239|560254963|FG000|Maintenance Month 3|Lack of Efficacy|14|||
155222736|NCT02449239|560254963|FG000|Maintenance Month 6|Lack of Efficacy|10|||
155222737|NCT02449239|560254963|FG000|Maintenance Month 6|Adverse Event|2|||
155222738|NCT02449239|560254963|FG000|Maintenance Month 6|Physician Decision|1|||
155222739|NCT02449239|560254963|FG000|Maintenance Month 9|Lack of Efficacy|2|||
155222740|NCT02449239|560254963|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
155222741|NCT02449239|560254963|FG000|Maintenance Month 12|Lack of Efficacy|5|||
155222742|NCT02449239|560254963|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
155222743|NCT02449239|560254963|FG000|Maintenance Month 12|Subject moved from area|1|||
155222744|NCT02449239|560254963|FG000|Maintenance Month 15|Lack of Efficacy|1|||
155222745|NCT02449239|560254963|FG000|Maintenance Month 21|Lack of Efficacy|1|||
155222746|NCT02449239|560254963|FG000|Maintenance Month 21|Sponsor decision|1|||
155222747|NCT03239470|560254964|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
155222748|NCT03239470|560254965|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
155222749|NCT01023581|560254966|FG000|Overall Study|Adverse Event|4|||
155222750|NCT01023581|560254967|FG001|Overall Study|Adverse Event|4|||
155222751|NCT01023581|560254968|FG002|Overall Study|Adverse Event|7|||
155222752|NCT01023581|560254969|FG003|Overall Study|Adverse Event|3|||
155222753|NCT01023581|560254970|FG004|Overall Study|Adverse Event|2|||
155222754|NCT01023581|560254971|FG005|Overall Study|Adverse Event|5|||
155222755|NCT01023581|560254972|FG006|Overall Study|Adverse Event|11|||
155222756|NCT01023581|560254966|FG000|Overall Study|Major protocol deviation|2|||
155222757|NCT01023581|560254967|FG001|Overall Study|Major protocol deviation|0|||
155222758|NCT01023581|560254968|FG002|Overall Study|Major protocol deviation|3|||
155222759|NCT01023581|560254969|FG003|Overall Study|Major protocol deviation|0|||
155222760|NCT01023581|560254970|FG004|Overall Study|Major protocol deviation|0|||
155222761|NCT01023581|560254971|FG005|Overall Study|Major protocol deviation|0|||
155222762|NCT01023581|560254972|FG006|Overall Study|Major protocol deviation|0|||
155222763|NCT01023581|560254966|FG000|Overall Study|Lost to Follow-up|4|||
155222764|NCT01023581|560254967|FG001|Overall Study|Lost to Follow-up|8|||
155222765|NCT01023581|560254968|FG002|Overall Study|Lost to Follow-up|7|||
155222766|NCT01023581|560254969|FG003|Overall Study|Lost to Follow-up|2|||
155222767|NCT01023581|560254970|FG004|Overall Study|Lost to Follow-up|5|||
155222768|NCT01023581|560254971|FG005|Overall Study|Lost to Follow-up|2|||
155222769|NCT01023581|560254972|FG006|Overall Study|Lost to Follow-up|2|||
155222770|NCT01023581|560254966|FG000|Overall Study|Withdrawal by Subject|13|||
155222771|NCT01023581|560254967|FG001|Overall Study|Withdrawal by Subject|8|||
155222772|NCT01023581|560254968|FG002|Overall Study|Withdrawal by Subject|16|||
155222773|NCT01023581|560254969|FG003|Overall Study|Withdrawal by Subject|10|||
155222774|NCT01023581|560254970|FG004|Overall Study|Withdrawal by Subject|6|||
155222775|NCT01023581|560254971|FG005|Overall Study|Withdrawal by Subject|8|||
155222776|NCT01023581|560254972|FG006|Overall Study|Withdrawal by Subject|5|||
155222777|NCT01023581|560254966|FG000|Overall Study|Pregnancy|0|||
155222778|NCT01023581|560254967|FG001|Overall Study|Pregnancy|0|||
155222779|NCT01023581|560254968|FG002|Overall Study|Pregnancy|0|||
155222780|NCT01023581|560254969|FG003|Overall Study|Pregnancy|2|||
155222781|NCT01023581|560254970|FG004|Overall Study|Pregnancy|0|||
155222782|NCT01023581|560254971|FG005|Overall Study|Pregnancy|1|||
155222783|NCT01023581|560254972|FG006|Overall Study|Pregnancy|0|||
155222784|NCT01023581|560254966|FG000|Overall Study|Lack of Efficacy|9|||
155222785|NCT01023581|560254967|FG001|Overall Study|Lack of Efficacy|3|||
155222786|NCT01023581|560254968|FG002|Overall Study|Lack of Efficacy|6|||
155222787|NCT01023581|560254969|FG003|Overall Study|Lack of Efficacy|2|||
155222788|NCT01023581|560254970|FG004|Overall Study|Lack of Efficacy|1|||
155222789|NCT01023581|560254971|FG005|Overall Study|Lack of Efficacy|2|||
155222790|NCT01023581|560254972|FG006|Overall Study|Lack of Efficacy|1|||
155222791|NCT01023581|560254966|FG000|Overall Study|Physician Decision|2|||
155222792|NCT01023581|560254967|FG001|Overall Study|Physician Decision|0|||
155222793|NCT01023581|560254968|FG002|Overall Study|Physician Decision|2|||
155222794|NCT01023581|560254969|FG003|Overall Study|Physician Decision|1|||
155222795|NCT01023581|560254970|FG004|Overall Study|Physician Decision|1|||
155222796|NCT01023581|560254971|FG005|Overall Study|Physician Decision|1|||
155222797|NCT01023581|560254972|FG006|Overall Study|Physician Decision|1|||
155222798|NCT01023581|560254966|FG000|Overall Study|Other|1|||
155222799|NCT01023581|560254967|FG001|Overall Study|Other|0|||
155222800|NCT01023581|560254968|FG002|Overall Study|Other|1|||
155222801|NCT01023581|560254969|FG003|Overall Study|Other|0|||
155222802|NCT01023581|560254970|FG004|Overall Study|Other|1|||
155222803|NCT01023581|560254971|FG005|Overall Study|Other|0|||
155222804|NCT01023581|560254972|FG006|Overall Study|Other|0|||
155222805|NCT01176292|560254976|FG000|Overall Study|Lost to Follow-up|2|||
155222806|NCT01176292|560254977|FG001|Overall Study|Lost to Follow-up|4|||
155491443|NCT01791543|561223560|FG000|Overall Study|Lost to Follow-up|1|||
155491444|NCT01791543|561223560|FG000|Overall Study|Adverse Event|1|||
155222807|NCT01176292|560254976|FG000|Overall Study|Adverse Event|1|||
155222808|NCT01176292|560254977|FG001|Overall Study|Adverse Event|1|||
155222809|NCT01176292|560254976|FG000|Overall Study|Physician Decision|0|||
155222810|NCT01176292|560254977|FG001|Overall Study|Physician Decision|2|||
155222811|NCT01176292|560254976|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
155222812|NCT01176292|560254977|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
155222813|NCT00997503|560254978|FG000|Overall Study|Death|53|||
155222814|NCT00997503|560254978|FG000|Overall Study|Withdrawal by Subject|76|||
155222815|NCT00997503|560254978|FG000|Overall Study|Lost to Follow-up|33|||
155222816|NCT00997503|560254978|FG000|Overall Study|Adverse Event|3|||
155222817|NCT00997503|560254978|FG000|Overall Study|Physician Decision|10|||
155222818|NCT00997503|560254978|FG000|Overall Study|Missed 12-month follow-up|85|||
155222819|NCT00997503|560254978|FG000|Overall Study|Other reason|13|||
155222820|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
155222821|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
155222822|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
155222823|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
155222824|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
155222825|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
155222826|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
155222827|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
155222828|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
155222829|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
155222830|NCT00380393|560254979|FG000|Month 14|Withdrawal by Subject|9|||
155222831|NCT00380393|560254980|FG001|Month 14|Withdrawal by Subject|7|||
155222832|NCT00380393|560254979|FG000|Month 14|Death|1|||
155222833|NCT00380393|560254980|FG001|Month 14|Death|0|||
155222834|NCT00380393|560254979|FG000|Month 14|Lost to Follow-up|0|||
155222835|NCT00380393|560254980|FG001|Month 14|Lost to Follow-up|1|||
155222836|NCT00380393|560254979|FG000|Month 14|Migrated/moved from study area|39|||
155222837|NCT00380393|560254980|FG001|Month 14|Migrated/moved from study area|42|||
155222838|NCT00380393|560254979|FG000|Month 14|Protocol Violation|2|||
155222839|NCT00380393|560254980|FG001|Month 14|Protocol Violation|0|||
155222840|NCT00380393|560254979|FG000|Month 14|Others|6|||
155222841|NCT00380393|560254980|FG001|Month 14|Others|6|||
155222842|NCT01933048|560254981|FG000|Overall Study|Lost to Follow-up|15|||
155222843|NCT01933048|560254982|FG001|Overall Study|Lost to Follow-up|18|||
155222844|NCT01933048|560254981|FG000|Overall Study|personal reasons|1|||
155222845|NCT01933048|560254982|FG001|Overall Study|personal reasons|1|||
155222846|NCT01933048|560254981|FG000|Overall Study|Protocol Violation|7|||
155222847|NCT01933048|560254982|FG001|Overall Study|Protocol Violation|8|||
155222848|NCT01933048|560254981|FG000|Overall Study|Physician Decision|1|||
155222849|NCT01933048|560254982|FG001|Overall Study|Physician Decision|0|||
155222850|NCT01933048|560254981|FG000|Overall Study|unknown reasons|1|||
155222851|NCT01933048|560254982|FG001|Overall Study|unknown reasons|1|||
155222852|NCT02780804|560254983|FG000|Overall Study|Death|1|||
155222853|NCT02780804|560254984|FG001|Overall Study|Death|0|||
155222854|NCT02780804|560254985|FG002|Overall Study|Death|0|||
155222855|NCT02780804|560254983|FG000|Overall Study|Lack of Efficacy|5|||
155222856|NCT02780804|560254984|FG001|Overall Study|Lack of Efficacy|8|||
155222857|NCT02780804|560254985|FG002|Overall Study|Lack of Efficacy|4|||
155222858|NCT02780804|560254983|FG000|Overall Study|Physician Decision|0|||
155222859|NCT02780804|560254984|FG001|Overall Study|Physician Decision|0|||
155222860|NCT02780804|560254985|FG002|Overall Study|Physician Decision|2|||
155222861|NCT02780804|560254983|FG000|Overall Study|Withdrawal by Subject|0|||
155222862|NCT02780804|560254984|FG001|Overall Study|Withdrawal by Subject|1|||
155222863|NCT02780804|560254985|FG002|Overall Study|Withdrawal by Subject|0|||
155222864|NCT02476968|560254986|FG000|Overall Study|Other|0|||
155222865|NCT02476968|560254987|FG001|Overall Study|Other|2|||
155222866|NCT02476968|560254988|FG002|Overall Study|Other|0|||
155222867|NCT02476968|560254986|FG000|Overall Study|Lost to Follow-up|10|||
155222868|NCT02476968|560254987|FG001|Overall Study|Lost to Follow-up|0|||
155222869|NCT02476968|560254988|FG002|Overall Study|Lost to Follow-up|1|||
155222870|NCT02476968|560254986|FG000|Overall Study|Death|48|||
155222871|NCT02476968|560254987|FG001|Overall Study|Death|8|||
155222872|NCT02476968|560254988|FG002|Overall Study|Death|1|||
155222873|NCT02476968|560254986|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155222874|NCT02476968|560254987|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155222875|NCT02476968|560254988|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155222876|NCT02476968|560254986|FG000|Overall Study|Patient decision|37|||
155222877|NCT02476968|560254987|FG001|Overall Study|Patient decision|8|||
155222878|NCT02476968|560254988|FG002|Overall Study|Patient decision|0|||
155222879|NCT03897179|560254995|FG000|Overall Study|Withdrawal by Subject|1|||
155222880|NCT01085097|560254999|FG000|Overall Study|Adverse Event|0|||
155222881|NCT01085097|560255000|FG001|Overall Study|Adverse Event|0|||
155222882|NCT01085097|560255001|FG002|Overall Study|Adverse Event|2|||
155491445|NCT01740297|561225386|FG000|Overall Study|Withdrawal by Subject|4|||
155222883|NCT01085097|560254999|FG000|Overall Study|Treatment failure|2|||
155222884|NCT01085097|560255000|FG001|Overall Study|Treatment failure|0|||
155222885|NCT01085097|560255001|FG002|Overall Study|Treatment failure|0|||
155222886|NCT01737047|560255004|FG000|Overall Study|Death|10|||
155222887|NCT01737047|560255005|FG001|Overall Study|Death|0|||
155222888|NCT01737047|560255006|FG002|Overall Study|Death|1|||
155222889|NCT01737047|560255004|FG000|Overall Study|Withdrawal by Subject|17|||
155222890|NCT01737047|560255005|FG001|Overall Study|Withdrawal by Subject|11|||
155222891|NCT01737047|560255006|FG002|Overall Study|Withdrawal by Subject|4|||
155222892|NCT06049043|560255007|FG000|Overall Study|Lost to Follow-up|11|||
155222893|NCT06049043|560255008|FG001|Overall Study|Lost to Follow-up|9|||
155222894|NCT03089606|560255009|FG000|Overall Study|Progression after Cycle 1|1|||
155222895|NCT00335972|560255010|FG000|Overall Study|not given treatments|0|||
155222896|NCT00335972|560255011|FG001|Overall Study|not given treatments|3|||
155222897|NCT02140567|560255014|FG000|Overall Study|Problems with recording equipment|6|||
155222898|NCT02802592|560255016|FG000|Overall Study|Study terminated due to loss of funding|4|||
155222899|NCT02882854|560255017|FG000|Overall Study|Lost to Follow-up|1|||
155222900|NCT02882854|560255018|FG001|Overall Study|Lost to Follow-up|2|||
155222901|NCT02882854|560255017|FG000|Overall Study|Physician Decision|0|||
155222902|NCT02882854|560255018|FG001|Overall Study|Physician Decision|1|||
155222903|NCT01358357|560255021|FG000|Open Label Phase|Adverse Event|0|||
155222904|NCT01358357|560255022|FG001|Open Label Phase|Adverse Event|0|||
155222905|NCT01358357|560255023|FG002|Open Label Phase|Adverse Event|59|||
155222906|NCT01358357|560255021|FG000|Open Label Phase|Lack of Efficacy|0|||
155222907|NCT01358357|560255022|FG001|Open Label Phase|Lack of Efficacy|0|||
155222908|NCT01358357|560255023|FG002|Open Label Phase|Lack of Efficacy|107|||
155222909|NCT01358357|560255021|FG000|Open Label Phase|Lost to Follow-up|0|||
155222910|NCT01358357|560255022|FG001|Open Label Phase|Lost to Follow-up|0|||
155222911|NCT01358357|560255023|FG002|Open Label Phase|Lost to Follow-up|76|||
155222912|NCT01358357|560255021|FG000|Open Label Phase|Protocol Violation|0|||
155222913|NCT01358357|560255022|FG001|Open Label Phase|Protocol Violation|0|||
155222914|NCT01358357|560255023|FG002|Open Label Phase|Protocol Violation|45|||
155222915|NCT01358357|560255021|FG000|Open Label Phase|Withdrawal by Subject|0|||
155222916|NCT01358357|560255022|FG001|Open Label Phase|Withdrawal by Subject|0|||
155222917|NCT01358357|560255023|FG002|Open Label Phase|Withdrawal by Subject|112|||
155222918|NCT01358357|560255021|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
155222919|NCT01358357|560255022|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
155222920|NCT01358357|560255023|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
155222921|NCT01358357|560255021|FG000|Open Label Phase|Terminated at study completion|0|||
155222922|NCT01358357|560255022|FG001|Open Label Phase|Terminated at study completion|0|||
155222923|NCT01358357|560255023|FG002|Open Label Phase|Terminated at study completion|5|||
155222924|NCT01358357|560255021|FG000|Open Label Phase|Mood episode|0|||
155222925|NCT01358357|560255022|FG001|Open Label Phase|Mood episode|0|||
155222926|NCT01358357|560255023|FG002|Open Label Phase|Mood episode|42|||
155222927|NCT01358357|560255021|FG000|Double-Blind Phase|Adverse Event|8|||
155222928|NCT01358357|560255022|FG001|Double-Blind Phase|Adverse Event|5|||
155222929|NCT01358357|560255023|FG002|Double-Blind Phase|Adverse Event|0|||
155222930|NCT01358357|560255021|FG000|Double-Blind Phase|Lost to Follow-up|5|||
155222931|NCT01358357|560255022|FG001|Double-Blind Phase|Lost to Follow-up|7|||
155222932|NCT01358357|560255023|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155222933|NCT01358357|560255021|FG000|Double-Blind Phase|Protocol Violation|1|||
155222934|NCT01358357|560255022|FG001|Double-Blind Phase|Protocol Violation|11|||
155222935|NCT01358357|560255023|FG002|Double-Blind Phase|Protocol Violation|0|||
155222936|NCT01358357|560255021|FG000|Double-Blind Phase|Protocol Violation|16|||
155222937|NCT01358357|560255022|FG001|Double-Blind Phase|Protocol Violation|12|||
155222938|NCT01358357|560255023|FG002|Double-Blind Phase|Protocol Violation|0|||
155222939|NCT01358357|560255021|FG000|Double-Blind Phase|Terminated at study completion|2|||
155222940|NCT01358357|560255022|FG001|Double-Blind Phase|Terminated at study completion|0|||
155222941|NCT01358357|560255023|FG002|Double-Blind Phase|Terminated at study completion|0|||
155222942|NCT01358357|560255021|FG000|Double-Blind Phase|Recurrence of mood event|48|||
155222943|NCT01358357|560255022|FG001|Double-Blind Phase|Recurrence of mood event|64|||
155222944|NCT01358357|560255023|FG002|Double-Blind Phase|Recurrence of mood event|0|||
155222945|NCT01358357|560255021|FG000|Double-Blind Phase|Administrative|0|||
155222946|NCT01358357|560255022|FG001|Double-Blind Phase|Administrative|1|||
155222947|NCT01358357|560255023|FG002|Double-Blind Phase|Administrative|0|||
155222948|NCT01826487|560255024|FG000|Overall Study|Adverse Event|1|||
155222949|NCT01826487|560255025|FG001|Overall Study|Adverse Event|1|||
155222950|NCT01826487|560255024|FG000|Overall Study|Lost to Follow-up|1|||
155222951|NCT01826487|560255025|FG001|Overall Study|Lost to Follow-up|0|||
155222952|NCT01826487|560255024|FG000|Overall Study|Withdrawal by Subject|1|||
155222953|NCT01826487|560255025|FG001|Overall Study|Withdrawal by Subject|3|||
155222954|NCT01826487|560255024|FG000|Overall Study|Protocol Violation|1|||
155222955|NCT01826487|560255025|FG001|Overall Study|Protocol Violation|1|||
155222956|NCT00729183|560255026|FG000|Overall Study|Adverse Event|11|||
155222957|NCT00729183|560255027|FG001|Overall Study|Adverse Event|5|||
155222958|NCT00729183|560255026|FG000|Overall Study|Lack of Efficacy|0|||
155222959|NCT00729183|560255027|FG001|Overall Study|Lack of Efficacy|1|||
155222960|NCT00729183|560255026|FG000|Overall Study|Lost to Follow-up|3|||
155222961|NCT00729183|560255027|FG001|Overall Study|Lost to Follow-up|1|||
155222962|NCT00729183|560255026|FG000|Overall Study|Physician Decision|1|||
155222963|NCT00729183|560255027|FG001|Overall Study|Physician Decision|1|||
155222964|NCT00729183|560255026|FG000|Overall Study|Protocol Violation|1|||
155222965|NCT00729183|560255027|FG001|Overall Study|Protocol Violation|0|||
155222966|NCT00729183|560255026|FG000|Overall Study|Withdrawal by Subject|9|||
155222967|NCT00729183|560255027|FG001|Overall Study|Withdrawal by Subject|7|||
155222968|NCT01359254|560255030|FG000|Overall Study|Death|1|||
155222969|NCT01359254|560255031|FG001|Overall Study|Death|0|||
155222970|NCT04668950|560255036|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
155222971|NCT04668950|560255037|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
155222972|NCT04668950|560255036|FG000|Overall Study|Could not confirm started study medication|15|||
155222973|NCT04668950|560255037|FG001|Overall Study|Could not confirm started study medication|15|||
155222974|NCT04668950|560255036|FG000|Overall Study|Could not confirm baseline status|6|||
155222975|NCT04668950|560255037|FG001|Overall Study|Could not confirm baseline status|2|||
155222976|NCT04668950|560255036|FG000|Overall Study|Drop out and did not start medication|15|||
155222977|NCT04668950|560255037|FG001|Overall Study|Drop out and did not start medication|17|||
155222978|NCT04668950|560255036|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
155222979|NCT04668950|560255037|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
155222980|NCT04668950|560255036|FG000|Overall Study|Other|2|||
155222981|NCT04668950|560255037|FG001|Overall Study|Other|4|||
155222982|NCT01124643|560255040|FG000|Overall Study|Death|1|||
155222983|NCT02028988|560255041|FG000|Overall Study|Withdrawal by Subject|2|||
155222984|NCT01342510|560255044|FG000|Overall Study|Protocol Violation|12|||
155222985|NCT01342510|560255045|FG001|Overall Study|Protocol Violation|6|||
155222986|NCT01342510|560255046|FG002|Overall Study|Protocol Violation|13|||
155222987|NCT01342510|560255047|FG003|Overall Study|Protocol Violation|11|||
155222988|NCT00323115|560255048|FG000|Vaccine Administration|Adverse Event|1|||
155222989|NCT00323115|560255048|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
155222990|NCT04365556|560255049|FG000|Overall Study|No longer eligible due to treatment plan|1|||
155222991|NCT04365556|560255050|FG001|Overall Study|No longer eligible due to treatment plan|0|||
155222992|NCT04365556|560255049|FG000|Overall Study|Lost to Follow-up|3|||
155222993|NCT04365556|560255050|FG001|Overall Study|Lost to Follow-up|2|||
155222994|NCT04439318|560255051|FG000|Overall Study|Ineligible|1|||
155222995|NCT04439318|560255051|FG000|Overall Study|Never Started Treatment|3|||
155222996|NCT04439318|560255051|FG000|Overall Study|Adverse Event|10|||
155222997|NCT04439318|560255051|FG000|Overall Study|Death|2|||
155222998|NCT04439318|560255051|FG000|Overall Study|Disease Progression|25|||
155222999|NCT04439318|560255051|FG000|Overall Study|Other Complicating Disease|2|||
155223000|NCT04439318|560255051|FG000|Overall Study|Withdrawal by Subject|4|||
155223001|NCT04439318|560255051|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
155223002|NCT04439318|560255051|FG000|Overall Study|Non-Compliance|1|||
155223003|NCT04439318|560255051|FG000|Overall Study|Still on Treatment|1|||
155223004|NCT02558790|560256929|FG000|Overall Study|Lost to Follow-up|2|||
155223005|NCT02558790|560256929|FG000|Overall Study|Physician Decision|1|||
155223006|NCT02558790|560256929|FG000|Overall Study|Withdrawal by Subject|1|||
155223007|NCT02558790|560256929|FG000|Overall Study|Screen Fail|3|||
155223008|NCT04476030|560256933|FG000|Overall Study|Withdrawal by Subject|20|||
155223009|NCT04476030|560256934|FG001|Overall Study|Withdrawal by Subject|16|||
155223010|NCT04476030|560256933|FG000|Overall Study|Adverse Event|10|||
155223011|NCT04476030|560256934|FG001|Overall Study|Adverse Event|11|||
155223012|NCT04476030|560256933|FG000|Overall Study|Lost to Follow-up|7|||
155223013|NCT04476030|560256934|FG001|Overall Study|Lost to Follow-up|4|||
155223014|NCT04476030|560256933|FG000|Overall Study|Physician Decision|1|||
155223015|NCT04476030|560256934|FG001|Overall Study|Physician Decision|1|||
155223016|NCT04476030|560256933|FG000|Overall Study|Protocol Deviation|2|||
155223017|NCT04476030|560256934|FG001|Overall Study|Protocol Deviation|0|||
155223018|NCT04476030|560256933|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
155223019|NCT04476030|560256934|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
155223020|NCT04476030|560256933|FG000|Overall Study|Randomized but not Dosed|2|||
155223021|NCT04476030|560256934|FG001|Overall Study|Randomized but not Dosed|8|||
155223022|NCT02042924|560256935|FG000|Overall Study|Early Death|1|||
155223023|NCT04920123|560256940|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155223024|NCT04920123|560256941|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155223025|NCT04920123|560256942|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155223026|NCT00278954|560256946|FG000|Overall Study|Adverse Event|3|||
155223027|NCT00278954|560256946|FG000|Overall Study|Lost to Follow-up|1|||
155223028|NCT00278954|560256946|FG000|Overall Study|Withdrawal by Subject|1|||
155223029|NCT02211131|560256950|FG000|Overall Study|Death|26|||
155223030|NCT02211131|560256951|FG001|Overall Study|Death|16|||
155223031|NCT02211131|560256950|FG000|Overall Study|Lost to Follow-up|4|||
155223032|NCT02211131|560256951|FG001|Overall Study|Lost to Follow-up|3|||
155223033|NCT02211131|560256950|FG000|Overall Study|Decision by Sponsor|1|||
155223034|NCT02211131|560256951|FG001|Overall Study|Decision by Sponsor|1|||
155223035|NCT02211131|560256950|FG000|Overall Study|Withdrawal by Subject|3|||
155223036|NCT02211131|560256951|FG001|Overall Study|Withdrawal by Subject|8|||
155223037|NCT05664490|560256952|FG000|Overall Study|Withdrawal by Subject|0|||
155223038|NCT05664490|560256953|FG001|Overall Study|Withdrawal by Subject|1|||
155223039|NCT05664490|560256952|FG000|Overall Study|Lost to Follow-up|14|||
155223040|NCT05664490|560256953|FG001|Overall Study|Lost to Follow-up|22|||
155223041|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
155223042|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
155223043|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
155223044|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
155223045|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
155223046|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
155223047|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
155223048|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
155223049|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
155223050|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
155223051|NCT01990495|560256959|FG000|Overall Study|Physician Decision|5|||
155223052|NCT01990495|560256960|FG001|Overall Study|Physician Decision|4|||
155223053|NCT03412084|560256961|FG000|Overall Study|Withdrawal by Subject|2|||
155223054|NCT03412084|560256962|FG001|Overall Study|Withdrawal by Subject|0|||
155223055|NCT03412084|560256961|FG000|Overall Study|Participant moved|1|||
155223056|NCT03412084|560256962|FG001|Overall Study|Participant moved|0|||
155223057|NCT03412084|560256961|FG000|Overall Study|Lost to Follow-up|1|||
155223058|NCT03412084|560256962|FG001|Overall Study|Lost to Follow-up|1|||
155223059|NCT01928862|560256968|FG000|Overall Study|Lost to Follow-up|1|||
155223060|NCT01928862|560256969|FG001|Overall Study|Lost to Follow-up|0|||
155223061|NCT01928862|560256970|FG002|Overall Study|Lost to Follow-up|0|||
155223062|NCT01928862|560256971|FG003|Overall Study|Lost to Follow-up|0|||
155223063|NCT01928862|560256972|FG004|Overall Study|Lost to Follow-up|1|||
155223064|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
155223065|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
155223066|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
155223067|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
155223068|NCT01478321|560256973|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
155223069|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
155223070|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
155223071|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
155223072|NCT00314574|560256978|FG000|Overall Study|Death|3|||
155223073|NCT00314574|560256979|FG001|Overall Study|Death|0|||
155223074|NCT00314574|560256978|FG000|Overall Study|Adverse Event|11|||
155223075|NCT00314574|560256979|FG001|Overall Study|Adverse Event|16|||
155223076|NCT00314574|560256978|FG000|Overall Study|Lost to Follow-up|19|||
155223077|NCT00314574|560256979|FG001|Overall Study|Lost to Follow-up|25|||
155223078|NCT00314574|560256978|FG000|Overall Study|Withdrawal by Subject|33|||
155223079|NCT00314574|560256979|FG001|Overall Study|Withdrawal by Subject|22|||
155223080|NCT00314574|560256978|FG000|Overall Study|Physician Decision|22|||
155223081|NCT00314574|560256979|FG001|Overall Study|Physician Decision|15|||
155223082|NCT00314574|560256978|FG000|Overall Study|Pregnancy|6|||
155223083|NCT00314574|560256979|FG001|Overall Study|Pregnancy|4|||
155223084|NCT00314574|560256978|FG000|Overall Study|Data unknown at database lock|0|||
155223085|NCT00314574|560256979|FG001|Overall Study|Data unknown at database lock|1|||
155223086|NCT02053753|560256984|FG000|Overall Study|Withdrawal by Subject|2|||
155223087|NCT02053753|560256985|FG001|Overall Study|Withdrawal by Subject|4|||
155223088|NCT02053753|560256984|FG000|Overall Study|Decision by Sponsor|1|||
155223089|NCT02053753|560256985|FG001|Overall Study|Decision by Sponsor|1|||
155223090|NCT02053753|560256984|FG000|Overall Study|Lost to Follow-up|4|||
155223091|NCT02053753|560256985|FG001|Overall Study|Lost to Follow-up|3|||
155223092|NCT00449956|560256986|FG000|Overall Study|Adverse Event|7|||
155223093|NCT00449956|560256987|FG001|Overall Study|Adverse Event|1|||
155223094|NCT00449956|560256988|FG002|Overall Study|Adverse Event|6|||
155223095|NCT00449956|560256986|FG000|Overall Study|Lack of Efficacy|0|||
155223096|NCT00449956|560256987|FG001|Overall Study|Lack of Efficacy|0|||
155223097|NCT00449956|560256988|FG002|Overall Study|Lack of Efficacy|1|||
155223098|NCT00449956|560256986|FG000|Overall Study|Protocol Violation|1|||
155223099|NCT00449956|560256987|FG001|Overall Study|Protocol Violation|1|||
155223100|NCT00449956|560256988|FG002|Overall Study|Protocol Violation|1|||
155223101|NCT00449956|560256986|FG000|Overall Study|Withdrawal by Subject|0|||
155223102|NCT00449956|560256987|FG001|Overall Study|Withdrawal by Subject|1|||
155223103|NCT00449956|560256988|FG002|Overall Study|Withdrawal by Subject|0|||
155223104|NCT00449956|560256986|FG000|Overall Study|Physician Decision|2|||
155223105|NCT00449956|560256987|FG001|Overall Study|Physician Decision|1|||
155223106|NCT00449956|560256988|FG002|Overall Study|Physician Decision|1|||
155223107|NCT02972632|560256997|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155223108|NCT02972632|560256997|FG000|Overall Study|Lost to Follow-up|4|||
155223109|NCT02972632|560256997|FG000|Overall Study|Voluntary Withdrawal|10|||
155223110|NCT01828034|560256998|FG000|Overall Study|Withdrawal by Subject|0|||
155223111|NCT01828034|560256999|FG001|Overall Study|Withdrawal by Subject|0|||
155223112|NCT01828034|560257000|FG002|Overall Study|Withdrawal by Subject|0|||
155223113|NCT01828034|560257001|FG003|Overall Study|Withdrawal by Subject|1|||
155223114|NCT02023151|560257002|FG000|Overall Study|Lost to Follow-up|4|||
155223115|NCT04064294|560257003|FG000|Overall Study|Adverse Event|1|||
155223116|NCT04064294|560257004|FG001|Overall Study|Adverse Event|0|||
155223117|NCT04064294|560257005|FG002|Overall Study|Adverse Event|0|||
155223118|NCT03450707|560257006|FG000|Overall Study|Outside enrollment window|4|||
155223119|NCT03450707|560257007|FG001|Overall Study|Outside enrollment window|1|||
155223120|NCT03450707|560257006|FG000|Overall Study|Death|1|||
155223121|NCT03450707|560257007|FG001|Overall Study|Death|0|||
155223122|NCT03450707|560257006|FG000|Overall Study|Indication for thiamine|1|||
155223123|NCT03450707|560257007|FG001|Overall Study|Indication for thiamine|1|||
155223124|NCT03450707|560257006|FG000|Overall Study|Evidence of traumatic brain injury|1|||
155223125|NCT03450707|560257007|FG001|Overall Study|Evidence of traumatic brain injury|0|||
155223126|NCT03450707|560257006|FG000|Overall Study|Following commands|0|||
155223127|NCT03450707|560257007|FG001|Overall Study|Following commands|3|||
155223128|NCT03450707|560257006|FG000|Overall Study|Lactate < 3.5|0|||
155223129|NCT03450707|560257007|FG001|Overall Study|Lactate < 3.5|2|||
155223130|NCT03450707|560257006|FG000|Overall Study|Rearrest with ECMO|0|||
155223131|NCT03450707|560257007|FG001|Overall Study|Rearrest with ECMO|1|||
155223132|NCT03450707|560257006|FG000|Overall Study|Indication for thiamine + head CT results|0|||
155223133|NCT03450707|560257007|FG001|Overall Study|Indication for thiamine + head CT results|1|||
155223134|NCT03450707|560257006|FG000|Overall Study|Family/patient goals of care|0|||
155223135|NCT03450707|560257007|FG001|Overall Study|Family/patient goals of care|1|||
155223136|NCT01988571|560257008|FG000|Overall Study|Death|3|||
155223137|NCT01988571|560257009|FG001|Overall Study|Death|1|||
155223138|NCT01988571|560257008|FG000|Overall Study|Physician Decision|2|||
155223139|NCT01988571|560257009|FG001|Overall Study|Physician Decision|1|||
155223140|NCT01988571|560257008|FG000|Overall Study|Lost to Follow-up|3|||
155223141|NCT01988571|560257009|FG001|Overall Study|Lost to Follow-up|0|||
155223142|NCT01988571|560257008|FG000|Overall Study|Withdrawal by Subject|31|||
155223143|NCT01988571|560257009|FG001|Overall Study|Withdrawal by Subject|33|||
155223144|NCT00481195|560257013|FG000|Overall Study|Adverse Event|16|||
155223145|NCT00481195|560257014|FG001|Overall Study|Adverse Event|11|||
155223146|NCT00481195|560257013|FG000|Overall Study|Lack of Efficacy|1|||
155223147|NCT00481195|560257014|FG001|Overall Study|Lack of Efficacy|3|||
155223148|NCT00481195|560257013|FG000|Overall Study|Lost to Follow-up|4|||
155223149|NCT00481195|560257014|FG001|Overall Study|Lost to Follow-up|6|||
155223150|NCT00481195|560257013|FG000|Overall Study|Physician Decision|3|||
155223151|NCT00481195|560257014|FG001|Overall Study|Physician Decision|1|||
155223152|NCT00481195|560257013|FG000|Overall Study|Protocol Violation|10|||
155223153|NCT00481195|560257014|FG001|Overall Study|Protocol Violation|7|||
155223154|NCT00481195|560257013|FG000|Overall Study|Withdrawal by Subject|3|||
155223155|NCT00481195|560257014|FG001|Overall Study|Withdrawal by Subject|9|||
155223156|NCT00481195|560257013|FG000|Overall Study|Miscellaneous|2|||
155223157|NCT00481195|560257014|FG001|Overall Study|Miscellaneous|2|||
155223158|NCT02932904|560257022|FG000|Overall Study|Reason not Specified|1|||
155223159|NCT02932904|560257023|FG001|Overall Study|Reason not Specified|0|||
155223160|NCT02932904|560257024|FG002|Overall Study|Reason not Specified|2|||
155223161|NCT02932904|560257025|FG003|Overall Study|Reason not Specified|2|||
155223162|NCT02932904|560257022|FG000|Overall Study|Noncompliance with Study Drug|2|||
155223163|NCT02932904|560257023|FG001|Overall Study|Noncompliance with Study Drug|3|||
155223164|NCT02932904|560257024|FG002|Overall Study|Noncompliance with Study Drug|3|||
155223165|NCT02932904|560257025|FG003|Overall Study|Noncompliance with Study Drug|4|||
155223166|NCT02932904|560257022|FG000|Overall Study|Pregnancy|0|||
155223167|NCT02932904|560257023|FG001|Overall Study|Pregnancy|1|||
155223168|NCT02932904|560257024|FG002|Overall Study|Pregnancy|1|||
155223169|NCT02932904|560257025|FG003|Overall Study|Pregnancy|0|||
155223170|NCT02932904|560257022|FG000|Overall Study|Study Termination|0|||
155223171|NCT02932904|560257023|FG001|Overall Study|Study Termination|1|||
155223172|NCT02932904|560257024|FG002|Overall Study|Study Termination|0|||
155223173|NCT02932904|560257025|FG003|Overall Study|Study Termination|0|||
155223174|NCT02932904|560257022|FG000|Overall Study|Voluntary Withdrawal|2|||
155223175|NCT02932904|560257023|FG001|Overall Study|Voluntary Withdrawal|1|||
155223176|NCT02932904|560257024|FG002|Overall Study|Voluntary Withdrawal|4|||
155223177|NCT02932904|560257025|FG003|Overall Study|Voluntary Withdrawal|2|||
155223178|NCT02932904|560257022|FG000|Overall Study|Lost to Follow-up|5|||
155223179|NCT02932904|560257023|FG001|Overall Study|Lost to Follow-up|3|||
155223180|NCT02932904|560257024|FG002|Overall Study|Lost to Follow-up|6|||
155223181|NCT02932904|560257025|FG003|Overall Study|Lost to Follow-up|0|||
155223182|NCT02932904|560257022|FG000|Overall Study|Significant Protocol Deviation|2|||
155223183|NCT02932904|560257023|FG001|Overall Study|Significant Protocol Deviation|3|||
155223184|NCT02932904|560257024|FG002|Overall Study|Significant Protocol Deviation|6|||
155223185|NCT02932904|560257025|FG003|Overall Study|Significant Protocol Deviation|1|||
155223186|NCT02932904|560257022|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155223187|NCT02932904|560257023|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
155223188|NCT02932904|560257024|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155223189|NCT02932904|560257025|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
155223190|NCT02932904|560257022|FG000|Overall Study|Randomized But Not Treated|1|||
155223191|NCT02932904|560257023|FG001|Overall Study|Randomized But Not Treated|1|||
155223192|NCT02932904|560257024|FG002|Overall Study|Randomized But Not Treated|0|||
155223193|NCT02932904|560257025|FG003|Overall Study|Randomized But Not Treated|2|||
155223194|NCT03144180|560257029|FG000|Overall Study|STAT Delivery|1|||
155223195|NCT03144180|560257030|FG001|Overall Study|STAT Delivery|1|||
155223196|NCT03144180|560257029|FG000|Overall Study|Provider forgot to fill out forms|1|||
155223197|NCT03144180|560257030|FG001|Overall Study|Provider forgot to fill out forms|3|||
155223198|NCT03144180|560257029|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
155223199|NCT03144180|560257030|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
155223200|NCT03144180|560257029|FG000|Overall Study|Scrub tech removed tube cap|0|||
155223201|NCT03144180|560257030|FG001|Overall Study|Scrub tech removed tube cap|1|||
155223202|NCT00337103|560257031|FG000|Overall Study|Progressive Disease|414|||
155223203|NCT00337103|560257032|FG001|Overall Study|Progressive Disease|410|||
155223204|NCT00337103|560257031|FG000|Overall Study|Adverse Event|45|||
155223205|NCT00337103|560257032|FG001|Overall Study|Adverse Event|59|||
155223206|NCT00337103|560257031|FG000|Overall Study|Subject Choice|34|||
155223207|NCT00337103|560257032|FG001|Overall Study|Subject Choice|27|||
155223208|NCT00337103|560257031|FG000|Overall Study|Clinical Progression|27|||
155223209|NCT00337103|560257032|FG001|Overall Study|Clinical Progression|24|||
155223210|NCT00337103|560257031|FG000|Overall Study|Physician Decision|15|||
155223211|NCT00337103|560257032|FG001|Overall Study|Physician Decision|14|||
155223212|NCT00337103|560257031|FG000|Overall Study|Withdrawal by Subject|8|||
155223213|NCT00337103|560257032|FG001|Overall Study|Withdrawal by Subject|5|||
155223214|NCT00337103|560257031|FG000|Overall Study|Other|5|||
155223215|NCT00337103|560257032|FG001|Overall Study|Other|6|||
155223216|NCT00337103|560257031|FG000|Overall Study|Entry Criteria Not Met|4|||
155223217|NCT00337103|560257032|FG001|Overall Study|Entry Criteria Not Met|1|||
155223218|NCT00337103|560257031|FG000|Overall Study|Lost to Follow-up|1|||
155223219|NCT00337103|560257032|FG001|Overall Study|Lost to Follow-up|2|||
155223220|NCT00337103|560257031|FG000|Overall Study|Death|1|||
155223221|NCT00337103|560257032|FG001|Overall Study|Death|0|||
155223222|NCT02016482|560257035|FG000|Period A|Adverse Event|3|||
155223223|NCT02016482|560257036|FG001|Period A|Adverse Event|5|||
155223224|NCT02016482|560257035|FG000|Period A|Withdrawal by Subject|3|||
155223225|NCT02016482|560257036|FG001|Period A|Withdrawal by Subject|4|||
155223226|NCT02016482|560257035|FG000|Period A|Lost to Follow-up|3|||
155223227|NCT02016482|560257036|FG001|Period A|Lost to Follow-up|3|||
155223228|NCT02016482|560257035|FG000|Period A|Lack of Efficacy|2|||
155223229|NCT02016482|560257036|FG001|Period A|Lack of Efficacy|1|||
155223230|NCT02016482|560257035|FG000|Period A|Other|3|||
155223231|NCT02016482|560257036|FG001|Period A|Other|0|||
155223232|NCT02016482|560257035|FG000|Period A|Protocol Violation|0|||
155223233|NCT02016482|560257036|FG001|Period A|Protocol Violation|1|||
155223234|NCT02016482|560257035|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
155223235|NCT02016482|560257036|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
155223236|NCT02016482|560257035|FG000|Period B|Withdrawal by Subject|1|||
155223237|NCT02016482|560257036|FG001|Period B|Withdrawal by Subject|1|||
155223238|NCT02016482|560257035|FG000|Period B|Lost to Follow-up|2|||
155223239|NCT02016482|560257036|FG001|Period B|Lost to Follow-up|0|||
155223240|NCT02016482|560257035|FG000|Period B|Lack of Efficacy|6|||
155223241|NCT02016482|560257036|FG001|Period B|Lack of Efficacy|4|||
155223242|NCT02016482|560257035|FG000|Period B|Other|4|||
155223243|NCT02016482|560257036|FG001|Period B|Other|0|||
155223244|NCT02016482|560257035|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
155223245|NCT02016482|560257036|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
155223246|NCT03387813|560257037|FG000|Overall Study|Death|40|||
155223247|NCT03387813|560257038|FG001|Overall Study|Death|37|||
155223248|NCT03387813|560257039|FG002|Overall Study|Death|190|||
155223249|NCT03387813|560257037|FG000|Overall Study|Withdrawal by Subject|9|||
155223250|NCT03387813|560257038|FG001|Overall Study|Withdrawal by Subject|19|||
155223251|NCT03387813|560257039|FG002|Overall Study|Withdrawal by Subject|32|||
155223252|NCT03387813|560257037|FG000|Overall Study|Lost to Follow-up|3|||
155223253|NCT03387813|560257038|FG001|Overall Study|Lost to Follow-up|9|||
155223254|NCT03387813|560257039|FG002|Overall Study|Lost to Follow-up|15|||
155223255|NCT03387813|560257037|FG000|Overall Study|Non-Compliance|6|||
155223256|NCT03387813|560257038|FG001|Overall Study|Non-Compliance|6|||
155223257|NCT03387813|560257039|FG002|Overall Study|Non-Compliance|31|||
155223258|NCT03387813|560257037|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
155223259|NCT03387813|560257038|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
155223260|NCT03387813|560257039|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
155223261|NCT01289847|560257040|FG000|Overall Study|Patient could not comply with visits|1|||
155223262|NCT02063737|560257054|FG000|Overall Study|Lost to Follow-up|11|||
155223263|NCT02063737|560257055|FG001|Overall Study|Lost to Follow-up|4|||
155223264|NCT00439556|560257058|FG000|Overall Study|Patient was taken off study for non-comp|0|||
155223265|NCT00439556|560257059|FG001|Overall Study|Patient was taken off study for non-comp|1|||
155223266|NCT00439556|560257060|FG002|Overall Study|Patient was taken off study for non-comp|0|||
155223267|NCT03818516|560257061|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
155223268|NCT04372602|560257064|FG000|Overall Study|Withdrawal by Subject|1|||
155223269|NCT04372602|560257065|FG001|Overall Study|Withdrawal by Subject|1|||
155223270|NCT04372602|560257064|FG000|Overall Study|Adverse Event|0|||
155223271|NCT04372602|560257065|FG001|Overall Study|Adverse Event|1|||
155223272|NCT04372602|560257064|FG000|Overall Study|Transitioned to comfort care|0|||
155223273|NCT04372602|560257065|FG001|Overall Study|Transitioned to comfort care|1|||
155223274|NCT01324388|560257066|FG000|Part 1 of Study|Adverse Event|2|||
155223275|NCT01324388|560257067|FG001|Part 1 of Study|Adverse Event|0|||
155223276|NCT01324388|560257068|FG002|Part 1 of Study|Adverse Event|0|||
155223277|NCT01324388|560257069|FG003|Part 1 of Study|Adverse Event|0|||
155223278|NCT01324388|560257066|FG000|Part 1 of Study|Protocol Violation|1|||
155223279|NCT01324388|560257067|FG001|Part 1 of Study|Protocol Violation|2|||
155223280|NCT01324388|560257068|FG002|Part 1 of Study|Protocol Violation|0|||
155223281|NCT01324388|560257069|FG003|Part 1 of Study|Protocol Violation|0|||
155223282|NCT01324388|560257066|FG000|Part 1 of Study|Physician Decision|1|||
155223283|NCT01324388|560257067|FG001|Part 1 of Study|Physician Decision|0|||
155223284|NCT01324388|560257068|FG002|Part 1 of Study|Physician Decision|0|||
155223285|NCT01324388|560257069|FG003|Part 1 of Study|Physician Decision|0|||
155223286|NCT01324388|560257066|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223287|NCT01324388|560257067|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223288|NCT01324388|560257068|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223289|NCT01324388|560257069|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
155223290|NCT01324388|560257066|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223291|NCT01324388|560257067|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223292|NCT01324388|560257068|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
155223293|NCT01324388|560257069|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223294|NCT01405963|560257070|FG000|Overall Study|Moved Away|2|||
155223295|NCT01405963|560257071|FG001|Overall Study|Moved Away|0|||
155223296|NCT01405963|560257070|FG000|Overall Study|Adverse Event|0|||
155223297|NCT01405963|560257071|FG001|Overall Study|Adverse Event|1|||
155223298|NCT01405963|560257070|FG000|Overall Study|Lost to Follow-up|0|||
155223299|NCT01405963|560257071|FG001|Overall Study|Lost to Follow-up|1|||
155223300|NCT03742141|560257074|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
155223301|NCT01498640|560257075|FG000|Overall Study|Lost to Follow-up|1|||
155223302|NCT01498640|560257075|FG000|Overall Study|Death|1|||
155223303|NCT01498640|560257075|FG000|Overall Study|Other|3|||
155223304|NCT00850395|560257080|FG000|Overall Study|Death|1|||
155223305|NCT00850395|560257080|FG000|Overall Study|Adverse Event|1|||
155223306|NCT00850395|560257080|FG000|Overall Study|Insufficient clinical response|3|||
155223307|NCT00850395|560257080|FG000|Overall Study|Other|5|||
155223308|NCT00129129|560257081|FG000|Primary Phase|Adverse Event|2|||
155223309|NCT00129129|560257082|FG001|Primary Phase|Adverse Event|1|||
155223310|NCT00129129|560257083|FG002|Primary Phase|Adverse Event|0|||
155223311|NCT00129129|560257084|FG003|Primary Phase|Adverse Event|0|||
155223312|NCT00129129|560257085|FG004|Primary Phase|Adverse Event|0|||
155223313|NCT00129129|560257081|FG000|Primary Phase|Withdrawal by Subject|12|||
155223314|NCT00129129|560257082|FG001|Primary Phase|Withdrawal by Subject|10|||
155223315|NCT00129129|560257083|FG002|Primary Phase|Withdrawal by Subject|0|||
155223316|NCT00129129|560257084|FG003|Primary Phase|Withdrawal by Subject|0|||
155223317|NCT00129129|560257085|FG004|Primary Phase|Withdrawal by Subject|0|||
155223318|NCT00129129|560257081|FG000|Primary Phase|Migration from study area|1|||
155223319|NCT00129129|560257082|FG001|Primary Phase|Migration from study area|3|||
155223320|NCT00129129|560257083|FG002|Primary Phase|Migration from study area|0|||
155223321|NCT00129129|560257084|FG003|Primary Phase|Migration from study area|0|||
155223322|NCT00129129|560257085|FG004|Primary Phase|Migration from study area|0|||
155223323|NCT00129129|560257081|FG000|Primary Phase|Lost to Follow-up|8|||
155223324|NCT00129129|560257082|FG001|Primary Phase|Lost to Follow-up|6|||
155223325|NCT00129129|560257083|FG002|Primary Phase|Lost to Follow-up|0|||
155223326|NCT00129129|560257084|FG003|Primary Phase|Lost to Follow-up|0|||
155223327|NCT00129129|560257085|FG004|Primary Phase|Lost to Follow-up|0|||
155223328|NCT00129129|560257081|FG000|Primary Phase|Other|2|||
155223329|NCT00129129|560257082|FG001|Primary Phase|Other|5|||
155223330|NCT00129129|560257083|FG002|Primary Phase|Other|0|||
155223331|NCT00129129|560257084|FG003|Primary Phase|Other|0|||
155223332|NCT00129129|560257085|FG004|Primary Phase|Other|0|||
155223333|NCT00129129|560257081|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
155223334|NCT00129129|560257082|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
155223335|NCT00129129|560257083|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
155223336|NCT00129129|560257084|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
155223337|NCT00129129|560257085|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
155223338|NCT00129129|560257081|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
155223339|NCT00129129|560257082|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
155223340|NCT00129129|560257083|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
155223341|NCT00129129|560257084|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
155223342|NCT00129129|560257085|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
155223343|NCT00129129|560257081|FG000|Fourth Dose Phase|Migration from study area|0|||
155223344|NCT00129129|560257082|FG001|Fourth Dose Phase|Migration from study area|0|||
155223345|NCT00129129|560257083|FG002|Fourth Dose Phase|Migration from study area|0|||
155223346|NCT00129129|560257084|FG003|Fourth Dose Phase|Migration from study area|0|||
155223347|NCT00129129|560257085|FG004|Fourth Dose Phase|Migration from study area|2|||
155223348|NCT00129129|560257081|FG000|Fourth Dose Phase|Other|0|||
155223349|NCT00129129|560257082|FG001|Fourth Dose Phase|Other|0|||
155223350|NCT00129129|560257083|FG002|Fourth Dose Phase|Other|0|||
155223351|NCT00129129|560257084|FG003|Fourth Dose Phase|Other|1|||
155223352|NCT00129129|560257085|FG004|Fourth Dose Phase|Other|1|||
155223353|NCT00129129|560257081|FG000|Fourth Dose Phase|Protocol Violation|0|||
155223354|NCT00129129|560257082|FG001|Fourth Dose Phase|Protocol Violation|0|||
155223355|NCT00129129|560257083|FG002|Fourth Dose Phase|Protocol Violation|0|||
155223356|NCT00129129|560257084|FG003|Fourth Dose Phase|Protocol Violation|1|||
155223357|NCT00129129|560257085|FG004|Fourth Dose Phase|Protocol Violation|0|||
155223358|NCT03774433|560257088|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
155223359|NCT00108160|560257089|FG000|Overall Study|Lost to Follow-up|25|||
155223360|NCT00108160|560257090|FG001|Overall Study|Lost to Follow-up|12|||
155223361|NCT00108160|560257089|FG000|Overall Study|Death|1|||
155223362|NCT00108160|560257090|FG001|Overall Study|Death|2|||
155223363|NCT00108160|560257089|FG000|Overall Study|Withdrawal by Subject|4|||
155223364|NCT00108160|560257090|FG001|Overall Study|Withdrawal by Subject|2|||
155223365|NCT00108160|560257089|FG000|Overall Study|Protocol Violation|9|||
155223366|NCT00108160|560257090|FG001|Overall Study|Protocol Violation|5|||
155223367|NCT01062555|560257091|FG000|Phase 1|Death|10|||
155223368|NCT01062555|560257092|FG001|Phase 1|Death|17|||
155223369|NCT01062555|560257093|FG002|Phase 1|Death|0|||
155223370|NCT01062555|560257094|FG003|Phase 1|Death|0|||
155223371|NCT01062555|560257091|FG000|Phase 1|Graft Failure|12|||
155223372|NCT01062555|560257092|FG001|Phase 1|Graft Failure|8|||
155223373|NCT01062555|560257093|FG002|Phase 1|Graft Failure|0|||
155223374|NCT01062555|560257094|FG003|Phase 1|Graft Failure|0|||
155223375|NCT01062555|560257091|FG000|Phase 1|Withdrawal by Subject|1|||
155223376|NCT01062555|560257092|FG001|Phase 1|Withdrawal by Subject|1|||
155223377|NCT01062555|560257093|FG002|Phase 1|Withdrawal by Subject|0|||
155223378|NCT01062555|560257094|FG003|Phase 1|Withdrawal by Subject|0|||
155223379|NCT01062555|560257091|FG000|Phase 2|Death|0|||
155223380|NCT01062555|560257092|FG001|Phase 2|Death|0|||
155223381|NCT01062555|560257093|FG002|Phase 2|Death|8|||
155223382|NCT01062555|560257094|FG003|Phase 2|Death|3|||
155223383|NCT01062555|560257091|FG000|Phase 2|Graft failure|0|||
155223384|NCT01062555|560257092|FG001|Phase 2|Graft failure|0|||
155223385|NCT01062555|560257093|FG002|Phase 2|Graft failure|7|||
155223386|NCT01062555|560257094|FG003|Phase 2|Graft failure|4|||
155223387|NCT01062555|560257091|FG000|Phase 2|Withdrawal by Subject|0|||
155223388|NCT01062555|560257092|FG001|Phase 2|Withdrawal by Subject|0|||
155223389|NCT01062555|560257093|FG002|Phase 2|Withdrawal by Subject|0|||
155223390|NCT01062555|560257094|FG003|Phase 2|Withdrawal by Subject|7|||
155223391|NCT01062555|560257091|FG000|Phase 2|Protocol Violation|0|||
155223392|NCT01062555|560257092|FG001|Phase 2|Protocol Violation|0|||
155223393|NCT01062555|560257093|FG002|Phase 2|Protocol Violation|0|||
155223394|NCT01062555|560257094|FG003|Phase 2|Protocol Violation|3|||
155223395|NCT01062555|560257091|FG000|Phase 2|Physician Decision|0|||
155223396|NCT01062555|560257092|FG001|Phase 2|Physician Decision|0|||
155223397|NCT01062555|560257093|FG002|Phase 2|Physician Decision|0|||
155223398|NCT01062555|560257094|FG003|Phase 2|Physician Decision|17|||
155223399|NCT04837131|560257095|FG000|Overall Study|Death|1|||
155223400|NCT04837131|560257095|FG000|Overall Study|Withdrawal by Subject|1|||
155223401|NCT04837131|560257095|FG000|Overall Study|Adverse Event|1|||
155223402|NCT04837131|560257095|FG000|Overall Study|Protocol Violation|1|||
155223403|NCT00403273|560258298|FG000|Overall Study|Lost to Follow-up|3|||
155223404|NCT00403273|560258299|FG001|Overall Study|Lost to Follow-up|2|||
155223405|NCT00403273|560258298|FG000|Overall Study|Physician Decision|0|||
155223406|NCT00403273|560258299|FG001|Overall Study|Physician Decision|1|||
155223407|NCT00403273|560258298|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
155223408|NCT00403273|560258299|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
155223409|NCT00589108|560258300|FG000|Overall Study|Lost to Follow-up|1|||
155223410|NCT00589108|560258301|FG001|Overall Study|Lost to Follow-up|1|||
155223411|NCT00589108|560258302|FG002|Overall Study|Lost to Follow-up|1|||
155223412|NCT00589108|560258300|FG000|Overall Study|Death|3|||
155223413|NCT00589108|560258301|FG001|Overall Study|Death|3|||
155223414|NCT00589108|560258302|FG002|Overall Study|Death|4|||
155223415|NCT03026257|560258304|FG000|Overall Study|Adverse Event|3|||
155223416|NCT03026257|560258305|FG001|Overall Study|Adverse Event|0|||
155223417|NCT03026257|560258306|FG002|Overall Study|Adverse Event|0|||
155223418|NCT03026257|560258307|FG003|Overall Study|Adverse Event|0|||
155223419|NCT03026257|560258308|FG004|Overall Study|Adverse Event|0|||
155223420|NCT03026257|560258309|FG005|Overall Study|Adverse Event|0|||
155223421|NCT03026257|560258304|FG000|Overall Study|Lost to Follow-up|1|||
155223422|NCT03026257|560258305|FG001|Overall Study|Lost to Follow-up|0|||
155223423|NCT03026257|560258306|FG002|Overall Study|Lost to Follow-up|0|||
155223424|NCT03026257|560258307|FG003|Overall Study|Lost to Follow-up|0|||
155223425|NCT03026257|560258308|FG004|Overall Study|Lost to Follow-up|0|||
155223426|NCT03026257|560258309|FG005|Overall Study|Lost to Follow-up|0|||
155223427|NCT03026257|560258304|FG000|Overall Study|Protocol Violation|1|||
155223428|NCT03026257|560258305|FG001|Overall Study|Protocol Violation|0|||
155223429|NCT03026257|560258306|FG002|Overall Study|Protocol Violation|0|||
155223430|NCT03026257|560258307|FG003|Overall Study|Protocol Violation|1|||
155223431|NCT03026257|560258308|FG004|Overall Study|Protocol Violation|1|||
155223432|NCT03026257|560258309|FG005|Overall Study|Protocol Violation|0|||
155223433|NCT03026257|560258304|FG000|Overall Study|Withdrawal by Subject|1|||
155223434|NCT03026257|560258305|FG001|Overall Study|Withdrawal by Subject|1|||
155223435|NCT03026257|560258306|FG002|Overall Study|Withdrawal by Subject|0|||
155223436|NCT03026257|560258307|FG003|Overall Study|Withdrawal by Subject|0|||
155223437|NCT03026257|560258308|FG004|Overall Study|Withdrawal by Subject|0|||
155223438|NCT03026257|560258309|FG005|Overall Study|Withdrawal by Subject|0|||
155223439|NCT02181556|560258310|FG000|Overall Study|Withdrawal by Subject|1|||
155223440|NCT04380857|560258311|FG000|Overall Study|Lost to Follow-up|3|||
155223441|NCT04380857|560258312|FG001|Overall Study|Lost to Follow-up|3|||
155223442|NCT04865354|560258313|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
155223443|NCT04865354|560258314|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
155223444|NCT04865354|560258313|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
155223445|NCT04865354|560258314|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
155223446|NCT04865354|560258313|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
155223447|NCT04865354|560258314|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
155223448|NCT01465022|560258315|FG000|Overall Study|Lost to Follow-up|15|||
155223449|NCT01465022|560258316|FG001|Overall Study|Lost to Follow-up|14|||
155223450|NCT01465022|560258317|FG002|Overall Study|Lost to Follow-up|0|||
155223451|NCT01465022|560258315|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
155223452|NCT01465022|560258316|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
155223453|NCT01465022|560258317|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
155223454|NCT01465022|560258315|FG000|Overall Study|Not Randomized|0|||
155223455|NCT01465022|560258316|FG001|Overall Study|Not Randomized|0|||
155223456|NCT01465022|560258317|FG002|Overall Study|Not Randomized|70|||
155223457|NCT02256891|560258318|FG000|Overall Study|Death|0|||
155223458|NCT02256891|560258319|FG001|Overall Study|Death|2|||
155223459|NCT02256891|560258318|FG000|Overall Study|Lost to Follow-up|0|||
155223460|NCT02256891|560258319|FG001|Overall Study|Lost to Follow-up|3|||
155223461|NCT02256891|560258318|FG000|Overall Study|Physician Decision|7|||
155223462|NCT02256891|560258319|FG001|Overall Study|Physician Decision|3|||
155223463|NCT02256891|560258318|FG000|Overall Study|Screen Fail|5|||
155223464|NCT02256891|560258319|FG001|Overall Study|Screen Fail|4|||
155223465|NCT02256891|560258318|FG000|Overall Study|Equipment Malfunction|0|||
155223466|NCT02256891|560258319|FG001|Overall Study|Equipment Malfunction|1|||
155223467|NCT02487394|560258326|FG000|Phase 1|Withdrawal by Subject|0|||
155223468|NCT02487394|560258327|FG001|Phase 1|Withdrawal by Subject|1|||
155223469|NCT00218296|560258337|FG000|Overall Study|Lost to Follow-up|9|||
155223470|NCT00218296|560258338|FG001|Overall Study|Lost to Follow-up|7|||
155223471|NCT00218296|560258337|FG000|Overall Study|Withdrawal by Subject|36|||
155223472|NCT00218296|560258338|FG001|Overall Study|Withdrawal by Subject|47|||
155223473|NCT00218296|560258337|FG000|Overall Study|Randomized but did not enter treatment|66|||
155223474|NCT00218296|560258338|FG001|Overall Study|Randomized but did not enter treatment|67|||
155223475|NCT02711800|560258357|FG000|Overall Study|Lost to Follow-up|1|||
155223476|NCT02711800|560258357|FG000|Overall Study|Withdrawal by Subject|1|||
155223477|NCT05442554|560258362|FG000|Overall Study|Adverse Event|1|||
155223478|NCT01446965|560258364|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
155223479|NCT01446965|560258365|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
155223480|NCT01446965|560258364|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
155223481|NCT01446965|560258365|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
155223482|NCT00004412|560258366|FG000|Randomized Period|Moved to Crossover Period|3|||
155223483|NCT00004412|560258367|FG001|Randomized Period|Moved to Crossover Period|0|||
155223484|NCT00004412|560258368|FG002|Randomized Period|Moved to Crossover Period|0|||
155223485|NCT00006478|560258369|FG000|Overall Study|Vaccine could not be produced|1|||
155223486|NCT00006478|560258369|FG000|Overall Study|Physician Decision|6|||
155223487|NCT02039674|560258380|FG000|Overall Study|Adverse Event|0|||
155223488|NCT02039674|560258381|FG001|Overall Study|Adverse Event|0|||
155223489|NCT02039674|560258382|FG002|Overall Study|Adverse Event|0|||
155223490|NCT02039674|560258383|FG003|Overall Study|Adverse Event|1|||
155223491|NCT02039674|560258384|FG004|Overall Study|Adverse Event|0|||
155223492|NCT02039674|560258385|FG005|Overall Study|Adverse Event|0|||
155223493|NCT02039674|560258386|FG006|Overall Study|Adverse Event|0|||
155223494|NCT02039674|560258387|FG007|Overall Study|Adverse Event|0|||
155223495|NCT02039674|560258388|FG008|Overall Study|Adverse Event|2|||
155223496|NCT02039674|560258389|FG009|Overall Study|Adverse Event|1|||
155223497|NCT02039674|560258390|FG010|Overall Study|Adverse Event|0|||
155223498|NCT02039674|560258391|FG011|Overall Study|Adverse Event|2|||
155223499|NCT02039674|560258392|FG012|Overall Study|Adverse Event|3|||
155223500|NCT02039674|560258393|FG013|Overall Study|Adverse Event|1|||
155223501|NCT02039674|560258380|FG000|Overall Study|Death|2|||
155223502|NCT02039674|560258381|FG001|Overall Study|Death|0|||
155223503|NCT02039674|560258382|FG002|Overall Study|Death|2|||
155223504|NCT02039674|560258383|FG003|Overall Study|Death|3|||
155223505|NCT02039674|560258384|FG004|Overall Study|Death|0|||
155223506|NCT02039674|560258385|FG005|Overall Study|Death|0|||
155223507|NCT02039674|560258386|FG006|Overall Study|Death|1|||
155223508|NCT02039674|560258387|FG007|Overall Study|Death|0|||
155223509|NCT02039674|560258388|FG008|Overall Study|Death|2|||
155223510|NCT02039674|560258389|FG009|Overall Study|Death|0|||
155223511|NCT02039674|560258390|FG010|Overall Study|Death|1|||
155223512|NCT02039674|560258391|FG011|Overall Study|Death|3|||
155223513|NCT02039674|560258392|FG012|Overall Study|Death|2|||
155223514|NCT02039674|560258393|FG013|Overall Study|Death|8|||
155223515|NCT02039674|560258380|FG000|Overall Study|Excluded Medication|1|||
155223516|NCT02039674|560258381|FG001|Overall Study|Excluded Medication|1|||
155223517|NCT02039674|560258382|FG002|Overall Study|Excluded Medication|0|||
155223518|NCT02039674|560258383|FG003|Overall Study|Excluded Medication|1|||
155223519|NCT02039674|560258384|FG004|Overall Study|Excluded Medication|0|||
155223520|NCT02039674|560258385|FG005|Overall Study|Excluded Medication|1|||
155223521|NCT02039674|560258386|FG006|Overall Study|Excluded Medication|0|||
155223522|NCT02039674|560258387|FG007|Overall Study|Excluded Medication|0|||
155223523|NCT02039674|560258388|FG008|Overall Study|Excluded Medication|2|||
155223524|NCT02039674|560258389|FG009|Overall Study|Excluded Medication|3|||
155223525|NCT02039674|560258390|FG010|Overall Study|Excluded Medication|5|||
155223526|NCT02039674|560258391|FG011|Overall Study|Excluded Medication|6|||
155223527|NCT02039674|560258392|FG012|Overall Study|Excluded Medication|8|||
155223528|NCT02039674|560258393|FG013|Overall Study|Excluded Medication|3|||
155223529|NCT02039674|560258380|FG000|Overall Study|Lost to Follow-up|0|||
155223530|NCT02039674|560258381|FG001|Overall Study|Lost to Follow-up|0|||
155223531|NCT02039674|560258382|FG002|Overall Study|Lost to Follow-up|0|||
155223532|NCT02039674|560258383|FG003|Overall Study|Lost to Follow-up|0|||
155223533|NCT02039674|560258384|FG004|Overall Study|Lost to Follow-up|1|||
155223534|NCT02039674|560258385|FG005|Overall Study|Lost to Follow-up|1|||
155223535|NCT02039674|560258386|FG006|Overall Study|Lost to Follow-up|0|||
155223536|NCT02039674|560258387|FG007|Overall Study|Lost to Follow-up|0|||
155223537|NCT02039674|560258388|FG008|Overall Study|Lost to Follow-up|0|||
155223538|NCT02039674|560258389|FG009|Overall Study|Lost to Follow-up|0|||
155223539|NCT02039674|560258390|FG010|Overall Study|Lost to Follow-up|0|||
155223540|NCT02039674|560258391|FG011|Overall Study|Lost to Follow-up|2|||
155223541|NCT02039674|560258392|FG012|Overall Study|Lost to Follow-up|2|||
155223542|NCT02039674|560258393|FG013|Overall Study|Lost to Follow-up|1|||
155223543|NCT02039674|560258380|FG000|Overall Study|Physician Decision|0|||
155223544|NCT02039674|560258381|FG001|Overall Study|Physician Decision|0|||
155223545|NCT02039674|560258382|FG002|Overall Study|Physician Decision|0|||
155223546|NCT02039674|560258383|FG003|Overall Study|Physician Decision|0|||
155223547|NCT02039674|560258384|FG004|Overall Study|Physician Decision|0|||
155223548|NCT02039674|560258385|FG005|Overall Study|Physician Decision|0|||
155223549|NCT02039674|560258386|FG006|Overall Study|Physician Decision|0|||
155223550|NCT02039674|560258387|FG007|Overall Study|Physician Decision|0|||
155223551|NCT02039674|560258388|FG008|Overall Study|Physician Decision|0|||
155223552|NCT02039674|560258389|FG009|Overall Study|Physician Decision|0|||
155223553|NCT02039674|560258390|FG010|Overall Study|Physician Decision|0|||
155223554|NCT02039674|560258391|FG011|Overall Study|Physician Decision|1|||
155223555|NCT02039674|560258392|FG012|Overall Study|Physician Decision|1|||
155223556|NCT02039674|560258393|FG013|Overall Study|Physician Decision|0|||
155223557|NCT02039674|560258380|FG000|Overall Study|Progressive Disease|8|||
155223558|NCT02039674|560258381|FG001|Overall Study|Progressive Disease|8|||
155223559|NCT02039674|560258382|FG002|Overall Study|Progressive Disease|6|||
155223560|NCT02039674|560258383|FG003|Overall Study|Progressive Disease|7|||
155223561|NCT02039674|560258384|FG004|Overall Study|Progressive Disease|9|||
155223562|NCT02039674|560258385|FG005|Overall Study|Progressive Disease|10|||
155223563|NCT02039674|560258386|FG006|Overall Study|Progressive Disease|1|||
155223564|NCT02039674|560258387|FG007|Overall Study|Progressive Disease|3|||
155223565|NCT02039674|560258388|FG008|Overall Study|Progressive Disease|6|||
155223566|NCT02039674|560258389|FG009|Overall Study|Progressive Disease|4|||
155223567|NCT02039674|560258390|FG010|Overall Study|Progressive Disease|0|||
155223568|NCT02039674|560258391|FG011|Overall Study|Progressive Disease|34|||
155223569|NCT02039674|560258392|FG012|Overall Study|Progressive Disease|34|||
155223570|NCT02039674|560258393|FG013|Overall Study|Progressive Disease|18|||
155223571|NCT02039674|560258380|FG000|Overall Study|Withdrawal by Subject|1|||
155223572|NCT02039674|560258381|FG001|Overall Study|Withdrawal by Subject|2|||
155223573|NCT02039674|560258382|FG002|Overall Study|Withdrawal by Subject|3|||
155223574|NCT02039674|560258383|FG003|Overall Study|Withdrawal by Subject|0|||
155223575|NCT02039674|560258384|FG004|Overall Study|Withdrawal by Subject|1|||
155223576|NCT02039674|560258385|FG005|Overall Study|Withdrawal by Subject|0|||
155223577|NCT02039674|560258386|FG006|Overall Study|Withdrawal by Subject|0|||
155223578|NCT02039674|560258387|FG007|Overall Study|Withdrawal by Subject|0|||
155223579|NCT02039674|560258388|FG008|Overall Study|Withdrawal by Subject|0|||
155223580|NCT02039674|560258389|FG009|Overall Study|Withdrawal by Subject|1|||
155223581|NCT02039674|560258390|FG010|Overall Study|Withdrawal by Subject|1|||
155223582|NCT02039674|560258391|FG011|Overall Study|Withdrawal by Subject|4|||
155223583|NCT02039674|560258392|FG012|Overall Study|Withdrawal by Subject|6|||
155223584|NCT02039674|560258393|FG013|Overall Study|Withdrawal by Subject|2|||
155223585|NCT02039674|560258380|FG000|Overall Study|Clinical Progression|0|||
155223586|NCT02039674|560258381|FG001|Overall Study|Clinical Progression|0|||
155223587|NCT02039674|560258382|FG002|Overall Study|Clinical Progression|0|||
155223588|NCT02039674|560258383|FG003|Overall Study|Clinical Progression|0|||
155223589|NCT02039674|560258384|FG004|Overall Study|Clinical Progression|0|||
155223590|NCT02039674|560258385|FG005|Overall Study|Clinical Progression|0|||
155223591|NCT02039674|560258386|FG006|Overall Study|Clinical Progression|1|||
155223592|NCT02039674|560258387|FG007|Overall Study|Clinical Progression|0|||
155223593|NCT02039674|560258388|FG008|Overall Study|Clinical Progression|0|||
155223594|NCT02039674|560258389|FG009|Overall Study|Clinical Progression|0|||
155223595|NCT02039674|560258390|FG010|Overall Study|Clinical Progression|0|||
155223596|NCT02039674|560258391|FG011|Overall Study|Clinical Progression|0|||
155223597|NCT02039674|560258392|FG012|Overall Study|Clinical Progression|1|||
155223598|NCT02039674|560258393|FG013|Overall Study|Clinical Progression|0|||
155223599|NCT02039674|560258380|FG000|Overall Study|Sponsor Decision|1|||
155223600|NCT02039674|560258381|FG001|Overall Study|Sponsor Decision|1|||
155223601|NCT02039674|560258382|FG002|Overall Study|Sponsor Decision|1|||
155223602|NCT02039674|560258383|FG003|Overall Study|Sponsor Decision|1|||
155223603|NCT02039674|560258384|FG004|Overall Study|Sponsor Decision|1|||
155223604|NCT02039674|560258385|FG005|Overall Study|Sponsor Decision|0|||
155223605|NCT02039674|560258386|FG006|Overall Study|Sponsor Decision|0|||
155223606|NCT02039674|560258387|FG007|Overall Study|Sponsor Decision|0|||
155223607|NCT02039674|560258388|FG008|Overall Study|Sponsor Decision|0|||
155223608|NCT02039674|560258389|FG009|Overall Study|Sponsor Decision|3|||
155223609|NCT02039674|560258390|FG010|Overall Study|Sponsor Decision|0|||
155223610|NCT02039674|560258391|FG011|Overall Study|Sponsor Decision|8|||
155223611|NCT02039674|560258392|FG012|Overall Study|Sponsor Decision|5|||
155223612|NCT02039674|560258393|FG013|Overall Study|Sponsor Decision|0|||
155223613|NCT02039674|560258380|FG000|Overall Study|Other|0|||
155223614|NCT02039674|560258381|FG001|Overall Study|Other|0|||
155223615|NCT02039674|560258382|FG002|Overall Study|Other|0|||
155223616|NCT02039674|560258383|FG003|Overall Study|Other|0|||
155223617|NCT02039674|560258384|FG004|Overall Study|Other|0|||
155223618|NCT02039674|560258385|FG005|Overall Study|Other|0|||
155223619|NCT02039674|560258386|FG006|Overall Study|Other|0|||
155223620|NCT02039674|560258387|FG007|Overall Study|Other|0|||
155223621|NCT02039674|560258388|FG008|Overall Study|Other|0|||
155223622|NCT02039674|560258389|FG009|Overall Study|Other|0|||
155223623|NCT02039674|560258390|FG010|Overall Study|Other|0|||
155223624|NCT02039674|560258391|FG011|Overall Study|Other|0|||
155223625|NCT02039674|560258392|FG012|Overall Study|Other|1|||
155223626|NCT02039674|560258393|FG013|Overall Study|Other|0|||
155223627|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
155223628|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
155223629|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
155223630|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
155223631|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
155223632|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
155223633|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
155223634|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
155223635|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
155223636|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
155223637|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
155223638|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
155223639|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
155223640|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
155223641|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
155223642|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
155223643|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
155223644|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
155223645|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
155223646|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
155223647|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
155223648|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
155223649|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
155223650|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
155223651|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Other|1|||
155223652|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Other|1|||
155223653|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Other|1|||
155223654|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Other|1|||
155223655|NCT05045144|560258399|FG000|Overall Study|Lost to Follow-up|3|||
155223656|NCT05045144|560258400|FG001|Overall Study|Lost to Follow-up|2|||
155223657|NCT05045144|560258401|FG002|Overall Study|Lost to Follow-up|3|||
155223658|NCT05045144|560258402|FG003|Overall Study|Lost to Follow-up|5|||
155223659|NCT05045144|560258403|FG004|Overall Study|Lost to Follow-up|13|||
155223660|NCT05045144|560258399|FG000|Overall Study|Withdrawal by Subject|0|||
155223661|NCT05045144|560258400|FG001|Overall Study|Withdrawal by Subject|1|||
155223662|NCT05045144|560258401|FG002|Overall Study|Withdrawal by Subject|0|||
155223663|NCT05045144|560258402|FG003|Overall Study|Withdrawal by Subject|0|||
155223664|NCT05045144|560258403|FG004|Overall Study|Withdrawal by Subject|0|||
155223665|NCT05045144|560258399|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223666|NCT05045144|560258400|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223667|NCT05045144|560258401|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155223668|NCT05045144|560258402|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223669|NCT05045144|560258403|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223670|NCT02965703|560258404|FG000|Overall Study|Withdrawal by Subject|6|||
155223671|NCT02965703|560258405|FG001|Overall Study|Withdrawal by Subject|3|||
155223672|NCT02965703|560258406|FG002|Overall Study|Withdrawal by Subject|1|||
155223673|NCT02965703|560258404|FG000|Overall Study|Protocol Violation|1|||
155223674|NCT02965703|560258405|FG001|Overall Study|Protocol Violation|0|||
155223675|NCT02965703|560258406|FG002|Overall Study|Protocol Violation|0|||
155223676|NCT02965703|560258404|FG000|Overall Study|Adverse Event|1|||
155223677|NCT02965703|560258405|FG001|Overall Study|Adverse Event|1|||
155223678|NCT02965703|560258406|FG002|Overall Study|Adverse Event|0|||
155223679|NCT02965703|560258404|FG000|Overall Study|Lost to Follow-up|2|||
155223680|NCT02965703|560258405|FG001|Overall Study|Lost to Follow-up|1|||
155223681|NCT02965703|560258406|FG002|Overall Study|Lost to Follow-up|1|||
155223682|NCT02081079|560258407|FG000|Overall Study|Lack of Efficacy|3|||
155223683|NCT02081079|560258408|FG001|Overall Study|Lack of Efficacy|2|||
155223684|NCT02081079|560258407|FG000|Overall Study|Lost to Follow-up|1|||
155223685|NCT02081079|560258408|FG001|Overall Study|Lost to Follow-up|0|||
155223686|NCT02968979|560258414|FG000|Overall Study|Protocol Violation|7|||
155223687|NCT02968979|560258414|FG000|Overall Study|Withdrawal by Subject|1|||
155223688|NCT01471379|560258415|FG000|Overall Study|Adverse Event|1|||
155223689|NCT01471379|560258416|FG001|Overall Study|Adverse Event|0|||
155223690|NCT01471379|560258417|FG002|Overall Study|Adverse Event|0|||
155223691|NCT01471379|560258415|FG000|Overall Study|Study terminated|0|||
155223692|NCT01471379|560258416|FG001|Overall Study|Study terminated|1|||
155223693|NCT01471379|560258417|FG002|Overall Study|Study terminated|0|||
155223694|NCT00788827|560258418|FG000|Overall Study|Lack of Efficacy|2|||
155223695|NCT01200797|560258425|FG000|Overall Study|symptomatic deterioration|2|||
155223696|NCT01200797|560258425|FG000|Overall Study|Adverse Event|4|||
155223697|NCT01200797|560258425|FG000|Overall Study|Disease Progression|13|||
155223698|NCT03608774|560258426|FG000|Overall Study|Lost to Follow-up|5|||
155223699|NCT03608774|560258427|FG001|Overall Study|Lost to Follow-up|5|||
155223700|NCT03608774|560258426|FG000|Overall Study|Withdrawal by Subject|1|||
155223701|NCT03608774|560258427|FG001|Overall Study|Withdrawal by Subject|0|||
155223702|NCT03608774|560258426|FG000|Overall Study|Protocol Violation|1|||
155223703|NCT03608774|560258427|FG001|Overall Study|Protocol Violation|0|||
155223704|NCT03608774|560258426|FG000|Overall Study|Not eligible at enrollment|0|||
155223705|NCT03608774|560258427|FG001|Overall Study|Not eligible at enrollment|1|||
155223706|NCT03608774|560258426|FG000|Overall Study|Health related event|0|||
155223707|NCT03608774|560258427|FG001|Overall Study|Health related event|1|||
155223708|NCT00851799|560258430|FG000|Overall Study|Death|1|||
155223709|NCT00851799|560258431|FG001|Overall Study|Death|0|||
155223710|NCT00851799|560258432|FG002|Overall Study|Death|1|||
155223711|NCT00851799|560258430|FG000|Overall Study|Lost to Follow-up|5|||
155223712|NCT00851799|560258431|FG001|Overall Study|Lost to Follow-up|3|||
155223713|NCT00851799|560258432|FG002|Overall Study|Lost to Follow-up|10|||
155223714|NCT00851799|560258430|FG000|Overall Study|Not able to get to clinic|8|||
155223715|NCT00851799|560258431|FG001|Overall Study|Not able to get to clinic|5|||
155223716|NCT00851799|560258432|FG002|Overall Study|Not able to get to clinic|9|||
155223717|NCT00851799|560258430|FG000|Overall Study|Not willing to adhere to requirements|1|||
155223718|NCT00851799|560258431|FG001|Overall Study|Not willing to adhere to requirements|2|||
155223719|NCT00851799|560258432|FG002|Overall Study|Not willing to adhere to requirements|2|||
155223720|NCT00851799|560258430|FG000|Overall Study|Withdrew consent prior study completion|1|||
155491446|NCT01740297|561225387|FG001|Overall Study|Withdrawal by Subject|16|||
155223721|NCT00851799|560258431|FG001|Overall Study|Withdrew consent prior study completion|2|||
155223722|NCT00851799|560258432|FG002|Overall Study|Withdrew consent prior study completion|1|||
155223723|NCT00851799|560258430|FG000|Overall Study|Severe Debilitation|0|||
155223724|NCT00851799|560258431|FG001|Overall Study|Severe Debilitation|1|||
155223725|NCT00851799|560258432|FG002|Overall Study|Severe Debilitation|0|||
155223726|NCT00851799|560258430|FG000|Overall Study|Completed protocol due to pregnancy|0|||
155223727|NCT00851799|560258431|FG001|Overall Study|Completed protocol due to pregnancy|0|||
155223728|NCT00851799|560258432|FG002|Overall Study|Completed protocol due to pregnancy|1|||
155223729|NCT00502697|560260268|FG000|Overall Study|Withdrawal by Subject|3|||
155223730|NCT00502697|560260269|FG001|Overall Study|Withdrawal by Subject|1|||
155223731|NCT00502697|560260268|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
155223732|NCT00502697|560260269|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
155223733|NCT00502697|560260268|FG000|Overall Study|found not to meet eligibility criteria|3|||
155223734|NCT00502697|560260269|FG001|Overall Study|found not to meet eligibility criteria|4|||
155223735|NCT00502697|560260268|FG000|Overall Study|did not meet assignment criteria|4|||
155223736|NCT00502697|560260269|FG001|Overall Study|did not meet assignment criteria|2|||
155223737|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
155223738|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
155223739|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
155223740|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
155223741|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
155223742|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
155223743|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
155223744|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
155223745|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
155223746|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
155223747|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
155223748|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
155223749|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
155223750|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
155223751|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
155223752|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
155223753|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
155223754|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
155223755|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
155223756|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
155223757|NCT04033003|560260277|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
155223758|NCT04033003|560260278|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
155223759|NCT04033003|560260277|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
155223760|NCT04033003|560260278|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
155223761|NCT04033003|560260277|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
155223762|NCT04033003|560260278|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
155223763|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
155223764|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
155223765|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
155223766|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
155223767|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
155223768|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
155223769|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
155223770|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
155223771|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
155223772|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
155223773|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
155223774|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
155223775|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
155223776|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
155223777|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
155223778|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Death|5|||
155223779|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Death|0|||
155223780|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Death|2|||
155223781|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Death|0|||
155223782|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Death|4|||
155223783|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
155223784|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
155223785|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
155223786|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
155223787|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
155223788|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
155223789|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
155223790|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
155223791|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
155223792|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
155223793|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
155223794|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223795|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
155223796|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223797|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223798|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Other|15|||
155223799|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Other|0|||
155223800|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Other|10|||
155223801|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Other|0|||
155223802|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Other|6|||
155223803|NCT01604343|560260279|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
155223804|NCT01604343|560260280|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
155223805|NCT01604343|560260281|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
155223806|NCT01604343|560260282|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
155223807|NCT01604343|560260283|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
155223808|NCT01604343|560260279|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
155223809|NCT01604343|560260280|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
155223810|NCT01604343|560260281|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
155223811|NCT01604343|560260282|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
155223812|NCT01604343|560260283|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
155223813|NCT01604343|560260279|FG000|Week 52 to Week 104|Adverse Event|0|||
155223814|NCT01604343|560260280|FG001|Week 52 to Week 104|Adverse Event|12|||
155223815|NCT01604343|560260281|FG002|Week 52 to Week 104|Adverse Event|26|||
155223816|NCT01604343|560260282|FG003|Week 52 to Week 104|Adverse Event|21|||
155223817|NCT01604343|560260283|FG004|Week 52 to Week 104|Adverse Event|27|||
155223818|NCT01604343|560260279|FG000|Week 52 to Week 104|Death|0|||
155223819|NCT01604343|560260280|FG001|Week 52 to Week 104|Death|4|||
155223820|NCT01604343|560260281|FG002|Week 52 to Week 104|Death|2|||
155223821|NCT01604343|560260282|FG003|Week 52 to Week 104|Death|5|||
155223822|NCT01604343|560260283|FG004|Week 52 to Week 104|Death|0|||
155223823|NCT01604343|560260279|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
155223824|NCT01604343|560260280|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
155223825|NCT01604343|560260281|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
155223826|NCT01604343|560260282|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
155223827|NCT01604343|560260283|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
155223828|NCT01604343|560260279|FG000|Week 52 to Week 104|Physician Decision|0|||
155223829|NCT01604343|560260280|FG001|Week 52 to Week 104|Physician Decision|1|||
155223830|NCT01604343|560260281|FG002|Week 52 to Week 104|Physician Decision|0|||
155223831|NCT01604343|560260282|FG003|Week 52 to Week 104|Physician Decision|0|||
155223832|NCT01604343|560260283|FG004|Week 52 to Week 104|Physician Decision|2|||
155223833|NCT01604343|560260279|FG000|Week 52 to Week 104|Pregnancy|0|||
155223834|NCT01604343|560260280|FG001|Week 52 to Week 104|Pregnancy|0|||
155223835|NCT01604343|560260281|FG002|Week 52 to Week 104|Pregnancy|1|||
155223836|NCT01604343|560260282|FG003|Week 52 to Week 104|Pregnancy|2|||
155223837|NCT01604343|560260283|FG004|Week 52 to Week 104|Pregnancy|1|||
155223838|NCT01604343|560260279|FG000|Week 52 to Week 104|Other|0|||
155223839|NCT01604343|560260280|FG001|Week 52 to Week 104|Other|11|||
155223840|NCT01604343|560260281|FG002|Week 52 to Week 104|Other|11|||
155223841|NCT01604343|560260282|FG003|Week 52 to Week 104|Other|6|||
155223842|NCT01604343|560260283|FG004|Week 52 to Week 104|Other|3|||
155223843|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
155223844|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223845|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
155223846|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223847|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223848|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
155223849|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
155223850|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
155223851|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
155223852|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
155223853|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
155223854|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
155223855|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
155223856|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
155223857|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
155223858|NCT03161483|560260292|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223859|NCT03161483|560260293|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
155223860|NCT03161483|560260294|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223861|NCT03161483|560260295|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223862|NCT03161483|560260292|FG000|Treatment Period|Death|1|||
155223863|NCT03161483|560260293|FG001|Treatment Period|Death|0|||
155223864|NCT03161483|560260294|FG002|Treatment Period|Death|0|||
155223865|NCT03161483|560260295|FG003|Treatment Period|Death|0|||
155223866|NCT03161483|560260292|FG000|Treatment Period|Adverse Event|5|||
155223867|NCT03161483|560260293|FG001|Treatment Period|Adverse Event|2|||
155223868|NCT03161483|560260294|FG002|Treatment Period|Adverse Event|1|||
155223869|NCT03161483|560260295|FG003|Treatment Period|Adverse Event|11|||
155223870|NCT03161483|560260292|FG000|Treatment Period|Pregnancy|1|||
155223871|NCT03161483|560260293|FG001|Treatment Period|Pregnancy|0|||
155223872|NCT03161483|560260294|FG002|Treatment Period|Pregnancy|0|||
155223873|NCT03161483|560260295|FG003|Treatment Period|Pregnancy|0|||
155223874|NCT03161483|560260292|FG000|Treatment Period|Lack of Efficacy|0|||
155223875|NCT03161483|560260293|FG001|Treatment Period|Lack of Efficacy|0|||
155223876|NCT03161483|560260294|FG002|Treatment Period|Lack of Efficacy|0|||
155223877|NCT03161483|560260295|FG003|Treatment Period|Lack of Efficacy|1|||
155223878|NCT03161483|560260292|FG000|Treatment Period|Withdrawal by Subject|2|||
155223879|NCT03161483|560260293|FG001|Treatment Period|Withdrawal by Subject|5|||
155223880|NCT03161483|560260294|FG002|Treatment Period|Withdrawal by Subject|2|||
155223881|NCT03161483|560260295|FG003|Treatment Period|Withdrawal by Subject|6|||
155223882|NCT03161483|560260292|FG000|Treatment Period|Lost to Follow-up|0|||
155223883|NCT03161483|560260293|FG001|Treatment Period|Lost to Follow-up|0|||
155223884|NCT03161483|560260294|FG002|Treatment Period|Lost to Follow-up|0|||
155223885|NCT03161483|560260295|FG003|Treatment Period|Lost to Follow-up|1|||
155223886|NCT03161483|560260292|FG000|Treatment Period|Protocol Violation|0|||
155223887|NCT03161483|560260293|FG001|Treatment Period|Protocol Violation|0|||
155223888|NCT03161483|560260294|FG002|Treatment Period|Protocol Violation|0|||
155223889|NCT03161483|560260295|FG003|Treatment Period|Protocol Violation|1|||
155223890|NCT03161483|560260292|FG000|Treatment Period|Other reasons|1|||
155223891|NCT03161483|560260293|FG001|Treatment Period|Other reasons|1|||
155223892|NCT03161483|560260294|FG002|Treatment Period|Other reasons|0|||
155223893|NCT03161483|560260295|FG003|Treatment Period|Other reasons|0|||
155223894|NCT00743652|560260302|FG000|Overall Study|Parent/Legal Guardian Request|3|||
155223895|NCT00743652|560260303|FG001|Overall Study|Parent/Legal Guardian Request|2|||
155223896|NCT00743652|560260304|FG002|Overall Study|Parent/Legal Guardian Request|2|||
155223897|NCT00743652|560260305|FG003|Overall Study|Parent/Legal Guardian Request|2|||
155223898|NCT00743652|560260306|FG004|Overall Study|Parent/Legal Guardian Request|0|||
155223899|NCT00743652|560260302|FG000|Overall Study|Adverse Event|3|||
155223900|NCT00743652|560260303|FG001|Overall Study|Adverse Event|0|||
155223901|NCT00743652|560260304|FG002|Overall Study|Adverse Event|0|||
155223902|NCT00743652|560260305|FG003|Overall Study|Adverse Event|0|||
155223903|NCT00743652|560260306|FG004|Overall Study|Adverse Event|0|||
155223904|NCT00743652|560260302|FG000|Overall Study|Death|2|||
155223905|NCT00743652|560260303|FG001|Overall Study|Death|0|||
155223906|NCT00743652|560260304|FG002|Overall Study|Death|0|||
155223907|NCT00743652|560260305|FG003|Overall Study|Death|0|||
155223908|NCT00743652|560260306|FG004|Overall Study|Death|0|||
155223909|NCT00743652|560260302|FG000|Overall Study|Investigator Request|0|||
155223910|NCT00743652|560260303|FG001|Overall Study|Investigator Request|0|||
155223911|NCT00743652|560260304|FG002|Overall Study|Investigator Request|0|||
155223912|NCT00743652|560260305|FG003|Overall Study|Investigator Request|2|||
155223913|NCT00743652|560260306|FG004|Overall Study|Investigator Request|0|||
155223914|NCT00743652|560260302|FG000|Overall Study|Other|1|||
155223915|NCT00743652|560260303|FG001|Overall Study|Other|1|||
155223916|NCT00743652|560260304|FG002|Overall Study|Other|0|||
155223917|NCT00743652|560260305|FG003|Overall Study|Other|0|||
155223918|NCT00743652|560260306|FG004|Overall Study|Other|0|||
155223919|NCT00743652|560260302|FG000|Overall Study|Lost to Follow-up|1|||
155223920|NCT00743652|560260303|FG001|Overall Study|Lost to Follow-up|0|||
155223921|NCT00743652|560260304|FG002|Overall Study|Lost to Follow-up|0|||
155223922|NCT00743652|560260305|FG003|Overall Study|Lost to Follow-up|0|||
155223923|NCT00743652|560260306|FG004|Overall Study|Lost to Follow-up|0|||
155223924|NCT00805766|560260307|FG000|Screening Period|Adverse Event|1|||
155223925|NCT00805766|560260307|FG000|Screening Period|Lack of Efficacy|2|||
155223926|NCT00805766|560260307|FG000|Screening Period|Pregnancy|1|||
155223927|NCT00805766|560260307|FG000|Screening Period|Responder|2|||
155223928|NCT00805766|560260307|FG000|Increased Dose Period|Adverse Event|4|||
155223929|NCT00805766|560260307|FG000|Increased Dose Period|Lack of Efficacy|7|||
155223930|NCT00805766|560260307|FG000|Increased Dose Period|Pregnancy|1|||
155223931|NCT00805766|560260307|FG000|Increased Dose Period|Withdrawal by Subject|1|||
155223932|NCT00228917|560260312|FG000|Overall Study|Migrated/moved from study area|0|||
155223933|NCT00228917|560260313|FG001|Overall Study|Migrated/moved from study area|0|||
155223934|NCT00228917|560260314|FG002|Overall Study|Migrated/moved from study area|0|||
155223935|NCT00228917|560260315|FG003|Overall Study|Migrated/moved from study area|0|||
155223936|NCT00228917|560260316|FG004|Overall Study|Migrated/moved from study area|0|||
155223937|NCT00228917|560260317|FG005|Overall Study|Migrated/moved from study area|2|||
155223938|NCT00228917|560260318|FG006|Overall Study|Migrated/moved from study area|0|||
155223939|NCT00228917|560260319|FG007|Overall Study|Migrated/moved from study area|0|||
155223940|NCT00409617|560260320|FG000|Overall Study|Adverse Event|57|||
155223941|NCT00409617|560260320|FG000|Overall Study|Lack of Efficacy|54|||
155223942|NCT00409617|560260320|FG000|Overall Study|Lost to Follow-up|2|||
155223943|NCT00409617|560260320|FG000|Overall Study|Protocol Violation|24|||
155223944|NCT00409617|560260320|FG000|Overall Study|Withdrawal by Subject|8|||
155223945|NCT00409617|560260320|FG000|Overall Study|Administrative reasons|1|||
155223946|NCT00409617|560260320|FG000|Overall Study|Not described|14|||
155223947|NCT00149747|560260323|FG000|Overall Study|Death|1|||
155223948|NCT00149747|560260324|FG001|Overall Study|Death|0|||
155223949|NCT00149747|560260323|FG000|Overall Study|Withdrawal by Subject|3|||
155223950|NCT00149747|560260324|FG001|Overall Study|Withdrawal by Subject|3|||
155223951|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
155223952|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
155223953|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
155223954|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
155223955|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
155223956|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
155223957|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
155223958|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223959|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223960|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223961|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
155223962|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
155223963|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
155223964|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
155223965|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
155223966|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
155223967|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223968|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223969|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223970|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223971|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
155223972|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223973|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
155223974|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223975|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223976|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223977|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
155223978|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223979|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223980|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223981|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223982|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223983|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223984|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
155223985|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223986|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
155223987|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
155223988|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
155223989|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
155223990|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
155223991|NCT03373383|560260325|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
155223992|NCT03373383|560260326|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223993|NCT03373383|560260327|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223994|NCT03373383|560260328|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223995|NCT03373383|560260329|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223996|NCT02159521|560260330|FG000|Overall Study|Enrolled but not treated|3|||
155223997|NCT02159521|560260330|FG000|Overall Study|Withdrawal by Subject|7|||
155223998|NCT02159521|560260330|FG000|Overall Study|Lost to Follow-up|6|||
155223999|NCT02159521|560260330|FG000|Overall Study|Death|1|||
155224000|NCT02159521|560260330|FG000|Overall Study|Other than specified|1|||
155224001|NCT04753164|560260333|FG000|Overall Study|Adverse Event|0|||
155224002|NCT04753164|560260334|FG001|Overall Study|Adverse Event|2|||
155224003|NCT04753164|560260333|FG000|Overall Study|Withdrawal by Subject|9|||
155224004|NCT04753164|560260334|FG001|Overall Study|Withdrawal by Subject|7|||
155224005|NCT04753164|560260333|FG000|Overall Study|Lost to Follow-up|6|||
155224006|NCT04753164|560260334|FG001|Overall Study|Lost to Follow-up|6|||
155224007|NCT04753164|560260333|FG000|Overall Study|Other|12|||
155224008|NCT04753164|560260334|FG001|Overall Study|Other|5|||
155224009|NCT00694369|560260335|FG000|Overall Study|Adverse Event|0|||
155224010|NCT00694369|560260336|FG001|Overall Study|Adverse Event|1|||
155224011|NCT00694369|560260337|FG002|Overall Study|Adverse Event|0|||
155224012|NCT00694369|560260338|FG003|Overall Study|Adverse Event|1|||
155224013|NCT00694369|560260339|FG004|Overall Study|Adverse Event|3|||
155224014|NCT00694369|560260335|FG000|Overall Study|Lost to Follow-up|0|||
155224015|NCT00694369|560260336|FG001|Overall Study|Lost to Follow-up|0|||
155224016|NCT00694369|560260337|FG002|Overall Study|Lost to Follow-up|1|||
155224017|NCT00694369|560260338|FG003|Overall Study|Lost to Follow-up|1|||
155224018|NCT00694369|560260339|FG004|Overall Study|Lost to Follow-up|0|||
155224019|NCT00694369|560260335|FG000|Overall Study|Physician Decision|0|||
155224020|NCT00694369|560260336|FG001|Overall Study|Physician Decision|0|||
155224021|NCT00694369|560260337|FG002|Overall Study|Physician Decision|0|||
155224022|NCT00694369|560260338|FG003|Overall Study|Physician Decision|0|||
155224023|NCT00694369|560260339|FG004|Overall Study|Physician Decision|1|||
155224024|NCT00694369|560260335|FG000|Overall Study|Protocol Violation|0|||
155224025|NCT00694369|560260336|FG001|Overall Study|Protocol Violation|1|||
155224026|NCT00694369|560260337|FG002|Overall Study|Protocol Violation|0|||
155224027|NCT00694369|560260338|FG003|Overall Study|Protocol Violation|0|||
155224028|NCT00694369|560260339|FG004|Overall Study|Protocol Violation|0|||
155224029|NCT00694369|560260335|FG000|Overall Study|Withdrawal by Subject|1|||
155224030|NCT00694369|560260336|FG001|Overall Study|Withdrawal by Subject|1|||
155224031|NCT00694369|560260337|FG002|Overall Study|Withdrawal by Subject|1|||
155224032|NCT00694369|560260338|FG003|Overall Study|Withdrawal by Subject|1|||
155224033|NCT00694369|560260339|FG004|Overall Study|Withdrawal by Subject|2|||
155224034|NCT00907374|560260340|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
155224035|NCT00907374|560260341|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
155224036|NCT02871739|560260342|FG000|Overall Study|Lost to Follow-up|3|||
155224037|NCT02871739|560260343|FG001|Overall Study|Lost to Follow-up|2|||
155224038|NCT02871739|560260344|FG002|Overall Study|Lost to Follow-up|0|||
155224039|NCT02871739|560260345|FG003|Overall Study|Lost to Follow-up|2|||
155224040|NCT01354496|560260351|FG000|Period 1|Adverse Event|0|||
155224041|NCT01354496|560260352|FG001|Period 1|Adverse Event|0|||
155224042|NCT01354496|560260353|FG002|Period 1|Adverse Event|1|||
155224043|NCT01354496|560260354|FG003|Period 1|Adverse Event|0|||
155224044|NCT01354496|560260355|FG004|Period 1|Adverse Event|0|||
155224045|NCT01354496|560260356|FG005|Period 1|Adverse Event|0|||
155224046|NCT01354496|560260351|FG000|Period 1|Physician Decision|0|||
155224047|NCT01354496|560260352|FG001|Period 1|Physician Decision|0|||
155224048|NCT01354496|560260353|FG002|Period 1|Physician Decision|1|||
155224049|NCT01354496|560260354|FG003|Period 1|Physician Decision|0|||
155224050|NCT01354496|560260355|FG004|Period 1|Physician Decision|0|||
155224051|NCT01354496|560260356|FG005|Period 1|Physician Decision|0|||
155224052|NCT01354496|560260351|FG000|Period 2|Adverse Event|0|||
155224053|NCT01354496|560260352|FG001|Period 2|Adverse Event|0|||
155224054|NCT01354496|560260353|FG002|Period 2|Adverse Event|0|||
155224055|NCT01354496|560260354|FG003|Period 2|Adverse Event|1|||
155224056|NCT01354496|560260355|FG004|Period 2|Adverse Event|0|||
155224057|NCT01354496|560260356|FG005|Period 2|Adverse Event|0|||
155224058|NCT01354496|560260351|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224059|NCT01354496|560260352|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
155224060|NCT01354496|560260353|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224061|NCT01354496|560260354|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
155224062|NCT01354496|560260355|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224063|NCT01354496|560260356|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224064|NCT01524692|560260359|FG000|Overall Study|Withdrawal by Subject|3|||
155224065|NCT03190889|560260360|FG000|Overall Study|Lost to Follow-up|7|||
155224066|NCT03190889|560260361|FG001|Overall Study|Lost to Follow-up|7|||
155224067|NCT03190889|560260362|FG002|Overall Study|Lost to Follow-up|3|||
155224068|NCT03190889|560260360|FG000|Overall Study|Withdrawal by Subject|1|||
155224069|NCT03190889|560260361|FG001|Overall Study|Withdrawal by Subject|1|||
155224070|NCT03190889|560260362|FG002|Overall Study|Withdrawal by Subject|2|||
155224071|NCT03190889|560260360|FG000|Overall Study|Did not complete protocol|4|||
155224072|NCT03190889|560260361|FG001|Overall Study|Did not complete protocol|9|||
155224073|NCT03190889|560260362|FG002|Overall Study|Did not complete protocol|0|||
155224074|NCT03190889|560260360|FG000|Overall Study|COVID-19|1|||
155224075|NCT03190889|560260361|FG001|Overall Study|COVID-19|0|||
155224076|NCT03190889|560260362|FG002|Overall Study|COVID-19|2|||
155224077|NCT01709695|560260363|FG000|Overall Study|Withdrawal by Subject|1|||
155224078|NCT01709695|560260364|FG001|Overall Study|Withdrawal by Subject|1|||
155224079|NCT04007523|560260365|FG000|Overall Study|Withdrawal by Subject|0|||
155224080|NCT04007523|560260366|FG001|Overall Study|Withdrawal by Subject|1|||
155224081|NCT04007523|560260367|FG002|Overall Study|Withdrawal by Subject|1|||
155224082|NCT04007523|560260368|FG003|Overall Study|Withdrawal by Subject|0|||
155224083|NCT04007523|560260365|FG000|Overall Study|ICU Transfer|0|||
155224084|NCT04007523|560260366|FG001|Overall Study|ICU Transfer|1|||
155224085|NCT04007523|560260367|FG002|Overall Study|ICU Transfer|0|||
155224086|NCT04007523|560260368|FG003|Overall Study|ICU Transfer|0|||
155224087|NCT04007523|560260365|FG000|Overall Study|COVID hospital closure|0|||
155224088|NCT04007523|560260366|FG001|Overall Study|COVID hospital closure|0|||
155224089|NCT04007523|560260367|FG002|Overall Study|COVID hospital closure|1|||
155224090|NCT04007523|560260368|FG003|Overall Study|COVID hospital closure|2|||
155224091|NCT04007523|560260365|FG000|Overall Study|Surgery cancelled|0|||
155224092|NCT04007523|560260366|FG001|Overall Study|Surgery cancelled|0|||
155224093|NCT04007523|560260367|FG002|Overall Study|Surgery cancelled|1|||
155224094|NCT04007523|560260368|FG003|Overall Study|Surgery cancelled|1|||
155224095|NCT02136576|560260372|FG000|Overall Study|Lost to Follow-up|2|||
155224096|NCT02136576|560260373|FG001|Overall Study|Lost to Follow-up|0|||
155224097|NCT02136576|560260374|FG002|Overall Study|Lost to Follow-up|0|||
155224098|NCT00537381|560260375|FG000|Overall Study|Adverse Event|13|||
155224099|NCT00537381|560260376|FG001|Overall Study|Adverse Event|9|||
155224100|NCT00537381|560260375|FG000|Overall Study|Death|3|||
155224101|NCT00537381|560260376|FG001|Overall Study|Death|3|||
155224102|NCT00537381|560260375|FG000|Overall Study|Withdrawal by Subject|5|||
155224103|NCT00537381|560260376|FG001|Overall Study|Withdrawal by Subject|14|||
155224104|NCT00537381|560260375|FG000|Overall Study|Physician Decision|7|||
155224105|NCT00537381|560260376|FG001|Overall Study|Physician Decision|6|||
155224106|NCT00537381|560260375|FG000|Overall Study|Disease Progression|9|||
155224107|NCT00537381|560260376|FG001|Overall Study|Disease Progression|18|||
155224108|NCT00537381|560260375|FG000|Overall Study|Sponsor decision|14|||
155224109|NCT00537381|560260376|FG001|Overall Study|Sponsor decision|9|||
155224110|NCT00537381|560260375|FG000|Overall Study|Other|5|||
155224111|NCT00537381|560260376|FG001|Overall Study|Other|3|||
155224112|NCT00680901|560260377|FG000|Overall Study|Ongoing: On Study Treatment|1|||
155224113|NCT00680901|560260378|FG001|Overall Study|Ongoing: On Study Treatment|0|||
155224114|NCT00680901|560260377|FG000|Overall Study|Ongoing: In Follow Up|1|||
155224115|NCT00680901|560260378|FG001|Overall Study|Ongoing: In Follow Up|0|||
155224116|NCT00680901|560260377|FG000|Overall Study|Adverse Event|1|||
155224117|NCT00680901|560260378|FG001|Overall Study|Adverse Event|1|||
155224118|NCT00680901|560260377|FG000|Overall Study|Lost to Follow-up|3|||
155224119|NCT00680901|560260378|FG001|Overall Study|Lost to Follow-up|5|||
155224120|NCT00680901|560260377|FG000|Overall Study|Subject decided to withdraw from the study|4|||
155224121|NCT00680901|560260378|FG001|Overall Study|Subject decided to withdraw from the study|15|||
155224122|NCT00680901|560260377|FG000|Overall Study|Sponsor decision|1|||
155224123|NCT00680901|560260378|FG001|Overall Study|Sponsor decision|0|||
155224124|NCT00680901|560260377|FG000|Overall Study|Physician Decision|0|||
155224125|NCT00680901|560260378|FG001|Overall Study|Physician Decision|2|||
155224126|NCT00680901|560260377|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
155224127|NCT00680901|560260378|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
155224128|NCT00680901|560260377|FG000|Overall Study|Other protocol defined stopping criteria|17|||
155224129|NCT00680901|560260378|FG001|Overall Study|Other protocol defined stopping criteria|17|||
155224130|NCT03717480|560260385|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
155224131|NCT01708174|560260386|FG000|Treatment Period|Withdrawal by Subject|1|||
155224132|NCT01708174|560260387|FG001|Treatment Period|Withdrawal by Subject|0|||
155224133|NCT01708174|560260388|FG002|Treatment Period|Withdrawal by Subject|0|||
155224134|NCT01708174|560260386|FG000|Treatment Period|Progressive disease|0|||
155224135|NCT01708174|560260387|FG001|Treatment Period|Progressive disease|1|||
155224136|NCT01708174|560260388|FG002|Treatment Period|Progressive disease|0|||
155224137|NCT01708174|560260386|FG000|Treatment Period|Death|0|||
155224138|NCT01708174|560260387|FG001|Treatment Period|Death|0|||
155224139|NCT01708174|560260388|FG002|Treatment Period|Death|1|||
155224140|NCT01708174|560260386|FG000|Treatment Period|Adverse Event|0|||
155224141|NCT01708174|560260387|FG001|Treatment Period|Adverse Event|1|||
155224142|NCT01708174|560260388|FG002|Treatment Period|Adverse Event|0|||
155224143|NCT01894152|560260389|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
155224144|NCT02741700|560260390|FG000|Overall Study|Lost to Follow-up|17|||
155224145|NCT02741700|560260391|FG001|Overall Study|Lost to Follow-up|8|||
155224146|NCT02741700|560260390|FG000|Overall Study|Withdrawal by Subject|2|||
155224147|NCT02741700|560260391|FG001|Overall Study|Withdrawal by Subject|5|||
155224148|NCT02741700|560260390|FG000|Overall Study|Physician Decision|3|||
155224149|NCT02741700|560260391|FG001|Overall Study|Physician Decision|0|||
155224150|NCT02741700|560260390|FG000|Overall Study|Moved out of State|0|||
155224151|NCT02741700|560260391|FG001|Overall Study|Moved out of State|1|||
155224152|NCT02741700|560260390|FG000|Overall Study|Death|4|||
155224153|NCT02741700|560260391|FG001|Overall Study|Death|5|||
155224154|NCT00923559|560260392|FG000|Overall Study|Lost to Follow-up|2|||
155224155|NCT00923559|560260393|FG001|Overall Study|Lost to Follow-up|3|||
155224156|NCT01774786|560260394|FG000|Overall Study|Death|300|||
155224157|NCT01774786|560260395|FG001|Overall Study|Death|319|||
155224158|NCT01774786|560260394|FG000|Overall Study|Lost to Follow-up|6|||
155224159|NCT01774786|560260395|FG001|Overall Study|Lost to Follow-up|7|||
155224160|NCT01774786|560260394|FG000|Overall Study|Withdrawal by Subject|18|||
155224161|NCT01774786|560260395|FG001|Overall Study|Withdrawal by Subject|14|||
155224162|NCT01774786|560260394|FG000|Overall Study|Physician Decision|2|||
155224163|NCT01774786|560260395|FG001|Overall Study|Physician Decision|0|||
155224164|NCT01774786|560260394|FG000|Overall Study|Non-compliance|0|||
155224165|NCT01774786|560260395|FG001|Overall Study|Non-compliance|1|||
155224166|NCT01774786|560260394|FG000|Overall Study|Reason Not Specified|2|||
155224167|NCT01774786|560260395|FG001|Overall Study|Reason Not Specified|5|||
155224168|NCT02268812|560260396|FG000|Overall Study|Adverse Event|8|||
155224169|NCT02268812|560260397|FG001|Overall Study|Adverse Event|26|||
155224170|NCT02268812|560260398|FG002|Overall Study|Adverse Event|7|||
155224171|NCT02268812|560260399|FG003|Overall Study|Adverse Event|10|||
155224172|NCT02268812|560260396|FG000|Overall Study|Protocol deviation|0|||
155224173|NCT02268812|560260397|FG001|Overall Study|Protocol deviation|0|||
155224174|NCT02268812|560260398|FG002|Overall Study|Protocol deviation|1|||
155224175|NCT02268812|560260399|FG003|Overall Study|Protocol deviation|0|||
155224176|NCT02268812|560260396|FG000|Overall Study|Withdrawal by Subject|0|||
155224177|NCT02268812|560260397|FG001|Overall Study|Withdrawal by Subject|1|||
155224178|NCT02268812|560260398|FG002|Overall Study|Withdrawal by Subject|0|||
155224179|NCT02268812|560260399|FG003|Overall Study|Withdrawal by Subject|0|||
155491447|NCT01740297|561225388|FG002|Overall Study|Withdrawal by Subject|17|||
155224180|NCT02268812|560260396|FG000|Overall Study|Physician Decision|3|||
155224181|NCT02268812|560260397|FG001|Overall Study|Physician Decision|1|||
155224182|NCT02268812|560260398|FG002|Overall Study|Physician Decision|0|||
155224183|NCT02268812|560260399|FG003|Overall Study|Physician Decision|1|||
155224184|NCT02268812|560260396|FG000|Overall Study|Other|5|||
155224185|NCT02268812|560260397|FG001|Overall Study|Other|4|||
155224186|NCT02268812|560260398|FG002|Overall Study|Other|1|||
155224187|NCT02268812|560260399|FG003|Overall Study|Other|3|||
155224188|NCT00075582|560260400|FG000|Overall Study|Adverse Event|3|||
155224189|NCT00075582|560260401|FG001|Overall Study|Adverse Event|1|||
155224190|NCT00075582|560260400|FG000|Overall Study|Lack of Efficacy|4|||
155224191|NCT00075582|560260401|FG001|Overall Study|Lack of Efficacy|8|||
155224192|NCT00075582|560260400|FG000|Overall Study|Physician Decision|5|||
155224193|NCT00075582|560260401|FG001|Overall Study|Physician Decision|8|||
155224194|NCT00075582|560260400|FG000|Overall Study|Withdrawal by Subject|2|||
155224195|NCT00075582|560260401|FG001|Overall Study|Withdrawal by Subject|2|||
155224196|NCT00075582|560260400|FG000|Overall Study|Ineligible for study|36|||
155224197|NCT00075582|560260401|FG001|Overall Study|Ineligible for study|16|||
155224198|NCT02385084|560260402|FG000|Period 2|Protocol Violation|0|||
155224199|NCT02385084|560260403|FG001|Period 2|Protocol Violation|0|||
155224200|NCT02385084|560260404|FG002|Period 2|Protocol Violation|1|||
155224201|NCT02385084|560260405|FG003|Period 2|Protocol Violation|0|||
155224202|NCT02385084|560260406|FG004|Period 2|Protocol Violation|0|||
155224203|NCT02385084|560260407|FG005|Period 2|Protocol Violation|0|||
155224204|NCT04544293|560260408|FG000|Double-blind|Adverse Event|2|||
155224205|NCT04544293|560260409|FG001|Double-blind|Adverse Event|1|||
155224206|NCT04544293|560260408|FG000|Double-blind|Pregnancy|0|||
155224207|NCT04544293|560260409|FG001|Double-blind|Pregnancy|1|||
155224208|NCT04544293|560260408|FG000|Double-blind|Lost to Follow-up|0|||
155224209|NCT04544293|560260409|FG001|Double-blind|Lost to Follow-up|1|||
155224210|NCT04544293|560260408|FG000|Open-Label Extension|Study ongoing|79|||
155224211|NCT04544293|560260409|FG001|Open-Label Extension|Study ongoing|81|||
155224212|NCT01951157|560260416|FG000|Overall Study|Progressive Disease|12|||
155224213|NCT01951157|560260417|FG001|Overall Study|Progressive Disease|13|||
155224214|NCT01951157|560260418|FG002|Overall Study|Progressive Disease|10|||
155224215|NCT01951157|560260416|FG000|Overall Study|Treatment-unrelated AE|1|||
155224216|NCT01951157|560260417|FG001|Overall Study|Treatment-unrelated AE|0|||
155224217|NCT01951157|560260418|FG002|Overall Study|Treatment-unrelated AE|3|||
155224218|NCT01951157|560260416|FG000|Overall Study|Study Termination|0|||
155224219|NCT01951157|560260417|FG001|Overall Study|Study Termination|0|||
155224220|NCT01951157|560260418|FG002|Overall Study|Study Termination|1|||
155224221|NCT01951157|560260416|FG000|Overall Study|Physician Decision|5|||
155224222|NCT01951157|560260417|FG001|Overall Study|Physician Decision|3|||
155224223|NCT01951157|560260418|FG002|Overall Study|Physician Decision|2|||
155224224|NCT01951157|560260416|FG000|Overall Study|Non-treatmentrelated death|2|||
155224225|NCT01951157|560260417|FG001|Overall Study|Non-treatmentrelated death|2|||
155224226|NCT01951157|560260418|FG002|Overall Study|Non-treatmentrelated death|2|||
155224227|NCT01951157|560260416|FG000|Overall Study|No treated|0|||
155224228|NCT01951157|560260417|FG001|Overall Study|No treated|1|||
155224229|NCT01951157|560260418|FG002|Overall Study|No treated|0|||
155224230|NCT01951157|560260416|FG000|Overall Study|Treatment-related AE|2|||
155224231|NCT01951157|560260417|FG001|Overall Study|Treatment-related AE|0|||
155224232|NCT01951157|560260418|FG002|Overall Study|Treatment-related AE|4|||
155224233|NCT01951157|560260416|FG000|Overall Study|Consent withdrawn by subject|0|||
155224234|NCT01951157|560260417|FG001|Overall Study|Consent withdrawn by subject|1|||
155224235|NCT01951157|560260418|FG002|Overall Study|Consent withdrawn by subject|3|||
155224236|NCT01951157|560260416|FG000|Overall Study|Treatment-related death|0|||
155224237|NCT01951157|560260417|FG001|Overall Study|Treatment-related death|2|||
155224238|NCT01951157|560260418|FG002|Overall Study|Treatment-related death|0|||
155224239|NCT00744627|560260419|FG000|Overall Study|Adverse Event|6|||
155224240|NCT00744627|560260420|FG001|Overall Study|Adverse Event|9|||
155224241|NCT00744627|560260419|FG000|Overall Study|Lack of Efficacy|7|||
155224242|NCT00744627|560260420|FG001|Overall Study|Lack of Efficacy|3|||
155224243|NCT00744627|560260419|FG000|Overall Study|Noncompliance|0|||
155224244|NCT00744627|560260420|FG001|Overall Study|Noncompliance|1|||
155224245|NCT00744627|560260419|FG000|Overall Study|Protocol Deviations|0|||
155224246|NCT00744627|560260420|FG001|Overall Study|Protocol Deviations|2|||
155224247|NCT00744627|560260419|FG000|Overall Study|Voluntary Withdrawal|9|||
155224248|NCT00744627|560260420|FG001|Overall Study|Voluntary Withdrawal|6|||
155224249|NCT00744627|560260419|FG000|Overall Study|Lost to Follow-up|2|||
155224250|NCT00744627|560260420|FG001|Overall Study|Lost to Follow-up|1|||
155224251|NCT00744627|560260419|FG000|Overall Study|Other|1|||
155224252|NCT00744627|560260420|FG001|Overall Study|Other|0|||
155224253|NCT02268786|560260421|FG000|Overall Study|No Euploid Embryos available|42|||
155224254|NCT02268786|560260422|FG001|Overall Study|No Euploid Embryos available|0|||
155224255|NCT02268786|560260421|FG000|Overall Study|Withdrawal by Subject|7|||
155224256|NCT02268786|560260422|FG001|Overall Study|Withdrawal by Subject|14|||
155224257|NCT02268786|560260421|FG000|Overall Study|Thaw Failure|6|||
155224258|NCT02268786|560260422|FG001|Overall Study|Thaw Failure|4|||
155224259|NCT02268786|560260421|FG000|Overall Study|Protocol Violation|1|||
155224260|NCT02268786|560260422|FG001|Overall Study|Protocol Violation|0|||
155224261|NCT04809220|560260425|FG000|Overall Study|Adverse Event|4|||
155224262|NCT04809220|560260426|FG001|Overall Study|Adverse Event|0|||
155224263|NCT04809220|560260425|FG000|Overall Study|Death|1|||
155224264|NCT04809220|560260426|FG001|Overall Study|Death|0|||
155224265|NCT04809220|560260425|FG000|Overall Study|Lost to Follow-up|3|||
155224266|NCT04809220|560260426|FG001|Overall Study|Lost to Follow-up|0|||
155224267|NCT04809220|560260425|FG000|Overall Study|Physician Decision|0|||
155224268|NCT04809220|560260426|FG001|Overall Study|Physician Decision|1|||
155224269|NCT04809220|560260425|FG000|Overall Study|Withdrawal by Subject|9|||
155224270|NCT04809220|560260426|FG001|Overall Study|Withdrawal by Subject|5|||
155224271|NCT04809220|560260425|FG000|Overall Study|Due to long-term overseas business trips|1|||
155224272|NCT04809220|560260426|FG001|Overall Study|Due to long-term overseas business trips|0|||
155224273|NCT00642668|560260435|FG000|Overall Study|Lost to Follow-up|1|||
155224274|NCT00642668|560260435|FG000|Overall Study|Adverse Event|2|||
155224275|NCT00642668|560260435|FG000|Overall Study|Death|2|||
155224276|NCT00642668|560260435|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155224277|NCT00642668|560260435|FG000|Overall Study|Failure to Return|1|||
155224278|NCT00642668|560260435|FG000|Overall Study|Dialysis Initiation|5|||
155224279|NCT00642668|560260435|FG000|Overall Study|Blood Transfusion|2|||
155224280|NCT01586819|560260436|FG000|Overall Study|Withdrawal by Subject|1|||
155224281|NCT01586819|560260437|FG001|Overall Study|Withdrawal by Subject|0|||
155224282|NCT00896337|560260438|FG000|Overall Study|Death|7|||
155224283|NCT00896337|560260438|FG000|Overall Study|Withdrawal by Subject|7|||
155224284|NCT00896337|560260438|FG000|Overall Study|Lost to Follow-up|11|||
155224285|NCT01132495|560260449|FG000|Overall Study|Various reasons|40|||
155224286|NCT01132495|560260450|FG001|Overall Study|Various reasons|38|||
155224287|NCT01132495|560260451|FG002|Overall Study|Various reasons|20|||
155224288|NCT01132495|560260452|FG003|Overall Study|Various reasons|12|||
155224289|NCT01796197|560260455|FG000|Overall Study|Lost to Follow-up|1|||
155224290|NCT01796197|560260455|FG000|Overall Study|Lack of Efficacy|1|||
155224291|NCT00244712|560260456|FG000|Overall Study|Adverse Event|20|||
155224292|NCT00244712|560260457|FG001|Overall Study|Adverse Event|21|||
155224293|NCT00244712|560260456|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
155224294|NCT00244712|560260457|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
155224295|NCT00244712|560260456|FG000|Overall Study|Lack of Compliance|10|||
155224296|NCT00244712|560260457|FG001|Overall Study|Lack of Compliance|11|||
155224297|NCT00244712|560260456|FG000|Overall Study|Lost to Follow-up|45|||
155224298|NCT00244712|560260457|FG001|Overall Study|Lost to Follow-up|52|||
155224299|NCT00244712|560260456|FG000|Overall Study|Withdrawal by Subject|13|||
155224300|NCT00244712|560260457|FG001|Overall Study|Withdrawal by Subject|23|||
155224301|NCT00244712|560260456|FG000|Overall Study|Protocol Violation, disease progression|13|||
155224302|NCT00244712|560260457|FG001|Overall Study|Protocol Violation, disease progression|11|||
155224303|NCT01077804|560260460|FG000|Overall Study|Unreachable|102|||
155224304|NCT01077804|560260460|FG000|Overall Study|Refused to continue|79|||
155224305|NCT01077804|560260460|FG000|Overall Study|Other|18|||
155224306|NCT02776917|560260461|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
155224307|NCT00574405|560262447|FG000|Overall Study|Withdrawal by Subject|3|||
155224308|NCT00574405|560262448|FG001|Overall Study|Withdrawal by Subject|2|||
155224309|NCT01336738|560262449|FG000|Overall Study|Adverse Event|0|||
155224310|NCT01336738|560262450|FG001|Overall Study|Adverse Event|3|||
155224311|NCT01336738|560262451|FG002|Overall Study|Adverse Event|2|||
155224312|NCT01336738|560262452|FG003|Overall Study|Adverse Event|1|||
155224313|NCT01336738|560262453|FG004|Overall Study|Adverse Event|3|||
155224314|NCT01336738|560262449|FG000|Overall Study|Lost to Follow-up|2|||
155224315|NCT01336738|560262450|FG001|Overall Study|Lost to Follow-up|1|||
155224316|NCT01336738|560262451|FG002|Overall Study|Lost to Follow-up|2|||
155224317|NCT01336738|560262452|FG003|Overall Study|Lost to Follow-up|2|||
155224318|NCT01336738|560262453|FG004|Overall Study|Lost to Follow-up|2|||
155224319|NCT01336738|560262449|FG000|Overall Study|Did not meet entrance criteria|0|||
155224320|NCT01336738|560262450|FG001|Overall Study|Did not meet entrance criteria|1|||
155224321|NCT01336738|560262451|FG002|Overall Study|Did not meet entrance criteria|0|||
155224322|NCT01336738|560262452|FG003|Overall Study|Did not meet entrance criteria|0|||
155224323|NCT01336738|560262453|FG004|Overall Study|Did not meet entrance criteria|0|||
155224324|NCT01336738|560262449|FG000|Overall Study|Protocol Violation|0|||
155224325|NCT01336738|560262450|FG001|Overall Study|Protocol Violation|1|||
155224326|NCT01336738|560262451|FG002|Overall Study|Protocol Violation|0|||
155224327|NCT01336738|560262452|FG003|Overall Study|Protocol Violation|0|||
155224328|NCT01336738|560262453|FG004|Overall Study|Protocol Violation|0|||
155224329|NCT01336738|560262449|FG000|Overall Study|Withdrawal by Subject|2|||
155224330|NCT01336738|560262450|FG001|Overall Study|Withdrawal by Subject|0|||
155224331|NCT01336738|560262451|FG002|Overall Study|Withdrawal by Subject|2|||
155224332|NCT01336738|560262452|FG003|Overall Study|Withdrawal by Subject|1|||
155224333|NCT01336738|560262453|FG004|Overall Study|Withdrawal by Subject|1|||
155224334|NCT01336738|560262449|FG000|Overall Study|Other|3|||
155224335|NCT01336738|560262450|FG001|Overall Study|Other|3|||
155224336|NCT01336738|560262451|FG002|Overall Study|Other|2|||
155224337|NCT01336738|560262452|FG003|Overall Study|Other|3|||
155224338|NCT01336738|560262453|FG004|Overall Study|Other|4|||
155224339|NCT01083433|560262454|FG000|Overall Study|Lost to Follow-up|2|||
155224340|NCT01083433|560262455|FG001|Overall Study|Lost to Follow-up|1|||
155224341|NCT01083433|560262456|FG002|Overall Study|Lost to Follow-up|1|||
155224342|NCT01083433|560262454|FG000|Overall Study|Withdrawal by Subject|0|||
155224343|NCT01083433|560262455|FG001|Overall Study|Withdrawal by Subject|5|||
155224344|NCT01083433|560262456|FG002|Overall Study|Withdrawal by Subject|3|||
155224345|NCT01083433|560262454|FG000|Overall Study|Pregnancy|0|||
155224346|NCT01083433|560262455|FG001|Overall Study|Pregnancy|0|||
155224347|NCT01083433|560262456|FG002|Overall Study|Pregnancy|1|||
155224348|NCT01332149|560262458|FG000|Overall Study|Adverse Event|11|||
155224349|NCT01332149|560262459|FG001|Overall Study|Adverse Event|9|||
155224350|NCT01332149|560262458|FG000|Overall Study|Other unspecified|5|||
155224351|NCT01332149|560262459|FG001|Overall Study|Other unspecified|7|||
155224352|NCT01332149|560262458|FG000|Overall Study|Protocol Violation|1|||
155224353|NCT01332149|560262459|FG001|Overall Study|Protocol Violation|3|||
155224354|NCT01332149|560262458|FG000|Overall Study|Withdrawal by Subject|4|||
155224355|NCT01332149|560262459|FG001|Overall Study|Withdrawal by Subject|5|||
155224356|NCT01332149|560262458|FG000|Overall Study|Lost to Follow-up|1|||
155224357|NCT01332149|560262459|FG001|Overall Study|Lost to Follow-up|1|||
155224358|NCT01332149|560262458|FG000|Overall Study|Insufficient clinical response|4|||
155224359|NCT01332149|560262459|FG001|Overall Study|Insufficient clinical response|7|||
155224360|NCT01332149|560262458|FG000|Overall Study|Did not meet entrance criteria|3|||
155224361|NCT01332149|560262459|FG001|Overall Study|Did not meet entrance criteria|4|||
155224362|NCT01332149|560262458|FG000|Overall Study|Randomized but not treated|1|||
155224363|NCT01332149|560262459|FG001|Overall Study|Randomized but not treated|2|||
155224364|NCT04982029|560262460|FG000|Overall Study|Lost to Follow-up|2|||
155224365|NCT04982029|560262461|FG001|Overall Study|Lost to Follow-up|3|||
155224366|NCT04615949|560262462|FG000|Overall Study|Withdrawal by Subject|2|||
155224367|NCT04615949|560262463|FG001|Overall Study|Withdrawal by Subject|4|||
155224368|NCT04615949|560262462|FG000|Overall Study|Lost to Follow-up|2|||
155224369|NCT04615949|560262463|FG001|Overall Study|Lost to Follow-up|2|||
155224370|NCT04615949|560262462|FG000|Overall Study|Death|0|||
155224371|NCT04615949|560262463|FG001|Overall Study|Death|2|||
155224372|NCT03036566|560262464|FG000|Overall Study|Lost to Follow-up|3|||
155224373|NCT05458856|560262465|FG000|Overall Study|Withdrawal by Subject|5|||
155224374|NCT05458856|560262465|FG000|Overall Study|Death|4|||
155224375|NCT05458856|560262465|FG000|Overall Study|Protocol Deviation|3|||
155224376|NCT05458856|560262465|FG000|Overall Study|Physician Decision|1|||
155224377|NCT00110812|560262468|FG000|Main Study|Death|0|||
155224378|NCT00110812|560262469|FG001|Main Study|Death|0|||
155224379|NCT00110812|560262470|FG002|Main Study|Death|2|||
155224380|NCT00110812|560262468|FG000|Main Study|Withdrawal by Subject|0|||
155224381|NCT00110812|560262469|FG001|Main Study|Withdrawal by Subject|0|||
155224382|NCT00110812|560262470|FG002|Main Study|Withdrawal by Subject|1|||
155224383|NCT00110812|560262468|FG000|Main Study|Lost to Follow-up|8|||
155224384|NCT00110812|560262469|FG001|Main Study|Lost to Follow-up|11|||
155224385|NCT00110812|560262470|FG002|Main Study|Lost to Follow-up|10|||
155224386|NCT00110812|560262468|FG000|Extended Follow-up|Death|1|||
155224387|NCT00110812|560262469|FG001|Extended Follow-up|Death|0|||
155224388|NCT00110812|560262470|FG002|Extended Follow-up|Death|3|||
155224389|NCT00110812|560262468|FG000|Extended Follow-up|Withdrawal by Subject|0|||
155224390|NCT00110812|560262469|FG001|Extended Follow-up|Withdrawal by Subject|1|||
155224391|NCT00110812|560262470|FG002|Extended Follow-up|Withdrawal by Subject|0|||
155224392|NCT00110812|560262468|FG000|Extended Follow-up|Lost to Follow-up|1|||
155224393|NCT00110812|560262469|FG001|Extended Follow-up|Lost to Follow-up|3|||
155224394|NCT00110812|560262470|FG002|Extended Follow-up|Lost to Follow-up|1|||
155224395|NCT01344369|560262471|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155224396|NCT01344369|560262472|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
155224397|NCT01344369|560262471|FG000|Washout of 28 Days|Physician Decision|0|||
155224398|NCT01344369|560262472|FG001|Washout of 28 Days|Physician Decision|1|||
155224399|NCT01344369|560262471|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
155224400|NCT01344369|560262472|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
155224401|NCT01886833|560262473|FG000|Overall Study|IgA not available from both periods|204|||
155224402|NCT01454726|560262474|FG000|Overall Study|Withdrawal by Subject|0|||
155224403|NCT01454726|560262475|FG001|Overall Study|Withdrawal by Subject|1|||
155224404|NCT02919670|560262478|FG000|Overall Study|Only 17 participants met compliance|43|||
155224405|NCT02919670|560262479|FG001|Overall Study|Only 17 participants met compliance|39|||
155224406|NCT01714310|560262480|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
155224407|NCT01714310|560262481|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
155224408|NCT01714310|560262482|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
155224409|NCT01714310|560262480|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
155224410|NCT01714310|560262481|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
155224411|NCT01714310|560262482|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
155224412|NCT01714310|560262480|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
155224413|NCT01714310|560262481|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
155224414|NCT01714310|560262482|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
155491448|NCT01740297|561225386|FG000|Overall Study|Death|8|||
155224415|NCT01714310|560262480|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
155224416|NCT01714310|560262481|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
155224417|NCT01714310|560262482|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
155224418|NCT01641367|560262483|FG000|Cohorts|Death|18|||
155224419|NCT01641367|560262484|FG001|Cohorts|Death|1|||
155224420|NCT01641367|560262485|FG002|Cohorts|Death|2|||
155224421|NCT01641367|560262486|FG003|Cohorts|Death|0|||
155224422|NCT01641367|560262487|FG004|Cohorts|Death|1|||
155224423|NCT01641367|560262488|FG005|Cohorts|Death|1|||
155224424|NCT01641367|560262489|FG006|Cohorts|Death|0|||
155224425|NCT01641367|560262490|FG007|Cohorts|Death|0|||
155224426|NCT01641367|560262483|FG000|Cohorts|Lost to Follow-up|16|||
155224427|NCT01641367|560262484|FG001|Cohorts|Lost to Follow-up|0|||
155224428|NCT01641367|560262485|FG002|Cohorts|Lost to Follow-up|2|||
155224429|NCT01641367|560262486|FG003|Cohorts|Lost to Follow-up|0|||
155224430|NCT01641367|560262487|FG004|Cohorts|Lost to Follow-up|2|||
155224431|NCT01641367|560262488|FG005|Cohorts|Lost to Follow-up|0|||
155224432|NCT01641367|560262489|FG006|Cohorts|Lost to Follow-up|0|||
155224433|NCT01641367|560262490|FG007|Cohorts|Lost to Follow-up|0|||
155224434|NCT01641367|560262483|FG000|Randomized Adherence Intervention|Death|0|||
155224435|NCT01641367|560262484|FG001|Randomized Adherence Intervention|Death|0|||
155224436|NCT01641367|560262485|FG002|Randomized Adherence Intervention|Death|0|||
155224437|NCT01641367|560262486|FG003|Randomized Adherence Intervention|Death|0|||
155224438|NCT01641367|560262487|FG004|Randomized Adherence Intervention|Death|0|||
155224439|NCT01641367|560262488|FG005|Randomized Adherence Intervention|Death|0|||
155224440|NCT01641367|560262489|FG006|Randomized Adherence Intervention|Death|11|||
155224441|NCT01641367|560262490|FG007|Randomized Adherence Intervention|Death|12|||
155224442|NCT01641367|560262483|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224443|NCT01641367|560262484|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224444|NCT01641367|560262485|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224445|NCT01641367|560262486|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224446|NCT01641367|560262487|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224447|NCT01641367|560262488|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224448|NCT01641367|560262489|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
155224449|NCT01641367|560262490|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
155224450|NCT00826267|560262491|FG000|Overall Study|Other Adverse Event|1|||
155224451|NCT00826267|560262492|FG001|Overall Study|Other Adverse Event|0|||
155224452|NCT00826267|560262493|FG002|Overall Study|Other Adverse Event|0|||
155224453|NCT01675882|560262496|FG000|Overall Study|Adverse Event|0|||
155224454|NCT01675882|560262497|FG001|Overall Study|Adverse Event|2|||
155224455|NCT01675882|560262498|FG002|Overall Study|Adverse Event|1|||
155224456|NCT01675882|560262499|FG003|Overall Study|Adverse Event|0|||
155224457|NCT01675882|560262496|FG000|Overall Study|Participant unwilling to continue|2|||
155224458|NCT01675882|560262497|FG001|Overall Study|Participant unwilling to continue|4|||
155224459|NCT01675882|560262498|FG002|Overall Study|Participant unwilling to continue|2|||
155224460|NCT01675882|560262499|FG003|Overall Study|Participant unwilling to continue|1|||
155224461|NCT01675882|560262496|FG000|Overall Study|Lost to Follow-up|0|||
155224462|NCT01675882|560262497|FG001|Overall Study|Lost to Follow-up|1|||
155224463|NCT01675882|560262498|FG002|Overall Study|Lost to Follow-up|0|||
155224464|NCT01675882|560262499|FG003|Overall Study|Lost to Follow-up|0|||
155224465|NCT01675882|560262496|FG000|Overall Study|Non-compliance|0|||
155224466|NCT01675882|560262497|FG001|Overall Study|Non-compliance|0|||
155224467|NCT01675882|560262498|FG002|Overall Study|Non-compliance|0|||
155224468|NCT01675882|560262499|FG003|Overall Study|Non-compliance|1|||
155224469|NCT00850200|560262500|FG000|Overall Study|Physician Decision|2|||
155224470|NCT00850200|560262500|FG000|Overall Study|Did not recieve treatment|2|||
155224471|NCT00850200|560262500|FG000|Overall Study|Withdrawal by Subject|1|||
155224472|NCT02129803|560262506|FG000|Overall Study|Protocol Violation|4|||
155224473|NCT02129803|560262507|FG001|Overall Study|Protocol Violation|0|||
155224474|NCT02129803|560262506|FG000|Overall Study|Physician Decision|0|||
155224475|NCT02129803|560262507|FG001|Overall Study|Physician Decision|1|||
155224476|NCT02129803|560262506|FG000|Overall Study|Difficulty sleeping|1|||
155224477|NCT02129803|560262507|FG001|Overall Study|Difficulty sleeping|0|||
155224478|NCT02129803|560262506|FG000|Overall Study|Morning headache|0|||
155224479|NCT02129803|560262507|FG001|Overall Study|Morning headache|1|||
155224480|NCT02129803|560262506|FG000|Overall Study|Withdrawal by Subject|1|||
155224481|NCT02129803|560262507|FG001|Overall Study|Withdrawal by Subject|1|||
155224482|NCT02689258|560262511|FG000|Overall Study|Subject Non-Compliance|0|||
155224483|NCT02689258|560262512|FG001|Overall Study|Subject Non-Compliance|1|||
155224484|NCT02689258|560262513|FG002|Overall Study|Subject Non-Compliance|0|||
155224485|NCT02689258|560262514|FG003|Overall Study|Subject Non-Compliance|0|||
155224486|NCT02689258|560262515|FG004|Overall Study|Subject Non-Compliance|0|||
155224487|NCT02689258|560262516|FG005|Overall Study|Subject Non-Compliance|0|||
155224488|NCT02689258|560262517|FG006|Overall Study|Subject Non-Compliance|0|||
155224489|NCT02689258|560262518|FG007|Overall Study|Subject Non-Compliance|0|||
155224490|NCT02689258|560262519|FG008|Overall Study|Subject Non-Compliance|0|||
155224491|NCT02689258|560262520|FG009|Overall Study|Subject Non-Compliance|0|||
155224492|NCT02689258|560262521|FG010|Overall Study|Subject Non-Compliance|0|||
155224493|NCT02689258|560262522|FG011|Overall Study|Subject Non-Compliance|0|||
155224494|NCT02689258|560262511|FG000|Overall Study|Subject Refusal to Continue|0|||
155224495|NCT02689258|560262512|FG001|Overall Study|Subject Refusal to Continue|1|||
155224496|NCT02689258|560262513|FG002|Overall Study|Subject Refusal to Continue|0|||
155224497|NCT02689258|560262514|FG003|Overall Study|Subject Refusal to Continue|0|||
155224498|NCT02689258|560262515|FG004|Overall Study|Subject Refusal to Continue|0|||
155224499|NCT02689258|560262516|FG005|Overall Study|Subject Refusal to Continue|0|||
155224500|NCT02689258|560262517|FG006|Overall Study|Subject Refusal to Continue|0|||
155224501|NCT02689258|560262518|FG007|Overall Study|Subject Refusal to Continue|0|||
155224502|NCT02689258|560262519|FG008|Overall Study|Subject Refusal to Continue|1|||
155224503|NCT02689258|560262520|FG009|Overall Study|Subject Refusal to Continue|0|||
155224504|NCT02689258|560262521|FG010|Overall Study|Subject Refusal to Continue|0|||
155224505|NCT02689258|560262522|FG011|Overall Study|Subject Refusal to Continue|1|||
155224506|NCT02689258|560262511|FG000|Overall Study|Other|0|||
155224507|NCT02689258|560262512|FG001|Overall Study|Other|2|||
155224508|NCT02689258|560262513|FG002|Overall Study|Other|0|||
155224509|NCT02689258|560262514|FG003|Overall Study|Other|0|||
155224510|NCT02689258|560262515|FG004|Overall Study|Other|1|||
155224511|NCT02689258|560262516|FG005|Overall Study|Other|0|||
155224512|NCT02689258|560262517|FG006|Overall Study|Other|0|||
155224513|NCT02689258|560262518|FG007|Overall Study|Other|0|||
155224514|NCT02689258|560262519|FG008|Overall Study|Other|1|||
155224515|NCT02689258|560262520|FG009|Overall Study|Other|0|||
155224516|NCT02689258|560262521|FG010|Overall Study|Other|0|||
155224517|NCT02689258|560262522|FG011|Overall Study|Other|0|||
155224518|NCT00594464|560262524|FG000|Overall Study|Withdrawal by Subject|1|||
155224519|NCT00594464|560262524|FG000|Overall Study|Delay in operation|2|||
155224520|NCT00785486|560262525|FG000|Midazolam Alone|Withdrawal by Subject|1|||
155224521|NCT02907359|560262530|FG000|Overall Study|Death|234|||
155224522|NCT02907359|560262531|FG001|Overall Study|Death|117|||
155224523|NCT02907359|560262530|FG000|Overall Study|Withdrawal by Subject|6|||
155224524|NCT02907359|560262531|FG001|Overall Study|Withdrawal by Subject|11|||
155224525|NCT02907359|560262530|FG000|Overall Study|Lost to Follow-up|1|||
155224526|NCT02907359|560262531|FG001|Overall Study|Lost to Follow-up|0|||
155224527|NCT03131440|560262532|FG000|Overall Study|Withdrawal by Subject|1|||
155224528|NCT03131440|560262533|FG001|Overall Study|Withdrawal by Subject|3|||
155224529|NCT03131440|560262534|FG002|Overall Study|Withdrawal by Subject|0|||
155224530|NCT03131440|560262535|FG003|Overall Study|Withdrawal by Subject|0|||
155224531|NCT03131440|560262536|FG004|Overall Study|Withdrawal by Subject|1|||
155224532|NCT03131440|560262537|FG005|Overall Study|Withdrawal by Subject|0|||
155224533|NCT03131440|560262538|FG006|Overall Study|Withdrawal by Subject|0|||
155224534|NCT03131440|560262539|FG007|Overall Study|Withdrawal by Subject|1|||
155224535|NCT03131440|560262540|FG008|Overall Study|Withdrawal by Subject|1|||
155224536|NCT03131440|560262541|FG009|Overall Study|Withdrawal by Subject|1|||
155224537|NCT03131440|560262542|FG010|Overall Study|Withdrawal by Subject|0|||
155224538|NCT03131440|560262543|FG011|Overall Study|Withdrawal by Subject|1|||
155224539|NCT03131440|560262544|FG012|Overall Study|Withdrawal by Subject|1|||
155224540|NCT03131440|560262545|FG013|Overall Study|Withdrawal by Subject|0|||
155224541|NCT03131440|560262546|FG014|Overall Study|Withdrawal by Subject|1|||
155224542|NCT03131440|560262547|FG015|Overall Study|Withdrawal by Subject|0|||
155224543|NCT03131440|560262548|FG016|Overall Study|Withdrawal by Subject|0|||
155224544|NCT03131440|560262549|FG017|Overall Study|Withdrawal by Subject|0|||
155224545|NCT03131440|560262550|FG018|Overall Study|Withdrawal by Subject|1|||
155224546|NCT03131440|560262551|FG019|Overall Study|Withdrawal by Subject|0|||
155224547|NCT03131440|560262552|FG020|Overall Study|Withdrawal by Subject|1|||
155224548|NCT03131440|560262553|FG021|Overall Study|Withdrawal by Subject|1|||
155224549|NCT03131440|560262554|FG022|Overall Study|Withdrawal by Subject|1|||
155224550|NCT03131440|560262555|FG023|Overall Study|Withdrawal by Subject|0|||
155224551|NCT03131440|560262556|FG024|Overall Study|Withdrawal by Subject|0|||
155224552|NCT03131440|560262557|FG025|Overall Study|Withdrawal by Subject|0|||
155224553|NCT03131440|560262558|FG026|Overall Study|Withdrawal by Subject|0|||
155224554|NCT03131440|560262559|FG027|Overall Study|Withdrawal by Subject|0|||
155224555|NCT03131440|560262560|FG028|Overall Study|Withdrawal by Subject|0|||
155224556|NCT03131440|560262561|FG029|Overall Study|Withdrawal by Subject|0|||
155224557|NCT03131440|560262562|FG030|Overall Study|Withdrawal by Subject|1|||
155224558|NCT03131440|560262563|FG031|Overall Study|Withdrawal by Subject|0|||
155224559|NCT03131440|560262532|FG000|Overall Study|Lost to Follow-up|0|||
155224560|NCT03131440|560262533|FG001|Overall Study|Lost to Follow-up|0|||
155224561|NCT03131440|560262534|FG002|Overall Study|Lost to Follow-up|0|||
155224562|NCT03131440|560262535|FG003|Overall Study|Lost to Follow-up|0|||
155224563|NCT03131440|560262536|FG004|Overall Study|Lost to Follow-up|0|||
155224564|NCT03131440|560262537|FG005|Overall Study|Lost to Follow-up|1|||
155224565|NCT03131440|560262538|FG006|Overall Study|Lost to Follow-up|0|||
155224566|NCT03131440|560262539|FG007|Overall Study|Lost to Follow-up|0|||
155224567|NCT03131440|560262540|FG008|Overall Study|Lost to Follow-up|0|||
155224568|NCT03131440|560262541|FG009|Overall Study|Lost to Follow-up|0|||
155224569|NCT03131440|560262542|FG010|Overall Study|Lost to Follow-up|0|||
155224570|NCT03131440|560262543|FG011|Overall Study|Lost to Follow-up|0|||
155224571|NCT03131440|560262544|FG012|Overall Study|Lost to Follow-up|0|||
155224572|NCT03131440|560262545|FG013|Overall Study|Lost to Follow-up|0|||
155224573|NCT03131440|560262546|FG014|Overall Study|Lost to Follow-up|0|||
155224574|NCT03131440|560262547|FG015|Overall Study|Lost to Follow-up|0|||
155224575|NCT03131440|560262548|FG016|Overall Study|Lost to Follow-up|0|||
155224576|NCT03131440|560262549|FG017|Overall Study|Lost to Follow-up|0|||
155224577|NCT03131440|560262550|FG018|Overall Study|Lost to Follow-up|0|||
155224578|NCT03131440|560262551|FG019|Overall Study|Lost to Follow-up|2|||
155224579|NCT03131440|560262552|FG020|Overall Study|Lost to Follow-up|1|||
155224580|NCT03131440|560262553|FG021|Overall Study|Lost to Follow-up|0|||
155224581|NCT03131440|560262554|FG022|Overall Study|Lost to Follow-up|1|||
155224582|NCT03131440|560262555|FG023|Overall Study|Lost to Follow-up|0|||
155224583|NCT03131440|560262556|FG024|Overall Study|Lost to Follow-up|1|||
155224584|NCT03131440|560262557|FG025|Overall Study|Lost to Follow-up|0|||
155224585|NCT03131440|560262558|FG026|Overall Study|Lost to Follow-up|0|||
155224586|NCT03131440|560262559|FG027|Overall Study|Lost to Follow-up|2|||
155224587|NCT03131440|560262560|FG028|Overall Study|Lost to Follow-up|0|||
155224588|NCT03131440|560262561|FG029|Overall Study|Lost to Follow-up|2|||
155224589|NCT03131440|560262562|FG030|Overall Study|Lost to Follow-up|0|||
155224590|NCT03131440|560262563|FG031|Overall Study|Lost to Follow-up|0|||
155224591|NCT03131440|560262532|FG000|Overall Study|Death|0|||
155224592|NCT03131440|560262533|FG001|Overall Study|Death|0|||
155224593|NCT03131440|560262534|FG002|Overall Study|Death|0|||
155224594|NCT03131440|560262535|FG003|Overall Study|Death|0|||
155224595|NCT03131440|560262536|FG004|Overall Study|Death|0|||
155224596|NCT03131440|560262537|FG005|Overall Study|Death|0|||
155224597|NCT03131440|560262538|FG006|Overall Study|Death|0|||
155224598|NCT03131440|560262539|FG007|Overall Study|Death|0|||
155224599|NCT03131440|560262540|FG008|Overall Study|Death|0|||
155224600|NCT03131440|560262541|FG009|Overall Study|Death|0|||
155224601|NCT03131440|560262542|FG010|Overall Study|Death|0|||
155224602|NCT03131440|560262543|FG011|Overall Study|Death|0|||
155224603|NCT03131440|560262544|FG012|Overall Study|Death|0|||
155224604|NCT03131440|560262545|FG013|Overall Study|Death|0|||
155224605|NCT03131440|560262546|FG014|Overall Study|Death|0|||
155224606|NCT03131440|560262547|FG015|Overall Study|Death|0|||
155224607|NCT03131440|560262548|FG016|Overall Study|Death|0|||
155224608|NCT03131440|560262549|FG017|Overall Study|Death|0|||
155224609|NCT03131440|560262550|FG018|Overall Study|Death|0|||
155224610|NCT03131440|560262551|FG019|Overall Study|Death|0|||
155224611|NCT03131440|560262552|FG020|Overall Study|Death|0|||
155224612|NCT03131440|560262553|FG021|Overall Study|Death|0|||
155224613|NCT03131440|560262554|FG022|Overall Study|Death|0|||
155224614|NCT03131440|560262555|FG023|Overall Study|Death|0|||
155224615|NCT03131440|560262556|FG024|Overall Study|Death|0|||
155224616|NCT03131440|560262557|FG025|Overall Study|Death|1|||
155224617|NCT03131440|560262558|FG026|Overall Study|Death|0|||
155224618|NCT03131440|560262559|FG027|Overall Study|Death|0|||
155224619|NCT03131440|560262560|FG028|Overall Study|Death|0|||
155224620|NCT03131440|560262561|FG029|Overall Study|Death|0|||
155224621|NCT03131440|560262562|FG030|Overall Study|Death|0|||
155224622|NCT03131440|560262563|FG031|Overall Study|Death|0|||
155224623|NCT00746941|560262566|FG000|Overall Study|Death|2|||
155224624|NCT00746941|560262567|FG001|Overall Study|Death|0|||
155224625|NCT00746941|560262568|FG002|Overall Study|Death|0|||
155224626|NCT00746941|560262569|FG003|Overall Study|Death|6|||
155224627|NCT00746941|560262566|FG000|Overall Study|Physician Decision|0|||
155224628|NCT00746941|560262567|FG001|Overall Study|Physician Decision|0|||
155224629|NCT00746941|560262568|FG002|Overall Study|Physician Decision|2|||
155224630|NCT00746941|560262569|FG003|Overall Study|Physician Decision|0|||
155224631|NCT00746941|560262566|FG000|Overall Study|Withdrawal by Subject|3|||
155224632|NCT00746941|560262567|FG001|Overall Study|Withdrawal by Subject|0|||
155224633|NCT00746941|560262568|FG002|Overall Study|Withdrawal by Subject|0|||
155224634|NCT00746941|560262569|FG003|Overall Study|Withdrawal by Subject|2|||
155224635|NCT00746941|560262566|FG000|Overall Study|Other, reason not provided|2|||
155224636|NCT00746941|560262567|FG001|Overall Study|Other, reason not provided|4|||
155224637|NCT00746941|560262568|FG002|Overall Study|Other, reason not provided|0|||
155224638|NCT00746941|560262569|FG003|Overall Study|Other, reason not provided|4|||
155224639|NCT00746941|560262566|FG000|Overall Study|Adverse Event|0|||
155224640|NCT00746941|560262567|FG001|Overall Study|Adverse Event|0|||
155224641|NCT00746941|560262568|FG002|Overall Study|Adverse Event|0|||
155224642|NCT00746941|560262569|FG003|Overall Study|Adverse Event|1|||
155224643|NCT02197806|560262579|FG000|Overall Study|Adverse Event|0|||
155224644|NCT02197806|560262580|FG001|Overall Study|Adverse Event|1|||
155224645|NCT02197806|560262581|FG002|Overall Study|Adverse Event|0|||
155224646|NCT02197806|560262582|FG003|Overall Study|Adverse Event|1|||
155224647|NCT03065244|560262584|FG000|Overall Study|Lost to Follow-up|1|||
155224648|NCT03065244|560262585|FG001|Overall Study|Lost to Follow-up|1|||
155224649|NCT03065244|560262584|FG000|Overall Study|Diagnosed with a different disease|1|||
155224650|NCT03065244|560262585|FG001|Overall Study|Diagnosed with a different disease|1|||
155224651|NCT03065244|560262584|FG000|Overall Study|Protocol Violation|0|||
155224652|NCT03065244|560262585|FG001|Overall Study|Protocol Violation|1|||
155224653|NCT03065244|560262584|FG000|Overall Study|Withdrawal by Subject|1|||
155224654|NCT03065244|560262585|FG001|Overall Study|Withdrawal by Subject|1|||
155224655|NCT00500292|560262586|FG000|Overall Study|Adverse Event|3|||
155224656|NCT00500292|560262587|FG001|Overall Study|Adverse Event|6|||
155224657|NCT00500292|560262588|FG002|Overall Study|Adverse Event|4|||
155224658|NCT00500292|560262586|FG000|Overall Study|Condition under investigation worsened|21|||
155224659|NCT00500292|560262587|FG001|Overall Study|Condition under investigation worsened|23|||
155224660|NCT00500292|560262588|FG002|Overall Study|Condition under investigation worsened|19|||
155224661|NCT00500292|560262586|FG000|Overall Study|Withdrawal by Subject|0|||
155224662|NCT00500292|560262587|FG001|Overall Study|Withdrawal by Subject|1|||
155224663|NCT00500292|560262588|FG002|Overall Study|Withdrawal by Subject|0|||
155224664|NCT00500292|560262586|FG000|Overall Study|Other|1|||
155224665|NCT00500292|560262587|FG001|Overall Study|Other|1|||
155224666|NCT00500292|560262588|FG002|Overall Study|Other|4|||
155224667|NCT03560531|560262592|FG000|Overall Study|Death|4|||
155224668|NCT03560531|560262593|FG001|Overall Study|Death|1|||
155224669|NCT03560531|560262594|FG002|Overall Study|Death|1|||
155224670|NCT03560531|560262595|FG003|Overall Study|Death|2|||
155224671|NCT03560531|560262596|FG004|Overall Study|Death|6|||
155224672|NCT03560531|560262597|FG005|Overall Study|Death|1|||
155224673|NCT03560531|560262598|FG006|Overall Study|Death|4|||
155224674|NCT03560531|560262599|FG007|Overall Study|Death|8|||
155224675|NCT03560531|560262600|FG008|Overall Study|Death|1|||
155224676|NCT03560531|560262601|FG009|Overall Study|Death|3|||
155224677|NCT03560531|560262602|FG010|Overall Study|Death|2|||
155224678|NCT03560531|560262603|FG011|Overall Study|Death|0|||
155224679|NCT03560531|560262604|FG012|Overall Study|Death|4|||
155224680|NCT03560531|560262605|FG013|Overall Study|Death|1|||
155224681|NCT03560531|560262592|FG000|Overall Study|Lost to Follow-up|1|||
155224682|NCT03560531|560262593|FG001|Overall Study|Lost to Follow-up|1|||
155224683|NCT03560531|560262594|FG002|Overall Study|Lost to Follow-up|0|||
155224684|NCT03560531|560262595|FG003|Overall Study|Lost to Follow-up|0|||
155224685|NCT03560531|560262596|FG004|Overall Study|Lost to Follow-up|0|||
155224686|NCT03560531|560262597|FG005|Overall Study|Lost to Follow-up|0|||
155224687|NCT03560531|560262598|FG006|Overall Study|Lost to Follow-up|1|||
155224688|NCT03560531|560262599|FG007|Overall Study|Lost to Follow-up|0|||
155224689|NCT03560531|560262600|FG008|Overall Study|Lost to Follow-up|0|||
155224690|NCT03560531|560262601|FG009|Overall Study|Lost to Follow-up|0|||
155224691|NCT03560531|560262602|FG010|Overall Study|Lost to Follow-up|0|||
155224692|NCT03560531|560262603|FG011|Overall Study|Lost to Follow-up|0|||
155224693|NCT03560531|560262604|FG012|Overall Study|Lost to Follow-up|0|||
155224694|NCT03560531|560262605|FG013|Overall Study|Lost to Follow-up|0|||
155224695|NCT03560531|560262592|FG000|Overall Study|Withdrawal by Subject|1|||
155224696|NCT03560531|560262593|FG001|Overall Study|Withdrawal by Subject|0|||
155224697|NCT03560531|560262594|FG002|Overall Study|Withdrawal by Subject|0|||
155224698|NCT03560531|560262595|FG003|Overall Study|Withdrawal by Subject|0|||
155224699|NCT03560531|560262596|FG004|Overall Study|Withdrawal by Subject|0|||
155224700|NCT03560531|560262597|FG005|Overall Study|Withdrawal by Subject|0|||
155224701|NCT03560531|560262598|FG006|Overall Study|Withdrawal by Subject|0|||
155224702|NCT03560531|560262599|FG007|Overall Study|Withdrawal by Subject|3|||
155224703|NCT03560531|560262600|FG008|Overall Study|Withdrawal by Subject|2|||
155224704|NCT03560531|560262601|FG009|Overall Study|Withdrawal by Subject|0|||
155224705|NCT03560531|560262602|FG010|Overall Study|Withdrawal by Subject|0|||
155224706|NCT03560531|560262603|FG011|Overall Study|Withdrawal by Subject|0|||
155224707|NCT03560531|560262604|FG012|Overall Study|Withdrawal by Subject|2|||
155224708|NCT03560531|560262605|FG013|Overall Study|Withdrawal by Subject|0|||
155224709|NCT03560531|560262592|FG000|Overall Study|Study end per-protocol|1|||
155224710|NCT03560531|560262593|FG001|Overall Study|Study end per-protocol|1|||
155224711|NCT03560531|560262594|FG002|Overall Study|Study end per-protocol|2|||
155224712|NCT03560531|560262595|FG003|Overall Study|Study end per-protocol|0|||
155224713|NCT03560531|560262596|FG004|Overall Study|Study end per-protocol|1|||
155224714|NCT03560531|560262597|FG005|Overall Study|Study end per-protocol|0|||
155224715|NCT03560531|560262598|FG006|Overall Study|Study end per-protocol|0|||
155224716|NCT03560531|560262599|FG007|Overall Study|Study end per-protocol|0|||
155224717|NCT03560531|560262600|FG008|Overall Study|Study end per-protocol|0|||
155224718|NCT03560531|560262601|FG009|Overall Study|Study end per-protocol|0|||
155224719|NCT03560531|560262602|FG010|Overall Study|Study end per-protocol|0|||
155224720|NCT03560531|560262603|FG011|Overall Study|Study end per-protocol|0|||
155224721|NCT03560531|560262604|FG012|Overall Study|Study end per-protocol|0|||
155224722|NCT03560531|560262605|FG013|Overall Study|Study end per-protocol|0|||
155224723|NCT03560531|560262592|FG000|Overall Study|Early study termination by sponsor|9|||
155224724|NCT03560531|560262593|FG001|Overall Study|Early study termination by sponsor|0|||
155224725|NCT03560531|560262594|FG002|Overall Study|Early study termination by sponsor|0|||
155224726|NCT03560531|560262595|FG003|Overall Study|Early study termination by sponsor|4|||
155224727|NCT03560531|560262596|FG004|Overall Study|Early study termination by sponsor|8|||
155224728|NCT03560531|560262597|FG005|Overall Study|Early study termination by sponsor|2|||
155224729|NCT03560531|560262598|FG006|Overall Study|Early study termination by sponsor|5|||
155224730|NCT03560531|560262599|FG007|Overall Study|Early study termination by sponsor|64|||
155224731|NCT03560531|560262600|FG008|Overall Study|Early study termination by sponsor|7|||
155224732|NCT03560531|560262601|FG009|Overall Study|Early study termination by sponsor|2|||
155224733|NCT03560531|560262602|FG010|Overall Study|Early study termination by sponsor|16|||
155224734|NCT03560531|560262603|FG011|Overall Study|Early study termination by sponsor|2|||
155224735|NCT03560531|560262604|FG012|Overall Study|Early study termination by sponsor|6|||
155224736|NCT03560531|560262605|FG013|Overall Study|Early study termination by sponsor|2|||
155224737|NCT03745144|560262606|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
155224738|NCT03745144|560262607|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
155224739|NCT03745144|560262608|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
155224740|NCT03745144|560262606|FG000|Period 1|Other|0|||
155224741|NCT03745144|560262607|FG001|Period 1|Other|0|||
155224742|NCT03745144|560262608|FG002|Period 1|Other|1|||
155224743|NCT01177540|560262609|FG000|Overall Study|Adverse Event|1|||
155224744|NCT01177540|560262610|FG001|Overall Study|Adverse Event|0|||
155224745|NCT02818777|560262616|FG000|Overall Study|Adverse Event|3|||
155224746|NCT00747435|560262628|FG000|Overall Study|Lost to Follow-up|2|||
155224747|NCT00747435|560262628|FG000|Overall Study|Withdrawal by Subject|3|||
155224748|NCT00747435|560262628|FG000|Overall Study|Still undergoing follow up|1|||
155224749|NCT01324349|560262629|FG000|Overall Study|Death|1|||
155224750|NCT01324349|560262630|FG001|Overall Study|Death|1|||
155224751|NCT01324349|560262629|FG000|Overall Study|Withdrawal by Subject|0|||
155224752|NCT01324349|560262630|FG001|Overall Study|Withdrawal by Subject|1|||
155224753|NCT00748215|560262631|FG000|Overall Study|Withdrawal by Subject|7|||
155224754|NCT00748215|560262632|FG001|Overall Study|Withdrawal by Subject|7|||
155224755|NCT00748215|560262631|FG000|Overall Study|Treatment change|2|||
155224756|NCT00748215|560262632|FG001|Overall Study|Treatment change|1|||
155224757|NCT00748215|560262631|FG000|Overall Study|Change in patient condition|0|||
155224758|NCT00748215|560262632|FG001|Overall Study|Change in patient condition|3|||
155224759|NCT00748215|560262631|FG000|Overall Study|Non-compliant|0|||
155224760|NCT00748215|560262632|FG001|Overall Study|Non-compliant|2|||
155224761|NCT00748215|560262631|FG000|Overall Study|Adverse Event|0|||
155224762|NCT00748215|560262632|FG001|Overall Study|Adverse Event|5|||
155224763|NCT02013167|560262633|FG000|Overall Study|Withdrawal by Subject|15|||
155224764|NCT02013167|560262634|FG001|Overall Study|Withdrawal by Subject|14|||
155224765|NCT02013167|560262633|FG000|Overall Study|Sponsor Decision|1|||
155224766|NCT02013167|560262634|FG001|Overall Study|Sponsor Decision|3|||
155224767|NCT02013167|560262633|FG000|Overall Study|Lost to Follow-up|0|||
155224768|NCT02013167|560262634|FG001|Overall Study|Lost to Follow-up|1|||
155224769|NCT02013167|560262633|FG000|Overall Study|Death|85|||
155224770|NCT02013167|560262634|FG001|Overall Study|Death|160|||
155224771|NCT01113879|560262639|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
155224772|NCT01113879|560262640|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
155224773|NCT04151290|560262641|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
155224774|NCT01449526|560262642|FG000|Overall Study|Lost to Follow-up|1|||
155224775|NCT01449526|560262643|FG001|Overall Study|Lost to Follow-up|2|||
155224776|NCT01449526|560262642|FG000|Overall Study|Withdrawal by Subject|1|||
155224777|NCT01449526|560262643|FG001|Overall Study|Withdrawal by Subject|1|||
155224778|NCT01449526|560262642|FG000|Overall Study|Symptoms/complaints|0|||
155224779|NCT01449526|560262643|FG001|Overall Study|Symptoms/complaints|1|||
155224780|NCT01449526|560262642|FG000|Overall Study|Lack of Motivation|0|||
155224781|NCT01449526|560262643|FG001|Overall Study|Lack of Motivation|1|||
155224782|NCT01449526|560262642|FG000|Overall Study|Cannot maintain visits|0|||
155224783|NCT01449526|560262643|FG001|Overall Study|Cannot maintain visits|1|||
155224784|NCT00082433|560262644|FG000|Overall Study|Adverse Event|12|||
155224785|NCT00082433|560262645|FG001|Overall Study|Adverse Event|17|||
155224786|NCT00082433|560262644|FG000|Overall Study|Death|8|||
155224787|NCT00082433|560262645|FG001|Overall Study|Death|18|||
155224788|NCT00082433|560262644|FG000|Overall Study|Disease Progression/Relapse|270|||
155224789|NCT00082433|560262645|FG001|Overall Study|Disease Progression/Relapse|388|||
155224790|NCT00082433|560262644|FG000|Overall Study|Physician Decision|50|||
155224791|NCT00082433|560262645|FG001|Overall Study|Physician Decision|61|||
155224792|NCT00082433|560262644|FG000|Overall Study|Lost to Follow-up|1|||
155224793|NCT00082433|560262645|FG001|Overall Study|Lost to Follow-up|2|||
155224794|NCT00082433|560262644|FG000|Overall Study|Study Drug Toxicity|179|||
155224795|NCT00082433|560262645|FG001|Overall Study|Study Drug Toxicity|66|||
155224796|NCT00082433|560262644|FG000|Overall Study|Withdrawal by Subject|55|||
155224797|NCT00082433|560262645|FG001|Overall Study|Withdrawal by Subject|30|||
155224798|NCT00082433|560262644|FG000|Overall Study|Still On Treatment|2|||
155224799|NCT00082433|560262645|FG001|Overall Study|Still On Treatment|1|||
155224800|NCT00082433|560262644|FG000|Overall Study|Not Treated|12|||
155224801|NCT00082433|560262645|FG001|Overall Study|Not Treated|11|||
155224802|NCT00082433|560262644|FG000|Overall Study|Ineligible|2|||
155224803|NCT00082433|560262645|FG001|Overall Study|Ineligible|1|||
155224804|NCT00082433|560262644|FG000|Overall Study|Noncompliance|2|||
155224805|NCT00082433|560262645|FG001|Overall Study|Noncompliance|1|||
155224806|NCT00082433|560262644|FG000|Overall Study|New primary cancer|1|||
155224807|NCT00082433|560262645|FG001|Overall Study|New primary cancer|0|||
155224808|NCT00082433|560262644|FG000|Overall Study|Impending surgery|0|||
155224809|NCT00082433|560262645|FG001|Overall Study|Impending surgery|1|||
155224810|NCT02276612|560262648|FG000|Overall Study|Death|1|||
155224811|NCT02276612|560262649|FG001|Overall Study|Death|0|||
155224812|NCT02276612|560262648|FG000|Overall Study|Pregnancy|1|||
155224813|NCT02276612|560262649|FG001|Overall Study|Pregnancy|0|||
155224814|NCT02276612|560262648|FG000|Overall Study|Withdrew Consent|1|||
155224815|NCT02276612|560262649|FG001|Overall Study|Withdrew Consent|0|||
155224816|NCT02276612|560262648|FG000|Overall Study|Lost to Follow-up|1|||
155224817|NCT02276612|560262649|FG001|Overall Study|Lost to Follow-up|0|||
155224818|NCT04097821|560262650|FG000|Overall Study|Subject Decision|0|||
155224819|NCT04097821|560262651|FG001|Overall Study|Subject Decision|0|||
155224820|NCT04097821|560262652|FG002|Overall Study|Subject Decision|0|||
155224821|NCT04097821|560262653|FG003|Overall Study|Subject Decision|1|||
155224822|NCT04097821|560262654|FG004|Overall Study|Subject Decision|2|||
155224823|NCT04097821|560262655|FG005|Overall Study|Subject Decision|2|||
155224824|NCT04097821|560262656|FG006|Overall Study|Subject Decision|0|||
155224825|NCT04097821|560262657|FG007|Overall Study|Subject Decision|1|||
155224826|NCT04097821|560262650|FG000|Overall Study|Death|0|||
155224827|NCT04097821|560262651|FG001|Overall Study|Death|0|||
155224828|NCT04097821|560262652|FG002|Overall Study|Death|3|||
155224829|NCT04097821|560262653|FG003|Overall Study|Death|1|||
155224830|NCT04097821|560262654|FG004|Overall Study|Death|0|||
155224831|NCT04097821|560262655|FG005|Overall Study|Death|0|||
155224832|NCT04097821|560262656|FG006|Overall Study|Death|0|||
155224833|NCT04097821|560262657|FG007|Overall Study|Death|0|||
155224834|NCT04097821|560262650|FG000|Overall Study|Physician Decision|1|||
155224835|NCT04097821|560262651|FG001|Overall Study|Physician Decision|2|||
155224836|NCT04097821|560262652|FG002|Overall Study|Physician Decision|0|||
155224837|NCT04097821|560262653|FG003|Overall Study|Physician Decision|0|||
155224838|NCT04097821|560262654|FG004|Overall Study|Physician Decision|0|||
155224839|NCT04097821|560262655|FG005|Overall Study|Physician Decision|0|||
155224840|NCT04097821|560262656|FG006|Overall Study|Physician Decision|0|||
155224841|NCT04097821|560262657|FG007|Overall Study|Physician Decision|0|||
155224842|NCT04097821|560262650|FG000|Overall Study|Adverse Event|0|||
155224843|NCT04097821|560262651|FG001|Overall Study|Adverse Event|0|||
155224844|NCT04097821|560262652|FG002|Overall Study|Adverse Event|1|||
155224845|NCT04097821|560262653|FG003|Overall Study|Adverse Event|1|||
155224846|NCT04097821|560262654|FG004|Overall Study|Adverse Event|0|||
155224847|NCT04097821|560262655|FG005|Overall Study|Adverse Event|0|||
155224848|NCT04097821|560262656|FG006|Overall Study|Adverse Event|0|||
155224849|NCT04097821|560262657|FG007|Overall Study|Adverse Event|0|||
155224850|NCT04097821|560262650|FG000|Overall Study|New Therapy For Study Indication|0|||
155224851|NCT04097821|560262651|FG001|Overall Study|New Therapy For Study Indication|0|||
155224852|NCT04097821|560262652|FG002|Overall Study|New Therapy For Study Indication|0|||
155224853|NCT04097821|560262653|FG003|Overall Study|New Therapy For Study Indication|0|||
155224854|NCT04097821|560262654|FG004|Overall Study|New Therapy For Study Indication|0|||
155224855|NCT04097821|560262655|FG005|Overall Study|New Therapy For Study Indication|0|||
155224856|NCT04097821|560262656|FG006|Overall Study|New Therapy For Study Indication|1|||
155224857|NCT04097821|560262657|FG007|Overall Study|New Therapy For Study Indication|0|||
155224858|NCT03003520|560264563|FG000|Overall Study|Adverse Event|9|||
155224859|NCT03003520|560264564|FG001|Overall Study|Adverse Event|0|||
155224860|NCT03003520|560264563|FG000|Overall Study|Death|1|||
155224861|NCT03003520|560264564|FG001|Overall Study|Death|0|||
155224862|NCT03003520|560264563|FG000|Overall Study|Other reasons|4|||
155224863|NCT03003520|560264564|FG001|Overall Study|Other reasons|0|||
155224864|NCT03003520|560264563|FG000|Overall Study|Withdrawal by Subject|6|||
155224865|NCT03003520|560264564|FG001|Overall Study|Withdrawal by Subject|0|||
155224866|NCT03003520|560264563|FG000|Overall Study|Progressive disease|9|||
155224867|NCT03003520|560264564|FG001|Overall Study|Progressive disease|1|||
155224868|NCT03264404|560264565|FG000|Overall Study|Death|2|||
155224869|NCT03264404|560264565|FG000|Overall Study|Physician Decision|1|||
155224870|NCT03264404|560264565|FG000|Overall Study|Disease Progression|28|||
155224871|NCT03264404|560264565|FG000|Overall Study|Adverse Event|1|||
155224872|NCT03264404|560264565|FG000|Overall Study|Off study prior to treatment|2|||
155224873|NCT01852292|560264571|FG000|Overall Study|Untreated - did not receive study drug|3|||
155224874|NCT01852292|560264572|FG001|Overall Study|Untreated - did not receive study drug|1|||
155224875|NCT01852292|560264571|FG000|Overall Study|Death|9|||
155224876|NCT01852292|560264572|FG001|Overall Study|Death|8|||
155224877|NCT01852292|560264571|FG000|Overall Study|Patient/guardian decision|8|||
155224878|NCT01852292|560264572|FG001|Overall Study|Patient/guardian decision|4|||
155224879|NCT01852292|560264571|FG000|Overall Study|Adverse Event|8|||
155224880|NCT01852292|560264572|FG001|Overall Study|Adverse Event|11|||
155224881|NCT01852292|560264571|FG000|Overall Study|Physician Decision|6|||
155224882|NCT01852292|560264572|FG001|Overall Study|Physician Decision|2|||
155224883|NCT01852292|560264571|FG000|Overall Study|Protocol Violation|2|||
155224884|NCT01852292|560264572|FG001|Overall Study|Protocol Violation|0|||
155224885|NCT01852292|560264571|FG000|Overall Study|Non-compliance with study treatment|1|||
155224886|NCT01852292|560264572|FG001|Overall Study|Non-compliance with study treatment|0|||
155224887|NCT01852292|560264571|FG000|Overall Study|Study terminated by Sponsor|0|||
155224888|NCT01852292|560264572|FG001|Overall Study|Study terminated by Sponsor|1|||
155224889|NCT01852292|560264571|FG000|Overall Study|Progressive disease|42|||
155224890|NCT01852292|560264572|FG001|Overall Study|Progressive disease|52|||
155224891|NCT01914666|560264573|FG000|Treatment Period|Lack of Efficacy|0|||
155224892|NCT01914666|560264574|FG001|Treatment Period|Lack of Efficacy|0|||
155224893|NCT01914666|560264575|FG002|Treatment Period|Lack of Efficacy|2|||
155224894|NCT01914666|560264573|FG000|Treatment Period|Adverse Event|10|||
155224895|NCT01914666|560264574|FG001|Treatment Period|Adverse Event|4|||
155224896|NCT01914666|560264575|FG002|Treatment Period|Adverse Event|2|||
155224897|NCT01914666|560264573|FG000|Treatment Period|Withdrawal by Subject|3|||
155224898|NCT01914666|560264574|FG001|Treatment Period|Withdrawal by Subject|2|||
155224899|NCT01914666|560264575|FG002|Treatment Period|Withdrawal by Subject|2|||
155224900|NCT01914666|560264573|FG000|Treatment Period|Physician Decision|0|||
155224901|NCT01914666|560264574|FG001|Treatment Period|Physician Decision|0|||
155224902|NCT01914666|560264575|FG002|Treatment Period|Physician Decision|2|||
155224903|NCT01572038|560264578|FG000|Overall Study|Death|648|||
155224904|NCT01572038|560264578|FG000|Overall Study|Withdrawal by Subject|204|||
155224905|NCT01572038|560264578|FG000|Overall Study|Lost to Follow-up|81|||
155224906|NCT01572038|560264578|FG000|Overall Study|Physician Decision|20|||
155224907|NCT01572038|560264578|FG000|Overall Study|Patient Decision|14|||
155224908|NCT01572038|560264578|FG000|Overall Study|Progressive Disease|8|||
155224909|NCT01572038|560264578|FG000|Overall Study|Site Closed Before Completing Form|6|||
155224910|NCT01572038|560264578|FG000|Overall Study|Enrolled into Another Trial|3|||
155224911|NCT01572038|560264578|FG000|Overall Study|Participated in Another Trial|3|||
155224912|NCT01572038|560264578|FG000|Overall Study|Termination by Sponsor|2|||
155224913|NCT01572038|560264578|FG000|Overall Study|Patient Deterioration|1|||
155224914|NCT01572038|560264578|FG000|Overall Study|Sponsor Decision|1|||
155224915|NCT03711162|560264579|FG000|Overall Study|Adverse Event|5|||
155224916|NCT03711162|560264580|FG001|Overall Study|Adverse Event|2|||
155224917|NCT03711162|560264581|FG002|Overall Study|Adverse Event|4|||
155224918|NCT03711162|560264579|FG000|Overall Study|Death|11|||
155224919|NCT03711162|560264580|FG001|Overall Study|Death|7|||
155224920|NCT03711162|560264581|FG002|Overall Study|Death|8|||
155224921|NCT03711162|560264579|FG000|Overall Study|Lost to Follow-up|1|||
155224922|NCT03711162|560264580|FG001|Overall Study|Lost to Follow-up|0|||
155224923|NCT03711162|560264581|FG002|Overall Study|Lost to Follow-up|1|||
155224924|NCT03711162|560264579|FG000|Overall Study|Study Terminated by Sponsor|139|||
155224925|NCT03711162|560264580|FG001|Overall Study|Study Terminated by Sponsor|152|||
155224926|NCT03711162|560264581|FG002|Overall Study|Study Terminated by Sponsor|146|||
155224927|NCT03711162|560264579|FG000|Overall Study|Withdrawal by Subject|17|||
155224928|NCT03711162|560264580|FG001|Overall Study|Withdrawal by Subject|10|||
155224929|NCT03711162|560264581|FG002|Overall Study|Withdrawal by Subject|10|||
155224930|NCT03711162|560264579|FG000|Overall Study|Miscellaneous|1|||
155224931|NCT03711162|560264580|FG001|Overall Study|Miscellaneous|2|||
155224932|NCT03711162|560264581|FG002|Overall Study|Miscellaneous|2|||
155224933|NCT03711162|560264579|FG000|Overall Study|Not Treated|1|||
155224934|NCT03711162|560264580|FG001|Overall Study|Not Treated|0|||
155224935|NCT03711162|560264581|FG002|Overall Study|Not Treated|1|||
155224936|NCT03711162|560264579|FG000|Overall Study|Physician Decision|0|||
155224937|NCT03711162|560264580|FG001|Overall Study|Physician Decision|2|||
155224938|NCT03711162|560264581|FG002|Overall Study|Physician Decision|0|||
155224939|NCT03711162|560264579|FG000|Overall Study|Lack of Efficacy|0|||
155224940|NCT03711162|560264580|FG001|Overall Study|Lack of Efficacy|0|||
155224941|NCT03711162|560264581|FG002|Overall Study|Lack of Efficacy|2|||
155224942|NCT03711162|560264579|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
155224943|NCT03711162|560264580|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
155224944|NCT03711162|560264581|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
155224945|NCT01275066|560264584|FG000|Overall Study|Withdrawal by Subject|0|||
155224946|NCT01275066|560264585|FG001|Overall Study|Withdrawal by Subject|0|||
155224947|NCT01275066|560264586|FG002|Overall Study|Withdrawal by Subject|1|||
155224948|NCT01275066|560264584|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
155224949|NCT01275066|560264585|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
155224950|NCT01275066|560264586|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
155224951|NCT00394212|560264589|FG000|Overall Study|Lost to Follow-up|3|||
155224952|NCT00394212|560264590|FG001|Overall Study|Lost to Follow-up|0|||
155224953|NCT00394212|560264589|FG000|Overall Study|Withdrawal by Subject|4|||
155224954|NCT00394212|560264590|FG001|Overall Study|Withdrawal by Subject|1|||
155224955|NCT00588445|560264591|FG000|Overall Study|Protocol Violation|1|||
155224956|NCT00588445|560264591|FG000|Overall Study|Withdrawal by Subject|3|||
155224957|NCT00588445|560264591|FG000|Overall Study|Disease Progression|1|||
155224958|NCT00588445|560264591|FG000|Overall Study|Not Treated|10|||
155224959|NCT03240133|560264592|FG000|Overall Study|Withdrawal by Subject|0|||
155224960|NCT03240133|560264593|FG001|Overall Study|Withdrawal by Subject|1|||
155224961|NCT03240133|560264594|FG002|Overall Study|Withdrawal by Subject|0|||
155224962|NCT03240133|560264592|FG000|Overall Study|Adverse Event|1|||
155224963|NCT03240133|560264593|FG001|Overall Study|Adverse Event|1|||
155224964|NCT03240133|560264594|FG002|Overall Study|Adverse Event|0|||
155224965|NCT03240133|560264592|FG000|Overall Study|Rash|1|||
155224966|NCT03240133|560264593|FG001|Overall Study|Rash|0|||
155224967|NCT03240133|560264594|FG002|Overall Study|Rash|0|||
155224968|NCT03240133|560264592|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
155224969|NCT03240133|560264593|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
155224970|NCT03240133|560264594|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
155224971|NCT03240133|560264592|FG000|Overall Study|Intercurrent illness.|0|||
155224972|NCT03240133|560264593|FG001|Overall Study|Intercurrent illness.|1|||
155224973|NCT03240133|560264594|FG002|Overall Study|Intercurrent illness.|0|||
155224974|NCT03240133|560264592|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
155224975|NCT03240133|560264593|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
155224976|NCT03240133|560264594|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
155224977|NCT00116831|560264597|FG000|Overall Study|Adverse Event|14|||
155224978|NCT00116831|560264598|FG001|Overall Study|Adverse Event|16|||
155224979|NCT00116831|560264597|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
155224980|NCT00116831|560264598|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
155224981|NCT00116831|560264597|FG000|Overall Study|Lost to Follow-up|8|||
155224982|NCT00116831|560264598|FG001|Overall Study|Lost to Follow-up|6|||
155224983|NCT00116831|560264597|FG000|Overall Study|Protocol Violation|3|||
155224984|NCT00116831|560264598|FG001|Overall Study|Protocol Violation|6|||
155224985|NCT00116831|560264597|FG000|Overall Study|Hypoglycaemic events|1|||
155224986|NCT00116831|560264598|FG001|Overall Study|Hypoglycaemic events|0|||
155224987|NCT00116831|560264597|FG000|Overall Study|Low haemoglobin on screening|1|||
155224988|NCT00116831|560264598|FG001|Overall Study|Low haemoglobin on screening|0|||
155224989|NCT00116831|560264597|FG000|Overall Study|Withdrawn investigational product|1|||
155224990|NCT00116831|560264598|FG001|Overall Study|Withdrawn investigational product|0|||
155224991|NCT00116831|560264597|FG000|Overall Study|Withdrawal by Subject|32|||
155224992|NCT00116831|560264598|FG001|Overall Study|Withdrawal by Subject|32|||
155224993|NCT00116831|560264597|FG000|Overall Study|Insufficient therapeutic effect|0|||
155224994|NCT00116831|560264598|FG001|Overall Study|Insufficient therapeutic effect|1|||
155224995|NCT00116831|560264597|FG000|Overall Study|Missing data for participant|1|||
155224996|NCT00116831|560264598|FG001|Overall Study|Missing data for participant|0|||
155224997|NCT02945410|560264599|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155224998|NCT02945410|560264600|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
155224999|NCT02945410|560264601|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225000|NCT02945410|560264602|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225001|NCT02945410|560264603|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225002|NCT02945410|560264604|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225003|NCT02945410|560264599|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
155225004|NCT02945410|560264600|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
155225005|NCT02945410|560264601|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
155225006|NCT02945410|560264602|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
155225007|NCT02945410|560264603|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
155225008|NCT02945410|560264604|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
155225009|NCT02945410|560264599|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225010|NCT02945410|560264600|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225011|NCT02945410|560264601|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
155225012|NCT02945410|560264602|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225013|NCT02945410|560264603|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
155225014|NCT02945410|560264604|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225015|NCT04904185|560264605|FG000|Overall Study|Expansion failure|1|||
155225016|NCT04904185|560264606|FG001|Overall Study|Expansion failure|0|||
155225017|NCT04904185|560264605|FG000|Overall Study|Late response on prior treatment|1|||
155225018|NCT04904185|560264606|FG001|Overall Study|Late response on prior treatment|0|||
155225019|NCT04200248|560264613|FG000|Overall Study|Personal reasons|0|||
155225020|NCT04200248|560264614|FG001|Overall Study|Personal reasons|0|||
155225021|NCT04200248|560264615|FG002|Overall Study|Personal reasons|1|||
155225022|NCT04200248|560264613|FG000|Overall Study|Discontinued prior to treatment|3|||
155225023|NCT04200248|560264614|FG001|Overall Study|Discontinued prior to treatment|3|||
155225024|NCT04200248|560264615|FG002|Overall Study|Discontinued prior to treatment|2|||
155225025|NCT02342704|560264618|FG000|Overall Study|Physician Decision|0|||
155225026|NCT02342704|560264619|FG001|Overall Study|Physician Decision|3|||
155225027|NCT02342704|560264618|FG000|Overall Study|Sponsor Termination|49|||
155225028|NCT02342704|560264619|FG001|Overall Study|Sponsor Termination|43|||
155225029|NCT02342704|560264618|FG000|Overall Study|Other|0|||
155225030|NCT02342704|560264619|FG001|Overall Study|Other|1|||
155225031|NCT02342704|560264618|FG000|Overall Study|Withdrawal by Subject|1|||
155225032|NCT02342704|560264619|FG001|Overall Study|Withdrawal by Subject|0|||
155225033|NCT02342704|560264618|FG000|Overall Study|Lost to Follow-up|2|||
155225034|NCT02342704|560264619|FG001|Overall Study|Lost to Follow-up|1|||
155225035|NCT02342704|560264618|FG000|Overall Study|Adverse Event|1|||
155225036|NCT02342704|560264619|FG001|Overall Study|Adverse Event|3|||
155225037|NCT00302003|560264620|FG000|Overall Study|Lack of Efficacy|62|||
155225038|NCT00302003|560264620|FG000|Overall Study|Lost to Follow-up|1|||
155225039|NCT00302003|560264620|FG000|Overall Study|Physician Decision|2|||
155225040|NCT00302003|560264620|FG000|Overall Study|Withdrawal by Subject|5|||
155225041|NCT00302003|560264620|FG000|Overall Study|Ineligible|9|||
155225042|NCT00302003|560264620|FG000|Overall Study|Protocol Violation|1|||
155491449|NCT01740297|561225387|FG001|Overall Study|Death|46|||
155225043|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
155225044|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
155225045|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
155225046|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
155225047|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225048|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
155225049|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225050|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225051|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
155225052|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
155225053|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
155225054|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
155225055|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
155225056|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225057|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225058|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225059|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
155225060|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
155225061|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
155225062|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
155225063|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225064|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
155225065|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225066|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225067|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225068|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
155225069|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225070|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225071|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225072|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
155225073|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225074|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225075|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
155225076|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
155225077|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
155225078|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
155225079|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225080|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
155225081|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225082|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225083|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
155225084|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
155225085|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
155225086|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
155225087|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
155225088|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
155225089|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
155225090|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
155225091|NCT01539226|560264625|FG000|Overall Study|Withdrawal by Subject|24|||
155225092|NCT01539226|560264626|FG001|Overall Study|Withdrawal by Subject|54|||
155225093|NCT01539226|560264625|FG000|Overall Study|Lost to Follow-up|20|||
155225094|NCT01539226|560264626|FG001|Overall Study|Lost to Follow-up|54|||
155225095|NCT01539226|560264625|FG000|Overall Study|Death|1|||
155225096|NCT01539226|560264626|FG001|Overall Study|Death|2|||
155225097|NCT01539226|560264625|FG000|Overall Study|Adverse Event|2|||
155225098|NCT01539226|560264626|FG001|Overall Study|Adverse Event|0|||
155225099|NCT01539226|560264625|FG000|Overall Study|Pregnancy|13|||
155225100|NCT01539226|560264626|FG001|Overall Study|Pregnancy|29|||
155225101|NCT01539226|560264625|FG000|Overall Study|inappropriate enrollment|0|||
155225102|NCT01539226|560264626|FG001|Overall Study|inappropriate enrollment|1|||
155225103|NCT01539226|560264625|FG000|Overall Study|Multiple Reasons|3|||
155225104|NCT01539226|560264626|FG001|Overall Study|Multiple Reasons|1|||
155225105|NCT01539226|560264625|FG000|Overall Study|not HIV seroconversion-related|93|||
155225106|NCT01539226|560264626|FG001|Overall Study|not HIV seroconversion-related|176|||
155225107|NCT01539226|560264625|FG000|Overall Study|HIV seroconversion-related|55|||
155225108|NCT01539226|560264626|FG001|Overall Study|HIV seroconversion-related|80|||
155225109|NCT01539226|560264625|FG000|Overall Study|Non-compliance|6|||
155225110|NCT01539226|560264626|FG001|Overall Study|Non-compliance|8|||
155225111|NCT01632891|560264627|FG000|Overall Study|Lost to Follow-up|0|||
155225112|NCT01632891|560264628|FG001|Overall Study|Lost to Follow-up|1|||
155225113|NCT01632891|560264627|FG000|Overall Study|Withdrawal by Subject|1|||
155225114|NCT01632891|560264628|FG001|Overall Study|Withdrawal by Subject|0|||
155225115|NCT02118428|560264636|FG000|Overall Study|Physician Decision|0|||
155225116|NCT02118428|560264637|FG001|Overall Study|Physician Decision|1|||
155225117|NCT02118428|560264638|FG002|Overall Study|Physician Decision|0|||
155225118|NCT02118428|560264636|FG000|Overall Study|Withdrawal by Subject|2|||
155225119|NCT02118428|560264637|FG001|Overall Study|Withdrawal by Subject|2|||
155225120|NCT02118428|560264638|FG002|Overall Study|Withdrawal by Subject|0|||
155225121|NCT02118428|560264636|FG000|Overall Study|Death|7|||
155225122|NCT02118428|560264637|FG001|Overall Study|Death|5|||
155225123|NCT02118428|560264638|FG002|Overall Study|Death|0|||
155225124|NCT02118428|560264636|FG000|Overall Study|Lost to Follow-up|3|||
155225125|NCT02118428|560264637|FG001|Overall Study|Lost to Follow-up|1|||
155225126|NCT02118428|560264638|FG002|Overall Study|Lost to Follow-up|0|||
155225127|NCT02118428|560264636|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
155225128|NCT02118428|560264637|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
155225129|NCT02118428|560264638|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
155225130|NCT00735371|560264647|FG000|Overall Study|Adverse Event|3|||
155225131|NCT00735371|560264648|FG001|Overall Study|Adverse Event|3|||
155225132|NCT00735371|560264649|FG002|Overall Study|Adverse Event|4|||
155225133|NCT00735371|560264650|FG003|Overall Study|Adverse Event|1|||
155225134|NCT00735371|560264647|FG000|Overall Study|Protocol Violation|2|||
155225135|NCT00735371|560264648|FG001|Overall Study|Protocol Violation|2|||
155225136|NCT00735371|560264649|FG002|Overall Study|Protocol Violation|0|||
155225137|NCT00735371|560264650|FG003|Overall Study|Protocol Violation|3|||
155225138|NCT00735371|560264647|FG000|Overall Study|Withdrawal by Subject|0|||
155225139|NCT00735371|560264648|FG001|Overall Study|Withdrawal by Subject|2|||
155225140|NCT00735371|560264649|FG002|Overall Study|Withdrawal by Subject|2|||
155225141|NCT00735371|560264650|FG003|Overall Study|Withdrawal by Subject|0|||
155225142|NCT00735371|560264647|FG000|Overall Study|Lost to Follow-up|1|||
155225143|NCT00735371|560264648|FG001|Overall Study|Lost to Follow-up|1|||
155225144|NCT00735371|560264649|FG002|Overall Study|Lost to Follow-up|3|||
155225145|NCT00735371|560264650|FG003|Overall Study|Lost to Follow-up|1|||
155225146|NCT00735371|560264647|FG000|Overall Study|Lack of Efficacy|4|||
155225147|NCT00735371|560264648|FG001|Overall Study|Lack of Efficacy|2|||
155225148|NCT00735371|560264649|FG002|Overall Study|Lack of Efficacy|0|||
155225149|NCT00735371|560264650|FG003|Overall Study|Lack of Efficacy|4|||
155225150|NCT00735371|560264647|FG000|Overall Study|Sponsor Decision|3|||
155225151|NCT00735371|560264648|FG001|Overall Study|Sponsor Decision|1|||
155225152|NCT00735371|560264649|FG002|Overall Study|Sponsor Decision|0|||
155225153|NCT00735371|560264650|FG003|Overall Study|Sponsor Decision|1|||
155225154|NCT00735371|560264647|FG000|Overall Study|Protocol Violation|0|||
155225155|NCT00735371|560264648|FG001|Overall Study|Protocol Violation|1|||
155225156|NCT00735371|560264649|FG002|Overall Study|Protocol Violation|2|||
155225157|NCT00735371|560264650|FG003|Overall Study|Protocol Violation|0|||
155225158|NCT00735371|560264647|FG000|Overall Study|Prior Vyvanse Exposure|1|||
155225159|NCT00735371|560264648|FG001|Overall Study|Prior Vyvanse Exposure|1|||
155225160|NCT00735371|560264649|FG002|Overall Study|Prior Vyvanse Exposure|0|||
155225161|NCT00735371|560264650|FG003|Overall Study|Prior Vyvanse Exposure|0|||
155225162|NCT00735371|560264647|FG000|Overall Study|Exclusion criteria|1|||
155225163|NCT00735371|560264648|FG001|Overall Study|Exclusion criteria|0|||
155225164|NCT00735371|560264649|FG002|Overall Study|Exclusion criteria|0|||
155225165|NCT00735371|560264650|FG003|Overall Study|Exclusion criteria|0|||
155225166|NCT00436748|560264653|FG000|Overall Study|Ineligibility Determined|1|||
155225167|NCT00436748|560264654|FG001|Overall Study|Ineligibility Determined|1|||
155225168|NCT00436748|560264653|FG000|Overall Study|Adverse Event|0|||
155225169|NCT00436748|560264654|FG001|Overall Study|Adverse Event|2|||
155225170|NCT00436748|560264653|FG000|Overall Study|Consent Withdrawn|1|||
155225171|NCT00436748|560264654|FG001|Overall Study|Consent Withdrawn|4|||
155225172|NCT00436748|560264653|FG000|Overall Study|Administrative Decision|1|||
155225173|NCT00436748|560264654|FG001|Overall Study|Administrative Decision|0|||
155225174|NCT00436748|560264653|FG000|Overall Study|Lost to Follow-up|0|||
155225175|NCT00436748|560264654|FG001|Overall Study|Lost to Follow-up|1|||
155225176|NCT00436748|560264653|FG000|Overall Study|Protocol-specified Criteria|5|||
155225177|NCT00436748|560264654|FG001|Overall Study|Protocol-specified Criteria|4|||
155225178|NCT00436748|560264653|FG000|Overall Study|Other|3|||
155225179|NCT00436748|560264654|FG001|Overall Study|Other|0|||
155225180|NCT01610791|560264655|FG000|Overall Study|Lost to Follow-up|7|||
155225181|NCT01610791|560264655|FG000|Overall Study|Adverse Event|6|||
155225182|NCT01610791|560264655|FG000|Overall Study|Physician Decision|1|||
155225183|NCT01610791|560264655|FG000|Overall Study|Adverse event and Investigator decision|1|||
155225184|NCT01610791|560264655|FG000|Overall Study|Death|1|||
155225185|NCT01610791|560264655|FG000|Overall Study|Not determined|5|||
155225186|NCT04627064|560264658|FG000|Overall Study|Progressive disease|8|||
155225187|NCT04627064|560264659|FG001|Overall Study|Progressive disease|0|||
155225188|NCT04627064|560264658|FG000|Overall Study|Withdrawal by Subject|2|||
155225189|NCT04627064|560264659|FG001|Overall Study|Withdrawal by Subject|0|||
155225190|NCT04627064|560264658|FG000|Overall Study|Physician Decision|1|||
155225191|NCT04627064|560264659|FG001|Overall Study|Physician Decision|0|||
155225192|NCT00097721|560264660|FG000|Overall Study|Adverse Event|8|||
155225193|NCT00097721|560264661|FG001|Overall Study|Adverse Event|1|||
155225194|NCT00097721|560264660|FG000|Overall Study|Withdrawal by Subject|6|||
155225195|NCT00097721|560264661|FG001|Overall Study|Withdrawal by Subject|1|||
155225196|NCT00097721|560264660|FG000|Overall Study|Progressive Disease|55|||
155225197|NCT00097721|560264661|FG001|Overall Study|Progressive Disease|27|||
155225198|NCT00097721|560264660|FG000|Overall Study|Physician Decision|1|||
155225199|NCT00097721|560264661|FG001|Overall Study|Physician Decision|3|||
155225200|NCT00097721|560264660|FG000|Overall Study|Reason not given|1|||
155225201|NCT00097721|560264661|FG001|Overall Study|Reason not given|1|||
155225202|NCT02126969|560264664|FG000|Overall Study|Withdrawal by Subject|1|||
155225203|NCT02126969|560264665|FG001|Overall Study|Withdrawal by Subject|2|||
155225204|NCT01533246|560264668|FG000|Overall Study|Adverse Event|1|||
155225205|NCT01533246|560264668|FG000|Overall Study|Withdrawal by Subject|1|||
155225206|NCT00354172|560264669|FG000|Overall Study|Did not receive transplant|1|||
155225207|NCT03792672|560264672|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
155225208|NCT03792672|560264673|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225209|NCT03792672|560264674|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225210|NCT03792672|560264675|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
155225211|NCT03792672|560264676|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225212|NCT03792672|560264677|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225213|NCT03792672|560264672|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
155225214|NCT03792672|560264673|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
155225215|NCT03792672|560264674|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
155225216|NCT03792672|560264675|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
155225217|NCT03792672|560264676|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
155225218|NCT03792672|560264677|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
155225219|NCT03792672|560264672|FG000|Treatment Period 4 (2 Days)|Other|1|||
155225220|NCT03792672|560264673|FG001|Treatment Period 4 (2 Days)|Other|0|||
155225221|NCT03792672|560264674|FG002|Treatment Period 4 (2 Days)|Other|0|||
155225222|NCT03792672|560264675|FG003|Treatment Period 4 (2 Days)|Other|0|||
155225223|NCT03792672|560264676|FG004|Treatment Period 4 (2 Days)|Other|0|||
155225224|NCT03792672|560264677|FG005|Treatment Period 4 (2 Days)|Other|0|||
155225225|NCT00453999|560264678|FG000|Overall Study|Adverse Event|1|||
155225226|NCT00453999|560264679|FG001|Overall Study|Adverse Event|2|||
155225227|NCT00453999|560264680|FG002|Overall Study|Adverse Event|1|||
155225228|NCT00453999|560264678|FG000|Overall Study|Lost to Follow-up|0|||
155225229|NCT00453999|560264679|FG001|Overall Study|Lost to Follow-up|1|||
155225230|NCT00453999|560264680|FG002|Overall Study|Lost to Follow-up|1|||
155225231|NCT00453999|560264678|FG000|Overall Study|Withdrawal by Subject|2|||
155225232|NCT00453999|560264679|FG001|Overall Study|Withdrawal by Subject|1|||
155225233|NCT00453999|560264680|FG002|Overall Study|Withdrawal by Subject|1|||
155225234|NCT00453999|560264678|FG000|Overall Study|Subject Request|2|||
155225235|NCT00453999|560264679|FG001|Overall Study|Subject Request|1|||
155225236|NCT00453999|560264680|FG002|Overall Study|Subject Request|0|||
155225237|NCT04238728|560264682|FG000|Overall Study|Withdrawal by Subject|1|||
155225238|NCT04238728|560264682|FG000|Overall Study|Lost to Follow-up|2|||
155225239|NCT00829296|560264685|FG000|Overall Study|Adverse Event|5|||
155225240|NCT00829296|560264686|FG001|Overall Study|Adverse Event|4|||
155225241|NCT04960228|560264688|FG000|Overall Study|Withdrawal by Subject|216|||
155225242|NCT04960228|560264689|FG001|Overall Study|Withdrawal by Subject|35|||
155225243|NCT04960228|560264688|FG000|Overall Study|Failed attention check|69|||
155225244|NCT04960228|560264689|FG001|Overall Study|Failed attention check|148|||
155225245|NCT04960228|560264688|FG000|Overall Study|Flagged for response quality by Dynata|3|||
155225246|NCT04960228|560264689|FG001|Overall Study|Flagged for response quality by Dynata|3|||
155225247|NCT01987427|560264690|FG000|Overall Study|Adverse Event|4|||
155225248|NCT01987427|560264691|FG001|Overall Study|Adverse Event|2|||
155225249|NCT01987427|560264692|FG002|Overall Study|Adverse Event|8|||
155225250|NCT01987427|560264690|FG000|Overall Study|Lost to Follow-up|6|||
155225251|NCT01987427|560264691|FG001|Overall Study|Lost to Follow-up|6|||
155225252|NCT01987427|560264692|FG002|Overall Study|Lost to Follow-up|9|||
155225253|NCT01987427|560264690|FG000|Overall Study|Withdrawal by Subject|2|||
155225254|NCT01987427|560264691|FG001|Overall Study|Withdrawal by Subject|1|||
155225255|NCT01987427|560264692|FG002|Overall Study|Withdrawal by Subject|3|||
155225256|NCT01987427|560264690|FG000|Overall Study|Lack of Efficacy|1|||
155225257|NCT01987427|560264691|FG001|Overall Study|Lack of Efficacy|0|||
155225258|NCT01987427|560264692|FG002|Overall Study|Lack of Efficacy|0|||
155225259|NCT01987427|560264690|FG000|Overall Study|Other|1|||
155225260|NCT01987427|560264691|FG001|Overall Study|Other|1|||
155225261|NCT01987427|560264692|FG002|Overall Study|Other|0|||
155225262|NCT01073865|560264694|FG000|Overall Study|Reasons other than below|19|||
155225263|NCT01073865|560264695|FG001|Overall Study|Reasons other than below|31|||
155225264|NCT01073865|560264694|FG000|Overall Study|Lost to Follow-up|1|||
155225265|NCT01073865|560264695|FG001|Overall Study|Lost to Follow-up|1|||
155225266|NCT01073865|560264694|FG000|Overall Study|Death|3|||
155225267|NCT01073865|560264695|FG001|Overall Study|Death|2|||
155225268|NCT01073865|560264694|FG000|Overall Study|Withdrawal by Subject|5|||
155225269|NCT01073865|560264695|FG001|Overall Study|Withdrawal by Subject|5|||
155225270|NCT02547129|560264699|FG000|Overall Study|Difficulty with ongoing infection|1|||
155225271|NCT02547129|560264700|FG001|Overall Study|Difficulty with ongoing infection|0|||
155225272|NCT03925324|560264701|FG000|Overall Study|Death|1|||
155225273|NCT03925324|560264702|FG001|Overall Study|Death|1|||
155225274|NCT00794196|560264704|FG000|Overall Study|Lost to Follow-up|5|||
155225275|NCT00794196|560264705|FG001|Overall Study|Lost to Follow-up|23|||
155225276|NCT04414553|560264706|FG000|Overall Study|Lost to Follow-up|20|||
155225277|NCT02319031|560264710|FG000|Treatment Period|Death|1|||
155225278|NCT02319031|560264711|FG001|Treatment Period|Death|0|||
155225279|NCT04371380|560264716|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
155225280|NCT04371380|560264717|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
155225281|NCT04371380|560264718|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
155225282|NCT02244580|560264719|FG000|Overall Study|No cancer tissues available|241|||
155225283|NCT02910167|560264722|FG000|Overall Study|Adverse Event|1|||
155225284|NCT02910167|560264722|FG000|Overall Study|Lost to Follow-up|18|||
155225285|NCT01418937|560264723|FG000|Overall Study|Lost to Follow-up|5|||
155225286|NCT01418937|560264723|FG000|Overall Study|Protocol Violation|1|||
155225287|NCT01418937|560264723|FG000|Overall Study|Pregnancy|1|||
155225288|NCT01418937|560264723|FG000|Overall Study|Withdrawal by Subject|1|||
155225289|NCT00856908|560264741|FG000|Overall Study|Lost to Follow-up|1|||
155225290|NCT00856908|560264742|FG001|Overall Study|Lost to Follow-up|0|||
155225291|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
155225292|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
155225293|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
155225294|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
155225295|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
155225296|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
155225297|NCT01063595|560264743|FG000|First Intervention|Adverse Event|1|||
155225298|NCT01063595|560264744|FG001|First Intervention|Adverse Event|4|||
155225299|NCT01063595|560264743|FG000|First Intervention|Withdrawal by Subject|1|||
155225300|NCT01063595|560264744|FG001|First Intervention|Withdrawal by Subject|0|||
155225301|NCT01063595|560264743|FG000|First Intervention|Reason not Specified|0|||
155225302|NCT01063595|560264744|FG001|First Intervention|Reason not Specified|1|||
155225303|NCT04059146|560264747|FG000|Overall Study|Withdrawal by Subject|0|||
155225304|NCT04059146|560264748|FG001|Overall Study|Withdrawal by Subject|1|||
155225305|NCT01623596|560264749|FG000|Overall Study|Abnormal laboratory values|2|||
155225306|NCT01623596|560264750|FG001|Overall Study|Abnormal laboratory values|0|||
155225307|NCT01623596|560264749|FG000|Overall Study|Administrative problems|9|||
155225308|NCT01623596|560264750|FG001|Overall Study|Administrative problems|13|||
155225309|NCT01623596|560264749|FG000|Overall Study|Adverse Event|20|||
155225310|NCT01623596|560264750|FG001|Overall Study|Adverse Event|29|||
155225311|NCT01623596|560264749|FG000|Overall Study|Death|0|||
155225312|NCT01623596|560264750|FG001|Overall Study|Death|2|||
155225313|NCT01623596|560264749|FG000|Overall Study|Lost to Follow-up|12|||
155225314|NCT01623596|560264750|FG001|Overall Study|Lost to Follow-up|16|||
155225315|NCT01623596|560264749|FG000|Overall Study|Withdrawal by Subject|13|||
155225316|NCT01623596|560264750|FG001|Overall Study|Withdrawal by Subject|31|||
155225317|NCT01623596|560264749|FG000|Overall Study|Patient no longer requires study drug|1|||
155225318|NCT01623596|560264750|FG001|Overall Study|Patient no longer requires study drug|0|||
155225319|NCT01623596|560264749|FG000|Overall Study|Protocol Violation|0|||
155225320|NCT01623596|560264750|FG001|Overall Study|Protocol Violation|6|||
155225321|NCT01623596|560264749|FG000|Overall Study|Lack of Efficacy|5|||
155225322|NCT01623596|560264750|FG001|Overall Study|Lack of Efficacy|3|||
155225323|NCT01070316|560264751|FG000|Extension Phase|Lack of Efficacy|3|||
155225324|NCT01070316|560264751|FG000|Extension Phase|Withdrawal by Subject|1|||
155225325|NCT00026793|560264752|FG000|Overall Study|Death on study due to underlying disease|4|||
155225326|NCT00026793|560264752|FG000|Overall Study|Physician Decision|2|||
155225327|NCT00026793|560264752|FG000|Overall Study|Off study|2|||
155225328|NCT04243538|560264753|FG000|Overall Study|Withdrawal by Subject|0|||
155225329|NCT04243538|560264754|FG001|Overall Study|Withdrawal by Subject|2|||
155225330|NCT04243538|560264753|FG000|Overall Study|Lost to Follow-up|0|||
155225331|NCT04243538|560264754|FG001|Overall Study|Lost to Follow-up|3|||
155225332|NCT00655564|560264755|FG000|Overall Study|Adverse Event|1|||
155225333|NCT00655564|560264755|FG000|Overall Study|Lost to Follow-up|1|||
155225334|NCT00655564|560264755|FG000|Overall Study|Desired Alternate Therapy|1|||
155225335|NCT04536727|560264756|FG000|Overall Study|Lost to Follow-up|1|||
155225336|NCT04536727|560264757|FG001|Overall Study|Lost to Follow-up|1|||
155225337|NCT04536727|560264756|FG000|Overall Study|Death|0|||
155225338|NCT04536727|560264757|FG001|Overall Study|Death|1|||
155225339|NCT00500370|560264761|FG000|Overall Study|Adverse Event|9|||
155225340|NCT00500370|560264762|FG001|Overall Study|Adverse Event|3|||
155225341|NCT00500370|560264761|FG000|Overall Study|Lost to Follow-up|10|||
155225342|NCT00500370|560264762|FG001|Overall Study|Lost to Follow-up|10|||
155225343|NCT00500370|560264761|FG000|Overall Study|Protocol Violation|2|||
155225344|NCT00500370|560264762|FG001|Overall Study|Protocol Violation|4|||
155225345|NCT00500370|560264761|FG000|Overall Study|Sponsor Decision|2|||
155225346|NCT00500370|560264762|FG001|Overall Study|Sponsor Decision|0|||
155225347|NCT00500370|560264761|FG000|Overall Study|Subject Decision|10|||
155225348|NCT00500370|560264762|FG001|Overall Study|Subject Decision|17|||
155225349|NCT05627518|560264763|FG000|Treatment Period 1|Adverse Event|0|||
155225350|NCT05627518|560264764|FG001|Treatment Period 1|Adverse Event|0|||
155225351|NCT05627518|560264765|FG002|Treatment Period 1|Adverse Event|1|||
155225352|NCT05627518|560264766|FG003|Treatment Period 1|Adverse Event|0|||
155225353|NCT05627518|560264767|FG004|Treatment Period 1|Adverse Event|0|||
155225354|NCT05627518|560264768|FG005|Treatment Period 1|Adverse Event|0|||
155225355|NCT05627518|560264769|FG006|Treatment Period 1|Adverse Event|0|||
155225356|NCT05627518|560264770|FG007|Treatment Period 1|Adverse Event|1|||
155225357|NCT05627518|560264763|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155225358|NCT05627518|560264764|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155225359|NCT05627518|560264765|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155225360|NCT05627518|560264766|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155225361|NCT05627518|560264767|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155225362|NCT05627518|560264768|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155225363|NCT05627518|560264769|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155225364|NCT05627518|560264770|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155225365|NCT05627518|560264763|FG000|Treatment Period 1|Protocol Violation|0|||
155225366|NCT05627518|560264764|FG001|Treatment Period 1|Protocol Violation|0|||
155225367|NCT05627518|560264765|FG002|Treatment Period 1|Protocol Violation|0|||
155225368|NCT05627518|560264766|FG003|Treatment Period 1|Protocol Violation|0|||
155225369|NCT05627518|560264767|FG004|Treatment Period 1|Protocol Violation|0|||
155225370|NCT05627518|560264768|FG005|Treatment Period 1|Protocol Violation|0|||
155225371|NCT05627518|560264769|FG006|Treatment Period 1|Protocol Violation|6|||
155225372|NCT05627518|560264770|FG007|Treatment Period 1|Protocol Violation|6|||
155225373|NCT05627518|560264763|FG000|Treatment Period 2|Adverse Event|1|||
155225374|NCT05627518|560264764|FG001|Treatment Period 2|Adverse Event|0|||
155225375|NCT05627518|560264765|FG002|Treatment Period 2|Adverse Event|0|||
155225376|NCT05627518|560264766|FG003|Treatment Period 2|Adverse Event|0|||
155225377|NCT05627518|560264767|FG004|Treatment Period 2|Adverse Event|0|||
155225378|NCT05627518|560264768|FG005|Treatment Period 2|Adverse Event|0|||
155225379|NCT05627518|560264769|FG006|Treatment Period 2|Adverse Event|0|||
155225380|NCT05627518|560264770|FG007|Treatment Period 2|Adverse Event|0|||
155225381|NCT05627518|560264763|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155225382|NCT05627518|560264764|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155225383|NCT05627518|560264765|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155225384|NCT05627518|560264766|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155225385|NCT05627518|560264767|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155225386|NCT05627518|560264768|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155225387|NCT05627518|560264769|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155225388|NCT05627518|560264770|FG007|Treatment Period 2|Withdrawal by Subject|0|||
155225389|NCT00749463|560266494|FG000|Overall Study|Adverse Event|0|||
155225390|NCT00749463|560266495|FG001|Overall Study|Adverse Event|4|||
155225391|NCT00749463|560266496|FG002|Overall Study|Adverse Event|1|||
155225392|NCT00749463|560266494|FG000|Overall Study|Withdrawal by Subject|1|||
155225393|NCT00749463|560266495|FG001|Overall Study|Withdrawal by Subject|0|||
155225394|NCT00749463|560266496|FG002|Overall Study|Withdrawal by Subject|0|||
155225395|NCT00782210|560266498|FG000|Overall Study|Adverse Event|21|||
155225396|NCT00782210|560266499|FG001|Overall Study|Adverse Event|17|||
155225397|NCT00782210|560266500|FG002|Overall Study|Adverse Event|16|||
155225398|NCT00782210|560266498|FG000|Overall Study|Lost to Follow-up|2|||
155225399|NCT00782210|560266499|FG001|Overall Study|Lost to Follow-up|1|||
155225400|NCT00782210|560266500|FG002|Overall Study|Lost to Follow-up|2|||
155225401|NCT00782210|560266498|FG000|Overall Study|Withdrawal by Subject|11|||
155225402|NCT00782210|560266499|FG001|Overall Study|Withdrawal by Subject|8|||
155225403|NCT00782210|560266500|FG002|Overall Study|Withdrawal by Subject|11|||
155225404|NCT00782210|560266498|FG000|Overall Study|Non compliance with protocol|0|||
155225405|NCT00782210|560266499|FG001|Overall Study|Non compliance with protocol|3|||
155225406|NCT00782210|560266500|FG002|Overall Study|Non compliance with protocol|2|||
155225407|NCT00782210|560266498|FG000|Overall Study|Lack of Efficacy|13|||
155225408|NCT00782210|560266499|FG001|Overall Study|Lack of Efficacy|4|||
155225409|NCT00782210|560266500|FG002|Overall Study|Lack of Efficacy|1|||
155225410|NCT00782210|560266498|FG000|Overall Study|Other reason not described above|3|||
155225411|NCT00782210|560266499|FG001|Overall Study|Other reason not described above|2|||
155225412|NCT00782210|560266500|FG002|Overall Study|Other reason not described above|3|||
155225413|NCT05358821|560266503|FG000|Overall Study|Withdrawal by Subject|0|||
155225414|NCT05358821|560266504|FG001|Overall Study|Withdrawal by Subject|1|||
155225415|NCT05358821|560266505|FG002|Overall Study|Withdrawal by Subject|0|||
155225416|NCT05358821|560266503|FG000|Overall Study|Withdrawal of Consent|0|||
155225417|NCT05358821|560266504|FG001|Overall Study|Withdrawal of Consent|0|||
155225418|NCT05358821|560266505|FG002|Overall Study|Withdrawal of Consent|1|||
155225419|NCT02704364|560266506|FG000|Overall Study|Adverse Event|1|||
155225420|NCT02704364|560266507|FG001|Overall Study|Adverse Event|1|||
155225421|NCT02704364|560266508|FG002|Overall Study|Adverse Event|0|||
155225422|NCT02704364|560266506|FG000|Overall Study|Noncompliance with study drug|1|||
155225423|NCT02704364|560266507|FG001|Overall Study|Noncompliance with study drug|1|||
155225424|NCT02704364|560266508|FG002|Overall Study|Noncompliance with study drug|0|||
155225425|NCT02704364|560266506|FG000|Overall Study|Other|0|||
155225426|NCT02704364|560266507|FG001|Overall Study|Other|1|||
155225427|NCT02704364|560266508|FG002|Overall Study|Other|1|||
155225428|NCT02086110|560266511|FG000|Overall Study|Withdrawal by Subject|1|||
155225429|NCT02086110|560266512|FG001|Overall Study|Withdrawal by Subject|1|||
155225430|NCT01869192|560266513|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
155225431|NCT01869192|560266514|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
155225432|NCT01869192|560266513|FG000|Postoperative Chemotherapy|Physician Decision|0|||
155225433|NCT01869192|560266514|FG001|Postoperative Chemotherapy|Physician Decision|2|||
155225434|NCT01203072|560266518|FG000|Overall Study|Adverse Event|5|||
155225435|NCT01203072|560266519|FG001|Overall Study|Adverse Event|3|||
155225436|NCT01203072|560266520|FG002|Overall Study|Adverse Event|2|||
155225437|NCT01203072|560266521|FG003|Overall Study|Adverse Event|4|||
155225438|NCT01203072|560266522|FG004|Overall Study|Adverse Event|2|||
155225439|NCT01203072|560266518|FG000|Overall Study|Lack of Efficacy|1|||
155225440|NCT01203072|560266519|FG001|Overall Study|Lack of Efficacy|0|||
155225441|NCT01203072|560266520|FG002|Overall Study|Lack of Efficacy|0|||
155225442|NCT01203072|560266521|FG003|Overall Study|Lack of Efficacy|0|||
155225443|NCT01203072|560266522|FG004|Overall Study|Lack of Efficacy|0|||
155225444|NCT01203072|560266518|FG000|Overall Study|Lost to Follow-up|0|||
155225445|NCT01203072|560266519|FG001|Overall Study|Lost to Follow-up|1|||
155225446|NCT01203072|560266520|FG002|Overall Study|Lost to Follow-up|0|||
155225447|NCT01203072|560266521|FG003|Overall Study|Lost to Follow-up|0|||
155225448|NCT01203072|560266522|FG004|Overall Study|Lost to Follow-up|0|||
155225449|NCT01203072|560266518|FG000|Overall Study|Protocol Violation|2|||
155225450|NCT01203072|560266519|FG001|Overall Study|Protocol Violation|0|||
155225451|NCT01203072|560266520|FG002|Overall Study|Protocol Violation|0|||
155225452|NCT01203072|560266521|FG003|Overall Study|Protocol Violation|0|||
155225453|NCT01203072|560266522|FG004|Overall Study|Protocol Violation|1|||
155225454|NCT01203072|560266518|FG000|Overall Study|Withdrawal by Subject|2|||
155225455|NCT01203072|560266519|FG001|Overall Study|Withdrawal by Subject|2|||
155225456|NCT01203072|560266520|FG002|Overall Study|Withdrawal by Subject|1|||
155225457|NCT01203072|560266521|FG003|Overall Study|Withdrawal by Subject|2|||
155225458|NCT01203072|560266522|FG004|Overall Study|Withdrawal by Subject|3|||
155225459|NCT02272413|560266524|FG000|Randomized Through Treatment Start|Not treated|3|||
155225460|NCT02272413|560266525|FG001|Randomized Through Treatment Start|Not treated|5|||
155225461|NCT02272413|560266524|FG000|Pre-switch Period|Adverse Event|38|||
155225462|NCT02272413|560266525|FG001|Pre-switch Period|Adverse Event|37|||
155225463|NCT02272413|560266524|FG000|Pre-switch Period|Death|26|||
155225464|NCT02272413|560266525|FG001|Pre-switch Period|Death|26|||
155225465|NCT02272413|560266524|FG000|Pre-switch Period|Withdrawal by Subject|27|||
155225466|NCT02272413|560266525|FG001|Pre-switch Period|Withdrawal by Subject|15|||
155225467|NCT02272413|560266524|FG000|Pre-switch Period|Physician Decision|6|||
155225468|NCT02272413|560266525|FG001|Pre-switch Period|Physician Decision|18|||
155225469|NCT02272413|560266524|FG000|Pre-switch Period|Progressive disease|185|||
155225470|NCT02272413|560266525|FG001|Pre-switch Period|Progressive disease|173|||
155225471|NCT02272413|560266524|FG000|Pre-switch Period|Lost to Follow-up|0|||
155225472|NCT02272413|560266525|FG001|Pre-switch Period|Lost to Follow-up|2|||
155225473|NCT02272413|560266524|FG000|Pre-switch Period|Protocol Violation|1|||
155225474|NCT02272413|560266525|FG001|Pre-switch Period|Protocol Violation|0|||
155225475|NCT02272413|560266524|FG000|Pre-switch Period|Other than listed|10|||
155225476|NCT02272413|560266525|FG001|Pre-switch Period|Other than listed|11|||
155225477|NCT02272413|560266524|FG000|Post-switch Period|Adverse Event|4|||
155225478|NCT02272413|560266525|FG001|Post-switch Period|Adverse Event|4|||
155225479|NCT02272413|560266524|FG000|Post-switch Period|Death|3|||
155225480|NCT02272413|560266525|FG001|Post-switch Period|Death|2|||
155225481|NCT02272413|560266524|FG000|Post-switch Period|Withdrawal by Subject|1|||
155225482|NCT02272413|560266525|FG001|Post-switch Period|Withdrawal by Subject|2|||
155225483|NCT02272413|560266524|FG000|Post-switch Period|Physician Decision|1|||
155225484|NCT02272413|560266525|FG001|Post-switch Period|Physician Decision|1|||
155225485|NCT02272413|560266524|FG000|Post-switch Period|Progressive disease|21|||
155225486|NCT02272413|560266525|FG001|Post-switch Period|Progressive disease|21|||
155225487|NCT02272413|560266524|FG000|Post-switch Period|Study terminated by sponsor|8|||
155225488|NCT02272413|560266525|FG001|Post-switch Period|Study terminated by sponsor|11|||
155225489|NCT02272413|560266524|FG000|Post-switch Period|Other than listed|4|||
155225490|NCT02272413|560266525|FG001|Post-switch Period|Other than listed|5|||
155225491|NCT02286193|560266531|FG000|Overall Study|Referred: CRS unable to make contact|62|||
155225492|NCT02286193|560266531|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
155225493|NCT02286193|560266531|FG000|Overall Study|Referred: Declined service|38|||
155225494|NCT00423891|560266532|FG000|Enrolled|Withdrawal by Subject|0|||
155225495|NCT00423891|560266533|FG001|Enrolled|Withdrawal by Subject|0|||
155225496|NCT00423891|560266534|FG002|Enrolled|Withdrawal by Subject|1|||
155225497|NCT00423891|560266532|FG000|Enrolled|Lost to Follow-up|0|||
155225498|NCT00423891|560266533|FG001|Enrolled|Lost to Follow-up|0|||
155225499|NCT00423891|560266534|FG002|Enrolled|Lost to Follow-up|1|||
155225500|NCT00423891|560266532|FG000|Enrolled|No longer met criteria|11|||
155225501|NCT00423891|560266533|FG001|Enrolled|No longer met criteria|2|||
155225502|NCT00423891|560266534|FG002|Enrolled|No longer met criteria|1|||
155225503|NCT00423891|560266532|FG000|Treatment|Withdrawal by Subject|1|||
155225504|NCT00423891|560266533|FG001|Treatment|Withdrawal by Subject|0|||
155225505|NCT00423891|560266534|FG002|Treatment|Withdrawal by Subject|0|||
155225506|NCT00423891|560266532|FG000|Treatment|Lost to Follow-up|1|||
155225507|NCT00423891|560266533|FG001|Treatment|Lost to Follow-up|0|||
155225508|NCT00423891|560266534|FG002|Treatment|Lost to Follow-up|0|||
155225509|NCT00423891|560266532|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
155225510|NCT00423891|560266533|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
155225511|NCT00423891|560266534|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
155225512|NCT00423891|560266532|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
155225513|NCT00423891|560266533|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
155225514|NCT00423891|560266534|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
155225515|NCT02871375|560266535|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
155225516|NCT02871375|560266536|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
155225517|NCT04327999|560266544|FG000|Overall Study|Protocol Violation|1|||
155225518|NCT02872116|560266549|FG000|Pre-Treatment|Disease Progression|0|||
155225519|NCT02872116|560266550|FG001|Pre-Treatment|Disease Progression|1|||
155225520|NCT02872116|560266551|FG002|Pre-Treatment|Disease Progression|0|||
155225521|NCT02872116|560266549|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
155225522|NCT02872116|560266550|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
155225523|NCT02872116|560266551|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
155225524|NCT02872116|560266549|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
155225525|NCT02872116|560266550|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
155225526|NCT02872116|560266551|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
155225527|NCT02872116|560266549|FG000|Pre-Treatment|Participant withdrew consent|2|||
155225528|NCT02872116|560266550|FG001|Pre-Treatment|Participant withdrew consent|20|||
155225529|NCT02872116|560266551|FG002|Pre-Treatment|Participant withdrew consent|3|||
155225530|NCT02872116|560266549|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
155225531|NCT02872116|560266550|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
155225532|NCT02872116|560266551|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
155225533|NCT02872116|560266549|FG000|Pre-Treatment|Other reasons|1|||
155225534|NCT02872116|560266550|FG001|Pre-Treatment|Other reasons|2|||
155225535|NCT02872116|560266551|FG002|Pre-Treatment|Other reasons|2|||
155225536|NCT02872116|560266549|FG000|Treatment|Death|121|||
155225537|NCT02872116|560266550|FG001|Treatment|Death|94|||
155225538|NCT02872116|560266551|FG002|Treatment|Death|68|||
155225539|NCT02872116|560266549|FG000|Treatment|Lost to Follow-up|5|||
155225540|NCT02872116|560266550|FG001|Treatment|Lost to Follow-up|7|||
155225541|NCT02872116|560266551|FG002|Treatment|Lost to Follow-up|3|||
155225542|NCT02872116|560266549|FG000|Treatment|Participant withdrew consent|20|||
155225543|NCT02872116|560266550|FG001|Treatment|Participant withdrew consent|40|||
155225544|NCT02872116|560266551|FG002|Treatment|Participant withdrew consent|8|||
155225545|NCT02872116|560266549|FG000|Treatment|Other reasons|13|||
155225546|NCT02872116|560266550|FG001|Treatment|Other reasons|12|||
155225547|NCT02872116|560266551|FG002|Treatment|Other reasons|5|||
155225548|NCT02346136|560266552|FG000|Overall Study|Withdrawal by Subject|7|||
155225549|NCT02346136|560266553|FG001|Overall Study|Withdrawal by Subject|5|||
155225550|NCT02346136|560266552|FG000|Overall Study|Death|1|||
155225551|NCT02346136|560266553|FG001|Overall Study|Death|0|||
155225552|NCT02346136|560266552|FG000|Overall Study|Study termination|14|||
155225553|NCT02346136|560266553|FG001|Overall Study|Study termination|18|||
155225554|NCT00606892|560266560|FG000|First Intervention|Protocol Violation|1|||
155225555|NCT00606892|560266561|FG001|First Intervention|Protocol Violation|4|||
155225556|NCT04225923|560266570|FG000|Overall Study|Protocol Violation|1|||
155225557|NCT04225923|560266571|FG001|Overall Study|Protocol Violation|0|||
155491450|NCT01740297|561225388|FG002|Overall Study|Death|40|||
155225558|NCT04225923|560266572|FG002|Overall Study|Protocol Violation|1|||
155225559|NCT04225923|560266570|FG000|Overall Study|Withdrawal by Subject|4|||
155225560|NCT04225923|560266571|FG001|Overall Study|Withdrawal by Subject|1|||
155225561|NCT04225923|560266572|FG002|Overall Study|Withdrawal by Subject|3|||
155225562|NCT04225923|560266570|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
155225563|NCT04225923|560266571|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
155225564|NCT04225923|560266572|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
155225565|NCT00855309|560266573|FG000|Overall Study|patient never recieved drug|1|||
155225566|NCT00855309|560266574|FG001|Overall Study|patient never recieved drug|0|||
155225567|NCT01907828|560266580|FG000|Overall Study|Exclusion criteria not met|0|||
155491451|NCT01740297|561225386|FG000|Overall Study|Lost to Follow-up|1|||
155225568|NCT01907828|560266581|FG001|Overall Study|Exclusion criteria not met|1|||
155225569|NCT01907828|560266580|FG000|Overall Study|Withdrawal by Subject|3|||
155225570|NCT01907828|560266581|FG001|Overall Study|Withdrawal by Subject|4|||
155225571|NCT01907828|560266580|FG000|Overall Study|Lost to Follow-up|3|||
155225572|NCT01907828|560266581|FG001|Overall Study|Lost to Follow-up|0|||
155225573|NCT01907828|560266580|FG000|Overall Study|Participant refused 24-month follow-up|1|||
155225574|NCT01907828|560266581|FG001|Overall Study|Participant refused 24-month follow-up|0|||
155225575|NCT01907828|560266580|FG000|Overall Study|Participant met exclusion criteria|0|||
155225576|NCT01907828|560266581|FG001|Overall Study|Participant met exclusion criteria|1|||
155225577|NCT01364428|560266586|FG000|Overall Study|Adverse Event|1|||
155225578|NCT01364428|560266587|FG001|Overall Study|Adverse Event|2|||
155225579|NCT01364428|560266586|FG000|Overall Study|Protocol Violation|2|||
155225580|NCT01364428|560266587|FG001|Overall Study|Protocol Violation|0|||
155225581|NCT01364428|560266586|FG000|Overall Study|Withdrawal Criteria|14|||
155225582|NCT01364428|560266587|FG001|Overall Study|Withdrawal Criteria|10|||
155225583|NCT01364428|560266586|FG000|Overall Study|Other|3|||
155225584|NCT01364428|560266587|FG001|Overall Study|Other|3|||
155225585|NCT01585766|560266588|FG000|Overall Study|Withdrawal by Subject|0|||
155225586|NCT01585766|560266589|FG001|Overall Study|Withdrawal by Subject|1|||
155225587|NCT01585766|560266590|FG002|Overall Study|Withdrawal by Subject|1|||
155225588|NCT01585766|560266591|FG003|Overall Study|Withdrawal by Subject|0|||
155225589|NCT01585766|560266592|FG004|Overall Study|Withdrawal by Subject|0|||
155225590|NCT01585766|560266593|FG005|Overall Study|Withdrawal by Subject|0|||
155225591|NCT01585766|560266588|FG000|Overall Study|Death|0|||
155225592|NCT01585766|560266589|FG001|Overall Study|Death|1|||
155225593|NCT01585766|560266590|FG002|Overall Study|Death|0|||
155225594|NCT01585766|560266591|FG003|Overall Study|Death|0|||
155225595|NCT01585766|560266592|FG004|Overall Study|Death|0|||
155225596|NCT01585766|560266593|FG005|Overall Study|Death|0|||
155225597|NCT01585766|560266588|FG000|Overall Study|Physician Decision|0|||
155225598|NCT01585766|560266589|FG001|Overall Study|Physician Decision|0|||
155225599|NCT01585766|560266590|FG002|Overall Study|Physician Decision|1|||
155225600|NCT01585766|560266591|FG003|Overall Study|Physician Decision|0|||
155225601|NCT01585766|560266592|FG004|Overall Study|Physician Decision|0|||
155225602|NCT01585766|560266593|FG005|Overall Study|Physician Decision|0|||
155225603|NCT00582933|560266594|FG000|Overall Study|Physician Decision|3|||
155225604|NCT01371656|560266600|FG000|Overall Study|Death|7|||
155225605|NCT01371656|560266601|FG001|Overall Study|Death|4|||
155225606|NCT01371656|560266600|FG000|Overall Study|Physician Decision|46|||
155225607|NCT01371656|560266601|FG001|Overall Study|Physician Decision|7|||
155225608|NCT01371656|560266600|FG000|Overall Study|Withdrawal by Subject|7|||
155225609|NCT01371656|560266601|FG001|Overall Study|Withdrawal by Subject|0|||
155225610|NCT01371656|560266600|FG000|Overall Study|Ineligible|4|||
155225611|NCT01371656|560266601|FG001|Overall Study|Ineligible|3|||
155225612|NCT00696137|560266606|FG000|Overall Study|Withdrawal by Subject|2|||
155225613|NCT04334460|560266620|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
155225614|NCT04334460|560266621|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
155225615|NCT04334460|560266620|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
155225616|NCT04334460|560266621|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
155225617|NCT01465464|560266622|FG000|Overall Study|Adverse Event|96|||
155225618|NCT01465464|560266623|FG001|Overall Study|Adverse Event|49|||
155225619|NCT01465464|560266622|FG000|Overall Study|Lack of Efficacy|139|||
155225620|NCT01465464|560266623|FG001|Overall Study|Lack of Efficacy|190|||
155225621|NCT01465464|560266622|FG000|Overall Study|Physician Decision|13|||
155225622|NCT01465464|560266623|FG001|Overall Study|Physician Decision|5|||
155225623|NCT01465464|560266622|FG000|Overall Study|Protocol Violation|1|||
155225624|NCT01465464|560266623|FG001|Overall Study|Protocol Violation|1|||
155225625|NCT01465464|560266622|FG000|Overall Study|Withdrawal by Subject|46|||
155225626|NCT01465464|560266623|FG001|Overall Study|Withdrawal by Subject|30|||
155225627|NCT01465464|560266622|FG000|Overall Study|Other|9|||
155225628|NCT01465464|560266623|FG001|Overall Study|Other|3|||
155225629|NCT01465464|560266622|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
155225630|NCT01465464|560266623|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
155225631|NCT00775437|560266629|FG000|Overall Study|Loss of efficacy|2|||
155225632|NCT00775437|560266629|FG000|Overall Study|Withdrawal by Subject|3|||
155225633|NCT00775437|560266629|FG000|Overall Study|Lost to Follow-up|1|||
155225634|NCT01183975|560266630|FG000|Overall Study|Lost to Follow-up|73|||
155225635|NCT03316885|560266631|FG000|Overall Study|Adverse Event|1|||
155225636|NCT03316885|560266631|FG000|Overall Study|Death|10|||
155225637|NCT03316885|560266631|FG000|Overall Study|Lost to Follow-up|4|||
155225638|NCT03316885|560266631|FG000|Overall Study|Withdrawal by Subject|9|||
155225639|NCT03316885|560266631|FG000|Overall Study|COVID related|8|||
155225640|NCT04964128|560266640|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
155225641|NCT04964128|560266640|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
155225642|NCT02120794|560266641|FG000|Overall Study|Withdrawal by Subject|43|||
155225643|NCT02120794|560266641|FG000|Overall Study|Adverse Event|10|||
155225644|NCT02120794|560266641|FG000|Overall Study|Physician Decision|4|||
155225645|NCT02120794|560266641|FG000|Overall Study|Due to insurance coverage|1|||
155225646|NCT00994240|560266644|FG000|Overall Study|Lost to Follow-up|3|||
155225647|NCT00994240|560266645|FG001|Overall Study|Lost to Follow-up|2|||
155225648|NCT00994240|560266644|FG000|Overall Study|Withdrawal by Subject|1|||
155225649|NCT00994240|560266645|FG001|Overall Study|Withdrawal by Subject|0|||
155225650|NCT00994240|560266644|FG000|Overall Study|study termination|2|||
155225651|NCT00994240|560266645|FG001|Overall Study|study termination|3|||
155225652|NCT01148511|560266646|FG000|Exposed to Study Drug|Protocol Violation|2|||
155225653|NCT01148511|560266647|FG001|Exposed to Study Drug|Protocol Violation|0|||
155225654|NCT01148511|560266648|FG002|Exposed to Study Drug|Protocol Violation|0|||
155225655|NCT01148511|560266646|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
155225656|NCT01148511|560266647|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
155225657|NCT01148511|560266648|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
155225658|NCT01148511|560266646|FG000|Randomized|Adverse Event|0|||
155225659|NCT01148511|560266647|FG001|Randomized|Adverse Event|1|||
155225660|NCT01148511|560266648|FG002|Randomized|Adverse Event|0|||
155225661|NCT01148511|560266646|FG000|Randomized|Protocol Violation|0|||
155225662|NCT01148511|560266647|FG001|Randomized|Protocol Violation|2|||
155225663|NCT01148511|560266648|FG002|Randomized|Protocol Violation|1|||
155225664|NCT01148511|560266646|FG000|Randomized|Lost to Follow-up|0|||
155225665|NCT01148511|560266647|FG001|Randomized|Lost to Follow-up|1|||
155225666|NCT01148511|560266648|FG002|Randomized|Lost to Follow-up|1|||
155225667|NCT01148511|560266646|FG000|Randomized|Consent withdrawal|0|||
155225668|NCT01148511|560266647|FG001|Randomized|Consent withdrawal|5|||
155225669|NCT01148511|560266648|FG002|Randomized|Consent withdrawal|3|||
155225670|NCT01148511|560266646|FG000|Randomized|Other|0|||
155225671|NCT01148511|560266647|FG001|Randomized|Other|1|||
155225672|NCT01148511|560266648|FG002|Randomized|Other|1|||
155225673|NCT04258605|560266650|FG000|Overall Study|Death|1|||
155225674|NCT04258605|560266651|FG001|Overall Study|Death|0|||
155225675|NCT04258605|560266650|FG000|Overall Study|Early study termination|21|||
155225676|NCT04258605|560266651|FG001|Overall Study|Early study termination|2|||
155225677|NCT00842348|560266655|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
155225678|NCT00842348|560266656|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
155225679|NCT00842348|560266655|FG000|Study 729|Disease progression/death|19|||
155225680|NCT00842348|560266656|FG001|Study 729|Disease progression/death|30|||
155225681|NCT00842348|560266655|FG000|Study 729|Adverse Event|1|||
155225682|NCT00842348|560266656|FG001|Study 729|Adverse Event|1|||
155225683|NCT00842348|560266655|FG000|Study 729|Protocol Violation|1|||
155225684|NCT00842348|560266656|FG001|Study 729|Protocol Violation|1|||
155225685|NCT00842348|560266655|FG000|Study 729|Withdrawal by Subject|2|||
155225686|NCT00842348|560266656|FG001|Study 729|Withdrawal by Subject|4|||
155225687|NCT00842348|560266655|FG000|Study 729|Due to Sponsor stopping the study|1|||
155225688|NCT00842348|560266656|FG001|Study 729|Due to Sponsor stopping the study|1|||
155225689|NCT00842348|560266655|FG000|Study 729|Due to non-availability of IP|0|||
155225690|NCT00842348|560266656|FG001|Study 729|Due to non-availability of IP|1|||
155225691|NCT00842348|560266655|FG000|Study 729|Sponsor's decision|1|||
155225692|NCT00842348|560266656|FG001|Study 729|Sponsor's decision|0|||
155225693|NCT00842348|560266655|FG000|Study 729|Surgical resection|1|||
155225694|NCT00842348|560266656|FG001|Study 729|Surgical resection|0|||
155225695|NCT03274986|560266657|FG000|Overall Study|Withdrawal by Subject|0|||
155225696|NCT03274986|560266658|FG001|Overall Study|Withdrawal by Subject|1|||
155225697|NCT03274986|560266657|FG000|Overall Study|Lost to Follow-up|0|||
155225698|NCT03274986|560266658|FG001|Overall Study|Lost to Follow-up|1|||
155225699|NCT02196324|560266661|FG000|Overall Study|Withdrawal by Subject|8|||
155225700|NCT02196324|560266662|FG001|Overall Study|Withdrawal by Subject|4|||
155225701|NCT02196324|560266661|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
155225702|NCT02196324|560266662|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
155225703|NCT02196324|560266661|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
155225704|NCT02196324|560266662|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
155225705|NCT02196324|560266661|FG000|Overall Study|Other|1|||
155225706|NCT02196324|560266662|FG001|Overall Study|Other|0|||
155225707|NCT02620046|560266663|FG000|Overall Study|Adverse Event|22|||
155225708|NCT02620046|560266664|FG001|Overall Study|Adverse Event|42|||
155225709|NCT02620046|560266663|FG000|Overall Study|Lost to Follow-up|4|||
155225710|NCT02620046|560266664|FG001|Overall Study|Lost to Follow-up|10|||
155225711|NCT02620046|560266663|FG000|Overall Study|Withdrawal by Subject|36|||
155225712|NCT02620046|560266664|FG001|Overall Study|Withdrawal by Subject|66|||
155225713|NCT02620046|560266663|FG000|Overall Study|Site Termination|3|||
155225714|NCT02620046|560266664|FG001|Overall Study|Site Termination|3|||
155225715|NCT02620046|560266663|FG000|Overall Study|Pregnancy|3|||
155225716|NCT02620046|560266664|FG001|Overall Study|Pregnancy|7|||
155225717|NCT02620046|560266663|FG000|Overall Study|Lack of Efficacy|81|||
155225718|NCT02620046|560266664|FG001|Overall Study|Lack of Efficacy|146|||
155225719|NCT02620046|560266663|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
155225720|NCT02620046|560266664|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
155225721|NCT02620046|560266663|FG000|Overall Study|Reason Not Specified|13|||
155225722|NCT02620046|560266664|FG001|Overall Study|Reason Not Specified|21|||
155225723|NCT02620046|560266663|FG000|Overall Study|Significant Protocol Deviation|0|||
155225724|NCT02620046|560266664|FG001|Overall Study|Significant Protocol Deviation|1|||
155225725|NCT02970968|560268578|FG000|Overall Study|Withdrawal by Subject|3|||
155225726|NCT02970968|560268579|FG001|Overall Study|Withdrawal by Subject|3|||
155225727|NCT02970968|560268578|FG000|Overall Study|Adverse Event|1|||
155225728|NCT02970968|560268579|FG001|Overall Study|Adverse Event|2|||
155225729|NCT02970968|560268578|FG000|Overall Study|Lost to Follow-up|1|||
155225730|NCT02970968|560268579|FG001|Overall Study|Lost to Follow-up|1|||
155225731|NCT02970968|560268578|FG000|Overall Study|Non-Compliance|0|||
155225732|NCT02970968|560268579|FG001|Overall Study|Non-Compliance|1|||
155225733|NCT02565381|560268580|FG000|Overall Study|Lost to Follow-up|1|||
155225734|NCT02565381|560268581|FG001|Overall Study|Lost to Follow-up|0|||
155225735|NCT02565381|560268582|FG002|Overall Study|Lost to Follow-up|1|||
155225736|NCT05308901|560268585|FG000|Overall Study|Death|6|||
155225737|NCT02388737|560268586|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
155225738|NCT02388737|560268587|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
155225739|NCT02388737|560268588|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
155225740|NCT02388737|560268586|FG000|Overall Study|Major Protocol Deviation|18|||
155225741|NCT02388737|560268587|FG001|Overall Study|Major Protocol Deviation|25|||
155225742|NCT02388737|560268588|FG002|Overall Study|Major Protocol Deviation|22|||
155225743|NCT02388737|560268586|FG000|Overall Study|Lost to Follow-up|5|||
155225744|NCT02388737|560268587|FG001|Overall Study|Lost to Follow-up|1|||
155225745|NCT02388737|560268588|FG002|Overall Study|Lost to Follow-up|4|||
155225746|NCT02388737|560268586|FG000|Overall Study|Voluntary Withdrawal|10|||
155225747|NCT02388737|560268587|FG001|Overall Study|Voluntary Withdrawal|18|||
155225748|NCT02388737|560268588|FG002|Overall Study|Voluntary Withdrawal|17|||
155225749|NCT02388737|560268586|FG000|Overall Study|Lack of Efficacy|3|||
155225750|NCT02388737|560268587|FG001|Overall Study|Lack of Efficacy|0|||
155225751|NCT02388737|560268588|FG002|Overall Study|Lack of Efficacy|3|||
155225752|NCT02388737|560268586|FG000|Overall Study|Reason Not Specified|5|||
155225753|NCT02388737|560268587|FG001|Overall Study|Reason Not Specified|5|||
155225754|NCT02388737|560268588|FG002|Overall Study|Reason Not Specified|4|||
155225755|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
155225756|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
155225757|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
155225758|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
155225759|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
155225760|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
155225761|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
155225762|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
155225763|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
155225764|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
155225765|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
155225766|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
155225767|NCT03252522|560268589|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
155225768|NCT03252522|560268590|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
155225769|NCT03252522|560268591|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
155225770|NCT03252522|560268589|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
155225771|NCT03252522|560268590|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
155225772|NCT03252522|560268591|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
155225773|NCT03252522|560268589|FG000|Phase 2: Open Label|Adverse Event|0|||
155225774|NCT03252522|560268590|FG001|Phase 2: Open Label|Adverse Event|0|||
155225775|NCT03252522|560268591|FG002|Phase 2: Open Label|Adverse Event|2|||
155225776|NCT03252522|560268589|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
155225777|NCT03252522|560268590|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
155225778|NCT03252522|560268591|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
155225779|NCT03299842|560268593|FG000|Overall Study|Caregiver withdrew consent|2|||
155225780|NCT03299842|560268593|FG000|Overall Study|Child would not keep the watch on|3|||
155225781|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Adverse Event|2|||
155225782|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Adverse Event|3|||
155225783|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Adverse Event|4|||
155225784|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Adverse Event|4|||
155225785|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
155225786|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
155225787|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
155225788|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
155225789|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
155225790|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
155225791|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
155225792|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155225793|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
155225794|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
155225795|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
155225796|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
155225797|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
155225798|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
155225799|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
155225800|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
155225801|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
155225802|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
155225803|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
155225804|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
155225805|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225806|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225807|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225808|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
155225809|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225810|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225811|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225812|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
155225813|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225814|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225815|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225816|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
155225817|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155225818|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155225819|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
155225820|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
155225821|NCT01816139|560268600|FG000|Overall Study|Adverse Event|6|||
155225822|NCT01816139|560268601|FG001|Overall Study|Adverse Event|8|||
155225823|NCT01816139|560268600|FG000|Overall Study|Lack of Efficacy|1|||
155225824|NCT01816139|560268601|FG001|Overall Study|Lack of Efficacy|2|||
155225825|NCT01816139|560268600|FG000|Overall Study|Lost to Follow-up|5|||
155225826|NCT01816139|560268601|FG001|Overall Study|Lost to Follow-up|3|||
155225827|NCT01816139|560268600|FG000|Overall Study|Withdrew Consent|6|||
155225828|NCT01816139|560268601|FG001|Overall Study|Withdrew Consent|4|||
155225829|NCT01816139|560268600|FG000|Overall Study|Protocol Violation|6|||
155225830|NCT01816139|560268601|FG001|Overall Study|Protocol Violation|3|||
155225831|NCT01816139|560268600|FG000|Overall Study|Reason not Specified|4|||
155225832|NCT01816139|560268601|FG001|Overall Study|Reason not Specified|2|||
155225833|NCT01940120|560268602|FG000|Overall Study|Death|40|||
155225834|NCT01940120|560268602|FG000|Overall Study|Withdrawal by Subject|8|||
155225835|NCT01888497|560268603|FG000|Washout Period 1|Withdrawal by Subject|0|||
155225836|NCT01888497|560268604|FG001|Washout Period 1|Withdrawal by Subject|0|||
155225837|NCT01888497|560268605|FG002|Washout Period 1|Withdrawal by Subject|1|||
155225838|NCT01888497|560268606|FG003|Washout Period 1|Withdrawal by Subject|1|||
155225839|NCT01888497|560268603|FG000|Washout Period 2|Adverse Event|0|||
155225840|NCT01888497|560268604|FG001|Washout Period 2|Adverse Event|0|||
155225841|NCT01888497|560268605|FG002|Washout Period 2|Adverse Event|0|||
155225842|NCT01888497|560268606|FG003|Washout Period 2|Adverse Event|1|||
155225843|NCT01888497|560268603|FG000|Washout Period 2|Withdrawal by Subject|0|||
155225844|NCT01888497|560268604|FG001|Washout Period 2|Withdrawal by Subject|0|||
155225845|NCT01888497|560268605|FG002|Washout Period 2|Withdrawal by Subject|0|||
155225846|NCT01888497|560268606|FG003|Washout Period 2|Withdrawal by Subject|1|||
155225847|NCT04152447|560268607|FG000|Overall Study|Lost to Follow-up|1|||
155225848|NCT04152447|560268608|FG001|Overall Study|Lost to Follow-up|0|||
155225849|NCT04152447|560268607|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
155225850|NCT04152447|560268608|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
155225851|NCT04152447|560268607|FG000|Overall Study|Withdrawal by Subject|0|||
155225852|NCT04152447|560268608|FG001|Overall Study|Withdrawal by Subject|1|||
155225853|NCT04152447|560268607|FG000|Overall Study|Found ineligible after enrolling|1|||
155225854|NCT04152447|560268608|FG001|Overall Study|Found ineligible after enrolling|1|||
155225855|NCT04152447|560268607|FG000|Overall Study|Did not receive VR headset in time.|0|||
155225856|NCT04152447|560268608|FG001|Overall Study|Did not receive VR headset in time.|2|||
155225857|NCT04013191|560268609|FG000|Overall Study|Adverse Event|1|||
155225858|NCT04013191|560268610|FG001|Overall Study|Adverse Event|0|||
155225859|NCT04127786|560268621|FG000|Primary Series|Adverse Event|1|||
155225860|NCT04127786|560268622|FG001|Primary Series|Adverse Event|0|||
155225861|NCT04127786|560268623|FG002|Primary Series|Adverse Event|0|||
155225862|NCT04127786|560268624|FG003|Primary Series|Adverse Event|1|||
155225863|NCT04127786|560268625|FG004|Primary Series|Adverse Event|0|||
155225864|NCT04127786|560268626|FG005|Primary Series|Adverse Event|1|||
155225865|NCT04127786|560268621|FG000|Primary Series|Protocol Violation|5|||
155225866|NCT04127786|560268622|FG001|Primary Series|Protocol Violation|3|||
155225867|NCT04127786|560268623|FG002|Primary Series|Protocol Violation|4|||
155225868|NCT04127786|560268624|FG003|Primary Series|Protocol Violation|3|||
155225869|NCT04127786|560268625|FG004|Primary Series|Protocol Violation|2|||
155225870|NCT04127786|560268626|FG005|Primary Series|Protocol Violation|0|||
155225871|NCT04127786|560268621|FG000|Primary Series|Withdrawal by Subject|0|||
155225872|NCT04127786|560268622|FG001|Primary Series|Withdrawal by Subject|0|||
155225873|NCT04127786|560268623|FG002|Primary Series|Withdrawal by Subject|0|||
155225874|NCT04127786|560268624|FG003|Primary Series|Withdrawal by Subject|1|||
155225875|NCT04127786|560268625|FG004|Primary Series|Withdrawal by Subject|0|||
155225876|NCT04127786|560268626|FG005|Primary Series|Withdrawal by Subject|0|||
155225877|NCT04127786|560268621|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
155225878|NCT04127786|560268622|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
155225879|NCT04127786|560268623|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
155225880|NCT04127786|560268624|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
155225881|NCT04127786|560268625|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
155225882|NCT04127786|560268626|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
155225883|NCT04127786|560268621|FG000|Booster Phase|Withdrawal by Subject|2|||
155225884|NCT04127786|560268622|FG001|Booster Phase|Withdrawal by Subject|0|||
155225885|NCT04127786|560268623|FG002|Booster Phase|Withdrawal by Subject|0|||
155225886|NCT04127786|560268624|FG003|Booster Phase|Withdrawal by Subject|0|||
155225887|NCT04127786|560268625|FG004|Booster Phase|Withdrawal by Subject|0|||
155225888|NCT04127786|560268626|FG005|Booster Phase|Withdrawal by Subject|0|||
155225889|NCT03034954|560268627|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
155225890|NCT03034954|560268628|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
155225891|NCT03568942|560268633|FG000|Overall Study|Family emergency|1|||
155225892|NCT03568942|560268633|FG000|Overall Study|Lost to Follow-up|1|||
155225893|NCT00358527|560268634|FG000|Overall Study|Adverse Event|4|||
155225894|NCT00358527|560268635|FG001|Overall Study|Adverse Event|0|||
155225895|NCT00358527|560268634|FG000|Overall Study|Withdrawal by Subject|1|||
155225896|NCT00358527|560268635|FG001|Overall Study|Withdrawal by Subject|1|||
155225897|NCT00358527|560268634|FG000|Overall Study|Non-compliance with protocol|6|||
155225898|NCT00358527|560268635|FG001|Overall Study|Non-compliance with protocol|1|||
155225899|NCT00358527|560268634|FG000|Overall Study|Administrative|2|||
155225900|NCT00358527|560268635|FG001|Overall Study|Administrative|1|||
155225901|NCT04144166|560268636|FG000|Overall Study|Discharged before study start|1|||
155225902|NCT04144166|560268636|FG000|Overall Study|Pregnancy|1|||
155225903|NCT04144166|560268636|FG000|Overall Study|Nail polish could not be removed from finger|1|||
155225904|NCT00913744|560268638|FG000|Overall Study|Adverse Event|2|||
155225905|NCT00913744|560268639|FG001|Overall Study|Adverse Event|0|||
155225906|NCT00913744|560268638|FG000|Overall Study|Withdrawal by Subject|2|||
155225907|NCT00913744|560268639|FG001|Overall Study|Withdrawal by Subject|1|||
155225908|NCT00913744|560268638|FG000|Overall Study|Death|1|||
155225909|NCT00913744|560268639|FG001|Overall Study|Death|0|||
155225910|NCT00805935|560268640|FG000|Overall Study|Stimulation Failure|1|||
155225911|NCT00805935|560268641|FG001|Overall Study|Stimulation Failure|5|||
155225912|NCT00805935|560268642|FG002|Overall Study|Stimulation Failure|2|||
155225913|NCT00805935|560268643|FG003|Overall Study|Stimulation Failure|2|||
155225914|NCT00805935|560268640|FG000|Overall Study|Cycle cancelled|0|||
155225915|NCT00805935|560268641|FG001|Overall Study|Cycle cancelled|0|||
155225916|NCT00805935|560268642|FG002|Overall Study|Cycle cancelled|2|||
155225917|NCT00805935|560268643|FG003|Overall Study|Cycle cancelled|0|||
155225918|NCT00805935|560268640|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
155225919|NCT00805935|560268641|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
155225920|NCT00805935|560268642|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
155225921|NCT00805935|560268643|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
155225922|NCT00805935|560268640|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225923|NCT00805935|560268641|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225924|NCT00805935|560268642|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225925|NCT00805935|560268643|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
155225926|NCT00805935|560268640|FG000|Overall Study|Lost to Follow-up|1|||
155225927|NCT00805935|560268641|FG001|Overall Study|Lost to Follow-up|0|||
155225928|NCT00805935|560268642|FG002|Overall Study|Lost to Follow-up|0|||
155225929|NCT00805935|560268643|FG003|Overall Study|Lost to Follow-up|0|||
155225930|NCT00805935|560268640|FG000|Overall Study|No positive serum pregnancy|8|||
155225931|NCT00805935|560268641|FG001|Overall Study|No positive serum pregnancy|7|||
155225932|NCT00805935|560268642|FG002|Overall Study|No positive serum pregnancy|6|||
155225933|NCT00805935|560268643|FG003|Overall Study|No positive serum pregnancy|5|||
155225934|NCT00805935|560268640|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225935|NCT00805935|560268641|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225936|NCT00805935|560268642|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225937|NCT00805935|560268643|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
155225938|NCT00805935|560268640|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
155225939|NCT00805935|560268641|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
155225940|NCT00805935|560268642|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
155225941|NCT00805935|560268643|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
155225942|NCT00805935|560268640|FG000|Overall Study|Biochemical pregnancy|0|||
155225943|NCT00805935|560268641|FG001|Overall Study|Biochemical pregnancy|1|||
155491452|NCT01740297|561225387|FG001|Overall Study|Lost to Follow-up|2|||
155225944|NCT00805935|560268642|FG002|Overall Study|Biochemical pregnancy|0|||
155225945|NCT00805935|560268643|FG003|Overall Study|Biochemical pregnancy|0|||
155225946|NCT00805935|560268640|FG000|Overall Study|Chemical pregnancy|0|||
155225947|NCT00805935|560268641|FG001|Overall Study|Chemical pregnancy|5|||
155225948|NCT00805935|560268642|FG002|Overall Study|Chemical pregnancy|3|||
155225949|NCT00805935|560268643|FG003|Overall Study|Chemical pregnancy|2|||
155225950|NCT00805935|560268640|FG000|Overall Study|Ectopic pregnancy|0|||
155225951|NCT00805935|560268641|FG001|Overall Study|Ectopic pregnancy|0|||
155225952|NCT00805935|560268642|FG002|Overall Study|Ectopic pregnancy|1|||
155225953|NCT00805935|560268643|FG003|Overall Study|Ectopic pregnancy|0|||
155225954|NCT00805935|560268640|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225955|NCT00805935|560268641|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
155225956|NCT00805935|560268642|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225957|NCT00805935|560268643|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225958|NCT02433834|560268644|FG000|Overall Study|Protocol-specified criteria|7|||
155225959|NCT02433834|560268644|FG000|Overall Study|Protocol Violation|3|||
155225960|NCT02433834|560268644|FG000|Overall Study|Lost to Follow-up|6|||
155225961|NCT02433834|560268644|FG000|Overall Study|Withdrawal by Subject|14|||
155225962|NCT02433834|560268644|FG000|Overall Study|Adverse Event|6|||
155225963|NCT02433834|560268644|FG000|Overall Study|Physician Decision|1|||
155225964|NCT00283439|560268646|FG000|Overall Study|Adverse Event|0|||
155225965|NCT00283439|560268647|FG001|Overall Study|Adverse Event|0|||
155225966|NCT00283439|560268648|FG002|Overall Study|Adverse Event|0|||
155225967|NCT00283439|560268649|FG003|Overall Study|Adverse Event|1|||
155225968|NCT00283439|560268646|FG000|Overall Study|Death|0|||
155225969|NCT00283439|560268647|FG001|Overall Study|Death|0|||
155225970|NCT00283439|560268648|FG002|Overall Study|Death|1|||
155225971|NCT00283439|560268649|FG003|Overall Study|Death|0|||
155225972|NCT00283439|560268646|FG000|Overall Study|Disease progression|0|||
155225973|NCT00283439|560268647|FG001|Overall Study|Disease progression|1|||
155225974|NCT00283439|560268648|FG002|Overall Study|Disease progression|0|||
155225975|NCT00283439|560268649|FG003|Overall Study|Disease progression|0|||
155225976|NCT00283439|560268646|FG000|Overall Study|Requirement for alternative therapy|1|||
155225977|NCT00283439|560268647|FG001|Overall Study|Requirement for alternative therapy|2|||
155225978|NCT00283439|560268648|FG002|Overall Study|Requirement for alternative therapy|5|||
155225979|NCT00283439|560268649|FG003|Overall Study|Requirement for alternative therapy|2|||
155225980|NCT00283439|560268646|FG000|Overall Study|Stem cell transplant|6|||
155225981|NCT00283439|560268647|FG001|Overall Study|Stem cell transplant|6|||
155225982|NCT00283439|560268648|FG002|Overall Study|Stem cell transplant|4|||
155225983|NCT00283439|560268649|FG003|Overall Study|Stem cell transplant|3|||
155225984|NCT00283439|560268646|FG000|Overall Study|Treatment discontinued|0|||
155225985|NCT00283439|560268647|FG001|Overall Study|Treatment discontinued|2|||
155225986|NCT00283439|560268648|FG002|Overall Study|Treatment discontinued|1|||
155225987|NCT00283439|560268649|FG003|Overall Study|Treatment discontinued|3|||
155225988|NCT00283439|560268646|FG000|Overall Study|Other|1|||
155225989|NCT00283439|560268647|FG001|Overall Study|Other|0|||
155225990|NCT00283439|560268648|FG002|Overall Study|Other|0|||
155225991|NCT00283439|560268649|FG003|Overall Study|Other|0|||
155225992|NCT00333229|560268650|FG000|Overall Study|Lack of Efficacy|0|||
155225993|NCT00333229|560268651|FG001|Overall Study|Lack of Efficacy|1|||
155225994|NCT00348556|560268654|FG000|Overall Study|Adverse Event|1|||
155225995|NCT01466270|560268655|FG000|Overall Study|Withdrawal by Subject|4|||
155225996|NCT01466270|560268656|FG001|Overall Study|Withdrawal by Subject|1|||
155225997|NCT01466270|560268655|FG000|Overall Study|Physician Decision|1|||
155225998|NCT01466270|560268656|FG001|Overall Study|Physician Decision|0|||
155225999|NCT01466270|560268655|FG000|Overall Study|Lost to Follow-up|1|||
155226000|NCT01466270|560268656|FG001|Overall Study|Lost to Follow-up|3|||
155226001|NCT01466270|560268655|FG000|Overall Study|Progression|1|||
155226002|NCT01466270|560268656|FG001|Overall Study|Progression|0|||
155226003|NCT01466270|560268655|FG000|Overall Study|Toxicity|4|||
155226004|NCT01466270|560268656|FG001|Overall Study|Toxicity|1|||
155226005|NCT01466270|560268655|FG000|Overall Study|Multiple|1|||
155226006|NCT01466270|560268656|FG001|Overall Study|Multiple|1|||
155226007|NCT01944059|560268657|FG000|Overall Study|Lost to Follow-up|1|||
155226008|NCT01944059|560268657|FG000|Overall Study|Physician Decision|3|||
155226009|NCT01944059|560268657|FG000|Overall Study|Withdrawal by Subject|1|||
155226010|NCT01944059|560268657|FG000|Overall Study|Adverse Event|2|||
155226011|NCT02821962|560268658|FG000|Overall Study|Lost to Follow-up|2|||
155226012|NCT02821962|560268659|FG001|Overall Study|Lost to Follow-up|0|||
155226013|NCT00430092|560268661|FG000|Overall Study|Adverse Event|0|||
155226014|NCT00430092|560268662|FG001|Overall Study|Adverse Event|0|||
155226015|NCT00430092|560268663|FG002|Overall Study|Adverse Event|1|||
155226016|NCT00430092|560268661|FG000|Overall Study|Lack of Efficacy|5|||
155226017|NCT00430092|560268662|FG001|Overall Study|Lack of Efficacy|2|||
155226018|NCT00430092|560268663|FG002|Overall Study|Lack of Efficacy|54|||
155226019|NCT00430092|560268661|FG000|Overall Study|Lost to Follow-up|1|||
155226020|NCT00430092|560268662|FG001|Overall Study|Lost to Follow-up|0|||
155226021|NCT00430092|560268663|FG002|Overall Study|Lost to Follow-up|0|||
155226022|NCT00430092|560268661|FG000|Overall Study|Protocol Violation|0|||
155226023|NCT00430092|560268662|FG001|Overall Study|Protocol Violation|1|||
155226024|NCT00430092|560268663|FG002|Overall Study|Protocol Violation|1|||
155226025|NCT00430092|560268661|FG000|Overall Study|Withdrawal by Subject|0|||
155226026|NCT00430092|560268662|FG001|Overall Study|Withdrawal by Subject|1|||
155226027|NCT00430092|560268663|FG002|Overall Study|Withdrawal by Subject|1|||
155226028|NCT00654381|560268664|FG000|1st Stage|Adverse Event|3|||
155226029|NCT00654381|560268665|FG001|1st Stage|Adverse Event|3|||
155226030|NCT00654381|560268666|FG002|1st Stage|Adverse Event|3|||
155226031|NCT00654381|560268667|FG003|1st Stage|Adverse Event|3|||
155226032|NCT00654381|560268668|FG004|1st Stage|Adverse Event|2|||
155226033|NCT00654381|560268669|FG005|1st Stage|Adverse Event|1|||
155226034|NCT00654381|560268664|FG000|1st Stage|Withdrawal by Subject|0|||
155226035|NCT00654381|560268665|FG001|1st Stage|Withdrawal by Subject|0|||
155226036|NCT00654381|560268666|FG002|1st Stage|Withdrawal by Subject|0|||
155226037|NCT00654381|560268667|FG003|1st Stage|Withdrawal by Subject|1|||
155226038|NCT00654381|560268668|FG004|1st Stage|Withdrawal by Subject|0|||
155226039|NCT00654381|560268669|FG005|1st Stage|Withdrawal by Subject|1|||
155226040|NCT00654381|560268664|FG000|1st Stage|Investigator's decision|0|||
155226041|NCT00654381|560268665|FG001|1st Stage|Investigator's decision|0|||
155226042|NCT00654381|560268666|FG002|1st Stage|Investigator's decision|0|||
155226043|NCT00654381|560268667|FG003|1st Stage|Investigator's decision|1|||
155226044|NCT00654381|560268668|FG004|1st Stage|Investigator's decision|0|||
155226045|NCT00654381|560268669|FG005|1st Stage|Investigator's decision|0|||
155226046|NCT00654381|560268664|FG000|2nd Stage|Adverse Event|2|||
155226047|NCT00654381|560268665|FG001|2nd Stage|Adverse Event|0|||
155226048|NCT00654381|560268666|FG002|2nd Stage|Adverse Event|2|||
155226049|NCT00654381|560268667|FG003|2nd Stage|Adverse Event|3|||
155226050|NCT00654381|560268668|FG004|2nd Stage|Adverse Event|7|||
155226051|NCT00654381|560268669|FG005|2nd Stage|Adverse Event|2|||
155226052|NCT00654381|560268664|FG000|2nd Stage|Withdrawal by Subject|0|||
155226053|NCT00654381|560268665|FG001|2nd Stage|Withdrawal by Subject|0|||
155226054|NCT00654381|560268666|FG002|2nd Stage|Withdrawal by Subject|0|||
155226055|NCT00654381|560268667|FG003|2nd Stage|Withdrawal by Subject|0|||
155226056|NCT00654381|560268668|FG004|2nd Stage|Withdrawal by Subject|1|||
155226057|NCT00654381|560268669|FG005|2nd Stage|Withdrawal by Subject|1|||
155226058|NCT00654381|560268664|FG000|2nd Stage|Investigator's decision|0|||
155226059|NCT00654381|560268665|FG001|2nd Stage|Investigator's decision|0|||
155226060|NCT00654381|560268666|FG002|2nd Stage|Investigator's decision|1|||
155226061|NCT00654381|560268667|FG003|2nd Stage|Investigator's decision|1|||
155226062|NCT00654381|560268668|FG004|2nd Stage|Investigator's decision|0|||
155226063|NCT00654381|560268669|FG005|2nd Stage|Investigator's decision|0|||
155226064|NCT00654381|560268664|FG000|Extension Stage|Adverse Event|1|||
155226065|NCT00654381|560268665|FG001|Extension Stage|Adverse Event|2|||
155226066|NCT00654381|560268666|FG002|Extension Stage|Adverse Event|9|||
155226067|NCT00654381|560268667|FG003|Extension Stage|Adverse Event|7|||
155226068|NCT00654381|560268668|FG004|Extension Stage|Adverse Event|1|||
155226069|NCT00654381|560268669|FG005|Extension Stage|Adverse Event|1|||
155226070|NCT00654381|560268664|FG000|Extension Stage|Protocol Violation|0|||
155226071|NCT00654381|560268665|FG001|Extension Stage|Protocol Violation|0|||
155226072|NCT00654381|560268666|FG002|Extension Stage|Protocol Violation|0|||
155226073|NCT00654381|560268667|FG003|Extension Stage|Protocol Violation|1|||
155226074|NCT00654381|560268668|FG004|Extension Stage|Protocol Violation|0|||
155226075|NCT00654381|560268669|FG005|Extension Stage|Protocol Violation|0|||
155226076|NCT00654381|560268664|FG000|Extension Stage|Lack of Efficacy|0|||
155226077|NCT00654381|560268665|FG001|Extension Stage|Lack of Efficacy|0|||
155226078|NCT00654381|560268666|FG002|Extension Stage|Lack of Efficacy|1|||
155226079|NCT00654381|560268667|FG003|Extension Stage|Lack of Efficacy|0|||
155226080|NCT00654381|560268668|FG004|Extension Stage|Lack of Efficacy|0|||
155226081|NCT00654381|560268669|FG005|Extension Stage|Lack of Efficacy|0|||
155226082|NCT00654381|560268664|FG000|Extension Stage|Withdrawal by Subject|0|||
155226083|NCT00654381|560268665|FG001|Extension Stage|Withdrawal by Subject|0|||
155226084|NCT00654381|560268666|FG002|Extension Stage|Withdrawal by Subject|1|||
155226085|NCT00654381|560268667|FG003|Extension Stage|Withdrawal by Subject|1|||
155226086|NCT00654381|560268668|FG004|Extension Stage|Withdrawal by Subject|1|||
155226087|NCT00654381|560268669|FG005|Extension Stage|Withdrawal by Subject|1|||
155226088|NCT00654381|560268664|FG000|Extension Stage|Closure of the trial site|0|||
155226089|NCT00654381|560268665|FG001|Extension Stage|Closure of the trial site|0|||
155226090|NCT00654381|560268666|FG002|Extension Stage|Closure of the trial site|0|||
155226091|NCT00654381|560268667|FG003|Extension Stage|Closure of the trial site|0|||
155226092|NCT00654381|560268668|FG004|Extension Stage|Closure of the trial site|1|||
155226093|NCT00654381|560268669|FG005|Extension Stage|Closure of the trial site|1|||
155226094|NCT00048542|560268679|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155226095|NCT00048542|560268680|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
155226096|NCT00048542|560268681|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155226097|NCT00048542|560268682|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155226098|NCT00048542|560268683|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155226099|NCT00048542|560268684|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
155226100|NCT00048542|560268685|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
155226101|NCT00048542|560268686|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
155226102|NCT00048542|560268679|FG000|Double-Blind Phase|Protocol Violation|0|||
155226103|NCT00048542|560268680|FG001|Double-Blind Phase|Protocol Violation|0|||
155226104|NCT00048542|560268681|FG002|Double-Blind Phase|Protocol Violation|1|||
155226105|NCT00048542|560268682|FG003|Double-Blind Phase|Protocol Violation|0|||
155226106|NCT00048542|560268683|FG004|Double-Blind Phase|Protocol Violation|0|||
155226107|NCT00048542|560268684|FG005|Double-Blind Phase|Protocol Violation|0|||
155226108|NCT00048542|560268685|FG006|Double-Blind Phase|Protocol Violation|0|||
155226109|NCT00048542|560268686|FG007|Double-Blind Phase|Protocol Violation|0|||
155226110|NCT00048542|560268679|FG000|Double-Blind Phase|Sponsor request or decision|2|||
155226111|NCT00048542|560268680|FG001|Double-Blind Phase|Sponsor request or decision|0|||
155226112|NCT00048542|560268681|FG002|Double-Blind Phase|Sponsor request or decision|0|||
155226113|NCT00048542|560268682|FG003|Double-Blind Phase|Sponsor request or decision|0|||
155226114|NCT00048542|560268683|FG004|Double-Blind Phase|Sponsor request or decision|0|||
155226115|NCT00048542|560268684|FG005|Double-Blind Phase|Sponsor request or decision|0|||
155226116|NCT00048542|560268685|FG006|Double-Blind Phase|Sponsor request or decision|0|||
155226117|NCT00048542|560268686|FG007|Double-Blind Phase|Sponsor request or decision|0|||
155226118|NCT00048542|560268679|FG000|Double-Blind Phase|Randomized in error|1|||
155226119|NCT00048542|560268680|FG001|Double-Blind Phase|Randomized in error|0|||
155226120|NCT00048542|560268681|FG002|Double-Blind Phase|Randomized in error|0|||
155226121|NCT00048542|560268682|FG003|Double-Blind Phase|Randomized in error|0|||
155226122|NCT00048542|560268683|FG004|Double-Blind Phase|Randomized in error|0|||
155226123|NCT00048542|560268684|FG005|Double-Blind Phase|Randomized in error|0|||
155226124|NCT00048542|560268685|FG006|Double-Blind Phase|Randomized in error|0|||
155226125|NCT00048542|560268686|FG007|Double-Blind Phase|Randomized in error|0|||
155226126|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226127|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226128|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226129|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226130|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
155226131|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
155226132|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226133|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226134|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226135|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226136|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226137|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226138|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226139|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
155226140|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226141|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226142|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226143|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226144|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226145|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226146|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
155226147|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
155226148|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226149|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226150|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
155226151|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
155226152|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
155226153|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
155226154|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
155226155|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
155226156|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
155226157|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
155226158|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226159|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226160|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226161|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226162|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
155226163|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
155226164|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226165|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226166|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226167|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226168|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226169|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226170|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226171|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155491453|NCT01740297|561225388|FG002|Overall Study|Lost to Follow-up|4|||
155226172|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
155226173|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
155226174|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226175|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226176|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226177|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226178|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226179|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226180|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
155226181|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
155226182|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226183|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226184|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226185|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226186|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226187|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226188|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
155226189|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
155226190|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226191|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226192|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226193|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226194|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226195|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226196|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
155226197|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
155226198|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226199|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226200|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226201|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226202|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226203|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226204|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
155226205|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
155226206|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226207|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226208|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226209|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226210|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226211|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226212|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
155226213|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
155226214|NCT00006489|560268692|FG000|Overall Study|Adverse Event|3|||
155226215|NCT00006489|560268693|FG001|Overall Study|Adverse Event|2|||
155226216|NCT00006489|560268694|FG002|Overall Study|Adverse Event|4|||
155226217|NCT00006489|560268695|FG003|Overall Study|Adverse Event|3|||
155226218|NCT00006489|560268692|FG000|Overall Study|Withdrawal by Subject|10|||
155226219|NCT00006489|560268693|FG001|Overall Study|Withdrawal by Subject|9|||
155226220|NCT00006489|560268694|FG002|Overall Study|Withdrawal by Subject|9|||
155226221|NCT00006489|560268695|FG003|Overall Study|Withdrawal by Subject|6|||
155226222|NCT00006489|560268692|FG000|Overall Study|Scheduling Conflict|0|||
155226223|NCT00006489|560268693|FG001|Overall Study|Scheduling Conflict|3|||
155226224|NCT00006489|560268694|FG002|Overall Study|Scheduling Conflict|2|||
155226225|NCT00006489|560268695|FG003|Overall Study|Scheduling Conflict|1|||
155226226|NCT00006489|560268692|FG000|Overall Study|Death|0|||
155226227|NCT00006489|560268693|FG001|Overall Study|Death|0|||
155226228|NCT00006489|560268694|FG002|Overall Study|Death|0|||
155226229|NCT00006489|560268695|FG003|Overall Study|Death|1|||
155226230|NCT00578175|560268696|FG000|Overall Study|Adverse Event|0|||
155226231|NCT00578175|560268697|FG001|Overall Study|Adverse Event|1|||
155226232|NCT00578175|560268698|FG002|Overall Study|Adverse Event|1|||
155226233|NCT00578175|560268696|FG000|Overall Study|Other reasons|70|||
155226234|NCT00578175|560268697|FG001|Overall Study|Other reasons|42|||
155226235|NCT00578175|560268698|FG002|Overall Study|Other reasons|23|||
155226236|NCT02308735|560268699|FG000|Overall Study|Physician Decision|2|||
155226237|NCT02308735|560268700|FG001|Overall Study|Physician Decision|0|||
155226238|NCT02308735|560268701|FG002|Overall Study|Physician Decision|0|||
155226239|NCT02308735|560268702|FG003|Overall Study|Physician Decision|2|||
155226240|NCT01417481|560268709|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155226241|NCT01417481|560268710|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155226242|NCT03029624|560268711|FG000|Overall Study|Adverse Event|1|||
155226243|NCT03029624|560268711|FG000|Overall Study|Withdrawal by Subject|1|||
155226244|NCT03029624|560268711|FG000|Overall Study|Lack of Efficacy|1|||
155226245|NCT03029624|560268711|FG000|Overall Study|MRI need|2|||
155226246|NCT02376166|560268712|FG000|Overall Study|Adverse Event|1|||
155226247|NCT02376166|560268712|FG000|Overall Study|Discontinued metformin early|2|||
155226248|NCT04180020|560268713|FG000|Overall Study|missed visit|18|||
155226249|NCT04180020|560268714|FG001|Overall Study|missed visit|16|||
155226250|NCT04180020|560268713|FG000|Overall Study|Death|2|||
155226251|NCT04180020|560268714|FG001|Overall Study|Death|3|||
155226252|NCT04180020|560268713|FG000|Overall Study|Withdrawal by Subject|1|||
155226253|NCT04180020|560268714|FG001|Overall Study|Withdrawal by Subject|5|||
155226254|NCT04180020|560268713|FG000|Overall Study|incarcerated|1|||
155226255|NCT04180020|560268714|FG001|Overall Study|incarcerated|1|||
155226256|NCT04180020|560268713|FG000|Overall Study|Physician Decision|0|||
155226257|NCT04180020|560268714|FG001|Overall Study|Physician Decision|2|||
155226258|NCT01640366|560268716|FG000|Overall Study|Withdrawal by Subject|1|||
155226259|NCT01640366|560268716|FG000|Overall Study|Protocol Violation|16|||
155226260|NCT01640366|560268716|FG000|Overall Study|Lost to Follow-up|5|||
155226261|NCT02739269|560268723|FG000|Overall Study|Protocol Violation|5|||
155226262|NCT02739269|560268724|FG001|Overall Study|Protocol Violation|0|||
155226263|NCT02739269|560268723|FG000|Overall Study|Cycle cancellation|2|||
155226264|NCT02739269|560268724|FG001|Overall Study|Cycle cancellation|2|||
155226265|NCT02739269|560268723|FG000|Overall Study|Withdrawal by Subject|0|||
155226266|NCT02739269|560268724|FG001|Overall Study|Withdrawal by Subject|2|||
155226267|NCT03554291|560268727|FG000|Overall Study|Death|2|||
155226268|NCT03554291|560268728|FG001|Overall Study|Death|1|||
155226269|NCT03554291|560268727|FG000|Overall Study|Lost to Follow-up|1|||
155226270|NCT03554291|560268728|FG001|Overall Study|Lost to Follow-up|0|||
155226271|NCT03554291|560268727|FG000|Overall Study|Withdrawal by Subject|1|||
155226272|NCT03554291|560268728|FG001|Overall Study|Withdrawal by Subject|0|||
155226273|NCT03554291|560268727|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
155226274|NCT03554291|560268728|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
155226275|NCT01228747|560268729|FG000|Overall Study|Adverse Event|8|||
155226276|NCT01228747|560268730|FG001|Overall Study|Adverse Event|4|||
155226277|NCT01228747|560268729|FG000|Overall Study|Lack of Efficacy|40|||
155226278|NCT01228747|560268730|FG001|Overall Study|Lack of Efficacy|27|||
155226279|NCT01228747|560268729|FG000|Overall Study|Protocol Violation|6|||
155226280|NCT01228747|560268730|FG001|Overall Study|Protocol Violation|5|||
155226281|NCT01228747|560268729|FG000|Overall Study|Lost to Follow-up|4|||
155226282|NCT01228747|560268730|FG001|Overall Study|Lost to Follow-up|3|||
155226283|NCT01228747|560268729|FG000|Overall Study|Withdrawal by Subject|5|||
155226284|NCT01228747|560268730|FG001|Overall Study|Withdrawal by Subject|1|||
155226285|NCT01228747|560268729|FG000|Overall Study|Other Reason|2|||
155226286|NCT01228747|560268730|FG001|Overall Study|Other Reason|5|||
155226287|NCT04251221|560268736|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
155226288|NCT04251221|560268737|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
155226289|NCT01165138|560268738|FG000|Overall Study|Adverse Event|0|||
155226290|NCT01165138|560268739|FG001|Overall Study|Adverse Event|1|||
155226291|NCT01165138|560268740|FG002|Overall Study|Adverse Event|0|||
155226292|NCT01165138|560268741|FG003|Overall Study|Adverse Event|2|||
155226293|NCT01165138|560268738|FG000|Overall Study|Lack of Efficacy|0|||
155226294|NCT01165138|560268739|FG001|Overall Study|Lack of Efficacy|32|||
155226295|NCT01165138|560268740|FG002|Overall Study|Lack of Efficacy|6|||
155226296|NCT01165138|560268741|FG003|Overall Study|Lack of Efficacy|7|||
155226297|NCT01165138|560268738|FG000|Overall Study|Protocol Violation|0|||
155226298|NCT01165138|560268739|FG001|Overall Study|Protocol Violation|7|||
155226299|NCT01165138|560268740|FG002|Overall Study|Protocol Violation|0|||
155226300|NCT01165138|560268741|FG003|Overall Study|Protocol Violation|2|||
155226301|NCT01165138|560268738|FG000|Overall Study|Lost to Follow-up|0|||
155226302|NCT01165138|560268739|FG001|Overall Study|Lost to Follow-up|0|||
155226303|NCT01165138|560268740|FG002|Overall Study|Lost to Follow-up|1|||
155226304|NCT01165138|560268741|FG003|Overall Study|Lost to Follow-up|2|||
155226305|NCT01165138|560268738|FG000|Overall Study|Physician Decision|0|||
155226306|NCT01165138|560268739|FG001|Overall Study|Physician Decision|6|||
155226307|NCT01165138|560268740|FG002|Overall Study|Physician Decision|7|||
155226308|NCT01165138|560268741|FG003|Overall Study|Physician Decision|6|||
155226309|NCT01165138|560268738|FG000|Overall Study|Withdrawal by Subject|0|||
155226310|NCT01165138|560268739|FG001|Overall Study|Withdrawal by Subject|6|||
155226311|NCT01165138|560268740|FG002|Overall Study|Withdrawal by Subject|6|||
155226312|NCT01165138|560268741|FG003|Overall Study|Withdrawal by Subject|3|||
155226313|NCT02641379|560268742|FG000|Overall Study|Exclusion criterion during screening|1|||
155226314|NCT02641379|560268743|FG001|Overall Study|Exclusion criterion during screening|0|||
155226315|NCT02641379|560268744|FG002|Overall Study|Exclusion criterion during screening|0|||
155226316|NCT02641379|560268745|FG003|Overall Study|Exclusion criterion during screening|1|||
155226317|NCT02641379|560268746|FG004|Overall Study|Exclusion criterion during screening|2|||
155226318|NCT02641379|560268747|FG005|Overall Study|Exclusion criterion during screening|0|||
155226319|NCT02641379|560268748|FG006|Overall Study|Exclusion criterion during screening|0|||
155226320|NCT02641379|560268749|FG007|Overall Study|Exclusion criterion during screening|0|||
155226321|NCT02641379|560268750|FG008|Overall Study|Exclusion criterion during screening|0|||
155226322|NCT02641379|560268751|FG009|Overall Study|Exclusion criterion during screening|0|||
155226323|NCT02641379|560268752|FG010|Overall Study|Exclusion criterion during screening|0|||
155226324|NCT02641379|560268742|FG000|Overall Study|Withdrawal of informed consent|0|||
155226325|NCT02641379|560268743|FG001|Overall Study|Withdrawal of informed consent|1|||
155226326|NCT02641379|560268744|FG002|Overall Study|Withdrawal of informed consent|0|||
155226327|NCT02641379|560268745|FG003|Overall Study|Withdrawal of informed consent|0|||
155226328|NCT02641379|560268746|FG004|Overall Study|Withdrawal of informed consent|0|||
155226329|NCT02641379|560268747|FG005|Overall Study|Withdrawal of informed consent|0|||
155226330|NCT02641379|560268748|FG006|Overall Study|Withdrawal of informed consent|0|||
155226331|NCT02641379|560268749|FG007|Overall Study|Withdrawal of informed consent|1|||
155226332|NCT02641379|560268750|FG008|Overall Study|Withdrawal of informed consent|0|||
155226333|NCT02641379|560268751|FG009|Overall Study|Withdrawal of informed consent|0|||
155226334|NCT02641379|560268752|FG010|Overall Study|Withdrawal of informed consent|0|||
155226335|NCT02641379|560268742|FG000|Overall Study|Adverse Event|7|||
155226336|NCT02641379|560268743|FG001|Overall Study|Adverse Event|8|||
155226337|NCT02641379|560268744|FG002|Overall Study|Adverse Event|2|||
155226338|NCT02641379|560268745|FG003|Overall Study|Adverse Event|2|||
155226339|NCT02641379|560268746|FG004|Overall Study|Adverse Event|5|||
155226340|NCT02641379|560268747|FG005|Overall Study|Adverse Event|1|||
155226341|NCT02641379|560268748|FG006|Overall Study|Adverse Event|5|||
155226342|NCT02641379|560268749|FG007|Overall Study|Adverse Event|0|||
155226343|NCT02641379|560268750|FG008|Overall Study|Adverse Event|1|||
155226344|NCT02641379|560268751|FG009|Overall Study|Adverse Event|1|||
155226345|NCT02641379|560268752|FG010|Overall Study|Adverse Event|5|||
155226346|NCT02641379|560268742|FG000|Overall Study|Lack of Efficacy|0|||
155226347|NCT02641379|560268743|FG001|Overall Study|Lack of Efficacy|0|||
155226348|NCT02641379|560268744|FG002|Overall Study|Lack of Efficacy|2|||
155226349|NCT02641379|560268745|FG003|Overall Study|Lack of Efficacy|0|||
155226350|NCT02641379|560268746|FG004|Overall Study|Lack of Efficacy|0|||
155226351|NCT02641379|560268747|FG005|Overall Study|Lack of Efficacy|2|||
155226352|NCT02641379|560268748|FG006|Overall Study|Lack of Efficacy|0|||
155226353|NCT02641379|560268749|FG007|Overall Study|Lack of Efficacy|5|||
155226354|NCT02641379|560268750|FG008|Overall Study|Lack of Efficacy|0|||
155226355|NCT02641379|560268751|FG009|Overall Study|Lack of Efficacy|0|||
155226356|NCT02641379|560268752|FG010|Overall Study|Lack of Efficacy|0|||
155226357|NCT02641379|560268742|FG000|Overall Study|Participant unable to attend study visit|4|||
155226358|NCT02641379|560268743|FG001|Overall Study|Participant unable to attend study visit|10|||
155226359|NCT02641379|560268744|FG002|Overall Study|Participant unable to attend study visit|1|||
155226360|NCT02641379|560268745|FG003|Overall Study|Participant unable to attend study visit|2|||
155226361|NCT02641379|560268746|FG004|Overall Study|Participant unable to attend study visit|5|||
155226362|NCT02641379|560268747|FG005|Overall Study|Participant unable to attend study visit|1|||
155226363|NCT02641379|560268748|FG006|Overall Study|Participant unable to attend study visit|1|||
155226364|NCT02641379|560268749|FG007|Overall Study|Participant unable to attend study visit|1|||
155226365|NCT02641379|560268750|FG008|Overall Study|Participant unable to attend study visit|0|||
155226366|NCT02641379|560268751|FG009|Overall Study|Participant unable to attend study visit|2|||
155226367|NCT02641379|560268752|FG010|Overall Study|Participant unable to attend study visit|0|||
155226368|NCT02641379|560268742|FG000|Overall Study|Participant's compliance|0|||
155226369|NCT02641379|560268743|FG001|Overall Study|Participant's compliance|1|||
155226370|NCT02641379|560268744|FG002|Overall Study|Participant's compliance|0|||
155226371|NCT02641379|560268745|FG003|Overall Study|Participant's compliance|1|||
155226372|NCT02641379|560268746|FG004|Overall Study|Participant's compliance|0|||
155226373|NCT02641379|560268747|FG005|Overall Study|Participant's compliance|2|||
155226374|NCT02641379|560268748|FG006|Overall Study|Participant's compliance|0|||
155226375|NCT02641379|560268749|FG007|Overall Study|Participant's compliance|0|||
155226376|NCT02641379|560268750|FG008|Overall Study|Participant's compliance|1|||
155226377|NCT02641379|560268751|FG009|Overall Study|Participant's compliance|1|||
155226378|NCT02641379|560268752|FG010|Overall Study|Participant's compliance|1|||
155226379|NCT02641379|560268742|FG000|Overall Study|Participant cannot be reached|4|||
155226380|NCT02641379|560268743|FG001|Overall Study|Participant cannot be reached|4|||
155226381|NCT02641379|560268744|FG002|Overall Study|Participant cannot be reached|0|||
155226382|NCT02641379|560268745|FG003|Overall Study|Participant cannot be reached|8|||
155226383|NCT02641379|560268746|FG004|Overall Study|Participant cannot be reached|2|||
155226384|NCT02641379|560268747|FG005|Overall Study|Participant cannot be reached|1|||
155226385|NCT02641379|560268748|FG006|Overall Study|Participant cannot be reached|0|||
155226386|NCT02641379|560268749|FG007|Overall Study|Participant cannot be reached|1|||
155226387|NCT02641379|560268750|FG008|Overall Study|Participant cannot be reached|0|||
155226388|NCT02641379|560268751|FG009|Overall Study|Participant cannot be reached|2|||
155226389|NCT02641379|560268752|FG010|Overall Study|Participant cannot be reached|1|||
155226390|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 24|15|||
155226391|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 24|21|||
155226392|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 24|62|||
155226393|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 24|0|||
155226394|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 24|0|||
155226395|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 24|6|||
155226396|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 24|3|||
155226397|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 24|8|||
155226398|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 24|0|||
155226399|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 24|1|||
155226400|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 24|0|||
155226401|NCT02641379|560268742|FG000|Overall Study|PCR positive at follow up 2|1|||
155226402|NCT02641379|560268743|FG001|Overall Study|PCR positive at follow up 2|0|||
155226403|NCT02641379|560268744|FG002|Overall Study|PCR positive at follow up 2|0|||
155226404|NCT02641379|560268745|FG003|Overall Study|PCR positive at follow up 2|0|||
155226405|NCT02641379|560268746|FG004|Overall Study|PCR positive at follow up 2|0|||
155226406|NCT02641379|560268747|FG005|Overall Study|PCR positive at follow up 2|0|||
155226407|NCT02641379|560268748|FG006|Overall Study|PCR positive at follow up 2|0|||
155226408|NCT02641379|560268749|FG007|Overall Study|PCR positive at follow up 2|0|||
155226409|NCT02641379|560268750|FG008|Overall Study|PCR positive at follow up 2|0|||
155226410|NCT02641379|560268751|FG009|Overall Study|PCR positive at follow up 2|0|||
155226411|NCT02641379|560268752|FG010|Overall Study|PCR positive at follow up 2|0|||
155226412|NCT02641379|560268742|FG000|Overall Study|Participant showed relapse|1|||
155226413|NCT02641379|560268743|FG001|Overall Study|Participant showed relapse|0|||
155226414|NCT02641379|560268744|FG002|Overall Study|Participant showed relapse|0|||
155226415|NCT02641379|560268745|FG003|Overall Study|Participant showed relapse|0|||
155226416|NCT02641379|560268746|FG004|Overall Study|Participant showed relapse|0|||
155226417|NCT02641379|560268747|FG005|Overall Study|Participant showed relapse|0|||
155226418|NCT02641379|560268748|FG006|Overall Study|Participant showed relapse|1|||
155226419|NCT02641379|560268749|FG007|Overall Study|Participant showed relapse|0|||
155226420|NCT02641379|560268750|FG008|Overall Study|Participant showed relapse|0|||
155226421|NCT02641379|560268751|FG009|Overall Study|Participant showed relapse|0|||
155226422|NCT02641379|560268752|FG010|Overall Study|Participant showed relapse|0|||
155226423|NCT02641379|560268742|FG000|Overall Study|Participant stopped study/treatment|1|||
155226424|NCT02641379|560268743|FG001|Overall Study|Participant stopped study/treatment|3|||
155226425|NCT02641379|560268744|FG002|Overall Study|Participant stopped study/treatment|1|||
155226426|NCT02641379|560268745|FG003|Overall Study|Participant stopped study/treatment|0|||
155226427|NCT02641379|560268746|FG004|Overall Study|Participant stopped study/treatment|0|||
155226428|NCT02641379|560268747|FG005|Overall Study|Participant stopped study/treatment|1|||
155226429|NCT02641379|560268748|FG006|Overall Study|Participant stopped study/treatment|2|||
155226430|NCT02641379|560268749|FG007|Overall Study|Participant stopped study/treatment|0|||
155226431|NCT02641379|560268750|FG008|Overall Study|Participant stopped study/treatment|1|||
155226432|NCT02641379|560268751|FG009|Overall Study|Participant stopped study/treatment|0|||
155226433|NCT02641379|560268752|FG010|Overall Study|Participant stopped study/treatment|0|||
155226434|NCT02641379|560268742|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
155226435|NCT02641379|560268743|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
155226436|NCT02641379|560268744|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
155226437|NCT02641379|560268745|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
155226438|NCT02641379|560268746|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
155226439|NCT02641379|560268747|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
155226440|NCT02641379|560268748|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
155226441|NCT02641379|560268749|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
155226442|NCT02641379|560268750|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
155226443|NCT02641379|560268751|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
155226444|NCT02641379|560268752|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
155226445|NCT02641379|560268742|FG000|Overall Study|Financial problems|0|||
155226446|NCT02641379|560268743|FG001|Overall Study|Financial problems|1|||
155226447|NCT02641379|560268744|FG002|Overall Study|Financial problems|0|||
155226448|NCT02641379|560268745|FG003|Overall Study|Financial problems|0|||
155226449|NCT02641379|560268746|FG004|Overall Study|Financial problems|0|||
155226450|NCT02641379|560268747|FG005|Overall Study|Financial problems|0|||
155226451|NCT02641379|560268748|FG006|Overall Study|Financial problems|0|||
155226452|NCT02641379|560268749|FG007|Overall Study|Financial problems|0|||
155226453|NCT02641379|560268750|FG008|Overall Study|Financial problems|0|||
155226454|NCT02641379|560268751|FG009|Overall Study|Financial problems|0|||
155226455|NCT02641379|560268752|FG010|Overall Study|Financial problems|0|||
155226456|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 68|0|||
155226457|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 68|1|||
155226458|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 68|0|||
155226459|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 68|0|||
155226460|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 68|0|||
155226461|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 68|0|||
155226462|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 68|0|||
155226463|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 68|0|||
155226464|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 68|0|||
155226465|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 68|0|||
155226466|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 68|0|||
155226467|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 48|0|||
155226468|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 48|1|||
155226469|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 48|0|||
155226470|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 48|0|||
155226471|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 48|0|||
155226472|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 48|0|||
155226473|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 48|0|||
155226474|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 48|0|||
155226475|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 48|0|||
155226476|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 48|0|||
155226477|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 48|0|||
155226478|NCT02641379|560268742|FG000|Overall Study|PCR not performed at Week 12|0|||
155226479|NCT02641379|560268743|FG001|Overall Study|PCR not performed at Week 12|0|||
155226480|NCT02641379|560268744|FG002|Overall Study|PCR not performed at Week 12|1|||
155226481|NCT02641379|560268745|FG003|Overall Study|PCR not performed at Week 12|0|||
155226482|NCT02641379|560268746|FG004|Overall Study|PCR not performed at Week 12|0|||
155226483|NCT02641379|560268747|FG005|Overall Study|PCR not performed at Week 12|0|||
155226484|NCT02641379|560268748|FG006|Overall Study|PCR not performed at Week 12|0|||
155226485|NCT02641379|560268749|FG007|Overall Study|PCR not performed at Week 12|0|||
155226486|NCT02641379|560268750|FG008|Overall Study|PCR not performed at Week 12|0|||
155226487|NCT02641379|560268751|FG009|Overall Study|PCR not performed at Week 12|0|||
155226488|NCT02641379|560268752|FG010|Overall Study|PCR not performed at Week 12|0|||
155226489|NCT02641379|560268742|FG000|Overall Study|No PCR at baseline|0|||
155226490|NCT02641379|560268743|FG001|Overall Study|No PCR at baseline|0|||
155226491|NCT02641379|560268744|FG002|Overall Study|No PCR at baseline|1|||
155226492|NCT02641379|560268745|FG003|Overall Study|No PCR at baseline|0|||
155226493|NCT02641379|560268746|FG004|Overall Study|No PCR at baseline|0|||
155226494|NCT02641379|560268747|FG005|Overall Study|No PCR at baseline|0|||
155226495|NCT02641379|560268748|FG006|Overall Study|No PCR at baseline|0|||
155226496|NCT02641379|560268749|FG007|Overall Study|No PCR at baseline|0|||
155226497|NCT02641379|560268750|FG008|Overall Study|No PCR at baseline|0|||
155226498|NCT02641379|560268751|FG009|Overall Study|No PCR at baseline|0|||
155226499|NCT02641379|560268752|FG010|Overall Study|No PCR at baseline|0|||
155226500|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 28|0|||
155226501|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 28|0|||
155226502|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 28|1|||
155226503|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 28|0|||
155226504|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 28|0|||
155226505|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 28|0|||
155226506|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 28|0|||
155226507|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 28|0|||
155226508|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 28|0|||
155226509|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 28|0|||
155226510|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 28|0|||
155226511|NCT02641379|560268742|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
155226512|NCT02641379|560268743|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
155226513|NCT02641379|560268744|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
155226514|NCT02641379|560268745|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
155226515|NCT02641379|560268746|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
155226516|NCT02641379|560268747|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
155226517|NCT02641379|560268748|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
155226518|NCT02641379|560268749|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
155226519|NCT02641379|560268750|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
155226520|NCT02641379|560268751|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
155226521|NCT02641379|560268752|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
155226522|NCT02641379|560268742|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
155226523|NCT02641379|560268743|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
155226524|NCT02641379|560268744|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
155226525|NCT02641379|560268745|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
155226526|NCT02641379|560268746|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
155226527|NCT02641379|560268747|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
155226528|NCT02641379|560268748|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
155226529|NCT02641379|560268749|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
155226530|NCT02641379|560268750|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
155226531|NCT02641379|560268751|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
155226532|NCT02641379|560268752|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
155226533|NCT02641379|560268742|FG000|Overall Study|Baseline viral load unavailable|0|||
155226534|NCT02641379|560268743|FG001|Overall Study|Baseline viral load unavailable|0|||
155226535|NCT02641379|560268744|FG002|Overall Study|Baseline viral load unavailable|0|||
155226536|NCT02641379|560268745|FG003|Overall Study|Baseline viral load unavailable|1|||
155226537|NCT02641379|560268746|FG004|Overall Study|Baseline viral load unavailable|0|||
155226538|NCT02641379|560268747|FG005|Overall Study|Baseline viral load unavailable|0|||
155226539|NCT02641379|560268748|FG006|Overall Study|Baseline viral load unavailable|0|||
155226540|NCT02641379|560268749|FG007|Overall Study|Baseline viral load unavailable|0|||
155226541|NCT02641379|560268750|FG008|Overall Study|Baseline viral load unavailable|0|||
155226542|NCT02641379|560268751|FG009|Overall Study|Baseline viral load unavailable|0|||
155226543|NCT02641379|560268752|FG010|Overall Study|Baseline viral load unavailable|0|||
155226544|NCT02641379|560268742|FG000|Overall Study|Blood could not be drawn|0|||
155226545|NCT02641379|560268743|FG001|Overall Study|Blood could not be drawn|0|||
155226546|NCT02641379|560268744|FG002|Overall Study|Blood could not be drawn|0|||
155226547|NCT02641379|560268745|FG003|Overall Study|Blood could not be drawn|0|||
155226548|NCT02641379|560268746|FG004|Overall Study|Blood could not be drawn|1|||
155226549|NCT02641379|560268747|FG005|Overall Study|Blood could not be drawn|0|||
155226550|NCT02641379|560268748|FG006|Overall Study|Blood could not be drawn|0|||
155226551|NCT02641379|560268749|FG007|Overall Study|Blood could not be drawn|0|||
155226552|NCT02641379|560268750|FG008|Overall Study|Blood could not be drawn|0|||
155226553|NCT02641379|560268751|FG009|Overall Study|Blood could not be drawn|0|||
155226554|NCT02641379|560268752|FG010|Overall Study|Blood could not be drawn|0|||
155226555|NCT02641379|560268742|FG000|Overall Study|Protocol Violation|0|||
155226556|NCT02641379|560268743|FG001|Overall Study|Protocol Violation|0|||
155226557|NCT02641379|560268744|FG002|Overall Study|Protocol Violation|0|||
155226558|NCT02641379|560268745|FG003|Overall Study|Protocol Violation|0|||
155226559|NCT02641379|560268746|FG004|Overall Study|Protocol Violation|2|||
155226560|NCT02641379|560268747|FG005|Overall Study|Protocol Violation|0|||
155226561|NCT02641379|560268748|FG006|Overall Study|Protocol Violation|0|||
155226562|NCT02641379|560268749|FG007|Overall Study|Protocol Violation|0|||
155226563|NCT02641379|560268750|FG008|Overall Study|Protocol Violation|1|||
155226564|NCT02641379|560268751|FG009|Overall Study|Protocol Violation|0|||
155226565|NCT02641379|560268752|FG010|Overall Study|Protocol Violation|0|||
155226566|NCT02641379|560268742|FG000|Overall Study|Participation in sili rescue study|0|||
155226567|NCT02641379|560268743|FG001|Overall Study|Participation in sili rescue study|0|||
155226568|NCT02641379|560268744|FG002|Overall Study|Participation in sili rescue study|0|||
155226569|NCT02641379|560268745|FG003|Overall Study|Participation in sili rescue study|0|||
155226570|NCT02641379|560268746|FG004|Overall Study|Participation in sili rescue study|0|||
155226571|NCT02641379|560268747|FG005|Overall Study|Participation in sili rescue study|1|||
155226572|NCT02641379|560268748|FG006|Overall Study|Participation in sili rescue study|0|||
155226573|NCT02641379|560268749|FG007|Overall Study|Participation in sili rescue study|0|||
155226574|NCT02641379|560268750|FG008|Overall Study|Participation in sili rescue study|0|||
155226575|NCT02641379|560268751|FG009|Overall Study|Participation in sili rescue study|0|||
155226576|NCT02641379|560268752|FG010|Overall Study|Participation in sili rescue study|0|||
155226577|NCT02641379|560268742|FG000|Overall Study|Lost to Follow-up|0|||
155226578|NCT02641379|560268743|FG001|Overall Study|Lost to Follow-up|0|||
155226579|NCT02641379|560268744|FG002|Overall Study|Lost to Follow-up|0|||
155226580|NCT02641379|560268745|FG003|Overall Study|Lost to Follow-up|0|||
155226581|NCT02641379|560268746|FG004|Overall Study|Lost to Follow-up|0|||
155226582|NCT02641379|560268747|FG005|Overall Study|Lost to Follow-up|0|||
155226583|NCT02641379|560268748|FG006|Overall Study|Lost to Follow-up|0|||
155226584|NCT02641379|560268749|FG007|Overall Study|Lost to Follow-up|0|||
155226585|NCT02641379|560268750|FG008|Overall Study|Lost to Follow-up|1|||
155226586|NCT02641379|560268751|FG009|Overall Study|Lost to Follow-up|0|||
155226587|NCT02641379|560268752|FG010|Overall Study|Lost to Follow-up|0|||
155226588|NCT02641379|560268742|FG000|Overall Study|Source data not found|0|||
155226589|NCT02641379|560268743|FG001|Overall Study|Source data not found|0|||
155226590|NCT02641379|560268744|FG002|Overall Study|Source data not found|0|||
155226591|NCT02641379|560268745|FG003|Overall Study|Source data not found|0|||
155226592|NCT02641379|560268746|FG004|Overall Study|Source data not found|0|||
155226593|NCT02641379|560268747|FG005|Overall Study|Source data not found|1|||
155226594|NCT02641379|560268748|FG006|Overall Study|Source data not found|0|||
155226595|NCT02641379|560268749|FG007|Overall Study|Source data not found|0|||
155226596|NCT02641379|560268750|FG008|Overall Study|Source data not found|0|||
155226597|NCT02641379|560268751|FG009|Overall Study|Source data not found|0|||
155226598|NCT02641379|560268752|FG010|Overall Study|Source data not found|0|||
155226599|NCT02641379|560268742|FG000|Overall Study|Participant showed weight reduction|0|||
155226600|NCT02641379|560268743|FG001|Overall Study|Participant showed weight reduction|0|||
155226601|NCT02641379|560268744|FG002|Overall Study|Participant showed weight reduction|0|||
155226602|NCT02641379|560268745|FG003|Overall Study|Participant showed weight reduction|0|||
155226603|NCT02641379|560268746|FG004|Overall Study|Participant showed weight reduction|0|||
155226604|NCT02641379|560268747|FG005|Overall Study|Participant showed weight reduction|0|||
155226605|NCT02641379|560268748|FG006|Overall Study|Participant showed weight reduction|0|||
155226606|NCT02641379|560268749|FG007|Overall Study|Participant showed weight reduction|1|||
155226607|NCT02641379|560268750|FG008|Overall Study|Participant showed weight reduction|0|||
155226608|NCT02641379|560268751|FG009|Overall Study|Participant showed weight reduction|0|||
155226609|NCT02641379|560268752|FG010|Overall Study|Participant showed weight reduction|0|||
155226610|NCT02641379|560268742|FG000|Overall Study|Non-response Week 12|0|||
155226611|NCT02641379|560268743|FG001|Overall Study|Non-response Week 12|0|||
155226612|NCT02641379|560268744|FG002|Overall Study|Non-response Week 12|0|||
155226613|NCT02641379|560268745|FG003|Overall Study|Non-response Week 12|0|||
155226614|NCT02641379|560268746|FG004|Overall Study|Non-response Week 12|0|||
155226615|NCT02641379|560268747|FG005|Overall Study|Non-response Week 12|0|||
155226616|NCT02641379|560268748|FG006|Overall Study|Non-response Week 12|0|||
155226617|NCT02641379|560268749|FG007|Overall Study|Non-response Week 12|1|||
155226618|NCT02641379|560268750|FG008|Overall Study|Non-response Week 12|0|||
155226619|NCT02641379|560268751|FG009|Overall Study|Non-response Week 12|0|||
155226620|NCT02641379|560268752|FG010|Overall Study|Non-response Week 12|0|||
155226621|NCT02641379|560268742|FG000|Overall Study|No 2 Log drop at Week 12|0|||
155226622|NCT02641379|560268743|FG001|Overall Study|No 2 Log drop at Week 12|0|||
155226623|NCT02641379|560268744|FG002|Overall Study|No 2 Log drop at Week 12|0|||
155226624|NCT02641379|560268745|FG003|Overall Study|No 2 Log drop at Week 12|0|||
155226625|NCT02641379|560268746|FG004|Overall Study|No 2 Log drop at Week 12|0|||
155226626|NCT02641379|560268747|FG005|Overall Study|No 2 Log drop at Week 12|0|||
155226627|NCT02641379|560268748|FG006|Overall Study|No 2 Log drop at Week 12|0|||
155226628|NCT02641379|560268749|FG007|Overall Study|No 2 Log drop at Week 12|0|||
155226629|NCT02641379|560268750|FG008|Overall Study|No 2 Log drop at Week 12|0|||
155226630|NCT02641379|560268751|FG009|Overall Study|No 2 Log drop at Week 12|0|||
155226631|NCT02641379|560268752|FG010|Overall Study|No 2 Log drop at Week 12|1|||
155226632|NCT02641379|560268742|FG000|Overall Study|Negative PCR result|0|||
155226633|NCT02641379|560268743|FG001|Overall Study|Negative PCR result|0|||
155226634|NCT02641379|560268744|FG002|Overall Study|Negative PCR result|0|||
155226635|NCT02641379|560268745|FG003|Overall Study|Negative PCR result|0|||
155226636|NCT02641379|560268746|FG004|Overall Study|Negative PCR result|0|||
155226637|NCT02641379|560268747|FG005|Overall Study|Negative PCR result|0|||
155226638|NCT02641379|560268748|FG006|Overall Study|Negative PCR result|0|||
155226639|NCT02641379|560268749|FG007|Overall Study|Negative PCR result|0|||
155226640|NCT02641379|560268750|FG008|Overall Study|Negative PCR result|0|||
155226641|NCT02641379|560268751|FG009|Overall Study|Negative PCR result|1|||
155226642|NCT02641379|560268752|FG010|Overall Study|Negative PCR result|0|||
155226643|NCT02641379|560268742|FG000|Overall Study|Participant's PCR high|0|||
155226644|NCT02641379|560268743|FG001|Overall Study|Participant's PCR high|0|||
155226645|NCT02641379|560268744|FG002|Overall Study|Participant's PCR high|0|||
155226646|NCT02641379|560268745|FG003|Overall Study|Participant's PCR high|0|||
155226647|NCT02641379|560268746|FG004|Overall Study|Participant's PCR high|0|||
155226648|NCT02641379|560268747|FG005|Overall Study|Participant's PCR high|0|||
155226649|NCT02641379|560268748|FG006|Overall Study|Participant's PCR high|0|||
155226650|NCT02641379|560268749|FG007|Overall Study|Participant's PCR high|1|||
155226651|NCT02641379|560268750|FG008|Overall Study|Participant's PCR high|0|||
155226652|NCT02641379|560268751|FG009|Overall Study|Participant's PCR high|0|||
155226653|NCT02641379|560268752|FG010|Overall Study|Participant's PCR high|0|||
155226654|NCT02641379|560268742|FG000|Overall Study|Participant treated after Week 24|0|||
155226655|NCT02641379|560268743|FG001|Overall Study|Participant treated after Week 24|0|||
155226656|NCT02641379|560268744|FG002|Overall Study|Participant treated after Week 24|0|||
155226657|NCT02641379|560268745|FG003|Overall Study|Participant treated after Week 24|0|||
155226658|NCT02641379|560268746|FG004|Overall Study|Participant treated after Week 24|0|||
155226659|NCT02641379|560268747|FG005|Overall Study|Participant treated after Week 24|0|||
155226660|NCT02641379|560268748|FG006|Overall Study|Participant treated after Week 24|0|||
155226661|NCT02641379|560268749|FG007|Overall Study|Participant treated after Week 24|0|||
155226662|NCT02641379|560268750|FG008|Overall Study|Participant treated after Week 24|1|||
155226663|NCT02641379|560268751|FG009|Overall Study|Participant treated after Week 24|0|||
155226664|NCT02641379|560268752|FG010|Overall Study|Participant treated after Week 24|0|||
155226665|NCT02641379|560268742|FG000|Overall Study|Missing PCR result at Week 8|0|||
155226666|NCT02641379|560268743|FG001|Overall Study|Missing PCR result at Week 8|0|||
155226667|NCT02641379|560268744|FG002|Overall Study|Missing PCR result at Week 8|0|||
155226668|NCT02641379|560268745|FG003|Overall Study|Missing PCR result at Week 8|0|||
155226669|NCT02641379|560268746|FG004|Overall Study|Missing PCR result at Week 8|0|||
155226670|NCT02641379|560268747|FG005|Overall Study|Missing PCR result at Week 8|0|||
155226671|NCT02641379|560268748|FG006|Overall Study|Missing PCR result at Week 8|0|||
155226672|NCT02641379|560268749|FG007|Overall Study|Missing PCR result at Week 8|0|||
155226673|NCT02641379|560268750|FG008|Overall Study|Missing PCR result at Week 8|0|||
155226674|NCT02641379|560268751|FG009|Overall Study|Missing PCR result at Week 8|1|||
155226675|NCT02641379|560268752|FG010|Overall Study|Missing PCR result at Week 8|0|||
155226676|NCT02641379|560268742|FG000|Overall Study|PCR positive|0|||
155226677|NCT02641379|560268743|FG001|Overall Study|PCR positive|0|||
155226678|NCT02641379|560268744|FG002|Overall Study|PCR positive|0|||
155226679|NCT02641379|560268745|FG003|Overall Study|PCR positive|0|||
155226680|NCT02641379|560268746|FG004|Overall Study|PCR positive|0|||
155226681|NCT02641379|560268747|FG005|Overall Study|PCR positive|0|||
155226682|NCT02641379|560268748|FG006|Overall Study|PCR positive|1|||
155226683|NCT02641379|560268749|FG007|Overall Study|PCR positive|0|||
155226684|NCT02641379|560268750|FG008|Overall Study|PCR positive|0|||
155226685|NCT02641379|560268751|FG009|Overall Study|PCR positive|0|||
155226686|NCT02641379|560268752|FG010|Overall Study|PCR positive|0|||
155226687|NCT01398956|560268753|FG000|Overall Study|Withdrawal by Subject|4|||
155226688|NCT01398956|560268753|FG000|Overall Study|AE, non-serious non-fatal|4|||
155226689|NCT01398956|560268753|FG000|Overall Study|Withdrawal Criteria No.3|1|||
155226690|NCT01398956|560268753|FG000|Overall Study|Subject moved a long distance|1|||
155226691|NCT00962104|560268756|FG000|Overall Study|Adverse Event|10|||
155226692|NCT00962104|560268757|FG001|Overall Study|Adverse Event|3|||
155226693|NCT00962104|560268756|FG000|Overall Study|Entry Criteria Not Met|1|||
155226694|NCT00962104|560268757|FG001|Overall Study|Entry Criteria Not Met|2|||
155226695|NCT00962104|560268756|FG000|Overall Study|Lack of Efficacy|0|||
155226696|NCT00962104|560268757|FG001|Overall Study|Lack of Efficacy|1|||
155226697|NCT00962104|560268756|FG000|Overall Study|Lost to Follow-up|10|||
155226698|NCT00962104|560268757|FG001|Overall Study|Lost to Follow-up|4|||
155226699|NCT00962104|560268756|FG000|Overall Study|Physician Decision|1|||
155226700|NCT00962104|560268757|FG001|Overall Study|Physician Decision|0|||
155226701|NCT00962104|560268756|FG000|Overall Study|Protocol Violation|6|||
155226702|NCT00962104|560268757|FG001|Overall Study|Protocol Violation|8|||
155226703|NCT00962104|560268756|FG000|Overall Study|Sponsor Decision|0|||
155226704|NCT00962104|560268757|FG001|Overall Study|Sponsor Decision|1|||
155226705|NCT00962104|560268756|FG000|Overall Study|Withdrawal by Subject|10|||
155226706|NCT00962104|560268757|FG001|Overall Study|Withdrawal by Subject|6|||
155226707|NCT00962104|560268756|FG000|Overall Study|Other|2|||
155226708|NCT00962104|560268757|FG001|Overall Study|Other|0|||
155226709|NCT02554656|560270594|FG000|Overall Study|Protocol Violation|3|||
155226710|NCT03240575|560270595|FG000|Overall Study|Adverse Event|0|||
155226711|NCT03240575|560270596|FG001|Overall Study|Adverse Event|2|||
155226712|NCT03240575|560270597|FG002|Overall Study|Adverse Event|0|||
155226713|NCT03240575|560270598|FG003|Overall Study|Adverse Event|1|||
155226714|NCT03240575|560270595|FG000|Overall Study|Withdrawal by Subject|2|||
155226715|NCT03240575|560270596|FG001|Overall Study|Withdrawal by Subject|11|||
155226716|NCT03240575|560270597|FG002|Overall Study|Withdrawal by Subject|0|||
155226717|NCT03240575|560270598|FG003|Overall Study|Withdrawal by Subject|1|||
155226718|NCT03240575|560270595|FG000|Overall Study|Other|0|||
155226719|NCT03240575|560270596|FG001|Overall Study|Other|1|||
155226720|NCT03240575|560270597|FG002|Overall Study|Other|0|||
155226721|NCT03240575|560270598|FG003|Overall Study|Other|0|||
155226722|NCT01140477|560270601|FG000|Overall Study|Lost to Follow-up|4|||
155226723|NCT01140477|560270602|FG001|Overall Study|Lost to Follow-up|0|||
155226724|NCT01140477|560270601|FG000|Overall Study|Withdrawal by Subject|1|||
155226725|NCT01140477|560270602|FG001|Overall Study|Withdrawal by Subject|4|||
155226726|NCT01140477|560270601|FG000|Overall Study|Surgical complication preventing implant|2|||
155226727|NCT01140477|560270602|FG001|Overall Study|Surgical complication preventing implant|0|||
155226728|NCT01140477|560270601|FG000|Overall Study|Death|1|||
155226729|NCT01140477|560270602|FG001|Overall Study|Death|1|||
155226730|NCT01140477|560270601|FG000|Overall Study|Subject explanted|0|||
155226731|NCT01140477|560270602|FG001|Overall Study|Subject explanted|1|||
155226732|NCT04482179|560270603|FG000|Overall Study|Death|1|||
155226733|NCT04482179|560270604|FG001|Overall Study|Death|0|||
155226734|NCT04482179|560270603|FG000|Overall Study|Withdrawal by Subject|1|||
155226735|NCT04482179|560270604|FG001|Overall Study|Withdrawal by Subject|0|||
155226736|NCT01481116|560270607|FG000|Overall Study|Adverse Event|26|||
155226737|NCT01481116|560270608|FG001|Overall Study|Adverse Event|26|||
155226738|NCT01481116|560270609|FG002|Overall Study|Adverse Event|42|||
155226739|NCT01481116|560270607|FG000|Overall Study|Major Protocol Deviation|3|||
155226740|NCT01481116|560270608|FG001|Overall Study|Major Protocol Deviation|7|||
155226741|NCT01481116|560270609|FG002|Overall Study|Major Protocol Deviation|1|||
155226742|NCT01481116|560270607|FG000|Overall Study|Lost to Follow-up|8|||
155226743|NCT01481116|560270608|FG001|Overall Study|Lost to Follow-up|12|||
155226744|NCT01481116|560270609|FG002|Overall Study|Lost to Follow-up|11|||
155226745|NCT01481116|560270607|FG000|Overall Study|Withdrawal by Subject|37|||
155226746|NCT01481116|560270608|FG001|Overall Study|Withdrawal by Subject|33|||
155226747|NCT01481116|560270609|FG002|Overall Study|Withdrawal by Subject|37|||
155226748|NCT01481116|560270607|FG000|Overall Study|Study Termination|730|||
155226749|NCT01481116|560270608|FG001|Overall Study|Study Termination|729|||
155226750|NCT01481116|560270609|FG002|Overall Study|Study Termination|713|||
155226751|NCT01481116|560270607|FG000|Overall Study|Pregnancy|0|||
155226752|NCT01481116|560270608|FG001|Overall Study|Pregnancy|0|||
155226753|NCT01481116|560270609|FG002|Overall Study|Pregnancy|1|||
155226754|NCT01481116|560270607|FG000|Overall Study|Lack of Efficacy|3|||
155226755|NCT01481116|560270608|FG001|Overall Study|Lack of Efficacy|3|||
155226756|NCT01481116|560270609|FG002|Overall Study|Lack of Efficacy|1|||
155226757|NCT01481116|560270607|FG000|Overall Study|Contraindications|1|||
155226758|NCT01481116|560270608|FG001|Overall Study|Contraindications|1|||
155226759|NCT01481116|560270609|FG002|Overall Study|Contraindications|0|||
155226760|NCT01481116|560270607|FG000|Overall Study|Other|1|||
155226761|NCT01481116|560270608|FG001|Overall Study|Other|1|||
155226762|NCT01481116|560270609|FG002|Overall Study|Other|0|||
155226763|NCT01481116|560270607|FG000|Overall Study|Participant Started Taking Glipizide|1|||
155226764|NCT01481116|560270608|FG001|Overall Study|Participant Started Taking Glipizide|0|||
155226765|NCT01481116|560270609|FG002|Overall Study|Participant Started Taking Glipizide|0|||
155226766|NCT01481116|560270607|FG000|Overall Study|Participant Moved Out of Area|2|||
155226767|NCT01481116|560270608|FG001|Overall Study|Participant Moved Out of Area|0|||
155226768|NCT01481116|560270609|FG002|Overall Study|Participant Moved Out of Area|1|||
155226769|NCT01481116|560270607|FG000|Overall Study|Participant Moved Out of Country|1|||
155226770|NCT01481116|560270608|FG001|Overall Study|Participant Moved Out of Country|0|||
155226771|NCT01481116|560270609|FG002|Overall Study|Participant Moved Out of Country|1|||
155226772|NCT01481116|560270607|FG000|Overall Study|Investigator Decision|3|||
155226773|NCT01481116|560270608|FG001|Overall Study|Investigator Decision|2|||
155226774|NCT01481116|560270609|FG002|Overall Study|Investigator Decision|1|||
155226775|NCT01481116|560270607|FG000|Overall Study|Sponsor Decision|0|||
155226776|NCT01481116|560270608|FG001|Overall Study|Sponsor Decision|1|||
155226777|NCT01481116|560270609|FG002|Overall Study|Sponsor Decision|3|||
155226778|NCT01481116|560270607|FG000|Overall Study|Non-Compliant With Study Drug|0|||
155226779|NCT01481116|560270608|FG001|Overall Study|Non-Compliant With Study Drug|1|||
155226780|NCT01481116|560270609|FG002|Overall Study|Non-Compliant With Study Drug|1|||
155226781|NCT01481116|560270607|FG000|Overall Study|Investigator's Discretion|2|||
155226782|NCT01481116|560270608|FG001|Overall Study|Investigator's Discretion|0|||
155226783|NCT01481116|560270609|FG002|Overall Study|Investigator's Discretion|0|||
155226784|NCT01481116|560270607|FG000|Overall Study|Death|2|||
155226785|NCT01481116|560270608|FG001|Overall Study|Death|1|||
155226786|NCT01481116|560270609|FG002|Overall Study|Death|0|||
155226787|NCT01481116|560270607|FG000|Overall Study|Hypoglycemic Event|4|||
155226788|NCT01481116|560270608|FG001|Overall Study|Hypoglycemic Event|0|||
155226789|NCT01481116|560270609|FG002|Overall Study|Hypoglycemic Event|0|||
155226790|NCT01232296|560270610|FG000|Overall Study|Adverse Event|24|||
155226791|NCT01232296|560270611|FG001|Overall Study|Adverse Event|12|||
155226792|NCT01232296|560270610|FG000|Overall Study|Physician Decision|1|||
155226793|NCT01232296|560270611|FG001|Overall Study|Physician Decision|1|||
155226794|NCT01232296|560270610|FG000|Overall Study|Progressive disease|43|||
155226795|NCT01232296|560270611|FG001|Overall Study|Progressive disease|61|||
155226796|NCT01232296|560270610|FG000|Overall Study|Study terminated by sponsor|0|||
155226797|NCT01232296|560270611|FG001|Overall Study|Study terminated by sponsor|1|||
155226798|NCT01232296|560270610|FG000|Overall Study|Technical problems|3|||
155226799|NCT01232296|560270611|FG001|Overall Study|Technical problems|0|||
155226800|NCT01232296|560270610|FG000|Overall Study|Subject/guardian decision|10|||
155226801|NCT01232296|560270611|FG001|Overall Study|Subject/guardian decision|2|||
155226802|NCT01232296|560270610|FG000|Overall Study|Death|1|||
155226803|NCT01232296|560270611|FG001|Overall Study|Death|6|||
155226804|NCT00559962|560270613|FG000|Overall Study|Adverse Event|1|||
155226805|NCT00559962|560270614|FG001|Overall Study|Adverse Event|7|||
155226806|NCT00559962|560270615|FG002|Overall Study|Adverse Event|8|||
155226807|NCT00559962|560270616|FG003|Overall Study|Adverse Event|5|||
155226808|NCT00559962|560270617|FG004|Overall Study|Adverse Event|11|||
155226809|NCT00559962|560270618|FG005|Overall Study|Adverse Event|4|||
155226810|NCT00559962|560270619|FG006|Overall Study|Adverse Event|4|||
155226811|NCT00559962|560270620|FG007|Overall Study|Adverse Event|2|||
155226812|NCT00559962|560270613|FG000|Overall Study|Lost to Follow-up|0|||
155226813|NCT00559962|560270614|FG001|Overall Study|Lost to Follow-up|1|||
155226814|NCT00559962|560270615|FG002|Overall Study|Lost to Follow-up|0|||
155226815|NCT00559962|560270616|FG003|Overall Study|Lost to Follow-up|0|||
155226816|NCT00559962|560270617|FG004|Overall Study|Lost to Follow-up|0|||
155226817|NCT00559962|560270618|FG005|Overall Study|Lost to Follow-up|0|||
155226818|NCT00559962|560270619|FG006|Overall Study|Lost to Follow-up|0|||
155226819|NCT00559962|560270620|FG007|Overall Study|Lost to Follow-up|0|||
155226820|NCT00559962|560270613|FG000|Overall Study|Withdrawal by Subject|1|||
155226821|NCT00559962|560270614|FG001|Overall Study|Withdrawal by Subject|1|||
155226822|NCT00559962|560270615|FG002|Overall Study|Withdrawal by Subject|2|||
155226823|NCT00559962|560270616|FG003|Overall Study|Withdrawal by Subject|0|||
155226824|NCT00559962|560270617|FG004|Overall Study|Withdrawal by Subject|3|||
155226825|NCT00559962|560270618|FG005|Overall Study|Withdrawal by Subject|1|||
155226826|NCT00559962|560270619|FG006|Overall Study|Withdrawal by Subject|0|||
155226827|NCT00559962|560270620|FG007|Overall Study|Withdrawal by Subject|2|||
155226828|NCT00559962|560270613|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155226829|NCT00559962|560270614|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
155226830|NCT00559962|560270615|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155226831|NCT00559962|560270616|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
155226832|NCT00559962|560270617|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
155226833|NCT00559962|560270618|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
155226834|NCT00559962|560270619|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
155226835|NCT00559962|560270620|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
155226836|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
155226837|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
155226838|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
155226839|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
155226840|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
155226841|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
155226842|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
155226843|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
155226844|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
155226845|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
155226846|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
155226847|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
155226848|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
155226849|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
155226850|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
155226851|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
155226852|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
155226853|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
155226854|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Death|0|||
155226855|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Death|0|||
155226856|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Death|1|||
155226857|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Death|0|||
155226858|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Death|0|||
155226859|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Death|0|||
155226860|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Death|0|||
155226861|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Death|0|||
155226862|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Death|0|||
155226863|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
155226864|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
155226865|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
155226866|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226867|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226868|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226869|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226870|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226871|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226872|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
155226873|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
155226874|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
155226875|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226876|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226877|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226878|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226879|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226880|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226881|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
155226882|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
155226883|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
155226884|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
155226885|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
155226886|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
155226887|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
155226888|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
155226889|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
155226890|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
155226891|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
155226892|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
155226893|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
155226894|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
155226895|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
155226896|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
155226897|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
155226898|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
155226899|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
155226900|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
155226901|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
155226902|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226903|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226904|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226905|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226906|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226907|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226908|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226909|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
155226910|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226911|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226912|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226913|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226914|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226915|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226916|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226917|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
155226918|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
155226919|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
155226920|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
155226921|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
155226922|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
155226923|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
155226924|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
155226925|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
155226926|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Other|0|||
155226927|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Other|1|||
155226928|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Other|0|||
155226929|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Other|0|||
155226930|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Other|0|||
155226931|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Other|0|||
155226932|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Other|0|||
155226933|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Other|0|||
155226934|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Other|0|||
155226935|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
155226936|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
155226937|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
155226938|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
155226939|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
155226940|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
155226941|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
155226942|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
155226943|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
155226944|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
155226945|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
155226946|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
155226947|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
155226948|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
155226949|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
155226950|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
155226951|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
155226952|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
155226953|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226954|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226955|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226956|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226957|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
155226958|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226959|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226960|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226961|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226962|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226963|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226964|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226965|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226966|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226967|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
155226968|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226969|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226970|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226971|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Disease progression|0|||
155226972|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Disease progression|0|||
155226973|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Disease progression|0|||
155226974|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Disease progression|1|||
155226975|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Disease progression|0|||
155226976|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Disease progression|0|||
155226977|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Disease progression|0|||
155226978|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Disease progression|0|||
155226979|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Disease progression|0|||
155226980|NCT00404352|560270621|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226981|NCT00404352|560270622|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226982|NCT00404352|560270623|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226983|NCT00404352|560270624|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226984|NCT00404352|560270625|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226985|NCT00404352|560270626|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226986|NCT00404352|560270627|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
155226987|NCT00404352|560270628|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
155226988|NCT00404352|560270629|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226989|NCT00404352|560270621|FG000|Open Label Extension (up to 36 Months)|Other|0|||
155226990|NCT00404352|560270622|FG001|Open Label Extension (up to 36 Months)|Other|0|||
155226991|NCT00404352|560270623|FG002|Open Label Extension (up to 36 Months)|Other|0|||
155226992|NCT00404352|560270624|FG003|Open Label Extension (up to 36 Months)|Other|0|||
155226993|NCT00404352|560270625|FG004|Open Label Extension (up to 36 Months)|Other|0|||
155226994|NCT00404352|560270626|FG005|Open Label Extension (up to 36 Months)|Other|0|||
155226995|NCT00404352|560270627|FG006|Open Label Extension (up to 36 Months)|Other|0|||
155226996|NCT00404352|560270628|FG007|Open Label Extension (up to 36 Months)|Other|0|||
155226997|NCT00404352|560270629|FG008|Open Label Extension (up to 36 Months)|Other|2|||
155226998|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
155226999|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227000|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227001|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227002|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227003|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227004|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227005|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
155227006|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227007|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227008|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227009|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227010|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227011|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227012|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
155227013|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227014|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227015|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227016|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227017|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227018|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227019|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
155227020|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227021|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227022|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227023|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227024|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227025|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227026|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
155227027|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227028|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227029|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227030|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227031|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227032|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227033|NCT01479621|560270632|FG000|Treatment Period|Adverse Event|0|||
155227034|NCT01479621|560270633|FG001|Treatment Period|Adverse Event|0|||
155227035|NCT01479621|560270634|FG002|Treatment Period|Adverse Event|0|||
155227036|NCT01479621|560270635|FG003|Treatment Period|Adverse Event|0|||
155227037|NCT01479621|560270636|FG004|Treatment Period|Adverse Event|1|||
155227038|NCT01479621|560270637|FG005|Treatment Period|Adverse Event|2|||
155227039|NCT01479621|560270638|FG006|Treatment Period|Adverse Event|2|||
155227040|NCT01479621|560270632|FG000|Treatment Period|Withdrawal by Subject|0|||
155227041|NCT01479621|560270633|FG001|Treatment Period|Withdrawal by Subject|4|||
155227042|NCT01479621|560270634|FG002|Treatment Period|Withdrawal by Subject|2|||
155227043|NCT01479621|560270635|FG003|Treatment Period|Withdrawal by Subject|2|||
155227044|NCT01479621|560270636|FG004|Treatment Period|Withdrawal by Subject|5|||
155227045|NCT01479621|560270637|FG005|Treatment Period|Withdrawal by Subject|5|||
155491454|NCT00563706|561225393|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
155227046|NCT01479621|560270638|FG006|Treatment Period|Withdrawal by Subject|1|||
155227047|NCT01479621|560270632|FG000|Treatment Period|Physician Decision|0|||
155227048|NCT01479621|560270633|FG001|Treatment Period|Physician Decision|0|||
155227049|NCT01479621|560270634|FG002|Treatment Period|Physician Decision|0|||
155227050|NCT01479621|560270635|FG003|Treatment Period|Physician Decision|0|||
155227051|NCT01479621|560270636|FG004|Treatment Period|Physician Decision|1|||
155227052|NCT01479621|560270637|FG005|Treatment Period|Physician Decision|1|||
155227053|NCT01479621|560270638|FG006|Treatment Period|Physician Decision|0|||
155227054|NCT01479621|560270632|FG000|Treatment Period|Non-compliance to study drug|0|||
155227055|NCT01479621|560270633|FG001|Treatment Period|Non-compliance to study drug|1|||
155227056|NCT01479621|560270634|FG002|Treatment Period|Non-compliance to study drug|0|||
155227057|NCT01479621|560270635|FG003|Treatment Period|Non-compliance to study drug|0|||
155227058|NCT01479621|560270636|FG004|Treatment Period|Non-compliance to study drug|0|||
155227059|NCT01479621|560270637|FG005|Treatment Period|Non-compliance to study drug|0|||
155227060|NCT01479621|560270638|FG006|Treatment Period|Non-compliance to study drug|1|||
155227061|NCT01479621|560270632|FG000|Treatment Period|Protocol Violation|0|||
155227062|NCT01479621|560270633|FG001|Treatment Period|Protocol Violation|9|||
155227063|NCT01479621|560270634|FG002|Treatment Period|Protocol Violation|6|||
155227064|NCT01479621|560270635|FG003|Treatment Period|Protocol Violation|5|||
155227065|NCT01479621|560270636|FG004|Treatment Period|Protocol Violation|2|||
155227066|NCT01479621|560270637|FG005|Treatment Period|Protocol Violation|10|||
155227067|NCT01479621|560270638|FG006|Treatment Period|Protocol Violation|6|||
155227068|NCT01479621|560270632|FG000|Treatment Period|Pregnancy|0|||
155227069|NCT01479621|560270633|FG001|Treatment Period|Pregnancy|0|||
155227070|NCT01479621|560270634|FG002|Treatment Period|Pregnancy|2|||
155227071|NCT01479621|560270635|FG003|Treatment Period|Pregnancy|0|||
155227072|NCT01479621|560270636|FG004|Treatment Period|Pregnancy|0|||
155227073|NCT01479621|560270637|FG005|Treatment Period|Pregnancy|0|||
155227074|NCT01479621|560270638|FG006|Treatment Period|Pregnancy|0|||
155227075|NCT01479621|560270632|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
155227076|NCT01479621|560270633|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
155227077|NCT01479621|560270634|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
155227078|NCT01479621|560270635|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227079|NCT01479621|560270636|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227080|NCT01479621|560270637|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227081|NCT01479621|560270638|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
155227082|NCT01479621|560270632|FG000|Treatment Period|Lost to Follow-up|0|||
155227083|NCT01479621|560270633|FG001|Treatment Period|Lost to Follow-up|0|||
155227084|NCT01479621|560270634|FG002|Treatment Period|Lost to Follow-up|1|||
155227085|NCT01479621|560270635|FG003|Treatment Period|Lost to Follow-up|0|||
155227086|NCT01479621|560270636|FG004|Treatment Period|Lost to Follow-up|2|||
155227087|NCT01479621|560270637|FG005|Treatment Period|Lost to Follow-up|2|||
155227088|NCT01479621|560270638|FG006|Treatment Period|Lost to Follow-up|1|||
155227089|NCT01479621|560270632|FG000|Treatment Period|Met stopping criteria|0|||
155227090|NCT01479621|560270633|FG001|Treatment Period|Met stopping criteria|8|||
155227091|NCT01479621|560270634|FG002|Treatment Period|Met stopping criteria|7|||
155227092|NCT01479621|560270635|FG003|Treatment Period|Met stopping criteria|4|||
155227093|NCT01479621|560270636|FG004|Treatment Period|Met stopping criteria|9|||
155227094|NCT01479621|560270637|FG005|Treatment Period|Met stopping criteria|20|||
155227095|NCT01479621|560270638|FG006|Treatment Period|Met stopping criteria|6|||
155227096|NCT03216850|560270640|FG000|Overall Study|Pre-analytical error|6|||
155227097|NCT00405548|560270641|FG000|Overall Study|Cognitive Memory problems on study day|1|||
155227098|NCT00405548|560270642|FG001|Overall Study|Cognitive Memory problems on study day|0|||
155227099|NCT00405548|560270641|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
155227100|NCT00405548|560270642|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
155227101|NCT00405548|560270641|FG000|Overall Study|Unable to self-administer shots|1|||
155227102|NCT00405548|560270642|FG001|Overall Study|Unable to self-administer shots|0|||
155227103|NCT00405548|560270641|FG000|Overall Study|Venous access failed during study day|1|||
155227104|NCT00405548|560270642|FG001|Overall Study|Venous access failed during study day|0|||
155227105|NCT00405548|560270641|FG000|Overall Study|Withdrawal by Subject|1|||
155227106|NCT00405548|560270642|FG001|Overall Study|Withdrawal by Subject|0|||
155227107|NCT01116232|560270643|FG000|Overall Study|Progressive diease|4|||
155227108|NCT00811577|560270644|FG000|Overall Study|Lost to Follow-up|7|||
155227109|NCT00811577|560270645|FG001|Overall Study|Lost to Follow-up|1|||
155227110|NCT00811577|560270644|FG000|Overall Study|Withdrawal by Subject|3|||
155227111|NCT00811577|560270645|FG001|Overall Study|Withdrawal by Subject|0|||
155227112|NCT01068509|560270646|FG000|Overall Study|Death|0|||
155227113|NCT01068509|560270647|FG001|Overall Study|Death|0|||
155227114|NCT01068509|560270648|FG002|Overall Study|Death|1|||
155227115|NCT01068509|560270646|FG000|Overall Study|Disease Progression|5|||
155227116|NCT01068509|560270647|FG001|Overall Study|Disease Progression|20|||
155227117|NCT01068509|560270648|FG002|Overall Study|Disease Progression|18|||
155227118|NCT01068509|560270646|FG000|Overall Study|Lost to Follow-up|1|||
155227119|NCT01068509|560270647|FG001|Overall Study|Lost to Follow-up|0|||
155227120|NCT01068509|560270648|FG002|Overall Study|Lost to Follow-up|0|||
155227121|NCT01068509|560270646|FG000|Overall Study|Withdrew Consent|0|||
155227122|NCT01068509|560270647|FG001|Overall Study|Withdrew Consent|1|||
155227123|NCT01068509|560270648|FG002|Overall Study|Withdrew Consent|2|||
155227124|NCT01068509|560270646|FG000|Overall Study|Reason Not Specified|0|||
155227125|NCT01068509|560270647|FG001|Overall Study|Reason Not Specified|1|||
155227126|NCT01068509|560270648|FG002|Overall Study|Reason Not Specified|0|||
155227127|NCT00329407|560270653|FG000|Overall Study|Withdrawal by Subject|1|||
155227128|NCT02357940|560270654|FG000|Overall Study|Adverse Event|0|||
155227129|NCT02357940|560270655|FG001|Overall Study|Adverse Event|1|||
155227130|NCT02357940|560270654|FG000|Overall Study|Investigator's judgement|0|||
155227131|NCT02357940|560270655|FG001|Overall Study|Investigator's judgement|1|||
155227132|NCT02442778|560270656|FG000|Overall Study|Adverse Event|2|||
155227133|NCT02442778|560270657|FG001|Overall Study|Adverse Event|6|||
155227134|NCT02442778|560270658|FG002|Overall Study|Adverse Event|6|||
155227135|NCT02442778|560270656|FG000|Overall Study|Death|0|||
155227136|NCT02442778|560270657|FG001|Overall Study|Death|2|||
155227137|NCT02442778|560270658|FG002|Overall Study|Death|0|||
155227138|NCT02442778|560270656|FG000|Overall Study|Lack of Efficacy|1|||
155227139|NCT02442778|560270657|FG001|Overall Study|Lack of Efficacy|0|||
155227140|NCT02442778|560270658|FG002|Overall Study|Lack of Efficacy|0|||
155227141|NCT02442778|560270656|FG000|Overall Study|Lost to Follow-up|1|||
155227142|NCT02442778|560270657|FG001|Overall Study|Lost to Follow-up|1|||
155227143|NCT02442778|560270658|FG002|Overall Study|Lost to Follow-up|1|||
155227144|NCT02442778|560270656|FG000|Overall Study|Non-compliance with study drug|2|||
155227145|NCT02442778|560270657|FG001|Overall Study|Non-compliance with study drug|0|||
155227146|NCT02442778|560270658|FG002|Overall Study|Non-compliance with study drug|1|||
155227147|NCT02442778|560270656|FG000|Overall Study|Physician Decision|1|||
155227148|NCT02442778|560270657|FG001|Overall Study|Physician Decision|1|||
155227149|NCT02442778|560270658|FG002|Overall Study|Physician Decision|1|||
155227150|NCT02442778|560270656|FG000|Overall Study|Protocol Deviation|3|||
155227151|NCT02442778|560270657|FG001|Overall Study|Protocol Deviation|0|||
155227152|NCT02442778|560270658|FG002|Overall Study|Protocol Deviation|1|||
155227153|NCT02442778|560270656|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
155227154|NCT02442778|560270657|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
155227155|NCT02442778|560270658|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
155227156|NCT02442778|560270656|FG000|Overall Study|Withdrawal by Subject|4|||
155227157|NCT02442778|560270657|FG001|Overall Study|Withdrawal by Subject|4|||
155227158|NCT02442778|560270658|FG002|Overall Study|Withdrawal by Subject|3|||
155227159|NCT02442778|560270656|FG000|Overall Study|Reason not specified|1|||
155227160|NCT02442778|560270657|FG001|Overall Study|Reason not specified|4|||
155227161|NCT02442778|560270658|FG002|Overall Study|Reason not specified|0|||
155227162|NCT01644175|560270663|FG000|Overall Study|Randomized But Not Treated|0|||
155227163|NCT01644175|560270664|FG001|Overall Study|Randomized But Not Treated|2|||
155227164|NCT01644175|560270663|FG000|Overall Study|Adverse Event|8|||
155227165|NCT01644175|560270664|FG001|Overall Study|Adverse Event|13|||
155227166|NCT01644175|560270663|FG000|Overall Study|Death|1|||
155227167|NCT01644175|560270664|FG001|Overall Study|Death|2|||
155227168|NCT01644175|560270663|FG000|Overall Study|Poor compliance to protocol|9|||
155227169|NCT01644175|560270664|FG001|Overall Study|Poor compliance to protocol|10|||
155227170|NCT01644175|560270663|FG000|Overall Study|Physician Decision|1|||
155227171|NCT01644175|560270664|FG001|Overall Study|Physician Decision|2|||
155227172|NCT01644175|560270663|FG000|Overall Study|Participant Moved|1|||
155227173|NCT01644175|560270664|FG001|Overall Study|Participant Moved|2|||
155227174|NCT01644175|560270663|FG000|Overall Study|Consent withdrawn by participant|3|||
155227175|NCT01644175|560270664|FG001|Overall Study|Consent withdrawn by participant|4|||
155227176|NCT01644175|560270663|FG000|Overall Study|Related to Autoinjector Administration|2|||
155227177|NCT01644175|560270664|FG001|Overall Study|Related to Autoinjector Administration|1|||
155227178|NCT01644175|560270663|FG000|Overall Study|Last visit outside protocol visit window|4|||
155227179|NCT01644175|560270664|FG001|Overall Study|Last visit outside protocol visit window|11|||
155227180|NCT01644175|560270663|FG000|Overall Study|Selection criteria finally not met|0|||
155227181|NCT01644175|560270664|FG001|Overall Study|Selection criteria finally not met|1|||
155227182|NCT01644175|560270663|FG000|Overall Study|Site closure|2|||
155227183|NCT01644175|560270664|FG001|Overall Study|Site closure|2|||
155227184|NCT01644175|560270663|FG000|Overall Study|Lost to Follow-up|1|||
155227185|NCT01644175|560270664|FG001|Overall Study|Lost to Follow-up|0|||
155227186|NCT01644175|560270663|FG000|Overall Study|Other than specified above|0|||
155227187|NCT01644175|560270664|FG001|Overall Study|Other than specified above|3|||
155227188|NCT00451035|560270671|FG000|Overall Study|Disease progression|11|||
155227189|NCT00451035|560270671|FG000|Overall Study|Death|3|||
155227190|NCT00451035|560270671|FG000|Overall Study|New anti-neoplastic therapy|3|||
155227191|NCT01712256|560270677|FG000|Overall Study|Lost to Follow-up|1|||
155227192|NCT00603746|560270682|FG000|Overall Study|Adverse Event|2|||
155227193|NCT00603746|560270683|FG001|Overall Study|Adverse Event|3|||
155227194|NCT00603746|560270684|FG002|Overall Study|Adverse Event|0|||
155227195|NCT00603746|560270685|FG003|Overall Study|Adverse Event|1|||
155227196|NCT00603746|560270686|FG004|Overall Study|Adverse Event|0|||
155227197|NCT00603746|560270687|FG005|Overall Study|Adverse Event|4|||
155227198|NCT00603746|560270682|FG000|Overall Study|Lack of Efficacy|34|||
155227199|NCT00603746|560270683|FG001|Overall Study|Lack of Efficacy|11|||
155227200|NCT00603746|560270684|FG002|Overall Study|Lack of Efficacy|6|||
155227201|NCT00603746|560270685|FG003|Overall Study|Lack of Efficacy|11|||
155227202|NCT00603746|560270686|FG004|Overall Study|Lack of Efficacy|12|||
155227203|NCT00603746|560270687|FG005|Overall Study|Lack of Efficacy|8|||
155227204|NCT00603746|560270682|FG000|Overall Study|Protocol Violation|0|||
155227205|NCT00603746|560270683|FG001|Overall Study|Protocol Violation|3|||
155227206|NCT00603746|560270684|FG002|Overall Study|Protocol Violation|1|||
155227207|NCT00603746|560270685|FG003|Overall Study|Protocol Violation|0|||
155227208|NCT00603746|560270686|FG004|Overall Study|Protocol Violation|1|||
155227209|NCT00603746|560270687|FG005|Overall Study|Protocol Violation|0|||
155227210|NCT00603746|560270682|FG000|Overall Study|Lost to Follow-up|0|||
155227211|NCT00603746|560270683|FG001|Overall Study|Lost to Follow-up|1|||
155227212|NCT00603746|560270684|FG002|Overall Study|Lost to Follow-up|1|||
155227213|NCT00603746|560270685|FG003|Overall Study|Lost to Follow-up|0|||
155227214|NCT00603746|560270686|FG004|Overall Study|Lost to Follow-up|0|||
155227215|NCT00603746|560270687|FG005|Overall Study|Lost to Follow-up|0|||
155227216|NCT00603746|560270682|FG000|Overall Study|Physician Decision|1|||
155227217|NCT00603746|560270683|FG001|Overall Study|Physician Decision|0|||
155227218|NCT00603746|560270684|FG002|Overall Study|Physician Decision|0|||
155227219|NCT00603746|560270685|FG003|Overall Study|Physician Decision|0|||
155227220|NCT00603746|560270686|FG004|Overall Study|Physician Decision|1|||
155227221|NCT00603746|560270687|FG005|Overall Study|Physician Decision|0|||
155227222|NCT00603746|560270682|FG000|Overall Study|Withdrawal by Subject|1|||
155227223|NCT00603746|560270683|FG001|Overall Study|Withdrawal by Subject|0|||
155227224|NCT00603746|560270684|FG002|Overall Study|Withdrawal by Subject|0|||
155227225|NCT00603746|560270685|FG003|Overall Study|Withdrawal by Subject|1|||
155227226|NCT00603746|560270686|FG004|Overall Study|Withdrawal by Subject|3|||
155227227|NCT00603746|560270687|FG005|Overall Study|Withdrawal by Subject|1|||
155227228|NCT01524627|560270692|FG000|Overall Study|Physician Decision|0|||
155227229|NCT01524627|560270693|FG001|Overall Study|Physician Decision|1|||
155227230|NCT01524627|560270692|FG000|Overall Study|Lost to Follow-up|1|||
155227231|NCT01524627|560270693|FG001|Overall Study|Lost to Follow-up|1|||
155227232|NCT03323658|560270694|FG000|Overall Study|Adverse Event|0|||
155227233|NCT03323658|560270695|FG001|Overall Study|Adverse Event|1|||
155227234|NCT03323658|560270696|FG002|Overall Study|Adverse Event|0|||
155227235|NCT03913091|560270697|FG000|Overall Study|Lost to Follow-up|18|||
155227236|NCT03913091|560270698|FG001|Overall Study|Lost to Follow-up|11|||
155227237|NCT03913091|560270697|FG000|Overall Study|Required additional meds/surgery|1|||
155227238|NCT03913091|560270698|FG001|Overall Study|Required additional meds/surgery|2|||
155227239|NCT03913091|560270697|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
155227240|NCT03913091|560270698|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
155227241|NCT00969553|560270699|FG000|Overall Study|Progressive disease (PD)|2|||
155227242|NCT00969553|560270700|FG001|Overall Study|Progressive disease (PD)|2|||
155227243|NCT00969553|560270701|FG002|Overall Study|Progressive disease (PD)|6|||
155227244|NCT00969553|560270702|FG003|Overall Study|Progressive disease (PD)|9|||
155227245|NCT00969553|560270703|FG004|Overall Study|Progressive disease (PD)|2|||
155227246|NCT00969553|560270704|FG005|Overall Study|Progressive disease (PD)|4|||
155227247|NCT00969553|560270705|FG006|Overall Study|Progressive disease (PD)|2|||
155227248|NCT00969553|560270706|FG007|Overall Study|Progressive disease (PD)|12|||
155227249|NCT00969553|560270707|FG008|Overall Study|Progressive disease (PD)|3|||
155227250|NCT00969553|560270699|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227251|NCT00969553|560270700|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227252|NCT00969553|560270701|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227253|NCT00969553|560270702|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227254|NCT00969553|560270703|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
155227255|NCT00969553|560270704|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227256|NCT00969553|560270705|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227257|NCT00969553|560270706|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227258|NCT00969553|560270707|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227259|NCT00969553|560270699|FG000|Overall Study|Other Adverse Event|0|||
155227260|NCT00969553|560270700|FG001|Overall Study|Other Adverse Event|0|||
155227261|NCT00969553|560270701|FG002|Overall Study|Other Adverse Event|0|||
155227262|NCT00969553|560270702|FG003|Overall Study|Other Adverse Event|1|||
155227263|NCT00969553|560270703|FG004|Overall Study|Other Adverse Event|0|||
155227264|NCT00969553|560270704|FG005|Overall Study|Other Adverse Event|0|||
155227265|NCT00969553|560270705|FG006|Overall Study|Other Adverse Event|1|||
155227266|NCT00969553|560270706|FG007|Overall Study|Other Adverse Event|0|||
155227267|NCT00969553|560270707|FG008|Overall Study|Other Adverse Event|0|||
155227268|NCT00969553|560270699|FG000|Overall Study|Refused cont. medication|1|||
155227269|NCT00969553|560270700|FG001|Overall Study|Refused cont. medication|1|||
155227270|NCT00969553|560270701|FG002|Overall Study|Refused cont. medication|0|||
155227271|NCT00969553|560270702|FG003|Overall Study|Refused cont. medication|2|||
155227272|NCT00969553|560270703|FG004|Overall Study|Refused cont. medication|0|||
155227273|NCT00969553|560270704|FG005|Overall Study|Refused cont. medication|0|||
155227274|NCT00969553|560270705|FG006|Overall Study|Refused cont. medication|0|||
155227275|NCT00969553|560270706|FG007|Overall Study|Refused cont. medication|1|||
155227276|NCT00969553|560270707|FG008|Overall Study|Refused cont. medication|0|||
155227277|NCT00969553|560270699|FG000|Overall Study|Not specified above|0|||
155227278|NCT00969553|560270700|FG001|Overall Study|Not specified above|0|||
155227279|NCT00969553|560270701|FG002|Overall Study|Not specified above|0|||
155227280|NCT00969553|560270702|FG003|Overall Study|Not specified above|4|||
155227281|NCT00969553|560270703|FG004|Overall Study|Not specified above|0|||
155227282|NCT00969553|560270704|FG005|Overall Study|Not specified above|0|||
155227283|NCT00969553|560270705|FG006|Overall Study|Not specified above|1|||
155227284|NCT00969553|560270706|FG007|Overall Study|Not specified above|1|||
155227285|NCT00969553|560270707|FG008|Overall Study|Not specified above|0|||
155227286|NCT00615056|560270708|FG000|Overall Study|Death|31|||
155227287|NCT00615056|560270709|FG001|Overall Study|Death|31|||
155227288|NCT00615056|560270710|FG002|Overall Study|Death|21|||
155227289|NCT00615056|560270711|FG003|Overall Study|Death|23|||
155227290|NCT00615056|560270708|FG000|Overall Study|Lost to Follow-up|1|||
155227291|NCT00615056|560270709|FG001|Overall Study|Lost to Follow-up|2|||
155227292|NCT00615056|560270710|FG002|Overall Study|Lost to Follow-up|4|||
155227293|NCT00615056|560270711|FG003|Overall Study|Lost to Follow-up|5|||
155227294|NCT00615056|560270708|FG000|Overall Study|Other|13|||
155227295|NCT00615056|560270709|FG001|Overall Study|Other|15|||
155227296|NCT00615056|560270710|FG002|Overall Study|Other|10|||
155227297|NCT00615056|560270711|FG003|Overall Study|Other|7|||
155227298|NCT00615056|560270708|FG000|Overall Study|Objective progression or relapse|0|||
155227299|NCT00615056|560270709|FG001|Overall Study|Objective progression or relapse|2|||
155227300|NCT00615056|560270710|FG002|Overall Study|Objective progression or relapse|0|||
155227301|NCT00615056|560270711|FG003|Overall Study|Objective progression or relapse|0|||
155227302|NCT00615056|560270708|FG000|Overall Study|Withdrawal by Subject|0|||
155227303|NCT00615056|560270709|FG001|Overall Study|Withdrawal by Subject|1|||
155227304|NCT00615056|560270710|FG002|Overall Study|Withdrawal by Subject|1|||
155227305|NCT00615056|560270711|FG003|Overall Study|Withdrawal by Subject|0|||
155227306|NCT00615056|560270708|FG000|Overall Study|Discontinued by Sponsor|1|||
155227307|NCT00615056|560270709|FG001|Overall Study|Discontinued by Sponsor|0|||
155227308|NCT00615056|560270710|FG002|Overall Study|Discontinued by Sponsor|0|||
155227309|NCT00615056|560270711|FG003|Overall Study|Discontinued by Sponsor|0|||
155227310|NCT00615056|560270708|FG000|Overall Study|Randomized but not treated|3|||
155227311|NCT00615056|560270709|FG001|Overall Study|Randomized but not treated|0|||
155227312|NCT00615056|560270710|FG002|Overall Study|Randomized but not treated|0|||
155227313|NCT00615056|560270711|FG003|Overall Study|Randomized but not treated|0|||
155227314|NCT01380184|560270715|FG000|Part 1 (19 Days)|Adverse Event|1|||
155227315|NCT01380184|560270715|FG000|Part 2|Adverse Event|5|||
155227316|NCT01380184|560270715|FG000|Part 2|Disease Progression|8|||
155227317|NCT01380184|560270715|FG000|Part 2|Lost to Follow-up|1|||
155227318|NCT04248816|560270716|FG000|Overall Study|Ineligible post-randomization|7|||
155227319|NCT04248816|560270717|FG001|Overall Study|Ineligible post-randomization|21|||
155227320|NCT04248816|560270718|FG002|Overall Study|Ineligible post-randomization|25|||
155227321|NCT03350503|560270719|FG000|Overall Study|Adverse Event|5|||
155227322|NCT03350503|560270719|FG000|Overall Study|Withdrawal by Subject|5|||
155227323|NCT03350503|560270719|FG000|Overall Study|Continuation impossible due to move|4|||
155227324|NCT03350503|560270719|FG000|Overall Study|Physician Decision|3|||
155227325|NCT00262067|560270722|FG000|Overall Study|Death|190|||
155227326|NCT00262067|560270723|FG001|Overall Study|Death|89|||
155227327|NCT00262067|560270724|FG002|Overall Study|Death|186|||
155227328|NCT00262067|560270725|FG003|Overall Study|Death|99|||
155227329|NCT00262067|560270722|FG000|Overall Study|Lost to Follow-up|5|||
155227330|NCT00262067|560270723|FG001|Overall Study|Lost to Follow-up|4|||
155227331|NCT00262067|560270724|FG002|Overall Study|Lost to Follow-up|7|||
155227332|NCT00262067|560270725|FG003|Overall Study|Lost to Follow-up|5|||
155227333|NCT00262067|560270722|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
155227334|NCT00262067|560270723|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227335|NCT00262067|560270724|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227336|NCT00262067|560270725|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227337|NCT00262067|560270722|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
155227338|NCT00262067|560270723|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
155227339|NCT00262067|560270724|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
155227340|NCT00262067|560270725|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
155227341|NCT03829046|560270726|FG000|Overall Study|Withdrawal by Subject|1|||
155227342|NCT03829046|560270727|FG001|Overall Study|Withdrawal by Subject|0|||
155227343|NCT01399593|560270732|FG000|Overall Study|Physician Decision|1|||
155227344|NCT01399593|560270733|FG001|Overall Study|Physician Decision|0|||
155227345|NCT01399593|560270732|FG000|Overall Study|Adverse Event|1|||
155227346|NCT01399593|560270733|FG001|Overall Study|Adverse Event|0|||
155227347|NCT01399593|560270732|FG000|Overall Study|Death|1|||
155227348|NCT01399593|560270733|FG001|Overall Study|Death|1|||
155227349|NCT01399593|560270732|FG000|Overall Study|Transplantectomy|0|||
155227350|NCT01399593|560270733|FG001|Overall Study|Transplantectomy|1|||
155227351|NCT00344773|560270735|FG000|Overall Study|Adverse Event|2|||
155227352|NCT00344773|560270735|FG000|Overall Study|Objective Disease Progression|16|||
155227353|NCT00344773|560270735|FG000|Overall Study|Withdrawal by Subject|1|||
155227354|NCT00344773|560270735|FG000|Overall Study|Not Eligible for the study|2|||
155227355|NCT02849548|560270745|FG000|Overall Study|Lost to Follow-up|1|||
155227356|NCT02849548|560270746|FG001|Overall Study|Lost to Follow-up|2|||
155227357|NCT02849548|560270745|FG000|Overall Study|Protocol Violation|1|||
155227358|NCT02849548|560270746|FG001|Overall Study|Protocol Violation|0|||
155227359|NCT00714259|560270747|FG000|Overall Study|Death|2|||
155227360|NCT04804813|560270749|FG000|Overall Study|Protocol Violation|2|||
155227361|NCT04804813|560270750|FG001|Overall Study|Protocol Violation|0|||
155227362|NCT04804813|560270749|FG000|Overall Study|Withdrawal by Subject|1|||
155227363|NCT04804813|560270750|FG001|Overall Study|Withdrawal by Subject|0|||
155227364|NCT00560950|560270752|FG000|Overall Study|Lost to Follow-up|1|||
155227365|NCT00560950|560270753|FG001|Overall Study|Lost to Follow-up|0|||
155227366|NCT01581593|560272166|FG000|Overall Study|Withdrawal by Subject|1|||
155227367|NCT02586012|560272167|FG000|Overall Study|Withdrawal by Subject|1|||
155227368|NCT02586012|560272168|FG001|Overall Study|Withdrawal by Subject|1|||
155227369|NCT02586012|560272169|FG002|Overall Study|Withdrawal by Subject|0|||
155227370|NCT02586012|560272170|FG003|Overall Study|Withdrawal by Subject|1|||
155227371|NCT02586012|560272171|FG004|Overall Study|Withdrawal by Subject|0|||
155227372|NCT02586012|560272172|FG005|Overall Study|Withdrawal by Subject|2|||
155227373|NCT02586012|560272167|FG000|Overall Study|Protocol Violation|0|||
155227374|NCT02586012|560272168|FG001|Overall Study|Protocol Violation|0|||
155227375|NCT02586012|560272169|FG002|Overall Study|Protocol Violation|0|||
155227376|NCT02586012|560272170|FG003|Overall Study|Protocol Violation|0|||
155227377|NCT02586012|560272171|FG004|Overall Study|Protocol Violation|0|||
155227378|NCT02586012|560272172|FG005|Overall Study|Protocol Violation|1|||
155227379|NCT02586012|560272167|FG000|Overall Study|study terminated|0|||
155227380|NCT02586012|560272168|FG001|Overall Study|study terminated|2|||
155227381|NCT02586012|560272169|FG002|Overall Study|study terminated|1|||
155227382|NCT02586012|560272170|FG003|Overall Study|study terminated|1|||
155227383|NCT02586012|560272171|FG004|Overall Study|study terminated|1|||
155227384|NCT02586012|560272172|FG005|Overall Study|study terminated|0|||
155227385|NCT03277846|560272173|FG000|Overall Study|Inpatient stay too brief|12|||
155227386|NCT03277846|560272174|FG001|Overall Study|Inpatient stay too brief|11|||
155227387|NCT05168475|560272175|FG000|Period 1|Protocol Violation|1|||
155227388|NCT05168475|560272175|FG000|Period 1|IMP shortage|2|||
155227389|NCT05168475|560272175|FG000|Period 1|Not randomised|2|||
155227390|NCT05168475|560272175|FG000|Period 2|IMP shortage|1|||
155227391|NCT01589822|560272176|FG000|Overall Study|Withdrawal by Subject|1|||
155227392|NCT01589822|560272177|FG001|Overall Study|Withdrawal by Subject|2|||
155227393|NCT01589822|560272178|FG002|Overall Study|Withdrawal by Subject|0|||
155227394|NCT01589822|560272176|FG000|Overall Study|Death|1|||
155227395|NCT01589822|560272177|FG001|Overall Study|Death|0|||
155227396|NCT01589822|560272178|FG002|Overall Study|Death|0|||
155227397|NCT01589822|560272176|FG000|Overall Study|Missed 90 day visit|2|||
155227398|NCT01589822|560272177|FG001|Overall Study|Missed 90 day visit|1|||
155227399|NCT01589822|560272178|FG002|Overall Study|Missed 90 day visit|1|||
155227400|NCT01302964|560272179|FG000|Overall Study|Adverse Event|1|||
155227401|NCT01302964|560272180|FG001|Overall Study|Adverse Event|0|||
155227402|NCT01904604|560272183|FG000|Overall Study|Withdrew before receiving dosing|0|||
155227403|NCT01904604|560272184|FG001|Overall Study|Withdrew before receiving dosing|1|||
155227404|NCT01904604|560272185|FG002|Overall Study|Withdrew before receiving dosing|0|||
155227405|NCT01904604|560272183|FG000|Overall Study|Non-compliance|1|||
155227406|NCT01904604|560272184|FG001|Overall Study|Non-compliance|0|||
155227407|NCT01904604|560272185|FG002|Overall Study|Non-compliance|0|||
155227408|NCT01904604|560272183|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
155227409|NCT01904604|560272184|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
155227410|NCT01904604|560272185|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
155227411|NCT01904604|560272183|FG000|Overall Study|Patch site reactions|1|||
155227412|NCT01904604|560272184|FG001|Overall Study|Patch site reactions|1|||
155227413|NCT01904604|560272185|FG002|Overall Study|Patch site reactions|0|||
155227414|NCT01904604|560272183|FG000|Overall Study|Increased syncope|0|||
155227415|NCT01904604|560272184|FG001|Overall Study|Increased syncope|1|||
155227416|NCT01904604|560272185|FG002|Overall Study|Increased syncope|0|||
155227417|NCT01904604|560272183|FG000|Overall Study|Unrelated illness|0|||
155227418|NCT01904604|560272184|FG001|Overall Study|Unrelated illness|1|||
155227419|NCT01904604|560272185|FG002|Overall Study|Unrelated illness|0|||
155227420|NCT01904604|560272183|FG000|Overall Study|Passed Week 52 OFC|1|||
155227421|NCT01904604|560272184|FG001|Overall Study|Passed Week 52 OFC|0|||
155227422|NCT01904604|560272185|FG002|Overall Study|Passed Week 52 OFC|0|||
155227423|NCT01904604|560272183|FG000|Overall Study|Withdrawal by Subject|1|||
155227424|NCT01904604|560272184|FG001|Overall Study|Withdrawal by Subject|2|||
155227425|NCT01904604|560272185|FG002|Overall Study|Withdrawal by Subject|0|||
155227426|NCT01904604|560272183|FG000|Overall Study|Participant Relocated|1|||
155227427|NCT01904604|560272184|FG001|Overall Study|Participant Relocated|1|||
155227428|NCT01904604|560272185|FG002|Overall Study|Participant Relocated|1|||
155227429|NCT01904604|560272183|FG000|Overall Study|Lost to Follow-up|0|||
155227430|NCT01904604|560272184|FG001|Overall Study|Lost to Follow-up|0|||
155227431|NCT01904604|560272185|FG002|Overall Study|Lost to Follow-up|1|||
155227432|NCT01945489|560272188|FG000|Cycle 1|Adverse Event|2|||
155227433|NCT01945489|560272189|FG001|Cycle 1|Adverse Event|0|||
155227434|NCT01945489|560272188|FG000|Cycle 1|Lost to Follow-up|4|||
155227435|NCT01945489|560272189|FG001|Cycle 1|Lost to Follow-up|0|||
155227436|NCT01945489|560272188|FG000|Cycle 1|Personal Reasons|4|||
155227437|NCT01945489|560272189|FG001|Cycle 1|Personal Reasons|2|||
155227438|NCT01945489|560272188|FG000|Cycle 1|Protocol Violation|0|||
155227439|NCT01945489|560272189|FG001|Cycle 1|Protocol Violation|1|||
155227440|NCT01945489|560272188|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
155227441|NCT01945489|560272189|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
155227442|NCT01945489|560272188|FG000|Cycle 2|Adverse Event|1|||
155227443|NCT01945489|560272189|FG001|Cycle 2|Adverse Event|0|||
155227444|NCT01945489|560272188|FG000|Cycle 2|Lost to Follow-up|0|||
155227445|NCT01945489|560272189|FG001|Cycle 2|Lost to Follow-up|1|||
155227446|NCT00697346|560272191|FG000|Overall Study|Adverse Event|4|||
155227447|NCT00697346|560272192|FG001|Overall Study|Adverse Event|5|||
155227448|NCT00697346|560272193|FG002|Overall Study|Adverse Event|0|||
155227449|NCT00697346|560272191|FG000|Overall Study|Progressive Disease|19|||
155227450|NCT00697346|560272192|FG001|Overall Study|Progressive Disease|18|||
155227451|NCT00697346|560272193|FG002|Overall Study|Progressive Disease|0|||
155227452|NCT00697346|560272191|FG000|Overall Study|Symptomatic Deterioration|0|||
155227453|NCT00697346|560272192|FG001|Overall Study|Symptomatic Deterioration|1|||
155227454|NCT00697346|560272193|FG002|Overall Study|Symptomatic Deterioration|0|||
155227455|NCT00697346|560272191|FG000|Overall Study|Withdrawal by Subject|2|||
155227456|NCT00697346|560272192|FG001|Overall Study|Withdrawal by Subject|2|||
155227457|NCT00697346|560272193|FG002|Overall Study|Withdrawal by Subject|0|||
155227458|NCT00697346|560272191|FG000|Overall Study|Reason not Specified|3|||
155227459|NCT00697346|560272192|FG001|Overall Study|Reason not Specified|0|||
155227460|NCT00697346|560272193|FG002|Overall Study|Reason not Specified|1|||
155227461|NCT03569371|560272194|FG000|Overall Study|Lack of Efficacy|1|||
155227462|NCT03569371|560272194|FG000|Overall Study|Lost to Follow-up|1|||
155227463|NCT03569371|560272194|FG000|Overall Study|Adverse Event|1|||
155227464|NCT03643562|560272195|FG000|Overall Study|Adverse Event|1|||
155227465|NCT03643562|560272196|FG001|Overall Study|Adverse Event|0|||
155227466|NCT03643562|560272195|FG000|Overall Study|Lack of Efficacy|0|||
155227467|NCT03643562|560272196|FG001|Overall Study|Lack of Efficacy|1|||
155227468|NCT03643562|560272195|FG000|Overall Study|Physician Decision|0|||
155227469|NCT03643562|560272196|FG001|Overall Study|Physician Decision|1|||
155227470|NCT03643562|560272195|FG000|Overall Study|Study Terminated by Sponsor|2|||
155227471|NCT03643562|560272196|FG001|Overall Study|Study Terminated by Sponsor|10|||
155227472|NCT03643562|560272195|FG000|Overall Study|Withdrawal by Subject|2|||
155227473|NCT03643562|560272196|FG001|Overall Study|Withdrawal by Subject|2|||
155227474|NCT03643562|560272195|FG000|Overall Study|Other than specified|3|||
155227475|NCT03643562|560272196|FG001|Overall Study|Other than specified|2|||
155227476|NCT04145895|560272197|FG000|Overall Study|Physician Decision|2|||
155227477|NCT04145895|560272198|FG001|Overall Study|Physician Decision|0|||
155227478|NCT04145895|560272197|FG000|Overall Study|Withdrawal by Subject|0|||
155227479|NCT04145895|560272198|FG001|Overall Study|Withdrawal by Subject|2|||
155227480|NCT01236755|560272199|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
155227481|NCT01236755|560272199|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
155227482|NCT01236755|560272199|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
155227483|NCT01236755|560272199|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
155227484|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227485|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
155227486|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227487|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227488|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227489|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227490|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
155227491|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227492|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
155227493|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
155227494|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
155227495|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
155227496|NCT03848845|560272200|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227497|NCT03848845|560272201|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227498|NCT03848845|560272202|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227499|NCT03848845|560272203|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
155227500|NCT00596011|560272206|FG000|Overall Study|Withdrawal by Subject|2|||
155227501|NCT00596011|560272207|FG001|Overall Study|Withdrawal by Subject|3|||
155227502|NCT00596011|560272206|FG000|Overall Study|Adverse Event|11|||
155227503|NCT00596011|560272207|FG001|Overall Study|Adverse Event|7|||
155227504|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
155227505|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
155227506|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
155227507|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
155227508|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
155227509|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
155227510|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
155227511|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
155227512|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
155227513|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
155227514|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
155227515|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
155227516|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
155227517|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
155227518|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
155227519|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
155227520|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
155227521|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
155227522|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
155227523|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
155227524|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
155227525|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
155227526|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
155227527|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
155227528|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
155227529|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
155227530|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
155227531|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
155227532|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
155227533|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
155227534|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
155227535|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
155227536|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
155227537|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
155227538|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
155227539|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
155227540|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
155227541|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
155227542|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
155227543|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
155227544|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
155227545|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
155227546|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
155227547|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
155227548|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
155227549|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
155227550|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
155227551|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
155227552|NCT02643251|560272211|FG000|Overall Study|Adverse Event|3|||
155227553|NCT02643251|560272212|FG001|Overall Study|Adverse Event|1|||
155227554|NCT02643251|560272211|FG000|Overall Study|Withdrawal by Subject|2|||
155227555|NCT02643251|560272212|FG001|Overall Study|Withdrawal by Subject|0|||
155227556|NCT02643251|560272211|FG000|Overall Study|Lost to Follow-up|4|||
155227557|NCT02643251|560272212|FG001|Overall Study|Lost to Follow-up|1|||
155227558|NCT02643251|560272211|FG000|Overall Study|Protocol Violation|1|||
155227559|NCT02643251|560272212|FG001|Overall Study|Protocol Violation|0|||
155227560|NCT02643251|560272211|FG000|Overall Study|PI Decision to terminate patient|1|||
155227561|NCT02643251|560272212|FG001|Overall Study|PI Decision to terminate patient|0|||
155227562|NCT00240071|560272213|FG000|Overall Study|Withdrawal by Subject|3|||
155227563|NCT04206293|560272225|FG000|Overall Study|Consent withdrawal|1|||
155227564|NCT01956110|560272230|FG000|Overall Study|Protocol Violation|25|||
155227565|NCT01956110|560272231|FG001|Overall Study|Protocol Violation|11|||
155227566|NCT01956110|560272230|FG000|Overall Study|Adverse Event|9|||
155227567|NCT01956110|560272231|FG001|Overall Study|Adverse Event|10|||
155227568|NCT01956110|560272230|FG000|Overall Study|Personal reasons|1|||
155227569|NCT01956110|560272231|FG001|Overall Study|Personal reasons|1|||
155227570|NCT03325166|560272236|FG000|Overall Study|Adverse Event|1|||
155227571|NCT00706966|560272238|FG000|Overall Study|Adverse Event|1|||
155227572|NCT01631474|560272243|FG000|Overall Study|Lost to Follow-up|8|||
155227573|NCT01631474|560272244|FG001|Overall Study|Lost to Follow-up|5|||
155227574|NCT01631474|560272245|FG002|Overall Study|Lost to Follow-up|7|||
155227575|NCT01631474|560272246|FG003|Overall Study|Lost to Follow-up|5|||
155227576|NCT01631474|560272247|FG004|Overall Study|Lost to Follow-up|5|||
155227577|NCT01631474|560272243|FG000|Overall Study|Withdrawal by Subject|4|||
155227578|NCT01631474|560272244|FG001|Overall Study|Withdrawal by Subject|4|||
155227579|NCT01631474|560272245|FG002|Overall Study|Withdrawal by Subject|2|||
155227580|NCT01631474|560272246|FG003|Overall Study|Withdrawal by Subject|6|||
155227581|NCT01631474|560272247|FG004|Overall Study|Withdrawal by Subject|5|||
155227582|NCT01631474|560272243|FG000|Overall Study|Lack of Efficacy|2|||
155227583|NCT01631474|560272244|FG001|Overall Study|Lack of Efficacy|2|||
155227584|NCT01631474|560272245|FG002|Overall Study|Lack of Efficacy|0|||
155227585|NCT01631474|560272246|FG003|Overall Study|Lack of Efficacy|0|||
155227586|NCT01631474|560272247|FG004|Overall Study|Lack of Efficacy|2|||
155227587|NCT01631474|560272243|FG000|Overall Study|Noncompliance with Study Drug|0|||
155227588|NCT01631474|560272244|FG001|Overall Study|Noncompliance with Study Drug|0|||
155227589|NCT01631474|560272245|FG002|Overall Study|Noncompliance with Study Drug|0|||
155227590|NCT01631474|560272246|FG003|Overall Study|Noncompliance with Study Drug|0|||
155227591|NCT01631474|560272247|FG004|Overall Study|Noncompliance with Study Drug|1|||
155227592|NCT01631474|560272243|FG000|Overall Study|Adverse Event|0|||
155227593|NCT01631474|560272244|FG001|Overall Study|Adverse Event|1|||
155227594|NCT01631474|560272245|FG002|Overall Study|Adverse Event|0|||
155227595|NCT01631474|560272246|FG003|Overall Study|Adverse Event|0|||
155227596|NCT01631474|560272247|FG004|Overall Study|Adverse Event|0|||
155227597|NCT01467076|560272248|FG000|Overall Study|Lost to Follow-up|1|||
155227598|NCT01467076|560272249|FG001|Overall Study|Lost to Follow-up|0|||
155227599|NCT01467076|560272250|FG002|Overall Study|Lost to Follow-up|0|||
155227600|NCT03354429|560272251|FG000|Overall Study|Withdrawal by Subject|8|||
155227601|NCT03354429|560272252|FG001|Overall Study|Withdrawal by Subject|7|||
155227602|NCT03354429|560272251|FG000|Overall Study|Lost to Follow-up|1|||
155227603|NCT03354429|560272252|FG001|Overall Study|Lost to Follow-up|0|||
155227604|NCT03100825|560272253|FG000|Overall Study|Participant/Guardian Decision|7|||
155227605|NCT03100825|560272253|FG000|Overall Study|Physician Decision|1|||
155227606|NCT00994448|560272255|FG000|Overall Study|Adverse Event|1|||
155227607|NCT00994448|560272256|FG001|Overall Study|Adverse Event|0|||
155227608|NCT00994448|560272255|FG000|Overall Study|Lost to Follow-up|5|||
155227609|NCT00994448|560272256|FG001|Overall Study|Lost to Follow-up|1|||
155227610|NCT00994448|560272255|FG000|Overall Study|Withdrawal by Subject|1|||
155227611|NCT00994448|560272256|FG001|Overall Study|Withdrawal by Subject|1|||
155227612|NCT00994448|560272255|FG000|Overall Study|Physician Decision|1|||
155227613|NCT00994448|560272256|FG001|Overall Study|Physician Decision|0|||
155227614|NCT05923229|560272259|FG000|Overall Study|Withdrawal by Subject|3|||
155227615|NCT05923229|560272260|FG001|Overall Study|Withdrawal by Subject|0|||
155227616|NCT05923229|560272259|FG000|Overall Study|Health related|2|||
155227617|NCT05923229|560272260|FG001|Overall Study|Health related|1|||
155227618|NCT04164901|560272261|FG000|Overall Study|Withdrawal by Subject|4|||
155227619|NCT04164901|560272262|FG001|Overall Study|Withdrawal by Subject|4|||
155227620|NCT04098458|560272263|FG000|Overall Study|Death|1|||
155227621|NCT04098458|560272263|FG000|Overall Study|did not meet study inclusion criteria|3|||
155227622|NCT01800916|560272264|FG000|Test Period 1 (1 Week)|Convex product user|0|||
155227623|NCT01800916|560272265|FG001|Test Period 1 (1 Week)|Convex product user|0|||
155227624|NCT01800916|560272266|FG002|Test Period 1 (1 Week)|Convex product user|0|||
155227625|NCT01800916|560272267|FG003|Test Period 1 (1 Week)|Convex product user|1|||
155227626|NCT01800916|560272268|FG004|Test Period 1 (1 Week)|Convex product user|0|||
155227627|NCT01800916|560272269|FG005|Test Period 1 (1 Week)|Convex product user|0|||
155227628|NCT01800916|560272270|FG006|Test Period 1 (1 Week)|Convex product user|0|||
155227629|NCT01800916|560272271|FG007|Test Period 1 (1 Week)|Convex product user|0|||
155227630|NCT01800916|560272272|FG008|Test Period 1 (1 Week)|Convex product user|0|||
155227631|NCT01800916|560272264|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
155227632|NCT01800916|560272265|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
155227633|NCT01800916|560272266|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
155227634|NCT01800916|560272267|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
155227635|NCT01800916|560272268|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
155227636|NCT01800916|560272269|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
155227637|NCT01800916|560272270|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
155227638|NCT01800916|560272271|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
155227639|NCT01800916|560272272|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
155227640|NCT01461096|560272273|FG000|Overall Study|Death|3|||
155227641|NCT01461096|560272274|FG001|Overall Study|Death|6|||
155227642|NCT01461096|560272273|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155227643|NCT01461096|560272274|FG001|Overall Study|Severe debilitation, unable to continue|1|||
155227644|NCT01461096|560272273|FG000|Overall Study|Subj not able to get to clinic|15|||
155227645|NCT01461096|560272274|FG001|Overall Study|Subj not able to get to clinic|13|||
155227646|NCT01461096|560272273|FG000|Overall Study|Site is closing|27|||
155227647|NCT01461096|560272274|FG001|Overall Study|Site is closing|30|||
155227648|NCT01461096|560272273|FG000|Overall Study|Withdrawal by Subject|5|||
155227649|NCT01461096|560272274|FG001|Overall Study|Withdrawal by Subject|3|||
155227650|NCT01461096|560272273|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
155227651|NCT01461096|560272274|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
155227652|NCT01461096|560272273|FG000|Overall Study|Lost to Follow-up|8|||
155227653|NCT01461096|560272274|FG001|Overall Study|Lost to Follow-up|4|||
155227654|NCT04889625|560272275|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
155227655|NCT04889625|560272276|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
155227656|NCT04889625|560272275|FG000|Period 1|Subject out of window|0|||
155227657|NCT04889625|560272276|FG001|Period 1|Subject out of window|1|||
155227658|NCT04889625|560272275|FG000|Period 1|Wrong add power dispensed|0|||
155227659|NCT04889625|560272276|FG001|Period 1|Wrong add power dispensed|1|||
155227660|NCT04889625|560272275|FG000|Period 1|Discontinued due to fitting guide error|1|||
155227661|NCT04889625|560272276|FG001|Period 1|Discontinued due to fitting guide error|1|||
155227662|NCT04889625|560272275|FG000|Period 2|Test article no longer available|1|||
155227663|NCT04889625|560272276|FG001|Period 2|Test article no longer available|0|||
155227664|NCT04889625|560272275|FG000|Period 2|Incorrect lens dispensed|1|||
155227665|NCT04889625|560272276|FG001|Period 2|Incorrect lens dispensed|0|||
155227666|NCT04889625|560272275|FG000|Period 2|Wrong add power dispensed|0|||
155227667|NCT04889625|560272276|FG001|Period 2|Wrong add power dispensed|1|||
155227668|NCT03047135|560272289|FG000|Overall Study|Still being treated|3|||
155227669|NCT01256593|560272290|FG000|Overall Study|Protocol Violation|26|||
155227670|NCT01256593|560272290|FG000|Overall Study|No Drug Administration Information|2|||
155227671|NCT01256593|560272290|FG000|Overall Study|No Visit After Treatment|186|||
155227672|NCT05619692|560272291|FG000|Overall Study|Adverse Event|2|||
155227673|NCT05619692|560272292|FG001|Overall Study|Adverse Event|2|||
155227674|NCT05619692|560272291|FG000|Overall Study|Withdrawal by Participant|3|||
155227675|NCT05619692|560272292|FG001|Overall Study|Withdrawal by Participant|4|||
155227676|NCT05619692|560272291|FG000|Overall Study|Lost to Follow-up|2|||
155227677|NCT05619692|560272292|FG001|Overall Study|Lost to Follow-up|1|||
155227678|NCT05619692|560272291|FG000|Overall Study|Randomized but not treated|1|||
155227679|NCT05619692|560272292|FG001|Overall Study|Randomized but not treated|3|||
155227680|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Death|3|||
155227681|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Death|2|||
155227682|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Death|0|||
155227683|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Death|0|||
155227684|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Death|0|||
155227685|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Death|0|||
155227686|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Death|0|||
155227687|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Death|0|||
155227688|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
155227689|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227690|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227691|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227692|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227693|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227694|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227695|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227696|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227697|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
155227698|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227699|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227700|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227701|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227702|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227703|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227704|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
155227705|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
155227706|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
155227707|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
155227708|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
155227709|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
155227710|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
155227711|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
155227712|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227713|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227714|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
155227715|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
155227716|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
155227717|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227718|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155491455|NCT00563706|561225394|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
155491456|NCT00563706|561225395|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
155227719|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227720|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227721|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227722|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
155227723|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227724|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227725|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227726|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227727|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227728|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Death|0|||
155227729|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Death|0|||
155227730|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Death|1|||
155227731|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Death|0|||
155227732|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Death|0|||
155227733|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Death|0|||
155227734|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Death|0|||
155227735|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Death|0|||
155227736|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Not treated|0|||
155227737|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Not treated|0|||
155227738|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Not treated|0|||
155227739|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Not treated|1|||
155227740|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Not treated|0|||
155227741|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Not treated|0|||
155227742|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Not treated|0|||
155227743|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Not treated|0|||
155227744|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Adverse Event|0|||
155227745|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Adverse Event|0|||
155227746|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Adverse Event|0|||
155227747|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Adverse Event|0|||
155227748|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Adverse Event|0|||
155227749|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Adverse Event|4|||
155227750|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Adverse Event|0|||
155227751|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Adverse Event|2|||
155227752|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Death|0|||
155227753|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Death|0|||
155227754|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Death|0|||
155227755|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Death|0|||
155227756|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Death|0|||
155227757|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Death|24|||
155227758|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Death|0|||
155227759|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Death|3|||
155227760|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227761|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227762|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227763|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227764|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227765|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227766|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227767|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
155227768|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Physician Decision|0|||
155227769|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Physician Decision|0|||
155227770|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Physician Decision|0|||
155227771|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Physician Decision|0|||
155227772|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Physician Decision|0|||
155227773|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Physician Decision|1|||
155227774|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Physician Decision|0|||
155227775|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Physician Decision|0|||
155227776|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
155227777|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
155227778|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
155227779|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
155227780|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
155227781|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
155227782|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
155227783|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
155227784|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227785|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227786|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227787|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227788|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227789|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
155227790|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227791|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
155227792|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227793|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227794|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227795|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227796|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227797|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
155227798|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
155227799|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
155227800|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Not Treated|0|||
155227801|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Not Treated|0|||
155227802|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Not Treated|0|||
155227803|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Not Treated|0|||
155227804|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Not Treated|0|||
155227805|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Not Treated|2|||
155227806|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Not Treated|0|||
155227807|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Not Treated|0|||
155227808|NCT00978068|560272312|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
155227809|NCT00978068|560272313|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
155227810|NCT00978068|560272312|FG000|Overall Study|Death|1|||
155227811|NCT00978068|560272313|FG001|Overall Study|Death|2|||
155227812|NCT00978068|560272312|FG000|Overall Study|Lost to Follow-up|1|||
155227813|NCT00978068|560272313|FG001|Overall Study|Lost to Follow-up|2|||
155227814|NCT00978068|560272312|FG000|Overall Study|Physician Decision|0|||
155227815|NCT00978068|560272313|FG001|Overall Study|Physician Decision|1|||
155227816|NCT00978068|560272312|FG000|Overall Study|Unable to Comply with Study|0|||
155227817|NCT00978068|560272313|FG001|Overall Study|Unable to Comply with Study|2|||
155227818|NCT02357147|560272319|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
155227819|NCT02357147|560272320|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
155227820|NCT02357147|560272319|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
155227821|NCT02357147|560272320|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
155227822|NCT02357147|560272319|FG000|Combination Treatment Phase|Investigator Discretion|1|||
155227823|NCT02357147|560272320|FG001|Combination Treatment Phase|Investigator Discretion|1|||
155227824|NCT02357147|560272319|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
155227825|NCT02357147|560272320|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
155227826|NCT02357147|560272319|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
155227827|NCT02357147|560272320|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
155227828|NCT02357147|560272319|FG000|Combination Treatment Phase|Adverse Event|12|||
155227829|NCT02357147|560272320|FG001|Combination Treatment Phase|Adverse Event|4|||
155227830|NCT02357147|560272319|FG000|Combination Treatment Phase|Death|1|||
155227831|NCT02357147|560272320|FG001|Combination Treatment Phase|Death|1|||
155227832|NCT02357147|560272319|FG000|Combination Treatment Phase|Sponsor Decision|0|||
155227833|NCT02357147|560272320|FG001|Combination Treatment Phase|Sponsor Decision|12|||
155227834|NCT02357147|560272319|FG000|Combination Treatment Phase|Other|1|||
155227835|NCT02357147|560272320|FG001|Combination Treatment Phase|Other|0|||
155227836|NCT02357147|560272319|FG000|Combination Treatment Phase|Not treated|0|||
155227837|NCT02357147|560272320|FG001|Combination Treatment Phase|Not treated|2|||
155227838|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
155227839|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
155227840|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155227841|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
155227842|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
155227843|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
155227844|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155227845|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Adverse Event|3|||
155227846|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
155227847|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
155227848|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Not Treated|1|||
155227849|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Not Treated|0|||
155227850|NCT03962543|560272321|FG000|Treatment Phase|Death|0|||
155227851|NCT03962543|560272322|FG001|Treatment Phase|Death|1|||
155227852|NCT03962543|560272321|FG000|Treatment Phase|Withdrawal by Subject|3|||
155227853|NCT03962543|560272322|FG001|Treatment Phase|Withdrawal by Subject|0|||
155227854|NCT03962543|560272321|FG000|Treatment Phase|Adverse Event|3|||
155227855|NCT03962543|560272322|FG001|Treatment Phase|Adverse Event|12|||
155227856|NCT03962543|560272321|FG000|Treatment Phase|Lost to Follow-up|1|||
155227857|NCT03962543|560272322|FG001|Treatment Phase|Lost to Follow-up|2|||
155227858|NCT03962543|560272321|FG000|Treatment Phase|Radiographic PD|9|||
155227859|NCT03962543|560272322|FG001|Treatment Phase|Radiographic PD|3|||
155227860|NCT03962543|560272321|FG000|Treatment Phase|Participant Decision|3|||
155227861|NCT03962543|560272322|FG001|Treatment Phase|Participant Decision|8|||
155227862|NCT03962543|560272321|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
155227863|NCT03962543|560272322|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
155227864|NCT03962543|560272321|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
155227865|NCT03962543|560272322|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
155227866|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
155227867|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
155227868|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
155227869|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
155227870|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
155227871|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
155227872|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
155227873|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
155227874|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
155227875|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
155227876|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
155227877|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
155227878|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
155227879|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
155227880|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
155227881|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
155227882|NCT01101841|560274064|FG000|Overall Study|Adverse Event|15|||
155227883|NCT01101841|560274065|FG001|Overall Study|Adverse Event|15|||
155227884|NCT01101841|560274064|FG000|Overall Study|Lost to Follow-up|9|||
155227885|NCT01101841|560274065|FG001|Overall Study|Lost to Follow-up|3|||
155227886|NCT01101841|560274064|FG000|Overall Study|Withdrawal by Subject|21|||
155227887|NCT01101841|560274065|FG001|Overall Study|Withdrawal by Subject|40|||
155227888|NCT01101841|560274064|FG000|Overall Study|Protocol Violation|1|||
155227889|NCT01101841|560274065|FG001|Overall Study|Protocol Violation|1|||
155227890|NCT01101841|560274064|FG000|Overall Study|Physician Decision|0|||
155227891|NCT01101841|560274065|FG001|Overall Study|Physician Decision|2|||
155227892|NCT01101841|560274064|FG000|Overall Study|Lack of Efficacy|0|||
155227893|NCT01101841|560274065|FG001|Overall Study|Lack of Efficacy|2|||
155227894|NCT01101841|560274064|FG000|Overall Study|Other|0|||
155227895|NCT01101841|560274065|FG001|Overall Study|Other|1|||
155227896|NCT01101841|560274064|FG000|Overall Study|Suicidality Tracking Scale|3|||
155227897|NCT01101841|560274065|FG001|Overall Study|Suicidality Tracking Scale|1|||
155227898|NCT01101841|560274064|FG000|Overall Study|Eligibility Criteria|1|||
155227899|NCT01101841|560274065|FG001|Overall Study|Eligibility Criteria|2|||
155227900|NCT00653224|560274068|FG000|Overall Study|Adverse Event|2|||
155227901|NCT00653224|560274069|FG001|Overall Study|Adverse Event|1|||
155227902|NCT00653224|560274068|FG000|Overall Study|Lack of Efficacy|1|||
155227903|NCT00653224|560274069|FG001|Overall Study|Lack of Efficacy|2|||
155227904|NCT00653224|560274068|FG000|Overall Study|Loss of efficacy|1|||
155227905|NCT00653224|560274069|FG001|Overall Study|Loss of efficacy|0|||
155227906|NCT00653224|560274068|FG000|Overall Study|Lost to Follow-up|1|||
155227907|NCT00653224|560274069|FG001|Overall Study|Lost to Follow-up|0|||
155227908|NCT00653224|560274068|FG000|Overall Study|Other|2|||
155227909|NCT00653224|560274069|FG001|Overall Study|Other|4|||
155227910|NCT03756558|560274070|FG000|Overall Study|Death|1|||
155227911|NCT03756558|560274070|FG000|Overall Study|Lost to Follow-up|2|||
155227912|NCT03756558|560274070|FG000|Overall Study|Withdrawal by Subject|2|||
155227913|NCT00773175|560274074|FG000|Overall Study|Adverse Event|2|||
155227914|NCT00773175|560274075|FG001|Overall Study|Adverse Event|0|||
155227915|NCT00773175|560274074|FG000|Overall Study|Consent Withdrawn|0|||
155227916|NCT00773175|560274075|FG001|Overall Study|Consent Withdrawn|2|||
155227917|NCT00503841|560274076|FG000|Overall Study|All screen failures|44|||
155227918|NCT01982253|560274082|FG000|Overall Study|Withdrawal by Subject|1|||
155227919|NCT01982253|560274083|FG001|Overall Study|Withdrawal by Subject|0|||
155227920|NCT01982253|560274084|FG002|Overall Study|Withdrawal by Subject|0|||
155227921|NCT01982253|560274082|FG000|Overall Study|Study terminated by sponsor|1|||
155227922|NCT01982253|560274083|FG001|Overall Study|Study terminated by sponsor|4|||
155227923|NCT01982253|560274084|FG002|Overall Study|Study terminated by sponsor|4|||
155227924|NCT02789176|560274088|FG000|Overall Study|Death|0|||
155227925|NCT02789176|560274089|FG001|Overall Study|Death|0|||
155227926|NCT02789176|560274090|FG002|Overall Study|Death|3|||
155227927|NCT02789176|560274091|FG003|Overall Study|Death|0|||
155227928|NCT02789176|560274088|FG000|Overall Study|Withdrawal by Subject|0|||
155227929|NCT02789176|560274089|FG001|Overall Study|Withdrawal by Subject|0|||
155227930|NCT02789176|560274090|FG002|Overall Study|Withdrawal by Subject|1|||
155227931|NCT02789176|560274091|FG003|Overall Study|Withdrawal by Subject|0|||
155227932|NCT02789176|560274088|FG000|Overall Study|Lost to Follow-up|8|||
155227933|NCT02789176|560274089|FG001|Overall Study|Lost to Follow-up|2|||
155227934|NCT02789176|560274090|FG002|Overall Study|Lost to Follow-up|6|||
155227935|NCT02789176|560274091|FG003|Overall Study|Lost to Follow-up|1|||
155227936|NCT02223767|560274092|FG000|Overall Study|Withdrawal by Subject|4|||
155227937|NCT02223767|560274093|FG001|Overall Study|Withdrawal by Subject|4|||
155227938|NCT02347527|560274094|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
155227939|NCT02347527|560274095|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
155227940|NCT02347527|560274096|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
155227941|NCT02347527|560274097|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
155227942|NCT02347527|560274094|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
155227943|NCT02347527|560274095|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
155227944|NCT02347527|560274096|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
155227945|NCT02347527|560274097|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
155227946|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
155227947|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
155227948|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
155227949|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
155227950|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
155227951|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
155227952|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
155227953|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
155227954|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227955|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
155227956|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227957|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227958|NCT00192075|560274098|FG000|Overall Study|Disease Progression|23|||
155227959|NCT00192075|560274099|FG001|Overall Study|Disease Progression|6|||
155227960|NCT00192075|560274098|FG000|Overall Study|Adverse Event|1|||
155227961|NCT00192075|560274099|FG001|Overall Study|Adverse Event|3|||
155227962|NCT00192075|560274098|FG000|Overall Study|Death|0|||
155227963|NCT00192075|560274099|FG001|Overall Study|Death|1|||
155227964|NCT00192075|560274098|FG000|Overall Study|Lack of Efficacy|0|||
155227965|NCT00192075|560274099|FG001|Overall Study|Lack of Efficacy|0|||
155227966|NCT00192075|560274098|FG000|Overall Study|Physician Decision|3|||
155227967|NCT00192075|560274099|FG001|Overall Study|Physician Decision|0|||
155227968|NCT00192075|560274098|FG000|Overall Study|Withdrawal by Subject|5|||
155227969|NCT00192075|560274099|FG001|Overall Study|Withdrawal by Subject|5|||
155227970|NCT00192075|560274098|FG000|Overall Study|Patient Non-Compliance|0|||
155227971|NCT00192075|560274099|FG001|Overall Study|Patient Non-Compliance|1|||
155227972|NCT00192075|560274098|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
155227973|NCT00192075|560274099|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
155227974|NCT00192075|560274098|FG000|Overall Study|Other|5|||
155227975|NCT00192075|560274099|FG001|Overall Study|Other|2|||
155227976|NCT00910715|560274102|FG000|Overall Study|Lost to Follow-up|22|||
155227977|NCT00910715|560274103|FG001|Overall Study|Lost to Follow-up|26|||
155227978|NCT00910715|560274104|FG002|Overall Study|Lost to Follow-up|0|||
155227979|NCT02412631|560274105|FG000|Overall Study|Adverse Event|1|||
155227980|NCT02412631|560274106|FG001|Overall Study|Adverse Event|2|||
155227981|NCT02412631|560274105|FG000|Overall Study|Lost to Follow-up|5|||
155227982|NCT02412631|560274106|FG001|Overall Study|Lost to Follow-up|9|||
155227983|NCT02412631|560274105|FG000|Overall Study|Withdrawal by Subject|9|||
155227984|NCT02412631|560274106|FG001|Overall Study|Withdrawal by Subject|3|||
155227985|NCT02412631|560274105|FG000|Overall Study|Early stop by FDA|5|||
155227986|NCT02412631|560274106|FG001|Overall Study|Early stop by FDA|2|||
155227987|NCT02412631|560274105|FG000|Overall Study|Unspecified reason|6|||
155227988|NCT02412631|560274106|FG001|Overall Study|Unspecified reason|8|||
155227989|NCT02884089|560274107|FG000|Period 1|Dosing error|2|||
155227990|NCT02884089|560274108|FG001|Period 1|Dosing error|2|||
155227991|NCT02884089|560274109|FG002|Period 1|Dosing error|0|||
155227992|NCT02884089|560274110|FG003|Period 1|Dosing error|0|||
155227993|NCT02884089|560274107|FG000|Washout Period 1|Lost to Follow-up|0|||
155227994|NCT02884089|560274108|FG001|Washout Period 1|Lost to Follow-up|1|||
155227995|NCT02884089|560274109|FG002|Washout Period 1|Lost to Follow-up|0|||
155227996|NCT02884089|560274110|FG003|Washout Period 1|Lost to Follow-up|1|||
155227997|NCT02884089|560274107|FG000|Washout Period 1|Withdrawal by Subject|0|||
155227998|NCT02884089|560274108|FG001|Washout Period 1|Withdrawal by Subject|1|||
155227999|NCT02884089|560274109|FG002|Washout Period 1|Withdrawal by Subject|0|||
155228000|NCT02884089|560274110|FG003|Washout Period 1|Withdrawal by Subject|0|||
155228001|NCT02884089|560274107|FG000|Period 2|Adverse Event|1|||
155228002|NCT02884089|560274108|FG001|Period 2|Adverse Event|0|||
155228003|NCT02884089|560274109|FG002|Period 2|Adverse Event|0|||
155228004|NCT02884089|560274110|FG003|Period 2|Adverse Event|0|||
155228005|NCT02884089|560274107|FG000|Period 3|Withdrawal by Subject|0|||
155228006|NCT02884089|560274108|FG001|Period 3|Withdrawal by Subject|0|||
155228007|NCT02884089|560274109|FG002|Period 3|Withdrawal by Subject|1|||
155228008|NCT02884089|560274110|FG003|Period 3|Withdrawal by Subject|0|||
155228009|NCT02884089|560274107|FG000|Washout Period 3|Withdrawal by Subject|0|||
155228010|NCT02884089|560274108|FG001|Washout Period 3|Withdrawal by Subject|0|||
155228011|NCT02884089|560274109|FG002|Washout Period 3|Withdrawal by Subject|1|||
155228012|NCT02884089|560274110|FG003|Washout Period 3|Withdrawal by Subject|0|||
155228013|NCT02884089|560274107|FG000|Washout Period 3|Lost to Follow-up|0|||
155228014|NCT02884089|560274108|FG001|Washout Period 3|Lost to Follow-up|0|||
155228015|NCT02884089|560274109|FG002|Washout Period 3|Lost to Follow-up|0|||
155228016|NCT02884089|560274110|FG003|Washout Period 3|Lost to Follow-up|1|||
155228017|NCT02884089|560274107|FG000|Period 4|Withdrawal by Subject|0|||
155228018|NCT02884089|560274108|FG001|Period 4|Withdrawal by Subject|1|||
155228019|NCT02884089|560274109|FG002|Period 4|Withdrawal by Subject|0|||
155228020|NCT02884089|560274110|FG003|Period 4|Withdrawal by Subject|0|||
155228021|NCT02884089|560274107|FG000|Period 4|Lost to Follow-up|1|||
155228022|NCT02884089|560274108|FG001|Period 4|Lost to Follow-up|0|||
155228023|NCT02884089|560274109|FG002|Period 4|Lost to Follow-up|0|||
155228024|NCT02884089|560274110|FG003|Period 4|Lost to Follow-up|0|||
155228025|NCT02884089|560274107|FG000|Follow-up Visit|Withdrawal by Subject|1|||
155228026|NCT02884089|560274108|FG001|Follow-up Visit|Withdrawal by Subject|0|||
155228027|NCT02884089|560274109|FG002|Follow-up Visit|Withdrawal by Subject|0|||
155228028|NCT02884089|560274110|FG003|Follow-up Visit|Withdrawal by Subject|1|||
155228029|NCT05288556|560274116|FG000|Overall Study|Protocol Violation|1|||
155228030|NCT05288556|560274116|FG000|Overall Study|Withdrawal by Subject|1|||
155228031|NCT02465528|560274117|FG000|Overall Study|Progressive disease|0|||
155228032|NCT02465528|560274118|FG001|Overall Study|Progressive disease|2|||
155228033|NCT02465528|560274119|FG002|Overall Study|Progressive disease|9|||
155228034|NCT02465528|560274120|FG003|Overall Study|Progressive disease|4|||
155228035|NCT02465528|560274117|FG000|Overall Study|Study terminated by sponsor|1|||
155228036|NCT02465528|560274118|FG001|Overall Study|Study terminated by sponsor|2|||
155228037|NCT02465528|560274119|FG002|Overall Study|Study terminated by sponsor|0|||
155228038|NCT02465528|560274120|FG003|Overall Study|Study terminated by sponsor|0|||
155228039|NCT02465528|560274117|FG000|Overall Study|Withdrawal by Subject|0|||
155228040|NCT02465528|560274118|FG001|Overall Study|Withdrawal by Subject|0|||
155228041|NCT02465528|560274119|FG002|Overall Study|Withdrawal by Subject|2|||
155228042|NCT02465528|560274120|FG003|Overall Study|Withdrawal by Subject|0|||
155228043|NCT02465528|560274117|FG000|Overall Study|Adverse Event|0|||
155228044|NCT02465528|560274118|FG001|Overall Study|Adverse Event|0|||
155228045|NCT02465528|560274119|FG002|Overall Study|Adverse Event|0|||
155228046|NCT02465528|560274120|FG003|Overall Study|Adverse Event|1|||
155228047|NCT02465528|560274117|FG000|Overall Study|Physician Decision|0|||
155228048|NCT02465528|560274118|FG001|Overall Study|Physician Decision|0|||
155228049|NCT02465528|560274119|FG002|Overall Study|Physician Decision|1|||
155228050|NCT02465528|560274120|FG003|Overall Study|Physician Decision|0|||
155228051|NCT05040152|560274125|FG000|Overall Study|Withdrawal by Subject|5|||
155228052|NCT05040152|560274126|FG001|Overall Study|Withdrawal by Subject|0|||
155228053|NCT05040152|560274125|FG000|Overall Study|Lost to Follow-up|0|||
155228054|NCT05040152|560274126|FG001|Overall Study|Lost to Follow-up|2|||
155228055|NCT03400332|560274127|FG000|Pre-Treatment|Other reasons|0|||
155228056|NCT03400332|560274128|FG001|Pre-Treatment|Other reasons|0|||
155228057|NCT03400332|560274129|FG002|Pre-Treatment|Other reasons|0|||
155228058|NCT03400332|560274130|FG003|Pre-Treatment|Other reasons|0|||
155228059|NCT03400332|560274131|FG004|Pre-Treatment|Other reasons|0|||
155228060|NCT03400332|560274132|FG005|Pre-Treatment|Other reasons|0|||
155228061|NCT03400332|560274133|FG006|Pre-Treatment|Other reasons|0|||
155228062|NCT03400332|560274134|FG007|Pre-Treatment|Other reasons|0|||
155228063|NCT03400332|560274135|FG008|Pre-Treatment|Other reasons|1|||
155228064|NCT03400332|560274127|FG000|Pre-Treatment|No longer met study criteria|0|||
155228065|NCT03400332|560274128|FG001|Pre-Treatment|No longer met study criteria|0|||
155228066|NCT03400332|560274129|FG002|Pre-Treatment|No longer met study criteria|0|||
155228067|NCT03400332|560274130|FG003|Pre-Treatment|No longer met study criteria|0|||
155228068|NCT03400332|560274131|FG004|Pre-Treatment|No longer met study criteria|0|||
155228069|NCT03400332|560274132|FG005|Pre-Treatment|No longer met study criteria|0|||
155228070|NCT03400332|560274133|FG006|Pre-Treatment|No longer met study criteria|0|||
155228071|NCT03400332|560274134|FG007|Pre-Treatment|No longer met study criteria|0|||
155228072|NCT03400332|560274135|FG008|Pre-Treatment|No longer met study criteria|1|||
155228073|NCT03400332|560274127|FG000|Pre-Treatment|Withdrawal by Subject|0|||
155228074|NCT03400332|560274128|FG001|Pre-Treatment|Withdrawal by Subject|0|||
155228075|NCT03400332|560274129|FG002|Pre-Treatment|Withdrawal by Subject|0|||
155228076|NCT03400332|560274130|FG003|Pre-Treatment|Withdrawal by Subject|0|||
155228077|NCT03400332|560274131|FG004|Pre-Treatment|Withdrawal by Subject|0|||
155228078|NCT03400332|560274132|FG005|Pre-Treatment|Withdrawal by Subject|0|||
155228079|NCT03400332|560274133|FG006|Pre-Treatment|Withdrawal by Subject|0|||
155228080|NCT03400332|560274134|FG007|Pre-Treatment|Withdrawal by Subject|0|||
155228081|NCT03400332|560274135|FG008|Pre-Treatment|Withdrawal by Subject|1|||
155228082|NCT03400332|560274127|FG000|Treatment|Participant withdrew consent|2|||
155491457|NCT00563706|561225396|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
155228083|NCT03400332|560274128|FG001|Treatment|Participant withdrew consent|2|||
155228084|NCT03400332|560274129|FG002|Treatment|Participant withdrew consent|0|||
155228085|NCT03400332|560274130|FG003|Treatment|Participant withdrew consent|0|||
155228086|NCT03400332|560274131|FG004|Treatment|Participant withdrew consent|3|||
155228087|NCT03400332|560274132|FG005|Treatment|Participant withdrew consent|3|||
155228088|NCT03400332|560274133|FG006|Treatment|Participant withdrew consent|1|||
155228089|NCT03400332|560274134|FG007|Treatment|Participant withdrew consent|1|||
155228090|NCT03400332|560274135|FG008|Treatment|Participant withdrew consent|1|||
155228091|NCT03400332|560274127|FG000|Treatment|Other reasons|0|||
155228092|NCT03400332|560274128|FG001|Treatment|Other reasons|1|||
155228093|NCT03400332|560274129|FG002|Treatment|Other reasons|1|||
155228094|NCT03400332|560274130|FG003|Treatment|Other reasons|0|||
155228095|NCT03400332|560274131|FG004|Treatment|Other reasons|3|||
155228096|NCT03400332|560274132|FG005|Treatment|Other reasons|1|||
155228097|NCT03400332|560274133|FG006|Treatment|Other reasons|2|||
155228098|NCT03400332|560274134|FG007|Treatment|Other reasons|0|||
155228099|NCT03400332|560274135|FG008|Treatment|Other reasons|1|||
155228100|NCT03400332|560274127|FG000|Treatment|Lost to Follow-up|0|||
155228101|NCT03400332|560274128|FG001|Treatment|Lost to Follow-up|1|||
155228102|NCT03400332|560274129|FG002|Treatment|Lost to Follow-up|0|||
155228103|NCT03400332|560274130|FG003|Treatment|Lost to Follow-up|0|||
155228104|NCT03400332|560274131|FG004|Treatment|Lost to Follow-up|0|||
155228105|NCT03400332|560274132|FG005|Treatment|Lost to Follow-up|0|||
155228106|NCT03400332|560274133|FG006|Treatment|Lost to Follow-up|0|||
155228107|NCT03400332|560274134|FG007|Treatment|Lost to Follow-up|0|||
155228108|NCT03400332|560274135|FG008|Treatment|Lost to Follow-up|0|||
155228109|NCT03400332|560274127|FG000|Treatment|Death|3|||
155228110|NCT03400332|560274128|FG001|Treatment|Death|1|||
155228111|NCT03400332|560274129|FG002|Treatment|Death|2|||
155228112|NCT03400332|560274130|FG003|Treatment|Death|3|||
155228113|NCT03400332|560274131|FG004|Treatment|Death|6|||
155228114|NCT03400332|560274132|FG005|Treatment|Death|2|||
155228115|NCT03400332|560274133|FG006|Treatment|Death|1|||
155228116|NCT03400332|560274134|FG007|Treatment|Death|3|||
155228117|NCT03400332|560274135|FG008|Treatment|Death|6|||
155228118|NCT03795610|560274139|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
155228119|NCT03795610|560274139|FG000|Overall Study|Withdrawal by Subject|1|||
155228120|NCT03795610|560274139|FG000|Overall Study|Screen Failure (Unknown)|1|||
155228121|NCT02775344|560274140|FG000|Overall Study|No ovarian cyst identified|3|||
155228122|NCT02775344|560274141|FG001|Overall Study|No ovarian cyst identified|2|||
155228123|NCT00235872|560274142|FG000|Overall Study|Adverse Event|34|||
155228124|NCT00235872|560274142|FG000|Overall Study|Death|1|||
155228125|NCT00235872|560274142|FG000|Overall Study|Lost to Follow-up|1|||
155228126|NCT00235872|560274142|FG000|Overall Study|Withdrawal by Subject|50|||
155228127|NCT00235872|560274142|FG000|Overall Study|Administrative reason|61|||
155228128|NCT02027844|560274143|FG000|Overall Study|Withdrawal by Subject|3|||
155228129|NCT02027844|560274144|FG001|Overall Study|Withdrawal by Subject|2|||
155228130|NCT02027844|560274145|FG002|Overall Study|Withdrawal by Subject|1|||
155228131|NCT02027844|560274143|FG000|Overall Study|Lost to Follow-up|0|||
155228132|NCT02027844|560274144|FG001|Overall Study|Lost to Follow-up|2|||
155228133|NCT02027844|560274145|FG002|Overall Study|Lost to Follow-up|1|||
155228134|NCT02027844|560274143|FG000|Overall Study|Protocol Violation|0|||
155228135|NCT02027844|560274144|FG001|Overall Study|Protocol Violation|2|||
155228136|NCT02027844|560274145|FG002|Overall Study|Protocol Violation|0|||
155228137|NCT02027844|560274143|FG000|Overall Study|Incomlete data|2|||
155228138|NCT02027844|560274144|FG001|Overall Study|Incomlete data|0|||
155228139|NCT02027844|560274145|FG002|Overall Study|Incomlete data|0|||
155228140|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
155228141|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
155228142|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Graft loss|1|||
155228143|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Graft loss|2|||
155228144|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Death|5|||
155228145|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Death|3|||
155228146|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
155228147|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
155228148|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
155228149|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
155228150|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
155228151|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
155228152|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
155228153|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
155228154|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
155228155|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
155228156|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
155228157|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
155228158|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Death|1|||
155228159|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Death|2|||
155228160|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
155228161|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
155228162|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
155228163|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
155228164|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
155228165|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
155228166|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
155228167|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
155228168|NCT00414661|560274151|FG000|Overall Study|Death|2|||
155228169|NCT00414661|560274152|FG001|Overall Study|Death|5|||
155228170|NCT00414661|560274153|FG002|Overall Study|Death|0|||
155228171|NCT00414661|560274154|FG003|Overall Study|Death|0|||
155228172|NCT00414661|560274151|FG000|Overall Study|Lost to Follow-up|1|||
155228173|NCT00414661|560274152|FG001|Overall Study|Lost to Follow-up|4|||
155228174|NCT00414661|560274153|FG002|Overall Study|Lost to Follow-up|0|||
155228175|NCT00414661|560274154|FG003|Overall Study|Lost to Follow-up|1|||
155228176|NCT00414661|560274151|FG000|Overall Study|Withdrawal by Subject|5|||
155228177|NCT00414661|560274152|FG001|Overall Study|Withdrawal by Subject|2|||
155228178|NCT00414661|560274153|FG002|Overall Study|Withdrawal by Subject|2|||
155228179|NCT00414661|560274154|FG003|Overall Study|Withdrawal by Subject|2|||
155228180|NCT00414661|560274151|FG000|Overall Study|Other|6|||
155228181|NCT00414661|560274152|FG001|Overall Study|Other|3|||
155228182|NCT00414661|560274153|FG002|Overall Study|Other|0|||
155228183|NCT00414661|560274154|FG003|Overall Study|Other|0|||
155228184|NCT02852265|560274155|FG000|3-month Follow-up|Lost to Follow-up|1|||
155228185|NCT02852265|560274156|FG001|3-month Follow-up|Lost to Follow-up|1|||
155228186|NCT04370691|560274165|FG000|Overall Study|Pending visit|48|||
155228187|NCT04370691|560274165|FG000|Overall Study|Have Not Reached Lower Window|15|||
155228188|NCT04370691|560274165|FG000|Overall Study|Termination|14|||
155228189|NCT04370691|560274165|FG000|Overall Study|Missed or Overdue|10|||
155228190|NCT03013543|560274166|FG000|Overall Study|Withdrawal by Subject|0|||
155228191|NCT03013543|560274167|FG001|Overall Study|Withdrawal by Subject|2|||
155228192|NCT03013543|560274168|FG002|Overall Study|Withdrawal by Subject|0|||
155228193|NCT03013543|560274169|FG003|Overall Study|Withdrawal by Subject|5|||
155228194|NCT03013543|560274170|FG004|Overall Study|Withdrawal by Subject|6|||
155228195|NCT03013543|560274171|FG005|Overall Study|Withdrawal by Subject|2|||
155228196|NCT03013543|560274172|FG006|Overall Study|Withdrawal by Subject|3|||
155228197|NCT03013543|560274173|FG007|Overall Study|Withdrawal by Subject|1|||
155228198|NCT03013543|560274174|FG008|Overall Study|Withdrawal by Subject|0|||
155228199|NCT03013543|560274175|FG009|Overall Study|Withdrawal by Subject|4|||
155228200|NCT03013543|560274166|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155228201|NCT03013543|560274167|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155228202|NCT03013543|560274168|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
155228203|NCT03013543|560274169|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
155228204|NCT03013543|560274170|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
155228205|NCT03013543|560274171|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
155228206|NCT03013543|560274172|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
155228207|NCT03013543|560274173|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
155228208|NCT03013543|560274174|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
155228209|NCT03013543|560274175|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
155228210|NCT03013543|560274166|FG000|Overall Study|Other|0|||
155228211|NCT03013543|560274167|FG001|Overall Study|Other|0|||
155228212|NCT03013543|560274168|FG002|Overall Study|Other|2|||
155228213|NCT03013543|560274169|FG003|Overall Study|Other|0|||
155228214|NCT03013543|560274170|FG004|Overall Study|Other|2|||
155228215|NCT03013543|560274171|FG005|Overall Study|Other|0|||
155228216|NCT03013543|560274172|FG006|Overall Study|Other|0|||
155228217|NCT03013543|560274173|FG007|Overall Study|Other|0|||
155228218|NCT03013543|560274174|FG008|Overall Study|Other|1|||
155228219|NCT03013543|560274175|FG009|Overall Study|Other|0|||
155228220|NCT03013543|560274166|FG000|Overall Study|Adverse Event|0|||
155228221|NCT03013543|560274167|FG001|Overall Study|Adverse Event|0|||
155228222|NCT03013543|560274168|FG002|Overall Study|Adverse Event|0|||
155228223|NCT03013543|560274169|FG003|Overall Study|Adverse Event|3|||
155228224|NCT03013543|560274170|FG004|Overall Study|Adverse Event|2|||
155228225|NCT03013543|560274171|FG005|Overall Study|Adverse Event|1|||
155228226|NCT03013543|560274172|FG006|Overall Study|Adverse Event|3|||
155228227|NCT03013543|560274173|FG007|Overall Study|Adverse Event|8|||
155228228|NCT03013543|560274174|FG008|Overall Study|Adverse Event|0|||
155228229|NCT03013543|560274175|FG009|Overall Study|Adverse Event|2|||
155228230|NCT03013543|560274166|FG000|Overall Study|Death|0|||
155228231|NCT03013543|560274167|FG001|Overall Study|Death|0|||
155228232|NCT03013543|560274168|FG002|Overall Study|Death|0|||
155228233|NCT03013543|560274169|FG003|Overall Study|Death|1|||
155228234|NCT03013543|560274170|FG004|Overall Study|Death|0|||
155228235|NCT03013543|560274171|FG005|Overall Study|Death|0|||
155228236|NCT03013543|560274172|FG006|Overall Study|Death|0|||
155228237|NCT03013543|560274173|FG007|Overall Study|Death|0|||
155228238|NCT03013543|560274174|FG008|Overall Study|Death|0|||
155228239|NCT03013543|560274175|FG009|Overall Study|Death|0|||
155228240|NCT03013543|560274166|FG000|Overall Study|Lack of Efficacy|0|||
155228241|NCT03013543|560274167|FG001|Overall Study|Lack of Efficacy|0|||
155228242|NCT03013543|560274168|FG002|Overall Study|Lack of Efficacy|0|||
155228243|NCT03013543|560274169|FG003|Overall Study|Lack of Efficacy|1|||
155228244|NCT03013543|560274170|FG004|Overall Study|Lack of Efficacy|0|||
155228245|NCT03013543|560274171|FG005|Overall Study|Lack of Efficacy|0|||
155228246|NCT03013543|560274172|FG006|Overall Study|Lack of Efficacy|0|||
155228247|NCT03013543|560274173|FG007|Overall Study|Lack of Efficacy|0|||
155228248|NCT03013543|560274174|FG008|Overall Study|Lack of Efficacy|0|||
155228249|NCT03013543|560274175|FG009|Overall Study|Lack of Efficacy|0|||
155228250|NCT03013543|560274166|FG000|Overall Study|Lost to Follow-up|0|||
155228251|NCT03013543|560274167|FG001|Overall Study|Lost to Follow-up|0|||
155228252|NCT03013543|560274168|FG002|Overall Study|Lost to Follow-up|0|||
155228253|NCT03013543|560274169|FG003|Overall Study|Lost to Follow-up|1|||
155228254|NCT03013543|560274170|FG004|Overall Study|Lost to Follow-up|0|||
155228255|NCT03013543|560274171|FG005|Overall Study|Lost to Follow-up|0|||
155228256|NCT03013543|560274172|FG006|Overall Study|Lost to Follow-up|1|||
155228257|NCT03013543|560274173|FG007|Overall Study|Lost to Follow-up|0|||
155228258|NCT03013543|560274174|FG008|Overall Study|Lost to Follow-up|0|||
155228259|NCT03013543|560274175|FG009|Overall Study|Lost to Follow-up|2|||
155228260|NCT03013543|560274166|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155228261|NCT03013543|560274167|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155228262|NCT03013543|560274168|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155228263|NCT03013543|560274169|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155228264|NCT03013543|560274170|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155228265|NCT03013543|560274171|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155228266|NCT03013543|560274172|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155228267|NCT03013543|560274173|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155228268|NCT03013543|560274174|FG008|Overall Study|Non-Compliance With Study Drug|1|||
155228269|NCT03013543|560274175|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155228270|NCT03013543|560274166|FG000|Overall Study|Physician Decision|0|||
155228271|NCT03013543|560274167|FG001|Overall Study|Physician Decision|0|||
155228272|NCT03013543|560274168|FG002|Overall Study|Physician Decision|0|||
155228273|NCT03013543|560274169|FG003|Overall Study|Physician Decision|0|||
155228274|NCT03013543|560274170|FG004|Overall Study|Physician Decision|1|||
155228275|NCT03013543|560274171|FG005|Overall Study|Physician Decision|0|||
155228276|NCT03013543|560274172|FG006|Overall Study|Physician Decision|0|||
155228277|NCT03013543|560274173|FG007|Overall Study|Physician Decision|0|||
155228278|NCT03013543|560274174|FG008|Overall Study|Physician Decision|0|||
155228279|NCT03013543|560274175|FG009|Overall Study|Physician Decision|0|||
155228280|NCT03013543|560274166|FG000|Overall Study|Protocol Violation|0|||
155228281|NCT03013543|560274167|FG001|Overall Study|Protocol Violation|0|||
155228282|NCT03013543|560274168|FG002|Overall Study|Protocol Violation|0|||
155228283|NCT03013543|560274169|FG003|Overall Study|Protocol Violation|0|||
155228284|NCT03013543|560274170|FG004|Overall Study|Protocol Violation|0|||
155228285|NCT03013543|560274171|FG005|Overall Study|Protocol Violation|0|||
155228286|NCT03013543|560274172|FG006|Overall Study|Protocol Violation|0|||
155228287|NCT03013543|560274173|FG007|Overall Study|Protocol Violation|0|||
155228288|NCT03013543|560274174|FG008|Overall Study|Protocol Violation|0|||
155228289|NCT03013543|560274175|FG009|Overall Study|Protocol Violation|1|||
155228290|NCT00323414|560274176|FG000|Overall Study|Withdrawal by Subject|0|||
155228291|NCT00323414|560274177|FG001|Overall Study|Withdrawal by Subject|1|||
155228292|NCT02552316|560274178|FG000|Overall Study|Withdrawal by Subject|1|||
155228293|NCT02552316|560274178|FG000|Overall Study|Withdrawal due to non-compliance|1|||
155228294|NCT04116710|560274181|FG000|Overall Study|Death|4|||
155228295|NCT04116710|560274182|FG001|Overall Study|Death|6|||
155228296|NCT04116710|560274183|FG002|Overall Study|Death|3|||
155228297|NCT04116710|560274184|FG003|Overall Study|Death|1|||
155228298|NCT04116710|560274181|FG000|Overall Study|Withdrawal by Subject|0|||
155228299|NCT04116710|560274182|FG001|Overall Study|Withdrawal by Subject|0|||
155228300|NCT04116710|560274183|FG002|Overall Study|Withdrawal by Subject|0|||
155228301|NCT04116710|560274184|FG003|Overall Study|Withdrawal by Subject|1|||
155228302|NCT04049760|560274188|FG000|Overall Study|Withdrawal by Subject|1|||
155228303|NCT00974571|560274189|FG000|Overall Study|Adverse Event|31|||
155228304|NCT00974571|560274190|FG001|Overall Study|Adverse Event|4|||
155228305|NCT00974571|560274191|FG002|Overall Study|Adverse Event|27|||
155228306|NCT00974571|560274189|FG000|Overall Study|Lack of Efficacy|3|||
155228307|NCT00974571|560274190|FG001|Overall Study|Lack of Efficacy|2|||
155228308|NCT00974571|560274191|FG002|Overall Study|Lack of Efficacy|9|||
155228309|NCT00974571|560274189|FG000|Overall Study|Lost to Follow-up|2|||
155228310|NCT00974571|560274190|FG001|Overall Study|Lost to Follow-up|1|||
155228311|NCT00974571|560274191|FG002|Overall Study|Lost to Follow-up|2|||
155228312|NCT00974571|560274189|FG000|Overall Study|Protocol Violation|13|||
155228313|NCT00974571|560274190|FG001|Overall Study|Protocol Violation|4|||
155228314|NCT00974571|560274191|FG002|Overall Study|Protocol Violation|18|||
155228315|NCT00974571|560274189|FG000|Overall Study|Withdrawal by Subject|14|||
155228316|NCT00974571|560274190|FG001|Overall Study|Withdrawal by Subject|5|||
155228317|NCT00974571|560274191|FG002|Overall Study|Withdrawal by Subject|16|||
155228318|NCT00974571|560274189|FG000|Overall Study|Patient Moved|1|||
155228319|NCT00974571|560274190|FG001|Overall Study|Patient Moved|0|||
155228320|NCT00974571|560274191|FG002|Overall Study|Patient Moved|1|||
155228321|NCT00974571|560274189|FG000|Overall Study|Other|4|||
155228322|NCT00974571|560274190|FG001|Overall Study|Other|0|||
155228323|NCT00974571|560274191|FG002|Overall Study|Other|10|||
155228324|NCT03778931|560274197|FG000|Overall Study|Withdrawal by Subject|12|||
155228325|NCT03778931|560274198|FG001|Overall Study|Withdrawal by Subject|25|||
155228326|NCT03778931|560274197|FG000|Overall Study|Physician Decision|1|||
155228327|NCT03778931|560274198|FG001|Overall Study|Physician Decision|3|||
155228328|NCT03778931|560274197|FG000|Overall Study|Participant Noncompliance|1|||
155228329|NCT03778931|560274198|FG001|Overall Study|Participant Noncompliance|1|||
155228330|NCT03778931|560274197|FG000|Overall Study|Lost to Follow-up|4|||
155228331|NCT03778931|560274198|FG001|Overall Study|Lost to Follow-up|1|||
155228332|NCT03778931|560274197|FG000|Overall Study|Death|69|||
155228333|NCT03778931|560274198|FG001|Overall Study|Death|79|||
155228334|NCT02130765|560274199|FG000|Overall Study|Did not receive treatment|4|||
155228335|NCT02130765|560274200|FG001|Overall Study|Did not receive treatment|0|||
155228336|NCT02130765|560274201|FG002|Overall Study|Did not receive treatment|0|||
155228337|NCT02130765|560274202|FG003|Overall Study|Did not receive treatment|0|||
155228338|NCT00717769|560274210|FG000|Overall Study|Adverse Event|9|||
155228339|NCT00717769|560274211|FG001|Overall Study|Adverse Event|6|||
155228340|NCT00717769|560274212|FG002|Overall Study|Adverse Event|1|||
155228341|NCT00717769|560274210|FG000|Overall Study|Lack of compliance|0|||
155228342|NCT00717769|560274211|FG001|Overall Study|Lack of compliance|2|||
155228343|NCT00717769|560274212|FG002|Overall Study|Lack of compliance|0|||
155228344|NCT00717769|560274210|FG000|Overall Study|Lost to Follow-up|3|||
155228345|NCT00717769|560274211|FG001|Overall Study|Lost to Follow-up|4|||
155228346|NCT00717769|560274212|FG002|Overall Study|Lost to Follow-up|0|||
155228347|NCT00717769|560274210|FG000|Overall Study|Lack of Efficacy|1|||
155228348|NCT00717769|560274211|FG001|Overall Study|Lack of Efficacy|2|||
155228349|NCT00717769|560274212|FG002|Overall Study|Lack of Efficacy|0|||
155228350|NCT00717769|560274210|FG000|Overall Study|Protocol Violation|0|||
155228351|NCT00717769|560274211|FG001|Overall Study|Protocol Violation|2|||
155228352|NCT00717769|560274212|FG002|Overall Study|Protocol Violation|0|||
155228353|NCT00717769|560274210|FG000|Overall Study|Sponsor decision|1|||
155228354|NCT00717769|560274211|FG001|Overall Study|Sponsor decision|0|||
155228355|NCT00717769|560274212|FG002|Overall Study|Sponsor decision|10|||
155228356|NCT00717769|560274210|FG000|Overall Study|Withdrew consent|2|||
155228357|NCT00717769|560274211|FG001|Overall Study|Withdrew consent|2|||
155228358|NCT00717769|560274212|FG002|Overall Study|Withdrew consent|0|||
155228359|NCT00692770|560274213|FG000|Overall Study|Protocol Violation|2|||
155228360|NCT00692770|560274214|FG001|Overall Study|Protocol Violation|7|||
155228361|NCT00692770|560274213|FG000|Overall Study|Withdrawal by Subject|97|||
155228362|NCT00692770|560274214|FG001|Overall Study|Withdrawal by Subject|36|||
155228363|NCT00692770|560274213|FG000|Overall Study|Adverse Event|136|||
155228364|NCT00692770|560274214|FG001|Overall Study|Adverse Event|41|||
155228365|NCT00692770|560274213|FG000|Overall Study|Death|10|||
155228366|NCT00692770|560274214|FG001|Overall Study|Death|5|||
155228367|NCT00692770|560274213|FG000|Overall Study|Lost to Follow-up|7|||
155228368|NCT00692770|560274214|FG001|Overall Study|Lost to Follow-up|3|||
155228369|NCT00692770|560274213|FG000|Overall Study|Non-compliant with study medication|11|||
155228370|NCT00692770|560274214|FG001|Overall Study|Non-compliant with study medication|5|||
155228371|NCT00692770|560274213|FG000|Overall Study|Progression by clinical judgment|2|||
155228372|NCT00692770|560274214|FG001|Overall Study|Progression by clinical judgment|3|||
155228373|NCT00692770|560274213|FG000|Overall Study|Physician decision not protocol driven|10|||
155228374|NCT00692770|560274214|FG001|Overall Study|Physician decision not protocol driven|14|||
155228375|NCT00692770|560274213|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
155228376|NCT00692770|560274214|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
155228377|NCT00692770|560274213|FG000|Overall Study|Protocol driven decision point|3|||
155228378|NCT00692770|560274214|FG001|Overall Study|Protocol driven decision point|7|||
155228379|NCT00692770|560274213|FG000|Overall Study|Completed all planned assessments|79|||
155228380|NCT00692770|560274214|FG001|Overall Study|Completed all planned assessments|101|||
155228381|NCT00692770|560274213|FG000|Overall Study|Radiological and clinical progression|8|||
155228382|NCT00692770|560274214|FG001|Overall Study|Radiological and clinical progression|8|||
155228383|NCT00692770|560274213|FG000|Overall Study|Clinical endpoint reached|16|||
155228384|NCT00692770|560274214|FG001|Overall Study|Clinical endpoint reached|43|||
155228385|NCT00692770|560274213|FG000|Overall Study|Study terminated by sponsor|2|||
155228386|NCT00692770|560274214|FG001|Overall Study|Study terminated by sponsor|2|||
155228387|NCT00692770|560274213|FG000|Overall Study|Randomized but not treated|3|||
155228388|NCT00692770|560274214|FG001|Overall Study|Randomized but not treated|4|||
155228389|NCT04327986|560274215|FG000|Overall Study|Physician Decision|2|||
155228390|NCT04327986|560274216|FG001|Overall Study|Physician Decision|0|||
155228391|NCT04327986|560274217|FG002|Overall Study|Physician Decision|0|||
155228392|NCT04327986|560274215|FG000|Overall Study|Death|1|||
155228393|NCT04327986|560274216|FG001|Overall Study|Death|0|||
155228394|NCT04327986|560274217|FG002|Overall Study|Death|0|||
155228395|NCT02917031|560274219|FG000|Overall Study|Reason not specified|7|||
155228396|NCT02917031|560274220|FG001|Overall Study|Reason not specified|5|||
155228397|NCT02917031|560274221|FG002|Overall Study|Reason not specified|6|||
155228398|NCT02917031|560274219|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
155228399|NCT02917031|560274220|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
155228400|NCT02917031|560274221|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
155228401|NCT02917031|560274219|FG000|Overall Study|Withdrawal by Subject|3|||
155228402|NCT02917031|560274220|FG001|Overall Study|Withdrawal by Subject|3|||
155228403|NCT02917031|560274221|FG002|Overall Study|Withdrawal by Subject|0|||
155228404|NCT02917031|560274219|FG000|Overall Study|Physician Decision|1|||
155228405|NCT02917031|560274220|FG001|Overall Study|Physician Decision|0|||
155228406|NCT02917031|560274221|FG002|Overall Study|Physician Decision|0|||
155228407|NCT02917031|560274219|FG000|Overall Study|Adverse Event|4|||
155228408|NCT02917031|560274220|FG001|Overall Study|Adverse Event|1|||
155228409|NCT02917031|560274221|FG002|Overall Study|Adverse Event|5|||
155228410|NCT02917031|560274219|FG000|Overall Study|Death|2|||
155228411|NCT02917031|560274220|FG001|Overall Study|Death|3|||
155228412|NCT02917031|560274221|FG002|Overall Study|Death|4|||
155228413|NCT02896400|560275571|FG000|1 Month Follow-up|Lost to Follow-up|7|||
155228414|NCT02896400|560275572|FG001|1 Month Follow-up|Lost to Follow-up|7|||
155228415|NCT02896400|560275573|FG002|1 Month Follow-up|Lost to Follow-up|5|||
155228416|NCT02896400|560275574|FG003|1 Month Follow-up|Lost to Follow-up|8|||
155228417|NCT02896400|560275575|FG004|1 Month Follow-up|Lost to Follow-up|9|||
155228418|NCT02896400|560275576|FG005|1 Month Follow-up|Lost to Follow-up|6|||
155228419|NCT02896400|560275577|FG006|1 Month Follow-up|Lost to Follow-up|5|||
155228420|NCT02896400|560275578|FG007|1 Month Follow-up|Lost to Follow-up|6|||
155228421|NCT02896400|560275579|FG008|1 Month Follow-up|Lost to Follow-up|4|||
155228422|NCT02896400|560275580|FG009|1 Month Follow-up|Lost to Follow-up|7|||
155228423|NCT02896400|560275581|FG010|1 Month Follow-up|Lost to Follow-up|5|||
155228424|NCT02896400|560275582|FG011|1 Month Follow-up|Lost to Follow-up|5|||
155228425|NCT02896400|560275583|FG012|1 Month Follow-up|Lost to Follow-up|3|||
155228426|NCT02896400|560275584|FG013|1 Month Follow-up|Lost to Follow-up|4|||
155228427|NCT02896400|560275585|FG014|1 Month Follow-up|Lost to Follow-up|1|||
155228428|NCT02896400|560275586|FG015|1 Month Follow-up|Lost to Follow-up|2|||
155228429|NCT02896400|560275571|FG000|1 Month Follow-up|Death|0|||
155228430|NCT02896400|560275572|FG001|1 Month Follow-up|Death|0|||
155228431|NCT02896400|560275573|FG002|1 Month Follow-up|Death|0|||
155228432|NCT02896400|560275574|FG003|1 Month Follow-up|Death|0|||
155228433|NCT02896400|560275575|FG004|1 Month Follow-up|Death|0|||
155228434|NCT02896400|560275576|FG005|1 Month Follow-up|Death|0|||
155228435|NCT02896400|560275577|FG006|1 Month Follow-up|Death|0|||
155228436|NCT02896400|560275578|FG007|1 Month Follow-up|Death|0|||
155228437|NCT02896400|560275579|FG008|1 Month Follow-up|Death|0|||
155228438|NCT02896400|560275580|FG009|1 Month Follow-up|Death|0|||
155228439|NCT02896400|560275581|FG010|1 Month Follow-up|Death|0|||
155228440|NCT02896400|560275582|FG011|1 Month Follow-up|Death|0|||
155228441|NCT02896400|560275583|FG012|1 Month Follow-up|Death|0|||
155228442|NCT02896400|560275584|FG013|1 Month Follow-up|Death|0|||
155228443|NCT02896400|560275585|FG014|1 Month Follow-up|Death|0|||
155228444|NCT02896400|560275586|FG015|1 Month Follow-up|Death|1|||
155228445|NCT02896400|560275571|FG000|3 Month Follow-up|Lost to Follow-up|6|||
155228446|NCT02896400|560275572|FG001|3 Month Follow-up|Lost to Follow-up|3|||
155228447|NCT02896400|560275573|FG002|3 Month Follow-up|Lost to Follow-up|6|||
155228448|NCT02896400|560275574|FG003|3 Month Follow-up|Lost to Follow-up|11|||
155228449|NCT02896400|560275575|FG004|3 Month Follow-up|Lost to Follow-up|12|||
155228450|NCT02896400|560275576|FG005|3 Month Follow-up|Lost to Follow-up|6|||
155228451|NCT02896400|560275577|FG006|3 Month Follow-up|Lost to Follow-up|4|||
155228452|NCT02896400|560275578|FG007|3 Month Follow-up|Lost to Follow-up|3|||
155228453|NCT02896400|560275579|FG008|3 Month Follow-up|Lost to Follow-up|6|||
155228454|NCT02896400|560275580|FG009|3 Month Follow-up|Lost to Follow-up|5|||
155228455|NCT02896400|560275581|FG010|3 Month Follow-up|Lost to Follow-up|6|||
155228456|NCT02896400|560275582|FG011|3 Month Follow-up|Lost to Follow-up|6|||
155228457|NCT02896400|560275583|FG012|3 Month Follow-up|Lost to Follow-up|3|||
155228458|NCT02896400|560275584|FG013|3 Month Follow-up|Lost to Follow-up|5|||
155228459|NCT02896400|560275585|FG014|3 Month Follow-up|Lost to Follow-up|3|||
155228460|NCT02896400|560275586|FG015|3 Month Follow-up|Lost to Follow-up|2|||
155228461|NCT02896400|560275571|FG000|3 Month Follow-up|Death|0|||
155228462|NCT02896400|560275572|FG001|3 Month Follow-up|Death|0|||
155228463|NCT02896400|560275573|FG002|3 Month Follow-up|Death|0|||
155228464|NCT02896400|560275574|FG003|3 Month Follow-up|Death|0|||
155228465|NCT02896400|560275575|FG004|3 Month Follow-up|Death|0|||
155228466|NCT02896400|560275576|FG005|3 Month Follow-up|Death|0|||
155228467|NCT02896400|560275577|FG006|3 Month Follow-up|Death|0|||
155228468|NCT02896400|560275578|FG007|3 Month Follow-up|Death|0|||
155228469|NCT02896400|560275579|FG008|3 Month Follow-up|Death|0|||
155491458|NCT00563706|561225397|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
155228470|NCT02896400|560275580|FG009|3 Month Follow-up|Death|0|||
155228471|NCT02896400|560275581|FG010|3 Month Follow-up|Death|0|||
155228472|NCT02896400|560275582|FG011|3 Month Follow-up|Death|0|||
155228473|NCT02896400|560275583|FG012|3 Month Follow-up|Death|0|||
155228474|NCT02896400|560275584|FG013|3 Month Follow-up|Death|1|||
155228475|NCT02896400|560275585|FG014|3 Month Follow-up|Death|1|||
155228476|NCT02896400|560275586|FG015|3 Month Follow-up|Death|0|||
155228477|NCT02896400|560275571|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228478|NCT02896400|560275572|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228479|NCT02896400|560275573|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228480|NCT02896400|560275574|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228481|NCT02896400|560275575|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228482|NCT02896400|560275576|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228483|NCT02896400|560275577|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
155228484|NCT02896400|560275578|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
155228485|NCT02896400|560275579|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228486|NCT02896400|560275580|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228487|NCT02896400|560275581|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228488|NCT02896400|560275582|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228489|NCT02896400|560275583|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228490|NCT02896400|560275584|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228491|NCT02896400|560275585|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
155228492|NCT02896400|560275586|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228493|NCT02896400|560275571|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
155228494|NCT02896400|560275572|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228495|NCT02896400|560275573|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
155228496|NCT02896400|560275574|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
155228497|NCT02896400|560275575|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
155228498|NCT02896400|560275576|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228499|NCT02896400|560275577|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228500|NCT02896400|560275578|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
155228501|NCT02896400|560275579|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
155228502|NCT02896400|560275580|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228503|NCT02896400|560275581|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
155228504|NCT02896400|560275582|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
155228505|NCT02896400|560275583|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228506|NCT02896400|560275584|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228507|NCT02896400|560275585|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228508|NCT02896400|560275586|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
155228509|NCT02984020|560275587|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
155228510|NCT02984020|560275587|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
155228511|NCT02984020|560275587|FG000|Overall Study|Other significant protocol violation|2|||
155228512|NCT01700179|560275588|FG000|Overall Study|Physician Decision|2|||
155228513|NCT01896895|560275589|FG000|Double-blind MP|Physician Decision|0|||
155228514|NCT01896895|560275590|FG001|Double-blind MP|Physician Decision|0|||
155228515|NCT01896895|560275591|FG002|Double-blind MP|Physician Decision|1|||
155228516|NCT01896895|560275592|FG003|Double-blind MP|Physician Decision|0|||
155228517|NCT01896895|560275589|FG000|Double-blind MP|Withdrawal by Subject|0|||
155228518|NCT01896895|560275590|FG001|Double-blind MP|Withdrawal by Subject|2|||
155228519|NCT01896895|560275591|FG002|Double-blind MP|Withdrawal by Subject|1|||
155228520|NCT01896895|560275592|FG003|Double-blind MP|Withdrawal by Subject|0|||
155228521|NCT01896895|560275589|FG000|Double-blind MP|Lost to Follow-up|1|||
155228522|NCT01896895|560275590|FG001|Double-blind MP|Lost to Follow-up|0|||
155228523|NCT01896895|560275591|FG002|Double-blind MP|Lost to Follow-up|1|||
155228524|NCT01896895|560275592|FG003|Double-blind MP|Lost to Follow-up|0|||
155228525|NCT01207778|560275593|FG000|Overall Study|Lost to Follow-up|0|||
155228526|NCT01207778|560275594|FG001|Overall Study|Lost to Follow-up|3|||
155228527|NCT01207778|560275595|FG002|Overall Study|Lost to Follow-up|3|||
155228528|NCT00646204|560275598|FG000|Overall Study|Adverse Event|3|||
155228529|NCT00646204|560275599|FG001|Overall Study|Adverse Event|0|||
155228530|NCT00646204|560275598|FG000|Overall Study|Withdrawal by Subject|1|||
155228531|NCT00646204|560275599|FG001|Overall Study|Withdrawal by Subject|0|||
155228532|NCT00779675|560275601|FG000|Treatment Period|Adverse Event|87|||
155228533|NCT00779675|560275601|FG000|Treatment Period|Treatment Failure|80|||
155228534|NCT00779675|560275601|FG000|Treatment Period|Transferred to Another Study|38|||
155228535|NCT00779675|560275601|FG000|Treatment Period|Lost to Follow-up|23|||
155228536|NCT00779675|560275601|FG000|Treatment Period|Withdrawal by Subject|46|||
155228537|NCT00779675|560275601|FG000|Treatment Period|Protocol Violation|54|||
155228538|NCT00779675|560275601|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
155228539|NCT00779675|560275601|FG000|Treatment Period|Administrative|3|||
155228540|NCT00779675|560275601|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
155228541|NCT00779675|560275601|FG000|Extended Treatment Period|Protocol Violation|13|||
155228542|NCT00779675|560275601|FG000|Extended Treatment Period|Adverse Event|6|||
155228543|NCT00779675|560275601|FG000|Extended Treatment Period|Treatment Failure|11|||
155228544|NCT00779675|560275601|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
155228545|NCT00779675|560275601|FG000|Extended Treatment Period|Lost to Follow-up|6|||
155228546|NCT01633944|560275614|FG000|Open-label Titration Phase|Adverse Event|109|||
155228547|NCT01633944|560275615|FG001|Open-label Titration Phase|Adverse Event|0|||
155228548|NCT01633944|560275616|FG002|Open-label Titration Phase|Adverse Event|0|||
155228549|NCT01633944|560275614|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
155228550|NCT01633944|560275615|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
155228551|NCT01633944|560275616|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
155228552|NCT01633944|560275614|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
155228553|NCT01633944|560275615|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
155228554|NCT01633944|560275616|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
155228555|NCT01633944|560275614|FG000|Open-label Titration Phase|Protocol Violation|24|||
155228556|NCT01633944|560275615|FG001|Open-label Titration Phase|Protocol Violation|0|||
155228557|NCT01633944|560275616|FG002|Open-label Titration Phase|Protocol Violation|0|||
155228558|NCT01633944|560275614|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
155228559|NCT01633944|560275615|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
155228560|NCT01633944|560275616|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
155228561|NCT01633944|560275614|FG000|Open-label Titration Phase|Other|68|||
155228562|NCT01633944|560275615|FG001|Open-label Titration Phase|Other|0|||
155228563|NCT01633944|560275616|FG002|Open-label Titration Phase|Other|0|||
155228564|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155228565|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Adverse Event|13|||
155228566|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Adverse Event|7|||
155228567|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155228568|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
155228569|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
155228570|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155228571|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155228572|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
155228573|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155228574|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
155228575|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
155228576|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155228577|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
155228578|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
155228579|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
155228580|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
155228581|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
155228582|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
155228583|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
155228584|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
155228585|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Other|0|||
155228586|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Other|7|||
155228587|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Other|0|||
155228588|NCT00463060|560275620|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
155228589|NCT00463060|560275620|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
155228590|NCT01400841|560275621|FG000|Initial Study Phase (6 Months)|Death|1|||
155228591|NCT01400841|560275621|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
155228592|NCT00701129|560275622|FG000|Overall Study|Death|2|||
155228593|NCT00770120|560275625|FG000|Overall Study|Progression|31|||
155228594|NCT00770120|560275625|FG000|Overall Study|Adverse Event|11|||
155228595|NCT00770120|560275625|FG000|Overall Study|Not Protocol Specified|11|||
155228596|NCT00770120|560275625|FG000|Overall Study|Death|3|||
155228597|NCT00770120|560275625|FG000|Overall Study|Withdrawal by Subject|2|||
155228598|NCT00770120|560275625|FG000|Overall Study|Ineligible|1|||
155228599|NCT00770120|560275625|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
155228600|NCT00770120|560275625|FG000|Overall Study|Reason under Review|1|||
155228601|NCT04304001|560275626|FG000|Overall Study|Lost to Follow-up|13|||
155228602|NCT04304001|560275627|FG001|Overall Study|Lost to Follow-up|9|||
155228603|NCT03752619|560275628|FG000|Overall Study|Lost to Follow-up|2|||
155228604|NCT03752619|560275629|FG001|Overall Study|Lost to Follow-up|1|||
155228605|NCT03752619|560275628|FG000|Overall Study|Withdrawal by Subject|1|||
155228606|NCT03752619|560275629|FG001|Overall Study|Withdrawal by Subject|1|||
155228607|NCT03752619|560275628|FG000|Overall Study|Adverse Event|0|||
155228608|NCT03752619|560275629|FG001|Overall Study|Adverse Event|1|||
155228609|NCT03907683|560275630|FG000|Overall Study|Pregnancy|1|||
155228610|NCT03907683|560275630|FG000|Overall Study|Withdrawal by Subject|1|||
155228611|NCT00727714|560275631|FG000|Overall Study|Lost to Follow-up|2|||
155228612|NCT00486265|560275634|FG000|Overall Study|Adverse Event|1|||
155228613|NCT00486265|560275634|FG000|Overall Study|Lack of Efficacy|8|||
155228614|NCT01452412|560275635|FG000|Overall Study|Withdrawal by Subject|15|||
155228615|NCT01452412|560275636|FG001|Overall Study|Withdrawal by Subject|11|||
155228616|NCT01452412|560275635|FG000|Overall Study|Adverse Event|4|||
155228617|NCT01452412|560275636|FG001|Overall Study|Adverse Event|3|||
155228618|NCT01452412|560275635|FG000|Overall Study|Lost to Follow-up|5|||
155228619|NCT01452412|560275636|FG001|Overall Study|Lost to Follow-up|3|||
155228620|NCT01452412|560275635|FG000|Overall Study|Death|1|||
155228621|NCT01452412|560275636|FG001|Overall Study|Death|0|||
155228622|NCT01452412|560275635|FG000|Overall Study|Initiated dialysis|1|||
155228623|NCT01452412|560275636|FG001|Overall Study|Initiated dialysis|0|||
155228624|NCT01452412|560275635|FG000|Overall Study|Other|2|||
155228625|NCT01452412|560275636|FG001|Overall Study|Other|0|||
155228626|NCT05132127|560275637|FG000|Overall Study|Adverse Event|1|||
155228627|NCT02659020|560275639|FG000|Overall Study|Adverse Event|0|||
155228628|NCT02659020|560275640|FG001|Overall Study|Adverse Event|0|||
155228629|NCT02659020|560275641|FG002|Overall Study|Adverse Event|0|||
155228630|NCT02659020|560275642|FG003|Overall Study|Adverse Event|2|||
155228631|NCT02659020|560275643|FG004|Overall Study|Adverse Event|0|||
155228632|NCT02659020|560275644|FG005|Overall Study|Adverse Event|0|||
155228633|NCT02659020|560275645|FG006|Overall Study|Adverse Event|2|||
155228634|NCT02659020|560275639|FG000|Overall Study|Lost to Follow-up|1|||
155228635|NCT02659020|560275640|FG001|Overall Study|Lost to Follow-up|2|||
155228636|NCT02659020|560275641|FG002|Overall Study|Lost to Follow-up|1|||
155228637|NCT02659020|560275642|FG003|Overall Study|Lost to Follow-up|6|||
155228638|NCT02659020|560275643|FG004|Overall Study|Lost to Follow-up|1|||
155228639|NCT02659020|560275644|FG005|Overall Study|Lost to Follow-up|5|||
155228640|NCT02659020|560275645|FG006|Overall Study|Lost to Follow-up|0|||
155228641|NCT02659020|560275639|FG000|Overall Study|Physician Decision|0|||
155228642|NCT02659020|560275640|FG001|Overall Study|Physician Decision|0|||
155228643|NCT02659020|560275641|FG002|Overall Study|Physician Decision|0|||
155228644|NCT02659020|560275642|FG003|Overall Study|Physician Decision|1|||
155228645|NCT02659020|560275643|FG004|Overall Study|Physician Decision|1|||
155228646|NCT02659020|560275644|FG005|Overall Study|Physician Decision|0|||
155228647|NCT02659020|560275645|FG006|Overall Study|Physician Decision|1|||
155228648|NCT02659020|560275639|FG000|Overall Study|Withdrawal by Subject|2|||
155228649|NCT02659020|560275640|FG001|Overall Study|Withdrawal by Subject|1|||
155228650|NCT02659020|560275641|FG002|Overall Study|Withdrawal by Subject|0|||
155228651|NCT02659020|560275642|FG003|Overall Study|Withdrawal by Subject|3|||
155228652|NCT02659020|560275643|FG004|Overall Study|Withdrawal by Subject|3|||
155228653|NCT02659020|560275644|FG005|Overall Study|Withdrawal by Subject|6|||
155228654|NCT02659020|560275645|FG006|Overall Study|Withdrawal by Subject|3|||
155228655|NCT02659020|560275639|FG000|Overall Study|Progressive Disease|0|||
155228656|NCT02659020|560275640|FG001|Overall Study|Progressive Disease|0|||
155228657|NCT02659020|560275641|FG002|Overall Study|Progressive Disease|0|||
155228658|NCT02659020|560275642|FG003|Overall Study|Progressive Disease|4|||
155228659|NCT02659020|560275643|FG004|Overall Study|Progressive Disease|1|||
155228660|NCT02659020|560275644|FG005|Overall Study|Progressive Disease|0|||
155228661|NCT02659020|560275645|FG006|Overall Study|Progressive Disease|2|||
155228662|NCT04382911|560275646|FG000|Overall Study|unable to be imaged prior to surgery|2|||
155228663|NCT01120210|560275650|FG000|MAIN INFUSION|Adverse Event|1|||
155228664|NCT01120210|560275651|FG001|MAIN INFUSION|Adverse Event|0|||
155228665|NCT01120210|560275650|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
155228666|NCT01120210|560275651|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
155228667|NCT02703636|560275663|FG000|Overall Study|Adverse Event|14|||
155228668|NCT02703636|560275663|FG000|Overall Study|Study stopped by sponsor|1|||
155228669|NCT02703636|560275663|FG000|Overall Study|Withdrawal by Subject|1|||
155228670|NCT01554618|560275679|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
155228671|NCT01554618|560275680|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
155228672|NCT01554618|560275679|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
155228673|NCT01554618|560275680|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
155228674|NCT01554618|560275679|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
155228675|NCT01554618|560275680|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
155228676|NCT01554618|560275679|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
155228677|NCT01554618|560275680|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
155228678|NCT01554618|560275679|FG000|Open-Label Extension Period|Physician Decision|0|||
155228679|NCT01554618|560275680|FG001|Open-Label Extension Period|Physician Decision|1|||
155228680|NCT01554618|560275679|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
155228681|NCT01554618|560275680|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
155228682|NCT00477672|560275681|FG000|Overall Study|Adverse Event|3|||
155228683|NCT00477672|560275682|FG001|Overall Study|Adverse Event|5|||
155228684|NCT00477672|560275683|FG002|Overall Study|Adverse Event|6|||
155228685|NCT00477672|560275681|FG000|Overall Study|Death|0|||
155228686|NCT00477672|560275682|FG001|Overall Study|Death|1|||
155228687|NCT00477672|560275683|FG002|Overall Study|Death|0|||
155228688|NCT00477672|560275681|FG000|Overall Study|Disease progression|0|||
155228689|NCT00477672|560275682|FG001|Overall Study|Disease progression|1|||
155228690|NCT00477672|560275683|FG002|Overall Study|Disease progression|0|||
155228691|NCT00477672|560275681|FG000|Overall Study|Physician Decision|1|||
155228692|NCT00477672|560275682|FG001|Overall Study|Physician Decision|0|||
155228693|NCT00477672|560275683|FG002|Overall Study|Physician Decision|0|||
155228694|NCT00477672|560275681|FG000|Overall Study|Protocol noncompliance|0|||
155228695|NCT00477672|560275682|FG001|Overall Study|Protocol noncompliance|2|||
155228696|NCT00477672|560275683|FG002|Overall Study|Protocol noncompliance|0|||
155228697|NCT00477672|560275681|FG000|Overall Study|Consent withdrawn|2|||
155228698|NCT00477672|560275682|FG001|Overall Study|Consent withdrawn|5|||
155228699|NCT00477672|560275683|FG002|Overall Study|Consent withdrawn|10|||
155228700|NCT00477672|560275681|FG000|Overall Study|Discretion of Sponsor|1|||
155228701|NCT00477672|560275682|FG001|Overall Study|Discretion of Sponsor|2|||
155228702|NCT00477672|560275683|FG002|Overall Study|Discretion of Sponsor|0|||
155228703|NCT02275481|560275684|FG000|Overall Study|Death|2|||
155228704|NCT02275481|560275685|FG001|Overall Study|Death|1|||
155228705|NCT02275481|560275684|FG000|Overall Study|Lost to Follow-up|2|||
155228706|NCT02275481|560275685|FG001|Overall Study|Lost to Follow-up|0|||
155228707|NCT02275481|560275684|FG000|Overall Study|Withdrawal by Subject|3|||
155228708|NCT02275481|560275685|FG001|Overall Study|Withdrawal by Subject|0|||
155228709|NCT02275481|560275684|FG000|Overall Study|all other reasons combined|2|||
155228710|NCT02275481|560275685|FG001|Overall Study|all other reasons combined|1|||
155228711|NCT02275481|560275684|FG000|Overall Study|Physician Decision|0|||
155228712|NCT02275481|560275685|FG001|Overall Study|Physician Decision|1|||
155228713|NCT01215227|560275686|FG000|Overall Study|Adverse Event|11|||
155228714|NCT01215227|560275687|FG001|Overall Study|Adverse Event|11|||
155228715|NCT01215227|560275688|FG002|Overall Study|Adverse Event|4|||
155228716|NCT01215227|560275689|FG003|Overall Study|Adverse Event|8|||
155228717|NCT01215227|560275690|FG004|Overall Study|Adverse Event|7|||
155228718|NCT01215227|560275691|FG005|Overall Study|Adverse Event|6|||
155228719|NCT01215227|560275686|FG000|Overall Study|Treatment Failure|8|||
155228720|NCT01215227|560275687|FG001|Overall Study|Treatment Failure|4|||
155228721|NCT01215227|560275688|FG002|Overall Study|Treatment Failure|1|||
155228722|NCT01215227|560275689|FG003|Overall Study|Treatment Failure|5|||
155228723|NCT01215227|560275690|FG004|Overall Study|Treatment Failure|1|||
155228724|NCT01215227|560275691|FG005|Overall Study|Treatment Failure|1|||
155228725|NCT01215227|560275686|FG000|Overall Study|Lost to Follow-up|1|||
155228726|NCT01215227|560275687|FG001|Overall Study|Lost to Follow-up|4|||
155228727|NCT01215227|560275688|FG002|Overall Study|Lost to Follow-up|1|||
155228728|NCT01215227|560275689|FG003|Overall Study|Lost to Follow-up|1|||
155228729|NCT01215227|560275690|FG004|Overall Study|Lost to Follow-up|1|||
155228730|NCT01215227|560275691|FG005|Overall Study|Lost to Follow-up|2|||
155228731|NCT01215227|560275686|FG000|Overall Study|Subject Withdrew Consent|16|||
155228732|NCT01215227|560275687|FG001|Overall Study|Subject Withdrew Consent|20|||
155228733|NCT01215227|560275688|FG002|Overall Study|Subject Withdrew Consent|7|||
155228734|NCT01215227|560275689|FG003|Overall Study|Subject Withdrew Consent|10|||
155228735|NCT01215227|560275690|FG004|Overall Study|Subject Withdrew Consent|11|||
155228736|NCT01215227|560275691|FG005|Overall Study|Subject Withdrew Consent|8|||
155228737|NCT01215227|560275686|FG000|Overall Study|Non-Compliance With Protocol|2|||
155228738|NCT01215227|560275687|FG001|Overall Study|Non-Compliance With Protocol|6|||
155228739|NCT01215227|560275688|FG002|Overall Study|Non-Compliance With Protocol|1|||
155228740|NCT01215227|560275689|FG003|Overall Study|Non-Compliance With Protocol|0|||
155228741|NCT01215227|560275690|FG004|Overall Study|Non-Compliance With Protocol|0|||
155228742|NCT01215227|560275691|FG005|Overall Study|Non-Compliance With Protocol|0|||
155228743|NCT01215227|560275686|FG000|Overall Study|Administrative|83|||
155228744|NCT01215227|560275687|FG001|Overall Study|Administrative|73|||
155228745|NCT01215227|560275688|FG002|Overall Study|Administrative|42|||
155228746|NCT01215227|560275689|FG003|Overall Study|Administrative|24|||
155228747|NCT01215227|560275690|FG004|Overall Study|Administrative|28|||
155228748|NCT01215227|560275691|FG005|Overall Study|Administrative|40|||
155228749|NCT01215227|560275686|FG000|Overall Study|Missing Status|0|||
155228750|NCT01215227|560275687|FG001|Overall Study|Missing Status|1|||
155228751|NCT01215227|560275688|FG002|Overall Study|Missing Status|0|||
155228752|NCT01215227|560275689|FG003|Overall Study|Missing Status|0|||
155228753|NCT01215227|560275690|FG004|Overall Study|Missing Status|0|||
155228754|NCT01215227|560275691|FG005|Overall Study|Missing Status|0|||
155228755|NCT01215227|560275686|FG000|Overall Study|Randomized but not treated|0|||
155228756|NCT01215227|560275687|FG001|Overall Study|Randomized but not treated|0|||
155228757|NCT01215227|560275688|FG002|Overall Study|Randomized but not treated|1|||
155228758|NCT01215227|560275689|FG003|Overall Study|Randomized but not treated|1|||
155228759|NCT01215227|560275690|FG004|Overall Study|Randomized but not treated|0|||
155228760|NCT01215227|560275691|FG005|Overall Study|Randomized but not treated|1|||
155228761|NCT01393405|560275692|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
155228762|NCT01393405|560275693|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
155228763|NCT01393405|560275694|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
155228764|NCT01393405|560275692|FG000|Induction Period (week1-16)|Adverse Event|16|||
155228765|NCT01393405|560275693|FG001|Induction Period (week1-16)|Adverse Event|0|||
155228766|NCT01393405|560275694|FG002|Induction Period (week1-16)|Adverse Event|0|||
155228767|NCT01393405|560275692|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
155228768|NCT01393405|560275693|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
155228769|NCT01393405|560275694|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
155228770|NCT01393405|560275692|FG000|Maintenance Period Week|Lack of Efficacy|0|||
155228771|NCT01393405|560275693|FG001|Maintenance Period Week|Lack of Efficacy|22|||
155491459|NCT00563706|561225398|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
155228772|NCT01393405|560275694|FG002|Maintenance Period Week|Lack of Efficacy|22|||
155228773|NCT01393405|560275692|FG000|Maintenance Period Week|Adverse Event|0|||
155228774|NCT01393405|560275693|FG001|Maintenance Period Week|Adverse Event|5|||
155228775|NCT01393405|560275694|FG002|Maintenance Period Week|Adverse Event|2|||
155228776|NCT01393405|560275692|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
155228777|NCT01393405|560275693|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
155228778|NCT01393405|560275694|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
155228779|NCT01393405|560275692|FG000|Maintenance Period Week|Lost to Follow-up|0|||
155228780|NCT01393405|560275693|FG001|Maintenance Period Week|Lost to Follow-up|1|||
155228781|NCT01393405|560275694|FG002|Maintenance Period Week|Lost to Follow-up|0|||
155228782|NCT02281552|560275701|FG000|Overall Study|Medication error|1|||
155228783|NCT02281552|560275702|FG001|Overall Study|Medication error|0|||
155228784|NCT02281552|560275701|FG000|Overall Study|Insufficient clinical response|0|||
155228785|NCT02281552|560275702|FG001|Overall Study|Insufficient clinical response|1|||
155228786|NCT02281552|560275701|FG000|Overall Study|Adverse Event|3|||
155228787|NCT02281552|560275702|FG001|Overall Study|Adverse Event|9|||
155228788|NCT01224639|560275703|FG000|Overall Study|Withdrawal by Subject|0|||
155228789|NCT01224639|560275704|FG001|Overall Study|Withdrawal by Subject|0|||
155228790|NCT01224639|560275705|FG002|Overall Study|Withdrawal by Subject|0|||
155228791|NCT01224639|560275706|FG003|Overall Study|Withdrawal by Subject|0|||
155228792|NCT01224639|560275707|FG004|Overall Study|Withdrawal by Subject|2|||
155228793|NCT01224639|560275708|FG005|Overall Study|Withdrawal by Subject|0|||
155228794|NCT01224639|560275709|FG006|Overall Study|Withdrawal by Subject|1|||
155228795|NCT01224639|560275710|FG007|Overall Study|Withdrawal by Subject|1|||
155228796|NCT01224639|560275703|FG000|Overall Study|Adverse Event|0|||
155228797|NCT01224639|560275704|FG001|Overall Study|Adverse Event|0|||
155228798|NCT01224639|560275705|FG002|Overall Study|Adverse Event|0|||
155228799|NCT01224639|560275706|FG003|Overall Study|Adverse Event|0|||
155228800|NCT01224639|560275707|FG004|Overall Study|Adverse Event|0|||
155228801|NCT01224639|560275708|FG005|Overall Study|Adverse Event|0|||
155228802|NCT01224639|560275709|FG006|Overall Study|Adverse Event|0|||
155228803|NCT01224639|560275710|FG007|Overall Study|Adverse Event|1|||
155228804|NCT04656132|560275711|FG000|Overall Study|Lost to Follow-up|4|||
155228805|NCT04656132|560275711|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
155228806|NCT04365699|560275712|FG000|Overall Study|Death|2|||
155228807|NCT04365699|560275713|FG001|Overall Study|Death|5|||
155228808|NCT04365699|560275714|FG002|Overall Study|Death|15|||
155228809|NCT03925727|560275716|FG000|Overall Study|Adverse Event|4|||
155228810|NCT03925727|560275717|FG001|Overall Study|Adverse Event|0|||
155228811|NCT03925727|560275718|FG002|Overall Study|Adverse Event|3|||
155228812|NCT03925727|560275716|FG000|Overall Study|Protocol Violation|1|||
155228813|NCT03925727|560275717|FG001|Overall Study|Protocol Violation|2|||
155228814|NCT03925727|560275718|FG002|Overall Study|Protocol Violation|2|||
155228815|NCT03925727|560275716|FG000|Overall Study|Withdrawal by Subject|3|||
155228816|NCT03925727|560275717|FG001|Overall Study|Withdrawal by Subject|2|||
155228817|NCT03925727|560275718|FG002|Overall Study|Withdrawal by Subject|4|||
155228818|NCT03925727|560275716|FG000|Overall Study|Administrative Reasons|3|||
155228819|NCT03925727|560275717|FG001|Overall Study|Administrative Reasons|1|||
155228820|NCT03925727|560275718|FG002|Overall Study|Administrative Reasons|2|||
155228821|NCT03925727|560275716|FG000|Overall Study|Randomized in error or Disqualified|8|||
155228822|NCT03925727|560275717|FG001|Overall Study|Randomized in error or Disqualified|1|||
155228823|NCT03925727|560275718|FG002|Overall Study|Randomized in error or Disqualified|7|||
155228824|NCT02321462|560275721|FG000|Overall Study|Withdrawal by Subject|5|||
155228825|NCT02321462|560275722|FG001|Overall Study|Withdrawal by Subject|2|||
155228826|NCT02321462|560275721|FG000|Overall Study|Subject withdrawn before any treatment|1|||
155228827|NCT02321462|560275722|FG001|Overall Study|Subject withdrawn before any treatment|1|||
155228828|NCT03044197|560275733|FG000|Overall Study|Withdrawal by Subject|3|||
155228829|NCT03044197|560275734|FG001|Overall Study|Withdrawal by Subject|1|||
155228830|NCT00834912|560275735|FG000|Treatment Period 1|Adverse Event|0|||
155228831|NCT00834912|560275736|FG001|Treatment Period 1|Adverse Event|1|||
155228832|NCT00834912|560275737|FG002|Treatment Period 1|Adverse Event|0|||
155228833|NCT00834912|560275738|FG003|Treatment Period 1|Adverse Event|1|||
155228834|NCT00834912|560275739|FG004|Treatment Period 1|Adverse Event|0|||
155228835|NCT00834912|560275740|FG005|Treatment Period 1|Adverse Event|0|||
155228836|NCT00834912|560275735|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155228837|NCT00834912|560275736|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155228838|NCT00834912|560275737|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155228839|NCT00834912|560275738|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155228840|NCT00834912|560275739|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155228841|NCT00834912|560275740|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155228842|NCT01574352|560275743|FG000|Overall Study|Withdrawal by Subject|6|||
155228843|NCT01574352|560275744|FG001|Overall Study|Withdrawal by Subject|13|||
155228844|NCT01574352|560275743|FG000|Overall Study|Injury in non-camp related sport|1|||
155228845|NCT01574352|560275744|FG001|Overall Study|Injury in non-camp related sport|0|||
155228846|NCT06425458|560275745|FG000|Overall Study|Removed by study team|2|||
155228847|NCT06425458|560275745|FG000|Overall Study|Lost to Follow-up|5|||
155228848|NCT01340976|560277877|FG000|Overall Study|Physician Decision|2|||
155228849|NCT01340976|560277878|FG001|Overall Study|Physician Decision|0|||
155228850|NCT01340976|560277879|FG002|Overall Study|Physician Decision|1|||
155228851|NCT01340976|560277880|FG003|Overall Study|Physician Decision|1|||
155228852|NCT01340976|560277881|FG004|Overall Study|Physician Decision|1|||
155228853|NCT01340976|560277882|FG005|Overall Study|Physician Decision|0|||
155228854|NCT01340976|560277877|FG000|Overall Study|Death|0|||
155228855|NCT01340976|560277878|FG001|Overall Study|Death|1|||
155228856|NCT01340976|560277879|FG002|Overall Study|Death|0|||
155228857|NCT01340976|560277880|FG003|Overall Study|Death|0|||
155228858|NCT01340976|560277881|FG004|Overall Study|Death|0|||
155228859|NCT01340976|560277882|FG005|Overall Study|Death|0|||
155228860|NCT01340976|560277877|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
155228861|NCT01340976|560277878|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228862|NCT01340976|560277879|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228863|NCT01340976|560277880|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228864|NCT01340976|560277881|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228865|NCT01340976|560277882|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228866|NCT01340976|560277877|FG000|Overall Study|Withdrawal by Subject|0|||
155228867|NCT01340976|560277878|FG001|Overall Study|Withdrawal by Subject|0|||
155228868|NCT01340976|560277879|FG002|Overall Study|Withdrawal by Subject|0|||
155228869|NCT01340976|560277880|FG003|Overall Study|Withdrawal by Subject|1|||
155228870|NCT01340976|560277881|FG004|Overall Study|Withdrawal by Subject|1|||
155228871|NCT01340976|560277882|FG005|Overall Study|Withdrawal by Subject|0|||
155228872|NCT01340976|560277877|FG000|Overall Study|Other anemia treatment|1|||
155228873|NCT01340976|560277878|FG001|Overall Study|Other anemia treatment|0|||
155228874|NCT01340976|560277879|FG002|Overall Study|Other anemia treatment|2|||
155228875|NCT01340976|560277880|FG003|Overall Study|Other anemia treatment|1|||
155228876|NCT01340976|560277881|FG004|Overall Study|Other anemia treatment|0|||
155228877|NCT01340976|560277882|FG005|Overall Study|Other anemia treatment|1|||
155228878|NCT01340976|560277877|FG000|Overall Study|Adverse Event|0|||
155228879|NCT01340976|560277878|FG001|Overall Study|Adverse Event|1|||
155228880|NCT01340976|560277879|FG002|Overall Study|Adverse Event|0|||
155228881|NCT01340976|560277880|FG003|Overall Study|Adverse Event|0|||
155228882|NCT01340976|560277881|FG004|Overall Study|Adverse Event|0|||
155228883|NCT01340976|560277882|FG005|Overall Study|Adverse Event|0|||
155228884|NCT02953821|560277883|FG000|Overall Study|Adverse Event|0|||
155228885|NCT02953821|560277884|FG001|Overall Study|Adverse Event|4|||
155228886|NCT02953821|560277883|FG000|Overall Study|Death|1|||
155228887|NCT02953821|560277884|FG001|Overall Study|Death|0|||
155228888|NCT02953821|560277883|FG000|Overall Study|Progressive Disease|5|||
155228889|NCT02953821|560277884|FG001|Overall Study|Progressive Disease|1|||
155228890|NCT02953821|560277883|FG000|Overall Study|Lost to Follow-up|2|||
155228891|NCT02953821|560277884|FG001|Overall Study|Lost to Follow-up|0|||
155228892|NCT02953821|560277883|FG000|Overall Study|Physician Decision|1|||
155228893|NCT02953821|560277884|FG001|Overall Study|Physician Decision|1|||
155228894|NCT02953821|560277883|FG000|Overall Study|Withdrawal by Subject|3|||
155228895|NCT02953821|560277884|FG001|Overall Study|Withdrawal by Subject|3|||
155228896|NCT02953821|560277883|FG000|Overall Study|Change of address|0|||
155228897|NCT02953821|560277884|FG001|Overall Study|Change of address|1|||
155228898|NCT02953821|560277883|FG000|Overall Study|Lack of Efficacy|1|||
155228899|NCT02953821|560277884|FG001|Overall Study|Lack of Efficacy|0|||
155228900|NCT02953821|560277883|FG000|Overall Study|Out of state for indeterminate time|0|||
155228901|NCT02953821|560277884|FG001|Overall Study|Out of state for indeterminate time|1|||
155228902|NCT02953821|560277883|FG000|Overall Study|No improvement|0|||
155228903|NCT02953821|560277884|FG001|Overall Study|No improvement|1|||
155228904|NCT02953821|560277883|FG000|Overall Study|Refused follow-up visit|2|||
155228905|NCT02953821|560277884|FG001|Overall Study|Refused follow-up visit|1|||
155228906|NCT01067352|560277885|FG000|Overall Study|Withdrawal by Subject|1|||
155228907|NCT01067352|560277886|FG001|Overall Study|Withdrawal by Subject|2|||
155228908|NCT01067352|560277887|FG002|Overall Study|Withdrawal by Subject|1|||
155228909|NCT01067352|560277885|FG000|Overall Study|Physician Decision|0|||
155228910|NCT01067352|560277886|FG001|Overall Study|Physician Decision|1|||
155228911|NCT01067352|560277887|FG002|Overall Study|Physician Decision|0|||
155228912|NCT02566759|560277888|FG000|All Parts|Withdrawal by Subject|0|||
155228913|NCT02566759|560277889|FG001|All Parts|Withdrawal by Subject|1|||
155228914|NCT02566759|560277890|FG002|All Parts|Withdrawal by Subject|0|||
155228915|NCT02566759|560277891|FG003|All Parts|Withdrawal by Subject|0|||
155228916|NCT02566759|560277892|FG004|All Parts|Withdrawal by Subject|0|||
155228917|NCT02566759|560277893|FG005|All Parts|Withdrawal by Subject|0|||
155228918|NCT02566759|560277894|FG006|All Parts|Withdrawal by Subject|0|||
155228919|NCT02566759|560277895|FG007|All Parts|Withdrawal by Subject|0|||
155228920|NCT02566759|560277896|FG008|All Parts|Withdrawal by Subject|0|||
155228921|NCT02566759|560277897|FG009|All Parts|Withdrawal by Subject|0|||
155228922|NCT02566759|560277898|FG010|All Parts|Withdrawal by Subject|0|||
155228923|NCT02566759|560277899|FG011|All Parts|Withdrawal by Subject|0|||
155228924|NCT02566759|560277900|FG012|All Parts|Withdrawal by Subject|0|||
155228925|NCT02566759|560277901|FG013|All Parts|Withdrawal by Subject|0|||
155228926|NCT02566759|560277902|FG014|All Parts|Withdrawal by Subject|0|||
155228927|NCT02566759|560277903|FG015|All Parts|Withdrawal by Subject|0|||
155228928|NCT02566759|560277904|FG016|All Parts|Withdrawal by Subject|0|||
155228929|NCT02566759|560277888|FG000|All Parts|Adverse Event|0|||
155228930|NCT02566759|560277889|FG001|All Parts|Adverse Event|0|||
155228931|NCT02566759|560277890|FG002|All Parts|Adverse Event|0|||
155228932|NCT02566759|560277891|FG003|All Parts|Adverse Event|0|||
155228933|NCT02566759|560277892|FG004|All Parts|Adverse Event|0|||
155228934|NCT02566759|560277893|FG005|All Parts|Adverse Event|0|||
155228935|NCT02566759|560277894|FG006|All Parts|Adverse Event|0|||
155228936|NCT02566759|560277895|FG007|All Parts|Adverse Event|0|||
155228937|NCT02566759|560277896|FG008|All Parts|Adverse Event|0|||
155228938|NCT02566759|560277897|FG009|All Parts|Adverse Event|0|||
155228939|NCT02566759|560277898|FG010|All Parts|Adverse Event|0|||
155228940|NCT02566759|560277899|FG011|All Parts|Adverse Event|0|||
155228941|NCT02566759|560277900|FG012|All Parts|Adverse Event|1|||
155228942|NCT02566759|560277901|FG013|All Parts|Adverse Event|3|||
155228943|NCT02566759|560277902|FG014|All Parts|Adverse Event|0|||
155228944|NCT02566759|560277903|FG015|All Parts|Adverse Event|0|||
155228945|NCT02566759|560277904|FG016|All Parts|Adverse Event|0|||
155228946|NCT02566759|560277888|FG000|All Parts|Other|0|||
155228947|NCT02566759|560277889|FG001|All Parts|Other|0|||
155228948|NCT02566759|560277890|FG002|All Parts|Other|0|||
155228949|NCT02566759|560277891|FG003|All Parts|Other|0|||
155228950|NCT02566759|560277892|FG004|All Parts|Other|0|||
155228951|NCT02566759|560277893|FG005|All Parts|Other|0|||
155228952|NCT02566759|560277894|FG006|All Parts|Other|0|||
155228953|NCT02566759|560277895|FG007|All Parts|Other|0|||
155228954|NCT02566759|560277896|FG008|All Parts|Other|0|||
155228955|NCT02566759|560277897|FG009|All Parts|Other|0|||
155228956|NCT02566759|560277898|FG010|All Parts|Other|0|||
155228957|NCT02566759|560277899|FG011|All Parts|Other|0|||
155228958|NCT02566759|560277900|FG012|All Parts|Other|0|||
155228959|NCT02566759|560277901|FG013|All Parts|Other|2|||
155228960|NCT02566759|560277902|FG014|All Parts|Other|0|||
155228961|NCT02566759|560277903|FG015|All Parts|Other|0|||
155228962|NCT02566759|560277904|FG016|All Parts|Other|0|||
155228963|NCT02566759|560277888|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228964|NCT02566759|560277889|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228965|NCT02566759|560277890|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228966|NCT02566759|560277891|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228967|NCT02566759|560277892|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228968|NCT02566759|560277893|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228969|NCT02566759|560277894|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228970|NCT02566759|560277895|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228971|NCT02566759|560277896|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228972|NCT02566759|560277897|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228973|NCT02566759|560277898|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228974|NCT02566759|560277899|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228975|NCT02566759|560277900|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228976|NCT02566759|560277901|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228977|NCT02566759|560277902|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228978|NCT02566759|560277903|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228979|NCT02566759|560277904|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
155228980|NCT01096784|560277905|FG000|Overall Study|Withdrawal by Subject|2|||
155228981|NCT01096784|560277906|FG001|Overall Study|Withdrawal by Subject|1|||
155228982|NCT01096784|560277905|FG000|Overall Study|Adverse Event|11|||
155228983|NCT01096784|560277906|FG001|Overall Study|Adverse Event|9|||
155228984|NCT01096784|560277905|FG000|Overall Study|Protocol Deviation|2|||
155228985|NCT01096784|560277906|FG001|Overall Study|Protocol Deviation|2|||
155228986|NCT01096784|560277905|FG000|Overall Study|Administrative Decision|0|||
155228987|NCT01096784|560277906|FG001|Overall Study|Administrative Decision|1|||
155228988|NCT01096784|560277905|FG000|Overall Study|Other Unspecified|0|||
155228989|NCT01096784|560277906|FG001|Overall Study|Other Unspecified|1|||
155228990|NCT00976898|560277907|FG000|Overall Study|Protocol Violation|1|||
155228991|NCT00976898|560277907|FG000|Overall Study|Adverse Event|1|||
155228992|NCT00976898|560277907|FG000|Overall Study|Physician Decision|1|||
155228993|NCT00976898|560277907|FG000|Overall Study|Liver Transplant|1|||
155228994|NCT00976898|560277907|FG000|Overall Study|Progressive Disease|1|||
155228995|NCT05107128|560277908|FG000|Overall Study|Adverse Event|2|||
155228996|NCT05107128|560277909|FG001|Overall Study|Adverse Event|0|||
155228997|NCT05107128|560277908|FG000|Overall Study|Withdrawal by Subject|3|||
155228998|NCT05107128|560277909|FG001|Overall Study|Withdrawal by Subject|3|||
155228999|NCT05107128|560277908|FG000|Overall Study|Withdrawal of Consent|0|||
155229000|NCT05107128|560277909|FG001|Overall Study|Withdrawal of Consent|1|||
155229001|NCT05107128|560277908|FG000|Overall Study|Reason Not Specified|2|||
155229002|NCT05107128|560277909|FG001|Overall Study|Reason Not Specified|0|||
155229003|NCT03761628|560277910|FG000|Overall Study|Withdrawal by Subject|3|||
155229004|NCT03761628|560277910|FG000|Overall Study|Physician Decision|1|||
155229005|NCT03761628|560277910|FG000|Overall Study|Pregnancy|1|||
155229006|NCT03761628|560277910|FG000|Overall Study|Lost to Follow-up|1|||
155229007|NCT05459129|560277913|FG000|Overall Study|Death|1|||
155229008|NCT05459129|560277914|FG001|Overall Study|Death|0|||
155229009|NCT05459129|560277913|FG000|Overall Study|Study Terminated By Sponsor|5|||
155229010|NCT05459129|560277914|FG001|Overall Study|Study Terminated By Sponsor|6|||
155229011|NCT03064126|560277915|FG000|Overall Study|Death|40|||
155229012|NCT03064126|560277916|FG001|Overall Study|Death|16|||
155229013|NCT03064126|560277917|FG002|Overall Study|Death|4|||
155229014|NCT03064126|560277918|FG003|Overall Study|Death|2|||
155229015|NCT03064126|560277915|FG000|Overall Study|Withdrawal by Subject|17|||
155229016|NCT03064126|560277916|FG001|Overall Study|Withdrawal by Subject|9|||
155229017|NCT03064126|560277917|FG002|Overall Study|Withdrawal by Subject|0|||
155229018|NCT03064126|560277918|FG003|Overall Study|Withdrawal by Subject|2|||
155229019|NCT03064126|560277915|FG000|Overall Study|Lost to Follow-up|7|||
155229020|NCT03064126|560277916|FG001|Overall Study|Lost to Follow-up|3|||
155229021|NCT03064126|560277917|FG002|Overall Study|Lost to Follow-up|0|||
155229022|NCT03064126|560277918|FG003|Overall Study|Lost to Follow-up|0|||
155229023|NCT03064126|560277915|FG000|Overall Study|Adverse Event|2|||
155229024|NCT03064126|560277916|FG001|Overall Study|Adverse Event|0|||
155229025|NCT03064126|560277917|FG002|Overall Study|Adverse Event|0|||
155229026|NCT03064126|560277918|FG003|Overall Study|Adverse Event|0|||
155229027|NCT03064126|560277915|FG000|Overall Study|Physician Decision|3|||
155229028|NCT03064126|560277916|FG001|Overall Study|Physician Decision|0|||
155229029|NCT03064126|560277917|FG002|Overall Study|Physician Decision|0|||
155229030|NCT03064126|560277918|FG003|Overall Study|Physician Decision|0|||
155229031|NCT03064126|560277915|FG000|Overall Study|Other reason for early termination|3|||
155229032|NCT03064126|560277916|FG001|Overall Study|Other reason for early termination|2|||
155229033|NCT03064126|560277917|FG002|Overall Study|Other reason for early termination|0|||
155229034|NCT03064126|560277918|FG003|Overall Study|Other reason for early termination|0|||
155229035|NCT03064126|560277915|FG000|Overall Study|Missed Visit|3|||
155229036|NCT03064126|560277916|FG001|Overall Study|Missed Visit|1|||
155229037|NCT03064126|560277917|FG002|Overall Study|Missed Visit|0|||
155229038|NCT03064126|560277918|FG003|Overall Study|Missed Visit|0|||
155229039|NCT04649151|560277924|FG000|Overall Study|Pregnancy|0|||
155229040|NCT04649151|560277925|FG001|Overall Study|Pregnancy|0|||
155229041|NCT04649151|560277926|FG002|Overall Study|Pregnancy|0|||
155229042|NCT04649151|560277927|FG003|Overall Study|Pregnancy|0|||
155229043|NCT04649151|560277928|FG004|Overall Study|Pregnancy|3|||
155229044|NCT04649151|560277924|FG000|Overall Study|Physician Decision|10|||
155229045|NCT04649151|560277925|FG001|Overall Study|Physician Decision|0|||
155229046|NCT04649151|560277926|FG002|Overall Study|Physician Decision|0|||
155229047|NCT04649151|560277927|FG003|Overall Study|Physician Decision|1|||
155229048|NCT04649151|560277928|FG004|Overall Study|Physician Decision|1|||
155229049|NCT04649151|560277924|FG000|Overall Study|Protocol Deviation|25|||
155229050|NCT04649151|560277925|FG001|Overall Study|Protocol Deviation|3|||
155229051|NCT04649151|560277926|FG002|Overall Study|Protocol Deviation|0|||
155229052|NCT04649151|560277927|FG003|Overall Study|Protocol Deviation|0|||
155229053|NCT04649151|560277928|FG004|Overall Study|Protocol Deviation|0|||
155229054|NCT04649151|560277924|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
155229055|NCT04649151|560277925|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
155229056|NCT04649151|560277926|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229057|NCT04649151|560277927|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229058|NCT04649151|560277928|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229059|NCT04649151|560277924|FG000|Overall Study|Withdrawal by Subject|370|||
155229060|NCT04649151|560277925|FG001|Overall Study|Withdrawal by Subject|113|||
155229061|NCT04649151|560277926|FG002|Overall Study|Withdrawal by Subject|2|||
155229062|NCT04649151|560277927|FG003|Overall Study|Withdrawal by Subject|7|||
155229063|NCT04649151|560277928|FG004|Overall Study|Withdrawal by Subject|15|||
155229064|NCT04649151|560277924|FG000|Overall Study|Adverse Event|1|||
155229065|NCT04649151|560277925|FG001|Overall Study|Adverse Event|0|||
155229066|NCT04649151|560277926|FG002|Overall Study|Adverse Event|0|||
155229067|NCT04649151|560277927|FG003|Overall Study|Adverse Event|0|||
155229068|NCT04649151|560277928|FG004|Overall Study|Adverse Event|0|||
155229069|NCT04649151|560277924|FG000|Overall Study|Lost to Follow-up|256|||
155229070|NCT04649151|560277925|FG001|Overall Study|Lost to Follow-up|29|||
155229071|NCT04649151|560277926|FG002|Overall Study|Lost to Follow-up|10|||
155229072|NCT04649151|560277927|FG003|Overall Study|Lost to Follow-up|3|||
155229073|NCT04649151|560277928|FG004|Overall Study|Lost to Follow-up|6|||
155229074|NCT04649151|560277924|FG000|Overall Study|Other than specified|59|||
155229075|NCT04649151|560277925|FG001|Overall Study|Other than specified|294|||
155229076|NCT04649151|560277926|FG002|Overall Study|Other than specified|0|||
155229077|NCT04649151|560277927|FG003|Overall Study|Other than specified|0|||
155229078|NCT04649151|560277928|FG004|Overall Study|Other than specified|4|||
155229079|NCT04649151|560277924|FG000|Overall Study|Death|0|||
155229080|NCT04649151|560277925|FG001|Overall Study|Death|0|||
155229081|NCT04649151|560277926|FG002|Overall Study|Death|0|||
155229082|NCT04649151|560277927|FG003|Overall Study|Death|0|||
155229083|NCT04649151|560277928|FG004|Overall Study|Death|1|||
155229084|NCT04476017|560277929|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
155229085|NCT04476017|560277930|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
155229086|NCT03909165|560277938|FG000|Overall Study|Physician Decision|0|||
155229087|NCT03909165|560277939|FG001|Overall Study|Physician Decision|1|||
155229088|NCT03909165|560277940|FG002|Overall Study|Physician Decision|0|||
155229089|NCT03909165|560277941|FG003|Overall Study|Physician Decision|0|||
155229090|NCT03909165|560277942|FG004|Overall Study|Physician Decision|0|||
155229091|NCT03909165|560277938|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229092|NCT03909165|560277939|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229093|NCT03909165|560277940|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229094|NCT03909165|560277941|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229095|NCT03909165|560277942|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155229096|NCT03909165|560277938|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155229097|NCT03909165|560277939|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
155229098|NCT03909165|560277940|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
155229099|NCT03909165|560277941|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
155229100|NCT03909165|560277942|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
155229101|NCT03909165|560277938|FG000|Overall Study|Previous Drug Exposure|0|||
155229102|NCT03909165|560277939|FG001|Overall Study|Previous Drug Exposure|0|||
155229103|NCT03909165|560277940|FG002|Overall Study|Previous Drug Exposure|1|||
155229104|NCT03909165|560277941|FG003|Overall Study|Previous Drug Exposure|0|||
155229105|NCT03909165|560277942|FG004|Overall Study|Previous Drug Exposure|0|||
155229106|NCT03909165|560277938|FG000|Overall Study|Early Discharge|1|||
155229107|NCT03909165|560277939|FG001|Overall Study|Early Discharge|0|||
155229108|NCT03909165|560277940|FG002|Overall Study|Early Discharge|0|||
155229109|NCT03909165|560277941|FG003|Overall Study|Early Discharge|0|||
155229110|NCT03909165|560277942|FG004|Overall Study|Early Discharge|0|||
155229111|NCT06034496|560277943|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
155229112|NCT06034496|560277944|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
155229113|NCT06034496|560277943|FG000|Overall Study|Withdrawal by Subject|5|||
155229114|NCT06034496|560277944|FG001|Overall Study|Withdrawal by Subject|4|||
155229115|NCT02018458|560277945|FG000|Overall Study|Death|4|||
155229116|NCT01428193|560277948|FG000|Overall Study|Physician Decision|1|||
155229117|NCT01428193|560277948|FG000|Overall Study|Elevated screening liver enzymes|1|||
155229118|NCT03277261|560277953|FG000|Overall Study|Adverse Event|17|||
155229119|NCT03277261|560277954|FG001|Overall Study|Adverse Event|1|||
155229120|NCT03277261|560277953|FG000|Overall Study|Participant Withdrawal of Consent|6|||
155229121|NCT03277261|560277954|FG001|Overall Study|Participant Withdrawal of Consent|15|||
155229122|NCT03277261|560277953|FG000|Overall Study|Investigator / Sponsor Decision|4|||
155229123|NCT03277261|560277954|FG001|Overall Study|Investigator / Sponsor Decision|2|||
155229124|NCT03277261|560277953|FG000|Overall Study|Pregnancy|2|||
155229125|NCT03277261|560277954|FG001|Overall Study|Pregnancy|0|||
155229126|NCT03277261|560277953|FG000|Overall Study|Lost to Follow-up|2|||
155229127|NCT03277261|560277954|FG001|Overall Study|Lost to Follow-up|2|||
155229128|NCT03277261|560277953|FG000|Overall Study|Lack of Efficacy|2|||
155229129|NCT03277261|560277954|FG001|Overall Study|Lack of Efficacy|2|||
155229130|NCT03277261|560277953|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
155229131|NCT03277261|560277954|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
155229132|NCT03762083|560277955|FG000|Overall Study|Withdrawal by Subject|2|||
155229133|NCT03762083|560277955|FG000|Overall Study|Physician Decision|1|||
155229134|NCT03491150|560277956|FG000|Overall Study|Adverse Event|1|||
155229135|NCT03491150|560277957|FG001|Overall Study|Adverse Event|0|||
155229136|NCT03491150|560277956|FG000|Overall Study|Study Terminated by Sponsor|74|||
155229137|NCT03491150|560277957|FG001|Overall Study|Study Terminated by Sponsor|70|||
155229138|NCT03491150|560277956|FG000|Overall Study|Other|0|||
155229139|NCT03491150|560277957|FG001|Overall Study|Other|1|||
155229140|NCT03491150|560277956|FG000|Overall Study|Withdrawal by Subject|1|||
155229141|NCT03491150|560277957|FG001|Overall Study|Withdrawal by Subject|2|||
155229142|NCT00937547|560277966|FG000|Overall Study|misdiagnosis|1|||
155229143|NCT00937547|560277967|FG001|Overall Study|misdiagnosis|6|||
155229144|NCT00937547|560277968|FG002|Overall Study|misdiagnosis|7|||
155229145|NCT00325234|560277969|FG000|Overall Study|Adverse Event|10|||
155229146|NCT00325234|560277970|FG001|Overall Study|Adverse Event|7|||
155229147|NCT00325234|560277969|FG000|Overall Study|Death due to Study Disease|1|||
155229148|NCT00325234|560277970|FG001|Overall Study|Death due to Study Disease|0|||
155229149|NCT00325234|560277969|FG000|Overall Study|Entry Criteria Not Met|1|||
155229150|NCT00325234|560277970|FG001|Overall Study|Entry Criteria Not Met|2|||
155229151|NCT00325234|560277969|FG000|Overall Study|Subject Decision|6|||
155229152|NCT00325234|560277970|FG001|Overall Study|Subject Decision|8|||
155229153|NCT00325234|560277969|FG000|Overall Study|Physician Decision|17|||
155229154|NCT00325234|560277970|FG001|Overall Study|Physician Decision|12|||
155229155|NCT00325234|560277969|FG000|Overall Study|Progressive Disease|34|||
155229156|NCT00325234|560277970|FG001|Overall Study|Progressive Disease|37|||
155229157|NCT01234467|560277971|FG000|Overall Study|Adverse Event|3|||
155229158|NCT01234467|560277971|FG000|Overall Study|Death|2|||
155229159|NCT01234467|560277971|FG000|Overall Study|Withdrawal by Subject|2|||
155229160|NCT01234467|560277971|FG000|Overall Study|Disease Progression|2|||
155229161|NCT01234467|560277971|FG000|Overall Study|Clinical deterioration|1|||
155229162|NCT01234467|560277971|FG000|Overall Study|Physician Decision|1|||
155229163|NCT01234467|560277971|FG000|Overall Study|Other complicating disease (stroke)|1|||
155229164|NCT02644967|560277975|FG000|Overall Study|Death|26|||
155229165|NCT02644967|560277975|FG000|Overall Study|Physician Decision|1|||
155229166|NCT02644967|560277975|FG000|Overall Study|Withdrawal by Subject|2|||
155229167|NCT02644967|560277975|FG000|Overall Study|Protocol Violation|1|||
155229168|NCT02644967|560277975|FG000|Overall Study|Progressive Disease|1|||
155229169|NCT02644967|560277975|FG000|Overall Study|Study Terminated by Sponsor|4|||
155229170|NCT02287896|560277976|FG000|Second Injection Visit|Withdrawal by Subject|0|||
155229171|NCT02287896|560277977|FG001|Second Injection Visit|Withdrawal by Subject|1|||
155229172|NCT05179421|560277978|FG000|First Infusion Day|Adverse Event|1|||
155229173|NCT05179421|560277979|FG001|First Infusion Day|Adverse Event|0|||
155229174|NCT03746522|560277981|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
155229175|NCT03746522|560277982|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
155229176|NCT03746522|560277983|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
155229177|NCT03746522|560277981|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
155229178|NCT03746522|560277982|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
155229179|NCT03746522|560277983|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
155229180|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
155229181|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
155229182|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
155229183|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
155229184|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
155229185|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
155229186|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
155229187|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
155229188|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
155229189|NCT01639040|560277984|FG000|Overall Study|Adverse Event|1|||
155229190|NCT01639040|560277985|FG001|Overall Study|Adverse Event|0|||
155229191|NCT01077960|560277989|FG000|Overall Study|Adverse Event|6|||
155229192|NCT01077960|560277989|FG000|Overall Study|Protocol Violation|3|||
155229193|NCT01077960|560277989|FG000|Overall Study|Lost to Follow-up|5|||
155229194|NCT01077960|560277989|FG000|Overall Study|Subject decision|1|||
155229195|NCT01077960|560277989|FG000|Overall Study|Reason unspecified|1|||
155229196|NCT02457598|560277990|FG000|Overall Study|Progressive Disease|2|||
155229197|NCT02457598|560277991|FG001|Overall Study|Progressive Disease|2|||
155229198|NCT02457598|560277992|FG002|Overall Study|Progressive Disease|1|||
155229199|NCT02457598|560277993|FG003|Overall Study|Progressive Disease|11|||
155229200|NCT02457598|560277994|FG004|Overall Study|Progressive Disease|7|||
155229201|NCT02457598|560277995|FG005|Overall Study|Progressive Disease|3|||
155229202|NCT02457598|560277996|FG006|Overall Study|Progressive Disease|2|||
155229203|NCT02457598|560277997|FG007|Overall Study|Progressive Disease|1|||
155229204|NCT02457598|560277998|FG008|Overall Study|Progressive Disease|1|||
155229205|NCT02457598|560277999|FG009|Overall Study|Progressive Disease|2|||
155229206|NCT02457598|560278000|FG010|Overall Study|Progressive Disease|45|||
155229207|NCT02457598|560278001|FG011|Overall Study|Progressive Disease|6|||
155229208|NCT02457598|560278002|FG012|Overall Study|Progressive Disease|2|||
155229209|NCT02457598|560278003|FG013|Overall Study|Progressive Disease|2|||
155229210|NCT02457598|560278004|FG014|Overall Study|Progressive Disease|10|||
155229211|NCT02457598|560278005|FG015|Overall Study|Progressive Disease|1|||
155229212|NCT02457598|560278006|FG016|Overall Study|Progressive Disease|1|||
155229213|NCT02457598|560277990|FG000|Overall Study|Investigator's Discretion|0|||
155229214|NCT02457598|560277991|FG001|Overall Study|Investigator's Discretion|2|||
155229215|NCT02457598|560277992|FG002|Overall Study|Investigator's Discretion|2|||
155229216|NCT02457598|560277993|FG003|Overall Study|Investigator's Discretion|2|||
155229217|NCT02457598|560277994|FG004|Overall Study|Investigator's Discretion|0|||
155229218|NCT02457598|560277995|FG005|Overall Study|Investigator's Discretion|0|||
155229219|NCT02457598|560277996|FG006|Overall Study|Investigator's Discretion|0|||
155229220|NCT02457598|560277997|FG007|Overall Study|Investigator's Discretion|1|||
155229221|NCT02457598|560277998|FG008|Overall Study|Investigator's Discretion|2|||
155229222|NCT02457598|560277999|FG009|Overall Study|Investigator's Discretion|0|||
155229223|NCT02457598|560278000|FG010|Overall Study|Investigator's Discretion|10|||
155229224|NCT02457598|560278001|FG011|Overall Study|Investigator's Discretion|2|||
155229225|NCT02457598|560278002|FG012|Overall Study|Investigator's Discretion|2|||
155229226|NCT02457598|560278003|FG013|Overall Study|Investigator's Discretion|1|||
155229227|NCT02457598|560278004|FG014|Overall Study|Investigator's Discretion|5|||
155229228|NCT02457598|560278005|FG015|Overall Study|Investigator's Discretion|0|||
155229229|NCT02457598|560278006|FG016|Overall Study|Investigator's Discretion|0|||
155229230|NCT02457598|560277990|FG000|Overall Study|Study Terminated by Sponsor|0|||
155229231|NCT02457598|560277991|FG001|Overall Study|Study Terminated by Sponsor|1|||
155229232|NCT02457598|560277992|FG002|Overall Study|Study Terminated by Sponsor|0|||
155229233|NCT02457598|560277993|FG003|Overall Study|Study Terminated by Sponsor|4|||
155229234|NCT02457598|560277994|FG004|Overall Study|Study Terminated by Sponsor|1|||
155229235|NCT02457598|560277995|FG005|Overall Study|Study Terminated by Sponsor|0|||
155229236|NCT02457598|560277996|FG006|Overall Study|Study Terminated by Sponsor|1|||
155229237|NCT02457598|560277997|FG007|Overall Study|Study Terminated by Sponsor|0|||
155229238|NCT02457598|560277998|FG008|Overall Study|Study Terminated by Sponsor|0|||
155229239|NCT02457598|560277999|FG009|Overall Study|Study Terminated by Sponsor|0|||
155229240|NCT02457598|560278000|FG010|Overall Study|Study Terminated by Sponsor|4|||
155229241|NCT02457598|560278001|FG011|Overall Study|Study Terminated by Sponsor|0|||
155229242|NCT02457598|560278002|FG012|Overall Study|Study Terminated by Sponsor|1|||
155229243|NCT02457598|560278003|FG013|Overall Study|Study Terminated by Sponsor|0|||
155229244|NCT02457598|560278004|FG014|Overall Study|Study Terminated by Sponsor|8|||
155229245|NCT02457598|560278005|FG015|Overall Study|Study Terminated by Sponsor|1|||
155229246|NCT02457598|560278006|FG016|Overall Study|Study Terminated by Sponsor|0|||
155229247|NCT02457598|560277990|FG000|Overall Study|Adverse Event|0|||
155229248|NCT02457598|560277991|FG001|Overall Study|Adverse Event|1|||
155229249|NCT02457598|560277992|FG002|Overall Study|Adverse Event|1|||
155229250|NCT02457598|560277993|FG003|Overall Study|Adverse Event|4|||
155229251|NCT02457598|560277994|FG004|Overall Study|Adverse Event|1|||
155229252|NCT02457598|560277995|FG005|Overall Study|Adverse Event|0|||
155229253|NCT02457598|560277996|FG006|Overall Study|Adverse Event|0|||
155229254|NCT02457598|560277997|FG007|Overall Study|Adverse Event|1|||
155229255|NCT02457598|560277998|FG008|Overall Study|Adverse Event|0|||
155229256|NCT02457598|560277999|FG009|Overall Study|Adverse Event|1|||
155229257|NCT02457598|560278000|FG010|Overall Study|Adverse Event|6|||
155229258|NCT02457598|560278001|FG011|Overall Study|Adverse Event|0|||
155229259|NCT02457598|560278002|FG012|Overall Study|Adverse Event|0|||
155229260|NCT02457598|560278003|FG013|Overall Study|Adverse Event|1|||
155229261|NCT02457598|560278004|FG014|Overall Study|Adverse Event|2|||
155229262|NCT02457598|560278005|FG015|Overall Study|Adverse Event|0|||
155229263|NCT02457598|560278006|FG016|Overall Study|Adverse Event|0|||
155229264|NCT02457598|560277990|FG000|Overall Study|Death|0|||
155229265|NCT02457598|560277991|FG001|Overall Study|Death|0|||
155229266|NCT02457598|560277992|FG002|Overall Study|Death|0|||
155229267|NCT02457598|560277993|FG003|Overall Study|Death|3|||
155229268|NCT02457598|560277994|FG004|Overall Study|Death|0|||
155229269|NCT02457598|560277995|FG005|Overall Study|Death|1|||
155229270|NCT02457598|560277996|FG006|Overall Study|Death|0|||
155229271|NCT02457598|560277997|FG007|Overall Study|Death|0|||
155229272|NCT02457598|560277998|FG008|Overall Study|Death|0|||
155229273|NCT02457598|560277999|FG009|Overall Study|Death|0|||
155229274|NCT02457598|560278000|FG010|Overall Study|Death|3|||
155229275|NCT02457598|560278001|FG011|Overall Study|Death|0|||
155229276|NCT02457598|560278002|FG012|Overall Study|Death|0|||
155229277|NCT02457598|560278003|FG013|Overall Study|Death|1|||
155229278|NCT02457598|560278004|FG014|Overall Study|Death|2|||
155229279|NCT02457598|560278005|FG015|Overall Study|Death|0|||
155229280|NCT02457598|560278006|FG016|Overall Study|Death|1|||
155229281|NCT02457598|560277990|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229282|NCT02457598|560277991|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
155229283|NCT02457598|560277992|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229284|NCT02457598|560277993|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229285|NCT02457598|560277994|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229286|NCT02457598|560277995|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229287|NCT02457598|560277996|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229288|NCT02457598|560277997|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229289|NCT02457598|560277998|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229290|NCT02457598|560277999|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229291|NCT02457598|560278000|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
155229292|NCT02457598|560278001|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229293|NCT02457598|560278002|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229294|NCT02457598|560278003|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229295|NCT02457598|560278004|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229296|NCT02457598|560278005|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229297|NCT02457598|560278006|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229298|NCT02457598|560277990|FG000|Overall Study|Withdrew Consent|0|||
155229299|NCT02457598|560277991|FG001|Overall Study|Withdrew Consent|0|||
155229300|NCT02457598|560277992|FG002|Overall Study|Withdrew Consent|0|||
155229301|NCT02457598|560277993|FG003|Overall Study|Withdrew Consent|0|||
155229302|NCT02457598|560277994|FG004|Overall Study|Withdrew Consent|0|||
155229303|NCT02457598|560277995|FG005|Overall Study|Withdrew Consent|0|||
155229304|NCT02457598|560277996|FG006|Overall Study|Withdrew Consent|0|||
155229305|NCT02457598|560277997|FG007|Overall Study|Withdrew Consent|2|||
155229306|NCT02457598|560277998|FG008|Overall Study|Withdrew Consent|0|||
155229307|NCT02457598|560277999|FG009|Overall Study|Withdrew Consent|0|||
155229308|NCT02457598|560278000|FG010|Overall Study|Withdrew Consent|3|||
155229309|NCT02457598|560278001|FG011|Overall Study|Withdrew Consent|0|||
155229310|NCT02457598|560278002|FG012|Overall Study|Withdrew Consent|0|||
155229311|NCT02457598|560278003|FG013|Overall Study|Withdrew Consent|1|||
155229312|NCT02457598|560278004|FG014|Overall Study|Withdrew Consent|0|||
155229313|NCT02457598|560278005|FG015|Overall Study|Withdrew Consent|0|||
155229314|NCT02457598|560278006|FG016|Overall Study|Withdrew Consent|0|||
155229315|NCT02457598|560277990|FG000|Overall Study|Unacceptable Toxicity|0|||
155229316|NCT02457598|560277991|FG001|Overall Study|Unacceptable Toxicity|0|||
155229317|NCT02457598|560277992|FG002|Overall Study|Unacceptable Toxicity|0|||
155229318|NCT02457598|560277993|FG003|Overall Study|Unacceptable Toxicity|0|||
155229319|NCT02457598|560277994|FG004|Overall Study|Unacceptable Toxicity|0|||
155229320|NCT02457598|560277995|FG005|Overall Study|Unacceptable Toxicity|0|||
155229321|NCT02457598|560277996|FG006|Overall Study|Unacceptable Toxicity|0|||
155229322|NCT02457598|560277997|FG007|Overall Study|Unacceptable Toxicity|0|||
155229323|NCT02457598|560277998|FG008|Overall Study|Unacceptable Toxicity|0|||
155229324|NCT02457598|560277999|FG009|Overall Study|Unacceptable Toxicity|0|||
155229325|NCT02457598|560278000|FG010|Overall Study|Unacceptable Toxicity|1|||
155229326|NCT02457598|560278001|FG011|Overall Study|Unacceptable Toxicity|0|||
155229327|NCT02457598|560278002|FG012|Overall Study|Unacceptable Toxicity|1|||
155229328|NCT02457598|560278003|FG013|Overall Study|Unacceptable Toxicity|1|||
155229329|NCT02457598|560278004|FG014|Overall Study|Unacceptable Toxicity|1|||
155229330|NCT02457598|560278005|FG015|Overall Study|Unacceptable Toxicity|0|||
155229331|NCT02457598|560278006|FG016|Overall Study|Unacceptable Toxicity|0|||
155229332|NCT02457598|560277990|FG000|Overall Study|Intercurrent Illness|0|||
155229333|NCT02457598|560277991|FG001|Overall Study|Intercurrent Illness|0|||
155229334|NCT02457598|560277992|FG002|Overall Study|Intercurrent Illness|0|||
155229335|NCT02457598|560277993|FG003|Overall Study|Intercurrent Illness|0|||
155229336|NCT02457598|560277994|FG004|Overall Study|Intercurrent Illness|0|||
155229337|NCT02457598|560277995|FG005|Overall Study|Intercurrent Illness|0|||
155229338|NCT02457598|560277996|FG006|Overall Study|Intercurrent Illness|0|||
155229339|NCT02457598|560277997|FG007|Overall Study|Intercurrent Illness|0|||
155229340|NCT02457598|560277998|FG008|Overall Study|Intercurrent Illness|0|||
155229341|NCT02457598|560277999|FG009|Overall Study|Intercurrent Illness|0|||
155229342|NCT02457598|560278000|FG010|Overall Study|Intercurrent Illness|1|||
155229343|NCT02457598|560278001|FG011|Overall Study|Intercurrent Illness|0|||
155229344|NCT02457598|560278002|FG012|Overall Study|Intercurrent Illness|0|||
155229345|NCT02457598|560278003|FG013|Overall Study|Intercurrent Illness|0|||
155229346|NCT02457598|560278004|FG014|Overall Study|Intercurrent Illness|0|||
155229347|NCT02457598|560278005|FG015|Overall Study|Intercurrent Illness|0|||
155229348|NCT02457598|560278006|FG016|Overall Study|Intercurrent Illness|0|||
155229349|NCT02457598|560277990|FG000|Overall Study|Protocol Violation|0|||
155229350|NCT02457598|560277991|FG001|Overall Study|Protocol Violation|0|||
155229351|NCT02457598|560277992|FG002|Overall Study|Protocol Violation|0|||
155229352|NCT02457598|560277993|FG003|Overall Study|Protocol Violation|0|||
155229353|NCT02457598|560277994|FG004|Overall Study|Protocol Violation|0|||
155229354|NCT02457598|560277995|FG005|Overall Study|Protocol Violation|0|||
155229355|NCT02457598|560277996|FG006|Overall Study|Protocol Violation|0|||
155229356|NCT02457598|560277997|FG007|Overall Study|Protocol Violation|0|||
155229357|NCT02457598|560277998|FG008|Overall Study|Protocol Violation|0|||
155229358|NCT02457598|560277999|FG009|Overall Study|Protocol Violation|0|||
155229359|NCT02457598|560278000|FG010|Overall Study|Protocol Violation|1|||
155229360|NCT02457598|560278001|FG011|Overall Study|Protocol Violation|0|||
155229361|NCT02457598|560278002|FG012|Overall Study|Protocol Violation|0|||
155229362|NCT02457598|560278003|FG013|Overall Study|Protocol Violation|0|||
155229363|NCT02457598|560278004|FG014|Overall Study|Protocol Violation|0|||
155229364|NCT02457598|560278005|FG015|Overall Study|Protocol Violation|0|||
155229365|NCT02457598|560278006|FG016|Overall Study|Protocol Violation|0|||
155229366|NCT03837899|560278007|FG000|Overall Study|Death|6|||
155229367|NCT03837899|560278008|FG001|Overall Study|Death|8|||
155229368|NCT03837899|560278009|FG002|Overall Study|Death|3|||
155229369|NCT03837899|560278010|FG003|Overall Study|Death|7|||
155229370|NCT03837899|560278011|FG004|Overall Study|Death|8|||
155229371|NCT03837899|560278012|FG005|Overall Study|Death|7|||
155229372|NCT03837899|560278007|FG000|Overall Study|Moved to post-trial access program|0|||
155229373|NCT03837899|560278008|FG001|Overall Study|Moved to post-trial access program|1|||
155229374|NCT03837899|560278009|FG002|Overall Study|Moved to post-trial access program|0|||
155229375|NCT03837899|560278010|FG003|Overall Study|Moved to post-trial access program|0|||
155229376|NCT03837899|560278011|FG004|Overall Study|Moved to post-trial access program|0|||
155229377|NCT03837899|560278012|FG005|Overall Study|Moved to post-trial access program|0|||
155229378|NCT03837899|560278007|FG000|Overall Study|Other|0|||
155229379|NCT03837899|560278008|FG001|Overall Study|Other|0|||
155229380|NCT03837899|560278009|FG002|Overall Study|Other|0|||
155229381|NCT03837899|560278010|FG003|Overall Study|Other|0|||
155229382|NCT03837899|560278011|FG004|Overall Study|Other|0|||
155229383|NCT03837899|560278012|FG005|Overall Study|Other|2|||
155229384|NCT03837899|560278007|FG000|Overall Study|Lost to Follow-up|0|||
155229385|NCT03837899|560278008|FG001|Overall Study|Lost to Follow-up|1|||
155229386|NCT03837899|560278009|FG002|Overall Study|Lost to Follow-up|0|||
155229387|NCT03837899|560278010|FG003|Overall Study|Lost to Follow-up|0|||
155229388|NCT03837899|560278011|FG004|Overall Study|Lost to Follow-up|0|||
155229389|NCT03837899|560278012|FG005|Overall Study|Lost to Follow-up|0|||
155229390|NCT03837899|560278007|FG000|Overall Study|Withdrawal by Subject|0|||
155229391|NCT03837899|560278008|FG001|Overall Study|Withdrawal by Subject|0|||
155229392|NCT03837899|560278009|FG002|Overall Study|Withdrawal by Subject|0|||
155229393|NCT03837899|560278010|FG003|Overall Study|Withdrawal by Subject|1|||
155229394|NCT03837899|560278011|FG004|Overall Study|Withdrawal by Subject|0|||
155229395|NCT03837899|560278012|FG005|Overall Study|Withdrawal by Subject|0|||
155229396|NCT03837899|560278007|FG000|Overall Study|Study specific discontinuation criteria|0|||
155229397|NCT03837899|560278008|FG001|Overall Study|Study specific discontinuation criteria|1|||
155229398|NCT03837899|560278009|FG002|Overall Study|Study specific discontinuation criteria|0|||
155229399|NCT03837899|560278010|FG003|Overall Study|Study specific discontinuation criteria|0|||
155229400|NCT03837899|560278011|FG004|Overall Study|Study specific discontinuation criteria|3|||
155229401|NCT03837899|560278012|FG005|Overall Study|Study specific discontinuation criteria|1|||
155229402|NCT00393939|560278016|FG000|Overall Study|Protocol Violation|1|||
155229403|NCT00393939|560278017|FG001|Overall Study|Protocol Violation|1|||
155229404|NCT00393939|560278016|FG000|Overall Study|Lost to Follow-up|2|||
155229405|NCT00393939|560278017|FG001|Overall Study|Lost to Follow-up|4|||
155229406|NCT00393939|560278016|FG000|Overall Study|Death|10|||
155229407|NCT00393939|560278017|FG001|Overall Study|Death|4|||
155229408|NCT00393939|560278016|FG000|Overall Study|Sponsor|5|||
155229409|NCT00393939|560278017|FG001|Overall Study|Sponsor|13|||
155229410|NCT00393939|560278016|FG000|Overall Study|Objective progression or relapse|239|||
155229411|NCT00393939|560278017|FG001|Overall Study|Objective progression or relapse|223|||
155229412|NCT00393939|560278016|FG000|Overall Study|Withdrawal by Subject|2|||
155229413|NCT00393939|560278017|FG001|Overall Study|Withdrawal by Subject|7|||
155229414|NCT00393939|560278016|FG000|Overall Study|Other|37|||
155229415|NCT00393939|560278017|FG001|Overall Study|Other|45|||
155229416|NCT01494610|560278018|FG000|Period 1|Withdrawal by Subject|1|||
155229417|NCT01494610|560278019|FG001|Period 1|Withdrawal by Subject|1|||
155229418|NCT01494610|560278018|FG000|Period 3|Adverse Event|1|||
155229419|NCT01494610|560278019|FG001|Period 3|Adverse Event|0|||
155229420|NCT01494610|560278018|FG000|Period 3|Withdrawal by Subject|1|||
155229421|NCT01494610|560278019|FG001|Period 3|Withdrawal by Subject|0|||
155229422|NCT01494610|560278018|FG000|Period 4|Protocol Violation|1|||
155229423|NCT01494610|560278019|FG001|Period 4|Protocol Violation|0|||
155229424|NCT02385799|560278020|FG000|Overall Study|Lost to Follow-up|1|||
155229425|NCT02385799|560278021|FG001|Overall Study|Lost to Follow-up|2|||
155229426|NCT02385799|560278020|FG000|Overall Study|Adverse Event|4|||
155229427|NCT02385799|560278021|FG001|Overall Study|Adverse Event|2|||
155229428|NCT02385799|560278020|FG000|Overall Study|Withdrawal by Subject|0|||
155229429|NCT02385799|560278021|FG001|Overall Study|Withdrawal by Subject|4|||
155229430|NCT01110915|560278026|FG000|Overall Study|Death|2|||
155229431|NCT01110915|560278027|FG001|Overall Study|Death|1|||
155229432|NCT01110915|560278026|FG000|Overall Study|Lost to Follow-up|1|||
155229433|NCT01110915|560278027|FG001|Overall Study|Lost to Follow-up|0|||
155229434|NCT01110915|560278026|FG000|Overall Study|Withdrawal by Subject|7|||
155229435|NCT01110915|560278027|FG001|Overall Study|Withdrawal by Subject|1|||
155229436|NCT02948842|560278028|FG000|Overall Study|Withdrawal by Subject|4|||
155229437|NCT01537783|560278029|FG000|Overall Study|Lost to Follow-up|11|||
155229438|NCT01537783|560278030|FG001|Overall Study|Lost to Follow-up|2|||
155229439|NCT02350309|560278031|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229440|NCT02350309|560278032|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229441|NCT02350309|560278033|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
155229442|NCT02350309|560278034|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229443|NCT02350309|560278035|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229444|NCT02350309|560278036|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229445|NCT02350309|560278031|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229446|NCT02350309|560278032|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229447|NCT02350309|560278033|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229448|NCT02350309|560278034|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229449|NCT02350309|560278035|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229450|NCT02350309|560278036|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
155229451|NCT01205165|560278037|FG000|Overall Study|Lost to Follow-up|2|||
155229452|NCT01736696|560278040|FG000|Overall Study|Withdrawal by Subject|0|||
155229453|NCT01736696|560278041|FG001|Overall Study|Withdrawal by Subject|0|||
155229454|NCT01736696|560278042|FG002|Overall Study|Withdrawal by Subject|1|||
155229455|NCT01736696|560278043|FG003|Overall Study|Withdrawal by Subject|0|||
155229456|NCT01736696|560278044|FG004|Overall Study|Withdrawal by Subject|0|||
155229457|NCT01736696|560278045|FG005|Overall Study|Withdrawal by Subject|0|||
155229458|NCT01736696|560278046|FG006|Overall Study|Withdrawal by Subject|0|||
155229459|NCT04011410|560278047|FG000|Overall Study|Withdrawal by Subject|1|||
155229460|NCT01455012|560278048|FG000|Overall Study|Adverse Event|0|||
155229461|NCT01455012|560278049|FG001|Overall Study|Adverse Event|2|||
155229462|NCT01455012|560278048|FG000|Overall Study|Lack of Efficacy|6|||
155229463|NCT01455012|560278049|FG001|Overall Study|Lack of Efficacy|1|||
155229464|NCT01455012|560278048|FG000|Overall Study|Withdrawal by Subject|3|||
155229465|NCT01455012|560278049|FG001|Overall Study|Withdrawal by Subject|1|||
155229466|NCT01455012|560278048|FG000|Overall Study|Unknown reason|2|||
155229467|NCT01455012|560278049|FG001|Overall Study|Unknown reason|0|||
155229468|NCT01434290|560278054|FG000|Overall Study|Protocol Violation|6|||
155229469|NCT01434290|560278055|FG001|Overall Study|Protocol Violation|3|||
155229470|NCT01434290|560278054|FG000|Overall Study|No protocol treatment|2|||
155229471|NCT01434290|560278055|FG001|Overall Study|No protocol treatment|4|||
155229472|NCT03945981|560278056|FG000|Overall Study|Lost to Follow-up|12|||
155229473|NCT03945981|560278056|FG000|Overall Study|Physician Decision|4|||
155229474|NCT03945981|560278056|FG000|Overall Study|Withdrawal by Subject|6|||
155229475|NCT03945981|560278056|FG000|Overall Study|Protocol Violation|1|||
155229476|NCT00256698|560278059|FG000|Overall Study|Withdrawal by Subject|7|||
155229477|NCT00256698|560278060|FG001|Overall Study|Withdrawal by Subject|7|||
155229478|NCT00256698|560278059|FG000|Overall Study|Adverse Event|13|||
155229479|NCT00256698|560278060|FG001|Overall Study|Adverse Event|6|||
155229480|NCT00256698|560278059|FG000|Overall Study|Protocol Violation|6|||
155229481|NCT00256698|560278060|FG001|Overall Study|Protocol Violation|5|||
155229482|NCT00256698|560278059|FG000|Overall Study|Lost to Follow-up|1|||
155229483|NCT00256698|560278060|FG001|Overall Study|Lost to Follow-up|3|||
155229484|NCT00256698|560278059|FG000|Overall Study|disease progression|97|||
155229485|NCT00256698|560278060|FG001|Overall Study|disease progression|105|||
155229486|NCT00256698|560278059|FG000|Overall Study|still ongoing at data cut-off|41|||
155229487|NCT00256698|560278060|FG001|Overall Study|still ongoing at data cut-off|46|||
155229488|NCT00256698|560278059|FG000|Overall Study|withdrawn due to osteoporosis|1|||
155229489|NCT00256698|560278060|FG001|Overall Study|withdrawn due to osteoporosis|0|||
155229490|NCT00256698|560278059|FG000|Overall Study|Prematurely Discontinued|1|||
155229491|NCT00256698|560278060|FG001|Overall Study|Prematurely Discontinued|0|||
155229492|NCT02777125|560278062|FG000|Overall Study|Consent form violation|14|||
155229493|NCT02777125|560278063|FG001|Overall Study|Consent form violation|12|||
155229494|NCT02777125|560278062|FG000|Overall Study|Assent form violation|21|||
155229495|NCT02777125|560278063|FG001|Overall Study|Assent form violation|23|||
155229496|NCT02777125|560278062|FG000|Overall Study|Protocol Violation|8|||
155229497|NCT02777125|560278063|FG001|Overall Study|Protocol Violation|12|||
155229498|NCT00634647|560280110|FG000|Overall Study|death on study|3|||
155229499|NCT00634647|560280110|FG000|Overall Study|refused further treatment|3|||
155229500|NCT00634647|560280110|FG000|Overall Study|declined to participate before treatment|1|||
155229501|NCT00667342|560280111|FG000|Overall Study|Protocol Violation|1|||
155229502|NCT00667342|560280112|FG001|Overall Study|Protocol Violation|0|||
155229503|NCT00667342|560280113|FG002|Overall Study|Protocol Violation|0|||
155229504|NCT00667342|560280111|FG000|Overall Study|Withdrawal by Subject|1|||
155229505|NCT00667342|560280112|FG001|Overall Study|Withdrawal by Subject|0|||
155229506|NCT00667342|560280113|FG002|Overall Study|Withdrawal by Subject|0|||
155229507|NCT00667342|560280111|FG000|Overall Study|Physician Decision|3|||
155229508|NCT00667342|560280112|FG001|Overall Study|Physician Decision|0|||
155229509|NCT00667342|560280113|FG002|Overall Study|Physician Decision|0|||
155229510|NCT00667342|560280111|FG000|Overall Study|Relapse or tumor progression|9|||
155229511|NCT00667342|560280112|FG001|Overall Study|Relapse or tumor progression|0|||
155229512|NCT00667342|560280113|FG002|Overall Study|Relapse or tumor progression|7|||
155229513|NCT00667342|560280111|FG000|Overall Study|Adverse Event|0|||
155229514|NCT00667342|560280112|FG001|Overall Study|Adverse Event|0|||
155229515|NCT00667342|560280113|FG002|Overall Study|Adverse Event|1|||
155229516|NCT00667342|560280111|FG000|Overall Study|Ineligible|0|||
155229517|NCT00667342|560280112|FG001|Overall Study|Ineligible|0|||
155229518|NCT00667342|560280113|FG002|Overall Study|Ineligible|1|||
155229519|NCT01433263|560280114|FG000|Overall Study|Adverse Event|3|||
155229520|NCT01433263|560280115|FG001|Overall Study|Adverse Event|1|||
155229521|NCT01433263|560280114|FG000|Overall Study|Death|5|||
155229522|NCT01433263|560280115|FG001|Overall Study|Death|3|||
155229523|NCT01433263|560280114|FG000|Overall Study|Lost to Follow-up|0|||
155229524|NCT01433263|560280115|FG001|Overall Study|Lost to Follow-up|1|||
155229525|NCT01433263|560280114|FG000|Overall Study|Protocol Deviation|1|||
155229526|NCT01433263|560280115|FG001|Overall Study|Protocol Deviation|0|||
155229527|NCT01433263|560280114|FG000|Overall Study|Withdrawal by Subject|10|||
155229528|NCT01433263|560280115|FG001|Overall Study|Withdrawal by Subject|7|||
155229529|NCT04709237|560280117|FG000|Overall Study|Lost to Follow-up|1|||
155229530|NCT04709237|560280118|FG001|Overall Study|Lost to Follow-up|0|||
155229531|NCT04709237|560280119|FG002|Overall Study|Lost to Follow-up|0|||
155229532|NCT02610192|560280120|FG000|Overall Study|Received other treatment|8|||
155229533|NCT02610192|560280120|FG000|Overall Study|Physician Decision|1|||
155229534|NCT05723770|560280126|FG000|Overall Study|Lost to Follow-up|4|||
155229535|NCT05723770|560280126|FG000|Overall Study|Withdrawal by Subject|2|||
155229536|NCT00145509|560280127|FG000|Overall Study|Adverse Event|10|||
155229537|NCT00145509|560280128|FG001|Overall Study|Adverse Event|3|||
155229538|NCT00145509|560280127|FG000|Overall Study|Lack of Efficacy|3|||
155229539|NCT00145509|560280128|FG001|Overall Study|Lack of Efficacy|1|||
155229540|NCT00145509|560280127|FG000|Overall Study|Lost to Follow-up|5|||
155229541|NCT00145509|560280128|FG001|Overall Study|Lost to Follow-up|9|||
155229542|NCT00145509|560280127|FG000|Overall Study|Withdrew Consent|2|||
155229543|NCT00145509|560280128|FG001|Overall Study|Withdrew Consent|7|||
155229544|NCT00145509|560280127|FG000|Overall Study|Reason not provided|2|||
155229545|NCT00145509|560280128|FG001|Overall Study|Reason not provided|1|||
155229546|NCT01359592|560280129|FG000|Initial Registration|Adverse Event|1|||
155229547|NCT01359592|560280130|FG001|Initial Registration|Adverse Event|0|||
155229548|NCT01359592|560280131|FG002|Initial Registration|Adverse Event|0|||
155229549|NCT01359592|560280132|FG003|Initial Registration|Adverse Event|0|||
155229550|NCT01359592|560280129|FG000|Initial Registration|Death|1|||
155229551|NCT01359592|560280130|FG001|Initial Registration|Death|0|||
155229552|NCT01359592|560280131|FG002|Initial Registration|Death|0|||
155229553|NCT01359592|560280132|FG003|Initial Registration|Death|0|||
155229554|NCT01359592|560280129|FG000|Initial Registration|Other reason not protocol specified|1|||
155229555|NCT01359592|560280130|FG001|Initial Registration|Other reason not protocol specified|0|||
155229556|NCT01359592|560280131|FG002|Initial Registration|Other reason not protocol specified|0|||
155229557|NCT01359592|560280132|FG003|Initial Registration|Other reason not protocol specified|0|||
155229558|NCT01359592|560280129|FG000|Initial Registration|Ineligible|26|||
155229559|NCT01359592|560280130|FG001|Initial Registration|Ineligible|0|||
155229560|NCT01359592|560280131|FG002|Initial Registration|Ineligible|0|||
155229561|NCT01359592|560280132|FG003|Initial Registration|Ineligible|0|||
155229562|NCT01359592|560280129|FG000|PET-Directed Therapy|Adverse Event|0|||
155229563|NCT01359592|560280130|FG001|PET-Directed Therapy|Adverse Event|0|||
155229564|NCT01359592|560280131|FG002|PET-Directed Therapy|Adverse Event|1|||
155229565|NCT01359592|560280132|FG003|PET-Directed Therapy|Adverse Event|0|||
155229566|NCT01359592|560280129|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229567|NCT01359592|560280130|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229568|NCT01359592|560280131|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
155229569|NCT01359592|560280132|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229570|NCT01359592|560280129|FG000|PET-Directed Therapy|Ineligible|0|||
155229571|NCT01359592|560280130|FG001|PET-Directed Therapy|Ineligible|0|||
155229572|NCT01359592|560280131|FG002|PET-Directed Therapy|Ineligible|24|||
155229573|NCT01359592|560280132|FG003|PET-Directed Therapy|Ineligible|0|||
155229574|NCT00326612|560280137|FG000|Overall Study|They did not have a seizure requiring tx|129|||
155229575|NCT00326612|560280138|FG001|Overall Study|They did not have a seizure requiring tx|137|||
155229576|NCT00419562|560280139|FG000|Overall Study|Lost to Follow-up|12|||
155229577|NCT00419562|560280140|FG001|Overall Study|Lost to Follow-up|13|||
155229578|NCT00419562|560280139|FG000|Overall Study|Withdrawal by Subject|20|||
155229579|NCT00419562|560280140|FG001|Overall Study|Withdrawal by Subject|18|||
155229580|NCT00419562|560280139|FG000|Overall Study|Participant Institutionalized|1|||
155229581|NCT00419562|560280140|FG001|Overall Study|Participant Institutionalized|0|||
155229582|NCT02365636|560280145|FG000|Overall Study|Adverse Event|3|||
155229583|NCT02365636|560280146|FG001|Overall Study|Adverse Event|3|||
155229584|NCT02365636|560280147|FG002|Overall Study|Adverse Event|2|||
155229585|NCT02365636|560280145|FG000|Overall Study|Protocol Violation|1|||
155229586|NCT02365636|560280146|FG001|Overall Study|Protocol Violation|4|||
155229587|NCT02365636|560280147|FG002|Overall Study|Protocol Violation|0|||
155229588|NCT02365636|560280145|FG000|Overall Study|Lost to Follow-up|0|||
155229589|NCT02365636|560280146|FG001|Overall Study|Lost to Follow-up|0|||
155229590|NCT02365636|560280147|FG002|Overall Study|Lost to Follow-up|1|||
155229591|NCT02365636|560280145|FG000|Overall Study|Other|2|||
155229592|NCT02365636|560280146|FG001|Overall Study|Other|0|||
155229593|NCT02365636|560280147|FG002|Overall Study|Other|0|||
155229594|NCT00355238|560280148|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155229595|NCT00355238|560280149|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155229596|NCT00355238|560280150|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155229597|NCT00355238|560280151|FG003|Overall Study|Adverse event unrelated to study drug|1|||
155229598|NCT00355238|560280148|FG000|Overall Study|Death|1|||
155229599|NCT00355238|560280149|FG001|Overall Study|Death|0|||
155229600|NCT00355238|560280150|FG002|Overall Study|Death|0|||
155229601|NCT00355238|560280151|FG003|Overall Study|Death|0|||
155229602|NCT00355238|560280148|FG000|Overall Study|Disease progression|37|||
155229603|NCT00355238|560280149|FG001|Overall Study|Disease progression|36|||
155229604|NCT00355238|560280150|FG002|Overall Study|Disease progression|16|||
155229605|NCT00355238|560280151|FG003|Overall Study|Disease progression|11|||
155229606|NCT00355238|560280148|FG000|Overall Study|Study drug toxicity|11|||
155229607|NCT00355238|560280149|FG001|Overall Study|Study drug toxicity|7|||
155229608|NCT00355238|560280150|FG002|Overall Study|Study drug toxicity|5|||
155229609|NCT00355238|560280151|FG003|Overall Study|Study drug toxicity|2|||
155229610|NCT00355238|560280148|FG000|Overall Study|Participant withdrew consent|3|||
155229611|NCT00355238|560280149|FG001|Overall Study|Participant withdrew consent|1|||
155229612|NCT00355238|560280150|FG002|Overall Study|Participant withdrew consent|0|||
155229613|NCT00355238|560280151|FG003|Overall Study|Participant withdrew consent|0|||
155229614|NCT00355238|560280148|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155229615|NCT00355238|560280149|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155229616|NCT00355238|560280150|FG002|Overall Study|Participant request to discontinue study treatment|1|||
155229617|NCT00355238|560280151|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155229618|NCT01454934|560280152|FG000|Overall Study|Clinical progression|28|||
155229619|NCT01454934|560280153|FG001|Overall Study|Clinical progression|25|||
155229620|NCT01454934|560280152|FG000|Overall Study|Other|6|||
155229621|NCT01454934|560280153|FG001|Overall Study|Other|17|||
155229622|NCT01454934|560280152|FG000|Overall Study|Adverse Event|28|||
155229623|NCT01454934|560280153|FG001|Overall Study|Adverse Event|24|||
155229624|NCT01454934|560280152|FG000|Overall Study|Withdrawn consent|2|||
155229625|NCT01454934|560280153|FG001|Overall Study|Withdrawn consent|5|||
155229626|NCT01454934|560280152|FG000|Overall Study|Withdrawal by Subject|11|||
155229627|NCT01454934|560280153|FG001|Overall Study|Withdrawal by Subject|15|||
155229628|NCT01454934|560280152|FG000|Overall Study|Disease progression|194|||
155229629|NCT01454934|560280153|FG001|Overall Study|Disease progression|181|||
155229630|NCT01454934|560280152|FG000|Overall Study|Lost to Follow-up|0|||
155229631|NCT01454934|560280153|FG001|Overall Study|Lost to Follow-up|1|||
155229632|NCT01454934|560280152|FG000|Overall Study|Not treated|1|||
155229633|NCT01454934|560280153|FG001|Overall Study|Not treated|2|||
155229634|NCT00749775|560280154|FG000|Overall Study|Protocol Violation|24|||
155229635|NCT00749775|560280154|FG000|Overall Study|Lost to Follow-up|36|||
155229636|NCT00749775|560280154|FG000|Overall Study|No visit after first day of treatment|44|||
155229637|NCT00749775|560280154|FG000|Overall Study|No drug administration|3|||
155229638|NCT05044234|560280155|FG000|Overall Study|Lost to Follow-up|2|||
155229639|NCT05044234|560280156|FG001|Overall Study|Lost to Follow-up|1|||
155229640|NCT05044234|560280157|FG002|Overall Study|Lost to Follow-up|1|||
155229641|NCT05044234|560280158|FG003|Overall Study|Lost to Follow-up|2|||
155229642|NCT05044234|560280155|FG000|Overall Study|Withdrawal by Subject|6|||
155229643|NCT05044234|560280156|FG001|Overall Study|Withdrawal by Subject|4|||
155229644|NCT05044234|560280157|FG002|Overall Study|Withdrawal by Subject|5|||
155229645|NCT05044234|560280158|FG003|Overall Study|Withdrawal by Subject|8|||
155229646|NCT05044234|560280155|FG000|Overall Study|Study terminated by Sponsor|21|||
155229647|NCT05044234|560280156|FG001|Overall Study|Study terminated by Sponsor|21|||
155229648|NCT05044234|560280157|FG002|Overall Study|Study terminated by Sponsor|20|||
155229649|NCT05044234|560280158|FG003|Overall Study|Study terminated by Sponsor|14|||
155229650|NCT05044234|560280155|FG000|Overall Study|Other, not specified|0|||
155229651|NCT05044234|560280156|FG001|Overall Study|Other, not specified|0|||
155229652|NCT05044234|560280157|FG002|Overall Study|Other, not specified|1|||
155229653|NCT05044234|560280158|FG003|Overall Study|Other, not specified|2|||
155229654|NCT05044234|560280155|FG000|Overall Study|Delayed data entry|0|||
155229655|NCT05044234|560280156|FG001|Overall Study|Delayed data entry|0|||
155229656|NCT05044234|560280157|FG002|Overall Study|Delayed data entry|0|||
155229657|NCT05044234|560280158|FG003|Overall Study|Delayed data entry|1|||
155229658|NCT00480636|560280159|FG000|Overall Study|Death|12|||
155229659|NCT00480636|560280159|FG000|Overall Study|Lost to Follow-up|4|||
155229660|NCT00480636|560280159|FG000|Overall Study|Other|2|||
155229661|NCT00480636|560280159|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
155229662|NCT03912233|560280160|FG000|Overall Study|Adverse Event|1|||
155229663|NCT03912233|560280161|FG001|Overall Study|Adverse Event|0|||
155229664|NCT03912233|560280162|FG002|Overall Study|Adverse Event|0|||
155229665|NCT03912233|560280163|FG003|Overall Study|Adverse Event|0|||
155229666|NCT03912233|560280164|FG004|Overall Study|Adverse Event|0|||
155229667|NCT03912233|560280165|FG005|Overall Study|Adverse Event|0|||
155229668|NCT03912233|560280160|FG000|Overall Study|Physician Decision|1|||
155229669|NCT03912233|560280161|FG001|Overall Study|Physician Decision|0|||
155229670|NCT03912233|560280162|FG002|Overall Study|Physician Decision|0|||
155229671|NCT03912233|560280163|FG003|Overall Study|Physician Decision|0|||
155229672|NCT03912233|560280164|FG004|Overall Study|Physician Decision|0|||
155229673|NCT03912233|560280165|FG005|Overall Study|Physician Decision|0|||
155229674|NCT03912233|560280160|FG000|Overall Study|Other|0|||
155229675|NCT03912233|560280161|FG001|Overall Study|Other|0|||
155229676|NCT03912233|560280162|FG002|Overall Study|Other|0|||
155229677|NCT03912233|560280163|FG003|Overall Study|Other|0|||
155229678|NCT03912233|560280164|FG004|Overall Study|Other|7|||
155229679|NCT03912233|560280165|FG005|Overall Study|Other|12|||
155229680|NCT02583256|560280168|FG000|Overall Study|Withdrawal by Subject|0|||
155229681|NCT02583256|560280169|FG001|Overall Study|Withdrawal by Subject|1|||
155229682|NCT02583256|560280170|FG002|Overall Study|Withdrawal by Subject|1|||
155229683|NCT02583256|560280171|FG003|Overall Study|Withdrawal by Subject|0|||
155229684|NCT02583256|560280168|FG000|Overall Study|Lost to Follow-up|1|||
155229685|NCT02583256|560280169|FG001|Overall Study|Lost to Follow-up|1|||
155229686|NCT02583256|560280170|FG002|Overall Study|Lost to Follow-up|0|||
155229687|NCT02583256|560280171|FG003|Overall Study|Lost to Follow-up|1|||
155229688|NCT02583256|560280168|FG000|Overall Study|Administrative/Other|2|||
155229689|NCT02583256|560280169|FG001|Overall Study|Administrative/Other|0|||
155229690|NCT02583256|560280170|FG002|Overall Study|Administrative/Other|1|||
155229691|NCT02583256|560280171|FG003|Overall Study|Administrative/Other|2|||
155229692|NCT02177266|560280177|FG000|Overall Study|Adverse Event|0|||
155229693|NCT02177266|560280178|FG001|Overall Study|Adverse Event|1|||
155229694|NCT02177266|560280177|FG000|Overall Study|Withdrawal by Subject|1|||
155229695|NCT02177266|560280178|FG001|Overall Study|Withdrawal by Subject|0|||
155229696|NCT01023659|560280179|FG000|Overall Study|Lost to Follow-up|73|||
155229697|NCT01023659|560280180|FG001|Overall Study|Lost to Follow-up|228|||
155229698|NCT01023659|560280181|FG002|Overall Study|Lost to Follow-up|99|||
155229699|NCT04537806|560280184|FG000|Overall Study|Randomized but not treated|1|||
155229700|NCT04537806|560280185|FG001|Overall Study|Randomized but not treated|0|||
155229701|NCT04537806|560280184|FG000|Overall Study|Adverse Event|1|||
155229702|NCT04537806|560280185|FG001|Overall Study|Adverse Event|1|||
155229703|NCT03019627|560280186|FG000|Overall Study|Adverse Event|8|||
155229704|NCT03019627|560280187|FG001|Overall Study|Adverse Event|0|||
155229705|NCT03019627|560280186|FG000|Overall Study|Unrelated to adverse event|1|||
155229706|NCT03019627|560280187|FG001|Overall Study|Unrelated to adverse event|3|||
155229707|NCT03019627|560280186|FG000|Overall Study|Lost to Follow-up|2|||
155229708|NCT03019627|560280187|FG001|Overall Study|Lost to Follow-up|1|||
155229709|NCT03019627|560280186|FG000|Overall Study|not compliance|2|||
155229710|NCT03019627|560280187|FG001|Overall Study|not compliance|2|||
155229711|NCT03019627|560280186|FG000|Overall Study|Other|2|||
155229712|NCT03019627|560280187|FG001|Overall Study|Other|2|||
155229713|NCT03364049|560280188|FG000|Overall Study|Death|6|||
155229714|NCT03364049|560280189|FG001|Overall Study|Death|4|||
155229715|NCT03364049|560280190|FG002|Overall Study|Death|5|||
155229716|NCT03364049|560280191|FG003|Overall Study|Death|14|||
155229717|NCT03364049|560280188|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229718|NCT03364049|560280189|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
155229719|NCT03364049|560280190|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229720|NCT03364049|560280191|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229721|NCT03364049|560280188|FG000|Overall Study|Withdrawal by Subject|0|||
155229722|NCT03364049|560280189|FG001|Overall Study|Withdrawal by Subject|1|||
155229723|NCT03364049|560280190|FG002|Overall Study|Withdrawal by Subject|1|||
155229724|NCT03364049|560280191|FG003|Overall Study|Withdrawal by Subject|1|||
155229725|NCT00546715|560280192|FG000|Overall Study|Withdrawal by Subject|0|||
155229726|NCT00546715|560280193|FG001|Overall Study|Withdrawal by Subject|1|||
155229727|NCT00546715|560280194|FG002|Overall Study|Withdrawal by Subject|0|||
155229728|NCT00546715|560280195|FG003|Overall Study|Withdrawal by Subject|0|||
155229729|NCT00418691|560280196|FG000|Overall Study|Lost to Follow-up|1|||
155229730|NCT00418691|560280197|FG001|Overall Study|Lost to Follow-up|2|||
155229731|NCT00418691|560280198|FG002|Overall Study|Lost to Follow-up|3|||
155229732|NCT00418691|560280196|FG000|Overall Study|Started new medication voiding entry|0|||
155229733|NCT00418691|560280197|FG001|Overall Study|Started new medication voiding entry|0|||
155229734|NCT00418691|560280198|FG002|Overall Study|Started new medication voiding entry|1|||
155229735|NCT00418691|560280196|FG000|Overall Study|Progressive Disease|1|||
155229736|NCT00418691|560280197|FG001|Overall Study|Progressive Disease|0|||
155229737|NCT00418691|560280198|FG002|Overall Study|Progressive Disease|1|||
155229738|NCT02477020|560280201|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
155229739|NCT02477020|560280202|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
155229740|NCT02477020|560280201|FG000|Overall Study|Voluntary Withdrawal|7|||
155229741|NCT02477020|560280202|FG001|Overall Study|Voluntary Withdrawal|16|||
155229742|NCT02477020|560280201|FG000|Overall Study|Reason not Specified|3|||
155229743|NCT02477020|560280202|FG001|Overall Study|Reason not Specified|1|||
155229744|NCT02477020|560280201|FG000|Overall Study|Lack of Efficacy|14|||
155229745|NCT02477020|560280202|FG001|Overall Study|Lack of Efficacy|5|||
155229746|NCT01802775|560280203|FG000|Overall Study|Death|0|||
155229747|NCT01802775|560280204|FG001|Overall Study|Death|3|||
155229748|NCT01802775|560280203|FG000|Overall Study|Reason not provided|0|||
155229749|NCT01802775|560280204|FG001|Overall Study|Reason not provided|1|||
155229750|NCT01802775|560280203|FG000|Overall Study|Physician Decision|1|||
155229751|NCT01802775|560280204|FG001|Overall Study|Physician Decision|0|||
155229752|NCT01802775|560280203|FG000|Overall Study|Adverse Event|1|||
155229753|NCT01802775|560280204|FG001|Overall Study|Adverse Event|1|||
155229754|NCT01802775|560280203|FG000|Overall Study|Withdrawal by Subject|3|||
155229755|NCT01802775|560280204|FG001|Overall Study|Withdrawal by Subject|5|||
155229756|NCT01802775|560280203|FG000|Overall Study|Lost to Follow-up|1|||
155229757|NCT01802775|560280204|FG001|Overall Study|Lost to Follow-up|2|||
155229758|NCT00519649|560280207|FG000|Overall Study|Withdrawal by Subject|1|||
155229759|NCT01465802|560280208|FG000|Overall Study|Study terminated by sponsor|1|||
155229760|NCT01465802|560280209|FG001|Overall Study|Study terminated by sponsor|0|||
155229761|NCT01465802|560280210|FG002|Overall Study|Study terminated by sponsor|0|||
155229762|NCT01465802|560280211|FG003|Overall Study|Study terminated by sponsor|1|||
155229763|NCT01465802|560280212|FG004|Overall Study|Study terminated by sponsor|7|||
155229764|NCT01465802|560280208|FG000|Overall Study|Withdrawal by Subject|7|||
155229765|NCT01465802|560280209|FG001|Overall Study|Withdrawal by Subject|7|||
155229766|NCT01465802|560280210|FG002|Overall Study|Withdrawal by Subject|0|||
155229767|NCT01465802|560280211|FG003|Overall Study|Withdrawal by Subject|8|||
155229768|NCT01465802|560280212|FG004|Overall Study|Withdrawal by Subject|1|||
155229769|NCT01465802|560280208|FG000|Overall Study|Lost to Follow-up|1|||
155229770|NCT01465802|560280209|FG001|Overall Study|Lost to Follow-up|1|||
155229771|NCT01465802|560280210|FG002|Overall Study|Lost to Follow-up|0|||
155229772|NCT01465802|560280211|FG003|Overall Study|Lost to Follow-up|0|||
155229773|NCT01465802|560280212|FG004|Overall Study|Lost to Follow-up|0|||
155229774|NCT01465802|560280208|FG000|Overall Study|Reason not specified|9|||
155229775|NCT01465802|560280209|FG001|Overall Study|Reason not specified|4|||
155229776|NCT01465802|560280210|FG002|Overall Study|Reason not specified|0|||
155229777|NCT01465802|560280211|FG003|Overall Study|Reason not specified|10|||
155229778|NCT01465802|560280212|FG004|Overall Study|Reason not specified|2|||
155229779|NCT01465802|560280208|FG000|Overall Study|Death|15|||
155229780|NCT01465802|560280209|FG001|Overall Study|Death|12|||
155229781|NCT01465802|560280210|FG002|Overall Study|Death|0|||
155229782|NCT01465802|560280211|FG003|Overall Study|Death|10|||
155229783|NCT01465802|560280212|FG004|Overall Study|Death|2|||
155229784|NCT03852316|560280213|FG000|Overall Study|Protocol Violation|1|||
155229785|NCT03852316|560280213|FG000|Overall Study|Withdrawal by Subject|2|||
155229786|NCT03852316|560280213|FG000|Overall Study|Enrolled but Device not Utilized|1|||
155229787|NCT03219333|560280214|FG000|Overall Study|Withdrawal by Subject|9|||
155229788|NCT03219333|560280215|FG001|Overall Study|Withdrawal by Subject|4|||
155229789|NCT03219333|560280214|FG000|Overall Study|Lost to Follow-up|1|||
155229790|NCT03219333|560280215|FG001|Overall Study|Lost to Follow-up|1|||
155229791|NCT03219333|560280214|FG000|Overall Study|Death|104|||
155229792|NCT03219333|560280215|FG001|Overall Study|Death|72|||
155229793|NCT03219333|560280214|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
155229794|NCT03219333|560280215|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
155229795|NCT03219333|560280214|FG000|Overall Study|Other|2|||
155229796|NCT03219333|560280215|FG001|Overall Study|Other|2|||
155229797|NCT02975934|560280216|FG000|Treatment Phase|Never initiated study drug|0|||
155229798|NCT02975934|560280217|FG001|Treatment Phase|Never initiated study drug|5|||
155229799|NCT02975934|560280218|FG002|Treatment Phase|Never initiated study drug|0|||
155229800|NCT02075840|560280220|FG000|Overall Study|Withdrawal by Subject|13|||
155229801|NCT02075840|560280221|FG001|Overall Study|Withdrawal by Subject|22|||
155229802|NCT02075840|560280220|FG000|Overall Study|Reason not specified|1|||
155229803|NCT02075840|560280221|FG001|Overall Study|Reason not specified|0|||
155229804|NCT02075840|560280220|FG000|Overall Study|Adverse Event|0|||
155229805|NCT02075840|560280221|FG001|Overall Study|Adverse Event|2|||
155229806|NCT02075840|560280220|FG000|Overall Study|Death|35|||
155229807|NCT02075840|560280221|FG001|Overall Study|Death|40|||
155229808|NCT02075840|560280220|FG000|Overall Study|Lost to Follow-up|3|||
155229809|NCT02075840|560280221|FG001|Overall Study|Lost to Follow-up|2|||
155229810|NCT02075840|560280220|FG000|Overall Study|Physician Decision|1|||
155229811|NCT02075840|560280221|FG001|Overall Study|Physician Decision|3|||
155229812|NCT02075840|560280220|FG000|Overall Study|Ongoing at CCOD|99|||
155229813|NCT02075840|560280221|FG001|Overall Study|Ongoing at CCOD|82|||
155229814|NCT00433654|560280226|FG000|Overall Study|Death|4|||
155229815|NCT00433654|560280227|FG001|Overall Study|Death|0|||
155229816|NCT00433654|560280226|FG000|Overall Study|Missed visit|6|||
155229817|NCT00433654|560280227|FG001|Overall Study|Missed visit|3|||
155229818|NCT00433654|560280226|FG000|Overall Study|Subject not yet due for visit|4|||
155229819|NCT00433654|560280227|FG001|Overall Study|Subject not yet due for visit|0|||
155229820|NCT00433654|560280226|FG000|Overall Study|Withdrawal by Subject|1|||
155229821|NCT00433654|560280227|FG001|Overall Study|Withdrawal by Subject|2|||
155229822|NCT04033159|560280232|FG000|Washout Period|Physician Decision|0|||
155229823|NCT04033159|560280233|FG001|Washout Period|Physician Decision|1|||
155229824|NCT04033159|560280234|FG002|Washout Period|Physician Decision|0|||
155229825|NCT04033159|560280232|FG000|Washout Period|Study terminated by Sponsor|0|||
155229826|NCT04033159|560280233|FG001|Washout Period|Study terminated by Sponsor|7|||
155229827|NCT04033159|560280234|FG002|Washout Period|Study terminated by Sponsor|0|||
155229828|NCT04033159|560280232|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
155229829|NCT04033159|560280233|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
155229830|NCT04033159|560280234|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
155229831|NCT00116558|560280237|FG000|Overall Study|Death|11|||
155229832|NCT00116558|560280238|FG001|Overall Study|Death|5|||
155229833|NCT00116558|560280239|FG002|Overall Study|Death|3|||
155229834|NCT00116558|560280237|FG000|Overall Study|Withdrawal by Subject|17|||
155229835|NCT00116558|560280238|FG001|Overall Study|Withdrawal by Subject|3|||
155229836|NCT00116558|560280239|FG002|Overall Study|Withdrawal by Subject|12|||
155229837|NCT00116558|560280237|FG000|Overall Study|disease progression|3|||
155229838|NCT00116558|560280238|FG001|Overall Study|disease progression|7|||
155229839|NCT00116558|560280239|FG002|Overall Study|disease progression|18|||
155229840|NCT00357370|560280240|FG000|Cohort 2|Lack of Efficacy|0|||
155229841|NCT00357370|560280241|FG001|Cohort 2|Lack of Efficacy|2|||
155229842|NCT00357370|560280242|FG002|Cohort 2|Lack of Efficacy|1|||
155229843|NCT00357370|560280240|FG000|Cohort 2|Adverse Event|1|||
155229844|NCT00357370|560280241|FG001|Cohort 2|Adverse Event|1|||
155229845|NCT00357370|560280242|FG002|Cohort 2|Adverse Event|1|||
155229846|NCT00357370|560280240|FG000|Cohort 2|Lost to Follow-up|0|||
155229847|NCT00357370|560280241|FG001|Cohort 2|Lost to Follow-up|1|||
155229848|NCT00357370|560280242|FG002|Cohort 2|Lost to Follow-up|0|||
155229849|NCT00357370|560280240|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
155229850|NCT00357370|560280241|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
155229851|NCT00357370|560280242|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
155229852|NCT00357370|560280240|FG000|Cohort 2|Withdrawal by Subject|0|||
155229853|NCT00357370|560280241|FG001|Cohort 2|Withdrawal by Subject|2|||
155229854|NCT00357370|560280242|FG002|Cohort 2|Withdrawal by Subject|0|||
155229855|NCT01143090|560280243|FG000|Overall Study|Lack of Efficacy|2|||
155229856|NCT01143090|560280243|FG000|Overall Study|Adverse Event|17|||
155229857|NCT01143090|560280243|FG000|Overall Study|Lost to Follow-up|9|||
155229858|NCT01143090|560280243|FG000|Overall Study|Protocol Violation|2|||
155229859|NCT01143090|560280243|FG000|Overall Study|Withdrawal by Subject|18|||
155229860|NCT01143090|560280243|FG000|Overall Study|Non-compliance with study drug|1|||
155229861|NCT01143090|560280243|FG000|Overall Study|Failure to meet eligibility criteria|1|||
155229862|NCT01143090|560280243|FG000|Overall Study|Administrative|1|||
155229863|NCT00499603|560280244|FG000|Overall Study|Adverse Event|0|||
155229864|NCT00499603|560280245|FG001|Overall Study|Adverse Event|1|||
155229865|NCT05220397|560280248|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229866|NCT05220397|560280249|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229867|NCT05220397|560280250|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
155229868|NCT05220397|560280251|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229869|NCT05220397|560280252|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229870|NCT02052739|560280253|FG000|Overall Study|Withdrew due to Adverse Event|3|||
155229871|NCT02052739|560280254|FG001|Overall Study|Withdrew due to Adverse Event|0|||
155229872|NCT02052739|560280253|FG000|Overall Study|Participant Died|2|||
155229873|NCT02052739|560280254|FG001|Overall Study|Participant Died|1|||
155229874|NCT02043015|560280255|FG000|Overall Study|Lost to Follow-up|4|||
155229875|NCT02043015|560280255|FG000|Overall Study|Withdrawal by Subject|4|||
155229876|NCT02043015|560280255|FG000|Overall Study|Removed once target enrollment reached|15|||
155229877|NCT02043015|560280255|FG000|Overall Study|Participant moved away from study city|4|||
155229878|NCT02043015|560280255|FG000|Overall Study|Incarceration|1|||
155229879|NCT01403974|560280256|FG000|Overall Study|Progressive disease according to RECIST|3|||
155229880|NCT01403974|560280257|FG001|Overall Study|Progressive disease according to RECIST|3|||
155229881|NCT01403974|560280258|FG002|Overall Study|Progressive disease according to RECIST|2|||
155229882|NCT01403974|560280259|FG003|Overall Study|Progressive disease according to RECIST|3|||
155229883|NCT01403974|560280260|FG004|Overall Study|Progressive disease according to RECIST|3|||
155229884|NCT01403974|560280261|FG005|Overall Study|Progressive disease according to RECIST|2|||
155229885|NCT01403974|560280262|FG006|Overall Study|Progressive disease according to RECIST|3|||
155229886|NCT01403974|560280263|FG007|Overall Study|Progressive disease according to RECIST|2|||
155229887|NCT01403974|560280264|FG008|Overall Study|Progressive disease according to RECIST|6|||
155229888|NCT01403974|560280265|FG009|Overall Study|Progressive disease according to RECIST|2|||
155229889|NCT01403974|560280266|FG010|Overall Study|Progressive disease according to RECIST|3|||
155229890|NCT01403974|560280267|FG011|Overall Study|Progressive disease according to RECIST|2|||
155229891|NCT01403974|560280268|FG012|Overall Study|Progressive disease according to RECIST|2|||
155229892|NCT01403974|560280269|FG013|Overall Study|Progressive disease according to RECIST|3|||
155229893|NCT01403974|560280270|FG014|Overall Study|Progressive disease according to RECIST|1|||
155229894|NCT01403974|560280271|FG015|Overall Study|Progressive disease according to RECIST|8|||
155229895|NCT01403974|560280256|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
155229896|NCT01403974|560280257|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
155229897|NCT01403974|560280258|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155229898|NCT01403974|560280259|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
155229899|NCT01403974|560280260|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
155229900|NCT01403974|560280261|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
155229901|NCT01403974|560280262|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
155229902|NCT01403974|560280263|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
155229903|NCT01403974|560280264|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
155229904|NCT01403974|560280265|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
155229905|NCT01403974|560280266|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
155229906|NCT01403974|560280267|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
155229907|NCT01403974|560280268|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
155229908|NCT01403974|560280269|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
155229909|NCT01403974|560280270|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
155229910|NCT01403974|560280271|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
155229911|NCT01403974|560280256|FG000|Overall Study|Refused to continue study medication|0|||
155229912|NCT01403974|560280257|FG001|Overall Study|Refused to continue study medication|0|||
155229913|NCT01403974|560280258|FG002|Overall Study|Refused to continue study medication|0|||
155229914|NCT01403974|560280259|FG003|Overall Study|Refused to continue study medication|0|||
155229915|NCT01403974|560280260|FG004|Overall Study|Refused to continue study medication|0|||
155229916|NCT01403974|560280261|FG005|Overall Study|Refused to continue study medication|1|||
155229917|NCT01403974|560280262|FG006|Overall Study|Refused to continue study medication|0|||
155229918|NCT01403974|560280263|FG007|Overall Study|Refused to continue study medication|0|||
155229919|NCT01403974|560280264|FG008|Overall Study|Refused to continue study medication|1|||
155229920|NCT01403974|560280265|FG009|Overall Study|Refused to continue study medication|0|||
155229921|NCT01403974|560280266|FG010|Overall Study|Refused to continue study medication|1|||
155229922|NCT01403974|560280267|FG011|Overall Study|Refused to continue study medication|0|||
155229923|NCT01403974|560280268|FG012|Overall Study|Refused to continue study medication|0|||
155229924|NCT01403974|560280269|FG013|Overall Study|Refused to continue study medication|0|||
155229925|NCT01403974|560280270|FG014|Overall Study|Refused to continue study medication|0|||
155229926|NCT01403974|560280271|FG015|Overall Study|Refused to continue study medication|4|||
155229927|NCT01403974|560280256|FG000|Overall Study|Adverse Event|0|||
155229928|NCT01403974|560280257|FG001|Overall Study|Adverse Event|0|||
155229929|NCT01403974|560280258|FG002|Overall Study|Adverse Event|1|||
155229930|NCT01403974|560280259|FG003|Overall Study|Adverse Event|0|||
155229931|NCT01403974|560280260|FG004|Overall Study|Adverse Event|0|||
155229932|NCT01403974|560280261|FG005|Overall Study|Adverse Event|0|||
155229933|NCT01403974|560280262|FG006|Overall Study|Adverse Event|0|||
155229934|NCT01403974|560280263|FG007|Overall Study|Adverse Event|1|||
155229935|NCT01403974|560280264|FG008|Overall Study|Adverse Event|0|||
155229936|NCT01403974|560280265|FG009|Overall Study|Adverse Event|0|||
155229937|NCT01403974|560280266|FG010|Overall Study|Adverse Event|0|||
155229938|NCT01403974|560280267|FG011|Overall Study|Adverse Event|0|||
155229939|NCT01403974|560280268|FG012|Overall Study|Adverse Event|1|||
155229940|NCT01403974|560280269|FG013|Overall Study|Adverse Event|0|||
155229941|NCT01403974|560280270|FG014|Overall Study|Adverse Event|0|||
155229942|NCT01403974|560280271|FG015|Overall Study|Adverse Event|0|||
155229943|NCT01403974|560280256|FG000|Overall Study|Other than specified|0|||
155229944|NCT01403974|560280257|FG001|Overall Study|Other than specified|0|||
155229945|NCT01403974|560280258|FG002|Overall Study|Other than specified|0|||
155229946|NCT01403974|560280259|FG003|Overall Study|Other than specified|0|||
155229947|NCT01403974|560280260|FG004|Overall Study|Other than specified|0|||
155229948|NCT01403974|560280261|FG005|Overall Study|Other than specified|0|||
155229949|NCT01403974|560280262|FG006|Overall Study|Other than specified|0|||
155229950|NCT01403974|560280263|FG007|Overall Study|Other than specified|0|||
155229951|NCT01403974|560280264|FG008|Overall Study|Other than specified|0|||
155229952|NCT01403974|560280265|FG009|Overall Study|Other than specified|1|||
155229953|NCT01403974|560280266|FG010|Overall Study|Other than specified|0|||
155229954|NCT01403974|560280267|FG011|Overall Study|Other than specified|1|||
155229955|NCT01403974|560280268|FG012|Overall Study|Other than specified|0|||
155229956|NCT01403974|560280269|FG013|Overall Study|Other than specified|0|||
155229957|NCT01403974|560280270|FG014|Overall Study|Other than specified|0|||
155229958|NCT01403974|560280271|FG015|Overall Study|Other than specified|0|||
155229959|NCT01526889|560280272|FG000|Treatment Period|Adverse Event|2|||
155229960|NCT01526889|560280273|FG001|Treatment Period|Adverse Event|0|||
155229961|NCT01526889|560280272|FG000|Treatment Extension Period|Administrative problems|1|||
155229962|NCT01526889|560280273|FG001|Treatment Extension Period|Administrative problems|0|||
155229963|NCT03995953|560280276|FG000|Overall Study|Death|3|||
155229964|NCT03995953|560280277|FG001|Overall Study|Death|0|||
155229965|NCT03995953|560280278|FG002|Overall Study|Death|3|||
155229966|NCT03995953|560280279|FG003|Overall Study|Death|0|||
155229967|NCT03995953|560280280|FG004|Overall Study|Death|3|||
155229968|NCT03995953|560280281|FG005|Overall Study|Death|0|||
155229969|NCT03995953|560280282|FG006|Overall Study|Death|0|||
155229970|NCT03995953|560280283|FG007|Overall Study|Death|0|||
155229971|NCT03995953|560280284|FG008|Overall Study|Death|1|||
155229972|NCT03995953|560280285|FG009|Overall Study|Death|0|||
155229973|NCT03995953|560280286|FG010|Overall Study|Death|0|||
155229974|NCT03995953|560280287|FG011|Overall Study|Death|0|||
155229975|NCT03995953|560280276|FG000|Overall Study|Lost to Follow-up|6|||
155229976|NCT03995953|560280277|FG001|Overall Study|Lost to Follow-up|54|||
155229977|NCT03995953|560280278|FG002|Overall Study|Lost to Follow-up|3|||
155229978|NCT03995953|560280279|FG003|Overall Study|Lost to Follow-up|32|||
155229979|NCT03995953|560280280|FG004|Overall Study|Lost to Follow-up|5|||
155229980|NCT03995953|560280281|FG005|Overall Study|Lost to Follow-up|44|||
155229981|NCT03995953|560280282|FG006|Overall Study|Lost to Follow-up|0|||
155229982|NCT03995953|560280283|FG007|Overall Study|Lost to Follow-up|31|||
155229983|NCT03995953|560280284|FG008|Overall Study|Lost to Follow-up|8|||
155229984|NCT03995953|560280285|FG009|Overall Study|Lost to Follow-up|36|||
155229985|NCT03995953|560280286|FG010|Overall Study|Lost to Follow-up|5|||
155229986|NCT03995953|560280287|FG011|Overall Study|Lost to Follow-up|41|||
155229987|NCT03995953|560280276|FG000|Overall Study|Withdrawal by Subject|4|||
155229988|NCT03995953|560280277|FG001|Overall Study|Withdrawal by Subject|0|||
155229989|NCT03995953|560280278|FG002|Overall Study|Withdrawal by Subject|1|||
155229990|NCT03995953|560280279|FG003|Overall Study|Withdrawal by Subject|0|||
155229991|NCT03995953|560280280|FG004|Overall Study|Withdrawal by Subject|1|||
155229992|NCT03995953|560280281|FG005|Overall Study|Withdrawal by Subject|0|||
155229993|NCT03995953|560280282|FG006|Overall Study|Withdrawal by Subject|1|||
155229994|NCT03995953|560280283|FG007|Overall Study|Withdrawal by Subject|0|||
155229995|NCT03995953|560280284|FG008|Overall Study|Withdrawal by Subject|3|||
155229996|NCT03995953|560280285|FG009|Overall Study|Withdrawal by Subject|0|||
155229997|NCT03995953|560280286|FG010|Overall Study|Withdrawal by Subject|3|||
155229998|NCT03995953|560280287|FG011|Overall Study|Withdrawal by Subject|0|||
155229999|NCT03995953|560280276|FG000|Overall Study|Health Issues|0|||
155491460|NCT00563706|561225399|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
155230000|NCT03995953|560280277|FG001|Overall Study|Health Issues|0|||
155230001|NCT03995953|560280278|FG002|Overall Study|Health Issues|0|||
155230002|NCT03995953|560280279|FG003|Overall Study|Health Issues|0|||
155230003|NCT03995953|560280280|FG004|Overall Study|Health Issues|1|||
155230004|NCT03995953|560280281|FG005|Overall Study|Health Issues|0|||
155230005|NCT03995953|560280282|FG006|Overall Study|Health Issues|0|||
155230006|NCT03995953|560280283|FG007|Overall Study|Health Issues|0|||
155230007|NCT03995953|560280284|FG008|Overall Study|Health Issues|4|||
155230008|NCT03995953|560280285|FG009|Overall Study|Health Issues|0|||
155230009|NCT03995953|560280286|FG010|Overall Study|Health Issues|0|||
155230010|NCT03995953|560280287|FG011|Overall Study|Health Issues|0|||
155230011|NCT03995953|560280276|FG000|Overall Study|Relocated|11|||
155230012|NCT03995953|560280277|FG001|Overall Study|Relocated|0|||
155230013|NCT03995953|560280278|FG002|Overall Study|Relocated|16|||
155230014|NCT03995953|560280279|FG003|Overall Study|Relocated|0|||
155230015|NCT03995953|560280280|FG004|Overall Study|Relocated|14|||
155230016|NCT03995953|560280281|FG005|Overall Study|Relocated|0|||
155230017|NCT03995953|560280282|FG006|Overall Study|Relocated|16|||
155230018|NCT03995953|560280283|FG007|Overall Study|Relocated|0|||
155230019|NCT03995953|560280284|FG008|Overall Study|Relocated|14|||
155230020|NCT03995953|560280285|FG009|Overall Study|Relocated|0|||
155230021|NCT03995953|560280286|FG010|Overall Study|Relocated|15|||
155230022|NCT03995953|560280287|FG011|Overall Study|Relocated|0|||
155230023|NCT00006184|560280288|FG000|Overall Study|Death|1|||
155230024|NCT00006184|560280289|FG001|Overall Study|Death|0|||
155230025|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
155230026|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
155230027|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
155230028|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
155230029|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
155230030|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
155230031|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
155230032|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
155230033|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
155230034|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
155230035|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
155230036|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
155230037|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
155230038|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
155230039|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
155230040|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
155230041|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
155230042|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
155230043|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
155230044|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
155230045|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
155230046|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
155230047|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
155230048|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
155230049|NCT02161718|560280290|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
155230050|NCT02161718|560280291|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
155230051|NCT02161718|560280292|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
155230052|NCT02161718|560280290|FG000|Post- Randomization Period|Lost to Follow-up|0|||
155230053|NCT02161718|560280291|FG001|Post- Randomization Period|Lost to Follow-up|9|||
155230054|NCT02161718|560280292|FG002|Post- Randomization Period|Lost to Follow-up|15|||
155230055|NCT02161718|560280290|FG000|Post- Randomization Period|Adverse Event|0|||
155230056|NCT02161718|560280291|FG001|Post- Randomization Period|Adverse Event|9|||
155230057|NCT02161718|560280292|FG002|Post- Randomization Period|Adverse Event|10|||
155230058|NCT02161718|560280290|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
155230059|NCT02161718|560280291|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
155230060|NCT02161718|560280292|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
155230061|NCT02161718|560280290|FG000|Post- Randomization Period|Physician Decision|0|||
155230062|NCT02161718|560280291|FG001|Post- Randomization Period|Physician Decision|2|||
155230063|NCT02161718|560280292|FG002|Post- Randomization Period|Physician Decision|4|||
155230064|NCT02161718|560280290|FG000|Post- Randomization Period|Protocol Violation|0|||
155230065|NCT02161718|560280291|FG001|Post- Randomization Period|Protocol Violation|2|||
155230066|NCT02161718|560280292|FG002|Post- Randomization Period|Protocol Violation|3|||
155230067|NCT02161718|560280290|FG000|Post- Randomization Period|Lack of Efficacy|0|||
155230068|NCT02161718|560280291|FG001|Post- Randomization Period|Lack of Efficacy|0|||
155230069|NCT02161718|560280292|FG002|Post- Randomization Period|Lack of Efficacy|1|||
155230070|NCT02161718|560280290|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
155230071|NCT02161718|560280291|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
155230072|NCT02161718|560280292|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
155230073|NCT02161718|560280290|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
155230074|NCT02161718|560280291|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
155230075|NCT02161718|560280292|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
155230076|NCT02161718|560280290|FG000|Post- Randomization Period|Relocation|0|||
155230077|NCT02161718|560280291|FG001|Post- Randomization Period|Relocation|3|||
155230078|NCT02161718|560280292|FG002|Post- Randomization Period|Relocation|0|||
155230079|NCT00207142|560280295|FG000|Induction Phase|Adverse Event|9|||
155230080|NCT00207142|560280296|FG001|Induction Phase|Adverse Event|0|||
155230081|NCT00207142|560280297|FG002|Induction Phase|Adverse Event|0|||
155230082|NCT00207142|560280298|FG003|Induction Phase|Adverse Event|0|||
155230083|NCT00207142|560280295|FG000|Induction Phase|Death|1|||
155230084|NCT00207142|560280296|FG001|Induction Phase|Death|0|||
155230085|NCT00207142|560280297|FG002|Induction Phase|Death|0|||
155230086|NCT00207142|560280298|FG003|Induction Phase|Death|0|||
155230087|NCT00207142|560280295|FG000|Induction Phase|Lack of Efficacy|1|||
155230088|NCT00207142|560280296|FG001|Induction Phase|Lack of Efficacy|0|||
155230089|NCT00207142|560280297|FG002|Induction Phase|Lack of Efficacy|0|||
155230090|NCT00207142|560280298|FG003|Induction Phase|Lack of Efficacy|0|||
155230091|NCT00207142|560280295|FG000|Induction Phase|Lost to Follow-up|5|||
155230092|NCT00207142|560280296|FG001|Induction Phase|Lost to Follow-up|0|||
155230093|NCT00207142|560280297|FG002|Induction Phase|Lost to Follow-up|0|||
155230094|NCT00207142|560280298|FG003|Induction Phase|Lost to Follow-up|0|||
155230095|NCT00207142|560280295|FG000|Induction Phase|Physician Decision|2|||
155230096|NCT00207142|560280296|FG001|Induction Phase|Physician Decision|0|||
155230097|NCT00207142|560280297|FG002|Induction Phase|Physician Decision|0|||
155230098|NCT00207142|560280298|FG003|Induction Phase|Physician Decision|0|||
155230099|NCT00207142|560280295|FG000|Induction Phase|Poor/noncompliance|2|||
155230100|NCT00207142|560280296|FG001|Induction Phase|Poor/noncompliance|0|||
155230101|NCT00207142|560280297|FG002|Induction Phase|Poor/noncompliance|0|||
155230102|NCT00207142|560280298|FG003|Induction Phase|Poor/noncompliance|0|||
155230103|NCT00207142|560280295|FG000|Induction Phase|Pregnancy|1|||
155230104|NCT00207142|560280296|FG001|Induction Phase|Pregnancy|0|||
155230105|NCT00207142|560280297|FG002|Induction Phase|Pregnancy|0|||
155230106|NCT00207142|560280298|FG003|Induction Phase|Pregnancy|0|||
155230107|NCT00207142|560280295|FG000|Induction Phase|Subject no longer meets study criteria|3|||
155230108|NCT00207142|560280296|FG001|Induction Phase|Subject no longer meets study criteria|0|||
155230109|NCT00207142|560280297|FG002|Induction Phase|Subject no longer meets study criteria|0|||
155230110|NCT00207142|560280298|FG003|Induction Phase|Subject no longer meets study criteria|0|||
155230111|NCT00207142|560280295|FG000|Induction Phase|Withdrawal by Subject|4|||
155230112|NCT00207142|560280296|FG001|Induction Phase|Withdrawal by Subject|0|||
155230113|NCT00207142|560280297|FG002|Induction Phase|Withdrawal by Subject|0|||
155230114|NCT00207142|560280298|FG003|Induction Phase|Withdrawal by Subject|0|||
155230115|NCT00207142|560280295|FG000|Induction Phase|Incarceration|1|||
155230116|NCT00207142|560280296|FG001|Induction Phase|Incarceration|0|||
155230117|NCT00207142|560280297|FG002|Induction Phase|Incarceration|0|||
155230118|NCT00207142|560280298|FG003|Induction Phase|Incarceration|0|||
155230119|NCT00207142|560280295|FG000|Induction Phase|Missing lab data|1|||
155230120|NCT00207142|560280296|FG001|Induction Phase|Missing lab data|0|||
155230121|NCT00207142|560280297|FG002|Induction Phase|Missing lab data|0|||
155230122|NCT00207142|560280298|FG003|Induction Phase|Missing lab data|0|||
155230123|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
155230124|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
155230125|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
155230126|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
155230127|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
155230128|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
155230129|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
155230130|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
155230131|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230132|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230133|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
155230134|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230135|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
155230136|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
155230137|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
155230138|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
155230139|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
155230140|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
155230141|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
155230142|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
155230143|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230144|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230145|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
155230146|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230147|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
155230148|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
155230149|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
155230150|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
155230151|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Death|0|||
155230152|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Death|0|||
155230153|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Death|0|||
155230154|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Death|1|||
155230155|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230156|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230157|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230158|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
155230159|NCT01857063|560280299|FG000|Period 1 (7 Days)|Adverse Event|0|||
155230160|NCT01857063|560280300|FG001|Period 1 (7 Days)|Adverse Event|1|||
155230161|NCT01857063|560280299|FG000|Period 1 (7 Days)|Physician Decision|1|||
155230162|NCT01857063|560280300|FG001|Period 1 (7 Days)|Physician Decision|0|||
155230163|NCT01857063|560280299|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
155230164|NCT01857063|560280300|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
155230165|NCT01857063|560280299|FG000|Period 2 (7 Days)|Adverse Event|2|||
155230166|NCT01857063|560280300|FG001|Period 2 (7 Days)|Adverse Event|1|||
155230167|NCT01857063|560280299|FG000|Period 2 (7 Days)|Physician Decision|1|||
155230168|NCT01857063|560280300|FG001|Period 2 (7 Days)|Physician Decision|1|||
155230169|NCT01857063|560280299|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
155230170|NCT01857063|560280300|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
155230171|NCT04958109|560280301|FG000|Overall Study|Withdrawal by Subject|0|||
155230172|NCT04958109|560280302|FG001|Overall Study|Withdrawal by Subject|1|||
155230173|NCT04958109|560280301|FG000|Overall Study|Lost to Follow-up|0|||
155230174|NCT04958109|560280302|FG001|Overall Study|Lost to Follow-up|1|||
155230175|NCT01256710|560280303|FG000|Overall Study|Death|449|||
155230176|NCT01256710|560280303|FG000|Overall Study|System Explant|67|||
155230177|NCT01256710|560280303|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
155230178|NCT01256710|560280303|FG000|Overall Study|Lost to Follow-up|67|||
155230179|NCT01256710|560280303|FG000|Overall Study|Withdrawal by Subject|29|||
155230180|NCT01256710|560280303|FG000|Overall Study|Physician Decision|9|||
155230181|NCT01256710|560280303|FG000|Overall Study|Subject Noncompliance|2|||
155230182|NCT01256710|560280303|FG000|Overall Study|Study Terminated by Sponsor|273|||
155230183|NCT00058825|560280304|FG000|Overall Study|Relapse|9|||
155230184|NCT00058825|560280304|FG000|Overall Study|Progressive Disease|5|||
155230185|NCT00058825|560280304|FG000|Overall Study|Graft Failure|5|||
155230186|NCT00058825|560280304|FG000|Overall Study|Death|3|||
155230187|NCT02681302|560280306|FG000|Overall Study|Withdrawal by Subject|1|||
155230188|NCT02681302|560280307|FG001|Overall Study|Withdrawal by Subject|1|||
155230189|NCT02681302|560280308|FG002|Overall Study|Withdrawal by Subject|0|||
155230190|NCT02681302|560280309|FG003|Overall Study|Withdrawal by Subject|0|||
155230191|NCT02681302|560280310|FG004|Overall Study|Withdrawal by Subject|1|||
155230192|NCT02681302|560280311|FG005|Overall Study|Withdrawal by Subject|0|||
155230193|NCT02681302|560280306|FG000|Overall Study|Screen Failure|2|||
155230194|NCT02681302|560280307|FG001|Overall Study|Screen Failure|4|||
155230195|NCT02681302|560280308|FG002|Overall Study|Screen Failure|2|||
155230196|NCT02681302|560280309|FG003|Overall Study|Screen Failure|0|||
155230197|NCT02681302|560280310|FG004|Overall Study|Screen Failure|1|||
155230198|NCT02681302|560280311|FG005|Overall Study|Screen Failure|1|||
155230199|NCT02681302|560280306|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230200|NCT02681302|560280307|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230201|NCT02681302|560280308|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230202|NCT02681302|560280309|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230203|NCT02681302|560280310|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230204|NCT02681302|560280311|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
155230205|NCT00838565|560280312|FG000|Overall Study|Withdrawal by Subject|0|||
155230206|NCT00838565|560280313|FG001|Overall Study|Withdrawal by Subject|0|||
155230207|NCT00838565|560280314|FG002|Overall Study|Withdrawal by Subject|1|||
155230208|NCT00838565|560280315|FG003|Overall Study|Withdrawal by Subject|0|||
155230209|NCT00838565|560280316|FG004|Overall Study|Withdrawal by Subject|0|||
155230210|NCT00838565|560280317|FG005|Overall Study|Withdrawal by Subject|2|||
155230211|NCT00838565|560280312|FG000|Overall Study|Other|0|||
155230212|NCT00838565|560280313|FG001|Overall Study|Other|2|||
155230213|NCT00838565|560280314|FG002|Overall Study|Other|0|||
155230214|NCT00838565|560280315|FG003|Overall Study|Other|0|||
155230215|NCT00838565|560280316|FG004|Overall Study|Other|0|||
155230216|NCT00838565|560280317|FG005|Overall Study|Other|0|||
155230217|NCT00838565|560280312|FG000|Overall Study|Randomized but not Treated|0|||
155230218|NCT00838565|560280313|FG001|Overall Study|Randomized but not Treated|1|||
155230219|NCT00838565|560280314|FG002|Overall Study|Randomized but not Treated|0|||
155230220|NCT00838565|560280315|FG003|Overall Study|Randomized but not Treated|0|||
155230221|NCT00838565|560280316|FG004|Overall Study|Randomized but not Treated|0|||
155230222|NCT00838565|560280317|FG005|Overall Study|Randomized but not Treated|0|||
155230223|NCT00458484|560280318|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
155230224|NCT00458484|560280319|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
155230225|NCT00458484|560280320|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
155230226|NCT00458484|560280321|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
155230227|NCT00458484|560280322|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
155230228|NCT00458484|560280323|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
155230229|NCT00458484|560280324|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
155230230|NCT01838642|560280325|FG000|Overall Study|Died on study|1|||
155230231|NCT01557400|560280326|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
155230232|NCT01557400|560280326|FG000|Overall Study|Adverse Event|3|||
155230233|NCT01557400|560280326|FG000|Overall Study|Lost to Follow-up|5|||
155230234|NCT01557400|560280326|FG000|Overall Study|Withdrawal by Subject|9|||
155230235|NCT00245765|560280328|FG000|Overall Study|Adverse Event|1|||
155230236|NCT00245765|560280329|FG001|Overall Study|Adverse Event|1|||
155230237|NCT00245765|560280330|FG002|Overall Study|Adverse Event|0|||
155230238|NCT00245765|560280328|FG000|Overall Study|Lack of Efficacy|14|||
155230239|NCT00245765|560280329|FG001|Overall Study|Lack of Efficacy|7|||
155230240|NCT00245765|560280330|FG002|Overall Study|Lack of Efficacy|0|||
155230241|NCT00245765|560280328|FG000|Overall Study|Lost to Follow-up|1|||
155230242|NCT00245765|560280329|FG001|Overall Study|Lost to Follow-up|2|||
155230243|NCT00245765|560280330|FG002|Overall Study|Lost to Follow-up|0|||
155230244|NCT00245765|560280328|FG000|Overall Study|Withdrawal by Subject|1|||
155230245|NCT00245765|560280329|FG001|Overall Study|Withdrawal by Subject|0|||
155230246|NCT00245765|560280330|FG002|Overall Study|Withdrawal by Subject|3|||
155230247|NCT00245765|560280328|FG000|Overall Study|Other reason|2|||
155230248|NCT00245765|560280329|FG001|Overall Study|Other reason|0|||
155230249|NCT00245765|560280330|FG002|Overall Study|Other reason|1|||
155230250|NCT00245765|560280328|FG000|Overall Study|Other|13|||
155230251|NCT00245765|560280329|FG001|Overall Study|Other|4|||
155230252|NCT00245765|560280330|FG002|Overall Study|Other|4|||
155230253|NCT04477304|560280333|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
155230254|NCT04477304|560280334|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
155230255|NCT03548584|560281752|FG000|Overall Study|Lost to Follow-up|0|||
155230256|NCT03548584|560281753|FG001|Overall Study|Lost to Follow-up|0|||
155230257|NCT03548584|560281754|FG002|Overall Study|Lost to Follow-up|1|||
155230258|NCT03548584|560281752|FG000|Overall Study|Adverse Event|1|||
155230259|NCT03548584|560281753|FG001|Overall Study|Adverse Event|11|||
155230260|NCT03548584|560281754|FG002|Overall Study|Adverse Event|5|||
155230261|NCT03548584|560281752|FG000|Overall Study|Site Terminated by Sponsor|1|||
155230262|NCT03548584|560281753|FG001|Overall Study|Site Terminated by Sponsor|3|||
155230263|NCT03548584|560281754|FG002|Overall Study|Site Terminated by Sponsor|2|||
155230264|NCT03548584|560281752|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
155230265|NCT03548584|560281753|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
155230266|NCT03548584|560281754|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
155230267|NCT03548584|560281752|FG000|Overall Study|Lack of Efficacy|0|||
155230268|NCT03548584|560281753|FG001|Overall Study|Lack of Efficacy|1|||
155230269|NCT03548584|560281754|FG002|Overall Study|Lack of Efficacy|0|||
155230270|NCT03548584|560281752|FG000|Overall Study|Non-compliance with Study Drug|0|||
155230271|NCT03548584|560281753|FG001|Overall Study|Non-compliance with Study Drug|1|||
155230272|NCT03548584|560281754|FG002|Overall Study|Non-compliance with Study Drug|0|||
155230273|NCT03548584|560281752|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
155230274|NCT03548584|560281753|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
155230275|NCT03548584|560281754|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
155230276|NCT00293384|560281755|FG000|Overall Study|Non-compliance|2|||
155230277|NCT00293384|560281755|FG000|Overall Study|Missed dosage/study drug|1|||
155230278|NCT00293384|560281755|FG000|Overall Study|Ineligible|2|||
155230279|NCT00640510|560281756|FG000|Overall Study|Lack of Efficacy|0|||
155230280|NCT00640510|560281757|FG001|Overall Study|Lack of Efficacy|1|||
155230281|NCT00640510|560281756|FG000|Overall Study|Protocol Violation|1|||
155230282|NCT00640510|560281757|FG001|Overall Study|Protocol Violation|0|||
155230283|NCT00640510|560281756|FG000|Overall Study|Physician Decision|0|||
155230284|NCT00640510|560281757|FG001|Overall Study|Physician Decision|1|||
155230285|NCT01440322|560281758|FG000|Overall Study|Discomfort|2|||
155230286|NCT01440322|560281759|FG001|Overall Study|Discomfort|0|||
155230287|NCT01440322|560281758|FG000|Overall Study|Biomicroscopy|1|||
155230288|NCT01440322|560281759|FG001|Overall Study|Biomicroscopy|0|||
155230289|NCT01440322|560281758|FG000|Overall Study|Symptoms and Problems|1|||
155230290|NCT01440322|560281759|FG001|Overall Study|Symptoms and Problems|0|||
155230291|NCT01440322|560281758|FG000|Overall Study|Unacceptable Subjective Vision|1|||
155230292|NCT01440322|560281759|FG001|Overall Study|Unacceptable Subjective Vision|0|||
155230293|NCT01440322|560281758|FG000|Overall Study|Other Product Related|1|||
155230294|NCT01440322|560281759|FG001|Overall Study|Other Product Related|0|||
155230295|NCT01440322|560281758|FG000|Overall Study|Unrelated Medical Problem|0|||
155230296|NCT01440322|560281759|FG001|Overall Study|Unrelated Medical Problem|1|||
155230297|NCT01440322|560281758|FG000|Overall Study|Other Non-Product Related|1|||
155230298|NCT01440322|560281759|FG001|Overall Study|Other Non-Product Related|0|||
155230299|NCT02624284|560281768|FG000|Overall Study|Withdrawal by Subject|3|||
155230300|NCT02624284|560281769|FG001|Overall Study|Withdrawal by Subject|6|||
155230301|NCT02624284|560281770|FG002|Overall Study|Withdrawal by Subject|3|||
155230302|NCT02624284|560281768|FG000|Overall Study|Protocol Violation|9|||
155230303|NCT02624284|560281769|FG001|Overall Study|Protocol Violation|10|||
155230304|NCT02624284|560281770|FG002|Overall Study|Protocol Violation|7|||
155230305|NCT02624284|560281768|FG000|Overall Study|Revealed exclusionary condition|2|||
155230306|NCT02624284|560281769|FG001|Overall Study|Revealed exclusionary condition|2|||
155230307|NCT02624284|560281770|FG002|Overall Study|Revealed exclusionary condition|0|||
155230308|NCT02624284|560281768|FG000|Overall Study|Adverse Event|0|||
155230309|NCT02624284|560281769|FG001|Overall Study|Adverse Event|0|||
155230310|NCT02624284|560281770|FG002|Overall Study|Adverse Event|1|||
155230311|NCT01782313|560281771|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
155230312|NCT01782313|560281771|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
155230313|NCT01782313|560281771|FG000|Treated Cycle 3|Progressive Disease|21|||
155230314|NCT01782313|560281771|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
155230315|NCT01782313|560281771|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
155230316|NCT01782313|560281771|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
155230317|NCT01782313|560281771|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
155230318|NCT01782313|560281771|FG000|Survival Follow up|Lost to Follow-up|1|||
155230319|NCT00958776|560281772|FG000|Overall Study|Adverse Event|0|||
155230320|NCT00958776|560281773|FG001|Overall Study|Adverse Event|1|||
155230321|NCT00958776|560281772|FG000|Overall Study|Physician Decision|1|||
155230322|NCT00958776|560281773|FG001|Overall Study|Physician Decision|0|||
155230323|NCT00958776|560281772|FG000|Overall Study|Lost to Follow-up|2|||
155230324|NCT00958776|560281773|FG001|Overall Study|Lost to Follow-up|6|||
155230325|NCT00958776|560281772|FG000|Overall Study|Withdrawal by Subject|7|||
155230326|NCT00958776|560281773|FG001|Overall Study|Withdrawal by Subject|16|||
155230327|NCT00958776|560281772|FG000|Overall Study|Protocol Violation|1|||
155230328|NCT00958776|560281773|FG001|Overall Study|Protocol Violation|1|||
155230329|NCT00958776|560281772|FG000|Overall Study|Death|2|||
155230330|NCT00958776|560281773|FG001|Overall Study|Death|1|||
155230331|NCT00958776|560281772|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
155230332|NCT00958776|560281773|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
155230333|NCT00958776|560281772|FG000|Overall Study|Missing|1|||
155230334|NCT00958776|560281773|FG001|Overall Study|Missing|1|||
155230335|NCT00326911|560281774|FG000|Overall Study|Hospitalization prior to treatment|0|||
155230336|NCT00326911|560281775|FG001|Overall Study|Hospitalization prior to treatment|1|||
155230337|NCT00326911|560281774|FG000|Overall Study|Physician decision prior to treatment|1|||
155230338|NCT00326911|560281775|FG001|Overall Study|Physician decision prior to treatment|0|||
155230339|NCT00326911|560281774|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
155230340|NCT00326911|560281775|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
155230341|NCT02506816|560281782|FG000|Overall Study|Adverse Event|3|||
155230342|NCT02103478|560281787|FG000|Overall Study|Adverse Event|0|||
155230343|NCT02103478|560281788|FG001|Overall Study|Adverse Event|0|||
155230344|NCT02103478|560281789|FG002|Overall Study|Adverse Event|1|||
155230345|NCT02103478|560281790|FG003|Overall Study|Adverse Event|1|||
155230346|NCT02103478|560281791|FG004|Overall Study|Adverse Event|2|||
155230347|NCT02103478|560281792|FG005|Overall Study|Adverse Event|1|||
155230348|NCT02103478|560281793|FG006|Overall Study|Adverse Event|0|||
155230349|NCT02103478|560281794|FG007|Overall Study|Adverse Event|0|||
155230350|NCT02103478|560281795|FG008|Overall Study|Adverse Event|0|||
155230351|NCT02103478|560281787|FG000|Overall Study|Death|2|||
155230352|NCT02103478|560281788|FG001|Overall Study|Death|2|||
155230353|NCT02103478|560281789|FG002|Overall Study|Death|1|||
155230354|NCT02103478|560281790|FG003|Overall Study|Death|1|||
155230355|NCT02103478|560281791|FG004|Overall Study|Death|5|||
155230356|NCT02103478|560281792|FG005|Overall Study|Death|15|||
155230357|NCT02103478|560281793|FG006|Overall Study|Death|14|||
155230358|NCT02103478|560281794|FG007|Overall Study|Death|10|||
155230359|NCT02103478|560281795|FG008|Overall Study|Death|11|||
155230360|NCT02103478|560281787|FG000|Overall Study|Progressive Disease|2|||
155230361|NCT02103478|560281788|FG001|Overall Study|Progressive Disease|1|||
155230362|NCT02103478|560281789|FG002|Overall Study|Progressive Disease|2|||
155230363|NCT02103478|560281790|FG003|Overall Study|Progressive Disease|0|||
155230364|NCT02103478|560281791|FG004|Overall Study|Progressive Disease|9|||
155230365|NCT02103478|560281792|FG005|Overall Study|Progressive Disease|1|||
155230366|NCT02103478|560281793|FG006|Overall Study|Progressive Disease|2|||
155230367|NCT02103478|560281794|FG007|Overall Study|Progressive Disease|0|||
155230368|NCT02103478|560281795|FG008|Overall Study|Progressive Disease|1|||
155230369|NCT02103478|560281787|FG000|Overall Study|Withdrawal by Subject|2|||
155230370|NCT02103478|560281788|FG001|Overall Study|Withdrawal by Subject|0|||
155230371|NCT02103478|560281789|FG002|Overall Study|Withdrawal by Subject|0|||
155230372|NCT02103478|560281790|FG003|Overall Study|Withdrawal by Subject|4|||
155230373|NCT02103478|560281791|FG004|Overall Study|Withdrawal by Subject|0|||
155230374|NCT02103478|560281792|FG005|Overall Study|Withdrawal by Subject|0|||
155230375|NCT02103478|560281793|FG006|Overall Study|Withdrawal by Subject|1|||
155230376|NCT02103478|560281794|FG007|Overall Study|Withdrawal by Subject|1|||
155230377|NCT02103478|560281795|FG008|Overall Study|Withdrawal by Subject|0|||
155230378|NCT02103478|560281787|FG000|Overall Study|Lost to Follow-up|0|||
155230379|NCT02103478|560281788|FG001|Overall Study|Lost to Follow-up|0|||
155230380|NCT02103478|560281789|FG002|Overall Study|Lost to Follow-up|0|||
155230381|NCT02103478|560281790|FG003|Overall Study|Lost to Follow-up|0|||
155230382|NCT02103478|560281791|FG004|Overall Study|Lost to Follow-up|0|||
155230383|NCT02103478|560281792|FG005|Overall Study|Lost to Follow-up|0|||
155230384|NCT02103478|560281793|FG006|Overall Study|Lost to Follow-up|0|||
155230385|NCT02103478|560281794|FG007|Overall Study|Lost to Follow-up|1|||
155230386|NCT02103478|560281795|FG008|Overall Study|Lost to Follow-up|0|||
155230387|NCT02103478|560281787|FG000|Overall Study|Other|1|||
155230388|NCT02103478|560281788|FG001|Overall Study|Other|3|||
155230389|NCT02103478|560281789|FG002|Overall Study|Other|2|||
155230390|NCT02103478|560281790|FG003|Overall Study|Other|0|||
155230391|NCT02103478|560281791|FG004|Overall Study|Other|3|||
155230392|NCT02103478|560281792|FG005|Overall Study|Other|8|||
155230393|NCT02103478|560281793|FG006|Overall Study|Other|8|||
155230394|NCT02103478|560281794|FG007|Overall Study|Other|4|||
155230395|NCT02103478|560281795|FG008|Overall Study|Other|2|||
155230396|NCT00723606|560281796|FG000|Overall Study|Adverse Event|2|||
155230397|NCT00723606|560281797|FG001|Overall Study|Adverse Event|5|||
155230398|NCT00723606|560281796|FG000|Overall Study|Other|2|||
155230399|NCT00723606|560281797|FG001|Overall Study|Other|0|||
155230400|NCT00723606|560281796|FG000|Overall Study|Withdrawal by Subject|0|||
155230401|NCT00723606|560281797|FG001|Overall Study|Withdrawal by Subject|2|||
155230402|NCT01470469|560281798|FG000|Overall Study|Withdrawal by Subject|4|||
155230403|NCT01470469|560281799|FG001|Overall Study|Withdrawal by Subject|6|||
155230404|NCT01470469|560281798|FG000|Overall Study|Lack of Efficacy|1|||
155230405|NCT01470469|560281799|FG001|Overall Study|Lack of Efficacy|7|||
155230406|NCT01470469|560281798|FG000|Overall Study|Adverse Event|0|||
155230407|NCT01470469|560281799|FG001|Overall Study|Adverse Event|7|||
155230408|NCT01470469|560281798|FG000|Overall Study|Lost to Follow-up|2|||
155230409|NCT01470469|560281799|FG001|Overall Study|Lost to Follow-up|2|||
155230410|NCT01470469|560281798|FG000|Overall Study|Protocol Violation|1|||
155230411|NCT01470469|560281799|FG001|Overall Study|Protocol Violation|1|||
155230412|NCT01470469|560281798|FG000|Overall Study|Other|2|||
155230413|NCT01470469|560281799|FG001|Overall Study|Other|1|||
155230414|NCT03362502|560281800|FG000|Overall Study|Death|0|||
155230415|NCT03362502|560281801|FG001|Overall Study|Death|0|||
155230416|NCT03362502|560281802|FG002|Overall Study|Death|1|||
155230417|NCT02388997|560281829|FG000|Overall Study|Adverse Event|1|||
155230418|NCT02388997|560281830|FG001|Overall Study|Adverse Event|2|||
155230419|NCT02388997|560281829|FG000|Overall Study|Withdrawal by Subject|2|||
155230420|NCT02388997|560281830|FG001|Overall Study|Withdrawal by Subject|1|||
155230421|NCT02388997|560281829|FG000|Overall Study|Lung function exclusion criteria|0|||
155230422|NCT02388997|560281830|FG001|Overall Study|Lung function exclusion criteria|2|||
155230423|NCT02388997|560281829|FG000|Overall Study|Tested positive for virus during run-in|0|||
155230424|NCT02388997|560281830|FG001|Overall Study|Tested positive for virus during run-in|1|||
155230425|NCT00715793|560281833|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
155230426|NCT00715793|560281834|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
155230427|NCT00715793|560281833|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
155230428|NCT00715793|560281834|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
155230429|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230430|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
155230431|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
155230432|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
155230433|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230434|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230435|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230436|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230437|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230438|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230439|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230440|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230441|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230442|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230443|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230444|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230445|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230446|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230447|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230448|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230449|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230450|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230451|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230452|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230453|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155491461|NCT00563706|561225400|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
155230454|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
155230455|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230456|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230457|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230458|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230459|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230460|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230461|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230462|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230463|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230464|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230465|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230466|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230467|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230468|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230469|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230470|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230471|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230472|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230473|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230474|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230475|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230476|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230477|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230478|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
155230479|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230480|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230481|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230482|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230483|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230484|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230485|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230486|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230487|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230488|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230489|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230490|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230491|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230492|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230493|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230494|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230495|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230496|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230497|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230498|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230499|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230500|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230501|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
155230502|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
155230503|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
155230504|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
155230505|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230506|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230507|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230508|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230509|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230510|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230511|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230512|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230513|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230514|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230515|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230516|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230517|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230518|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230519|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230520|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230521|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230522|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230523|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230524|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230525|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
155230526|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
155230527|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
155230528|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
155230529|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230530|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230531|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230532|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230533|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230534|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230535|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230536|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230537|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230538|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230539|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230540|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230541|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230542|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230543|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230544|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230545|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230546|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230547|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230548|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230549|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230550|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
155230551|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230552|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
155230553|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230554|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230555|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230556|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230557|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230558|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230559|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230560|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230561|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230562|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230563|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230564|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230565|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230566|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230567|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230568|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230569|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230570|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230571|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230572|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230573|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230574|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230575|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
155230576|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230577|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230578|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230579|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230580|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230581|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230582|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230583|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230584|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230585|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230586|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230587|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230588|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230589|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230590|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230591|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230592|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230593|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230594|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230595|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230596|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230597|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230598|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230599|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230600|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230601|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230602|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230603|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230604|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230605|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155230606|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230607|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230608|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230609|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230610|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230611|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
155230612|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230613|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155230614|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230615|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230616|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230617|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230618|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230619|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230620|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230621|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230622|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230623|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230624|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230625|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230626|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230627|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230628|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230629|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230630|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230631|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230632|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230633|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230634|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155230635|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230636|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
155230637|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230638|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230639|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230640|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230641|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230642|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230643|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230644|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230645|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230646|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230647|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230648|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230649|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230650|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230651|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230652|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230653|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230654|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230655|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230656|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230657|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230658|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230659|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
155230660|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230661|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230662|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230663|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230664|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230665|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230666|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230667|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230668|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230669|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230670|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230671|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230672|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230673|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230674|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230675|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230676|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230677|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230678|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230679|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230680|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230681|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230682|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230683|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
155230684|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230685|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230686|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230687|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230688|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230689|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230690|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230691|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230692|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230693|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230694|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230695|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230696|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230697|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230698|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230699|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230700|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230701|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230702|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230703|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230704|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230705|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230706|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
155230707|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
155230708|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
155230709|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
155230710|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230711|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230712|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230713|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230714|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230715|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230716|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230717|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230718|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230719|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230720|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230721|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230722|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230723|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
155230724|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230725|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230726|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230727|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230728|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230729|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230730|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230731|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230732|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230733|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230734|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230735|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230736|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230737|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230738|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230739|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230740|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230741|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230742|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230743|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230744|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230745|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230746|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230747|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230748|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230749|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230750|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230751|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230752|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230753|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230754|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230755|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230756|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230757|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230758|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230759|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230760|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230761|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230762|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230763|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230764|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230765|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230766|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230767|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230768|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230769|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230770|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230771|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230772|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230773|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230774|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
155230775|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230776|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230777|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230778|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230779|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230780|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230781|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230782|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230783|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230784|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230785|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230786|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230787|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230788|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230789|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230790|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230791|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230792|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230793|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230794|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230795|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230796|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230797|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230798|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230799|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
155230800|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230801|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230802|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230803|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230804|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230805|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230806|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230807|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230808|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230809|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230810|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230811|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230812|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230813|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230814|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230815|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230816|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230817|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230818|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230819|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230820|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230821|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230822|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230823|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230824|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230825|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230826|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230827|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
155230828|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230829|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230830|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230831|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230832|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230833|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230834|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230835|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230836|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230837|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230838|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230839|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230840|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230841|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230842|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230843|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230844|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230845|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230846|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230847|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230848|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230849|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230850|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230851|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
155230852|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230853|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230854|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230855|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230856|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230857|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230858|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230859|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230860|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230861|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230862|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230863|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230864|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230865|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230866|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230867|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230868|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230869|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230870|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230871|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230872|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230873|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230874|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230875|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
155230876|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230877|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230878|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230879|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230880|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230881|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230882|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230883|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230884|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230885|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230886|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230887|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230888|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230889|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230890|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230891|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230892|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230893|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230894|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230895|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230896|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230897|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230898|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230899|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230900|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230901|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230902|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
155230903|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
155230904|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
155230905|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230906|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
155230907|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230908|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230909|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230910|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230911|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230912|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230913|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230914|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230915|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230916|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230917|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230918|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230919|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230920|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230921|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230922|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230923|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230924|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230925|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230926|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230927|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230928|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230929|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230930|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230931|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230932|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230933|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230934|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230935|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230936|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230937|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230938|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230939|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230940|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230941|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230942|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230943|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230944|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230945|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230946|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230947|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230948|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230949|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230950|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230951|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155230952|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230953|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230954|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155230955|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230956|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230957|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230958|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230959|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230960|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230961|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230962|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230963|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230964|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230965|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230966|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230967|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230968|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230969|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230970|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230971|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230972|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230973|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230974|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230975|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230976|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230977|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230978|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
155230979|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230980|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230981|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230982|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230983|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230984|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230985|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230986|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230987|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230988|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230989|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230990|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230991|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230992|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230993|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230994|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230995|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230996|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230997|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230998|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155230999|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155231000|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155231001|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155231002|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231003|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231004|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231005|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231006|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231007|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231008|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231009|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231010|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231011|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231012|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231013|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231014|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231015|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231016|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231017|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231018|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231019|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231020|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231021|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231022|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231023|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
155231024|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231025|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231026|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
155231027|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231028|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231029|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231030|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231031|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231032|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231033|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231034|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231035|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231036|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231037|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231038|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231039|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231040|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231041|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231042|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231043|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231044|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231045|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231046|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231047|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
155231048|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231049|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231050|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
155231051|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
155231052|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
155231053|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231054|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231055|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231056|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231057|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231058|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231059|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231060|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231061|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231062|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231063|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231064|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231065|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231066|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231067|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231068|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231069|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231070|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231071|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
155231072|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231073|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231074|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231075|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231076|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231077|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231078|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231079|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
155231080|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231081|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231082|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
155231083|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231084|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
155231085|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
155231086|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
155231087|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155231088|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
155231089|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155231090|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155231091|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
155231092|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231093|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231094|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231095|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231096|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231097|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231098|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155231099|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231100|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155231101|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231102|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231103|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
155231104|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231105|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231106|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231107|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231108|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231109|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231110|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231111|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231112|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231113|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231114|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231115|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231116|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231117|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
155231118|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231119|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231120|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231121|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231122|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231123|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231124|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231125|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231126|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155231127|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231128|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
155231129|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155491462|NCT00563706|561225401|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
155491463|NCT00563706|561225393|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
155231130|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231131|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231132|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231133|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231134|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231135|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231136|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231137|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231138|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
155231139|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231140|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231141|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231142|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231143|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
155231144|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231145|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231146|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155231147|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231148|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231149|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231150|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231151|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231152|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231153|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231154|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
155231155|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
155231156|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
155231157|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
155231158|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
155231159|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
155231160|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
155231161|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231162|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
155231163|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231164|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231165|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231166|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
155231167|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231168|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
155231169|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231170|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231171|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231172|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231173|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231174|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231175|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231176|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231177|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231178|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231179|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231180|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231181|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231182|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
155231183|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231184|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231185|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231186|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231187|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231188|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231189|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
155231190|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231191|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231192|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231193|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231194|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231195|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
155231196|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
155231197|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231198|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231199|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231200|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231201|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
155231202|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231203|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231204|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
155231205|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231206|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231207|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231208|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231209|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231210|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231211|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
155231212|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231213|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231214|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231215|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231216|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231217|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231218|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231219|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231220|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231221|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231222|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155231223|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155231224|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231225|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231226|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231227|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231228|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231229|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231230|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231231|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
155231232|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231233|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231234|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231235|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155231236|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155231237|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
155231238|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231239|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
155231240|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231241|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231242|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231243|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
155231244|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231245|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
155231246|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231247|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231248|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231249|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231250|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231251|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231252|NCT01573624|560281859|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231253|NCT01573624|560281860|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231254|NCT01573624|560281861|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231255|NCT01573624|560281862|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231256|NCT01573624|560281863|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
155231257|NCT01573624|560281864|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
155231258|NCT01573624|560281865|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231259|NCT01573624|560281859|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
155231260|NCT01573624|560281860|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231261|NCT01573624|560281861|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231262|NCT01573624|560281862|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231263|NCT01573624|560281863|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231264|NCT01573624|560281864|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231265|NCT01573624|560281865|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231266|NCT02942017|560281866|FG000|Overall Study|Adverse Event|0|||
155231267|NCT02942017|560281867|FG001|Overall Study|Adverse Event|1|||
155231268|NCT02942017|560281866|FG000|Overall Study|Withdrawal by Subject|0|||
155231269|NCT02942017|560281867|FG001|Overall Study|Withdrawal by Subject|1|||
155231270|NCT02942017|560281866|FG000|Overall Study|Lost to Follow-up|1|||
155231271|NCT02942017|560281867|FG001|Overall Study|Lost to Follow-up|1|||
155231272|NCT02942017|560281866|FG000|Overall Study|Randomized but not dosed|1|||
155231273|NCT02942017|560281867|FG001|Overall Study|Randomized but not dosed|3|||
155231274|NCT04399161|560281868|FG000|Overall Study|Withdrawal by Subject|1|||
155231275|NCT04399161|560281869|FG001|Overall Study|Withdrawal by Subject|0|||
155231276|NCT04399161|560281870|FG002|Overall Study|Withdrawal by Subject|2|||
155231277|NCT04399161|560281868|FG000|Overall Study|Protocol Violation|1|||
155231278|NCT04399161|560281869|FG001|Overall Study|Protocol Violation|2|||
155231279|NCT04399161|560281870|FG002|Overall Study|Protocol Violation|0|||
155231280|NCT03417141|560281871|FG000|Overall Study|Withdrawal by Subject|1|||
155231281|NCT03417141|560281871|FG000|Overall Study|Protocol Violation|3|||
155231282|NCT02722928|560281872|FG000|Overall Study|Standard CT was not as required per prot|5|||
155231283|NCT02722928|560281873|FG001|Overall Study|Standard CT was not as required per prot|13|||
155231284|NCT02722928|560281872|FG000|Overall Study|Required Intraoperative MRI|5|||
155231285|NCT02722928|560281873|FG001|Overall Study|Required Intraoperative MRI|7|||
155231286|NCT03571516|560281874|FG000|Overall Study|Severe diarrhea|1|||
155231287|NCT03571516|560281875|FG001|Overall Study|Severe diarrhea|0|||
155231288|NCT03571516|560281874|FG000|Overall Study|Withdrawal by Subject|0|||
155231289|NCT03571516|560281875|FG001|Overall Study|Withdrawal by Subject|1|||
155231290|NCT04552587|560281876|FG000|Overall Study|Lost to Follow-up|4|||
155231291|NCT01822132|560281877|FG000|Overall Study|Lost to Follow-up|4|||
155231292|NCT01822132|560281878|FG001|Overall Study|Lost to Follow-up|2|||
155231293|NCT00291668|560281880|FG000|Overall Study|Lack of Efficacy|1|||
155231294|NCT00291668|560281881|FG001|Overall Study|Lack of Efficacy|0|||
155231295|NCT00291668|560281882|FG002|Overall Study|Lack of Efficacy|0|||
155231296|NCT00291668|560281880|FG000|Overall Study|SAE, non-fatal|1|||
155231297|NCT00291668|560281881|FG001|Overall Study|SAE, non-fatal|1|||
155231298|NCT00291668|560281882|FG002|Overall Study|SAE, non-fatal|1|||
155231299|NCT00291668|560281880|FG000|Overall Study|AE, non-serious non-fatal|1|||
155231300|NCT00291668|560281881|FG001|Overall Study|AE, non-serious non-fatal|0|||
155231301|NCT00291668|560281882|FG002|Overall Study|AE, non-serious non-fatal|0|||
155231302|NCT00291668|560281880|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155231303|NCT00291668|560281881|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155231304|NCT00291668|560281882|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155231305|NCT00313612|560281883|FG000|Overall Study|Patient never received treatment|0|||
155231306|NCT00313612|560281884|FG001|Overall Study|Patient never received treatment|1|||
155231307|NCT02540954|560281885|FG000|Overall Study|Physician Decision|3|||
155231308|NCT02540954|560281886|FG001|Overall Study|Physician Decision|1|||
155231309|NCT02540954|560281885|FG000|Overall Study|Withdrawal by Subject|6|||
155231310|NCT02540954|560281886|FG001|Overall Study|Withdrawal by Subject|5|||
155231311|NCT02540954|560281885|FG000|Overall Study|Lost to Follow-up|1|||
155231312|NCT02540954|560281886|FG001|Overall Study|Lost to Follow-up|1|||
155231313|NCT02540954|560281885|FG000|Overall Study|Adverse Event|4|||
155231314|NCT02540954|560281886|FG001|Overall Study|Adverse Event|2|||
155231315|NCT02540954|560281885|FG000|Overall Study|Death|0|||
155231316|NCT02540954|560281886|FG001|Overall Study|Death|3|||
155231317|NCT02540954|560281885|FG000|Overall Study|Treatment failure|1|||
155231318|NCT02540954|560281886|FG001|Overall Study|Treatment failure|0|||
155231319|NCT02540954|560281885|FG000|Overall Study|Other reason|4|||
155231320|NCT02540954|560281886|FG001|Overall Study|Other reason|2|||
155231321|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
155231322|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
155231323|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
155231324|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
155231325|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
155231326|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
155231327|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
155231328|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
155231329|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
155231330|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
155231331|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
155231332|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
155231333|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
155231334|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
155231335|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
155231336|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
155231337|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
155231338|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
155231339|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
155231340|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
155231341|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Other|3|||
155231342|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Other|0|||
155231343|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Other|2|||
155231344|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Other|2|||
155231345|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Other|7|||
155231346|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231347|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231348|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231349|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
155231350|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231351|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231352|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231353|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231354|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231355|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
155231356|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
155231357|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
155231358|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
155231359|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
155231360|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
155231361|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
155231362|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
155231363|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
155231364|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
155231365|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
155231366|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
155231367|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
155231368|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
155231369|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
155231370|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
155231371|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Other|2|||
155231372|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Other|1|||
155231373|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Other|2|||
155231374|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Other|8|||
155231375|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Other|7|||
155231376|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231377|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
155231378|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231379|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231380|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231381|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
155231382|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231383|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231384|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231385|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231386|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
155231387|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
155231388|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
155231389|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
155231390|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
155231391|NCT00213148|560281887|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231392|NCT00213148|560281888|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
155231393|NCT00213148|560281889|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231394|NCT00213148|560281890|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231395|NCT00213148|560281891|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
155231396|NCT00213148|560281887|FG000|Cycle 3 (1 Month)|Other|0|||
155231397|NCT00213148|560281888|FG001|Cycle 3 (1 Month)|Other|0|||
155231398|NCT00213148|560281889|FG002|Cycle 3 (1 Month)|Other|1|||
155231399|NCT00213148|560281890|FG003|Cycle 3 (1 Month)|Other|1|||
155231400|NCT00213148|560281891|FG004|Cycle 3 (1 Month)|Other|0|||
155231401|NCT01723228|560281892|FG000|Overall Study|Adverse Event|2|||
155231402|NCT01723228|560281893|FG001|Overall Study|Adverse Event|6|||
155231403|NCT01723228|560281892|FG000|Overall Study|Withdrawal by Subject|2|||
155231404|NCT01723228|560281893|FG001|Overall Study|Withdrawal by Subject|1|||
155231405|NCT01723228|560281892|FG000|Overall Study|Protocol Violation|0|||
155231406|NCT01723228|560281893|FG001|Overall Study|Protocol Violation|2|||
155231407|NCT01723228|560281892|FG000|Overall Study|Lost to Follow-up|2|||
155231408|NCT01723228|560281893|FG001|Overall Study|Lost to Follow-up|1|||
155231409|NCT01723228|560281892|FG000|Overall Study|Other|2|||
155231410|NCT01723228|560281893|FG001|Overall Study|Other|1|||
155231411|NCT02434770|560281894|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
155231412|NCT02434770|560281895|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
155231413|NCT02434770|560281896|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
155231414|NCT02434770|560281894|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
155231415|NCT02434770|560281895|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
155231416|NCT02434770|560281896|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
155231417|NCT02434770|560281894|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
155231418|NCT02434770|560281895|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
155231419|NCT02434770|560281896|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
155231420|NCT02434770|560281894|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
155231421|NCT02434770|560281895|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
155231422|NCT02434770|560281896|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
155231423|NCT02434770|560281894|FG000|Week 1 to Week 18|Death|1|||
155231424|NCT02434770|560281895|FG001|Week 1 to Week 18|Death|0|||
155231425|NCT02434770|560281896|FG002|Week 1 to Week 18|Death|0|||
155231426|NCT02434770|560281894|FG000|Week 18 to Week|Lost to Follow-up|2|||
155231427|NCT02434770|560281895|FG001|Week 18 to Week|Lost to Follow-up|2|||
155231428|NCT02434770|560281896|FG002|Week 18 to Week|Lost to Follow-up|1|||
155231429|NCT02434770|560281894|FG000|Week 18 to Week|Withdrawal by Subject|0|||
155231430|NCT02434770|560281895|FG001|Week 18 to Week|Withdrawal by Subject|0|||
155231431|NCT02434770|560281896|FG002|Week 18 to Week|Withdrawal by Subject|2|||
155231432|NCT02434770|560281894|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
155231433|NCT02434770|560281895|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
155231434|NCT02434770|560281896|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
155231435|NCT03080961|560281897|FG000|Overall Study|Withdrawal by Subject|3|||
155231436|NCT00660348|560281898|FG000|Overall Study|Withdrawal by Subject|1|||
155231437|NCT00660348|560281899|FG001|Overall Study|Withdrawal by Subject|0|||
155231438|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
155231439|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
155231440|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
155231441|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
155231442|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
155231443|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
155231444|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
155231445|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
155231446|NCT02741115|560281906|FG000|Overall Study|Adverse Event|1|||
155231447|NCT02741115|560281907|FG001|Overall Study|Adverse Event|0|||
155231448|NCT02741115|560281906|FG000|Overall Study|Lost to Follow-up|7|||
155231449|NCT02741115|560281907|FG001|Overall Study|Lost to Follow-up|4|||
155231450|NCT02741115|560281906|FG000|Overall Study|Withdrawal by Subject|4|||
155231451|NCT02741115|560281907|FG001|Overall Study|Withdrawal by Subject|2|||
155231452|NCT04602624|560281908|FG000|Overall Study|Protocol Deviation|1|||
155231453|NCT04602624|560281908|FG000|Overall Study|Withdrawal by Participant|1|||
155231454|NCT00445328|560281909|FG000|Overall Study|Death|0|||
155231455|NCT00445328|560281910|FG001|Overall Study|Death|1|||
155231456|NCT00445328|560281909|FG000|Overall Study|Adverse Event|0|||
155231457|NCT00445328|560281910|FG001|Overall Study|Adverse Event|3|||
155231458|NCT00445328|560281909|FG000|Overall Study|Other|0|||
155231459|NCT00445328|560281910|FG001|Overall Study|Other|2|||
155231460|NCT00445328|560281909|FG000|Overall Study|Withdrawal by Subject|2|||
155231461|NCT00445328|560281910|FG001|Overall Study|Withdrawal by Subject|0|||
155231462|NCT00445328|560281909|FG000|Overall Study|Protocol Violation|1|||
155231463|NCT00445328|560281910|FG001|Overall Study|Protocol Violation|0|||
155231464|NCT00316199|560281911|FG000|Overall Study|Adverse Event|2|||
155231465|NCT00316199|560281911|FG000|Overall Study|Death|8|||
155231466|NCT00316199|560281911|FG000|Overall Study|Lost to Follow-up|2|||
155231467|NCT03316872|560281912|FG000|Overall Study|Death|1|||
155231468|NCT02742103|560283140|FG000|Overall Study|Protocol Violation|1|||
155231469|NCT02742103|560283141|FG001|Overall Study|Protocol Violation|0|||
155231470|NCT02742103|560283140|FG000|Overall Study|Death|2|||
155231471|NCT02742103|560283141|FG001|Overall Study|Death|2|||
155231472|NCT02742103|560283140|FG000|Overall Study|Adverse Event|1|||
155231473|NCT02742103|560283141|FG001|Overall Study|Adverse Event|0|||
155231474|NCT02742103|560283140|FG000|Overall Study|Moved to another town|0|||
155231475|NCT02742103|560283141|FG001|Overall Study|Moved to another town|1|||
155231476|NCT02742103|560283140|FG000|Overall Study|Withdrawal by Subject|5|||
155231477|NCT02742103|560283141|FG001|Overall Study|Withdrawal by Subject|2|||
155231478|NCT04346615|560283142|FG000|Overall Study|Lost to Follow-up|0|||
155231479|NCT04346615|560283143|FG001|Overall Study|Lost to Follow-up|2|||
155231480|NCT04346615|560283142|FG000|Overall Study|Withdrawal by Subject|1|||
155231481|NCT04346615|560283143|FG001|Overall Study|Withdrawal by Subject|0|||
155231482|NCT04346615|560283142|FG000|Overall Study|Death|5|||
155231483|NCT04346615|560283143|FG001|Overall Study|Death|1|||
155231484|NCT04346615|560283142|FG000|Overall Study|Other|0|||
155231485|NCT04346615|560283143|FG001|Overall Study|Other|2|||
155231486|NCT04346615|560283142|FG000|Overall Study|Randomized not treated|1|||
155231487|NCT04346615|560283143|FG001|Overall Study|Randomized not treated|0|||
155231488|NCT00533949|560283146|FG000|Overall Study|Protocol Violation|12|||
155231489|NCT00533949|560283147|FG001|Overall Study|Protocol Violation|12|||
155231490|NCT00533949|560283148|FG002|Overall Study|Protocol Violation|9|||
155231491|NCT00533949|560283149|FG003|Overall Study|Protocol Violation|9|||
155231492|NCT00533949|560283146|FG000|Overall Study|Withdrawal by Subject|3|||
155231493|NCT00533949|560283147|FG001|Overall Study|Withdrawal by Subject|2|||
155231494|NCT00533949|560283148|FG002|Overall Study|Withdrawal by Subject|1|||
155231495|NCT00533949|560283149|FG003|Overall Study|Withdrawal by Subject|1|||
155231496|NCT00727194|560283150|FG000|Screening Period|Low QMG scores|0|||
155231497|NCT00727194|560283151|FG001|Screening Period|Low QMG scores|0|||
155231498|NCT00727194|560283152|FG002|Screening Period|Low QMG scores|6|||
155231499|NCT00727194|560283150|FG000|Screening Period|Lacked AChR antibodies|0|||
155231500|NCT00727194|560283151|FG001|Screening Period|Lacked AChR antibodies|0|||
155231501|NCT00727194|560283152|FG002|Screening Period|Lacked AChR antibodies|5|||
155231502|NCT00727194|560283150|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
155231503|NCT00727194|560283151|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
155231504|NCT00727194|560283152|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
155231505|NCT00727194|560283150|FG000|Screening Period|Severe infections|0|||
155231506|NCT00727194|560283151|FG001|Screening Period|Severe infections|0|||
155231507|NCT00727194|560283152|FG002|Screening Period|Severe infections|2|||
155231508|NCT00727194|560283150|FG000|Screening Period|History of thymoma|0|||
155231509|NCT00727194|560283151|FG001|Screening Period|History of thymoma|0|||
155231510|NCT00727194|560283152|FG002|Screening Period|History of thymoma|1|||
155231511|NCT00727194|560283150|FG000|Treatment Period 2|Lack of Efficacy|0|||
155231512|NCT00727194|560283151|FG001|Treatment Period 2|Lack of Efficacy|1|||
155231513|NCT00727194|560283152|FG002|Treatment Period 2|Lack of Efficacy|0|||
155231514|NCT01677195|560283159|FG000|Overall Study|Lost to Follow-up|14|||
155231515|NCT01677195|560283160|FG001|Overall Study|Lost to Follow-up|22|||
155231516|NCT01677195|560283161|FG002|Overall Study|Lost to Follow-up|22|||
155231517|NCT01677195|560283159|FG000|Overall Study|Withdrawal by Subject|1|||
155231518|NCT01677195|560283160|FG001|Overall Study|Withdrawal by Subject|0|||
155231519|NCT01677195|560283161|FG002|Overall Study|Withdrawal by Subject|1|||
155231520|NCT01677195|560283159|FG000|Overall Study|Adverse Event|6|||
155231521|NCT01677195|560283160|FG001|Overall Study|Adverse Event|4|||
155231522|NCT01677195|560283161|FG002|Overall Study|Adverse Event|1|||
155231523|NCT01677195|560283159|FG000|Overall Study|Physician Decision|1|||
155231524|NCT01677195|560283160|FG001|Overall Study|Physician Decision|2|||
155231525|NCT01677195|560283161|FG002|Overall Study|Physician Decision|2|||
155231526|NCT01677195|560283159|FG000|Overall Study|Pregnancy|0|||
155231527|NCT01677195|560283160|FG001|Overall Study|Pregnancy|1|||
155231528|NCT01677195|560283161|FG002|Overall Study|Pregnancy|0|||
155231529|NCT01677195|560283159|FG000|Overall Study|Protocol Violation|7|||
155231530|NCT01677195|560283160|FG001|Overall Study|Protocol Violation|3|||
155231531|NCT01677195|560283161|FG002|Overall Study|Protocol Violation|4|||
155231532|NCT04368429|560283162|FG000|Overall Study|Adverse Event|1|||
155231533|NCT04368429|560283163|FG001|Overall Study|Adverse Event|0|||
155231534|NCT03633396|560283164|FG000|Overall Study|Withdrawal by Subject|4|||
155231535|NCT03633396|560283165|FG001|Overall Study|Withdrawal by Subject|4|||
155231536|NCT03633396|560283164|FG000|Overall Study|Adverse Event|1|||
155231537|NCT03633396|560283165|FG001|Overall Study|Adverse Event|1|||
155231538|NCT03633396|560283164|FG000|Overall Study|Lack of Efficacy|1|||
155231539|NCT03633396|560283165|FG001|Overall Study|Lack of Efficacy|0|||
155231540|NCT03633396|560283164|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
155231541|NCT03633396|560283165|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
155231542|NCT01012817|560283166|FG000|Overall Study|Withdrawal by Subject|0|||
155231543|NCT01012817|560283167|FG001|Overall Study|Withdrawal by Subject|0|||
155231544|NCT01012817|560283168|FG002|Overall Study|Withdrawal by Subject|0|||
155231545|NCT01012817|560283169|FG003|Overall Study|Withdrawal by Subject|1|||
155231546|NCT01012817|560283170|FG004|Overall Study|Withdrawal by Subject|0|||
155231547|NCT01012817|560283171|FG005|Overall Study|Withdrawal by Subject|0|||
155231548|NCT01012817|560283172|FG006|Overall Study|Withdrawal by Subject|0|||
155231549|NCT01012817|560283173|FG007|Overall Study|Withdrawal by Subject|1|||
155231550|NCT01012817|560283174|FG008|Overall Study|Withdrawal by Subject|0|||
155231551|NCT01012817|560283175|FG009|Overall Study|Withdrawal by Subject|0|||
155231552|NCT01012817|560283176|FG010|Overall Study|Withdrawal by Subject|1|||
155231553|NCT01012817|560283177|FG011|Overall Study|Withdrawal by Subject|1|||
155231554|NCT01012817|560283178|FG012|Overall Study|Withdrawal by Subject|0|||
155231555|NCT01012817|560283179|FG013|Overall Study|Withdrawal by Subject|1|||
155231556|NCT01012817|560283166|FG000|Overall Study|Adverse Event|0|||
155231557|NCT01012817|560283167|FG001|Overall Study|Adverse Event|0|||
155231558|NCT01012817|560283168|FG002|Overall Study|Adverse Event|0|||
155231559|NCT01012817|560283169|FG003|Overall Study|Adverse Event|0|||
155231560|NCT01012817|560283170|FG004|Overall Study|Adverse Event|0|||
155231561|NCT01012817|560283171|FG005|Overall Study|Adverse Event|1|||
155231562|NCT01012817|560283172|FG006|Overall Study|Adverse Event|0|||
155231563|NCT01012817|560283173|FG007|Overall Study|Adverse Event|0|||
155231564|NCT01012817|560283174|FG008|Overall Study|Adverse Event|0|||
155231565|NCT01012817|560283175|FG009|Overall Study|Adverse Event|0|||
155231566|NCT01012817|560283176|FG010|Overall Study|Adverse Event|1|||
155231567|NCT01012817|560283177|FG011|Overall Study|Adverse Event|0|||
155231568|NCT01012817|560283178|FG012|Overall Study|Adverse Event|0|||
155231569|NCT01012817|560283179|FG013|Overall Study|Adverse Event|1|||
155231570|NCT00023673|560283180|FG000|Overall Study|Ineligible / no protocol treatment|0|||
155231571|NCT00023673|560283181|FG001|Overall Study|Ineligible / no protocol treatment|0|||
155231572|NCT00023673|560283182|FG002|Overall Study|Ineligible / no protocol treatment|0|||
155231573|NCT00023673|560283183|FG003|Overall Study|Ineligible / no protocol treatment|1|||
155231574|NCT00023673|560283180|FG000|Overall Study|Patient withdrew consent|0|||
155231575|NCT00023673|560283181|FG001|Overall Study|Patient withdrew consent|0|||
155231576|NCT00023673|560283182|FG002|Overall Study|Patient withdrew consent|0|||
155231577|NCT00023673|560283183|FG003|Overall Study|Patient withdrew consent|1|||
155231578|NCT02472756|560283184|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
155231579|NCT02472756|560283184|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
155231580|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
155231581|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
155231582|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
155231583|NCT00110266|560283185|FG000|Overall Study|Adverse Event|27|||
155231584|NCT00110266|560283185|FG000|Overall Study|Abnormal laboratory value|15|||
155231585|NCT00110266|560283185|FG000|Overall Study|Withdrawal by Subject|16|||
155231586|NCT00110266|560283185|FG000|Overall Study|Death|17|||
155231587|NCT00110266|560283185|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155231588|NCT00110266|560283185|FG000|Overall Study|Participant condition no longer requires study drug|1|||
155231589|NCT01344057|560283188|FG000|Overall Study|Premature Withdrawal|1|||
155231590|NCT00548808|560283194|FG000|Overall Study|Lost to Follow-up|9|||
155231591|NCT00548808|560283195|FG001|Overall Study|Lost to Follow-up|3|||
155231592|NCT00548808|560283194|FG000|Overall Study|Protocol Violation|8|||
155231593|NCT00548808|560283195|FG001|Overall Study|Protocol Violation|8|||
155231594|NCT00548808|560283194|FG000|Overall Study|Withdrawal by Subject|8|||
155231595|NCT00548808|560283195|FG001|Overall Study|Withdrawal by Subject|4|||
155231596|NCT00548808|560283194|FG000|Overall Study|Physician Decision|6|||
155231597|NCT00548808|560283195|FG001|Overall Study|Physician Decision|3|||
155231598|NCT00548808|560283194|FG000|Overall Study|Adverse Event|4|||
155231599|NCT00548808|560283195|FG001|Overall Study|Adverse Event|5|||
155231600|NCT00548808|560283194|FG000|Overall Study|Death|2|||
155231601|NCT00548808|560283195|FG001|Overall Study|Death|0|||
155231602|NCT00548808|560283194|FG000|Overall Study|Entry Criteria Not Met|2|||
155231603|NCT00548808|560283195|FG001|Overall Study|Entry Criteria Not Met|2|||
155231604|NCT00548808|560283194|FG000|Overall Study|Lack of Efficacy|2|||
155231605|NCT00548808|560283195|FG001|Overall Study|Lack of Efficacy|0|||
155231606|NCT00548808|560283194|FG000|Overall Study|Sponsor Decision|1|||
155231607|NCT00548808|560283195|FG001|Overall Study|Sponsor Decision|1|||
155231608|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
155231609|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231610|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231611|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231612|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231613|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231614|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231615|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231616|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231617|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231618|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
155231619|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231620|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
155231621|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
155231622|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231623|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231624|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231625|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
155231626|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
155231627|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231628|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
155231629|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231630|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
155231631|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231632|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
155231633|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231634|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
155231635|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231636|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
155231637|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231638|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231639|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
155231640|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231641|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231642|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231643|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231644|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
155231645|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
155231646|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
155231647|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
155231648|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
155231649|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
155231650|NCT00279708|560283204|FG000|Overall Study|Withdrawal by Subject|2|||
155231651|NCT00279708|560283205|FG001|Overall Study|Withdrawal by Subject|3|||
155231652|NCT00279708|560283204|FG000|Overall Study|Adverse Event|1|||
155231653|NCT00279708|560283205|FG001|Overall Study|Adverse Event|1|||
155231654|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Adverse Event|9|||
155231655|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Adverse Event|2|||
155231656|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
155231657|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
155231658|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
155231659|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
155231660|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Physician Decision|1|||
155231661|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Physician Decision|1|||
155231662|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Pregnancy|2|||
155231663|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Pregnancy|0|||
155231664|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
155231665|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
155231666|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Technical problems|1|||
155231667|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Technical problems|0|||
155231668|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
155231669|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
155231670|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
155231671|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
155231672|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
155231673|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
155231674|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
155231675|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
155231676|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
155231677|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
155231678|NCT02940691|560283208|FG000|Overall Study|Lost to Follow-up|5|||
155231679|NCT02940691|560283208|FG000|Overall Study|Incarceration|1|||
155231680|NCT03592641|560283211|FG000|Overall Study|Withdrawal by Subject|1|||
155231681|NCT01049919|560283213|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
155231682|NCT01049919|560283214|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
155231683|NCT01049919|560283213|FG000|Overall Study|Withdrawal by Subject|5|||
155231684|NCT01049919|560283214|FG001|Overall Study|Withdrawal by Subject|0|||
155231685|NCT01049919|560283213|FG000|Overall Study|Lost to Follow-up|6|||
155231686|NCT01049919|560283214|FG001|Overall Study|Lost to Follow-up|1|||
155231687|NCT01049919|560283213|FG000|Overall Study|Physician Decision|2|||
155231688|NCT01049919|560283214|FG001|Overall Study|Physician Decision|0|||
155231689|NCT01049919|560283213|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
155231690|NCT01049919|560283214|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
155231691|NCT01049919|560283213|FG000|Overall Study|Early study termination by sponsor.|2|||
155231692|NCT01049919|560283214|FG001|Overall Study|Early study termination by sponsor.|0|||
155231693|NCT01126541|560283215|FG000|Overall Study|Adverse Event|0|||
155231694|NCT01126541|560283216|FG001|Overall Study|Adverse Event|2|||
155231695|NCT01126541|560283217|FG002|Overall Study|Adverse Event|4|||
155231696|NCT01126541|560283215|FG000|Overall Study|Death|0|||
155231697|NCT01126541|560283216|FG001|Overall Study|Death|1|||
155231698|NCT01126541|560283217|FG002|Overall Study|Death|0|||
155231699|NCT01126541|560283215|FG000|Overall Study|Lack of Efficacy|6|||
155231700|NCT01126541|560283216|FG001|Overall Study|Lack of Efficacy|1|||
155231701|NCT01126541|560283217|FG002|Overall Study|Lack of Efficacy|11|||
155231702|NCT01126541|560283215|FG000|Overall Study|Lost to Follow-up|1|||
155231703|NCT01126541|560283216|FG001|Overall Study|Lost to Follow-up|2|||
155231704|NCT01126541|560283217|FG002|Overall Study|Lost to Follow-up|2|||
155231705|NCT01126541|560283215|FG000|Overall Study|Withdrawal by Subject|2|||
155231706|NCT01126541|560283216|FG001|Overall Study|Withdrawal by Subject|5|||
155231707|NCT01126541|560283217|FG002|Overall Study|Withdrawal by Subject|6|||
155231708|NCT01126541|560283215|FG000|Overall Study|Protocol Violation|0|||
155231709|NCT01126541|560283216|FG001|Overall Study|Protocol Violation|0|||
155231710|NCT01126541|560283217|FG002|Overall Study|Protocol Violation|1|||
155231711|NCT01126541|560283215|FG000|Overall Study|Administrative reason or other|1|||
155231712|NCT01126541|560283216|FG001|Overall Study|Administrative reason or other|1|||
155231713|NCT01126541|560283217|FG002|Overall Study|Administrative reason or other|2|||
155231714|NCT02984995|560283218|FG000|Overall Study|Required stem cell transplant|13|||
155231715|NCT02984995|560283219|FG001|Overall Study|Required stem cell transplant|2|||
155231716|NCT02984995|560283218|FG000|Overall Study|Progressive disease|11|||
155231717|NCT02984995|560283219|FG001|Overall Study|Progressive disease|1|||
155231718|NCT02984995|560283218|FG000|Overall Study|Adverse Event|1|||
155231719|NCT02984995|560283219|FG001|Overall Study|Adverse Event|0|||
155231720|NCT04354831|560283220|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
155231721|NCT04354831|560283221|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
155231722|NCT02504372|560283225|FG000|Overall Study|Death|136|||
155231723|NCT02504372|560283226|FG001|Overall Study|Death|154|||
155231724|NCT02504372|560283225|FG000|Overall Study|Lost to Follow-up|0|||
155231725|NCT02504372|560283226|FG001|Overall Study|Lost to Follow-up|2|||
155231726|NCT02504372|560283225|FG000|Overall Study|Withdrawal of consent|25|||
155231727|NCT02504372|560283226|FG001|Overall Study|Withdrawal of consent|16|||
155231728|NCT02504372|560283225|FG000|Overall Study|Participants ongoing|429|||
155231729|NCT02504372|560283226|FG001|Overall Study|Participants ongoing|415|||
155231730|NCT03323099|560283227|FG000|Overall Study|Withdrawal by Subject|6|||
155231731|NCT03323099|560283228|FG001|Overall Study|Withdrawal by Subject|12|||
155231732|NCT03323099|560283227|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
155231733|NCT03323099|560283228|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
155231734|NCT00767676|560283229|FG000|Overall Study|Investigator error|54|||
155231735|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
155231736|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231737|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231738|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231739|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
155231740|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231741|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231742|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231743|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
155231744|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231745|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231746|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231747|NCT01502644|560283232|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
155231748|NCT01502644|560283233|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
155231749|NCT01502644|560283234|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
155231750|NCT01502644|560283235|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
155231751|NCT01502644|560283232|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
155231752|NCT01502644|560283233|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
155231753|NCT01502644|560283234|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
155231754|NCT01502644|560283235|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
155231755|NCT00547703|560283238|FG000|Overall Study|Lost to Follow-up|1|||
155231756|NCT00547703|560283239|FG001|Overall Study|Lost to Follow-up|0|||
155231757|NCT03120013|560283244|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155231758|NCT03120013|560283245|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155231759|NCT05059600|560283246|FG000|Overall Study|Enrolled but not Treated|10|||
155231760|NCT04907032|560283252|FG000|Overall Study|Withdrawal by Subject|7|||
155231761|NCT04907032|560283253|FG001|Overall Study|Withdrawal by Subject|1|||
155231762|NCT02253810|560283254|FG000|Overall Study|Withdrawal by Subject|2|||
155231763|NCT02253810|560283255|FG001|Overall Study|Withdrawal by Subject|1|||
155231764|NCT02253810|560283254|FG000|Overall Study|Unknown concomitant procedure|3|||
155231765|NCT02253810|560283255|FG001|Overall Study|Unknown concomitant procedure|2|||
155231766|NCT03465878|560283258|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155491464|NCT00563706|561225394|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
155231767|NCT03465878|560283259|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
155231768|NCT03465878|560283260|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155231769|NCT03465878|560283261|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155231770|NCT03465878|560283258|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231771|NCT03465878|560283259|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231772|NCT03465878|560283260|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231773|NCT03465878|560283261|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
155231774|NCT03465878|560283258|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231775|NCT03465878|560283259|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231776|NCT03465878|560283260|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231777|NCT03465878|560283261|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
155231778|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
155231779|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
155231780|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155231781|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231782|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231783|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231784|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231785|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231786|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
155231787|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231788|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231789|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231790|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
155231791|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
155231792|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
155231793|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231794|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231795|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231796|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231797|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231798|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
155231799|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231800|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231801|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231802|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231803|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231804|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231805|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
155231806|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
155231807|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
155231808|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231809|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231810|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231811|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
155231812|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231813|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231814|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231815|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231816|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231817|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231818|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
155231819|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231820|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231821|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231822|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231823|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
155231824|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
155231825|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155231826|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231827|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231828|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231829|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231830|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
155231831|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
155231832|NCT01393743|560283268|FG000|Core Study|Adverse Event|5|||
155231833|NCT01393743|560283269|FG001|Core Study|Adverse Event|9|||
155231834|NCT01393743|560283270|FG002|Core Study|Adverse Event|0|||
155231835|NCT01393743|560283268|FG000|Core Study|Lost to Follow-up|1|||
155231836|NCT01393743|560283269|FG001|Core Study|Lost to Follow-up|1|||
155231837|NCT01393743|560283270|FG002|Core Study|Lost to Follow-up|0|||
155231838|NCT01393743|560283268|FG000|Core Study|Participant's Choice|2|||
155231839|NCT01393743|560283269|FG001|Core Study|Participant's Choice|3|||
155231840|NCT01393743|560283270|FG002|Core Study|Participant's Choice|0|||
155231841|NCT01393743|560283268|FG000|Core Study|Inadequate therapeutic effect|2|||
155231842|NCT01393743|560283269|FG001|Core Study|Inadequate therapeutic effect|0|||
155231843|NCT01393743|560283270|FG002|Core Study|Inadequate therapeutic effect|0|||
155231844|NCT01393743|560283268|FG000|Extension Phase|Adverse Event|0|||
155231845|NCT01393743|560283269|FG001|Extension Phase|Adverse Event|0|||
155231846|NCT01393743|560283270|FG002|Extension Phase|Adverse Event|12|||
155231847|NCT01393743|560283268|FG000|Extension Phase|Lost to Follow-up|0|||
155231848|NCT01393743|560283269|FG001|Extension Phase|Lost to Follow-up|0|||
155231849|NCT01393743|560283270|FG002|Extension Phase|Lost to Follow-up|2|||
155231850|NCT01393743|560283268|FG000|Extension Phase|Participant choice|0|||
155231851|NCT01393743|560283269|FG001|Extension Phase|Participant choice|0|||
155231852|NCT01393743|560283270|FG002|Extension Phase|Participant choice|16|||
155231853|NCT01393743|560283268|FG000|Extension Phase|Inadequate therapeutic effect|0|||
155231854|NCT01393743|560283269|FG001|Extension Phase|Inadequate therapeutic effect|0|||
155231855|NCT01393743|560283270|FG002|Extension Phase|Inadequate therapeutic effect|7|||
155231856|NCT01393743|560283268|FG000|Extension Phase|Withdrawal by Subject|0|||
155231857|NCT01393743|560283269|FG001|Extension Phase|Withdrawal by Subject|0|||
155231858|NCT01393743|560283270|FG002|Extension Phase|Withdrawal by Subject|8|||
155231859|NCT01393743|560283268|FG000|Extension Phase|Pregnancy|0|||
155231860|NCT01393743|560283269|FG001|Extension Phase|Pregnancy|0|||
155231861|NCT01393743|560283270|FG002|Extension Phase|Pregnancy|1|||
155231862|NCT01393743|560283268|FG000|Extension Phase|Other|0|||
155231863|NCT01393743|560283269|FG001|Extension Phase|Other|0|||
155231864|NCT01393743|560283270|FG002|Extension Phase|Other|14|||
155231865|NCT01524770|560283277|FG000|First Intervention|Withdrawal by Subject|1|||
155231866|NCT01524770|560283278|FG001|First Intervention|Withdrawal by Subject|0|||
155231867|NCT01524770|560283277|FG000|First Intervention|Adverse Event|1|||
155231868|NCT01524770|560283278|FG001|First Intervention|Adverse Event|1|||
155231869|NCT01524770|560283277|FG000|First Intervention|Protocol Violation|1|||
155231870|NCT01524770|560283278|FG001|First Intervention|Protocol Violation|0|||
155231871|NCT01864291|560283280|FG000|Overall Study|need for revision surgery|2|||
155231872|NCT01806896|560283281|FG000|Overall Study|Adverse Event|2|||
155231873|NCT01806896|560283282|FG001|Overall Study|Adverse Event|0|||
155231874|NCT01806896|560283281|FG000|Overall Study|Other|1|||
155231875|NCT01806896|560283282|FG001|Overall Study|Other|0|||
155231876|NCT01282216|560283283|FG000|Overall Study|Graft failure|0|||
155231877|NCT01282216|560283284|FG001|Overall Study|Graft failure|0|||
155231878|NCT01282216|560283285|FG002|Overall Study|Graft failure|3|||
155231879|NCT01282216|560283286|FG003|Overall Study|Graft failure|2|||
155231880|NCT01282216|560283283|FG000|Overall Study|Physician Decision|0|||
155231881|NCT01282216|560283284|FG001|Overall Study|Physician Decision|0|||
155231882|NCT01282216|560283285|FG002|Overall Study|Physician Decision|11|||
155231883|NCT01282216|560283286|FG003|Overall Study|Physician Decision|0|||
155231884|NCT01282216|560283283|FG000|Overall Study|Relapse|0|||
155231885|NCT01282216|560283284|FG001|Overall Study|Relapse|0|||
155231886|NCT01282216|560283285|FG002|Overall Study|Relapse|17|||
155231887|NCT01282216|560283286|FG003|Overall Study|Relapse|6|||
155231888|NCT01282216|560283283|FG000|Overall Study|Death|0|||
155231889|NCT01282216|560283284|FG001|Overall Study|Death|0|||
155231890|NCT01282216|560283285|FG002|Overall Study|Death|2|||
155231891|NCT01282216|560283286|FG003|Overall Study|Death|0|||
155231892|NCT02448875|560283287|FG000|Overall Study|Adverse Event|2|||
155231893|NCT02448875|560283288|FG001|Overall Study|Adverse Event|1|||
155231894|NCT02448875|560283289|FG002|Overall Study|Adverse Event|0|||
155231895|NCT02448875|560283287|FG000|Overall Study|Lost to Follow-up|1|||
155231896|NCT02448875|560283288|FG001|Overall Study|Lost to Follow-up|0|||
155231897|NCT02448875|560283289|FG002|Overall Study|Lost to Follow-up|0|||
155231898|NCT02448875|560283287|FG000|Overall Study|Investigator Decision|3|||
155231899|NCT02448875|560283288|FG001|Overall Study|Investigator Decision|0|||
155231900|NCT02448875|560283289|FG002|Overall Study|Investigator Decision|1|||
155231901|NCT02448875|560283287|FG000|Overall Study|Withdrawal by Subject|1|||
155231902|NCT02448875|560283288|FG001|Overall Study|Withdrawal by Subject|0|||
155231903|NCT02448875|560283289|FG002|Overall Study|Withdrawal by Subject|0|||
155231904|NCT00590954|560283291|FG000|Overall Study|Inevaluable|2|||
155231905|NCT02283788|560283292|FG000|Overall Study|Adverse Event|1|||
155231906|NCT02283788|560283293|FG001|Overall Study|Adverse Event|3|||
155231907|NCT02283788|560283294|FG002|Overall Study|Adverse Event|5|||
155231908|NCT02283788|560283295|FG003|Overall Study|Adverse Event|1|||
155231909|NCT02283788|560283292|FG000|Overall Study|Withdrawal by Subject|0|||
155231910|NCT02283788|560283293|FG001|Overall Study|Withdrawal by Subject|1|||
155231911|NCT02283788|560283294|FG002|Overall Study|Withdrawal by Subject|0|||
155231912|NCT02283788|560283295|FG003|Overall Study|Withdrawal by Subject|1|||
155231913|NCT04269161|560284431|FG000|Overall Study|Change of modality and no longer eligible|3|||
155231914|NCT04269161|560284432|FG001|Overall Study|Change of modality and no longer eligible|3|||
155231915|NCT04269161|560284431|FG000|Overall Study|Required procedure outside of NICU|1|||
155231916|NCT04269161|560284432|FG001|Overall Study|Required procedure outside of NICU|0|||
155231917|NCT04269161|560284431|FG000|Overall Study|Equipment issue|1|||
155231918|NCT04269161|560284432|FG001|Overall Study|Equipment issue|1|||
155231919|NCT02096835|560284433|FG000|Overall Study|Withdrawal by Subject|1|||
155231920|NCT02096835|560284434|FG001|Overall Study|Withdrawal by Subject|0|||
155231921|NCT02096835|560284435|FG002|Overall Study|Withdrawal by Subject|0|||
155231922|NCT02096835|560284433|FG000|Overall Study|converted to open procedures|1|||
155231923|NCT02096835|560284434|FG001|Overall Study|converted to open procedures|0|||
155231924|NCT02096835|560284435|FG002|Overall Study|converted to open procedures|0|||
155231925|NCT02096835|560284433|FG000|Overall Study|Lost to Follow-up|1|||
155231926|NCT02096835|560284434|FG001|Overall Study|Lost to Follow-up|0|||
155231927|NCT02096835|560284435|FG002|Overall Study|Lost to Follow-up|1|||
155231928|NCT03107988|560284444|FG000|Overall Study|Adverse Event|0|||
155231929|NCT03107988|560284445|FG001|Overall Study|Adverse Event|0|||
155231930|NCT03107988|560284446|FG002|Overall Study|Adverse Event|0|||
155231931|NCT03107988|560284447|FG003|Overall Study|Adverse Event|1|||
155231932|NCT03107988|560284448|FG004|Overall Study|Adverse Event|0|||
155231933|NCT03107988|560284449|FG005|Overall Study|Adverse Event|1|||
155231934|NCT03107988|560284450|FG006|Overall Study|Adverse Event|0|||
155231935|NCT03107988|560284451|FG007|Overall Study|Adverse Event|1|||
155231936|NCT03107988|560284452|FG008|Overall Study|Adverse Event|0|||
155231937|NCT03107988|560284453|FG009|Overall Study|Adverse Event|0|||
155231938|NCT03107988|560284454|FG010|Overall Study|Adverse Event|0|||
155231939|NCT03107988|560284455|FG011|Overall Study|Adverse Event|0|||
155231940|NCT03107988|560284456|FG012|Overall Study|Adverse Event|0|||
155231941|NCT03107988|560284444|FG000|Overall Study|Disease Progression or Relapse|1|||
155231942|NCT03107988|560284445|FG001|Overall Study|Disease Progression or Relapse|2|||
155231943|NCT03107988|560284446|FG002|Overall Study|Disease Progression or Relapse|2|||
155231944|NCT03107988|560284447|FG003|Overall Study|Disease Progression or Relapse|5|||
155231945|NCT03107988|560284448|FG004|Overall Study|Disease Progression or Relapse|1|||
155231946|NCT03107988|560284449|FG005|Overall Study|Disease Progression or Relapse|1|||
155231947|NCT03107988|560284450|FG006|Overall Study|Disease Progression or Relapse|0|||
155231948|NCT03107988|560284451|FG007|Overall Study|Disease Progression or Relapse|0|||
155231949|NCT03107988|560284452|FG008|Overall Study|Disease Progression or Relapse|0|||
155231950|NCT03107988|560284453|FG009|Overall Study|Disease Progression or Relapse|1|||
155231951|NCT03107988|560284454|FG010|Overall Study|Disease Progression or Relapse|4|||
155231952|NCT03107988|560284455|FG011|Overall Study|Disease Progression or Relapse|0|||
155231953|NCT03107988|560284456|FG012|Overall Study|Disease Progression or Relapse|0|||
155231954|NCT03107988|560284444|FG000|Overall Study|Ineligible|0|||
155231955|NCT03107988|560284445|FG001|Overall Study|Ineligible|0|||
155231956|NCT03107988|560284446|FG002|Overall Study|Ineligible|0|||
155231957|NCT03107988|560284447|FG003|Overall Study|Ineligible|0|||
155231958|NCT03107988|560284448|FG004|Overall Study|Ineligible|0|||
155231959|NCT03107988|560284449|FG005|Overall Study|Ineligible|0|||
155231960|NCT03107988|560284450|FG006|Overall Study|Ineligible|0|||
155231961|NCT03107988|560284451|FG007|Overall Study|Ineligible|0|||
155231962|NCT03107988|560284452|FG008|Overall Study|Ineligible|1|||
155231963|NCT03107988|560284453|FG009|Overall Study|Ineligible|0|||
155231964|NCT03107988|560284454|FG010|Overall Study|Ineligible|0|||
155231965|NCT03107988|560284455|FG011|Overall Study|Ineligible|0|||
155231966|NCT03107988|560284456|FG012|Overall Study|Ineligible|0|||
155231967|NCT01018264|560284457|FG000|Overall Study|Withdrawal by Subject|1|||
155231968|NCT01018264|560284458|FG001|Overall Study|Withdrawal by Subject|0|||
155231969|NCT01018264|560284457|FG000|Overall Study|Lost to Follow-up|0|||
155231970|NCT01018264|560284458|FG001|Overall Study|Lost to Follow-up|1|||
155231971|NCT00812929|560284459|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
155231972|NCT00812929|560284460|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
155231973|NCT00812929|560284461|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
155231974|NCT00812929|560284462|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
155231975|NCT00812929|560284463|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
155231976|NCT00812929|560284464|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
155231977|NCT00812929|560284465|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
155231978|NCT00812929|560284466|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
155231979|NCT00812929|560284467|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
155231980|NCT00812929|560284468|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
155231981|NCT00812929|560284459|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
155231982|NCT00812929|560284460|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
155231983|NCT00812929|560284461|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
155231984|NCT00812929|560284462|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
155231985|NCT00812929|560284463|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
155231986|NCT00812929|560284464|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
155231987|NCT00812929|560284465|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
155231988|NCT00812929|560284466|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
155231989|NCT00812929|560284467|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
155231990|NCT00812929|560284468|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
155231991|NCT00812929|560284459|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
155231992|NCT00812929|560284460|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
155231993|NCT00812929|560284461|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
155231994|NCT00812929|560284462|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
155231995|NCT00812929|560284463|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
155231996|NCT00812929|560284464|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
155231997|NCT00812929|560284465|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
155231998|NCT00812929|560284466|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
155231999|NCT00812929|560284467|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
155232000|NCT00812929|560284468|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
155232001|NCT04027686|560284469|FG000|Overall Study|Lost to Follow-up|2|||
155232002|NCT04027686|560284470|FG001|Overall Study|Lost to Follow-up|0|||
155232003|NCT04027686|560284469|FG000|Overall Study|Withdrawal by Subject|0|||
155232004|NCT04027686|560284470|FG001|Overall Study|Withdrawal by Subject|1|||
155232005|NCT00079274|560284471|FG000|Overall Study|Withdrawal by Subject|111|||
155232006|NCT00079274|560284472|FG001|Overall Study|Withdrawal by Subject|10|||
155232007|NCT00079274|560284473|FG002|Overall Study|Withdrawal by Subject|12|||
155232008|NCT00079274|560284474|FG003|Overall Study|Withdrawal by Subject|163|||
155232009|NCT00079274|560284475|FG004|Overall Study|Withdrawal by Subject|7|||
155232010|NCT00079274|560284476|FG005|Overall Study|Withdrawal by Subject|8|||
155232011|NCT00079274|560284477|FG006|Overall Study|Withdrawal by Subject|0|||
155232012|NCT00079274|560284471|FG000|Overall Study|Adverse Event|130|||
155232013|NCT00079274|560284472|FG001|Overall Study|Adverse Event|8|||
155232014|NCT00079274|560284473|FG002|Overall Study|Adverse Event|8|||
155232015|NCT00079274|560284474|FG003|Overall Study|Adverse Event|184|||
155232016|NCT00079274|560284475|FG004|Overall Study|Adverse Event|7|||
155232017|NCT00079274|560284476|FG005|Overall Study|Adverse Event|8|||
155232018|NCT00079274|560284477|FG006|Overall Study|Adverse Event|0|||
155232019|NCT00079274|560284471|FG000|Overall Study|Recurrence|21|||
155232020|NCT00079274|560284472|FG001|Overall Study|Recurrence|0|||
155232021|NCT00079274|560284473|FG002|Overall Study|Recurrence|1|||
155232022|NCT00079274|560284474|FG003|Overall Study|Recurrence|15|||
155232023|NCT00079274|560284475|FG004|Overall Study|Recurrence|0|||
155232024|NCT00079274|560284476|FG005|Overall Study|Recurrence|2|||
155232025|NCT00079274|560284477|FG006|Overall Study|Recurrence|0|||
155232026|NCT00079274|560284471|FG000|Overall Study|Alternate Treatment|6|||
155232027|NCT00079274|560284472|FG001|Overall Study|Alternate Treatment|1|||
155232028|NCT00079274|560284473|FG002|Overall Study|Alternate Treatment|0|||
155232029|NCT00079274|560284474|FG003|Overall Study|Alternate Treatment|3|||
155232030|NCT00079274|560284475|FG004|Overall Study|Alternate Treatment|0|||
155232031|NCT00079274|560284476|FG005|Overall Study|Alternate Treatment|0|||
155232032|NCT00079274|560284477|FG006|Overall Study|Alternate Treatment|0|||
155232033|NCT00079274|560284471|FG000|Overall Study|Other Medical Problems|6|||
155232034|NCT00079274|560284472|FG001|Overall Study|Other Medical Problems|1|||
155232035|NCT00079274|560284473|FG002|Overall Study|Other Medical Problems|0|||
155232036|NCT00079274|560284474|FG003|Overall Study|Other Medical Problems|7|||
155232037|NCT00079274|560284475|FG004|Overall Study|Other Medical Problems|0|||
155232038|NCT00079274|560284476|FG005|Overall Study|Other Medical Problems|0|||
155232039|NCT00079274|560284477|FG006|Overall Study|Other Medical Problems|0|||
155232040|NCT00079274|560284471|FG000|Overall Study|Death|4|||
155232041|NCT00079274|560284472|FG001|Overall Study|Death|0|||
155232042|NCT00079274|560284473|FG002|Overall Study|Death|1|||
155232043|NCT00079274|560284474|FG003|Overall Study|Death|15|||
155232044|NCT00079274|560284475|FG004|Overall Study|Death|0|||
155232045|NCT00079274|560284476|FG005|Overall Study|Death|0|||
155232046|NCT00079274|560284477|FG006|Overall Study|Death|0|||
155232047|NCT00079274|560284471|FG000|Overall Study|Cytogenetic resistance|0|||
155232048|NCT00079274|560284472|FG001|Overall Study|Cytogenetic resistance|0|||
155232049|NCT00079274|560284473|FG002|Overall Study|Cytogenetic resistance|0|||
155232050|NCT00079274|560284474|FG003|Overall Study|Cytogenetic resistance|2|||
155232051|NCT00079274|560284475|FG004|Overall Study|Cytogenetic resistance|0|||
155232052|NCT00079274|560284476|FG005|Overall Study|Cytogenetic resistance|0|||
155232053|NCT00079274|560284477|FG006|Overall Study|Cytogenetic resistance|0|||
155232054|NCT00079274|560284471|FG000|Overall Study|Other|43|||
155232055|NCT00079274|560284472|FG001|Overall Study|Other|7|||
155232056|NCT00079274|560284473|FG002|Overall Study|Other|5|||
155232057|NCT00079274|560284474|FG003|Overall Study|Other|55|||
155232058|NCT00079274|560284475|FG004|Overall Study|Other|1|||
155232059|NCT00079274|560284476|FG005|Overall Study|Other|2|||
155232060|NCT00079274|560284477|FG006|Overall Study|Other|0|||
155232061|NCT01696032|560284478|FG000|Overall Study|Withdrawal by Subject|0|||
155232062|NCT01696032|560284479|FG001|Overall Study|Withdrawal by Subject|0|||
155232063|NCT01696032|560284480|FG002|Overall Study|Withdrawal by Subject|1|||
155232064|NCT01696032|560284481|FG003|Overall Study|Withdrawal by Subject|2|||
155232065|NCT01696032|560284478|FG000|Overall Study|Death|14|||
155232066|NCT01696032|560284479|FG001|Overall Study|Death|4|||
155232067|NCT01696032|560284480|FG002|Overall Study|Death|43|||
155232068|NCT01696032|560284481|FG003|Overall Study|Death|18|||
155232069|NCT01696032|560284478|FG000|Overall Study|Lost to Follow-up|0|||
155232070|NCT01696032|560284479|FG001|Overall Study|Lost to Follow-up|1|||
155232071|NCT01696032|560284480|FG002|Overall Study|Lost to Follow-up|0|||
155232072|NCT01696032|560284481|FG003|Overall Study|Lost to Follow-up|0|||
155232073|NCT01696032|560284478|FG000|Overall Study|Database lock|0|||
155232074|NCT01696032|560284479|FG001|Overall Study|Database lock|1|||
155232075|NCT01696032|560284480|FG002|Overall Study|Database lock|7|||
155232076|NCT01696032|560284481|FG003|Overall Study|Database lock|2|||
155232077|NCT00376168|560284484|FG000|Overall Study|Adverse Event|1|||
155232078|NCT00376168|560284485|FG001|Overall Study|Adverse Event|1|||
155232079|NCT00376168|560284484|FG000|Overall Study|Pregnancy|1|||
155232080|NCT00376168|560284485|FG001|Overall Study|Pregnancy|0|||
155232081|NCT01020019|560284486|FG000|Overall Study|Lost to Follow-up|21|||
155232082|NCT01020019|560284487|FG001|Overall Study|Lost to Follow-up|18|||
155232083|NCT01020019|560284486|FG000|Overall Study|Adverse Event|1|||
155232084|NCT01020019|560284487|FG001|Overall Study|Adverse Event|5|||
155232085|NCT01020019|560284486|FG000|Overall Study|not interested in treatment|4|||
155232086|NCT01020019|560284487|FG001|Overall Study|not interested in treatment|4|||
155232087|NCT01020019|560284486|FG000|Overall Study|moving|0|||
155232088|NCT01020019|560284487|FG001|Overall Study|moving|2|||
155232089|NCT02375672|560284488|FG000|Overall Study|remain on follow up|20|||
155232090|NCT04115358|560284489|FG000|Overall Study|exfoliation|0|||
155232091|NCT04115358|560284490|FG001|Overall Study|exfoliation|0|||
155232092|NCT04115358|560284491|FG002|Overall Study|exfoliation|1|||
155232093|NCT02152995|560284494|FG000|Overall Study|Withdrawal by Subject|1|||
155232094|NCT02152995|560284495|FG001|Overall Study|Withdrawal by Subject|0|||
155232095|NCT02098109|560284496|FG000|Overall Study|Protocol Violation|3|||
155232096|NCT02098109|560284497|FG001|Overall Study|Protocol Violation|0|||
155232097|NCT01565291|560284498|FG000|Overall Study|Withdrawal by Subject|1|||
155232098|NCT01565291|560284499|FG001|Overall Study|Withdrawal by Subject|0|||
155232099|NCT03508219|560284506|FG000|Overall Study|Death|2|||
155232100|NCT03508219|560284506|FG000|Overall Study|Withdrawal by Subject|1|||
155232101|NCT03508219|560284506|FG000|Overall Study|Lost to Follow-up|4|||
155232102|NCT03508219|560284506|FG000|Overall Study|Missed visit|2|||
155232103|NCT04466891|560284507|FG000|Overall Study|Death|60|||
155232104|NCT04466891|560284508|FG001|Overall Study|Death|6|||
155232105|NCT04466891|560284507|FG000|Overall Study|Withdrawal by Subject|8|||
155232106|NCT04466891|560284508|FG001|Overall Study|Withdrawal by Subject|1|||
155232107|NCT04466891|560284507|FG000|Overall Study|Study terminated by sponsor|5|||
155232108|NCT04466891|560284508|FG001|Overall Study|Study terminated by sponsor|0|||
155232109|NCT04466891|560284507|FG000|Overall Study|Lost to Follow-up|2|||
155232110|NCT04466891|560284508|FG001|Overall Study|Lost to Follow-up|0|||
155232111|NCT04466891|560284507|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
155232112|NCT04466891|560284508|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
155232113|NCT02782949|560284512|FG000|Overall Study|Protocol Violation|1|||
155232114|NCT02782949|560284513|FG001|Overall Study|Protocol Violation|0|||
155232115|NCT02782949|560284512|FG000|Overall Study|Withdrawal by Subject|0|||
155232116|NCT02782949|560284513|FG001|Overall Study|Withdrawal by Subject|1|||
155232117|NCT02239536|560284518|FG000|Overall Study|Non-neoplastic polyp|23|||
155232118|NCT02239536|560284519|FG001|Overall Study|Non-neoplastic polyp|17|||
155232119|NCT04074317|560284520|FG000|Third Period|Withdrawal by Subject|0|||
155232120|NCT04074317|560284521|FG001|Third Period|Withdrawal by Subject|0|||
155232121|NCT04074317|560284522|FG002|Third Period|Withdrawal by Subject|0|||
155232122|NCT04074317|560284523|FG003|Third Period|Withdrawal by Subject|1|||
155232123|NCT04074317|560284524|FG004|Third Period|Withdrawal by Subject|0|||
155232124|NCT04074317|560284525|FG005|Third Period|Withdrawal by Subject|0|||
155232125|NCT03091192|560284526|FG000|Overall Study|Study terminated by sponsor|21|||
155232126|NCT03091192|560284527|FG001|Overall Study|Study terminated by sponsor|14|||
155232127|NCT03091192|560284526|FG000|Overall Study|Death|9|||
155232128|NCT03091192|560284527|FG001|Overall Study|Death|13|||
155232129|NCT03091192|560284526|FG000|Overall Study|Withdrawal by Subject|2|||
155232130|NCT03091192|560284527|FG001|Overall Study|Withdrawal by Subject|0|||
155232131|NCT03091192|560284526|FG000|Overall Study|Lost to Follow-up|1|||
155232132|NCT03091192|560284527|FG001|Overall Study|Lost to Follow-up|0|||
155232133|NCT01038778|560284528|FG000|Overall Study|Withdrawal by Subject|0|||
155232134|NCT01038778|560284529|FG001|Overall Study|Withdrawal by Subject|2|||
155232135|NCT01038778|560284530|FG002|Overall Study|Withdrawal by Subject|3|||
155232136|NCT06023394|560284531|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
155232137|NCT06023394|560284532|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
155232138|NCT06023394|560284531|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
155232139|NCT06023394|560284532|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
155232140|NCT06023394|560284531|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
155232141|NCT06023394|560284532|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
155232142|NCT06023394|560284531|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
155232143|NCT06023394|560284532|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
155232144|NCT05645432|560284533|FG000|Overall Study|Withdrawal by Subject|1|||
155232145|NCT03195478|560284534|FG000|Overall Study|Disease Progression|5|||
155232146|NCT03195478|560284535|FG001|Overall Study|Disease Progression|4|||
155232147|NCT03195478|560284536|FG002|Overall Study|Disease Progression|6|||
155232148|NCT03195478|560284537|FG003|Overall Study|Disease Progression|1|||
155232149|NCT03195478|560284534|FG000|Overall Study|Study Drug Toxicity|2|||
155232150|NCT03195478|560284535|FG001|Overall Study|Study Drug Toxicity|0|||
155232151|NCT03195478|560284536|FG002|Overall Study|Study Drug Toxicity|0|||
155232152|NCT03195478|560284537|FG003|Overall Study|Study Drug Toxicity|1|||
155232153|NCT03195478|560284534|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155232154|NCT03195478|560284535|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
155232155|NCT03195478|560284536|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155232156|NCT03195478|560284537|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
155232157|NCT03195478|560284534|FG000|Overall Study|Participant Withdrew Consent|1|||
155232158|NCT03195478|560284535|FG001|Overall Study|Participant Withdrew Consent|0|||
155232159|NCT03195478|560284536|FG002|Overall Study|Participant Withdrew Consent|0|||
155232160|NCT03195478|560284537|FG003|Overall Study|Participant Withdrew Consent|0|||
155232161|NCT03195478|560284534|FG000|Overall Study|Maximum Clinical benefit|0|||
155232162|NCT03195478|560284535|FG001|Overall Study|Maximum Clinical benefit|0|||
155232163|NCT03195478|560284536|FG002|Overall Study|Maximum Clinical benefit|1|||
155232164|NCT03195478|560284537|FG003|Overall Study|Maximum Clinical benefit|0|||
155232165|NCT03195478|560284534|FG000|Overall Study|Other Reasons|0|||
155232166|NCT03195478|560284535|FG001|Overall Study|Other Reasons|0|||
155232167|NCT03195478|560284536|FG002|Overall Study|Other Reasons|1|||
155232168|NCT03195478|560284537|FG003|Overall Study|Other Reasons|0|||
155232169|NCT02143414|560286292|FG000|Induction|Adverse Event|1|||
155232170|NCT02143414|560286293|FG001|Induction|Adverse Event|2|||
155232171|NCT02143414|560286292|FG000|Induction|Death|1|||
155232172|NCT02143414|560286293|FG001|Induction|Death|2|||
155232173|NCT02143414|560286292|FG000|Induction|Patient refusal|1|||
155232174|NCT02143414|560286293|FG001|Induction|Patient refusal|1|||
155232175|NCT02143414|560286292|FG000|Induction|Refractory|1|||
155232176|NCT02143414|560286293|FG001|Induction|Refractory|0|||
155232177|NCT02143414|560286292|FG000|Induction|Began alternative treatment|1|||
155232178|NCT02143414|560286293|FG001|Induction|Began alternative treatment|0|||
155232179|NCT02143414|560286292|FG000|Induction|Ineligible for postremission|5|||
155232180|NCT02143414|560286293|FG001|Induction|Ineligible for postremission|1|||
155232181|NCT02143414|560286292|FG000|Post-remission|Adverse Event|0|||
155232182|NCT02143414|560286293|FG001|Post-remission|Adverse Event|2|||
155232183|NCT02143414|560286292|FG000|Post-remission|Disease progression/relapse|5|||
155232184|NCT02143414|560286293|FG001|Post-remission|Disease progression/relapse|0|||
155232185|NCT02143414|560286292|FG000|Maintenance|Adverse Event|4|||
155232186|NCT02143414|560286293|FG001|Maintenance|Adverse Event|6|||
155232187|NCT02143414|560286292|FG000|Maintenance|Disease progression/relapse|3|||
155232188|NCT02143414|560286293|FG001|Maintenance|Disease progression/relapse|2|||
155232189|NCT02143414|560286292|FG000|Maintenance|Patient refusal|2|||
155232190|NCT02143414|560286293|FG001|Maintenance|Patient refusal|1|||
155232191|NCT02143414|560286292|FG000|Maintenance|Physician Decision|1|||
155232192|NCT02143414|560286293|FG001|Maintenance|Physician Decision|0|||
155232193|NCT02143414|560286292|FG000|Maintenance|Death|0|||
155232194|NCT02143414|560286293|FG001|Maintenance|Death|1|||
155232195|NCT02143414|560286292|FG000|Maintenance|On protocol treatment|0|||
155232196|NCT02143414|560286293|FG001|Maintenance|On protocol treatment|6|||
155232197|NCT00978731|560286297|FG000|Overall Study|Death|4|||
155232198|NCT00978731|560286298|FG001|Overall Study|Death|1|||
155232199|NCT00978731|560286299|FG002|Overall Study|Death|1|||
155232200|NCT00978731|560286300|FG003|Overall Study|Death|0|||
155232201|NCT00978731|560286297|FG000|Overall Study|Lost to Follow-up|0|||
155232202|NCT00978731|560286298|FG001|Overall Study|Lost to Follow-up|0|||
155232203|NCT00978731|560286299|FG002|Overall Study|Lost to Follow-up|0|||
155232204|NCT00978731|560286300|FG003|Overall Study|Lost to Follow-up|1|||
155232205|NCT00978731|560286297|FG000|Overall Study|Adverse Event|5|||
155232206|NCT00978731|560286298|FG001|Overall Study|Adverse Event|2|||
155232207|NCT00978731|560286299|FG002|Overall Study|Adverse Event|0|||
155232208|NCT00978731|560286300|FG003|Overall Study|Adverse Event|0|||
155232209|NCT00978731|560286297|FG000|Overall Study|Participant's request|1|||
155232210|NCT00978731|560286298|FG001|Overall Study|Participant's request|0|||
155232211|NCT00978731|560286299|FG002|Overall Study|Participant's request|0|||
155232212|NCT00978731|560286300|FG003|Overall Study|Participant's request|0|||
155232213|NCT00978731|560286297|FG000|Overall Study|Administrative reason|3|||
155232214|NCT00978731|560286298|FG001|Overall Study|Administrative reason|3|||
155232215|NCT00978731|560286299|FG002|Overall Study|Administrative reason|1|||
155232216|NCT00978731|560286300|FG003|Overall Study|Administrative reason|0|||
155232217|NCT00978731|560286297|FG000|Overall Study|Deterioration without progression|0|||
155232218|NCT00978731|560286298|FG001|Overall Study|Deterioration without progression|1|||
155232219|NCT00978731|560286299|FG002|Overall Study|Deterioration without progression|0|||
155232220|NCT00978731|560286300|FG003|Overall Study|Deterioration without progression|0|||
155232221|NCT00978731|560286297|FG000|Overall Study|Disease progression/relapse|5|||
155232222|NCT00978731|560286298|FG001|Overall Study|Disease progression/relapse|4|||
155232223|NCT00978731|560286299|FG002|Overall Study|Disease progression/relapse|2|||
155232224|NCT00978731|560286300|FG003|Overall Study|Disease progression/relapse|2|||
155232225|NCT00978731|560286297|FG000|Overall Study|Study closure|3|||
155232226|NCT00978731|560286298|FG001|Overall Study|Study closure|4|||
155232227|NCT00978731|560286299|FG002|Overall Study|Study closure|1|||
155232228|NCT00978731|560286300|FG003|Overall Study|Study closure|1|||
155232229|NCT00978731|560286297|FG000|Overall Study|No response|1|||
155232230|NCT00978731|560286298|FG001|Overall Study|No response|0|||
155232231|NCT00978731|560286299|FG002|Overall Study|No response|0|||
155232232|NCT00978731|560286300|FG003|Overall Study|No response|0|||
155232233|NCT02649972|560286306|FG000|Overall Study|Not treated|1|||
155232234|NCT00501540|560286311|FG000|Overall Study|Death|5|||
155232235|NCT02331446|560286312|FG000|Overall Study|Lost to Follow-up|2|||
155232236|NCT02331446|560286313|FG001|Overall Study|Lost to Follow-up|1|||
155232237|NCT02331446|560286314|FG002|Overall Study|Lost to Follow-up|0|||
155232238|NCT02331446|560286315|FG003|Overall Study|Lost to Follow-up|1|||
155232239|NCT02331446|560286312|FG000|Overall Study|Personal Problem|2|||
155232240|NCT02331446|560286313|FG001|Overall Study|Personal Problem|0|||
155232241|NCT02331446|560286314|FG002|Overall Study|Personal Problem|0|||
155232242|NCT02331446|560286315|FG003|Overall Study|Personal Problem|0|||
155232243|NCT02331446|560286312|FG000|Overall Study|Disease|0|||
155232244|NCT02331446|560286313|FG001|Overall Study|Disease|2|||
155232245|NCT02331446|560286314|FG002|Overall Study|Disease|2|||
155232246|NCT02331446|560286315|FG003|Overall Study|Disease|1|||
155232247|NCT02331446|560286312|FG000|Overall Study|Physician Decision|0|||
155232248|NCT02331446|560286313|FG001|Overall Study|Physician Decision|1|||
155232249|NCT02331446|560286314|FG002|Overall Study|Physician Decision|0|||
155232250|NCT02331446|560286315|FG003|Overall Study|Physician Decision|1|||
155232251|NCT02331446|560286312|FG000|Overall Study|Lost before baseline analysis|0|||
155232252|NCT02331446|560286313|FG001|Overall Study|Lost before baseline analysis|1|||
155232253|NCT02331446|560286314|FG002|Overall Study|Lost before baseline analysis|1|||
155232254|NCT02331446|560286315|FG003|Overall Study|Lost before baseline analysis|0|||
155232255|NCT04879745|560286316|FG000|Overall Study|Lost to Follow-up|4|||
155232256|NCT04879745|560286317|FG001|Overall Study|Lost to Follow-up|1|||
155232257|NCT00120042|560286318|FG000|Overall Study|all completed protocl|0|||
155232258|NCT00120042|560286319|FG001|Overall Study|all completed protocl|0|||
155232259|NCT00120042|560286320|FG002|Overall Study|all completed protocl|0|||
155232260|NCT04532112|560286323|FG000|Overall Study|Adverse Event|3|||
155232261|NCT04532112|560286324|FG001|Overall Study|Adverse Event|0|||
155232262|NCT00529386|560286325|FG000|Overall Study|Lost to Follow-up|1|||
155232263|NCT02939404|560286326|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
155232264|NCT02939404|560286327|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
155232265|NCT02939404|560286326|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
155232266|NCT02939404|560286327|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
155232267|NCT04182100|560286328|FG000|Overall Study|Adverse Event|1|||
155232268|NCT04182100|560286328|FG000|Overall Study|Withdrawal by Subject|1|||
155232269|NCT04439240|560286336|FG000|Overall Study|Ineligible|2|||
155232270|NCT04439240|560286336|FG000|Overall Study|Never started treatment|2|||
155232271|NCT04439240|560286336|FG000|Overall Study|Adverse Event|12|||
155232272|NCT04439240|560286336|FG000|Overall Study|Death|2|||
155232273|NCT04439240|560286336|FG000|Overall Study|Disease progression|25|||
155232274|NCT04439240|560286336|FG000|Overall Study|Other diseases|2|||
155232275|NCT04439240|560286336|FG000|Overall Study|Withdrawal by Subject|3|||
155232276|NCT04439240|560286336|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
155232277|NCT04439240|560286336|FG000|Overall Study|Symptomatic decline|1|||
155232278|NCT04439240|560286336|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
155232279|NCT04439240|560286336|FG000|Overall Study|Clinical progression|1|||
155232280|NCT00813124|560286338|FG000|Overall Study|Death|2|||
155232281|NCT00813124|560286338|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
155232282|NCT00813124|560286338|FG000|Overall Study|Withdrawal by Subject|1|||
155232283|NCT00617240|560286345|FG000|Overall Study|Lack of Efficacy|1|||
155232284|NCT00617240|560286346|FG001|Overall Study|Lack of Efficacy|0|||
155232285|NCT01611259|560286347|FG000|Overall Study|Physician Decision|1|||
155232286|NCT01611259|560286347|FG000|Overall Study|Lack of Efficacy|2|||
155232287|NCT01611259|560286347|FG000|Overall Study|Adverse Event|4|||
155232288|NCT01611259|560286347|FG000|Overall Study|Withdrawal by Subject|7|||
155232289|NCT04936685|560286348|FG000|Overall Study|Protocol Violation|1|||
155232290|NCT04936685|560286349|FG001|Overall Study|Protocol Violation|0|||
155232291|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
155232292|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
155232293|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
155232294|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
155232295|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
155232296|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
155232297|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
155232298|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
155232299|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
155232300|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
155232301|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
155232302|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
155232303|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
155232304|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
155232305|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
155232306|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
155232307|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
155232308|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
155232309|NCT00280566|560286350|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
155232310|NCT00280566|560286351|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
155232311|NCT00280566|560286352|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
155232312|NCT00280566|560286350|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
155232313|NCT00280566|560286351|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
155232314|NCT00280566|560286352|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
155232315|NCT00280566|560286350|FG000|Period 2 Double Blind|Adverse Event|0|||
155232316|NCT00280566|560286351|FG001|Period 2 Double Blind|Adverse Event|11|||
155232317|NCT00280566|560286352|FG002|Period 2 Double Blind|Adverse Event|15|||
155232318|NCT00280566|560286350|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
155232319|NCT00280566|560286351|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
155232320|NCT00280566|560286352|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
155232321|NCT00280566|560286350|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
155232322|NCT00280566|560286351|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
155232323|NCT00280566|560286352|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
155232324|NCT00280566|560286350|FG000|Period 2 Double Blind|miscellaneous|0|||
155232325|NCT00280566|560286351|FG001|Period 2 Double Blind|miscellaneous|10|||
155232326|NCT00280566|560286352|FG002|Period 2 Double Blind|miscellaneous|5|||
155232327|NCT01302392|560286353|FG000|Overall Study|Lost to Follow-up|1|||
155232328|NCT01302392|560286354|FG001|Overall Study|Lost to Follow-up|0|||
155232329|NCT01302392|560286353|FG000|Overall Study|Withdrawal by Subject|6|||
155232330|NCT01302392|560286354|FG001|Overall Study|Withdrawal by Subject|1|||
155232331|NCT03604692|560286358|FG000|Overall Study|Investigator's Decision|0|||
155232332|NCT03604692|560286359|FG001|Overall Study|Investigator's Decision|0|||
155232333|NCT03604692|560286360|FG002|Overall Study|Investigator's Decision|0|||
155232334|NCT03604692|560286361|FG003|Overall Study|Investigator's Decision|1|||
155232335|NCT03604692|560286362|FG004|Overall Study|Investigator's Decision|0|||
155232336|NCT03604692|560286363|FG005|Overall Study|Investigator's Decision|7|||
155232337|NCT03604692|560286358|FG000|Overall Study|Withdrawal by Subject|0|||
155232338|NCT03604692|560286359|FG001|Overall Study|Withdrawal by Subject|0|||
155232339|NCT03604692|560286360|FG002|Overall Study|Withdrawal by Subject|0|||
155232340|NCT03604692|560286361|FG003|Overall Study|Withdrawal by Subject|0|||
155232341|NCT03604692|560286362|FG004|Overall Study|Withdrawal by Subject|0|||
155232342|NCT03604692|560286363|FG005|Overall Study|Withdrawal by Subject|2|||
155232343|NCT03604692|560286358|FG000|Overall Study|Progressive Disease|1|||
155232344|NCT03604692|560286359|FG001|Overall Study|Progressive Disease|0|||
155232345|NCT03604692|560286360|FG002|Overall Study|Progressive Disease|1|||
155232346|NCT03604692|560286361|FG003|Overall Study|Progressive Disease|0|||
155232347|NCT03604692|560286362|FG004|Overall Study|Progressive Disease|3|||
155232348|NCT03604692|560286363|FG005|Overall Study|Progressive Disease|4|||
155232349|NCT03604692|560286358|FG000|Overall Study|Difficulty Coming into Site|0|||
155232350|NCT03604692|560286359|FG001|Overall Study|Difficulty Coming into Site|0|||
155232351|NCT03604692|560286360|FG002|Overall Study|Difficulty Coming into Site|0|||
155232352|NCT03604692|560286361|FG003|Overall Study|Difficulty Coming into Site|0|||
155232353|NCT03604692|560286362|FG004|Overall Study|Difficulty Coming into Site|0|||
155232354|NCT03604692|560286363|FG005|Overall Study|Difficulty Coming into Site|1|||
155232355|NCT03604692|560286358|FG000|Overall Study|Death|0|||
155232356|NCT03604692|560286359|FG001|Overall Study|Death|0|||
155232357|NCT03604692|560286360|FG002|Overall Study|Death|1|||
155232358|NCT03604692|560286361|FG003|Overall Study|Death|0|||
155232359|NCT03604692|560286362|FG004|Overall Study|Death|0|||
155232360|NCT03604692|560286363|FG005|Overall Study|Death|0|||
155232361|NCT03604692|560286358|FG000|Overall Study|Drug Intolerance|0|||
155232362|NCT03604692|560286359|FG001|Overall Study|Drug Intolerance|0|||
155232363|NCT03604692|560286360|FG002|Overall Study|Drug Intolerance|0|||
155232364|NCT03604692|560286361|FG003|Overall Study|Drug Intolerance|1|||
155232365|NCT03604692|560286362|FG004|Overall Study|Drug Intolerance|0|||
155232366|NCT03604692|560286363|FG005|Overall Study|Drug Intolerance|0|||
155232367|NCT03604692|560286358|FG000|Overall Study|Noncompliance with follow-up visit|0|||
155232368|NCT03604692|560286359|FG001|Overall Study|Noncompliance with follow-up visit|0|||
155232369|NCT03604692|560286360|FG002|Overall Study|Noncompliance with follow-up visit|0|||
155232370|NCT03604692|560286361|FG003|Overall Study|Noncompliance with follow-up visit|1|||
155232371|NCT03604692|560286362|FG004|Overall Study|Noncompliance with follow-up visit|0|||
155232372|NCT03604692|560286363|FG005|Overall Study|Noncompliance with follow-up visit|0|||
155232373|NCT03604692|560286358|FG000|Overall Study|Not Treated|0|||
155232374|NCT03604692|560286359|FG001|Overall Study|Not Treated|0|||
155232375|NCT03604692|560286360|FG002|Overall Study|Not Treated|0|||
155232376|NCT03604692|560286361|FG003|Overall Study|Not Treated|0|||
155232377|NCT03604692|560286362|FG004|Overall Study|Not Treated|1|||
155232378|NCT03604692|560286363|FG005|Overall Study|Not Treated|0|||
155232379|NCT00637195|560286364|FG000|Overall Study|Lost to Follow-up|1|||
155232380|NCT00637195|560286365|FG001|Overall Study|Lost to Follow-up|0|||
155232381|NCT00637195|560286364|FG000|Overall Study|Other|2|||
155232382|NCT00637195|560286365|FG001|Overall Study|Other|0|||
155232383|NCT00637195|560286364|FG000|Overall Study|Withdrawal by Subject|0|||
155232384|NCT00637195|560286365|FG001|Overall Study|Withdrawal by Subject|1|||
155232385|NCT05091528|560286370|FG000|Overall Study|Study Termination by Sponsor|0|||
155232386|NCT05091528|560286371|FG001|Overall Study|Study Termination by Sponsor|1|||
155232387|NCT05091528|560286372|FG002|Overall Study|Study Termination by Sponsor|0|||
155232388|NCT05091528|560286373|FG003|Overall Study|Study Termination by Sponsor|1|||
155232389|NCT02214121|560286374|FG000|Part A|Patient decision|2|||
155232390|NCT02214121|560286375|FG001|Part A|Patient decision|0|||
155232391|NCT02214121|560286376|FG002|Part A|Patient decision|0|||
155232392|NCT02214121|560286374|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
155232393|NCT02214121|560286375|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
155232394|NCT02214121|560286376|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
155232395|NCT02214121|560286374|FG000|Part A|Other|1|||
155232396|NCT02214121|560286375|FG001|Part A|Other|0|||
155232397|NCT02214121|560286376|FG002|Part A|Other|0|||
155232398|NCT02214121|560286374|FG000|Part B|Patient decision|0|||
155232399|NCT02214121|560286375|FG001|Part B|Patient decision|1|||
155232400|NCT02214121|560286376|FG002|Part B|Patient decision|0|||
155232401|NCT02214121|560286374|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
155232402|NCT02214121|560286375|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
155232403|NCT02214121|560286376|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
155232404|NCT02214121|560286374|FG000|Part B|Lost to Follow-up|0|||
155232405|NCT02214121|560286375|FG001|Part B|Lost to Follow-up|0|||
155232406|NCT02214121|560286376|FG002|Part B|Lost to Follow-up|1|||
155232407|NCT02203591|560286377|FG000|Overall Study|Did not meet treatment day baseline|147|||
155232408|NCT02203591|560286378|FG001|Overall Study|Did not meet treatment day baseline|141|||
155232409|NCT02203591|560286379|FG002|Overall Study|Did not meet treatment day baseline|150|||
155232410|NCT02203591|560286380|FG003|Overall Study|Did not meet treatment day baseline|45|||
155232411|NCT02203591|560286381|FG004|Overall Study|Did not meet treatment day baseline|33|||
155232412|NCT02203591|560286382|FG005|Overall Study|Did not meet treatment day baseline|35|||
155232413|NCT02203591|560286383|FG006|Overall Study|Did not meet treatment day baseline|29|||
155232414|NCT02203591|560286384|FG007|Overall Study|Did not meet treatment day baseline|12|||
155232415|NCT02203591|560286377|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
155232416|NCT02203591|560286378|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
155232417|NCT02203591|560286379|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
155232418|NCT02203591|560286380|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
155232419|NCT02203591|560286381|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
155232420|NCT02203591|560286382|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
155232421|NCT02203591|560286383|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
155232422|NCT02203591|560286384|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
155232423|NCT03306264|560286387|FG000|Overall Study|Death|33|||
155232424|NCT03306264|560286388|FG001|Overall Study|Death|25|||
155232425|NCT03306264|560286389|FG002|Overall Study|Death|34|||
155232426|NCT03306264|560286390|FG003|Overall Study|Death|34|||
155232427|NCT03306264|560286387|FG000|Overall Study|Complete Consent Withdrawal|4|||
155232428|NCT03306264|560286388|FG001|Overall Study|Complete Consent Withdrawal|4|||
155232429|NCT03306264|560286389|FG002|Overall Study|Complete Consent Withdrawal|1|||
155232430|NCT03306264|560286390|FG003|Overall Study|Complete Consent Withdrawal|8|||
155232431|NCT03306264|560286387|FG000|Overall Study|Lost to Follow-up|1|||
155232432|NCT03306264|560286388|FG001|Overall Study|Lost to Follow-up|0|||
155232433|NCT03306264|560286389|FG002|Overall Study|Lost to Follow-up|1|||
155232434|NCT03306264|560286390|FG003|Overall Study|Lost to Follow-up|0|||
155232435|NCT03306264|560286387|FG000|Overall Study|Rollover to ASTX727-06|10|||
155491465|NCT00563706|561225395|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
155232436|NCT03306264|560286388|FG001|Overall Study|Rollover to ASTX727-06|18|||
155232437|NCT03306264|560286389|FG002|Overall Study|Rollover to ASTX727-06|4|||
155232438|NCT03306264|560286390|FG003|Overall Study|Rollover to ASTX727-06|2|||
155232439|NCT03306264|560286387|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
155232440|NCT03306264|560286388|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
155232441|NCT03306264|560286389|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
155232442|NCT03306264|560286390|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
155232443|NCT02114879|560286391|FG000|Overall Study|Withdrawal by Subject|9|||
155232444|NCT02114879|560286392|FG001|Overall Study|Withdrawal by Subject|5|||
155232445|NCT02114879|560286391|FG000|Overall Study|Death|6|||
155232446|NCT02114879|560286392|FG001|Overall Study|Death|11|||
155232447|NCT02114879|560286391|FG000|Overall Study|Lost to Follow-up|4|||
155232448|NCT02114879|560286392|FG001|Overall Study|Lost to Follow-up|6|||
155232449|NCT02114879|560286391|FG000|Overall Study|Physician Decision|0|||
155232450|NCT02114879|560286392|FG001|Overall Study|Physician Decision|2|||
155232451|NCT02519712|560286398|FG000|Overall Study|Disease Relapse|1|||
155232452|NCT02519712|560286398|FG000|Overall Study|Disease Progression|1|||
155232453|NCT02519712|560286398|FG000|Overall Study|Accruals are donors|2|||
155232454|NCT00613509|560286399|FG000|Cycle 1|Adverse Event|2|||
155232455|NCT00613509|560286400|FG001|Cycle 1|Adverse Event|1|||
155232456|NCT00613509|560286399|FG000|Cycle 1|Disease Progression|2|||
155232457|NCT00613509|560286400|FG001|Cycle 1|Disease Progression|6|||
155232458|NCT00613509|560286399|FG000|Cycle 1|Unacceptable Toxicity|1|||
155232459|NCT00613509|560286400|FG001|Cycle 1|Unacceptable Toxicity|0|||
155232460|NCT00613509|560286399|FG000|Cycle 1|Other administrative reason|0|||
155232461|NCT00613509|560286400|FG001|Cycle 1|Other administrative reason|1|||
155232462|NCT04847674|560286401|FG000|Overall Study|Withdrawal by Subject|0|||
155232463|NCT04847674|560286402|FG001|Overall Study|Withdrawal by Subject|1|||
155232464|NCT04847674|560286403|FG002|Overall Study|Withdrawal by Subject|0|||
155232465|NCT04847674|560286401|FG000|Overall Study|Lost to Follow-up|0|||
155232466|NCT04847674|560286402|FG001|Overall Study|Lost to Follow-up|0|||
155232467|NCT04847674|560286403|FG002|Overall Study|Lost to Follow-up|2|||
155232468|NCT04847674|560286401|FG000|Overall Study|Other than specified|21|||
155232469|NCT04847674|560286402|FG001|Overall Study|Other than specified|20|||
155232470|NCT04847674|560286403|FG002|Overall Study|Other than specified|20|||
155232471|NCT00677807|560286404|FG000|Overall Study|Adverse Event|4|||
155232472|NCT00677807|560286405|FG001|Overall Study|Adverse Event|1|||
155232473|NCT00677807|560286406|FG002|Overall Study|Adverse Event|6|||
155232474|NCT00677807|560286404|FG000|Overall Study|Lack of Efficacy|0|||
155232475|NCT00677807|560286405|FG001|Overall Study|Lack of Efficacy|0|||
155232476|NCT00677807|560286406|FG002|Overall Study|Lack of Efficacy|2|||
155232477|NCT00677807|560286404|FG000|Overall Study|Participant no longer needs study drug|0|||
155232478|NCT00677807|560286405|FG001|Overall Study|Participant no longer needs study drug|0|||
155232479|NCT00677807|560286406|FG002|Overall Study|Participant no longer needs study drug|1|||
155232480|NCT00677807|560286404|FG000|Overall Study|Withdrawal by Subject|10|||
155232481|NCT00677807|560286405|FG001|Overall Study|Withdrawal by Subject|3|||
155232482|NCT00677807|560286406|FG002|Overall Study|Withdrawal by Subject|6|||
155232483|NCT00677807|560286404|FG000|Overall Study|Lost to Follow-up|2|||
155232484|NCT00677807|560286405|FG001|Overall Study|Lost to Follow-up|2|||
155232485|NCT00677807|560286406|FG002|Overall Study|Lost to Follow-up|2|||
155232486|NCT00677807|560286404|FG000|Overall Study|Administrative problems|1|||
155232487|NCT00677807|560286405|FG001|Overall Study|Administrative problems|1|||
155232488|NCT00677807|560286406|FG002|Overall Study|Administrative problems|2|||
155232489|NCT00677807|560286404|FG000|Overall Study|Death|0|||
155232490|NCT00677807|560286405|FG001|Overall Study|Death|1|||
155232491|NCT00677807|560286406|FG002|Overall Study|Death|1|||
155232492|NCT00677807|560286404|FG000|Overall Study|Protocol Deviation|1|||
155232493|NCT00677807|560286405|FG001|Overall Study|Protocol Deviation|3|||
155232494|NCT00677807|560286406|FG002|Overall Study|Protocol Deviation|0|||
155232495|NCT01420081|560286407|FG000|Overall Study|Death|1|||
155232496|NCT01420081|560286408|FG001|Overall Study|Death|0|||
155232497|NCT01420081|560286409|FG002|Overall Study|Death|8|||
155232498|NCT01420081|560286410|FG003|Overall Study|Death|0|||
155232499|NCT01420081|560286411|FG004|Overall Study|Death|7|||
155232500|NCT01420081|560286412|FG005|Overall Study|Death|12|||
155232501|NCT01420081|560286413|FG006|Overall Study|Death|0|||
155232502|NCT01420081|560286414|FG007|Overall Study|Death|1|||
155232503|NCT01420081|560286415|FG008|Overall Study|Death|1|||
155232504|NCT01420081|560286407|FG000|Overall Study|Lost to Follow-up|0|||
155232505|NCT01420081|560286408|FG001|Overall Study|Lost to Follow-up|0|||
155232506|NCT01420081|560286409|FG002|Overall Study|Lost to Follow-up|0|||
155232507|NCT01420081|560286410|FG003|Overall Study|Lost to Follow-up|0|||
155232508|NCT01420081|560286411|FG004|Overall Study|Lost to Follow-up|1|||
155232509|NCT01420081|560286412|FG005|Overall Study|Lost to Follow-up|1|||
155232510|NCT01420081|560286413|FG006|Overall Study|Lost to Follow-up|0|||
155232511|NCT01420081|560286414|FG007|Overall Study|Lost to Follow-up|0|||
155232512|NCT01420081|560286415|FG008|Overall Study|Lost to Follow-up|0|||
155232513|NCT01420081|560286407|FG000|Overall Study|Study Terminated by Sponsor|2|||
155232514|NCT01420081|560286408|FG001|Overall Study|Study Terminated by Sponsor|1|||
155232515|NCT01420081|560286409|FG002|Overall Study|Study Terminated by Sponsor|1|||
155232516|NCT01420081|560286410|FG003|Overall Study|Study Terminated by Sponsor|3|||
155232517|NCT01420081|560286411|FG004|Overall Study|Study Terminated by Sponsor|11|||
155232518|NCT01420081|560286412|FG005|Overall Study|Study Terminated by Sponsor|7|||
155232519|NCT01420081|560286413|FG006|Overall Study|Study Terminated by Sponsor|3|||
155232520|NCT01420081|560286414|FG007|Overall Study|Study Terminated by Sponsor|2|||
155232521|NCT01420081|560286415|FG008|Overall Study|Study Terminated by Sponsor|2|||
155232522|NCT01420081|560286407|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
155232523|NCT01420081|560286408|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
155232524|NCT01420081|560286409|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
155232525|NCT01420081|560286410|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
155232526|NCT01420081|560286411|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
155232527|NCT01420081|560286412|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
155232528|NCT01420081|560286413|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
155232529|NCT01420081|560286414|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
155232530|NCT01420081|560286415|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
155232531|NCT01420081|560286407|FG000|Overall Study|Other Reasons|0|||
155232532|NCT01420081|560286408|FG001|Overall Study|Other Reasons|0|||
155232533|NCT01420081|560286409|FG002|Overall Study|Other Reasons|1|||
155232534|NCT01420081|560286410|FG003|Overall Study|Other Reasons|0|||
155232535|NCT01420081|560286411|FG004|Overall Study|Other Reasons|0|||
155232536|NCT01420081|560286412|FG005|Overall Study|Other Reasons|0|||
155232537|NCT01420081|560286413|FG006|Overall Study|Other Reasons|0|||
155232538|NCT01420081|560286414|FG007|Overall Study|Other Reasons|0|||
155232539|NCT01420081|560286415|FG008|Overall Study|Other Reasons|0|||
155232540|NCT02469610|560286416|FG000|Overall Study|Death|1|||
155232541|NCT02469610|560286417|FG001|Overall Study|Death|0|||
155232542|NCT02469610|560286416|FG000|Overall Study|Lost to Follow-up|1|||
155232543|NCT02469610|560286417|FG001|Overall Study|Lost to Follow-up|0|||
155232544|NCT02469610|560286416|FG000|Overall Study|exclusion criteria|2|||
155232545|NCT02469610|560286417|FG001|Overall Study|exclusion criteria|1|||
155232546|NCT00414388|560286420|FG000|Overall Study|Adverse Event|1|||
155232547|NCT03467425|560286421|FG000|Overall Study|Adverse Event|9|||
155232548|NCT03467425|560286422|FG001|Overall Study|Adverse Event|9|||
155232549|NCT03467425|560286421|FG000|Overall Study|Lack of Efficacy|3|||
155232550|NCT03467425|560286422|FG001|Overall Study|Lack of Efficacy|1|||
155232551|NCT03467425|560286421|FG000|Overall Study|Protocol Violation|0|||
155232552|NCT03467425|560286422|FG001|Overall Study|Protocol Violation|1|||
155232553|NCT03467425|560286421|FG000|Overall Study|Lost to Follow-up|18|||
155232554|NCT03467425|560286422|FG001|Overall Study|Lost to Follow-up|25|||
155232555|NCT03467425|560286421|FG000|Overall Study|Physician Decision|2|||
155232556|NCT03467425|560286422|FG001|Overall Study|Physician Decision|1|||
155232557|NCT03467425|560286421|FG000|Overall Study|Withdrawal by Subject|15|||
155232558|NCT03467425|560286422|FG001|Overall Study|Withdrawal by Subject|17|||
155232559|NCT00025883|560286424|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
155232560|NCT00025883|560286424|FG000|Overall Study|no baseline data|1|||
155232561|NCT00025883|560286424|FG000|Overall Study|Death|1|||
155232562|NCT00025883|560286424|FG000|Overall Study|Adverse Event|1|||
155232563|NCT00025883|560286424|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
155232564|NCT00678561|560286425|FG000|Overall Study|Adverse Event|0|||
155232565|NCT00678561|560286426|FG001|Overall Study|Adverse Event|1|||
155232566|NCT00678561|560286427|FG002|Overall Study|Adverse Event|1|||
155232567|NCT00678561|560286428|FG003|Overall Study|Adverse Event|0|||
155232568|NCT00678561|560286429|FG004|Overall Study|Adverse Event|1|||
155232569|NCT00678561|560286430|FG005|Overall Study|Adverse Event|0|||
155232570|NCT00678561|560286431|FG006|Overall Study|Adverse Event|0|||
155232571|NCT00678561|560286432|FG007|Overall Study|Adverse Event|0|||
155232572|NCT00678561|560286425|FG000|Overall Study|Protocol Violation|0|||
155232573|NCT00678561|560286426|FG001|Overall Study|Protocol Violation|0|||
155232574|NCT00678561|560286427|FG002|Overall Study|Protocol Violation|0|||
155232575|NCT00678561|560286428|FG003|Overall Study|Protocol Violation|0|||
155232576|NCT00678561|560286429|FG004|Overall Study|Protocol Violation|1|||
155232577|NCT00678561|560286430|FG005|Overall Study|Protocol Violation|1|||
155232578|NCT00678561|560286431|FG006|Overall Study|Protocol Violation|0|||
155232579|NCT00678561|560286432|FG007|Overall Study|Protocol Violation|0|||
155232580|NCT00678561|560286425|FG000|Overall Study|Withdrawal by Subject|0|||
155232581|NCT00678561|560286426|FG001|Overall Study|Withdrawal by Subject|0|||
155232582|NCT00678561|560286427|FG002|Overall Study|Withdrawal by Subject|0|||
155232583|NCT00678561|560286428|FG003|Overall Study|Withdrawal by Subject|0|||
155232584|NCT00678561|560286429|FG004|Overall Study|Withdrawal by Subject|0|||
155232585|NCT00678561|560286430|FG005|Overall Study|Withdrawal by Subject|0|||
155232586|NCT00678561|560286431|FG006|Overall Study|Withdrawal by Subject|0|||
155232587|NCT00678561|560286432|FG007|Overall Study|Withdrawal by Subject|1|||
155232588|NCT00218543|560286433|FG000|Overall Study|Lost to Follow-up|8|||
155232589|NCT00218543|560286433|FG000|Overall Study|relocated|1|||
155232590|NCT00218543|560286433|FG000|Overall Study|Withdrawal by Subject|1|||
155232591|NCT00218543|560286433|FG000|Overall Study|Physician Decision|3|||
155232592|NCT00218543|560286433|FG000|Overall Study|Adverse Event|2|||
155232593|NCT02920983|560286434|FG000|Dispense 1|Unacceptable Lens Fit|0|||
155232594|NCT02920983|560286435|FG001|Dispense 1|Unacceptable Lens Fit|0|||
155232595|NCT02920983|560286436|FG002|Dispense 1|Unacceptable Lens Fit|0|||
155232596|NCT02920983|560286437|FG003|Dispense 1|Unacceptable Lens Fit|0|||
155232597|NCT02920983|560286438|FG004|Dispense 1|Unacceptable Lens Fit|1|||
155232598|NCT02920983|560286439|FG005|Dispense 1|Unacceptable Lens Fit|0|||
155232599|NCT02920983|560286434|FG000|Dispense 2|Unscceptable lens fit|1|||
155232600|NCT02920983|560286435|FG001|Dispense 2|Unscceptable lens fit|0|||
155232601|NCT02920983|560286436|FG002|Dispense 2|Unscceptable lens fit|0|||
155232602|NCT02920983|560286437|FG003|Dispense 2|Unscceptable lens fit|0|||
155232603|NCT02920983|560286438|FG004|Dispense 2|Unscceptable lens fit|1|||
155232604|NCT02920983|560286439|FG005|Dispense 2|Unscceptable lens fit|0|||
155232605|NCT02920983|560286434|FG000|Dispense 3|Unacceptable Lens Fit|1|||
155232606|NCT02920983|560286435|FG001|Dispense 3|Unacceptable Lens Fit|1|||
155232607|NCT02920983|560286436|FG002|Dispense 3|Unacceptable Lens Fit|0|||
155232608|NCT02920983|560286437|FG003|Dispense 3|Unacceptable Lens Fit|0|||
155232609|NCT02920983|560286438|FG004|Dispense 3|Unacceptable Lens Fit|1|||
155232610|NCT02920983|560286439|FG005|Dispense 3|Unacceptable Lens Fit|0|||
155232611|NCT01451424|560286440|FG000|Overall Study|Withdrawal by Subject|1|||
155232612|NCT01451424|560286441|FG001|Overall Study|Withdrawal by Subject|1|||
155232613|NCT01451424|560286442|FG002|Overall Study|Withdrawal by Subject|0|||
155232614|NCT01451424|560286443|FG003|Overall Study|Withdrawal by Subject|2|||
155232615|NCT01451424|560286440|FG000|Overall Study|Lost to Follow-up|0|||
155232616|NCT01451424|560286441|FG001|Overall Study|Lost to Follow-up|1|||
155232617|NCT01451424|560286442|FG002|Overall Study|Lost to Follow-up|0|||
155232618|NCT01451424|560286443|FG003|Overall Study|Lost to Follow-up|1|||
155232619|NCT01451424|560286440|FG000|Overall Study|Physician Decision|0|||
155232620|NCT01451424|560286441|FG001|Overall Study|Physician Decision|0|||
155232621|NCT01451424|560286442|FG002|Overall Study|Physician Decision|1|||
155232622|NCT01451424|560286443|FG003|Overall Study|Physician Decision|1|||
155232623|NCT01451424|560286440|FG000|Overall Study|Adverse Event|0|||
155232624|NCT01451424|560286441|FG001|Overall Study|Adverse Event|0|||
155232625|NCT01451424|560286442|FG002|Overall Study|Adverse Event|0|||
155232626|NCT01451424|560286443|FG003|Overall Study|Adverse Event|1|||
155232627|NCT01387607|560286449|FG000|Overall Study|Adverse Event|23|||
155232628|NCT01387607|560286450|FG001|Overall Study|Adverse Event|11|||
155232629|NCT01387607|560286449|FG000|Overall Study|Lack of Efficacy|8|||
155232630|NCT01387607|560286450|FG001|Overall Study|Lack of Efficacy|6|||
155232631|NCT01387607|560286449|FG000|Overall Study|Lost to Follow-up|2|||
155232632|NCT01387607|560286450|FG001|Overall Study|Lost to Follow-up|1|||
155232633|NCT01387607|560286449|FG000|Overall Study|No longer meets eligibility criteria|0|||
155232634|NCT01387607|560286450|FG001|Overall Study|No longer meets eligibility criteria|1|||
155232635|NCT01387607|560286449|FG000|Overall Study|Protocol Violation|1|||
155232636|NCT01387607|560286450|FG001|Overall Study|Protocol Violation|5|||
155232637|NCT01387607|560286449|FG000|Overall Study|Withdrawal by Subject|13|||
155232638|NCT01387607|560286450|FG001|Overall Study|Withdrawal by Subject|14|||
155232639|NCT01387607|560286449|FG000|Overall Study|Other|1|||
155232640|NCT01387607|560286450|FG001|Overall Study|Other|1|||
155232641|NCT01387607|560286449|FG000|Overall Study|Randomized, not treated|3|||
155232642|NCT01387607|560286450|FG001|Overall Study|Randomized, not treated|6|||
155232643|NCT02908529|560286452|FG000|Overall Study|Lost to Follow-up|0|||
155232644|NCT02908529|560286453|FG001|Overall Study|Lost to Follow-up|2|||
155232645|NCT00689481|560286454|FG000|Overall Study|Adverse Event|7|||
155232646|NCT00689481|560286455|FG001|Overall Study|Adverse Event|1|||
155232647|NCT00689481|560286454|FG000|Overall Study|Lost to Follow-up|4|||
155232648|NCT00689481|560286455|FG001|Overall Study|Lost to Follow-up|3|||
155232649|NCT00689481|560286454|FG000|Overall Study|Lack of Efficacy|4|||
155232650|NCT00689481|560286455|FG001|Overall Study|Lack of Efficacy|3|||
155232651|NCT00689481|560286454|FG000|Overall Study|Non-compliance with study treatment|1|||
155232652|NCT00689481|560286455|FG001|Overall Study|Non-compliance with study treatment|1|||
155232653|NCT00689481|560286454|FG000|Overall Study|Withdrawal by Subject|8|||
155232654|NCT00689481|560286455|FG001|Overall Study|Withdrawal by Subject|4|||
155232655|NCT00689481|560286454|FG000|Overall Study|Excluded medication started during study|0|||
155232656|NCT00689481|560286455|FG001|Overall Study|Excluded medication started during study|1|||
155232657|NCT00689481|560286454|FG000|Overall Study|Subject early term, left on vacation|0|||
155232658|NCT00689481|560286455|FG001|Overall Study|Subject early term, left on vacation|1|||
155232659|NCT00528528|560286456|FG000|Overall Study|Lost to Follow-up|0|||
155232660|NCT00528528|560286457|FG001|Overall Study|Lost to Follow-up|0|||
155232661|NCT00528528|560286458|FG002|Overall Study|Lost to Follow-up|1|||
155232662|NCT00528528|560286459|FG003|Overall Study|Lost to Follow-up|1|||
155232663|NCT00528528|560286456|FG000|Overall Study|Ineligible to continue the trial|0|||
155232664|NCT00528528|560286457|FG001|Overall Study|Ineligible to continue the trial|0|||
155232665|NCT00528528|560286458|FG002|Overall Study|Ineligible to continue the trial|0|||
155232666|NCT00528528|560286459|FG003|Overall Study|Ineligible to continue the trial|1|||
155232667|NCT00528528|560286456|FG000|Overall Study|Other|0|||
155232668|NCT00528528|560286457|FG001|Overall Study|Other|1|||
155232669|NCT00528528|560286458|FG002|Overall Study|Other|0|||
155232670|NCT00528528|560286459|FG003|Overall Study|Other|0|||
155232671|NCT00528528|560286456|FG000|Overall Study|Withdrawal by Subject|3|||
155232672|NCT00528528|560286457|FG001|Overall Study|Withdrawal by Subject|2|||
155232673|NCT00528528|560286458|FG002|Overall Study|Withdrawal by Subject|1|||
155232674|NCT00528528|560286459|FG003|Overall Study|Withdrawal by Subject|1|||
155232675|NCT00528528|560286456|FG000|Overall Study|Ongoing participant|0|||
155232676|NCT00528528|560286457|FG001|Overall Study|Ongoing participant|0|||
155232677|NCT00528528|560286458|FG002|Overall Study|Ongoing participant|1|||
155232678|NCT00528528|560286459|FG003|Overall Study|Ongoing participant|0|||
155232679|NCT03238911|560286463|FG000|Overall Study|Withdrawal by Subject|1|||
155232680|NCT03238911|560286464|FG001|Overall Study|Withdrawal by Subject|2|||
155232681|NCT03238911|560286463|FG000|Overall Study|Lost to Follow-up|2|||
155232682|NCT03238911|560286464|FG001|Overall Study|Lost to Follow-up|1|||
155232683|NCT02097134|560287977|FG000|Overall Study|Physician Decision|4|||
155232684|NCT02097134|560287977|FG000|Overall Study|Non-Protocol Therapy|1|||
155232685|NCT02097134|560287977|FG000|Overall Study|Progressive Disease|3|||
155232686|NCT02097134|560287977|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
155232687|NCT03285646|560287984|FG000|Overall Study|Adverse Event|1|||
155232688|NCT03285646|560287985|FG001|Overall Study|Adverse Event|0|||
155232689|NCT03285646|560287984|FG000|Overall Study|Withdrawal by Subject|10|||
155232690|NCT03285646|560287985|FG001|Overall Study|Withdrawal by Subject|2|||
155232691|NCT03285646|560287984|FG000|Overall Study|Lost to Follow-up|2|||
155232692|NCT03285646|560287985|FG001|Overall Study|Lost to Follow-up|1|||
155232693|NCT03285646|560287984|FG000|Overall Study|Investigator/Sponsor Decision|0|||
155232694|NCT03285646|560287985|FG001|Overall Study|Investigator/Sponsor Decision|1|||
155232695|NCT00424372|560287988|FG000|Overall Study|Death|1|||
155232696|NCT00424372|560287988|FG000|Overall Study|Adverse Event|18|||
155232697|NCT00424372|560287988|FG000|Overall Study|Lack of Efficacy|6|||
155232698|NCT00424372|560287988|FG000|Overall Study|Withdrawal by Subject|4|||
155232699|NCT00424372|560287988|FG000|Overall Study|Protocol Violation|1|||
155232700|NCT00424372|560287988|FG000|Overall Study|Health deterioration|1|||
155232701|NCT02652624|560287989|FG000|Randomized Phase|Pregnancy|3|||
155232702|NCT02652624|560287990|FG001|Randomized Phase|Pregnancy|1|||
155232703|NCT02652624|560287989|FG000|Randomized Phase|Investigator's Discretion|0|||
155232704|NCT02652624|560287990|FG001|Randomized Phase|Investigator's Discretion|2|||
155232705|NCT02652624|560287989|FG000|Randomized Phase|Death|0|||
155232706|NCT02652624|560287990|FG001|Randomized Phase|Death|1|||
155232707|NCT02652624|560287989|FG000|Randomized Phase|Lost to Follow-up|0|||
155232708|NCT02652624|560287990|FG001|Randomized Phase|Lost to Follow-up|1|||
155232709|NCT02652624|560287989|FG000|Extension Phase|Lost to Follow-up|3|||
155232710|NCT02652624|560287990|FG001|Extension Phase|Lost to Follow-up|1|||
155232711|NCT02652624|560287989|FG000|Extension Phase|Pregnancy|1|||
155232712|NCT02652624|560287990|FG001|Extension Phase|Pregnancy|1|||
155232713|NCT02652624|560287989|FG000|Extension Phase|Adverse Event|0|||
155232714|NCT02652624|560287990|FG001|Extension Phase|Adverse Event|1|||
155232715|NCT02652624|560287989|FG000|Extension Phase|Withdrew Consent|0|||
155232716|NCT02652624|560287990|FG001|Extension Phase|Withdrew Consent|1|||
155232717|NCT00796861|560287993|FG000|Overall Study|Withdrawal by Subject|2|||
155232718|NCT00796861|560287993|FG000|Overall Study|Death|2|||
155232719|NCT02664038|560287996|FG000|13 Week|Lost to Follow-up|7|||
155232720|NCT02664038|560287997|FG001|13 Week|Lost to Follow-up|14|||
155232721|NCT02664038|560287996|FG000|13 Week|Withdrawal by Subject|1|||
155232722|NCT02664038|560287997|FG001|13 Week|Withdrawal by Subject|0|||
155232723|NCT02664038|560287996|FG000|26 Week|Lost to Follow-up|5|||
155232724|NCT02664038|560287997|FG001|26 Week|Lost to Follow-up|4|||
155232725|NCT04456699|560288008|FG000|Overall Study|Death|48|||
155232726|NCT04456699|560288009|FG001|Overall Study|Death|50|||
155232727|NCT04456699|560288010|FG002|Overall Study|Death|52|||
155232728|NCT04456699|560288008|FG000|Overall Study|Physician Decision|0|||
155232729|NCT04456699|560288009|FG001|Overall Study|Physician Decision|0|||
155232730|NCT04456699|560288010|FG002|Overall Study|Physician Decision|2|||
155232731|NCT04456699|560288008|FG000|Overall Study|Sponsor Decision|55|||
155232732|NCT04456699|560288009|FG001|Overall Study|Sponsor Decision|61|||
155232733|NCT04456699|560288010|FG002|Overall Study|Sponsor Decision|50|||
155232734|NCT04456699|560288008|FG000|Overall Study|Withdrawal by Subject|8|||
155232735|NCT04456699|560288009|FG001|Overall Study|Withdrawal by Subject|4|||
155232736|NCT04456699|560288010|FG002|Overall Study|Withdrawal by Subject|5|||
155232737|NCT01147653|560288016|FG000|Year 2|Withdrawal by Subject|2|||
155232738|NCT01147653|560288017|FG001|Year 2|Withdrawal by Subject|3|||
155232739|NCT00670228|560288018|FG000|Overall Study|Adverse Event|1|||
155232740|NCT00670228|560288019|FG001|Overall Study|Adverse Event|0|||
155232741|NCT00670228|560288018|FG000|Overall Study|Death or MACE|0|||
155232742|NCT00670228|560288019|FG001|Overall Study|Death or MACE|1|||
155232743|NCT00670228|560288018|FG000|Overall Study|Not treated|2|||
155232744|NCT00670228|560288019|FG001|Overall Study|Not treated|2|||
155232745|NCT00670228|560288018|FG000|Overall Study|Not meeting the selection criteria|2|||
155232746|NCT00670228|560288019|FG001|Overall Study|Not meeting the selection criteria|0|||
155232747|NCT05267054|560288020|FG000|Overall Study|Death|13|||
155232748|NCT05267054|560288021|FG001|Overall Study|Death|14|||
155232749|NCT05267054|560288020|FG000|Overall Study|Study Ended by Sponsor|9|||
155232750|NCT05267054|560288021|FG001|Overall Study|Study Ended by Sponsor|13|||
155232751|NCT05267054|560288020|FG000|Overall Study|Lost to Follow-up|1|||
155232752|NCT05267054|560288021|FG001|Overall Study|Lost to Follow-up|1|||
155232753|NCT05267054|560288020|FG000|Overall Study|Withdrawal by Subject|1|||
155232754|NCT05267054|560288021|FG001|Overall Study|Withdrawal by Subject|1|||
155232755|NCT01813019|560288025|FG000|Overall Study|Adverse Event|0|||
155232756|NCT01813019|560288026|FG001|Overall Study|Adverse Event|3|||
155232757|NCT01813019|560288025|FG000|Overall Study|Withdrawal by Subject|3|||
155232758|NCT01813019|560288026|FG001|Overall Study|Withdrawal by Subject|2|||
155232759|NCT01813019|560288025|FG000|Overall Study|administrative problems|2|||
155232760|NCT01813019|560288026|FG001|Overall Study|administrative problems|0|||
155232761|NCT01813019|560288025|FG000|Overall Study|Protocol Deviation|2|||
155232762|NCT01813019|560288026|FG001|Overall Study|Protocol Deviation|1|||
155232763|NCT01193556|560288027|FG000|Overall Study|Study termination|26|||
155232764|NCT01193556|560288028|FG001|Overall Study|Study termination|25|||
155232765|NCT03921411|560288034|FG000|Overall Study|Withdrawal by Subject|1|||
155232766|NCT03921411|560288034|FG000|Overall Study|Protocol Deviation|2|||
155232767|NCT03921411|560288034|FG000|Overall Study|Enrolled, but never treated|2|||
155232768|NCT01541826|560288035|FG000|Overall Study|Lost to Follow-up|2|||
155232769|NCT01541826|560288036|FG001|Overall Study|Lost to Follow-up|3|||
155232770|NCT01541826|560288037|FG002|Overall Study|Lost to Follow-up|0|||
155232771|NCT01541826|560288035|FG000|Overall Study|Withdrawal by Subject|2|||
155232772|NCT01541826|560288036|FG001|Overall Study|Withdrawal by Subject|0|||
155232773|NCT01541826|560288037|FG002|Overall Study|Withdrawal by Subject|0|||
155232774|NCT01365273|560288038|FG000|Overall Study|Lost to Follow-up|1|||
155232775|NCT01365273|560288039|FG001|Overall Study|Lost to Follow-up|0|||
155232776|NCT01365273|560288038|FG000|Overall Study|Protocol Violation|0|||
155232777|NCT01365273|560288039|FG001|Overall Study|Protocol Violation|1|||
155232778|NCT01365273|560288038|FG000|Overall Study|Physician Decision|1|||
155232779|NCT01365273|560288039|FG001|Overall Study|Physician Decision|0|||
155232780|NCT02705820|560288052|FG000|Overall Study|Death|2|||
155232781|NCT02705820|560288052|FG000|Overall Study|Disease Progression|34|||
155232782|NCT02705820|560288052|FG000|Overall Study|Clinical Deterioration|3|||
155232783|NCT02702401|560288054|FG000|Overall Study|Death|242|||
155232784|NCT02702401|560288055|FG001|Overall Study|Death|125|||
155232785|NCT02702401|560288054|FG000|Overall Study|Withdrawal by Subject|15|||
155232786|NCT02702401|560288055|FG001|Overall Study|Withdrawal by Subject|5|||
155232787|NCT02702401|560288054|FG000|Overall Study|Sponsor Decision|19|||
155232788|NCT02702401|560288055|FG001|Overall Study|Sponsor Decision|3|||
155232789|NCT02702401|560288054|FG000|Overall Study|Physician Decision|1|||
155232790|NCT02702401|560288055|FG001|Overall Study|Physician Decision|2|||
155232791|NCT02702401|560288054|FG000|Overall Study|Lost to Follow-up|1|||
155232792|NCT02702401|560288055|FG001|Overall Study|Lost to Follow-up|0|||
155232793|NCT01462357|560288061|FG000|Overall Study|Death|0|||
155232794|NCT01462357|560288062|FG001|Overall Study|Death|0|||
155232795|NCT01462357|560288063|FG002|Overall Study|Death|1|||
155232796|NCT01462357|560288061|FG000|Overall Study|Withdrawal by Subject|3|||
155232797|NCT01462357|560288062|FG001|Overall Study|Withdrawal by Subject|11|||
155232798|NCT01462357|560288063|FG002|Overall Study|Withdrawal by Subject|3|||
155232799|NCT01462357|560288061|FG000|Overall Study|Migrated/moved from study area|2|||
155232800|NCT01462357|560288062|FG001|Overall Study|Migrated/moved from study area|3|||
155232801|NCT01462357|560288063|FG002|Overall Study|Migrated/moved from study area|1|||
155232802|NCT01462357|560288061|FG000|Overall Study|Lost to Follow-up|3|||
155232803|NCT01462357|560288062|FG001|Overall Study|Lost to Follow-up|5|||
155232804|NCT01462357|560288063|FG002|Overall Study|Lost to Follow-up|7|||
155232805|NCT04292730|560288073|FG000|Overall Study|Lost to Follow-up|8|||
155232806|NCT04292730|560288074|FG001|Overall Study|Lost to Follow-up|12|||
155232807|NCT04292730|560288075|FG002|Overall Study|Lost to Follow-up|12|||
155232808|NCT04292730|560288076|FG003|Overall Study|Lost to Follow-up|48|||
155232809|NCT04292730|560288073|FG000|Overall Study|Death|2|||
155232810|NCT04292730|560288074|FG001|Overall Study|Death|2|||
155232811|NCT04292730|560288075|FG002|Overall Study|Death|4|||
155232812|NCT04292730|560288076|FG003|Overall Study|Death|12|||
155232813|NCT04292730|560288073|FG000|Overall Study|Withdrew Consent|2|||
155232814|NCT04292730|560288074|FG001|Overall Study|Withdrew Consent|2|||
155232815|NCT04292730|560288075|FG002|Overall Study|Withdrew Consent|5|||
155232816|NCT04292730|560288076|FG003|Overall Study|Withdrew Consent|6|||
155232817|NCT04292730|560288073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155232818|NCT04292730|560288074|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155232819|NCT04292730|560288075|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155232820|NCT04292730|560288076|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155232821|NCT04292730|560288073|FG000|Overall Study|Protocol Violation|0|||
155232822|NCT04292730|560288074|FG001|Overall Study|Protocol Violation|0|||
155232823|NCT04292730|560288075|FG002|Overall Study|Protocol Violation|1|||
155232824|NCT04292730|560288076|FG003|Overall Study|Protocol Violation|0|||
155232825|NCT04292730|560288073|FG000|Overall Study|Randomized but not Treated|8|||
155232826|NCT04292730|560288074|FG001|Overall Study|Randomized but not Treated|4|||
155232827|NCT04292730|560288075|FG002|Overall Study|Randomized but not Treated|0|||
155232828|NCT04292730|560288076|FG003|Overall Study|Randomized but not Treated|14|||
155232829|NCT01527292|560288077|FG000|Overall Study|Physician Decision|0|||
155232830|NCT01527292|560288078|FG001|Overall Study|Physician Decision|3|||
155232831|NCT00314366|560288081|FG000|Overall Study|not treated due to patient medical condi|1|||
155232832|NCT00314366|560288082|FG001|Overall Study|not treated due to patient medical condi|0|||
155232833|NCT03400033|560288083|FG000|Overall Study|Withdrawal by Subject|1|||
155232834|NCT03400033|560288084|FG001|Overall Study|Withdrawal by Subject|2|||
155232835|NCT00006916|560288085|FG000|Overall Study|Device not inserted|4|||
155232836|NCT00006916|560288085|FG000|Overall Study|Complication of device insertion|1|||
155232837|NCT00558103|560288086|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
155232838|NCT00558103|560288087|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
155232839|NCT00558103|560288088|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
155232840|NCT00558103|560288089|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
155232841|NCT00558103|560288090|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
155232842|NCT00558103|560288091|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
155232843|NCT00558103|560288086|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
155232844|NCT00558103|560288087|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
155232845|NCT00558103|560288088|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232846|NCT00558103|560288089|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232847|NCT00558103|560288090|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
155232848|NCT00558103|560288091|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232849|NCT00558103|560288086|FG000|Randomized Treatment Phase|Disease Progression|1|||
155232850|NCT00558103|560288087|FG001|Randomized Treatment Phase|Disease Progression|0|||
155232851|NCT00558103|560288088|FG002|Randomized Treatment Phase|Disease Progression|1|||
155232852|NCT00558103|560288089|FG003|Randomized Treatment Phase|Disease Progression|0|||
155232853|NCT00558103|560288090|FG004|Randomized Treatment Phase|Disease Progression|0|||
155232854|NCT00558103|560288091|FG005|Randomized Treatment Phase|Disease Progression|0|||
155232855|NCT00558103|560288086|FG000|Randomized Treatment Phase|Adverse Event|0|||
155232856|NCT00558103|560288087|FG001|Randomized Treatment Phase|Adverse Event|0|||
155232857|NCT00558103|560288088|FG002|Randomized Treatment Phase|Adverse Event|0|||
155232858|NCT00558103|560288089|FG003|Randomized Treatment Phase|Adverse Event|1|||
155232859|NCT00558103|560288090|FG004|Randomized Treatment Phase|Adverse Event|1|||
155232860|NCT00558103|560288091|FG005|Randomized Treatment Phase|Adverse Event|0|||
155232861|NCT00558103|560288086|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
155232862|NCT00558103|560288087|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
155232863|NCT00558103|560288088|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
155232864|NCT00558103|560288089|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
155232865|NCT00558103|560288090|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
155232866|NCT00558103|560288091|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
155232867|NCT00558103|560288086|FG000|Monotherapy Extension Phase|Disease Progression|0|||
155232868|NCT00558103|560288087|FG001|Monotherapy Extension Phase|Disease Progression|0|||
155232869|NCT00558103|560288088|FG002|Monotherapy Extension Phase|Disease Progression|0|||
155232870|NCT00558103|560288089|FG003|Monotherapy Extension Phase|Disease Progression|0|||
155232871|NCT00558103|560288090|FG004|Monotherapy Extension Phase|Disease Progression|0|||
155232872|NCT00558103|560288091|FG005|Monotherapy Extension Phase|Disease Progression|8|||
155232873|NCT02457325|560288092|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
155232874|NCT02457325|560288093|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
155232875|NCT01574703|560288094|FG000|Overall Study|Adverse Event|0|||
155232876|NCT01574703|560288095|FG001|Overall Study|Adverse Event|2|||
155232877|NCT01574703|560288096|FG002|Overall Study|Adverse Event|1|||
155232878|NCT01574703|560288097|FG003|Overall Study|Adverse Event|1|||
155232879|NCT01574703|560288094|FG000|Overall Study|Protocol Violation|0|||
155232880|NCT01574703|560288095|FG001|Overall Study|Protocol Violation|0|||
155232881|NCT01574703|560288096|FG002|Overall Study|Protocol Violation|0|||
155232882|NCT01574703|560288097|FG003|Overall Study|Protocol Violation|1|||
155232883|NCT01574703|560288094|FG000|Overall Study|Unspecified Reason|27|||
155232884|NCT01574703|560288095|FG001|Overall Study|Unspecified Reason|15|||
155232885|NCT01574703|560288096|FG002|Overall Study|Unspecified Reason|20|||
155232886|NCT01574703|560288097|FG003|Overall Study|Unspecified Reason|16|||
155232887|NCT01574703|560288094|FG000|Overall Study|Withdrawal by Subject|53|||
155232888|NCT01574703|560288095|FG001|Overall Study|Withdrawal by Subject|52|||
155232889|NCT01574703|560288096|FG002|Overall Study|Withdrawal by Subject|36|||
155232890|NCT01574703|560288097|FG003|Overall Study|Withdrawal by Subject|61|||
155232891|NCT01574703|560288094|FG000|Overall Study|Met Withdrawal Criteria|0|||
155232892|NCT01574703|560288095|FG001|Overall Study|Met Withdrawal Criteria|1|||
155232893|NCT01574703|560288096|FG002|Overall Study|Met Withdrawal Criteria|1|||
155232894|NCT01574703|560288097|FG003|Overall Study|Met Withdrawal Criteria|0|||
155232895|NCT01574703|560288094|FG000|Overall Study|Lost to Follow-up|43|||
155232896|NCT01574703|560288095|FG001|Overall Study|Lost to Follow-up|41|||
155232897|NCT01574703|560288096|FG002|Overall Study|Lost to Follow-up|46|||
155232898|NCT01574703|560288097|FG003|Overall Study|Lost to Follow-up|35|||
155232899|NCT01574703|560288094|FG000|Overall Study|Death|2|||
155232900|NCT01574703|560288095|FG001|Overall Study|Death|1|||
155232901|NCT01574703|560288096|FG002|Overall Study|Death|1|||
155232902|NCT01574703|560288097|FG003|Overall Study|Death|0|||
155232903|NCT02751983|560288103|FG000|Treatment|Stopped ACT, but Remained in study|2|||
155232904|NCT02751983|560288104|FG001|Treatment|Stopped ACT, but Remained in study|0|||
155232905|NCT02751983|560288103|FG000|Treatment|Discharged prior to beginning ACT|2|||
155232906|NCT02751983|560288104|FG001|Treatment|Discharged prior to beginning ACT|0|||
155232907|NCT02751983|560288103|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
155232908|NCT02751983|560288104|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
155232909|NCT02751983|560288103|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
155232910|NCT02751983|560288104|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
155232911|NCT02751983|560288103|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
155232912|NCT02751983|560288104|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
155232913|NCT00989833|560288105|FG000|Overall Study|Lost to Follow-up|0|||
155232914|NCT00989833|560288106|FG001|Overall Study|Lost to Follow-up|1|||
155232915|NCT00989833|560288107|FG002|Overall Study|Lost to Follow-up|0|||
155232916|NCT00989833|560288105|FG000|Overall Study|Protocol Violation|1|||
155232917|NCT00989833|560288106|FG001|Overall Study|Protocol Violation|2|||
155232918|NCT00989833|560288107|FG002|Overall Study|Protocol Violation|1|||
155232919|NCT00989833|560288105|FG000|Overall Study|Withdrawal by Subject|0|||
155232920|NCT00989833|560288106|FG001|Overall Study|Withdrawal by Subject|0|||
155232921|NCT00989833|560288107|FG002|Overall Study|Withdrawal by Subject|1|||
155232922|NCT00989833|560288105|FG000|Overall Study|Incorrectly randomized|1|||
155232923|NCT00989833|560288106|FG001|Overall Study|Incorrectly randomized|0|||
155232924|NCT00989833|560288107|FG002|Overall Study|Incorrectly randomized|0|||
155232925|NCT00308711|560288108|FG000|Overall Study|Withdrawal by Subject|1|||
155232926|NCT00308711|560288109|FG001|Overall Study|Withdrawal by Subject|0|||
155232927|NCT00308711|560288110|FG002|Overall Study|Withdrawal by Subject|1|||
155232928|NCT00308711|560288108|FG000|Overall Study|Protocol Violation|0|||
155232929|NCT00308711|560288109|FG001|Overall Study|Protocol Violation|1|||
155232930|NCT00308711|560288110|FG002|Overall Study|Protocol Violation|1|||
155232931|NCT00308711|560288108|FG000|Overall Study|Lost to Follow-up|0|||
155232932|NCT00308711|560288109|FG001|Overall Study|Lost to Follow-up|1|||
155232933|NCT00308711|560288110|FG002|Overall Study|Lost to Follow-up|0|||
155232934|NCT00308711|560288108|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
155232935|NCT00308711|560288109|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
155232936|NCT00308711|560288110|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
155232937|NCT00308711|560288108|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
155232938|NCT00308711|560288109|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
155232939|NCT00308711|560288110|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
155232940|NCT02318693|560288111|FG000|Overall Study|Protocol Violation|0|||
155232941|NCT02318693|560288112|FG001|Overall Study|Protocol Violation|1|||
155232942|NCT04497987|560288113|FG000|Overall Study|Adverse Event|1|||
155232943|NCT04497987|560288114|FG001|Overall Study|Adverse Event|0|||
155232944|NCT04497987|560288113|FG000|Overall Study|Death|21|||
155232945|NCT04497987|560288114|FG001|Overall Study|Death|13|||
155232946|NCT04497987|560288113|FG000|Overall Study|Lost to Follow-up|19|||
155232947|NCT04497987|560288114|FG001|Overall Study|Lost to Follow-up|17|||
155232948|NCT04497987|560288113|FG000|Overall Study|Other - as reported by the investigator|22|||
155232949|NCT04497987|560288114|FG001|Overall Study|Other - as reported by the investigator|16|||
155232950|NCT04497987|560288113|FG000|Overall Study|Physician Decision|1|||
155232951|NCT04497987|560288114|FG001|Overall Study|Physician Decision|0|||
155232952|NCT04497987|560288113|FG000|Overall Study|Withdrawal by Subject|35|||
155232953|NCT04497987|560288114|FG001|Overall Study|Withdrawal by Subject|21|||
155232954|NCT03337724|560288123|FG000|Overall Study|Reason not Specified|12|||
155232955|NCT03337724|560288124|FG001|Overall Study|Reason not Specified|21|||
155232956|NCT03337724|560288125|FG002|Overall Study|Reason not Specified|9|||
155232957|NCT03337724|560288126|FG003|Overall Study|Reason not Specified|9|||
155232958|NCT03337724|560288127|FG004|Overall Study|Reason not Specified|29|||
155232959|NCT03337724|560288123|FG000|Overall Study|Withdrawal by Subject|13|||
155232960|NCT03337724|560288124|FG001|Overall Study|Withdrawal by Subject|15|||
155232961|NCT03337724|560288125|FG002|Overall Study|Withdrawal by Subject|4|||
155232962|NCT03337724|560288126|FG003|Overall Study|Withdrawal by Subject|15|||
155232963|NCT03337724|560288127|FG004|Overall Study|Withdrawal by Subject|6|||
155232964|NCT03337724|560288123|FG000|Overall Study|Protocol Deviation|0|||
155232965|NCT03337724|560288124|FG001|Overall Study|Protocol Deviation|1|||
155232966|NCT03337724|560288125|FG002|Overall Study|Protocol Deviation|1|||
155232967|NCT03337724|560288126|FG003|Overall Study|Protocol Deviation|1|||
155232968|NCT03337724|560288127|FG004|Overall Study|Protocol Deviation|0|||
155232969|NCT03337724|560288123|FG000|Overall Study|Adverse Event|1|||
155232970|NCT03337724|560288124|FG001|Overall Study|Adverse Event|1|||
155232971|NCT03337724|560288125|FG002|Overall Study|Adverse Event|0|||
155232972|NCT03337724|560288126|FG003|Overall Study|Adverse Event|1|||
155232973|NCT03337724|560288127|FG004|Overall Study|Adverse Event|0|||
155232974|NCT03337724|560288123|FG000|Overall Study|Death|40|||
155232975|NCT03337724|560288124|FG001|Overall Study|Death|89|||
155232976|NCT03337724|560288125|FG002|Overall Study|Death|43|||
155232977|NCT03337724|560288126|FG003|Overall Study|Death|76|||
155232978|NCT03337724|560288127|FG004|Overall Study|Death|50|||
155232979|NCT03337724|560288123|FG000|Overall Study|Lost to Follow-up|5|||
155232980|NCT03337724|560288124|FG001|Overall Study|Lost to Follow-up|5|||
155232981|NCT03337724|560288125|FG002|Overall Study|Lost to Follow-up|4|||
155232982|NCT03337724|560288126|FG003|Overall Study|Lost to Follow-up|7|||
155232983|NCT03337724|560288127|FG004|Overall Study|Lost to Follow-up|4|||
155232984|NCT03337724|560288123|FG000|Overall Study|Physician Decision|16|||
155232985|NCT03337724|560288124|FG001|Overall Study|Physician Decision|34|||
155232986|NCT03337724|560288125|FG002|Overall Study|Physician Decision|14|||
155232987|NCT03337724|560288126|FG003|Overall Study|Physician Decision|34|||
155232988|NCT03337724|560288127|FG004|Overall Study|Physician Decision|13|||
155232989|NCT03337724|560288123|FG000|Overall Study|Progressive Disease|0|||
155232990|NCT03337724|560288124|FG001|Overall Study|Progressive Disease|2|||
155232991|NCT03337724|560288125|FG002|Overall Study|Progressive Disease|1|||
155232992|NCT03337724|560288126|FG003|Overall Study|Progressive Disease|2|||
155232993|NCT03337724|560288127|FG004|Overall Study|Progressive Disease|0|||
155232994|NCT03337724|560288123|FG000|Overall Study|Symptomatic Deterioration|0|||
155232995|NCT03337724|560288124|FG001|Overall Study|Symptomatic Deterioration|0|||
155232996|NCT03337724|560288125|FG002|Overall Study|Symptomatic Deterioration|0|||
155232997|NCT03337724|560288126|FG003|Overall Study|Symptomatic Deterioration|1|||
155232998|NCT03337724|560288127|FG004|Overall Study|Symptomatic Deterioration|0|||
155232999|NCT00773097|560288128|FG000|Overall Study|Withdrawal by Subject|1|||
155233000|NCT00773097|560288128|FG000|Overall Study|Physician Decision|6|||
155233001|NCT00991302|560290289|FG000|Overall Study|Death|0|||
155233002|NCT00991302|560290290|FG001|Overall Study|Death|1|||
155233003|NCT00991302|560290289|FG000|Overall Study|Lost to Follow-up|14|||
155233004|NCT00991302|560290290|FG001|Overall Study|Lost to Follow-up|12|||
155233005|NCT01707004|560290291|FG000|Overall Study|Physician Decision|3|||
155233006|NCT03085927|560290293|FG000|Overall Study|Withdrawal by Subject|1|||
155233007|NCT03085927|560290294|FG001|Overall Study|Withdrawal by Subject|4|||
155233008|NCT03085927|560290293|FG000|Overall Study|Lost to Follow-up|3|||
155233009|NCT03085927|560290294|FG001|Overall Study|Lost to Follow-up|1|||
155233010|NCT03085927|560290293|FG000|Overall Study|Death|1|||
155233011|NCT03085927|560290294|FG001|Overall Study|Death|0|||
155233012|NCT03085927|560290293|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
155233013|NCT03085927|560290294|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
155233014|NCT03085927|560290293|FG000|Overall Study|Dyad Became Ineligible|0|||
155233015|NCT03085927|560290294|FG001|Overall Study|Dyad Became Ineligible|1|||
155233016|NCT02573324|560290297|FG000|Overall Study|Withdrawal by Subject|26|||
155233017|NCT02573324|560290298|FG001|Overall Study|Withdrawal by Subject|23|||
155233018|NCT02573324|560290299|FG002|Overall Study|Withdrawal by Subject|3|||
155233019|NCT02573324|560290297|FG000|Overall Study|Lost to Follow-up|4|||
155233020|NCT02573324|560290298|FG001|Overall Study|Lost to Follow-up|5|||
155233021|NCT02573324|560290299|FG002|Overall Study|Lost to Follow-up|0|||
155233022|NCT02573324|560290297|FG000|Overall Study|Study Terminated by Sponsor|107|||
155233023|NCT02573324|560290298|FG001|Overall Study|Study Terminated by Sponsor|89|||
155233024|NCT02573324|560290299|FG002|Overall Study|Study Terminated by Sponsor|2|||
155233025|NCT02573324|560290297|FG000|Overall Study|Death|182|||
155233026|NCT02573324|560290298|FG001|Overall Study|Death|200|||
155233027|NCT02573324|560290299|FG002|Overall Study|Death|1|||
155233028|NCT02573324|560290297|FG000|Overall Study|Other, Not Specified|20|||
155233029|NCT02573324|560290298|FG001|Overall Study|Other, Not Specified|27|||
155233030|NCT02573324|560290299|FG002|Overall Study|Other, Not Specified|0|||
155233031|NCT02573324|560290297|FG000|Overall Study|Unknown Reason|2|||
155233032|NCT02573324|560290298|FG001|Overall Study|Unknown Reason|0|||
155233033|NCT02573324|560290299|FG002|Overall Study|Unknown Reason|0|||
155233034|NCT02349711|560290300|FG000|Overall Study|Withdrawal by Subject|2|||
155233035|NCT02349711|560290301|FG001|Overall Study|Withdrawal by Subject|1|||
155233036|NCT02349711|560290300|FG000|Overall Study|Lost to Follow-up|1|||
155233037|NCT02349711|560290301|FG001|Overall Study|Lost to Follow-up|1|||
155233038|NCT00941733|560290302|FG000|Overall Study|Death|24|||
155233039|NCT00941733|560290303|FG001|Overall Study|Death|10|||
155233040|NCT00941733|560290302|FG000|Overall Study|Withdrawal by Subject|14|||
155233041|NCT00941733|560290303|FG001|Overall Study|Withdrawal by Subject|6|||
155233042|NCT00941733|560290302|FG000|Overall Study|Adverse Event|20|||
155233043|NCT00941733|560290303|FG001|Overall Study|Adverse Event|4|||
155233044|NCT00941733|560290302|FG000|Overall Study|Lost to Follow-up|1|||
155233045|NCT00941733|560290303|FG001|Overall Study|Lost to Follow-up|2|||
155233046|NCT00941733|560290302|FG000|Overall Study|Protocol Violation|15|||
155233047|NCT00941733|560290303|FG001|Overall Study|Protocol Violation|6|||
155233048|NCT00194012|560290304|FG000|Randomized Phase|Lack of Efficacy|8|||
155233049|NCT00194012|560290305|FG001|Randomized Phase|Lack of Efficacy|18|||
155233050|NCT00194012|560290304|FG000|Randomized Phase|Study nonadherence|2|||
155233051|NCT00194012|560290305|FG001|Randomized Phase|Study nonadherence|1|||
155233052|NCT00194012|560290304|FG000|Randomized Phase|Withdrawal by Subject|3|||
155233053|NCT00194012|560290305|FG001|Randomized Phase|Withdrawal by Subject|3|||
155233054|NCT00194012|560290304|FG000|Randomized Phase|Adverse Event|2|||
155233055|NCT00194012|560290305|FG001|Randomized Phase|Adverse Event|1|||
155233056|NCT00194012|560290304|FG000|Randomized Phase|Participant reported having a rash|1|||
155233057|NCT00194012|560290305|FG001|Randomized Phase|Participant reported having a rash|0|||
155233058|NCT00194012|560290304|FG000|Randomized Phase|Emesis and enuresis|0|||
155233059|NCT00194012|560290305|FG001|Randomized Phase|Emesis and enuresis|1|||
155233060|NCT00194012|560290304|FG000|Randomized Phase|Oral/nasal twitching|0|||
155233061|NCT00194012|560290305|FG001|Randomized Phase|Oral/nasal twitching|1|||
155233062|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Weight Gain|1|||
155233063|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Weight Gain|0|||
155233064|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
155233065|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
155233066|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
155233067|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
155233068|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
155233069|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
155233070|NCT01105533|560290310|FG000|Overall Study|Death|0|||
155233071|NCT01105533|560290311|FG001|Overall Study|Death|0|||
155233072|NCT01105533|560290312|FG002|Overall Study|Death|0|||
155233073|NCT01105533|560290313|FG003|Overall Study|Death|0|||
155233074|NCT01105533|560290314|FG004|Overall Study|Death|1|||
155233075|NCT01105533|560290315|FG005|Overall Study|Death|0|||
155233076|NCT01105533|560290316|FG006|Overall Study|Death|0|||
155233077|NCT01105533|560290317|FG007|Overall Study|Death|0|||
155233078|NCT01105533|560290318|FG008|Overall Study|Death|0|||
155233079|NCT01105533|560290310|FG000|Overall Study|Lack of Efficacy|1|||
155233080|NCT01105533|560290311|FG001|Overall Study|Lack of Efficacy|1|||
155233081|NCT01105533|560290312|FG002|Overall Study|Lack of Efficacy|3|||
155233082|NCT01105533|560290313|FG003|Overall Study|Lack of Efficacy|3|||
155233083|NCT01105533|560290314|FG004|Overall Study|Lack of Efficacy|4|||
155233084|NCT01105533|560290315|FG005|Overall Study|Lack of Efficacy|5|||
155233085|NCT01105533|560290316|FG006|Overall Study|Lack of Efficacy|3|||
155233086|NCT01105533|560290317|FG007|Overall Study|Lack of Efficacy|2|||
155233087|NCT01105533|560290318|FG008|Overall Study|Lack of Efficacy|9|||
155233088|NCT01105533|560290310|FG000|Overall Study|Adverse Event|0|||
155233089|NCT01105533|560290311|FG001|Overall Study|Adverse Event|0|||
155233090|NCT01105533|560290312|FG002|Overall Study|Adverse Event|0|||
155233091|NCT01105533|560290313|FG003|Overall Study|Adverse Event|0|||
155233092|NCT01105533|560290314|FG004|Overall Study|Adverse Event|1|||
155233093|NCT01105533|560290315|FG005|Overall Study|Adverse Event|2|||
155233094|NCT01105533|560290316|FG006|Overall Study|Adverse Event|2|||
155233095|NCT01105533|560290317|FG007|Overall Study|Adverse Event|0|||
155233096|NCT01105533|560290318|FG008|Overall Study|Adverse Event|1|||
155233097|NCT01105533|560290310|FG000|Overall Study|Other|0|||
155233098|NCT01105533|560290311|FG001|Overall Study|Other|0|||
155233099|NCT01105533|560290312|FG002|Overall Study|Other|0|||
155233100|NCT01105533|560290313|FG003|Overall Study|Other|0|||
155233101|NCT01105533|560290314|FG004|Overall Study|Other|1|||
155233102|NCT01105533|560290315|FG005|Overall Study|Other|0|||
155233103|NCT01105533|560290316|FG006|Overall Study|Other|3|||
155233104|NCT01105533|560290317|FG007|Overall Study|Other|1|||
155233105|NCT01105533|560290318|FG008|Overall Study|Other|2|||
155233106|NCT01105533|560290310|FG000|Overall Study|Physician Decision|0|||
155233107|NCT01105533|560290311|FG001|Overall Study|Physician Decision|0|||
155233108|NCT01105533|560290312|FG002|Overall Study|Physician Decision|0|||
155233109|NCT01105533|560290313|FG003|Overall Study|Physician Decision|0|||
155233110|NCT01105533|560290314|FG004|Overall Study|Physician Decision|0|||
155233111|NCT01105533|560290315|FG005|Overall Study|Physician Decision|0|||
155233112|NCT01105533|560290316|FG006|Overall Study|Physician Decision|0|||
155233113|NCT01105533|560290317|FG007|Overall Study|Physician Decision|1|||
155233114|NCT01105533|560290318|FG008|Overall Study|Physician Decision|0|||
155233115|NCT01610700|560290319|FG000|Overall Study|Adverse Event|3|||
155233116|NCT01610700|560290320|FG001|Overall Study|Adverse Event|1|||
155233117|NCT01610700|560290319|FG000|Overall Study|Withdrawal by Subject|0|||
155233118|NCT01610700|560290320|FG001|Overall Study|Withdrawal by Subject|1|||
155233119|NCT01610700|560290319|FG000|Overall Study|subject took one dose of street cannabis|0|||
155233120|NCT01610700|560290320|FG001|Overall Study|subject took one dose of street cannabis|1|||
155233121|NCT01639001|560290326|FG000|Overall Study|Refused further follow-up|9|||
155233122|NCT01639001|560290327|FG001|Overall Study|Refused further follow-up|12|||
155233123|NCT01639001|560290326|FG000|Overall Study|Lost to Follow-up|3|||
155233124|NCT01639001|560290327|FG001|Overall Study|Lost to Follow-up|0|||
155233125|NCT01639001|560290326|FG000|Overall Study|Death|62|||
155233126|NCT01639001|560290327|FG001|Overall Study|Death|61|||
155233127|NCT01639001|560290326|FG000|Overall Study|Randomized but not treated|0|||
155233128|NCT01639001|560290327|FG001|Overall Study|Randomized but not treated|2|||
155233129|NCT01639001|560290326|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
155233130|NCT01639001|560290327|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
155233131|NCT02453594|560290328|FG000|Overall Study|Protocol Violation|0|||
155233132|NCT02453594|560290329|FG001|Overall Study|Protocol Violation|0|||
155233133|NCT02453594|560290330|FG002|Overall Study|Protocol Violation|1|||
155233134|NCT02453594|560290328|FG000|Overall Study|Cohort Was Closed|17|||
155233135|NCT02453594|560290329|FG001|Overall Study|Cohort Was Closed|21|||
155233136|NCT02453594|560290330|FG002|Overall Study|Cohort Was Closed|14|||
155233137|NCT02453594|560290328|FG000|Overall Study|Death|20|||
155233138|NCT02453594|560290329|FG001|Overall Study|Death|24|||
155233139|NCT02453594|560290330|FG002|Overall Study|Death|16|||
155233140|NCT02453594|560290328|FG000|Overall Study|Lost to Follow-up|6|||
155233141|NCT02453594|560290329|FG001|Overall Study|Lost to Follow-up|14|||
155233142|NCT02453594|560290330|FG002|Overall Study|Lost to Follow-up|2|||
155233143|NCT02453594|560290328|FG000|Overall Study|Physician Decision|2|||
155233144|NCT02453594|560290329|FG001|Overall Study|Physician Decision|4|||
155233145|NCT02453594|560290330|FG002|Overall Study|Physician Decision|0|||
155233146|NCT02453594|560290328|FG000|Overall Study|Site Terminated by Sponsor|1|||
155233147|NCT02453594|560290329|FG001|Overall Study|Site Terminated by Sponsor|0|||
155233148|NCT02453594|560290330|FG002|Overall Study|Site Terminated by Sponsor|1|||
155233149|NCT02453594|560290328|FG000|Overall Study|Transitioned to Extension Study|16|||
155233150|NCT02453594|560290329|FG001|Overall Study|Transitioned to Extension Study|9|||
155233151|NCT02453594|560290330|FG002|Overall Study|Transitioned to Extension Study|16|||
155233152|NCT02453594|560290328|FG000|Overall Study|Withdrawal by Subject|7|||
155233153|NCT02453594|560290329|FG001|Overall Study|Withdrawal by Subject|9|||
155233154|NCT02453594|560290330|FG002|Overall Study|Withdrawal by Subject|11|||
155233155|NCT00679341|560290332|FG000|Overall Study|Disease progression|42|||
155233156|NCT00679341|560290333|FG001|Overall Study|Disease progression|36|||
155233157|NCT00679341|560290332|FG000|Overall Study|Adverse Event|5|||
155233158|NCT00679341|560290333|FG001|Overall Study|Adverse Event|6|||
155233159|NCT00679341|560290332|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
155233160|NCT00679341|560290333|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
155233161|NCT00679341|560290332|FG000|Overall Study|Death|1|||
155233162|NCT00679341|560290333|FG001|Overall Study|Death|1|||
155233163|NCT00679341|560290332|FG000|Overall Study|Other|1|||
155233164|NCT00679341|560290333|FG001|Overall Study|Other|0|||
155233165|NCT00679341|560290332|FG000|Overall Study|Physician Decision|1|||
155233166|NCT00679341|560290333|FG001|Overall Study|Physician Decision|0|||
155233167|NCT00679341|560290332|FG000|Overall Study|Not treated|0|||
155233168|NCT00679341|560290333|FG001|Overall Study|Not treated|2|||
155233169|NCT00679341|560290332|FG000|Overall Study|Physician/patient decision to withdraw|0|||
155233170|NCT00679341|560290333|FG001|Overall Study|Physician/patient decision to withdraw|6|||
155233171|NCT02660359|560290334|FG000|Overall Study|Protocol Deviation|0|||
155233172|NCT02660359|560290335|FG001|Overall Study|Protocol Deviation|0|||
155233173|NCT02660359|560290336|FG002|Overall Study|Protocol Deviation|1|||
155233174|NCT02660359|560290334|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
155233175|NCT02660359|560290335|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
155233176|NCT02660359|560290336|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
155233177|NCT02660359|560290334|FG000|Overall Study|Lack of Efficacy|1|||
155233178|NCT02660359|560290335|FG001|Overall Study|Lack of Efficacy|1|||
155233179|NCT02660359|560290336|FG002|Overall Study|Lack of Efficacy|1|||
155233180|NCT02660359|560290334|FG000|Overall Study|Adverse Event|0|||
155233181|NCT02660359|560290335|FG001|Overall Study|Adverse Event|1|||
155233182|NCT02660359|560290336|FG002|Overall Study|Adverse Event|0|||
155233183|NCT02660359|560290334|FG000|Overall Study|Other|2|||
155233184|NCT02660359|560290335|FG001|Overall Study|Other|1|||
155233185|NCT02660359|560290336|FG002|Overall Study|Other|3|||
155233186|NCT02660359|560290334|FG000|Overall Study|Withdrawal by Subject|7|||
155233187|NCT02660359|560290335|FG001|Overall Study|Withdrawal by Subject|5|||
155233188|NCT02660359|560290336|FG002|Overall Study|Withdrawal by Subject|8|||
155233189|NCT02660359|560290334|FG000|Overall Study|Lost to Follow-up|3|||
155233190|NCT02660359|560290335|FG001|Overall Study|Lost to Follow-up|3|||
155233191|NCT02660359|560290336|FG002|Overall Study|Lost to Follow-up|0|||
155233192|NCT00306592|560290337|FG000|Overall Study|Adverse Event|8|||
155233193|NCT00306592|560290338|FG001|Overall Study|Adverse Event|15|||
155233194|NCT00306592|560290337|FG000|Overall Study|Lost to Follow-up|1|||
155233195|NCT00306592|560290338|FG001|Overall Study|Lost to Follow-up|0|||
155233196|NCT00306592|560290337|FG000|Overall Study|Noncompliance|0|||
155233197|NCT00306592|560290338|FG001|Overall Study|Noncompliance|2|||
155233198|NCT00306592|560290337|FG000|Overall Study|Persistent Antibodies|6|||
155233199|NCT00306592|560290338|FG001|Overall Study|Persistent Antibodies|3|||
155233200|NCT00306592|560290337|FG000|Overall Study|Voluntary|10|||
155233201|NCT00306592|560290338|FG001|Overall Study|Voluntary|6|||
155233202|NCT00306592|560290337|FG000|Overall Study|Other|5|||
155233203|NCT00306592|560290338|FG001|Overall Study|Other|10|||
155233204|NCT00306592|560290337|FG000|Overall Study|Other|1|||
155233205|NCT00306592|560290338|FG001|Overall Study|Other|2|||
155233206|NCT00306592|560290337|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
155233207|NCT00306592|560290338|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
155233208|NCT04101526|560290339|FG000|Overall Study|Did not complete all sleep diary entries|0|||
155233209|NCT04101526|560290340|FG001|Overall Study|Did not complete all sleep diary entries|1|||
155233210|NCT00953329|560290343|FG000|Overall Study|Lack of Efficacy|1|||
155233211|NCT01434823|560290344|FG000|Overall Study|Incomplete data in medical record|4|||
155233212|NCT01434823|560290345|FG001|Overall Study|Incomplete data in medical record|7|||
155233213|NCT03670810|560290347|FG000|Main Study|Adverse Event|37|||
155233214|NCT03670810|560290348|FG001|Main Study|Adverse Event|38|||
155233215|NCT03670810|560290349|FG002|Main Study|Adverse Event|3|||
155233216|NCT03670810|560290350|FG003|Main Study|Adverse Event|4|||
155233217|NCT03670810|560290351|FG004|Main Study|Adverse Event|4|||
155233218|NCT03670810|560290352|FG005|Main Study|Adverse Event|5|||
155233219|NCT03670810|560290353|FG006|Main Study|Adverse Event|0|||
155233220|NCT03670810|560290354|FG007|Main Study|Adverse Event|0|||
155233221|NCT03670810|560290355|FG008|Main Study|Adverse Event|0|||
155233222|NCT03670810|560290347|FG000|Main Study|Lack of Efficacy|8|||
155233223|NCT03670810|560290348|FG001|Main Study|Lack of Efficacy|9|||
155233224|NCT03670810|560290349|FG002|Main Study|Lack of Efficacy|3|||
155233225|NCT03670810|560290350|FG003|Main Study|Lack of Efficacy|4|||
155233226|NCT03670810|560290351|FG004|Main Study|Lack of Efficacy|0|||
155233227|NCT03670810|560290352|FG005|Main Study|Lack of Efficacy|0|||
155233228|NCT03670810|560290353|FG006|Main Study|Lack of Efficacy|0|||
155233229|NCT03670810|560290354|FG007|Main Study|Lack of Efficacy|0|||
155233230|NCT03670810|560290355|FG008|Main Study|Lack of Efficacy|0|||
155233231|NCT03670810|560290347|FG000|Main Study|Lost to Follow-up|9|||
155233232|NCT03670810|560290348|FG001|Main Study|Lost to Follow-up|7|||
155233233|NCT03670810|560290349|FG002|Main Study|Lost to Follow-up|4|||
155233234|NCT03670810|560290350|FG003|Main Study|Lost to Follow-up|6|||
155233235|NCT03670810|560290351|FG004|Main Study|Lost to Follow-up|1|||
155233236|NCT03670810|560290352|FG005|Main Study|Lost to Follow-up|0|||
155233237|NCT03670810|560290353|FG006|Main Study|Lost to Follow-up|0|||
155233238|NCT03670810|560290354|FG007|Main Study|Lost to Follow-up|0|||
155233239|NCT03670810|560290355|FG008|Main Study|Lost to Follow-up|0|||
155233240|NCT03670810|560290347|FG000|Main Study|Non-compliance with Study Drug|0|||
155233241|NCT03670810|560290348|FG001|Main Study|Non-compliance with Study Drug|2|||
155233242|NCT03670810|560290349|FG002|Main Study|Non-compliance with Study Drug|3|||
155233243|NCT03670810|560290350|FG003|Main Study|Non-compliance with Study Drug|0|||
155233244|NCT03670810|560290351|FG004|Main Study|Non-compliance with Study Drug|0|||
155233245|NCT03670810|560290352|FG005|Main Study|Non-compliance with Study Drug|0|||
155233246|NCT03670810|560290353|FG006|Main Study|Non-compliance with Study Drug|0|||
155233247|NCT03670810|560290354|FG007|Main Study|Non-compliance with Study Drug|1|||
155233248|NCT03670810|560290355|FG008|Main Study|Non-compliance with Study Drug|0|||
155233249|NCT03670810|560290347|FG000|Main Study|Physician Decision|3|||
155233250|NCT03670810|560290348|FG001|Main Study|Physician Decision|0|||
155233251|NCT03670810|560290349|FG002|Main Study|Physician Decision|1|||
155233252|NCT03670810|560290350|FG003|Main Study|Physician Decision|0|||
155233253|NCT03670810|560290351|FG004|Main Study|Physician Decision|0|||
155233254|NCT03670810|560290352|FG005|Main Study|Physician Decision|0|||
155233255|NCT03670810|560290353|FG006|Main Study|Physician Decision|1|||
155233256|NCT03670810|560290354|FG007|Main Study|Physician Decision|1|||
155233257|NCT03670810|560290355|FG008|Main Study|Physician Decision|0|||
155233258|NCT03670810|560290347|FG000|Main Study|Pregnancy|1|||
155233259|NCT03670810|560290348|FG001|Main Study|Pregnancy|2|||
155233260|NCT03670810|560290349|FG002|Main Study|Pregnancy|0|||
155233261|NCT03670810|560290350|FG003|Main Study|Pregnancy|0|||
155233262|NCT03670810|560290351|FG004|Main Study|Pregnancy|0|||
155233263|NCT03670810|560290352|FG005|Main Study|Pregnancy|0|||
155233264|NCT03670810|560290353|FG006|Main Study|Pregnancy|0|||
155233265|NCT03670810|560290354|FG007|Main Study|Pregnancy|0|||
155233266|NCT03670810|560290355|FG008|Main Study|Pregnancy|0|||
155233267|NCT03670810|560290347|FG000|Main Study|Protocol Deviation|2|||
155233268|NCT03670810|560290348|FG001|Main Study|Protocol Deviation|12|||
155233269|NCT03670810|560290349|FG002|Main Study|Protocol Deviation|8|||
155233270|NCT03670810|560290350|FG003|Main Study|Protocol Deviation|4|||
155233271|NCT03670810|560290351|FG004|Main Study|Protocol Deviation|0|||
155233272|NCT03670810|560290352|FG005|Main Study|Protocol Deviation|0|||
155233273|NCT03670810|560290353|FG006|Main Study|Protocol Deviation|0|||
155233274|NCT03670810|560290354|FG007|Main Study|Protocol Deviation|0|||
155233275|NCT03670810|560290355|FG008|Main Study|Protocol Deviation|0|||
155233276|NCT03670810|560290347|FG000|Main Study|Withdrawal by Subject|21|||
155233277|NCT03670810|560290348|FG001|Main Study|Withdrawal by Subject|21|||
155233278|NCT03670810|560290349|FG002|Main Study|Withdrawal by Subject|8|||
155233279|NCT03670810|560290350|FG003|Main Study|Withdrawal by Subject|9|||
155233280|NCT03670810|560290351|FG004|Main Study|Withdrawal by Subject|5|||
155233281|NCT03670810|560290352|FG005|Main Study|Withdrawal by Subject|2|||
155233282|NCT03670810|560290353|FG006|Main Study|Withdrawal by Subject|1|||
155233283|NCT03670810|560290354|FG007|Main Study|Withdrawal by Subject|1|||
155233284|NCT03670810|560290355|FG008|Main Study|Withdrawal by Subject|0|||
155233285|NCT03670810|560290347|FG000|Main Study|Participant did not want to take the three other treatments|1|||
155233286|NCT03670810|560290348|FG001|Main Study|Participant did not want to take the three other treatments|0|||
155233287|NCT03670810|560290349|FG002|Main Study|Participant did not want to take the three other treatments|0|||
155233288|NCT03670810|560290350|FG003|Main Study|Participant did not want to take the three other treatments|0|||
155233289|NCT03670810|560290351|FG004|Main Study|Participant did not want to take the three other treatments|0|||
155233290|NCT03670810|560290352|FG005|Main Study|Participant did not want to take the three other treatments|0|||
155233291|NCT03670810|560290353|FG006|Main Study|Participant did not want to take the three other treatments|0|||
155233292|NCT03670810|560290354|FG007|Main Study|Participant did not want to take the three other treatments|0|||
155233293|NCT03670810|560290355|FG008|Main Study|Participant did not want to take the three other treatments|0|||
155233294|NCT03670810|560290347|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233295|NCT03670810|560290348|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
155233296|NCT03670810|560290349|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233297|NCT03670810|560290350|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233298|NCT03670810|560290351|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233299|NCT03670810|560290352|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155491466|NCT00563706|561225396|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
155233300|NCT03670810|560290353|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233301|NCT03670810|560290354|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233302|NCT03670810|560290355|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233303|NCT03670810|560290347|FG000|Main Study|Travel and Coronavirus issues|0|||
155233304|NCT03670810|560290348|FG001|Main Study|Travel and Coronavirus issues|0|||
155233305|NCT03670810|560290349|FG002|Main Study|Travel and Coronavirus issues|0|||
155233306|NCT03670810|560290350|FG003|Main Study|Travel and Coronavirus issues|1|||
155233307|NCT03670810|560290351|FG004|Main Study|Travel and Coronavirus issues|0|||
155233308|NCT03670810|560290352|FG005|Main Study|Travel and Coronavirus issues|0|||
155233309|NCT03670810|560290353|FG006|Main Study|Travel and Coronavirus issues|0|||
155233310|NCT03670810|560290354|FG007|Main Study|Travel and Coronavirus issues|0|||
155233311|NCT03670810|560290355|FG008|Main Study|Travel and Coronavirus issues|0|||
155233312|NCT03670810|560290347|FG000|Open Label Extension|Protocol Deviation|0|||
155233313|NCT03670810|560290348|FG001|Open Label Extension|Protocol Deviation|0|||
155233314|NCT03670810|560290349|FG002|Open Label Extension|Protocol Deviation|0|||
155233315|NCT03670810|560290350|FG003|Open Label Extension|Protocol Deviation|0|||
155233316|NCT03670810|560290351|FG004|Open Label Extension|Protocol Deviation|0|||
155233317|NCT03670810|560290352|FG005|Open Label Extension|Protocol Deviation|0|||
155233318|NCT03670810|560290353|FG006|Open Label Extension|Protocol Deviation|0|||
155233319|NCT03670810|560290354|FG007|Open Label Extension|Protocol Deviation|0|||
155233320|NCT03670810|560290355|FG008|Open Label Extension|Protocol Deviation|5|||
155233321|NCT03670810|560290347|FG000|Open Label Extension|Death|0|||
155233322|NCT03670810|560290348|FG001|Open Label Extension|Death|0|||
155233323|NCT03670810|560290349|FG002|Open Label Extension|Death|0|||
155233324|NCT03670810|560290350|FG003|Open Label Extension|Death|0|||
155233325|NCT03670810|560290351|FG004|Open Label Extension|Death|0|||
155233326|NCT03670810|560290352|FG005|Open Label Extension|Death|0|||
155233327|NCT03670810|560290353|FG006|Open Label Extension|Death|0|||
155233328|NCT03670810|560290354|FG007|Open Label Extension|Death|0|||
155233329|NCT03670810|560290355|FG008|Open Label Extension|Death|1|||
155233330|NCT03670810|560290347|FG000|Open Label Extension|COVID-19|0|||
155233331|NCT03670810|560290348|FG001|Open Label Extension|COVID-19|0|||
155233332|NCT03670810|560290349|FG002|Open Label Extension|COVID-19|0|||
155233333|NCT03670810|560290350|FG003|Open Label Extension|COVID-19|0|||
155233334|NCT03670810|560290351|FG004|Open Label Extension|COVID-19|0|||
155233335|NCT03670810|560290352|FG005|Open Label Extension|COVID-19|0|||
155233336|NCT03670810|560290353|FG006|Open Label Extension|COVID-19|0|||
155233337|NCT03670810|560290354|FG007|Open Label Extension|COVID-19|0|||
155233338|NCT03670810|560290355|FG008|Open Label Extension|COVID-19|1|||
155233339|NCT03670810|560290347|FG000|Open Label Extension|Lack of Efficacy|0|||
155233340|NCT03670810|560290348|FG001|Open Label Extension|Lack of Efficacy|0|||
155233341|NCT03670810|560290349|FG002|Open Label Extension|Lack of Efficacy|0|||
155233342|NCT03670810|560290350|FG003|Open Label Extension|Lack of Efficacy|0|||
155233343|NCT03670810|560290351|FG004|Open Label Extension|Lack of Efficacy|0|||
155233344|NCT03670810|560290352|FG005|Open Label Extension|Lack of Efficacy|0|||
155233345|NCT03670810|560290353|FG006|Open Label Extension|Lack of Efficacy|0|||
155233346|NCT03670810|560290354|FG007|Open Label Extension|Lack of Efficacy|0|||
155233347|NCT03670810|560290355|FG008|Open Label Extension|Lack of Efficacy|39|||
155233348|NCT03670810|560290347|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
155233349|NCT03670810|560290348|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
155233350|NCT03670810|560290349|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
155233351|NCT03670810|560290350|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
155233352|NCT03670810|560290351|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
155233353|NCT03670810|560290352|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
155233354|NCT03670810|560290353|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
155233355|NCT03670810|560290354|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
155233356|NCT03670810|560290355|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
155233357|NCT03670810|560290347|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233358|NCT03670810|560290348|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233359|NCT03670810|560290349|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233360|NCT03670810|560290350|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233361|NCT03670810|560290351|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233362|NCT03670810|560290352|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233363|NCT03670810|560290353|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233364|NCT03670810|560290354|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233365|NCT03670810|560290355|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
155233366|NCT03670810|560290347|FG000|Open Label Extension|Withdrawal by Subject|0|||
155233367|NCT03670810|560290348|FG001|Open Label Extension|Withdrawal by Subject|0|||
155233368|NCT03670810|560290349|FG002|Open Label Extension|Withdrawal by Subject|0|||
155233369|NCT03670810|560290350|FG003|Open Label Extension|Withdrawal by Subject|0|||
155233370|NCT03670810|560290351|FG004|Open Label Extension|Withdrawal by Subject|0|||
155233371|NCT03670810|560290352|FG005|Open Label Extension|Withdrawal by Subject|0|||
155233372|NCT03670810|560290353|FG006|Open Label Extension|Withdrawal by Subject|0|||
155233373|NCT03670810|560290354|FG007|Open Label Extension|Withdrawal by Subject|0|||
155233374|NCT03670810|560290355|FG008|Open Label Extension|Withdrawal by Subject|46|||
155233375|NCT03670810|560290347|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233376|NCT03670810|560290348|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233377|NCT03670810|560290349|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233378|NCT03670810|560290350|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233379|NCT03670810|560290351|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233380|NCT03670810|560290352|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233381|NCT03670810|560290353|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233382|NCT03670810|560290354|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233383|NCT03670810|560290355|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
155233384|NCT03670810|560290347|FG000|Open Label Extension|Physician Decision|0|||
155233385|NCT03670810|560290348|FG001|Open Label Extension|Physician Decision|0|||
155233386|NCT03670810|560290349|FG002|Open Label Extension|Physician Decision|0|||
155233387|NCT03670810|560290350|FG003|Open Label Extension|Physician Decision|0|||
155233388|NCT03670810|560290351|FG004|Open Label Extension|Physician Decision|0|||
155233389|NCT03670810|560290352|FG005|Open Label Extension|Physician Decision|0|||
155233390|NCT03670810|560290353|FG006|Open Label Extension|Physician Decision|0|||
155233391|NCT03670810|560290354|FG007|Open Label Extension|Physician Decision|0|||
155233392|NCT03670810|560290355|FG008|Open Label Extension|Physician Decision|2|||
155233393|NCT03670810|560290347|FG000|Open Label Extension|Non-compliance with study drug|0|||
155233394|NCT03670810|560290348|FG001|Open Label Extension|Non-compliance with study drug|0|||
155233395|NCT03670810|560290349|FG002|Open Label Extension|Non-compliance with study drug|0|||
155233396|NCT03670810|560290350|FG003|Open Label Extension|Non-compliance with study drug|0|||
155233397|NCT03670810|560290351|FG004|Open Label Extension|Non-compliance with study drug|0|||
155233398|NCT03670810|560290352|FG005|Open Label Extension|Non-compliance with study drug|0|||
155233399|NCT03670810|560290353|FG006|Open Label Extension|Non-compliance with study drug|0|||
155233400|NCT03670810|560290354|FG007|Open Label Extension|Non-compliance with study drug|0|||
155233401|NCT03670810|560290355|FG008|Open Label Extension|Non-compliance with study drug|5|||
155233402|NCT03670810|560290347|FG000|Open Label Extension|Pregnancy|0|||
155233403|NCT03670810|560290348|FG001|Open Label Extension|Pregnancy|0|||
155233404|NCT03670810|560290349|FG002|Open Label Extension|Pregnancy|0|||
155233405|NCT03670810|560290350|FG003|Open Label Extension|Pregnancy|0|||
155233406|NCT03670810|560290351|FG004|Open Label Extension|Pregnancy|0|||
155233407|NCT03670810|560290352|FG005|Open Label Extension|Pregnancy|0|||
155233408|NCT03670810|560290353|FG006|Open Label Extension|Pregnancy|0|||
155233409|NCT03670810|560290354|FG007|Open Label Extension|Pregnancy|0|||
155233410|NCT03670810|560290355|FG008|Open Label Extension|Pregnancy|3|||
155233411|NCT03670810|560290347|FG000|Open Label Extension|Adverse Event|0|||
155233412|NCT03670810|560290348|FG001|Open Label Extension|Adverse Event|0|||
155233413|NCT03670810|560290349|FG002|Open Label Extension|Adverse Event|0|||
155233414|NCT03670810|560290350|FG003|Open Label Extension|Adverse Event|0|||
155233415|NCT03670810|560290351|FG004|Open Label Extension|Adverse Event|0|||
155233416|NCT03670810|560290352|FG005|Open Label Extension|Adverse Event|0|||
155233417|NCT03670810|560290353|FG006|Open Label Extension|Adverse Event|0|||
155233418|NCT03670810|560290354|FG007|Open Label Extension|Adverse Event|0|||
155233419|NCT03670810|560290355|FG008|Open Label Extension|Adverse Event|24|||
155233420|NCT03670810|560290347|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
155233421|NCT03670810|560290348|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
155233422|NCT03670810|560290349|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
155233423|NCT03670810|560290350|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
155233424|NCT03670810|560290351|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
155233425|NCT03670810|560290352|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
155233426|NCT03670810|560290353|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
155233427|NCT03670810|560290354|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
155233428|NCT03670810|560290355|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
155233429|NCT03670810|560290347|FG000|Open Label Extension|Lost to Follow-up|0|||
155233430|NCT03670810|560290348|FG001|Open Label Extension|Lost to Follow-up|0|||
155233431|NCT03670810|560290349|FG002|Open Label Extension|Lost to Follow-up|0|||
155233432|NCT03670810|560290350|FG003|Open Label Extension|Lost to Follow-up|0|||
155233433|NCT03670810|560290351|FG004|Open Label Extension|Lost to Follow-up|0|||
155233434|NCT03670810|560290352|FG005|Open Label Extension|Lost to Follow-up|0|||
155233435|NCT03670810|560290353|FG006|Open Label Extension|Lost to Follow-up|0|||
155233436|NCT03670810|560290354|FG007|Open Label Extension|Lost to Follow-up|0|||
155233437|NCT03670810|560290355|FG008|Open Label Extension|Lost to Follow-up|23|||
155233438|NCT00678691|560290356|FG000|Overall Study|Adverse Event|6|||
155233439|NCT00678691|560290357|FG001|Overall Study|Adverse Event|4|||
155233440|NCT02606136|560290372|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
155233441|NCT02606136|560290372|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
155233442|NCT02606136|560290372|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
155233443|NCT02606136|560290372|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
155233444|NCT06640829|560290373|FG000|Overall Study|Withdrawal by Subject|1|||
155233445|NCT06640829|560290373|FG000|Overall Study|Lost to Follow-up|1|||
155233446|NCT01350128|560290374|FG000|Overall Study|Withdrawal by Subject|3|||
155233447|NCT01350128|560290374|FG000|Overall Study|Protocol discontinuation criteria|8|||
155233448|NCT01350128|560290374|FG000|Overall Study|Physician Decision|1|||
155233449|NCT01350128|560290374|FG000|Overall Study|Lost to Follow-up|2|||
155233450|NCT01252290|560290375|FG000|Overall Study|Withdrawal by Subject|1|||
155233451|NCT02075437|560290379|FG000|Overall Study|Withdrawal by Subject|5|||
155233452|NCT02075437|560290379|FG000|Overall Study|Lost to Follow-up|1|||
155233453|NCT01632800|560290380|FG000|Overall Study|Subject did not fit in apparatus|1|||
155233454|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Adverse Event|41|||
155233455|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Adverse Event|24|||
155233456|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
155233457|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
155233458|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
155233459|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
155233460|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Physician Decision|0|||
155233461|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Physician Decision|6|||
155233462|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
155233463|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
155233464|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
155233465|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
155233466|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
155233467|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
155233468|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
155233469|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
155233470|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
155233471|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
155233472|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
155233473|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
155233474|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
155233475|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
155233476|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
155233477|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
155233478|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
155233479|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
155233480|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
155233481|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
155233482|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
155233483|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
155233484|NCT02410811|560290386|FG000|Overall Study|Withdrawal by Subject|0|||
155233485|NCT02410811|560290387|FG001|Overall Study|Withdrawal by Subject|0|||
155233486|NCT02410811|560290388|FG002|Overall Study|Withdrawal by Subject|1|||
155233487|NCT02410811|560290389|FG003|Overall Study|Withdrawal by Subject|0|||
155233488|NCT00353366|560290390|FG000|Overall Study|Adverse Event|8|||
155233489|NCT00353366|560290390|FG000|Overall Study|Protocol Violation|12|||
155233490|NCT00353366|560290390|FG000|Overall Study|Withdrawal by Subject|12|||
155233491|NCT00353366|560290390|FG000|Overall Study|Lost to Follow-up|92|||
155233492|NCT00353366|560290390|FG000|Overall Study|Other|19|||
155233493|NCT00259857|560290391|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
155233494|NCT00259857|560290392|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
155233495|NCT00259857|560290391|FG000|24 Months Treatment|Lost to Follow-up|0|||
155233496|NCT00259857|560290392|FG001|24 Months Treatment|Lost to Follow-up|3|||
155233497|NCT01552226|560290395|FG000|Overall Study|Withdrawal by Subject|4|||
155233498|NCT01552226|560290396|FG001|Overall Study|Withdrawal by Subject|4|||
155233499|NCT01469065|560290400|FG000|Overall Study|Lack of Efficacy|0|||
155233500|NCT01469065|560290401|FG001|Overall Study|Lack of Efficacy|0|||
155233501|NCT01469065|560290402|FG002|Overall Study|Lack of Efficacy|0|||
155233502|NCT01469065|560290403|FG003|Overall Study|Lack of Efficacy|0|||
155233503|NCT01469065|560290404|FG004|Overall Study|Lack of Efficacy|1|||
155233504|NCT01469065|560290400|FG000|Overall Study|Other|0|||
155233505|NCT01469065|560290401|FG001|Overall Study|Other|1|||
155233506|NCT01469065|560290402|FG002|Overall Study|Other|0|||
155233507|NCT01469065|560290403|FG003|Overall Study|Other|0|||
155233508|NCT01469065|560290404|FG004|Overall Study|Other|0|||
155233509|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
155233510|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
155233511|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
155233512|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
155233513|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
155233514|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
155233515|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
155233516|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
155233517|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
155233518|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
155233519|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
155233520|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
155233521|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
155233522|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
155233523|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
155233524|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
155233525|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
155233526|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
155233527|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
155233528|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
155233529|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
155233530|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
155233531|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
155233532|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
155233533|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
155233534|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
155233535|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
155233536|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
155233537|NCT04542070|560290405|FG000|Maintenance + Extension Period|Adverse Event|10|||
155233538|NCT04542070|560290406|FG001|Maintenance + Extension Period|Adverse Event|2|||
155233539|NCT04542070|560290407|FG002|Maintenance + Extension Period|Adverse Event|0|||
155233540|NCT04542070|560290408|FG003|Maintenance + Extension Period|Adverse Event|0|||
155233541|NCT04542070|560290405|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
155233542|NCT04542070|560290406|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
155233543|NCT04542070|560290407|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
155233544|NCT04542070|560290408|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
155233545|NCT04542070|560290405|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
155233546|NCT04542070|560290406|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
155233547|NCT04542070|560290407|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
155233548|NCT04542070|560290408|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
155233549|NCT04542070|560290405|FG000|Maintenance + Extension Period|Physician Decision|1|||
155233550|NCT04542070|560290406|FG001|Maintenance + Extension Period|Physician Decision|1|||
155233551|NCT04542070|560290407|FG002|Maintenance + Extension Period|Physician Decision|0|||
155233552|NCT04542070|560290408|FG003|Maintenance + Extension Period|Physician Decision|0|||
155233553|NCT04542070|560290405|FG000|Maintenance + Extension Period|Protocol Violation|2|||
155233554|NCT04542070|560290406|FG001|Maintenance + Extension Period|Protocol Violation|5|||
155233555|NCT04542070|560290407|FG002|Maintenance + Extension Period|Protocol Violation|0|||
155233556|NCT04542070|560290408|FG003|Maintenance + Extension Period|Protocol Violation|0|||
155233557|NCT04542070|560290405|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
155233558|NCT04542070|560290406|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
155233559|NCT04542070|560290407|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
155233560|NCT04542070|560290408|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
155233561|NCT04542070|560290405|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
155233562|NCT04542070|560290406|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
155233563|NCT04542070|560290407|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
155233564|NCT04542070|560290408|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
155491467|NCT00563706|561225397|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
155233565|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233566|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233567|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233568|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
155233569|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233570|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233571|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233572|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
155233573|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233574|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233575|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233576|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
155233577|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233578|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233579|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233580|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
155233581|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233582|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233583|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233584|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
155233585|NCT02985736|560290409|FG000|Overall Study|Lost to Follow-up|3|||
155233586|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233587|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
155233588|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233589|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233590|NCT03049813|560290410|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
155233591|NCT03049813|560290411|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
155233592|NCT03049813|560290412|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
155233593|NCT03049813|560290413|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
155233594|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233595|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
155233596|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233597|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233598|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
155233599|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
155233600|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
155233601|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
155233602|NCT03025828|560290419|FG000|Overall Study|Lost to Follow-up|1|||
155233603|NCT00094653|560290420|FG000|Overall Study|Death|306|||
155233604|NCT00094653|560290421|FG001|Overall Study|Death|100|||
155233605|NCT00094653|560290422|FG002|Overall Study|Death|119|||
155233606|NCT00094653|560290420|FG000|Overall Study|Subject Withdrew Consent|10|||
155233607|NCT00094653|560290421|FG001|Overall Study|Subject Withdrew Consent|2|||
155233608|NCT00094653|560290422|FG002|Overall Study|Subject Withdrew Consent|3|||
155233609|NCT00094653|560290420|FG000|Overall Study|Other|2|||
155233610|NCT00094653|560290421|FG001|Overall Study|Other|2|||
155233611|NCT00094653|560290422|FG002|Overall Study|Other|2|||
155233612|NCT00094653|560290420|FG000|Overall Study|Lost to Follow-up|3|||
155233613|NCT00094653|560290421|FG001|Overall Study|Lost to Follow-up|2|||
155233614|NCT00094653|560290422|FG002|Overall Study|Lost to Follow-up|1|||
155233615|NCT00094653|560290420|FG000|Overall Study|Protocol Violation|0|||
155233616|NCT00094653|560290421|FG001|Overall Study|Protocol Violation|0|||
155233617|NCT00094653|560290422|FG002|Overall Study|Protocol Violation|1|||
155233618|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
155233619|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Death|1|||
155233620|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Physician Decision|1|||
155233621|NCT00854581|560290425|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
155233622|NCT03181542|560290427|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
155233623|NCT03181542|560290428|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
155233624|NCT00806546|560290440|FG000|Overall Study|Enrolled, not treated|35|||
155233625|NCT00806546|560290440|FG000|Overall Study|Lost to Follow-up|32|||
155233626|NCT00806546|560290440|FG000|Overall Study|Adverse Event|74|||
155233627|NCT00806546|560290440|FG000|Overall Study|Withdrawal by Subject|75|||
155233628|NCT00806546|560290440|FG000|Overall Study|Protocol Violation|49|||
155233629|NCT00806546|560290440|FG000|Overall Study|Various|42|||
155233630|NCT01247090|560290441|FG000|Overall Study|Physician Decision|1|||
155233631|NCT01247090|560290442|FG001|Overall Study|Physician Decision|0|||
155233632|NCT01247090|560290443|FG002|Overall Study|Physician Decision|0|||
155233633|NCT01247090|560290441|FG000|Overall Study|Withdrawal by Subject|0|||
155233634|NCT01247090|560290442|FG001|Overall Study|Withdrawal by Subject|1|||
155233635|NCT01247090|560290443|FG002|Overall Study|Withdrawal by Subject|0|||
155233636|NCT03385239|560290453|FG000|Overall Study|Voluntary Withdrawal|2|||
155233637|NCT03385239|560290454|FG001|Overall Study|Voluntary Withdrawal|3|||
155233638|NCT03385239|560290455|FG002|Overall Study|Voluntary Withdrawal|2|||
155233639|NCT03385239|560290456|FG003|Overall Study|Voluntary Withdrawal|3|||
155233640|NCT03385239|560290457|FG004|Overall Study|Voluntary Withdrawal|0|||
155233641|NCT03385239|560290453|FG000|Overall Study|Adverse Event|0|||
155233642|NCT03385239|560290454|FG001|Overall Study|Adverse Event|0|||
155233643|NCT03385239|560290455|FG002|Overall Study|Adverse Event|1|||
155233644|NCT03385239|560290456|FG003|Overall Study|Adverse Event|0|||
155233645|NCT03385239|560290457|FG004|Overall Study|Adverse Event|0|||
155233646|NCT03385239|560290453|FG000|Overall Study|Other|0|||
155233647|NCT03385239|560290454|FG001|Overall Study|Other|0|||
155233648|NCT03385239|560290455|FG002|Overall Study|Other|0|||
155233649|NCT03385239|560290456|FG003|Overall Study|Other|1|||
155233650|NCT03385239|560290457|FG004|Overall Study|Other|0|||
155233651|NCT02167256|560290460|FG000|Overall Study|Adverse Event|13|||
155233652|NCT02167256|560290461|FG001|Overall Study|Adverse Event|6|||
155233653|NCT02167256|560290460|FG000|Overall Study|Withdrawal by Subject|4|||
155233654|NCT02167256|560290461|FG001|Overall Study|Withdrawal by Subject|4|||
155233655|NCT02167256|560290460|FG000|Overall Study|non-compliance|3|||
155233656|NCT02167256|560290461|FG001|Overall Study|non-compliance|0|||
155233657|NCT02167256|560290460|FG000|Overall Study|Study partner unable to participate|1|||
155233658|NCT02167256|560290461|FG001|Overall Study|Study partner unable to participate|0|||
155233659|NCT03139916|560290462|FG000|Overall Study|Withdrawal by Subject|2|||
155233660|NCT03139916|560290462|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
155233661|NCT01957475|560290463|FG000|Test Period 1|Withdrawal by Subject|1|||
155233662|NCT01957475|560290464|FG001|Test Period 1|Withdrawal by Subject|0|||
155233663|NCT01957475|560290463|FG000|Test Period 1|Other|1|||
155233664|NCT01957475|560290464|FG001|Test Period 1|Other|0|||
155233665|NCT01957475|560290463|FG000|Test Period 1|Lack of Efficacy|0|||
155233666|NCT01957475|560290464|FG001|Test Period 1|Lack of Efficacy|1|||
155233667|NCT01957475|560290463|FG000|Test Period 2|Adverse Event|1|||
155233668|NCT01957475|560290464|FG001|Test Period 2|Adverse Event|0|||
155233669|NCT03591575|560290465|FG000|Overall Study|Adverse Event|2|||
155233670|NCT03591575|560290466|FG001|Overall Study|Adverse Event|0|||
155233671|NCT03591575|560290465|FG000|Overall Study|Withdrawal by Subject|4|||
155233672|NCT03591575|560290466|FG001|Overall Study|Withdrawal by Subject|1|||
155233673|NCT00813358|560290469|FG000|Overall Study|Death|32|||
155233674|NCT00813358|560290469|FG000|Overall Study|Lost to Follow-up|12|||
155233675|NCT00813358|560290469|FG000|Overall Study|other endpoints|5|||
155233676|NCT00813358|560290469|FG000|Overall Study|Withdrawal by Subject|20|||
155233677|NCT00700011|560290470|FG000|Overall Study|Death|0|||
155233678|NCT00700011|560290471|FG001|Overall Study|Death|1|||
155233679|NCT00004031|560290472|FG000|Overall Study|Adverse Event|5|||
155233680|NCT00004031|560290473|FG001|Overall Study|Adverse Event|0|||
155233681|NCT00004031|560290472|FG000|Overall Study|Refusal unrelated to adverse events|2|||
155233682|NCT00004031|560290473|FG001|Overall Study|Refusal unrelated to adverse events|11|||
155233683|NCT00004031|560290472|FG000|Overall Study|Progression/relapse|9|||
155233684|NCT00004031|560290473|FG001|Overall Study|Progression/relapse|4|||
155233685|NCT00004031|560290472|FG000|Overall Study|Death|3|||
155233686|NCT00004031|560290473|FG001|Overall Study|Death|1|||
155233687|NCT00004031|560290472|FG000|Overall Study|Other- not protocol specified|3|||
155233688|NCT00004031|560290473|FG001|Overall Study|Other- not protocol specified|3|||
155233689|NCT00004031|560290472|FG000|Overall Study|Reason under review|3|||
155233690|NCT00004031|560290473|FG001|Overall Study|Reason under review|2|||
155233691|NCT02553421|560290474|FG000|Overall Study|Lost to Follow-up|21|||
155233692|NCT02553421|560290475|FG001|Overall Study|Lost to Follow-up|1|||
155233693|NCT02553421|560290474|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
155233694|NCT02553421|560290475|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
155233695|NCT02553421|560290474|FG000|Overall Study|Improper Device Placement|3|||
155233696|NCT02553421|560290475|FG001|Overall Study|Improper Device Placement|0|||
155233697|NCT04084769|560290479|FG000|Overall Study|Protocol Violation|1|||
155233698|NCT04084769|560290480|FG001|Overall Study|Protocol Violation|3|||
155233699|NCT04084769|560290481|FG002|Overall Study|Protocol Violation|0|||
155233700|NCT04084769|560290482|FG003|Overall Study|Protocol Violation|1|||
155233701|NCT04084769|560290479|FG000|Overall Study|Withdrawal by Subject|0|||
155233702|NCT04084769|560290480|FG001|Overall Study|Withdrawal by Subject|1|||
155491468|NCT00563706|561225398|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
155233703|NCT04084769|560290481|FG002|Overall Study|Withdrawal by Subject|0|||
155233704|NCT04084769|560290482|FG003|Overall Study|Withdrawal by Subject|0|||
155233705|NCT04084769|560290479|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155233706|NCT04084769|560290480|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155233707|NCT04084769|560290481|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155233708|NCT04084769|560290482|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155233709|NCT04084769|560290479|FG000|Overall Study|Lost to Follow-up|2|||
155233710|NCT04084769|560290480|FG001|Overall Study|Lost to Follow-up|0|||
155233711|NCT04084769|560290481|FG002|Overall Study|Lost to Follow-up|0|||
155233712|NCT04084769|560290482|FG003|Overall Study|Lost to Follow-up|0|||
155233713|NCT04579679|560290483|FG000|Overall Study|New Antitumor Therapy|6|||
155233714|NCT04579679|560290484|FG001|Overall Study|New Antitumor Therapy|4|||
155233715|NCT04579679|560290485|FG002|Overall Study|New Antitumor Therapy|7|||
155233716|NCT04579679|560290486|FG003|Overall Study|New Antitumor Therapy|0|||
155233717|NCT04579679|560290483|FG000|Overall Study|Withdrawal of Consent|1|||
155233718|NCT04579679|560290484|FG001|Overall Study|Withdrawal of Consent|1|||
155233719|NCT04579679|560290485|FG002|Overall Study|Withdrawal of Consent|2|||
155233720|NCT04579679|560290486|FG003|Overall Study|Withdrawal of Consent|4|||
155233721|NCT04579679|560290483|FG000|Overall Study|Death|2|||
155233722|NCT04579679|560290484|FG001|Overall Study|Death|2|||
155233723|NCT04579679|560290485|FG002|Overall Study|Death|2|||
155233724|NCT04579679|560290486|FG003|Overall Study|Death|0|||
155233725|NCT04579679|560290483|FG000|Overall Study|Adverse Event|0|||
155233726|NCT04579679|560290484|FG001|Overall Study|Adverse Event|4|||
155233727|NCT04579679|560290485|FG002|Overall Study|Adverse Event|0|||
155233728|NCT04579679|560290486|FG003|Overall Study|Adverse Event|0|||
155233729|NCT04579679|560290483|FG000|Overall Study|Disease Progression|9|||
155233730|NCT04579679|560290484|FG001|Overall Study|Disease Progression|13|||
155233731|NCT04579679|560290485|FG002|Overall Study|Disease Progression|7|||
155233732|NCT04579679|560290486|FG003|Overall Study|Disease Progression|0|||
155233733|NCT04579679|560290483|FG000|Overall Study|Physician Decision|0|||
155233734|NCT04579679|560290484|FG001|Overall Study|Physician Decision|0|||
155233735|NCT04579679|560290485|FG002|Overall Study|Physician Decision|1|||
155233736|NCT04579679|560290486|FG003|Overall Study|Physician Decision|0|||
155233737|NCT04579679|560290483|FG000|Overall Study|Study Terminated by Sponsor|2|||
155233738|NCT04579679|560290484|FG001|Overall Study|Study Terminated by Sponsor|7|||
155233739|NCT04579679|560290485|FG002|Overall Study|Study Terminated by Sponsor|1|||
155233740|NCT04579679|560290486|FG003|Overall Study|Study Terminated by Sponsor|0|||
155233741|NCT01709318|560292409|FG000|Overall Study|Adverse Event|3|||
155233742|NCT01709318|560292410|FG001|Overall Study|Adverse Event|4|||
155233743|NCT01709318|560292411|FG002|Overall Study|Adverse Event|2|||
155233744|NCT01709318|560292412|FG003|Overall Study|Adverse Event|2|||
155233745|NCT01709318|560292413|FG004|Overall Study|Adverse Event|0|||
155233746|NCT01709318|560292414|FG005|Overall Study|Adverse Event|1|||
155233747|NCT01709318|560292415|FG006|Overall Study|Adverse Event|2|||
155233748|NCT01709318|560292409|FG000|Overall Study|Lost to Follow-up|2|||
155233749|NCT01709318|560292410|FG001|Overall Study|Lost to Follow-up|0|||
155233750|NCT01709318|560292411|FG002|Overall Study|Lost to Follow-up|0|||
155233751|NCT01709318|560292412|FG003|Overall Study|Lost to Follow-up|0|||
155233752|NCT01709318|560292413|FG004|Overall Study|Lost to Follow-up|1|||
155233753|NCT01709318|560292414|FG005|Overall Study|Lost to Follow-up|1|||
155233754|NCT01709318|560292415|FG006|Overall Study|Lost to Follow-up|1|||
155233755|NCT01709318|560292409|FG000|Overall Study|Non-compliance with Study Drug|0|||
155233756|NCT01709318|560292410|FG001|Overall Study|Non-compliance with Study Drug|2|||
155233757|NCT01709318|560292411|FG002|Overall Study|Non-compliance with Study Drug|1|||
155233758|NCT01709318|560292412|FG003|Overall Study|Non-compliance with Study Drug|1|||
155233759|NCT01709318|560292413|FG004|Overall Study|Non-compliance with Study Drug|0|||
155233760|NCT01709318|560292414|FG005|Overall Study|Non-compliance with Study Drug|0|||
155233761|NCT01709318|560292415|FG006|Overall Study|Non-compliance with Study Drug|2|||
155233762|NCT01709318|560292409|FG000|Overall Study|Physician Decision|0|||
155233763|NCT01709318|560292410|FG001|Overall Study|Physician Decision|0|||
155233764|NCT01709318|560292411|FG002|Overall Study|Physician Decision|0|||
155233765|NCT01709318|560292412|FG003|Overall Study|Physician Decision|0|||
155233766|NCT01709318|560292413|FG004|Overall Study|Physician Decision|0|||
155233767|NCT01709318|560292414|FG005|Overall Study|Physician Decision|0|||
155233768|NCT01709318|560292415|FG006|Overall Study|Physician Decision|1|||
155233769|NCT01709318|560292409|FG000|Overall Study|Pregnancy|0|||
155233770|NCT01709318|560292410|FG001|Overall Study|Pregnancy|0|||
155233771|NCT01709318|560292411|FG002|Overall Study|Pregnancy|0|||
155233772|NCT01709318|560292412|FG003|Overall Study|Pregnancy|0|||
155233773|NCT01709318|560292413|FG004|Overall Study|Pregnancy|1|||
155233774|NCT01709318|560292414|FG005|Overall Study|Pregnancy|0|||
155233775|NCT01709318|560292415|FG006|Overall Study|Pregnancy|0|||
155233776|NCT01709318|560292409|FG000|Overall Study|Protocol Violation|0|||
155233777|NCT01709318|560292410|FG001|Overall Study|Protocol Violation|0|||
155233778|NCT01709318|560292411|FG002|Overall Study|Protocol Violation|0|||
155233779|NCT01709318|560292412|FG003|Overall Study|Protocol Violation|0|||
155233780|NCT01709318|560292413|FG004|Overall Study|Protocol Violation|2|||
155233781|NCT01709318|560292414|FG005|Overall Study|Protocol Violation|0|||
155233782|NCT01709318|560292415|FG006|Overall Study|Protocol Violation|1|||
155233783|NCT01709318|560292409|FG000|Overall Study|Technical Problems|1|||
155233784|NCT01709318|560292410|FG001|Overall Study|Technical Problems|0|||
155233785|NCT01709318|560292411|FG002|Overall Study|Technical Problems|0|||
155233786|NCT01709318|560292412|FG003|Overall Study|Technical Problems|0|||
155233787|NCT01709318|560292413|FG004|Overall Study|Technical Problems|0|||
155233788|NCT01709318|560292414|FG005|Overall Study|Technical Problems|0|||
155233789|NCT01709318|560292415|FG006|Overall Study|Technical Problems|0|||
155233790|NCT01709318|560292409|FG000|Overall Study|Withdrawal by Subject|3|||
155233791|NCT01709318|560292410|FG001|Overall Study|Withdrawal by Subject|0|||
155233792|NCT01709318|560292411|FG002|Overall Study|Withdrawal by Subject|3|||
155233793|NCT01709318|560292412|FG003|Overall Study|Withdrawal by Subject|3|||
155233794|NCT01709318|560292413|FG004|Overall Study|Withdrawal by Subject|0|||
155233795|NCT01709318|560292414|FG005|Overall Study|Withdrawal by Subject|2|||
155233796|NCT01709318|560292415|FG006|Overall Study|Withdrawal by Subject|4|||
155233797|NCT01709318|560292409|FG000|Overall Study|Other Protocol Specified Criteria|0|||
155233798|NCT01709318|560292410|FG001|Overall Study|Other Protocol Specified Criteria|1|||
155233799|NCT01709318|560292411|FG002|Overall Study|Other Protocol Specified Criteria|0|||
155233800|NCT01709318|560292412|FG003|Overall Study|Other Protocol Specified Criteria|0|||
155233801|NCT01709318|560292413|FG004|Overall Study|Other Protocol Specified Criteria|0|||
155233802|NCT01709318|560292414|FG005|Overall Study|Other Protocol Specified Criteria|0|||
155233803|NCT01709318|560292415|FG006|Overall Study|Other Protocol Specified Criteria|0|||
155233804|NCT02383758|560292416|FG000|Overall Study|Withdrawal by Subject|0|||
155233805|NCT02383758|560292417|FG001|Overall Study|Withdrawal by Subject|2|||
155233806|NCT03892889|560292418|FG000|Overall Study|Adverse Event|17|||
155233807|NCT03892889|560292418|FG000|Overall Study|Lack of Efficacy|1|||
155233808|NCT03892889|560292418|FG000|Overall Study|Lost to Follow-up|46|||
155233809|NCT03892889|560292418|FG000|Overall Study|Non-compliance with study drug|22|||
155233810|NCT03892889|560292418|FG000|Overall Study|Pregnancy|1|||
155233811|NCT03892889|560292418|FG000|Overall Study|Protocol Deviation|3|||
155233812|NCT03892889|560292418|FG000|Overall Study|Withdrawal by Subject|50|||
155233813|NCT03892889|560292418|FG000|Overall Study|Withdrawal by Caregiver|1|||
155233814|NCT03892889|560292418|FG000|Overall Study|Study Terminated by Sponsor|50|||
155233815|NCT03892889|560292418|FG000|Overall Study|Physician Decision|8|||
155233816|NCT03892889|560292418|FG000|Overall Study|Reason not Specified|5|||
155233817|NCT02066298|560292419|FG000|Overall Study|Lost to Follow-up|3|||
155233818|NCT02066298|560292420|FG001|Overall Study|Lost to Follow-up|2|||
155233819|NCT02066298|560292421|FG002|Overall Study|Lost to Follow-up|3|||
155233820|NCT02066298|560292422|FG003|Overall Study|Lost to Follow-up|2|||
155233821|NCT02066298|560292423|FG004|Overall Study|Lost to Follow-up|3|||
155233822|NCT02066298|560292424|FG005|Overall Study|Lost to Follow-up|4|||
155233823|NCT02066298|560292419|FG000|Overall Study|Withdrawal by Subject|6|||
155233824|NCT02066298|560292420|FG001|Overall Study|Withdrawal by Subject|6|||
155233825|NCT02066298|560292421|FG002|Overall Study|Withdrawal by Subject|6|||
155233826|NCT02066298|560292422|FG003|Overall Study|Withdrawal by Subject|4|||
155233827|NCT02066298|560292423|FG004|Overall Study|Withdrawal by Subject|5|||
155233828|NCT02066298|560292424|FG005|Overall Study|Withdrawal by Subject|8|||
155233829|NCT02066298|560292419|FG000|Overall Study|Physician Decision|0|||
155233830|NCT02066298|560292420|FG001|Overall Study|Physician Decision|0|||
155233831|NCT02066298|560292421|FG002|Overall Study|Physician Decision|1|||
155233832|NCT02066298|560292422|FG003|Overall Study|Physician Decision|0|||
155233833|NCT02066298|560292423|FG004|Overall Study|Physician Decision|1|||
155233834|NCT02066298|560292424|FG005|Overall Study|Physician Decision|0|||
155233835|NCT04260191|560292425|FG000|Overall Study|Decision by Sponsor|0|||
155233836|NCT04260191|560292426|FG001|Overall Study|Decision by Sponsor|1|||
155233837|NCT04260191|560292427|FG002|Overall Study|Decision by Sponsor|0|||
155233838|NCT04260191|560292425|FG000|Overall Study|Withdrawal by Subject|1|||
155233839|NCT04260191|560292426|FG001|Overall Study|Withdrawal by Subject|0|||
155233840|NCT04260191|560292427|FG002|Overall Study|Withdrawal by Subject|3|||
155233841|NCT04260191|560292425|FG000|Overall Study|Death|4|||
155233842|NCT04260191|560292426|FG001|Overall Study|Death|3|||
155233843|NCT04260191|560292427|FG002|Overall Study|Death|2|||
155233844|NCT01519518|560292429|FG000|Overall Study|Consent not available|7|||
155233845|NCT01519518|560292430|FG001|Overall Study|Consent not available|10|||
155233846|NCT00298896|560292435|FG000|Overall Study|Death|3|||
155233847|NCT00298896|560292435|FG000|Overall Study|Physician Decision|2|||
155233848|NCT00298896|560292435|FG000|Overall Study|Intercurrent Illness|1|||
155233849|NCT00298896|560292435|FG000|Overall Study|Disease Progression|41|||
155233850|NCT00298896|560292435|FG000|Overall Study|Withdrawal by Subject|2|||
155233851|NCT00298896|560292435|FG000|Overall Study|Assigned to treatment in error|1|||
155233852|NCT02488629|560292440|FG000|Overall Study|Lack of Efficacy|3|||
155233853|NCT02488629|560292441|FG001|Overall Study|Lack of Efficacy|1|||
155233854|NCT02488629|560292442|FG002|Overall Study|Lack of Efficacy|0|||
155233855|NCT02488629|560292443|FG003|Overall Study|Lack of Efficacy|0|||
155233856|NCT02488629|560292440|FG000|Overall Study|Withdrawal by Subject|0|||
155233857|NCT02488629|560292441|FG001|Overall Study|Withdrawal by Subject|1|||
155233858|NCT02488629|560292442|FG002|Overall Study|Withdrawal by Subject|0|||
155233859|NCT02488629|560292443|FG003|Overall Study|Withdrawal by Subject|0|||
155233860|NCT00654628|560292444|FG000|6-week Active Treatment Period|Adverse Event|9|||
155233861|NCT00654628|560292444|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
155233862|NCT00654628|560292444|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
155233863|NCT00654628|560292444|FG000|6-week Active Treatment Period|Out of window period|1|||
155233864|NCT00654628|560292444|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
155233865|NCT00654628|560292444|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
155233866|NCT00912405|560292445|FG000|Overall Study|Lost to Follow-up|5|||
155233867|NCT01797536|560292446|FG000|Overall Study|Adverse Event|0|||
155233868|NCT01797536|560292447|FG001|Overall Study|Adverse Event|1|||
155233869|NCT01797536|560292448|FG002|Overall Study|Adverse Event|0|||
155233870|NCT01797536|560292449|FG003|Overall Study|Adverse Event|0|||
155233871|NCT00844545|560292453|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
155233872|NCT00844545|560292453|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
155233873|NCT00844545|560292453|FG000|Extension Treatment Period|Adverse Event|2|||
155233874|NCT00844545|560292453|FG000|Post Treatment Period|Withdrawal by Subject|1|||
155233875|NCT01532687|560292457|FG000|Overall Study|Death|2|||
155233876|NCT01532687|560292458|FG001|Overall Study|Death|0|||
155233877|NCT01532687|560292457|FG000|Overall Study|Adverse Event|6|||
155233878|NCT01532687|560292458|FG001|Overall Study|Adverse Event|1|||
155233879|NCT01532687|560292457|FG000|Overall Study|Withdrawal by Subject|1|||
155233880|NCT01532687|560292458|FG001|Overall Study|Withdrawal by Subject|0|||
155233881|NCT01532687|560292457|FG000|Overall Study|Physician Decision|2|||
155233882|NCT01532687|560292458|FG001|Overall Study|Physician Decision|1|||
155233883|NCT01532687|560292457|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
155233884|NCT01532687|560292458|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
155233885|NCT00403455|560292459|FG000|Overall Study|Withdrawal by Subject|1|||
155233886|NCT03160703|560292460|FG000|Overall Study|Withdrawal by Subject|0|||
155233887|NCT03160703|560292461|FG001|Overall Study|Withdrawal by Subject|0|||
155233888|NCT03160703|560292462|FG002|Overall Study|Withdrawal by Subject|0|||
155233889|NCT03160703|560292463|FG003|Overall Study|Withdrawal by Subject|1|||
155233890|NCT01358981|560292470|FG000|Period 1|Withdrawal by Subject|0|||
155233891|NCT01358981|560292471|FG001|Period 1|Withdrawal by Subject|0|||
155233892|NCT01358981|560292472|FG002|Period 1|Withdrawal by Subject|0|||
155233893|NCT01358981|560292473|FG003|Period 1|Withdrawal by Subject|1|||
155233894|NCT01358981|560292474|FG004|Period 1|Withdrawal by Subject|0|||
155233895|NCT01358981|560292475|FG005|Period 1|Withdrawal by Subject|0|||
155233896|NCT01358981|560292476|FG006|Period 1|Withdrawal by Subject|0|||
155233897|NCT02738775|560292477|FG000|Overall Study|Withdrawal by Subject|0|||
155233898|NCT02738775|560292478|FG001|Overall Study|Withdrawal by Subject|1|||
155233899|NCT02738775|560292479|FG002|Overall Study|Withdrawal by Subject|0|||
155233900|NCT02738775|560292480|FG003|Overall Study|Withdrawal by Subject|0|||
155233901|NCT02738775|560292481|FG004|Overall Study|Withdrawal by Subject|0|||
155233902|NCT02738775|560292482|FG005|Overall Study|Withdrawal by Subject|0|||
155233903|NCT02738775|560292477|FG000|Overall Study|Adverse Event|0|||
155233904|NCT02738775|560292478|FG001|Overall Study|Adverse Event|0|||
155233905|NCT02738775|560292479|FG002|Overall Study|Adverse Event|0|||
155233906|NCT02738775|560292480|FG003|Overall Study|Adverse Event|1|||
155233907|NCT02738775|560292481|FG004|Overall Study|Adverse Event|0|||
155233908|NCT02738775|560292482|FG005|Overall Study|Adverse Event|0|||
155233909|NCT02738775|560292477|FG000|Overall Study|Pregnancy|0|||
155233910|NCT02738775|560292478|FG001|Overall Study|Pregnancy|1|||
155233911|NCT02738775|560292479|FG002|Overall Study|Pregnancy|0|||
155233912|NCT02738775|560292480|FG003|Overall Study|Pregnancy|0|||
155233913|NCT02738775|560292481|FG004|Overall Study|Pregnancy|0|||
155233914|NCT02738775|560292482|FG005|Overall Study|Pregnancy|0|||
155233915|NCT02738775|560292477|FG000|Overall Study|Missing|0|||
155233916|NCT02738775|560292478|FG001|Overall Study|Missing|0|||
155233917|NCT02738775|560292479|FG002|Overall Study|Missing|0|||
155233918|NCT02738775|560292480|FG003|Overall Study|Missing|0|||
155233919|NCT02738775|560292481|FG004|Overall Study|Missing|0|||
155233920|NCT02738775|560292482|FG005|Overall Study|Missing|1|||
155233921|NCT01060384|560292483|FG000|Overall Study|Withdrawal by Subject|0|||
155233922|NCT01060384|560292484|FG001|Overall Study|Withdrawal by Subject|1|||
155233923|NCT01060384|560292485|FG002|Overall Study|Withdrawal by Subject|0|||
155233924|NCT01060384|560292486|FG003|Overall Study|Withdrawal by Subject|0|||
155233925|NCT01060384|560292487|FG004|Overall Study|Withdrawal by Subject|0|||
155233926|NCT01060384|560292483|FG000|Overall Study|Death|0|||
155233927|NCT01060384|560292484|FG001|Overall Study|Death|0|||
155233928|NCT01060384|560292485|FG002|Overall Study|Death|0|||
155233929|NCT01060384|560292486|FG003|Overall Study|Death|0|||
155233930|NCT01060384|560292487|FG004|Overall Study|Death|1|||
155233931|NCT01060384|560292483|FG000|Overall Study|Intercurrent illness|0|||
155233932|NCT01060384|560292484|FG001|Overall Study|Intercurrent illness|0|||
155233933|NCT01060384|560292485|FG002|Overall Study|Intercurrent illness|0|||
155233934|NCT01060384|560292486|FG003|Overall Study|Intercurrent illness|0|||
155233935|NCT01060384|560292487|FG004|Overall Study|Intercurrent illness|1|||
155233936|NCT01401530|560292488|FG000|Overall Study|Disease Progression|1|||
155233937|NCT01401530|560292489|FG001|Overall Study|Disease Progression|2|||
155233938|NCT01401530|560292490|FG002|Overall Study|Disease Progression|1|||
155233939|NCT01401530|560292488|FG000|Overall Study|Adverse Event|1|||
155233940|NCT01401530|560292489|FG001|Overall Study|Adverse Event|1|||
155233941|NCT01401530|560292490|FG002|Overall Study|Adverse Event|1|||
155233942|NCT01401530|560292488|FG000|Overall Study|Participant Choice|1|||
155233943|NCT01401530|560292489|FG001|Overall Study|Participant Choice|2|||
155233944|NCT01401530|560292490|FG002|Overall Study|Participant Choice|1|||
155233945|NCT01401530|560292488|FG000|Overall Study|Physician Decision|0|||
155233946|NCT01401530|560292489|FG001|Overall Study|Physician Decision|1|||
155233947|NCT01401530|560292490|FG002|Overall Study|Physician Decision|0|||
155233948|NCT02247349|560292491|FG000|Overall Study|Disease Progression|7|||
155233949|NCT02247349|560292492|FG001|Overall Study|Disease Progression|4|||
155233950|NCT02247349|560292493|FG002|Overall Study|Disease Progression|26|||
155233951|NCT02247349|560292494|FG003|Overall Study|Disease Progression|31|||
155233952|NCT02247349|560292495|FG004|Overall Study|Disease Progression|16|||
155233953|NCT02247349|560292496|FG005|Overall Study|Disease Progression|6|||
155233954|NCT02247349|560292491|FG000|Overall Study|Study drug toxicity|0|||
155233955|NCT02247349|560292492|FG001|Overall Study|Study drug toxicity|1|||
155233956|NCT02247349|560292493|FG002|Overall Study|Study drug toxicity|1|||
155233957|NCT02247349|560292494|FG003|Overall Study|Study drug toxicity|1|||
155233958|NCT02247349|560292495|FG004|Overall Study|Study drug toxicity|2|||
155233959|NCT02247349|560292496|FG005|Overall Study|Study drug toxicity|2|||
155233960|NCT02247349|560292491|FG000|Overall Study|Death|0|||
155233961|NCT02247349|560292492|FG001|Overall Study|Death|0|||
155233962|NCT02247349|560292493|FG002|Overall Study|Death|0|||
155233963|NCT02247349|560292494|FG003|Overall Study|Death|1|||
155233964|NCT02247349|560292495|FG004|Overall Study|Death|0|||
155233965|NCT02247349|560292496|FG005|Overall Study|Death|0|||
155233966|NCT02247349|560292491|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155233967|NCT02247349|560292492|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155233968|NCT02247349|560292493|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155233969|NCT02247349|560292494|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
155233970|NCT02247349|560292495|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
155233971|NCT02247349|560292496|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
155233972|NCT02247349|560292491|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155233973|NCT02247349|560292492|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155233974|NCT02247349|560292493|FG002|Overall Study|Participant request to discontinue study treatment|1|||
155233975|NCT02247349|560292494|FG003|Overall Study|Participant request to discontinue study treatment|2|||
155233976|NCT02247349|560292495|FG004|Overall Study|Participant request to discontinue study treatment|1|||
155233977|NCT02247349|560292496|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155233978|NCT02247349|560292491|FG000|Overall Study|Withdrawal by Subject|0|||
155233979|NCT02247349|560292492|FG001|Overall Study|Withdrawal by Subject|1|||
155233980|NCT02247349|560292493|FG002|Overall Study|Withdrawal by Subject|0|||
155233981|NCT02247349|560292494|FG003|Overall Study|Withdrawal by Subject|0|||
155233982|NCT02247349|560292495|FG004|Overall Study|Withdrawal by Subject|0|||
155233983|NCT02247349|560292496|FG005|Overall Study|Withdrawal by Subject|0|||
155233984|NCT02247349|560292491|FG000|Overall Study|Administrative reason by sponsor|0|||
155233985|NCT02247349|560292492|FG001|Overall Study|Administrative reason by sponsor|0|||
155233986|NCT02247349|560292493|FG002|Overall Study|Administrative reason by sponsor|0|||
155233987|NCT02247349|560292494|FG003|Overall Study|Administrative reason by sponsor|0|||
155233988|NCT02247349|560292495|FG004|Overall Study|Administrative reason by sponsor|1|||
155233989|NCT02247349|560292496|FG005|Overall Study|Administrative reason by sponsor|0|||
155233990|NCT02247349|560292491|FG000|Overall Study|Other reasons|0|||
155233991|NCT02247349|560292492|FG001|Overall Study|Other reasons|0|||
155233992|NCT02247349|560292493|FG002|Overall Study|Other reasons|1|||
155233993|NCT02247349|560292494|FG003|Overall Study|Other reasons|0|||
155233994|NCT02247349|560292495|FG004|Overall Study|Other reasons|0|||
155233995|NCT02247349|560292496|FG005|Overall Study|Other reasons|0|||
155233996|NCT03969212|560292497|FG000|Overall Study|Adverse Event|1|||
155233997|NCT03969212|560292498|FG001|Overall Study|Adverse Event|0|||
155233998|NCT03969212|560292499|FG002|Overall Study|Adverse Event|0|||
155233999|NCT03969212|560292500|FG003|Overall Study|Adverse Event|0|||
155234000|NCT03969212|560292497|FG000|Overall Study|Lost to Follow-up|2|||
155234001|NCT03969212|560292498|FG001|Overall Study|Lost to Follow-up|2|||
155234002|NCT03969212|560292499|FG002|Overall Study|Lost to Follow-up|2|||
155234003|NCT03969212|560292500|FG003|Overall Study|Lost to Follow-up|2|||
155234004|NCT03969212|560292497|FG000|Overall Study|Protocol Violation|0|||
155234005|NCT03969212|560292498|FG001|Overall Study|Protocol Violation|0|||
155234006|NCT03969212|560292499|FG002|Overall Study|Protocol Violation|0|||
155234007|NCT03969212|560292500|FG003|Overall Study|Protocol Violation|1|||
155234008|NCT03969212|560292497|FG000|Overall Study|Withdrawal by Subject|7|||
155234009|NCT03969212|560292498|FG001|Overall Study|Withdrawal by Subject|13|||
155234010|NCT03969212|560292499|FG002|Overall Study|Withdrawal by Subject|5|||
155234011|NCT03969212|560292500|FG003|Overall Study|Withdrawal by Subject|11|||
155234012|NCT03969212|560292497|FG000|Overall Study|Physician Decision|0|||
155234013|NCT03969212|560292498|FG001|Overall Study|Physician Decision|0|||
155234014|NCT03969212|560292499|FG002|Overall Study|Physician Decision|1|||
155234015|NCT03969212|560292500|FG003|Overall Study|Physician Decision|0|||
155234016|NCT03969212|560292497|FG000|Overall Study|Reason not Specified|22|||
155234017|NCT03969212|560292498|FG001|Overall Study|Reason not Specified|23|||
155234018|NCT03969212|560292499|FG002|Overall Study|Reason not Specified|28|||
155234019|NCT03969212|560292500|FG003|Overall Study|Reason not Specified|26|||
155234020|NCT03511560|560292501|FG000|Overall Study|Death|0|||
155234021|NCT03511560|560292502|FG001|Overall Study|Death|1|||
155234022|NCT03511560|560292501|FG000|Overall Study|Adverse Event|0|||
155234023|NCT03511560|560292502|FG001|Overall Study|Adverse Event|2|||
155234024|NCT03511560|560292501|FG000|Overall Study|Transplant cancelled|0|||
155234025|NCT03511560|560292502|FG001|Overall Study|Transplant cancelled|1|||
155234026|NCT03511560|560292501|FG000|Overall Study|Patient switched to another drug|1|||
155234027|NCT03511560|560292502|FG001|Overall Study|Patient switched to another drug|0|||
155234028|NCT00382733|560292507|FG000|Overall Study|Withdrawal by Subject|0|||
155234029|NCT00382733|560292508|FG001|Overall Study|Withdrawal by Subject|1|||
155234030|NCT00382733|560292509|FG002|Overall Study|Withdrawal by Subject|0|||
155234031|NCT00382733|560292510|FG003|Overall Study|Withdrawal by Subject|0|||
155234032|NCT00382733|560292511|FG004|Overall Study|Withdrawal by Subject|0|||
155234033|NCT03075644|560292512|FG000|Overall Study|Withdrawal by Subject|1|||
155234034|NCT03075644|560292513|FG001|Overall Study|Withdrawal by Subject|1|||
155234035|NCT00439140|560292514|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155234036|NCT00439140|560292515|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
155234037|NCT00439140|560292516|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
155234038|NCT00439140|560292514|FG000|Treatment Cycle 1|Personal reasons|0|||
155234039|NCT00439140|560292515|FG001|Treatment Cycle 1|Personal reasons|2|||
155234040|NCT00439140|560292516|FG002|Treatment Cycle 1|Personal reasons|0|||
155234041|NCT00439140|560292514|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
155234042|NCT00439140|560292515|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
155234043|NCT00439140|560292516|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
155234044|NCT00439140|560292514|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
155234045|NCT00439140|560292515|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
155234046|NCT00439140|560292516|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
155234047|NCT00439140|560292514|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
155234048|NCT00439140|560292515|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
155234049|NCT00439140|560292516|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
155234050|NCT01458171|560292519|FG000|Overall Study|Adverse Event|1|||
155234051|NCT00578565|560292524|FG000|Overall Study|Adverse Event|3|||
155234052|NCT02143843|560292526|FG000|Overall Study|Adverse Event|8|||
155234053|NCT02143843|560292526|FG000|Overall Study|Lack of Efficacy|2|||
155234054|NCT02143843|560292526|FG000|Overall Study|Withdrawal by Subject|2|||
155234055|NCT00480779|560292527|FG000|Overall Study|Other|2|||
155234056|NCT00480779|560292528|FG001|Overall Study|Other|0|||
155234057|NCT00480779|560292527|FG000|Overall Study|Job and Health-related|0|||
155234058|NCT00480779|560292528|FG001|Overall Study|Job and Health-related|3|||
155234059|NCT01339390|560292531|FG000|Overall Study|Death|32|||
155234060|NCT01339390|560292532|FG001|Overall Study|Death|29|||
155234061|NCT01339390|560292531|FG000|Overall Study|Lost to Follow-up|125|||
155234062|NCT01339390|560292532|FG001|Overall Study|Lost to Follow-up|127|||
155234063|NCT00378703|560292535|FG000|Overall Study|Disease progression|59|||
155234064|NCT00378703|560292536|FG001|Overall Study|Disease progression|43|||
155234065|NCT00378703|560292537|FG002|Overall Study|Disease progression|48|||
155234066|NCT00378703|560292538|FG003|Overall Study|Disease progression|49|||
155234067|NCT00378703|560292535|FG000|Overall Study|Adverse Event|11|||
155234068|NCT00378703|560292536|FG001|Overall Study|Adverse Event|17|||
155234069|NCT00378703|560292537|FG002|Overall Study|Adverse Event|20|||
155234070|NCT00378703|560292538|FG003|Overall Study|Adverse Event|18|||
155234071|NCT00378703|560292535|FG000|Overall Study|Death|2|||
155234072|NCT00378703|560292536|FG001|Overall Study|Death|2|||
155234073|NCT00378703|560292537|FG002|Overall Study|Death|4|||
155234074|NCT00378703|560292538|FG003|Overall Study|Death|3|||
155234075|NCT00378703|560292535|FG000|Overall Study|Withdrawal by Subject|4|||
155234076|NCT00378703|560292536|FG001|Overall Study|Withdrawal by Subject|8|||
155234077|NCT00378703|560292537|FG002|Overall Study|Withdrawal by Subject|5|||
155234078|NCT00378703|560292538|FG003|Overall Study|Withdrawal by Subject|7|||
155234079|NCT00378703|560292535|FG000|Overall Study|Physician Decision|1|||
155234080|NCT00378703|560292536|FG001|Overall Study|Physician Decision|4|||
155234081|NCT00378703|560292537|FG002|Overall Study|Physician Decision|1|||
155234082|NCT00378703|560292538|FG003|Overall Study|Physician Decision|0|||
155234083|NCT00378703|560292535|FG000|Overall Study|Alternative therapy|4|||
155234084|NCT00378703|560292536|FG001|Overall Study|Alternative therapy|2|||
155234085|NCT00378703|560292537|FG002|Overall Study|Alternative therapy|0|||
155234086|NCT00378703|560292538|FG003|Overall Study|Alternative therapy|0|||
155234087|NCT00378703|560292535|FG000|Overall Study|Other complicated disease|0|||
155234088|NCT00378703|560292536|FG001|Overall Study|Other complicated disease|2|||
155234089|NCT00378703|560292537|FG002|Overall Study|Other complicated disease|2|||
155234090|NCT00378703|560292538|FG003|Overall Study|Other complicated disease|0|||
155234091|NCT00378703|560292535|FG000|Overall Study|Symptomatic deterioration|0|||
155234092|NCT00378703|560292536|FG001|Overall Study|Symptomatic deterioration|1|||
155234093|NCT00378703|560292537|FG002|Overall Study|Symptomatic deterioration|0|||
155234094|NCT00378703|560292538|FG003|Overall Study|Symptomatic deterioration|2|||
155234095|NCT00378703|560292535|FG000|Overall Study|Surgery|1|||
155234096|NCT00378703|560292536|FG001|Overall Study|Surgery|0|||
155234097|NCT00378703|560292537|FG002|Overall Study|Surgery|0|||
155234098|NCT00378703|560292538|FG003|Overall Study|Surgery|1|||
155234099|NCT00378703|560292535|FG000|Overall Study|Joint decision of physician and patient|1|||
155234100|NCT00378703|560292536|FG001|Overall Study|Joint decision of physician and patient|0|||
155234101|NCT00378703|560292537|FG002|Overall Study|Joint decision of physician and patient|0|||
155234102|NCT00378703|560292538|FG003|Overall Study|Joint decision of physician and patient|0|||
155234103|NCT00378703|560292535|FG000|Overall Study|Adverse events and progressive disease|0|||
155234104|NCT00378703|560292536|FG001|Overall Study|Adverse events and progressive disease|0|||
155234105|NCT00378703|560292537|FG002|Overall Study|Adverse events and progressive disease|0|||
155234106|NCT00378703|560292538|FG003|Overall Study|Adverse events and progressive disease|1|||
155234107|NCT00378703|560292535|FG000|Overall Study|Relocation|0|||
155234108|NCT00378703|560292536|FG001|Overall Study|Relocation|0|||
155234109|NCT00378703|560292537|FG002|Overall Study|Relocation|1|||
155234110|NCT00378703|560292538|FG003|Overall Study|Relocation|0|||
155234111|NCT00378703|560292535|FG000|Overall Study|Ineligible|4|||
155234112|NCT00378703|560292536|FG001|Overall Study|Ineligible|7|||
155234113|NCT00378703|560292537|FG002|Overall Study|Ineligible|7|||
155234114|NCT00378703|560292538|FG003|Overall Study|Ineligible|7|||
155234115|NCT00378703|560292535|FG000|Overall Study|Never started treatment|1|||
155234116|NCT00378703|560292536|FG001|Overall Study|Never started treatment|4|||
155234117|NCT00378703|560292537|FG002|Overall Study|Never started treatment|0|||
155234118|NCT00378703|560292538|FG003|Overall Study|Never started treatment|0|||
155234119|NCT00378703|560292535|FG000|Overall Study|Other|1|||
155234120|NCT00378703|560292536|FG001|Overall Study|Other|1|||
155234121|NCT00378703|560292537|FG002|Overall Study|Other|2|||
155234122|NCT00378703|560292538|FG003|Overall Study|Other|3|||
155234123|NCT01482767|560292544|FG000|Overall Study|Death|1|||
155234124|NCT01482767|560292545|FG001|Overall Study|Death|1|||
155234125|NCT01482767|560292544|FG000|Overall Study|Withdrawal by Subject|7|||
155234126|NCT01482767|560292545|FG001|Overall Study|Withdrawal by Subject|5|||
155234127|NCT01482767|560292544|FG000|Overall Study|Lost to Follow-up|12|||
155234128|NCT01482767|560292545|FG001|Overall Study|Lost to Follow-up|6|||
155234129|NCT01482767|560292544|FG000|Overall Study|Adverse Event|0|||
155234130|NCT01482767|560292545|FG001|Overall Study|Adverse Event|3|||
155234131|NCT01482767|560292544|FG000|Overall Study|Site closure|22|||
155234132|NCT01482767|560292545|FG001|Overall Study|Site closure|14|||
155234133|NCT01482767|560292544|FG000|Overall Study|Non-adherence to study requirements|4|||
155234134|NCT01482767|560292545|FG001|Overall Study|Non-adherence to study requirements|7|||
155234135|NCT01482767|560292544|FG000|Overall Study|Alternate HCV treatment|7|||
155234136|NCT01482767|560292545|FG001|Overall Study|Alternate HCV treatment|8|||
155234137|NCT01482767|560292544|FG000|Overall Study|Ineligible|0|||
155234138|NCT01482767|560292545|FG001|Overall Study|Ineligible|5|||
155234139|NCT01482767|560292544|FG000|Overall Study|Nurse error|1|||
155234140|NCT01482767|560292545|FG001|Overall Study|Nurse error|0|||
155234141|NCT01541930|560292550|FG000|Overall Study|Withdrawal by Subject|1|||
155234142|NCT01466192|560292551|FG000|Overall Study|Physician Decision|1|||
155234143|NCT01466192|560292551|FG000|Overall Study|Withdrawal by Subject|3|||
155234144|NCT03665038|560292553|FG000|Overall Study|Lost to Follow-up|0|||
155234145|NCT03665038|560292554|FG001|Overall Study|Lost to Follow-up|0|||
155234146|NCT03665038|560292555|FG002|Overall Study|Lost to Follow-up|1|||
155234147|NCT03013491|560292556|FG000|Main Study|Death|2|||
155234148|NCT03013491|560292557|FG001|Main Study|Death|2|||
155234149|NCT03013491|560292558|FG002|Main Study|Death|5|||
155234150|NCT03013491|560292559|FG003|Main Study|Death|3|||
155234151|NCT03013491|560292560|FG004|Main Study|Death|9|||
155234152|NCT03013491|560292561|FG005|Main Study|Death|12|||
155234153|NCT03013491|560292562|FG006|Main Study|Death|3|||
155234154|NCT03013491|560292563|FG007|Main Study|Death|5|||
155234155|NCT03013491|560292564|FG008|Main Study|Death|1|||
155234156|NCT03013491|560292565|FG009|Main Study|Death|2|||
155234157|NCT03013491|560292566|FG010|Main Study|Death|4|||
155234158|NCT03013491|560292567|FG011|Main Study|Death|1|||
155234159|NCT03013491|560292568|FG012|Main Study|Death|1|||
155234160|NCT03013491|560292569|FG013|Main Study|Death|4|||
155234161|NCT03013491|560292570|FG014|Main Study|Death|0|||
155234162|NCT03013491|560292571|FG015|Main Study|Death|3|||
155234163|NCT03013491|560292572|FG016|Main Study|Death|5|||
155234164|NCT03013491|560292573|FG017|Main Study|Death|1|||
155234165|NCT03013491|560292574|FG018|Main Study|Death|47|||
155234166|NCT03013491|560292556|FG000|Main Study|Lost to Follow-up|0|||
155234167|NCT03013491|560292557|FG001|Main Study|Lost to Follow-up|0|||
155234168|NCT03013491|560292558|FG002|Main Study|Lost to Follow-up|1|||
155234169|NCT03013491|560292559|FG003|Main Study|Lost to Follow-up|0|||
155234170|NCT03013491|560292560|FG004|Main Study|Lost to Follow-up|1|||
155234171|NCT03013491|560292561|FG005|Main Study|Lost to Follow-up|0|||
155234172|NCT03013491|560292562|FG006|Main Study|Lost to Follow-up|0|||
155234173|NCT03013491|560292563|FG007|Main Study|Lost to Follow-up|0|||
155234174|NCT03013491|560292564|FG008|Main Study|Lost to Follow-up|0|||
155234175|NCT03013491|560292565|FG009|Main Study|Lost to Follow-up|0|||
155234176|NCT03013491|560292566|FG010|Main Study|Lost to Follow-up|0|||
155234177|NCT03013491|560292567|FG011|Main Study|Lost to Follow-up|0|||
155234178|NCT03013491|560292568|FG012|Main Study|Lost to Follow-up|0|||
155234179|NCT03013491|560292569|FG013|Main Study|Lost to Follow-up|0|||
155234180|NCT03013491|560292570|FG014|Main Study|Lost to Follow-up|0|||
155234181|NCT03013491|560292571|FG015|Main Study|Lost to Follow-up|0|||
155234182|NCT03013491|560292572|FG016|Main Study|Lost to Follow-up|0|||
155234183|NCT03013491|560292573|FG017|Main Study|Lost to Follow-up|0|||
155234184|NCT03013491|560292574|FG018|Main Study|Lost to Follow-up|3|||
155234185|NCT03013491|560292556|FG000|Main Study|Termination of the study by Sponsor|0|||
155234186|NCT03013491|560292557|FG001|Main Study|Termination of the study by Sponsor|0|||
155234187|NCT03013491|560292558|FG002|Main Study|Termination of the study by Sponsor|2|||
155234188|NCT03013491|560292559|FG003|Main Study|Termination of the study by Sponsor|0|||
155234189|NCT03013491|560292560|FG004|Main Study|Termination of the study by Sponsor|1|||
155234190|NCT03013491|560292561|FG005|Main Study|Termination of the study by Sponsor|2|||
155234191|NCT03013491|560292562|FG006|Main Study|Termination of the study by Sponsor|0|||
155234192|NCT03013491|560292563|FG007|Main Study|Termination of the study by Sponsor|0|||
155234193|NCT03013491|560292564|FG008|Main Study|Termination of the study by Sponsor|1|||
155234194|NCT03013491|560292565|FG009|Main Study|Termination of the study by Sponsor|1|||
155234195|NCT03013491|560292566|FG010|Main Study|Termination of the study by Sponsor|1|||
155234196|NCT03013491|560292567|FG011|Main Study|Termination of the study by Sponsor|2|||
155234197|NCT03013491|560292568|FG012|Main Study|Termination of the study by Sponsor|0|||
155234198|NCT03013491|560292569|FG013|Main Study|Termination of the study by Sponsor|0|||
155234199|NCT03013491|560292570|FG014|Main Study|Termination of the study by Sponsor|0|||
155234200|NCT03013491|560292571|FG015|Main Study|Termination of the study by Sponsor|0|||
155234201|NCT03013491|560292572|FG016|Main Study|Termination of the study by Sponsor|0|||
155234202|NCT03013491|560292573|FG017|Main Study|Termination of the study by Sponsor|1|||
155234203|NCT03013491|560292574|FG018|Main Study|Termination of the study by Sponsor|13|||
155234204|NCT03013491|560292556|FG000|Main Study|Withdrawal by Subject|0|||
155234205|NCT03013491|560292557|FG001|Main Study|Withdrawal by Subject|0|||
155234206|NCT03013491|560292558|FG002|Main Study|Withdrawal by Subject|0|||
155234207|NCT03013491|560292559|FG003|Main Study|Withdrawal by Subject|4|||
155234208|NCT03013491|560292560|FG004|Main Study|Withdrawal by Subject|2|||
155234209|NCT03013491|560292561|FG005|Main Study|Withdrawal by Subject|1|||
155234210|NCT03013491|560292562|FG006|Main Study|Withdrawal by Subject|0|||
155234211|NCT03013491|560292563|FG007|Main Study|Withdrawal by Subject|0|||
155234212|NCT03013491|560292564|FG008|Main Study|Withdrawal by Subject|0|||
155234213|NCT03013491|560292565|FG009|Main Study|Withdrawal by Subject|0|||
155234214|NCT03013491|560292566|FG010|Main Study|Withdrawal by Subject|1|||
155234215|NCT03013491|560292567|FG011|Main Study|Withdrawal by Subject|2|||
155234216|NCT03013491|560292568|FG012|Main Study|Withdrawal by Subject|0|||
155234217|NCT03013491|560292569|FG013|Main Study|Withdrawal by Subject|2|||
155234218|NCT03013491|560292570|FG014|Main Study|Withdrawal by Subject|0|||
155234219|NCT03013491|560292571|FG015|Main Study|Withdrawal by Subject|0|||
155234220|NCT03013491|560292572|FG016|Main Study|Withdrawal by Subject|0|||
155234221|NCT03013491|560292573|FG017|Main Study|Withdrawal by Subject|0|||
155234222|NCT03013491|560292574|FG018|Main Study|Withdrawal by Subject|18|||
155234223|NCT03013491|560292556|FG000|Main Study|Disease progression|0|||
155234224|NCT03013491|560292557|FG001|Main Study|Disease progression|0|||
155234225|NCT03013491|560292558|FG002|Main Study|Disease progression|0|||
155234226|NCT03013491|560292559|FG003|Main Study|Disease progression|1|||
155234227|NCT03013491|560292560|FG004|Main Study|Disease progression|0|||
155234228|NCT03013491|560292561|FG005|Main Study|Disease progression|0|||
155234229|NCT03013491|560292562|FG006|Main Study|Disease progression|0|||
155234230|NCT03013491|560292563|FG007|Main Study|Disease progression|0|||
155234231|NCT03013491|560292564|FG008|Main Study|Disease progression|1|||
155234232|NCT03013491|560292565|FG009|Main Study|Disease progression|0|||
155234233|NCT03013491|560292566|FG010|Main Study|Disease progression|1|||
155234234|NCT03013491|560292567|FG011|Main Study|Disease progression|0|||
155234235|NCT03013491|560292568|FG012|Main Study|Disease progression|0|||
155234236|NCT03013491|560292569|FG013|Main Study|Disease progression|0|||
155234237|NCT03013491|560292570|FG014|Main Study|Disease progression|0|||
155234238|NCT03013491|560292571|FG015|Main Study|Disease progression|0|||
155234239|NCT03013491|560292572|FG016|Main Study|Disease progression|0|||
155234240|NCT03013491|560292573|FG017|Main Study|Disease progression|0|||
155234241|NCT03013491|560292574|FG018|Main Study|Disease progression|4|||
155234242|NCT03013491|560292556|FG000|Main Study|Symptomatic deterioration|0|||
155234243|NCT03013491|560292557|FG001|Main Study|Symptomatic deterioration|0|||
155234244|NCT03013491|560292558|FG002|Main Study|Symptomatic deterioration|0|||
155234245|NCT03013491|560292559|FG003|Main Study|Symptomatic deterioration|0|||
155234246|NCT03013491|560292560|FG004|Main Study|Symptomatic deterioration|0|||
155234247|NCT03013491|560292561|FG005|Main Study|Symptomatic deterioration|1|||
155234248|NCT03013491|560292562|FG006|Main Study|Symptomatic deterioration|0|||
155234249|NCT03013491|560292563|FG007|Main Study|Symptomatic deterioration|0|||
155234250|NCT03013491|560292564|FG008|Main Study|Symptomatic deterioration|0|||
155234251|NCT03013491|560292565|FG009|Main Study|Symptomatic deterioration|0|||
155234252|NCT03013491|560292566|FG010|Main Study|Symptomatic deterioration|0|||
155234253|NCT03013491|560292567|FG011|Main Study|Symptomatic deterioration|0|||
155234254|NCT03013491|560292568|FG012|Main Study|Symptomatic deterioration|0|||
155234255|NCT03013491|560292569|FG013|Main Study|Symptomatic deterioration|0|||
155234256|NCT03013491|560292570|FG014|Main Study|Symptomatic deterioration|0|||
155234257|NCT03013491|560292571|FG015|Main Study|Symptomatic deterioration|0|||
155234258|NCT03013491|560292572|FG016|Main Study|Symptomatic deterioration|0|||
155234259|NCT03013491|560292573|FG017|Main Study|Symptomatic deterioration|0|||
155234260|NCT03013491|560292574|FG018|Main Study|Symptomatic deterioration|0|||
155234261|NCT03013491|560292556|FG000|Main Study|Protocol version 8.0 approval|0|||
155234262|NCT03013491|560292557|FG001|Main Study|Protocol version 8.0 approval|0|||
155234263|NCT03013491|560292558|FG002|Main Study|Protocol version 8.0 approval|0|||
155234264|NCT03013491|560292559|FG003|Main Study|Protocol version 8.0 approval|0|||
155234265|NCT03013491|560292560|FG004|Main Study|Protocol version 8.0 approval|0|||
155234266|NCT03013491|560292561|FG005|Main Study|Protocol version 8.0 approval|0|||
155234267|NCT03013491|560292562|FG006|Main Study|Protocol version 8.0 approval|0|||
155234268|NCT03013491|560292563|FG007|Main Study|Protocol version 8.0 approval|0|||
155234269|NCT03013491|560292564|FG008|Main Study|Protocol version 8.0 approval|0|||
155234270|NCT03013491|560292565|FG009|Main Study|Protocol version 8.0 approval|0|||
155234271|NCT03013491|560292566|FG010|Main Study|Protocol version 8.0 approval|1|||
155234272|NCT03013491|560292567|FG011|Main Study|Protocol version 8.0 approval|0|||
155234273|NCT03013491|560292568|FG012|Main Study|Protocol version 8.0 approval|0|||
155234274|NCT03013491|560292569|FG013|Main Study|Protocol version 8.0 approval|0|||
155234275|NCT03013491|560292570|FG014|Main Study|Protocol version 8.0 approval|0|||
155234276|NCT03013491|560292571|FG015|Main Study|Protocol version 8.0 approval|0|||
155234277|NCT03013491|560292572|FG016|Main Study|Protocol version 8.0 approval|0|||
155234278|NCT03013491|560292573|FG017|Main Study|Protocol version 8.0 approval|0|||
155234279|NCT03013491|560292574|FG018|Main Study|Protocol version 8.0 approval|0|||
155234280|NCT03013491|560292556|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
155234281|NCT03013491|560292557|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
155234282|NCT03013491|560292558|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
155234283|NCT03013491|560292559|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
155234284|NCT03013491|560292560|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
155234285|NCT03013491|560292561|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
155234286|NCT03013491|560292562|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
155234287|NCT03013491|560292563|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
155234288|NCT03013491|560292564|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
155234289|NCT03013491|560292565|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
155234290|NCT03013491|560292566|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
155234291|NCT03013491|560292567|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
155234292|NCT03013491|560292568|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
155234293|NCT03013491|560292569|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
155234294|NCT03013491|560292570|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
155234295|NCT03013491|560292571|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
155234296|NCT03013491|560292572|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
155234297|NCT03013491|560292573|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
155234298|NCT03013491|560292574|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
155234299|NCT03013491|560292556|FG000|Main Study|Start of new anticancer therapy|0|||
155234300|NCT03013491|560292557|FG001|Main Study|Start of new anticancer therapy|0|||
155234301|NCT03013491|560292558|FG002|Main Study|Start of new anticancer therapy|0|||
155234302|NCT03013491|560292559|FG003|Main Study|Start of new anticancer therapy|0|||
155234303|NCT03013491|560292560|FG004|Main Study|Start of new anticancer therapy|0|||
155234304|NCT03013491|560292561|FG005|Main Study|Start of new anticancer therapy|0|||
155234305|NCT03013491|560292562|FG006|Main Study|Start of new anticancer therapy|0|||
155234306|NCT03013491|560292563|FG007|Main Study|Start of new anticancer therapy|0|||
155234307|NCT03013491|560292564|FG008|Main Study|Start of new anticancer therapy|0|||
155234308|NCT03013491|560292565|FG009|Main Study|Start of new anticancer therapy|0|||
155234309|NCT03013491|560292566|FG010|Main Study|Start of new anticancer therapy|0|||
155234310|NCT03013491|560292567|FG011|Main Study|Start of new anticancer therapy|0|||
155234311|NCT03013491|560292568|FG012|Main Study|Start of new anticancer therapy|0|||
155234312|NCT03013491|560292569|FG013|Main Study|Start of new anticancer therapy|0|||
155234313|NCT03013491|560292570|FG014|Main Study|Start of new anticancer therapy|0|||
155234314|NCT03013491|560292571|FG015|Main Study|Start of new anticancer therapy|0|||
155234315|NCT03013491|560292572|FG016|Main Study|Start of new anticancer therapy|0|||
155234316|NCT03013491|560292573|FG017|Main Study|Start of new anticancer therapy|0|||
155234317|NCT03013491|560292574|FG018|Main Study|Start of new anticancer therapy|2|||
155234318|NCT03013491|560292556|FG000|Long-term Extension|Disease progression|0|||
155234319|NCT03013491|560292557|FG001|Long-term Extension|Disease progression|0|||
155234320|NCT03013491|560292558|FG002|Long-term Extension|Disease progression|0|||
155234321|NCT03013491|560292559|FG003|Long-term Extension|Disease progression|1|||
155234322|NCT03013491|560292560|FG004|Long-term Extension|Disease progression|0|||
155234323|NCT03013491|560292561|FG005|Long-term Extension|Disease progression|0|||
155234324|NCT03013491|560292562|FG006|Long-term Extension|Disease progression|0|||
155234325|NCT03013491|560292563|FG007|Long-term Extension|Disease progression|0|||
155234326|NCT03013491|560292564|FG008|Long-term Extension|Disease progression|0|||
155234327|NCT03013491|560292565|FG009|Long-term Extension|Disease progression|0|||
155234328|NCT03013491|560292566|FG010|Long-term Extension|Disease progression|0|||
155234329|NCT03013491|560292567|FG011|Long-term Extension|Disease progression|0|||
155234330|NCT03013491|560292568|FG012|Long-term Extension|Disease progression|0|||
155234331|NCT03013491|560292569|FG013|Long-term Extension|Disease progression|0|||
155234332|NCT03013491|560292570|FG014|Long-term Extension|Disease progression|0|||
155234333|NCT03013491|560292571|FG015|Long-term Extension|Disease progression|0|||
155234334|NCT03013491|560292572|FG016|Long-term Extension|Disease progression|0|||
155234335|NCT03013491|560292573|FG017|Long-term Extension|Disease progression|0|||
155234336|NCT03013491|560292574|FG018|Long-term Extension|Disease progression|1|||
155234337|NCT03013491|560292556|FG000|Long-term Extension|Withdrawal by Subject|0|||
155234338|NCT03013491|560292557|FG001|Long-term Extension|Withdrawal by Subject|0|||
155234339|NCT03013491|560292558|FG002|Long-term Extension|Withdrawal by Subject|0|||
155234340|NCT03013491|560292559|FG003|Long-term Extension|Withdrawal by Subject|0|||
155234341|NCT03013491|560292560|FG004|Long-term Extension|Withdrawal by Subject|0|||
155234342|NCT03013491|560292561|FG005|Long-term Extension|Withdrawal by Subject|0|||
155234343|NCT03013491|560292562|FG006|Long-term Extension|Withdrawal by Subject|0|||
155234344|NCT03013491|560292563|FG007|Long-term Extension|Withdrawal by Subject|1|||
155234345|NCT03013491|560292564|FG008|Long-term Extension|Withdrawal by Subject|0|||
155234346|NCT03013491|560292565|FG009|Long-term Extension|Withdrawal by Subject|0|||
155234347|NCT03013491|560292566|FG010|Long-term Extension|Withdrawal by Subject|0|||
155234348|NCT03013491|560292567|FG011|Long-term Extension|Withdrawal by Subject|0|||
155234349|NCT03013491|560292568|FG012|Long-term Extension|Withdrawal by Subject|0|||
155234350|NCT03013491|560292569|FG013|Long-term Extension|Withdrawal by Subject|0|||
155234351|NCT03013491|560292570|FG014|Long-term Extension|Withdrawal by Subject|0|||
155234352|NCT03013491|560292571|FG015|Long-term Extension|Withdrawal by Subject|0|||
155234353|NCT03013491|560292572|FG016|Long-term Extension|Withdrawal by Subject|0|||
155234354|NCT03013491|560292573|FG017|Long-term Extension|Withdrawal by Subject|0|||
155234355|NCT03013491|560292574|FG018|Long-term Extension|Withdrawal by Subject|0|||
155234356|NCT03013491|560292556|FG000|Long-term Extension|Adverse Event|0|||
155234357|NCT03013491|560292557|FG001|Long-term Extension|Adverse Event|0|||
155234358|NCT03013491|560292558|FG002|Long-term Extension|Adverse Event|0|||
155234359|NCT03013491|560292559|FG003|Long-term Extension|Adverse Event|0|||
155234360|NCT03013491|560292560|FG004|Long-term Extension|Adverse Event|0|||
155234361|NCT03013491|560292561|FG005|Long-term Extension|Adverse Event|0|||
155234362|NCT03013491|560292562|FG006|Long-term Extension|Adverse Event|0|||
155234363|NCT03013491|560292563|FG007|Long-term Extension|Adverse Event|0|||
155234364|NCT03013491|560292564|FG008|Long-term Extension|Adverse Event|0|||
155234365|NCT03013491|560292565|FG009|Long-term Extension|Adverse Event|0|||
155234366|NCT03013491|560292566|FG010|Long-term Extension|Adverse Event|0|||
155234367|NCT03013491|560292567|FG011|Long-term Extension|Adverse Event|0|||
155234368|NCT03013491|560292568|FG012|Long-term Extension|Adverse Event|0|||
155234369|NCT03013491|560292569|FG013|Long-term Extension|Adverse Event|0|||
155234370|NCT03013491|560292570|FG014|Long-term Extension|Adverse Event|0|||
155234371|NCT03013491|560292571|FG015|Long-term Extension|Adverse Event|0|||
155234372|NCT03013491|560292572|FG016|Long-term Extension|Adverse Event|0|||
155234373|NCT03013491|560292573|FG017|Long-term Extension|Adverse Event|0|||
155234374|NCT03013491|560292574|FG018|Long-term Extension|Adverse Event|1|||
155234375|NCT03013491|560292556|FG000|Long-term Extension|Death|0|||
155234376|NCT03013491|560292557|FG001|Long-term Extension|Death|0|||
155234377|NCT03013491|560292558|FG002|Long-term Extension|Death|0|||
155234378|NCT03013491|560292559|FG003|Long-term Extension|Death|0|||
155234379|NCT03013491|560292560|FG004|Long-term Extension|Death|0|||
155234380|NCT03013491|560292561|FG005|Long-term Extension|Death|0|||
155234381|NCT03013491|560292562|FG006|Long-term Extension|Death|0|||
155234382|NCT03013491|560292563|FG007|Long-term Extension|Death|0|||
155234383|NCT03013491|560292564|FG008|Long-term Extension|Death|0|||
155234384|NCT03013491|560292565|FG009|Long-term Extension|Death|0|||
155234385|NCT03013491|560292566|FG010|Long-term Extension|Death|0|||
155234386|NCT03013491|560292567|FG011|Long-term Extension|Death|0|||
155234387|NCT03013491|560292568|FG012|Long-term Extension|Death|0|||
155234388|NCT03013491|560292569|FG013|Long-term Extension|Death|0|||
155234389|NCT03013491|560292570|FG014|Long-term Extension|Death|0|||
155234390|NCT03013491|560292571|FG015|Long-term Extension|Death|0|||
155234391|NCT03013491|560292572|FG016|Long-term Extension|Death|0|||
155234392|NCT03013491|560292573|FG017|Long-term Extension|Death|0|||
155234393|NCT03013491|560292574|FG018|Long-term Extension|Death|1|||
155234394|NCT04740034|560292577|FG000|Overall Study|Death|0|||
155234395|NCT04740034|560292578|FG001|Overall Study|Death|1|||
155234396|NCT04740034|560292579|FG002|Overall Study|Death|2|||
155234397|NCT04740034|560292580|FG003|Overall Study|Death|3|||
155234398|NCT04740034|560292581|FG004|Overall Study|Death|4|||
155234399|NCT04740034|560292582|FG005|Overall Study|Death|4|||
155234400|NCT04740034|560292583|FG006|Overall Study|Death|2|||
155234401|NCT04740034|560292584|FG007|Overall Study|Death|2|||
155234402|NCT04740034|560292585|FG008|Overall Study|Death|2|||
155234403|NCT04740034|560292586|FG009|Overall Study|Death|4|||
155234404|NCT04740034|560292587|FG010|Overall Study|Death|0|||
155234405|NCT04740034|560292577|FG000|Overall Study|Lost to Follow-up|0|||
155234406|NCT04740034|560292578|FG001|Overall Study|Lost to Follow-up|0|||
155234407|NCT04740034|560292579|FG002|Overall Study|Lost to Follow-up|0|||
155234408|NCT04740034|560292580|FG003|Overall Study|Lost to Follow-up|1|||
155234409|NCT04740034|560292581|FG004|Overall Study|Lost to Follow-up|2|||
155234410|NCT04740034|560292582|FG005|Overall Study|Lost to Follow-up|2|||
155234411|NCT04740034|560292583|FG006|Overall Study|Lost to Follow-up|0|||
155234412|NCT04740034|560292584|FG007|Overall Study|Lost to Follow-up|0|||
155234413|NCT04740034|560292585|FG008|Overall Study|Lost to Follow-up|0|||
155234414|NCT04740034|560292586|FG009|Overall Study|Lost to Follow-up|1|||
155234415|NCT04740034|560292587|FG010|Overall Study|Lost to Follow-up|0|||
155234416|NCT04740034|560292577|FG000|Overall Study|Withdrawal by Subject|1|||
155234417|NCT04740034|560292578|FG001|Overall Study|Withdrawal by Subject|0|||
155234418|NCT04740034|560292579|FG002|Overall Study|Withdrawal by Subject|0|||
155234419|NCT04740034|560292580|FG003|Overall Study|Withdrawal by Subject|0|||
155234420|NCT04740034|560292581|FG004|Overall Study|Withdrawal by Subject|0|||
155234421|NCT04740034|560292582|FG005|Overall Study|Withdrawal by Subject|0|||
155234422|NCT04740034|560292583|FG006|Overall Study|Withdrawal by Subject|0|||
155234423|NCT04740034|560292584|FG007|Overall Study|Withdrawal by Subject|1|||
155234424|NCT04740034|560292585|FG008|Overall Study|Withdrawal by Subject|0|||
155234425|NCT04740034|560292586|FG009|Overall Study|Withdrawal by Subject|1|||
155234426|NCT04740034|560292587|FG010|Overall Study|Withdrawal by Subject|0|||
155234427|NCT04740034|560292577|FG000|Overall Study|Decision by sponsor|0|||
155234428|NCT04740034|560292578|FG001|Overall Study|Decision by sponsor|0|||
155234429|NCT04740034|560292579|FG002|Overall Study|Decision by sponsor|1|||
155234430|NCT04740034|560292580|FG003|Overall Study|Decision by sponsor|0|||
155234431|NCT04740034|560292581|FG004|Overall Study|Decision by sponsor|0|||
155234432|NCT04740034|560292582|FG005|Overall Study|Decision by sponsor|0|||
155234433|NCT04740034|560292583|FG006|Overall Study|Decision by sponsor|1|||
155234434|NCT04740034|560292584|FG007|Overall Study|Decision by sponsor|2|||
155234435|NCT04740034|560292585|FG008|Overall Study|Decision by sponsor|1|||
155234436|NCT04740034|560292586|FG009|Overall Study|Decision by sponsor|1|||
155234437|NCT04740034|560292587|FG010|Overall Study|Decision by sponsor|2|||
155234438|NCT03890367|560292594|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155234439|NCT03890367|560292595|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155234440|NCT03890367|560292596|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155234441|NCT03890367|560292594|FG000|Overall Study|Protocol deviation|2|||
155234442|NCT03890367|560292595|FG001|Overall Study|Protocol deviation|2|||
155234443|NCT03890367|560292596|FG002|Overall Study|Protocol deviation|1|||
155234444|NCT03890367|560292594|FG000|Overall Study|Lost to Follow-up|1|||
155234445|NCT03890367|560292595|FG001|Overall Study|Lost to Follow-up|1|||
155234446|NCT03890367|560292596|FG002|Overall Study|Lost to Follow-up|0|||
155234447|NCT02556710|560295088|FG000|Overall Study|Surgical treatment|3|||
155234448|NCT02556710|560295089|FG001|Overall Study|Surgical treatment|0|||
155234449|NCT02556710|560295088|FG000|Overall Study|Required proscribed pain medication|2|||
155234450|NCT02556710|560295089|FG001|Overall Study|Required proscribed pain medication|1|||
155234451|NCT02556710|560295088|FG000|Overall Study|Lack of Efficacy|1|||
155234452|NCT02556710|560295089|FG001|Overall Study|Lack of Efficacy|0|||
155234453|NCT02556710|560295088|FG000|Overall Study|Worsening osteoarthritis|1|||
155234454|NCT02556710|560295089|FG001|Overall Study|Worsening osteoarthritis|0|||
155234455|NCT02556710|560295088|FG000|Overall Study|Moved out of state|1|||
155234456|NCT02556710|560295089|FG001|Overall Study|Moved out of state|0|||
155234457|NCT02556710|560295088|FG000|Overall Study|Missing reason|3|||
155234458|NCT02556710|560295089|FG001|Overall Study|Missing reason|1|||
155234459|NCT02556710|560295088|FG000|Overall Study|Pain as lack of efficacy|0|||
155234460|NCT02556710|560295089|FG001|Overall Study|Pain as lack of efficacy|4|||
155234461|NCT04524403|560295090|FG000|Overall Study|Withdrawal by Subject|10|||
155234462|NCT04524403|560295091|FG001|Overall Study|Withdrawal by Subject|3|||
155234463|NCT04524403|560295092|FG002|Overall Study|Withdrawal by Subject|8|||
155234464|NCT04524403|560295090|FG000|Overall Study|Lost to Follow-up|3|||
155234465|NCT04524403|560295091|FG001|Overall Study|Lost to Follow-up|4|||
155234466|NCT04524403|560295092|FG002|Overall Study|Lost to Follow-up|3|||
155234467|NCT04524403|560295090|FG000|Overall Study|Adverse Event|3|||
155234468|NCT04524403|560295091|FG001|Overall Study|Adverse Event|1|||
155234469|NCT04524403|560295092|FG002|Overall Study|Adverse Event|4|||
155234470|NCT04524403|560295090|FG000|Overall Study|Non-compliant with study drug|1|||
155234471|NCT04524403|560295091|FG001|Overall Study|Non-compliant with study drug|2|||
155234472|NCT04524403|560295092|FG002|Overall Study|Non-compliant with study drug|3|||
155234473|NCT04524403|560295090|FG000|Overall Study|Moved|0|||
155234474|NCT04524403|560295091|FG001|Overall Study|Moved|1|||
155234475|NCT04524403|560295092|FG002|Overall Study|Moved|0|||
155234476|NCT03370341|560295093|FG000|Overall Study|Lost to Follow-up|0|||
155234477|NCT03370341|560295094|FG001|Overall Study|Lost to Follow-up|1|||
155234478|NCT00646958|560295103|FG000|Overall Study|Lack of Efficacy|1|||
155234479|NCT00646958|560295104|FG001|Overall Study|Lack of Efficacy|0|||
155234480|NCT00646958|560295105|FG002|Overall Study|Lack of Efficacy|0|||
155234481|NCT00646958|560295103|FG000|Overall Study|Adverse Event|4|||
155234482|NCT00646958|560295104|FG001|Overall Study|Adverse Event|0|||
155234483|NCT00646958|560295105|FG002|Overall Study|Adverse Event|0|||
155234484|NCT00646958|560295103|FG000|Overall Study|Lost to Follow-up|1|||
155234485|NCT00646958|560295104|FG001|Overall Study|Lost to Follow-up|5|||
155234486|NCT00646958|560295105|FG002|Overall Study|Lost to Follow-up|7|||
155234487|NCT00646958|560295103|FG000|Overall Study|Protocol Violation|1|||
155234488|NCT00646958|560295104|FG001|Overall Study|Protocol Violation|1|||
155234489|NCT00646958|560295105|FG002|Overall Study|Protocol Violation|0|||
155234490|NCT00646958|560295103|FG000|Overall Study|Abnormal screening lab tests|1|||
155234491|NCT00646958|560295104|FG001|Overall Study|Abnormal screening lab tests|1|||
155234492|NCT00646958|560295105|FG002|Overall Study|Abnormal screening lab tests|0|||
155234493|NCT00646958|560295103|FG000|Overall Study|Withdrawal by Subject|1|||
155234494|NCT00646958|560295104|FG001|Overall Study|Withdrawal by Subject|2|||
155234495|NCT00646958|560295105|FG002|Overall Study|Withdrawal by Subject|0|||
155234496|NCT00646958|560295103|FG000|Overall Study|Did not receive study drug|2|||
155234497|NCT00646958|560295104|FG001|Overall Study|Did not receive study drug|0|||
155234498|NCT00646958|560295105|FG002|Overall Study|Did not receive study drug|2|||
155234499|NCT01607905|560295106|FG000|Overall Study|Withdrawal by participant|7|||
155234500|NCT01607905|560295107|FG001|Overall Study|Withdrawal by participant|2|||
155234501|NCT01607905|560295108|FG002|Overall Study|Withdrawal by participant|4|||
155234502|NCT01607905|560295109|FG003|Overall Study|Withdrawal by participant|6|||
155234503|NCT01607905|560295110|FG004|Overall Study|Withdrawal by participant|0|||
155234504|NCT01607905|560295111|FG005|Overall Study|Withdrawal by participant|4|||
155234505|NCT01607905|560295112|FG006|Overall Study|Withdrawal by participant|12|||
155234506|NCT01607905|560295106|FG000|Overall Study|Incidence or severity of AEs|5|||
155234507|NCT01607905|560295107|FG001|Overall Study|Incidence or severity of AEs|1|||
155234508|NCT01607905|560295108|FG002|Overall Study|Incidence or severity of AEs|1|||
155234509|NCT01607905|560295109|FG003|Overall Study|Incidence or severity of AEs|3|||
155234510|NCT01607905|560295110|FG004|Overall Study|Incidence or severity of AEs|0|||
155234511|NCT01607905|560295111|FG005|Overall Study|Incidence or severity of AEs|2|||
155234512|NCT01607905|560295112|FG006|Overall Study|Incidence or severity of AEs|8|||
155234513|NCT01607905|560295106|FG000|Overall Study|Disease progression|44|||
155234514|NCT01607905|560295107|FG001|Overall Study|Disease progression|16|||
155234515|NCT01607905|560295108|FG002|Overall Study|Disease progression|15|||
155234516|NCT01607905|560295109|FG003|Overall Study|Disease progression|11|||
155234517|NCT01607905|560295110|FG004|Overall Study|Disease progression|6|||
155234518|NCT01607905|560295111|FG005|Overall Study|Disease progression|7|||
155234519|NCT01607905|560295112|FG006|Overall Study|Disease progression|21|||
155234520|NCT01607905|560295106|FG000|Overall Study|Non-compliance with study procedures|0|||
155234521|NCT01607905|560295107|FG001|Overall Study|Non-compliance with study procedures|0|||
155234522|NCT01607905|560295108|FG002|Overall Study|Non-compliance with study procedures|0|||
155234523|NCT01607905|560295109|FG003|Overall Study|Non-compliance with study procedures|0|||
155234524|NCT01607905|560295110|FG004|Overall Study|Non-compliance with study procedures|0|||
155234525|NCT01607905|560295111|FG005|Overall Study|Non-compliance with study procedures|0|||
155234526|NCT01607905|560295112|FG006|Overall Study|Non-compliance with study procedures|1|||
155234527|NCT01607905|560295106|FG000|Overall Study|Death|1|||
155234528|NCT01607905|560295107|FG001|Overall Study|Death|1|||
155234529|NCT01607905|560295108|FG002|Overall Study|Death|1|||
155234530|NCT01607905|560295109|FG003|Overall Study|Death|1|||
155234531|NCT01607905|560295110|FG004|Overall Study|Death|0|||
155234532|NCT01607905|560295111|FG005|Overall Study|Death|0|||
155234533|NCT01607905|560295112|FG006|Overall Study|Death|3|||
155234534|NCT01607905|560295106|FG000|Overall Study|Other treatments become available|1|||
155234535|NCT01607905|560295107|FG001|Overall Study|Other treatments become available|0|||
155234536|NCT01607905|560295108|FG002|Overall Study|Other treatments become available|0|||
155234537|NCT01607905|560295109|FG003|Overall Study|Other treatments become available|0|||
155234538|NCT01607905|560295110|FG004|Overall Study|Other treatments become available|0|||
155234539|NCT01607905|560295111|FG005|Overall Study|Other treatments become available|0|||
155234540|NCT01607905|560295112|FG006|Overall Study|Other treatments become available|1|||
155234541|NCT01607905|560295106|FG000|Overall Study|Investigator discretion|0|||
155234542|NCT01607905|560295107|FG001|Overall Study|Investigator discretion|0|||
155234543|NCT01607905|560295108|FG002|Overall Study|Investigator discretion|0|||
155234544|NCT01607905|560295109|FG003|Overall Study|Investigator discretion|0|||
155234545|NCT01607905|560295110|FG004|Overall Study|Investigator discretion|0|||
155234546|NCT01607905|560295111|FG005|Overall Study|Investigator discretion|1|||
155234547|NCT01607905|560295112|FG006|Overall Study|Investigator discretion|0|||
155234548|NCT01607905|560295106|FG000|Overall Study|Other|1|||
155234549|NCT01607905|560295107|FG001|Overall Study|Other|0|||
155234550|NCT01607905|560295108|FG002|Overall Study|Other|0|||
155234551|NCT01607905|560295109|FG003|Overall Study|Other|0|||
155234552|NCT01607905|560295110|FG004|Overall Study|Other|0|||
155234553|NCT01607905|560295111|FG005|Overall Study|Other|0|||
155234554|NCT01607905|560295112|FG006|Overall Study|Other|1|||
155234555|NCT01607905|560295106|FG000|Overall Study|Randomized but not treated|1|||
155234556|NCT01607905|560295107|FG001|Overall Study|Randomized but not treated|0|||
155234557|NCT01607905|560295108|FG002|Overall Study|Randomized but not treated|0|||
155234558|NCT01607905|560295109|FG003|Overall Study|Randomized but not treated|0|||
155234559|NCT01607905|560295110|FG004|Overall Study|Randomized but not treated|1|||
155234560|NCT01607905|560295111|FG005|Overall Study|Randomized but not treated|1|||
155234561|NCT01607905|560295112|FG006|Overall Study|Randomized but not treated|0|||
155234562|NCT01310413|560295113|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
155234563|NCT01310413|560295114|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
155234564|NCT01310413|560295115|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
155234565|NCT01310413|560295116|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
155234566|NCT01310413|560295117|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
155234567|NCT01310413|560295118|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
155234568|NCT01310413|560295119|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
155234569|NCT01310413|560295113|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
155234570|NCT01310413|560295114|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
155234571|NCT01310413|560295115|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
155234572|NCT01310413|560295116|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
155234573|NCT01310413|560295117|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
155234574|NCT01310413|560295118|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
155234575|NCT01310413|560295119|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
155234576|NCT01310413|560295113|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
155234577|NCT01310413|560295114|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
155234578|NCT01310413|560295115|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
155234579|NCT01310413|560295116|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
155234580|NCT01310413|560295117|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
155234581|NCT01310413|560295118|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
155234582|NCT01310413|560295119|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
155234583|NCT01310413|560295113|FG000|Day 0 to Day 385|Other|1|||
155234584|NCT01310413|560295114|FG001|Day 0 to Day 385|Other|0|||
155234585|NCT01310413|560295115|FG002|Day 0 to Day 385|Other|3|||
155234586|NCT01310413|560295116|FG003|Day 0 to Day 385|Other|0|||
155234587|NCT01310413|560295117|FG004|Day 0 to Day 385|Other|0|||
155234588|NCT01310413|560295118|FG005|Day 0 to Day 385|Other|0|||
155234589|NCT01310413|560295119|FG006|Day 0 to Day 385|Other|0|||
155234590|NCT01310413|560295113|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234591|NCT01310413|560295114|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234592|NCT01310413|560295115|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234593|NCT01310413|560295116|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234594|NCT01310413|560295117|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234595|NCT01310413|560295118|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234596|NCT01310413|560295119|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
155234597|NCT01310413|560295113|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
155234598|NCT01310413|560295114|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
155234599|NCT01310413|560295115|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
155234600|NCT01310413|560295116|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
155234601|NCT01310413|560295117|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
155234602|NCT01310413|560295118|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
155234603|NCT01310413|560295119|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
155234604|NCT02564471|560295120|FG000|Overall Study|Adverse Event|1|||
155234605|NCT02564471|560295121|FG001|Overall Study|Adverse Event|0|||
155234606|NCT02564471|560295122|FG002|Overall Study|Adverse Event|0|||
155234607|NCT02564471|560295123|FG003|Overall Study|Adverse Event|0|||
155234608|NCT02564471|560295120|FG000|Overall Study|Withdrawal by Subject|2|||
155234609|NCT02564471|560295121|FG001|Overall Study|Withdrawal by Subject|1|||
155234610|NCT02564471|560295122|FG002|Overall Study|Withdrawal by Subject|3|||
155234611|NCT02564471|560295123|FG003|Overall Study|Withdrawal by Subject|0|||
155234612|NCT02564471|560295120|FG000|Overall Study|Lost to Follow-up|0|||
155234613|NCT02564471|560295121|FG001|Overall Study|Lost to Follow-up|2|||
155234614|NCT02564471|560295122|FG002|Overall Study|Lost to Follow-up|0|||
155234615|NCT02564471|560295123|FG003|Overall Study|Lost to Follow-up|0|||
155234616|NCT00630877|560295126|FG000|Overall Study|Adverse Event|11|||
155234617|NCT00630877|560295127|FG001|Overall Study|Adverse Event|8|||
155234618|NCT00630877|560295128|FG002|Overall Study|Adverse Event|7|||
155234619|NCT00630877|560295126|FG000|Overall Study|Withdrawal by Subject|3|||
155234620|NCT00630877|560295127|FG001|Overall Study|Withdrawal by Subject|4|||
155234621|NCT00630877|560295128|FG002|Overall Study|Withdrawal by Subject|0|||
155234622|NCT00630877|560295126|FG000|Overall Study|Lost to Follow-up|2|||
155234623|NCT00630877|560295127|FG001|Overall Study|Lost to Follow-up|0|||
155234624|NCT00630877|560295128|FG002|Overall Study|Lost to Follow-up|0|||
155234625|NCT00630877|560295126|FG000|Overall Study|Noncompliance|2|||
155234626|NCT00630877|560295127|FG001|Overall Study|Noncompliance|3|||
155234627|NCT00630877|560295128|FG002|Overall Study|Noncompliance|1|||
155234628|NCT00630877|560295126|FG000|Overall Study|Protocol violation|1|||
155234629|NCT00630877|560295127|FG001|Overall Study|Protocol violation|0|||
155234630|NCT00630877|560295128|FG002|Overall Study|Protocol violation|1|||
155234631|NCT00630877|560295126|FG000|Overall Study|Personal reasons|0|||
155234632|NCT00630877|560295127|FG001|Overall Study|Personal reasons|0|||
155234633|NCT00630877|560295128|FG002|Overall Study|Personal reasons|1|||
155234634|NCT01643473|560295129|FG000|Overall Study|Lost to Follow-up|1|||
155234635|NCT01643473|560295130|FG001|Overall Study|Lost to Follow-up|0|||
155234636|NCT02033889|560295131|FG000|Overall Study|Adverse Event|3|||
155234637|NCT02033889|560295132|FG001|Overall Study|Adverse Event|1|||
155234638|NCT02033889|560295133|FG002|Overall Study|Adverse Event|3|||
155234639|NCT02033889|560295131|FG000|Overall Study|Death|3|||
155234640|NCT02033889|560295132|FG001|Overall Study|Death|1|||
155234641|NCT02033889|560295133|FG002|Overall Study|Death|2|||
155234642|NCT02033889|560295131|FG000|Overall Study|Excluded Medication|1|||
155234643|NCT02033889|560295132|FG001|Overall Study|Excluded Medication|1|||
155234644|NCT02033889|560295133|FG002|Overall Study|Excluded Medication|0|||
155234645|NCT02033889|560295131|FG000|Overall Study|Lost to Follow-up|8|||
155234646|NCT02033889|560295132|FG001|Overall Study|Lost to Follow-up|5|||
155234647|NCT02033889|560295133|FG002|Overall Study|Lost to Follow-up|6|||
155234648|NCT02033889|560295131|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155234649|NCT02033889|560295132|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155234650|NCT02033889|560295133|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155234651|NCT02033889|560295131|FG000|Overall Study|Physician Decision|0|||
155234652|NCT02033889|560295132|FG001|Overall Study|Physician Decision|1|||
155234653|NCT02033889|560295133|FG002|Overall Study|Physician Decision|1|||
155234654|NCT02033889|560295131|FG000|Overall Study|Participant moved|0|||
155234655|NCT02033889|560295132|FG001|Overall Study|Participant moved|1|||
155234656|NCT02033889|560295133|FG002|Overall Study|Participant moved|0|||
155234657|NCT02033889|560295131|FG000|Overall Study|Withdrawal by Subject|18|||
155234658|NCT02033889|560295132|FG001|Overall Study|Withdrawal by Subject|10|||
155234659|NCT02033889|560295133|FG002|Overall Study|Withdrawal by Subject|13|||
155234660|NCT02343458|560295134|FG000|Overall Study|Adverse Event|15|||
155234661|NCT02343458|560295135|FG001|Overall Study|Adverse Event|14|||
155234662|NCT02343458|560295136|FG002|Overall Study|Adverse Event|15|||
155234663|NCT02343458|560295137|FG003|Overall Study|Adverse Event|3|||
155234664|NCT02343458|560295134|FG000|Overall Study|Lack of Efficacy|3|||
155234665|NCT02343458|560295135|FG001|Overall Study|Lack of Efficacy|8|||
155234666|NCT02343458|560295136|FG002|Overall Study|Lack of Efficacy|4|||
155234667|NCT02343458|560295137|FG003|Overall Study|Lack of Efficacy|8|||
155234668|NCT02343458|560295134|FG000|Overall Study|Withdrawal by Subject|18|||
155234669|NCT02343458|560295135|FG001|Overall Study|Withdrawal by Subject|17|||
155234670|NCT02343458|560295136|FG002|Overall Study|Withdrawal by Subject|23|||
155234671|NCT02343458|560295137|FG003|Overall Study|Withdrawal by Subject|14|||
155234672|NCT02343458|560295134|FG000|Overall Study|Physician Decision|1|||
155234673|NCT02343458|560295135|FG001|Overall Study|Physician Decision|4|||
155234674|NCT02343458|560295136|FG002|Overall Study|Physician Decision|2|||
155234675|NCT02343458|560295137|FG003|Overall Study|Physician Decision|2|||
155234676|NCT02343458|560295134|FG000|Overall Study|Lost to Follow-up|5|||
155234677|NCT02343458|560295135|FG001|Overall Study|Lost to Follow-up|5|||
155234678|NCT02343458|560295136|FG002|Overall Study|Lost to Follow-up|3|||
155234679|NCT02343458|560295137|FG003|Overall Study|Lost to Follow-up|1|||
155234680|NCT02343458|560295134|FG000|Overall Study|Protocol Violation|2|||
155234681|NCT02343458|560295135|FG001|Overall Study|Protocol Violation|5|||
155234682|NCT02343458|560295136|FG002|Overall Study|Protocol Violation|2|||
155234683|NCT02343458|560295137|FG003|Overall Study|Protocol Violation|2|||
155234684|NCT02343458|560295134|FG000|Overall Study|Protocol Specified Criteria|17|||
155234685|NCT02343458|560295135|FG001|Overall Study|Protocol Specified Criteria|13|||
155234686|NCT02343458|560295136|FG002|Overall Study|Protocol Specified Criteria|14|||
155234687|NCT02343458|560295137|FG003|Overall Study|Protocol Specified Criteria|8|||
155234688|NCT01312909|560295138|FG000|Overall Study|Randomized but not treated|1|||
155234689|NCT01312909|560295139|FG001|Overall Study|Randomized but not treated|3|||
155234690|NCT01312909|560295140|FG002|Overall Study|Randomized but not treated|1|||
155234691|NCT01312909|560295138|FG000|Overall Study|Adverse Event|1|||
155234692|NCT01312909|560295139|FG001|Overall Study|Adverse Event|0|||
155234693|NCT01312909|560295140|FG002|Overall Study|Adverse Event|3|||
155234694|NCT01312909|560295138|FG000|Overall Study|Protocol Violation|2|||
155234695|NCT01312909|560295139|FG001|Overall Study|Protocol Violation|0|||
155234696|NCT01312909|560295140|FG002|Overall Study|Protocol Violation|2|||
155234697|NCT01312909|560295138|FG000|Overall Study|Other|9|||
155234698|NCT01312909|560295139|FG001|Overall Study|Other|6|||
155234699|NCT01312909|560295140|FG002|Overall Study|Other|11|||
155234700|NCT01312909|560295138|FG000|Overall Study|Withdrawal by Subject|8|||
155234701|NCT01312909|560295139|FG001|Overall Study|Withdrawal by Subject|10|||
155234702|NCT01312909|560295140|FG002|Overall Study|Withdrawal by Subject|7|||
155234703|NCT01312909|560295138|FG000|Overall Study|Lost to Follow-up|21|||
155234704|NCT01312909|560295139|FG001|Overall Study|Lost to Follow-up|17|||
155234705|NCT01312909|560295140|FG002|Overall Study|Lost to Follow-up|20|||
155234706|NCT01312909|560295138|FG000|Overall Study|Insufficient clinical response|0|||
155234707|NCT01312909|560295139|FG001|Overall Study|Insufficient clinical response|0|||
155234708|NCT01312909|560295140|FG002|Overall Study|Insufficient clinical response|1|||
155234709|NCT01312909|560295138|FG000|Overall Study|Entrance criteria not met|0|||
155234710|NCT01312909|560295139|FG001|Overall Study|Entrance criteria not met|0|||
155234711|NCT01312909|560295140|FG002|Overall Study|Entrance criteria not met|2|||
155234712|NCT01913041|560295146|FG000|Overall Study|Protocol Violation|35|||
155234713|NCT01913041|560295146|FG000|Overall Study|Withdrawal by Subject|3|||
155234714|NCT01913041|560295146|FG000|Overall Study|Physician Decision|1|||
155234715|NCT01513317|560295147|FG000|Overall Study|Withdrawal by Subject|15|||
155234716|NCT01513317|560295148|FG001|Overall Study|Withdrawal by Subject|4|||
155234717|NCT01513317|560295147|FG000|Overall Study|Death|1|||
155234718|NCT01513317|560295148|FG001|Overall Study|Death|1|||
155234719|NCT01513317|560295147|FG000|Overall Study|Study terminated by sponsor|18|||
155234720|NCT01513317|560295148|FG001|Overall Study|Study terminated by sponsor|18|||
155234721|NCT01513317|560295147|FG000|Overall Study|Other|0|||
155234722|NCT01513317|560295148|FG001|Overall Study|Other|1|||
155234723|NCT00182689|560295149|FG000|Overall Study|Adverse Event|8|||
155234724|NCT00182689|560295150|FG001|Overall Study|Adverse Event|11|||
155234725|NCT00182689|560295149|FG000|Overall Study|Withdrawal by Subject|2|||
155234726|NCT00182689|560295150|FG001|Overall Study|Withdrawal by Subject|2|||
155234727|NCT00182689|560295149|FG000|Overall Study|Progression|27|||
155234728|NCT00182689|560295150|FG001|Overall Study|Progression|29|||
155234729|NCT00182689|560295149|FG000|Overall Study|Death|1|||
155234730|NCT00182689|560295150|FG001|Overall Study|Death|0|||
155491469|NCT00563706|561225399|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
155234731|NCT00182689|560295149|FG000|Overall Study|not protocol specified|0|||
155234732|NCT00182689|560295150|FG001|Overall Study|not protocol specified|3|||
155234733|NCT00182689|560295149|FG000|Overall Study|Ineligible|1|||
155234734|NCT00182689|560295150|FG001|Overall Study|Ineligible|4|||
155234735|NCT00182689|560295149|FG000|Overall Study|Never received treatment|1|||
155234736|NCT00182689|560295150|FG001|Overall Study|Never received treatment|0|||
155234737|NCT02564198|560295151|FG000|Overall Study|Withdrawal by Subject|2|||
155234738|NCT02564198|560295152|FG001|Overall Study|Withdrawal by Subject|4|||
155234739|NCT02564198|560295153|FG002|Overall Study|Withdrawal by Subject|0|||
155234740|NCT02564198|560295151|FG000|Overall Study|Adverse Event|0|||
155234741|NCT02564198|560295152|FG001|Overall Study|Adverse Event|1|||
155234742|NCT02564198|560295153|FG002|Overall Study|Adverse Event|0|||
155234743|NCT01640301|560295154|FG000|Overall Study|Death|0|||
155234744|NCT01640301|560295155|FG001|Overall Study|Death|8|||
155234745|NCT02200042|560295158|FG000|Overall Study|Withdrawal by Subject|0|||
155234746|NCT02200042|560295159|FG001|Overall Study|Withdrawal by Subject|1|||
155234747|NCT01969838|560295160|FG000|Double-blind Phase|Adverse Event|10|||
155234748|NCT01969838|560295161|FG001|Double-blind Phase|Adverse Event|4|||
155234749|NCT01969838|560295162|FG002|Double-blind Phase|Adverse Event|0|||
155234750|NCT01969838|560295163|FG003|Double-blind Phase|Adverse Event|0|||
155234751|NCT01969838|560295160|FG000|Double-blind Phase|Death|5|||
155234752|NCT01969838|560295161|FG001|Double-blind Phase|Death|2|||
155234753|NCT01969838|560295162|FG002|Double-blind Phase|Death|0|||
155234754|NCT01969838|560295163|FG003|Double-blind Phase|Death|0|||
155234755|NCT01969838|560295160|FG000|Double-blind Phase|Physician Decision|5|||
155234756|NCT01969838|560295161|FG001|Double-blind Phase|Physician Decision|1|||
155234757|NCT01969838|560295162|FG002|Double-blind Phase|Physician Decision|0|||
155234758|NCT01969838|560295163|FG003|Double-blind Phase|Physician Decision|0|||
155234759|NCT01969838|560295160|FG000|Double-blind Phase|Subject Decision|4|||
155234760|NCT01969838|560295161|FG001|Double-blind Phase|Subject Decision|2|||
155234761|NCT01969838|560295162|FG002|Double-blind Phase|Subject Decision|0|||
155234762|NCT01969838|560295163|FG003|Double-blind Phase|Subject Decision|0|||
155234763|NCT01969838|560295160|FG000|Double-blind Phase|Disease Progression|2|||
155234764|NCT01969838|560295161|FG001|Double-blind Phase|Disease Progression|0|||
155234765|NCT01969838|560295162|FG002|Double-blind Phase|Disease Progression|0|||
155234766|NCT01969838|560295163|FG003|Double-blind Phase|Disease Progression|0|||
155234767|NCT01969838|560295160|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
155234768|NCT01969838|560295161|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234769|NCT01969838|560295162|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234770|NCT01969838|560295163|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234771|NCT01969838|560295160|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
155234772|NCT01969838|560295161|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
155234773|NCT01969838|560295162|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
155234774|NCT01969838|560295163|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
155234775|NCT01969838|560295160|FG000|Open-label Phase|Adverse Event|0|||
155234776|NCT01969838|560295161|FG001|Open-label Phase|Adverse Event|0|||
155234777|NCT01969838|560295162|FG002|Open-label Phase|Adverse Event|37|||
155234778|NCT01969838|560295163|FG003|Open-label Phase|Adverse Event|49|||
155234779|NCT01969838|560295160|FG000|Open-label Phase|Disease Progression|0|||
155234780|NCT01969838|560295161|FG001|Open-label Phase|Disease Progression|0|||
155234781|NCT01969838|560295162|FG002|Open-label Phase|Disease Progression|26|||
155234782|NCT01969838|560295163|FG003|Open-label Phase|Disease Progression|27|||
155234783|NCT01969838|560295160|FG000|Open-label Phase|Lack of Efficacy|0|||
155234784|NCT01969838|560295161|FG001|Open-label Phase|Lack of Efficacy|0|||
155234785|NCT01969838|560295162|FG002|Open-label Phase|Lack of Efficacy|17|||
155234786|NCT01969838|560295163|FG003|Open-label Phase|Lack of Efficacy|19|||
155234787|NCT01969838|560295160|FG000|Open-label Phase|Subject Decision|0|||
155234788|NCT01969838|560295161|FG001|Open-label Phase|Subject Decision|0|||
155234789|NCT01969838|560295162|FG002|Open-label Phase|Subject Decision|14|||
155234790|NCT01969838|560295163|FG003|Open-label Phase|Subject Decision|15|||
155234791|NCT01969838|560295160|FG000|Open-label Phase|Death|0|||
155234792|NCT01969838|560295161|FG001|Open-label Phase|Death|0|||
155234793|NCT01969838|560295162|FG002|Open-label Phase|Death|13|||
155234794|NCT01969838|560295163|FG003|Open-label Phase|Death|11|||
155234795|NCT01969838|560295160|FG000|Open-label Phase|Physician Decision|0|||
155234796|NCT01969838|560295161|FG001|Open-label Phase|Physician Decision|0|||
155234797|NCT01969838|560295162|FG002|Open-label Phase|Physician Decision|9|||
155234798|NCT01969838|560295163|FG003|Open-label Phase|Physician Decision|14|||
155234799|NCT01969838|560295160|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
155234800|NCT01969838|560295161|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
155234801|NCT01969838|560295162|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
155234802|NCT01969838|560295163|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
155234803|NCT00408993|560295164|FG000|Overall Study|Adverse Event|15|||
155234804|NCT00408993|560295165|FG001|Overall Study|Adverse Event|4|||
155234805|NCT00408993|560295164|FG000|Overall Study|Protocol Violation|1|||
155234806|NCT00408993|560295165|FG001|Overall Study|Protocol Violation|6|||
155234807|NCT00408993|560295164|FG000|Overall Study|Lack of Efficacy|1|||
155234808|NCT00408993|560295165|FG001|Overall Study|Lack of Efficacy|4|||
155234809|NCT00408993|560295164|FG000|Overall Study|Withdrawal by Subject|2|||
155234810|NCT00408993|560295165|FG001|Overall Study|Withdrawal by Subject|3|||
155234811|NCT02880371|560295166|FG000|Phase 1b|Lost to Follow-up|1|||
155234812|NCT02880371|560295167|FG001|Phase 1b|Lost to Follow-up|0|||
155234813|NCT02880371|560295168|FG002|Phase 1b|Lost to Follow-up|0|||
155234814|NCT02880371|560295169|FG003|Phase 1b|Lost to Follow-up|0|||
155234815|NCT02880371|560295170|FG004|Phase 1b|Lost to Follow-up|0|||
155234816|NCT02880371|560295171|FG005|Phase 1b|Lost to Follow-up|0|||
155234817|NCT02880371|560295172|FG006|Phase 1b|Lost to Follow-up|0|||
155234818|NCT02880371|560295173|FG007|Phase 1b|Lost to Follow-up|0|||
155234819|NCT02880371|560295166|FG000|Phase 1b|Participants terminated by Sponsor|1|||
155234820|NCT02880371|560295167|FG001|Phase 1b|Participants terminated by Sponsor|0|||
155234821|NCT02880371|560295168|FG002|Phase 1b|Participants terminated by Sponsor|0|||
155234822|NCT02880371|560295169|FG003|Phase 1b|Participants terminated by Sponsor|0|||
155234823|NCT02880371|560295170|FG004|Phase 1b|Participants terminated by Sponsor|0|||
155234824|NCT02880371|560295171|FG005|Phase 1b|Participants terminated by Sponsor|0|||
155234825|NCT02880371|560295172|FG006|Phase 1b|Participants terminated by Sponsor|0|||
155234826|NCT02880371|560295173|FG007|Phase 1b|Participants terminated by Sponsor|0|||
155234827|NCT02880371|560295166|FG000|Phase 1b|Withdrawal by Subject|0|||
155234828|NCT02880371|560295167|FG001|Phase 1b|Withdrawal by Subject|0|||
155234829|NCT02880371|560295168|FG002|Phase 1b|Withdrawal by Subject|1|||
155234830|NCT02880371|560295169|FG003|Phase 1b|Withdrawal by Subject|0|||
155234831|NCT02880371|560295170|FG004|Phase 1b|Withdrawal by Subject|0|||
155234832|NCT02880371|560295171|FG005|Phase 1b|Withdrawal by Subject|0|||
155234833|NCT02880371|560295172|FG006|Phase 1b|Withdrawal by Subject|0|||
155234834|NCT02880371|560295173|FG007|Phase 1b|Withdrawal by Subject|0|||
155234835|NCT02880371|560295166|FG000|Phase 1b|Death|4|||
155234836|NCT02880371|560295167|FG001|Phase 1b|Death|6|||
155234837|NCT02880371|560295168|FG002|Phase 1b|Death|5|||
155234838|NCT02880371|560295169|FG003|Phase 1b|Death|1|||
155234839|NCT02880371|560295170|FG004|Phase 1b|Death|0|||
155234840|NCT02880371|560295171|FG005|Phase 1b|Death|0|||
155234841|NCT02880371|560295172|FG006|Phase 1b|Death|0|||
155234842|NCT02880371|560295173|FG007|Phase 1b|Death|0|||
155234843|NCT02880371|560295166|FG000|Phase 1b|Enrolled but not Treated|0|||
155234844|NCT02880371|560295167|FG001|Phase 1b|Enrolled but not Treated|1|||
155234845|NCT02880371|560295168|FG002|Phase 1b|Enrolled but not Treated|0|||
155234846|NCT02880371|560295169|FG003|Phase 1b|Enrolled but not Treated|0|||
155234847|NCT02880371|560295170|FG004|Phase 1b|Enrolled but not Treated|0|||
155234848|NCT02880371|560295171|FG005|Phase 1b|Enrolled but not Treated|0|||
155234849|NCT02880371|560295172|FG006|Phase 1b|Enrolled but not Treated|0|||
155234850|NCT02880371|560295173|FG007|Phase 1b|Enrolled but not Treated|0|||
155234851|NCT02880371|560295166|FG000|Phase 2|Enrolled but not Treated|0|||
155234852|NCT02880371|560295167|FG001|Phase 2|Enrolled but not Treated|0|||
155234853|NCT02880371|560295168|FG002|Phase 2|Enrolled but not Treated|0|||
155234854|NCT02880371|560295169|FG003|Phase 2|Enrolled but not Treated|0|||
155234855|NCT02880371|560295170|FG004|Phase 2|Enrolled but not Treated|0|||
155234856|NCT02880371|560295171|FG005|Phase 2|Enrolled but not Treated|1|||
155234857|NCT02880371|560295172|FG006|Phase 2|Enrolled but not Treated|1|||
155234858|NCT02880371|560295173|FG007|Phase 2|Enrolled but not Treated|0|||
155234859|NCT02880371|560295166|FG000|Phase 2|Other|0|||
155234860|NCT02880371|560295167|FG001|Phase 2|Other|0|||
155234861|NCT02880371|560295168|FG002|Phase 2|Other|0|||
155234862|NCT02880371|560295169|FG003|Phase 2|Other|0|||
155234863|NCT02880371|560295170|FG004|Phase 2|Other|0|||
155234864|NCT02880371|560295171|FG005|Phase 2|Other|1|||
155234865|NCT02880371|560295172|FG006|Phase 2|Other|2|||
155234866|NCT02880371|560295173|FG007|Phase 2|Other|1|||
155234867|NCT02880371|560295166|FG000|Phase 2|Participants terminated by Sponsor|0|||
155234868|NCT02880371|560295167|FG001|Phase 2|Participants terminated by Sponsor|0|||
155234869|NCT02880371|560295168|FG002|Phase 2|Participants terminated by Sponsor|0|||
155234870|NCT02880371|560295169|FG003|Phase 2|Participants terminated by Sponsor|0|||
155234871|NCT02880371|560295170|FG004|Phase 2|Participants terminated by Sponsor|1|||
155234872|NCT02880371|560295171|FG005|Phase 2|Participants terminated by Sponsor|6|||
155234873|NCT02880371|560295172|FG006|Phase 2|Participants terminated by Sponsor|1|||
155234874|NCT02880371|560295173|FG007|Phase 2|Participants terminated by Sponsor|5|||
155234875|NCT02880371|560295166|FG000|Phase 2|Death|0|||
155234876|NCT02880371|560295167|FG001|Phase 2|Death|0|||
155234877|NCT02880371|560295168|FG002|Phase 2|Death|0|||
155234878|NCT02880371|560295169|FG003|Phase 2|Death|0|||
155234879|NCT02880371|560295170|FG004|Phase 2|Death|1|||
155234880|NCT02880371|560295171|FG005|Phase 2|Death|10|||
155234881|NCT02880371|560295172|FG006|Phase 2|Death|20|||
155234882|NCT02880371|560295173|FG007|Phase 2|Death|5|||
155234883|NCT02880371|560295166|FG000|Phase 2|Lost to Follow-up|0|||
155234884|NCT02880371|560295167|FG001|Phase 2|Lost to Follow-up|0|||
155234885|NCT02880371|560295168|FG002|Phase 2|Lost to Follow-up|0|||
155234886|NCT02880371|560295169|FG003|Phase 2|Lost to Follow-up|0|||
155234887|NCT02880371|560295170|FG004|Phase 2|Lost to Follow-up|0|||
155234888|NCT02880371|560295171|FG005|Phase 2|Lost to Follow-up|0|||
155234889|NCT02880371|560295172|FG006|Phase 2|Lost to Follow-up|3|||
155234890|NCT02880371|560295173|FG007|Phase 2|Lost to Follow-up|0|||
155234891|NCT02880371|560295166|FG000|Phase 2|Withdrawal by Subject|0|||
155234892|NCT02880371|560295167|FG001|Phase 2|Withdrawal by Subject|0|||
155234893|NCT02880371|560295168|FG002|Phase 2|Withdrawal by Subject|0|||
155234894|NCT02880371|560295169|FG003|Phase 2|Withdrawal by Subject|0|||
155234895|NCT02880371|560295170|FG004|Phase 2|Withdrawal by Subject|0|||
155234896|NCT02880371|560295171|FG005|Phase 2|Withdrawal by Subject|1|||
155234897|NCT02880371|560295172|FG006|Phase 2|Withdrawal by Subject|1|||
155234898|NCT02880371|560295173|FG007|Phase 2|Withdrawal by Subject|0|||
155234899|NCT02880371|560295166|FG000|Phase 2|End of Study page not completed by error|0|||
155234900|NCT02880371|560295167|FG001|Phase 2|End of Study page not completed by error|0|||
155234901|NCT02880371|560295168|FG002|Phase 2|End of Study page not completed by error|0|||
155234902|NCT02880371|560295169|FG003|Phase 2|End of Study page not completed by error|0|||
155234903|NCT02880371|560295170|FG004|Phase 2|End of Study page not completed by error|0|||
155234904|NCT02880371|560295171|FG005|Phase 2|End of Study page not completed by error|1|||
155234905|NCT02880371|560295172|FG006|Phase 2|End of Study page not completed by error|0|||
155234906|NCT02880371|560295173|FG007|Phase 2|End of Study page not completed by error|0|||
155234907|NCT01777997|560295176|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
155234908|NCT01777997|560295176|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
155234909|NCT01777997|560295176|FG000|Weeks 48 to 72/96 on ART|Death|1|||
155234910|NCT01777997|560295176|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
155234911|NCT01694706|560295177|FG000|Overall Study|Adverse Event|0|||
155234912|NCT01694706|560295178|FG001|Overall Study|Adverse Event|1|||
155234913|NCT01694706|560295179|FG002|Overall Study|Adverse Event|0|||
155234914|NCT01694706|560295177|FG000|Overall Study|other reason not defined above|1|||
155234915|NCT01694706|560295178|FG001|Overall Study|other reason not defined above|0|||
155234916|NCT01694706|560295179|FG002|Overall Study|other reason not defined above|0|||
155234917|NCT01923181|560295180|FG000|Overall Study|Protocol Violation|2|||
155234918|NCT01923181|560295181|FG001|Overall Study|Protocol Violation|2|||
155234919|NCT01923181|560295182|FG002|Overall Study|Protocol Violation|0|||
155234920|NCT01923181|560295183|FG003|Overall Study|Protocol Violation|2|||
155234921|NCT01923181|560295184|FG004|Overall Study|Protocol Violation|2|||
155234922|NCT01923181|560295185|FG005|Overall Study|Protocol Violation|1|||
155234923|NCT01923181|560295186|FG006|Overall Study|Protocol Violation|1|||
155234924|NCT01923181|560295187|FG007|Overall Study|Protocol Violation|2|||
155234925|NCT01923181|560295188|FG008|Overall Study|Protocol Violation|1|||
155234926|NCT01923181|560295180|FG000|Overall Study|Withdrawal by Subject|0|||
155234927|NCT01923181|560295181|FG001|Overall Study|Withdrawal by Subject|1|||
155234928|NCT01923181|560295182|FG002|Overall Study|Withdrawal by Subject|0|||
155234929|NCT01923181|560295183|FG003|Overall Study|Withdrawal by Subject|1|||
155234930|NCT01923181|560295184|FG004|Overall Study|Withdrawal by Subject|4|||
155234931|NCT01923181|560295185|FG005|Overall Study|Withdrawal by Subject|2|||
155234932|NCT01923181|560295186|FG006|Overall Study|Withdrawal by Subject|4|||
155234933|NCT01923181|560295187|FG007|Overall Study|Withdrawal by Subject|3|||
155234934|NCT01923181|560295188|FG008|Overall Study|Withdrawal by Subject|1|||
155234935|NCT01923181|560295180|FG000|Overall Study|Other|1|||
155234936|NCT01923181|560295181|FG001|Overall Study|Other|0|||
155234937|NCT01923181|560295182|FG002|Overall Study|Other|0|||
155234938|NCT01923181|560295183|FG003|Overall Study|Other|1|||
155234939|NCT01923181|560295184|FG004|Overall Study|Other|0|||
155234940|NCT01923181|560295185|FG005|Overall Study|Other|0|||
155234941|NCT01923181|560295186|FG006|Overall Study|Other|0|||
155234942|NCT01923181|560295187|FG007|Overall Study|Other|0|||
155234943|NCT01923181|560295188|FG008|Overall Study|Other|0|||
155234944|NCT01923181|560295180|FG000|Overall Study|Lost to Follow-up|0|||
155234945|NCT01923181|560295181|FG001|Overall Study|Lost to Follow-up|3|||
155234946|NCT01923181|560295182|FG002|Overall Study|Lost to Follow-up|2|||
155234947|NCT01923181|560295183|FG003|Overall Study|Lost to Follow-up|1|||
155234948|NCT01923181|560295184|FG004|Overall Study|Lost to Follow-up|2|||
155234949|NCT01923181|560295185|FG005|Overall Study|Lost to Follow-up|1|||
155234950|NCT01923181|560295186|FG006|Overall Study|Lost to Follow-up|3|||
155234951|NCT01923181|560295187|FG007|Overall Study|Lost to Follow-up|3|||
155234952|NCT01923181|560295188|FG008|Overall Study|Lost to Follow-up|1|||
155234953|NCT02944578|560295189|FG000|Overall Study|Physician Decision|1|||
155234954|NCT02944578|560295190|FG001|Overall Study|Physician Decision|0|||
155234955|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155234956|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
155234957|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
155234958|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
155234959|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
155234960|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
155234961|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155234962|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
155234963|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155234964|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155234965|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
155234966|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155234967|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
155234968|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
155234969|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
155234970|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
155234971|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
155234972|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
155234973|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
155234974|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
155234975|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
155234976|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
155234977|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
155234978|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
155234979|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Other|0|||
155234980|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Other|0|||
155234981|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Other|5|||
155234982|NCT03394391|560295195|FG000|Overall Study|Lost to Follow-up|1|||
155234983|NCT03394391|560295196|FG001|Overall Study|Lost to Follow-up|2|||
155234984|NCT02932891|560295197|FG000|Overall Study|Lost to Follow-up|2|||
155234985|NCT02932891|560295197|FG000|Overall Study|HPA Suppress|2|||
155234986|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234987|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
155234988|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234989|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234990|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234991|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234992|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
155234993|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
155234994|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
155234995|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234996|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234997|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234998|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
155234999|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235000|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235001|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235002|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235003|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235004|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235005|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
155235006|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
155235007|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235008|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235009|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235010|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235011|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235012|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235013|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
155235014|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235015|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235016|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235017|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235018|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235019|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
155235020|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235021|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
155235022|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235023|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235024|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235025|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
155235026|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235027|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235028|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235029|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235030|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235031|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
155235032|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235033|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235034|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235035|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235036|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235037|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
155235038|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
155235039|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
155235040|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235041|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235042|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235043|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
155235044|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
155235045|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
155235046|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
155235047|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
155235048|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
155235049|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
155235050|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
155235051|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
155235052|NCT00451282|560295208|FG000|Overall Study|Lost to Follow-up|6|||
155235053|NCT00451282|560295209|FG001|Overall Study|Lost to Follow-up|5|||
155235054|NCT00098839|560295210|FG000|Overall Study|Adverse Event|5|||
155235055|NCT00098839|560295211|FG001|Overall Study|Adverse Event|2|||
155235056|NCT00098839|560295210|FG000|Overall Study|Death|1|||
155235057|NCT00098839|560295211|FG001|Overall Study|Death|2|||
155235058|NCT00098839|560295210|FG000|Overall Study|Physician Decision|4|||
155235059|NCT00098839|560295211|FG001|Overall Study|Physician Decision|14|||
155235060|NCT00098839|560295210|FG000|Overall Study|Withdrawal by Subject|1|||
155235061|NCT00098839|560295211|FG001|Overall Study|Withdrawal by Subject|0|||
155235062|NCT00098839|560295210|FG000|Overall Study|Refusal of further protocol therapy|3|||
155235063|NCT00098839|560295211|FG001|Overall Study|Refusal of further protocol therapy|1|||
155235064|NCT00098839|560295210|FG000|Overall Study|Relapse|6|||
155235065|NCT00098839|560295211|FG001|Overall Study|Relapse|3|||
155235066|NCT00098839|560295210|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
155235067|NCT00098839|560295211|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
155235068|NCT00098839|560295210|FG000|Overall Study|Ineligible|2|||
155235069|NCT00098839|560295211|FG001|Overall Study|Ineligible|0|||
155235070|NCT00577122|560295212|FG000|Overall Study|Adverse Event|0|||
155235071|NCT00577122|560295213|FG001|Overall Study|Adverse Event|2|||
155235072|NCT00577122|560295212|FG000|Overall Study|Progression, relapse during active trt|6|||
155235073|NCT00577122|560295213|FG001|Overall Study|Progression, relapse during active trt|8|||
155235074|NCT00577122|560295212|FG000|Overall Study|Prog, refract disease during active trt|8|||
155235075|NCT00577122|560295213|FG001|Overall Study|Prog, refract disease during active trt|5|||
155235076|NCT00577122|560295212|FG000|Overall Study|Alternative Therapy|0|||
155235077|NCT00577122|560295213|FG001|Overall Study|Alternative Therapy|1|||
155235078|NCT00456092|560295216|FG000|Extension Phase|Grade 2 or Greater AE|2|||
155235079|NCT00456092|560295217|FG001|Extension Phase|Grade 2 or Greater AE|2|||
155235080|NCT00456092|560295218|FG002|Extension Phase|Grade 2 or Greater AE|0|||
155235081|NCT00456092|560295219|FG003|Extension Phase|Grade 2 or Greater AE|0|||
155235082|NCT00456092|560295220|FG004|Extension Phase|Grade 2 or Greater AE|2|||
155235083|NCT00456092|560295216|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
155235084|NCT00456092|560295217|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235085|NCT00456092|560295218|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235086|NCT00456092|560295219|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235087|NCT00456092|560295220|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
155235088|NCT00456092|560295216|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
155235089|NCT00456092|560295217|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
155235090|NCT00456092|560295218|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
155235091|NCT00456092|560295219|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
155235092|NCT00456092|560295220|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
155235093|NCT00456092|560295216|FG000|Extension Phase|Withdrew Consent|2|||
155235094|NCT00456092|560295217|FG001|Extension Phase|Withdrew Consent|0|||
155235095|NCT00456092|560295218|FG002|Extension Phase|Withdrew Consent|0|||
155235096|NCT00456092|560295219|FG003|Extension Phase|Withdrew Consent|0|||
155235097|NCT00456092|560295220|FG004|Extension Phase|Withdrew Consent|0|||
155235098|NCT00456092|560295216|FG000|Extension Phase|Lost to Follow-up|1|||
155235099|NCT00456092|560295217|FG001|Extension Phase|Lost to Follow-up|1|||
155235100|NCT00456092|560295218|FG002|Extension Phase|Lost to Follow-up|0|||
155235101|NCT00456092|560295219|FG003|Extension Phase|Lost to Follow-up|0|||
155235102|NCT00456092|560295220|FG004|Extension Phase|Lost to Follow-up|1|||
155235103|NCT00456092|560295216|FG000|Extension Phase|Other|2|||
155235104|NCT00456092|560295217|FG001|Extension Phase|Other|0|||
155235105|NCT00456092|560295218|FG002|Extension Phase|Other|0|||
155235106|NCT00456092|560295219|FG003|Extension Phase|Other|1|||
155235107|NCT00456092|560295220|FG004|Extension Phase|Other|1|||
155235108|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
155235109|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
155235110|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
155235111|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
155235112|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
155235113|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
155235114|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
155235115|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235116|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235117|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235118|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
155235119|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235120|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235121|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235122|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235123|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235124|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
155235125|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
155235126|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235127|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235128|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235129|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
155235130|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
155235131|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235132|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235133|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235134|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
155235135|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
155235136|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235137|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235138|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235139|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
155235140|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
155235141|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235142|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235143|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235144|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155235145|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155235146|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235147|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235148|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Other|1|||
155235149|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Other|0|||
155235150|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Other|1|||
155235151|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Other|0|||
155235152|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Other|0|||
155235153|NCT03228680|560295221|FG000|Overall Study|Adverse Event|13|||
155235154|NCT03228680|560295222|FG001|Overall Study|Adverse Event|18|||
155235155|NCT03228680|560295221|FG000|Overall Study|Randomization failure|0|||
155235156|NCT03228680|560295222|FG001|Overall Study|Randomization failure|1|||
155235157|NCT03228680|560295221|FG000|Overall Study|Withdrawal by Subject|1|||
155235158|NCT03228680|560295222|FG001|Overall Study|Withdrawal by Subject|0|||
155235159|NCT03228680|560295221|FG000|Overall Study|Other|9|||
155235160|NCT03228680|560295222|FG001|Overall Study|Other|16|||
155235161|NCT02039427|560295230|FG000|Overall Study|Duration of surgery > 3h|1|||
155235162|NCT02039427|560295231|FG001|Overall Study|Duration of surgery > 3h|1|||
155235163|NCT02039427|560295232|FG002|Overall Study|Duration of surgery > 3h|0|||
155235164|NCT02039427|560295233|FG003|Overall Study|Duration of surgery > 3h|0|||
155235165|NCT02039427|560295230|FG000|Overall Study|Withdrawal on concent|0|||
155235166|NCT02039427|560295231|FG001|Overall Study|Withdrawal on concent|0|||
155235167|NCT02039427|560295232|FG002|Overall Study|Withdrawal on concent|0|||
155235168|NCT02039427|560295233|FG003|Overall Study|Withdrawal on concent|1|||
155235169|NCT02039427|560295230|FG000|Overall Study|Cancellation of surgery|0|||
155235170|NCT02039427|560295231|FG001|Overall Study|Cancellation of surgery|0|||
155235171|NCT02039427|560295232|FG002|Overall Study|Cancellation of surgery|1|||
155235172|NCT02039427|560295233|FG003|Overall Study|Cancellation of surgery|0|||
155235173|NCT02039427|560295230|FG000|Overall Study|Loss of follow - up|1|||
155235174|NCT02039427|560295231|FG001|Overall Study|Loss of follow - up|0|||
155235175|NCT02039427|560295232|FG002|Overall Study|Loss of follow - up|2|||
155235176|NCT02039427|560295233|FG003|Overall Study|Loss of follow - up|4|||
155235177|NCT02039427|560295230|FG000|Overall Study|Steroid Use|1|||
155235178|NCT02039427|560295231|FG001|Overall Study|Steroid Use|0|||
155235179|NCT02039427|560295232|FG002|Overall Study|Steroid Use|0|||
155235180|NCT02039427|560295233|FG003|Overall Study|Steroid Use|0|||
155235181|NCT00087568|560295237|FG000|Overall Study|Adverse Event|4|||
155235182|NCT00087568|560295238|FG001|Overall Study|Adverse Event|0|||
155235183|NCT00087568|560295237|FG000|Overall Study|Withdrawal by Subject|1|||
155235184|NCT00087568|560295238|FG001|Overall Study|Withdrawal by Subject|1|||
155235185|NCT00087568|560295237|FG000|Overall Study|Lost to Follow-up|1|||
155235186|NCT00087568|560295238|FG001|Overall Study|Lost to Follow-up|0|||
155235187|NCT00087568|560295237|FG000|Overall Study|Lack of Efficacy|24|||
155235188|NCT00087568|560295238|FG001|Overall Study|Lack of Efficacy|1|||
155235189|NCT00226941|560295239|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
155235190|NCT00226941|560295240|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
155235191|NCT00226941|560295241|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
155235192|NCT00226941|560295242|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
155235193|NCT00226941|560295239|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235194|NCT00226941|560295240|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235195|NCT00226941|560295241|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235196|NCT00226941|560295242|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
155235197|NCT01513291|560295243|FG000|Treatment Period|Adverse Event|8|||
155235198|NCT01513291|560295244|FG001|Treatment Period|Adverse Event|4|||
155235199|NCT01513291|560295245|FG002|Treatment Period|Adverse Event|0|||
155235200|NCT01513291|560295246|FG003|Treatment Period|Adverse Event|0|||
155235201|NCT01513291|560295247|FG004|Treatment Period|Adverse Event|0|||
155235202|NCT01513291|560295243|FG000|Treatment Period|Lack of Efficacy|3|||
155235203|NCT01513291|560295244|FG001|Treatment Period|Lack of Efficacy|0|||
155235204|NCT01513291|560295245|FG002|Treatment Period|Lack of Efficacy|0|||
155235205|NCT01513291|560295246|FG003|Treatment Period|Lack of Efficacy|0|||
155235206|NCT01513291|560295247|FG004|Treatment Period|Lack of Efficacy|0|||
155235207|NCT01513291|560295243|FG000|Treatment Period|Lost to Follow-up|2|||
155235208|NCT01513291|560295244|FG001|Treatment Period|Lost to Follow-up|3|||
155235209|NCT01513291|560295245|FG002|Treatment Period|Lost to Follow-up|0|||
155235210|NCT01513291|560295246|FG003|Treatment Period|Lost to Follow-up|0|||
155235211|NCT01513291|560295247|FG004|Treatment Period|Lost to Follow-up|0|||
155235212|NCT01513291|560295243|FG000|Treatment Period|Physician Decision|1|||
155235213|NCT01513291|560295244|FG001|Treatment Period|Physician Decision|0|||
155235214|NCT01513291|560295245|FG002|Treatment Period|Physician Decision|0|||
155235215|NCT01513291|560295246|FG003|Treatment Period|Physician Decision|0|||
155235216|NCT01513291|560295247|FG004|Treatment Period|Physician Decision|0|||
155235217|NCT01513291|560295243|FG000|Treatment Period|Protocol Violation|1|||
155235218|NCT01513291|560295244|FG001|Treatment Period|Protocol Violation|2|||
155235219|NCT01513291|560295245|FG002|Treatment Period|Protocol Violation|0|||
155235220|NCT01513291|560295246|FG003|Treatment Period|Protocol Violation|0|||
155235221|NCT01513291|560295247|FG004|Treatment Period|Protocol Violation|0|||
155235222|NCT01513291|560295243|FG000|Treatment Period|Withdrawal by Subject|8|||
155235223|NCT01513291|560295244|FG001|Treatment Period|Withdrawal by Subject|5|||
155235224|NCT01513291|560295245|FG002|Treatment Period|Withdrawal by Subject|0|||
155235225|NCT01513291|560295246|FG003|Treatment Period|Withdrawal by Subject|0|||
155235226|NCT01513291|560295247|FG004|Treatment Period|Withdrawal by Subject|0|||
155235227|NCT01513291|560295243|FG000|Treatment Period|Randomized not treated|0|||
155235228|NCT01513291|560295244|FG001|Treatment Period|Randomized not treated|2|||
155235229|NCT01513291|560295245|FG002|Treatment Period|Randomized not treated|0|||
155235230|NCT01513291|560295246|FG003|Treatment Period|Randomized not treated|0|||
155235231|NCT01513291|560295247|FG004|Treatment Period|Randomized not treated|0|||
155235232|NCT01513291|560295243|FG000|Run-out Period|Lost to Follow-up|0|||
155235233|NCT01513291|560295244|FG001|Run-out Period|Lost to Follow-up|0|||
155235234|NCT01513291|560295245|FG002|Run-out Period|Lost to Follow-up|0|||
155235235|NCT01513291|560295246|FG003|Run-out Period|Lost to Follow-up|1|||
155235236|NCT01513291|560295247|FG004|Run-out Period|Lost to Follow-up|0|||
155235237|NCT01513291|560295243|FG000|Run-out Period|Withdrawal by Subject|0|||
155235238|NCT01513291|560295244|FG001|Run-out Period|Withdrawal by Subject|0|||
155235239|NCT01513291|560295245|FG002|Run-out Period|Withdrawal by Subject|0|||
155235240|NCT01513291|560295246|FG003|Run-out Period|Withdrawal by Subject|1|||
155235241|NCT01513291|560295247|FG004|Run-out Period|Withdrawal by Subject|0|||
155235242|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
155235243|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
155235244|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
155235245|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
155235246|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
155235247|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
155235248|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
155235249|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
155235250|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
155235251|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
155235252|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
155235253|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
155235254|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
155235255|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
155235256|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
155235257|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
155235258|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
155235259|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
155235260|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
155235261|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
155235262|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
155235263|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
155235264|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
155235265|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
155235266|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
155235267|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
155235268|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
155235269|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
155235270|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
155235271|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
155235272|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
155235273|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
155235274|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
155235275|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
155235276|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
155235277|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
155235278|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
155235279|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
155235280|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
155235281|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
155235282|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
155235283|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
155235284|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
155235285|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
155235286|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
155235287|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
155235288|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
155235289|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
155235290|NCT03728582|560295254|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
155235291|NCT03728582|560295255|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
155235292|NCT03728582|560295254|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
155235293|NCT03728582|560295255|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
155235294|NCT02992899|560295256|FG000|Overall Study|Withdrawal by Subject|1|||
155235295|NCT02992899|560295257|FG001|Overall Study|Withdrawal by Subject|0|||
155235296|NCT02992899|560295256|FG000|Overall Study|Lost to Follow-up|1|||
155235297|NCT02992899|560295257|FG001|Overall Study|Lost to Follow-up|3|||
155235298|NCT01332305|560295260|FG000|Overall Study|Adverse Event|1|||
155235299|NCT01332305|560295261|FG001|Overall Study|Adverse Event|4|||
155235300|NCT01332305|560295262|FG002|Overall Study|Adverse Event|6|||
155235301|NCT01332305|560295263|FG003|Overall Study|Adverse Event|3|||
155235302|NCT01332305|560295264|FG004|Overall Study|Adverse Event|5|||
155235303|NCT01332305|560295260|FG000|Overall Study|Withdrawal by Subject|6|||
155235304|NCT01332305|560295261|FG001|Overall Study|Withdrawal by Subject|5|||
155235305|NCT01332305|560295262|FG002|Overall Study|Withdrawal by Subject|4|||
155235306|NCT01332305|560295263|FG003|Overall Study|Withdrawal by Subject|1|||
155235307|NCT01332305|560295264|FG004|Overall Study|Withdrawal by Subject|0|||
155235308|NCT01332305|560295260|FG000|Overall Study|Lost to Follow-up|0|||
155235309|NCT01332305|560295261|FG001|Overall Study|Lost to Follow-up|2|||
155235310|NCT01332305|560295262|FG002|Overall Study|Lost to Follow-up|3|||
155235311|NCT01332305|560295263|FG003|Overall Study|Lost to Follow-up|2|||
155235312|NCT01332305|560295264|FG004|Overall Study|Lost to Follow-up|3|||
155235313|NCT01332305|560295260|FG000|Overall Study|Protocol Violation|1|||
155235314|NCT01332305|560295261|FG001|Overall Study|Protocol Violation|2|||
155235315|NCT01332305|560295262|FG002|Overall Study|Protocol Violation|1|||
155235316|NCT01332305|560295263|FG003|Overall Study|Protocol Violation|0|||
155235317|NCT01332305|560295264|FG004|Overall Study|Protocol Violation|3|||
155235318|NCT01332305|560295260|FG000|Overall Study|Withdrawal by Sponsor|1|||
155235319|NCT01332305|560295261|FG001|Overall Study|Withdrawal by Sponsor|0|||
155235320|NCT01332305|560295262|FG002|Overall Study|Withdrawal by Sponsor|0|||
155235321|NCT01332305|560295263|FG003|Overall Study|Withdrawal by Sponsor|1|||
155235322|NCT01332305|560295264|FG004|Overall Study|Withdrawal by Sponsor|1|||
155235323|NCT01332305|560295260|FG000|Overall Study|Treatment Failure|1|||
155235324|NCT01332305|560295261|FG001|Overall Study|Treatment Failure|1|||
155235325|NCT01332305|560295262|FG002|Overall Study|Treatment Failure|0|||
155235326|NCT01332305|560295263|FG003|Overall Study|Treatment Failure|0|||
155235327|NCT01332305|560295264|FG004|Overall Study|Treatment Failure|0|||
155235328|NCT01332305|560295260|FG000|Overall Study|Physician Decision|0|||
155235329|NCT01332305|560295261|FG001|Overall Study|Physician Decision|0|||
155235330|NCT01332305|560295262|FG002|Overall Study|Physician Decision|0|||
155235331|NCT01332305|560295263|FG003|Overall Study|Physician Decision|1|||
155235332|NCT01332305|560295264|FG004|Overall Study|Physician Decision|0|||
155235333|NCT01600040|560295267|FG000|Overall Study|Withdrawal by Subject|1|||
155235334|NCT01263873|560295268|FG000|Overall Study|One provider unable to complete numbers|1|||
155235335|NCT01263873|560295269|FG001|Overall Study|One provider unable to complete numbers|1|||
155235336|NCT00642304|560295274|FG000|Overall Study|Adverse Event|1|||
155235337|NCT00642304|560295274|FG000|Overall Study|Death|1|||
155235338|NCT00642304|560295274|FG000|Overall Study|Blood transfusion|2|||
155235339|NCT00642304|560295274|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
155235340|NCT00642304|560295274|FG000|Overall Study|Transplantation|1|||
155235341|NCT03217136|560295280|FG000|Overall Study|Lost to Follow-up|2|||
155235342|NCT03217136|560295281|FG001|Overall Study|Lost to Follow-up|1|||
155235343|NCT03217136|560295280|FG000|Overall Study|Site Randomized Participant in Error|0|||
155235344|NCT03217136|560295281|FG001|Overall Study|Site Randomized Participant in Error|1|||
155235345|NCT03217136|560295280|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
155235346|NCT03217136|560295281|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
155235347|NCT03217136|560295280|FG000|Overall Study|Dispensing Error|1|||
155235348|NCT03217136|560295281|FG001|Overall Study|Dispensing Error|0|||
155235349|NCT03217136|560295280|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155235350|NCT03217136|560295281|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155235351|NCT03192150|560295282|FG000|Overall Study|Adverse Event|14|||
155235352|NCT03192150|560295283|FG001|Overall Study|Adverse Event|12|||
155235353|NCT03192150|560295282|FG000|Overall Study|Lack of Efficacy|23|||
155235354|NCT03192150|560295283|FG001|Overall Study|Lack of Efficacy|30|||
155235355|NCT03192150|560295282|FG000|Overall Study|Lost to Follow-up|1|||
155235356|NCT03192150|560295283|FG001|Overall Study|Lost to Follow-up|1|||
155235357|NCT03192150|560295282|FG000|Overall Study|Withdrawal by Subject|4|||
155235358|NCT03192150|560295283|FG001|Overall Study|Withdrawal by Subject|2|||
155235359|NCT03192150|560295282|FG000|Overall Study|Protocol Violation|5|||
155235360|NCT03192150|560295283|FG001|Overall Study|Protocol Violation|2|||
155235361|NCT03192150|560295282|FG000|Overall Study|Surgery Canceled|6|||
155235362|NCT03192150|560295283|FG001|Overall Study|Surgery Canceled|2|||
155235363|NCT03192150|560295282|FG000|Overall Study|Other-Various Administrative Reasons|2|||
155235364|NCT03192150|560295283|FG001|Overall Study|Other-Various Administrative Reasons|5|||
155235365|NCT01824303|560295284|FG000|Randomized Study|Withdrawal by Subject|1|||
155235366|NCT01824303|560295285|FG001|Randomized Study|Withdrawal by Subject|1|||
155235367|NCT01824303|560295284|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
155235368|NCT01824303|560295285|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
155235369|NCT01859715|560295289|FG000|Overall Study|No 2nd VAS|16|||
155235370|NCT01859715|560295290|FG001|Overall Study|No 2nd VAS|8|||
155235371|NCT01859715|560295291|FG002|Overall Study|No 2nd VAS|23|||
155235372|NCT00086580|560295292|FG000|Treatment Period|Disease progression|9|||
155235373|NCT00086580|560295293|FG001|Treatment Period|Disease progression|8|||
155235374|NCT00086580|560295292|FG000|Treatment Period|Unable to comply with protocol|3|||
155235375|NCT00086580|560295293|FG001|Treatment Period|Unable to comply with protocol|1|||
155235376|NCT00086580|560295292|FG000|Treatment Period|Withdrawal by Subject|7|||
155235377|NCT00086580|560295293|FG001|Treatment Period|Withdrawal by Subject|8|||
155235378|NCT00086580|560295292|FG000|Treatment Period|Physician Decision|13|||
155235379|NCT00086580|560295293|FG001|Treatment Period|Physician Decision|7|||
155235380|NCT00086580|560295292|FG000|Treatment Period|AE - not treatment related|7|||
155235381|NCT00086580|560295293|FG001|Treatment Period|AE - not treatment related|7|||
155235382|NCT00086580|560295292|FG000|Treatment Period|Toxicity - treatment related|15|||
155235383|NCT00086580|560295293|FG001|Treatment Period|Toxicity - treatment related|15|||
155235384|NCT00086580|560295292|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
155235385|NCT00086580|560295293|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
155235386|NCT00086580|560295292|FG000|Treatment Period|Death|5|||
155235387|NCT00086580|560295293|FG001|Treatment Period|Death|7|||
155235388|NCT00086580|560295292|FG000|Treatment Period|Other|5|||
155235389|NCT00086580|560295293|FG001|Treatment Period|Other|3|||
155235390|NCT00086580|560295292|FG000|Follow-up Period|Disease progression|72|||
155235391|NCT00086580|560295293|FG001|Follow-up Period|Disease progression|99|||
155235392|NCT00086580|560295292|FG000|Follow-up Period|Unable to comply with protocol|5|||
155235393|NCT00086580|560295293|FG001|Follow-up Period|Unable to comply with protocol|0|||
155235394|NCT00086580|560295292|FG000|Follow-up Period|Withdrawal by Subject|6|||
155235395|NCT00086580|560295293|FG001|Follow-up Period|Withdrawal by Subject|6|||
155235396|NCT00086580|560295292|FG000|Follow-up Period|Physician Decision|0|||
155235397|NCT00086580|560295293|FG001|Follow-up Period|Physician Decision|1|||
155235398|NCT00086580|560295292|FG000|Follow-up Period|AE - not related|1|||
155235399|NCT00086580|560295293|FG001|Follow-up Period|AE - not related|0|||
155235400|NCT00086580|560295292|FG000|Follow-up Period|Death|13|||
155235401|NCT00086580|560295293|FG001|Follow-up Period|Death|7|||
155235402|NCT00086580|560295292|FG000|Follow-up Period|Other|7|||
155235403|NCT00086580|560295293|FG001|Follow-up Period|Other|6|||
155235404|NCT00086580|560295292|FG000|Observation Period|Unable to comply with protocol|1|||
155235405|NCT00086580|560295293|FG001|Observation Period|Unable to comply with protocol|1|||
155235406|NCT00086580|560295292|FG000|Observation Period|Withdrawal by Subject|4|||
155235407|NCT00086580|560295293|FG001|Observation Period|Withdrawal by Subject|2|||
155235408|NCT00086580|560295292|FG000|Observation Period|Death|33|||
155235409|NCT00086580|560295293|FG001|Observation Period|Death|55|||
155235410|NCT00086580|560295292|FG000|Observation Period|Other|8|||
155235411|NCT00086580|560295293|FG001|Observation Period|Other|7|||
155235412|NCT01000051|560295297|FG000|Overall Study|Withdrawal by Subject|1|||
155235413|NCT01000051|560295298|FG001|Overall Study|Withdrawal by Subject|1|||
155235414|NCT01000051|560295297|FG000|Overall Study|Disease Progression|1|||
155235415|NCT01000051|560295298|FG001|Overall Study|Disease Progression|0|||
155235416|NCT01000051|560295297|FG000|Overall Study|Serious noncompliance|1|||
155235417|NCT01000051|560295298|FG001|Overall Study|Serious noncompliance|0|||
155235418|NCT03773757|560295301|FG000|Overall Study|Withdrawal by Subject|2|||
155235419|NCT03773757|560295302|FG001|Overall Study|Withdrawal by Subject|4|||
155235420|NCT00550836|560295303|FG000|Overall Study|Withdrawal by Subject|3|||
155235421|NCT00550836|560295304|FG001|Overall Study|Withdrawal by Subject|9|||
155235422|NCT00179413|560295305|FG000|Overall Study|Adverse Event|38|||
155235423|NCT00179413|560295306|FG001|Overall Study|Adverse Event|20|||
155235424|NCT00179413|560295305|FG000|Overall Study|Withdrawal by Subject|87|||
155235425|NCT00179413|560295306|FG001|Overall Study|Withdrawal by Subject|95|||
155235426|NCT01192152|560295307|FG000|Period 1|left prematurely (while on treatment B)|0|||
155235427|NCT01192152|560295308|FG001|Period 1|left prematurely (while on treatment B)|1|||
155235428|NCT01192152|560295307|FG000|Period 3|family emergency|1|||
155235429|NCT01192152|560295308|FG001|Period 3|family emergency|0|||
155235430|NCT00827372|560296801|FG000|Overall Study|Adverse Event|5|||
155235431|NCT00827372|560296801|FG000|Overall Study|Lack of Efficacy|3|||
155235432|NCT00659646|560296802|FG000|Overall Study|Protocol Violation|12|||
155235433|NCT00659646|560296803|FG001|Overall Study|Protocol Violation|8|||
155235434|NCT00659646|560296802|FG000|Overall Study|Adverse Event|1|||
155235435|NCT00659646|560296803|FG001|Overall Study|Adverse Event|0|||
155235436|NCT00659646|560296802|FG000|Overall Study|Lost to Follow-up|1|||
155235437|NCT00659646|560296803|FG001|Overall Study|Lost to Follow-up|0|||
155235438|NCT00659646|560296802|FG000|Overall Study|protocol noncompliance after randomized|1|||
155235439|NCT00659646|560296803|FG001|Overall Study|protocol noncompliance after randomized|0|||
155235440|NCT02348489|560296807|FG000|Overall Study|Death|336|||
155235441|NCT02348489|560296808|FG001|Overall Study|Death|335|||
155235442|NCT02348489|560296807|FG000|Overall Study|Withdrawal by Subject|14|||
155235443|NCT02348489|560296808|FG001|Overall Study|Withdrawal by Subject|27|||
155235444|NCT02348489|560296807|FG000|Overall Study|Lost to Follow-up|3|||
155235445|NCT02348489|560296808|FG001|Overall Study|Lost to Follow-up|5|||
155235446|NCT02866682|560296809|FG000|Overall Study|Death|0|||
155235447|NCT02866682|560296810|FG001|Overall Study|Death|1|||
155235448|NCT02866682|560296809|FG000|Overall Study|Lost to Follow-up|0|||
155235449|NCT02866682|560296810|FG001|Overall Study|Lost to Follow-up|4|||
155235450|NCT02866682|560296809|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
155235451|NCT02866682|560296810|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
155235452|NCT02866682|560296809|FG000|Overall Study|Other|0|||
155235453|NCT02866682|560296810|FG001|Overall Study|Other|1|||
155235454|NCT00201006|560296811|FG000|Overall Study|Withdrawal by Subject|7|||
155235455|NCT00201006|560296812|FG001|Overall Study|Withdrawal by Subject|2|||
155235456|NCT00201006|560296813|FG002|Overall Study|Withdrawal by Subject|3|||
155235457|NCT00201006|560296811|FG000|Overall Study|Adverse Event|1|||
155235458|NCT00201006|560296812|FG001|Overall Study|Adverse Event|0|||
155235459|NCT00201006|560296813|FG002|Overall Study|Adverse Event|1|||
155235460|NCT01750268|560296815|FG000|Overall Study|Lost to Follow-up|0|||
155235461|NCT01750268|560296816|FG001|Overall Study|Lost to Follow-up|2|||
155235462|NCT01750268|560296815|FG000|Overall Study|Physician Decision|0|||
155235463|NCT01750268|560296816|FG001|Overall Study|Physician Decision|3|||
155235464|NCT01750268|560296815|FG000|Overall Study|Withdrawal by Subject|2|||
155235465|NCT01750268|560296816|FG001|Overall Study|Withdrawal by Subject|0|||
155235466|NCT02086591|560296821|FG000|Overall Study|Adverse Event|1|||
155235467|NCT02086591|560296821|FG000|Overall Study|Withdrawal by Subject|1|||
155235468|NCT02086591|560296821|FG000|Overall Study|protocol terminated|3|||
155235469|NCT01529645|560296822|FG000|Overall Study|Lost to Follow-up|0|||
155235470|NCT01529645|560296823|FG001|Overall Study|Lost to Follow-up|1|||
155235471|NCT01529645|560296824|FG002|Overall Study|Lost to Follow-up|1|||
155235472|NCT01529645|560296825|FG003|Overall Study|Lost to Follow-up|1|||
155235473|NCT01529645|560296826|FG004|Overall Study|Lost to Follow-up|1|||
155235474|NCT01529645|560296827|FG005|Overall Study|Lost to Follow-up|0|||
155235475|NCT01529645|560296828|FG006|Overall Study|Lost to Follow-up|2|||
155235476|NCT01529645|560296829|FG007|Overall Study|Lost to Follow-up|0|||
155235477|NCT01529645|560296830|FG008|Overall Study|Lost to Follow-up|1|||
155235478|NCT01529645|560296831|FG009|Overall Study|Lost to Follow-up|0|||
155235479|NCT01529645|560296822|FG000|Overall Study|SAE - Premature contractions|0|||
155235480|NCT01529645|560296823|FG001|Overall Study|SAE - Premature contractions|0|||
155235481|NCT01529645|560296824|FG002|Overall Study|SAE - Premature contractions|1|||
155235482|NCT01529645|560296825|FG003|Overall Study|SAE - Premature contractions|0|||
155235483|NCT01529645|560296826|FG004|Overall Study|SAE - Premature contractions|0|||
155235484|NCT01529645|560296827|FG005|Overall Study|SAE - Premature contractions|0|||
155235485|NCT01529645|560296828|FG006|Overall Study|SAE - Premature contractions|0|||
155235486|NCT01529645|560296829|FG007|Overall Study|SAE - Premature contractions|0|||
155235487|NCT01529645|560296830|FG008|Overall Study|SAE - Premature contractions|0|||
155235488|NCT01529645|560296831|FG009|Overall Study|SAE - Premature contractions|0|||
155235489|NCT01529645|560296822|FG000|Overall Study|Withdrawal by Subject|2|||
155235490|NCT01529645|560296823|FG001|Overall Study|Withdrawal by Subject|0|||
155235491|NCT01529645|560296824|FG002|Overall Study|Withdrawal by Subject|0|||
155235492|NCT01529645|560296825|FG003|Overall Study|Withdrawal by Subject|1|||
155235493|NCT01529645|560296826|FG004|Overall Study|Withdrawal by Subject|1|||
155235494|NCT01529645|560296827|FG005|Overall Study|Withdrawal by Subject|1|||
155235495|NCT01529645|560296828|FG006|Overall Study|Withdrawal by Subject|0|||
155235496|NCT01529645|560296829|FG007|Overall Study|Withdrawal by Subject|0|||
155235497|NCT01529645|560296830|FG008|Overall Study|Withdrawal by Subject|0|||
155235498|NCT01529645|560296831|FG009|Overall Study|Withdrawal by Subject|0|||
155235499|NCT00274716|560296836|FG000|Phase A|Other non-reported reason|4|||
155235500|NCT00274716|560296837|FG001|Phase A|Other non-reported reason|2|||
155235501|NCT00274716|560296838|FG002|Phase A|Other non-reported reason|1|||
155235502|NCT00274716|560296839|FG003|Phase A|Other non-reported reason|2|||
155235503|NCT00274716|560296840|FG004|Phase A|Other non-reported reason|0|||
155235504|NCT00274716|560296841|FG005|Phase A|Other non-reported reason|1|||
155235505|NCT00274716|560296836|FG000|Phase A|Participant moved|0|||
155235506|NCT00274716|560296837|FG001|Phase A|Participant moved|0|||
155235507|NCT00274716|560296838|FG002|Phase A|Participant moved|1|||
155235508|NCT00274716|560296839|FG003|Phase A|Participant moved|0|||
155235509|NCT00274716|560296840|FG004|Phase A|Participant moved|0|||
155235510|NCT00274716|560296841|FG005|Phase A|Participant moved|1|||
155235511|NCT00274716|560296836|FG000|Phase A|Site Terminated|0|||
155235512|NCT00274716|560296837|FG001|Phase A|Site Terminated|0|||
155235513|NCT00274716|560296838|FG002|Phase A|Site Terminated|0|||
155235514|NCT00274716|560296839|FG003|Phase A|Site Terminated|1|||
155235515|NCT00274716|560296840|FG004|Phase A|Site Terminated|0|||
155235516|NCT00274716|560296841|FG005|Phase A|Site Terminated|0|||
155235517|NCT00274716|560296836|FG000|Phase A|Protocol Violation|1|||
155235518|NCT00274716|560296837|FG001|Phase A|Protocol Violation|0|||
155235519|NCT00274716|560296838|FG002|Phase A|Protocol Violation|0|||
155235520|NCT00274716|560296839|FG003|Phase A|Protocol Violation|1|||
155235521|NCT00274716|560296840|FG004|Phase A|Protocol Violation|0|||
155235522|NCT00274716|560296841|FG005|Phase A|Protocol Violation|0|||
155235523|NCT00274716|560296836|FG000|Phase A|Met criteria for discontinuation|1|||
155235524|NCT00274716|560296837|FG001|Phase A|Met criteria for discontinuation|1|||
155235525|NCT00274716|560296838|FG002|Phase A|Met criteria for discontinuation|0|||
155235526|NCT00274716|560296839|FG003|Phase A|Met criteria for discontinuation|0|||
155235527|NCT00274716|560296840|FG004|Phase A|Met criteria for discontinuation|0|||
155235528|NCT00274716|560296841|FG005|Phase A|Met criteria for discontinuation|0|||
155235529|NCT00274716|560296836|FG000|Phase A|Withdrawal by Subject|2|||
155235530|NCT00274716|560296837|FG001|Phase A|Withdrawal by Subject|2|||
155235531|NCT00274716|560296838|FG002|Phase A|Withdrawal by Subject|1|||
155235532|NCT00274716|560296839|FG003|Phase A|Withdrawal by Subject|3|||
155235533|NCT00274716|560296840|FG004|Phase A|Withdrawal by Subject|0|||
155235534|NCT00274716|560296841|FG005|Phase A|Withdrawal by Subject|1|||
155235535|NCT00274716|560296836|FG000|Phase A|Adverse Event|2|||
155235536|NCT00274716|560296837|FG001|Phase A|Adverse Event|3|||
155235537|NCT00274716|560296838|FG002|Phase A|Adverse Event|3|||
155235538|NCT00274716|560296839|FG003|Phase A|Adverse Event|0|||
155235539|NCT00274716|560296840|FG004|Phase A|Adverse Event|2|||
155235540|NCT00274716|560296841|FG005|Phase A|Adverse Event|0|||
155235541|NCT00274716|560296836|FG000|Phase A|Completed but did not enter Phase B|1|||
155235542|NCT00274716|560296837|FG001|Phase A|Completed but did not enter Phase B|2|||
155235543|NCT00274716|560296838|FG002|Phase A|Completed but did not enter Phase B|2|||
155235544|NCT00274716|560296839|FG003|Phase A|Completed but did not enter Phase B|2|||
155235545|NCT00274716|560296840|FG004|Phase A|Completed but did not enter Phase B|1|||
155235546|NCT00274716|560296841|FG005|Phase A|Completed but did not enter Phase B|1|||
155235547|NCT00274716|560296836|FG000|Phase B|Adverse Event|0|||
155235548|NCT00274716|560296837|FG001|Phase B|Adverse Event|0|||
155235549|NCT00274716|560296838|FG002|Phase B|Adverse Event|2|||
155235550|NCT00274716|560296839|FG003|Phase B|Adverse Event|0|||
155235551|NCT00274716|560296840|FG004|Phase B|Adverse Event|0|||
155235552|NCT00274716|560296841|FG005|Phase B|Adverse Event|1|||
155235553|NCT00274716|560296836|FG000|Phase B|Protocol Violation|0|||
155235554|NCT00274716|560296837|FG001|Phase B|Protocol Violation|2|||
155235555|NCT00274716|560296838|FG002|Phase B|Protocol Violation|0|||
155235556|NCT00274716|560296839|FG003|Phase B|Protocol Violation|0|||
155235557|NCT00274716|560296840|FG004|Phase B|Protocol Violation|0|||
155235558|NCT00274716|560296841|FG005|Phase B|Protocol Violation|0|||
155235559|NCT00274716|560296836|FG000|Phase B|Withdrawal by Subject|0|||
155235560|NCT00274716|560296837|FG001|Phase B|Withdrawal by Subject|1|||
155235561|NCT00274716|560296838|FG002|Phase B|Withdrawal by Subject|0|||
155491470|NCT00563706|561225400|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
155235562|NCT00274716|560296839|FG003|Phase B|Withdrawal by Subject|0|||
155235563|NCT00274716|560296840|FG004|Phase B|Withdrawal by Subject|0|||
155235564|NCT00274716|560296841|FG005|Phase B|Withdrawal by Subject|0|||
155235565|NCT00274716|560296836|FG000|Phase B|Participant moved|1|||
155235566|NCT00274716|560296837|FG001|Phase B|Participant moved|0|||
155235567|NCT00274716|560296838|FG002|Phase B|Participant moved|0|||
155235568|NCT00274716|560296839|FG003|Phase B|Participant moved|0|||
155235569|NCT00274716|560296840|FG004|Phase B|Participant moved|0|||
155235570|NCT00274716|560296841|FG005|Phase B|Participant moved|0|||
155235571|NCT00274716|560296836|FG000|Phase B|Other non-reported reason|0|||
155235572|NCT00274716|560296837|FG001|Phase B|Other non-reported reason|0|||
155235573|NCT00274716|560296838|FG002|Phase B|Other non-reported reason|1|||
155235574|NCT00274716|560296839|FG003|Phase B|Other non-reported reason|1|||
155235575|NCT00274716|560296840|FG004|Phase B|Other non-reported reason|0|||
155235576|NCT00274716|560296841|FG005|Phase B|Other non-reported reason|0|||
155235577|NCT00274716|560296836|FG000|Phase B|Lost to Follow-up|0|||
155235578|NCT00274716|560296837|FG001|Phase B|Lost to Follow-up|1|||
155235579|NCT00274716|560296838|FG002|Phase B|Lost to Follow-up|0|||
155235580|NCT00274716|560296839|FG003|Phase B|Lost to Follow-up|0|||
155235581|NCT00274716|560296840|FG004|Phase B|Lost to Follow-up|0|||
155235582|NCT00274716|560296841|FG005|Phase B|Lost to Follow-up|0|||
155235583|NCT04193202|560296842|FG000|Overall Study|Adverse Event|2|||
155235584|NCT04193202|560296843|FG001|Overall Study|Adverse Event|1|||
155235585|NCT04193202|560296842|FG000|Overall Study|Death|0|||
155235586|NCT04193202|560296843|FG001|Overall Study|Death|1|||
155235587|NCT04193202|560296842|FG000|Overall Study|Physician Decision|1|||
155235588|NCT04193202|560296843|FG001|Overall Study|Physician Decision|1|||
155235589|NCT04193202|560296842|FG000|Overall Study|Protocol Violation|2|||
155235590|NCT04193202|560296843|FG001|Overall Study|Protocol Violation|2|||
155235591|NCT04193202|560296842|FG000|Overall Study|Withdrawal by Subject|11|||
155235592|NCT04193202|560296843|FG001|Overall Study|Withdrawal by Subject|5|||
155235593|NCT00723801|560296844|FG000|Overall Study|Lost to Follow-up|1|||
155235594|NCT00723801|560296845|FG001|Overall Study|Lost to Follow-up|2|||
155235595|NCT00723801|560296844|FG000|Overall Study|Protocol Violation|2|||
155235596|NCT00723801|560296845|FG001|Overall Study|Protocol Violation|1|||
155235597|NCT02167035|560296846|FG000|Overall Study|Adverse Event|2|||
155235598|NCT02167035|560296847|FG001|Overall Study|Adverse Event|2|||
155235599|NCT02167035|560296846|FG000|Overall Study|Lost to Follow-up|3|||
155235600|NCT02167035|560296847|FG001|Overall Study|Lost to Follow-up|3|||
155235601|NCT02167035|560296846|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
155235602|NCT02167035|560296847|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
155235603|NCT02148003|560296848|FG000|Overall Study|Failed inclusion criteria|1|||
155235604|NCT02148003|560296849|FG001|Overall Study|Failed inclusion criteria|0|||
155235605|NCT02148003|560296848|FG000|Overall Study|Met exclusion criteria|0|||
155235606|NCT02148003|560296849|FG001|Overall Study|Met exclusion criteria|1|||
155235607|NCT02148003|560296848|FG000|Overall Study|Withdrawal by Subject|0|||
155235608|NCT02148003|560296849|FG001|Overall Study|Withdrawal by Subject|1|||
155235609|NCT02489981|560296850|FG000|Overall Study|Adverse Event|21|||
155235610|NCT02489981|560296850|FG000|Overall Study|Insufficient effectiveness|16|||
155235611|NCT02489981|560296850|FG000|Overall Study|Improved|31|||
155235612|NCT02489981|560296850|FG000|Overall Study|Lost to Follow-up|31|||
155235613|NCT02489981|560296850|FG000|Overall Study|Other than listed|28|||
155235614|NCT01565993|560296858|FG000|Overall Study|Physician Decision|0|||
155235615|NCT01565993|560296859|FG001|Overall Study|Physician Decision|3|||
155235616|NCT02732847|560296860|FG000|Overall Study|some filled early|42|||
155235617|NCT02732847|560296861|FG001|Overall Study|some filled early|42|||
155235618|NCT02370888|560296862|FG000|Overall Study|disease progression|2|||
155235619|NCT02370888|560296862|FG000|Overall Study|did not meet chimerism criteria|6|||
155235620|NCT01034397|560296863|FG000|Overall Study|Lack of compliance|0|||
155235621|NCT01034397|560296864|FG001|Overall Study|Lack of compliance|1|||
155235622|NCT01034397|560296863|FG000|Overall Study|Lack of Efficacy|3|||
155235623|NCT01034397|560296864|FG001|Overall Study|Lack of Efficacy|0|||
155235624|NCT01034397|560296863|FG000|Overall Study|Adverse Event|4|||
155235625|NCT01034397|560296864|FG001|Overall Study|Adverse Event|0|||
155235626|NCT01034397|560296863|FG000|Overall Study|Other|0|||
155235627|NCT01034397|560296864|FG001|Overall Study|Other|1|||
155235628|NCT04574362|560296865|FG000|Overall Study|Other|0|||
155235629|NCT04574362|560296866|FG001|Overall Study|Other|5|||
155235630|NCT04574362|560296865|FG000|Overall Study|COVID-19|0|||
155235631|NCT04574362|560296866|FG001|Overall Study|COVID-19|1|||
155235632|NCT04574362|560296865|FG000|Overall Study|Adverse Event|1|||
155235633|NCT04574362|560296866|FG001|Overall Study|Adverse Event|1|||
155235634|NCT04574362|560296865|FG000|Overall Study|Withdrawal by Subject|2|||
155235635|NCT04574362|560296866|FG001|Overall Study|Withdrawal by Subject|4|||
155235636|NCT04574362|560296865|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
155235637|NCT04574362|560296866|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
155235638|NCT04574362|560296865|FG000|Overall Study|Participant refused to come to the hospital|1|||
155235639|NCT04574362|560296866|FG001|Overall Study|Participant refused to come to the hospital|0|||
155235640|NCT04574362|560296865|FG000|Overall Study|Participant refused the visit|1|||
155235641|NCT04574362|560296866|FG001|Overall Study|Participant refused the visit|0|||
155235642|NCT04574362|560296865|FG000|Overall Study|Participant quit early because of business trip|1|||
155235643|NCT04574362|560296866|FG001|Overall Study|Participant quit early because of business trip|0|||
155235644|NCT01785524|560296867|FG000|Overall Study|Withdrawal by Subject|2|||
155235645|NCT01785524|560296868|FG001|Overall Study|Withdrawal by Subject|2|||
155235646|NCT02104557|560296869|FG000|Overall Study|Adverse Event|24|||
155235647|NCT02104557|560296869|FG000|Overall Study|Lost to Follow-up|34|||
155235648|NCT02104557|560296869|FG000|Overall Study|Violated the usage and dosage|14|||
155235649|NCT02104557|560296869|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
155235650|NCT02104557|560296869|FG000|Overall Study|Administered Sayana prior to the contract|1|||
155235651|NCT02104557|560296869|FG000|Overall Study|Other|17|||
155235652|NCT02104557|560296869|FG000|Overall Study|Change to other contraception methods|5|||
155235653|NCT02104557|560296869|FG000|Overall Study|Discontinuation due to no pain|1|||
155235654|NCT02104557|560296869|FG000|Overall Study|Withdrawal consent|2|||
155235655|NCT02104557|560296869|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
155235656|NCT02104557|560296869|FG000|Overall Study|Discontinuation of contraception|9|||
155235657|NCT02579616|560296870|FG000|Overall Study|Participants did not receive treatment|3|||
155235658|NCT02178475|560296871|FG000|Overall Study|Withdrawal by Subject|7|||
155235659|NCT02178475|560296871|FG000|Overall Study|Lost to Follow-up|10|||
155235660|NCT02178475|560296871|FG000|Overall Study|Death|13|||
155235661|NCT02178475|560296871|FG000|Overall Study|Protocol-specified Criteria|99|||
155235662|NCT01430585|560296872|FG000|Overall Study|Death|1|||
155235663|NCT01430585|560296872|FG000|Overall Study|Objective Progression or Relapse|3|||
155235664|NCT01430585|560296872|FG000|Overall Study|Study Terminated by Sponsor|3|||
155235665|NCT01430585|560296872|FG000|Overall Study|Other|7|||
155235666|NCT00482391|560296873|FG000|Overall Study|Withdrawal by Subject|1|||
155235667|NCT00482391|560296873|FG000|Overall Study|Adverse Event|1|||
155235668|NCT00482391|560296873|FG000|Overall Study|Death|1|||
155235669|NCT01448850|560296874|FG000|Overall Study|Death|3|||
155235670|NCT01448850|560296875|FG001|Overall Study|Death|6|||
155235671|NCT01448850|560296874|FG000|Overall Study|Withdrawal by Subject|13|||
155235672|NCT01448850|560296875|FG001|Overall Study|Withdrawal by Subject|21|||
155235673|NCT01448850|560296874|FG000|Overall Study|Lost to Follow-up|3|||
155235674|NCT01448850|560296875|FG001|Overall Study|Lost to Follow-up|1|||
155235675|NCT01448850|560296874|FG000|Overall Study|Other|15|||
155235676|NCT01448850|560296875|FG001|Overall Study|Other|12|||
155235677|NCT00779766|560296876|FG000|Month 24|Serious Adverse Event|2|||
155235678|NCT00779766|560296877|FG001|Month 24|Serious Adverse Event|3|||
155235679|NCT00779766|560296876|FG000|Month 24|Adverse Event|3|||
155235680|NCT00779766|560296877|FG001|Month 24|Adverse Event|3|||
155235681|NCT00779766|560296876|FG000|Month 24|Protocol Violation|3|||
155235682|NCT00779766|560296877|FG001|Month 24|Protocol Violation|1|||
155235683|NCT00779766|560296876|FG000|Month 24|Withdrawal by Subject|159|||
155235684|NCT00779766|560296877|FG001|Month 24|Withdrawal by Subject|127|||
155235685|NCT00779766|560296876|FG000|Month 24|Migrated/moved from study area|138|||
155235686|NCT00779766|560296877|FG001|Month 24|Migrated/moved from study area|162|||
155235687|NCT00779766|560296876|FG000|Month 24|Lost to Follow-up|9|||
155235688|NCT00779766|560296877|FG001|Month 24|Lost to Follow-up|9|||
155235689|NCT00779766|560296876|FG000|Month 24|Other|18|||
155235690|NCT00779766|560296877|FG001|Month 24|Other|27|||
155235691|NCT00779766|560296876|FG000|Month 48|Withdrawal by Subject|68|||
155235692|NCT00779766|560296877|FG001|Month 48|Withdrawal by Subject|63|||
155235693|NCT00779766|560296876|FG000|Month 48|Migrated/moved from study area|76|||
155235694|NCT00779766|560296877|FG001|Month 48|Migrated/moved from study area|75|||
155235695|NCT00779766|560296876|FG000|Month 48|Lost to Follow-up|29|||
155235696|NCT00779766|560296877|FG001|Month 48|Lost to Follow-up|30|||
155235697|NCT00779766|560296876|FG000|Month 48|Other|1|||
155235698|NCT00779766|560296877|FG001|Month 48|Other|0|||
155235699|NCT00779766|560296876|FG000|Month 72|Withdrawal by Subject|55|||
155235700|NCT00779766|560296877|FG001|Month 72|Withdrawal by Subject|71|||
155235701|NCT00779766|560296876|FG000|Month 72|Migrated/moved from study area|124|||
155235702|NCT00779766|560296877|FG001|Month 72|Migrated/moved from study area|109|||
155235703|NCT00779766|560296876|FG000|Month 72|Lost to Follow-up|6|||
155235704|NCT00779766|560296877|FG001|Month 72|Lost to Follow-up|8|||
155235705|NCT00779766|560296876|FG000|Month 72|Other|0|||
155235706|NCT00779766|560296877|FG001|Month 72|Other|1|||
155235707|NCT01412424|560296882|FG000|Core Treatment Period|Treatment Failure|24|||
155235708|NCT01412424|560296882|FG000|Core Treatment Period|Adverse Event|21|||
155235709|NCT01412424|560296882|FG000|Core Treatment Period|Patient Request|5|||
155235710|NCT01412424|560296882|FG000|Core Treatment Period|Lost to Follow-up|2|||
155235711|NCT01412424|560296882|FG000|Core Treatment Period|Sponsor Request|1|||
155235712|NCT01412424|560296882|FG000|Extension Treatment Period|Adverse Event|2|||
155235713|NCT01412424|560296882|FG000|Extension Treatment Period|Treatment Failure|2|||
155235714|NCT01412424|560296882|FG000|Extension Treatment Period|Patient Request|2|||
155235715|NCT01274637|560296883|FG000|Overall Study|Withdrawal by Subject|0|||
155235716|NCT01274637|560296884|FG001|Overall Study|Withdrawal by Subject|1|||
155235717|NCT01274637|560296883|FG000|Overall Study|Lost to Follow-up|0|||
155235718|NCT01274637|560296884|FG001|Overall Study|Lost to Follow-up|1|||
155235719|NCT03296696|560296891|FG000|Overall Study|Started Other Antitumor Therapy|1|||
155235720|NCT03296696|560296892|FG001|Overall Study|Started Other Antitumor Therapy|2|||
155235721|NCT03296696|560296893|FG002|Overall Study|Started Other Antitumor Therapy|1|||
155235722|NCT03296696|560296894|FG003|Overall Study|Started Other Antitumor Therapy|2|||
155235723|NCT03296696|560296895|FG004|Overall Study|Started Other Antitumor Therapy|1|||
155235724|NCT03296696|560296896|FG005|Overall Study|Started Other Antitumor Therapy|1|||
155235725|NCT03296696|560296897|FG006|Overall Study|Started Other Antitumor Therapy|2|||
155235726|NCT03296696|560296898|FG007|Overall Study|Started Other Antitumor Therapy|3|||
155235727|NCT03296696|560296899|FG008|Overall Study|Started Other Antitumor Therapy|1|||
155235728|NCT03296696|560296900|FG009|Overall Study|Started Other Antitumor Therapy|0|||
155235729|NCT03296696|560296891|FG000|Overall Study|Death|0|||
155235730|NCT03296696|560296892|FG001|Overall Study|Death|1|||
155235731|NCT03296696|560296893|FG002|Overall Study|Death|1|||
155235732|NCT03296696|560296894|FG003|Overall Study|Death|2|||
155235733|NCT03296696|560296895|FG004|Overall Study|Death|2|||
155235734|NCT03296696|560296896|FG005|Overall Study|Death|3|||
155235735|NCT03296696|560296897|FG006|Overall Study|Death|1|||
155235736|NCT03296696|560296898|FG007|Overall Study|Death|2|||
155235737|NCT03296696|560296899|FG008|Overall Study|Death|0|||
155235738|NCT03296696|560296900|FG009|Overall Study|Death|0|||
155235739|NCT03296696|560296891|FG000|Overall Study|Withdrawal by Subject|0|||
155235740|NCT03296696|560296892|FG001|Overall Study|Withdrawal by Subject|0|||
155235741|NCT03296696|560296893|FG002|Overall Study|Withdrawal by Subject|1|||
155235742|NCT03296696|560296894|FG003|Overall Study|Withdrawal by Subject|0|||
155235743|NCT03296696|560296895|FG004|Overall Study|Withdrawal by Subject|1|||
155235744|NCT03296696|560296896|FG005|Overall Study|Withdrawal by Subject|0|||
155235745|NCT03296696|560296897|FG006|Overall Study|Withdrawal by Subject|0|||
155235746|NCT03296696|560296898|FG007|Overall Study|Withdrawal by Subject|0|||
155235747|NCT03296696|560296899|FG008|Overall Study|Withdrawal by Subject|0|||
155235748|NCT03296696|560296900|FG009|Overall Study|Withdrawal by Subject|1|||
155235749|NCT04694131|560296901|FG000|Overall Study|Withdrawal by Subject|7|||
155235750|NCT04694131|560296901|FG000|Overall Study|Screen Failure|1|||
155235751|NCT04694131|560296901|FG000|Overall Study|High stimulation threshold|3|||
155235752|NCT00261716|560296902|FG000|Overall Study|Withdrawal by Subject|6|||
155235753|NCT00261716|560296903|FG001|Overall Study|Withdrawal by Subject|8|||
155235754|NCT00261716|560296902|FG000|Overall Study|Lost to Follow-up|0|||
155235755|NCT00261716|560296903|FG001|Overall Study|Lost to Follow-up|2|||
155235756|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
155235757|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
155235758|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
155235759|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
155235760|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
155235761|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235762|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235763|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235764|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
155235765|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235766|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235767|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235768|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
155235769|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
155235770|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
155235771|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
155235772|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
155235773|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
155235774|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
155235775|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
155235776|NCT02047110|560296906|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235777|NCT02047110|560296907|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
155235778|NCT02047110|560296908|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235779|NCT02047110|560296909|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235780|NCT02047110|560296906|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
155235781|NCT02047110|560296907|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
155235782|NCT02047110|560296908|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
155235783|NCT02047110|560296909|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
155235784|NCT02047110|560296906|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
155235785|NCT02047110|560296907|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
155235786|NCT02047110|560296908|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
155235787|NCT02047110|560296909|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
155235788|NCT02047110|560296906|FG000|Escape Treatment Period|Adverse Event|1|||
155235789|NCT02047110|560296907|FG001|Escape Treatment Period|Adverse Event|2|||
155235790|NCT02047110|560296908|FG002|Escape Treatment Period|Adverse Event|2|||
155235791|NCT02047110|560296909|FG003|Escape Treatment Period|Adverse Event|0|||
155235792|NCT02047110|560296906|FG000|Escape Treatment Period|Other than specified|1|||
155235793|NCT02047110|560296907|FG001|Escape Treatment Period|Other than specified|2|||
155235794|NCT02047110|560296908|FG002|Escape Treatment Period|Other than specified|0|||
155235795|NCT02047110|560296909|FG003|Escape Treatment Period|Other than specified|1|||
155235796|NCT02047110|560296906|FG000|OLE Treatment Period|Other than specified|0|||
155235797|NCT02047110|560296907|FG001|OLE Treatment Period|Other than specified|0|||
155235798|NCT02047110|560296908|FG002|OLE Treatment Period|Other than specified|1|||
155235799|NCT02047110|560296909|FG003|OLE Treatment Period|Other than specified|0|||
155235800|NCT00705575|560296910|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155235801|NCT00705575|560296911|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155235802|NCT00705575|560296910|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155235803|NCT00705575|560296911|FG001|Overall Study|Abnormal test procedure result(s)|12|||
155235804|NCT00705575|560296910|FG000|Overall Study|Adverse Event|11|||
155235805|NCT00705575|560296911|FG001|Overall Study|Adverse Event|15|||
155235806|NCT00705575|560296910|FG000|Overall Study|Lost to Follow-up|3|||
155235807|NCT00705575|560296911|FG001|Overall Study|Lost to Follow-up|4|||
155235808|NCT00705575|560296910|FG000|Overall Study|Protocol Violation|2|||
155235809|NCT00705575|560296911|FG001|Overall Study|Protocol Violation|2|||
155235810|NCT00705575|560296910|FG000|Overall Study|Withdrawal by Subject|5|||
155235811|NCT00705575|560296911|FG001|Overall Study|Withdrawal by Subject|10|||
155235812|NCT02170727|560296913|FG000|Overall Study|Lost to Follow-up|1|||
155235813|NCT02170727|560296914|FG001|Overall Study|Lost to Follow-up|0|||
155235814|NCT02170727|560296913|FG000|Overall Study|Withdrawal by Subject|2|||
155235815|NCT02170727|560296914|FG001|Overall Study|Withdrawal by Subject|0|||
155235816|NCT01959581|560296917|FG000|Overall Study|Lost to Follow-up|5|||
155235817|NCT00057746|560296918|FG000|Overall Study|Withdrawal by Subject|0|||
155235818|NCT00057746|560296919|FG001|Overall Study|Withdrawal by Subject|0|||
155235819|NCT00057746|560296920|FG002|Overall Study|Withdrawal by Subject|1|||
155235820|NCT01660412|560296925|FG000|Overall Study|Protocol Violation|0|||
155235821|NCT01660412|560296926|FG001|Overall Study|Protocol Violation|3|||
155235822|NCT03551210|560296927|FG000|Overall Study|Adverse Event|5|||
155235823|NCT03551210|560296928|FG001|Overall Study|Adverse Event|6|||
155235824|NCT03551210|560296927|FG000|Overall Study|Withdrawal by Subject|1|||
155235825|NCT03551210|560296928|FG001|Overall Study|Withdrawal by Subject|7|||
155235826|NCT03551210|560296927|FG000|Overall Study|Needed in other antibiotic treatment|2|||
155235827|NCT03551210|560296928|FG001|Overall Study|Needed in other antibiotic treatment|5|||
155235828|NCT03551210|560296927|FG000|Overall Study|Lost to Follow-up|1|||
155235829|NCT03551210|560296928|FG001|Overall Study|Lost to Follow-up|1|||
155235830|NCT03551210|560296927|FG000|Overall Study|Absence of visit 4 and 5|1|||
155235831|NCT03551210|560296928|FG001|Overall Study|Absence of visit 4 and 5|0|||
155235832|NCT03551210|560296927|FG000|Overall Study|No drug for dispensing|0|||
155235833|NCT03551210|560296928|FG001|Overall Study|No drug for dispensing|1|||
155235834|NCT03265119|560296929|FG000|Overall Study|Adverse Event|2|||
155235835|NCT03265119|560296930|FG001|Overall Study|Adverse Event|1|||
155235836|NCT03265119|560296929|FG000|Overall Study|Lack of Efficacy|3|||
155235837|NCT03265119|560296930|FG001|Overall Study|Lack of Efficacy|0|||
155235838|NCT03265119|560296929|FG000|Overall Study|Protocol Violation|1|||
155235839|NCT03265119|560296930|FG001|Overall Study|Protocol Violation|2|||
155235840|NCT03265119|560296929|FG000|Overall Study|Withdrawal by Subject|2|||
155235841|NCT03265119|560296930|FG001|Overall Study|Withdrawal by Subject|4|||
155235842|NCT03265119|560296929|FG000|Overall Study|Lost to Follow-up|1|||
155235843|NCT03265119|560296930|FG001|Overall Study|Lost to Follow-up|0|||
155235844|NCT03265119|560296929|FG000|Overall Study|Lack of Compliance|1|||
155235845|NCT03265119|560296930|FG001|Overall Study|Lack of Compliance|0|||
155235846|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
155235847|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235848|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235849|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235850|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235851|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235852|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
155235853|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235854|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235855|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235856|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235857|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235858|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
155235859|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235860|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235861|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235862|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235863|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235864|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
155235865|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235866|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235867|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235868|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235869|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235870|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
155235871|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235872|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235873|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235874|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235875|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235876|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
155235877|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235878|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235879|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235880|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235881|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235882|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Other|6|||
155235883|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Other|0|||
155235884|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Other|0|||
155235885|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Other|0|||
155235886|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Other|0|||
155235887|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Other|0|||
155235888|NCT02139644|560298193|FG000|Treatment Period|Adverse Event|0|||
155235889|NCT02139644|560298194|FG001|Treatment Period|Adverse Event|0|||
155235890|NCT02139644|560298195|FG002|Treatment Period|Adverse Event|3|||
155235891|NCT02139644|560298196|FG003|Treatment Period|Adverse Event|2|||
155235892|NCT02139644|560298197|FG004|Treatment Period|Adverse Event|1|||
155235893|NCT02139644|560298198|FG005|Treatment Period|Adverse Event|6|||
155235894|NCT02139644|560298193|FG000|Treatment Period|Withdrawal by Subject|0|||
155235895|NCT02139644|560298194|FG001|Treatment Period|Withdrawal by Subject|0|||
155235896|NCT02139644|560298195|FG002|Treatment Period|Withdrawal by Subject|2|||
155235897|NCT02139644|560298196|FG003|Treatment Period|Withdrawal by Subject|2|||
155235898|NCT02139644|560298197|FG004|Treatment Period|Withdrawal by Subject|3|||
155235899|NCT02139644|560298198|FG005|Treatment Period|Withdrawal by Subject|2|||
155235900|NCT02139644|560298193|FG000|Treatment Period|Non-compliance|0|||
155235901|NCT02139644|560298194|FG001|Treatment Period|Non-compliance|0|||
155235902|NCT02139644|560298195|FG002|Treatment Period|Non-compliance|0|||
155235903|NCT02139644|560298196|FG003|Treatment Period|Non-compliance|1|||
155235904|NCT02139644|560298197|FG004|Treatment Period|Non-compliance|0|||
155235905|NCT02139644|560298198|FG005|Treatment Period|Non-compliance|0|||
155235906|NCT02139644|560298193|FG000|Treatment Period|Protocol Violation|0|||
155235907|NCT02139644|560298194|FG001|Treatment Period|Protocol Violation|0|||
155235908|NCT02139644|560298195|FG002|Treatment Period|Protocol Violation|0|||
155235909|NCT02139644|560298196|FG003|Treatment Period|Protocol Violation|1|||
155235910|NCT02139644|560298197|FG004|Treatment Period|Protocol Violation|1|||
155235911|NCT02139644|560298198|FG005|Treatment Period|Protocol Violation|1|||
155235912|NCT02139644|560298193|FG000|Treatment Period|Disease progression|0|||
155235913|NCT02139644|560298194|FG001|Treatment Period|Disease progression|0|||
155235914|NCT02139644|560298195|FG002|Treatment Period|Disease progression|0|||
155235915|NCT02139644|560298196|FG003|Treatment Period|Disease progression|1|||
155235916|NCT02139644|560298197|FG004|Treatment Period|Disease progression|1|||
155235917|NCT02139644|560298198|FG005|Treatment Period|Disease progression|2|||
155235918|NCT02139644|560298193|FG000|Treatment Period|Lost to Follow-up|0|||
155235919|NCT02139644|560298194|FG001|Treatment Period|Lost to Follow-up|0|||
155235920|NCT02139644|560298195|FG002|Treatment Period|Lost to Follow-up|1|||
155235921|NCT02139644|560298196|FG003|Treatment Period|Lost to Follow-up|1|||
155235922|NCT02139644|560298197|FG004|Treatment Period|Lost to Follow-up|1|||
155235923|NCT02139644|560298198|FG005|Treatment Period|Lost to Follow-up|1|||
155235924|NCT02139644|560298193|FG000|Treatment Period|Lack of Efficacy|0|||
155235925|NCT02139644|560298194|FG001|Treatment Period|Lack of Efficacy|0|||
155235926|NCT02139644|560298195|FG002|Treatment Period|Lack of Efficacy|1|||
155235927|NCT02139644|560298196|FG003|Treatment Period|Lack of Efficacy|0|||
155235928|NCT02139644|560298197|FG004|Treatment Period|Lack of Efficacy|1|||
155235929|NCT02139644|560298198|FG005|Treatment Period|Lack of Efficacy|4|||
155235930|NCT02139644|560298193|FG000|Treatment Period|Other|0|||
155235931|NCT02139644|560298194|FG001|Treatment Period|Other|3|||
155235932|NCT02139644|560298195|FG002|Treatment Period|Other|1|||
155235933|NCT02139644|560298196|FG003|Treatment Period|Other|1|||
155235934|NCT02139644|560298197|FG004|Treatment Period|Other|0|||
155235935|NCT02139644|560298198|FG005|Treatment Period|Other|1|||
155235936|NCT00600821|560298203|FG000|Overall Study|Death|45|||
155235937|NCT00600821|560298204|FG001|Overall Study|Death|46|||
155235938|NCT00600821|560298203|FG000|Overall Study|Lost to Follow-up|2|||
155235939|NCT00600821|560298204|FG001|Overall Study|Lost to Follow-up|2|||
155235940|NCT00600821|560298203|FG000|Overall Study|Withdrawal by Subject|1|||
155235941|NCT00600821|560298204|FG001|Overall Study|Withdrawal by Subject|1|||
155235942|NCT00600821|560298203|FG000|Overall Study|Terminated by sponsor|8|||
155235943|NCT00600821|560298204|FG001|Overall Study|Terminated by sponsor|6|||
155235944|NCT00600821|560298203|FG000|Overall Study|Objective progression or relapse|0|||
155235945|NCT00600821|560298204|FG001|Overall Study|Objective progression or relapse|1|||
155235946|NCT00600821|560298203|FG000|Overall Study|Randomized but not treated|0|||
155235947|NCT00600821|560298204|FG001|Overall Study|Randomized but not treated|1|||
155235948|NCT00600821|560298203|FG000|Overall Study|Other|2|||
155235949|NCT00600821|560298204|FG001|Overall Study|Other|3|||
155235950|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
155235951|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
155235952|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
155235953|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
155235954|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
155235955|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
155235956|NCT02602288|560298207|FG000|12 Month Follow-up|Lost to Follow-up|0|||
155235957|NCT02602288|560298208|FG001|12 Month Follow-up|Lost to Follow-up|4|||
155235958|NCT02602288|560298207|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
155235959|NCT02602288|560298208|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
155235960|NCT01076400|560298212|FG000|Overall Study|Adverse Event|2|||
155235961|NCT01076400|560298213|FG001|Overall Study|Adverse Event|0|||
155235962|NCT01076400|560298214|FG002|Overall Study|Adverse Event|0|||
155235963|NCT01076400|560298212|FG000|Overall Study|Progressive Disease|5|||
155235964|NCT01076400|560298213|FG001|Overall Study|Progressive Disease|0|||
155235965|NCT01076400|560298214|FG002|Overall Study|Progressive Disease|0|||
155235966|NCT02766608|560298217|FG000|Overall Study|Adverse Event|27|||
155235967|NCT02766608|560298218|FG001|Overall Study|Adverse Event|22|||
155235968|NCT02766608|560298219|FG002|Overall Study|Adverse Event|17|||
155235969|NCT02766608|560298220|FG003|Overall Study|Adverse Event|13|||
155235970|NCT02766608|560298221|FG004|Overall Study|Adverse Event|12|||
155235971|NCT02766608|560298217|FG000|Overall Study|Withdrawal by Subject|21|||
155235972|NCT02766608|560298218|FG001|Overall Study|Withdrawal by Subject|20|||
155235973|NCT02766608|560298219|FG002|Overall Study|Withdrawal by Subject|24|||
155235974|NCT02766608|560298220|FG003|Overall Study|Withdrawal by Subject|13|||
155235975|NCT02766608|560298221|FG004|Overall Study|Withdrawal by Subject|10|||
155235976|NCT02766608|560298217|FG000|Overall Study|Lack of Efficacy|16|||
155235977|NCT02766608|560298218|FG001|Overall Study|Lack of Efficacy|15|||
155235978|NCT02766608|560298219|FG002|Overall Study|Lack of Efficacy|32|||
155235979|NCT02766608|560298220|FG003|Overall Study|Lack of Efficacy|8|||
155235980|NCT02766608|560298221|FG004|Overall Study|Lack of Efficacy|2|||
155235981|NCT02766608|560298217|FG000|Overall Study|Lost to Follow-up|6|||
155235982|NCT02766608|560298218|FG001|Overall Study|Lost to Follow-up|3|||
155235983|NCT02766608|560298219|FG002|Overall Study|Lost to Follow-up|5|||
155235984|NCT02766608|560298220|FG003|Overall Study|Lost to Follow-up|2|||
155235985|NCT02766608|560298221|FG004|Overall Study|Lost to Follow-up|2|||
155235986|NCT02766608|560298217|FG000|Overall Study|Physician Decision|3|||
155235987|NCT02766608|560298218|FG001|Overall Study|Physician Decision|2|||
155235988|NCT02766608|560298219|FG002|Overall Study|Physician Decision|3|||
155235989|NCT02766608|560298220|FG003|Overall Study|Physician Decision|1|||
155235990|NCT02766608|560298221|FG004|Overall Study|Physician Decision|2|||
155235991|NCT02766608|560298217|FG000|Overall Study|Protocol disc criteria|3|||
155235992|NCT02766608|560298218|FG001|Overall Study|Protocol disc criteria|3|||
155235993|NCT02766608|560298219|FG002|Overall Study|Protocol disc criteria|4|||
155235994|NCT02766608|560298220|FG003|Overall Study|Protocol disc criteria|0|||
155235995|NCT02766608|560298221|FG004|Overall Study|Protocol disc criteria|0|||
155235996|NCT02766608|560298217|FG000|Overall Study|Protocol Violation|0|||
155235997|NCT02766608|560298218|FG001|Overall Study|Protocol Violation|4|||
155235998|NCT02766608|560298219|FG002|Overall Study|Protocol Violation|4|||
155235999|NCT02766608|560298220|FG003|Overall Study|Protocol Violation|0|||
155236000|NCT02766608|560298221|FG004|Overall Study|Protocol Violation|1|||
155236001|NCT02766608|560298217|FG000|Overall Study|Administrative Reasons|3|||
155236002|NCT02766608|560298218|FG001|Overall Study|Administrative Reasons|1|||
155236003|NCT02766608|560298219|FG002|Overall Study|Administrative Reasons|1|||
155236004|NCT02766608|560298220|FG003|Overall Study|Administrative Reasons|0|||
155236005|NCT02766608|560298221|FG004|Overall Study|Administrative Reasons|0|||
155236006|NCT02080091|560298223|FG000|Overall Study|Study Terminated|22|||
155236007|NCT02080091|560298223|FG000|Overall Study|Death|1|||
155236008|NCT02080091|560298223|FG000|Overall Study|Withdrawal by Subject|1|||
155236009|NCT02080091|560298223|FG000|Overall Study|Other|1|||
155236010|NCT03019536|560298224|FG000|Overall Study|Withdrawal by Subject|1|||
155236011|NCT03019536|560298225|FG001|Overall Study|Withdrawal by Subject|1|||
155236012|NCT03019536|560298226|FG002|Overall Study|Withdrawal by Subject|0|||
155236013|NCT03019536|560298224|FG000|Overall Study|Adverse Event|0|||
155236014|NCT03019536|560298225|FG001|Overall Study|Adverse Event|0|||
155236015|NCT03019536|560298226|FG002|Overall Study|Adverse Event|2|||
155236016|NCT01265953|560298229|FG000|Overall Study|Non compliance|5|||
155236017|NCT01265953|560298230|FG001|Overall Study|Non compliance|3|||
155491471|NCT00563706|561225401|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
155236018|NCT03143829|560298231|FG000|Overall Study|Withdrawal by Subject|2|||
155236019|NCT03143829|560298232|FG001|Overall Study|Withdrawal by Subject|5|||
155236020|NCT03143829|560298231|FG000|Overall Study|Lost to Follow-up|0|||
155236021|NCT03143829|560298232|FG001|Overall Study|Lost to Follow-up|2|||
155236022|NCT03143829|560298231|FG000|Overall Study|Death|1|||
155236023|NCT03143829|560298232|FG001|Overall Study|Death|1|||
155236024|NCT03143829|560298231|FG000|Overall Study|changed treatment, no longer eligible|2|||
155236025|NCT03143829|560298232|FG001|Overall Study|changed treatment, no longer eligible|2|||
155236026|NCT03738865|560298237|FG000|Overall Study|Withdrawal by Subject|3|||
155236027|NCT03738865|560298238|FG001|Overall Study|Withdrawal by Subject|3|||
155236028|NCT03738865|560298237|FG000|Overall Study|Adverse Event|2|||
155236029|NCT03738865|560298238|FG001|Overall Study|Adverse Event|0|||
155236030|NCT03738865|560298237|FG000|Overall Study|Physician Decision|0|||
155236031|NCT03738865|560298238|FG001|Overall Study|Physician Decision|1|||
155236032|NCT04086472|560298239|FG000|Overall Study|Lost to Follow-up|1|||
155236033|NCT04086472|560298240|FG001|Overall Study|Lost to Follow-up|0|||
155236034|NCT04086472|560298241|FG002|Overall Study|Lost to Follow-up|0|||
155236035|NCT04086472|560298242|FG003|Overall Study|Lost to Follow-up|0|||
155236036|NCT04086472|560298243|FG004|Overall Study|Lost to Follow-up|1|||
155236037|NCT04086472|560298239|FG000|Overall Study|Physician Decision|0|||
155236038|NCT04086472|560298240|FG001|Overall Study|Physician Decision|1|||
155236039|NCT04086472|560298241|FG002|Overall Study|Physician Decision|1|||
155236040|NCT04086472|560298242|FG003|Overall Study|Physician Decision|0|||
155236041|NCT04086472|560298243|FG004|Overall Study|Physician Decision|0|||
155236042|NCT04086472|560298239|FG000|Overall Study|Withdrawal by Subject|1|||
155236043|NCT04086472|560298240|FG001|Overall Study|Withdrawal by Subject|1|||
155236044|NCT04086472|560298241|FG002|Overall Study|Withdrawal by Subject|1|||
155236045|NCT04086472|560298242|FG003|Overall Study|Withdrawal by Subject|0|||
155236046|NCT04086472|560298243|FG004|Overall Study|Withdrawal by Subject|0|||
155236047|NCT04086472|560298239|FG000|Overall Study|Various reasons|2|||
155236048|NCT04086472|560298240|FG001|Overall Study|Various reasons|0|||
155236049|NCT04086472|560298241|FG002|Overall Study|Various reasons|0|||
155236050|NCT04086472|560298242|FG003|Overall Study|Various reasons|3|||
155236051|NCT04086472|560298243|FG004|Overall Study|Various reasons|1|||
155236052|NCT03348904|560298244|FG000|Overall Study|Administrative reason by the sponsor|0|||
155236053|NCT03348904|560298245|FG001|Overall Study|Administrative reason by the sponsor|1|||
155236054|NCT03348904|560298246|FG002|Overall Study|Administrative reason by the sponsor|0|||
155236055|NCT00048724|560298247|FG000|Overall Study|Adverse Event|53|||
155236056|NCT00048724|560298248|FG001|Overall Study|Adverse Event|12|||
155236057|NCT00048724|560298247|FG000|Overall Study|Withdrawal by Subject|34|||
155236058|NCT00048724|560298248|FG001|Overall Study|Withdrawal by Subject|54|||
155236059|NCT00048724|560298247|FG000|Overall Study|Lost to Follow-up|5|||
155236060|NCT00048724|560298248|FG001|Overall Study|Lost to Follow-up|5|||
155236061|NCT00048724|560298247|FG000|Overall Study|Protocol-defined Clinical Event|17|||
155236062|NCT00048724|560298248|FG001|Overall Study|Protocol-defined Clinical Event|32|||
155236063|NCT00048724|560298247|FG000|Overall Study|Noncompliance With Protocol|4|||
155236064|NCT00048724|560298248|FG001|Overall Study|Noncompliance With Protocol|12|||
155236065|NCT00048724|560298247|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
155236066|NCT00048724|560298248|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
155236067|NCT00048724|560298247|FG000|Overall Study|Administrative|1|||
155236068|NCT00048724|560298248|FG001|Overall Study|Administrative|1|||
155236069|NCT01743092|560298249|FG000|Overall Study|Lost to Follow-up|14|||
155236070|NCT01743092|560298250|FG001|Overall Study|Lost to Follow-up|15|||
155236071|NCT03586869|560298251|FG000|Overall Study|Progressive Disease|3|||
155236072|NCT04116229|560298252|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
155236073|NCT04116229|560298253|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
155236074|NCT04116229|560298252|FG000|Overall Study|Scheduling not possible.|0|||
155236075|NCT04116229|560298253|FG001|Overall Study|Scheduling not possible.|1|||
155236076|NCT02809976|560298256|FG000|Overall Study|Lost to Follow-up|1|||
155236077|NCT02809976|560298256|FG000|Overall Study|Withdrawal by Subject|1|||
155236078|NCT00211081|560298258|FG000|Overall Study|Withdrawal by Subject|2|||
155236079|NCT00113516|560298259|FG000|Part 1|Adverse Event|6|||
155236080|NCT00113516|560298260|FG001|Part 1|Adverse Event|0|||
155236081|NCT00113516|560298259|FG000|Part 1|Death|3|||
155236082|NCT00113516|560298260|FG001|Part 1|Death|0|||
155236083|NCT00113516|560298259|FG000|Part 1|Other|3|||
155236084|NCT00113516|560298260|FG001|Part 1|Other|0|||
155236085|NCT00113516|560298259|FG000|Part 1|Withdrawal by Subject|2|||
155236086|NCT00113516|560298260|FG001|Part 1|Withdrawal by Subject|0|||
155236087|NCT00113516|560298259|FG000|Part 1|Lack of Efficacy|2|||
155236088|NCT00113516|560298260|FG001|Part 1|Lack of Efficacy|0|||
155236089|NCT00113516|560298259|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
155236090|NCT00113516|560298260|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
155236091|NCT00113516|560298259|FG000|Part 1|Laboratory Abnormality|1|||
155236092|NCT00113516|560298260|FG001|Part 1|Laboratory Abnormality|0|||
155236093|NCT00113516|560298259|FG000|Part 1|Ongoing|1|||
155236094|NCT00113516|560298260|FG001|Part 1|Ongoing|0|||
155236095|NCT00113516|560298259|FG000|Part 1|Missing|65|||
155236096|NCT00113516|560298260|FG001|Part 1|Missing|0|||
155236097|NCT00113516|560298259|FG000|Part 2|Adverse Event|0|||
155236098|NCT00113516|560298260|FG001|Part 2|Adverse Event|16|||
155236099|NCT00113516|560298259|FG000|Part 2|Death|0|||
155236100|NCT00113516|560298260|FG001|Part 2|Death|5|||
155236101|NCT00113516|560298259|FG000|Part 2|Lack of Efficacy|0|||
155236102|NCT00113516|560298260|FG001|Part 2|Lack of Efficacy|37|||
155236103|NCT00113516|560298259|FG000|Part 2|Withdrawal by Subject|0|||
155236104|NCT00113516|560298260|FG001|Part 2|Withdrawal by Subject|3|||
155236105|NCT00113516|560298259|FG000|Part 2|Other|0|||
155236106|NCT00113516|560298260|FG001|Part 2|Other|3|||
155236107|NCT00113516|560298259|FG000|Part 2|Laboratory Abnormality|0|||
155236108|NCT00113516|560298260|FG001|Part 2|Laboratory Abnormality|1|||
155236109|NCT00113516|560298259|FG000|Part 2|Ongoing|0|||
155236110|NCT00113516|560298260|FG001|Part 2|Ongoing|1|||
155236111|NCT00047463|560298261|FG000|Overall Study|Withdrawal by Subject|0|||
155236112|NCT00047463|560298262|FG001|Overall Study|Withdrawal by Subject|3|||
155236113|NCT00111228|560298270|FG000|Overall Study|Withdrawal by Subject|5|||
155236114|NCT00111228|560298271|FG001|Overall Study|Withdrawal by Subject|1|||
155236115|NCT00111228|560298272|FG002|Overall Study|Withdrawal by Subject|0|||
155236116|NCT03698773|560298279|FG000|Overall Study|Lost to Follow-up|2|||
155236117|NCT03698773|560298280|FG001|Overall Study|Lost to Follow-up|1|||
155236118|NCT03235024|560298281|FG000|Overall Study|Adverse Event|2|||
155236119|NCT03235024|560298282|FG001|Overall Study|Adverse Event|2|||
155236120|NCT03235024|560298281|FG000|Overall Study|Death|1|||
155236121|NCT03235024|560298282|FG001|Overall Study|Death|0|||
155236122|NCT03235024|560298281|FG000|Overall Study|Lost to Follow-up|2|||
155236123|NCT03235024|560298282|FG001|Overall Study|Lost to Follow-up|5|||
155236124|NCT03235024|560298281|FG000|Overall Study|Protocol Violation|1|||
155236125|NCT03235024|560298282|FG001|Overall Study|Protocol Violation|0|||
155236126|NCT03235024|560298281|FG000|Overall Study|Withdrawal by Subject|0|||
155236127|NCT03235024|560298282|FG001|Overall Study|Withdrawal by Subject|3|||
155236128|NCT02357576|560298283|FG000|Treatment Period|Withdrawal by Subject|0|||
155236129|NCT02357576|560298284|FG001|Treatment Period|Withdrawal by Subject|1|||
155236130|NCT02357576|560298283|FG000|Treatment Period|Physician Decision|0|||
155236131|NCT02357576|560298284|FG001|Treatment Period|Physician Decision|1|||
155236132|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
155236133|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
155236134|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
155236135|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
155236136|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
155236137|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
155236138|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
155236139|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
155236140|NCT03495908|560298285|FG000|Overall Study|Withdrawal by Subject|3|||
155236141|NCT03495908|560298286|FG001|Overall Study|Withdrawal by Subject|1|||
155236142|NCT03495908|560298285|FG000|Overall Study|Lost to Follow-up|1|||
155236143|NCT03495908|560298286|FG001|Overall Study|Lost to Follow-up|4|||
155236144|NCT03495908|560298285|FG000|Overall Study|Adverse Event|0|||
155236145|NCT03495908|560298286|FG001|Overall Study|Adverse Event|2|||
155236146|NCT03495908|560298285|FG000|Overall Study|Death|1|||
155236147|NCT03495908|560298286|FG001|Overall Study|Death|0|||
155236148|NCT03495908|560298285|FG000|Overall Study|Physician Decision|5|||
155236149|NCT03495908|560298286|FG001|Overall Study|Physician Decision|4|||
155236150|NCT03495908|560298285|FG000|Overall Study|No documented reason|0|||
155236151|NCT03495908|560298286|FG001|Overall Study|No documented reason|2|||
155236152|NCT02802345|560298291|FG000|Overall Study|Not Treated|0|||
155236153|NCT02802345|560298292|FG001|Overall Study|Not Treated|1|||
155236154|NCT02802345|560298291|FG000|Overall Study|Adverse Event|28|||
155236155|NCT02802345|560298292|FG001|Overall Study|Adverse Event|20|||
155236156|NCT02802345|560298291|FG000|Overall Study|Withdrawal by Subject|3|||
155236157|NCT02802345|560298292|FG001|Overall Study|Withdrawal by Subject|3|||
155236158|NCT02802345|560298291|FG000|Overall Study|Protocol Violation|0|||
155236159|NCT02802345|560298292|FG001|Overall Study|Protocol Violation|1|||
155236160|NCT02802345|560298291|FG000|Overall Study|Other than listed|1|||
155236161|NCT02802345|560298292|FG001|Overall Study|Other than listed|5|||
155236162|NCT02075320|560298295|FG000|Overall Study|Withdrawal by Subject|2|||
155236163|NCT01109316|560298297|FG000|Study Period 1|Adverse Event|0|||
155236164|NCT01109316|560298298|FG001|Study Period 1|Adverse Event|0|||
155236165|NCT01109316|560298299|FG002|Study Period 1|Adverse Event|1|||
155236166|NCT01109316|560298300|FG003|Study Period 1|Adverse Event|0|||
155236167|NCT01109316|560298301|FG004|Study Period 1|Adverse Event|0|||
155236168|NCT01109316|560298302|FG005|Study Period 1|Adverse Event|0|||
155236169|NCT01109316|560298297|FG000|Study Period 1|Lost to Follow-up|0|||
155236170|NCT01109316|560298298|FG001|Study Period 1|Lost to Follow-up|0|||
155236171|NCT01109316|560298299|FG002|Study Period 1|Lost to Follow-up|1|||
155236172|NCT01109316|560298300|FG003|Study Period 1|Lost to Follow-up|1|||
155236173|NCT01109316|560298301|FG004|Study Period 1|Lost to Follow-up|0|||
155236174|NCT01109316|560298302|FG005|Study Period 1|Lost to Follow-up|0|||
155236175|NCT01109316|560298297|FG000|Study Period 1|Withdrawal by Subject|0|||
155236176|NCT01109316|560298298|FG001|Study Period 1|Withdrawal by Subject|0|||
155236177|NCT01109316|560298299|FG002|Study Period 1|Withdrawal by Subject|1|||
155236178|NCT01109316|560298300|FG003|Study Period 1|Withdrawal by Subject|0|||
155236179|NCT01109316|560298301|FG004|Study Period 1|Withdrawal by Subject|2|||
155236180|NCT01109316|560298302|FG005|Study Period 1|Withdrawal by Subject|0|||
155236181|NCT01109316|560298297|FG000|Study Period 1|Sponsor Decision|0|||
155236182|NCT01109316|560298298|FG001|Study Period 1|Sponsor Decision|0|||
155236183|NCT01109316|560298299|FG002|Study Period 1|Sponsor Decision|0|||
155236184|NCT01109316|560298300|FG003|Study Period 1|Sponsor Decision|0|||
155236185|NCT01109316|560298301|FG004|Study Period 1|Sponsor Decision|0|||
155236186|NCT01109316|560298302|FG005|Study Period 1|Sponsor Decision|2|||
155236187|NCT01109316|560298297|FG000|Study Period 2|Entry Criteria Not Met|0|||
155236188|NCT01109316|560298298|FG001|Study Period 2|Entry Criteria Not Met|1|||
155236189|NCT01109316|560298299|FG002|Study Period 2|Entry Criteria Not Met|0|||
155236190|NCT01109316|560298300|FG003|Study Period 2|Entry Criteria Not Met|0|||
155236191|NCT01109316|560298301|FG004|Study Period 2|Entry Criteria Not Met|0|||
155236192|NCT01109316|560298302|FG005|Study Period 2|Entry Criteria Not Met|0|||
155236193|NCT01109316|560298297|FG000|Study Period 2|Physician Decision|0|||
155236194|NCT01109316|560298298|FG001|Study Period 2|Physician Decision|0|||
155236195|NCT01109316|560298299|FG002|Study Period 2|Physician Decision|0|||
155236196|NCT01109316|560298300|FG003|Study Period 2|Physician Decision|1|||
155236197|NCT01109316|560298301|FG004|Study Period 2|Physician Decision|0|||
155236198|NCT01109316|560298302|FG005|Study Period 2|Physician Decision|0|||
155236199|NCT01109316|560298297|FG000|Study Period 2|Protocol Violation|1|||
155236200|NCT01109316|560298298|FG001|Study Period 2|Protocol Violation|0|||
155236201|NCT01109316|560298299|FG002|Study Period 2|Protocol Violation|0|||
155236202|NCT01109316|560298300|FG003|Study Period 2|Protocol Violation|0|||
155236203|NCT01109316|560298301|FG004|Study Period 2|Protocol Violation|0|||
155236204|NCT01109316|560298302|FG005|Study Period 2|Protocol Violation|0|||
155236205|NCT01109316|560298297|FG000|Study Period 2|Withdrawal by Subject|0|||
155236206|NCT01109316|560298298|FG001|Study Period 2|Withdrawal by Subject|0|||
155236207|NCT01109316|560298299|FG002|Study Period 2|Withdrawal by Subject|1|||
155236208|NCT01109316|560298300|FG003|Study Period 2|Withdrawal by Subject|0|||
155236209|NCT01109316|560298301|FG004|Study Period 2|Withdrawal by Subject|0|||
155236210|NCT01109316|560298302|FG005|Study Period 2|Withdrawal by Subject|1|||
155236211|NCT01109316|560298297|FG000|Study Period 3|Lost to Follow-up|0|||
155236212|NCT01109316|560298298|FG001|Study Period 3|Lost to Follow-up|0|||
155236213|NCT01109316|560298299|FG002|Study Period 3|Lost to Follow-up|0|||
155236214|NCT01109316|560298300|FG003|Study Period 3|Lost to Follow-up|0|||
155236215|NCT01109316|560298301|FG004|Study Period 3|Lost to Follow-up|1|||
155236216|NCT01109316|560298302|FG005|Study Period 3|Lost to Follow-up|0|||
155236217|NCT01109316|560298297|FG000|Study Period 3|Withdrawal by Subject|1|||
155236218|NCT01109316|560298298|FG001|Study Period 3|Withdrawal by Subject|0|||
155236219|NCT01109316|560298299|FG002|Study Period 3|Withdrawal by Subject|0|||
155236220|NCT01109316|560298300|FG003|Study Period 3|Withdrawal by Subject|0|||
155236221|NCT01109316|560298301|FG004|Study Period 3|Withdrawal by Subject|1|||
155236222|NCT01109316|560298302|FG005|Study Period 3|Withdrawal by Subject|0|||
155236223|NCT01826825|560298312|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
155236224|NCT01826825|560298313|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
155236225|NCT00515827|560298314|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
155236226|NCT00515827|560298315|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
155236227|NCT00515827|560298314|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
155236228|NCT00515827|560298315|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
155236229|NCT03254134|560298317|FG000|Overall Study|Not eligible patients|599|||
155236230|NCT03254134|560298318|FG001|Overall Study|Not eligible patients|3630|||
155236231|NCT01712984|560298323|FG000|Overall Study|Adverse Event|0|||
155236232|NCT01712984|560298324|FG001|Overall Study|Adverse Event|0|||
155236233|NCT01712984|560298325|FG002|Overall Study|Adverse Event|1|||
155236234|NCT01712984|560298323|FG000|Overall Study|Protocol Violation|2|||
155236235|NCT01712984|560298324|FG001|Overall Study|Protocol Violation|0|||
155236236|NCT01712984|560298325|FG002|Overall Study|Protocol Violation|1|||
155236237|NCT01712984|560298323|FG000|Overall Study|Lost to Follow-up|8|||
155236238|NCT01712984|560298324|FG001|Overall Study|Lost to Follow-up|10|||
155236239|NCT01712984|560298325|FG002|Overall Study|Lost to Follow-up|1|||
155236240|NCT01712984|560298323|FG000|Overall Study|Withdrawal by Subject|6|||
155236241|NCT01712984|560298324|FG001|Overall Study|Withdrawal by Subject|6|||
155236242|NCT01712984|560298325|FG002|Overall Study|Withdrawal by Subject|7|||
155236243|NCT01552772|560298326|FG000|Overall Study|Lost to Follow-up|2|||
155236244|NCT01552772|560298326|FG000|Overall Study|Adverse Event|1|||
155236245|NCT01552772|560298326|FG000|Overall Study|Protocol Deviation|1|||
155236246|NCT01848990|560298327|FG000|Overall Study|Adverse Event|6|||
155236247|NCT01848990|560298328|FG001|Overall Study|Adverse Event|2|||
155236248|NCT01848990|560298329|FG002|Overall Study|Adverse Event|0|||
155236249|NCT01848990|560298327|FG000|Overall Study|Lost to Follow-up|6|||
155236250|NCT01848990|560298328|FG001|Overall Study|Lost to Follow-up|2|||
155236251|NCT01848990|560298329|FG002|Overall Study|Lost to Follow-up|2|||
155236252|NCT01848990|560298327|FG000|Overall Study|Protocol Violation|1|||
155236253|NCT01848990|560298328|FG001|Overall Study|Protocol Violation|1|||
155236254|NCT01848990|560298329|FG002|Overall Study|Protocol Violation|0|||
155236255|NCT01848990|560298327|FG000|Overall Study|Withdrawal by Subject|29|||
155236256|NCT01848990|560298328|FG001|Overall Study|Withdrawal by Subject|10|||
155236257|NCT01848990|560298329|FG002|Overall Study|Withdrawal by Subject|11|||
155236258|NCT01848990|560298327|FG000|Overall Study|Physician Decision|1|||
155236259|NCT01848990|560298328|FG001|Overall Study|Physician Decision|1|||
155236260|NCT01848990|560298329|FG002|Overall Study|Physician Decision|0|||
155236261|NCT01848990|560298327|FG000|Overall Study|Non Compliance|1|||
155236262|NCT01848990|560298328|FG001|Overall Study|Non Compliance|0|||
155236263|NCT01848990|560298329|FG002|Overall Study|Non Compliance|0|||
155236264|NCT01848990|560298327|FG000|Overall Study|Death|1|||
155236265|NCT01848990|560298328|FG001|Overall Study|Death|0|||
155236266|NCT01848990|560298329|FG002|Overall Study|Death|1|||
155236267|NCT01848990|560298327|FG000|Overall Study|Other|1|||
155236268|NCT01848990|560298328|FG001|Overall Study|Other|4|||
155236269|NCT01848990|560298329|FG002|Overall Study|Other|2|||
155236270|NCT00512096|560298338|FG000|Overall Study|Adverse Event|2|||
155236271|NCT00512096|560298338|FG000|Overall Study|Withdrawal by Subject|2|||
155236272|NCT00512096|560298338|FG000|Overall Study|Lack of Efficacy|3|||
155236273|NCT02391948|560300096|FG000|6-month Assessment|Death|0|||
155236274|NCT02391948|560300097|FG001|6-month Assessment|Death|0|||
155236275|NCT02391948|560300098|FG002|6-month Assessment|Death|0|||
155236276|NCT02391948|560300099|FG003|6-month Assessment|Death|0|||
155236277|NCT02391948|560300100|FG004|6-month Assessment|Death|1|||
155236278|NCT02391948|560300096|FG000|6-month Assessment|Withdrawal by Subject|0|||
155236279|NCT02391948|560300097|FG001|6-month Assessment|Withdrawal by Subject|0|||
155236280|NCT02391948|560300098|FG002|6-month Assessment|Withdrawal by Subject|1|||
155236281|NCT02391948|560300099|FG003|6-month Assessment|Withdrawal by Subject|2|||
155236282|NCT02391948|560300100|FG004|6-month Assessment|Withdrawal by Subject|0|||
155236283|NCT02391948|560300096|FG000|6-month Assessment|Lost to Follow-up|4|||
155236284|NCT02391948|560300097|FG001|6-month Assessment|Lost to Follow-up|5|||
155236285|NCT02391948|560300098|FG002|6-month Assessment|Lost to Follow-up|2|||
155236286|NCT02391948|560300099|FG003|6-month Assessment|Lost to Follow-up|3|||
155236287|NCT02391948|560300100|FG004|6-month Assessment|Lost to Follow-up|1|||
155236288|NCT02391948|560300096|FG000|6-month Assessment|Medical issue/illness|1|||
155236289|NCT02391948|560300097|FG001|6-month Assessment|Medical issue/illness|1|||
155236290|NCT02391948|560300098|FG002|6-month Assessment|Medical issue/illness|0|||
155236291|NCT02391948|560300099|FG003|6-month Assessment|Medical issue/illness|0|||
155236292|NCT02391948|560300100|FG004|6-month Assessment|Medical issue/illness|0|||
155236293|NCT02391948|560300096|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
155236294|NCT02391948|560300097|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
155236295|NCT02391948|560300098|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
155236296|NCT02391948|560300099|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
155236297|NCT02391948|560300100|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
155236298|NCT02391948|560300096|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
155236299|NCT02391948|560300097|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
155236300|NCT02391948|560300098|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
155236301|NCT02391948|560300099|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
155236302|NCT02391948|560300100|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
155236303|NCT02391948|560300096|FG000|12-month Assessment|Death|0|||
155236304|NCT02391948|560300097|FG001|12-month Assessment|Death|0|||
155236305|NCT02391948|560300098|FG002|12-month Assessment|Death|0|||
155236306|NCT02391948|560300099|FG003|12-month Assessment|Death|1|||
155236307|NCT02391948|560300100|FG004|12-month Assessment|Death|0|||
155236308|NCT02391948|560300096|FG000|12-month Assessment|Withdrawal by Subject|1|||
155236309|NCT02391948|560300097|FG001|12-month Assessment|Withdrawal by Subject|0|||
155236310|NCT02391948|560300098|FG002|12-month Assessment|Withdrawal by Subject|0|||
155236311|NCT02391948|560300099|FG003|12-month Assessment|Withdrawal by Subject|1|||
155236312|NCT02391948|560300100|FG004|12-month Assessment|Withdrawal by Subject|0|||
155236313|NCT02391948|560300096|FG000|12-month Assessment|Lost to Follow-up|5|||
155236314|NCT02391948|560300097|FG001|12-month Assessment|Lost to Follow-up|4|||
155236315|NCT02391948|560300098|FG002|12-month Assessment|Lost to Follow-up|4|||
155236316|NCT02391948|560300099|FG003|12-month Assessment|Lost to Follow-up|4|||
155236317|NCT02391948|560300100|FG004|12-month Assessment|Lost to Follow-up|5|||
155236318|NCT02391948|560300096|FG000|12-month Assessment|Medical issue/illness|0|||
155236319|NCT02391948|560300097|FG001|12-month Assessment|Medical issue/illness|1|||
155236320|NCT02391948|560300098|FG002|12-month Assessment|Medical issue/illness|0|||
155236321|NCT02391948|560300099|FG003|12-month Assessment|Medical issue/illness|1|||
155236322|NCT02391948|560300100|FG004|12-month Assessment|Medical issue/illness|0|||
155236323|NCT02391948|560300096|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
155236324|NCT02391948|560300097|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
155236325|NCT02391948|560300098|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
155236326|NCT02391948|560300099|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
155236327|NCT02391948|560300100|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
155236328|NCT02391948|560300096|FG000|18-month Assessment|Death|0|||
155236329|NCT02391948|560300097|FG001|18-month Assessment|Death|0|||
155236330|NCT02391948|560300098|FG002|18-month Assessment|Death|0|||
155236331|NCT02391948|560300099|FG003|18-month Assessment|Death|1|||
155236332|NCT02391948|560300100|FG004|18-month Assessment|Death|1|||
155236333|NCT02391948|560300096|FG000|18-month Assessment|Withdrawal by Subject|1|||
155236334|NCT02391948|560300097|FG001|18-month Assessment|Withdrawal by Subject|0|||
155236335|NCT02391948|560300098|FG002|18-month Assessment|Withdrawal by Subject|0|||
155236336|NCT02391948|560300099|FG003|18-month Assessment|Withdrawal by Subject|1|||
155236337|NCT02391948|560300100|FG004|18-month Assessment|Withdrawal by Subject|0|||
155236338|NCT02391948|560300096|FG000|18-month Assessment|Lost to Follow-up|2|||
155236339|NCT02391948|560300097|FG001|18-month Assessment|Lost to Follow-up|6|||
155236340|NCT02391948|560300098|FG002|18-month Assessment|Lost to Follow-up|2|||
155236341|NCT02391948|560300099|FG003|18-month Assessment|Lost to Follow-up|2|||
155236342|NCT02391948|560300100|FG004|18-month Assessment|Lost to Follow-up|3|||
155236343|NCT02391948|560300096|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
155236344|NCT02391948|560300097|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
155236345|NCT02391948|560300098|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
155236346|NCT02391948|560300099|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
155236347|NCT02391948|560300100|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
155236348|NCT02391948|560300096|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
155236349|NCT02391948|560300097|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
155236350|NCT02391948|560300098|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
155236351|NCT02391948|560300099|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
155236352|NCT02391948|560300100|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
155236353|NCT02391948|560300096|FG000|24-month Assessment|Death|0|||
155236354|NCT02391948|560300097|FG001|24-month Assessment|Death|0|||
155236355|NCT02391948|560300098|FG002|24-month Assessment|Death|0|||
155236356|NCT02391948|560300099|FG003|24-month Assessment|Death|0|||
155236357|NCT02391948|560300100|FG004|24-month Assessment|Death|1|||
155236358|NCT02391948|560300096|FG000|24-month Assessment|Withdrawal by Subject|1|||
155236359|NCT02391948|560300097|FG001|24-month Assessment|Withdrawal by Subject|1|||
155236360|NCT02391948|560300098|FG002|24-month Assessment|Withdrawal by Subject|0|||
155236361|NCT02391948|560300099|FG003|24-month Assessment|Withdrawal by Subject|0|||
155236362|NCT02391948|560300100|FG004|24-month Assessment|Withdrawal by Subject|1|||
155236363|NCT02391948|560300096|FG000|24-month Assessment|Lost to Follow-up|5|||
155236364|NCT02391948|560300097|FG001|24-month Assessment|Lost to Follow-up|4|||
155236365|NCT02391948|560300098|FG002|24-month Assessment|Lost to Follow-up|0|||
155236366|NCT02391948|560300099|FG003|24-month Assessment|Lost to Follow-up|0|||
155236367|NCT02391948|560300100|FG004|24-month Assessment|Lost to Follow-up|0|||
155236368|NCT02391948|560300096|FG000|24-month Assessment|Medical issue/illness|0|||
155236369|NCT02391948|560300097|FG001|24-month Assessment|Medical issue/illness|0|||
155236370|NCT02391948|560300098|FG002|24-month Assessment|Medical issue/illness|1|||
155236371|NCT02391948|560300099|FG003|24-month Assessment|Medical issue/illness|0|||
155236372|NCT02391948|560300100|FG004|24-month Assessment|Medical issue/illness|0|||
155236373|NCT02391948|560300096|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
155236374|NCT02391948|560300097|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
155236375|NCT02391948|560300098|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
155236376|NCT02391948|560300099|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
155236377|NCT02391948|560300100|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
155236378|NCT01602315|560300101|FG000|Overall Study|Protocol Violation|0|||
155236379|NCT01602315|560300102|FG001|Overall Study|Protocol Violation|0|||
155236380|NCT01602315|560300103|FG002|Overall Study|Protocol Violation|0|||
155236381|NCT01602315|560300104|FG003|Overall Study|Protocol Violation|0|||
155236382|NCT01602315|560300105|FG004|Overall Study|Protocol Violation|0|||
155236383|NCT01602315|560300106|FG005|Overall Study|Protocol Violation|1|||
155236384|NCT01602315|560300107|FG006|Overall Study|Protocol Violation|0|||
155236385|NCT01602315|560300101|FG000|Overall Study|Physician Decision|2|||
155236386|NCT01602315|560300102|FG001|Overall Study|Physician Decision|0|||
155236387|NCT01602315|560300103|FG002|Overall Study|Physician Decision|0|||
155236388|NCT01602315|560300104|FG003|Overall Study|Physician Decision|0|||
155236389|NCT01602315|560300105|FG004|Overall Study|Physician Decision|2|||
155236390|NCT01602315|560300106|FG005|Overall Study|Physician Decision|1|||
155236391|NCT01602315|560300107|FG006|Overall Study|Physician Decision|1|||
155236392|NCT01602315|560300101|FG000|Overall Study|Disease progression|6|||
155236393|NCT01602315|560300102|FG001|Overall Study|Disease progression|3|||
155236394|NCT01602315|560300103|FG002|Overall Study|Disease progression|10|||
155236395|NCT01602315|560300104|FG003|Overall Study|Disease progression|1|||
155236396|NCT01602315|560300105|FG004|Overall Study|Disease progression|41|||
155236397|NCT01602315|560300106|FG005|Overall Study|Disease progression|12|||
155236398|NCT01602315|560300107|FG006|Overall Study|Disease progression|15|||
155236399|NCT01602315|560300101|FG000|Overall Study|Death|1|||
155236400|NCT01602315|560300102|FG001|Overall Study|Death|1|||
155236401|NCT01602315|560300103|FG002|Overall Study|Death|1|||
155236402|NCT01602315|560300104|FG003|Overall Study|Death|1|||
155236403|NCT01602315|560300105|FG004|Overall Study|Death|7|||
155236404|NCT01602315|560300106|FG005|Overall Study|Death|2|||
155236405|NCT01602315|560300107|FG006|Overall Study|Death|2|||
155236406|NCT01602315|560300101|FG000|Overall Study|Withdrawal by Subject|2|||
155236407|NCT01602315|560300102|FG001|Overall Study|Withdrawal by Subject|0|||
155236408|NCT01602315|560300103|FG002|Overall Study|Withdrawal by Subject|2|||
155236409|NCT01602315|560300104|FG003|Overall Study|Withdrawal by Subject|0|||
155236410|NCT01602315|560300105|FG004|Overall Study|Withdrawal by Subject|6|||
155236411|NCT01602315|560300106|FG005|Overall Study|Withdrawal by Subject|0|||
155236412|NCT01602315|560300107|FG006|Overall Study|Withdrawal by Subject|1|||
155236413|NCT01602315|560300101|FG000|Overall Study|Adverse Event|5|||
155236414|NCT01602315|560300102|FG001|Overall Study|Adverse Event|1|||
155236415|NCT01602315|560300103|FG002|Overall Study|Adverse Event|5|||
155236416|NCT01602315|560300104|FG003|Overall Study|Adverse Event|4|||
155236417|NCT01602315|560300105|FG004|Overall Study|Adverse Event|15|||
155236418|NCT01602315|560300106|FG005|Overall Study|Adverse Event|3|||
155236419|NCT01602315|560300107|FG006|Overall Study|Adverse Event|9|||
155236420|NCT01602315|560300101|FG000|Overall Study|Subject/guardian decision|0|||
155236421|NCT01602315|560300102|FG001|Overall Study|Subject/guardian decision|0|||
155236422|NCT01602315|560300103|FG002|Overall Study|Subject/guardian decision|0|||
155236423|NCT01602315|560300104|FG003|Overall Study|Subject/guardian decision|0|||
155236424|NCT01602315|560300105|FG004|Overall Study|Subject/guardian decision|0|||
155236425|NCT01602315|560300106|FG005|Overall Study|Subject/guardian decision|0|||
155236426|NCT01602315|560300107|FG006|Overall Study|Subject/guardian decision|1|||
155236427|NCT01602315|560300101|FG000|Overall Study|Cross-over patients to combo treatment|0|||
155236428|NCT01602315|560300102|FG001|Overall Study|Cross-over patients to combo treatment|0|||
155236429|NCT01602315|560300103|FG002|Overall Study|Cross-over patients to combo treatment|0|||
155236430|NCT01602315|560300104|FG003|Overall Study|Cross-over patients to combo treatment|0|||
155236431|NCT01602315|560300105|FG004|Overall Study|Cross-over patients to combo treatment|0|||
155236432|NCT01602315|560300106|FG005|Overall Study|Cross-over patients to combo treatment|16|||
155236433|NCT01602315|560300107|FG006|Overall Study|Cross-over patients to combo treatment|0|||
155236434|NCT02212730|560300110|FG000|Overall Study|Tumor not of the required cell histology|1|||
155236435|NCT02212730|560300111|FG001|Overall Study|Tumor not of the required cell histology|0|||
155236436|NCT02212730|560300110|FG000|Overall Study|Withdrawal by Subject|1|||
155236437|NCT02212730|560300111|FG001|Overall Study|Withdrawal by Subject|0|||
155236438|NCT02212730|560300110|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
155236439|NCT02212730|560300111|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
155236440|NCT02691455|560300114|FG000|Overall Study|Withdrawal by Subject|1|||
155236441|NCT02691455|560300115|FG001|Overall Study|Withdrawal by Subject|2|||
155236442|NCT02691455|560300114|FG000|Overall Study|Lost to Follow-up|15|||
155236443|NCT02691455|560300115|FG001|Overall Study|Lost to Follow-up|15|||
155236444|NCT02057757|560300116|FG000|Overall Study|Withdrawal by Subject|3|||
155236445|NCT02057757|560300117|FG001|Overall Study|Withdrawal by Subject|5|||
155236446|NCT02057757|560300116|FG000|Overall Study|Death|2|||
155236447|NCT02057757|560300117|FG001|Overall Study|Death|0|||
155236448|NCT02057757|560300116|FG000|Overall Study|Lost to Follow-up|8|||
155236449|NCT02057757|560300117|FG001|Overall Study|Lost to Follow-up|3|||
155236450|NCT02057757|560300116|FG000|Overall Study|Non-compliance|1|||
155236451|NCT02057757|560300117|FG001|Overall Study|Non-compliance|0|||
155236452|NCT00440271|560300118|FG000|Overall Study|Protocol Violation|1|||
155236453|NCT00440271|560300119|FG001|Overall Study|Protocol Violation|1|||
155236454|NCT00440271|560300118|FG000|Overall Study|Adverse Event|0|||
155236455|NCT00440271|560300119|FG001|Overall Study|Adverse Event|1|||
155236456|NCT00440271|560300118|FG000|Overall Study|Lost to Follow-up|1|||
155236457|NCT00440271|560300119|FG001|Overall Study|Lost to Follow-up|0|||
155236458|NCT00440271|560300118|FG000|Overall Study|Withdrawal by Subject|0|||
155236459|NCT00440271|560300119|FG001|Overall Study|Withdrawal by Subject|2|||
155236460|NCT00440271|560300118|FG000|Overall Study|Lack of Efficacy|0|||
155236461|NCT00440271|560300119|FG001|Overall Study|Lack of Efficacy|1|||
155236462|NCT00440271|560300118|FG000|Overall Study|Due to closure of trial|8|||
155236463|NCT00440271|560300119|FG001|Overall Study|Due to closure of trial|10|||
155236464|NCT00440271|560300118|FG000|Overall Study|Other|2|||
155236465|NCT00440271|560300119|FG001|Overall Study|Other|0|||
155236466|NCT02252081|560300132|FG000|Overall Study|Withdrawal by Subject|2|||
155236467|NCT02252081|560300133|FG001|Overall Study|Withdrawal by Subject|1|||
155236468|NCT02252081|560300132|FG000|Overall Study|Adverse Event|4|||
155236469|NCT02252081|560300133|FG001|Overall Study|Adverse Event|1|||
155236470|NCT02252081|560300132|FG000|Overall Study|non compliance & others|0|||
155236471|NCT02252081|560300133|FG001|Overall Study|non compliance & others|2|||
155236472|NCT00436280|560300139|FG000|Period 1: Induction|Adverse Event|8|||
155236473|NCT00436280|560300139|FG000|Period 1: Induction|Progressive Disease|12|||
155236474|NCT00436280|560300139|FG000|Period 1: Induction|Stable Disease|6|||
155236475|NCT00436280|560300139|FG000|Period 1: Induction|Withdrawal by Subject|1|||
155236476|NCT00436280|560300139|FG000|Period 1: Induction|Death|1|||
155236477|NCT00436280|560300139|FG000|Period 2: Consolidation|Adverse Event|1|||
155236478|NCT00436280|560300139|FG000|Period 2: Consolidation|Progressive Disease|10|||
155236479|NCT00436280|560300139|FG000|Period 2: Consolidation|Stable Disease|1|||
155236480|NCT00436280|560300139|FG000|Period 2: Consolidation|Physician Decision|2|||
155236481|NCT00436280|560300139|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
155236482|NCT00436280|560300139|FG000|Period 2: Consolidation|Death|1|||
155236483|NCT00436280|560300139|FG000|Period 3: Maintenance|Adverse Event|6|||
155236484|NCT00436280|560300139|FG000|Period 3: Maintenance|Progressive Disease|12|||
155236485|NCT03603964|560300140|FG000|Overall Study|Death|9|||
155236486|NCT03603964|560300140|FG000|Overall Study|Withdrawal by participant|7|||
155236487|NCT03603964|560300140|FG000|Overall Study|Study terminated by Sponsor|19|||
155236488|NCT00563797|560300141|FG000|Overall Study|Lost to Follow-up|7|||
155236489|NCT00563797|560300142|FG001|Overall Study|Lost to Follow-up|2|||
155236490|NCT03755765|560300143|FG000|Overall Study|Withdrawal by Subject|2|||
155236491|NCT03755765|560300144|FG001|Overall Study|Withdrawal by Subject|4|||
155236492|NCT03755765|560300145|FG002|Overall Study|Withdrawal by Subject|4|||
155236493|NCT01158222|560300148|FG000|Overall Study|Not eligible for intermediate phase|17|||
155236494|NCT01490060|560300149|FG000|Cycle 1|Change of Treatment|0|||
155236495|NCT01490060|560300150|FG001|Cycle 1|Change of Treatment|1|||
155236496|NCT01490060|560300151|FG002|Cycle 1|Change of Treatment|1|||
155236497|NCT01490060|560300152|FG003|Cycle 1|Change of Treatment|1|||
155236498|NCT01490060|560300149|FG000|Cycle 1|Insurance Denied|0|||
155236499|NCT01490060|560300150|FG001|Cycle 1|Insurance Denied|0|||
155236500|NCT01490060|560300151|FG002|Cycle 1|Insurance Denied|2|||
155236501|NCT01490060|560300152|FG003|Cycle 1|Insurance Denied|0|||
155236502|NCT01490060|560300149|FG000|Cycle 1|Withdrawal by Subject|0|||
155236503|NCT01490060|560300150|FG001|Cycle 1|Withdrawal by Subject|0|||
155236504|NCT01490060|560300151|FG002|Cycle 1|Withdrawal by Subject|0|||
155236505|NCT01490060|560300152|FG003|Cycle 1|Withdrawal by Subject|1|||
155236506|NCT01490060|560300149|FG000|Cycle 1|Treatment at Another Facility|0|||
155236507|NCT01490060|560300150|FG001|Cycle 1|Treatment at Another Facility|0|||
155236508|NCT01490060|560300151|FG002|Cycle 1|Treatment at Another Facility|0|||
155236509|NCT01490060|560300152|FG003|Cycle 1|Treatment at Another Facility|1|||
155236510|NCT01490060|560300149|FG000|Cycle 2|Change of Treatment|1|||
155236511|NCT01490060|560300150|FG001|Cycle 2|Change of Treatment|1|||
155236512|NCT01490060|560300151|FG002|Cycle 2|Change of Treatment|0|||
155236513|NCT01490060|560300152|FG003|Cycle 2|Change of Treatment|0|||
155236514|NCT01490060|560300149|FG000|Cycle 2|Non-Compliance|0|||
155236515|NCT01490060|560300150|FG001|Cycle 2|Non-Compliance|0|||
155236516|NCT01490060|560300151|FG002|Cycle 2|Non-Compliance|1|||
155236517|NCT01490060|560300152|FG003|Cycle 2|Non-Compliance|0|||
155236518|NCT01490060|560300149|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
155236519|NCT01490060|560300150|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236520|NCT01490060|560300151|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236521|NCT01490060|560300152|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236522|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
155236523|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
155236524|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
155236525|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
155236526|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
155236527|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
155236528|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
155236529|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
155236530|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
155236531|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
155236532|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
155236533|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
155236534|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
155236535|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
155491472|NCT00563706|561225393|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
155491473|NCT00563706|561225394|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
155491474|NCT00563706|561225395|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
155491475|NCT00563706|561225396|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
155491476|NCT00563706|561225397|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
155491477|NCT00563706|561225398|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
155491478|NCT00563706|561225399|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
155491479|NCT00563706|561225400|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
155491480|NCT00563706|561225401|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
155491481|NCT00563706|561225393|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
155491482|NCT00563706|561225394|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491483|NCT00563706|561225395|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491484|NCT00563706|561225396|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491485|NCT00563706|561225397|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491486|NCT00563706|561225398|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155236536|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
155236537|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
155236538|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
155236539|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
155236540|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
155236541|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
155236542|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
155236543|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
155236544|NCT02399085|560300161|FG000|Overall Study|Adverse Event|16|||
155236545|NCT02399085|560300161|FG000|Overall Study|Death|2|||
155236546|NCT02399085|560300161|FG000|Overall Study|Withdrawal by Subject|8|||
155236547|NCT02399085|560300161|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
155236548|NCT02399085|560300161|FG000|Overall Study|Physician Decision|5|||
155236549|NCT00699699|560300162|FG000|Overall Study|Adverse Event|36|||
155236550|NCT00699699|560300162|FG000|Overall Study|Individual different reasons|21|||
155236551|NCT00414050|560300163|FG000|Overall Study|Adverse Event|1|||
155236552|NCT00414050|560300164|FG001|Overall Study|Adverse Event|1|||
155236553|NCT00414050|560300165|FG002|Overall Study|Adverse Event|1|||
155236554|NCT00414050|560300166|FG003|Overall Study|Adverse Event|1|||
155236555|NCT00414050|560300163|FG000|Overall Study|Lost to Follow-up|2|||
155236556|NCT00414050|560300164|FG001|Overall Study|Lost to Follow-up|2|||
155236557|NCT00414050|560300165|FG002|Overall Study|Lost to Follow-up|1|||
155236558|NCT00414050|560300166|FG003|Overall Study|Lost to Follow-up|1|||
155236559|NCT00414050|560300163|FG000|Overall Study|Withdrawal by Subject|5|||
155236560|NCT00414050|560300164|FG001|Overall Study|Withdrawal by Subject|3|||
155236561|NCT00414050|560300165|FG002|Overall Study|Withdrawal by Subject|2|||
155236562|NCT00414050|560300166|FG003|Overall Study|Withdrawal by Subject|4|||
155236563|NCT00414050|560300163|FG000|Overall Study|Subject discontinued for other reason|1|||
155236564|NCT00414050|560300164|FG001|Overall Study|Subject discontinued for other reason|2|||
155236565|NCT00414050|560300165|FG002|Overall Study|Subject discontinued for other reason|2|||
155236566|NCT00414050|560300166|FG003|Overall Study|Subject discontinued for other reason|1|||
155236567|NCT00414050|560300163|FG000|Overall Study|Subject Moved|0|||
155236568|NCT00414050|560300164|FG001|Overall Study|Subject Moved|0|||
155236569|NCT00414050|560300165|FG002|Overall Study|Subject Moved|0|||
155236570|NCT00414050|560300166|FG003|Overall Study|Subject Moved|1|||
155236571|NCT00720876|560300177|FG000|Overall Study|found to be ineligible after starting tx|2|||
155236572|NCT03304379|560300179|FG000|Overall Study|Protocol Violation|8|||
155236573|NCT03304379|560300180|FG001|Overall Study|Protocol Violation|10|||
155236574|NCT03304379|560300181|FG002|Overall Study|Protocol Violation|5|||
155236575|NCT03304379|560300182|FG003|Overall Study|Protocol Violation|0|||
155236576|NCT03304379|560300183|FG004|Overall Study|Protocol Violation|2|||
155236577|NCT03304379|560300179|FG000|Overall Study|Adverse Event|4|||
155236578|NCT03304379|560300180|FG001|Overall Study|Adverse Event|20|||
155236579|NCT03304379|560300181|FG002|Overall Study|Adverse Event|17|||
155236580|NCT03304379|560300182|FG003|Overall Study|Adverse Event|1|||
155236581|NCT03304379|560300183|FG004|Overall Study|Adverse Event|0|||
155236582|NCT03304379|560300179|FG000|Overall Study|Lack of Efficacy|17|||
155236583|NCT03304379|560300180|FG001|Overall Study|Lack of Efficacy|16|||
155236584|NCT03304379|560300181|FG002|Overall Study|Lack of Efficacy|20|||
155236585|NCT03304379|560300182|FG003|Overall Study|Lack of Efficacy|0|||
155236586|NCT03304379|560300183|FG004|Overall Study|Lack of Efficacy|0|||
155236587|NCT03304379|560300179|FG000|Overall Study|Physician Decision|6|||
155236588|NCT03304379|560300180|FG001|Overall Study|Physician Decision|10|||
155236589|NCT03304379|560300181|FG002|Overall Study|Physician Decision|6|||
155236590|NCT03304379|560300182|FG003|Overall Study|Physician Decision|9|||
155236591|NCT03304379|560300183|FG004|Overall Study|Physician Decision|10|||
155236592|NCT03304379|560300179|FG000|Overall Study|Withdrawal by Subject|26|||
155236593|NCT03304379|560300180|FG001|Overall Study|Withdrawal by Subject|58|||
155236594|NCT03304379|560300181|FG002|Overall Study|Withdrawal by Subject|66|||
155236595|NCT03304379|560300182|FG003|Overall Study|Withdrawal by Subject|3|||
155236596|NCT03304379|560300183|FG004|Overall Study|Withdrawal by Subject|5|||
155236597|NCT03304379|560300179|FG000|Overall Study|Lost to Follow-up|8|||
155236598|NCT03304379|560300180|FG001|Overall Study|Lost to Follow-up|24|||
155236599|NCT03304379|560300181|FG002|Overall Study|Lost to Follow-up|35|||
155236600|NCT03304379|560300182|FG003|Overall Study|Lost to Follow-up|4|||
155236601|NCT03304379|560300183|FG004|Overall Study|Lost to Follow-up|0|||
155236602|NCT03304379|560300179|FG000|Overall Study|Death|1|||
155236603|NCT03304379|560300180|FG001|Overall Study|Death|2|||
155236604|NCT03304379|560300181|FG002|Overall Study|Death|0|||
155236605|NCT03304379|560300182|FG003|Overall Study|Death|0|||
155236606|NCT03304379|560300183|FG004|Overall Study|Death|0|||
155236607|NCT03304379|560300179|FG000|Overall Study|Other|0|||
155236608|NCT03304379|560300180|FG001|Overall Study|Other|1|||
155236609|NCT03304379|560300181|FG002|Overall Study|Other|0|||
155236610|NCT03304379|560300182|FG003|Overall Study|Other|0|||
155236611|NCT03304379|560300183|FG004|Overall Study|Other|0|||
155236612|NCT01559311|560300191|FG000|Overall Study|Protocol Violation|0|||
155236613|NCT01559311|560300192|FG001|Overall Study|Protocol Violation|0|||
155236614|NCT01559311|560300193|FG002|Overall Study|Protocol Violation|2|||
155236615|NCT01559311|560300191|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
155236616|NCT01559311|560300192|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
155236617|NCT01559311|560300193|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
155236618|NCT01559311|560300191|FG000|Overall Study|Withdrawal by Subject|2|||
155236619|NCT01559311|560300192|FG001|Overall Study|Withdrawal by Subject|1|||
155236620|NCT01559311|560300193|FG002|Overall Study|Withdrawal by Subject|0|||
155236621|NCT01559311|560300191|FG000|Overall Study|Death|0|||
155236622|NCT01559311|560300192|FG001|Overall Study|Death|2|||
155236623|NCT01559311|560300193|FG002|Overall Study|Death|3|||
155236624|NCT01559311|560300191|FG000|Overall Study|Lost to Follow-up|0|||
155236625|NCT01559311|560300192|FG001|Overall Study|Lost to Follow-up|3|||
155236626|NCT01559311|560300193|FG002|Overall Study|Lost to Follow-up|2|||
155236627|NCT01559311|560300191|FG000|Overall Study|Adverse Event|0|||
155236628|NCT01559311|560300192|FG001|Overall Study|Adverse Event|0|||
155236629|NCT01559311|560300193|FG002|Overall Study|Adverse Event|1|||
155236630|NCT01649856|560300194|FG000|Overall Study|Withdrawal by Subject|14|||
155236631|NCT01649856|560300195|FG001|Overall Study|Withdrawal by Subject|14|||
155236632|NCT01649856|560300194|FG000|Overall Study|Protocol Violation|4|||
155236633|NCT01649856|560300195|FG001|Overall Study|Protocol Violation|4|||
155236634|NCT01649856|560300194|FG000|Overall Study|Treatment Failure|1|||
155236635|NCT01649856|560300195|FG001|Overall Study|Treatment Failure|1|||
155236636|NCT01649856|560300194|FG000|Overall Study|Death|69|||
155236637|NCT01649856|560300195|FG001|Overall Study|Death|34|||
155236638|NCT01649856|560300194|FG000|Overall Study|Stable or Progressed Disease|5|||
155236639|NCT01649856|560300195|FG001|Overall Study|Stable or Progressed Disease|3|||
155236640|NCT01649856|560300194|FG000|Overall Study|Lost to Follow-up|20|||
155236641|NCT01649856|560300195|FG001|Overall Study|Lost to Follow-up|16|||
155236642|NCT01649856|560300194|FG000|Overall Study|Lack of Compliance|6|||
155236643|NCT01649856|560300195|FG001|Overall Study|Lack of Compliance|1|||
155236644|NCT01649856|560300194|FG000|Overall Study|Other|20|||
155236645|NCT01649856|560300195|FG001|Overall Study|Other|5|||
155236646|NCT00179647|560300196|FG000|Overall Study|Adverse Event|294|||
155236647|NCT00179647|560300196|FG000|Overall Study|Lack of Efficacy|478|||
155236648|NCT00179647|560300196|FG000|Overall Study|Withdrawal by Subject|83|||
155236649|NCT00179647|560300196|FG000|Overall Study|Lost to Follow-up|4|||
155236650|NCT00179647|560300196|FG000|Overall Study|Death|94|||
155236651|NCT00179647|560300196|FG000|Overall Study|Other|960|||
155236652|NCT05013905|560300197|FG000|Overall Study|Adverse Event|1|||
155236653|NCT05013905|560300197|FG000|Overall Study|Lack of Efficacy|1|||
155236654|NCT01849588|560300199|FG000|Overall Study|Lack of Efficacy|3|||
155236655|NCT02550652|560300207|FG000|Overall Study|Death|1|||
155236656|NCT02550652|560300208|FG001|Overall Study|Death|4|||
155236657|NCT02550652|560300207|FG000|Overall Study|Lack of Efficacy|1|||
155236658|NCT02550652|560300208|FG001|Overall Study|Lack of Efficacy|0|||
155236659|NCT02550652|560300207|FG000|Overall Study|Withdrawal by Subject|4|||
155236660|NCT02550652|560300208|FG001|Overall Study|Withdrawal by Subject|7|||
155236661|NCT02550652|560300207|FG000|Overall Study|Post Trial Access|1|||
155236662|NCT02550652|560300208|FG001|Overall Study|Post Trial Access|0|||
155236663|NCT02550652|560300207|FG000|Overall Study|Lost to Follow-up|1|||
155236664|NCT02550652|560300208|FG001|Overall Study|Lost to Follow-up|3|||
155236665|NCT02550652|560300207|FG000|Overall Study|Physician Decision|0|||
155236666|NCT02550652|560300208|FG001|Overall Study|Physician Decision|2|||
155236667|NCT02550652|560300207|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
155236668|NCT02550652|560300208|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
155236669|NCT03027466|560300209|FG000|Overall Study|Opting out of the app|1869|||
155236670|NCT03027466|560300210|FG001|Overall Study|Opting out of the app|1819|||
155236671|NCT03027466|560300211|FG002|Overall Study|Opting out of the app|1743|||
155236672|NCT03027466|560300212|FG003|Overall Study|Opting out of the app|1821|||
155236673|NCT01706250|560300213|FG000|Overall Study|Lost to Follow-up|2|||
155236674|NCT03286140|560300214|FG000|Overall Study|Withdrawal by Subject|10|||
155236675|NCT03286140|560300215|FG001|Overall Study|Withdrawal by Subject|5|||
155236676|NCT03286140|560300214|FG000|Overall Study|Lost to Follow-up|5|||
155236677|NCT03286140|560300215|FG001|Overall Study|Lost to Follow-up|10|||
155236678|NCT03286140|560300214|FG000|Overall Study|Failure to comply|0|||
155236679|NCT03286140|560300215|FG001|Overall Study|Failure to comply|1|||
155236680|NCT02158039|560300216|FG000|Overall Study|Withdrawal by Subject|1|||
155236681|NCT02158039|560300216|FG000|Overall Study|Screen Failure|9|||
155236682|NCT02563028|560300218|FG000|Overall Study|Lack of equipment|1|||
155236683|NCT02563028|560300218|FG000|Overall Study|Unable to elicit VEP post induction|1|||
155236684|NCT01009099|560300219|FG000|Overall Study|Lost to Follow-up|1|||
155236685|NCT01009099|560300220|FG001|Overall Study|Lost to Follow-up|0|||
155236686|NCT01009099|560300219|FG000|Overall Study|Physician Decision|3|||
155236687|NCT01009099|560300220|FG001|Overall Study|Physician Decision|2|||
155236688|NCT01009099|560300219|FG000|Overall Study|Withdrawal by Subject|1|||
155236689|NCT01009099|560300220|FG001|Overall Study|Withdrawal by Subject|1|||
155236690|NCT01009099|560300219|FG000|Overall Study|Death|0|||
155236691|NCT01009099|560300220|FG001|Overall Study|Death|1|||
155236692|NCT01856543|560300221|FG000|Overall Study|Treatment discontinued|6|||
155236693|NCT01856543|560300222|FG001|Overall Study|Treatment discontinued|3|||
155236694|NCT01856543|560300221|FG000|Overall Study|Withdrawn before start|7|||
155236695|NCT01856543|560300222|FG001|Overall Study|Withdrawn before start|3|||
155236696|NCT02188485|560300223|FG000|Overall Study|Withdrawal by Subject|2|||
155236697|NCT02188485|560300224|FG001|Overall Study|Withdrawal by Subject|1|||
155236698|NCT02188485|560300223|FG000|Overall Study|PI withdrew, lack of capacity|0|||
155236699|NCT02188485|560300224|FG001|Overall Study|PI withdrew, lack of capacity|2|||
155236700|NCT00799617|560300225|FG000|Main Testosterone Trial|Randomized in error|1|||
155236701|NCT00799617|560300226|FG001|Main Testosterone Trial|Randomized in error|1|||
155236702|NCT00799617|560300225|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
155236703|NCT00799617|560300226|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
155236704|NCT00799617|560300225|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
155236705|NCT00799617|560300226|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
155236706|NCT00799617|560300225|FG000|Sexual Funtion Trial|No Baseline Data|4|||
155236707|NCT00799617|560300226|FG001|Sexual Funtion Trial|No Baseline Data|7|||
155236708|NCT00799617|560300225|FG000|Physical Function Trial|Lost to Follow-up|6|||
155236709|NCT00799617|560300226|FG001|Physical Function Trial|Lost to Follow-up|11|||
155236710|NCT00799617|560300225|FG000|Vitality Trial|Lost to Follow-up|7|||
155236711|NCT00799617|560300226|FG001|Vitality Trial|Lost to Follow-up|22|||
155236712|NCT00799617|560300225|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
155236713|NCT00799617|560300226|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
155236714|NCT00799617|560300225|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
155236715|NCT00799617|560300226|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
155236716|NCT00799617|560300225|FG000|Bone Trial|Month 12 scan not available|6|||
155236717|NCT00799617|560300226|FG001|Bone Trial|Month 12 scan not available|16|||
155236718|NCT00799617|560300225|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
155236719|NCT00799617|560300226|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
155236720|NCT00799617|560300225|FG000|Anemia Trial|Withdrawal by Subject|3|||
155236721|NCT00799617|560300226|FG001|Anemia Trial|Withdrawal by Subject|3|||
155236722|NCT04545515|560300227|FG000|Overall Study|Adverse Event|1|||
155236723|NCT04545515|560300227|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
155236724|NCT04545515|560300227|FG000|Overall Study|Commercial drug is available for participant|7|||
155236725|NCT03149237|560300230|FG000|Overall Study|Withdrawal by Subject|4|||
155236726|NCT03149237|560300231|FG001|Overall Study|Withdrawal by Subject|5|||
155236727|NCT04587193|560300232|FG000|Overall Study|Screen failure after consent|3|||
155236728|NCT04587193|560300233|FG001|Overall Study|Screen failure after consent|0|||
155236729|NCT04587193|560300232|FG000|Overall Study|Device broke during study|3|||
155236730|NCT04587193|560300233|FG001|Overall Study|Device broke during study|2|||
155236731|NCT02501096|560300234|FG000|Overall Study|Lost to Follow-up|0|||
155236732|NCT02501096|560300235|FG001|Overall Study|Lost to Follow-up|0|||
155236733|NCT02501096|560300236|FG002|Overall Study|Lost to Follow-up|0|||
155236734|NCT02501096|560300237|FG003|Overall Study|Lost to Follow-up|0|||
155236735|NCT02501096|560300238|FG004|Overall Study|Lost to Follow-up|1|||
155236736|NCT02501096|560300239|FG005|Overall Study|Lost to Follow-up|1|||
155236737|NCT02501096|560300240|FG006|Overall Study|Lost to Follow-up|3|||
155236738|NCT02501096|560300241|FG007|Overall Study|Lost to Follow-up|0|||
155236739|NCT02501096|560300242|FG008|Overall Study|Lost to Follow-up|0|||
155236740|NCT02501096|560300234|FG000|Overall Study|Withdrawal by Subject|1|||
155236741|NCT02501096|560300235|FG001|Overall Study|Withdrawal by Subject|0|||
155236742|NCT02501096|560300236|FG002|Overall Study|Withdrawal by Subject|7|||
155236743|NCT02501096|560300237|FG003|Overall Study|Withdrawal by Subject|13|||
155236744|NCT02501096|560300238|FG004|Overall Study|Withdrawal by Subject|2|||
155236745|NCT02501096|560300239|FG005|Overall Study|Withdrawal by Subject|2|||
155236746|NCT02501096|560300240|FG006|Overall Study|Withdrawal by Subject|2|||
155236747|NCT02501096|560300241|FG007|Overall Study|Withdrawal by Subject|3|||
155236748|NCT02501096|560300242|FG008|Overall Study|Withdrawal by Subject|0|||
155236749|NCT02501096|560300234|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236750|NCT02501096|560300235|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236751|NCT02501096|560300236|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
155236752|NCT02501096|560300237|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
155236753|NCT02501096|560300238|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
155236754|NCT02501096|560300239|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
155236755|NCT02501096|560300240|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
155236756|NCT02501096|560300241|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
155236757|NCT02501096|560300242|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236758|NCT02501096|560300234|FG000|Overall Study|Death|1|||
155236759|NCT02501096|560300235|FG001|Overall Study|Death|1|||
155236760|NCT02501096|560300236|FG002|Overall Study|Death|88|||
155236761|NCT02501096|560300237|FG003|Overall Study|Death|74|||
155236762|NCT02501096|560300238|FG004|Overall Study|Death|15|||
155236763|NCT02501096|560300239|FG005|Overall Study|Death|16|||
155236764|NCT02501096|560300240|FG006|Overall Study|Death|15|||
155236765|NCT02501096|560300241|FG007|Overall Study|Death|16|||
155236766|NCT02501096|560300242|FG008|Overall Study|Death|1|||
155236767|NCT03878134|560300243|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
155236768|NCT03851016|560300244|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155236769|NCT03851016|560300245|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
155236770|NCT00853658|560300246|FG000|Overall Study|Death|713|||
155236771|NCT00853658|560300247|FG001|Overall Study|Death|768|||
155236772|NCT00853658|560300248|FG002|Overall Study|Death|753|||
155236773|NCT00853658|560300246|FG000|Overall Study|Lost to Follow-up|11|||
155236774|NCT00853658|560300247|FG001|Overall Study|Lost to Follow-up|6|||
155236775|NCT00853658|560300248|FG002|Overall Study|Lost to Follow-up|11|||
155236776|NCT00853658|560300246|FG000|Overall Study|H.A. Request|26|||
155236777|NCT00853658|560300247|FG001|Overall Study|H.A. Request|23|||
155236778|NCT00853658|560300248|FG002|Overall Study|H.A. Request|19|||
155236779|NCT00853658|560300246|FG000|Overall Study|IRB request|0|||
155236780|NCT00853658|560300247|FG001|Overall Study|IRB request|0|||
155236781|NCT00853658|560300248|FG002|Overall Study|IRB request|2|||
155236782|NCT00853658|560300246|FG000|Overall Study|Vital Status known (alive) at study end|2|||
155236783|NCT00853658|560300247|FG001|Overall Study|Vital Status known (alive) at study end|3|||
155236784|NCT00853658|560300248|FG002|Overall Study|Vital Status known (alive) at study end|3|||
155236785|NCT00853658|560300246|FG000|Overall Study|Vital Status unknown at study end|1|||
155236786|NCT00853658|560300247|FG001|Overall Study|Vital Status unknown at study end|1|||
155236787|NCT00853658|560300248|FG002|Overall Study|Vital Status unknown at study end|0|||
155236788|NCT00853658|560300246|FG000|Overall Study|Vital Status at study end N/A|8|||
155236789|NCT00853658|560300247|FG001|Overall Study|Vital Status at study end N/A|10|||
155236790|NCT00853658|560300248|FG002|Overall Study|Vital Status at study end N/A|10|||
155236791|NCT00853658|560300246|FG000|Overall Study|Patient's request|21|||
155236792|NCT00853658|560300247|FG001|Overall Study|Patient's request|17|||
155236793|NCT00853658|560300248|FG002|Overall Study|Patient's request|11|||
155236794|NCT00853658|560300246|FG000|Overall Study|Missing study completion information|5|||
155236795|NCT00853658|560300247|FG001|Overall Study|Missing study completion information|4|||
155236796|NCT00853658|560300248|FG002|Overall Study|Missing study completion information|6|||
155236797|NCT01227512|560300249|FG000|Overall Study|Physician Decision|6|||
155236798|NCT01227512|560300250|FG001|Overall Study|Physician Decision|6|||
155236799|NCT01227512|560300249|FG000|Overall Study|Adverse Event|4|||
155236800|NCT01227512|560300250|FG001|Overall Study|Adverse Event|3|||
155236801|NCT01227512|560300249|FG000|Overall Study|Withdrawal by Subject|3|||
155236802|NCT01227512|560300250|FG001|Overall Study|Withdrawal by Subject|0|||
155236803|NCT01227512|560300249|FG000|Overall Study|Participant met withdrawal criteria|0|||
155236804|NCT01227512|560300250|FG001|Overall Study|Participant met withdrawal criteria|1|||
155236805|NCT02774681|560300257|FG000|Treatment on Study|Progressive Disease|7|||
155236806|NCT02774681|560300257|FG000|Follow-Up for 3 Years|Death|11|||
155236807|NCT02774681|560300257|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
155236808|NCT01069289|560300258|FG000|Overall Study|Withdrawal by Subject|15|||
155236809|NCT01069289|560300259|FG001|Overall Study|Withdrawal by Subject|26|||
155236810|NCT01069289|560300258|FG000|Overall Study|Adverse Event|21|||
155236811|NCT01069289|560300259|FG001|Overall Study|Adverse Event|28|||
155236812|NCT01069289|560300258|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155236813|NCT01069289|560300259|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155236814|NCT01069289|560300258|FG000|Overall Study|Severe non-compliance to protocol|3|||
155236815|NCT01069289|560300259|FG001|Overall Study|Severe non-compliance to protocol|2|||
155236816|NCT01069289|560300258|FG000|Overall Study|Due to deteriorating health condition|1|||
155236817|NCT01069289|560300259|FG001|Overall Study|Due to deteriorating health condition|0|||
155236818|NCT00298038|560300260|FG000|Overall Study|Lost to Follow-up|0|||
155236819|NCT00298038|560300261|FG001|Overall Study|Lost to Follow-up|1|||
155236820|NCT00298038|560300260|FG000|Overall Study|Liver Transplant|0|||
155236821|NCT00298038|560300261|FG001|Overall Study|Liver Transplant|1|||
155236822|NCT00298038|560300260|FG000|Overall Study|Protocol Violation|1|||
155236823|NCT00298038|560300261|FG001|Overall Study|Protocol Violation|3|||
155236824|NCT00298038|560300260|FG000|Overall Study|Death|6|||
155236825|NCT00298038|560300261|FG001|Overall Study|Death|3|||
155236826|NCT00298038|560300260|FG000|Overall Study|Withdrawal by Subject|6|||
155236827|NCT00298038|560300261|FG001|Overall Study|Withdrawal by Subject|9|||
155236828|NCT00298038|560300260|FG000|Overall Study|Adverse Event|8|||
155236829|NCT00298038|560300261|FG001|Overall Study|Adverse Event|7|||
155236830|NCT00298038|560300260|FG000|Overall Study|Breakthrough overt HE episode|28|||
155236831|NCT00298038|560300261|FG001|Overall Study|Breakthrough overt HE episode|69|||
155236832|NCT00298038|560300260|FG000|Overall Study|Noncompliance|1|||
155236833|NCT00298038|560300261|FG001|Overall Study|Noncompliance|0|||
155236834|NCT00298038|560300260|FG000|Overall Study|Cocaine Abuse|1|||
155236835|NCT00298038|560300261|FG001|Overall Study|Cocaine Abuse|0|||
155236836|NCT00298038|560300260|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
155236837|NCT00298038|560300261|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
155236838|NCT02696096|560300262|FG000|Overall Study|ruled out at screening|1|||
155236839|NCT02696096|560300262|FG000|Overall Study|did not attend second fMRI|1|||
155236840|NCT01940705|560300263|FG000|Overall Study|Lost to Follow-up|1|||
155236841|NCT01940705|560300264|FG001|Overall Study|Lost to Follow-up|3|||
155236842|NCT01940705|560300265|FG002|Overall Study|Lost to Follow-up|2|||
155236843|NCT01940705|560300266|FG003|Overall Study|Lost to Follow-up|2|||
155236844|NCT01940705|560300263|FG000|Overall Study|Withdrawal by Subject|2|||
155236845|NCT01940705|560300264|FG001|Overall Study|Withdrawal by Subject|2|||
155236846|NCT01940705|560300265|FG002|Overall Study|Withdrawal by Subject|3|||
155236847|NCT01940705|560300266|FG003|Overall Study|Withdrawal by Subject|2|||
155236848|NCT01940705|560300263|FG000|Overall Study|Intervention not given|0|||
155236849|NCT01940705|560300264|FG001|Overall Study|Intervention not given|3|||
155236850|NCT01940705|560300265|FG002|Overall Study|Intervention not given|3|||
155236851|NCT01940705|560300266|FG003|Overall Study|Intervention not given|0|||
155236852|NCT01940705|560300263|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
155236853|NCT01940705|560300264|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
155236854|NCT01940705|560300265|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
155236855|NCT01940705|560300266|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
155236856|NCT02447991|560300267|FG000|Overall Study|Withdrawn by subject - no data|0|||
155236857|NCT02447991|560300268|FG001|Overall Study|Withdrawn by subject - no data|2|||
155236858|NCT02447991|560300267|FG000|Overall Study|Withdrawn by Subject - with data|4|||
155236859|NCT02447991|560300268|FG001|Overall Study|Withdrawn by Subject - with data|4|||
155236860|NCT02447991|560300267|FG000|Overall Study|Lost to Follow-up - no data|3|||
155236861|NCT02447991|560300268|FG001|Overall Study|Lost to Follow-up - no data|6|||
155236862|NCT02447991|560300267|FG000|Overall Study|Lost to follow-up - with data|0|||
155236863|NCT02447991|560300268|FG001|Overall Study|Lost to follow-up - with data|3|||
155236864|NCT02447991|560300267|FG000|Overall Study|End of study - no treatment results|3|||
155236865|NCT02447991|560300268|FG001|Overall Study|End of study - no treatment results|6|||
155236866|NCT02447991|560300267|FG000|Overall Study|End of study - partial treatment results|0|||
155236867|NCT02447991|560300268|FG001|Overall Study|End of study - partial treatment results|9|||
155236868|NCT01976845|560300269|FG000|Overall Study|Physician Decision|8|||
155236869|NCT01976845|560300270|FG001|Overall Study|Physician Decision|8|||
155236870|NCT01976845|560300271|FG002|Overall Study|Physician Decision|3|||
155236871|NCT03042312|560302128|FG000|Overall Study|Administrative Reason|1|||
155236872|NCT03042312|560302129|FG001|Overall Study|Administrative Reason|1|||
155236873|NCT03042312|560302128|FG000|Overall Study|Adverse Event|0|||
155236874|NCT03042312|560302129|FG001|Overall Study|Adverse Event|1|||
155236875|NCT03042312|560302128|FG000|Overall Study|Lost to Follow-up|1|||
155236876|NCT03042312|560302129|FG001|Overall Study|Lost to Follow-up|3|||
155236877|NCT03042312|560302128|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
155236878|NCT03042312|560302129|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
155236879|NCT03042312|560302128|FG000|Overall Study|Withdrawal by Subject|4|||
155236880|NCT03042312|560302129|FG001|Overall Study|Withdrawal by Subject|5|||
155236881|NCT02293005|560302132|FG000|Overall Study|Adverse Event|2|||
155236882|NCT02293005|560302132|FG000|Overall Study|Death|4|||
155236883|NCT02293005|560302132|FG000|Overall Study|Lost to Follow-up|1|||
155236884|NCT02293005|560302132|FG000|Overall Study|Withdrawal by Subject|2|||
155236885|NCT02293005|560302132|FG000|Overall Study|Progression|17|||
155236886|NCT00938431|560302138|FG000|Overall Study|Adverse Event|5|||
155236887|NCT00938431|560302139|FG001|Overall Study|Adverse Event|8|||
155236888|NCT00938431|560302140|FG002|Overall Study|Adverse Event|6|||
155236889|NCT00938431|560302138|FG000|Overall Study|Lack of Efficacy|0|||
155236890|NCT00938431|560302139|FG001|Overall Study|Lack of Efficacy|1|||
155236891|NCT00938431|560302140|FG002|Overall Study|Lack of Efficacy|0|||
155236892|NCT00938431|560302138|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
155236893|NCT00938431|560302139|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
155236894|NCT00938431|560302140|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
155236895|NCT00938431|560302138|FG000|Overall Study|Dosing compliance issue|0|||
155236896|NCT00938431|560302139|FG001|Overall Study|Dosing compliance issue|0|||
155236897|NCT00938431|560302140|FG002|Overall Study|Dosing compliance issue|1|||
155236898|NCT00938431|560302138|FG000|Overall Study|Reached maximum dose early|0|||
155236899|NCT00938431|560302139|FG001|Overall Study|Reached maximum dose early|0|||
155236900|NCT00938431|560302140|FG002|Overall Study|Reached maximum dose early|1|||
155236901|NCT01774903|560302141|FG000|Overall Study|Adverse Event|7|||
155236902|NCT01774903|560302141|FG000|Overall Study|Withdrawal by Subject|2|||
155236903|NCT01774903|560302141|FG000|Overall Study|Lack of Efficacy|1|||
155236904|NCT01774903|560302141|FG000|Overall Study|Ineligible to continue the trial|1|||
155236905|NCT00961259|560302146|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
155236906|NCT00961259|560302147|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
155236907|NCT00961259|560302148|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
155236908|NCT01252251|560302149|FG000|Overall Study|Withdrawal by Subject|1|||
155236909|NCT01324024|560302150|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
155236910|NCT01324024|560302151|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155236911|NCT00530023|560302152|FG000|Overall Study|Withdrawal by Subject|0|||
155236912|NCT00530023|560302153|FG001|Overall Study|Withdrawal by Subject|1|||
155236913|NCT01858194|560302159|FG000|Overall Study|Total Artificial Heart Implant|0|||
155236914|NCT01858194|560302160|FG001|Overall Study|Total Artificial Heart Implant|1|||
155236915|NCT01858194|560302159|FG000|Overall Study|Lost to Follow-up|0|||
155236916|NCT01858194|560302160|FG001|Overall Study|Lost to Follow-up|1|||
155236917|NCT00205712|560302172|FG000|Overall Study|Lost to Follow-up|0|||
155236918|NCT00205712|560302173|FG001|Overall Study|Lost to Follow-up|1|||
155236919|NCT00096044|560302174|FG000|Overall Study|Withdrawal by Subject|9|||
155236920|NCT00096044|560302174|FG000|Overall Study|Adverse Event|21|||
155236921|NCT00096044|560302174|FG000|Overall Study|Disease Progression|4|||
155236922|NCT02442830|560302175|FG000|Overall Study|Technical Failure|0|||
155236923|NCT02442830|560302176|FG001|Overall Study|Technical Failure|1|||
155236924|NCT00437034|560302177|FG000|Overall Study|Adverse Event|1|||
155236925|NCT00437034|560302177|FG000|Overall Study|Disease progression during treatment|5|||
155236926|NCT02460224|560302179|FG000|Overall Study|Adverse Event|0|||
155236927|NCT02460224|560302180|FG001|Overall Study|Adverse Event|0|||
155236928|NCT02460224|560302181|FG002|Overall Study|Adverse Event|0|||
155236929|NCT02460224|560302182|FG003|Overall Study|Adverse Event|0|||
155236930|NCT02460224|560302183|FG004|Overall Study|Adverse Event|0|||
155236931|NCT02460224|560302184|FG005|Overall Study|Adverse Event|0|||
155236932|NCT02460224|560302185|FG006|Overall Study|Adverse Event|1|||
155236933|NCT02460224|560302186|FG007|Overall Study|Adverse Event|0|||
155236934|NCT02460224|560302187|FG008|Overall Study|Adverse Event|0|||
155236935|NCT02460224|560302188|FG009|Overall Study|Adverse Event|0|||
155236936|NCT02460224|560302189|FG010|Overall Study|Adverse Event|0|||
155236937|NCT02460224|560302190|FG011|Overall Study|Adverse Event|0|||
155236938|NCT02460224|560302191|FG012|Overall Study|Adverse Event|1|||
155236939|NCT02460224|560302192|FG013|Overall Study|Adverse Event|0|||
155236940|NCT02460224|560302193|FG014|Overall Study|Adverse Event|0|||
155236941|NCT02460224|560302194|FG015|Overall Study|Adverse Event|0|||
155236942|NCT02460224|560302195|FG016|Overall Study|Adverse Event|1|||
155236943|NCT02460224|560302196|FG017|Overall Study|Adverse Event|0|||
155236944|NCT02460224|560302197|FG018|Overall Study|Adverse Event|1|||
155236945|NCT02460224|560302198|FG019|Overall Study|Adverse Event|0|||
155236946|NCT02460224|560302199|FG020|Overall Study|Adverse Event|1|||
155236947|NCT02460224|560302200|FG021|Overall Study|Adverse Event|1|||
155236948|NCT02460224|560302201|FG022|Overall Study|Adverse Event|1|||
155236949|NCT02460224|560302202|FG023|Overall Study|Adverse Event|0|||
155236950|NCT02460224|560302203|FG024|Overall Study|Adverse Event|0|||
155236951|NCT02460224|560302204|FG025|Overall Study|Adverse Event|0|||
155236952|NCT02460224|560302205|FG026|Overall Study|Adverse Event|11|||
155236953|NCT02460224|560302206|FG027|Overall Study|Adverse Event|1|||
155236954|NCT02460224|560302207|FG028|Overall Study|Adverse Event|6|||
155236955|NCT02460224|560302179|FG000|Overall Study|Death|0|||
155236956|NCT02460224|560302180|FG001|Overall Study|Death|0|||
155236957|NCT02460224|560302181|FG002|Overall Study|Death|0|||
155236958|NCT02460224|560302182|FG003|Overall Study|Death|0|||
155236959|NCT02460224|560302183|FG004|Overall Study|Death|0|||
155236960|NCT02460224|560302184|FG005|Overall Study|Death|2|||
155236961|NCT02460224|560302185|FG006|Overall Study|Death|1|||
155236962|NCT02460224|560302186|FG007|Overall Study|Death|0|||
155236963|NCT02460224|560302187|FG008|Overall Study|Death|0|||
155236964|NCT02460224|560302188|FG009|Overall Study|Death|1|||
155236965|NCT02460224|560302189|FG010|Overall Study|Death|0|||
155236966|NCT02460224|560302190|FG011|Overall Study|Death|0|||
155236967|NCT02460224|560302191|FG012|Overall Study|Death|0|||
155236968|NCT02460224|560302192|FG013|Overall Study|Death|1|||
155236969|NCT02460224|560302193|FG014|Overall Study|Death|0|||
155236970|NCT02460224|560302194|FG015|Overall Study|Death|0|||
155236971|NCT02460224|560302195|FG016|Overall Study|Death|2|||
155236972|NCT02460224|560302196|FG017|Overall Study|Death|1|||
155236973|NCT02460224|560302197|FG018|Overall Study|Death|0|||
155236974|NCT02460224|560302198|FG019|Overall Study|Death|2|||
155236975|NCT02460224|560302199|FG020|Overall Study|Death|0|||
155236976|NCT02460224|560302200|FG021|Overall Study|Death|0|||
155236977|NCT02460224|560302201|FG022|Overall Study|Death|0|||
155236978|NCT02460224|560302202|FG023|Overall Study|Death|0|||
155236979|NCT02460224|560302203|FG024|Overall Study|Death|1|||
155236980|NCT02460224|560302204|FG025|Overall Study|Death|1|||
155236981|NCT02460224|560302205|FG026|Overall Study|Death|5|||
155236982|NCT02460224|560302206|FG027|Overall Study|Death|0|||
155236983|NCT02460224|560302207|FG028|Overall Study|Death|1|||
155236984|NCT02460224|560302179|FG000|Overall Study|Lost to Follow-up|0|||
155236985|NCT02460224|560302180|FG001|Overall Study|Lost to Follow-up|0|||
155236986|NCT02460224|560302181|FG002|Overall Study|Lost to Follow-up|0|||
155236987|NCT02460224|560302182|FG003|Overall Study|Lost to Follow-up|0|||
155236988|NCT02460224|560302183|FG004|Overall Study|Lost to Follow-up|0|||
155236989|NCT02460224|560302184|FG005|Overall Study|Lost to Follow-up|0|||
155236990|NCT02460224|560302185|FG006|Overall Study|Lost to Follow-up|0|||
155236991|NCT02460224|560302186|FG007|Overall Study|Lost to Follow-up|0|||
155236992|NCT02460224|560302187|FG008|Overall Study|Lost to Follow-up|0|||
155236993|NCT02460224|560302188|FG009|Overall Study|Lost to Follow-up|0|||
155236994|NCT02460224|560302189|FG010|Overall Study|Lost to Follow-up|0|||
155236995|NCT02460224|560302190|FG011|Overall Study|Lost to Follow-up|0|||
155236996|NCT02460224|560302191|FG012|Overall Study|Lost to Follow-up|0|||
155236997|NCT02460224|560302192|FG013|Overall Study|Lost to Follow-up|0|||
155236998|NCT02460224|560302193|FG014|Overall Study|Lost to Follow-up|0|||
155236999|NCT02460224|560302194|FG015|Overall Study|Lost to Follow-up|0|||
155237000|NCT02460224|560302195|FG016|Overall Study|Lost to Follow-up|0|||
155237001|NCT02460224|560302196|FG017|Overall Study|Lost to Follow-up|0|||
155237002|NCT02460224|560302197|FG018|Overall Study|Lost to Follow-up|0|||
155237003|NCT02460224|560302198|FG019|Overall Study|Lost to Follow-up|0|||
155237004|NCT02460224|560302199|FG020|Overall Study|Lost to Follow-up|0|||
155237005|NCT02460224|560302200|FG021|Overall Study|Lost to Follow-up|0|||
155237006|NCT02460224|560302201|FG022|Overall Study|Lost to Follow-up|1|||
155237007|NCT02460224|560302202|FG023|Overall Study|Lost to Follow-up|0|||
155237008|NCT02460224|560302203|FG024|Overall Study|Lost to Follow-up|0|||
155237009|NCT02460224|560302204|FG025|Overall Study|Lost to Follow-up|0|||
155237010|NCT02460224|560302205|FG026|Overall Study|Lost to Follow-up|0|||
155237011|NCT02460224|560302206|FG027|Overall Study|Lost to Follow-up|0|||
155237012|NCT02460224|560302207|FG028|Overall Study|Lost to Follow-up|0|||
155237013|NCT02460224|560302179|FG000|Overall Study|Physician Decision|0|||
155237014|NCT02460224|560302180|FG001|Overall Study|Physician Decision|1|||
155237015|NCT02460224|560302181|FG002|Overall Study|Physician Decision|0|||
155237016|NCT02460224|560302182|FG003|Overall Study|Physician Decision|0|||
155237017|NCT02460224|560302183|FG004|Overall Study|Physician Decision|1|||
155237018|NCT02460224|560302184|FG005|Overall Study|Physician Decision|0|||
155237019|NCT02460224|560302185|FG006|Overall Study|Physician Decision|0|||
155237020|NCT02460224|560302186|FG007|Overall Study|Physician Decision|1|||
155237021|NCT02460224|560302187|FG008|Overall Study|Physician Decision|0|||
155237022|NCT02460224|560302188|FG009|Overall Study|Physician Decision|0|||
155237023|NCT02460224|560302189|FG010|Overall Study|Physician Decision|0|||
155237024|NCT02460224|560302190|FG011|Overall Study|Physician Decision|1|||
155237025|NCT02460224|560302191|FG012|Overall Study|Physician Decision|0|||
155237026|NCT02460224|560302192|FG013|Overall Study|Physician Decision|1|||
155237027|NCT02460224|560302193|FG014|Overall Study|Physician Decision|0|||
155237028|NCT02460224|560302194|FG015|Overall Study|Physician Decision|0|||
155237029|NCT02460224|560302195|FG016|Overall Study|Physician Decision|2|||
155237030|NCT02460224|560302196|FG017|Overall Study|Physician Decision|1|||
155237031|NCT02460224|560302197|FG018|Overall Study|Physician Decision|1|||
155237032|NCT02460224|560302198|FG019|Overall Study|Physician Decision|2|||
155237033|NCT02460224|560302199|FG020|Overall Study|Physician Decision|1|||
155237034|NCT02460224|560302200|FG021|Overall Study|Physician Decision|1|||
155237035|NCT02460224|560302201|FG022|Overall Study|Physician Decision|0|||
155237036|NCT02460224|560302202|FG023|Overall Study|Physician Decision|0|||
155237037|NCT02460224|560302203|FG024|Overall Study|Physician Decision|1|||
155237038|NCT02460224|560302204|FG025|Overall Study|Physician Decision|0|||
155237039|NCT02460224|560302205|FG026|Overall Study|Physician Decision|14|||
155237040|NCT02460224|560302206|FG027|Overall Study|Physician Decision|1|||
155237041|NCT02460224|560302207|FG028|Overall Study|Physician Decision|6|||
155237042|NCT02460224|560302179|FG000|Overall Study|Progressive disease|15|||
155237043|NCT02460224|560302180|FG001|Overall Study|Progressive disease|11|||
155237044|NCT02460224|560302181|FG002|Overall Study|Progressive disease|5|||
155237045|NCT02460224|560302182|FG003|Overall Study|Progressive disease|6|||
155237046|NCT02460224|560302183|FG004|Overall Study|Progressive disease|3|||
155237047|NCT02460224|560302184|FG005|Overall Study|Progressive disease|26|||
155237048|NCT02460224|560302185|FG006|Overall Study|Progressive disease|28|||
155237049|NCT02460224|560302186|FG007|Overall Study|Progressive disease|4|||
155237050|NCT02460224|560302187|FG008|Overall Study|Progressive disease|5|||
155237051|NCT02460224|560302188|FG009|Overall Study|Progressive disease|9|||
155237052|NCT02460224|560302189|FG010|Overall Study|Progressive disease|5|||
155237053|NCT02460224|560302190|FG011|Overall Study|Progressive disease|4|||
155237054|NCT02460224|560302191|FG012|Overall Study|Progressive disease|5|||
155237055|NCT02460224|560302192|FG013|Overall Study|Progressive disease|4|||
155237056|NCT02460224|560302193|FG014|Overall Study|Progressive disease|5|||
155237057|NCT02460224|560302194|FG015|Overall Study|Progressive disease|5|||
155237058|NCT02460224|560302195|FG016|Overall Study|Progressive disease|15|||
155237059|NCT02460224|560302196|FG017|Overall Study|Progressive disease|3|||
155237060|NCT02460224|560302197|FG018|Overall Study|Progressive disease|8|||
155237061|NCT02460224|560302198|FG019|Overall Study|Progressive disease|3|||
155237062|NCT02460224|560302199|FG020|Overall Study|Progressive disease|4|||
155237063|NCT02460224|560302200|FG021|Overall Study|Progressive disease|9|||
155237064|NCT02460224|560302201|FG022|Overall Study|Progressive disease|4|||
155237065|NCT02460224|560302202|FG023|Overall Study|Progressive disease|11|||
155237066|NCT02460224|560302203|FG024|Overall Study|Progressive disease|4|||
155237067|NCT02460224|560302204|FG025|Overall Study|Progressive disease|5|||
155237068|NCT02460224|560302205|FG026|Overall Study|Progressive disease|85|||
155237069|NCT02460224|560302206|FG027|Overall Study|Progressive disease|17|||
155237070|NCT02460224|560302207|FG028|Overall Study|Progressive disease|77|||
155237071|NCT02460224|560302179|FG000|Overall Study|Subject/guardian decision|2|||
155237072|NCT02460224|560302180|FG001|Overall Study|Subject/guardian decision|0|||
155237073|NCT02460224|560302181|FG002|Overall Study|Subject/guardian decision|1|||
155237074|NCT02460224|560302182|FG003|Overall Study|Subject/guardian decision|0|||
155237075|NCT02460224|560302183|FG004|Overall Study|Subject/guardian decision|2|||
155607042|NCT01897571|561649623|FG010|Overall Study|Enrolled in rollover study|1|||
155237076|NCT02460224|560302184|FG005|Overall Study|Subject/guardian decision|2|||
155237077|NCT02460224|560302185|FG006|Overall Study|Subject/guardian decision|0|||
155237078|NCT02460224|560302186|FG007|Overall Study|Subject/guardian decision|0|||
155237079|NCT02460224|560302187|FG008|Overall Study|Subject/guardian decision|1|||
155237080|NCT02460224|560302188|FG009|Overall Study|Subject/guardian decision|1|||
155237081|NCT02460224|560302189|FG010|Overall Study|Subject/guardian decision|0|||
155237082|NCT02460224|560302190|FG011|Overall Study|Subject/guardian decision|1|||
155237083|NCT02460224|560302191|FG012|Overall Study|Subject/guardian decision|0|||
155237084|NCT02460224|560302192|FG013|Overall Study|Subject/guardian decision|0|||
155237085|NCT02460224|560302193|FG014|Overall Study|Subject/guardian decision|0|||
155237086|NCT02460224|560302194|FG015|Overall Study|Subject/guardian decision|1|||
155237087|NCT02460224|560302195|FG016|Overall Study|Subject/guardian decision|0|||
155237088|NCT02460224|560302196|FG017|Overall Study|Subject/guardian decision|1|||
155237089|NCT02460224|560302197|FG018|Overall Study|Subject/guardian decision|2|||
155237090|NCT02460224|560302198|FG019|Overall Study|Subject/guardian decision|0|||
155237091|NCT02460224|560302199|FG020|Overall Study|Subject/guardian decision|0|||
155237092|NCT02460224|560302200|FG021|Overall Study|Subject/guardian decision|1|||
155237093|NCT02460224|560302201|FG022|Overall Study|Subject/guardian decision|0|||
155237094|NCT02460224|560302202|FG023|Overall Study|Subject/guardian decision|0|||
155237095|NCT02460224|560302203|FG024|Overall Study|Subject/guardian decision|0|||
155237096|NCT02460224|560302204|FG025|Overall Study|Subject/guardian decision|0|||
155237097|NCT02460224|560302205|FG026|Overall Study|Subject/guardian decision|6|||
155237098|NCT02460224|560302206|FG027|Overall Study|Subject/guardian decision|2|||
155237099|NCT02460224|560302207|FG028|Overall Study|Subject/guardian decision|3|||
155237100|NCT00586469|560302208|FG000|Overall Study|Adverse Event|0|||
155237101|NCT00586469|560302209|FG001|Overall Study|Adverse Event|1|||
155237102|NCT04055116|560302210|FG000|First Intervention|Physician Decision|2|||
155237103|NCT04055116|560302211|FG001|First Intervention|Physician Decision|7|||
155237104|NCT01978184|560302212|FG000|Overall Study|Progressive disease|5|||
155237105|NCT01978184|560302213|FG001|Overall Study|Progressive disease|5|||
155237106|NCT01978184|560302212|FG000|Overall Study|Other than PDA|2|||
155237107|NCT01978184|560302213|FG001|Overall Study|Other than PDA|2|||
155237108|NCT01978184|560302212|FG000|Overall Study|Physician Decision|0|||
155237109|NCT01978184|560302213|FG001|Overall Study|Physician Decision|3|||
155237110|NCT01978184|560302212|FG000|Overall Study|Noncompliance|1|||
155237111|NCT01978184|560302213|FG001|Overall Study|Noncompliance|2|||
155237112|NCT01978184|560302212|FG000|Overall Study|Death|1|||
155237113|NCT01978184|560302213|FG001|Overall Study|Death|0|||
155237114|NCT01978184|560302212|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
155237115|NCT01978184|560302213|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
155237116|NCT02047604|560302220|FG000|Overall Study|Withdrawal by Subject|0|||
155237117|NCT02047604|560302221|FG001|Overall Study|Withdrawal by Subject|0|||
155237118|NCT02047604|560302222|FG002|Overall Study|Withdrawal by Subject|0|||
155237119|NCT02047604|560302223|FG003|Overall Study|Withdrawal by Subject|0|||
155237120|NCT02047604|560302224|FG004|Overall Study|Withdrawal by Subject|1|||
155237121|NCT02047604|560302225|FG005|Overall Study|Withdrawal by Subject|1|||
155237122|NCT01208233|560302227|FG000|Overall Study|Adverse Event|0|||
155237123|NCT01208233|560302228|FG001|Overall Study|Adverse Event|1|||
155237124|NCT01208233|560302229|FG002|Overall Study|Adverse Event|2|||
155237125|NCT01208233|560302230|FG003|Overall Study|Adverse Event|0|||
155237126|NCT01208233|560302231|FG004|Overall Study|Adverse Event|3|||
155237127|NCT01208233|560302232|FG005|Overall Study|Adverse Event|5|||
155237128|NCT01208233|560302227|FG000|Overall Study|Death|0|||
155237129|NCT01208233|560302228|FG001|Overall Study|Death|0|||
155237130|NCT01208233|560302229|FG002|Overall Study|Death|0|||
155237131|NCT01208233|560302230|FG003|Overall Study|Death|0|||
155237132|NCT01208233|560302231|FG004|Overall Study|Death|3|||
155237133|NCT01208233|560302232|FG005|Overall Study|Death|5|||
155237134|NCT01208233|560302227|FG000|Overall Study|Did not meet entrance criteria|2|||
155237135|NCT01208233|560302228|FG001|Overall Study|Did not meet entrance criteria|1|||
155237136|NCT01208233|560302229|FG002|Overall Study|Did not meet entrance criteria|1|||
155237137|NCT01208233|560302230|FG003|Overall Study|Did not meet entrance criteria|0|||
155237138|NCT01208233|560302231|FG004|Overall Study|Did not meet entrance criteria|1|||
155237139|NCT01208233|560302232|FG005|Overall Study|Did not meet entrance criteria|0|||
155237140|NCT01208233|560302227|FG000|Overall Study|Medication error without adverse event|0|||
155237141|NCT01208233|560302228|FG001|Overall Study|Medication error without adverse event|0|||
155237142|NCT01208233|560302229|FG002|Overall Study|Medication error without adverse event|0|||
155237143|NCT01208233|560302230|FG003|Overall Study|Medication error without adverse event|0|||
155237144|NCT01208233|560302231|FG004|Overall Study|Medication error without adverse event|0|||
155237145|NCT01208233|560302232|FG005|Overall Study|Medication error without adverse event|1|||
155237146|NCT01208233|560302227|FG000|Overall Study|Study terminated by sponsor|0|||
155237147|NCT01208233|560302228|FG001|Overall Study|Study terminated by sponsor|0|||
155237148|NCT01208233|560302229|FG002|Overall Study|Study terminated by sponsor|0|||
155237149|NCT01208233|560302230|FG003|Overall Study|Study terminated by sponsor|0|||
155237150|NCT01208233|560302231|FG004|Overall Study|Study terminated by sponsor|10|||
155237151|NCT01208233|560302232|FG005|Overall Study|Study terminated by sponsor|7|||
155237152|NCT01208233|560302227|FG000|Overall Study|Protocol Violation|0|||
155237153|NCT01208233|560302228|FG001|Overall Study|Protocol Violation|0|||
155237154|NCT01208233|560302229|FG002|Overall Study|Protocol Violation|0|||
155237155|NCT01208233|560302230|FG003|Overall Study|Protocol Violation|0|||
155237156|NCT01208233|560302231|FG004|Overall Study|Protocol Violation|3|||
155237157|NCT01208233|560302232|FG005|Overall Study|Protocol Violation|0|||
155237158|NCT01208233|560302227|FG000|Overall Study|Other|2|||
155237159|NCT01208233|560302228|FG001|Overall Study|Other|1|||
155237160|NCT01208233|560302229|FG002|Overall Study|Other|0|||
155237161|NCT01208233|560302230|FG003|Overall Study|Other|0|||
155237162|NCT01208233|560302231|FG004|Overall Study|Other|0|||
155237163|NCT01208233|560302232|FG005|Overall Study|Other|1|||
155237164|NCT01208233|560302227|FG000|Overall Study|Withdrawal by Subject|1|||
155237165|NCT01208233|560302228|FG001|Overall Study|Withdrawal by Subject|0|||
155237166|NCT01208233|560302229|FG002|Overall Study|Withdrawal by Subject|1|||
155237167|NCT01208233|560302230|FG003|Overall Study|Withdrawal by Subject|1|||
155237168|NCT01208233|560302231|FG004|Overall Study|Withdrawal by Subject|4|||
155237169|NCT01208233|560302232|FG005|Overall Study|Withdrawal by Subject|2|||
155237170|NCT01181895|560302233|FG000|Overall Study|Adverse Event|3|||
155237171|NCT01181895|560302234|FG001|Overall Study|Adverse Event|1|||
155237172|NCT01181895|560302235|FG002|Overall Study|Adverse Event|1|||
155237173|NCT01181895|560302233|FG000|Overall Study|Lack of Efficacy|8|||
155237174|NCT01181895|560302234|FG001|Overall Study|Lack of Efficacy|9|||
155237175|NCT01181895|560302235|FG002|Overall Study|Lack of Efficacy|9|||
155237176|NCT01181895|560302233|FG000|Overall Study|Protocol Violation|2|||
155237177|NCT01181895|560302234|FG001|Overall Study|Protocol Violation|1|||
155237178|NCT01181895|560302235|FG002|Overall Study|Protocol Violation|0|||
155237179|NCT01181895|560302233|FG000|Overall Study|Lost to Follow-up|0|||
155237180|NCT01181895|560302234|FG001|Overall Study|Lost to Follow-up|1|||
155237181|NCT01181895|560302235|FG002|Overall Study|Lost to Follow-up|2|||
155237182|NCT01181895|560302233|FG000|Overall Study|Investigator Discretion|1|||
155237183|NCT01181895|560302234|FG001|Overall Study|Investigator Discretion|2|||
155237184|NCT01181895|560302235|FG002|Overall Study|Investigator Discretion|1|||
155237185|NCT01181895|560302233|FG000|Overall Study|Withdrawal by Subject|3|||
155237186|NCT01181895|560302234|FG001|Overall Study|Withdrawal by Subject|0|||
155237187|NCT01181895|560302235|FG002|Overall Study|Withdrawal by Subject|5|||
155237188|NCT00023452|560302236|FG000|Overall Study|Ineligible for Study|163|||
155237189|NCT00023452|560302237|FG001|Overall Study|Ineligible for Study|159|||
155237190|NCT00023452|560302236|FG000|Overall Study|Out of Window|129|||
155237191|NCT00023452|560302237|FG001|Overall Study|Out of Window|69|||
155237192|NCT00023452|560302236|FG000|Overall Study|Death|2|||
155237193|NCT00023452|560302237|FG001|Overall Study|Death|0|||
155237194|NCT00023452|560302236|FG000|Overall Study|Withdrawal by Subject|66|||
155237195|NCT00023452|560302237|FG001|Overall Study|Withdrawal by Subject|54|||
155237196|NCT00023452|560302236|FG000|Overall Study|Adverse Event|139|||
155237197|NCT00023452|560302237|FG001|Overall Study|Adverse Event|196|||
155237198|NCT00023452|560302236|FG000|Overall Study|Lost to Follow-up|293|||
155237199|NCT00023452|560302237|FG001|Overall Study|Lost to Follow-up|60|||
155237200|NCT00023452|560302236|FG000|Overall Study|Physician Decision|49|||
155237201|NCT00023452|560302237|FG001|Overall Study|Physician Decision|21|||
155237202|NCT00023452|560302236|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
155237203|NCT00023452|560302237|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
155237204|NCT00023452|560302236|FG000|Overall Study|Pregnant|53|||
155237205|NCT00023452|560302237|FG001|Overall Study|Pregnant|20|||
155237206|NCT00023452|560302236|FG000|Overall Study|Other|204|||
155237207|NCT00023452|560302237|FG001|Overall Study|Other|69|||
155237208|NCT00459134|560302244|FG000|Overall Study|Physician Decision|1|||
155237209|NCT00459134|560302245|FG001|Overall Study|Physician Decision|1|||
155237210|NCT00459134|560302244|FG000|Overall Study|Withdrawal by Subject|8|||
155237211|NCT00459134|560302245|FG001|Overall Study|Withdrawal by Subject|7|||
155237212|NCT00459134|560302244|FG000|Overall Study|Lost to Follow-up|6|||
155237213|NCT00459134|560302245|FG001|Overall Study|Lost to Follow-up|7|||
155237214|NCT00459134|560302244|FG000|Overall Study|Surgery|1|||
155237215|NCT00459134|560302245|FG001|Overall Study|Surgery|2|||
155237216|NCT00459134|560302244|FG000|Overall Study|Toxicity|4|||
155237217|NCT00459134|560302245|FG001|Overall Study|Toxicity|5|||
155237218|NCT00459134|560302244|FG000|Overall Study|Progression|1|||
155237219|NCT00459134|560302245|FG001|Overall Study|Progression|0|||
155237220|NCT00459134|560302244|FG000|Overall Study|Multiple Reasons|2|||
155237221|NCT00459134|560302245|FG001|Overall Study|Multiple Reasons|3|||
155237222|NCT00829621|560302246|FG000|Overall Study|Death|1|||
155237223|NCT00829621|560302247|FG001|Overall Study|Death|0|||
155237224|NCT00829621|560302246|FG000|Overall Study|Lost to Follow-up|3|||
155237225|NCT00829621|560302247|FG001|Overall Study|Lost to Follow-up|4|||
155237226|NCT02770391|560302250|FG000|Overall Study|Lost to Follow-up|2|||
155237227|NCT02770391|560302250|FG000|Overall Study|Withdrawal by Subject|1|||
155237228|NCT02770391|560302250|FG000|Overall Study|Surgery delayed unevaluable|2|||
155237229|NCT02770391|560302250|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
155237230|NCT03333486|560302253|FG000|Overall Study|Withdrawal by Subject|1|||
155237231|NCT03333486|560302253|FG000|Overall Study|Lost to Follow-up|1|||
155237232|NCT01755416|560302259|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
155237233|NCT01755416|560302260|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
155237234|NCT00441337|560302268|FG000|Overall Study|Disease Progression|6|||
155237235|NCT00441337|560302269|FG001|Overall Study|Disease Progression|6|||
155237236|NCT00441337|560302270|FG002|Overall Study|Disease Progression|4|||
155237237|NCT00441337|560302271|FG003|Overall Study|Disease Progression|18|||
155237238|NCT00441337|560302268|FG000|Overall Study|Lost to Follow-up|0|||
155237239|NCT00441337|560302269|FG001|Overall Study|Lost to Follow-up|0|||
155237240|NCT00441337|560302270|FG002|Overall Study|Lost to Follow-up|0|||
155237241|NCT00441337|560302271|FG003|Overall Study|Lost to Follow-up|1|||
155237242|NCT00441337|560302268|FG000|Overall Study|Sponsor Decision|0|||
155237243|NCT00441337|560302269|FG001|Overall Study|Sponsor Decision|0|||
155237244|NCT00441337|560302270|FG002|Overall Study|Sponsor Decision|1|||
155237245|NCT00441337|560302271|FG003|Overall Study|Sponsor Decision|2|||
155237246|NCT00441337|560302268|FG000|Overall Study|Did not meet inclusion criteria|0|||
155237247|NCT00441337|560302269|FG001|Overall Study|Did not meet inclusion criteria|0|||
155237248|NCT00441337|560302270|FG002|Overall Study|Did not meet inclusion criteria|1|||
155237249|NCT00441337|560302271|FG003|Overall Study|Did not meet inclusion criteria|0|||
155237250|NCT04258839|560303873|FG000|Overall Study|Adverse Event|2|||
155237251|NCT04258839|560303874|FG001|Overall Study|Adverse Event|4|||
155237252|NCT04258839|560303873|FG000|Overall Study|Lack of Efficacy|0|||
155237253|NCT04258839|560303874|FG001|Overall Study|Lack of Efficacy|2|||
155237254|NCT04258839|560303873|FG000|Overall Study|Lost to Follow-up|2|||
155237255|NCT04258839|560303874|FG001|Overall Study|Lost to Follow-up|0|||
155237256|NCT04258839|560303873|FG000|Overall Study|Withdrawal by Subject|1|||
155237257|NCT04258839|560303874|FG001|Overall Study|Withdrawal by Subject|2|||
155237258|NCT04258839|560303873|FG000|Overall Study|Withdrawal by Caregiver|5|||
155237259|NCT04258839|560303874|FG001|Overall Study|Withdrawal by Caregiver|6|||
155237260|NCT04258839|560303873|FG000|Overall Study|Reason not Specified|0|||
155237261|NCT04258839|560303874|FG001|Overall Study|Reason not Specified|1|||
155237262|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Adverse Event|4|||
155237263|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Adverse Event|1|||
155237264|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Adverse Event|1|||
155237265|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
155237266|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
155237267|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
155237268|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Pregnancy|3|||
155237269|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Pregnancy|0|||
155237270|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Pregnancy|0|||
155237271|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
155237272|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
155237273|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
155237274|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
155237275|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
155237276|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
155237277|NCT03328897|560303875|FG000|Follow-up Epoch|Adverse Event|4|||
155237278|NCT03328897|560303876|FG001|Follow-up Epoch|Adverse Event|0|||
155237279|NCT03328897|560303877|FG002|Follow-up Epoch|Adverse Event|1|||
155237280|NCT03328897|560303875|FG000|Follow-up Epoch|Lack of Efficacy|1|||
155237281|NCT03328897|560303876|FG001|Follow-up Epoch|Lack of Efficacy|1|||
155237282|NCT03328897|560303877|FG002|Follow-up Epoch|Lack of Efficacy|1|||
155237283|NCT03328897|560303875|FG000|Follow-up Epoch|Lost to Follow-up|0|||
155237284|NCT03328897|560303876|FG001|Follow-up Epoch|Lost to Follow-up|1|||
155237285|NCT03328897|560303877|FG002|Follow-up Epoch|Lost to Follow-up|0|||
155237286|NCT03328897|560303875|FG000|Follow-up Epoch|Pregnancy|1|||
155237287|NCT03328897|560303876|FG001|Follow-up Epoch|Pregnancy|0|||
155237288|NCT03328897|560303877|FG002|Follow-up Epoch|Pregnancy|0|||
155237289|NCT03328897|560303875|FG000|Follow-up Epoch|Patient/guardian decision|2|||
155237290|NCT03328897|560303876|FG001|Follow-up Epoch|Patient/guardian decision|1|||
155237291|NCT03328897|560303877|FG002|Follow-up Epoch|Patient/guardian decision|0|||
155237292|NCT02648698|560303881|FG000|Overall Study|Protocol Violation|1|||
155237293|NCT02648698|560303882|FG001|Overall Study|Protocol Violation|5|||
155237294|NCT00317772|560303885|FG000|Overall Study|Adverse Event|0|||
155237295|NCT00317772|560303886|FG001|Overall Study|Adverse Event|0|||
155237296|NCT00317772|560303887|FG002|Overall Study|Adverse Event|0|||
155237297|NCT00317772|560303888|FG003|Overall Study|Adverse Event|2|||
155237298|NCT00317772|560303885|FG000|Overall Study|Disease Progression|2|||
155237299|NCT00317772|560303886|FG001|Overall Study|Disease Progression|2|||
155237300|NCT00317772|560303887|FG002|Overall Study|Disease Progression|1|||
155237301|NCT00317772|560303888|FG003|Overall Study|Disease Progression|7|||
155237302|NCT00966940|560303889|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
155237303|NCT00966940|560303890|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
155237304|NCT00966940|560303889|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
155237305|NCT00966940|560303890|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
155237306|NCT01040871|560303893|FG000|Overall Study|Adverse Event|6|||
155237307|NCT01040871|560303894|FG001|Overall Study|Adverse Event|2|||
155237308|NCT01040871|560303893|FG000|Overall Study|Withdrawal by Subject|2|||
155237309|NCT01040871|560303894|FG001|Overall Study|Withdrawal by Subject|0|||
155237310|NCT01040871|560303893|FG000|Overall Study|Death|1|||
155237311|NCT01040871|560303894|FG001|Overall Study|Death|3|||
155237312|NCT01040871|560303893|FG000|Overall Study|Lack of Efficacy|1|||
155237313|NCT01040871|560303894|FG001|Overall Study|Lack of Efficacy|1|||
155237314|NCT01040871|560303893|FG000|Overall Study|drug supply issue|1|||
155237315|NCT01040871|560303894|FG001|Overall Study|drug supply issue|0|||
155237316|NCT01040871|560303893|FG000|Overall Study|Randomized and Not Treated|2|||
155237317|NCT01040871|560303894|FG001|Overall Study|Randomized and Not Treated|1|||
155237318|NCT02886572|560303895|FG000|Overall Study|Death|8|||
155237319|NCT02621606|560303896|FG000|Overall Study|Withdrawal by Subject|0|||
155237320|NCT02621606|560303897|FG001|Overall Study|Withdrawal by Subject|1|||
155237321|NCT02621606|560303898|FG002|Overall Study|Withdrawal by Subject|0|||
155237322|NCT01175824|560303899|FG000|Overall Study|Adverse Event|2|||
155237323|NCT01175824|560303900|FG001|Overall Study|Adverse Event|1|||
155237324|NCT01175824|560303899|FG000|Overall Study|Lack of Efficacy|2|||
155237325|NCT01175824|560303900|FG001|Overall Study|Lack of Efficacy|0|||
155237326|NCT01175824|560303899|FG000|Overall Study|Lost to Follow-up|0|||
155237327|NCT01175824|560303900|FG001|Overall Study|Lost to Follow-up|1|||
155237328|NCT01175824|560303899|FG000|Overall Study|Physician Decision|0|||
155237329|NCT01175824|560303900|FG001|Overall Study|Physician Decision|4|||
155237330|NCT01175824|560303899|FG000|Overall Study|Protocol Violation|2|||
155237331|NCT01175824|560303900|FG001|Overall Study|Protocol Violation|5|||
155237332|NCT01175824|560303899|FG000|Overall Study|Withdrawal by Subject|3|||
155237333|NCT01175824|560303900|FG001|Overall Study|Withdrawal by Subject|7|||
155237334|NCT01175824|560303899|FG000|Overall Study|Sponsor Decision|1|||
155237335|NCT01175824|560303900|FG001|Overall Study|Sponsor Decision|0|||
155237336|NCT01175824|560303899|FG000|Overall Study|Entry Criteria Not Met|6|||
155237337|NCT01175824|560303900|FG001|Overall Study|Entry Criteria Not Met|4|||
155237338|NCT03455855|560303901|FG000|Overall Study|Lost to Follow-up|4|||
155237339|NCT03455855|560303902|FG001|Overall Study|Lost to Follow-up|2|||
155237340|NCT00924950|560303903|FG000|Overall Study|Lost to Follow-up|2|||
155237341|NCT00009737|560303904|FG000|Overall Study|Adverse Event|112|||
155237342|NCT00009737|560303905|FG001|Overall Study|Adverse Event|75|||
155237343|NCT00009737|560303904|FG000|Overall Study|Death|4|||
155237344|NCT00009737|560303905|FG001|Overall Study|Death|6|||
155237345|NCT00009737|560303904|FG000|Overall Study|Lack of Efficacy|17|||
155237346|NCT00009737|560303905|FG001|Overall Study|Lack of Efficacy|15|||
155237347|NCT00009737|560303904|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
155491487|NCT00563706|561225399|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491488|NCT00563706|561225400|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
155491489|NCT00563706|561225401|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155491490|NCT00563706|561225393|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491491|NCT00563706|561225394|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491492|NCT00563706|561225395|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491493|NCT00563706|561225396|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491494|NCT00563706|561225397|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491495|NCT00563706|561225398|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491496|NCT00563706|561225399|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
155491497|NCT00563706|561225400|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
155491498|NCT00563706|561225401|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
155491499|NCT02383966|561225404|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
155491500|NCT02383966|561225405|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
155491501|NCT02383966|561225404|FG000|Overall Study|Randomized, but not treated|1|||
155491502|NCT02383966|561225405|FG001|Overall Study|Randomized, but not treated|3|||
155491503|NCT00270205|561225409|FG000|Overall Study|Lost to Follow-up|1|||
155491504|NCT00270205|561225410|FG001|Overall Study|Lost to Follow-up|0|||
155491505|NCT00270205|561225411|FG002|Overall Study|Lost to Follow-up|0|||
155491506|NCT00270205|561225412|FG003|Overall Study|Lost to Follow-up|1|||
155491507|NCT00066573|561225413|FG000|Overall Study|Did not received protocol treatment|28|||
155491508|NCT00066573|561225414|FG001|Overall Study|Did not received protocol treatment|28|||
155491509|NCT00437294|561225419|FG000|Overall Study|Adverse Event|5|||
155491510|NCT00437294|561225420|FG001|Overall Study|Adverse Event|4|||
155491511|NCT00437294|561225419|FG000|Overall Study|Death|5|||
155491512|NCT00437294|561225420|FG001|Overall Study|Death|2|||
155491513|NCT00437294|561225419|FG000|Overall Study|Physician Decision|0|||
155491514|NCT00437294|561225420|FG001|Overall Study|Physician Decision|3|||
155491515|NCT00437294|561225419|FG000|Overall Study|Withdrawal by Subject|5|||
155491516|NCT00437294|561225420|FG001|Overall Study|Withdrawal by Subject|0|||
155491517|NCT00437294|561225419|FG000|Overall Study|Progressive Disease|19|||
155491518|NCT00437294|561225420|FG001|Overall Study|Progressive Disease|23|||
155491519|NCT00437294|561225419|FG000|Overall Study|Sponsor Decision|8|||
155491520|NCT00437294|561225420|FG001|Overall Study|Sponsor Decision|9|||
155491521|NCT00437294|561225419|FG000|Overall Study|Protocol Violation|0|||
155491522|NCT00437294|561225420|FG001|Overall Study|Protocol Violation|1|||
155491523|NCT00437294|561225419|FG000|Overall Study|Entry criteria not met|1|||
155491524|NCT00437294|561225420|FG001|Overall Study|Entry criteria not met|1|||
155491525|NCT02064231|561225423|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
155491526|NCT02064231|561225424|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
155491527|NCT02064231|561225425|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
155491528|NCT02064231|561225426|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
155491529|NCT02064231|561225423|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
155491530|NCT02064231|561225424|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
155237348|NCT00009737|560303905|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
155237349|NCT00009737|560303904|FG000|Overall Study|Other Protocol Violation|1|||
155237350|NCT00009737|560303905|FG001|Overall Study|Other Protocol Violation|0|||
155237351|NCT00009737|560303904|FG000|Overall Study|Refused Treatment|15|||
155237352|NCT00009737|560303905|FG001|Overall Study|Refused Treatment|16|||
155237353|NCT00009737|560303904|FG000|Overall Study|Lost to Follow-up|1|||
155237354|NCT00009737|560303905|FG001|Overall Study|Lost to Follow-up|1|||
155237355|NCT00009737|560303904|FG000|Overall Study|Administrative/Other Reasons|7|||
155237356|NCT00009737|560303905|FG001|Overall Study|Administrative/Other Reasons|1|||
155237357|NCT01163682|560303907|FG000|Overall Study|Lost to Follow-up|6|||
155237358|NCT01163682|560303908|FG001|Overall Study|Lost to Follow-up|9|||
155237359|NCT01931839|560303909|FG000|Overall Study|Death|0|||
155237360|NCT01931839|560303910|FG001|Overall Study|Death|1|||
155237361|NCT01931839|560303911|FG002|Overall Study|Death|2|||
155237362|NCT01931839|560303912|FG003|Overall Study|Death|0|||
155237363|NCT01931839|560303913|FG004|Overall Study|Death|0|||
155237364|NCT01931839|560303914|FG005|Overall Study|Death|0|||
155237365|NCT01931839|560303915|FG006|Overall Study|Death|0|||
155237366|NCT01931839|560303909|FG000|Overall Study|Physician Decision|1|||
155237367|NCT01931839|560303910|FG001|Overall Study|Physician Decision|0|||
155237368|NCT01931839|560303911|FG002|Overall Study|Physician Decision|1|||
155237369|NCT01931839|560303912|FG003|Overall Study|Physician Decision|0|||
155237370|NCT01931839|560303913|FG004|Overall Study|Physician Decision|0|||
155237371|NCT01931839|560303914|FG005|Overall Study|Physician Decision|0|||
155237372|NCT01931839|560303915|FG006|Overall Study|Physician Decision|1|||
155237373|NCT01931839|560303909|FG000|Overall Study|Withdrawal of consent|0|||
155237374|NCT01931839|560303910|FG001|Overall Study|Withdrawal of consent|0|||
155237375|NCT01931839|560303911|FG002|Overall Study|Withdrawal of consent|0|||
155237376|NCT01931839|560303912|FG003|Overall Study|Withdrawal of consent|0|||
155237377|NCT01931839|560303913|FG004|Overall Study|Withdrawal of consent|1|||
155237378|NCT01931839|560303914|FG005|Overall Study|Withdrawal of consent|0|||
155237379|NCT01931839|560303915|FG006|Overall Study|Withdrawal of consent|0|||
155237380|NCT01931839|560303909|FG000|Overall Study|Adverse Event|9|||
155237381|NCT01931839|560303910|FG001|Overall Study|Adverse Event|4|||
155237382|NCT01931839|560303911|FG002|Overall Study|Adverse Event|1|||
155237383|NCT01931839|560303912|FG003|Overall Study|Adverse Event|3|||
155237384|NCT01931839|560303913|FG004|Overall Study|Adverse Event|0|||
155237385|NCT01931839|560303914|FG005|Overall Study|Adverse Event|0|||
155237386|NCT01931839|560303915|FG006|Overall Study|Adverse Event|1|||
155237387|NCT01931839|560303909|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
155237388|NCT01931839|560303910|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
155237389|NCT01931839|560303911|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
155237390|NCT01931839|560303912|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
155237391|NCT01931839|560303913|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
155237392|NCT01931839|560303914|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
155237393|NCT01931839|560303915|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
155237394|NCT01931839|560303909|FG000|Overall Study|Other non-compliance|15|||
155237395|NCT01931839|560303910|FG001|Overall Study|Other non-compliance|9|||
155237396|NCT01931839|560303911|FG002|Overall Study|Other non-compliance|12|||
155237397|NCT01931839|560303912|FG003|Overall Study|Other non-compliance|3|||
155237398|NCT01931839|560303913|FG004|Overall Study|Other non-compliance|0|||
155237399|NCT01931839|560303914|FG005|Overall Study|Other non-compliance|3|||
155237400|NCT01931839|560303915|FG006|Overall Study|Other non-compliance|0|||
155237401|NCT01931839|560303909|FG000|Overall Study|Lost to Follow-up|1|||
155237402|NCT01931839|560303910|FG001|Overall Study|Lost to Follow-up|2|||
155237403|NCT01931839|560303911|FG002|Overall Study|Lost to Follow-up|4|||
155237404|NCT01931839|560303912|FG003|Overall Study|Lost to Follow-up|5|||
155237405|NCT01931839|560303913|FG004|Overall Study|Lost to Follow-up|0|||
155237406|NCT01931839|560303914|FG005|Overall Study|Lost to Follow-up|0|||
155237407|NCT01931839|560303915|FG006|Overall Study|Lost to Follow-up|0|||
155237408|NCT01931839|560303909|FG000|Overall Study|Other|4|||
155237409|NCT01931839|560303910|FG001|Overall Study|Other|2|||
155237410|NCT01931839|560303911|FG002|Overall Study|Other|6|||
155237411|NCT01931839|560303912|FG003|Overall Study|Other|0|||
155237412|NCT01931839|560303913|FG004|Overall Study|Other|0|||
155237413|NCT01931839|560303914|FG005|Overall Study|Other|0|||
155237414|NCT01931839|560303915|FG006|Overall Study|Other|0|||
155237415|NCT03224468|560303916|FG000|Overall Study|Did not obtain MM card|53|||
155237416|NCT03224468|560303917|FG001|Overall Study|Did not obtain MM card|0|||
155237417|NCT03224468|560303916|FG000|Overall Study|Lost to Follow-up|4|||
155237418|NCT03224468|560303917|FG001|Overall Study|Lost to Follow-up|11|||
155237419|NCT03224468|560303916|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
155237420|NCT03224468|560303917|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
155237421|NCT02571452|560303918|FG000|Overall Study Treatment|Protocol Violation|0|||
155237422|NCT02571452|560303919|FG001|Overall Study Treatment|Protocol Violation|1|||
155237423|NCT02571452|560303918|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
155237424|NCT02571452|560303919|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
155237425|NCT02571452|560303918|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
155607043|NCT01897571|561649613|FG000|Overall Study|Death|2|||
155237426|NCT02571452|560303919|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
155237427|NCT02863354|560303922|FG000|Year 1|Lost to Follow-up|1|||
155237428|NCT02863354|560303923|FG001|Year 1|Lost to Follow-up|1|||
155237429|NCT02863354|560303922|FG000|Year 1|Withdrawal by Subject|3|||
155237430|NCT02863354|560303923|FG001|Year 1|Withdrawal by Subject|0|||
155237431|NCT02863354|560303922|FG000|Year 1|Death|0|||
155237432|NCT02863354|560303923|FG001|Year 1|Death|1|||
155237433|NCT02863354|560303922|FG000|Year 2|Lost to Follow-up|2|||
155237434|NCT02863354|560303923|FG001|Year 2|Lost to Follow-up|2|||
155237435|NCT00724451|560303929|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
155237436|NCT00724451|560303929|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
155237437|NCT00724451|560303929|FG000|Overall Study|Not Eligible for Treatment|431|||
155237438|NCT00724451|560303929|FG000|Overall Study|Participant Refused Treatment|89|||
155237439|NCT00724451|560303929|FG000|Overall Study|Never Started Treatment|89|||
155237440|NCT00724451|560303929|FG000|Overall Study|Unknown; No Data Sources Available|9|||
155237441|NCT00724451|560303929|FG000|Overall Study|Physician Decision|116|||
155237442|NCT00724451|560303929|FG000|Overall Study|Withdrawal by Subject|45|||
155237443|NCT00724451|560303929|FG000|Overall Study|Investigator + Participant Decision|13|||
155237444|NCT01599650|560303934|FG000|Overall Study|Administrative issue|1|||
155237445|NCT01599650|560303935|FG001|Overall Study|Administrative issue|0|||
155237446|NCT01599650|560303936|FG002|Overall Study|Administrative issue|1|||
155237447|NCT01599650|560303934|FG000|Overall Study|Physician Decision|2|||
155237448|NCT01599650|560303935|FG001|Overall Study|Physician Decision|0|||
155237449|NCT01599650|560303936|FG002|Overall Study|Physician Decision|7|||
155237450|NCT01599650|560303934|FG000|Overall Study|Protocol Violation|0|||
155237451|NCT01599650|560303935|FG001|Overall Study|Protocol Violation|3|||
155237452|NCT01599650|560303936|FG002|Overall Study|Protocol Violation|0|||
155237453|NCT01599650|560303934|FG000|Overall Study|Death|2|||
155237454|NCT01599650|560303935|FG001|Overall Study|Death|1|||
155237455|NCT01599650|560303936|FG002|Overall Study|Death|2|||
155237456|NCT01599650|560303934|FG000|Overall Study|Lost to Follow-up|3|||
155237457|NCT01599650|560303935|FG001|Overall Study|Lost to Follow-up|3|||
155237458|NCT01599650|560303936|FG002|Overall Study|Lost to Follow-up|3|||
155237459|NCT01599650|560303934|FG000|Overall Study|Withdrawal by Subject|11|||
155237460|NCT01599650|560303935|FG001|Overall Study|Withdrawal by Subject|11|||
155237461|NCT01599650|560303936|FG002|Overall Study|Withdrawal by Subject|10|||
155237462|NCT01599650|560303934|FG000|Overall Study|Adverse Event|3|||
155237463|NCT01599650|560303935|FG001|Overall Study|Adverse Event|8|||
155237464|NCT01599650|560303936|FG002|Overall Study|Adverse Event|4|||
155237465|NCT02520531|560303950|FG000|Overall Study|Revision of study device components|2|||
155237466|NCT02520531|560303951|FG001|Overall Study|Revision of study device components|2|||
155237467|NCT02520531|560303950|FG000|Overall Study|Death|1|||
155237468|NCT02520531|560303951|FG001|Overall Study|Death|2|||
155237469|NCT02520531|560303950|FG000|Overall Study|Lost to Follow-up|1|||
155237470|NCT02520531|560303951|FG001|Overall Study|Lost to Follow-up|1|||
155237471|NCT02520531|560303950|FG000|Overall Study|Meet exclusion criterion|0|||
155237472|NCT02520531|560303951|FG001|Overall Study|Meet exclusion criterion|1|||
155237473|NCT02520531|560303950|FG000|Overall Study|Withdrawal by Subject|1|||
155237474|NCT02520531|560303951|FG001|Overall Study|Withdrawal by Subject|0|||
155237475|NCT02520531|560303950|FG000|Overall Study|Not study device|1|||
155237476|NCT02520531|560303951|FG001|Overall Study|Not study device|0|||
155237477|NCT00622635|560303952|FG000|Treatment Period 1|Adverse Event|0|||
155237478|NCT00622635|560303953|FG001|Treatment Period 1|Adverse Event|0|||
155237479|NCT00622635|560303954|FG002|Treatment Period 1|Adverse Event|1|||
155237480|NCT00622635|560303955|FG003|Treatment Period 1|Adverse Event|0|||
155237481|NCT00622635|560303956|FG004|Treatment Period 1|Adverse Event|0|||
155237482|NCT00622635|560303957|FG005|Treatment Period 1|Adverse Event|0|||
155237483|NCT00622635|560303952|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155237484|NCT00622635|560303953|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155237485|NCT00622635|560303954|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155237486|NCT00622635|560303955|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155237487|NCT00622635|560303956|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155237488|NCT00622635|560303957|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155237489|NCT00622635|560303952|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237490|NCT00622635|560303953|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237491|NCT00622635|560303954|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237492|NCT00622635|560303955|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237493|NCT00622635|560303956|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
155237494|NCT00622635|560303957|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
155491531|NCT02064231|561225425|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
155237495|NCT00622635|560303952|FG000|Treatment Period 2|Adverse Event|1|||
155237496|NCT00622635|560303953|FG001|Treatment Period 2|Adverse Event|0|||
155237497|NCT00622635|560303954|FG002|Treatment Period 2|Adverse Event|0|||
155237498|NCT00622635|560303955|FG003|Treatment Period 2|Adverse Event|0|||
155237499|NCT00622635|560303956|FG004|Treatment Period 2|Adverse Event|0|||
155237500|NCT00622635|560303957|FG005|Treatment Period 2|Adverse Event|0|||
155237501|NCT00622635|560303952|FG000|Treatment Period 3|Adverse Event|0|||
155237502|NCT00622635|560303953|FG001|Treatment Period 3|Adverse Event|0|||
155237503|NCT00622635|560303954|FG002|Treatment Period 3|Adverse Event|0|||
155237504|NCT00622635|560303955|FG003|Treatment Period 3|Adverse Event|2|||
155237505|NCT00622635|560303956|FG004|Treatment Period 3|Adverse Event|0|||
155237506|NCT00622635|560303957|FG005|Treatment Period 3|Adverse Event|0|||
155237507|NCT00622635|560303952|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155237508|NCT00622635|560303953|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155237509|NCT00622635|560303954|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155237510|NCT00622635|560303955|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155237511|NCT00622635|560303956|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155237512|NCT00622635|560303957|FG005|Treatment Period 3|Withdrawal by Subject|0|||
155237513|NCT00835406|560303958|FG000|Period: First Intervention|Adverse Event|0|||
155237514|NCT00835406|560303959|FG001|Period: First Intervention|Adverse Event|1|||
155237515|NCT00835406|560303958|FG000|Period: First Intervention|Withdrawal by Subject|2|||
155237516|NCT00835406|560303959|FG001|Period: First Intervention|Withdrawal by Subject|0|||
155237517|NCT00835406|560303958|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
155237518|NCT00835406|560303959|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
155237519|NCT00281840|560303960|FG000|Overall Study|Adverse Event|12|||
155237520|NCT00281840|560303960|FG000|Overall Study|Physician Decision|6|||
155237521|NCT00281840|560303960|FG000|Overall Study|Withdrawal by Subject|3|||
155237522|NCT00281840|560303960|FG000|Overall Study|Disease Progression|2|||
155237523|NCT00281840|560303960|FG000|Overall Study|exceed maximum delay in treatment|1|||
155237524|NCT00281840|560303960|FG000|Overall Study|Complicating Disease|1|||
155237525|NCT02138214|560303963|FG000|Overall Study|Withdrawal by Subject|0|||
155237526|NCT02138214|560303964|FG001|Overall Study|Withdrawal by Subject|1|||
155237527|NCT02138214|560303965|FG002|Overall Study|Withdrawal by Subject|0|||
155237528|NCT02138214|560303963|FG000|Overall Study|Lost to Follow-up|0|||
155237529|NCT02138214|560303964|FG001|Overall Study|Lost to Follow-up|2|||
155237530|NCT02138214|560303965|FG002|Overall Study|Lost to Follow-up|4|||
155237531|NCT02138214|560303963|FG000|Overall Study|Screen Failure|0|||
155237532|NCT02138214|560303964|FG001|Overall Study|Screen Failure|1|||
155237533|NCT02138214|560303965|FG002|Overall Study|Screen Failure|0|||
155237534|NCT02185768|560303966|FG000|Overall Study|Patients were not treated|2|||
155237535|NCT02486406|560303968|FG000|Overall Study|Withdrew consent|1|||
155237536|NCT02486406|560303969|FG001|Overall Study|Withdrew consent|0|||
155237537|NCT02486406|560303970|FG002|Overall Study|Withdrew consent|0|||
155237538|NCT02486406|560303971|FG003|Overall Study|Withdrew consent|1|||
155237539|NCT02486406|560303968|FG000|Overall Study|Lost to Follow-up|1|||
155237540|NCT02486406|560303969|FG001|Overall Study|Lost to Follow-up|3|||
155237541|NCT02486406|560303970|FG002|Overall Study|Lost to Follow-up|1|||
155237542|NCT02486406|560303971|FG003|Overall Study|Lost to Follow-up|3|||
155237543|NCT02486406|560303968|FG000|Overall Study|Other, not specified|0|||
155237544|NCT02486406|560303969|FG001|Overall Study|Other, not specified|0|||
155237545|NCT02486406|560303970|FG002|Overall Study|Other, not specified|1|||
155237546|NCT02486406|560303971|FG003|Overall Study|Other, not specified|0|||
155237547|NCT01079234|560303974|FG000|Main: Week 0 to 26|Adverse Event|5|||
155237548|NCT01079234|560303975|FG001|Main: Week 0 to 26|Adverse Event|4|||
155237549|NCT01079234|560303976|FG002|Main: Week 0 to 26|Adverse Event|1|||
155237550|NCT01079234|560303977|FG003|Main: Week 0 to 26|Adverse Event|0|||
155237551|NCT01079234|560303974|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
155237552|NCT01079234|560303975|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
155237553|NCT01079234|560303976|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
155237554|NCT01079234|560303977|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
155237555|NCT01079234|560303974|FG000|Main: Week 0 to 26|Protocol Violation|6|||
155237556|NCT01079234|560303975|FG001|Main: Week 0 to 26|Protocol Violation|2|||
155237557|NCT01079234|560303976|FG002|Main: Week 0 to 26|Protocol Violation|4|||
155237558|NCT01079234|560303977|FG003|Main: Week 0 to 26|Protocol Violation|0|||
155237559|NCT01079234|560303974|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
155237560|NCT01079234|560303975|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
155237561|NCT01079234|560303976|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
155237562|NCT01079234|560303977|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
155237563|NCT01079234|560303974|FG000|Main: Week 0 to 26|Unclassified|7|||
155237564|NCT01079234|560303975|FG001|Main: Week 0 to 26|Unclassified|13|||
155237565|NCT01079234|560303976|FG002|Main: Week 0 to 26|Unclassified|4|||
155237566|NCT01079234|560303977|FG003|Main: Week 0 to 26|Unclassified|0|||
155237567|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Adverse Event|0|||
155237568|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Adverse Event|0|||
155237569|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Adverse Event|1|||
155237570|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Adverse Event|0|||
155237571|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237572|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237573|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237574|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
155237575|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
155237576|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
155237577|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
155237578|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
155237579|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
155237580|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
155237581|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
155237582|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
155237583|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Unclassified|0|||
155237584|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Unclassified|0|||
155237585|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Unclassified|4|||
155237586|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Unclassified|7|||
155237587|NCT05402995|560303987|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
155237588|NCT05402995|560303988|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237589|NCT05402995|560303989|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237590|NCT05402995|560303990|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237591|NCT01071512|560303993|FG000|Overall Study|Adverse Event|1|||
155237592|NCT01071512|560303993|FG000|Overall Study|Development of antibodies to drug|2|||
155237593|NCT01071512|560303993|FG000|Overall Study|positive anti-JC virus antibody test|2|||
155237594|NCT02316717|560303996|FG000|Overall Study|Adverse Event|2|||
155237595|NCT02316717|560303997|FG001|Overall Study|Adverse Event|2|||
155237596|NCT02316717|560303998|FG002|Overall Study|Adverse Event|0|||
155237597|NCT02316717|560303996|FG000|Overall Study|Lost to Follow-up|1|||
155237598|NCT02316717|560303997|FG001|Overall Study|Lost to Follow-up|2|||
155237599|NCT02316717|560303998|FG002|Overall Study|Lost to Follow-up|1|||
155237600|NCT02316717|560303996|FG000|Overall Study|Non compliance|3|||
155237601|NCT02316717|560303997|FG001|Overall Study|Non compliance|1|||
155237602|NCT02316717|560303998|FG002|Overall Study|Non compliance|0|||
155237603|NCT02316717|560303996|FG000|Overall Study|Protocol Violation|2|||
155237604|NCT02316717|560303997|FG001|Overall Study|Protocol Violation|0|||
155237605|NCT02316717|560303998|FG002|Overall Study|Protocol Violation|0|||
155237606|NCT02316717|560303996|FG000|Overall Study|Withdrawal by Subject|2|||
155237607|NCT02316717|560303997|FG001|Overall Study|Withdrawal by Subject|1|||
155237608|NCT02316717|560303998|FG002|Overall Study|Withdrawal by Subject|1|||
155237609|NCT02316717|560303996|FG000|Overall Study|Death|0|||
155237610|NCT02316717|560303997|FG001|Overall Study|Death|0|||
155237611|NCT02316717|560303998|FG002|Overall Study|Death|1|||
155237612|NCT02316717|560303996|FG000|Overall Study|Physician Decision|0|||
155237613|NCT02316717|560303997|FG001|Overall Study|Physician Decision|1|||
155237614|NCT02316717|560303998|FG002|Overall Study|Physician Decision|0|||
155237615|NCT02316717|560303996|FG000|Overall Study|TBC|1|||
155237616|NCT02316717|560303997|FG001|Overall Study|TBC|0|||
155237617|NCT02316717|560303998|FG002|Overall Study|TBC|0|||
155237618|NCT00183872|560303999|FG000|Overall Study|Death|3|||
155237619|NCT00183872|560303999|FG000|Overall Study|Adverse Event|9|||
155237620|NCT00183872|560303999|FG000|Overall Study|Withdrawal by Subject|2|||
155237621|NCT00183872|560303999|FG000|Overall Study|Drug delayed more than 28 days|2|||
155237622|NCT02052466|560304000|FG000|Overall Study|Withdrawal by Subject|1|||
155237623|NCT02052466|560304000|FG000|Overall Study|Acromial fracture|1|||
155237624|NCT00508742|560304001|FG000|Period 1: Infant Series|Adverse Event|5|||
155237625|NCT00508742|560304002|FG001|Period 1: Infant Series|Adverse Event|4|||
155237626|NCT00508742|560304001|FG000|Period 1: Infant Series|Protocol Violation|1|||
155237627|NCT00508742|560304002|FG001|Period 1: Infant Series|Protocol Violation|0|||
155237628|NCT00508742|560304001|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
155237629|NCT00508742|560304002|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
155237630|NCT00508742|560304001|FG000|Period 1: Infant Series|Physician Decision|1|||
155237631|NCT00508742|560304002|FG001|Period 1: Infant Series|Physician Decision|0|||
155237632|NCT00508742|560304001|FG000|Period 1: Infant Series|Other|4|||
155237633|NCT00508742|560304002|FG001|Period 1: Infant Series|Other|1|||
155237634|NCT00508742|560304001|FG000|Period 2: After Infant Series|Adverse Event|2|||
155237635|NCT00508742|560304002|FG001|Period 2: After Infant Series|Adverse Event|6|||
155237636|NCT00508742|560304001|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
155237637|NCT00508742|560304002|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
155237638|NCT00508742|560304001|FG000|Period 2: After Infant Series|Protocol Violation|1|||
155237639|NCT00508742|560304002|FG001|Period 2: After Infant Series|Protocol Violation|0|||
155237640|NCT00508742|560304001|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
155237641|NCT00508742|560304002|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
155237642|NCT00508742|560304001|FG000|Period 2: After Infant Series|Failed to Return|1|||
155237643|NCT00508742|560304002|FG001|Period 2: After Infant Series|Failed to Return|0|||
155237644|NCT00508742|560304001|FG000|Period 2: After Infant Series|Other|2|||
155237645|NCT00508742|560304002|FG001|Period 2: After Infant Series|Other|1|||
155237646|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Adverse Event|1|||
155237647|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Adverse Event|0|||
155237648|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
155237649|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
155237650|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
155237651|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
155491532|NCT02064231|561225426|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
155237652|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Other|5|||
155237653|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Other|4|||
155237654|NCT00595582|560304004|FG000|Overall Study|Pilot study that PI terminated|2|||
155237655|NCT00595582|560304004|FG000|Overall Study|Lost to Follow-up|1|||
155237656|NCT00595582|560304004|FG000|Overall Study|Adverse Event|2|||
155237657|NCT00595582|560304004|FG000|Overall Study|Physician Decision|5|||
155237658|NCT02797262|560304005|FG000|Overall Study|Withdrawal by Subject|5|||
155237659|NCT02797262|560304006|FG001|Overall Study|Withdrawal by Subject|1|||
155237660|NCT02797262|560304005|FG000|Overall Study|Lost to Follow-up|10|||
155237661|NCT02797262|560304006|FG001|Overall Study|Lost to Follow-up|7|||
155237662|NCT02797262|560304005|FG000|Overall Study|Death|1|||
155237663|NCT02797262|560304006|FG001|Overall Study|Death|2|||
155237664|NCT02797262|560304005|FG000|Overall Study|Adverse Event|1|||
155237665|NCT02797262|560304006|FG001|Overall Study|Adverse Event|0|||
155237666|NCT02797262|560304005|FG000|Overall Study|COVID-19|2|||
155237667|NCT02797262|560304006|FG001|Overall Study|COVID-19|1|||
155237668|NCT02797262|560304005|FG000|Overall Study|Out-of-country|1|||
155237669|NCT02797262|560304006|FG001|Overall Study|Out-of-country|0|||
155237670|NCT01600586|560304007|FG000|Overall Study|Physician Decision|3|||
155237671|NCT01600586|560304008|FG001|Overall Study|Physician Decision|3|||
155237672|NCT03146650|560304011|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
155237673|NCT03146650|560304011|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
155237674|NCT03146650|560304011|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
155237675|NCT03146650|560304011|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
155237676|NCT03146650|560304011|FG000|2 Year Follow-up|Death|11|||
155237677|NCT03146650|560304011|FG000|2 Year Follow-up|Still in follow-up|7|||
155237678|NCT03146650|560304011|FG000|2 Year Follow-up|Lost to Follow-up|1|||
155237679|NCT02460198|560304012|FG000|Overall Study|Adverse Event|1|||
155237680|NCT02460198|560304013|FG001|Overall Study|Adverse Event|3|||
155237681|NCT02460198|560304012|FG000|Overall Study|Death|36|||
155237682|NCT02460198|560304013|FG001|Overall Study|Death|28|||
155237683|NCT02460198|560304012|FG000|Overall Study|Lost to Follow-up|1|||
155237684|NCT02460198|560304013|FG001|Overall Study|Lost to Follow-up|1|||
155237685|NCT02460198|560304012|FG000|Overall Study|Transferred to Extension Study|15|||
155237686|NCT02460198|560304013|FG001|Overall Study|Transferred to Extension Study|15|||
155237687|NCT02460198|560304012|FG000|Overall Study|Withdrawal by Subject|2|||
155237688|NCT02460198|560304013|FG001|Overall Study|Withdrawal by Subject|4|||
155237689|NCT02460198|560304012|FG000|Overall Study|Site Terminated By Sponsor|0|||
155237690|NCT02460198|560304013|FG001|Overall Study|Site Terminated By Sponsor|1|||
155237691|NCT02460198|560304012|FG000|Overall Study|Did Not Continue on Extension Study|6|||
155237692|NCT02460198|560304013|FG001|Overall Study|Did Not Continue on Extension Study|11|||
155237693|NCT00931307|560304014|FG000|Overall Study|Lack of Efficacy|12|||
155237694|NCT00931307|560304014|FG000|Overall Study|Biomicroscopy|1|||
155237695|NCT00965848|560304015|FG000|Overall Study|Protocol Violation|3|||
155237696|NCT00965848|560304016|FG001|Overall Study|Protocol Violation|0|||
155237697|NCT00965848|560304017|FG002|Overall Study|Protocol Violation|1|||
155237698|NCT00965848|560304015|FG000|Overall Study|Death|11|||
155237699|NCT00965848|560304016|FG001|Overall Study|Death|1|||
155237700|NCT00965848|560304017|FG002|Overall Study|Death|5|||
155237701|NCT00965848|560304015|FG000|Overall Study|Lost to Follow-up|0|||
155237702|NCT00965848|560304016|FG001|Overall Study|Lost to Follow-up|0|||
155237703|NCT00965848|560304017|FG002|Overall Study|Lost to Follow-up|1|||
155237704|NCT00965848|560304015|FG000|Overall Study|Withdrawal by Subject|1|||
155237705|NCT00965848|560304016|FG001|Overall Study|Withdrawal by Subject|0|||
155237706|NCT00965848|560304017|FG002|Overall Study|Withdrawal by Subject|0|||
155237707|NCT00965848|560304015|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
155237708|NCT00965848|560304016|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
155237709|NCT00965848|560304017|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
155237710|NCT00965848|560304015|FG000|Overall Study|Not Clinically Evaluable|7|||
155237711|NCT00965848|560304016|FG001|Overall Study|Not Clinically Evaluable|1|||
155237712|NCT00965848|560304017|FG002|Overall Study|Not Clinically Evaluable|1|||
155237713|NCT00965848|560304015|FG000|Overall Study|Other|5|||
155237714|NCT00965848|560304016|FG001|Overall Study|Other|0|||
155237715|NCT00965848|560304017|FG002|Overall Study|Other|1|||
155237716|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
155237717|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237718|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237719|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237720|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
155237721|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
155237722|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
155237723|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
155237724|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237725|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237726|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237727|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
155237728|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237729|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237730|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
155237731|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237732|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237733|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237734|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
155237735|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237736|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237737|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
155237738|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237739|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237740|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
155237741|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
155237742|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
155237743|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
155237744|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
155237745|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
155237746|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
155237747|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
155237748|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
155237749|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
155237750|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
155237751|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
155237752|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155491533|NCT02064231|561225423|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
155491534|NCT02064231|561225424|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
155491535|NCT02064231|561225425|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
155491536|NCT02064231|561225426|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
155491537|NCT02064231|561225423|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
155491538|NCT02064231|561225424|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
155491539|NCT02064231|561225425|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
155491540|NCT02064231|561225426|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
155491541|NCT01422876|561225429|FG000|Week 24|Lost to Follow-up|1|||
155491542|NCT01422876|561225430|FG001|Week 24|Lost to Follow-up|1|||
155491543|NCT01422876|561225431|FG002|Week 24|Lost to Follow-up|2|||
155491544|NCT01422876|561225432|FG003|Week 24|Lost to Follow-up|4|||
155491545|NCT01422876|561225433|FG004|Week 24|Lost to Follow-up|2|||
155491546|NCT01422876|561225434|FG005|Week 24|Lost to Follow-up|0|||
155491547|NCT01422876|561225435|FG006|Week 24|Lost to Follow-up|1|||
155491548|NCT01422876|561225436|FG007|Week 24|Lost to Follow-up|3|||
155491549|NCT01422876|561225437|FG008|Week 24|Lost to Follow-up|3|||
155491550|NCT01422876|561225438|FG009|Week 24|Lost to Follow-up|4|||
155491551|NCT01422876|561225429|FG000|Week 24|Consent withdrawn|5|||
155491552|NCT01422876|561225430|FG001|Week 24|Consent withdrawn|1|||
155491553|NCT01422876|561225431|FG002|Week 24|Consent withdrawn|3|||
155491554|NCT01422876|561225432|FG003|Week 24|Consent withdrawn|4|||
155491555|NCT01422876|561225433|FG004|Week 24|Consent withdrawn|5|||
155491556|NCT01422876|561225434|FG005|Week 24|Consent withdrawn|6|||
155491557|NCT01422876|561225435|FG006|Week 24|Consent withdrawn|5|||
155491558|NCT01422876|561225436|FG007|Week 24|Consent withdrawn|4|||
155491559|NCT01422876|561225437|FG008|Week 24|Consent withdrawn|3|||
155491560|NCT01422876|561225438|FG009|Week 24|Consent withdrawn|6|||
155491561|NCT01422876|561225429|FG000|Week 24|Death|0|||
155491562|NCT01422876|561225430|FG001|Week 24|Death|1|||
155491563|NCT01422876|561225431|FG002|Week 24|Death|0|||
155491564|NCT01422876|561225432|FG003|Week 24|Death|0|||
155491565|NCT01422876|561225433|FG004|Week 24|Death|0|||
155491566|NCT01422876|561225434|FG005|Week 24|Death|0|||
155491567|NCT01422876|561225435|FG006|Week 24|Death|0|||
155491568|NCT01422876|561225436|FG007|Week 24|Death|0|||
155491569|NCT01422876|561225437|FG008|Week 24|Death|0|||
155491570|NCT01422876|561225438|FG009|Week 24|Death|0|||
155491571|NCT01422876|561225429|FG000|Week 52|Lost to Follow-up|3|||
155491572|NCT01422876|561225430|FG001|Week 52|Lost to Follow-up|5|||
155237753|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155237754|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155237755|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
155237756|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
155491573|NCT01422876|561225431|FG002|Week 52|Lost to Follow-up|7|||
155491574|NCT01422876|561225432|FG003|Week 52|Lost to Follow-up|5|||
155491575|NCT01422876|561225433|FG004|Week 52|Lost to Follow-up|8|||
155491576|NCT01422876|561225434|FG005|Week 52|Lost to Follow-up|5|||
155491577|NCT01422876|561225435|FG006|Week 52|Lost to Follow-up|5|||
155491578|NCT01422876|561225436|FG007|Week 52|Lost to Follow-up|8|||
155491579|NCT01422876|561225437|FG008|Week 52|Lost to Follow-up|7|||
155491580|NCT01422876|561225438|FG009|Week 52|Lost to Follow-up|8|||
155491581|NCT01422876|561225429|FG000|Week 52|Consent withdrawn|9|||
155491582|NCT01422876|561225430|FG001|Week 52|Consent withdrawn|4|||
155491583|NCT01422876|561225431|FG002|Week 52|Consent withdrawn|6|||
155237757|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
155237758|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
155237759|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
155237760|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
155237761|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
155237762|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
155237763|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
155237764|NCT00691210|560304022|FG000|Overall Study|Progression of Disease|0|||
155237765|NCT00691210|560304023|FG001|Overall Study|Progression of Disease|0|||
155237766|NCT00691210|560304024|FG002|Overall Study|Progression of Disease|0|||
155237767|NCT00691210|560304025|FG003|Overall Study|Progression of Disease|2|||
155237768|NCT00691210|560304026|FG004|Overall Study|Progression of Disease|0|||
155237769|NCT00691210|560304027|FG005|Overall Study|Progression of Disease|0|||
155237770|NCT00691210|560304028|FG006|Overall Study|Progression of Disease|0|||
155237771|NCT00691210|560304029|FG007|Overall Study|Progression of Disease|0|||
155237772|NCT00691210|560304022|FG000|Overall Study|Lack of Efficacy|0|||
155237773|NCT00691210|560304023|FG001|Overall Study|Lack of Efficacy|0|||
155237774|NCT00691210|560304024|FG002|Overall Study|Lack of Efficacy|0|||
155237775|NCT00691210|560304025|FG003|Overall Study|Lack of Efficacy|1|||
155237776|NCT00691210|560304026|FG004|Overall Study|Lack of Efficacy|0|||
155237777|NCT00691210|560304027|FG005|Overall Study|Lack of Efficacy|1|||
155237778|NCT00691210|560304028|FG006|Overall Study|Lack of Efficacy|0|||
155237779|NCT00691210|560304029|FG007|Overall Study|Lack of Efficacy|0|||
155237780|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
155237781|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
155237782|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
155237783|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
155237784|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
155237785|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
155237786|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
155237787|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
155237788|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
155237789|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
155237790|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
155237791|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
155237792|NCT00983814|560304032|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
155237793|NCT00983814|560304033|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
155237794|NCT00983814|560304034|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
155237795|NCT00555438|560304037|FG000|10 Days Post-operative|Death|4|||
155237796|NCT00555438|560304037|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
155237797|NCT02707640|560304038|FG000|Overall Study|Adverse Event|4|||
155237798|NCT02707640|560304039|FG001|Overall Study|Adverse Event|2|||
155237799|NCT02707640|560304038|FG000|Overall Study|Death|1|||
155237800|NCT02707640|560304039|FG001|Overall Study|Death|2|||
155237801|NCT02707640|560304038|FG000|Overall Study|Physician Decision|2|||
155237802|NCT02707640|560304039|FG001|Overall Study|Physician Decision|0|||
155237803|NCT02707640|560304038|FG000|Overall Study|Withdrawal by Subject|0|||
155237804|NCT02707640|560304039|FG001|Overall Study|Withdrawal by Subject|1|||
155237805|NCT02707640|560304038|FG000|Overall Study|Participant's Personal Decision|1|||
155237806|NCT02707640|560304039|FG001|Overall Study|Participant's Personal Decision|2|||
155237807|NCT02707640|560304038|FG000|Overall Study|Sponsor Discretion|1|||
155237808|NCT02707640|560304039|FG001|Overall Study|Sponsor Discretion|0|||
155237809|NCT02517905|560304040|FG000|Overall Study|Lost to Follow-up|4|||
155237810|NCT02517905|560304041|FG001|Overall Study|Lost to Follow-up|0|||
155237811|NCT02517905|560304040|FG000|Overall Study|Withdrawal by Subject|4|||
155237812|NCT02517905|560304041|FG001|Overall Study|Withdrawal by Subject|0|||
155237813|NCT02517905|560304040|FG000|Overall Study|Screen failure|2|||
155237814|NCT02517905|560304041|FG001|Overall Study|Screen failure|2|||
155237815|NCT02758236|560304046|FG000|Overall Study|Investigator discretion|43|||
155237816|NCT05789875|560304047|FG000|Overall Study|Lost to Follow-up|6|||
155237817|NCT01994395|560304048|FG000|Overall Study|Withdrawal by Subject|1|||
155237818|NCT01994395|560304049|FG001|Overall Study|Withdrawal by Subject|2|||
155237819|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
155237820|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
155237821|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
155237822|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
155237823|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
155237824|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
155237825|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
155237826|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
155237827|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
155237828|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
155237829|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
155491584|NCT01422876|561225432|FG003|Week 52|Consent withdrawn|12|||
155237830|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
155237831|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
155237832|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
155237833|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
155237834|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
155237835|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
155237836|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
155237837|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
155237838|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
155237839|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
155237840|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
155237841|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
155237842|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
155237843|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
155237844|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
155237845|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
155237846|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
155237847|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
155237848|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
155237849|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Death|1|||
155237850|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Death|0|||
155237851|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Death|0|||
155237852|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
155237853|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
155237854|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
155237855|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
155237856|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
155237857|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
155237858|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
155237859|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
155237860|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
155237861|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
155237862|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
155237863|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
155237864|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
155237865|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
155237866|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
155237867|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
155237868|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
155237869|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
155237870|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
155237871|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
155237872|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
155237873|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
155237874|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
155237875|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
155237876|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
155237877|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
155237878|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
155237879|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Other|0|||
155237880|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Other|2|||
155237881|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Other|2|||
155237882|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
155237883|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
155237884|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
155237885|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
155237886|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
155237887|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
155237888|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
155237889|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
155237890|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
155237891|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
155237892|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
155491585|NCT01422876|561225433|FG004|Week 52|Consent withdrawn|7|||
155237893|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
155237894|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
155237895|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
155237896|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
155237897|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
155237898|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
155237899|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
155237900|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
155237901|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
155237902|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
155237903|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
155237904|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
155237905|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
155237906|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Other|1|||
155237907|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Other|0|||
155237908|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Other|0|||
155237909|NCT01818336|560305289|FG000|Overall Study|Declined retest visit|0|||
155237910|NCT01818336|560305290|FG001|Overall Study|Declined retest visit|11|||
155237911|NCT01818336|560305289|FG000|Overall Study|Lost to Follow-up|0|||
155237912|NCT01818336|560305290|FG001|Overall Study|Lost to Follow-up|1|||
155237913|NCT00608829|560305293|FG000|Overall Study|Death|6|||
155237914|NCT00608829|560305293|FG000|Overall Study|Withdrawal by Subject|4|||
155237915|NCT00608829|560305293|FG000|Overall Study|Subject refuses to follow up or return.|5|||
155237916|NCT00672477|560305296|FG000|Overall Study|Adverse Event|10|||
155237917|NCT00672477|560305297|FG001|Overall Study|Adverse Event|7|||
155491586|NCT01422876|561225434|FG005|Week 52|Consent withdrawn|12|||
155491587|NCT01422876|561225435|FG006|Week 52|Consent withdrawn|10|||
155491588|NCT01422876|561225436|FG007|Week 52|Consent withdrawn|12|||
155491589|NCT01422876|561225437|FG008|Week 52|Consent withdrawn|13|||
155491590|NCT01422876|561225438|FG009|Week 52|Consent withdrawn|9|||
155491591|NCT01422876|561225429|FG000|Week 52|Death|0|||
155491592|NCT01422876|561225430|FG001|Week 52|Death|1|||
155491593|NCT01422876|561225431|FG002|Week 52|Death|0|||
155491594|NCT01422876|561225432|FG003|Week 52|Death|1|||
155491595|NCT01422876|561225433|FG004|Week 52|Death|0|||
155491596|NCT01422876|561225434|FG005|Week 52|Death|0|||
155491597|NCT01422876|561225435|FG006|Week 52|Death|1|||
155491598|NCT01422876|561225436|FG007|Week 52|Death|3|||
155491599|NCT01422876|561225437|FG008|Week 52|Death|1|||
155491600|NCT01422876|561225438|FG009|Week 52|Death|0|||
155491601|NCT00536991|561225440|FG000|Overall Study|Withdrawal by Subject|10|||
155491602|NCT00536991|561225440|FG000|Overall Study|Physician Decision|1|||
155491603|NCT00536991|561225440|FG000|Overall Study|patient ineligible|2|||
155491604|NCT01600755|561225441|FG000|Overall Study|Withdrawal by Subject|6|||
155491605|NCT00938392|561225442|FG000|Overall Study|Adverse Event|0|||
155491606|NCT00938392|561225443|FG001|Overall Study|Adverse Event|1|||
155491607|NCT00938392|561225442|FG000|Overall Study|Withdrawal by Subject|0|||
155491608|NCT00938392|561225443|FG001|Overall Study|Withdrawal by Subject|1|||
155491609|NCT00938392|561225442|FG000|Overall Study|Lost to Follow-up|2|||
155491610|NCT00938392|561225443|FG001|Overall Study|Lost to Follow-up|2|||
155491611|NCT01366846|561225444|FG000|Overall Study|Withdrawal by Subject|2|||
155491612|NCT01366846|561225445|FG001|Overall Study|Withdrawal by Subject|0|||
155491613|NCT01366846|561225446|FG002|Overall Study|Withdrawal by Subject|0|||
155491614|NCT01366846|561225447|FG003|Overall Study|Withdrawal by Subject|0|||
155491615|NCT01366846|561225444|FG000|Overall Study|Communication Difficulties|1|||
155491616|NCT01366846|561225445|FG001|Overall Study|Communication Difficulties|4|||
155491617|NCT01366846|561225446|FG002|Overall Study|Communication Difficulties|0|||
155491618|NCT01366846|561225447|FG003|Overall Study|Communication Difficulties|1|||
155491619|NCT01366846|561225444|FG000|Overall Study|Scheduling Conflicts|0|||
155491620|NCT01366846|561225445|FG001|Overall Study|Scheduling Conflicts|0|||
155491621|NCT01366846|561225446|FG002|Overall Study|Scheduling Conflicts|1|||
155491622|NCT01366846|561225447|FG003|Overall Study|Scheduling Conflicts|0|||
155491623|NCT00122954|561225448|FG000|Overall Study|Withdrawal by Subject|2|||
155491624|NCT00122954|561225449|FG001|Overall Study|Withdrawal by Subject|2|||
155491625|NCT00122954|561225448|FG000|Overall Study|Protocol Violation|0|||
155491626|NCT00122954|561225449|FG001|Overall Study|Protocol Violation|1|||
155491627|NCT00558831|561225454|FG000|Overall Study|Lost to Follow-up|1|||
155491628|NCT04341727|561225455|FG000|Overall Study|Withdrawal by Subject|0|||
155491629|NCT04341727|561225456|FG001|Overall Study|Withdrawal by Subject|0|||
155491630|NCT04341727|561225457|FG002|Overall Study|Withdrawal by Subject|1|||
155491631|NCT04341727|561225458|FG003|Overall Study|Withdrawal by Subject|0|||
155491632|NCT04341727|561225455|FG000|Overall Study|Lost to Follow-up|0|||
155491633|NCT04341727|561225456|FG001|Overall Study|Lost to Follow-up|0|||
155491634|NCT04341727|561225457|FG002|Overall Study|Lost to Follow-up|0|||
155491635|NCT04341727|561225458|FG003|Overall Study|Lost to Follow-up|1|||
155491636|NCT02856282|561225459|FG000|Overall Study|Withdrawal by Subject|1|||
155237918|NCT00672477|560305296|FG000|Overall Study|Death|7|||
155237919|NCT00672477|560305297|FG001|Overall Study|Death|11|||
155237920|NCT00672477|560305296|FG000|Overall Study|Physician Decision|2|||
155237921|NCT00672477|560305297|FG001|Overall Study|Physician Decision|0|||
155237922|NCT00672477|560305296|FG000|Overall Study|Protocol Violation|1|||
155237923|NCT00672477|560305297|FG001|Overall Study|Protocol Violation|1|||
155237924|NCT00672477|560305296|FG000|Overall Study|Withdrawal by Subject|5|||
155237925|NCT00672477|560305297|FG001|Overall Study|Withdrawal by Subject|3|||
155237926|NCT00672477|560305296|FG000|Overall Study|Lack of Efficacy|1|||
155237927|NCT00672477|560305297|FG001|Overall Study|Lack of Efficacy|1|||
155237928|NCT00672477|560305296|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
155237929|NCT00672477|560305297|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
155237930|NCT00982319|560305299|FG000|Overall Study|Surgery date change|1|||
155237931|NCT00982319|560305300|FG001|Overall Study|Surgery date change|0|||
155237932|NCT00982319|560305299|FG000|Overall Study|Preop values out of acceptable range|1|||
155237933|NCT00982319|560305300|FG001|Overall Study|Preop values out of acceptable range|1|||
155237934|NCT00982319|560305299|FG000|Overall Study|Pregnancy|0|||
155237935|NCT00982319|560305300|FG001|Overall Study|Pregnancy|1|||
155237936|NCT00975975|560305301|FG000|Overall Study|Death|6|||
155237937|NCT02496884|560305307|FG000|Overall Study|Counted twice as enrolled|2|||
155237938|NCT02496884|560305308|FG001|Overall Study|Counted twice as enrolled|0|||
155237939|NCT02496884|560305309|FG002|Overall Study|Counted twice as enrolled|0|||
155237940|NCT02496884|560305310|FG003|Overall Study|Counted twice as enrolled|0|||
155237941|NCT02496884|560305307|FG000|Overall Study|Withdrawal by Subject|0|||
155237942|NCT02496884|560305308|FG001|Overall Study|Withdrawal by Subject|3|||
155237943|NCT02496884|560305309|FG002|Overall Study|Withdrawal by Subject|0|||
155237944|NCT02496884|560305310|FG003|Overall Study|Withdrawal by Subject|0|||
155237945|NCT00097591|560305311|FG000|Overall Study|Withdrawal of consent|342|||
155237946|NCT00097591|560305312|FG001|Overall Study|Withdrawal of consent|323|||
155237947|NCT00097591|560305311|FG000|Overall Study|Less than 6 months on study drug|9|||
155237948|NCT00097591|560305312|FG001|Overall Study|Less than 6 months on study drug|7|||
155237949|NCT00097591|560305311|FG000|Overall Study|Unable to attend termination visit|53|||
155237950|NCT00097591|560305312|FG001|Overall Study|Unable to attend termination visit|51|||
155237951|NCT00097591|560305311|FG000|Overall Study|Lost to follow up|6|||
155237952|NCT00097591|560305312|FG001|Overall Study|Lost to follow up|10|||
155237953|NCT00097591|560305311|FG000|Overall Study|Other|0|||
155237954|NCT00097591|560305312|FG001|Overall Study|Other|3|||
155237955|NCT00807092|560305315|FG000|Overall Study|Adverse Event|0|||
155237956|NCT00807092|560305316|FG001|Overall Study|Adverse Event|1|||
155237957|NCT00807092|560305315|FG000|Overall Study|Protocol Violation|0|||
155237958|NCT00807092|560305316|FG001|Overall Study|Protocol Violation|2|||
155237959|NCT00807092|560305315|FG000|Overall Study|Withdrawal by Subject|1|||
155237960|NCT00807092|560305316|FG001|Overall Study|Withdrawal by Subject|0|||
155237961|NCT00807092|560305315|FG000|Overall Study|CGMS data collection failed|0|||
155237962|NCT00807092|560305316|FG001|Overall Study|CGMS data collection failed|1|||
155237963|NCT02013765|560305324|FG000|Overall Study|Trial was terminated by sponsor|1|||
155237964|NCT03095417|560305327|FG000|Overall Study|missed|1|||
155237965|NCT03095417|560305328|FG001|Overall Study|missed|2|||
155237966|NCT03095417|560305329|FG002|Overall Study|missed|0|||
155237967|NCT03095417|560305330|FG003|Overall Study|missed|1|||
155237968|NCT03095417|560305327|FG000|Overall Study|Lost to Follow-up|2|||
155237969|NCT03095417|560305328|FG001|Overall Study|Lost to Follow-up|2|||
155237970|NCT03095417|560305329|FG002|Overall Study|Lost to Follow-up|1|||
155237971|NCT03095417|560305330|FG003|Overall Study|Lost to Follow-up|0|||
155237972|NCT03095417|560305327|FG000|Overall Study|refusal|0|||
155237973|NCT03095417|560305328|FG001|Overall Study|refusal|1|||
155237974|NCT03095417|560305329|FG002|Overall Study|refusal|0|||
155237975|NCT03095417|560305330|FG003|Overall Study|refusal|1|||
155237976|NCT03095417|560305327|FG000|Overall Study|Withdrawal by Subject|8|||
155237977|NCT03095417|560305328|FG001|Overall Study|Withdrawal by Subject|2|||
155237978|NCT03095417|560305329|FG002|Overall Study|Withdrawal by Subject|5|||
155237979|NCT03095417|560305330|FG003|Overall Study|Withdrawal by Subject|4|||
155237980|NCT03095417|560305327|FG000|Overall Study|Physician Decision|1|||
155237981|NCT03095417|560305328|FG001|Overall Study|Physician Decision|2|||
155237982|NCT03095417|560305329|FG002|Overall Study|Physician Decision|2|||
155491637|NCT00057330|561225460|FG000|Overall Study|Adverse Event|9|||
155491638|NCT00057330|561225461|FG001|Overall Study|Adverse Event|12|||
155237983|NCT03095417|560305330|FG003|Overall Study|Physician Decision|2|||
155237984|NCT03095417|560305327|FG000|Overall Study|Death|1|||
155237985|NCT03095417|560305328|FG001|Overall Study|Death|2|||
155237986|NCT03095417|560305329|FG002|Overall Study|Death|1|||
155237987|NCT03095417|560305330|FG003|Overall Study|Death|3|||
155237988|NCT01260922|560305333|FG000|First Intervention|Withdrawal by Subject|0|||
155237989|NCT01260922|560305334|FG001|First Intervention|Withdrawal by Subject|1|||
155237990|NCT01260922|560305333|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
155237991|NCT01260922|560305334|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
155237992|NCT01260922|560305333|FG000|Second Intervention|Emesis|0|||
155237993|NCT01260922|560305334|FG001|Second Intervention|Emesis|2|||
155237994|NCT01731171|560305335|FG000|Overall Study|Withdrawal by Subject|4|||
155237995|NCT01731171|560305336|FG001|Overall Study|Withdrawal by Subject|1|||
155237996|NCT01731171|560305335|FG000|Overall Study|Lost to Follow-up|3|||
155237997|NCT01731171|560305336|FG001|Overall Study|Lost to Follow-up|2|||
155237998|NCT01731171|560305335|FG000|Overall Study|Moved out of Area|0|||
155237999|NCT01731171|560305336|FG001|Overall Study|Moved out of Area|2|||
155238000|NCT01731171|560305335|FG000|Overall Study|Terminated for Lack of Adherence|0|||
155238001|NCT01731171|560305336|FG001|Overall Study|Terminated for Lack of Adherence|1|||
155238002|NCT01731171|560305335|FG000|Overall Study|Terminated for Safety Reasons|0|||
155238003|NCT01731171|560305336|FG001|Overall Study|Terminated for Safety Reasons|1|||
155238004|NCT01410110|560305337|FG000|Overall Study|Withdrawal by Subject|4|||
155238005|NCT01410110|560305338|FG001|Overall Study|Withdrawal by Subject|2|||
155238006|NCT01416805|560305339|FG000|Overall Study|Lost to Follow-up|4|||
155238007|NCT01416805|560305340|FG001|Overall Study|Lost to Follow-up|4|||
155238008|NCT03653429|560305341|FG000|Overall Study|Physician Decision|4|||
155238009|NCT03653429|560305342|FG001|Overall Study|Physician Decision|10|||
155238010|NCT02604589|560305347|FG000|Overall Study|catheter dislodgement|0|||
155238011|NCT02604589|560305348|FG001|Overall Study|catheter dislodgement|0|||
155238012|NCT02604589|560305349|FG002|Overall Study|catheter dislodgement|1|||
155238013|NCT01700946|560305350|FG000|Overall Study|Lost to Follow-up|1|||
155238014|NCT01700946|560305351|FG001|Overall Study|Lost to Follow-up|0|||
155238015|NCT01700946|560305350|FG000|Overall Study|Physician Decision|7|||
155238016|NCT01700946|560305351|FG001|Overall Study|Physician Decision|12|||
155238017|NCT01700946|560305350|FG000|Overall Study|Withdrawal by Subject|0|||
155238018|NCT01700946|560305351|FG001|Overall Study|Withdrawal by Subject|2|||
155238019|NCT01700946|560305350|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
155238020|NCT01700946|560305351|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
155238021|NCT01700946|560305350|FG000|Overall Study|Relapse|2|||
155238022|NCT01700946|560305351|FG001|Overall Study|Relapse|1|||
155238023|NCT01700946|560305350|FG000|Overall Study|Unacceptable toxicity|1|||
155238024|NCT01700946|560305351|FG001|Overall Study|Unacceptable toxicity|0|||
155238025|NCT04632940|560305359|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
155238026|NCT04632940|560305360|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
155238027|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
155238028|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
155238029|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
155238030|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
155238031|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
155238032|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
155238033|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
155238034|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
155238035|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
155238036|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
155238037|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Other than specified|0|||
155238038|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Other than specified|1|||
155238039|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
155238040|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
155238041|NCT00684424|560305361|FG000|Overall Study|Adverse Event|1|||
155238042|NCT00684424|560305361|FG000|Overall Study|Lost to Follow-up|2|||
155238043|NCT00684424|560305361|FG000|Overall Study|Other|2|||
155238044|NCT01723904|560305365|FG000|Overall Study|Noncompliant|3|||
155238045|NCT01723904|560305365|FG000|Overall Study|Adverse Event|5|||
155238046|NCT01723904|560305365|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
155238047|NCT02610140|560305378|FG000|Randomization and Treatment Period|Radiological progression|23|||
155238048|NCT02610140|560305379|FG001|Randomization and Treatment Period|Radiological progression|15|||
155238049|NCT02610140|560305378|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
155238050|NCT02610140|560305379|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
155238051|NCT02610140|560305378|FG000|Randomization and Treatment Period|Protocol Violation|1|||
155238052|NCT02610140|560305379|FG001|Randomization and Treatment Period|Protocol Violation|0|||
155238053|NCT02610140|560305378|FG000|Randomization and Treatment Period|Physician Decision|0|||
155238054|NCT02610140|560305379|FG001|Randomization and Treatment Period|Physician Decision|1|||
155238055|NCT02610140|560305378|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
155238056|NCT02610140|560305379|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
155238057|NCT02610140|560305378|FG000|Randomization and Treatment Period|Death|7|||
155238058|NCT02610140|560305379|FG001|Randomization and Treatment Period|Death|1|||
155238059|NCT02610140|560305378|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
155238060|NCT02610140|560305379|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
155238061|NCT02610140|560305378|FG000|Randomization and Treatment Period|Adverse Event|44|||
155238062|NCT02610140|560305379|FG001|Randomization and Treatment Period|Adverse Event|13|||
155238063|NCT02610140|560305378|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
155238064|NCT02610140|560305379|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
155238065|NCT02610140|560305378|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
155238066|NCT02610140|560305379|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
155238067|NCT02610140|560305378|FG000|Randomization and Treatment Period|Not treated|3|||
155238068|NCT02610140|560305379|FG001|Randomization and Treatment Period|Not treated|10|||
155238069|NCT02610140|560305378|FG000|Safety Follow-up|Other|0|||
155238070|NCT02610140|560305379|FG001|Safety Follow-up|Other|2|||
155238071|NCT02610140|560305378|FG000|Safety Follow-up|Lost to Follow-up|1|||
155238072|NCT02610140|560305379|FG001|Safety Follow-up|Lost to Follow-up|0|||
155238073|NCT02610140|560305378|FG000|Safety Follow-up|No follow-up|5|||
155238074|NCT02610140|560305379|FG001|Safety Follow-up|No follow-up|3|||
155238075|NCT02610140|560305378|FG000|Safety Follow-up|Death|12|||
155238076|NCT02610140|560305379|FG001|Safety Follow-up|Death|2|||
155238077|NCT02610140|560305378|FG000|Safety Follow-up|Deterioration of general conditions|15|||
155238078|NCT02610140|560305379|FG001|Safety Follow-up|Deterioration of general conditions|5|||
155238079|NCT02610140|560305378|FG000|Safety Follow-up|Withdrawal by Subject|12|||
155238080|NCT02610140|560305379|FG001|Safety Follow-up|Withdrawal by Subject|12|||
155238081|NCT02610140|560305378|FG000|Active Follow-up|Progressive disease - radiological|30|||
155238082|NCT02610140|560305379|FG001|Active Follow-up|Progressive disease - radiological|22|||
155238083|NCT02610140|560305378|FG000|Active Follow-up|Death|8|||
155238084|NCT02610140|560305379|FG001|Active Follow-up|Death|1|||
155238085|NCT02610140|560305378|FG000|Active Follow-up|Withdrawal by Subject|4|||
155238086|NCT02610140|560305379|FG001|Active Follow-up|Withdrawal by Subject|0|||
155238087|NCT02610140|560305378|FG000|Active Follow-up|Progressive disease - clinical|1|||
155238088|NCT02610140|560305379|FG001|Active Follow-up|Progressive disease - clinical|2|||
155238089|NCT02610140|560305378|FG000|Active Follow-up|Deterioration of general conditions|1|||
155238090|NCT02610140|560305379|FG001|Active Follow-up|Deterioration of general conditions|0|||
155238091|NCT02610140|560305378|FG000|Active Follow-up|Ongoing but not completed|4|||
155238092|NCT02610140|560305379|FG001|Active Follow-up|Ongoing but not completed|1|||
155238093|NCT02610140|560305378|FG000|Long-term Follow-up|Death|86|||
155238094|NCT02610140|560305379|FG001|Long-term Follow-up|Death|44|||
155238095|NCT02610140|560305378|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
155238096|NCT02610140|560305379|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
155238097|NCT02610140|560305378|FG000|Long-term Follow-up|Lost to Follow-up|1|||
155238098|NCT02610140|560305379|FG001|Long-term Follow-up|Lost to Follow-up|2|||
155238099|NCT02610140|560305378|FG000|Long-term Follow-up|Ongoing but not completed|30|||
155238100|NCT02610140|560305379|FG001|Long-term Follow-up|Ongoing but not completed|17|||
155238101|NCT00887341|560305380|FG000|Overall Study|Refused treatment|1|||
155238102|NCT00887341|560305381|FG001|Overall Study|Refused treatment|0|||
155238103|NCT00887341|560305380|FG000|Overall Study|Withdrawal by Subject|1|||
155238104|NCT00887341|560305381|FG001|Overall Study|Withdrawal by Subject|1|||
155238105|NCT00887341|560305380|FG000|Overall Study|Adverse Event|0|||
155238106|NCT00887341|560305381|FG001|Overall Study|Adverse Event|1|||
155238107|NCT00887341|560305380|FG000|Overall Study|Lost to Follow-up|0|||
155238108|NCT00887341|560305381|FG001|Overall Study|Lost to Follow-up|1|||
155238109|NCT02617589|560305382|FG000|Randomization|Request to Discontinue Study Treatment|1|||
155238110|NCT02617589|560305383|FG001|Randomization|Request to Discontinue Study Treatment|3|||
155238111|NCT02617589|560305382|FG000|Randomization|Participant Withdrew Consent|1|||
155238112|NCT02617589|560305383|FG001|Randomization|Participant Withdrew Consent|2|||
155238113|NCT02617589|560305382|FG000|Treatment|Other Reasons|3|||
155238114|NCT02617589|560305383|FG001|Treatment|Other Reasons|3|||
155238115|NCT02617589|560305382|FG000|Treatment|Poor/Non Compliance|1|||
155238116|NCT02617589|560305383|FG001|Treatment|Poor/Non Compliance|1|||
155238117|NCT02617589|560305382|FG000|Treatment|Maximum Clinical Benefit|0|||
155238118|NCT02617589|560305383|FG001|Treatment|Maximum Clinical Benefit|2|||
155238119|NCT02617589|560305382|FG000|Treatment|Participant Withdrew Consent|2|||
155238120|NCT02617589|560305383|FG001|Treatment|Participant Withdrew Consent|6|||
155238121|NCT02617589|560305382|FG000|Treatment|Participant Request to Discontinue|12|||
155238122|NCT02617589|560305383|FG001|Treatment|Participant Request to Discontinue|21|||
155238123|NCT02617589|560305382|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
155238124|NCT02617589|560305383|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
155238125|NCT02617589|560305382|FG000|Treatment|Death|1|||
155238126|NCT02617589|560305383|FG001|Treatment|Death|1|||
155238127|NCT02617589|560305382|FG000|Treatment|Study Drug Toxicity|27|||
155238128|NCT02617589|560305383|FG001|Treatment|Study Drug Toxicity|20|||
155238129|NCT02617589|560305382|FG000|Treatment|Disease Progression|216|||
155238130|NCT02617589|560305383|FG001|Treatment|Disease Progression|136|||
155238131|NCT01752933|560305386|FG000|Treatment|Disease Progression|3|||
155238132|NCT01752933|560305387|FG001|Treatment|Disease Progression|29|||
155238133|NCT01752933|560305386|FG000|Treatment|Withdrawal by Subject|0|||
155238134|NCT01752933|560305387|FG001|Treatment|Withdrawal by Subject|5|||
155238135|NCT01752933|560305386|FG000|Treatment|Adverse Event|1|||
155238136|NCT01752933|560305387|FG001|Treatment|Adverse Event|4|||
155238137|NCT01752933|560305386|FG000|Treatment|Physician Decision|0|||
155238138|NCT01752933|560305387|FG001|Treatment|Physician Decision|3|||
155238139|NCT01752933|560305386|FG000|Treatment|Death|0|||
155238140|NCT01752933|560305387|FG001|Treatment|Death|2|||
155238141|NCT01752933|560305386|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
155238142|NCT01752933|560305387|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
155238143|NCT01752933|560305386|FG000|Treatment|Patient noncompliant|0|||
155238144|NCT01752933|560305387|FG001|Treatment|Patient noncompliant|1|||
155238145|NCT01752933|560305386|FG000|Treatment|Patient unable to travel to appointments|0|||
155238146|NCT01752933|560305387|FG001|Treatment|Patient unable to travel to appointments|1|||
155238147|NCT01752933|560305386|FG000|Overall Study and Follow-up|Death|4|||
155238148|NCT01752933|560305387|FG001|Overall Study and Follow-up|Death|34|||
155238149|NCT01752933|560305386|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
155238150|NCT01752933|560305387|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
155238151|NCT01752933|560305386|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
155238152|NCT01752933|560305387|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
155238153|NCT01752933|560305386|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
155238154|NCT01752933|560305387|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
155238155|NCT01591681|560305388|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
155238156|NCT01591681|560305388|FG000|Overall Study|Failed to use system during run-in|1|||
155238157|NCT03062891|560305389|FG000|Overall Study|Withdrawal by Subject|2|||
155238158|NCT03062891|560305390|FG001|Overall Study|Withdrawal by Subject|0|||
155238159|NCT03062891|560305389|FG000|Overall Study|Lost to Follow-up|50|||
155238160|NCT03062891|560305390|FG001|Overall Study|Lost to Follow-up|38|||
155238161|NCT03509948|560305394|FG000|Overall Study|Protocol Violation|0|||
155238162|NCT03509948|560305395|FG001|Overall Study|Protocol Violation|1|||
155238163|NCT03221257|560305396|FG000|Overall Study|Lost to Follow-up|0|||
155238164|NCT03221257|560305397|FG001|Overall Study|Lost to Follow-up|1|||
155238165|NCT03221257|560305396|FG000|Overall Study|Withdrawal by Subject|1|||
155238166|NCT03221257|560305397|FG001|Overall Study|Withdrawal by Subject|1|||
155238167|NCT01334866|560305406|FG000|Overall Study|Withdrawal by Subject|10|||
155238168|NCT01334866|560305406|FG000|Overall Study|Lost to Follow-up|3|||
155238169|NCT01334866|560305406|FG000|Overall Study|Physician Decision|3|||
155238170|NCT01334866|560305406|FG000|Overall Study|medically necessary prior to procedure|2|||
155238171|NCT01334866|560305406|FG000|Overall Study|medically necessary post-procedure|1|||
155238172|NCT00958880|560305414|FG000|Overall Study|Lost to Follow-up|2|||
155238173|NCT00958880|560305415|FG001|Overall Study|Lost to Follow-up|2|||
155238174|NCT01971346|560305416|FG000|Overall Study|Protocol Violation|3|||
155238175|NCT01971346|560305416|FG000|Overall Study|Lost to Follow-up|2|||
155238176|NCT01971346|560305416|FG000|Overall Study|Withdrawal by Subject|2|||
155238177|NCT01971346|560305416|FG000|Overall Study|Physician Decision|1|||
155238178|NCT04187196|560305419|FG000|Overall Study|Screen Failure|2|||
155238179|NCT04187196|560305420|FG001|Overall Study|Screen Failure|0|||
155238180|NCT01687166|560305421|FG000|Overall Study|Attempt subject|2|||
155238181|NCT01687166|560305422|FG001|Overall Study|Attempt subject|3|||
155238182|NCT01687166|560305423|FG002|Overall Study|Attempt subject|2|||
155238183|NCT01687166|560305424|FG003|Overall Study|Attempt subject|0|||
155238184|NCT01687166|560305421|FG000|Overall Study|Did not meet eligibility criteria|4|||
155238185|NCT01687166|560305422|FG001|Overall Study|Did not meet eligibility criteria|6|||
155238186|NCT01687166|560305423|FG002|Overall Study|Did not meet eligibility criteria|1|||
155238187|NCT01687166|560305424|FG003|Overall Study|Did not meet eligibility criteria|1|||
155238188|NCT01687166|560305421|FG000|Overall Study|Adverse Event|2|||
155238189|NCT01687166|560305422|FG001|Overall Study|Adverse Event|1|||
155238190|NCT01687166|560305423|FG002|Overall Study|Adverse Event|0|||
155238191|NCT01687166|560305424|FG003|Overall Study|Adverse Event|0|||
155238192|NCT01687166|560305421|FG000|Overall Study|Physician Decision|3|||
155238193|NCT01687166|560305422|FG001|Overall Study|Physician Decision|2|||
155238194|NCT01687166|560305423|FG002|Overall Study|Physician Decision|1|||
155238195|NCT01687166|560305424|FG003|Overall Study|Physician Decision|0|||
155238196|NCT01687166|560305421|FG000|Overall Study|Withdrawal by Subject|11|||
155238197|NCT01687166|560305422|FG001|Overall Study|Withdrawal by Subject|4|||
155238198|NCT01687166|560305423|FG002|Overall Study|Withdrawal by Subject|3|||
155238199|NCT01687166|560305424|FG003|Overall Study|Withdrawal by Subject|0|||
155238200|NCT01687166|560305421|FG000|Overall Study|Lost to Follow-up|2|||
155238201|NCT01687166|560305422|FG001|Overall Study|Lost to Follow-up|5|||
155238202|NCT01687166|560305423|FG002|Overall Study|Lost to Follow-up|1|||
155238203|NCT01687166|560305424|FG003|Overall Study|Lost to Follow-up|0|||
155238204|NCT01687166|560305421|FG000|Overall Study|Equipment/Device Availability|0|||
155238205|NCT01687166|560305422|FG001|Overall Study|Equipment/Device Availability|1|||
155238206|NCT01687166|560305423|FG002|Overall Study|Equipment/Device Availability|0|||
155238207|NCT01687166|560305424|FG003|Overall Study|Equipment/Device Availability|0|||
155238208|NCT01687166|560305421|FG000|Overall Study|Death|1|||
155238209|NCT01687166|560305422|FG001|Overall Study|Death|1|||
155238210|NCT01687166|560305423|FG002|Overall Study|Death|0|||
155238211|NCT01687166|560305424|FG003|Overall Study|Death|0|||
155238212|NCT01687166|560305421|FG000|Overall Study|Protocol Violation|1|||
155238213|NCT01687166|560305422|FG001|Overall Study|Protocol Violation|1|||
155238214|NCT01687166|560305423|FG002|Overall Study|Protocol Violation|1|||
155238215|NCT01687166|560305424|FG003|Overall Study|Protocol Violation|0|||
155238216|NCT01687166|560305421|FG000|Overall Study|Subject moved out of state|0|||
155238217|NCT01687166|560305422|FG001|Overall Study|Subject moved out of state|1|||
155238218|NCT01687166|560305423|FG002|Overall Study|Subject moved out of state|0|||
155238219|NCT01687166|560305424|FG003|Overall Study|Subject moved out of state|0|||
155238220|NCT01687166|560305421|FG000|Overall Study|Patient unable to be compliant|1|||
155238221|NCT01687166|560305422|FG001|Overall Study|Patient unable to be compliant|0|||
155238222|NCT01687166|560305423|FG002|Overall Study|Patient unable to be compliant|0|||
155238223|NCT01687166|560305424|FG003|Overall Study|Patient unable to be compliant|0|||
155238224|NCT01687166|560305421|FG000|Overall Study|Physician choice to use different device|1|||
155238225|NCT01687166|560305422|FG001|Overall Study|Physician choice to use different device|2|||
155238226|NCT01687166|560305423|FG002|Overall Study|Physician choice to use different device|4|||
155238227|NCT01687166|560305424|FG003|Overall Study|Physician choice to use different device|0|||
155238228|NCT01687166|560305421|FG000|Overall Study|Insurance|0|||
155238229|NCT01687166|560305422|FG001|Overall Study|Insurance|0|||
155238230|NCT01687166|560305423|FG002|Overall Study|Insurance|1|||
155238231|NCT01687166|560305424|FG003|Overall Study|Insurance|1|||
155238232|NCT02755831|560305425|FG000|Overall Study|Lost to Follow-up|3|||
155238233|NCT02755831|560305426|FG001|Overall Study|Lost to Follow-up|3|||
155238234|NCT02296112|560305427|FG000|Overall Study|Disease progression|7|||
155238235|NCT02296112|560305427|FG000|Overall Study|Toxicity|1|||
155238236|NCT02296112|560305427|FG000|Overall Study|Began an alternate therapy|1|||
155238237|NCT00298831|560305428|FG000|Overall Study|Adverse Event|1|||
155238238|NCT00298831|560305428|FG000|Overall Study|Lost to Follow-up|3|||
155238239|NCT00298831|560305428|FG000|Overall Study|Withdrawal by Subject|1|||
155238240|NCT00298831|560305428|FG000|Overall Study|Participants did not receive treatment|27|||
155238241|NCT01516879|560305429|FG000|Overall Study|Withdrawal by Subject|9|||
155238242|NCT01516879|560305430|FG001|Overall Study|Withdrawal by Subject|11|||
155238243|NCT01516879|560305429|FG000|Overall Study|Death|0|||
155238244|NCT01516879|560305430|FG001|Overall Study|Death|2|||
155238245|NCT01516879|560305429|FG000|Overall Study|Lost to Follow-up|2|||
155238246|NCT01516879|560305430|FG001|Overall Study|Lost to Follow-up|11|||
155238247|NCT01516879|560305429|FG000|Overall Study|Other|5|||
155238248|NCT01516879|560305430|FG001|Overall Study|Other|10|||
155238249|NCT01720069|560305431|FG000|Overall Study|Could not use e-diary correctly|0|||
155238250|NCT01720069|560305432|FG001|Overall Study|Could not use e-diary correctly|1|||
155238251|NCT01720069|560305433|FG002|Overall Study|Could not use e-diary correctly|1|||
155238252|NCT01720069|560305431|FG000|Overall Study|Randomised without baseline values|0|||
155238253|NCT01720069|560305432|FG001|Overall Study|Randomised without baseline values|0|||
155238254|NCT01720069|560305433|FG002|Overall Study|Randomised without baseline values|1|||
155238255|NCT01720069|560305431|FG000|Overall Study|Adverse Event|0|||
155238256|NCT01720069|560305432|FG001|Overall Study|Adverse Event|0|||
155238257|NCT01720069|560305433|FG002|Overall Study|Adverse Event|1|||
155238258|NCT01720069|560305431|FG000|Overall Study|Lack of Efficacy|0|||
155238259|NCT01720069|560305432|FG001|Overall Study|Lack of Efficacy|4|||
155238260|NCT01720069|560305433|FG002|Overall Study|Lack of Efficacy|0|||
155238261|NCT01720069|560305431|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
155238262|NCT01720069|560305432|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
155238263|NCT01720069|560305433|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
155238264|NCT01720069|560305431|FG000|Overall Study|Withdrawal by Subject|0|||
155238265|NCT01720069|560305432|FG001|Overall Study|Withdrawal by Subject|2|||
155238266|NCT01720069|560305433|FG002|Overall Study|Withdrawal by Subject|1|||
155238267|NCT01720069|560305431|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
155238268|NCT01720069|560305432|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
155238269|NCT01720069|560305433|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
155238270|NCT01720069|560305431|FG000|Overall Study|Non-compliance on using e-diary|0|||
155238271|NCT01720069|560305432|FG001|Overall Study|Non-compliance on using e-diary|0|||
155238272|NCT01720069|560305433|FG002|Overall Study|Non-compliance on using e-diary|1|||
155238273|NCT01720069|560305431|FG000|Overall Study|Lost to Follow-up|0|||
155238274|NCT01720069|560305432|FG001|Overall Study|Lost to Follow-up|0|||
155238275|NCT01720069|560305433|FG002|Overall Study|Lost to Follow-up|1|||
155238276|NCT04568122|560305434|FG000|Overall Study|Lost to Follow-up|48|||
155238277|NCT04568122|560305435|FG001|Overall Study|Lost to Follow-up|44|||
155238278|NCT04568122|560305436|FG002|Overall Study|Lost to Follow-up|4|||
155238279|NCT04568122|560305437|FG003|Overall Study|Lost to Follow-up|0|||
155238280|NCT04568122|560305438|FG004|Overall Study|Lost to Follow-up|0|||
155238281|NCT03136068|560307154|FG000|Overall Study|Lost to Follow-up|1|||
155238282|NCT03136068|560307155|FG001|Overall Study|Lost to Follow-up|1|||
155238283|NCT03136068|560307154|FG000|Overall Study|Protocol Violation|1|||
155238284|NCT03136068|560307155|FG001|Overall Study|Protocol Violation|0|||
155238285|NCT00432380|560307159|FG000|Overall Study|Migrated/moved from study area|3|||
155238286|NCT00432380|560307160|FG001|Overall Study|Migrated/moved from study area|4|||
155238287|NCT00432380|560307161|FG002|Overall Study|Migrated/moved from study area|1|||
155238288|NCT00432380|560307159|FG000|Overall Study|Adverse Event|1|||
155238289|NCT00432380|560307160|FG001|Overall Study|Adverse Event|0|||
155238290|NCT00432380|560307161|FG002|Overall Study|Adverse Event|0|||
155238291|NCT01071395|560307169|FG000|Overall Study|Withdrawal by Subject|2|||
155238292|NCT01071395|560307170|FG001|Overall Study|Withdrawal by Subject|1|||
155238293|NCT01071395|560307169|FG000|Overall Study|Adverse Event|3|||
155238294|NCT01071395|560307170|FG001|Overall Study|Adverse Event|1|||
155238295|NCT02805257|560307171|FG000|Overall Study|Lost to Follow-up|7|||
155238296|NCT02805257|560307172|FG001|Overall Study|Lost to Follow-up|6|||
155238297|NCT02805257|560307171|FG000|Overall Study|Death|0|||
155238298|NCT02805257|560307172|FG001|Overall Study|Death|1|||
155238299|NCT00612066|560307173|FG000|Overall Study|Adverse Event|1|||
155238300|NCT01043874|560307177|FG000|Overall Study|Adverse Event|3|||
155238301|NCT01043874|560307177|FG000|Overall Study|Withdrawal by Subject|1|||
155238302|NCT01043874|560307177|FG000|Overall Study|Lack of Efficacy|1|||
155238303|NCT01043874|560307177|FG000|Overall Study|Administrative Problems|1|||
155238304|NCT03422003|560307178|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
155238305|NCT03422003|560307179|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
155238306|NCT03422003|560307178|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
155238307|NCT03422003|560307179|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
155238308|NCT01337089|560307180|FG000|Overall Study|Adverse Event|237|||
155238309|NCT01337089|560307180|FG000|Overall Study|Withdrawal by Subject|129|||
155238310|NCT01337089|560307180|FG000|Overall Study|Withdrawal by Investigator|33|||
155238311|NCT01337089|560307180|FG000|Overall Study|Met Withdrawal Criteria|3|||
155238312|NCT01337089|560307180|FG000|Overall Study|Lost to Follow-up|2|||
155238313|NCT01404312|560307181|FG000|Overall Study|Death|21|||
155238314|NCT01404312|560307182|FG001|Overall Study|Death|27|||
155238315|NCT01404312|560307181|FG000|Overall Study|Withdrawal by Subject|15|||
155238316|NCT01404312|560307182|FG001|Overall Study|Withdrawal by Subject|18|||
155238317|NCT01404312|560307181|FG000|Overall Study|Participant Unable to get to clinic|93|||
155238318|NCT01404312|560307182|FG001|Overall Study|Participant Unable to get to clinic|103|||
155238319|NCT01404312|560307181|FG000|Overall Study|Lost to Follow-up|115|||
155238320|NCT01404312|560307182|FG001|Overall Study|Lost to Follow-up|111|||
155238321|NCT01404312|560307181|FG000|Overall Study|Site closed|22|||
155238322|NCT01404312|560307182|FG001|Overall Study|Site closed|21|||
155238323|NCT01404312|560307181|FG000|Overall Study|Participant not willing to adhere to req|31|||
155238324|NCT01404312|560307182|FG001|Overall Study|Participant not willing to adhere to req|29|||
155238325|NCT01404312|560307181|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155238326|NCT01404312|560307182|FG001|Overall Study|Severe debilitation, unable to continue|2|||
155238327|NCT04419493|560307183|FG000|Wash-out After Period 1|Adverse Event|1|||
155238328|NCT04419493|560307184|FG001|Wash-out After Period 1|Adverse Event|2|||
155238329|NCT04419493|560307185|FG002|Wash-out After Period 1|Adverse Event|1|||
155238330|NCT04419493|560307186|FG003|Wash-out After Period 1|Adverse Event|0|||
155238331|NCT00524134|560307187|FG000|Overall Study|Withdrawal by Subject|1|||
155238332|NCT00524134|560307187|FG000|Overall Study|Physician Decision|1|||
155238333|NCT03266588|560307188|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
155238334|NCT03266588|560307189|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
155238335|NCT03266588|560307190|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
155238336|NCT03266588|560307188|FG000|Observational Period|Withdrawal by Subject|44|||
155238337|NCT03266588|560307189|FG001|Observational Period|Withdrawal by Subject|22|||
155238338|NCT03266588|560307190|FG002|Observational Period|Withdrawal by Subject|13|||
155238339|NCT03266588|560307188|FG000|Observational Period|Non-compliance|18|||
155238340|NCT03266588|560307189|FG001|Observational Period|Non-compliance|12|||
155238341|NCT03266588|560307190|FG002|Observational Period|Non-compliance|10|||
155238342|NCT03266588|560307188|FG000|Observational Period|Lost to Follow-up|8|||
155238343|NCT03266588|560307189|FG001|Observational Period|Lost to Follow-up|12|||
155238344|NCT03266588|560307190|FG002|Observational Period|Lost to Follow-up|4|||
155238345|NCT03266588|560307188|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
155238346|NCT03266588|560307189|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
155238347|NCT03266588|560307190|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
155238348|NCT03266588|560307188|FG000|Observational Period|Protocol Deviation|1|||
155238349|NCT03266588|560307189|FG001|Observational Period|Protocol Deviation|0|||
155238350|NCT03266588|560307190|FG002|Observational Period|Protocol Deviation|0|||
155238351|NCT03266588|560307188|FG000|Observational Period|Other Reasons|3|||
155238352|NCT03266588|560307189|FG001|Observational Period|Other Reasons|0|||
155238353|NCT03266588|560307190|FG002|Observational Period|Other Reasons|1|||
155238354|NCT03266588|560307188|FG000|Long-term Treatment Period|Adverse Event|33|||
155238355|NCT03266588|560307189|FG001|Long-term Treatment Period|Adverse Event|17|||
155238356|NCT03266588|560307190|FG002|Long-term Treatment Period|Adverse Event|8|||
155238357|NCT03266588|560307188|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
155238358|NCT03266588|560307189|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
155238359|NCT03266588|560307190|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
155238360|NCT03266588|560307188|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
155238361|NCT03266588|560307189|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
155238362|NCT03266588|560307190|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
155238363|NCT03266588|560307188|FG000|Long-term Treatment Period|Non-Compliance|126|||
155238364|NCT03266588|560307189|FG001|Long-term Treatment Period|Non-Compliance|57|||
155238365|NCT03266588|560307190|FG002|Long-term Treatment Period|Non-Compliance|7|||
155238366|NCT03266588|560307188|FG000|Long-term Treatment Period|Pregnancy|11|||
155238367|NCT03266588|560307189|FG001|Long-term Treatment Period|Pregnancy|5|||
155238368|NCT03266588|560307190|FG002|Long-term Treatment Period|Pregnancy|0|||
155238369|NCT03266588|560307188|FG000|Long-term Treatment Period|Protocol Deviation|17|||
155238370|NCT03266588|560307189|FG001|Long-term Treatment Period|Protocol Deviation|10|||
155238371|NCT03266588|560307190|FG002|Long-term Treatment Period|Protocol Deviation|4|||
155238372|NCT03266588|560307188|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
155238373|NCT03266588|560307189|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
155238374|NCT03266588|560307190|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
155238375|NCT03266588|560307188|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
155238376|NCT03266588|560307189|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
155238377|NCT03266588|560307190|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
155238378|NCT03266588|560307188|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
155238379|NCT03266588|560307189|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
155238380|NCT03266588|560307190|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
155238381|NCT03266588|560307188|FG000|Long-term Treatment Period|Other Reasons|5|||
155238382|NCT03266588|560307189|FG001|Long-term Treatment Period|Other Reasons|0|||
155238383|NCT03266588|560307190|FG002|Long-term Treatment Period|Other Reasons|0|||
155238384|NCT03266588|560307188|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
155238385|NCT03266588|560307189|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
155238386|NCT03266588|560307190|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
155238387|NCT02627677|560307192|FG000|Overall Study|Adverse event (not progressive disease)|1|||
155238388|NCT02627677|560307193|FG001|Overall Study|Adverse event (not progressive disease)|4|||
155238389|NCT02627677|560307194|FG002|Overall Study|Adverse event (not progressive disease)|1|||
155238390|NCT02627677|560307192|FG000|Overall Study|Progressive disease|1|||
155238391|NCT02627677|560307193|FG001|Overall Study|Progressive disease|3|||
155238392|NCT02627677|560307194|FG002|Overall Study|Progressive disease|0|||
155238393|NCT02627677|560307192|FG000|Overall Study|Lack of Efficacy|1|||
155238394|NCT02627677|560307193|FG001|Overall Study|Lack of Efficacy|2|||
155238395|NCT02627677|560307194|FG002|Overall Study|Lack of Efficacy|0|||
155238396|NCT02627677|560307192|FG000|Overall Study|Lost to Follow-up|0|||
155238397|NCT02627677|560307193|FG001|Overall Study|Lost to Follow-up|0|||
155238398|NCT02627677|560307194|FG002|Overall Study|Lost to Follow-up|1|||
155238399|NCT02627677|560307192|FG000|Overall Study|Pregnancy|0|||
155238400|NCT02627677|560307193|FG001|Overall Study|Pregnancy|1|||
155238401|NCT02627677|560307194|FG002|Overall Study|Pregnancy|0|||
155238402|NCT02627677|560307192|FG000|Overall Study|Study Terminated by Sponsor|5|||
155238403|NCT02627677|560307193|FG001|Overall Study|Study Terminated by Sponsor|10|||
155238404|NCT02627677|560307194|FG002|Overall Study|Study Terminated by Sponsor|6|||
155238405|NCT02627677|560307192|FG000|Overall Study|Physician Decision|0|||
155238406|NCT02627677|560307193|FG001|Overall Study|Physician Decision|0|||
155238407|NCT02627677|560307194|FG002|Overall Study|Physician Decision|2|||
155238408|NCT02627677|560307192|FG000|Overall Study|Withdrawal by Subject|2|||
155238409|NCT02627677|560307193|FG001|Overall Study|Withdrawal by Subject|1|||
155238410|NCT02627677|560307194|FG002|Overall Study|Withdrawal by Subject|1|||
155238411|NCT02627677|560307192|FG000|Overall Study|Reason not Specified|0|||
155238412|NCT02627677|560307193|FG001|Overall Study|Reason not Specified|0|||
155238413|NCT02627677|560307194|FG002|Overall Study|Reason not Specified|1|||
155238414|NCT02627677|560307192|FG000|Overall Study|Randomized but not Treated|1|||
155238415|NCT02627677|560307193|FG001|Overall Study|Randomized but not Treated|0|||
155238416|NCT02627677|560307194|FG002|Overall Study|Randomized but not Treated|0|||
155238417|NCT03087591|560307197|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
155238418|NCT03087591|560307197|FG000|Overall Study|Withdrawal by Subject|1|||
155238419|NCT01073618|560307200|FG000|Overall Study|Death|208|||
155238420|NCT01073618|560307200|FG000|Overall Study|Adverse Event|19|||
155238421|NCT01073618|560307200|FG000|Overall Study|Other|80|||
155238422|NCT02696850|560307201|FG000|Overall Study|Withdrawal by Subject|3|||
155238423|NCT02696850|560307202|FG001|Overall Study|Withdrawal by Subject|3|||
155238424|NCT02696850|560307201|FG000|Overall Study|Lost to Follow-up|8|||
155238425|NCT02696850|560307202|FG001|Overall Study|Lost to Follow-up|5|||
155238426|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
155238427|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
155238428|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
155238429|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
155238430|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Death|235|||
155238431|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Death|167|||
155238432|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Death|1|||
155238433|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Death|0|||
155238434|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
155238435|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
155238436|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
155238437|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
155238438|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
155238439|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
155491639|NCT00057330|561225460|FG000|Overall Study|Death|1|||
155238440|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
155238441|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
155238442|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Other|1|||
155238443|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Other|2|||
155238444|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Other|0|||
155238445|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Other|0|||
155238446|NCT00673049|560307205|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
155238447|NCT00673049|560307206|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
155238448|NCT00673049|560307207|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
155238449|NCT00673049|560307208|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
155238450|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238451|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
155238452|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238453|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238454|NCT00673049|560307205|FG000|After Progression on Erlotinib|Death|0|||
155238455|NCT00673049|560307206|FG001|After Progression on Erlotinib|Death|0|||
155238456|NCT00673049|560307207|FG002|After Progression on Erlotinib|Death|0|||
155238457|NCT00673049|560307208|FG003|After Progression on Erlotinib|Death|71|||
155238458|NCT00673049|560307205|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
155238459|NCT00673049|560307206|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
155238460|NCT00673049|560307207|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
155238461|NCT00673049|560307208|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
155238462|NCT00673049|560307205|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238463|NCT00673049|560307206|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238464|NCT00673049|560307207|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238465|NCT00673049|560307208|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
155238466|NCT00673049|560307205|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
155238467|NCT00673049|560307206|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
155238468|NCT00673049|560307207|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
155238469|NCT00673049|560307208|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
155238470|NCT01933334|560307215|FG000|Overall Study|Adverse Event|5|||
155238471|NCT01933334|560307216|FG001|Overall Study|Adverse Event|1|||
155238472|NCT01933334|560307215|FG000|Overall Study|Withdrawal by Subject|0|||
155238473|NCT01933334|560307216|FG001|Overall Study|Withdrawal by Subject|1|||
155238474|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
155238475|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
155238476|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
155238477|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238478|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238479|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238480|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238481|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
155238482|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
155238483|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
155238484|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238485|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238486|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238487|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238488|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
155238489|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238490|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238491|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238492|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238493|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238494|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238495|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238496|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238497|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238498|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
155238499|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
155238500|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
155238501|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238502|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238503|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238504|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238505|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
155238506|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
155238507|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
155238508|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238509|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238510|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238511|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238512|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
155238513|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
155238514|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
155238515|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238516|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238517|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238518|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238519|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
155238520|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238521|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238522|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238523|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238524|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238525|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238526|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238527|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238528|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238529|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
155238530|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238531|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238532|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238533|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238534|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238535|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238536|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
155238537|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238538|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238539|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238540|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238541|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238542|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238543|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
155238544|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238545|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238546|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238547|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238548|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238549|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238550|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
155238551|NCT04265755|560307224|FG000|Overall Study|Withdrawal by Subject|39|||
155238552|NCT04265755|560307224|FG000|Overall Study|Decision by sponsor|2|||
155238553|NCT04265755|560307224|FG000|Overall Study|Lost to Follow-up|11|||
155238554|NCT04265755|560307224|FG000|Overall Study|Death|1|||
155238555|NCT01863446|560307227|FG000|Overall Study|Withdrawal by Subject|1|||
155238556|NCT01863446|560307228|FG001|Overall Study|Withdrawal by Subject|0|||
155238557|NCT01863446|560307229|FG002|Overall Study|Withdrawal by Subject|1|||
155238558|NCT01863446|560307230|FG003|Overall Study|Withdrawal by Subject|2|||
155238559|NCT01863446|560307227|FG000|Overall Study|Physician Decision|0|||
155238560|NCT01863446|560307228|FG001|Overall Study|Physician Decision|0|||
155238561|NCT01863446|560307229|FG002|Overall Study|Physician Decision|1|||
155238562|NCT01863446|560307230|FG003|Overall Study|Physician Decision|0|||
155238563|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
155238564|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
155238565|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
155238566|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
155238567|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
155238568|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
155238569|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Death|1|||
155238570|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Death|0|||
155238571|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Other|4|||
155238572|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Other|0|||
155238573|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
155238574|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
155238575|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
155238576|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
155238577|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
155238578|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
155238579|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
155238580|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
155238581|NCT01794949|560307237|FG000|Overall Study|Lost to Follow-up|1|||
155238582|NCT01794949|560307238|FG001|Overall Study|Lost to Follow-up|0|||
155238583|NCT04713748|560307247|FG000|Overall Study|Not enough kits allocated|35|||
155238584|NCT00406029|560307252|FG000|Overall Study|Adverse Event|12|||
155238585|NCT00406029|560307253|FG001|Overall Study|Adverse Event|2|||
155238586|NCT00406029|560307254|FG002|Overall Study|Adverse Event|5|||
155238587|NCT00406029|560307255|FG003|Overall Study|Adverse Event|10|||
155238588|NCT00406029|560307256|FG004|Overall Study|Adverse Event|7|||
155238589|NCT00406029|560307252|FG000|Overall Study|Withdrawal by Subject|3|||
155238590|NCT00406029|560307253|FG001|Overall Study|Withdrawal by Subject|4|||
155238591|NCT00406029|560307254|FG002|Overall Study|Withdrawal by Subject|2|||
155238592|NCT00406029|560307255|FG003|Overall Study|Withdrawal by Subject|2|||
155238593|NCT00406029|560307256|FG004|Overall Study|Withdrawal by Subject|0|||
155238594|NCT00406029|560307252|FG000|Overall Study|Protocol Violation|1|||
155238595|NCT00406029|560307253|FG001|Overall Study|Protocol Violation|2|||
155238596|NCT00406029|560307254|FG002|Overall Study|Protocol Violation|0|||
155238597|NCT00406029|560307255|FG003|Overall Study|Protocol Violation|2|||
155238598|NCT00406029|560307256|FG004|Overall Study|Protocol Violation|0|||
155238599|NCT00406029|560307252|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238600|NCT00406029|560307253|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238601|NCT00406029|560307254|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
155238602|NCT00406029|560307255|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238603|NCT00406029|560307256|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238604|NCT00406029|560307252|FG000|Overall Study|Randomized in Error|0|||
155238605|NCT00406029|560307253|FG001|Overall Study|Randomized in Error|0|||
155238606|NCT00406029|560307254|FG002|Overall Study|Randomized in Error|2|||
155238607|NCT00406029|560307255|FG003|Overall Study|Randomized in Error|3|||
155238608|NCT00406029|560307256|FG004|Overall Study|Randomized in Error|1|||
155238609|NCT00889421|560307257|FG000|Overall Study|Lack of Efficacy|3|||
155238610|NCT01958918|560307258|FG000|Overall Study|Death|1|||
155238611|NCT01958918|560307259|FG001|Overall Study|Death|3|||
155238612|NCT01958918|560307258|FG000|Overall Study|Lost to Follow-up|4|||
155238613|NCT01958918|560307259|FG001|Overall Study|Lost to Follow-up|7|||
155238614|NCT01958918|560307258|FG000|Overall Study|Withdrawal by Subject|13|||
155238615|NCT01958918|560307259|FG001|Overall Study|Withdrawal by Subject|8|||
155238616|NCT01958918|560307258|FG000|Overall Study|Lack of Efficacy|13|||
155238617|NCT01958918|560307259|FG001|Overall Study|Lack of Efficacy|10|||
155238618|NCT01958918|560307258|FG000|Overall Study|Adverse Event|12|||
155238619|NCT01958918|560307259|FG001|Overall Study|Adverse Event|12|||
155238620|NCT01958918|560307258|FG000|Overall Study|administrative problems|0|||
155238621|NCT01958918|560307259|FG001|Overall Study|administrative problems|2|||
155238622|NCT02114892|560307263|FG000|Overall Study|Lost to Follow-up|1|||
155238623|NCT02114892|560307264|FG001|Overall Study|Lost to Follow-up|2|||
155238624|NCT04479618|560307268|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
155238625|NCT04479618|560307269|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
155238626|NCT04479618|560307270|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
155238627|NCT04479618|560307268|FG000|Overall Study|Lack of Efficacy|1|||
155238628|NCT04479618|560307269|FG001|Overall Study|Lack of Efficacy|0|||
155238629|NCT04479618|560307270|FG002|Overall Study|Lack of Efficacy|0|||
155238630|NCT04479618|560307268|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
155238631|NCT04479618|560307269|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
155238632|NCT04479618|560307270|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
155238633|NCT04479618|560307268|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
155238634|NCT04479618|560307269|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
155238635|NCT04479618|560307270|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
155238636|NCT04479618|560307268|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
155238637|NCT04479618|560307269|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
155238638|NCT04479618|560307270|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
155238639|NCT04479618|560307268|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
155491640|NCT00057330|561225461|FG001|Overall Study|Death|0|||
155238640|NCT04479618|560307269|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
155238641|NCT04479618|560307270|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
155238642|NCT00659269|560307275|FG000|Overall Study|Physician Decision|1|||
155238643|NCT00659269|560307276|FG001|Overall Study|Physician Decision|1|||
155238644|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238645|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238646|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238647|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238648|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
155238649|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238650|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
155238651|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238652|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238653|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238654|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
155238655|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238656|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238657|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
155238658|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
155238659|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238660|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238661|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238662|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238663|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
155238664|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238665|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238666|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238667|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238668|NCT00718042|560307278|FG000|Donor Follow-up|Lost to Follow-up|13|||
155238669|NCT00718042|560307279|FG001|Donor Follow-up|Lost to Follow-up|0|||
155238670|NCT00718042|560307280|FG002|Donor Follow-up|Lost to Follow-up|0|||
155238671|NCT00718042|560307281|FG003|Donor Follow-up|Lost to Follow-up|0|||
155238672|NCT00718042|560307282|FG004|Donor Follow-up|Lost to Follow-up|19|||
155238673|NCT00718042|560307283|FG005|Donor Follow-up|Lost to Follow-up|0|||
155238674|NCT04327934|560307284|FG000|Overall Study|Did not qualify|7|||
155238675|NCT04327934|560307285|FG001|Overall Study|Did not qualify|4|||
155238676|NCT04327934|560307284|FG000|Overall Study|Physician Decision|0|||
155238677|NCT04327934|560307285|FG001|Overall Study|Physician Decision|1|||
155238678|NCT02443298|560307286|FG000|Overall Study|Adverse Event|3|||
155238679|NCT02443298|560307287|FG001|Overall Study|Adverse Event|3|||
155238680|NCT02443298|560307286|FG000|Overall Study|Withdrawal by Subject|1|||
155238681|NCT02443298|560307287|FG001|Overall Study|Withdrawal by Subject|2|||
155238682|NCT01877421|560307288|FG000|Phase 2|Lost to Follow-up|0|||
155238683|NCT01877421|560307289|FG001|Phase 2|Lost to Follow-up|0|||
155238684|NCT01877421|560307290|FG002|Phase 2|Lost to Follow-up|0|||
155238685|NCT01877421|560307291|FG003|Phase 2|Lost to Follow-up|0|||
155238686|NCT01877421|560307292|FG004|Phase 2|Lost to Follow-up|0|||
155238687|NCT01877421|560307293|FG005|Phase 2|Lost to Follow-up|0|||
155238688|NCT01877421|560307294|FG006|Phase 2|Lost to Follow-up|1|||
155238689|NCT01877421|560307295|FG007|Phase 2|Lost to Follow-up|0|||
155238690|NCT01877421|560307296|FG008|Phase 2|Lost to Follow-up|0|||
155238691|NCT01877421|560307297|FG009|Phase 2|Lost to Follow-up|0|||
155238692|NCT01877421|560307298|FG010|Phase 2|Lost to Follow-up|0|||
155238693|NCT01877421|560307299|FG011|Phase 2|Lost to Follow-up|0|||
155238694|NCT01877421|560307300|FG012|Phase 2|Lost to Follow-up|0|||
155238695|NCT01877421|560307301|FG013|Phase 2|Lost to Follow-up|0|||
155238696|NCT01877421|560307302|FG014|Phase 2|Lost to Follow-up|0|||
155238697|NCT01877421|560307303|FG015|Phase 2|Lost to Follow-up|0|||
155238698|NCT01877421|560307304|FG016|Phase 2|Lost to Follow-up|0|||
155238699|NCT01877421|560307305|FG017|Phase 2|Lost to Follow-up|0|||
155238700|NCT01877421|560307288|FG000|Phase 2|Withdrawal by Subject|0|||
155238701|NCT01877421|560307289|FG001|Phase 2|Withdrawal by Subject|0|||
155238702|NCT01877421|560307290|FG002|Phase 2|Withdrawal by Subject|0|||
155238703|NCT01877421|560307291|FG003|Phase 2|Withdrawal by Subject|0|||
155238704|NCT01877421|560307292|FG004|Phase 2|Withdrawal by Subject|0|||
155238705|NCT01877421|560307293|FG005|Phase 2|Withdrawal by Subject|0|||
155238706|NCT01877421|560307294|FG006|Phase 2|Withdrawal by Subject|0|||
155238707|NCT01877421|560307295|FG007|Phase 2|Withdrawal by Subject|0|||
155238708|NCT01877421|560307296|FG008|Phase 2|Withdrawal by Subject|1|||
155238709|NCT01877421|560307297|FG009|Phase 2|Withdrawal by Subject|0|||
155238710|NCT01877421|560307298|FG010|Phase 2|Withdrawal by Subject|1|||
155491641|NCT00057330|561225460|FG000|Overall Study|Protocol Violation|1|||
155491642|NCT00057330|561225461|FG001|Overall Study|Protocol Violation|1|||
155238711|NCT01877421|560307299|FG011|Phase 2|Withdrawal by Subject|0|||
155238712|NCT01877421|560307300|FG012|Phase 2|Withdrawal by Subject|1|||
155238713|NCT01877421|560307301|FG013|Phase 2|Withdrawal by Subject|0|||
155238714|NCT01877421|560307302|FG014|Phase 2|Withdrawal by Subject|0|||
155238715|NCT01877421|560307303|FG015|Phase 2|Withdrawal by Subject|1|||
155238716|NCT01877421|560307304|FG016|Phase 2|Withdrawal by Subject|0|||
155238717|NCT01877421|560307305|FG017|Phase 2|Withdrawal by Subject|0|||
155238718|NCT01877421|560307288|FG000|Phase 2|Protocol Violation|0|||
155238719|NCT01877421|560307289|FG001|Phase 2|Protocol Violation|0|||
155238720|NCT01877421|560307290|FG002|Phase 2|Protocol Violation|0|||
155238721|NCT01877421|560307291|FG003|Phase 2|Protocol Violation|0|||
155238722|NCT01877421|560307292|FG004|Phase 2|Protocol Violation|0|||
155238723|NCT01877421|560307293|FG005|Phase 2|Protocol Violation|0|||
155238724|NCT01877421|560307294|FG006|Phase 2|Protocol Violation|0|||
155238725|NCT01877421|560307295|FG007|Phase 2|Protocol Violation|0|||
155238726|NCT01877421|560307296|FG008|Phase 2|Protocol Violation|0|||
155238727|NCT01877421|560307297|FG009|Phase 2|Protocol Violation|0|||
155238728|NCT01877421|560307298|FG010|Phase 2|Protocol Violation|1|||
155238729|NCT01877421|560307299|FG011|Phase 2|Protocol Violation|0|||
155238730|NCT01877421|560307300|FG012|Phase 2|Protocol Violation|0|||
155238731|NCT01877421|560307301|FG013|Phase 2|Protocol Violation|0|||
155238732|NCT01877421|560307302|FG014|Phase 2|Protocol Violation|0|||
155238733|NCT01877421|560307303|FG015|Phase 2|Protocol Violation|0|||
155238734|NCT01877421|560307304|FG016|Phase 2|Protocol Violation|0|||
155238735|NCT01877421|560307305|FG017|Phase 2|Protocol Violation|0|||
155238736|NCT00908960|560307318|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
155238737|NCT00908960|560307319|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
155238738|NCT00908960|560307320|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
155238739|NCT01158924|560307321|FG000|Overall Study|Withdrawal by Subject|1|||
155238740|NCT01158924|560307322|FG001|Overall Study|Withdrawal by Subject|2|||
155238741|NCT01158924|560307321|FG000|Overall Study|Lost to Follow-up|0|||
155238742|NCT01158924|560307322|FG001|Overall Study|Lost to Follow-up|1|||
155238743|NCT03795922|560307323|FG000|Overall Study|Adverse Event|2|||
155238744|NCT03795922|560307324|FG001|Overall Study|Adverse Event|1|||
155238745|NCT03795922|560307323|FG000|Overall Study|Withdrawal by Subject|5|||
155238746|NCT03795922|560307324|FG001|Overall Study|Withdrawal by Subject|13|||
155238747|NCT03795922|560307323|FG000|Overall Study|Lost to Follow-up|2|||
155238748|NCT03795922|560307324|FG001|Overall Study|Lost to Follow-up|3|||
155238749|NCT03795922|560307323|FG000|Overall Study|Pregnancy|0|||
155238750|NCT03795922|560307324|FG001|Overall Study|Pregnancy|1|||
155238751|NCT03795922|560307323|FG000|Overall Study|Physician Decision|1|||
155238752|NCT03795922|560307324|FG001|Overall Study|Physician Decision|2|||
155238753|NCT03795922|560307323|FG000|Overall Study|Protocol Violation|0|||
155238754|NCT03795922|560307324|FG001|Overall Study|Protocol Violation|1|||
155238755|NCT03795922|560307323|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
155238756|NCT03795922|560307324|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
155238757|NCT04788147|560307325|FG000|Overall Study|Screen Failure|3|||
155238758|NCT04788147|560307326|FG001|Overall Study|Screen Failure|10|||
155238759|NCT04788147|560307325|FG000|Overall Study|Incomplete RMRS image session|2|||
155238760|NCT04788147|560307326|FG001|Overall Study|Incomplete RMRS image session|0|||
155238761|NCT00781326|560307329|FG000|Phase I|Adverse Event|1|||
155238762|NCT00781326|560307329|FG000|Phase I|Withdrawal by Subject|1|||
155238763|NCT00781326|560307329|FG000|Phase I|Physician Decision|2|||
155238764|NCT05101252|560307330|FG000|Overall Study|Unsatisfactory Test Article|1|||
155238765|NCT05101252|560307331|FG001|Overall Study|Unsatisfactory Test Article|0|||
155238766|NCT05101252|560307330|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155238767|NCT05101252|560307331|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155238768|NCT05101252|560307330|FG000|Overall Study|Withdrew Consent during study|0|||
155238769|NCT05101252|560307331|FG001|Overall Study|Withdrew Consent during study|1|||
155238770|NCT05101252|560307330|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
155238771|NCT05101252|560307331|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
155238772|NCT03732248|560307332|FG000|Overall Study|Withdrawal by Subject|1|||
155238773|NCT03732248|560307333|FG001|Overall Study|Withdrawal by Subject|0|||
155238774|NCT02266381|560307334|FG000|Overall Study|Physician Decision|3|||
155238775|NCT02266381|560307335|FG001|Overall Study|Physician Decision|5|||
155238776|NCT02266381|560307336|FG002|Overall Study|Physician Decision|4|||
155238777|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
155238778|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
155238779|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
155238780|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
155238781|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
155238782|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
155238783|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
155238784|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
155238785|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
155238786|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
155238787|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
155238788|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
155238789|NCT00403546|560307339|FG000|Screening Phase|Screening Failure|22|||
155238790|NCT00403546|560307340|FG001|Screening Phase|Screening Failure|0|||
155238791|NCT00403546|560307341|FG002|Screening Phase|Screening Failure|0|||
155238792|NCT00403546|560307339|FG000|Screening Phase|Adverse Event|1|||
155238793|NCT00403546|560307340|FG001|Screening Phase|Adverse Event|0|||
155238794|NCT00403546|560307341|FG002|Screening Phase|Adverse Event|0|||
155238795|NCT00403546|560307339|FG000|Screening Phase|Terminated Prior to Randomization|5|||
155238796|NCT00403546|560307340|FG001|Screening Phase|Terminated Prior to Randomization|0|||
155238797|NCT00403546|560307341|FG002|Screening Phase|Terminated Prior to Randomization|0|||
155238798|NCT00403546|560307339|FG000|Randomized Trial|Early Terminations|0|||
155238799|NCT00403546|560307340|FG001|Randomized Trial|Early Terminations|17|||
155238800|NCT00403546|560307341|FG002|Randomized Trial|Early Terminations|16|||
155238801|NCT00793910|560307342|FG000|Overall Study|discarded study pills|0|||
155238802|NCT00793910|560307343|FG001|Overall Study|discarded study pills|1|||
155238803|NCT00793910|560307342|FG000|Overall Study|did not pick up medications|1|||
155238804|NCT00793910|560307343|FG001|Overall Study|did not pick up medications|1|||
155238805|NCT00793910|560307342|FG000|Overall Study|ineligible based on entry criteria|2|||
155238806|NCT00793910|560307343|FG001|Overall Study|ineligible based on entry criteria|3|||
155238807|NCT00793910|560307342|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
155238808|NCT00793910|560307343|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
155238809|NCT00793910|560307342|FG000|Overall Study|Withdrawal by Subject|0|||
155238810|NCT00793910|560307343|FG001|Overall Study|Withdrawal by Subject|1|||
155238811|NCT03634579|560307346|FG000|Overall Study|study termination|9|||
155238812|NCT02480621|560307347|FG000|Randomization|Withdrawal by Subject|1|||
155238813|NCT02480621|560307348|FG001|Randomization|Withdrawal by Subject|0|||
155238814|NCT02480621|560307347|FG000|Randomization|Surgeon did not give intervention|0|||
155238815|NCT02480621|560307348|FG001|Randomization|Surgeon did not give intervention|1|||
155238816|NCT02480621|560307347|FG000|Follow Up|Lost to Follow-up|4|||
155238817|NCT02480621|560307348|FG001|Follow Up|Lost to Follow-up|2|||
155238818|NCT00235989|560307349|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238819|NCT00235989|560307350|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238820|NCT00235989|560307351|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238821|NCT00235989|560307352|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238822|NCT00235989|560307353|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238823|NCT00235989|560307354|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
155238824|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
155238825|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
155238826|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
155238827|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
155238828|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
155238829|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
155238830|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
155238831|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238832|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
155238833|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238834|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238835|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238836|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238837|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238838|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238839|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
155238840|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
155238841|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
155238842|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
155238843|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
155238844|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
155238845|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
155238846|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
155238847|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
155238848|NCT06748040|560307365|FG000|Overall Study|Death|3|||
155238849|NCT06748040|560307366|FG001|Overall Study|Death|4|||
155238850|NCT06748040|560307365|FG000|Overall Study|Lost to Follow-up|134|||
155238851|NCT06748040|560307366|FG001|Overall Study|Lost to Follow-up|132|||
155238852|NCT06748040|560307365|FG000|Overall Study|Withdrawal by Subject|3|||
155238853|NCT06748040|560307366|FG001|Overall Study|Withdrawal by Subject|5|||
155491643|NCT00057330|561225460|FG000|Overall Study|Withdrawal by Subject|115|||
155491644|NCT00057330|561225461|FG001|Overall Study|Withdrawal by Subject|84|||
155491645|NCT00057330|561225460|FG000|Overall Study|Lost to Follow-up|745|||
155491646|NCT00057330|561225461|FG001|Overall Study|Lost to Follow-up|617|||
155491647|NCT00057330|561225460|FG000|Overall Study|Physician Decision|1|||
155491648|NCT00057330|561225461|FG001|Overall Study|Physician Decision|0|||
155491649|NCT00057330|561225460|FG000|Overall Study|Other|260|||
155238854|NCT01782131|560309293|FG000|Overall Study|Death|93|||
155238855|NCT01782131|560309294|FG001|Overall Study|Death|96|||
155238856|NCT01782131|560309293|FG000|Overall Study|Lost to Follow-up|1|||
155238857|NCT01782131|560309294|FG001|Overall Study|Lost to Follow-up|3|||
155238858|NCT01782131|560309293|FG000|Overall Study|Withdrawal by Subject|10|||
155238859|NCT01782131|560309294|FG001|Overall Study|Withdrawal by Subject|10|||
155238860|NCT01782131|560309293|FG000|Overall Study|Randomized but not treated|5|||
155238861|NCT01782131|560309294|FG001|Overall Study|Randomized but not treated|5|||
155238862|NCT01782131|560309293|FG000|Overall Study|Reason not provided|0|||
155238863|NCT01782131|560309294|FG001|Overall Study|Reason not provided|1|||
155238864|NCT01627249|560309295|FG000|Overall Study|Death|3|||
155238865|NCT01627249|560309296|FG001|Overall Study|Death|5|||
155238866|NCT01627249|560309297|FG002|Overall Study|Death|3|||
155238867|NCT01627249|560309295|FG000|Overall Study|Withdrawal by Subject|12|||
155238868|NCT01627249|560309296|FG001|Overall Study|Withdrawal by Subject|6|||
155238869|NCT01627249|560309297|FG002|Overall Study|Withdrawal by Subject|9|||
155238870|NCT01627249|560309295|FG000|Overall Study|Missed Visit|1|||
155238871|NCT01627249|560309296|FG001|Overall Study|Missed Visit|1|||
155238872|NCT01627249|560309297|FG002|Overall Study|Missed Visit|0|||
155238873|NCT00796718|560309298|FG000|Overall Study|Adverse Event|2|||
155238874|NCT00796718|560309298|FG000|Overall Study|Exclusion Criteria|1|||
155238875|NCT00796718|560309298|FG000|Overall Study|Lost to Follow-up|5|||
155238876|NCT00796718|560309298|FG000|Overall Study|Withdrawal by Informed Consent|1|||
155238877|NCT02318329|560309302|FG000|Overall Study|Progressive Disease|2|||
155238878|NCT02318329|560309303|FG001|Overall Study|Progressive Disease|3|||
155238879|NCT02318329|560309304|FG002|Overall Study|Progressive Disease|2|||
155238880|NCT02318329|560309305|FG003|Overall Study|Progressive Disease|3|||
155238881|NCT02318329|560309306|FG004|Overall Study|Progressive Disease|3|||
155238882|NCT02318329|560309307|FG005|Overall Study|Progressive Disease|3|||
155238883|NCT02318329|560309308|FG006|Overall Study|Progressive Disease|1|||
155238884|NCT02318329|560309309|FG007|Overall Study|Progressive Disease|1|||
155238885|NCT02318329|560309310|FG008|Overall Study|Progressive Disease|5|||
155238886|NCT02318329|560309311|FG009|Overall Study|Progressive Disease|39|||
155238887|NCT02318329|560309302|FG000|Overall Study|Death|0|||
155238888|NCT02318329|560309303|FG001|Overall Study|Death|0|||
155238889|NCT02318329|560309304|FG002|Overall Study|Death|0|||
155238890|NCT02318329|560309305|FG003|Overall Study|Death|0|||
155238891|NCT02318329|560309306|FG004|Overall Study|Death|0|||
155238892|NCT02318329|560309307|FG005|Overall Study|Death|0|||
155238893|NCT02318329|560309308|FG006|Overall Study|Death|0|||
155238894|NCT02318329|560309309|FG007|Overall Study|Death|0|||
155238895|NCT02318329|560309310|FG008|Overall Study|Death|0|||
155238896|NCT02318329|560309311|FG009|Overall Study|Death|5|||
155238897|NCT02318329|560309302|FG000|Overall Study|Lost to Follow-up|0|||
155238898|NCT02318329|560309303|FG001|Overall Study|Lost to Follow-up|0|||
155238899|NCT02318329|560309304|FG002|Overall Study|Lost to Follow-up|0|||
155238900|NCT02318329|560309305|FG003|Overall Study|Lost to Follow-up|0|||
155238901|NCT02318329|560309306|FG004|Overall Study|Lost to Follow-up|0|||
155238902|NCT02318329|560309307|FG005|Overall Study|Lost to Follow-up|0|||
155238903|NCT02318329|560309308|FG006|Overall Study|Lost to Follow-up|0|||
155238904|NCT02318329|560309309|FG007|Overall Study|Lost to Follow-up|0|||
155238905|NCT02318329|560309310|FG008|Overall Study|Lost to Follow-up|0|||
155238906|NCT02318329|560309311|FG009|Overall Study|Lost to Follow-up|1|||
155238907|NCT02318329|560309302|FG000|Overall Study|Withdrawal by Subject|0|||
155238908|NCT02318329|560309303|FG001|Overall Study|Withdrawal by Subject|0|||
155238909|NCT02318329|560309304|FG002|Overall Study|Withdrawal by Subject|0|||
155238910|NCT02318329|560309305|FG003|Overall Study|Withdrawal by Subject|0|||
155238911|NCT02318329|560309306|FG004|Overall Study|Withdrawal by Subject|0|||
155238912|NCT02318329|560309307|FG005|Overall Study|Withdrawal by Subject|0|||
155238913|NCT02318329|560309308|FG006|Overall Study|Withdrawal by Subject|0|||
155238914|NCT02318329|560309309|FG007|Overall Study|Withdrawal by Subject|0|||
155238915|NCT02318329|560309310|FG008|Overall Study|Withdrawal by Subject|0|||
155238916|NCT02318329|560309311|FG009|Overall Study|Withdrawal by Subject|6|||
155238917|NCT02318329|560309302|FG000|Overall Study|Other|1|||
155238918|NCT02318329|560309303|FG001|Overall Study|Other|1|||
155238919|NCT02318329|560309304|FG002|Overall Study|Other|1|||
155238920|NCT02318329|560309305|FG003|Overall Study|Other|0|||
155238921|NCT02318329|560309306|FG004|Overall Study|Other|0|||
155238922|NCT02318329|560309307|FG005|Overall Study|Other|0|||
155238923|NCT02318329|560309308|FG006|Overall Study|Other|0|||
155238924|NCT02318329|560309309|FG007|Overall Study|Other|0|||
155491650|NCT00057330|561225461|FG001|Overall Study|Other|206|||
155238925|NCT02318329|560309310|FG008|Overall Study|Other|1|||
155238926|NCT02318329|560309311|FG009|Overall Study|Other|1|||
155238927|NCT02044510|560309312|FG000|Overall Study|Adverse Event|1|||
155238928|NCT02044510|560309313|FG001|Overall Study|Adverse Event|2|||
155238929|NCT02979535|560309316|FG000|Overall Study|Non compliance with the protocol|78|||
155238930|NCT02979535|560309317|FG001|Overall Study|Non compliance with the protocol|82|||
155238931|NCT02979535|560309316|FG000|Overall Study|Consent withdrawn by participant|11|||
155238932|NCT02979535|560309317|FG001|Overall Study|Consent withdrawn by participant|18|||
155238933|NCT02979535|560309316|FG000|Overall Study|Lost to Follow-up|6|||
155238934|NCT02979535|560309317|FG001|Overall Study|Lost to Follow-up|1|||
155238935|NCT00767000|560309320|FG000|54-week Study|Adverse Event|4|||
155238936|NCT00767000|560309321|FG001|54-week Study|Adverse Event|6|||
155238937|NCT00767000|560309322|FG002|54-week Study|Adverse Event|6|||
155238938|NCT00767000|560309323|FG003|54-week Study|Adverse Event|8|||
155238939|NCT00767000|560309324|FG004|54-week Study|Adverse Event|4|||
155238940|NCT00767000|560309320|FG000|54-week Study|Creaninine/creatinine clearance|2|||
155238941|NCT00767000|560309321|FG001|54-week Study|Creaninine/creatinine clearance|1|||
155238942|NCT00767000|560309322|FG002|54-week Study|Creaninine/creatinine clearance|2|||
155238943|NCT00767000|560309323|FG003|54-week Study|Creaninine/creatinine clearance|2|||
155238944|NCT00767000|560309324|FG004|54-week Study|Creaninine/creatinine clearance|4|||
155238945|NCT00767000|560309320|FG000|54-week Study|Hyperglycemia|0|||
155238946|NCT00767000|560309321|FG001|54-week Study|Hyperglycemia|0|||
155238947|NCT00767000|560309322|FG002|54-week Study|Hyperglycemia|1|||
155238948|NCT00767000|560309323|FG003|54-week Study|Hyperglycemia|0|||
155238949|NCT00767000|560309324|FG004|54-week Study|Hyperglycemia|1|||
155238950|NCT00767000|560309320|FG000|54-week Study|Hypoglycemia|0|||
155238951|NCT00767000|560309321|FG001|54-week Study|Hypoglycemia|1|||
155238952|NCT00767000|560309322|FG002|54-week Study|Hypoglycemia|0|||
155238953|NCT00767000|560309323|FG003|54-week Study|Hypoglycemia|0|||
155238954|NCT00767000|560309324|FG004|54-week Study|Hypoglycemia|0|||
155238955|NCT00767000|560309320|FG000|54-week Study|Interruption of study medication|0|||
155238956|NCT00767000|560309321|FG001|54-week Study|Interruption of study medication|0|||
155238957|NCT00767000|560309322|FG002|54-week Study|Interruption of study medication|1|||
155238958|NCT00767000|560309323|FG003|54-week Study|Interruption of study medication|0|||
155238959|NCT00767000|560309324|FG004|54-week Study|Interruption of study medication|0|||
155238960|NCT00767000|560309320|FG000|54-week Study|Lack of Efficacy|2|||
155238961|NCT00767000|560309321|FG001|54-week Study|Lack of Efficacy|0|||
155238962|NCT00767000|560309322|FG002|54-week Study|Lack of Efficacy|1|||
155238963|NCT00767000|560309323|FG003|54-week Study|Lack of Efficacy|0|||
155238964|NCT00767000|560309324|FG004|54-week Study|Lack of Efficacy|5|||
155238965|NCT00767000|560309320|FG000|54-week Study|Lost to Follow-up|4|||
155238966|NCT00767000|560309321|FG001|54-week Study|Lost to Follow-up|0|||
155238967|NCT00767000|560309322|FG002|54-week Study|Lost to Follow-up|1|||
155238968|NCT00767000|560309323|FG003|54-week Study|Lost to Follow-up|4|||
155238969|NCT00767000|560309324|FG004|54-week Study|Lost to Follow-up|2|||
155238970|NCT00767000|560309320|FG000|54-week Study|Physician Decision|4|||
155238971|NCT00767000|560309321|FG001|54-week Study|Physician Decision|0|||
155238972|NCT00767000|560309322|FG002|54-week Study|Physician Decision|1|||
155238973|NCT00767000|560309323|FG003|54-week Study|Physician Decision|1|||
155238974|NCT00767000|560309324|FG004|54-week Study|Physician Decision|1|||
155238975|NCT00767000|560309320|FG000|54-week Study|Progressive disease|0|||
155238976|NCT00767000|560309321|FG001|54-week Study|Progressive disease|0|||
155238977|NCT00767000|560309322|FG002|54-week Study|Progressive disease|1|||
155238978|NCT00767000|560309323|FG003|54-week Study|Progressive disease|0|||
155238979|NCT00767000|560309324|FG004|54-week Study|Progressive disease|0|||
155238980|NCT00767000|560309320|FG000|54-week Study|Protocol Violation|0|||
155238981|NCT00767000|560309321|FG001|54-week Study|Protocol Violation|0|||
155238982|NCT00767000|560309322|FG002|54-week Study|Protocol Violation|1|||
155238983|NCT00767000|560309323|FG003|54-week Study|Protocol Violation|2|||
155238984|NCT00767000|560309324|FG004|54-week Study|Protocol Violation|0|||
155238985|NCT00767000|560309320|FG000|54-week Study|Withdrawal by Subject|2|||
155238986|NCT00767000|560309321|FG001|54-week Study|Withdrawal by Subject|3|||
155238987|NCT00767000|560309322|FG002|54-week Study|Withdrawal by Subject|5|||
155238988|NCT00767000|560309323|FG003|54-week Study|Withdrawal by Subject|11|||
155238989|NCT00767000|560309324|FG004|54-week Study|Withdrawal by Subject|13|||
155238990|NCT00767000|560309320|FG000|54-week Study|Study terminated by sponsor|90|||
155238991|NCT00767000|560309321|FG001|54-week Study|Study terminated by sponsor|102|||
155238992|NCT00767000|560309322|FG002|54-week Study|Study terminated by sponsor|89|||
155238993|NCT00767000|560309323|FG003|54-week Study|Study terminated by sponsor|196|||
155238994|NCT00767000|560309324|FG004|54-week Study|Study terminated by sponsor|194|||
155238995|NCT00767000|560309320|FG000|54-week Study|Reason not reported|0|||
155238996|NCT00767000|560309321|FG001|54-week Study|Reason not reported|0|||
155238997|NCT00767000|560309322|FG002|54-week Study|Reason not reported|0|||
155238998|NCT00767000|560309323|FG003|54-week Study|Reason not reported|1|||
155238999|NCT00767000|560309324|FG004|54-week Study|Reason not reported|0|||
155239000|NCT00767000|560309320|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
155239001|NCT00767000|560309321|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
155239002|NCT00767000|560309322|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
155239003|NCT00767000|560309323|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
155239004|NCT00767000|560309324|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
155239005|NCT01722331|560309326|FG000|Part 1|Adverse Event|5|||
155239006|NCT01722331|560309327|FG001|Part 1|Adverse Event|0|||
155239007|NCT01722331|560309328|FG002|Part 1|Adverse Event|0|||
155239008|NCT01722331|560309329|FG003|Part 1|Adverse Event|0|||
155239009|NCT01722331|560309330|FG004|Part 1|Adverse Event|0|||
155239010|NCT01722331|560309331|FG005|Part 1|Adverse Event|0|||
155239011|NCT01722331|560309332|FG006|Part 1|Adverse Event|0|||
155239012|NCT01722331|560309326|FG000|Part 1|Lack of Efficacy|0|||
155239013|NCT01722331|560309327|FG001|Part 1|Lack of Efficacy|0|||
155239014|NCT01722331|560309328|FG002|Part 1|Lack of Efficacy|1|||
155239015|NCT01722331|560309329|FG003|Part 1|Lack of Efficacy|0|||
155239016|NCT01722331|560309330|FG004|Part 1|Lack of Efficacy|2|||
155239017|NCT01722331|560309331|FG005|Part 1|Lack of Efficacy|0|||
155239018|NCT01722331|560309332|FG006|Part 1|Lack of Efficacy|0|||
155239019|NCT01722331|560309326|FG000|Part 1|Lost to Follow-up|1|||
155239020|NCT01722331|560309327|FG001|Part 1|Lost to Follow-up|0|||
155239021|NCT01722331|560309328|FG002|Part 1|Lost to Follow-up|2|||
155239022|NCT01722331|560309329|FG003|Part 1|Lost to Follow-up|0|||
155239023|NCT01722331|560309330|FG004|Part 1|Lost to Follow-up|1|||
155239024|NCT01722331|560309331|FG005|Part 1|Lost to Follow-up|0|||
155239025|NCT01722331|560309332|FG006|Part 1|Lost to Follow-up|0|||
155239026|NCT01722331|560309326|FG000|Part 1|Physician Decision|0|||
155239027|NCT01722331|560309327|FG001|Part 1|Physician Decision|0|||
155239028|NCT01722331|560309328|FG002|Part 1|Physician Decision|3|||
155239029|NCT01722331|560309329|FG003|Part 1|Physician Decision|0|||
155239030|NCT01722331|560309330|FG004|Part 1|Physician Decision|1|||
155239031|NCT01722331|560309331|FG005|Part 1|Physician Decision|0|||
155239032|NCT01722331|560309332|FG006|Part 1|Physician Decision|0|||
155239033|NCT01722331|560309326|FG000|Part 1|Pregnancy|1|||
155239034|NCT01722331|560309327|FG001|Part 1|Pregnancy|0|||
155239035|NCT01722331|560309328|FG002|Part 1|Pregnancy|0|||
155239036|NCT01722331|560309329|FG003|Part 1|Pregnancy|0|||
155239037|NCT01722331|560309330|FG004|Part 1|Pregnancy|0|||
155239038|NCT01722331|560309331|FG005|Part 1|Pregnancy|0|||
155239039|NCT01722331|560309332|FG006|Part 1|Pregnancy|0|||
155239040|NCT01722331|560309326|FG000|Part 1|Progressive Disease|0|||
155239041|NCT01722331|560309327|FG001|Part 1|Progressive Disease|0|||
155239042|NCT01722331|560309328|FG002|Part 1|Progressive Disease|0|||
155239043|NCT01722331|560309329|FG003|Part 1|Progressive Disease|0|||
155239044|NCT01722331|560309330|FG004|Part 1|Progressive Disease|1|||
155239045|NCT01722331|560309331|FG005|Part 1|Progressive Disease|0|||
155239046|NCT01722331|560309332|FG006|Part 1|Progressive Disease|0|||
155239047|NCT01722331|560309326|FG000|Part 1|Protocol Violation|1|||
155239048|NCT01722331|560309327|FG001|Part 1|Protocol Violation|0|||
155239049|NCT01722331|560309328|FG002|Part 1|Protocol Violation|0|||
155239050|NCT01722331|560309329|FG003|Part 1|Protocol Violation|0|||
155239051|NCT01722331|560309330|FG004|Part 1|Protocol Violation|1|||
155239052|NCT01722331|560309331|FG005|Part 1|Protocol Violation|0|||
155239053|NCT01722331|560309332|FG006|Part 1|Protocol Violation|0|||
155239054|NCT01722331|560309326|FG000|Part 1|Withdrawal by Subject|2|||
155239055|NCT01722331|560309327|FG001|Part 1|Withdrawal by Subject|0|||
155239056|NCT01722331|560309328|FG002|Part 1|Withdrawal by Subject|3|||
155239057|NCT01722331|560309329|FG003|Part 1|Withdrawal by Subject|0|||
155239058|NCT01722331|560309330|FG004|Part 1|Withdrawal by Subject|3|||
155239059|NCT01722331|560309331|FG005|Part 1|Withdrawal by Subject|0|||
155239060|NCT01722331|560309332|FG006|Part 1|Withdrawal by Subject|0|||
155239061|NCT01722331|560309326|FG000|Part 2|Adverse Event|3|||
155239062|NCT01722331|560309327|FG001|Part 2|Adverse Event|0|||
155239063|NCT01722331|560309328|FG002|Part 2|Adverse Event|0|||
155239064|NCT01722331|560309329|FG003|Part 2|Adverse Event|0|||
155239065|NCT01722331|560309330|FG004|Part 2|Adverse Event|0|||
155239066|NCT01722331|560309331|FG005|Part 2|Adverse Event|1|||
155239067|NCT01722331|560309332|FG006|Part 2|Adverse Event|0|||
155239068|NCT01722331|560309326|FG000|Part 2|Lack of Efficacy|3|||
155239069|NCT01722331|560309327|FG001|Part 2|Lack of Efficacy|0|||
155239070|NCT01722331|560309328|FG002|Part 2|Lack of Efficacy|11|||
155239071|NCT01722331|560309329|FG003|Part 2|Lack of Efficacy|0|||
155239072|NCT01722331|560309330|FG004|Part 2|Lack of Efficacy|0|||
155239073|NCT01722331|560309331|FG005|Part 2|Lack of Efficacy|3|||
155239074|NCT01722331|560309332|FG006|Part 2|Lack of Efficacy|3|||
155239075|NCT01722331|560309326|FG000|Part 2|Lost to Follow-up|0|||
155239076|NCT01722331|560309327|FG001|Part 2|Lost to Follow-up|0|||
155239077|NCT01722331|560309328|FG002|Part 2|Lost to Follow-up|3|||
155239078|NCT01722331|560309329|FG003|Part 2|Lost to Follow-up|0|||
155239079|NCT01722331|560309330|FG004|Part 2|Lost to Follow-up|0|||
155239080|NCT01722331|560309331|FG005|Part 2|Lost to Follow-up|1|||
155239081|NCT01722331|560309332|FG006|Part 2|Lost to Follow-up|1|||
155239082|NCT01722331|560309326|FG000|Part 2|Non-Compliance with Study Drug|1|||
155239083|NCT01722331|560309327|FG001|Part 2|Non-Compliance with Study Drug|0|||
155239084|NCT01722331|560309328|FG002|Part 2|Non-Compliance with Study Drug|1|||
155239085|NCT01722331|560309329|FG003|Part 2|Non-Compliance with Study Drug|0|||
155239086|NCT01722331|560309330|FG004|Part 2|Non-Compliance with Study Drug|0|||
155239087|NCT01722331|560309331|FG005|Part 2|Non-Compliance with Study Drug|0|||
155239088|NCT01722331|560309332|FG006|Part 2|Non-Compliance with Study Drug|0|||
155239089|NCT01722331|560309326|FG000|Part 2|Physician Decision|0|||
155239090|NCT01722331|560309327|FG001|Part 2|Physician Decision|0|||
155239091|NCT01722331|560309328|FG002|Part 2|Physician Decision|2|||
155239092|NCT01722331|560309329|FG003|Part 2|Physician Decision|0|||
155239093|NCT01722331|560309330|FG004|Part 2|Physician Decision|0|||
155239094|NCT01722331|560309331|FG005|Part 2|Physician Decision|0|||
155239095|NCT01722331|560309332|FG006|Part 2|Physician Decision|0|||
155239096|NCT01722331|560309326|FG000|Part 2|Pregnancy|0|||
155239097|NCT01722331|560309327|FG001|Part 2|Pregnancy|0|||
155239098|NCT01722331|560309328|FG002|Part 2|Pregnancy|0|||
155239099|NCT01722331|560309329|FG003|Part 2|Pregnancy|0|||
155239100|NCT01722331|560309330|FG004|Part 2|Pregnancy|0|||
155239101|NCT01722331|560309331|FG005|Part 2|Pregnancy|1|||
155239102|NCT01722331|560309332|FG006|Part 2|Pregnancy|0|||
155239103|NCT01722331|560309326|FG000|Part 2|Progressive Disease|0|||
155239104|NCT01722331|560309327|FG001|Part 2|Progressive Disease|0|||
155239105|NCT01722331|560309328|FG002|Part 2|Progressive Disease|1|||
155239106|NCT01722331|560309329|FG003|Part 2|Progressive Disease|0|||
155239107|NCT01722331|560309330|FG004|Part 2|Progressive Disease|0|||
155239108|NCT01722331|560309331|FG005|Part 2|Progressive Disease|0|||
155239109|NCT01722331|560309332|FG006|Part 2|Progressive Disease|0|||
155239110|NCT01722331|560309326|FG000|Part 2|Protocol Violation|1|||
155239111|NCT01722331|560309327|FG001|Part 2|Protocol Violation|0|||
155239112|NCT01722331|560309328|FG002|Part 2|Protocol Violation|0|||
155239113|NCT01722331|560309329|FG003|Part 2|Protocol Violation|0|||
155239114|NCT01722331|560309330|FG004|Part 2|Protocol Violation|0|||
155239115|NCT01722331|560309331|FG005|Part 2|Protocol Violation|0|||
155239116|NCT01722331|560309332|FG006|Part 2|Protocol Violation|0|||
155239117|NCT01722331|560309326|FG000|Part 2|Withdrawal by Subject|5|||
155239118|NCT01722331|560309327|FG001|Part 2|Withdrawal by Subject|0|||
155239119|NCT01722331|560309328|FG002|Part 2|Withdrawal by Subject|3|||
155239120|NCT01722331|560309329|FG003|Part 2|Withdrawal by Subject|0|||
155239121|NCT01722331|560309330|FG004|Part 2|Withdrawal by Subject|0|||
155239122|NCT01722331|560309331|FG005|Part 2|Withdrawal by Subject|2|||
155239123|NCT01722331|560309332|FG006|Part 2|Withdrawal by Subject|2|||
155239124|NCT01722331|560309326|FG000|Part 2|Other Protocol Specified Criteria|6|||
155239125|NCT01722331|560309327|FG001|Part 2|Other Protocol Specified Criteria|0|||
155239126|NCT01722331|560309328|FG002|Part 2|Other Protocol Specified Criteria|10|||
155239127|NCT01722331|560309329|FG003|Part 2|Other Protocol Specified Criteria|0|||
155239128|NCT01722331|560309330|FG004|Part 2|Other Protocol Specified Criteria|0|||
155239129|NCT01722331|560309331|FG005|Part 2|Other Protocol Specified Criteria|2|||
155239130|NCT01722331|560309332|FG006|Part 2|Other Protocol Specified Criteria|1|||
155239131|NCT01722331|560309326|FG000|Part 3|Adverse Event|2|||
155239132|NCT01722331|560309327|FG001|Part 3|Adverse Event|2|||
155239133|NCT01722331|560309328|FG002|Part 3|Adverse Event|0|||
155239134|NCT01722331|560309329|FG003|Part 3|Adverse Event|1|||
155239135|NCT01722331|560309330|FG004|Part 3|Adverse Event|0|||
155239136|NCT01722331|560309331|FG005|Part 3|Adverse Event|0|||
155239137|NCT01722331|560309332|FG006|Part 3|Adverse Event|0|||
155239138|NCT01722331|560309326|FG000|Part 3|Death|1|||
155239139|NCT01722331|560309327|FG001|Part 3|Death|0|||
155239140|NCT01722331|560309328|FG002|Part 3|Death|0|||
155239141|NCT01722331|560309329|FG003|Part 3|Death|0|||
155239142|NCT01722331|560309330|FG004|Part 3|Death|0|||
155239143|NCT01722331|560309331|FG005|Part 3|Death|0|||
155239144|NCT01722331|560309332|FG006|Part 3|Death|0|||
155239145|NCT01722331|560309326|FG000|Part 3|Lack of Efficacy|1|||
155239146|NCT01722331|560309327|FG001|Part 3|Lack of Efficacy|0|||
155239147|NCT01722331|560309328|FG002|Part 3|Lack of Efficacy|0|||
155239148|NCT01722331|560309329|FG003|Part 3|Lack of Efficacy|0|||
155239149|NCT01722331|560309330|FG004|Part 3|Lack of Efficacy|0|||
155239150|NCT01722331|560309331|FG005|Part 3|Lack of Efficacy|0|||
155239151|NCT01722331|560309332|FG006|Part 3|Lack of Efficacy|0|||
155239152|NCT01722331|560309326|FG000|Part 3|Lost to Follow-up|3|||
155239153|NCT01722331|560309327|FG001|Part 3|Lost to Follow-up|4|||
155239154|NCT01722331|560309328|FG002|Part 3|Lost to Follow-up|0|||
155239155|NCT01722331|560309329|FG003|Part 3|Lost to Follow-up|0|||
155239156|NCT01722331|560309330|FG004|Part 3|Lost to Follow-up|0|||
155239157|NCT01722331|560309331|FG005|Part 3|Lost to Follow-up|1|||
155239158|NCT01722331|560309332|FG006|Part 3|Lost to Follow-up|0|||
155239159|NCT01722331|560309326|FG000|Part 3|Non-Compliance with Study Drug|0|||
155239160|NCT01722331|560309327|FG001|Part 3|Non-Compliance with Study Drug|1|||
155239161|NCT01722331|560309328|FG002|Part 3|Non-Compliance with Study Drug|0|||
155239162|NCT01722331|560309329|FG003|Part 3|Non-Compliance with Study Drug|0|||
155239163|NCT01722331|560309330|FG004|Part 3|Non-Compliance with Study Drug|0|||
155239164|NCT01722331|560309331|FG005|Part 3|Non-Compliance with Study Drug|0|||
155239165|NCT01722331|560309332|FG006|Part 3|Non-Compliance with Study Drug|0|||
155239166|NCT01722331|560309326|FG000|Part 3|Physician Decision|1|||
155239167|NCT01722331|560309327|FG001|Part 3|Physician Decision|1|||
155239168|NCT01722331|560309328|FG002|Part 3|Physician Decision|0|||
155239169|NCT01722331|560309329|FG003|Part 3|Physician Decision|0|||
155239170|NCT01722331|560309330|FG004|Part 3|Physician Decision|0|||
155491651|NCT04311411|561225465|FG000|Overall Study|Adverse Event|2|||
155239171|NCT01722331|560309331|FG005|Part 3|Physician Decision|0|||
155239172|NCT01722331|560309332|FG006|Part 3|Physician Decision|1|||
155239173|NCT01722331|560309326|FG000|Part 3|Protocol Violation|2|||
155239174|NCT01722331|560309327|FG001|Part 3|Protocol Violation|1|||
155239175|NCT01722331|560309328|FG002|Part 3|Protocol Violation|0|||
155239176|NCT01722331|560309329|FG003|Part 3|Protocol Violation|0|||
155239177|NCT01722331|560309330|FG004|Part 3|Protocol Violation|0|||
155239178|NCT01722331|560309331|FG005|Part 3|Protocol Violation|0|||
155239179|NCT01722331|560309332|FG006|Part 3|Protocol Violation|0|||
155239180|NCT01722331|560309326|FG000|Part 3|Withdrawal by Subject|4|||
155239181|NCT01722331|560309327|FG001|Part 3|Withdrawal by Subject|7|||
155239182|NCT01722331|560309328|FG002|Part 3|Withdrawal by Subject|0|||
155239183|NCT01722331|560309329|FG003|Part 3|Withdrawal by Subject|0|||
155239184|NCT01722331|560309330|FG004|Part 3|Withdrawal by Subject|0|||
155239185|NCT01722331|560309331|FG005|Part 3|Withdrawal by Subject|2|||
155239186|NCT01722331|560309332|FG006|Part 3|Withdrawal by Subject|1|||
155239187|NCT01722331|560309326|FG000|Part 3|Other Protocol Specified Criteria|1|||
155239188|NCT01722331|560309327|FG001|Part 3|Other Protocol Specified Criteria|1|||
155239189|NCT01722331|560309328|FG002|Part 3|Other Protocol Specified Criteria|0|||
155239190|NCT01722331|560309329|FG003|Part 3|Other Protocol Specified Criteria|0|||
155239191|NCT01722331|560309330|FG004|Part 3|Other Protocol Specified Criteria|0|||
155239192|NCT01722331|560309331|FG005|Part 3|Other Protocol Specified Criteria|0|||
155239193|NCT01722331|560309332|FG006|Part 3|Other Protocol Specified Criteria|0|||
155239194|NCT00353704|560309345|FG000|Overall Study|Protocol Violation|3|||
155239195|NCT00353704|560309346|FG001|Overall Study|Protocol Violation|1|||
155239196|NCT02525133|560309347|FG000|Overall Study|Adverse Event|0|||
155239197|NCT02525133|560309348|FG001|Overall Study|Adverse Event|1|||
155239198|NCT02525133|560309347|FG000|Overall Study|Death|0|||
155239199|NCT02525133|560309348|FG001|Overall Study|Death|1|||
155239200|NCT02525133|560309347|FG000|Overall Study|did not meet randomization criteria|1|||
155239201|NCT02525133|560309348|FG001|Overall Study|did not meet randomization criteria|0|||
155239202|NCT02525133|560309347|FG000|Overall Study|Lost to Follow-up|5|||
155239203|NCT02525133|560309348|FG001|Overall Study|Lost to Follow-up|1|||
155239204|NCT02525133|560309347|FG000|Overall Study|randomized not enrolled|3|||
155239205|NCT02525133|560309348|FG001|Overall Study|randomized not enrolled|0|||
155239206|NCT02525133|560309347|FG000|Overall Study|Withdrawal by Subject|1|||
155239207|NCT02525133|560309348|FG001|Overall Study|Withdrawal by Subject|0|||
155239208|NCT01343082|560309349|FG000|The run-in Period|Not meeting criteria|3|||
155239209|NCT01343082|560309350|FG001|The run-in Period|Not meeting criteria|4|||
155239210|NCT01343082|560309351|FG002|The run-in Period|Not meeting criteria|5|||
155239211|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
155239212|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
155239213|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
155239214|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
155239215|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
155239216|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
155239217|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
155239218|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
155239219|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
155239220|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
155239221|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
155239222|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
155239223|NCT01154166|560309352|FG000|Overall Study|Adverse Event|14|||
155239224|NCT01154166|560309353|FG001|Overall Study|Adverse Event|9|||
155239225|NCT01154166|560309352|FG000|Overall Study|Lost to Follow-up|1|||
155239226|NCT01154166|560309353|FG001|Overall Study|Lost to Follow-up|1|||
155239227|NCT01154166|560309352|FG000|Overall Study|Protocol Violation|4|||
155239228|NCT01154166|560309353|FG001|Overall Study|Protocol Violation|1|||
155239229|NCT01154166|560309352|FG000|Overall Study|Withdrawal by Subject|10|||
155239230|NCT01154166|560309353|FG001|Overall Study|Withdrawal by Subject|1|||
155239231|NCT01154166|560309352|FG000|Overall Study|Lack of Efficacy|3|||
155239232|NCT01154166|560309353|FG001|Overall Study|Lack of Efficacy|0|||
155239233|NCT01154166|560309352|FG000|Overall Study|Disease Progression|1|||
155239234|NCT01154166|560309353|FG001|Overall Study|Disease Progression|0|||
155239235|NCT01154166|560309352|FG000|Overall Study|Poor Compliance|1|||
155239236|NCT01154166|560309353|FG001|Overall Study|Poor Compliance|0|||
155239237|NCT01375049|560309354|FG000|Overall Study|Adverse Event|2|||
155239238|NCT01375049|560309354|FG000|Overall Study|Lost to Follow-up|1|||
155239239|NCT01375049|560309354|FG000|Overall Study|Withdrawal by Subject|2|||
155239240|NCT01375049|560309354|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
155239241|NCT03614793|560309355|FG000|Overall Study|Lost to Follow-up|1|||
155239242|NCT03614793|560309356|FG001|Overall Study|Lost to Follow-up|2|||
155239243|NCT03614793|560309355|FG000|Overall Study|Lack of Efficacy|0|||
155239244|NCT03614793|560309356|FG001|Overall Study|Lack of Efficacy|5|||
155239245|NCT03614793|560309355|FG000|Overall Study|Withdrawal by Subject|0|||
155239246|NCT03614793|560309356|FG001|Overall Study|Withdrawal by Subject|1|||
155239247|NCT03614793|560309355|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
155239248|NCT03614793|560309356|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
155239249|NCT02082522|560309357|FG000|Overall Study|Sponsor termination|5|||
155239250|NCT02082522|560309358|FG001|Overall Study|Sponsor termination|3|||
155239251|NCT02082522|560309357|FG000|Overall Study|Withdrawal by Subject|2|||
155239252|NCT02082522|560309358|FG001|Overall Study|Withdrawal by Subject|4|||
155239253|NCT02082522|560309357|FG000|Overall Study|Death|1|||
155239254|NCT02082522|560309358|FG001|Overall Study|Death|0|||
155239255|NCT02082522|560309357|FG000|Overall Study|Lost to Follow-up|1|||
155239256|NCT02082522|560309358|FG001|Overall Study|Lost to Follow-up|0|||
155239257|NCT02082522|560309357|FG000|Overall Study|Physician Decision|3|||
155239258|NCT02082522|560309358|FG001|Overall Study|Physician Decision|1|||
155239259|NCT02082522|560309357|FG000|Overall Study|Disease progression|2|||
155239260|NCT02082522|560309358|FG001|Overall Study|Disease progression|2|||
155239261|NCT02082522|560309357|FG000|Overall Study|Chemotherapy change|1|||
155239262|NCT02082522|560309358|FG001|Overall Study|Chemotherapy change|3|||
155239263|NCT01575561|560309359|FG000|Overall Study|Adverse Event|9|||
155239264|NCT01575561|560309359|FG000|Overall Study|Lack of Efficacy|8|||
155239265|NCT01575561|560309359|FG000|Overall Study|Lost to Follow-up|6|||
155239266|NCT01575561|560309359|FG000|Overall Study|Protocol Violation|4|||
155239267|NCT01575561|560309359|FG000|Overall Study|Withdrawal by Subject|11|||
155239268|NCT01575561|560309359|FG000|Overall Study|administration|1|||
155239269|NCT00633984|560309360|FG000|Overall Study|Lost to Follow-up|0|||
155239270|NCT00633984|560309361|FG001|Overall Study|Lost to Follow-up|6|||
155239271|NCT00633984|560309360|FG000|Overall Study|Withdrawal by Subject|8|||
155239272|NCT00633984|560309361|FG001|Overall Study|Withdrawal by Subject|7|||
155239273|NCT00633984|560309360|FG000|Overall Study|Hospitalized|1|||
155239274|NCT00633984|560309361|FG001|Overall Study|Hospitalized|0|||
155239275|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
155239276|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
155239277|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
155239278|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Death|1|||
155239279|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
155239280|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
155239281|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
155239282|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Treatment failure|1|||
155239283|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
155239284|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
155239285|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Death|1|||
155239286|NCT02840877|560309362|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
155239287|NCT02840877|560309362|FG000|6 Months to 18 Months|Treatment failure|7|||
155239288|NCT02840877|560309362|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
155239289|NCT02840877|560309362|FG000|6 Months to 18 Months|Moved/transferred out|6|||
155239290|NCT02840877|560309362|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
155239291|NCT02840877|560309362|FG000|6 Months to 18 Months|Death|4|||
155239292|NCT02840877|560309362|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
155239293|NCT02840877|560309362|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
155239294|NCT02840877|560309362|FG000|6 Months to 18 Months|Still in study.|14|||
155239295|NCT01168999|560309363|FG000|Overall Study|Lost to Follow-up|2|||
155239296|NCT01168999|560309364|FG001|Overall Study|Lost to Follow-up|1|||
155239297|NCT01168999|560309365|FG002|Overall Study|Lost to Follow-up|0|||
155239298|NCT01168999|560309366|FG003|Overall Study|Lost to Follow-up|0|||
155239299|NCT01276327|560309367|FG000|Overall Study|Adverse Event|1|||
155239300|NCT01276327|560309368|FG001|Overall Study|Adverse Event|3|||
155239301|NCT01276327|560309367|FG000|Overall Study|Withdrawal by Subject|1|||
155239302|NCT01276327|560309368|FG001|Overall Study|Withdrawal by Subject|0|||
155239303|NCT03766646|560309370|FG000|Overall Study|Withdrawal by Subject|1|||
155239304|NCT03766646|560309371|FG001|Overall Study|Withdrawal by Subject|0|||
155239305|NCT03766646|560309370|FG000|Overall Study|Protocol Violation|0|||
155239306|NCT03766646|560309371|FG001|Overall Study|Protocol Violation|3|||
155239307|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
155239308|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
155239309|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
155239310|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239311|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239312|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239313|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239314|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239315|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239316|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
155239317|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
155239318|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
155239319|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239320|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239321|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239322|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239323|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239324|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239325|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239326|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
155239327|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
155239328|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239329|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239330|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239331|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239332|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239333|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239334|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
155239335|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
155239336|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
155239337|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239338|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239339|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239340|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239341|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239342|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239343|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239344|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
155239345|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239346|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239347|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239348|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239349|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239350|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239351|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239352|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
155239353|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239354|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239355|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239356|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239357|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239358|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239359|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239360|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239361|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239362|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
155239363|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
155239364|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239365|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239366|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239367|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239368|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239369|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239370|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239371|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
155239372|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
155239373|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
155239374|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
155239375|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
155239376|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239377|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239378|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239379|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239380|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
155239381|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
155239382|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
155239383|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
155239384|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
155239385|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239386|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239387|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239388|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239389|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239390|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
155239391|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239392|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155491652|NCT04311411|561225466|FG001|Overall Study|Adverse Event|3|||
155491653|NCT04311411|561225467|FG002|Overall Study|Adverse Event|2|||
155239393|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239394|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239395|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239396|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239397|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239398|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
155239399|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
155239400|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
155239401|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
155239402|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
155239403|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
155239404|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239405|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239406|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239407|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239408|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239409|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239410|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239411|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239412|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239413|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239414|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239415|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239416|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239417|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239418|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239419|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239420|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
155239421|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
155239422|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239423|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239424|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239425|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
155239426|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
155239427|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239428|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239429|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239430|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239431|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
155239432|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
155239433|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239434|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
155239435|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
155239436|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239437|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239438|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239439|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239440|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
155239441|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239442|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239443|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239444|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
155239445|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239446|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239447|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239448|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239449|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239450|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239451|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239452|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
155239453|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
155239454|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239455|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155607044|NCT01897571|561649614|FG001|Overall Study|Death|2|||
155239456|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239457|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239458|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
155239459|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
155239460|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239461|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239462|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
155239463|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239464|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239465|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239466|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239467|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239468|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239469|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239470|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
155239471|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
155239472|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239473|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239474|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239475|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239476|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
155239477|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239478|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239479|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
155239480|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239481|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239482|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239483|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239484|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239485|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239486|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
155239487|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239488|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
155239489|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239490|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239491|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239492|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239493|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239494|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239495|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239496|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239497|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239498|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239499|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239500|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239501|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239502|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239503|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239504|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
155239505|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239506|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
155239507|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239508|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239509|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239510|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239511|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239512|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239513|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239514|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239515|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
155239516|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
155239517|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239518|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239519|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239520|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239521|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
155239522|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
155239523|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239524|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239525|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239526|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239527|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239528|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239529|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239530|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
155239531|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239532|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239533|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
155239534|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239535|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239536|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239537|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239538|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239539|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239540|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239541|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239542|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239543|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
155239544|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239545|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239546|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239547|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239548|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239549|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239550|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239551|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
155239552|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
155239553|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239554|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239555|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239556|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239557|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
155239558|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239559|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239560|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
155239561|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
155239562|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239563|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239564|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239565|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239566|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
155239567|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
155239568|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239569|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
155239570|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
155239571|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239572|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239573|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239574|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239575|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
155239576|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
155239577|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239578|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239579|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
155239580|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239581|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239582|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239583|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239584|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239585|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
155239586|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155607045|NCT01897571|561649615|FG002|Overall Study|Death|3|||
155239587|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239588|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239589|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239590|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239591|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239592|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239593|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
155239594|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239595|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239596|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239597|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239598|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239599|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239600|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239601|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239602|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239603|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239604|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239605|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239606|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
155239607|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239608|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239609|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239610|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239611|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239612|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239613|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239614|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
155239615|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239616|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239617|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239618|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239619|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239620|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
155239621|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239622|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239623|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
155239624|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
155239625|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239626|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239627|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239628|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239629|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
155239630|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239631|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239632|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239633|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
155239634|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239635|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239636|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239637|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239638|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239639|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239640|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239641|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239642|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
155239643|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239644|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239645|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239646|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239647|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239648|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239649|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239650|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239651|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239652|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239653|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239654|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239655|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239656|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239657|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
155239658|NCT01033747|560309391|FG000|Overall Study|Adverse Event|9|||
155239659|NCT01033747|560309392|FG001|Overall Study|Adverse Event|4|||
155239660|NCT01033747|560309391|FG000|Overall Study|Abnormal Laboratory Value|1|||
155239661|NCT01033747|560309392|FG001|Overall Study|Abnormal Laboratory Value|0|||
155239662|NCT01033747|560309391|FG000|Overall Study|Abnormal test procedure|0|||
155239663|NCT01033747|560309392|FG001|Overall Study|Abnormal test procedure|1|||
155239664|NCT01033747|560309391|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
155239665|NCT01033747|560309392|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155239666|NCT01033747|560309391|FG000|Overall Study|Protocol Violation|1|||
155239667|NCT01033747|560309392|FG001|Overall Study|Protocol Violation|0|||
155239668|NCT01033747|560309391|FG000|Overall Study|Withdrawal by Subject|9|||
155239669|NCT01033747|560309392|FG001|Overall Study|Withdrawal by Subject|6|||
155239670|NCT01033747|560309391|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
155239671|NCT01033747|560309392|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
155239672|NCT01033747|560309391|FG000|Overall Study|Stopped at end of Extension 1|2|||
155239673|NCT01033747|560309392|FG001|Overall Study|Stopped at end of Extension 1|0|||
155239674|NCT00003498|560309393|FG000|Overall Study|Not evaluable.|4|||
155239675|NCT02956629|560309394|FG000|Overall Study|Adverse Event|0|||
155239676|NCT02956629|560309395|FG001|Overall Study|Adverse Event|0|||
155239677|NCT02956629|560309396|FG002|Overall Study|Adverse Event|1|||
155239678|NCT02956629|560309397|FG003|Overall Study|Adverse Event|0|||
155239679|NCT02956629|560309398|FG004|Overall Study|Adverse Event|0|||
155239680|NCT02956629|560309399|FG005|Overall Study|Adverse Event|0|||
155239681|NCT02956629|560309394|FG000|Overall Study|Lost to Follow-up|2|||
155239682|NCT02956629|560309395|FG001|Overall Study|Lost to Follow-up|5|||
155239683|NCT02956629|560309396|FG002|Overall Study|Lost to Follow-up|3|||
155239684|NCT02956629|560309397|FG003|Overall Study|Lost to Follow-up|1|||
155239685|NCT02956629|560309398|FG004|Overall Study|Lost to Follow-up|0|||
155239686|NCT02956629|560309399|FG005|Overall Study|Lost to Follow-up|1|||
155239687|NCT02956629|560309394|FG000|Overall Study|Withdrawal by Subject|3|||
155239688|NCT02956629|560309395|FG001|Overall Study|Withdrawal by Subject|1|||
155239689|NCT02956629|560309396|FG002|Overall Study|Withdrawal by Subject|0|||
155239690|NCT02956629|560309397|FG003|Overall Study|Withdrawal by Subject|0|||
155239691|NCT02956629|560309398|FG004|Overall Study|Withdrawal by Subject|0|||
155239692|NCT02956629|560309399|FG005|Overall Study|Withdrawal by Subject|0|||
155239693|NCT04067141|560309406|FG000|First Intervention|Withdrawal by Subject|0|||
155239694|NCT04067141|560309407|FG001|First Intervention|Withdrawal by Subject|1|||
155239695|NCT04067141|560309406|FG000|Second Intervention|Adverse Event|0|||
155239696|NCT04067141|560309407|FG001|Second Intervention|Adverse Event|2|||
155239697|NCT01557946|560309408|FG000|Overall Study|Adverse Event|3|||
155239698|NCT01557946|560309409|FG001|Overall Study|Adverse Event|0|||
155239699|NCT01978119|560309411|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
155239700|NCT01978119|560309412|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
155239701|NCT01978119|560309411|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155239702|NCT01978119|560309412|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155239703|NCT01978119|560309411|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155239704|NCT01978119|560309412|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
155239705|NCT00812812|560309414|FG000|Overall Study|Adverse Event|2|||
155239706|NCT00812812|560309415|FG001|Overall Study|Adverse Event|1|||
155239707|NCT00812812|560309414|FG000|Overall Study|Lack of Efficacy|1|||
155239708|NCT00812812|560309415|FG001|Overall Study|Lack of Efficacy|0|||
155239709|NCT00812812|560309414|FG000|Overall Study|Lost to Follow-up|0|||
155239710|NCT00812812|560309415|FG001|Overall Study|Lost to Follow-up|1|||
155239711|NCT00812812|560309414|FG000|Overall Study|Withdrawal by Subject|0|||
155239712|NCT00812812|560309415|FG001|Overall Study|Withdrawal by Subject|2|||
155239713|NCT01047683|560309416|FG000|Overall Study|Adverse Event|3|||
155239714|NCT01047683|560309417|FG001|Overall Study|Adverse Event|1|||
155239715|NCT01047683|560309418|FG002|Overall Study|Adverse Event|0|||
155239716|NCT01047683|560309416|FG000|Overall Study|Withdrew Consent|1|||
155239717|NCT01047683|560309417|FG001|Overall Study|Withdrew Consent|4|||
155239718|NCT01047683|560309418|FG002|Overall Study|Withdrew Consent|2|||
155239719|NCT01047683|560309416|FG000|Overall Study|Lost to Follow-up|0|||
155239720|NCT01047683|560309417|FG001|Overall Study|Lost to Follow-up|1|||
155239721|NCT01047683|560309418|FG002|Overall Study|Lost to Follow-up|0|||
155239722|NCT01047683|560309416|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
155239723|NCT01047683|560309417|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
155239724|NCT01047683|560309418|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
155239725|NCT02822794|560309419|FG000|Overall Study|Withdrew Consent|1|||
155239726|NCT02822794|560309420|FG001|Overall Study|Withdrew Consent|0|||
155239727|NCT05061446|560309423|FG000|Overall Study|Adverse Event|2|||
155239728|NCT05061446|560309424|FG001|Overall Study|Adverse Event|0|||
155239729|NCT05061446|560309425|FG002|Overall Study|Adverse Event|0|||
155239730|NCT05061446|560309423|FG000|Overall Study|Participant no longer available due to personal reason|0|||
155239731|NCT05061446|560309424|FG001|Overall Study|Participant no longer available due to personal reason|1|||
155239732|NCT05061446|560309425|FG002|Overall Study|Participant no longer available due to personal reason|0|||
155239733|NCT05857527|560309430|FG000|Overall Study|Withdrawal by Subject|0|||
155239734|NCT05857527|560309431|FG001|Overall Study|Withdrawal by Subject|1|||
155239735|NCT02543346|560309432|FG000|Second Priming Visit|Withdrawal by Subject|0|||
155239736|NCT02543346|560309433|FG001|Second Priming Visit|Withdrawal by Subject|2|||
155239737|NCT02543346|560309434|FG002|Second Priming Visit|Withdrawal by Subject|2|||
155239738|NCT02543346|560309435|FG003|Second Priming Visit|Withdrawal by Subject|2|||
155239739|NCT02543346|560309432|FG000|Second Priming Visit|Adverse Event|1|||
155239740|NCT02543346|560309433|FG001|Second Priming Visit|Adverse Event|0|||
155239741|NCT02543346|560309434|FG002|Second Priming Visit|Adverse Event|0|||
155239742|NCT02543346|560309435|FG003|Second Priming Visit|Adverse Event|0|||
155239743|NCT01440946|560309440|FG000|Overall Study|Lost to Follow-up|1|||
155239744|NCT01440946|560309441|FG001|Overall Study|Lost to Follow-up|1|||
155239745|NCT01440946|560309440|FG000|Overall Study|Physician Decision|1|||
155239746|NCT01440946|560309441|FG001|Overall Study|Physician Decision|0|||
155239747|NCT01975389|560309442|FG000|Overall Study|Adverse Event|10|||
155239748|NCT01975389|560309443|FG001|Overall Study|Adverse Event|6|||
155239749|NCT01975389|560309442|FG000|Overall Study|Death|61|||
155239750|NCT01975389|560309443|FG001|Overall Study|Death|54|||
155239751|NCT01975389|560309442|FG000|Overall Study|Lost to Follow-up|81|||
155239752|NCT01975389|560309443|FG001|Overall Study|Lost to Follow-up|86|||
155239753|NCT01975389|560309442|FG000|Overall Study|Withdrawal by Subject|90|||
155239754|NCT01975389|560309443|FG001|Overall Study|Withdrawal by Subject|76|||
155239755|NCT01975389|560309442|FG000|Overall Study|Other|6|||
155239756|NCT01975389|560309443|FG001|Overall Study|Other|9|||
155239757|NCT01975389|560309442|FG000|Overall Study|Randomized, not treated|4|||
155239758|NCT01975389|560309443|FG001|Overall Study|Randomized, not treated|5|||
155239759|NCT02127307|560309444|FG000|Overall Study|Protocol Violation|36|||
155239760|NCT02127307|560309444|FG000|Overall Study|Lost to Follow-up|2|||
155239761|NCT02127307|560309444|FG000|Overall Study|Death|101|||
155239762|NCT02127307|560309444|FG000|Overall Study|Other than specified above|169|||
155239763|NCT01312961|560309445|FG000|Overall Study|Adverse Event|3|||
155239764|NCT01312961|560309446|FG001|Overall Study|Adverse Event|3|||
155239765|NCT01312961|560309445|FG000|Overall Study|Lack of Efficacy|11|||
155239766|NCT01312961|560309446|FG001|Overall Study|Lack of Efficacy|1|||
155239767|NCT01312961|560309445|FG000|Overall Study|Poor compliance to protocol|1|||
155239768|NCT01312961|560309446|FG001|Overall Study|Poor compliance to protocol|0|||
155239769|NCT01312961|560309445|FG000|Overall Study|Other than specified above|2|||
155239770|NCT01312961|560309446|FG001|Overall Study|Other than specified above|3|||
155239771|NCT04666441|560309452|FG000|Overall Study|Lost to Follow-up|1|||
155239772|NCT04666441|560309453|FG001|Overall Study|Lost to Follow-up|4|||
155239773|NCT04666441|560309454|FG002|Overall Study|Lost to Follow-up|1|||
155239774|NCT04666441|560309455|FG003|Overall Study|Lost to Follow-up|3|||
155239775|NCT04666441|560309456|FG004|Overall Study|Lost to Follow-up|0|||
155239776|NCT04666441|560309457|FG005|Overall Study|Lost to Follow-up|2|||
155239777|NCT04666441|560309458|FG006|Overall Study|Lost to Follow-up|2|||
155239778|NCT04666441|560309459|FG007|Overall Study|Lost to Follow-up|2|||
155239779|NCT04666441|560309452|FG000|Overall Study|Subject Decision|1|||
155239780|NCT04666441|560309453|FG001|Overall Study|Subject Decision|1|||
155239781|NCT04666441|560309454|FG002|Overall Study|Subject Decision|3|||
155239782|NCT04666441|560309455|FG003|Overall Study|Subject Decision|1|||
155239783|NCT04666441|560309456|FG004|Overall Study|Subject Decision|0|||
155239784|NCT04666441|560309457|FG005|Overall Study|Subject Decision|1|||
155239785|NCT04666441|560309458|FG006|Overall Study|Subject Decision|3|||
155239786|NCT04666441|560309459|FG007|Overall Study|Subject Decision|2|||
155239787|NCT00766415|560309460|FG000|Overall Study|Withdrawal by Subject|0|||
155239788|NCT00766415|560309461|FG001|Overall Study|Withdrawal by Subject|1|||
155239789|NCT01114516|560309462|FG000|Overall Study|Lost to Follow-up|2|||
155239790|NCT01114516|560309463|FG001|Overall Study|Lost to Follow-up|1|||
155239791|NCT00132769|560309464|FG000|Overall Study|Withdrawal by Subject|1|||
155239792|NCT00132769|560309465|FG001|Overall Study|Withdrawal by Subject|3|||
155239793|NCT00132769|560309464|FG000|Overall Study|Lack of Efficacy|7|||
155239794|NCT00132769|560309465|FG001|Overall Study|Lack of Efficacy|6|||
155239795|NCT00132769|560309464|FG000|Overall Study|Adverse Event|2|||
155239796|NCT00132769|560309465|FG001|Overall Study|Adverse Event|1|||
155491654|NCT04311411|561225465|FG000|Overall Study|Withdrawal by Subject|3|||
155239797|NCT00132769|560309464|FG000|Overall Study|Protocol Violation|1|||
155239798|NCT00132769|560309465|FG001|Overall Study|Protocol Violation|1|||
155239799|NCT01431508|560309466|FG000|Overall Study|Lack of Efficacy|1|||
155239800|NCT01431508|560309466|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
155239801|NCT00129259|560309468|FG000|Overall Study|Lost to Follow-up|1|||
155239802|NCT00129259|560309469|FG001|Overall Study|Lost to Follow-up|1|||
155239803|NCT00129259|560309468|FG000|Overall Study|Withdrawal by Subject|2|||
155239804|NCT00129259|560309469|FG001|Overall Study|Withdrawal by Subject|1|||
155239805|NCT00129259|560309468|FG000|Overall Study|Only available minimal phone assessments|0|||
155239806|NCT00129259|560309469|FG001|Overall Study|Only available minimal phone assessments|1|||
155239807|NCT03794089|560311521|FG000|Overall Study|Lost to Follow-up|4|||
155239808|NCT03794089|560311522|FG001|Overall Study|Lost to Follow-up|1|||
155239809|NCT03794089|560311521|FG000|Overall Study|Withdrawal by Subject|2|||
155239810|NCT03794089|560311522|FG001|Overall Study|Withdrawal by Subject|0|||
155239811|NCT03985423|560311523|FG000|Overall Study|Adverse Event|1|||
155239812|NCT03985423|560311523|FG000|Overall Study|Death|2|||
155239813|NCT03985423|560311523|FG000|Overall Study|Physician Decision|1|||
155239814|NCT03985423|560311523|FG000|Overall Study|Withdrawal by Subject|2|||
155239815|NCT03985423|560311523|FG000|Overall Study|Lack of insurance and citizenship|1|||
155239816|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Adverse Event|5|||
155239817|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Adverse Event|8|||
155239818|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Adverse Event|4|||
155239819|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Adverse Event|8|||
155239820|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
155239821|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
155239822|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
155239823|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
155239824|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239825|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
155239826|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239827|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239828|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Physician Decision|1|||
155239829|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Physician Decision|0|||
155239830|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Physician Decision|0|||
155239831|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Physician Decision|0|||
155239832|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
155239833|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
155239834|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
155239835|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
155239836|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Pregnancy|0|||
155239837|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Pregnancy|1|||
155239838|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Pregnancy|0|||
155239839|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Pregnancy|0|||
155239840|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
155239841|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
155239842|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
155239843|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
155239844|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Death|0|||
155239845|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Death|1|||
155239846|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Death|0|||
155239847|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Death|0|||
155239848|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
155239849|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
155239850|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
155239851|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
155239852|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
155239853|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
155239854|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
155239855|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
155239856|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239857|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239858|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239859|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
155239860|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239861|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239862|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239863|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
155239864|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
155239865|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
155239866|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
155239867|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
155239868|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239869|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239870|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239871|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
155239872|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239873|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239874|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239875|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
155239876|NCT00581945|560311532|FG000|Overall Study|Adverse Event|4|||
155239877|NCT00581945|560311533|FG001|Overall Study|Adverse Event|4|||
155239878|NCT00581945|560311532|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155239879|NCT00581945|560311533|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155239880|NCT00581945|560311532|FG000|Overall Study|Withdrawal by Subject|2|||
155239881|NCT00581945|560311533|FG001|Overall Study|Withdrawal by Subject|6|||
155239882|NCT00581945|560311532|FG000|Overall Study|Death|1|||
155239883|NCT00581945|560311533|FG001|Overall Study|Death|0|||
155239884|NCT04820673|560311537|FG000|Overall Study|Adverse Event|6|||
155239885|NCT04820673|560311537|FG000|Overall Study|Due to Lack of Effectiveness|1|||
155239886|NCT04820673|560311537|FG000|Overall Study|Pregnancy|1|||
155239887|NCT04820673|560311537|FG000|Overall Study|Voluntary Withdrawal|20|||
155239888|NCT04820673|560311537|FG000|Overall Study|Lost to Follow-up|10|||
155239889|NCT02032901|560311540|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
155239890|NCT02032901|560311541|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
155239891|NCT02032901|560311540|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
155239892|NCT02032901|560311541|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
155239893|NCT00982020|560311542|FG000|Overall Study|Adverse Event|19|||
155239894|NCT00982020|560311543|FG001|Overall Study|Adverse Event|15|||
155239895|NCT00982020|560311542|FG000|Overall Study|Withdrawal by Subject|11|||
155239896|NCT00982020|560311543|FG001|Overall Study|Withdrawal by Subject|14|||
155239897|NCT00982020|560311542|FG000|Overall Study|Lost to Follow-up|5|||
155239898|NCT00982020|560311543|FG001|Overall Study|Lost to Follow-up|11|||
155239899|NCT00982020|560311542|FG000|Overall Study|Lack of Efficacy|10|||
155239900|NCT00982020|560311543|FG001|Overall Study|Lack of Efficacy|4|||
155239901|NCT00982020|560311542|FG000|Overall Study|Parent/Caregiver Decision|5|||
155239902|NCT00982020|560311543|FG001|Overall Study|Parent/Caregiver Decision|5|||
155239903|NCT00982020|560311542|FG000|Overall Study|Treatment Non-compliance|3|||
155239904|NCT00982020|560311543|FG001|Overall Study|Treatment Non-compliance|6|||
155239905|NCT00982020|560311542|FG000|Overall Study|Physician Decision|2|||
155239906|NCT00982020|560311543|FG001|Overall Study|Physician Decision|5|||
155239907|NCT00982020|560311542|FG000|Overall Study|Entry Criteria Not Met|2|||
155239908|NCT00982020|560311543|FG001|Overall Study|Entry Criteria Not Met|1|||
155239909|NCT00982020|560311542|FG000|Overall Study|Protocol Violation|0|||
155239910|NCT00982020|560311543|FG001|Overall Study|Protocol Violation|2|||
155239911|NCT00982020|560311542|FG000|Overall Study|Clinical Relapse|0|||
155239912|NCT00982020|560311543|FG001|Overall Study|Clinical Relapse|1|||
155239913|NCT04317586|560311544|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
155239914|NCT04317586|560311544|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
155239915|NCT03003676|560311545|FG000|Overall Study|Lack of Efficacy|5|||
155239916|NCT03003676|560311546|FG001|Overall Study|Lack of Efficacy|7|||
155239917|NCT03003676|560311545|FG000|Overall Study|Withdrawal by Subject|0|||
155239918|NCT03003676|560311546|FG001|Overall Study|Withdrawal by Subject|1|||
155239919|NCT03003676|560311545|FG000|Overall Study|Hepatitis B infection|1|||
155239920|NCT03003676|560311546|FG001|Overall Study|Hepatitis B infection|0|||
155239921|NCT02530619|560311547|FG000|Registered for Study|Withdrawal by Subject|2|||
155239922|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
155239923|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
155239924|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
155239925|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
155239926|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Death|4|||
155239927|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
155239928|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
155239929|NCT01854554|560311555|FG000|Overall Study|Denial of Insurance Coverage|12|||
155239930|NCT01854554|560311556|FG001|Overall Study|Denial of Insurance Coverage|0|||
155239931|NCT01854554|560311555|FG000|Overall Study|Decided to get treatment locally|1|||
155239932|NCT01854554|560311556|FG001|Overall Study|Decided to get treatment locally|5|||
155239933|NCT01854554|560311555|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
155239934|NCT01854554|560311556|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
155239935|NCT01854554|560311555|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155239936|NCT01854554|560311556|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155239937|NCT01854554|560311555|FG000|Overall Study|Progression|0|||
155239938|NCT01854554|560311556|FG001|Overall Study|Progression|1|||
155239939|NCT01854554|560311555|FG000|Overall Study|Lost to Follow-up|0|||
155239940|NCT01854554|560311556|FG001|Overall Study|Lost to Follow-up|1|||
155239941|NCT02819726|560311557|FG000|Part A (All Participants)|Lost to Follow-up|0|||
155239942|NCT02819726|560311558|FG001|Part A (All Participants)|Lost to Follow-up|1|||
155239943|NCT02819726|560311559|FG002|Part A (All Participants)|Lost to Follow-up|0|||
155239944|NCT02819726|560311560|FG003|Part A (All Participants)|Lost to Follow-up|0|||
155239945|NCT02819726|560311557|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
155239946|NCT02819726|560311558|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
155239947|NCT02819726|560311559|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
155239948|NCT02819726|560311560|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
155239949|NCT02819726|560311557|FG000|Part A (All Participants)|Protocol non-compliance|3|||
155239950|NCT02819726|560311558|FG001|Part A (All Participants)|Protocol non-compliance|4|||
155239951|NCT02819726|560311559|FG002|Part A (All Participants)|Protocol non-compliance|5|||
155239952|NCT02819726|560311560|FG003|Part A (All Participants)|Protocol non-compliance|0|||
155239953|NCT02819726|560311557|FG000|Part B (All Participants)|Lost to Follow-up|1|||
155239954|NCT02819726|560311558|FG001|Part B (All Participants)|Lost to Follow-up|1|||
155239955|NCT02819726|560311559|FG002|Part B (All Participants)|Lost to Follow-up|2|||
155239956|NCT02819726|560311560|FG003|Part B (All Participants)|Lost to Follow-up|2|||
155239957|NCT02819726|560311557|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
155239958|NCT02819726|560311558|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
155239959|NCT02819726|560311559|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
155239960|NCT02819726|560311560|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
155239961|NCT02819726|560311557|FG000|Part B (All Participants)|Protocol non-compliance|0|||
155239962|NCT02819726|560311558|FG001|Part B (All Participants)|Protocol non-compliance|0|||
155239963|NCT02819726|560311559|FG002|Part B (All Participants)|Protocol non-compliance|1|||
155239964|NCT02819726|560311560|FG003|Part B (All Participants)|Protocol non-compliance|0|||
155239965|NCT00359762|560311561|FG000|Period II|Adverse Event|17|||
155239966|NCT00359762|560311562|FG001|Period II|Adverse Event|0|||
155239967|NCT00359762|560311563|FG002|Period II|Adverse Event|0|||
155239968|NCT00359762|560311564|FG003|Period II|Adverse Event|0|||
155239969|NCT00359762|560311565|FG004|Period II|Adverse Event|49|||
155239970|NCT00359762|560311561|FG000|Period II|Protocol Violation|18|||
155239971|NCT00359762|560311562|FG001|Period II|Protocol Violation|0|||
155239972|NCT00359762|560311563|FG002|Period II|Protocol Violation|0|||
155239973|NCT00359762|560311564|FG003|Period II|Protocol Violation|0|||
155239974|NCT00359762|560311565|FG004|Period II|Protocol Violation|11|||
155239975|NCT00359762|560311561|FG000|Period II|Physician Decision|17|||
155239976|NCT00359762|560311562|FG001|Period II|Physician Decision|0|||
155239977|NCT00359762|560311563|FG002|Period II|Physician Decision|0|||
155239978|NCT00359762|560311564|FG003|Period II|Physician Decision|0|||
155239979|NCT00359762|560311565|FG004|Period II|Physician Decision|23|||
155239980|NCT00359762|560311561|FG000|Period II|Death|2|||
155239981|NCT00359762|560311562|FG001|Period II|Death|0|||
155239982|NCT00359762|560311563|FG002|Period II|Death|0|||
155239983|NCT00359762|560311564|FG003|Period II|Death|0|||
155239984|NCT00359762|560311565|FG004|Period II|Death|4|||
155239985|NCT00359762|560311561|FG000|Period II|Lack of Efficacy|11|||
155239986|NCT00359762|560311562|FG001|Period II|Lack of Efficacy|0|||
155239987|NCT00359762|560311563|FG002|Period II|Lack of Efficacy|0|||
155239988|NCT00359762|560311564|FG003|Period II|Lack of Efficacy|0|||
155239989|NCT00359762|560311565|FG004|Period II|Lack of Efficacy|8|||
155239990|NCT00359762|560311561|FG000|Period II|Lost to follow up|5|||
155239991|NCT00359762|560311562|FG001|Period II|Lost to follow up|0|||
155239992|NCT00359762|560311563|FG002|Period II|Lost to follow up|0|||
155239993|NCT00359762|560311564|FG003|Period II|Lost to follow up|0|||
155239994|NCT00359762|560311565|FG004|Period II|Lost to follow up|5|||
155239995|NCT00359762|560311561|FG000|Period II|Entry Criteria Not Met|8|||
155239996|NCT00359762|560311562|FG001|Period II|Entry Criteria Not Met|0|||
155239997|NCT00359762|560311563|FG002|Period II|Entry Criteria Not Met|0|||
155239998|NCT00359762|560311564|FG003|Period II|Entry Criteria Not Met|0|||
155239999|NCT00359762|560311565|FG004|Period II|Entry Criteria Not Met|4|||
155240000|NCT00359762|560311561|FG000|Period II|Subject Decision|50|||
155240001|NCT00359762|560311562|FG001|Period II|Subject Decision|0|||
155240002|NCT00359762|560311563|FG002|Period II|Subject Decision|0|||
155240003|NCT00359762|560311564|FG003|Period II|Subject Decision|0|||
155240004|NCT00359762|560311565|FG004|Period II|Subject Decision|70|||
155240005|NCT00359762|560311561|FG000|Period III|Protocol Violation|0|||
155240006|NCT00359762|560311562|FG001|Period III|Protocol Violation|5|||
155240007|NCT00359762|560311563|FG002|Period III|Protocol Violation|3|||
155240008|NCT00359762|560311564|FG003|Period III|Protocol Violation|8|||
155240009|NCT00359762|560311565|FG004|Period III|Protocol Violation|0|||
155240010|NCT00359762|560311561|FG000|Period III|Adverse Event|0|||
155240011|NCT00359762|560311562|FG001|Period III|Adverse Event|3|||
155240012|NCT00359762|560311563|FG002|Period III|Adverse Event|4|||
155240013|NCT00359762|560311564|FG003|Period III|Adverse Event|10|||
155240014|NCT00359762|560311565|FG004|Period III|Adverse Event|0|||
155240015|NCT00359762|560311561|FG000|Period III|Physician Decision|0|||
155240016|NCT00359762|560311562|FG001|Period III|Physician Decision|5|||
155240017|NCT00359762|560311563|FG002|Period III|Physician Decision|9|||
155240018|NCT00359762|560311564|FG003|Period III|Physician Decision|15|||
155240019|NCT00359762|560311565|FG004|Period III|Physician Decision|0|||
155240020|NCT00359762|560311561|FG000|Period III|Lack of Efficacy|0|||
155240021|NCT00359762|560311562|FG001|Period III|Lack of Efficacy|7|||
155240022|NCT00359762|560311563|FG002|Period III|Lack of Efficacy|5|||
155240023|NCT00359762|560311564|FG003|Period III|Lack of Efficacy|9|||
155240024|NCT00359762|560311565|FG004|Period III|Lack of Efficacy|0|||
155240025|NCT00359762|560311561|FG000|Period III|Lost to follow up|0|||
155240026|NCT00359762|560311562|FG001|Period III|Lost to follow up|1|||
155240027|NCT00359762|560311563|FG002|Period III|Lost to follow up|1|||
155240028|NCT00359762|560311564|FG003|Period III|Lost to follow up|2|||
155240029|NCT00359762|560311565|FG004|Period III|Lost to follow up|0|||
155240030|NCT00359762|560311561|FG000|Period III|Entry Criteria Not Met|0|||
155240031|NCT00359762|560311562|FG001|Period III|Entry Criteria Not Met|1|||
155240032|NCT00359762|560311563|FG002|Period III|Entry Criteria Not Met|0|||
155240033|NCT00359762|560311564|FG003|Period III|Entry Criteria Not Met|1|||
155240034|NCT00359762|560311565|FG004|Period III|Entry Criteria Not Met|0|||
155240035|NCT00359762|560311561|FG000|Period III|Subject Decision|0|||
155240036|NCT00359762|560311562|FG001|Period III|Subject Decision|7|||
155240037|NCT00359762|560311563|FG002|Period III|Subject Decision|8|||
155240038|NCT00359762|560311564|FG003|Period III|Subject Decision|20|||
155240039|NCT00359762|560311565|FG004|Period III|Subject Decision|0|||
155240040|NCT02613481|560311568|FG000|Overall Study|Lost to Follow-up|7|||
155240041|NCT02613481|560311568|FG000|Overall Study|Withdrawal by Subject|2|||
155240042|NCT00803023|560311573|FG000|Overall Study|Adverse Event|5|||
155240043|NCT00803023|560311574|FG001|Overall Study|Adverse Event|4|||
155240044|NCT00803023|560311575|FG002|Overall Study|Adverse Event|8|||
155240045|NCT00803023|560311576|FG003|Overall Study|Adverse Event|6|||
155240046|NCT00803023|560311573|FG000|Overall Study|Withdrawal by Subject|0|||
155240047|NCT00803023|560311574|FG001|Overall Study|Withdrawal by Subject|2|||
155240048|NCT00803023|560311575|FG002|Overall Study|Withdrawal by Subject|0|||
155240049|NCT00803023|560311576|FG003|Overall Study|Withdrawal by Subject|0|||
155240050|NCT00803023|560311573|FG000|Overall Study|Lost to Follow-up|0|||
155240051|NCT00803023|560311574|FG001|Overall Study|Lost to Follow-up|1|||
155240052|NCT00803023|560311575|FG002|Overall Study|Lost to Follow-up|2|||
155240053|NCT00803023|560311576|FG003|Overall Study|Lost to Follow-up|1|||
155240054|NCT00803023|560311573|FG000|Overall Study|Lack of Efficacy|0|||
155240055|NCT00803023|560311574|FG001|Overall Study|Lack of Efficacy|1|||
155240056|NCT00803023|560311575|FG002|Overall Study|Lack of Efficacy|1|||
155240057|NCT00803023|560311576|FG003|Overall Study|Lack of Efficacy|1|||
155240058|NCT02647658|560311577|FG000|Overall Study|Consent refusal|15|||
155240059|NCT02647658|560311578|FG001|Overall Study|Consent refusal|24|||
155240060|NCT01542528|560311579|FG000|Overall Study|Lost to Follow-up|2|||
155240061|NCT01542528|560311580|FG001|Overall Study|Lost to Follow-up|1|||
155240062|NCT01542528|560311579|FG000|Overall Study|Physician Decision|1|||
155240063|NCT01542528|560311580|FG001|Overall Study|Physician Decision|0|||
155240064|NCT01542528|560311579|FG000|Overall Study|Withdrawal by Subject|9|||
155240065|NCT01542528|560311580|FG001|Overall Study|Withdrawal by Subject|6|||
155240066|NCT05282004|560311581|FG000|Overall Study|Adverse Event|2|||
155240067|NCT04382326|560311585|FG000|Overall Study|Adverse Event, not serious|1|||
155240068|NCT04382326|560311586|FG001|Overall Study|Adverse Event, not serious|2|||
155240069|NCT04382326|560311585|FG000|Overall Study|Other|1|||
155240070|NCT04382326|560311586|FG001|Overall Study|Other|0|||
155240071|NCT04382326|560311585|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
155240072|NCT04382326|560311586|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
155240073|NCT04382326|560311585|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
155240074|NCT04382326|560311586|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
155240075|NCT04382326|560311585|FG000|Overall Study|Protocol Violation|29|||
155240076|NCT04382326|560311586|FG001|Overall Study|Protocol Violation|23|||
155240077|NCT04382326|560311585|FG000|Overall Study|Physician Decision|0|||
155240078|NCT04382326|560311586|FG001|Overall Study|Physician Decision|1|||
155240079|NCT04382326|560311585|FG000|Overall Study|Lost to Follow-up|48|||
155240080|NCT04382326|560311586|FG001|Overall Study|Lost to Follow-up|63|||
155240081|NCT04382326|560311585|FG000|Overall Study|Adverse Event, non-fatal|1|||
155240082|NCT04382326|560311586|FG001|Overall Study|Adverse Event, non-fatal|1|||
155240083|NCT02461589|560311592|FG000|Overall Study|Withdrawal by Subject|5|||
155240084|NCT02461589|560311593|FG001|Overall Study|Withdrawal by Subject|1|||
155240085|NCT02461589|560311594|FG002|Overall Study|Withdrawal by Subject|3|||
155240086|NCT02461589|560311595|FG003|Overall Study|Withdrawal by Subject|2|||
155240087|NCT02461589|560311596|FG004|Overall Study|Withdrawal by Subject|1|||
155240088|NCT02461589|560311597|FG005|Overall Study|Withdrawal by Subject|2|||
155240089|NCT02461589|560311598|FG006|Overall Study|Withdrawal by Subject|1|||
155240090|NCT02461589|560311599|FG007|Overall Study|Withdrawal by Subject|3|||
155240091|NCT02461589|560311600|FG008|Overall Study|Withdrawal by Subject|3|||
155240092|NCT02461589|560311601|FG009|Overall Study|Withdrawal by Subject|1|||
155240093|NCT02461589|560311592|FG000|Overall Study|Lost to Follow-up|0|||
155240094|NCT02461589|560311593|FG001|Overall Study|Lost to Follow-up|0|||
155240095|NCT02461589|560311594|FG002|Overall Study|Lost to Follow-up|2|||
155240096|NCT02461589|560311595|FG003|Overall Study|Lost to Follow-up|3|||
155240097|NCT02461589|560311596|FG004|Overall Study|Lost to Follow-up|1|||
155240098|NCT02461589|560311597|FG005|Overall Study|Lost to Follow-up|1|||
155240099|NCT02461589|560311598|FG006|Overall Study|Lost to Follow-up|3|||
155240100|NCT02461589|560311599|FG007|Overall Study|Lost to Follow-up|1|||
155240101|NCT02461589|560311600|FG008|Overall Study|Lost to Follow-up|3|||
155240102|NCT02461589|560311601|FG009|Overall Study|Lost to Follow-up|1|||
155240103|NCT02461589|560311592|FG000|Overall Study|Death|0|||
155240104|NCT02461589|560311593|FG001|Overall Study|Death|0|||
155240105|NCT02461589|560311594|FG002|Overall Study|Death|0|||
155240106|NCT02461589|560311595|FG003|Overall Study|Death|0|||
155240107|NCT02461589|560311596|FG004|Overall Study|Death|0|||
155240108|NCT02461589|560311597|FG005|Overall Study|Death|0|||
155240109|NCT02461589|560311598|FG006|Overall Study|Death|0|||
155240110|NCT02461589|560311599|FG007|Overall Study|Death|1|||
155240111|NCT02461589|560311600|FG008|Overall Study|Death|0|||
155240112|NCT02461589|560311601|FG009|Overall Study|Death|0|||
155240113|NCT02461589|560311592|FG000|Overall Study|Unclassified|0|||
155240114|NCT02461589|560311593|FG001|Overall Study|Unclassified|0|||
155240115|NCT02461589|560311594|FG002|Overall Study|Unclassified|0|||
155240116|NCT02461589|560311595|FG003|Overall Study|Unclassified|0|||
155240117|NCT02461589|560311596|FG004|Overall Study|Unclassified|0|||
155240118|NCT02461589|560311597|FG005|Overall Study|Unclassified|0|||
155240119|NCT02461589|560311598|FG006|Overall Study|Unclassified|1|||
155240120|NCT02461589|560311599|FG007|Overall Study|Unclassified|0|||
155240121|NCT02461589|560311600|FG008|Overall Study|Unclassified|0|||
155240122|NCT02461589|560311601|FG009|Overall Study|Unclassified|2|||
155240123|NCT02461589|560311592|FG000|Overall Study|Missing follow-up information|1|||
155240124|NCT02461589|560311593|FG001|Overall Study|Missing follow-up information|1|||
155240125|NCT02461589|560311594|FG002|Overall Study|Missing follow-up information|0|||
155240126|NCT02461589|560311595|FG003|Overall Study|Missing follow-up information|0|||
155240127|NCT02461589|560311596|FG004|Overall Study|Missing follow-up information|0|||
155240128|NCT02461589|560311597|FG005|Overall Study|Missing follow-up information|0|||
155240129|NCT02461589|560311598|FG006|Overall Study|Missing follow-up information|1|||
155240130|NCT02461589|560311599|FG007|Overall Study|Missing follow-up information|0|||
155240131|NCT02461589|560311600|FG008|Overall Study|Missing follow-up information|0|||
155240132|NCT02461589|560311601|FG009|Overall Study|Missing follow-up information|0|||
155240133|NCT02461589|560311592|FG000|Overall Study|Withdrawal from trial before exposure|0|||
155240134|NCT02461589|560311593|FG001|Overall Study|Withdrawal from trial before exposure|0|||
155240135|NCT02461589|560311594|FG002|Overall Study|Withdrawal from trial before exposure|0|||
155240136|NCT02461589|560311595|FG003|Overall Study|Withdrawal from trial before exposure|0|||
155240137|NCT02461589|560311596|FG004|Overall Study|Withdrawal from trial before exposure|0|||
155240138|NCT02461589|560311597|FG005|Overall Study|Withdrawal from trial before exposure|0|||
155240139|NCT02461589|560311598|FG006|Overall Study|Withdrawal from trial before exposure|0|||
155240140|NCT02461589|560311599|FG007|Overall Study|Withdrawal from trial before exposure|0|||
155240141|NCT02461589|560311600|FG008|Overall Study|Withdrawal from trial before exposure|0|||
155240142|NCT02461589|560311601|FG009|Overall Study|Withdrawal from trial before exposure|1|||
155240143|NCT01038921|560311602|FG000|Overall Study|Withdrawal by Subject|1|||
155240144|NCT01038921|560311603|FG001|Overall Study|Withdrawal by Subject|0|||
155240145|NCT01038921|560311602|FG000|Overall Study|Physician Decision|1|||
155240146|NCT01038921|560311603|FG001|Overall Study|Physician Decision|0|||
155240147|NCT03295201|560311606|FG000|Overall Study|Lost to Follow-up|1|||
155240148|NCT03295201|560311607|FG001|Overall Study|Lost to Follow-up|1|||
155240149|NCT03295201|560311606|FG000|Overall Study|Hospital admission|0|||
155240150|NCT03295201|560311607|FG001|Overall Study|Hospital admission|1|||
155240151|NCT02519504|560311608|FG000|Overall Study|Protocol Violation|6|||
155240152|NCT02519504|560311609|FG001|Overall Study|Protocol Violation|5|||
155240153|NCT02519504|560311608|FG000|Overall Study|Ineligible for direct testing|12|||
155240154|NCT02519504|560311609|FG001|Overall Study|Ineligible for direct testing|12|||
155240155|NCT02519504|560311608|FG000|Overall Study|Did not participate in direct testing|95|||
155240156|NCT02519504|560311609|FG001|Overall Study|Did not participate in direct testing|86|||
155240157|NCT00572572|560311610|FG000|Overall Study|Withdrawal by Subject|3|||
155240158|NCT00572572|560311611|FG001|Overall Study|Withdrawal by Subject|6|||
155240159|NCT01831089|560311612|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
155240160|NCT01831089|560311613|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
155240161|NCT01831089|560311614|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
155240162|NCT01831089|560311615|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
155240163|NCT01831089|560311616|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
155240164|NCT01831089|560311617|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
155240165|NCT01831089|560311612|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
155240166|NCT01831089|560311613|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
155240167|NCT01831089|560311614|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
155240168|NCT01831089|560311615|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
155240169|NCT01831089|560311616|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
155240170|NCT01831089|560311617|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
155240171|NCT01831089|560311612|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240172|NCT01831089|560311613|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
155240173|NCT01831089|560311614|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240174|NCT01831089|560311615|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240175|NCT01831089|560311616|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240176|NCT01831089|560311617|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240177|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
155240178|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
155240179|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
155240180|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
155240181|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
155240182|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
155240183|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240184|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240185|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
155240186|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240187|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240188|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240189|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
155240190|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
155240191|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
155240192|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
155240193|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
155240194|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
155240195|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Global end of study|0|||
155240196|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Global end of study|0|||
155240197|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Global end of study|1|||
155240198|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Global end of study|0|||
155240199|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Global end of study|0|||
155240200|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Global end of study|0|||
155240201|NCT01831089|560311612|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
155240202|NCT01831089|560311613|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
155240203|NCT01831089|560311614|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
155240204|NCT01831089|560311615|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
155240205|NCT01831089|560311616|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
155240206|NCT01831089|560311617|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
155240207|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
155240208|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
155240209|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
155240210|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
155240211|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
155240212|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
155240213|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240214|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240215|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240216|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240217|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
155240218|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240219|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Death|0|||
155240220|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Death|0|||
155240221|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Death|0|||
155240222|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Death|0|||
155240223|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Death|1|||
155240224|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Death|0|||
155240225|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Global end of study|0|||
155240226|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Global end of study|0|||
155240227|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Global end of study|0|||
155240228|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Global end of study|0|||
155240229|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Global end of study|2|||
155240230|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Global end of study|0|||
155240231|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240232|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240233|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240234|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240235|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
155240236|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240237|NCT01831089|560311612|FG000|Cohort B: Arm B|Progressive disease|0|||
155240238|NCT01831089|560311613|FG001|Cohort B: Arm B|Progressive disease|0|||
155240239|NCT01831089|560311614|FG002|Cohort B: Arm B|Progressive disease|0|||
155240240|NCT01831089|560311615|FG003|Cohort B: Arm B|Progressive disease|0|||
155240241|NCT01831089|560311616|FG004|Cohort B: Arm B|Progressive disease|0|||
155240242|NCT01831089|560311617|FG005|Cohort B: Arm B|Progressive disease|8|||
155240243|NCT01831089|560311612|FG000|Cohort B: Arm B|Physician Decision|0|||
155240244|NCT01831089|560311613|FG001|Cohort B: Arm B|Physician Decision|0|||
155240245|NCT01831089|560311614|FG002|Cohort B: Arm B|Physician Decision|0|||
155240246|NCT01831089|560311615|FG003|Cohort B: Arm B|Physician Decision|0|||
155240247|NCT01831089|560311616|FG004|Cohort B: Arm B|Physician Decision|0|||
155240248|NCT01831089|560311617|FG005|Cohort B: Arm B|Physician Decision|2|||
155240249|NCT01831089|560311612|FG000|Cohort B: Arm B|Never treated|0|||
155240250|NCT01831089|560311613|FG001|Cohort B: Arm B|Never treated|0|||
155240251|NCT01831089|560311614|FG002|Cohort B: Arm B|Never treated|0|||
155240252|NCT01831089|560311615|FG003|Cohort B: Arm B|Never treated|0|||
155240253|NCT01831089|560311616|FG004|Cohort B: Arm B|Never treated|0|||
155240254|NCT01831089|560311617|FG005|Cohort B: Arm B|Never treated|2|||
155240255|NCT01831089|560311612|FG000|Cohort B: Arm B|Adverse Event|0|||
155240256|NCT01831089|560311613|FG001|Cohort B: Arm B|Adverse Event|0|||
155240257|NCT01831089|560311614|FG002|Cohort B: Arm B|Adverse Event|0|||
155240258|NCT01831089|560311615|FG003|Cohort B: Arm B|Adverse Event|0|||
155240259|NCT01831089|560311616|FG004|Cohort B: Arm B|Adverse Event|0|||
155240260|NCT01831089|560311617|FG005|Cohort B: Arm B|Adverse Event|1|||
155240261|NCT01831089|560311612|FG000|Cohort B: Arm B|Global end of study|0|||
155240262|NCT01831089|560311613|FG001|Cohort B: Arm B|Global end of study|0|||
155240263|NCT01831089|560311614|FG002|Cohort B: Arm B|Global end of study|0|||
155240264|NCT01831089|560311615|FG003|Cohort B: Arm B|Global end of study|0|||
155240265|NCT01831089|560311616|FG004|Cohort B: Arm B|Global end of study|0|||
155240266|NCT01831089|560311617|FG005|Cohort B: Arm B|Global end of study|1|||
155240267|NCT02548962|560311618|FG000|Overall Study|Withdrawal by Subject|1|||
155240268|NCT02548962|560311619|FG001|Overall Study|Withdrawal by Subject|0|||
155240269|NCT01485861|560311622|FG000|Phase Ib|Death|1|||
155240270|NCT01485861|560311623|FG001|Phase Ib|Death|0|||
155240271|NCT01485861|560311624|FG002|Phase Ib|Death|0|||
155240272|NCT01485861|560311625|FG003|Phase Ib|Death|0|||
155240273|NCT01485861|560311626|FG004|Phase Ib|Death|0|||
155240274|NCT01485861|560311627|FG005|Phase Ib|Death|0|||
155240275|NCT01485861|560311622|FG000|Phase Ib|Physician Decision|1|||
155240276|NCT01485861|560311623|FG001|Phase Ib|Physician Decision|1|||
155240277|NCT01485861|560311624|FG002|Phase Ib|Physician Decision|0|||
155240278|NCT01485861|560311625|FG003|Phase Ib|Physician Decision|0|||
155240279|NCT01485861|560311626|FG004|Phase Ib|Physician Decision|0|||
155240280|NCT01485861|560311627|FG005|Phase Ib|Physician Decision|0|||
155240281|NCT01485861|560311622|FG000|Phase Ib|Adverse Event|0|||
155240282|NCT01485861|560311623|FG001|Phase Ib|Adverse Event|4|||
155240283|NCT01485861|560311624|FG002|Phase Ib|Adverse Event|0|||
155240284|NCT01485861|560311625|FG003|Phase Ib|Adverse Event|0|||
155240285|NCT01485861|560311626|FG004|Phase Ib|Adverse Event|0|||
155240286|NCT01485861|560311627|FG005|Phase Ib|Adverse Event|0|||
155240287|NCT01485861|560311622|FG000|Phase Ib|Progression of disease|5|||
155240288|NCT01485861|560311623|FG001|Phase Ib|Progression of disease|0|||
155240289|NCT01485861|560311624|FG002|Phase Ib|Progression of disease|0|||
155240290|NCT01485861|560311625|FG003|Phase Ib|Progression of disease|0|||
155240291|NCT01485861|560311626|FG004|Phase Ib|Progression of disease|0|||
155240292|NCT01485861|560311627|FG005|Phase Ib|Progression of disease|0|||
155240293|NCT01485861|560311622|FG000|Phase Ib|Other|3|||
155240294|NCT01485861|560311623|FG001|Phase Ib|Other|0|||
155240295|NCT01485861|560311624|FG002|Phase Ib|Other|0|||
155240296|NCT01485861|560311625|FG003|Phase Ib|Other|0|||
155240297|NCT01485861|560311626|FG004|Phase Ib|Other|0|||
155240298|NCT01485861|560311627|FG005|Phase Ib|Other|0|||
155240299|NCT01485861|560311622|FG000|Phase Ib|Withdrawal by Subject|4|||
155240300|NCT01485861|560311623|FG001|Phase Ib|Withdrawal by Subject|1|||
155240301|NCT01485861|560311624|FG002|Phase Ib|Withdrawal by Subject|0|||
155240302|NCT01485861|560311625|FG003|Phase Ib|Withdrawal by Subject|0|||
155240303|NCT01485861|560311626|FG004|Phase Ib|Withdrawal by Subject|0|||
155240304|NCT01485861|560311627|FG005|Phase Ib|Withdrawal by Subject|0|||
155240305|NCT01485861|560311622|FG000|Phase II|Death|0|||
155240306|NCT01485861|560311623|FG001|Phase II|Death|0|||
155240307|NCT01485861|560311624|FG002|Phase II|Death|67|||
155240308|NCT01485861|560311625|FG003|Phase II|Death|71|||
155240309|NCT01485861|560311626|FG004|Phase II|Death|68|||
155240310|NCT01485861|560311627|FG005|Phase II|Death|0|||
155240311|NCT01485861|560311622|FG000|Phase II|Progression of Disease|0|||
155240312|NCT01485861|560311623|FG001|Phase II|Progression of Disease|0|||
155240313|NCT01485861|560311624|FG002|Phase II|Progression of Disease|1|||
155240314|NCT01485861|560311625|FG003|Phase II|Progression of Disease|0|||
155240315|NCT01485861|560311626|FG004|Phase II|Progression of Disease|0|||
155240316|NCT01485861|560311627|FG005|Phase II|Progression of Disease|0|||
155240317|NCT01485861|560311622|FG000|Phase II|Other|0|||
155240318|NCT01485861|560311623|FG001|Phase II|Other|0|||
155240319|NCT01485861|560311624|FG002|Phase II|Other|0|||
155240320|NCT01485861|560311625|FG003|Phase II|Other|1|||
155240321|NCT01485861|560311626|FG004|Phase II|Other|0|||
155240322|NCT01485861|560311627|FG005|Phase II|Other|0|||
155240323|NCT01485861|560311622|FG000|Phase II|Withdrawal by Subject|0|||
155240324|NCT01485861|560311623|FG001|Phase II|Withdrawal by Subject|0|||
155240325|NCT01485861|560311624|FG002|Phase II|Withdrawal by Subject|6|||
155240326|NCT01485861|560311625|FG003|Phase II|Withdrawal by Subject|3|||
155240327|NCT01485861|560311626|FG004|Phase II|Withdrawal by Subject|4|||
155240328|NCT01485861|560311627|FG005|Phase II|Withdrawal by Subject|0|||
155240329|NCT01485861|560311622|FG000|Phase II|Lost to Follow-up|0|||
155240330|NCT01485861|560311623|FG001|Phase II|Lost to Follow-up|0|||
155240331|NCT01485861|560311624|FG002|Phase II|Lost to Follow-up|2|||
155240332|NCT01485861|560311625|FG003|Phase II|Lost to Follow-up|3|||
155240333|NCT01485861|560311626|FG004|Phase II|Lost to Follow-up|5|||
155240334|NCT01485861|560311627|FG005|Phase II|Lost to Follow-up|0|||
155240335|NCT01485861|560311622|FG000|Phase II|Study Ended|0|||
155240336|NCT01485861|560311623|FG001|Phase II|Study Ended|0|||
155240337|NCT01485861|560311624|FG002|Phase II|Study Ended|7|||
155240338|NCT01485861|560311625|FG003|Phase II|Study Ended|8|||
155240339|NCT01485861|560311626|FG004|Phase II|Study Ended|6|||
155240340|NCT01485861|560311627|FG005|Phase II|Study Ended|0|||
155240341|NCT01485861|560311622|FG000|Safety Phase|Death|0|||
155240342|NCT01485861|560311623|FG001|Safety Phase|Death|0|||
155240343|NCT01485861|560311624|FG002|Safety Phase|Death|0|||
155240344|NCT01485861|560311625|FG003|Safety Phase|Death|0|||
155240345|NCT01485861|560311626|FG004|Safety Phase|Death|0|||
155240346|NCT01485861|560311627|FG005|Safety Phase|Death|2|||
155240347|NCT01485861|560311622|FG000|Safety Phase|Adverse Event|0|||
155240348|NCT01485861|560311623|FG001|Safety Phase|Adverse Event|0|||
155240349|NCT01485861|560311624|FG002|Safety Phase|Adverse Event|0|||
155240350|NCT01485861|560311625|FG003|Safety Phase|Adverse Event|0|||
155240351|NCT01485861|560311626|FG004|Safety Phase|Adverse Event|0|||
155240352|NCT01485861|560311627|FG005|Safety Phase|Adverse Event|1|||
155240353|NCT01485861|560311622|FG000|Safety Phase|Other|0|||
155240354|NCT01485861|560311623|FG001|Safety Phase|Other|0|||
155240355|NCT01485861|560311624|FG002|Safety Phase|Other|0|||
155240356|NCT01485861|560311625|FG003|Safety Phase|Other|0|||
155240357|NCT01485861|560311626|FG004|Safety Phase|Other|0|||
155240358|NCT01485861|560311627|FG005|Safety Phase|Other|5|||
155240359|NCT01485861|560311622|FG000|Safety Phase|Progression of Disease|0|||
155240360|NCT01485861|560311623|FG001|Safety Phase|Progression of Disease|0|||
155240361|NCT01485861|560311624|FG002|Safety Phase|Progression of Disease|0|||
155240362|NCT01485861|560311625|FG003|Safety Phase|Progression of Disease|0|||
155240363|NCT01485861|560311626|FG004|Safety Phase|Progression of Disease|0|||
155240364|NCT01485861|560311627|FG005|Safety Phase|Progression of Disease|9|||
155240365|NCT01485861|560311622|FG000|Safety Phase|Withdrawal by Subject|0|||
155240366|NCT01485861|560311623|FG001|Safety Phase|Withdrawal by Subject|0|||
155240367|NCT01485861|560311624|FG002|Safety Phase|Withdrawal by Subject|0|||
155240368|NCT01485861|560311625|FG003|Safety Phase|Withdrawal by Subject|0|||
155240369|NCT01485861|560311626|FG004|Safety Phase|Withdrawal by Subject|0|||
155240370|NCT01485861|560311627|FG005|Safety Phase|Withdrawal by Subject|6|||
155240371|NCT01485861|560311622|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240372|NCT01485861|560311623|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240373|NCT01485861|560311624|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240374|NCT01485861|560311625|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240375|NCT01485861|560311626|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240376|NCT01485861|560311627|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
155240377|NCT04111497|560311628|FG000|Overall Study|relapse of primary disease|1|||
155240378|NCT04111497|560311628|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
155240379|NCT03056690|560311629|FG000|Overall Study|Adverse Event|3|||
155240380|NCT03056690|560311630|FG001|Overall Study|Adverse Event|2|||
155240381|NCT03056690|560311629|FG000|Overall Study|Lack of Efficacy|1|||
155240382|NCT03056690|560311630|FG001|Overall Study|Lack of Efficacy|2|||
155240383|NCT03056690|560311629|FG000|Overall Study|Lost to Follow-up|3|||
155240384|NCT03056690|560311630|FG001|Overall Study|Lost to Follow-up|2|||
155240385|NCT03056690|560311629|FG000|Overall Study|Protocol Violation|2|||
155240386|NCT03056690|560311630|FG001|Overall Study|Protocol Violation|2|||
155240387|NCT03056690|560311629|FG000|Overall Study|Withdrawal by Subject|3|||
155240388|NCT03056690|560311630|FG001|Overall Study|Withdrawal by Subject|6|||
155240389|NCT03056690|560311629|FG000|Overall Study|Non-compliance with Study Drug|1|||
155240390|NCT03056690|560311630|FG001|Overall Study|Non-compliance with Study Drug|0|||
155240391|NCT03056690|560311629|FG000|Overall Study|Miscellaneous|1|||
155240392|NCT03056690|560311630|FG001|Overall Study|Miscellaneous|2|||
155240393|NCT02056301|560311632|FG000|Overall Study|Protocol Violation|1|||
155240394|NCT02056301|560311633|FG001|Overall Study|Protocol Violation|2|||
155240395|NCT02056301|560311632|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
155240396|NCT02056301|560311633|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
155240397|NCT02056301|560311632|FG000|Overall Study|Withdrawal by Subject|0|||
155240398|NCT02056301|560311633|FG001|Overall Study|Withdrawal by Subject|1|||
155240399|NCT02056301|560311632|FG000|Overall Study|Issues with epidural|0|||
155240400|NCT02056301|560311633|FG001|Overall Study|Issues with epidural|3|||
155240401|NCT02328326|560311634|FG000|Overall Study|Withdrawal by Subject|10|||
155240402|NCT02328326|560311635|FG001|Overall Study|Withdrawal by Subject|3|||
155240403|NCT02328326|560311634|FG000|Overall Study|Death|2|||
155240404|NCT02328326|560311635|FG001|Overall Study|Death|1|||
155240405|NCT02328326|560311634|FG000|Overall Study|Lost to Follow-up|10|||
155240406|NCT02328326|560311635|FG001|Overall Study|Lost to Follow-up|4|||
155240407|NCT01748994|560311636|FG000|Overall Study|Lost to Follow-up|8|||
155240408|NCT01748994|560311637|FG001|Overall Study|Lost to Follow-up|6|||
155240409|NCT02141516|560311638|FG000|Overall Study|Adverse Event|0|||
155240410|NCT02141516|560311639|FG001|Overall Study|Adverse Event|1|||
155240411|NCT02141516|560311640|FG002|Overall Study|Adverse Event|0|||
155240412|NCT02141516|560311638|FG000|Overall Study|Lost to Follow-up|0|||
155240413|NCT02141516|560311639|FG001|Overall Study|Lost to Follow-up|1|||
155240414|NCT02141516|560311640|FG002|Overall Study|Lost to Follow-up|0|||
155240415|NCT02141516|560311638|FG000|Overall Study|Other|0|||
155240416|NCT02141516|560311639|FG001|Overall Study|Other|3|||
155240417|NCT02141516|560311640|FG002|Overall Study|Other|0|||
155240418|NCT00861341|560311641|FG000|Overall Study|Withdrawal by Subject|2|||
155240419|NCT00983580|560311648|FG000|Overall Study|Cancel Prior to treatment|1|||
155240420|NCT00983580|560311649|FG001|Overall Study|Cancel Prior to treatment|3|||
155240421|NCT00983580|560311648|FG000|Overall Study|Protocol Violation|1|||
155240422|NCT00983580|560311649|FG001|Overall Study|Protocol Violation|1|||
155240423|NCT00983580|560311648|FG000|Overall Study|Ineligible|3|||
155240424|NCT00983580|560311649|FG001|Overall Study|Ineligible|0|||
155240425|NCT01337297|560311651|FG000|Overall Study|They entered to single anodal tDCS|4|||
155240426|NCT01337297|560311652|FG001|Overall Study|They entered to single anodal tDCS|3|||
155240427|NCT01337297|560311651|FG000|Overall Study|Lost to Follow-up|1|||
155240428|NCT01337297|560311652|FG001|Overall Study|Lost to Follow-up|3|||
155240429|NCT02778204|560311653|FG000|Overall Study|Adverse Event|1|||
155240430|NCT02778204|560311654|FG001|Overall Study|Adverse Event|0|||
155240431|NCT02778204|560311655|FG002|Overall Study|Adverse Event|0|||
155240432|NCT02778204|560311656|FG003|Overall Study|Adverse Event|0|||
155240433|NCT02778204|560311653|FG000|Overall Study|Withdrawal by Subject|0|||
155240434|NCT02778204|560311654|FG001|Overall Study|Withdrawal by Subject|0|||
155240435|NCT02778204|560311655|FG002|Overall Study|Withdrawal by Subject|1|||
155240436|NCT02778204|560311656|FG003|Overall Study|Withdrawal by Subject|2|||
155240437|NCT02778204|560311653|FG000|Overall Study|Lost to Follow-up|1|||
155240438|NCT02778204|560311654|FG001|Overall Study|Lost to Follow-up|0|||
155240439|NCT02778204|560311655|FG002|Overall Study|Lost to Follow-up|2|||
155240440|NCT02778204|560311656|FG003|Overall Study|Lost to Follow-up|1|||
155240441|NCT02778204|560311653|FG000|Overall Study|Protocol Violation|0|||
155240442|NCT02778204|560311654|FG001|Overall Study|Protocol Violation|0|||
155240443|NCT02778204|560311655|FG002|Overall Study|Protocol Violation|1|||
155240444|NCT02778204|560311656|FG003|Overall Study|Protocol Violation|0|||
155240445|NCT02778204|560311653|FG000|Overall Study|Eligibility Violation|0|||
155240446|NCT02778204|560311654|FG001|Overall Study|Eligibility Violation|0|||
155240447|NCT02778204|560311655|FG002|Overall Study|Eligibility Violation|0|||
155240448|NCT02778204|560311656|FG003|Overall Study|Eligibility Violation|1|||
155240449|NCT04122443|560311657|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
155240450|NCT04122443|560311658|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
155240451|NCT04122443|560311659|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
155240452|NCT04122443|560311657|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
155240453|NCT04122443|560311658|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
155240454|NCT04122443|560311659|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
155240455|NCT01072201|560311660|FG000|Overall Study|Lost to Follow-up|0|||
155240456|NCT01072201|560311661|FG001|Overall Study|Lost to Follow-up|1|||
155240457|NCT00360334|560311662|FG000|Overall Study|Adverse Event|7|||
155240458|NCT00360334|560311663|FG001|Overall Study|Adverse Event|4|||
155240459|NCT00360334|560311662|FG000|Overall Study|Protocol Violation|1|||
155240460|NCT00360334|560311663|FG001|Overall Study|Protocol Violation|1|||
155240461|NCT00360334|560311662|FG000|Overall Study|Physician Decision|2|||
155240462|NCT00360334|560311663|FG001|Overall Study|Physician Decision|3|||
155240463|NCT00360334|560311662|FG000|Overall Study|Lack of Efficacy|0|||
155240464|NCT00360334|560311663|FG001|Overall Study|Lack of Efficacy|1|||
155240465|NCT00360334|560311662|FG000|Overall Study|Entry criterion not met|1|||
155240466|NCT00360334|560311663|FG001|Overall Study|Entry criterion not met|2|||
155240467|NCT00360334|560311662|FG000|Overall Study|Subject decision|8|||
155240468|NCT00360334|560311663|FG001|Overall Study|Subject decision|2|||
155240469|NCT01916304|560311664|FG000|Overall Study|Screening failure|17|||
155240470|NCT01898793|560311665|FG000|Overall Study|Death|2|||
155240471|NCT01898793|560311666|FG001|Overall Study|Death|1|||
155240472|NCT01898793|560311667|FG002|Overall Study|Death|4|||
155240473|NCT01898793|560311668|FG003|Overall Study|Death|0|||
155240474|NCT01898793|560311669|FG004|Overall Study|Death|0|||
155240475|NCT01898793|560311670|FG005|Overall Study|Death|0|||
155240476|NCT01898793|560311671|FG006|Overall Study|Death|0|||
155240477|NCT01306617|560311677|FG000|Overall Study|Adverse Event|1|||
155240478|NCT01306617|560311678|FG001|Overall Study|Adverse Event|0|||
155240479|NCT01306617|560311679|FG002|Overall Study|Adverse Event|0|||
155240480|NCT01306617|560311677|FG000|Overall Study|Virologic Failure|0|||
155240481|NCT01306617|560311678|FG001|Overall Study|Virologic Failure|0|||
155240482|NCT01306617|560311679|FG002|Overall Study|Virologic Failure|5|||
155240483|NCT01306617|560311677|FG000|Overall Study|Non-compliance|0|||
155240484|NCT01306617|560311678|FG001|Overall Study|Non-compliance|1|||
155240485|NCT01306617|560311679|FG002|Overall Study|Non-compliance|0|||
155240486|NCT04028388|560311687|FG000|Overall Study|Evaluations missing|3|||
155240487|NCT04028388|560311688|FG001|Overall Study|Evaluations missing|6|||
155240488|NCT04028388|560311687|FG000|Overall Study|Not started|2|||
155240489|NCT04028388|560311688|FG001|Overall Study|Not started|0|||
155240490|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240491|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240492|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240493|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155607046|NCT01897571|561649616|FG003|Overall Study|Death|6|||
155240494|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240495|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240496|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240497|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240498|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240499|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240500|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240501|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240502|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240503|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240504|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240505|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240506|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240507|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240508|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240509|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240510|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
155240511|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
155240512|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
155240513|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
155240514|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240515|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240516|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
155240517|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240518|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240519|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240520|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240521|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240522|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240523|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240524|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240525|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240526|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240527|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240528|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240529|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240530|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240531|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
155240532|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
155240533|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240534|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240535|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240536|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240537|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240538|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240539|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240540|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240541|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240542|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240543|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
155240544|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240545|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240546|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240547|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240548|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240549|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
155240550|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240551|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240552|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240553|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240554|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240555|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155491655|NCT04311411|561225466|FG001|Overall Study|Withdrawal by Subject|3|||
155491656|NCT04311411|561225467|FG002|Overall Study|Withdrawal by Subject|0|||
155491657|NCT02940392|561225481|FG000|Overall Study|Lost to Follow-up|3|||
155240556|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240557|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240558|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240559|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
155240560|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240561|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240562|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240563|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240564|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240565|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240566|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240567|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240568|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240569|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240570|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240571|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240572|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240573|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240574|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240575|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240576|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240577|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240578|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
155240579|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240580|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240581|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240582|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240583|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240584|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240585|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240586|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
155240587|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240588|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240589|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240590|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240591|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
155240592|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240593|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240594|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240595|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240596|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
155240597|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240598|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240599|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240600|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240601|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240602|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240603|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240604|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240605|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240606|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240607|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240608|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240609|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240610|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240611|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240612|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240613|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240614|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
155240615|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240616|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240617|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240618|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240619|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240620|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240621|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240622|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240623|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240624|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240625|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240626|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240627|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240628|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240629|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240630|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
155240631|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
155240632|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
155240633|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
155240634|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240635|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240636|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240637|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240638|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240639|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240640|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240641|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240642|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240643|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240644|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240645|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240646|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240647|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240648|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240649|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
155240650|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240651|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240652|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240653|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240654|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240655|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240656|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240657|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240658|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240659|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240660|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240661|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240662|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
155240663|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240664|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240665|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240666|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240667|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240668|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240669|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240670|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240671|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240672|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240673|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240674|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240675|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240676|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240677|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240678|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
155240679|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
155240680|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
155240681|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
155240682|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240683|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240684|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155491658|NCT02940392|561225481|FG000|Overall Study|Retreatment|3|||
155491659|NCT02940392|561225481|FG000|Overall Study|Death|2|||
155240685|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240686|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240687|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240688|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240689|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240690|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240691|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240692|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240693|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240694|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240695|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240696|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240697|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
155240698|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240699|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240700|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240701|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240702|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240703|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240704|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240705|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240706|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240707|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240708|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240709|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240710|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
155240711|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
155240712|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240713|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
155240714|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240715|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240716|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240717|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240718|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240719|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240720|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240721|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240722|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240723|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240724|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240725|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240726|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
155240727|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240728|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240729|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240730|NCT01632579|560311713|FG000|Washout Period|Adverse Event|1|||
155240731|NCT01632579|560311714|FG001|Washout Period|Adverse Event|0|||
155240732|NCT01632579|560311715|FG002|Washout Period|Adverse Event|0|||
155240733|NCT01632579|560311716|FG003|Washout Period|Adverse Event|0|||
155240734|NCT01632579|560311717|FG004|Washout Period|Adverse Event|0|||
155240735|NCT01632579|560311718|FG005|Washout Period|Adverse Event|0|||
155240736|NCT01632579|560311719|FG006|Washout Period|Adverse Event|0|||
155240737|NCT01632579|560311720|FG007|Washout Period|Adverse Event|0|||
155240738|NCT01632579|560311721|FG008|Washout Period|Adverse Event|0|||
155240739|NCT01632579|560311713|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
155240740|NCT01632579|560311714|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
155240741|NCT01632579|560311715|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
155240742|NCT01632579|560311716|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
155240743|NCT01632579|560311717|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
155240744|NCT01632579|560311718|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
155240745|NCT01632579|560311719|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
155240746|NCT01632579|560311720|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
155240747|NCT01632579|560311721|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
155240748|NCT02788175|560311722|FG000|Overall Study|Protocol Violation|3|||
155240749|NCT02788175|560311722|FG000|Overall Study|Withdrawal by Subject|4|||
155240750|NCT02788175|560311722|FG000|Overall Study|Ineligible prior to study agent|6|||
155240751|NCT00162136|560311723|FG000|Overall Study|Adverse Event|1|||
155240752|NCT00162136|560311723|FG000|Overall Study|Death|1|||
155240753|NCT00162136|560311723|FG000|Overall Study|Disease Progression/Relapse|23|||
155491660|NCT00978120|561225482|FG000|Overall Study|Death|0|||
155240754|NCT00162136|560311723|FG000|Overall Study|Investigator Request|5|||
155240755|NCT00162136|560311723|FG000|Overall Study|Study Drug Toxicity|4|||
155240756|NCT00162136|560311723|FG000|Overall Study|Withdrawal by Subject|1|||
155240757|NCT00898677|560311726|FG000|Overall Study|Adverse Event|0|||
155240758|NCT00898677|560311727|FG001|Overall Study|Adverse Event|0|||
155240759|NCT00898677|560311728|FG002|Overall Study|Adverse Event|1|||
155240760|NCT00898677|560311729|FG003|Overall Study|Adverse Event|0|||
155240761|NCT00898677|560311726|FG000|Overall Study|Lost to Follow-up|0|||
155240762|NCT00898677|560311727|FG001|Overall Study|Lost to Follow-up|0|||
155240763|NCT00898677|560311728|FG002|Overall Study|Lost to Follow-up|2|||
155240764|NCT00898677|560311729|FG003|Overall Study|Lost to Follow-up|0|||
155240765|NCT00898677|560311726|FG000|Overall Study|Protocol Violation|1|||
155240766|NCT00898677|560311727|FG001|Overall Study|Protocol Violation|1|||
155240767|NCT00898677|560311728|FG002|Overall Study|Protocol Violation|2|||
155240768|NCT00898677|560311729|FG003|Overall Study|Protocol Violation|0|||
155240769|NCT00898677|560311726|FG000|Overall Study|Withdrawal by Subject|0|||
155240770|NCT00898677|560311727|FG001|Overall Study|Withdrawal by Subject|0|||
155240771|NCT00898677|560311728|FG002|Overall Study|Withdrawal by Subject|0|||
155240772|NCT00898677|560311729|FG003|Overall Study|Withdrawal by Subject|1|||
155240773|NCT00898677|560311726|FG000|Overall Study|Not Treated: Adverse Event|0|||
155240774|NCT00898677|560311727|FG001|Overall Study|Not Treated: Adverse Event|2|||
155240775|NCT00898677|560311728|FG002|Overall Study|Not Treated: Adverse Event|1|||
155240776|NCT00898677|560311729|FG003|Overall Study|Not Treated: Adverse Event|0|||
155240777|NCT00898677|560311726|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
155240778|NCT00898677|560311727|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
155240779|NCT00898677|560311728|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
155240780|NCT00898677|560311729|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
155240781|NCT00898677|560311726|FG000|Overall Study|Not Treated: Pregnancy|0|||
155240782|NCT00898677|560311727|FG001|Overall Study|Not Treated: Pregnancy|0|||
155240783|NCT00898677|560311728|FG002|Overall Study|Not Treated: Pregnancy|1|||
155240784|NCT00898677|560311729|FG003|Overall Study|Not Treated: Pregnancy|0|||
155240785|NCT00898677|560311726|FG000|Overall Study|Not Treated: Protocol Violation|2|||
155240786|NCT00898677|560311727|FG001|Overall Study|Not Treated: Protocol Violation|0|||
155240787|NCT00898677|560311728|FG002|Overall Study|Not Treated: Protocol Violation|2|||
155240788|NCT00898677|560311729|FG003|Overall Study|Not Treated: Protocol Violation|0|||
155240789|NCT00898677|560311726|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
155240790|NCT00898677|560311727|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
155240791|NCT00898677|560311728|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
155240792|NCT00898677|560311729|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
155240793|NCT00898677|560311726|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
155240794|NCT00898677|560311727|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
155240795|NCT00898677|560311728|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
155240796|NCT00898677|560311729|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
155240797|NCT00898677|560311726|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240798|NCT00898677|560311727|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240799|NCT00898677|560311728|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240800|NCT00898677|560311729|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
155240801|NCT00898677|560311726|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
155240802|NCT00898677|560311727|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240803|NCT00898677|560311728|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240804|NCT00898677|560311729|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240805|NCT00898677|560311726|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
155240806|NCT00898677|560311727|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
155240807|NCT00898677|560311728|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
155240808|NCT00898677|560311729|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
155240809|NCT00898677|560311726|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
155240810|NCT00898677|560311727|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
155240811|NCT00898677|560311728|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
155240812|NCT00898677|560311729|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
155240813|NCT00898677|560311726|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
155240814|NCT00898677|560311727|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
155240815|NCT00898677|560311728|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
155240816|NCT00898677|560311729|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
155240817|NCT00836875|560311731|FG000|Overall Study|Death|3|||
155240818|NCT00836875|560311732|FG001|Overall Study|Death|2|||
155240819|NCT00836875|560311731|FG000|Overall Study|Withdrawal by Subject|0|||
155240820|NCT00836875|560311732|FG001|Overall Study|Withdrawal by Subject|1|||
155240821|NCT01539291|560313540|FG000|Study GS-US-312-0116|Adverse Event|9|||
155240822|NCT01539291|560313541|FG001|Study GS-US-312-0116|Adverse Event|0|||
155240823|NCT01539291|560313542|FG002|Study GS-US-312-0116|Adverse Event|0|||
155240824|NCT01539291|560313543|FG003|Study GS-US-312-0116|Adverse Event|0|||
155240825|NCT01539291|560313540|FG000|Study GS-US-312-0116|Physician Decision|1|||
155491661|NCT00978120|561225483|FG001|Overall Study|Death|0|||
155240826|NCT01539291|560313541|FG001|Study GS-US-312-0116|Physician Decision|0|||
155240827|NCT01539291|560313542|FG002|Study GS-US-312-0116|Physician Decision|0|||
155240828|NCT01539291|560313543|FG003|Study GS-US-312-0116|Physician Decision|0|||
155240829|NCT01539291|560313540|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
155240830|NCT01539291|560313541|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240831|NCT01539291|560313542|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240832|NCT01539291|560313543|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240833|NCT01539291|560313540|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
155240834|NCT01539291|560313541|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240835|NCT01539291|560313542|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240836|NCT01539291|560313543|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240837|NCT01539291|560313540|FG000|Study GS-US-312-0116|Other|1|||
155240838|NCT01539291|560313541|FG001|Study GS-US-312-0116|Other|0|||
155240839|NCT01539291|560313542|FG002|Study GS-US-312-0116|Other|0|||
155240840|NCT01539291|560313543|FG003|Study GS-US-312-0116|Other|0|||
155240841|NCT01539291|560313540|FG000|Study GS-US-312-0117|Adverse Event|22|||
155240842|NCT01539291|560313541|FG001|Study GS-US-312-0117|Adverse Event|1|||
155240843|NCT01539291|560313542|FG002|Study GS-US-312-0117|Adverse Event|9|||
155240844|NCT01539291|560313543|FG003|Study GS-US-312-0117|Adverse Event|12|||
155240845|NCT01539291|560313540|FG000|Study GS-US-312-0117|Physician Decision|9|||
155240846|NCT01539291|560313541|FG001|Study GS-US-312-0117|Physician Decision|0|||
155240847|NCT01539291|560313542|FG002|Study GS-US-312-0117|Physician Decision|6|||
155240848|NCT01539291|560313543|FG003|Study GS-US-312-0117|Physician Decision|4|||
155240849|NCT01539291|560313540|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
155240850|NCT01539291|560313541|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
155240851|NCT01539291|560313542|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
155240852|NCT01539291|560313543|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
155240853|NCT01539291|560313540|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
155240854|NCT01539291|560313541|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
155240855|NCT01539291|560313542|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
155240856|NCT01539291|560313543|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
155240857|NCT01539291|560313540|FG000|Study GS-US-312-0117|Other|2|||
155240858|NCT01539291|560313541|FG001|Study GS-US-312-0117|Other|1|||
155240859|NCT01539291|560313542|FG002|Study GS-US-312-0117|Other|1|||
155240860|NCT01539291|560313543|FG003|Study GS-US-312-0117|Other|1|||
155240861|NCT01045447|560313556|FG000|Overall Study|Adverse Event|0|||
155240862|NCT01045447|560313557|FG001|Overall Study|Adverse Event|1|||
155240863|NCT01045447|560313556|FG000|Overall Study|Lack of Efficacy|3|||
155240864|NCT01045447|560313557|FG001|Overall Study|Lack of Efficacy|1|||
155240865|NCT01045447|560313556|FG000|Overall Study|Protocol Violation|6|||
155240866|NCT01045447|560313557|FG001|Overall Study|Protocol Violation|3|||
155240867|NCT01045447|560313556|FG000|Overall Study|Withdrawal Criteria|10|||
155240868|NCT01045447|560313557|FG001|Overall Study|Withdrawal Criteria|10|||
155240869|NCT01045447|560313556|FG000|Overall Study|Unclassified|17|||
155240870|NCT01045447|560313557|FG001|Overall Study|Unclassified|13|||
155240871|NCT00129987|560313558|FG000|1st Educational Session|Withdrawal by Subject|141|||
155240872|NCT00129987|560313559|FG001|1st Educational Session|Withdrawal by Subject|109|||
155240873|NCT00129987|560313558|FG000|1 Year|Withdrawal by Subject|32|||
155240874|NCT00129987|560313559|FG001|1 Year|Withdrawal by Subject|21|||
155240875|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
155240876|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
155240877|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
155240878|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
155240879|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
155240880|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
155240881|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
155240882|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
155240883|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
155240884|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
155240885|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
155240886|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
155240887|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
155240888|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
155240889|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
155240890|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
155240891|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
155240892|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
155240893|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
155240894|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
155491662|NCT00978120|561225484|FG002|Overall Study|Death|0|||
155240895|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
155240896|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
155240897|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
155240898|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
155240899|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
155240900|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
155240901|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
155240902|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
155240903|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
155240904|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
155240905|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
155240906|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
155240907|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
155240908|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
155240909|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
155240910|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
155240911|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
155240912|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
155240913|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
155240914|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
155240915|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
155240916|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
155240917|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
155240918|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
155240919|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
155240920|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
155240921|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
155240922|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
155240923|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
155240924|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
155240925|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155240926|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155240927|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
155240928|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
155240929|NCT00116805|560313560|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
155240930|NCT00116805|560313561|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
155240931|NCT00116805|560313560|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
155240932|NCT00116805|560313561|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
155240933|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
155240934|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
155240935|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
155240936|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
155240937|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
155240938|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
155240939|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
155240940|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
155240941|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
155240942|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
155240943|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
155240944|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
155240945|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
155240946|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
155240947|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
155240948|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
155240949|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
155240950|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
155240951|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
155240952|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
155240953|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
155240954|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
155240955|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
155240956|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
155240957|NCT00116805|560313560|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
155240958|NCT00116805|560313561|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
155240959|NCT00116805|560313560|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
155240960|NCT00116805|560313561|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
155240961|NCT00116805|560313560|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
155240962|NCT00116805|560313561|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
155240963|NCT00116805|560313560|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
155240964|NCT00116805|560313561|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
155240965|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
155240966|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
155240967|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
155240968|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
155240969|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Adverse Event|5|||
155240970|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Adverse Event|3|||
155240971|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Adverse Event|4|||
155240972|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Adverse Event|10|||
155240973|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
155240974|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
155240975|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
155240976|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
155240977|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240978|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240979|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240980|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
155240981|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Pregnancy|5|||
155240982|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Pregnancy|0|||
155240983|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Pregnancy|3|||
155240984|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Pregnancy|2|||
155240985|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Non-compliance|1|||
155240986|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Non-compliance|4|||
155240987|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Non-compliance|0|||
155240988|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Non-compliance|3|||
155240989|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Other|0|||
155240990|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Other|3|||
155240991|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Other|3|||
155240992|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Other|1|||
155240993|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
155240994|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
155240995|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
155240996|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
155240997|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
155240998|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
155240999|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
155241000|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
155241001|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155241002|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155241003|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
155241004|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
155241005|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
155241006|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
155241007|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
155241008|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
155241009|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
155241010|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
155241011|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
155241012|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
155241013|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
155241014|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
155241015|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
155241016|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
155241017|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241018|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241019|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
155241020|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241021|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
155241022|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
155241023|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
155241024|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
155241025|NCT01159938|560313566|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241026|NCT01159938|560313567|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155491663|NCT00978120|561225485|FG003|Overall Study|Death|1|||
155241027|NCT01159938|560313568|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
155241028|NCT01159938|560313569|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241029|NCT01159938|560313570|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241030|NCT04837482|560313571|FG000|Period 2|Withdrawal by Subject|0|||
155241031|NCT04837482|560313572|FG001|Period 2|Withdrawal by Subject|1|||
155241032|NCT00587587|560313573|FG000|Overall Study|Lost to Follow-up|6|||
155241033|NCT00587587|560313574|FG001|Overall Study|Lost to Follow-up|1|||
155241034|NCT04808609|560313582|FG000|Overall Study|Lost to Follow-up|0|||
155241035|NCT04808609|560313583|FG001|Overall Study|Lost to Follow-up|2|||
155241036|NCT04808609|560313582|FG000|Overall Study|Administrative Withdrawal|0|||
155241037|NCT04808609|560313583|FG001|Overall Study|Administrative Withdrawal|1|||
155241038|NCT00562159|560313584|FG000|Overall Study|Adverse Event|11|||
155241039|NCT00562159|560313585|FG001|Overall Study|Adverse Event|8|||
155241040|NCT00562159|560313584|FG000|Overall Study|Lost to Follow-up|5|||
155241041|NCT00562159|560313585|FG001|Overall Study|Lost to Follow-up|4|||
155241042|NCT00562159|560313584|FG000|Overall Study|Withdrawal by Subject|9|||
155241043|NCT00562159|560313585|FG001|Overall Study|Withdrawal by Subject|8|||
155241044|NCT00562159|560313584|FG000|Overall Study|Protocol Violation|12|||
155241045|NCT00562159|560313585|FG001|Overall Study|Protocol Violation|12|||
155241046|NCT00562159|560313584|FG000|Overall Study|Did not meet protocol eligibility|1|||
155241047|NCT00562159|560313585|FG001|Overall Study|Did not meet protocol eligibility|1|||
155241048|NCT01181921|560313586|FG000|Overall Study|Lost to Follow-up|1|||
155241049|NCT01762761|560313587|FG000|Overall Study|Adverse Event|15|||
155241050|NCT01762761|560313588|FG001|Overall Study|Adverse Event|17|||
155241051|NCT01762761|560313587|FG000|Overall Study|Lack of Efficacy|9|||
155241052|NCT01762761|560313588|FG001|Overall Study|Lack of Efficacy|25|||
155241053|NCT01762761|560313587|FG000|Overall Study|Protocol Violation|1|||
155241054|NCT01762761|560313588|FG001|Overall Study|Protocol Violation|1|||
155241055|NCT01762761|560313587|FG000|Overall Study|Study closed/terminated|0|||
155241056|NCT01762761|560313588|FG001|Overall Study|Study closed/terminated|2|||
155241057|NCT01762761|560313587|FG000|Overall Study|Lost to Follow-up|3|||
155241058|NCT01762761|560313588|FG001|Overall Study|Lost to Follow-up|6|||
155241059|NCT01762761|560313587|FG000|Overall Study|Physician Decision|4|||
155241060|NCT01762761|560313588|FG001|Overall Study|Physician Decision|6|||
155241061|NCT01762761|560313587|FG000|Overall Study|Withdrawal by Subject|7|||
155241062|NCT01762761|560313588|FG001|Overall Study|Withdrawal by Subject|8|||
155241063|NCT01709227|560313589|FG000|Overall Study|Physician Decision|1|||
155241064|NCT01709227|560313590|FG001|Overall Study|Physician Decision|0|||
155241065|NCT01709227|560313589|FG000|Overall Study|Pleural Peritoneal communication|0|||
155241066|NCT01709227|560313590|FG001|Overall Study|Pleural Peritoneal communication|9|||
155241067|NCT02317575|560313591|FG000|Period 1|Difficulty with venous cannulation|0|||
155241068|NCT02317575|560313592|FG001|Period 1|Difficulty with venous cannulation|1|||
155241069|NCT02317575|560313593|FG002|Period 1|Difficulty with venous cannulation|0|||
155241070|NCT02317575|560313594|FG003|Period 1|Difficulty with venous cannulation|0|||
155241071|NCT02317575|560313595|FG004|Period 1|Difficulty with venous cannulation|0|||
155241072|NCT02317575|560313591|FG000|Period 1|Withdrawal by Subject|1|||
155241073|NCT02317575|560313592|FG001|Period 1|Withdrawal by Subject|0|||
155241074|NCT02317575|560313593|FG002|Period 1|Withdrawal by Subject|0|||
155241075|NCT02317575|560313594|FG003|Period 1|Withdrawal by Subject|0|||
155241076|NCT02317575|560313595|FG004|Period 1|Withdrawal by Subject|0|||
155241077|NCT01046110|560313596|FG000|Overall Study|Adverse Event|9|||
155241078|NCT01046110|560313597|FG001|Overall Study|Adverse Event|2|||
155241079|NCT01046110|560313596|FG000|Overall Study|Lack of Efficacy|0|||
155241080|NCT01046110|560313597|FG001|Overall Study|Lack of Efficacy|1|||
155241081|NCT01046110|560313596|FG000|Overall Study|Protocol Violation|7|||
155241082|NCT01046110|560313597|FG001|Overall Study|Protocol Violation|12|||
155241083|NCT01046110|560313596|FG000|Overall Study|Withdrawal Criteria|3|||
155241084|NCT01046110|560313597|FG001|Overall Study|Withdrawal Criteria|5|||
155241085|NCT01046110|560313596|FG000|Overall Study|Unclassified|36|||
155241086|NCT01046110|560313597|FG001|Overall Study|Unclassified|35|||
155241087|NCT01202773|560313598|FG000|Overall Study|Adverse Event|4|||
155241088|NCT01202773|560313599|FG001|Overall Study|Adverse Event|5|||
155241089|NCT01202773|560313600|FG002|Overall Study|Adverse Event|5|||
155241090|NCT01202773|560313598|FG000|Overall Study|Lack of Efficacy|5|||
155241091|NCT01202773|560313599|FG001|Overall Study|Lack of Efficacy|4|||
155241092|NCT01202773|560313600|FG002|Overall Study|Lack of Efficacy|9|||
155241093|NCT01202773|560313598|FG000|Overall Study|Entry Criteria Not Met|2|||
155241094|NCT01202773|560313599|FG001|Overall Study|Entry Criteria Not Met|0|||
155241095|NCT01202773|560313600|FG002|Overall Study|Entry Criteria Not Met|1|||
155241096|NCT01202773|560313598|FG000|Overall Study|Lost to Follow-up|1|||
155241097|NCT01202773|560313599|FG001|Overall Study|Lost to Follow-up|2|||
155241098|NCT01202773|560313600|FG002|Overall Study|Lost to Follow-up|2|||
155241099|NCT01202773|560313598|FG000|Overall Study|Withdrawal by Subject|13|||
155241100|NCT01202773|560313599|FG001|Overall Study|Withdrawal by Subject|6|||
155241101|NCT01202773|560313600|FG002|Overall Study|Withdrawal by Subject|5|||
155241102|NCT01202773|560313598|FG000|Overall Study|Physician Decision|2|||
155241103|NCT01202773|560313599|FG001|Overall Study|Physician Decision|0|||
155241104|NCT01202773|560313600|FG002|Overall Study|Physician Decision|0|||
155241105|NCT01202773|560313598|FG000|Overall Study|Protocol Violation|11|||
155241106|NCT01202773|560313599|FG001|Overall Study|Protocol Violation|6|||
155241107|NCT01202773|560313600|FG002|Overall Study|Protocol Violation|10|||
155241108|NCT01202773|560313598|FG000|Overall Study|Sponsor Decision|19|||
155241109|NCT01202773|560313599|FG001|Overall Study|Sponsor Decision|20|||
155241110|NCT01202773|560313600|FG002|Overall Study|Sponsor Decision|23|||
155241111|NCT02828111|560313605|FG000|Overall Study|Withdrawal by Subject|0|||
155241112|NCT02828111|560313606|FG001|Overall Study|Withdrawal by Subject|0|||
155241113|NCT02828111|560313607|FG002|Overall Study|Withdrawal by Subject|2|||
155241114|NCT02828111|560313608|FG003|Overall Study|Withdrawal by Subject|0|||
155241115|NCT02828111|560313609|FG004|Overall Study|Withdrawal by Subject|0|||
155241116|NCT02828111|560313605|FG000|Overall Study|Lost to Follow-up|0|||
155241117|NCT02828111|560313606|FG001|Overall Study|Lost to Follow-up|0|||
155241118|NCT02828111|560313607|FG002|Overall Study|Lost to Follow-up|0|||
155241119|NCT02828111|560313608|FG003|Overall Study|Lost to Follow-up|1|||
155241120|NCT02828111|560313609|FG004|Overall Study|Lost to Follow-up|1|||
155241121|NCT03465540|560313610|FG000|Overall Study|Withdrawal by Subject|0|||
155241122|NCT03465540|560313611|FG001|Overall Study|Withdrawal by Subject|0|||
155241123|NCT03465540|560313612|FG002|Overall Study|Withdrawal by Subject|1|||
155241124|NCT03465540|560313613|FG003|Overall Study|Withdrawal by Subject|1|||
155241125|NCT03465540|560313614|FG004|Overall Study|Withdrawal by Subject|1|||
155241126|NCT03465540|560313615|FG005|Overall Study|Withdrawal by Subject|0|||
155241127|NCT03465540|560313610|FG000|Overall Study|Lost to Follow-up|0|||
155241128|NCT03465540|560313611|FG001|Overall Study|Lost to Follow-up|1|||
155241129|NCT03465540|560313612|FG002|Overall Study|Lost to Follow-up|0|||
155241130|NCT03465540|560313613|FG003|Overall Study|Lost to Follow-up|0|||
155241131|NCT03465540|560313614|FG004|Overall Study|Lost to Follow-up|1|||
155241132|NCT03465540|560313615|FG005|Overall Study|Lost to Follow-up|0|||
155241133|NCT03465540|560313610|FG000|Overall Study|Death|1|||
155241134|NCT03465540|560313611|FG001|Overall Study|Death|1|||
155241135|NCT03465540|560313612|FG002|Overall Study|Death|0|||
155241136|NCT03465540|560313613|FG003|Overall Study|Death|2|||
155241137|NCT03465540|560313614|FG004|Overall Study|Death|0|||
155241138|NCT03465540|560313615|FG005|Overall Study|Death|2|||
155241139|NCT03465540|560313610|FG000|Overall Study|Protocol specified criteria|0|||
155241140|NCT03465540|560313611|FG001|Overall Study|Protocol specified criteria|2|||
155241141|NCT03465540|560313612|FG002|Overall Study|Protocol specified criteria|2|||
155241142|NCT03465540|560313613|FG003|Overall Study|Protocol specified criteria|0|||
155241143|NCT03465540|560313614|FG004|Overall Study|Protocol specified criteria|2|||
155241144|NCT03465540|560313615|FG005|Overall Study|Protocol specified criteria|0|||
155241145|NCT04096560|560313616|FG000|Overall Study|Reason not Specified|1|||
155241146|NCT04096560|560313617|FG001|Overall Study|Reason not Specified|0|||
155241147|NCT04096560|560313618|FG002|Overall Study|Reason not Specified|0|||
155241148|NCT04096560|560313619|FG003|Overall Study|Reason not Specified|0|||
155241149|NCT04096560|560313620|FG004|Overall Study|Reason not Specified|1|||
155241150|NCT04096560|560313621|FG005|Overall Study|Reason not Specified|1|||
155241151|NCT04096560|560313622|FG006|Overall Study|Reason not Specified|1|||
155241152|NCT04096560|560313623|FG007|Overall Study|Reason not Specified|0|||
155241153|NCT04096560|560313616|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241154|NCT04096560|560313617|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241155|NCT04096560|560313618|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241156|NCT04096560|560313619|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241157|NCT04096560|560313620|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241158|NCT04096560|560313621|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
155241159|NCT04096560|560313622|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
155241160|NCT04096560|560313623|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241161|NCT04096560|560313616|FG000|Overall Study|Study Terminated by Sponsor|0|||
155241162|NCT04096560|560313617|FG001|Overall Study|Study Terminated by Sponsor|0|||
155241163|NCT04096560|560313618|FG002|Overall Study|Study Terminated by Sponsor|0|||
155241164|NCT04096560|560313619|FG003|Overall Study|Study Terminated by Sponsor|5|||
155241165|NCT04096560|560313620|FG004|Overall Study|Study Terminated by Sponsor|6|||
155241166|NCT04096560|560313621|FG005|Overall Study|Study Terminated by Sponsor|4|||
155241167|NCT04096560|560313622|FG006|Overall Study|Study Terminated by Sponsor|6|||
155241168|NCT04096560|560313623|FG007|Overall Study|Study Terminated by Sponsor|1|||
155241169|NCT04096560|560313616|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241170|NCT04096560|560313617|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241171|NCT04096560|560313618|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241172|NCT04096560|560313619|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241173|NCT04096560|560313620|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241174|NCT04096560|560313621|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241175|NCT04096560|560313622|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241176|NCT04096560|560313623|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
155241177|NCT00833924|560313626|FG000|Overall Study|Death|21|||
155241178|NCT00833924|560313626|FG000|Overall Study|Conversion|2|||
155241179|NCT00833924|560313626|FG000|Overall Study|Lost to Follow-up|2|||
155241180|NCT00833924|560313626|FG000|Overall Study|Withdrawal by Subject|13|||
155241181|NCT00833924|560313626|FG000|Overall Study|In study follow-up|71|||
155241182|NCT00096941|560313631|FG000|Overall Study|disease progression|3|||
155241183|NCT02401672|560313632|FG000|Overall Study|Withdrawal by Subject|1|||
155241184|NCT02401672|560313633|FG001|Overall Study|Withdrawal by Subject|3|||
155241185|NCT04796610|560313634|FG000|Overall Study|Withdrawal by Subject|1|||
155241186|NCT04796610|560313635|FG001|Overall Study|Withdrawal by Subject|0|||
155241187|NCT04796610|560313636|FG002|Overall Study|Withdrawal by Subject|0|||
155241188|NCT04796610|560313637|FG003|Overall Study|Withdrawal by Subject|0|||
155241189|NCT04796610|560313634|FG000|Overall Study|Lost to Follow-up|2|||
155241190|NCT04796610|560313635|FG001|Overall Study|Lost to Follow-up|0|||
155241191|NCT04796610|560313636|FG002|Overall Study|Lost to Follow-up|1|||
155241192|NCT04796610|560313637|FG003|Overall Study|Lost to Follow-up|1|||
155241193|NCT00733824|560313638|FG000|Phase I|Withdrawal by Subject|1|||
155241194|NCT00733824|560313639|FG001|Phase I|Withdrawal by Subject|0|||
155241195|NCT00733824|560313640|FG002|Phase I|Withdrawal by Subject|0|||
155241196|NCT00733824|560313641|FG003|Phase I|Withdrawal by Subject|0|||
155241197|NCT00733824|560313642|FG004|Phase I|Withdrawal by Subject|0|||
155241198|NCT01459796|560313643|FG000|Overall Study|Non compliance with protocol|2|||
155241199|NCT01459796|560313644|FG001|Overall Study|Non compliance with protocol|4|||
155241200|NCT01459796|560313643|FG000|Overall Study|Adverse Event|5|||
155241201|NCT01459796|560313644|FG001|Overall Study|Adverse Event|5|||
155241202|NCT01459796|560313643|FG000|Overall Study|Withdrawal by Subject|6|||
155241203|NCT01459796|560313644|FG001|Overall Study|Withdrawal by Subject|3|||
155241204|NCT01459796|560313643|FG000|Overall Study|Lost to Follow-up|5|||
155241205|NCT01459796|560313644|FG001|Overall Study|Lost to Follow-up|4|||
155241206|NCT01459796|560313643|FG000|Overall Study|Reason unspecified|1|||
155241207|NCT01459796|560313644|FG001|Overall Study|Reason unspecified|2|||
155241208|NCT01459796|560313643|FG000|Overall Study|Decision by the sponsor|75|||
155241209|NCT01459796|560313644|FG001|Overall Study|Decision by the sponsor|108|||
155241210|NCT00701051|560313645|FG000|Screening|Failed Screening|40|||
155241211|NCT00701051|560313646|FG001|Screening|Failed Screening|0|||
155241212|NCT00701051|560313647|FG002|Screening|Failed Screening|0|||
155241213|NCT00701051|560313645|FG000|Screening|Time conflicts|19|||
155241214|NCT00701051|560313646|FG001|Screening|Time conflicts|0|||
155241215|NCT00701051|560313647|FG002|Screening|Time conflicts|0|||
155241216|NCT00701051|560313645|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
155241217|NCT00701051|560313646|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
155241218|NCT00701051|560313647|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
155241219|NCT01243944|560313656|FG000|Overall Study|Adverse Event|15|||
155241220|NCT01243944|560313657|FG001|Overall Study|Adverse Event|13|||
155241221|NCT01243944|560313656|FG000|Overall Study|Lost to Follow-up|2|||
155241222|NCT01243944|560313657|FG001|Overall Study|Lost to Follow-up|1|||
155241223|NCT01243944|560313656|FG000|Overall Study|Physician Decision|2|||
155241224|NCT01243944|560313657|FG001|Overall Study|Physician Decision|7|||
155241225|NCT01243944|560313656|FG000|Overall Study|Disease progression|12|||
155241226|NCT01243944|560313657|FG001|Overall Study|Disease progression|11|||
155241227|NCT01243944|560313656|FG000|Overall Study|Protocol deviation|1|||
155241228|NCT01243944|560313657|FG001|Overall Study|Protocol deviation|1|||
155241229|NCT01243944|560313656|FG000|Overall Study|Participant decision|10|||
155241230|NCT01243944|560313657|FG001|Overall Study|Participant decision|15|||
155241231|NCT01243944|560313656|FG000|Overall Study|Death|2|||
155241232|NCT01243944|560313657|FG001|Overall Study|Death|3|||
155241233|NCT01243944|560313656|FG000|Overall Study|Non-compliance with study treatment|1|||
155241234|NCT01243944|560313657|FG001|Overall Study|Non-compliance with study treatment|0|||
155241235|NCT03321019|560313666|FG000|Overall Study|Withdrawal by Subject|0|||
155241236|NCT03321019|560313667|FG001|Overall Study|Withdrawal by Subject|6|||
155241237|NCT03321019|560313666|FG000|Overall Study|Lost to Follow-up|0|||
155241238|NCT03321019|560313667|FG001|Overall Study|Lost to Follow-up|22|||
155241239|NCT03880578|560313668|FG000|Overall Study|Withdrawal by Subject|0|||
155241240|NCT03880578|560313669|FG001|Overall Study|Withdrawal by Subject|3|||
155241241|NCT03880578|560313670|FG002|Overall Study|Withdrawal by Subject|1|||
155241242|NCT03880578|560313668|FG000|Overall Study|Death|0|||
155241243|NCT03880578|560313669|FG001|Overall Study|Death|1|||
155241244|NCT03880578|560313670|FG002|Overall Study|Death|0|||
155241245|NCT04934670|560313671|FG000|Overall Study|Death|4|||
155241246|NCT04934670|560313672|FG001|Overall Study|Death|0|||
155241247|NCT04934670|560313671|FG000|Overall Study|Lost to Follow-up|1|||
155241248|NCT04934670|560313672|FG001|Overall Study|Lost to Follow-up|4|||
155241249|NCT01993719|560313673|FG000|First Drug Administration|Not treated|1|||
155241250|NCT01993719|560313674|FG001|First Drug Administration|Not treated|0|||
155241251|NCT01993719|560313675|FG002|First Drug Administration|Not treated|0|||
155241252|NCT01993719|560313676|FG003|First Drug Administration|Not treated|0|||
155241253|NCT01993719|560313677|FG004|First Drug Administration|Not treated|0|||
155241254|NCT02799082|560313681|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
155241255|NCT02799082|560313682|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
155241256|NCT02799082|560313681|FG000|Overall Study|Protocol Violation|0|||
155241257|NCT02799082|560313682|FG001|Overall Study|Protocol Violation|1|||
155241258|NCT01592708|560313683|FG000|Overall Study|Protocol Violation|3|||
155241259|NCT01592708|560313684|FG001|Overall Study|Protocol Violation|0|||
155241260|NCT03433456|560313686|FG000|Overall Study|Death|1|||
155241261|NCT03433456|560313687|FG001|Overall Study|Death|1|||
155241262|NCT03433456|560313686|FG000|Overall Study|Lost to Follow-up|14|||
155241263|NCT03433456|560313687|FG001|Overall Study|Lost to Follow-up|11|||
155241264|NCT03433456|560313686|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
155241265|NCT03433456|560313687|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
155241266|NCT03105362|560313688|FG000|Overall Study|Withdrawal by Subject|1|||
155241267|NCT03105362|560313688|FG000|Overall Study|Lost to Follow-up|1|||
155241268|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
155241269|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241270|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241271|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241272|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
155241273|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241274|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241275|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241276|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241277|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
155241278|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241279|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241280|NCT01198600|560313689|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241281|NCT01198600|560313690|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
155241282|NCT01198600|560313691|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241283|NCT01198600|560313692|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241284|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241285|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241286|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
155241287|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241288|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
155241289|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
155241290|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
155241291|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
155241292|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241293|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241294|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
155241295|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241296|NCT03299192|560313694|FG000|Overall Study|Fell before classes started|1|||
155241297|NCT03299192|560313695|FG001|Overall Study|Fell before classes started|0|||
155241298|NCT03299192|560313696|FG002|Overall Study|Fell before classes started|0|||
155241299|NCT03299192|560313694|FG000|Overall Study|Other|0|||
155241300|NCT03299192|560313695|FG001|Overall Study|Other|2|||
155241301|NCT03299192|560313696|FG002|Overall Study|Other|1|||
155241302|NCT01603875|560313697|FG000|Overall Study|Preexisting rabies antibody|3|||
155241303|NCT01603875|560313698|FG001|Overall Study|Preexisting rabies antibody|4|||
155241304|NCT01603875|560313699|FG002|Overall Study|Preexisting rabies antibody|3|||
155241305|NCT01603875|560313697|FG000|Overall Study|Lost to Follow-up|4|||
155241306|NCT01603875|560313698|FG001|Overall Study|Lost to Follow-up|3|||
155241307|NCT01603875|560313699|FG002|Overall Study|Lost to Follow-up|6|||
155241308|NCT01603875|560313697|FG000|Overall Study|Protocol Violation|0|||
155241309|NCT01603875|560313698|FG001|Overall Study|Protocol Violation|1|||
155241310|NCT01603875|560313699|FG002|Overall Study|Protocol Violation|0|||
155241311|NCT01652716|560313703|FG000|Overall Study|Loss of glucose control|1|||
155241312|NCT01652716|560313704|FG001|Overall Study|Loss of glucose control|0|||
155241313|NCT01652716|560313703|FG000|Overall Study|Administrative|0|||
155241314|NCT01652716|560313704|FG001|Overall Study|Administrative|2|||
155241315|NCT01652716|560313703|FG000|Overall Study|Investigator decision|1|||
155241316|NCT01652716|560313704|FG001|Overall Study|Investigator decision|4|||
155241317|NCT01652716|560313703|FG000|Overall Study|Lost to Follow-up|12|||
155241318|NCT01652716|560313704|FG001|Overall Study|Lost to Follow-up|11|||
155241319|NCT01652716|560313703|FG000|Overall Study|Protocol Violation|2|||
155241320|NCT01652716|560313704|FG001|Overall Study|Protocol Violation|1|||
155241321|NCT01652716|560313703|FG000|Overall Study|Adverse Event|7|||
155241322|NCT01652716|560313704|FG001|Overall Study|Adverse Event|10|||
155241323|NCT01652716|560313703|FG000|Overall Study|Withdrawal by Subject|33|||
155241324|NCT01652716|560313704|FG001|Overall Study|Withdrawal by Subject|18|||
155241325|NCT05204134|560313705|FG000|Overall Study|Withdrawal by Subject|3|||
155241326|NCT05204134|560313705|FG000|Overall Study|Physician Decision|1|||
155241327|NCT01312467|560313706|FG000|Overall Study|Adverse Event|4|||
155241328|NCT01312467|560313706|FG000|Overall Study|Lost to Follow-up|1|||
155241329|NCT01312467|560313706|FG000|Overall Study|Withdrawal by Subject|2|||
155241330|NCT01312467|560313706|FG000|Overall Study|Deported to country of origin|1|||
155241331|NCT01312467|560313706|FG000|Overall Study|Another medical condition|1|||
155241332|NCT01312467|560313706|FG000|Overall Study|Ineligible|4|||
155241333|NCT00061048|560313707|FG000|Overall Study|Adverse Event|2|||
155241334|NCT00061048|560313707|FG000|Overall Study|disease progression|20|||
155241335|NCT02752048|560313708|FG000|Overall Study|Withdrawal by Subject|0|||
155241336|NCT02752048|560313709|FG001|Overall Study|Withdrawal by Subject|0|||
155241337|NCT02752048|560313710|FG002|Overall Study|Withdrawal by Subject|3|||
155241338|NCT03779841|560313714|FG000|Randomized Population|Did Not Receive Treatment|3|||
155241339|NCT03779841|560313715|FG001|Randomized Population|Did Not Receive Treatment|1|||
155241340|NCT03779841|560313716|FG002|Randomized Population|Did Not Receive Treatment|0|||
155241341|NCT03779841|560313714|FG000|Treated (Safety) Population|Adverse Event|1|||
155241342|NCT03779841|560313715|FG001|Treated (Safety) Population|Adverse Event|1|||
155241343|NCT03779841|560313716|FG002|Treated (Safety) Population|Adverse Event|0|||
155241344|NCT03779841|560313714|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
155241345|NCT03779841|560313715|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
155241346|NCT03779841|560313716|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
155241347|NCT03779841|560313714|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
155241348|NCT03779841|560313715|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
155241349|NCT03779841|560313716|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
155241350|NCT03779841|560313714|FG000|Treated (Safety) Population|Death|1|||
155241351|NCT03779841|560313715|FG001|Treated (Safety) Population|Death|0|||
155241352|NCT03779841|560313716|FG002|Treated (Safety) Population|Death|2|||
155241353|NCT00818441|560313717|FG000|Overall Study|Death|69|||
155241354|NCT00818441|560313718|FG001|Overall Study|Death|26|||
155241355|NCT00818441|560313717|FG000|Overall Study|Other|5|||
155241356|NCT00818441|560313718|FG001|Overall Study|Other|0|||
155241357|NCT00818441|560313717|FG000|Overall Study|Lost to Follow-up|2|||
155241358|NCT00818441|560313718|FG001|Overall Study|Lost to Follow-up|1|||
155241359|NCT00818441|560313717|FG000|Overall Study|Withdrawal by Subject|2|||
155241360|NCT00818441|560313718|FG001|Overall Study|Withdrawal by Subject|0|||
155241361|NCT00818441|560313717|FG000|Overall Study|Adverse Event|0|||
155241362|NCT00818441|560313718|FG001|Overall Study|Adverse Event|1|||
155241363|NCT00818441|560313717|FG000|Overall Study|Study terminated by sponsor|11|||
155241364|NCT00818441|560313718|FG001|Overall Study|Study terminated by sponsor|2|||
155241365|NCT04450264|560315592|FG000|Overall Study|Incomplete survey|13|||
155241366|NCT04450264|560315593|FG001|Overall Study|Incomplete survey|19|||
155241367|NCT00970502|560315594|FG000|Overall Study|Withdrawal by Subject|1|||
155241368|NCT02707055|560315595|FG000|Phase 1|Withdrawal by Subject|1|||
155241369|NCT02707055|560315596|FG001|Phase 1|Withdrawal by Subject|2|||
155241370|NCT02707055|560315595|FG000|Phase 1|Physician Decision|0|||
155241371|NCT02707055|560315596|FG001|Phase 1|Physician Decision|1|||
155241372|NCT02707055|560315595|FG000|Phase 2|Adverse Event|1|||
155241373|NCT02707055|560315596|FG001|Phase 2|Adverse Event|2|||
155241374|NCT01880424|560315597|FG000|Overall Study|Adverse Event|7|||
155241375|NCT01880424|560315598|FG001|Overall Study|Adverse Event|6|||
155241376|NCT01880424|560315597|FG000|Overall Study|Lack of Efficacy|1|||
155241377|NCT01880424|560315598|FG001|Overall Study|Lack of Efficacy|4|||
155241378|NCT01880424|560315597|FG000|Overall Study|Lost to Follow-up|3|||
155241379|NCT01880424|560315598|FG001|Overall Study|Lost to Follow-up|2|||
155241380|NCT01880424|560315597|FG000|Overall Study|Protocol Violation|11|||
155241381|NCT01880424|560315598|FG001|Overall Study|Protocol Violation|13|||
155241382|NCT01880424|560315597|FG000|Overall Study|Withdrawal by Subject|10|||
155241383|NCT01880424|560315598|FG001|Overall Study|Withdrawal by Subject|30|||
155241384|NCT01880424|560315597|FG000|Overall Study|Other|1|||
155241385|NCT01880424|560315598|FG001|Overall Study|Other|0|||
155241386|NCT02280044|560315601|FG000|Overall Study|Planned alternate|0|||
155241387|NCT02280044|560315602|FG001|Overall Study|Planned alternate|2|||
155241388|NCT00466193|560315605|FG000|Overall Study|Adverse Event|0|||
155241389|NCT00466193|560315606|FG001|Overall Study|Adverse Event|1|||
155241390|NCT00466193|560315605|FG000|Overall Study|Lost to Follow-up|2|||
155241391|NCT00466193|560315606|FG001|Overall Study|Lost to Follow-up|4|||
155241392|NCT00466193|560315605|FG000|Overall Study|Physician Decision|1|||
155241393|NCT00466193|560315606|FG001|Overall Study|Physician Decision|0|||
155241394|NCT00466193|560315605|FG000|Overall Study|Protocol Violation|1|||
155241395|NCT00466193|560315606|FG001|Overall Study|Protocol Violation|1|||
155241396|NCT00466193|560315605|FG000|Overall Study|Withdrawal by Subject|7|||
155241397|NCT00466193|560315606|FG001|Overall Study|Withdrawal by Subject|2|||
155241398|NCT00466193|560315605|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
155241399|NCT00466193|560315606|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
155241400|NCT00086346|560315607|FG000|Randomization|Did not receive test article|4|||
155241401|NCT00086346|560315608|FG001|Randomization|Did not receive test article|4|||
155241402|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Adverse Event|94|||
155241403|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Adverse Event|11|||
155241404|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
155241405|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
155491664|NCT00978120|561225482|FG000|Overall Study|Lost to Follow-up|0|||
155241406|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
155241407|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
155241408|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
155241409|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
155241410|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
155241411|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
155241412|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
155241413|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
155241414|NCT02807948|560315609|FG000|Overall Study|Physician Decision|1|||
155241415|NCT02807948|560315610|FG001|Overall Study|Physician Decision|0|||
155241416|NCT02473614|560315611|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
155241417|NCT02473614|560315612|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
155241418|NCT01075074|560315615|FG000|Overall Study|Surgeon changed to open incisional case|1|||
155241419|NCT01075074|560315616|FG001|Overall Study|Surgeon changed to open incisional case|2|||
155241420|NCT01075074|560315617|FG002|Overall Study|Surgeon changed to open incisional case|2|||
155241421|NCT01054729|560315618|FG000|Overall Study|Randomized but Not Treated|0|||
155241422|NCT01054729|560315619|FG001|Overall Study|Randomized but Not Treated|1|||
155241423|NCT01054729|560315620|FG002|Overall Study|Randomized but Not Treated|0|||
155241424|NCT01054729|560315621|FG003|Overall Study|Randomized but Not Treated|0|||
155241425|NCT01054729|560315618|FG000|Overall Study|Adverse Event|1|||
155241426|NCT01054729|560315619|FG001|Overall Study|Adverse Event|1|||
155241427|NCT01054729|560315620|FG002|Overall Study|Adverse Event|2|||
155241428|NCT01054729|560315621|FG003|Overall Study|Adverse Event|1|||
155241429|NCT01054729|560315618|FG000|Overall Study|Withdrawal by Subject|1|||
155241430|NCT01054729|560315619|FG001|Overall Study|Withdrawal by Subject|0|||
155241431|NCT01054729|560315620|FG002|Overall Study|Withdrawal by Subject|1|||
155241432|NCT01054729|560315621|FG003|Overall Study|Withdrawal by Subject|0|||
155241433|NCT01054729|560315618|FG000|Overall Study|Lost to Follow-up|0|||
155241434|NCT01054729|560315619|FG001|Overall Study|Lost to Follow-up|1|||
155241435|NCT01054729|560315620|FG002|Overall Study|Lost to Follow-up|0|||
155241436|NCT01054729|560315621|FG003|Overall Study|Lost to Follow-up|0|||
155241437|NCT01054729|560315618|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241438|NCT01054729|560315619|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
155241439|NCT01054729|560315620|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241440|NCT01054729|560315621|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241441|NCT01054729|560315618|FG000|Overall Study|Non-responder|1|||
155241442|NCT01054729|560315619|FG001|Overall Study|Non-responder|0|||
155241443|NCT01054729|560315620|FG002|Overall Study|Non-responder|1|||
155241444|NCT01054729|560315621|FG003|Overall Study|Non-responder|1|||
155241445|NCT01054729|560315618|FG000|Overall Study|PEG/RBV Non-responder|1|||
155241446|NCT01054729|560315619|FG001|Overall Study|PEG/RBV Non-responder|0|||
155241447|NCT01054729|560315620|FG002|Overall Study|PEG/RBV Non-responder|1|||
155241448|NCT01054729|560315621|FG003|Overall Study|PEG/RBV Non-responder|0|||
155241449|NCT01054729|560315618|FG000|Overall Study|Personal/Obligations|0|||
155241450|NCT01054729|560315619|FG001|Overall Study|Personal/Obligations|1|||
155241451|NCT01054729|560315620|FG002|Overall Study|Personal/Obligations|0|||
155241452|NCT01054729|560315621|FG003|Overall Study|Personal/Obligations|0|||
155241453|NCT01054729|560315618|FG000|Overall Study|Subject moved|0|||
155241454|NCT01054729|560315619|FG001|Overall Study|Subject moved|0|||
155241455|NCT01054729|560315620|FG002|Overall Study|Subject moved|1|||
155241456|NCT01054729|560315621|FG003|Overall Study|Subject moved|0|||
155241457|NCT01054729|560315618|FG000|Overall Study|Lack of Efficacy|0|||
155241458|NCT01054729|560315619|FG001|Overall Study|Lack of Efficacy|0|||
155241459|NCT01054729|560315620|FG002|Overall Study|Lack of Efficacy|0|||
155241460|NCT01054729|560315621|FG003|Overall Study|Lack of Efficacy|1|||
155241461|NCT02162810|560315624|FG000|Overall Study|Protocol Violation|1|||
155241462|NCT02162810|560315625|FG001|Overall Study|Protocol Violation|0|||
155241463|NCT02162810|560315624|FG000|Overall Study|patients did not report compliance|4|||
155241464|NCT02162810|560315625|FG001|Overall Study|patients did not report compliance|1|||
155241465|NCT01465334|560315626|FG000|Overall Study|Disease Progression|1|||
155241466|NCT01465334|560315627|FG001|Overall Study|Disease Progression|0|||
155241467|NCT01465334|560315626|FG000|Overall Study|Adverse Event|1|||
155241468|NCT01465334|560315627|FG001|Overall Study|Adverse Event|0|||
155241469|NCT01465334|560315626|FG000|Overall Study|Richter's transformation|0|||
155241470|NCT01465334|560315627|FG001|Overall Study|Richter's transformation|3|||
155241471|NCT01465334|560315626|FG000|Overall Study|Refractory Disease|0|||
155241472|NCT01465334|560315627|FG001|Overall Study|Refractory Disease|3|||
155241473|NCT04831736|560315633|FG000|Overall Study|Withdrawal by Subject|0|||
155241474|NCT04831736|560315634|FG001|Overall Study|Withdrawal by Subject|1|||
155241475|NCT00795600|560315635|FG000|Overall Study|Adverse Event|1|||
155241476|NCT00795600|560315636|FG001|Overall Study|Adverse Event|1|||
155241477|NCT00795600|560315635|FG000|Overall Study|Protocol Violation|1|||
155241478|NCT00795600|560315636|FG001|Overall Study|Protocol Violation|2|||
155241479|NCT00795600|560315635|FG000|Overall Study|Withdrawal by Subject|1|||
155241480|NCT00795600|560315636|FG001|Overall Study|Withdrawal by Subject|0|||
155241481|NCT00795600|560315635|FG000|Overall Study|Unclassified|1|||
155241482|NCT00795600|560315636|FG001|Overall Study|Unclassified|1|||
155241483|NCT01659021|560315637|FG000|Main Study|Adverse Event|2|||
155241484|NCT01659021|560315638|FG001|Main Study|Adverse Event|3|||
155241485|NCT01659021|560315637|FG000|Main Study|Lost to Follow-up|1|||
155241486|NCT01659021|560315638|FG001|Main Study|Lost to Follow-up|0|||
155241487|NCT01659021|560315637|FG000|Main Study|Unknown Reasons|2|||
155241488|NCT01659021|560315638|FG001|Main Study|Unknown Reasons|1|||
155241489|NCT01659021|560315637|FG000|Main Study|Physician Decision|34|||
155241490|NCT01659021|560315638|FG001|Main Study|Physician Decision|16|||
155241491|NCT01659021|560315637|FG000|Main Study|Withdrawal by Subject|19|||
155241492|NCT01659021|560315638|FG001|Main Study|Withdrawal by Subject|16|||
155241493|NCT01659021|560315637|FG000|Main Study|Study Terminated by Sponsor|16|||
155241494|NCT01659021|560315638|FG001|Main Study|Study Terminated by Sponsor|1|||
155241495|NCT01659021|560315637|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
155241496|NCT01659021|560315638|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
155241497|NCT01659021|560315637|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
155241498|NCT01659021|560315638|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
155241499|NCT03551938|560315644|FG000|3-Month Follow Up|Lost to Follow-up|39|||
155241500|NCT03551938|560315645|FG001|3-Month Follow Up|Lost to Follow-up|38|||
155241501|NCT03551938|560315644|FG000|6-Month Follow Up|Lost to Follow-up|46|||
155241502|NCT03551938|560315645|FG001|6-Month Follow Up|Lost to Follow-up|42|||
155241503|NCT03551938|560315644|FG000|9-Month Follow Up|Lost to Follow-up|44|||
155241504|NCT03551938|560315645|FG001|9-Month Follow Up|Lost to Follow-up|43|||
155241505|NCT01925183|560315646|FG000|Overall Study|Adverse Event|1|||
155241506|NCT01925183|560315647|FG001|Overall Study|Adverse Event|0|||
155241507|NCT01114646|560315648|FG000|Overall Study|Withdrawal by Subject|3|||
155241508|NCT01114646|560315649|FG001|Overall Study|Withdrawal by Subject|2|||
155241509|NCT01233817|560315654|FG000|Overall Study|Lost to Follow-up|1|||
155241510|NCT01233817|560315654|FG000|Overall Study|Withdrawal by Subject|2|||
155241511|NCT02159482|560315657|FG000|Overall Study|Withdrawal by Subject|2|||
155241512|NCT02159482|560315657|FG000|Overall Study|Physician Decision|3|||
155241513|NCT01248884|560315660|FG000|Overall Study|Withdrawal by Subject|1|||
155241514|NCT01248884|560315661|FG001|Overall Study|Withdrawal by Subject|3|||
155241515|NCT01248884|560315662|FG002|Overall Study|Withdrawal by Subject|1|||
155241516|NCT01248884|560315660|FG000|Overall Study|Adverse Event|1|||
155241517|NCT01248884|560315661|FG001|Overall Study|Adverse Event|0|||
155241518|NCT01248884|560315662|FG002|Overall Study|Adverse Event|0|||
155241519|NCT00575588|560315663|FG000|Overall Study|Adverse Event|11|||
155241520|NCT00575588|560315664|FG001|Overall Study|Adverse Event|13|||
155241521|NCT00575588|560315663|FG000|Overall Study|Withdrawal by Subject|27|||
155241522|NCT00575588|560315664|FG001|Overall Study|Withdrawal by Subject|31|||
155241523|NCT00575588|560315663|FG000|Overall Study|Lost to Follow-up|1|||
155241524|NCT00575588|560315664|FG001|Overall Study|Lost to Follow-up|3|||
155241525|NCT00575588|560315663|FG000|Overall Study|Death|4|||
155241526|NCT00575588|560315664|FG001|Overall Study|Death|2|||
155241527|NCT00575588|560315663|FG000|Overall Study|Incorrect enrollment|8|||
155241528|NCT00575588|560315664|FG001|Overall Study|Incorrect enrollment|4|||
155241529|NCT00575588|560315663|FG000|Overall Study|Study specific discontinuation criteria|203|||
155241530|NCT00575588|560315664|FG001|Overall Study|Study specific discontinuation criteria|218|||
155241531|NCT00575588|560315663|FG000|Overall Study|Severe non-compliance to protocol|5|||
155241532|NCT00575588|560315664|FG001|Overall Study|Severe non-compliance to protocol|7|||
155241533|NCT00575588|560315663|FG000|Overall Study|Safety reasons|2|||
155241534|NCT00575588|560315664|FG001|Overall Study|Safety reasons|1|||
155241535|NCT00575588|560315663|FG000|Overall Study|Elevated triglyceride|1|||
155241536|NCT00575588|560315664|FG001|Overall Study|Elevated triglyceride|0|||
155241537|NCT00575588|560315663|FG000|Overall Study|Patient moved|1|||
155241538|NCT00575588|560315664|FG001|Overall Study|Patient moved|3|||
155241539|NCT00575588|560315663|FG000|Overall Study|Impossible to determine HbA1c|0|||
155241540|NCT00575588|560315664|FG001|Overall Study|Impossible to determine HbA1c|1|||
155241541|NCT01430130|560315665|FG000|Overall Study|Lost to Follow-up|1|||
155241542|NCT01430130|560315665|FG000|Overall Study|Infection on Control Side of Incision|1|||
155241543|NCT03525834|560315666|FG000|Overall Study|Progressive disease|1|||
155241544|NCT00840970|560315670|FG000|Overall Study|Adverse Event|0|||
155241545|NCT00840970|560315671|FG001|Overall Study|Adverse Event|0|||
155241546|NCT00840970|560315672|FG002|Overall Study|Adverse Event|1|||
155241547|NCT00534352|560315673|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
155241548|NCT00534352|560315673|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
155241549|NCT00534352|560315673|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
155241550|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
155241551|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
155241552|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
155241553|NCT02059148|560315680|FG000|Treatment 1|Protocol Violation|0|||
155241554|NCT02059148|560315681|FG001|Treatment 1|Protocol Violation|0|||
155241555|NCT02059148|560315682|FG002|Treatment 1|Protocol Violation|0|||
155241556|NCT02059148|560315683|FG003|Treatment 1|Protocol Violation|0|||
155241557|NCT02059148|560315684|FG004|Treatment 1|Protocol Violation|0|||
155241558|NCT02059148|560315685|FG005|Treatment 1|Protocol Violation|1|||
155241559|NCT03321981|560315686|FG000|Overall Study|Progressive Disease (PD)|15|||
155241560|NCT03321981|560315687|FG001|Overall Study|Progressive Disease (PD)|30|||
155241561|NCT03321981|560315688|FG002|Overall Study|Progressive Disease (PD)|47|||
155241562|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
155241563|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
155241564|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
155241565|NCT03321981|560315686|FG000|Overall Study|Adverse Event|0|||
155241566|NCT03321981|560315687|FG001|Overall Study|Adverse Event|0|||
155241567|NCT03321981|560315688|FG002|Overall Study|Adverse Event|2|||
155241568|NCT03321981|560315686|FG000|Overall Study|symptomatic deterioration|0|||
155241569|NCT03321981|560315687|FG001|Overall Study|symptomatic deterioration|1|||
155241570|NCT03321981|560315688|FG002|Overall Study|symptomatic deterioration|1|||
155241571|NCT03321981|560315686|FG000|Overall Study|Lack of compliance|0|||
155241572|NCT03321981|560315687|FG001|Overall Study|Lack of compliance|1|||
155241573|NCT03321981|560315688|FG002|Overall Study|Lack of compliance|0|||
155241574|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
155241575|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
155241576|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
155241577|NCT03321981|560315686|FG000|Overall Study|Death|0|||
155241578|NCT03321981|560315687|FG001|Overall Study|Death|1|||
155241579|NCT03321981|560315688|FG002|Overall Study|Death|0|||
155241580|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of investigational product|0|||
155241581|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of investigational product|1|||
155241582|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of investigational product|0|||
155241583|NCT03321981|560315686|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
155241584|NCT03321981|560315687|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
155241585|NCT03321981|560315688|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
155241586|NCT03321981|560315686|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
155241587|NCT03321981|560315687|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
155241588|NCT03321981|560315688|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
155241589|NCT03067441|560315697|FG000|Overall Study|Withdrawal by Subject|16|||
155241590|NCT03067441|560315698|FG001|Overall Study|Withdrawal by Subject|34|||
155241591|NCT03067441|560315697|FG000|Overall Study|Lost to Follow-up|7|||
155241592|NCT03067441|560315698|FG001|Overall Study|Lost to Follow-up|5|||
155241593|NCT03067441|560315697|FG000|Overall Study|Adverse Event|7|||
155241594|NCT03067441|560315698|FG001|Overall Study|Adverse Event|14|||
155241595|NCT03067441|560315697|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
155241596|NCT03067441|560315698|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
155241597|NCT03067441|560315697|FG000|Overall Study|Physician Decision|1|||
155241598|NCT03067441|560315698|FG001|Overall Study|Physician Decision|3|||
155241599|NCT03067441|560315697|FG000|Overall Study|Other|1|||
155241600|NCT03067441|560315698|FG001|Overall Study|Other|1|||
155241601|NCT01785602|560315715|FG000|Overall Study|Withdrawal by Subject|2|||
155241602|NCT01785602|560315716|FG001|Overall Study|Withdrawal by Subject|0|||
155241603|NCT01785602|560315715|FG000|Overall Study|Lost to Follow-up|1|||
155241604|NCT01785602|560315716|FG001|Overall Study|Lost to Follow-up|1|||
155241605|NCT01785602|560315715|FG000|Overall Study|Adverse Event|3|||
155241606|NCT01785602|560315716|FG001|Overall Study|Adverse Event|5|||
155241607|NCT01785602|560315715|FG000|Overall Study|Administrative problems|7|||
155241608|NCT01785602|560315716|FG001|Overall Study|Administrative problems|3|||
155241609|NCT02041429|560315719|FG000|Overall Study|Progressive Disease|2|||
155241610|NCT02041429|560315720|FG001|Overall Study|Progressive Disease|2|||
155241611|NCT02041429|560315721|FG002|Overall Study|Progressive Disease|3|||
155241612|NCT02041429|560315722|FG003|Overall Study|Progressive Disease|2|||
155241613|NCT02041429|560315719|FG000|Overall Study|Toxicity|0|||
155241614|NCT02041429|560315720|FG001|Overall Study|Toxicity|1|||
155241615|NCT02041429|560315721|FG002|Overall Study|Toxicity|4|||
155241616|NCT02041429|560315722|FG003|Overall Study|Toxicity|2|||
155241617|NCT02041429|560315719|FG000|Overall Study|Withdrawal by Subject|0|||
155241618|NCT02041429|560315720|FG001|Overall Study|Withdrawal by Subject|1|||
155491665|NCT00978120|561225483|FG001|Overall Study|Lost to Follow-up|0|||
155241619|NCT02041429|560315721|FG002|Overall Study|Withdrawal by Subject|0|||
155241620|NCT02041429|560315722|FG003|Overall Study|Withdrawal by Subject|0|||
155241621|NCT02041429|560315719|FG000|Overall Study|On Maintenance Therapy|1|||
155241622|NCT02041429|560315720|FG001|Overall Study|On Maintenance Therapy|0|||
155241623|NCT02041429|560315721|FG002|Overall Study|On Maintenance Therapy|0|||
155241624|NCT02041429|560315722|FG003|Overall Study|On Maintenance Therapy|2|||
155241625|NCT03251924|560315723|FG000|Overall Study|Disease Progression|6|||
155241626|NCT03251924|560315724|FG001|Overall Study|Disease Progression|6|||
155241627|NCT03251924|560315725|FG002|Overall Study|Disease Progression|7|||
155241628|NCT03251924|560315726|FG003|Overall Study|Disease Progression|8|||
155241629|NCT03251924|560315727|FG004|Overall Study|Disease Progression|8|||
155241630|NCT03251924|560315728|FG005|Overall Study|Disease Progression|7|||
155241631|NCT03251924|560315729|FG006|Overall Study|Disease Progression|6|||
155241632|NCT03251924|560315730|FG007|Overall Study|Disease Progression|10|||
155241633|NCT03251924|560315731|FG008|Overall Study|Disease Progression|6|||
155241634|NCT03251924|560315723|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155241635|NCT03251924|560315724|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155241636|NCT03251924|560315725|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155241637|NCT03251924|560315726|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
155241638|NCT03251924|560315727|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
155241639|NCT03251924|560315728|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
155241640|NCT03251924|560315729|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
155241641|NCT03251924|560315730|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
155241642|NCT03251924|560315731|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
155241643|NCT03251924|560315723|FG000|Overall Study|Death|0|||
155241644|NCT03251924|560315724|FG001|Overall Study|Death|1|||
155241645|NCT03251924|560315725|FG002|Overall Study|Death|0|||
155241646|NCT03251924|560315726|FG003|Overall Study|Death|1|||
155241647|NCT03251924|560315727|FG004|Overall Study|Death|1|||
155241648|NCT03251924|560315728|FG005|Overall Study|Death|1|||
155241649|NCT03251924|560315729|FG006|Overall Study|Death|0|||
155241650|NCT03251924|560315730|FG007|Overall Study|Death|0|||
155241651|NCT03251924|560315731|FG008|Overall Study|Death|0|||
155241652|NCT03251924|560315723|FG000|Overall Study|Study Drug Toxicity|0|||
155241653|NCT03251924|560315724|FG001|Overall Study|Study Drug Toxicity|0|||
155241654|NCT03251924|560315725|FG002|Overall Study|Study Drug Toxicity|0|||
155241655|NCT03251924|560315726|FG003|Overall Study|Study Drug Toxicity|1|||
155241656|NCT03251924|560315727|FG004|Overall Study|Study Drug Toxicity|0|||
155241657|NCT03251924|560315728|FG005|Overall Study|Study Drug Toxicity|0|||
155241658|NCT03251924|560315729|FG006|Overall Study|Study Drug Toxicity|0|||
155241659|NCT03251924|560315730|FG007|Overall Study|Study Drug Toxicity|0|||
155241660|NCT03251924|560315731|FG008|Overall Study|Study Drug Toxicity|1|||
155241661|NCT03251924|560315723|FG000|Overall Study|Other Reasons|0|||
155241662|NCT03251924|560315724|FG001|Overall Study|Other Reasons|0|||
155241663|NCT03251924|560315725|FG002|Overall Study|Other Reasons|0|||
155241664|NCT03251924|560315726|FG003|Overall Study|Other Reasons|0|||
155241665|NCT03251924|560315727|FG004|Overall Study|Other Reasons|0|||
155241666|NCT03251924|560315728|FG005|Overall Study|Other Reasons|0|||
155241667|NCT03251924|560315729|FG006|Overall Study|Other Reasons|0|||
155241668|NCT03251924|560315730|FG007|Overall Study|Other Reasons|0|||
155241669|NCT03251924|560315731|FG008|Overall Study|Other Reasons|1|||
155241670|NCT03251924|560315723|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155241671|NCT03251924|560315724|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155241672|NCT03251924|560315725|FG002|Overall Study|Participant request to discontinue study treatment|0|||
155241673|NCT03251924|560315726|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155241674|NCT03251924|560315727|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155241675|NCT03251924|560315728|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155241676|NCT03251924|560315729|FG006|Overall Study|Participant request to discontinue study treatment|0|||
155241677|NCT03251924|560315730|FG007|Overall Study|Participant request to discontinue study treatment|1|||
155241678|NCT03251924|560315731|FG008|Overall Study|Participant request to discontinue study treatment|0|||
155241679|NCT00153101|560315732|FG000|Overall Study|Lost to Follow-up|14|||
155241680|NCT00153101|560315733|FG001|Overall Study|Lost to Follow-up|14|||
155241681|NCT00153101|560315734|FG002|Overall Study|Lost to Follow-up|12|||
155241682|NCT00153101|560315735|FG003|Overall Study|Lost to Follow-up|5|||
155241683|NCT00153101|560315736|FG004|Overall Study|Lost to Follow-up|5|||
155241684|NCT00153101|560315732|FG000|Overall Study|Withdrawal by Subject|3|||
155241685|NCT00153101|560315733|FG001|Overall Study|Withdrawal by Subject|4|||
155241686|NCT00153101|560315734|FG002|Overall Study|Withdrawal by Subject|3|||
155241687|NCT00153101|560315735|FG003|Overall Study|Withdrawal by Subject|3|||
155241688|NCT00153101|560315736|FG004|Overall Study|Withdrawal by Subject|5|||
155241689|NCT03169153|560315737|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155241690|NCT03169153|560315738|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155241691|NCT03169153|560315737|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
155241692|NCT03169153|560315738|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
155241693|NCT03169153|560315737|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
155241694|NCT03169153|560315738|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
155241695|NCT03169153|560315737|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
155241696|NCT03169153|560315738|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
155241697|NCT00439777|560315739|FG000|Treatment Period|Death|29|||
155241698|NCT00439777|560315740|FG001|Treatment Period|Death|21|||
155241699|NCT00439777|560315739|FG000|Treatment Period|Study terminated by sponsor|125|||
155241700|NCT00439777|560315740|FG001|Treatment Period|Study terminated by sponsor|132|||
155241701|NCT00439777|560315739|FG000|Treatment Period|Site closed by investigator|0|||
155491666|NCT00978120|561225484|FG002|Overall Study|Lost to Follow-up|3|||
155241702|NCT00439777|560315740|FG001|Treatment Period|Site closed by investigator|1|||
155241703|NCT00439777|560315739|FG000|Treatment Period|Did not take study treatment|7|||
155241704|NCT00439777|560315740|FG001|Treatment Period|Did not take study treatment|8|||
155241705|NCT00439777|560315739|FG000|Treatment Period|Adverse Event|111|||
155241706|NCT00439777|560315740|FG001|Treatment Period|Adverse Event|92|||
155241707|NCT00439777|560315739|FG000|Treatment Period|Protocol Violation|23|||
155241708|NCT00439777|560315740|FG001|Treatment Period|Protocol Violation|30|||
155241709|NCT00439777|560315739|FG000|Treatment Period|Withdrawal by Subject|66|||
155241710|NCT00439777|560315740|FG001|Treatment Period|Withdrawal by Subject|118|||
155241711|NCT00439777|560315739|FG000|Treatment Period|Lack of Efficacy|1|||
155241712|NCT00439777|560315740|FG001|Treatment Period|Lack of Efficacy|4|||
155241713|NCT00439777|560315739|FG000|Treatment Period|Lost to Follow-up|8|||
155241714|NCT00439777|560315740|FG001|Treatment Period|Lost to Follow-up|10|||
155241715|NCT00439777|560315739|FG000|Treatment Period|Protocol driven decision point|1|||
155241716|NCT00439777|560315740|FG001|Treatment Period|Protocol driven decision point|3|||
155241717|NCT00439777|560315739|FG000|Treatment Period|Physician Decision|7|||
155241718|NCT00439777|560315740|FG001|Treatment Period|Physician Decision|18|||
155241719|NCT00439777|560315739|FG000|Treatment Period|Clinical endpoint reached|26|||
155241720|NCT00439777|560315740|FG001|Treatment Period|Clinical endpoint reached|13|||
155241721|NCT00439777|560315739|FG000|Treatment Period|Technical problems|3|||
155241722|NCT00439777|560315740|FG001|Treatment Period|Technical problems|1|||
155241723|NCT00439777|560315739|FG000|Treatment Period|Participant convenience|12|||
155241724|NCT00439777|560315740|FG001|Treatment Period|Participant convenience|8|||
155241725|NCT00439777|560315739|FG000|Observational Period|Protocol Violation|0|||
155241726|NCT00439777|560315740|FG001|Observational Period|Protocol Violation|2|||
155241727|NCT00439777|560315739|FG000|Observational Period|Withdrawal by Subject|9|||
155241728|NCT00439777|560315740|FG001|Observational Period|Withdrawal by Subject|5|||
155241729|NCT00439777|560315739|FG000|Observational Period|Lost to Follow-up|1|||
155241730|NCT00439777|560315740|FG001|Observational Period|Lost to Follow-up|11|||
155241731|NCT00439777|560315739|FG000|Observational Period|Death|27|||
155241732|NCT00439777|560315740|FG001|Observational Period|Death|20|||
155241733|NCT00439777|560315739|FG000|Observational Period|Study terminated by sponsor|3|||
155241734|NCT00439777|560315740|FG001|Observational Period|Study terminated by sponsor|1|||
155241735|NCT00439777|560315739|FG000|Observational Period|Protocol driven decision point|0|||
155241736|NCT00439777|560315740|FG001|Observational Period|Protocol driven decision point|1|||
155241737|NCT00439777|560315739|FG000|Observational Period|Lack of Efficacy|1|||
155241738|NCT00439777|560315740|FG001|Observational Period|Lack of Efficacy|0|||
155241739|NCT00439777|560315739|FG000|Observational Period|Technical problems|0|||
155241740|NCT00439777|560315740|FG001|Observational Period|Technical problems|1|||
155241741|NCT00784043|560315741|FG000|Overall Study|Withdrawal by Subject|8|||
155241742|NCT00784043|560315742|FG001|Overall Study|Withdrawal by Subject|5|||
155241743|NCT00784043|560315741|FG000|Overall Study|Protocol Terminated|23|||
155241744|NCT00784043|560315742|FG001|Overall Study|Protocol Terminated|1|||
155241745|NCT03791398|560315749|FG000|Overall Study|Progression of Disease Under Study|2|||
155241746|NCT03791398|560315750|FG001|Overall Study|Progression of Disease Under Study|0|||
155241747|NCT03791398|560315751|FG002|Overall Study|Progression of Disease Under Study|0|||
155241748|NCT02207829|560315752|FG000|Overall Study|Adverse Event|10|||
155241749|NCT02207829|560315753|FG001|Overall Study|Adverse Event|9|||
155241750|NCT02207829|560315752|FG000|Overall Study|Lack of Efficacy|7|||
155241751|NCT02207829|560315753|FG001|Overall Study|Lack of Efficacy|5|||
155241752|NCT02207829|560315752|FG000|Overall Study|Lost to Follow-up|2|||
155241753|NCT02207829|560315753|FG001|Overall Study|Lost to Follow-up|2|||
155241754|NCT02207829|560315752|FG000|Overall Study|Protocol deviation|5|||
155241755|NCT02207829|560315753|FG001|Overall Study|Protocol deviation|4|||
155241756|NCT02207829|560315752|FG000|Overall Study|Withdrew consent|18|||
155241757|NCT02207829|560315753|FG001|Overall Study|Withdrew consent|14|||
155241758|NCT01418209|560315754|FG000|Overall Study|Withdrawal by Subject|1|||
155241759|NCT01418209|560315755|FG001|Overall Study|Withdrawal by Subject|0|||
155241760|NCT01418209|560315756|FG002|Overall Study|Withdrawal by Subject|1|||
155241761|NCT01418209|560315754|FG000|Overall Study|Did not provide hot flash diary data|1|||
155241762|NCT01418209|560315755|FG001|Overall Study|Did not provide hot flash diary data|3|||
155241763|NCT01418209|560315756|FG002|Overall Study|Did not provide hot flash diary data|3|||
155241764|NCT00101101|560315757|FG000|Overall Study|never received vaccine|20|||
155241765|NCT01800903|560315758|FG000|Second Test Period|unable to catheterise|1|||
155241766|NCT01800903|560315759|FG001|Second Test Period|unable to catheterise|0|||
155241767|NCT01800903|560315760|FG002|Second Test Period|unable to catheterise|0|||
155241768|NCT01800903|560315761|FG003|Second Test Period|unable to catheterise|0|||
155241769|NCT01800903|560315762|FG004|Second Test Period|unable to catheterise|0|||
155241770|NCT01800903|560315763|FG005|Second Test Period|unable to catheterise|0|||
155241771|NCT04382612|560315764|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
155241772|NCT01328002|560315766|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
155241773|NCT01328002|560315767|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
155241774|NCT01328002|560315766|FG000|Open-Label Period|Adverse Event|8|||
155241775|NCT01328002|560315767|FG001|Open-Label Period|Adverse Event|0|||
155241776|NCT01328002|560315766|FG000|Open-Label Period|Lack of Efficacy|3|||
155241777|NCT01328002|560315767|FG001|Open-Label Period|Lack of Efficacy|0|||
155241778|NCT01328002|560315766|FG000|Open-Label Period|Protocol Violation|2|||
155241779|NCT01328002|560315767|FG001|Open-Label Period|Protocol Violation|0|||
155241780|NCT01328002|560315766|FG000|Open-Label Period|Withdrawal by Subject|9|||
155241781|NCT01328002|560315767|FG001|Open-Label Period|Withdrawal by Subject|0|||
155241782|NCT01328002|560315766|FG000|Open-Label Period|Lost to Follow-up|6|||
155241783|NCT01328002|560315767|FG001|Open-Label Period|Lost to Follow-up|0|||
155241784|NCT01328002|560315766|FG000|Open-Label Period|Other Reason|2|||
155241785|NCT01328002|560315767|FG001|Open-Label Period|Other Reason|0|||
155241786|NCT01328002|560315766|FG000|Double-Blind Period|Adverse Event|1|||
155241787|NCT01328002|560315767|FG001|Double-Blind Period|Adverse Event|0|||
155241788|NCT01328002|560315766|FG000|Double-Blind Period|Lack of Efficacy|1|||
155241789|NCT01328002|560315767|FG001|Double-Blind Period|Lack of Efficacy|0|||
155241790|NCT01578551|560315768|FG000|Overall Study|Adverse Event|1|||
155241791|NCT01578551|560315769|FG001|Overall Study|Adverse Event|0|||
155241792|NCT00074282|560317769|FG000|Step 1|Adverse Event|32|||
155241793|NCT00074282|560317770|FG001|Step 1|Adverse Event|0|||
155241794|NCT00074282|560317771|FG002|Step 1|Adverse Event|0|||
155241795|NCT00074282|560317769|FG000|Step 1|Death|6|||
155241796|NCT00074282|560317770|FG001|Step 1|Death|0|||
155241797|NCT00074282|560317771|FG002|Step 1|Death|0|||
155241798|NCT00074282|560317769|FG000|Step 1|Withdrawal by Subject|7|||
155241799|NCT00074282|560317770|FG001|Step 1|Withdrawal by Subject|0|||
155241800|NCT00074282|560317771|FG002|Step 1|Withdrawal by Subject|0|||
155241801|NCT00074282|560317769|FG000|Step 1|Disease progression|2|||
155241802|NCT00074282|560317770|FG001|Step 1|Disease progression|0|||
155241803|NCT00074282|560317771|FG002|Step 1|Disease progression|0|||
155241804|NCT00074282|560317769|FG000|Step 1|Alternative therapy|2|||
155241805|NCT00074282|560317770|FG001|Step 1|Alternative therapy|0|||
155241806|NCT00074282|560317771|FG002|Step 1|Alternative therapy|0|||
155241807|NCT00074282|560317769|FG000|Step 1|Other complicating disease|2|||
155241808|NCT00074282|560317770|FG001|Step 1|Other complicating disease|0|||
155241809|NCT00074282|560317771|FG002|Step 1|Other complicating disease|0|||
155241810|NCT00074282|560317769|FG000|Step 1|Physician Decision|1|||
155241811|NCT00074282|560317770|FG001|Step 1|Physician Decision|0|||
155241812|NCT00074282|560317771|FG002|Step 1|Physician Decision|0|||
155241813|NCT00074282|560317769|FG000|Step 1|Ineligible|4|||
155241814|NCT00074282|560317770|FG001|Step 1|Ineligible|0|||
155241815|NCT00074282|560317771|FG002|Step 1|Ineligible|0|||
155241816|NCT00074282|560317769|FG000|Step 1|Never started treatment|2|||
155241817|NCT00074282|560317770|FG001|Step 1|Never started treatment|0|||
155241818|NCT00074282|560317771|FG002|Step 1|Never started treatment|0|||
155241819|NCT00074282|560317769|FG000|Step 2|Adverse Event|0|||
155241820|NCT00074282|560317770|FG001|Step 2|Adverse Event|2|||
155241821|NCT00074282|560317771|FG002|Step 2|Adverse Event|12|||
155241822|NCT00074282|560317769|FG000|Step 2|Disease progression|0|||
155241823|NCT00074282|560317770|FG001|Step 2|Disease progression|0|||
155241824|NCT00074282|560317771|FG002|Step 2|Disease progression|5|||
155241825|NCT00074282|560317769|FG000|Step 2|Death|0|||
155241826|NCT00074282|560317770|FG001|Step 2|Death|0|||
155241827|NCT00074282|560317771|FG002|Step 2|Death|3|||
155241828|NCT00074282|560317769|FG000|Step 2|Withdrawal by Subject|0|||
155241829|NCT00074282|560317770|FG001|Step 2|Withdrawal by Subject|0|||
155241830|NCT00074282|560317771|FG002|Step 2|Withdrawal by Subject|2|||
155241831|NCT00074282|560317769|FG000|Step 2|Physician Decision|0|||
155241832|NCT00074282|560317770|FG001|Step 2|Physician Decision|0|||
155241833|NCT00074282|560317771|FG002|Step 2|Physician Decision|1|||
155241834|NCT00074282|560317769|FG000|Step 2|Ineligible|0|||
155241835|NCT00074282|560317770|FG001|Step 2|Ineligible|0|||
155241836|NCT00074282|560317771|FG002|Step 2|Ineligible|1|||
155241837|NCT00464542|560317772|FG000|Pre-treatment|Withdrawal by Subject|2|||
155241838|NCT01773226|560317774|FG000|Overall Study|Withdrawal by Subject|1|||
155241839|NCT02055352|560317775|FG000|Overall Study|Adverse Event|0|||
155241840|NCT02055352|560317776|FG001|Overall Study|Adverse Event|1|||
155241841|NCT02055352|560317775|FG000|Overall Study|Non-eligible|0|||
155241842|NCT02055352|560317776|FG001|Overall Study|Non-eligible|1|||
155241843|NCT02055352|560317775|FG000|Overall Study|Poor compliance|1|||
155241844|NCT02055352|560317776|FG001|Overall Study|Poor compliance|1|||
155241845|NCT02055352|560317775|FG000|Overall Study|Death|1|||
155241846|NCT02055352|560317776|FG001|Overall Study|Death|2|||
155241847|NCT02055352|560317775|FG000|Overall Study|Patient decision|1|||
155241848|NCT02055352|560317776|FG001|Overall Study|Patient decision|1|||
155241849|NCT02055352|560317775|FG000|Overall Study|Use of prohibited treatment|0|||
155241850|NCT02055352|560317776|FG001|Overall Study|Use of prohibited treatment|3|||
155241851|NCT02055352|560317775|FG000|Overall Study|AE, study drug would be detrimental|1|||
155241852|NCT02055352|560317776|FG001|Overall Study|AE, study drug would be detrimental|3|||
155241853|NCT02055352|560317775|FG000|Overall Study|Withdrawal of informed consent|1|||
155241854|NCT02055352|560317776|FG001|Overall Study|Withdrawal of informed consent|0|||
155241855|NCT02055352|560317775|FG000|Overall Study|Reason unknown|1|||
155241856|NCT02055352|560317776|FG001|Overall Study|Reason unknown|5|||
155241857|NCT02105116|560317780|FG000|Overall Study|not eligible for step 2 of trial|5|||
155241858|NCT02105116|560317780|FG000|Overall Study|Death|1|||
155241859|NCT01075321|560317788|FG000|Overall Study|Withdrawal by Subject|0|||
155241860|NCT01075321|560317789|FG001|Overall Study|Withdrawal by Subject|0|||
155241861|NCT01075321|560317790|FG002|Overall Study|Withdrawal by Subject|1|||
155241862|NCT01075321|560317791|FG003|Overall Study|Withdrawal by Subject|1|||
155241863|NCT01075321|560317788|FG000|Overall Study|Protocol Violation|0|||
155241864|NCT01075321|560317789|FG001|Overall Study|Protocol Violation|0|||
155241865|NCT01075321|560317790|FG002|Overall Study|Protocol Violation|1|||
155241866|NCT01075321|560317791|FG003|Overall Study|Protocol Violation|0|||
155241867|NCT01075321|560317788|FG000|Overall Study|Treatment Incomplete due to progression|1|||
155241868|NCT01075321|560317789|FG001|Overall Study|Treatment Incomplete due to progression|0|||
155241869|NCT01075321|560317790|FG002|Overall Study|Treatment Incomplete due to progression|0|||
155241870|NCT01075321|560317791|FG003|Overall Study|Treatment Incomplete due to progression|0|||
155241871|NCT01075321|560317788|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
155241872|NCT01075321|560317789|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
155241873|NCT01075321|560317790|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
155241874|NCT01075321|560317791|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
155241875|NCT02646423|560317792|FG000|Overall Study|Adverse Event|5|||
155241876|NCT02646423|560317793|FG001|Overall Study|Adverse Event|7|||
155241877|NCT02646423|560317792|FG000|Overall Study|Ineligible|2|||
155241878|NCT02646423|560317793|FG001|Overall Study|Ineligible|1|||
155241879|NCT00003457|560317794|FG000|Overall Study|Not evaluable|9|||
155241880|NCT02246998|560317798|FG000|Overall Study|Adverse Event|0|||
155241881|NCT02246998|560317799|FG001|Overall Study|Adverse Event|1|||
155241882|NCT02246998|560317800|FG002|Overall Study|Adverse Event|1|||
155241883|NCT02246998|560317801|FG003|Overall Study|Adverse Event|0|||
155241884|NCT02246998|560317798|FG000|Overall Study|Lost to Follow-up|1|||
155241885|NCT02246998|560317799|FG001|Overall Study|Lost to Follow-up|0|||
155241886|NCT02246998|560317800|FG002|Overall Study|Lost to Follow-up|0|||
155241887|NCT02246998|560317801|FG003|Overall Study|Lost to Follow-up|1|||
155241888|NCT02246998|560317798|FG000|Overall Study|Randomized but Never Dosed|1|||
155241889|NCT02246998|560317799|FG001|Overall Study|Randomized but Never Dosed|2|||
155241890|NCT02246998|560317800|FG002|Overall Study|Randomized but Never Dosed|2|||
155241891|NCT02246998|560317801|FG003|Overall Study|Randomized but Never Dosed|1|||
155241892|NCT04495374|560317802|FG000|Overall Study|Protocol Violation|2|||
155241893|NCT04495374|560317803|FG001|Overall Study|Protocol Violation|1|||
155241894|NCT03727750|560317804|FG000|Overall Study|Death|45|||
155241895|NCT03727750|560317804|FG000|Overall Study|Withdrawal by Subject|2|||
155241896|NCT03727750|560317804|FG000|Overall Study|Lost to Follow-up|1|||
155241897|NCT03727750|560317804|FG000|Overall Study|Other|1|||
155241898|NCT00844194|560317807|FG000|Overall Study|Adverse Event|17|||
155241899|NCT00844194|560317808|FG001|Overall Study|Adverse Event|5|||
155241900|NCT00844194|560317807|FG000|Overall Study|Protocol Violation|1|||
155241901|NCT00844194|560317808|FG001|Overall Study|Protocol Violation|1|||
155241902|NCT00844194|560317807|FG000|Overall Study|Lost to Follow-up|1|||
155241903|NCT00844194|560317808|FG001|Overall Study|Lost to Follow-up|1|||
155241904|NCT00844194|560317807|FG000|Overall Study|Withdrawal by Subject|2|||
155241905|NCT00844194|560317808|FG001|Overall Study|Withdrawal by Subject|1|||
155241906|NCT00844194|560317807|FG000|Overall Study|Lack of Efficacy|3|||
155241907|NCT00844194|560317808|FG001|Overall Study|Lack of Efficacy|0|||
155241908|NCT00844194|560317807|FG000|Overall Study|Other reason (not specified)|1|||
155241909|NCT00844194|560317808|FG001|Overall Study|Other reason (not specified)|0|||
155241910|NCT01992536|560317814|FG000|Overall Study|Administrative Reason|0|||
155241911|NCT01992536|560317815|FG001|Overall Study|Administrative Reason|0|||
155241912|NCT01992536|560317816|FG002|Overall Study|Administrative Reason|0|||
155241913|NCT01992536|560317817|FG003|Overall Study|Administrative Reason|0|||
155241914|NCT01992536|560317818|FG004|Overall Study|Administrative Reason|0|||
155241915|NCT01992536|560317819|FG005|Overall Study|Administrative Reason|0|||
155241916|NCT01992536|560317820|FG006|Overall Study|Administrative Reason|7|||
155241917|NCT01992536|560317821|FG007|Overall Study|Administrative Reason|0|||
155241918|NCT01992536|560317822|FG008|Overall Study|Administrative Reason|0|||
155241919|NCT01992536|560317823|FG009|Overall Study|Administrative Reason|0|||
155241920|NCT01992536|560317814|FG000|Overall Study|Lost to Follow-up|4|||
155241921|NCT01992536|560317815|FG001|Overall Study|Lost to Follow-up|2|||
155241922|NCT01992536|560317816|FG002|Overall Study|Lost to Follow-up|1|||
155241923|NCT01992536|560317817|FG003|Overall Study|Lost to Follow-up|0|||
155241924|NCT01992536|560317818|FG004|Overall Study|Lost to Follow-up|0|||
155241925|NCT01992536|560317819|FG005|Overall Study|Lost to Follow-up|1|||
155241926|NCT01992536|560317820|FG006|Overall Study|Lost to Follow-up|0|||
155241927|NCT01992536|560317821|FG007|Overall Study|Lost to Follow-up|0|||
155241928|NCT01992536|560317822|FG008|Overall Study|Lost to Follow-up|1|||
155241929|NCT01992536|560317823|FG009|Overall Study|Lost to Follow-up|1|||
155241930|NCT01992536|560317814|FG000|Overall Study|Withdrawal by Subject|0|||
155241931|NCT01992536|560317815|FG001|Overall Study|Withdrawal by Subject|1|||
155241932|NCT01992536|560317816|FG002|Overall Study|Withdrawal by Subject|0|||
155241933|NCT01992536|560317817|FG003|Overall Study|Withdrawal by Subject|2|||
155241934|NCT01992536|560317818|FG004|Overall Study|Withdrawal by Subject|0|||
155241935|NCT01992536|560317819|FG005|Overall Study|Withdrawal by Subject|0|||
155241936|NCT01992536|560317820|FG006|Overall Study|Withdrawal by Subject|0|||
155241937|NCT01992536|560317821|FG007|Overall Study|Withdrawal by Subject|0|||
155241938|NCT01992536|560317822|FG008|Overall Study|Withdrawal by Subject|0|||
155241939|NCT01992536|560317823|FG009|Overall Study|Withdrawal by Subject|0|||
155241940|NCT03669081|560317829|FG000|Overall Study|Data could not be validated|1|||
155241941|NCT03669081|560317830|FG001|Overall Study|Data could not be validated|1|||
155241942|NCT02352493|560317831|FG000|Overall Study|Pregnancy|0|||
155241943|NCT02352493|560317832|FG001|Overall Study|Pregnancy|0|||
155241944|NCT02352493|560317833|FG002|Overall Study|Pregnancy|0|||
155241945|NCT02352493|560317834|FG003|Overall Study|Pregnancy|0|||
155241946|NCT02352493|560317835|FG004|Overall Study|Pregnancy|0|||
155241947|NCT02352493|560317836|FG005|Overall Study|Pregnancy|0|||
155241948|NCT02352493|560317837|FG006|Overall Study|Pregnancy|1|||
155241949|NCT02352493|560317838|FG007|Overall Study|Pregnancy|0|||
155241950|NCT02352493|560317839|FG008|Overall Study|Pregnancy|1|||
155241951|NCT02352493|560317840|FG009|Overall Study|Pregnancy|0|||
155241952|NCT02352493|560317841|FG010|Overall Study|Pregnancy|0|||
155241953|NCT02352493|560317842|FG011|Overall Study|Pregnancy|0|||
155241954|NCT02352493|560317843|FG012|Overall Study|Pregnancy|0|||
155241955|NCT02352493|560317844|FG013|Overall Study|Pregnancy|0|||
155241956|NCT02352493|560317845|FG014|Overall Study|Pregnancy|0|||
155241957|NCT02352493|560317846|FG015|Overall Study|Pregnancy|0|||
155241958|NCT02352493|560317847|FG016|Overall Study|Pregnancy|0|||
155241959|NCT02352493|560317848|FG017|Overall Study|Pregnancy|0|||
155241960|NCT02352493|560317831|FG000|Overall Study|Withdrawal by Subject|0|||
155241961|NCT02352493|560317832|FG001|Overall Study|Withdrawal by Subject|0|||
155241962|NCT02352493|560317833|FG002|Overall Study|Withdrawal by Subject|0|||
155241963|NCT02352493|560317834|FG003|Overall Study|Withdrawal by Subject|0|||
155241964|NCT02352493|560317835|FG004|Overall Study|Withdrawal by Subject|0|||
155241965|NCT02352493|560317836|FG005|Overall Study|Withdrawal by Subject|0|||
155241966|NCT02352493|560317837|FG006|Overall Study|Withdrawal by Subject|0|||
155241967|NCT02352493|560317838|FG007|Overall Study|Withdrawal by Subject|0|||
155241968|NCT02352493|560317839|FG008|Overall Study|Withdrawal by Subject|1|||
155241969|NCT02352493|560317840|FG009|Overall Study|Withdrawal by Subject|0|||
155241970|NCT02352493|560317841|FG010|Overall Study|Withdrawal by Subject|0|||
155241971|NCT02352493|560317842|FG011|Overall Study|Withdrawal by Subject|0|||
155241972|NCT02352493|560317843|FG012|Overall Study|Withdrawal by Subject|0|||
155241973|NCT02352493|560317844|FG013|Overall Study|Withdrawal by Subject|0|||
155241974|NCT02352493|560317845|FG014|Overall Study|Withdrawal by Subject|1|||
155241975|NCT02352493|560317846|FG015|Overall Study|Withdrawal by Subject|0|||
155241976|NCT02352493|560317847|FG016|Overall Study|Withdrawal by Subject|0|||
155241977|NCT02352493|560317848|FG017|Overall Study|Withdrawal by Subject|0|||
155241978|NCT02352493|560317831|FG000|Overall Study|Lost to Follow-up|0|||
155241979|NCT02352493|560317832|FG001|Overall Study|Lost to Follow-up|0|||
155241980|NCT02352493|560317833|FG002|Overall Study|Lost to Follow-up|0|||
155241981|NCT02352493|560317834|FG003|Overall Study|Lost to Follow-up|0|||
155241982|NCT02352493|560317835|FG004|Overall Study|Lost to Follow-up|0|||
155241983|NCT02352493|560317836|FG005|Overall Study|Lost to Follow-up|0|||
155241984|NCT02352493|560317837|FG006|Overall Study|Lost to Follow-up|0|||
155241985|NCT02352493|560317838|FG007|Overall Study|Lost to Follow-up|0|||
155241986|NCT02352493|560317839|FG008|Overall Study|Lost to Follow-up|0|||
155241987|NCT02352493|560317840|FG009|Overall Study|Lost to Follow-up|1|||
155241988|NCT02352493|560317841|FG010|Overall Study|Lost to Follow-up|0|||
155241989|NCT02352493|560317842|FG011|Overall Study|Lost to Follow-up|0|||
155241990|NCT02352493|560317843|FG012|Overall Study|Lost to Follow-up|1|||
155241991|NCT02352493|560317844|FG013|Overall Study|Lost to Follow-up|2|||
155241992|NCT02352493|560317845|FG014|Overall Study|Lost to Follow-up|0|||
155241993|NCT02352493|560317846|FG015|Overall Study|Lost to Follow-up|0|||
155241994|NCT02352493|560317847|FG016|Overall Study|Lost to Follow-up|0|||
155241995|NCT02352493|560317848|FG017|Overall Study|Lost to Follow-up|0|||
155241996|NCT00389324|560317849|FG000|Run-In Phase|Adverse Event|1|||
155241997|NCT00389324|560317849|FG000|Run-In Phase|Lost to Follow-up|1|||
155241998|NCT00389324|560317849|FG000|Run-In Phase|Withdrawal by Subject|1|||
155241999|NCT00389324|560317849|FG000|Subcutaneous Phase|Adverse Event|2|||
155242000|NCT00389324|560317849|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
155242001|NCT00389324|560317849|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
155242002|NCT00389324|560317849|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
155242003|NCT03936244|560317854|FG000|Overall Study|Lost to Follow-up|5|||
155242004|NCT03936244|560317855|FG001|Overall Study|Lost to Follow-up|1|||
155242005|NCT03936244|560317854|FG000|Overall Study|Physician Decision|7|||
155242006|NCT03936244|560317855|FG001|Overall Study|Physician Decision|3|||
155242007|NCT00504829|560317856|FG000|Overall Study|Protocol Violation|6|||
155242008|NCT00504829|560317857|FG001|Overall Study|Protocol Violation|4|||
155242009|NCT00504829|560317858|FG002|Overall Study|Protocol Violation|10|||
155242010|NCT01854827|560317859|FG000|Overall Study|Death|1|||
155242011|NCT02667912|560317860|FG000|Overall Study|Death|3|||
155242012|NCT02667912|560317861|FG001|Overall Study|Death|1|||
155242013|NCT02667912|560317860|FG000|Overall Study|Withdrawal by Subject|1|||
155242014|NCT02667912|560317861|FG001|Overall Study|Withdrawal by Subject|2|||
155242015|NCT02667912|560317860|FG000|Overall Study|Withdrawal by Subject|1|||
155242016|NCT02667912|560317861|FG001|Overall Study|Withdrawal by Subject|0|||
155242017|NCT04443218|560317862|FG000|Overall Study|Exited study for other reasons|9|||
155242018|NCT04443218|560317862|FG000|Overall Study|Withdrawal by Subject|1|||
155242019|NCT04443218|560317862|FG000|Overall Study|Lost to Follow-up|4|||
155242020|NCT04443218|560317862|FG000|Overall Study|Death|19|||
155242021|NCT01131312|560317863|FG000|Overall Study|Lost to Follow-up|425|||
155242022|NCT01131312|560317864|FG001|Overall Study|Lost to Follow-up|229|||
155242023|NCT01131312|560317865|FG002|Overall Study|Lost to Follow-up|351|||
155242024|NCT01751568|560317878|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
155242025|NCT01751568|560317879|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
155242026|NCT01751568|560317880|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
155242027|NCT02660944|560317881|FG000|Overall Study|Adverse Event|3|||
155242028|NCT02660944|560317882|FG001|Overall Study|Adverse Event|4|||
155242029|NCT02660944|560317881|FG000|Overall Study|Physician Decision|3|||
155242030|NCT02660944|560317882|FG001|Overall Study|Physician Decision|1|||
155242031|NCT02660944|560317881|FG000|Overall Study|Withdrawal by Subject|5|||
155242032|NCT02660944|560317882|FG001|Overall Study|Withdrawal by Subject|3|||
155242033|NCT02660944|560317881|FG000|Overall Study|Lost to Follow-up|4|||
155242034|NCT02660944|560317882|FG001|Overall Study|Lost to Follow-up|1|||
155242035|NCT02660944|560317881|FG000|Overall Study|Subject schedule|0|||
155242036|NCT02660944|560317882|FG001|Overall Study|Subject schedule|1|||
155242037|NCT02660944|560317881|FG000|Overall Study|Exclusion criteria met|2|||
155242038|NCT02660944|560317882|FG001|Overall Study|Exclusion criteria met|0|||
155242039|NCT02843568|560317883|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
155242040|NCT02843568|560317884|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
155242041|NCT02843568|560317883|FG000|Overall Study|Death|3|||
155242042|NCT02843568|560317884|FG001|Overall Study|Death|3|||
155242043|NCT02843568|560317883|FG000|Overall Study|Withdrawal by Subject|1|||
155242044|NCT02843568|560317884|FG001|Overall Study|Withdrawal by Subject|1|||
155242045|NCT02843568|560317883|FG000|Overall Study|Lost to Follow-up|2|||
155242046|NCT02843568|560317884|FG001|Overall Study|Lost to Follow-up|0|||
155242047|NCT03586999|560317885|FG000|Overall Study|Lack of Efficacy|2|||
155242048|NCT03447769|560317886|FG000|Overall Study|Progressive disease|138|||
155242049|NCT03447769|560317887|FG001|Overall Study|Progressive disease|148|||
155242050|NCT03447769|560317886|FG000|Overall Study|Study terminated by Sponsor|60|||
155242051|NCT03447769|560317887|FG001|Overall Study|Study terminated by Sponsor|44|||
155242052|NCT03447769|560317886|FG000|Overall Study|Adverse Event|34|||
155242053|NCT03447769|560317887|FG001|Overall Study|Adverse Event|31|||
155242054|NCT03447769|560317886|FG000|Overall Study|Patient decision|27|||
155242055|NCT03447769|560317887|FG001|Overall Study|Patient decision|27|||
155242056|NCT03447769|560317886|FG000|Overall Study|Protocol deviation|4|||
155242057|NCT03447769|560317887|FG001|Overall Study|Protocol deviation|6|||
155242058|NCT03447769|560317886|FG000|Overall Study|Death|2|||
155242059|NCT03447769|560317887|FG001|Overall Study|Death|7|||
155242060|NCT03447769|560317886|FG000|Overall Study|Technical problems|1|||
155242061|NCT03447769|560317887|FG001|Overall Study|Technical problems|0|||
155242062|NCT03447769|560317886|FG000|Overall Study|Lost to Follow-up|0|||
155242063|NCT03447769|560317887|FG001|Overall Study|Lost to Follow-up|1|||
155242064|NCT03447769|560317886|FG000|Overall Study|Physician Decision|13|||
155242065|NCT03447769|560317887|FG001|Overall Study|Physician Decision|5|||
155242066|NCT03264989|560317890|FG000|Overall Study|Lost to Follow-up|1|||
155242067|NCT03264989|560317891|FG001|Overall Study|Lost to Follow-up|0|||
155242068|NCT03264989|560317890|FG000|Overall Study|New Therapy for study Indication|1|||
155242069|NCT03264989|560317891|FG001|Overall Study|New Therapy for study Indication|0|||
155242070|NCT03264989|560317890|FG000|Overall Study|Protocol Violation|0|||
155242071|NCT03264989|560317891|FG001|Overall Study|Protocol Violation|1|||
155242072|NCT03264989|560317890|FG000|Overall Study|Patient decision|13|||
155242073|NCT03264989|560317891|FG001|Overall Study|Patient decision|0|||
155242074|NCT03264989|560317890|FG000|Overall Study|Physician Decision|6|||
155242075|NCT03264989|560317891|FG001|Overall Study|Physician Decision|4|||
155242076|NCT03264989|560317890|FG000|Overall Study|Adverse Event|2|||
155242077|NCT03264989|560317891|FG001|Overall Study|Adverse Event|1|||
155242078|NCT03264989|560317890|FG000|Overall Study|Death|1|||
155242079|NCT03264989|560317891|FG001|Overall Study|Death|1|||
155242080|NCT03264989|560317890|FG000|Overall Study|Pregnancy|2|||
155242081|NCT03264989|560317891|FG001|Overall Study|Pregnancy|0|||
155242082|NCT03264989|560317890|FG000|Overall Study|End of Study|19|||
155242083|NCT03264989|560317891|FG001|Overall Study|End of Study|5|||
155242084|NCT00797667|560317897|FG000|Overall Study|Lack of Efficacy|0|||
155242085|NCT00797667|560317898|FG001|Overall Study|Lack of Efficacy|1|||
155242086|NCT00797667|560317899|FG002|Overall Study|Lack of Efficacy|0|||
155242087|NCT00797667|560317897|FG000|Overall Study|Lost to Follow-up|8|||
155242088|NCT00797667|560317898|FG001|Overall Study|Lost to Follow-up|12|||
155242089|NCT00797667|560317899|FG002|Overall Study|Lost to Follow-up|2|||
155242090|NCT00797667|560317897|FG000|Overall Study|Physician Decision|3|||
155242091|NCT00797667|560317898|FG001|Overall Study|Physician Decision|1|||
155242092|NCT00797667|560317899|FG002|Overall Study|Physician Decision|0|||
155242093|NCT00797667|560317897|FG000|Overall Study|Pregnancy|2|||
155242094|NCT00797667|560317898|FG001|Overall Study|Pregnancy|0|||
155242095|NCT00797667|560317899|FG002|Overall Study|Pregnancy|0|||
155242096|NCT00797667|560317897|FG000|Overall Study|Protocol Violation|2|||
155242097|NCT00797667|560317898|FG001|Overall Study|Protocol Violation|7|||
155242098|NCT00797667|560317899|FG002|Overall Study|Protocol Violation|0|||
155242099|NCT00797667|560317897|FG000|Overall Study|Study Terminated by Sponsor|217|||
155242100|NCT00797667|560317898|FG001|Overall Study|Study Terminated by Sponsor|216|||
155242101|NCT00797667|560317899|FG002|Overall Study|Study Terminated by Sponsor|115|||
155242102|NCT00797667|560317897|FG000|Overall Study|Withdrawal by Subject|9|||
155242103|NCT00797667|560317898|FG001|Overall Study|Withdrawal by Subject|14|||
155242104|NCT00797667|560317899|FG002|Overall Study|Withdrawal by Subject|2|||
155242105|NCT00797667|560317897|FG000|Overall Study|Adverse Event|19|||
155242106|NCT00797667|560317898|FG001|Overall Study|Adverse Event|8|||
155242107|NCT00797667|560317899|FG002|Overall Study|Adverse Event|8|||
155242108|NCT01986829|560317900|FG000|Overall Study|Death|1|||
155242109|NCT02673697|560317906|FG000|Overall Study|Adverse Event|2|||
155242110|NCT02673697|560317907|FG001|Overall Study|Adverse Event|0|||
155242111|NCT02673697|560317906|FG000|Overall Study|Death|32|||
155242112|NCT02673697|560317907|FG001|Overall Study|Death|24|||
155242113|NCT02673697|560317906|FG000|Overall Study|Lost to Follow-up|5|||
155242114|NCT02673697|560317907|FG001|Overall Study|Lost to Follow-up|2|||
155242115|NCT02673697|560317906|FG000|Overall Study|Physician Decision|2|||
155242116|NCT02673697|560317907|FG001|Overall Study|Physician Decision|1|||
155242117|NCT02673697|560317906|FG000|Overall Study|Withdrawal by Subject|10|||
155242118|NCT02673697|560317907|FG001|Overall Study|Withdrawal by Subject|7|||
155242119|NCT02673697|560317906|FG000|Overall Study|Change subj medical status|1|||
155242120|NCT02673697|560317907|FG001|Overall Study|Change subj medical status|2|||
155242121|NCT02673697|560317906|FG000|Overall Study|Explant|10|||
155242122|NCT02673697|560317907|FG001|Overall Study|Explant|5|||
155242123|NCT02673697|560317906|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
155242124|NCT02673697|560317907|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
155242125|NCT00437489|560317908|FG000|Overall Study|Study terminated by sponsor|23|||
155242126|NCT00437489|560317909|FG001|Overall Study|Study terminated by sponsor|21|||
155242127|NCT00437489|560317908|FG000|Overall Study|Lost to Follow-up|0|||
155242128|NCT00437489|560317909|FG001|Overall Study|Lost to Follow-up|1|||
155242129|NCT01525082|560317911|FG000|Overall Study|Death|1|||
155242130|NCT02209324|560317915|FG000|Overall Study|Adverse Event|2|||
155242131|NCT02209324|560317915|FG000|Overall Study|Lack of Efficacy|1|||
155242132|NCT02209324|560317915|FG000|Overall Study|Lost to Follow-up|1|||
155242133|NCT02209324|560317915|FG000|Overall Study|Physician Decision|3|||
155242134|NCT02209324|560317915|FG000|Overall Study|Protocol Violation|14|||
155242135|NCT02209324|560317915|FG000|Overall Study|Withdrawal by Subject|8|||
155242136|NCT02209324|560317915|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
155242137|NCT02209324|560317915|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
155242138|NCT02209324|560317915|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
155242139|NCT01985126|560317916|FG000|Overall Study|Death|15|||
155242140|NCT01985126|560317917|FG001|Overall Study|Death|69|||
155242141|NCT01985126|560317916|FG000|Overall Study|Lost to Follow-up|0|||
155242142|NCT01985126|560317917|FG001|Overall Study|Lost to Follow-up|8|||
155242143|NCT01985126|560317916|FG000|Overall Study|Study Terminated By Sponsor|1|||
155242144|NCT01985126|560317917|FG001|Overall Study|Study Terminated By Sponsor|22|||
155242145|NCT01985126|560317916|FG000|Overall Study|Withdrawal by Subject|2|||
155242146|NCT01985126|560317917|FG001|Overall Study|Withdrawal by Subject|7|||
155242147|NCT04177108|560317920|FG000|Overall Study|Withdrawal by Subject|4|||
155242148|NCT04177108|560317921|FG001|Overall Study|Withdrawal by Subject|8|||
155242149|NCT04177108|560317922|FG002|Overall Study|Withdrawal by Subject|9|||
155242150|NCT04177108|560317923|FG003|Overall Study|Withdrawal by Subject|11|||
155242151|NCT04177108|560317924|FG004|Overall Study|Withdrawal by Subject|13|||
155242152|NCT04177108|560317920|FG000|Overall Study|Physician Decision|23|||
155242153|NCT04177108|560317921|FG001|Overall Study|Physician Decision|15|||
155242154|NCT04177108|560317922|FG002|Overall Study|Physician Decision|18|||
155242155|NCT04177108|560317923|FG003|Overall Study|Physician Decision|29|||
155242156|NCT04177108|560317924|FG004|Overall Study|Physician Decision|23|||
155242157|NCT04177108|560317920|FG000|Overall Study|Reason Not Specified|0|||
155242158|NCT04177108|560317921|FG001|Overall Study|Reason Not Specified|1|||
155242159|NCT04177108|560317922|FG002|Overall Study|Reason Not Specified|0|||
155242160|NCT04177108|560317923|FG003|Overall Study|Reason Not Specified|0|||
155242161|NCT04177108|560317924|FG004|Overall Study|Reason Not Specified|2|||
155242162|NCT04177108|560317920|FG000|Overall Study|Lost to Follow-up|0|||
155242163|NCT04177108|560317921|FG001|Overall Study|Lost to Follow-up|0|||
155242164|NCT04177108|560317922|FG002|Overall Study|Lost to Follow-up|1|||
155242165|NCT04177108|560317923|FG003|Overall Study|Lost to Follow-up|1|||
155242166|NCT04177108|560317924|FG004|Overall Study|Lost to Follow-up|1|||
155242167|NCT04177108|560317920|FG000|Overall Study|Death|16|||
155242168|NCT04177108|560317921|FG001|Overall Study|Death|19|||
155242169|NCT04177108|560317922|FG002|Overall Study|Death|13|||
155242170|NCT04177108|560317923|FG003|Overall Study|Death|17|||
155242171|NCT04177108|560317924|FG004|Overall Study|Death|18|||
155242172|NCT04496258|560317925|FG000|Overall Study|Withdrawal by Subject|2|||
155242173|NCT04496258|560317926|FG001|Overall Study|Withdrawal by Subject|1|||
155242174|NCT00499889|560317927|FG000|Overall Study|Infection prior to treatment|1|||
155242175|NCT00766376|560317931|FG000|Overall Study|Withdrawal by Subject|27|||
155242176|NCT03149328|560317934|FG000|Overall Study|Withdrawal by Subject|30|||
155242177|NCT03149328|560317935|FG001|Overall Study|Withdrawal by Subject|26|||
155242178|NCT03149328|560317934|FG000|Overall Study|Changed Dialysis Modality|18|||
155242179|NCT03149328|560317935|FG001|Overall Study|Changed Dialysis Modality|1|||
155242180|NCT03149328|560317934|FG000|Overall Study|Transplant|9|||
155242181|NCT03149328|560317935|FG001|Overall Study|Transplant|1|||
155242182|NCT03149328|560317934|FG000|Overall Study|Lost to Follow-up|25|||
155242183|NCT03149328|560317935|FG001|Overall Study|Lost to Follow-up|16|||
155242184|NCT03149328|560317934|FG000|Overall Study|Left Study Site|1|||
155242185|NCT03149328|560317935|FG001|Overall Study|Left Study Site|2|||
155242186|NCT03149328|560317934|FG000|Overall Study|Language Barrier|1|||
155242187|NCT03149328|560317935|FG001|Overall Study|Language Barrier|0|||
155242188|NCT00852397|560317939|FG000|Overall Study|Adverse Event|4|||
155242189|NCT00852397|560317940|FG001|Overall Study|Adverse Event|6|||
155242190|NCT00852397|560317941|FG002|Overall Study|Adverse Event|4|||
155242191|NCT00852397|560317939|FG000|Overall Study|Death|0|||
155242192|NCT00852397|560317940|FG001|Overall Study|Death|0|||
155242193|NCT00852397|560317941|FG002|Overall Study|Death|1|||
155242194|NCT00852397|560317939|FG000|Overall Study|Withdrawal by Subject|4|||
155242195|NCT00852397|560317940|FG001|Overall Study|Withdrawal by Subject|1|||
155242196|NCT00852397|560317941|FG002|Overall Study|Withdrawal by Subject|2|||
155242197|NCT00852397|560317939|FG000|Overall Study|Study terminated by sponsor|2|||
155242198|NCT00852397|560317940|FG001|Overall Study|Study terminated by sponsor|1|||
155242199|NCT00852397|560317941|FG002|Overall Study|Study terminated by sponsor|6|||
155242200|NCT00852397|560317939|FG000|Overall Study|Difficulty in study site visit|1|||
155242201|NCT00852397|560317940|FG001|Overall Study|Difficulty in study site visit|0|||
155242202|NCT00852397|560317941|FG002|Overall Study|Difficulty in study site visit|0|||
155242203|NCT00852397|560317939|FG000|Overall Study|Protocol Violation|0|||
155242204|NCT00852397|560317940|FG001|Overall Study|Protocol Violation|0|||
155242205|NCT00852397|560317941|FG002|Overall Study|Protocol Violation|1|||
155242206|NCT01968434|560317947|FG000|Overall Study|Lost to Follow-up|3|||
155242207|NCT01968434|560317948|FG001|Overall Study|Lost to Follow-up|6|||
155242208|NCT02199691|560317949|FG000|Overall Study|Protocol Violation|3|||
155242209|NCT02199691|560317950|FG001|Overall Study|Protocol Violation|3|||
155242210|NCT02199691|560317951|FG002|Overall Study|Protocol Violation|6|||
155242211|NCT02199691|560317952|FG003|Overall Study|Protocol Violation|7|||
155242212|NCT02199691|560317949|FG000|Overall Study|Withdrawal by Subject|5|||
155242213|NCT02199691|560317950|FG001|Overall Study|Withdrawal by Subject|3|||
155242214|NCT02199691|560317951|FG002|Overall Study|Withdrawal by Subject|12|||
155242215|NCT02199691|560317952|FG003|Overall Study|Withdrawal by Subject|13|||
155242216|NCT02199691|560317949|FG000|Overall Study|Lost to Follow-up|2|||
155242217|NCT02199691|560317950|FG001|Overall Study|Lost to Follow-up|1|||
155242218|NCT02199691|560317951|FG002|Overall Study|Lost to Follow-up|9|||
155242219|NCT02199691|560317952|FG003|Overall Study|Lost to Follow-up|10|||
155242220|NCT00774995|560317953|FG000|Overall Study|Protocol Violation|0|||
155242221|NCT00774995|560317954|FG001|Overall Study|Protocol Violation|0|||
155242222|NCT00774995|560317955|FG002|Overall Study|Protocol Violation|1|||
155242223|NCT00774995|560317956|FG003|Overall Study|Protocol Violation|0|||
155242224|NCT03964454|560317957|FG000|Overall Study|Lost to Follow-up|13|||
155242225|NCT03964454|560317958|FG001|Overall Study|Lost to Follow-up|7|||
155242226|NCT03964454|560317957|FG000|Overall Study|Withdrawal by Subject|4|||
155242227|NCT03964454|560317958|FG001|Overall Study|Withdrawal by Subject|11|||
155242228|NCT00136955|560319875|FG000|Overall Study|Adverse Event|8|||
155242229|NCT00136955|560319875|FG000|Overall Study|Lost to Follow-up|1|||
155242230|NCT00136955|560319875|FG000|Overall Study|Withdrawal by Subject|2|||
155242231|NCT00136955|560319875|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
155242232|NCT02239510|560319876|FG000|Overall Study|Lost to Follow-up|2|||
155242233|NCT02239510|560319877|FG001|Overall Study|Lost to Follow-up|1|||
155242234|NCT05349617|560319885|FG000|Overall Study|Death|1|||
155242235|NCT05349617|560319886|FG001|Overall Study|Death|1|||
155242236|NCT05349617|560319885|FG000|Overall Study|Lost to Follow-up|3|||
155242237|NCT05349617|560319886|FG001|Overall Study|Lost to Follow-up|8|||
155242238|NCT05349617|560319885|FG000|Overall Study|Withdrawal by Subject|2|||
155242239|NCT05349617|560319886|FG001|Overall Study|Withdrawal by Subject|10|||
155242240|NCT00566228|560319887|FG000|Overall Study|Withdrawal by Subject|1|||
155242241|NCT00566228|560319888|FG001|Overall Study|Withdrawal by Subject|0|||
155242242|NCT00566228|560319887|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
155242243|NCT00566228|560319888|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
155242244|NCT00566228|560319887|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
155242245|NCT00566228|560319888|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
155242246|NCT00566228|560319887|FG000|Overall Study|progressed before infusion could occur|0|||
155242247|NCT00566228|560319888|FG001|Overall Study|progressed before infusion could occur|1|||
155242248|NCT05706506|560319889|FG000|Overall Study|Adverse Event|1|||
155491667|NCT00978120|561225485|FG003|Overall Study|Lost to Follow-up|0|||
155242249|NCT05706506|560319889|FG000|Overall Study|Withdrawal by Subject|4|||
155242250|NCT05706506|560319889|FG000|Overall Study|Lost to Follow-up|2|||
155242251|NCT05706506|560319889|FG000|Overall Study|Inadvertent Enrolment|12|||
155242252|NCT05706506|560319889|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
155242253|NCT05706506|560319889|FG000|Overall Study|Participant Moved Out of State|1|||
155242254|NCT00987467|560319890|FG000|Overall Study|Lost to Follow-up|2|||
155242255|NCT00262834|560319891|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
155242256|NCT00262834|560319892|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
155242257|NCT01303627|560319894|FG000|Overall Study|the failure while performing URS|0|||
155242258|NCT01303627|560319895|FG001|Overall Study|the failure while performing URS|1|||
155242259|NCT02416791|560319897|FG000|6 Months|Lost to Follow-up|0|||
155242260|NCT02416791|560319898|FG001|6 Months|Lost to Follow-up|0|||
155242261|NCT02416791|560319899|FG002|6 Months|Lost to Follow-up|1|||
155242262|NCT01054820|560319900|FG000|Overall Study|Withdrawal by Subject|2|||
155242263|NCT00321919|560319901|FG000|Overall Study|Adverse Event|17|||
155242264|NCT00321919|560319902|FG001|Overall Study|Adverse Event|10|||
155242265|NCT00321919|560319901|FG000|Overall Study|Death|21|||
155242266|NCT00321919|560319902|FG001|Overall Study|Death|17|||
155242267|NCT00321919|560319901|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155242268|NCT00321919|560319902|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155242269|NCT00321919|560319901|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155242270|NCT00321919|560319902|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155242271|NCT00321919|560319901|FG000|Overall Study|Refused Treatment|23|||
155242272|NCT00321919|560319902|FG001|Overall Study|Refused Treatment|14|||
155242273|NCT00321919|560319901|FG000|Overall Study|Other Protocol Violation|2|||
155242274|NCT00321919|560319902|FG001|Overall Study|Other Protocol Violation|3|||
155242275|NCT00321919|560319901|FG000|Overall Study|Failure to Return|3|||
155242276|NCT00321919|560319902|FG001|Overall Study|Failure to Return|1|||
155242277|NCT00321919|560319901|FG000|Overall Study|Other withdrawal reason|7|||
155242278|NCT00321919|560319902|FG001|Overall Study|Other withdrawal reason|6|||
155242279|NCT02624804|560319903|FG000|Overall Study|Screen Failure|5|||
155242280|NCT02590354|560319904|FG000|Phase 1|Active hepatitis B or C infection|1|||
155242281|NCT02590354|560319904|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
155242282|NCT02590354|560319904|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
155242283|NCT02590354|560319904|FG000|Phase 1|Subject does not want to participate|20|||
155242284|NCT02590354|560319904|FG000|Phase 1|Lost to Follow-up|1|||
155242285|NCT02590354|560319904|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
155242286|NCT00996996|560319905|FG000|Overall Study|Progressive Disease|10|||
155242287|NCT00996996|560319905|FG000|Overall Study|Non-compliance|8|||
155242288|NCT00996996|560319905|FG000|Overall Study|Lost to Follow-up|9|||
155242289|NCT00996996|560319905|FG000|Overall Study|Death|5|||
155242290|NCT00996996|560319905|FG000|Overall Study|Did Not Receive Study Medications|1|||
155242291|NCT00760929|560319906|FG000|Overall Study|Adverse Event|2|||
155242292|NCT00760929|560319907|FG001|Overall Study|Adverse Event|0|||
155242293|NCT00760929|560319908|FG002|Overall Study|Adverse Event|6|||
155242294|NCT00760929|560319909|FG003|Overall Study|Adverse Event|10|||
155242295|NCT00760929|560319906|FG000|Overall Study|Lack of Efficacy|0|||
155242296|NCT00760929|560319907|FG001|Overall Study|Lack of Efficacy|2|||
155242297|NCT00760929|560319908|FG002|Overall Study|Lack of Efficacy|1|||
155242298|NCT00760929|560319909|FG003|Overall Study|Lack of Efficacy|0|||
155242299|NCT00760929|560319906|FG000|Overall Study|Withdrawal by Subject|1|||
155242300|NCT00760929|560319907|FG001|Overall Study|Withdrawal by Subject|0|||
155242301|NCT00760929|560319908|FG002|Overall Study|Withdrawal by Subject|9|||
155242302|NCT00760929|560319909|FG003|Overall Study|Withdrawal by Subject|1|||
155242303|NCT00760929|560319906|FG000|Overall Study|Lost to Follow-up|0|||
155242304|NCT00760929|560319907|FG001|Overall Study|Lost to Follow-up|0|||
155242305|NCT00760929|560319908|FG002|Overall Study|Lost to Follow-up|1|||
155242306|NCT00760929|560319909|FG003|Overall Study|Lost to Follow-up|0|||
155242307|NCT00760929|560319906|FG000|Overall Study|Progression of Disease|21|||
155242308|NCT00760929|560319907|FG001|Overall Study|Progression of Disease|26|||
155242309|NCT00760929|560319908|FG002|Overall Study|Progression of Disease|38|||
155242310|NCT00760929|560319909|FG003|Overall Study|Progression of Disease|42|||
155242311|NCT00760929|560319906|FG000|Overall Study|Other|2|||
155242312|NCT00760929|560319907|FG001|Overall Study|Other|0|||
155242313|NCT00760929|560319908|FG002|Overall Study|Other|2|||
155242314|NCT00760929|560319909|FG003|Overall Study|Other|1|||
155242315|NCT00760929|560319906|FG000|Overall Study|Death|0|||
155242316|NCT00760929|560319907|FG001|Overall Study|Death|0|||
155242317|NCT00760929|560319908|FG002|Overall Study|Death|1|||
155242318|NCT00760929|560319909|FG003|Overall Study|Death|0|||
155242319|NCT00760929|560319906|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155242320|NCT00760929|560319907|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155242321|NCT00760929|560319908|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
155242322|NCT00760929|560319909|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
155242323|NCT02019719|560319910|FG000|Overall Study|Adverse Event|1|||
155242324|NCT02019719|560319911|FG001|Overall Study|Adverse Event|0|||
155242325|NCT02019719|560319912|FG002|Overall Study|Adverse Event|0|||
155242326|NCT02019719|560319913|FG003|Overall Study|Adverse Event|1|||
155242327|NCT02019719|560319914|FG004|Overall Study|Adverse Event|1|||
155242328|NCT02019719|560319910|FG000|Overall Study|Protocol Violation|1|||
155242329|NCT02019719|560319911|FG001|Overall Study|Protocol Violation|1|||
155242330|NCT02019719|560319912|FG002|Overall Study|Protocol Violation|0|||
155242331|NCT02019719|560319913|FG003|Overall Study|Protocol Violation|0|||
155242332|NCT02019719|560319914|FG004|Overall Study|Protocol Violation|0|||
155242333|NCT02019719|560319910|FG000|Overall Study|Protocol defined stopping criteria|2|||
155242334|NCT02019719|560319911|FG001|Overall Study|Protocol defined stopping criteria|0|||
155242335|NCT02019719|560319912|FG002|Overall Study|Protocol defined stopping criteria|0|||
155242336|NCT02019719|560319913|FG003|Overall Study|Protocol defined stopping criteria|1|||
155242337|NCT02019719|560319914|FG004|Overall Study|Protocol defined stopping criteria|1|||
155242338|NCT02019719|560319910|FG000|Overall Study|Physician Decision|2|||
155242339|NCT02019719|560319911|FG001|Overall Study|Physician Decision|0|||
155242340|NCT02019719|560319912|FG002|Overall Study|Physician Decision|0|||
155242341|NCT02019719|560319913|FG003|Overall Study|Physician Decision|0|||
155242342|NCT02019719|560319914|FG004|Overall Study|Physician Decision|0|||
155242343|NCT02348216|560319916|FG000|Overall Study|Death|5|||
155242344|NCT02348216|560319917|FG001|Overall Study|Death|53|||
155242345|NCT02348216|560319918|FG002|Overall Study|Death|11|||
155242346|NCT02348216|560319919|FG003|Overall Study|Death|20|||
155242347|NCT02348216|560319920|FG004|Overall Study|Death|16|||
155242348|NCT02348216|560319921|FG005|Overall Study|Death|32|||
155242349|NCT02348216|560319922|FG006|Overall Study|Death|17|||
155242350|NCT02348216|560319916|FG000|Overall Study|Full consent withdrawal|0|||
155242351|NCT02348216|560319917|FG001|Overall Study|Full consent withdrawal|0|||
155242352|NCT02348216|560319918|FG002|Overall Study|Full consent withdrawal|0|||
155242353|NCT02348216|560319919|FG003|Overall Study|Full consent withdrawal|1|||
155242354|NCT02348216|560319920|FG004|Overall Study|Full consent withdrawal|3|||
155242355|NCT02348216|560319921|FG005|Overall Study|Full consent withdrawal|0|||
155242356|NCT02348216|560319922|FG006|Overall Study|Full consent withdrawal|3|||
155242357|NCT02348216|560319916|FG000|Overall Study|Lost to Follow-up|0|||
155242358|NCT02348216|560319917|FG001|Overall Study|Lost to Follow-up|5|||
155242359|NCT02348216|560319918|FG002|Overall Study|Lost to Follow-up|2|||
155242360|NCT02348216|560319919|FG003|Overall Study|Lost to Follow-up|0|||
155242361|NCT02348216|560319920|FG004|Overall Study|Lost to Follow-up|1|||
155242362|NCT02348216|560319921|FG005|Overall Study|Lost to Follow-up|1|||
155242363|NCT02348216|560319922|FG006|Overall Study|Lost to Follow-up|1|||
155242364|NCT02348216|560319916|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
155242365|NCT02348216|560319917|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
155242366|NCT02348216|560319918|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
155242367|NCT02348216|560319919|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
155242368|NCT02348216|560319920|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
155242369|NCT02348216|560319921|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
155242370|NCT02348216|560319922|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
155242371|NCT02348216|560319916|FG000|Overall Study|Reason not specified|2|||
155242372|NCT02348216|560319917|FG001|Overall Study|Reason not specified|19|||
155242373|NCT02348216|560319918|FG002|Overall Study|Reason not specified|11|||
155242374|NCT02348216|560319919|FG003|Overall Study|Reason not specified|17|||
155242375|NCT02348216|560319920|FG004|Overall Study|Reason not specified|21|||
155242376|NCT02348216|560319921|FG005|Overall Study|Reason not specified|17|||
155242377|NCT02348216|560319922|FG006|Overall Study|Reason not specified|19|||
155242378|NCT01055639|560319923|FG000|Overall Study|Adverse Event|0|||
155242379|NCT01055639|560319924|FG001|Overall Study|Adverse Event|1|||
155242380|NCT01055639|560319923|FG000|Overall Study|Lack of Efficacy|0|||
155242381|NCT01055639|560319924|FG001|Overall Study|Lack of Efficacy|1|||
155242382|NCT01055639|560319923|FG000|Overall Study|Lost to Follow-up|8|||
155242383|NCT01055639|560319924|FG001|Overall Study|Lost to Follow-up|11|||
155242384|NCT01055639|560319923|FG000|Overall Study|Protocol Violation|5|||
155242385|NCT01055639|560319924|FG001|Overall Study|Protocol Violation|5|||
155242386|NCT01055639|560319923|FG000|Overall Study|Withdrawal by Subject|8|||
155242387|NCT01055639|560319924|FG001|Overall Study|Withdrawal by Subject|11|||
155242388|NCT00765245|560319925|FG000|Overall Study|disease progression|3|||
155242389|NCT00765245|560319926|FG001|Overall Study|disease progression|2|||
155242390|NCT00765245|560319925|FG000|Overall Study|Withdrawal by Subject|3|||
155242391|NCT00765245|560319926|FG001|Overall Study|Withdrawal by Subject|0|||
155242392|NCT00765245|560319925|FG000|Overall Study|Adverse Event|5|||
155242393|NCT00765245|560319926|FG001|Overall Study|Adverse Event|0|||
155242394|NCT00765245|560319925|FG000|Overall Study|Physician Decision|1|||
155242395|NCT00765245|560319926|FG001|Overall Study|Physician Decision|0|||
155242396|NCT00765245|560319925|FG000|Overall Study|Death|1|||
155242397|NCT00765245|560319926|FG001|Overall Study|Death|0|||
155242398|NCT02546544|560319930|FG000|Overall Study|Disease Progression|14|||
155242399|NCT02546544|560319930|FG000|Overall Study|Adverse Event|1|||
155242400|NCT02546544|560319930|FG000|Overall Study|Withdrawal by Subject|1|||
155242401|NCT01921348|560319931|FG000|Overall Study|Withdrawal by Subject|1|||
155242402|NCT01921348|560319932|FG001|Overall Study|Withdrawal by Subject|0|||
155242403|NCT01921348|560319931|FG000|Overall Study|Lost to Follow-up|0|||
155242404|NCT01921348|560319932|FG001|Overall Study|Lost to Follow-up|2|||
155242405|NCT02223390|560319933|FG000|Overall Study|Lost to Follow-up|9|||
155242406|NCT02223390|560319934|FG001|Overall Study|Lost to Follow-up|4|||
155242407|NCT02896855|560319936|FG000|Overall Study|Death|50|||
155242408|NCT02896855|560319937|FG001|Overall Study|Death|40|||
155242409|NCT02896855|560319936|FG000|Overall Study|Lost to Follow-up|15|||
155242410|NCT02896855|560319937|FG001|Overall Study|Lost to Follow-up|9|||
155242411|NCT02896855|560319936|FG000|Overall Study|Withdrawal by Subject|7|||
155242412|NCT02896855|560319937|FG001|Overall Study|Withdrawal by Subject|4|||
155242413|NCT02169674|560319938|FG000|Overall Study|Withdrawal by Subject|2|||
155242414|NCT02169674|560319939|FG001|Overall Study|Withdrawal by Subject|1|||
155242415|NCT02169674|560319938|FG000|Overall Study|Seroprotected|30|||
155242416|NCT02169674|560319939|FG001|Overall Study|Seroprotected|76|||
155242417|NCT02169674|560319938|FG000|Overall Study|Lost to Follow-up|0|||
155242418|NCT02169674|560319939|FG001|Overall Study|Lost to Follow-up|1|||
155242419|NCT02511431|560319940|FG000|Treatment|Lost to Follow-up|0|||
155242420|NCT02511431|560319941|FG001|Treatment|Lost to Follow-up|0|||
155242421|NCT02511431|560319942|FG002|Treatment|Lost to Follow-up|1|||
155242422|NCT02511431|560319943|FG003|Treatment|Lost to Follow-up|0|||
155242423|NCT02511431|560319944|FG004|Treatment|Lost to Follow-up|0|||
155242424|NCT02511431|560319945|FG005|Treatment|Lost to Follow-up|1|||
155242425|NCT00614939|560319948|FG000|Overall Study|Withdrawal by Subject|10|||
155242426|NCT00614939|560319949|FG001|Overall Study|Withdrawal by Subject|17|||
155242427|NCT00614939|560319948|FG000|Overall Study|Study specific discontinuation criteris|13|||
155242428|NCT00614939|560319949|FG001|Overall Study|Study specific discontinuation criteris|16|||
155242429|NCT00614939|560319948|FG000|Overall Study|Adverse Event|2|||
155242430|NCT00614939|560319949|FG001|Overall Study|Adverse Event|5|||
155242431|NCT00614939|560319948|FG000|Overall Study|Incorrect enrollment|1|||
155242432|NCT00614939|560319949|FG001|Overall Study|Incorrect enrollment|2|||
155242433|NCT00614939|560319948|FG000|Overall Study|Death|4|||
155242434|NCT00614939|560319949|FG001|Overall Study|Death|3|||
155242435|NCT00614939|560319948|FG000|Overall Study|Poor/non-compliance|4|||
155242436|NCT00614939|560319949|FG001|Overall Study|Poor/non-compliance|0|||
155242437|NCT00614939|560319948|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
155242438|NCT00614939|560319949|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
155242439|NCT00736996|560319950|FG000|Overall Study|Lost to Follow-up|1|||
155242440|NCT00736996|560319951|FG001|Overall Study|Lost to Follow-up|9|||
155242441|NCT00736996|560319952|FG002|Overall Study|Lost to Follow-up|2|||
155242442|NCT01343407|560319954|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
155242443|NCT01343407|560319955|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
155242444|NCT01343407|560319956|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
155242445|NCT01343407|560319957|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
155242446|NCT01343407|560319958|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
155242447|NCT01343407|560319959|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
155242448|NCT01343407|560319954|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242449|NCT01343407|560319955|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242450|NCT01343407|560319956|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
155242451|NCT01343407|560319957|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242452|NCT01343407|560319958|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242453|NCT01343407|560319959|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242454|NCT04079933|560319962|FG000|Overall Study|Withdrawal by Subject|3|||
155242455|NCT04079933|560319963|FG001|Overall Study|Withdrawal by Subject|4|||
155242456|NCT04079933|560319962|FG000|Overall Study|Lost to Follow-up|0|||
155242457|NCT04079933|560319963|FG001|Overall Study|Lost to Follow-up|1|||
155242458|NCT02504866|560319964|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
155242459|NCT02504866|560319965|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
155242460|NCT02504866|560319966|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
155242461|NCT01229436|560319967|FG000|Overall Study|Withdrawal by Subject|2|||
155242462|NCT01229436|560319967|FG000|Overall Study|Lost to Follow-up|3|||
155242463|NCT01775137|560319968|FG000|Overall Study|Death|1|||
155242464|NCT01775137|560319968|FG000|Overall Study|Protocol deviation|2|||
155242465|NCT01775137|560319968|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155242466|NCT01775137|560319968|FG000|Overall Study|Adverse Event|1|||
155242467|NCT01775137|560319968|FG000|Overall Study|Withdrawal by participants|5|||
155242468|NCT01343056|560319969|FG000|Overall Study|Lost to Follow-up|7|||
155242469|NCT01343056|560319970|FG001|Overall Study|Lost to Follow-up|5|||
155242470|NCT01343056|560319971|FG002|Overall Study|Lost to Follow-up|3|||
155242471|NCT01343056|560319972|FG003|Overall Study|Lost to Follow-up|9|||
155242472|NCT03893448|560319975|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
155242473|NCT03893448|560319976|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
155491668|NCT00978120|561225482|FG000|Overall Study|Withdrawal by Subject|2|||
155242474|NCT03893448|560319975|FG000|Overall Study|Physician Decision|8|||
155242475|NCT03893448|560319976|FG001|Overall Study|Physician Decision|14|||
155242476|NCT03893448|560319975|FG000|Overall Study|Lost to Follow-up|34|||
155242477|NCT03893448|560319976|FG001|Overall Study|Lost to Follow-up|27|||
155242478|NCT03893448|560319975|FG000|Overall Study|Death|1|||
155242479|NCT03893448|560319976|FG001|Overall Study|Death|0|||
155242480|NCT00022516|560319981|FG000|Overall Study|Adverse Event|0|||
155242481|NCT00022516|560319982|FG001|Overall Study|Adverse Event|59|||
155242482|NCT00022516|560319981|FG000|Overall Study|Lack of Efficacy|0|||
155242483|NCT00022516|560319982|FG001|Overall Study|Lack of Efficacy|27|||
155242484|NCT00022516|560319981|FG000|Overall Study|Physician Decision|0|||
155242485|NCT00022516|560319982|FG001|Overall Study|Physician Decision|1|||
155242486|NCT00022516|560319981|FG000|Overall Study|Protocol Violation|1|||
155242487|NCT00022516|560319982|FG001|Overall Study|Protocol Violation|3|||
155242488|NCT00022516|560319981|FG000|Overall Study|Withdrawal by Subject|2|||
155242489|NCT00022516|560319982|FG001|Overall Study|Withdrawal by Subject|113|||
155242490|NCT00022516|560319981|FG000|Overall Study|Incomplete documentation|0|||
155242491|NCT00022516|560319982|FG001|Overall Study|Incomplete documentation|27|||
155242492|NCT01568047|560319983|FG000|Overall Study|Ineligibility|1|||
155242493|NCT01568047|560319984|FG001|Overall Study|Ineligibility|0|||
155242494|NCT01568047|560319985|FG002|Overall Study|Ineligibility|0|||
155242495|NCT01568047|560319986|FG003|Overall Study|Ineligibility|0|||
155242496|NCT01568047|560319983|FG000|Overall Study|Withdrawal by Subject|0|||
155242497|NCT01568047|560319984|FG001|Overall Study|Withdrawal by Subject|1|||
155242498|NCT01568047|560319985|FG002|Overall Study|Withdrawal by Subject|0|||
155242499|NCT01568047|560319986|FG003|Overall Study|Withdrawal by Subject|0|||
155242500|NCT01568047|560319983|FG000|Overall Study|Adverse Event|0|||
155242501|NCT01568047|560319984|FG001|Overall Study|Adverse Event|0|||
155242502|NCT01568047|560319985|FG002|Overall Study|Adverse Event|1|||
155242503|NCT01568047|560319986|FG003|Overall Study|Adverse Event|1|||
155242504|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
155242505|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
155242506|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
155242507|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
155242508|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
155242509|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
155242510|NCT03783923|560319987|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
155242511|NCT03783923|560319988|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
155242512|NCT03783923|560319987|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
155242513|NCT03783923|560319988|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
155242514|NCT01427712|560319992|FG000|Overall Study|Transfer to a different hospital|2|||
155242515|NCT01427712|560319992|FG000|Overall Study|Lost to Follow-up|1|||
155242516|NCT01427712|560319992|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
155242517|NCT01427712|560319992|FG000|Overall Study|Failure to visit|1|||
155242518|NCT00661492|560319993|FG000|Overall Study|Adverse Event|16|||
155242519|NCT00661492|560319994|FG001|Overall Study|Adverse Event|13|||
155242520|NCT00661492|560319993|FG000|Overall Study|Disease Progression|44|||
155242521|NCT00661492|560319994|FG001|Overall Study|Disease Progression|14|||
155242522|NCT00661492|560319993|FG000|Overall Study|Patient Request|6|||
155242523|NCT00661492|560319994|FG001|Overall Study|Patient Request|1|||
155242524|NCT00661492|560319993|FG000|Overall Study|Investigator Request|1|||
155242525|NCT00661492|560319994|FG001|Overall Study|Investigator Request|0|||
155242526|NCT00661492|560319993|FG000|Overall Study|Lost to Follow-up|0|||
155242527|NCT00661492|560319994|FG001|Overall Study|Lost to Follow-up|1|||
155242528|NCT00661492|560319993|FG000|Overall Study|Other|1|||
155242529|NCT00661492|560319994|FG001|Overall Study|Other|0|||
155242530|NCT01143259|560319995|FG000|Overall Study|Withdrawal by Subject|3|||
155242531|NCT01143259|560319996|FG001|Overall Study|Withdrawal by Subject|2|||
155242532|NCT01143259|560319995|FG000|Overall Study|Protocol Violation|13|||
155242533|NCT01143259|560319996|FG001|Overall Study|Protocol Violation|9|||
155242534|NCT01143259|560319995|FG000|Overall Study|Screen Failure|7|||
155242535|NCT01143259|560319996|FG001|Overall Study|Screen Failure|9|||
155242536|NCT00099983|560319997|FG000|Overall Study|Lost to Follow-up|2|||
155242537|NCT00099983|560319998|FG001|Overall Study|Lost to Follow-up|3|||
155242538|NCT00099983|560319997|FG000|Overall Study|Missing Source Documents|14|||
155242539|NCT00099983|560319998|FG001|Overall Study|Missing Source Documents|15|||
155242540|NCT00099983|560319997|FG000|Overall Study|Withdrawal by Subject|3|||
155242541|NCT00099983|560319998|FG001|Overall Study|Withdrawal by Subject|2|||
155242542|NCT00099983|560319997|FG000|Overall Study|Adverse Event|1|||
155242543|NCT00099983|560319998|FG001|Overall Study|Adverse Event|1|||
155242544|NCT00099983|560319997|FG000|Overall Study|Lack of Efficacy|0|||
155242545|NCT00099983|560319998|FG001|Overall Study|Lack of Efficacy|1|||
155242546|NCT00099983|560319997|FG000|Overall Study|Unable to return for appointments|1|||
155242547|NCT00099983|560319998|FG001|Overall Study|Unable to return for appointments|1|||
155242548|NCT00099983|560319997|FG000|Overall Study|Moved|1|||
155242549|NCT00099983|560319998|FG001|Overall Study|Moved|0|||
155242550|NCT00099983|560319997|FG000|Overall Study|Other psychiatric problem|1|||
155242551|NCT00099983|560319998|FG001|Overall Study|Other psychiatric problem|0|||
155242552|NCT00099983|560319997|FG000|Overall Study|Incarcerated|0|||
155242553|NCT00099983|560319998|FG001|Overall Study|Incarcerated|1|||
155242554|NCT00099983|560319997|FG000|Overall Study|Intolerant of burden of visits|0|||
155242555|NCT00099983|560319998|FG001|Overall Study|Intolerant of burden of visits|1|||
155242556|NCT00099983|560319997|FG000|Overall Study|Other issue|1|||
155242557|NCT00099983|560319998|FG001|Overall Study|Other issue|0|||
155242558|NCT02641080|560319999|FG000|Overall Study|Physician Decision|2|||
155242559|NCT02641080|560320000|FG001|Overall Study|Physician Decision|0|||
155242560|NCT02641080|560319999|FG000|Overall Study|Withdrawal by Subject|0|||
155242561|NCT02641080|560320000|FG001|Overall Study|Withdrawal by Subject|1|||
155242562|NCT02641080|560319999|FG000|Overall Study|Rehab Center denied use of pumps|0|||
155242563|NCT02641080|560320000|FG001|Overall Study|Rehab Center denied use of pumps|3|||
155242564|NCT02641080|560319999|FG000|Overall Study|Lost to Follow-up|0|||
155242565|NCT02641080|560320000|FG001|Overall Study|Lost to Follow-up|3|||
155242566|NCT00803634|560320001|FG000|Overall Study|Withdrew Consent|1|||
155242567|NCT00803634|560320002|FG001|Overall Study|Withdrew Consent|0|||
155242568|NCT00803634|560320001|FG000|Overall Study|Lost to Follow-up|2|||
155242569|NCT00803634|560320002|FG001|Overall Study|Lost to Follow-up|3|||
155242570|NCT00803634|560320001|FG000|Overall Study|Death|3|||
155242571|NCT00803634|560320002|FG001|Overall Study|Death|2|||
155242572|NCT03835533|560320003|FG000|Overall Study|Death|5|||
155242573|NCT03835533|560320004|FG001|Overall Study|Death|10|||
155242574|NCT03835533|560320005|FG002|Overall Study|Death|9|||
155242575|NCT03835533|560320003|FG000|Overall Study|Withdrawal by Subject|2|||
155242576|NCT03835533|560320004|FG001|Overall Study|Withdrawal by Subject|2|||
155242577|NCT03835533|560320005|FG002|Overall Study|Withdrawal by Subject|2|||
155242578|NCT03835533|560320003|FG000|Overall Study|Lost to Follow-up|1|||
155242579|NCT03835533|560320004|FG001|Overall Study|Lost to Follow-up|0|||
155242580|NCT03835533|560320005|FG002|Overall Study|Lost to Follow-up|0|||
155242581|NCT01866709|560320012|FG000|Overall Study|Adverse Event|1|||
155242582|NCT01866709|560320013|FG001|Overall Study|Adverse Event|0|||
155242583|NCT03285477|560320015|FG000|Treatment and Response Assessment Period|Death|1|||
155242584|NCT03285477|560320016|FG001|Treatment and Response Assessment Period|Death|0|||
155242585|NCT03285477|560320015|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
155242586|NCT03285477|560320016|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
155242587|NCT03285477|560320015|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
155242588|NCT03285477|560320016|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
155242589|NCT03285477|560320015|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
155242590|NCT03285477|560320016|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
155242591|NCT03285477|560320015|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
155242592|NCT03285477|560320016|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
155242593|NCT00560833|560320017|FG000|Overall Study|Adverse Event|16|||
155242594|NCT00560833|560320018|FG001|Overall Study|Adverse Event|10|||
155242595|NCT00560833|560320019|FG002|Overall Study|Adverse Event|25|||
155242596|NCT00560833|560320020|FG003|Overall Study|Adverse Event|23|||
155242597|NCT00560833|560320021|FG004|Overall Study|Adverse Event|35|||
155242598|NCT00560833|560320017|FG000|Overall Study|Lost to Follow-up|0|||
155242599|NCT00560833|560320018|FG001|Overall Study|Lost to Follow-up|0|||
155242600|NCT00560833|560320019|FG002|Overall Study|Lost to Follow-up|1|||
155242601|NCT00560833|560320020|FG003|Overall Study|Lost to Follow-up|0|||
155242602|NCT00560833|560320021|FG004|Overall Study|Lost to Follow-up|0|||
155242603|NCT00560833|560320017|FG000|Overall Study|Lack of Efficacy|22|||
155242604|NCT00560833|560320018|FG001|Overall Study|Lack of Efficacy|9|||
155242605|NCT00560833|560320019|FG002|Overall Study|Lack of Efficacy|6|||
155242606|NCT00560833|560320020|FG003|Overall Study|Lack of Efficacy|4|||
155242607|NCT00560833|560320021|FG004|Overall Study|Lack of Efficacy|4|||
155242608|NCT00560833|560320017|FG000|Overall Study|Participant uncooperative|5|||
155242609|NCT00560833|560320018|FG001|Overall Study|Participant uncooperative|5|||
155242610|NCT00560833|560320019|FG002|Overall Study|Participant uncooperative|4|||
155242611|NCT00560833|560320020|FG003|Overall Study|Participant uncooperative|4|||
155242612|NCT00560833|560320021|FG004|Overall Study|Participant uncooperative|2|||
155242613|NCT00560833|560320017|FG000|Overall Study|Other|1|||
155242614|NCT00560833|560320018|FG001|Overall Study|Other|1|||
155242615|NCT00560833|560320019|FG002|Overall Study|Other|3|||
155242616|NCT00560833|560320020|FG003|Overall Study|Other|0|||
155242617|NCT00560833|560320021|FG004|Overall Study|Other|0|||
155242618|NCT00560833|560320017|FG000|Overall Study|Never received drug|0|||
155242619|NCT00560833|560320018|FG001|Overall Study|Never received drug|1|||
155242620|NCT00560833|560320019|FG002|Overall Study|Never received drug|0|||
155242621|NCT00560833|560320020|FG003|Overall Study|Never received drug|0|||
155242622|NCT00560833|560320021|FG004|Overall Study|Never received drug|1|||
155242623|NCT03283670|560320022|FG000|Placebo Gas|Withdrawal by Subject|2|||
155242624|NCT03283670|560320022|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
155242625|NCT03283670|560320022|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
155242626|NCT01059617|560320025|FG000|Overall Study|Other|7|||
155242627|NCT01059617|560320026|FG001|Overall Study|Other|1|||
155242628|NCT01059617|560320027|FG002|Overall Study|Other|8|||
155242629|NCT01059617|560320028|FG003|Overall Study|Other|6|||
155242630|NCT01307501|560320029|FG000|Overall Study|Treatment Failure|1|||
155242631|NCT01307501|560320029|FG000|Overall Study|Death|20|||
155242632|NCT01307501|560320029|FG000|Overall Study|Lost to Follow-up|1|||
155242633|NCT01307501|560320029|FG000|Overall Study|Starting Hospice|1|||
155242634|NCT01209624|560320037|FG000|Overall Study|Death|2|||
155242635|NCT01209624|560320037|FG000|Overall Study|Adverse Event|13|||
155242636|NCT01209624|560320037|FG000|Overall Study|Lack of Efficacy|17|||
155242637|NCT01209624|560320037|FG000|Overall Study|Lost to Follow-up|290|||
155242638|NCT01209624|560320037|FG000|Overall Study|Other|4|||
155242639|NCT03403634|560320038|FG000|Overall Study|Disease progression|3|||
155242640|NCT03403634|560320038|FG000|Overall Study|Did not meet eligibility criteria|4|||
155242641|NCT03859323|560322167|FG000|Overall Study|Lost to Follow-up|0|||
155242642|NCT03859323|560322168|FG001|Overall Study|Lost to Follow-up|0|||
155242643|NCT03859323|560322169|FG002|Overall Study|Lost to Follow-up|0|||
155242644|NCT03859323|560322170|FG003|Overall Study|Lost to Follow-up|0|||
155242645|NCT03859323|560322171|FG004|Overall Study|Lost to Follow-up|0|||
155242646|NCT03859323|560322172|FG005|Overall Study|Lost to Follow-up|0|||
155242647|NCT03859323|560322173|FG006|Overall Study|Lost to Follow-up|1|||
155242648|NCT03859323|560322174|FG007|Overall Study|Lost to Follow-up|0|||
155242649|NCT03859323|560322175|FG008|Overall Study|Lost to Follow-up|0|||
155242650|NCT03859323|560322176|FG009|Overall Study|Lost to Follow-up|0|||
155242651|NCT03859323|560322177|FG010|Overall Study|Lost to Follow-up|0|||
155242652|NCT03859323|560322178|FG011|Overall Study|Lost to Follow-up|0|||
155242653|NCT03859323|560322179|FG012|Overall Study|Lost to Follow-up|0|||
155242654|NCT03859323|560322167|FG000|Overall Study|Withdrawal by Subject|0|||
155242655|NCT03859323|560322168|FG001|Overall Study|Withdrawal by Subject|0|||
155242656|NCT03859323|560322169|FG002|Overall Study|Withdrawal by Subject|1|||
155242657|NCT03859323|560322170|FG003|Overall Study|Withdrawal by Subject|0|||
155242658|NCT03859323|560322171|FG004|Overall Study|Withdrawal by Subject|0|||
155242659|NCT03859323|560322172|FG005|Overall Study|Withdrawal by Subject|1|||
155242660|NCT03859323|560322173|FG006|Overall Study|Withdrawal by Subject|0|||
155242661|NCT03859323|560322174|FG007|Overall Study|Withdrawal by Subject|0|||
155242662|NCT03859323|560322175|FG008|Overall Study|Withdrawal by Subject|0|||
155242663|NCT03859323|560322176|FG009|Overall Study|Withdrawal by Subject|1|||
155242664|NCT03859323|560322177|FG010|Overall Study|Withdrawal by Subject|1|||
155242665|NCT03859323|560322178|FG011|Overall Study|Withdrawal by Subject|2|||
155242666|NCT03859323|560322179|FG012|Overall Study|Withdrawal by Subject|1|||
155242667|NCT03859323|560322167|FG000|Overall Study|Pregnancy|0|||
155242668|NCT03859323|560322168|FG001|Overall Study|Pregnancy|0|||
155242669|NCT03859323|560322169|FG002|Overall Study|Pregnancy|0|||
155242670|NCT03859323|560322170|FG003|Overall Study|Pregnancy|0|||
155242671|NCT03859323|560322171|FG004|Overall Study|Pregnancy|0|||
155242672|NCT03859323|560322172|FG005|Overall Study|Pregnancy|0|||
155242673|NCT03859323|560322173|FG006|Overall Study|Pregnancy|0|||
155242674|NCT03859323|560322174|FG007|Overall Study|Pregnancy|0|||
155242675|NCT03859323|560322175|FG008|Overall Study|Pregnancy|0|||
155242676|NCT03859323|560322176|FG009|Overall Study|Pregnancy|1|||
155242677|NCT03859323|560322177|FG010|Overall Study|Pregnancy|0|||
155242678|NCT03859323|560322178|FG011|Overall Study|Pregnancy|0|||
155242679|NCT03859323|560322179|FG012|Overall Study|Pregnancy|0|||
155242680|NCT00993447|560322182|FG000|Overall Study|Withdrawal by Subject|23|||
155242681|NCT00993447|560322183|FG001|Overall Study|Withdrawal by Subject|8|||
155242682|NCT00993447|560322182|FG000|Overall Study|Protocol Violation|12|||
155242683|NCT00993447|560322183|FG001|Overall Study|Protocol Violation|8|||
155242684|NCT00993447|560322182|FG000|Overall Study|Lost to Follow-up|1|||
155242685|NCT00993447|560322183|FG001|Overall Study|Lost to Follow-up|3|||
155242686|NCT00993447|560322182|FG000|Overall Study|Adverse Event|1|||
155242687|NCT00993447|560322183|FG001|Overall Study|Adverse Event|0|||
155242688|NCT04401579|560322185|FG000|Overall Study|Death|23|||
155242689|NCT04401579|560322186|FG001|Overall Study|Death|36|||
155242690|NCT04401579|560322185|FG000|Overall Study|Lost to Follow-up|40|||
155242691|NCT04401579|560322186|FG001|Overall Study|Lost to Follow-up|41|||
155242692|NCT04401579|560322185|FG000|Overall Study|Withdrawal by Subject|8|||
155242693|NCT04401579|560322186|FG001|Overall Study|Withdrawal by Subject|16|||
155242694|NCT04401579|560322185|FG000|Overall Study|Physician Decision|1|||
155242695|NCT04401579|560322186|FG001|Overall Study|Physician Decision|2|||
155242696|NCT04401579|560322185|FG000|Overall Study|Became ineligible after enrollment|1|||
155242697|NCT04401579|560322186|FG001|Overall Study|Became ineligible after enrollment|1|||
155242698|NCT04401579|560322185|FG000|Overall Study|Enrolled but treatment not administered|7|||
155242699|NCT04401579|560322186|FG001|Overall Study|Enrolled but treatment not administered|9|||
155242700|NCT04401579|560322185|FG000|Overall Study|Adverse Event|2|||
155242701|NCT04401579|560322186|FG001|Overall Study|Adverse Event|1|||
155242702|NCT04401579|560322185|FG000|Overall Study|Scheduling error|1|||
155242703|NCT04401579|560322186|FG001|Overall Study|Scheduling error|2|||
155242704|NCT04401579|560322185|FG000|Overall Study|Transferred to another hospital|1|||
155242705|NCT04401579|560322186|FG001|Overall Study|Transferred to another hospital|2|||
155242706|NCT00489970|560322187|FG000|Persistence Year 9|Lost to Follow-up|2|||
155242707|NCT00489970|560322188|FG001|Persistence Year 9|Lost to Follow-up|2|||
155242708|NCT00489970|560322189|FG002|Persistence Year 9|Lost to Follow-up|3|||
155242709|NCT00489970|560322187|FG000|Persistence Year 9|Other|1|||
155242710|NCT00489970|560322188|FG001|Persistence Year 9|Other|0|||
155242711|NCT00489970|560322189|FG002|Persistence Year 9|Other|2|||
155242712|NCT01438411|560322190|FG000|Overall Study|Adverse Event|8|||
155242713|NCT01438411|560322190|FG000|Overall Study|Lost to Follow-up|1|||
155242714|NCT01438411|560322190|FG000|Overall Study|Lack of Efficacy|1|||
155242715|NCT01438411|560322190|FG000|Overall Study|Withdrawal by Subject|3|||
155242716|NCT01863680|560322191|FG000|Overall Study|Adverse Event|17|||
155242717|NCT01863680|560322191|FG000|Overall Study|Risk of OHSS|17|||
155242718|NCT01863680|560322191|FG000|Overall Study|Spontaneous pregnancy|2|||
155242719|NCT01863680|560322191|FG000|Overall Study|Withdrawal by Subject|1|||
155242720|NCT01863680|560322191|FG000|Overall Study|Did not undergo IVF/ET|14|||
155242721|NCT01863680|560322191|FG000|Overall Study|Other|6|||
155242722|NCT00618514|560322192|FG000|Overall Study|Lost to Follow-up|11|||
155242723|NCT00618514|560322193|FG001|Overall Study|Lost to Follow-up|12|||
155242724|NCT00618514|560322194|FG002|Overall Study|Lost to Follow-up|4|||
155242725|NCT03320070|560322201|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
155242726|NCT03320070|560322202|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
155242727|NCT03320070|560322201|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
155242728|NCT03320070|560322202|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
155242729|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
155242730|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
155242731|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
155242732|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
155242733|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
155242734|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
155242735|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
155242736|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
155242737|NCT02041195|560322203|FG000|Overall Study|Adverse Event|1|||
155242738|NCT02041195|560322204|FG001|Overall Study|Adverse Event|2|||
155242739|NCT02041195|560322205|FG002|Overall Study|Adverse Event|0|||
155242740|NCT02041195|560322206|FG003|Overall Study|Adverse Event|0|||
155242741|NCT02041195|560322207|FG004|Overall Study|Adverse Event|0|||
155242742|NCT02041195|560322208|FG005|Overall Study|Adverse Event|0|||
155242743|NCT02041195|560322209|FG006|Overall Study|Adverse Event|3|||
155242744|NCT02041195|560322210|FG007|Overall Study|Adverse Event|0|||
155242745|NCT02041195|560322203|FG000|Overall Study|Withdrawal by Subject|1|||
155242746|NCT02041195|560322204|FG001|Overall Study|Withdrawal by Subject|0|||
155242747|NCT02041195|560322205|FG002|Overall Study|Withdrawal by Subject|0|||
155242748|NCT02041195|560322206|FG003|Overall Study|Withdrawal by Subject|0|||
155242749|NCT02041195|560322207|FG004|Overall Study|Withdrawal by Subject|0|||
155242750|NCT02041195|560322208|FG005|Overall Study|Withdrawal by Subject|0|||
155242751|NCT02041195|560322209|FG006|Overall Study|Withdrawal by Subject|4|||
155242752|NCT02041195|560322210|FG007|Overall Study|Withdrawal by Subject|3|||
155242753|NCT02041195|560322203|FG000|Overall Study|Unable to comply with study visits|0|||
155242754|NCT02041195|560322204|FG001|Overall Study|Unable to comply with study visits|1|||
155242755|NCT02041195|560322205|FG002|Overall Study|Unable to comply with study visits|0|||
155242756|NCT02041195|560322206|FG003|Overall Study|Unable to comply with study visits|0|||
155242757|NCT02041195|560322207|FG004|Overall Study|Unable to comply with study visits|1|||
155242758|NCT02041195|560322208|FG005|Overall Study|Unable to comply with study visits|0|||
155242759|NCT02041195|560322209|FG006|Overall Study|Unable to comply with study visits|0|||
155242760|NCT02041195|560322210|FG007|Overall Study|Unable to comply with study visits|0|||
155242761|NCT03564496|560322211|FG000|Overall Study|Withdrawal by Subject|1|||
155242762|NCT03564496|560322212|FG001|Overall Study|Withdrawal by Subject|1|||
155242763|NCT03564496|560322213|FG002|Overall Study|Withdrawal by Subject|0|||
155242764|NCT03564496|560322211|FG000|Overall Study|Screen failure|0|||
155242765|NCT03564496|560322212|FG001|Overall Study|Screen failure|3|||
155242766|NCT03564496|560322213|FG002|Overall Study|Screen failure|0|||
155242767|NCT00674986|560322214|FG000|Overall Study|Adverse Event|2|||
155242768|NCT00674986|560322215|FG001|Overall Study|Adverse Event|1|||
155242769|NCT00674986|560322214|FG000|Overall Study|Subject withdrew consent|12|||
155242770|NCT00674986|560322215|FG001|Overall Study|Subject withdrew consent|19|||
155242771|NCT00674986|560322214|FG000|Overall Study|Lost to Follow-up|25|||
155242772|NCT00674986|560322215|FG001|Overall Study|Lost to Follow-up|53|||
155242773|NCT00674986|560322214|FG000|Overall Study|Other reasons|4|||
155242774|NCT00674986|560322215|FG001|Overall Study|Other reasons|8|||
155242775|NCT02244944|560322218|FG000|Overall Study|Withdrawal by Subject|1|||
155242776|NCT02244944|560322218|FG000|Overall Study|Study Terminated|1|||
155242777|NCT01747772|560322219|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
155242778|NCT02492100|560322220|FG000|Overall Study|Death|1|||
155242779|NCT04121962|560322221|FG000|Overall Study|Lost to Follow-up|42|||
155242780|NCT04121962|560322222|FG001|Overall Study|Lost to Follow-up|39|||
155242781|NCT01308749|560322223|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
155242782|NCT01308749|560322224|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
155242783|NCT01308749|560322223|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
155242784|NCT01308749|560322224|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
155242785|NCT01308749|560322223|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
155242786|NCT01308749|560322224|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
155242787|NCT01197950|560322227|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
155491669|NCT00978120|561225483|FG001|Overall Study|Withdrawal by Subject|0|||
155242788|NCT01197950|560322228|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
155242789|NCT01197950|560322229|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
155242790|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Adverse Event|3|||
155242791|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Adverse Event|2|||
155242792|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Adverse Event|0|||
155242793|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Adverse Event|0|||
155242794|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Adverse Event|0|||
155242795|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Adverse Event|0|||
155242796|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Adverse Event|0|||
155242797|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
155242798|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
155242799|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242800|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242801|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242802|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242803|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242804|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Physician Decision|1|||
155242805|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Physician Decision|0|||
155242806|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Physician Decision|0|||
155242807|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Physician Decision|0|||
155242808|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Physician Decision|0|||
155242809|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Physician Decision|0|||
155242810|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Physician Decision|0|||
155242811|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
155242812|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
155242813|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242814|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242815|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242816|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242817|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242818|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242819|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
155242820|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242821|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242822|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242823|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242824|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242825|NCT02265705|560322242|FG000|Rescue Period|Withdrawal by Subject|0|||
155242826|NCT02265705|560322243|FG001|Rescue Period|Withdrawal by Subject|0|||
155242827|NCT02265705|560322244|FG002|Rescue Period|Withdrawal by Subject|1|||
155242828|NCT02265705|560322245|FG003|Rescue Period|Withdrawal by Subject|0|||
155242829|NCT02265705|560322246|FG004|Rescue Period|Withdrawal by Subject|0|||
155242830|NCT02265705|560322247|FG005|Rescue Period|Withdrawal by Subject|0|||
155242831|NCT02265705|560322248|FG006|Rescue Period|Withdrawal by Subject|0|||
155242832|NCT02265705|560322242|FG000|Rescue Period|Death|0|||
155242833|NCT02265705|560322243|FG001|Rescue Period|Death|0|||
155242834|NCT02265705|560322244|FG002|Rescue Period|Death|1|||
155242835|NCT02265705|560322245|FG003|Rescue Period|Death|0|||
155242836|NCT02265705|560322246|FG004|Rescue Period|Death|0|||
155242837|NCT02265705|560322247|FG005|Rescue Period|Death|0|||
155242838|NCT02265705|560322248|FG006|Rescue Period|Death|0|||
155242839|NCT02265705|560322242|FG000|Rescue Period|Lack of Efficacy|0|||
155242840|NCT02265705|560322243|FG001|Rescue Period|Lack of Efficacy|0|||
155242841|NCT02265705|560322244|FG002|Rescue Period|Lack of Efficacy|1|||
155242842|NCT02265705|560322245|FG003|Rescue Period|Lack of Efficacy|0|||
155242843|NCT02265705|560322246|FG004|Rescue Period|Lack of Efficacy|0|||
155242844|NCT02265705|560322247|FG005|Rescue Period|Lack of Efficacy|0|||
155242845|NCT02265705|560322248|FG006|Rescue Period|Lack of Efficacy|0|||
155242846|NCT02265705|560322242|FG000|Open Label Period|Adverse Event|0|||
155242847|NCT02265705|560322243|FG001|Open Label Period|Adverse Event|0|||
155242848|NCT02265705|560322244|FG002|Open Label Period|Adverse Event|0|||
155242849|NCT02265705|560322245|FG003|Open Label Period|Adverse Event|2|||
155242850|NCT02265705|560322246|FG004|Open Label Period|Adverse Event|2|||
155242851|NCT02265705|560322247|FG005|Open Label Period|Adverse Event|0|||
155242852|NCT02265705|560322248|FG006|Open Label Period|Adverse Event|0|||
155242853|NCT02265705|560322242|FG000|Open Label Period|Physician Decision|0|||
155242854|NCT02265705|560322243|FG001|Open Label Period|Physician Decision|0|||
155242855|NCT02265705|560322244|FG002|Open Label Period|Physician Decision|0|||
155242856|NCT02265705|560322245|FG003|Open Label Period|Physician Decision|0|||
155242857|NCT02265705|560322246|FG004|Open Label Period|Physician Decision|1|||
155242858|NCT02265705|560322247|FG005|Open Label Period|Physician Decision|0|||
155242859|NCT02265705|560322248|FG006|Open Label Period|Physician Decision|0|||
155242860|NCT02265705|560322242|FG000|Open Label Period|Withdrawal by Subject|0|||
155242861|NCT02265705|560322243|FG001|Open Label Period|Withdrawal by Subject|0|||
155242862|NCT02265705|560322244|FG002|Open Label Period|Withdrawal by Subject|0|||
155242863|NCT02265705|560322245|FG003|Open Label Period|Withdrawal by Subject|0|||
155242864|NCT02265705|560322246|FG004|Open Label Period|Withdrawal by Subject|2|||
155242865|NCT02265705|560322247|FG005|Open Label Period|Withdrawal by Subject|0|||
155242866|NCT02265705|560322248|FG006|Open Label Period|Withdrawal by Subject|0|||
155242867|NCT02265705|560322242|FG000|Follow-up Period|Sponsor Decision|0|||
155242868|NCT02265705|560322243|FG001|Follow-up Period|Sponsor Decision|0|||
155242869|NCT02265705|560322244|FG002|Follow-up Period|Sponsor Decision|0|||
155242870|NCT02265705|560322245|FG003|Follow-up Period|Sponsor Decision|0|||
155242871|NCT02265705|560322246|FG004|Follow-up Period|Sponsor Decision|0|||
155242872|NCT02265705|560322247|FG005|Follow-up Period|Sponsor Decision|1|||
155242873|NCT02265705|560322248|FG006|Follow-up Period|Sponsor Decision|6|||
155242874|NCT02265705|560322242|FG000|Follow-up Period|Adverse Event|0|||
155242875|NCT02265705|560322243|FG001|Follow-up Period|Adverse Event|0|||
155242876|NCT02265705|560322244|FG002|Follow-up Period|Adverse Event|0|||
155242877|NCT02265705|560322245|FG003|Follow-up Period|Adverse Event|0|||
155242878|NCT02265705|560322246|FG004|Follow-up Period|Adverse Event|0|||
155242879|NCT02265705|560322247|FG005|Follow-up Period|Adverse Event|0|||
155242880|NCT02265705|560322248|FG006|Follow-up Period|Adverse Event|3|||
155242881|NCT02265705|560322242|FG000|Follow-up Period|Physician Decision|0|||
155242882|NCT02265705|560322243|FG001|Follow-up Period|Physician Decision|0|||
155242883|NCT02265705|560322244|FG002|Follow-up Period|Physician Decision|0|||
155242884|NCT02265705|560322245|FG003|Follow-up Period|Physician Decision|0|||
155242885|NCT02265705|560322246|FG004|Follow-up Period|Physician Decision|0|||
155242886|NCT02265705|560322247|FG005|Follow-up Period|Physician Decision|0|||
155242887|NCT02265705|560322248|FG006|Follow-up Period|Physician Decision|1|||
155242888|NCT02265705|560322242|FG000|Follow-up Period|Withdrawal by Subject|0|||
155242889|NCT02265705|560322243|FG001|Follow-up Period|Withdrawal by Subject|0|||
155242890|NCT02265705|560322244|FG002|Follow-up Period|Withdrawal by Subject|0|||
155242891|NCT02265705|560322245|FG003|Follow-up Period|Withdrawal by Subject|0|||
155242892|NCT02265705|560322246|FG004|Follow-up Period|Withdrawal by Subject|0|||
155242893|NCT02265705|560322247|FG005|Follow-up Period|Withdrawal by Subject|0|||
155242894|NCT02265705|560322248|FG006|Follow-up Period|Withdrawal by Subject|1|||
155242895|NCT00462384|560322250|FG000|Overall Study|Adverse Event|2|||
155242896|NCT00462384|560322250|FG000|Overall Study|Death|2|||
155242897|NCT00462384|560322250|FG000|Overall Study|Withdrawal by Subject|1|||
155242898|NCT00462384|560322250|FG000|Overall Study|Other|4|||
155242899|NCT04000165|560322251|FG000|Overall Study|Physician Decision|1|||
155242900|NCT04000165|560322251|FG000|Overall Study|Withdrawal by Subject|1|||
155242901|NCT01753193|560322252|FG000|Overall Study|Withdrawal by Subject|23|||
155242902|NCT01753193|560322252|FG000|Overall Study|Lost to Follow-up|6|||
155242903|NCT01753193|560322252|FG000|Overall Study|Death|1|||
155242904|NCT01753193|560322252|FG000|Overall Study|Other|16|||
155242905|NCT02682264|560322253|FG000|Overall Study|Withdrawal by Subject|56|||
155242906|NCT02682264|560322254|FG001|Overall Study|Withdrawal by Subject|45|||
155242907|NCT02682264|560322253|FG000|Overall Study|Lost to Follow-up|49|||
155242908|NCT02682264|560322254|FG001|Overall Study|Lost to Follow-up|41|||
155242909|NCT02682264|560322253|FG000|Overall Study|Lack of Efficacy|14|||
155242910|NCT02682264|560322254|FG001|Overall Study|Lack of Efficacy|16|||
155242911|NCT02682264|560322253|FG000|Overall Study|Withdrawal by Parent|6|||
155242912|NCT02682264|560322254|FG001|Overall Study|Withdrawal by Parent|7|||
155242913|NCT02682264|560322253|FG000|Overall Study|Adverse Event|9|||
155242914|NCT02682264|560322254|FG001|Overall Study|Adverse Event|0|||
155242915|NCT02682264|560322253|FG000|Overall Study|Noncompliance with study drug|1|||
155242916|NCT02682264|560322254|FG001|Overall Study|Noncompliance with study drug|4|||
155242917|NCT02682264|560322253|FG000|Overall Study|Pregnancy|1|||
155242918|NCT02682264|560322254|FG001|Overall Study|Pregnancy|2|||
155242919|NCT02682264|560322253|FG000|Overall Study|Recovery|1|||
155242920|NCT02682264|560322254|FG001|Overall Study|Recovery|2|||
155242921|NCT02682264|560322253|FG000|Overall Study|Progressive Disease|1|||
155242922|NCT02682264|560322254|FG001|Overall Study|Progressive Disease|0|||
155242923|NCT02682264|560322253|FG000|Overall Study|Technical Problems|0|||
155242924|NCT02682264|560322254|FG001|Overall Study|Technical Problems|1|||
155242925|NCT02682264|560322253|FG000|Overall Study|Moved abroad and unable to continue|0|||
155242926|NCT02682264|560322254|FG001|Overall Study|Moved abroad and unable to continue|3|||
155242927|NCT02682264|560322253|FG000|Overall Study|Stopped test article application|0|||
155242928|NCT02682264|560322254|FG001|Overall Study|Stopped test article application|1|||
155242929|NCT03879798|560322256|FG000|Overall Study|Adverse Event|0|||
155242930|NCT03879798|560322257|FG001|Overall Study|Adverse Event|0|||
155242931|NCT03879798|560322258|FG002|Overall Study|Adverse Event|0|||
155242932|NCT03879798|560322259|FG003|Overall Study|Adverse Event|0|||
155242933|NCT03879798|560322260|FG004|Overall Study|Adverse Event|0|||
155242934|NCT03879798|560322261|FG005|Overall Study|Adverse Event|1|||
155242935|NCT03879798|560322256|FG000|Overall Study|Lack of Efficacy|0|||
155242936|NCT03879798|560322257|FG001|Overall Study|Lack of Efficacy|0|||
155242937|NCT03879798|560322258|FG002|Overall Study|Lack of Efficacy|0|||
155242938|NCT03879798|560322259|FG003|Overall Study|Lack of Efficacy|0|||
155242939|NCT03879798|560322260|FG004|Overall Study|Lack of Efficacy|0|||
155242940|NCT03879798|560322261|FG005|Overall Study|Lack of Efficacy|1|||
155242941|NCT03879798|560322256|FG000|Overall Study|Withdrawal by Subject|0|||
155242942|NCT03879798|560322257|FG001|Overall Study|Withdrawal by Subject|0|||
155242943|NCT03879798|560322258|FG002|Overall Study|Withdrawal by Subject|0|||
155242944|NCT03879798|560322259|FG003|Overall Study|Withdrawal by Subject|0|||
155242945|NCT03879798|560322260|FG004|Overall Study|Withdrawal by Subject|0|||
155242946|NCT03879798|560322261|FG005|Overall Study|Withdrawal by Subject|1|||
155242947|NCT01255358|560322262|FG000|Overall Study|Adverse Event|2|||
155242948|NCT01255358|560322262|FG000|Overall Study|Protocol Violation|2|||
155242949|NCT06027216|560322263|FG000|Overall Study|Did not qualify|8|||
155242950|NCT03231371|560322264|FG000|Overall Study|Withdrawal by Subject|1|||
155242951|NCT03231371|560322264|FG000|Overall Study|chose or were ineligible to have MRI|12|||
155242952|NCT00345579|560322268|FG000|Overall Study|Adverse Event|9|||
155242953|NCT00345579|560322269|FG001|Overall Study|Adverse Event|6|||
155242954|NCT00345579|560322268|FG000|Overall Study|Protocol Violation|14|||
155242955|NCT00345579|560322269|FG001|Overall Study|Protocol Violation|5|||
155242956|NCT00345579|560322268|FG000|Overall Study|Withdrawal by Subject|50|||
155242957|NCT00345579|560322269|FG001|Overall Study|Withdrawal by Subject|17|||
155242958|NCT00345579|560322268|FG000|Overall Study|Lost to Follow-up|82|||
155242959|NCT00345579|560322269|FG001|Overall Study|Lost to Follow-up|36|||
155242960|NCT00345579|560322268|FG000|Overall Study|Other|9|||
155242961|NCT00345579|560322269|FG001|Overall Study|Other|1|||
155242962|NCT03029208|560322270|FG000|Overall Study|Withdrawal by Subject|2|||
155242963|NCT03029208|560322271|FG001|Overall Study|Withdrawal by Subject|3|||
155242964|NCT03029208|560322270|FG000|Overall Study|Lost to Follow-up|0|||
155242965|NCT03029208|560322271|FG001|Overall Study|Lost to Follow-up|1|||
155242966|NCT03207750|560322274|FG000|Overall Study|Adverse Event|3|||
155242967|NCT03207750|560322275|FG001|Overall Study|Adverse Event|2|||
155242968|NCT03207750|560322274|FG000|Overall Study|Lost to Follow-up|21|||
155242969|NCT03207750|560322275|FG001|Overall Study|Lost to Follow-up|29|||
155242970|NCT03207750|560322274|FG000|Overall Study|Protocol Violation|0|||
155242971|NCT03207750|560322275|FG001|Overall Study|Protocol Violation|1|||
155242972|NCT03207750|560322274|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
155242973|NCT03207750|560322275|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
155242974|NCT03207750|560322274|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
155242975|NCT03207750|560322275|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
155242976|NCT03207750|560322274|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
155242977|NCT03207750|560322275|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
155242978|NCT03207750|560322274|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
155242979|NCT03207750|560322275|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
155242980|NCT03207750|560322274|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
155242981|NCT03207750|560322275|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
155242982|NCT02493361|560322276|FG000|Overall Study|Withdrawal by Subject|3|||
155242983|NCT00856583|560322279|FG000|Overall Study|Lack of Efficacy|389|||
155242984|NCT00856583|560322280|FG001|Overall Study|Lack of Efficacy|377|||
155242985|NCT00856583|560322279|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
155242986|NCT00856583|560322280|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
155242987|NCT00856583|560322279|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
155242988|NCT00856583|560322280|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
155242989|NCT00856583|560322279|FG000|Overall Study|Non-compliance|305|||
155242990|NCT00856583|560322280|FG001|Overall Study|Non-compliance|262|||
155242991|NCT00856583|560322279|FG000|Overall Study|Withdrawal by Subject|1092|||
155242992|NCT00856583|560322280|FG001|Overall Study|Withdrawal by Subject|919|||
155242993|NCT00856583|560322279|FG000|Overall Study|Physician Decision|59|||
155242994|NCT00856583|560322280|FG001|Overall Study|Physician Decision|82|||
155242995|NCT00856583|560322279|FG000|Overall Study|Pregnancy|14|||
155242996|NCT00856583|560322280|FG001|Overall Study|Pregnancy|5|||
155242997|NCT00856583|560322279|FG000|Overall Study|Other|92|||
155242998|NCT00856583|560322280|FG001|Overall Study|Other|104|||
155242999|NCT00856583|560322279|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
155243000|NCT00856583|560322280|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
155243001|NCT01944046|560322281|FG000|Randomized to DB|Adverse Event|5|||
155243002|NCT01944046|560322282|FG001|Randomized to DB|Adverse Event|2|||
155243003|NCT01944046|560322281|FG000|Randomized to DB|Clinical Worsening|3|||
155243004|NCT01944046|560322282|FG001|Randomized to DB|Clinical Worsening|2|||
155243005|NCT01944046|560322281|FG000|Randomized to DB|Lost to Follow-up|3|||
155243006|NCT01944046|560322282|FG001|Randomized to DB|Lost to Follow-up|3|||
155243007|NCT01944046|560322281|FG000|Randomized to DB|Withdrawal by Subject|2|||
155243008|NCT01944046|560322282|FG001|Randomized to DB|Withdrawal by Subject|4|||
155243009|NCT01944046|560322281|FG000|Randomized to DB|Physician Decision|1|||
155243010|NCT01944046|560322282|FG001|Randomized to DB|Physician Decision|2|||
155243011|NCT01944046|560322281|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
155243012|NCT01944046|560322282|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
155243013|NCT01944046|560322281|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
155243014|NCT01944046|560322282|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
155243015|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
155607047|NCT01897571|561649617|FG004|Overall Study|Death|7|||
155243016|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
155243017|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Adverse Event|6|||
155243018|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Adverse Event|1|||
155243019|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
155243020|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
155243021|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
155243022|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
155243023|NCT02007577|560322285|FG000|Overall Study|Adverse Event|1|||
155243024|NCT02007577|560322286|FG001|Overall Study|Adverse Event|0|||
155243025|NCT02007577|560322285|FG000|Overall Study|Withdrawal by Subject|0|||
155243026|NCT02007577|560322286|FG001|Overall Study|Withdrawal by Subject|1|||
155243027|NCT02504294|560322289|FG000|Overall Study|Adverse Event|15|||
155243028|NCT02504294|560322290|FG001|Overall Study|Adverse Event|12|||
155243029|NCT02504294|560322289|FG000|Overall Study|Withdrawal by Subject|7|||
155243030|NCT02504294|560322290|FG001|Overall Study|Withdrawal by Subject|1|||
155243031|NCT02504294|560322289|FG000|Overall Study|Protocol Violation|27|||
155243032|NCT02504294|560322290|FG001|Overall Study|Protocol Violation|26|||
155243033|NCT02504294|560322289|FG000|Overall Study|Physician Decision|1|||
155243034|NCT02504294|560322290|FG001|Overall Study|Physician Decision|2|||
155243035|NCT02504294|560322289|FG000|Overall Study|Lost to Follow-up|6|||
155243036|NCT02504294|560322290|FG001|Overall Study|Lost to Follow-up|7|||
155243037|NCT02252211|560322296|FG000|Overall Study|Adverse Event|0|||
155243038|NCT02252211|560322297|FG001|Overall Study|Adverse Event|1|||
155243039|NCT02252211|560322298|FG002|Overall Study|Adverse Event|0|||
155243040|NCT02252211|560322296|FG000|Overall Study|Progressive disease|3|||
155243041|NCT02252211|560322297|FG001|Overall Study|Progressive disease|2|||
155243042|NCT02252211|560322298|FG002|Overall Study|Progressive disease|0|||
155243043|NCT02252211|560322296|FG000|Overall Study|Withdrawal by Subject|1|||
155243044|NCT02252211|560322297|FG001|Overall Study|Withdrawal by Subject|0|||
155243045|NCT02252211|560322298|FG002|Overall Study|Withdrawal by Subject|0|||
155243046|NCT02252211|560322296|FG000|Overall Study|Serious Adverse Event During Screening|1|||
155243047|NCT02252211|560322297|FG001|Overall Study|Serious Adverse Event During Screening|0|||
155243048|NCT02252211|560322298|FG002|Overall Study|Serious Adverse Event During Screening|1|||
155243049|NCT03694548|560322299|FG000|Part A Survey|Protocol Violation|3|||
155243050|NCT03694548|560322300|FG001|Part A Survey|Protocol Violation|3|||
155243051|NCT03694548|560322301|FG002|Part A Survey|Protocol Violation|0|||
155243052|NCT03694548|560322299|FG000|Part B Yoga Program|Protocol Violation|0|||
155243053|NCT03694548|560322300|FG001|Part B Yoga Program|Protocol Violation|0|||
155243054|NCT03694548|560322301|FG002|Part B Yoga Program|Protocol Violation|3|||
155243055|NCT03694548|560322299|FG000|Part B Yoga Program|Did not attend intervention|0|||
155243056|NCT03694548|560322300|FG001|Part B Yoga Program|Did not attend intervention|0|||
155243057|NCT03694548|560322301|FG002|Part B Yoga Program|Did not attend intervention|8|||
155243058|NCT04307186|560322302|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
155243059|NCT04307186|560322302|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
155243060|NCT04307186|560322302|FG000|Washout 3-14 Days|Progressive disease|1|||
155243061|NCT04307186|560322302|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
155243062|NCT04307186|560322302|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
155243063|NCT06281548|560322305|FG000|Overall Study|Lost to Follow-up|3|||
155243064|NCT01618838|560322306|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
155243065|NCT01587651|560322307|FG000|Overall Study|Adverse Event|0|||
155243066|NCT01587651|560322308|FG001|Overall Study|Adverse Event|1|||
155243067|NCT01587651|560322309|FG002|Overall Study|Adverse Event|0|||
155243068|NCT01587651|560322307|FG000|Overall Study|Protocol Violation|0|||
155243069|NCT01587651|560322308|FG001|Overall Study|Protocol Violation|1|||
155243070|NCT01587651|560322309|FG002|Overall Study|Protocol Violation|1|||
155243071|NCT01587651|560322307|FG000|Overall Study|Withdrawal by Subject|0|||
155243072|NCT01587651|560322308|FG001|Overall Study|Withdrawal by Subject|1|||
155243073|NCT01587651|560322309|FG002|Overall Study|Withdrawal by Subject|0|||
155243074|NCT03191903|560322310|FG000|Overall Study|Withdrawal by Subject|6|||
155243075|NCT03191903|560322311|FG001|Overall Study|Withdrawal by Subject|5|||
155243076|NCT03191903|560322312|FG002|Overall Study|Withdrawal by Subject|4|||
155243077|NCT03191903|560322310|FG000|Overall Study|Adverse Event|1|||
155243078|NCT03191903|560322311|FG001|Overall Study|Adverse Event|0|||
155243079|NCT03191903|560322312|FG002|Overall Study|Adverse Event|0|||
155243080|NCT00503685|560322316|FG000|Overall Study|Adverse Event|0|||
155243081|NCT00503685|560322317|FG001|Overall Study|Adverse Event|0|||
155243082|NCT00503685|560322318|FG002|Overall Study|Adverse Event|2|||
155243083|NCT00503685|560322316|FG000|Overall Study|Withdrawal by Subject|0|||
155243084|NCT00503685|560322317|FG001|Overall Study|Withdrawal by Subject|1|||
155243085|NCT00503685|560322318|FG002|Overall Study|Withdrawal by Subject|0|||
155243086|NCT00503685|560322316|FG000|Overall Study|Protocol Violation|0|||
155243087|NCT00503685|560322317|FG001|Overall Study|Protocol Violation|1|||
155243088|NCT00503685|560322318|FG002|Overall Study|Protocol Violation|0|||
155243089|NCT00503685|560322316|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155243090|NCT00503685|560322317|FG001|Overall Study|Eligibility Criteria Not Met|1|||
155243091|NCT00503685|560322318|FG002|Overall Study|Eligibility Criteria Not Met|0|||
155243092|NCT01110239|560322323|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
155243093|NCT01110239|560322324|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
155243094|NCT01110239|560322325|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
155243095|NCT01110239|560322326|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
155243096|NCT01110239|560322323|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243097|NCT01110239|560322324|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243098|NCT01110239|560322325|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
155243099|NCT01110239|560322326|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243100|NCT00080223|560322329|FG000|Overall Study|Adverse Event|23|||
155243101|NCT00080223|560322329|FG000|Overall Study|Death|21|||
155243102|NCT00080223|560322329|FG000|Overall Study|Withdrawal by Subject|13|||
155243103|NCT00080223|560322329|FG000|Overall Study|Lung Transplantation|9|||
155243104|NCT00080223|560322329|FG000|Overall Study|Non-compliance With Study Treatment|7|||
155243105|NCT00080223|560322329|FG000|Overall Study|Participant unwilling to continue|2|||
155243106|NCT00080223|560322329|FG000|Overall Study|Physician Decision|1|||
155243107|NCT03099382|560322338|FG000|Overall Study|Protocol Violation|2|||
155243108|NCT03099382|560322339|FG001|Overall Study|Protocol Violation|3|||
155243109|NCT00499369|560322340|FG000|Overall Study|Adverse Event|2|||
155243110|NCT00499369|560322341|FG001|Overall Study|Adverse Event|2|||
155243111|NCT00499369|560322342|FG002|Overall Study|Adverse Event|3|||
155243112|NCT00499369|560322343|FG003|Overall Study|Adverse Event|1|||
155243113|NCT00499369|560322344|FG004|Overall Study|Adverse Event|2|||
155243114|NCT00499369|560322340|FG000|Overall Study|Withdrawal by Subject|0|||
155243115|NCT00499369|560322341|FG001|Overall Study|Withdrawal by Subject|1|||
155243116|NCT00499369|560322342|FG002|Overall Study|Withdrawal by Subject|1|||
155243117|NCT00499369|560322343|FG003|Overall Study|Withdrawal by Subject|0|||
155243118|NCT00499369|560322344|FG004|Overall Study|Withdrawal by Subject|0|||
155243119|NCT00499369|560322340|FG000|Overall Study|Progression|10|||
155243120|NCT00499369|560322341|FG001|Overall Study|Progression|12|||
155243121|NCT00499369|560322342|FG002|Overall Study|Progression|9|||
155243122|NCT00499369|560322343|FG003|Overall Study|Progression|6|||
155243123|NCT00499369|560322344|FG004|Overall Study|Progression|10|||
155243124|NCT00499369|560322340|FG000|Overall Study|Death|0|||
155243125|NCT00499369|560322341|FG001|Overall Study|Death|1|||
155243126|NCT00499369|560322342|FG002|Overall Study|Death|0|||
155243127|NCT00499369|560322343|FG003|Overall Study|Death|0|||
155243128|NCT00499369|560322344|FG004|Overall Study|Death|0|||
155243129|NCT00499369|560322340|FG000|Overall Study|Not protocol specified|2|||
155243130|NCT00499369|560322341|FG001|Overall Study|Not protocol specified|0|||
155243131|NCT00499369|560322342|FG002|Overall Study|Not protocol specified|3|||
155243132|NCT00499369|560322343|FG003|Overall Study|Not protocol specified|1|||
155243133|NCT00499369|560322344|FG004|Overall Study|Not protocol specified|0|||
155243134|NCT00499369|560322340|FG000|Overall Study|Ineligible|2|||
155243135|NCT00499369|560322341|FG001|Overall Study|Ineligible|2|||
155243136|NCT00499369|560322342|FG002|Overall Study|Ineligible|1|||
155243137|NCT00499369|560322343|FG003|Overall Study|Ineligible|1|||
155243138|NCT00499369|560322344|FG004|Overall Study|Ineligible|0|||
155243139|NCT01898195|560322346|FG000|Smoking Abstinence|Did not have good measurements|35|||
155243140|NCT01898195|560322347|FG001|Smoking Abstinence|Did not have good measurements|38|||
155243141|NCT01898195|560322348|FG002|Smoking Abstinence|Did not have good measurements|36|||
155243142|NCT01802411|560322349|FG000|Overall Study|Death|2|||
155243143|NCT01802411|560322350|FG001|Overall Study|Death|1|||
155243144|NCT01802411|560322349|FG000|Overall Study|Adverse Event|2|||
155243145|NCT01802411|560322350|FG001|Overall Study|Adverse Event|7|||
155243146|NCT01802411|560322349|FG000|Overall Study|Lack of Efficacy|8|||
155243147|NCT01802411|560322350|FG001|Overall Study|Lack of Efficacy|10|||
155243148|NCT01802411|560322349|FG000|Overall Study|Withdrawal by Subject|0|||
155243149|NCT01802411|560322350|FG001|Overall Study|Withdrawal by Subject|2|||
155243150|NCT01802411|560322349|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
155243151|NCT01802411|560322350|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
155243152|NCT01802411|560322349|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
155243153|NCT01802411|560322350|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
155243154|NCT01802411|560322349|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
155243155|NCT01802411|560322350|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
155243156|NCT01337245|560322351|FG000|Overall Study|Lost to Follow-up|1|||
155243157|NCT03930745|560322352|FG000|Overall Study|Lost to Follow-up|10|||
155243158|NCT03930745|560322353|FG001|Overall Study|Lost to Follow-up|5|||
155243159|NCT03930745|560322352|FG000|Overall Study|Withdrawal by Subject|1|||
155243160|NCT03930745|560322353|FG001|Overall Study|Withdrawal by Subject|2|||
155243161|NCT03930745|560322352|FG000|Overall Study|Protocol Violation|2|||
155243162|NCT03930745|560322353|FG001|Overall Study|Protocol Violation|2|||
155243163|NCT03930745|560322352|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
155243164|NCT03930745|560322353|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
155243165|NCT03930745|560322352|FG000|Overall Study|Adverse Event|0|||
155243166|NCT03930745|560322353|FG001|Overall Study|Adverse Event|1|||
155243167|NCT03930745|560322352|FG000|Overall Study|Pregnancy|0|||
155243168|NCT03930745|560322353|FG001|Overall Study|Pregnancy|1|||
155243169|NCT04095858|560322356|FG000|Overall Study|Death|1|||
155243170|NCT04095858|560322357|FG001|Overall Study|Death|0|||
155243171|NCT04095858|560322356|FG000|Overall Study|Study terminated by Sponsor|2|||
155243172|NCT04095858|560322357|FG001|Overall Study|Study terminated by Sponsor|4|||
155243173|NCT00612313|560322374|FG000|Overall Study|Withdrawal by Subject|6|||
155243174|NCT00612313|560322375|FG001|Overall Study|Withdrawal by Subject|9|||
155243175|NCT00612313|560322374|FG000|Overall Study|Lost to Follow-up|11|||
155243176|NCT00612313|560322375|FG001|Overall Study|Lost to Follow-up|4|||
155243177|NCT00428610|560322376|FG000|Overall Study|Death Due to Adverse Event|3|||
155243178|NCT00428610|560322377|FG001|Overall Study|Death Due to Adverse Event|0|||
155243179|NCT00428610|560322378|FG002|Overall Study|Death Due to Adverse Event|5|||
155243180|NCT00428610|560322376|FG000|Overall Study|Death Due to Progressive Disease|0|||
155243181|NCT00428610|560322377|FG001|Overall Study|Death Due to Progressive Disease|0|||
155243182|NCT00428610|560322378|FG002|Overall Study|Death Due to Progressive Disease|2|||
155243183|NCT00428610|560322376|FG000|Overall Study|Adverse Event|2|||
155243184|NCT00428610|560322377|FG001|Overall Study|Adverse Event|3|||
155243185|NCT00428610|560322378|FG002|Overall Study|Adverse Event|2|||
155243186|NCT00428610|560322376|FG000|Overall Study|Investigator Decision|2|||
155243187|NCT00428610|560322377|FG001|Overall Study|Investigator Decision|1|||
155243188|NCT00428610|560322378|FG002|Overall Study|Investigator Decision|1|||
155243189|NCT00428610|560322376|FG000|Overall Study|Progressive Disease|42|||
155243190|NCT00428610|560322377|FG001|Overall Study|Progressive Disease|14|||
155243191|NCT00428610|560322378|FG002|Overall Study|Progressive Disease|22|||
155243192|NCT00428610|560322376|FG000|Overall Study|Withdrawal by Subject|4|||
155243193|NCT00428610|560322377|FG001|Overall Study|Withdrawal by Subject|0|||
155243194|NCT00428610|560322378|FG002|Overall Study|Withdrawal by Subject|0|||
155243195|NCT04745169|560324292|FG000|Overall Study|Kidney transplantation|1|||
155243196|NCT04745169|560324292|FG000|Overall Study|Participant health problems|3|||
155243197|NCT04745169|560324292|FG000|Overall Study|Physician Decision|2|||
155243198|NCT02053350|560324299|FG000|Overall Study|Withdrawal by Subject|1|||
155243199|NCT02053350|560324299|FG000|Overall Study|Adverse Event|4|||
155243200|NCT03521635|560324300|FG000|Overall Study|Adverse Event|1|||
155243201|NCT03521635|560324301|FG001|Overall Study|Adverse Event|1|||
155243202|NCT03521635|560324300|FG000|Overall Study|Refused to complete study visit|1|||
155243203|NCT03521635|560324301|FG001|Overall Study|Refused to complete study visit|0|||
155243204|NCT03521635|560324300|FG000|Overall Study|Refused to continue trial medication|2|||
155243205|NCT03521635|560324301|FG001|Overall Study|Refused to continue trial medication|2|||
155243206|NCT03521635|560324300|FG000|Overall Study|Lost to Follow-up|0|||
155243207|NCT03521635|560324301|FG001|Overall Study|Lost to Follow-up|1|||
155243208|NCT03521635|560324300|FG000|Overall Study|Meet exclusion criteria|0|||
155243209|NCT03521635|560324301|FG001|Overall Study|Meet exclusion criteria|1|||
155243210|NCT03521635|560324300|FG000|Overall Study|Patient not taken study medicine|0|||
155243211|NCT03521635|560324301|FG001|Overall Study|Patient not taken study medicine|1|||
155243212|NCT00896168|560324302|FG000|Overall Study|Adverse Event|4|||
155243213|NCT00896168|560324303|FG001|Overall Study|Adverse Event|7|||
155243214|NCT00896168|560324302|FG000|Overall Study|Treatment failure|8|||
155243215|NCT00896168|560324303|FG001|Overall Study|Treatment failure|10|||
155243216|NCT00896168|560324302|FG000|Overall Study|Lost to Follow-up|1|||
155243217|NCT00896168|560324303|FG001|Overall Study|Lost to Follow-up|1|||
155243218|NCT00896168|560324302|FG000|Overall Study|Other|1|||
155243219|NCT00896168|560324303|FG001|Overall Study|Other|1|||
155243220|NCT03832010|560324304|FG000|Overall Study|Withdrawal by Subject|2|||
155243221|NCT03832010|560324305|FG001|Overall Study|Withdrawal by Subject|1|||
155243222|NCT03832010|560324306|FG002|Overall Study|Withdrawal by Subject|0|||
155243223|NCT03832010|560324304|FG000|Overall Study|Lost to Follow-up|2|||
155243224|NCT03832010|560324305|FG001|Overall Study|Lost to Follow-up|1|||
155243225|NCT03832010|560324306|FG002|Overall Study|Lost to Follow-up|1|||
155243226|NCT01227889|560324307|FG000|Randomized Phase (RP)|Adverse Event|13|||
155243227|NCT01227889|560324308|FG001|Randomized Phase (RP)|Adverse Event|0|||
155243228|NCT01227889|560324307|FG000|Randomized Phase (RP)|Physician Decision|13|||
155243229|NCT01227889|560324308|FG001|Randomized Phase (RP)|Physician Decision|5|||
155243230|NCT01227889|560324307|FG000|Randomized Phase (RP)|Progressive Disease|135|||
155243231|NCT01227889|560324308|FG001|Randomized Phase (RP)|Progressive Disease|52|||
155243232|NCT01227889|560324307|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
155243233|NCT01227889|560324308|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
155243234|NCT01227889|560324307|FG000|Randomized Phase (RP)|Missing|1|||
155243235|NCT01227889|560324308|FG001|Randomized Phase (RP)|Missing|3|||
155243236|NCT01227889|560324307|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
155243237|NCT01227889|560324308|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
155243238|NCT01227889|560324307|FG000|Crossover Phase|Adverse Event|0|||
155243239|NCT01227889|560324308|FG001|Crossover Phase|Adverse Event|1|||
155243240|NCT01227889|560324307|FG000|Crossover Phase|Physician Decision|0|||
155243241|NCT01227889|560324308|FG001|Crossover Phase|Physician Decision|3|||
155243242|NCT01227889|560324307|FG000|Crossover Phase|Progressive Disease|0|||
155243243|NCT01227889|560324308|FG001|Crossover Phase|Progressive Disease|31|||
155243244|NCT01227889|560324307|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
155243245|NCT01227889|560324308|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
155243246|NCT01227889|560324307|FG000|Crossover Phase|Withdrawal by Subject|0|||
155243247|NCT01227889|560324308|FG001|Crossover Phase|Withdrawal by Subject|1|||
155243248|NCT01148810|560324309|FG000|Overall Study|Adverse Event|0|||
155243249|NCT01148810|560324310|FG001|Overall Study|Adverse Event|2|||
155243250|NCT01148810|560324309|FG000|Overall Study|Lack of Efficacy|0|||
155243251|NCT01148810|560324310|FG001|Overall Study|Lack of Efficacy|1|||
155243252|NCT01148810|560324309|FG000|Overall Study|Withdrawal by Subject|0|||
155243253|NCT01148810|560324310|FG001|Overall Study|Withdrawal by Subject|2|||
155243254|NCT01148810|560324309|FG000|Overall Study|Protocol Violation|1|||
155243255|NCT01148810|560324310|FG001|Overall Study|Protocol Violation|0|||
155243256|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
155243257|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
155243258|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
155243259|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
155243260|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
155243261|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
155243262|NCT02417246|560324318|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
155243263|NCT02417246|560324319|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
155243264|NCT04408469|560324323|FG000|Overall Study|Lost to Follow-up|6|||
155243265|NCT04408469|560324324|FG001|Overall Study|Lost to Follow-up|9|||
155243266|NCT04408469|560324323|FG000|Overall Study|Withdrawal by Subject|6|||
155243267|NCT04408469|560324324|FG001|Overall Study|Withdrawal by Subject|1|||
155243268|NCT04408469|560324323|FG000|Overall Study|Dismissal due to ineligibility|0|||
155243269|NCT04408469|560324324|FG001|Overall Study|Dismissal due to ineligibility|1|||
155243270|NCT04321460|560324325|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
155243271|NCT04321460|560324326|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
155243272|NCT02553330|560324329|FG000|Overall Study|Study Terminated by Sponsor|2|||
155243273|NCT02553330|560324330|FG001|Overall Study|Study Terminated by Sponsor|13|||
155243274|NCT02553330|560324331|FG002|Overall Study|Study Terminated by Sponsor|12|||
155243275|NCT02553330|560324329|FG000|Overall Study|Withdrawal by Subject|3|||
155243276|NCT02553330|560324330|FG001|Overall Study|Withdrawal by Subject|19|||
155243277|NCT02553330|560324331|FG002|Overall Study|Withdrawal by Subject|21|||
155243278|NCT02553330|560324329|FG000|Overall Study|Other|0|||
155243279|NCT02553330|560324330|FG001|Overall Study|Other|1|||
155243280|NCT02553330|560324331|FG002|Overall Study|Other|0|||
155243281|NCT02553330|560324329|FG000|Overall Study|Non compliance to study treatment|0|||
155243282|NCT02553330|560324330|FG001|Overall Study|Non compliance to study treatment|1|||
155243283|NCT02553330|560324331|FG002|Overall Study|Non compliance to study treatment|0|||
155243284|NCT02553330|560324329|FG000|Overall Study|Adverse Event|0|||
155243285|NCT02553330|560324330|FG001|Overall Study|Adverse Event|1|||
155243286|NCT02553330|560324331|FG002|Overall Study|Adverse Event|0|||
155243287|NCT02553330|560324329|FG000|Overall Study|Lost to Follow-up|0|||
155243288|NCT02553330|560324330|FG001|Overall Study|Lost to Follow-up|4|||
155243289|NCT02553330|560324331|FG002|Overall Study|Lost to Follow-up|4|||
155243290|NCT01205685|560324332|FG000|Overall Study|Disease Progression|10|||
155243291|NCT01205685|560324332|FG000|Overall Study|Withdrawal by Subject|1|||
155243292|NCT01666002|560324333|FG000|Overall Study|Lost to Follow-up|5|||
155243293|NCT01666002|560324334|FG001|Overall Study|Lost to Follow-up|0|||
155243294|NCT03058679|560324342|FG000|Baseline to Week 6|Lost to Follow-up|3|||
155243295|NCT03058679|560324343|FG001|Baseline to Week 6|Lost to Follow-up|2|||
155243296|NCT03058679|560324342|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
155243297|NCT03058679|560324343|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
155243298|NCT03058679|560324342|FG000|Baseline to Week 6|Adverse Event|6|||
155243299|NCT03058679|560324343|FG001|Baseline to Week 6|Adverse Event|6|||
155243300|NCT03058679|560324342|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
155243301|NCT03058679|560324343|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
155243302|NCT03058679|560324342|FG000|Baseline to Week 6|Difficulty following the diet|0|||
155243303|NCT03058679|560324343|FG001|Baseline to Week 6|Difficulty following the diet|2|||
155243304|NCT03058679|560324342|FG000|Baseline to Week 6|Physician Decision|1|||
155243305|NCT03058679|560324343|FG001|Baseline to Week 6|Physician Decision|0|||
155243306|NCT03058679|560324342|FG000|Week 6 to Week 12|Change in medication|5|||
155243307|NCT03058679|560324343|FG001|Week 6 to Week 12|Change in medication|7|||
155243308|NCT03058679|560324342|FG000|Week 6 to Week 12|Adverse Event|4|||
155243309|NCT03058679|560324343|FG001|Week 6 to Week 12|Adverse Event|3|||
155243310|NCT03058679|560324342|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
155243311|NCT03058679|560324343|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
155243312|NCT03058679|560324342|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
155243313|NCT03058679|560324343|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
155243314|NCT04137380|560324348|FG000|Overall Study|Physician Decision|0|||
155243315|NCT04137380|560324349|FG001|Overall Study|Physician Decision|0|||
155243316|NCT04137380|560324350|FG002|Overall Study|Physician Decision|0|||
155243317|NCT04137380|560324351|FG003|Overall Study|Physician Decision|1|||
155243318|NCT04137380|560324352|FG004|Overall Study|Physician Decision|0|||
155243319|NCT04137380|560324353|FG005|Overall Study|Physician Decision|0|||
155243320|NCT04137380|560324354|FG006|Overall Study|Physician Decision|0|||
155243321|NCT00346034|560324357|FG000|Overall Study|Adverse Event|34|||
155243322|NCT00346034|560324357|FG000|Overall Study|Lack of Efficacy|8|||
155243323|NCT00346034|560324357|FG000|Overall Study|Withdrawal by Subject|13|||
155243324|NCT00346034|560324357|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
155243325|NCT00346034|560324357|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
155243326|NCT00941603|560324361|FG000|Overall Study|Adverse Event|10|||
155243327|NCT00941603|560324362|FG001|Overall Study|Adverse Event|15|||
155243328|NCT00941603|560324363|FG002|Overall Study|Adverse Event|5|||
155243329|NCT00941603|560324364|FG003|Overall Study|Adverse Event|1|||
155243330|NCT00941603|560324365|FG004|Overall Study|Adverse Event|4|||
155243331|NCT00941603|560324366|FG005|Overall Study|Adverse Event|0|||
155243332|NCT00941603|560324361|FG000|Overall Study|Lost to Follow-up|0|||
155243333|NCT00941603|560324362|FG001|Overall Study|Lost to Follow-up|0|||
155243334|NCT00941603|560324363|FG002|Overall Study|Lost to Follow-up|0|||
155243335|NCT00941603|560324364|FG003|Overall Study|Lost to Follow-up|1|||
155243336|NCT00941603|560324365|FG004|Overall Study|Lost to Follow-up|0|||
155243337|NCT00941603|560324366|FG005|Overall Study|Lost to Follow-up|2|||
155243338|NCT00941603|560324361|FG000|Overall Study|Withdrawal by Subject|0|||
155243339|NCT00941603|560324362|FG001|Overall Study|Withdrawal by Subject|0|||
155243340|NCT00941603|560324363|FG002|Overall Study|Withdrawal by Subject|0|||
155243341|NCT00941603|560324364|FG003|Overall Study|Withdrawal by Subject|2|||
155243342|NCT00941603|560324365|FG004|Overall Study|Withdrawal by Subject|0|||
155243343|NCT00941603|560324366|FG005|Overall Study|Withdrawal by Subject|1|||
155243344|NCT00941603|560324361|FG000|Overall Study|Protocol Violation|0|||
155243345|NCT00941603|560324362|FG001|Overall Study|Protocol Violation|1|||
155243346|NCT00941603|560324363|FG002|Overall Study|Protocol Violation|0|||
155243347|NCT00941603|560324364|FG003|Overall Study|Protocol Violation|0|||
155243348|NCT00941603|560324365|FG004|Overall Study|Protocol Violation|0|||
155243349|NCT00941603|560324366|FG005|Overall Study|Protocol Violation|0|||
155243350|NCT00941603|560324361|FG000|Overall Study|Did not meet protocol eligibility|1|||
155243351|NCT00941603|560324362|FG001|Overall Study|Did not meet protocol eligibility|0|||
155243352|NCT00941603|560324363|FG002|Overall Study|Did not meet protocol eligibility|0|||
155243353|NCT00941603|560324364|FG003|Overall Study|Did not meet protocol eligibility|0|||
155243354|NCT00941603|560324365|FG004|Overall Study|Did not meet protocol eligibility|0|||
155243355|NCT00941603|560324366|FG005|Overall Study|Did not meet protocol eligibility|0|||
155243356|NCT02079805|560324367|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155243357|NCT02079805|560324368|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155243358|NCT02079805|560324367|FG000|Overall Study|Voluntary Withdrawal|0|||
155243359|NCT02079805|560324368|FG001|Overall Study|Voluntary Withdrawal|1|||
155243360|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
155243361|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
155243362|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
155243363|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
155243364|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
155243365|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155243366|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
155243367|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155243368|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
155243369|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
155243370|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
155243371|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
155243372|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
155243373|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155243374|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155243375|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
155243376|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
155243377|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
155243378|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
155243379|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
155243380|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
155243381|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
155243382|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
155243383|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
155243384|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
155243385|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
155243386|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
155243387|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
155243388|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
155243389|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
155243390|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
155243391|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
155243392|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
155243393|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155243394|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
155243395|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
155243396|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
155243397|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
155243398|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
155243399|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
155243400|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
155243401|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
155243402|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
155243403|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
155243404|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
155243405|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243406|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243407|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243408|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243409|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
155243410|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155243411|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
155243412|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155243413|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155243414|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155243415|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
155243416|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
155243417|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
155243418|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
155243419|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
155243420|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155243421|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
155243422|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
155243423|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
155243424|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155243425|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
155243426|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243427|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243428|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243429|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
155243430|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155243431|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243432|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243433|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155243434|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243435|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Administrative|1|||
155243436|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Administrative|1|||
155243437|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Administrative|0|||
155243438|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Administrative|1|||
155243439|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Administrative|0|||
155243440|NCT00583557|560324374|FG000|Overall Study|Withdrawal by Subject|18|||
155243441|NCT00583557|560324374|FG000|Overall Study|Adverse Event|9|||
155243442|NCT00583557|560324374|FG000|Overall Study|Lack of Efficacy|31|||
155243443|NCT00583557|560324374|FG000|Overall Study|Lack of Compliance|5|||
155243444|NCT00583557|560324374|FG000|Overall Study|Other|5|||
155243445|NCT00583557|560324374|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
155243446|NCT02347761|560324375|FG000|All Collected|Death|1|||
155243447|NCT02347761|560324376|FG001|All Collected|Death|0|||
155243448|NCT02347761|560324377|FG002|All Collected|Death|0|||
155243449|NCT02347761|560324375|FG000|All Collected|Lost to Follow-up|3|||
155243450|NCT02347761|560324376|FG001|All Collected|Lost to Follow-up|2|||
155243451|NCT02347761|560324377|FG002|All Collected|Lost to Follow-up|3|||
155243452|NCT02347761|560324375|FG000|All Collected|Withdrawal by Subject|11|||
155243453|NCT02347761|560324376|FG001|All Collected|Withdrawal by Subject|11|||
155243454|NCT02347761|560324377|FG002|All Collected|Withdrawal by Subject|22|||
155491670|NCT00978120|561225484|FG002|Overall Study|Withdrawal by Subject|0|||
155607048|NCT01897571|561649618|FG005|Overall Study|Death|9|||
155243455|NCT02347761|560324375|FG000|All Collected|invetigator disretion|2|||
155243456|NCT02347761|560324376|FG001|All Collected|invetigator disretion|0|||
155243457|NCT02347761|560324377|FG002|All Collected|invetigator disretion|0|||
155243458|NCT02347761|560324375|FG000|All Collected|instillation site pain|0|||
155243459|NCT02347761|560324376|FG001|All Collected|instillation site pain|0|||
155243460|NCT02347761|560324377|FG002|All Collected|instillation site pain|1|||
155243461|NCT02347761|560324375|FG000|All Collected|exacerbation of COPD|0|||
155243462|NCT02347761|560324376|FG001|All Collected|exacerbation of COPD|0|||
155243463|NCT02347761|560324377|FG002|All Collected|exacerbation of COPD|1|||
155243464|NCT02347761|560324375|FG000|All Collected|moved/travel|0|||
155243465|NCT02347761|560324376|FG001|All Collected|moved/travel|1|||
155243466|NCT02347761|560324377|FG002|All Collected|moved/travel|0|||
155243467|NCT02347761|560324375|FG000|On Study Treatment|Lack of Efficacy|2|||
155243468|NCT02347761|560324376|FG001|On Study Treatment|Lack of Efficacy|3|||
155243469|NCT02347761|560324377|FG002|On Study Treatment|Lack of Efficacy|4|||
155243470|NCT02347761|560324375|FG000|On Study Treatment|non-compliance with study medication|0|||
155243471|NCT02347761|560324376|FG001|On Study Treatment|non-compliance with study medication|0|||
155243472|NCT02347761|560324377|FG002|On Study Treatment|non-compliance with study medication|2|||
155243473|NCT02347761|560324375|FG000|On Study Treatment|Withdrawal by Subject|7|||
155243474|NCT02347761|560324376|FG001|On Study Treatment|Withdrawal by Subject|3|||
155243475|NCT02347761|560324377|FG002|On Study Treatment|Withdrawal by Subject|5|||
155243476|NCT02347761|560324375|FG000|On Study Treatment|move/travel|2|||
155243477|NCT02347761|560324376|FG001|On Study Treatment|move/travel|6|||
155243478|NCT02347761|560324377|FG002|On Study Treatment|move/travel|5|||
155243479|NCT02347761|560324375|FG000|On Study Treatment|dissastisfaction with device|2|||
155243480|NCT02347761|560324376|FG001|On Study Treatment|dissastisfaction with device|1|||
155243481|NCT02347761|560324377|FG002|On Study Treatment|dissastisfaction with device|4|||
155243482|NCT02347761|560324375|FG000|On Study Treatment|Lost to Follow-up|2|||
155243483|NCT02347761|560324376|FG001|On Study Treatment|Lost to Follow-up|1|||
155243484|NCT02347761|560324377|FG002|On Study Treatment|Lost to Follow-up|1|||
155243485|NCT02347761|560324375|FG000|On Study Treatment|investigator discretion|2|||
155243486|NCT02347761|560324376|FG001|On Study Treatment|investigator discretion|0|||
155243487|NCT02347761|560324377|FG002|On Study Treatment|investigator discretion|0|||
155243488|NCT02347761|560324375|FG000|On Study Treatment|durg not working|0|||
155243489|NCT02347761|560324376|FG001|On Study Treatment|durg not working|1|||
155243490|NCT02347761|560324377|FG002|On Study Treatment|durg not working|1|||
155243491|NCT02347761|560324375|FG000|On Study Treatment|Adverse Event|10|||
155243492|NCT02347761|560324376|FG001|On Study Treatment|Adverse Event|8|||
155243493|NCT02347761|560324377|FG002|On Study Treatment|Adverse Event|20|||
155243494|NCT03950739|560324378|FG000|Treatment Phase|Adverse Event|2|||
155243495|NCT03950739|560324378|FG000|Optional Extension Phase|Death|1|||
155243496|NCT03950739|560324378|FG000|Optional Extension Phase|Progressive Disease|5|||
155243497|NCT03950739|560324378|FG000|Optional Extension Phase|Adverse Event|7|||
155243498|NCT03950739|560324378|FG000|Optional Extension Phase|Lost to Follow-up|2|||
155243499|NCT03950739|560324378|FG000|Optional Extension Phase|Site Closure|2|||
155243500|NCT03950739|560324378|FG000|Optional Extension Phase|Pregnancy|1|||
155243501|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
155243502|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
155243503|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
155243504|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
155243505|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
155243506|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
155243507|NCT03646513|560324381|FG000|Overall Study|Premature study termination|4|||
155243508|NCT01732835|560324382|FG000|6-month Primary Endpoint|Did not receive device|19|||
155243509|NCT01732835|560324382|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
155243510|NCT01732835|560324382|FG000|6-month Primary Endpoint|Adverse Event|3|||
155243511|NCT01732835|560324382|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
155243512|NCT01732835|560324382|FG000|2-year Extended Follow-up|Adverse Event|3|||
155243513|NCT01732835|560324382|FG000|2-year Extended Follow-up|Death|1|||
155243514|NCT02334748|560324383|FG000|Overall Study|Adverse Event|1|||
155243515|NCT02334748|560324383|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
155243516|NCT02334748|560324383|FG000|Overall Study|Patient no longer required study drug|2|||
155243517|NCT02334748|560324383|FG000|Overall Study|Lack of Efficacy|4|||
155243518|NCT01046643|560324384|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243519|NCT01046643|560324385|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
155243520|NCT01046643|560324386|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243521|NCT01046643|560324387|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243522|NCT00817089|560324392|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
155243523|NCT00817089|560324393|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
155243524|NCT00817089|560324394|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
155243525|NCT00817089|560324395|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
155243526|NCT00817089|560324392|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
155607049|NCT01897571|561649619|FG006|Overall Study|Death|5|||
155243527|NCT00817089|560324393|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
155243528|NCT00817089|560324394|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
155243529|NCT00817089|560324395|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
155243530|NCT02937545|560324406|FG000|Overall Study|Withdrawal by Subject|1|||
155243531|NCT02937545|560324407|FG001|Overall Study|Withdrawal by Subject|2|||
155243532|NCT02937545|560324408|FG002|Overall Study|Withdrawal by Subject|6|||
155243533|NCT02937545|560324409|FG003|Overall Study|Withdrawal by Subject|7|||
155243534|NCT02937545|560324406|FG000|Overall Study|Lost to Follow-up|1|||
155243535|NCT02937545|560324407|FG001|Overall Study|Lost to Follow-up|0|||
155243536|NCT02937545|560324408|FG002|Overall Study|Lost to Follow-up|0|||
155243537|NCT02937545|560324409|FG003|Overall Study|Lost to Follow-up|0|||
155243538|NCT01767116|560324410|FG000|Overall Study|Lost to Follow-up|2|||
155243539|NCT01767116|560324411|FG001|Overall Study|Lost to Follow-up|2|||
155243540|NCT00968669|560324413|FG000|Overall Study|Lost to Follow-up|5|||
155243541|NCT00968669|560324414|FG001|Overall Study|Lost to Follow-up|2|||
155243542|NCT00968669|560324415|FG002|Overall Study|Lost to Follow-up|1|||
155243543|NCT00968669|560324416|FG003|Overall Study|Lost to Follow-up|4|||
155243544|NCT00968669|560324413|FG000|Overall Study|Withdrawal by Subject|9|||
155243545|NCT00968669|560324414|FG001|Overall Study|Withdrawal by Subject|7|||
155243546|NCT00968669|560324415|FG002|Overall Study|Withdrawal by Subject|5|||
155243547|NCT00968669|560324416|FG003|Overall Study|Withdrawal by Subject|3|||
155243548|NCT00968669|560324413|FG000|Overall Study|Pregnancy|0|||
155243549|NCT00968669|560324414|FG001|Overall Study|Pregnancy|0|||
155243550|NCT00968669|560324415|FG002|Overall Study|Pregnancy|2|||
155243551|NCT00968669|560324416|FG003|Overall Study|Pregnancy|0|||
155243552|NCT00968669|560324413|FG000|Overall Study|AE|1|||
155243553|NCT00968669|560324414|FG001|Overall Study|AE|0|||
155243554|NCT00968669|560324415|FG002|Overall Study|AE|0|||
155243555|NCT00968669|560324416|FG003|Overall Study|AE|0|||
155243556|NCT00968669|560324413|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243557|NCT00968669|560324414|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243558|NCT00968669|560324415|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243559|NCT00968669|560324416|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
155243560|NCT00968669|560324413|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
155243561|NCT00968669|560324414|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243562|NCT00968669|560324415|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243563|NCT00968669|560324416|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243564|NCT00968669|560324413|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
155243565|NCT00968669|560324414|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243566|NCT00968669|560324415|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243567|NCT00968669|560324416|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243568|NCT00968669|560324413|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243569|NCT00968669|560324414|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243570|NCT00968669|560324415|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
155243571|NCT00968669|560324416|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243572|NCT00968669|560324413|FG000|Overall Study|EARLY WITHDRAWAL|0|||
155243573|NCT00968669|560324414|FG001|Overall Study|EARLY WITHDRAWAL|1|||
155243574|NCT00968669|560324415|FG002|Overall Study|EARLY WITHDRAWAL|0|||
155243575|NCT00968669|560324416|FG003|Overall Study|EARLY WITHDRAWAL|0|||
155243576|NCT00968669|560324413|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243577|NCT00968669|560324414|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243578|NCT00968669|560324415|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
155243579|NCT00968669|560324416|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243580|NCT00968669|560324413|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
155243581|NCT00968669|560324414|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243582|NCT00968669|560324415|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243583|NCT00968669|560324416|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243584|NCT00968669|560324413|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243585|NCT00968669|560324414|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
155243586|NCT00968669|560324415|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243587|NCT00968669|560324416|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243588|NCT00968669|560324413|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243589|NCT00968669|560324414|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
155243590|NCT00968669|560324415|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243591|NCT00968669|560324416|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243592|NCT00968669|560324413|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243593|NCT00968669|560324414|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
155243594|NCT00968669|560324415|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243595|NCT00968669|560324416|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243596|NCT00968669|560324413|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243597|NCT00968669|560324414|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
155243598|NCT00968669|560324415|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243599|NCT00968669|560324416|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243600|NCT00968669|560324413|FG000|Overall Study|SPONSOR DECISION|0|||
155243601|NCT00968669|560324414|FG001|Overall Study|SPONSOR DECISION|1|||
155243602|NCT00968669|560324415|FG002|Overall Study|SPONSOR DECISION|0|||
155243603|NCT00968669|560324416|FG003|Overall Study|SPONSOR DECISION|0|||
155243604|NCT00968669|560324413|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243605|NCT00968669|560324414|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243606|NCT00968669|560324415|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
155243607|NCT00968669|560324416|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243608|NCT00968669|560324413|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243609|NCT00968669|560324414|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
155243610|NCT00968669|560324415|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243611|NCT00968669|560324416|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243612|NCT00968669|560324413|FG000|Overall Study|SUBJECT INCARCERATED|0|||
155243613|NCT00968669|560324414|FG001|Overall Study|SUBJECT INCARCERATED|1|||
155243614|NCT00968669|560324415|FG002|Overall Study|SUBJECT INCARCERATED|0|||
155243615|NCT00968669|560324416|FG003|Overall Study|SUBJECT INCARCERATED|0|||
155243616|NCT00968669|560324413|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243617|NCT00968669|560324414|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
155243618|NCT00968669|560324415|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243619|NCT00968669|560324416|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243620|NCT00968669|560324413|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243621|NCT00968669|560324414|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243622|NCT00968669|560324415|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243623|NCT00968669|560324416|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
155243624|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
155243625|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
155243626|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
155243627|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
155243628|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243629|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243630|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243631|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
155243632|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Other|0|||
155243633|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Other|1|||
155243634|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Other|0|||
155243635|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Other|0|||
155243636|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243637|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243638|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243639|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
155243640|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
155243641|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243642|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243643|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243644|NCT05799495|560324422|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243645|NCT05799495|560324423|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243646|NCT05799495|560324424|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
155243647|NCT05799495|560324425|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243648|NCT04102501|560324429|FG000|Overall Study|Withdrawal by Subject|7|||
155243649|NCT04102501|560324430|FG001|Overall Study|Withdrawal by Subject|9|||
155243650|NCT04102501|560324429|FG000|Overall Study|Adverse Event|1|||
155243651|NCT04102501|560324430|FG001|Overall Study|Adverse Event|3|||
155243652|NCT02338362|560324432|FG000|Overall Study|Withdrawal by Subject|1|||
155243653|NCT02338362|560324433|FG001|Overall Study|Withdrawal by Subject|1|||
155243654|NCT04798586|560324434|FG000|Overall Study|Death|2|||
155243655|NCT01669343|560324435|FG000|Part A: All Patients|Withdrawal by Subject|7|||
155243656|NCT01669343|560324435|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
155243657|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
155243658|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
155243659|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
155243660|NCT00968617|560324436|FG000|Overall Study|Study terminated by sponsor|6|||
155243661|NCT02371369|560324441|FG000|Part 1|Physician Decision|0|||
155243662|NCT02371369|560324442|FG001|Part 1|Physician Decision|3|||
155243663|NCT02371369|560324441|FG000|Part 1|Adverse Event|8|||
155243664|NCT02371369|560324442|FG001|Part 1|Adverse Event|0|||
155243665|NCT02371369|560324441|FG000|Part 1|Withdrawal by Subject|1|||
155243666|NCT02371369|560324442|FG001|Part 1|Withdrawal by Subject|6|||
155243667|NCT02371369|560324441|FG000|Part 1|Disease progression|0|||
155243668|NCT02371369|560324442|FG001|Part 1|Disease progression|1|||
155243669|NCT02371369|560324441|FG000|Part 1|Protocol Violation|0|||
155243670|NCT02371369|560324442|FG001|Part 1|Protocol Violation|1|||
155243671|NCT02371369|560324441|FG000|Part 2|Adverse Event|6|||
155243672|NCT02371369|560324442|FG001|Part 2|Adverse Event|5|||
155243673|NCT02371369|560324441|FG000|Part 2|Withdrawal by Subject|16|||
155243674|NCT02371369|560324442|FG001|Part 2|Withdrawal by Subject|6|||
155243675|NCT02371369|560324441|FG000|Part 2|Investigator decision|1|||
155243676|NCT02371369|560324442|FG001|Part 2|Investigator decision|2|||
155243677|NCT02371369|560324441|FG000|Part 2|Death|0|||
155243678|NCT02371369|560324442|FG001|Part 2|Death|1|||
155243679|NCT02371369|560324441|FG000|Part 2|Disease progression|1|||
155243680|NCT02371369|560324442|FG001|Part 2|Disease progression|0|||
155243681|NCT02371369|560324441|FG000|Part 2|Subject Noncompliance|1|||
155243682|NCT02371369|560324442|FG001|Part 2|Subject Noncompliance|0|||
155243683|NCT02371369|560324441|FG000|Part 2|Lost to Follow-up|1|||
155243684|NCT02371369|560324442|FG001|Part 2|Lost to Follow-up|1|||
155243685|NCT02371369|560324441|FG000|Part 2|Subject transitioned to commercial supply|6|||
155243686|NCT02371369|560324442|FG001|Part 2|Subject transitioned to commercial supply|4|||
155243687|NCT02371369|560324441|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
155243688|NCT02371369|560324442|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
155243689|NCT02371369|560324441|FG000|Part 2|Surgical resection of tumor|1|||
155243690|NCT02371369|560324442|FG001|Part 2|Surgical resection of tumor|1|||
155243691|NCT02371369|560324441|FG000|Part 2|Other|0|||
155243692|NCT02371369|560324442|FG001|Part 2|Other|1|||
155243693|NCT01024387|560324443|FG000|Overall Study|Radiographic Progression|29|||
155243694|NCT01024387|560324443|FG000|Overall Study|Symptomatic Progression|10|||
155243695|NCT01024387|560324443|FG000|Overall Study|Physician Decision|5|||
155243696|NCT01024387|560324443|FG000|Overall Study|Withdrawal by Subject|5|||
155243697|NCT01024387|560324443|FG000|Overall Study|Death|2|||
155243698|NCT01024387|560324443|FG000|Overall Study|Prolonged Treatment Delay|1|||
155243699|NCT01024387|560324443|FG000|Overall Study|Adverse Event|3|||
155243700|NCT01024387|560324443|FG000|Overall Study|Other|5|||
155243701|NCT03855189|560324444|FG000|Overall Study|Adverse Event|5|||
155243702|NCT03855189|560324445|FG001|Overall Study|Adverse Event|2|||
155243703|NCT03855189|560324446|FG002|Overall Study|Adverse Event|4|||
155243704|NCT03855189|560324444|FG000|Overall Study|Treatment Failure|1|||
155243705|NCT03855189|560324445|FG001|Overall Study|Treatment Failure|1|||
155243706|NCT03855189|560324446|FG002|Overall Study|Treatment Failure|2|||
155243707|NCT03855189|560324444|FG000|Overall Study|Noncompliance with Protocol|0|||
155243708|NCT03855189|560324445|FG001|Overall Study|Noncompliance with Protocol|1|||
155243709|NCT03855189|560324446|FG002|Overall Study|Noncompliance with Protocol|0|||
155243710|NCT03855189|560324444|FG000|Overall Study|Did Not Return|4|||
155243711|NCT03855189|560324445|FG001|Overall Study|Did Not Return|3|||
155243712|NCT03855189|560324446|FG002|Overall Study|Did Not Return|0|||
155243713|NCT00586105|560324448|FG000|Overall Study|Adverse Event|4|||
155243714|NCT00586105|560324448|FG000|Overall Study|Death|2|||
155243715|NCT00586105|560324448|FG000|Overall Study|Protocol Violation|1|||
155243716|NCT00586105|560324448|FG000|Overall Study|Withdrawal by Subject|3|||
155243717|NCT00586105|560324448|FG000|Overall Study|Disease progression|19|||
155243718|NCT00586105|560324448|FG000|Overall Study|Switched to commercial drug|9|||
155243719|NCT00586105|560324448|FG000|Overall Study|Reason not reported|1|||
155243720|NCT00927927|560324455|FG000|Overall Study|Withdrawal by Subject|0|||
155243721|NCT00927927|560324456|FG001|Overall Study|Withdrawal by Subject|0|||
155243722|NCT00927927|560324457|FG002|Overall Study|Withdrawal by Subject|0|||
155243723|NCT00927927|560324458|FG003|Overall Study|Withdrawal by Subject|0|||
155243724|NCT00927927|560324459|FG004|Overall Study|Withdrawal by Subject|0|||
155243725|NCT00927927|560324460|FG005|Overall Study|Withdrawal by Subject|0|||
155243726|NCT00927927|560324461|FG006|Overall Study|Withdrawal by Subject|0|||
155243727|NCT00927927|560324462|FG007|Overall Study|Withdrawal by Subject|2|||
155243728|NCT00927927|560324463|FG008|Overall Study|Withdrawal by Subject|0|||
155243729|NCT00927927|560324464|FG009|Overall Study|Withdrawal by Subject|0|||
155243730|NCT00927927|560324465|FG010|Overall Study|Withdrawal by Subject|0|||
155243731|NCT00927927|560324466|FG011|Overall Study|Withdrawal by Subject|2|||
155243732|NCT00927927|560324467|FG012|Overall Study|Withdrawal by Subject|0|||
155243733|NCT00927927|560324468|FG013|Overall Study|Withdrawal by Subject|0|||
155243734|NCT00927927|560324469|FG014|Overall Study|Withdrawal by Subject|0|||
155243735|NCT01344460|560324470|FG000|Overall Study|Withdrawal by Subject|1|||
155243736|NCT01344460|560324470|FG000|Overall Study|Lost to Follow-up|2|||
155243737|NCT00558285|560324471|FG000|Overall Study|Adverse Event|1|||
155243738|NCT00558285|560324472|FG001|Overall Study|Adverse Event|1|||
155243739|NCT00558285|560324473|FG002|Overall Study|Adverse Event|4|||
155243740|NCT00558285|560324474|FG003|Overall Study|Adverse Event|1|||
155243741|NCT00558285|560324475|FG004|Overall Study|Adverse Event|2|||
155243742|NCT00558285|560324471|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155243743|NCT00558285|560324472|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155243744|NCT00558285|560324473|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155243745|NCT00558285|560324474|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155243746|NCT00558285|560324475|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155243747|NCT00558285|560324471|FG000|Overall Study|Subject withdrew consent|2|||
155243748|NCT00558285|560324472|FG001|Overall Study|Subject withdrew consent|0|||
155243749|NCT00558285|560324473|FG002|Overall Study|Subject withdrew consent|1|||
155243750|NCT00558285|560324474|FG003|Overall Study|Subject withdrew consent|1|||
155243751|NCT00558285|560324475|FG004|Overall Study|Subject withdrew consent|1|||
155243752|NCT00558285|560324471|FG000|Overall Study|Lost to Follow-up|1|||
155243753|NCT00558285|560324472|FG001|Overall Study|Lost to Follow-up|1|||
155243754|NCT00558285|560324473|FG002|Overall Study|Lost to Follow-up|0|||
155243755|NCT00558285|560324474|FG003|Overall Study|Lost to Follow-up|0|||
155243756|NCT00558285|560324475|FG004|Overall Study|Lost to Follow-up|0|||
155243757|NCT00558285|560324471|FG000|Overall Study|Administrative problems|0|||
155243758|NCT00558285|560324472|FG001|Overall Study|Administrative problems|0|||
155243759|NCT00558285|560324473|FG002|Overall Study|Administrative problems|0|||
155243760|NCT00558285|560324474|FG003|Overall Study|Administrative problems|1|||
155243761|NCT00558285|560324475|FG004|Overall Study|Administrative problems|1|||
155243762|NCT00558285|560324471|FG000|Overall Study|Protocol deviation|1|||
155243763|NCT00558285|560324472|FG001|Overall Study|Protocol deviation|1|||
155243764|NCT00558285|560324473|FG002|Overall Study|Protocol deviation|0|||
155243765|NCT00558285|560324474|FG003|Overall Study|Protocol deviation|1|||
155243766|NCT00558285|560324475|FG004|Overall Study|Protocol deviation|0|||
155243767|NCT01682460|560326251|FG000|Overall Study|Withdrawal by Subject|2|||
155243768|NCT01682460|560326251|FG000|Overall Study|Did not meet inclusion criteria|2|||
155243769|NCT00724282|560326252|FG000|Overall Study|Withdrawal by Subject|3|||
155243770|NCT00724282|560326252|FG000|Overall Study|Physician Decision|1|||
155243771|NCT03811912|560326253|FG000|Overall Study|Withdrew Consent|4|||
155243772|NCT03811912|560326254|FG001|Overall Study|Withdrew Consent|2|||
155243773|NCT03586648|560326257|FG000|Period 1|Withdrawal by Subject|0|||
155243774|NCT03586648|560326258|FG001|Period 1|Withdrawal by Subject|1|||
155243775|NCT03586648|560326257|FG000|Period 1|Lost to Follow-up|1|||
155243776|NCT03586648|560326258|FG001|Period 1|Lost to Follow-up|1|||
155243777|NCT03586648|560326257|FG000|Period 1|Adverse Event|1|||
155243778|NCT03586648|560326258|FG001|Period 1|Adverse Event|0|||
155243779|NCT03586648|560326257|FG000|Period 1|Study related symptoms or complaints|2|||
155243780|NCT03586648|560326258|FG001|Period 1|Study related symptoms or complaints|1|||
155243781|NCT03586648|560326257|FG000|Period 1|Physician Decision|0|||
155243782|NCT03586648|560326258|FG001|Period 1|Physician Decision|1|||
155243783|NCT03586648|560326257|FG000|Period 2|Adverse Event|1|||
155243784|NCT03586648|560326258|FG001|Period 2|Adverse Event|0|||
155243785|NCT00377234|560326259|FG000|Overall Study|Adverse Event|14|||
155243786|NCT00377234|560326260|FG001|Overall Study|Adverse Event|17|||
155243787|NCT00377234|560326259|FG000|Overall Study|Withdrawal by Subject|11|||
155243788|NCT00377234|560326260|FG001|Overall Study|Withdrawal by Subject|9|||
155243789|NCT00377234|560326259|FG000|Overall Study|Lost to Follow-up|4|||
155243790|NCT00377234|560326260|FG001|Overall Study|Lost to Follow-up|2|||
155243791|NCT00377234|560326259|FG000|Overall Study|Administrative|2|||
155243792|NCT00377234|560326260|FG001|Overall Study|Administrative|1|||
155243793|NCT00377234|560326259|FG000|Overall Study|Not assigned|3|||
155243794|NCT00377234|560326260|FG001|Overall Study|Not assigned|2|||
155243795|NCT00626522|560326265|FG000|Overall Study|Protocol Violation|0|||
155243796|NCT00626522|560326266|FG001|Overall Study|Protocol Violation|0|||
155243797|NCT00626522|560326267|FG002|Overall Study|Protocol Violation|0|||
155243798|NCT00626522|560326268|FG003|Overall Study|Protocol Violation|0|||
155243799|NCT00626522|560326269|FG004|Overall Study|Protocol Violation|1|||
155243800|NCT00626522|560326270|FG005|Overall Study|Protocol Violation|0|||
155243801|NCT00626522|560326265|FG000|Overall Study|Adverse Event|2|||
155243802|NCT00626522|560326266|FG001|Overall Study|Adverse Event|1|||
155243803|NCT00626522|560326267|FG002|Overall Study|Adverse Event|2|||
155243804|NCT00626522|560326268|FG003|Overall Study|Adverse Event|0|||
155243805|NCT00626522|560326269|FG004|Overall Study|Adverse Event|1|||
155243806|NCT00626522|560326270|FG005|Overall Study|Adverse Event|1|||
155243807|NCT00626522|560326265|FG000|Overall Study|Withdrawal by Subject|2|||
155243808|NCT00626522|560326266|FG001|Overall Study|Withdrawal by Subject|5|||
155243809|NCT00626522|560326267|FG002|Overall Study|Withdrawal by Subject|5|||
155243810|NCT00626522|560326268|FG003|Overall Study|Withdrawal by Subject|0|||
155243811|NCT00626522|560326269|FG004|Overall Study|Withdrawal by Subject|4|||
155243812|NCT00626522|560326270|FG005|Overall Study|Withdrawal by Subject|1|||
155243813|NCT00626522|560326265|FG000|Overall Study|COPD exacerbation|0|||
155243814|NCT00626522|560326266|FG001|Overall Study|COPD exacerbation|0|||
155243815|NCT00626522|560326267|FG002|Overall Study|COPD exacerbation|0|||
155243816|NCT00626522|560326268|FG003|Overall Study|COPD exacerbation|1|||
155243817|NCT00626522|560326269|FG004|Overall Study|COPD exacerbation|1|||
155243818|NCT00626522|560326270|FG005|Overall Study|COPD exacerbation|0|||
155243819|NCT00626522|560326265|FG000|Overall Study|Lost to Follow-up|0|||
155243820|NCT00626522|560326266|FG001|Overall Study|Lost to Follow-up|1|||
155243821|NCT00626522|560326267|FG002|Overall Study|Lost to Follow-up|0|||
155243822|NCT00626522|560326268|FG003|Overall Study|Lost to Follow-up|0|||
155243823|NCT00626522|560326269|FG004|Overall Study|Lost to Follow-up|0|||
155243824|NCT00626522|560326270|FG005|Overall Study|Lost to Follow-up|0|||
155491671|NCT00978120|561225485|FG003|Overall Study|Withdrawal by Subject|0|||
155243825|NCT00626522|560326265|FG000|Overall Study|Inconsistent reason reported|1|||
155243826|NCT00626522|560326266|FG001|Overall Study|Inconsistent reason reported|0|||
155243827|NCT00626522|560326267|FG002|Overall Study|Inconsistent reason reported|0|||
155243828|NCT00626522|560326268|FG003|Overall Study|Inconsistent reason reported|0|||
155243829|NCT00626522|560326269|FG004|Overall Study|Inconsistent reason reported|0|||
155243830|NCT00626522|560326270|FG005|Overall Study|Inconsistent reason reported|0|||
155243831|NCT00626522|560326265|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243832|NCT00626522|560326266|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243833|NCT00626522|560326267|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243834|NCT00626522|560326268|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243835|NCT00626522|560326269|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243836|NCT00626522|560326270|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243837|NCT01928719|560326271|FG000|Overall Study|Lost to Follow-up|26|||
155243838|NCT01928719|560326272|FG001|Overall Study|Lost to Follow-up|11|||
155243839|NCT01928719|560326271|FG000|Overall Study|Withdrawal by Subject|22|||
155243840|NCT01928719|560326272|FG001|Overall Study|Withdrawal by Subject|7|||
155243841|NCT01928719|560326271|FG000|Overall Study|Protocol Violation|3|||
155243842|NCT01928719|560326272|FG001|Overall Study|Protocol Violation|1|||
155243843|NCT01928719|560326271|FG000|Overall Study|Adverse Event|1|||
155243844|NCT01928719|560326272|FG001|Overall Study|Adverse Event|0|||
155243845|NCT02367911|560326275|FG000|Overall Study|Withdrawal by Subject|3|||
155243846|NCT02367911|560326276|FG001|Overall Study|Withdrawal by Subject|2|||
155243847|NCT02367911|560326275|FG000|Overall Study|Lost to Follow-up|2|||
155243848|NCT02367911|560326276|FG001|Overall Study|Lost to Follow-up|2|||
155243849|NCT00263666|560326277|FG000|Overall Study|Adverse Event|6|||
155243850|NCT00263666|560326278|FG001|Overall Study|Adverse Event|8|||
155243851|NCT00263666|560326277|FG000|Overall Study|Lost to Follow-up|1|||
155243852|NCT00263666|560326278|FG001|Overall Study|Lost to Follow-up|2|||
155243853|NCT00263666|560326277|FG000|Overall Study|Withdrawal by Subject|0|||
155243854|NCT00263666|560326278|FG001|Overall Study|Withdrawal by Subject|1|||
155243855|NCT00902304|560326279|FG000|Overall Study|Adverse Event|4|||
155243856|NCT00902304|560326280|FG001|Overall Study|Adverse Event|10|||
155243857|NCT00902304|560326281|FG002|Overall Study|Adverse Event|25|||
155243858|NCT00902304|560326279|FG000|Overall Study|Investigator discretion|3|||
155243859|NCT00902304|560326280|FG001|Overall Study|Investigator discretion|5|||
155243860|NCT00902304|560326281|FG002|Overall Study|Investigator discretion|13|||
155243861|NCT00902304|560326279|FG000|Overall Study|Lost to Follow-up|7|||
155243862|NCT00902304|560326280|FG001|Overall Study|Lost to Follow-up|7|||
155243863|NCT00902304|560326281|FG002|Overall Study|Lost to Follow-up|7|||
155243864|NCT00902304|560326279|FG000|Overall Study|Protocol Violation|9|||
155243865|NCT00902304|560326280|FG001|Overall Study|Protocol Violation|18|||
155243866|NCT00902304|560326281|FG002|Overall Study|Protocol Violation|20|||
155243867|NCT00902304|560326279|FG000|Overall Study|Withdrawal by Subject|32|||
155243868|NCT00902304|560326280|FG001|Overall Study|Withdrawal by Subject|22|||
155243869|NCT00902304|560326281|FG002|Overall Study|Withdrawal by Subject|43|||
155243870|NCT00902304|560326279|FG000|Overall Study|includes pregnancy|3|||
155243871|NCT00902304|560326280|FG001|Overall Study|includes pregnancy|9|||
155243872|NCT00902304|560326281|FG002|Overall Study|includes pregnancy|2|||
155243873|NCT00838110|560326282|FG000|Overall Study|Death|0|||
155243874|NCT00838110|560326283|FG001|Overall Study|Death|0|||
155243875|NCT00838110|560326284|FG002|Overall Study|Death|1|||
155243876|NCT00838110|560326285|FG003|Overall Study|Death|2|||
155243877|NCT00838110|560326282|FG000|Overall Study|Adverse Event|11|||
155243878|NCT00838110|560326283|FG001|Overall Study|Adverse Event|10|||
155243879|NCT00838110|560326284|FG002|Overall Study|Adverse Event|8|||
155243880|NCT00838110|560326285|FG003|Overall Study|Adverse Event|7|||
155243881|NCT00838110|560326282|FG000|Overall Study|Withdrawal by Subject|5|||
155243882|NCT00838110|560326283|FG001|Overall Study|Withdrawal by Subject|6|||
155243883|NCT00838110|560326284|FG002|Overall Study|Withdrawal by Subject|3|||
155243884|NCT00838110|560326285|FG003|Overall Study|Withdrawal by Subject|4|||
155243885|NCT00838110|560326282|FG000|Overall Study|Other|3|||
155243886|NCT00838110|560326283|FG001|Overall Study|Other|3|||
155243887|NCT00838110|560326284|FG002|Overall Study|Other|3|||
155243888|NCT00838110|560326285|FG003|Overall Study|Other|2|||
155243889|NCT00838110|560326282|FG000|Overall Study|Protocol Violation|0|||
155243890|NCT00838110|560326283|FG001|Overall Study|Protocol Violation|2|||
155243891|NCT00838110|560326284|FG002|Overall Study|Protocol Violation|1|||
155243892|NCT00838110|560326285|FG003|Overall Study|Protocol Violation|1|||
155243893|NCT00838110|560326282|FG000|Overall Study|Lost to Follow-up|3|||
155243894|NCT00838110|560326283|FG001|Overall Study|Lost to Follow-up|0|||
155243895|NCT00838110|560326284|FG002|Overall Study|Lost to Follow-up|0|||
155243896|NCT00838110|560326285|FG003|Overall Study|Lost to Follow-up|0|||
155243897|NCT00838110|560326282|FG000|Overall Study|Did not meet eligibility criteria|0|||
155243898|NCT00838110|560326283|FG001|Overall Study|Did not meet eligibility criteria|0|||
155243899|NCT00838110|560326284|FG002|Overall Study|Did not meet eligibility criteria|1|||
155243900|NCT00838110|560326285|FG003|Overall Study|Did not meet eligibility criteria|2|||
155243901|NCT00838110|560326282|FG000|Overall Study|Randomized but not treated|0|||
155243902|NCT00838110|560326283|FG001|Overall Study|Randomized but not treated|1|||
155243903|NCT00838110|560326284|FG002|Overall Study|Randomized but not treated|0|||
155243904|NCT00838110|560326285|FG003|Overall Study|Randomized but not treated|0|||
155243905|NCT01003899|560326286|FG000|Overall Study|Other Adverse Event|8|||
155243906|NCT01003899|560326286|FG000|Overall Study|Not entered|4|||
155243907|NCT01003899|560326286|FG000|Overall Study|Not treated|1|||
155243908|NCT01003899|560326286|FG000|Overall Study|Progressive disease|34|||
155243909|NCT00352365|560326287|FG000|Induction Therapy|Adverse Event|7|||
155243910|NCT00352365|560326287|FG000|Induction Therapy|Progression/Relapse|8|||
155243911|NCT00352365|560326287|FG000|Induction Therapy|Death|7|||
155243912|NCT00352365|560326287|FG000|Induction Therapy|Not protocol specified|1|||
155243913|NCT00352365|560326287|FG000|Induction Therapy|Not eligible|3|||
155243914|NCT00352365|560326287|FG000|Induction Therapy|Death before starting protocol therapy|1|||
155243915|NCT00352365|560326287|FG000|Maintenance Therapy|Progression/Relapse|3|||
155243916|NCT00352365|560326287|FG000|Maintenance Therapy|Death|2|||
155243917|NCT00352365|560326287|FG000|Maintenance Therapy|Not protocol specified|3|||
155243918|NCT00352365|560326287|FG000|Maintenance Therapy|Not eligible|4|||
155243919|NCT02811861|560326288|FG000|Overall Study|Radiological Disease Progression|123|||
155243920|NCT02811861|560326289|FG001|Overall Study|Radiological Disease Progression|97|||
155243921|NCT02811861|560326290|FG002|Overall Study|Radiological Disease Progression|174|||
155243922|NCT02811861|560326288|FG000|Overall Study|Clinical Disease Progression|20|||
155243923|NCT02811861|560326289|FG001|Overall Study|Clinical Disease Progression|19|||
155243924|NCT02811861|560326290|FG002|Overall Study|Clinical Disease Progression|22|||
155243925|NCT02811861|560326288|FG000|Overall Study|Adverse Event|63|||
155243926|NCT02811861|560326289|FG001|Overall Study|Adverse Event|60|||
155243927|NCT02811861|560326290|FG002|Overall Study|Adverse Event|41|||
155243928|NCT02811861|560326288|FG000|Overall Study|Lost to Follow-up|0|||
155243929|NCT02811861|560326289|FG001|Overall Study|Lost to Follow-up|0|||
155243930|NCT02811861|560326290|FG002|Overall Study|Lost to Follow-up|1|||
155243931|NCT02811861|560326288|FG000|Overall Study|Subject Choice|29|||
155243932|NCT02811861|560326289|FG001|Overall Study|Subject Choice|17|||
155243933|NCT02811861|560326290|FG002|Overall Study|Subject Choice|23|||
155243934|NCT02811861|560326288|FG000|Overall Study|Withdrawal by Subject|4|||
155243935|NCT02811861|560326289|FG001|Overall Study|Withdrawal by Subject|4|||
155243936|NCT02811861|560326290|FG002|Overall Study|Withdrawal by Subject|9|||
155243937|NCT02811861|560326288|FG000|Overall Study|Other|4|||
155243938|NCT02811861|560326289|FG001|Overall Study|Other|13|||
155243939|NCT02811861|560326290|FG002|Overall Study|Other|3|||
155243940|NCT02811861|560326288|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
155243941|NCT02811861|560326289|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
155243942|NCT02811861|560326290|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
155243943|NCT02811861|560326288|FG000|Overall Study|Randomized but not treated|2|||
155243944|NCT02811861|560326289|FG001|Overall Study|Randomized but not treated|3|||
155243945|NCT02811861|560326290|FG002|Overall Study|Randomized but not treated|17|||
155243946|NCT04743908|560326291|FG000|Overall Study|Death|1|||
155243947|NCT04743908|560326292|FG001|Overall Study|Death|0|||
155243948|NCT04743908|560326291|FG000|Overall Study|Lost to Follow-up|181|||
155243949|NCT04743908|560326292|FG001|Overall Study|Lost to Follow-up|180|||
155243950|NCT04743908|560326291|FG000|Overall Study|Withdrawal by Subject|1|||
155243951|NCT04743908|560326292|FG001|Overall Study|Withdrawal by Subject|2|||
155243952|NCT03822533|560326293|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
155243953|NCT03822533|560326294|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
155243954|NCT03822533|560326293|FG000|3 Month Follow-up|Lost to Follow-up|2|||
155243955|NCT03822533|560326294|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155243956|NCT03822533|560326293|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155243957|NCT03822533|560326294|FG001|6 Month Follow-up|Lost to Follow-up|0|||
155243958|NCT03822533|560326293|FG000|12 Month Follow-up|Lost to Follow-up|2|||
155243959|NCT03822533|560326294|FG001|12 Month Follow-up|Lost to Follow-up|3|||
155243960|NCT03822533|560326293|FG000|12 Month Follow-up|Pregnancy|0|||
155243961|NCT03822533|560326294|FG001|12 Month Follow-up|Pregnancy|1|||
155243962|NCT03822533|560326293|FG000|12 Month Follow-up|Surgery|2|||
155243963|NCT03822533|560326294|FG001|12 Month Follow-up|Surgery|0|||
155243964|NCT03822533|560326293|FG000|12 Month Follow-up|Wrong address|1|||
155243965|NCT03822533|560326294|FG001|12 Month Follow-up|Wrong address|0|||
155243966|NCT03822533|560326293|FG000|12 Month Follow-up|No symptoms|1|||
155243967|NCT03822533|560326294|FG001|12 Month Follow-up|No symptoms|0|||
155243968|NCT03822533|560326293|FG000|12 Month Follow-up|Changed primary care center|0|||
155243969|NCT03822533|560326294|FG001|12 Month Follow-up|Changed primary care center|1|||
155243970|NCT04969783|560326297|FG000|Overall Study|Lost to Follow-up|2|||
155243971|NCT04969783|560326298|FG001|Overall Study|Lost to Follow-up|0|||
155243972|NCT04969783|560326297|FG000|Overall Study|Withdrawal by Subject|4|||
155243973|NCT04969783|560326298|FG001|Overall Study|Withdrawal by Subject|0|||
155243974|NCT04969783|560326297|FG000|Overall Study|Physician Decision|6|||
155243975|NCT04969783|560326298|FG001|Overall Study|Physician Decision|0|||
155243976|NCT02489500|560326299|FG000|Overall Study|Death|1|||
155243977|NCT02489500|560326300|FG001|Overall Study|Death|1|||
155243978|NCT00512135|560326301|FG000|Overall Study|Not Treated|5|||
155243979|NCT00512135|560326301|FG000|Overall Study|Lack of Efficacy|2|||
155243980|NCT00512135|560326301|FG000|Overall Study|Adverse Event|6|||
155243981|NCT00512135|560326301|FG000|Overall Study|Withdrawal by Subject|22|||
155243982|NCT00512135|560326301|FG000|Overall Study|Lost to Follow-up|27|||
155243983|NCT00512135|560326301|FG000|Overall Study|Other|22|||
155243984|NCT03422250|560326302|FG000|Intervention|Adverse Event|0|||
155243985|NCT03422250|560326303|FG001|Intervention|Adverse Event|1|||
155243986|NCT03422250|560326304|FG002|Intervention|Adverse Event|0|||
155243987|NCT03422250|560326305|FG003|Intervention|Adverse Event|1|||
155243988|NCT03422250|560326302|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
155243989|NCT03422250|560326303|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
155243990|NCT03422250|560326304|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
155243991|NCT03422250|560326305|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
155243992|NCT03422250|560326302|FG000|Follow-up|Withdrawal by Subject|0|||
155243993|NCT03422250|560326303|FG001|Follow-up|Withdrawal by Subject|0|||
155243994|NCT03422250|560326304|FG002|Follow-up|Withdrawal by Subject|0|||
155243995|NCT03422250|560326305|FG003|Follow-up|Withdrawal by Subject|1|||
155243996|NCT03422250|560326302|FG000|Follow-up|Adverse Event|0|||
155243997|NCT03422250|560326303|FG001|Follow-up|Adverse Event|0|||
155243998|NCT03422250|560326304|FG002|Follow-up|Adverse Event|0|||
155243999|NCT03422250|560326305|FG003|Follow-up|Adverse Event|1|||
155244000|NCT00377819|560326308|FG000|Overall Study|Adverse Event|2|||
155244001|NCT00377819|560326309|FG001|Overall Study|Adverse Event|3|||
155244002|NCT00377819|560326308|FG000|Overall Study|Withdrawal by Subject|10|||
155244003|NCT00377819|560326309|FG001|Overall Study|Withdrawal by Subject|4|||
155244004|NCT00377819|560326308|FG000|Overall Study|Death|0|||
155244005|NCT00377819|560326309|FG001|Overall Study|Death|1|||
155244006|NCT00377819|560326308|FG000|Overall Study|Lost to Follow-up|0|||
155244007|NCT00377819|560326309|FG001|Overall Study|Lost to Follow-up|1|||
155244008|NCT00377819|560326308|FG000|Overall Study|Protocol Violation|1|||
155244009|NCT00377819|560326309|FG001|Overall Study|Protocol Violation|1|||
155244010|NCT01917526|560326310|FG000|Overall Study|Protocol Violation|1|||
155244011|NCT01917526|560326311|FG001|Overall Study|Protocol Violation|1|||
155244012|NCT02099838|560326312|FG000|Overall Study|Death|1|||
155244013|NCT02099838|560326313|FG001|Overall Study|Death|0|||
155244014|NCT02099838|560326312|FG000|Overall Study|Lost to Follow-up|3|||
155244015|NCT02099838|560326313|FG001|Overall Study|Lost to Follow-up|1|||
155244016|NCT02099838|560326312|FG000|Overall Study|Withdrawal by Subject|0|||
155244017|NCT02099838|560326313|FG001|Overall Study|Withdrawal by Subject|1|||
155244018|NCT01175382|560326316|FG000|Overall Study|Lost to Follow-up|4|||
155244019|NCT01175382|560326317|FG001|Overall Study|Lost to Follow-up|3|||
155244020|NCT01175382|560326318|FG002|Overall Study|Lost to Follow-up|1|||
155244021|NCT01175382|560326316|FG000|Overall Study|Physician Decision|0|||
155244022|NCT01175382|560326317|FG001|Overall Study|Physician Decision|1|||
155244023|NCT01175382|560326318|FG002|Overall Study|Physician Decision|0|||
155244024|NCT01175382|560326316|FG000|Overall Study|Withdrawal by Subject|0|||
155244025|NCT01175382|560326317|FG001|Overall Study|Withdrawal by Subject|0|||
155244026|NCT01175382|560326318|FG002|Overall Study|Withdrawal by Subject|1|||
155244027|NCT01175382|560326316|FG000|Overall Study|No longer having problem|1|||
155244028|NCT01175382|560326317|FG001|Overall Study|No longer having problem|0|||
155244029|NCT01175382|560326318|FG002|Overall Study|No longer having problem|1|||
155244030|NCT01175382|560326316|FG000|Overall Study|Unable/unwilling to attend visits|3|||
155244031|NCT01175382|560326317|FG001|Overall Study|Unable/unwilling to attend visits|1|||
155244032|NCT01175382|560326318|FG002|Overall Study|Unable/unwilling to attend visits|2|||
155244033|NCT01175382|560326316|FG000|Overall Study|Unwilling to follow protocol|0|||
155244034|NCT01175382|560326317|FG001|Overall Study|Unwilling to follow protocol|1|||
155244035|NCT01175382|560326318|FG002|Overall Study|Unwilling to follow protocol|0|||
155244036|NCT01175382|560326316|FG000|Overall Study|Unable to tolerate study meds|0|||
155244037|NCT01175382|560326317|FG001|Overall Study|Unable to tolerate study meds|1|||
155244038|NCT01175382|560326318|FG002|Overall Study|Unable to tolerate study meds|1|||
155244039|NCT00774787|560326319|FG000|Overall Study|Lost to Follow-up|1|||
155244040|NCT04535037|560326320|FG000|Overall Study|Protocol Violation|1|||
155244041|NCT04535037|560326321|FG001|Overall Study|Protocol Violation|0|||
155244042|NCT04535037|560326320|FG000|Overall Study|Withdrawal by Subject|8|||
155244043|NCT04535037|560326321|FG001|Overall Study|Withdrawal by Subject|9|||
155244044|NCT04535037|560326320|FG000|Overall Study|Migrated / moved from the study area|1|||
155244045|NCT04535037|560326321|FG001|Overall Study|Migrated / moved from the study area|4|||
155244046|NCT04535037|560326320|FG000|Overall Study|Other|2|||
155244047|NCT04535037|560326321|FG001|Overall Study|Other|5|||
155244048|NCT02031276|560326322|FG000|Period 1 Double-blind IV|Adverse Event|6|||
155244049|NCT02031276|560326323|FG001|Period 1 Double-blind IV|Adverse Event|5|||
155244050|NCT02031276|560326324|FG002|Period 1 Double-blind IV|Adverse Event|1|||
155244051|NCT02031276|560326322|FG000|Period 1 Double-blind IV|Other|0|||
155244052|NCT02031276|560326323|FG001|Period 1 Double-blind IV|Other|1|||
155244053|NCT02031276|560326324|FG002|Period 1 Double-blind IV|Other|0|||
155244054|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
155244055|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
155244056|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
155244057|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
155244058|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
155244059|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
155244060|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
155244061|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
155244062|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
155244063|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
155244064|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
155244065|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
155244066|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
155244067|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
155244068|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
155244069|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244070|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244071|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244072|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
155244073|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
155244074|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
155244075|NCT02731131|560326325|FG000|Overall Study|Psychiatric Disorder|0|||
155244076|NCT02731131|560326326|FG001|Overall Study|Psychiatric Disorder|1|||
155244077|NCT02731131|560326325|FG000|Overall Study|Refused Therapy|0|||
155244078|NCT02731131|560326326|FG001|Overall Study|Refused Therapy|1|||
155244079|NCT02043782|560326331|FG000|Period 1|Adverse Event|0|||
155244080|NCT02043782|560326332|FG001|Period 1|Adverse Event|0|||
155244081|NCT02043782|560326333|FG002|Period 1|Adverse Event|1|||
155244082|NCT02043782|560326334|FG003|Period 1|Adverse Event|0|||
155244083|NCT02043782|560326335|FG004|Period 1|Adverse Event|0|||
155244084|NCT02043782|560326336|FG005|Period 1|Adverse Event|0|||
155244085|NCT00874029|560326337|FG000|Overall Study|Withdrawal by Subject|10|||
155244086|NCT00874029|560326337|FG000|Overall Study|Pregnancy|4|||
155244087|NCT00874029|560326337|FG000|Overall Study|Physician Decision|1|||
155244088|NCT00874029|560326337|FG000|Overall Study|Adverse Event|1|||
155244089|NCT00874029|560326337|FG000|Overall Study|Lost to Follow-up|5|||
155244090|NCT01953926|560326338|FG000|Overall Study|Withdrawal by Subject|23|||
155244091|NCT01953926|560326339|FG001|Overall Study|Withdrawal by Subject|3|||
155244092|NCT01953926|560326340|FG002|Overall Study|Withdrawal by Subject|3|||
155244093|NCT01953926|560326341|FG003|Overall Study|Withdrawal by Subject|5|||
155244094|NCT01953926|560326342|FG004|Overall Study|Withdrawal by Subject|6|||
155244095|NCT01953926|560326343|FG005|Overall Study|Withdrawal by Subject|0|||
155244096|NCT01953926|560326344|FG006|Overall Study|Withdrawal by Subject|1|||
155244097|NCT01953926|560326338|FG000|Overall Study|Physician Decision|1|||
155244098|NCT01953926|560326339|FG001|Overall Study|Physician Decision|0|||
155244099|NCT01953926|560326340|FG002|Overall Study|Physician Decision|0|||
155244100|NCT01953926|560326341|FG003|Overall Study|Physician Decision|0|||
155244101|NCT01953926|560326342|FG004|Overall Study|Physician Decision|2|||
155244102|NCT01953926|560326343|FG005|Overall Study|Physician Decision|0|||
155244103|NCT01953926|560326344|FG006|Overall Study|Physician Decision|0|||
155244104|NCT01953926|560326338|FG000|Overall Study|Lost to Follow-up|18|||
155244105|NCT01953926|560326339|FG001|Overall Study|Lost to Follow-up|3|||
155244106|NCT01953926|560326340|FG002|Overall Study|Lost to Follow-up|0|||
155244107|NCT01953926|560326341|FG003|Overall Study|Lost to Follow-up|5|||
155244108|NCT01953926|560326342|FG004|Overall Study|Lost to Follow-up|3|||
155244109|NCT01953926|560326343|FG005|Overall Study|Lost to Follow-up|0|||
155244110|NCT01953926|560326344|FG006|Overall Study|Lost to Follow-up|0|||
155244111|NCT01953926|560326338|FG000|Overall Study|Protocol Violation|1|||
155244112|NCT01953926|560326339|FG001|Overall Study|Protocol Violation|0|||
155244113|NCT01953926|560326340|FG002|Overall Study|Protocol Violation|0|||
155244114|NCT01953926|560326341|FG003|Overall Study|Protocol Violation|0|||
155244115|NCT01953926|560326342|FG004|Overall Study|Protocol Violation|0|||
155244116|NCT01953926|560326343|FG005|Overall Study|Protocol Violation|0|||
155244117|NCT01953926|560326344|FG006|Overall Study|Protocol Violation|0|||
155244118|NCT01953926|560326338|FG000|Overall Study|Other, Disease progression|2|||
155244119|NCT01953926|560326339|FG001|Overall Study|Other, Disease progression|1|||
155244120|NCT01953926|560326340|FG002|Overall Study|Other, Disease progression|0|||
155244121|NCT01953926|560326341|FG003|Overall Study|Other, Disease progression|0|||
155244122|NCT01953926|560326342|FG004|Overall Study|Other, Disease progression|1|||
155244123|NCT01953926|560326343|FG005|Overall Study|Other, Disease progression|0|||
155244124|NCT01953926|560326344|FG006|Overall Study|Other, Disease progression|0|||
155244125|NCT01953926|560326338|FG000|Overall Study|Discontinuation of study by sponsor|41|||
155244126|NCT01953926|560326339|FG001|Overall Study|Discontinuation of study by sponsor|7|||
155244127|NCT01953926|560326340|FG002|Overall Study|Discontinuation of study by sponsor|5|||
155244128|NCT01953926|560326341|FG003|Overall Study|Discontinuation of study by sponsor|12|||
155244129|NCT01953926|560326342|FG004|Overall Study|Discontinuation of study by sponsor|46|||
155244130|NCT01953926|560326343|FG005|Overall Study|Discontinuation of study by sponsor|5|||
155244131|NCT01953926|560326344|FG006|Overall Study|Discontinuation of study by sponsor|6|||
155244132|NCT01953926|560326338|FG000|Overall Study|Not Treated|1|||
155244133|NCT01953926|560326339|FG001|Overall Study|Not Treated|0|||
155244134|NCT01953926|560326340|FG002|Overall Study|Not Treated|1|||
155244135|NCT01953926|560326341|FG003|Overall Study|Not Treated|0|||
155244136|NCT01953926|560326342|FG004|Overall Study|Not Treated|0|||
155244137|NCT01953926|560326343|FG005|Overall Study|Not Treated|0|||
155244138|NCT01953926|560326344|FG006|Overall Study|Not Treated|0|||
155244139|NCT01949480|560326346|FG000|Overall Study|Physician Decision|5|||
155244140|NCT01949480|560326347|FG001|Overall Study|Physician Decision|8|||
155244141|NCT00144339|560326348|FG000|Overall Study|Adverse Event|746|||
155244142|NCT00144339|560326349|FG001|Overall Study|Adverse Event|627|||
155244143|NCT00144339|560326348|FG000|Overall Study|Protocol Violation|75|||
155244144|NCT00144339|560326349|FG001|Overall Study|Protocol Violation|48|||
155244145|NCT00144339|560326348|FG000|Overall Study|Withdrawal by Subject|403|||
155244146|NCT00144339|560326349|FG001|Overall Study|Withdrawal by Subject|300|||
155244147|NCT00144339|560326348|FG000|Overall Study|Lost to Follow-up|76|||
155244148|NCT00144339|560326349|FG001|Overall Study|Lost to Follow-up|64|||
155244149|NCT00144339|560326348|FG000|Overall Study|Other|58|||
155244150|NCT00144339|560326349|FG001|Overall Study|Other|60|||
155244151|NCT00305058|560326350|FG000|Overall Study|Participant too young|1|||
155244152|NCT00305058|560326351|FG001|Overall Study|Participant too young|0|||
155244153|NCT00305058|560326350|FG000|Overall Study|Missing data collection instrument|3|||
155244154|NCT00305058|560326351|FG001|Overall Study|Missing data collection instrument|2|||
155244155|NCT00305058|560326350|FG000|Overall Study|Missing outcome data|3|||
155244156|NCT00305058|560326351|FG001|Overall Study|Missing outcome data|2|||
155244157|NCT00288587|560326354|FG000|Overall Study|Death|4|||
155244158|NCT00288587|560326355|FG001|Overall Study|Death|4|||
155244159|NCT00288587|560326354|FG000|Overall Study|Transplant|0|||
155244160|NCT00288587|560326355|FG001|Overall Study|Transplant|3|||
155244161|NCT00288587|560326354|FG000|Overall Study|Adverse Event|0|||
155244162|NCT00288587|560326355|FG001|Overall Study|Adverse Event|1|||
155244163|NCT00288587|560326354|FG000|Overall Study|Physician Decision|0|||
155244164|NCT00288587|560326355|FG001|Overall Study|Physician Decision|2|||
155244165|NCT00288587|560326354|FG000|Overall Study|Severe Aortic Stenosis|1|||
155244166|NCT00288587|560326355|FG001|Overall Study|Severe Aortic Stenosis|0|||
155244167|NCT01136291|560326358|FG000|Overall Study|Lost to Follow-up|1|||
155244168|NCT01136291|560326359|FG001|Overall Study|Lost to Follow-up|1|||
155244169|NCT03238001|560326364|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
155244170|NCT03238001|560326364|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
155244171|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
155244172|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
155244173|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
155244174|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
155244175|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
155244176|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
155244177|NCT04964089|560326365|FG000|Overall Study|Adverse Event|8|||
155244178|NCT04964089|560326366|FG001|Overall Study|Adverse Event|6|||
155244179|NCT04964089|560326365|FG000|Overall Study|Non-compliance with study schedule|1|||
155244180|NCT04964089|560326366|FG001|Overall Study|Non-compliance with study schedule|0|||
155244181|NCT04964089|560326365|FG000|Overall Study|Withdrawal by Subject|6|||
155244182|NCT04964089|560326366|FG001|Overall Study|Withdrawal by Subject|5|||
155244183|NCT04964089|560326365|FG000|Overall Study|Lost to Follow-up|1|||
155244184|NCT04964089|560326366|FG001|Overall Study|Lost to Follow-up|1|||
155244185|NCT04964089|560326365|FG000|Overall Study|Progressive disease|4|||
155244186|NCT04964089|560326366|FG001|Overall Study|Progressive disease|0|||
155244187|NCT04964089|560326365|FG000|Overall Study|Physician Decision|1|||
155244188|NCT04964089|560326366|FG001|Overall Study|Physician Decision|0|||
155244189|NCT04964089|560326365|FG000|Overall Study|Participant did not want to continue study treatment|1|||
155244190|NCT04964089|560326366|FG001|Overall Study|Participant did not want to continue study treatment|0|||
155244191|NCT04964089|560326365|FG000|Overall Study|Participant moved to different state|1|||
155244192|NCT04964089|560326366|FG001|Overall Study|Participant moved to different state|0|||
155244193|NCT04964089|560326365|FG000|Overall Study|Participant decided to discontinue|0|||
155244194|NCT04964089|560326366|FG001|Overall Study|Participant decided to discontinue|1|||
155244195|NCT04369469|560326367|FG000|Overall Study|Lost to Follow-up|2|||
155244196|NCT04369469|560326368|FG001|Overall Study|Lost to Follow-up|4|||
155244197|NCT04369469|560326367|FG000|Overall Study|Physician Decision|2|||
155244198|NCT04369469|560326368|FG001|Overall Study|Physician Decision|1|||
155244199|NCT04369469|560326367|FG000|Overall Study|Withdrawal by Subject|2|||
155244200|NCT04369469|560326368|FG001|Overall Study|Withdrawal by Subject|3|||
155244201|NCT04369469|560326367|FG000|Overall Study|Adverse Event|1|||
155244202|NCT04369469|560326368|FG001|Overall Study|Adverse Event|0|||
155244203|NCT04369469|560326367|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
155244204|NCT04369469|560326368|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
155244205|NCT04369469|560326367|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
155244206|NCT04369469|560326368|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
155244207|NCT04369469|560326367|FG000|Overall Study|Unable to Provide Consent|0|||
155244208|NCT04369469|560326368|FG001|Overall Study|Unable to Provide Consent|1|||
155244209|NCT03135522|560326369|FG000|Overall Study|Adverse Event|1|||
155244210|NCT03135522|560326370|FG001|Overall Study|Adverse Event|0|||
155244211|NCT03483623|560326371|FG000|Overall Study|43 complete sets achieved|1|||
155244212|NCT01165281|560326372|FG000|Overall Study|Adverse Event|12|||
155244213|NCT01165281|560326373|FG001|Overall Study|Adverse Event|14|||
155244214|NCT01165281|560326372|FG000|Overall Study|Death|3|||
155244215|NCT01165281|560326373|FG001|Overall Study|Death|4|||
155244216|NCT01165281|560326372|FG000|Overall Study|Lack of Efficacy|4|||
155244217|NCT01165281|560326373|FG001|Overall Study|Lack of Efficacy|1|||
155244218|NCT01165281|560326372|FG000|Overall Study|Lost to Follow-up|0|||
155244219|NCT01165281|560326373|FG001|Overall Study|Lost to Follow-up|1|||
155244220|NCT01165281|560326372|FG000|Overall Study|Physician Decision|8|||
155244221|NCT01165281|560326373|FG001|Overall Study|Physician Decision|1|||
155244222|NCT01165281|560326372|FG000|Overall Study|Protocol Violation|6|||
155244223|NCT01165281|560326373|FG001|Overall Study|Protocol Violation|5|||
155244224|NCT01165281|560326372|FG000|Overall Study|Withdrawal by Subject|8|||
155244225|NCT01165281|560326373|FG001|Overall Study|Withdrawal by Subject|7|||
155244226|NCT01165281|560326372|FG000|Overall Study|Noncompliance with Study Drug|1|||
155244227|NCT01165281|560326373|FG001|Overall Study|Noncompliance with Study Drug|4|||
155244228|NCT01165281|560326372|FG000|Overall Study|Progressive Disease|10|||
155244229|NCT01165281|560326373|FG001|Overall Study|Progressive Disease|14|||
155244230|NCT01165281|560326372|FG000|Overall Study|Other|6|||
155244231|NCT01165281|560326373|FG001|Overall Study|Other|0|||
155244232|NCT02863991|560326374|FG000|Overall Study|Death|0|||
155244233|NCT02863991|560326375|FG001|Overall Study|Death|3|||
155244234|NCT02863991|560326374|FG000|Overall Study|Lack of Efficacy|0|||
155244235|NCT02863991|560326375|FG001|Overall Study|Lack of Efficacy|1|||
155244236|NCT02863991|560326374|FG000|Overall Study|Study Terminated|2|||
155244237|NCT02863991|560326375|FG001|Overall Study|Study Terminated|8|||
155244238|NCT00364858|560326380|FG000|Overall Study|Adverse Event|1|||
155244239|NCT00364858|560326381|FG001|Overall Study|Adverse Event|5|||
155244240|NCT00364858|560326380|FG000|Overall Study|Withdrawal by Subject|1|||
155244241|NCT00364858|560326381|FG001|Overall Study|Withdrawal by Subject|1|||
155244242|NCT00364858|560326380|FG000|Overall Study|Pregnancy|1|||
155244243|NCT00364858|560326381|FG001|Overall Study|Pregnancy|1|||
155244244|NCT00364858|560326380|FG000|Overall Study|Clinical failure|2|||
155244245|NCT00364858|560326381|FG001|Overall Study|Clinical failure|13|||
155244246|NCT00364858|560326380|FG000|Overall Study|Discontinuation at baseline|1|||
155244247|NCT00364858|560326381|FG001|Overall Study|Discontinuation at baseline|0|||
155244248|NCT00364858|560326380|FG000|Overall Study|Non-compliant|1|||
155244249|NCT00364858|560326381|FG001|Overall Study|Non-compliant|0|||
155244250|NCT00364858|560326380|FG000|Overall Study|Return to Q2 regimen|0|||
155244251|NCT00364858|560326381|FG001|Overall Study|Return to Q2 regimen|1|||
155244252|NCT00364858|560326380|FG000|Overall Study|Clinical baseline issue|0|||
155244253|NCT00364858|560326381|FG001|Overall Study|Clinical baseline issue|1|||
155244254|NCT00363766|560326382|FG000|Overall Study|Progressive Disease|15|||
155244255|NCT00363766|560326383|FG001|Overall Study|Progressive Disease|9|||
155244256|NCT00363766|560326382|FG000|Overall Study|Adverse Event|10|||
155244257|NCT00363766|560326383|FG001|Overall Study|Adverse Event|2|||
155244258|NCT00363766|560326382|FG000|Overall Study|Disease Related Death|1|||
155244259|NCT00363766|560326383|FG001|Overall Study|Disease Related Death|3|||
155244260|NCT00363766|560326382|FG000|Overall Study|Not Disease Related Death|3|||
155244261|NCT00363766|560326383|FG001|Overall Study|Not Disease Related Death|4|||
155244262|NCT00363766|560326382|FG000|Overall Study|Withdrawal by Subject|2|||
155244263|NCT00363766|560326383|FG001|Overall Study|Withdrawal by Subject|0|||
155244264|NCT00363766|560326382|FG000|Overall Study|Physician Decision|1|||
155244265|NCT00363766|560326383|FG001|Overall Study|Physician Decision|2|||
155244266|NCT02345512|560326387|FG000|Overall Study|Adverse Event|1|||
155244267|NCT02345512|560326387|FG000|Overall Study|Withdrawal by Subject|1|||
155244268|NCT02121847|560326388|FG000|Overall Study|Administrative Reasons|1|||
155244269|NCT02121847|560326388|FG000|Overall Study|Adverse Event|2|||
155244270|NCT01660906|560326389|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
155244271|NCT03478891|560326395|FG000|Overall Study|Enrolled, but product never administered|0|||
155244272|NCT03478891|560326396|FG001|Overall Study|Enrolled, but product never administered|0|||
155244273|NCT03478891|560326397|FG002|Overall Study|Enrolled, but product never administered|1|||
155244274|NCT03478891|560326395|FG000|Overall Study|Moved from area|0|||
155244275|NCT03478891|560326396|FG001|Overall Study|Moved from area|0|||
155244276|NCT03478891|560326397|FG002|Overall Study|Moved from area|1|||
155244277|NCT03478891|560326395|FG000|Overall Study|Lost to Follow-up|1|||
155244278|NCT03478891|560326396|FG001|Overall Study|Lost to Follow-up|0|||
155244279|NCT03478891|560326397|FG002|Overall Study|Lost to Follow-up|1|||
155244280|NCT03864614|560326402|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
155244281|NCT03864614|560326403|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
155244282|NCT03864614|560326404|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
155244283|NCT03864614|560326405|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
155244284|NCT03864614|560326402|FG000|Overall Study|Withdrawal by Subject|72|||
155244285|NCT03864614|560326403|FG001|Overall Study|Withdrawal by Subject|100|||
155244286|NCT03864614|560326404|FG002|Overall Study|Withdrawal by Subject|1|||
155244287|NCT03864614|560326405|FG003|Overall Study|Withdrawal by Subject|21|||
155244288|NCT03864614|560326402|FG000|Overall Study|Lost to Follow-up|45|||
155244289|NCT03864614|560326403|FG001|Overall Study|Lost to Follow-up|54|||
155244290|NCT03864614|560326404|FG002|Overall Study|Lost to Follow-up|0|||
155244291|NCT03864614|560326405|FG003|Overall Study|Lost to Follow-up|9|||
155244292|NCT03864614|560326402|FG000|Overall Study|Adverse Event|42|||
155244293|NCT03864614|560326403|FG001|Overall Study|Adverse Event|30|||
155244294|NCT03864614|560326404|FG002|Overall Study|Adverse Event|1|||
155244295|NCT03864614|560326405|FG003|Overall Study|Adverse Event|9|||
155244296|NCT03864614|560326402|FG000|Overall Study|Protocol Deviation|6|||
155244297|NCT03864614|560326403|FG001|Overall Study|Protocol Deviation|26|||
155244298|NCT03864614|560326404|FG002|Overall Study|Protocol Deviation|0|||
155244299|NCT03864614|560326405|FG003|Overall Study|Protocol Deviation|1|||
155244300|NCT03864614|560326402|FG000|Overall Study|Physician Decision|7|||
155244301|NCT03864614|560326403|FG001|Overall Study|Physician Decision|10|||
155244302|NCT03864614|560326404|FG002|Overall Study|Physician Decision|1|||
155244303|NCT03864614|560326405|FG003|Overall Study|Physician Decision|5|||
155244304|NCT03864614|560326402|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
155244305|NCT03864614|560326403|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
155244306|NCT03864614|560326404|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
155244307|NCT03864614|560326405|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
155244308|NCT03864614|560326402|FG000|Overall Study|Sponsor Decision|1|||
155244309|NCT03864614|560326403|FG001|Overall Study|Sponsor Decision|2|||
155244310|NCT03864614|560326404|FG002|Overall Study|Sponsor Decision|0|||
155244311|NCT03864614|560326405|FG003|Overall Study|Sponsor Decision|0|||
155244312|NCT03864614|560326402|FG000|Overall Study|Pregnancy|0|||
155244313|NCT03864614|560326403|FG001|Overall Study|Pregnancy|1|||
155244314|NCT03864614|560326404|FG002|Overall Study|Pregnancy|0|||
155244315|NCT03864614|560326405|FG003|Overall Study|Pregnancy|0|||
155244316|NCT03864614|560326402|FG000|Overall Study|Other|7|||
155244317|NCT03864614|560326403|FG001|Overall Study|Other|9|||
155244318|NCT03864614|560326404|FG002|Overall Study|Other|1|||
155244319|NCT03864614|560326405|FG003|Overall Study|Other|4|||
155244320|NCT03864614|560326402|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244321|NCT03864614|560326403|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244322|NCT03864614|560326404|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244323|NCT03864614|560326405|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
155244324|NCT01850004|560326406|FG000|Overall Study|Poor/Non-compliance|1|||
155244325|NCT01850004|560326406|FG000|Overall Study|Participant Withdrew Consent|9|||
155244326|NCT01850004|560326406|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
155244327|NCT01850004|560326406|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155244328|NCT01850004|560326406|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
155244329|NCT01850004|560326406|FG000|Overall Study|Other Reasons|2|||
155244330|NCT01850004|560326406|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
155244331|NCT01850004|560326406|FG000|Overall Study|Maximum Clinical Benefit|4|||
155244332|NCT04827576|560328616|FG000|Overall Study|Death|5|||
155244333|NCT04827576|560328617|FG001|Overall Study|Death|17|||
155244334|NCT04827576|560328618|FG002|Overall Study|Death|17|||
155244335|NCT04827576|560328619|FG003|Overall Study|Death|32|||
155244336|NCT04827576|560328616|FG000|Overall Study|Study Terminated by Sponsor|2|||
155244337|NCT04827576|560328617|FG001|Overall Study|Study Terminated by Sponsor|9|||
155244338|NCT04827576|560328618|FG002|Overall Study|Study Terminated by Sponsor|7|||
155244339|NCT04827576|560328619|FG003|Overall Study|Study Terminated by Sponsor|5|||
155244340|NCT04827576|560328616|FG000|Overall Study|Investigator's Discretion|1|||
155244341|NCT04827576|560328617|FG001|Overall Study|Investigator's Discretion|0|||
155244342|NCT04827576|560328618|FG002|Overall Study|Investigator's Discretion|2|||
155244343|NCT04827576|560328619|FG003|Overall Study|Investigator's Discretion|5|||
155244344|NCT04827576|560328616|FG000|Overall Study|Withdrew Consent|0|||
155244345|NCT04827576|560328617|FG001|Overall Study|Withdrew Consent|3|||
155244346|NCT04827576|560328618|FG002|Overall Study|Withdrew Consent|0|||
155244347|NCT04827576|560328619|FG003|Overall Study|Withdrew Consent|0|||
155244348|NCT04827576|560328616|FG000|Overall Study|Lost to Follow-up|1|||
155244349|NCT04827576|560328617|FG001|Overall Study|Lost to Follow-up|0|||
155244350|NCT04827576|560328618|FG002|Overall Study|Lost to Follow-up|0|||
155244351|NCT04827576|560328619|FG003|Overall Study|Lost to Follow-up|0|||
155244352|NCT04295564|560328620|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
155244353|NCT04295564|560328621|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
155244354|NCT04537923|560328622|FG000|Overall Study|Adverse Event|2|||
155244355|NCT04537923|560328623|FG001|Overall Study|Adverse Event|1|||
155244356|NCT04537923|560328624|FG002|Overall Study|Adverse Event|2|||
155244357|NCT04537923|560328625|FG003|Overall Study|Adverse Event|4|||
155244358|NCT04537923|560328622|FG000|Overall Study|Death|3|||
155244359|NCT04537923|560328623|FG001|Overall Study|Death|3|||
155244360|NCT04537923|560328624|FG002|Overall Study|Death|1|||
155244361|NCT04537923|560328625|FG003|Overall Study|Death|11|||
155244362|NCT04537923|560328622|FG000|Overall Study|Lost to Follow-up|1|||
155244363|NCT04537923|560328623|FG001|Overall Study|Lost to Follow-up|2|||
155244364|NCT04537923|560328624|FG002|Overall Study|Lost to Follow-up|1|||
155244365|NCT04537923|560328625|FG003|Overall Study|Lost to Follow-up|6|||
155244366|NCT04537923|560328622|FG000|Overall Study|Physician Decision|1|||
155244367|NCT04537923|560328623|FG001|Overall Study|Physician Decision|0|||
155244368|NCT04537923|560328624|FG002|Overall Study|Physician Decision|2|||
155244369|NCT04537923|560328625|FG003|Overall Study|Physician Decision|5|||
155244370|NCT04537923|560328622|FG000|Overall Study|Pregnancy|1|||
155244371|NCT04537923|560328623|FG001|Overall Study|Pregnancy|0|||
155244372|NCT04537923|560328624|FG002|Overall Study|Pregnancy|0|||
155244373|NCT04537923|560328625|FG003|Overall Study|Pregnancy|0|||
155244374|NCT04537923|560328622|FG000|Overall Study|Withdrawal by Subject|4|||
155244375|NCT04537923|560328623|FG001|Overall Study|Withdrawal by Subject|4|||
155244376|NCT04537923|560328624|FG002|Overall Study|Withdrawal by Subject|4|||
155244377|NCT04537923|560328625|FG003|Overall Study|Withdrawal by Subject|58|||
155244378|NCT04537923|560328622|FG000|Overall Study|Missed study visits|2|||
155244379|NCT04537923|560328623|FG001|Overall Study|Missed study visits|0|||
155244380|NCT04537923|560328624|FG002|Overall Study|Missed study visits|0|||
155244381|NCT04537923|560328625|FG003|Overall Study|Missed study visits|3|||
155244382|NCT04537923|560328622|FG000|Overall Study|Sponsor's decision|0|||
155244383|NCT04537923|560328623|FG001|Overall Study|Sponsor's decision|0|||
155244384|NCT04537923|560328624|FG002|Overall Study|Sponsor's decision|1|||
155244385|NCT04537923|560328625|FG003|Overall Study|Sponsor's decision|1|||
155244386|NCT04537923|560328622|FG000|Overall Study|Safety reasons|1|||
155244387|NCT04537923|560328623|FG001|Overall Study|Safety reasons|0|||
155244388|NCT04537923|560328624|FG002|Overall Study|Safety reasons|0|||
155244389|NCT04537923|560328625|FG003|Overall Study|Safety reasons|0|||
155244390|NCT01261611|560328626|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
155244391|NCT01261611|560328627|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
155244392|NCT01261611|560328628|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
155244393|NCT01261611|560328626|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155244394|NCT01261611|560328627|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
155244395|NCT01261611|560328628|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
155244396|NCT01261611|560328626|FG000|Treatment Cycle 1|Adverse Event|0|||
155244397|NCT01261611|560328627|FG001|Treatment Cycle 1|Adverse Event|1|||
155244398|NCT01261611|560328628|FG002|Treatment Cycle 1|Adverse Event|0|||
155244399|NCT01261611|560328626|FG000|Treatment Cycle 1|Protocol Violation|0|||
155244400|NCT01261611|560328627|FG001|Treatment Cycle 1|Protocol Violation|0|||
155244401|NCT01261611|560328628|FG002|Treatment Cycle 1|Protocol Violation|2|||
155244402|NCT01261611|560328626|FG000|Treatment Cycle 2|Completed study|4|||
155244403|NCT01261611|560328627|FG001|Treatment Cycle 2|Completed study|0|||
155244404|NCT01261611|560328628|FG002|Treatment Cycle 2|Completed study|0|||
155244405|NCT01261611|560328626|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
155244406|NCT01261611|560328627|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
155244407|NCT01261611|560328628|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
155244408|NCT01261611|560328626|FG000|Treatment Cycle 2|Adverse Event|1|||
155244409|NCT01261611|560328627|FG001|Treatment Cycle 2|Adverse Event|0|||
155244410|NCT01261611|560328628|FG002|Treatment Cycle 2|Adverse Event|0|||
155244411|NCT01261611|560328626|FG000|Treatment Cycle 2|Protocol Violation|2|||
155244412|NCT01261611|560328627|FG001|Treatment Cycle 2|Protocol Violation|0|||
155244413|NCT01261611|560328628|FG002|Treatment Cycle 2|Protocol Violation|0|||
155244414|NCT01261611|560328626|FG000|Treatment Cycle 2|Not otherwise specified|2|||
155244415|NCT01261611|560328627|FG001|Treatment Cycle 2|Not otherwise specified|0|||
155244416|NCT01261611|560328628|FG002|Treatment Cycle 2|Not otherwise specified|0|||
155244417|NCT01261611|560328626|FG000|Treatment Cycle 3|Completed study|24|||
155244418|NCT01261611|560328627|FG001|Treatment Cycle 3|Completed study|0|||
155244419|NCT01261611|560328628|FG002|Treatment Cycle 3|Completed study|0|||
155244420|NCT01261611|560328626|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
155244421|NCT01261611|560328627|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
155244422|NCT01261611|560328628|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
155244423|NCT01261611|560328626|FG000|Treatment Cycle 3|Adverse Event|1|||
155244424|NCT01261611|560328627|FG001|Treatment Cycle 3|Adverse Event|0|||
155244425|NCT01261611|560328628|FG002|Treatment Cycle 3|Adverse Event|0|||
155244426|NCT01261611|560328626|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
155244427|NCT01261611|560328627|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
155244428|NCT01261611|560328628|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
155244429|NCT01261611|560328626|FG000|Treatment Cycle 4|Completed study|87|||
155244430|NCT01261611|560328627|FG001|Treatment Cycle 4|Completed study|0|||
155244431|NCT01261611|560328628|FG002|Treatment Cycle 4|Completed study|0|||
155244432|NCT01261611|560328626|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
155244433|NCT01261611|560328627|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
155244434|NCT01261611|560328628|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
155244435|NCT01261611|560328626|FG000|Treatment Cycle 4|Adverse Event|1|||
155244436|NCT01261611|560328627|FG001|Treatment Cycle 4|Adverse Event|0|||
155244437|NCT01261611|560328628|FG002|Treatment Cycle 4|Adverse Event|0|||
155244438|NCT01261611|560328626|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
155244439|NCT01261611|560328627|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
155244440|NCT01261611|560328628|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
155244441|NCT01261611|560328626|FG000|Treatment Cycle 4|Not otherwise specified|3|||
155244442|NCT01261611|560328627|FG001|Treatment Cycle 4|Not otherwise specified|0|||
155244443|NCT01261611|560328628|FG002|Treatment Cycle 4|Not otherwise specified|0|||
155244444|NCT01261611|560328626|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
155244445|NCT01261611|560328627|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
155244446|NCT01261611|560328628|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
155244447|NCT01261611|560328626|FG000|Treatment Cycle 5|Adverse Event|1|||
155244448|NCT01261611|560328627|FG001|Treatment Cycle 5|Adverse Event|0|||
155244449|NCT01261611|560328628|FG002|Treatment Cycle 5|Adverse Event|0|||
155244450|NCT01261611|560328626|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
155244451|NCT01261611|560328627|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
155244452|NCT01261611|560328628|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
155244453|NCT02527798|560328629|FG000|Overall Study|Physician Decision|1|||
155244454|NCT02527798|560328630|FG001|Overall Study|Physician Decision|0|||
155244455|NCT02527798|560328631|FG002|Overall Study|Physician Decision|1|||
155244456|NCT02527798|560328632|FG003|Overall Study|Physician Decision|1|||
155244457|NCT02527798|560328633|FG004|Overall Study|Physician Decision|0|||
155244458|NCT02527798|560328634|FG005|Overall Study|Physician Decision|0|||
155244459|NCT02527798|560328629|FG000|Overall Study|Death|0|||
155244460|NCT02527798|560328630|FG001|Overall Study|Death|0|||
155244461|NCT02527798|560328631|FG002|Overall Study|Death|1|||
155244462|NCT02527798|560328632|FG003|Overall Study|Death|0|||
155244463|NCT02527798|560328633|FG004|Overall Study|Death|0|||
155244464|NCT02527798|560328634|FG005|Overall Study|Death|0|||
155244465|NCT02527798|560328629|FG000|Overall Study|Withdrawal by Subject|0|||
155244466|NCT02527798|560328630|FG001|Overall Study|Withdrawal by Subject|1|||
155244467|NCT02527798|560328631|FG002|Overall Study|Withdrawal by Subject|2|||
155244468|NCT02527798|560328632|FG003|Overall Study|Withdrawal by Subject|0|||
155244469|NCT02527798|560328633|FG004|Overall Study|Withdrawal by Subject|0|||
155244470|NCT02527798|560328634|FG005|Overall Study|Withdrawal by Subject|0|||
155244471|NCT02527798|560328629|FG000|Overall Study|Reason undisclosed|1|||
155244472|NCT02527798|560328630|FG001|Overall Study|Reason undisclosed|0|||
155244473|NCT02527798|560328631|FG002|Overall Study|Reason undisclosed|1|||
155244474|NCT02527798|560328632|FG003|Overall Study|Reason undisclosed|0|||
155244475|NCT02527798|560328633|FG004|Overall Study|Reason undisclosed|0|||
155244476|NCT02527798|560328634|FG005|Overall Study|Reason undisclosed|0|||
155244477|NCT02527798|560328629|FG000|Overall Study|Did not receive intervention|1|||
155244478|NCT02527798|560328630|FG001|Overall Study|Did not receive intervention|1|||
155244479|NCT02527798|560328631|FG002|Overall Study|Did not receive intervention|0|||
155244480|NCT02527798|560328632|FG003|Overall Study|Did not receive intervention|0|||
155244481|NCT02527798|560328633|FG004|Overall Study|Did not receive intervention|0|||
155244482|NCT02527798|560328634|FG005|Overall Study|Did not receive intervention|0|||
155244483|NCT01808690|560328636|FG000|Overall Study|Withdrawal by Subject|1|||
155244484|NCT01808690|560328637|FG001|Overall Study|Withdrawal by Subject|2|||
155244485|NCT02395120|560328638|FG000|Overall Study|Missed follow-up dental exam|57|||
155244486|NCT02395120|560328639|FG001|Overall Study|Missed follow-up dental exam|62|||
155244487|NCT02395120|560328640|FG002|Overall Study|Missed follow-up dental exam|6|||
155244488|NCT02395120|560328641|FG003|Overall Study|Missed follow-up dental exam|6|||
155244489|NCT02395120|560328642|FG004|Overall Study|Missed follow-up dental exam|51|||
155244490|NCT01275625|560328643|FG000|Overall Study|Death|1|||
155244491|NCT01275625|560328643|FG000|Overall Study|Lack of Efficacy|2|||
155244492|NCT01275625|560328643|FG000|Overall Study|Lost to Follow-up|1|||
155244493|NCT01275625|560328643|FG000|Overall Study|Withdrawal by Subject|3|||
155244494|NCT01275625|560328643|FG000|Overall Study|Protocol Violation|1|||
155244495|NCT01275625|560328643|FG000|Overall Study|Adverse Event|4|||
155244496|NCT01275625|560328643|FG000|Overall Study|Other|1|||
155244497|NCT05732454|560328645|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
155244498|NCT05732454|560328646|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
155244499|NCT05732454|560328645|FG000|Part 1: DB Period|Adverse Event|1|||
155244500|NCT05732454|560328646|FG001|Part 1: DB Period|Adverse Event|0|||
155244501|NCT05732454|560328645|FG000|Part 1: DB Period|Lost to Follow-up|1|||
155244502|NCT05732454|560328646|FG001|Part 1: DB Period|Lost to Follow-up|0|||
155244503|NCT05732454|560328645|FG000|Part 1: DB Period|Protocol Violation|0|||
155244504|NCT05732454|560328646|FG001|Part 1: DB Period|Protocol Violation|1|||
155244505|NCT05732454|560328645|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
155244506|NCT05732454|560328646|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
155244507|NCT05732454|560328645|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
155244508|NCT05732454|560328646|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
155244509|NCT05732454|560328645|FG000|Part 1: OLE Period|Adverse Event|0|||
155244510|NCT05732454|560328646|FG001|Part 1: OLE Period|Adverse Event|1|||
155244511|NCT05732454|560328645|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
155244512|NCT05732454|560328646|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
155244513|NCT01153633|560328647|FG000|Overall Study|Protocol Violation|1|||
155244514|NCT01153633|560328648|FG001|Overall Study|Protocol Violation|1|||
155244515|NCT01153633|560328647|FG000|Overall Study|Therapeutic failure|3|||
155244516|NCT01153633|560328648|FG001|Overall Study|Therapeutic failure|3|||
155244517|NCT03725982|560328651|FG000|First Intervention|Withdrawal by Subject|0|||
155244518|NCT03725982|560328652|FG001|First Intervention|Withdrawal by Subject|1|||
155244519|NCT03725982|560328651|FG000|First Intervention|Physician Decision|1|||
155244520|NCT03725982|560328652|FG001|First Intervention|Physician Decision|1|||
155244521|NCT01262651|560328655|FG000|Overall Study|Adverse Event|40|||
155244522|NCT01262651|560328656|FG001|Overall Study|Adverse Event|35|||
155244523|NCT01262651|560328655|FG000|Overall Study|Withdrawal by Subject|15|||
155244524|NCT01262651|560328656|FG001|Overall Study|Withdrawal by Subject|11|||
155244525|NCT01262651|560328655|FG000|Overall Study|Withdrawal by Investigator|2|||
155244526|NCT01262651|560328656|FG001|Overall Study|Withdrawal by Investigator|2|||
155244527|NCT01262651|560328655|FG000|Overall Study|Met Withdrawal Criteria|1|||
155244528|NCT01262651|560328656|FG001|Overall Study|Met Withdrawal Criteria|0|||
155244529|NCT02239679|560328663|FG000|Overall Study|Lost to Follow-up|1|||
155244530|NCT02239679|560328664|FG001|Overall Study|Lost to Follow-up|0|||
155244531|NCT02239679|560328665|FG002|Overall Study|Lost to Follow-up|0|||
155244532|NCT02239679|560328663|FG000|Overall Study|Withdrawal by Subject|2|||
155244533|NCT02239679|560328664|FG001|Overall Study|Withdrawal by Subject|3|||
155244534|NCT02239679|560328665|FG002|Overall Study|Withdrawal by Subject|1|||
155244535|NCT01517802|560328666|FG000|Overall Study|Death|1|||
155244536|NCT02605954|560328670|FG000|Overall Study|Adverse Event|5|||
155244537|NCT02605954|560328671|FG001|Overall Study|Adverse Event|1|||
155244538|NCT02605954|560328670|FG000|Overall Study|Investigator's Discretion|1|||
155244539|NCT02605954|560328671|FG001|Overall Study|Investigator's Discretion|0|||
155244540|NCT02605954|560328670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155244541|NCT02605954|560328671|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155244542|NCT02605954|560328670|FG000|Overall Study|Withdrew Consent|2|||
155244543|NCT02605954|560328671|FG001|Overall Study|Withdrew Consent|2|||
155244544|NCT02605954|560328670|FG000|Overall Study|Lost to Follow-up|3|||
155244545|NCT02605954|560328671|FG001|Overall Study|Lost to Follow-up|0|||
155244546|NCT02605954|560328670|FG000|Overall Study|Randomized but not treated|0|||
155244547|NCT02605954|560328671|FG001|Overall Study|Randomized but not treated|1|||
155244548|NCT00093145|560328672|FG000|Overall Study|Unacceptable Toxicity Only|2|||
155244549|NCT00093145|560328672|FG000|Overall Study|Physician Decision|5|||
155244550|NCT00093145|560328672|FG000|Overall Study|Withdrawal by Subject|9|||
155244551|NCT00093145|560328672|FG000|Overall Study|Other|1|||
155244552|NCT01310036|560328673|FG000|Overall Study|Administrative/other|10|||
155244553|NCT01310036|560328673|FG000|Overall Study|Withdrew Consent|11|||
155244554|NCT01310036|560328673|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
155244555|NCT01310036|560328673|FG000|Overall Study|Progression of Disease|164|||
155244556|NCT01310036|560328673|FG000|Overall Study|Death|1|||
155244557|NCT01310036|560328673|FG000|Overall Study|Adverse event or intercurrent illness|12|||
155244558|NCT01175668|560328674|FG000|Overall Study|Withdrawal by Subject|2|||
155244559|NCT01175668|560328675|FG001|Overall Study|Withdrawal by Subject|0|||
155244560|NCT00709722|560328676|FG000|Overall Study|Adverse Event|1|||
155244561|NCT03359096|560328677|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
155244562|NCT03359096|560328678|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
155244563|NCT03359096|560328677|FG000|First Intervention (4 Weeks)|Death|1|||
155244564|NCT03359096|560328678|FG001|First Intervention (4 Weeks)|Death|0|||
155244565|NCT03359096|560328677|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
155244566|NCT03359096|560328678|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
155244567|NCT04433767|560328679|FG000|Overall Study|Adverse Event|1|||
155244568|NCT03538626|560328685|FG000|Overall Study|Withdrawal by Subject|0|||
155244569|NCT03538626|560328686|FG001|Overall Study|Withdrawal by Subject|1|||
155244570|NCT03538626|560328687|FG002|Overall Study|Withdrawal by Subject|0|||
155244571|NCT03538626|560328688|FG003|Overall Study|Withdrawal by Subject|0|||
155244572|NCT03538626|560328689|FG004|Overall Study|Withdrawal by Subject|0|||
155244573|NCT03538626|560328690|FG005|Overall Study|Withdrawal by Subject|0|||
155244574|NCT03538626|560328691|FG006|Overall Study|Withdrawal by Subject|0|||
155244575|NCT03538626|560328692|FG007|Overall Study|Withdrawal by Subject|0|||
155244576|NCT03538626|560328685|FG000|Overall Study|Lost to Follow-up|0|||
155244577|NCT03538626|560328686|FG001|Overall Study|Lost to Follow-up|0|||
155244578|NCT03538626|560328687|FG002|Overall Study|Lost to Follow-up|0|||
155244579|NCT03538626|560328688|FG003|Overall Study|Lost to Follow-up|0|||
155244580|NCT03538626|560328689|FG004|Overall Study|Lost to Follow-up|0|||
155244581|NCT03538626|560328690|FG005|Overall Study|Lost to Follow-up|0|||
155244582|NCT03538626|560328691|FG006|Overall Study|Lost to Follow-up|1|||
155244583|NCT03538626|560328692|FG007|Overall Study|Lost to Follow-up|0|||
155244584|NCT01434602|560328697|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244585|NCT01434602|560328698|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
155244586|NCT01434602|560328699|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244587|NCT01434602|560328700|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244588|NCT01434602|560328701|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244589|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244590|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244591|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244592|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
155244593|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244594|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244595|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244596|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244597|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
155244598|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244599|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244600|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244601|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244602|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
155244603|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244604|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244605|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244606|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244607|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
155244608|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244609|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244610|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244611|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244612|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
155244613|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244614|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244615|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244616|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244617|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244618|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
155244619|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244620|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244621|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244622|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
155244623|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
155244624|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244625|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244626|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244627|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
155244628|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244629|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244630|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244631|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244632|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
155244633|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244634|NCT02232893|560328703|FG000|Overall Study|Withdrawal by Subject|4|||
155244635|NCT02232893|560328704|FG001|Overall Study|Withdrawal by Subject|1|||
155244636|NCT02232893|560328703|FG000|Overall Study|Adverse Event|0|||
155244637|NCT02232893|560328704|FG001|Overall Study|Adverse Event|1|||
155244638|NCT02232893|560328703|FG000|Overall Study|Sponsor request early termination|0|||
155244639|NCT02232893|560328704|FG001|Overall Study|Sponsor request early termination|1|||
155244640|NCT02232893|560328703|FG000|Overall Study|Developed exclusion criteria|0|||
155244641|NCT02232893|560328704|FG001|Overall Study|Developed exclusion criteria|1|||
155244642|NCT02232893|560328703|FG000|Overall Study|Other|0|||
155244643|NCT02232893|560328704|FG001|Overall Study|Other|3|||
155244644|NCT01764945|560328709|FG000|Overall Study|Adverse Event|0|||
155244645|NCT01764945|560328710|FG001|Overall Study|Adverse Event|1|||
155244646|NCT01764945|560328711|FG002|Overall Study|Adverse Event|0|||
155244647|NCT01764945|560328712|FG003|Overall Study|Adverse Event|0|||
155244648|NCT01764945|560328713|FG004|Overall Study|Adverse Event|0|||
155244649|NCT01764945|560328714|FG005|Overall Study|Adverse Event|0|||
155244650|NCT01764945|560328715|FG006|Overall Study|Adverse Event|1|||
155244651|NCT01764945|560328716|FG007|Overall Study|Adverse Event|0|||
155244652|NCT05077267|560328719|FG000|Treatment Period|Lost to Follow-up|0|||
155244653|NCT05077267|560328720|FG001|Treatment Period|Lost to Follow-up|1|||
155244654|NCT05077267|560328721|FG002|Treatment Period|Lost to Follow-up|0|||
155244655|NCT05077267|560328719|FG000|Treatment Period|Withdrawal by Subject|0|||
155244656|NCT05077267|560328720|FG001|Treatment Period|Withdrawal by Subject|1|||
155244657|NCT05077267|560328721|FG002|Treatment Period|Withdrawal by Subject|0|||
155244658|NCT05077267|560328719|FG000|Follow-up Period|Lost to Follow-up|0|||
155244659|NCT05077267|560328720|FG001|Follow-up Period|Lost to Follow-up|5|||
155244660|NCT05077267|560328721|FG002|Follow-up Period|Lost to Follow-up|7|||
155244661|NCT05077267|560328719|FG000|Follow-up Period|Withdrawal by Subject|0|||
155244662|NCT05077267|560328720|FG001|Follow-up Period|Withdrawal by Subject|2|||
155244663|NCT05077267|560328721|FG002|Follow-up Period|Withdrawal by Subject|5|||
155244664|NCT05077267|560328719|FG000|Follow-up Period|Study terminated by sponsor|0|||
155244665|NCT05077267|560328720|FG001|Follow-up Period|Study terminated by sponsor|27|||
155244666|NCT05077267|560328721|FG002|Follow-up Period|Study terminated by sponsor|23|||
155244667|NCT05077267|560328719|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
155244668|NCT05077267|560328720|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
155244669|NCT05077267|560328721|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
155244670|NCT05077267|560328719|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
155244671|NCT05077267|560328720|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
155244672|NCT05077267|560328721|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
155244673|NCT02911948|560328722|FG000|Overall Study|Protocol Violation|0|||
155244674|NCT02911948|560328723|FG001|Overall Study|Protocol Violation|1|||
155244675|NCT02911948|560328722|FG000|Overall Study|Withdrawal by Subject|0|||
155244676|NCT02911948|560328723|FG001|Overall Study|Withdrawal by Subject|2|||
155244677|NCT02911948|560328722|FG000|Overall Study|Lack of Efficacy|0|||
155244678|NCT02911948|560328723|FG001|Overall Study|Lack of Efficacy|1|||
155244679|NCT02911948|560328722|FG000|Overall Study|Unclassified|0|||
155244680|NCT02911948|560328723|FG001|Overall Study|Unclassified|3|||
155244681|NCT03864900|560328732|FG000|Overall Study|Withdrawal by Subject|1|||
155244682|NCT03864900|560328733|FG001|Overall Study|Withdrawal by Subject|1|||
155244683|NCT03864900|560328732|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
155244684|NCT03864900|560328733|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
155244685|NCT03165045|560328734|FG000|Visit 1|No registration after visit 1|9|||
155244686|NCT03165045|560328734|FG000|Visit 1|No treatment documented|10|||
155244687|NCT03165045|560328734|FG000|Visit 1|No visit 1|10|||
155244688|NCT03165045|560328734|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
155244689|NCT03165045|560328734|FG000|Visit 2|No available total CCQ score at all|29|||
155244690|NCT03165045|560328734|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
155244691|NCT02308033|560328735|FG000|Overall Study|Normal Gram stain at Baseline|13|||
155244692|NCT02308033|560328736|FG001|Overall Study|Normal Gram stain at Baseline|10|||
155244693|NCT02308033|560328735|FG000|Overall Study|Positive for STD at Baseline|7|||
155244694|NCT02308033|560328736|FG001|Overall Study|Positive for STD at Baseline|4|||
155244695|NCT02308033|560328735|FG000|Overall Study|Lost to Follow-up|6|||
155244696|NCT02308033|560328736|FG001|Overall Study|Lost to Follow-up|5|||
155244697|NCT00759109|560328737|FG000|Overall Study|Adverse Event|17|||
155244698|NCT00759109|560328738|FG001|Overall Study|Adverse Event|12|||
155244699|NCT00759109|560328737|FG000|Overall Study|Inability to comply|1|||
155244700|NCT00759109|560328738|FG001|Overall Study|Inability to comply|1|||
155244701|NCT00759109|560328737|FG000|Overall Study|Withdrawal by Subject|9|||
155244702|NCT00759109|560328738|FG001|Overall Study|Withdrawal by Subject|5|||
155244703|NCT00759109|560328737|FG000|Overall Study|Death|4|||
155244704|NCT00759109|560328738|FG001|Overall Study|Death|3|||
155244705|NCT00759109|560328737|FG000|Overall Study|Lost to Follow-up|4|||
155244706|NCT00759109|560328738|FG001|Overall Study|Lost to Follow-up|6|||
155244707|NCT00759109|560328737|FG000|Overall Study|Started new therapy|2|||
155244708|NCT00759109|560328738|FG001|Overall Study|Started new therapy|6|||
155244709|NCT00759109|560328737|FG000|Overall Study|HCV RNA negative|1|||
155244710|NCT00759109|560328738|FG001|Overall Study|HCV RNA negative|0|||
155244711|NCT00759109|560328737|FG000|Overall Study|Participant moved to a different city|0|||
155244712|NCT00759109|560328738|FG001|Overall Study|Participant moved to a different city|1|||
155244713|NCT00759109|560328737|FG000|Overall Study|Participant had a liver transplant|0|||
155244714|NCT00759109|560328738|FG001|Overall Study|Participant had a liver transplant|1|||
155244715|NCT00759109|560328737|FG000|Overall Study|Lost during study|1|||
155244716|NCT00759109|560328738|FG001|Overall Study|Lost during study|0|||
155244717|NCT01827904|560328739|FG000|Main Study|Withdrawal by Subject|1|||
155244718|NCT01827904|560328740|FG001|Main Study|Withdrawal by Subject|0|||
155244719|NCT01827904|560328741|FG002|Main Study|Withdrawal by Subject|0|||
155244720|NCT01827904|560328739|FG000|Main Study|Adverse Event|1|||
155244721|NCT01827904|560328740|FG001|Main Study|Adverse Event|0|||
155244722|NCT01827904|560328741|FG002|Main Study|Adverse Event|0|||
155244723|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
155244724|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
155244725|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
155244726|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
155244727|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
155244728|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
155244729|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
155244730|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
155244731|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
155244732|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
155244733|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
155244734|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
155244735|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
155244736|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
155244737|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
155244738|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
155244739|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
155244740|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
155244741|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
155244742|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
155244743|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
155244744|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Physician Decision|1|||
155244745|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Physician Decision|0|||
155244746|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Physician Decision|0|||
155244747|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
155244748|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
155244749|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
155244750|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
155244751|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
155244752|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
155244753|NCT00142909|560328749|FG000|Randomization|Various Reasons|7|||
155244754|NCT00142909|560328750|FG001|Randomization|Various Reasons|10|||
155244755|NCT00142909|560328749|FG000|Medications Begin|Protocol Violation|2|||
155244756|NCT00142909|560328750|FG001|Medications Begin|Protocol Violation|0|||
155244757|NCT00142909|560328749|FG000|Medications Begin|Withdrawal by Subject|5|||
155244758|NCT00142909|560328750|FG001|Medications Begin|Withdrawal by Subject|3|||
155244759|NCT00142909|560328749|FG000|Medications Begin|Withdrawal by Subject|2|||
155244760|NCT00142909|560328750|FG001|Medications Begin|Withdrawal by Subject|0|||
155244761|NCT01660763|560328754|FG000|Overall Study|Lack of Efficacy|45|||
155244762|NCT01660763|560328755|FG001|Overall Study|Lack of Efficacy|50|||
155244763|NCT01660763|560328754|FG000|Overall Study|Adverse Event|22|||
155244764|NCT01660763|560328755|FG001|Overall Study|Adverse Event|7|||
155244765|NCT01660763|560328754|FG000|Overall Study|Protocol Violation|1|||
155244766|NCT01660763|560328755|FG001|Overall Study|Protocol Violation|0|||
155244767|NCT01660763|560328754|FG000|Overall Study|Withdrawal by Subject|4|||
155244768|NCT01660763|560328755|FG001|Overall Study|Withdrawal by Subject|0|||
155244769|NCT01660763|560328754|FG000|Overall Study|Patient ready for early discharge|28|||
155244770|NCT01660763|560328755|FG001|Overall Study|Patient ready for early discharge|4|||
155244771|NCT00345397|560328756|FG000|Overall Study|Death|1|||
155244772|NCT01870843|560328757|FG000|Overall Study|Adverse Event|10|||
155244773|NCT01870843|560328757|FG000|Overall Study|Lost to Follow-up|24|||
155244774|NCT01870843|560328757|FG000|Overall Study|Death|1|||
155244775|NCT01870843|560328757|FG000|Overall Study|Withdrawal by Subject|18|||
155244776|NCT01910519|560328758|FG000|Overall Study|Withdrawal by Subject|2|||
155244777|NCT01910519|560328759|FG001|Overall Study|Withdrawal by Subject|0|||
155244778|NCT01910519|560328758|FG000|Overall Study|Adverse Event|2|||
155244779|NCT01910519|560328759|FG001|Overall Study|Adverse Event|0|||
155244780|NCT04266028|560328760|FG000|Overall Study|Adverse Event|0|||
155244781|NCT04266028|560328761|FG001|Overall Study|Adverse Event|0|||
155244782|NCT04266028|560328762|FG002|Overall Study|Adverse Event|1|||
155244783|NCT04266028|560328763|FG003|Overall Study|Adverse Event|0|||
155244784|NCT04266028|560328764|FG004|Overall Study|Adverse Event|1|||
155244785|NCT04266028|560328765|FG005|Overall Study|Adverse Event|0|||
155244786|NCT04266028|560328766|FG006|Overall Study|Adverse Event|2|||
155244787|NCT04266028|560328767|FG007|Overall Study|Adverse Event|0|||
155244788|NCT04266028|560328760|FG000|Overall Study|temporary halt of the study|0|||
155244789|NCT04266028|560328761|FG001|Overall Study|temporary halt of the study|0|||
155244790|NCT04266028|560328762|FG002|Overall Study|temporary halt of the study|0|||
155244791|NCT04266028|560328763|FG003|Overall Study|temporary halt of the study|0|||
155244792|NCT04266028|560328764|FG004|Overall Study|temporary halt of the study|0|||
155244793|NCT04266028|560328765|FG005|Overall Study|temporary halt of the study|0|||
155244794|NCT04266028|560328766|FG006|Overall Study|temporary halt of the study|2|||
155244795|NCT04266028|560328767|FG007|Overall Study|temporary halt of the study|1|||
155244796|NCT04266028|560328760|FG000|Overall Study|Onset of birch pollen season|0|||
155244797|NCT04266028|560328761|FG001|Overall Study|Onset of birch pollen season|0|||
155244798|NCT04266028|560328762|FG002|Overall Study|Onset of birch pollen season|0|||
155244799|NCT04266028|560328763|FG003|Overall Study|Onset of birch pollen season|0|||
155244800|NCT04266028|560328764|FG004|Overall Study|Onset of birch pollen season|1|||
155244801|NCT04266028|560328765|FG005|Overall Study|Onset of birch pollen season|0|||
155244802|NCT04266028|560328766|FG006|Overall Study|Onset of birch pollen season|0|||
155244803|NCT04266028|560328767|FG007|Overall Study|Onset of birch pollen season|0|||
155244804|NCT03325712|560328768|FG000|Overall Study|Protocol Violation|0|||
155244805|NCT03325712|560328769|FG001|Overall Study|Protocol Violation|0|||
155244806|NCT03325712|560328770|FG002|Overall Study|Protocol Violation|0|||
155244807|NCT03325712|560328771|FG003|Overall Study|Protocol Violation|0|||
155244808|NCT03325712|560328772|FG004|Overall Study|Protocol Violation|1|||
155244809|NCT03325712|560328773|FG005|Overall Study|Protocol Violation|0|||
155244810|NCT03325712|560328774|FG006|Overall Study|Protocol Violation|0|||
155244811|NCT03325712|560328775|FG007|Overall Study|Protocol Violation|0|||
155244812|NCT03325712|560328768|FG000|Overall Study|Adverse Event|0|||
155244813|NCT03325712|560328769|FG001|Overall Study|Adverse Event|0|||
155244814|NCT03325712|560328770|FG002|Overall Study|Adverse Event|0|||
155244815|NCT03325712|560328771|FG003|Overall Study|Adverse Event|0|||
155244816|NCT03325712|560328772|FG004|Overall Study|Adverse Event|1|||
155244817|NCT03325712|560328773|FG005|Overall Study|Adverse Event|0|||
155244818|NCT03325712|560328774|FG006|Overall Study|Adverse Event|0|||
155244819|NCT03325712|560328775|FG007|Overall Study|Adverse Event|0|||
155244820|NCT02265237|560328777|FG000|As Treated (Overall Study)|Adverse Event|1|||
155244821|NCT02265237|560328778|FG001|As Treated (Overall Study)|Adverse Event|1|||
155244822|NCT02265237|560328779|FG002|As Treated (Overall Study)|Adverse Event|0|||
155244823|NCT02265237|560328780|FG003|As Treated (Overall Study)|Adverse Event|0|||
155244824|NCT02265237|560328777|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
155244825|NCT02265237|560328778|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
155244826|NCT02265237|560328779|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
155244827|NCT02265237|560328780|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
155244828|NCT02265237|560328777|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
155244829|NCT02265237|560328778|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
155244830|NCT02265237|560328779|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
155244831|NCT02265237|560328780|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
155244832|NCT02265237|560328777|FG000|As Treated (Overall Study)|Other|2|||
155244833|NCT02265237|560328778|FG001|As Treated (Overall Study)|Other|0|||
155244834|NCT02265237|560328779|FG002|As Treated (Overall Study)|Other|3|||
155244835|NCT02265237|560328780|FG003|As Treated (Overall Study)|Other|1|||
155244836|NCT01178853|560328782|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
155244837|NCT01178853|560328783|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
155244838|NCT01178853|560328782|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
155244839|NCT01178853|560328783|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
155244840|NCT01178853|560328782|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
155244841|NCT01178853|560328783|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
155244842|NCT01178853|560328782|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
155244843|NCT01178853|560328783|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
155244844|NCT01178853|560328782|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
155244845|NCT01178853|560328783|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
155244846|NCT03550313|560328784|FG000|Overall Study|Adverse Event|0|||
155244847|NCT03550313|560328785|FG001|Overall Study|Adverse Event|1|||
155244848|NCT03550313|560328786|FG002|Overall Study|Adverse Event|0|||
155244849|NCT03550313|560328784|FG000|Overall Study|Lost to Follow-up|5|||
155244850|NCT03550313|560328785|FG001|Overall Study|Lost to Follow-up|7|||
155244851|NCT03550313|560328786|FG002|Overall Study|Lost to Follow-up|12|||
155244852|NCT03550313|560328784|FG000|Overall Study|Study terminated by sponsor|44|||
155244853|NCT03550313|560328785|FG001|Overall Study|Study terminated by sponsor|37|||
155244854|NCT03550313|560328786|FG002|Overall Study|Study terminated by sponsor|48|||
155244855|NCT03550313|560328784|FG000|Overall Study|No longer met eligibility criteria|3|||
155244856|NCT03550313|560328785|FG001|Overall Study|No longer met eligibility criteria|5|||
155244857|NCT03550313|560328786|FG002|Overall Study|No longer met eligibility criteria|6|||
155244858|NCT03550313|560328784|FG000|Overall Study|Withdrawal by parent/guardian|20|||
155244859|NCT03550313|560328785|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155244860|NCT03550313|560328786|FG002|Overall Study|Withdrawal by parent/guardian|26|||
155244861|NCT03550313|560328784|FG000|Overall Study|Other|4|||
155244862|NCT03550313|560328785|FG001|Overall Study|Other|2|||
155244863|NCT03550313|560328786|FG002|Overall Study|Other|2|||
155244864|NCT03550313|560328784|FG000|Overall Study|Randomized but not vaccinated|3|||
155244865|NCT03550313|560328785|FG001|Overall Study|Randomized but not vaccinated|23|||
155244866|NCT03550313|560328786|FG002|Overall Study|Randomized but not vaccinated|2|||
155244867|NCT03550313|560328784|FG000|Overall Study|Sites terminated due to quality issues|18|||
155244868|NCT03550313|560328785|FG001|Overall Study|Sites terminated due to quality issues|17|||
155244869|NCT03550313|560328786|FG002|Overall Study|Sites terminated due to quality issues|18|||
155244870|NCT00839072|560328787|FG000|First Intervention Period|Withdrawal by Subject|1|||
155244871|NCT00839072|560328788|FG001|First Intervention Period|Withdrawal by Subject|0|||
155244872|NCT00839072|560328787|FG000|First Intervention Period|Adverse Event|1|||
155244873|NCT00839072|560328788|FG001|First Intervention Period|Adverse Event|1|||
155244874|NCT00839072|560328787|FG000|Second Intervention Period|Withdrawal by Subject|1|||
155244875|NCT00839072|560328788|FG001|Second Intervention Period|Withdrawal by Subject|0|||
155244876|NCT00380068|560328789|FG000|Overall Study|Adverse Event|40|||
155244877|NCT00380068|560328789|FG000|Overall Study|Withdrawal by Subject|10|||
155244878|NCT00380068|560328789|FG000|Overall Study|Not compliant|6|||
155244879|NCT00380068|560328789|FG000|Overall Study|Lost to Follow-up|1|||
155244880|NCT00380068|560328789|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
155244881|NCT00380068|560328789|FG000|Overall Study|Lung transplant|3|||
155244882|NCT00380068|560328789|FG000|Overall Study|Physician Decision|2|||
155244883|NCT00380068|560328789|FG000|Overall Study|Partipant moved away|1|||
155244884|NCT00380068|560328789|FG000|Overall Study|Lack of Efficacy|5|||
155244885|NCT01297062|560328790|FG000|Overall Study|Adverse Event|2|||
155244886|NCT01297062|560328791|FG001|Overall Study|Adverse Event|0|||
155244887|NCT01297062|560328792|FG002|Overall Study|Adverse Event|1|||
155244888|NCT01297062|560328793|FG003|Overall Study|Adverse Event|0|||
155244889|NCT01297062|560328794|FG004|Overall Study|Adverse Event|0|||
155244890|NCT01297062|560328795|FG005|Overall Study|Adverse Event|0|||
155244891|NCT01297062|560328796|FG006|Overall Study|Adverse Event|0|||
155244892|NCT01297062|560328790|FG000|Overall Study|Physician Decision|1|||
155244893|NCT01297062|560328791|FG001|Overall Study|Physician Decision|0|||
155244894|NCT01297062|560328792|FG002|Overall Study|Physician Decision|1|||
155244895|NCT01297062|560328793|FG003|Overall Study|Physician Decision|0|||
155244896|NCT01297062|560328794|FG004|Overall Study|Physician Decision|0|||
155244897|NCT01297062|560328795|FG005|Overall Study|Physician Decision|0|||
155244898|NCT01297062|560328796|FG006|Overall Study|Physician Decision|6|||
155244899|NCT01297062|560328790|FG000|Overall Study|Protocol Violation|0|||
155244900|NCT01297062|560328791|FG001|Overall Study|Protocol Violation|0|||
155244901|NCT01297062|560328792|FG002|Overall Study|Protocol Violation|0|||
155244902|NCT01297062|560328793|FG003|Overall Study|Protocol Violation|0|||
155244903|NCT01297062|560328794|FG004|Overall Study|Protocol Violation|1|||
155244904|NCT01297062|560328795|FG005|Overall Study|Protocol Violation|0|||
155244905|NCT01297062|560328796|FG006|Overall Study|Protocol Violation|0|||
155244906|NCT01297062|560328790|FG000|Overall Study|Subject Decision|1|||
155244907|NCT01297062|560328791|FG001|Overall Study|Subject Decision|1|||
155244908|NCT01297062|560328792|FG002|Overall Study|Subject Decision|0|||
155244909|NCT01297062|560328793|FG003|Overall Study|Subject Decision|1|||
155244910|NCT01297062|560328794|FG004|Overall Study|Subject Decision|1|||
155244911|NCT01297062|560328795|FG005|Overall Study|Subject Decision|1|||
155244912|NCT01297062|560328796|FG006|Overall Study|Subject Decision|2|||
155244913|NCT01682837|560328799|FG000|Baseline|Withdrawal by Subject|5|||
155244914|NCT03021187|560328802|FG000|Overall Study|Death|0|||
155244915|NCT03021187|560328803|FG001|Overall Study|Death|0|||
155244916|NCT03021187|560328804|FG002|Overall Study|Death|3|||
155244917|NCT03021187|560328805|FG003|Overall Study|Death|0|||
155244918|NCT03021187|560328802|FG000|Overall Study|Withdrawal by Subject|0|||
155244919|NCT03021187|560328803|FG001|Overall Study|Withdrawal by Subject|6|||
155244920|NCT03021187|560328804|FG002|Overall Study|Withdrawal by Subject|2|||
155244921|NCT03021187|560328805|FG003|Overall Study|Withdrawal by Subject|5|||
155244922|NCT03021187|560328802|FG000|Overall Study|Lost to Follow-up|10|||
155244923|NCT03021187|560328803|FG001|Overall Study|Lost to Follow-up|3|||
155244924|NCT03021187|560328804|FG002|Overall Study|Lost to Follow-up|1|||
155244925|NCT03021187|560328805|FG003|Overall Study|Lost to Follow-up|4|||
155244926|NCT01664078|560328806|FG000|Overall Study|Death|9|||
155244927|NCT01664078|560328806|FG000|Overall Study|Withdrawal by Subject|4|||
155244928|NCT01664078|560328806|FG000|Overall Study|Lost to Follow-up|2|||
155244929|NCT01664078|560328806|FG000|Overall Study|missed 5 year visit|1|||
155244930|NCT01664078|560328806|FG000|Overall Study|Other|53|||
155244931|NCT04782323|560328807|FG000|Overall Study|Death|1|||
155244932|NCT04782323|560328808|FG001|Overall Study|Death|0|||
155244933|NCT04782323|560328809|FG002|Overall Study|Death|0|||
155244934|NCT04782323|560328810|FG003|Overall Study|Death|0|||
155244935|NCT04782323|560328811|FG004|Overall Study|Death|1|||
155244936|NCT04782323|560328812|FG005|Overall Study|Death|1|||
155244937|NCT04782323|560328813|FG006|Overall Study|Death|1|||
155244938|NCT04782323|560328814|FG007|Overall Study|Death|0|||
155244939|NCT04782323|560328807|FG000|Overall Study|Withdrawal by Subject|0|||
155244940|NCT04782323|560328808|FG001|Overall Study|Withdrawal by Subject|0|||
155244941|NCT04782323|560328809|FG002|Overall Study|Withdrawal by Subject|1|||
155244942|NCT04782323|560328810|FG003|Overall Study|Withdrawal by Subject|0|||
155244943|NCT04782323|560328811|FG004|Overall Study|Withdrawal by Subject|0|||
155244944|NCT04782323|560328812|FG005|Overall Study|Withdrawal by Subject|1|||
155244945|NCT04782323|560328813|FG006|Overall Study|Withdrawal by Subject|0|||
155244946|NCT04782323|560328814|FG007|Overall Study|Withdrawal by Subject|1|||
155244947|NCT04782323|560328807|FG000|Overall Study|Lost to Follow-up|0|||
155244948|NCT04782323|560328808|FG001|Overall Study|Lost to Follow-up|1|||
155244949|NCT04782323|560328809|FG002|Overall Study|Lost to Follow-up|1|||
155244950|NCT04782323|560328810|FG003|Overall Study|Lost to Follow-up|0|||
155244951|NCT04782323|560328811|FG004|Overall Study|Lost to Follow-up|0|||
155244952|NCT04782323|560328812|FG005|Overall Study|Lost to Follow-up|1|||
155244953|NCT04782323|560328813|FG006|Overall Study|Lost to Follow-up|1|||
155244954|NCT04782323|560328814|FG007|Overall Study|Lost to Follow-up|2|||
155244955|NCT04782323|560328807|FG000|Overall Study|randomization in error|1|||
155244956|NCT04782323|560328808|FG001|Overall Study|randomization in error|0|||
155244957|NCT04782323|560328809|FG002|Overall Study|randomization in error|0|||
155244958|NCT04782323|560328810|FG003|Overall Study|randomization in error|0|||
155244959|NCT04782323|560328811|FG004|Overall Study|randomization in error|0|||
155244960|NCT04782323|560328812|FG005|Overall Study|randomization in error|0|||
155244961|NCT04782323|560328813|FG006|Overall Study|randomization in error|0|||
155244962|NCT04782323|560328814|FG007|Overall Study|randomization in error|0|||
155244963|NCT03351049|560328815|FG000|Overall Study|Withdrawal|26|||
155244964|NCT03351049|560328816|FG001|Overall Study|Withdrawal|22|||
155244965|NCT03832192|560328821|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
155244966|NCT03832192|560328822|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
155244967|NCT02730819|560328829|FG000|Overall Study|Lost to Follow-up|9|||
155244968|NCT00156065|560330815|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
155244969|NCT00156065|560330816|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
155244970|NCT00156065|560330817|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
155244971|NCT00156065|560330815|FG000|Overall Study|Adverse Event|8|||
155244972|NCT00156065|560330816|FG001|Overall Study|Adverse Event|11|||
155244973|NCT00156065|560330817|FG002|Overall Study|Adverse Event|4|||
155244974|NCT00156065|560330815|FG000|Overall Study|Lack of Efficacy|2|||
155244975|NCT00156065|560330816|FG001|Overall Study|Lack of Efficacy|9|||
155244976|NCT00156065|560330817|FG002|Overall Study|Lack of Efficacy|3|||
155244977|NCT00156065|560330815|FG000|Overall Study|Withdrawal by Subject|13|||
155244978|NCT00156065|560330816|FG001|Overall Study|Withdrawal by Subject|26|||
155244979|NCT00156065|560330817|FG002|Overall Study|Withdrawal by Subject|16|||
155244980|NCT00156065|560330815|FG000|Overall Study|Lost to Follow-up|5|||
155244981|NCT00156065|560330816|FG001|Overall Study|Lost to Follow-up|7|||
155244982|NCT00156065|560330817|FG002|Overall Study|Lost to Follow-up|1|||
155244983|NCT00156065|560330815|FG000|Overall Study|Other|2|||
155244984|NCT00156065|560330816|FG001|Overall Study|Other|9|||
155244985|NCT00156065|560330817|FG002|Overall Study|Other|3|||
155244986|NCT02891187|560330818|FG000|Overall Study|Lost to Follow-up|1|||
155244987|NCT02891187|560330819|FG001|Overall Study|Lost to Follow-up|2|||
155244988|NCT03581305|560330820|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
155244989|NCT03581305|560330821|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
155244990|NCT03581305|560330820|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
155244991|NCT03581305|560330821|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
155244992|NCT03581305|560330820|FG000|Serotonergic Study|Withdrawal by Subject|5|||
155244993|NCT03581305|560330821|FG001|Serotonergic Study|Withdrawal by Subject|1|||
155244994|NCT01798927|560330822|FG000|Overall Study|Withdrawal by Subject|1|||
155244995|NCT01159691|560330823|FG000|Overall Study|Lost to Follow-up|2|||
155244996|NCT01159691|560330823|FG000|Overall Study|Unknown reasons|1|||
155244997|NCT01159691|560330823|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
155244998|NCT01159691|560330823|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
155244999|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
155245000|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
155245001|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
155245002|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
155245003|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
155245004|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
155245005|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
155245006|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
155245007|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
155245008|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
155245009|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
155245010|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
155245011|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
155245012|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
155245013|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
155245014|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
155245015|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
155245016|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
155245017|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
155245018|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
155245019|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
155245020|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
155245021|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
155245022|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
155245023|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
155245024|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
155245025|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
155245026|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
155245027|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245028|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245029|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245030|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245031|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245032|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245033|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245034|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245035|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245036|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245037|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245038|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245039|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245040|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245041|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245042|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245043|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245044|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245045|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
155245046|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
155245047|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
155245048|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245049|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245050|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245051|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245052|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245053|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245054|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245055|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245056|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245057|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245058|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245059|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245060|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245061|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245062|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245063|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
155245064|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
155245065|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
155245066|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
155245067|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
155245068|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
155245069|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
155245070|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
155245071|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
155245072|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
155245073|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
155245074|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
155245075|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
155245076|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
155245077|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
155245078|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
155245079|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
155245080|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
155245081|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
155245082|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
155245083|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
155245084|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245085|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245086|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245087|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245088|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245089|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245090|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245091|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245092|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245093|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245094|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245095|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245096|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245097|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245098|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245099|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245100|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245101|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245102|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245103|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245104|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245105|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245106|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
155245107|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245108|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245109|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245110|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245111|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245112|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245113|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245114|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245115|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245116|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245117|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245118|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245119|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245120|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245121|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245122|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245123|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245124|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245125|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245126|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245127|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
155245128|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245129|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245130|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245131|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245132|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245133|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245134|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245135|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245136|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245137|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245138|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245139|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245140|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245141|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245142|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245143|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245144|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245145|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245146|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245147|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245148|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245149|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245150|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245151|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245152|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245153|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
155245154|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
155245155|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245156|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245157|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245158|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245159|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245160|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245161|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245162|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245163|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245164|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245165|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245166|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245167|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245168|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245169|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245170|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245171|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245172|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
155245173|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245174|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245175|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245176|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245177|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245178|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245179|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245180|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245181|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245182|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245183|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245184|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245185|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245186|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245187|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245188|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245189|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
155245190|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245191|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245192|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
155245193|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245194|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245195|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245196|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245197|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245198|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245199|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245200|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245201|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245202|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245203|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245204|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245205|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245206|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245207|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245208|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245209|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
155245210|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245211|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245212|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245213|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245214|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245215|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245216|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245217|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245218|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245219|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245220|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245221|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245222|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245223|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245224|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245225|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245226|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245227|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245228|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
155245229|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245230|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245231|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245232|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155491672|NCT00978120|561225482|FG000|Overall Study|Moved out of state|0|||
155245233|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245234|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245235|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245236|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245237|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245238|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245239|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245240|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245241|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245242|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245243|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245244|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245245|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245246|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245247|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245248|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245249|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245250|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245251|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245252|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245253|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245254|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
155245255|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245256|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245257|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245258|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245259|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245260|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245261|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245262|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245263|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245264|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245265|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245266|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245267|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245268|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
155245269|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
155245270|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
155245271|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
155245272|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
155245273|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
155245274|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
155245275|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245276|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245277|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245278|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245279|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245280|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245281|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245282|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245283|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245284|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245285|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245286|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245287|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245288|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245289|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245290|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245291|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245292|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245293|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
155491673|NCT00978120|561225483|FG001|Overall Study|Moved out of state|0|||
155491674|NCT00978120|561225484|FG002|Overall Study|Moved out of state|0|||
155245294|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245295|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245296|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245297|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
155245298|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
155245299|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245300|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245301|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245302|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245303|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245304|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245305|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245306|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245307|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245308|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245309|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245310|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245311|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245312|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245313|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245314|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245315|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245316|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
155245317|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245318|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245319|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245320|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245321|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245322|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245323|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245324|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245325|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245326|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245327|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245328|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245329|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245330|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245331|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245332|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245333|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245334|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245335|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245336|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245337|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
155245338|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
155245339|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245340|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245341|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245342|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245343|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245344|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245345|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245346|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245347|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245348|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245349|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245350|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245351|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245352|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245353|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245354|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245355|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
155491675|NCT00978120|561225485|FG003|Overall Study|Moved out of state|1|||
155491676|NCT03253809|561225486|FG000|Overall Study|Unable to obtain study related data|14|||
155245356|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
155245357|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
155245358|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
155245359|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245360|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245361|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245362|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245363|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
155245364|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
155245365|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
155245366|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
155245367|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
155245368|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
155245369|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
155245370|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
155245371|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
155245372|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
155245373|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
155245374|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
155245375|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
155245376|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
155245377|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
155245378|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
155245379|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
155245380|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
155245381|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
155245382|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
155245383|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Death|0|||
155245384|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Death|0|||
155245385|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Death|0|||
155245386|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Death|0|||
155245387|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Death|0|||
155245388|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Death|0|||
155245389|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Death|0|||
155245390|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Death|0|||
155245391|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Death|0|||
155245392|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Death|0|||
155245393|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Death|0|||
155245394|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Death|0|||
155245395|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Death|0|||
155245396|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Death|0|||
155245397|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Death|0|||
155245398|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Death|0|||
155245399|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Death|0|||
155245400|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Death|0|||
155245401|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Death|1|||
155245402|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Death|0|||
155245403|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245404|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245405|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245406|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245407|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245408|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245409|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245410|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245411|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245412|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245413|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245414|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245415|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245416|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245417|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245418|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245419|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245420|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
155245421|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
155245422|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
155491677|NCT03992456|561225487|FG000|Overall Study|Withdrawal by Subject|1|||
155245423|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245424|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245425|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245426|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245427|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245428|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245429|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245430|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245431|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245432|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245433|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245434|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245435|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245436|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245437|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245438|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245439|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245440|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245441|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
155245442|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245443|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
155245444|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
155245445|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
155245446|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
155245447|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
155245448|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
155245449|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
155245450|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
155245451|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
155245452|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
155245453|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
155245454|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
155245455|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
155245456|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
155245457|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
155245458|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
155245459|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
155245460|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
155245461|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
155245462|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
155245463|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
155245464|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
155245465|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
155245466|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
155245467|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
155245468|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
155245469|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
155245470|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
155245471|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
155245472|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
155245473|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
155245474|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
155245475|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
155245476|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
155245477|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
155245478|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
155245479|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
155245480|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
155245481|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
155245482|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
155245483|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245484|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245485|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245486|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245487|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245488|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245489|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245490|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245491|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245492|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245493|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245494|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245495|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245496|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245497|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245498|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245499|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245500|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245501|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245502|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245503|NCT02332720|560330849|FG000|Part A and Part B|Lost to Follow-up|1|||
155245504|NCT02332720|560330850|FG001|Part A and Part B|Lost to Follow-up|0|||
155245505|NCT02332720|560330851|FG002|Part A and Part B|Lost to Follow-up|0|||
155245506|NCT02332720|560330852|FG003|Part A and Part B|Lost to Follow-up|0|||
155245507|NCT02332720|560330853|FG004|Part A and Part B|Lost to Follow-up|0|||
155245508|NCT02332720|560330854|FG005|Part A and Part B|Lost to Follow-up|2|||
155245509|NCT02332720|560330855|FG006|Part A and Part B|Lost to Follow-up|1|||
155245510|NCT02332720|560330856|FG007|Part A and Part B|Lost to Follow-up|1|||
155245511|NCT02332720|560330857|FG008|Part A and Part B|Lost to Follow-up|0|||
155245512|NCT02332720|560330858|FG009|Part A and Part B|Lost to Follow-up|0|||
155245513|NCT02332720|560330859|FG010|Part A and Part B|Lost to Follow-up|0|||
155245514|NCT02332720|560330860|FG011|Part A and Part B|Lost to Follow-up|0|||
155245515|NCT02332720|560330861|FG012|Part A and Part B|Lost to Follow-up|0|||
155245516|NCT02332720|560330862|FG013|Part A and Part B|Lost to Follow-up|0|||
155245517|NCT02332720|560330863|FG014|Part A and Part B|Lost to Follow-up|0|||
155245518|NCT02332720|560330864|FG015|Part A and Part B|Lost to Follow-up|1|||
155245519|NCT02332720|560330865|FG016|Part A and Part B|Lost to Follow-up|0|||
155245520|NCT02332720|560330866|FG017|Part A and Part B|Lost to Follow-up|0|||
155245521|NCT02332720|560330867|FG018|Part A and Part B|Lost to Follow-up|0|||
155245522|NCT02332720|560330868|FG019|Part A and Part B|Lost to Follow-up|0|||
155245523|NCT02332720|560330869|FG020|Part A and Part B|Lost to Follow-up|0|||
155245524|NCT02332720|560330870|FG021|Part A and Part B|Lost to Follow-up|0|||
155245525|NCT02332720|560330871|FG022|Part A and Part B|Lost to Follow-up|0|||
155245526|NCT02332720|560330849|FG000|Part A and Part B|Adverse Event|0|||
155245527|NCT02332720|560330850|FG001|Part A and Part B|Adverse Event|0|||
155245528|NCT02332720|560330851|FG002|Part A and Part B|Adverse Event|0|||
155245529|NCT02332720|560330852|FG003|Part A and Part B|Adverse Event|0|||
155245530|NCT02332720|560330853|FG004|Part A and Part B|Adverse Event|0|||
155245531|NCT02332720|560330854|FG005|Part A and Part B|Adverse Event|0|||
155245532|NCT02332720|560330855|FG006|Part A and Part B|Adverse Event|0|||
155245533|NCT02332720|560330856|FG007|Part A and Part B|Adverse Event|0|||
155245534|NCT02332720|560330857|FG008|Part A and Part B|Adverse Event|0|||
155245535|NCT02332720|560330858|FG009|Part A and Part B|Adverse Event|0|||
155245536|NCT02332720|560330859|FG010|Part A and Part B|Adverse Event|0|||
155245537|NCT02332720|560330860|FG011|Part A and Part B|Adverse Event|0|||
155245538|NCT02332720|560330861|FG012|Part A and Part B|Adverse Event|0|||
155245539|NCT02332720|560330862|FG013|Part A and Part B|Adverse Event|0|||
155245540|NCT02332720|560330863|FG014|Part A and Part B|Adverse Event|0|||
155245541|NCT02332720|560330864|FG015|Part A and Part B|Adverse Event|0|||
155245542|NCT02332720|560330865|FG016|Part A and Part B|Adverse Event|0|||
155245543|NCT02332720|560330866|FG017|Part A and Part B|Adverse Event|1|||
155245544|NCT02332720|560330867|FG018|Part A and Part B|Adverse Event|0|||
155245545|NCT02332720|560330868|FG019|Part A and Part B|Adverse Event|0|||
155245546|NCT02332720|560330869|FG020|Part A and Part B|Adverse Event|0|||
155245547|NCT02332720|560330870|FG021|Part A and Part B|Adverse Event|0|||
155245548|NCT02332720|560330871|FG022|Part A and Part B|Adverse Event|0|||
155245549|NCT02332720|560330849|FG000|Part A and Part B|Physician Decision|0|||
155245550|NCT02332720|560330850|FG001|Part A and Part B|Physician Decision|0|||
155245551|NCT02332720|560330851|FG002|Part A and Part B|Physician Decision|0|||
155245552|NCT02332720|560330852|FG003|Part A and Part B|Physician Decision|0|||
155245553|NCT02332720|560330853|FG004|Part A and Part B|Physician Decision|0|||
155245554|NCT02332720|560330854|FG005|Part A and Part B|Physician Decision|0|||
155245555|NCT02332720|560330855|FG006|Part A and Part B|Physician Decision|0|||
155245556|NCT02332720|560330856|FG007|Part A and Part B|Physician Decision|0|||
155245557|NCT02332720|560330857|FG008|Part A and Part B|Physician Decision|0|||
155245558|NCT02332720|560330858|FG009|Part A and Part B|Physician Decision|0|||
155245559|NCT02332720|560330859|FG010|Part A and Part B|Physician Decision|0|||
155245560|NCT02332720|560330860|FG011|Part A and Part B|Physician Decision|0|||
155245561|NCT02332720|560330861|FG012|Part A and Part B|Physician Decision|0|||
155245562|NCT02332720|560330862|FG013|Part A and Part B|Physician Decision|0|||
155245563|NCT02332720|560330863|FG014|Part A and Part B|Physician Decision|0|||
155245564|NCT02332720|560330864|FG015|Part A and Part B|Physician Decision|0|||
155245565|NCT02332720|560330865|FG016|Part A and Part B|Physician Decision|0|||
155245566|NCT02332720|560330866|FG017|Part A and Part B|Physician Decision|0|||
155245567|NCT02332720|560330867|FG018|Part A and Part B|Physician Decision|1|||
155245568|NCT02332720|560330868|FG019|Part A and Part B|Physician Decision|0|||
155245569|NCT02332720|560330869|FG020|Part A and Part B|Physician Decision|0|||
155245570|NCT02332720|560330870|FG021|Part A and Part B|Physician Decision|0|||
155245571|NCT02332720|560330871|FG022|Part A and Part B|Physician Decision|0|||
155245572|NCT02332720|560330849|FG000|Part A and Part B|Withdrawal by Subject|0|||
155245573|NCT02332720|560330850|FG001|Part A and Part B|Withdrawal by Subject|0|||
155245574|NCT02332720|560330851|FG002|Part A and Part B|Withdrawal by Subject|0|||
155245575|NCT02332720|560330852|FG003|Part A and Part B|Withdrawal by Subject|0|||
155245576|NCT02332720|560330853|FG004|Part A and Part B|Withdrawal by Subject|0|||
155245577|NCT02332720|560330854|FG005|Part A and Part B|Withdrawal by Subject|1|||
155245578|NCT02332720|560330855|FG006|Part A and Part B|Withdrawal by Subject|0|||
155245579|NCT02332720|560330856|FG007|Part A and Part B|Withdrawal by Subject|0|||
155245580|NCT02332720|560330857|FG008|Part A and Part B|Withdrawal by Subject|0|||
155245581|NCT02332720|560330858|FG009|Part A and Part B|Withdrawal by Subject|0|||
155245582|NCT02332720|560330859|FG010|Part A and Part B|Withdrawal by Subject|0|||
155245583|NCT02332720|560330860|FG011|Part A and Part B|Withdrawal by Subject|0|||
155245584|NCT02332720|560330861|FG012|Part A and Part B|Withdrawal by Subject|0|||
155245585|NCT02332720|560330862|FG013|Part A and Part B|Withdrawal by Subject|0|||
155245586|NCT02332720|560330863|FG014|Part A and Part B|Withdrawal by Subject|0|||
155245587|NCT02332720|560330864|FG015|Part A and Part B|Withdrawal by Subject|0|||
155245588|NCT02332720|560330865|FG016|Part A and Part B|Withdrawal by Subject|0|||
155245589|NCT02332720|560330866|FG017|Part A and Part B|Withdrawal by Subject|0|||
155245590|NCT02332720|560330867|FG018|Part A and Part B|Withdrawal by Subject|0|||
155245591|NCT02332720|560330868|FG019|Part A and Part B|Withdrawal by Subject|1|||
155245592|NCT02332720|560330869|FG020|Part A and Part B|Withdrawal by Subject|0|||
155245593|NCT02332720|560330870|FG021|Part A and Part B|Withdrawal by Subject|0|||
155245594|NCT02332720|560330871|FG022|Part A and Part B|Withdrawal by Subject|0|||
155245595|NCT00384085|560330872|FG000|Overall Study|Adverse Event|5|||
155245596|NCT00384085|560330873|FG001|Overall Study|Adverse Event|5|||
155245597|NCT00384085|560330874|FG002|Overall Study|Adverse Event|4|||
155245598|NCT00384085|560330872|FG000|Overall Study|Lack of Efficacy|0|||
155245599|NCT00384085|560330873|FG001|Overall Study|Lack of Efficacy|3|||
155245600|NCT00384085|560330874|FG002|Overall Study|Lack of Efficacy|2|||
155245601|NCT00384085|560330872|FG000|Overall Study|No longer Requires Study Treatment|1|||
155245602|NCT00384085|560330873|FG001|Overall Study|No longer Requires Study Treatment|0|||
155245603|NCT00384085|560330874|FG002|Overall Study|No longer Requires Study Treatment|1|||
155245604|NCT00384085|560330872|FG000|Overall Study|Protocol Violation|2|||
155245605|NCT00384085|560330873|FG001|Overall Study|Protocol Violation|2|||
155245606|NCT00384085|560330874|FG002|Overall Study|Protocol Violation|2|||
155245607|NCT00384085|560330872|FG000|Overall Study|Lost to Follow-up|9|||
155245608|NCT00384085|560330873|FG001|Overall Study|Lost to Follow-up|9|||
155245609|NCT00384085|560330874|FG002|Overall Study|Lost to Follow-up|10|||
155245610|NCT00384085|560330872|FG000|Overall Study|Progressive Disease|0|||
155245611|NCT00384085|560330873|FG001|Overall Study|Progressive Disease|1|||
155245612|NCT00384085|560330874|FG002|Overall Study|Progressive Disease|0|||
155245613|NCT00384085|560330872|FG000|Overall Study|Withdrawal by Subject|14|||
155245614|NCT00384085|560330873|FG001|Overall Study|Withdrawal by Subject|19|||
155245615|NCT00384085|560330874|FG002|Overall Study|Withdrawal by Subject|29|||
155245616|NCT00384085|560330872|FG000|Overall Study|Patient non-compliant|4|||
155245617|NCT00384085|560330873|FG001|Overall Study|Patient non-compliant|4|||
155245618|NCT00384085|560330874|FG002|Overall Study|Patient non-compliant|5|||
155245619|NCT00384085|560330872|FG000|Overall Study|Physician Decision|1|||
155245620|NCT00384085|560330873|FG001|Overall Study|Physician Decision|0|||
155245621|NCT00384085|560330874|FG002|Overall Study|Physician Decision|0|||
155245622|NCT00384085|560330872|FG000|Overall Study|Loss of site personnel|1|||
155245623|NCT00384085|560330873|FG001|Overall Study|Loss of site personnel|0|||
155245624|NCT00384085|560330874|FG002|Overall Study|Loss of site personnel|1|||
155245625|NCT00384085|560330872|FG000|Overall Study|Sponsor decision|1|||
155245626|NCT00384085|560330873|FG001|Overall Study|Sponsor decision|2|||
155245627|NCT00384085|560330874|FG002|Overall Study|Sponsor decision|1|||
155245628|NCT00384085|560330872|FG000|Overall Study|Patient moved|1|||
155245629|NCT00384085|560330873|FG001|Overall Study|Patient moved|0|||
155245630|NCT00384085|560330874|FG002|Overall Study|Patient moved|1|||
155245631|NCT00384085|560330872|FG000|Overall Study|Patient required surgery|0|||
155245632|NCT00384085|560330873|FG001|Overall Study|Patient required surgery|1|||
155245633|NCT00384085|560330874|FG002|Overall Study|Patient required surgery|0|||
155245634|NCT00467870|560330876|FG000|Overall Study|Adverse Event|13|||
155245635|NCT00467870|560330877|FG001|Overall Study|Adverse Event|9|||
155245636|NCT00467870|560330878|FG002|Overall Study|Adverse Event|1|||
155245637|NCT00467870|560330879|FG003|Overall Study|Adverse Event|15|||
155607050|NCT01897571|561649620|FG007|Overall Study|Death|22|||
155245638|NCT00467870|560330880|FG004|Overall Study|Adverse Event|15|||
155245639|NCT00467870|560330881|FG005|Overall Study|Adverse Event|1|||
155245640|NCT00467870|560330876|FG000|Overall Study|Protocol Violation|2|||
155245641|NCT00467870|560330877|FG001|Overall Study|Protocol Violation|1|||
155245642|NCT00467870|560330878|FG002|Overall Study|Protocol Violation|1|||
155245643|NCT00467870|560330879|FG003|Overall Study|Protocol Violation|2|||
155245644|NCT00467870|560330880|FG004|Overall Study|Protocol Violation|0|||
155245645|NCT00467870|560330881|FG005|Overall Study|Protocol Violation|0|||
155245646|NCT00467870|560330876|FG000|Overall Study|Withdrawal by Subject|14|||
155245647|NCT00467870|560330877|FG001|Overall Study|Withdrawal by Subject|21|||
155245648|NCT00467870|560330878|FG002|Overall Study|Withdrawal by Subject|0|||
155245649|NCT00467870|560330879|FG003|Overall Study|Withdrawal by Subject|9|||
155245650|NCT00467870|560330880|FG004|Overall Study|Withdrawal by Subject|10|||
155245651|NCT00467870|560330881|FG005|Overall Study|Withdrawal by Subject|1|||
155245652|NCT00467870|560330876|FG000|Overall Study|Lost to Follow-up|5|||
155245653|NCT00467870|560330877|FG001|Overall Study|Lost to Follow-up|3|||
155245654|NCT00467870|560330878|FG002|Overall Study|Lost to Follow-up|1|||
155245655|NCT00467870|560330879|FG003|Overall Study|Lost to Follow-up|1|||
155245656|NCT00467870|560330880|FG004|Overall Study|Lost to Follow-up|3|||
155245657|NCT00467870|560330881|FG005|Overall Study|Lost to Follow-up|0|||
155245658|NCT00467870|560330876|FG000|Overall Study|Subject Non-compliance|3|||
155245659|NCT00467870|560330877|FG001|Overall Study|Subject Non-compliance|4|||
155245660|NCT00467870|560330878|FG002|Overall Study|Subject Non-compliance|0|||
155245661|NCT00467870|560330879|FG003|Overall Study|Subject Non-compliance|1|||
155245662|NCT00467870|560330880|FG004|Overall Study|Subject Non-compliance|5|||
155245663|NCT00467870|560330881|FG005|Overall Study|Subject Non-compliance|0|||
155245664|NCT00467870|560330876|FG000|Overall Study|Other/Unknown|8|||
155245665|NCT00467870|560330877|FG001|Overall Study|Other/Unknown|5|||
155245666|NCT00467870|560330878|FG002|Overall Study|Other/Unknown|1|||
155245667|NCT00467870|560330879|FG003|Overall Study|Other/Unknown|5|||
155245668|NCT00467870|560330880|FG004|Overall Study|Other/Unknown|4|||
155245669|NCT00467870|560330881|FG005|Overall Study|Other/Unknown|0|||
155245670|NCT03489304|560330882|FG000|Overall Study|Lost to Follow-up|4|||
155245671|NCT02261363|560330883|FG000|Overall Study|Lost to Follow-up|21|||
155245672|NCT02301143|560330884|FG000|Induction Period|Enrolled But Not Treated|1|||
155245673|NCT02301143|560330885|FG001|Induction Period|Enrolled But Not Treated|0|||
155245674|NCT02301143|560330884|FG000|Induction Period|Death|1|||
155245675|NCT02301143|560330885|FG001|Induction Period|Death|0|||
155245676|NCT02301143|560330884|FG000|Induction Period|Adverse Event|22|||
155245677|NCT02301143|560330885|FG001|Induction Period|Adverse Event|0|||
155245678|NCT02301143|560330884|FG000|Induction Period|Progressive Disease|8|||
155245679|NCT02301143|560330885|FG001|Induction Period|Progressive Disease|0|||
155245680|NCT02301143|560330884|FG000|Induction Period|Withdrawal by Subject|3|||
155245681|NCT02301143|560330885|FG001|Induction Period|Withdrawal by Subject|0|||
155245682|NCT02301143|560330884|FG000|Induction Period|Noncompliance with Study Drug|1|||
155245683|NCT02301143|560330885|FG001|Induction Period|Noncompliance with Study Drug|0|||
155245684|NCT02301143|560330884|FG000|Induction Period|Physician Decision|4|||
155245685|NCT02301143|560330885|FG001|Induction Period|Physician Decision|0|||
155245686|NCT02301143|560330884|FG000|Induction Period|Symptomatic Deterioration|2|||
155245687|NCT02301143|560330885|FG001|Induction Period|Symptomatic Deterioration|0|||
155245688|NCT02301143|560330884|FG000|Induction Period|Protocol Violation|2|||
155245689|NCT02301143|560330885|FG001|Induction Period|Protocol Violation|0|||
155245690|NCT02301143|560330884|FG000|Induction Period|Other|1|||
155245691|NCT02301143|560330885|FG001|Induction Period|Other|0|||
155245692|NCT02301143|560330884|FG000|Investigator's Choice|Adverse Event|0|||
155245693|NCT02301143|560330885|FG001|Investigator's Choice|Adverse Event|3|||
155245694|NCT02301143|560330884|FG000|Investigator's Choice|Progressive Disease|0|||
155245695|NCT02301143|560330885|FG001|Investigator's Choice|Progressive Disease|3|||
155245696|NCT02301143|560330884|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
155245697|NCT02301143|560330885|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
155245698|NCT02301143|560330884|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
155245699|NCT02301143|560330885|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
155245700|NCT02301143|560330884|FG000|Investigator's Choice|Other|0|||
155245701|NCT02301143|560330885|FG001|Investigator's Choice|Other|1|||
155245702|NCT02301143|560330884|FG000|Investigator's Choice|Unresectable Surgery|0|||
155245703|NCT02301143|560330885|FG001|Investigator's Choice|Unresectable Surgery|1|||
155245704|NCT03214367|560330888|FG000|Lead-in Period|Withdrawal by Subject|50|||
155245705|NCT03214367|560330889|FG001|Lead-in Period|Withdrawal by Subject|0|||
155245706|NCT03214367|560330890|FG002|Lead-in Period|Withdrawal by Subject|0|||
155245707|NCT03214367|560330891|FG003|Lead-in Period|Withdrawal by Subject|0|||
155245708|NCT03214367|560330892|FG004|Lead-in Period|Withdrawal by Subject|2|||
155245709|NCT03214367|560330893|FG005|Lead-in Period|Withdrawal by Subject|0|||
155245710|NCT03214367|560330894|FG006|Lead-in Period|Withdrawal by Subject|0|||
155245711|NCT03214367|560330895|FG007|Lead-in Period|Withdrawal by Subject|0|||
155245712|NCT03214367|560330888|FG000|Lead-in Period|Adverse Event|3|||
155245713|NCT03214367|560330889|FG001|Lead-in Period|Adverse Event|0|||
155245714|NCT03214367|560330890|FG002|Lead-in Period|Adverse Event|0|||
155245715|NCT03214367|560330891|FG003|Lead-in Period|Adverse Event|0|||
155245716|NCT03214367|560330892|FG004|Lead-in Period|Adverse Event|0|||
155245717|NCT03214367|560330893|FG005|Lead-in Period|Adverse Event|0|||
155245718|NCT03214367|560330894|FG006|Lead-in Period|Adverse Event|0|||
155245719|NCT03214367|560330895|FG007|Lead-in Period|Adverse Event|0|||
155245720|NCT03214367|560330888|FG000|Lead-in Period|Lost to Follow-up|12|||
155245721|NCT03214367|560330889|FG001|Lead-in Period|Lost to Follow-up|0|||
155245722|NCT03214367|560330890|FG002|Lead-in Period|Lost to Follow-up|0|||
155245723|NCT03214367|560330891|FG003|Lead-in Period|Lost to Follow-up|0|||
155245724|NCT03214367|560330892|FG004|Lead-in Period|Lost to Follow-up|0|||
155245725|NCT03214367|560330893|FG005|Lead-in Period|Lost to Follow-up|0|||
155245726|NCT03214367|560330894|FG006|Lead-in Period|Lost to Follow-up|0|||
155245727|NCT03214367|560330895|FG007|Lead-in Period|Lost to Follow-up|0|||
155245728|NCT03214367|560330888|FG000|Lead-in Period|Sponsor Decision|11|||
155245729|NCT03214367|560330889|FG001|Lead-in Period|Sponsor Decision|0|||
155245730|NCT03214367|560330890|FG002|Lead-in Period|Sponsor Decision|0|||
155245731|NCT03214367|560330891|FG003|Lead-in Period|Sponsor Decision|0|||
155245732|NCT03214367|560330892|FG004|Lead-in Period|Sponsor Decision|0|||
155245733|NCT03214367|560330893|FG005|Lead-in Period|Sponsor Decision|0|||
155245734|NCT03214367|560330894|FG006|Lead-in Period|Sponsor Decision|0|||
155245735|NCT03214367|560330895|FG007|Lead-in Period|Sponsor Decision|0|||
155245736|NCT03214367|560330888|FG000|Lead-in Period|Physician Decision|12|||
155245737|NCT03214367|560330889|FG001|Lead-in Period|Physician Decision|0|||
155245738|NCT03214367|560330890|FG002|Lead-in Period|Physician Decision|0|||
155245739|NCT03214367|560330891|FG003|Lead-in Period|Physician Decision|0|||
155245740|NCT03214367|560330892|FG004|Lead-in Period|Physician Decision|0|||
155245741|NCT03214367|560330893|FG005|Lead-in Period|Physician Decision|0|||
155245742|NCT03214367|560330894|FG006|Lead-in Period|Physician Decision|0|||
155245743|NCT03214367|560330895|FG007|Lead-in Period|Physician Decision|0|||
155245744|NCT03214367|560330888|FG000|Lead-in Period|Protocol Violation|5|||
155245745|NCT03214367|560330889|FG001|Lead-in Period|Protocol Violation|0|||
155245746|NCT03214367|560330890|FG002|Lead-in Period|Protocol Violation|0|||
155245747|NCT03214367|560330891|FG003|Lead-in Period|Protocol Violation|0|||
155245748|NCT03214367|560330892|FG004|Lead-in Period|Protocol Violation|0|||
155245749|NCT03214367|560330893|FG005|Lead-in Period|Protocol Violation|0|||
155245750|NCT03214367|560330894|FG006|Lead-in Period|Protocol Violation|0|||
155245751|NCT03214367|560330895|FG007|Lead-in Period|Protocol Violation|0|||
155245752|NCT03214367|560330888|FG000|Lead-in Period|Treatment Interruption|1|||
155245753|NCT03214367|560330889|FG001|Lead-in Period|Treatment Interruption|0|||
155245754|NCT03214367|560330890|FG002|Lead-in Period|Treatment Interruption|0|||
155245755|NCT03214367|560330891|FG003|Lead-in Period|Treatment Interruption|0|||
155245756|NCT03214367|560330892|FG004|Lead-in Period|Treatment Interruption|0|||
155245757|NCT03214367|560330893|FG005|Lead-in Period|Treatment Interruption|0|||
155245758|NCT03214367|560330894|FG006|Lead-in Period|Treatment Interruption|0|||
155245759|NCT03214367|560330895|FG007|Lead-in Period|Treatment Interruption|0|||
155245760|NCT03214367|560330888|FG000|Treatment Period|Adverse Event|0|||
155245761|NCT03214367|560330889|FG001|Treatment Period|Adverse Event|1|||
155245762|NCT03214367|560330890|FG002|Treatment Period|Adverse Event|4|||
155245763|NCT03214367|560330891|FG003|Treatment Period|Adverse Event|2|||
155245764|NCT03214367|560330892|FG004|Treatment Period|Adverse Event|0|||
155245765|NCT03214367|560330893|FG005|Treatment Period|Adverse Event|0|||
155245766|NCT03214367|560330894|FG006|Treatment Period|Adverse Event|0|||
155245767|NCT03214367|560330895|FG007|Treatment Period|Adverse Event|0|||
155245768|NCT03214367|560330888|FG000|Treatment Period|Death|0|||
155245769|NCT03214367|560330889|FG001|Treatment Period|Death|1|||
155245770|NCT03214367|560330890|FG002|Treatment Period|Death|1|||
155245771|NCT03214367|560330891|FG003|Treatment Period|Death|1|||
155245772|NCT03214367|560330892|FG004|Treatment Period|Death|0|||
155245773|NCT03214367|560330893|FG005|Treatment Period|Death|0|||
155245774|NCT03214367|560330894|FG006|Treatment Period|Death|0|||
155245775|NCT03214367|560330895|FG007|Treatment Period|Death|0|||
155245776|NCT03214367|560330888|FG000|Treatment Period|Lost to Follow-up|0|||
155245777|NCT03214367|560330889|FG001|Treatment Period|Lost to Follow-up|5|||
155245778|NCT03214367|560330890|FG002|Treatment Period|Lost to Follow-up|3|||
155245779|NCT03214367|560330891|FG003|Treatment Period|Lost to Follow-up|2|||
155245780|NCT03214367|560330892|FG004|Treatment Period|Lost to Follow-up|0|||
155245781|NCT03214367|560330893|FG005|Treatment Period|Lost to Follow-up|2|||
155245782|NCT03214367|560330894|FG006|Treatment Period|Lost to Follow-up|1|||
155245783|NCT03214367|560330895|FG007|Treatment Period|Lost to Follow-up|0|||
155245784|NCT03214367|560330888|FG000|Treatment Period|Sponsor Decision|0|||
155245785|NCT03214367|560330889|FG001|Treatment Period|Sponsor Decision|3|||
155245786|NCT03214367|560330890|FG002|Treatment Period|Sponsor Decision|0|||
155245787|NCT03214367|560330891|FG003|Treatment Period|Sponsor Decision|0|||
155245788|NCT03214367|560330892|FG004|Treatment Period|Sponsor Decision|0|||
155245789|NCT03214367|560330893|FG005|Treatment Period|Sponsor Decision|0|||
155245790|NCT03214367|560330894|FG006|Treatment Period|Sponsor Decision|0|||
155245791|NCT03214367|560330895|FG007|Treatment Period|Sponsor Decision|0|||
155245792|NCT03214367|560330888|FG000|Treatment Period|Physician Decision|0|||
155245793|NCT03214367|560330889|FG001|Treatment Period|Physician Decision|1|||
155245794|NCT03214367|560330890|FG002|Treatment Period|Physician Decision|2|||
155245795|NCT03214367|560330891|FG003|Treatment Period|Physician Decision|0|||
155245796|NCT03214367|560330892|FG004|Treatment Period|Physician Decision|0|||
155245797|NCT03214367|560330893|FG005|Treatment Period|Physician Decision|0|||
155245798|NCT03214367|560330894|FG006|Treatment Period|Physician Decision|0|||
155245799|NCT03214367|560330895|FG007|Treatment Period|Physician Decision|0|||
155245800|NCT03214367|560330888|FG000|Treatment Period|Protocol Violation|0|||
155245801|NCT03214367|560330889|FG001|Treatment Period|Protocol Violation|3|||
155245802|NCT03214367|560330890|FG002|Treatment Period|Protocol Violation|0|||
155245803|NCT03214367|560330891|FG003|Treatment Period|Protocol Violation|0|||
155245804|NCT03214367|560330892|FG004|Treatment Period|Protocol Violation|0|||
155245805|NCT03214367|560330893|FG005|Treatment Period|Protocol Violation|0|||
155245806|NCT03214367|560330894|FG006|Treatment Period|Protocol Violation|0|||
155245807|NCT03214367|560330895|FG007|Treatment Period|Protocol Violation|0|||
155245808|NCT03214367|560330888|FG000|Treatment Period|Withdrawal by Subject|0|||
155245809|NCT03214367|560330889|FG001|Treatment Period|Withdrawal by Subject|20|||
155245810|NCT03214367|560330890|FG002|Treatment Period|Withdrawal by Subject|23|||
155245811|NCT03214367|560330891|FG003|Treatment Period|Withdrawal by Subject|14|||
155245812|NCT03214367|560330892|FG004|Treatment Period|Withdrawal by Subject|0|||
155245813|NCT03214367|560330893|FG005|Treatment Period|Withdrawal by Subject|1|||
155245814|NCT03214367|560330894|FG006|Treatment Period|Withdrawal by Subject|1|||
155245815|NCT03214367|560330895|FG007|Treatment Period|Withdrawal by Subject|1|||
155245816|NCT03268811|560330898|FG000|Overall Study|Adverse Event|0|||
155245817|NCT03268811|560330899|FG001|Overall Study|Adverse Event|1|||
155245818|NCT04726709|560330903|FG000|Overall Study|Withdrawal by Subject|2|||
155245819|NCT04726709|560330904|FG001|Overall Study|Withdrawal by Subject|2|||
155245820|NCT01286779|560330905|FG000|Overall Study|Withdrawal by Subject|9|||
155245821|NCT01286779|560330905|FG000|Overall Study|Protocol Violation|5|||
155245822|NCT01286779|560330905|FG000|Overall Study|Physician Decision|2|||
155245823|NCT01286779|560330905|FG000|Overall Study|Participant had scheduled surgery|1|||
155245824|NCT01286779|560330905|FG000|Overall Study|Participant moved to another country|1|||
155245825|NCT01286779|560330905|FG000|Overall Study|Discontinued by sponsor|1|||
155245826|NCT04827212|560330906|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
155245827|NCT04827212|560330907|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
155245828|NCT04827212|560330906|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
155245829|NCT04827212|560330907|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
155245830|NCT00574080|560330908|FG000|Overall Study|Death|10|||
155245831|NCT00574080|560330909|FG001|Overall Study|Death|10|||
155245832|NCT00599326|560330910|FG000|Overall Study|Lost to Follow-up|1|||
155245833|NCT00599326|560330910|FG000|Overall Study|Noncompliant|1|||
155245834|NCT00784810|560330911|FG000|Overall Study|Adverse Event|32|||
155245835|NCT00784810|560330912|FG001|Overall Study|Adverse Event|20|||
155245836|NCT00784810|560330911|FG000|Overall Study|Lack of Efficacy|14|||
155245837|NCT00784810|560330912|FG001|Overall Study|Lack of Efficacy|11|||
155245838|NCT00784810|560330911|FG000|Overall Study|Withdrawal by Subject|11|||
155245839|NCT00784810|560330912|FG001|Overall Study|Withdrawal by Subject|9|||
155245840|NCT00784810|560330911|FG000|Overall Study|Administrative|5|||
155245841|NCT00784810|560330912|FG001|Overall Study|Administrative|8|||
155245842|NCT00784810|560330911|FG000|Overall Study|Lost to Follow-up|1|||
155245843|NCT00784810|560330912|FG001|Overall Study|Lost to Follow-up|1|||
155245844|NCT04969250|560330913|FG000|Overall Study|Protocol Violation|0|||
155245845|NCT04969250|560330914|FG001|Overall Study|Protocol Violation|2|||
155245846|NCT04969250|560330915|FG002|Overall Study|Protocol Violation|3|||
155245847|NCT04969250|560330916|FG003|Overall Study|Protocol Violation|8|||
155245848|NCT04969250|560330913|FG000|Overall Study|Withdrawal by Subject|0|||
155245849|NCT04969250|560330914|FG001|Overall Study|Withdrawal by Subject|1|||
155245850|NCT04969250|560330915|FG002|Overall Study|Withdrawal by Subject|0|||
155245851|NCT04969250|560330916|FG003|Overall Study|Withdrawal by Subject|0|||
155245852|NCT00563784|560330917|FG000|Overall Study|Withdrawal by Subject|2|||
155245853|NCT00563784|560330917|FG000|Overall Study|Screen Failures|20|||
155245854|NCT02119416|560330918|FG000|Overall Study|Protocol Violation|1|||
155245855|NCT02119416|560330919|FG001|Overall Study|Protocol Violation|1|||
155245856|NCT02119416|560330920|FG002|Overall Study|Protocol Violation|1|||
155245857|NCT02119416|560330918|FG000|Overall Study|wrong pubertal stage|1|||
155245858|NCT02119416|560330919|FG001|Overall Study|wrong pubertal stage|0|||
155245859|NCT02119416|560330920|FG002|Overall Study|wrong pubertal stage|1|||
155245860|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245861|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245862|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245863|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245864|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245865|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245866|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245867|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245868|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
155245869|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245870|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245871|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245872|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245873|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245874|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
155245875|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
155245876|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245877|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
155245878|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245879|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245880|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245881|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245882|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
155245883|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245884|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245885|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245886|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245887|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
155245888|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
155245889|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
155245890|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
155245891|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
155245892|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
155245893|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
155245894|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
155245895|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
155245896|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
155245897|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245898|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
155245899|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245900|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245901|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245902|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245903|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245904|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245905|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245906|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
155245907|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245908|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245909|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245910|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245911|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245912|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245913|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245914|NCT03434119|560330930|FG000|Overall Study|Randomized but not treated|1|||
155245915|NCT03434119|560330931|FG001|Overall Study|Randomized but not treated|0|||
155245916|NCT03434119|560330930|FG000|Overall Study|Adverse Event|1|||
155245917|NCT03434119|560330931|FG001|Overall Study|Adverse Event|0|||
155245918|NCT03434119|560330930|FG000|Overall Study|Poor Compliance to Protocol|0|||
155245919|NCT03434119|560330931|FG001|Overall Study|Poor Compliance to Protocol|1|||
155245920|NCT03434119|560330930|FG000|Overall Study|Study Terminated by Sponsor|91|||
155245921|NCT03434119|560330931|FG001|Overall Study|Study Terminated by Sponsor|102|||
155245922|NCT03434119|560330930|FG000|Overall Study|Withdrawal by Subject|7|||
155245923|NCT03434119|560330931|FG001|Overall Study|Withdrawal by Subject|5|||
155245924|NCT03434119|560330930|FG000|Overall Study|Other than specified|7|||
155245925|NCT03434119|560330931|FG001|Overall Study|Other than specified|5|||
155245926|NCT04360824|560330932|FG000|Overall Study|Withdrawal by Subject|2|||
155245927|NCT04360824|560330933|FG001|Overall Study|Withdrawal by Subject|1|||
155245928|NCT04360824|560330932|FG000|Overall Study|Did not receive assigned treatment|1|||
155245929|NCT04360824|560330933|FG001|Overall Study|Did not receive assigned treatment|3|||
155245930|NCT00304070|560330934|FG000|Overall Study|Death|0|||
155245931|NCT00304070|560330935|FG001|Overall Study|Death|0|||
155245932|NCT00304070|560330936|FG002|Overall Study|Death|3|||
155245933|NCT00304070|560330934|FG000|Overall Study|Lost to Follow-up|0|||
155245934|NCT00304070|560330935|FG001|Overall Study|Lost to Follow-up|0|||
155245935|NCT00304070|560330936|FG002|Overall Study|Lost to Follow-up|1|||
155245936|NCT00304070|560330934|FG000|Overall Study|Physician Decision|0|||
155245937|NCT00304070|560330935|FG001|Overall Study|Physician Decision|0|||
155245938|NCT00304070|560330936|FG002|Overall Study|Physician Decision|3|||
155245939|NCT00304070|560330934|FG000|Overall Study|Withdrawal by Subject|0|||
155245940|NCT00304070|560330935|FG001|Overall Study|Withdrawal by Subject|0|||
155245941|NCT00304070|560330936|FG002|Overall Study|Withdrawal by Subject|1|||
155245942|NCT00304070|560330934|FG000|Overall Study|Progressive Disease|3|||
155245943|NCT00304070|560330935|FG001|Overall Study|Progressive Disease|7|||
155245944|NCT00304070|560330936|FG002|Overall Study|Progressive Disease|4|||
155245945|NCT00320216|560330937|FG000|Overall Study|Adverse Event|0|||
155245946|NCT00320216|560330938|FG001|Overall Study|Adverse Event|6|||
155245947|NCT00320216|560330939|FG002|Overall Study|Adverse Event|0|||
155245948|NCT00320216|560330940|FG003|Overall Study|Adverse Event|2|||
155245949|NCT00320216|560330941|FG004|Overall Study|Adverse Event|2|||
155245950|NCT00320216|560330937|FG000|Overall Study|Lack of Efficacy|6|||
155245951|NCT00320216|560330938|FG001|Overall Study|Lack of Efficacy|2|||
155245952|NCT00320216|560330939|FG002|Overall Study|Lack of Efficacy|1|||
155245953|NCT00320216|560330940|FG003|Overall Study|Lack of Efficacy|0|||
155245954|NCT00320216|560330941|FG004|Overall Study|Lack of Efficacy|1|||
155245955|NCT00320216|560330937|FG000|Overall Study|Lost to Follow-up|3|||
155245956|NCT00320216|560330938|FG001|Overall Study|Lost to Follow-up|0|||
155245957|NCT00320216|560330939|FG002|Overall Study|Lost to Follow-up|0|||
155245958|NCT00320216|560330940|FG003|Overall Study|Lost to Follow-up|0|||
155245959|NCT00320216|560330941|FG004|Overall Study|Lost to Follow-up|0|||
155245960|NCT00320216|560330937|FG000|Overall Study|Other|7|||
155245961|NCT00320216|560330938|FG001|Overall Study|Other|2|||
155245962|NCT00320216|560330939|FG002|Overall Study|Other|5|||
155245963|NCT00320216|560330940|FG003|Overall Study|Other|1|||
155245964|NCT00320216|560330941|FG004|Overall Study|Other|3|||
155245965|NCT00779246|560330950|FG000|Overall Study|Missing sufficient data for analysis|33|||
155245966|NCT00779246|560330951|FG001|Overall Study|Missing sufficient data for analysis|53|||
155245967|NCT03579459|560330954|FG000|Overall Study|Adverse Event|7|||
155245968|NCT03579459|560330955|FG001|Overall Study|Adverse Event|6|||
155245969|NCT03579459|560330956|FG002|Overall Study|Adverse Event|2|||
155245970|NCT03579459|560330957|FG003|Overall Study|Adverse Event|6|||
155245971|NCT03579459|560330954|FG000|Overall Study|Death|1|||
155245972|NCT03579459|560330955|FG001|Overall Study|Death|0|||
155245973|NCT03579459|560330956|FG002|Overall Study|Death|1|||
155245974|NCT03579459|560330957|FG003|Overall Study|Death|2|||
155245975|NCT03579459|560330954|FG000|Overall Study|Lost to Follow-up|6|||
155245976|NCT03579459|560330955|FG001|Overall Study|Lost to Follow-up|2|||
155245977|NCT03579459|560330956|FG002|Overall Study|Lost to Follow-up|4|||
155245978|NCT03579459|560330957|FG003|Overall Study|Lost to Follow-up|1|||
155245979|NCT03579459|560330954|FG000|Overall Study|Physician Decision|0|||
155245980|NCT03579459|560330955|FG001|Overall Study|Physician Decision|1|||
155245981|NCT03579459|560330956|FG002|Overall Study|Physician Decision|0|||
155245982|NCT03579459|560330957|FG003|Overall Study|Physician Decision|1|||
155245983|NCT03579459|560330954|FG000|Overall Study|Protocol Violation|1|||
155245984|NCT03579459|560330955|FG001|Overall Study|Protocol Violation|2|||
155245985|NCT03579459|560330956|FG002|Overall Study|Protocol Violation|3|||
155245986|NCT03579459|560330957|FG003|Overall Study|Protocol Violation|5|||
155245987|NCT03579459|560330954|FG000|Overall Study|Withdrawal by Subject|12|||
155245988|NCT03579459|560330955|FG001|Overall Study|Withdrawal by Subject|8|||
155245989|NCT03579459|560330956|FG002|Overall Study|Withdrawal by Subject|11|||
155245990|NCT03579459|560330957|FG003|Overall Study|Withdrawal by Subject|8|||
155245991|NCT03579459|560330954|FG000|Overall Study|Medication error without associated adverse event|2|||
155245992|NCT03579459|560330955|FG001|Overall Study|Medication error without associated adverse event|1|||
155245993|NCT03579459|560330956|FG002|Overall Study|Medication error without associated adverse event|1|||
155245994|NCT03579459|560330957|FG003|Overall Study|Medication error without associated adverse event|0|||
155245995|NCT03579459|560330954|FG000|Overall Study|Other|0|||
155245996|NCT03579459|560330955|FG001|Overall Study|Other|1|||
155245997|NCT03579459|560330956|FG002|Overall Study|Other|1|||
155245998|NCT03579459|560330957|FG003|Overall Study|Other|0|||
155245999|NCT03579459|560330954|FG000|Overall Study|Randomized not vaccinated|0|||
155246000|NCT03579459|560330955|FG001|Overall Study|Randomized not vaccinated|2|||
155246001|NCT03579459|560330956|FG002|Overall Study|Randomized not vaccinated|0|||
155246002|NCT03579459|560330957|FG003|Overall Study|Randomized not vaccinated|1|||
155246003|NCT00148343|560330958|FG000|Overall Study|Withdrawal by Subject|12|||
155246004|NCT00148343|560330959|FG001|Overall Study|Withdrawal by Subject|7|||
155246005|NCT00148343|560330958|FG000|Overall Study|Physician Decision|3|||
155246006|NCT00148343|560330959|FG001|Overall Study|Physician Decision|4|||
155246007|NCT02844946|560330963|FG000|Overall Study|Lost to Follow-up|7|||
155246008|NCT02844946|560330964|FG001|Overall Study|Lost to Follow-up|0|||
155246009|NCT02528214|560330970|FG000|Overall Study|Protocol Violation|0|||
155246010|NCT02528214|560330971|FG001|Overall Study|Protocol Violation|1|||
155246011|NCT02528214|560330970|FG000|Overall Study|Adverse Event|0|||
155246012|NCT02528214|560330971|FG001|Overall Study|Adverse Event|1|||
155246013|NCT02528214|560330970|FG000|Overall Study|Other than specified above|0|||
155246014|NCT02528214|560330971|FG001|Overall Study|Other than specified above|1|||
155246015|NCT00407537|560330972|FG000|Overall Study|Death|5|||
155246016|NCT00407537|560330973|FG001|Overall Study|Death|2|||
155246017|NCT00407537|560330972|FG000|Overall Study|Adverse Event|36|||
155246018|NCT00407537|560330973|FG001|Overall Study|Adverse Event|0|||
155246019|NCT00407537|560330972|FG000|Overall Study|Lost to Follow-up|12|||
155246020|NCT00407537|560330973|FG001|Overall Study|Lost to Follow-up|19|||
155246021|NCT00407537|560330972|FG000|Overall Study|Other|6|||
155246022|NCT00407537|560330973|FG001|Overall Study|Other|7|||
155246023|NCT00407537|560330972|FG000|Overall Study|Withdrawal by Subject|34|||
155246024|NCT00407537|560330973|FG001|Overall Study|Withdrawal by Subject|16|||
155246025|NCT02384759|560330974|FG000|Overall Study|Patients not treated|3|||
155246026|NCT02384759|560330975|FG001|Overall Study|Patients not treated|2|||
155246027|NCT01605617|560330976|FG000|First Intervention|Adverse Event|0|||
155246028|NCT01605617|560330977|FG001|First Intervention|Adverse Event|1|||
155246029|NCT01605617|560330976|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
155246030|NCT01605617|560330977|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
155246031|NCT00121238|560330979|FG000|Overall Study|disease progression before intervention|1|||
155246032|NCT00121238|560330979|FG000|Overall Study|Protocol Violation|2|||
155246033|NCT01380327|560330980|FG000|Overall Study|Lost to Follow-up|0|||
155246034|NCT01380327|560330981|FG001|Overall Study|Lost to Follow-up|1|||
155246035|NCT01380327|560330982|FG002|Overall Study|Lost to Follow-up|1|||
155246036|NCT01380327|560330980|FG000|Overall Study|Protocol Violation|3|||
155246037|NCT01380327|560330981|FG001|Overall Study|Protocol Violation|2|||
155246038|NCT01380327|560330982|FG002|Overall Study|Protocol Violation|3|||
155246039|NCT01380327|560330980|FG000|Overall Study|Withdrawal by Subject|0|||
155246040|NCT01380327|560330981|FG001|Overall Study|Withdrawal by Subject|0|||
155246041|NCT01380327|560330982|FG002|Overall Study|Withdrawal by Subject|1|||
155246042|NCT01380327|560330980|FG000|Overall Study|Housing situation precluded ability to k|0|||
155246043|NCT01380327|560330981|FG001|Overall Study|Housing situation precluded ability to k|0|||
155246044|NCT01380327|560330982|FG002|Overall Study|Housing situation precluded ability to k|1|||
155246045|NCT01380327|560330980|FG000|Overall Study|Questionable onset of epilepsy|0|||
155246046|NCT01380327|560330981|FG001|Overall Study|Questionable onset of epilepsy|0|||
155246047|NCT01380327|560330982|FG002|Overall Study|Questionable onset of epilepsy|1|||
155246048|NCT00325468|560330983|FG000|Overall Study|Adverse Event|1|||
155246049|NCT00325468|560330984|FG001|Overall Study|Adverse Event|1|||
155246050|NCT00325468|560330985|FG002|Overall Study|Adverse Event|0|||
155246051|NCT00325468|560330986|FG003|Overall Study|Adverse Event|5|||
155246052|NCT00325468|560330987|FG004|Overall Study|Adverse Event|1|||
155246053|NCT00325468|560330983|FG000|Overall Study|Death|2|||
155246054|NCT00325468|560330984|FG001|Overall Study|Death|0|||
155246055|NCT00325468|560330985|FG002|Overall Study|Death|2|||
155246056|NCT00325468|560330986|FG003|Overall Study|Death|4|||
155246057|NCT00325468|560330987|FG004|Overall Study|Death|0|||
155246058|NCT00325468|560330983|FG000|Overall Study|Lost to Follow-up|0|||
155246059|NCT00325468|560330984|FG001|Overall Study|Lost to Follow-up|0|||
155246060|NCT00325468|560330985|FG002|Overall Study|Lost to Follow-up|1|||
155246061|NCT00325468|560330986|FG003|Overall Study|Lost to Follow-up|2|||
155246062|NCT00325468|560330987|FG004|Overall Study|Lost to Follow-up|2|||
155246063|NCT00325468|560330983|FG000|Overall Study|Physician Decision|1|||
155246064|NCT00325468|560330984|FG001|Overall Study|Physician Decision|1|||
155246065|NCT00325468|560330985|FG002|Overall Study|Physician Decision|0|||
155246066|NCT00325468|560330986|FG003|Overall Study|Physician Decision|1|||
155246067|NCT00325468|560330987|FG004|Overall Study|Physician Decision|0|||
155246068|NCT00325468|560330983|FG000|Overall Study|Withdrawal by Subject|3|||
155246069|NCT00325468|560330984|FG001|Overall Study|Withdrawal by Subject|1|||
155246070|NCT00325468|560330985|FG002|Overall Study|Withdrawal by Subject|0|||
155246071|NCT00325468|560330986|FG003|Overall Study|Withdrawal by Subject|14|||
155246072|NCT00325468|560330987|FG004|Overall Study|Withdrawal by Subject|4|||
155246073|NCT00325468|560330983|FG000|Overall Study|site closure etc|4|||
155246074|NCT00325468|560330984|FG001|Overall Study|site closure etc|2|||
155246075|NCT00325468|560330985|FG002|Overall Study|site closure etc|1|||
155246076|NCT00325468|560330986|FG003|Overall Study|site closure etc|8|||
155246077|NCT00325468|560330987|FG004|Overall Study|site closure etc|1|||
155246078|NCT03593655|560330988|FG000|First Product Use Period|Withdrawal by Subject|1|||
155246079|NCT03593655|560330989|FG001|First Product Use Period|Withdrawal by Subject|1|||
155246080|NCT03593655|560330988|FG000|First Product Use Period|Lost to Follow-up|1|||
155246081|NCT03593655|560330989|FG001|First Product Use Period|Lost to Follow-up|3|||
155246082|NCT03593655|560330988|FG000|Second Product Use Period|Withdrawal by Subject|1|||
155246083|NCT03593655|560330989|FG001|Second Product Use Period|Withdrawal by Subject|1|||
155246084|NCT03593655|560330988|FG000|Second Product Use Period|Lost to Follow-up|1|||
155246085|NCT03593655|560330989|FG001|Second Product Use Period|Lost to Follow-up|0|||
155246086|NCT03593655|560330988|FG000|Third Product Use Period|Lost to Follow-up|1|||
155246087|NCT03593655|560330989|FG001|Third Product Use Period|Lost to Follow-up|2|||
155246088|NCT03593655|560330988|FG000|Third Product Use Period|Physician Decision|0|||
155246089|NCT03593655|560330989|FG001|Third Product Use Period|Physician Decision|1|||
155246090|NCT03593655|560330988|FG000|Third Product Use Period|Withdrawal by Subject|0|||
155246091|NCT03593655|560330989|FG001|Third Product Use Period|Withdrawal by Subject|1|||
155246092|NCT05046795|560330990|FG000|Overall Study|Adverse Event|13|||
155246093|NCT05046795|560330991|FG001|Overall Study|Adverse Event|15|||
155246094|NCT05046795|560330990|FG000|Overall Study|Withdrawal by Subject|4|||
155246095|NCT05046795|560330991|FG001|Overall Study|Withdrawal by Subject|7|||
155246096|NCT05046795|560330990|FG000|Overall Study|Physician Decision|1|||
155246097|NCT05046795|560330991|FG001|Overall Study|Physician Decision|2|||
155246098|NCT05046795|560330990|FG000|Overall Study|Protocol Violation|1|||
155246099|NCT05046795|560330991|FG001|Overall Study|Protocol Violation|2|||
155246100|NCT05046795|560330990|FG000|Overall Study|Death|1|||
155246101|NCT05046795|560330991|FG001|Overall Study|Death|0|||
155246102|NCT05046795|560330990|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
155246103|NCT05046795|560330991|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
155246104|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
155246105|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
155246106|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
155246107|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
155246108|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Other|2|||
155246109|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Other|0|||
155246110|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
155246111|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
155246112|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
155246113|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
155246114|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Other|1|||
155246115|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Other|0|||
155246116|NCT02365467|560330997|FG000|Overall Study|Death|3|||
155246117|NCT04667117|560330998|FG000|Investigational Period|Lost to Follow-up|0|||
155246118|NCT04667117|560330999|FG001|Investigational Period|Lost to Follow-up|0|||
155246119|NCT04667117|560331000|FG002|Investigational Period|Lost to Follow-up|1|||
155246120|NCT04667117|560330998|FG000|Investigational Period|Protocol Deviation|0|||
155246121|NCT04667117|560330999|FG001|Investigational Period|Protocol Deviation|1|||
155246122|NCT04667117|560331000|FG002|Investigational Period|Protocol Deviation|0|||
155246123|NCT04667117|560330998|FG000|Extension Period|Lost to Follow-up|1|||
155246124|NCT04667117|560330999|FG001|Extension Period|Lost to Follow-up|0|||
155246125|NCT04667117|560331000|FG002|Extension Period|Lost to Follow-up|0|||
155246126|NCT03965052|560331004|FG000|Overall Study|Protocol Violation|1|||
155246127|NCT03965052|560331005|FG001|Overall Study|Protocol Violation|0|||
155246128|NCT04323436|560331014|FG000|Overall Study|Adverse Event|7|||
155246129|NCT04323436|560331015|FG001|Overall Study|Adverse Event|0|||
155246130|NCT04323436|560331016|FG002|Overall Study|Adverse Event|0|||
155246131|NCT04323436|560331014|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
155246132|NCT04323436|560331015|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
155246133|NCT04323436|560331016|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
155246134|NCT04323436|560331014|FG000|Overall Study|Death|1|||
155246135|NCT04323436|560331015|FG001|Overall Study|Death|0|||
155246136|NCT04323436|560331016|FG002|Overall Study|Death|0|||
155246137|NCT04323436|560331014|FG000|Overall Study|Physician Decision|2|||
155246138|NCT04323436|560331015|FG001|Overall Study|Physician Decision|0|||
155246139|NCT04323436|560331016|FG002|Overall Study|Physician Decision|0|||
155246140|NCT04323436|560331014|FG000|Overall Study|Progressive disease|10|||
155246141|NCT04323436|560331015|FG001|Overall Study|Progressive disease|0|||
155246142|NCT04323436|560331016|FG002|Overall Study|Progressive disease|0|||
155246143|NCT04323436|560331014|FG000|Overall Study|Subject decision|3|||
155246144|NCT04323436|560331015|FG001|Overall Study|Subject decision|0|||
155246145|NCT04323436|560331016|FG002|Overall Study|Subject decision|0|||
155246146|NCT02720484|560331017|FG000|Treatment on Study|Adverse Event|1|||
155246147|NCT02720484|560331017|FG000|Treatment on Study|Withdrawal by Subject|1|||
155246148|NCT02720484|560331017|FG000|Treatment on Study|Progressive Disease|4|||
155246149|NCT02720484|560331017|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
155246150|NCT02720484|560331017|FG000|Follow Up for 2 Years|Death|3|||
155246151|NCT02720484|560331017|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
155246152|NCT01617629|560331022|FG000|Overall Study|Death|2|||
155246153|NCT01617629|560331022|FG000|Overall Study|Investigator's Clinical Judgement|1|||
155246154|NCT01617629|560331022|FG000|Overall Study|Reason Not Specified|1|||
155246155|NCT01617629|560331022|FG000|Overall Study|Participant Withdrew Consent|2|||
155246156|NCT01663636|560331023|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
155246157|NCT01663636|560331024|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
155246158|NCT02715765|560331025|FG000|Overall Study|Study Termination|3|||
155246159|NCT02715765|560331026|FG001|Overall Study|Study Termination|0|||
155246160|NCT02715765|560331027|FG002|Overall Study|Study Termination|0|||
155246161|NCT02838017|560331029|FG000|Overall Study|Lost to Follow-up|14|||
155246162|NCT02838017|560331030|FG001|Overall Study|Lost to Follow-up|11|||
155246163|NCT01692197|560331031|FG000|Overall Study|Failed Screening|3|||
155246164|NCT02120924|560331032|FG000|Overall Study|Lack of Efficacy|1|||
155246165|NCT02120924|560331033|FG001|Overall Study|Lack of Efficacy|2|||
155246166|NCT02120924|560331034|FG002|Overall Study|Lack of Efficacy|3|||
155246167|NCT02120924|560331032|FG000|Overall Study|Adverse Event|0|||
155246168|NCT02120924|560331033|FG001|Overall Study|Adverse Event|1|||
155246169|NCT02120924|560331034|FG002|Overall Study|Adverse Event|3|||
155246170|NCT02120924|560331032|FG000|Overall Study|Withdrawal by Subject|16|||
155246171|NCT02120924|560331033|FG001|Overall Study|Withdrawal by Subject|20|||
155246172|NCT02120924|560331034|FG002|Overall Study|Withdrawal by Subject|8|||
155246173|NCT02120924|560331032|FG000|Overall Study|Lost to Follow-up|14|||
155246174|NCT02120924|560331033|FG001|Overall Study|Lost to Follow-up|14|||
155246175|NCT02120924|560331034|FG002|Overall Study|Lost to Follow-up|11|||
155246176|NCT02120924|560331032|FG000|Overall Study|Pregnancy|2|||
155246177|NCT02120924|560331033|FG001|Overall Study|Pregnancy|0|||
155246178|NCT02120924|560331034|FG002|Overall Study|Pregnancy|0|||
155246179|NCT02120924|560331032|FG000|Overall Study|Protocol Violation|3|||
155246180|NCT02120924|560331033|FG001|Overall Study|Protocol Violation|7|||
155246181|NCT02120924|560331034|FG002|Overall Study|Protocol Violation|2|||
155246182|NCT02120924|560331032|FG000|Overall Study|Physician Decision|0|||
155246183|NCT02120924|560331033|FG001|Overall Study|Physician Decision|1|||
155246184|NCT02120924|560331034|FG002|Overall Study|Physician Decision|1|||
155246185|NCT02120924|560331032|FG000|Overall Study|Death|1|||
155246186|NCT02120924|560331033|FG001|Overall Study|Death|0|||
155246187|NCT02120924|560331034|FG002|Overall Study|Death|0|||
155246188|NCT02120924|560331032|FG000|Overall Study|Compliance with IP|5|||
155246189|NCT02120924|560331033|FG001|Overall Study|Compliance with IP|1|||
155246190|NCT02120924|560331034|FG002|Overall Study|Compliance with IP|1|||
155246191|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
155246192|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
155246193|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
155246194|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
155246195|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
155246196|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
155246197|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
155246198|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
155246199|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
155246200|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
155246201|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
155246202|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
155246203|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
155246204|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
155246205|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
155246206|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246207|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
155246208|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246209|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
155246210|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
155246211|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
155246212|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
155246213|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
155246214|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
155246215|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
155246216|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
155246217|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
155246218|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
155246219|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
155246220|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
155246221|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
155246222|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
155246223|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
155246224|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
155246225|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
155246226|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
155246227|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
155246228|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
155246229|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
155246230|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
155246231|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
155246232|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
155246233|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
155246234|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
155246235|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
155246236|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
155246237|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
155246238|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
155246239|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
155246240|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246241|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
155246242|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
155246243|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
155246244|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
155246245|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
155246246|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
155246247|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
155246248|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
155246249|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
155246250|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
155246251|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
155246252|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
155246253|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
155246254|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
155246255|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
155246256|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
155246257|NCT03588572|560331044|FG000|Visitation 1|Lack of Efficacy|1|||
155246258|NCT03588572|560331045|FG001|Visitation 1|Lack of Efficacy|1|||
155246259|NCT03588572|560331044|FG000|Visitation 2|Lost to Follow-up|1|||
155246260|NCT03588572|560331045|FG001|Visitation 2|Lost to Follow-up|1|||
155246261|NCT03588572|560331044|FG000|Visitation 2|Lack of Efficacy|0|||
155246262|NCT03588572|560331045|FG001|Visitation 2|Lack of Efficacy|1|||
155246263|NCT03588572|560331044|FG000|Visitation 2|Withdrawal by Subject|1|||
155246264|NCT03588572|560331045|FG001|Visitation 2|Withdrawal by Subject|0|||
155246265|NCT03588572|560331044|FG000|Visitation 3|Lost to Follow-up|1|||
155246266|NCT03588572|560331045|FG001|Visitation 3|Lost to Follow-up|1|||
155246267|NCT03588572|560331044|FG000|Visitation 3|Physician Decision|1|||
155246268|NCT03588572|560331045|FG001|Visitation 3|Physician Decision|1|||
155246269|NCT03588572|560331044|FG000|Visitation 3|Withdrawal by Subject|1|||
155246270|NCT03588572|560331045|FG001|Visitation 3|Withdrawal by Subject|0|||
155246271|NCT01308580|560331051|FG000|Overall Study|Lost to Follow-up|12|||
155246272|NCT01308580|560331052|FG001|Overall Study|Lost to Follow-up|7|||
155246273|NCT03823651|560331053|FG000|Overall Study|Death|5|||
155246274|NCT03823651|560331054|FG001|Overall Study|Death|0|||
155246275|NCT03823651|560331053|FG000|Overall Study|Physician Decision|1|||
155246276|NCT03823651|560331054|FG001|Overall Study|Physician Decision|0|||
155246277|NCT03823651|560331053|FG000|Overall Study|Caregiver to patient who died|0|||
155246278|NCT03823651|560331054|FG001|Overall Study|Caregiver to patient who died|5|||
155246279|NCT03823651|560331053|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
155246280|NCT03823651|560331054|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
155246281|NCT05350449|560331055|FG000|Overall Study|Withdrawal by Subject|4|||
155246282|NCT05350449|560331056|FG001|Overall Study|Withdrawal by Subject|8|||
155246283|NCT01625897|560332690|FG000|Overall Study|Adverse Event|27|||
155246284|NCT01625897|560332691|FG001|Overall Study|Adverse Event|10|||
155246285|NCT01625897|560332690|FG000|Overall Study|Physician Decision|0|||
155246286|NCT01625897|560332691|FG001|Overall Study|Physician Decision|1|||
155246287|NCT01625897|560332690|FG000|Overall Study|Withdrawal by Subject|25|||
155246288|NCT01625897|560332691|FG001|Overall Study|Withdrawal by Subject|3|||
155246289|NCT01432366|560332692|FG000|Overall Study|Non-Responder|7|||
155246290|NCT01432366|560332692|FG000|Overall Study|Adverse Event|8|||
155246291|NCT01432366|560332692|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
155246292|NCT01432366|560332692|FG000|Overall Study|Pregnancy|1|||
155246293|NCT01432366|560332692|FG000|Overall Study|Lost to Follow-up|13|||
155246294|NCT01432366|560332692|FG000|Overall Study|Lack of Efficacy|1|||
155246295|NCT01432366|560332692|FG000|Overall Study|Site Closed|20|||
155246296|NCT01432366|560332692|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
155246297|NCT01432366|560332692|FG000|Overall Study|Other|14|||
155246298|NCT04546581|560332694|FG000|Overall Study|Adverse Event|9|||
155246299|NCT04546581|560332695|FG001|Overall Study|Adverse Event|3|||
155246300|NCT04546581|560332694|FG000|Overall Study|Physician Decision|0|||
155246301|NCT04546581|560332695|FG001|Overall Study|Physician Decision|1|||
155246302|NCT04546581|560332694|FG000|Overall Study|Protocol Violation|1|||
155246303|NCT04546581|560332695|FG001|Overall Study|Protocol Violation|2|||
155246304|NCT04546581|560332694|FG000|Overall Study|Withdrawal by Subject|3|||
155246305|NCT04546581|560332695|FG001|Overall Study|Withdrawal by Subject|7|||
155246306|NCT02526693|560332696|FG000|Overall Study|Physician Decision|3|||
155246307|NCT02526693|560332697|FG001|Overall Study|Physician Decision|1|||
155246308|NCT01585103|560332699|FG000|Overall Study|Unable to swallow Cytosponge|6|||
155246309|NCT01349569|560332700|FG000|Overall Study|Lack of Efficacy|4|||
155246310|NCT01944631|560332701|FG000|Overall Study|Adverse Event|1|||
155246311|NCT01944631|560332702|FG001|Overall Study|Adverse Event|0|||
155246312|NCT01944631|560332701|FG000|Overall Study|Lost to Follow-up|3|||
155246313|NCT01944631|560332702|FG001|Overall Study|Lost to Follow-up|1|||
155246314|NCT01944631|560332701|FG000|Overall Study|Withdrawal by Subject|0|||
155246315|NCT01944631|560332702|FG001|Overall Study|Withdrawal by Subject|1|||
155246316|NCT00328510|560332705|FG000|Overall Study|Gag disorder, could not use frame|4|||
155246317|NCT00328510|560332706|FG001|Overall Study|Gag disorder, could not use frame|0|||
155246318|NCT00328510|560332705|FG000|Overall Study|Dentition problems, could not use frame|1|||
155246319|NCT00328510|560332706|FG001|Overall Study|Dentition problems, could not use frame|0|||
155246320|NCT00328510|560332705|FG000|Overall Study|Withdrawal by Subject|4|||
155246321|NCT00328510|560332706|FG001|Overall Study|Withdrawal by Subject|2|||
155246322|NCT00328510|560332705|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
155246323|NCT00328510|560332706|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
155246324|NCT00328510|560332705|FG000|Overall Study|Treatment changed to a single fraction|1|||
155246325|NCT00328510|560332706|FG001|Overall Study|Treatment changed to a single fraction|1|||
155246326|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246327|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246328|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
155246329|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246330|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246331|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246332|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246333|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246334|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246335|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246336|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246337|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
155246338|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246339|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246340|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246341|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246342|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246343|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
155246344|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
155246345|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246346|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246347|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246348|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246349|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246350|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
155246351|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
155246352|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
155246353|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
155246354|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
155246355|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
155246356|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246357|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
155246358|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246359|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246360|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246361|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246362|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246363|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246364|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246365|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246366|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246367|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246368|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Adverse Event|0|||
155246369|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Adverse Event|0|||
155246370|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Adverse Event|0|||
155246371|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Adverse Event|0|||
155246372|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Adverse Event|1|||
155246373|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Adverse Event|0|||
155246374|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
155246375|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
155246376|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
155246377|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
155246378|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
155246379|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
155246380|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246381|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246382|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246383|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246384|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246385|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
155246386|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246387|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246388|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246389|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246390|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
155246391|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246392|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
155246393|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246394|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246395|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246396|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246397|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246398|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
155246399|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
155246400|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
155246401|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
155246402|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
155246403|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
155246404|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246405|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
155246406|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246407|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246408|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246409|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246410|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246411|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
155246412|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246413|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246414|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246415|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246416|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Adverse Event|0|||
155246417|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Adverse Event|1|||
155246418|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Adverse Event|0|||
155246419|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Adverse Event|0|||
155246420|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Adverse Event|0|||
155246421|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Adverse Event|0|||
155246422|NCT01990950|560332713|FG000|Overall Study|Death|3|||
155246423|NCT01990950|560332713|FG000|Overall Study|Lost to Follow-up|2|||
155246424|NCT01990950|560332713|FG000|Overall Study|Withdrawal by Subject|6|||
155246425|NCT02863926|560332714|FG000|Overall Study|Physician Decision|1|||
155246426|NCT02863926|560332715|FG001|Overall Study|Physician Decision|0|||
155246427|NCT02863926|560332714|FG000|Overall Study|Lost to Follow-up|1|||
155246428|NCT02863926|560332715|FG001|Overall Study|Lost to Follow-up|1|||
155246429|NCT02473952|560332720|FG000|Overall Study|Adverse Event|2|||
155246430|NCT02473952|560332721|FG001|Overall Study|Adverse Event|2|||
155246431|NCT02473952|560332720|FG000|Overall Study|Withdrawal by Subject|0|||
155246432|NCT02473952|560332721|FG001|Overall Study|Withdrawal by Subject|6|||
155246433|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
155246434|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
155246435|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Death|1|||
155246436|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Death|0|||
155246437|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
155246438|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
155246439|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
155246440|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
155246441|NCT00823719|560332726|FG000|Overall Study|Adverse Event|1|||
155246442|NCT00823719|560332727|FG001|Overall Study|Adverse Event|2|||
155246443|NCT00823719|560332726|FG000|Overall Study|Physician Decision|1|||
155246444|NCT00823719|560332727|FG001|Overall Study|Physician Decision|4|||
155246445|NCT00823719|560332726|FG000|Overall Study|Withdrawal by Subject|0|||
155246446|NCT00823719|560332727|FG001|Overall Study|Withdrawal by Subject|1|||
155246447|NCT00823719|560332726|FG000|Overall Study|Disease Progression|4|||
155246448|NCT00823719|560332727|FG001|Overall Study|Disease Progression|4|||
155246449|NCT02117570|560332728|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
155246450|NCT02117570|560332729|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
155246451|NCT02117570|560332730|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
155246452|NCT02117570|560332728|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
155246453|NCT02117570|560332729|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
155246454|NCT02117570|560332730|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
155246455|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
155246456|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
155246457|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
155246458|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
155246459|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
155246460|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
155246461|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
155607051|NCT01897571|561649621|FG008|Overall Study|Death|23|||
155246462|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
155246463|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
155246464|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
155246465|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
155246466|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
155246467|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
155246468|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
155246469|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
155246470|NCT02148250|560332731|FG000|Screening|Withdrawal by Subject|5|||
155246471|NCT02148250|560332732|FG001|Screening|Withdrawal by Subject|0|||
155246472|NCT02806986|560332738|FG000|Treatment Stage 1|Adverse Event|1|||
155246473|NCT02806986|560332738|FG000|Treatment Stage 2|Adverse Event|3|||
155246474|NCT02806986|560332738|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
155246475|NCT03043664|560332739|FG000|Overall Study|Lost to Follow-up|1|||
155246476|NCT01540851|560332740|FG000|Overall Study|Lost to Follow-up|14|||
155246477|NCT01540851|560332741|FG001|Overall Study|Lost to Follow-up|15|||
155246478|NCT01540851|560332740|FG000|Overall Study|Withdrawal by Subject|7|||
155246479|NCT01540851|560332741|FG001|Overall Study|Withdrawal by Subject|3|||
155246480|NCT03732209|560332742|FG000|Overall Study|Lost to Follow-up|4|||
155246481|NCT03732209|560332743|FG001|Overall Study|Lost to Follow-up|4|||
155246482|NCT03732209|560332742|FG000|Overall Study|Withdrawal by Subject|8|||
155246483|NCT03732209|560332743|FG001|Overall Study|Withdrawal by Subject|9|||
155246484|NCT04139317|560332744|FG000|Overall Study|Adverse Event|10|||
155246485|NCT04139317|560332745|FG001|Overall Study|Adverse Event|2|||
155246486|NCT04139317|560332744|FG000|Overall Study|Death|6|||
155246487|NCT04139317|560332745|FG001|Overall Study|Death|4|||
155246488|NCT04139317|560332744|FG000|Overall Study|Lost to Follow-up|1|||
155246489|NCT04139317|560332745|FG001|Overall Study|Lost to Follow-up|0|||
155246490|NCT04139317|560332744|FG000|Overall Study|Physician Decision|3|||
155246491|NCT04139317|560332745|FG001|Overall Study|Physician Decision|1|||
155246492|NCT04139317|560332744|FG000|Overall Study|Progressive Disease|19|||
155246493|NCT04139317|560332745|FG001|Overall Study|Progressive Disease|9|||
155246494|NCT04139317|560332744|FG000|Overall Study|Subject Decision|2|||
155246495|NCT04139317|560332745|FG001|Overall Study|Subject Decision|2|||
155246496|NCT03621696|560332748|FG000|Overall Study|Not eligible|0|||
155246497|NCT03621696|560332749|FG001|Overall Study|Not eligible|0|||
155246498|NCT03621696|560332750|FG002|Overall Study|Not eligible|0|||
155246499|NCT03621696|560332751|FG003|Overall Study|Not eligible|5|||
155246500|NCT03621696|560332748|FG000|Overall Study|Withdrawal by Subject|1|||
155246501|NCT03621696|560332749|FG001|Overall Study|Withdrawal by Subject|1|||
155246502|NCT03621696|560332750|FG002|Overall Study|Withdrawal by Subject|1|||
155246503|NCT03621696|560332751|FG003|Overall Study|Withdrawal by Subject|0|||
155246504|NCT03621696|560332748|FG000|Overall Study|Physician Decision|0|||
155246505|NCT03621696|560332749|FG001|Overall Study|Physician Decision|0|||
155246506|NCT03621696|560332750|FG002|Overall Study|Physician Decision|1|||
155246507|NCT03621696|560332751|FG003|Overall Study|Physician Decision|0|||
155246508|NCT00413413|560332752|FG000|Single-Blind|Adverse Event|0|||
155246509|NCT00413413|560332753|FG001|Single-Blind|Adverse Event|9|||
155246510|NCT00413413|560332754|FG002|Single-Blind|Adverse Event|0|||
155246511|NCT00413413|560332752|FG000|Single-Blind|Lack of Efficacy|0|||
155246512|NCT00413413|560332753|FG001|Single-Blind|Lack of Efficacy|5|||
155246513|NCT00413413|560332754|FG002|Single-Blind|Lack of Efficacy|0|||
155246514|NCT00413413|560332752|FG000|Single-Blind|Subject no longer requires study drug|0|||
155246515|NCT00413413|560332753|FG001|Single-Blind|Subject no longer requires study drug|151|||
155246516|NCT00413413|560332754|FG002|Single-Blind|Subject no longer requires study drug|0|||
155246517|NCT00413413|560332752|FG000|Single-Blind|Protocol Violation|0|||
155246518|NCT00413413|560332753|FG001|Single-Blind|Protocol Violation|16|||
155246519|NCT00413413|560332754|FG002|Single-Blind|Protocol Violation|0|||
155246520|NCT00413413|560332752|FG000|Single-Blind|Withdrawal by Subject|0|||
155246521|NCT00413413|560332753|FG001|Single-Blind|Withdrawal by Subject|27|||
155246522|NCT00413413|560332754|FG002|Single-Blind|Withdrawal by Subject|0|||
155246523|NCT00413413|560332752|FG000|Single-Blind|Lost to Follow-up|0|||
155246524|NCT00413413|560332753|FG001|Single-Blind|Lost to Follow-up|8|||
155246525|NCT00413413|560332754|FG002|Single-Blind|Lost to Follow-up|0|||
155246526|NCT00413413|560332752|FG000|Double-Blind|Adverse Event|6|||
155246527|NCT00413413|560332753|FG001|Double-Blind|Adverse Event|0|||
155246528|NCT00413413|560332754|FG002|Double-Blind|Adverse Event|5|||
155246529|NCT00413413|560332752|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
155246530|NCT00413413|560332753|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
155246531|NCT00413413|560332754|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
155246532|NCT00413413|560332752|FG000|Double-Blind|Protocol deviation|1|||
155246533|NCT00413413|560332753|FG001|Double-Blind|Protocol deviation|2|||
155246534|NCT00413413|560332754|FG002|Double-Blind|Protocol deviation|1|||
155246535|NCT00413413|560332752|FG000|Double-Blind|Subject withdrew consent|4|||
155246536|NCT00413413|560332753|FG001|Double-Blind|Subject withdrew consent|6|||
155246537|NCT00413413|560332754|FG002|Double-Blind|Subject withdrew consent|9|||
155246538|NCT00413413|560332752|FG000|Double-Blind|Lost to Follow-up|3|||
155246539|NCT00413413|560332753|FG001|Double-Blind|Lost to Follow-up|4|||
155246540|NCT00413413|560332754|FG002|Double-Blind|Lost to Follow-up|2|||
155246541|NCT05348681|560332755|FG000|Overall Study|Study terminated by Sponsor|8|||
155246542|NCT05348681|560332756|FG001|Overall Study|Study terminated by Sponsor|3|||
155246543|NCT05348681|560332755|FG000|Overall Study|Withdrawal by Subject|1|||
155246544|NCT05348681|560332756|FG001|Overall Study|Withdrawal by Subject|1|||
155246545|NCT05348681|560332755|FG000|Overall Study|Lost to Follow-up|1|||
155246546|NCT05348681|560332756|FG001|Overall Study|Lost to Follow-up|1|||
155246547|NCT05348681|560332755|FG000|Overall Study|Adverse Event|1|||
155246548|NCT05348681|560332756|FG001|Overall Study|Adverse Event|0|||
155246549|NCT05348681|560332755|FG000|Overall Study|Other|2|||
155246550|NCT05348681|560332756|FG001|Overall Study|Other|1|||
155246551|NCT00782340|560332757|FG000|Open Label Titration|Adverse Event|12|||
155246552|NCT00782340|560332758|FG001|Open Label Titration|Adverse Event|0|||
155246553|NCT00782340|560332759|FG002|Open Label Titration|Adverse Event|0|||
155246554|NCT00782340|560332757|FG000|Open Label Titration|Treatment failure|50|||
155246555|NCT00782340|560332758|FG001|Open Label Titration|Treatment failure|0|||
155246556|NCT00782340|560332759|FG002|Open Label Titration|Treatment failure|0|||
155246557|NCT00782340|560332757|FG000|Open Label Titration|Protocol Violation|5|||
155246558|NCT00782340|560332758|FG001|Open Label Titration|Protocol Violation|0|||
155246559|NCT00782340|560332759|FG002|Open Label Titration|Protocol Violation|0|||
155246560|NCT00782340|560332757|FG000|Open Label Titration|Withdrawal by Subject|5|||
155246561|NCT00782340|560332758|FG001|Open Label Titration|Withdrawal by Subject|0|||
155246562|NCT00782340|560332759|FG002|Open Label Titration|Withdrawal by Subject|0|||
155246563|NCT00782340|560332757|FG000|Open Label Titration|Enrollment capped|16|||
155246564|NCT00782340|560332758|FG001|Open Label Titration|Enrollment capped|0|||
155246565|NCT00782340|560332759|FG002|Open Label Titration|Enrollment capped|0|||
155246566|NCT00782340|560332757|FG000|Open Label Titration|Did not meet responder criteria|2|||
155246567|NCT00782340|560332758|FG001|Open Label Titration|Did not meet responder criteria|0|||
155246568|NCT00782340|560332759|FG002|Open Label Titration|Did not meet responder criteria|0|||
155246569|NCT00782340|560332757|FG000|Open Label Titration|Lost to Follow-up|5|||
155246570|NCT00782340|560332758|FG001|Open Label Titration|Lost to Follow-up|0|||
155246571|NCT00782340|560332759|FG002|Open Label Titration|Lost to Follow-up|0|||
155246572|NCT00782340|560332757|FG000|Open Label Titration|Randomized in error|6|||
155246573|NCT00782340|560332758|FG001|Open Label Titration|Randomized in error|0|||
155246574|NCT00782340|560332759|FG002|Open Label Titration|Randomized in error|0|||
155246575|NCT00553267|560332761|FG000|Overall Study|Adverse Event|8|||
155246576|NCT00553267|560332762|FG001|Overall Study|Adverse Event|10|||
155246577|NCT00553267|560332763|FG002|Overall Study|Adverse Event|5|||
155246578|NCT00553267|560332761|FG000|Overall Study|Non compliant with protocol|3|||
155246579|NCT00553267|560332762|FG001|Overall Study|Non compliant with protocol|3|||
155246580|NCT00553267|560332763|FG002|Overall Study|Non compliant with protocol|2|||
155246581|NCT00553267|560332761|FG000|Overall Study|Lost to Follow-up|0|||
155246582|NCT00553267|560332762|FG001|Overall Study|Lost to Follow-up|0|||
155246583|NCT00553267|560332763|FG002|Overall Study|Lost to Follow-up|1|||
155246584|NCT00553267|560332761|FG000|Overall Study|Consent withdrawn|2|||
155246585|NCT00553267|560332762|FG001|Overall Study|Consent withdrawn|3|||
155246586|NCT00553267|560332763|FG002|Overall Study|Consent withdrawn|1|||
155246587|NCT00553267|560332761|FG000|Overall Study|Specified category|1|||
155246588|NCT00553267|560332762|FG001|Overall Study|Specified category|2|||
155246589|NCT00553267|560332763|FG002|Overall Study|Specified category|1|||
155246590|NCT04389840|560332764|FG000|Overall Study|Adverse Event|0|||
155246591|NCT04389840|560332765|FG001|Overall Study|Adverse Event|0|||
155246592|NCT04389840|560332766|FG002|Overall Study|Adverse Event|0|||
155246593|NCT04389840|560332767|FG003|Overall Study|Adverse Event|1|||
155246594|NCT04389840|560332768|FG004|Overall Study|Adverse Event|0|||
155246595|NCT04389840|560332769|FG005|Overall Study|Adverse Event|0|||
155246596|NCT04389840|560332764|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
155246597|NCT04389840|560332765|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
155246598|NCT04389840|560332766|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
155246599|NCT04389840|560332767|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
155246600|NCT04389840|560332768|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
155246601|NCT04389840|560332769|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
155246602|NCT04389840|560332764|FG000|Overall Study|Death|0|||
155246603|NCT04389840|560332765|FG001|Overall Study|Death|1|||
155246604|NCT04389840|560332766|FG002|Overall Study|Death|0|||
155246605|NCT04389840|560332767|FG003|Overall Study|Death|0|||
155246606|NCT04389840|560332768|FG004|Overall Study|Death|0|||
155246607|NCT04389840|560332769|FG005|Overall Study|Death|0|||
155246608|NCT00096135|560332775|FG000|Overall Study|Physician Decision|20|||
155246609|NCT00096135|560332776|FG001|Overall Study|Physician Decision|4|||
155246610|NCT00096135|560332775|FG000|Overall Study|Refusal of further protocol therapy|4|||
155246611|NCT00096135|560332776|FG001|Overall Study|Refusal of further protocol therapy|1|||
155246612|NCT00096135|560332775|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
155607052|NCT01897571|561649622|FG009|Overall Study|Death|129|||
155246613|NCT00096135|560332776|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
155246614|NCT00096135|560332775|FG000|Overall Study|Other, specify|15|||
155246615|NCT00096135|560332776|FG001|Overall Study|Other, specify|3|||
155246616|NCT00096135|560332775|FG000|Overall Study|Ineligible|2|||
155246617|NCT00096135|560332776|FG001|Overall Study|Ineligible|0|||
155246618|NCT01306162|560332777|FG000|Period 1|Adverse Event|0|||
155246619|NCT01306162|560332778|FG001|Period 1|Adverse Event|0|||
155246620|NCT01306162|560332779|FG002|Period 1|Adverse Event|0|||
155246621|NCT01306162|560332780|FG003|Period 1|Adverse Event|1|||
155246622|NCT01306162|560332777|FG000|Washout 1|Non-compliance to protocol|0|||
155246623|NCT01306162|560332778|FG001|Washout 1|Non-compliance to protocol|1|||
155246624|NCT01306162|560332779|FG002|Washout 1|Non-compliance to protocol|0|||
155246625|NCT01306162|560332780|FG003|Washout 1|Non-compliance to protocol|0|||
155246626|NCT00833989|560332784|FG000|Overall Study|Physician Decision|0|||
155246627|NCT00833989|560332785|FG001|Overall Study|Physician Decision|0|||
155246628|NCT00833989|560332786|FG002|Overall Study|Physician Decision|0|||
155246629|NCT00833989|560332787|FG003|Overall Study|Physician Decision|1|||
155246630|NCT00833989|560332784|FG000|Overall Study|Withdrawal by Subject|3|||
155246631|NCT00833989|560332785|FG001|Overall Study|Withdrawal by Subject|0|||
155246632|NCT00833989|560332786|FG002|Overall Study|Withdrawal by Subject|1|||
155246633|NCT00833989|560332787|FG003|Overall Study|Withdrawal by Subject|1|||
155246634|NCT01458574|560332788|FG000|Overall Study|Adverse Event|5|||
155246635|NCT01458574|560332789|FG001|Overall Study|Adverse Event|9|||
155246636|NCT01458574|560332790|FG002|Overall Study|Adverse Event|7|||
155246637|NCT01458574|560332788|FG000|Overall Study|Lack of Efficacy|70|||
155246638|NCT01458574|560332789|FG001|Overall Study|Lack of Efficacy|53|||
155246639|NCT01458574|560332790|FG002|Overall Study|Lack of Efficacy|132|||
155246640|NCT01458574|560332788|FG000|Overall Study|Lost to Follow-up|3|||
155246641|NCT01458574|560332789|FG001|Overall Study|Lost to Follow-up|2|||
155246642|NCT01458574|560332790|FG002|Overall Study|Lost to Follow-up|1|||
155246643|NCT01458574|560332788|FG000|Overall Study|Pregnancy|1|||
155246644|NCT01458574|560332789|FG001|Overall Study|Pregnancy|1|||
155246645|NCT01458574|560332790|FG002|Overall Study|Pregnancy|0|||
155246646|NCT01458574|560332788|FG000|Overall Study|Protocol Violation|0|||
155246647|NCT01458574|560332789|FG001|Overall Study|Protocol Violation|1|||
155246648|NCT01458574|560332790|FG002|Overall Study|Protocol Violation|0|||
155246649|NCT01458574|560332788|FG000|Overall Study|Withdrawal by Subject|6|||
155246650|NCT01458574|560332789|FG001|Overall Study|Withdrawal by Subject|3|||
155246651|NCT01458574|560332790|FG002|Overall Study|Withdrawal by Subject|5|||
155246652|NCT01458574|560332788|FG000|Overall Study|Other|2|||
155246653|NCT01458574|560332789|FG001|Overall Study|Other|1|||
155246654|NCT01458574|560332790|FG002|Overall Study|Other|0|||
155246655|NCT01458574|560332788|FG000|Overall Study|Randomized but not treated|0|||
155246656|NCT01458574|560332789|FG001|Overall Study|Randomized but not treated|1|||
155246657|NCT01458574|560332790|FG002|Overall Study|Randomized but not treated|0|||
155246658|NCT02125786|560332791|FG000|Overall Study|Still in Follow-up|3|||
155246659|NCT02125786|560332791|FG000|Overall Study|Screen Failure|2|||
155246660|NCT02125786|560332791|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
155246661|NCT02125786|560332791|FG000|Overall Study|Progressive Disease|44|||
155246662|NCT02125786|560332791|FG000|Overall Study|Death|8|||
155246663|NCT01365494|560332792|FG000|Overall Study|Adverse Event|1|||
155246664|NCT01365494|560332793|FG001|Overall Study|Adverse Event|0|||
155246665|NCT01365494|560332792|FG000|Overall Study|Withdrawal by Subject|0|||
155246666|NCT01365494|560332793|FG001|Overall Study|Withdrawal by Subject|1|||
155246667|NCT01365494|560332792|FG000|Overall Study|Lost to Follow-up|1|||
155246668|NCT01365494|560332793|FG001|Overall Study|Lost to Follow-up|2|||
155246669|NCT02663128|560332794|FG000|Period 2|Physician Decision|0|||
155246670|NCT02663128|560332795|FG001|Period 2|Physician Decision|0|||
155246671|NCT02663128|560332796|FG002|Period 2|Physician Decision|0|||
155246672|NCT02663128|560332797|FG003|Period 2|Physician Decision|0|||
155246673|NCT02663128|560332798|FG004|Period 2|Physician Decision|1|||
155246674|NCT02663128|560332799|FG005|Period 2|Physician Decision|0|||
155246675|NCT05070897|560332803|FG000|Overall Study|Protocol Violation|123|||
155246676|NCT05070897|560332804|FG001|Overall Study|Protocol Violation|68|||
155246677|NCT03832946|560332805|FG000|Overall Study|Adverse Event|3|||
155246678|NCT03832946|560332806|FG001|Overall Study|Adverse Event|1|||
155246679|NCT03832946|560332805|FG000|Overall Study|Lost to Follow-up|1|||
155246680|NCT03832946|560332806|FG001|Overall Study|Lost to Follow-up|0|||
155246681|NCT03832946|560332805|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
155246682|NCT03832946|560332806|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
155246683|NCT03832946|560332805|FG000|Overall Study|Lack of Efficacy|1|||
155246684|NCT03832946|560332806|FG001|Overall Study|Lack of Efficacy|0|||
155246685|NCT03832946|560332805|FG000|Overall Study|Withdrawal by Subject|12|||
155246686|NCT03832946|560332806|FG001|Overall Study|Withdrawal by Subject|9|||
155246687|NCT03394924|560332807|FG000|Overall Study|Adverse Event|0|||
155246688|NCT03394924|560332808|FG001|Overall Study|Adverse Event|5|||
155246689|NCT03394924|560332809|FG002|Overall Study|Adverse Event|0|||
155246690|NCT03394924|560332807|FG000|Overall Study|Withdrawal by Subject|2|||
155246691|NCT03394924|560332808|FG001|Overall Study|Withdrawal by Subject|0|||
155246692|NCT03394924|560332809|FG002|Overall Study|Withdrawal by Subject|0|||
155246693|NCT03394924|560332807|FG000|Overall Study|Lost to Follow-up|0|||
155246694|NCT03394924|560332808|FG001|Overall Study|Lost to Follow-up|1|||
155246695|NCT03394924|560332809|FG002|Overall Study|Lost to Follow-up|0|||
155246696|NCT03394924|560332807|FG000|Overall Study|Did not meet all inclusion criteria|1|||
155246697|NCT03394924|560332808|FG001|Overall Study|Did not meet all inclusion criteria|0|||
155246698|NCT03394924|560332809|FG002|Overall Study|Did not meet all inclusion criteria|0|||
155246699|NCT03277313|560332816|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
155246700|NCT03277313|560332817|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
155246701|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
155246702|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
155246703|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
155246704|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
155246705|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
155246706|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
155246707|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
155246708|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
155246709|NCT02005471|560332818|FG000|Main Study|Adverse Event|0|||
155246710|NCT02005471|560332819|FG001|Main Study|Adverse Event|1|||
155246711|NCT02005471|560332820|FG002|Main Study|Adverse Event|0|||
155246712|NCT02005471|560332821|FG003|Main Study|Adverse Event|0|||
155246713|NCT02005471|560332818|FG000|Main Study|Death|83|||
155246714|NCT02005471|560332819|FG001|Main Study|Death|52|||
155246715|NCT02005471|560332820|FG002|Main Study|Death|0|||
155246716|NCT02005471|560332821|FG003|Main Study|Death|0|||
155246717|NCT02005471|560332818|FG000|Main Study|Lost to Follow-up|4|||
155246718|NCT02005471|560332819|FG001|Main Study|Lost to Follow-up|5|||
155246719|NCT02005471|560332820|FG002|Main Study|Lost to Follow-up|0|||
155246720|NCT02005471|560332821|FG003|Main Study|Lost to Follow-up|0|||
155246721|NCT02005471|560332818|FG000|Main Study|Physician Decision|3|||
155246722|NCT02005471|560332819|FG001|Main Study|Physician Decision|1|||
155246723|NCT02005471|560332820|FG002|Main Study|Physician Decision|0|||
155246724|NCT02005471|560332821|FG003|Main Study|Physician Decision|0|||
155246725|NCT02005471|560332818|FG000|Main Study|Withdrawal by Subject|26|||
155246726|NCT02005471|560332819|FG001|Main Study|Withdrawal by Subject|11|||
155246727|NCT02005471|560332820|FG002|Main Study|Withdrawal by Subject|0|||
155246728|NCT02005471|560332821|FG003|Main Study|Withdrawal by Subject|0|||
155246729|NCT02005471|560332818|FG000|Main Study|Reason not Specified|0|||
155246730|NCT02005471|560332819|FG001|Main Study|Reason not Specified|6|||
155246731|NCT02005471|560332820|FG002|Main Study|Reason not Specified|0|||
155246732|NCT02005471|560332821|FG003|Main Study|Reason not Specified|0|||
155246733|NCT02005471|560332818|FG000|Main Study|Randomized but not Dosed|8|||
155246734|NCT02005471|560332819|FG001|Main Study|Randomized but not Dosed|0|||
155246735|NCT02005471|560332820|FG002|Main Study|Randomized but not Dosed|0|||
155246736|NCT02005471|560332821|FG003|Main Study|Randomized but not Dosed|0|||
155246737|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246738|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246739|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246740|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
155246741|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
155246742|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
155246743|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
155246744|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
155246745|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
155246746|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
155246747|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
155246748|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
155246749|NCT00627705|560332823|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
155246750|NCT00627705|560332824|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
155246751|NCT00627705|560332823|FG000|Overall Study|Adverse Event|1|||
155246752|NCT00627705|560332824|FG001|Overall Study|Adverse Event|0|||
155246753|NCT00627705|560332823|FG000|Overall Study|Withdrawal by Subject|0|||
155246754|NCT00627705|560332824|FG001|Overall Study|Withdrawal by Subject|2|||
155246755|NCT00627705|560332823|FG000|Overall Study|Lost to Follow-up|0|||
155246756|NCT00627705|560332824|FG001|Overall Study|Lost to Follow-up|1|||
155246757|NCT02663817|560332825|FG000|Overall Study|Screen failure|2|||
155246758|NCT01410448|560332828|FG000|Overall Study|No conversion to everolimus|0|||
155246759|NCT01410448|560332829|FG001|Overall Study|No conversion to everolimus|24|||
155246760|NCT01410448|560332828|FG000|Overall Study|Graft loss|4|||
155246761|NCT01410448|560332829|FG001|Overall Study|Graft loss|1|||
155246762|NCT01410448|560332828|FG000|Overall Study|Administrative issues|2|||
155246763|NCT01410448|560332829|FG001|Overall Study|Administrative issues|1|||
155246764|NCT01410448|560332828|FG000|Overall Study|Lost to Follow-up|1|||
155246765|NCT01410448|560332829|FG001|Overall Study|Lost to Follow-up|0|||
155246766|NCT01410448|560332828|FG000|Overall Study|Withdrawal by Subject|3|||
155246767|NCT01410448|560332829|FG001|Overall Study|Withdrawal by Subject|2|||
155246768|NCT01410448|560332828|FG000|Overall Study|Protocol Violation|0|||
155246769|NCT01410448|560332829|FG001|Overall Study|Protocol Violation|4|||
155246770|NCT01410448|560332828|FG000|Overall Study|Death|2|||
155246771|NCT01410448|560332829|FG001|Overall Study|Death|3|||
155246772|NCT02535065|560332830|FG000|Overall Study|Death|13|||
155246773|NCT02535065|560332830|FG000|Overall Study|Lost to Follow-up|1|||
155246774|NCT02535065|560332830|FG000|Overall Study|Withdrawal by Subject|6|||
155246775|NCT03712917|560332831|FG000|Overall Study|Pregnancy|0|||
155246776|NCT03712917|560332832|FG001|Overall Study|Pregnancy|0|||
155246777|NCT03712917|560332833|FG002|Overall Study|Pregnancy|1|||
155246778|NCT03712917|560332831|FG000|Overall Study|Adverse Event|0|||
155246779|NCT03712917|560332832|FG001|Overall Study|Adverse Event|4|||
155246780|NCT03712917|560332833|FG002|Overall Study|Adverse Event|3|||
155246781|NCT03712917|560332831|FG000|Overall Study|Lost to Follow-up|9|||
155246782|NCT03712917|560332832|FG001|Overall Study|Lost to Follow-up|4|||
155246783|NCT03712917|560332833|FG002|Overall Study|Lost to Follow-up|5|||
155246784|NCT00932893|560332838|FG000|Overall Study|Death|115|||
155246785|NCT00932893|560332839|FG001|Overall Study|Death|24|||
155246786|NCT00932893|560332838|FG000|Overall Study|Lost to Follow-up|8|||
155246787|NCT00932893|560332839|FG001|Overall Study|Lost to Follow-up|0|||
155246788|NCT00932893|560332838|FG000|Overall Study|Withdrawal by Subject|5|||
155246789|NCT00932893|560332839|FG001|Overall Study|Withdrawal by Subject|2|||
155246790|NCT00932893|560332838|FG000|Overall Study|Other|5|||
155246791|NCT00932893|560332839|FG001|Overall Study|Other|144|||
155246792|NCT00791765|560335176|FG000|Weeks 1 to 12|Adverse Event|0|||
155246793|NCT00791765|560335177|FG001|Weeks 1 to 12|Adverse Event|1|||
155246794|NCT00791765|560335176|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
155246795|NCT00791765|560335177|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
155246796|NCT00791765|560335176|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
155246797|NCT00791765|560335177|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
155246798|NCT00791765|560335176|FG000|Weeks 1 to 12|Physician Decision|1|||
155246799|NCT00791765|560335177|FG001|Weeks 1 to 12|Physician Decision|0|||
155246800|NCT00791765|560335176|FG000|Weeks 1 to 12|Disease progression|3|||
155246801|NCT00791765|560335177|FG001|Weeks 1 to 12|Disease progression|0|||
155246802|NCT00791765|560335176|FG000|Weeks 1 to 12|Ineligibility determined|0|||
155246803|NCT00791765|560335177|FG001|Weeks 1 to 12|Ineligibility determined|3|||
155246804|NCT00791765|560335176|FG000|Weeks 13 to 24|Protocol deviation|2|||
155246805|NCT00791765|560335177|FG001|Weeks 13 to 24|Protocol deviation|0|||
155246806|NCT00791765|560335176|FG000|Weeks 13 to 24|Adverse Event|0|||
155246807|NCT00791765|560335177|FG001|Weeks 13 to 24|Adverse Event|3|||
155246808|NCT00791765|560335176|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
155246809|NCT00791765|560335177|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
155246810|NCT00791765|560335176|FG000|Weeks 13 to 24|Disease progression|0|||
155246811|NCT00791765|560335177|FG001|Weeks 13 to 24|Disease progression|1|||
155246812|NCT00791765|560335176|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
155246813|NCT00791765|560335177|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
155246814|NCT00791765|560335176|FG000|Weeks 13 to 24|Other|0|||
155246815|NCT00791765|560335177|FG001|Weeks 13 to 24|Other|1|||
155246816|NCT00924287|560335179|FG000|Overall Study|Death|1|||
155246817|NCT04579757|560335190|FG000|Overall Study|Adverse Event|0|||
155246818|NCT04579757|560335191|FG001|Overall Study|Adverse Event|0|||
155246819|NCT04579757|560335192|FG002|Overall Study|Adverse Event|0|||
155246820|NCT04579757|560335193|FG003|Overall Study|Adverse Event|2|||
155246821|NCT04579757|560335194|FG004|Overall Study|Adverse Event|1|||
155246822|NCT04579757|560335195|FG005|Overall Study|Adverse Event|1|||
155246823|NCT04579757|560335196|FG006|Overall Study|Adverse Event|0|||
155246824|NCT04579757|560335197|FG007|Overall Study|Adverse Event|0|||
155246825|NCT04579757|560335198|FG008|Overall Study|Adverse Event|0|||
155246826|NCT04579757|560335190|FG000|Overall Study|Death|4|||
155246827|NCT04579757|560335191|FG001|Overall Study|Death|1|||
155246828|NCT04579757|560335192|FG002|Overall Study|Death|14|||
155246829|NCT04579757|560335193|FG003|Overall Study|Death|3|||
155246830|NCT04579757|560335194|FG004|Overall Study|Death|2|||
155246831|NCT04579757|560335195|FG005|Overall Study|Death|7|||
155246832|NCT04579757|560335196|FG006|Overall Study|Death|0|||
155246833|NCT04579757|560335197|FG007|Overall Study|Death|1|||
155246834|NCT04579757|560335198|FG008|Overall Study|Death|3|||
155246835|NCT04579757|560335190|FG000|Overall Study|Physician Decision|0|||
155246836|NCT04579757|560335191|FG001|Overall Study|Physician Decision|0|||
155246837|NCT04579757|560335192|FG002|Overall Study|Physician Decision|0|||
155246838|NCT04579757|560335193|FG003|Overall Study|Physician Decision|2|||
155246839|NCT04579757|560335194|FG004|Overall Study|Physician Decision|1|||
155246840|NCT04579757|560335195|FG005|Overall Study|Physician Decision|1|||
155246841|NCT04579757|560335196|FG006|Overall Study|Physician Decision|1|||
155246842|NCT04579757|560335197|FG007|Overall Study|Physician Decision|0|||
155246843|NCT04579757|560335198|FG008|Overall Study|Physician Decision|0|||
155246844|NCT04579757|560335190|FG000|Overall Study|Study Terminated By Sponsor|0|||
155246845|NCT04579757|560335191|FG001|Overall Study|Study Terminated By Sponsor|0|||
155246846|NCT04579757|560335192|FG002|Overall Study|Study Terminated By Sponsor|0|||
155246847|NCT04579757|560335193|FG003|Overall Study|Study Terminated By Sponsor|0|||
155246848|NCT04579757|560335194|FG004|Overall Study|Study Terminated By Sponsor|2|||
155246849|NCT04579757|560335195|FG005|Overall Study|Study Terminated By Sponsor|0|||
155246850|NCT04579757|560335196|FG006|Overall Study|Study Terminated By Sponsor|0|||
155246851|NCT04579757|560335197|FG007|Overall Study|Study Terminated By Sponsor|2|||
155246852|NCT04579757|560335198|FG008|Overall Study|Study Terminated By Sponsor|0|||
155246853|NCT04579757|560335190|FG000|Overall Study|Withdrawal by Subject|1|||
155246854|NCT04579757|560335191|FG001|Overall Study|Withdrawal by Subject|1|||
155246855|NCT04579757|560335192|FG002|Overall Study|Withdrawal by Subject|0|||
155246856|NCT04579757|560335193|FG003|Overall Study|Withdrawal by Subject|0|||
155246857|NCT04579757|560335194|FG004|Overall Study|Withdrawal by Subject|2|||
155246858|NCT04579757|560335195|FG005|Overall Study|Withdrawal by Subject|1|||
155246859|NCT04579757|560335196|FG006|Overall Study|Withdrawal by Subject|0|||
155246860|NCT04579757|560335197|FG007|Overall Study|Withdrawal by Subject|3|||
155246861|NCT04579757|560335198|FG008|Overall Study|Withdrawal by Subject|0|||
155246862|NCT04579757|560335190|FG000|Overall Study|Radiological or Clinical PD|1|||
155246863|NCT04579757|560335191|FG001|Overall Study|Radiological or Clinical PD|4|||
155246864|NCT04579757|560335192|FG002|Overall Study|Radiological or Clinical PD|1|||
155246865|NCT04579757|560335193|FG003|Overall Study|Radiological or Clinical PD|3|||
155246866|NCT04579757|560335194|FG004|Overall Study|Radiological or Clinical PD|9|||
155246867|NCT04579757|560335195|FG005|Overall Study|Radiological or Clinical PD|4|||
155246868|NCT04579757|560335196|FG006|Overall Study|Radiological or Clinical PD|2|||
155246869|NCT04579757|560335197|FG007|Overall Study|Radiological or Clinical PD|2|||
155246870|NCT04579757|560335198|FG008|Overall Study|Radiological or Clinical PD|0|||
155246871|NCT04579757|560335190|FG000|Overall Study|Start of New Therapy|0|||
155246872|NCT04579757|560335191|FG001|Overall Study|Start of New Therapy|0|||
155246873|NCT04579757|560335192|FG002|Overall Study|Start of New Therapy|0|||
155246874|NCT04579757|560335193|FG003|Overall Study|Start of New Therapy|0|||
155246875|NCT04579757|560335194|FG004|Overall Study|Start of New Therapy|2|||
155246876|NCT04579757|560335195|FG005|Overall Study|Start of New Therapy|1|||
155246877|NCT04579757|560335196|FG006|Overall Study|Start of New Therapy|0|||
155246878|NCT04579757|560335197|FG007|Overall Study|Start of New Therapy|0|||
155246879|NCT04579757|560335198|FG008|Overall Study|Start of New Therapy|0|||
155246880|NCT01843192|560335199|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
155246881|NCT01843192|560335200|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
155246882|NCT01843192|560335201|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
155246883|NCT00856856|560335203|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
155246884|NCT00856856|560335203|FG000|4-year Clinical Follow-up|Missed visit|1|||
155246885|NCT00434057|560335206|FG000|Overall Study|Withdrawal by Subject|1|||
155246886|NCT03073603|560335208|FG000|Overall Study|Noncompliance|3|||
155246887|NCT03073603|560335209|FG001|Overall Study|Noncompliance|1|||
155246888|NCT03073603|560335208|FG000|Overall Study|Adverse Event|5|||
155246889|NCT03073603|560335209|FG001|Overall Study|Adverse Event|3|||
155246890|NCT03073603|560335208|FG000|Overall Study|Physician Decision|1|||
155246891|NCT03073603|560335209|FG001|Overall Study|Physician Decision|2|||
155246892|NCT03073603|560335208|FG000|Overall Study|Required treatment not allowed by protocol|1|||
155246893|NCT03073603|560335209|FG001|Overall Study|Required treatment not allowed by protocol|0|||
155246894|NCT03073603|560335208|FG000|Overall Study|Financial or insurance-related|8|||
155246895|NCT03073603|560335209|FG001|Overall Study|Financial or insurance-related|0|||
155246896|NCT03073603|560335208|FG000|Overall Study|Withdrawal by Subject|0|||
155246897|NCT03073603|560335209|FG001|Overall Study|Withdrawal by Subject|1|||
155246898|NCT03073603|560335208|FG000|Overall Study|Discontinued DMT|4|||
155246899|NCT03073603|560335209|FG001|Overall Study|Discontinued DMT|0|||
155246900|NCT03073603|560335208|FG000|Overall Study|Restarted DMT|0|||
155246901|NCT03073603|560335209|FG001|Overall Study|Restarted DMT|1|||
155246902|NCT03701555|560335210|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
155246903|NCT03701555|560335211|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
155246904|NCT03701555|560335212|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
155246905|NCT03701555|560335213|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
155246906|NCT03701555|560335214|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
155246907|NCT03701555|560335215|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
155246908|NCT03701555|560335216|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
155246909|NCT03701555|560335217|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
155246910|NCT03701555|560335218|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
155246911|NCT03701555|560335219|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
155246912|NCT03701555|560335220|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
155491678|NCT03992456|561225488|FG001|Overall Study|Withdrawal by Subject|0|||
155246913|NCT03701555|560335221|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
155246914|NCT03701555|560335222|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
155246915|NCT03701555|560335223|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
155246916|NCT03701555|560335224|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
155246917|NCT03701555|560335225|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
155246918|NCT03701555|560335226|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
155246919|NCT03701555|560335227|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
155246920|NCT03701555|560335228|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
155246921|NCT03701555|560335229|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
155246922|NCT03701555|560335230|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
155246923|NCT03701555|560335231|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
155491679|NCT03992456|561225487|FG000|Overall Study|Disease progression|4|||
155246924|NCT03701555|560335232|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
155246925|NCT03701555|560335233|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
155246926|NCT03701555|560335234|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
155246927|NCT03701555|560335235|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
155246928|NCT03701555|560335236|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
155246929|NCT03701555|560335237|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
155246930|NCT03701555|560335238|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
155246931|NCT03701555|560335239|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
155246932|NCT03701555|560335240|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
155246933|NCT03701555|560335241|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
155246934|NCT03701555|560335242|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
155246935|NCT03701555|560335243|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
155246936|NCT03701555|560335244|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
155246937|NCT03701555|560335245|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
155246938|NCT03701555|560335210|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
155246939|NCT03701555|560335211|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
155246940|NCT03701555|560335212|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
155246941|NCT03701555|560335213|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
155246942|NCT03701555|560335214|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
155246943|NCT03701555|560335215|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
155246944|NCT03701555|560335216|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
155246945|NCT03701555|560335217|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
155246946|NCT03701555|560335218|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
155246947|NCT03701555|560335219|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
155246948|NCT03701555|560335220|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
155246949|NCT03701555|560335221|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
155246950|NCT03701555|560335222|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
155246951|NCT03701555|560335223|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
155246952|NCT03701555|560335224|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
155246953|NCT03701555|560335225|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
155246954|NCT03701555|560335226|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
155246955|NCT03701555|560335227|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
155246956|NCT03701555|560335228|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
155246957|NCT03701555|560335229|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
155246958|NCT03701555|560335230|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
155246959|NCT03701555|560335231|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
155246960|NCT03701555|560335232|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
155246961|NCT03701555|560335233|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
155246962|NCT03701555|560335234|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
155246963|NCT03701555|560335235|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
155246964|NCT03701555|560335236|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
155246965|NCT03701555|560335237|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
155246966|NCT03701555|560335238|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
155246967|NCT03701555|560335239|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
155246968|NCT03701555|560335240|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
155246969|NCT03701555|560335241|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
155246970|NCT03701555|560335242|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
155246971|NCT03701555|560335243|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
155246972|NCT03701555|560335244|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
155246973|NCT03701555|560335245|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
155246974|NCT03701555|560335210|FG000|Part 2 (Day 1)|Other|0|||
155246975|NCT03701555|560335211|FG001|Part 2 (Day 1)|Other|0|||
155246976|NCT03701555|560335212|FG002|Part 2 (Day 1)|Other|0|||
155246977|NCT03701555|560335213|FG003|Part 2 (Day 1)|Other|0|||
155246978|NCT03701555|560335214|FG004|Part 2 (Day 1)|Other|0|||
155246979|NCT03701555|560335215|FG005|Part 2 (Day 1)|Other|0|||
155246980|NCT03701555|560335216|FG006|Part 2 (Day 1)|Other|0|||
155246981|NCT03701555|560335217|FG007|Part 2 (Day 1)|Other|0|||
155246982|NCT03701555|560335218|FG008|Part 2 (Day 1)|Other|0|||
155246983|NCT03701555|560335219|FG009|Part 2 (Day 1)|Other|0|||
155246984|NCT03701555|560335220|FG010|Part 2 (Day 1)|Other|3|||
155246985|NCT03701555|560335221|FG011|Part 2 (Day 1)|Other|1|||
155246986|NCT03701555|560335222|FG012|Part 2 (Day 1)|Other|0|||
155246987|NCT03701555|560335223|FG013|Part 2 (Day 1)|Other|1|||
155246988|NCT03701555|560335224|FG014|Part 2 (Day 1)|Other|0|||
155246989|NCT03701555|560335225|FG015|Part 2 (Day 1)|Other|2|||
155246990|NCT03701555|560335226|FG016|Part 2 (Day 1)|Other|2|||
155246991|NCT03701555|560335227|FG017|Part 2 (Day 1)|Other|0|||
155246992|NCT03701555|560335228|FG018|Part 2 (Day 1)|Other|0|||
155246993|NCT03701555|560335229|FG019|Part 2 (Day 1)|Other|0|||
155246994|NCT03701555|560335230|FG020|Part 2 (Day 1)|Other|0|||
155246995|NCT03701555|560335231|FG021|Part 2 (Day 1)|Other|0|||
155246996|NCT03701555|560335232|FG022|Part 2 (Day 1)|Other|0|||
155246997|NCT03701555|560335233|FG023|Part 2 (Day 1)|Other|0|||
155246998|NCT03701555|560335234|FG024|Part 2 (Day 1)|Other|0|||
155246999|NCT03701555|560335235|FG025|Part 2 (Day 1)|Other|0|||
155247000|NCT03701555|560335236|FG026|Part 2 (Day 1)|Other|0|||
155247001|NCT03701555|560335237|FG027|Part 2 (Day 1)|Other|0|||
155247002|NCT03701555|560335238|FG028|Part 2 (Day 1)|Other|0|||
155247003|NCT03701555|560335239|FG029|Part 2 (Day 1)|Other|0|||
155247004|NCT03701555|560335240|FG030|Part 2 (Day 1)|Other|0|||
155247005|NCT03701555|560335241|FG031|Part 2 (Day 1)|Other|0|||
155247006|NCT03701555|560335242|FG032|Part 2 (Day 1)|Other|0|||
155247007|NCT03701555|560335243|FG033|Part 2 (Day 1)|Other|0|||
155247008|NCT03701555|560335244|FG034|Part 2 (Day 1)|Other|0|||
155247009|NCT03701555|560335245|FG035|Part 2 (Day 1)|Other|0|||
155247010|NCT03701555|560335210|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
155247011|NCT03701555|560335211|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
155247012|NCT03701555|560335212|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
155247013|NCT03701555|560335213|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
155247014|NCT03701555|560335214|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
155247015|NCT03701555|560335215|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
155247016|NCT03701555|560335216|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
155247017|NCT03701555|560335217|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
155247018|NCT03701555|560335218|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
155247019|NCT03701555|560335219|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
155247020|NCT03701555|560335220|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
155247021|NCT03701555|560335221|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
155247022|NCT03701555|560335222|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
155247023|NCT03701555|560335223|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
155247024|NCT03701555|560335224|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
155247025|NCT03701555|560335225|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
155247026|NCT03701555|560335226|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
155247027|NCT03701555|560335227|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
155247028|NCT03701555|560335228|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
155247029|NCT03701555|560335229|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
155247030|NCT03701555|560335230|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
155247031|NCT03701555|560335231|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
155247032|NCT03701555|560335232|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
155247033|NCT03701555|560335233|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
155247034|NCT03701555|560335234|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
155247035|NCT03701555|560335235|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
155247036|NCT03701555|560335236|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
155247037|NCT03701555|560335237|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
155247038|NCT03701555|560335238|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
155247039|NCT03701555|560335239|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
155247040|NCT03701555|560335240|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
155247041|NCT03701555|560335241|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
155247042|NCT03701555|560335242|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
155247043|NCT03701555|560335243|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
155247044|NCT03701555|560335244|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
155247045|NCT03701555|560335245|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
155247046|NCT03701555|560335210|FG000|Part 3 (Day 1)|Subject Decision|0|||
155247047|NCT03701555|560335211|FG001|Part 3 (Day 1)|Subject Decision|0|||
155247048|NCT03701555|560335212|FG002|Part 3 (Day 1)|Subject Decision|0|||
155247049|NCT03701555|560335213|FG003|Part 3 (Day 1)|Subject Decision|0|||
155247050|NCT03701555|560335214|FG004|Part 3 (Day 1)|Subject Decision|0|||
155247051|NCT03701555|560335215|FG005|Part 3 (Day 1)|Subject Decision|0|||
155247052|NCT03701555|560335216|FG006|Part 3 (Day 1)|Subject Decision|0|||
155247053|NCT03701555|560335217|FG007|Part 3 (Day 1)|Subject Decision|0|||
155247054|NCT03701555|560335218|FG008|Part 3 (Day 1)|Subject Decision|0|||
155247055|NCT03701555|560335219|FG009|Part 3 (Day 1)|Subject Decision|0|||
155247056|NCT03701555|560335220|FG010|Part 3 (Day 1)|Subject Decision|0|||
155247057|NCT03701555|560335221|FG011|Part 3 (Day 1)|Subject Decision|0|||
155247058|NCT03701555|560335222|FG012|Part 3 (Day 1)|Subject Decision|0|||
155247059|NCT03701555|560335223|FG013|Part 3 (Day 1)|Subject Decision|0|||
155247060|NCT03701555|560335224|FG014|Part 3 (Day 1)|Subject Decision|0|||
155247061|NCT03701555|560335225|FG015|Part 3 (Day 1)|Subject Decision|0|||
155247062|NCT03701555|560335226|FG016|Part 3 (Day 1)|Subject Decision|0|||
155247063|NCT03701555|560335227|FG017|Part 3 (Day 1)|Subject Decision|0|||
155247064|NCT03701555|560335228|FG018|Part 3 (Day 1)|Subject Decision|0|||
155247065|NCT03701555|560335229|FG019|Part 3 (Day 1)|Subject Decision|0|||
155247066|NCT03701555|560335230|FG020|Part 3 (Day 1)|Subject Decision|0|||
155247067|NCT03701555|560335231|FG021|Part 3 (Day 1)|Subject Decision|0|||
155247068|NCT03701555|560335232|FG022|Part 3 (Day 1)|Subject Decision|0|||
155247069|NCT03701555|560335233|FG023|Part 3 (Day 1)|Subject Decision|0|||
155247070|NCT03701555|560335234|FG024|Part 3 (Day 1)|Subject Decision|0|||
155247071|NCT03701555|560335235|FG025|Part 3 (Day 1)|Subject Decision|0|||
155247072|NCT03701555|560335236|FG026|Part 3 (Day 1)|Subject Decision|1|||
155247073|NCT03701555|560335237|FG027|Part 3 (Day 1)|Subject Decision|0|||
155247074|NCT03701555|560335238|FG028|Part 3 (Day 1)|Subject Decision|0|||
155247075|NCT03701555|560335239|FG029|Part 3 (Day 1)|Subject Decision|0|||
155247076|NCT03701555|560335240|FG030|Part 3 (Day 1)|Subject Decision|0|||
155247077|NCT03701555|560335241|FG031|Part 3 (Day 1)|Subject Decision|2|||
155247078|NCT03701555|560335242|FG032|Part 3 (Day 1)|Subject Decision|1|||
155247079|NCT03701555|560335243|FG033|Part 3 (Day 1)|Subject Decision|1|||
155247080|NCT03701555|560335244|FG034|Part 3 (Day 1)|Subject Decision|0|||
155247081|NCT03701555|560335245|FG035|Part 3 (Day 1)|Subject Decision|0|||
155247082|NCT03701555|560335210|FG000|Part 3 (Day 1)|Other|0|||
155247083|NCT03701555|560335211|FG001|Part 3 (Day 1)|Other|0|||
155247084|NCT03701555|560335212|FG002|Part 3 (Day 1)|Other|0|||
155247085|NCT03701555|560335213|FG003|Part 3 (Day 1)|Other|0|||
155247086|NCT03701555|560335214|FG004|Part 3 (Day 1)|Other|0|||
155247087|NCT03701555|560335215|FG005|Part 3 (Day 1)|Other|0|||
155247088|NCT03701555|560335216|FG006|Part 3 (Day 1)|Other|0|||
155247089|NCT03701555|560335217|FG007|Part 3 (Day 1)|Other|0|||
155247090|NCT03701555|560335218|FG008|Part 3 (Day 1)|Other|0|||
155247091|NCT03701555|560335219|FG009|Part 3 (Day 1)|Other|0|||
155247092|NCT03701555|560335220|FG010|Part 3 (Day 1)|Other|0|||
155247093|NCT03701555|560335221|FG011|Part 3 (Day 1)|Other|0|||
155247094|NCT03701555|560335222|FG012|Part 3 (Day 1)|Other|0|||
155247095|NCT03701555|560335223|FG013|Part 3 (Day 1)|Other|0|||
155247096|NCT03701555|560335224|FG014|Part 3 (Day 1)|Other|0|||
155247097|NCT03701555|560335225|FG015|Part 3 (Day 1)|Other|0|||
155247098|NCT03701555|560335226|FG016|Part 3 (Day 1)|Other|0|||
155247099|NCT03701555|560335227|FG017|Part 3 (Day 1)|Other|0|||
155247100|NCT03701555|560335228|FG018|Part 3 (Day 1)|Other|0|||
155247101|NCT03701555|560335229|FG019|Part 3 (Day 1)|Other|0|||
155247102|NCT03701555|560335230|FG020|Part 3 (Day 1)|Other|0|||
155247103|NCT03701555|560335231|FG021|Part 3 (Day 1)|Other|0|||
155247104|NCT03701555|560335232|FG022|Part 3 (Day 1)|Other|0|||
155247105|NCT03701555|560335233|FG023|Part 3 (Day 1)|Other|0|||
155247106|NCT03701555|560335234|FG024|Part 3 (Day 1)|Other|1|||
155247107|NCT03701555|560335235|FG025|Part 3 (Day 1)|Other|1|||
155247108|NCT03701555|560335236|FG026|Part 3 (Day 1)|Other|0|||
155247109|NCT03701555|560335237|FG027|Part 3 (Day 1)|Other|0|||
155247110|NCT03701555|560335238|FG028|Part 3 (Day 1)|Other|0|||
155247111|NCT03701555|560335239|FG029|Part 3 (Day 1)|Other|1|||
155247112|NCT03701555|560335240|FG030|Part 3 (Day 1)|Other|1|||
155247113|NCT03701555|560335241|FG031|Part 3 (Day 1)|Other|0|||
155247114|NCT03701555|560335242|FG032|Part 3 (Day 1)|Other|1|||
155247115|NCT03701555|560335243|FG033|Part 3 (Day 1)|Other|1|||
155247116|NCT03701555|560335244|FG034|Part 3 (Day 1)|Other|0|||
155247117|NCT03701555|560335245|FG035|Part 3 (Day 1)|Other|0|||
155247118|NCT04757649|560335246|FG000|Overall Study|Withdrawal by Subject|1|||
155247119|NCT04757649|560335246|FG000|Overall Study|Adverse Event|1|||
155247120|NCT02508311|560335251|FG000|Overall Study|Withdrawal by Subject|1|||
155247121|NCT02508311|560335252|FG001|Overall Study|Withdrawal by Subject|0|||
155247122|NCT04955639|560335253|FG000|Overall Study|Withdrawal by Subject|2|||
155247123|NCT04955639|560335254|FG001|Overall Study|Withdrawal by Subject|2|||
155247124|NCT04955639|560335253|FG000|Overall Study|Week 26 survey not completed|2|||
155247125|NCT04955639|560335254|FG001|Overall Study|Week 26 survey not completed|2|||
155247126|NCT04447404|560335255|FG000|Overall Study|Death|2|||
155247127|NCT04447404|560335256|FG001|Overall Study|Death|0|||
155247128|NCT00413153|560335257|FG000|Overall Study|Withdrawal by Subject|1|||
155247129|NCT00413153|560335258|FG001|Overall Study|Withdrawal by Subject|1|||
155247130|NCT00413153|560335257|FG000|Overall Study|Adverse Event|1|||
155247131|NCT00413153|560335258|FG001|Overall Study|Adverse Event|0|||
155247132|NCT00454051|560335261|FG000|Overall Study|Adverse Event|1|||
155247133|NCT00454051|560335262|FG001|Overall Study|Adverse Event|2|||
155247134|NCT00454051|560335261|FG000|Overall Study|Withdrawal by Subject|1|||
155247135|NCT00454051|560335262|FG001|Overall Study|Withdrawal by Subject|0|||
155247136|NCT00454051|560335261|FG000|Overall Study|Protocol Violation|1|||
155247137|NCT00454051|560335262|FG001|Overall Study|Protocol Violation|1|||
155247138|NCT02097472|560335263|FG000|Received Vaccination 2|Adverse Event|0|||
155247139|NCT02097472|560335264|FG001|Received Vaccination 2|Adverse Event|0|||
155247140|NCT02097472|560335265|FG002|Received Vaccination 2|Adverse Event|0|||
155247141|NCT02097472|560335266|FG003|Received Vaccination 2|Adverse Event|0|||
155247142|NCT02097472|560335267|FG004|Received Vaccination 2|Adverse Event|0|||
155247143|NCT02097472|560335268|FG005|Received Vaccination 2|Adverse Event|0|||
155247144|NCT02097472|560335269|FG006|Received Vaccination 2|Adverse Event|1|||
155247145|NCT02097472|560335270|FG007|Received Vaccination 2|Adverse Event|0|||
155247146|NCT02862106|560335273|FG000|Overall Study|Adverse Event|4|||
155247147|NCT02862106|560335274|FG001|Overall Study|Adverse Event|0|||
155247148|NCT02862106|560335273|FG000|Overall Study|Protocol Violation|16|||
155247149|NCT02862106|560335274|FG001|Overall Study|Protocol Violation|1|||
155247150|NCT02862106|560335273|FG000|Overall Study|Lost to Follow-up|15|||
155247151|NCT02862106|560335274|FG001|Overall Study|Lost to Follow-up|5|||
155247152|NCT02862106|560335273|FG000|Overall Study|Withdrawal by Subject|2|||
155247153|NCT02862106|560335274|FG001|Overall Study|Withdrawal by Subject|0|||
155247154|NCT02862106|560335273|FG000|Overall Study|Subjects moved to other city|1|||
155247155|NCT02862106|560335274|FG001|Overall Study|Subjects moved to other city|0|||
155247156|NCT03966157|560335275|FG000|Overall Study|Physician Decision|1|||
155247157|NCT03966157|560335276|FG001|Overall Study|Physician Decision|0|||
155247158|NCT01221597|560335279|FG000|Overall Study|Adverse Event|4|||
155247159|NCT01221597|560335280|FG001|Overall Study|Adverse Event|1|||
155247160|NCT01221597|560335279|FG000|Overall Study|Withdrawal by Subject|20|||
155247161|NCT01221597|560335280|FG001|Overall Study|Withdrawal by Subject|6|||
155247162|NCT01221597|560335279|FG000|Overall Study|Lost to Follow-up|6|||
155247163|NCT01221597|560335280|FG001|Overall Study|Lost to Follow-up|5|||
155247164|NCT01221597|560335279|FG000|Overall Study|Protocol Violation|1|||
155247165|NCT01221597|560335280|FG001|Overall Study|Protocol Violation|0|||
155247166|NCT01221597|560335279|FG000|Overall Study|Other|3|||
155247167|NCT01221597|560335280|FG001|Overall Study|Other|4|||
155247168|NCT01221597|560335279|FG000|Overall Study|Death|2|||
155247169|NCT01221597|560335280|FG001|Overall Study|Death|0|||
155247170|NCT03305016|560335281|FG000|Overall Study|Withdrawal by Subject|2|||
155247171|NCT04420689|560335283|FG000|Overall Study|COVID-19 related hospitalization|0|||
155247172|NCT04420689|560335284|FG001|Overall Study|COVID-19 related hospitalization|0|||
155247173|NCT04420689|560335285|FG002|Overall Study|COVID-19 related hospitalization|0|||
155247174|NCT04420689|560335286|FG003|Overall Study|COVID-19 related hospitalization|0|||
155247175|NCT04420689|560335287|FG004|Overall Study|COVID-19 related hospitalization|1|||
155247176|NCT04420689|560335288|FG005|Overall Study|COVID-19 related hospitalization|0|||
155247177|NCT04420689|560335289|FG006|Overall Study|COVID-19 related hospitalization|0|||
155247178|NCT04420689|560335283|FG000|Overall Study|Physician Decision|0|||
155247179|NCT04420689|560335284|FG001|Overall Study|Physician Decision|0|||
155247180|NCT04420689|560335285|FG002|Overall Study|Physician Decision|0|||
155247181|NCT04420689|560335286|FG003|Overall Study|Physician Decision|0|||
155247182|NCT04420689|560335287|FG004|Overall Study|Physician Decision|0|||
155247183|NCT04420689|560335288|FG005|Overall Study|Physician Decision|1|||
155247184|NCT04420689|560335289|FG006|Overall Study|Physician Decision|0|||
155247185|NCT02278328|560335295|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
155247186|NCT02278328|560335296|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
155247187|NCT02278328|560335297|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
155247188|NCT02278328|560335295|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
155247189|NCT02278328|560335296|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
155247190|NCT02278328|560335297|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
155247191|NCT02278328|560335295|FG000|Neuropsych Screening|incomplete consent|0|||
155247192|NCT02278328|560335296|FG001|Neuropsych Screening|incomplete consent|0|||
155247193|NCT02278328|560335297|FG002|Neuropsych Screening|incomplete consent|2|||
155247194|NCT00377676|560335298|FG000|Overall Study|Adverse Event|498|||
155247195|NCT00377676|560335299|FG001|Overall Study|Adverse Event|107|||
155247196|NCT00377676|560335298|FG000|Overall Study|Protocol Violation|33|||
155247197|NCT00377676|560335299|FG001|Overall Study|Protocol Violation|27|||
155247198|NCT00377676|560335298|FG000|Overall Study|Death|5|||
155247199|NCT00377676|560335299|FG001|Overall Study|Death|2|||
155247200|NCT00377676|560335298|FG000|Overall Study|Withdrawal by Subject|187|||
155247201|NCT00377676|560335299|FG001|Overall Study|Withdrawal by Subject|72|||
155247202|NCT00377676|560335298|FG000|Overall Study|Lost to Follow-up|120|||
155247203|NCT00377676|560335299|FG001|Overall Study|Lost to Follow-up|56|||
155247204|NCT00377676|560335298|FG000|Overall Study|Other|118|||
155247205|NCT00377676|560335299|FG001|Overall Study|Other|58|||
155247206|NCT03834779|560335300|FG000|Overall Study|Death|1|||
155247207|NCT03834779|560335301|FG001|Overall Study|Death|2|||
155247208|NCT03834779|560335300|FG000|Overall Study|Lost to Follow-up|6|||
155247209|NCT03834779|560335301|FG001|Overall Study|Lost to Follow-up|4|||
155247210|NCT01519206|560335307|FG000|Overall Study|Lost to Follow-up|3|||
155247211|NCT01519206|560335307|FG000|Overall Study|Missed Visit|2|||
155247212|NCT02014116|560335308|FG000|Overall Study|Progressive Disease|3|||
155247213|NCT02014116|560335309|FG001|Overall Study|Progressive Disease|4|||
155247214|NCT02014116|560335310|FG002|Overall Study|Progressive Disease|2|||
155247215|NCT02014116|560335311|FG003|Overall Study|Progressive Disease|6|||
155247216|NCT02014116|560335312|FG004|Overall Study|Progressive Disease|1|||
155247217|NCT02014116|560335313|FG005|Overall Study|Progressive Disease|13|||
155247218|NCT02014116|560335314|FG006|Overall Study|Progressive Disease|1|||
155247219|NCT02014116|560335315|FG007|Overall Study|Progressive Disease|3|||
155247220|NCT02014116|560335316|FG008|Overall Study|Progressive Disease|7|||
155247221|NCT02014116|560335308|FG000|Overall Study|Adverse Event|0|||
155247222|NCT02014116|560335309|FG001|Overall Study|Adverse Event|0|||
155247223|NCT02014116|560335310|FG002|Overall Study|Adverse Event|0|||
155247224|NCT02014116|560335311|FG003|Overall Study|Adverse Event|0|||
155247225|NCT02014116|560335312|FG004|Overall Study|Adverse Event|1|||
155247226|NCT02014116|560335313|FG005|Overall Study|Adverse Event|0|||
155247227|NCT02014116|560335314|FG006|Overall Study|Adverse Event|0|||
155247228|NCT02014116|560335315|FG007|Overall Study|Adverse Event|1|||
155247229|NCT02014116|560335316|FG008|Overall Study|Adverse Event|0|||
155247230|NCT02014116|560335308|FG000|Overall Study|Lost to Follow-up|0|||
155247231|NCT02014116|560335309|FG001|Overall Study|Lost to Follow-up|0|||
155247232|NCT02014116|560335310|FG002|Overall Study|Lost to Follow-up|0|||
155247233|NCT02014116|560335311|FG003|Overall Study|Lost to Follow-up|0|||
155247234|NCT02014116|560335312|FG004|Overall Study|Lost to Follow-up|0|||
155247235|NCT02014116|560335313|FG005|Overall Study|Lost to Follow-up|1|||
155247236|NCT02014116|560335314|FG006|Overall Study|Lost to Follow-up|0|||
155247237|NCT02014116|560335315|FG007|Overall Study|Lost to Follow-up|0|||
155247238|NCT02014116|560335316|FG008|Overall Study|Lost to Follow-up|1|||
155247239|NCT02014116|560335308|FG000|Overall Study|Death|0|||
155247240|NCT02014116|560335309|FG001|Overall Study|Death|0|||
155247241|NCT02014116|560335310|FG002|Overall Study|Death|0|||
155247242|NCT02014116|560335311|FG003|Overall Study|Death|0|||
155247243|NCT02014116|560335312|FG004|Overall Study|Death|0|||
155247244|NCT02014116|560335313|FG005|Overall Study|Death|0|||
155247245|NCT02014116|560335314|FG006|Overall Study|Death|0|||
155247246|NCT02014116|560335315|FG007|Overall Study|Death|1|||
155247247|NCT02014116|560335316|FG008|Overall Study|Death|1|||
155247248|NCT02014116|560335308|FG000|Overall Study|Withdrawal by Subject|0|||
155247249|NCT02014116|560335309|FG001|Overall Study|Withdrawal by Subject|0|||
155247250|NCT02014116|560335310|FG002|Overall Study|Withdrawal by Subject|1|||
155247251|NCT02014116|560335311|FG003|Overall Study|Withdrawal by Subject|1|||
155247252|NCT02014116|560335312|FG004|Overall Study|Withdrawal by Subject|0|||
155247253|NCT02014116|560335313|FG005|Overall Study|Withdrawal by Subject|1|||
155247254|NCT02014116|560335314|FG006|Overall Study|Withdrawal by Subject|0|||
155247255|NCT02014116|560335315|FG007|Overall Study|Withdrawal by Subject|0|||
155247256|NCT02014116|560335316|FG008|Overall Study|Withdrawal by Subject|0|||
155247257|NCT02014116|560335308|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
155247258|NCT02014116|560335309|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
155247259|NCT02014116|560335310|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
155247260|NCT02014116|560335311|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
155247261|NCT02014116|560335312|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
155247262|NCT02014116|560335313|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
155247263|NCT02014116|560335314|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
155247264|NCT02014116|560335315|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
155247265|NCT02014116|560335316|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
155247266|NCT02014116|560335308|FG000|Overall Study|Physician Decision|0|||
155247267|NCT02014116|560335309|FG001|Overall Study|Physician Decision|0|||
155247268|NCT02014116|560335310|FG002|Overall Study|Physician Decision|0|||
155247269|NCT02014116|560335311|FG003|Overall Study|Physician Decision|0|||
155247270|NCT02014116|560335312|FG004|Overall Study|Physician Decision|0|||
155247271|NCT02014116|560335313|FG005|Overall Study|Physician Decision|0|||
155247272|NCT02014116|560335314|FG006|Overall Study|Physician Decision|0|||
155247273|NCT02014116|560335315|FG007|Overall Study|Physician Decision|0|||
155247274|NCT02014116|560335316|FG008|Overall Study|Physician Decision|1|||
155247275|NCT01040130|560335320|FG000|Overall Study|Adverse Event|1|||
155247276|NCT01040130|560335321|FG001|Overall Study|Adverse Event|1|||
155247277|NCT01040130|560335322|FG002|Overall Study|Adverse Event|0|||
155247278|NCT01040130|560335323|FG003|Overall Study|Adverse Event|5|||
155247279|NCT01040130|560335324|FG004|Overall Study|Adverse Event|0|||
155247280|NCT01040130|560335325|FG005|Overall Study|Adverse Event|3|||
155247281|NCT01040130|560335320|FG000|Overall Study|Protocol Violation|0|||
155247282|NCT01040130|560335321|FG001|Overall Study|Protocol Violation|0|||
155247283|NCT01040130|560335322|FG002|Overall Study|Protocol Violation|2|||
155247284|NCT01040130|560335323|FG003|Overall Study|Protocol Violation|0|||
155247285|NCT01040130|560335324|FG004|Overall Study|Protocol Violation|0|||
155247286|NCT01040130|560335325|FG005|Overall Study|Protocol Violation|0|||
155247287|NCT01040130|560335320|FG000|Overall Study|Withdrawal by Subject|0|||
155247288|NCT01040130|560335321|FG001|Overall Study|Withdrawal by Subject|2|||
155247289|NCT01040130|560335322|FG002|Overall Study|Withdrawal by Subject|0|||
155247290|NCT01040130|560335323|FG003|Overall Study|Withdrawal by Subject|0|||
155247291|NCT01040130|560335324|FG004|Overall Study|Withdrawal by Subject|0|||
155247292|NCT01040130|560335325|FG005|Overall Study|Withdrawal by Subject|1|||
155247293|NCT01040130|560335320|FG000|Overall Study|Other reasons not listed above|2|||
155247294|NCT01040130|560335321|FG001|Overall Study|Other reasons not listed above|0|||
155247295|NCT01040130|560335322|FG002|Overall Study|Other reasons not listed above|0|||
155247296|NCT01040130|560335323|FG003|Overall Study|Other reasons not listed above|0|||
155247297|NCT01040130|560335324|FG004|Overall Study|Other reasons not listed above|0|||
155247298|NCT01040130|560335325|FG005|Overall Study|Other reasons not listed above|0|||
155247299|NCT01618864|560335331|FG000|Overall Study|Withdrawal by Subject|2|||
155247300|NCT01618864|560335331|FG000|Overall Study|Lost to Follow-up|2|||
155247301|NCT01109992|560335332|FG000|Overall Study|Withdrawal by Subject|0|||
155247302|NCT01109992|560335333|FG001|Overall Study|Withdrawal by Subject|1|||
155247303|NCT01109992|560335332|FG000|Overall Study|Movement during rest scan.|0|||
155247304|NCT01109992|560335333|FG001|Overall Study|Movement during rest scan.|1|||
155247305|NCT00690755|560335336|FG000|Overall Study|Physician Decision|2|||
155247306|NCT00690755|560335337|FG001|Overall Study|Physician Decision|0|||
155247307|NCT00690755|560335338|FG002|Overall Study|Physician Decision|46|||
155247308|NCT00690755|560335339|FG003|Overall Study|Physician Decision|5|||
155247309|NCT00690755|560335340|FG004|Overall Study|Physician Decision|0|||
155247310|NCT00690755|560335341|FG005|Overall Study|Physician Decision|4|||
155247311|NCT00690755|560335342|FG006|Overall Study|Physician Decision|0|||
155247312|NCT04287920|560335343|FG000|Overall Study|Lost to Follow-up|1|||
155247313|NCT04287920|560335344|FG001|Overall Study|Lost to Follow-up|1|||
155247314|NCT04287920|560335343|FG000|Overall Study|Withdrawal by Subject|0|||
155247315|NCT04287920|560335344|FG001|Overall Study|Withdrawal by Subject|3|||
155247316|NCT02952924|560335347|FG000|Overall Study|Protocol Violation|0|||
155247317|NCT02952924|560335348|FG001|Overall Study|Protocol Violation|0|||
155247318|NCT02952924|560335349|FG002|Overall Study|Protocol Violation|0|||
155247319|NCT02952924|560335350|FG003|Overall Study|Protocol Violation|0|||
155247320|NCT02952924|560335351|FG004|Overall Study|Protocol Violation|0|||
155247321|NCT02952924|560335352|FG005|Overall Study|Protocol Violation|0|||
155247322|NCT02952924|560335353|FG006|Overall Study|Protocol Violation|0|||
155247323|NCT02952924|560335354|FG007|Overall Study|Protocol Violation|0|||
155247324|NCT02952924|560335355|FG008|Overall Study|Protocol Violation|0|||
155247325|NCT02952924|560335356|FG009|Overall Study|Protocol Violation|0|||
155247326|NCT02952924|560335357|FG010|Overall Study|Protocol Violation|0|||
155247327|NCT02952924|560335358|FG011|Overall Study|Protocol Violation|0|||
155247328|NCT02952924|560335359|FG012|Overall Study|Protocol Violation|0|||
155247329|NCT02952924|560335360|FG013|Overall Study|Protocol Violation|0|||
155247330|NCT02952924|560335361|FG014|Overall Study|Protocol Violation|0|||
155247331|NCT02952924|560335362|FG015|Overall Study|Protocol Violation|0|||
155247332|NCT02952924|560335363|FG016|Overall Study|Protocol Violation|0|||
155247333|NCT02952924|560335364|FG017|Overall Study|Protocol Violation|0|||
155247334|NCT02952924|560335365|FG018|Overall Study|Protocol Violation|0|||
155247335|NCT02952924|560335366|FG019|Overall Study|Protocol Violation|1|||
155247336|NCT02952924|560335367|FG020|Overall Study|Protocol Violation|0|||
155247337|NCT02952924|560335368|FG021|Overall Study|Protocol Violation|0|||
155247338|NCT02952924|560335347|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
155247339|NCT02952924|560335348|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
155247340|NCT02952924|560335349|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
155247341|NCT02952924|560335350|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
155247342|NCT02952924|560335351|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
155247343|NCT02952924|560335352|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
155247344|NCT02952924|560335353|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
155247345|NCT02952924|560335354|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
155247346|NCT02952924|560335355|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
155247347|NCT02952924|560335356|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
155247348|NCT02952924|560335357|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
155247349|NCT02952924|560335358|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
155247350|NCT02952924|560335359|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
155247351|NCT02952924|560335360|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
155247352|NCT02952924|560335361|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
155247353|NCT02952924|560335362|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
155247354|NCT02952924|560335363|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
155247355|NCT02952924|560335364|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
155247356|NCT02952924|560335365|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
155247357|NCT02952924|560335366|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
155247358|NCT02952924|560335367|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
155247359|NCT02952924|560335368|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
155247360|NCT02952924|560335347|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247361|NCT02952924|560335348|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247362|NCT02952924|560335349|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247363|NCT02952924|560335350|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247364|NCT02952924|560335351|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247365|NCT02952924|560335352|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247366|NCT02952924|560335353|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247367|NCT02952924|560335354|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247368|NCT02952924|560335355|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247369|NCT02952924|560335356|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247370|NCT02952924|560335357|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247371|NCT02952924|560335358|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247372|NCT02952924|560335359|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247373|NCT02952924|560335360|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247374|NCT02952924|560335361|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247375|NCT02952924|560335362|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247376|NCT02952924|560335363|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247377|NCT02952924|560335364|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247378|NCT02952924|560335365|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247379|NCT02952924|560335366|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247380|NCT02952924|560335367|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247381|NCT02952924|560335368|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
155247382|NCT02952924|560335347|FG000|Overall Study|Noncompliance with study drug|0|||
155247383|NCT02952924|560335348|FG001|Overall Study|Noncompliance with study drug|0|||
155247384|NCT02952924|560335349|FG002|Overall Study|Noncompliance with study drug|0|||
155247385|NCT02952924|560335350|FG003|Overall Study|Noncompliance with study drug|0|||
155247386|NCT02952924|560335351|FG004|Overall Study|Noncompliance with study drug|0|||
155491680|NCT03992456|561225488|FG001|Overall Study|Disease progression|5|||
155247387|NCT02952924|560335352|FG005|Overall Study|Noncompliance with study drug|0|||
155247388|NCT02952924|560335353|FG006|Overall Study|Noncompliance with study drug|0|||
155247389|NCT02952924|560335354|FG007|Overall Study|Noncompliance with study drug|0|||
155247390|NCT02952924|560335355|FG008|Overall Study|Noncompliance with study drug|0|||
155247391|NCT02952924|560335356|FG009|Overall Study|Noncompliance with study drug|0|||
155247392|NCT02952924|560335357|FG010|Overall Study|Noncompliance with study drug|0|||
155247393|NCT02952924|560335358|FG011|Overall Study|Noncompliance with study drug|0|||
155247394|NCT02952924|560335359|FG012|Overall Study|Noncompliance with study drug|0|||
155247395|NCT02952924|560335360|FG013|Overall Study|Noncompliance with study drug|0|||
155247396|NCT02952924|560335361|FG014|Overall Study|Noncompliance with study drug|0|||
155247397|NCT02952924|560335362|FG015|Overall Study|Noncompliance with study drug|0|||
155247398|NCT02952924|560335363|FG016|Overall Study|Noncompliance with study drug|0|||
155247399|NCT02952924|560335364|FG017|Overall Study|Noncompliance with study drug|0|||
155247400|NCT02952924|560335365|FG018|Overall Study|Noncompliance with study drug|0|||
155247401|NCT02952924|560335366|FG019|Overall Study|Noncompliance with study drug|0|||
155247402|NCT02952924|560335367|FG020|Overall Study|Noncompliance with study drug|0|||
155247403|NCT02952924|560335368|FG021|Overall Study|Noncompliance with study drug|1|||
155247404|NCT01435577|560335371|FG000|Overall Study|Adverse Event|10|||
155247405|NCT01435577|560335372|FG001|Overall Study|Adverse Event|0|||
155247406|NCT01435577|560335371|FG000|Overall Study|Lack of Efficacy|7|||
155247407|NCT01435577|560335372|FG001|Overall Study|Lack of Efficacy|51|||
155247408|NCT01435577|560335371|FG000|Overall Study|Alternative treatment started|0|||
155247409|NCT01435577|560335372|FG001|Overall Study|Alternative treatment started|1|||
155247410|NCT03585244|560335373|FG000|Overall Study|Withdrawal by Subject|15|||
155247411|NCT01934218|560335375|FG000|Double-blind Phase|Adverse Event|8|||
155247412|NCT01934218|560335376|FG001|Double-blind Phase|Adverse Event|8|||
155247413|NCT01934218|560335375|FG000|Double-blind Phase|Lack of Efficacy|6|||
155247414|NCT01934218|560335376|FG001|Double-blind Phase|Lack of Efficacy|7|||
155247415|NCT01934218|560335375|FG000|Double-blind Phase|Lost to Follow-up|7|||
155247416|NCT01934218|560335376|FG001|Double-blind Phase|Lost to Follow-up|14|||
155247417|NCT01934218|560335375|FG000|Double-blind Phase|Physician Decision|1|||
155247418|NCT01934218|560335376|FG001|Double-blind Phase|Physician Decision|2|||
155247419|NCT01934218|560335375|FG000|Double-blind Phase|Protocol Violation|4|||
155247420|NCT01934218|560335376|FG001|Double-blind Phase|Protocol Violation|0|||
155247421|NCT01934218|560335375|FG000|Double-blind Phase|Withdrawal by Subject|16|||
155247422|NCT01934218|560335376|FG001|Double-blind Phase|Withdrawal by Subject|13|||
155247423|NCT01934218|560335375|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
155247424|NCT01934218|560335376|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
155247425|NCT01934218|560335375|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
155247426|NCT01934218|560335376|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
155247427|NCT01934218|560335375|FG000|Open-Label Phase|Adverse Event|2|||
155247428|NCT01934218|560335376|FG001|Open-Label Phase|Adverse Event|4|||
155247429|NCT01934218|560335375|FG000|Open-Label Phase|Lack of Efficacy|1|||
155247430|NCT01934218|560335376|FG001|Open-Label Phase|Lack of Efficacy|4|||
155247431|NCT01934218|560335375|FG000|Open-Label Phase|Lost to Follow-up|4|||
155247432|NCT01934218|560335376|FG001|Open-Label Phase|Lost to Follow-up|2|||
155247433|NCT01934218|560335375|FG000|Open-Label Phase|Physician Decision|1|||
155247434|NCT01934218|560335376|FG001|Open-Label Phase|Physician Decision|0|||
155247435|NCT01934218|560335375|FG000|Open-Label Phase|Protocol Violation|1|||
155247436|NCT01934218|560335376|FG001|Open-Label Phase|Protocol Violation|0|||
155247437|NCT01934218|560335375|FG000|Open-Label Phase|Withdrawal by Subject|13|||
155247438|NCT01934218|560335376|FG001|Open-Label Phase|Withdrawal by Subject|11|||
155247439|NCT01934218|560335375|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
155247440|NCT01934218|560335376|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
155247441|NCT01934218|560335375|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
155247442|NCT01934218|560335376|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
155247443|NCT03273946|560335381|FG000|Overall Study|Withdrawal by Subject|5|||
155247444|NCT03273946|560335381|FG000|Overall Study|Unwillingness of the guardian|1|||
155247445|NCT03273946|560335381|FG000|Overall Study|Participant refused to use the drug|2|||
155247446|NCT03273946|560335381|FG000|Overall Study|Participant relative refused to use drug|1|||
155247447|NCT01220557|560335382|FG000|Overall Study|Lost to Follow-up|5|||
155247448|NCT01220557|560335383|FG001|Overall Study|Lost to Follow-up|3|||
155247449|NCT01220557|560335382|FG000|Overall Study|attended less than 6 lessons|1|||
155247450|NCT01220557|560335383|FG001|Overall Study|attended less than 6 lessons|2|||
155247451|NCT02199028|560335388|FG000|Week 1|Adverse Event|1|||
155247452|NCT02199028|560335389|FG001|Week 1|Adverse Event|0|||
155247453|NCT02199028|560335388|FG000|Week 3|Adverse Event|1|||
155247454|NCT02199028|560335389|FG001|Week 3|Adverse Event|0|||
155247455|NCT01881126|560335392|FG000|Overall Study|Non-compliance|1|||
155247456|NCT01881126|560335393|FG001|Overall Study|Non-compliance|1|||
155247457|NCT01881126|560335392|FG000|Overall Study|Adverse Event|0|||
155247458|NCT01881126|560335393|FG001|Overall Study|Adverse Event|1|||
155247459|NCT01983293|560338261|FG000|Overall Study|Withdrawal by Subject|29|||
155247460|NCT01983293|560338262|FG001|Overall Study|Withdrawal by Subject|15|||
155247461|NCT01983293|560338261|FG000|Overall Study|Missing 12-month visit|3|||
155247462|NCT01983293|560338262|FG001|Overall Study|Missing 12-month visit|3|||
155247463|NCT01983293|560338261|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
155247464|NCT01983293|560338262|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
155247465|NCT03147248|560338263|FG000|Overall Study|Adverse Event|0|||
155247466|NCT03147248|560338264|FG001|Overall Study|Adverse Event|2|||
155247467|NCT03147248|560338265|FG002|Overall Study|Adverse Event|2|||
155247468|NCT03147248|560338266|FG003|Overall Study|Adverse Event|2|||
155247469|NCT03147248|560338267|FG004|Overall Study|Adverse Event|6|||
155247470|NCT03147248|560338268|FG005|Overall Study|Adverse Event|11|||
155247471|NCT03147248|560338263|FG000|Overall Study|Disease progression|1|||
155247472|NCT03147248|560338264|FG001|Overall Study|Disease progression|0|||
155247473|NCT03147248|560338265|FG002|Overall Study|Disease progression|0|||
155247474|NCT03147248|560338266|FG003|Overall Study|Disease progression|0|||
155247475|NCT03147248|560338267|FG004|Overall Study|Disease progression|0|||
155247476|NCT03147248|560338268|FG005|Overall Study|Disease progression|2|||
155247477|NCT03147248|560338263|FG000|Overall Study|Withdrawal by Subject|0|||
155247478|NCT03147248|560338264|FG001|Overall Study|Withdrawal by Subject|0|||
155247479|NCT03147248|560338265|FG002|Overall Study|Withdrawal by Subject|0|||
155247480|NCT03147248|560338266|FG003|Overall Study|Withdrawal by Subject|0|||
155247481|NCT03147248|560338267|FG004|Overall Study|Withdrawal by Subject|12|||
155247482|NCT03147248|560338268|FG005|Overall Study|Withdrawal by Subject|9|||
155247483|NCT03147248|560338263|FG000|Overall Study|Protocol Violation|0|||
155247484|NCT03147248|560338264|FG001|Overall Study|Protocol Violation|0|||
155247485|NCT03147248|560338265|FG002|Overall Study|Protocol Violation|0|||
155247486|NCT03147248|560338266|FG003|Overall Study|Protocol Violation|0|||
155247487|NCT03147248|560338267|FG004|Overall Study|Protocol Violation|2|||
155247488|NCT03147248|560338268|FG005|Overall Study|Protocol Violation|0|||
155247489|NCT03147248|560338263|FG000|Overall Study|Lost to Follow-up|0|||
155247490|NCT03147248|560338264|FG001|Overall Study|Lost to Follow-up|0|||
155247491|NCT03147248|560338265|FG002|Overall Study|Lost to Follow-up|0|||
155247492|NCT03147248|560338266|FG003|Overall Study|Lost to Follow-up|0|||
155247493|NCT03147248|560338267|FG004|Overall Study|Lost to Follow-up|2|||
155247494|NCT03147248|560338268|FG005|Overall Study|Lost to Follow-up|0|||
155247495|NCT03147248|560338263|FG000|Overall Study|Pregnancy|0|||
155247496|NCT03147248|560338264|FG001|Overall Study|Pregnancy|0|||
155247497|NCT03147248|560338265|FG002|Overall Study|Pregnancy|0|||
155247498|NCT03147248|560338266|FG003|Overall Study|Pregnancy|0|||
155247499|NCT03147248|560338267|FG004|Overall Study|Pregnancy|1|||
155247500|NCT03147248|560338268|FG005|Overall Study|Pregnancy|0|||
155247501|NCT03147248|560338263|FG000|Overall Study|Death|0|||
155247502|NCT03147248|560338264|FG001|Overall Study|Death|0|||
155247503|NCT03147248|560338265|FG002|Overall Study|Death|0|||
155247504|NCT03147248|560338266|FG003|Overall Study|Death|0|||
155247505|NCT03147248|560338267|FG004|Overall Study|Death|0|||
155247506|NCT03147248|560338268|FG005|Overall Study|Death|4|||
155247507|NCT03147248|560338263|FG000|Overall Study|Physician Decision|0|||
155247508|NCT03147248|560338264|FG001|Overall Study|Physician Decision|0|||
155247509|NCT03147248|560338265|FG002|Overall Study|Physician Decision|0|||
155247510|NCT03147248|560338266|FG003|Overall Study|Physician Decision|0|||
155247511|NCT03147248|560338267|FG004|Overall Study|Physician Decision|2|||
155247512|NCT03147248|560338268|FG005|Overall Study|Physician Decision|4|||
155247513|NCT03147248|560338263|FG000|Overall Study|Prolonged Dosing Interval|0|||
155247514|NCT03147248|560338264|FG001|Overall Study|Prolonged Dosing Interval|0|||
155247515|NCT03147248|560338265|FG002|Overall Study|Prolonged Dosing Interval|0|||
155247516|NCT03147248|560338266|FG003|Overall Study|Prolonged Dosing Interval|0|||
155247517|NCT03147248|560338267|FG004|Overall Study|Prolonged Dosing Interval|1|||
155247518|NCT03147248|560338268|FG005|Overall Study|Prolonged Dosing Interval|1|||
155247519|NCT03750552|560338269|FG000|Overall Study|Adverse Event|5|||
155247520|NCT03750552|560338270|FG001|Overall Study|Adverse Event|1|||
155247521|NCT03750552|560338269|FG000|Overall Study|Withdrawal by Subject|1|||
155247522|NCT03750552|560338270|FG001|Overall Study|Withdrawal by Subject|1|||
155247523|NCT03750552|560338269|FG000|Overall Study|Other|2|||
155247524|NCT03750552|560338270|FG001|Overall Study|Other|0|||
155247525|NCT02062632|560338271|FG000|Overall Study|No treatment data|1|||
155247526|NCT00773968|560338273|FG000|Overall Study|Adverse Event|2|||
155247527|NCT00773968|560338273|FG000|Overall Study|Death|1|||
155247528|NCT00773968|560338273|FG000|Overall Study|Failure to Return|2|||
155247529|NCT00773968|560338273|FG000|Overall Study|Lack of Efficacy|3|||
155247530|NCT00773968|560338273|FG000|Overall Study|Protocol Violation|1|||
155247531|NCT00773968|560338273|FG000|Overall Study|Withdrawal by Subject|11|||
155247532|NCT00773968|560338273|FG000|Overall Study|Screen Failure|17|||
155247533|NCT00773968|560338273|FG000|Overall Study|Other|8|||
155247534|NCT02008890|560338277|FG000|Period 1|Withdrawal by Subject|7|||
155247535|NCT02008890|560338278|FG001|Period 1|Withdrawal by Subject|7|||
155247536|NCT02008890|560338279|FG002|Period 1|Withdrawal by Subject|5|||
155247537|NCT02008890|560338280|FG003|Period 1|Withdrawal by Subject|0|||
155247538|NCT02008890|560338281|FG004|Period 1|Withdrawal by Subject|0|||
155247539|NCT02008890|560338277|FG000|Period 1|Pregnancy|1|||
155247540|NCT02008890|560338278|FG001|Period 1|Pregnancy|0|||
155247541|NCT02008890|560338279|FG002|Period 1|Pregnancy|0|||
155247542|NCT02008890|560338280|FG003|Period 1|Pregnancy|0|||
155247543|NCT02008890|560338281|FG004|Period 1|Pregnancy|0|||
155247544|NCT02008890|560338277|FG000|Period 1|Physician Decision|1|||
155247545|NCT02008890|560338278|FG001|Period 1|Physician Decision|0|||
155247546|NCT02008890|560338279|FG002|Period 1|Physician Decision|1|||
155247547|NCT02008890|560338280|FG003|Period 1|Physician Decision|0|||
155247548|NCT02008890|560338281|FG004|Period 1|Physician Decision|0|||
155247549|NCT02008890|560338277|FG000|Period 1|Adverse Event|6|||
155247550|NCT02008890|560338278|FG001|Period 1|Adverse Event|8|||
155247551|NCT02008890|560338279|FG002|Period 1|Adverse Event|6|||
155247552|NCT02008890|560338280|FG003|Period 1|Adverse Event|0|||
155247553|NCT02008890|560338281|FG004|Period 1|Adverse Event|0|||
155247554|NCT02008890|560338277|FG000|Period 2|Adverse Event|12|||
155247555|NCT02008890|560338278|FG001|Period 2|Adverse Event|7|||
155247556|NCT02008890|560338279|FG002|Period 2|Adverse Event|0|||
155247557|NCT02008890|560338280|FG003|Period 2|Adverse Event|5|||
155247558|NCT02008890|560338281|FG004|Period 2|Adverse Event|5|||
155247559|NCT02008890|560338277|FG000|Period 2|Withdrawal by Subject|11|||
155247560|NCT02008890|560338278|FG001|Period 2|Withdrawal by Subject|8|||
155247561|NCT02008890|560338279|FG002|Period 2|Withdrawal by Subject|0|||
155247562|NCT02008890|560338280|FG003|Period 2|Withdrawal by Subject|7|||
155247563|NCT02008890|560338281|FG004|Period 2|Withdrawal by Subject|2|||
155247564|NCT02008890|560338277|FG000|Period 2|Physician Decision|4|||
155247565|NCT02008890|560338278|FG001|Period 2|Physician Decision|0|||
155247566|NCT02008890|560338279|FG002|Period 2|Physician Decision|0|||
155247567|NCT02008890|560338280|FG003|Period 2|Physician Decision|2|||
155247568|NCT02008890|560338281|FG004|Period 2|Physician Decision|1|||
155247569|NCT02008890|560338277|FG000|Period 2|Lost to Follow-up|0|||
155247570|NCT02008890|560338278|FG001|Period 2|Lost to Follow-up|0|||
155247571|NCT02008890|560338279|FG002|Period 2|Lost to Follow-up|1|||
155247572|NCT02008890|560338280|FG003|Period 2|Lost to Follow-up|0|||
155247573|NCT02008890|560338281|FG004|Period 2|Lost to Follow-up|0|||
155247574|NCT02008890|560338277|FG000|Extension Period|Withdrawal by Subject|3|||
155247575|NCT02008890|560338278|FG001|Extension Period|Withdrawal by Subject|2|||
155247576|NCT02008890|560338279|FG002|Extension Period|Withdrawal by Subject|0|||
155247577|NCT02008890|560338280|FG003|Extension Period|Withdrawal by Subject|4|||
155247578|NCT02008890|560338281|FG004|Extension Period|Withdrawal by Subject|2|||
155247579|NCT02008890|560338277|FG000|Extension Period|Lost to Follow-up|1|||
155247580|NCT02008890|560338278|FG001|Extension Period|Lost to Follow-up|0|||
155247581|NCT02008890|560338279|FG002|Extension Period|Lost to Follow-up|0|||
155247582|NCT02008890|560338280|FG003|Extension Period|Lost to Follow-up|0|||
155247583|NCT02008890|560338281|FG004|Extension Period|Lost to Follow-up|0|||
155247584|NCT02008890|560338277|FG000|Extension Period|Adverse Event|1|||
155247585|NCT02008890|560338278|FG001|Extension Period|Adverse Event|3|||
155247586|NCT02008890|560338279|FG002|Extension Period|Adverse Event|0|||
155247587|NCT02008890|560338280|FG003|Extension Period|Adverse Event|0|||
155247588|NCT02008890|560338281|FG004|Extension Period|Adverse Event|2|||
155247589|NCT02207816|560338282|FG000|Overall Study|Serious Adverse Event|0|||
155247590|NCT02207816|560338283|FG001|Overall Study|Serious Adverse Event|5|||
155247591|NCT02207816|560338284|FG002|Overall Study|Serious Adverse Event|2|||
155247592|NCT02207816|560338282|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155247593|NCT02207816|560338283|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
155247594|NCT02207816|560338284|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155247595|NCT02207816|560338282|FG000|Overall Study|Withdrawal by Subject|4|||
155247596|NCT02207816|560338283|FG001|Overall Study|Withdrawal by Subject|9|||
155247597|NCT02207816|560338284|FG002|Overall Study|Withdrawal by Subject|7|||
155247598|NCT02207816|560338282|FG000|Overall Study|Migrated/Moved From Study Area|41|||
155247599|NCT02207816|560338283|FG001|Overall Study|Migrated/Moved From Study Area|60|||
155247600|NCT02207816|560338284|FG002|Overall Study|Migrated/Moved From Study Area|51|||
155247601|NCT02207816|560338282|FG000|Overall Study|Lost to Follow-up|3|||
155247602|NCT02207816|560338283|FG001|Overall Study|Lost to Follow-up|9|||
155247603|NCT02207816|560338284|FG002|Overall Study|Lost to Follow-up|1|||
155247604|NCT02207816|560338282|FG000|Overall Study|Other|1|||
155247605|NCT02207816|560338283|FG001|Overall Study|Other|2|||
155247606|NCT02207816|560338284|FG002|Overall Study|Other|4|||
155247607|NCT05912400|560338285|FG000|Overall Study|Lost to Follow-up|1|||
155247608|NCT05912400|560338286|FG001|Overall Study|Lost to Follow-up|0|||
155247609|NCT05912400|560338285|FG000|Overall Study|Physician Decision|6|||
155247610|NCT05912400|560338286|FG001|Overall Study|Physician Decision|0|||
155247611|NCT05912400|560338285|FG000|Overall Study|Withdrawal by Subject|1|||
155247612|NCT05912400|560338286|FG001|Overall Study|Withdrawal by Subject|0|||
155247613|NCT02522494|560338287|FG000|Overall Study|Lost to Follow-up|6|||
155247614|NCT02522494|560338288|FG001|Overall Study|Lost to Follow-up|2|||
155247615|NCT02522494|560338287|FG000|Overall Study|Withdrawal by Subject|1|||
155247616|NCT02522494|560338288|FG001|Overall Study|Withdrawal by Subject|0|||
155247617|NCT02522494|560338287|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
155247618|NCT02522494|560338288|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
155247619|NCT02522494|560338287|FG000|Overall Study|Participant did not watch the video|1|||
155247620|NCT02522494|560338288|FG001|Overall Study|Participant did not watch the video|0|||
155247621|NCT02522494|560338287|FG000|Overall Study|Death|0|||
155247622|NCT02522494|560338288|FG001|Overall Study|Death|1|||
155247623|NCT03240588|560338289|FG000|Overall Study|Death|3|||
155247624|NCT03240588|560338290|FG001|Overall Study|Death|0|||
155247625|NCT03240588|560338291|FG002|Overall Study|Death|0|||
155247626|NCT03240588|560338289|FG000|Overall Study|Adverse Event|5|||
155247627|NCT03240588|560338290|FG001|Overall Study|Adverse Event|4|||
155247628|NCT03240588|560338291|FG002|Overall Study|Adverse Event|0|||
155247629|NCT03240588|560338289|FG000|Overall Study|Lost to Follow-up|9|||
155247630|NCT03240588|560338290|FG001|Overall Study|Lost to Follow-up|4|||
155247631|NCT03240588|560338291|FG002|Overall Study|Lost to Follow-up|0|||
155247632|NCT03240588|560338289|FG000|Overall Study|Physician Decision|3|||
155247633|NCT03240588|560338290|FG001|Overall Study|Physician Decision|2|||
155247634|NCT03240588|560338291|FG002|Overall Study|Physician Decision|0|||
155247635|NCT03240588|560338289|FG000|Overall Study|Did not meet eligibility criteria|0|||
155247636|NCT03240588|560338290|FG001|Overall Study|Did not meet eligibility criteria|6|||
155247637|NCT03240588|560338291|FG002|Overall Study|Did not meet eligibility criteria|0|||
155247638|NCT03240588|560338289|FG000|Overall Study|No longer meets protocol criteria|12|||
155247639|NCT03240588|560338290|FG001|Overall Study|No longer meets protocol criteria|7|||
155247640|NCT03240588|560338291|FG002|Overall Study|No longer meets protocol criteria|0|||
155247641|NCT03240588|560338289|FG000|Overall Study|Withdrawal by Subject|60|||
155247642|NCT03240588|560338290|FG001|Overall Study|Withdrawal by Subject|52|||
155247643|NCT03240588|560338291|FG002|Overall Study|Withdrawal by Subject|7|||
155247644|NCT03240588|560338289|FG000|Overall Study|Other, additional details not available.|0|||
155247645|NCT03240588|560338290|FG001|Overall Study|Other, additional details not available.|12|||
155247646|NCT03240588|560338291|FG002|Overall Study|Other, additional details not available.|1|||
155247647|NCT03240588|560338289|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
155247648|NCT03240588|560338290|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
155247649|NCT03240588|560338291|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
155247650|NCT03240588|560338289|FG000|Overall Study|Closure of study|55|||
155247651|NCT03240588|560338290|FG001|Overall Study|Closure of study|3|||
155247652|NCT03240588|560338291|FG002|Overall Study|Closure of study|0|||
155247653|NCT03240588|560338289|FG000|Overall Study|Subject non-compliance|23|||
155247654|NCT03240588|560338290|FG001|Overall Study|Subject non-compliance|2|||
155247655|NCT03240588|560338291|FG002|Overall Study|Subject non-compliance|1|||
155247656|NCT03240588|560338289|FG000|Overall Study|Device Deficiency|1|||
155247657|NCT03240588|560338290|FG001|Overall Study|Device Deficiency|0|||
155247658|NCT03240588|560338291|FG002|Overall Study|Device Deficiency|0|||
155247659|NCT03240588|560338289|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
155247660|NCT03240588|560338290|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
155247661|NCT03240588|560338291|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
155247662|NCT01259713|560338293|FG000|Overall Study|Adverse Event|54|||
155247663|NCT01259713|560338294|FG001|Overall Study|Adverse Event|23|||
155247664|NCT01259713|560338293|FG000|Overall Study|Death Not Related to IFI|8|||
155247665|NCT01259713|560338294|FG001|Overall Study|Death Not Related to IFI|1|||
155247666|NCT01259713|560338293|FG000|Overall Study|Investigators Discretion|14|||
155247667|NCT01259713|560338294|FG001|Overall Study|Investigators Discretion|6|||
155247668|NCT01259713|560338293|FG000|Overall Study|Lack of Efficacy|2|||
155247669|NCT01259713|560338294|FG001|Overall Study|Lack of Efficacy|0|||
155247670|NCT01259713|560338293|FG000|Overall Study|Protocol Violation|5|||
155247671|NCT01259713|560338294|FG001|Overall Study|Protocol Violation|4|||
155247672|NCT01259713|560338293|FG000|Overall Study|Subject Withdrew Consent|12|||
155247673|NCT01259713|560338294|FG001|Overall Study|Subject Withdrew Consent|7|||
155247674|NCT02091726|560338295|FG000|Overall Study|Lost to Follow-up|6|||
155247675|NCT06111742|560338296|FG000|Overall Study|Did not receive intervention|1|||
155247676|NCT06111742|560338297|FG001|Overall Study|Did not receive intervention|0|||
155247677|NCT06111742|560338298|FG002|Overall Study|Did not receive intervention|0|||
155247678|NCT06111742|560338296|FG000|Overall Study|Withdrawal by Subject|2|||
155247679|NCT06111742|560338297|FG001|Overall Study|Withdrawal by Subject|0|||
155247680|NCT06111742|560338298|FG002|Overall Study|Withdrawal by Subject|0|||
155247681|NCT03461003|560338299|FG000|Overall Study|Lost to Follow-up|2|||
155247682|NCT03461003|560338300|FG001|Overall Study|Lost to Follow-up|2|||
155247683|NCT03461003|560338299|FG000|Overall Study|Withdrawal by Subject|3|||
155247684|NCT03461003|560338300|FG001|Overall Study|Withdrawal by Subject|1|||
155247685|NCT01914926|560338301|FG000|Overall Study|Adverse Event|1|||
155247686|NCT01914926|560338302|FG001|Overall Study|Adverse Event|0|||
155247687|NCT01914926|560338301|FG000|Overall Study|uncooperative, agitated and removed|0|||
155247688|NCT01914926|560338302|FG001|Overall Study|uncooperative, agitated and removed|1|||
155247689|NCT02047045|560338306|FG000|Baseline|Withdrawal by Subject|3|||
155247690|NCT02047045|560338307|FG001|Baseline|Withdrawal by Subject|2|||
155247691|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
155247692|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
155247693|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
155247694|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
155247695|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
155247696|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
155247697|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
155247698|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
155247699|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
155247700|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
155247701|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
155247702|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
155247703|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
155247704|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
155247705|NCT02047045|560338306|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
155247706|NCT02047045|560338307|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
155247707|NCT03508843|560338308|FG000|Overall Study|Withdrawal by Subject|1|||
155247708|NCT03508843|560338308|FG000|Overall Study|technical difficulties|2|||
155247709|NCT03555396|560338309|FG000|Overall Study|Death|3|||
155247710|NCT03555396|560338310|FG001|Overall Study|Death|1|||
155247711|NCT03555396|560338309|FG000|Overall Study|Lost to Follow-up|0|||
155247712|NCT03555396|560338310|FG001|Overall Study|Lost to Follow-up|2|||
155247713|NCT02536508|560338311|FG000|Overall Study|Withdrawal by Subject|18|||
155247714|NCT02536508|560338312|FG001|Overall Study|Withdrawal by Subject|13|||
155247715|NCT02536508|560338313|FG002|Overall Study|Withdrawal by Subject|7|||
155247716|NCT02536508|560338311|FG000|Overall Study|Adverse Event|14|||
155247717|NCT02536508|560338312|FG001|Overall Study|Adverse Event|13|||
155247718|NCT02536508|560338313|FG002|Overall Study|Adverse Event|6|||
155247719|NCT02536508|560338311|FG000|Overall Study|Lost to Follow-up|12|||
155247720|NCT02536508|560338312|FG001|Overall Study|Lost to Follow-up|4|||
155247721|NCT02536508|560338313|FG002|Overall Study|Lost to Follow-up|0|||
155247722|NCT02536508|560338311|FG000|Overall Study|Lack of Efficacy|3|||
155247723|NCT02536508|560338312|FG001|Overall Study|Lack of Efficacy|5|||
155247724|NCT02536508|560338313|FG002|Overall Study|Lack of Efficacy|4|||
155247725|NCT02536508|560338311|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
155247726|NCT02536508|560338312|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
155247727|NCT02536508|560338313|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
155247728|NCT02536508|560338311|FG000|Overall Study|Physician Decision|0|||
155247729|NCT02536508|560338312|FG001|Overall Study|Physician Decision|4|||
155247730|NCT02536508|560338313|FG002|Overall Study|Physician Decision|2|||
155247731|NCT02536508|560338311|FG000|Overall Study|Major Protocol Deviation|2|||
155247732|NCT02536508|560338312|FG001|Overall Study|Major Protocol Deviation|2|||
155247733|NCT02536508|560338313|FG002|Overall Study|Major Protocol Deviation|2|||
155247734|NCT02536508|560338311|FG000|Overall Study|Administrative Reasons|0|||
155247735|NCT02536508|560338312|FG001|Overall Study|Administrative Reasons|1|||
155247736|NCT02536508|560338313|FG002|Overall Study|Administrative Reasons|0|||
155247737|NCT00922428|560338319|FG000|Overall Study|retrospective/extremely implausible data|2|||
155247738|NCT00922428|560338319|FG000|Overall Study|no medication use or questionable use|13|||
155247739|NCT04862143|560338336|FG000|Overall Study|Adverse Event|1|||
155247740|NCT04862143|560338336|FG000|Overall Study|Study terminated by sponsor|1|||
155247741|NCT02103439|560338337|FG000|Overall Study|Adverse Event|0|||
155247742|NCT02103439|560338338|FG001|Overall Study|Adverse Event|2|||
155247743|NCT02103439|560338337|FG000|Overall Study|Withdrawal by Subject|3|||
155247744|NCT02103439|560338338|FG001|Overall Study|Withdrawal by Subject|1|||
155247745|NCT02370602|560338339|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155247746|NCT02370602|560338340|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155247747|NCT02370602|560338341|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155247748|NCT02370602|560338342|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
155247749|NCT02370602|560338343|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155247750|NCT02370602|560338344|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155247751|NCT02864082|560338348|FG000|Overall Study|Adverse Event|1|||
155247752|NCT02864082|560338349|FG001|Overall Study|Adverse Event|1|||
155247753|NCT02864082|560338348|FG000|Overall Study|Lost to Follow-up|0|||
155247754|NCT02864082|560338349|FG001|Overall Study|Lost to Follow-up|1|||
155247755|NCT02864082|560338348|FG000|Overall Study|Withdrawal by Subject|2|||
155247756|NCT02864082|560338349|FG001|Overall Study|Withdrawal by Subject|2|||
155247757|NCT02310750|560338352|FG000|HP Period 1|Lost to Follow-up|0|||
155247758|NCT02310750|560338353|FG001|HP Period 1|Lost to Follow-up|0|||
155247759|NCT02310750|560338354|FG002|HP Period 1|Lost to Follow-up|0|||
155247760|NCT02310750|560338355|FG003|HP Period 1|Lost to Follow-up|0|||
155247761|NCT02310750|560338356|FG004|HP Period 1|Lost to Follow-up|0|||
155247762|NCT02310750|560338357|FG005|HP Period 1|Lost to Follow-up|0|||
155247763|NCT02310750|560338358|FG006|HP Period 1|Lost to Follow-up|1|||
155247764|NCT02310750|560338359|FG007|HP Period 1|Lost to Follow-up|0|||
155247765|NCT02310750|560338360|FG008|HP Period 1|Lost to Follow-up|0|||
155247766|NCT02310750|560338361|FG009|HP Period 1|Lost to Follow-up|0|||
155247767|NCT02310750|560338362|FG010|HP Period 1|Lost to Follow-up|0|||
155247768|NCT02310750|560338363|FG011|HP Period 1|Lost to Follow-up|0|||
155247769|NCT02310750|560338364|FG012|HP Period 1|Lost to Follow-up|0|||
155247770|NCT02310750|560338365|FG013|HP Period 1|Lost to Follow-up|0|||
155247771|NCT02310750|560338366|FG014|HP Period 1|Lost to Follow-up|0|||
155247772|NCT02310750|560338367|FG015|HP Period 1|Lost to Follow-up|0|||
155247773|NCT02310750|560338352|FG000|HP Period 1|Withdrawal by Subject|1|||
155247774|NCT02310750|560338353|FG001|HP Period 1|Withdrawal by Subject|0|||
155247775|NCT02310750|560338354|FG002|HP Period 1|Withdrawal by Subject|0|||
155247776|NCT02310750|560338355|FG003|HP Period 1|Withdrawal by Subject|1|||
155247777|NCT02310750|560338356|FG004|HP Period 1|Withdrawal by Subject|0|||
155247778|NCT02310750|560338357|FG005|HP Period 1|Withdrawal by Subject|0|||
155247779|NCT02310750|560338358|FG006|HP Period 1|Withdrawal by Subject|0|||
155247780|NCT02310750|560338359|FG007|HP Period 1|Withdrawal by Subject|0|||
155247781|NCT02310750|560338360|FG008|HP Period 1|Withdrawal by Subject|0|||
155247782|NCT02310750|560338361|FG009|HP Period 1|Withdrawal by Subject|0|||
155247783|NCT02310750|560338362|FG010|HP Period 1|Withdrawal by Subject|0|||
155247784|NCT02310750|560338363|FG011|HP Period 1|Withdrawal by Subject|0|||
155247785|NCT02310750|560338364|FG012|HP Period 1|Withdrawal by Subject|0|||
155247786|NCT02310750|560338365|FG013|HP Period 1|Withdrawal by Subject|0|||
155247787|NCT02310750|560338366|FG014|HP Period 1|Withdrawal by Subject|0|||
155247788|NCT02310750|560338367|FG015|HP Period 1|Withdrawal by Subject|0|||
155247789|NCT02310750|560338352|FG000|HP Washout 1|Lost to Follow-up|0|||
155247790|NCT02310750|560338353|FG001|HP Washout 1|Lost to Follow-up|0|||
155247791|NCT02310750|560338354|FG002|HP Washout 1|Lost to Follow-up|1|||
155247792|NCT02310750|560338355|FG003|HP Washout 1|Lost to Follow-up|1|||
155247793|NCT02310750|560338356|FG004|HP Washout 1|Lost to Follow-up|2|||
155247794|NCT02310750|560338357|FG005|HP Washout 1|Lost to Follow-up|2|||
155247795|NCT02310750|560338358|FG006|HP Washout 1|Lost to Follow-up|3|||
155247796|NCT02310750|560338359|FG007|HP Washout 1|Lost to Follow-up|0|||
155247797|NCT02310750|560338360|FG008|HP Washout 1|Lost to Follow-up|0|||
155247798|NCT02310750|560338361|FG009|HP Washout 1|Lost to Follow-up|0|||
155247799|NCT02310750|560338362|FG010|HP Washout 1|Lost to Follow-up|0|||
155247800|NCT02310750|560338363|FG011|HP Washout 1|Lost to Follow-up|0|||
155247801|NCT02310750|560338364|FG012|HP Washout 1|Lost to Follow-up|0|||
155247802|NCT02310750|560338365|FG013|HP Washout 1|Lost to Follow-up|0|||
155247803|NCT02310750|560338366|FG014|HP Washout 1|Lost to Follow-up|0|||
155247804|NCT02310750|560338367|FG015|HP Washout 1|Lost to Follow-up|0|||
155247805|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247806|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247807|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247808|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
155247809|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247810|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
155247811|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247812|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247813|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
155247814|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
155247815|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247816|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247817|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247818|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247819|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247820|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247821|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247822|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247823|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247824|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247825|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247826|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247827|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247828|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247829|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247830|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
155247831|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247832|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247833|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247834|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247835|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247836|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247837|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247838|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247839|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247840|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247841|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247842|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247843|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247844|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247845|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247846|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247847|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247848|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247849|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247850|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247851|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247852|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247853|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247854|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247855|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247856|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247857|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247858|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247859|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247860|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
155247861|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
155247862|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247863|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247864|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247865|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247866|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247867|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247868|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247869|NCT02310750|560338352|FG000|HP Washout 2|Lost to Follow-up|0|||
155247870|NCT02310750|560338353|FG001|HP Washout 2|Lost to Follow-up|0|||
155247871|NCT02310750|560338354|FG002|HP Washout 2|Lost to Follow-up|0|||
155247872|NCT02310750|560338355|FG003|HP Washout 2|Lost to Follow-up|0|||
155247873|NCT02310750|560338356|FG004|HP Washout 2|Lost to Follow-up|1|||
155247874|NCT02310750|560338357|FG005|HP Washout 2|Lost to Follow-up|0|||
155247875|NCT02310750|560338358|FG006|HP Washout 2|Lost to Follow-up|7|||
155247876|NCT02310750|560338359|FG007|HP Washout 2|Lost to Follow-up|0|||
155247877|NCT02310750|560338360|FG008|HP Washout 2|Lost to Follow-up|0|||
155247878|NCT02310750|560338361|FG009|HP Washout 2|Lost to Follow-up|0|||
155247879|NCT02310750|560338362|FG010|HP Washout 2|Lost to Follow-up|0|||
155247880|NCT02310750|560338363|FG011|HP Washout 2|Lost to Follow-up|0|||
155247881|NCT02310750|560338364|FG012|HP Washout 2|Lost to Follow-up|0|||
155247882|NCT02310750|560338365|FG013|HP Washout 2|Lost to Follow-up|0|||
155247883|NCT02310750|560338366|FG014|HP Washout 2|Lost to Follow-up|0|||
155247884|NCT02310750|560338367|FG015|HP Washout 2|Lost to Follow-up|0|||
155247885|NCT01226745|560338368|FG000|Overall Study|Did not complete schedule of assessments|8|||
155247886|NCT01226745|560338369|FG001|Overall Study|Did not complete schedule of assessments|3|||
155247887|NCT01226745|560338370|FG002|Overall Study|Did not complete schedule of assessments|6|||
155247888|NCT01226745|560338371|FG003|Overall Study|Did not complete schedule of assessments|0|||
155247889|NCT01226745|560338372|FG004|Overall Study|Did not complete schedule of assessments|0|||
155247890|NCT01226745|560338373|FG005|Overall Study|Did not complete schedule of assessments|1|||
155247891|NCT01226745|560338368|FG000|Overall Study|Lost to Follow-up|2|||
155247892|NCT01226745|560338369|FG001|Overall Study|Lost to Follow-up|6|||
155247893|NCT01226745|560338370|FG002|Overall Study|Lost to Follow-up|6|||
155247894|NCT01226745|560338371|FG003|Overall Study|Lost to Follow-up|1|||
155247895|NCT01226745|560338372|FG004|Overall Study|Lost to Follow-up|1|||
155247896|NCT01226745|560338373|FG005|Overall Study|Lost to Follow-up|2|||
155247897|NCT01226745|560338368|FG000|Overall Study|Death|1|||
155247898|NCT01226745|560338369|FG001|Overall Study|Death|0|||
155247899|NCT01226745|560338370|FG002|Overall Study|Death|0|||
155247900|NCT01226745|560338371|FG003|Overall Study|Death|0|||
155247901|NCT01226745|560338372|FG004|Overall Study|Death|0|||
155247902|NCT01226745|560338373|FG005|Overall Study|Death|1|||
155247903|NCT01226745|560338368|FG000|Overall Study|Other|6|||
155247904|NCT01226745|560338369|FG001|Overall Study|Other|7|||
155247905|NCT01226745|560338370|FG002|Overall Study|Other|8|||
155247906|NCT01226745|560338371|FG003|Overall Study|Other|4|||
155247907|NCT01226745|560338372|FG004|Overall Study|Other|3|||
155247908|NCT01226745|560338373|FG005|Overall Study|Other|1|||
155247909|NCT01090453|560338376|FG000|Overall Study|Withdrawal by Subject|1|||
155247910|NCT01090453|560338377|FG001|Overall Study|Withdrawal by Subject|2|||
155247911|NCT01090453|560338376|FG000|Overall Study|Lost to Follow-up|7|||
155247912|NCT01090453|560338377|FG001|Overall Study|Lost to Follow-up|7|||
155247913|NCT01090453|560338376|FG000|Overall Study|Non serious AEs|1|||
155247914|NCT01090453|560338377|FG001|Overall Study|Non serious AEs|0|||
155247915|NCT01090453|560338376|FG000|Overall Study|Protocol Violation|2|||
155247916|NCT01090453|560338377|FG001|Overall Study|Protocol Violation|0|||
155247917|NCT01090453|560338376|FG000|Overall Study|Other|2|||
155247918|NCT01090453|560338377|FG001|Overall Study|Other|4|||
155247919|NCT01090453|560338376|FG000|Overall Study|Eligibility Criteria|0|||
155247920|NCT01090453|560338377|FG001|Overall Study|Eligibility Criteria|1|||
155247921|NCT00522275|560338378|FG000|Overall Study|Adverse Event|35|||
155247922|NCT00522275|560338378|FG000|Overall Study|Lack of Efficacy|80|||
155247923|NCT00522275|560338378|FG000|Overall Study|Subject withdrew consent|16|||
155247924|NCT00522275|560338378|FG000|Overall Study|Protocol deviation|1|||
155247925|NCT00522275|560338378|FG000|Overall Study|Unsatisfactory compliance|11|||
155247926|NCT00522275|560338378|FG000|Overall Study|Lost to Follow-up|8|||
155247927|NCT00522275|560338378|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
155247928|NCT00522275|560338378|FG000|Overall Study|Other: Subject is pregnant|2|||
155247929|NCT00522275|560338378|FG000|Overall Study|Other: Subject relocated|2|||
155247930|NCT00522275|560338378|FG000|Overall Study|Other: Subject arrested|1|||
155247931|NCT00522275|560338378|FG000|Overall Study|Other: Site / clinic closed|4|||
155247932|NCT00522275|560338378|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
155247933|NCT00522275|560338378|FG000|Overall Study|Other: Sponsor request|2|||
155247934|NCT00522275|560338378|FG000|Overall Study|Other: Subject ran out of medication|1|||
155247935|NCT00522275|560338378|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
155247936|NCT05045625|560338379|FG000|Overall Study|Lost to Follow-up|3|||
155247937|NCT03867734|560338380|FG000|Overall Study|Lost to Follow-up|2|||
155247938|NCT00718718|560338381|FG000|Prior to Week 12|Adverse Event|0|||
155247939|NCT00718718|560338382|FG001|Prior to Week 12|Adverse Event|0|||
155247940|NCT00718718|560338383|FG002|Prior to Week 12|Adverse Event|0|||
155247941|NCT00718718|560338384|FG003|Prior to Week 12|Adverse Event|0|||
155247942|NCT00718718|560338385|FG004|Prior to Week 12|Adverse Event|0|||
155247943|NCT00718718|560338386|FG005|Prior to Week 12|Adverse Event|0|||
155247944|NCT00718718|560338387|FG006|Prior to Week 12|Adverse Event|0|||
155247945|NCT00718718|560338388|FG007|Prior to Week 12|Adverse Event|1|||
155247946|NCT00718718|560338389|FG008|Prior to Week 12|Adverse Event|1|||
155247947|NCT00718718|560338390|FG009|Prior to Week 12|Adverse Event|0|||
155247948|NCT00718718|560338381|FG000|Prior to Week 12|Withdrawal by Subject|0|||
155247949|NCT00718718|560338382|FG001|Prior to Week 12|Withdrawal by Subject|0|||
155247950|NCT00718718|560338383|FG002|Prior to Week 12|Withdrawal by Subject|0|||
155247951|NCT00718718|560338384|FG003|Prior to Week 12|Withdrawal by Subject|0|||
155247952|NCT00718718|560338385|FG004|Prior to Week 12|Withdrawal by Subject|3|||
155247953|NCT00718718|560338386|FG005|Prior to Week 12|Withdrawal by Subject|0|||
155247954|NCT00718718|560338387|FG006|Prior to Week 12|Withdrawal by Subject|1|||
155247955|NCT00718718|560338388|FG007|Prior to Week 12|Withdrawal by Subject|1|||
155247956|NCT00718718|560338389|FG008|Prior to Week 12|Withdrawal by Subject|1|||
155247957|NCT00718718|560338390|FG009|Prior to Week 12|Withdrawal by Subject|0|||
155247958|NCT00718718|560338381|FG000|Prior to Week 12|Other|1|||
155247959|NCT00718718|560338382|FG001|Prior to Week 12|Other|0|||
155247960|NCT00718718|560338383|FG002|Prior to Week 12|Other|1|||
155247961|NCT00718718|560338384|FG003|Prior to Week 12|Other|0|||
155247962|NCT00718718|560338385|FG004|Prior to Week 12|Other|0|||
155247963|NCT00718718|560338386|FG005|Prior to Week 12|Other|0|||
155247964|NCT00718718|560338387|FG006|Prior to Week 12|Other|0|||
155247965|NCT00718718|560338388|FG007|Prior to Week 12|Other|0|||
155247966|NCT00718718|560338389|FG008|Prior to Week 12|Other|0|||
155247967|NCT00718718|560338390|FG009|Prior to Week 12|Other|0|||
155247968|NCT00718718|560338381|FG000|Week 12 to End of Study|Adverse Event|0|||
155247969|NCT00718718|560338382|FG001|Week 12 to End of Study|Adverse Event|0|||
155247970|NCT00718718|560338383|FG002|Week 12 to End of Study|Adverse Event|0|||
155247971|NCT00718718|560338384|FG003|Week 12 to End of Study|Adverse Event|0|||
155247972|NCT00718718|560338385|FG004|Week 12 to End of Study|Adverse Event|0|||
155247973|NCT00718718|560338386|FG005|Week 12 to End of Study|Adverse Event|0|||
155247974|NCT00718718|560338387|FG006|Week 12 to End of Study|Adverse Event|0|||
155247975|NCT00718718|560338388|FG007|Week 12 to End of Study|Adverse Event|1|||
155247976|NCT00718718|560338389|FG008|Week 12 to End of Study|Adverse Event|0|||
155247977|NCT00718718|560338390|FG009|Week 12 to End of Study|Adverse Event|0|||
155247978|NCT00718718|560338381|FG000|Week 12 to End of Study|Death|0|||
155247979|NCT00718718|560338382|FG001|Week 12 to End of Study|Death|0|||
155247980|NCT00718718|560338383|FG002|Week 12 to End of Study|Death|0|||
155247981|NCT00718718|560338384|FG003|Week 12 to End of Study|Death|0|||
155247982|NCT00718718|560338385|FG004|Week 12 to End of Study|Death|0|||
155247983|NCT00718718|560338386|FG005|Week 12 to End of Study|Death|1|||
155247984|NCT00718718|560338387|FG006|Week 12 to End of Study|Death|0|||
155247985|NCT00718718|560338388|FG007|Week 12 to End of Study|Death|0|||
155247986|NCT00718718|560338389|FG008|Week 12 to End of Study|Death|0|||
155247987|NCT00718718|560338390|FG009|Week 12 to End of Study|Death|0|||
155247988|NCT00718718|560338381|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
155247989|NCT00718718|560338382|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
155247990|NCT00718718|560338383|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
155247991|NCT00718718|560338384|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
155247992|NCT00718718|560338385|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
155247993|NCT00718718|560338386|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
155247994|NCT00718718|560338387|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
155247995|NCT00718718|560338388|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
155247996|NCT00718718|560338389|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
155247997|NCT00718718|560338390|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
155247998|NCT00718718|560338381|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
155247999|NCT00718718|560338382|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
155248000|NCT00718718|560338383|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
155248001|NCT00718718|560338384|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
155248002|NCT00718718|560338385|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
155248003|NCT00718718|560338386|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
155248004|NCT00718718|560338387|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
155248005|NCT00718718|560338388|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
155248006|NCT00718718|560338389|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
155248007|NCT00718718|560338390|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
155248008|NCT00718718|560338381|FG000|Week 12 to End of Study|Other|0|||
155248009|NCT00718718|560338382|FG001|Week 12 to End of Study|Other|1|||
155248010|NCT00718718|560338383|FG002|Week 12 to End of Study|Other|0|||
155248011|NCT00718718|560338384|FG003|Week 12 to End of Study|Other|1|||
155248012|NCT00718718|560338385|FG004|Week 12 to End of Study|Other|0|||
155248013|NCT00718718|560338386|FG005|Week 12 to End of Study|Other|0|||
155248014|NCT00718718|560338387|FG006|Week 12 to End of Study|Other|1|||
155248015|NCT00718718|560338388|FG007|Week 12 to End of Study|Other|0|||
155248016|NCT00718718|560338389|FG008|Week 12 to End of Study|Other|0|||
155248017|NCT00718718|560338390|FG009|Week 12 to End of Study|Other|0|||
155248018|NCT02276482|560338393|FG000|Overall Study|Adverse Event|1|||
155248019|NCT02276482|560338394|FG001|Overall Study|Adverse Event|0|||
155248020|NCT02276482|560338393|FG000|Overall Study|Withdrawal by Subject|1|||
155248021|NCT02276482|560338394|FG001|Overall Study|Withdrawal by Subject|0|||
155248022|NCT02276482|560338393|FG000|Overall Study|Gram-negative infection|1|||
155248023|NCT02276482|560338394|FG001|Overall Study|Gram-negative infection|0|||
155248024|NCT02276482|560338393|FG000|Overall Study|Reason not specified|0|||
155248025|NCT02276482|560338394|FG001|Overall Study|Reason not specified|1|||
155248026|NCT00253864|560338395|FG000|Overall Study|Lost to Follow-up|5|||
155248027|NCT00253864|560338396|FG001|Overall Study|Lost to Follow-up|8|||
155248028|NCT00360529|560338400|FG000|Overall Study|Adverse Event|10|||
155248029|NCT00360529|560338401|FG001|Overall Study|Adverse Event|23|||
155248030|NCT00360529|560338402|FG002|Overall Study|Adverse Event|33|||
155248031|NCT00360529|560338400|FG000|Overall Study|Protocol Violation|3|||
155248032|NCT00360529|560338401|FG001|Overall Study|Protocol Violation|3|||
155248033|NCT00360529|560338402|FG002|Overall Study|Protocol Violation|11|||
155248034|NCT00360529|560338400|FG000|Overall Study|Lost to Follow-up|14|||
155248035|NCT00360529|560338401|FG001|Overall Study|Lost to Follow-up|10|||
155248036|NCT00360529|560338402|FG002|Overall Study|Lost to Follow-up|13|||
155248037|NCT00360529|560338400|FG000|Overall Study|Withdrawal by Subject|22|||
155248038|NCT00360529|560338401|FG001|Overall Study|Withdrawal by Subject|14|||
155248039|NCT00360529|560338402|FG002|Overall Study|Withdrawal by Subject|18|||
155248040|NCT00360529|560338400|FG000|Overall Study|Lack of Efficacy|8|||
155248041|NCT00360529|560338401|FG001|Overall Study|Lack of Efficacy|6|||
155248042|NCT00360529|560338402|FG002|Overall Study|Lack of Efficacy|5|||
155248043|NCT00360529|560338400|FG000|Overall Study|Reason discontinued not explained above|4|||
155248044|NCT00360529|560338401|FG001|Overall Study|Reason discontinued not explained above|9|||
155248045|NCT00360529|560338402|FG002|Overall Study|Reason discontinued not explained above|11|||
155248046|NCT00110617|560338406|FG000|Overall Study|Adverse Event|2|||
155248047|NCT00110617|560338407|FG001|Overall Study|Adverse Event|4|||
155248048|NCT00110617|560338406|FG000|Overall Study|Abnormal Laboratory Value|4|||
155248049|NCT00110617|560338407|FG001|Overall Study|Abnormal Laboratory Value|2|||
155248050|NCT00110617|560338406|FG000|Overall Study|Lack of Efficacy|1|||
155248051|NCT00110617|560338407|FG001|Overall Study|Lack of Efficacy|0|||
155248052|NCT00110617|560338406|FG000|Overall Study|Patient no longer requires study drug|1|||
155248053|NCT00110617|560338407|FG001|Overall Study|Patient no longer requires study drug|0|||
155248054|NCT00110617|560338406|FG000|Overall Study|Protocol Violation|5|||
155248055|NCT00110617|560338407|FG001|Overall Study|Protocol Violation|0|||
155248056|NCT00110617|560338406|FG000|Overall Study|Withdrawal by Subject|10|||
155248057|NCT00110617|560338407|FG001|Overall Study|Withdrawal by Subject|4|||
155248058|NCT00110617|560338406|FG000|Overall Study|Lost to Follow-up|9|||
155248059|NCT00110617|560338407|FG001|Overall Study|Lost to Follow-up|1|||
155248060|NCT00110617|560338406|FG000|Overall Study|Administrative problems|6|||
155248061|NCT00110617|560338407|FG001|Overall Study|Administrative problems|5|||
155248062|NCT00110617|560338406|FG000|Overall Study|Death|1|||
155248063|NCT00110617|560338407|FG001|Overall Study|Death|1|||
155248064|NCT00110617|560338406|FG000|Overall Study|Did not receive study drug|0|||
155248065|NCT00110617|560338407|FG001|Overall Study|Did not receive study drug|12|||
155248066|NCT04764396|560338408|FG000|Overall Study|Physician Decision|1|||
155248067|NCT04764396|560338409|FG001|Overall Study|Physician Decision|0|||
155248068|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
155248069|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
155248070|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
155248071|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
155248072|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
155248073|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
155248074|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
155248075|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
155248076|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
155248077|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
155248078|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
155248079|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
155248080|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
155248081|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
155248082|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
155248083|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
155248084|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
155248085|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
155248086|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
155248087|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
155248088|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
155248089|NCT01781572|560338411|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
155248090|NCT01781572|560338412|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
155248091|NCT01781572|560338413|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
155248092|NCT01781572|560338411|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
155248093|NCT01781572|560338412|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
155248094|NCT01781572|560338413|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
155248095|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
155248096|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
155248097|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
155248098|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
155248099|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
155248100|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
155248101|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
155248102|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
155248103|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
155248104|NCT01781572|560338411|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
155248105|NCT01781572|560338412|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
155248106|NCT01781572|560338413|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
155248107|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
155248108|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
155248109|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
155248110|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
155248111|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
155248112|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
155248113|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
155248114|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
155248115|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
155248116|NCT01781572|560338411|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
155248117|NCT01781572|560338412|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
155248118|NCT01781572|560338413|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
155248119|NCT01781572|560338411|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
155248120|NCT01781572|560338412|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
155248121|NCT01781572|560338413|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
155248122|NCT01218438|560338414|FG000|Epoch 1|Physician Decision|2|||
155248123|NCT01218438|560338414|FG000|Epoch 1|Adverse Event|1|||
155248124|NCT01218438|560338414|FG000|Epoch 3|Withdrawal by Subject|3|||
155248125|NCT01218438|560338414|FG000|Epoch 3|Adverse Event|1|||
155248126|NCT01218438|560338414|FG000|Epoch 4|Physician Decision|1|||
155248127|NCT01218438|560338414|FG000|Epoch 4|Withdrawal by Subject|2|||
155248128|NCT03230916|560338415|FG000|Overall Study|Withdrawal by Subject|0|||
155248129|NCT03230916|560338416|FG001|Overall Study|Withdrawal by Subject|0|||
155248130|NCT03230916|560338417|FG002|Overall Study|Withdrawal by Subject|0|||
155248131|NCT03230916|560338418|FG003|Overall Study|Withdrawal by Subject|0|||
155248132|NCT03230916|560338419|FG004|Overall Study|Withdrawal by Subject|0|||
155248133|NCT03230916|560338420|FG005|Overall Study|Withdrawal by Subject|1|||
155248134|NCT03230916|560338421|FG006|Overall Study|Withdrawal by Subject|0|||
155248135|NCT03230916|560338422|FG007|Overall Study|Withdrawal by Subject|0|||
155248136|NCT03230916|560338423|FG008|Overall Study|Withdrawal by Subject|0|||
155248137|NCT03230916|560338424|FG009|Overall Study|Withdrawal by Subject|0|||
155248138|NCT03230916|560338425|FG010|Overall Study|Withdrawal by Subject|0|||
155248139|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
155248140|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
155248141|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
155248142|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
155248143|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
155248144|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
155248145|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
155248146|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
155248147|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
155248148|NCT01438541|560338433|FG000|Overall Study|Physician Decision|1|||
155248149|NCT01438541|560338433|FG000|Overall Study|Withdrawal by Subject|1|||
155248150|NCT01438541|560338433|FG000|Overall Study|discharge from the hospital|5|||
155248151|NCT02091167|560338434|FG000|Overall Study|Lost to Follow-up|0|||
155248152|NCT02091167|560338435|FG001|Overall Study|Lost to Follow-up|2|||
155248153|NCT01218646|560338436|FG000|Overall Study|Adverse Event|0|||
155248154|NCT01218646|560338437|FG001|Overall Study|Adverse Event|0|||
155248155|NCT01218646|560338438|FG002|Overall Study|Adverse Event|1|||
155248156|NCT01218646|560338439|FG003|Overall Study|Adverse Event|0|||
155248157|NCT01218646|560338436|FG000|Overall Study|Lost to Follow-up|1|||
155248158|NCT01218646|560338437|FG001|Overall Study|Lost to Follow-up|0|||
155248159|NCT01218646|560338438|FG002|Overall Study|Lost to Follow-up|0|||
155248160|NCT01218646|560338439|FG003|Overall Study|Lost to Follow-up|0|||
155248161|NCT01218646|560338436|FG000|Overall Study|Protocol Violation|0|||
155248162|NCT01218646|560338437|FG001|Overall Study|Protocol Violation|0|||
155248163|NCT01218646|560338438|FG002|Overall Study|Protocol Violation|1|||
155248164|NCT01218646|560338439|FG003|Overall Study|Protocol Violation|1|||
155248165|NCT00722761|560338440|FG000|Overall Study|Lost to Follow-up|1|||
155248166|NCT00722761|560338441|FG001|Overall Study|Lost to Follow-up|4|||
155248167|NCT00722761|560338440|FG000|Overall Study|Withdrawal by Subject|5|||
155248168|NCT00722761|560338441|FG001|Overall Study|Withdrawal by Subject|2|||
155248169|NCT02693665|560338444|FG000|Overall Study|Death|3|||
155248170|NCT02693665|560338445|FG001|Overall Study|Death|2|||
155248171|NCT02693665|560338444|FG000|Overall Study|Lost to Follow-up|7|||
155248172|NCT02693665|560338445|FG001|Overall Study|Lost to Follow-up|3|||
155248173|NCT02693665|560338444|FG000|Overall Study|Protocol Violation|1|||
155248174|NCT02693665|560338445|FG001|Overall Study|Protocol Violation|0|||
155248175|NCT02693665|560338444|FG000|Overall Study|Withdrawal by Subject|2|||
155248176|NCT02693665|560338445|FG001|Overall Study|Withdrawal by Subject|0|||
155248177|NCT02693665|560338444|FG000|Overall Study|patient wanted to leave it behind|1|||
155248178|NCT02693665|560338445|FG001|Overall Study|patient wanted to leave it behind|0|||
155248179|NCT02693665|560338444|FG000|Overall Study|anxiety|1|||
155248180|NCT02693665|560338445|FG001|Overall Study|anxiety|0|||
155248181|NCT02693665|560338444|FG000|Overall Study|family issues|1|||
155248182|NCT02693665|560338445|FG001|Overall Study|family issues|0|||
155248183|NCT02693665|560338444|FG000|Overall Study|no reason given|1|||
155248184|NCT02693665|560338445|FG001|Overall Study|no reason given|0|||
155248185|NCT03096782|560338446|FG000|Overall Study|Death|1|||
155248186|NCT03096782|560338446|FG000|Overall Study|Participant Relapsed|1|||
155248187|NCT03662750|560338447|FG000|Overall Study|Withdrawal by Subject|1|||
155248188|NCT03156023|560338448|FG000|Overall Study|Withdrawal by Subject|1|||
155248189|NCT03156023|560338449|FG001|Overall Study|Withdrawal by Subject|0|||
155248190|NCT03156023|560338450|FG002|Overall Study|Withdrawal by Subject|2|||
155248191|NCT03156023|560338451|FG003|Overall Study|Withdrawal by Subject|1|||
155248192|NCT03156023|560338452|FG004|Overall Study|Withdrawal by Subject|1|||
155248193|NCT03156023|560338448|FG000|Overall Study|Lost to Follow-up|0|||
155248194|NCT03156023|560338449|FG001|Overall Study|Lost to Follow-up|0|||
155248195|NCT03156023|560338450|FG002|Overall Study|Lost to Follow-up|0|||
155248196|NCT03156023|560338451|FG003|Overall Study|Lost to Follow-up|0|||
155248197|NCT03156023|560338452|FG004|Overall Study|Lost to Follow-up|1|||
155248198|NCT05819749|560338457|FG000|Overall Study|Lost to Follow-up|1|||
155248199|NCT00844857|560340826|FG000|Overall Study|Adverse Event|24|||
155248200|NCT00844857|560340827|FG001|Overall Study|Adverse Event|5|||
155248201|NCT00844857|560340826|FG000|Overall Study|Sponsor Decision|1|||
155248202|NCT00844857|560340827|FG001|Overall Study|Sponsor Decision|1|||
155248203|NCT00844857|560340826|FG000|Overall Study|Physician Decision|2|||
155248204|NCT00844857|560340827|FG001|Overall Study|Physician Decision|0|||
155248205|NCT00844857|560340826|FG000|Overall Study|Parent/Caregiver Decision|6|||
155248206|NCT00844857|560340827|FG001|Overall Study|Parent/Caregiver Decision|2|||
155248207|NCT00844857|560340826|FG000|Overall Study|Withdrawal by Subject|8|||
155248208|NCT00844857|560340827|FG001|Overall Study|Withdrawal by Subject|7|||
155248209|NCT00844857|560340826|FG000|Overall Study|Protocol Violation|6|||
155248210|NCT00844857|560340827|FG001|Overall Study|Protocol Violation|0|||
155248211|NCT00844857|560340826|FG000|Overall Study|Lack of Efficacy|5|||
155248212|NCT00844857|560340827|FG001|Overall Study|Lack of Efficacy|5|||
155248213|NCT00844857|560340826|FG000|Overall Study|Clinical Relapse|0|||
155248214|NCT00844857|560340827|FG001|Overall Study|Clinical Relapse|1|||
155248215|NCT00844857|560340826|FG000|Overall Study|Entry Criteria Not Met|0|||
155248216|NCT00844857|560340827|FG001|Overall Study|Entry Criteria Not Met|1|||
155248217|NCT00844857|560340826|FG000|Overall Study|Lost to Follow-up|2|||
155248218|NCT00844857|560340827|FG001|Overall Study|Lost to Follow-up|3|||
155248219|NCT00844857|560340826|FG000|Overall Study|Did Not Take Study Drug|3|||
155248220|NCT00844857|560340827|FG001|Overall Study|Did Not Take Study Drug|1|||
155248221|NCT00844857|560340826|FG000|Overall Study|Good Clinical Practice Violations|21|||
155248222|NCT00844857|560340827|FG001|Overall Study|Good Clinical Practice Violations|11|||
155248223|NCT00570674|560340828|FG000|Overall Study|Withdrawal by Subject|0|||
155248224|NCT00570674|560340829|FG001|Overall Study|Withdrawal by Subject|0|||
155248225|NCT00570674|560340830|FG002|Overall Study|Withdrawal by Subject|1|||
155248226|NCT00570674|560340831|FG003|Overall Study|Withdrawal by Subject|0|||
155248227|NCT00570674|560340832|FG004|Overall Study|Withdrawal by Subject|0|||
155248228|NCT00570674|560340833|FG005|Overall Study|Withdrawal by Subject|0|||
155248229|NCT00570674|560340834|FG006|Overall Study|Withdrawal by Subject|0|||
155248230|NCT03069482|560340835|FG000|Overall Study|Lost to Follow-up|0|||
155248231|NCT03069482|560340836|FG001|Overall Study|Lost to Follow-up|1|||
155248232|NCT03069482|560340835|FG000|Overall Study|Physician Decision|1|||
155248233|NCT03069482|560340836|FG001|Overall Study|Physician Decision|0|||
155248234|NCT01912612|560340845|FG000|Overall Study|Adverse Event|4|||
155248235|NCT01912612|560340846|FG001|Overall Study|Adverse Event|0|||
155248236|NCT01912612|560340847|FG002|Overall Study|Adverse Event|0|||
155248237|NCT01912612|560340845|FG000|Overall Study|Withdrew consent|1|||
155248238|NCT01912612|560340846|FG001|Overall Study|Withdrew consent|0|||
155248239|NCT01912612|560340847|FG002|Overall Study|Withdrew consent|0|||
155248240|NCT01912612|560340845|FG000|Overall Study|Study design change|0|||
155248241|NCT01912612|560340846|FG001|Overall Study|Study design change|0|||
155248242|NCT01912612|560340847|FG002|Overall Study|Study design change|3|||
155248243|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
155248244|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
155248245|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
155248246|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248247|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248248|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248249|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248250|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248251|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248252|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248253|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248254|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248255|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248256|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248257|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
155248258|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
155248259|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
155248260|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248261|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248262|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248263|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248264|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248265|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248266|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248267|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248268|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248269|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248270|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248271|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
155248272|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
155248273|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
155248274|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248275|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248276|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248277|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248278|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248279|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248280|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248281|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248282|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248283|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248284|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248285|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
155248286|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
155248287|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
155248288|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248289|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248290|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248291|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248292|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248293|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248294|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248295|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248296|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248297|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248298|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248299|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248300|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
155248301|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
155248302|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248303|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248304|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248305|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248306|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248307|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248308|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248309|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248310|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248311|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248312|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248313|NCT02349295|560340852|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
155248314|NCT02349295|560340853|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
155248315|NCT02349295|560340854|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
155248316|NCT02349295|560340855|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
155248317|NCT02349295|560340856|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
155248318|NCT02349295|560340857|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
155248319|NCT02349295|560340858|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
155248320|NCT02349295|560340859|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
155248321|NCT02349295|560340860|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
155248322|NCT02349295|560340861|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
155248323|NCT02349295|560340862|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
155248324|NCT02349295|560340863|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
155248325|NCT02349295|560340864|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
155248326|NCT02349295|560340865|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
155248327|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248328|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248329|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248330|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248331|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248332|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248333|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248334|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
155248335|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
155248336|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
155248337|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
155248338|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248339|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248340|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248341|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248342|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248343|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248344|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248345|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248346|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248347|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248348|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
155248349|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
155248350|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
155248351|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
155248352|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248353|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248354|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248355|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248356|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248357|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248358|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248359|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248360|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248361|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248362|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
155248363|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248364|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
155248365|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248366|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248367|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248368|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248369|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
155248370|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
155248371|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
155248372|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
155248373|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
155248374|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
155248375|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
155248376|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
155248377|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
155248378|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
155248379|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
155248380|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
155248381|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
155248382|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
155248383|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248384|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248385|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248386|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248387|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248388|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248389|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248390|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
155248391|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
155248392|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
155248393|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
155248394|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248395|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248396|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248397|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248398|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248399|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248400|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248401|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248402|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248403|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248404|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
155248405|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
155248406|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248407|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248408|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248409|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248410|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248411|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248412|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248413|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248414|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248415|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248416|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248417|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248418|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
155248419|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
155248420|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248421|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248422|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248423|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248424|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248425|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248426|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248427|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248428|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248429|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248430|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248431|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248432|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248433|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248434|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248435|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248436|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
155248437|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
155248438|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
155248439|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248440|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248441|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248442|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248443|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248444|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248445|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248446|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248447|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248448|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248449|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248450|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
155248451|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
155248452|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248453|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248454|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248455|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248456|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248457|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248458|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248459|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248460|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248461|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248462|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248463|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248464|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
155248465|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
155248466|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248467|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248468|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248469|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248470|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248471|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248472|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248473|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248474|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248475|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248476|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248477|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248478|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
155248479|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248480|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248481|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248482|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248483|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248484|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248485|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248486|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155607053|NCT01897571|561649623|FG010|Overall Study|Death|59|||
155248487|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248488|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248489|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248490|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248491|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248492|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
155248493|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248494|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248495|NCT00620750|560340874|FG000|Overall Study|Lost to Follow-up|25|||
155248496|NCT04717596|560340876|FG000|Overall Study|Withdrawal by Subject|4|||
155248497|NCT00765843|560340877|FG000|Overall Study|Lost to Follow-up|1|||
155248498|NCT00765843|560340878|FG001|Overall Study|Lost to Follow-up|3|||
155248499|NCT00765843|560340879|FG002|Overall Study|Lost to Follow-up|2|||
155248500|NCT00765843|560340877|FG000|Overall Study|did not return to receive intervention|0|||
155248501|NCT00765843|560340878|FG001|Overall Study|did not return to receive intervention|1|||
155248502|NCT00765843|560340879|FG002|Overall Study|did not return to receive intervention|0|||
155248503|NCT00765843|560340877|FG000|Overall Study|Adverse Event|0|||
155248504|NCT00765843|560340878|FG001|Overall Study|Adverse Event|0|||
155248505|NCT00765843|560340879|FG002|Overall Study|Adverse Event|1|||
155248506|NCT04066114|560340880|FG000|Overall Study|Adverse Event|1|||
155248507|NCT04066114|560340881|FG001|Overall Study|Adverse Event|0|||
155248508|NCT04066114|560340882|FG002|Overall Study|Adverse Event|0|||
155248509|NCT04066114|560340880|FG000|Overall Study|Withdrawal by Subject|1|||
155248510|NCT04066114|560340881|FG001|Overall Study|Withdrawal by Subject|0|||
155248511|NCT04066114|560340882|FG002|Overall Study|Withdrawal by Subject|0|||
155248512|NCT04066114|560340880|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155248513|NCT04066114|560340881|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
155248514|NCT04066114|560340882|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
155248515|NCT02564523|560340883|FG000|Overall Study|Withdrawal by Subject|3|||
155248516|NCT02564523|560340884|FG001|Overall Study|Withdrawal by Subject|0|||
155248517|NCT02564523|560340885|FG002|Overall Study|Withdrawal by Subject|1|||
155248518|NCT02564523|560340886|FG003|Overall Study|Withdrawal by Subject|0|||
155248519|NCT02564523|560340887|FG004|Overall Study|Withdrawal by Subject|1|||
155248520|NCT02564523|560340888|FG005|Overall Study|Withdrawal by Subject|0|||
155248521|NCT02564523|560340889|FG006|Overall Study|Withdrawal by Subject|1|||
155248522|NCT02564523|560340890|FG007|Overall Study|Withdrawal by Subject|0|||
155248523|NCT02564523|560340891|FG008|Overall Study|Withdrawal by Subject|0|||
155248524|NCT02564523|560340892|FG009|Overall Study|Withdrawal by Subject|0|||
155248525|NCT02564523|560340893|FG010|Overall Study|Withdrawal by Subject|1|||
155248526|NCT02564523|560340894|FG011|Overall Study|Withdrawal by Subject|0|||
155248527|NCT02564523|560340895|FG012|Overall Study|Withdrawal by Subject|1|||
155248528|NCT02564523|560340896|FG013|Overall Study|Withdrawal by Subject|0|||
155248529|NCT02564523|560340897|FG014|Overall Study|Withdrawal by Subject|0|||
155248530|NCT02564523|560340898|FG015|Overall Study|Withdrawal by Subject|0|||
155248531|NCT02564523|560340899|FG016|Overall Study|Withdrawal by Subject|0|||
155248532|NCT02564523|560340900|FG017|Overall Study|Withdrawal by Subject|0|||
155248533|NCT02564523|560340883|FG000|Overall Study|Adverse Event|0|||
155248534|NCT02564523|560340884|FG001|Overall Study|Adverse Event|0|||
155248535|NCT02564523|560340885|FG002|Overall Study|Adverse Event|0|||
155248536|NCT02564523|560340886|FG003|Overall Study|Adverse Event|0|||
155248537|NCT02564523|560340887|FG004|Overall Study|Adverse Event|0|||
155248538|NCT02564523|560340888|FG005|Overall Study|Adverse Event|0|||
155248539|NCT02564523|560340889|FG006|Overall Study|Adverse Event|0|||
155248540|NCT02564523|560340890|FG007|Overall Study|Adverse Event|0|||
155248541|NCT02564523|560340891|FG008|Overall Study|Adverse Event|0|||
155248542|NCT02564523|560340892|FG009|Overall Study|Adverse Event|0|||
155248543|NCT02564523|560340893|FG010|Overall Study|Adverse Event|0|||
155248544|NCT02564523|560340894|FG011|Overall Study|Adverse Event|0|||
155248545|NCT02564523|560340895|FG012|Overall Study|Adverse Event|0|||
155248546|NCT02564523|560340896|FG013|Overall Study|Adverse Event|0|||
155248547|NCT02564523|560340897|FG014|Overall Study|Adverse Event|0|||
155248548|NCT02564523|560340898|FG015|Overall Study|Adverse Event|0|||
155248549|NCT02564523|560340899|FG016|Overall Study|Adverse Event|0|||
155248550|NCT02564523|560340900|FG017|Overall Study|Adverse Event|1|||
155248551|NCT02564523|560340883|FG000|Overall Study|Death|0|||
155248552|NCT02564523|560340884|FG001|Overall Study|Death|0|||
155248553|NCT02564523|560340885|FG002|Overall Study|Death|0|||
155248554|NCT02564523|560340886|FG003|Overall Study|Death|0|||
155248555|NCT02564523|560340887|FG004|Overall Study|Death|0|||
155248556|NCT02564523|560340888|FG005|Overall Study|Death|0|||
155248557|NCT02564523|560340889|FG006|Overall Study|Death|1|||
155248558|NCT02564523|560340890|FG007|Overall Study|Death|0|||
155248559|NCT02564523|560340891|FG008|Overall Study|Death|0|||
155248560|NCT02564523|560340892|FG009|Overall Study|Death|0|||
155248561|NCT02564523|560340893|FG010|Overall Study|Death|1|||
155248562|NCT02564523|560340894|FG011|Overall Study|Death|0|||
155248563|NCT02564523|560340895|FG012|Overall Study|Death|0|||
155248564|NCT02564523|560340896|FG013|Overall Study|Death|0|||
155248565|NCT02564523|560340897|FG014|Overall Study|Death|0|||
155248566|NCT02564523|560340898|FG015|Overall Study|Death|0|||
155248567|NCT02564523|560340899|FG016|Overall Study|Death|0|||
155248568|NCT02564523|560340900|FG017|Overall Study|Death|0|||
155248569|NCT02564523|560340883|FG000|Overall Study|Lost to Follow-up|2|||
155248570|NCT02564523|560340884|FG001|Overall Study|Lost to Follow-up|1|||
155248571|NCT02564523|560340885|FG002|Overall Study|Lost to Follow-up|4|||
155248572|NCT02564523|560340886|FG003|Overall Study|Lost to Follow-up|0|||
155248573|NCT02564523|560340887|FG004|Overall Study|Lost to Follow-up|1|||
155248574|NCT02564523|560340888|FG005|Overall Study|Lost to Follow-up|0|||
155248575|NCT02564523|560340889|FG006|Overall Study|Lost to Follow-up|1|||
155248576|NCT02564523|560340890|FG007|Overall Study|Lost to Follow-up|0|||
155248577|NCT02564523|560340891|FG008|Overall Study|Lost to Follow-up|0|||
155248578|NCT02564523|560340892|FG009|Overall Study|Lost to Follow-up|0|||
155248579|NCT02564523|560340893|FG010|Overall Study|Lost to Follow-up|0|||
155248580|NCT02564523|560340894|FG011|Overall Study|Lost to Follow-up|1|||
155248581|NCT02564523|560340895|FG012|Overall Study|Lost to Follow-up|1|||
155248582|NCT02564523|560340896|FG013|Overall Study|Lost to Follow-up|0|||
155248583|NCT02564523|560340897|FG014|Overall Study|Lost to Follow-up|0|||
155248584|NCT02564523|560340898|FG015|Overall Study|Lost to Follow-up|0|||
155248585|NCT02564523|560340899|FG016|Overall Study|Lost to Follow-up|0|||
155248586|NCT02564523|560340900|FG017|Overall Study|Lost to Follow-up|0|||
155248587|NCT02564523|560340883|FG000|Overall Study|Physician Decision|0|||
155248588|NCT02564523|560340884|FG001|Overall Study|Physician Decision|0|||
155248589|NCT02564523|560340885|FG002|Overall Study|Physician Decision|0|||
155248590|NCT02564523|560340886|FG003|Overall Study|Physician Decision|0|||
155248591|NCT02564523|560340887|FG004|Overall Study|Physician Decision|1|||
155248592|NCT02564523|560340888|FG005|Overall Study|Physician Decision|0|||
155248593|NCT02564523|560340889|FG006|Overall Study|Physician Decision|0|||
155248594|NCT02564523|560340890|FG007|Overall Study|Physician Decision|0|||
155248595|NCT02564523|560340891|FG008|Overall Study|Physician Decision|0|||
155248596|NCT02564523|560340892|FG009|Overall Study|Physician Decision|0|||
155248597|NCT02564523|560340893|FG010|Overall Study|Physician Decision|1|||
155248598|NCT02564523|560340894|FG011|Overall Study|Physician Decision|0|||
155248599|NCT02564523|560340895|FG012|Overall Study|Physician Decision|0|||
155248600|NCT02564523|560340896|FG013|Overall Study|Physician Decision|0|||
155248601|NCT02564523|560340897|FG014|Overall Study|Physician Decision|0|||
155248602|NCT02564523|560340898|FG015|Overall Study|Physician Decision|0|||
155248603|NCT02564523|560340899|FG016|Overall Study|Physician Decision|0|||
155248604|NCT02564523|560340900|FG017|Overall Study|Physician Decision|0|||
155248605|NCT02564523|560340883|FG000|Overall Study|Protocol Violation|2|||
155248606|NCT02564523|560340884|FG001|Overall Study|Protocol Violation|2|||
155248607|NCT02564523|560340885|FG002|Overall Study|Protocol Violation|5|||
155248608|NCT02564523|560340886|FG003|Overall Study|Protocol Violation|0|||
155248609|NCT02564523|560340887|FG004|Overall Study|Protocol Violation|1|||
155248610|NCT02564523|560340888|FG005|Overall Study|Protocol Violation|0|||
155248611|NCT02564523|560340889|FG006|Overall Study|Protocol Violation|0|||
155248612|NCT02564523|560340890|FG007|Overall Study|Protocol Violation|0|||
155248613|NCT02564523|560340891|FG008|Overall Study|Protocol Violation|0|||
155248614|NCT02564523|560340892|FG009|Overall Study|Protocol Violation|0|||
155248615|NCT02564523|560340893|FG010|Overall Study|Protocol Violation|0|||
155248616|NCT02564523|560340894|FG011|Overall Study|Protocol Violation|0|||
155248617|NCT02564523|560340895|FG012|Overall Study|Protocol Violation|0|||
155248618|NCT02564523|560340896|FG013|Overall Study|Protocol Violation|0|||
155248619|NCT02564523|560340897|FG014|Overall Study|Protocol Violation|0|||
155248620|NCT02564523|560340898|FG015|Overall Study|Protocol Violation|0|||
155248621|NCT02564523|560340899|FG016|Overall Study|Protocol Violation|0|||
155248622|NCT02564523|560340900|FG017|Overall Study|Protocol Violation|0|||
155248623|NCT02564523|560340883|FG000|Overall Study|Other|3|||
155248624|NCT02564523|560340884|FG001|Overall Study|Other|0|||
155248625|NCT02564523|560340885|FG002|Overall Study|Other|0|||
155248626|NCT02564523|560340886|FG003|Overall Study|Other|1|||
155248627|NCT02564523|560340887|FG004|Overall Study|Other|0|||
155248628|NCT02564523|560340888|FG005|Overall Study|Other|0|||
155248629|NCT02564523|560340889|FG006|Overall Study|Other|0|||
155248630|NCT02564523|560340890|FG007|Overall Study|Other|0|||
155248631|NCT02564523|560340891|FG008|Overall Study|Other|0|||
155248632|NCT02564523|560340892|FG009|Overall Study|Other|0|||
155248633|NCT02564523|560340893|FG010|Overall Study|Other|0|||
155248634|NCT02564523|560340894|FG011|Overall Study|Other|0|||
155248635|NCT02564523|560340895|FG012|Overall Study|Other|0|||
155248636|NCT02564523|560340896|FG013|Overall Study|Other|0|||
155248637|NCT02564523|560340897|FG014|Overall Study|Other|0|||
155248638|NCT02564523|560340898|FG015|Overall Study|Other|0|||
155248639|NCT02564523|560340899|FG016|Overall Study|Other|0|||
155248640|NCT02564523|560340900|FG017|Overall Study|Other|0|||
155248641|NCT00448539|560340901|FG000|Overall Study|Medication non-compliance|4|||
155248642|NCT00448539|560340902|FG001|Overall Study|Medication non-compliance|1|||
155248643|NCT00448539|560340901|FG000|Overall Study|Protocol Violation|1|||
155248644|NCT00448539|560340902|FG001|Overall Study|Protocol Violation|0|||
155248645|NCT00448539|560340901|FG000|Overall Study|Request of the investigator or sponsor|67|||
155248646|NCT00448539|560340902|FG001|Overall Study|Request of the investigator or sponsor|54|||
155248647|NCT00448539|560340901|FG000|Overall Study|Withdrawal by Subject|20|||
155248648|NCT00448539|560340902|FG001|Overall Study|Withdrawal by Subject|24|||
155248649|NCT00448539|560340901|FG000|Overall Study|Diary non-compliance|1|||
155248650|NCT00448539|560340902|FG001|Overall Study|Diary non-compliance|0|||
155248651|NCT00448539|560340901|FG000|Overall Study|Adverse Event|9|||
155248652|NCT00448539|560340902|FG001|Overall Study|Adverse Event|26|||
155248653|NCT00448539|560340901|FG000|Overall Study|Lack of Efficacy|27|||
155248654|NCT00448539|560340902|FG001|Overall Study|Lack of Efficacy|40|||
155248655|NCT00448539|560340901|FG000|Overall Study|Miscellaneous|2|||
155248656|NCT00448539|560340902|FG001|Overall Study|Miscellaneous|1|||
155248657|NCT00448539|560340901|FG000|Overall Study|Change of meds|2|||
155248658|NCT00448539|560340902|FG001|Overall Study|Change of meds|3|||
155248659|NCT00448539|560340901|FG000|Overall Study|Lost to Follow-up|1|||
155248660|NCT00448539|560340902|FG001|Overall Study|Lost to Follow-up|3|||
155248661|NCT03349710|560340903|FG000|Treatment Period|Death|0|||
155248662|NCT03349710|560340904|FG001|Treatment Period|Death|0|||
155248663|NCT03349710|560340905|FG002|Treatment Period|Death|1|||
155248664|NCT03349710|560340906|FG003|Treatment Period|Death|0|||
155248665|NCT03349710|560340903|FG000|Treatment Period|Disease Progression|0|||
155248666|NCT03349710|560340904|FG001|Treatment Period|Disease Progression|2|||
155248667|NCT03349710|560340905|FG002|Treatment Period|Disease Progression|0|||
155248668|NCT03349710|560340906|FG003|Treatment Period|Disease Progression|1|||
155248669|NCT03349710|560340903|FG000|Treatment Period|Study Drug Toxicity|1|||
155248670|NCT03349710|560340904|FG001|Treatment Period|Study Drug Toxicity|0|||
155248671|NCT03349710|560340905|FG002|Treatment Period|Study Drug Toxicity|1|||
155248672|NCT03349710|560340906|FG003|Treatment Period|Study Drug Toxicity|1|||
155248673|NCT03349710|560340903|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
155248674|NCT03349710|560340904|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248675|NCT03349710|560340905|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248676|NCT03349710|560340906|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248677|NCT03349710|560340903|FG000|Treatment Period|admin reason by sponsor|0|||
155248678|NCT03349710|560340904|FG001|Treatment Period|admin reason by sponsor|7|||
155248679|NCT03349710|560340905|FG002|Treatment Period|admin reason by sponsor|0|||
155248680|NCT03349710|560340906|FG003|Treatment Period|admin reason by sponsor|19|||
155248681|NCT03349710|560340903|FG000|Treatment Period|Other Reason|2|||
155248682|NCT03349710|560340904|FG001|Treatment Period|Other Reason|0|||
155248683|NCT03349710|560340905|FG002|Treatment Period|Other Reason|2|||
155248684|NCT03349710|560340906|FG003|Treatment Period|Other Reason|1|||
155248685|NCT03349710|560340903|FG000|Treatment Period|completed|6|||
155248686|NCT03349710|560340904|FG001|Treatment Period|completed|0|||
155248687|NCT03349710|560340905|FG002|Treatment Period|completed|18|||
155248688|NCT03349710|560340906|FG003|Treatment Period|completed|1|||
155248689|NCT03349710|560340903|FG000|Treatment Period|participant request to discontinue|0|||
155248690|NCT03349710|560340904|FG001|Treatment Period|participant request to discontinue|0|||
155248691|NCT03349710|560340905|FG002|Treatment Period|participant request to discontinue|4|||
155248692|NCT03349710|560340906|FG003|Treatment Period|participant request to discontinue|0|||
155248693|NCT03349710|560340903|FG000|Treatment Period|participant withdrew consent|1|||
155248694|NCT03349710|560340904|FG001|Treatment Period|participant withdrew consent|0|||
155248695|NCT03349710|560340905|FG002|Treatment Period|participant withdrew consent|0|||
155248696|NCT03349710|560340906|FG003|Treatment Period|participant withdrew consent|0|||
155248697|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
155248698|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
155248699|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
155248700|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
155248701|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
155248702|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
155248703|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
155248704|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
155248705|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
155248706|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
155248707|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
155248708|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
155248709|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
155248710|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
155248711|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
155248712|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
155248713|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
155248714|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
155248715|NCT02696317|560340909|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
155248716|NCT02696317|560340910|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
155248717|NCT02696317|560340909|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
155248718|NCT02696317|560340910|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
155248719|NCT01343368|560340911|FG000|Overall Study|Death|1|||
155248720|NCT01343368|560340912|FG001|Overall Study|Death|0|||
155248721|NCT01343368|560340911|FG000|Overall Study|Lost to Follow-up|1|||
155248722|NCT01343368|560340912|FG001|Overall Study|Lost to Follow-up|0|||
155248723|NCT00237744|560340918|FG000|Overall Study|Withdrawal by Subject|3|||
155248724|NCT00237744|560340919|FG001|Overall Study|Withdrawal by Subject|1|||
155248725|NCT00237744|560340920|FG002|Overall Study|Withdrawal by Subject|0|||
155248726|NCT01369342|560340923|FG000|Overall Study|Withdrawal by Subject|7|||
155248727|NCT01369342|560340924|FG001|Overall Study|Withdrawal by Subject|7|||
155248728|NCT01369342|560340925|FG002|Overall Study|Withdrawal by Subject|2|||
155248729|NCT01369342|560340923|FG000|Overall Study|Lost to Follow-up|5|||
155248730|NCT01369342|560340924|FG001|Overall Study|Lost to Follow-up|2|||
155248731|NCT01369342|560340925|FG002|Overall Study|Lost to Follow-up|1|||
155248732|NCT01369342|560340923|FG000|Overall Study|Not Treated|1|||
155248733|NCT01369342|560340924|FG001|Overall Study|Not Treated|0|||
155248734|NCT01369342|560340925|FG002|Overall Study|Not Treated|0|||
155248735|NCT01816594|560340926|FG000|Overall Study|Local Progress|0|||
155248736|NCT01816594|560340927|FG001|Overall Study|Local Progress|2|||
155248737|NCT01816594|560340926|FG000|Overall Study|Adverse Event|9|||
155248738|NCT01816594|560340927|FG001|Overall Study|Adverse Event|0|||
155248739|NCT01816594|560340926|FG000|Overall Study|Withdrawal by Subject|1|||
155248740|NCT01816594|560340927|FG001|Overall Study|Withdrawal by Subject|0|||
155248741|NCT01816594|560340926|FG000|Overall Study|Physician Decision|1|||
155248742|NCT01816594|560340927|FG001|Overall Study|Physician Decision|0|||
155248743|NCT04723576|560340928|FG000|Overall Study|Withdrawal by Subject|2133|||
155248744|NCT04723576|560340929|FG001|Overall Study|Withdrawal by Subject|3234|||
155248745|NCT03204279|560340933|FG000|Overall Study|Withdrawal by Subject|0|||
155248746|NCT03204279|560340934|FG001|Overall Study|Withdrawal by Subject|1|||
155248747|NCT01064739|560340935|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
155248748|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
155248749|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
155248750|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
155248751|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
155248752|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
155248753|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
155248754|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
155248755|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
155248756|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
155248757|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
155248758|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
155248759|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
155248760|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
155248761|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
155248762|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
155248763|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
155248764|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
155248765|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
155248766|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155248767|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
155248768|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
155248769|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155248770|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
155248771|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
155248772|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155248773|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Adverse Event|9|||
155248774|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Adverse Event|14|||
155248775|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155248776|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
155248777|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
155248778|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
155248779|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
155248780|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
155248781|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
155248782|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
155248783|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
155248784|NCT04258020|560340939|FG000|Overall Study|Withdrawal by Subject|1|||
155248785|NCT04258020|560340940|FG001|Overall Study|Withdrawal by Subject|0|||
155248786|NCT03117738|560340941|FG000|Overall Study|Withdrawal by Subject|3|||
155248787|NCT03117738|560340942|FG001|Overall Study|Withdrawal by Subject|1|||
155248788|NCT03117738|560340941|FG000|Overall Study|Lost to Follow-up|1|||
155248789|NCT03117738|560340942|FG001|Overall Study|Lost to Follow-up|4|||
155248790|NCT01669629|560340943|FG000|Period 1|protocol deviation|1|||
155248791|NCT01669629|560340944|FG001|Period 1|protocol deviation|2|||
155248792|NCT00130533|560340950|FG000|Overall Study|Withdrawal by Subject|33|||
155248793|NCT00130533|560340951|FG001|Overall Study|Withdrawal by Subject|6|||
155248794|NCT00130533|560340950|FG000|Overall Study|Adverse Event|34|||
155248795|NCT00130533|560340951|FG001|Overall Study|Adverse Event|1|||
155248796|NCT00130533|560340950|FG000|Overall Study|Disease relapse|9|||
155248797|NCT00130533|560340951|FG001|Overall Study|Disease relapse|13|||
155248798|NCT00130533|560340950|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
155248799|NCT00130533|560340951|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
155248800|NCT00130533|560340950|FG000|Overall Study|Death|4|||
155248801|NCT00130533|560340951|FG001|Overall Study|Death|2|||
155248802|NCT00130533|560340950|FG000|Overall Study|Protocol Violation|5|||
155248803|NCT00130533|560340951|FG001|Overall Study|Protocol Violation|1|||
155248804|NCT00130533|560340950|FG000|Overall Study|Lost to Follow-up|1|||
155248805|NCT00130533|560340951|FG001|Overall Study|Lost to Follow-up|1|||
155248806|NCT00130533|560340950|FG000|Overall Study|Sponsor´s decision|2|||
155248807|NCT00130533|560340951|FG001|Overall Study|Sponsor´s decision|0|||
155248808|NCT00130533|560340950|FG000|Overall Study|Second Primary Malignancy|0|||
155248809|NCT00130533|560340951|FG001|Overall Study|Second Primary Malignancy|1|||
155248810|NCT00130533|560340950|FG000|Overall Study|Other|12|||
155248811|NCT00130533|560340951|FG001|Overall Study|Other|5|||
155248812|NCT03927950|560340952|FG000|Overall Study|Adverse Event|9|||
155248813|NCT01491854|560340953|FG000|Overall Study|mainly due to premature termination|93|||
155248814|NCT01491854|560340953|FG000|Overall Study|Death|1|||
155248815|NCT01491854|560340953|FG000|Overall Study|Withdrawal by Subject|3|||
155248816|NCT01491854|560340953|FG000|Overall Study|Lost to Follow-up|33|||
155248817|NCT01026974|560340954|FG000|Overall Study|Withdrawal by Subject|0|||
155248818|NCT01026974|560340955|FG001|Overall Study|Withdrawal by Subject|1|||
155248819|NCT01026974|560340956|FG002|Overall Study|Withdrawal by Subject|7|||
155248820|NCT01026974|560340957|FG003|Overall Study|Withdrawal by Subject|2|||
155248821|NCT01026974|560340954|FG000|Overall Study|Lost to Follow-up|1|||
155248822|NCT01026974|560340955|FG001|Overall Study|Lost to Follow-up|1|||
155248823|NCT01026974|560340956|FG002|Overall Study|Lost to Follow-up|4|||
155248824|NCT01026974|560340957|FG003|Overall Study|Lost to Follow-up|0|||
155248825|NCT01026974|560340954|FG000|Overall Study|Adverse Event|0|||
155248826|NCT01026974|560340955|FG001|Overall Study|Adverse Event|0|||
155248827|NCT01026974|560340956|FG002|Overall Study|Adverse Event|0|||
155248828|NCT01026974|560340957|FG003|Overall Study|Adverse Event|1|||
155248829|NCT01026974|560340954|FG000|Overall Study|Inappropriate enrollment|0|||
155248830|NCT01026974|560340955|FG001|Overall Study|Inappropriate enrollment|0|||
155248831|NCT01026974|560340956|FG002|Overall Study|Inappropriate enrollment|1|||
155248832|NCT01026974|560340957|FG003|Overall Study|Inappropriate enrollment|0|||
155248833|NCT03638141|560340965|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
155248834|NCT03579563|560340966|FG000|Overall Study|Lost to Follow-up|0|||
155248835|NCT03579563|560340967|FG001|Overall Study|Lost to Follow-up|0|||
155248836|NCT03579563|560340968|FG002|Overall Study|Lost to Follow-up|0|||
155248837|NCT03579563|560340969|FG003|Overall Study|Lost to Follow-up|0|||
155248838|NCT03579563|560340970|FG004|Overall Study|Lost to Follow-up|1|||
155248839|NCT03579563|560340971|FG005|Overall Study|Lost to Follow-up|0|||
155248840|NCT03579563|560340966|FG000|Overall Study|Lack of Efficacy|1|||
155248841|NCT03579563|560340967|FG001|Overall Study|Lack of Efficacy|1|||
155248842|NCT03579563|560340968|FG002|Overall Study|Lack of Efficacy|4|||
155248843|NCT03579563|560340969|FG003|Overall Study|Lack of Efficacy|1|||
155248844|NCT03579563|560340970|FG004|Overall Study|Lack of Efficacy|2|||
155248845|NCT03579563|560340971|FG005|Overall Study|Lack of Efficacy|3|||
155248846|NCT03579563|560340966|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248847|NCT03579563|560340967|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155248848|NCT03579563|560340968|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155248849|NCT03579563|560340969|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
155248850|NCT03579563|560340970|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248851|NCT03579563|560340971|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248852|NCT03579563|560340966|FG000|Overall Study|Time/distance concern|0|||
155248853|NCT03579563|560340967|FG001|Overall Study|Time/distance concern|0|||
155248854|NCT03579563|560340968|FG002|Overall Study|Time/distance concern|1|||
155248855|NCT03579563|560340969|FG003|Overall Study|Time/distance concern|0|||
155248856|NCT03579563|560340970|FG004|Overall Study|Time/distance concern|0|||
155248857|NCT03579563|560340971|FG005|Overall Study|Time/distance concern|1|||
155248858|NCT03579563|560340966|FG000|Overall Study|COVID shutdown|2|||
155248859|NCT03579563|560340967|FG001|Overall Study|COVID shutdown|3|||
155248860|NCT03579563|560340968|FG002|Overall Study|COVID shutdown|4|||
155248861|NCT03579563|560340969|FG003|Overall Study|COVID shutdown|3|||
155248862|NCT03579563|560340970|FG004|Overall Study|COVID shutdown|1|||
155248863|NCT03579563|560340971|FG005|Overall Study|COVID shutdown|2|||
155248864|NCT03579563|560340966|FG000|Overall Study|Protocol administration error|1|||
155248865|NCT03579563|560340967|FG001|Overall Study|Protocol administration error|0|||
155248866|NCT03579563|560340968|FG002|Overall Study|Protocol administration error|1|||
155248867|NCT03579563|560340969|FG003|Overall Study|Protocol administration error|0|||
155248868|NCT03579563|560340970|FG004|Overall Study|Protocol administration error|1|||
155248869|NCT03579563|560340971|FG005|Overall Study|Protocol administration error|5|||
155248870|NCT03526250|560340972|FG000|Overall Study|Adverse Event|4|||
155248871|NCT03526250|560340972|FG000|Overall Study|Progressive Disease|16|||
155248872|NCT03526250|560340972|FG000|Overall Study|No Treatment|3|||
155248873|NCT04420221|560340973|FG000|Overall Study|Withdrawal by Subject|0|||
155248874|NCT04420221|560340974|FG001|Overall Study|Withdrawal by Subject|0|||
155248875|NCT04420221|560340975|FG002|Overall Study|Withdrawal by Subject|0|||
155248876|NCT04420221|560340976|FG003|Overall Study|Withdrawal by Subject|0|||
155248877|NCT04420221|560340977|FG004|Overall Study|Withdrawal by Subject|0|||
155248878|NCT04420221|560340978|FG005|Overall Study|Withdrawal by Subject|20|||
155248879|NCT04420221|560340979|FG006|Overall Study|Withdrawal by Subject|5|||
155248880|NCT04420221|560340973|FG000|Overall Study|Other|0|||
155248881|NCT04420221|560340974|FG001|Overall Study|Other|0|||
155248882|NCT04420221|560340975|FG002|Overall Study|Other|0|||
155248883|NCT04420221|560340976|FG003|Overall Study|Other|0|||
155248884|NCT04420221|560340977|FG004|Overall Study|Other|0|||
155248885|NCT04420221|560340978|FG005|Overall Study|Other|1|||
155248886|NCT04420221|560340979|FG006|Overall Study|Other|1|||
155248887|NCT04420221|560340973|FG000|Overall Study|Lost to Follow-up|0|||
155248888|NCT04420221|560340974|FG001|Overall Study|Lost to Follow-up|0|||
155248889|NCT04420221|560340975|FG002|Overall Study|Lost to Follow-up|0|||
155248890|NCT04420221|560340976|FG003|Overall Study|Lost to Follow-up|0|||
155248891|NCT04420221|560340977|FG004|Overall Study|Lost to Follow-up|0|||
155248892|NCT04420221|560340978|FG005|Overall Study|Lost to Follow-up|3|||
155248893|NCT04420221|560340979|FG006|Overall Study|Lost to Follow-up|2|||
155248894|NCT04420221|560340973|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
155248895|NCT04420221|560340974|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
155248896|NCT04420221|560340975|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
155248897|NCT04420221|560340976|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
155248898|NCT04420221|560340977|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
155248899|NCT04420221|560340978|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
155248900|NCT04420221|560340979|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
155248901|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
155248902|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248903|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248904|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248905|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
155248906|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248907|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248908|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248909|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
155248910|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248911|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248912|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248913|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
155248914|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248915|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248916|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248917|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
155248918|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248919|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248920|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248921|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
155248922|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248923|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248924|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248925|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
155248926|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248927|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248928|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248929|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248930|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248931|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248932|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
155248933|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
155248934|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
155248935|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
155248936|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
155248937|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
155248938|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
155248939|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
155248940|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
155248941|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
155248942|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
155248943|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
155248944|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
155248945|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
155248946|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
155248947|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
155248948|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
155248949|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
155248950|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
155248951|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
155248952|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
155248953|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248954|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
155248955|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248956|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248957|NCT02105948|560340988|FG000|Overall Study|Adverse Event|10|||
155248958|NCT02105948|560340989|FG001|Overall Study|Adverse Event|7|||
155248959|NCT02105948|560340990|FG002|Overall Study|Adverse Event|11|||
155248960|NCT02105948|560340991|FG003|Overall Study|Adverse Event|11|||
155248961|NCT02105948|560340988|FG000|Overall Study|Lack of Efficacy|0|||
155248962|NCT02105948|560340989|FG001|Overall Study|Lack of Efficacy|1|||
155248963|NCT02105948|560340990|FG002|Overall Study|Lack of Efficacy|3|||
155248964|NCT02105948|560340991|FG003|Overall Study|Lack of Efficacy|2|||
155248965|NCT02105948|560340988|FG000|Overall Study|Lost to Follow-up|0|||
155248966|NCT02105948|560340989|FG001|Overall Study|Lost to Follow-up|0|||
155248967|NCT02105948|560340990|FG002|Overall Study|Lost to Follow-up|2|||
155248968|NCT02105948|560340991|FG003|Overall Study|Lost to Follow-up|1|||
155248969|NCT02105948|560340988|FG000|Overall Study|Physician Decision|2|||
155248970|NCT02105948|560340989|FG001|Overall Study|Physician Decision|2|||
155248971|NCT02105948|560340990|FG002|Overall Study|Physician Decision|2|||
155248972|NCT02105948|560340991|FG003|Overall Study|Physician Decision|2|||
155248973|NCT02105948|560340988|FG000|Overall Study|Withdrawal by Subject|15|||
155248974|NCT02105948|560340989|FG001|Overall Study|Withdrawal by Subject|10|||
155248975|NCT02105948|560340990|FG002|Overall Study|Withdrawal by Subject|10|||
155248976|NCT02105948|560340991|FG003|Overall Study|Withdrawal by Subject|11|||
155248977|NCT04072159|560340995|FG000|Overall Study|Lost to Follow-up|6|||
155248978|NCT04072159|560340996|FG001|Overall Study|Lost to Follow-up|6|||
155248979|NCT04072159|560340995|FG000|Overall Study|Withdrawal by Subject|2|||
155248980|NCT04072159|560340996|FG001|Overall Study|Withdrawal by Subject|0|||
155248981|NCT01196975|560340998|FG000|Overall Study|Adverse Event|2|||
155248982|NCT01196975|560340999|FG001|Overall Study|Adverse Event|2|||
155248983|NCT01196975|560341000|FG002|Overall Study|Adverse Event|0|||
155248984|NCT01196975|560341001|FG003|Overall Study|Adverse Event|0|||
155248985|NCT01196975|560341002|FG004|Overall Study|Adverse Event|2|||
155248986|NCT01196975|560340998|FG000|Overall Study|Withdrawal by Subject|2|||
155248987|NCT01196975|560340999|FG001|Overall Study|Withdrawal by Subject|1|||
155248988|NCT01196975|560341000|FG002|Overall Study|Withdrawal by Subject|0|||
155248989|NCT01196975|560341001|FG003|Overall Study|Withdrawal by Subject|1|||
155248990|NCT01196975|560341002|FG004|Overall Study|Withdrawal by Subject|0|||
155248991|NCT01196975|560340998|FG000|Overall Study|Lost to Follow-up|11|||
155248992|NCT01196975|560340999|FG001|Overall Study|Lost to Follow-up|6|||
155248993|NCT01196975|560341000|FG002|Overall Study|Lost to Follow-up|5|||
155248994|NCT01196975|560341001|FG003|Overall Study|Lost to Follow-up|5|||
155248995|NCT01196975|560341002|FG004|Overall Study|Lost to Follow-up|11|||
155248996|NCT04558346|560341009|FG000|Overall Study|Withdrawal by Subject|2|||
155248997|NCT04558346|560341010|FG001|Overall Study|Withdrawal by Subject|0|||
155248998|NCT04558346|560341009|FG000|Overall Study|Lost to Follow-up|0|||
155248999|NCT04558346|560341010|FG001|Overall Study|Lost to Follow-up|1|||
155249000|NCT04558346|560341009|FG000|Overall Study|Adverse Event|0|||
155249001|NCT04558346|560341010|FG001|Overall Study|Adverse Event|1|||
155249002|NCT00724971|560341011|FG000|Overall Study|Adverse Event|5|||
155249003|NCT00724971|560341011|FG000|Overall Study|Withdrawal by Subject|1|||
155249004|NCT01462344|560341012|FG000|Overall Study|Withdrawal by Subject|245|||
155249005|NCT01462344|560341013|FG001|Overall Study|Withdrawal by Subject|226|||
155249006|NCT01462344|560341012|FG000|Overall Study|Adverse Event|24|||
155249007|NCT01462344|560341013|FG001|Overall Study|Adverse Event|23|||
155249008|NCT01462344|560341012|FG000|Overall Study|Asthma Exacerbation|34|||
155249009|NCT01462344|560341013|FG001|Overall Study|Asthma Exacerbation|35|||
155249010|NCT01462344|560341012|FG000|Overall Study|Lack of Efficacy|5|||
155249011|NCT01462344|560341013|FG001|Overall Study|Lack of Efficacy|6|||
155249012|NCT01462344|560341012|FG000|Overall Study|Protocol Violation|68|||
155249013|NCT01462344|560341013|FG001|Overall Study|Protocol Violation|53|||
155249014|NCT01462344|560341012|FG000|Overall Study|Lost to Follow-up|7|||
155249015|NCT01462344|560341013|FG001|Overall Study|Lost to Follow-up|7|||
155249016|NCT03086447|560341016|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155249017|NCT03086447|560341017|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
155249018|NCT03086447|560341016|FG000|Overall Study|Lost Lens|2|||
155249019|NCT03086447|560341017|FG001|Overall Study|Lost Lens|5|||
155249020|NCT03086447|560341016|FG000|Overall Study|Product quality complaint|0|||
155249021|NCT03086447|560341017|FG001|Overall Study|Product quality complaint|1|||
155249022|NCT03086447|560341016|FG000|Overall Study|Lens Damage|1|||
155249023|NCT03086447|560341017|FG001|Overall Study|Lens Damage|6|||
155249024|NCT03086447|560341016|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155249025|NCT03086447|560341017|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155249026|NCT03086447|560341016|FG000|Overall Study|Test Article No Longer Available|1|||
155249027|NCT03086447|560341017|FG001|Overall Study|Test Article No Longer Available|0|||
155249028|NCT03086447|560341016|FG000|Overall Study|Protocol Violation|2|||
155249029|NCT03086447|560341017|FG001|Overall Study|Protocol Violation|4|||
155249030|NCT03086447|560341016|FG000|Overall Study|Lost to Follow-up|0|||
155249031|NCT03086447|560341017|FG001|Overall Study|Lost to Follow-up|1|||
155249032|NCT03086447|560341016|FG000|Overall Study|Adverse Event|3|||
155249033|NCT03086447|560341017|FG001|Overall Study|Adverse Event|0|||
155249034|NCT03086447|560341016|FG000|Overall Study|Lens Discomfort|2|||
155249035|NCT03086447|560341017|FG001|Overall Study|Lens Discomfort|1|||
155249036|NCT01128413|560341020|FG000|Overall Study|Withdrawal by Subject|1|||
155249037|NCT01128413|560341021|FG001|Overall Study|Withdrawal by Subject|0|||
155249038|NCT01128413|560341020|FG000|Overall Study|NICOM Monitor Problems|2|||
155249039|NCT01128413|560341021|FG001|Overall Study|NICOM Monitor Problems|1|||
155249040|NCT01128413|560341020|FG000|Overall Study|Pt made DNR|1|||
155249041|NCT01128413|560341021|FG001|Overall Study|Pt made DNR|0|||
155249042|NCT02075593|560341025|FG000|Overall Study|Withdrawal by Subject|1|||
155249043|NCT00726752|560341026|FG000|Overall Study|Lack of Efficacy|6|||
155249044|NCT01588184|560342721|FG000|Overall Study|Death|1|||
155249045|NCT01588184|560342722|FG001|Overall Study|Death|0|||
155249046|NCT01588184|560342723|FG002|Overall Study|Death|0|||
155249047|NCT01588184|560342724|FG003|Overall Study|Death|1|||
155249048|NCT01588184|560342725|FG004|Overall Study|Death|1|||
155249049|NCT01588184|560342726|FG005|Overall Study|Death|1|||
155249050|NCT01588184|560342721|FG000|Overall Study|Withdrawal by Subject|2|||
155249051|NCT01588184|560342722|FG001|Overall Study|Withdrawal by Subject|4|||
155249052|NCT01588184|560342723|FG002|Overall Study|Withdrawal by Subject|0|||
155249053|NCT01588184|560342724|FG003|Overall Study|Withdrawal by Subject|1|||
155249054|NCT01588184|560342725|FG004|Overall Study|Withdrawal by Subject|0|||
155249055|NCT01588184|560342726|FG005|Overall Study|Withdrawal by Subject|0|||
155249056|NCT01588184|560342721|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
155249057|NCT01588184|560342722|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
155249058|NCT01588184|560342723|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
155249059|NCT01588184|560342724|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
155249060|NCT01588184|560342725|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
155249061|NCT01588184|560342726|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
155249062|NCT01588184|560342721|FG000|Overall Study|multiple reasons|0|||
155249063|NCT01588184|560342722|FG001|Overall Study|multiple reasons|3|||
155249064|NCT01588184|560342723|FG002|Overall Study|multiple reasons|0|||
155249065|NCT01588184|560342724|FG003|Overall Study|multiple reasons|1|||
155249066|NCT01588184|560342725|FG004|Overall Study|multiple reasons|0|||
155249067|NCT01588184|560342726|FG005|Overall Study|multiple reasons|0|||
155249068|NCT00907153|560342732|FG000|Overall Study|Lost to Follow-up|1|||
155249069|NCT00907153|560342733|FG001|Overall Study|Lost to Follow-up|1|||
155249070|NCT00907153|560342732|FG000|Overall Study|Withdrawal by Subject|1|||
155249071|NCT00907153|560342733|FG001|Overall Study|Withdrawal by Subject|3|||
155249072|NCT01773070|560342739|FG000|Overall Study|Withdrawal by Subject|24|||
155249073|NCT01773070|560342739|FG000|Overall Study|Lost to Follow-up|39|||
155249074|NCT01773070|560342739|FG000|Overall Study|Other|15|||
155249075|NCT01773070|560342739|FG000|Overall Study|Death (unrelated to study procedures)|3|||
155249076|NCT01559844|560342740|FG000|Overall Study|Consent Withdrawn|7|||
155249077|NCT01559844|560342740|FG000|Overall Study|Death|5|||
155249078|NCT01559844|560342740|FG000|Overall Study|Efficacy Failure|10|||
155249079|NCT01559844|560342740|FG000|Overall Study|No Longer A Transplant Candidate|3|||
155249080|NCT02181803|560342741|FG000|Overall Study|Withdrawal by Subject|0|||
155249081|NCT02181803|560342742|FG001|Overall Study|Withdrawal by Subject|2|||
155249082|NCT02181803|560342743|FG002|Overall Study|Withdrawal by Subject|0|||
155249083|NCT02181803|560342744|FG003|Overall Study|Withdrawal by Subject|0|||
155249084|NCT02181803|560342745|FG004|Overall Study|Withdrawal by Subject|0|||
155249085|NCT02181803|560342746|FG005|Overall Study|Withdrawal by Subject|0|||
155249086|NCT02181803|560342747|FG006|Overall Study|Withdrawal by Subject|0|||
155249087|NCT02181803|560342748|FG007|Overall Study|Withdrawal by Subject|0|||
155249088|NCT02181803|560342749|FG008|Overall Study|Withdrawal by Subject|0|||
155249089|NCT02181803|560342741|FG000|Overall Study|Physician Decision|0|||
155249090|NCT02181803|560342742|FG001|Overall Study|Physician Decision|0|||
155249091|NCT02181803|560342743|FG002|Overall Study|Physician Decision|0|||
155249092|NCT02181803|560342744|FG003|Overall Study|Physician Decision|1|||
155249093|NCT02181803|560342745|FG004|Overall Study|Physician Decision|0|||
155249094|NCT02181803|560342746|FG005|Overall Study|Physician Decision|0|||
155249095|NCT02181803|560342747|FG006|Overall Study|Physician Decision|0|||
155249096|NCT02181803|560342748|FG007|Overall Study|Physician Decision|1|||
155249097|NCT02181803|560342749|FG008|Overall Study|Physician Decision|0|||
155249098|NCT02181803|560342741|FG000|Overall Study|Adverse Event|0|||
155249099|NCT02181803|560342742|FG001|Overall Study|Adverse Event|2|||
155249100|NCT02181803|560342743|FG002|Overall Study|Adverse Event|0|||
155249101|NCT02181803|560342744|FG003|Overall Study|Adverse Event|1|||
155249102|NCT02181803|560342745|FG004|Overall Study|Adverse Event|0|||
155249103|NCT02181803|560342746|FG005|Overall Study|Adverse Event|0|||
155249104|NCT02181803|560342747|FG006|Overall Study|Adverse Event|1|||
155249105|NCT02181803|560342748|FG007|Overall Study|Adverse Event|0|||
155249106|NCT02181803|560342749|FG008|Overall Study|Adverse Event|0|||
155249107|NCT00951041|560342750|FG000|Overall Study|Withdrawal by Subject|1|||
155249108|NCT00951041|560342751|FG001|Overall Study|Withdrawal by Subject|1|||
155249109|NCT00951041|560342750|FG000|Overall Study|Lost to Follow-up|1|||
155249110|NCT00951041|560342751|FG001|Overall Study|Lost to Follow-up|0|||
155249111|NCT00951041|560342750|FG000|Overall Study|Other|3|||
155249112|NCT00951041|560342751|FG001|Overall Study|Other|0|||
155249113|NCT04477187|560342758|FG000|Overall Study|Lost to Follow-up|2|||
155249114|NCT02460991|560342759|FG000|Overall Study|Withdrawal by Subject|0|||
155249115|NCT02460991|560342760|FG001|Overall Study|Withdrawal by Subject|2|||
155249116|NCT01296568|560342761|FG000|Continued Access Phase|Lost to Follow-up|1|||
155249117|NCT01296568|560342761|FG000|Continued Access Phase|Withdrawal by Subject|1|||
155249118|NCT01296568|560342761|FG000|Continued Access Phase|Disease Progression|1|||
155249119|NCT00321854|560342762|FG000|Overall Study|Adverse Event|41|||
155249120|NCT00321854|560342763|FG001|Overall Study|Adverse Event|43|||
155249121|NCT00321854|560342762|FG000|Overall Study|Lack of Efficacy|9|||
155249122|NCT00321854|560342763|FG001|Overall Study|Lack of Efficacy|14|||
155249123|NCT00321854|560342762|FG000|Overall Study|Protocol Violation|6|||
155249124|NCT00321854|560342763|FG001|Overall Study|Protocol Violation|5|||
155249125|NCT00321854|560342762|FG000|Overall Study|Lost to Follow-up|0|||
155249126|NCT00321854|560342763|FG001|Overall Study|Lost to Follow-up|2|||
155249127|NCT00321854|560342762|FG000|Overall Study|Withdrawal by Subject|6|||
155249128|NCT00321854|560342763|FG001|Overall Study|Withdrawal by Subject|17|||
155249129|NCT00321854|560342762|FG000|Overall Study|Other|1|||
155249130|NCT00321854|560342763|FG001|Overall Study|Other|1|||
155249131|NCT03905655|560342764|FG000|Overall Study|Adverse Event|1|||
155249132|NCT03905655|560342765|FG001|Overall Study|Adverse Event|0|||
155249133|NCT03905655|560342766|FG002|Overall Study|Adverse Event|1|||
155249134|NCT03905655|560342767|FG003|Overall Study|Adverse Event|1|||
155249135|NCT02277106|560342768|FG000|Stage 2|Adverse Event|0|||
155249136|NCT02277106|560342769|FG001|Stage 2|Adverse Event|0|||
155249137|NCT02277106|560342770|FG002|Stage 2|Adverse Event|1|||
155249138|NCT01292928|560342771|FG000|Overall Study|Death|8|||
155249139|NCT01292928|560342771|FG000|Overall Study|Withdrawal by Subject|8|||
155249140|NCT01292928|560342771|FG000|Overall Study|Lost to Follow-up|6|||
155249141|NCT01292928|560342771|FG000|Overall Study|Physician Decision|2|||
155249142|NCT01059565|560342772|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
155249143|NCT01059565|560342773|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
155249144|NCT01059565|560342772|FG000|24-Week Randomized Phase|Adverse Event|5|||
155249145|NCT01059565|560342773|FG001|24-Week Randomized Phase|Adverse Event|0|||
155249146|NCT01059565|560342772|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
155249147|NCT01059565|560342773|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
155249148|NCT01059565|560342772|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
155249149|NCT01059565|560342773|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
155249150|NCT01059565|560342772|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
155249151|NCT01059565|560342773|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
155249152|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Adverse Event|2|||
155249153|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Adverse Event|0|||
155249154|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
155249155|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
155249156|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
155249157|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
155249158|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
155249159|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
155249160|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
155249161|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
155249162|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
155249163|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
155249164|NCT03263429|560342774|FG000|Overall Study|Withdrawal by Subject|0|||
155249165|NCT03263429|560342775|FG001|Overall Study|Withdrawal by Subject|1|||
155249166|NCT03263429|560342776|FG002|Overall Study|Withdrawal by Subject|0|||
155249167|NCT03263429|560342774|FG000|Overall Study|Follow-Up Period Completed|0|||
155249168|NCT03263429|560342775|FG001|Overall Study|Follow-Up Period Completed|2|||
155249169|NCT03263429|560342776|FG002|Overall Study|Follow-Up Period Completed|0|||
155249170|NCT03263429|560342774|FG000|Overall Study|Death|3|||
155249171|NCT03263429|560342775|FG001|Overall Study|Death|5|||
155249172|NCT03263429|560342776|FG002|Overall Study|Death|16|||
155249173|NCT03263429|560342774|FG000|Overall Study|Participant unable to return|0|||
155249174|NCT03263429|560342775|FG001|Overall Study|Participant unable to return|0|||
155249175|NCT03263429|560342776|FG002|Overall Study|Participant unable to return|1|||
155249176|NCT03263429|560342774|FG000|Overall Study|Study Closed|0|||
155249177|NCT03263429|560342775|FG001|Overall Study|Study Closed|0|||
155249178|NCT03263429|560342776|FG002|Overall Study|Study Closed|1|||
155249179|NCT04530448|560342777|FG000|Overall Study|Physician Decision|3|||
155249180|NCT04530448|560342778|FG001|Overall Study|Physician Decision|0|||
155249181|NCT02219932|560342785|FG000|Overall Study|Other|5|||
155249182|NCT02219932|560342786|FG001|Overall Study|Other|11|||
155249183|NCT02219932|560342785|FG000|Overall Study|Death|1|||
155249184|NCT02219932|560342786|FG001|Overall Study|Death|1|||
155249185|NCT02219932|560342785|FG000|Overall Study|Investigator Decision|0|||
155249186|NCT02219932|560342786|FG001|Overall Study|Investigator Decision|1|||
155249187|NCT02219932|560342785|FG000|Overall Study|Consent Withdrawn|11|||
155249188|NCT02219932|560342786|FG001|Overall Study|Consent Withdrawn|7|||
155249189|NCT02219932|560342785|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
155249190|NCT02219932|560342786|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
155249191|NCT02219932|560342785|FG000|Overall Study|Protocol Violation|10|||
155249192|NCT02219932|560342786|FG001|Overall Study|Protocol Violation|6|||
155249193|NCT02219932|560342785|FG000|Overall Study|Pregnancy|1|||
155249194|NCT02219932|560342786|FG001|Overall Study|Pregnancy|0|||
155249195|NCT02219932|560342785|FG000|Overall Study|Lost to Follow-up|4|||
155249196|NCT02219932|560342786|FG001|Overall Study|Lost to Follow-up|2|||
155249197|NCT02219932|560342785|FG000|Overall Study|Adverse Event|23|||
155249198|NCT02219932|560342786|FG001|Overall Study|Adverse Event|21|||
155249199|NCT00511004|560342787|FG000|Overall Study|Lost to Follow-up|0|||
155249200|NCT00511004|560342788|FG001|Overall Study|Lost to Follow-up|0|||
155249201|NCT00511004|560342789|FG002|Overall Study|Lost to Follow-up|4|||
155249202|NCT00990652|560342790|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
155249203|NCT00990652|560342790|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
155249204|NCT05177770|560342791|FG000|Overall Study|Death|4|||
155249205|NCT05177770|560342791|FG000|Overall Study|Withdrawal by Subject|1|||
155249206|NCT05177770|560342791|FG000|Overall Study|Adverse Event prior to dosing|1|||
155249207|NCT01672801|560342796|FG000|Overall Study|Screen Failure|0|||
155249208|NCT01672801|560342797|FG001|Overall Study|Screen Failure|1|||
155249209|NCT02384954|560342805|FG000|Phase 1|Progressive Disease|2|||
155249210|NCT02384954|560342806|FG001|Phase 1|Progressive Disease|0|||
155249211|NCT02384954|560342807|FG002|Phase 1|Progressive Disease|1|||
155249212|NCT02384954|560342808|FG003|Phase 1|Progressive Disease|1|||
155249213|NCT02384954|560342809|FG004|Phase 1|Progressive Disease|0|||
155249214|NCT02384954|560342810|FG005|Phase 1|Progressive Disease|0|||
155249215|NCT02384954|560342811|FG006|Phase 1|Progressive Disease|0|||
155249216|NCT02384954|560342812|FG007|Phase 1|Progressive Disease|0|||
155249217|NCT02384954|560342813|FG008|Phase 1|Progressive Disease|0|||
155249218|NCT02384954|560342805|FG000|Phase 1|Adverse Event|0|||
155249219|NCT02384954|560342806|FG001|Phase 1|Adverse Event|0|||
155249220|NCT02384954|560342807|FG002|Phase 1|Adverse Event|1|||
155249221|NCT02384954|560342808|FG003|Phase 1|Adverse Event|0|||
155249222|NCT02384954|560342809|FG004|Phase 1|Adverse Event|0|||
155249223|NCT02384954|560342810|FG005|Phase 1|Adverse Event|0|||
155249224|NCT02384954|560342811|FG006|Phase 1|Adverse Event|0|||
155249225|NCT02384954|560342812|FG007|Phase 1|Adverse Event|0|||
155249226|NCT02384954|560342813|FG008|Phase 1|Adverse Event|0|||
155249227|NCT02384954|560342805|FG000|Phase 2|Progressive Disease|0|||
155249228|NCT02384954|560342806|FG001|Phase 2|Progressive Disease|0|||
155249229|NCT02384954|560342807|FG002|Phase 2|Progressive Disease|0|||
155249230|NCT02384954|560342808|FG003|Phase 2|Progressive Disease|0|||
155249231|NCT02384954|560342809|FG004|Phase 2|Progressive Disease|0|||
155249232|NCT02384954|560342810|FG005|Phase 2|Progressive Disease|0|||
155249233|NCT02384954|560342811|FG006|Phase 2|Progressive Disease|0|||
155249234|NCT02384954|560342812|FG007|Phase 2|Progressive Disease|1|||
155249235|NCT02384954|560342813|FG008|Phase 2|Progressive Disease|2|||
155249236|NCT02384954|560342805|FG000|Phase 2|Adverse Event|0|||
155249237|NCT02384954|560342806|FG001|Phase 2|Adverse Event|0|||
155249238|NCT02384954|560342807|FG002|Phase 2|Adverse Event|0|||
155249239|NCT02384954|560342808|FG003|Phase 2|Adverse Event|0|||
155249240|NCT02384954|560342809|FG004|Phase 2|Adverse Event|0|||
155249241|NCT02384954|560342810|FG005|Phase 2|Adverse Event|0|||
155249242|NCT02384954|560342811|FG006|Phase 2|Adverse Event|0|||
155249243|NCT02384954|560342812|FG007|Phase 2|Adverse Event|1|||
155249244|NCT02384954|560342813|FG008|Phase 2|Adverse Event|1|||
155249245|NCT02384954|560342805|FG000|Phase 2|Failure to meet continuation criteria|0|||
155249246|NCT02384954|560342806|FG001|Phase 2|Failure to meet continuation criteria|0|||
155249247|NCT02384954|560342807|FG002|Phase 2|Failure to meet continuation criteria|0|||
155249248|NCT02384954|560342808|FG003|Phase 2|Failure to meet continuation criteria|0|||
155249249|NCT02384954|560342809|FG004|Phase 2|Failure to meet continuation criteria|0|||
155249250|NCT02384954|560342810|FG005|Phase 2|Failure to meet continuation criteria|0|||
155249251|NCT02384954|560342811|FG006|Phase 2|Failure to meet continuation criteria|0|||
155249252|NCT02384954|560342812|FG007|Phase 2|Failure to meet continuation criteria|1|||
155249253|NCT02384954|560342813|FG008|Phase 2|Failure to meet continuation criteria|0|||
155249254|NCT02372396|560342817|FG000|Overall Study|Lost to Follow-up|7|||
155249255|NCT02372396|560342818|FG001|Overall Study|Lost to Follow-up|9|||
155249256|NCT00214136|560342823|FG000|Overall Study|Death|5|||
155249257|NCT01272934|560342824|FG000|Overall Study|Adverse Event|0|||
155249258|NCT01272934|560342825|FG001|Overall Study|Adverse Event|1|||
155249259|NCT01272934|560342824|FG000|Overall Study|Abnormal Laboratory Value|0|||
155249260|NCT01272934|560342825|FG001|Overall Study|Abnormal Laboratory Value|1|||
155249261|NCT04313634|560342826|FG000|Overall Study|Adverse Event|2|||
155249262|NCT04313634|560342827|FG001|Overall Study|Adverse Event|2|||
155249263|NCT04313634|560342828|FG002|Overall Study|Adverse Event|0|||
155249264|NCT04313634|560342826|FG000|Overall Study|Withdrawal by Subject|1|||
155249265|NCT04313634|560342827|FG001|Overall Study|Withdrawal by Subject|0|||
155249266|NCT04313634|560342828|FG002|Overall Study|Withdrawal by Subject|1|||
155249267|NCT04313634|560342826|FG000|Overall Study|Protocol Violation|0|||
155249268|NCT04313634|560342827|FG001|Overall Study|Protocol Violation|0|||
155249269|NCT04313634|560342828|FG002|Overall Study|Protocol Violation|1|||
155249270|NCT03595904|560342834|FG000|Overall Study|Protocol Violation|3|||
155249271|NCT03595904|560342835|FG001|Overall Study|Protocol Violation|1|||
155249272|NCT03595904|560342834|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
155249273|NCT03595904|560342835|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
155249274|NCT03595904|560342834|FG000|Overall Study|Insurance complications|1|||
155249275|NCT03595904|560342835|FG001|Overall Study|Insurance complications|0|||
155249276|NCT03595904|560342834|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
155249277|NCT03595904|560342835|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
155249278|NCT01581281|560342836|FG000|Overall Study|Early Study Closure|15|||
155249279|NCT01581281|560342837|FG001|Overall Study|Early Study Closure|6|||
155249280|NCT01581281|560342838|FG002|Overall Study|Early Study Closure|12|||
155249281|NCT02187991|560342841|FG000|Overall Study|Adverse Event|13|||
155249282|NCT02187991|560342842|FG001|Overall Study|Adverse Event|14|||
155249283|NCT02187991|560342843|FG002|Overall Study|Adverse Event|3|||
155249284|NCT02187991|560342844|FG003|Overall Study|Adverse Event|2|||
155249285|NCT02187991|560342841|FG000|Overall Study|Withdrawal by Subject|9|||
155249286|NCT02187991|560342842|FG001|Overall Study|Withdrawal by Subject|6|||
155249287|NCT02187991|560342843|FG002|Overall Study|Withdrawal by Subject|3|||
155249288|NCT02187991|560342844|FG003|Overall Study|Withdrawal by Subject|2|||
155249289|NCT02187991|560342841|FG000|Overall Study|Physician Decision|4|||
155249290|NCT02187991|560342842|FG001|Overall Study|Physician Decision|4|||
155249291|NCT02187991|560342843|FG002|Overall Study|Physician Decision|0|||
155249292|NCT02187991|560342844|FG003|Overall Study|Physician Decision|2|||
155249293|NCT02187991|560342841|FG000|Overall Study|Other, unrelated complication|7|||
155249294|NCT02187991|560342842|FG001|Overall Study|Other, unrelated complication|1|||
155249295|NCT02187991|560342843|FG002|Overall Study|Other, unrelated complication|1|||
155249296|NCT02187991|560342844|FG003|Overall Study|Other, unrelated complication|2|||
155249297|NCT02187991|560342841|FG000|Overall Study|Death|1|||
155249298|NCT02187991|560342842|FG001|Overall Study|Death|3|||
155249299|NCT02187991|560342843|FG002|Overall Study|Death|0|||
155249300|NCT02187991|560342844|FG003|Overall Study|Death|0|||
155249301|NCT01358526|560342853|FG000|Open-label Titration Period|Adverse Event|95|||
155249302|NCT01358526|560342854|FG001|Open-label Titration Period|Adverse Event|0|||
155249303|NCT01358526|560342855|FG002|Open-label Titration Period|Adverse Event|0|||
155249304|NCT01358526|560342853|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
155249305|NCT01358526|560342854|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
155249306|NCT01358526|560342855|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
155249307|NCT01358526|560342853|FG000|Open-label Titration Period|Lost to Follow-up|25|||
155249308|NCT01358526|560342854|FG001|Open-label Titration Period|Lost to Follow-up|0|||
155249309|NCT01358526|560342855|FG002|Open-label Titration Period|Lost to Follow-up|0|||
155249310|NCT01358526|560342853|FG000|Open-label Titration Period|Lack of Efficacy|107|||
155249311|NCT01358526|560342854|FG001|Open-label Titration Period|Lack of Efficacy|0|||
155249312|NCT01358526|560342855|FG002|Open-label Titration Period|Lack of Efficacy|0|||
155249313|NCT01358526|560342853|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
155249314|NCT01358526|560342854|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
155249315|NCT01358526|560342855|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
155249316|NCT01358526|560342853|FG000|Open-label Titration Period|Administrative|8|||
155249317|NCT01358526|560342854|FG001|Open-label Titration Period|Administrative|0|||
155249318|NCT01358526|560342855|FG002|Open-label Titration Period|Administrative|0|||
155249319|NCT01358526|560342853|FG000|Open-label Titration Period|Did not qualify|178|||
155249320|NCT01358526|560342854|FG001|Open-label Titration Period|Did not qualify|0|||
155249321|NCT01358526|560342855|FG002|Open-label Titration Period|Did not qualify|0|||
155249322|NCT01358526|560342853|FG000|Double-blind Phase|Adverse Event|0|||
155249323|NCT01358526|560342854|FG001|Double-blind Phase|Adverse Event|24|||
155249324|NCT01358526|560342855|FG002|Double-blind Phase|Adverse Event|23|||
155249325|NCT01358526|560342853|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155249326|NCT01358526|560342854|FG001|Double-blind Phase|Withdrawal by Subject|10|||
155249327|NCT01358526|560342855|FG002|Double-blind Phase|Withdrawal by Subject|8|||
155249328|NCT01358526|560342853|FG000|Double-blind Phase|Lost to Follow-up|0|||
155249329|NCT01358526|560342854|FG001|Double-blind Phase|Lost to Follow-up|4|||
155249330|NCT01358526|560342855|FG002|Double-blind Phase|Lost to Follow-up|1|||
155249331|NCT01358526|560342853|FG000|Double-blind Phase|Lack of Efficacy|0|||
155249332|NCT01358526|560342854|FG001|Double-blind Phase|Lack of Efficacy|31|||
155249333|NCT01358526|560342855|FG002|Double-blind Phase|Lack of Efficacy|73|||
155249334|NCT01358526|560342853|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
155249335|NCT01358526|560342854|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
155249336|NCT01358526|560342855|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
155249337|NCT01358526|560342853|FG000|Double-blind Phase|Administrative|0|||
155249338|NCT01358526|560342854|FG001|Double-blind Phase|Administrative|6|||
155249339|NCT01358526|560342855|FG002|Double-blind Phase|Administrative|10|||
155249340|NCT01003249|560342858|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249341|NCT01003249|560342859|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249342|NCT01003249|560342858|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
155249343|NCT01003249|560342859|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
155249344|NCT01003249|560342858|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155249345|NCT01003249|560342859|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249346|NCT01003249|560342858|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
155249347|NCT01003249|560342859|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
155249348|NCT02194621|560342860|FG000|Overall Study|6 withdrew prior to randomization|2|||
155249349|NCT02194621|560342861|FG001|Overall Study|6 withdrew prior to randomization|2|||
155249350|NCT02194621|560342862|FG002|Overall Study|6 withdrew prior to randomization|2|||
155249351|NCT02194621|560342860|FG000|Overall Study|Withdrawal by Subject|4|||
155249352|NCT02194621|560342861|FG001|Overall Study|Withdrawal by Subject|4|||
155249353|NCT02194621|560342862|FG002|Overall Study|Withdrawal by Subject|7|||
155249354|NCT00714168|560342870|FG000|Overall Study|Pregnancy|5|||
155249355|NCT00714168|560342871|FG001|Overall Study|Pregnancy|4|||
155249356|NCT00714168|560342870|FG000|Overall Study|Lost to Follow-up|32|||
155249357|NCT00714168|560342871|FG001|Overall Study|Lost to Follow-up|50|||
155249358|NCT00714168|560342870|FG000|Overall Study|Relocation|4|||
155249359|NCT00714168|560342871|FG001|Overall Study|Relocation|3|||
155249360|NCT00714168|560342870|FG000|Overall Study|Non-study medical condition|3|||
155249361|NCT00714168|560342871|FG001|Overall Study|Non-study medical condition|2|||
155249362|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
155249363|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155249364|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155249365|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249366|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249367|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249368|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249369|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249370|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
155249371|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249372|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249373|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249374|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
155249375|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
155249376|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249377|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249378|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249379|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249380|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
155249381|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
155249382|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
155249383|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249384|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249385|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249386|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
155249387|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
155249388|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
155249389|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249390|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249391|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249392|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249393|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249394|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249395|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
155249396|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
155249397|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
155249398|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249399|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249400|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249401|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155249402|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155249403|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
155249404|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249405|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249406|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249407|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
155249408|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
155249409|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
155249410|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249411|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249412|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249413|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
155249414|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
155249415|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
155249416|NCT00809757|560342882|FG000|Overall Study|Adverse Event|2|||
155249417|NCT00809757|560342883|FG001|Overall Study|Adverse Event|3|||
155249418|NCT00809757|560342884|FG002|Overall Study|Adverse Event|3|||
155249419|NCT00809757|560342882|FG000|Overall Study|Lost to Follow-up|0|||
155249420|NCT00809757|560342883|FG001|Overall Study|Lost to Follow-up|0|||
155249421|NCT00809757|560342884|FG002|Overall Study|Lost to Follow-up|1|||
155249422|NCT00809757|560342882|FG000|Overall Study|Protocol Violation|1|||
155249423|NCT00809757|560342883|FG001|Overall Study|Protocol Violation|1|||
155249424|NCT00809757|560342884|FG002|Overall Study|Protocol Violation|1|||
155249425|NCT00809757|560342882|FG000|Overall Study|Withdrawal by Subject|2|||
155249426|NCT00809757|560342883|FG001|Overall Study|Withdrawal by Subject|1|||
155249427|NCT00809757|560342884|FG002|Overall Study|Withdrawal by Subject|3|||
155249428|NCT00809757|560342882|FG000|Overall Study|Subject Uncooperative|1|||
155249429|NCT00809757|560342883|FG001|Overall Study|Subject Uncooperative|0|||
155249430|NCT00809757|560342884|FG002|Overall Study|Subject Uncooperative|2|||
155249431|NCT00809757|560342882|FG000|Overall Study|Noncompliance with Medication|0|||
155249432|NCT00809757|560342883|FG001|Overall Study|Noncompliance with Medication|0|||
155249433|NCT00809757|560342884|FG002|Overall Study|Noncompliance with Medication|1|||
155249434|NCT00659334|560342885|FG000|Overall Study|Screen Failure|8|||
155249435|NCT00659334|560342886|FG001|Overall Study|Screen Failure|5|||
155249436|NCT00659334|560342887|FG002|Overall Study|Screen Failure|0|||
155249437|NCT00659334|560342888|FG003|Overall Study|Screen Failure|0|||
155249438|NCT00659334|560342889|FG004|Overall Study|Screen Failure|0|||
155249439|NCT00659334|560342890|FG005|Overall Study|Screen Failure|0|||
155249440|NCT00659334|560342891|FG006|Overall Study|Screen Failure|1|||
155249441|NCT03034577|560342892|FG000|Overall Study|Withdrawal by Subject|6|||
155249442|NCT03034577|560342893|FG001|Overall Study|Withdrawal by Subject|9|||
155249443|NCT03034577|560342892|FG000|Overall Study|Lost to Follow-up|25|||
155249444|NCT03034577|560342893|FG001|Overall Study|Lost to Follow-up|26|||
155249445|NCT01174342|560342894|FG000|Overall Study|Conversion to cesarean section|4|||
155249446|NCT02625623|560342895|FG000|Overall Study|Participants randomized but not treated|9|||
155249447|NCT02625623|560342896|FG001|Overall Study|Participants randomized but not treated|1|||
155249448|NCT02338154|560344940|FG000|Overall Study|Death|46|||
155249449|NCT02338154|560344940|FG000|Overall Study|Valve Implant Failure|17|||
155249450|NCT02338154|560344940|FG000|Overall Study|Valve Explant|11|||
155249451|NCT02338154|560344940|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
155249452|NCT02338154|560344940|FG000|Overall Study|Lost to Follow-up|8|||
155249453|NCT02338154|560344940|FG000|Overall Study|Other Reason|3|||
155249454|NCT02338154|560344940|FG000|Overall Study|Patients Without Exit Form|47|||
155249455|NCT02338154|560344940|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
155249456|NCT03393000|560344943|FG000|Overall Study|Death|11|||
155249457|NCT03393000|560344943|FG000|Overall Study|Withdrawal by Subject|2|||
155249458|NCT03393000|560344943|FG000|Overall Study|Physician Decision|1|||
155249459|NCT02388724|560344944|FG000|Overall Study|Reason not Specified|0|||
155249460|NCT02388724|560344945|FG001|Overall Study|Reason not Specified|1|||
155249461|NCT02388724|560344944|FG000|Overall Study|Major Protocol Deviation|3|||
155249462|NCT02388724|560344945|FG001|Overall Study|Major Protocol Deviation|3|||
155249463|NCT02388724|560344944|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155249464|NCT02388724|560344945|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155249465|NCT02388724|560344944|FG000|Overall Study|Voluntary Withdrawal|6|||
155249466|NCT02388724|560344945|FG001|Overall Study|Voluntary Withdrawal|5|||
155249467|NCT02388724|560344944|FG000|Overall Study|Randomized but not Treated|0|||
155249468|NCT02388724|560344945|FG001|Overall Study|Randomized but not Treated|2|||
155249469|NCT01217073|560344946|FG000|Base Period|Adverse Event|1|||
155249470|NCT01217073|560344947|FG001|Base Period|Adverse Event|0|||
155249471|NCT01217073|560344948|FG002|Base Period|Adverse Event|1|||
155249472|NCT01217073|560344949|FG003|Base Period|Adverse Event|0|||
155249473|NCT01217073|560344950|FG004|Base Period|Adverse Event|4|||
155249474|NCT01217073|560344951|FG005|Base Period|Adverse Event|1|||
155249475|NCT01217073|560344952|FG006|Base Period|Adverse Event|0|||
155249476|NCT01217073|560344953|FG007|Base Period|Adverse Event|0|||
155249477|NCT01217073|560344946|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
155249478|NCT01217073|560344947|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249479|NCT01217073|560344948|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249480|NCT01217073|560344949|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249481|NCT01217073|560344950|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249482|NCT01217073|560344951|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249483|NCT01217073|560344952|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249484|NCT01217073|560344953|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249485|NCT01217073|560344946|FG000|Base Period|Excluded medication|0|||
155249486|NCT01217073|560344947|FG001|Base Period|Excluded medication|0|||
155249487|NCT01217073|560344948|FG002|Base Period|Excluded medication|0|||
155249488|NCT01217073|560344949|FG003|Base Period|Excluded medication|0|||
155249489|NCT01217073|560344950|FG004|Base Period|Excluded medication|1|||
155249490|NCT01217073|560344951|FG005|Base Period|Excluded medication|0|||
155249491|NCT01217073|560344952|FG006|Base Period|Excluded medication|0|||
155249492|NCT01217073|560344953|FG007|Base Period|Excluded medication|0|||
155249493|NCT01217073|560344946|FG000|Base Period|Lack of Efficacy|0|||
155249494|NCT01217073|560344947|FG001|Base Period|Lack of Efficacy|0|||
155249495|NCT01217073|560344948|FG002|Base Period|Lack of Efficacy|0|||
155249496|NCT01217073|560344949|FG003|Base Period|Lack of Efficacy|0|||
155249497|NCT01217073|560344950|FG004|Base Period|Lack of Efficacy|0|||
155249498|NCT01217073|560344951|FG005|Base Period|Lack of Efficacy|1|||
155249499|NCT01217073|560344952|FG006|Base Period|Lack of Efficacy|0|||
155249500|NCT01217073|560344953|FG007|Base Period|Lack of Efficacy|0|||
155249501|NCT01217073|560344946|FG000|Base Period|Lost to Follow-up|0|||
155249502|NCT01217073|560344947|FG001|Base Period|Lost to Follow-up|0|||
155249503|NCT01217073|560344948|FG002|Base Period|Lost to Follow-up|1|||
155249504|NCT01217073|560344949|FG003|Base Period|Lost to Follow-up|1|||
155249505|NCT01217073|560344950|FG004|Base Period|Lost to Follow-up|3|||
155249506|NCT01217073|560344951|FG005|Base Period|Lost to Follow-up|0|||
155249507|NCT01217073|560344952|FG006|Base Period|Lost to Follow-up|0|||
155249508|NCT01217073|560344953|FG007|Base Period|Lost to Follow-up|0|||
155249509|NCT01217073|560344946|FG000|Base Period|Physician Decision|0|||
155249510|NCT01217073|560344947|FG001|Base Period|Physician Decision|0|||
155249511|NCT01217073|560344948|FG002|Base Period|Physician Decision|0|||
155249512|NCT01217073|560344949|FG003|Base Period|Physician Decision|0|||
155249513|NCT01217073|560344950|FG004|Base Period|Physician Decision|1|||
155249514|NCT01217073|560344951|FG005|Base Period|Physician Decision|0|||
155249515|NCT01217073|560344952|FG006|Base Period|Physician Decision|0|||
155249516|NCT01217073|560344953|FG007|Base Period|Physician Decision|0|||
155249517|NCT01217073|560344946|FG000|Base Period|Protocol Violation|1|||
155249518|NCT01217073|560344947|FG001|Base Period|Protocol Violation|0|||
155249519|NCT01217073|560344948|FG002|Base Period|Protocol Violation|0|||
155249520|NCT01217073|560344949|FG003|Base Period|Protocol Violation|0|||
155249521|NCT01217073|560344950|FG004|Base Period|Protocol Violation|1|||
155249522|NCT01217073|560344951|FG005|Base Period|Protocol Violation|2|||
155249523|NCT01217073|560344952|FG006|Base Period|Protocol Violation|0|||
155249524|NCT01217073|560344953|FG007|Base Period|Protocol Violation|0|||
155249525|NCT01217073|560344946|FG000|Base Period|Withdrawal by Subject|4|||
155249526|NCT01217073|560344947|FG001|Base Period|Withdrawal by Subject|5|||
155249527|NCT01217073|560344948|FG002|Base Period|Withdrawal by Subject|5|||
155249528|NCT01217073|560344949|FG003|Base Period|Withdrawal by Subject|1|||
155249529|NCT01217073|560344950|FG004|Base Period|Withdrawal by Subject|5|||
155249530|NCT01217073|560344951|FG005|Base Period|Withdrawal by Subject|5|||
155249531|NCT01217073|560344952|FG006|Base Period|Withdrawal by Subject|0|||
155249532|NCT01217073|560344953|FG007|Base Period|Withdrawal by Subject|0|||
155249533|NCT01217073|560344946|FG000|Extension Period|Adverse Event|0|||
155249534|NCT01217073|560344947|FG001|Extension Period|Adverse Event|0|||
155249535|NCT01217073|560344948|FG002|Extension Period|Adverse Event|0|||
155249536|NCT01217073|560344949|FG003|Extension Period|Adverse Event|0|||
155249537|NCT01217073|560344950|FG004|Extension Period|Adverse Event|0|||
155249538|NCT01217073|560344951|FG005|Extension Period|Adverse Event|0|||
155249539|NCT01217073|560344952|FG006|Extension Period|Adverse Event|19|||
155249540|NCT01217073|560344953|FG007|Extension Period|Adverse Event|5|||
155249541|NCT01217073|560344946|FG000|Extension Period|ALT/AST|0|||
155249542|NCT01217073|560344947|FG001|Extension Period|ALT/AST|0|||
155249543|NCT01217073|560344948|FG002|Extension Period|ALT/AST|0|||
155249544|NCT01217073|560344949|FG003|Extension Period|ALT/AST|0|||
155249545|NCT01217073|560344950|FG004|Extension Period|ALT/AST|0|||
155249546|NCT01217073|560344951|FG005|Extension Period|ALT/AST|0|||
155249547|NCT01217073|560344952|FG006|Extension Period|ALT/AST|2|||
155249548|NCT01217073|560344953|FG007|Extension Period|ALT/AST|0|||
155249549|NCT01217073|560344946|FG000|Extension Period|Contraindication to study medication|0|||
155249550|NCT01217073|560344947|FG001|Extension Period|Contraindication to study medication|0|||
155249551|NCT01217073|560344948|FG002|Extension Period|Contraindication to study medication|0|||
155249552|NCT01217073|560344949|FG003|Extension Period|Contraindication to study medication|0|||
155249553|NCT01217073|560344950|FG004|Extension Period|Contraindication to study medication|0|||
155249554|NCT01217073|560344951|FG005|Extension Period|Contraindication to study medication|0|||
155249555|NCT01217073|560344952|FG006|Extension Period|Contraindication to study medication|1|||
155249556|NCT01217073|560344953|FG007|Extension Period|Contraindication to study medication|0|||
155249557|NCT01217073|560344946|FG000|Extension Period|Creatinine/eGFR|0|||
155249558|NCT01217073|560344947|FG001|Extension Period|Creatinine/eGFR|0|||
155249559|NCT01217073|560344948|FG002|Extension Period|Creatinine/eGFR|0|||
155249560|NCT01217073|560344949|FG003|Extension Period|Creatinine/eGFR|0|||
155249561|NCT01217073|560344950|FG004|Extension Period|Creatinine/eGFR|0|||
155249562|NCT01217073|560344951|FG005|Extension Period|Creatinine/eGFR|0|||
155249563|NCT01217073|560344952|FG006|Extension Period|Creatinine/eGFR|11|||
155249564|NCT01217073|560344953|FG007|Extension Period|Creatinine/eGFR|1|||
155249565|NCT01217073|560344946|FG000|Extension Period|Death|0|||
155249566|NCT01217073|560344947|FG001|Extension Period|Death|0|||
155249567|NCT01217073|560344948|FG002|Extension Period|Death|0|||
155249568|NCT01217073|560344949|FG003|Extension Period|Death|0|||
155249569|NCT01217073|560344950|FG004|Extension Period|Death|0|||
155249570|NCT01217073|560344951|FG005|Extension Period|Death|0|||
155249571|NCT01217073|560344952|FG006|Extension Period|Death|1|||
155249572|NCT01217073|560344953|FG007|Extension Period|Death|0|||
155249573|NCT01217073|560344946|FG000|Extension Period|Excluded medication|0|||
155249574|NCT01217073|560344947|FG001|Extension Period|Excluded medication|0|||
155249575|NCT01217073|560344948|FG002|Extension Period|Excluded medication|0|||
155249576|NCT01217073|560344949|FG003|Extension Period|Excluded medication|0|||
155249577|NCT01217073|560344950|FG004|Extension Period|Excluded medication|0|||
155249578|NCT01217073|560344951|FG005|Extension Period|Excluded medication|0|||
155249579|NCT01217073|560344952|FG006|Extension Period|Excluded medication|2|||
155249580|NCT01217073|560344953|FG007|Extension Period|Excluded medication|0|||
155249581|NCT01217073|560344946|FG000|Extension Period|Lack of Efficacy|0|||
155249582|NCT01217073|560344947|FG001|Extension Period|Lack of Efficacy|0|||
155249583|NCT01217073|560344948|FG002|Extension Period|Lack of Efficacy|0|||
155249584|NCT01217073|560344949|FG003|Extension Period|Lack of Efficacy|0|||
155249585|NCT01217073|560344950|FG004|Extension Period|Lack of Efficacy|0|||
155249586|NCT01217073|560344951|FG005|Extension Period|Lack of Efficacy|0|||
155249587|NCT01217073|560344952|FG006|Extension Period|Lack of Efficacy|3|||
155249588|NCT01217073|560344953|FG007|Extension Period|Lack of Efficacy|0|||
155249589|NCT01217073|560344946|FG000|Extension Period|Lost to Follow-up|0|||
155249590|NCT01217073|560344947|FG001|Extension Period|Lost to Follow-up|0|||
155249591|NCT01217073|560344948|FG002|Extension Period|Lost to Follow-up|0|||
155249592|NCT01217073|560344949|FG003|Extension Period|Lost to Follow-up|0|||
155249593|NCT01217073|560344950|FG004|Extension Period|Lost to Follow-up|0|||
155249594|NCT01217073|560344951|FG005|Extension Period|Lost to Follow-up|0|||
155249595|NCT01217073|560344952|FG006|Extension Period|Lost to Follow-up|9|||
155249596|NCT01217073|560344953|FG007|Extension Period|Lost to Follow-up|1|||
155249597|NCT01217073|560344946|FG000|Extension Period|Non-compliance with study drug|0|||
155249598|NCT01217073|560344947|FG001|Extension Period|Non-compliance with study drug|0|||
155249599|NCT01217073|560344948|FG002|Extension Period|Non-compliance with study drug|0|||
155249600|NCT01217073|560344949|FG003|Extension Period|Non-compliance with study drug|0|||
155249601|NCT01217073|560344950|FG004|Extension Period|Non-compliance with study drug|0|||
155249602|NCT01217073|560344951|FG005|Extension Period|Non-compliance with study drug|0|||
155249603|NCT01217073|560344952|FG006|Extension Period|Non-compliance with study drug|0|||
155249604|NCT01217073|560344953|FG007|Extension Period|Non-compliance with study drug|1|||
155249605|NCT01217073|560344946|FG000|Extension Period|Physician Decision|0|||
155249606|NCT01217073|560344947|FG001|Extension Period|Physician Decision|0|||
155249607|NCT01217073|560344948|FG002|Extension Period|Physician Decision|0|||
155249608|NCT01217073|560344949|FG003|Extension Period|Physician Decision|0|||
155249609|NCT01217073|560344950|FG004|Extension Period|Physician Decision|0|||
155249610|NCT01217073|560344951|FG005|Extension Period|Physician Decision|0|||
155249611|NCT01217073|560344952|FG006|Extension Period|Physician Decision|4|||
155249612|NCT01217073|560344953|FG007|Extension Period|Physician Decision|1|||
155249613|NCT01217073|560344946|FG000|Extension Period|Protocol Violation|0|||
155249614|NCT01217073|560344947|FG001|Extension Period|Protocol Violation|0|||
155249615|NCT01217073|560344948|FG002|Extension Period|Protocol Violation|0|||
155249616|NCT01217073|560344949|FG003|Extension Period|Protocol Violation|0|||
155249617|NCT01217073|560344950|FG004|Extension Period|Protocol Violation|0|||
155249618|NCT01217073|560344951|FG005|Extension Period|Protocol Violation|0|||
155249619|NCT01217073|560344952|FG006|Extension Period|Protocol Violation|2|||
155249620|NCT01217073|560344953|FG007|Extension Period|Protocol Violation|1|||
155249621|NCT01217073|560344946|FG000|Extension Period|Site discontinued study participation|0|||
155249622|NCT01217073|560344947|FG001|Extension Period|Site discontinued study participation|0|||
155249623|NCT01217073|560344948|FG002|Extension Period|Site discontinued study participation|0|||
155249624|NCT01217073|560344949|FG003|Extension Period|Site discontinued study participation|0|||
155249625|NCT01217073|560344950|FG004|Extension Period|Site discontinued study participation|0|||
155249626|NCT01217073|560344951|FG005|Extension Period|Site discontinued study participation|0|||
155249627|NCT01217073|560344952|FG006|Extension Period|Site discontinued study participation|7|||
155249628|NCT01217073|560344953|FG007|Extension Period|Site discontinued study participation|2|||
155249629|NCT01217073|560344946|FG000|Extension Period|Withdrawal by Subject|0|||
155249630|NCT01217073|560344947|FG001|Extension Period|Withdrawal by Subject|0|||
155249631|NCT01217073|560344948|FG002|Extension Period|Withdrawal by Subject|0|||
155249632|NCT01217073|560344949|FG003|Extension Period|Withdrawal by Subject|0|||
155249633|NCT01217073|560344950|FG004|Extension Period|Withdrawal by Subject|0|||
155249634|NCT01217073|560344951|FG005|Extension Period|Withdrawal by Subject|0|||
155249635|NCT01217073|560344952|FG006|Extension Period|Withdrawal by Subject|30|||
155249636|NCT01217073|560344953|FG007|Extension Period|Withdrawal by Subject|8|||
155249637|NCT02015676|560344969|FG000|Overall Study|Adverse Event|2|||
155249638|NCT02015676|560344970|FG001|Overall Study|Adverse Event|18|||
155249639|NCT02015676|560344971|FG002|Overall Study|Adverse Event|0|||
155249640|NCT02015676|560344969|FG000|Overall Study|Lack of Efficacy|2|||
155249641|NCT02015676|560344970|FG001|Overall Study|Lack of Efficacy|4|||
155249642|NCT02015676|560344971|FG002|Overall Study|Lack of Efficacy|0|||
155249643|NCT02015676|560344969|FG000|Overall Study|Protocol Violation|1|||
155249644|NCT02015676|560344970|FG001|Overall Study|Protocol Violation|0|||
155249645|NCT02015676|560344971|FG002|Overall Study|Protocol Violation|0|||
155249646|NCT02015676|560344969|FG000|Overall Study|Withdrawal by Subject|1|||
155249647|NCT02015676|560344970|FG001|Overall Study|Withdrawal by Subject|7|||
155249648|NCT02015676|560344971|FG002|Overall Study|Withdrawal by Subject|1|||
155249649|NCT02015676|560344969|FG000|Overall Study|Administrative reasons|0|||
155249650|NCT02015676|560344970|FG001|Overall Study|Administrative reasons|3|||
155249651|NCT02015676|560344971|FG002|Overall Study|Administrative reasons|1|||
155249652|NCT02015676|560344969|FG000|Overall Study|Death|0|||
155249653|NCT02015676|560344970|FG001|Overall Study|Death|1|||
155249654|NCT02015676|560344971|FG002|Overall Study|Death|0|||
155249655|NCT02015676|560344969|FG000|Overall Study|Disease progression|3|||
155249656|NCT02015676|560344970|FG001|Overall Study|Disease progression|1|||
155249657|NCT02015676|560344971|FG002|Overall Study|Disease progression|1|||
155249658|NCT00476476|560344973|FG000|Overall Study|Adverse Event|2|||
155249659|NCT00476476|560344974|FG001|Overall Study|Adverse Event|7|||
155249660|NCT00476476|560344973|FG000|Overall Study|Progressive Disease|0|||
155249661|NCT00476476|560344974|FG001|Overall Study|Progressive Disease|17|||
155249662|NCT00971048|560344975|FG000|Overall Study|Protocol Violation|1|||
155249663|NCT00971048|560344976|FG001|Overall Study|Protocol Violation|2|||
155249664|NCT00971048|560344977|FG002|Overall Study|Protocol Violation|0|||
155249665|NCT00971048|560344978|FG003|Overall Study|Protocol Violation|1|||
155249666|NCT00971048|560344975|FG000|Overall Study|Adverse Event|0|||
155249667|NCT00971048|560344976|FG001|Overall Study|Adverse Event|0|||
155249668|NCT00971048|560344977|FG002|Overall Study|Adverse Event|1|||
155249669|NCT00971048|560344978|FG003|Overall Study|Adverse Event|0|||
155249670|NCT00971048|560344975|FG000|Overall Study|Physician Decision|0|||
155249671|NCT00971048|560344976|FG001|Overall Study|Physician Decision|0|||
155249672|NCT00971048|560344977|FG002|Overall Study|Physician Decision|0|||
155249673|NCT00971048|560344978|FG003|Overall Study|Physician Decision|1|||
155249674|NCT03321396|560344982|FG000|Overall Study|Physician Decision|1|||
155249675|NCT03280121|560344983|FG000|Overall Study|Physician Decision|1|||
155249676|NCT03280121|560344983|FG000|Overall Study|Lost to Follow-up|1|||
155249677|NCT03280121|560344983|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
155249678|NCT02633137|560344988|FG000|Overall Study|Adverse Event|1|||
155249679|NCT02633137|560344988|FG000|Overall Study|Lack of Efficacy|2|||
155249680|NCT02633137|560344988|FG000|Overall Study|Withdrawal by Subject|1|||
155249681|NCT03996473|560344991|FG000|Treatment Assignment|Withdrawal by Subject|1|||
155249682|NCT03996473|560344991|FG000|Treatment Assignment|Progressive disease|6|||
155249683|NCT03996473|560344991|FG000|Treatment Assignment|Study drug never administered|1|||
155249684|NCT03996473|560344991|FG000|Active Follow-up|Death|1|||
155249685|NCT03996473|560344991|FG000|Long-term Follow-up|Death|5|||
155249686|NCT03759873|560344992|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
155249687|NCT03759873|560344993|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
155249688|NCT03759873|560344994|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
155249689|NCT03759873|560344995|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
155249690|NCT03759873|560344992|FG000|Overall Study|Moved outside eligible area|0|||
155249691|NCT03759873|560344993|FG001|Overall Study|Moved outside eligible area|2|||
155249692|NCT03759873|560344994|FG002|Overall Study|Moved outside eligible area|0|||
155249693|NCT03759873|560344995|FG003|Overall Study|Moved outside eligible area|0|||
155249694|NCT03759873|560344992|FG000|Overall Study|Withdrawal by Subject|0|||
155249695|NCT03759873|560344993|FG001|Overall Study|Withdrawal by Subject|0|||
155249696|NCT03759873|560344994|FG002|Overall Study|Withdrawal by Subject|1|||
155249697|NCT03759873|560344995|FG003|Overall Study|Withdrawal by Subject|0|||
155249698|NCT04349553|560344999|FG000|Overall Study|Withdrawal by Subject|1|||
155249699|NCT04349553|560345000|FG001|Overall Study|Withdrawal by Subject|0|||
155249700|NCT04349553|560345001|FG002|Overall Study|Withdrawal by Subject|1|||
155249701|NCT04349553|560345002|FG003|Overall Study|Withdrawal by Subject|0|||
155249702|NCT01869491|560345005|FG000|Overall Study|Adverse Event|3|||
155249703|NCT01869491|560345006|FG001|Overall Study|Adverse Event|5|||
155249704|NCT01869491|560345005|FG000|Overall Study|Lack of Efficacy|0|||
155249705|NCT01869491|560345006|FG001|Overall Study|Lack of Efficacy|3|||
155249706|NCT01869491|560345005|FG000|Overall Study|Withdrawal by Subject|6|||
155249707|NCT01869491|560345006|FG001|Overall Study|Withdrawal by Subject|7|||
155249708|NCT01869491|560345005|FG000|Overall Study|Lost to Follow-up|11|||
155249709|NCT01869491|560345006|FG001|Overall Study|Lost to Follow-up|9|||
155249710|NCT01869491|560345005|FG000|Overall Study|No further need of investigational product|1|||
155249711|NCT01869491|560345006|FG001|Overall Study|No further need of investigational product|0|||
155249712|NCT01910129|560345014|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
155249713|NCT01910129|560345015|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
155249714|NCT01910129|560345016|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
155249715|NCT01910129|560345014|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
155249716|NCT01910129|560345015|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
155249717|NCT01910129|560345016|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
155249718|NCT03449030|560345018|FG000|Overall Study|Withdrawal by Subject|0|||
155249719|NCT03449030|560345019|FG001|Overall Study|Withdrawal by Subject|0|||
155249720|NCT03449030|560345020|FG002|Overall Study|Withdrawal by Subject|0|||
155249721|NCT03449030|560345021|FG003|Overall Study|Withdrawal by Subject|1|||
155249722|NCT03449030|560345022|FG004|Overall Study|Withdrawal by Subject|1|||
155249723|NCT03449030|560345023|FG005|Overall Study|Withdrawal by Subject|1|||
155249724|NCT03449030|560345024|FG006|Overall Study|Withdrawal by Subject|1|||
155249725|NCT03449030|560345025|FG007|Overall Study|Withdrawal by Subject|2|||
155249726|NCT03449030|560345026|FG008|Overall Study|Withdrawal by Subject|0|||
155249727|NCT03449030|560345027|FG009|Overall Study|Withdrawal by Subject|0|||
155249728|NCT03449030|560345018|FG000|Overall Study|Symptomatic Deterioration|0|||
155249729|NCT03449030|560345019|FG001|Overall Study|Symptomatic Deterioration|1|||
155249730|NCT03449030|560345020|FG002|Overall Study|Symptomatic Deterioration|0|||
155249731|NCT03449030|560345021|FG003|Overall Study|Symptomatic Deterioration|0|||
155249732|NCT03449030|560345022|FG004|Overall Study|Symptomatic Deterioration|0|||
155249733|NCT03449030|560345023|FG005|Overall Study|Symptomatic Deterioration|1|||
155249734|NCT03449030|560345024|FG006|Overall Study|Symptomatic Deterioration|1|||
155249735|NCT03449030|560345025|FG007|Overall Study|Symptomatic Deterioration|0|||
155249736|NCT03449030|560345026|FG008|Overall Study|Symptomatic Deterioration|2|||
155249737|NCT03449030|560345027|FG009|Overall Study|Symptomatic Deterioration|0|||
155249738|NCT03449030|560345018|FG000|Overall Study|Progressive Disease|1|||
155249739|NCT03449030|560345019|FG001|Overall Study|Progressive Disease|0|||
155249740|NCT03449030|560345020|FG002|Overall Study|Progressive Disease|1|||
155249741|NCT03449030|560345021|FG003|Overall Study|Progressive Disease|4|||
155249742|NCT03449030|560345022|FG004|Overall Study|Progressive Disease|5|||
155249743|NCT03449030|560345023|FG005|Overall Study|Progressive Disease|3|||
155249744|NCT03449030|560345024|FG006|Overall Study|Progressive Disease|0|||
155249745|NCT03449030|560345025|FG007|Overall Study|Progressive Disease|1|||
155249746|NCT03449030|560345026|FG008|Overall Study|Progressive Disease|1|||
155249747|NCT03449030|560345027|FG009|Overall Study|Progressive Disease|1|||
155249748|NCT03449030|560345018|FG000|Overall Study|Adverse Event|0|||
155249749|NCT03449030|560345019|FG001|Overall Study|Adverse Event|0|||
155249750|NCT03449030|560345020|FG002|Overall Study|Adverse Event|0|||
155249751|NCT03449030|560345021|FG003|Overall Study|Adverse Event|0|||
155249752|NCT03449030|560345022|FG004|Overall Study|Adverse Event|0|||
155249753|NCT03449030|560345023|FG005|Overall Study|Adverse Event|2|||
155249754|NCT03449030|560345024|FG006|Overall Study|Adverse Event|0|||
155249755|NCT03449030|560345025|FG007|Overall Study|Adverse Event|0|||
155249756|NCT03449030|560345026|FG008|Overall Study|Adverse Event|0|||
155249757|NCT03449030|560345027|FG009|Overall Study|Adverse Event|0|||
155249758|NCT03449030|560345018|FG000|Overall Study|Death|0|||
155249759|NCT03449030|560345019|FG001|Overall Study|Death|0|||
155249760|NCT03449030|560345020|FG002|Overall Study|Death|0|||
155249761|NCT03449030|560345021|FG003|Overall Study|Death|0|||
155249762|NCT03449030|560345022|FG004|Overall Study|Death|1|||
155249763|NCT03449030|560345023|FG005|Overall Study|Death|0|||
155249764|NCT03449030|560345024|FG006|Overall Study|Death|0|||
155249765|NCT03449030|560345025|FG007|Overall Study|Death|0|||
155249766|NCT03449030|560345026|FG008|Overall Study|Death|0|||
155249767|NCT03449030|560345027|FG009|Overall Study|Death|0|||
155249768|NCT00965523|560345028|FG000|Study 221|Progressive Disease|4|||
155249769|NCT00965523|560345028|FG000|Study 221|Physician Decision|3|||
155249770|NCT00965523|560345028|FG000|Study 224|Progressive Disease|5|||
155249771|NCT00965523|560345028|FG000|Study 224|Physician Decision|1|||
155249772|NCT02415400|560345029|FG000|Overall Study|Adverse Event|0|||
155249773|NCT02415400|560345030|FG001|Overall Study|Adverse Event|1|||
155249774|NCT02415400|560345031|FG002|Overall Study|Adverse Event|1|||
155249775|NCT02415400|560345032|FG003|Overall Study|Adverse Event|2|||
155249776|NCT02415400|560345029|FG000|Overall Study|Participant request to stop therapy|4|||
155249777|NCT02415400|560345030|FG001|Overall Study|Participant request to stop therapy|3|||
155249778|NCT02415400|560345031|FG002|Overall Study|Participant request to stop therapy|8|||
155249779|NCT02415400|560345032|FG003|Overall Study|Participant request to stop therapy|6|||
155249780|NCT02415400|560345029|FG000|Overall Study|Participant withdrew consent|14|||
155249781|NCT02415400|560345030|FG001|Overall Study|Participant withdrew consent|12|||
155249782|NCT02415400|560345031|FG002|Overall Study|Participant withdrew consent|30|||
155249783|NCT02415400|560345032|FG003|Overall Study|Participant withdrew consent|21|||
155249784|NCT02415400|560345029|FG000|Overall Study|Death|39|||
155249785|NCT02415400|560345030|FG001|Overall Study|Death|41|||
155249786|NCT02415400|560345031|FG002|Overall Study|Death|35|||
155249787|NCT02415400|560345032|FG003|Overall Study|Death|42|||
155249788|NCT02415400|560345029|FG000|Overall Study|Lost to Follow-up|3|||
155249789|NCT02415400|560345030|FG001|Overall Study|Lost to Follow-up|3|||
155249790|NCT02415400|560345031|FG002|Overall Study|Lost to Follow-up|2|||
155249791|NCT02415400|560345032|FG003|Overall Study|Lost to Follow-up|5|||
155249792|NCT02415400|560345029|FG000|Overall Study|Poor/Non-Compliance|0|||
155249793|NCT02415400|560345030|FG001|Overall Study|Poor/Non-Compliance|1|||
155249794|NCT02415400|560345031|FG002|Overall Study|Poor/Non-Compliance|3|||
155249795|NCT02415400|560345032|FG003|Overall Study|Poor/Non-Compliance|4|||
155249796|NCT02415400|560345029|FG000|Overall Study|Participant no longer meets criteria|2|||
155249797|NCT02415400|560345030|FG001|Overall Study|Participant no longer meets criteria|0|||
155249798|NCT02415400|560345031|FG002|Overall Study|Participant no longer meets criteria|0|||
155249799|NCT02415400|560345032|FG003|Overall Study|Participant no longer meets criteria|1|||
155249800|NCT02415400|560345029|FG000|Overall Study|Participant doesn't answer phone|1|||
155249801|NCT02415400|560345030|FG001|Overall Study|Participant doesn't answer phone|0|||
155249802|NCT02415400|560345031|FG002|Overall Study|Participant doesn't answer phone|0|||
155249803|NCT02415400|560345032|FG003|Overall Study|Participant doesn't answer phone|0|||
155249804|NCT02415400|560345029|FG000|Overall Study|Participant wanted home visits|1|||
155249805|NCT02415400|560345030|FG001|Overall Study|Participant wanted home visits|0|||
155249806|NCT02415400|560345031|FG002|Overall Study|Participant wanted home visits|0|||
155249807|NCT02415400|560345032|FG003|Overall Study|Participant wanted home visits|0|||
155249808|NCT02415400|560345029|FG000|Overall Study|Randomized in error|2|||
155249809|NCT02415400|560345030|FG001|Overall Study|Randomized in error|0|||
155249810|NCT02415400|560345031|FG002|Overall Study|Randomized in error|0|||
155249811|NCT02415400|560345032|FG003|Overall Study|Randomized in error|0|||
155249812|NCT02415400|560345029|FG000|Overall Study|No study drug on site|0|||
155249813|NCT02415400|560345030|FG001|Overall Study|No study drug on site|1|||
155249814|NCT02415400|560345031|FG002|Overall Study|No study drug on site|0|||
155249815|NCT02415400|560345032|FG003|Overall Study|No study drug on site|0|||
155249816|NCT02415400|560345029|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
155249817|NCT02415400|560345030|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
155249818|NCT02415400|560345031|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
155249819|NCT02415400|560345032|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
155249820|NCT02415400|560345029|FG000|Overall Study|Coagulation values cannot be set|0|||
155249821|NCT02415400|560345030|FG001|Overall Study|Coagulation values cannot be set|0|||
155249822|NCT02415400|560345031|FG002|Overall Study|Coagulation values cannot be set|1|||
155249823|NCT02415400|560345032|FG003|Overall Study|Coagulation values cannot be set|0|||
155249824|NCT02415400|560345029|FG000|Overall Study|State regulations prevent participation|0|||
155249825|NCT02415400|560345030|FG001|Overall Study|State regulations prevent participation|0|||
155249826|NCT02415400|560345031|FG002|Overall Study|State regulations prevent participation|1|||
155249827|NCT02415400|560345032|FG003|Overall Study|State regulations prevent participation|0|||
155249828|NCT02415400|560345029|FG000|Overall Study|Poor treatment monitoring|0|||
155249829|NCT02415400|560345030|FG001|Overall Study|Poor treatment monitoring|0|||
155249830|NCT02415400|560345031|FG002|Overall Study|Poor treatment monitoring|1|||
155249831|NCT02415400|560345032|FG003|Overall Study|Poor treatment monitoring|0|||
155249832|NCT02415400|560345029|FG000|Overall Study|Participant in jail|0|||
155249833|NCT02415400|560345030|FG001|Overall Study|Participant in jail|0|||
155249834|NCT02415400|560345031|FG002|Overall Study|Participant in jail|1|||
155249835|NCT02415400|560345032|FG003|Overall Study|Participant in jail|0|||
155249836|NCT02415400|560345029|FG000|Overall Study|Investigator decision|0|||
155249837|NCT02415400|560345030|FG001|Overall Study|Investigator decision|0|||
155249838|NCT02415400|560345031|FG002|Overall Study|Investigator decision|1|||
155249839|NCT02415400|560345032|FG003|Overall Study|Investigator decision|1|||
155249840|NCT02415400|560345029|FG000|Overall Study|Site closure; participant won't transfer|0|||
155249841|NCT02415400|560345030|FG001|Overall Study|Site closure; participant won't transfer|0|||
155249842|NCT02415400|560345031|FG002|Overall Study|Site closure; participant won't transfer|0|||
155249843|NCT02415400|560345032|FG003|Overall Study|Site closure; participant won't transfer|1|||
155249844|NCT01392560|560345040|FG000|Overall Study|Adverse Event|2|||
155249845|NCT01392560|560345040|FG000|Overall Study|not entered|8|||
155249846|NCT01392560|560345040|FG000|Overall Study|discontinued during placebo run-in|2|||
155249847|NCT02081846|560345041|FG000|Overall Study|Withdrawal by Subject|1|||
155249848|NCT02081846|560345042|FG001|Overall Study|Withdrawal by Subject|0|||
155249849|NCT02081846|560345041|FG000|Overall Study|invalid consent|1|||
155249850|NCT02081846|560345042|FG001|Overall Study|invalid consent|0|||
155249851|NCT01939028|560345043|FG000|Overall Study|Withdrawal by Subject|5|||
155249852|NCT01939028|560345043|FG000|Overall Study|Physician Decision|7|||
155249853|NCT00295750|560345047|FG000|Overall Study|Adverse Event|19|||
155249854|NCT00295750|560345048|FG001|Overall Study|Adverse Event|15|||
155249855|NCT00295750|560345049|FG002|Overall Study|Adverse Event|12|||
155249856|NCT00295750|560345047|FG000|Overall Study|Lack of Efficacy|1|||
155249857|NCT00295750|560345048|FG001|Overall Study|Lack of Efficacy|1|||
155249858|NCT00295750|560345049|FG002|Overall Study|Lack of Efficacy|0|||
155249859|NCT00295750|560345047|FG000|Overall Study|Lost to Follow-up|1|||
155249860|NCT00295750|560345048|FG001|Overall Study|Lost to Follow-up|4|||
155249861|NCT00295750|560345049|FG002|Overall Study|Lost to Follow-up|1|||
155249862|NCT00295750|560345047|FG000|Overall Study|Taking prohibited therapy|2|||
155249863|NCT00295750|560345048|FG001|Overall Study|Taking prohibited therapy|3|||
155249864|NCT00295750|560345049|FG002|Overall Study|Taking prohibited therapy|2|||
155249865|NCT00295750|560345047|FG000|Overall Study|Administrative errors|2|||
155249866|NCT00295750|560345048|FG001|Overall Study|Administrative errors|4|||
155249867|NCT00295750|560345049|FG002|Overall Study|Administrative errors|5|||
155249868|NCT00295750|560345047|FG000|Overall Study|Trial drug errors|1|||
155249869|NCT00295750|560345048|FG001|Overall Study|Trial drug errors|1|||
155249870|NCT00295750|560345049|FG002|Overall Study|Trial drug errors|0|||
155249871|NCT00295750|560345047|FG000|Overall Study|Disease progression|2|||
155249872|NCT00295750|560345048|FG001|Overall Study|Disease progression|1|||
155249873|NCT00295750|560345049|FG002|Overall Study|Disease progression|0|||
155249874|NCT00295750|560345047|FG000|Overall Study|Personal reasons|0|||
155249875|NCT00295750|560345048|FG001|Overall Study|Personal reasons|1|||
155249876|NCT00295750|560345049|FG002|Overall Study|Personal reasons|0|||
155249877|NCT00295750|560345047|FG000|Overall Study|Randomized but never received trial drug|4|||
155249878|NCT00295750|560345048|FG001|Overall Study|Randomized but never received trial drug|3|||
155249879|NCT00295750|560345049|FG002|Overall Study|Randomized but never received trial drug|3|||
155249880|NCT00295750|560345047|FG000|Overall Study|Withdrawal by Subject|9|||
155249881|NCT00295750|560345048|FG001|Overall Study|Withdrawal by Subject|4|||
155249882|NCT00295750|560345049|FG002|Overall Study|Withdrawal by Subject|7|||
155249883|NCT00295750|560345047|FG000|Overall Study|Protocol Violation|2|||
155249884|NCT00295750|560345048|FG001|Overall Study|Protocol Violation|4|||
155249885|NCT00295750|560345049|FG002|Overall Study|Protocol Violation|2|||
155249886|NCT00322348|560345050|FG000|Overall Study|Adverse Event|0|||
155249887|NCT00322348|560345051|FG001|Overall Study|Adverse Event|1|||
155249888|NCT00322348|560345050|FG000|Overall Study|Withdrawal by Subject|1|||
155249889|NCT00322348|560345051|FG001|Overall Study|Withdrawal by Subject|4|||
155249890|NCT00322348|560345050|FG000|Overall Study|Lost to Follow-up|1|||
155249891|NCT00322348|560345051|FG001|Overall Study|Lost to Follow-up|0|||
155249892|NCT00322348|560345050|FG000|Overall Study|Death|0|||
155249893|NCT00322348|560345051|FG001|Overall Study|Death|2|||
155249894|NCT00322348|560345050|FG000|Overall Study|Disease Progression|30|||
155249895|NCT00322348|560345051|FG001|Overall Study|Disease Progression|25|||
155249896|NCT00322348|560345050|FG000|Overall Study|Reasons not specified|5|||
155249897|NCT00322348|560345051|FG001|Overall Study|Reasons not specified|1|||
155249898|NCT01650259|560345052|FG000|Overall Study|Improvement|105|||
155249899|NCT01650259|560345053|FG001|Overall Study|Improvement|0|||
155249900|NCT01650259|560345052|FG000|Overall Study|Adverse Event|127|||
155249901|NCT01650259|560345053|FG001|Overall Study|Adverse Event|0|||
155249902|NCT01650259|560345052|FG000|Overall Study|Lack of Efficacy|143|||
155249903|NCT01650259|560345053|FG001|Overall Study|Lack of Efficacy|0|||
155249904|NCT01650259|560345052|FG000|Overall Study|Lost to Follow-up|435|||
155249905|NCT01650259|560345053|FG001|Overall Study|Lost to Follow-up|0|||
155249906|NCT01650259|560345052|FG000|Overall Study|Patients had no visit after entry|70|||
155249907|NCT01650259|560345053|FG001|Overall Study|Patients had no visit after entry|0|||
155249908|NCT01650259|560345052|FG000|Overall Study|CRF not collected|98|||
155249909|NCT01650259|560345053|FG001|Overall Study|CRF not collected|82|||
155249910|NCT01650259|560345052|FG000|Overall Study|Not treated|1|||
155491681|NCT03992456|561225487|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
155249911|NCT01650259|560345053|FG001|Overall Study|Not treated|7|||
155249912|NCT01650259|560345052|FG000|Overall Study|Other than listed|64|||
155249913|NCT01650259|560345053|FG001|Overall Study|Other than listed|146|||
155249914|NCT00989287|560345065|FG000|Overall Study|Adverse Event|1|||
155249915|NCT00989287|560345066|FG001|Overall Study|Adverse Event|0|||
155249916|NCT00989287|560345065|FG000|Overall Study|Lost to Follow-up|0|||
155249917|NCT00989287|560345066|FG001|Overall Study|Lost to Follow-up|1|||
155249918|NCT00695669|560345067|FG000|Overall Study|Adverse Event|0|||
155249919|NCT00695669|560345068|FG001|Overall Study|Adverse Event|0|||
155249920|NCT00695669|560345069|FG002|Overall Study|Adverse Event|2|||
155249921|NCT00695669|560345070|FG003|Overall Study|Adverse Event|0|||
155249922|NCT00695669|560345067|FG000|Overall Study|Lost to Follow-up|4|||
155249923|NCT00695669|560345068|FG001|Overall Study|Lost to Follow-up|4|||
155249924|NCT00695669|560345069|FG002|Overall Study|Lost to Follow-up|1|||
155249925|NCT00695669|560345070|FG003|Overall Study|Lost to Follow-up|4|||
155249926|NCT01808313|560345089|FG000|Overall Study|Adverse Event|5|||
155249927|NCT01808313|560345089|FG000|Overall Study|Protocol Violation|2|||
155249928|NCT01808313|560345089|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155249929|NCT01808313|560345089|FG000|Overall Study|Lost to Follow-up|1|||
155249930|NCT01808313|560345089|FG000|Overall Study|Physician Decision|1|||
155249931|NCT04656847|560345092|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
155249932|NCT03301051|560345093|FG000|Overall Study|Adverse Event|0|||
155249933|NCT03301051|560345094|FG001|Overall Study|Adverse Event|4|||
155249934|NCT03301051|560345093|FG000|Overall Study|Withdrawal by Subject|59|||
155249935|NCT03301051|560345094|FG001|Overall Study|Withdrawal by Subject|65|||
155249936|NCT03301051|560345093|FG000|Overall Study|Lost to Follow-up|263|||
155249937|NCT03301051|560345094|FG001|Overall Study|Lost to Follow-up|282|||
155249938|NCT03301051|560345093|FG000|Overall Study|Protocol Violation|1|||
155249939|NCT03301051|560345094|FG001|Overall Study|Protocol Violation|3|||
155249940|NCT03301051|560345093|FG000|Overall Study|Physician Decision|1|||
155249941|NCT03301051|560345094|FG001|Overall Study|Physician Decision|3|||
155249942|NCT03301051|560345093|FG000|Overall Study|Death|1|||
155249943|NCT03301051|560345094|FG001|Overall Study|Death|1|||
155249944|NCT03301051|560345093|FG000|Overall Study|Miscellaneous|8|||
155249945|NCT03301051|560345094|FG001|Overall Study|Miscellaneous|4|||
155249946|NCT03301051|560345093|FG000|Overall Study|Randomized, not vaccinated|13|||
155249947|NCT03301051|560345094|FG001|Overall Study|Randomized, not vaccinated|10|||
155249948|NCT00047879|560345095|FG000|Overall Study|Progressive disease|4|||
155249949|NCT00047879|560345096|FG001|Overall Study|Progressive disease|3|||
155249950|NCT03738150|560345111|FG000|Base Study|Withdrawal by Subject|1|||
155249951|NCT03738150|560345111|FG000|Extension Study|Withdrawal by Subject|1|||
155249952|NCT01962974|560345114|FG000|Overall Study|Study termination|7|||
155249953|NCT04598152|560345116|FG000|Overall Study|Lost to Follow-up|0|||
155249954|NCT04598152|560345117|FG001|Overall Study|Lost to Follow-up|1|||
155249955|NCT01965834|560345122|FG000|Overall Study|Lack of Efficacy|4|||
155249956|NCT03674177|560345125|FG000|Overall Study|Lost to Follow-up|2|||
155249957|NCT03674177|560345126|FG001|Overall Study|Lost to Follow-up|1|||
155249958|NCT03674177|560345127|FG002|Overall Study|Lost to Follow-up|0|||
155249959|NCT03674177|560345128|FG003|Overall Study|Lost to Follow-up|2|||
155249960|NCT03387852|560345129|FG000|Overall Study|Adverse event (AE)|3|||
155249961|NCT03387852|560345130|FG001|Overall Study|Adverse event (AE)|0|||
155249962|NCT03387852|560345131|FG002|Overall Study|Adverse event (AE)|2|||
155249963|NCT03387852|560345132|FG003|Overall Study|Adverse event (AE)|0|||
155249964|NCT03387852|560345129|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
155249965|NCT03387852|560345130|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
155249966|NCT03387852|560345131|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
155249967|NCT03387852|560345132|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
155249968|NCT03387852|560345129|FG000|Overall Study|Withdrawal by participant|1|||
155249969|NCT03387852|560345130|FG001|Overall Study|Withdrawal by participant|1|||
155249970|NCT03387852|560345131|FG002|Overall Study|Withdrawal by participant|3|||
155249971|NCT03387852|560345132|FG003|Overall Study|Withdrawal by participant|2|||
155249972|NCT03387852|560345129|FG000|Overall Study|Other- Unspecified|1|||
155249973|NCT03387852|560345130|FG001|Overall Study|Other- Unspecified|1|||
155249974|NCT03387852|560345131|FG002|Overall Study|Other- Unspecified|2|||
155249975|NCT03387852|560345132|FG003|Overall Study|Other- Unspecified|1|||
155249976|NCT03387852|560345129|FG000|Overall Study|Poor compliance to protocol|0|||
155249977|NCT03387852|560345130|FG001|Overall Study|Poor compliance to protocol|0|||
155249978|NCT03387852|560345131|FG002|Overall Study|Poor compliance to protocol|0|||
155249979|NCT03387852|560345132|FG003|Overall Study|Poor compliance to protocol|1|||
155249980|NCT03387852|560345129|FG000|Overall Study|Randomized and not treated|0|||
155249981|NCT03387852|560345130|FG001|Overall Study|Randomized and not treated|0|||
155249982|NCT03387852|560345131|FG002|Overall Study|Randomized and not treated|0|||
155249983|NCT03387852|560345132|FG003|Overall Study|Randomized and not treated|1|||
155249984|NCT02493127|560345133|FG000|Overall Study|Lost to Follow-up|1|||
155249985|NCT02493127|560345134|FG001|Overall Study|Lost to Follow-up|1|||
155249986|NCT02010060|560345137|FG000|Overall Study|Lost to Follow-up|1|||
155249987|NCT02010060|560345138|FG001|Overall Study|Lost to Follow-up|2|||
155249988|NCT02010060|560345139|FG002|Overall Study|Lost to Follow-up|2|||
155249989|NCT02010060|560345137|FG000|Overall Study|Injury|0|||
155249990|NCT02010060|560345138|FG001|Overall Study|Injury|1|||
155249991|NCT02010060|560345139|FG002|Overall Study|Injury|0|||
155249992|NCT04414696|560345140|FG000|3-month Follow up|Withdrawal by Subject|1|||
155491682|NCT03992456|561225488|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
155491683|NCT00762073|561225491|FG000|Overall Study|Lack of Efficacy|1|||
155249993|NCT04414696|560345141|FG001|3-month Follow up|Withdrawal by Subject|0|||
155249994|NCT04414696|560345140|FG000|3-month Follow up|Lost to Follow-up|22|||
155249995|NCT04414696|560345141|FG001|3-month Follow up|Lost to Follow-up|23|||
155249996|NCT04414696|560345140|FG000|6-month Follow up|Withdrawal by Subject|1|||
155249997|NCT04414696|560345141|FG001|6-month Follow up|Withdrawal by Subject|2|||
155249998|NCT04414696|560345140|FG000|6-month Follow up|Lost to Follow-up|5|||
155249999|NCT04414696|560345141|FG001|6-month Follow up|Lost to Follow-up|2|||
155491684|NCT00762073|561225492|FG001|Overall Study|Lack of Efficacy|1|||
155250000|NCT02979639|560347332|FG000|Overall Study|Withdrawal based on medical judgement|1|||
155250001|NCT02979639|560347332|FG000|Overall Study|Lost to Follow-up|8|||
155250002|NCT02979639|560347332|FG000|Overall Study|Withdrawal by Subject|3|||
155250003|NCT02979639|560347332|FG000|Overall Study|Adverse Event|2|||
155250004|NCT01877408|560347336|FG000|Overall Study|Lost to Follow-up|0|||
155250005|NCT01877408|560347337|FG001|Overall Study|Lost to Follow-up|2|||
155250006|NCT02621931|560347338|FG000|Overall Study|Death|0|||
155250007|NCT02621931|560347339|FG001|Overall Study|Death|1|||
155250008|NCT02621931|560347340|FG002|Overall Study|Death|0|||
155250009|NCT02621931|560347338|FG000|Overall Study|Adverse Event|8|||
155250010|NCT02621931|560347339|FG001|Overall Study|Adverse Event|5|||
155250011|NCT02621931|560347340|FG002|Overall Study|Adverse Event|7|||
155250012|NCT02621931|560347338|FG000|Overall Study|Withdrawal by Subject|12|||
155250013|NCT02621931|560347339|FG001|Overall Study|Withdrawal by Subject|10|||
155250014|NCT02621931|560347340|FG002|Overall Study|Withdrawal by Subject|11|||
155250015|NCT02621931|560347338|FG000|Overall Study|Protocol Violation|2|||
155250016|NCT02621931|560347339|FG001|Overall Study|Protocol Violation|2|||
155250017|NCT02621931|560347340|FG002|Overall Study|Protocol Violation|2|||
155250018|NCT02621931|560347338|FG000|Overall Study|Pregnancy|2|||
155250019|NCT02621931|560347339|FG001|Overall Study|Pregnancy|0|||
155250020|NCT02621931|560347340|FG002|Overall Study|Pregnancy|0|||
155250021|NCT02621931|560347338|FG000|Overall Study|Noncompliance to study procedures|0|||
155250022|NCT02621931|560347339|FG001|Overall Study|Noncompliance to study procedures|1|||
155250023|NCT02621931|560347340|FG002|Overall Study|Noncompliance to study procedures|2|||
155250024|NCT02621931|560347338|FG000|Overall Study|Lost to Follow-up|8|||
155250025|NCT02621931|560347339|FG001|Overall Study|Lost to Follow-up|7|||
155250026|NCT02621931|560347340|FG002|Overall Study|Lost to Follow-up|10|||
155250027|NCT02621931|560347338|FG000|Overall Study|Lack of Efficacy|0|||
155250028|NCT02621931|560347339|FG001|Overall Study|Lack of Efficacy|0|||
155250029|NCT02621931|560347340|FG002|Overall Study|Lack of Efficacy|1|||
155250030|NCT02621931|560347338|FG000|Overall Study|Other|1|||
155250031|NCT02621931|560347339|FG001|Overall Study|Other|1|||
155250032|NCT02621931|560347340|FG002|Overall Study|Other|3|||
155250033|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250034|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250035|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250036|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
155250037|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250038|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250039|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
155250040|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
155250041|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
155250042|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
155250043|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
155250044|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
155250045|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250046|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250047|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250048|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
155250049|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250050|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250051|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250052|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250053|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250054|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
155250055|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250056|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250057|NCT01292603|560347341|FG000|Part 1: Regular Follow-Up Period|Death|3|||
155250058|NCT01292603|560347342|FG001|Part 1: Regular Follow-Up Period|Death|1|||
155250059|NCT01292603|560347343|FG002|Part 1: Regular Follow-Up Period|Death|3|||
155250060|NCT01292603|560347344|FG003|Part 1: Regular Follow-Up Period|Death|1|||
155250061|NCT01292603|560347345|FG004|Part 1: Regular Follow-Up Period|Death|0|||
155250062|NCT01292603|560347346|FG005|Part 1: Regular Follow-Up Period|Death|0|||
155250063|NCT01292603|560347341|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
155250064|NCT01292603|560347342|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
155250065|NCT01292603|560347343|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
155250066|NCT01292603|560347344|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250067|NCT01292603|560347345|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250068|NCT01292603|560347346|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250069|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Death|0|||
155250070|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Death|0|||
155250071|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Death|0|||
155250072|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Death|0|||
155250073|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Death|1|||
155250074|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Death|0|||
155250075|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250076|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250077|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250078|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250079|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
155250080|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250081|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250082|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250083|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250084|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250085|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
155250086|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
155250087|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250088|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250089|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250090|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250091|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
155250092|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
155250093|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250094|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250095|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250096|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250097|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
155250098|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
155250099|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250100|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250101|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250102|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250103|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250104|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
155250105|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Death|0|||
155250106|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Death|0|||
155250107|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Death|0|||
155250108|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Death|0|||
155250109|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Death|6|||
155250110|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Death|3|||
155250111|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
155250112|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
155250113|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
155250114|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
155250115|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
155250116|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
155250117|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
155250118|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
155250119|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
155250120|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
155250121|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
155250122|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
155250123|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250124|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250125|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250126|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250127|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250128|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
155250129|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250130|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250131|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250132|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250133|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
155250134|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250135|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
155250136|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
155250137|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
155250138|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
155250139|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
155250140|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
155250141|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155491685|NCT00762073|561225493|FG002|Overall Study|Lack of Efficacy|0|||
155250142|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250143|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250144|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250145|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
155250146|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
155250147|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
155250148|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
155250149|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
155250150|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
155250151|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
155250152|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
155250153|NCT01292603|560347341|FG000|Overall Survival Status|Death|3|||
155250154|NCT01292603|560347342|FG001|Overall Survival Status|Death|1|||
155250155|NCT01292603|560347343|FG002|Overall Survival Status|Death|3|||
155250156|NCT01292603|560347344|FG003|Overall Survival Status|Death|1|||
155250157|NCT01292603|560347345|FG004|Overall Survival Status|Death|16|||
155250158|NCT01292603|560347346|FG005|Overall Survival Status|Death|10|||
155250159|NCT03870763|560347349|FG000|Overall Study|Study terminated by sponsor|0|||
155250160|NCT03870763|560347350|FG001|Overall Study|Study terminated by sponsor|2|||
155250161|NCT03870763|560347351|FG002|Overall Study|Study terminated by sponsor|0|||
155250162|NCT03870763|560347349|FG000|Overall Study|Withdrawal by Subject|0|||
155250163|NCT03870763|560347350|FG001|Overall Study|Withdrawal by Subject|1|||
155250164|NCT03870763|560347351|FG002|Overall Study|Withdrawal by Subject|0|||
155250165|NCT03870763|560347349|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
155250166|NCT03870763|560347350|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
155250167|NCT03870763|560347351|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
155250168|NCT02985866|560347352|FG000|Overall Study|Poor CGM data|1|||
155250169|NCT02985866|560347353|FG001|Overall Study|Poor CGM data|1|||
155250170|NCT01949311|560347354|FG000|Overall Study|Lost to Follow-up|73|||
155250171|NCT01949311|560347354|FG000|Overall Study|Terminated by Sponsor|708|||
155250172|NCT01949311|560347354|FG000|Overall Study|Withdrawal by Subject|375|||
155250173|NCT01949311|560347354|FG000|Overall Study|Lack of Efficacy|50|||
155250174|NCT01949311|560347354|FG000|Overall Study|Protocol Deviation|34|||
155250175|NCT01949311|560347354|FG000|Overall Study|Pregnancy|20|||
155250176|NCT01949311|560347354|FG000|Overall Study|Physician Decision|9|||
155250177|NCT01949311|560347354|FG000|Overall Study|Other|4|||
155250178|NCT01949311|560347354|FG000|Overall Study|Adverse Event|107|||
155250179|NCT04279314|560347357|FG000|Overall Study|Adverse Event|55|||
155250180|NCT04279314|560347357|FG000|Overall Study|Withdrawal by Subject|5|||
155250181|NCT04279314|560347357|FG000|Overall Study|Lack of Efficacy|5|||
155250182|NCT04279314|560347357|FG000|Overall Study|Protocol Violation|3|||
155250183|NCT04279314|560347357|FG000|Overall Study|Other (not COVID-19 related)|2|||
155250184|NCT02120027|560347358|FG000|Overall Study|Adverse Event|4|||
155250185|NCT02120027|560347359|FG001|Overall Study|Adverse Event|5|||
155250186|NCT02120027|560347358|FG000|Overall Study|Lack of Efficacy|3|||
155250187|NCT02120027|560347359|FG001|Overall Study|Lack of Efficacy|5|||
155250188|NCT02120027|560347358|FG000|Overall Study|Lost to Follow-up|5|||
155250189|NCT02120027|560347359|FG001|Overall Study|Lost to Follow-up|13|||
155250190|NCT02120027|560347358|FG000|Overall Study|Other|4|||
155250191|NCT02120027|560347359|FG001|Overall Study|Other|0|||
155250192|NCT02120027|560347358|FG000|Overall Study|Physician Decision|4|||
155250193|NCT02120027|560347359|FG001|Overall Study|Physician Decision|3|||
155250194|NCT02120027|560347358|FG000|Overall Study|Protocol Violation|18|||
155250195|NCT02120027|560347359|FG001|Overall Study|Protocol Violation|21|||
155250196|NCT02120027|560347358|FG000|Overall Study|Study terminated by Sponsor|45|||
155250197|NCT02120027|560347359|FG001|Overall Study|Study terminated by Sponsor|47|||
155250198|NCT02120027|560347358|FG000|Overall Study|Withdrawal by Subject|33|||
155250199|NCT02120027|560347359|FG001|Overall Study|Withdrawal by Subject|25|||
155250200|NCT01471054|560347366|FG000|Overall Study|Study terminated prematurely|4|||
155250201|NCT01471054|560347367|FG001|Overall Study|Study terminated prematurely|0|||
155250202|NCT03166618|560347368|FG000|Overall Study|Study was Terminated|0|||
155250203|NCT03166618|560347369|FG001|Overall Study|Study was Terminated|1|||
155250204|NCT03137303|560347371|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
155250205|NCT03137303|560347372|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
155250206|NCT03137303|560347371|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
155250207|NCT03137303|560347372|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
155250208|NCT03137303|560347371|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
155250209|NCT03137303|560347372|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
155250210|NCT03137303|560347371|FG000|T3: 9-month Follow-up|Death|1|||
155250211|NCT03137303|560347372|FG001|T3: 9-month Follow-up|Death|0|||
155250212|NCT03137303|560347371|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
155250213|NCT03137303|560347372|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
155250214|NCT03137303|560347371|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
155250215|NCT03137303|560347372|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
155250216|NCT03137303|560347371|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
155250217|NCT03137303|560347372|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
155250218|NCT03561090|560347373|FG000|Overall Study|Adverse Event|11|||
155250219|NCT03561090|560347374|FG001|Overall Study|Adverse Event|7|||
155250220|NCT03561090|560347373|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155250221|NCT03561090|560347374|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155250222|NCT03561090|560347373|FG000|Overall Study|Protocol Violation|2|||
155250223|NCT03561090|560347374|FG001|Overall Study|Protocol Violation|2|||
155250224|NCT03561090|560347373|FG000|Overall Study|Withdrawal by Subject|7|||
155250225|NCT03561090|560347374|FG001|Overall Study|Withdrawal by Subject|7|||
155250226|NCT03561090|560347373|FG000|Overall Study|Lost to Follow-up|7|||
155250227|NCT03561090|560347374|FG001|Overall Study|Lost to Follow-up|2|||
155250228|NCT03561090|560347373|FG000|Overall Study|Study Terminated by Sponsor|10|||
155250229|NCT03561090|560347374|FG001|Overall Study|Study Terminated by Sponsor|15|||
155250230|NCT03561090|560347373|FG000|Overall Study|Randomized by Mistake|1|||
155250231|NCT03561090|560347374|FG001|Overall Study|Randomized by Mistake|1|||
155250232|NCT03561090|560347373|FG000|Overall Study|Other Not Specified|0|||
155250233|NCT03561090|560347374|FG001|Overall Study|Other Not Specified|2|||
155250234|NCT02566031|560347377|FG000|Overall Study|Patient/guardian decision|14|||
155250235|NCT02566031|560347378|FG001|Overall Study|Patient/guardian decision|7|||
155250236|NCT02566031|560347377|FG000|Overall Study|Protocol deviation|2|||
155250237|NCT02566031|560347378|FG001|Overall Study|Protocol deviation|3|||
155250238|NCT02566031|560347377|FG000|Overall Study|Adverse Event|3|||
155250239|NCT02566031|560347378|FG001|Overall Study|Adverse Event|1|||
155250240|NCT02566031|560347377|FG000|Overall Study|Lost to Follow-up|1|||
155250241|NCT02566031|560347378|FG001|Overall Study|Lost to Follow-up|1|||
155250242|NCT03031938|560347379|FG000|Overall Study|Death|1|||
155250243|NCT03031938|560347380|FG001|Overall Study|Death|0|||
155250244|NCT02479412|560347385|FG000|Overall Study|Adverse Event|0|||
155250245|NCT02479412|560347386|FG001|Overall Study|Adverse Event|0|||
155250246|NCT02479412|560347387|FG002|Overall Study|Adverse Event|1|||
155250247|NCT02479412|560347388|FG003|Overall Study|Adverse Event|0|||
155250248|NCT02479412|560347389|FG004|Overall Study|Adverse Event|0|||
155250249|NCT02479412|560347390|FG005|Overall Study|Adverse Event|0|||
155250250|NCT02479412|560347391|FG006|Overall Study|Adverse Event|0|||
155250251|NCT02479412|560347392|FG007|Overall Study|Adverse Event|0|||
155250252|NCT02479412|560347393|FG008|Overall Study|Adverse Event|0|||
155250253|NCT02479412|560347385|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155250254|NCT02479412|560347386|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155250255|NCT02479412|560347387|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155250256|NCT02479412|560347388|FG003|Overall Study|Study-specific withdrawal criteria|1|||
155250257|NCT02479412|560347389|FG004|Overall Study|Study-specific withdrawal criteria|0|||
155250258|NCT02479412|560347390|FG005|Overall Study|Study-specific withdrawal criteria|0|||
155250259|NCT02479412|560347391|FG006|Overall Study|Study-specific withdrawal criteria|0|||
155250260|NCT02479412|560347392|FG007|Overall Study|Study-specific withdrawal criteria|1|||
155250261|NCT02479412|560347393|FG008|Overall Study|Study-specific withdrawal criteria|1|||
155250262|NCT02479412|560347385|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
155250263|NCT02479412|560347386|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
155250264|NCT02479412|560347387|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
155250265|NCT02479412|560347388|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
155250266|NCT02479412|560347389|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
155250267|NCT02479412|560347390|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
155250268|NCT02479412|560347391|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
155250269|NCT02479412|560347392|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
155250270|NCT02479412|560347393|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
155250271|NCT04402866|560347398|FG000|Overall Study|Discontinued Prior to Treatment|0|||
155250272|NCT04402866|560347399|FG001|Overall Study|Discontinued Prior to Treatment|0|||
155250273|NCT04402866|560347400|FG002|Overall Study|Discontinued Prior to Treatment|0|||
155250274|NCT04402866|560347401|FG003|Overall Study|Discontinued Prior to Treatment|0|||
155250275|NCT04402866|560347402|FG004|Overall Study|Discontinued Prior to Treatment|2|||
155250276|NCT04402866|560347403|FG005|Overall Study|Discontinued Prior to Treatment|3|||
155250277|NCT04402866|560347398|FG000|Overall Study|Adverse Event|2|||
155250278|NCT04402866|560347399|FG001|Overall Study|Adverse Event|1|||
155250279|NCT04402866|560347400|FG002|Overall Study|Adverse Event|0|||
155250280|NCT04402866|560347401|FG003|Overall Study|Adverse Event|0|||
155250281|NCT04402866|560347402|FG004|Overall Study|Adverse Event|13|||
155250282|NCT04402866|560347403|FG005|Overall Study|Adverse Event|8|||
155250283|NCT04402866|560347398|FG000|Overall Study|Miscellaneous|0|||
155250284|NCT04402866|560347399|FG001|Overall Study|Miscellaneous|0|||
155250285|NCT04402866|560347400|FG002|Overall Study|Miscellaneous|1|||
155250286|NCT04402866|560347401|FG003|Overall Study|Miscellaneous|0|||
155250287|NCT04402866|560347402|FG004|Overall Study|Miscellaneous|0|||
155250288|NCT04402866|560347403|FG005|Overall Study|Miscellaneous|0|||
155250289|NCT04402866|560347398|FG000|Overall Study|Lost to Follow-up|0|||
155491686|NCT00762073|561225494|FG003|Overall Study|Lack of Efficacy|0|||
155250290|NCT04402866|560347399|FG001|Overall Study|Lost to Follow-up|0|||
155250291|NCT04402866|560347400|FG002|Overall Study|Lost to Follow-up|0|||
155250292|NCT04402866|560347401|FG003|Overall Study|Lost to Follow-up|0|||
155250293|NCT04402866|560347402|FG004|Overall Study|Lost to Follow-up|0|||
155250294|NCT04402866|560347403|FG005|Overall Study|Lost to Follow-up|1|||
155250295|NCT04402866|560347398|FG000|Overall Study|Withdrawal by Subject|0|||
155250296|NCT04402866|560347399|FG001|Overall Study|Withdrawal by Subject|0|||
155250297|NCT04402866|560347400|FG002|Overall Study|Withdrawal by Subject|0|||
155250298|NCT04402866|560347401|FG003|Overall Study|Withdrawal by Subject|0|||
155250299|NCT04402866|560347402|FG004|Overall Study|Withdrawal by Subject|0|||
155250300|NCT04402866|560347403|FG005|Overall Study|Withdrawal by Subject|2|||
155250301|NCT03667053|560347404|FG000|Overall Study|Withdrawal by Subject|1|||
155250302|NCT03667053|560347405|FG001|Overall Study|Withdrawal by Subject|0|||
155250303|NCT03667053|560347406|FG002|Overall Study|Withdrawal by Subject|0|||
155250304|NCT00515502|560347408|FG000|Treatment Period 1|Adverse Event|0|||
155250305|NCT00515502|560347409|FG001|Treatment Period 1|Adverse Event|0|||
155250306|NCT00515502|560347410|FG002|Treatment Period 1|Adverse Event|0|||
155250307|NCT00515502|560347411|FG003|Treatment Period 1|Adverse Event|0|||
155250308|NCT00515502|560347412|FG004|Treatment Period 1|Adverse Event|0|||
155250309|NCT00515502|560347413|FG005|Treatment Period 1|Adverse Event|0|||
155250310|NCT00515502|560347414|FG006|Treatment Period 1|Adverse Event|1|||
155250311|NCT00515502|560347415|FG007|Treatment Period 1|Adverse Event|0|||
155250312|NCT00515502|560347416|FG008|Treatment Period 1|Adverse Event|1|||
155250313|NCT00515502|560347417|FG009|Treatment Period 1|Adverse Event|0|||
155250314|NCT00515502|560347418|FG010|Treatment Period 1|Adverse Event|0|||
155250315|NCT00515502|560347419|FG011|Treatment Period 1|Adverse Event|1|||
155250316|NCT00515502|560347408|FG000|Treatment Period 2|Adverse Event|0|||
155250317|NCT00515502|560347409|FG001|Treatment Period 2|Adverse Event|1|||
155250318|NCT00515502|560347410|FG002|Treatment Period 2|Adverse Event|0|||
155250319|NCT00515502|560347411|FG003|Treatment Period 2|Adverse Event|0|||
155250320|NCT00515502|560347412|FG004|Treatment Period 2|Adverse Event|0|||
155250321|NCT00515502|560347413|FG005|Treatment Period 2|Adverse Event|0|||
155250322|NCT00515502|560347414|FG006|Treatment Period 2|Adverse Event|0|||
155250323|NCT00515502|560347415|FG007|Treatment Period 2|Adverse Event|0|||
155250324|NCT00515502|560347416|FG008|Treatment Period 2|Adverse Event|0|||
155250325|NCT00515502|560347417|FG009|Treatment Period 2|Adverse Event|0|||
155250326|NCT00515502|560347418|FG010|Treatment Period 2|Adverse Event|0|||
155250327|NCT00515502|560347419|FG011|Treatment Period 2|Adverse Event|0|||
155250328|NCT02732938|560347420|FG000|Overall Study|Death|0|||
155250329|NCT02732938|560347421|FG001|Overall Study|Death|11|||
155250330|NCT02732938|560347422|FG002|Overall Study|Death|0|||
155250331|NCT02732938|560347420|FG000|Overall Study|Randomized but did not receive treatment|0|||
155250332|NCT02732938|560347421|FG001|Overall Study|Randomized but did not receive treatment|1|||
155250333|NCT02732938|560347422|FG002|Overall Study|Randomized but did not receive treatment|0|||
155250334|NCT02732938|560347420|FG000|Overall Study|Refused further follow-up|1|||
155250335|NCT02732938|560347421|FG001|Overall Study|Refused further follow-up|0|||
155250336|NCT02732938|560347422|FG002|Overall Study|Refused further follow-up|0|||
155250337|NCT02732938|560347420|FG000|Overall Study|Study terminated by sponsor|3|||
155250338|NCT02732938|560347421|FG001|Overall Study|Study terminated by sponsor|6|||
155250339|NCT02732938|560347422|FG002|Overall Study|Study terminated by sponsor|0|||
155250340|NCT03647501|560347423|FG000|Overall Study|Lost to Follow-up|1|||
155250341|NCT03647501|560347424|FG001|Overall Study|Lost to Follow-up|1|||
155250342|NCT03647501|560347423|FG000|Overall Study|Withdrawal by Subject|0|||
155250343|NCT03647501|560347424|FG001|Overall Study|Withdrawal by Subject|1|||
155250344|NCT01613248|560347425|FG000|Overall Study|Adverse Event|0|||
155250345|NCT01613248|560347426|FG001|Overall Study|Adverse Event|0|||
155250346|NCT01613248|560347427|FG002|Overall Study|Adverse Event|0|||
155250347|NCT01613248|560347428|FG003|Overall Study|Adverse Event|1|||
155250348|NCT01613248|560347429|FG004|Overall Study|Adverse Event|0|||
155250349|NCT01613248|560347430|FG005|Overall Study|Adverse Event|0|||
155250350|NCT01613248|560347425|FG000|Overall Study|Withdrawal by Subject|3|||
155250351|NCT01613248|560347426|FG001|Overall Study|Withdrawal by Subject|2|||
155250352|NCT01613248|560347427|FG002|Overall Study|Withdrawal by Subject|2|||
155250353|NCT01613248|560347428|FG003|Overall Study|Withdrawal by Subject|5|||
155250354|NCT01613248|560347429|FG004|Overall Study|Withdrawal by Subject|0|||
155250355|NCT01613248|560347430|FG005|Overall Study|Withdrawal by Subject|1|||
155250356|NCT01613248|560347425|FG000|Overall Study|Lost to Follow-up|5|||
155250357|NCT01613248|560347426|FG001|Overall Study|Lost to Follow-up|7|||
155250358|NCT01613248|560347427|FG002|Overall Study|Lost to Follow-up|4|||
155250359|NCT01613248|560347428|FG003|Overall Study|Lost to Follow-up|8|||
155250360|NCT01613248|560347429|FG004|Overall Study|Lost to Follow-up|4|||
155250361|NCT01613248|560347430|FG005|Overall Study|Lost to Follow-up|2|||
155250362|NCT01613248|560347425|FG000|Overall Study|Study Terminated by Sponsor|4|||
155250363|NCT01613248|560347426|FG001|Overall Study|Study Terminated by Sponsor|6|||
155250364|NCT01613248|560347427|FG002|Overall Study|Study Terminated by Sponsor|8|||
155250365|NCT01613248|560347428|FG003|Overall Study|Study Terminated by Sponsor|8|||
155250366|NCT01613248|560347429|FG004|Overall Study|Study Terminated by Sponsor|9|||
155250367|NCT01613248|560347430|FG005|Overall Study|Study Terminated by Sponsor|11|||
155250368|NCT01613248|560347425|FG000|Overall Study|Physician Decision|8|||
155250369|NCT01613248|560347426|FG001|Overall Study|Physician Decision|8|||
155250370|NCT01613248|560347427|FG002|Overall Study|Physician Decision|9|||
155250371|NCT01613248|560347428|FG003|Overall Study|Physician Decision|4|||
155250372|NCT01613248|560347429|FG004|Overall Study|Physician Decision|7|||
155250373|NCT01613248|560347430|FG005|Overall Study|Physician Decision|6|||
155250374|NCT01613248|560347425|FG000|Overall Study|Lack of Qualifying Event|9|||
155250375|NCT01613248|560347426|FG001|Overall Study|Lack of Qualifying Event|11|||
155250376|NCT01613248|560347427|FG002|Overall Study|Lack of Qualifying Event|10|||
155250377|NCT01613248|560347428|FG003|Overall Study|Lack of Qualifying Event|11|||
155250378|NCT01613248|560347429|FG004|Overall Study|Lack of Qualifying Event|15|||
155250379|NCT01613248|560347430|FG005|Overall Study|Lack of Qualifying Event|18|||
155250380|NCT01613248|560347425|FG000|Overall Study|Pregnancy|0|||
155250381|NCT01613248|560347426|FG001|Overall Study|Pregnancy|0|||
155250382|NCT01613248|560347427|FG002|Overall Study|Pregnancy|0|||
155250383|NCT01613248|560347428|FG003|Overall Study|Pregnancy|1|||
155250384|NCT01613248|560347429|FG004|Overall Study|Pregnancy|0|||
155250385|NCT01613248|560347430|FG005|Overall Study|Pregnancy|0|||
155250386|NCT04307004|560347434|FG000|Randomization 1|Withdrawal by Subject|25|||
155250387|NCT04307004|560347435|FG001|Randomization 1|Withdrawal by Subject|26|||
155250388|NCT04307004|560347436|FG002|Randomization 1|Withdrawal by Subject|0|||
155250389|NCT04307004|560347437|FG003|Randomization 1|Withdrawal by Subject|0|||
155250390|NCT04307004|560347434|FG000|Randomization 2|Withdrawal by Subject|0|||
155250391|NCT04307004|560347435|FG001|Randomization 2|Withdrawal by Subject|0|||
155250392|NCT04307004|560347436|FG002|Randomization 2|Withdrawal by Subject|28|||
155250393|NCT04307004|560347437|FG003|Randomization 2|Withdrawal by Subject|23|||
155250394|NCT05545072|560347438|FG000|Overall Study|Lost to Follow-up|1|||
155250395|NCT05545072|560347439|FG001|Overall Study|Lost to Follow-up|0|||
155250396|NCT05545072|560347438|FG000|Overall Study|Study ended prematurely due to funding|2|||
155250397|NCT05545072|560347439|FG001|Overall Study|Study ended prematurely due to funding|2|||
155250398|NCT02395042|560347440|FG000|Treatment 1 Period|Adverse Event|1|||
155250399|NCT02395042|560347441|FG001|Treatment 1 Period|Adverse Event|3|||
155250400|NCT02395042|560347442|FG002|Treatment 1 Period|Adverse Event|1|||
155250401|NCT02395042|560347440|FG000|Treatment 1 Period|Lack of Efficacy|1|||
155250402|NCT02395042|560347441|FG001|Treatment 1 Period|Lack of Efficacy|1|||
155250403|NCT02395042|560347442|FG002|Treatment 1 Period|Lack of Efficacy|0|||
155250404|NCT02395042|560347440|FG000|Treatment 1 Period|Lost to Follow-up|1|||
155250405|NCT02395042|560347441|FG001|Treatment 1 Period|Lost to Follow-up|0|||
155250406|NCT02395042|560347442|FG002|Treatment 1 Period|Lost to Follow-up|0|||
155250407|NCT02395042|560347440|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
155250408|NCT02395042|560347441|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
155250409|NCT02395042|560347442|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
155250410|NCT02395042|560347440|FG000|Treatment 2 Period|Lack of Efficacy|1|||
155250411|NCT02395042|560347441|FG001|Treatment 2 Period|Lack of Efficacy|1|||
155250412|NCT02395042|560347442|FG002|Treatment 2 Period|Lack of Efficacy|0|||
155250413|NCT02647359|560347443|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
155250414|NCT02647359|560347444|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
155250415|NCT02647359|560347443|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
155250416|NCT02647359|560347444|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
155250417|NCT02647359|560347443|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
155250418|NCT02647359|560347444|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
155250419|NCT02647359|560347443|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
155250420|NCT02647359|560347444|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
155250421|NCT02647359|560347443|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
155250422|NCT02647359|560347444|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
155250423|NCT02647359|560347443|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
155250424|NCT02647359|560347444|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
155250425|NCT04642638|560347445|FG000|Overall Study|Withdrawal by Subject|23|||
155250426|NCT04642638|560347446|FG001|Overall Study|Withdrawal by Subject|29|||
155250427|NCT04642638|560347447|FG002|Overall Study|Withdrawal by Subject|9|||
155250428|NCT04642638|560347448|FG003|Overall Study|Withdrawal by Subject|7|||
155250429|NCT04642638|560347449|FG004|Overall Study|Withdrawal by Subject|61|||
155250430|NCT04642638|560347450|FG005|Overall Study|Withdrawal by Subject|27|||
155250431|NCT04642638|560347445|FG000|Overall Study|Lost to Follow-up|17|||
155250432|NCT04642638|560347446|FG001|Overall Study|Lost to Follow-up|18|||
155250433|NCT04642638|560347447|FG002|Overall Study|Lost to Follow-up|5|||
155250434|NCT04642638|560347448|FG003|Overall Study|Lost to Follow-up|5|||
155250435|NCT04642638|560347449|FG004|Overall Study|Lost to Follow-up|6|||
155250436|NCT04642638|560347450|FG005|Overall Study|Lost to Follow-up|3|||
155250437|NCT04642638|560347445|FG000|Overall Study|Adverse Event|0|||
155250438|NCT04642638|560347446|FG001|Overall Study|Adverse Event|0|||
155250439|NCT04642638|560347447|FG002|Overall Study|Adverse Event|1|||
155250440|NCT04642638|560347448|FG003|Overall Study|Adverse Event|0|||
155250441|NCT04642638|560347449|FG004|Overall Study|Adverse Event|10|||
155250442|NCT04642638|560347450|FG005|Overall Study|Adverse Event|3|||
155250443|NCT04642638|560347445|FG000|Overall Study|Reason Not Specified|1|||
155250444|NCT04642638|560347446|FG001|Overall Study|Reason Not Specified|4|||
155250445|NCT04642638|560347447|FG002|Overall Study|Reason Not Specified|0|||
155250446|NCT04642638|560347448|FG003|Overall Study|Reason Not Specified|0|||
155250447|NCT04642638|560347449|FG004|Overall Study|Reason Not Specified|38|||
155250448|NCT04642638|560347450|FG005|Overall Study|Reason Not Specified|16|||
155250449|NCT04642638|560347445|FG000|Overall Study|Physician Decision|0|||
155250450|NCT04642638|560347446|FG001|Overall Study|Physician Decision|0|||
155250451|NCT04642638|560347447|FG002|Overall Study|Physician Decision|0|||
155250452|NCT04642638|560347448|FG003|Overall Study|Physician Decision|0|||
155250453|NCT04642638|560347449|FG004|Overall Study|Physician Decision|2|||
155250454|NCT04642638|560347450|FG005|Overall Study|Physician Decision|1|||
155250455|NCT04642638|560347445|FG000|Overall Study|Protocol Deviation|0|||
155250456|NCT04642638|560347446|FG001|Overall Study|Protocol Deviation|0|||
155250457|NCT04642638|560347447|FG002|Overall Study|Protocol Deviation|0|||
155250458|NCT04642638|560347448|FG003|Overall Study|Protocol Deviation|0|||
155250459|NCT04642638|560347449|FG004|Overall Study|Protocol Deviation|1|||
155250460|NCT04642638|560347450|FG005|Overall Study|Protocol Deviation|3|||
155250461|NCT04642638|560347445|FG000|Overall Study|Study Terminated|0|||
155250462|NCT04642638|560347446|FG001|Overall Study|Study Terminated|0|||
155250463|NCT04642638|560347447|FG002|Overall Study|Study Terminated|0|||
155250464|NCT04642638|560347448|FG003|Overall Study|Study Terminated|0|||
155250465|NCT04642638|560347449|FG004|Overall Study|Study Terminated|484|||
155250466|NCT04642638|560347450|FG005|Overall Study|Study Terminated|250|||
155250467|NCT04642638|560347445|FG000|Overall Study|Pregnancy|0|||
155250468|NCT04642638|560347446|FG001|Overall Study|Pregnancy|0|||
155250469|NCT04642638|560347447|FG002|Overall Study|Pregnancy|0|||
155250470|NCT04642638|560347448|FG003|Overall Study|Pregnancy|0|||
155250471|NCT04642638|560347449|FG004|Overall Study|Pregnancy|1|||
155250472|NCT04642638|560347450|FG005|Overall Study|Pregnancy|0|||
155250473|NCT06476366|560347451|FG000|Overall Study|Lost to Follow-up|1|||
155250474|NCT06476366|560347452|FG001|Overall Study|Lost to Follow-up|3|||
155250475|NCT06476366|560347451|FG000|Overall Study|Adverse Event|1|||
155250476|NCT06476366|560347452|FG001|Overall Study|Adverse Event|0|||
155250477|NCT04313881|560347453|FG000|Overall Study|Death|138|||
155250478|NCT04313881|560347454|FG001|Overall Study|Death|126|||
155250479|NCT04313881|560347453|FG000|Overall Study|Study terminated by sponsor|108|||
155250480|NCT04313881|560347454|FG001|Overall Study|Study terminated by sponsor|129|||
155250481|NCT04313881|560347453|FG000|Overall Study|Consent withdrawn|19|||
155250482|NCT04313881|560347454|FG001|Overall Study|Consent withdrawn|15|||
155250483|NCT04313881|560347453|FG000|Overall Study|Reason not Specified|3|||
155250484|NCT04313881|560347454|FG001|Overall Study|Reason not Specified|1|||
155250485|NCT00727272|560347455|FG000|Washout Period A|Adverse Event|0|||
155250486|NCT00727272|560347456|FG001|Washout Period A|Adverse Event|0|||
155250487|NCT00727272|560347457|FG002|Washout Period A|Adverse Event|1|||
155250488|NCT00727272|560347455|FG000|Washout Period B|Withdrawal by Subject|0|||
155250489|NCT00727272|560347456|FG001|Washout Period B|Withdrawal by Subject|0|||
155250490|NCT00727272|560347457|FG002|Washout Period B|Withdrawal by Subject|1|||
155250491|NCT00651664|560347458|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
155250492|NCT00651664|560347459|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
155250493|NCT00651664|560347460|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
155250494|NCT00651664|560347461|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
155250495|NCT00651664|560347462|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
155250496|NCT00651664|560347463|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
155250497|NCT00651664|560347464|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
155250498|NCT00651664|560347465|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
155250499|NCT00651664|560347466|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
155250500|NCT00651664|560347467|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
155250501|NCT00651664|560347458|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250502|NCT00651664|560347459|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250503|NCT00651664|560347460|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250504|NCT00651664|560347461|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250505|NCT00651664|560347462|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250506|NCT00651664|560347463|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250507|NCT00651664|560347464|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250508|NCT00651664|560347465|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250509|NCT00651664|560347466|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250510|NCT00651664|560347467|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250511|NCT00651664|560347458|FG000|Overall Study|Progressive Disease|3|||
155250512|NCT00651664|560347459|FG001|Overall Study|Progressive Disease|3|||
155250513|NCT00651664|560347460|FG002|Overall Study|Progressive Disease|3|||
155250514|NCT00651664|560347461|FG003|Overall Study|Progressive Disease|12|||
155250515|NCT00651664|560347462|FG004|Overall Study|Progressive Disease|4|||
155250516|NCT00651664|560347463|FG005|Overall Study|Progressive Disease|1|||
155250517|NCT00651664|560347464|FG006|Overall Study|Progressive Disease|3|||
155250518|NCT00651664|560347465|FG007|Overall Study|Progressive Disease|6|||
155250519|NCT00651664|560347466|FG008|Overall Study|Progressive Disease|5|||
155250520|NCT00651664|560347467|FG009|Overall Study|Progressive Disease|5|||
155250521|NCT00651664|560347458|FG000|Overall Study|Patient Declined Further Treatment|0|||
155250522|NCT00651664|560347459|FG001|Overall Study|Patient Declined Further Treatment|0|||
155250523|NCT00651664|560347460|FG002|Overall Study|Patient Declined Further Treatment|0|||
155250524|NCT00651664|560347461|FG003|Overall Study|Patient Declined Further Treatment|1|||
155250525|NCT00651664|560347462|FG004|Overall Study|Patient Declined Further Treatment|1|||
155250526|NCT00651664|560347463|FG005|Overall Study|Patient Declined Further Treatment|1|||
155250527|NCT00651664|560347464|FG006|Overall Study|Patient Declined Further Treatment|0|||
155250528|NCT00651664|560347465|FG007|Overall Study|Patient Declined Further Treatment|0|||
155250529|NCT00651664|560347466|FG008|Overall Study|Patient Declined Further Treatment|0|||
155250530|NCT00651664|560347467|FG009|Overall Study|Patient Declined Further Treatment|1|||
155250531|NCT00651664|560347458|FG000|Overall Study|Symptomatic Deterioration|0|||
155250532|NCT00651664|560347459|FG001|Overall Study|Symptomatic Deterioration|0|||
155250533|NCT00651664|560347460|FG002|Overall Study|Symptomatic Deterioration|0|||
155250534|NCT00651664|560347461|FG003|Overall Study|Symptomatic Deterioration|1|||
155250535|NCT00651664|560347462|FG004|Overall Study|Symptomatic Deterioration|0|||
155250536|NCT00651664|560347463|FG005|Overall Study|Symptomatic Deterioration|0|||
155250537|NCT00651664|560347464|FG006|Overall Study|Symptomatic Deterioration|1|||
155250538|NCT00651664|560347465|FG007|Overall Study|Symptomatic Deterioration|0|||
155250539|NCT00651664|560347466|FG008|Overall Study|Symptomatic Deterioration|1|||
155250540|NCT00651664|560347467|FG009|Overall Study|Symptomatic Deterioration|0|||
155250541|NCT00651664|560347458|FG000|Overall Study|Reason not Specified|0|||
155250542|NCT00651664|560347459|FG001|Overall Study|Reason not Specified|0|||
155250543|NCT00651664|560347460|FG002|Overall Study|Reason not Specified|0|||
155250544|NCT00651664|560347461|FG003|Overall Study|Reason not Specified|0|||
155250545|NCT00651664|560347462|FG004|Overall Study|Reason not Specified|0|||
155250546|NCT00651664|560347463|FG005|Overall Study|Reason not Specified|0|||
155250547|NCT00651664|560347464|FG006|Overall Study|Reason not Specified|1|||
155250548|NCT00651664|560347465|FG007|Overall Study|Reason not Specified|0|||
155250549|NCT00651664|560347466|FG008|Overall Study|Reason not Specified|0|||
155250550|NCT00651664|560347467|FG009|Overall Study|Reason not Specified|0|||
155250551|NCT04053764|560347468|FG000|Overall Study|Withdrawal by Subject|6|||
155250552|NCT04053764|560347469|FG001|Overall Study|Withdrawal by Subject|2|||
155250553|NCT04053764|560347468|FG000|Overall Study|Physician Decision|2|||
155250554|NCT04053764|560347469|FG001|Overall Study|Physician Decision|1|||
155250555|NCT04053764|560347468|FG000|Overall Study|Adverse Event|1|||
155250556|NCT04053764|560347469|FG001|Overall Study|Adverse Event|0|||
155250557|NCT04053764|560347468|FG000|Overall Study|Pregnancy|1|||
155250558|NCT04053764|560347469|FG001|Overall Study|Pregnancy|0|||
155250559|NCT04732286|560347470|FG000|Overall Study|Progressive Disease|2|||
155250560|NCT04732286|560347470|FG000|Overall Study|Physician Decision|1|||
155250561|NCT04732286|560347470|FG000|Overall Study|Study Terminated by Sponsor|31|||
155250562|NCT04732286|560347470|FG000|Overall Study|Withdrawal by Subject|10|||
155250563|NCT04732286|560347470|FG000|Overall Study|Non-compliance With Study Drug|1|||
155250564|NCT04732286|560347470|FG000|Overall Study|Lost to Follow-up|4|||
155250565|NCT04732286|560347470|FG000|Overall Study|Death|51|||
155250566|NCT00319098|560347474|FG000|Overall Study|Serious adverse event|3|||
155250567|NCT00319098|560347475|FG001|Overall Study|Serious adverse event|0|||
155250568|NCT00319098|560347474|FG000|Overall Study|Adverse Event|20|||
155250569|NCT00319098|560347475|FG001|Overall Study|Adverse Event|1|||
155250570|NCT00319098|560347474|FG000|Overall Study|Withdrawal by Subject|37|||
155250571|NCT00319098|560347475|FG001|Overall Study|Withdrawal by Subject|8|||
155250572|NCT00319098|560347474|FG000|Overall Study|Migrated/moved from study area|2|||
155250573|NCT00319098|560347475|FG001|Overall Study|Migrated/moved from study area|1|||
155250574|NCT00319098|560347474|FG000|Overall Study|Lost to Follow-up|37|||
155250575|NCT00319098|560347475|FG001|Overall Study|Lost to Follow-up|13|||
155250576|NCT00319098|560347474|FG000|Overall Study|Others|33|||
155250577|NCT00319098|560347475|FG001|Overall Study|Others|8|||
155250578|NCT00319098|560347474|FG000|Overall Study|Protocol Violation|3|||
155250579|NCT00319098|560347475|FG001|Overall Study|Protocol Violation|1|||
155250580|NCT00936858|560347480|FG000|Overall Study|Death|3|||
155250581|NCT00936858|560347480|FG000|Overall Study|Progression|29|||
155250582|NCT00936858|560347480|FG000|Overall Study|Withdrawal by Subject|5|||
155250583|NCT00936858|560347480|FG000|Overall Study|Adverse Event|1|||
155250584|NCT00936858|560347480|FG000|Overall Study|Physician Decision|7|||
155250585|NCT00936858|560347480|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
155250586|NCT00936858|560347480|FG000|Overall Study|Lost to Follow-up|1|||
155250587|NCT00584727|560347481|FG000|First Intervention|Discontinuation|0|||
155250588|NCT00584727|560347482|FG001|First Intervention|Discontinuation|0|||
155250589|NCT00584727|560347483|FG002|First Intervention|Discontinuation|1|||
155250590|NCT00584727|560347484|FG003|First Intervention|Discontinuation|0|||
155250591|NCT00584727|560347485|FG004|First Intervention|Discontinuation|0|||
155250592|NCT00584727|560347486|FG005|First Intervention|Discontinuation|0|||
155250593|NCT00584727|560347481|FG000|Third Intervention|Protocol Violation|0|||
155250594|NCT00584727|560347482|FG001|Third Intervention|Protocol Violation|0|||
155250595|NCT00584727|560347483|FG002|Third Intervention|Protocol Violation|1|||
155250596|NCT00584727|560347484|FG003|Third Intervention|Protocol Violation|0|||
155250597|NCT00584727|560347485|FG004|Third Intervention|Protocol Violation|4|||
155250598|NCT00584727|560347486|FG005|Third Intervention|Protocol Violation|2|||
155250599|NCT00092131|560347487|FG000|Treatment Period I|Adverse Event|1|||
155250600|NCT00092131|560347488|FG001|Treatment Period I|Adverse Event|0|||
155250601|NCT00092131|560347487|FG000|Treatment Period II|Adverse Event|0|||
155250602|NCT00092131|560347488|FG001|Treatment Period II|Adverse Event|1|||
155250603|NCT02341417|560347489|FG000|Overall Study|Withdrawal by Subject|0|||
155250604|NCT02341417|560347490|FG001|Overall Study|Withdrawal by Subject|2|||
155250605|NCT02341417|560347491|FG002|Overall Study|Withdrawal by Subject|0|||
155250606|NCT02341417|560347489|FG000|Overall Study|Decision by sponsor|2|||
155250607|NCT02341417|560347490|FG001|Overall Study|Decision by sponsor|0|||
155250608|NCT02341417|560347491|FG002|Overall Study|Decision by sponsor|0|||
155250609|NCT02341417|560347489|FG000|Overall Study|Death|0|||
155250610|NCT02341417|560347490|FG001|Overall Study|Death|0|||
155250611|NCT02341417|560347491|FG002|Overall Study|Death|1|||
155250612|NCT01857531|560347492|FG000|Overall Study|Withdrawal by Subject|4|||
155250613|NCT02576067|560347493|FG000|Overall Study|Death|0|||
155250614|NCT02576067|560347494|FG001|Overall Study|Death|1|||
155250615|NCT02576067|560347493|FG000|Overall Study|Lack of Efficacy|1|||
155250616|NCT02576067|560347494|FG001|Overall Study|Lack of Efficacy|0|||
155250617|NCT02576067|560347493|FG000|Overall Study|Lost to Follow-up|11|||
155250618|NCT02576067|560347494|FG001|Overall Study|Lost to Follow-up|0|||
155250619|NCT02576067|560347493|FG000|Overall Study|Withdrawal by Subject|11|||
155250620|NCT02576067|560347494|FG001|Overall Study|Withdrawal by Subject|2|||
155250621|NCT02576067|560347493|FG000|Overall Study|study closure of main CIRT trial)|0|||
155250622|NCT02576067|560347494|FG001|Overall Study|study closure of main CIRT trial)|8|||
155250623|NCT02576067|560347493|FG000|Overall Study|not randomized, failed run-in|7|||
155250624|NCT02576067|560347494|FG001|Overall Study|not randomized, failed run-in|0|||
155250625|NCT02576067|560347493|FG000|Overall Study|screen failure/ re-enrolled|0|||
155250626|NCT02576067|560347494|FG001|Overall Study|screen failure/ re-enrolled|25|||
155250627|NCT02576067|560347493|FG000|Overall Study|Physician Decision|4|||
155250628|NCT02576067|560347494|FG001|Overall Study|Physician Decision|0|||
155250629|NCT04773587|560347495|FG000|Overall Study|Lost to Follow-up|11|||
155250630|NCT04773587|560347496|FG001|Overall Study|Lost to Follow-up|3|||
155250631|NCT04773587|560347495|FG000|Overall Study|Adverse Event|6|||
155250632|NCT04773587|560347496|FG001|Overall Study|Adverse Event|3|||
155250633|NCT04773587|560347495|FG000|Overall Study|Lack of Efficacy|5|||
155250634|NCT04773587|560347496|FG001|Overall Study|Lack of Efficacy|2|||
155250635|NCT04773587|560347495|FG000|Overall Study|Withdrawal by Subject|4|||
155250636|NCT04773587|560347496|FG001|Overall Study|Withdrawal by Subject|5|||
155250637|NCT04773587|560347495|FG000|Overall Study|Noncompliance|1|||
155250638|NCT04773587|560347496|FG001|Overall Study|Noncompliance|0|||
155250639|NCT04773587|560347495|FG000|Overall Study|Protocol Violation|1|||
155250640|NCT04773587|560347496|FG001|Overall Study|Protocol Violation|0|||
155250641|NCT04773587|560347495|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
155250642|NCT04773587|560347496|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
155250643|NCT00435370|560347497|FG000|Overall Study|Adverse Event|8|||
155250644|NCT00435370|560347498|FG001|Overall Study|Adverse Event|8|||
155250645|NCT00435370|560347497|FG000|Overall Study|Withdrawal by Subject|10|||
155250646|NCT00435370|560347498|FG001|Overall Study|Withdrawal by Subject|10|||
155250647|NCT00435370|560347497|FG000|Overall Study|Antipsychotic medication changed|4|||
155250648|NCT00435370|560347498|FG001|Overall Study|Antipsychotic medication changed|2|||
155250649|NCT02132611|560347499|FG000|Overall Study|Death|2|||
155250650|NCT03943095|560347500|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
155250651|NCT03943095|560347501|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
155250652|NCT03943095|560347500|FG000|Overall Study|Withdrawal by Subject|1|||
155250653|NCT03943095|560347501|FG001|Overall Study|Withdrawal by Subject|0|||
155250654|NCT02298192|560347502|FG000|Overall Study|Unclassified|3|||
155250655|NCT02298192|560347503|FG001|Overall Study|Unclassified|2|||
155250656|NCT02298192|560347502|FG000|Overall Study|Withdrawal criteria|2|||
155250657|NCT02298192|560347503|FG001|Overall Study|Withdrawal criteria|0|||
155250658|NCT02298192|560347502|FG000|Overall Study|Withdrawal by Subject|6|||
155250659|NCT02298192|560347503|FG001|Overall Study|Withdrawal by Subject|1|||
155250660|NCT02298192|560347502|FG000|Overall Study|Lost to Follow-up|2|||
155250661|NCT02298192|560347503|FG001|Overall Study|Lost to Follow-up|1|||
155250662|NCT02298192|560347502|FG000|Overall Study|Adverse Event|6|||
155250663|NCT02298192|560347503|FG001|Overall Study|Adverse Event|2|||
155250664|NCT02352948|560347504|FG000|Overall Study|Death|47|||
155250665|NCT02352948|560347505|FG001|Overall Study|Death|48|||
155250666|NCT02352948|560347506|FG002|Overall Study|Death|114|||
155250667|NCT02352948|560347507|FG003|Overall Study|Death|74|||
155250668|NCT02352948|560347508|FG004|Overall Study|Death|77|||
155250669|NCT02352948|560347509|FG005|Overall Study|Death|44|||
155250670|NCT02352948|560347504|FG000|Overall Study|Lost to Follow-up|1|||
155250671|NCT02352948|560347505|FG001|Overall Study|Lost to Follow-up|0|||
155250672|NCT02352948|560347506|FG002|Overall Study|Lost to Follow-up|2|||
155250673|NCT02352948|560347507|FG003|Overall Study|Lost to Follow-up|1|||
155250674|NCT02352948|560347508|FG004|Overall Study|Lost to Follow-up|2|||
155250675|NCT02352948|560347509|FG005|Overall Study|Lost to Follow-up|1|||
155250676|NCT02352948|560347504|FG000|Overall Study|Withdrawal by Subject|1|||
155250677|NCT02352948|560347505|FG001|Overall Study|Withdrawal by Subject|10|||
155250678|NCT02352948|560347506|FG002|Overall Study|Withdrawal by Subject|11|||
155250679|NCT02352948|560347507|FG003|Overall Study|Withdrawal by Subject|23|||
155250680|NCT02352948|560347508|FG004|Overall Study|Withdrawal by Subject|9|||
155250681|NCT02352948|560347509|FG005|Overall Study|Withdrawal by Subject|4|||
155250682|NCT02352948|560347504|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155250683|NCT02352948|560347505|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155250684|NCT02352948|560347506|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155250685|NCT02352948|560347507|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155250686|NCT02352948|560347508|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155250687|NCT02352948|560347509|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
155250688|NCT02352948|560347504|FG000|Overall Study|Other|0|||
155250689|NCT02352948|560347505|FG001|Overall Study|Other|0|||
155250690|NCT02352948|560347506|FG002|Overall Study|Other|2|||
155250691|NCT02352948|560347507|FG003|Overall Study|Other|0|||
155250692|NCT02352948|560347508|FG004|Overall Study|Other|0|||
155250693|NCT02352948|560347509|FG005|Overall Study|Other|0|||
155250694|NCT02096900|560347515|FG000|Overall Study|Did not receive medication|3|||
155250695|NCT02096900|560347516|FG001|Overall Study|Did not receive medication|1|||
155250696|NCT02096900|560347515|FG000|Overall Study|Surgery cancelled- medication received|1|||
155250697|NCT02096900|560347516|FG001|Overall Study|Surgery cancelled- medication received|1|||
155250698|NCT02763384|560347517|FG000|Overall Study|Physician Decision|1|||
155250699|NCT02763384|560347517|FG000|Overall Study|Rapid decline - went on hospice|1|||
155250700|NCT04657211|560347518|FG000|Overall Study|Withdrawal by Subject|21|||
155250701|NCT04657211|560347518|FG000|Overall Study|Lost to Follow-up|113|||
155250702|NCT04657211|560347518|FG000|Overall Study|Death|47|||
155250703|NCT04657211|560347518|FG000|Overall Study|Transfer to another institution|21|||
155250704|NCT04657211|560347518|FG000|Overall Study|Other|29|||
155250705|NCT06273774|560347521|FG000|Overall Study|Participant was out of state.|0|||
155250706|NCT06273774|560347522|FG001|Overall Study|Participant was out of state.|0|||
155250707|NCT06273774|560347523|FG002|Overall Study|Participant was out of state.|0|||
155250708|NCT06273774|560347524|FG003|Overall Study|Participant was out of state.|0|||
155250709|NCT06273774|560347525|FG004|Overall Study|Participant was out of state.|0|||
155250710|NCT06273774|560347526|FG005|Overall Study|Participant was out of state.|1|||
155250711|NCT06273774|560347521|FG000|Overall Study|Lost to Follow-up|0|||
155250712|NCT06273774|560347522|FG001|Overall Study|Lost to Follow-up|0|||
155250713|NCT06273774|560347523|FG002|Overall Study|Lost to Follow-up|0|||
155250714|NCT06273774|560347524|FG003|Overall Study|Lost to Follow-up|0|||
155250715|NCT06273774|560347525|FG004|Overall Study|Lost to Follow-up|1|||
155250716|NCT06273774|560347526|FG005|Overall Study|Lost to Follow-up|0|||
155250717|NCT00660010|560347527|FG000|Overall Study|Withdrawal by Subject|2|||
155250718|NCT00660010|560347527|FG000|Overall Study|Lost to Follow-up|3|||
155250719|NCT00660010|560347527|FG000|Overall Study|Adverse Event|1|||
155250720|NCT00660010|560347527|FG000|Overall Study|Noncompliance with visit schedule|3|||
155250721|NCT06167031|560347530|FG000|Overall Study|Lost to Follow-up|5|||
155250722|NCT06167031|560347531|FG001|Overall Study|Lost to Follow-up|1|||
155250723|NCT00360308|560349887|FG000|Overall Study|Adverse Event|15|||
155250724|NCT00360308|560349888|FG001|Overall Study|Adverse Event|14|||
155250725|NCT00360308|560349889|FG002|Overall Study|Adverse Event|25|||
155250726|NCT00360308|560349887|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155250727|NCT00360308|560349888|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155250728|NCT00360308|560349889|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155250729|NCT00360308|560349887|FG000|Overall Study|Protocol Violation|2|||
155250730|NCT00360308|560349888|FG001|Overall Study|Protocol Violation|1|||
155250731|NCT00360308|560349889|FG002|Overall Study|Protocol Violation|2|||
155250732|NCT00360308|560349887|FG000|Overall Study|Withdrawal by Subject|11|||
155250733|NCT00360308|560349888|FG001|Overall Study|Withdrawal by Subject|7|||
155250734|NCT00360308|560349889|FG002|Overall Study|Withdrawal by Subject|14|||
155250735|NCT00360308|560349887|FG000|Overall Study|Lack of Efficacy|3|||
155250736|NCT00360308|560349888|FG001|Overall Study|Lack of Efficacy|0|||
155250737|NCT00360308|560349889|FG002|Overall Study|Lack of Efficacy|2|||
155250738|NCT00360308|560349887|FG000|Overall Study|Other|2|||
155250739|NCT00360308|560349888|FG001|Overall Study|Other|1|||
155250740|NCT00360308|560349889|FG002|Overall Study|Other|1|||
155250741|NCT00360308|560349887|FG000|Overall Study|Study termination by sponsor|43|||
155250742|NCT00360308|560349888|FG001|Overall Study|Study termination by sponsor|55|||
155250743|NCT00360308|560349889|FG002|Overall Study|Study termination by sponsor|44|||
155250744|NCT04786444|560349890|FG000|Overall Study|Withdrawal by Subject|4|||
155250745|NCT04786444|560349891|FG001|Overall Study|Withdrawal by Subject|7|||
155250746|NCT04786444|560349892|FG002|Overall Study|Withdrawal by Subject|2|||
155250747|NCT04786444|560349890|FG000|Overall Study|Lost to Follow-up|11|||
155250748|NCT04786444|560349891|FG001|Overall Study|Lost to Follow-up|9|||
155250749|NCT04786444|560349892|FG002|Overall Study|Lost to Follow-up|10|||
155250750|NCT04786444|560349890|FG000|Overall Study|Subject would like to become pregnant|0|||
155250751|NCT04786444|560349891|FG001|Overall Study|Subject would like to become pregnant|1|||
155250752|NCT04786444|560349892|FG002|Overall Study|Subject would like to become pregnant|0|||
155250753|NCT00725452|560349900|FG000|Overall Study|Adverse Event|3|||
155250754|NCT00725452|560349900|FG000|Overall Study|Lack of Efficacy|2|||
155250755|NCT00725452|560349900|FG000|Overall Study|Reason not specified|1|||
155250756|NCT00725452|560349900|FG000|Overall Study|Physician Decision|1|||
155250757|NCT00725452|560349900|FG000|Overall Study|Withdrawal by Subject|3|||
155250758|NCT00725452|560349900|FG000|Overall Study|Lost to Follow-up|1|||
155250759|NCT00713648|560349901|FG000|Overall Study|Adverse Event|1|||
155250760|NCT00713648|560349901|FG000|Overall Study|Unclassified|2|||
155250761|NCT00713648|560349901|FG000|Overall Study|According to Protocol|2|||
155250762|NCT00713648|560349901|FG000|Overall Study|Development of antibodies|3|||
155250763|NCT01733732|560349902|FG000|Overall Study|Adverse Event|1|||
155250764|NCT01733732|560349903|FG001|Overall Study|Adverse Event|0|||
155250765|NCT01733732|560349902|FG000|Overall Study|Did not attend all study visits|1|||
155250766|NCT01733732|560349903|FG001|Overall Study|Did not attend all study visits|0|||
155250767|NCT00464815|560349904|FG000|Overall Study|Withdrawal by Subject|6|||
155250768|NCT00464815|560349905|FG001|Overall Study|Withdrawal by Subject|3|||
155250769|NCT01324271|560349913|FG000|Overall Study|Lost to Follow-up|3|||
155250770|NCT01324271|560349914|FG001|Overall Study|Lost to Follow-up|0|||
155250771|NCT01324271|560349913|FG000|Overall Study|Physician Decision|1|||
155250772|NCT01324271|560349914|FG001|Overall Study|Physician Decision|0|||
155250773|NCT02807558|560349915|FG000|Overall Study|Consent withdrawn by participant|4|||
155250774|NCT02807558|560349916|FG001|Overall Study|Consent withdrawn by participant|0|||
155250775|NCT02807558|560349917|FG002|Overall Study|Consent withdrawn by participant|4|||
155250776|NCT02807558|560349918|FG003|Overall Study|Consent withdrawn by participant|2|||
155250777|NCT02807558|560349919|FG004|Overall Study|Consent withdrawn by participant|1|||
155250778|NCT02807558|560349920|FG005|Overall Study|Consent withdrawn by participant|0|||
155250779|NCT02807558|560349915|FG000|Overall Study|Non-compliance with Study Drug|0|||
155250780|NCT02807558|560349916|FG001|Overall Study|Non-compliance with Study Drug|0|||
155250781|NCT02807558|560349917|FG002|Overall Study|Non-compliance with Study Drug|1|||
155250782|NCT02807558|560349918|FG003|Overall Study|Non-compliance with Study Drug|0|||
155250783|NCT02807558|560349919|FG004|Overall Study|Non-compliance with Study Drug|0|||
155250784|NCT02807558|560349920|FG005|Overall Study|Non-compliance with Study Drug|0|||
155250785|NCT02807558|560349915|FG000|Overall Study|Adverse Event|0|||
155250786|NCT02807558|560349916|FG001|Overall Study|Adverse Event|0|||
155250787|NCT02807558|560349917|FG002|Overall Study|Adverse Event|9|||
155250788|NCT02807558|560349918|FG003|Overall Study|Adverse Event|0|||
155250789|NCT02807558|560349919|FG004|Overall Study|Adverse Event|0|||
155250790|NCT02807558|560349920|FG005|Overall Study|Adverse Event|0|||
155250791|NCT02807558|560349915|FG000|Overall Study|Death|23|||
155250792|NCT02807558|560349916|FG001|Overall Study|Death|2|||
155250793|NCT02807558|560349917|FG002|Overall Study|Death|3|||
155250794|NCT02807558|560349918|FG003|Overall Study|Death|43|||
155250795|NCT02807558|560349919|FG004|Overall Study|Death|24|||
155250796|NCT02807558|560349920|FG005|Overall Study|Death|15|||
155250797|NCT02807558|560349915|FG000|Overall Study|Progressive Disease|0|||
155250798|NCT02807558|560349916|FG001|Overall Study|Progressive Disease|0|||
155250799|NCT02807558|560349917|FG002|Overall Study|Progressive Disease|1|||
155250800|NCT02807558|560349918|FG003|Overall Study|Progressive Disease|0|||
155250801|NCT02807558|560349919|FG004|Overall Study|Progressive Disease|0|||
155250802|NCT02807558|560349920|FG005|Overall Study|Progressive Disease|0|||
155250803|NCT02807558|560349915|FG000|Overall Study|Other than specified|1|||
155250804|NCT02807558|560349916|FG001|Overall Study|Other than specified|0|||
155250805|NCT02807558|560349917|FG002|Overall Study|Other than specified|2|||
155250806|NCT02807558|560349918|FG003|Overall Study|Other than specified|0|||
155250807|NCT02807558|560349919|FG004|Overall Study|Other than specified|1|||
155250808|NCT02807558|560349920|FG005|Overall Study|Other than specified|1|||
155250809|NCT02807558|560349915|FG000|Overall Study|Lack of Efficacy|0|||
155250810|NCT02807558|560349916|FG001|Overall Study|Lack of Efficacy|0|||
155250811|NCT02807558|560349917|FG002|Overall Study|Lack of Efficacy|9|||
155250812|NCT02807558|560349918|FG003|Overall Study|Lack of Efficacy|0|||
155250813|NCT02807558|560349919|FG004|Overall Study|Lack of Efficacy|0|||
155250814|NCT02807558|560349920|FG005|Overall Study|Lack of Efficacy|0|||
155250815|NCT06116591|560349921|FG000|Overall Study|No longer met eligibility criteria|0|||
155250816|NCT06116591|560349922|FG001|Overall Study|No longer met eligibility criteria|1|||
155250817|NCT06116591|560349921|FG000|Overall Study|Other: Change in life situation|0|||
155250818|NCT06116591|560349922|FG001|Overall Study|Other: Change in life situation|1|||
155250819|NCT05585307|560349923|FG000|Overall Study|Lost to Follow-up|0|||
155250820|NCT05585307|560349924|FG001|Overall Study|Lost to Follow-up|0|||
155250821|NCT05585307|560349925|FG002|Overall Study|Lost to Follow-up|0|||
155250822|NCT05585307|560349926|FG003|Overall Study|Lost to Follow-up|0|||
155250823|NCT05585307|560349927|FG004|Overall Study|Lost to Follow-up|0|||
155250824|NCT05585307|560349928|FG005|Overall Study|Lost to Follow-up|0|||
155250825|NCT05585307|560349929|FG006|Overall Study|Lost to Follow-up|1|||
155250826|NCT05585307|560349930|FG007|Overall Study|Lost to Follow-up|0|||
155250827|NCT01972841|560349931|FG000|Overall Study|Randomized but Never Received Treatment|2|||
155250828|NCT01972841|560349932|FG001|Overall Study|Randomized but Never Received Treatment|5|||
155250829|NCT01972841|560349933|FG002|Overall Study|Randomized but Never Received Treatment|4|||
155250830|NCT01972841|560349934|FG003|Overall Study|Randomized but Never Received Treatment|2|||
155250831|NCT01972841|560349935|FG004|Overall Study|Randomized but Never Received Treatment|6|||
155250832|NCT01972841|560349936|FG005|Overall Study|Randomized but Never Received Treatment|13|||
155250833|NCT01972841|560349931|FG000|Overall Study|Adverse Event|13|||
155250834|NCT01972841|560349932|FG001|Overall Study|Adverse Event|8|||
155250835|NCT01972841|560349933|FG002|Overall Study|Adverse Event|12|||
155250836|NCT01972841|560349934|FG003|Overall Study|Adverse Event|9|||
155250837|NCT01972841|560349935|FG004|Overall Study|Adverse Event|21|||
155250838|NCT01972841|560349936|FG005|Overall Study|Adverse Event|26|||
155250839|NCT01972841|560349931|FG000|Overall Study|Lack of Efficacy|1|||
155250840|NCT01972841|560349932|FG001|Overall Study|Lack of Efficacy|0|||
155250841|NCT01972841|560349933|FG002|Overall Study|Lack of Efficacy|0|||
155250842|NCT01972841|560349934|FG003|Overall Study|Lack of Efficacy|2|||
155250843|NCT01972841|560349935|FG004|Overall Study|Lack of Efficacy|4|||
155250844|NCT01972841|560349936|FG005|Overall Study|Lack of Efficacy|1|||
155250845|NCT01972841|560349931|FG000|Overall Study|Lost to Follow-up|4|||
155250846|NCT01972841|560349932|FG001|Overall Study|Lost to Follow-up|2|||
155250847|NCT01972841|560349933|FG002|Overall Study|Lost to Follow-up|4|||
155250848|NCT01972841|560349934|FG003|Overall Study|Lost to Follow-up|2|||
155250849|NCT01972841|560349935|FG004|Overall Study|Lost to Follow-up|9|||
155250850|NCT01972841|560349936|FG005|Overall Study|Lost to Follow-up|3|||
155250851|NCT01972841|560349931|FG000|Overall Study|Protocol Violation|2|||
155250852|NCT01972841|560349932|FG001|Overall Study|Protocol Violation|2|||
155250853|NCT01972841|560349933|FG002|Overall Study|Protocol Violation|3|||
155250854|NCT01972841|560349934|FG003|Overall Study|Protocol Violation|5|||
155250855|NCT01972841|560349935|FG004|Overall Study|Protocol Violation|9|||
155250856|NCT01972841|560349936|FG005|Overall Study|Protocol Violation|4|||
155250857|NCT01972841|560349931|FG000|Overall Study|Withdrawal by participants|21|||
155250858|NCT01972841|560349932|FG001|Overall Study|Withdrawal by participants|27|||
155250859|NCT01972841|560349933|FG002|Overall Study|Withdrawal by participants|23|||
155250860|NCT01972841|560349934|FG003|Overall Study|Withdrawal by participants|16|||
155250861|NCT01972841|560349935|FG004|Overall Study|Withdrawal by participants|33|||
155250862|NCT01972841|560349936|FG005|Overall Study|Withdrawal by participants|34|||
155250863|NCT01972841|560349931|FG000|Overall Study|Miscellaneous|0|||
155250864|NCT01972841|560349932|FG001|Overall Study|Miscellaneous|0|||
155250865|NCT01972841|560349933|FG002|Overall Study|Miscellaneous|4|||
155250866|NCT01972841|560349934|FG003|Overall Study|Miscellaneous|1|||
155250867|NCT01972841|560349935|FG004|Overall Study|Miscellaneous|0|||
155250868|NCT01972841|560349936|FG005|Overall Study|Miscellaneous|4|||
155250869|NCT01972841|560349931|FG000|Overall Study|Did not have end of treatment page|0|||
155250870|NCT01972841|560349932|FG001|Overall Study|Did not have end of treatment page|0|||
155250871|NCT01972841|560349933|FG002|Overall Study|Did not have end of treatment page|0|||
155250872|NCT01972841|560349934|FG003|Overall Study|Did not have end of treatment page|0|||
155250873|NCT01972841|560349935|FG004|Overall Study|Did not have end of treatment page|1|||
155250874|NCT01972841|560349936|FG005|Overall Study|Did not have end of treatment page|0|||
155250875|NCT02734212|560349939|FG000|Overall Study|Lost to Follow-up|5|||
155250876|NCT02734212|560349940|FG001|Overall Study|Lost to Follow-up|10|||
155250877|NCT00688636|560349941|FG000|Overall Study|Adverse Event|2|||
155250878|NCT00688636|560349942|FG001|Overall Study|Adverse Event|1|||
155250879|NCT01572727|560349943|FG000|Overall Study|Adverse Event|43|||
155250880|NCT01572727|560349944|FG001|Overall Study|Adverse Event|15|||
155250881|NCT01572727|560349943|FG000|Overall Study|Lost to Follow-up|1|||
155250882|NCT01572727|560349944|FG001|Overall Study|Lost to Follow-up|1|||
155250883|NCT01572727|560349943|FG000|Overall Study|Physician Decision|23|||
155250884|NCT01572727|560349944|FG001|Overall Study|Physician Decision|9|||
155250885|NCT01572727|560349943|FG000|Overall Study|Progressive disease|59|||
155250886|NCT01572727|560349944|FG001|Overall Study|Progressive disease|82|||
155250887|NCT01572727|560349943|FG000|Overall Study|Protocol Violation|0|||
155250888|NCT01572727|560349944|FG001|Overall Study|Protocol Violation|1|||
155250889|NCT01572727|560349943|FG000|Overall Study|Study terminated by sponsor|61|||
155250890|NCT01572727|560349944|FG001|Overall Study|Study terminated by sponsor|83|||
155250891|NCT01572727|560349943|FG000|Overall Study|Parent/guardian decision|14|||
155250892|NCT01572727|560349944|FG001|Overall Study|Parent/guardian decision|9|||
155250893|NCT01572727|560349943|FG000|Overall Study|Death|2|||
155250894|NCT01572727|560349944|FG001|Overall Study|Death|2|||
155250895|NCT01572727|560349943|FG000|Overall Study|Untreated|4|||
155250896|NCT01572727|560349944|FG001|Overall Study|Untreated|7|||
155250897|NCT02195986|560349945|FG000|Overall Study|Adverse Event|3|||
155250898|NCT02195986|560349946|FG001|Overall Study|Adverse Event|0|||
155250899|NCT02195986|560349947|FG002|Overall Study|Adverse Event|0|||
155250900|NCT02195986|560349945|FG000|Overall Study|Withdrawal by Subject|0|||
155250901|NCT02195986|560349946|FG001|Overall Study|Withdrawal by Subject|3|||
155250902|NCT02195986|560349947|FG002|Overall Study|Withdrawal by Subject|0|||
155250903|NCT02195986|560349945|FG000|Overall Study|Family Emergency|0|||
155250904|NCT02195986|560349946|FG001|Overall Study|Family Emergency|0|||
155250905|NCT02195986|560349947|FG002|Overall Study|Family Emergency|1|||
155250906|NCT02195986|560349945|FG000|Overall Study|Protocol Violation|0|||
155250907|NCT02195986|560349946|FG001|Overall Study|Protocol Violation|1|||
155250908|NCT02195986|560349947|FG002|Overall Study|Protocol Violation|1|||
155250909|NCT02195986|560349945|FG000|Overall Study|Non-compliance|0|||
155250910|NCT02195986|560349946|FG001|Overall Study|Non-compliance|1|||
155250911|NCT02195986|560349947|FG002|Overall Study|Non-compliance|0|||
155250912|NCT02834780|560349950|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
155250913|NCT02834780|560349951|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250914|NCT02834780|560349952|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
155250915|NCT02834780|560349953|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
155250916|NCT02834780|560349954|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
155250917|NCT02834780|560349955|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
155250918|NCT02834780|560349956|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
155250919|NCT02834780|560349957|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
155250920|NCT02834780|560349958|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250921|NCT02834780|560349959|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
155250922|NCT02834780|560349960|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250923|NCT02834780|560349961|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
155250924|NCT02834780|560349962|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
155250925|NCT02834780|560349950|FG000|Overall Study|Withdrawal by Subject|0|||
155250926|NCT02834780|560349951|FG001|Overall Study|Withdrawal by Subject|0|||
155250927|NCT02834780|560349952|FG002|Overall Study|Withdrawal by Subject|1|||
155250928|NCT02834780|560349953|FG003|Overall Study|Withdrawal by Subject|0|||
155250929|NCT02834780|560349954|FG004|Overall Study|Withdrawal by Subject|0|||
155250930|NCT02834780|560349955|FG005|Overall Study|Withdrawal by Subject|0|||
155250931|NCT02834780|560349956|FG006|Overall Study|Withdrawal by Subject|0|||
155250932|NCT02834780|560349957|FG007|Overall Study|Withdrawal by Subject|0|||
155250933|NCT02834780|560349958|FG008|Overall Study|Withdrawal by Subject|0|||
155250934|NCT02834780|560349959|FG009|Overall Study|Withdrawal by Subject|0|||
155250935|NCT02834780|560349960|FG010|Overall Study|Withdrawal by Subject|1|||
155250936|NCT02834780|560349961|FG011|Overall Study|Withdrawal by Subject|0|||
155250937|NCT02834780|560349962|FG012|Overall Study|Withdrawal by Subject|0|||
155250938|NCT02834780|560349950|FG000|Overall Study|Adverse Event|0|||
155250939|NCT02834780|560349951|FG001|Overall Study|Adverse Event|0|||
155250940|NCT02834780|560349952|FG002|Overall Study|Adverse Event|0|||
155250941|NCT02834780|560349953|FG003|Overall Study|Adverse Event|0|||
155250942|NCT02834780|560349954|FG004|Overall Study|Adverse Event|1|||
155250943|NCT02834780|560349955|FG005|Overall Study|Adverse Event|0|||
155250944|NCT02834780|560349956|FG006|Overall Study|Adverse Event|1|||
155250945|NCT02834780|560349957|FG007|Overall Study|Adverse Event|1|||
155250946|NCT02834780|560349958|FG008|Overall Study|Adverse Event|0|||
155250947|NCT02834780|560349959|FG009|Overall Study|Adverse Event|2|||
155250948|NCT02834780|560349960|FG010|Overall Study|Adverse Event|0|||
155250949|NCT02834780|560349961|FG011|Overall Study|Adverse Event|3|||
155250950|NCT02834780|560349962|FG012|Overall Study|Adverse Event|2|||
155250951|NCT02834780|560349950|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250952|NCT02834780|560349951|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250953|NCT02834780|560349952|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250954|NCT02834780|560349953|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250955|NCT02834780|560349954|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250956|NCT02834780|560349955|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250957|NCT02834780|560349956|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250958|NCT02834780|560349957|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250959|NCT02834780|560349958|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250960|NCT02834780|560349959|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250961|NCT02834780|560349960|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250962|NCT02834780|560349961|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250963|NCT02834780|560349962|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
155250964|NCT02834780|560349950|FG000|Overall Study|Other|1|||
155250965|NCT02834780|560349951|FG001|Overall Study|Other|0|||
155250966|NCT02834780|560349952|FG002|Overall Study|Other|1|||
155250967|NCT02834780|560349953|FG003|Overall Study|Other|2|||
155250968|NCT02834780|560349954|FG004|Overall Study|Other|0|||
155250969|NCT02834780|560349955|FG005|Overall Study|Other|0|||
155250970|NCT02834780|560349956|FG006|Overall Study|Other|0|||
155250971|NCT02834780|560349957|FG007|Overall Study|Other|0|||
155250972|NCT02834780|560349958|FG008|Overall Study|Other|0|||
155250973|NCT02834780|560349959|FG009|Overall Study|Other|0|||
155250974|NCT02834780|560349960|FG010|Overall Study|Other|0|||
155250975|NCT02834780|560349961|FG011|Overall Study|Other|0|||
155250976|NCT02834780|560349962|FG012|Overall Study|Other|1|||
155250977|NCT03150056|560349963|FG000|Overall Study|Withdrawal by Subject|0|||
155250978|NCT03150056|560349964|FG001|Overall Study|Withdrawal by Subject|0|||
155250979|NCT03150056|560349965|FG002|Overall Study|Withdrawal by Subject|0|||
155250980|NCT03150056|560349966|FG003|Overall Study|Withdrawal by Subject|0|||
155250981|NCT03150056|560349967|FG004|Overall Study|Withdrawal by Subject|0|||
155250982|NCT03150056|560349968|FG005|Overall Study|Withdrawal by Subject|2|||
155250983|NCT03150056|560349963|FG000|Overall Study|Study terminated by Sponsor|1|||
155250984|NCT03150056|560349964|FG001|Overall Study|Study terminated by Sponsor|3|||
155250985|NCT03150056|560349965|FG002|Overall Study|Study terminated by Sponsor|1|||
155250986|NCT03150056|560349966|FG003|Overall Study|Study terminated by Sponsor|1|||
155250987|NCT03150056|560349967|FG004|Overall Study|Study terminated by Sponsor|5|||
155250988|NCT03150056|560349968|FG005|Overall Study|Study terminated by Sponsor|6|||
155250989|NCT03150056|560349963|FG000|Overall Study|Death|9|||
155250990|NCT03150056|560349964|FG001|Overall Study|Death|2|||
155250991|NCT03150056|560349965|FG002|Overall Study|Death|2|||
155250992|NCT03150056|560349966|FG003|Overall Study|Death|7|||
155250993|NCT03150056|560349967|FG004|Overall Study|Death|8|||
155250994|NCT03150056|560349968|FG005|Overall Study|Death|10|||
155250995|NCT02270450|560349973|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155250996|NCT02270450|560349974|FG001|Overall Study|Refusal unrelated to adverse event|1|||
155250997|NCT02270450|560349975|FG002|Overall Study|Refusal unrelated to adverse event|5|||
155250998|NCT02270450|560349976|FG003|Overall Study|Refusal unrelated to adverse event|14|||
155250999|NCT02270450|560349973|FG000|Overall Study|Progression/relapse|1|||
155251000|NCT02270450|560349974|FG001|Overall Study|Progression/relapse|2|||
155251001|NCT02270450|560349975|FG002|Overall Study|Progression/relapse|4|||
155251002|NCT02270450|560349976|FG003|Overall Study|Progression/relapse|9|||
155251003|NCT02270450|560349973|FG000|Overall Study|Death|19|||
155251004|NCT02270450|560349974|FG001|Overall Study|Death|19|||
155251005|NCT02270450|560349975|FG002|Overall Study|Death|31|||
155251006|NCT02270450|560349976|FG003|Overall Study|Death|59|||
155251007|NCT02363738|560349977|FG000|Overall Study|Adverse Event|5|||
155251008|NCT02363738|560349978|FG001|Overall Study|Adverse Event|2|||
155251009|NCT02363738|560349977|FG000|Overall Study|Lack of Efficacy|1|||
155251010|NCT02363738|560349978|FG001|Overall Study|Lack of Efficacy|2|||
155251011|NCT02363738|560349977|FG000|Overall Study|Lost to Follow-up|2|||
155251012|NCT02363738|560349978|FG001|Overall Study|Lost to Follow-up|1|||
155251013|NCT03282227|560349979|FG000|Overall Study|Exposure Goals Achieved|60|||
155251014|NCT03282227|560349979|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
155251015|NCT03282227|560349979|FG000|Overall Study|Adverse Event|15|||
155251016|NCT03282227|560349979|FG000|Overall Study|Lost to Follow-up|21|||
155251017|NCT03282227|560349979|FG000|Overall Study|Withdrawal by Subject|20|||
155251018|NCT03282227|560349979|FG000|Overall Study|Lack of Efficacy|12|||
155251019|NCT03282227|560349979|FG000|Overall Study|Sponsor decision|3|||
155251020|NCT03282227|560349979|FG000|Overall Study|Physician Decision|2|||
155251021|NCT03282227|560349979|FG000|Overall Study|Pregnancy|2|||
155251022|NCT03282227|560349979|FG000|Overall Study|Other|1|||
155251023|NCT00700401|560349985|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
155251024|NCT00700401|560349985|FG000|Overall Study|Adverse Event|5|||
155251025|NCT00700401|560349985|FG000|Overall Study|Refused Treatment|2|||
155251026|NCT00700401|560349985|FG000|Overall Study|Lost to Follow-up|1|||
155251027|NCT00700401|560349985|FG000|Overall Study|Treatment never started|1|||
155251028|NCT00700401|560349985|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
155251029|NCT00700401|560349985|FG000|Overall Study|Withdrawal by Subject|2|||
155251030|NCT02491671|560349986|FG000|Overall Study|Adverse Event|6|||
155251031|NCT02491671|560349987|FG001|Overall Study|Adverse Event|8|||
155251032|NCT02491671|560349986|FG000|Overall Study|Death|0|||
155251033|NCT02491671|560349987|FG001|Overall Study|Death|2|||
155251034|NCT02491671|560349986|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
155251035|NCT02491671|560349987|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
155251036|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
155251037|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
155251038|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
155251039|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
155251040|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
155251041|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
155251042|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
155251043|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
155251044|NCT02251990|560349991|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
155251045|NCT02251990|560349992|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
155251046|NCT02251990|560349991|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
155251047|NCT02251990|560349992|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
155251048|NCT03265600|560349993|FG000|Overall Study|Lost to Follow-up|17|||
155251049|NCT03265600|560349994|FG001|Overall Study|Lost to Follow-up|5|||
155251050|NCT03265600|560349993|FG000|Overall Study|Withdrawal by Subject|4|||
155251051|NCT03265600|560349994|FG001|Overall Study|Withdrawal by Subject|2|||
155251052|NCT03265600|560349993|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
155251053|NCT03265600|560349994|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
155251054|NCT00535730|560349995|FG000|Overall Study|Adverse Event|1|||
155251055|NCT00535730|560349996|FG001|Overall Study|Adverse Event|1|||
155251056|NCT00535730|560349995|FG000|Overall Study|Lost to Follow-up|0|||
155251057|NCT00535730|560349996|FG001|Overall Study|Lost to Follow-up|1|||
155251058|NCT00535730|560349995|FG000|Overall Study|Physician Decision|0|||
155251059|NCT00535730|560349996|FG001|Overall Study|Physician Decision|1|||
155251060|NCT00535730|560349995|FG000|Overall Study|Protocol Violation|1|||
155251061|NCT00535730|560349996|FG001|Overall Study|Protocol Violation|0|||
155251062|NCT00535730|560349995|FG000|Overall Study|Withdrawal by Subject|0|||
155251063|NCT00535730|560349996|FG001|Overall Study|Withdrawal by Subject|4|||
155251064|NCT00729833|560350006|FG000|Overall Study|Death|5|||
155251065|NCT00729833|560350007|FG001|Overall Study|Death|1|||
155251066|NCT00729833|560350008|FG002|Overall Study|Death|3|||
155251067|NCT00729833|560350009|FG003|Overall Study|Death|5|||
155251068|NCT00729833|560350006|FG000|Overall Study|Study Terminated by Sponsor|0|||
155251069|NCT00729833|560350007|FG001|Overall Study|Study Terminated by Sponsor|0|||
155251070|NCT00729833|560350008|FG002|Overall Study|Study Terminated by Sponsor|1|||
155251071|NCT00729833|560350009|FG003|Overall Study|Study Terminated by Sponsor|0|||
155251072|NCT00729833|560350006|FG000|Overall Study|Lost to Follow-up|1|||
155251073|NCT00729833|560350007|FG001|Overall Study|Lost to Follow-up|0|||
155251074|NCT00729833|560350008|FG002|Overall Study|Lost to Follow-up|0|||
155251075|NCT00729833|560350009|FG003|Overall Study|Lost to Follow-up|0|||
155251076|NCT00729833|560350006|FG000|Overall Study|Withdrawal by Subject|3|||
155251077|NCT00729833|560350007|FG001|Overall Study|Withdrawal by Subject|1|||
155251078|NCT00729833|560350008|FG002|Overall Study|Withdrawal by Subject|3|||
155251079|NCT00729833|560350009|FG003|Overall Study|Withdrawal by Subject|0|||
155251080|NCT00729833|560350006|FG000|Overall Study|Unspecified Reasons|11|||
155251081|NCT00729833|560350007|FG001|Overall Study|Unspecified Reasons|5|||
155251082|NCT00729833|560350008|FG002|Overall Study|Unspecified Reasons|5|||
155251083|NCT00729833|560350009|FG003|Overall Study|Unspecified Reasons|1|||
155251084|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
155251085|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
155251086|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
155251087|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
155251088|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
155251089|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
155251090|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
155251091|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
155251092|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
155251093|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
155251094|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
155251095|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
155251096|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
155251097|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
155251098|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
155251099|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
155251100|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
155251101|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
155251102|NCT00355082|560350010|FG000|Continuation Phase|Adverse Event|2|||
155251103|NCT00355082|560350011|FG001|Continuation Phase|Adverse Event|0|||
155251104|NCT00355082|560350012|FG002|Continuation Phase|Adverse Event|1|||
155251105|NCT00355082|560350010|FG000|Continuation Phase|Lost to Follow-up|2|||
155251106|NCT00355082|560350011|FG001|Continuation Phase|Lost to Follow-up|0|||
155251107|NCT00355082|560350012|FG002|Continuation Phase|Lost to Follow-up|1|||
155251108|NCT00355082|560350010|FG000|Continuation Phase|Protocol Violation|1|||
155251109|NCT00355082|560350011|FG001|Continuation Phase|Protocol Violation|0|||
155251110|NCT00355082|560350012|FG002|Continuation Phase|Protocol Violation|1|||
155251111|NCT00355082|560350010|FG000|Continuation Phase|Withdrawal by Subject|4|||
155251112|NCT00355082|560350011|FG001|Continuation Phase|Withdrawal by Subject|0|||
155251113|NCT00355082|560350012|FG002|Continuation Phase|Withdrawal by Subject|0|||
155251114|NCT00355082|560350010|FG000|Continuation Phase|Lack of Efficacy|5|||
155251115|NCT00355082|560350011|FG001|Continuation Phase|Lack of Efficacy|0|||
155251116|NCT00355082|560350012|FG002|Continuation Phase|Lack of Efficacy|0|||
155251117|NCT00355082|560350010|FG000|Continuation Phase|Site Closed by Sponsor|8|||
155251118|NCT00355082|560350011|FG001|Continuation Phase|Site Closed by Sponsor|0|||
155251119|NCT00355082|560350012|FG002|Continuation Phase|Site Closed by Sponsor|0|||
155251120|NCT00355082|560350010|FG000|Continuation Phase|Scheduling Error|1|||
155251121|NCT00355082|560350011|FG001|Continuation Phase|Scheduling Error|0|||
155251122|NCT00355082|560350012|FG002|Continuation Phase|Scheduling Error|0|||
155251123|NCT00355082|560350010|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
155251124|NCT00355082|560350011|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
155251125|NCT00355082|560350012|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
155251126|NCT03570619|560350013|FG000|Overall Study|Adverse Event|2|||
155251127|NCT03570619|560350014|FG001|Overall Study|Adverse Event|0|||
155251128|NCT03570619|560350015|FG002|Overall Study|Adverse Event|1|||
155251129|NCT03570619|560350013|FG000|Overall Study|new diagnosis of new malignancy|1|||
155251130|NCT03570619|560350014|FG001|Overall Study|new diagnosis of new malignancy|0|||
155251131|NCT03570619|560350015|FG002|Overall Study|new diagnosis of new malignancy|0|||
155251132|NCT03570619|560350013|FG000|Overall Study|Physician Decision|1|||
155251133|NCT03570619|560350014|FG001|Overall Study|Physician Decision|1|||
155251134|NCT03570619|560350015|FG002|Overall Study|Physician Decision|0|||
155251135|NCT03570619|560350013|FG000|Overall Study|Withdrawal by Subject|0|||
155251136|NCT03570619|560350014|FG001|Overall Study|Withdrawal by Subject|2|||
155251137|NCT03570619|560350015|FG002|Overall Study|Withdrawal by Subject|0|||
155251138|NCT01954017|560350018|FG000|Overall Study|Adverse Event|0|||
155251139|NCT01954017|560350019|FG001|Overall Study|Adverse Event|0|||
155251140|NCT01954017|560350020|FG002|Overall Study|Adverse Event|1|||
155251141|NCT01954017|560350018|FG000|Overall Study|Death|2|||
155251142|NCT01954017|560350019|FG001|Overall Study|Death|1|||
155251143|NCT01954017|560350020|FG002|Overall Study|Death|1|||
155251144|NCT01954017|560350018|FG000|Overall Study|Withdrawal by Subject|0|||
155251145|NCT01954017|560350019|FG001|Overall Study|Withdrawal by Subject|1|||
155251146|NCT01954017|560350020|FG002|Overall Study|Withdrawal by Subject|0|||
155251147|NCT01954017|560350018|FG000|Overall Study|Protocol Violation|0|||
155251148|NCT01954017|560350019|FG001|Overall Study|Protocol Violation|3|||
155251149|NCT01954017|560350020|FG002|Overall Study|Protocol Violation|2|||
155251150|NCT01954017|560350018|FG000|Overall Study|Necrotizing enterocolitis|1|||
155251151|NCT01954017|560350019|FG001|Overall Study|Necrotizing enterocolitis|0|||
155251152|NCT01954017|560350020|FG002|Overall Study|Necrotizing enterocolitis|1|||
155251153|NCT01954017|560350018|FG000|Overall Study|Enteral intake stopped >7 days|0|||
155251154|NCT01954017|560350019|FG001|Overall Study|Enteral intake stopped >7 days|1|||
155251155|NCT01954017|560350020|FG002|Overall Study|Enteral intake stopped >7 days|1|||
155251156|NCT01954017|560350018|FG000|Overall Study|All other reasons|2|||
155251157|NCT01954017|560350019|FG001|Overall Study|All other reasons|2|||
155251158|NCT01954017|560350020|FG002|Overall Study|All other reasons|7|||
155251159|NCT03346759|560350021|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
155251160|NCT03346759|560350022|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
155251161|NCT03346759|560350021|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
155251162|NCT03346759|560350022|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
155251163|NCT03346759|560350021|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
155251164|NCT03346759|560350022|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
155251165|NCT04177758|560350031|FG000|Overall Study|Lost to Follow-up|19|||
155251166|NCT04177758|560350032|FG001|Overall Study|Lost to Follow-up|11|||
155251167|NCT00744653|560350036|FG000|Overall Study|antineoplastic treatment|11|||
155251168|NCT00744653|560350036|FG000|Overall Study|Death|1|||
155251169|NCT00744653|560350036|FG000|Overall Study|Lost to Follow-up|1|||
155251170|NCT00744653|560350036|FG000|Overall Study|Physician Decision|3|||
155251171|NCT03826667|560350037|FG000|Overall Study|Protocol deviation|21|||
155251172|NCT00808808|560350038|FG000|Overall Study|Vaccinated; survey not completed|131|||
155251173|NCT00808808|560350039|FG001|Overall Study|Vaccinated; survey not completed|169|||
155251174|NCT00808808|560350040|FG002|Overall Study|Vaccinated; survey not completed|302|||
155251175|NCT00808808|560350038|FG000|Overall Study|Employee was not vaccinated.|2686|||
155251176|NCT00808808|560350039|FG001|Overall Study|Employee was not vaccinated.|2268|||
155251177|NCT00808808|560350040|FG002|Overall Study|Employee was not vaccinated.|2255|||
155251178|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
155251179|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
155251180|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
155251181|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
155251182|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
155251183|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
155251184|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
155251185|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
155251186|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155251187|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
155251188|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
155251189|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
155251190|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
155251191|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
155251192|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
155251193|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
155251194|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
155251195|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
155251196|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
155251197|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
155251198|NCT01453595|560350048|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155251199|NCT01453595|560350049|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155251200|NCT01453595|560350050|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155251201|NCT02653482|560350053|FG000|Overall Study|Death|1|||
155251202|NCT02653482|560350054|FG001|Overall Study|Death|1|||
155251203|NCT01864564|560350057|FG000|Overall Study|Lost to Follow-up|17|||
155251204|NCT01864564|560350058|FG001|Overall Study|Lost to Follow-up|23|||
155251205|NCT01864564|560350057|FG000|Overall Study|Withdrawal by Subject|20|||
155251206|NCT01864564|560350058|FG001|Overall Study|Withdrawal by Subject|11|||
155251207|NCT01864564|560350057|FG000|Overall Study|Protocol Violation|0|||
155251208|NCT01864564|560350058|FG001|Overall Study|Protocol Violation|27|||
155251209|NCT01864564|560350057|FG000|Overall Study|not reported|0|||
155251210|NCT01864564|560350058|FG001|Overall Study|not reported|34|||
155251211|NCT03077724|560350059|FG000|Overall Study|Lost to Follow-up|5|||
155251212|NCT03077724|560350060|FG001|Overall Study|Lost to Follow-up|1|||
155251213|NCT03077724|560350059|FG000|Overall Study|Withdrawal by Subject|3|||
155251214|NCT03077724|560350060|FG001|Overall Study|Withdrawal by Subject|1|||
155251215|NCT02269670|560350061|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
155251216|NCT00234065|560350062|FG000|Overall Study|Adverse Event|268|||
155251217|NCT00234065|560350063|FG001|Overall Study|Adverse Event|166|||
155251218|NCT00234065|560350062|FG000|Overall Study|Withdrawal by Subject|73|||
155251219|NCT00234065|560350063|FG001|Overall Study|Withdrawal by Subject|56|||
155251220|NCT00234065|560350062|FG000|Overall Study|Physician Decision|23|||
155251221|NCT00234065|560350063|FG001|Overall Study|Physician Decision|22|||
155251222|NCT00234065|560350062|FG000|Overall Study|Not Classified|111|||
155251223|NCT00234065|560350063|FG001|Overall Study|Not Classified|112|||
155251224|NCT00003508|560351709|FG000|Overall Study|Not evaluable|5|||
155251225|NCT02160314|560351710|FG000|Overall Study|Adverse Event|0|||
155251226|NCT02160314|560351711|FG001|Overall Study|Adverse Event|6|||
155251227|NCT02160314|560351710|FG000|Overall Study|Protocol Violation|0|||
155251228|NCT02160314|560351711|FG001|Overall Study|Protocol Violation|4|||
155251229|NCT02160314|560351710|FG000|Overall Study|Withdrawal by Subject|1|||
155251230|NCT02160314|560351711|FG001|Overall Study|Withdrawal by Subject|2|||
155251231|NCT02160314|560351710|FG000|Overall Study|Lost to Follow-up|0|||
155251232|NCT02160314|560351711|FG001|Overall Study|Lost to Follow-up|1|||
155251233|NCT00593567|560351712|FG000|Overall Study|Adverse Event|2|||
155251234|NCT00593567|560351713|FG001|Overall Study|Adverse Event|0|||
155251235|NCT00593567|560351712|FG000|Overall Study|Physician Decision|2|||
155251236|NCT00593567|560351713|FG001|Overall Study|Physician Decision|0|||
155251237|NCT00593567|560351712|FG000|Overall Study|Protocol Violation|13|||
155251238|NCT00593567|560351713|FG001|Overall Study|Protocol Violation|7|||
155251239|NCT00593567|560351712|FG000|Overall Study|Lack of Efficacy|2|||
155251240|NCT00593567|560351713|FG001|Overall Study|Lack of Efficacy|1|||
155251241|NCT00593567|560351712|FG000|Overall Study|Withdrawal by Subject|1|||
155251242|NCT00593567|560351713|FG001|Overall Study|Withdrawal by Subject|2|||
155251243|NCT03576768|560351719|FG000|Overall Study|Lost to Follow-up|3|||
155251244|NCT03576768|560351720|FG001|Overall Study|Lost to Follow-up|3|||
155251245|NCT03576768|560351721|FG002|Overall Study|Lost to Follow-up|0|||
155251246|NCT03576768|560351722|FG003|Overall Study|Lost to Follow-up|0|||
155251247|NCT00590902|560351723|FG000|Overall Study|Death|1|||
155251248|NCT00785291|560351724|FG000|Overall Study|Never began treatment|8|||
155251249|NCT00785291|560351725|FG001|Overall Study|Never began treatment|4|||
155251250|NCT00785291|560351726|FG002|Overall Study|Never began treatment|4|||
155251251|NCT00785291|560351724|FG000|Overall Study|Adverse Event|39|||
155251252|NCT00785291|560351725|FG001|Overall Study|Adverse Event|70|||
155251253|NCT00785291|560351726|FG002|Overall Study|Adverse Event|56|||
155251254|NCT00785291|560351724|FG000|Overall Study|Death|7|||
155251255|NCT00785291|560351725|FG001|Overall Study|Death|4|||
155251256|NCT00785291|560351726|FG002|Overall Study|Death|3|||
155251257|NCT00785291|560351724|FG000|Overall Study|Withdrawal by Subject|35|||
155251258|NCT00785291|560351725|FG001|Overall Study|Withdrawal by Subject|36|||
155251259|NCT00785291|560351726|FG002|Overall Study|Withdrawal by Subject|17|||
155251260|NCT00785291|560351724|FG000|Overall Study|Alternative Therapy|12|||
155251261|NCT00785291|560351725|FG001|Overall Study|Alternative Therapy|6|||
155251262|NCT00785291|560351726|FG002|Overall Study|Alternative Therapy|7|||
155251263|NCT00785291|560351724|FG000|Overall Study|Complicating illness|6|||
155251264|NCT00785291|560351725|FG001|Overall Study|Complicating illness|4|||
155251265|NCT00785291|560351726|FG002|Overall Study|Complicating illness|4|||
155251266|NCT00785291|560351724|FG000|Overall Study|Other Medical Reasons|29|||
155251267|NCT00785291|560351725|FG001|Overall Study|Other Medical Reasons|25|||
155251268|NCT00785291|560351726|FG002|Overall Study|Other Medical Reasons|15|||
155251269|NCT02119260|560351727|FG000|Overall Study|Adverse Event|1|||
155251270|NCT02119260|560351728|FG001|Overall Study|Adverse Event|0|||
155251271|NCT02119260|560351729|FG002|Overall Study|Adverse Event|0|||
155251272|NCT02119260|560351730|FG003|Overall Study|Adverse Event|0|||
155251273|NCT02119260|560351731|FG004|Overall Study|Adverse Event|0|||
155251274|NCT02119260|560351732|FG005|Overall Study|Adverse Event|0|||
155251275|NCT02119260|560351733|FG006|Overall Study|Adverse Event|0|||
155251276|NCT02119260|560351727|FG000|Overall Study|Withdrew consent|0|||
155251277|NCT02119260|560351728|FG001|Overall Study|Withdrew consent|1|||
155251278|NCT02119260|560351729|FG002|Overall Study|Withdrew consent|1|||
155251279|NCT02119260|560351730|FG003|Overall Study|Withdrew consent|0|||
155251280|NCT02119260|560351731|FG004|Overall Study|Withdrew consent|0|||
155251281|NCT02119260|560351732|FG005|Overall Study|Withdrew consent|0|||
155251282|NCT02119260|560351733|FG006|Overall Study|Withdrew consent|0|||
155251283|NCT02057874|560351735|FG000|Overall Study|participant did not return for scan|1|||
155251284|NCT01738984|560351738|FG000|Overall Study|Pregnancy|4|||
155251285|NCT01738984|560351739|FG001|Overall Study|Pregnancy|0|||
155251286|NCT01738984|560351738|FG000|Overall Study|Withdrawal by Subject|1|||
155251287|NCT01738984|560351739|FG001|Overall Study|Withdrawal by Subject|0|||
155251288|NCT01738984|560351738|FG000|Overall Study|Lost to Follow-up|59|||
155251289|NCT01738984|560351739|FG001|Overall Study|Lost to Follow-up|39|||
155251290|NCT00920426|560351744|FG000|ITZ111451|Adverse Event|1|||
155251291|NCT00920426|560351745|FG001|ITZ111451|Adverse Event|0|||
155251292|NCT00920426|560351746|FG002|ITZ111451|Adverse Event|0|||
155251293|NCT00920426|560351747|FG003|ITZ111451|Adverse Event|0|||
155251294|NCT00955357|560351752|FG000|Titration Phase|Adverse Event|9|||
155251295|NCT00955357|560351753|FG001|Titration Phase|Adverse Event|46|||
155251296|NCT00955357|560351752|FG000|Titration Phase|Lack of Efficacy|0|||
155251297|NCT00955357|560351753|FG001|Titration Phase|Lack of Efficacy|2|||
155251298|NCT00955357|560351752|FG000|Titration Phase|Protocol Violation|3|||
155251299|NCT00955357|560351753|FG001|Titration Phase|Protocol Violation|7|||
155251300|NCT00955357|560351752|FG000|Titration Phase|Lost to Follow-up|1|||
155251301|NCT00955357|560351753|FG001|Titration Phase|Lost to Follow-up|3|||
155251302|NCT00955357|560351752|FG000|Titration Phase|Withdrawal by Subject|3|||
155251303|NCT00955357|560351753|FG001|Titration Phase|Withdrawal by Subject|5|||
155251304|NCT00955357|560351752|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
155251305|NCT00955357|560351753|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
155251306|NCT00955357|560351752|FG000|Titration Phase|Study medication not tolerated|0|||
155251307|NCT00955357|560351753|FG001|Titration Phase|Study medication not tolerated|1|||
155251308|NCT00955357|560351752|FG000|Titration Phase|Non compliance to study procedures|0|||
155251309|NCT00955357|560351753|FG001|Titration Phase|Non compliance to study procedures|1|||
155251310|NCT00955357|560351752|FG000|Maintenance Phase|Adverse Event|3|||
155251311|NCT00955357|560351753|FG001|Maintenance Phase|Adverse Event|23|||
155251312|NCT00955357|560351752|FG000|Maintenance Phase|Lack of Efficacy|0|||
155251313|NCT00955357|560351753|FG001|Maintenance Phase|Lack of Efficacy|4|||
155251314|NCT00955357|560351752|FG000|Maintenance Phase|Protocol Violation|2|||
155251315|NCT00955357|560351753|FG001|Maintenance Phase|Protocol Violation|6|||
155251316|NCT00955357|560351752|FG000|Maintenance Phase|Lost to Follow-up|2|||
155251317|NCT00955357|560351753|FG001|Maintenance Phase|Lost to Follow-up|7|||
155251318|NCT00955357|560351752|FG000|Maintenance Phase|Withdrawal by Subject|4|||
155251319|NCT00955357|560351753|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155251320|NCT00955357|560351752|FG000|Maintenance Phase|Patient moving out of area|0|||
155251321|NCT00955357|560351753|FG001|Maintenance Phase|Patient moving out of area|1|||
155251322|NCT00955357|560351752|FG000|Maintenance Phase|Non compliance to study procedures|1|||
155251323|NCT00955357|560351753|FG001|Maintenance Phase|Non compliance to study procedures|0|||
155251324|NCT02481310|560351754|FG000|Follow up|Still in follow up|0|||
155251325|NCT02481310|560351755|FG001|Follow up|Still in follow up|3|||
155251326|NCT02481310|560351756|FG002|Follow up|Still in follow up|0|||
155251327|NCT00643916|560351758|FG000|Overall Study|Protocol Violation|0|||
155251328|NCT00643916|560351759|FG001|Overall Study|Protocol Violation|1|||
155251329|NCT00643916|560351760|FG002|Overall Study|Protocol Violation|1|||
155251330|NCT00643916|560351761|FG003|Overall Study|Protocol Violation|1|||
155251331|NCT00643916|560351762|FG004|Overall Study|Protocol Violation|0|||
155251332|NCT00643916|560351763|FG005|Overall Study|Protocol Violation|0|||
155251333|NCT00643916|560351758|FG000|Overall Study|Lost to Follow-up|0|||
155251334|NCT00643916|560351759|FG001|Overall Study|Lost to Follow-up|1|||
155251335|NCT00643916|560351760|FG002|Overall Study|Lost to Follow-up|0|||
155251336|NCT00643916|560351761|FG003|Overall Study|Lost to Follow-up|0|||
155251337|NCT00643916|560351762|FG004|Overall Study|Lost to Follow-up|0|||
155251338|NCT00643916|560351763|FG005|Overall Study|Lost to Follow-up|0|||
155251339|NCT00643916|560351758|FG000|Overall Study|Withdrawal by Subject|2|||
155251340|NCT00643916|560351759|FG001|Overall Study|Withdrawal by Subject|2|||
155251341|NCT00643916|560351760|FG002|Overall Study|Withdrawal by Subject|2|||
155251342|NCT00643916|560351761|FG003|Overall Study|Withdrawal by Subject|1|||
155251343|NCT00643916|560351762|FG004|Overall Study|Withdrawal by Subject|0|||
155251344|NCT00643916|560351763|FG005|Overall Study|Withdrawal by Subject|1|||
155251345|NCT00643916|560351758|FG000|Overall Study|Not Vaccinated|2|||
155251346|NCT00643916|560351759|FG001|Overall Study|Not Vaccinated|2|||
155251347|NCT00643916|560351760|FG002|Overall Study|Not Vaccinated|3|||
155251348|NCT00643916|560351761|FG003|Overall Study|Not Vaccinated|0|||
155251349|NCT00643916|560351762|FG004|Overall Study|Not Vaccinated|2|||
155251350|NCT00643916|560351763|FG005|Overall Study|Not Vaccinated|0|||
155251351|NCT02925455|560351768|FG000|Overall Study|Withdrawal by Subject|2|||
155251352|NCT02925455|560351769|FG001|Overall Study|Withdrawal by Subject|0|||
155251353|NCT00686166|560351775|FG000|Overall Study|Adverse Event|7|||
155251354|NCT00686166|560351775|FG000|Overall Study|Withdrawal by Subject|1|||
155251355|NCT00686166|560351775|FG000|Overall Study|Progression/Relapse|1|||
155251356|NCT00686166|560351775|FG000|Overall Study|Death|1|||
155251357|NCT00686166|560351775|FG000|Overall Study|Not Protocol Specified|1|||
155251358|NCT00686166|560351775|FG000|Overall Study|Ineligible|5|||
155251359|NCT00686166|560351775|FG000|Overall Study|Did not begin protocol therapy|4|||
155251360|NCT01514448|560351776|FG000|Overall Study|Death|7|||
155251361|NCT01514448|560351777|FG001|Overall Study|Death|8|||
155251362|NCT01514448|560351776|FG000|Overall Study|Withdrawal by Subject|2|||
155251363|NCT01514448|560351777|FG001|Overall Study|Withdrawal by Subject|0|||
155251364|NCT01514448|560351776|FG000|Overall Study|Lost to Follow-up|2|||
155251365|NCT01514448|560351777|FG001|Overall Study|Lost to Follow-up|0|||
155251366|NCT01514448|560351776|FG000|Overall Study|New Cancer Therapy|1|||
155251367|NCT01514448|560351777|FG001|Overall Study|New Cancer Therapy|0|||
155251368|NCT00985725|560351778|FG000|Overall Study|Adverse Event|4|||
155251369|NCT00985725|560351779|FG001|Overall Study|Adverse Event|1|||
155251370|NCT00985725|560351778|FG000|Overall Study|Protocol Violation|1|||
155251371|NCT00985725|560351779|FG001|Overall Study|Protocol Violation|3|||
155251372|NCT00985725|560351778|FG000|Overall Study|Withdrawal by Subject|4|||
155251373|NCT00985725|560351779|FG001|Overall Study|Withdrawal by Subject|4|||
155251374|NCT00985725|560351778|FG000|Overall Study|Lost to Follow-up|1|||
155251375|NCT00985725|560351779|FG001|Overall Study|Lost to Follow-up|1|||
155251376|NCT00985725|560351778|FG000|Overall Study|Lack of Efficacy|0|||
155251377|NCT00985725|560351779|FG001|Overall Study|Lack of Efficacy|1|||
155251378|NCT00985725|560351778|FG000|Overall Study|Non-compliance|1|||
155251379|NCT00985725|560351779|FG001|Overall Study|Non-compliance|2|||
155251380|NCT00985725|560351778|FG000|Overall Study|Out-of-window visits|0|||
155251381|NCT00985725|560351779|FG001|Overall Study|Out-of-window visits|1|||
155251382|NCT03912259|560351783|FG000|Overall Study|Adverse Event (AE)|2|||
155251383|NCT03912259|560351784|FG001|Overall Study|Adverse Event (AE)|4|||
155251384|NCT03912259|560351783|FG000|Overall Study|Lack of Efficacy|4|||
155251385|NCT03912259|560351784|FG001|Overall Study|Lack of Efficacy|1|||
155251386|NCT03912259|560351783|FG000|Overall Study|Withdrawal by Subject|11|||
155251387|NCT03912259|560351784|FG001|Overall Study|Withdrawal by Subject|1|||
155251388|NCT01549613|560351785|FG000|Overall Study|Lost to Follow-up|11|||
155251389|NCT01549613|560351786|FG001|Overall Study|Lost to Follow-up|11|||
155251390|NCT02131272|560351787|FG000|Overall Study|Withdrawal by parent|0|||
155251391|NCT02131272|560351788|FG001|Overall Study|Withdrawal by parent|1|||
155251392|NCT02131272|560351787|FG000|Overall Study|Withdrawal by Subject|0|||
155251393|NCT02131272|560351788|FG001|Overall Study|Withdrawal by Subject|1|||
155251394|NCT02131272|560351787|FG000|Overall Study|Withdrawal Criteria|1|||
155251395|NCT02131272|560351788|FG001|Overall Study|Withdrawal Criteria|0|||
155251396|NCT01925950|560351789|FG000|Part 2|Withdrawal by Subject|1|||
155251397|NCT01925950|560351790|FG001|Part 2|Withdrawal by Subject|0|||
155251398|NCT00381940|560351791|FG000|Overall Study|Lack of Efficacy|3|||
155251399|NCT00381940|560351791|FG000|Overall Study|Protocol Violation|1|||
155251400|NCT00381940|560351791|FG000|Overall Study|Ineligible|1|||
155251401|NCT03162224|560351792|FG000|Overall Study|Death|4|||
155251402|NCT03162224|560351793|FG001|Overall Study|Death|5|||
155251403|NCT03162224|560351794|FG002|Overall Study|Death|8|||
155251404|NCT03162224|560351792|FG000|Overall Study|Withdrawal by Subject|1|||
155251405|NCT03162224|560351793|FG001|Overall Study|Withdrawal by Subject|0|||
155251406|NCT03162224|560351794|FG002|Overall Study|Withdrawal by Subject|1|||
155251407|NCT03162224|560351792|FG000|Overall Study|Lost to Follow-up|0|||
155251408|NCT03162224|560351793|FG001|Overall Study|Lost to Follow-up|1|||
155251409|NCT03162224|560351794|FG002|Overall Study|Lost to Follow-up|0|||
155251410|NCT03162224|560351792|FG000|Overall Study|Other|6|||
155251411|NCT03162224|560351793|FG001|Overall Study|Other|2|||
155251412|NCT03162224|560351794|FG002|Overall Study|Other|1|||
155251413|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
155251414|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
155251415|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
155251416|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
155251417|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
155251418|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
155251419|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
155251420|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
155251421|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
155251422|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251423|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251424|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251425|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
155251426|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
155251427|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
155251428|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
155251429|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
155251430|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
155251431|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
155251432|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
155251433|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Other|0|||
155251434|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Other|1|||
155251435|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Other|1|||
155251436|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Other|0|||
155251437|NCT04162769|560351795|FG000|OLE Period (52-Week)|Adverse Event|0|||
155251438|NCT04162769|560351796|FG001|OLE Period (52-Week)|Adverse Event|0|||
155251439|NCT04162769|560351797|FG002|OLE Period (52-Week)|Adverse Event|0|||
155251440|NCT04162769|560351798|FG003|OLE Period (52-Week)|Adverse Event|5|||
155251441|NCT04162769|560351795|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251442|NCT04162769|560351796|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251443|NCT04162769|560351797|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251444|NCT04162769|560351798|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
155251445|NCT04162769|560351795|FG000|OLE Period (52-Week)|Physician Decision|0|||
155251446|NCT04162769|560351796|FG001|OLE Period (52-Week)|Physician Decision|0|||
155251447|NCT04162769|560351797|FG002|OLE Period (52-Week)|Physician Decision|0|||
155251448|NCT04162769|560351798|FG003|OLE Period (52-Week)|Physician Decision|1|||
155251449|NCT04162769|560351795|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
155251450|NCT04162769|560351796|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
155251451|NCT04162769|560351797|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
155251452|NCT04162769|560351798|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
155251453|NCT04162769|560351795|FG000|OLE Period (52-Week)|Protocol deviation|0|||
155251454|NCT04162769|560351796|FG001|OLE Period (52-Week)|Protocol deviation|0|||
155251455|NCT04162769|560351797|FG002|OLE Period (52-Week)|Protocol deviation|0|||
155251456|NCT04162769|560351798|FG003|OLE Period (52-Week)|Protocol deviation|2|||
155251457|NCT04052204|560351808|FG000|Overall Study|Death|1|||
155251458|NCT04052204|560351809|FG001|Overall Study|Death|0|||
155251459|NCT04052204|560351810|FG002|Overall Study|Death|0|||
155251460|NCT04052204|560351808|FG000|Overall Study|Progressive disease|1|||
155251461|NCT04052204|560351809|FG001|Overall Study|Progressive disease|0|||
155251462|NCT04052204|560351810|FG002|Overall Study|Progressive disease|0|||
155251463|NCT04052204|560351808|FG000|Overall Study|Other|1|||
155251464|NCT04052204|560351809|FG001|Overall Study|Other|0|||
155251465|NCT04052204|560351810|FG002|Overall Study|Other|0|||
155251466|NCT01433354|560351811|FG000|Overall Study|Adverse Event|6|||
155251467|NCT01433354|560351811|FG000|Overall Study|Lost to Follow-up|1|||
155251468|NCT01433354|560351811|FG000|Overall Study|Administrative problems|90|||
155251469|NCT01433354|560351811|FG000|Overall Study|Protocol Violation|2|||
155251470|NCT01433354|560351811|FG000|Overall Study|Lack of Efficacy|17|||
155251471|NCT01433354|560351811|FG000|Overall Study|Subject Withdrew Consent|3|||
155251472|NCT04794803|560351812|FG000|Overall Study|Death|1|||
155251473|NCT04794803|560351813|FG001|Overall Study|Death|3|||
155251474|NCT04794803|560351812|FG000|Overall Study|Lost to Follow-up|2|||
155251475|NCT04794803|560351813|FG001|Overall Study|Lost to Follow-up|2|||
155251476|NCT04794803|560351812|FG000|Overall Study|Withdrawal by Subject|1|||
155251477|NCT04794803|560351813|FG001|Overall Study|Withdrawal by Subject|0|||
155251478|NCT04794803|560351812|FG000|Overall Study|Physician Decision|1|||
155251479|NCT04794803|560351813|FG001|Overall Study|Physician Decision|1|||
155251480|NCT04794803|560351812|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
155251481|NCT04794803|560351813|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
155251482|NCT04794803|560351812|FG000|Overall Study|Refused to continue the treatment|1|||
155251483|NCT04794803|560351813|FG001|Overall Study|Refused to continue the treatment|0|||
155251484|NCT04794803|560351812|FG000|Overall Study|Patient admitted to ICU|0|||
155251485|NCT04794803|560351813|FG001|Overall Study|Patient admitted to ICU|1|||
155251486|NCT00937924|560351820|FG000|Overall Study|Lost to Follow-up|44|||
155251487|NCT00937924|560351821|FG001|Overall Study|Lost to Follow-up|44|||
155251488|NCT00937924|560351822|FG002|Overall Study|Lost to Follow-up|41|||
155251489|NCT03152526|560351828|FG000|Overall Study|Withdrawal by Subject|0|||
155251490|NCT03152526|560351829|FG001|Overall Study|Withdrawal by Subject|1|||
155251491|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
155251492|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
155251493|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
155251494|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
155251495|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
155251496|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
155251497|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
155251498|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
155251499|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
155251500|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
155251501|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
155251502|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
155251503|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
155251504|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
155251505|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
155251506|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
155251507|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
155251508|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
155251509|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
155251510|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
155251511|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
155251512|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251513|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251514|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251515|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
155251516|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251517|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251518|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251519|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251520|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251521|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
155251522|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251523|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251524|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251525|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251526|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
155251527|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
155251528|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
155251529|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
155251530|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
155251531|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251532|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
155251533|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251534|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251535|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
155251536|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
155251537|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
155251538|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
155251539|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
155251540|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
155251541|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
155251542|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
155251543|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251544|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
155251545|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251546|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251547|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251548|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251549|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251550|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
155251551|NCT05553808|560351834|FG000|Overall Study|Death|25|||
155251552|NCT05553808|560351835|FG001|Overall Study|Death|62|||
155251553|NCT05553808|560351834|FG000|Overall Study|Site Closed|6|||
155251554|NCT05553808|560351835|FG001|Overall Study|Site Closed|6|||
155251555|NCT05553808|560351834|FG000|Overall Study|Lost to Follow-up|1|||
155251556|NCT05553808|560351835|FG001|Overall Study|Lost to Follow-up|0|||
155251557|NCT05553808|560351834|FG000|Overall Study|Withdrawal by Subject|3|||
155251558|NCT05553808|560351835|FG001|Overall Study|Withdrawal by Subject|2|||
155251559|NCT02273141|560351836|FG000|Overall Study|Adverse Event|0|||
155251560|NCT02273141|560351837|FG001|Overall Study|Adverse Event|1|||
155251561|NCT02273141|560351836|FG000|Overall Study|Lost to Follow-up|1|||
155251562|NCT02273141|560351837|FG001|Overall Study|Lost to Follow-up|3|||
155251563|NCT02273141|560351836|FG000|Overall Study|Withdrawal by Subject|10|||
155251564|NCT02273141|560351837|FG001|Overall Study|Withdrawal by Subject|15|||
155251565|NCT02273141|560351836|FG000|Overall Study|Various|6|||
155251566|NCT02273141|560351837|FG001|Overall Study|Various|6|||
155251567|NCT00492284|560351838|FG000|Overall Study|Adverse Event|0|||
155251568|NCT00492284|560351839|FG001|Overall Study|Adverse Event|1|||
155251569|NCT00492284|560351840|FG002|Overall Study|Adverse Event|1|||
155251570|NCT00492284|560351841|FG003|Overall Study|Adverse Event|2|||
155251571|NCT00492284|560351838|FG000|Overall Study|Lost to Follow-up|0|||
155251572|NCT00492284|560351839|FG001|Overall Study|Lost to Follow-up|0|||
155251573|NCT00492284|560351840|FG002|Overall Study|Lost to Follow-up|3|||
155251574|NCT00492284|560351841|FG003|Overall Study|Lost to Follow-up|1|||
155251575|NCT00492284|560351838|FG000|Overall Study|Death|0|||
155251576|NCT00492284|560351839|FG001|Overall Study|Death|3|||
155251577|NCT00492284|560351840|FG002|Overall Study|Death|2|||
155251578|NCT00492284|560351841|FG003|Overall Study|Death|5|||
155251579|NCT00492284|560351838|FG000|Overall Study|Withdrawal by Subject|1|||
155491687|NCT00762073|561225491|FG000|Overall Study|Adverse Event|1|||
155251580|NCT00492284|560351839|FG001|Overall Study|Withdrawal by Subject|0|||
155251581|NCT00492284|560351840|FG002|Overall Study|Withdrawal by Subject|0|||
155251582|NCT00492284|560351841|FG003|Overall Study|Withdrawal by Subject|2|||
155251583|NCT02293538|560351844|FG000|Overall Study|Adverse Event|0|||
155251584|NCT02293538|560351845|FG001|Overall Study|Adverse Event|1|||
155251585|NCT02293538|560351844|FG000|Overall Study|Lost to Follow-up|1|||
155251586|NCT02293538|560351845|FG001|Overall Study|Lost to Follow-up|0|||
155251587|NCT02293538|560351844|FG000|Overall Study|Withdrawal by Subject|0|||
155251588|NCT02293538|560351845|FG001|Overall Study|Withdrawal by Subject|1|||
155251589|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
155251590|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
155251591|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
155251592|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
155251593|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
155251594|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251595|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
155251596|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251597|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251598|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251599|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
155251600|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
155251601|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
155251602|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
155251603|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
155251604|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251605|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251606|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155251607|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251608|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251609|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251610|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251611|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
155251612|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251613|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251614|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251615|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251616|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251617|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
155251618|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251619|NCT03152552|560351848|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
155251620|NCT03152552|560351849|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
155251621|NCT03152552|560351850|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
155251622|NCT03152552|560351851|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
155251623|NCT03152552|560351852|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
155251624|NCT02372409|560351855|FG000|Overall Study|Lost to Follow-up|1|||
155251625|NCT02372409|560351856|FG001|Overall Study|Lost to Follow-up|0|||
155251626|NCT02372409|560351855|FG000|Overall Study|Disease progression|1|||
155251627|NCT02372409|560351856|FG001|Overall Study|Disease progression|1|||
155251628|NCT04084314|560351857|FG000|Overall Study|Subject/guardian decision|91|||
155251629|NCT04084314|560351857|FG000|Overall Study|Adverse Event|24|||
155251630|NCT04084314|560351857|FG000|Overall Study|Lost to Follow-up|19|||
155251631|NCT04084314|560351857|FG000|Overall Study|New therapy for study indication|9|||
155251632|NCT04084314|560351857|FG000|Overall Study|Pregnancy|9|||
155251633|NCT04084314|560351857|FG000|Overall Study|Withdrawal of informed consent|8|||
155251634|NCT04084314|560351857|FG000|Overall Study|Physician Decision|4|||
155251635|NCT04084314|560351857|FG000|Overall Study|Protocol Deviation|3|||
155251636|NCT00622167|560351858|FG000|Overall Study|Did not meet angiographic criteria|20|||
155251637|NCT03336619|560351859|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
155251638|NCT03336619|560351860|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
155251639|NCT03336619|560351859|FG000|Overall Study|Withdrawal by Subject|17|||
155251640|NCT03336619|560351860|FG001|Overall Study|Withdrawal by Subject|16|||
155251641|NCT03336619|560351859|FG000|Overall Study|Adverse Event|2|||
155251642|NCT03336619|560351860|FG001|Overall Study|Adverse Event|5|||
155251643|NCT03336619|560351859|FG000|Overall Study|Physician Decision|3|||
155251644|NCT03336619|560351860|FG001|Overall Study|Physician Decision|0|||
155251645|NCT01300546|560351861|FG000|Overall Study|Withdrawal by Subject|1|||
155251646|NCT01300546|560351862|FG001|Overall Study|Withdrawal by Subject|0|||
155251647|NCT01300546|560351861|FG000|Overall Study|Lost to Follow-up|0|||
155251648|NCT01300546|560351862|FG001|Overall Study|Lost to Follow-up|2|||
155251649|NCT01300546|560351861|FG000|Overall Study|Lack of Efficacy|0|||
155251650|NCT01300546|560351862|FG001|Overall Study|Lack of Efficacy|3|||
155251651|NCT01300546|560351861|FG000|Overall Study|Adverse Event|0|||
155251652|NCT01300546|560351862|FG001|Overall Study|Adverse Event|1|||
155251653|NCT02820623|560351863|FG000|Overall Study|Withdrawal by Subject|1|||
155251654|NCT02820623|560351864|FG001|Overall Study|Withdrawal by Subject|3|||
155251655|NCT02820623|560351865|FG002|Overall Study|Withdrawal by Subject|3|||
155251656|NCT02820623|560351863|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
155251657|NCT02820623|560351864|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
155251658|NCT02820623|560351865|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
155251659|NCT02820623|560351863|FG000|Overall Study|Therapist unable to enroll clients|1|||
155251660|NCT02820623|560351864|FG001|Overall Study|Therapist unable to enroll clients|1|||
155251661|NCT02820623|560351865|FG002|Overall Study|Therapist unable to enroll clients|3|||
155251662|NCT02820623|560351863|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
155251663|NCT02820623|560351864|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
155251664|NCT02820623|560351865|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
155251665|NCT00126438|560351872|FG000|Overall Study|Withdrawal due to adverse event|1|||
155251666|NCT00126438|560351873|FG001|Overall Study|Withdrawal due to adverse event|0|||
155251667|NCT00126438|560351872|FG000|Overall Study|Lost to Follow-up|22|||
155251668|NCT00126438|560351873|FG001|Overall Study|Lost to Follow-up|0|||
155251669|NCT00126438|560351872|FG000|Overall Study|Protocol Violation|8|||
155251670|NCT00126438|560351873|FG001|Overall Study|Protocol Violation|8|||
155251671|NCT00126438|560351872|FG000|Overall Study|Withdrawal by Subject|3|||
155251672|NCT00126438|560351873|FG001|Overall Study|Withdrawal by Subject|2|||
155251673|NCT02313428|560351874|FG000|Overall Study|Lost to Follow-up|1|||
155251674|NCT02313428|560351875|FG001|Overall Study|Lost to Follow-up|1|||
155251675|NCT05374421|560351876|FG000|Overall Study|Withdrawal by Subject|3|||
155251676|NCT05374421|560351877|FG001|Overall Study|Withdrawal by Subject|4|||
155251677|NCT05132699|560351880|FG000|Overall Study|Withdrawal by Subject|3|||
155251678|NCT05132699|560351881|FG001|Overall Study|Withdrawal by Subject|0|||
155251679|NCT04370054|560351882|FG000|Treatment Phase|Lost to Follow-up|1|||
155251680|NCT04370054|560351882|FG000|Treatment Phase|Withdrawal by Subject|1|||
155251681|NCT04370054|560351882|FG000|Follow-Up Phase|Ongoing|75|||
155251682|NCT02314624|560353431|FG000|Overall Study|No participating patient|16|||
155251683|NCT02314624|560353432|FG001|Overall Study|No participating patient|13|||
155251684|NCT02314624|560353431|FG000|Overall Study|Participant withdrew|7|||
155251685|NCT02314624|560353432|FG001|Overall Study|Participant withdrew|2|||
155251686|NCT02314624|560353431|FG000|Overall Study|Lost to Follow-up|2|||
155251687|NCT02314624|560353432|FG001|Overall Study|Lost to Follow-up|5|||
155251688|NCT02314624|560353431|FG000|Overall Study|Dropped/Excluded by PI|6|||
155251689|NCT02314624|560353432|FG001|Overall Study|Dropped/Excluded by PI|6|||
155251690|NCT03151005|560353435|FG000|Overall Study|Lost to Follow-up|5|||
155251691|NCT03151005|560353436|FG001|Overall Study|Lost to Follow-up|5|||
155251692|NCT02216123|560353439|FG000|Overall Study|Lost to Follow-up|4|||
155251693|NCT02216123|560353440|FG001|Overall Study|Lost to Follow-up|2|||
155251694|NCT02216123|560353439|FG000|Overall Study|Withdrawal by Subject|2|||
155251695|NCT02216123|560353440|FG001|Overall Study|Withdrawal by Subject|0|||
155251696|NCT05159622|560353441|FG000|Overall Study|Lost to Follow-up|4|||
155251697|NCT05159622|560353442|FG001|Overall Study|Lost to Follow-up|5|||
155251698|NCT02163733|560353443|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
155251699|NCT02163733|560353444|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
155251700|NCT02163733|560353445|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
155251701|NCT02163733|560353443|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
155251702|NCT02163733|560353444|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
155251703|NCT02163733|560353445|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
155251704|NCT02723864|560353446|FG000|Overall Study|Refused further treatment|1|||
155251705|NCT02723864|560353447|FG001|Overall Study|Refused further treatment|0|||
155251706|NCT02723864|560353448|FG002|Overall Study|Refused further treatment|0|||
155251707|NCT02723864|560353449|FG003|Overall Study|Refused further treatment|0|||
155251708|NCT02723864|560353450|FG004|Overall Study|Refused further treatment|1|||
155251709|NCT02723864|560353451|FG005|Overall Study|Refused further treatment|2|||
155251710|NCT02723864|560353452|FG006|Overall Study|Refused further treatment|0|||
155251711|NCT02723864|560353446|FG000|Overall Study|Exceed treatment hold time|0|||
155251712|NCT02723864|560353447|FG001|Overall Study|Exceed treatment hold time|1|||
155251713|NCT02723864|560353448|FG002|Overall Study|Exceed treatment hold time|0|||
155251714|NCT02723864|560353449|FG003|Overall Study|Exceed treatment hold time|0|||
155251715|NCT02723864|560353450|FG004|Overall Study|Exceed treatment hold time|0|||
155251716|NCT02723864|560353451|FG005|Overall Study|Exceed treatment hold time|0|||
155251717|NCT02723864|560353452|FG006|Overall Study|Exceed treatment hold time|0|||
155251718|NCT02723864|560353446|FG000|Overall Study|Clinical progression|0|||
155251719|NCT02723864|560353447|FG001|Overall Study|Clinical progression|0|||
155251720|NCT02723864|560353448|FG002|Overall Study|Clinical progression|1|||
155251721|NCT02723864|560353449|FG003|Overall Study|Clinical progression|0|||
155251722|NCT02723864|560353450|FG004|Overall Study|Clinical progression|0|||
155251723|NCT02723864|560353451|FG005|Overall Study|Clinical progression|3|||
155251724|NCT02723864|560353452|FG006|Overall Study|Clinical progression|1|||
155251725|NCT02723864|560353446|FG000|Overall Study|Physician Decision|0|||
155251726|NCT02723864|560353447|FG001|Overall Study|Physician Decision|0|||
155251727|NCT02723864|560353448|FG002|Overall Study|Physician Decision|0|||
155251728|NCT02723864|560353449|FG003|Overall Study|Physician Decision|0|||
155251729|NCT02723864|560353450|FG004|Overall Study|Physician Decision|0|||
155251730|NCT02723864|560353451|FG005|Overall Study|Physician Decision|0|||
155251731|NCT02723864|560353452|FG006|Overall Study|Physician Decision|1|||
155251732|NCT02723864|560353446|FG000|Overall Study|Changes in patient condition|0|||
155251733|NCT02723864|560353447|FG001|Overall Study|Changes in patient condition|0|||
155251734|NCT02723864|560353448|FG002|Overall Study|Changes in patient condition|0|||
155251735|NCT02723864|560353449|FG003|Overall Study|Changes in patient condition|0|||
155251736|NCT02723864|560353450|FG004|Overall Study|Changes in patient condition|0|||
155251737|NCT02723864|560353451|FG005|Overall Study|Changes in patient condition|1|||
155251738|NCT02723864|560353452|FG006|Overall Study|Changes in patient condition|0|||
155251739|NCT02723864|560353446|FG000|Overall Study|Patient choice|0|||
155251740|NCT02723864|560353447|FG001|Overall Study|Patient choice|0|||
155251741|NCT02723864|560353448|FG002|Overall Study|Patient choice|0|||
155251742|NCT02723864|560353449|FG003|Overall Study|Patient choice|0|||
155251743|NCT02723864|560353450|FG004|Overall Study|Patient choice|0|||
155251744|NCT02723864|560353451|FG005|Overall Study|Patient choice|1|||
155251745|NCT02723864|560353452|FG006|Overall Study|Patient choice|0|||
155251746|NCT02723864|560353446|FG000|Overall Study|Adverse Event|0|||
155251747|NCT02723864|560353447|FG001|Overall Study|Adverse Event|0|||
155251748|NCT02723864|560353448|FG002|Overall Study|Adverse Event|0|||
155251749|NCT02723864|560353449|FG003|Overall Study|Adverse Event|0|||
155251750|NCT02723864|560353450|FG004|Overall Study|Adverse Event|0|||
155251751|NCT02723864|560353451|FG005|Overall Study|Adverse Event|1|||
155251752|NCT02723864|560353452|FG006|Overall Study|Adverse Event|0|||
155251753|NCT02723864|560353446|FG000|Overall Study|Started new treatment|0|||
155251754|NCT02723864|560353447|FG001|Overall Study|Started new treatment|0|||
155251755|NCT02723864|560353448|FG002|Overall Study|Started new treatment|0|||
155251756|NCT02723864|560353449|FG003|Overall Study|Started new treatment|0|||
155251757|NCT02723864|560353450|FG004|Overall Study|Started new treatment|0|||
155251758|NCT02723864|560353451|FG005|Overall Study|Started new treatment|1|||
155251759|NCT02723864|560353452|FG006|Overall Study|Started new treatment|0|||
155251760|NCT02723864|560353446|FG000|Overall Study|Switched to alternative treatment|0|||
155251761|NCT02723864|560353447|FG001|Overall Study|Switched to alternative treatment|0|||
155251762|NCT02723864|560353448|FG002|Overall Study|Switched to alternative treatment|0|||
155251763|NCT02723864|560353449|FG003|Overall Study|Switched to alternative treatment|0|||
155251764|NCT02723864|560353450|FG004|Overall Study|Switched to alternative treatment|0|||
155251765|NCT02723864|560353451|FG005|Overall Study|Switched to alternative treatment|1|||
155251766|NCT02723864|560353452|FG006|Overall Study|Switched to alternative treatment|0|||
155251767|NCT02723864|560353446|FG000|Overall Study|Late determination of ineligibility|0|||
155251768|NCT02723864|560353447|FG001|Overall Study|Late determination of ineligibility|0|||
155251769|NCT02723864|560353448|FG002|Overall Study|Late determination of ineligibility|0|||
155251770|NCT02723864|560353449|FG003|Overall Study|Late determination of ineligibility|0|||
155251771|NCT02723864|560353450|FG004|Overall Study|Late determination of ineligibility|0|||
155251772|NCT02723864|560353451|FG005|Overall Study|Late determination of ineligibility|1|||
155251773|NCT02723864|560353452|FG006|Overall Study|Late determination of ineligibility|0|||
155251774|NCT00082173|560353453|FG000|Overall Study|Withdrawal by Subject|3|||
155251775|NCT00082173|560353454|FG001|Overall Study|Withdrawal by Subject|5|||
155251776|NCT00082173|560353453|FG000|Overall Study|Lost to Follow-up|1|||
155251777|NCT00082173|560353454|FG001|Overall Study|Lost to Follow-up|0|||
155251778|NCT00082173|560353453|FG000|Overall Study|Adverse Event|1|||
155251779|NCT00082173|560353454|FG001|Overall Study|Adverse Event|0|||
155251780|NCT00082173|560353453|FG000|Overall Study|Culture negative or resistant at baselin|5|||
155251781|NCT00082173|560353454|FG001|Overall Study|Culture negative or resistant at baselin|6|||
155251782|NCT00746590|560353455|FG000|Overall Study|Death|1|||
155251783|NCT02633800|560353460|FG000|Overall Study|Death|3|||
155251784|NCT02633800|560353461|FG001|Overall Study|Death|3|||
155251785|NCT02633800|560353460|FG000|Overall Study|Reason not provided|1|||
155251786|NCT02633800|560353461|FG001|Overall Study|Reason not provided|0|||
155251787|NCT02633800|560353460|FG000|Overall Study|Radiologic(al) progression|23|||
155251788|NCT02633800|560353461|FG001|Overall Study|Radiologic(al) progression|23|||
155251789|NCT02633800|560353460|FG000|Overall Study|Clinical progression|3|||
155251790|NCT02633800|560353461|FG001|Overall Study|Clinical progression|6|||
155251791|NCT02633800|560353460|FG000|Overall Study|Study terminated by sponsor|6|||
155251792|NCT02633800|560353461|FG001|Overall Study|Study terminated by sponsor|5|||
155251793|NCT02633800|560353460|FG000|Overall Study|Adverse event, non-fatal|7|||
155251794|NCT02633800|560353461|FG001|Overall Study|Adverse event, non-fatal|2|||
155251795|NCT02633800|560353460|FG000|Overall Study|Withdrawal by Subject|0|||
155251796|NCT02633800|560353461|FG001|Overall Study|Withdrawal by Subject|3|||
155251797|NCT02633800|560353460|FG000|Overall Study|Patient Request|1|||
155251798|NCT02633800|560353461|FG001|Overall Study|Patient Request|1|||
155251799|NCT02261493|560353465|FG000|Overall Study|Noncompliance|0|||
155251800|NCT02261493|560353466|FG001|Overall Study|Noncompliance|0|||
155251801|NCT02261493|560353467|FG002|Overall Study|Noncompliance|2|||
155251802|NCT02261493|560353465|FG000|Overall Study|Physician Decision|0|||
155251803|NCT02261493|560353466|FG001|Overall Study|Physician Decision|1|||
155251804|NCT02261493|560353467|FG002|Overall Study|Physician Decision|0|||
155251805|NCT02261493|560353465|FG000|Overall Study|Undisclosed alcohol abuse|0|||
155251806|NCT02261493|560353466|FG001|Overall Study|Undisclosed alcohol abuse|1|||
155251807|NCT02261493|560353467|FG002|Overall Study|Undisclosed alcohol abuse|0|||
155251808|NCT02261493|560353465|FG000|Overall Study|Protocol Violation|1|||
155251809|NCT02261493|560353466|FG001|Overall Study|Protocol Violation|0|||
155251810|NCT02261493|560353467|FG002|Overall Study|Protocol Violation|0|||
155251811|NCT02261493|560353465|FG000|Overall Study|Personal Reasons|14|||
155251812|NCT02261493|560353466|FG001|Overall Study|Personal Reasons|14|||
155251813|NCT02261493|560353467|FG002|Overall Study|Personal Reasons|16|||
155251814|NCT02261493|560353465|FG000|Overall Study|Lost to Follow-up|14|||
155251815|NCT02261493|560353466|FG001|Overall Study|Lost to Follow-up|27|||
155251816|NCT02261493|560353467|FG002|Overall Study|Lost to Follow-up|8|||
155251817|NCT02261493|560353465|FG000|Overall Study|Pregnancy|1|||
155251818|NCT02261493|560353466|FG001|Overall Study|Pregnancy|2|||
155251819|NCT02261493|560353467|FG002|Overall Study|Pregnancy|0|||
155251820|NCT02261493|560353465|FG000|Overall Study|Lack of Efficacy|0|||
155251821|NCT02261493|560353466|FG001|Overall Study|Lack of Efficacy|1|||
155251822|NCT02261493|560353467|FG002|Overall Study|Lack of Efficacy|0|||
155251823|NCT02261493|560353465|FG000|Overall Study|Adverse Event|0|||
155251824|NCT02261493|560353466|FG001|Overall Study|Adverse Event|1|||
155251825|NCT02261493|560353467|FG002|Overall Study|Adverse Event|0|||
155251826|NCT03643952|560353468|FG000|Overall Study|Lack of Efficacy|1|||
155251827|NCT01358968|560353469|FG000|Period 2|Adverse Event|0|||
155251828|NCT01358968|560353470|FG001|Period 2|Adverse Event|1|||
155251829|NCT01358968|560353471|FG002|Period 2|Adverse Event|0|||
155251830|NCT01358968|560353472|FG003|Period 2|Adverse Event|0|||
155251831|NCT01358968|560353469|FG000|Continued Access Phase|Progression of Disease|0|||
155251832|NCT01358968|560353470|FG001|Continued Access Phase|Progression of Disease|0|||
155251833|NCT01358968|560353471|FG002|Continued Access Phase|Progression of Disease|8|||
155251834|NCT01358968|560353472|FG003|Continued Access Phase|Progression of Disease|4|||
155251835|NCT01358968|560353469|FG000|Continued Access Phase|Protocol Violation|0|||
155251836|NCT01358968|560353470|FG001|Continued Access Phase|Protocol Violation|0|||
155251837|NCT01358968|560353471|FG002|Continued Access Phase|Protocol Violation|0|||
155251838|NCT01358968|560353472|FG003|Continued Access Phase|Protocol Violation|2|||
155251839|NCT01358968|560353469|FG000|Continued Access Phase|Withdrawal by Subject|0|||
155251840|NCT01358968|560353470|FG001|Continued Access Phase|Withdrawal by Subject|0|||
155251841|NCT01358968|560353471|FG002|Continued Access Phase|Withdrawal by Subject|3|||
155251842|NCT01358968|560353472|FG003|Continued Access Phase|Withdrawal by Subject|0|||
155251843|NCT01358968|560353469|FG000|Continued Access Phase|Death|0|||
155251844|NCT01358968|560353470|FG001|Continued Access Phase|Death|0|||
155251845|NCT01358968|560353471|FG002|Continued Access Phase|Death|1|||
155251846|NCT01358968|560353472|FG003|Continued Access Phase|Death|1|||
155251847|NCT01597050|560353473|FG000|Overall Study|Withdrawal by Subject|1|||
155251848|NCT01597050|560353474|FG001|Overall Study|Withdrawal by Subject|0|||
155251849|NCT02065336|560353478|FG000|Extension Phase|Study Terminated by Sponsor|0|||
155251850|NCT02065336|560353479|FG001|Extension Phase|Study Terminated by Sponsor|0|||
155251851|NCT02065336|560353480|FG002|Extension Phase|Study Terminated by Sponsor|0|||
155251852|NCT02065336|560353481|FG003|Extension Phase|Study Terminated by Sponsor|0|||
155251853|NCT02065336|560353482|FG004|Extension Phase|Study Terminated by Sponsor|0|||
155251854|NCT02065336|560353483|FG005|Extension Phase|Study Terminated by Sponsor|0|||
155251855|NCT02065336|560353484|FG006|Extension Phase|Study Terminated by Sponsor|0|||
155251856|NCT02065336|560353485|FG007|Extension Phase|Study Terminated by Sponsor|0|||
155251857|NCT02065336|560353486|FG008|Extension Phase|Study Terminated by Sponsor|2|||
155251858|NCT02065336|560353487|FG009|Extension Phase|Study Terminated by Sponsor|8|||
155251859|NCT01618162|560353513|FG000|Overall Study|Protocol Violation|13|||
155251860|NCT01618162|560353514|FG001|Overall Study|Protocol Violation|10|||
155251861|NCT01618162|560353513|FG000|Overall Study|Adverse Event|9|||
155251862|NCT01618162|560353514|FG001|Overall Study|Adverse Event|2|||
155251863|NCT01618162|560353513|FG000|Overall Study|Withdrawal Criteria|2|||
155251864|NCT01618162|560353514|FG001|Overall Study|Withdrawal Criteria|10|||
155251865|NCT01618162|560353513|FG000|Overall Study|Unclassified|14|||
155251866|NCT01618162|560353514|FG001|Overall Study|Unclassified|13|||
155251867|NCT01654549|560353515|FG000|Overall Study|H.pylori eradication not successful|0|||
155251868|NCT01654549|560353516|FG001|Overall Study|H.pylori eradication not successful|1|||
155491688|NCT00762073|561225492|FG001|Overall Study|Adverse Event|0|||
155251869|NCT04391023|560353521|FG000|Overall Study|Withdrawal by Subject|2|||
155251870|NCT04391023|560353522|FG001|Overall Study|Withdrawal by Subject|2|||
155251871|NCT01270347|560353523|FG000|Core Phase|Adverse Event|1|||
155251872|NCT01270347|560353524|FG001|Core Phase|Adverse Event|6|||
155251873|NCT01270347|560353523|FG000|Core Phase|Withdrawal by Subject|1|||
155251874|NCT01270347|560353524|FG001|Core Phase|Withdrawal by Subject|2|||
155251875|NCT01270347|560353523|FG000|Core Phase|Lost to Follow-up|0|||
155251876|NCT01270347|560353524|FG001|Core Phase|Lost to Follow-up|1|||
155251877|NCT01270347|560353523|FG000|Core Phase|Miscellaneous|8|||
155251878|NCT01270347|560353524|FG001|Core Phase|Miscellaneous|14|||
155251879|NCT01270347|560353523|FG000|Extension Phase|Adverse Event|1|||
155251880|NCT01270347|560353524|FG001|Extension Phase|Adverse Event|3|||
155251881|NCT01270347|560353523|FG000|Extension Phase|Withdrawal by Subject|3|||
155251882|NCT01270347|560353524|FG001|Extension Phase|Withdrawal by Subject|4|||
155251883|NCT01270347|560353523|FG000|Extension Phase|Miscellaneous|2|||
155251884|NCT01270347|560353524|FG001|Extension Phase|Miscellaneous|2|||
155251885|NCT02085408|560353525|FG000|Step 1: Induction|Disease Progression|19|||
155251886|NCT02085408|560353526|FG001|Step 1: Induction|Disease Progression|19|||
155251887|NCT02085408|560353525|FG000|Step 1: Induction|Adverse Event|18|||
155251888|NCT02085408|560353526|FG001|Step 1: Induction|Adverse Event|17|||
155251889|NCT02085408|560353525|FG000|Step 1: Induction|Death|33|||
155251890|NCT02085408|560353526|FG001|Step 1: Induction|Death|30|||
155251891|NCT02085408|560353525|FG000|Step 1: Induction|Withdrawal by Subject|16|||
155251892|NCT02085408|560353526|FG001|Step 1: Induction|Withdrawal by Subject|8|||
155251893|NCT02085408|560353525|FG000|Step 1: Induction|Alternative Therapy|15|||
155251894|NCT02085408|560353526|FG001|Step 1: Induction|Alternative Therapy|19|||
155251895|NCT02085408|560353525|FG000|Step 1: Induction|Complicating Disease|2|||
155251896|NCT02085408|560353526|FG001|Step 1: Induction|Complicating Disease|3|||
155251897|NCT02085408|560353525|FG000|Step 1: Induction|Other|27|||
155251898|NCT02085408|560353526|FG001|Step 1: Induction|Other|39|||
155251899|NCT02085408|560353525|FG000|Step 1: Induction|Never started treatment|6|||
155251900|NCT02085408|560353526|FG001|Step 1: Induction|Never started treatment|4|||
155251901|NCT02085408|560353525|FG000|Step 2: Consolidation|Disease Progression|5|||
155251902|NCT02085408|560353526|FG001|Step 2: Consolidation|Disease Progression|20|||
155251903|NCT02085408|560353525|FG000|Step 2: Consolidation|Adverse Event|9|||
155251904|NCT02085408|560353526|FG001|Step 2: Consolidation|Adverse Event|8|||
155251905|NCT02085408|560353525|FG000|Step 2: Consolidation|Death|4|||
155251906|NCT02085408|560353526|FG001|Step 2: Consolidation|Death|3|||
155251907|NCT02085408|560353525|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
155251908|NCT02085408|560353526|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
155251909|NCT02085408|560353525|FG000|Step 2: Consolidation|Alternative Therapy|9|||
155251910|NCT02085408|560353526|FG001|Step 2: Consolidation|Alternative Therapy|3|||
155251911|NCT02085408|560353525|FG000|Step 2: Consolidation|Complicating Disease|0|||
155251912|NCT02085408|560353526|FG001|Step 2: Consolidation|Complicating Disease|2|||
155251913|NCT02085408|560353525|FG000|Step 2: Consolidation|Other|6|||
155251914|NCT02085408|560353526|FG001|Step 2: Consolidation|Other|6|||
155251915|NCT02085408|560353525|FG000|Step 2: Consolidation|Never started treatment|4|||
155251916|NCT02085408|560353526|FG001|Step 2: Consolidation|Never started treatment|3|||
155251917|NCT02085408|560353525|FG000|Step 3: Maintenance|Disease Progression|13|||
155251918|NCT02085408|560353526|FG001|Step 3: Maintenance|Disease Progression|11|||
155251919|NCT02085408|560353525|FG000|Step 3: Maintenance|Adverse Event|2|||
155251920|NCT02085408|560353526|FG001|Step 3: Maintenance|Adverse Event|4|||
155251921|NCT02085408|560353525|FG000|Step 3: Maintenance|Death|1|||
155251922|NCT02085408|560353526|FG001|Step 3: Maintenance|Death|2|||
155251923|NCT02085408|560353525|FG000|Step 3: Maintenance|Alternative Therapy|1|||
155251924|NCT02085408|560353526|FG001|Step 3: Maintenance|Alternative Therapy|1|||
155251925|NCT02085408|560353525|FG000|Step 3: Maintenance|Complicating Disease|0|||
155251926|NCT02085408|560353526|FG001|Step 3: Maintenance|Complicating Disease|1|||
155251927|NCT02085408|560353525|FG000|Step 3: Maintenance|Other|3|||
155251928|NCT02085408|560353526|FG001|Step 3: Maintenance|Other|2|||
155251929|NCT02085408|560353525|FG000|Step 3: Maintenance|Never started treatment|5|||
155251930|NCT02085408|560353526|FG001|Step 3: Maintenance|Never started treatment|1|||
155251931|NCT02189798|560353527|FG000|Extended Use Phase|Withdrawal by Subject|0|||
155251932|NCT02189798|560353528|FG001|Extended Use Phase|Withdrawal by Subject|4|||
155251933|NCT02189798|560353527|FG000|Extended Use Phase|Physician Decision|1|||
155251934|NCT02189798|560353528|FG001|Extended Use Phase|Physician Decision|0|||
155251935|NCT02189798|560353527|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
155251936|NCT02189798|560353528|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
155251937|NCT02189798|560353527|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
155251938|NCT02189798|560353528|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
155251939|NCT02189798|560353527|FG000|Extended Use Phase|Travel Issues|2|||
155251940|NCT02189798|560353528|FG001|Extended Use Phase|Travel Issues|1|||
155251941|NCT02189798|560353527|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
155251942|NCT02189798|560353528|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
155251943|NCT01362140|560353531|FG000|Overall Study|Noncompliance|1|||
155251944|NCT01362140|560353532|FG001|Overall Study|Noncompliance|0|||
155251945|NCT01362140|560353531|FG000|Overall Study|Adverse Event|2|||
155251946|NCT01362140|560353532|FG001|Overall Study|Adverse Event|2|||
155251947|NCT01362140|560353531|FG000|Overall Study|Withdrawal by Subject|3|||
155251948|NCT01362140|560353532|FG001|Overall Study|Withdrawal by Subject|3|||
155251949|NCT01362140|560353531|FG000|Overall Study|Administrative Decision|0|||
155251950|NCT01362140|560353532|FG001|Overall Study|Administrative Decision|1|||
155251951|NCT01362140|560353531|FG000|Overall Study|Death|2|||
155251952|NCT01362140|560353532|FG001|Overall Study|Death|1|||
155251953|NCT01362140|560353531|FG000|Overall Study|Other|1|||
155251954|NCT01362140|560353532|FG001|Overall Study|Other|1|||
155251955|NCT01362140|560353531|FG000|Overall Study|Protocol-specified Criteria|1|||
155251956|NCT01362140|560353532|FG001|Overall Study|Protocol-specified Criteria|2|||
155251957|NCT01362140|560353531|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
155251958|NCT01362140|560353532|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
155251959|NCT00529399|560353535|FG000|Overall Study|Lost to Follow-up|1|||
155251960|NCT00529399|560353536|FG001|Overall Study|Lost to Follow-up|0|||
155251961|NCT00529399|560353537|FG002|Overall Study|Lost to Follow-up|1|||
155251962|NCT00529399|560353535|FG000|Overall Study|Withdrawal by Subject|1|||
155251963|NCT00529399|560353536|FG001|Overall Study|Withdrawal by Subject|0|||
155251964|NCT00529399|560353537|FG002|Overall Study|Withdrawal by Subject|1|||
155251965|NCT00529399|560353535|FG000|Overall Study|Non-compliant|0|||
155251966|NCT00529399|560353536|FG001|Overall Study|Non-compliant|1|||
155251967|NCT00529399|560353537|FG002|Overall Study|Non-compliant|0|||
155251968|NCT03695172|560353538|FG000|Overall Study|Withdrawal by Subject|1|||
155251969|NCT03695172|560353539|FG001|Overall Study|Withdrawal by Subject|1|||
155251970|NCT03695172|560353540|FG002|Overall Study|Withdrawal by Subject|0|||
155251971|NCT01474681|560353559|FG000|Overall Study|Death|0|||
155251972|NCT01474681|560353560|FG001|Overall Study|Death|3|||
155251973|NCT01474681|560353561|FG002|Overall Study|Death|2|||
155251974|NCT01474681|560353562|FG003|Overall Study|Death|6|||
155251975|NCT01483924|560353565|FG000|Overall Study|Withdrawal by Subject|2|||
155251976|NCT01483924|560353566|FG001|Overall Study|Withdrawal by Subject|0|||
155251977|NCT01483924|560353567|FG002|Overall Study|Withdrawal by Subject|0|||
155251978|NCT01483924|560353568|FG003|Overall Study|Withdrawal by Subject|1|||
155251979|NCT01483924|560353569|FG004|Overall Study|Withdrawal by Subject|1|||
155251980|NCT01483924|560353565|FG000|Overall Study|Adverse Event|0|||
155251981|NCT01483924|560353566|FG001|Overall Study|Adverse Event|0|||
155251982|NCT01483924|560353567|FG002|Overall Study|Adverse Event|1|||
155251983|NCT01483924|560353568|FG003|Overall Study|Adverse Event|1|||
155251984|NCT01483924|560353569|FG004|Overall Study|Adverse Event|0|||
155251985|NCT01483924|560353565|FG000|Overall Study|Non-compliance|0|||
155251986|NCT01483924|560353566|FG001|Overall Study|Non-compliance|0|||
155251987|NCT01483924|560353567|FG002|Overall Study|Non-compliance|0|||
155251988|NCT01483924|560353568|FG003|Overall Study|Non-compliance|1|||
155251989|NCT01483924|560353569|FG004|Overall Study|Non-compliance|1|||
155251990|NCT01483924|560353565|FG000|Overall Study|Sponsor concern over ECG result|0|||
155251991|NCT01483924|560353566|FG001|Overall Study|Sponsor concern over ECG result|0|||
155251992|NCT01483924|560353567|FG002|Overall Study|Sponsor concern over ECG result|0|||
155251993|NCT01483924|560353568|FG003|Overall Study|Sponsor concern over ECG result|1|||
155251994|NCT01483924|560353569|FG004|Overall Study|Sponsor concern over ECG result|0|||
155251995|NCT00003298|560353570|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
155251996|NCT00003298|560353570|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
155251997|NCT00003298|560353570|FG000|Surgery|Unresectable at surgery|3|||
155251998|NCT00003298|560353570|FG000|Surgery|Progression before surgery|2|||
155251999|NCT00003298|560353570|FG000|Surgery|Unevaluable and off study|2|||
155252000|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
155252001|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
155252002|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
155252003|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
155252004|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
155252005|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
155252006|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
155252007|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
155252008|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
155252009|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
155252010|NCT04330638|560353575|FG000|Overall Study|Adverse Event|9|||
155252011|NCT04330638|560353576|FG001|Overall Study|Adverse Event|10|||
155252012|NCT04330638|560353577|FG002|Overall Study|Adverse Event|15|||
155252013|NCT04330638|560353578|FG003|Overall Study|Adverse Event|6|||
155252014|NCT04330638|560353579|FG004|Overall Study|Adverse Event|10|||
155252015|NCT04330638|560353580|FG005|Overall Study|Adverse Event|5|||
155252016|NCT04330638|560353575|FG000|Overall Study|Other|2|||
155252017|NCT04330638|560353576|FG001|Overall Study|Other|2|||
155252018|NCT04330638|560353577|FG002|Overall Study|Other|5|||
155252019|NCT04330638|560353578|FG003|Overall Study|Other|1|||
155252020|NCT04330638|560353579|FG004|Overall Study|Other|3|||
155252021|NCT04330638|560353580|FG005|Overall Study|Other|2|||
155252022|NCT04330638|560353575|FG000|Overall Study|Withdrawal by Subject|4|||
155252023|NCT04330638|560353576|FG001|Overall Study|Withdrawal by Subject|0|||
155252024|NCT04330638|560353577|FG002|Overall Study|Withdrawal by Subject|0|||
155252025|NCT04330638|560353578|FG003|Overall Study|Withdrawal by Subject|0|||
155252026|NCT04330638|560353579|FG004|Overall Study|Withdrawal by Subject|0|||
155252027|NCT04330638|560353580|FG005|Overall Study|Withdrawal by Subject|0|||
155252028|NCT04330638|560353575|FG000|Overall Study|Lost to Follow-up|3|||
155252029|NCT04330638|560353576|FG001|Overall Study|Lost to Follow-up|2|||
155252030|NCT04330638|560353577|FG002|Overall Study|Lost to Follow-up|3|||
155252031|NCT04330638|560353578|FG003|Overall Study|Lost to Follow-up|2|||
155252032|NCT04330638|560353579|FG004|Overall Study|Lost to Follow-up|3|||
155252033|NCT04330638|560353580|FG005|Overall Study|Lost to Follow-up|0|||
155252034|NCT01041638|560353584|FG000|Overall Study|Adverse Event|4|||
155252035|NCT01041638|560353584|FG000|Overall Study|Death|1|||
155252036|NCT01041638|560353584|FG000|Overall Study|Lack of Efficacy|7|||
155252037|NCT01041638|560353584|FG000|Overall Study|Physician Decision|4|||
155252038|NCT01041638|560353584|FG000|Overall Study|Withdrawal by Subject|11|||
155252039|NCT05207813|560353585|FG000|Overall Study|Lost to Follow-up|2|||
155252040|NCT03762473|560353589|FG000|Overall Study|Death|1|||
155252041|NCT03762473|560353590|FG001|Overall Study|Death|0|||
155252042|NCT00710424|560353593|FG000|Overall Study|Adverse Event|30|||
155252043|NCT00710424|560353594|FG001|Overall Study|Adverse Event|12|||
155252044|NCT00710424|560353593|FG000|Overall Study|Lack of Efficacy|4|||
155252045|NCT00710424|560353594|FG001|Overall Study|Lack of Efficacy|5|||
155252046|NCT00710424|560353593|FG000|Overall Study|Withdrawal by Subject|5|||
155252047|NCT00710424|560353594|FG001|Overall Study|Withdrawal by Subject|3|||
155252048|NCT00710424|560353593|FG000|Overall Study|Lost to Follow-up|0|||
155252049|NCT00710424|560353594|FG001|Overall Study|Lost to Follow-up|1|||
155252050|NCT00710424|560353593|FG000|Overall Study|Refused medication, no side effects|1|||
155252051|NCT00710424|560353594|FG001|Overall Study|Refused medication, no side effects|0|||
155252052|NCT00710424|560353593|FG000|Overall Study|Non-compliance with stable analgesia|1|||
155252053|NCT00710424|560353594|FG001|Overall Study|Non-compliance with stable analgesia|0|||
155252054|NCT00710424|560353593|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
155252055|NCT00710424|560353594|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
155252056|NCT00710424|560353593|FG000|Overall Study|Subject thought medication changed|1|||
155252057|NCT00710424|560353594|FG001|Overall Study|Subject thought medication changed|0|||
155252058|NCT00710424|560353593|FG000|Overall Study|Ceased treatment due to travel|1|||
155252059|NCT00710424|560353594|FG001|Overall Study|Ceased treatment due to travel|0|||
155252060|NCT00710424|560353593|FG000|Overall Study|Subject preferred paracetamol|0|||
155252061|NCT00710424|560353594|FG001|Overall Study|Subject preferred paracetamol|1|||
155252062|NCT00710424|560353593|FG000|Overall Study|Felt good so stopped treatment|0|||
155252063|NCT00710424|560353594|FG001|Overall Study|Felt good so stopped treatment|1|||
155252064|NCT01986881|560355565|FG000|Overall Study|Death|228|||
155252065|NCT01986881|560355566|FG001|Overall Study|Death|233|||
155252066|NCT01986881|560355567|FG002|Overall Study|Death|247|||
155252067|NCT01986881|560355565|FG000|Overall Study|Lost to Follow-up|51|||
155252068|NCT01986881|560355566|FG001|Overall Study|Lost to Follow-up|44|||
155252069|NCT01986881|560355567|FG002|Overall Study|Lost to Follow-up|55|||
155252070|NCT01986881|560355565|FG000|Overall Study|Physician Decision|7|||
155252071|NCT01986881|560355566|FG001|Overall Study|Physician Decision|4|||
155252072|NCT01986881|560355567|FG002|Overall Study|Physician Decision|6|||
155252073|NCT01986881|560355565|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
155252074|NCT01986881|560355566|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
155252075|NCT01986881|560355567|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
155252076|NCT01986881|560355565|FG000|Overall Study|Withdrawal by Subject|41|||
155252077|NCT01986881|560355566|FG001|Overall Study|Withdrawal by Subject|60|||
155252078|NCT01986881|560355567|FG002|Overall Study|Withdrawal by Subject|45|||
155252079|NCT01986881|560355565|FG000|Overall Study|Subject Moved|0|||
155252080|NCT01986881|560355566|FG001|Overall Study|Subject Moved|1|||
155252081|NCT01986881|560355567|FG002|Overall Study|Subject Moved|0|||
155252082|NCT01986881|560355565|FG000|Overall Study|Other|1|||
155252083|NCT01986881|560355566|FG001|Overall Study|Other|2|||
155252084|NCT01986881|560355567|FG002|Overall Study|Other|2|||
155252085|NCT01258608|560355568|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
155252086|NCT01258608|560355569|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
155252087|NCT01258608|560355568|FG000|Overall Study|Clinical progression|1|||
155252088|NCT01258608|560355569|FG001|Overall Study|Clinical progression|0|||
155252089|NCT01258608|560355568|FG000|Overall Study|Sponsor decision|0|||
155252090|NCT01258608|560355569|FG001|Overall Study|Sponsor decision|1|||
155252091|NCT01258608|560355568|FG000|Overall Study|Physician Decision|6|||
155252092|NCT01258608|560355569|FG001|Overall Study|Physician Decision|1|||
155252093|NCT01258608|560355568|FG000|Overall Study|Lost to Follow-up|0|||
155252094|NCT01258608|560355569|FG001|Overall Study|Lost to Follow-up|1|||
155252095|NCT01258608|560355568|FG000|Overall Study|Lack of compliance|1|||
155252096|NCT01258608|560355569|FG001|Overall Study|Lack of compliance|0|||
155252097|NCT01258608|560355568|FG000|Overall Study|Lack of Efficacy|0|||
155252098|NCT01258608|560355569|FG001|Overall Study|Lack of Efficacy|1|||
155252099|NCT01258608|560355568|FG000|Overall Study|Adverse Event|6|||
155252100|NCT01258608|560355569|FG001|Overall Study|Adverse Event|10|||
155252101|NCT01258608|560355568|FG000|Overall Study|Withdrawal by Subject|6|||
155252102|NCT01258608|560355569|FG001|Overall Study|Withdrawal by Subject|5|||
155252103|NCT04205630|560355570|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
155252104|NCT04205630|560355570|FG000|Overall Study|Disease clinical progression|7|||
155252105|NCT04205630|560355570|FG000|Overall Study|Withdrawal by Subject|2|||
155252106|NCT04205630|560355570|FG000|Overall Study|Adverse Event|17|||
155252107|NCT04205630|560355570|FG000|Overall Study|Other|1|||
155252108|NCT02943408|560355576|FG000|Overall Study|Lost to Follow-up|7|||
155252109|NCT02943408|560355577|FG001|Overall Study|Lost to Follow-up|1|||
155252110|NCT02943408|560355576|FG000|Overall Study|Withdrawal by Subject|0|||
155252111|NCT02943408|560355577|FG001|Overall Study|Withdrawal by Subject|1|||
155252112|NCT01621126|560355580|FG000|Overall Study|Physician Decision|6|||
155252113|NCT00886340|560355581|FG000|Overall Study|Withdrawal by Subject|0|||
155252114|NCT00886340|560355582|FG001|Overall Study|Withdrawal by Subject|7|||
155252115|NCT03224182|560355583|FG000|Overall Study|Study Drug Not Instilled|6|||
155252116|NCT03224182|560355584|FG001|Overall Study|Study Drug Not Instilled|1|||
155252117|NCT03224182|560355583|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
155252118|NCT03224182|560355584|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
155252119|NCT03224182|560355583|FG000|Overall Study|Withdrew of Consent|4|||
155252120|NCT03224182|560355584|FG001|Overall Study|Withdrew of Consent|2|||
155252121|NCT03224182|560355583|FG000|Overall Study|Investigator Decision|3|||
155252122|NCT03224182|560355584|FG001|Overall Study|Investigator Decision|1|||
155252123|NCT03224182|560355583|FG000|Overall Study|Sponsor Decision|26|||
155252124|NCT03224182|560355584|FG001|Overall Study|Sponsor Decision|12|||
155252125|NCT03224182|560355583|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
155252126|NCT03224182|560355584|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
155252127|NCT03224182|560355583|FG000|Overall Study|Lost to Follow-up|1|||
155252128|NCT03224182|560355584|FG001|Overall Study|Lost to Follow-up|0|||
155252129|NCT03224182|560355583|FG000|Overall Study|Participant Had Recurrence|11|||
155252130|NCT03224182|560355584|FG001|Overall Study|Participant Had Recurrence|5|||
155252131|NCT03224182|560355583|FG000|Overall Study|Death|0|||
155252132|NCT03224182|560355584|FG001|Overall Study|Death|1|||
155252133|NCT03224182|560355583|FG000|Overall Study|Reason not Specified|3|||
155252134|NCT03224182|560355584|FG001|Overall Study|Reason not Specified|3|||
155252135|NCT03224182|560355583|FG000|Overall Study|Other|1|||
155252136|NCT03224182|560355584|FG001|Overall Study|Other|0|||
155252137|NCT02606279|560355585|FG000|Overall Study|Lost to Follow-up|0|||
155252138|NCT02606279|560355586|FG001|Overall Study|Lost to Follow-up|1|||
155252139|NCT02184611|560355589|FG000|Overall Study|Lack of Efficacy|11|||
155252140|NCT02184611|560355590|FG001|Overall Study|Lack of Efficacy|15|||
155252141|NCT02184611|560355589|FG000|Overall Study|Withdrawal by Subject|5|||
155252142|NCT02184611|560355590|FG001|Overall Study|Withdrawal by Subject|6|||
155252143|NCT02184611|560355589|FG000|Overall Study|Adverse Event|4|||
155252144|NCT02184611|560355590|FG001|Overall Study|Adverse Event|5|||
155252145|NCT02184611|560355589|FG000|Overall Study|Protocol Violation|1|||
155252146|NCT02184611|560355590|FG001|Overall Study|Protocol Violation|1|||
155252147|NCT02184611|560355589|FG000|Overall Study|Protocol defined stopping criteria|0|||
155252148|NCT02184611|560355590|FG001|Overall Study|Protocol defined stopping criteria|1|||
155252149|NCT00160680|560355591|FG000|Overall Study|Adverse Event|0|||
155252150|NCT00160680|560355592|FG001|Overall Study|Adverse Event|1|||
155252151|NCT00160680|560355591|FG000|Overall Study|Lack of Efficacy|2|||
155252152|NCT00160680|560355592|FG001|Overall Study|Lack of Efficacy|1|||
155252153|NCT00160680|560355591|FG000|Overall Study|Lost to Follow-up|3|||
155252154|NCT00160680|560355592|FG001|Overall Study|Lost to Follow-up|2|||
155252155|NCT00160680|560355591|FG000|Overall Study|Withdrawal by Subject|4|||
155252156|NCT00160680|560355592|FG001|Overall Study|Withdrawal by Subject|9|||
155252157|NCT04493216|560355593|FG000|Overall Study|Study terminated by sponsor|30|||
155252158|NCT04493216|560355594|FG001|Overall Study|Study terminated by sponsor|33|||
155252159|NCT04493216|560355595|FG002|Overall Study|Study terminated by sponsor|28|||
155252160|NCT04493216|560355596|FG003|Overall Study|Study terminated by sponsor|27|||
155252161|NCT04493216|560355593|FG000|Overall Study|Withdrawal by Subject|2|||
155252162|NCT04493216|560355594|FG001|Overall Study|Withdrawal by Subject|1|||
155252163|NCT04493216|560355595|FG002|Overall Study|Withdrawal by Subject|1|||
155252164|NCT04493216|560355596|FG003|Overall Study|Withdrawal by Subject|2|||
155252165|NCT04493216|560355593|FG000|Overall Study|Protocol Violation|1|||
155252166|NCT04493216|560355594|FG001|Overall Study|Protocol Violation|2|||
155252167|NCT04493216|560355595|FG002|Overall Study|Protocol Violation|0|||
155252168|NCT04493216|560355596|FG003|Overall Study|Protocol Violation|2|||
155252169|NCT04493216|560355593|FG000|Overall Study|Physician Decision|0|||
155252170|NCT04493216|560355594|FG001|Overall Study|Physician Decision|0|||
155252171|NCT04493216|560355595|FG002|Overall Study|Physician Decision|1|||
155252172|NCT04493216|560355596|FG003|Overall Study|Physician Decision|0|||
155252173|NCT04493216|560355593|FG000|Overall Study|Lost to Follow-up|2|||
155252174|NCT04493216|560355594|FG001|Overall Study|Lost to Follow-up|1|||
155252175|NCT04493216|560355595|FG002|Overall Study|Lost to Follow-up|0|||
155252176|NCT04493216|560355596|FG003|Overall Study|Lost to Follow-up|1|||
155252177|NCT04493216|560355593|FG000|Overall Study|Adverse Event|1|||
155252178|NCT04493216|560355594|FG001|Overall Study|Adverse Event|4|||
155252179|NCT04493216|560355595|FG002|Overall Study|Adverse Event|5|||
155252180|NCT04493216|560355596|FG003|Overall Study|Adverse Event|2|||
155252181|NCT04493216|560355593|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
155252182|NCT04493216|560355594|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
155252183|NCT04493216|560355595|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
155252184|NCT04493216|560355596|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
155491689|NCT00762073|561225493|FG002|Overall Study|Adverse Event|1|||
155252185|NCT03318523|560355599|FG000|PC Period: Up to Year 1|Adverse Event|1|||
155252186|NCT03318523|560355600|FG001|PC Period: Up to Year 1|Adverse Event|0|||
155252187|NCT03318523|560355601|FG002|PC Period: Up to Year 1|Adverse Event|2|||
155252188|NCT03318523|560355602|FG003|PC Period: Up to Year 1|Adverse Event|0|||
155252189|NCT03318523|560355603|FG004|PC Period: Up to Year 1|Adverse Event|0|||
155252190|NCT03318523|560355604|FG005|PC Period: Up to Year 1|Adverse Event|0|||
155252191|NCT03318523|560355605|FG006|PC Period: Up to Year 1|Adverse Event|0|||
155252192|NCT03318523|560355606|FG007|PC Period: Up to Year 1|Adverse Event|0|||
155252193|NCT03318523|560355607|FG008|PC Period: Up to Year 1|Adverse Event|0|||
155252194|NCT03318523|560355608|FG009|PC Period: Up to Year 1|Adverse Event|0|||
155252195|NCT03318523|560355599|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
155252196|NCT03318523|560355600|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
155252197|NCT03318523|560355601|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252198|NCT03318523|560355602|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
155252199|NCT03318523|560355603|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252200|NCT03318523|560355604|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252201|NCT03318523|560355605|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252202|NCT03318523|560355606|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252203|NCT03318523|560355607|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252204|NCT03318523|560355608|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252205|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252206|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252207|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252208|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252209|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
155252210|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252211|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252212|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
155252213|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252214|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
155252215|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252216|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252217|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252218|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252219|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
155252220|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252221|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252222|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
155252223|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
155252224|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
155252225|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252226|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252227|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252228|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252229|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252230|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
155252231|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252232|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252233|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252234|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252235|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252236|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252237|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252238|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252239|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252240|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252241|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252242|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252243|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252244|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
155252245|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252246|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252247|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252248|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252249|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
155252250|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
155491690|NCT00762073|561225494|FG003|Overall Study|Adverse Event|1|||
155252251|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
155252252|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
155252253|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
155252254|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
155252255|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252256|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252257|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252258|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252259|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
155252260|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252261|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252262|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
155252263|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
155252264|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252265|NCT01615328|560355613|FG000|Overall Study|Lost to Follow-up|3|||
155252266|NCT01615328|560355614|FG001|Overall Study|Lost to Follow-up|5|||
155252267|NCT00254982|560355615|FG000|Overall Study|Other|2|||
155252268|NCT00254982|560355616|FG001|Overall Study|Other|1|||
155252269|NCT00254982|560355615|FG000|Overall Study|Lack of Efficacy|5|||
155252270|NCT00254982|560355616|FG001|Overall Study|Lack of Efficacy|3|||
155252271|NCT00254982|560355615|FG000|Overall Study|Lost to Follow-up|5|||
155252272|NCT00254982|560355616|FG001|Overall Study|Lost to Follow-up|3|||
155252273|NCT00254982|560355615|FG000|Overall Study|Adverse Event|18|||
155252274|NCT00254982|560355616|FG001|Overall Study|Adverse Event|16|||
155252275|NCT00254982|560355615|FG000|Overall Study|Withdrawal by Subject|1|||
155252276|NCT00254982|560355616|FG001|Overall Study|Withdrawal by Subject|1|||
155252277|NCT00254982|560355615|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
155252278|NCT00254982|560355616|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
155252279|NCT00254982|560355615|FG000|Overall Study|Protocol deviation|1|||
155252280|NCT00254982|560355616|FG001|Overall Study|Protocol deviation|1|||
155252281|NCT00254982|560355615|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
155252282|NCT00254982|560355616|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
155252283|NCT00254982|560355615|FG000|Overall Study|Malignancy|0|||
155252284|NCT00254982|560355616|FG001|Overall Study|Malignancy|2|||
155252285|NCT00254982|560355615|FG000|Overall Study|Opportunistic infection|1|||
155252286|NCT00254982|560355616|FG001|Overall Study|Opportunistic infection|0|||
155252287|NCT00254982|560355615|FG000|Overall Study|Abnormal liver function tests|2|||
155252288|NCT00254982|560355616|FG001|Overall Study|Abnormal liver function tests|1|||
155252289|NCT00483184|560355617|FG000|Overall Study|Withdrawal by Subject|2|||
155252290|NCT00483184|560355618|FG001|Overall Study|Withdrawal by Subject|2|||
155252291|NCT00483184|560355619|FG002|Overall Study|Withdrawal by Subject|0|||
155252292|NCT00483184|560355617|FG000|Overall Study|Lost to Follow-up|1|||
155252293|NCT00483184|560355618|FG001|Overall Study|Lost to Follow-up|0|||
155252294|NCT00483184|560355619|FG002|Overall Study|Lost to Follow-up|0|||
155252295|NCT00483184|560355617|FG000|Overall Study|Adverse Event|1|||
155252296|NCT00483184|560355618|FG001|Overall Study|Adverse Event|2|||
155252297|NCT00483184|560355619|FG002|Overall Study|Adverse Event|2|||
155252298|NCT00483184|560355617|FG000|Overall Study|Protocol Violation|1|||
155252299|NCT00483184|560355618|FG001|Overall Study|Protocol Violation|0|||
155252300|NCT00483184|560355619|FG002|Overall Study|Protocol Violation|1|||
155252301|NCT02794285|560355622|FG000|Overall Study|Adverse Event|11|||
155252302|NCT02794285|560355623|FG001|Overall Study|Adverse Event|4|||
155252303|NCT02794285|560355624|FG002|Overall Study|Adverse Event|5|||
155252304|NCT02794285|560355625|FG003|Overall Study|Adverse Event|8|||
155252305|NCT02794285|560355622|FG000|Overall Study|Condition Under Investigation Improved|1|||
155252306|NCT02794285|560355623|FG001|Overall Study|Condition Under Investigation Improved|0|||
155252307|NCT02794285|560355624|FG002|Overall Study|Condition Under Investigation Improved|0|||
155252308|NCT02794285|560355625|FG003|Overall Study|Condition Under Investigation Improved|0|||
155252309|NCT02794285|560355622|FG000|Overall Study|Condition Under Investigation Worsened|0|||
155252310|NCT02794285|560355623|FG001|Overall Study|Condition Under Investigation Worsened|2|||
155252311|NCT02794285|560355624|FG002|Overall Study|Condition Under Investigation Worsened|1|||
155252312|NCT02794285|560355625|FG003|Overall Study|Condition Under Investigation Worsened|0|||
155252313|NCT02794285|560355622|FG000|Overall Study|Death|2|||
155252314|NCT02794285|560355623|FG001|Overall Study|Death|1|||
155252315|NCT02794285|560355624|FG002|Overall Study|Death|2|||
155252316|NCT02794285|560355625|FG003|Overall Study|Death|0|||
155252317|NCT02794285|560355622|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
155252318|NCT02794285|560355623|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
155252319|NCT02794285|560355624|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
155252320|NCT02794285|560355625|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
155252321|NCT02794285|560355622|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252322|NCT02794285|560355623|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252323|NCT02794285|560355624|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
155252324|NCT02794285|560355625|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252325|NCT02794285|560355622|FG000|Overall Study|Lack of Efficacy|10|||
155252326|NCT02794285|560355623|FG001|Overall Study|Lack of Efficacy|6|||
155252327|NCT02794285|560355624|FG002|Overall Study|Lack of Efficacy|3|||
155252328|NCT02794285|560355625|FG003|Overall Study|Lack of Efficacy|3|||
155252329|NCT02794285|560355622|FG000|Overall Study|Lost to Follow-up|5|||
155252330|NCT02794285|560355623|FG001|Overall Study|Lost to Follow-up|6|||
155252331|NCT02794285|560355624|FG002|Overall Study|Lost to Follow-up|3|||
155252332|NCT02794285|560355625|FG003|Overall Study|Lost to Follow-up|1|||
155252333|NCT02794285|560355622|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
155252334|NCT02794285|560355623|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
155252335|NCT02794285|560355624|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
155252336|NCT02794285|560355625|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
155252337|NCT02794285|560355622|FG000|Overall Study|Withdrawal by Subject|38|||
155252338|NCT02794285|560355623|FG001|Overall Study|Withdrawal by Subject|29|||
155252339|NCT02794285|560355624|FG002|Overall Study|Withdrawal by Subject|20|||
155252340|NCT02794285|560355625|FG003|Overall Study|Withdrawal by Subject|12|||
155252341|NCT02794285|560355622|FG000|Overall Study|Missing|1|||
155252342|NCT02794285|560355623|FG001|Overall Study|Missing|0|||
155252343|NCT02794285|560355624|FG002|Overall Study|Missing|0|||
155252344|NCT02794285|560355625|FG003|Overall Study|Missing|0|||
155252345|NCT02794285|560355622|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
155252346|NCT02794285|560355623|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
155252347|NCT02794285|560355624|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
155252348|NCT02794285|560355625|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
155252349|NCT02794285|560355622|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
155252350|NCT02794285|560355623|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
155252351|NCT02794285|560355624|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
155252352|NCT02794285|560355625|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
155252353|NCT03252587|560355626|FG000|Overall Study|Adverse Event|3|||
155252354|NCT03252587|560355627|FG001|Overall Study|Adverse Event|8|||
155252355|NCT03252587|560355628|FG002|Overall Study|Adverse Event|6|||
155252356|NCT03252587|560355629|FG003|Overall Study|Adverse Event|12|||
155252357|NCT03252587|560355626|FG000|Overall Study|Lack of Efficacy|7|||
155252358|NCT03252587|560355627|FG001|Overall Study|Lack of Efficacy|2|||
155252359|NCT03252587|560355628|FG002|Overall Study|Lack of Efficacy|2|||
155252360|NCT03252587|560355629|FG003|Overall Study|Lack of Efficacy|4|||
155252361|NCT03252587|560355626|FG000|Overall Study|Lost to Follow-up|2|||
155252362|NCT03252587|560355627|FG001|Overall Study|Lost to Follow-up|0|||
155252363|NCT03252587|560355628|FG002|Overall Study|Lost to Follow-up|0|||
155252364|NCT03252587|560355629|FG003|Overall Study|Lost to Follow-up|2|||
155252365|NCT03252587|560355626|FG000|Overall Study|Pregnancy|2|||
155252366|NCT03252587|560355627|FG001|Overall Study|Pregnancy|1|||
155252367|NCT03252587|560355628|FG002|Overall Study|Pregnancy|0|||
155252368|NCT03252587|560355629|FG003|Overall Study|Pregnancy|1|||
155252369|NCT03252587|560355626|FG000|Overall Study|Withdrawal by Subject|8|||
155252370|NCT03252587|560355627|FG001|Overall Study|Withdrawal by Subject|4|||
155252371|NCT03252587|560355628|FG002|Overall Study|Withdrawal by Subject|4|||
155252372|NCT03252587|560355629|FG003|Overall Study|Withdrawal by Subject|4|||
155252373|NCT03252587|560355626|FG000|Overall Study|Other Reasons|2|||
155252374|NCT03252587|560355627|FG001|Overall Study|Other Reasons|5|||
155252375|NCT03252587|560355628|FG002|Overall Study|Other Reasons|5|||
155252376|NCT03252587|560355629|FG003|Overall Study|Other Reasons|4|||
155252377|NCT03945188|560355630|FG000|Overall Study|Protocol Violation|1|||
155252378|NCT03945188|560355631|FG001|Overall Study|Protocol Violation|0|||
155252379|NCT03945188|560355630|FG000|Overall Study|Disease worsening|79|||
155252380|NCT03945188|560355631|FG001|Overall Study|Disease worsening|73|||
155252381|NCT03945188|560355630|FG000|Overall Study|Physician Decision|2|||
155252382|NCT03945188|560355631|FG001|Overall Study|Physician Decision|2|||
155252383|NCT03945188|560355630|FG000|Overall Study|Lack of Efficacy|7|||
155252384|NCT03945188|560355631|FG001|Overall Study|Lack of Efficacy|4|||
155252385|NCT03945188|560355630|FG000|Overall Study|Pregnancy|2|||
155252386|NCT03945188|560355631|FG001|Overall Study|Pregnancy|0|||
155252387|NCT03945188|560355630|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
155252388|NCT03945188|560355631|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
155252389|NCT03945188|560355630|FG000|Overall Study|Adverse Event|10|||
155252390|NCT03945188|560355631|FG001|Overall Study|Adverse Event|5|||
155252391|NCT03945188|560355630|FG000|Overall Study|Other|2|||
155252392|NCT03945188|560355631|FG001|Overall Study|Other|2|||
155252393|NCT03945188|560355630|FG000|Overall Study|Lost to Follow-up|1|||
155252394|NCT03945188|560355631|FG001|Overall Study|Lost to Follow-up|2|||
155252395|NCT04969198|560355637|FG000|Overall Study|Withdrawal by Subject|20|||
155252396|NCT04969198|560355637|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
155252397|NCT04969198|560355637|FG000|Overall Study|Lost to Follow-up|20|||
155252398|NCT04009291|560355639|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252399|NCT04009291|560355640|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252400|NCT04009291|560355641|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252401|NCT04009291|560355642|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252402|NCT04009291|560355643|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
155252403|NCT04009291|560355639|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252404|NCT04009291|560355640|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252405|NCT04009291|560355641|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252406|NCT04009291|560355642|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252407|NCT04009291|560355643|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
155252408|NCT03998618|560355644|FG000|Overall Study|Death|7|||
155252409|NCT03998618|560355645|FG001|Overall Study|Death|11|||
155252410|NCT03998618|560355644|FG000|Overall Study|hospice enrollment|3|||
155252411|NCT03998618|560355645|FG001|Overall Study|hospice enrollment|3|||
155252412|NCT03998618|560355644|FG000|Overall Study|Not feeling well/health problems|3|||
155252413|NCT03998618|560355645|FG001|Overall Study|Not feeling well/health problems|5|||
155252414|NCT03998618|560355644|FG000|Overall Study|Lost to Follow-up|6|||
155252415|NCT03998618|560355645|FG001|Overall Study|Lost to Follow-up|6|||
155252416|NCT03998618|560355644|FG000|Overall Study|Withdrawal by Subject|0|||
155252417|NCT03998618|560355645|FG001|Overall Study|Withdrawal by Subject|4|||
155252418|NCT00335322|560355647|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
155252419|NCT00335322|560355648|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
155252420|NCT00335322|560355649|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
155252421|NCT02576678|560355650|FG000|Overall Study|Adverse Event|0|||
155252422|NCT02576678|560355651|FG001|Overall Study|Adverse Event|0|||
155252423|NCT02576678|560355652|FG002|Overall Study|Adverse Event|2|||
155252424|NCT02576678|560355650|FG000|Overall Study|Withdrawal by Subject|3|||
155252425|NCT02576678|560355651|FG001|Overall Study|Withdrawal by Subject|1|||
155252426|NCT02576678|560355652|FG002|Overall Study|Withdrawal by Subject|2|||
155252427|NCT02576678|560355650|FG000|Overall Study|Lost to Follow-up|0|||
155252428|NCT02576678|560355651|FG001|Overall Study|Lost to Follow-up|0|||
155252429|NCT02576678|560355652|FG002|Overall Study|Lost to Follow-up|1|||
155252430|NCT02576678|560355650|FG000|Overall Study|Miscellaneous|2|||
155252431|NCT02576678|560355651|FG001|Overall Study|Miscellaneous|0|||
155252432|NCT02576678|560355652|FG002|Overall Study|Miscellaneous|0|||
155252433|NCT01988779|560355655|FG000|Overall Study|Withdrawal by Subject|2|||
155252434|NCT01988779|560355656|FG001|Overall Study|Withdrawal by Subject|2|||
155252435|NCT01988779|560355655|FG000|Overall Study|Protocol Violation|1|||
155252436|NCT01988779|560355656|FG001|Overall Study|Protocol Violation|0|||
155252437|NCT02275065|560355657|FG000|Overall Study|Randomized but not treated|1|||
155252438|NCT02275065|560355658|FG001|Overall Study|Randomized but not treated|0|||
155252439|NCT02275065|560355659|FG002|Overall Study|Randomized but not treated|1|||
155252440|NCT02275065|560355660|FG003|Overall Study|Randomized but not treated|1|||
155252441|NCT02275065|560355661|FG004|Overall Study|Randomized but not treated|0|||
155252442|NCT00417079|560355663|FG000|Overall Study|Disease progression|267|||
155252443|NCT00417079|560355664|FG001|Overall Study|Disease progression|180|||
155252444|NCT00417079|560355663|FG000|Overall Study|Adverse Event|32|||
155252445|NCT00417079|560355664|FG001|Overall Study|Adverse Event|67|||
155252446|NCT00417079|560355663|FG000|Overall Study|Non-compliance to protocol|0|||
155252447|NCT00417079|560355664|FG001|Overall Study|Non-compliance to protocol|1|||
155252448|NCT00417079|560355663|FG000|Overall Study|Lost to Follow-up|2|||
155252449|NCT00417079|560355664|FG001|Overall Study|Lost to Follow-up|0|||
155252450|NCT00417079|560355663|FG000|Overall Study|Withdrawal by Subject|17|||
155252451|NCT00417079|560355664|FG001|Overall Study|Withdrawal by Subject|8|||
155252452|NCT00417079|560355663|FG000|Overall Study|Not treated|6|||
155252453|NCT00417079|560355664|FG001|Overall Study|Not treated|7|||
155252454|NCT00417079|560355663|FG000|Overall Study|Screened failure|2|||
155252455|NCT00417079|560355664|FG001|Overall Study|Screened failure|1|||
155252456|NCT00417079|560355663|FG000|Overall Study|Investigator's decision|1|||
155252457|NCT00417079|560355664|FG001|Overall Study|Investigator's decision|4|||
155252458|NCT00417079|560355663|FG000|Overall Study|Non-confirmed Disease progression|1|||
155252459|NCT00417079|560355664|FG001|Overall Study|Non-confirmed Disease progression|1|||
155252460|NCT00417079|560355663|FG000|Overall Study|Clinical deterioration|1|||
155252461|NCT00417079|560355664|FG001|Overall Study|Clinical deterioration|0|||
155252462|NCT00417079|560355663|FG000|Overall Study|Screening error|2|||
155252463|NCT00417079|560355664|FG001|Overall Study|Screening error|1|||
155252464|NCT00417079|560355663|FG000|Overall Study|Withdrawal by subject's family|0|||
155252465|NCT00417079|560355664|FG001|Overall Study|Withdrawal by subject's family|1|||
155252466|NCT00417079|560355663|FG000|Overall Study|Patient unable to come to the clinic|0|||
155252467|NCT00417079|560355664|FG001|Overall Study|Patient unable to come to the clinic|1|||
155252468|NCT00417079|560355663|FG000|Overall Study|abnormal liver function tests|0|||
155252469|NCT00417079|560355664|FG001|Overall Study|abnormal liver function tests|1|||
155252470|NCT01687257|560355666|FG000|Overall Study|Efficacy Failure|6|||
155252471|NCT01687257|560355667|FG001|Overall Study|Efficacy Failure|0|||
155252472|NCT01687257|560355668|FG002|Overall Study|Efficacy Failure|5|||
155252473|NCT01687257|560355666|FG000|Overall Study|Subject Withdrew Consent|1|||
155252474|NCT01687257|560355667|FG001|Overall Study|Subject Withdrew Consent|1|||
155252475|NCT01687257|560355668|FG002|Overall Study|Subject Withdrew Consent|1|||
155252476|NCT01687257|560355666|FG000|Overall Study|Adverse Event|1|||
155252477|NCT01687257|560355667|FG001|Overall Study|Adverse Event|0|||
155252478|NCT01687257|560355668|FG002|Overall Study|Adverse Event|0|||
155252479|NCT01687257|560355666|FG000|Overall Study|Investigator's Discretion|0|||
155252480|NCT01687257|560355667|FG001|Overall Study|Investigator's Discretion|3|||
155252481|NCT01687257|560355668|FG002|Overall Study|Investigator's Discretion|0|||
155252482|NCT01922076|560355669|FG000|Overall Study|Adverse Event|0|||
155252483|NCT01922076|560355670|FG001|Overall Study|Adverse Event|0|||
155252484|NCT01922076|560355671|FG002|Overall Study|Adverse Event|0|||
155252485|NCT01922076|560355672|FG003|Overall Study|Adverse Event|0|||
155252486|NCT01922076|560355673|FG004|Overall Study|Adverse Event|1|||
155252487|NCT01922076|560355674|FG005|Overall Study|Adverse Event|0|||
155252488|NCT01922076|560355675|FG006|Overall Study|Adverse Event|0|||
155252489|NCT01922076|560355669|FG000|Overall Study|Physician Decision|0|||
155252490|NCT01922076|560355670|FG001|Overall Study|Physician Decision|0|||
155252491|NCT01922076|560355671|FG002|Overall Study|Physician Decision|1|||
155252492|NCT01922076|560355672|FG003|Overall Study|Physician Decision|0|||
155252493|NCT01922076|560355673|FG004|Overall Study|Physician Decision|0|||
155252494|NCT01922076|560355674|FG005|Overall Study|Physician Decision|0|||
155252495|NCT01922076|560355675|FG006|Overall Study|Physician Decision|0|||
155252496|NCT01922076|560355669|FG000|Overall Study|Withdrawal by Subject|0|||
155252497|NCT01922076|560355670|FG001|Overall Study|Withdrawal by Subject|0|||
155252498|NCT01922076|560355671|FG002|Overall Study|Withdrawal by Subject|0|||
155252499|NCT01922076|560355672|FG003|Overall Study|Withdrawal by Subject|1|||
155252500|NCT01922076|560355673|FG004|Overall Study|Withdrawal by Subject|0|||
155252501|NCT01922076|560355674|FG005|Overall Study|Withdrawal by Subject|1|||
155252502|NCT01922076|560355675|FG006|Overall Study|Withdrawal by Subject|1|||
155252503|NCT04899349|560355683|FG000|Overall Study|Study terminated by Sponsor|2|||
155252504|NCT04899349|560355684|FG001|Overall Study|Study terminated by Sponsor|0|||
155252505|NCT01018394|560355685|FG000|Overall Study|Withdrawal by Subject|5|||
155252506|NCT01018394|560355686|FG001|Overall Study|Withdrawal by Subject|5|||
155252507|NCT01018394|560355685|FG000|Overall Study|Lost to Follow-up|4|||
155252508|NCT01018394|560355686|FG001|Overall Study|Lost to Follow-up|3|||
155252509|NCT03792126|560355687|FG000|Overall Study|Adverse Event|1|||
155252510|NCT03792126|560355688|FG001|Overall Study|Adverse Event|2|||
155252511|NCT03792126|560355687|FG000|Overall Study|Death|0|||
155252512|NCT03792126|560355688|FG001|Overall Study|Death|1|||
155252513|NCT03792126|560355687|FG000|Overall Study|Lost to Follow-up|1|||
155252514|NCT03792126|560355688|FG001|Overall Study|Lost to Follow-up|0|||
155252515|NCT03792126|560355687|FG000|Overall Study|Withdrawal by Subject|0|||
155252516|NCT03792126|560355688|FG001|Overall Study|Withdrawal by Subject|1|||
155252517|NCT03792126|560355687|FG000|Overall Study|COVID-19 Restrictions|1|||
155252518|NCT03792126|560355688|FG001|Overall Study|COVID-19 Restrictions|3|||
155252519|NCT03792126|560355687|FG000|Overall Study|Symptoms resolved|0|||
155252520|NCT03792126|560355688|FG001|Overall Study|Symptoms resolved|3|||
155252521|NCT03240692|560355689|FG000|Overall Study|Physician Decision|1|||
155252522|NCT03240692|560355689|FG000|Overall Study|Withdrawal by Subject|1|||
155252523|NCT00683644|560355690|FG000|Overall Study|Withdrawal by Subject|4|||
155252524|NCT00683644|560355691|FG001|Overall Study|Withdrawal by Subject|2|||
155252525|NCT00683644|560355690|FG000|Overall Study|Lost to Follow-up|1|||
155252526|NCT00683644|560355691|FG001|Overall Study|Lost to Follow-up|4|||
155252527|NCT00683644|560355690|FG000|Overall Study|Adverse Event|1|||
155252528|NCT00683644|560355691|FG001|Overall Study|Adverse Event|2|||
155252529|NCT00683644|560355690|FG000|Overall Study|Low copper, other health problems,|7|||
155252530|NCT00683644|560355691|FG001|Overall Study|Low copper, other health problems,|6|||
155252531|NCT00617344|560355694|FG000|Overall Study|Serious adverse event|1|||
155252532|NCT00617344|560355695|FG001|Overall Study|Serious adverse event|0|||
155252533|NCT00617344|560355696|FG002|Overall Study|Serious adverse event|0|||
155252534|NCT00617344|560355694|FG000|Overall Study|Other Adverse Event|1|||
155252535|NCT00617344|560355695|FG001|Overall Study|Other Adverse Event|1|||
155252536|NCT00617344|560355696|FG002|Overall Study|Other Adverse Event|0|||
155252537|NCT00617344|560355694|FG000|Overall Study|Protocol Violation|10|||
155252538|NCT00617344|560355695|FG001|Overall Study|Protocol Violation|8|||
155252539|NCT00617344|560355696|FG002|Overall Study|Protocol Violation|5|||
155252540|NCT00617344|560355694|FG000|Overall Study|Lost to Follow-up|5|||
155252541|NCT00617344|560355695|FG001|Overall Study|Lost to Follow-up|4|||
155252542|NCT00617344|560355696|FG002|Overall Study|Lost to Follow-up|1|||
155252543|NCT00617344|560355694|FG000|Overall Study|Withdrawal by Subject|8|||
155252544|NCT00617344|560355695|FG001|Overall Study|Withdrawal by Subject|9|||
155252545|NCT00617344|560355696|FG002|Overall Study|Withdrawal by Subject|2|||
155252546|NCT01178086|560355697|FG000|Overall Study|Participant refusal|7|||
155252547|NCT01178086|560355697|FG000|Overall Study|Physician Decision|44|||
155252548|NCT01178086|560355697|FG000|Overall Study|Switch to other CLL therapy|113|||
155252549|NCT01178086|560355697|FG000|Overall Study|Death|59|||
155252550|NCT01178086|560355697|FG000|Overall Study|Other unspecified|89|||
155252551|NCT01178086|560355697|FG000|Overall Study|Excluded from EAS|20|||
155491691|NCT00762073|561225491|FG000|Overall Study|Significant Subject Noncompliance|0|||
155252552|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
155252553|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
155252554|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
155252555|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
155252556|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Other reason|4|||
155252557|NCT00983073|560355699|FG000|Maintenance Period|Adverse Event|5|||
155252558|NCT00983073|560355699|FG000|Maintenance Period|Withdrawal by Subject|2|||
155252559|NCT00983073|560355699|FG000|Maintenance Period|Lack of Efficacy|2|||
155252560|NCT00983073|560355699|FG000|Maintenance Period|Other Reason|7|||
155252561|NCT01400503|560355700|FG000|Overall Study|Withdrawal by Subject|1|||
155252562|NCT01400503|560355700|FG000|Overall Study|Study Terminated by Sponsor|58|||
155252563|NCT01400503|560355700|FG000|Overall Study|Other|1|||
155252564|NCT01669122|560355703|FG000|Period I|Lost to Follow-up|1|||
155252565|NCT01669122|560355703|FG000|Washout Period II|Protocol Violation|2|||
155252566|NCT02962908|560355706|FG000|Overall Study|Lost to Follow-up|0|||
155252567|NCT02962908|560355707|FG001|Overall Study|Lost to Follow-up|3|||
155252568|NCT02962908|560355708|FG002|Overall Study|Lost to Follow-up|0|||
155252569|NCT02962908|560355709|FG003|Overall Study|Lost to Follow-up|1|||
155252570|NCT02962908|560355706|FG000|Overall Study|Withdrawal by Subject|0|||
155252571|NCT02962908|560355707|FG001|Overall Study|Withdrawal by Subject|3|||
155252572|NCT02962908|560355708|FG002|Overall Study|Withdrawal by Subject|0|||
155252573|NCT02962908|560355709|FG003|Overall Study|Withdrawal by Subject|2|||
155252574|NCT02962908|560355706|FG000|Overall Study|Protocol Violation|0|||
155252575|NCT02962908|560355707|FG001|Overall Study|Protocol Violation|1|||
155252576|NCT02962908|560355708|FG002|Overall Study|Protocol Violation|0|||
155252577|NCT02962908|560355709|FG003|Overall Study|Protocol Violation|0|||
155252578|NCT02962908|560355706|FG000|Overall Study|Physician Decision|0|||
155252579|NCT02962908|560355707|FG001|Overall Study|Physician Decision|1|||
155252580|NCT02962908|560355708|FG002|Overall Study|Physician Decision|0|||
155252581|NCT02962908|560355709|FG003|Overall Study|Physician Decision|0|||
155252582|NCT01261338|560355710|FG000|Overall Study|Withdrawal by Subject|3|||
155252583|NCT01261338|560355711|FG001|Overall Study|Withdrawal by Subject|2|||
155252584|NCT05557942|560355712|FG000|Overall Study|Death|0|||
155252585|NCT05557942|560355713|FG001|Overall Study|Death|0|||
155252586|NCT05557942|560355714|FG002|Overall Study|Death|0|||
155252587|NCT05557942|560355715|FG003|Overall Study|Death|2|||
155252588|NCT05557942|560355716|FG004|Overall Study|Death|1|||
155252589|NCT05557942|560355717|FG005|Overall Study|Death|1|||
155252590|NCT05557942|560355712|FG000|Overall Study|Physician Decision|1|||
155252591|NCT05557942|560355713|FG001|Overall Study|Physician Decision|1|||
155252592|NCT05557942|560355714|FG002|Overall Study|Physician Decision|2|||
155252593|NCT05557942|560355715|FG003|Overall Study|Physician Decision|3|||
155252594|NCT05557942|560355716|FG004|Overall Study|Physician Decision|0|||
155252595|NCT05557942|560355717|FG005|Overall Study|Physician Decision|2|||
155252596|NCT05557942|560355712|FG000|Overall Study|Study terminated by sponsor|17|||
155252597|NCT05557942|560355713|FG001|Overall Study|Study terminated by sponsor|17|||
155252598|NCT05557942|560355714|FG002|Overall Study|Study terminated by sponsor|14|||
155252599|NCT05557942|560355715|FG003|Overall Study|Study terminated by sponsor|40|||
155252600|NCT05557942|560355716|FG004|Overall Study|Study terminated by sponsor|45|||
155252601|NCT05557942|560355717|FG005|Overall Study|Study terminated by sponsor|37|||
155252602|NCT05557942|560355712|FG000|Overall Study|Protocol Violation|0|||
155252603|NCT05557942|560355713|FG001|Overall Study|Protocol Violation|0|||
155252604|NCT05557942|560355714|FG002|Overall Study|Protocol Violation|0|||
155252605|NCT05557942|560355715|FG003|Overall Study|Protocol Violation|0|||
155252606|NCT05557942|560355716|FG004|Overall Study|Protocol Violation|0|||
155252607|NCT05557942|560355717|FG005|Overall Study|Protocol Violation|1|||
155252608|NCT05557942|560355712|FG000|Overall Study|Withdrawal by Subject|0|||
155252609|NCT05557942|560355713|FG001|Overall Study|Withdrawal by Subject|0|||
155252610|NCT05557942|560355714|FG002|Overall Study|Withdrawal by Subject|0|||
155252611|NCT05557942|560355715|FG003|Overall Study|Withdrawal by Subject|0|||
155252612|NCT05557942|560355716|FG004|Overall Study|Withdrawal by Subject|2|||
155252613|NCT05557942|560355717|FG005|Overall Study|Withdrawal by Subject|0|||
155252614|NCT01962493|560355718|FG000|Overall Study|Adverse Event|1|||
155252615|NCT01962493|560355719|FG001|Overall Study|Adverse Event|2|||
155252616|NCT01962493|560355718|FG000|Overall Study|Protocol Violation|0|||
155252617|NCT01962493|560355719|FG001|Overall Study|Protocol Violation|1|||
155252618|NCT01962493|560355718|FG000|Overall Study|Withdrawal by Subject|4|||
155252619|NCT01962493|560355719|FG001|Overall Study|Withdrawal by Subject|2|||
155252620|NCT01329029|560355726|FG000|Overall Study|Withdrawal by Subject|117|||
155252621|NCT01329029|560355727|FG001|Overall Study|Withdrawal by Subject|87|||
155252622|NCT01329029|560355726|FG000|Overall Study|Adverse Event|82|||
155252623|NCT01329029|560355727|FG001|Overall Study|Adverse Event|29|||
155252624|NCT01329029|560355726|FG000|Overall Study|Death|16|||
155252625|NCT01329029|560355727|FG001|Overall Study|Death|19|||
155252626|NCT01329029|560355726|FG000|Overall Study|Other|14|||
155252627|NCT01329029|560355727|FG001|Overall Study|Other|20|||
155252628|NCT01329029|560355726|FG000|Overall Study|COPD Exacerbation|11|||
155252629|NCT01329029|560355727|FG001|Overall Study|COPD Exacerbation|18|||
155252630|NCT01329029|560355726|FG000|Overall Study|Physician Decision|16|||
155252631|NCT01329029|560355727|FG001|Overall Study|Physician Decision|13|||
155252632|NCT01329029|560355726|FG000|Overall Study|Lost to Follow-up|8|||
155252633|NCT01329029|560355727|FG001|Overall Study|Lost to Follow-up|5|||
155252634|NCT01329029|560355726|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
155252635|NCT01329029|560355727|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
155252636|NCT01332227|560357400|FG000|Overall Study|Adverse Event|4|||
155252637|NCT01332227|560357401|FG001|Overall Study|Adverse Event|1|||
155252638|NCT01332227|560357400|FG000|Overall Study|Withdrawal by Subject|5|||
155252639|NCT01332227|560357401|FG001|Overall Study|Withdrawal by Subject|1|||
155252640|NCT01332227|560357400|FG000|Overall Study|Lost to Follow-up|2|||
155252641|NCT01332227|560357401|FG001|Overall Study|Lost to Follow-up|0|||
155252642|NCT01332227|560357400|FG000|Overall Study|Lack of Efficacy|3|||
155252643|NCT01332227|560357401|FG001|Overall Study|Lack of Efficacy|1|||
155252644|NCT01332227|560357400|FG000|Overall Study|Poor compliance/noncompliance|1|||
155252645|NCT01332227|560357401|FG001|Overall Study|Poor compliance/noncompliance|1|||
155252646|NCT01332227|560357400|FG000|Overall Study|Patient moved from area|1|||
155252647|NCT01332227|560357401|FG001|Overall Study|Patient moved from area|0|||
155252648|NCT01332227|560357400|FG000|Overall Study|Patient began prohibited medication|0|||
155252649|NCT01332227|560357401|FG001|Overall Study|Patient began prohibited medication|1|||
155252650|NCT03751631|560357402|FG000|Overall Study|Withdrawal by Subject|0|||
155252651|NCT03751631|560357403|FG001|Overall Study|Withdrawal by Subject|0|||
155252652|NCT03751631|560357404|FG002|Overall Study|Withdrawal by Subject|1|||
155252653|NCT03751631|560357405|FG003|Overall Study|Withdrawal by Subject|1|||
155252654|NCT03751631|560357406|FG004|Overall Study|Withdrawal by Subject|0|||
155252655|NCT03751631|560357407|FG005|Overall Study|Withdrawal by Subject|0|||
155252656|NCT02822222|560357408|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
155252657|NCT02822222|560357409|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
155252658|NCT00428090|560357411|FG000|Overall Study|Adverse Event|10|||
155252659|NCT00428090|560357412|FG001|Overall Study|Adverse Event|8|||
155252660|NCT00428090|560357413|FG002|Overall Study|Adverse Event|10|||
155252661|NCT00428090|560357414|FG003|Overall Study|Adverse Event|11|||
155252662|NCT00428090|560357411|FG000|Overall Study|Lost to Follow-up|3|||
155252663|NCT00428090|560357412|FG001|Overall Study|Lost to Follow-up|6|||
155252664|NCT00428090|560357413|FG002|Overall Study|Lost to Follow-up|1|||
155252665|NCT00428090|560357414|FG003|Overall Study|Lost to Follow-up|4|||
155252666|NCT00428090|560357411|FG000|Overall Study|Protocol Violation|3|||
155252667|NCT00428090|560357412|FG001|Overall Study|Protocol Violation|1|||
155252668|NCT00428090|560357413|FG002|Overall Study|Protocol Violation|3|||
155252669|NCT00428090|560357414|FG003|Overall Study|Protocol Violation|3|||
155252670|NCT00428090|560357411|FG000|Overall Study|Withdrawal by Subject|10|||
155252671|NCT00428090|560357412|FG001|Overall Study|Withdrawal by Subject|12|||
155252672|NCT00428090|560357413|FG002|Overall Study|Withdrawal by Subject|15|||
155252673|NCT00428090|560357414|FG003|Overall Study|Withdrawal by Subject|5|||
155252674|NCT00428090|560357411|FG000|Overall Study|Sponsor terminated study|0|||
155252675|NCT00428090|560357412|FG001|Overall Study|Sponsor terminated study|1|||
155252676|NCT00428090|560357413|FG002|Overall Study|Sponsor terminated study|0|||
155252677|NCT00428090|560357414|FG003|Overall Study|Sponsor terminated study|0|||
155252678|NCT00428090|560357411|FG000|Overall Study|Non-compliance|4|||
155252679|NCT00428090|560357412|FG001|Overall Study|Non-compliance|0|||
155252680|NCT00428090|560357413|FG002|Overall Study|Non-compliance|1|||
155252681|NCT00428090|560357414|FG003|Overall Study|Non-compliance|3|||
155252682|NCT00428090|560357411|FG000|Overall Study|Par. did not returned to visit|1|||
155252683|NCT00428090|560357412|FG001|Overall Study|Par. did not returned to visit|0|||
155252684|NCT00428090|560357413|FG002|Overall Study|Par. did not returned to visit|0|||
155252685|NCT00428090|560357414|FG003|Overall Study|Par. did not returned to visit|1|||
155252686|NCT00428090|560357411|FG000|Overall Study|Follow-Up visit not possible|1|||
155252687|NCT00428090|560357412|FG001|Overall Study|Follow-Up visit not possible|0|||
155252688|NCT00428090|560357413|FG002|Overall Study|Follow-Up visit not possible|0|||
155252689|NCT00428090|560357414|FG003|Overall Study|Follow-Up visit not possible|0|||
155252690|NCT00428090|560357411|FG000|Overall Study|Prohibited medication used for SAE|1|||
155252691|NCT00428090|560357412|FG001|Overall Study|Prohibited medication used for SAE|0|||
155252692|NCT00428090|560357413|FG002|Overall Study|Prohibited medication used for SAE|0|||
155252693|NCT00428090|560357414|FG003|Overall Study|Prohibited medication used for SAE|0|||
155252694|NCT00428090|560357411|FG000|Overall Study|Death of par.|1|||
155252695|NCT00428090|560357412|FG001|Overall Study|Death of par.|0|||
155252696|NCT00428090|560357413|FG002|Overall Study|Death of par.|1|||
155252697|NCT00428090|560357414|FG003|Overall Study|Death of par.|0|||
155252698|NCT00428090|560357411|FG000|Overall Study|Visit 7 exceed the visit window|0|||
155252699|NCT00428090|560357412|FG001|Overall Study|Visit 7 exceed the visit window|1|||
155252700|NCT00428090|560357413|FG002|Overall Study|Visit 7 exceed the visit window|0|||
155252701|NCT00428090|560357414|FG003|Overall Study|Visit 7 exceed the visit window|0|||
155252702|NCT00428090|560357411|FG000|Overall Study|Medical monitor terminated par.|0|||
155252703|NCT00428090|560357412|FG001|Overall Study|Medical monitor terminated par.|1|||
155252704|NCT00428090|560357413|FG002|Overall Study|Medical monitor terminated par.|0|||
155252705|NCT00428090|560357414|FG003|Overall Study|Medical monitor terminated par.|0|||
155252706|NCT00428090|560357411|FG000|Overall Study|Mental status of par. was|0|||
155252707|NCT00428090|560357412|FG001|Overall Study|Mental status of par. was|1|||
155252708|NCT00428090|560357413|FG002|Overall Study|Mental status of par. was|0|||
155252709|NCT00428090|560357414|FG003|Overall Study|Mental status of par. was|0|||
155252710|NCT00428090|560357411|FG000|Overall Study|Worsening of AD|0|||
155252711|NCT00428090|560357412|FG001|Overall Study|Worsening of AD|0|||
155252712|NCT00428090|560357413|FG002|Overall Study|Worsening of AD|1|||
155252713|NCT00428090|560357414|FG003|Overall Study|Worsening of AD|0|||
155252714|NCT00428090|560357411|FG000|Overall Study|Excluded for concerning QTc value|0|||
155252715|NCT00428090|560357412|FG001|Overall Study|Excluded for concerning QTc value|0|||
155252716|NCT00428090|560357413|FG002|Overall Study|Excluded for concerning QTc value|1|||
155252717|NCT00428090|560357414|FG003|Overall Study|Excluded for concerning QTc value|0|||
155252718|NCT00428090|560357411|FG000|Overall Study|Insufficient AD documentation|0|||
155252719|NCT00428090|560357412|FG001|Overall Study|Insufficient AD documentation|0|||
155252720|NCT00428090|560357413|FG002|Overall Study|Insufficient AD documentation|1|||
155252721|NCT00428090|560357414|FG003|Overall Study|Insufficient AD documentation|0|||
155252722|NCT00428090|560357411|FG000|Overall Study|High MMSE scores|0|||
155252723|NCT00428090|560357412|FG001|Overall Study|High MMSE scores|0|||
155252724|NCT00428090|560357413|FG002|Overall Study|High MMSE scores|1|||
155252725|NCT00428090|560357414|FG003|Overall Study|High MMSE scores|0|||
155252726|NCT00428090|560357411|FG000|Overall Study|Deterioration of cognitive status|0|||
155252727|NCT00428090|560357412|FG001|Overall Study|Deterioration of cognitive status|0|||
155252728|NCT00428090|560357413|FG002|Overall Study|Deterioration of cognitive status|1|||
155252729|NCT00428090|560357414|FG003|Overall Study|Deterioration of cognitive status|0|||
155252730|NCT00428090|560357411|FG000|Overall Study|Serious adverse event|0|||
155252731|NCT00428090|560357412|FG001|Overall Study|Serious adverse event|0|||
155252732|NCT00428090|560357413|FG002|Overall Study|Serious adverse event|1|||
155252733|NCT00428090|560357414|FG003|Overall Study|Serious adverse event|0|||
155252734|NCT00428090|560357411|FG000|Overall Study|Excluded for heart insufficiency|0|||
155252735|NCT00428090|560357412|FG001|Overall Study|Excluded for heart insufficiency|0|||
155252736|NCT00428090|560357413|FG002|Overall Study|Excluded for heart insufficiency|1|||
155252737|NCT00428090|560357414|FG003|Overall Study|Excluded for heart insufficiency|0|||
155252738|NCT00428090|560357411|FG000|Overall Study|Raised Creatinine Value|0|||
155252739|NCT00428090|560357412|FG001|Overall Study|Raised Creatinine Value|0|||
155252740|NCT00428090|560357413|FG002|Overall Study|Raised Creatinine Value|0|||
155252741|NCT00428090|560357414|FG003|Overall Study|Raised Creatinine Value|1|||
155252742|NCT00440531|560357417|FG000|Overall Study|Adverse Event|1|||
155252743|NCT00440531|560357418|FG001|Overall Study|Adverse Event|0|||
155252744|NCT00440531|560357419|FG002|Overall Study|Adverse Event|2|||
155252745|NCT00440531|560357417|FG000|Overall Study|Withdrawal by Subject|2|||
155252746|NCT00440531|560357418|FG001|Overall Study|Withdrawal by Subject|0|||
155252747|NCT00440531|560357419|FG002|Overall Study|Withdrawal by Subject|0|||
155252748|NCT00440531|560357417|FG000|Overall Study|Protocol Violation|1|||
155252749|NCT00440531|560357418|FG001|Overall Study|Protocol Violation|2|||
155252750|NCT00440531|560357419|FG002|Overall Study|Protocol Violation|0|||
155252751|NCT00440531|560357417|FG000|Overall Study|Lost to Follow-up|4|||
155252752|NCT00440531|560357418|FG001|Overall Study|Lost to Follow-up|3|||
155252753|NCT00440531|560357419|FG002|Overall Study|Lost to Follow-up|5|||
155252754|NCT00440531|560357417|FG000|Overall Study|see pre-assignment details|2|||
155252755|NCT00440531|560357418|FG001|Overall Study|see pre-assignment details|0|||
155252756|NCT00440531|560357419|FG002|Overall Study|see pre-assignment details|0|||
155252757|NCT00447057|560357420|FG000|Overall Study|Adverse Event|4|||
155252758|NCT00447057|560357421|FG001|Overall Study|Adverse Event|10|||
155252759|NCT00447057|560357422|FG002|Overall Study|Adverse Event|0|||
155252760|NCT00447057|560357423|FG003|Overall Study|Adverse Event|3|||
155252761|NCT00447057|560357420|FG000|Overall Study|Death due to study disease|6|||
155252762|NCT00447057|560357421|FG001|Overall Study|Death due to study disease|4|||
155252763|NCT00447057|560357422|FG002|Overall Study|Death due to study disease|1|||
155252764|NCT00447057|560357423|FG003|Overall Study|Death due to study disease|1|||
155252765|NCT00447057|560357420|FG000|Overall Study|Lost to Follow-up|0|||
155252766|NCT00447057|560357421|FG001|Overall Study|Lost to Follow-up|1|||
155252767|NCT00447057|560357422|FG002|Overall Study|Lost to Follow-up|0|||
155252768|NCT00447057|560357423|FG003|Overall Study|Lost to Follow-up|0|||
155252769|NCT00447057|560357420|FG000|Overall Study|Entry criteria not met|1|||
155252770|NCT00447057|560357421|FG001|Overall Study|Entry criteria not met|1|||
155252771|NCT00447057|560357422|FG002|Overall Study|Entry criteria not met|0|||
155252772|NCT00447057|560357423|FG003|Overall Study|Entry criteria not met|0|||
155252773|NCT00447057|560357420|FG000|Overall Study|Protocol Violation|0|||
155252774|NCT00447057|560357421|FG001|Overall Study|Protocol Violation|1|||
155252775|NCT00447057|560357422|FG002|Overall Study|Protocol Violation|0|||
155252776|NCT00447057|560357423|FG003|Overall Study|Protocol Violation|0|||
155252777|NCT00447057|560357420|FG000|Overall Study|Withdrawal by Subject|4|||
155252778|NCT00447057|560357421|FG001|Overall Study|Withdrawal by Subject|5|||
155252779|NCT00447057|560357422|FG002|Overall Study|Withdrawal by Subject|1|||
155252780|NCT00447057|560357423|FG003|Overall Study|Withdrawal by Subject|1|||
155252781|NCT00447057|560357420|FG000|Overall Study|Physician Decision|9|||
155252782|NCT00447057|560357421|FG001|Overall Study|Physician Decision|6|||
155252783|NCT00447057|560357422|FG002|Overall Study|Physician Decision|3|||
155252784|NCT00447057|560357423|FG003|Overall Study|Physician Decision|1|||
155252785|NCT00447057|560357420|FG000|Overall Study|Sponsor decision|1|||
155252786|NCT00447057|560357421|FG001|Overall Study|Sponsor decision|1|||
155252787|NCT00447057|560357422|FG002|Overall Study|Sponsor decision|0|||
155252788|NCT00447057|560357423|FG003|Overall Study|Sponsor decision|0|||
155252789|NCT00447057|560357420|FG000|Overall Study|Progressive disease|58|||
155252790|NCT00447057|560357421|FG001|Overall Study|Progressive disease|43|||
155252791|NCT00447057|560357422|FG002|Overall Study|Progressive disease|13|||
155252792|NCT00447057|560357423|FG003|Overall Study|Progressive disease|18|||
155252793|NCT00447057|560357420|FG000|Overall Study|Death due to adverse event|0|||
155252794|NCT00447057|560357421|FG001|Overall Study|Death due to adverse event|0|||
155252795|NCT00447057|560357422|FG002|Overall Study|Death due to adverse event|1|||
155252796|NCT00447057|560357423|FG003|Overall Study|Death due to adverse event|2|||
155252797|NCT00447057|560357420|FG000|Overall Study|Death, study drug related|0|||
155252798|NCT00447057|560357421|FG001|Overall Study|Death, study drug related|1|||
155252799|NCT00447057|560357422|FG002|Overall Study|Death, study drug related|0|||
155252800|NCT00447057|560357423|FG003|Overall Study|Death, study drug related|0|||
155252801|NCT00677833|560357426|FG000|Overall Study|Withdrawal by Subject|4|||
155252802|NCT00677833|560357427|FG001|Overall Study|Withdrawal by Subject|0|||
155252803|NCT00677833|560357428|FG002|Overall Study|Withdrawal by Subject|1|||
155252804|NCT00677833|560357429|FG003|Overall Study|Withdrawal by Subject|3|||
155252805|NCT00677833|560357426|FG000|Overall Study|Lost to Follow-up|0|||
155252806|NCT00677833|560357427|FG001|Overall Study|Lost to Follow-up|0|||
155252807|NCT00677833|560357428|FG002|Overall Study|Lost to Follow-up|1|||
155252808|NCT00677833|560357429|FG003|Overall Study|Lost to Follow-up|0|||
155252809|NCT02583425|560357434|FG000|Screening|Did not meet entry criteria|12|||
155252810|NCT02583425|560357434|FG000|Baseline|Did not meet continued criteria|5|||
155252811|NCT02583425|560357434|FG000|Treatment Period|Adverse Event|1|||
155252812|NCT03232983|560357435|FG000|Period 1|Physician Decision|0|||
155252813|NCT03232983|560357436|FG001|Period 1|Physician Decision|0|||
155252814|NCT03232983|560357437|FG002|Period 1|Physician Decision|1|||
155252815|NCT03232983|560357438|FG003|Period 1|Physician Decision|0|||
155252816|NCT03232983|560357435|FG000|Washout Period 2|Physician Decision|0|||
155252817|NCT03232983|560357436|FG001|Washout Period 2|Physician Decision|0|||
155252818|NCT03232983|560357437|FG002|Washout Period 2|Physician Decision|1|||
155252819|NCT03232983|560357438|FG003|Washout Period 2|Physician Decision|0|||
155252820|NCT03232983|560357435|FG000|Washout Period 2|Withdrawal by Subject|0|||
155252821|NCT03232983|560357436|FG001|Washout Period 2|Withdrawal by Subject|0|||
155252822|NCT03232983|560357437|FG002|Washout Period 2|Withdrawal by Subject|0|||
155252823|NCT03232983|560357438|FG003|Washout Period 2|Withdrawal by Subject|1|||
155252824|NCT03232983|560357435|FG000|Period 4|Withdrawal by Subject|1|||
155252825|NCT03232983|560357436|FG001|Period 4|Withdrawal by Subject|0|||
155252826|NCT03232983|560357437|FG002|Period 4|Withdrawal by Subject|0|||
155252827|NCT03232983|560357438|FG003|Period 4|Withdrawal by Subject|0|||
155252828|NCT02548455|560357439|FG000|Overall Study|Withdrawal by Subject|27|||
155252829|NCT02548455|560357439|FG000|Overall Study|Death|26|||
155252830|NCT02548455|560357439|FG000|Overall Study|Lost to Follow-up|14|||
155252831|NCT02548455|560357439|FG000|Overall Study|Visit not completed|173|||
155252832|NCT00530855|560357440|FG000|Overall Study|Lack of Efficacy|20|||
155252833|NCT00530855|560357440|FG000|Overall Study|Withdrawal by Subject|30|||
155252834|NCT00530855|560357440|FG000|Overall Study|Fatal Serious AE|3|||
155252835|NCT00530855|560357440|FG000|Overall Study|Non Fatal Serious AE|7|||
155252836|NCT00530855|560357440|FG000|Overall Study|Non Fatal Non Serious AE|12|||
155252837|NCT00530855|560357440|FG000|Overall Study|Protocol Violation|3|||
155252838|NCT00530855|560357440|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
155252839|NCT00530855|560357440|FG000|Overall Study|Lost to Follow-up|9|||
155252840|NCT00530855|560357440|FG000|Overall Study|Other reason for premature termination|17|||
155252841|NCT00815295|560357441|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
155252842|NCT00815295|560357442|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
155252843|NCT00815295|560357443|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
155252844|NCT01137474|560357444|FG000|Overall Study|Adverse Event|3|||
155252845|NCT01137474|560357445|FG001|Overall Study|Adverse Event|5|||
155252846|NCT01137474|560357446|FG002|Overall Study|Adverse Event|1|||
155252847|NCT01137474|560357447|FG003|Overall Study|Adverse Event|3|||
155252848|NCT01137474|560357444|FG000|Overall Study|Withdrawal by Subject|7|||
155252849|NCT01137474|560357445|FG001|Overall Study|Withdrawal by Subject|2|||
155252850|NCT01137474|560357446|FG002|Overall Study|Withdrawal by Subject|6|||
155252851|NCT01137474|560357447|FG003|Overall Study|Withdrawal by Subject|9|||
155252852|NCT01137474|560357444|FG000|Overall Study|No longer met study criteria|6|||
155252853|NCT01137474|560357445|FG001|Overall Study|No longer met study criteria|1|||
155252854|NCT01137474|560357446|FG002|Overall Study|No longer met study criteria|0|||
155252855|NCT01137474|560357447|FG003|Overall Study|No longer met study criteria|5|||
155252856|NCT01137474|560357444|FG000|Overall Study|Lost to Follow-up|5|||
155252857|NCT01137474|560357445|FG001|Overall Study|Lost to Follow-up|1|||
155252858|NCT01137474|560357446|FG002|Overall Study|Lost to Follow-up|0|||
155252859|NCT01137474|560357447|FG003|Overall Study|Lost to Follow-up|2|||
155252860|NCT01137474|560357444|FG000|Overall Study|Lack of Efficacy|0|||
155252861|NCT01137474|560357445|FG001|Overall Study|Lack of Efficacy|0|||
155252862|NCT01137474|560357446|FG002|Overall Study|Lack of Efficacy|0|||
155252863|NCT01137474|560357447|FG003|Overall Study|Lack of Efficacy|2|||
155252864|NCT01137474|560357444|FG000|Overall Study|Other|3|||
155252865|NCT01137474|560357445|FG001|Overall Study|Other|1|||
155252866|NCT01137474|560357446|FG002|Overall Study|Other|0|||
155252867|NCT01137474|560357447|FG003|Overall Study|Other|0|||
155252868|NCT01137474|560357444|FG000|Overall Study|Pregnancy|0|||
155252869|NCT01137474|560357445|FG001|Overall Study|Pregnancy|1|||
155252870|NCT01137474|560357446|FG002|Overall Study|Pregnancy|0|||
155252871|NCT01137474|560357447|FG003|Overall Study|Pregnancy|0|||
155252872|NCT01137474|560357444|FG000|Overall Study|Administrative reason by sponsor|0|||
155252873|NCT01137474|560357445|FG001|Overall Study|Administrative reason by sponsor|1|||
155252874|NCT01137474|560357446|FG002|Overall Study|Administrative reason by sponsor|0|||
155252875|NCT01137474|560357447|FG003|Overall Study|Administrative reason by sponsor|0|||
155252876|NCT04124926|560357450|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
155252877|NCT04124926|560357451|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
155252878|NCT04124926|560357452|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252879|NCT04124926|560357453|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252880|NCT04124926|560357454|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252881|NCT04124926|560357450|FG000|Healing Phase|Protocol Violation|0|||
155252882|NCT04124926|560357451|FG001|Healing Phase|Protocol Violation|1|||
155252883|NCT04124926|560357452|FG002|Healing Phase|Protocol Violation|0|||
155252884|NCT04124926|560357453|FG003|Healing Phase|Protocol Violation|0|||
155252885|NCT04124926|560357454|FG004|Healing Phase|Protocol Violation|0|||
155252886|NCT04124926|560357450|FG000|Healing Phase|Lost to Follow-up|5|||
155252887|NCT04124926|560357451|FG001|Healing Phase|Lost to Follow-up|4|||
155252888|NCT04124926|560357452|FG002|Healing Phase|Lost to Follow-up|0|||
155252889|NCT04124926|560357453|FG003|Healing Phase|Lost to Follow-up|0|||
155252890|NCT04124926|560357454|FG004|Healing Phase|Lost to Follow-up|0|||
155252891|NCT04124926|560357450|FG000|Healing Phase|Voluntary Withdrawal|10|||
155252892|NCT04124926|560357451|FG001|Healing Phase|Voluntary Withdrawal|7|||
155252893|NCT04124926|560357452|FG002|Healing Phase|Voluntary Withdrawal|0|||
155252894|NCT04124926|560357453|FG003|Healing Phase|Voluntary Withdrawal|0|||
155252895|NCT04124926|560357454|FG004|Healing Phase|Voluntary Withdrawal|0|||
155252896|NCT04124926|560357450|FG000|Healing Phase|Withdrawal of Consent|5|||
155252897|NCT04124926|560357451|FG001|Healing Phase|Withdrawal of Consent|3|||
155252898|NCT04124926|560357452|FG002|Healing Phase|Withdrawal of Consent|0|||
155252899|NCT04124926|560357453|FG003|Healing Phase|Withdrawal of Consent|0|||
155252900|NCT04124926|560357454|FG004|Healing Phase|Withdrawal of Consent|0|||
155252901|NCT04124926|560357450|FG000|Healing Phase|Miscellaneous|8|||
155252902|NCT04124926|560357451|FG001|Healing Phase|Miscellaneous|7|||
155252903|NCT04124926|560357452|FG002|Healing Phase|Miscellaneous|0|||
155252904|NCT04124926|560357453|FG003|Healing Phase|Miscellaneous|0|||
155252905|NCT04124926|560357454|FG004|Healing Phase|Miscellaneous|0|||
155252906|NCT04124926|560357450|FG000|Healing Phase|Randomized but not Treated|0|||
155252907|NCT04124926|560357451|FG001|Healing Phase|Randomized but not Treated|3|||
155252908|NCT04124926|560357452|FG002|Healing Phase|Randomized but not Treated|0|||
155252909|NCT04124926|560357453|FG003|Healing Phase|Randomized but not Treated|0|||
155252910|NCT04124926|560357454|FG004|Healing Phase|Randomized but not Treated|0|||
155252911|NCT04124926|560357450|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
155252912|NCT04124926|560357451|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
155252913|NCT04124926|560357452|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
155252914|NCT04124926|560357453|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
155252915|NCT04124926|560357454|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
155252916|NCT04124926|560357450|FG000|Maintenance Phase|Protocol Violation|0|||
155252917|NCT04124926|560357451|FG001|Maintenance Phase|Protocol Violation|0|||
155252918|NCT04124926|560357452|FG002|Maintenance Phase|Protocol Violation|3|||
155252919|NCT04124926|560357453|FG003|Maintenance Phase|Protocol Violation|0|||
155252920|NCT04124926|560357454|FG004|Maintenance Phase|Protocol Violation|0|||
155252921|NCT04124926|560357450|FG000|Maintenance Phase|Lost to Follow-up|0|||
155252922|NCT04124926|560357451|FG001|Maintenance Phase|Lost to Follow-up|0|||
155252923|NCT04124926|560357452|FG002|Maintenance Phase|Lost to Follow-up|7|||
155252924|NCT04124926|560357453|FG003|Maintenance Phase|Lost to Follow-up|8|||
155252925|NCT04124926|560357454|FG004|Maintenance Phase|Lost to Follow-up|9|||
155252926|NCT04124926|560357450|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
155252927|NCT04124926|560357451|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
155252928|NCT04124926|560357452|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
155252929|NCT04124926|560357453|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
155252930|NCT04124926|560357454|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
155252931|NCT04124926|560357450|FG000|Maintenance Phase|Pregnancy|0|||
155252932|NCT04124926|560357451|FG001|Maintenance Phase|Pregnancy|0|||
155252933|NCT04124926|560357452|FG002|Maintenance Phase|Pregnancy|0|||
155252934|NCT04124926|560357453|FG003|Maintenance Phase|Pregnancy|1|||
155252935|NCT04124926|560357454|FG004|Maintenance Phase|Pregnancy|0|||
155252936|NCT04124926|560357450|FG000|Maintenance Phase|Lack of Efficacy|0|||
155252937|NCT04124926|560357451|FG001|Maintenance Phase|Lack of Efficacy|0|||
155252938|NCT04124926|560357452|FG002|Maintenance Phase|Lack of Efficacy|0|||
155252939|NCT04124926|560357453|FG003|Maintenance Phase|Lack of Efficacy|0|||
155252940|NCT04124926|560357454|FG004|Maintenance Phase|Lack of Efficacy|1|||
155252941|NCT04124926|560357450|FG000|Maintenance Phase|Withdrawal of Consent|0|||
155252942|NCT04124926|560357451|FG001|Maintenance Phase|Withdrawal of Consent|0|||
155252943|NCT04124926|560357452|FG002|Maintenance Phase|Withdrawal of Consent|5|||
155252944|NCT04124926|560357453|FG003|Maintenance Phase|Withdrawal of Consent|5|||
155252945|NCT04124926|560357454|FG004|Maintenance Phase|Withdrawal of Consent|5|||
155252946|NCT04124926|560357450|FG000|Maintenance Phase|Miscellaneous|0|||
155252947|NCT04124926|560357451|FG001|Maintenance Phase|Miscellaneous|0|||
155252948|NCT04124926|560357452|FG002|Maintenance Phase|Miscellaneous|1|||
155252949|NCT04124926|560357453|FG003|Maintenance Phase|Miscellaneous|2|||
155252950|NCT04124926|560357454|FG004|Maintenance Phase|Miscellaneous|4|||
155252951|NCT04124926|560357450|FG000|Maintenance Phase|Randomized but not Treated|0|||
155252952|NCT04124926|560357451|FG001|Maintenance Phase|Randomized but not Treated|0|||
155252953|NCT04124926|560357452|FG002|Maintenance Phase|Randomized but not Treated|2|||
155252954|NCT04124926|560357453|FG003|Maintenance Phase|Randomized but not Treated|2|||
155252955|NCT04124926|560357454|FG004|Maintenance Phase|Randomized but not Treated|0|||
155252956|NCT03644186|560357458|FG000|Overall Study|Withdrawal by Subject|1|||
155252957|NCT03644186|560357459|FG001|Overall Study|Withdrawal by Subject|1|||
155252958|NCT02701985|560357462|FG000|Overall Study|Withdrawal by Subject|1|||
155252959|NCT02701985|560357463|FG001|Overall Study|Withdrawal by Subject|1|||
155252960|NCT02701985|560357462|FG000|Overall Study|Lost to Follow-up|1|||
155252961|NCT02701985|560357463|FG001|Overall Study|Lost to Follow-up|0|||
155252962|NCT02701985|560357462|FG000|Overall Study|Death|1|||
155252963|NCT02701985|560357463|FG001|Overall Study|Death|0|||
155252964|NCT02701985|560357462|FG000|Overall Study|Adverse Event|0|||
155252965|NCT02701985|560357463|FG001|Overall Study|Adverse Event|5|||
155252966|NCT01640808|560357465|FG000|Overall Study|Unable to continue dynamic CT|14|||
155252967|NCT01640808|560357466|FG001|Overall Study|Unable to continue dynamic CT|4|||
155252968|NCT01640808|560357465|FG000|Overall Study|Withdrawal by Subject|12|||
155252969|NCT01640808|560357466|FG001|Overall Study|Withdrawal by Subject|4|||
155252970|NCT01640808|560357465|FG000|Overall Study|Lost to Follow-up|4|||
155252971|NCT01640808|560357466|FG001|Overall Study|Lost to Follow-up|0|||
155252972|NCT01640808|560357465|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
155252973|NCT01640808|560357466|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
155252974|NCT01640808|560357465|FG000|Overall Study|Administration of anticancer drugs|2|||
155252975|NCT01640808|560357466|FG001|Overall Study|Administration of anticancer drugs|1|||
155252976|NCT01640808|560357465|FG000|Overall Study|Physician Decision|19|||
155252977|NCT01640808|560357466|FG001|Overall Study|Physician Decision|5|||
155252978|NCT01640808|560357465|FG000|Overall Study|Randomized but not treated|4|||
155252979|NCT01640808|560357466|FG001|Overall Study|Randomized but not treated|2|||
155252980|NCT02477111|560357467|FG000|Overall Study|Death|28|||
155252981|NCT02477111|560357467|FG000|Overall Study|Withdrawal by Subject|19|||
155252982|NCT02477111|560357467|FG000|Overall Study|Lost to Follow-up|4|||
155252983|NCT02192502|560357469|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
155252984|NCT02192502|560357470|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
155252985|NCT02192502|560357469|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
155252986|NCT02192502|560357470|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
155252987|NCT02192502|560357469|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
155252988|NCT02192502|560357470|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
155252989|NCT01381692|560357471|FG000|Overall Study|Adverse Event|1|||
155252990|NCT01381692|560357472|FG001|Overall Study|Adverse Event|0|||
155252991|NCT01381692|560357473|FG002|Overall Study|Adverse Event|0|||
155252992|NCT01381692|560357474|FG003|Overall Study|Adverse Event|0|||
155252993|NCT01381692|560357475|FG004|Overall Study|Adverse Event|0|||
155252994|NCT01381692|560357476|FG005|Overall Study|Adverse Event|0|||
155252995|NCT01328574|560357477|FG000|Overall Study|Refused further treatment|1|||
155252996|NCT03206203|560357478|FG000|Treatment|Death|38|||
155252997|NCT03206203|560357479|FG001|Treatment|Death|26|||
155252998|NCT03206203|560357480|FG002|Treatment|Death|0|||
155252999|NCT03206203|560357478|FG000|Treatment|Withdrawal by Subject|1|||
155253000|NCT03206203|560357479|FG001|Treatment|Withdrawal by Subject|0|||
155253001|NCT03206203|560357480|FG002|Treatment|Withdrawal by Subject|0|||
155253002|NCT03206203|560357478|FG000|Treatment|Lost to Follow-up|4|||
155253003|NCT03206203|560357479|FG001|Treatment|Lost to Follow-up|0|||
155253004|NCT03206203|560357480|FG002|Treatment|Lost to Follow-up|0|||
155253005|NCT03206203|560357478|FG000|Treatment|N/A in Follow-Up|8|||
155253006|NCT03206203|560357479|FG001|Treatment|N/A in Follow-Up|1|||
155253007|NCT03206203|560357480|FG002|Treatment|N/A in Follow-Up|0|||
155253008|NCT03206203|560357478|FG000|Treatment|Disease progression|0|||
155253009|NCT03206203|560357479|FG001|Treatment|Disease progression|1|||
155253010|NCT03206203|560357480|FG002|Treatment|Disease progression|0|||
155253011|NCT03206203|560357478|FG000|Treatment|Refused follow-up|0|||
155253012|NCT03206203|560357479|FG001|Treatment|Refused follow-up|1|||
155253013|NCT03206203|560357480|FG002|Treatment|Refused follow-up|0|||
155253014|NCT03206203|560357478|FG000|Treatment|Cross over to Arm 1|0|||
155253015|NCT03206203|560357479|FG001|Treatment|Cross over to Arm 1|19|||
155253016|NCT03206203|560357480|FG002|Treatment|Cross over to Arm 1|0|||
155253017|NCT03206203|560357478|FG000|Optional Cross-Over|Death|0|||
155253018|NCT03206203|560357479|FG001|Optional Cross-Over|Death|0|||
155253019|NCT03206203|560357480|FG002|Optional Cross-Over|Death|14|||
155253020|NCT03206203|560357478|FG000|Optional Cross-Over|Refused follow-up|0|||
155253021|NCT03206203|560357479|FG001|Optional Cross-Over|Refused follow-up|0|||
155253022|NCT03206203|560357480|FG002|Optional Cross-Over|Refused follow-up|2|||
155253023|NCT02308748|560357487|FG000|Period 1|Withdrawal by Subject|0|||
155253024|NCT02308748|560357488|FG001|Period 1|Withdrawal by Subject|0|||
155253025|NCT02308748|560357489|FG002|Period 1|Withdrawal by Subject|1|||
155253026|NCT02308748|560357490|FG003|Period 1|Withdrawal by Subject|0|||
155253027|NCT02308748|560357491|FG004|Period 1|Withdrawal by Subject|0|||
155253028|NCT02308748|560357492|FG005|Period 1|Withdrawal by Subject|0|||
155253029|NCT02308748|560357493|FG006|Period 1|Withdrawal by Subject|0|||
155253030|NCT02308748|560357494|FG007|Period 1|Withdrawal by Subject|0|||
155253031|NCT02308748|560357495|FG008|Period 1|Withdrawal by Subject|0|||
155253032|NCT02308748|560357496|FG009|Period 1|Withdrawal by Subject|0|||
155253033|NCT02308748|560357487|FG000|Period 2|Adverse Event|0|||
155253034|NCT02308748|560357488|FG001|Period 2|Adverse Event|0|||
155253035|NCT02308748|560357489|FG002|Period 2|Adverse Event|0|||
155253036|NCT02308748|560357490|FG003|Period 2|Adverse Event|0|||
155253037|NCT02308748|560357491|FG004|Period 2|Adverse Event|0|||
155253038|NCT02308748|560357492|FG005|Period 2|Adverse Event|0|||
155253039|NCT02308748|560357493|FG006|Period 2|Adverse Event|0|||
155253040|NCT02308748|560357494|FG007|Period 2|Adverse Event|1|||
155253041|NCT02308748|560357495|FG008|Period 2|Adverse Event|0|||
155253042|NCT02308748|560357496|FG009|Period 2|Adverse Event|0|||
155253043|NCT02308748|560357487|FG000|Period 3|Protocol Violation|0|||
155253044|NCT02308748|560357488|FG001|Period 3|Protocol Violation|0|||
155253045|NCT02308748|560357489|FG002|Period 3|Protocol Violation|0|||
155253046|NCT02308748|560357490|FG003|Period 3|Protocol Violation|0|||
155253047|NCT02308748|560357491|FG004|Period 3|Protocol Violation|0|||
155253048|NCT02308748|560357492|FG005|Period 3|Protocol Violation|0|||
155253049|NCT02308748|560357493|FG006|Period 3|Protocol Violation|0|||
155253050|NCT02308748|560357494|FG007|Period 3|Protocol Violation|0|||
155253051|NCT02308748|560357495|FG008|Period 3|Protocol Violation|0|||
155253052|NCT02308748|560357496|FG009|Period 3|Protocol Violation|1|||
155253053|NCT02308748|560357487|FG000|Period 5|Adverse Event|1|||
155253054|NCT02308748|560357488|FG001|Period 5|Adverse Event|0|||
155253055|NCT02308748|560357489|FG002|Period 5|Adverse Event|0|||
155253056|NCT02308748|560357490|FG003|Period 5|Adverse Event|0|||
155253057|NCT02308748|560357491|FG004|Period 5|Adverse Event|0|||
155253058|NCT02308748|560357492|FG005|Period 5|Adverse Event|0|||
155253059|NCT02308748|560357493|FG006|Period 5|Adverse Event|0|||
155253060|NCT02308748|560357494|FG007|Period 5|Adverse Event|0|||
155253061|NCT02308748|560357495|FG008|Period 5|Adverse Event|1|||
155253062|NCT02308748|560357496|FG009|Period 5|Adverse Event|0|||
155253063|NCT01152580|560357497|FG000|Overall Study|Withdrawal by Subject|0|||
155253064|NCT01152580|560357498|FG001|Overall Study|Withdrawal by Subject|1|||
155253065|NCT01994954|560357501|FG000|Overall Study|Death|1|||
155253066|NCT01994954|560357502|FG001|Overall Study|Death|0|||
155253067|NCT01994954|560357501|FG000|Overall Study|Withdrawal by Subject|9|||
155253068|NCT01994954|560357502|FG001|Overall Study|Withdrawal by Subject|14|||
155253069|NCT01994954|560357501|FG000|Overall Study|Physician Decision|2|||
155253070|NCT01994954|560357502|FG001|Overall Study|Physician Decision|2|||
155253071|NCT01994954|560357501|FG000|Overall Study|Lost to Follow-up|8|||
155253072|NCT01994954|560357502|FG001|Overall Study|Lost to Follow-up|10|||
155253073|NCT01994954|560357501|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
155253074|NCT01994954|560357502|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
155253075|NCT00449176|560357503|FG000|Overall Study|Withdrawal by Subject|39|||
155253076|NCT00449176|560357504|FG001|Overall Study|Withdrawal by Subject|43|||
155253077|NCT00449176|560357505|FG002|Overall Study|Withdrawal by Subject|59|||
155253078|NCT00449176|560357503|FG000|Overall Study|Lost to Follow-up|13|||
155253079|NCT00449176|560357504|FG001|Overall Study|Lost to Follow-up|8|||
155253080|NCT00449176|560357505|FG002|Overall Study|Lost to Follow-up|12|||
155253081|NCT00449176|560357503|FG000|Overall Study|Adverse Event|51|||
155253082|NCT00449176|560357504|FG001|Overall Study|Adverse Event|107|||
155253083|NCT00449176|560357505|FG002|Overall Study|Adverse Event|15|||
155253084|NCT00449176|560357503|FG000|Overall Study|Lack of Efficacy|13|||
155253085|NCT00449176|560357504|FG001|Overall Study|Lack of Efficacy|7|||
155253086|NCT00449176|560357505|FG002|Overall Study|Lack of Efficacy|50|||
155253087|NCT00449176|560357503|FG000|Overall Study|Study drug non-compliant|14|||
155253088|NCT00449176|560357504|FG001|Overall Study|Study drug non-compliant|11|||
155253089|NCT00449176|560357505|FG002|Overall Study|Study drug non-compliant|11|||
155253090|NCT00449176|560357503|FG000|Overall Study|all other|22|||
155253091|NCT00449176|560357504|FG001|Overall Study|all other|19|||
155253092|NCT00449176|560357505|FG002|Overall Study|all other|20|||
155253093|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
155253094|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
155253095|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|disease progression|58|||
155253096|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|disease progression|47|||
155253097|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Death|3|||
155253098|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Death|6|||
155253099|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
155253100|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
155253101|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
155253102|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
155253103|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
155253104|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
155253105|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Other|2|||
155253106|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Other|1|||
155253107|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
155253108|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
155253109|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
155253110|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
155253111|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Death|0|||
155253112|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Death|1|||
155253113|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
155253114|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
155253115|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
155253116|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
155253117|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
155253118|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
155253119|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
155253120|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
155253121|NCT01454583|560357508|FG000|1st Year|Lost to Follow-up|1057|||
155253122|NCT01454583|560357509|FG001|1st Year|Lost to Follow-up|318|||
155253123|NCT01454583|560357510|FG002|1st Year|Lost to Follow-up|180|||
155253124|NCT01454583|560357508|FG000|2nd Year|Lost to Follow-up|3965|||
155253125|NCT01454583|560357509|FG001|2nd Year|Lost to Follow-up|1049|||
155253126|NCT01454583|560357510|FG002|2nd Year|Lost to Follow-up|737|||
155253127|NCT01454583|560357508|FG000|3rd Year|Lost to Follow-up|1959|||
155253128|NCT01454583|560357509|FG001|3rd Year|Lost to Follow-up|512|||
155253129|NCT01454583|560357510|FG002|3rd Year|Lost to Follow-up|297|||
155253130|NCT01749982|560357511|FG000|Overall Study|Physician Decision|0|||
155253131|NCT01749982|560357512|FG001|Overall Study|Physician Decision|0|||
155253132|NCT01749982|560357513|FG002|Overall Study|Physician Decision|0|||
155253133|NCT01749982|560357514|FG003|Overall Study|Physician Decision|1|||
155253134|NCT01749982|560357511|FG000|Overall Study|Lost to Follow-up|0|||
155253135|NCT01749982|560357512|FG001|Overall Study|Lost to Follow-up|0|||
155253136|NCT01749982|560357513|FG002|Overall Study|Lost to Follow-up|0|||
155253137|NCT01749982|560357514|FG003|Overall Study|Lost to Follow-up|1|||
155253138|NCT01749982|560357511|FG000|Overall Study|Withdrawal by Subject|0|||
155253139|NCT01749982|560357512|FG001|Overall Study|Withdrawal by Subject|0|||
155253140|NCT01749982|560357513|FG002|Overall Study|Withdrawal by Subject|0|||
155253141|NCT01749982|560357514|FG003|Overall Study|Withdrawal by Subject|1|||
155253142|NCT00113568|560357519|FG000|Overall Study|Adverse Event|97|||
155253143|NCT00113568|560357519|FG000|Overall Study|Death|1|||
155253144|NCT00113568|560357519|FG000|Overall Study|Lack of Efficacy|30|||
155253145|NCT00113568|560357519|FG000|Overall Study|Lost to Follow-up|156|||
155253146|NCT00113568|560357519|FG000|Overall Study|Protocol Violation|32|||
155253147|NCT00113568|560357519|FG000|Overall Study|Withdrawal by Subject|117|||
155253148|NCT00113568|560357519|FG000|Overall Study|Other|112|||
155253149|NCT00377403|560357522|FG000|Overall Study|Unable to contact for telephone intervie|4|||
155253150|NCT00377403|560357523|FG001|Overall Study|Unable to contact for telephone intervie|7|||
155253151|NCT01207102|560357531|FG000|Overall Study|Withdrawal by Subject|5|||
155253152|NCT01207102|560357531|FG000|Overall Study|Adverse Event|2|||
155253153|NCT01207102|560357531|FG000|Overall Study|progression|2|||
155253154|NCT01207102|560357531|FG000|Overall Study|Withdrawal by Treating Physician|1|||
155253155|NCT00736645|560357534|FG000|Overall Study|Adverse Event|0|||
155253156|NCT00736645|560357535|FG001|Overall Study|Adverse Event|2|||
155253157|NCT00736645|560357536|FG002|Overall Study|Adverse Event|0|||
155253158|NCT00736645|560357537|FG003|Overall Study|Adverse Event|0|||
155253159|NCT04403698|560357538|FG000|Overall Study|Adverse Event|1|||
155253160|NCT04403698|560357539|FG001|Overall Study|Adverse Event|1|||
155253161|NCT04403698|560357538|FG000|Overall Study|Lost to Follow-up|1|||
155253162|NCT04403698|560357539|FG001|Overall Study|Lost to Follow-up|0|||
155253163|NCT04403698|560357538|FG000|Overall Study|Protocol Violation|0|||
155253164|NCT04403698|560357539|FG001|Overall Study|Protocol Violation|1|||
155253165|NCT00977665|560357540|FG000|Overall Study|Withdrawal by Subject|1|||
155253166|NCT00977665|560357541|FG001|Overall Study|Withdrawal by Subject|3|||
155253167|NCT00977665|560357540|FG000|Overall Study|Physician Decision|2|||
155253168|NCT00977665|560357541|FG001|Overall Study|Physician Decision|1|||
155253169|NCT00977665|560357540|FG000|Overall Study|Sponsor requested withdrawal|0|||
155253170|NCT00977665|560357541|FG001|Overall Study|Sponsor requested withdrawal|1|||
155253171|NCT00977665|560357540|FG000|Overall Study|Lost to Follow-up|1|||
155253172|NCT00977665|560357541|FG001|Overall Study|Lost to Follow-up|0|||
155253173|NCT00977665|560357540|FG000|Overall Study|Death|3|||
155253174|NCT00977665|560357541|FG001|Overall Study|Death|2|||
155253175|NCT00977665|560357540|FG000|Overall Study|Adverse Event|14|||
155253176|NCT00977665|560357541|FG001|Overall Study|Adverse Event|7|||
155253177|NCT00977665|560357540|FG000|Overall Study|Treatment failure|0|||
155253178|NCT00977665|560357541|FG001|Overall Study|Treatment failure|1|||
155253179|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
155253180|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
155253181|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
155253182|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
155253183|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
155253184|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
155253185|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
155253186|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
155253187|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
155253188|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
155253189|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
155253190|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
155253191|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253192|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253193|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253194|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
155253195|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
155253196|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
155253197|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
155253198|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
155253199|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
155253200|NCT00833638|560357542|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
155253201|NCT00833638|560357543|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
155253202|NCT00833638|560357544|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
155253203|NCT00833638|560357542|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
155253204|NCT00833638|560357543|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
155253205|NCT00833638|560357544|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
155253206|NCT00490646|560357545|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
155253207|NCT00490646|560357546|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
155253208|NCT00490646|560357545|FG000|Overall Study|Never Treated (had an adverse event)|1|||
155253209|NCT00490646|560357546|FG001|Overall Study|Never Treated (had an adverse event)|0|||
155253210|NCT00490646|560357545|FG000|Overall Study|Never Treated (withdrew consent)|0|||
155253211|NCT00490646|560357546|FG001|Overall Study|Never Treated (withdrew consent)|1|||
155253212|NCT02137369|560357547|FG000|Overall Study|Withdrawal by Subject|3|||
155253213|NCT02137369|560357548|FG001|Overall Study|Withdrawal by Subject|2|||
155253214|NCT02137369|560357547|FG000|Overall Study|Adverse Event|2|||
155253215|NCT02137369|560357548|FG001|Overall Study|Adverse Event|0|||
155253216|NCT02137369|560357547|FG000|Overall Study|Lost to Follow-up|1|||
155253217|NCT02137369|560357548|FG001|Overall Study|Lost to Follow-up|0|||
155253218|NCT02137369|560357547|FG000|Overall Study|Moved away|2|||
155253219|NCT02137369|560357548|FG001|Overall Study|Moved away|0|||
155253220|NCT03543254|560357549|FG000|Overall Study|Lost to Follow-up|1|||
155253221|NCT02077166|560357550|FG000|Overall Study|Death|6|||
155253222|NCT02077166|560357551|FG001|Overall Study|Death|7|||
155253223|NCT02077166|560357552|FG002|Overall Study|Death|5|||
155253224|NCT02077166|560357553|FG003|Overall Study|Death|6|||
155253225|NCT02077166|560357554|FG004|Overall Study|Death|4|||
155253226|NCT02077166|560357555|FG005|Overall Study|Death|32|||
155253227|NCT02077166|560357556|FG006|Overall Study|Death|22|||
155253228|NCT02077166|560357550|FG000|Overall Study|Study Closure by Sponsor|3|||
155253229|NCT02077166|560357551|FG001|Overall Study|Study Closure by Sponsor|0|||
155253230|NCT02077166|560357552|FG002|Overall Study|Study Closure by Sponsor|2|||
155253231|NCT02077166|560357553|FG003|Overall Study|Study Closure by Sponsor|2|||
155253232|NCT02077166|560357554|FG004|Overall Study|Study Closure by Sponsor|2|||
155253233|NCT02077166|560357555|FG005|Overall Study|Study Closure by Sponsor|12|||
155253234|NCT02077166|560357556|FG006|Overall Study|Study Closure by Sponsor|4|||
155253235|NCT02077166|560357550|FG000|Overall Study|Lost to Follow-up|0|||
155253236|NCT02077166|560357551|FG001|Overall Study|Lost to Follow-up|0|||
155253237|NCT02077166|560357552|FG002|Overall Study|Lost to Follow-up|0|||
155253238|NCT02077166|560357553|FG003|Overall Study|Lost to Follow-up|0|||
155253239|NCT02077166|560357554|FG004|Overall Study|Lost to Follow-up|0|||
155253240|NCT02077166|560357555|FG005|Overall Study|Lost to Follow-up|1|||
155253241|NCT02077166|560357556|FG006|Overall Study|Lost to Follow-up|0|||
155253242|NCT02077166|560357550|FG000|Overall Study|Withdrawal by Subject|3|||
155253243|NCT02077166|560357551|FG001|Overall Study|Withdrawal by Subject|0|||
155253244|NCT02077166|560357552|FG002|Overall Study|Withdrawal by Subject|1|||
155253245|NCT02077166|560357553|FG003|Overall Study|Withdrawal by Subject|1|||
155253246|NCT02077166|560357554|FG004|Overall Study|Withdrawal by Subject|1|||
155253247|NCT02077166|560357555|FG005|Overall Study|Withdrawal by Subject|3|||
155253248|NCT02077166|560357556|FG006|Overall Study|Withdrawal by Subject|0|||
155253249|NCT02077166|560357550|FG000|Overall Study|Other, Not Specified|0|||
155253250|NCT02077166|560357551|FG001|Overall Study|Other, Not Specified|0|||
155253251|NCT02077166|560357552|FG002|Overall Study|Other, Not Specified|1|||
155253252|NCT02077166|560357553|FG003|Overall Study|Other, Not Specified|0|||
155253253|NCT02077166|560357554|FG004|Overall Study|Other, Not Specified|1|||
155253254|NCT02077166|560357555|FG005|Overall Study|Other, Not Specified|7|||
155253255|NCT02077166|560357556|FG006|Overall Study|Other, Not Specified|8|||
155253256|NCT03519854|560357557|FG000|Overall Study|Technical Error|0|||
155253257|NCT03519854|560357558|FG001|Overall Study|Technical Error|0|||
155253258|NCT03519854|560357559|FG002|Overall Study|Technical Error|1|||
155253259|NCT03519854|560357560|FG003|Overall Study|Technical Error|0|||
155253260|NCT03519854|560357561|FG004|Overall Study|Technical Error|0|||
155253261|NCT03519854|560357562|FG005|Overall Study|Technical Error|0|||
155253262|NCT03519854|560357563|FG006|Overall Study|Technical Error|0|||
155253263|NCT03519854|560357564|FG007|Overall Study|Technical Error|0|||
155253264|NCT03519854|560357565|FG008|Overall Study|Technical Error|0|||
155253265|NCT03519854|560357566|FG009|Overall Study|Technical Error|0|||
155253266|NCT03519854|560357567|FG010|Overall Study|Technical Error|0|||
155253267|NCT03519854|560357568|FG011|Overall Study|Technical Error|0|||
155253268|NCT03519854|560357569|FG012|Overall Study|Technical Error|0|||
155253269|NCT03519854|560357570|FG013|Overall Study|Technical Error|0|||
155253270|NCT03519854|560357571|FG014|Overall Study|Technical Error|0|||
155253271|NCT03519854|560357572|FG015|Overall Study|Technical Error|0|||
155253272|NCT03519854|560357573|FG016|Overall Study|Technical Error|0|||
155253273|NCT03519854|560357574|FG017|Overall Study|Technical Error|0|||
155253274|NCT02899728|560357578|FG000|Overall Study|Withdrawal by Subject|1|||
155253275|NCT02899728|560357579|FG001|Overall Study|Withdrawal by Subject|1|||
155253276|NCT03776136|560357580|FG000|Overall Study|Death|85|||
155253277|NCT03776136|560357580|FG000|Overall Study|Withdrawal by Subject|3|||
155253278|NCT03776136|560357580|FG000|Overall Study|Sponsor Decision|15|||
155253279|NCT03754803|560357581|FG000|Overall Study|Withdrawal by Subject|2|||
155253280|NCT04348604|560357584|FG000|Week 8|Withdrawal by Subject|1|||
155253281|NCT04348604|560357585|FG001|Week 8|Withdrawal by Subject|1|||
155253282|NCT04348604|560357584|FG000|Week 8|Lost to Follow-up|1|||
155253283|NCT04348604|560357585|FG001|Week 8|Lost to Follow-up|2|||
155253284|NCT04348604|560357584|FG000|Week 8|Suspended|0|||
155253285|NCT04348604|560357585|FG001|Week 8|Suspended|1|||
155253286|NCT04348604|560357584|FG000|Week 12|Lost to Follow-up|1|||
155253287|NCT04348604|560357585|FG001|Week 12|Lost to Follow-up|2|||
155253288|NCT04348604|560357584|FG000|Week 12|Withdrawal by Subject|1|||
155253289|NCT04348604|560357585|FG001|Week 12|Withdrawal by Subject|0|||
155253290|NCT04348604|560357584|FG000|Week 24|Lost to Follow-up|2|||
155253291|NCT04348604|560357585|FG001|Week 24|Lost to Follow-up|1|||
155253292|NCT02097108|560357586|FG000|Overall Study|Adverse Event|1|||
155253293|NCT02097108|560357586|FG000|Overall Study|patient was abroad for 6 months|1|||
155253294|NCT00127608|560357589|FG000|Overall Study|VZV DNA negative|1|||
155253295|NCT05245864|560357590|FG000|Overall Study|Withdrawal by Subject|1|||
155253296|NCT05245864|560357591|FG001|Overall Study|Withdrawal by Subject|1|||
155253297|NCT01475136|560357594|FG000|Overall Study|Sponsor Decision|0|||
155253298|NCT01475136|560357595|FG001|Overall Study|Sponsor Decision|1|||
155253299|NCT01475136|560357596|FG002|Overall Study|Sponsor Decision|0|||
155253300|NCT01475136|560357597|FG003|Overall Study|Sponsor Decision|0|||
155253301|NCT01475136|560357594|FG000|Overall Study|Entry Criteria Not Met|0|||
155253302|NCT01475136|560357595|FG001|Overall Study|Entry Criteria Not Met|2|||
155253303|NCT01475136|560357596|FG002|Overall Study|Entry Criteria Not Met|3|||
155253304|NCT01475136|560357597|FG003|Overall Study|Entry Criteria Not Met|1|||
155253305|NCT01475136|560357594|FG000|Overall Study|Withdrawal by Subject|0|||
155253306|NCT01475136|560357595|FG001|Overall Study|Withdrawal by Subject|0|||
155253307|NCT01475136|560357596|FG002|Overall Study|Withdrawal by Subject|0|||
155253308|NCT01475136|560357597|FG003|Overall Study|Withdrawal by Subject|2|||
155253309|NCT01475136|560357594|FG000|Overall Study|Adverse Event|1|||
155253310|NCT01475136|560357595|FG001|Overall Study|Adverse Event|0|||
155253311|NCT01475136|560357596|FG002|Overall Study|Adverse Event|0|||
155253312|NCT01475136|560357597|FG003|Overall Study|Adverse Event|1|||
155253313|NCT01475136|560357594|FG000|Overall Study|Death|0|||
155253314|NCT01475136|560357595|FG001|Overall Study|Death|0|||
155253315|NCT01475136|560357596|FG002|Overall Study|Death|0|||
155253316|NCT01475136|560357597|FG003|Overall Study|Death|1|||
155253317|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
155253318|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253319|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253320|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253321|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253322|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
155253323|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253324|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253325|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253326|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253327|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253328|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
155253329|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253330|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253331|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253332|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253333|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253334|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253335|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253336|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253337|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253338|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253339|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253340|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253341|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253342|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253343|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253344|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
155253345|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253346|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253347|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253348|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253349|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253350|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253351|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
155253352|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253353|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253354|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253355|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253356|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253357|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253358|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
155253359|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253360|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253361|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253362|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253363|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253364|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253365|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
155253366|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253367|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253368|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253369|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253370|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253371|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253372|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
155253373|NCT01194570|560359624|FG000|Overall Study|Adverse Event|22|||
155253374|NCT01194570|560359625|FG001|Overall Study|Adverse Event|40|||
155253375|NCT01194570|560359624|FG000|Overall Study|Death|6|||
155253376|NCT01194570|560359625|FG001|Overall Study|Death|20|||
155253377|NCT01194570|560359624|FG000|Overall Study|Lack of Efficacy|32|||
155253378|NCT01194570|560359625|FG001|Overall Study|Lack of Efficacy|33|||
155253379|NCT01194570|560359624|FG000|Overall Study|Lost to Follow-up|4|||
155253380|NCT01194570|560359625|FG001|Overall Study|Lost to Follow-up|15|||
155253381|NCT01194570|560359624|FG000|Overall Study|Non-Compliance|2|||
155253382|NCT01194570|560359625|FG001|Overall Study|Non-Compliance|2|||
155253383|NCT01194570|560359624|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155253384|NCT01194570|560359625|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155253385|NCT01194570|560359624|FG000|Overall Study|Other|18|||
155253386|NCT01194570|560359625|FG001|Overall Study|Other|47|||
155253387|NCT01194570|560359624|FG000|Overall Study|Physician Decision|10|||
155253388|NCT01194570|560359625|FG001|Overall Study|Physician Decision|25|||
155253389|NCT01194570|560359624|FG000|Overall Study|Protocol Violation|1|||
155253390|NCT01194570|560359625|FG001|Overall Study|Protocol Violation|2|||
155253391|NCT01194570|560359624|FG000|Overall Study|Study Terminated By Sponsor|0|||
155253392|NCT01194570|560359625|FG001|Overall Study|Study Terminated By Sponsor|1|||
155253393|NCT01194570|560359624|FG000|Overall Study|Withdrawal by Subject|57|||
155253394|NCT01194570|560359625|FG001|Overall Study|Withdrawal by Subject|82|||
155253395|NCT01194570|560359624|FG000|Overall Study|Pregnancy|1|||
155253396|NCT01194570|560359625|FG001|Overall Study|Pregnancy|1|||
155253397|NCT04918784|560359629|FG000|Overall Study|Amputation - no longer eligible|1|||
155253398|NCT04918784|560359630|FG001|Overall Study|Amputation - no longer eligible|2|||
155253399|NCT04918784|560359629|FG000|Overall Study|Death|1|||
155253400|NCT04918784|560359630|FG001|Overall Study|Death|0|||
155253401|NCT04918784|560359629|FG000|Overall Study|patient non-compliance|3|||
155253402|NCT04918784|560359630|FG001|Overall Study|patient non-compliance|1|||
155253403|NCT04918784|560359629|FG000|Overall Study|Adverse Event|1|||
155253404|NCT04918784|560359630|FG001|Overall Study|Adverse Event|0|||
155253405|NCT01712009|560359631|FG000|Overall Study|Withdrawal by Subject|24|||
155253406|NCT01712009|560359632|FG001|Overall Study|Withdrawal by Subject|15|||
155253407|NCT01712009|560359633|FG002|Overall Study|Withdrawal by Subject|8|||
155253408|NCT01712009|560359631|FG000|Overall Study|Lost to Follow-up|2|||
155253409|NCT01712009|560359632|FG001|Overall Study|Lost to Follow-up|0|||
155253410|NCT01712009|560359633|FG002|Overall Study|Lost to Follow-up|1|||
155253411|NCT01712009|560359631|FG000|Overall Study|Decision by Sponsor|12|||
155253412|NCT01712009|560359632|FG001|Overall Study|Decision by Sponsor|14|||
155253413|NCT01712009|560359633|FG002|Overall Study|Decision by Sponsor|12|||
155253414|NCT01111123|560359634|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
155253415|NCT01111123|560359635|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
155253416|NCT01111123|560359634|FG000|Maintenance Phase|Lost to Follow-up|0|||
155253417|NCT01111123|560359635|FG001|Maintenance Phase|Lost to Follow-up|2|||
155253418|NCT01203930|560359641|FG000|Overall Study|Disease Progression|0|||
155253419|NCT01203930|560359642|FG001|Overall Study|Disease Progression|4|||
155253420|NCT01203930|560359641|FG000|Overall Study|Death|3|||
155253421|NCT01203930|560359642|FG001|Overall Study|Death|1|||
155253422|NCT01203930|560359641|FG000|Overall Study|Withdrew Consent|1|||
155253423|NCT01203930|560359642|FG001|Overall Study|Withdrew Consent|10|||
155253424|NCT01203930|560359641|FG000|Overall Study|Investigator Request|0|||
155253425|NCT01203930|560359642|FG001|Overall Study|Investigator Request|8|||
155253426|NCT01203930|560359641|FG000|Overall Study|Study Terminated by Sponsor|0|||
155253427|NCT01203930|560359642|FG001|Overall Study|Study Terminated by Sponsor|12|||
155253428|NCT01203930|560359641|FG000|Overall Study|Poor tolerance of study drug|0|||
155253429|NCT01203930|560359642|FG001|Overall Study|Poor tolerance of study drug|1|||
155253430|NCT01203930|560359641|FG000|Overall Study|Adverse Event|17|||
155253431|NCT01203930|560359642|FG001|Overall Study|Adverse Event|5|||
155253432|NCT04050865|560359645|FG000|Overall Study|Adverse Event|1|||
155253433|NCT04050865|560359646|FG001|Overall Study|Adverse Event|0|||
155253434|NCT04050865|560359645|FG000|Overall Study|no insert|1|||
155253435|NCT04050865|560359646|FG001|Overall Study|no insert|0|||
155253436|NCT04050865|560359645|FG000|Overall Study|Only 1 insert|2|||
155253437|NCT04050865|560359646|FG001|Overall Study|Only 1 insert|3|||
155253438|NCT04050865|560359645|FG000|Overall Study|Physician Decision|0|||
155253439|NCT04050865|560359646|FG001|Overall Study|Physician Decision|1|||
155253440|NCT04050865|560359645|FG000|Overall Study|Withdrawal by Subject|0|||
155253441|NCT04050865|560359646|FG001|Overall Study|Withdrawal by Subject|1|||
155253442|NCT01266850|560359647|FG000|Overall Study|Lost to Follow-up|19|||
155253443|NCT01266850|560359648|FG001|Overall Study|Lost to Follow-up|19|||
155253444|NCT01266850|560359649|FG002|Overall Study|Lost to Follow-up|13|||
155253445|NCT01266850|560359650|FG003|Overall Study|Lost to Follow-up|13|||
155253446|NCT01266850|560359651|FG004|Overall Study|Lost to Follow-up|12|||
155253447|NCT01266850|560359647|FG000|Overall Study|Withdrawal by Subject|8|||
155253448|NCT01266850|560359648|FG001|Overall Study|Withdrawal by Subject|9|||
155253449|NCT01266850|560359649|FG002|Overall Study|Withdrawal by Subject|6|||
155253450|NCT01266850|560359650|FG003|Overall Study|Withdrawal by Subject|9|||
155253451|NCT01266850|560359651|FG004|Overall Study|Withdrawal by Subject|12|||
155253452|NCT01266850|560359647|FG000|Overall Study|Physician Decision|3|||
155253453|NCT01266850|560359648|FG001|Overall Study|Physician Decision|6|||
155253454|NCT01266850|560359649|FG002|Overall Study|Physician Decision|4|||
155253455|NCT01266850|560359650|FG003|Overall Study|Physician Decision|4|||
155253456|NCT01266850|560359651|FG004|Overall Study|Physician Decision|3|||
155253457|NCT01266850|560359647|FG000|Overall Study|Protocol Violation|0|||
155253458|NCT01266850|560359648|FG001|Overall Study|Protocol Violation|1|||
155253459|NCT01266850|560359649|FG002|Overall Study|Protocol Violation|0|||
155253460|NCT01266850|560359650|FG003|Overall Study|Protocol Violation|1|||
155253461|NCT01266850|560359651|FG004|Overall Study|Protocol Violation|2|||
155253462|NCT01266850|560359647|FG000|Overall Study|Adverse Event|0|||
155253463|NCT01266850|560359648|FG001|Overall Study|Adverse Event|0|||
155253464|NCT01266850|560359649|FG002|Overall Study|Adverse Event|0|||
155253465|NCT01266850|560359650|FG003|Overall Study|Adverse Event|0|||
155253466|NCT01266850|560359651|FG004|Overall Study|Adverse Event|1|||
155253467|NCT01266850|560359647|FG000|Overall Study|Site Closure|0|||
155253468|NCT01266850|560359648|FG001|Overall Study|Site Closure|1|||
155253469|NCT01266850|560359649|FG002|Overall Study|Site Closure|1|||
155253470|NCT01266850|560359650|FG003|Overall Study|Site Closure|1|||
155253471|NCT01266850|560359651|FG004|Overall Study|Site Closure|0|||
155253472|NCT02035332|560359653|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
155253473|NCT00857207|560359654|FG000|Overall Study|Withdrawal by Subject|13|||
155253474|NCT00857207|560359655|FG001|Overall Study|Withdrawal by Subject|0|||
155253475|NCT00857207|560359654|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
155253476|NCT00857207|560359655|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
155253477|NCT00857207|560359654|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
155253478|NCT00857207|560359655|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
155253479|NCT01791725|560359666|FG000|Overall Study|Withdrawal by Subject|0|||
155253480|NCT01791725|560359667|FG001|Overall Study|Withdrawal by Subject|1|||
155253481|NCT01791725|560359668|FG002|Overall Study|Withdrawal by Subject|0|||
155253482|NCT02690974|560359669|FG000|Overall Study|Adverse Event|16|||
155253483|NCT02690974|560359669|FG000|Overall Study|Death|9|||
155253484|NCT02690974|560359669|FG000|Overall Study|Subject/guardian decision|4|||
155253485|NCT02690974|560359669|FG000|Overall Study|Lost to Follow-up|3|||
155253486|NCT02690974|560359669|FG000|Overall Study|Withdrawal of Informed Consent|3|||
155253487|NCT02690974|560359669|FG000|Overall Study|Physician Decision|2|||
155253488|NCT02690974|560359669|FG000|Overall Study|Non-compliance with study treatment|1|||
155253489|NCT02690974|560359669|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155253490|NCT02690974|560359669|FG000|Overall Study|Protocol Deviation|1|||
155253491|NCT01644734|560359675|FG000|Overall Study|Adverse Event|4|||
155253492|NCT01644734|560359675|FG000|Overall Study|Lost to Follow-up|17|||
155253493|NCT01644734|560359675|FG000|Overall Study|Reasons other than stated above|7|||
155253494|NCT01644734|560359675|FG000|Overall Study|Missing documentation|238|||
155253495|NCT02157779|560359680|FG000|Overall Study|Logistical|9|||
155253496|NCT02157779|560359681|FG001|Overall Study|Logistical|3|||
155253497|NCT02157779|560359680|FG000|Overall Study|Stopped attending, reason unknown|11|||
155253498|NCT02157779|560359681|FG001|Overall Study|Stopped attending, reason unknown|7|||
155253499|NCT02157779|560359680|FG000|Overall Study|No response to outreach after Baseline|1|||
155253500|NCT02157779|560359681|FG001|Overall Study|No response to outreach after Baseline|1|||
155253501|NCT02157779|560359680|FG000|Overall Study|Moved|1|||
155253502|NCT02157779|560359681|FG001|Overall Study|Moved|0|||
155253503|NCT02157779|560359680|FG000|Overall Study|Medical|1|||
155253504|NCT02157779|560359681|FG001|Overall Study|Medical|0|||
155253505|NCT02157779|560359680|FG000|Overall Study|Legal issue|1|||
155253506|NCT02157779|560359681|FG001|Overall Study|Legal issue|0|||
155253507|NCT00487162|560359683|FG000|Overall Study|Adverse Event|0|||
155253508|NCT00487162|560359684|FG001|Overall Study|Adverse Event|1|||
155253509|NCT00487162|560359683|FG000|Overall Study|Physician Decision|0|||
155253510|NCT00487162|560359684|FG001|Overall Study|Physician Decision|1|||
155253511|NCT00487162|560359683|FG000|Overall Study|Withdrawal by Subject|2|||
155253512|NCT00487162|560359684|FG001|Overall Study|Withdrawal by Subject|3|||
155253513|NCT01292876|560359685|FG000|Overall Study|Physician Decision|4|||
155253514|NCT01627327|560359686|FG000|Overall Study|Adverse Event|6|||
155253515|NCT01627327|560359687|FG001|Overall Study|Adverse Event|12|||
155253516|NCT01627327|560359686|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
155253517|NCT01627327|560359687|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
155253518|NCT01627327|560359686|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
155253519|NCT01627327|560359687|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
155253520|NCT01627327|560359686|FG000|Overall Study|Protocol Violation|4|||
155253521|NCT01627327|560359687|FG001|Overall Study|Protocol Violation|10|||
155253522|NCT01627327|560359686|FG000|Overall Study|Lost to Follow-up|1|||
155253523|NCT01627327|560359687|FG001|Overall Study|Lost to Follow-up|3|||
155253524|NCT01627327|560359686|FG000|Overall Study|Physician Decision|1|||
155253525|NCT01627327|560359687|FG001|Overall Study|Physician Decision|0|||
155253526|NCT01627327|560359686|FG000|Overall Study|Withdrawal by Subject|3|||
155253527|NCT01627327|560359687|FG001|Overall Study|Withdrawal by Subject|3|||
155253528|NCT02525874|560359693|FG000|Overall Study|Other|1|||
155253529|NCT02525874|560359693|FG000|Overall Study|Investigator Decision|1|||
155253530|NCT02525874|560359693|FG000|Overall Study|Consent withdrawn|22|||
155253531|NCT02525874|560359693|FG000|Overall Study|Non-compliance with study drug|3|||
155253532|NCT02525874|560359693|FG000|Overall Study|Adverse Event|17|||
155253533|NCT02525874|560359693|FG000|Overall Study|Lost to Follow-up|7|||
155253534|NCT02525874|560359693|FG000|Overall Study|Disease progression, defined by protocol|2|||
155253535|NCT02525874|560359693|FG000|Overall Study|Disease relapse|4|||
155253536|NCT02525874|560359693|FG000|Overall Study|Alternative Treatment for MS|2|||
155253537|NCT02525874|560359693|FG000|Overall Study|New lesions in Brain|1|||
155253538|NCT01692782|560359694|FG000|Overall Study|Adverse Event|12|||
155253539|NCT01692782|560359695|FG001|Overall Study|Adverse Event|32|||
155253540|NCT01692782|560359696|FG002|Overall Study|Adverse Event|2|||
155253541|NCT01692782|560359694|FG000|Overall Study|Lack of Efficacy|1|||
155253542|NCT01692782|560359695|FG001|Overall Study|Lack of Efficacy|2|||
155253543|NCT01692782|560359696|FG002|Overall Study|Lack of Efficacy|0|||
155253544|NCT01692782|560359694|FG000|Overall Study|Lost to Follow-up|2|||
155253545|NCT01692782|560359695|FG001|Overall Study|Lost to Follow-up|7|||
155253546|NCT01692782|560359696|FG002|Overall Study|Lost to Follow-up|1|||
155253547|NCT01692782|560359694|FG000|Overall Study|Pregnancy|1|||
155253548|NCT01692782|560359695|FG001|Overall Study|Pregnancy|0|||
155253549|NCT01692782|560359696|FG002|Overall Study|Pregnancy|0|||
155253550|NCT01692782|560359694|FG000|Overall Study|Protocol Violation|1|||
155253551|NCT01692782|560359695|FG001|Overall Study|Protocol Violation|0|||
155253552|NCT01692782|560359696|FG002|Overall Study|Protocol Violation|2|||
155253553|NCT01692782|560359694|FG000|Overall Study|Non-complance with study drug|0|||
155253554|NCT01692782|560359695|FG001|Overall Study|Non-complance with study drug|4|||
155253555|NCT01692782|560359696|FG002|Overall Study|Non-complance with study drug|1|||
155253556|NCT01692782|560359694|FG000|Overall Study|Non-compliant with study visits|0|||
155253557|NCT01692782|560359695|FG001|Overall Study|Non-compliant with study visits|0|||
155253558|NCT01692782|560359696|FG002|Overall Study|Non-compliant with study visits|1|||
155253559|NCT01692782|560359694|FG000|Overall Study|SAE not related to study drug|0|||
155253560|NCT01692782|560359695|FG001|Overall Study|SAE not related to study drug|1|||
155253561|NCT01692782|560359696|FG002|Overall Study|SAE not related to study drug|0|||
155253562|NCT01692782|560359694|FG000|Overall Study|Withdrawal by Subject|3|||
155253563|NCT01692782|560359695|FG001|Overall Study|Withdrawal by Subject|10|||
155253564|NCT01692782|560359696|FG002|Overall Study|Withdrawal by Subject|3|||
155253565|NCT00338884|560359708|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
155253566|NCT00338884|560359708|FG000|Overall Study|Adverse Event|14|||
155253567|NCT00338884|560359708|FG000|Overall Study|Death|8|||
155253568|NCT00338884|560359708|FG000|Overall Study|Other|4|||
155253569|NCT00338884|560359708|FG000|Overall Study|Global Deterioration of Health Status|3|||
155253570|NCT00338884|560359708|FG000|Overall Study|Withdrawal by Subject|3|||
155253571|NCT00338884|560359708|FG000|Overall Study|Lost to Follow-up|1|||
155253572|NCT00338884|560359708|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
155253573|NCT00423176|560359709|FG000|Overall Study|Adverse Event|4|||
155253574|NCT00423176|560359710|FG001|Overall Study|Adverse Event|6|||
155253575|NCT00423176|560359709|FG000|Overall Study|Treatment Failure|1|||
155253576|NCT00423176|560359710|FG001|Overall Study|Treatment Failure|6|||
155253577|NCT00423176|560359709|FG000|Overall Study|Lost to Follow-up|4|||
155253578|NCT00423176|560359710|FG001|Overall Study|Lost to Follow-up|7|||
155253579|NCT00423176|560359709|FG000|Overall Study|Withdrawal by Subject|4|||
155253580|NCT00423176|560359710|FG001|Overall Study|Withdrawal by Subject|3|||
155253581|NCT00423176|560359709|FG000|Overall Study|Protocol Violation|1|||
155253582|NCT00423176|560359710|FG001|Overall Study|Protocol Violation|3|||
155253583|NCT00423176|560359709|FG000|Overall Study|Did not meet protocol eligibility|2|||
155253584|NCT00423176|560359710|FG001|Overall Study|Did not meet protocol eligibility|4|||
155253585|NCT02013622|560359711|FG000|Overall Study|Lost to Follow-up|10|||
155253586|NCT02013622|560359711|FG000|Overall Study|Adverse Event|3|||
155253587|NCT02013622|560359711|FG000|Overall Study|Met Withdrawal Criteria|3|||
155253588|NCT02013622|560359711|FG000|Overall Study|Withdrawal by Subject|6|||
155253589|NCT02013622|560359711|FG000|Overall Study|Protocol Deviation|1|||
155253590|NCT02013622|560359711|FG000|Overall Study|Lack of Efficacy|1|||
155253591|NCT00224874|560359712|FG000|Overall Study|Withdrawal by Subject|0|||
155253592|NCT00224874|560359713|FG001|Overall Study|Withdrawal by Subject|0|||
155253593|NCT00224874|560359714|FG002|Overall Study|Withdrawal by Subject|1|||
155253594|NCT00224874|560359715|FG003|Overall Study|Withdrawal by Subject|0|||
155253595|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
155253596|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
155253597|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
155253598|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
155253599|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
155253600|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
155253601|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
155253602|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
155253603|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
155253604|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
155253605|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
155253606|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
155253607|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
155253608|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
155253609|NCT05554237|560359718|FG000|Part 2 (7 Days)|Adverse Event|0|||
155253610|NCT05554237|560359719|FG001|Part 2 (7 Days)|Adverse Event|0|||
155253611|NCT05554237|560359720|FG002|Part 2 (7 Days)|Adverse Event|0|||
155253612|NCT05554237|560359721|FG003|Part 2 (7 Days)|Adverse Event|0|||
155253613|NCT05554237|560359722|FG004|Part 2 (7 Days)|Adverse Event|2|||
155253614|NCT05554237|560359723|FG005|Part 2 (7 Days)|Adverse Event|0|||
155253615|NCT05554237|560359724|FG006|Part 2 (7 Days)|Adverse Event|0|||
155253616|NCT05554237|560359725|FG007|Part 2 (7 Days)|Adverse Event|0|||
155253617|NCT05554237|560359726|FG008|Part 2 (7 Days)|Adverse Event|0|||
155253618|NCT05554237|560359727|FG009|Part 2 (7 Days)|Adverse Event|1|||
155253619|NCT05554237|560359728|FG010|Part 2 (7 Days)|Adverse Event|0|||
155253620|NCT05554237|560359729|FG011|Part 2 (7 Days)|Adverse Event|0|||
155253621|NCT05554237|560359730|FG012|Part 2 (7 Days)|Adverse Event|1|||
155253622|NCT05554237|560359731|FG013|Part 2 (7 Days)|Adverse Event|0|||
155253623|NCT05130970|560359734|FG000|Overall Study|Adverse Event|1|||
155253624|NCT05130970|560359735|FG001|Overall Study|Adverse Event|1|||
155253625|NCT05130970|560359734|FG000|Overall Study|Death|0|||
155253626|NCT05130970|560359735|FG001|Overall Study|Death|1|||
155253627|NCT05130970|560359734|FG000|Overall Study|Lost to Follow-up|0|||
155253628|NCT05130970|560359735|FG001|Overall Study|Lost to Follow-up|1|||
155253629|NCT05130970|560359734|FG000|Overall Study|Physician Decision|0|||
155253630|NCT05130970|560359735|FG001|Overall Study|Physician Decision|1|||
155253631|NCT05130970|560359734|FG000|Overall Study|Withdrawal by Subject|1|||
155253632|NCT05130970|560359735|FG001|Overall Study|Withdrawal by Subject|1|||
155253633|NCT03896035|560359740|FG000|Overall Study|Lost to Follow-up|2|||
155253634|NCT03896035|560359741|FG001|Overall Study|Lost to Follow-up|6|||
155253635|NCT03896035|560359740|FG000|Overall Study|Withdrawal by Subject|0|||
155253636|NCT03896035|560359741|FG001|Overall Study|Withdrawal by Subject|1|||
155253637|NCT03896035|560359740|FG000|Overall Study|Health/family health issues during COVID|0|||
155253638|NCT03896035|560359741|FG001|Overall Study|Health/family health issues during COVID|4|||
155253639|NCT01556438|560359742|FG000|Overall Study|Adverse Event|4|||
155253640|NCT01556438|560359743|FG001|Overall Study|Adverse Event|2|||
155253641|NCT01556438|560359742|FG000|Overall Study|Sponsor Decision|0|||
155253642|NCT01556438|560359743|FG001|Overall Study|Sponsor Decision|2|||
155253643|NCT01556438|560359742|FG000|Overall Study|Progressive Disease|0|||
155253644|NCT01556438|560359743|FG001|Overall Study|Progressive Disease|6|||
155253645|NCT01556438|560359742|FG000|Overall Study|Death|0|||
155253646|NCT01556438|560359743|FG001|Overall Study|Death|1|||
155253647|NCT01506193|560359746|FG000|Overall Study|Protocol Violation|1|||
155253648|NCT01506193|560359747|FG001|Overall Study|Protocol Violation|0|||
155253649|NCT01506193|560359748|FG002|Overall Study|Protocol Violation|1|||
155253650|NCT01506193|560359746|FG000|Overall Study|Migrated/moved from study area|0|||
155253651|NCT01506193|560359747|FG001|Overall Study|Migrated/moved from study area|0|||
155253652|NCT01506193|560359748|FG002|Overall Study|Migrated/moved from study area|1|||
155253653|NCT01506193|560359746|FG000|Overall Study|Adverse event, non-fatal|0|||
155253654|NCT01506193|560359747|FG001|Overall Study|Adverse event, non-fatal|0|||
155253655|NCT01506193|560359748|FG002|Overall Study|Adverse event, non-fatal|1|||
155253656|NCT01506193|560359746|FG000|Overall Study|Withdrawal by Subject|5|||
155253657|NCT01506193|560359747|FG001|Overall Study|Withdrawal by Subject|1|||
155253658|NCT01506193|560359748|FG002|Overall Study|Withdrawal by Subject|8|||
155253659|NCT01506193|560359746|FG000|Overall Study|Lost to Follow-up|8|||
155253660|NCT01506193|560359747|FG001|Overall Study|Lost to Follow-up|3|||
155253661|NCT01506193|560359748|FG002|Overall Study|Lost to Follow-up|3|||
155253662|NCT01388816|560359752|FG000|Overall Study|Adverse Event|0|||
155253663|NCT01388816|560359753|FG001|Overall Study|Adverse Event|2|||
155253664|NCT01388816|560359754|FG002|Overall Study|Adverse Event|0|||
155253665|NCT01388816|560359755|FG003|Overall Study|Adverse Event|0|||
155253666|NCT01388816|560359752|FG000|Overall Study|Lost to Follow-up|0|||
155253667|NCT01388816|560359753|FG001|Overall Study|Lost to Follow-up|1|||
155253668|NCT01388816|560359754|FG002|Overall Study|Lost to Follow-up|0|||
155253669|NCT01388816|560359755|FG003|Overall Study|Lost to Follow-up|0|||
155253670|NCT01388816|560359752|FG000|Overall Study|Withdrawal by Subject|2|||
155253671|NCT01388816|560359753|FG001|Overall Study|Withdrawal by Subject|1|||
155253672|NCT01388816|560359754|FG002|Overall Study|Withdrawal by Subject|1|||
155253673|NCT01388816|560359755|FG003|Overall Study|Withdrawal by Subject|0|||
155253674|NCT01388816|560359752|FG000|Overall Study|Protocol Violation|0|||
155253675|NCT01388816|560359753|FG001|Overall Study|Protocol Violation|0|||
155253676|NCT01388816|560359754|FG002|Overall Study|Protocol Violation|2|||
155253677|NCT01388816|560359755|FG003|Overall Study|Protocol Violation|0|||
155253678|NCT04575467|560359756|FG000|Overall Study|Adverse Event|0|||
155253679|NCT04575467|560359757|FG001|Overall Study|Adverse Event|1|||
155253680|NCT04575467|560359758|FG002|Overall Study|Adverse Event|0|||
155253681|NCT04575467|560359759|FG003|Overall Study|Adverse Event|0|||
155253682|NCT00743366|560359760|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
155253683|NCT00743366|560359761|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
155253684|NCT00675766|560359762|FG000|Overall Study|Lost to Follow-up|6|||
155253685|NCT00675766|560359763|FG001|Overall Study|Lost to Follow-up|5|||
155253686|NCT00675766|560359764|FG002|Overall Study|Lost to Follow-up|21|||
155253687|NCT00675766|560359765|FG003|Overall Study|Lost to Follow-up|26|||
155253688|NCT01967732|560359766|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253689|NCT01967732|560359767|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
155253690|NCT01967732|560359768|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253691|NCT01967732|560359769|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253692|NCT01967732|560359766|FG000|First Intervention (Day 1)|Poor venous access|0|||
155253693|NCT01967732|560359767|FG001|First Intervention (Day 1)|Poor venous access|1|||
155253694|NCT01967732|560359768|FG002|First Intervention (Day 1)|Poor venous access|0|||
155253695|NCT01967732|560359769|FG003|First Intervention (Day 1)|Poor venous access|0|||
155253696|NCT01569438|560359778|FG000|Overall Study|Lack of Efficacy|1|||
155253697|NCT01569438|560359779|FG001|Overall Study|Lack of Efficacy|2|||
155253698|NCT01569438|560359778|FG000|Overall Study|Withdrawal by Subject|0|||
155253699|NCT01569438|560359779|FG001|Overall Study|Withdrawal by Subject|3|||
155253700|NCT01569438|560359778|FG000|Overall Study|Adverse Event|2|||
155253701|NCT01569438|560359779|FG001|Overall Study|Adverse Event|15|||
155253702|NCT01569438|560359778|FG000|Overall Study|Protocol Violation|2|||
155253703|NCT01569438|560359779|FG001|Overall Study|Protocol Violation|0|||
155253704|NCT01569438|560359778|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
155253705|NCT01569438|560359779|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
155253706|NCT01569438|560359778|FG000|Overall Study|Sponsor/Physician decision|1|||
155253707|NCT01569438|560359779|FG001|Overall Study|Sponsor/Physician decision|1|||
155253708|NCT01569438|560359778|FG000|Overall Study|Unable to adhere to study schedule|0|||
155253709|NCT01569438|560359779|FG001|Overall Study|Unable to adhere to study schedule|1|||
155253710|NCT01330433|560359780|FG000|Overall Study|Death|1|||
155253711|NCT01330433|560359781|FG001|Overall Study|Death|3|||
155253712|NCT01330433|560359780|FG000|Overall Study|Lost to Follow-up|1|||
155253713|NCT01330433|560359781|FG001|Overall Study|Lost to Follow-up|0|||
155253714|NCT02300220|560359784|FG000|Overall Study|Lost to Follow-up|1|||
155253715|NCT02300220|560359785|FG001|Overall Study|Lost to Follow-up|2|||
155253716|NCT02300220|560359784|FG000|Overall Study|Death|1|||
155253717|NCT02300220|560359785|FG001|Overall Study|Death|1|||
155253718|NCT02300220|560359784|FG000|Overall Study|Adverse Event|1|||
155253719|NCT02300220|560359785|FG001|Overall Study|Adverse Event|1|||
155253720|NCT02300220|560359784|FG000|Overall Study|Protocol Violation|1|||
155253721|NCT02300220|560359785|FG001|Overall Study|Protocol Violation|0|||
155253722|NCT02300220|560359784|FG000|Overall Study|Withdrawal by Subject|0|||
155253723|NCT02300220|560359785|FG001|Overall Study|Withdrawal by Subject|2|||
155253724|NCT02300220|560359784|FG000|Overall Study|Did not tolerate IMP|0|||
155253725|NCT02300220|560359785|FG001|Overall Study|Did not tolerate IMP|1|||
155253726|NCT04322682|560359786|FG000|Overall Study|Withdrawal by Subject|33|||
155253727|NCT04322682|560359787|FG001|Overall Study|Withdrawal by Subject|47|||
155253728|NCT04322682|560359786|FG000|Overall Study|Death|5|||
155253729|NCT04322682|560359787|FG001|Overall Study|Death|9|||
155253730|NCT04322682|560359786|FG000|Overall Study|Lost to Follow-up|4|||
155253731|NCT04322682|560359787|FG001|Overall Study|Lost to Follow-up|8|||
155253732|NCT04322682|560359786|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
155253733|NCT04322682|560359787|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
155253734|NCT02238379|560359788|FG000|Overall Study|Lost to Follow-up|1|||
155253735|NCT02238379|560359789|FG001|Overall Study|Lost to Follow-up|0|||
155253736|NCT04123067|560359790|FG000|Overall Study|Lost to Follow-up|0|||
155253737|NCT04123067|560359791|FG001|Overall Study|Lost to Follow-up|1|||
155253738|NCT00441090|560359792|FG000|Overall Study|Adverse Event|0|||
155253739|NCT00441090|560359793|FG001|Overall Study|Adverse Event|1|||
155253740|NCT00441090|560359794|FG002|Overall Study|Adverse Event|1|||
155253741|NCT00441090|560359795|FG003|Overall Study|Adverse Event|0|||
155253742|NCT00441090|560359796|FG004|Overall Study|Adverse Event|0|||
155253743|NCT00441090|560359792|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253744|NCT00441090|560359793|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253745|NCT00441090|560359794|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253746|NCT00441090|560359795|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
155253747|NCT00441090|560359796|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253748|NCT00441090|560359792|FG000|Overall Study|Withdrawal by Subject|1|||
155253749|NCT00441090|560359793|FG001|Overall Study|Withdrawal by Subject|0|||
155253750|NCT00441090|560359794|FG002|Overall Study|Withdrawal by Subject|1|||
155253751|NCT00441090|560359795|FG003|Overall Study|Withdrawal by Subject|0|||
155253752|NCT00441090|560359796|FG004|Overall Study|Withdrawal by Subject|0|||
155253753|NCT00441090|560359792|FG000|Overall Study|Lack of Efficacy|1|||
155253754|NCT00441090|560359793|FG001|Overall Study|Lack of Efficacy|0|||
155253755|NCT00441090|560359794|FG002|Overall Study|Lack of Efficacy|0|||
155253756|NCT00441090|560359795|FG003|Overall Study|Lack of Efficacy|0|||
155253757|NCT00441090|560359796|FG004|Overall Study|Lack of Efficacy|0|||
155253758|NCT01441102|560359797|FG000|Overall Study|Adverse Event|1|||
155253759|NCT01441102|560359797|FG000|Overall Study|Withdrawal by Subject|2|||
155253760|NCT03085485|560359798|FG000|Overall Study|Death|1|||
155253761|NCT03085485|560359799|FG001|Overall Study|Death|0|||
155253762|NCT03085485|560359798|FG000|Overall Study|Lost to Follow-up|1|||
155253763|NCT03085485|560359799|FG001|Overall Study|Lost to Follow-up|0|||
155253764|NCT01022762|560359800|FG000|Overall Study|Adverse Event|3|||
155253765|NCT01022762|560359801|FG001|Overall Study|Adverse Event|1|||
155253766|NCT01022762|560359800|FG000|Overall Study|Lack of Efficacy|0|||
155253767|NCT01022762|560359801|FG001|Overall Study|Lack of Efficacy|1|||
155253768|NCT01022762|560359800|FG000|Overall Study|Protocol Violation|7|||
155253769|NCT01022762|560359801|FG001|Overall Study|Protocol Violation|6|||
155253770|NCT01022762|560359800|FG000|Overall Study|Unclassified|12|||
155253771|NCT01022762|560359801|FG001|Overall Study|Unclassified|20|||
155253772|NCT00605280|560359802|FG000|Year 1|Protocol Violation|0|||
155253773|NCT00605280|560359803|FG001|Year 1|Protocol Violation|0|||
155253774|NCT00605280|560359804|FG002|Year 1|Protocol Violation|0|||
155253775|NCT00605280|560359805|FG003|Year 1|Protocol Violation|1|||
155253776|NCT00605280|560359802|FG000|Year 1|Adverse Event|3|||
155253777|NCT00605280|560359803|FG001|Year 1|Adverse Event|1|||
155253778|NCT00605280|560359804|FG002|Year 1|Adverse Event|1|||
155253779|NCT00605280|560359805|FG003|Year 1|Adverse Event|5|||
155253780|NCT00605280|560359802|FG000|Year 1|Physician Decision|7|||
155253781|NCT00605280|560359803|FG001|Year 1|Physician Decision|4|||
155253782|NCT00605280|560359804|FG002|Year 1|Physician Decision|0|||
155253783|NCT00605280|560359805|FG003|Year 1|Physician Decision|6|||
155253784|NCT00605280|560359802|FG000|Year 1|Withdrawal by Subject|2|||
155253785|NCT00605280|560359803|FG001|Year 1|Withdrawal by Subject|4|||
155253786|NCT00605280|560359804|FG002|Year 1|Withdrawal by Subject|0|||
155253787|NCT00605280|560359805|FG003|Year 1|Withdrawal by Subject|4|||
155253788|NCT00605280|560359802|FG000|Year 1|Other|2|||
155253789|NCT00605280|560359803|FG001|Year 1|Other|1|||
155253790|NCT00605280|560359804|FG002|Year 1|Other|0|||
155253791|NCT00605280|560359805|FG003|Year 1|Other|1|||
155253792|NCT00605280|560359802|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
155253793|NCT00605280|560359803|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
155253794|NCT00605280|560359804|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
155253795|NCT00605280|560359805|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
155253796|NCT00605280|560359802|FG000|Year 2|Adverse Event|4|||
155253797|NCT00605280|560359803|FG001|Year 2|Adverse Event|0|||
155253798|NCT00605280|560359804|FG002|Year 2|Adverse Event|2|||
155253799|NCT00605280|560359805|FG003|Year 2|Adverse Event|4|||
155253800|NCT00605280|560359802|FG000|Year 2|Physician Decision|11|||
155253801|NCT00605280|560359803|FG001|Year 2|Physician Decision|6|||
155253802|NCT00605280|560359804|FG002|Year 2|Physician Decision|4|||
155253803|NCT00605280|560359805|FG003|Year 2|Physician Decision|11|||
155253804|NCT00605280|560359802|FG000|Year 2|Withdrawal by Subject|4|||
155253805|NCT00605280|560359803|FG001|Year 2|Withdrawal by Subject|0|||
155253806|NCT00605280|560359804|FG002|Year 2|Withdrawal by Subject|0|||
155253807|NCT00605280|560359805|FG003|Year 2|Withdrawal by Subject|4|||
155253808|NCT00605280|560359802|FG000|Year 2|Other|1|||
155253809|NCT00605280|560359803|FG001|Year 2|Other|0|||
155253810|NCT00605280|560359804|FG002|Year 2|Other|0|||
155253811|NCT00605280|560359805|FG003|Year 2|Other|1|||
155253812|NCT00605280|560359802|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
155253813|NCT00605280|560359803|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
155253814|NCT00605280|560359804|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
155253815|NCT00605280|560359805|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
155253816|NCT00605280|560359802|FG000|Year 3 Extension|Adverse Event|2|||
155253817|NCT00605280|560359803|FG001|Year 3 Extension|Adverse Event|0|||
155253818|NCT00605280|560359804|FG002|Year 3 Extension|Adverse Event|0|||
155253819|NCT00605280|560359805|FG003|Year 3 Extension|Adverse Event|2|||
155253820|NCT00605280|560359802|FG000|Year 3 Extension|Physician Decision|0|||
155253821|NCT00605280|560359803|FG001|Year 3 Extension|Physician Decision|0|||
155253822|NCT00605280|560359804|FG002|Year 3 Extension|Physician Decision|0|||
155253823|NCT00605280|560359805|FG003|Year 3 Extension|Physician Decision|2|||
155253824|NCT00605280|560359802|FG000|Year 3 Extension|Withdrawal by Subject|2|||
155253825|NCT00605280|560359803|FG001|Year 3 Extension|Withdrawal by Subject|0|||
155253826|NCT00605280|560359804|FG002|Year 3 Extension|Withdrawal by Subject|0|||
155253827|NCT00605280|560359805|FG003|Year 3 Extension|Withdrawal by Subject|5|||
155253828|NCT00605280|560359802|FG000|Year 3 Extension|Other|2|||
155253829|NCT00605280|560359803|FG001|Year 3 Extension|Other|0|||
155253830|NCT00605280|560359804|FG002|Year 3 Extension|Other|0|||
155253831|NCT00605280|560359805|FG003|Year 3 Extension|Other|0|||
155253832|NCT00605280|560359802|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
155253833|NCT00605280|560359803|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253834|NCT00605280|560359804|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253835|NCT00605280|560359805|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253836|NCT01302119|560359806|FG000|Overall Study|Withdrawal by Subject|30|||
155253837|NCT01302119|560359807|FG001|Overall Study|Withdrawal by Subject|20|||
155253838|NCT01302119|560359806|FG000|Overall Study|Lost to Follow-up|10|||
155253839|NCT01302119|560359807|FG001|Overall Study|Lost to Follow-up|4|||
155253840|NCT01302119|560359806|FG000|Overall Study|Adverse Event|2|||
155253841|NCT01302119|560359807|FG001|Overall Study|Adverse Event|1|||
155253842|NCT01302119|560359806|FG000|Overall Study|Non-compliance|4|||
155253843|NCT01302119|560359807|FG001|Overall Study|Non-compliance|2|||
155253844|NCT01302119|560359806|FG000|Overall Study|Non-specific|4|||
155253845|NCT01302119|560359807|FG001|Overall Study|Non-specific|1|||
155253846|NCT01775904|560359811|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
155253847|NCT01775904|560359811|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
155253848|NCT00518115|560359812|FG000|Overall Study|Adverse Event|6|||
155253849|NCT00518115|560359813|FG001|Overall Study|Adverse Event|1|||
155253850|NCT00518115|560359814|FG002|Overall Study|Adverse Event|5|||
155253851|NCT00518115|560359815|FG003|Overall Study|Adverse Event|6|||
155253852|NCT00518115|560359816|FG004|Overall Study|Adverse Event|5|||
155253853|NCT00518115|560359817|FG005|Overall Study|Adverse Event|5|||
155253854|NCT00518115|560359818|FG006|Overall Study|Adverse Event|5|||
155253855|NCT00518115|560359819|FG007|Overall Study|Adverse Event|10|||
155253856|NCT00518115|560359820|FG008|Overall Study|Adverse Event|2|||
155253857|NCT00518115|560359821|FG009|Overall Study|Adverse Event|9|||
155253858|NCT00518115|560359812|FG000|Overall Study|Lost to Follow-up|0|||
155253859|NCT00518115|560359813|FG001|Overall Study|Lost to Follow-up|0|||
155253860|NCT00518115|560359814|FG002|Overall Study|Lost to Follow-up|2|||
155253861|NCT00518115|560359815|FG003|Overall Study|Lost to Follow-up|3|||
155253862|NCT00518115|560359816|FG004|Overall Study|Lost to Follow-up|1|||
155253863|NCT00518115|560359817|FG005|Overall Study|Lost to Follow-up|3|||
155253864|NCT00518115|560359818|FG006|Overall Study|Lost to Follow-up|0|||
155253865|NCT00518115|560359819|FG007|Overall Study|Lost to Follow-up|1|||
155253866|NCT00518115|560359820|FG008|Overall Study|Lost to Follow-up|1|||
155253867|NCT00518115|560359821|FG009|Overall Study|Lost to Follow-up|1|||
155253868|NCT00518115|560359812|FG000|Overall Study|Protocol Violation|1|||
155253869|NCT00518115|560359813|FG001|Overall Study|Protocol Violation|3|||
155253870|NCT00518115|560359814|FG002|Overall Study|Protocol Violation|1|||
155253871|NCT00518115|560359815|FG003|Overall Study|Protocol Violation|0|||
155253872|NCT00518115|560359816|FG004|Overall Study|Protocol Violation|0|||
155253873|NCT00518115|560359817|FG005|Overall Study|Protocol Violation|0|||
155253874|NCT00518115|560359818|FG006|Overall Study|Protocol Violation|0|||
155253875|NCT00518115|560359819|FG007|Overall Study|Protocol Violation|0|||
155253876|NCT00518115|560359820|FG008|Overall Study|Protocol Violation|0|||
155253877|NCT00518115|560359821|FG009|Overall Study|Protocol Violation|0|||
155253878|NCT00518115|560359812|FG000|Overall Study|Withdrawal by Subject|1|||
155253879|NCT00518115|560359813|FG001|Overall Study|Withdrawal by Subject|1|||
155253880|NCT00518115|560359814|FG002|Overall Study|Withdrawal by Subject|5|||
155253881|NCT00518115|560359815|FG003|Overall Study|Withdrawal by Subject|0|||
155253882|NCT00518115|560359816|FG004|Overall Study|Withdrawal by Subject|2|||
155253883|NCT00518115|560359817|FG005|Overall Study|Withdrawal by Subject|1|||
155253884|NCT00518115|560359818|FG006|Overall Study|Withdrawal by Subject|0|||
155253885|NCT00518115|560359819|FG007|Overall Study|Withdrawal by Subject|2|||
155253886|NCT00518115|560359820|FG008|Overall Study|Withdrawal by Subject|1|||
155253887|NCT00518115|560359821|FG009|Overall Study|Withdrawal by Subject|3|||
155253888|NCT00518115|560359812|FG000|Overall Study|Lack of Efficacy|1|||
155253889|NCT00518115|560359813|FG001|Overall Study|Lack of Efficacy|0|||
155253890|NCT00518115|560359814|FG002|Overall Study|Lack of Efficacy|1|||
155253891|NCT00518115|560359815|FG003|Overall Study|Lack of Efficacy|1|||
155253892|NCT00518115|560359816|FG004|Overall Study|Lack of Efficacy|0|||
155253893|NCT00518115|560359817|FG005|Overall Study|Lack of Efficacy|0|||
155253894|NCT00518115|560359818|FG006|Overall Study|Lack of Efficacy|0|||
155253895|NCT00518115|560359819|FG007|Overall Study|Lack of Efficacy|1|||
155253896|NCT00518115|560359820|FG008|Overall Study|Lack of Efficacy|0|||
155253897|NCT00518115|560359821|FG009|Overall Study|Lack of Efficacy|0|||
155253898|NCT00518115|560359812|FG000|Overall Study|Non-Compliance|1|||
155253899|NCT00518115|560359813|FG001|Overall Study|Non-Compliance|0|||
155253900|NCT00518115|560359814|FG002|Overall Study|Non-Compliance|1|||
155253901|NCT00518115|560359815|FG003|Overall Study|Non-Compliance|0|||
155253902|NCT00518115|560359816|FG004|Overall Study|Non-Compliance|1|||
155253903|NCT00518115|560359817|FG005|Overall Study|Non-Compliance|1|||
155253904|NCT00518115|560359818|FG006|Overall Study|Non-Compliance|1|||
155253905|NCT00518115|560359819|FG007|Overall Study|Non-Compliance|1|||
155253906|NCT00518115|560359820|FG008|Overall Study|Non-Compliance|0|||
155253907|NCT00518115|560359821|FG009|Overall Study|Non-Compliance|1|||
155253908|NCT00518115|560359812|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
155253909|NCT00518115|560359813|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
155253910|NCT00518115|560359814|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253911|NCT00518115|560359815|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253912|NCT00518115|560359816|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253913|NCT00518115|560359817|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
155253914|NCT00518115|560359818|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253915|NCT00518115|560359819|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253916|NCT00518115|560359820|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253917|NCT00518115|560359821|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253918|NCT00518115|560359812|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
155253919|NCT00518115|560359813|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253920|NCT00518115|560359814|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253921|NCT00518115|560359815|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253922|NCT00518115|560359816|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253923|NCT00518115|560359817|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253924|NCT00518115|560359818|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253925|NCT00518115|560359819|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253926|NCT00518115|560359820|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253927|NCT00518115|560359821|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253928|NCT00518115|560359812|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253929|NCT00518115|560359813|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253930|NCT00518115|560359814|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
155253931|NCT00518115|560359815|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253932|NCT00518115|560359816|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253933|NCT00518115|560359817|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253934|NCT00518115|560359818|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253935|NCT00518115|560359819|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253936|NCT00518115|560359820|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
155253937|NCT00518115|560359821|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253938|NCT00518115|560359812|FG000|Overall Study|Wrong Monotherapy Administered|0|||
155253939|NCT00518115|560359813|FG001|Overall Study|Wrong Monotherapy Administered|0|||
155253940|NCT00518115|560359814|FG002|Overall Study|Wrong Monotherapy Administered|1|||
155253941|NCT00518115|560359815|FG003|Overall Study|Wrong Monotherapy Administered|0|||
155253942|NCT00518115|560359816|FG004|Overall Study|Wrong Monotherapy Administered|0|||
155253943|NCT00518115|560359817|FG005|Overall Study|Wrong Monotherapy Administered|0|||
155253944|NCT00518115|560359818|FG006|Overall Study|Wrong Monotherapy Administered|1|||
155253945|NCT00518115|560359819|FG007|Overall Study|Wrong Monotherapy Administered|0|||
155253946|NCT00518115|560359820|FG008|Overall Study|Wrong Monotherapy Administered|0|||
155253947|NCT00518115|560359821|FG009|Overall Study|Wrong Monotherapy Administered|0|||
155253948|NCT00518115|560359812|FG000|Overall Study|Violation of Exclusion Criteria|0|||
155253949|NCT00518115|560359813|FG001|Overall Study|Violation of Exclusion Criteria|0|||
155253950|NCT00518115|560359814|FG002|Overall Study|Violation of Exclusion Criteria|0|||
155253951|NCT00518115|560359815|FG003|Overall Study|Violation of Exclusion Criteria|1|||
155253952|NCT00518115|560359816|FG004|Overall Study|Violation of Exclusion Criteria|0|||
155253953|NCT00518115|560359817|FG005|Overall Study|Violation of Exclusion Criteria|0|||
155253954|NCT00518115|560359818|FG006|Overall Study|Violation of Exclusion Criteria|1|||
155253955|NCT00518115|560359819|FG007|Overall Study|Violation of Exclusion Criteria|0|||
155253956|NCT00518115|560359820|FG008|Overall Study|Violation of Exclusion Criteria|0|||
155253957|NCT00518115|560359821|FG009|Overall Study|Violation of Exclusion Criteria|0|||
155253958|NCT00518115|560359812|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
155253959|NCT00518115|560359813|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
155253960|NCT00518115|560359814|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
155253961|NCT00518115|560359815|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
155253962|NCT00518115|560359816|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
155253963|NCT00518115|560359817|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
155253964|NCT00518115|560359818|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
155253965|NCT00518115|560359819|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
155253966|NCT00518115|560359820|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
155253967|NCT00518115|560359821|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
155253968|NCT00518115|560359812|FG000|Overall Study|Withdrew Consent|0|||
155253969|NCT00518115|560359813|FG001|Overall Study|Withdrew Consent|0|||
155253970|NCT00518115|560359814|FG002|Overall Study|Withdrew Consent|0|||
155253971|NCT00518115|560359815|FG003|Overall Study|Withdrew Consent|0|||
155253972|NCT00518115|560359816|FG004|Overall Study|Withdrew Consent|0|||
155253973|NCT00518115|560359817|FG005|Overall Study|Withdrew Consent|1|||
155253974|NCT00518115|560359818|FG006|Overall Study|Withdrew Consent|0|||
155253975|NCT00518115|560359819|FG007|Overall Study|Withdrew Consent|0|||
155253976|NCT00518115|560359820|FG008|Overall Study|Withdrew Consent|0|||
155253977|NCT00518115|560359821|FG009|Overall Study|Withdrew Consent|0|||
155253978|NCT00518115|560359812|FG000|Overall Study|Moved Out of State|0|||
155253979|NCT00518115|560359813|FG001|Overall Study|Moved Out of State|0|||
155253980|NCT00518115|560359814|FG002|Overall Study|Moved Out of State|0|||
155253981|NCT00518115|560359815|FG003|Overall Study|Moved Out of State|0|||
155253982|NCT00518115|560359816|FG004|Overall Study|Moved Out of State|0|||
155253983|NCT00518115|560359817|FG005|Overall Study|Moved Out of State|0|||
155253984|NCT00518115|560359818|FG006|Overall Study|Moved Out of State|0|||
155253985|NCT00518115|560359819|FG007|Overall Study|Moved Out of State|0|||
155253986|NCT00518115|560359820|FG008|Overall Study|Moved Out of State|0|||
155253987|NCT00518115|560359821|FG009|Overall Study|Moved Out of State|1|||
155253988|NCT04891419|560359822|FG000|Overall Study|Withdrawal by Subject|4|||
155253989|NCT04891419|560359823|FG001|Overall Study|Withdrawal by Subject|0|||
155253990|NCT04891419|560359822|FG000|Overall Study|Lost to Follow-up|1|||
155253991|NCT04891419|560359823|FG001|Overall Study|Lost to Follow-up|3|||
155253992|NCT00680407|560359831|FG000|Overall Study|Lost to Follow-up|3|||
155253993|NCT00680407|560359832|FG001|Overall Study|Lost to Follow-up|3|||
155253994|NCT00680407|560359833|FG002|Overall Study|Lost to Follow-up|1|||
155253995|NCT00680407|560359831|FG000|Overall Study|Withdrawal by Subject|5|||
155253996|NCT00680407|560359832|FG001|Overall Study|Withdrawal by Subject|2|||
155253997|NCT00680407|560359833|FG002|Overall Study|Withdrawal by Subject|2|||
155253998|NCT01377480|560362226|FG000|Overall Study|Protocol Violation|0|||
155253999|NCT01377480|560362227|FG001|Overall Study|Protocol Violation|0|||
155254000|NCT01377480|560362228|FG002|Overall Study|Protocol Violation|0|||
155254001|NCT01377480|560362229|FG003|Overall Study|Protocol Violation|4|||
155254002|NCT01377480|560362226|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
155254003|NCT01377480|560362227|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
155254004|NCT01377480|560362228|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
155254005|NCT01377480|560362229|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
155254006|NCT01377480|560362226|FG000|Overall Study|Withdrawal by Subject|0|||
155254007|NCT01377480|560362227|FG001|Overall Study|Withdrawal by Subject|0|||
155254008|NCT01377480|560362228|FG002|Overall Study|Withdrawal by Subject|1|||
155254009|NCT01377480|560362229|FG003|Overall Study|Withdrawal by Subject|0|||
155254010|NCT01377480|560362226|FG000|Overall Study|Serious adverse event|0|||
155254011|NCT01377480|560362227|FG001|Overall Study|Serious adverse event|0|||
155254012|NCT01377480|560362228|FG002|Overall Study|Serious adverse event|1|||
155254013|NCT01377480|560362229|FG003|Overall Study|Serious adverse event|1|||
155254014|NCT01377480|560362226|FG000|Overall Study|Other|0|||
155254015|NCT01377480|560362227|FG001|Overall Study|Other|0|||
155254016|NCT01377480|560362228|FG002|Overall Study|Other|7|||
155254017|NCT01377480|560362229|FG003|Overall Study|Other|6|||
155254018|NCT04128293|560362236|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254019|NCT04128293|560362237|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254020|NCT04128293|560362238|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254021|NCT04128293|560362239|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254022|NCT03014674|560362245|FG000|Overall Study|Withdrawal by Subject|1|||
155254023|NCT03014674|560362246|FG001|Overall Study|Withdrawal by Subject|0|||
155254024|NCT03014674|560362247|FG002|Overall Study|Withdrawal by Subject|0|||
155254025|NCT00499031|560362251|FG000|Overall Study|Improper pre-protocol treatment|1|||
155254026|NCT00499031|560362251|FG000|Overall Study|Required test not done|1|||
155254027|NCT00499031|560362251|FG000|Overall Study|Never treated|1|||
155254028|NCT00911534|560362252|FG000|Overall Study|Adverse Event|4|||
155254029|NCT00911534|560362253|FG001|Overall Study|Adverse Event|4|||
155254030|NCT00911534|560362252|FG000|Overall Study|Lost to Follow-up|2|||
155254031|NCT00911534|560362253|FG001|Overall Study|Lost to Follow-up|4|||
155254032|NCT00911534|560362252|FG000|Overall Study|Withdrawal by Subject|2|||
155254033|NCT00911534|560362253|FG001|Overall Study|Withdrawal by Subject|1|||
155254034|NCT00911534|560362252|FG000|Overall Study|Lack of Efficacy|4|||
155254035|NCT00911534|560362253|FG001|Overall Study|Lack of Efficacy|1|||
155254036|NCT00911534|560362252|FG000|Overall Study|Withdrawal of consent|1|||
155254037|NCT00911534|560362253|FG001|Overall Study|Withdrawal of consent|4|||
155254038|NCT00911534|560362252|FG000|Overall Study|Other|2|||
155254039|NCT00911534|560362253|FG001|Overall Study|Other|2|||
155254040|NCT02677116|560362265|FG000|Overall Study|Adverse Event|0|||
155254041|NCT02677116|560362266|FG001|Overall Study|Adverse Event|1|||
155254042|NCT02677116|560362267|FG002|Overall Study|Adverse Event|0|||
155254043|NCT02677116|560362268|FG003|Overall Study|Adverse Event|0|||
155254044|NCT02677116|560362269|FG004|Overall Study|Adverse Event|0|||
155254045|NCT02677116|560362270|FG005|Overall Study|Adverse Event|1|||
155254046|NCT02677116|560362271|FG006|Overall Study|Adverse Event|1|||
155254047|NCT02677116|560362272|FG007|Overall Study|Adverse Event|0|||
155254048|NCT02677116|560362273|FG008|Overall Study|Adverse Event|0|||
155254049|NCT02677116|560362265|FG000|Overall Study|Physician Decision|0|||
155254050|NCT02677116|560362266|FG001|Overall Study|Physician Decision|2|||
155254051|NCT02677116|560362267|FG002|Overall Study|Physician Decision|3|||
155254052|NCT02677116|560362268|FG003|Overall Study|Physician Decision|2|||
155254053|NCT02677116|560362269|FG004|Overall Study|Physician Decision|1|||
155254054|NCT02677116|560362270|FG005|Overall Study|Physician Decision|3|||
155254055|NCT02677116|560362271|FG006|Overall Study|Physician Decision|1|||
155254056|NCT02677116|560362272|FG007|Overall Study|Physician Decision|1|||
155254057|NCT02677116|560362273|FG008|Overall Study|Physician Decision|2|||
155254058|NCT02677116|560362265|FG000|Overall Study|Withdrawal by parent or guardian|2|||
155254059|NCT02677116|560362266|FG001|Overall Study|Withdrawal by parent or guardian|1|||
155254060|NCT02677116|560362267|FG002|Overall Study|Withdrawal by parent or guardian|0|||
155254061|NCT02677116|560362268|FG003|Overall Study|Withdrawal by parent or guardian|1|||
155254062|NCT02677116|560362269|FG004|Overall Study|Withdrawal by parent or guardian|0|||
155254063|NCT02677116|560362270|FG005|Overall Study|Withdrawal by parent or guardian|0|||
155254064|NCT02677116|560362271|FG006|Overall Study|Withdrawal by parent or guardian|2|||
155254065|NCT02677116|560362272|FG007|Overall Study|Withdrawal by parent or guardian|1|||
155254066|NCT02677116|560362273|FG008|Overall Study|Withdrawal by parent or guardian|0|||
155254067|NCT02677116|560362265|FG000|Overall Study|Withdrawal by Subject|1|||
155254068|NCT02677116|560362266|FG001|Overall Study|Withdrawal by Subject|0|||
155254069|NCT02677116|560362267|FG002|Overall Study|Withdrawal by Subject|0|||
155254070|NCT02677116|560362268|FG003|Overall Study|Withdrawal by Subject|0|||
155254071|NCT02677116|560362269|FG004|Overall Study|Withdrawal by Subject|0|||
155254072|NCT02677116|560362270|FG005|Overall Study|Withdrawal by Subject|0|||
155254073|NCT02677116|560362271|FG006|Overall Study|Withdrawal by Subject|0|||
155254074|NCT02677116|560362272|FG007|Overall Study|Withdrawal by Subject|0|||
155254075|NCT02677116|560362273|FG008|Overall Study|Withdrawal by Subject|0|||
155254076|NCT03342638|560362274|FG000|Overall Study|Withdrawal by Subject|1|||
155254077|NCT03342638|560362275|FG001|Overall Study|Withdrawal by Subject|0|||
155254078|NCT03342638|560362274|FG000|Overall Study|Physician Decision|0|||
155254079|NCT03342638|560362275|FG001|Overall Study|Physician Decision|1|||
155254080|NCT01292239|560362280|FG000|Overall Study|Other|1|||
155254081|NCT01292239|560362281|FG001|Overall Study|Other|1|||
155254082|NCT01292239|560362280|FG000|Overall Study|Withdrawal by Subject|3|||
155254083|NCT01292239|560362281|FG001|Overall Study|Withdrawal by Subject|6|||
155254084|NCT03213158|560362282|FG000|Overall Study|Withdrawal by Subject|1|||
155254085|NCT03213158|560362282|FG000|Overall Study|Physician Decision|2|||
155254086|NCT03649230|560362283|FG000|Overall Study|Adverse Event|12|||
155254087|NCT03649230|560362283|FG000|Overall Study|Death|8|||
155254088|NCT03649230|560362283|FG000|Overall Study|Withdrawal by Subject|6|||
155254089|NCT03649230|560362283|FG000|Overall Study|Physician Decision|5|||
155254090|NCT03649230|560362283|FG000|Overall Study|Disease progression|5|||
155254091|NCT03649230|560362283|FG000|Overall Study|Switched to non-HEC|5|||
155254092|NCT03649230|560362283|FG000|Overall Study|Chemotherapy discontinued|4|||
155254093|NCT03649230|560362283|FG000|Overall Study|Received only 3 HEC cycles|4|||
155254094|NCT03649230|560362283|FG000|Overall Study|Screen Failure|3|||
155254095|NCT03649230|560362283|FG000|Overall Study|Patient stopped treatment|2|||
155254096|NCT03649230|560362283|FG000|Overall Study|Protocol Violation|1|||
155254097|NCT03649230|560362283|FG000|Overall Study|Non-compliance|1|||
155254098|NCT03649230|560362283|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
155254099|NCT01693068|560362287|FG000|Randomization Period|On-study|2|||
155254100|NCT01693068|560362288|FG001|Randomization Period|On-study|5|||
155254101|NCT01693068|560362289|FG002|Randomization Period|On-study|0|||
155254102|NCT01693068|560362287|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
155254103|NCT01693068|560362288|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
155254104|NCT01693068|560362289|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
155254105|NCT00295022|560362292|FG000|Overall Study|Adverse Event|1|||
155254106|NCT00295022|560362293|FG001|Overall Study|Adverse Event|1|||
155254107|NCT00295022|560362294|FG002|Overall Study|Adverse Event|2|||
155254108|NCT00295022|560362292|FG000|Overall Study|Lost to Follow-up|0|||
155254109|NCT00295022|560362293|FG001|Overall Study|Lost to Follow-up|0|||
155254110|NCT00295022|560362294|FG002|Overall Study|Lost to Follow-up|1|||
155254111|NCT00295022|560362292|FG000|Overall Study|Withdrawal by Subject|0|||
155254112|NCT00295022|560362293|FG001|Overall Study|Withdrawal by Subject|0|||
155254113|NCT00295022|560362294|FG002|Overall Study|Withdrawal by Subject|2|||
155254114|NCT00734630|560362296|FG000|Overall Study|Lack of Efficacy|4|||
155254115|NCT00734630|560362297|FG001|Overall Study|Lack of Efficacy|4|||
155254116|NCT00734630|560362296|FG000|Overall Study|Withdrawal by Subject|7|||
155254117|NCT00734630|560362297|FG001|Overall Study|Withdrawal by Subject|9|||
155254118|NCT00734630|560362296|FG000|Overall Study|Lost to Follow-up|13|||
155254119|NCT00734630|560362297|FG001|Overall Study|Lost to Follow-up|7|||
155254120|NCT00734630|560362296|FG000|Overall Study|Protocol Violation|0|||
155254121|NCT00734630|560362297|FG001|Overall Study|Protocol Violation|3|||
155254122|NCT00734630|560362296|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155254123|NCT00734630|560362297|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155254124|NCT00734630|560362296|FG000|Overall Study|Adverse Event|3|||
155254125|NCT00734630|560362297|FG001|Overall Study|Adverse Event|6|||
155254126|NCT00734630|560362296|FG000|Overall Study|Randomized in Error|0|||
155254127|NCT00734630|560362297|FG001|Overall Study|Randomized in Error|1|||
155254128|NCT00734630|560362296|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
155254129|NCT00734630|560362297|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
155254130|NCT00734630|560362296|FG000|Overall Study|Poor Compliance|1|||
155254131|NCT00734630|560362297|FG001|Overall Study|Poor Compliance|1|||
155254132|NCT01239030|560362298|FG000|Double Blind|Adverse Event|0|||
155254133|NCT01239030|560362299|FG001|Double Blind|Adverse Event|1|||
155254134|NCT01239030|560362300|FG002|Double Blind|Adverse Event|0|||
155254135|NCT01239030|560362301|FG003|Double Blind|Adverse Event|2|||
155254136|NCT01239030|560362302|FG004|Double Blind|Adverse Event|0|||
155254137|NCT01239030|560362298|FG000|Double Blind|Withdrawal by Subject|0|||
155254138|NCT01239030|560362299|FG001|Double Blind|Withdrawal by Subject|1|||
155254139|NCT01239030|560362300|FG002|Double Blind|Withdrawal by Subject|1|||
155254140|NCT01239030|560362301|FG003|Double Blind|Withdrawal by Subject|0|||
155254141|NCT01239030|560362302|FG004|Double Blind|Withdrawal by Subject|1|||
155254142|NCT01239030|560362298|FG000|Double Blind|Lost to Follow-up|1|||
155254143|NCT01239030|560362299|FG001|Double Blind|Lost to Follow-up|1|||
155254144|NCT01239030|560362300|FG002|Double Blind|Lost to Follow-up|0|||
155254145|NCT01239030|560362301|FG003|Double Blind|Lost to Follow-up|0|||
155254146|NCT01239030|560362302|FG004|Double Blind|Lost to Follow-up|0|||
155254147|NCT01239030|560362298|FG000|Double Blind|Physician Decision|0|||
155254148|NCT01239030|560362299|FG001|Double Blind|Physician Decision|1|||
155254149|NCT01239030|560362300|FG002|Double Blind|Physician Decision|0|||
155254150|NCT01239030|560362301|FG003|Double Blind|Physician Decision|0|||
155254151|NCT01239030|560362302|FG004|Double Blind|Physician Decision|0|||
155254152|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
155254153|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
155254154|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
155254155|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
155254156|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
155254157|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
155254158|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
155254159|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
155254160|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
155254161|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
155254162|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254163|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254164|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
155254165|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
155254166|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254167|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
155254168|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
155254169|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
155254170|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
155254171|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
155254172|NCT00827918|560362304|FG000|Overall Study|Adverse Event|4|||
155254173|NCT00827918|560362305|FG001|Overall Study|Adverse Event|0|||
155254174|NCT00827918|560362306|FG002|Overall Study|Adverse Event|0|||
155254175|NCT00827918|560362304|FG000|Overall Study|Lack of Efficacy|16|||
155254176|NCT00827918|560362305|FG001|Overall Study|Lack of Efficacy|4|||
155254177|NCT00827918|560362306|FG002|Overall Study|Lack of Efficacy|15|||
155254178|NCT00827918|560362304|FG000|Overall Study|Physician Decision|1|||
155254179|NCT00827918|560362305|FG001|Overall Study|Physician Decision|0|||
155254180|NCT00827918|560362306|FG002|Overall Study|Physician Decision|0|||
155254181|NCT00827918|560362304|FG000|Overall Study|Pregnancy|0|||
155254182|NCT00827918|560362305|FG001|Overall Study|Pregnancy|1|||
155254183|NCT00827918|560362306|FG002|Overall Study|Pregnancy|0|||
155254184|NCT00827918|560362304|FG000|Overall Study|Progressive Disease|1|||
155254185|NCT00827918|560362305|FG001|Overall Study|Progressive Disease|1|||
155254186|NCT00827918|560362306|FG002|Overall Study|Progressive Disease|0|||
155254187|NCT00827918|560362304|FG000|Overall Study|Protocol Violation|0|||
155254188|NCT00827918|560362305|FG001|Overall Study|Protocol Violation|1|||
155254189|NCT00827918|560362306|FG002|Overall Study|Protocol Violation|0|||
155254190|NCT00827918|560362304|FG000|Overall Study|Withdrawal by Subject|6|||
155254191|NCT00827918|560362305|FG001|Overall Study|Withdrawal by Subject|2|||
155254192|NCT00827918|560362306|FG002|Overall Study|Withdrawal by Subject|6|||
155254193|NCT00802074|560362307|FG000|Overall Study|Adverse Event|1|||
155254194|NCT00802074|560362308|FG001|Overall Study|Adverse Event|1|||
155254195|NCT00802074|560362309|FG002|Overall Study|Adverse Event|1|||
155254196|NCT00802074|560362310|FG003|Overall Study|Adverse Event|0|||
155254197|NCT00802074|560362311|FG004|Overall Study|Adverse Event|0|||
155254198|NCT00802074|560362312|FG005|Overall Study|Adverse Event|0|||
155254199|NCT00802074|560362307|FG000|Overall Study|Withdrawal by Subject|1|||
155254200|NCT00802074|560362308|FG001|Overall Study|Withdrawal by Subject|0|||
155254201|NCT00802074|560362309|FG002|Overall Study|Withdrawal by Subject|0|||
155254202|NCT00802074|560362310|FG003|Overall Study|Withdrawal by Subject|0|||
155254203|NCT00802074|560362311|FG004|Overall Study|Withdrawal by Subject|0|||
155254204|NCT00802074|560362312|FG005|Overall Study|Withdrawal by Subject|0|||
155254205|NCT02291614|560362315|FG000|Overall Study|Lost to Follow-up|0|||
155254206|NCT02291614|560362316|FG001|Overall Study|Lost to Follow-up|0|||
155254207|NCT02291614|560362317|FG002|Overall Study|Lost to Follow-up|0|||
155254208|NCT02291614|560362318|FG003|Overall Study|Lost to Follow-up|0|||
155254209|NCT02291614|560362319|FG004|Overall Study|Lost to Follow-up|0|||
155254210|NCT02291614|560362320|FG005|Overall Study|Lost to Follow-up|0|||
155254211|NCT02291614|560362321|FG006|Overall Study|Lost to Follow-up|0|||
155254212|NCT02291614|560362322|FG007|Overall Study|Lost to Follow-up|1|||
155254213|NCT02291614|560362323|FG008|Overall Study|Lost to Follow-up|0|||
155254214|NCT02291614|560362324|FG009|Overall Study|Lost to Follow-up|0|||
155254215|NCT02291614|560362325|FG010|Overall Study|Lost to Follow-up|0|||
155254216|NCT02291614|560362315|FG000|Overall Study|Withdrawal by Subject|0|||
155254217|NCT02291614|560362316|FG001|Overall Study|Withdrawal by Subject|1|||
155254218|NCT02291614|560362317|FG002|Overall Study|Withdrawal by Subject|0|||
155254219|NCT02291614|560362318|FG003|Overall Study|Withdrawal by Subject|0|||
155254220|NCT02291614|560362319|FG004|Overall Study|Withdrawal by Subject|0|||
155254221|NCT02291614|560362320|FG005|Overall Study|Withdrawal by Subject|0|||
155254222|NCT02291614|560362321|FG006|Overall Study|Withdrawal by Subject|0|||
155254223|NCT02291614|560362322|FG007|Overall Study|Withdrawal by Subject|0|||
155254224|NCT02291614|560362323|FG008|Overall Study|Withdrawal by Subject|0|||
155254225|NCT02291614|560362324|FG009|Overall Study|Withdrawal by Subject|2|||
155254226|NCT02291614|560362325|FG010|Overall Study|Withdrawal by Subject|2|||
155254227|NCT02291614|560362315|FG000|Overall Study|Decision by sponsor|0|||
155254228|NCT02291614|560362316|FG001|Overall Study|Decision by sponsor|0|||
155254229|NCT02291614|560362317|FG002|Overall Study|Decision by sponsor|0|||
155254230|NCT02291614|560362318|FG003|Overall Study|Decision by sponsor|1|||
155254231|NCT02291614|560362319|FG004|Overall Study|Decision by sponsor|0|||
155254232|NCT02291614|560362320|FG005|Overall Study|Decision by sponsor|0|||
155254233|NCT02291614|560362321|FG006|Overall Study|Decision by sponsor|0|||
155254234|NCT02291614|560362322|FG007|Overall Study|Decision by sponsor|0|||
155254235|NCT02291614|560362323|FG008|Overall Study|Decision by sponsor|0|||
155254236|NCT02291614|560362324|FG009|Overall Study|Decision by sponsor|0|||
155254237|NCT02291614|560362325|FG010|Overall Study|Decision by sponsor|0|||
155254238|NCT02291614|560362315|FG000|Overall Study|Death|0|||
155254239|NCT02291614|560362316|FG001|Overall Study|Death|0|||
155254240|NCT02291614|560362317|FG002|Overall Study|Death|1|||
155254241|NCT02291614|560362318|FG003|Overall Study|Death|0|||
155254242|NCT02291614|560362319|FG004|Overall Study|Death|1|||
155254243|NCT02291614|560362320|FG005|Overall Study|Death|1|||
155254244|NCT02291614|560362321|FG006|Overall Study|Death|1|||
155254245|NCT02291614|560362322|FG007|Overall Study|Death|0|||
155254246|NCT02291614|560362323|FG008|Overall Study|Death|0|||
155254247|NCT02291614|560362324|FG009|Overall Study|Death|0|||
155254248|NCT02291614|560362325|FG010|Overall Study|Death|0|||
155254249|NCT00127101|560362326|FG000|Base Protocol|Adverse Event|0|||
155254250|NCT00127101|560362327|FG001|Base Protocol|Adverse Event|2|||
155254251|NCT00127101|560362328|FG002|Base Protocol|Adverse Event|1|||
155254252|NCT00127101|560362329|FG003|Base Protocol|Adverse Event|0|||
155254253|NCT00127101|560362330|FG004|Base Protocol|Adverse Event|0|||
155254254|NCT00127101|560362331|FG005|Base Protocol|Adverse Event|0|||
155254255|NCT00127101|560362326|FG000|Base Protocol|Lack of Efficacy|1|||
155254256|NCT00127101|560362327|FG001|Base Protocol|Lack of Efficacy|0|||
155254257|NCT00127101|560362328|FG002|Base Protocol|Lack of Efficacy|0|||
155254258|NCT00127101|560362329|FG003|Base Protocol|Lack of Efficacy|0|||
155254259|NCT00127101|560362330|FG004|Base Protocol|Lack of Efficacy|2|||
155254260|NCT00127101|560362331|FG005|Base Protocol|Lack of Efficacy|0|||
155254261|NCT00127101|560362326|FG000|Base Protocol|Withdrawal by Subject|1|||
155254262|NCT00127101|560362327|FG001|Base Protocol|Withdrawal by Subject|2|||
155254263|NCT00127101|560362328|FG002|Base Protocol|Withdrawal by Subject|1|||
155254264|NCT00127101|560362329|FG003|Base Protocol|Withdrawal by Subject|0|||
155254265|NCT00127101|560362330|FG004|Base Protocol|Withdrawal by Subject|0|||
155254266|NCT00127101|560362331|FG005|Base Protocol|Withdrawal by Subject|1|||
155254267|NCT00127101|560362326|FG000|Continuation Phase|Adverse Event|0|||
155254268|NCT00127101|560362327|FG001|Continuation Phase|Adverse Event|0|||
155254269|NCT00127101|560362328|FG002|Continuation Phase|Adverse Event|0|||
155254270|NCT00127101|560362329|FG003|Continuation Phase|Adverse Event|0|||
155254271|NCT00127101|560362330|FG004|Continuation Phase|Adverse Event|1|||
155254272|NCT00127101|560362331|FG005|Continuation Phase|Adverse Event|1|||
155254273|NCT00127101|560362326|FG000|Continuation Phase|Lack of Efficacy|0|||
155254274|NCT00127101|560362327|FG001|Continuation Phase|Lack of Efficacy|0|||
155254275|NCT00127101|560362328|FG002|Continuation Phase|Lack of Efficacy|0|||
155254276|NCT00127101|560362329|FG003|Continuation Phase|Lack of Efficacy|0|||
155254277|NCT00127101|560362330|FG004|Continuation Phase|Lack of Efficacy|0|||
155254278|NCT00127101|560362331|FG005|Continuation Phase|Lack of Efficacy|1|||
155254279|NCT00127101|560362326|FG000|Continuation Phase|Withdrawal by Subject|0|||
155254280|NCT00127101|560362327|FG001|Continuation Phase|Withdrawal by Subject|0|||
155254281|NCT00127101|560362328|FG002|Continuation Phase|Withdrawal by Subject|1|||
155254282|NCT00127101|560362329|FG003|Continuation Phase|Withdrawal by Subject|0|||
155254283|NCT00127101|560362330|FG004|Continuation Phase|Withdrawal by Subject|2|||
155254284|NCT00127101|560362331|FG005|Continuation Phase|Withdrawal by Subject|1|||
155254285|NCT00843167|560362332|FG000|Treatment Period|Adverse Event|1|||
155254286|NCT00843167|560362333|FG001|Treatment Period|Adverse Event|5|||
155254287|NCT00843167|560362332|FG000|Treatment Period|Withdrawal by Subject|2|||
155254288|NCT00843167|560362333|FG001|Treatment Period|Withdrawal by Subject|3|||
155254289|NCT03743038|560362334|FG000|Overall Study|Physician Decision|1|||
155254290|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
155254291|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
155254292|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
155254293|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
155254294|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
155254295|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
155254296|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254297|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254298|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254299|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254300|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
155254301|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155491692|NCT00762073|561225492|FG001|Overall Study|Significant Subject Noncompliance|1|||
155254302|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254303|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254304|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254305|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
155254306|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
155254307|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
155254308|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
155254309|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
155254310|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
155254311|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254312|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254313|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254314|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254315|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Other|1|||
155254316|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Other|0|||
155254317|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Other|0|||
155254318|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Other|0|||
155254319|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Other|0|||
155254320|NCT01662310|560362336|FG000|Double-Blind Phase|Adverse Event|0|||
155254321|NCT01662310|560362337|FG001|Double-Blind Phase|Adverse Event|0|||
155254322|NCT01662310|560362338|FG002|Double-Blind Phase|Adverse Event|1|||
155254323|NCT01662310|560362339|FG003|Double-Blind Phase|Adverse Event|0|||
155254324|NCT01662310|560362340|FG004|Double-Blind Phase|Adverse Event|0|||
155254325|NCT01662310|560362336|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155254326|NCT01662310|560362337|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155254327|NCT01662310|560362338|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155254328|NCT01662310|560362339|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155254329|NCT01662310|560362340|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155254330|NCT01662310|560362336|FG000|Double-Blind Phase|Pregnancy|0|||
155254331|NCT01662310|560362337|FG001|Double-Blind Phase|Pregnancy|2|||
155254332|NCT01662310|560362338|FG002|Double-Blind Phase|Pregnancy|0|||
155254333|NCT01662310|560362339|FG003|Double-Blind Phase|Pregnancy|0|||
155254334|NCT01662310|560362340|FG004|Double-Blind Phase|Pregnancy|0|||
155254335|NCT01662310|560362336|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155254336|NCT01662310|560362337|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
155254337|NCT01662310|560362338|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
155254338|NCT01662310|560362339|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155254339|NCT01662310|560362340|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155254340|NCT01662310|560362336|FG000|Double-Blind Phase|Other|0|||
155254341|NCT01662310|560362337|FG001|Double-Blind Phase|Other|0|||
155254342|NCT01662310|560362338|FG002|Double-Blind Phase|Other|1|||
155254343|NCT01662310|560362339|FG003|Double-Blind Phase|Other|0|||
155254344|NCT01662310|560362340|FG004|Double-Blind Phase|Other|0|||
155254345|NCT01662310|560362336|FG000|Double-Blind Phase|Randomized but not treated|0|||
155254346|NCT01662310|560362337|FG001|Double-Blind Phase|Randomized but not treated|1|||
155254347|NCT01662310|560362338|FG002|Double-Blind Phase|Randomized but not treated|0|||
155254348|NCT01662310|560362339|FG003|Double-Blind Phase|Randomized but not treated|0|||
155254349|NCT01662310|560362340|FG004|Double-Blind Phase|Randomized but not treated|0|||
155254350|NCT01662310|560362336|FG000|Open-Label Extension Phase|Adverse Event|0|||
155254351|NCT01662310|560362337|FG001|Open-Label Extension Phase|Adverse Event|0|||
155254352|NCT01662310|560362338|FG002|Open-Label Extension Phase|Adverse Event|0|||
155254353|NCT01662310|560362339|FG003|Open-Label Extension Phase|Adverse Event|3|||
155254354|NCT01662310|560362340|FG004|Open-Label Extension Phase|Adverse Event|0|||
155254355|NCT01662310|560362336|FG000|Open-Label Extension Phase|Death|0|||
155254356|NCT01662310|560362337|FG001|Open-Label Extension Phase|Death|0|||
155254357|NCT01662310|560362338|FG002|Open-Label Extension Phase|Death|0|||
155254358|NCT01662310|560362339|FG003|Open-Label Extension Phase|Death|1|||
155254359|NCT01662310|560362340|FG004|Open-Label Extension Phase|Death|0|||
155254360|NCT01662310|560362336|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
155254361|NCT01662310|560362337|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
155254362|NCT01662310|560362338|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
155254363|NCT01662310|560362339|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
155254364|NCT01662310|560362340|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
155254365|NCT01662310|560362336|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155254366|NCT01662310|560362337|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155254367|NCT01662310|560362338|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155254368|NCT01662310|560362339|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
155254369|NCT01662310|560362340|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
155254370|NCT01662310|560362336|FG000|Open-Label Extension Phase|Pregnancy|0|||
155254371|NCT01662310|560362337|FG001|Open-Label Extension Phase|Pregnancy|0|||
155254372|NCT01662310|560362338|FG002|Open-Label Extension Phase|Pregnancy|0|||
155254373|NCT01662310|560362339|FG003|Open-Label Extension Phase|Pregnancy|1|||
155254374|NCT01662310|560362340|FG004|Open-Label Extension Phase|Pregnancy|0|||
155254375|NCT01662310|560362336|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254376|NCT01662310|560362337|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254377|NCT01662310|560362338|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254378|NCT01662310|560362339|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
155254379|NCT01662310|560362340|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
155254380|NCT02432105|560362346|FG000|Overall Study|Lost to Follow-up|1|||
155254381|NCT02432105|560362347|FG001|Overall Study|Lost to Follow-up|1|||
155254382|NCT02432105|560362348|FG002|Overall Study|Lost to Follow-up|0|||
155254383|NCT02432105|560362346|FG000|Overall Study|Withdrawal by Subject|1|||
155254384|NCT02432105|560362347|FG001|Overall Study|Withdrawal by Subject|0|||
155254385|NCT02432105|560362348|FG002|Overall Study|Withdrawal by Subject|1|||
155254386|NCT02432105|560362346|FG000|Overall Study|Culture positive for yeast|0|||
155254387|NCT02432105|560362347|FG001|Overall Study|Culture positive for yeast|1|||
155254388|NCT02432105|560362348|FG002|Overall Study|Culture positive for yeast|0|||
155254389|NCT02432105|560362346|FG000|Overall Study|Randomized in error|0|||
155254390|NCT02432105|560362347|FG001|Overall Study|Randomized in error|0|||
155254391|NCT02432105|560362348|FG002|Overall Study|Randomized in error|2|||
155254392|NCT01302847|560362350|FG000|Overall Study|Death|0|||
155254393|NCT01302847|560362351|FG001|Overall Study|Death|1|||
155254394|NCT01302847|560362352|FG002|Overall Study|Death|0|||
155254395|NCT01302847|560362353|FG003|Overall Study|Death|0|||
155254396|NCT01302847|560362354|FG004|Overall Study|Death|0|||
155254397|NCT01302847|560362355|FG005|Overall Study|Death|1|||
155254398|NCT01302847|560362356|FG006|Overall Study|Death|1|||
155254399|NCT01302847|560362357|FG007|Overall Study|Death|0|||
155254400|NCT01302847|560362350|FG000|Overall Study|Pregnancy|2|||
155254401|NCT01302847|560362351|FG001|Overall Study|Pregnancy|0|||
155254402|NCT01302847|560362352|FG002|Overall Study|Pregnancy|0|||
155254403|NCT01302847|560362353|FG003|Overall Study|Pregnancy|0|||
155254404|NCT01302847|560362354|FG004|Overall Study|Pregnancy|0|||
155254405|NCT01302847|560362355|FG005|Overall Study|Pregnancy|0|||
155254406|NCT01302847|560362356|FG006|Overall Study|Pregnancy|0|||
155254407|NCT01302847|560362357|FG007|Overall Study|Pregnancy|0|||
155254408|NCT01302847|560362350|FG000|Overall Study|Virologic failure|0|||
155254409|NCT01302847|560362351|FG001|Overall Study|Virologic failure|2|||
155254410|NCT01302847|560362352|FG002|Overall Study|Virologic failure|0|||
155254411|NCT01302847|560362353|FG003|Overall Study|Virologic failure|2|||
155254412|NCT01302847|560362354|FG004|Overall Study|Virologic failure|1|||
155254413|NCT01302847|560362355|FG005|Overall Study|Virologic failure|3|||
155254414|NCT01302847|560362356|FG006|Overall Study|Virologic failure|1|||
155254415|NCT01302847|560362357|FG007|Overall Study|Virologic failure|2|||
155254416|NCT01302847|560362350|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155254417|NCT01302847|560362351|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155254418|NCT01302847|560362352|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155254419|NCT01302847|560362353|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155254420|NCT01302847|560362354|FG004|Overall Study|Severe debilitation, unable to continue|0|||
155254421|NCT01302847|560362355|FG005|Overall Study|Severe debilitation, unable to continue|1|||
155254422|NCT01302847|560362356|FG006|Overall Study|Severe debilitation, unable to continue|1|||
155254423|NCT01302847|560362357|FG007|Overall Study|Severe debilitation, unable to continue|0|||
155254424|NCT01302847|560362350|FG000|Overall Study|Not able to get to clinic|1|||
155254425|NCT01302847|560362351|FG001|Overall Study|Not able to get to clinic|1|||
155254426|NCT01302847|560362352|FG002|Overall Study|Not able to get to clinic|0|||
155254427|NCT01302847|560362353|FG003|Overall Study|Not able to get to clinic|0|||
155254428|NCT01302847|560362354|FG004|Overall Study|Not able to get to clinic|0|||
155254429|NCT01302847|560362355|FG005|Overall Study|Not able to get to clinic|0|||
155254430|NCT01302847|560362356|FG006|Overall Study|Not able to get to clinic|0|||
155254431|NCT01302847|560362357|FG007|Overall Study|Not able to get to clinic|0|||
155254432|NCT01302847|560362350|FG000|Overall Study|Site closing|2|||
155254433|NCT01302847|560362351|FG001|Overall Study|Site closing|2|||
155254434|NCT01302847|560362352|FG002|Overall Study|Site closing|0|||
155254435|NCT01302847|560362353|FG003|Overall Study|Site closing|0|||
155254436|NCT01302847|560362354|FG004|Overall Study|Site closing|0|||
155254437|NCT01302847|560362355|FG005|Overall Study|Site closing|0|||
155254438|NCT01302847|560362356|FG006|Overall Study|Site closing|0|||
155254439|NCT01302847|560362357|FG007|Overall Study|Site closing|0|||
155254440|NCT01302847|560362350|FG000|Overall Study|Withdrawal by Subject|1|||
155254441|NCT01302847|560362351|FG001|Overall Study|Withdrawal by Subject|0|||
155254442|NCT01302847|560362352|FG002|Overall Study|Withdrawal by Subject|0|||
155254443|NCT01302847|560362353|FG003|Overall Study|Withdrawal by Subject|0|||
155254444|NCT01302847|560362354|FG004|Overall Study|Withdrawal by Subject|1|||
155254445|NCT01302847|560362355|FG005|Overall Study|Withdrawal by Subject|0|||
155254446|NCT01302847|560362356|FG006|Overall Study|Withdrawal by Subject|0|||
155254447|NCT01302847|560362357|FG007|Overall Study|Withdrawal by Subject|1|||
155254448|NCT01302847|560362350|FG000|Overall Study|Not willing to adhere to requirements|5|||
155254449|NCT01302847|560362351|FG001|Overall Study|Not willing to adhere to requirements|0|||
155254450|NCT01302847|560362352|FG002|Overall Study|Not willing to adhere to requirements|1|||
155254451|NCT01302847|560362353|FG003|Overall Study|Not willing to adhere to requirements|0|||
155254452|NCT01302847|560362354|FG004|Overall Study|Not willing to adhere to requirements|0|||
155254453|NCT01302847|560362355|FG005|Overall Study|Not willing to adhere to requirements|0|||
155254454|NCT01302847|560362356|FG006|Overall Study|Not willing to adhere to requirements|0|||
155254455|NCT01302847|560362357|FG007|Overall Study|Not willing to adhere to requirements|2|||
155254456|NCT01302847|560362350|FG000|Overall Study|Site unable to contact participant|2|||
155254457|NCT01302847|560362351|FG001|Overall Study|Site unable to contact participant|1|||
155254458|NCT01302847|560362352|FG002|Overall Study|Site unable to contact participant|0|||
155254459|NCT01302847|560362353|FG003|Overall Study|Site unable to contact participant|0|||
155254460|NCT01302847|560362354|FG004|Overall Study|Site unable to contact participant|0|||
155254461|NCT01302847|560362355|FG005|Overall Study|Site unable to contact participant|0|||
155254462|NCT01302847|560362356|FG006|Overall Study|Site unable to contact participant|2|||
155254463|NCT01302847|560362357|FG007|Overall Study|Site unable to contact participant|0|||
155254464|NCT01565707|560362358|FG000|Overall Study|Adverse Event|1|||
155254465|NCT01565707|560362359|FG001|Overall Study|Adverse Event|6|||
155254466|NCT01565707|560362360|FG002|Overall Study|Adverse Event|2|||
155254467|NCT01565707|560362361|FG003|Overall Study|Adverse Event|1|||
155254468|NCT01565707|560362358|FG000|Overall Study|Lost to Follow-up|1|||
155254469|NCT01565707|560362359|FG001|Overall Study|Lost to Follow-up|0|||
155254470|NCT01565707|560362360|FG002|Overall Study|Lost to Follow-up|0|||
155254471|NCT01565707|560362361|FG003|Overall Study|Lost to Follow-up|0|||
155254472|NCT01565707|560362358|FG000|Overall Study|Protocol Violation|1|||
155254473|NCT01565707|560362359|FG001|Overall Study|Protocol Violation|0|||
155254474|NCT01565707|560362360|FG002|Overall Study|Protocol Violation|0|||
155254475|NCT01565707|560362361|FG003|Overall Study|Protocol Violation|1|||
155254476|NCT01565707|560362358|FG000|Overall Study|Withdrawal by Subject|3|||
155254477|NCT01565707|560362359|FG001|Overall Study|Withdrawal by Subject|1|||
155254478|NCT01565707|560362360|FG002|Overall Study|Withdrawal by Subject|1|||
155254479|NCT01565707|560362361|FG003|Overall Study|Withdrawal by Subject|1|||
155254480|NCT01565707|560362358|FG000|Overall Study|Randomized but not evaluable|2|||
155254481|NCT01565707|560362359|FG001|Overall Study|Randomized but not evaluable|0|||
155254482|NCT01565707|560362360|FG002|Overall Study|Randomized but not evaluable|0|||
155254483|NCT01565707|560362361|FG003|Overall Study|Randomized but not evaluable|0|||
155254484|NCT01565707|560362358|FG000|Overall Study|Miscellaneous|1|||
155254485|NCT01565707|560362359|FG001|Overall Study|Miscellaneous|1|||
155254486|NCT01565707|560362360|FG002|Overall Study|Miscellaneous|0|||
155254487|NCT01565707|560362361|FG003|Overall Study|Miscellaneous|2|||
155254488|NCT04302350|560362363|FG000|Overall Study|Physician Decision|1|||
155254489|NCT04302350|560362364|FG001|Overall Study|Physician Decision|1|||
155254490|NCT04302350|560362365|FG002|Overall Study|Physician Decision|2|||
155254491|NCT04302350|560362363|FG000|Overall Study|Lack of Efficacy|1|||
155254492|NCT04302350|560362364|FG001|Overall Study|Lack of Efficacy|1|||
155254493|NCT04302350|560362365|FG002|Overall Study|Lack of Efficacy|4|||
155254494|NCT04302350|560362363|FG000|Overall Study|Adverse Event|0|||
155254495|NCT04302350|560362364|FG001|Overall Study|Adverse Event|1|||
155254496|NCT04302350|560362365|FG002|Overall Study|Adverse Event|2|||
155254497|NCT01371851|560362368|FG000|Overall Study|Lost to Follow-up|5|||
155254498|NCT01371851|560362369|FG001|Overall Study|Lost to Follow-up|8|||
155254499|NCT01371851|560362368|FG000|Overall Study|was arrested and put in jail|0|||
155254500|NCT01371851|560362369|FG001|Overall Study|was arrested and put in jail|1|||
155254501|NCT01371851|560362368|FG000|Overall Study|non study related adverse event|1|||
155254502|NCT01371851|560362369|FG001|Overall Study|non study related adverse event|0|||
155254503|NCT01371851|560362368|FG000|Overall Study|Blood Pressure outside study parameters|2|||
155254504|NCT01371851|560362369|FG001|Overall Study|Blood Pressure outside study parameters|0|||
155254505|NCT02012491|560362370|FG000|Overall Study|Lost to Follow-up|1|||
155254506|NCT02012491|560362371|FG001|Overall Study|Lost to Follow-up|0|||
155254507|NCT02012491|560362370|FG000|Overall Study|Protocol Violation|0|||
155254508|NCT02012491|560362371|FG001|Overall Study|Protocol Violation|1|||
155254509|NCT02012491|560362370|FG000|Overall Study|Withdrawal by Subject|1|||
155254510|NCT02012491|560362371|FG001|Overall Study|Withdrawal by Subject|0|||
155254511|NCT00450411|560362372|FG000|Overall Study|Protocol Violation|6|||
155254512|NCT00450411|560362372|FG000|Overall Study|No protocol treatment|2|||
155254513|NCT03969719|560362383|FG000|Overall Study|Other reasons not specified|1|||
155254514|NCT03969719|560362384|FG001|Overall Study|Other reasons not specified|1|||
155254515|NCT03969719|560362385|FG002|Overall Study|Other reasons not specified|3|||
155254516|NCT03969719|560362383|FG000|Overall Study|Withdrawal by Subject|2|||
155254517|NCT03969719|560362384|FG001|Overall Study|Withdrawal by Subject|3|||
155254518|NCT03969719|560362385|FG002|Overall Study|Withdrawal by Subject|2|||
155254519|NCT03969719|560362383|FG000|Overall Study|Protocol Violation|1|||
155254520|NCT03969719|560362384|FG001|Overall Study|Protocol Violation|2|||
155254521|NCT03969719|560362385|FG002|Overall Study|Protocol Violation|0|||
155254522|NCT03969719|560362383|FG000|Overall Study|Adverse Event|0|||
155254523|NCT03969719|560362384|FG001|Overall Study|Adverse Event|2|||
155254524|NCT03969719|560362385|FG002|Overall Study|Adverse Event|0|||
155254525|NCT03969719|560362383|FG000|Overall Study|Lost to Follow-up|0|||
155254526|NCT03969719|560362384|FG001|Overall Study|Lost to Follow-up|1|||
155254527|NCT03969719|560362385|FG002|Overall Study|Lost to Follow-up|0|||
155254528|NCT05608629|560362386|FG000|Overall Study|Lost to Follow-up|2|||
155254529|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
155254530|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
155254531|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
155254532|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
155254533|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
155254534|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
155254535|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
155254536|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
155254537|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
155254538|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
155254539|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
155254540|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
155254541|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
155254542|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
155254543|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
155254544|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254545|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254546|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254547|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254548|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254549|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254550|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
155254551|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
155254552|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
155254553|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254554|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254555|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254556|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254557|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254558|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254559|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
155254560|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
155254561|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
155254562|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254563|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254564|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254565|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254566|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254567|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254568|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155254569|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254570|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
155254571|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254572|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254573|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254574|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254575|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254576|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254577|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254578|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254579|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155254580|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254581|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254582|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254583|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254584|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254585|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254586|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
155254587|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
155254588|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
155254589|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254590|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254591|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254592|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254593|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254594|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254595|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254596|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
155254597|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
155254598|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
155254599|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254600|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254601|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
155254602|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254603|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254604|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254605|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
155254606|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
155254607|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
155254608|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
155254609|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
155254610|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254611|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254612|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254613|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254614|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
155254615|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
155254616|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
155254617|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254618|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254619|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254620|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254621|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254622|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254623|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254624|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
155254625|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254626|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254627|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254628|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254629|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254630|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254631|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254632|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254633|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254634|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
155254635|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254636|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254637|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254638|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254639|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254640|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254641|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254642|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
155254643|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
155254644|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254645|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254646|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254647|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254648|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254649|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254650|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
155254651|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
155254652|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254653|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254654|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254655|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254656|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254657|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
155254658|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254659|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
155254660|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
155254661|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254662|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254663|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254664|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254665|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
155254666|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
155254667|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254668|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
155254669|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254670|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254671|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254672|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254673|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254674|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254675|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254676|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254677|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
155254678|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
155254679|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254680|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254681|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254682|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254683|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155254684|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155254685|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254686|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
155254687|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254688|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254689|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254690|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254691|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254692|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254693|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254694|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254695|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
155254696|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155254697|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254698|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254699|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254700|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254701|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254702|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155254703|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254704|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254705|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254706|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254707|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254708|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254709|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254710|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254711|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
155254712|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254713|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
155254714|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
155254715|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254716|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254717|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254718|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254719|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155254720|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155254721|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254722|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
155254723|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
155254724|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254725|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254726|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254727|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254728|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155254729|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155254730|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254731|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
155254732|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254733|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254734|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254735|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254736|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254737|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254738|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254739|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254740|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254741|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254742|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254743|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254744|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254745|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254746|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
155254747|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254748|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254749|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
155254750|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254751|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254752|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254753|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254754|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254755|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254756|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254757|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254758|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254759|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254760|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254761|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254762|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254763|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254764|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254765|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254766|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254767|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
155254768|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
155254769|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254770|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254771|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254772|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254773|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
155254774|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254775|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254776|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254777|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254778|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254779|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254780|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254781|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254782|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254783|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254784|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254785|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
155254786|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
155254787|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254788|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254789|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254790|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254791|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254792|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254793|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254794|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254795|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
155254796|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254797|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254798|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254799|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254800|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254801|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254802|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254803|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
155254804|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254805|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254806|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254807|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254808|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254809|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254810|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
155254811|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
155254812|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
155254813|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
155254814|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
155254815|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
155254816|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
155254817|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
155254818|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
155254819|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
155254820|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254821|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254822|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
155254823|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254824|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254825|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254826|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254827|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254828|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254829|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254830|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254831|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
155254832|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254833|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254834|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254835|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254836|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254837|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
155254838|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254839|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254840|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
155254841|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254842|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254843|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254844|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254845|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254846|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254847|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254848|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
155254849|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155254850|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254851|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254852|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254853|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254854|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155254855|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254856|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Death|0|||
155254857|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Death|0|||
155254858|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Death|0|||
155254859|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Death|0|||
155254860|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Death|0|||
155254861|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Death|0|||
155254862|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Death|0|||
155254863|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Death|1|||
155254864|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Death|0|||
155254865|NCT00829387|560362401|FG000|Overall Study|Withdrawal by Subject|2|||
155254866|NCT00829387|560362402|FG001|Overall Study|Withdrawal by Subject|3|||
155254867|NCT00829387|560362401|FG000|Overall Study|Disqualified by PI|1|||
155254868|NCT00829387|560362402|FG001|Overall Study|Disqualified by PI|0|||
155254869|NCT00707031|560362410|FG000|Overall Study|Adverse Event|45|||
155254870|NCT00707031|560362411|FG001|Overall Study|Adverse Event|45|||
155254871|NCT00707031|560362410|FG000|Overall Study|Lack of Efficacy|19|||
155254872|NCT00707031|560362411|FG001|Overall Study|Lack of Efficacy|6|||
155254873|NCT00707031|560362410|FG000|Overall Study|Lost to Follow-up|2|||
155254874|NCT00707031|560362411|FG001|Overall Study|Lost to Follow-up|1|||
155254875|NCT00707031|560362410|FG000|Overall Study|Protocol Violation|1|||
155254876|NCT00707031|560362411|FG001|Overall Study|Protocol Violation|0|||
155254877|NCT00707031|560362410|FG000|Overall Study|Withdrawal by Subject|7|||
155254878|NCT00707031|560362411|FG001|Overall Study|Withdrawal by Subject|8|||
155254879|NCT00707031|560362410|FG000|Overall Study|Poor Compliance to Protocol|7|||
155254880|NCT00707031|560362411|FG001|Overall Study|Poor Compliance to Protocol|13|||
155254881|NCT00707031|560362410|FG000|Overall Study|Familial or Personal Reasons|12|||
155254882|NCT00707031|560362411|FG001|Overall Study|Familial or Personal Reasons|15|||
155254883|NCT00707031|560362410|FG000|Overall Study|Serious Noncompliance|2|||
155254884|NCT00707031|560362411|FG001|Overall Study|Serious Noncompliance|3|||
155254885|NCT00707031|560362410|FG000|Overall Study|Sponsor Decision|9|||
155254886|NCT00707031|560362411|FG001|Overall Study|Sponsor Decision|8|||
155254887|NCT02747238|560362412|FG000|Overall Study|Lack of Efficacy|0|||
155254888|NCT02747238|560362413|FG001|Overall Study|Lack of Efficacy|1|||
155254889|NCT02747238|560362412|FG000|Overall Study|Data lost|3|||
155254890|NCT02747238|560362413|FG001|Overall Study|Data lost|5|||
155254891|NCT01951625|560362417|FG000|Treatment Period|Protocol Violation|2|||
155254892|NCT01951625|560362418|FG001|Treatment Period|Protocol Violation|0|||
155254893|NCT01951625|560362419|FG002|Treatment Period|Protocol Violation|1|||
155254894|NCT01951625|560362420|FG003|Treatment Period|Protocol Violation|3|||
155254895|NCT01951625|560362421|FG004|Treatment Period|Protocol Violation|2|||
155254896|NCT01951625|560362417|FG000|Treatment Period|Physician Decision|0|||
155254897|NCT01951625|560362418|FG001|Treatment Period|Physician Decision|0|||
155254898|NCT01951625|560362419|FG002|Treatment Period|Physician Decision|0|||
155254899|NCT01951625|560362420|FG003|Treatment Period|Physician Decision|0|||
155254900|NCT01951625|560362421|FG004|Treatment Period|Physician Decision|1|||
155254901|NCT01951625|560362417|FG000|Treatment Period|Protocol driven decision point|0|||
155254902|NCT01951625|560362418|FG001|Treatment Period|Protocol driven decision point|5|||
155254903|NCT01951625|560362419|FG002|Treatment Period|Protocol driven decision point|0|||
155254904|NCT01951625|560362420|FG003|Treatment Period|Protocol driven decision point|2|||
155254905|NCT01951625|560362421|FG004|Treatment Period|Protocol driven decision point|1|||
155254906|NCT01951625|560362417|FG000|Treatment Period|Non compliance with study drug|1|||
155254907|NCT01951625|560362418|FG001|Treatment Period|Non compliance with study drug|2|||
155254908|NCT01951625|560362419|FG002|Treatment Period|Non compliance with study drug|2|||
155254909|NCT01951625|560362420|FG003|Treatment Period|Non compliance with study drug|0|||
155254910|NCT01951625|560362421|FG004|Treatment Period|Non compliance with study drug|0|||
155254911|NCT01951625|560362417|FG000|Treatment Period|Death|3|||
155254912|NCT01951625|560362418|FG001|Treatment Period|Death|2|||
155254913|NCT01951625|560362419|FG002|Treatment Period|Death|2|||
155254914|NCT01951625|560362420|FG003|Treatment Period|Death|1|||
155254915|NCT01951625|560362421|FG004|Treatment Period|Death|2|||
155254916|NCT01951625|560362417|FG000|Treatment Period|Adverse Event|7|||
155254917|NCT01951625|560362418|FG001|Treatment Period|Adverse Event|10|||
155254918|NCT01951625|560362419|FG002|Treatment Period|Adverse Event|9|||
155254919|NCT01951625|560362420|FG003|Treatment Period|Adverse Event|8|||
155254920|NCT01951625|560362421|FG004|Treatment Period|Adverse Event|8|||
155254921|NCT01951625|560362417|FG000|Treatment Period|Withdrawal by Subject|5|||
155254922|NCT01951625|560362418|FG001|Treatment Period|Withdrawal by Subject|2|||
155254923|NCT01951625|560362419|FG002|Treatment Period|Withdrawal by Subject|1|||
155254924|NCT01951625|560362420|FG003|Treatment Period|Withdrawal by Subject|7|||
155254925|NCT01951625|560362421|FG004|Treatment Period|Withdrawal by Subject|3|||
155254926|NCT01951625|560362417|FG000|Treatment Period|Lost to Follow-up|1|||
155254927|NCT01951625|560362418|FG001|Treatment Period|Lost to Follow-up|0|||
155254928|NCT01951625|560362419|FG002|Treatment Period|Lost to Follow-up|0|||
155254929|NCT01951625|560362420|FG003|Treatment Period|Lost to Follow-up|1|||
155254930|NCT01951625|560362421|FG004|Treatment Period|Lost to Follow-up|0|||
155254931|NCT01951625|560362417|FG000|Follow Up Period|Non-compliance with study drug|1|||
155254932|NCT01951625|560362418|FG001|Follow Up Period|Non-compliance with study drug|0|||
155254933|NCT01951625|560362419|FG002|Follow Up Period|Non-compliance with study drug|0|||
155254934|NCT01951625|560362420|FG003|Follow Up Period|Non-compliance with study drug|0|||
155254935|NCT01951625|560362421|FG004|Follow Up Period|Non-compliance with study drug|0|||
155254936|NCT01951625|560362417|FG000|Follow Up Period|Death|1|||
155254937|NCT01951625|560362418|FG001|Follow Up Period|Death|3|||
155254938|NCT01951625|560362419|FG002|Follow Up Period|Death|2|||
155254939|NCT01951625|560362420|FG003|Follow Up Period|Death|2|||
155254940|NCT01951625|560362421|FG004|Follow Up Period|Death|1|||
155254941|NCT01951625|560362417|FG000|Follow Up Period|Logistical difficulties|1|||
155254942|NCT01951625|560362418|FG001|Follow Up Period|Logistical difficulties|2|||
155254943|NCT01951625|560362419|FG002|Follow Up Period|Logistical difficulties|0|||
155254944|NCT01951625|560362420|FG003|Follow Up Period|Logistical difficulties|0|||
155254945|NCT01951625|560362421|FG004|Follow Up Period|Logistical difficulties|0|||
155254946|NCT01951625|560362417|FG000|Follow Up Period|Adverse Event|0|||
155254947|NCT01951625|560362418|FG001|Follow Up Period|Adverse Event|3|||
155254948|NCT01951625|560362419|FG002|Follow Up Period|Adverse Event|2|||
155254949|NCT01951625|560362420|FG003|Follow Up Period|Adverse Event|3|||
155254950|NCT01951625|560362421|FG004|Follow Up Period|Adverse Event|5|||
155254951|NCT01951625|560362417|FG000|Follow Up Period|Withdrawal by Subject|4|||
155254952|NCT01951625|560362418|FG001|Follow Up Period|Withdrawal by Subject|1|||
155254953|NCT01951625|560362419|FG002|Follow Up Period|Withdrawal by Subject|0|||
155254954|NCT01951625|560362420|FG003|Follow Up Period|Withdrawal by Subject|5|||
155254955|NCT01951625|560362421|FG004|Follow Up Period|Withdrawal by Subject|3|||
155254956|NCT01951625|560362417|FG000|Follow Up Period|Lost to Follow-up|1|||
155254957|NCT01951625|560362418|FG001|Follow Up Period|Lost to Follow-up|0|||
155254958|NCT01951625|560362419|FG002|Follow Up Period|Lost to Follow-up|0|||
155254959|NCT01951625|560362420|FG003|Follow Up Period|Lost to Follow-up|1|||
155254960|NCT01951625|560362421|FG004|Follow Up Period|Lost to Follow-up|1|||
155254961|NCT02030015|560364066|FG000|Overall Study|Withdrawal by Subject|3|||
155254962|NCT02030015|560364066|FG000|Overall Study|Death|13|||
155254963|NCT00514943|560364067|FG000|Stage 1|Progressive disease|4|||
155254964|NCT00514943|560364068|FG001|Stage 1|Progressive disease|8|||
155254965|NCT00514943|560364067|FG000|Stage 1|Other Adverse Event|16|||
155254966|NCT00514943|560364068|FG001|Stage 1|Other Adverse Event|6|||
155254967|NCT00514943|560364067|FG000|Stage 1|Not treated|1|||
155254968|NCT00514943|560364068|FG001|Stage 1|Not treated|2|||
155254969|NCT00514943|560364067|FG000|Stage 1|Patient refused to continue study meds|8|||
155254970|NCT00514943|560364068|FG001|Stage 1|Patient refused to continue study meds|3|||
155254971|NCT00514943|560364067|FG000|Stage 1|Other than stated above|1|||
155254972|NCT00514943|560364068|FG001|Stage 1|Other than stated above|7|||
155254973|NCT00514943|560364067|FG000|Stage 2|Progressive disease|27|||
155254974|NCT00514943|560364068|FG001|Stage 2|Progressive disease|24|||
155254975|NCT00514943|560364067|FG000|Stage 2|Other Adverse Event|3|||
155254976|NCT00514943|560364068|FG001|Stage 2|Other Adverse Event|10|||
155254977|NCT00514943|560364067|FG000|Stage 2|Patient refused to continue study meds|2|||
155254978|NCT00514943|560364068|FG001|Stage 2|Patient refused to continue study meds|0|||
155254979|NCT00514943|560364067|FG000|Stage 2|Other than stated above|0|||
155254980|NCT00514943|560364068|FG001|Stage 2|Other than stated above|2|||
155254981|NCT00833560|560364069|FG000|Overall Study|Toxicity|13|||
155254982|NCT00833560|560364069|FG000|Overall Study|Adverse Event|11|||
155254983|NCT00833560|560364069|FG000|Overall Study|Protocol Violation|6|||
155254984|NCT00833560|560364069|FG000|Overall Study|Lack of Efficacy|4|||
155254985|NCT00833560|560364069|FG000|Overall Study|Death|2|||
155254986|NCT00833560|560364069|FG000|Overall Study|Pregression of other disease|1|||
155254987|NCT00833560|560364069|FG000|Overall Study|Other|5|||
155254988|NCT03382782|560364072|FG000|Cohort 1|Withdrawal by Subject|11|||
155254989|NCT03382782|560364073|FG001|Cohort 1|Withdrawal by Subject|5|||
155254990|NCT03382782|560364074|FG002|Cohort 1|Withdrawal by Subject|0|||
155254991|NCT03382782|560364072|FG000|Cohort 2|Withdrawal by Subject|1|||
155254992|NCT03382782|560364073|FG001|Cohort 2|Withdrawal by Subject|1|||
155254993|NCT03382782|560364074|FG002|Cohort 2|Withdrawal by Subject|0|||
155254994|NCT03382782|560364072|FG000|Cohort 3|Withdrawal by Subject|1|||
155254995|NCT03382782|560364073|FG001|Cohort 3|Withdrawal by Subject|2|||
155254996|NCT03382782|560364074|FG002|Cohort 3|Withdrawal by Subject|0|||
155254997|NCT03409666|560364079|FG000|Overall Study|Physician Decision|0|||
155254998|NCT03409666|560364080|FG001|Overall Study|Physician Decision|1|||
155254999|NCT03409666|560364079|FG000|Overall Study|Protocol Violation|0|||
155255000|NCT03409666|560364080|FG001|Overall Study|Protocol Violation|3|||
155255001|NCT01666951|560364083|FG000|Overall Study|Not dosed|1|||
155255002|NCT01666951|560364084|FG001|Overall Study|Not dosed|1|||
155255003|NCT02366910|560364085|FG000|Overall Study|Withdrawal by Subject|2|||
155255004|NCT02366910|560364085|FG000|Overall Study|Screen Failure|3|||
155255005|NCT02623322|560364086|FG000|Overall Study|Lost to Follow-up|2|||
155255006|NCT02623322|560364087|FG001|Overall Study|Lost to Follow-up|1|||
155255007|NCT02623322|560364088|FG002|Overall Study|Lost to Follow-up|0|||
155255008|NCT03563716|560364089|FG000|Overall Study|Death|20|||
155255009|NCT03563716|560364090|FG001|Overall Study|Death|14|||
155255010|NCT03563716|560364089|FG000|Overall Study|Withdrawal by Subject|3|||
155255011|NCT03563716|560364090|FG001|Overall Study|Withdrawal by Subject|3|||
155255012|NCT03563716|560364089|FG000|Overall Study|Still on Study|45|||
155255013|NCT03563716|560364090|FG001|Overall Study|Still on Study|50|||
155255014|NCT01786512|560364094|FG000|Overall Study|Lost to Follow-up|0|||
155255015|NCT01786512|560364095|FG001|Overall Study|Lost to Follow-up|0|||
155255016|NCT01786512|560364096|FG002|Overall Study|Lost to Follow-up|0|||
155255017|NCT01786512|560364097|FG003|Overall Study|Lost to Follow-up|0|||
155255018|NCT01786512|560364098|FG004|Overall Study|Lost to Follow-up|0|||
155255019|NCT01786512|560364099|FG005|Overall Study|Lost to Follow-up|0|||
155255020|NCT01786512|560364100|FG006|Overall Study|Lost to Follow-up|0|||
155255021|NCT01786512|560364101|FG007|Overall Study|Lost to Follow-up|0|||
155255022|NCT01786512|560364102|FG008|Overall Study|Lost to Follow-up|0|||
155255023|NCT01786512|560364103|FG009|Overall Study|Lost to Follow-up|1|||
155255024|NCT01786512|560364104|FG010|Overall Study|Lost to Follow-up|0|||
155255025|NCT01786512|560364094|FG000|Overall Study|Decision by sponsor|0|||
155255026|NCT01786512|560364095|FG001|Overall Study|Decision by sponsor|0|||
155255027|NCT01786512|560364096|FG002|Overall Study|Decision by sponsor|0|||
155255028|NCT01786512|560364097|FG003|Overall Study|Decision by sponsor|0|||
155255029|NCT01786512|560364098|FG004|Overall Study|Decision by sponsor|0|||
155255030|NCT01786512|560364099|FG005|Overall Study|Decision by sponsor|0|||
155255031|NCT01786512|560364100|FG006|Overall Study|Decision by sponsor|0|||
155255032|NCT01786512|560364101|FG007|Overall Study|Decision by sponsor|0|||
155255033|NCT01786512|560364102|FG008|Overall Study|Decision by sponsor|0|||
155255034|NCT01786512|560364103|FG009|Overall Study|Decision by sponsor|0|||
155255035|NCT01786512|560364104|FG010|Overall Study|Decision by sponsor|2|||
155255036|NCT01786512|560364094|FG000|Overall Study|Withdrawal by Subject|0|||
155255037|NCT01786512|560364095|FG001|Overall Study|Withdrawal by Subject|1|||
155255038|NCT01786512|560364096|FG002|Overall Study|Withdrawal by Subject|0|||
155255039|NCT01786512|560364097|FG003|Overall Study|Withdrawal by Subject|0|||
155255040|NCT01786512|560364098|FG004|Overall Study|Withdrawal by Subject|0|||
155255041|NCT01786512|560364099|FG005|Overall Study|Withdrawal by Subject|0|||
155255042|NCT01786512|560364100|FG006|Overall Study|Withdrawal by Subject|1|||
155255043|NCT01786512|560364101|FG007|Overall Study|Withdrawal by Subject|0|||
155255044|NCT01786512|560364102|FG008|Overall Study|Withdrawal by Subject|0|||
155255045|NCT01786512|560364103|FG009|Overall Study|Withdrawal by Subject|3|||
155255046|NCT01786512|560364104|FG010|Overall Study|Withdrawal by Subject|7|||
155255047|NCT01786512|560364094|FG000|Overall Study|Death|0|||
155255048|NCT01786512|560364095|FG001|Overall Study|Death|0|||
155255049|NCT01786512|560364096|FG002|Overall Study|Death|0|||
155255050|NCT01786512|560364097|FG003|Overall Study|Death|0|||
155255051|NCT01786512|560364098|FG004|Overall Study|Death|0|||
155255052|NCT01786512|560364099|FG005|Overall Study|Death|0|||
155255053|NCT01786512|560364100|FG006|Overall Study|Death|0|||
155255054|NCT01786512|560364101|FG007|Overall Study|Death|0|||
155255055|NCT01786512|560364102|FG008|Overall Study|Death|4|||
155255056|NCT01786512|560364103|FG009|Overall Study|Death|1|||
155255057|NCT01786512|560364104|FG010|Overall Study|Death|3|||
155255058|NCT02450331|560364108|FG000|Overall Study|Death|162|||
155255059|NCT02450331|560364109|FG001|Overall Study|Death|171|||
155255060|NCT02450331|560364108|FG000|Overall Study|Lost to Follow-up|14|||
155255061|NCT02450331|560364109|FG001|Overall Study|Lost to Follow-up|12|||
155255062|NCT02450331|560364108|FG000|Overall Study|Withdrawal by Subject|55|||
155255063|NCT02450331|560364109|FG001|Overall Study|Withdrawal by Subject|44|||
155255064|NCT02450331|560364108|FG000|Overall Study|Non-specified other|1|||
155255065|NCT02450331|560364109|FG001|Overall Study|Non-specified other|1|||
155255066|NCT02080871|560364110|FG000|Overall Study|Death|1|||
155255067|NCT02080871|560364110|FG000|Overall Study|Lost to Follow-up|1|||
155255068|NCT00234052|560364111|FG000|Treatment|Withdrawal by Subject|3|||
155255069|NCT00234052|560364111|FG000|Treatment|Adverse Event|5|||
155255070|NCT00234052|560364111|FG000|Treatment|Death|2|||
155255071|NCT00234052|560364111|FG000|Treatment|Progressive Disease|11|||
155255072|NCT00234052|560364111|FG000|Follow-up for 5 Years|Death|41|||
155255073|NCT00234052|560364111|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
155255074|NCT00234052|560364111|FG000|Follow-up for 5 Years|Other|7|||
155255075|NCT01410474|560364112|FG000|Overall Study|Withdrawal by Subject|0|||
155255076|NCT01410474|560364113|FG001|Overall Study|Withdrawal by Subject|1|||
155255077|NCT02428296|560364114|FG000|Overall Study|Adverse Event|7|||
155255078|NCT02428296|560364114|FG000|Overall Study|Withdrawal by Subject|2|||
155255079|NCT00828984|560364116|FG000|Overall Study|Adverse Event|2|||
155255080|NCT00828984|560364117|FG001|Overall Study|Adverse Event|3|||
155255081|NCT00828984|560364118|FG002|Overall Study|Adverse Event|0|||
155255082|NCT00828984|560364116|FG000|Overall Study|Lost to Follow-up|5|||
155255083|NCT00828984|560364117|FG001|Overall Study|Lost to Follow-up|3|||
155255084|NCT00828984|560364118|FG002|Overall Study|Lost to Follow-up|1|||
155255085|NCT00828984|560364116|FG000|Overall Study|Withdrawal by Subject|4|||
155255086|NCT00828984|560364117|FG001|Overall Study|Withdrawal by Subject|4|||
155255087|NCT00828984|560364118|FG002|Overall Study|Withdrawal by Subject|4|||
155255088|NCT00828984|560364116|FG000|Overall Study|Ineligable|1|||
155255089|NCT00828984|560364117|FG001|Overall Study|Ineligable|2|||
155255090|NCT00828984|560364118|FG002|Overall Study|Ineligable|0|||
155255091|NCT00828984|560364116|FG000|Overall Study|Medical Contraindication|0|||
155255092|NCT00828984|560364117|FG001|Overall Study|Medical Contraindication|1|||
155255093|NCT00828984|560364118|FG002|Overall Study|Medical Contraindication|0|||
155255094|NCT00828984|560364116|FG000|Overall Study|Noncompliant|1|||
155255095|NCT00828984|560364117|FG001|Overall Study|Noncompliant|2|||
155255096|NCT00828984|560364118|FG002|Overall Study|Noncompliant|3|||
155255097|NCT00828984|560364116|FG000|Overall Study|ConMed|1|||
155255098|NCT00828984|560364117|FG001|Overall Study|ConMed|1|||
155255099|NCT00828984|560364118|FG002|Overall Study|ConMed|1|||
155255100|NCT04493931|560364123|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
155255101|NCT04493931|560364124|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255102|NCT04493931|560364125|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255103|NCT04493931|560364126|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255104|NCT04493931|560364127|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255105|NCT04493931|560364128|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255106|NCT04493931|560364129|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255107|NCT04493931|560364123|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255108|NCT04493931|560364124|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
155255109|NCT04493931|560364125|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255110|NCT04493931|560364126|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255111|NCT04493931|560364127|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255112|NCT04493931|560364128|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255113|NCT04493931|560364129|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255114|NCT04493931|560364123|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255115|NCT04493931|560364124|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
155255116|NCT04493931|560364125|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255117|NCT04493931|560364126|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255118|NCT04493931|560364127|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255119|NCT04493931|560364128|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255120|NCT04493931|560364129|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255121|NCT04493931|560364123|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255122|NCT04493931|560364124|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255123|NCT04493931|560364125|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
155255124|NCT04493931|560364126|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255125|NCT04493931|560364127|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255126|NCT04493931|560364128|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255127|NCT04493931|560364129|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255128|NCT00863655|560364130|FG000|Overall Study|Protocol Violation|4|||
155255129|NCT00863655|560364131|FG001|Overall Study|Protocol Violation|0|||
155255130|NCT00863655|560364130|FG000|Overall Study|Adverse Event|52|||
155255131|NCT00863655|560364131|FG001|Overall Study|Adverse Event|8|||
155255132|NCT00863655|560364130|FG000|Overall Study|Withdrawal by Subject|47|||
155255133|NCT00863655|560364131|FG001|Overall Study|Withdrawal by Subject|7|||
155255134|NCT00863655|560364130|FG000|Overall Study|Administrative problems|1|||
155255135|NCT00863655|560364131|FG001|Overall Study|Administrative problems|0|||
155255136|NCT00863655|560364130|FG000|Overall Study|Death|7|||
155255137|NCT00863655|560364131|FG001|Overall Study|Death|1|||
155255138|NCT00863655|560364130|FG000|Overall Study|New cancer therapy|5|||
155255139|NCT00863655|560364131|FG001|Overall Study|New cancer therapy|1|||
155255140|NCT00863655|560364130|FG000|Overall Study|Disease progression|364|||
155255141|NCT00863655|560364131|FG001|Overall Study|Disease progression|221|||
155255142|NCT00863655|560364130|FG000|Overall Study|Treatment completed as per protocol|5|||
155255143|NCT00863655|560364131|FG001|Overall Study|Treatment completed as per protocol|1|||
155255144|NCT00002558|560364138|FG000|Overall Study|Withdrawal by Subject|0|||
155255145|NCT00002558|560364139|FG001|Overall Study|Withdrawal by Subject|1|||
155255146|NCT00558428|560364140|FG000|Overall Study|Adverse Event|6|||
155255147|NCT00558428|560364141|FG001|Overall Study|Adverse Event|22|||
155255148|NCT00558428|560364142|FG002|Overall Study|Adverse Event|3|||
155255149|NCT00558428|560364143|FG003|Overall Study|Adverse Event|4|||
155255150|NCT00558428|560364140|FG000|Overall Study|Lost to Follow-up|0|||
155255151|NCT00558428|560364141|FG001|Overall Study|Lost to Follow-up|1|||
155255152|NCT00558428|560364142|FG002|Overall Study|Lost to Follow-up|0|||
155255153|NCT00558428|560364143|FG003|Overall Study|Lost to Follow-up|0|||
155255154|NCT00558428|560364140|FG000|Overall Study|Lack of Efficacy|0|||
155255155|NCT00558428|560364141|FG001|Overall Study|Lack of Efficacy|0|||
155255156|NCT00558428|560364142|FG002|Overall Study|Lack of Efficacy|1|||
155255157|NCT00558428|560364143|FG003|Overall Study|Lack of Efficacy|2|||
155255158|NCT00558428|560364140|FG000|Overall Study|Non compliant with protocol|1|||
155255159|NCT00558428|560364141|FG001|Overall Study|Non compliant with protocol|0|||
155255160|NCT00558428|560364142|FG002|Overall Study|Non compliant with protocol|0|||
155255161|NCT00558428|560364143|FG003|Overall Study|Non compliant with protocol|3|||
155255162|NCT00558428|560364140|FG000|Overall Study|Consent withdrawn|2|||
155255163|NCT00558428|560364141|FG001|Overall Study|Consent withdrawn|1|||
155491693|NCT00762073|561225493|FG002|Overall Study|Significant Subject Noncompliance|0|||
155491694|NCT00762073|561225494|FG003|Overall Study|Significant Subject Noncompliance|1|||
155255164|NCT00558428|560364142|FG002|Overall Study|Consent withdrawn|0|||
155255165|NCT00558428|560364143|FG003|Overall Study|Consent withdrawn|1|||
155255166|NCT00558428|560364140|FG000|Overall Study|Other|3|||
155255167|NCT00558428|560364141|FG001|Overall Study|Other|0|||
155255168|NCT00558428|560364142|FG002|Overall Study|Other|0|||
155255169|NCT00558428|560364143|FG003|Overall Study|Other|1|||
155255170|NCT04528069|560364144|FG000|Overall Study|Adverse Event|1|||
155255171|NCT04528069|560364144|FG000|Overall Study|Lost to Follow-up|1|||
155255172|NCT04528069|560364144|FG000|Overall Study|Patient Unable to Come|1|||
155255173|NCT04528069|560364144|FG000|Overall Study|Patient Unable to Attend|1|||
155255174|NCT01814371|560364145|FG000|Overall Study|Lost to Follow-up|30|||
155255175|NCT01814371|560364146|FG001|Overall Study|Lost to Follow-up|27|||
155255176|NCT02123108|560364152|FG000|Overall Study|Death|2|||
155255177|NCT02123108|560364153|FG001|Overall Study|Death|3|||
155255178|NCT00716092|560364157|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
155255179|NCT00716092|560364158|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
155255180|NCT00716092|560364159|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
155255181|NCT02219048|560364160|FG000|Overall Study|Adverse Event|2|||
155255182|NCT02219048|560364161|FG001|Overall Study|Adverse Event|5|||
155255183|NCT02219048|560364160|FG000|Overall Study|No longer meets eligibility criteria|1|||
155255184|NCT02219048|560364161|FG001|Overall Study|No longer meets eligibility criteria|0|||
155255185|NCT02219048|560364160|FG000|Overall Study|Study terminated by sponsor|16|||
155255186|NCT02219048|560364161|FG001|Overall Study|Study terminated by sponsor|15|||
155255187|NCT02219048|560364160|FG000|Overall Study|Withdrawal by Subject|2|||
155255188|NCT02219048|560364161|FG001|Overall Study|Withdrawal by Subject|0|||
155255189|NCT02219048|560364160|FG000|Overall Study|Other|0|||
155255190|NCT02219048|560364161|FG001|Overall Study|Other|1|||
155255191|NCT02436330|560364162|FG000|Cohort 1|Lost to Follow-up|5|||
155255192|NCT02436330|560364163|FG001|Cohort 1|Lost to Follow-up|2|||
155255193|NCT02436330|560364162|FG000|Cohort 1|Withdrawal by Subject|0|||
155255194|NCT02436330|560364163|FG001|Cohort 1|Withdrawal by Subject|1|||
155255195|NCT02436330|560364162|FG000|Cohort 2|Lost to Follow-up|2|||
155255196|NCT02436330|560364163|FG001|Cohort 2|Lost to Follow-up|0|||
155255197|NCT02436330|560364162|FG000|Cohort 2|Withdrawal by Subject|2|||
155255198|NCT02436330|560364163|FG001|Cohort 2|Withdrawal by Subject|3|||
155255199|NCT02436330|560364162|FG000|Cohort 3|Lost to Follow-up|1|||
155255200|NCT02436330|560364163|FG001|Cohort 3|Lost to Follow-up|0|||
155255201|NCT02436330|560364162|FG000|Cohort 3|Withdrawal by Subject|4|||
155255202|NCT02436330|560364163|FG001|Cohort 3|Withdrawal by Subject|0|||
155255203|NCT02436330|560364162|FG000|Cohort 4|Lost to Follow-up|1|||
155255204|NCT02436330|560364163|FG001|Cohort 4|Lost to Follow-up|0|||
155255205|NCT02436330|560364162|FG000|Cohort 4|Withdrawal by Subject|1|||
155255206|NCT02436330|560364163|FG001|Cohort 4|Withdrawal by Subject|0|||
155255207|NCT02436330|560364162|FG000|Cohort 5|Lost to Follow-up|3|||
155255208|NCT02436330|560364163|FG001|Cohort 5|Lost to Follow-up|2|||
155255209|NCT02436330|560364162|FG000|Cohort 5|Withdrawal by Subject|3|||
155255210|NCT02436330|560364163|FG001|Cohort 5|Withdrawal by Subject|2|||
155255211|NCT02436330|560364162|FG000|Cohort 6|Lost to Follow-up|2|||
155255212|NCT02436330|560364163|FG001|Cohort 6|Lost to Follow-up|0|||
155255213|NCT02436330|560364162|FG000|Cohort 6|Withdrawal by Subject|1|||
155255214|NCT02436330|560364163|FG001|Cohort 6|Withdrawal by Subject|1|||
155255215|NCT00868439|560364164|FG000|Overall Study|Adverse Event|4|||
155255216|NCT00868439|560364165|FG001|Overall Study|Adverse Event|3|||
155255217|NCT00868439|560364164|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
155255218|NCT00868439|560364165|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
155255219|NCT00868439|560364164|FG000|Overall Study|Death|0|||
155255220|NCT00868439|560364165|FG001|Overall Study|Death|1|||
155255221|NCT00868439|560364164|FG000|Overall Study|Protocol Violation|1|||
155255222|NCT00868439|560364165|FG001|Overall Study|Protocol Violation|1|||
155255223|NCT00868439|560364164|FG000|Overall Study|Physician Decision|1|||
155255224|NCT00868439|560364165|FG001|Overall Study|Physician Decision|0|||
155255225|NCT00868439|560364164|FG000|Overall Study|Withdrawal by Subject|0|||
155255226|NCT00868439|560364165|FG001|Overall Study|Withdrawal by Subject|1|||
155255227|NCT01132326|560364166|FG000|Overall Study|Lack of Efficacy|25|||
155255228|NCT01132326|560364166|FG000|Overall Study|Adverse Event|37|||
155255229|NCT01132326|560364166|FG000|Overall Study|Protocol Violation|1|||
155255230|NCT01132326|560364166|FG000|Overall Study|Lost to Follow-up|16|||
155255231|NCT01132326|560364166|FG000|Overall Study|Withdrawal by Subject|40|||
155255232|NCT01132326|560364166|FG000|Overall Study|Physician Decision|10|||
155255233|NCT01132326|560364166|FG000|Overall Study|Study Termination|80|||
155255234|NCT01132326|560364166|FG000|Overall Study|Declining Health|1|||
155255235|NCT01132326|560364166|FG000|Overall Study|Pregnancy|1|||
155255236|NCT01132326|560364166|FG000|Overall Study|Caregiver Withdrew Consent|1|||
155255237|NCT01132326|560364166|FG000|Overall Study|Death|5|||
155255238|NCT01132326|560364166|FG000|Overall Study|Subject Unable to Come To Visits|1|||
155255239|NCT04535947|560364167|FG000|Overall Study|Adverse Event|1|||
155255240|NCT04535947|560364168|FG001|Overall Study|Adverse Event|4|||
155255241|NCT04535947|560364167|FG000|Overall Study|Other reasons not specified|2|||
155255242|NCT04535947|560364168|FG001|Overall Study|Other reasons not specified|0|||
155255243|NCT04535947|560364167|FG000|Overall Study|Withdrawal by Subject|1|||
155255244|NCT04535947|560364168|FG001|Overall Study|Withdrawal by Subject|1|||
155255245|NCT04867369|560364171|FG000|Overall Study|Withdrawal by Subject|1|||
155255246|NCT04867369|560364172|FG001|Overall Study|Withdrawal by Subject|0|||
155255247|NCT04212091|560364173|FG000|Overall Study|Lost to Follow-up|0|||
155255248|NCT04212091|560364174|FG001|Overall Study|Lost to Follow-up|0|||
155255249|NCT04212091|560364175|FG002|Overall Study|Lost to Follow-up|0|||
155255250|NCT04212091|560364176|FG003|Overall Study|Lost to Follow-up|0|||
155255251|NCT04212091|560364177|FG004|Overall Study|Lost to Follow-up|1|||
155255252|NCT04212091|560364178|FG005|Overall Study|Lost to Follow-up|1|||
155255253|NCT04212091|560364173|FG000|Overall Study|Participant unable to adhere to visit|0|||
155255254|NCT04212091|560364174|FG001|Overall Study|Participant unable to adhere to visit|0|||
155255255|NCT04212091|560364175|FG002|Overall Study|Participant unable to adhere to visit|0|||
155255256|NCT04212091|560364176|FG003|Overall Study|Participant unable to adhere to visit|0|||
155255257|NCT04212091|560364177|FG004|Overall Study|Participant unable to adhere to visit|1|||
155255258|NCT04212091|560364178|FG005|Overall Study|Participant unable to adhere to visit|0|||
155255259|NCT03492281|560364179|FG000|Overall Study|Withdrawal by Subject|21|||
155255260|NCT03492281|560364180|FG001|Overall Study|Withdrawal by Subject|14|||
155255261|NCT03492281|560364181|FG002|Overall Study|Withdrawal by Subject|13|||
155255262|NCT03492281|560364179|FG000|Overall Study|Lost to Follow-up|14|||
155255263|NCT03492281|560364180|FG001|Overall Study|Lost to Follow-up|15|||
155255264|NCT03492281|560364181|FG002|Overall Study|Lost to Follow-up|10|||
155255265|NCT03492281|560364179|FG000|Overall Study|Adverse Event|6|||
155255266|NCT03492281|560364180|FG001|Overall Study|Adverse Event|8|||
155255267|NCT03492281|560364181|FG002|Overall Study|Adverse Event|13|||
155255268|NCT03492281|560364179|FG000|Overall Study|Lack of Efficacy|3|||
155255269|NCT03492281|560364180|FG001|Overall Study|Lack of Efficacy|0|||
155255270|NCT03492281|560364181|FG002|Overall Study|Lack of Efficacy|1|||
155255271|NCT03492281|560364179|FG000|Overall Study|Physician Decision|1|||
155255272|NCT03492281|560364180|FG001|Overall Study|Physician Decision|0|||
155255273|NCT03492281|560364181|FG002|Overall Study|Physician Decision|3|||
155255274|NCT03492281|560364179|FG000|Overall Study|Protocol Violation|0|||
155255275|NCT03492281|560364180|FG001|Overall Study|Protocol Violation|2|||
155255276|NCT03492281|560364181|FG002|Overall Study|Protocol Violation|1|||
155255277|NCT03492281|560364179|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
155255278|NCT03492281|560364180|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
155255279|NCT03492281|560364181|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
155255280|NCT03492281|560364179|FG000|Overall Study|Death|0|||
155255281|NCT03492281|560364180|FG001|Overall Study|Death|0|||
155255282|NCT03492281|560364181|FG002|Overall Study|Death|1|||
155255283|NCT03492281|560364179|FG000|Overall Study|Captured as Other in Database|8|||
155255284|NCT03492281|560364180|FG001|Overall Study|Captured as Other in Database|6|||
155255285|NCT03492281|560364181|FG002|Overall Study|Captured as Other in Database|3|||
155255286|NCT00587964|560364182|FG000|Overall Study|Withdrawal by Subject|1|||
155255287|NCT00587964|560364182|FG000|Overall Study|Lost to Follow-up|1|||
155255288|NCT00587964|560364182|FG000|Overall Study|Patient found to be ineligible|1|||
155255289|NCT00587964|560364182|FG000|Overall Study|Patient did not receive intervention|5|||
155255290|NCT00587964|560364182|FG000|Overall Study|Progression of Disease|4|||
155255291|NCT00818753|560364188|FG000|Overall Study|Protocol Violation|1|||
155255292|NCT00818753|560364189|FG001|Overall Study|Protocol Violation|0|||
155255293|NCT00818753|560364190|FG002|Overall Study|Protocol Violation|0|||
155255294|NCT00818753|560364188|FG000|Overall Study|Other reason (not specified)|0|||
155255295|NCT00818753|560364189|FG001|Overall Study|Other reason (not specified)|0|||
155255296|NCT00818753|560364190|FG002|Overall Study|Other reason (not specified)|1|||
155255297|NCT00818753|560364188|FG000|Overall Study|Randomised and not treated|2|||
155255298|NCT00818753|560364189|FG001|Overall Study|Randomised and not treated|0|||
155255299|NCT00818753|560364190|FG002|Overall Study|Randomised and not treated|0|||
155255300|NCT01389973|560364191|FG000|Overall Study|Lost to Follow-up|1|||
155255301|NCT01389973|560364191|FG000|Overall Study|Trial Stopped by Sponsor|9|||
155255302|NCT01389973|560364191|FG000|Overall Study|Other|10|||
155255303|NCT02693743|560364192|FG000|Overall Study|Physician Decision|1|||
155255304|NCT02693743|560364193|FG001|Overall Study|Physician Decision|0|||
155255305|NCT02626780|560364194|FG000|Overall Study|Withdrawal by Subject|3|||
155255306|NCT04304833|560364195|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
155255307|NCT04304833|560364196|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
155255308|NCT02858895|560364197|FG000|Overall Study|Disease progression|31|||
155255309|NCT02858895|560364197|FG000|Overall Study|Death|2|||
155255310|NCT02858895|560364197|FG000|Overall Study|Adverse Event|1|||
155255311|NCT02858895|560364197|FG000|Overall Study|Withdrawal by Subject|3|||
155255312|NCT02858895|560364197|FG000|Overall Study|hospice,|1|||
155255313|NCT02858895|560364197|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
155255314|NCT05338333|560364202|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
155255315|NCT05338333|560364203|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
155255316|NCT00251745|560364204|FG000|Overall Study|Adverse Event|7|||
155255317|NCT00251745|560364205|FG001|Overall Study|Adverse Event|9|||
155255318|NCT00251745|560364206|FG002|Overall Study|Adverse Event|11|||
155255319|NCT00251745|560364204|FG000|Overall Study|Lost to Follow-up|4|||
155255320|NCT00251745|560364205|FG001|Overall Study|Lost to Follow-up|2|||
155255321|NCT00251745|560364206|FG002|Overall Study|Lost to Follow-up|5|||
155255322|NCT00251745|560364204|FG000|Overall Study|Withdrawal by Subject|13|||
155255323|NCT00251745|560364205|FG001|Overall Study|Withdrawal by Subject|7|||
155255324|NCT00251745|560364206|FG002|Overall Study|Withdrawal by Subject|3|||
155255325|NCT00251745|560364204|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155255326|NCT00251745|560364205|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
155255327|NCT00251745|560364206|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
155255328|NCT00251745|560364204|FG000|Overall Study|Lack of Efficacy|3|||
155255329|NCT00251745|560364205|FG001|Overall Study|Lack of Efficacy|0|||
155255330|NCT00251745|560364206|FG002|Overall Study|Lack of Efficacy|0|||
155255331|NCT00251745|560364204|FG000|Overall Study|Noncompliant|0|||
155255332|NCT00251745|560364205|FG001|Overall Study|Noncompliant|2|||
155255333|NCT00251745|560364206|FG002|Overall Study|Noncompliant|2|||
155255334|NCT00251745|560364204|FG000|Overall Study|Pregnancy|0|||
155255335|NCT00251745|560364205|FG001|Overall Study|Pregnancy|1|||
155255336|NCT00251745|560364206|FG002|Overall Study|Pregnancy|0|||
155491695|NCT00762073|561225491|FG000|Overall Study|Withdrawal by Subject|1|||
155255337|NCT00251745|560364204|FG000|Overall Study|Per Subject Request|0|||
155255338|NCT00251745|560364205|FG001|Overall Study|Per Subject Request|0|||
155255339|NCT00251745|560364206|FG002|Overall Study|Per Subject Request|1|||
155255340|NCT00251745|560364204|FG000|Overall Study|Per Investigator Request|1|||
155255341|NCT00251745|560364205|FG001|Overall Study|Per Investigator Request|0|||
155255342|NCT00251745|560364206|FG002|Overall Study|Per Investigator Request|0|||
155255343|NCT00512148|560366552|FG000|Primay Study Period|Withdrawal by Subject|1|||
155255344|NCT03284788|560366557|FG000|Overall Study|Withdrawal by Subject|2|||
155255345|NCT04605978|560366558|FG000|Overall Study|Adverse Event|2|||
155255346|NCT04605978|560366559|FG001|Overall Study|Adverse Event|1|||
155255347|NCT04605978|560366558|FG000|Overall Study|Withdrawal nonmedical reason|1|||
155255348|NCT04605978|560366559|FG001|Overall Study|Withdrawal nonmedical reason|1|||
155255349|NCT03813238|560366560|FG000|Overall Study|Adverse Event|0|||
155255350|NCT03813238|560366561|FG001|Overall Study|Adverse Event|6|||
155255351|NCT03813238|560366560|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155255352|NCT03813238|560366561|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155255353|NCT03813238|560366560|FG000|Overall Study|Lost to Follow-up|0|||
155255354|NCT03813238|560366561|FG001|Overall Study|Lost to Follow-up|1|||
155255355|NCT03813238|560366560|FG000|Overall Study|Other than specified|1|||
155255356|NCT03813238|560366561|FG001|Overall Study|Other than specified|2|||
155255357|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
155255358|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
155255359|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
155255360|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
155255361|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
155255362|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155255363|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
155255364|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
155255365|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
155255366|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
155255367|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
155255368|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
155255369|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Death|6|||
155255370|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Death|3|||
155255371|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Death|0|||
155255372|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Death|1|||
155255373|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Death|1|||
155255374|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Death|0|||
155255375|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255376|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255377|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
155255378|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
155255379|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255380|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
155255381|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255382|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
155255383|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
155255384|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255385|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255386|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255387|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
155255388|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
155255389|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
155255390|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
155255391|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
155255392|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
155255393|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
155255394|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
155255395|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
155255396|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
155255397|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
155255398|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
155255399|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
155255400|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
155255401|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
155255402|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
155255403|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
155255404|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
155255405|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255406|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255407|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255408|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255409|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255410|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
155255411|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Death|0|||
155255412|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Death|0|||
155255413|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Death|0|||
155255414|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Death|0|||
155255415|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Death|0|||
155255416|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Death|107|||
155255417|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255418|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255419|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255420|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255421|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255422|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
155255423|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255424|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255425|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255426|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255427|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255428|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
155255429|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255430|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255431|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255432|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255433|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255434|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
155255435|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
155255436|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
155255437|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
155255438|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
155255439|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
155255440|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
155255441|NCT01690130|560366568|FG000|Overall Study|Subject have cancelled visit.|1|||
155255442|NCT01690130|560366569|FG001|Overall Study|Subject have cancelled visit.|0|||
155255443|NCT00605293|560366570|FG000|Overall Study|Death|2|||
155255444|NCT00605293|560366571|FG001|Overall Study|Death|1|||
155255445|NCT00605293|560366570|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155255446|NCT00605293|560366571|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155255447|NCT00605293|560366570|FG000|Overall Study|Adverse Event|1|||
155255448|NCT00605293|560366571|FG001|Overall Study|Adverse Event|0|||
155255449|NCT00605293|560366570|FG000|Overall Study|Holidays Dialysis Out|1|||
155255450|NCT00605293|560366571|FG001|Overall Study|Holidays Dialysis Out|0|||
155255451|NCT00605293|560366570|FG000|Overall Study|Blood Transfusion|7|||
155255452|NCT00605293|560366571|FG001|Overall Study|Blood Transfusion|1|||
155255453|NCT00605293|560366570|FG000|Overall Study|Renal Transplantation|3|||
155255454|NCT00605293|560366571|FG001|Overall Study|Renal Transplantation|1|||
155255455|NCT00605293|560366570|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
155255456|NCT00605293|560366571|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
155255457|NCT00605293|560366570|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
155255458|NCT00605293|560366571|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
155255459|NCT00605293|560366570|FG000|Overall Study|Principal Investigator Decision|0|||
155255460|NCT00605293|560366571|FG001|Overall Study|Principal Investigator Decision|1|||
155255461|NCT03581981|560366572|FG000|Overall Study|Withdrawal by Subject|12|||
155255462|NCT03581981|560366573|FG001|Overall Study|Withdrawal by Subject|13|||
155255463|NCT03581981|560366572|FG000|Overall Study|Physician Decision|1|||
155255464|NCT03581981|560366573|FG001|Overall Study|Physician Decision|2|||
155255465|NCT03581981|560366572|FG000|Overall Study|Lost to Follow-up|0|||
155255466|NCT03581981|560366573|FG001|Overall Study|Lost to Follow-up|4|||
155255467|NCT00420199|560366576|FG000|Overall Study|Participant no longer met study criteria|1|||
155255468|NCT00420199|560366577|FG001|Overall Study|Participant no longer met study criteria|0|||
155255469|NCT01260350|560366582|FG000|Overall Study|Lack of Efficacy|0|||
155255470|NCT01260350|560366583|FG001|Overall Study|Lack of Efficacy|0|||
155255471|NCT01260350|560366584|FG002|Overall Study|Lack of Efficacy|0|||
155255472|NCT01260350|560366585|FG003|Overall Study|Lack of Efficacy|0|||
155255473|NCT01260350|560366586|FG004|Overall Study|Lack of Efficacy|0|||
155255474|NCT01260350|560366587|FG005|Overall Study|Lack of Efficacy|0|||
155255475|NCT01260350|560366588|FG006|Overall Study|Lack of Efficacy|0|||
155255476|NCT01260350|560366589|FG007|Overall Study|Lack of Efficacy|0|||
155255477|NCT01260350|560366590|FG008|Overall Study|Lack of Efficacy|0|||
155255478|NCT01260350|560366591|FG009|Overall Study|Lack of Efficacy|0|||
155255479|NCT01260350|560366592|FG010|Overall Study|Lack of Efficacy|0|||
155255480|NCT01260350|560366593|FG011|Overall Study|Lack of Efficacy|0|||
155255481|NCT01260350|560366594|FG012|Overall Study|Lack of Efficacy|0|||
155255482|NCT01260350|560366595|FG013|Overall Study|Lack of Efficacy|0|||
155255483|NCT01260350|560366596|FG014|Overall Study|Lack of Efficacy|0|||
155255484|NCT01260350|560366597|FG015|Overall Study|Lack of Efficacy|0|||
155255485|NCT01260350|560366598|FG016|Overall Study|Lack of Efficacy|0|||
155255486|NCT01260350|560366599|FG017|Overall Study|Lack of Efficacy|1|||
155255487|NCT01260350|560366600|FG018|Overall Study|Lack of Efficacy|0|||
155255488|NCT01260350|560366601|FG019|Overall Study|Lack of Efficacy|0|||
155255489|NCT01260350|560366602|FG020|Overall Study|Lack of Efficacy|3|||
155255490|NCT01260350|560366603|FG021|Overall Study|Lack of Efficacy|0|||
155255491|NCT01260350|560366582|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255492|NCT01260350|560366583|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255493|NCT01260350|560366584|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255494|NCT01260350|560366585|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255495|NCT01260350|560366586|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255496|NCT01260350|560366587|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255497|NCT01260350|560366588|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255498|NCT01260350|560366589|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255499|NCT01260350|560366590|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
155255500|NCT01260350|560366591|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255501|NCT01260350|560366592|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255502|NCT01260350|560366593|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255503|NCT01260350|560366594|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255504|NCT01260350|560366595|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255505|NCT01260350|560366596|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255506|NCT01260350|560366597|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255507|NCT01260350|560366598|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255508|NCT01260350|560366599|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255509|NCT01260350|560366600|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255510|NCT01260350|560366601|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255511|NCT01260350|560366602|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255512|NCT01260350|560366603|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255513|NCT02570126|560366606|FG000|Overall Study|Lost to Follow-up|2|||
155255514|NCT02570126|560366607|FG001|Overall Study|Lost to Follow-up|0|||
155255515|NCT02570126|560366606|FG000|Overall Study|Unable To Arrange Visit 3|1|||
155255516|NCT02570126|560366607|FG001|Overall Study|Unable To Arrange Visit 3|0|||
155255517|NCT02570126|560366606|FG000|Overall Study|Violation Of Procedures GSK|0|||
155255518|NCT02570126|560366607|FG001|Overall Study|Violation Of Procedures GSK|1|||
155255519|NCT02570126|560366606|FG000|Overall Study|Protocol Violation|0|||
155255520|NCT02570126|560366607|FG001|Overall Study|Protocol Violation|1|||
155255521|NCT02570126|560366606|FG000|Overall Study|Withdrawal by Subject|3|||
155255522|NCT02570126|560366607|FG001|Overall Study|Withdrawal by Subject|7|||
155255523|NCT00626028|560366608|FG000|Overall Study|Adverse Event|1|||
155255524|NCT00626028|560366609|FG001|Overall Study|Adverse Event|1|||
155255525|NCT00626028|560366608|FG000|Overall Study|Device Failure|0|||
155255526|NCT00626028|560366609|FG001|Overall Study|Device Failure|1|||
155255527|NCT00626028|560366608|FG000|Overall Study|Physician Decision|2|||
155255528|NCT00626028|560366609|FG001|Overall Study|Physician Decision|1|||
155255529|NCT00626028|560366608|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
155255530|NCT00626028|560366609|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
155255531|NCT05224050|560366610|FG000|Overall Study|Withdrawal by Subject|9|||
155255532|NCT05224050|560366610|FG000|Overall Study|Lost to Follow-up|3|||
155255533|NCT00917579|560366612|FG000|Washout >= 2 Weeks|Adverse Event|1|||
155255534|NCT00917579|560366613|FG001|Washout >= 2 Weeks|Adverse Event|0|||
155255535|NCT00917579|560366612|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
155255536|NCT00917579|560366613|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
155255537|NCT00754338|560366614|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255538|NCT00754338|560366615|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
155255539|NCT00754338|560366616|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
155255540|NCT00754338|560366617|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255541|NCT00754338|560366614|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255542|NCT00754338|560366615|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
155255543|NCT00754338|560366616|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255544|NCT00754338|560366617|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
155255545|NCT00831779|560366620|FG000|Overall Study|Lost to Follow-up|1|||
155255546|NCT00831779|560366621|FG001|Overall Study|Lost to Follow-up|0|||
155255547|NCT00831779|560366620|FG000|Overall Study|No longer met criteria|0|||
155255548|NCT00831779|560366621|FG001|Overall Study|No longer met criteria|1|||
155255549|NCT04020341|560366622|FG000|Overall Study|Adverse Event|8|||
155255550|NCT04020341|560366623|FG001|Overall Study|Adverse Event|6|||
155255551|NCT04020341|560366622|FG000|Overall Study|Lost to Follow-up|8|||
155255552|NCT04020341|560366623|FG001|Overall Study|Lost to Follow-up|2|||
155255553|NCT04020341|560366622|FG000|Overall Study|Withdrawal by Subject|16|||
155255554|NCT04020341|560366623|FG001|Overall Study|Withdrawal by Subject|16|||
155255555|NCT04020341|560366622|FG000|Overall Study|Participant not able to swallow the tablet|1|||
155255556|NCT04020341|560366623|FG001|Overall Study|Participant not able to swallow the tablet|0|||
155255557|NCT04020341|560366622|FG000|Overall Study|Physician Decision|0|||
155255558|NCT04020341|560366623|FG001|Overall Study|Physician Decision|2|||
155255559|NCT04020341|560366622|FG000|Overall Study|Protocol Deviation|0|||
155255560|NCT04020341|560366623|FG001|Overall Study|Protocol Deviation|2|||
155255561|NCT05763628|560366624|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
155255562|NCT05763628|560366625|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
155255563|NCT05763628|560366624|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
155255564|NCT05763628|560366625|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
155255565|NCT05763628|560366624|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
155255566|NCT05763628|560366625|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
155255567|NCT04683926|560366633|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
155255568|NCT04683926|560366634|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
155255569|NCT04683926|560366635|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
155255570|NCT04683926|560366636|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
155255571|NCT04385368|560366638|FG000|Overall Study|Death|5|||
155255572|NCT04385368|560366639|FG001|Overall Study|Death|5|||
155255573|NCT04385368|560366638|FG000|Overall Study|Physician Decision|3|||
155255574|NCT04385368|560366639|FG001|Overall Study|Physician Decision|0|||
155255575|NCT04385368|560366638|FG000|Overall Study|Withdrawal by Subject|4|||
155255576|NCT04385368|560366639|FG001|Overall Study|Withdrawal by Subject|3|||
155255577|NCT02054806|560366641|FG000|Overall Study|Sponsor Decision|31|||
155255578|NCT02054806|560366641|FG000|Overall Study|Withdrawal by Subject|43|||
155255579|NCT02054806|560366641|FG000|Overall Study|Protocol Violation|2|||
155255580|NCT02054806|560366641|FG000|Overall Study|Lost to Follow-up|10|||
155255581|NCT02054806|560366641|FG000|Overall Study|Death|391|||
155255582|NCT04721925|560366642|FG000|2-Month Assessment|Lost to Follow-up|5|||
155255583|NCT04721925|560366643|FG001|2-Month Assessment|Lost to Follow-up|3|||
155255584|NCT04721925|560366642|FG000|4-Month Assessment|Lost to Follow-up|3|||
155255585|NCT04721925|560366643|FG001|4-Month Assessment|Lost to Follow-up|6|||
155255586|NCT00677235|560366644|FG000|Overall Study|Withdrawal by Subject|1|||
155255587|NCT00677235|560366645|FG001|Overall Study|Withdrawal by Subject|1|||
155255588|NCT00677235|560366644|FG000|Overall Study|Lost to Follow-up|2|||
155255589|NCT00677235|560366645|FG001|Overall Study|Lost to Follow-up|1|||
155255590|NCT00677235|560366644|FG000|Overall Study|Death|37|||
155255591|NCT00677235|560366645|FG001|Overall Study|Death|36|||
155255592|NCT00677235|560366644|FG000|Overall Study|Adverse Experience|1|||
155255593|NCT00677235|560366645|FG001|Overall Study|Adverse Experience|0|||
155255594|NCT05072080|560366658|FG000|Overall Study|Death|0|||
155255595|NCT05072080|560366659|FG001|Overall Study|Death|0|||
155255596|NCT05072080|560366660|FG002|Overall Study|Death|1|||
155255597|NCT05072080|560366661|FG003|Overall Study|Death|0|||
155255598|NCT05072080|560366658|FG000|Overall Study|Lost to Follow-up|65|||
155255599|NCT05072080|560366659|FG001|Overall Study|Lost to Follow-up|70|||
155255600|NCT05072080|560366660|FG002|Overall Study|Lost to Follow-up|58|||
155255601|NCT05072080|560366661|FG003|Overall Study|Lost to Follow-up|23|||
155255602|NCT05072080|560366658|FG000|Overall Study|Physician Decision|2|||
155255603|NCT05072080|560366659|FG001|Overall Study|Physician Decision|1|||
155255604|NCT05072080|560366660|FG002|Overall Study|Physician Decision|1|||
155255605|NCT05072080|560366661|FG003|Overall Study|Physician Decision|0|||
155255606|NCT05072080|560366658|FG000|Overall Study|Withdrawal by Subject|45|||
155255607|NCT05072080|560366659|FG001|Overall Study|Withdrawal by Subject|30|||
155255608|NCT05072080|560366660|FG002|Overall Study|Withdrawal by Subject|27|||
155255609|NCT05072080|560366661|FG003|Overall Study|Withdrawal by Subject|7|||
155255610|NCT05072080|560366658|FG000|Overall Study|Sponsor Decision|0|||
155255611|NCT05072080|560366659|FG001|Overall Study|Sponsor Decision|1|||
155255612|NCT05072080|560366660|FG002|Overall Study|Sponsor Decision|0|||
155255613|NCT05072080|560366661|FG003|Overall Study|Sponsor Decision|0|||
155255614|NCT05072080|560366658|FG000|Overall Study|Subject moved|1|||
155255615|NCT05072080|560366659|FG001|Overall Study|Subject moved|3|||
155255616|NCT05072080|560366660|FG002|Overall Study|Subject moved|5|||
155255617|NCT05072080|560366661|FG003|Overall Study|Subject moved|2|||
155255618|NCT05072080|560366658|FG000|Overall Study|Withdrawal by parent|0|||
155255619|NCT05072080|560366659|FG001|Overall Study|Withdrawal by parent|0|||
155255620|NCT05072080|560366660|FG002|Overall Study|Withdrawal by parent|1|||
155255621|NCT05072080|560366661|FG003|Overall Study|Withdrawal by parent|0|||
155255622|NCT05072080|560366658|FG000|Overall Study|Subject was deployed|0|||
155255623|NCT05072080|560366659|FG001|Overall Study|Subject was deployed|1|||
155255624|NCT05072080|560366660|FG002|Overall Study|Subject was deployed|0|||
155255625|NCT05072080|560366661|FG003|Overall Study|Subject was deployed|0|||
155255626|NCT05072080|560366658|FG000|Overall Study|Subject left site without receiving dose|0|||
155255627|NCT05072080|560366659|FG001|Overall Study|Subject left site without receiving dose|1|||
155255628|NCT05072080|560366660|FG002|Overall Study|Subject left site without receiving dose|0|||
155255629|NCT05072080|560366661|FG003|Overall Study|Subject left site without receiving dose|0|||
155255630|NCT05072080|560366658|FG000|Overall Study|Subject incarcerated|0|||
155255631|NCT05072080|560366659|FG001|Overall Study|Subject incarcerated|1|||
155255632|NCT05072080|560366660|FG002|Overall Study|Subject incarcerated|0|||
155255633|NCT05072080|560366661|FG003|Overall Study|Subject incarcerated|1|||
155255634|NCT05072080|560366658|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
155255635|NCT05072080|560366659|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
155255636|NCT05072080|560366660|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
155255637|NCT05072080|560366661|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
155255638|NCT05072080|560366658|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
155255639|NCT05072080|560366659|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
155255640|NCT05072080|560366660|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
155255641|NCT05072080|560366661|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
155255642|NCT03205371|560366663|FG000|Overall Study|Withdrawal by Subject|4|||
155255643|NCT03205371|560366664|FG001|Overall Study|Withdrawal by Subject|1|||
155255644|NCT03205371|560366665|FG002|Overall Study|Withdrawal by Subject|0|||
155255645|NCT03205371|560366666|FG003|Overall Study|Withdrawal by Subject|0|||
155255646|NCT03205371|560366667|FG004|Overall Study|Withdrawal by Subject|0|||
155255647|NCT03205371|560366668|FG005|Overall Study|Withdrawal by Subject|0|||
155255648|NCT03205371|560366669|FG006|Overall Study|Withdrawal by Subject|4|||
155255649|NCT03205371|560366670|FG007|Overall Study|Withdrawal by Subject|0|||
155255650|NCT03205371|560366671|FG008|Overall Study|Withdrawal by Subject|2|||
155255651|NCT03205371|560366672|FG009|Overall Study|Withdrawal by Subject|0|||
155255652|NCT03205371|560366673|FG010|Overall Study|Withdrawal by Subject|0|||
155255653|NCT03205371|560366674|FG011|Overall Study|Withdrawal by Subject|1|||
155255654|NCT03205371|560366663|FG000|Overall Study|Lost to Follow-up|0|||
155255655|NCT03205371|560366664|FG001|Overall Study|Lost to Follow-up|0|||
155255656|NCT03205371|560366665|FG002|Overall Study|Lost to Follow-up|0|||
155255657|NCT03205371|560366666|FG003|Overall Study|Lost to Follow-up|0|||
155255658|NCT03205371|560366667|FG004|Overall Study|Lost to Follow-up|0|||
155255659|NCT03205371|560366668|FG005|Overall Study|Lost to Follow-up|0|||
155255660|NCT03205371|560366669|FG006|Overall Study|Lost to Follow-up|5|||
155255661|NCT03205371|560366670|FG007|Overall Study|Lost to Follow-up|2|||
155255662|NCT03205371|560366671|FG008|Overall Study|Lost to Follow-up|3|||
155255663|NCT03205371|560366672|FG009|Overall Study|Lost to Follow-up|0|||
155255664|NCT03205371|560366673|FG010|Overall Study|Lost to Follow-up|0|||
155255665|NCT03205371|560366674|FG011|Overall Study|Lost to Follow-up|0|||
155255666|NCT03205371|560366663|FG000|Overall Study|Protocol Violation|0|||
155255667|NCT03205371|560366664|FG001|Overall Study|Protocol Violation|0|||
155255668|NCT03205371|560366665|FG002|Overall Study|Protocol Violation|0|||
155255669|NCT03205371|560366666|FG003|Overall Study|Protocol Violation|0|||
155255670|NCT03205371|560366667|FG004|Overall Study|Protocol Violation|0|||
155255671|NCT03205371|560366668|FG005|Overall Study|Protocol Violation|0|||
155255672|NCT03205371|560366669|FG006|Overall Study|Protocol Violation|1|||
155255673|NCT03205371|560366670|FG007|Overall Study|Protocol Violation|0|||
155255674|NCT03205371|560366671|FG008|Overall Study|Protocol Violation|0|||
155255675|NCT03205371|560366672|FG009|Overall Study|Protocol Violation|0|||
155255676|NCT03205371|560366673|FG010|Overall Study|Protocol Violation|0|||
155255677|NCT03205371|560366674|FG011|Overall Study|Protocol Violation|0|||
155255678|NCT03205371|560366663|FG000|Overall Study|Adverse Event|0|||
155255679|NCT03205371|560366664|FG001|Overall Study|Adverse Event|0|||
155255680|NCT03205371|560366665|FG002|Overall Study|Adverse Event|0|||
155255681|NCT03205371|560366666|FG003|Overall Study|Adverse Event|0|||
155255682|NCT03205371|560366667|FG004|Overall Study|Adverse Event|0|||
155255683|NCT03205371|560366668|FG005|Overall Study|Adverse Event|0|||
155255684|NCT03205371|560366669|FG006|Overall Study|Adverse Event|0|||
155255685|NCT03205371|560366670|FG007|Overall Study|Adverse Event|1|||
155255686|NCT03205371|560366671|FG008|Overall Study|Adverse Event|0|||
155255687|NCT03205371|560366672|FG009|Overall Study|Adverse Event|0|||
155255688|NCT03205371|560366673|FG010|Overall Study|Adverse Event|0|||
155255689|NCT03205371|560366674|FG011|Overall Study|Adverse Event|0|||
155255690|NCT04918147|560366684|FG000|Overall Study|Disease flare as defined in protocol|0|||
155255691|NCT04918147|560366685|FG001|Overall Study|Disease flare as defined in protocol|2|||
155255692|NCT03565887|560366686|FG000|Overall Study|Adverse Event|1|||
155255693|NCT03565887|560366687|FG001|Overall Study|Adverse Event|0|||
155255694|NCT03565887|560366686|FG000|Overall Study|Withdrawal by Subject|0|||
155255695|NCT03565887|560366687|FG001|Overall Study|Withdrawal by Subject|2|||
155255696|NCT02975973|560366688|FG000|Overall Study|Adverse Event|1|||
155255697|NCT02975973|560366689|FG001|Overall Study|Adverse Event|1|||
155255698|NCT02975973|560366690|FG002|Overall Study|Adverse Event|1|||
155255699|NCT02975973|560366691|FG003|Overall Study|Adverse Event|0|||
155255700|NCT03804710|560366692|FG000|Overall Study|Adverse Event|0|||
155255701|NCT03804710|560366693|FG001|Overall Study|Adverse Event|3|||
155255702|NCT03804710|560366692|FG000|Overall Study|Withdrawal by Subject|2|||
155255703|NCT03804710|560366693|FG001|Overall Study|Withdrawal by Subject|1|||
155255704|NCT03804710|560366692|FG000|Overall Study|Other|0|||
155255705|NCT03804710|560366693|FG001|Overall Study|Other|1|||
155255706|NCT03182868|560366696|FG000|Overall Study|Protocol Violation|3|||
155255707|NCT03182868|560366697|FG001|Overall Study|Protocol Violation|0|||
155255708|NCT03182868|560366698|FG002|Overall Study|Protocol Violation|4|||
155255709|NCT03182868|560366699|FG003|Overall Study|Protocol Violation|1|||
155255710|NCT03182868|560366700|FG004|Overall Study|Protocol Violation|8|||
155255711|NCT02191267|560366702|FG000|Overall Study|Withdrawal by Subject|1|||
155255712|NCT02191267|560366703|FG001|Overall Study|Withdrawal by Subject|0|||
155255713|NCT02191267|560366704|FG002|Overall Study|Withdrawal by Subject|0|||
155255714|NCT01830127|560366710|FG000|Overall Study|Adverse Event|1|||
155255715|NCT01830127|560366711|FG001|Overall Study|Adverse Event|6|||
155255716|NCT01830127|560366710|FG000|Overall Study|Lack of Efficacy|3|||
155255717|NCT01830127|560366711|FG001|Overall Study|Lack of Efficacy|0|||
155255718|NCT01830127|560366710|FG000|Overall Study|Withdrawal by Subject|1|||
155255719|NCT01830127|560366711|FG001|Overall Study|Withdrawal by Subject|1|||
155255720|NCT01830127|560366710|FG000|Overall Study|Other reason not defined above|0|||
155255721|NCT01830127|560366711|FG001|Overall Study|Other reason not defined above|2|||
155255722|NCT00941330|560366716|FG000|Overall Study|Other|1|||
155255723|NCT00941330|560366717|FG001|Overall Study|Other|0|||
155255724|NCT00941330|560366716|FG000|Overall Study|Physician Decision|0|||
155255725|NCT00941330|560366717|FG001|Overall Study|Physician Decision|2|||
155255726|NCT00951275|560366718|FG000|Overall Study|Administrative Reason|1|||
155255727|NCT00951275|560366718|FG000|Overall Study|Adverse Event|7|||
155255728|NCT00951275|560366718|FG000|Overall Study|Withdrawal by Subject|4|||
155255729|NCT00951275|560366718|FG000|Overall Study|Protocol Violation|1|||
155255730|NCT03260868|560366719|FG000|Overall Study|Poor Compliance to Protocol|0|||
155255731|NCT03260868|560366720|FG001|Overall Study|Poor Compliance to Protocol|2|||
155255732|NCT03260868|560366719|FG000|Overall Study|Study Terminated By Sponsor|2|||
155255733|NCT03260868|560366720|FG001|Overall Study|Study Terminated By Sponsor|1|||
155255734|NCT03260868|560366719|FG000|Overall Study|Other than specified above|1|||
155255735|NCT03260868|560366720|FG001|Overall Study|Other than specified above|0|||
155255736|NCT00541450|560366721|FG000|Phase A|Adverse Event|3|||
155255737|NCT00541450|560366722|FG001|Phase A|Adverse Event|0|||
155255738|NCT00541450|560366721|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
155255739|NCT00541450|560366722|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
155255740|NCT00541450|560366721|FG000|Phase A|Hyperglycemia|0|||
155255741|NCT00541450|560366722|FG001|Phase A|Hyperglycemia|1|||
155255742|NCT00541450|560366721|FG000|Phase A|Lost to Follow-up|6|||
155255743|NCT00541450|560366722|FG001|Phase A|Lost to Follow-up|4|||
155255744|NCT00541450|560366721|FG000|Phase A|Physician Decision|2|||
155255745|NCT00541450|560366722|FG001|Phase A|Physician Decision|0|||
155255746|NCT00541450|560366721|FG000|Phase A|Protocol Violation|2|||
155255747|NCT00541450|560366722|FG001|Phase A|Protocol Violation|3|||
155255748|NCT00541450|560366721|FG000|Phase A|Withdrawal by Subject|7|||
155255749|NCT00541450|560366722|FG001|Phase A|Withdrawal by Subject|7|||
155255750|NCT00541450|560366721|FG000|Phase B|Adverse Event|6|||
155255751|NCT00541450|560366722|FG001|Phase B|Adverse Event|6|||
155255752|NCT00541450|560366721|FG000|Phase B|Hyperglycemia|10|||
155255753|NCT00541450|560366722|FG001|Phase B|Hyperglycemia|9|||
155255754|NCT00541450|560366721|FG000|Phase B|Lost to Follow-up|6|||
155255755|NCT00541450|560366722|FG001|Phase B|Lost to Follow-up|4|||
155255756|NCT00541450|560366721|FG000|Phase B|Physician Decision|4|||
155255757|NCT00541450|560366722|FG001|Phase B|Physician Decision|2|||
155255758|NCT00541450|560366721|FG000|Phase B|Pregnancy|0|||
155255759|NCT00541450|560366722|FG001|Phase B|Pregnancy|1|||
155255760|NCT00541450|560366721|FG000|Phase B|Protocol Violation|3|||
155255761|NCT00541450|560366722|FG001|Phase B|Protocol Violation|3|||
155255762|NCT00541450|560366721|FG000|Phase B|Withdrawal by Subject|8|||
155255763|NCT00541450|560366722|FG001|Phase B|Withdrawal by Subject|6|||
155255764|NCT01112579|560366723|FG000|Overall Study|Missed Visit|1|||
155255765|NCT01112579|560366724|FG001|Overall Study|Missed Visit|1|||
155255766|NCT01112579|560366723|FG000|Overall Study|Death|0|||
155255767|NCT01112579|560366724|FG001|Overall Study|Death|2|||
155255768|NCT03645759|560366725|FG000|Overall Study|Lost to Follow-up|3|||
155255769|NCT03645759|560366726|FG001|Overall Study|Lost to Follow-up|2|||
155255770|NCT00902694|560366727|FG000|Overall Study|Death|1|||
155255771|NCT00902694|560366728|FG001|Overall Study|Death|3|||
155255772|NCT00902694|560366727|FG000|Overall Study|Lost to Follow-up|1|||
155255773|NCT00902694|560366728|FG001|Overall Study|Lost to Follow-up|0|||
155255774|NCT00902694|560366727|FG000|Overall Study|Censored per protocol|3|||
155255775|NCT00902694|560366728|FG001|Overall Study|Censored per protocol|1|||
155255776|NCT00902694|560366727|FG000|Overall Study|Pregnancy|1|||
155255777|NCT00902694|560366728|FG001|Overall Study|Pregnancy|1|||
155255778|NCT00902694|560366727|FG000|Overall Study|Incarceration|1|||
155255779|NCT00902694|560366728|FG001|Overall Study|Incarceration|0|||
155255780|NCT00725296|560366729|FG000|Overall Study|Adverse Event|11|||
155255781|NCT00725296|560366729|FG000|Overall Study|Lack of Efficacy|7|||
155255782|NCT00725296|560366729|FG000|Overall Study|Withdrawal by Subject|3|||
155255783|NCT00725296|560366729|FG000|Overall Study|Non-Compliance|2|||
155255784|NCT00725296|560366729|FG000|Overall Study|Lost to Follow-up|1|||
155255785|NCT00725296|560366729|FG000|Overall Study|Other|38|||
155255786|NCT03360942|560366730|FG000|Overall Study|Device explanted|2|||
155255787|NCT03360942|560366730|FG000|Overall Study|Study closure|1|||
155255788|NCT03360942|560366730|FG000|Overall Study|Withdrawal by Subject|2|||
155255789|NCT03456700|560366731|FG000|Overall Study|Withdrawal by Subject|1|||
155255790|NCT00613951|560366734|FG000|Overall Study|Adverse Event|1|||
155255791|NCT00613951|560366735|FG001|Overall Study|Adverse Event|0|||
155255792|NCT00613951|560366736|FG002|Overall Study|Adverse Event|1|||
155255793|NCT00613951|560366734|FG000|Overall Study|Lack of Efficacy|0|||
155255794|NCT00613951|560366735|FG001|Overall Study|Lack of Efficacy|1|||
155255795|NCT00613951|560366736|FG002|Overall Study|Lack of Efficacy|1|||
155255796|NCT00613951|560366734|FG000|Overall Study|Protocol Violation|1|||
155255797|NCT00613951|560366735|FG001|Overall Study|Protocol Violation|1|||
155255798|NCT00613951|560366736|FG002|Overall Study|Protocol Violation|1|||
155255799|NCT00613951|560366734|FG000|Overall Study|Unclassified|5|||
155255800|NCT00613951|560366735|FG001|Overall Study|Unclassified|3|||
155255801|NCT00613951|560366736|FG002|Overall Study|Unclassified|2|||
155255802|NCT00655980|560366738|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
155255803|NCT00655980|560366739|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
155255804|NCT00655980|560366740|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
155255805|NCT05540522|560366742|FG000|Overall Study|Adverse Event|1|||
155255806|NCT05540522|560366743|FG001|Overall Study|Adverse Event|0|||
155255807|NCT05540522|560366744|FG002|Overall Study|Adverse Event|2|||
155255808|NCT05540522|560366745|FG003|Overall Study|Adverse Event|5|||
155255809|NCT05540522|560366742|FG000|Overall Study|Lost to Follow-up|487|||
155255810|NCT05540522|560366743|FG001|Overall Study|Lost to Follow-up|427|||
155255811|NCT05540522|560366744|FG002|Overall Study|Lost to Follow-up|146|||
155255812|NCT05540522|560366745|FG003|Overall Study|Lost to Follow-up|166|||
155255813|NCT05540522|560366742|FG000|Overall Study|Physician Decision|11|||
155255814|NCT05540522|560366743|FG001|Overall Study|Physician Decision|19|||
155255815|NCT05540522|560366744|FG002|Overall Study|Physician Decision|8|||
155255816|NCT05540522|560366745|FG003|Overall Study|Physician Decision|13|||
155255817|NCT05540522|560366742|FG000|Overall Study|Pregnancy|1|||
155255818|NCT05540522|560366743|FG001|Overall Study|Pregnancy|0|||
155255819|NCT05540522|560366744|FG002|Overall Study|Pregnancy|0|||
155255820|NCT05540522|560366745|FG003|Overall Study|Pregnancy|0|||
155255821|NCT05540522|560366742|FG000|Overall Study|Protocol Violation|3|||
155255822|NCT05540522|560366743|FG001|Overall Study|Protocol Violation|1|||
155255823|NCT05540522|560366744|FG002|Overall Study|Protocol Violation|9|||
155255824|NCT05540522|560366745|FG003|Overall Study|Protocol Violation|7|||
155255825|NCT05540522|560366742|FG000|Overall Study|Withdrawal by Subject|168|||
155255826|NCT05540522|560366743|FG001|Overall Study|Withdrawal by Subject|134|||
155255827|NCT05540522|560366744|FG002|Overall Study|Withdrawal by Subject|331|||
155255828|NCT05540522|560366745|FG003|Overall Study|Withdrawal by Subject|322|||
155255829|NCT05540522|560366742|FG000|Overall Study|Death|7|||
155255830|NCT05540522|560366743|FG001|Overall Study|Death|9|||
155255831|NCT05540522|560366744|FG002|Overall Study|Death|49|||
155255832|NCT05540522|560366745|FG003|Overall Study|Death|46|||
155255833|NCT05540522|560366742|FG000|Overall Study|Not vaccinated|34|||
155255834|NCT05540522|560366743|FG001|Overall Study|Not vaccinated|53|||
155255835|NCT05540522|560366744|FG002|Overall Study|Not vaccinated|57|||
155255836|NCT05540522|560366745|FG003|Overall Study|Not vaccinated|50|||
155255837|NCT05540522|560366742|FG000|Overall Study|No longer meets eligibility criteria|0|||
155255838|NCT05540522|560366743|FG001|Overall Study|No longer meets eligibility criteria|0|||
155255839|NCT05540522|560366744|FG002|Overall Study|No longer meets eligibility criteria|3|||
155255840|NCT05540522|560366745|FG003|Overall Study|No longer meets eligibility criteria|2|||
155255841|NCT05540522|560366742|FG000|Overall Study|Other (Unspecified)|8|||
155255842|NCT05540522|560366743|FG001|Overall Study|Other (Unspecified)|10|||
155255843|NCT05540522|560366744|FG002|Overall Study|Other (Unspecified)|4|||
155255844|NCT05540522|560366745|FG003|Overall Study|Other (Unspecified)|2|||
155255845|NCT02459574|560366749|FG000|Overall Study|Withdrawal by Subject|6|||
155255846|NCT02459574|560366750|FG001|Overall Study|Withdrawal by Subject|6|||
155255847|NCT02459574|560366751|FG002|Overall Study|Withdrawal by Subject|2|||
155255848|NCT02459574|560366749|FG000|Overall Study|Lost to Follow-up|1|||
155255849|NCT02459574|560366750|FG001|Overall Study|Lost to Follow-up|1|||
155255850|NCT02459574|560366751|FG002|Overall Study|Lost to Follow-up|0|||
155255851|NCT02459574|560366749|FG000|Overall Study|Death|0|||
155255852|NCT02459574|560366750|FG001|Overall Study|Death|1|||
155255853|NCT02459574|560366751|FG002|Overall Study|Death|0|||
155255854|NCT04508699|560366757|FG000|Overall Study|Lack of Efficacy|2|||
155255855|NCT04508699|560366758|FG001|Overall Study|Lack of Efficacy|15|||
155255856|NCT04508699|560366757|FG000|Overall Study|Withdrawal by Subject|0|||
155255857|NCT04508699|560366758|FG001|Overall Study|Withdrawal by Subject|2|||
155255858|NCT04866017|560366759|FG000|Overall Study|Study Terminated by Sponsor|13|||
155255859|NCT04866017|560366760|FG001|Overall Study|Study Terminated by Sponsor|14|||
155255860|NCT04866017|560366761|FG002|Overall Study|Study Terminated by Sponsor|13|||
155255861|NCT04866017|560366759|FG000|Overall Study|Death|8|||
155255862|NCT04866017|560366760|FG001|Overall Study|Death|4|||
155255863|NCT04866017|560366761|FG002|Overall Study|Death|8|||
155255864|NCT04866017|560366759|FG000|Overall Study|Withdrawal by Subject|1|||
155255865|NCT04866017|560366760|FG001|Overall Study|Withdrawal by Subject|0|||
155255866|NCT04866017|560366761|FG002|Overall Study|Withdrawal by Subject|1|||
155255867|NCT04866017|560366759|FG000|Overall Study|Physician Decision|0|||
155255868|NCT04866017|560366760|FG001|Overall Study|Physician Decision|1|||
155255869|NCT04866017|560366761|FG002|Overall Study|Physician Decision|0|||
155255870|NCT00506493|560366762|FG000|Overall Study|Death|6|||
155255871|NCT00506493|560366762|FG000|Overall Study|Withdrawal by Subject|5|||
155255872|NCT01266642|560366763|FG000|Overall Study|Protocol Violation|0|||
155255873|NCT01266642|560366764|FG001|Overall Study|Protocol Violation|1|||
155255874|NCT01735201|560368094|FG000|Overall Study|Adverse Event|1|||
155255875|NCT01735201|560368095|FG001|Overall Study|Adverse Event|1|||
155255876|NCT01735201|560368096|FG002|Overall Study|Adverse Event|0|||
155255877|NCT01735201|560368097|FG003|Overall Study|Adverse Event|1|||
155255878|NCT01735201|560368098|FG004|Overall Study|Adverse Event|1|||
155255879|NCT01735201|560368099|FG005|Overall Study|Adverse Event|3|||
155255880|NCT01735201|560368100|FG006|Overall Study|Adverse Event|2|||
155255881|NCT01735201|560368101|FG007|Overall Study|Adverse Event|1|||
155255882|NCT01735201|560368094|FG000|Overall Study|Personal Reasons|1|||
155255883|NCT01735201|560368095|FG001|Overall Study|Personal Reasons|0|||
155255884|NCT01735201|560368096|FG002|Overall Study|Personal Reasons|0|||
155255885|NCT01735201|560368097|FG003|Overall Study|Personal Reasons|0|||
155255886|NCT01735201|560368098|FG004|Overall Study|Personal Reasons|0|||
155255887|NCT01735201|560368099|FG005|Overall Study|Personal Reasons|0|||
155255888|NCT01735201|560368100|FG006|Overall Study|Personal Reasons|0|||
155255889|NCT01735201|560368101|FG007|Overall Study|Personal Reasons|0|||
155255890|NCT01735201|560368094|FG000|Overall Study|Protocol Violation|1|||
155255891|NCT01735201|560368095|FG001|Overall Study|Protocol Violation|0|||
155255892|NCT01735201|560368096|FG002|Overall Study|Protocol Violation|0|||
155255893|NCT01735201|560368097|FG003|Overall Study|Protocol Violation|0|||
155255894|NCT01735201|560368098|FG004|Overall Study|Protocol Violation|0|||
155255895|NCT01735201|560368099|FG005|Overall Study|Protocol Violation|0|||
155255896|NCT01735201|560368100|FG006|Overall Study|Protocol Violation|0|||
155255897|NCT01735201|560368101|FG007|Overall Study|Protocol Violation|0|||
155255898|NCT01735201|560368094|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155255899|NCT01735201|560368095|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155255900|NCT01735201|560368096|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155255901|NCT01735201|560368097|FG003|Overall Study|Other Miscellaneous Reasons|1|||
155255902|NCT01735201|560368098|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155255903|NCT01735201|560368099|FG005|Overall Study|Other Miscellaneous Reasons|2|||
155255904|NCT01735201|560368100|FG006|Overall Study|Other Miscellaneous Reasons|1|||
155255905|NCT01735201|560368101|FG007|Overall Study|Other Miscellaneous Reasons|1|||
155255906|NCT02178059|560368107|FG000|Washout|Physician Decision|1|||
155255907|NCT02178059|560368108|FG001|Washout|Physician Decision|0|||
155255908|NCT00289887|560368109|FG000|Overall Study|Adverse Event|3|||
155255909|NCT00289887|560368110|FG001|Overall Study|Adverse Event|3|||
155255910|NCT00289887|560368109|FG000|Overall Study|Lack of Efficacy|3|||
155255911|NCT00289887|560368110|FG001|Overall Study|Lack of Efficacy|11|||
155255912|NCT00289887|560368109|FG000|Overall Study|Lost to Follow-up|3|||
155255913|NCT00289887|560368110|FG001|Overall Study|Lost to Follow-up|3|||
155255914|NCT00289887|560368109|FG000|Overall Study|Protocol Violation|3|||
155255915|NCT00289887|560368110|FG001|Overall Study|Protocol Violation|1|||
155255916|NCT00289887|560368109|FG000|Overall Study|Withdrawal by Subject|3|||
155255917|NCT00289887|560368110|FG001|Overall Study|Withdrawal by Subject|8|||
155255918|NCT00289887|560368109|FG000|Overall Study|Other|7|||
155255919|NCT00289887|560368110|FG001|Overall Study|Other|3|||
155255920|NCT00175825|560368111|FG000|Overall Study|Adverse Event|3|||
155255921|NCT00175825|560368112|FG001|Overall Study|Adverse Event|2|||
155255922|NCT00175825|560368113|FG002|Overall Study|Adverse Event|1|||
155255923|NCT00175825|560368114|FG003|Overall Study|Adverse Event|1|||
155255924|NCT00175825|560368111|FG000|Overall Study|Lost to Follow-up|1|||
155255925|NCT00175825|560368112|FG001|Overall Study|Lost to Follow-up|2|||
155255926|NCT00175825|560368113|FG002|Overall Study|Lost to Follow-up|0|||
155255927|NCT00175825|560368114|FG003|Overall Study|Lost to Follow-up|0|||
155255928|NCT00175825|560368111|FG000|Overall Study|Withdrawal by Subject|1|||
155255929|NCT00175825|560368112|FG001|Overall Study|Withdrawal by Subject|0|||
155255930|NCT00175825|560368113|FG002|Overall Study|Withdrawal by Subject|0|||
155255931|NCT00175825|560368114|FG003|Overall Study|Withdrawal by Subject|0|||
155255932|NCT04098406|560368115|FG000|Overall Study|Adverse Event|2|||
155255933|NCT04098406|560368116|FG001|Overall Study|Adverse Event|1|||
155255934|NCT04098406|560368115|FG000|Overall Study|Withdrawal by Subject|1|||
155255935|NCT04098406|560368116|FG001|Overall Study|Withdrawal by Subject|0|||
155255936|NCT02001194|560368117|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
155255937|NCT02001194|560368118|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
155255938|NCT02001194|560368119|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
155255939|NCT02001194|560368120|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
155255940|NCT02001194|560368117|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
155255941|NCT02001194|560368118|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
155255942|NCT02001194|560368119|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
155255943|NCT02001194|560368120|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
155255944|NCT03040713|560368121|FG000|Overall Study|Positive amyloid scan|3|||
155255945|NCT03338894|560368126|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
155255946|NCT00952367|560368133|FG000|Overall Study|Withdrawal by Subject|2|||
155255947|NCT00952367|560368133|FG000|Overall Study|Noncoordination|1|||
155255948|NCT00952367|560368133|FG000|Overall Study|Protocol Violation|3|||
155255949|NCT01040260|560368134|FG000|Overall Study|Withdrawal by Subject|12|||
155255950|NCT01040260|560368135|FG001|Overall Study|Withdrawal by Subject|6|||
155255951|NCT01040260|560368134|FG000|Overall Study|Lost to Follow-up|3|||
155255952|NCT01040260|560368135|FG001|Overall Study|Lost to Follow-up|5|||
155255953|NCT01113502|560368139|FG000|Overall Study|Withdrawal by Subject|1|||
155255954|NCT01113502|560368140|FG001|Overall Study|Withdrawal by Subject|0|||
155255955|NCT01113502|560368141|FG002|Overall Study|Withdrawal by Subject|1|||
155255956|NCT01113502|560368142|FG003|Overall Study|Withdrawal by Subject|1|||
155255957|NCT01113502|560368143|FG004|Overall Study|Withdrawal by Subject|0|||
155255958|NCT01113502|560368139|FG000|Overall Study|Adverse Event|0|||
155255959|NCT01113502|560368140|FG001|Overall Study|Adverse Event|0|||
155255960|NCT01113502|560368141|FG002|Overall Study|Adverse Event|3|||
155255961|NCT01113502|560368142|FG003|Overall Study|Adverse Event|2|||
155255962|NCT01113502|560368143|FG004|Overall Study|Adverse Event|0|||
155255963|NCT00781391|560368146|FG000|Overall Study|never received study drug|24|||
155255964|NCT00781391|560368147|FG001|Overall Study|never received study drug|23|||
155255965|NCT00781391|560368148|FG002|Overall Study|never received study drug|32|||
155255966|NCT00781391|560368146|FG000|Overall Study|Protocol Violation|19|||
155255967|NCT00781391|560368147|FG001|Overall Study|Protocol Violation|17|||
155255968|NCT00781391|560368148|FG002|Overall Study|Protocol Violation|20|||
155255969|NCT00781391|560368146|FG000|Overall Study|Death|789|||
155255970|NCT00781391|560368147|FG001|Overall Study|Death|730|||
155255971|NCT00781391|560368148|FG002|Overall Study|Death|706|||
155255972|NCT00781391|560368146|FG000|Overall Study|Withdrawal by Subject|47|||
155255973|NCT00781391|560368147|FG001|Overall Study|Withdrawal by Subject|37|||
155255974|NCT00781391|560368148|FG002|Overall Study|Withdrawal by Subject|25|||
155255975|NCT00781391|560368146|FG000|Overall Study|Lost to Follow-up|0|||
155255976|NCT00781391|560368147|FG001|Overall Study|Lost to Follow-up|0|||
155255977|NCT00781391|560368148|FG002|Overall Study|Lost to Follow-up|1|||
155255978|NCT00708916|560368150|FG000|Overall Study|Subject Noncompliance|2|||
155255979|NCT00708916|560368150|FG000|Overall Study|Adverse Event|2|||
155255980|NCT01984684|560368152|FG000|Overall Study|Lost to Follow-up|25|||
155255981|NCT01984684|560368153|FG001|Overall Study|Lost to Follow-up|24|||
155255982|NCT01984684|560368152|FG000|Overall Study|Adverse Event|8|||
155255983|NCT01984684|560368153|FG001|Overall Study|Adverse Event|12|||
155255984|NCT01984684|560368152|FG000|Overall Study|Withdrawal by Subject|9|||
155255985|NCT01984684|560368153|FG001|Overall Study|Withdrawal by Subject|9|||
155255986|NCT01984684|560368152|FG000|Overall Study|Lack of Efficacy|3|||
155255987|NCT01984684|560368153|FG001|Overall Study|Lack of Efficacy|6|||
155255988|NCT01984684|560368152|FG000|Overall Study|Physician Decision|4|||
155255989|NCT01984684|560368153|FG001|Overall Study|Physician Decision|2|||
155255990|NCT01984684|560368152|FG000|Overall Study|Protocol Violation|4|||
155255991|NCT01984684|560368153|FG001|Overall Study|Protocol Violation|2|||
155255992|NCT01984684|560368152|FG000|Overall Study|Death|0|||
155255993|NCT01984684|560368153|FG001|Overall Study|Death|1|||
155255994|NCT01984684|560368152|FG000|Overall Study|Noncompliance with study drug|2|||
155255995|NCT01984684|560368153|FG001|Overall Study|Noncompliance with study drug|1|||
155255996|NCT01984684|560368152|FG000|Overall Study|Subject incarcerated|1|||
155255997|NCT01984684|560368153|FG001|Overall Study|Subject incarcerated|0|||
155255998|NCT01984684|560368152|FG000|Overall Study|Study drug not available at site|1|||
155255999|NCT01984684|560368153|FG001|Overall Study|Study drug not available at site|1|||
155256000|NCT01984684|560368152|FG000|Overall Study|Subject had inadequate IV access|0|||
155256001|NCT01984684|560368153|FG001|Overall Study|Subject had inadequate IV access|1|||
155256002|NCT02835339|560368156|FG000|Overall Study|Did not receive allocated intervention|13|||
155256003|NCT02835339|560368157|FG001|Overall Study|Did not receive allocated intervention|16|||
155256004|NCT01077544|560368158|FG000|Overall Study|New Cancer Therapy|3|||
155256005|NCT01077544|560368159|FG001|Overall Study|New Cancer Therapy|3|||
155256006|NCT01077544|560368158|FG000|Overall Study|Adverse Event|0|||
155256007|NCT01077544|560368159|FG001|Overall Study|Adverse Event|1|||
155256008|NCT01077544|560368158|FG000|Overall Study|Disease Progression|0|||
155256009|NCT01077544|560368159|FG001|Overall Study|Disease Progression|1|||
155256010|NCT04575051|560368161|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
155256011|NCT04575051|560368162|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
155256012|NCT04575051|560368163|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
155256013|NCT04575051|560368164|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
155256014|NCT04575051|560368165|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
155256015|NCT04575051|560368161|FG000|Time Period 1|Missing follow up|1|||
155256016|NCT04575051|560368162|FG001|Time Period 1|Missing follow up|3|||
155256017|NCT04575051|560368163|FG002|Time Period 1|Missing follow up|1|||
155256018|NCT04575051|560368164|FG003|Time Period 1|Missing follow up|3|||
155256019|NCT04575051|560368165|FG004|Time Period 1|Missing follow up|2|||
155256020|NCT04575051|560368161|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
155256021|NCT04575051|560368162|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
155256022|NCT04575051|560368163|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
155256023|NCT04575051|560368164|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
155256024|NCT04575051|560368165|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
155256025|NCT04575051|560368161|FG000|Time Period 2|Missing follow up|1|||
155256026|NCT04575051|560368162|FG001|Time Period 2|Missing follow up|8|||
155256027|NCT04575051|560368163|FG002|Time Period 2|Missing follow up|7|||
155256028|NCT04575051|560368164|FG003|Time Period 2|Missing follow up|0|||
155256029|NCT04575051|560368165|FG004|Time Period 2|Missing follow up|1|||
155256030|NCT04575051|560368161|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
155256031|NCT04575051|560368162|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
155256032|NCT04575051|560368163|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
155256033|NCT04575051|560368164|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
155256034|NCT04575051|560368165|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
155256035|NCT04575051|560368161|FG000|Time Period 3|Missing follow up|8|||
155256036|NCT04575051|560368162|FG001|Time Period 3|Missing follow up|6|||
155256037|NCT04575051|560368163|FG002|Time Period 3|Missing follow up|4|||
155256038|NCT04575051|560368164|FG003|Time Period 3|Missing follow up|3|||
155256039|NCT04575051|560368165|FG004|Time Period 3|Missing follow up|0|||
155256040|NCT04575051|560368161|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
155256041|NCT04575051|560368162|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
155256042|NCT04575051|560368163|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
155256043|NCT04575051|560368164|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
155256044|NCT04575051|560368165|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
155256045|NCT04575051|560368161|FG000|Time Period 4|Missing follow up|17|||
155256046|NCT04575051|560368162|FG001|Time Period 4|Missing follow up|3|||
155256047|NCT04575051|560368163|FG002|Time Period 4|Missing follow up|4|||
155256048|NCT04575051|560368164|FG003|Time Period 4|Missing follow up|2|||
155256049|NCT04575051|560368165|FG004|Time Period 4|Missing follow up|1|||
155256050|NCT04575051|560368161|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
155256051|NCT04575051|560368162|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
155256052|NCT04575051|560368163|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
155256053|NCT04575051|560368164|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
155256054|NCT04575051|560368165|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
155256055|NCT04575051|560368161|FG000|Time Period 5|Missing follow up|11|||
155256056|NCT04575051|560368162|FG001|Time Period 5|Missing follow up|8|||
155256057|NCT04575051|560368163|FG002|Time Period 5|Missing follow up|12|||
155256058|NCT04575051|560368164|FG003|Time Period 5|Missing follow up|3|||
155256059|NCT04575051|560368165|FG004|Time Period 5|Missing follow up|11|||
155256060|NCT03624504|560368166|FG000|Overall Study|Unsuccessful Implant|1|||
155256061|NCT02862457|560368167|FG000|Overall Study|Death|1|||
155256062|NCT02862457|560368168|FG001|Overall Study|Death|3|||
155256063|NCT02862457|560368169|FG002|Overall Study|Death|2|||
155256064|NCT02862457|560368170|FG003|Overall Study|Death|3|||
155256065|NCT02862457|560368171|FG004|Overall Study|Death|0|||
155256066|NCT02862457|560368172|FG005|Overall Study|Death|2|||
155256067|NCT02862457|560368173|FG006|Overall Study|Death|1|||
155256068|NCT02862457|560368167|FG000|Overall Study|Lost to Follow-up|1|||
155256069|NCT02862457|560368168|FG001|Overall Study|Lost to Follow-up|0|||
155256070|NCT02862457|560368169|FG002|Overall Study|Lost to Follow-up|0|||
155256071|NCT02862457|560368170|FG003|Overall Study|Lost to Follow-up|1|||
155256072|NCT02862457|560368171|FG004|Overall Study|Lost to Follow-up|0|||
155256073|NCT02862457|560368172|FG005|Overall Study|Lost to Follow-up|0|||
155256074|NCT02862457|560368173|FG006|Overall Study|Lost to Follow-up|0|||
155256075|NCT02862457|560368167|FG000|Overall Study|Withdrawal by Subject|0|||
155256076|NCT02862457|560368168|FG001|Overall Study|Withdrawal by Subject|0|||
155256077|NCT02862457|560368169|FG002|Overall Study|Withdrawal by Subject|1|||
155256078|NCT02862457|560368170|FG003|Overall Study|Withdrawal by Subject|0|||
155256079|NCT02862457|560368171|FG004|Overall Study|Withdrawal by Subject|0|||
155256080|NCT02862457|560368172|FG005|Overall Study|Withdrawal by Subject|1|||
155256081|NCT02862457|560368173|FG006|Overall Study|Withdrawal by Subject|0|||
155256082|NCT00951483|560368174|FG000|Overall Study|Physician Decision|4|||
155256083|NCT00951483|560368175|FG001|Overall Study|Physician Decision|0|||
155256084|NCT00951483|560368174|FG000|Overall Study|Withdrawal by Subject|15|||
155256085|NCT00951483|560368175|FG001|Overall Study|Withdrawal by Subject|0|||
155256086|NCT03364751|560368176|FG000|Overall Study|Withdrawal by Subject|1|||
155256087|NCT03364751|560368177|FG001|Overall Study|Withdrawal by Subject|0|||
155256088|NCT03364751|560368178|FG002|Overall Study|Withdrawal by Subject|0|||
155256089|NCT03364751|560368179|FG003|Overall Study|Withdrawal by Subject|0|||
155256090|NCT03364751|560368176|FG000|Overall Study|Lost to Follow-up|0|||
155256091|NCT03364751|560368177|FG001|Overall Study|Lost to Follow-up|1|||
155256092|NCT03364751|560368178|FG002|Overall Study|Lost to Follow-up|0|||
155256093|NCT03364751|560368179|FG003|Overall Study|Lost to Follow-up|0|||
155256094|NCT04542018|560368180|FG000|Overall Study|Withdrawal by Subject|0|||
155256095|NCT04542018|560368181|FG001|Overall Study|Withdrawal by Subject|0|||
155256096|NCT04542018|560368182|FG002|Overall Study|Withdrawal by Subject|4|||
155256097|NCT04542018|560368180|FG000|Overall Study|Protocol Violation|0|||
155256098|NCT04542018|560368181|FG001|Overall Study|Protocol Violation|0|||
155256099|NCT04542018|560368182|FG002|Overall Study|Protocol Violation|2|||
155256100|NCT00689221|560368183|FG000|Overall Study|Ongoing at cut-off date|39|||
155256101|NCT00689221|560368184|FG001|Overall Study|Ongoing at cut-off date|36|||
155256102|NCT01939548|560368189|FG000|Overall Study|Non compliance|0|||
155256103|NCT01939548|560368190|FG001|Overall Study|Non compliance|2|||
155256104|NCT01939548|560368191|FG002|Overall Study|Non compliance|0|||
155256105|NCT01939548|560368189|FG000|Overall Study|Study Terminated by Sponsor|17|||
155256106|NCT01939548|560368190|FG001|Overall Study|Study Terminated by Sponsor|19|||
155256107|NCT01939548|560368191|FG002|Overall Study|Study Terminated by Sponsor|12|||
155256108|NCT01939548|560368189|FG000|Overall Study|Insufficient Clinical Response|1|||
155256109|NCT01939548|560368190|FG001|Overall Study|Insufficient Clinical Response|0|||
155256110|NCT01939548|560368191|FG002|Overall Study|Insufficient Clinical Response|0|||
155256111|NCT01939548|560368189|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155256112|NCT01939548|560368190|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
155256113|NCT01939548|560368191|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
155256114|NCT01939548|560368189|FG000|Overall Study|Withdrawal by Subject|4|||
155256115|NCT01939548|560368190|FG001|Overall Study|Withdrawal by Subject|4|||
155256116|NCT01939548|560368191|FG002|Overall Study|Withdrawal by Subject|1|||
155256117|NCT01939548|560368189|FG000|Overall Study|Protocol Violation|7|||
155256118|NCT01939548|560368190|FG001|Overall Study|Protocol Violation|6|||
155256119|NCT01939548|560368191|FG002|Overall Study|Protocol Violation|5|||
155256120|NCT01939548|560368189|FG000|Overall Study|Lost to Follow-up|5|||
155256121|NCT01939548|560368190|FG001|Overall Study|Lost to Follow-up|5|||
155256122|NCT01939548|560368191|FG002|Overall Study|Lost to Follow-up|3|||
155256123|NCT01939548|560368189|FG000|Overall Study|Adverse Event|2|||
155256124|NCT01939548|560368190|FG001|Overall Study|Adverse Event|9|||
155256125|NCT01939548|560368191|FG002|Overall Study|Adverse Event|7|||
155256126|NCT01939548|560368189|FG000|Overall Study|Death|0|||
155256127|NCT01939548|560368190|FG001|Overall Study|Death|0|||
155256128|NCT01939548|560368191|FG002|Overall Study|Death|1|||
155256129|NCT01939548|560368189|FG000|Overall Study|Participant dropped|0|||
155256130|NCT01939548|560368190|FG001|Overall Study|Participant dropped|0|||
155256131|NCT01939548|560368191|FG002|Overall Study|Participant dropped|1|||
155256132|NCT01939548|560368189|FG000|Overall Study|Participant unwilling to continue|0|||
155256133|NCT01939548|560368190|FG001|Overall Study|Participant unwilling to continue|1|||
155256134|NCT01939548|560368191|FG002|Overall Study|Participant unwilling to continue|0|||
155256135|NCT01939548|560368189|FG000|Overall Study|Participant withdrew consent|0|||
155256136|NCT01939548|560368190|FG001|Overall Study|Participant withdrew consent|2|||
155256137|NCT01939548|560368191|FG002|Overall Study|Participant withdrew consent|0|||
155256138|NCT01939548|560368189|FG000|Overall Study|Did not complete follow-up|0|||
155256139|NCT01939548|560368190|FG001|Overall Study|Did not complete follow-up|1|||
155256140|NCT01939548|560368191|FG002|Overall Study|Did not complete follow-up|0|||
155256141|NCT03311373|560368192|FG000|Overall Study|Adverse Event|1|||
155256142|NCT03311373|560368192|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
155256143|NCT03311373|560368192|FG000|Overall Study|Lost to Follow-up|1|||
155256144|NCT03311373|560368192|FG000|Overall Study|Physician Decision|1|||
155256145|NCT03311373|560368192|FG000|Overall Study|Withdrawal by Subject|3|||
155256146|NCT01297959|560368195|FG000|Overall Study|Adverse Event|0|||
155256147|NCT01297959|560368196|FG001|Overall Study|Adverse Event|1|||
155256148|NCT01297959|560368195|FG000|Overall Study|Protocol Violation|2|||
155256149|NCT01297959|560368196|FG001|Overall Study|Protocol Violation|1|||
155256150|NCT01297959|560368195|FG000|Overall Study|Withdrawal by Subject|5|||
155256151|NCT01297959|560368196|FG001|Overall Study|Withdrawal by Subject|4|||
155256152|NCT01297959|560368195|FG000|Overall Study|Physician Decision|0|||
155256153|NCT01297959|560368196|FG001|Overall Study|Physician Decision|1|||
155256154|NCT01297959|560368195|FG000|Overall Study|Unrelated medical illness / complication|0|||
155256155|NCT01297959|560368196|FG001|Overall Study|Unrelated medical illness / complication|2|||
155256156|NCT01297959|560368195|FG000|Overall Study|Other|13|||
155256157|NCT01297959|560368196|FG001|Overall Study|Other|7|||
155256158|NCT00344461|560368197|FG000|Overall Study|Adverse Event|6|||
155256159|NCT00344461|560368197|FG000|Overall Study|Death|1|||
155256160|NCT00344461|560368197|FG000|Overall Study|Lack of Efficacy|2|||
155256161|NCT00344461|560368197|FG000|Overall Study|Lost to Follow-up|2|||
155256162|NCT00344461|560368197|FG000|Overall Study|Physician Decision|2|||
155256163|NCT00344461|560368197|FG000|Overall Study|Protocol Violation|6|||
155256164|NCT00344461|560368197|FG000|Overall Study|Withdrawal by Subject|2|||
155256165|NCT01667432|560368198|FG000|Overall Study|Premature Study Termination|26|||
155256166|NCT01667432|560368198|FG000|Overall Study|Failure to Return|10|||
155256167|NCT01667432|560368198|FG000|Overall Study|Moved to Another Center|3|||
155256168|NCT01667432|560368198|FG000|Overall Study|Lost to Follow-up|3|||
155256169|NCT01667432|560368198|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
155256170|NCT01667432|560368198|FG000|Overall Study|Insufficient Therapeutic Response|4|||
155256171|NCT01667432|560368198|FG000|Overall Study|Adverse Event|1|||
155256172|NCT01667432|560368198|FG000|Overall Study|Protocol Deviation|2|||
155256173|NCT01667432|560368198|FG000|Overall Study|Principal Investigator Decision|1|||
155256174|NCT01667432|560368198|FG000|Overall Study|Reason Not Specified|2|||
155256175|NCT01667432|560368198|FG000|Overall Study|Missing Information|4|||
155256176|NCT00553696|560368201|FG000|Overall Study|Adverse Event|2|||
155256177|NCT00553696|560368202|FG001|Overall Study|Adverse Event|4|||
155256178|NCT00553696|560368203|FG002|Overall Study|Adverse Event|0|||
155256179|NCT00553696|560368204|FG003|Overall Study|Adverse Event|1|||
155256180|NCT00553696|560368201|FG000|Overall Study|Global deterioration of health status|0|||
155256181|NCT00553696|560368202|FG001|Overall Study|Global deterioration of health status|2|||
155256182|NCT00553696|560368203|FG002|Overall Study|Global deterioration of health status|0|||
155256183|NCT00553696|560368204|FG003|Overall Study|Global deterioration of health status|0|||
155256184|NCT00553696|560368201|FG000|Overall Study|Objective progression or relapse|2|||
155256185|NCT00553696|560368202|FG001|Overall Study|Objective progression or relapse|9|||
155256186|NCT00553696|560368203|FG002|Overall Study|Objective progression or relapse|6|||
155256187|NCT00553696|560368204|FG003|Overall Study|Objective progression or relapse|0|||
155256188|NCT00553696|560368201|FG000|Overall Study|Withdrawal by Subject|0|||
155256189|NCT00553696|560368202|FG001|Overall Study|Withdrawal by Subject|1|||
155256190|NCT00553696|560368203|FG002|Overall Study|Withdrawal by Subject|0|||
155256191|NCT00553696|560368204|FG003|Overall Study|Withdrawal by Subject|0|||
155256192|NCT00686881|560368207|FG000|Overall Study|Withdrawal by Subject|11|||
155256193|NCT00686881|560368208|FG001|Overall Study|Withdrawal by Subject|18|||
155256194|NCT00686881|560368207|FG000|Overall Study|Lost to Follow-up|0|||
155256195|NCT00686881|560368208|FG001|Overall Study|Lost to Follow-up|1|||
155256196|NCT00686881|560368207|FG000|Overall Study|Treatment-related adverse event|10|||
155256197|NCT00686881|560368208|FG001|Overall Study|Treatment-related adverse event|9|||
155256198|NCT00686881|560368207|FG000|Overall Study|Met discontinuation criteria|5|||
155256199|NCT00686881|560368208|FG001|Overall Study|Met discontinuation criteria|0|||
155256200|NCT00686881|560368207|FG000|Overall Study|Onset of malignant tumor|11|||
155256201|NCT00686881|560368208|FG001|Overall Study|Onset of malignant tumor|11|||
155256202|NCT00686881|560368207|FG000|Overall Study|Lack of Efficacy|4|||
155256203|NCT00686881|560368208|FG001|Overall Study|Lack of Efficacy|3|||
155256204|NCT00686881|560368207|FG000|Overall Study|Physician Decision|1|||
155256205|NCT00686881|560368208|FG001|Overall Study|Physician Decision|0|||
155256206|NCT00686881|560368207|FG000|Overall Study|Circumstances of site|1|||
155256207|NCT00686881|560368208|FG001|Overall Study|Circumstances of site|1|||
155256208|NCT00686881|560368207|FG000|Overall Study|Did not meet protocol eligibility|1|||
155256209|NCT00686881|560368208|FG001|Overall Study|Did not meet protocol eligibility|0|||
155256210|NCT00686881|560368207|FG000|Overall Study|Irregular visits|1|||
155256211|NCT00686881|560368208|FG001|Overall Study|Irregular visits|0|||
155256212|NCT00686881|560368207|FG000|Overall Study|Study discontinuation|35|||
155256213|NCT00686881|560368208|FG001|Overall Study|Study discontinuation|32|||
155256214|NCT00686881|560368207|FG000|Overall Study|Never received study drug|2|||
155256215|NCT00686881|560368208|FG001|Overall Study|Never received study drug|6|||
155256216|NCT02085252|560368211|FG000|Overall Study|Withdrawal of Consent|1|||
155256217|NCT02085252|560368212|FG001|Overall Study|Withdrawal of Consent|0|||
155256218|NCT02085252|560368211|FG000|Overall Study|Adverse Event|0|||
155256219|NCT02085252|560368212|FG001|Overall Study|Adverse Event|1|||
155256220|NCT02085252|560368211|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
155256221|NCT02085252|560368212|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
155256222|NCT02085252|560368211|FG000|Overall Study|Reason Not Specified|0|||
155256223|NCT02085252|560368212|FG001|Overall Study|Reason Not Specified|1|||
155256224|NCT02085252|560368211|FG000|Overall Study|Reason Unknown|0|||
155256225|NCT02085252|560368212|FG001|Overall Study|Reason Unknown|1|||
155256226|NCT00671931|560368213|FG000|Overall Study|Physician Decision|1|||
155256227|NCT00671931|560368214|FG001|Overall Study|Physician Decision|0|||
155256228|NCT00671931|560368215|FG002|Overall Study|Physician Decision|0|||
155256229|NCT00671931|560368216|FG003|Overall Study|Physician Decision|2|||
155256230|NCT00671931|560368217|FG004|Overall Study|Physician Decision|1|||
155256231|NCT02925676|560368219|FG000|Overall Study|Withdrawal by Subject|1|||
155256232|NCT02291679|560368220|FG000|Overall Study|Adverse Event|2|||
155256233|NCT02291679|560368221|FG001|Overall Study|Adverse Event|12|||
155256234|NCT02291679|560368222|FG002|Overall Study|Adverse Event|19|||
155256235|NCT02291679|560368220|FG000|Overall Study|Protocol Violation|5|||
155256236|NCT02291679|560368221|FG001|Overall Study|Protocol Violation|1|||
155256237|NCT02291679|560368222|FG002|Overall Study|Protocol Violation|7|||
155256238|NCT02291679|560368220|FG000|Overall Study|Withdrew Consent|18|||
155256239|NCT02291679|560368221|FG001|Overall Study|Withdrew Consent|10|||
155256240|NCT02291679|560368222|FG002|Overall Study|Withdrew Consent|15|||
155256241|NCT02291679|560368220|FG000|Overall Study|Lost to Follow-up|12|||
155256242|NCT02291679|560368221|FG001|Overall Study|Lost to Follow-up|10|||
155256243|NCT02291679|560368222|FG002|Overall Study|Lost to Follow-up|9|||
155256244|NCT02291679|560368220|FG000|Overall Study|Insufficient Therapeutic Response|5|||
155256245|NCT02291679|560368221|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155256246|NCT02291679|560368222|FG002|Overall Study|Insufficient Therapeutic Response|7|||
155256247|NCT02291679|560368220|FG000|Overall Study|Other|2|||
155256248|NCT02291679|560368221|FG001|Overall Study|Other|4|||
155256249|NCT02291679|560368222|FG002|Overall Study|Other|2|||
155256250|NCT02048072|560368223|FG000|Overall Study|Adverse Event|3|||
155256251|NCT02048072|560368223|FG000|Overall Study|Lost to Follow-up|1|||
155256252|NCT01648270|560368224|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
155256253|NCT04969263|560368225|FG000|Overall Study|Death|1|||
155256254|NCT04969263|560368225|FG000|Overall Study|Lost to Follow-up|2|||
155256255|NCT04969263|560368225|FG000|Overall Study|Withdrawal by Subject|5|||
155256256|NCT04969263|560368225|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
155256257|NCT04154787|560368226|FG000|Overall Study|Adverse Event|0|||
155256258|NCT04154787|560368227|FG001|Overall Study|Adverse Event|1|||
155256259|NCT04154787|560368228|FG002|Overall Study|Adverse Event|0|||
155256260|NCT04154787|560368226|FG000|Overall Study|Patient Requires Other Treatment|0|||
155256261|NCT04154787|560368227|FG001|Overall Study|Patient Requires Other Treatment|1|||
155256262|NCT04154787|560368228|FG002|Overall Study|Patient Requires Other Treatment|0|||
155256263|NCT04154787|560368226|FG000|Overall Study|Study Terminated By Sponsor|0|||
155256264|NCT04154787|560368227|FG001|Overall Study|Study Terminated By Sponsor|6|||
155256265|NCT04154787|560368228|FG002|Overall Study|Study Terminated By Sponsor|1|||
155256266|NCT04154787|560368226|FG000|Overall Study|Subject Decision|0|||
155256267|NCT04154787|560368227|FG001|Overall Study|Subject Decision|1|||
155256268|NCT04154787|560368228|FG002|Overall Study|Subject Decision|0|||
155256269|NCT04154787|560368226|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
155256270|NCT04154787|560368227|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
155256271|NCT04154787|560368228|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
155256272|NCT03053050|560368229|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
155256273|NCT03053050|560368230|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
155256274|NCT03053050|560368231|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
155256275|NCT03053050|560368232|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
155256276|NCT03053050|560368229|FG000|Randomized Phase|Withdrew Consent|16|||
155256277|NCT03053050|560368230|FG001|Randomized Phase|Withdrew Consent|8|||
155256278|NCT03053050|560368231|FG002|Randomized Phase|Withdrew Consent|9|||
155256279|NCT03053050|560368232|FG003|Randomized Phase|Withdrew Consent|0|||
155256280|NCT03053050|560368229|FG000|Randomized Phase|Investigator's Discretion|6|||
155256281|NCT03053050|560368230|FG001|Randomized Phase|Investigator's Discretion|6|||
155256282|NCT03053050|560368231|FG002|Randomized Phase|Investigator's Discretion|3|||
155256283|NCT03053050|560368232|FG003|Randomized Phase|Investigator's Discretion|0|||
155256284|NCT03053050|560368229|FG000|Randomized Phase|Lost to Follow-up|5|||
155256285|NCT03053050|560368230|FG001|Randomized Phase|Lost to Follow-up|1|||
155256286|NCT03053050|560368231|FG002|Randomized Phase|Lost to Follow-up|1|||
155256287|NCT03053050|560368232|FG003|Randomized Phase|Lost to Follow-up|0|||
155256288|NCT03053050|560368229|FG000|Randomized Phase|Adverse Event|0|||
155256289|NCT03053050|560368230|FG001|Randomized Phase|Adverse Event|1|||
155256290|NCT03053050|560368231|FG002|Randomized Phase|Adverse Event|0|||
155256291|NCT03053050|560368232|FG003|Randomized Phase|Adverse Event|0|||
155256292|NCT03053050|560368229|FG000|Randomized Phase|Randomized but Never Treated|2|||
155256293|NCT03053050|560368230|FG001|Randomized Phase|Randomized but Never Treated|2|||
155256294|NCT03053050|560368231|FG002|Randomized Phase|Randomized but Never Treated|2|||
155256295|NCT03053050|560368232|FG003|Randomized Phase|Randomized but Never Treated|0|||
155256296|NCT03053050|560368229|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
155256297|NCT03053050|560368230|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
155256298|NCT03053050|560368231|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
155256299|NCT03053050|560368232|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
155256300|NCT03053050|560368229|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
155256301|NCT03053050|560368230|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
155256302|NCT03053050|560368231|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
155256303|NCT03053050|560368232|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
155256304|NCT03053050|560368229|FG000|Open-label Phase|Withdrew Consent|0|||
155256305|NCT03053050|560368230|FG001|Open-label Phase|Withdrew Consent|0|||
155256306|NCT03053050|560368231|FG002|Open-label Phase|Withdrew Consent|0|||
155256307|NCT03053050|560368232|FG003|Open-label Phase|Withdrew Consent|6|||
155256308|NCT03053050|560368229|FG000|Open-label Phase|Investigator's Discretion|0|||
155256309|NCT03053050|560368230|FG001|Open-label Phase|Investigator's Discretion|0|||
155256310|NCT03053050|560368231|FG002|Open-label Phase|Investigator's Discretion|0|||
155256311|NCT03053050|560368232|FG003|Open-label Phase|Investigator's Discretion|4|||
155256312|NCT00999466|560369784|FG000|Main Part|Withdrawal by Subject|0|||
155256313|NCT00999466|560369785|FG001|Main Part|Withdrawal by Subject|0|||
155256314|NCT00999466|560369786|FG002|Main Part|Withdrawal by Subject|2|||
155256315|NCT00999466|560369784|FG000|Main Part|Adverse Event|0|||
155256316|NCT00999466|560369785|FG001|Main Part|Adverse Event|4|||
155256317|NCT00999466|560369786|FG002|Main Part|Adverse Event|2|||
155256318|NCT01357616|560369787|FG000|Overall Study|Adverse Event|1|||
155256319|NCT01357616|560369788|FG001|Overall Study|Adverse Event|1|||
155256320|NCT01357616|560369787|FG000|Overall Study|Lost to Follow-up|4|||
155256321|NCT01357616|560369788|FG001|Overall Study|Lost to Follow-up|3|||
155256322|NCT01357616|560369787|FG000|Overall Study|Protocol Violation|0|||
155256323|NCT01357616|560369788|FG001|Overall Study|Protocol Violation|2|||
155256324|NCT01357616|560369787|FG000|Overall Study|Inadequate Control of IOP|1|||
155256325|NCT01357616|560369788|FG001|Overall Study|Inadequate Control of IOP|2|||
155256326|NCT01357616|560369787|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
155256327|NCT01357616|560369788|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
155256328|NCT01357616|560369787|FG000|Overall Study|Withdrawal by Subject|1|||
155256329|NCT01357616|560369788|FG001|Overall Study|Withdrawal by Subject|0|||
155256330|NCT03255824|560369796|FG000|Overall Study|Under-sedation|2|||
155256331|NCT03255824|560369797|FG001|Overall Study|Under-sedation|1|||
155256332|NCT03432364|560369801|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
155256333|NCT00522301|560369802|FG000|Overall Study|Withdrawal by Subject|1|||
155256334|NCT00522301|560369802|FG000|Overall Study|Adverse Event|5|||
155256335|NCT01699022|560369805|FG000|Overall Study|Early discontinuation from the study|3|||
155256336|NCT04539821|560369806|FG000|Overall Study|Withdrawal by Subject|2|||
155256337|NCT04539821|560369806|FG000|Overall Study|continued care with their physician|20|||
155256338|NCT04539821|560369806|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
155256339|NCT02066402|560369809|FG000|Overall Study|Adverse Event|1|||
155256340|NCT02066402|560369810|FG001|Overall Study|Adverse Event|2|||
155256341|NCT02066402|560369809|FG000|Overall Study|Lost to Follow-up|11|||
155256342|NCT02066402|560369810|FG001|Overall Study|Lost to Follow-up|8|||
155256343|NCT02066402|560369809|FG000|Overall Study|Withdrawal by Subject|14|||
155256344|NCT02066402|560369810|FG001|Overall Study|Withdrawal by Subject|11|||
155256345|NCT02066402|560369809|FG000|Overall Study|Progressive disease-clinical progression|0|||
155256346|NCT02066402|560369810|FG001|Overall Study|Progressive disease-clinical progression|1|||
155256347|NCT02066402|560369809|FG000|Overall Study|Protocol driven decision point|0|||
155256348|NCT02066402|560369810|FG001|Overall Study|Protocol driven decision point|1|||
155256349|NCT00152464|560369811|FG000|Overall Study|Adverse Event|3|||
155256350|NCT00152464|560369812|FG001|Overall Study|Adverse Event|6|||
155256351|NCT00152464|560369811|FG000|Overall Study|Lost to Follow-up|8|||
155256352|NCT00152464|560369812|FG001|Overall Study|Lost to Follow-up|4|||
155256353|NCT00152464|560369811|FG000|Overall Study|Protocol Violation|3|||
155256354|NCT00152464|560369812|FG001|Overall Study|Protocol Violation|1|||
155256355|NCT00152464|560369811|FG000|Overall Study|Withdrawal by Subject|21|||
155256356|NCT00152464|560369812|FG001|Overall Study|Withdrawal by Subject|22|||
155256357|NCT00152464|560369811|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
155256358|NCT00152464|560369812|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
155256359|NCT00152464|560369811|FG000|Overall Study|Eczema deterioration|0|||
155256360|NCT00152464|560369812|FG001|Overall Study|Eczema deterioration|1|||
155256361|NCT00152464|560369811|FG000|Overall Study|Parent decision|1|||
155256362|NCT00152464|560369812|FG001|Overall Study|Parent decision|1|||
155256363|NCT00152464|560369811|FG000|Overall Study|Investigator decision|1|||
155256364|NCT00152464|560369812|FG001|Overall Study|Investigator decision|0|||
155256365|NCT00152464|560369811|FG000|Overall Study|Lack of Efficacy|1|||
155256366|NCT00152464|560369812|FG001|Overall Study|Lack of Efficacy|0|||
155256367|NCT00152464|560369811|FG000|Overall Study|Eczema poorly controlled|1|||
155256368|NCT00152464|560369812|FG001|Overall Study|Eczema poorly controlled|0|||
155256369|NCT00152464|560369811|FG000|Overall Study|Patient relocated|1|||
155256370|NCT00152464|560369812|FG001|Overall Study|Patient relocated|0|||
155256371|NCT02462876|560369813|FG000|Overall Study|Death|3|||
155256372|NCT02462876|560369813|FG000|Overall Study|Lost to Follow-up|7|||
155256373|NCT02462876|560369813|FG000|Overall Study|Surgical Bypass|9|||
155256374|NCT02462876|560369813|FG000|Overall Study|Amputation Above the Metatarsals|1|||
155256375|NCT02462876|560369813|FG000|Overall Study|36 months follow-up visit missed|1|||
155256376|NCT02462876|560369813|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
155256377|NCT02462876|560369813|FG000|Overall Study|Patient did not come back to the vascular department|1|||
155256378|NCT02462876|560369813|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
155256379|NCT02462876|560369813|FG000|Overall Study|Patient refused to come back|1|||
155256380|NCT02462876|560369813|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
155256381|NCT02462876|560369813|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
155256382|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
155256383|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
155256384|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
155256385|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
155256386|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
155256387|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
155256388|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
155256389|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
155256390|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Other|18|||
155256391|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
155256392|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
155256393|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Other|1|||
155256394|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
155256395|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
155256396|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
155256397|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
155256398|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
155256399|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
155256400|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
155256401|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
155256402|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
155256403|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
155256404|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
155256405|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
155256406|NCT04465357|560369815|FG000|Overall Study|Adverse Event|2|||
155256407|NCT04465357|560369815|FG000|Overall Study|Lack of Efficacy|1|||
155256408|NCT04465357|560369815|FG000|Overall Study|Lost to Follow-up|2|||
155256409|NCT04465357|560369815|FG000|Overall Study|Withdrawal by Subject|6|||
155256410|NCT04465357|560369815|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
155256411|NCT00266825|560369822|FG000|Completed Follow-Up|Lost to Follow-up|14|||
155256412|NCT00266825|560369823|FG001|Completed Follow-Up|Lost to Follow-up|19|||
155256413|NCT00266825|560369822|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
155256414|NCT00266825|560369823|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
155256415|NCT00430248|560369824|FG000|Overall Study|Adverse Event|49|||
155256416|NCT00430248|560369825|FG001|Overall Study|Adverse Event|61|||
155256417|NCT00430248|560369826|FG002|Overall Study|Adverse Event|64|||
155256418|NCT00430248|560369824|FG000|Overall Study|Protocol Violation|10|||
155256419|NCT00430248|560369825|FG001|Overall Study|Protocol Violation|2|||
155256420|NCT00430248|560369826|FG002|Overall Study|Protocol Violation|4|||
155256421|NCT00430248|560369824|FG000|Overall Study|Personal Reasons|12|||
155256422|NCT00430248|560369825|FG001|Overall Study|Personal Reasons|24|||
155256423|NCT00430248|560369826|FG002|Overall Study|Personal Reasons|9|||
155256424|NCT00430248|560369824|FG000|Overall Study|Lost to Follow-up|28|||
155256425|NCT00430248|560369825|FG001|Overall Study|Lost to Follow-up|33|||
155256426|NCT00430248|560369826|FG002|Overall Study|Lost to Follow-up|28|||
155256427|NCT00430248|560369824|FG000|Overall Study|Therapeutic Failure|1|||
155256428|NCT00430248|560369825|FG001|Overall Study|Therapeutic Failure|1|||
155256429|NCT00430248|560369826|FG002|Overall Study|Therapeutic Failure|1|||
155256430|NCT00430248|560369824|FG000|Overall Study|Withdrawal by Subject|14|||
155256431|NCT00430248|560369825|FG001|Overall Study|Withdrawal by Subject|20|||
155256432|NCT00430248|560369826|FG002|Overall Study|Withdrawal by Subject|16|||
155256433|NCT00430248|560369824|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155256434|NCT00430248|560369825|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155256435|NCT00430248|560369826|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155256436|NCT00430248|560369824|FG000|Overall Study|Gout Flare|3|||
155256437|NCT00430248|560369825|FG001|Overall Study|Gout Flare|7|||
155256438|NCT00430248|560369826|FG002|Overall Study|Gout Flare|2|||
155256439|NCT00430248|560369824|FG000|Overall Study|Reason Not Specified|8|||
155256440|NCT00430248|560369825|FG001|Overall Study|Reason Not Specified|8|||
155256441|NCT00430248|560369826|FG002|Overall Study|Reason Not Specified|11|||
155256442|NCT01754467|560369827|FG000|Overall Study|Lost to Follow-up|1|||
155256443|NCT01970462|560369828|FG000|Overall Study|Lost to Follow-up|0|||
155256444|NCT01970462|560369829|FG001|Overall Study|Lost to Follow-up|2|||
155256445|NCT02230956|560369830|FG000|Overall Study|Adverse Event|1|||
155256446|NCT02230956|560369831|FG001|Overall Study|Adverse Event|1|||
155256447|NCT02230956|560369832|FG002|Overall Study|Adverse Event|0|||
155256448|NCT02230956|560369830|FG000|Overall Study|Lack of Efficacy|1|||
155256449|NCT02230956|560369831|FG001|Overall Study|Lack of Efficacy|1|||
155256450|NCT02230956|560369832|FG002|Overall Study|Lack of Efficacy|1|||
155256451|NCT02230956|560369830|FG000|Overall Study|Lost to Follow-up|1|||
155256452|NCT02230956|560369831|FG001|Overall Study|Lost to Follow-up|1|||
155256453|NCT02230956|560369832|FG002|Overall Study|Lost to Follow-up|2|||
155256454|NCT02230956|560369830|FG000|Overall Study|Personal Reasons|2|||
155256455|NCT02230956|560369831|FG001|Overall Study|Personal Reasons|1|||
155256456|NCT02230956|560369832|FG002|Overall Study|Personal Reasons|1|||
155256457|NCT02230956|560369830|FG000|Overall Study|Protocol Violation|0|||
155256458|NCT02230956|560369831|FG001|Overall Study|Protocol Violation|1|||
155256459|NCT02230956|560369832|FG002|Overall Study|Protocol Violation|1|||
155256460|NCT02230956|560369830|FG000|Overall Study|Other Miscellaneous Reason|0|||
155256461|NCT02230956|560369831|FG001|Overall Study|Other Miscellaneous Reason|1|||
155256462|NCT02230956|560369832|FG002|Overall Study|Other Miscellaneous Reason|2|||
155256463|NCT01970982|560369833|FG000|Overall Study|Withdrawal by Subject|0|||
155256464|NCT01970982|560369834|FG001|Overall Study|Withdrawal by Subject|0|||
155256465|NCT01970982|560369835|FG002|Overall Study|Withdrawal by Subject|2|||
155256466|NCT04555096|560369842|FG000|Overall Study|Death|4|||
155256467|NCT04555096|560369843|FG001|Overall Study|Death|4|||
155256468|NCT04555096|560369842|FG000|Overall Study|Withdrawal by Subject|1|||
155256469|NCT04555096|560369843|FG001|Overall Study|Withdrawal by Subject|0|||
155256470|NCT04555096|560369842|FG000|Overall Study|Other|0|||
155256471|NCT04555096|560369843|FG001|Overall Study|Other|1|||
155256472|NCT03923959|560369846|FG000|Overall Study|Death|16|||
155256473|NCT03923959|560369847|FG001|Overall Study|Death|12|||
155256474|NCT03923959|560369846|FG000|Overall Study|Lost to Follow-up|56|||
155256475|NCT03923959|560369847|FG001|Overall Study|Lost to Follow-up|56|||
155256476|NCT03923959|560369846|FG000|Overall Study|Withdrawal by Subject|1|||
155256477|NCT03923959|560369847|FG001|Overall Study|Withdrawal by Subject|1|||
155256478|NCT03923959|560369846|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
155256479|NCT03923959|560369847|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
155256480|NCT05711641|560369848|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
155256481|NCT05711641|560369849|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
155256482|NCT05711641|560369848|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
155256483|NCT05711641|560369849|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
155256484|NCT03574597|560369850|FG000|Overall Study|Withdrawal by Subject|67|||
155256485|NCT03574597|560369851|FG001|Overall Study|Withdrawal by Subject|96|||
155256486|NCT03574597|560369850|FG000|Overall Study|Lost to Follow-up|192|||
155256487|NCT03574597|560369851|FG001|Overall Study|Lost to Follow-up|188|||
155256488|NCT04040751|560369852|FG000|Overall Study|Withdrawal by Subject|2|||
155256489|NCT04040751|560369853|FG001|Overall Study|Withdrawal by Subject|0|||
155256490|NCT04040751|560369854|FG002|Overall Study|Withdrawal by Subject|2|||
155256491|NCT04040751|560369855|FG003|Overall Study|Withdrawal by Subject|0|||
155256492|NCT02355743|560369856|FG000|Overall Study|Withdrawal by Subject|1|||
155256493|NCT02355743|560369856|FG000|Overall Study|Lost to Follow-up|1|||
155256494|NCT03583554|560369858|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
155256495|NCT03583554|560369859|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
155256496|NCT03583554|560369860|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
155256497|NCT01596582|560369867|FG000|Overall Study|Deemed ineligible after study visit|3|||
155256498|NCT01596582|560369868|FG001|Overall Study|Deemed ineligible after study visit|6|||
155256499|NCT01596582|560369867|FG000|Overall Study|Missing all outcome data|1|||
155256500|NCT01596582|560369868|FG001|Overall Study|Missing all outcome data|1|||
155256501|NCT01428076|560369869|FG000|Overall Study|Adverse Event|0|||
155256502|NCT01428076|560369870|FG001|Overall Study|Adverse Event|1|||
155256503|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong stage|0|||
155256504|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong stage|3|||
155256505|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong cell type|2|||
155256506|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong cell type|2|||
155256507|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong primary|0|||
155256508|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong primary|1|||
155256509|NCT00262821|560369871|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155256510|NCT00262821|560369872|FG001|Overall Study|Ineligible - inadequate pathology|3|||
155256511|NCT00262821|560369871|FG000|Overall Study|Ineligible - elevated creatinine|0|||
155256512|NCT00262821|560369872|FG001|Overall Study|Ineligible - elevated creatinine|2|||
155256513|NCT00262821|560369871|FG000|Overall Study|Ineligible - required test not done|1|||
155256514|NCT00262821|560369872|FG001|Overall Study|Ineligible - required test not done|4|||
155256515|NCT00262821|560369871|FG000|Overall Study|Inevaluable - inadequate data|0|||
155256516|NCT00262821|560369872|FG001|Overall Study|Inevaluable - inadequate data|4|||
155256517|NCT00765388|560369873|FG000|Period 1|Lack of Efficacy|1|||
155256518|NCT00765388|560369874|FG001|Period 1|Lack of Efficacy|2|||
155256519|NCT00765388|560369873|FG000|Period 1|Lost to Follow-up|0|||
155256520|NCT00765388|560369874|FG001|Period 1|Lost to Follow-up|1|||
155256521|NCT00765388|560369873|FG000|Period 1|Herpes Zoster|0|||
155256522|NCT00765388|560369874|FG001|Period 1|Herpes Zoster|1|||
155256523|NCT00765388|560369873|FG000|Period 1|Hip operation|0|||
155256524|NCT00765388|560369874|FG001|Period 1|Hip operation|1|||
155256525|NCT03923933|560369878|FG000|Overall Study|Lost to Follow-up|1|||
155256526|NCT03923933|560369879|FG001|Overall Study|Lost to Follow-up|0|||
155256527|NCT03923933|560369878|FG000|Overall Study|Withdrawal by Subject|0|||
155256528|NCT03923933|560369879|FG001|Overall Study|Withdrawal by Subject|1|||
155256529|NCT02454101|560369880|FG000|Overall Study|Adverse Event|2|||
155256530|NCT02454101|560369881|FG001|Overall Study|Adverse Event|3|||
155256531|NCT02454101|560369880|FG000|Overall Study|Lost to Follow-up|3|||
155256532|NCT02454101|560369881|FG001|Overall Study|Lost to Follow-up|4|||
155256533|NCT02342886|560369882|FG000|Overall Study|Treatment non-compliance|1|||
155256534|NCT02342886|560369883|FG001|Overall Study|Treatment non-compliance|0|||
155256535|NCT02342886|560369884|FG002|Overall Study|Treatment non-compliance|0|||
155256536|NCT02342886|560369885|FG003|Overall Study|Treatment non-compliance|1|||
155256537|NCT02342886|560369886|FG004|Overall Study|Treatment non-compliance|0|||
155256538|NCT02342886|560369882|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
155256539|NCT02342886|560369883|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
155256540|NCT02342886|560369884|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
155256541|NCT02342886|560369885|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
155256542|NCT02342886|560369886|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
155256543|NCT02342886|560369882|FG000|Overall Study|Adverse event/specific toxicity|4|||
155256544|NCT02342886|560369883|FG001|Overall Study|Adverse event/specific toxicity|3|||
155256545|NCT02342886|560369884|FG002|Overall Study|Adverse event/specific toxicity|11|||
155256546|NCT02342886|560369885|FG003|Overall Study|Adverse event/specific toxicity|2|||
155256547|NCT02342886|560369886|FG004|Overall Study|Adverse event/specific toxicity|1|||
155256548|NCT02342886|560369882|FG000|Overall Study|Lost to Follow-up|1|||
155256549|NCT02342886|560369883|FG001|Overall Study|Lost to Follow-up|0|||
155256550|NCT02342886|560369884|FG002|Overall Study|Lost to Follow-up|0|||
155256551|NCT02342886|560369885|FG003|Overall Study|Lost to Follow-up|0|||
155256552|NCT02342886|560369886|FG004|Overall Study|Lost to Follow-up|0|||
155256553|NCT02342886|560369882|FG000|Overall Study|Death|1|||
155256554|NCT02342886|560369883|FG001|Overall Study|Death|2|||
155256555|NCT02342886|560369884|FG002|Overall Study|Death|1|||
155256556|NCT02342886|560369885|FG003|Overall Study|Death|0|||
155256557|NCT02342886|560369886|FG004|Overall Study|Death|1|||
155256558|NCT02342886|560369882|FG000|Overall Study|Withdrawal by Subject|0|||
155256559|NCT02342886|560369883|FG001|Overall Study|Withdrawal by Subject|1|||
155256560|NCT02342886|560369884|FG002|Overall Study|Withdrawal by Subject|0|||
155256561|NCT02342886|560369885|FG003|Overall Study|Withdrawal by Subject|1|||
155256562|NCT02342886|560369886|FG004|Overall Study|Withdrawal by Subject|0|||
155256563|NCT02342886|560369882|FG000|Overall Study|Investigator/sponsor decision|0|||
155256564|NCT02342886|560369883|FG001|Overall Study|Investigator/sponsor decision|2|||
155256565|NCT02342886|560369884|FG002|Overall Study|Investigator/sponsor decision|0|||
155256566|NCT02342886|560369885|FG003|Overall Study|Investigator/sponsor decision|3|||
155256567|NCT02342886|560369886|FG004|Overall Study|Investigator/sponsor decision|1|||
155256568|NCT02342886|560369882|FG000|Overall Study|Pregnancy|0|||
155256569|NCT02342886|560369883|FG001|Overall Study|Pregnancy|0|||
155256570|NCT02342886|560369884|FG002|Overall Study|Pregnancy|2|||
155256571|NCT02342886|560369885|FG003|Overall Study|Pregnancy|0|||
155256572|NCT02342886|560369886|FG004|Overall Study|Pregnancy|0|||
155256573|NCT02342886|560369882|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256574|NCT02342886|560369883|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256575|NCT02342886|560369884|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
155256576|NCT02342886|560369885|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256577|NCT02342886|560369886|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256578|NCT02342886|560369882|FG000|Overall Study|Protocol Violation|0|||
155256579|NCT02342886|560369883|FG001|Overall Study|Protocol Violation|0|||
155256580|NCT02342886|560369884|FG002|Overall Study|Protocol Violation|0|||
155256581|NCT02342886|560369885|FG003|Overall Study|Protocol Violation|2|||
155256582|NCT02342886|560369886|FG004|Overall Study|Protocol Violation|0|||
155256583|NCT00765674|560369890|FG000|Overall Study|Adverse Event|7|||
155256584|NCT00765674|560369891|FG001|Overall Study|Adverse Event|2|||
155256585|NCT00765674|560369892|FG002|Overall Study|Adverse Event|8|||
155256586|NCT00765674|560369893|FG003|Overall Study|Adverse Event|11|||
155256587|NCT00765674|560369890|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155256588|NCT00765674|560369891|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
155256589|NCT00765674|560369892|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
155256590|NCT00765674|560369893|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155256591|NCT00765674|560369890|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155256592|NCT00765674|560369891|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
155256593|NCT00765674|560369892|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
155256594|NCT00765674|560369893|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
155256595|NCT00765674|560369890|FG000|Overall Study|Lack of Efficacy|2|||
155256596|NCT00765674|560369891|FG001|Overall Study|Lack of Efficacy|3|||
155256597|NCT00765674|560369892|FG002|Overall Study|Lack of Efficacy|1|||
155256598|NCT00765674|560369893|FG003|Overall Study|Lack of Efficacy|2|||
155256599|NCT00765674|560369890|FG000|Overall Study|Protocol Violation|2|||
155256600|NCT00765674|560369891|FG001|Overall Study|Protocol Violation|0|||
155256601|NCT00765674|560369892|FG002|Overall Study|Protocol Violation|1|||
155256602|NCT00765674|560369893|FG003|Overall Study|Protocol Violation|0|||
155256603|NCT00765674|560369890|FG000|Overall Study|Withdrawal by Subject|5|||
155256604|NCT00765674|560369891|FG001|Overall Study|Withdrawal by Subject|7|||
155256605|NCT00765674|560369892|FG002|Overall Study|Withdrawal by Subject|3|||
155256606|NCT00765674|560369893|FG003|Overall Study|Withdrawal by Subject|8|||
155256607|NCT00765674|560369890|FG000|Overall Study|Lost to Follow-up|4|||
155256608|NCT00765674|560369891|FG001|Overall Study|Lost to Follow-up|6|||
155256609|NCT00765674|560369892|FG002|Overall Study|Lost to Follow-up|2|||
155256610|NCT00765674|560369893|FG003|Overall Study|Lost to Follow-up|1|||
155256611|NCT00765674|560369890|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
155256612|NCT00765674|560369891|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
155256613|NCT00765674|560369892|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
155256614|NCT00765674|560369893|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
155256615|NCT01813474|560369899|FG000|Overall Study|Withdrawal by Subject|0|||
155256616|NCT01813474|560369900|FG001|Overall Study|Withdrawal by Subject|0|||
155256617|NCT01813474|560369901|FG002|Overall Study|Withdrawal by Subject|1|||
155256618|NCT01813474|560369899|FG000|Overall Study|Adverse Event|1|||
155256619|NCT01813474|560369900|FG001|Overall Study|Adverse Event|1|||
155256620|NCT01813474|560369901|FG002|Overall Study|Adverse Event|0|||
155256621|NCT01813474|560369899|FG000|Overall Study|Lack of Efficacy|2|||
155256622|NCT01813474|560369900|FG001|Overall Study|Lack of Efficacy|6|||
155256623|NCT01813474|560369901|FG002|Overall Study|Lack of Efficacy|9|||
155256624|NCT01813474|560369899|FG000|Overall Study|Death|0|||
155256625|NCT01813474|560369900|FG001|Overall Study|Death|0|||
155256626|NCT01813474|560369901|FG002|Overall Study|Death|1|||
155256627|NCT03015402|560369902|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155256628|NCT03015402|560369903|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
155256629|NCT03015402|560369902|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155256630|NCT03015402|560369903|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
155256631|NCT00316082|560369904|FG000|Overall Study|Lack of Efficacy|2|||
155256632|NCT00316082|560369905|FG001|Overall Study|Lack of Efficacy|3|||
155256633|NCT00316082|560369906|FG002|Overall Study|Lack of Efficacy|3|||
155256634|NCT00316082|560369907|FG003|Overall Study|Lack of Efficacy|4|||
155256635|NCT00316082|560369908|FG004|Overall Study|Lack of Efficacy|6|||
155256636|NCT00316082|560369904|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
155256637|NCT00316082|560369905|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
155256638|NCT00316082|560369906|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
155256639|NCT00316082|560369907|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
155256640|NCT00316082|560369908|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
155256641|NCT00316082|560369904|FG000|Overall Study|Lost to Follow-up|7|||
155256642|NCT00316082|560369905|FG001|Overall Study|Lost to Follow-up|6|||
155256643|NCT00316082|560369906|FG002|Overall Study|Lost to Follow-up|7|||
155256644|NCT00316082|560369907|FG003|Overall Study|Lost to Follow-up|8|||
155256645|NCT00316082|560369908|FG004|Overall Study|Lost to Follow-up|6|||
155256646|NCT00316082|560369904|FG000|Overall Study|Poor/noncompliance|6|||
155256647|NCT00316082|560369905|FG001|Overall Study|Poor/noncompliance|1|||
155256648|NCT00316082|560369906|FG002|Overall Study|Poor/noncompliance|4|||
155256649|NCT00316082|560369907|FG003|Overall Study|Poor/noncompliance|1|||
155256650|NCT00316082|560369908|FG004|Overall Study|Poor/noncompliance|4|||
155256651|NCT00316082|560369904|FG000|Overall Study|Adverse Event|4|||
155256652|NCT00316082|560369905|FG001|Overall Study|Adverse Event|2|||
155256653|NCT00316082|560369906|FG002|Overall Study|Adverse Event|5|||
155256654|NCT00316082|560369907|FG003|Overall Study|Adverse Event|1|||
155256655|NCT00316082|560369908|FG004|Overall Study|Adverse Event|3|||
155256656|NCT00316082|560369904|FG000|Overall Study|Subject no longer meets study criteria|3|||
155256657|NCT00316082|560369905|FG001|Overall Study|Subject no longer meets study criteria|1|||
155256658|NCT00316082|560369906|FG002|Overall Study|Subject no longer meets study criteria|2|||
155256659|NCT00316082|560369907|FG003|Overall Study|Subject no longer meets study criteria|2|||
155256660|NCT00316082|560369908|FG004|Overall Study|Subject no longer meets study criteria|1|||
155256661|NCT00316082|560369904|FG000|Overall Study|Physician Decision|1|||
155256662|NCT00316082|560369905|FG001|Overall Study|Physician Decision|1|||
155256663|NCT00316082|560369906|FG002|Overall Study|Physician Decision|2|||
155256664|NCT00316082|560369907|FG003|Overall Study|Physician Decision|1|||
155256665|NCT00316082|560369908|FG004|Overall Study|Physician Decision|1|||
155256666|NCT00316082|560369904|FG000|Overall Study|Death|0|||
155256667|NCT00316082|560369905|FG001|Overall Study|Death|0|||
155256668|NCT00316082|560369906|FG002|Overall Study|Death|1|||
155256669|NCT00316082|560369907|FG003|Overall Study|Death|0|||
155256670|NCT00316082|560369908|FG004|Overall Study|Death|0|||
155256671|NCT00316082|560369904|FG000|Overall Study|Administrative reason by sponsor|0|||
155256672|NCT00316082|560369905|FG001|Overall Study|Administrative reason by sponsor|0|||
155256673|NCT00316082|560369906|FG002|Overall Study|Administrative reason by sponsor|1|||
155256674|NCT00316082|560369907|FG003|Overall Study|Administrative reason by sponsor|0|||
155256675|NCT00316082|560369908|FG004|Overall Study|Administrative reason by sponsor|0|||
155256676|NCT02216773|560369911|FG000|Overall Study|Disease progression|4|||
155256677|NCT02216773|560369912|FG001|Overall Study|Disease progression|2|||
155256678|NCT02216773|560369911|FG000|Overall Study|Insufficient FLRV|4|||
155256679|NCT02216773|560369912|FG001|Overall Study|Insufficient FLRV|0|||
155256680|NCT02216773|560369911|FG000|Overall Study|Abandoned|4|||
155256681|NCT02216773|560369912|FG001|Overall Study|Abandoned|3|||
155256682|NCT00528775|560369913|FG000|Overall Study|Other not specified|1|||
155256683|NCT01995461|560369914|FG000|Overall Study|Death|1|||
155256684|NCT01995461|560369914|FG000|Overall Study|Lost to Follow-up|2|||
155256685|NCT01995461|560369914|FG000|Overall Study|Withdrawal by Subject|2|||
155256686|NCT00540124|560369915|FG000|Overall Study|Adverse Event|0|||
155256687|NCT00540124|560369916|FG001|Overall Study|Adverse Event|2|||
155256688|NCT00540124|560369917|FG002|Overall Study|Adverse Event|1|||
155256689|NCT00540124|560369915|FG000|Overall Study|Entry Criteria Not Met|2|||
155256690|NCT00540124|560369916|FG001|Overall Study|Entry Criteria Not Met|0|||
155256691|NCT00540124|560369917|FG002|Overall Study|Entry Criteria Not Met|0|||
155256692|NCT00540124|560369915|FG000|Overall Study|Lack of Efficacy|1|||
155256693|NCT00540124|560369916|FG001|Overall Study|Lack of Efficacy|0|||
155256694|NCT00540124|560369917|FG002|Overall Study|Lack of Efficacy|0|||
155256695|NCT00540124|560369915|FG000|Overall Study|Withdrawal by Subject|1|||
155256696|NCT00540124|560369916|FG001|Overall Study|Withdrawal by Subject|1|||
155256697|NCT00540124|560369917|FG002|Overall Study|Withdrawal by Subject|0|||
155256698|NCT01777854|560369925|FG000|Overall Study|Physician Decision|3|||
155256699|NCT01777854|560369926|FG001|Overall Study|Physician Decision|3|||
155256700|NCT02124265|560369929|FG000|Overall Study|Adverse Event|1|||
155256701|NCT00981084|560369933|FG000|Post Intervention (Data Analysis)|poor effort|1|||
155256702|NCT00981084|560369934|FG001|Post Intervention (Data Analysis)|poor effort|1|||
155256703|NCT00981084|560369933|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
155256704|NCT00981084|560369934|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
155256705|NCT02543658|560371714|FG000|Overall Study|Lack of Efficacy|0|||
155256706|NCT02543658|560371715|FG001|Overall Study|Lack of Efficacy|4|||
155256707|NCT00789815|560371716|FG000|Overall Study|Protocol Violation|6|||
155256708|NCT00789815|560371717|FG001|Overall Study|Protocol Violation|1|||
155256709|NCT00789815|560371716|FG000|Overall Study|Intubation due to massive bleeding|1|||
155256710|NCT00789815|560371717|FG001|Overall Study|Intubation due to massive bleeding|0|||
155256711|NCT01553318|560371724|FG000|Overall Study|Protocol Violation|3|||
155256712|NCT01553318|560371725|FG001|Overall Study|Protocol Violation|2|||
155256713|NCT01787097|560371727|FG000|Overall Study|Withdrawal by Subject|1|||
155256714|NCT01787097|560371728|FG001|Overall Study|Withdrawal by Subject|0|||
155256715|NCT01787097|560371729|FG002|Overall Study|Withdrawal by Subject|0|||
155256716|NCT01787097|560371730|FG003|Overall Study|Withdrawal by Subject|0|||
155256717|NCT00437645|560371742|FG000|Overall Study|Adverse Event|15|||
155256718|NCT00437645|560371743|FG001|Overall Study|Adverse Event|84|||
155256719|NCT00437645|560371742|FG000|Overall Study|Withdrawal by Subject|10|||
155256720|NCT00437645|560371743|FG001|Overall Study|Withdrawal by Subject|22|||
155256721|NCT00437645|560371742|FG000|Overall Study|Protocol Violation|3|||
155256722|NCT00437645|560371743|FG001|Overall Study|Protocol Violation|3|||
155256723|NCT00437645|560371742|FG000|Overall Study|Lost to Follow-up|2|||
155256724|NCT00437645|560371743|FG001|Overall Study|Lost to Follow-up|3|||
155256725|NCT00437645|560371742|FG000|Overall Study|Administrative problems|2|||
155256726|NCT00437645|560371743|FG001|Overall Study|Administrative problems|1|||
155256727|NCT00437645|560371742|FG000|Overall Study|Lack of Efficacy|2|||
155256728|NCT00437645|560371743|FG001|Overall Study|Lack of Efficacy|1|||
155256729|NCT00437645|560371742|FG000|Overall Study|Condition no longer requires study drug|1|||
155256730|NCT00437645|560371743|FG001|Overall Study|Condition no longer requires study drug|1|||
155256731|NCT00662857|560371744|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
155256732|NCT00662857|560371745|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
155256733|NCT00662857|560371744|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
155256734|NCT00662857|560371745|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
155256735|NCT00662857|560371744|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
155256736|NCT00662857|560371745|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
155256737|NCT03966053|560371746|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
155256738|NCT02832622|560371747|FG000|Overall Study|MPP not programmed|1259|||
155256739|NCT02832622|560371747|FG000|Overall Study|Withdrawal by Subject|123|||
155256740|NCT02832622|560371747|FG000|Overall Study|Death|119|||
155256741|NCT02832622|560371747|FG000|Overall Study|Unsuccessful CRT implant|93|||
155256742|NCT02832622|560371747|FG000|Overall Study|Lost to Follow-up|45|||
155256743|NCT02832622|560371747|FG000|Overall Study|Patient non-compliance|42|||
155256744|NCT02832622|560371747|FG000|Overall Study|Withdrawal by other reasons|25|||
155256745|NCT02832622|560371747|FG000|Overall Study|System explant|24|||
155256746|NCT02832622|560371747|FG000|Overall Study|Physician Decision|6|||
155256747|NCT02472652|560371748|FG000|Overall Study|Lost to Follow-up|1|||
155256748|NCT04586569|560371753|FG000|Overall Study|Withdrawal by Subject|0|||
155256749|NCT04586569|560371754|FG001|Overall Study|Withdrawal by Subject|2|||
155256750|NCT04586569|560371753|FG000|Overall Study|No longer eligible|2|||
155256751|NCT04586569|560371754|FG001|Overall Study|No longer eligible|3|||
155256752|NCT04586569|560371753|FG000|Overall Study|Physician Decision|1|||
155256753|NCT04586569|560371754|FG001|Overall Study|Physician Decision|0|||
155256754|NCT00998400|560371755|FG000|Overall Study|Lack of interest/motivation|1|||
155256755|NCT00998400|560371756|FG001|Overall Study|Lack of interest/motivation|2|||
155256756|NCT00998400|560371755|FG000|Overall Study|Logistical problems|1|||
155256757|NCT00998400|560371756|FG001|Overall Study|Logistical problems|0|||
155256758|NCT03704584|560371757|FG000|Overall Study|Withdrawal by Subject|1|||
155256759|NCT03704584|560371758|FG001|Overall Study|Withdrawal by Subject|0|||
155256760|NCT03185832|560371759|FG000|Overall Study|Death|9|||
155256761|NCT03185832|560371760|FG001|Overall Study|Death|14|||
155256762|NCT03185832|560371761|FG002|Overall Study|Death|9|||
155256763|NCT03185832|560371762|FG003|Overall Study|Death|7|||
155256764|NCT03185832|560371759|FG000|Overall Study|Withdrawn - vital status available|0|||
155256765|NCT03185832|560371760|FG001|Overall Study|Withdrawn - vital status available|1|||
155256766|NCT03185832|560371761|FG002|Overall Study|Withdrawn - vital status available|1|||
155256767|NCT03185832|560371762|FG003|Overall Study|Withdrawn - vital status available|4|||
155256768|NCT01777321|560371764|FG000|Overall Study|Withdrawal by Subject|0|||
155256769|NCT01777321|560371765|FG001|Overall Study|Withdrawal by Subject|1|||
155256770|NCT02127372|560371766|FG000|Overall Study|Withdrawal by Subject|1|||
155256771|NCT02127372|560371767|FG001|Overall Study|Withdrawal by Subject|0|||
155256772|NCT02173548|560371768|FG000|Overall Study|Lost to Follow-up|0|||
155256773|NCT02173548|560371769|FG001|Overall Study|Lost to Follow-up|2|||
155491696|NCT00762073|561225492|FG001|Overall Study|Withdrawal by Subject|2|||
155491697|NCT00762073|561225493|FG002|Overall Study|Withdrawal by Subject|1|||
155256774|NCT02173548|560371768|FG000|Overall Study|Withdrawal by Subject|1|||
155256775|NCT02173548|560371769|FG001|Overall Study|Withdrawal by Subject|0|||
155256776|NCT03597568|560371770|FG000|Overall Study|Withdrawal by Subject|1|||
155256777|NCT03597568|560371771|FG001|Overall Study|Withdrawal by Subject|1|||
155256778|NCT03597568|560371770|FG000|Overall Study|Unable to analyze vascular data|1|||
155256779|NCT03597568|560371771|FG001|Overall Study|Unable to analyze vascular data|1|||
155256780|NCT03822117|560371774|FG000|Overall Study|Death|18|||
155256781|NCT03822117|560371775|FG001|Overall Study|Death|17|||
155256782|NCT03822117|560371776|FG002|Overall Study|Death|12|||
155256783|NCT03822117|560371777|FG003|Overall Study|Death|4|||
155256784|NCT03822117|560371774|FG000|Overall Study|Lost to Follow-up|1|||
155256785|NCT03822117|560371775|FG001|Overall Study|Lost to Follow-up|2|||
155256786|NCT03822117|560371776|FG002|Overall Study|Lost to Follow-up|3|||
155256787|NCT03822117|560371777|FG003|Overall Study|Lost to Follow-up|0|||
155256788|NCT03822117|560371774|FG000|Overall Study|Study Terminated by Sponsor|25|||
155256789|NCT03822117|560371775|FG001|Overall Study|Study Terminated by Sponsor|11|||
155256790|NCT03822117|560371776|FG002|Overall Study|Study Terminated by Sponsor|6|||
155256791|NCT03822117|560371777|FG003|Overall Study|Study Terminated by Sponsor|0|||
155256792|NCT03822117|560371774|FG000|Overall Study|Withdrawal by Subject|4|||
155256793|NCT03822117|560371775|FG001|Overall Study|Withdrawal by Subject|0|||
155256794|NCT03822117|560371776|FG002|Overall Study|Withdrawal by Subject|3|||
155256795|NCT03822117|560371777|FG003|Overall Study|Withdrawal by Subject|0|||
155256796|NCT03822117|560371774|FG000|Overall Study|Disease Progression|1|||
155256797|NCT03822117|560371775|FG001|Overall Study|Disease Progression|2|||
155256798|NCT03822117|560371776|FG002|Overall Study|Disease Progression|1|||
155256799|NCT03822117|560371777|FG003|Overall Study|Disease Progression|0|||
155256800|NCT03822117|560371774|FG000|Overall Study|Never Returned to Hospital|0|||
155256801|NCT03822117|560371775|FG001|Overall Study|Never Returned to Hospital|0|||
155256802|NCT03822117|560371776|FG002|Overall Study|Never Returned to Hospital|1|||
155256803|NCT03822117|560371777|FG003|Overall Study|Never Returned to Hospital|0|||
155256804|NCT05131165|560371780|FG000|Overall Study|Death|1|||
155256805|NCT05131165|560371781|FG001|Overall Study|Death|1|||
155256806|NCT05131165|560371782|FG002|Overall Study|Death|0|||
155256807|NCT05131165|560371780|FG000|Overall Study|Lost to Follow-up|2|||
155256808|NCT05131165|560371781|FG001|Overall Study|Lost to Follow-up|2|||
155256809|NCT05131165|560371782|FG002|Overall Study|Lost to Follow-up|5|||
155256810|NCT05131165|560371780|FG000|Overall Study|Transferred out of clinic|1|||
155256811|NCT05131165|560371781|FG001|Overall Study|Transferred out of clinic|0|||
155256812|NCT05131165|560371782|FG002|Overall Study|Transferred out of clinic|3|||
155256813|NCT05131165|560371780|FG000|Overall Study|Dropped out|1|||
155256814|NCT05131165|560371781|FG001|Overall Study|Dropped out|2|||
155256815|NCT05131165|560371782|FG002|Overall Study|Dropped out|0|||
155256816|NCT01127646|560371785|FG000|Overall Study|Entry Criteria Not Met|1|||
155256817|NCT01127646|560371786|FG001|Overall Study|Entry Criteria Not Met|0|||
155256818|NCT01127646|560371785|FG000|Overall Study|Protocol Violation|0|||
155256819|NCT01127646|560371786|FG001|Overall Study|Protocol Violation|1|||
155256820|NCT03466086|560371787|FG000|Period 1|Sponsor decision due to study timeline|1|||
155256821|NCT03466086|560371788|FG001|Period 1|Sponsor decision due to study timeline|0|||
155256822|NCT03466086|560371787|FG000|Period 1|Withdrawal by Subject|1|||
155256823|NCT03466086|560371788|FG001|Period 1|Withdrawal by Subject|0|||
155256824|NCT03002610|560371792|FG000|Overall Study|Withdrawal by Subject|6|||
155256825|NCT03002610|560371793|FG001|Overall Study|Withdrawal by Subject|25|||
155256826|NCT03002610|560371794|FG002|Overall Study|Withdrawal by Subject|13|||
155256827|NCT03802123|560371795|FG000|Overall Study|Withdrawal by Subject|3|||
155256828|NCT03802123|560371795|FG000|Overall Study|Physician Decision|1|||
155256829|NCT03802123|560371795|FG000|Overall Study|Subject moved to hospice care|1|||
155256830|NCT03802123|560371795|FG000|Overall Study|technician error|1|||
155256831|NCT03802123|560371795|FG000|Overall Study|Death|3|||
155256832|NCT01822587|560371796|FG000|Overall Study|Lost to Follow-up|7|||
155256833|NCT01822587|560371797|FG001|Overall Study|Lost to Follow-up|9|||
155256834|NCT01822587|560371798|FG002|Overall Study|Lost to Follow-up|12|||
155256835|NCT01822587|560371796|FG000|Overall Study|Physician Decision|9|||
155256836|NCT01822587|560371797|FG001|Overall Study|Physician Decision|6|||
155256837|NCT01822587|560371798|FG002|Overall Study|Physician Decision|6|||
155256838|NCT01274182|560371799|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155256839|NCT01274182|560371800|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155256840|NCT01274182|560371801|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
155256841|NCT01274182|560371799|FG000|Overall Study|Adverse Event|4|||
155256842|NCT01274182|560371800|FG001|Overall Study|Adverse Event|5|||
155256843|NCT01274182|560371801|FG002|Overall Study|Adverse Event|3|||
155256844|NCT01274182|560371799|FG000|Overall Study|Withdrawal by Subject|5|||
155256845|NCT01274182|560371800|FG001|Overall Study|Withdrawal by Subject|5|||
155256846|NCT01274182|560371801|FG002|Overall Study|Withdrawal by Subject|3|||
155256847|NCT01274182|560371799|FG000|Overall Study|Lost to Follow-up|2|||
155256848|NCT01274182|560371800|FG001|Overall Study|Lost to Follow-up|3|||
155256849|NCT01274182|560371801|FG002|Overall Study|Lost to Follow-up|1|||
155256850|NCT01274182|560371799|FG000|Overall Study|Protocol Violation|3|||
155256851|NCT01274182|560371800|FG001|Overall Study|Protocol Violation|2|||
155256852|NCT01274182|560371801|FG002|Overall Study|Protocol Violation|0|||
155256853|NCT01274182|560371799|FG000|Overall Study|Death|1|||
155256854|NCT01274182|560371800|FG001|Overall Study|Death|0|||
155256855|NCT01274182|560371801|FG002|Overall Study|Death|1|||
155256856|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
155256857|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
155256858|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
155256859|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
155256860|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
155256861|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
155256862|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
155256863|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
155256864|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
155256865|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
155256866|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
155256867|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
155256868|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
155256869|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
155256870|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
155256871|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
155256872|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
155256873|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
155256874|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
155256875|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
155256876|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
155256877|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
155256878|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
155256879|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
155256880|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
155256881|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
155256882|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
155256883|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
155256884|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
155256885|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
155256886|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
155256887|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
155256888|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155256889|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
155256890|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
155256891|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
155256892|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
155256893|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
155256894|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
155256895|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
155256896|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
155256897|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
155256898|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
155256899|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
155256900|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
155256901|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
155256902|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
155256903|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
155256904|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
155256905|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
155256906|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
155256907|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
155256908|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
155256909|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
155256910|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
155256911|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
155256912|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
155256913|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
155256914|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
155256915|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
155256916|NCT00117676|560371804|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
155256917|NCT00117676|560371805|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
155491698|NCT00762073|561225494|FG003|Overall Study|Withdrawal by Subject|1|||
155256918|NCT00117676|560371804|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
155256919|NCT00117676|560371805|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
155256920|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
155256921|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
155256922|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
155256923|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
155256924|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
155256925|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
155256926|NCT00952822|560371806|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256927|NCT00952822|560371807|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
155256928|NCT00952822|560371808|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256929|NCT00952822|560371809|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256930|NCT00952822|560371806|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256931|NCT00952822|560371807|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256932|NCT00952822|560371808|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
155256933|NCT00952822|560371809|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256934|NCT01362439|560371810|FG000|Overall Study|Adverse Event|1|||
155256935|NCT01362439|560371810|FG000|Overall Study|Lack of Efficacy|3|||
155256936|NCT01362439|560371810|FG000|Overall Study|Lost to Follow-up|2|||
155256937|NCT01362439|560371810|FG000|Overall Study|Study medication non-compliant|1|||
155256938|NCT01362439|560371810|FG000|Overall Study|Participant who withdrew consent|8|||
155256939|NCT03575325|560371814|FG000|Overall Study|Death|1|||
155256940|NCT02712905|560371817|FG000|Monotherapy|Death|2|||
155256941|NCT02712905|560371818|FG001|Monotherapy|Death|5|||
155256942|NCT02712905|560371819|FG002|Monotherapy|Death|0|||
155256943|NCT02712905|560371820|FG003|Monotherapy|Death|3|||
155256944|NCT02712905|560371821|FG004|Monotherapy|Death|15|||
155256945|NCT02712905|560371822|FG005|Monotherapy|Death|1|||
155256946|NCT02712905|560371823|FG006|Monotherapy|Death|3|||
155256947|NCT02712905|560371824|FG007|Monotherapy|Death|3|||
155256948|NCT02712905|560371825|FG008|Monotherapy|Death|0|||
155256949|NCT02712905|560371826|FG009|Monotherapy|Death|27|||
155256950|NCT02712905|560371827|FG010|Monotherapy|Death|2|||
155256951|NCT02712905|560371828|FG011|Monotherapy|Death|5|||
155256952|NCT02712905|560371829|FG012|Monotherapy|Death|0|||
155256953|NCT02712905|560371830|FG013|Monotherapy|Death|0|||
155256954|NCT02712905|560371831|FG014|Monotherapy|Death|0|||
155256955|NCT02712905|560371832|FG015|Monotherapy|Death|0|||
155256956|NCT02712905|560371833|FG016|Monotherapy|Death|0|||
155256957|NCT02712905|560371834|FG017|Monotherapy|Death|0|||
155256958|NCT02712905|560371817|FG000|Monotherapy|Lost to Follow-up|0|||
155256959|NCT02712905|560371818|FG001|Monotherapy|Lost to Follow-up|1|||
155256960|NCT02712905|560371819|FG002|Monotherapy|Lost to Follow-up|0|||
155256961|NCT02712905|560371820|FG003|Monotherapy|Lost to Follow-up|1|||
155256962|NCT02712905|560371821|FG004|Monotherapy|Lost to Follow-up|0|||
155256963|NCT02712905|560371822|FG005|Monotherapy|Lost to Follow-up|0|||
155256964|NCT02712905|560371823|FG006|Monotherapy|Lost to Follow-up|0|||
155256965|NCT02712905|560371824|FG007|Monotherapy|Lost to Follow-up|0|||
155256966|NCT02712905|560371825|FG008|Monotherapy|Lost to Follow-up|0|||
155256967|NCT02712905|560371826|FG009|Monotherapy|Lost to Follow-up|2|||
155256968|NCT02712905|560371827|FG010|Monotherapy|Lost to Follow-up|0|||
155256969|NCT02712905|560371828|FG011|Monotherapy|Lost to Follow-up|0|||
155256970|NCT02712905|560371829|FG012|Monotherapy|Lost to Follow-up|0|||
155256971|NCT02712905|560371830|FG013|Monotherapy|Lost to Follow-up|0|||
155256972|NCT02712905|560371831|FG014|Monotherapy|Lost to Follow-up|0|||
155256973|NCT02712905|560371832|FG015|Monotherapy|Lost to Follow-up|0|||
155256974|NCT02712905|560371833|FG016|Monotherapy|Lost to Follow-up|0|||
155256975|NCT02712905|560371834|FG017|Monotherapy|Lost to Follow-up|0|||
155256976|NCT02712905|560371817|FG000|Monotherapy|Physician Decision|1|||
155256977|NCT02712905|560371818|FG001|Monotherapy|Physician Decision|0|||
155256978|NCT02712905|560371819|FG002|Monotherapy|Physician Decision|0|||
155256979|NCT02712905|560371820|FG003|Monotherapy|Physician Decision|1|||
155256980|NCT02712905|560371821|FG004|Monotherapy|Physician Decision|0|||
155256981|NCT02712905|560371822|FG005|Monotherapy|Physician Decision|0|||
155256982|NCT02712905|560371823|FG006|Monotherapy|Physician Decision|0|||
155256983|NCT02712905|560371824|FG007|Monotherapy|Physician Decision|0|||
155256984|NCT02712905|560371825|FG008|Monotherapy|Physician Decision|0|||
155256985|NCT02712905|560371826|FG009|Monotherapy|Physician Decision|1|||
155491699|NCT00762073|561225491|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
155491700|NCT00762073|561225492|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
155256986|NCT02712905|560371827|FG010|Monotherapy|Physician Decision|0|||
155256987|NCT02712905|560371828|FG011|Monotherapy|Physician Decision|0|||
155256988|NCT02712905|560371829|FG012|Monotherapy|Physician Decision|0|||
155256989|NCT02712905|560371830|FG013|Monotherapy|Physician Decision|0|||
155256990|NCT02712905|560371831|FG014|Monotherapy|Physician Decision|0|||
155256991|NCT02712905|560371832|FG015|Monotherapy|Physician Decision|0|||
155256992|NCT02712905|560371833|FG016|Monotherapy|Physician Decision|0|||
155256993|NCT02712905|560371834|FG017|Monotherapy|Physician Decision|0|||
155256994|NCT02712905|560371817|FG000|Monotherapy|Study Terminated by Sponsor|0|||
155256995|NCT02712905|560371818|FG001|Monotherapy|Study Terminated by Sponsor|0|||
155256996|NCT02712905|560371819|FG002|Monotherapy|Study Terminated by Sponsor|0|||
155256997|NCT02712905|560371820|FG003|Monotherapy|Study Terminated by Sponsor|0|||
155256998|NCT02712905|560371821|FG004|Monotherapy|Study Terminated by Sponsor|1|||
155256999|NCT02712905|560371822|FG005|Monotherapy|Study Terminated by Sponsor|0|||
155257000|NCT02712905|560371823|FG006|Monotherapy|Study Terminated by Sponsor|0|||
155257001|NCT02712905|560371824|FG007|Monotherapy|Study Terminated by Sponsor|0|||
155257002|NCT02712905|560371825|FG008|Monotherapy|Study Terminated by Sponsor|0|||
155257003|NCT02712905|560371826|FG009|Monotherapy|Study Terminated by Sponsor|2|||
155257004|NCT02712905|560371827|FG010|Monotherapy|Study Terminated by Sponsor|0|||
155257005|NCT02712905|560371828|FG011|Monotherapy|Study Terminated by Sponsor|0|||
155257006|NCT02712905|560371829|FG012|Monotherapy|Study Terminated by Sponsor|0|||
155257007|NCT02712905|560371830|FG013|Monotherapy|Study Terminated by Sponsor|0|||
155257008|NCT02712905|560371831|FG014|Monotherapy|Study Terminated by Sponsor|0|||
155257009|NCT02712905|560371832|FG015|Monotherapy|Study Terminated by Sponsor|0|||
155257010|NCT02712905|560371833|FG016|Monotherapy|Study Terminated by Sponsor|0|||
155257011|NCT02712905|560371834|FG017|Monotherapy|Study Terminated by Sponsor|0|||
155257012|NCT02712905|560371817|FG000|Monotherapy|Withdrawal by Subject|0|||
155257013|NCT02712905|560371818|FG001|Monotherapy|Withdrawal by Subject|0|||
155257014|NCT02712905|560371819|FG002|Monotherapy|Withdrawal by Subject|1|||
155257015|NCT02712905|560371820|FG003|Monotherapy|Withdrawal by Subject|0|||
155257016|NCT02712905|560371821|FG004|Monotherapy|Withdrawal by Subject|2|||
155257017|NCT02712905|560371822|FG005|Monotherapy|Withdrawal by Subject|0|||
155257018|NCT02712905|560371823|FG006|Monotherapy|Withdrawal by Subject|0|||
155257019|NCT02712905|560371824|FG007|Monotherapy|Withdrawal by Subject|0|||
155257020|NCT02712905|560371825|FG008|Monotherapy|Withdrawal by Subject|0|||
155257021|NCT02712905|560371826|FG009|Monotherapy|Withdrawal by Subject|4|||
155257022|NCT02712905|560371827|FG010|Monotherapy|Withdrawal by Subject|1|||
155257023|NCT02712905|560371828|FG011|Monotherapy|Withdrawal by Subject|2|||
155257024|NCT02712905|560371829|FG012|Monotherapy|Withdrawal by Subject|0|||
155257025|NCT02712905|560371830|FG013|Monotherapy|Withdrawal by Subject|0|||
155257026|NCT02712905|560371831|FG014|Monotherapy|Withdrawal by Subject|0|||
155257027|NCT02712905|560371832|FG015|Monotherapy|Withdrawal by Subject|0|||
155257028|NCT02712905|560371833|FG016|Monotherapy|Withdrawal by Subject|0|||
155257029|NCT02712905|560371834|FG017|Monotherapy|Withdrawal by Subject|0|||
155257030|NCT02712905|560371817|FG000|Monotherapy|Started New Cancer Drug|0|||
155257031|NCT02712905|560371818|FG001|Monotherapy|Started New Cancer Drug|0|||
155257032|NCT02712905|560371819|FG002|Monotherapy|Started New Cancer Drug|0|||
155257033|NCT02712905|560371820|FG003|Monotherapy|Started New Cancer Drug|0|||
155257034|NCT02712905|560371821|FG004|Monotherapy|Started New Cancer Drug|0|||
155257035|NCT02712905|560371822|FG005|Monotherapy|Started New Cancer Drug|1|||
155257036|NCT02712905|560371823|FG006|Monotherapy|Started New Cancer Drug|0|||
155257037|NCT02712905|560371824|FG007|Monotherapy|Started New Cancer Drug|0|||
155257038|NCT02712905|560371825|FG008|Monotherapy|Started New Cancer Drug|0|||
155257039|NCT02712905|560371826|FG009|Monotherapy|Started New Cancer Drug|0|||
155257040|NCT02712905|560371827|FG010|Monotherapy|Started New Cancer Drug|0|||
155257041|NCT02712905|560371828|FG011|Monotherapy|Started New Cancer Drug|0|||
155257042|NCT02712905|560371829|FG012|Monotherapy|Started New Cancer Drug|0|||
155257043|NCT02712905|560371830|FG013|Monotherapy|Started New Cancer Drug|0|||
155257044|NCT02712905|560371831|FG014|Monotherapy|Started New Cancer Drug|0|||
155257045|NCT02712905|560371832|FG015|Monotherapy|Started New Cancer Drug|0|||
155257046|NCT02712905|560371833|FG016|Monotherapy|Started New Cancer Drug|0|||
155257047|NCT02712905|560371834|FG017|Monotherapy|Started New Cancer Drug|0|||
155257048|NCT02712905|560371817|FG000|Monotherapy|Adverse Event|0|||
155257049|NCT02712905|560371818|FG001|Monotherapy|Adverse Event|0|||
155257050|NCT02712905|560371819|FG002|Monotherapy|Adverse Event|0|||
155257051|NCT02712905|560371820|FG003|Monotherapy|Adverse Event|0|||
155257052|NCT02712905|560371821|FG004|Monotherapy|Adverse Event|0|||
155257053|NCT02712905|560371822|FG005|Monotherapy|Adverse Event|0|||
155257054|NCT02712905|560371823|FG006|Monotherapy|Adverse Event|0|||
155257055|NCT02712905|560371824|FG007|Monotherapy|Adverse Event|0|||
155257056|NCT02712905|560371825|FG008|Monotherapy|Adverse Event|1|||
155257057|NCT02712905|560371826|FG009|Monotherapy|Adverse Event|0|||
155257058|NCT02712905|560371827|FG010|Monotherapy|Adverse Event|0|||
155257059|NCT02712905|560371828|FG011|Monotherapy|Adverse Event|0|||
155257060|NCT02712905|560371829|FG012|Monotherapy|Adverse Event|0|||
155257061|NCT02712905|560371830|FG013|Monotherapy|Adverse Event|0|||
155257062|NCT02712905|560371831|FG014|Monotherapy|Adverse Event|0|||
155257063|NCT02712905|560371832|FG015|Monotherapy|Adverse Event|0|||
155257064|NCT02712905|560371833|FG016|Monotherapy|Adverse Event|0|||
155257065|NCT02712905|560371834|FG017|Monotherapy|Adverse Event|0|||
155257066|NCT02712905|560371817|FG000|Combination Therapy|Death|0|||
155257067|NCT02712905|560371818|FG001|Combination Therapy|Death|0|||
155257068|NCT02712905|560371819|FG002|Combination Therapy|Death|0|||
155257069|NCT02712905|560371820|FG003|Combination Therapy|Death|0|||
155257070|NCT02712905|560371821|FG004|Combination Therapy|Death|0|||
155257071|NCT02712905|560371822|FG005|Combination Therapy|Death|0|||
155257072|NCT02712905|560371823|FG006|Combination Therapy|Death|0|||
155257073|NCT02712905|560371824|FG007|Combination Therapy|Death|0|||
155257074|NCT02712905|560371825|FG008|Combination Therapy|Death|0|||
155257075|NCT02712905|560371826|FG009|Combination Therapy|Death|0|||
155257076|NCT02712905|560371827|FG010|Combination Therapy|Death|0|||
155257077|NCT02712905|560371828|FG011|Combination Therapy|Death|0|||
155257078|NCT02712905|560371829|FG012|Combination Therapy|Death|5|||
155257079|NCT02712905|560371830|FG013|Combination Therapy|Death|6|||
155257080|NCT02712905|560371831|FG014|Combination Therapy|Death|1|||
155257081|NCT02712905|560371832|FG015|Combination Therapy|Death|3|||
155257082|NCT02712905|560371833|FG016|Combination Therapy|Death|1|||
155257083|NCT02712905|560371834|FG017|Combination Therapy|Death|3|||
155257084|NCT02712905|560371817|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
155257085|NCT02712905|560371818|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
155257086|NCT02712905|560371819|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
155257087|NCT02712905|560371820|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
155257088|NCT02712905|560371821|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
155257089|NCT02712905|560371822|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
155257090|NCT02712905|560371823|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
155257091|NCT02712905|560371824|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
155257092|NCT02712905|560371825|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
155257093|NCT02712905|560371826|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
155257094|NCT02712905|560371827|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
155257095|NCT02712905|560371828|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
155257096|NCT02712905|560371829|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
155257097|NCT02712905|560371830|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
155257098|NCT02712905|560371831|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
155257099|NCT02712905|560371832|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
155257100|NCT02712905|560371833|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
155257101|NCT02712905|560371834|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
155257102|NCT02712905|560371817|FG000|Combination Therapy|Withdrawal by Subject|0|||
155257103|NCT02712905|560371818|FG001|Combination Therapy|Withdrawal by Subject|0|||
155257104|NCT02712905|560371819|FG002|Combination Therapy|Withdrawal by Subject|0|||
155257105|NCT02712905|560371820|FG003|Combination Therapy|Withdrawal by Subject|0|||
155257106|NCT02712905|560371821|FG004|Combination Therapy|Withdrawal by Subject|0|||
155257107|NCT02712905|560371822|FG005|Combination Therapy|Withdrawal by Subject|0|||
155257108|NCT02712905|560371823|FG006|Combination Therapy|Withdrawal by Subject|0|||
155257109|NCT02712905|560371824|FG007|Combination Therapy|Withdrawal by Subject|0|||
155257110|NCT02712905|560371825|FG008|Combination Therapy|Withdrawal by Subject|0|||
155257111|NCT02712905|560371826|FG009|Combination Therapy|Withdrawal by Subject|0|||
155257112|NCT02712905|560371827|FG010|Combination Therapy|Withdrawal by Subject|0|||
155257113|NCT02712905|560371828|FG011|Combination Therapy|Withdrawal by Subject|0|||
155257114|NCT02712905|560371829|FG012|Combination Therapy|Withdrawal by Subject|0|||
155257115|NCT02712905|560371830|FG013|Combination Therapy|Withdrawal by Subject|0|||
155257116|NCT02712905|560371831|FG014|Combination Therapy|Withdrawal by Subject|0|||
155257117|NCT02712905|560371832|FG015|Combination Therapy|Withdrawal by Subject|1|||
155257118|NCT02712905|560371833|FG016|Combination Therapy|Withdrawal by Subject|0|||
155257119|NCT02712905|560371834|FG017|Combination Therapy|Withdrawal by Subject|2|||
155257120|NCT02712905|560371817|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257121|NCT02712905|560371818|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257122|NCT02712905|560371819|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257123|NCT02712905|560371820|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257124|NCT02712905|560371821|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257125|NCT02712905|560371822|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257126|NCT02712905|560371823|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257127|NCT02712905|560371824|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257128|NCT02712905|560371825|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257129|NCT02712905|560371826|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257130|NCT02712905|560371827|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257131|NCT02712905|560371828|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257132|NCT02712905|560371829|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257133|NCT02712905|560371830|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257134|NCT02712905|560371831|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257135|NCT02712905|560371832|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
155257136|NCT02712905|560371833|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257137|NCT02712905|560371834|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257138|NCT03178266|560371837|FG000|Overall Study|Death|0|||
155257139|NCT03178266|560371838|FG001|Overall Study|Death|1|||
155257140|NCT03178266|560371837|FG000|Overall Study|Disont. Early|0|||
155257141|NCT03178266|560371838|FG001|Overall Study|Disont. Early|1|||
155257142|NCT03178266|560371837|FG000|Overall Study|Withdrawal by Subject|0|||
155257143|NCT03178266|560371838|FG001|Overall Study|Withdrawal by Subject|2|||
155257144|NCT01812655|560371839|FG000|Overall Study|Protocol Violation|1|||
155257145|NCT01812655|560371840|FG001|Overall Study|Protocol Violation|1|||
155257146|NCT01812655|560371841|FG002|Overall Study|Protocol Violation|0|||
155257147|NCT02363946|560371842|FG000|Overall Study|Lost to Follow-up|0|||
155257148|NCT02363946|560371843|FG001|Overall Study|Lost to Follow-up|0|||
155257149|NCT02363946|560371844|FG002|Overall Study|Lost to Follow-up|0|||
155257150|NCT02363946|560371845|FG003|Overall Study|Lost to Follow-up|0|||
155257151|NCT02363946|560371846|FG004|Overall Study|Lost to Follow-up|0|||
155257152|NCT02363946|560371847|FG005|Overall Study|Lost to Follow-up|0|||
155257153|NCT02363946|560371848|FG006|Overall Study|Lost to Follow-up|0|||
155257154|NCT02363946|560371849|FG007|Overall Study|Lost to Follow-up|1|||
155257155|NCT02363946|560371850|FG008|Overall Study|Lost to Follow-up|0|||
155257156|NCT02363946|560371851|FG009|Overall Study|Lost to Follow-up|0|||
155257157|NCT02363946|560371852|FG010|Overall Study|Lost to Follow-up|0|||
155257158|NCT02363946|560371853|FG011|Overall Study|Lost to Follow-up|0|||
155257159|NCT02363946|560371854|FG012|Overall Study|Lost to Follow-up|0|||
155257160|NCT04435665|560371855|FG000|Overall Study|Lost to Follow-up|0|||
155257161|NCT04435665|560371856|FG001|Overall Study|Lost to Follow-up|0|||
155257162|NCT04435665|560371857|FG002|Overall Study|Lost to Follow-up|0|||
155257163|NCT04435665|560371858|FG003|Overall Study|Lost to Follow-up|1|||
155257164|NCT00419263|560371859|FG000|Overall Study|Lost to Follow-up|2|||
155257165|NCT00419263|560371860|FG001|Overall Study|Lost to Follow-up|1|||
155257166|NCT00419263|560371861|FG002|Overall Study|Lost to Follow-up|1|||
155257167|NCT00419263|560371859|FG000|Overall Study|Randomized in Error, Not Treated|1|||
155257168|NCT00419263|560371860|FG001|Overall Study|Randomized in Error, Not Treated|1|||
155257169|NCT00419263|560371861|FG002|Overall Study|Randomized in Error, Not Treated|0|||
155257170|NCT00419263|560371859|FG000|Overall Study|Adverse Event|0|||
155257171|NCT00419263|560371860|FG001|Overall Study|Adverse Event|0|||
155257172|NCT00419263|560371861|FG002|Overall Study|Adverse Event|1|||
155257173|NCT00419263|560371859|FG000|Overall Study|Withdrawal by Subject|0|||
155257174|NCT00419263|560371860|FG001|Overall Study|Withdrawal by Subject|0|||
155257175|NCT00419263|560371861|FG002|Overall Study|Withdrawal by Subject|1|||
155257176|NCT00862134|560371862|FG000|Overall Study|Death|1|||
155257177|NCT00862134|560371863|FG001|Overall Study|Death|0|||
155257178|NCT00862134|560371862|FG000|Overall Study|Physician Decision|0|||
155257179|NCT00862134|560371863|FG001|Overall Study|Physician Decision|1|||
155257180|NCT00862134|560371862|FG000|Overall Study|Withdrawal by Subject|1|||
155257181|NCT00862134|560371863|FG001|Overall Study|Withdrawal by Subject|2|||
155257182|NCT00862134|560371862|FG000|Overall Study|Sponsor terminated study|5|||
155257183|NCT00862134|560371863|FG001|Overall Study|Sponsor terminated study|7|||
155257184|NCT00862134|560371862|FG000|Overall Study|Adverse Event|2|||
155257185|NCT00862134|560371863|FG001|Overall Study|Adverse Event|2|||
155257186|NCT00862134|560371862|FG000|Overall Study|Withdrew prior to dosing|2|||
155257187|NCT00862134|560371863|FG001|Overall Study|Withdrew prior to dosing|0|||
155257188|NCT01494584|560371865|FG000|Overall Study|Study Closed/Terminated|1|||
155257189|NCT00374322|560371870|FG000|Overall Study|Lost to Follow-up|92|||
155257190|NCT00374322|560371871|FG001|Overall Study|Lost to Follow-up|90|||
155257191|NCT00374322|560371870|FG000|Overall Study|Protocol Violation|8|||
155257192|NCT00374322|560371871|FG001|Overall Study|Protocol Violation|3|||
155257193|NCT00374322|560371870|FG000|Overall Study|Withdrawal by Subject|235|||
155257194|NCT00374322|560371871|FG001|Overall Study|Withdrawal by Subject|167|||
155257195|NCT00374322|560371870|FG000|Overall Study|Sponsor Terminated Study|866|||
155257196|NCT00374322|560371871|FG001|Overall Study|Sponsor Terminated Study|990|||
155257197|NCT00374322|560371870|FG000|Overall Study|Physician Decision|36|||
155257198|NCT00374322|560371871|FG001|Overall Study|Physician Decision|32|||
155257199|NCT00374322|560371870|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
155257200|NCT00374322|560371871|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
155257201|NCT00374322|560371870|FG000|Overall Study|Sponsor Decision|2|||
155257202|NCT00374322|560371871|FG001|Overall Study|Sponsor Decision|3|||
155257203|NCT00374322|560371870|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
155257204|NCT00374322|560371871|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
155257205|NCT00374322|560371870|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
155257206|NCT00374322|560371871|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
155257207|NCT00374322|560371870|FG000|Overall Study|Severe Toxicity|1|||
155257208|NCT00374322|560371871|FG001|Overall Study|Severe Toxicity|0|||
155257209|NCT00374322|560371870|FG000|Overall Study|Site Closed|2|||
155257210|NCT00374322|560371871|FG001|Overall Study|Site Closed|2|||
155257211|NCT00374322|560371870|FG000|Overall Study|Participant Changed Physician|1|||
155257212|NCT00374322|560371871|FG001|Overall Study|Participant Changed Physician|0|||
155257213|NCT00374322|560371870|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
155257214|NCT00374322|560371871|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
155257215|NCT00374322|560371870|FG000|Overall Study|Noncompliance with Study Requirements|0|||
155257216|NCT00374322|560371871|FG001|Overall Study|Noncompliance with Study Requirements|1|||
155257217|NCT00374322|560371870|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
155257218|NCT00374322|560371871|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
155257219|NCT00374322|560371870|FG000|Overall Study|Did Not Receive Study Medication|8|||
155257220|NCT00374322|560371871|FG001|Overall Study|Did Not Receive Study Medication|6|||
155257221|NCT01298999|560371881|FG000|Overall Study|Physician Decision|0|||
155257222|NCT01298999|560371882|FG001|Overall Study|Physician Decision|1|||
155257223|NCT01298999|560371881|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
155257224|NCT01298999|560371882|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
155257225|NCT02532179|560373567|FG000|Overall Study|Lost to Follow-up|1|||
155257226|NCT02532179|560373567|FG000|Overall Study|Pregnancy|1|||
155257227|NCT02532179|560373567|FG000|Overall Study|Subject received depot steroid injection|1|||
155257228|NCT01337674|560373571|FG000|Treatment Period 1|Adverse Event|0|||
155257229|NCT01337674|560373572|FG001|Treatment Period 1|Adverse Event|1|||
155257230|NCT01337674|560373573|FG002|Treatment Period 1|Adverse Event|0|||
155257231|NCT01337674|560373574|FG003|Treatment Period 1|Adverse Event|0|||
155257232|NCT01337674|560373571|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
155257233|NCT01337674|560373572|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
155257234|NCT01337674|560373573|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
155257235|NCT01337674|560373574|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
155257236|NCT01337674|560373571|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155257237|NCT01337674|560373572|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155257238|NCT01337674|560373573|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155257239|NCT01337674|560373574|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155257240|NCT00119405|560373575|FG000|Overall Study|Withdrawal by Subject|1|||
155257241|NCT00939484|560373576|FG000|Overall Study|Progression/Relapse|8|||
155257242|NCT00939484|560373577|FG001|Overall Study|Progression/Relapse|20|||
155257243|NCT00939484|560373578|FG002|Overall Study|Progression/Relapse|3|||
155257244|NCT04233372|560373579|FG000|Overall Study|Lost to Follow-up|104|||
155257245|NCT04233372|560373579|FG000|Overall Study|Adverse Event|8|||
155257246|NCT04233372|560373579|FG000|Overall Study|Withdrawal by Subject|2|||
155257247|NCT04958785|560373580|FG000|Overall Study|Study Terminated by Sponsor|4|||
155257248|NCT04958785|560373581|FG001|Overall Study|Study Terminated by Sponsor|10|||
155257249|NCT04958785|560373582|FG002|Overall Study|Study Terminated by Sponsor|7|||
155257250|NCT04958785|560373583|FG003|Overall Study|Study Terminated by Sponsor|6|||
155257251|NCT04958785|560373584|FG004|Overall Study|Study Terminated by Sponsor|34|||
155257252|NCT04958785|560373580|FG000|Overall Study|Death|2|||
155257253|NCT04958785|560373581|FG001|Overall Study|Death|3|||
155257254|NCT04958785|560373582|FG002|Overall Study|Death|4|||
155257255|NCT04958785|560373583|FG003|Overall Study|Death|5|||
155257256|NCT04958785|560373584|FG004|Overall Study|Death|5|||
155257257|NCT04958785|560373580|FG000|Overall Study|Withdrew consent|2|||
155257258|NCT04958785|560373581|FG001|Overall Study|Withdrew consent|0|||
155257259|NCT04958785|560373582|FG002|Overall Study|Withdrew consent|3|||
155257260|NCT04958785|560373583|FG003|Overall Study|Withdrew consent|1|||
155257261|NCT04958785|560373584|FG004|Overall Study|Withdrew consent|0|||
155257262|NCT04958785|560373580|FG000|Overall Study|Investigator's discretion|0|||
155257263|NCT04958785|560373581|FG001|Overall Study|Investigator's discretion|1|||
155257264|NCT04958785|560373582|FG002|Overall Study|Investigator's discretion|0|||
155257265|NCT04958785|560373583|FG003|Overall Study|Investigator's discretion|1|||
155257266|NCT04958785|560373584|FG004|Overall Study|Investigator's discretion|2|||
155257267|NCT04958785|560373580|FG000|Overall Study|Adverse Event|0|||
155257268|NCT04958785|560373581|FG001|Overall Study|Adverse Event|0|||
155257269|NCT04958785|560373582|FG002|Overall Study|Adverse Event|0|||
155257270|NCT04958785|560373583|FG003|Overall Study|Adverse Event|0|||
155257271|NCT04958785|560373584|FG004|Overall Study|Adverse Event|1|||
155257272|NCT04958785|560373580|FG000|Overall Study|Lost to Follow-up|0|||
155257273|NCT04958785|560373581|FG001|Overall Study|Lost to Follow-up|0|||
155257274|NCT04958785|560373582|FG002|Overall Study|Lost to Follow-up|0|||
155257275|NCT04958785|560373583|FG003|Overall Study|Lost to Follow-up|0|||
155257276|NCT04958785|560373584|FG004|Overall Study|Lost to Follow-up|1|||
155257277|NCT03938454|560373585|FG000|Overall Study|Protocol Violation|1|||
155257278|NCT03938454|560373585|FG000|Overall Study|Withdrawal by Subject|2|||
155257279|NCT03938454|560373585|FG000|Overall Study|Lost to Follow-up|3|||
155257280|NCT01090310|560373586|FG000|Core Study|Adverse Event|2|||
155257281|NCT01090310|560373587|FG001|Core Study|Adverse Event|2|||
155257282|NCT01090310|560373588|FG002|Core Study|Adverse Event|1|||
155257283|NCT01090310|560373589|FG003|Core Study|Adverse Event|1|||
155257284|NCT01090310|560373586|FG000|Core Study|Subject withdrew consent|0|||
155257285|NCT01090310|560373587|FG001|Core Study|Subject withdrew consent|3|||
155257286|NCT01090310|560373588|FG002|Core Study|Subject withdrew consent|1|||
155257287|NCT01090310|560373589|FG003|Core Study|Subject withdrew consent|1|||
155257288|NCT01090310|560373586|FG000|Core Study|Abnormal test procedure result|0|||
155257289|NCT01090310|560373587|FG001|Core Study|Abnormal test procedure result|0|||
155257290|NCT01090310|560373588|FG002|Core Study|Abnormal test procedure result|1|||
155257291|NCT01090310|560373589|FG003|Core Study|Abnormal test procedure result|0|||
155257292|NCT01090310|560373586|FG000|Core Study|Administrative reasons|5|||
155257293|NCT01090310|560373587|FG001|Core Study|Administrative reasons|6|||
155257294|NCT01090310|560373588|FG002|Core Study|Administrative reasons|4|||
155257295|NCT01090310|560373589|FG003|Core Study|Administrative reasons|4|||
155257296|NCT01090310|560373586|FG000|Core Study|Protocol deviation|1|||
155257297|NCT01090310|560373587|FG001|Core Study|Protocol deviation|0|||
155257298|NCT01090310|560373588|FG002|Core Study|Protocol deviation|0|||
155257299|NCT01090310|560373589|FG003|Core Study|Protocol deviation|1|||
155257300|NCT01090310|560373586|FG000|Extension Study|Aministrative problems|13|||
155257301|NCT01090310|560373587|FG001|Extension Study|Aministrative problems|15|||
155257302|NCT01090310|560373588|FG002|Extension Study|Aministrative problems|14|||
155257303|NCT01090310|560373589|FG003|Extension Study|Aministrative problems|18|||
155257304|NCT01090310|560373586|FG000|Extension Study|Adverse Event|0|||
155257305|NCT01090310|560373587|FG001|Extension Study|Adverse Event|0|||
155257306|NCT01090310|560373588|FG002|Extension Study|Adverse Event|0|||
155257307|NCT01090310|560373589|FG003|Extension Study|Adverse Event|1|||
155257308|NCT01090310|560373586|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
155257309|NCT01090310|560373587|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
155257310|NCT01090310|560373588|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
155257311|NCT01090310|560373589|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
155257312|NCT01090310|560373586|FG000|Extension Study|Subject withdrew consent|0|||
155257313|NCT01090310|560373587|FG001|Extension Study|Subject withdrew consent|1|||
155257314|NCT01090310|560373588|FG002|Extension Study|Subject withdrew consent|0|||
155257315|NCT01090310|560373589|FG003|Extension Study|Subject withdrew consent|0|||
155257316|NCT00695786|560373590|FG000|Overall Study|Adverse Event|0|||
155257317|NCT00695786|560373591|FG001|Overall Study|Adverse Event|3|||
155257318|NCT00695786|560373592|FG002|Overall Study|Adverse Event|4|||
155257319|NCT00695786|560373593|FG003|Overall Study|Adverse Event|2|||
155257320|NCT00695786|560373590|FG000|Overall Study|Lost to Follow-up|0|||
155257321|NCT00695786|560373591|FG001|Overall Study|Lost to Follow-up|5|||
155257322|NCT00695786|560373592|FG002|Overall Study|Lost to Follow-up|1|||
155257323|NCT00695786|560373593|FG003|Overall Study|Lost to Follow-up|1|||
155257324|NCT00695786|560373590|FG000|Overall Study|Withdrawal by Subject|0|||
155257325|NCT00695786|560373591|FG001|Overall Study|Withdrawal by Subject|4|||
155257326|NCT00695786|560373592|FG002|Overall Study|Withdrawal by Subject|3|||
155257327|NCT00695786|560373593|FG003|Overall Study|Withdrawal by Subject|1|||
155257328|NCT00695786|560373590|FG000|Overall Study|Deemed Ineligible|1|||
155257329|NCT00695786|560373591|FG001|Overall Study|Deemed Ineligible|0|||
155257330|NCT00695786|560373592|FG002|Overall Study|Deemed Ineligible|0|||
155257331|NCT00695786|560373593|FG003|Overall Study|Deemed Ineligible|0|||
155257332|NCT00695786|560373590|FG000|Overall Study|Lack of Efficacy|0|||
155257333|NCT00695786|560373591|FG001|Overall Study|Lack of Efficacy|0|||
155257334|NCT00695786|560373592|FG002|Overall Study|Lack of Efficacy|0|||
155257335|NCT00695786|560373593|FG003|Overall Study|Lack of Efficacy|4|||
155257336|NCT01224925|560373594|FG000|Overall Study|Lost to Follow-up|3|||
155257337|NCT01224925|560373595|FG001|Overall Study|Lost to Follow-up|2|||
155257338|NCT04244396|560373599|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
155257339|NCT04244396|560373599|FG000|Overall Study|Withdrawal by Subject|2|||
155257340|NCT04244396|560373599|FG000|Overall Study|Study termination|37|||
155257341|NCT00949884|560373600|FG000|Overall Study|Adverse Event|14|||
155257342|NCT00949884|560373601|FG001|Overall Study|Adverse Event|3|||
155257343|NCT00949884|560373602|FG002|Overall Study|Adverse Event|12|||
155257344|NCT00949884|560373600|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
155257345|NCT00949884|560373601|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
155257346|NCT00949884|560373602|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
155257347|NCT00949884|560373600|FG000|Overall Study|Lost to Follow-up|7|||
155257348|NCT00949884|560373601|FG001|Overall Study|Lost to Follow-up|5|||
155257349|NCT00949884|560373602|FG002|Overall Study|Lost to Follow-up|5|||
155257350|NCT00949884|560373600|FG000|Overall Study|Physician Decision|5|||
155257351|NCT00949884|560373601|FG001|Overall Study|Physician Decision|0|||
155257352|NCT00949884|560373602|FG002|Overall Study|Physician Decision|6|||
155257353|NCT00949884|560373600|FG000|Overall Study|Treatment non-compliance|5|||
155257354|NCT00949884|560373601|FG001|Overall Study|Treatment non-compliance|0|||
155257355|NCT00949884|560373602|FG002|Overall Study|Treatment non-compliance|8|||
155257356|NCT00949884|560373600|FG000|Overall Study|Withdrawal by Subject|13|||
155257357|NCT00949884|560373601|FG001|Overall Study|Withdrawal by Subject|4|||
155257358|NCT00949884|560373602|FG002|Overall Study|Withdrawal by Subject|16|||
155257359|NCT00949884|560373600|FG000|Overall Study|Lack of Efficacy|4|||
155257360|NCT00949884|560373601|FG001|Overall Study|Lack of Efficacy|2|||
155257361|NCT00949884|560373602|FG002|Overall Study|Lack of Efficacy|7|||
155257362|NCT00949884|560373600|FG000|Overall Study|Study terminated by sponsor|0|||
155257363|NCT00949884|560373601|FG001|Overall Study|Study terminated by sponsor|0|||
155257364|NCT00949884|560373602|FG002|Overall Study|Study terminated by sponsor|1|||
155257365|NCT00245102|560373603|FG000|Overall Study|Not Treated|1|||
155257366|NCT00245102|560373604|FG001|Overall Study|Not Treated|0|||
155257367|NCT00245102|560373605|FG002|Overall Study|Not Treated|1|||
155257368|NCT00245102|560373606|FG003|Overall Study|Not Treated|0|||
155257369|NCT00245102|560373607|FG004|Overall Study|Not Treated|0|||
155257370|NCT00245102|560373608|FG005|Overall Study|Not Treated|0|||
155257371|NCT00245102|560373603|FG000|Overall Study|Protocol Violation|1|||
155257372|NCT00245102|560373604|FG001|Overall Study|Protocol Violation|0|||
155257373|NCT00245102|560373605|FG002|Overall Study|Protocol Violation|0|||
155257374|NCT00245102|560373606|FG003|Overall Study|Protocol Violation|0|||
155257375|NCT00245102|560373607|FG004|Overall Study|Protocol Violation|0|||
155257376|NCT00245102|560373608|FG005|Overall Study|Protocol Violation|0|||
155257377|NCT00245102|560373603|FG000|Overall Study|Death|0|||
155257378|NCT00245102|560373604|FG001|Overall Study|Death|0|||
155257379|NCT00245102|560373605|FG002|Overall Study|Death|0|||
155257380|NCT00245102|560373606|FG003|Overall Study|Death|1|||
155257381|NCT00245102|560373607|FG004|Overall Study|Death|0|||
155257382|NCT00245102|560373608|FG005|Overall Study|Death|0|||
155257383|NCT00245102|560373603|FG000|Overall Study|Adverse Event|4|||
155257384|NCT00245102|560373604|FG001|Overall Study|Adverse Event|2|||
155257385|NCT00245102|560373605|FG002|Overall Study|Adverse Event|5|||
155257386|NCT00245102|560373606|FG003|Overall Study|Adverse Event|1|||
155257387|NCT00245102|560373607|FG004|Overall Study|Adverse Event|0|||
155257388|NCT00245102|560373608|FG005|Overall Study|Adverse Event|2|||
155257389|NCT00245102|560373603|FG000|Overall Study|Decline in performance|0|||
155257390|NCT00245102|560373604|FG001|Overall Study|Decline in performance|2|||
155257391|NCT00245102|560373605|FG002|Overall Study|Decline in performance|0|||
155257392|NCT00245102|560373606|FG003|Overall Study|Decline in performance|1|||
155257393|NCT00245102|560373607|FG004|Overall Study|Decline in performance|0|||
155257394|NCT00245102|560373608|FG005|Overall Study|Decline in performance|2|||
155257395|NCT00245102|560373603|FG000|Overall Study|Participant needed surgery|0|||
155257396|NCT00245102|560373604|FG001|Overall Study|Participant needed surgery|0|||
155257397|NCT00245102|560373605|FG002|Overall Study|Participant needed surgery|1|||
155257398|NCT00245102|560373606|FG003|Overall Study|Participant needed surgery|0|||
155257399|NCT00245102|560373607|FG004|Overall Study|Participant needed surgery|0|||
155257400|NCT00245102|560373608|FG005|Overall Study|Participant needed surgery|0|||
155257401|NCT00245102|560373603|FG000|Overall Study|Clinical progression|1|||
155257402|NCT00245102|560373604|FG001|Overall Study|Clinical progression|0|||
155257403|NCT00245102|560373605|FG002|Overall Study|Clinical progression|0|||
155257404|NCT00245102|560373606|FG003|Overall Study|Clinical progression|0|||
155257405|NCT00245102|560373607|FG004|Overall Study|Clinical progression|0|||
155257406|NCT00245102|560373608|FG005|Overall Study|Clinical progression|0|||
155257407|NCT02293395|560373613|FG000|Overall Study|Lost to Follow-up|1|||
155257408|NCT02293395|560373614|FG001|Overall Study|Lost to Follow-up|0|||
155257409|NCT02293395|560373613|FG000|Overall Study|Withdrawal by Subject|8|||
155257410|NCT02293395|560373614|FG001|Overall Study|Withdrawal by Subject|7|||
155257411|NCT00224770|560373617|FG000|Overall Study|Lost to Follow-up|4|||
155257412|NCT00224770|560373618|FG001|Overall Study|Lost to Follow-up|2|||
155257413|NCT00224770|560373619|FG002|Overall Study|Lost to Follow-up|0|||
155257414|NCT01106430|560373620|FG000|Overall Study|Adverse Event|8|||
155257415|NCT01106430|560373621|FG001|Overall Study|Adverse Event|10|||
155257416|NCT01106430|560373620|FG000|Overall Study|Lack of Efficacy|2|||
155257417|NCT01106430|560373621|FG001|Overall Study|Lack of Efficacy|13|||
155257418|NCT01106430|560373620|FG000|Overall Study|Lost to Follow-up|5|||
155257419|NCT01106430|560373621|FG001|Overall Study|Lost to Follow-up|1|||
155257420|NCT01106430|560373620|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
155257421|NCT01106430|560373621|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
155257422|NCT01106430|560373620|FG000|Overall Study|Moved Out Of State|0|||
155257423|NCT01106430|560373621|FG001|Overall Study|Moved Out Of State|1|||
155257424|NCT01106430|560373620|FG000|Overall Study|Refused To Take Medication|0|||
155257425|NCT01106430|560373621|FG001|Overall Study|Refused To Take Medication|1|||
155257426|NCT01106430|560373620|FG000|Overall Study|Noncompliance|0|||
155257427|NCT01106430|560373621|FG001|Overall Study|Noncompliance|1|||
155257428|NCT01106430|560373620|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
155257429|NCT01106430|560373621|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
155257430|NCT01106430|560373620|FG000|Overall Study|Previous Use Of Marijuana|1|||
155257431|NCT01106430|560373621|FG001|Overall Study|Previous Use Of Marijuana|0|||
155257432|NCT01106430|560373620|FG000|Overall Study|Protocol Violation|7|||
155257433|NCT01106430|560373621|FG001|Overall Study|Protocol Violation|2|||
155257434|NCT01106430|560373620|FG000|Overall Study|Withdrawal by Subject|8|||
155257435|NCT01106430|560373621|FG001|Overall Study|Withdrawal by Subject|4|||
155257436|NCT00989092|560373626|FG000|Overall Study|Physician Decision|9|||
155257437|NCT00989092|560373627|FG001|Overall Study|Physician Decision|6|||
155257438|NCT00989092|560373626|FG000|Overall Study|Adverse Event|20|||
155257439|NCT00989092|560373627|FG001|Overall Study|Adverse Event|1|||
155257440|NCT00989092|560373626|FG000|Overall Study|Chemotherapy initiated|12|||
155257441|NCT00989092|560373627|FG001|Overall Study|Chemotherapy initiated|4|||
155257442|NCT00989092|560373626|FG000|Overall Study|Withdrawal by Subject|17|||
155257443|NCT00989092|560373627|FG001|Overall Study|Withdrawal by Subject|9|||
155257444|NCT00989092|560373626|FG000|Overall Study|Death|14|||
155257445|NCT00989092|560373627|FG001|Overall Study|Death|2|||
155257446|NCT00989092|560373626|FG000|Overall Study|Ineligibility determined|3|||
155257447|NCT00989092|560373627|FG001|Overall Study|Ineligibility determined|3|||
155257448|NCT00989092|560373626|FG000|Overall Study|Lost to Follow-up|6|||
155257449|NCT00989092|560373627|FG001|Overall Study|Lost to Follow-up|2|||
155257450|NCT00989092|560373626|FG000|Overall Study|Other|3|||
155257451|NCT00989092|560373627|FG001|Overall Study|Other|1|||
155257452|NCT00989092|560373626|FG000|Overall Study|Protocol deviation|2|||
155257453|NCT00989092|560373627|FG001|Overall Study|Protocol deviation|0|||
155257454|NCT00989092|560373626|FG000|Overall Study|Erythropoietin therapy initiated|2|||
155257455|NCT00989092|560373627|FG001|Overall Study|Erythropoietin therapy initiated|0|||
155257456|NCT00989092|560373626|FG000|Overall Study|Did not receive study drug|2|||
155257457|NCT00989092|560373627|FG001|Overall Study|Did not receive study drug|0|||
155257458|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
155257459|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
155257460|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
155257461|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
155257462|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
155257463|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
155257464|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Death|1|||
155257465|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Death|0|||
155257466|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Adverse Event|1|||
155257467|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Adverse Event|0|||
155257468|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Physician Decision|2|||
155257469|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Physician Decision|1|||
155257470|NCT02586025|560373631|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
155257471|NCT02586025|560373632|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
155257472|NCT02586025|560373631|FG000|Adjuvant Treatment|Recurrent Disease|4|||
155257473|NCT02586025|560373632|FG001|Adjuvant Treatment|Recurrent Disease|5|||
155257474|NCT02586025|560373631|FG000|Adjuvant Treatment|Physician Decision|0|||
155257475|NCT02586025|560373632|FG001|Adjuvant Treatment|Physician Decision|1|||
155257476|NCT02586025|560373631|FG000|Adjuvant Treatment|Pregnancy|1|||
155257477|NCT02586025|560373632|FG001|Adjuvant Treatment|Pregnancy|0|||
155257478|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Death|11|||
155257479|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Death|11|||
155257480|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
155257481|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
155257482|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
155257483|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
155257484|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
155257485|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
155257486|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
155257487|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
155257488|NCT01083641|560373633|FG000|Overall Study|Withdrawal by Subject|2|||
155257489|NCT03439189|560373634|FG000|Overall Study|Protocol Violation|19|||
155257490|NCT03439189|560373634|FG000|Overall Study|Lack of Efficacy|63|||
155257491|NCT03412812|560373635|FG000|Level 1|Death|3|||
155257492|NCT03412812|560373636|FG001|Level 1|Death|0|||
155257493|NCT03412812|560373635|FG000|Level 1|Adverse Event|0|||
155257494|NCT03412812|560373636|FG001|Level 1|Adverse Event|1|||
155257495|NCT03837509|560373637|FG000|Phase 1|Death|5|||
155257496|NCT03837509|560373638|FG001|Phase 1|Death|2|||
155257497|NCT03837509|560373639|FG002|Phase 1|Death|0|||
155257498|NCT03837509|560373640|FG003|Phase 1|Death|0|||
155257499|NCT03837509|560373641|FG004|Phase 1|Death|0|||
155257500|NCT03837509|560373637|FG000|Phase 2|Death|0|||
155257501|NCT03837509|560373638|FG001|Phase 2|Death|0|||
155257502|NCT03837509|560373639|FG002|Phase 2|Death|0|||
155257503|NCT03837509|560373640|FG003|Phase 2|Death|1|||
155257504|NCT03837509|560373641|FG004|Phase 2|Death|1|||
155257505|NCT03548207|560373646|FG000|Overall Study|Death|10|||
155257506|NCT03548207|560373647|FG001|Overall Study|Death|23|||
155257507|NCT03548207|560373648|FG002|Overall Study|Death|3|||
155257508|NCT03548207|560373646|FG000|Overall Study|Lost to Follow-up|0|||
155257509|NCT03548207|560373647|FG001|Overall Study|Lost to Follow-up|2|||
155257510|NCT03548207|560373648|FG002|Overall Study|Lost to Follow-up|0|||
155257511|NCT03548207|560373646|FG000|Overall Study|Withdrawal by Subject|0|||
155257512|NCT03548207|560373647|FG001|Overall Study|Withdrawal by Subject|3|||
155257513|NCT03548207|560373648|FG002|Overall Study|Withdrawal by Subject|0|||
155257514|NCT03548207|560373646|FG000|Overall Study|Sponsor decision|19|||
155257515|NCT03548207|560373647|FG001|Overall Study|Sponsor decision|40|||
155257516|NCT03548207|560373648|FG002|Overall Study|Sponsor decision|6|||
155257517|NCT03548207|560373646|FG000|Overall Study|Randomized but not treated|6|||
155257518|NCT03548207|560373647|FG001|Overall Study|Randomized but not treated|10|||
155257519|NCT03548207|560373648|FG002|Overall Study|Randomized but not treated|4|||
155257520|NCT01756352|560373649|FG000|Overall Study|moved away and lost to followup|1|||
155257521|NCT00415610|560373650|FG000|Overall Study|Death|3|||
155257522|NCT00415610|560373651|FG001|Overall Study|Death|2|||
155257523|NCT00415610|560373652|FG002|Overall Study|Death|5|||
155257524|NCT00526630|560373653|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
155257525|NCT00526630|560373654|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
155257526|NCT00526630|560373653|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
155257527|NCT00526630|560373654|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
155257528|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
155257529|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
155257530|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
155257531|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
155257532|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
155257533|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
155257534|NCT00337272|560373655|FG000|Treatment Period|Non-compliance|1|||
155257535|NCT00337272|560373656|FG001|Treatment Period|Non-compliance|1|||
155257536|NCT00337272|560373655|FG000|Treatment Period|Withdrawal by Subject|0|||
155257537|NCT00337272|560373656|FG001|Treatment Period|Withdrawal by Subject|1|||
155257538|NCT00337272|560373655|FG000|Withdrawal Period|Non-compliance|0|||
155257539|NCT00337272|560373656|FG001|Withdrawal Period|Non-compliance|1|||
155257540|NCT03320018|560373657|FG000|Treatment Period|Withdrawal by Subject|1|||
155257541|NCT03320018|560373658|FG001|Treatment Period|Withdrawal by Subject|0|||
155257542|NCT03320018|560373657|FG000|Day 90 Follow up|Death|0|||
155257543|NCT03320018|560373658|FG001|Day 90 Follow up|Death|1|||
155257544|NCT02641392|560373659|FG000|Overall Study|Lost to Follow-up|0|||
155257545|NCT02641392|560373660|FG001|Overall Study|Lost to Follow-up|0|||
155257546|NCT02641392|560373661|FG002|Overall Study|Lost to Follow-up|2|||
155257547|NCT02641392|560373659|FG000|Overall Study|Withdrawal by Subject|0|||
155257548|NCT02641392|560373660|FG001|Overall Study|Withdrawal by Subject|0|||
155257549|NCT02641392|560373661|FG002|Overall Study|Withdrawal by Subject|17|||
155257550|NCT02641392|560373659|FG000|Overall Study|Adverse Event|0|||
155257551|NCT02641392|560373660|FG001|Overall Study|Adverse Event|1|||
155257552|NCT02641392|560373661|FG002|Overall Study|Adverse Event|25|||
155257553|NCT02641392|560373659|FG000|Overall Study|Study Terminated by Sponsor|4|||
155257554|NCT02641392|560373660|FG001|Overall Study|Study Terminated by Sponsor|12|||
155257555|NCT02641392|560373661|FG002|Overall Study|Study Terminated by Sponsor|144|||
155257556|NCT02641392|560373659|FG000|Overall Study|Lack of Efficacy|0|||
155257557|NCT02641392|560373660|FG001|Overall Study|Lack of Efficacy|0|||
155257558|NCT02641392|560373661|FG002|Overall Study|Lack of Efficacy|101|||
155257559|NCT02641392|560373659|FG000|Overall Study|Miscellaneous|0|||
155257560|NCT02641392|560373660|FG001|Overall Study|Miscellaneous|0|||
155257561|NCT02641392|560373661|FG002|Overall Study|Miscellaneous|3|||
155257562|NCT02641392|560373659|FG000|Overall Study|Death|0|||
155257563|NCT02641392|560373660|FG001|Overall Study|Death|0|||
155257564|NCT02641392|560373661|FG002|Overall Study|Death|1|||
155257565|NCT02691182|560373662|FG000|Overall Study|Withdrawal by Subject|4|||
155257566|NCT02691182|560373663|FG001|Overall Study|Withdrawal by Subject|7|||
155257567|NCT02691182|560373664|FG002|Overall Study|Withdrawal by Subject|6|||
155257568|NCT02691182|560373665|FG003|Overall Study|Withdrawal by Subject|8|||
155257569|NCT02691182|560373662|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
155257570|NCT02691182|560373663|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
155257571|NCT02691182|560373664|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
155257572|NCT02691182|560373665|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
155257573|NCT02691182|560373662|FG000|Overall Study|Lost to Follow-up|8|||
155257574|NCT02691182|560373663|FG001|Overall Study|Lost to Follow-up|33|||
155257575|NCT02691182|560373664|FG002|Overall Study|Lost to Follow-up|19|||
155257576|NCT02691182|560373665|FG003|Overall Study|Lost to Follow-up|22|||
155257577|NCT02691182|560373662|FG000|Overall Study|Adverse Event|3|||
155257578|NCT02691182|560373663|FG001|Overall Study|Adverse Event|10|||
155257579|NCT02691182|560373664|FG002|Overall Study|Adverse Event|10|||
155257580|NCT02691182|560373665|FG003|Overall Study|Adverse Event|11|||
155257581|NCT02691182|560373662|FG000|Overall Study|Physician Decision|3|||
155257582|NCT02691182|560373663|FG001|Overall Study|Physician Decision|7|||
155257583|NCT02691182|560373664|FG002|Overall Study|Physician Decision|14|||
155257584|NCT02691182|560373665|FG003|Overall Study|Physician Decision|8|||
155257585|NCT02691182|560373662|FG000|Overall Study|Lack of Efficacy|0|||
155257586|NCT02691182|560373663|FG001|Overall Study|Lack of Efficacy|0|||
155257587|NCT02691182|560373664|FG002|Overall Study|Lack of Efficacy|0|||
155257588|NCT02691182|560373665|FG003|Overall Study|Lack of Efficacy|4|||
155257589|NCT02691182|560373662|FG000|Overall Study|Protocol Violation|2|||
155257590|NCT02691182|560373663|FG001|Overall Study|Protocol Violation|6|||
155257591|NCT02691182|560373664|FG002|Overall Study|Protocol Violation|6|||
155257592|NCT02691182|560373665|FG003|Overall Study|Protocol Violation|8|||
155257593|NCT02691182|560373662|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
155257594|NCT02691182|560373663|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
155257595|NCT02691182|560373664|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
155257596|NCT02691182|560373665|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
155257597|NCT02691182|560373662|FG000|Overall Study|Missing|0|||
155257598|NCT02691182|560373663|FG001|Overall Study|Missing|5|||
155257599|NCT02691182|560373664|FG002|Overall Study|Missing|1|||
155257600|NCT02691182|560373665|FG003|Overall Study|Missing|5|||
155257601|NCT02799784|560373672|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
155257602|NCT02799784|560373673|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
155257603|NCT02799784|560373672|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
155257604|NCT02799784|560373673|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
155257605|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
155257606|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
155257607|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
155257608|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
155257609|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
155257610|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
155257611|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
155257612|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
155257613|NCT02954354|560373674|FG000|Overall Study|Adverse Event|2|||
155257614|NCT02954354|560373675|FG001|Overall Study|Adverse Event|2|||
155257615|NCT02954354|560373676|FG002|Overall Study|Adverse Event|4|||
155257616|NCT02954354|560373674|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
155257617|NCT02954354|560373675|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
155257618|NCT02954354|560373676|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
155257619|NCT02954354|560373674|FG000|Overall Study|Lack of Efficacy|0|||
155257620|NCT02954354|560373675|FG001|Overall Study|Lack of Efficacy|2|||
155257621|NCT02954354|560373676|FG002|Overall Study|Lack of Efficacy|0|||
155257622|NCT02954354|560373674|FG000|Overall Study|Withdrawal by Subject|17|||
155257623|NCT02954354|560373675|FG001|Overall Study|Withdrawal by Subject|9|||
155257624|NCT02954354|560373676|FG002|Overall Study|Withdrawal by Subject|11|||
155257625|NCT02954354|560373674|FG000|Overall Study|Lost to Follow-up|12|||
155257626|NCT02954354|560373675|FG001|Overall Study|Lost to Follow-up|5|||
155257627|NCT02954354|560373676|FG002|Overall Study|Lost to Follow-up|0|||
155257628|NCT02954354|560373674|FG000|Overall Study|Miscellaneous|2|||
155257629|NCT02954354|560373675|FG001|Overall Study|Miscellaneous|2|||
155257630|NCT02954354|560373676|FG002|Overall Study|Miscellaneous|1|||
155257631|NCT03440372|560373680|FG000|Treatment|Adverse Event|16|||
155257632|NCT03440372|560373681|FG001|Treatment|Adverse Event|8|||
155257633|NCT03440372|560373680|FG000|Treatment|Lack of Efficacy|4|||
155257634|NCT03440372|560373681|FG001|Treatment|Lack of Efficacy|2|||
155257635|NCT03440372|560373680|FG000|Treatment|Withdrawal by Subject|12|||
155257636|NCT03440372|560373681|FG001|Treatment|Withdrawal by Subject|8|||
155257637|NCT03440372|560373680|FG000|Treatment|Lost to Follow-up|1|||
155257638|NCT03440372|560373681|FG001|Treatment|Lost to Follow-up|0|||
155257639|NCT03440372|560373680|FG000|Treatment|Pregnancy|1|||
155257640|NCT03440372|560373681|FG001|Treatment|Pregnancy|0|||
155257641|NCT03440372|560373680|FG000|Treatment|Study Terminated by Sponsor|2|||
155257642|NCT03440372|560373681|FG001|Treatment|Study Terminated by Sponsor|1|||
155257643|NCT03440372|560373680|FG000|Treatment|Other Reason|2|||
155257644|NCT03440372|560373681|FG001|Treatment|Other Reason|3|||
155257645|NCT03945292|560373682|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
155257646|NCT03945292|560373683|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257647|NCT03945292|560373684|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
155257648|NCT03945292|560373685|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257649|NCT03945292|560373686|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257650|NCT03945292|560373687|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257651|NCT03945292|560373688|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257652|NCT03945292|560373689|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257653|NCT03945292|560373682|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257654|NCT03945292|560373683|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257655|NCT03945292|560373684|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
155257656|NCT03945292|560373685|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257657|NCT03945292|560373686|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257658|NCT03945292|560373687|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257659|NCT03945292|560373688|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257660|NCT03945292|560373689|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257661|NCT03945292|560373682|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257662|NCT03945292|560373683|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257663|NCT03945292|560373684|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257664|NCT03945292|560373685|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257665|NCT03945292|560373686|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257666|NCT03945292|560373687|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257667|NCT03945292|560373688|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257668|NCT03945292|560373689|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
155257669|NCT03721965|560373703|FG000|Overall Study|Death|1|||
155257670|NCT03721965|560373703|FG000|Overall Study|Study Terminated by Sponsor|1|||
155257671|NCT01328080|560373704|FG000|Overall Study|Lost to Follow-up|5|||
155257672|NCT01499082|560373707|FG000|Overall Study|Randomized but not Treated|0|||
155257673|NCT01499082|560373708|FG001|Overall Study|Randomized but not Treated|1|||
155257674|NCT01499082|560373707|FG000|Overall Study|Adverse Event|12|||
155257675|NCT01499082|560373708|FG001|Overall Study|Adverse Event|16|||
155257676|NCT01499082|560373707|FG000|Overall Study|Lack of Efficacy|1|||
155257677|NCT01499082|560373708|FG001|Overall Study|Lack of Efficacy|1|||
155257678|NCT01499082|560373707|FG000|Overall Study|Protocol Violation|6|||
155257679|NCT01499082|560373708|FG001|Overall Study|Protocol Violation|8|||
155257680|NCT01499082|560373707|FG000|Overall Study|Diverse Reasons|18|||
155257681|NCT01499082|560373708|FG001|Overall Study|Diverse Reasons|14|||
155257682|NCT01499082|560373707|FG000|Overall Study|Site Closure for Noncompliance|5|||
155257683|NCT01499082|560373708|FG001|Overall Study|Site Closure for Noncompliance|2|||
155257684|NCT01499082|560373707|FG000|Overall Study|Hypoglycemia|2|||
155257685|NCT01499082|560373708|FG001|Overall Study|Hypoglycemia|3|||
155257686|NCT01499082|560373707|FG000|Overall Study|Lost to Follow-up|1|||
155257687|NCT01499082|560373708|FG001|Overall Study|Lost to Follow-up|3|||
155257688|NCT05380947|560373713|FG000|Washout Period 1|Not attend visit|1|||
155257689|NCT05380947|560373714|FG001|Washout Period 1|Not attend visit|0|||
155257690|NCT05380947|560373715|FG002|Washout Period 1|Not attend visit|0|||
155257691|NCT05380947|560373716|FG003|Washout Period 1|Not attend visit|0|||
155257692|NCT05380947|560373713|FG000|Washout Period 2|Adverse Event|1|||
155257693|NCT05380947|560373714|FG001|Washout Period 2|Adverse Event|0|||
155257694|NCT05380947|560373715|FG002|Washout Period 2|Adverse Event|0|||
155257695|NCT05380947|560373716|FG003|Washout Period 2|Adverse Event|0|||
155257696|NCT05380947|560373713|FG000|Washout Period 3|Adverse Event|0|||
155257697|NCT05380947|560373714|FG001|Washout Period 3|Adverse Event|1|||
155257698|NCT05380947|560373715|FG002|Washout Period 3|Adverse Event|0|||
155257699|NCT05380947|560373716|FG003|Washout Period 3|Adverse Event|0|||
155257700|NCT05380947|560373713|FG000|Washout Period 3|Not attend visit|0|||
155257701|NCT05380947|560373714|FG001|Washout Period 3|Not attend visit|1|||
155257702|NCT05380947|560373715|FG002|Washout Period 3|Not attend visit|0|||
155257703|NCT05380947|560373716|FG003|Washout Period 3|Not attend visit|1|||
155257704|NCT01563536|560373717|FG000|Overall Study|Withdrawal by Subject|0|||
155257705|NCT01563536|560373718|FG001|Overall Study|Withdrawal by Subject|2|||
155257706|NCT01563536|560373717|FG000|Overall Study|Lost to Follow-up|1|||
155257707|NCT01563536|560373718|FG001|Overall Study|Lost to Follow-up|0|||
155257708|NCT00058123|560373721|FG000|Overall Study|Wrong histology|9|||
155257709|NCT00058123|560373721|FG000|Overall Study|Received >3 prior treatments|1|||
155257710|NCT02151266|560373724|FG000|Overall Study|Lost to Follow-up|1|||
155257711|NCT02151266|560373725|FG001|Overall Study|Lost to Follow-up|4|||
155257712|NCT02151266|560373726|FG002|Overall Study|Lost to Follow-up|1|||
155257713|NCT02151266|560373724|FG000|Overall Study|Did NOT receive intervention|3|||
155257714|NCT02151266|560373725|FG001|Overall Study|Did NOT receive intervention|6|||
155257715|NCT02151266|560373726|FG002|Overall Study|Did NOT receive intervention|2|||
155257716|NCT02151266|560373724|FG000|Overall Study|Not able to exercise|4|||
155257717|NCT02151266|560373725|FG001|Overall Study|Not able to exercise|5|||
155257718|NCT02151266|560373726|FG002|Overall Study|Not able to exercise|4|||
155257719|NCT01169675|560373727|FG000|Overall Study|Progressive disease|13|||
155257720|NCT01169675|560373728|FG001|Overall Study|Progressive disease|2|||
155257721|NCT01169675|560373729|FG002|Overall Study|Progressive disease|5|||
155257722|NCT01169675|560373730|FG003|Overall Study|Progressive disease|15|||
155257723|NCT01169675|560373731|FG004|Overall Study|Progressive disease|1|||
155257724|NCT01169675|560373727|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155257725|NCT01169675|560373728|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257726|NCT01169675|560373729|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257727|NCT01169675|560373730|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257728|NCT01169675|560373731|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155257729|NCT01169675|560373727|FG000|Overall Study|Adverse Event|5|||
155257730|NCT01169675|560373728|FG001|Overall Study|Adverse Event|1|||
155257731|NCT01169675|560373729|FG002|Overall Study|Adverse Event|2|||
155257732|NCT01169675|560373730|FG003|Overall Study|Adverse Event|0|||
155257733|NCT01169675|560373731|FG004|Overall Study|Adverse Event|0|||
155257734|NCT01169675|560373727|FG000|Overall Study|Withdrawal by Subject|1|||
155257735|NCT01169675|560373728|FG001|Overall Study|Withdrawal by Subject|0|||
155257736|NCT01169675|560373729|FG002|Overall Study|Withdrawal by Subject|0|||
155257737|NCT01169675|560373730|FG003|Overall Study|Withdrawal by Subject|1|||
155257738|NCT01169675|560373731|FG004|Overall Study|Withdrawal by Subject|2|||
155257739|NCT01169675|560373727|FG000|Overall Study|Other Reason Not Defined Above|0|||
155257740|NCT01169675|560373728|FG001|Overall Study|Other Reason Not Defined Above|0|||
155257741|NCT01169675|560373729|FG002|Overall Study|Other Reason Not Defined Above|0|||
155257742|NCT01169675|560373730|FG003|Overall Study|Other Reason Not Defined Above|1|||
155257743|NCT01169675|560373731|FG004|Overall Study|Other Reason Not Defined Above|1|||
155257744|NCT02816138|560373734|FG000|Overall Study|Adverse Event|1|||
155257745|NCT04839965|560373735|FG000|Overall Study|Death|6|||
155257746|NCT04839965|560373736|FG001|Overall Study|Death|6|||
155257747|NCT04839965|560373735|FG000|Overall Study|Lost to Follow-up|1|||
155257748|NCT04839965|560373736|FG001|Overall Study|Lost to Follow-up|0|||
155257749|NCT02355028|560373737|FG000|Overall Study|Adverse Event|2|||
155257750|NCT02355028|560373738|FG001|Overall Study|Adverse Event|0|||
155257751|NCT02355028|560373737|FG000|Overall Study|Withdrawal by Subject|1|||
155257752|NCT02355028|560373738|FG001|Overall Study|Withdrawal by Subject|1|||
155257753|NCT02355028|560373737|FG000|Overall Study|Deemed ineligible after randomization|8|||
155257754|NCT02355028|560373738|FG001|Overall Study|Deemed ineligible after randomization|4|||
155257755|NCT02276222|560373739|FG000|Overall Study|Adverse Event|62|||
155257756|NCT02276222|560373740|FG001|Overall Study|Adverse Event|11|||
155257757|NCT02276222|560373739|FG000|Overall Study|Death|3|||
155257758|NCT02276222|560373740|FG001|Overall Study|Death|4|||
155257759|NCT02276222|560373739|FG000|Overall Study|Lack of Efficacy|13|||
155257760|NCT02276222|560373740|FG001|Overall Study|Lack of Efficacy|3|||
155257761|NCT02276222|560373739|FG000|Overall Study|Protocol Violation|3|||
155257762|NCT02276222|560373740|FG001|Overall Study|Protocol Violation|2|||
155257763|NCT02276222|560373739|FG000|Overall Study|Withdrawal by Subject|79|||
155257764|NCT02276222|560373740|FG001|Overall Study|Withdrawal by Subject|33|||
155257765|NCT02276222|560373739|FG000|Overall Study|non compliance with study medication|6|||
155257766|NCT02276222|560373740|FG001|Overall Study|non compliance with study medication|2|||
155257767|NCT02276222|560373739|FG000|Overall Study|sponsor decision|0|||
155257768|NCT02276222|560373740|FG001|Overall Study|sponsor decision|3|||
155257769|NCT02276222|560373739|FG000|Overall Study|Lost to Follow-up|15|||
155257770|NCT02276222|560373740|FG001|Overall Study|Lost to Follow-up|5|||
155257771|NCT02276222|560373739|FG000|Overall Study|Physician Decision|2|||
155257772|NCT02276222|560373740|FG001|Overall Study|Physician Decision|1|||
155257773|NCT02276222|560373739|FG000|Overall Study|sheduling conflict|1|||
155257774|NCT02276222|560373740|FG001|Overall Study|sheduling conflict|0|||
155257775|NCT02276222|560373739|FG000|Overall Study|subject withdrew after randomization|1|||
155257776|NCT02276222|560373740|FG001|Overall Study|subject withdrew after randomization|0|||
155257777|NCT04102579|560373741|FG000|Overall Study|Withdrawal by Subject|3|||
155257778|NCT04102579|560373742|FG001|Overall Study|Withdrawal by Subject|4|||
155257779|NCT04102579|560373741|FG000|Overall Study|Lost to Follow-up|0|||
155257780|NCT04102579|560373742|FG001|Overall Study|Lost to Follow-up|1|||
155257781|NCT04102579|560373741|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
155257782|NCT04102579|560373742|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
155257783|NCT04102579|560373741|FG000|Overall Study|Other than Specified|1|||
155257784|NCT04102579|560373742|FG001|Overall Study|Other than Specified|0|||
155257785|NCT04102579|560373741|FG000|Overall Study|Not Dosed with Study Drug|0|||
155257786|NCT04102579|560373742|FG001|Overall Study|Not Dosed with Study Drug|1|||
155257787|NCT05899686|560373743|FG000|Overall Study|Protocol Violation|1|||
155257788|NCT02170025|560373744|FG000|Overall Study|Adverse Event|2|||
155257789|NCT02170025|560373745|FG001|Overall Study|Adverse Event|0|||
155257790|NCT00572195|560373746|FG000|Overall Study|Withdrawal by Subject|50|||
155257791|NCT00572195|560373746|FG000|Overall Study|Death|9|||
155257792|NCT00572195|560373746|FG000|Overall Study|Adverse Event|4|||
155257793|NCT00572195|560373746|FG000|Overall Study|Lost to Follow-up|5|||
155257794|NCT01525602|560373747|FG000|Overall Study|Adverse Event|1|||
155257795|NCT01525602|560373748|FG001|Overall Study|Adverse Event|0|||
155257796|NCT01525602|560373749|FG002|Overall Study|Adverse Event|1|||
155257797|NCT01525602|560373750|FG003|Overall Study|Adverse Event|1|||
155257798|NCT01525602|560373751|FG004|Overall Study|Adverse Event|3|||
155257799|NCT01525602|560373752|FG005|Overall Study|Adverse Event|3|||
155257800|NCT01525602|560373753|FG006|Overall Study|Adverse Event|0|||
155257801|NCT01525602|560373754|FG007|Overall Study|Adverse Event|1|||
155257802|NCT01525602|560373747|FG000|Overall Study|Disease progression|6|||
155257803|NCT01525602|560373748|FG001|Overall Study|Disease progression|3|||
155257804|NCT01525602|560373749|FG002|Overall Study|Disease progression|2|||
155257805|NCT01525602|560373750|FG003|Overall Study|Disease progression|5|||
155257806|NCT01525602|560373751|FG004|Overall Study|Disease progression|22|||
155257807|NCT01525602|560373752|FG005|Overall Study|Disease progression|2|||
155257808|NCT01525602|560373753|FG006|Overall Study|Disease progression|3|||
155257809|NCT01525602|560373754|FG007|Overall Study|Disease progression|3|||
155257810|NCT01525602|560373747|FG000|Overall Study|Clinical progression|2|||
155257811|NCT01525602|560373748|FG001|Overall Study|Clinical progression|0|||
155257812|NCT01525602|560373749|FG002|Overall Study|Clinical progression|0|||
155257813|NCT01525602|560373750|FG003|Overall Study|Clinical progression|0|||
155257814|NCT01525602|560373751|FG004|Overall Study|Clinical progression|0|||
155257815|NCT01525602|560373752|FG005|Overall Study|Clinical progression|0|||
155257816|NCT01525602|560373753|FG006|Overall Study|Clinical progression|1|||
155257817|NCT01525602|560373754|FG007|Overall Study|Clinical progression|1|||
155257818|NCT01525602|560373747|FG000|Overall Study|Non-compliance|0|||
155257819|NCT01525602|560373748|FG001|Overall Study|Non-compliance|0|||
155257820|NCT01525602|560373749|FG002|Overall Study|Non-compliance|0|||
155257821|NCT01525602|560373750|FG003|Overall Study|Non-compliance|0|||
155257822|NCT01525602|560373751|FG004|Overall Study|Non-compliance|1|||
155257823|NCT01525602|560373752|FG005|Overall Study|Non-compliance|0|||
155257824|NCT01525602|560373753|FG006|Overall Study|Non-compliance|0|||
155257825|NCT01525602|560373754|FG007|Overall Study|Non-compliance|0|||
155257826|NCT01525602|560373747|FG000|Overall Study|Withdrawal by Subject|0|||
155257827|NCT01525602|560373748|FG001|Overall Study|Withdrawal by Subject|0|||
155257828|NCT01525602|560373749|FG002|Overall Study|Withdrawal by Subject|0|||
155257829|NCT01525602|560373750|FG003|Overall Study|Withdrawal by Subject|0|||
155257830|NCT01525602|560373751|FG004|Overall Study|Withdrawal by Subject|3|||
155257831|NCT01525602|560373752|FG005|Overall Study|Withdrawal by Subject|1|||
155257832|NCT01525602|560373753|FG006|Overall Study|Withdrawal by Subject|0|||
155257833|NCT01525602|560373754|FG007|Overall Study|Withdrawal by Subject|1|||
155257834|NCT01525602|560373747|FG000|Overall Study|Physician Decision|0|||
155257835|NCT01525602|560373748|FG001|Overall Study|Physician Decision|0|||
155257836|NCT01525602|560373749|FG002|Overall Study|Physician Decision|0|||
155257837|NCT01525602|560373750|FG003|Overall Study|Physician Decision|0|||
155257838|NCT01525602|560373751|FG004|Overall Study|Physician Decision|3|||
155257839|NCT01525602|560373752|FG005|Overall Study|Physician Decision|0|||
155257840|NCT01525602|560373753|FG006|Overall Study|Physician Decision|1|||
155257841|NCT01525602|560373754|FG007|Overall Study|Physician Decision|0|||
155257842|NCT01525602|560373747|FG000|Overall Study|Death|0|||
155257843|NCT01525602|560373748|FG001|Overall Study|Death|0|||
155257844|NCT01525602|560373749|FG002|Overall Study|Death|0|||
155257845|NCT01525602|560373750|FG003|Overall Study|Death|0|||
155257846|NCT01525602|560373751|FG004|Overall Study|Death|1|||
155257847|NCT01525602|560373752|FG005|Overall Study|Death|1|||
155257848|NCT01525602|560373753|FG006|Overall Study|Death|0|||
155257849|NCT01525602|560373754|FG007|Overall Study|Death|0|||
155257850|NCT01525602|560373747|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257851|NCT01525602|560373748|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257852|NCT01525602|560373749|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257853|NCT01525602|560373750|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257854|NCT01525602|560373751|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257855|NCT01525602|560373752|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257856|NCT01525602|560373753|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
155257857|NCT01525602|560373754|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
155257858|NCT03703466|560373755|FG000|Overall Study|Death|2|||
155257859|NCT03703466|560373756|FG001|Overall Study|Death|1|||
155257860|NCT03703466|560373757|FG002|Overall Study|Death|0|||
155257861|NCT03703466|560373755|FG000|Overall Study|Withdrawal by Subject|0|||
155257862|NCT03703466|560373756|FG001|Overall Study|Withdrawal by Subject|3|||
155257863|NCT03703466|560373757|FG002|Overall Study|Withdrawal by Subject|0|||
155257864|NCT03703466|560373755|FG000|Overall Study|Completed < 3 Cycles|2|||
155257865|NCT03703466|560373756|FG001|Overall Study|Completed < 3 Cycles|2|||
155257866|NCT03703466|560373757|FG002|Overall Study|Completed < 3 Cycles|2|||
155257867|NCT02563002|560375630|FG000|Overall Study|Death|72|||
155257868|NCT02563002|560375631|FG001|Overall Study|Death|87|||
155257869|NCT02563002|560375630|FG000|Overall Study|Lost to Follow-up|5|||
155257870|NCT02563002|560375631|FG001|Overall Study|Lost to Follow-up|0|||
155257871|NCT02563002|560375630|FG000|Overall Study|Physician Decision|0|||
155257872|NCT02563002|560375631|FG001|Overall Study|Physician Decision|2|||
155257873|NCT02563002|560375630|FG000|Overall Study|Withdrawal by Subject|2|||
155257874|NCT02563002|560375631|FG001|Overall Study|Withdrawal by Subject|10|||
155257875|NCT02563002|560375630|FG000|Overall Study|Sponsor decision|74|||
155257876|NCT02563002|560375631|FG001|Overall Study|Sponsor decision|55|||
155257877|NCT03518125|560375638|FG000|Overall Study|Lost to Follow-up|0|||
155257878|NCT03518125|560375639|FG001|Overall Study|Lost to Follow-up|2|||
155257879|NCT03518125|560375640|FG002|Overall Study|Lost to Follow-up|0|||
155257880|NCT03518125|560375641|FG003|Overall Study|Lost to Follow-up|0|||
155257881|NCT03518125|560375642|FG004|Overall Study|Lost to Follow-up|3|||
155257882|NCT03518125|560375643|FG005|Overall Study|Lost to Follow-up|5|||
155257883|NCT03518125|560375638|FG000|Overall Study|Physician Decision|0|||
155257884|NCT03518125|560375639|FG001|Overall Study|Physician Decision|1|||
155257885|NCT03518125|560375640|FG002|Overall Study|Physician Decision|0|||
155257886|NCT03518125|560375641|FG003|Overall Study|Physician Decision|0|||
155257887|NCT03518125|560375642|FG004|Overall Study|Physician Decision|0|||
155257888|NCT03518125|560375643|FG005|Overall Study|Physician Decision|0|||
155257889|NCT03518125|560375638|FG000|Overall Study|Withdrawal by Subject|1|||
155257890|NCT03518125|560375639|FG001|Overall Study|Withdrawal by Subject|1|||
155257891|NCT03518125|560375640|FG002|Overall Study|Withdrawal by Subject|0|||
155257892|NCT03518125|560375641|FG003|Overall Study|Withdrawal by Subject|1|||
155257893|NCT03518125|560375642|FG004|Overall Study|Withdrawal by Subject|1|||
155257894|NCT03518125|560375643|FG005|Overall Study|Withdrawal by Subject|3|||
155257895|NCT03518125|560375638|FG000|Overall Study|Missed Day 394 Visit|1|||
155257896|NCT03518125|560375639|FG001|Overall Study|Missed Day 394 Visit|0|||
155257897|NCT03518125|560375640|FG002|Overall Study|Missed Day 394 Visit|0|||
155257898|NCT03518125|560375641|FG003|Overall Study|Missed Day 394 Visit|0|||
155257899|NCT03518125|560375642|FG004|Overall Study|Missed Day 394 Visit|0|||
155257900|NCT03518125|560375643|FG005|Overall Study|Missed Day 394 Visit|0|||
155257901|NCT04452877|560375644|FG000|Overall Study|Adverse Event|5|||
155257902|NCT04452877|560375644|FG000|Overall Study|Lost to Follow-up|1|||
155257903|NCT04452877|560375644|FG000|Overall Study|Physician Decision|4|||
155257904|NCT04452877|560375644|FG000|Overall Study|Progressive Disease|18|||
155257905|NCT04452877|560375644|FG000|Overall Study|Withdrawal by Subject|3|||
155257906|NCT05453110|560375647|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
155257907|NCT05453110|560375648|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
155257908|NCT05453110|560375649|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
155257909|NCT01662063|560375653|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
155257910|NCT01662063|560375654|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
155257911|NCT01662063|560375655|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
155257912|NCT01662063|560375653|FG000|Overall Study|Lack of Efficacy|1|||
155257913|NCT01662063|560375654|FG001|Overall Study|Lack of Efficacy|6|||
155257914|NCT01662063|560375655|FG002|Overall Study|Lack of Efficacy|0|||
155257915|NCT01662063|560375653|FG000|Overall Study|Lost to Follow-up|0|||
155257916|NCT01662063|560375654|FG001|Overall Study|Lost to Follow-up|4|||
155257917|NCT01662063|560375655|FG002|Overall Study|Lost to Follow-up|0|||
155257918|NCT01662063|560375653|FG000|Overall Study|Protocol Violation|1|||
155257919|NCT01662063|560375654|FG001|Overall Study|Protocol Violation|0|||
155257920|NCT01662063|560375655|FG002|Overall Study|Protocol Violation|0|||
155257921|NCT01662063|560375653|FG000|Overall Study|Withdrawal by Subject|2|||
155257922|NCT01662063|560375654|FG001|Overall Study|Withdrawal by Subject|4|||
155257923|NCT01662063|560375655|FG002|Overall Study|Withdrawal by Subject|1|||
155257924|NCT01662063|560375653|FG000|Overall Study|Physician Decision|0|||
155257925|NCT01662063|560375654|FG001|Overall Study|Physician Decision|2|||
155257926|NCT01662063|560375655|FG002|Overall Study|Physician Decision|0|||
155257927|NCT01662063|560375653|FG000|Overall Study|Other|0|||
155257928|NCT01662063|560375654|FG001|Overall Study|Other|1|||
155257929|NCT01662063|560375655|FG002|Overall Study|Other|0|||
155257930|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
155257931|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
155257932|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155257933|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155257934|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
155257935|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
155257936|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
155257937|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155257938|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155257939|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155257940|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155257941|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155257942|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
155257943|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
155257944|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
155257945|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
155257946|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
155257947|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
155257948|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
155257949|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
155257950|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
155257951|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
155257952|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Death|3|||
155257953|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Death|0|||
155257954|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
155257955|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
155257956|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
155257957|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
155257958|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
155257959|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
155257960|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
155257961|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
155257962|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
155257963|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
155257964|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
155257965|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
155257966|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
155257967|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
155257968|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
155257969|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
155257970|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
155257971|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
155257972|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
155257973|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
155257974|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
155257975|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
155257976|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
155257977|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
155257978|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
155257979|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
155257980|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
155257981|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
155257982|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
155257983|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
155257984|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
155257985|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
155257986|NCT01050816|560375658|FG000|Overall Study|Lost to Follow-up|2|||
155257987|NCT01050816|560375658|FG000|Overall Study|patient's refusal|2|||
155257988|NCT01123382|560375661|FG000|Overall Study|Withdrawal by Subject|1|||
155257989|NCT01123382|560375662|FG001|Overall Study|Withdrawal by Subject|4|||
155257990|NCT01123382|560375661|FG000|Overall Study|Lost to Follow-up|1|||
155257991|NCT01123382|560375662|FG001|Overall Study|Lost to Follow-up|2|||
155257992|NCT02740049|560375663|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
155257993|NCT02274857|560375664|FG000|Overall Study|Adverse Event|1|||
155257994|NCT02274857|560375665|FG001|Overall Study|Adverse Event|0|||
155257995|NCT02274857|560375664|FG000|Overall Study|Death|1|||
155257996|NCT02274857|560375665|FG001|Overall Study|Death|2|||
155257997|NCT02274857|560375664|FG000|Overall Study|Lost to Follow-up|3|||
155257998|NCT02274857|560375665|FG001|Overall Study|Lost to Follow-up|0|||
155257999|NCT02274857|560375664|FG000|Overall Study|Physician Decision|2|||
155258000|NCT02274857|560375665|FG001|Overall Study|Physician Decision|0|||
155258001|NCT02274857|560375664|FG000|Overall Study|Trial screen failure|0|||
155258002|NCT02274857|560375665|FG001|Overall Study|Trial screen failure|2|||
155258003|NCT02274857|560375664|FG000|Overall Study|Withdrawal by Subject|11|||
155258004|NCT02274857|560375665|FG001|Overall Study|Withdrawal by Subject|2|||
155258005|NCT02274857|560375664|FG000|Overall Study|Other|2|||
155258006|NCT02274857|560375665|FG001|Overall Study|Other|0|||
155258007|NCT02403180|560375668|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
155258008|NCT02403180|560375669|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
155258009|NCT02403180|560375668|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
155258010|NCT02403180|560375669|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
155258011|NCT04570436|560375675|FG000|Overall Study|Adverse Event|0|||
155258012|NCT04570436|560375676|FG001|Overall Study|Adverse Event|0|||
155258013|NCT04570436|560375677|FG002|Overall Study|Adverse Event|1|||
155258014|NCT04570436|560375678|FG003|Overall Study|Adverse Event|0|||
155258015|NCT04570436|560375679|FG004|Overall Study|Adverse Event|0|||
155258016|NCT04570436|560375680|FG005|Overall Study|Adverse Event|0|||
155258017|NCT04570436|560375681|FG006|Overall Study|Adverse Event|0|||
155258018|NCT04570436|560375682|FG007|Overall Study|Adverse Event|0|||
155258019|NCT04570436|560375683|FG008|Overall Study|Adverse Event|0|||
155258020|NCT04570436|560375684|FG009|Overall Study|Adverse Event|0|||
155258021|NCT04570436|560375675|FG000|Overall Study|Physician Decision|1|||
155258022|NCT04570436|560375676|FG001|Overall Study|Physician Decision|0|||
155258023|NCT04570436|560375677|FG002|Overall Study|Physician Decision|0|||
155258024|NCT04570436|560375678|FG003|Overall Study|Physician Decision|0|||
155258025|NCT04570436|560375679|FG004|Overall Study|Physician Decision|0|||
155258026|NCT04570436|560375680|FG005|Overall Study|Physician Decision|0|||
155258027|NCT04570436|560375681|FG006|Overall Study|Physician Decision|0|||
155258028|NCT04570436|560375682|FG007|Overall Study|Physician Decision|0|||
155258029|NCT04570436|560375683|FG008|Overall Study|Physician Decision|0|||
155258030|NCT04570436|560375684|FG009|Overall Study|Physician Decision|0|||
155258031|NCT00594854|560375687|FG000|Overall Study|Study terminated|7|||
155258032|NCT00594854|560375688|FG001|Overall Study|Study terminated|10|||
155258033|NCT03172702|560375691|FG000|Overall Study|Adverse Event|9|||
155258034|NCT03172702|560375691|FG000|Overall Study|Death|2|||
155258035|NCT03172702|560375691|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
155258036|NCT03172702|560375691|FG000|Overall Study|Withdrawal by Subject|5|||
155258037|NCT03172702|560375691|FG000|Overall Study|Other|2|||
155258038|NCT03292146|560375692|FG000|Baseline to 12 months|Relocation|1|||
155258039|NCT03292146|560375693|FG001|Baseline to 12 months|Relocation|0|||
155258040|NCT03292146|560375692|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
155258041|NCT03292146|560375693|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
155258042|NCT03292146|560375692|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
155258043|NCT03292146|560375693|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
155258044|NCT03292146|560375692|FG000|12 months to 24 months|Planning pregnancy|2|||
155258045|NCT03292146|560375693|FG001|12 months to 24 months|Planning pregnancy|2|||
155258046|NCT03292146|560375692|FG000|12 months to 24 months|Personal reasons|1|||
155258047|NCT03292146|560375693|FG001|12 months to 24 months|Personal reasons|0|||
155258048|NCT03292146|560375692|FG000|12 months to 24 months|Lost to Follow-up|0|||
155258049|NCT03292146|560375693|FG001|12 months to 24 months|Lost to Follow-up|1|||
155258050|NCT06134180|560375696|FG000|Overall Study|Lost to Follow-up|4|||
155258051|NCT03039023|560375697|FG000|Overall Study|Withdrawal by Subject|1|||
155258052|NCT03039023|560375698|FG001|Overall Study|Withdrawal by Subject|0|||
155258053|NCT03039023|560375699|FG002|Overall Study|Withdrawal by Subject|1|||
155258054|NCT03039023|560375700|FG003|Overall Study|Withdrawal by Subject|1|||
155258055|NCT03039023|560375701|FG004|Overall Study|Withdrawal by Subject|0|||
155258056|NCT03039023|560375697|FG000|Overall Study|Physician Decision|0|||
155258057|NCT03039023|560375698|FG001|Overall Study|Physician Decision|0|||
155258058|NCT03039023|560375699|FG002|Overall Study|Physician Decision|0|||
155258059|NCT03039023|560375700|FG003|Overall Study|Physician Decision|1|||
155258060|NCT03039023|560375701|FG004|Overall Study|Physician Decision|0|||
155258061|NCT02340026|560375702|FG000|Treatment Phase|Withdrawal by Subject|2|||
155258062|NCT02340026|560375703|FG001|Treatment Phase|Withdrawal by Subject|2|||
155258063|NCT02340026|560375702|FG000|Follow-up Phase|Lost to Follow-up|1|||
155258064|NCT02340026|560375703|FG001|Follow-up Phase|Lost to Follow-up|0|||
155258065|NCT02684006|560375704|FG000|Overall Study|Other|18|||
155258066|NCT02684006|560375705|FG001|Overall Study|Other|6|||
155258067|NCT02684006|560375704|FG000|Overall Study|Protocol Violation|2|||
155258068|NCT02684006|560375705|FG001|Overall Study|Protocol Violation|1|||
155258069|NCT02684006|560375704|FG000|Overall Study|Non-compliance with study drug|1|||
155258070|NCT02684006|560375705|FG001|Overall Study|Non-compliance with study drug|1|||
155258071|NCT02684006|560375704|FG000|Overall Study|No longer met eligibility criteria|6|||
155258072|NCT02684006|560375705|FG001|Overall Study|No longer met eligibility criteria|2|||
155258073|NCT02684006|560375704|FG000|Overall Study|Lost to Follow-up|0|||
155258074|NCT02684006|560375705|FG001|Overall Study|Lost to Follow-up|1|||
155258075|NCT02684006|560375704|FG000|Overall Study|Death|25|||
155258076|NCT02684006|560375705|FG001|Overall Study|Death|22|||
155258077|NCT02684006|560375704|FG000|Overall Study|Global deterioration of health status|18|||
155258078|NCT02684006|560375705|FG001|Overall Study|Global deterioration of health status|20|||
155258079|NCT02684006|560375704|FG000|Overall Study|Physician Decision|15|||
155258080|NCT02684006|560375705|FG001|Overall Study|Physician Decision|8|||
155258081|NCT02684006|560375704|FG000|Overall Study|Adverse Event|86|||
155258082|NCT02684006|560375705|FG001|Overall Study|Adverse Event|65|||
155258083|NCT02684006|560375704|FG000|Overall Study|Withdrawal by Subject|29|||
155258084|NCT02684006|560375705|FG001|Overall Study|Withdrawal by Subject|43|||
155258085|NCT02684006|560375704|FG000|Overall Study|Progressive disease|236|||
155258086|NCT02684006|560375705|FG001|Overall Study|Progressive disease|266|||
155258087|NCT02684006|560375704|FG000|Overall Study|Participation terminated by sponsor|6|||
155258088|NCT02684006|560375705|FG001|Overall Study|Participation terminated by sponsor|9|||
155258089|NCT04642898|560375706|FG000|Overall Study|Withdrawal by Subject|2|||
155258090|NCT04642898|560375707|FG001|Overall Study|Withdrawal by Subject|4|||
155258091|NCT04642898|560375708|FG002|Overall Study|Withdrawal by Subject|4|||
155258092|NCT04642898|560375709|FG003|Overall Study|Withdrawal by Subject|6|||
155258093|NCT04642898|560375710|FG004|Overall Study|Withdrawal by Subject|2|||
155258094|NCT04642898|560375711|FG005|Overall Study|Withdrawal by Subject|6|||
155258095|NCT04642898|560375706|FG000|Overall Study|Lost to Follow-up|0|||
155258096|NCT04642898|560375707|FG001|Overall Study|Lost to Follow-up|0|||
155258097|NCT04642898|560375708|FG002|Overall Study|Lost to Follow-up|0|||
155258098|NCT04642898|560375709|FG003|Overall Study|Lost to Follow-up|2|||
155258099|NCT04642898|560375710|FG004|Overall Study|Lost to Follow-up|0|||
155258100|NCT04642898|560375711|FG005|Overall Study|Lost to Follow-up|1|||
155258101|NCT04642898|560375706|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
155258102|NCT04642898|560375707|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
155258103|NCT04642898|560375708|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
155258104|NCT04642898|560375709|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
155258105|NCT04642898|560375710|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
155258106|NCT04642898|560375711|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
155258107|NCT04642898|560375706|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258108|NCT04642898|560375707|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258109|NCT04642898|560375708|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258110|NCT04642898|560375709|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258111|NCT04642898|560375710|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
155258112|NCT04642898|560375711|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258113|NCT04495179|560375712|FG000|Overall Study|Lost to Follow-up|0|||
155258114|NCT04495179|560375713|FG001|Overall Study|Lost to Follow-up|1|||
155258115|NCT04495179|560375712|FG000|Overall Study|Withdrawal by Subject|2|||
155258116|NCT04495179|560375713|FG001|Overall Study|Withdrawal by Subject|4|||
155258117|NCT04495179|560375712|FG000|Overall Study|Study terminated by sponsor|0|||
155258118|NCT04495179|560375713|FG001|Overall Study|Study terminated by sponsor|18|||
155258119|NCT04495179|560375712|FG000|Overall Study|Death|0|||
155258120|NCT04495179|560375713|FG001|Overall Study|Death|4|||
155258121|NCT04495179|560375712|FG000|Overall Study|Adverse Event|0|||
155258122|NCT04495179|560375713|FG001|Overall Study|Adverse Event|1|||
155258123|NCT04280562|560375714|FG000|Study|Adverse Event|2|||
155258124|NCT04280562|560375715|FG001|Study|Adverse Event|0|||
155258125|NCT04280562|560375714|FG000|Study|Lost to Follow-up|3|||
155258126|NCT04280562|560375715|FG001|Study|Lost to Follow-up|3|||
155258127|NCT01368965|560375719|FG000|Overall Study|Lost to Follow-up|12|||
155258128|NCT00162370|560375720|FG000|Efficacy Population|Lost to Follow-up|51|||
155258129|NCT00569582|560375721|FG000|Overall Study|Withdrawal by Subject|5|||
155258130|NCT00569582|560375721|FG000|Overall Study|Death|2|||
155258131|NCT00569582|560375721|FG000|Overall Study|Adverse Event|7|||
155258132|NCT00569582|560375721|FG000|Overall Study|Subject was too ill to travel.|1|||
155258133|NCT00569582|560375721|FG000|Overall Study|Subject was non-compliant.|1|||
155258134|NCT04559568|560375722|FG000|Overall Study|Physician Decision|0|||
155258135|NCT04559568|560375723|FG001|Overall Study|Physician Decision|0|||
155258136|NCT04559568|560375724|FG002|Overall Study|Physician Decision|0|||
155258137|NCT04559568|560375725|FG003|Overall Study|Physician Decision|0|||
155258138|NCT04559568|560375726|FG004|Overall Study|Physician Decision|0|||
155258139|NCT04559568|560375727|FG005|Overall Study|Physician Decision|0|||
155258140|NCT04559568|560375728|FG006|Overall Study|Physician Decision|0|||
155258141|NCT04559568|560375729|FG007|Overall Study|Physician Decision|0|||
155258142|NCT04559568|560375730|FG008|Overall Study|Physician Decision|0|||
155258143|NCT04559568|560375731|FG009|Overall Study|Physician Decision|1|||
155258144|NCT04559568|560375732|FG010|Overall Study|Physician Decision|0|||
155258145|NCT04559568|560375722|FG000|Overall Study|Withdrawal by Subject|0|||
155258146|NCT04559568|560375723|FG001|Overall Study|Withdrawal by Subject|0|||
155258147|NCT04559568|560375724|FG002|Overall Study|Withdrawal by Subject|0|||
155258148|NCT04559568|560375725|FG003|Overall Study|Withdrawal by Subject|0|||
155258149|NCT04559568|560375726|FG004|Overall Study|Withdrawal by Subject|0|||
155258150|NCT04559568|560375727|FG005|Overall Study|Withdrawal by Subject|0|||
155258151|NCT04559568|560375728|FG006|Overall Study|Withdrawal by Subject|0|||
155258152|NCT04559568|560375729|FG007|Overall Study|Withdrawal by Subject|0|||
155258153|NCT04559568|560375730|FG008|Overall Study|Withdrawal by Subject|0|||
155258154|NCT04559568|560375731|FG009|Overall Study|Withdrawal by Subject|0|||
155258155|NCT04559568|560375732|FG010|Overall Study|Withdrawal by Subject|1|||
155258156|NCT05103384|560375735|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
155258157|NCT02612311|560375736|FG000|Overall Study|Adverse Event|16|||
155258158|NCT02612311|560375737|FG001|Overall Study|Adverse Event|12|||
155258159|NCT02612311|560375738|FG002|Overall Study|Adverse Event|7|||
155258160|NCT02612311|560375739|FG003|Overall Study|Adverse Event|13|||
155258161|NCT02612311|560375736|FG000|Overall Study|Death|29|||
155258162|NCT02612311|560375737|FG001|Overall Study|Death|10|||
155258163|NCT02612311|560375738|FG002|Overall Study|Death|11|||
155258164|NCT02612311|560375739|FG003|Overall Study|Death|11|||
155258165|NCT02612311|560375736|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
155258166|NCT02612311|560375737|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
155258167|NCT02612311|560375738|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
155258168|NCT02612311|560375739|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
155258169|NCT02612311|560375736|FG000|Overall Study|Investigator's Decision|11|||
155258170|NCT02612311|560375737|FG001|Overall Study|Investigator's Decision|15|||
155258171|NCT02612311|560375738|FG002|Overall Study|Investigator's Decision|6|||
155258172|NCT02612311|560375739|FG003|Overall Study|Investigator's Decision|6|||
155258173|NCT02612311|560375736|FG000|Overall Study|Lack of Efficacy|0|||
155258174|NCT02612311|560375737|FG001|Overall Study|Lack of Efficacy|0|||
155258175|NCT02612311|560375738|FG002|Overall Study|Lack of Efficacy|1|||
155258176|NCT02612311|560375739|FG003|Overall Study|Lack of Efficacy|1|||
155258177|NCT02612311|560375736|FG000|Overall Study|Lost to Follow-up|2|||
155258178|NCT02612311|560375737|FG001|Overall Study|Lost to Follow-up|2|||
155258179|NCT02612311|560375738|FG002|Overall Study|Lost to Follow-up|1|||
155258180|NCT02612311|560375739|FG003|Overall Study|Lost to Follow-up|2|||
155258181|NCT02612311|560375736|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
155258182|NCT02612311|560375737|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
155258183|NCT02612311|560375738|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
155258184|NCT02612311|560375739|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
155258185|NCT02612311|560375736|FG000|Overall Study|Site Terminated by Sponsor|29|||
155258186|NCT02612311|560375737|FG001|Overall Study|Site Terminated by Sponsor|12|||
155258187|NCT02612311|560375738|FG002|Overall Study|Site Terminated by Sponsor|13|||
155258188|NCT02612311|560375739|FG003|Overall Study|Site Terminated by Sponsor|5|||
155258189|NCT02612311|560375736|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
155258190|NCT02612311|560375737|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
155258191|NCT02612311|560375738|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
155258192|NCT02612311|560375739|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
155258193|NCT02612311|560375736|FG000|Overall Study|Reason Not Specified|3|||
155258194|NCT02612311|560375737|FG001|Overall Study|Reason Not Specified|7|||
155258195|NCT02612311|560375738|FG002|Overall Study|Reason Not Specified|4|||
155258196|NCT02612311|560375739|FG003|Overall Study|Reason Not Specified|5|||
155258197|NCT02612311|560375736|FG000|Overall Study|Unknown/Missing|10|||
155258198|NCT02612311|560375737|FG001|Overall Study|Unknown/Missing|13|||
155258199|NCT02612311|560375738|FG002|Overall Study|Unknown/Missing|4|||
155258200|NCT02612311|560375739|FG003|Overall Study|Unknown/Missing|0|||
155258201|NCT02612311|560375736|FG000|Overall Study|Non-Compliance with Study|1|||
155258202|NCT02612311|560375737|FG001|Overall Study|Non-Compliance with Study|0|||
155258203|NCT02612311|560375738|FG002|Overall Study|Non-Compliance with Study|0|||
155258204|NCT02612311|560375739|FG003|Overall Study|Non-Compliance with Study|0|||
155258205|NCT04085328|560375745|FG000|Overall Study|Witihdrew Consent|16|||
155258206|NCT04085328|560375746|FG001|Overall Study|Witihdrew Consent|16|||
155258207|NCT04085328|560375745|FG000|Overall Study|Adverse Event|8|||
155258208|NCT04085328|560375746|FG001|Overall Study|Adverse Event|7|||
155258209|NCT04085328|560375745|FG000|Overall Study|Lost to Follow-up|7|||
155258210|NCT04085328|560375746|FG001|Overall Study|Lost to Follow-up|2|||
155258211|NCT04085328|560375745|FG000|Overall Study|Physician Decision|0|||
155258212|NCT04085328|560375746|FG001|Overall Study|Physician Decision|1|||
155258213|NCT04085328|560375745|FG000|Overall Study|Pregnancy|0|||
155258214|NCT04085328|560375746|FG001|Overall Study|Pregnancy|1|||
155258215|NCT04085328|560375745|FG000|Overall Study|Reasons Related to COVID-19|5|||
155258216|NCT04085328|560375746|FG001|Overall Study|Reasons Related to COVID-19|8|||
155258217|NCT04085328|560375745|FG000|Overall Study|Did not meet inclusion criteria|1|||
155258218|NCT04085328|560375746|FG001|Overall Study|Did not meet inclusion criteria|1|||
155258219|NCT04085328|560375745|FG000|Overall Study|Early termination|1|||
155258220|NCT04085328|560375746|FG001|Overall Study|Early termination|0|||
155258221|NCT00514735|560375747|FG000|Overall Study|Withdrawal by Subject|13|||
155258222|NCT00514735|560375748|FG001|Overall Study|Withdrawal by Subject|5|||
155258223|NCT00514735|560375747|FG000|Overall Study|Death|1|||
155258224|NCT00514735|560375748|FG001|Overall Study|Death|0|||
155258225|NCT00514735|560375747|FG000|Overall Study|Lost to Follow-up|0|||
155258226|NCT00514735|560375748|FG001|Overall Study|Lost to Follow-up|1|||
155258227|NCT00724152|560375750|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
155258228|NCT00724152|560375751|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
155258229|NCT00724152|560375752|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
155258230|NCT00724152|560375750|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
155258231|NCT00724152|560375751|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
155258232|NCT00724152|560375752|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
155258233|NCT03266770|560375755|FG000|Overall Study|Physician Decision|3|||
155258234|NCT03266770|560375755|FG000|Overall Study|Insufficient study supplies|1|||
155258235|NCT03266770|560375755|FG000|Overall Study|Adverse Event|1|||
155258236|NCT04274894|560375756|FG000|Overall Study|Adverse Event|7|||
155258237|NCT04274894|560375756|FG000|Overall Study|Withdrew consent|5|||
155258238|NCT04274894|560375756|FG000|Overall Study|Lost to Follow-up|9|||
155258239|NCT04274894|560375756|FG000|Overall Study|COVID-19 infection|1|||
155258240|NCT04274894|560375756|FG000|Overall Study|Other, not specified|20|||
155258241|NCT01936857|560375757|FG000|Overall Study|Sent to prison or 06 center|11|||
155258242|NCT01936857|560375758|FG001|Overall Study|Sent to prison or 06 center|12|||
155258243|NCT01936857|560375757|FG000|Overall Study|Lost to Follow-up|10|||
155258244|NCT01936857|560375758|FG001|Overall Study|Lost to Follow-up|7|||
155258245|NCT01936857|560375757|FG000|Overall Study|Death|7|||
155258246|NCT01936857|560375758|FG001|Overall Study|Death|3|||
155258247|NCT01936857|560375757|FG000|Overall Study|Moved|2|||
155258248|NCT01936857|560375758|FG001|Overall Study|Moved|1|||
155258249|NCT01936857|560375757|FG000|Overall Study|Withdrawal by Subject|1|||
155258250|NCT01936857|560375758|FG001|Overall Study|Withdrawal by Subject|0|||
155258251|NCT01936857|560375757|FG000|Overall Study|Side effect of medication|1|||
155258252|NCT01936857|560375758|FG001|Overall Study|Side effect of medication|0|||
155258253|NCT01936857|560375757|FG000|Overall Study|Other|2|||
155258254|NCT01936857|560375758|FG001|Overall Study|Other|2|||
155258255|NCT00490282|560375759|FG000|Overall Study|Withdrawal by Subject|3|||
155258256|NCT04510675|560375762|FG000|Overall Study|Withdrawal by Subject|5|||
155258257|NCT00810264|560375767|FG000|Overall Study|Lost to Follow-up|191|||
155258258|NCT00810264|560375767|FG000|Overall Study|Withdrawal by subject or physician|721|||
155258259|NCT00810264|560375767|FG000|Overall Study|Death|641|||
155258260|NCT00538590|560375778|FG000|Overall Study|Death|1|||
155258261|NCT00538590|560375779|FG001|Overall Study|Death|0|||
155258262|NCT01256567|560375780|FG000|Overall Study|Withdrawal by Subject|1|||
155258263|NCT00567190|560375786|FG000|Overall Study|Death|235|||
155258264|NCT00567190|560375787|FG001|Overall Study|Death|280|||
155258265|NCT00567190|560375786|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
155258266|NCT00567190|560375787|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
155258267|NCT00636610|560375793|FG000|Overall Study|Adverse Event|4|||
155258268|NCT00636610|560375794|FG001|Overall Study|Adverse Event|4|||
155258269|NCT00636610|560375793|FG000|Overall Study|Death|6|||
155258270|NCT00636610|560375794|FG001|Overall Study|Death|3|||
155258271|NCT00636610|560375793|FG000|Overall Study|Physician decision to withdraw patient|15|||
155258272|NCT00636610|560375794|FG001|Overall Study|Physician decision to withdraw patient|9|||
155258273|NCT00636610|560375793|FG000|Overall Study|Subject decision to withdraw|15|||
155258274|NCT00636610|560375794|FG001|Overall Study|Subject decision to withdraw|11|||
155258275|NCT00636610|560375793|FG000|Overall Study|Disease progression - radiographic|41|||
155258276|NCT00636610|560375794|FG001|Overall Study|Disease progression - radiographic|51|||
155258277|NCT00636610|560375793|FG000|Overall Study|Disease progression - clinical|8|||
155258278|NCT00636610|560375794|FG001|Overall Study|Disease progression - clinical|3|||
155258279|NCT00636610|560375793|FG000|Overall Study|Reason for discontinuation not available|3|||
155258280|NCT00636610|560375794|FG001|Overall Study|Reason for discontinuation not available|2|||
155258281|NCT02412137|560375799|FG000|Overall Study|Withdrawal by Subject|2|||
155258282|NCT02412137|560375800|FG001|Overall Study|Withdrawal by Subject|0|||
155258283|NCT02412137|560375799|FG000|Overall Study|Lost to Follow-up|21|||
155258284|NCT02412137|560375800|FG001|Overall Study|Lost to Follow-up|14|||
155258285|NCT02412137|560375799|FG000|Overall Study|Physician Decision|28|||
155258286|NCT02412137|560375800|FG001|Overall Study|Physician Decision|9|||
155258287|NCT03355326|560375809|FG000|Overall Study|Protocol Violation|3|||
155258288|NCT03355326|560375810|FG001|Overall Study|Protocol Violation|3|||
155258289|NCT02240108|560377547|FG000|Overall Study|Other than specified|8|||
155258290|NCT02240108|560377548|FG001|Overall Study|Other than specified|6|||
155258291|NCT02240108|560377547|FG000|Overall Study|Adverse Event|1|||
155258292|NCT02240108|560377548|FG001|Overall Study|Adverse Event|9|||
155258293|NCT02240108|560377547|FG000|Overall Study|Pregnancy|1|||
155258294|NCT02240108|560377548|FG001|Overall Study|Pregnancy|0|||
155258295|NCT02240108|560377547|FG000|Overall Study|Withdrawal by Subject|4|||
155258296|NCT02240108|560377548|FG001|Overall Study|Withdrawal by Subject|9|||
155258297|NCT02240108|560377547|FG000|Overall Study|StudyTerminated by Sponsor|0|||
155258298|NCT02240108|560377548|FG001|Overall Study|StudyTerminated by Sponsor|1|||
155258299|NCT05178121|560377555|FG000|Overall Study|Other|4|||
155258300|NCT05178121|560377555|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
155258301|NCT01953003|560377556|FG000|Overall Study|Not treated|0|||
155258302|NCT01953003|560377557|FG001|Overall Study|Not treated|1|||
155258303|NCT01953003|560377556|FG000|Overall Study|Progressive disease|35|||
155258304|NCT01953003|560377557|FG001|Overall Study|Progressive disease|45|||
155258305|NCT01953003|560377556|FG000|Overall Study|Related Adverse events|7|||
155258306|NCT01953003|560377557|FG001|Overall Study|Related Adverse events|2|||
155258307|NCT01953003|560377556|FG000|Overall Study|Non-related adverse events|0|||
155258308|NCT01953003|560377557|FG001|Overall Study|Non-related adverse events|2|||
155258309|NCT01953003|560377556|FG000|Overall Study|Protocol Violation|0|||
155258310|NCT01953003|560377557|FG001|Overall Study|Protocol Violation|1|||
155258311|NCT01953003|560377556|FG000|Overall Study|Withdrawal by Subject|14|||
155258312|NCT01953003|560377557|FG001|Overall Study|Withdrawal by Subject|4|||
155258313|NCT00553501|560377560|FG000|Overall Study|Adverse Event|2|||
155258314|NCT00553501|560377560|FG000|Overall Study|Death|1|||
155258315|NCT00553501|560377560|FG000|Overall Study|Progression|1|||
155258316|NCT01464021|560377564|FG000|Overall Study|Withdrawal by Subject|13|||
155258317|NCT01464021|560377564|FG000|Overall Study|Lost to Follow-up|1|||
155258318|NCT01464021|560377564|FG000|Overall Study|Lack of Efficacy|1|||
155258319|NCT01464021|560377564|FG000|Overall Study|various|11|||
155258320|NCT03391765|560377566|FG000|Overall Study|Adverse Event|2|||
155258321|NCT03391765|560377567|FG001|Overall Study|Adverse Event|0|||
155258322|NCT03391765|560377568|FG002|Overall Study|Adverse Event|0|||
155258323|NCT03391765|560377569|FG003|Overall Study|Adverse Event|2|||
155258324|NCT03391765|560377566|FG000|Overall Study|Withdrew consent|5|||
155258325|NCT03391765|560377567|FG001|Overall Study|Withdrew consent|7|||
155258326|NCT03391765|560377568|FG002|Overall Study|Withdrew consent|2|||
155258327|NCT03391765|560377569|FG003|Overall Study|Withdrew consent|5|||
155258328|NCT03391765|560377566|FG000|Overall Study|Other, not specified|44|||
155258329|NCT03391765|560377567|FG001|Overall Study|Other, not specified|38|||
155258330|NCT03391765|560377568|FG002|Overall Study|Other, not specified|21|||
155258331|NCT03391765|560377569|FG003|Overall Study|Other, not specified|16|||
155258332|NCT00944658|560377570|FG000|Treatment 12 Weeks|Adverse Event|0|||
155258333|NCT00944658|560377571|FG001|Treatment 12 Weeks|Adverse Event|2|||
155258334|NCT03315143|560377598|FG000|Overall Study|Death|240|||
155258335|NCT03315143|560377599|FG001|Overall Study|Death|246|||
155258336|NCT03315143|560377598|FG000|Overall Study|Withdrawal by Subject|57|||
155258337|NCT03315143|560377599|FG001|Overall Study|Withdrawal by Subject|68|||
155258338|NCT03315143|560377598|FG000|Overall Study|Site Terminated by Sponsor|256|||
155258339|NCT03315143|560377599|FG001|Overall Study|Site Terminated by Sponsor|282|||
155258340|NCT03315143|560377598|FG000|Overall Study|Study Terminated by Sponsor|4723|||
155258341|NCT03315143|560377599|FG001|Overall Study|Study Terminated by Sponsor|4664|||
155258342|NCT03315143|560377598|FG000|Overall Study|Reason not Specified|16|||
155258343|NCT03315143|560377599|FG001|Overall Study|Reason not Specified|32|||
155258344|NCT01242748|560377600|FG000|Overall Study|Adverse Event|10|||
155258345|NCT01242748|560377601|FG001|Overall Study|Adverse Event|5|||
155258346|NCT01242748|560377600|FG000|Overall Study|Lost to Follow-up|6|||
155258347|NCT01242748|560377601|FG001|Overall Study|Lost to Follow-up|2|||
155258348|NCT01242748|560377600|FG000|Overall Study|Physician Decision|3|||
155258349|NCT01242748|560377601|FG001|Overall Study|Physician Decision|2|||
155258350|NCT01242748|560377600|FG000|Overall Study|Protocol Violation|1|||
155258351|NCT01242748|560377601|FG001|Overall Study|Protocol Violation|0|||
155258352|NCT01242748|560377600|FG000|Overall Study|Withdrawal by Subject|10|||
155258353|NCT01242748|560377601|FG001|Overall Study|Withdrawal by Subject|2|||
155258354|NCT01242748|560377600|FG000|Overall Study|Miscellaneous reasons|8|||
155258355|NCT01242748|560377601|FG001|Overall Study|Miscellaneous reasons|3|||
155258356|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
155258357|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
155258358|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
155258359|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
155258360|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
155258361|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
155258362|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
155258363|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
155258364|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
155258365|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
155258366|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
155258367|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
155258368|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
155258369|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
155258370|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
155258371|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
155258372|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
155258373|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
155258374|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
155258375|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
155258376|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
155258377|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
155258378|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Death|143|||
155258379|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Death|136|||
155258380|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
155258381|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
155258382|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
155258383|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
155258384|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
155258385|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
155258386|NCT00105235|560377613|FG000|Overall Study|Death|4|||
155258387|NCT00105235|560377613|FG000|Overall Study|Physician Decision|1|||
155258388|NCT00105235|560377613|FG000|Overall Study|Withdrawal by Subject|2|||
155258389|NCT02052310|560377614|FG000|Overall Study|Death|64|||
155258390|NCT02052310|560377615|FG001|Overall Study|Death|54|||
155258391|NCT02052310|560377614|FG000|Overall Study|Withdrawal by Subject|37|||
155258392|NCT02052310|560377615|FG001|Overall Study|Withdrawal by Subject|49|||
155258393|NCT02052310|560377614|FG000|Overall Study|Other than specified|32|||
155258394|NCT02052310|560377615|FG001|Overall Study|Other than specified|29|||
155258395|NCT02052310|560377614|FG000|Overall Study|Adverse Event|29|||
155258396|NCT02052310|560377615|FG001|Overall Study|Adverse Event|22|||
155258397|NCT02052310|560377614|FG000|Overall Study|Kidney Transplant|23|||
155258398|NCT02052310|560377615|FG001|Overall Study|Kidney Transplant|29|||
155258399|NCT02052310|560377614|FG000|Overall Study|Physician Decision|14|||
155258400|NCT02052310|560377615|FG001|Overall Study|Physician Decision|7|||
155258401|NCT02052310|560377614|FG000|Overall Study|Lack of Efficacy|6|||
155258402|NCT02052310|560377615|FG001|Overall Study|Lack of Efficacy|1|||
155258403|NCT02052310|560377614|FG000|Overall Study|Site Terminated by Sponsor|5|||
155258404|NCT02052310|560377615|FG001|Overall Study|Site Terminated by Sponsor|13|||
155258405|NCT02052310|560377614|FG000|Overall Study|Lost to Follow-up|4|||
155258406|NCT02052310|560377615|FG001|Overall Study|Lost to Follow-up|2|||
155258407|NCT02052310|560377614|FG000|Overall Study|Protocol Violation|1|||
155258408|NCT02052310|560377615|FG001|Overall Study|Protocol Violation|6|||
155258409|NCT01964326|560377616|FG000|Overall Study|Adverse Event|48|||
155258410|NCT01964326|560377616|FG000|Overall Study|Death|2|||
155258411|NCT01964326|560377616|FG000|Overall Study|Protocol Violation|4|||
155258412|NCT01964326|560377616|FG000|Overall Study|Lost to Follow-up|88|||
155258413|NCT01964326|560377616|FG000|Overall Study|Withdrawal by Subject|87|||
155258414|NCT01964326|560377616|FG000|Overall Study|Pregnancy|1|||
155258415|NCT01964326|560377616|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
155258416|NCT01964326|560377616|FG000|Overall Study|Physician Decision|55|||
155258417|NCT01964326|560377616|FG000|Overall Study|Investigator Discretion|1|||
155258418|NCT01964326|560377616|FG000|Overall Study|Other|9|||
155258419|NCT01964326|560377616|FG000|Overall Study|Did not meet eligibility criteria|1|||
155258420|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
155258421|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258422|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258423|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258424|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258425|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
155258426|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258427|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258428|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258429|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258430|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
155258431|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
155258432|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258433|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258434|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258435|NCT02093663|560377625|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258436|NCT02093663|560377626|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258437|NCT02093663|560377627|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
155258438|NCT02093663|560377628|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258439|NCT02093663|560377629|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258440|NCT02093663|560377625|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258441|NCT02093663|560377626|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258442|NCT02093663|560377627|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
155258443|NCT02093663|560377628|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258444|NCT02093663|560377629|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258445|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258446|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258447|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258448|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
155258449|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
155258450|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258451|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258452|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258453|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
155258454|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
155258455|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258456|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258457|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258458|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
155258459|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
155258460|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258461|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258462|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258463|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258464|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
155258465|NCT05906368|560377632|FG000|Overall Study|Withdrawal by Subject|1|||
155258466|NCT05906368|560377633|FG001|Overall Study|Withdrawal by Subject|1|||
155258467|NCT05906368|560377632|FG000|Overall Study|Ineligibility criteria identified|2|||
155258468|NCT05906368|560377633|FG001|Overall Study|Ineligibility criteria identified|0|||
155258469|NCT00595504|560377636|FG000|Overall Study|Withdrawal by Subject|1|||
155258470|NCT00595504|560377637|FG001|Overall Study|Withdrawal by Subject|3|||
155258471|NCT00595504|560377636|FG000|Overall Study|Physician Decision|1|||
155258472|NCT00595504|560377637|FG001|Overall Study|Physician Decision|0|||
155258473|NCT01477853|560377638|FG000|Phase A|Adverse Event|1|||
155258474|NCT01477853|560377639|FG001|Phase A|Adverse Event|2|||
155258475|NCT01477853|560377640|FG002|Phase A|Adverse Event|2|||
155258476|NCT01477853|560377638|FG000|Phase A|Lost to Follow-up|4|||
155258477|NCT01477853|560377639|FG001|Phase A|Lost to Follow-up|3|||
155258478|NCT01477853|560377640|FG002|Phase A|Lost to Follow-up|2|||
155258479|NCT01477853|560377638|FG000|Phase A|Physician Decision|1|||
155258480|NCT01477853|560377639|FG001|Phase A|Physician Decision|0|||
155258481|NCT01477853|560377640|FG002|Phase A|Physician Decision|1|||
155258482|NCT01477853|560377638|FG000|Phase A|Study terminated by sponsor|37|||
155258483|NCT01477853|560377639|FG001|Phase A|Study terminated by sponsor|40|||
155258484|NCT01477853|560377640|FG002|Phase A|Study terminated by sponsor|39|||
155258485|NCT01477853|560377638|FG000|Phase B|Lost to Follow-up|0|||
155258486|NCT01477853|560377639|FG001|Phase B|Lost to Follow-up|1|||
155258487|NCT01477853|560377640|FG002|Phase B|Lost to Follow-up|0|||
155258488|NCT01477853|560377638|FG000|Phase B|Study terminated by sponsor|12|||
155258489|NCT01477853|560377639|FG001|Phase B|Study terminated by sponsor|10|||
155258490|NCT01477853|560377640|FG002|Phase B|Study terminated by sponsor|11|||
155258491|NCT01804816|560377641|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
155258492|NCT01804816|560377641|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
155258493|NCT01235546|560377642|FG000|Overall Study|Staff error, medication not administered|1|||
155258494|NCT01235546|560377643|FG001|Overall Study|Staff error, medication not administered|0|||
155258495|NCT01235546|560377642|FG000|Overall Study|Protocol Violation|1|||
155258496|NCT01235546|560377643|FG001|Overall Study|Protocol Violation|1|||
155491701|NCT00762073|561225493|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
155491702|NCT00762073|561225494|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
155258497|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
155258498|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
155258499|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
155258500|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
155258501|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
155258502|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
155258503|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
155258504|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
155258505|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258506|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258507|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258508|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258509|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
155258510|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
155258511|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
155258512|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258513|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258514|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258515|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
155258516|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258517|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
155258518|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258519|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258520|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258521|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Adverse Event|4|||
155258522|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Adverse Event|2|||
155258523|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Adverse Event|1|||
155258524|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Adverse Event|0|||
155258525|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Adverse Event|0|||
155258526|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Adverse Event|0|||
155258527|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258528|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258529|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258530|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258531|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
155258532|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
155258533|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258534|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258535|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258536|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258537|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258538|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
155258539|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258540|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258541|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258542|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258543|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
155258544|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258545|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258546|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258547|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258548|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258549|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
155258550|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
155258551|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258552|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258553|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258554|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258555|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
155258556|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
155258557|NCT01445652|560377651|FG000|Overall Study|Not comfortable in lenses|5|||
155258558|NCT01445652|560377652|FG001|Overall Study|Not comfortable in lenses|0|||
155258559|NCT01445652|560377651|FG000|Overall Study|Failed to attend scheduled visit|2|||
155258560|NCT01445652|560377652|FG001|Overall Study|Failed to attend scheduled visit|3|||
155258561|NCT01445652|560377651|FG000|Overall Study|Failed teach session|2|||
155258562|NCT01445652|560377652|FG001|Overall Study|Failed teach session|0|||
155258563|NCT01445652|560377651|FG000|Overall Study|Adverse Event|1|||
155258564|NCT01445652|560377652|FG001|Overall Study|Adverse Event|0|||
155258565|NCT00929162|560377653|FG000|Overall Study|Adverse Event|8|||
155258566|NCT00929162|560377654|FG001|Overall Study|Adverse Event|5|||
155258567|NCT00929162|560377653|FG000|Overall Study|Withdrawal by Subject|3|||
155258568|NCT00929162|560377654|FG001|Overall Study|Withdrawal by Subject|1|||
155258569|NCT00929162|560377653|FG000|Overall Study|Protocol Violation|32|||
155258570|NCT00929162|560377654|FG001|Overall Study|Protocol Violation|30|||
155258571|NCT00929162|560377653|FG000|Overall Study|Other termination reason|5|||
155258572|NCT00929162|560377654|FG001|Overall Study|Other termination reason|6|||
155258573|NCT00658567|560377656|FG000|Overall Study|Adverse Event|5|||
155258574|NCT00658567|560377657|FG001|Overall Study|Adverse Event|2|||
155258575|NCT00658567|560377658|FG002|Overall Study|Adverse Event|3|||
155258576|NCT00658567|560377656|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
155258577|NCT00658567|560377657|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
155258578|NCT00658567|560377658|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
155258579|NCT00658567|560377656|FG000|Overall Study|Physician Decision|0|||
155258580|NCT00658567|560377657|FG001|Overall Study|Physician Decision|1|||
155258581|NCT00658567|560377658|FG002|Overall Study|Physician Decision|0|||
155258582|NCT00658567|560377656|FG000|Overall Study|At Discretion of Sponsor|1|||
155258583|NCT00658567|560377657|FG001|Overall Study|At Discretion of Sponsor|1|||
155258584|NCT00658567|560377658|FG002|Overall Study|At Discretion of Sponsor|1|||
155258585|NCT01755702|560377659|FG000|Wash Out Period I|Other Reason|3|||
155258586|NCT01755702|560377659|FG000|Washout Period II|Other Reason|5|||
155258587|NCT00691938|560377660|FG000|Overall Study|QTc prolongation|1|||
155258588|NCT00691938|560377661|FG001|Overall Study|QTc prolongation|0|||
155258589|NCT00691938|560377662|FG002|Overall Study|QTc prolongation|0|||
155258590|NCT00691938|560377663|FG003|Overall Study|QTc prolongation|0|||
155258591|NCT00691938|560377664|FG004|Overall Study|QTc prolongation|0|||
155258592|NCT00691938|560377665|FG005|Overall Study|QTc prolongation|0|||
155258593|NCT00691938|560377666|FG006|Overall Study|QTc prolongation|0|||
155258594|NCT04860518|560377668|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
155258595|NCT04860518|560377669|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
155258596|NCT03701399|560377672|FG000|Overall Study|Adverse Event|3|||
155258597|NCT03701399|560377673|FG001|Overall Study|Adverse Event|5|||
155258598|NCT03701399|560377672|FG000|Overall Study|Withdrawal by Subject|6|||
155258599|NCT03701399|560377673|FG001|Overall Study|Withdrawal by Subject|3|||
155258600|NCT03701399|560377672|FG000|Overall Study|Investigators decision|1|||
155258601|NCT03701399|560377673|FG001|Overall Study|Investigators decision|2|||
155258602|NCT03701399|560377672|FG000|Overall Study|Lost to Follow-up|1|||
155258603|NCT03701399|560377673|FG001|Overall Study|Lost to Follow-up|2|||
155258604|NCT03701399|560377672|FG000|Overall Study|Death|1|||
155258605|NCT03701399|560377673|FG001|Overall Study|Death|1|||
155258606|NCT03701399|560377672|FG000|Overall Study|Randomized but not treated|1|||
155258607|NCT03701399|560377673|FG001|Overall Study|Randomized but not treated|0|||
155258608|NCT00448448|560377674|FG000|Overall Study|Withdrawal by Subject|13|||
155258609|NCT00448448|560377675|FG001|Overall Study|Withdrawal by Subject|2|||
155258610|NCT00448448|560377674|FG000|Overall Study|On protocol when study ended|83|||
155258611|NCT00448448|560377675|FG001|Overall Study|On protocol when study ended|36|||
155258612|NCT00448448|560377674|FG000|Overall Study|Lost to Follow-up|2|||
155258613|NCT00448448|560377675|FG001|Overall Study|Lost to Follow-up|1|||
155258614|NCT00448448|560377674|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
155258615|NCT00448448|560377675|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
155258616|NCT00448448|560377674|FG000|Overall Study|Signed consent lost|0|||
155258617|NCT00448448|560377675|FG001|Overall Study|Signed consent lost|1|||
155258618|NCT00946296|560377676|FG000|Overall Study|Physician Decision|3|||
155258619|NCT00946296|560377677|FG001|Overall Study|Physician Decision|0|||
155258620|NCT04751942|560377681|FG000|Overall Study|Lost to Follow-up|9|||
155258621|NCT04751942|560377682|FG001|Overall Study|Lost to Follow-up|6|||
155258622|NCT01422408|560377683|FG000|Overall Study|Adverse Event|1|||
155258623|NCT01422408|560377683|FG000|Overall Study|Withdrawal by Subject|3|||
155258624|NCT03599349|560377693|FG000|Overall Study|Lost to Follow-up|1|||
155258625|NCT02638948|560377696|FG000|Overall Study|Withdrawal by Subject|4|||
155258626|NCT02638948|560377697|FG001|Overall Study|Withdrawal by Subject|5|||
155258627|NCT02638948|560377698|FG002|Overall Study|Withdrawal by Subject|3|||
155258628|NCT02638948|560377699|FG003|Overall Study|Withdrawal by Subject|1|||
155258629|NCT02638948|560377696|FG000|Overall Study|Administrative Reason by Sponsor|0|||
155258630|NCT02638948|560377697|FG001|Overall Study|Administrative Reason by Sponsor|1|||
155258631|NCT02638948|560377698|FG002|Overall Study|Administrative Reason by Sponsor|0|||
155258632|NCT02638948|560377699|FG003|Overall Study|Administrative Reason by Sponsor|4|||
155258633|NCT02638948|560377696|FG000|Overall Study|Adverse Event|0|||
155258634|NCT02638948|560377697|FG001|Overall Study|Adverse Event|0|||
155258635|NCT02638948|560377698|FG002|Overall Study|Adverse Event|1|||
155258636|NCT02638948|560377699|FG003|Overall Study|Adverse Event|1|||
155258637|NCT02638948|560377696|FG000|Overall Study|Lack of Efficacy|1|||
155258638|NCT02638948|560377697|FG001|Overall Study|Lack of Efficacy|1|||
155258639|NCT02638948|560377698|FG002|Overall Study|Lack of Efficacy|0|||
155258640|NCT02638948|560377699|FG003|Overall Study|Lack of Efficacy|0|||
155258641|NCT02638948|560377696|FG000|Overall Study|Lost to Follow-up|0|||
155258642|NCT02638948|560377697|FG001|Overall Study|Lost to Follow-up|0|||
155258643|NCT02638948|560377698|FG002|Overall Study|Lost to Follow-up|1|||
155258644|NCT02638948|560377699|FG003|Overall Study|Lost to Follow-up|1|||
155258645|NCT02638948|560377696|FG000|Overall Study|Poor/Non-Compliance|0|||
155258646|NCT02638948|560377697|FG001|Overall Study|Poor/Non-Compliance|2|||
155258647|NCT02638948|560377698|FG002|Overall Study|Poor/Non-Compliance|1|||
155258648|NCT02638948|560377699|FG003|Overall Study|Poor/Non-Compliance|0|||
155258649|NCT02638948|560377696|FG000|Overall Study|Participant no longer met study criteria|0|||
155258650|NCT02638948|560377697|FG001|Overall Study|Participant no longer met study criteria|1|||
155258651|NCT02638948|560377698|FG002|Overall Study|Participant no longer met study criteria|0|||
155258652|NCT02638948|560377699|FG003|Overall Study|Participant no longer met study criteria|0|||
155258653|NCT02638948|560377696|FG000|Overall Study|Other than specified above|4|||
155258654|NCT02638948|560377697|FG001|Overall Study|Other than specified above|1|||
155258655|NCT02638948|560377698|FG002|Overall Study|Other than specified above|1|||
155258656|NCT02638948|560377699|FG003|Overall Study|Other than specified above|1|||
155258657|NCT05007392|560377700|FG000|Overall Study|Randomized but not treated|1|||
155258658|NCT05007392|560377701|FG001|Overall Study|Randomized but not treated|2|||
155258659|NCT05007392|560377700|FG000|Overall Study|Other|5|||
155258660|NCT05007392|560377701|FG001|Overall Study|Other|4|||
155258661|NCT05007392|560377700|FG000|Overall Study|Lost to Follow-up|1|||
155258662|NCT05007392|560377701|FG001|Overall Study|Lost to Follow-up|2|||
155258663|NCT05007392|560377700|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
155258664|NCT05007392|560377701|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
155258665|NCT05007392|560377700|FG000|Overall Study|Use of prohibited concomitant drug|1|||
155258666|NCT05007392|560377701|FG001|Overall Study|Use of prohibited concomitant drug|1|||
155258667|NCT05007392|560377700|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
155258668|NCT05007392|560377701|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
155258669|NCT05007392|560377700|FG000|Overall Study|Adverse Event|10|||
155258670|NCT05007392|560377701|FG001|Overall Study|Adverse Event|6|||
155258671|NCT05007392|560377700|FG000|Overall Study|Participant choice|5|||
155258672|NCT05007392|560377701|FG001|Overall Study|Participant choice|10|||
155258673|NCT05007392|560377700|FG000|Overall Study|Withdrawal of consent|5|||
155258674|NCT05007392|560377701|FG001|Overall Study|Withdrawal of consent|4|||
155258675|NCT01218126|560377702|FG000|Overall Study|Adverse Event|8|||
155258676|NCT01218126|560377703|FG001|Overall Study|Adverse Event|10|||
155258677|NCT01218126|560377704|FG002|Overall Study|Adverse Event|12|||
155258678|NCT01218126|560377705|FG003|Overall Study|Adverse Event|16|||
155258679|NCT01218126|560377702|FG000|Overall Study|Lack of Efficacy|7|||
155258680|NCT01218126|560377703|FG001|Overall Study|Lack of Efficacy|2|||
155258681|NCT01218126|560377704|FG002|Overall Study|Lack of Efficacy|2|||
155258682|NCT01218126|560377705|FG003|Overall Study|Lack of Efficacy|6|||
155258683|NCT01218126|560377702|FG000|Overall Study|Protocol Violation|5|||
155258684|NCT01218126|560377703|FG001|Overall Study|Protocol Violation|2|||
155258685|NCT01218126|560377704|FG002|Overall Study|Protocol Violation|2|||
155258686|NCT01218126|560377705|FG003|Overall Study|Protocol Violation|3|||
155258687|NCT01218126|560377702|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155258688|NCT01218126|560377703|FG001|Overall Study|Protocol-defined stopping criteria|1|||
155258689|NCT01218126|560377704|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155258690|NCT01218126|560377705|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155258691|NCT01218126|560377702|FG000|Overall Study|Lost to Follow-up|0|||
155258692|NCT01218126|560377703|FG001|Overall Study|Lost to Follow-up|0|||
155258693|NCT01218126|560377704|FG002|Overall Study|Lost to Follow-up|0|||
155258694|NCT01218126|560377705|FG003|Overall Study|Lost to Follow-up|2|||
155258695|NCT01218126|560377702|FG000|Overall Study|Physician Decision|1|||
155258696|NCT01218126|560377703|FG001|Overall Study|Physician Decision|2|||
155258697|NCT01218126|560377704|FG002|Overall Study|Physician Decision|4|||
155258698|NCT01218126|560377705|FG003|Overall Study|Physician Decision|2|||
155258699|NCT01218126|560377702|FG000|Overall Study|Withdrawal by Subject|2|||
155258700|NCT01218126|560377703|FG001|Overall Study|Withdrawal by Subject|5|||
155258701|NCT01218126|560377704|FG002|Overall Study|Withdrawal by Subject|4|||
155258702|NCT01218126|560377705|FG003|Overall Study|Withdrawal by Subject|6|||
155258703|NCT01860703|560377708|FG000|Overall Study|Adverse Event|1|||
155258704|NCT01860703|560377709|FG001|Overall Study|Adverse Event|4|||
155258705|NCT01860703|560377710|FG002|Overall Study|Adverse Event|0|||
155258706|NCT01860703|560377711|FG003|Overall Study|Adverse Event|2|||
155258707|NCT01860703|560377708|FG000|Overall Study|Withdrawal by Subject|0|||
155258708|NCT01860703|560377709|FG001|Overall Study|Withdrawal by Subject|1|||
155258709|NCT01860703|560377710|FG002|Overall Study|Withdrawal by Subject|0|||
155258710|NCT01860703|560377711|FG003|Overall Study|Withdrawal by Subject|0|||
155258711|NCT01860703|560377708|FG000|Overall Study|Personal reason|1|||
155258712|NCT01860703|560377709|FG001|Overall Study|Personal reason|0|||
155258713|NCT01860703|560377710|FG002|Overall Study|Personal reason|1|||
155258714|NCT01860703|560377711|FG003|Overall Study|Personal reason|0|||
155258715|NCT06213701|560377715|FG000|Overall Study|Withdrawal by Subject|2|||
155258716|NCT06213701|560377716|FG001|Overall Study|Withdrawal by Subject|1|||
155258717|NCT06213701|560377717|FG002|Overall Study|Withdrawal by Subject|0|||
155258718|NCT02453685|560377720|FG000|Overall Study|Adverse Event|0|||
155258719|NCT02453685|560377721|FG001|Overall Study|Adverse Event|1|||
155258720|NCT02453685|560377720|FG000|Overall Study|Protocol Violation|7|||
155258721|NCT02453685|560377721|FG001|Overall Study|Protocol Violation|4|||
155258722|NCT02453685|560377720|FG000|Overall Study|Lost to Follow-up|0|||
155258723|NCT02453685|560377721|FG001|Overall Study|Lost to Follow-up|1|||
155258724|NCT02453685|560377720|FG000|Overall Study|Withdrawal by Subject|8|||
155258725|NCT02453685|560377721|FG001|Overall Study|Withdrawal by Subject|4|||
155258726|NCT02453685|560377720|FG000|Overall Study|Unclassified|4|||
155258727|NCT02453685|560377721|FG001|Overall Study|Unclassified|2|||
155258728|NCT00453986|560377722|FG000|Overall Study|Lost to Follow-up|6|||
155258729|NCT00453986|560377723|FG001|Overall Study|Lost to Follow-up|5|||
155258730|NCT00453986|560377724|FG002|Overall Study|Lost to Follow-up|6|||
155258731|NCT00453986|560377725|FG003|Overall Study|Lost to Follow-up|2|||
155258732|NCT00453986|560377726|FG004|Overall Study|Lost to Follow-up|0|||
155258733|NCT03221387|560377727|FG000|Overall Study|Lost to Follow-up|1|||
155258734|NCT03221387|560377727|FG000|Overall Study|Lung transplant|1|||
155258735|NCT00522626|560377728|FG000|Overall Study|Lost to Follow-up|7|||
155258736|NCT00803452|560377729|FG000|Overall Study|Adverse Event|0|||
155258737|NCT00803452|560377730|FG001|Overall Study|Adverse Event|2|||
155258738|NCT00803452|560377729|FG000|Overall Study|Lost to Follow-up|0|||
155258739|NCT00803452|560377730|FG001|Overall Study|Lost to Follow-up|3|||
155258740|NCT02365519|560377732|FG000|Randomized and Treated|Adverse Event|0|||
155258741|NCT02365519|560377733|FG001|Randomized and Treated|Adverse Event|1|||
155258742|NCT02365519|560377734|FG002|Randomized and Treated|Adverse Event|0|||
155258743|NCT02365519|560377732|FG000|Randomized and Treated|Withdrawal by Subject|0|||
155258744|NCT02365519|560377733|FG001|Randomized and Treated|Withdrawal by Subject|1|||
155258745|NCT02365519|560377734|FG002|Randomized and Treated|Withdrawal by Subject|1|||
155258746|NCT01971723|560377735|FG000|Overall Study|Withdrawal by Subject|1|||
155258747|NCT01971723|560377736|FG001|Overall Study|Withdrawal by Subject|1|||
155258748|NCT01971723|560377735|FG000|Overall Study|Protocol Violation|1|||
155258749|NCT01971723|560377736|FG001|Overall Study|Protocol Violation|2|||
155258750|NCT03076970|560379527|FG000|Washout Period 2|Adverse Event|0|||
155258751|NCT03076970|560379528|FG001|Washout Period 2|Adverse Event|0|||
155258752|NCT03076970|560379529|FG002|Washout Period 2|Adverse Event|0|||
155258753|NCT03076970|560379530|FG003|Washout Period 2|Adverse Event|0|||
155258754|NCT03076970|560379531|FG004|Washout Period 2|Adverse Event|1|||
155258755|NCT03076970|560379532|FG005|Washout Period 2|Adverse Event|0|||
155258756|NCT03076970|560379527|FG000|Period 3|Withdrawal by Subject|0|||
155258757|NCT03076970|560379528|FG001|Period 3|Withdrawal by Subject|0|||
155258758|NCT03076970|560379529|FG002|Period 3|Withdrawal by Subject|0|||
155258759|NCT03076970|560379530|FG003|Period 3|Withdrawal by Subject|0|||
155258760|NCT03076970|560379531|FG004|Period 3|Withdrawal by Subject|0|||
155258761|NCT03076970|560379532|FG005|Period 3|Withdrawal by Subject|1|||
155258762|NCT03076970|560379527|FG000|Period 3|Failure to meet I/E criteria|0|||
155258763|NCT03076970|560379528|FG001|Period 3|Failure to meet I/E criteria|0|||
155258764|NCT03076970|560379529|FG002|Period 3|Failure to meet I/E criteria|0|||
155258765|NCT03076970|560379530|FG003|Period 3|Failure to meet I/E criteria|0|||
155258766|NCT03076970|560379531|FG004|Period 3|Failure to meet I/E criteria|1|||
155258767|NCT03076970|560379532|FG005|Period 3|Failure to meet I/E criteria|0|||
155258768|NCT01364922|560379533|FG000|Open-label (OL) Period|Adverse Event|7|||
155258769|NCT01364922|560379534|FG001|Open-label (OL) Period|Adverse Event|0|||
155258770|NCT01364922|560379535|FG002|Open-label (OL) Period|Adverse Event|0|||
155258771|NCT01364922|560379533|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
155258772|NCT01364922|560379534|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
155258773|NCT01364922|560379535|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
155258774|NCT01364922|560379533|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
155258775|NCT01364922|560379534|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
155258776|NCT01364922|560379535|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
155258777|NCT01364922|560379533|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
155258778|NCT01364922|560379534|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
155258779|NCT01364922|560379535|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
155258780|NCT01364922|560379533|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
155258781|NCT01364922|560379534|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
155258782|NCT01364922|560379535|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
155258783|NCT01364922|560379533|FG000|Open-label (OL) Period|Other, Unspecified|1|||
155258784|NCT01364922|560379534|FG001|Open-label (OL) Period|Other, Unspecified|0|||
155258785|NCT01364922|560379535|FG002|Open-label (OL) Period|Other, Unspecified|0|||
155258786|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
155258787|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
155258788|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
155258789|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
155258790|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
155258791|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
155258792|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Adverse Event|0|||
155258793|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Adverse Event|0|||
155258794|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Adverse Event|1|||
155258795|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
155258796|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
155258797|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
155258798|NCT01289418|560379537|FG000|Day 8 Survey|email address invalid|283|||
155258799|NCT01289418|560379537|FG000|Day 8 Survey|participants did not complete the survey|1935|||
155258800|NCT01289418|560379537|FG000|Day 29 Survey|email address invalid|283|||
155258801|NCT01289418|560379537|FG000|Day 29 Survey|participants did not complete the survey|2185|||
155258802|NCT01352585|560379538|FG000|Overall Study|Adverse Event|2|||
155258803|NCT01352585|560379539|FG001|Overall Study|Adverse Event|1|||
155258804|NCT01352585|560379538|FG000|Overall Study|Lost to Follow-up|1|||
155258805|NCT01352585|560379539|FG001|Overall Study|Lost to Follow-up|0|||
155258806|NCT01352585|560379538|FG000|Overall Study|Other|5|||
155258807|NCT01352585|560379539|FG001|Overall Study|Other|2|||
155258808|NCT00838682|560379540|FG000|Overall Study|Lost to Follow-up|21|||
155258809|NCT00838682|560379541|FG001|Overall Study|Lost to Follow-up|14|||
155258810|NCT00838682|560379540|FG000|Overall Study|detection of exclusion criteria|4|||
155258811|NCT00838682|560379541|FG001|Overall Study|detection of exclusion criteria|3|||
155258812|NCT00838682|560379540|FG000|Overall Study|Protocol Violation|0|||
155258813|NCT00838682|560379541|FG001|Overall Study|Protocol Violation|1|||
155258814|NCT00838682|560379540|FG000|Overall Study|Withdrawal by Subject|0|||
155258815|NCT00838682|560379541|FG001|Overall Study|Withdrawal by Subject|1|||
155258816|NCT03928028|560379542|FG000|Overall Study|Physician Decision|9|||
155258817|NCT03928028|560379543|FG001|Overall Study|Physician Decision|6|||
155258818|NCT03928028|560379544|FG002|Overall Study|Physician Decision|3|||
155258819|NCT03928028|560379542|FG000|Overall Study|Withdrawal by Subject|12|||
155258820|NCT03928028|560379543|FG001|Overall Study|Withdrawal by Subject|3|||
155258821|NCT03928028|560379544|FG002|Overall Study|Withdrawal by Subject|3|||
155258822|NCT04525547|560379550|FG000|Overall Study|Not treated with Ofev|2|||
155258823|NCT04525547|560379550|FG000|Overall Study|Off-label use|2|||
155258824|NCT04525547|560379550|FG000|Overall Study|Lost to Follow-up|1|||
155258825|NCT00800202|560379551|FG000|Overall Study|Adverse Event|7|||
155258826|NCT00800202|560379552|FG001|Overall Study|Adverse Event|6|||
155258827|NCT00800202|560379551|FG000|Overall Study|Death|1|||
155258828|NCT00800202|560379552|FG001|Overall Study|Death|0|||
155258829|NCT00800202|560379551|FG000|Overall Study|Other|5|||
155258830|NCT00800202|560379552|FG001|Overall Study|Other|0|||
155258831|NCT00800202|560379551|FG000|Overall Study|Disease Progression|54|||
155258832|NCT00800202|560379552|FG001|Overall Study|Disease Progression|18|||
155258833|NCT00180479|560379553|FG000|Overall Study|Death|4|||
155258834|NCT00180479|560379554|FG001|Overall Study|Death|2|||
155258835|NCT00180479|560379553|FG000|Overall Study|Lost to Follow-up|9|||
155258836|NCT00180479|560379554|FG001|Overall Study|Lost to Follow-up|7|||
155258837|NCT00180479|560379553|FG000|Overall Study|Withdrawal by Subject|3|||
155258838|NCT00180479|560379554|FG001|Overall Study|Withdrawal by Subject|3|||
155258839|NCT00180479|560379553|FG000|Overall Study|Informed consent not signed|0|||
155258840|NCT00180479|560379554|FG001|Overall Study|Informed consent not signed|1|||
155258841|NCT02459262|560379555|FG000|Overall Study|Withdrawal by Subject|0|||
155258842|NCT02459262|560379556|FG001|Overall Study|Withdrawal by Subject|0|||
155258843|NCT02459262|560379557|FG002|Overall Study|Withdrawal by Subject|0|||
155258844|NCT02459262|560379558|FG003|Overall Study|Withdrawal by Subject|0|||
155258845|NCT02459262|560379559|FG004|Overall Study|Withdrawal by Subject|0|||
155258846|NCT02459262|560379560|FG005|Overall Study|Withdrawal by Subject|0|||
155258847|NCT02459262|560379561|FG006|Overall Study|Withdrawal by Subject|0|||
155258848|NCT02459262|560379562|FG007|Overall Study|Withdrawal by Subject|0|||
155258849|NCT02459262|560379563|FG008|Overall Study|Withdrawal by Subject|0|||
155258850|NCT02459262|560379564|FG009|Overall Study|Withdrawal by Subject|1|||
155258851|NCT02459262|560379565|FG010|Overall Study|Withdrawal by Subject|0|||
155258852|NCT05168579|560379566|FG000|Overall Study|Lack of Consent|1|||
155258853|NCT05168579|560379567|FG001|Overall Study|Lack of Consent|0|||
155258854|NCT05168579|560379566|FG000|Overall Study|Conflicts with time|2|||
155258855|NCT05168579|560379567|FG001|Overall Study|Conflicts with time|0|||
155258856|NCT05168579|560379566|FG000|Overall Study|Time slots were full|3|||
155258857|NCT05168579|560379567|FG001|Overall Study|Time slots were full|0|||
155258858|NCT05168579|560379566|FG000|Overall Study|Lost to Follow-up|0|||
155258859|NCT05168579|560379567|FG001|Overall Study|Lost to Follow-up|15|||
155258860|NCT00840801|560379568|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
155258861|NCT00840801|560379569|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
155258862|NCT00840801|560379570|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
155258863|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
155258864|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
155258865|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
155258866|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
155258867|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
155258868|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
155258869|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
155258870|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
155258871|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
155258872|NCT00508404|560379571|FG000|Overall Study|Ongoing at Data Cut-off|12|||
155258873|NCT00508404|560379571|FG000|Overall Study|Adverse Event|2|||
155258874|NCT00508404|560379571|FG000|Overall Study|Death|16|||
155258875|NCT00508404|560379571|FG000|Overall Study|Physician Decision|2|||
155258876|NCT00508404|560379571|FG000|Overall Study|Withdrawal by Subject|3|||
155258877|NCT00508404|560379571|FG000|Overall Study|Protocol-specified Criteria|2|||
155258878|NCT00508404|560379571|FG000|Overall Study|Lost to Follow-up|2|||
155258879|NCT00508404|560379571|FG000|Overall Study|Other - Not Specified|3|||
155258880|NCT01505387|560379572|FG000|Overall Study|Protocol Violation|1|||
155258881|NCT01505387|560379573|FG001|Overall Study|Protocol Violation|0|||
155258882|NCT01505387|560379572|FG000|Overall Study|Withdrawal by Subject|1|||
155258883|NCT01505387|560379573|FG001|Overall Study|Withdrawal by Subject|1|||
155258884|NCT01424930|560379574|FG000|Overall Study|Adverse Event|0|||
155258885|NCT01424930|560379575|FG001|Overall Study|Adverse Event|1|||
155258886|NCT01424930|560379574|FG000|Overall Study|Death|1|||
155258887|NCT01424930|560379575|FG001|Overall Study|Death|0|||
155258888|NCT01424930|560379574|FG000|Overall Study|Progressive Disease|3|||
155258889|NCT01424930|560379575|FG001|Overall Study|Progressive Disease|6|||
155258890|NCT01424930|560379574|FG000|Overall Study|Screen Failure|0|||
155258891|NCT01424930|560379575|FG001|Overall Study|Screen Failure|1|||
155258892|NCT01424930|560379574|FG000|Overall Study|Reason not specified|0|||
155258893|NCT01424930|560379575|FG001|Overall Study|Reason not specified|6|||
155258894|NCT01197508|560379578|FG000|Overall Study|Withdrawal by Subject|8|||
155258895|NCT01197508|560379579|FG001|Overall Study|Withdrawal by Subject|7|||
155258896|NCT01197508|560379580|FG002|Overall Study|Withdrawal by Subject|15|||
155258897|NCT01197508|560379581|FG003|Overall Study|Withdrawal by Subject|4|||
155258898|NCT01197508|560379578|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
155258899|NCT01197508|560379579|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
155258900|NCT01197508|560379580|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
155258901|NCT01197508|560379581|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
155258902|NCT01197508|560379578|FG000|Overall Study|Adverse Event|10|||
155258903|NCT01197508|560379579|FG001|Overall Study|Adverse Event|13|||
155258904|NCT01197508|560379580|FG002|Overall Study|Adverse Event|23|||
155258905|NCT01197508|560379581|FG003|Overall Study|Adverse Event|3|||
155258906|NCT01197508|560379578|FG000|Overall Study|Severe non-compliance to protocol|0|||
155258907|NCT01197508|560379579|FG001|Overall Study|Severe non-compliance to protocol|3|||
155258908|NCT01197508|560379580|FG002|Overall Study|Severe non-compliance to protocol|1|||
155258909|NCT01197508|560379581|FG003|Overall Study|Severe non-compliance to protocol|3|||
155258910|NCT01197508|560379578|FG000|Overall Study|Condition under investigation worsened|1|||
155258911|NCT01197508|560379579|FG001|Overall Study|Condition under investigation worsened|1|||
155258912|NCT01197508|560379580|FG002|Overall Study|Condition under investigation worsened|1|||
155258913|NCT01197508|560379581|FG003|Overall Study|Condition under investigation worsened|1|||
155258914|NCT01197508|560379578|FG000|Overall Study|Lack of Efficacy|1|||
155258915|NCT01197508|560379579|FG001|Overall Study|Lack of Efficacy|2|||
155258916|NCT01197508|560379580|FG002|Overall Study|Lack of Efficacy|2|||
155258917|NCT01197508|560379581|FG003|Overall Study|Lack of Efficacy|1|||
155258918|NCT01197508|560379578|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155258919|NCT01197508|560379579|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155258920|NCT01197508|560379580|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155258921|NCT01197508|560379581|FG003|Overall Study|Study-specific withdrawal criteria|2|||
155258922|NCT01197508|560379578|FG000|Overall Study|Lost to Follow-up|1|||
155258923|NCT01197508|560379579|FG001|Overall Study|Lost to Follow-up|1|||
155258924|NCT01197508|560379580|FG002|Overall Study|Lost to Follow-up|2|||
155258925|NCT01197508|560379581|FG003|Overall Study|Lost to Follow-up|0|||
155258926|NCT01197508|560379578|FG000|Overall Study|Other|2|||
155258927|NCT01197508|560379579|FG001|Overall Study|Other|3|||
155258928|NCT01197508|560379580|FG002|Overall Study|Other|2|||
155258929|NCT01197508|560379581|FG003|Overall Study|Other|2|||
155258930|NCT03286751|560379582|FG000|Washout Period 1|Withdrawal by Subject|0|||
155258931|NCT03286751|560379583|FG001|Washout Period 1|Withdrawal by Subject|0|||
155258932|NCT03286751|560379584|FG002|Washout Period 1|Withdrawal by Subject|0|||
155258933|NCT03286751|560379585|FG003|Washout Period 1|Withdrawal by Subject|0|||
155258934|NCT03286751|560379586|FG004|Washout Period 1|Withdrawal by Subject|1|||
155258935|NCT03286751|560379587|FG005|Washout Period 1|Withdrawal by Subject|0|||
155258936|NCT03286751|560379582|FG000|Washout Period 2|Personal Reasons|0|||
155258937|NCT03286751|560379583|FG001|Washout Period 2|Personal Reasons|1|||
155258938|NCT03286751|560379584|FG002|Washout Period 2|Personal Reasons|0|||
155258939|NCT03286751|560379585|FG003|Washout Period 2|Personal Reasons|0|||
155258940|NCT03286751|560379586|FG004|Washout Period 2|Personal Reasons|0|||
155258941|NCT03286751|560379587|FG005|Washout Period 2|Personal Reasons|0|||
155258942|NCT03286751|560379582|FG000|Washout Period 5|Adverse Event|0|||
155258943|NCT03286751|560379583|FG001|Washout Period 5|Adverse Event|0|||
155258944|NCT03286751|560379584|FG002|Washout Period 5|Adverse Event|0|||
155258945|NCT03286751|560379585|FG003|Washout Period 5|Adverse Event|0|||
155258946|NCT03286751|560379586|FG004|Washout Period 5|Adverse Event|1|||
155258947|NCT03286751|560379587|FG005|Washout Period 5|Adverse Event|0|||
155258948|NCT01621880|560379588|FG000|Overall Study|Adverse Event|5|||
155258949|NCT01621880|560379589|FG001|Overall Study|Adverse Event|1|||
155258950|NCT01621880|560379588|FG000|Overall Study|Withdrawal by Subject|5|||
155258951|NCT01621880|560379589|FG001|Overall Study|Withdrawal by Subject|4|||
155258952|NCT03086330|560379596|FG000|Overall Study|Withdrawal by Subject|3|||
155258953|NCT03086330|560379597|FG001|Overall Study|Withdrawal by Subject|2|||
155258954|NCT03086330|560379596|FG000|Overall Study|Lost to Follow-up|1|||
155258955|NCT03086330|560379597|FG001|Overall Study|Lost to Follow-up|2|||
155258956|NCT00645164|560379598|FG000|Overall Study|Lost to Follow-up|2|||
155258957|NCT00645164|560379598|FG000|Overall Study|Withdrawal by Subject|4|||
155258958|NCT00645164|560379598|FG000|Overall Study|Protocol Violation|1|||
155258959|NCT03338829|560379601|FG000|Overall Study|Lost to Follow-up|4|||
155258960|NCT03338829|560379602|FG001|Overall Study|Lost to Follow-up|2|||
155258961|NCT03338829|560379603|FG002|Overall Study|Lost to Follow-up|4|||
155258962|NCT03338829|560379601|FG000|Overall Study|Pregnancy loss|1|||
155258963|NCT03338829|560379602|FG001|Overall Study|Pregnancy loss|1|||
155258964|NCT03338829|560379603|FG002|Overall Study|Pregnancy loss|0|||
155258965|NCT03338829|560379601|FG000|Overall Study|Protocol Violation|0|||
155258966|NCT03338829|560379602|FG001|Overall Study|Protocol Violation|1|||
155258967|NCT03338829|560379603|FG002|Overall Study|Protocol Violation|0|||
155258968|NCT03434678|560379606|FG000|Overall Study|Withdrawal by Subject|13|||
155258969|NCT03434678|560379607|FG001|Overall Study|Withdrawal by Subject|13|||
155258970|NCT03434678|560379606|FG000|Overall Study|Found to be ineligible post randomization|2|||
155258971|NCT03434678|560379607|FG001|Overall Study|Found to be ineligible post randomization|1|||
155258972|NCT06060457|560379608|FG000|Overall Study|Adverse Event|1|||
155258973|NCT06060457|560379609|FG001|Overall Study|Adverse Event|1|||
155258974|NCT06060457|560379608|FG000|Overall Study|Death|2|||
155258975|NCT06060457|560379609|FG001|Overall Study|Death|2|||
155258976|NCT06060457|560379608|FG000|Overall Study|Lost to Follow-up|17|||
155258977|NCT06060457|560379609|FG001|Overall Study|Lost to Follow-up|19|||
155258978|NCT06060457|560379608|FG000|Overall Study|Physician Decision|0|||
155258979|NCT06060457|560379609|FG001|Overall Study|Physician Decision|1|||
155258980|NCT06060457|560379608|FG000|Overall Study|Protocol Violation|1|||
155258981|NCT06060457|560379609|FG001|Overall Study|Protocol Violation|1|||
155258982|NCT06060457|560379608|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
155258983|NCT06060457|560379609|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
155258984|NCT06060457|560379608|FG000|Overall Study|Withdrawal by Subject|12|||
155258985|NCT06060457|560379609|FG001|Overall Study|Withdrawal by Subject|15|||
155258986|NCT06060457|560379608|FG000|Overall Study|Other Than Specified|2|||
155258987|NCT06060457|560379609|FG001|Overall Study|Other Than Specified|1|||
155258988|NCT02061202|560379610|FG000|Overall Study|Lost to Follow-up|1|||
155258989|NCT02061202|560379611|FG001|Overall Study|Lost to Follow-up|1|||
155258990|NCT05608499|560379616|FG000|Overall Study|Lack of Efficacy|1|||
155258991|NCT05608499|560379617|FG001|Overall Study|Lack of Efficacy|0|||
155258992|NCT05608499|560379616|FG000|Overall Study|Lost to Follow-up|0|||
155258993|NCT05608499|560379617|FG001|Overall Study|Lost to Follow-up|1|||
155258994|NCT02660827|560379620|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
155258995|NCT02660827|560379620|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
155258996|NCT02660827|560379620|FG000|From Study to End of Continued Access|Adverse Event|3|||
155258997|NCT02660827|560379620|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
155258998|NCT02660827|560379620|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
155258999|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
155259000|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
155259001|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Adverse Event|3|||
155259002|NCT04672941|560379621|FG000|Overall Study|Investigator decision|1|||
155259003|NCT04672941|560379621|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
155259004|NCT04672941|560379621|FG000|Overall Study|COVID-19 related but no adverse event|1|||
155259005|NCT04672941|560379621|FG000|Overall Study|Adverse Event|2|||
155259006|NCT04672941|560379621|FG000|Overall Study|Lost to Follow-up|2|||
155259007|NCT00045305|560379622|FG000|Overall Study|Lack of Efficacy|6|||
155259008|NCT00045305|560379622|FG000|Overall Study|Adverse Event|3|||
155259009|NCT00045305|560379622|FG000|Overall Study|Death|3|||
155259010|NCT00045305|560379622|FG000|Overall Study|site error|2|||
155259011|NCT03848403|560379625|FG000|Period 2 (Day 8)|Adverse Event|1|||
155259012|NCT03848403|560379626|FG001|Period 2 (Day 8)|Adverse Event|2|||
155259013|NCT03848403|560379627|FG002|Period 2 (Day 8)|Adverse Event|2|||
155259014|NCT03848403|560379625|FG000|Period 2 (Day 8)|Physician Decision|0|||
155259015|NCT03848403|560379626|FG001|Period 2 (Day 8)|Physician Decision|1|||
155259016|NCT03848403|560379627|FG002|Period 2 (Day 8)|Physician Decision|0|||
155259017|NCT03848403|560379625|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
155259018|NCT03848403|560379626|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
155259019|NCT03848403|560379627|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
155259020|NCT02279043|560379628|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
155259021|NCT02279043|560379629|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
155259022|NCT02279043|560379630|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
155259023|NCT02279043|560379628|FG000|Overall Study|Lost to Follow-up|46|||
155259024|NCT02279043|560379629|FG001|Overall Study|Lost to Follow-up|88|||
155259025|NCT02279043|560379630|FG002|Overall Study|Lost to Follow-up|0|||
155259026|NCT00168038|560379631|FG000|Overall Study|Adverse Event|1|||
155259027|NCT00168038|560379631|FG000|Overall Study|Therapy failure|1|||
155259028|NCT02657031|560379635|FG000|Overall Study|Adverse Event|1|||
155259029|NCT02657031|560379636|FG001|Overall Study|Adverse Event|2|||
155259030|NCT04198805|560379637|FG000|Overall Study|Death|0|||
155259031|NCT04198805|560379638|FG001|Overall Study|Death|0|||
155259032|NCT04198805|560379639|FG002|Overall Study|Death|0|||
155259033|NCT04198805|560379640|FG003|Overall Study|Death|1|||
155259034|NCT04198805|560379637|FG000|Overall Study|Early Termination|8|||
155259035|NCT04198805|560379638|FG001|Overall Study|Early Termination|4|||
155259036|NCT04198805|560379639|FG002|Overall Study|Early Termination|6|||
155259037|NCT04198805|560379640|FG003|Overall Study|Early Termination|9|||
155259038|NCT03184792|560379643|FG000|Overall Study|Pandemic|2|||
155259039|NCT03184792|560379644|FG001|Overall Study|Pandemic|2|||
155259040|NCT02495025|560379645|FG000|Overall Study|Lost to Follow-up|21|||
155259041|NCT02495025|560379646|FG001|Overall Study|Lost to Follow-up|14|||
155259042|NCT02495025|560379645|FG000|Overall Study|Withdrawal by Subject|5|||
155259043|NCT02495025|560379646|FG001|Overall Study|Withdrawal by Subject|0|||
155259044|NCT00313820|560379648|FG000|Assigned to Treatment|Other|1|||
155259045|NCT00313820|560379649|FG001|Assigned to Treatment|Other|0|||
155259046|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
155259047|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
155259048|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
155259049|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
155259050|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
155259051|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
155259052|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
155259053|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
155259054|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
155259055|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
155259056|NCT02134587|560379653|FG000|Overall Study|Did not completed all meetings|30|||
155259057|NCT00265889|560379654|FG000|Overall Study|Physician Decision|1|||
155259058|NCT00265889|560379654|FG000|Overall Study|Protocol Violation|1|||
155259059|NCT00265889|560379654|FG000|Overall Study|Insurance denied the request|3|||
155259060|NCT02778100|560379660|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
155259061|NCT02778100|560379661|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
155259062|NCT01515748|560379669|FG000|Overall Study|Withdrawal by Subject|32|||
155259063|NCT01515748|560379670|FG001|Overall Study|Withdrawal by Subject|41|||
155259064|NCT01515748|560379669|FG000|Overall Study|Lost to Follow-up|2|||
155259065|NCT01515748|560379670|FG001|Overall Study|Lost to Follow-up|4|||
155259066|NCT01515748|560379669|FG000|Overall Study|Other than specified above|5|||
155259067|NCT01515748|560379670|FG001|Overall Study|Other than specified above|10|||
155259068|NCT01024608|560379673|FG000|Overall Study|Adverse Event|1|||
155259069|NCT01024608|560379674|FG001|Overall Study|Adverse Event|0|||
155259070|NCT01024608|560379673|FG000|Overall Study|Withdrawal by Subject|1|||
155259071|NCT01024608|560379674|FG001|Overall Study|Withdrawal by Subject|0|||
155259072|NCT01024608|560379673|FG000|Overall Study|Lost to Follow-up|0|||
155259073|NCT01024608|560379674|FG001|Overall Study|Lost to Follow-up|1|||
155259074|NCT01024608|560379673|FG000|Overall Study|Protocol Violation|0|||
155259075|NCT01024608|560379674|FG001|Overall Study|Protocol Violation|3|||
155259076|NCT01024608|560379673|FG000|Overall Study|Never received study treatment|2|||
155259077|NCT01024608|560379674|FG001|Overall Study|Never received study treatment|0|||
155259078|NCT04349280|560379675|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
155259079|NCT04349280|560379676|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
155259080|NCT04349280|560379675|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
155259081|NCT04349280|560379676|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
155259082|NCT04349280|560379675|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
155259083|NCT04349280|560379676|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
155259084|NCT05809596|560379679|FG000|Overall Study|Death|16|||
155259085|NCT05809596|560379679|FG000|Overall Study|Withdrawal by Subject|4|||
155259086|NCT05809596|560379679|FG000|Overall Study|Physician Decision|1|||
155259087|NCT05809596|560379679|FG000|Overall Study|Missed Visit|2|||
155259088|NCT05809596|560379679|FG000|Overall Study|Other|3|||
155259089|NCT03770494|560379681|FG000|Overall Study|Lost to Follow-up|0|||
155259090|NCT03770494|560379682|FG001|Overall Study|Lost to Follow-up|0|||
155259091|NCT03770494|560379683|FG002|Overall Study|Lost to Follow-up|1|||
155259092|NCT03770494|560379684|FG003|Overall Study|Lost to Follow-up|1|||
155259093|NCT03770494|560379685|FG004|Overall Study|Lost to Follow-up|1|||
155259094|NCT03770494|560379686|FG005|Overall Study|Lost to Follow-up|0|||
155259095|NCT03770494|560379687|FG006|Overall Study|Lost to Follow-up|0|||
155259096|NCT03770494|560379688|FG007|Overall Study|Lost to Follow-up|0|||
155259097|NCT03770494|560379689|FG008|Overall Study|Lost to Follow-up|0|||
155259098|NCT03770494|560379690|FG009|Overall Study|Lost to Follow-up|0|||
155259099|NCT03770494|560379691|FG010|Overall Study|Lost to Follow-up|0|||
155259100|NCT03770494|560379692|FG011|Overall Study|Lost to Follow-up|0|||
155259101|NCT03770494|560379693|FG012|Overall Study|Lost to Follow-up|0|||
155259102|NCT03770494|560379694|FG013|Overall Study|Lost to Follow-up|0|||
155259103|NCT03770494|560379681|FG000|Overall Study|Study terminated by sponsor|1|||
155259104|NCT03770494|560379682|FG001|Overall Study|Study terminated by sponsor|2|||
155259105|NCT03770494|560379683|FG002|Overall Study|Study terminated by sponsor|1|||
155259106|NCT03770494|560379684|FG003|Overall Study|Study terminated by sponsor|1|||
155259107|NCT03770494|560379685|FG004|Overall Study|Study terminated by sponsor|1|||
155259108|NCT03770494|560379686|FG005|Overall Study|Study terminated by sponsor|2|||
155259109|NCT03770494|560379687|FG006|Overall Study|Study terminated by sponsor|1|||
155259110|NCT03770494|560379688|FG007|Overall Study|Study terminated by sponsor|2|||
155259111|NCT03770494|560379689|FG008|Overall Study|Study terminated by sponsor|1|||
155259112|NCT03770494|560379690|FG009|Overall Study|Study terminated by sponsor|2|||
155259113|NCT03770494|560379691|FG010|Overall Study|Study terminated by sponsor|1|||
155259114|NCT03770494|560379692|FG011|Overall Study|Study terminated by sponsor|2|||
155259115|NCT03770494|560379693|FG012|Overall Study|Study terminated by sponsor|0|||
155259116|NCT03770494|560379694|FG013|Overall Study|Study terminated by sponsor|0|||
155259117|NCT03770494|560379681|FG000|Overall Study|Withdrawal by Subject|1|||
155259118|NCT03770494|560379682|FG001|Overall Study|Withdrawal by Subject|1|||
155259119|NCT03770494|560379683|FG002|Overall Study|Withdrawal by Subject|0|||
155259120|NCT03770494|560379684|FG003|Overall Study|Withdrawal by Subject|0|||
155259121|NCT03770494|560379685|FG004|Overall Study|Withdrawal by Subject|2|||
155259122|NCT03770494|560379686|FG005|Overall Study|Withdrawal by Subject|2|||
155259123|NCT03770494|560379687|FG006|Overall Study|Withdrawal by Subject|2|||
155259124|NCT03770494|560379688|FG007|Overall Study|Withdrawal by Subject|0|||
155259125|NCT03770494|560379689|FG008|Overall Study|Withdrawal by Subject|2|||
155259126|NCT03770494|560379690|FG009|Overall Study|Withdrawal by Subject|3|||
155259127|NCT03770494|560379691|FG010|Overall Study|Withdrawal by Subject|1|||
155259128|NCT03770494|560379692|FG011|Overall Study|Withdrawal by Subject|0|||
155259129|NCT03770494|560379693|FG012|Overall Study|Withdrawal by Subject|0|||
155259130|NCT03770494|560379694|FG013|Overall Study|Withdrawal by Subject|0|||
155259131|NCT00608582|560379704|FG000|Overall Study|Lost to Follow-up|2|||
155259132|NCT00608582|560379705|FG001|Overall Study|Lost to Follow-up|0|||
155259133|NCT00608582|560379704|FG000|Overall Study|No Best Response in Phase 1 located|1|||
155259134|NCT00608582|560379705|FG001|Overall Study|No Best Response in Phase 1 located|1|||
155259135|NCT00608582|560379704|FG000|Overall Study|Illicit Drug Use|1|||
155259136|NCT00608582|560379705|FG001|Overall Study|Illicit Drug Use|0|||
155259137|NCT00608582|560379704|FG000|Overall Study|Early stage Design Change|0|||
155259138|NCT00608582|560379705|FG001|Overall Study|Early stage Design Change|3|||
155259139|NCT04922554|560379706|FG000|Overall Study|Adverse Event|4|||
155259140|NCT04922554|560379707|FG001|Overall Study|Adverse Event|0|||
155259141|NCT04922554|560379706|FG000|Overall Study|Withdrawal by Subject|1|||
155259142|NCT04922554|560379707|FG001|Overall Study|Withdrawal by Subject|0|||
155259143|NCT01984697|560380927|FG000|Overall Study|Adverse Event|0|||
155259144|NCT01984697|560380928|FG001|Overall Study|Adverse Event|0|||
155259145|NCT01984697|560380929|FG002|Overall Study|Adverse Event|2|||
155259146|NCT01984697|560380930|FG003|Overall Study|Adverse Event|0|||
155259147|NCT01984697|560380931|FG004|Overall Study|Adverse Event|0|||
155259148|NCT01984697|560380927|FG000|Overall Study|Lost to Follow-up|14|||
155259149|NCT01984697|560380928|FG001|Overall Study|Lost to Follow-up|5|||
155259150|NCT01984697|560380929|FG002|Overall Study|Lost to Follow-up|10|||
155259151|NCT01984697|560380930|FG003|Overall Study|Lost to Follow-up|6|||
155259152|NCT01984697|560380931|FG004|Overall Study|Lost to Follow-up|21|||
155259153|NCT01984697|560380927|FG000|Overall Study|Physician Decision|3|||
155259154|NCT01984697|560380928|FG001|Overall Study|Physician Decision|0|||
155259155|NCT01984697|560380929|FG002|Overall Study|Physician Decision|0|||
155259156|NCT01984697|560380930|FG003|Overall Study|Physician Decision|1|||
155259157|NCT01984697|560380931|FG004|Overall Study|Physician Decision|0|||
155259158|NCT01984697|560380927|FG000|Overall Study|Protocol Violation|8|||
155259159|NCT01984697|560380928|FG001|Overall Study|Protocol Violation|5|||
155259160|NCT01984697|560380929|FG002|Overall Study|Protocol Violation|3|||
155259161|NCT01984697|560380930|FG003|Overall Study|Protocol Violation|2|||
155259162|NCT01984697|560380931|FG004|Overall Study|Protocol Violation|0|||
155259163|NCT01984697|560380927|FG000|Overall Study|Withdrawal by Subject|15|||
155259164|NCT01984697|560380928|FG001|Overall Study|Withdrawal by Subject|21|||
155259165|NCT01984697|560380929|FG002|Overall Study|Withdrawal by Subject|13|||
155259166|NCT01984697|560380930|FG003|Overall Study|Withdrawal by Subject|11|||
155259167|NCT01984697|560380931|FG004|Overall Study|Withdrawal by Subject|13|||
155259168|NCT01984697|560380927|FG000|Overall Study|Missed last follow-up visit|1|||
155259169|NCT01984697|560380928|FG001|Overall Study|Missed last follow-up visit|0|||
155259170|NCT01984697|560380929|FG002|Overall Study|Missed last follow-up visit|0|||
155259171|NCT01984697|560380930|FG003|Overall Study|Missed last follow-up visit|0|||
155259172|NCT01984697|560380931|FG004|Overall Study|Missed last follow-up visit|0|||
155259173|NCT01984697|560380927|FG000|Overall Study|Death|0|||
155259174|NCT01984697|560380928|FG001|Overall Study|Death|0|||
155259175|NCT01984697|560380929|FG002|Overall Study|Death|0|||
155259176|NCT01984697|560380930|FG003|Overall Study|Death|1|||
155259177|NCT01984697|560380931|FG004|Overall Study|Death|0|||
155259178|NCT01984697|560380927|FG000|Overall Study|Pregnancy|2|||
155259179|NCT01984697|560380928|FG001|Overall Study|Pregnancy|0|||
155259180|NCT01984697|560380929|FG002|Overall Study|Pregnancy|1|||
155259181|NCT01984697|560380930|FG003|Overall Study|Pregnancy|0|||
155259182|NCT01984697|560380931|FG004|Overall Study|Pregnancy|1|||
155259183|NCT01345630|560380932|FG000|Overall Study|Adverse Event|22|||
155259184|NCT01345630|560380933|FG001|Overall Study|Adverse Event|23|||
155259185|NCT01345630|560380932|FG000|Overall Study|Lost to Follow-up|17|||
155259186|NCT01345630|560380933|FG001|Overall Study|Lost to Follow-up|16|||
155259187|NCT01345630|560380932|FG000|Overall Study|Protocol Violation|4|||
155259188|NCT01345630|560380933|FG001|Overall Study|Protocol Violation|1|||
155259189|NCT01345630|560380932|FG000|Overall Study|Medication error without associated AE|0|||
155259190|NCT01345630|560380933|FG001|Overall Study|Medication error without associated AE|1|||
155259191|NCT01345630|560380932|FG000|Overall Study|Study terminated by sponsor|254|||
155259192|NCT01345630|560380933|FG001|Overall Study|Study terminated by sponsor|285|||
155259193|NCT01345630|560380932|FG000|Overall Study|Other reasons|6|||
155259194|NCT01345630|560380933|FG001|Overall Study|Other reasons|8|||
155259195|NCT01345630|560380932|FG000|Overall Study|Withdrawn due to pregnancy|1|||
155259196|NCT01345630|560380933|FG001|Overall Study|Withdrawn due to pregnancy|2|||
155259197|NCT01345630|560380932|FG000|Overall Study|No longer willing to participate|9|||
155259198|NCT01345630|560380933|FG001|Overall Study|No longer willing to participate|12|||
155259199|NCT01345630|560380932|FG000|Overall Study|Insufficient clinical response|48|||
155259200|NCT01345630|560380933|FG001|Overall Study|Insufficient clinical response|11|||
155259201|NCT00949715|560380936|FG000|Overall Study|Physician Decision|1|||
155259202|NCT00949715|560380937|FG001|Overall Study|Physician Decision|0|||
155259203|NCT00949715|560380936|FG000|Overall Study|Lost to Follow-up|1|||
155259204|NCT00949715|560380937|FG001|Overall Study|Lost to Follow-up|0|||
155259205|NCT00949715|560380936|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
155259206|NCT00949715|560380937|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
155259207|NCT01582789|560380938|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155259208|NCT01582789|560380939|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155259209|NCT01255592|560380940|FG000|Overall Study|Adverse Event|5|||
155259210|NCT01255592|560380941|FG001|Overall Study|Adverse Event|0|||
155259211|NCT01255592|560380940|FG000|Overall Study|Withdrawal by Subject|1|||
155259212|NCT01255592|560380941|FG001|Overall Study|Withdrawal by Subject|0|||
155259213|NCT01255592|560380940|FG000|Overall Study|Other|0|||
155259214|NCT01255592|560380941|FG001|Overall Study|Other|1|||
155259215|NCT01783418|560380949|FG000|Overall Study|Withdrawal by Subject|1|||
155259216|NCT01783418|560380950|FG001|Overall Study|Withdrawal by Subject|0|||
155259217|NCT00089141|560380951|FG000|Overall Study|Termination of trial|18|||
155259218|NCT00089141|560380952|FG001|Overall Study|Termination of trial|24|||
155259219|NCT00508261|560380955|FG000|Overall Study|Other|0|||
155259220|NCT00508261|560380956|FG001|Overall Study|Other|1|||
155259221|NCT00508261|560380957|FG002|Overall Study|Other|1|||
155259222|NCT00508261|560380958|FG003|Overall Study|Other|0|||
155259223|NCT00508261|560380955|FG000|Overall Study|Serious Adverse Event|0|||
155259224|NCT00508261|560380956|FG001|Overall Study|Serious Adverse Event|1|||
155259225|NCT00508261|560380957|FG002|Overall Study|Serious Adverse Event|0|||
155259226|NCT00508261|560380958|FG003|Overall Study|Serious Adverse Event|0|||
155259227|NCT00508261|560380955|FG000|Overall Study|Withdrawal by Subject|3|||
155259228|NCT00508261|560380956|FG001|Overall Study|Withdrawal by Subject|4|||
155259229|NCT00508261|560380957|FG002|Overall Study|Withdrawal by Subject|4|||
155259230|NCT00508261|560380958|FG003|Overall Study|Withdrawal by Subject|0|||
155259231|NCT00508261|560380955|FG000|Overall Study|Migrated/ moved from study area|0|||
155259232|NCT00508261|560380956|FG001|Overall Study|Migrated/ moved from study area|1|||
155259233|NCT00508261|560380957|FG002|Overall Study|Migrated/ moved from study area|0|||
155259234|NCT00508261|560380958|FG003|Overall Study|Migrated/ moved from study area|0|||
155259235|NCT00508261|560380955|FG000|Overall Study|Lost to Follow-up|0|||
155259236|NCT00508261|560380956|FG001|Overall Study|Lost to Follow-up|1|||
155259237|NCT00508261|560380957|FG002|Overall Study|Lost to Follow-up|1|||
155259238|NCT00508261|560380958|FG003|Overall Study|Lost to Follow-up|1|||
155259239|NCT04082884|560380959|FG000|Overall Study|Withdrawal by Subject|1|||
155259240|NCT00827541|560380960|FG000|Overall Study|Exitus|1|||
155259241|NCT00827541|560380961|FG001|Overall Study|Exitus|8|||
155259242|NCT00827541|560380960|FG000|Overall Study|Other|1|||
155259243|NCT00827541|560380961|FG001|Overall Study|Other|3|||
155259244|NCT00827541|560380960|FG000|Overall Study|Pathogen not susceptible|1|||
155259245|NCT00827541|560380961|FG001|Overall Study|Pathogen not susceptible|0|||
155259246|NCT00827541|560380960|FG000|Overall Study|Lack of effectiveness|1|||
155259247|NCT00827541|560380961|FG001|Overall Study|Lack of effectiveness|0|||
155259248|NCT01649232|560380962|FG000|Overall Study|Physician Decision|2|||
155259249|NCT01649232|560380963|FG001|Overall Study|Physician Decision|0|||
155259250|NCT02347657|560380964|FG000|Overall Study|Physician Decision|0|||
155259251|NCT02347657|560380965|FG001|Overall Study|Physician Decision|1|||
155259252|NCT02347657|560380964|FG000|Overall Study|Adverse Event|8|||
155259253|NCT02347657|560380965|FG001|Overall Study|Adverse Event|4|||
155259254|NCT02347657|560380964|FG000|Overall Study|Withdrawal by Subject|6|||
155259255|NCT02347657|560380965|FG001|Overall Study|Withdrawal by Subject|7|||
155259256|NCT02347657|560380964|FG000|Overall Study|Randomized but not treated|1|||
155259257|NCT02347657|560380965|FG001|Overall Study|Randomized but not treated|0|||
155259258|NCT02347657|560380964|FG000|Overall Study|Other|3|||
155259259|NCT02347657|560380965|FG001|Overall Study|Other|3|||
155259260|NCT01078155|560380967|FG000|Overall Study|Adverse Event|7|||
155259261|NCT01078155|560380967|FG000|Overall Study|Lack of Efficacy|16|||
155259262|NCT01078155|560380967|FG000|Overall Study|Participant's Decision|6|||
155259263|NCT01078155|560380967|FG000|Overall Study|Lost to Follow-up|15|||
155259264|NCT01119768|560380968|FG000|Treatment Period|Lack of Efficacy|18|||
155259265|NCT01119768|560380969|FG001|Treatment Period|Lack of Efficacy|25|||
155259266|NCT01301391|560380970|FG000|Overall Study|Death|13|||
155259267|NCT01301391|560380970|FG000|Overall Study|Lost to Follow-up|3|||
155259268|NCT01301391|560380970|FG000|Overall Study|Physician Decision|2|||
155259269|NCT01301391|560380970|FG000|Overall Study|Sponsor's decision|8|||
155259270|NCT01059643|560380971|FG000|Overall Study|Adverse Event|3|||
155259271|NCT01059643|560380971|FG000|Overall Study|Withdrawal by Subject|2|||
155259272|NCT01059643|560380971|FG000|Overall Study|Physician Decision|1|||
155259273|NCT01949870|560380972|FG000|Overall Study|Lack of Efficacy|2|||
155259274|NCT01949870|560380972|FG000|Overall Study|Adverse Event|1|||
155259275|NCT01949870|560380972|FG000|Overall Study|Study termination|1|||
155259276|NCT01949870|560380972|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
155259277|NCT04044456|560380978|FG000|Overall Study|Lost to Follow-up|4|||
155259278|NCT04044456|560380979|FG001|Overall Study|Lost to Follow-up|1|||
155259279|NCT04044456|560380978|FG000|Overall Study|Withdrawal by Subject|1|||
155259280|NCT04044456|560380979|FG001|Overall Study|Withdrawal by Subject|0|||
155259281|NCT00330174|560380980|FG000|Overall Study|Withdrawal by Subject|7|||
155259282|NCT00330174|560380981|FG001|Overall Study|Withdrawal by Subject|7|||
155259283|NCT00330174|560380980|FG000|Overall Study|Lost to Follow-up|4|||
155259284|NCT00330174|560380981|FG001|Overall Study|Lost to Follow-up|1|||
155259285|NCT00330174|560380980|FG000|Overall Study|Clinical deterioration|1|||
155259286|NCT00330174|560380981|FG001|Overall Study|Clinical deterioration|2|||
155259287|NCT00330174|560380980|FG000|Overall Study|Excessive missed visits|3|||
155259288|NCT00330174|560380981|FG001|Overall Study|Excessive missed visits|8|||
155259289|NCT00330174|560380980|FG000|Overall Study|Miscellaneous reasons|7|||
155259290|NCT00330174|560380981|FG001|Overall Study|Miscellaneous reasons|1|||
155259291|NCT02316769|560380984|FG000|Overall Study|Physician Decision|1|||
155259292|NCT02316769|560380985|FG001|Overall Study|Physician Decision|0|||
155259293|NCT02316769|560380984|FG000|Overall Study|Withdrawal by Subject|1|||
155259294|NCT02316769|560380985|FG001|Overall Study|Withdrawal by Subject|0|||
155259295|NCT01281644|560380988|FG000|Overall Study|Lost to Follow-up|3|||
155259296|NCT01281644|560380988|FG000|Overall Study|Withdrawal by Subject|2|||
155259297|NCT04393441|560380990|FG000|Overall Study|Adverse Event|0|||
155259298|NCT04393441|560380991|FG001|Overall Study|Adverse Event|3|||
155259299|NCT04393441|560380990|FG000|Overall Study|Withdrawal by Subject|5|||
155259300|NCT04393441|560380991|FG001|Overall Study|Withdrawal by Subject|7|||
155259301|NCT04393441|560380990|FG000|Overall Study|Lost to Follow-up|0|||
155259302|NCT04393441|560380991|FG001|Overall Study|Lost to Follow-up|2|||
155259303|NCT04393441|560380990|FG000|Overall Study|Protocol Deviation|2|||
155259304|NCT04393441|560380991|FG001|Overall Study|Protocol Deviation|1|||
155259305|NCT04393441|560380990|FG000|Overall Study|Reason not Specified|1|||
155259306|NCT04393441|560380991|FG001|Overall Study|Reason not Specified|1|||
155259307|NCT02782169|560380992|FG000|Overall Study|Lost to Follow-up|1|||
155259308|NCT02782169|560380993|FG001|Overall Study|Lost to Follow-up|2|||
155259309|NCT04003610|560380994|FG000|Overall Study|Lost to Follow-up|0|||
155259310|NCT04003610|560380995|FG001|Overall Study|Lost to Follow-up|1|||
155259311|NCT04003610|560380996|FG002|Overall Study|Lost to Follow-up|0|||
155259312|NCT04003610|560380994|FG000|Overall Study|Death|0|||
155259313|NCT04003610|560380995|FG001|Overall Study|Death|0|||
155259314|NCT04003610|560380996|FG002|Overall Study|Death|3|||
155259315|NCT04003610|560380994|FG000|Overall Study|Study Terminated by Sponsor|0|||
155259316|NCT04003610|560380995|FG001|Overall Study|Study Terminated by Sponsor|0|||
155259317|NCT04003610|560380996|FG002|Overall Study|Study Terminated by Sponsor|3|||
155259318|NCT00771810|560380997|FG000|Overall Study|Adverse Event|3|||
155259319|NCT00771810|560380998|FG001|Overall Study|Adverse Event|0|||
155259320|NCT00771810|560380999|FG002|Overall Study|Adverse Event|2|||
155259321|NCT00771810|560380997|FG000|Overall Study|Lost to Follow-up|0|||
155259322|NCT00771810|560380998|FG001|Overall Study|Lost to Follow-up|0|||
155259323|NCT00771810|560380999|FG002|Overall Study|Lost to Follow-up|1|||
155259324|NCT00771810|560380997|FG000|Overall Study|Physician Decision|1|||
155259325|NCT00771810|560380998|FG001|Overall Study|Physician Decision|2|||
155259326|NCT00771810|560380999|FG002|Overall Study|Physician Decision|2|||
155259327|NCT00771810|560380997|FG000|Overall Study|Protocol Violation|0|||
155259328|NCT00771810|560380998|FG001|Overall Study|Protocol Violation|1|||
155259329|NCT00771810|560380999|FG002|Overall Study|Protocol Violation|1|||
155259330|NCT00771810|560380997|FG000|Overall Study|Withdrawal by Subject|1|||
155259331|NCT00771810|560380998|FG001|Overall Study|Withdrawal by Subject|2|||
155259332|NCT00771810|560380999|FG002|Overall Study|Withdrawal by Subject|0|||
155259333|NCT00771810|560380997|FG000|Overall Study|Other|0|||
155259334|NCT00771810|560380998|FG001|Overall Study|Other|0|||
155259335|NCT00771810|560380999|FG002|Overall Study|Other|1|||
155259336|NCT02953938|560381004|FG000|Overall Study|Adverse Event|0|||
155259337|NCT02953938|560381005|FG001|Overall Study|Adverse Event|1|||
155259338|NCT02953938|560381004|FG000|Overall Study|Withdrawal by Subject|1|||
155259339|NCT02953938|560381005|FG001|Overall Study|Withdrawal by Subject|1|||
155259340|NCT03419364|560381010|FG000|Overall Study|Delivery due to maternal condition|2|||
155259341|NCT03419364|560381011|FG001|Overall Study|Delivery due to maternal condition|0|||
155259342|NCT03419364|560381012|FG002|Overall Study|Delivery due to maternal condition|0|||
155259343|NCT03188055|560381016|FG000|Overall Study|Unavailable for training|0|||
155259344|NCT03188055|560381017|FG001|Overall Study|Unavailable for training|0|||
155259345|NCT03188055|560381018|FG002|Overall Study|Unavailable for training|19|||
155259346|NCT03188055|560381019|FG003|Overall Study|Unavailable for training|0|||
155259347|NCT03188055|560381020|FG004|Overall Study|Unavailable for training|0|||
155259348|NCT03188055|560381021|FG005|Overall Study|Unavailable for training|0|||
155259349|NCT03188055|560381016|FG000|Overall Study|Lost to Follow-up|0|||
155259350|NCT03188055|560381017|FG001|Overall Study|Lost to Follow-up|18|||
155259351|NCT03188055|560381018|FG002|Overall Study|Lost to Follow-up|0|||
155259352|NCT03188055|560381019|FG003|Overall Study|Lost to Follow-up|11|||
155259353|NCT03188055|560381020|FG004|Overall Study|Lost to Follow-up|0|||
155259354|NCT03188055|560381021|FG005|Overall Study|Lost to Follow-up|0|||
155259355|NCT03188055|560381016|FG000|Overall Study|Withdrawal by Subject|0|||
155259356|NCT03188055|560381017|FG001|Overall Study|Withdrawal by Subject|1|||
155259357|NCT03188055|560381018|FG002|Overall Study|Withdrawal by Subject|0|||
155259358|NCT03188055|560381019|FG003|Overall Study|Withdrawal by Subject|1|||
155259359|NCT03188055|560381020|FG004|Overall Study|Withdrawal by Subject|0|||
155259360|NCT03188055|560381021|FG005|Overall Study|Withdrawal by Subject|0|||
155259361|NCT03017079|560381022|FG000|Overall Study|Physician Decision|1|||
155259362|NCT03017079|560381023|FG001|Overall Study|Physician Decision|1|||
155259363|NCT03017079|560381022|FG000|Overall Study|Death|3|||
155259364|NCT03017079|560381023|FG001|Overall Study|Death|2|||
155259365|NCT03017079|560381022|FG000|Overall Study|Lack of Efficacy|2|||
155259366|NCT03017079|560381023|FG001|Overall Study|Lack of Efficacy|2|||
155259367|NCT03017079|560381022|FG000|Overall Study|Protocol Violation|0|||
155259368|NCT03017079|560381023|FG001|Overall Study|Protocol Violation|1|||
155259369|NCT03657277|560381024|FG000|Overall Study|Physician Decision|2|||
155259370|NCT03657277|560381024|FG000|Overall Study|Lost to Follow-up|1|||
155259371|NCT03657277|560381024|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
155259372|NCT00657618|560381029|FG000|Overall Study|Adverse Event|32|||
155259373|NCT00657618|560381029|FG000|Overall Study|Withdrawal by Subject|8|||
155259374|NCT00657618|560381029|FG000|Overall Study|negative for leishmaniasis|2|||
155259375|NCT00657618|560381029|FG000|Overall Study|didn't start due to schedule conflicts|1|||
155259376|NCT04120233|560381030|FG000|Overall Study|Adverse Event|0|||
155259377|NCT04120233|560381031|FG001|Overall Study|Adverse Event|0|||
155259378|NCT04120233|560381032|FG002|Overall Study|Adverse Event|0|||
155259379|NCT04120233|560381033|FG003|Overall Study|Adverse Event|0|||
155259380|NCT04120233|560381034|FG004|Overall Study|Adverse Event|1|||
155259381|NCT04120233|560381035|FG005|Overall Study|Adverse Event|0|||
155259382|NCT03764774|560381036|FG000|Overall Study|Withdrawal by Subject|0|||
155259383|NCT03764774|560381037|FG001|Overall Study|Withdrawal by Subject|0|||
155259384|NCT03764774|560381038|FG002|Overall Study|Withdrawal by Subject|0|||
155259385|NCT03764774|560381039|FG003|Overall Study|Withdrawal by Subject|0|||
155259386|NCT03764774|560381040|FG004|Overall Study|Withdrawal by Subject|0|||
155259387|NCT03764774|560381041|FG005|Overall Study|Withdrawal by Subject|0|||
155259388|NCT03764774|560381042|FG006|Overall Study|Withdrawal by Subject|0|||
155259389|NCT03764774|560381043|FG007|Overall Study|Withdrawal by Subject|0|||
155259390|NCT03764774|560381044|FG008|Overall Study|Withdrawal by Subject|0|||
155259391|NCT03764774|560381045|FG009|Overall Study|Withdrawal by Subject|0|||
155259392|NCT03764774|560381046|FG010|Overall Study|Withdrawal by Subject|1|||
155259393|NCT03764774|560381047|FG011|Overall Study|Withdrawal by Subject|0|||
155259394|NCT03764774|560381048|FG012|Overall Study|Withdrawal by Subject|0|||
155259395|NCT03764774|560381049|FG013|Overall Study|Withdrawal by Subject|0|||
155259396|NCT03764774|560381036|FG000|Overall Study|Adverse Event|0|||
155259397|NCT03764774|560381037|FG001|Overall Study|Adverse Event|0|||
155259398|NCT03764774|560381038|FG002|Overall Study|Adverse Event|0|||
155259399|NCT03764774|560381039|FG003|Overall Study|Adverse Event|0|||
155259400|NCT03764774|560381040|FG004|Overall Study|Adverse Event|0|||
155259401|NCT03764774|560381041|FG005|Overall Study|Adverse Event|0|||
155259402|NCT03764774|560381042|FG006|Overall Study|Adverse Event|0|||
155259403|NCT03764774|560381043|FG007|Overall Study|Adverse Event|0|||
155259404|NCT03764774|560381044|FG008|Overall Study|Adverse Event|0|||
155259405|NCT03764774|560381045|FG009|Overall Study|Adverse Event|0|||
155259406|NCT03764774|560381046|FG010|Overall Study|Adverse Event|0|||
155259407|NCT03764774|560381047|FG011|Overall Study|Adverse Event|0|||
155259408|NCT03764774|560381048|FG012|Overall Study|Adverse Event|2|||
155259409|NCT03764774|560381049|FG013|Overall Study|Adverse Event|0|||
155259410|NCT03764774|560381036|FG000|Overall Study|Lost to Follow-up|0|||
155259411|NCT03764774|560381037|FG001|Overall Study|Lost to Follow-up|0|||
155259412|NCT03764774|560381038|FG002|Overall Study|Lost to Follow-up|0|||
155259413|NCT03764774|560381039|FG003|Overall Study|Lost to Follow-up|0|||
155259414|NCT03764774|560381040|FG004|Overall Study|Lost to Follow-up|0|||
155259415|NCT03764774|560381041|FG005|Overall Study|Lost to Follow-up|0|||
155259416|NCT03764774|560381042|FG006|Overall Study|Lost to Follow-up|0|||
155259417|NCT03764774|560381043|FG007|Overall Study|Lost to Follow-up|0|||
155259418|NCT03764774|560381044|FG008|Overall Study|Lost to Follow-up|0|||
155259419|NCT03764774|560381045|FG009|Overall Study|Lost to Follow-up|0|||
155259420|NCT03764774|560381046|FG010|Overall Study|Lost to Follow-up|0|||
155259421|NCT03764774|560381047|FG011|Overall Study|Lost to Follow-up|0|||
155259422|NCT03764774|560381048|FG012|Overall Study|Lost to Follow-up|0|||
155259423|NCT03764774|560381049|FG013|Overall Study|Lost to Follow-up|1|||
155259424|NCT03764774|560381036|FG000|Overall Study|Physician Decision|0|||
155259425|NCT03764774|560381037|FG001|Overall Study|Physician Decision|0|||
155259426|NCT03764774|560381038|FG002|Overall Study|Physician Decision|0|||
155259427|NCT03764774|560381039|FG003|Overall Study|Physician Decision|0|||
155259428|NCT03764774|560381040|FG004|Overall Study|Physician Decision|0|||
155259429|NCT03764774|560381041|FG005|Overall Study|Physician Decision|0|||
155259430|NCT03764774|560381042|FG006|Overall Study|Physician Decision|0|||
155259431|NCT03764774|560381043|FG007|Overall Study|Physician Decision|0|||
155259432|NCT03764774|560381044|FG008|Overall Study|Physician Decision|0|||
155259433|NCT03764774|560381045|FG009|Overall Study|Physician Decision|4|||
155259434|NCT03764774|560381046|FG010|Overall Study|Physician Decision|1|||
155259435|NCT03764774|560381047|FG011|Overall Study|Physician Decision|4|||
155259436|NCT03764774|560381048|FG012|Overall Study|Physician Decision|9|||
155259437|NCT03764774|560381049|FG013|Overall Study|Physician Decision|0|||
155259438|NCT03764774|560381036|FG000|Overall Study|Study Termination|0|||
155259439|NCT03764774|560381037|FG001|Overall Study|Study Termination|0|||
155259440|NCT03764774|560381038|FG002|Overall Study|Study Termination|0|||
155259441|NCT03764774|560381039|FG003|Overall Study|Study Termination|0|||
155259442|NCT03764774|560381040|FG004|Overall Study|Study Termination|0|||
155259443|NCT03764774|560381041|FG005|Overall Study|Study Termination|0|||
155259444|NCT03764774|560381042|FG006|Overall Study|Study Termination|0|||
155259445|NCT03764774|560381043|FG007|Overall Study|Study Termination|0|||
155259446|NCT03764774|560381044|FG008|Overall Study|Study Termination|0|||
155259447|NCT03764774|560381045|FG009|Overall Study|Study Termination|1|||
155259448|NCT03764774|560381046|FG010|Overall Study|Study Termination|0|||
155259449|NCT03764774|560381047|FG011|Overall Study|Study Termination|0|||
155259450|NCT03764774|560381048|FG012|Overall Study|Study Termination|0|||
155259451|NCT03764774|560381049|FG013|Overall Study|Study Termination|2|||
155259452|NCT00861614|560382373|FG000|Overall Study|Disease Progression|182|||
155259453|NCT00861614|560382374|FG001|Overall Study|Disease Progression|263|||
155259454|NCT00861614|560382373|FG000|Overall Study|Study Drug Toxicity|79|||
155259455|NCT00861614|560382374|FG001|Overall Study|Study Drug Toxicity|6|||
155259456|NCT00861614|560382373|FG000|Overall Study|Death|32|||
155259457|NCT00861614|560382374|FG001|Overall Study|Death|19|||
155259458|NCT00861614|560382373|FG000|Overall Study|Adverse Event|27|||
155259459|NCT00861614|560382374|FG001|Overall Study|Adverse Event|23|||
155259460|NCT00861614|560382373|FG000|Overall Study|Withdrawal by Subject|34|||
155259461|NCT00861614|560382374|FG001|Overall Study|Withdrawal by Subject|35|||
155259462|NCT00861614|560382373|FG000|Overall Study|Other|17|||
155259463|NCT00861614|560382374|FG001|Overall Study|Other|22|||
155259464|NCT02259517|560382375|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
155259465|NCT02259517|560382376|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
155259466|NCT02259517|560382377|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
155259467|NCT02259517|560382375|FG000|Overall Study|Withdrawal by Subject|0|||
155259468|NCT02259517|560382376|FG001|Overall Study|Withdrawal by Subject|0|||
155259469|NCT02259517|560382377|FG002|Overall Study|Withdrawal by Subject|3|||
155259470|NCT02276066|560382381|FG000|Overall Study|Lost to Follow-up|21|||
155259471|NCT02276066|560382382|FG001|Overall Study|Lost to Follow-up|11|||
155259472|NCT05050578|560382383|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
155259473|NCT05050578|560382384|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
155259474|NCT05050578|560382383|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
155259475|NCT05050578|560382384|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
155259476|NCT05050578|560382383|FG000|Period 2, 30 Days|Protocol Violation|0|||
155259477|NCT05050578|560382384|FG001|Period 2, 30 Days|Protocol Violation|1|||
155259478|NCT02243280|560382385|FG000|Treated|Adverse Event|1|||
155259479|NCT02243280|560382386|FG001|Treated|Adverse Event|0|||
155259480|NCT02243280|560382387|FG002|Treated|Adverse Event|0|||
155259481|NCT02243280|560382388|FG003|Treated|Adverse Event|0|||
155259482|NCT02243280|560382389|FG004|Treated|Adverse Event|0|||
155259483|NCT02243280|560382390|FG005|Treated|Adverse Event|0|||
155259484|NCT02243280|560382391|FG006|Treated|Adverse Event|0|||
155259485|NCT02243280|560382392|FG007|Treated|Adverse Event|0|||
155259486|NCT02243280|560382393|FG008|Treated|Adverse Event|0|||
155259487|NCT02243280|560382394|FG009|Treated|Adverse Event|0|||
155259488|NCT02243280|560382395|FG010|Treated|Adverse Event|1|||
155607054|NCT03217968|561649624|FG000|Overall Study|Withdrawal by Subject|4|||
155259489|NCT02243280|560382385|FG000|Treated|Lost to Follow-up|0|||
155259490|NCT02243280|560382386|FG001|Treated|Lost to Follow-up|0|||
155259491|NCT02243280|560382387|FG002|Treated|Lost to Follow-up|0|||
155259492|NCT02243280|560382388|FG003|Treated|Lost to Follow-up|0|||
155259493|NCT02243280|560382389|FG004|Treated|Lost to Follow-up|0|||
155259494|NCT02243280|560382390|FG005|Treated|Lost to Follow-up|0|||
155259495|NCT02243280|560382391|FG006|Treated|Lost to Follow-up|0|||
155259496|NCT02243280|560382392|FG007|Treated|Lost to Follow-up|0|||
155259497|NCT02243280|560382393|FG008|Treated|Lost to Follow-up|1|||
155259498|NCT02243280|560382394|FG009|Treated|Lost to Follow-up|0|||
155259499|NCT02243280|560382395|FG010|Treated|Lost to Follow-up|2|||
155259500|NCT03386032|560382396|FG000|Overall Study|Lack of Efficacy|6|||
155259501|NCT03386032|560382397|FG001|Overall Study|Lack of Efficacy|2|||
155259502|NCT03386032|560382398|FG002|Overall Study|Lack of Efficacy|0|||
155259503|NCT03386032|560382396|FG000|Overall Study|Adverse Event|2|||
155259504|NCT03386032|560382397|FG001|Overall Study|Adverse Event|2|||
155259505|NCT03386032|560382398|FG002|Overall Study|Adverse Event|0|||
155259506|NCT03386032|560382396|FG000|Overall Study|Withdrawal by Subject|1|||
155259507|NCT03386032|560382397|FG001|Overall Study|Withdrawal by Subject|0|||
155259508|NCT03386032|560382398|FG002|Overall Study|Withdrawal by Subject|0|||
155259509|NCT03386032|560382396|FG000|Overall Study|Lost to Follow-up|9|||
155259510|NCT03386032|560382397|FG001|Overall Study|Lost to Follow-up|3|||
155259511|NCT03386032|560382398|FG002|Overall Study|Lost to Follow-up|0|||
155259512|NCT01807156|560382399|FG000|Overall Study|Physician Decision|1|||
155259513|NCT02710292|560382404|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
155259514|NCT02710292|560382405|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
155259515|NCT02710292|560382404|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
155259516|NCT02710292|560382405|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
155259517|NCT03122119|560382406|FG000|Overall Study|Did not meet eligibility critria|1|||
155259518|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
155259519|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
155259520|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
155259521|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
155259522|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
155259523|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
155259524|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
155259525|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
155259526|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
155259527|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
155259528|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
155259529|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155259530|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
155259531|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
155259532|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
155259533|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
155259534|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
155259535|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
155259536|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
155259537|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
155259538|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
155259539|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
155259540|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
155259541|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
155259542|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
155259543|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
155259544|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
155259545|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
155259546|NCT01493687|560382409|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
155259547|NCT01493687|560382410|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
155259548|NCT02364180|560382413|FG000|Overall Study|Screen Fail|1|||
155259549|NCT02323646|560382414|FG000|Treatment Course 1|Adverse Event|1|||
155259550|NCT02323646|560382415|FG001|Treatment Course 1|Adverse Event|0|||
155259551|NCT02323646|560382416|FG002|Treatment Course 1|Adverse Event|1|||
155259552|NCT02323646|560382414|FG000|Treatment Course 1|Heavy Bleeding|1|||
155259553|NCT02323646|560382415|FG001|Treatment Course 1|Heavy Bleeding|1|||
155259554|NCT02323646|560382416|FG002|Treatment Course 1|Heavy Bleeding|0|||
155259555|NCT02323646|560382414|FG000|Treatment Course 1|Lost to Follow-up|1|||
155259556|NCT02323646|560382415|FG001|Treatment Course 1|Lost to Follow-up|0|||
155259557|NCT02323646|560382416|FG002|Treatment Course 1|Lost to Follow-up|2|||
155259558|NCT02323646|560382414|FG000|Treatment Course 1|Withdrawal by Subject|0|||
155259559|NCT02323646|560382415|FG001|Treatment Course 1|Withdrawal by Subject|2|||
155259560|NCT02323646|560382416|FG002|Treatment Course 1|Withdrawal by Subject|0|||
155259561|NCT02323646|560382414|FG000|Treatment Course 2|Adverse Event|1|||
155259562|NCT02323646|560382415|FG001|Treatment Course 2|Adverse Event|0|||
155259563|NCT02323646|560382416|FG002|Treatment Course 2|Adverse Event|1|||
155259564|NCT02323646|560382414|FG000|Treatment Course 2|Lost to Follow-up|0|||
155259565|NCT02323646|560382415|FG001|Treatment Course 2|Lost to Follow-up|0|||
155491703|NCT01068418|561225495|FG000|Overall Study|Physician Decision|12|||
155259566|NCT02323646|560382416|FG002|Treatment Course 2|Lost to Follow-up|1|||
155259567|NCT02323646|560382414|FG000|Treatment Course 2|Non-compliance|0|||
155259568|NCT02323646|560382415|FG001|Treatment Course 2|Non-compliance|1|||
155259569|NCT02323646|560382416|FG002|Treatment Course 2|Non-compliance|1|||
155259570|NCT00521144|560382417|FG000|Overall Study|Not Treated|0|||
155259571|NCT00521144|560382418|FG001|Overall Study|Not Treated|0|||
155259572|NCT00521144|560382419|FG002|Overall Study|Not Treated|0|||
155259573|NCT00521144|560382420|FG003|Overall Study|Not Treated|1|||
155259574|NCT00521144|560382421|FG004|Overall Study|Not Treated|0|||
155259575|NCT00521144|560382417|FG000|Overall Study|Adverse Event|0|||
155259576|NCT00521144|560382418|FG001|Overall Study|Adverse Event|1|||
155259577|NCT00521144|560382419|FG002|Overall Study|Adverse Event|0|||
155259578|NCT00521144|560382420|FG003|Overall Study|Adverse Event|0|||
155259579|NCT00521144|560382421|FG004|Overall Study|Adverse Event|1|||
155259580|NCT00521144|560382417|FG000|Overall Study|Progressive Disease|4|||
155259581|NCT00521144|560382418|FG001|Overall Study|Progressive Disease|2|||
155259582|NCT00521144|560382419|FG002|Overall Study|Progressive Disease|2|||
155259583|NCT00521144|560382420|FG003|Overall Study|Progressive Disease|0|||
155259584|NCT00521144|560382421|FG004|Overall Study|Progressive Disease|6|||
155259585|NCT02901626|560382422|FG000|Overall Study|Lost to Follow-up|1|||
155259586|NCT02901626|560382423|FG001|Overall Study|Lost to Follow-up|1|||
155259587|NCT00659490|560382426|FG000|Overall Study|Lost to Follow-up|2|||
155259588|NCT00659490|560382427|FG001|Overall Study|Lost to Follow-up|0|||
155259589|NCT00659490|560382428|FG002|Overall Study|Lost to Follow-up|1|||
155259590|NCT05674890|560382429|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
155259591|NCT05674890|560382430|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
155259592|NCT05674890|560382429|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
155259593|NCT05674890|560382430|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
155259594|NCT05674890|560382429|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
155259595|NCT05674890|560382430|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
155259596|NCT01750879|560382431|FG000|Overall Study|Adverse Event|8|||
155259597|NCT01750879|560382432|FG001|Overall Study|Adverse Event|0|||
155259598|NCT01750879|560382431|FG000|Overall Study|Lack of Efficacy|1|||
155259599|NCT01750879|560382432|FG001|Overall Study|Lack of Efficacy|0|||
155259600|NCT01750879|560382431|FG000|Overall Study|Withdrawal by Subject|1|||
155259601|NCT01750879|560382432|FG001|Overall Study|Withdrawal by Subject|0|||
155259602|NCT01750879|560382431|FG000|Overall Study|Did not complete per protocol|0|||
155259603|NCT01750879|560382432|FG001|Overall Study|Did not complete per protocol|3|||
155259604|NCT02421666|560382433|FG000|6-month Follow-up|Lost to Follow-up|8|||
155259605|NCT02421666|560382434|FG001|6-month Follow-up|Lost to Follow-up|7|||
155259606|NCT02421666|560382433|FG000|6-month Follow-up|Withdrawal by Subject|5|||
155259607|NCT02421666|560382434|FG001|6-month Follow-up|Withdrawal by Subject|6|||
155259608|NCT02421666|560382433|FG000|12-month Follow-up|Lost to Follow-up|5|||
155259609|NCT02421666|560382434|FG001|12-month Follow-up|Lost to Follow-up|5|||
155259610|NCT02421666|560382433|FG000|12-month Follow-up|Withdrawal by Subject|6|||
155259611|NCT02421666|560382434|FG001|12-month Follow-up|Withdrawal by Subject|11|||
155259612|NCT01226511|560382437|FG000|Acute Treatment Period|Adverse Event|7|||
155259613|NCT01226511|560382438|FG001|Acute Treatment Period|Adverse Event|6|||
155259614|NCT01226511|560382437|FG000|Acute Treatment Period|Lack of Efficacy|2|||
155259615|NCT01226511|560382438|FG001|Acute Treatment Period|Lack of Efficacy|1|||
155259616|NCT01226511|560382437|FG000|Acute Treatment Period|Lost to Follow-up|3|||
155259617|NCT01226511|560382438|FG001|Acute Treatment Period|Lost to Follow-up|6|||
155259618|NCT01226511|560382437|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
155259619|NCT01226511|560382438|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
155259620|NCT01226511|560382437|FG000|Acute Treatment Period|Protocol Violation|5|||
155259621|NCT01226511|560382438|FG001|Acute Treatment Period|Protocol Violation|5|||
155259622|NCT01226511|560382437|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
155259623|NCT01226511|560382438|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
155259624|NCT01226511|560382437|FG000|Extension Treatment Period|Adverse Event|8|||
155259625|NCT01226511|560382438|FG001|Extension Treatment Period|Adverse Event|8|||
155259626|NCT01226511|560382437|FG000|Extension Treatment Period|Lack of Efficacy|3|||
155259627|NCT01226511|560382438|FG001|Extension Treatment Period|Lack of Efficacy|2|||
155259628|NCT01226511|560382437|FG000|Extension Treatment Period|Lost to Follow-up|4|||
155259629|NCT01226511|560382438|FG001|Extension Treatment Period|Lost to Follow-up|3|||
155259630|NCT01226511|560382437|FG000|Extension Treatment Period|Protocol Violation|2|||
155259631|NCT01226511|560382438|FG001|Extension Treatment Period|Protocol Violation|2|||
155259632|NCT01226511|560382437|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
155259633|NCT01226511|560382438|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
155259634|NCT01226511|560382437|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
155259635|NCT01226511|560382438|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
155259636|NCT01226511|560382437|FG000|Extension Treatment Period|Sponsor Decision|1|||
155259637|NCT01226511|560382438|FG001|Extension Treatment Period|Sponsor Decision|1|||
155259638|NCT01226511|560382437|FG000|Taper Period|Adverse Event|1|||
155259639|NCT01226511|560382438|FG001|Taper Period|Adverse Event|0|||
155259640|NCT01226511|560382437|FG000|Taper Period|Lost to Follow-up|2|||
155259641|NCT01226511|560382438|FG001|Taper Period|Lost to Follow-up|2|||
155259642|NCT01226511|560382437|FG000|Taper Period|Protocol Violation|1|||
155259643|NCT01226511|560382438|FG001|Taper Period|Protocol Violation|0|||
155259644|NCT01226511|560382437|FG000|Taper Period|Parent/Caregiver Decision|1|||
155259645|NCT01226511|560382438|FG001|Taper Period|Parent/Caregiver Decision|1|||
155259646|NCT02923739|560382441|FG000|Overall Study|Withdrawal by Subject|2|||
155259647|NCT02923739|560382442|FG001|Overall Study|Withdrawal by Subject|0|||
155259648|NCT02923739|560382443|FG002|Overall Study|Withdrawal by Subject|0|||
155259649|NCT02923739|560382444|FG003|Overall Study|Withdrawal by Subject|0|||
155259650|NCT02923739|560382441|FG000|Overall Study|Failed Screening|3|||
155259651|NCT02923739|560382442|FG001|Overall Study|Failed Screening|0|||
155259652|NCT02923739|560382443|FG002|Overall Study|Failed Screening|0|||
155259653|NCT02923739|560382444|FG003|Overall Study|Failed Screening|0|||
155259654|NCT00677352|560382447|FG000|Treatment Phase|Adverse Event|14|||
155259655|NCT00677352|560382448|FG001|Treatment Phase|Adverse Event|22|||
155259656|NCT00677352|560382447|FG000|Treatment Phase|Lack of Efficacy|2|||
155259657|NCT00677352|560382448|FG001|Treatment Phase|Lack of Efficacy|3|||
155259658|NCT00677352|560382447|FG000|Treatment Phase|Lost to Follow-up|0|||
155259659|NCT00677352|560382448|FG001|Treatment Phase|Lost to Follow-up|1|||
155259660|NCT00677352|560382447|FG000|Treatment Phase|Withdrawal by Subject|7|||
155259661|NCT00677352|560382448|FG001|Treatment Phase|Withdrawal by Subject|7|||
155259662|NCT00677352|560382447|FG000|Treatment Phase|Physician Decision|1|||
155259663|NCT00677352|560382448|FG001|Treatment Phase|Physician Decision|0|||
155259664|NCT00677352|560382447|FG000|Treatment Phase|Pregnancy|0|||
155259665|NCT00677352|560382448|FG001|Treatment Phase|Pregnancy|1|||
155259666|NCT00677352|560382447|FG000|Treatment Phase|Protocol Violation|1|||
155259667|NCT00677352|560382448|FG001|Treatment Phase|Protocol Violation|1|||
155259668|NCT00677352|560382447|FG000|Treatment Phase|Transference or work related matter|0|||
155259669|NCT00677352|560382448|FG001|Treatment Phase|Transference or work related matter|5|||
155259670|NCT00677352|560382447|FG000|Treatment Phase|Not treated|0|||
155259671|NCT00677352|560382448|FG001|Treatment Phase|Not treated|2|||
155259672|NCT00677352|560382447|FG000|Tapering Phase|Adverse Event|1|||
155259673|NCT00677352|560382448|FG001|Tapering Phase|Adverse Event|5|||
155259674|NCT00677352|560382447|FG000|Tapering Phase|Withdrawal by Subject|5|||
155259675|NCT00677352|560382448|FG001|Tapering Phase|Withdrawal by Subject|3|||
155259676|NCT00677352|560382447|FG000|Tapering Phase|Pregnancy|0|||
155259677|NCT00677352|560382448|FG001|Tapering Phase|Pregnancy|1|||
155259678|NCT00677352|560382447|FG000|Tapering Phase|Job transfer|0|||
155259679|NCT00677352|560382448|FG001|Tapering Phase|Job transfer|1|||
155259680|NCT02182973|560382449|FG000|Overall Study|Withdrawal by Subject|3|||
155259681|NCT02182973|560382450|FG001|Overall Study|Withdrawal by Subject|0|||
155259682|NCT00948974|560382451|FG000|Overall Study|Lost to Follow-up|23|||
155259683|NCT00948974|560382452|FG001|Overall Study|Lost to Follow-up|20|||
155259684|NCT01814748|560382453|FG000|Overall Study|Lost to Follow-up|1|||
155259685|NCT01814748|560382454|FG001|Overall Study|Lost to Follow-up|2|||
155259686|NCT01814748|560382453|FG000|Overall Study|Study site terminated by sponsor|1|||
155259687|NCT01814748|560382454|FG001|Overall Study|Study site terminated by sponsor|1|||
155259688|NCT01814748|560382453|FG000|Overall Study|Withdrawal by Subject|6|||
155259689|NCT01814748|560382454|FG001|Overall Study|Withdrawal by Subject|4|||
155259690|NCT01972529|560382455|FG000|Overall Study|Adverse Event|0|||
155259691|NCT01972529|560382456|FG001|Overall Study|Adverse Event|1|||
155259692|NCT01972529|560382457|FG002|Overall Study|Adverse Event|0|||
155259693|NCT01972529|560382458|FG003|Overall Study|Adverse Event|0|||
155259694|NCT01972529|560382455|FG000|Overall Study|Lost to Follow-up|1|||
155259695|NCT01972529|560382456|FG001|Overall Study|Lost to Follow-up|0|||
155259696|NCT01972529|560382457|FG002|Overall Study|Lost to Follow-up|0|||
155259697|NCT01972529|560382458|FG003|Overall Study|Lost to Follow-up|0|||
155259698|NCT01972529|560382455|FG000|Overall Study|Participant Choice|0|||
155259699|NCT01972529|560382456|FG001|Overall Study|Participant Choice|1|||
155259700|NCT01972529|560382457|FG002|Overall Study|Participant Choice|0|||
155259701|NCT01972529|560382458|FG003|Overall Study|Participant Choice|0|||
155259702|NCT01972529|560382455|FG000|Overall Study|Withdrawl of Consent|1|||
155259703|NCT01972529|560382456|FG001|Overall Study|Withdrawl of Consent|2|||
155259704|NCT01972529|560382457|FG002|Overall Study|Withdrawl of Consent|0|||
155259705|NCT01972529|560382458|FG003|Overall Study|Withdrawl of Consent|1|||
155259706|NCT01972529|560382455|FG000|Overall Study|Other|0|||
155259707|NCT01972529|560382456|FG001|Overall Study|Other|0|||
155259708|NCT01972529|560382457|FG002|Overall Study|Other|0|||
155259709|NCT01972529|560382458|FG003|Overall Study|Other|2|||
155259710|NCT01972529|560382455|FG000|Overall Study|Not treated|0|||
155259711|NCT01972529|560382456|FG001|Overall Study|Not treated|1|||
155259712|NCT01972529|560382457|FG002|Overall Study|Not treated|2|||
155259713|NCT01972529|560382458|FG003|Overall Study|Not treated|1|||
155259714|NCT01376323|560382471|FG000|Overall Study|Adverse Event|1|||
155259715|NCT01376323|560382472|FG001|Overall Study|Adverse Event|0|||
155259716|NCT01376323|560382473|FG002|Overall Study|Adverse Event|0|||
155259717|NCT01376323|560382474|FG003|Overall Study|Adverse Event|2|||
155259718|NCT01376323|560382475|FG004|Overall Study|Adverse Event|0|||
155259719|NCT01376323|560382471|FG000|Overall Study|Lost to Follow-up|0|||
155259720|NCT01376323|560382472|FG001|Overall Study|Lost to Follow-up|0|||
155259721|NCT01376323|560382473|FG002|Overall Study|Lost to Follow-up|0|||
155259722|NCT01376323|560382474|FG003|Overall Study|Lost to Follow-up|2|||
155259723|NCT01376323|560382475|FG004|Overall Study|Lost to Follow-up|0|||
155259724|NCT01376323|560382471|FG000|Overall Study|Physician Decision|1|||
155259725|NCT01376323|560382472|FG001|Overall Study|Physician Decision|0|||
155259726|NCT01376323|560382473|FG002|Overall Study|Physician Decision|2|||
155259727|NCT01376323|560382474|FG003|Overall Study|Physician Decision|1|||
155259728|NCT01376323|560382475|FG004|Overall Study|Physician Decision|1|||
155259729|NCT01376323|560382471|FG000|Overall Study|Withdrawal by Subject|0|||
155259730|NCT01376323|560382472|FG001|Overall Study|Withdrawal by Subject|1|||
155259731|NCT01376323|560382473|FG002|Overall Study|Withdrawal by Subject|1|||
155259732|NCT01376323|560382474|FG003|Overall Study|Withdrawal by Subject|0|||
155259733|NCT01376323|560382475|FG004|Overall Study|Withdrawal by Subject|0|||
155259734|NCT04681729|560382476|FG000|Overall Study|Lack of Efficacy|2|||
155259735|NCT04681729|560382477|FG001|Overall Study|Lack of Efficacy|2|||
155259736|NCT04681729|560382476|FG000|Overall Study|Withdrawal by Subject|8|||
155259737|NCT04681729|560382477|FG001|Overall Study|Withdrawal by Subject|9|||
155259738|NCT02436811|560382478|FG000|Overall Study|Lost to Follow-up|2|||
155259739|NCT02436811|560382479|FG001|Overall Study|Lost to Follow-up|9|||
155259740|NCT02436811|560382480|FG002|Overall Study|Lost to Follow-up|7|||
155259741|NCT02227875|560382481|FG000|Overall Study|Protocol Violation|10|||
155259742|NCT02227875|560382482|FG001|Overall Study|Protocol Violation|7|||
155259743|NCT02227875|560382481|FG000|Overall Study|Other|1|||
155259744|NCT02227875|560382482|FG001|Overall Study|Other|3|||
155259745|NCT02227875|560382481|FG000|Overall Study|Physician Decision|1|||
155259746|NCT02227875|560382482|FG001|Overall Study|Physician Decision|0|||
155259747|NCT02227875|560382481|FG000|Overall Study|Adverse Event|3|||
155259748|NCT02227875|560382482|FG001|Overall Study|Adverse Event|0|||
155259749|NCT02227875|560382481|FG000|Overall Study|Withdrawal by Subject|12|||
155259750|NCT02227875|560382482|FG001|Overall Study|Withdrawal by Subject|13|||
155259751|NCT02227875|560382481|FG000|Overall Study|Lost to Follow-up|10|||
155259752|NCT02227875|560382482|FG001|Overall Study|Lost to Follow-up|10|||
155259753|NCT04209725|560382483|FG000|Overall Study|Adverse Event|1|||
155259754|NCT01201811|560382486|FG000|Overall Study|Adverse Event|6|||
155259755|NCT01201811|560382486|FG000|Overall Study|Disease progression|3|||
155259756|NCT01201811|560382486|FG000|Overall Study|Withdrawal by Subject|3|||
155259757|NCT01201811|560382486|FG000|Overall Study|Death|4|||
155259758|NCT01201811|560382486|FG000|Overall Study|Treatment Failure|2|||
155259759|NCT01201811|560382486|FG000|Overall Study|Physician Decision|1|||
155259760|NCT02856113|560382487|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155259761|NCT02856113|560382488|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155259762|NCT02856113|560382487|FG000|Overall Study|Significant Protocol Deviation|1|||
155259763|NCT02856113|560382488|FG001|Overall Study|Significant Protocol Deviation|0|||
155259764|NCT02856113|560382487|FG000|Overall Study|Lost to Follow-up|3|||
155259765|NCT02856113|560382488|FG001|Overall Study|Lost to Follow-up|5|||
155259766|NCT02856113|560382487|FG000|Overall Study|Voluntary Withdrawal|3|||
155259767|NCT02856113|560382488|FG001|Overall Study|Voluntary Withdrawal|5|||
155259768|NCT02856113|560382487|FG000|Overall Study|Pregnancy|0|||
155259769|NCT02856113|560382488|FG001|Overall Study|Pregnancy|1|||
155259770|NCT02856113|560382487|FG000|Overall Study|Principal Investigator Discretion|2|||
155259771|NCT02856113|560382488|FG001|Overall Study|Principal Investigator Discretion|1|||
155259772|NCT02856113|560382487|FG000|Overall Study|Randomized but not Treated|1|||
155259773|NCT02856113|560382488|FG001|Overall Study|Randomized but not Treated|0|||
155259774|NCT02856113|560382487|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
155259775|NCT02856113|560382488|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
155259776|NCT03494166|560382489|FG000|Overall Study|Death|0|||
155259777|NCT03494166|560382490|FG001|Overall Study|Death|0|||
155259778|NCT03494166|560382491|FG002|Overall Study|Death|0|||
155259779|NCT03494166|560382492|FG003|Overall Study|Death|1|||
155259780|NCT03494166|560382493|FG004|Overall Study|Death|3|||
155259781|NCT03494166|560382494|FG005|Overall Study|Death|0|||
155259782|NCT03494166|560382489|FG000|Overall Study|Lost to Follow-up|2|||
155259783|NCT03494166|560382490|FG001|Overall Study|Lost to Follow-up|2|||
155259784|NCT03494166|560382491|FG002|Overall Study|Lost to Follow-up|2|||
155259785|NCT03494166|560382492|FG003|Overall Study|Lost to Follow-up|2|||
155259786|NCT03494166|560382493|FG004|Overall Study|Lost to Follow-up|14|||
155259787|NCT03494166|560382494|FG005|Overall Study|Lost to Follow-up|0|||
155259788|NCT03494166|560382489|FG000|Overall Study|Withdrawal by Subject|10|||
155259789|NCT03494166|560382490|FG001|Overall Study|Withdrawal by Subject|7|||
155259790|NCT03494166|560382491|FG002|Overall Study|Withdrawal by Subject|0|||
155259791|NCT03494166|560382492|FG003|Overall Study|Withdrawal by Subject|5|||
155259792|NCT03494166|560382493|FG004|Overall Study|Withdrawal by Subject|3|||
155259793|NCT03494166|560382494|FG005|Overall Study|Withdrawal by Subject|17|||
155259794|NCT03494166|560382489|FG000|Overall Study|Screen failure|1|||
155259795|NCT03494166|560382490|FG001|Overall Study|Screen failure|0|||
155259796|NCT03494166|560382491|FG002|Overall Study|Screen failure|0|||
155259797|NCT03494166|560382492|FG003|Overall Study|Screen failure|0|||
155259798|NCT03494166|560382493|FG004|Overall Study|Screen failure|1|||
155259799|NCT03494166|560382494|FG005|Overall Study|Screen failure|0|||
155259800|NCT02831257|560382495|FG000|Overall Study|Lack of Efficacy|3|||
155259801|NCT02831257|560382495|FG000|Overall Study|Adverse Event|2|||
155259802|NCT02831257|560382495|FG000|Overall Study|Physician Decision|1|||
155259803|NCT02831257|560382495|FG000|Overall Study|Withdrawal by Subject|6|||
155259804|NCT02277990|560382496|FG000|Overall Study|Death|170|||
155259805|NCT02277990|560382497|FG001|Overall Study|Death|188|||
155259806|NCT02277990|560382496|FG000|Overall Study|Withdrawal by Subject|64|||
155259807|NCT02277990|560382497|FG001|Overall Study|Withdrawal by Subject|53|||
155259808|NCT02277990|560382496|FG000|Overall Study|Physician Decision|40|||
155259809|NCT02277990|560382497|FG001|Overall Study|Physician Decision|34|||
155259810|NCT02277990|560382496|FG000|Overall Study|Lost to Follow-up|66|||
155259811|NCT02277990|560382497|FG001|Overall Study|Lost to Follow-up|69|||
155259812|NCT02277990|560382496|FG000|Overall Study|Had other reason|26|||
155259813|NCT02277990|560382497|FG001|Overall Study|Had other reason|32|||
155259814|NCT04179032|560382500|FG000|Part B (Up to Week 52)|Adverse Event|1|||
155259815|NCT04179032|560382500|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
155259816|NCT04179032|560382500|FG000|Access Extension Phase|Ongoing|11|||
155259817|NCT00386022|560382511|FG000|Plus Estrogen|Lost to Follow-up|2|||
155259818|NCT00386022|560382512|FG001|Plus Estrogen|Lost to Follow-up|0|||
155259819|NCT00386022|560382511|FG000|Plus Estrogen|Adverse Event|0|||
155259820|NCT00386022|560382512|FG001|Plus Estrogen|Adverse Event|1|||
155259821|NCT03078816|560382513|FG000|Overall Study|Withdrawal by Subject|1|||
155259822|NCT02114151|560382514|FG000|Overall Study|Death|1|||
155259823|NCT02114151|560382514|FG000|Overall Study|Lost to Follow-up|1|||
155259824|NCT02114151|560382514|FG000|Overall Study|Withdrawal by Subject|5|||
155259825|NCT04992546|560382515|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155259826|NCT04992546|560382515|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
155259827|NCT04992546|560382515|FG000|Open-Label Treatment Period|Adverse Event|3|||
155259828|NCT04992546|560382515|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
155259829|NCT01659151|560382519|FG000|Overall Study|Inadequate TIL growth|1|||
155259830|NCT05774197|560382520|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
155259831|NCT04981678|560382523|FG000|Overall Study|Lost to Follow-up|0|||
155259832|NCT04981678|560382524|FG001|Overall Study|Lost to Follow-up|1|||
155259833|NCT03421808|560382525|FG000|Overall Study|COVID related problems|2|||
155259834|NCT03421808|560382526|FG001|Overall Study|COVID related problems|0|||
155259835|NCT03421808|560382525|FG000|Overall Study|Withdrawal by Subject|1|||
155259836|NCT03421808|560382526|FG001|Overall Study|Withdrawal by Subject|0|||
155259837|NCT03421808|560382525|FG000|Overall Study|Protocol Violation|0|||
155259838|NCT03421808|560382526|FG001|Overall Study|Protocol Violation|1|||
155259839|NCT01370525|560384106|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
155259840|NCT01370525|560384107|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
155259841|NCT01370525|560384106|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155259842|NCT01370525|560384107|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155259843|NCT01370525|560384106|FG000|Overall Study|Adverse Event|0|||
155259844|NCT01370525|560384107|FG001|Overall Study|Adverse Event|1|||
155259845|NCT01370525|560384106|FG000|Overall Study|Protocol Violation|2|||
155259846|NCT01370525|560384107|FG001|Overall Study|Protocol Violation|1|||
155259847|NCT01370525|560384106|FG000|Overall Study|Lost to follow up|2|||
155259848|NCT01370525|560384107|FG001|Overall Study|Lost to follow up|6|||
155259849|NCT04791761|560384108|FG000|Overall Study|Lost to Follow-up|8|||
155259850|NCT04791761|560384109|FG001|Overall Study|Lost to Follow-up|6|||
155259851|NCT04791761|560384110|FG002|Overall Study|Lost to Follow-up|10|||
155259852|NCT04791761|560384108|FG000|Overall Study|Withdrawal by Subject|0|||
155259853|NCT04791761|560384109|FG001|Overall Study|Withdrawal by Subject|1|||
155259854|NCT04791761|560384110|FG002|Overall Study|Withdrawal by Subject|1|||
155259855|NCT04791761|560384108|FG000|Overall Study|Protocol Violation|0|||
155259856|NCT04791761|560384109|FG001|Overall Study|Protocol Violation|1|||
155259857|NCT04791761|560384110|FG002|Overall Study|Protocol Violation|1|||
155259858|NCT00335452|560384111|FG000|Overall Study|Death|156|||
155259859|NCT00335452|560384112|FG001|Overall Study|Death|144|||
155259860|NCT00335452|560384113|FG002|Overall Study|Death|158|||
155259861|NCT00335452|560384114|FG003|Overall Study|Death|129|||
155259862|NCT00335452|560384111|FG000|Overall Study|Lost to Follow-up|2|||
155259863|NCT00335452|560384112|FG001|Overall Study|Lost to Follow-up|3|||
155259864|NCT00335452|560384113|FG002|Overall Study|Lost to Follow-up|1|||
155259865|NCT00335452|560384114|FG003|Overall Study|Lost to Follow-up|2|||
155259866|NCT02736825|560384116|FG000|Overall Study|Lost to Follow-up|10|||
155259867|NCT02736825|560384117|FG001|Overall Study|Lost to Follow-up|11|||
155259868|NCT02736825|560384116|FG000|Overall Study|Early Termination|0|||
155259869|NCT02736825|560384117|FG001|Overall Study|Early Termination|1|||
155259870|NCT00790452|560384118|FG000|Overall Study|Drug supply issue|1|||
155259871|NCT00790452|560384119|FG001|Overall Study|Drug supply issue|0|||
155259872|NCT02940574|560384120|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
155259873|NCT02940574|560384121|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
155491704|NCT00910000|561225496|FG000|Overall Study|Adverse Event|0|||
155491705|NCT00910000|561225497|FG001|Overall Study|Adverse Event|3|||
155259874|NCT02940574|560384120|FG000|1-year Follow-up|Lost to Follow-up|3|||
155259875|NCT02940574|560384121|FG001|1-year Follow-up|Lost to Follow-up|4|||
155259876|NCT00387894|560384122|FG000|Overall Study|Withdrawal by Subject|1|||
155259877|NCT04810221|560384123|FG000|Overall Study|Physician Decision|3|||
155259878|NCT03642938|560384124|FG000|Overall Study|Withdrawal by Subject|0|||
155259879|NCT03642938|560384125|FG001|Overall Study|Withdrawal by Subject|0|||
155259880|NCT03642938|560384126|FG002|Overall Study|Withdrawal by Subject|0|||
155259881|NCT03642938|560384127|FG003|Overall Study|Withdrawal by Subject|1|||
155259882|NCT00643123|560384135|FG000|Overall Study|Lost to Follow-up|4|||
155259883|NCT00643123|560384136|FG001|Overall Study|Lost to Follow-up|0|||
155259884|NCT00643123|560384135|FG000|Overall Study|Withdrawal by Subject|1|||
155259885|NCT00643123|560384136|FG001|Overall Study|Withdrawal by Subject|1|||
155259886|NCT02133872|560384138|FG000|Overall Study|Withdrawal by Subject|5|||
155259887|NCT02133872|560384139|FG001|Overall Study|Withdrawal by Subject|3|||
155259888|NCT02133872|560384140|FG002|Overall Study|Withdrawal by Subject|0|||
155259889|NCT00238433|560384146|FG000|Overall Study|Screen failure|1|||
155259890|NCT00238433|560384146|FG000|Overall Study|Lost to Follow-up|1|||
155259891|NCT00238433|560384146|FG000|Overall Study|Death|1|||
155259892|NCT00409682|560384148|FG000|Open-label Induction Period|Adverse Event|1|||
155259893|NCT00409682|560384149|FG001|Open-label Induction Period|Adverse Event|0|||
155259894|NCT00409682|560384150|FG002|Open-label Induction Period|Adverse Event|0|||
155259895|NCT00409682|560384148|FG000|Open-label Induction Period|Lack of Efficacy|1|||
155259896|NCT00409682|560384149|FG001|Open-label Induction Period|Lack of Efficacy|0|||
155259897|NCT00409682|560384150|FG002|Open-label Induction Period|Lack of Efficacy|0|||
155259898|NCT00409682|560384148|FG000|Open-label Induction Period|Protocol Violation|1|||
155259899|NCT00409682|560384149|FG001|Open-label Induction Period|Protocol Violation|0|||
155259900|NCT00409682|560384150|FG002|Open-label Induction Period|Protocol Violation|0|||
155259901|NCT00409682|560384148|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
155259902|NCT00409682|560384149|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
155259903|NCT00409682|560384150|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
155259904|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
155259905|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
155259906|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
155259907|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
155259908|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
155259909|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
155259910|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
155259911|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
155259912|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
155259913|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
155259914|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
155259915|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
155259916|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
155259917|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
155259918|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
155259919|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
155259920|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
155259921|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
155259922|NCT04710927|560384151|FG000|Overall Study|Lost to Follow-up|7|||
155259923|NCT04710927|560384152|FG001|Overall Study|Lost to Follow-up|6|||
155259924|NCT04710927|560384153|FG002|Overall Study|Lost to Follow-up|5|||
155259925|NCT00118716|560384154|FG000|Overall Study|Adverse Event|2|||
155259926|NCT00118716|560384155|FG001|Overall Study|Adverse Event|7|||
155259927|NCT00118716|560384154|FG000|Overall Study|Protocol Violation|5|||
155259928|NCT00118716|560384155|FG001|Overall Study|Protocol Violation|4|||
155259929|NCT00118716|560384154|FG000|Overall Study|Withdrawal by Subject|0|||
155259930|NCT00118716|560384155|FG001|Overall Study|Withdrawal by Subject|1|||
155259931|NCT00118716|560384154|FG000|Overall Study|Exacerbation|2|||
155259932|NCT00118716|560384155|FG001|Overall Study|Exacerbation|2|||
155259933|NCT00118716|560384154|FG000|Overall Study|Discontinued by sponsor|1|||
155259934|NCT00118716|560384155|FG001|Overall Study|Discontinued by sponsor|1|||
155259935|NCT00118716|560384154|FG000|Overall Study|Non-compliance|1|||
155259936|NCT00118716|560384155|FG001|Overall Study|Non-compliance|3|||
155259937|NCT00118716|560384154|FG000|Overall Study|misrandomized|1|||
155259938|NCT00118716|560384155|FG001|Overall Study|misrandomized|1|||
155259939|NCT00118716|560384154|FG000|Overall Study|Expired drug use|1|||
155259940|NCT00118716|560384155|FG001|Overall Study|Expired drug use|2|||
155259941|NCT00118716|560384154|FG000|Overall Study|Investigator discretion|0|||
155259942|NCT00118716|560384155|FG001|Overall Study|Investigator discretion|1|||
155259943|NCT00855062|560384157|FG000|Step1|Early Study Closure|5|||
155259944|NCT00855062|560384158|FG001|Step1|Early Study Closure|7|||
155259945|NCT00855062|560384157|FG000|Step1|Adverse Event|1|||
155491706|NCT00910000|561225498|FG002|Overall Study|Adverse Event|2|||
155491707|NCT00910000|561225499|FG003|Overall Study|Adverse Event|2|||
155259946|NCT00855062|560384158|FG001|Step1|Adverse Event|1|||
155259947|NCT00855062|560384157|FG000|Step1|Protocol Violation|1|||
155259948|NCT00855062|560384158|FG001|Step1|Protocol Violation|0|||
155259949|NCT00855062|560384157|FG000|Step1|Pregnancy|1|||
155259950|NCT00855062|560384158|FG001|Step1|Pregnancy|0|||
155259951|NCT00855062|560384157|FG000|Step1|Withdrawal by Subject|2|||
155259952|NCT00855062|560384158|FG001|Step1|Withdrawal by Subject|3|||
155259953|NCT00855062|560384157|FG000|Step2|Early Study Closure|6|||
155259954|NCT00855062|560384158|FG001|Step2|Early Study Closure|2|||
155259955|NCT00855062|560384157|FG000|Step2|Adverse Event|0|||
155259956|NCT00855062|560384158|FG001|Step2|Adverse Event|3|||
155259957|NCT00855062|560384157|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
155259958|NCT00855062|560384158|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
155259959|NCT03595332|560384164|FG000|Overall Study|Lost to Follow-up|16|||
155259960|NCT03595332|560384165|FG001|Overall Study|Lost to Follow-up|22|||
155259961|NCT03595332|560384164|FG000|Overall Study|Unable to retrieve ID from school|0|||
155259962|NCT03595332|560384165|FG001|Overall Study|Unable to retrieve ID from school|2|||
155259963|NCT03138733|560384177|FG000|Overall Study|Death|17|||
155259964|NCT03138733|560384178|FG001|Overall Study|Death|18|||
155259965|NCT03138733|560384177|FG000|Overall Study|Withdrawal by Subject|11|||
155259966|NCT03138733|560384178|FG001|Overall Study|Withdrawal by Subject|6|||
155259967|NCT03138733|560384177|FG000|Overall Study|Lost to Follow-up|3|||
155259968|NCT03138733|560384178|FG001|Overall Study|Lost to Follow-up|2|||
155259969|NCT03138733|560384177|FG000|Overall Study|Adverse Event|1|||
155259970|NCT03138733|560384178|FG001|Overall Study|Adverse Event|0|||
155259971|NCT03138733|560384177|FG000|Overall Study|Protocol Violation|1|||
155259972|NCT03138733|560384178|FG001|Overall Study|Protocol Violation|3|||
155259973|NCT03138733|560384177|FG000|Overall Study|Administrative or logistical reason|1|||
155259974|NCT03138733|560384178|FG001|Overall Study|Administrative or logistical reason|0|||
155259975|NCT03138733|560384177|FG000|Overall Study|The patient was transferred to another hospital|1|||
155259976|NCT03138733|560384178|FG001|Overall Study|The patient was transferred to another hospital|0|||
155259977|NCT02618967|560384186|FG000|Overall Study|Lost to Follow-up|0|||
155259978|NCT02618967|560384187|FG001|Overall Study|Lost to Follow-up|0|||
155259979|NCT02618967|560384188|FG002|Overall Study|Lost to Follow-up|1|||
155259980|NCT02618967|560384189|FG003|Overall Study|Lost to Follow-up|0|||
155259981|NCT02618967|560384190|FG004|Overall Study|Lost to Follow-up|2|||
155259982|NCT02618967|560384191|FG005|Overall Study|Lost to Follow-up|0|||
155259983|NCT02618967|560384192|FG006|Overall Study|Lost to Follow-up|0|||
155259984|NCT02618967|560384193|FG007|Overall Study|Lost to Follow-up|0|||
155259985|NCT02618967|560384186|FG000|Overall Study|Withdrawal by Subject|1|||
155259986|NCT02618967|560384187|FG001|Overall Study|Withdrawal by Subject|0|||
155259987|NCT02618967|560384188|FG002|Overall Study|Withdrawal by Subject|0|||
155259988|NCT02618967|560384189|FG003|Overall Study|Withdrawal by Subject|0|||
155259989|NCT02618967|560384190|FG004|Overall Study|Withdrawal by Subject|0|||
155259990|NCT02618967|560384191|FG005|Overall Study|Withdrawal by Subject|0|||
155259991|NCT02618967|560384192|FG006|Overall Study|Withdrawal by Subject|0|||
155259992|NCT02618967|560384193|FG007|Overall Study|Withdrawal by Subject|0|||
155259993|NCT01533493|560384194|FG000|Overall Study|Adverse Event|2|||
155259994|NCT01533493|560384195|FG001|Overall Study|Adverse Event|1|||
155259995|NCT01533493|560384194|FG000|Overall Study|Withdrawal by Subject|1|||
155259996|NCT01533493|560384195|FG001|Overall Study|Withdrawal by Subject|2|||
155259997|NCT01533493|560384194|FG000|Overall Study|Lost to Follow-up|2|||
155259998|NCT01533493|560384195|FG001|Overall Study|Lost to Follow-up|0|||
155259999|NCT05614089|560384201|FG000|Overall Study|Pregnancy|5|||
155260000|NCT05614089|560384202|FG001|Overall Study|Pregnancy|2|||
155260001|NCT05614089|560384201|FG000|Overall Study|Lost to Follow-up|5|||
155260002|NCT05614089|560384202|FG001|Overall Study|Lost to Follow-up|1|||
155260003|NCT05614089|560384201|FG000|Overall Study|Death|0|||
155260004|NCT05614089|560384202|FG001|Overall Study|Death|1|||
155260005|NCT05614089|560384201|FG000|Overall Study|Adverse Event|1|||
155260006|NCT05614089|560384202|FG001|Overall Study|Adverse Event|0|||
155260007|NCT02521285|560384203|FG000|Overall Study|Lost to Follow-up|1|||
155260008|NCT02521285|560384204|FG001|Overall Study|Lost to Follow-up|1|||
155260009|NCT02521285|560384203|FG000|Overall Study|Withdrawal by Subject|1|||
155260010|NCT02521285|560384204|FG001|Overall Study|Withdrawal by Subject|1|||
155260011|NCT02521285|560384203|FG000|Overall Study|Adverse Event|0|||
155260012|NCT02521285|560384204|FG001|Overall Study|Adverse Event|1|||
155260013|NCT05701995|560384206|FG000|Pre-Treatment|Randomization Error|1|||
155260014|NCT05701995|560384207|FG001|Pre-Treatment|Randomization Error|1|||
155260015|NCT05701995|560384206|FG000|Treatment|Withdrawal by Subject|8|||
155260016|NCT05701995|560384207|FG001|Treatment|Withdrawal by Subject|4|||
155260017|NCT05701995|560384206|FG000|Treatment|Lost to Follow-up|2|||
155260018|NCT05701995|560384207|FG001|Treatment|Lost to Follow-up|3|||
155260019|NCT05701995|560384206|FG000|Treatment|Adverse Event|3|||
155260020|NCT05701995|560384207|FG001|Treatment|Adverse Event|1|||
155260021|NCT05701995|560384206|FG000|Treatment|Other Reason|1|||
155260022|NCT05701995|560384207|FG001|Treatment|Other Reason|1|||
155260023|NCT05701995|560384206|FG000|Treatment|Death|1|||
155260024|NCT05701995|560384207|FG001|Treatment|Death|0|||
155260025|NCT05701995|560384206|FG000|Treatment|Physician Decision|0|||
155260026|NCT05701995|560384207|FG001|Treatment|Physician Decision|1|||
155260027|NCT00715429|560384208|FG000|Overall Study|Did not complete the study diary|0|||
155260028|NCT00715429|560384209|FG001|Overall Study|Did not complete the study diary|1|||
155260029|NCT04899245|560384214|FG000|Overall Study|Withdrawal by Subject|3|||
155260030|NCT04899245|560384215|FG001|Overall Study|Withdrawal by Subject|5|||
155260031|NCT04899245|560384216|FG002|Overall Study|Withdrawal by Subject|2|||
155260032|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Left staff position|0|||
155260033|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Left staff position|0|||
155260034|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Left staff position|1|||
155260035|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
155260036|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
155260037|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
155260038|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Moved away from area|2|||
155260039|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Moved away from area|2|||
155260040|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Moved away from area|0|||
155260041|NCT03933826|560384219|FG000|Overall Study|Withdrawal by Subject|8|||
155260042|NCT03933826|560384220|FG001|Overall Study|Withdrawal by Subject|1|||
155260043|NCT03933826|560384219|FG000|Overall Study|Death|19|||
155260044|NCT03933826|560384220|FG001|Overall Study|Death|11|||
155260045|NCT03933826|560384219|FG000|Overall Study|Lost to Follow-up|41|||
155260046|NCT03933826|560384220|FG001|Overall Study|Lost to Follow-up|13|||
155260047|NCT00500903|560384221|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
155260048|NCT00500903|560384222|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
155260049|NCT00500903|560384223|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
155260050|NCT00500903|560384221|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
155260051|NCT00500903|560384222|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155260052|NCT00500903|560384223|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155260053|NCT00500903|560384221|FG000|Overall Study|Progressive Disease|41|||
155260054|NCT00500903|560384222|FG001|Overall Study|Progressive Disease|2|||
155260055|NCT00500903|560384223|FG002|Overall Study|Progressive Disease|15|||
155260056|NCT00500903|560384221|FG000|Overall Study|Patient Declined Further Treatment|0|||
155260057|NCT00500903|560384222|FG001|Overall Study|Patient Declined Further Treatment|0|||
155260058|NCT00500903|560384223|FG002|Overall Study|Patient Declined Further Treatment|3|||
155260059|NCT00500903|560384221|FG000|Overall Study|Symptomatic Deterioration|2|||
155260060|NCT00500903|560384222|FG001|Overall Study|Symptomatic Deterioration|0|||
155260061|NCT00500903|560384223|FG002|Overall Study|Symptomatic Deterioration|0|||
155260062|NCT00500903|560384221|FG000|Overall Study|Reason Not Specified|10|||
155260063|NCT00500903|560384222|FG001|Overall Study|Reason Not Specified|0|||
155260064|NCT00500903|560384223|FG002|Overall Study|Reason Not Specified|2|||
155260065|NCT01648348|560384224|FG000|Overall Study|Cancel|1|||
155260066|NCT01648348|560384225|FG001|Overall Study|Cancel|0|||
155260067|NCT01648348|560384226|FG002|Overall Study|Cancel|0|||
155260068|NCT01648348|560384227|FG003|Overall Study|Cancel|0|||
155260069|NCT01648348|560384228|FG004|Overall Study|Cancel|3|||
155260070|NCT01648348|560384229|FG005|Overall Study|Cancel|6|||
155260071|NCT01648348|560384224|FG000|Overall Study|Replaced for MTD analysis|1|||
155260072|NCT01648348|560384225|FG001|Overall Study|Replaced for MTD analysis|0|||
155260073|NCT01648348|560384226|FG002|Overall Study|Replaced for MTD analysis|1|||
155260074|NCT01648348|560384227|FG003|Overall Study|Replaced for MTD analysis|0|||
155260075|NCT01648348|560384228|FG004|Overall Study|Replaced for MTD analysis|0|||
155260076|NCT01648348|560384229|FG005|Overall Study|Replaced for MTD analysis|0|||
155260077|NCT00696410|560384230|FG000|Overall Study|Lost to Follow-up|2|||
155260078|NCT00696410|560384231|FG001|Overall Study|Lost to Follow-up|0|||
155260079|NCT00696410|560384230|FG000|Overall Study|Withdrawal by Subject|8|||
155260080|NCT00696410|560384231|FG001|Overall Study|Withdrawal by Subject|0|||
155260081|NCT00696410|560384230|FG000|Overall Study|Physician Decision|3|||
155260082|NCT00696410|560384231|FG001|Overall Study|Physician Decision|0|||
155260083|NCT01951638|560384236|FG000|Treatment Period|Protocol Violation|0|||
155260084|NCT01951638|560384237|FG001|Treatment Period|Protocol Violation|0|||
155260085|NCT01951638|560384238|FG002|Treatment Period|Protocol Violation|0|||
155260086|NCT01951638|560384239|FG003|Treatment Period|Protocol Violation|2|||
155260087|NCT01951638|560384240|FG004|Treatment Period|Protocol Violation|0|||
155260088|NCT01951638|560384236|FG000|Treatment Period|Protocol-driven decision point|1|||
155260089|NCT01951638|560384237|FG001|Treatment Period|Protocol-driven decision point|3|||
155260090|NCT01951638|560384238|FG002|Treatment Period|Protocol-driven decision point|0|||
155260091|NCT01951638|560384239|FG003|Treatment Period|Protocol-driven decision point|0|||
155260092|NCT01951638|560384240|FG004|Treatment Period|Protocol-driven decision point|0|||
155260093|NCT01951638|560384236|FG000|Treatment Period|Logistical difficulties|0|||
155260094|NCT01951638|560384237|FG001|Treatment Period|Logistical difficulties|1|||
155260095|NCT01951638|560384238|FG002|Treatment Period|Logistical difficulties|1|||
155260096|NCT01951638|560384239|FG003|Treatment Period|Logistical difficulties|0|||
155260097|NCT01951638|560384240|FG004|Treatment Period|Logistical difficulties|0|||
155260098|NCT01951638|560384236|FG000|Treatment Period|Withdrawal by Subject|9|||
155260099|NCT01951638|560384237|FG001|Treatment Period|Withdrawal by Subject|6|||
155260100|NCT01951638|560384238|FG002|Treatment Period|Withdrawal by Subject|4|||
155260101|NCT01951638|560384239|FG003|Treatment Period|Withdrawal by Subject|5|||
155260102|NCT01951638|560384240|FG004|Treatment Period|Withdrawal by Subject|4|||
155260103|NCT01951638|560384236|FG000|Treatment Period|Death|0|||
155260104|NCT01951638|560384237|FG001|Treatment Period|Death|0|||
155260105|NCT01951638|560384238|FG002|Treatment Period|Death|0|||
155260106|NCT01951638|560384239|FG003|Treatment Period|Death|3|||
155260107|NCT01951638|560384240|FG004|Treatment Period|Death|1|||
155260108|NCT01951638|560384236|FG000|Treatment Period|Adverse Event|3|||
155260109|NCT01951638|560384237|FG001|Treatment Period|Adverse Event|4|||
155260110|NCT01951638|560384238|FG002|Treatment Period|Adverse Event|8|||
155260111|NCT01951638|560384239|FG003|Treatment Period|Adverse Event|6|||
155260112|NCT01951638|560384240|FG004|Treatment Period|Adverse Event|5|||
155260113|NCT01951638|560384236|FG000|Follow-up Period|Protocol Violation|0|||
155260114|NCT01951638|560384237|FG001|Follow-up Period|Protocol Violation|0|||
155260115|NCT01951638|560384238|FG002|Follow-up Period|Protocol Violation|0|||
155260116|NCT01951638|560384239|FG003|Follow-up Period|Protocol Violation|1|||
155260117|NCT01951638|560384240|FG004|Follow-up Period|Protocol Violation|0|||
155260118|NCT01951638|560384236|FG000|Follow-up Period|Logistical difficulties|0|||
155260119|NCT01951638|560384237|FG001|Follow-up Period|Logistical difficulties|2|||
155260120|NCT01951638|560384238|FG002|Follow-up Period|Logistical difficulties|0|||
155260121|NCT01951638|560384239|FG003|Follow-up Period|Logistical difficulties|0|||
155260122|NCT01951638|560384240|FG004|Follow-up Period|Logistical difficulties|1|||
155260123|NCT01951638|560384236|FG000|Follow-up Period|Withdrawal by Subject|1|||
155260124|NCT01951638|560384237|FG001|Follow-up Period|Withdrawal by Subject|5|||
155260125|NCT01951638|560384238|FG002|Follow-up Period|Withdrawal by Subject|2|||
155260126|NCT01951638|560384239|FG003|Follow-up Period|Withdrawal by Subject|1|||
155260127|NCT01951638|560384240|FG004|Follow-up Period|Withdrawal by Subject|2|||
155260128|NCT01951638|560384236|FG000|Follow-up Period|Lost to Follow-up|0|||
155260129|NCT01951638|560384237|FG001|Follow-up Period|Lost to Follow-up|1|||
155260130|NCT01951638|560384238|FG002|Follow-up Period|Lost to Follow-up|0|||
155260131|NCT01951638|560384239|FG003|Follow-up Period|Lost to Follow-up|1|||
155260132|NCT01951638|560384240|FG004|Follow-up Period|Lost to Follow-up|0|||
155260133|NCT01951638|560384236|FG000|Follow-up Period|Death|1|||
155260134|NCT01951638|560384237|FG001|Follow-up Period|Death|0|||
155260135|NCT01951638|560384238|FG002|Follow-up Period|Death|1|||
155260136|NCT01951638|560384239|FG003|Follow-up Period|Death|4|||
155260137|NCT01951638|560384240|FG004|Follow-up Period|Death|1|||
155260138|NCT01951638|560384236|FG000|Follow-up Period|Adverse Event|0|||
155260139|NCT01951638|560384237|FG001|Follow-up Period|Adverse Event|1|||
155260140|NCT01951638|560384238|FG002|Follow-up Period|Adverse Event|2|||
155260141|NCT01951638|560384239|FG003|Follow-up Period|Adverse Event|1|||
155260142|NCT01951638|560384240|FG004|Follow-up Period|Adverse Event|1|||
155260143|NCT00552084|560384241|FG000|Overall Study|Adverse Event|2|||
155260144|NCT00552084|560384242|FG001|Overall Study|Adverse Event|3|||
155260145|NCT00552084|560384241|FG000|Overall Study|Withdrawal by Subject|4|||
155260146|NCT00552084|560384242|FG001|Overall Study|Withdrawal by Subject|5|||
155260147|NCT00552084|560384241|FG000|Overall Study|Protocol Violation|1|||
155260148|NCT00552084|560384242|FG001|Overall Study|Protocol Violation|0|||
155260149|NCT00552084|560384241|FG000|Overall Study|change in anti-arrythmic drug|1|||
155260150|NCT00552084|560384242|FG001|Overall Study|change in anti-arrythmic drug|1|||
155260151|NCT01338025|560384243|FG000|Overall Study|Unexpected closure of study|10|||
155260152|NCT01338025|560384244|FG001|Overall Study|Unexpected closure of study|9|||
155260153|NCT01338025|560384243|FG000|Overall Study|Withdrawal by Subject|0|||
155260154|NCT01338025|560384244|FG001|Overall Study|Withdrawal by Subject|2|||
155260155|NCT01338025|560384243|FG000|Overall Study|Found ineligible after starting|1|||
155260156|NCT01338025|560384244|FG001|Overall Study|Found ineligible after starting|0|||
155260157|NCT02286089|560384247|FG000|Overall Study|Ongoing in Study|1|||
155260158|NCT02286089|560384248|FG001|Overall Study|Ongoing in Study|1|||
155260159|NCT02286089|560384249|FG002|Overall Study|Ongoing in Study|4|||
155260160|NCT02286089|560384250|FG003|Overall Study|Ongoing in Study|10|||
155260161|NCT02286089|560384247|FG000|Overall Study|Withdrawal by Subject|0|||
155260162|NCT02286089|560384248|FG001|Overall Study|Withdrawal by Subject|0|||
155260163|NCT02286089|560384249|FG002|Overall Study|Withdrawal by Subject|2|||
155260164|NCT02286089|560384250|FG003|Overall Study|Withdrawal by Subject|2|||
155260165|NCT05073133|560384252|FG000|Overall Study|Death|2|||
155260166|NCT05002218|560384256|FG000|Overall Study|Lost to Follow-up|5|||
155260167|NCT05002218|560384257|FG001|Overall Study|Lost to Follow-up|6|||
155260168|NCT06223373|560384258|FG000|Overall Study|Lost to Follow-up|1|||
155491708|NCT00910000|561225500|FG004|Overall Study|Adverse Event|0|||
155260169|NCT06223373|560384259|FG001|Overall Study|Lost to Follow-up|2|||
155260170|NCT01728792|560385834|FG000|Overall Study|Withdrawal of Consent|1|||
155260171|NCT01728792|560385835|FG001|Overall Study|Withdrawal of Consent|1|||
155260172|NCT01728792|560385836|FG002|Overall Study|Withdrawal of Consent|0|||
155260173|NCT01728792|560385837|FG003|Overall Study|Withdrawal of Consent|1|||
155260174|NCT01728792|560385838|FG004|Overall Study|Withdrawal of Consent|0|||
155260175|NCT01728792|560385834|FG000|Overall Study|Lost to Follow-up|2|||
155260176|NCT01728792|560385835|FG001|Overall Study|Lost to Follow-up|1|||
155260177|NCT01728792|560385836|FG002|Overall Study|Lost to Follow-up|4|||
155260178|NCT01728792|560385837|FG003|Overall Study|Lost to Follow-up|2|||
155260179|NCT01728792|560385838|FG004|Overall Study|Lost to Follow-up|0|||
155260180|NCT03559218|560385839|FG000|Overall Study|Withdrawal by Subject|1|||
155260181|NCT03559218|560385840|FG001|Overall Study|Withdrawal by Subject|0|||
155260182|NCT04277455|560385841|FG000|Overall Study|Lost to Follow-up|1|||
155260183|NCT04737109|560385849|FG000|Study Treatment|Disease Progression|5|||
155260184|NCT04737109|560385850|FG001|Study Treatment|Disease Progression|0|||
155260185|NCT04737109|560385851|FG002|Study Treatment|Disease Progression|0|||
155260186|NCT04737109|560385852|FG003|Study Treatment|Disease Progression|0|||
155260187|NCT04737109|560385849|FG000|Study Treatment|Death on study|1|||
155260188|NCT04737109|560385850|FG001|Study Treatment|Death on study|0|||
155260189|NCT04737109|560385851|FG002|Study Treatment|Death on study|0|||
155260190|NCT04737109|560385852|FG003|Study Treatment|Death on study|0|||
155260191|NCT03092375|560385853|FG000|Overall Study|Lack of Efficacy|0|||
155260192|NCT03092375|560385854|FG001|Overall Study|Lack of Efficacy|1|||
155260193|NCT03092375|560385855|FG002|Overall Study|Lack of Efficacy|1|||
155260194|NCT03092375|560385856|FG003|Overall Study|Lack of Efficacy|0|||
155260195|NCT01679301|560385857|FG000|Screening Period|screen failure|3|||
155260196|NCT01679301|560385858|FG001|Screening Period|screen failure|0|||
155260197|NCT01679301|560385859|FG002|Screening Period|screen failure|0|||
155260198|NCT03328143|560385860|FG000|Overall Study|Declined|3|||
155260199|NCT03328143|560385860|FG000|Overall Study|Required increased sedation|4|||
155260200|NCT03328143|560385860|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
155260201|NCT03328143|560385860|FG000|Overall Study|Surgery cancelled|1|||
155260202|NCT02305381|560385861|FG000|Overall Study|Unclassified|5|||
155260203|NCT02305381|560385862|FG001|Overall Study|Unclassified|5|||
155260204|NCT02305381|560385863|FG002|Overall Study|Unclassified|7|||
155260205|NCT04857034|560385866|FG000|Placebo-Controlled Period|Request to discontinue|2|||
155260206|NCT04857034|560385867|FG001|Placebo-Controlled Period|Request to discontinue|2|||
155260207|NCT04857034|560385868|FG002|Placebo-Controlled Period|Request to discontinue|0|||
155260208|NCT04857034|560385869|FG003|Placebo-Controlled Period|Request to discontinue|0|||
155260209|NCT04857034|560385870|FG004|Placebo-Controlled Period|Request to discontinue|0|||
155260210|NCT04857034|560385866|FG000|Placebo-Controlled Period|withdrew consent|1|||
155260211|NCT04857034|560385867|FG001|Placebo-Controlled Period|withdrew consent|1|||
155260212|NCT04857034|560385868|FG002|Placebo-Controlled Period|withdrew consent|2|||
155260213|NCT04857034|560385869|FG003|Placebo-Controlled Period|withdrew consent|0|||
155260214|NCT04857034|560385870|FG004|Placebo-Controlled Period|withdrew consent|0|||
155260215|NCT04857034|560385866|FG000|Placebo-Controlled Period|Pregnancy|1|||
155260216|NCT04857034|560385867|FG001|Placebo-Controlled Period|Pregnancy|1|||
155260217|NCT04857034|560385868|FG002|Placebo-Controlled Period|Pregnancy|0|||
155260218|NCT04857034|560385869|FG003|Placebo-Controlled Period|Pregnancy|0|||
155260219|NCT04857034|560385870|FG004|Placebo-Controlled Period|Pregnancy|0|||
155260220|NCT04857034|560385866|FG000|Placebo-Controlled Period|Ongoing study period|0|||
155260221|NCT04857034|560385867|FG001|Placebo-Controlled Period|Ongoing study period|1|||
155260222|NCT04857034|560385868|FG002|Placebo-Controlled Period|Ongoing study period|0|||
155260223|NCT04857034|560385869|FG003|Placebo-Controlled Period|Ongoing study period|0|||
155260224|NCT04857034|560385870|FG004|Placebo-Controlled Period|Ongoing study period|0|||
155260225|NCT04857034|560385866|FG000|Active Treatment Period|Lack of Efficacy|1|||
155260226|NCT04857034|560385867|FG001|Active Treatment Period|Lack of Efficacy|0|||
155260227|NCT04857034|560385868|FG002|Active Treatment Period|Lack of Efficacy|0|||
155260228|NCT04857034|560385869|FG003|Active Treatment Period|Lack of Efficacy|0|||
155260229|NCT04857034|560385870|FG004|Active Treatment Period|Lack of Efficacy|0|||
155260230|NCT04857034|560385866|FG000|Active Treatment Period|request to discontinue|0|||
155260231|NCT04857034|560385867|FG001|Active Treatment Period|request to discontinue|1|||
155260232|NCT04857034|560385868|FG002|Active Treatment Period|request to discontinue|0|||
155260233|NCT04857034|560385869|FG003|Active Treatment Period|request to discontinue|1|||
155260234|NCT04857034|560385870|FG004|Active Treatment Period|request to discontinue|0|||
155260235|NCT04857034|560385866|FG000|Active Treatment Period|administrative reason by sponsor|1|||
155260236|NCT04857034|560385867|FG001|Active Treatment Period|administrative reason by sponsor|5|||
155260237|NCT04857034|560385868|FG002|Active Treatment Period|administrative reason by sponsor|0|||
155260238|NCT04857034|560385869|FG003|Active Treatment Period|administrative reason by sponsor|2|||
155260239|NCT04857034|560385870|FG004|Active Treatment Period|administrative reason by sponsor|2|||
155260240|NCT04857034|560385866|FG000|Active Treatment Period|other reasons|1|||
155260241|NCT04857034|560385867|FG001|Active Treatment Period|other reasons|1|||
155260242|NCT04857034|560385868|FG002|Active Treatment Period|other reasons|0|||
155260243|NCT04857034|560385869|FG003|Active Treatment Period|other reasons|0|||
155260244|NCT04857034|560385870|FG004|Active Treatment Period|other reasons|1|||
155260245|NCT04857034|560385866|FG000|Active Treatment Period|Ongoing Study Period|2|||
155260246|NCT04857034|560385867|FG001|Active Treatment Period|Ongoing Study Period|4|||
155260247|NCT04857034|560385868|FG002|Active Treatment Period|Ongoing Study Period|0|||
155260248|NCT04857034|560385869|FG003|Active Treatment Period|Ongoing Study Period|1|||
155260249|NCT04857034|560385870|FG004|Active Treatment Period|Ongoing Study Period|0|||
155260250|NCT00520975|560385871|FG000|Overall Study|Disease progression|31|||
155260251|NCT00520975|560385872|FG001|Overall Study|Disease progression|23|||
155260252|NCT00520975|560385871|FG000|Overall Study|Adverse Event|7|||
155260253|NCT00520975|560385872|FG001|Overall Study|Adverse Event|10|||
155260254|NCT00520975|560385871|FG000|Overall Study|Death|0|||
155260255|NCT00520975|560385872|FG001|Overall Study|Death|2|||
155260256|NCT00520975|560385871|FG000|Overall Study|Withdrawal by Subject|3|||
155260257|NCT00520975|560385872|FG001|Overall Study|Withdrawal by Subject|5|||
155260258|NCT00520975|560385871|FG000|Overall Study|Other therapy|2|||
155260259|NCT00520975|560385872|FG001|Overall Study|Other therapy|4|||
155260260|NCT00520975|560385871|FG000|Overall Study|Other reasons|4|||
155260261|NCT00520975|560385872|FG001|Overall Study|Other reasons|2|||
155260262|NCT00520975|560385871|FG000|Overall Study|Not start protocol therapy|1|||
155260263|NCT00520975|560385872|FG001|Overall Study|Not start protocol therapy|2|||
155260264|NCT00642902|560385873|FG000|Overall Study|Adverse Event|0|||
155260265|NCT00642902|560385874|FG001|Overall Study|Adverse Event|1|||
155260266|NCT00642902|560385875|FG002|Overall Study|Adverse Event|3|||
155260267|NCT00642902|560385876|FG003|Overall Study|Adverse Event|1|||
155260268|NCT00642902|560385873|FG000|Overall Study|Lost to Follow-up|1|||
155260269|NCT00642902|560385874|FG001|Overall Study|Lost to Follow-up|1|||
155260270|NCT00642902|560385875|FG002|Overall Study|Lost to Follow-up|0|||
155260271|NCT00642902|560385876|FG003|Overall Study|Lost to Follow-up|0|||
155260272|NCT00642902|560385873|FG000|Overall Study|Lack of Efficacy|0|||
155260273|NCT00642902|560385874|FG001|Overall Study|Lack of Efficacy|3|||
155260274|NCT00642902|560385875|FG002|Overall Study|Lack of Efficacy|3|||
155260275|NCT00642902|560385876|FG003|Overall Study|Lack of Efficacy|0|||
155260276|NCT00642902|560385873|FG000|Overall Study|Death|1|||
155260277|NCT00642902|560385874|FG001|Overall Study|Death|0|||
155260278|NCT00642902|560385875|FG002|Overall Study|Death|0|||
155260279|NCT00642902|560385876|FG003|Overall Study|Death|0|||
155260280|NCT00642902|560385873|FG000|Overall Study|Premature termination of clinical trial|37|||
155260281|NCT00642902|560385874|FG001|Overall Study|Premature termination of clinical trial|32|||
155260282|NCT00642902|560385875|FG002|Overall Study|Premature termination of clinical trial|35|||
155260283|NCT00642902|560385876|FG003|Overall Study|Premature termination of clinical trial|35|||
155260284|NCT00642902|560385873|FG000|Overall Study|Randomized, but not treated|0|||
155260285|NCT00642902|560385874|FG001|Overall Study|Randomized, but not treated|0|||
155260286|NCT00642902|560385875|FG002|Overall Study|Randomized, but not treated|1|||
155260287|NCT00642902|560385876|FG003|Overall Study|Randomized, but not treated|0|||
155260288|NCT00642902|560385873|FG000|Overall Study|Other|1|||
155260289|NCT00642902|560385874|FG001|Overall Study|Other|5|||
155260290|NCT00642902|560385875|FG002|Overall Study|Other|1|||
155260291|NCT00642902|560385876|FG003|Overall Study|Other|4|||
155260292|NCT03953898|560385877|FG000|Overall Study|Lack of Efficacy|8|||
155260293|NCT03953898|560385877|FG000|Overall Study|Death|3|||
155260294|NCT03953898|560385877|FG000|Overall Study|Withdrawal by Subject|2|||
155260295|NCT03953898|560385877|FG000|Overall Study|Adverse Event|1|||
155260296|NCT00246337|560385878|FG000|Overall Study|Lost to Follow-up|3|||
155260297|NCT00246337|560385879|FG001|Overall Study|Lost to Follow-up|0|||
155260298|NCT00246337|560385880|FG002|Overall Study|Lost to Follow-up|0|||
155260299|NCT00246337|560385881|FG003|Overall Study|Lost to Follow-up|0|||
155260300|NCT00246337|560385882|FG004|Overall Study|Lost to Follow-up|2|||
155260301|NCT00246337|560385883|FG005|Overall Study|Lost to Follow-up|2|||
155260302|NCT00246337|560385884|FG006|Overall Study|Lost to Follow-up|1|||
155260303|NCT00246337|560385885|FG007|Overall Study|Lost to Follow-up|2|||
155260304|NCT00246337|560385886|FG008|Overall Study|Lost to Follow-up|0|||
155260305|NCT00246337|560385878|FG000|Overall Study|Protocol Violation|1|||
155260306|NCT00246337|560385879|FG001|Overall Study|Protocol Violation|0|||
155260307|NCT00246337|560385880|FG002|Overall Study|Protocol Violation|0|||
155260308|NCT00246337|560385881|FG003|Overall Study|Protocol Violation|0|||
155260309|NCT00246337|560385882|FG004|Overall Study|Protocol Violation|1|||
155260310|NCT00246337|560385883|FG005|Overall Study|Protocol Violation|0|||
155260311|NCT00246337|560385884|FG006|Overall Study|Protocol Violation|1|||
155260312|NCT00246337|560385885|FG007|Overall Study|Protocol Violation|1|||
155260313|NCT00246337|560385886|FG008|Overall Study|Protocol Violation|0|||
155260314|NCT00246337|560385878|FG000|Overall Study|Withdrawal by Subject|2|||
155260315|NCT00246337|560385879|FG001|Overall Study|Withdrawal by Subject|0|||
155260316|NCT00246337|560385880|FG002|Overall Study|Withdrawal by Subject|0|||
155260317|NCT00246337|560385881|FG003|Overall Study|Withdrawal by Subject|0|||
155260318|NCT00246337|560385882|FG004|Overall Study|Withdrawal by Subject|0|||
155260319|NCT00246337|560385883|FG005|Overall Study|Withdrawal by Subject|0|||
155260320|NCT00246337|560385884|FG006|Overall Study|Withdrawal by Subject|1|||
155260321|NCT00246337|560385885|FG007|Overall Study|Withdrawal by Subject|1|||
155260322|NCT00246337|560385886|FG008|Overall Study|Withdrawal by Subject|0|||
155260323|NCT00246337|560385878|FG000|Overall Study|Lack of Qualifying Event|8|||
155260324|NCT00246337|560385879|FG001|Overall Study|Lack of Qualifying Event|2|||
155260325|NCT00246337|560385880|FG002|Overall Study|Lack of Qualifying Event|1|||
155260326|NCT00246337|560385881|FG003|Overall Study|Lack of Qualifying Event|1|||
155260327|NCT00246337|560385882|FG004|Overall Study|Lack of Qualifying Event|1|||
155260328|NCT00246337|560385883|FG005|Overall Study|Lack of Qualifying Event|3|||
155260329|NCT00246337|560385884|FG006|Overall Study|Lack of Qualifying Event|3|||
155260330|NCT00246337|560385885|FG007|Overall Study|Lack of Qualifying Event|2|||
155260331|NCT00246337|560385886|FG008|Overall Study|Lack of Qualifying Event|5|||
155260332|NCT00246337|560385878|FG000|Overall Study|Site Terminated|10|||
155260333|NCT00246337|560385879|FG001|Overall Study|Site Terminated|0|||
155260334|NCT00246337|560385880|FG002|Overall Study|Site Terminated|0|||
155260335|NCT00246337|560385881|FG003|Overall Study|Site Terminated|0|||
155260336|NCT00246337|560385882|FG004|Overall Study|Site Terminated|0|||
155260337|NCT00246337|560385883|FG005|Overall Study|Site Terminated|7|||
155260338|NCT00246337|560385884|FG006|Overall Study|Site Terminated|1|||
155260339|NCT00246337|560385885|FG007|Overall Study|Site Terminated|6|||
155260340|NCT00246337|560385886|FG008|Overall Study|Site Terminated|2|||
155260341|NCT00246337|560385878|FG000|Overall Study|Abnormal baseline lab values|7|||
155260342|NCT00246337|560385879|FG001|Overall Study|Abnormal baseline lab values|0|||
155260343|NCT00246337|560385880|FG002|Overall Study|Abnormal baseline lab values|2|||
155260344|NCT00246337|560385881|FG003|Overall Study|Abnormal baseline lab values|0|||
155260345|NCT00246337|560385882|FG004|Overall Study|Abnormal baseline lab values|0|||
155260346|NCT00246337|560385883|FG005|Overall Study|Abnormal baseline lab values|2|||
155260347|NCT00246337|560385884|FG006|Overall Study|Abnormal baseline lab values|2|||
155260348|NCT00246337|560385885|FG007|Overall Study|Abnormal baseline lab values|0|||
155260349|NCT00246337|560385886|FG008|Overall Study|Abnormal baseline lab values|4|||
155260350|NCT00246337|560385878|FG000|Overall Study|Overwhelmed|0|||
155260351|NCT00246337|560385879|FG001|Overall Study|Overwhelmed|0|||
155260352|NCT00246337|560385880|FG002|Overall Study|Overwhelmed|0|||
155260353|NCT00246337|560385881|FG003|Overall Study|Overwhelmed|0|||
155260354|NCT00246337|560385882|FG004|Overall Study|Overwhelmed|0|||
155260355|NCT00246337|560385883|FG005|Overall Study|Overwhelmed|1|||
155260356|NCT00246337|560385884|FG006|Overall Study|Overwhelmed|0|||
155260357|NCT00246337|560385885|FG007|Overall Study|Overwhelmed|0|||
155260358|NCT00246337|560385886|FG008|Overall Study|Overwhelmed|0|||
155260359|NCT00246337|560385878|FG000|Overall Study|Protocol Violator|1|||
155260360|NCT00246337|560385879|FG001|Overall Study|Protocol Violator|0|||
155260361|NCT00246337|560385880|FG002|Overall Study|Protocol Violator|0|||
155260362|NCT00246337|560385881|FG003|Overall Study|Protocol Violator|0|||
155260363|NCT00246337|560385882|FG004|Overall Study|Protocol Violator|0|||
155260364|NCT00246337|560385883|FG005|Overall Study|Protocol Violator|0|||
155260365|NCT00246337|560385884|FG006|Overall Study|Protocol Violator|0|||
155260366|NCT00246337|560385885|FG007|Overall Study|Protocol Violator|0|||
155260367|NCT00246337|560385886|FG008|Overall Study|Protocol Violator|0|||
155260368|NCT00246337|560385878|FG000|Overall Study|Reported as completing trial in error|0|||
155260369|NCT00246337|560385879|FG001|Overall Study|Reported as completing trial in error|0|||
155260370|NCT00246337|560385880|FG002|Overall Study|Reported as completing trial in error|0|||
155260371|NCT00246337|560385881|FG003|Overall Study|Reported as completing trial in error|0|||
155260372|NCT00246337|560385882|FG004|Overall Study|Reported as completing trial in error|0|||
155260373|NCT00246337|560385883|FG005|Overall Study|Reported as completing trial in error|0|||
155260374|NCT00246337|560385884|FG006|Overall Study|Reported as completing trial in error|0|||
155260375|NCT00246337|560385885|FG007|Overall Study|Reported as completing trial in error|1|||
155260376|NCT00246337|560385886|FG008|Overall Study|Reported as completing trial in error|0|||
155260377|NCT02696564|560385889|FG000|Overall Study|Death|1|||
155260378|NCT02696564|560385890|FG001|Overall Study|Death|2|||
155260379|NCT02696564|560385889|FG000|Overall Study|Withdrawal by Subject|3|||
155260380|NCT02696564|560385890|FG001|Overall Study|Withdrawal by Subject|2|||
155260381|NCT02696564|560385889|FG000|Overall Study|Lost to Follow-up|3|||
155260382|NCT02696564|560385890|FG001|Overall Study|Lost to Follow-up|3|||
155260383|NCT02696564|560385889|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
155260384|NCT02696564|560385890|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
155260385|NCT02696564|560385889|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
155260386|NCT02696564|560385890|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
155260387|NCT02696564|560385889|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
155260388|NCT02696564|560385890|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
155260389|NCT02696564|560385889|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
155260390|NCT02696564|560385890|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
155260391|NCT02696564|560385889|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
155260392|NCT02696564|560385890|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
155260393|NCT05267600|560385895|FG000|Overall Study|Adverse Event|1|||
155260394|NCT05267600|560385896|FG001|Overall Study|Adverse Event|4|||
155260395|NCT05267600|560385895|FG000|Overall Study|Death|1|||
155260396|NCT05267600|560385896|FG001|Overall Study|Death|2|||
155260397|NCT05267600|560385895|FG000|Overall Study|Lack of Efficacy|1|||
155260398|NCT05267600|560385896|FG001|Overall Study|Lack of Efficacy|2|||
155260399|NCT05267600|560385895|FG000|Overall Study|Lost to Follow-up|3|||
155260400|NCT05267600|560385896|FG001|Overall Study|Lost to Follow-up|0|||
155260401|NCT05267600|560385895|FG000|Overall Study|Physician Decision|4|||
155260402|NCT05267600|560385896|FG001|Overall Study|Physician Decision|0|||
155260403|NCT05267600|560385895|FG000|Overall Study|Treatment Unblinded|0|||
155260404|NCT05267600|560385896|FG001|Overall Study|Treatment Unblinded|1|||
155260405|NCT05267600|560385895|FG000|Overall Study|Withdrawal by Subject|5|||
155260406|NCT05267600|560385896|FG001|Overall Study|Withdrawal by Subject|4|||
155260407|NCT03633929|560385897|FG000|Overall Study|Lost to Follow-up|1|||
155260408|NCT03633929|560385897|FG000|Overall Study|Did not login to software. Did not participate|3|||
155260409|NCT00106184|560385902|FG000|Overall Study|Withdrawal by Subject|3|||
155260410|NCT00106184|560385903|FG001|Overall Study|Withdrawal by Subject|2|||
155260411|NCT01722162|560385904|FG000|Overall Study|Withdrawal by Subject|1|||
155260412|NCT01722162|560385905|FG001|Overall Study|Withdrawal by Subject|1|||
155260413|NCT01722162|560385904|FG000|Overall Study|Found ineligible|1|||
155260414|NCT01722162|560385905|FG001|Overall Study|Found ineligible|0|||
155260415|NCT01722162|560385904|FG000|Overall Study|Unrelated to study adverse event|2|||
155260416|NCT01722162|560385905|FG001|Overall Study|Unrelated to study adverse event|2|||
155260417|NCT01722162|560385904|FG000|Overall Study|Adverse Event|1|||
155260418|NCT01722162|560385905|FG001|Overall Study|Adverse Event|1|||
155260419|NCT01722162|560385904|FG000|Overall Study|Insurance denial post enrollment|0|||
155260420|NCT01722162|560385905|FG001|Overall Study|Insurance denial post enrollment|1|||
155260421|NCT01722162|560385904|FG000|Overall Study|Noncompliance|0|||
155260422|NCT01722162|560385905|FG001|Overall Study|Noncompliance|1|||
155260423|NCT05292534|560385906|FG000|Overall Study|Protocol Violation|3|||
155260424|NCT05292534|560385907|FG001|Overall Study|Protocol Violation|4|||
155260425|NCT05292534|560385906|FG000|Overall Study|Withdrawal by Subject|0|||
155260426|NCT05292534|560385907|FG001|Overall Study|Withdrawal by Subject|1|||
155260427|NCT01538472|560385908|FG000|Overall Study|Disease Progression|3|||
155260428|NCT01538472|560385908|FG000|Overall Study|Death|1|||
155260429|NCT02309112|560385909|FG000|Overall Study|Withdrawal by Subject|1|||
155260430|NCT02309112|560385910|FG001|Overall Study|Withdrawal by Subject|0|||
155260431|NCT02309112|560385911|FG002|Overall Study|Withdrawal by Subject|1|||
155260432|NCT02309112|560385909|FG000|Overall Study|Lost to Follow-up|0|||
155260433|NCT02309112|560385910|FG001|Overall Study|Lost to Follow-up|1|||
155260434|NCT02309112|560385911|FG002|Overall Study|Lost to Follow-up|0|||
155260435|NCT01889186|560385912|FG000|Overall Study|Adverse event- not related to progression|18|||
155260436|NCT01889186|560385913|FG001|Overall Study|Adverse event- not related to progression|5|||
155260437|NCT01889186|560385912|FG000|Overall Study|Adverse event- related to progression|7|||
155260438|NCT01889186|560385913|FG001|Overall Study|Adverse event- related to progression|2|||
155260439|NCT01889186|560385912|FG000|Overall Study|COVID-19 logistical restrictions|1|||
155260440|NCT01889186|560385913|FG001|Overall Study|COVID-19 logistical restrictions|0|||
155260441|NCT01889186|560385912|FG000|Overall Study|Investigator request|1|||
155260442|NCT01889186|560385913|FG001|Overall Study|Investigator request|1|||
155260443|NCT01889186|560385912|FG000|Overall Study|Progressive disease- Richter's|12|||
155260444|NCT01889186|560385913|FG001|Overall Study|Progressive disease- Richter's|7|||
155260445|NCT01889186|560385912|FG000|Overall Study|Progressive disease per protocol|46|||
155260446|NCT01889186|560385913|FG001|Overall Study|Progressive disease per protocol|17|||
155260447|NCT01889186|560385912|FG000|Overall Study|Stem cell transplant|2|||
155260448|NCT01889186|560385913|FG001|Overall Study|Stem cell transplant|1|||
155260449|NCT01889186|560385912|FG000|Overall Study|Withdrew consent|2|||
155260450|NCT01889186|560385913|FG001|Overall Study|Withdrew consent|3|||
155260451|NCT01889186|560385912|FG000|Overall Study|Other, not specified|18|||
155260452|NCT01889186|560385913|FG001|Overall Study|Other, not specified|15|||
155260453|NCT01896869|560385915|FG000|Overall Study|Withdrawal by Subject|0|||
155260454|NCT01896869|560385916|FG001|Overall Study|Withdrawal by Subject|6|||
155260455|NCT01896869|560385915|FG000|Overall Study|Lost to Follow-up|1|||
155260456|NCT01896869|560385916|FG001|Overall Study|Lost to Follow-up|0|||
155260457|NCT00454571|560385924|FG000|Overall Study|Adverse Event|2|||
155260458|NCT00454571|560385925|FG001|Overall Study|Adverse Event|0|||
155260459|NCT00454571|560385924|FG000|Overall Study|Physician Decision|0|||
155260460|NCT00454571|560385925|FG001|Overall Study|Physician Decision|1|||
155260461|NCT00454571|560385924|FG000|Overall Study|Protocol Violation|1|||
155260462|NCT00454571|560385925|FG001|Overall Study|Protocol Violation|0|||
155260463|NCT00454571|560385924|FG000|Overall Study|Withdrawal by Subject|10|||
155260464|NCT00454571|560385925|FG001|Overall Study|Withdrawal by Subject|5|||
155260465|NCT01960725|560385926|FG000|Overall Study|Lost to Follow-up|4|||
155260466|NCT01960725|560385927|FG001|Overall Study|Lost to Follow-up|3|||
155260467|NCT01960725|560385926|FG000|Overall Study|Withdrawal by Subject|1|||
155260468|NCT01960725|560385927|FG001|Overall Study|Withdrawal by Subject|0|||
155260469|NCT01960725|560385926|FG000|Overall Study|unable to obtain blood sample|1|||
155260470|NCT01960725|560385927|FG001|Overall Study|unable to obtain blood sample|2|||
155260471|NCT01058304|560385930|FG000|Overall Study|Withdrawal by Subject|8|||
155260472|NCT01058304|560385931|FG001|Overall Study|Withdrawal by Subject|5|||
155260473|NCT01058304|560385930|FG000|Overall Study|Lost to Follow-up|13|||
155260474|NCT01058304|560385931|FG001|Overall Study|Lost to Follow-up|16|||
155260475|NCT01058304|560385930|FG000|Overall Study|Developed exclusion criterion|6|||
155260476|NCT01058304|560385931|FG001|Overall Study|Developed exclusion criterion|12|||
155260477|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Adverse Event|176|||
155260478|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Adverse Event|0|||
155260479|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Adverse Event|0|||
155260480|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Adverse Event|0|||
155260481|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Adverse Event|0|||
155260482|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Adverse Event|0|||
155260483|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Adverse Event|0|||
155260484|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Adverse Event|0|||
155260485|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
155260486|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
155260487|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
155260488|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
155260489|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
155260490|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
155260491|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
155260492|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
155260493|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
155260494|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260495|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260496|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260497|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260498|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260499|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260500|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260501|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260502|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
155260503|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
155260504|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
155260505|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
155260506|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260507|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260508|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260509|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260510|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
155260511|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
155260512|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
155260513|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
155260514|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260515|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260516|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260517|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
155260518|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
155260519|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
155260520|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
155260521|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
155260522|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
155260523|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
155260524|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
155260525|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
155260526|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
155260527|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
155260528|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
155260529|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
155260530|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
155260531|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
155260532|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
155260533|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260534|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
155260535|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
155260536|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
155260537|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
155260538|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260539|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260540|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260541|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260542|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
155260543|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
155260544|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260545|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260546|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260547|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260548|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260549|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260550|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
155260551|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260552|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
155260553|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
155260554|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260555|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260556|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260557|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260558|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
155260559|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260560|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260561|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260562|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260563|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260564|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260565|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260566|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260567|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260568|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260569|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260570|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
155260571|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260572|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
155260573|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260574|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260575|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260576|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260577|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260578|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
155260579|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
155260580|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
155260581|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Death|0|||
155260582|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Death|0|||
155260583|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Death|0|||
155260584|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Death|0|||
155260585|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Death|0|||
155260586|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Death|0|||
155260587|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Death|1|||
155260588|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Death|2|||
155260589|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260590|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260591|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260592|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260593|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260594|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260595|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260596|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260597|NCT04035200|560385940|FG000|Overall Study|Lost to Follow-up|0|||
155260598|NCT04035200|560385941|FG001|Overall Study|Lost to Follow-up|1|||
155260599|NCT04035200|560385942|FG002|Overall Study|Lost to Follow-up|0|||
155260600|NCT04035200|560385940|FG000|Overall Study|Withdrawal by Subject|1|||
155260601|NCT04035200|560385941|FG001|Overall Study|Withdrawal by Subject|4|||
155260602|NCT04035200|560385942|FG002|Overall Study|Withdrawal by Subject|4|||
155260603|NCT04035200|560385940|FG000|Overall Study|COVID-19|1|||
155260604|NCT04035200|560385941|FG001|Overall Study|COVID-19|0|||
155260605|NCT04035200|560385942|FG002|Overall Study|COVID-19|0|||
155260606|NCT04035200|560385940|FG000|Overall Study|Early Termination|0|||
155260607|NCT04035200|560385941|FG001|Overall Study|Early Termination|1|||
155260608|NCT04035200|560385942|FG002|Overall Study|Early Termination|0|||
155260609|NCT04035200|560385940|FG000|Overall Study|Non-compliance|0|||
155260610|NCT04035200|560385941|FG001|Overall Study|Non-compliance|1|||
155260611|NCT04035200|560385942|FG002|Overall Study|Non-compliance|0|||
155260612|NCT01089374|560385943|FG000|Overall Study|Lost to Follow-up|3|||
155260613|NCT01089374|560385944|FG001|Overall Study|Lost to Follow-up|0|||
155260614|NCT01089374|560385943|FG000|Overall Study|Withdrawal by Subject|1|||
155260615|NCT01089374|560385944|FG001|Overall Study|Withdrawal by Subject|0|||
155260616|NCT01089374|560385943|FG000|Overall Study|Study closed early - low accrual|6|||
155260617|NCT01089374|560385944|FG001|Overall Study|Study closed early - low accrual|0|||
155260618|NCT03641313|560385953|FG000|Overall Study|Death|1|||
155260619|NCT03641313|560385953|FG000|Overall Study|Withdrawal by Subject|2|||
155260620|NCT03641313|560385953|FG000|Overall Study|Declining health|1|||
155260621|NCT03641313|560385953|FG000|Overall Study|Adverse Event|1|||
155260622|NCT03033225|560385954|FG000|Overall Study|Withdrawal by Subject|5|||
155260623|NCT05163522|560385955|FG000|Overall Study|Withdrawal by Subject|0|||
155260624|NCT05163522|560385956|FG001|Overall Study|Withdrawal by Subject|0|||
155260625|NCT05163522|560385957|FG002|Overall Study|Withdrawal by Subject|1|||
155260626|NCT05163522|560385958|FG003|Overall Study|Withdrawal by Subject|0|||
155260627|NCT05163522|560385959|FG004|Overall Study|Withdrawal by Subject|0|||
155260628|NCT05163522|560385960|FG005|Overall Study|Withdrawal by Subject|0|||
155260629|NCT05163522|560385961|FG006|Overall Study|Withdrawal by Subject|0|||
155260630|NCT05163522|560385962|FG007|Overall Study|Withdrawal by Subject|0|||
155260631|NCT05163522|560385963|FG008|Overall Study|Withdrawal by Subject|0|||
155260632|NCT05163522|560385964|FG009|Overall Study|Withdrawal by Subject|0|||
155260633|NCT05163522|560385965|FG010|Overall Study|Withdrawal by Subject|0|||
155260634|NCT03937219|560385968|FG000|Overall Study|Death|223|||
155260635|NCT03937219|560385969|FG001|Overall Study|Death|211|||
155260636|NCT03937219|560385968|FG000|Overall Study|Withdrawal by Subject|17|||
155260637|NCT03937219|560385969|FG001|Overall Study|Withdrawal by Subject|25|||
155260638|NCT03937219|560385968|FG000|Overall Study|Lost to Follow-up|3|||
155260639|NCT03937219|560385969|FG001|Overall Study|Lost to Follow-up|4|||
155260640|NCT00031486|560385975|FG000|Overall Study|Adverse Event|1|||
155260641|NCT00031486|560385976|FG001|Overall Study|Adverse Event|0|||
155260642|NCT00031486|560385975|FG000|Overall Study|Lost to Follow-up|0|||
155260643|NCT00031486|560385976|FG001|Overall Study|Lost to Follow-up|1|||
155260644|NCT00031486|560385975|FG000|Overall Study|Withdrawal by Subject|3|||
155260645|NCT00031486|560385976|FG001|Overall Study|Withdrawal by Subject|2|||
155260646|NCT00031486|560385975|FG000|Overall Study|Death|0|||
155260647|NCT00031486|560385976|FG001|Overall Study|Death|3|||
155260648|NCT00031486|560385975|FG000|Overall Study|Non-compliant|0|||
155260649|NCT00031486|560385976|FG001|Overall Study|Non-compliant|4|||
155260650|NCT00031486|560385975|FG000|Overall Study|Did not meet eligibility requirement|2|||
155260651|NCT00031486|560385976|FG001|Overall Study|Did not meet eligibility requirement|1|||
155260652|NCT00031486|560385975|FG000|Overall Study|Other|1|||
155260653|NCT00031486|560385976|FG001|Overall Study|Other|1|||
155260654|NCT03685591|560385979|FG000|Overall Study|Global Deterioration of Health Status|0|||
155260655|NCT03685591|560385980|FG001|Overall Study|Global Deterioration of Health Status|0|||
155260656|NCT03685591|560385981|FG002|Overall Study|Global Deterioration of Health Status|0|||
155260657|NCT03685591|560385982|FG003|Overall Study|Global Deterioration of Health Status|1|||
155260658|NCT03685591|560385983|FG004|Overall Study|Global Deterioration of Health Status|2|||
155260659|NCT03685591|560385984|FG005|Overall Study|Global Deterioration of Health Status|4|||
155260660|NCT03685591|560385985|FG006|Overall Study|Global Deterioration of Health Status|1|||
155260661|NCT03685591|560385986|FG007|Overall Study|Global Deterioration of Health Status|1|||
155260662|NCT03685591|560385987|FG008|Overall Study|Global Deterioration of Health Status|0|||
155260663|NCT03685591|560385979|FG000|Overall Study|Progressive Disease|1|||
155260664|NCT03685591|560385980|FG001|Overall Study|Progressive Disease|1|||
155260665|NCT03685591|560385981|FG002|Overall Study|Progressive Disease|0|||
155260666|NCT03685591|560385982|FG003|Overall Study|Progressive Disease|3|||
155260667|NCT03685591|560385983|FG004|Overall Study|Progressive Disease|5|||
155260668|NCT03685591|560385984|FG005|Overall Study|Progressive Disease|4|||
155260669|NCT03685591|560385985|FG006|Overall Study|Progressive Disease|3|||
155260670|NCT03685591|560385986|FG007|Overall Study|Progressive Disease|2|||
155260671|NCT03685591|560385987|FG008|Overall Study|Progressive Disease|1|||
155260672|NCT03685591|560385979|FG000|Overall Study|Other|0|||
155260673|NCT03685591|560385980|FG001|Overall Study|Other|0|||
155260674|NCT03685591|560385981|FG002|Overall Study|Other|1|||
155260675|NCT03685591|560385982|FG003|Overall Study|Other|0|||
155260676|NCT03685591|560385983|FG004|Overall Study|Other|2|||
155260677|NCT03685591|560385984|FG005|Overall Study|Other|3|||
155260678|NCT03685591|560385985|FG006|Overall Study|Other|0|||
155260679|NCT03685591|560385986|FG007|Overall Study|Other|0|||
155260680|NCT03685591|560385987|FG008|Overall Study|Other|0|||
155260681|NCT03685591|560385979|FG000|Overall Study|Withdrawal by Subject|0|||
155260682|NCT03685591|560385980|FG001|Overall Study|Withdrawal by Subject|0|||
155260683|NCT03685591|560385981|FG002|Overall Study|Withdrawal by Subject|0|||
155260684|NCT03685591|560385982|FG003|Overall Study|Withdrawal by Subject|0|||
155260685|NCT03685591|560385983|FG004|Overall Study|Withdrawal by Subject|3|||
155260686|NCT03685591|560385984|FG005|Overall Study|Withdrawal by Subject|2|||
155260687|NCT03685591|560385985|FG006|Overall Study|Withdrawal by Subject|0|||
155260688|NCT03685591|560385986|FG007|Overall Study|Withdrawal by Subject|0|||
155260689|NCT03685591|560385987|FG008|Overall Study|Withdrawal by Subject|1|||
155260690|NCT03685591|560385979|FG000|Overall Study|Adverse Event|0|||
155260691|NCT03685591|560385980|FG001|Overall Study|Adverse Event|0|||
155260692|NCT03685591|560385981|FG002|Overall Study|Adverse Event|0|||
155260693|NCT03685591|560385982|FG003|Overall Study|Adverse Event|1|||
155260694|NCT03685591|560385983|FG004|Overall Study|Adverse Event|1|||
155260695|NCT03685591|560385984|FG005|Overall Study|Adverse Event|4|||
155260696|NCT03685591|560385985|FG006|Overall Study|Adverse Event|0|||
155260697|NCT03685591|560385986|FG007|Overall Study|Adverse Event|1|||
155260698|NCT03685591|560385987|FG008|Overall Study|Adverse Event|1|||
155260699|NCT01685138|560385988|FG000|Overall Study|Lost to Follow-up|1|||
155260700|NCT01685138|560385988|FG000|Overall Study|Protocol Violation|1|||
155260701|NCT01685138|560385988|FG000|Overall Study|No longer requires treatment|1|||
155260702|NCT01685138|560385988|FG000|Overall Study|Subject/guardian decision|2|||
155260703|NCT01685138|560385988|FG000|Overall Study|Physician Decision|6|||
155260704|NCT01685138|560385988|FG000|Overall Study|Death|10|||
155260705|NCT01685138|560385988|FG000|Overall Study|Adverse Event|18|||
155260706|NCT01685138|560385988|FG000|Overall Study|Progressive disease|53|||
155260707|NCT03988166|560385991|FG000|Overall Study|Lost to Follow-up|2|||
155260708|NCT03988166|560385991|FG000|Overall Study|Death|1|||
155260709|NCT02703922|560385993|FG000|Overall Study|Death|5|||
155260710|NCT02703922|560385994|FG001|Overall Study|Death|8|||
155260711|NCT02703922|560385993|FG000|Overall Study|Lost to Follow-up|10|||
155260712|NCT02703922|560385994|FG001|Overall Study|Lost to Follow-up|10|||
155260713|NCT05805657|560386001|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
155260714|NCT05805657|560386002|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
155260715|NCT04058353|560386003|FG000|Overall Study|Adverse Event|2|||
155260716|NCT04058353|560386004|FG001|Overall Study|Adverse Event|1|||
155260717|NCT04058353|560386003|FG000|Overall Study|Physician Decision|1|||
155260718|NCT04058353|560386004|FG001|Overall Study|Physician Decision|0|||
155260719|NCT04058353|560386003|FG000|Overall Study|Other|1|||
155260720|NCT04058353|560386004|FG001|Overall Study|Other|0|||
155260721|NCT00316173|560386007|FG000|Run-in Phase|Adverse Event|1|||
155260722|NCT00316173|560386008|FG001|Run-in Phase|Adverse Event|0|||
155260723|NCT00316173|560386007|FG000|Run-in Phase|Protocol Violation|1|||
155260724|NCT00316173|560386008|FG001|Run-in Phase|Protocol Violation|0|||
155260725|NCT00316173|560386007|FG000|Run-in Phase|Study Follow-up Stopped|5|||
155260726|NCT00316173|560386008|FG001|Run-in Phase|Study Follow-up Stopped|0|||
155260727|NCT00316173|560386007|FG000|Treatment Phase|Adverse Event|0|||
155260728|NCT00316173|560386008|FG001|Treatment Phase|Adverse Event|1|||
155260729|NCT00316173|560386007|FG000|Treatment Phase|Lack of Efficacy|0|||
155260730|NCT00316173|560386008|FG001|Treatment Phase|Lack of Efficacy|3|||
155260731|NCT00316173|560386007|FG000|Treatment Phase|Lost to Follow-up|0|||
155260732|NCT00316173|560386008|FG001|Treatment Phase|Lost to Follow-up|3|||
155260733|NCT00316173|560386007|FG000|Treatment Phase|Withdrawal by Subject|0|||
155260734|NCT00316173|560386008|FG001|Treatment Phase|Withdrawal by Subject|1|||
155260735|NCT00316173|560386007|FG000|Treatment Phase|Study Follow-up Stopped|0|||
155260736|NCT00316173|560386008|FG001|Treatment Phase|Study Follow-up Stopped|34|||
155260737|NCT02390531|560386009|FG000|Overall Study|Death|0|||
155260738|NCT02390531|560386010|FG001|Overall Study|Death|2|||
155260739|NCT02390531|560386011|FG002|Overall Study|Death|0|||
155260740|NCT02390531|560386012|FG003|Overall Study|Death|1|||
155260741|NCT02390531|560386013|FG004|Overall Study|Death|0|||
155260742|NCT02390531|560386014|FG005|Overall Study|Death|0|||
155260743|NCT02390531|560386015|FG006|Overall Study|Death|0|||
155260744|NCT02390531|560386016|FG007|Overall Study|Death|1|||
155260745|NCT02390531|560386009|FG000|Overall Study|Protocol Violation|0|||
155260746|NCT02390531|560386010|FG001|Overall Study|Protocol Violation|0|||
155260747|NCT02390531|560386011|FG002|Overall Study|Protocol Violation|0|||
155260748|NCT02390531|560386012|FG003|Overall Study|Protocol Violation|0|||
155260749|NCT02390531|560386013|FG004|Overall Study|Protocol Violation|1|||
155260750|NCT02390531|560386014|FG005|Overall Study|Protocol Violation|0|||
155260751|NCT02390531|560386015|FG006|Overall Study|Protocol Violation|2|||
155260752|NCT02390531|560386016|FG007|Overall Study|Protocol Violation|0|||
155260753|NCT03779906|560386017|FG000|Overall Study|Lost to Follow-up|7|||
155260754|NCT03779906|560386017|FG000|Overall Study|COVID pandemic|1|||
155260755|NCT00847405|560387695|FG000|First Intervention|Adverse Event|0|||
155260756|NCT00847405|560387696|FG001|First Intervention|Adverse Event|1|||
155260757|NCT00847405|560387695|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155260758|NCT00847405|560387696|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155260759|NCT02790073|560387699|FG000|Overall Study|Death|1|||
155260760|NCT02790073|560387699|FG000|Overall Study|Withdrawal from HD|1|||
155260761|NCT02790073|560387699|FG000|Overall Study|Withdrawal by Subject|1|||
155260762|NCT02882282|560387700|FG000|Overall Study|Adverse Event|1|||
155260763|NCT02882282|560387701|FG001|Overall Study|Adverse Event|0|||
155260764|NCT00514683|560387702|FG000|Overall Study|Not treated|2|||
155260765|NCT00514683|560387703|FG001|Overall Study|Not treated|1|||
155260766|NCT00514683|560387704|FG002|Overall Study|Not treated|0|||
155260767|NCT00514683|560387705|FG003|Overall Study|Not treated|0|||
155260768|NCT00514683|560387706|FG004|Overall Study|Not treated|1|||
155260769|NCT00514683|560387702|FG000|Overall Study|Adverse Event|21|||
155260770|NCT00514683|560387703|FG001|Overall Study|Adverse Event|20|||
155260771|NCT00514683|560387704|FG002|Overall Study|Adverse Event|15|||
155260772|NCT00514683|560387705|FG003|Overall Study|Adverse Event|13|||
155260773|NCT00514683|560387706|FG004|Overall Study|Adverse Event|27|||
155260774|NCT00514683|560387702|FG000|Overall Study|Protocol Violation|1|||
155260775|NCT00514683|560387703|FG001|Overall Study|Protocol Violation|1|||
155260776|NCT00514683|560387704|FG002|Overall Study|Protocol Violation|0|||
155260777|NCT00514683|560387705|FG003|Overall Study|Protocol Violation|1|||
155260778|NCT00514683|560387706|FG004|Overall Study|Protocol Violation|0|||
155260779|NCT00514683|560387702|FG000|Overall Study|Withdrawal by Subject|2|||
155260780|NCT00514683|560387703|FG001|Overall Study|Withdrawal by Subject|2|||
155260781|NCT00514683|560387704|FG002|Overall Study|Withdrawal by Subject|1|||
155260782|NCT00514683|560387705|FG003|Overall Study|Withdrawal by Subject|0|||
155260783|NCT00514683|560387706|FG004|Overall Study|Withdrawal by Subject|4|||
155260784|NCT00514683|560387702|FG000|Overall Study|Reason other than listed above|0|||
155260785|NCT00514683|560387703|FG001|Overall Study|Reason other than listed above|1|||
155260786|NCT00514683|560387704|FG002|Overall Study|Reason other than listed above|2|||
155260787|NCT00514683|560387705|FG003|Overall Study|Reason other than listed above|0|||
155260788|NCT00514683|560387706|FG004|Overall Study|Reason other than listed above|1|||
155260789|NCT02487498|560387707|FG000|Period: Period 1|Adverse Event|2|||
155260790|NCT02487498|560387708|FG001|Period: Period 1|Adverse Event|4|||
155260791|NCT02487498|560387707|FG000|Period: Period 1|Subject/guardian decision|2|||
155260792|NCT02487498|560387708|FG001|Period: Period 1|Subject/guardian decision|4|||
155260793|NCT02487498|560387707|FG000|Period: Period 1|Lost to Follow-up|0|||
155260794|NCT02487498|560387708|FG001|Period: Period 1|Lost to Follow-up|2|||
155260795|NCT02487498|560387707|FG000|Period: Period 1|Lack of Efficacy|1|||
155260796|NCT02487498|560387708|FG001|Period: Period 1|Lack of Efficacy|0|||
155260797|NCT02487498|560387707|FG000|Period: Period 1|Physician Decision|0|||
155260798|NCT02487498|560387708|FG001|Period: Period 1|Physician Decision|1|||
155260799|NCT02487498|560387707|FG000|Period: Period 1|Protocol deviation|1|||
155260800|NCT02487498|560387708|FG001|Period: Period 1|Protocol deviation|0|||
155260801|NCT02487498|560387707|FG000|Period: Washout|Subject/guardian decision|0|||
155260802|NCT02487498|560387708|FG001|Period: Washout|Subject/guardian decision|5|||
155260803|NCT02487498|560387707|FG000|Period: Washout|Lack of Efficacy|1|||
155260804|NCT02487498|560387708|FG001|Period: Washout|Lack of Efficacy|1|||
155260805|NCT02487498|560387707|FG000|Period: Washout|Physician Decision|1|||
155260806|NCT02487498|560387708|FG001|Period: Washout|Physician Decision|0|||
155260807|NCT02487498|560387707|FG000|Period: Washout|Non-compliance with study treatment|0|||
155260808|NCT02487498|560387708|FG001|Period: Washout|Non-compliance with study treatment|1|||
155260809|NCT02487498|560387707|FG000|Period: Period 2|Adverse Event|2|||
155260810|NCT02487498|560387708|FG001|Period: Period 2|Adverse Event|2|||
155260811|NCT02487498|560387707|FG000|Period: Period 2|Subject/guardian decision|2|||
155260812|NCT02487498|560387708|FG001|Period: Period 2|Subject/guardian decision|1|||
155260813|NCT02487498|560387707|FG000|Period: Period 2|Lost to Follow-up|1|||
155260814|NCT02487498|560387708|FG001|Period: Period 2|Lost to Follow-up|1|||
155260815|NCT02487498|560387707|FG000|Period: Period 2|Death|0|||
155260816|NCT02487498|560387708|FG001|Period: Period 2|Death|1|||
155260817|NCT02487498|560387707|FG000|Period: Period 2|Physician Decision|1|||
155260818|NCT02487498|560387708|FG001|Period: Period 2|Physician Decision|0|||
155260819|NCT00676130|560387715|FG000|Overall Study|Lost to Follow-up|0|||
155260820|NCT00676130|560387716|FG001|Overall Study|Lost to Follow-up|1|||
155260821|NCT00676130|560387715|FG000|Overall Study|Found ineligible|3|||
155260822|NCT00676130|560387716|FG001|Overall Study|Found ineligible|2|||
155260823|NCT00676130|560387715|FG000|Overall Study|Withdrawal by Subject|0|||
155260824|NCT00676130|560387716|FG001|Overall Study|Withdrawal by Subject|1|||
155260825|NCT01564368|560387717|FG000|Overall Study|Ineligible|18|||
155260826|NCT01564368|560387717|FG000|Overall Study|Not Randomized in Parent study|116|||
155260827|NCT01564368|560387717|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
155260828|NCT01564368|560387717|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
155260829|NCT01802437|560387718|FG000|Overall Study|Lost to Follow-up|1|||
155260830|NCT01802437|560387719|FG001|Overall Study|Lost to Follow-up|0|||
155260831|NCT01802437|560387718|FG000|Overall Study|Withdrawal by Subject|3|||
155260832|NCT01802437|560387719|FG001|Overall Study|Withdrawal by Subject|4|||
155260833|NCT01682213|560387722|FG000|Overall Study|Withdrawal by Subject|2|||
155260834|NCT01181726|560387723|FG000|First Intervention|Adverse Event|1|||
155260835|NCT01181726|560387724|FG001|First Intervention|Adverse Event|0|||
155260836|NCT04998604|560387725|FG000|Overall Study|Adverse Event|3|||
155260837|NCT04998604|560387726|FG001|Overall Study|Adverse Event|2|||
155260838|NCT04998604|560387725|FG000|Overall Study|Withdrawal by Subject|2|||
155260839|NCT04998604|560387726|FG001|Overall Study|Withdrawal by Subject|4|||
155260840|NCT04998604|560387725|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
155260841|NCT04998604|560387726|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
155260842|NCT00429663|560387727|FG000|Overall Study|Lost to Follow-up|24|||
155260843|NCT00429663|560387728|FG001|Overall Study|Lost to Follow-up|31|||
155260844|NCT00429663|560387727|FG000|Overall Study|Physician Decision|6|||
155260845|NCT00429663|560387728|FG001|Overall Study|Physician Decision|3|||
155260846|NCT00429663|560387727|FG000|Overall Study|Withdrawal by Subject|2|||
155260847|NCT00429663|560387728|FG001|Overall Study|Withdrawal by Subject|5|||
155260848|NCT00429663|560387727|FG000|Overall Study|Death|4|||
155260849|NCT00429663|560387728|FG001|Overall Study|Death|0|||
155260850|NCT03261271|560387734|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
155491709|NCT00910000|561225501|FG005|Overall Study|Adverse Event|1|||
155260851|NCT03261271|560387735|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
155260852|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
155260853|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
155260854|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
155260855|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
155260856|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
155260857|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
155260858|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
155260859|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260860|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260861|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260862|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
155260863|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
155260864|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260865|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260866|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260867|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
155260868|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
155260869|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260870|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260871|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260872|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Death|2|||
155260873|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Death|2|||
155260874|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Death|0|||
155260875|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Death|0|||
155260876|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Death|0|||
155260877|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
155260878|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
155260879|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
155260880|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
155260881|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
155260882|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260883|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
155260884|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260885|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260886|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260887|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
155260888|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
155260889|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260890|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260891|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260892|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
155260893|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260894|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260895|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260896|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260897|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
155260898|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260899|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260900|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260901|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260902|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260903|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260904|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260905|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
155260906|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260907|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260908|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260909|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260910|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260911|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
155260912|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
155260913|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
155260914|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
155260915|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
155260916|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
155260917|NCT04067401|560387741|FG000|Overall Study|Withdrawal by Subject|7|||
155260918|NCT04067401|560387742|FG001|Overall Study|Withdrawal by Subject|0|||
155260919|NCT04067401|560387741|FG000|Overall Study|no data provided|1|||
155260920|NCT04067401|560387742|FG001|Overall Study|no data provided|0|||
155260921|NCT02657317|560387743|FG000|Overall Study|Withdrawal by Subject|2|||
155260922|NCT02657317|560387744|FG001|Overall Study|Withdrawal by Subject|0|||
155260923|NCT02657317|560387743|FG000|Overall Study|Lost to Follow-up|3|||
155260924|NCT02657317|560387744|FG001|Overall Study|Lost to Follow-up|3|||
155260925|NCT02857426|560387745|FG000|Overall Study|Disease progression|34|||
155260926|NCT02857426|560387746|FG001|Overall Study|Disease progression|13|||
155260927|NCT02857426|560387745|FG000|Overall Study|Study drug toxicity|4|||
155260928|NCT02857426|560387746|FG001|Overall Study|Study drug toxicity|1|||
155260929|NCT02857426|560387745|FG000|Overall Study|Death|1|||
155260930|NCT02857426|560387746|FG001|Overall Study|Death|0|||
155260931|NCT02857426|560387745|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155260932|NCT02857426|560387746|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155260933|NCT02857426|560387745|FG000|Overall Study|Participant withdrew consent|1|||
155260934|NCT02857426|560387746|FG001|Overall Study|Participant withdrew consent|1|||
155260935|NCT02857426|560387745|FG000|Overall Study|Maximum clinical benefit|1|||
155260936|NCT02857426|560387746|FG001|Overall Study|Maximum clinical benefit|0|||
155260937|NCT02857426|560387745|FG000|Overall Study|Completed treatment|0|||
155260938|NCT02857426|560387746|FG001|Overall Study|Completed treatment|2|||
155260939|NCT02110901|560387747|FG000|Overall Study|Death|6|||
155260940|NCT02110901|560387748|FG001|Overall Study|Death|3|||
155260941|NCT02110901|560387747|FG000|Overall Study|Lost to Follow-up|12|||
155260942|NCT02110901|560387748|FG001|Overall Study|Lost to Follow-up|8|||
155260943|NCT02110901|560387747|FG000|Overall Study|Withdrawal by Subject|7|||
155260944|NCT02110901|560387748|FG001|Overall Study|Withdrawal by Subject|3|||
155260945|NCT02110901|560387747|FG000|Overall Study|received a kidney transplant|5|||
155260946|NCT02110901|560387748|FG001|Overall Study|received a kidney transplant|0|||
155260947|NCT02634788|560387749|FG000|Overall Study|Adverse Event|0|||
155260948|NCT02634788|560387750|FG001|Overall Study|Adverse Event|8|||
155260949|NCT02634788|560387751|FG002|Overall Study|Adverse Event|3|||
155260950|NCT02634788|560387752|FG003|Overall Study|Adverse Event|1|||
155260951|NCT02634788|560387749|FG000|Overall Study|Lack of Efficacy|4|||
155260952|NCT02634788|560387750|FG001|Overall Study|Lack of Efficacy|0|||
155260953|NCT02634788|560387751|FG002|Overall Study|Lack of Efficacy|1|||
155260954|NCT02634788|560387752|FG003|Overall Study|Lack of Efficacy|4|||
155260955|NCT02634788|560387749|FG000|Overall Study|Lost to Follow-up|0|||
155260956|NCT02634788|560387750|FG001|Overall Study|Lost to Follow-up|1|||
155260957|NCT02634788|560387751|FG002|Overall Study|Lost to Follow-up|0|||
155260958|NCT02634788|560387752|FG003|Overall Study|Lost to Follow-up|0|||
155260959|NCT02634788|560387749|FG000|Overall Study|Withdrawal by Subject|0|||
155260960|NCT02634788|560387750|FG001|Overall Study|Withdrawal by Subject|1|||
155260961|NCT02634788|560387751|FG002|Overall Study|Withdrawal by Subject|1|||
155260962|NCT02634788|560387752|FG003|Overall Study|Withdrawal by Subject|0|||
155260963|NCT00758459|560387753|FG000|Overall Study|Adverse Event|3|||
155260964|NCT00758459|560387754|FG001|Overall Study|Adverse Event|2|||
155260965|NCT00758459|560387753|FG000|Overall Study|Protocol Violation|0|||
155260966|NCT00758459|560387754|FG001|Overall Study|Protocol Violation|1|||
155260967|NCT00758459|560387753|FG000|Overall Study|Withdrawal by Subject|0|||
155260968|NCT00758459|560387754|FG001|Overall Study|Withdrawal by Subject|1|||
155260969|NCT00855595|560387766|FG000|Overall Study|Withdrawal by Subject|1|||
155260970|NCT00855595|560387767|FG001|Overall Study|Withdrawal by Subject|2|||
155260971|NCT00855595|560387766|FG000|Overall Study|Lost to Follow-up|3|||
155260972|NCT00855595|560387767|FG001|Overall Study|Lost to Follow-up|3|||
155260973|NCT00855595|560387766|FG000|Overall Study|Adverse Event|1|||
155260974|NCT00855595|560387767|FG001|Overall Study|Adverse Event|1|||
155260975|NCT00855595|560387766|FG000|Overall Study|patient moved out of state|1|||
155260976|NCT00855595|560387767|FG001|Overall Study|patient moved out of state|0|||
155260977|NCT00855595|560387766|FG000|Overall Study|patient left country|0|||
155260978|NCT00855595|560387767|FG001|Overall Study|patient left country|1|||
155260979|NCT01780935|560387768|FG000|Overall Study|Admin problems due to early termination|321|||
155260980|NCT01780935|560387769|FG001|Overall Study|Admin problems due to early termination|309|||
155260981|NCT01780935|560387768|FG000|Overall Study|Adverse Event|2|||
155260982|NCT01780935|560387769|FG001|Overall Study|Adverse Event|4|||
155260983|NCT01780935|560387768|FG000|Overall Study|Death|1|||
155260984|NCT01780935|560387769|FG001|Overall Study|Death|6|||
155260985|NCT01780935|560387768|FG000|Overall Study|Lost to Follow-up|2|||
155260986|NCT01780935|560387769|FG001|Overall Study|Lost to Follow-up|6|||
155260987|NCT01780935|560387768|FG000|Overall Study|Physician Decision|1|||
155260988|NCT01780935|560387769|FG001|Overall Study|Physician Decision|1|||
155260989|NCT01780935|560387768|FG000|Overall Study|Protocol deviation|0|||
155260990|NCT01780935|560387769|FG001|Overall Study|Protocol deviation|1|||
155260991|NCT01780935|560387768|FG000|Overall Study|Patient withdrew consent|8|||
155260992|NCT01780935|560387769|FG001|Overall Study|Patient withdrew consent|9|||
155260993|NCT00611858|560387770|FG000|Overall Study|Adverse Event|2|||
155260994|NCT00611858|560387770|FG000|Overall Study|Withdrawal by Subject|2|||
155260995|NCT01844284|560387771|FG000|Overall Study|Lost to Follow-up|12|||
155260996|NCT01844284|560387772|FG001|Overall Study|Lost to Follow-up|7|||
155260997|NCT01820559|560387773|FG000|Overall Study|Adverse Event|4|||
155260998|NCT01820559|560387774|FG001|Overall Study|Adverse Event|6|||
155260999|NCT01820559|560387775|FG002|Overall Study|Adverse Event|13|||
155261000|NCT01820559|560387773|FG000|Overall Study|Withdrawal by Subject|1|||
155261001|NCT01820559|560387774|FG001|Overall Study|Withdrawal by Subject|2|||
155261002|NCT01820559|560387775|FG002|Overall Study|Withdrawal by Subject|5|||
155261003|NCT01820559|560387773|FG000|Overall Study|Protocol Violation|2|||
155261004|NCT01820559|560387774|FG001|Overall Study|Protocol Violation|1|||
155261005|NCT01820559|560387775|FG002|Overall Study|Protocol Violation|3|||
155261006|NCT01820559|560387773|FG000|Overall Study|Subject's non-compliance|1|||
155261007|NCT01820559|560387774|FG001|Overall Study|Subject's non-compliance|0|||
155261008|NCT01820559|560387775|FG002|Overall Study|Subject's non-compliance|2|||
155261009|NCT01820559|560387773|FG000|Overall Study|Lost to Follow-up|3|||
155261010|NCT01820559|560387774|FG001|Overall Study|Lost to Follow-up|2|||
155261011|NCT01820559|560387775|FG002|Overall Study|Lost to Follow-up|2|||
155261012|NCT01820559|560387773|FG000|Overall Study|At sponsor request|0|||
155261013|NCT01820559|560387774|FG001|Overall Study|At sponsor request|0|||
155261014|NCT01820559|560387775|FG002|Overall Study|At sponsor request|1|||
155261015|NCT01820559|560387773|FG000|Overall Study|Lack of Efficacy|3|||
155261016|NCT01820559|560387774|FG001|Overall Study|Lack of Efficacy|2|||
155261017|NCT01820559|560387775|FG002|Overall Study|Lack of Efficacy|3|||
155261018|NCT02755597|560387776|FG000|Overall Study|Withdrew consent|27|||
155261019|NCT02755597|560387777|FG001|Overall Study|Withdrew consent|11|||
155261020|NCT02755597|560387776|FG000|Overall Study|Lost to Follow-up|1|||
155261021|NCT02755597|560387777|FG001|Overall Study|Lost to Follow-up|0|||
155261022|NCT02755597|560387776|FG000|Overall Study|Death|78|||
155261023|NCT02755597|560387777|FG001|Overall Study|Death|36|||
155261024|NCT02755597|560387776|FG000|Overall Study|Study terminated by Sponsor|67|||
155261025|NCT02755597|560387777|FG001|Overall Study|Study terminated by Sponsor|47|||
155261026|NCT02755597|560387776|FG000|Overall Study|Other, not specified|20|||
155261027|NCT02755597|560387777|FG001|Overall Study|Other, not specified|3|||
155261028|NCT02755597|560387776|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
155261029|NCT02755597|560387777|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
155261030|NCT00166296|560387778|FG000|Overall Study|Withdrawal by Subject|1|||
155261031|NCT00166296|560387779|FG001|Overall Study|Withdrawal by Subject|3|||
155261032|NCT00166296|560387778|FG000|Overall Study|Adverse Event|2|||
155261033|NCT00166296|560387779|FG001|Overall Study|Adverse Event|4|||
155261034|NCT00166296|560387778|FG000|Overall Study|Lost to Follow-up|4|||
155261035|NCT00166296|560387779|FG001|Overall Study|Lost to Follow-up|2|||
155261036|NCT03351738|560387780|FG000|Overall Study|Withdrawal by Subject|0|||
155261037|NCT03351738|560387781|FG001|Overall Study|Withdrawal by Subject|1|||
155261038|NCT03351738|560387782|FG002|Overall Study|Withdrawal by Subject|0|||
155261039|NCT03351738|560387783|FG003|Overall Study|Withdrawal by Subject|1|||
155261040|NCT03351738|560387784|FG004|Overall Study|Withdrawal by Subject|0|||
155261041|NCT03351738|560387785|FG005|Overall Study|Withdrawal by Subject|0|||
155261042|NCT02597036|560387788|FG000|Overall Study|Progressive Disease|0|||
155261043|NCT02597036|560387789|FG001|Overall Study|Progressive Disease|0|||
155261044|NCT02597036|560387790|FG002|Overall Study|Progressive Disease|0|||
155261045|NCT02597036|560387791|FG003|Overall Study|Progressive Disease|0|||
155261046|NCT02597036|560387792|FG004|Overall Study|Progressive Disease|1|||
155261047|NCT02597036|560387793|FG005|Overall Study|Progressive Disease|1|||
155261048|NCT02597036|560387794|FG006|Overall Study|Progressive Disease|1|||
155261049|NCT02597036|560387795|FG007|Overall Study|Progressive Disease|0|||
155261050|NCT02597036|560387796|FG008|Overall Study|Progressive Disease|0|||
155261051|NCT02597036|560387797|FG009|Overall Study|Progressive Disease|0|||
155261052|NCT02597036|560387798|FG010|Overall Study|Progressive Disease|0|||
155261053|NCT02597036|560387799|FG011|Overall Study|Progressive Disease|0|||
155261054|NCT02597036|560387788|FG000|Overall Study|Adverse Event|0|||
155261055|NCT02597036|560387789|FG001|Overall Study|Adverse Event|0|||
155261056|NCT02597036|560387790|FG002|Overall Study|Adverse Event|0|||
155261057|NCT02597036|560387791|FG003|Overall Study|Adverse Event|0|||
155261058|NCT02597036|560387792|FG004|Overall Study|Adverse Event|0|||
155261059|NCT02597036|560387793|FG005|Overall Study|Adverse Event|0|||
155261060|NCT02597036|560387794|FG006|Overall Study|Adverse Event|0|||
155261061|NCT02597036|560387795|FG007|Overall Study|Adverse Event|1|||
155261062|NCT02597036|560387796|FG008|Overall Study|Adverse Event|0|||
155261063|NCT02597036|560387797|FG009|Overall Study|Adverse Event|0|||
155261064|NCT02597036|560387798|FG010|Overall Study|Adverse Event|0|||
155261065|NCT02597036|560387799|FG011|Overall Study|Adverse Event|1|||
155261066|NCT02597036|560387788|FG000|Overall Study|Death|0|||
155261067|NCT02597036|560387789|FG001|Overall Study|Death|0|||
155261068|NCT02597036|560387790|FG002|Overall Study|Death|0|||
155261069|NCT02597036|560387791|FG003|Overall Study|Death|0|||
155261070|NCT02597036|560387792|FG004|Overall Study|Death|0|||
155261071|NCT02597036|560387793|FG005|Overall Study|Death|0|||
155261072|NCT02597036|560387794|FG006|Overall Study|Death|0|||
155261073|NCT02597036|560387795|FG007|Overall Study|Death|0|||
155261074|NCT02597036|560387796|FG008|Overall Study|Death|0|||
155261075|NCT02597036|560387797|FG009|Overall Study|Death|1|||
155261076|NCT02597036|560387798|FG010|Overall Study|Death|1|||
155261077|NCT02597036|560387799|FG011|Overall Study|Death|0|||
155261078|NCT02597036|560387788|FG000|Overall Study|Lost to Follow-up|0|||
155261079|NCT02597036|560387789|FG001|Overall Study|Lost to Follow-up|0|||
155261080|NCT02597036|560387790|FG002|Overall Study|Lost to Follow-up|0|||
155261081|NCT02597036|560387791|FG003|Overall Study|Lost to Follow-up|0|||
155261082|NCT02597036|560387792|FG004|Overall Study|Lost to Follow-up|0|||
155261083|NCT02597036|560387793|FG005|Overall Study|Lost to Follow-up|0|||
155261084|NCT02597036|560387794|FG006|Overall Study|Lost to Follow-up|0|||
155261085|NCT02597036|560387795|FG007|Overall Study|Lost to Follow-up|0|||
155261086|NCT02597036|560387796|FG008|Overall Study|Lost to Follow-up|0|||
155261087|NCT02597036|560387797|FG009|Overall Study|Lost to Follow-up|0|||
155261088|NCT02597036|560387798|FG010|Overall Study|Lost to Follow-up|1|||
155261089|NCT02597036|560387799|FG011|Overall Study|Lost to Follow-up|0|||
155261090|NCT02597036|560387788|FG000|Overall Study|Withdrawal by Subject|0|||
155261091|NCT02597036|560387789|FG001|Overall Study|Withdrawal by Subject|0|||
155261092|NCT02597036|560387790|FG002|Overall Study|Withdrawal by Subject|0|||
155261093|NCT02597036|560387791|FG003|Overall Study|Withdrawal by Subject|0|||
155261094|NCT02597036|560387792|FG004|Overall Study|Withdrawal by Subject|0|||
155261095|NCT02597036|560387793|FG005|Overall Study|Withdrawal by Subject|0|||
155261096|NCT02597036|560387794|FG006|Overall Study|Withdrawal by Subject|0|||
155261097|NCT02597036|560387795|FG007|Overall Study|Withdrawal by Subject|0|||
155261098|NCT02597036|560387796|FG008|Overall Study|Withdrawal by Subject|0|||
155261099|NCT02597036|560387797|FG009|Overall Study|Withdrawal by Subject|0|||
155261100|NCT02597036|560387798|FG010|Overall Study|Withdrawal by Subject|0|||
155261101|NCT02597036|560387799|FG011|Overall Study|Withdrawal by Subject|1|||
155261102|NCT06351371|560387800|FG000|Overall Study|Mutation Status Not Confirmed|9|||
155261103|NCT06351371|560387800|FG000|Overall Study|Ineligible|1|||
155261104|NCT06351371|560387800|FG000|Overall Study|Adverse Event|4|||
155261105|NCT06351371|560387800|FG000|Overall Study|Death|1|||
155261106|NCT06351371|560387800|FG000|Overall Study|Disease progression|14|||
155261107|NCT06351371|560387800|FG000|Overall Study|Withdrawal by Subject|3|||
155261108|NCT06351371|560387800|FG000|Overall Study|Physician Decision|3|||
155261109|NCT03759834|560387801|FG000|Overall Study|Withdrawal by Subject|1|||
155261110|NCT02515279|560387802|FG000|Overall Study|Adverse Event|7|||
155261111|NCT02515279|560387802|FG000|Overall Study|Lack of Efficacy|31|||
155261112|NCT02515279|560387802|FG000|Overall Study|Lost to Follow-up|9|||
155261113|NCT02515279|560387802|FG000|Overall Study|Withdrawal by Subject|18|||
155261114|NCT02515279|560387802|FG000|Overall Study|End-of-treatment visit not attended|17|||
155261115|NCT02515279|560387802|FG000|Overall Study|Other|22|||
155261116|NCT01800968|560387803|FG000|Overall Study|Death|23|||
155261117|NCT01800968|560387804|FG001|Overall Study|Death|16|||
155261118|NCT01800968|560387803|FG000|Overall Study|Lost to Follow-up|5|||
155261119|NCT01800968|560387804|FG001|Overall Study|Lost to Follow-up|7|||
155261120|NCT01800968|560387803|FG000|Overall Study|Withdrawal by Subject|7|||
155261121|NCT01800968|560387804|FG001|Overall Study|Withdrawal by Subject|9|||
155261122|NCT01800968|560387803|FG000|Overall Study|Physician Decision|1|||
155261123|NCT01800968|560387804|FG001|Overall Study|Physician Decision|0|||
155261124|NCT04987762|560387806|FG000|Overall Study|Study was Terminated by Sponsor|103|||
155261125|NCT03185481|560387807|FG000|Overall Study|Adverse Event|1|||
155261126|NCT03185481|560387807|FG000|Overall Study|Study Terminated by Sponsor|4|||
155261127|NCT00701038|560387813|FG000|Overall Study|study amended pilot group of patients|4|||
155261128|NCT00701038|560387814|FG001|Overall Study|study amended pilot group of patients|4|||
155261129|NCT03371940|560387820|FG000|Overall Study|Withdrawal by Subject|8|||
155261130|NCT03371940|560387821|FG001|Overall Study|Withdrawal by Subject|1|||
155261131|NCT03371940|560387822|FG002|Overall Study|Withdrawal by Subject|3|||
155261132|NCT03371940|560387823|FG003|Overall Study|Withdrawal by Subject|4|||
155261133|NCT05099926|560387824|FG000|Overall Study|Lost to Follow-up|1|||
155261134|NCT00689026|560387827|FG000|Overall Study|Withdrawal by Subject|13|||
155261135|NCT00689026|560387828|FG001|Overall Study|Withdrawal by Subject|6|||
155261136|NCT02618616|560387829|FG000|Overall Study|Lack of Efficacy|4|||
155261137|NCT02618616|560387830|FG001|Overall Study|Lack of Efficacy|0|||
155261138|NCT02618616|560387829|FG000|Overall Study|Pregnancy|0|||
155261139|NCT02618616|560387830|FG001|Overall Study|Pregnancy|1|||
155261140|NCT02618616|560387829|FG000|Overall Study|Adverse Event|8|||
155261141|NCT02618616|560387830|FG001|Overall Study|Adverse Event|0|||
155261142|NCT02618616|560387829|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
155261143|NCT02618616|560387830|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
155261144|NCT02618616|560387829|FG000|Overall Study|Consent withdrawn by subject|8|||
155261145|NCT02618616|560387830|FG001|Overall Study|Consent withdrawn by subject|5|||
155261146|NCT02618616|560387829|FG000|Overall Study|Lost to Follow-up|0|||
155261147|NCT02618616|560387830|FG001|Overall Study|Lost to Follow-up|1|||
155261148|NCT03764072|560387833|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261149|NCT03764072|560387834|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261150|NCT03764072|560387835|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
155261151|NCT03764072|560387836|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261152|NCT03764072|560387837|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261153|NCT03764072|560387838|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261154|NCT03764072|560387833|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
155261155|NCT03764072|560387834|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
155261156|NCT03764072|560387835|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
155261157|NCT03764072|560387836|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
155261158|NCT03764072|560387837|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
155261159|NCT03764072|560387838|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
155261160|NCT03764072|560387833|FG000|Overall Study|Lost to Follow-up|0|||
155261161|NCT03764072|560387834|FG001|Overall Study|Lost to Follow-up|0|||
155261162|NCT03764072|560387835|FG002|Overall Study|Lost to Follow-up|0|||
155261163|NCT03764072|560387836|FG003|Overall Study|Lost to Follow-up|0|||
155261164|NCT03764072|560387837|FG004|Overall Study|Lost to Follow-up|1|||
155261165|NCT03764072|560387838|FG005|Overall Study|Lost to Follow-up|0|||
155261166|NCT00766675|560389473|FG000|Overall Study|Adverse Event|16|||
155261167|NCT00766675|560389473|FG000|Overall Study|Lost to Follow-up|2|||
155261168|NCT00766675|560389473|FG000|Overall Study|Withdrawal by Subject|11|||
155261169|NCT00766675|560389473|FG000|Overall Study|Protocol Violation|8|||
155261170|NCT00766675|560389473|FG000|Overall Study|Participant took prohibited medication|1|||
155261171|NCT00766675|560389473|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
155261172|NCT00766675|560389473|FG000|Overall Study|Insufficient therapy|1|||
155261173|NCT03308825|560389474|FG000|Overall Study|Lost to Follow-up|2|||
155261174|NCT03308825|560389475|FG001|Overall Study|Lost to Follow-up|2|||
155261175|NCT03308825|560389476|FG002|Overall Study|Lost to Follow-up|1|||
155261176|NCT03308825|560389477|FG003|Overall Study|Lost to Follow-up|0|||
155261177|NCT03308825|560389474|FG000|Overall Study|Protocol Violation|0|||
155261178|NCT03308825|560389475|FG001|Overall Study|Protocol Violation|2|||
155261179|NCT03308825|560389476|FG002|Overall Study|Protocol Violation|0|||
155261180|NCT03308825|560389477|FG003|Overall Study|Protocol Violation|0|||
155261181|NCT02044848|560389479|FG000|Overall Study|Administrative Problems|2|||
155261182|NCT02044848|560389480|FG001|Overall Study|Administrative Problems|3|||
155261183|NCT00045708|560389481|FG000|Phase 1|early progressive disease|0|||
155261184|NCT00045708|560389482|FG001|Phase 1|early progressive disease|1|||
155261185|NCT00045708|560389483|FG002|Phase 1|early progressive disease|0|||
155261186|NCT00685945|560389485|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
155261187|NCT03183388|560389486|FG000|Overall Study|Lost to Follow-up|3|||
155261188|NCT03183388|560389487|FG001|Overall Study|Lost to Follow-up|5|||
155261189|NCT03183388|560389486|FG000|Overall Study|Physician Decision|1|||
155261190|NCT03183388|560389487|FG001|Overall Study|Physician Decision|4|||
155261191|NCT03183388|560389486|FG000|Overall Study|Withdrawal by Subject|4|||
155261192|NCT03183388|560389487|FG001|Overall Study|Withdrawal by Subject|1|||
155261193|NCT03183388|560389486|FG000|Overall Study|Moved|1|||
155261194|NCT03183388|560389487|FG001|Overall Study|Moved|0|||
155261195|NCT03183388|560389486|FG000|Overall Study|Met Exclusion Criteria|2|||
155261196|NCT03183388|560389487|FG001|Overall Study|Met Exclusion Criteria|2|||
155261197|NCT03183388|560389486|FG000|Overall Study|COVID Pandemic Related|2|||
155261198|NCT03183388|560389487|FG001|Overall Study|COVID Pandemic Related|4|||
155261199|NCT01679236|560389488|FG000|Overall Study|Lost to Follow-up|15|||
155261200|NCT01679236|560389489|FG001|Overall Study|Lost to Follow-up|15|||
155261201|NCT00803101|560389500|FG000|Overall Study|Death / Serious Adverse Event|4|||
155261202|NCT00803101|560389501|FG001|Overall Study|Death / Serious Adverse Event|6|||
155261203|NCT00803101|560389500|FG000|Overall Study|Withdrawal by Subject|6|||
155261204|NCT00803101|560389501|FG001|Overall Study|Withdrawal by Subject|4|||
155261205|NCT00803101|560389500|FG000|Overall Study|Lost to Follow-up|2|||
155261206|NCT00803101|560389501|FG001|Overall Study|Lost to Follow-up|2|||
155261207|NCT00803101|560389500|FG000|Overall Study|Protocol Violation|1|||
155261208|NCT00803101|560389501|FG001|Overall Study|Protocol Violation|7|||
155261209|NCT00803101|560389500|FG000|Overall Study|Surgery finished outside protocol window|1|||
155261210|NCT00803101|560389501|FG001|Overall Study|Surgery finished outside protocol window|1|||
155261211|NCT00803101|560389500|FG000|Overall Study|Patient died outside SAE report period|1|||
155261212|NCT00803101|560389501|FG001|Overall Study|Patient died outside SAE report period|0|||
155261213|NCT00803101|560389500|FG000|Overall Study|Patient did not attend scheduled visit|2|||
155261214|NCT00803101|560389501|FG001|Overall Study|Patient did not attend scheduled visit|1|||
155261215|NCT00803101|560389500|FG000|Overall Study|Patient did not have surgery|1|||
155261216|NCT00803101|560389501|FG001|Overall Study|Patient did not have surgery|1|||
155261217|NCT01782742|560389502|FG000|Double-blind Treatment Phase|Adverse Event|1|||
155261218|NCT01782742|560389503|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155261219|NCT01529008|560389504|FG000|Bone Marrow Harvesting|Physician Decision|1|||
155261220|NCT01529008|560389505|FG001|Bone Marrow Harvesting|Physician Decision|1|||
155261221|NCT01529008|560389504|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
155261222|NCT01529008|560389505|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
155261223|NCT01529008|560389504|FG000|Treatment|Adverse Event|6|||
155261224|NCT01529008|560389505|FG001|Treatment|Adverse Event|0|||
155261225|NCT01529008|560389504|FG000|Treatment|Other|3|||
155261226|NCT01529008|560389505|FG001|Treatment|Other|1|||
155261227|NCT01529008|560389504|FG000|Efficacy Analysis|Protocol Violation|2|||
155261228|NCT01529008|560389505|FG001|Efficacy Analysis|Protocol Violation|0|||
155261229|NCT01529008|560389504|FG000|Efficacy Analysis|Physician Decision|0|||
155261230|NCT01529008|560389505|FG001|Efficacy Analysis|Physician Decision|1|||
155261231|NCT01529008|560389504|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
155261232|NCT01529008|560389505|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
155261233|NCT04170686|560389506|FG000|Screening|Physician Decision|12|||
155261234|NCT04170686|560389507|FG001|Screening|Physician Decision|13|||
155261235|NCT04170686|560389506|FG000|Randomization and Treatment|Lost to Follow-up|26|||
155261236|NCT04170686|560389507|FG001|Randomization and Treatment|Lost to Follow-up|15|||
155261237|NCT04425902|560389510|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
155261238|NCT01191840|560389511|FG000|Overall Study|withdrew consent|2|||
155261239|NCT01191840|560389512|FG001|Overall Study|withdrew consent|1|||
155261240|NCT01191840|560389511|FG000|Overall Study|Subject discontinued treatment|1|||
155261241|NCT01191840|560389512|FG001|Overall Study|Subject discontinued treatment|2|||
155261242|NCT01191840|560389511|FG000|Overall Study|Lost to Follow-up|4|||
155261243|NCT01191840|560389512|FG001|Overall Study|Lost to Follow-up|6|||
155261244|NCT01191840|560389511|FG000|Overall Study|Non Staph Infection|4|||
155261245|NCT01191840|560389512|FG001|Overall Study|Non Staph Infection|3|||
155261246|NCT01191840|560389511|FG000|Overall Study|ineligible at enrollment|1|||
155261247|NCT01191840|560389512|FG001|Overall Study|ineligible at enrollment|0|||
155261248|NCT01191840|560389511|FG000|Overall Study|IRB approval lapse|0|||
155261249|NCT01191840|560389512|FG001|Overall Study|IRB approval lapse|2|||
155261250|NCT01191840|560389511|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
155261251|NCT01191840|560389512|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
155261252|NCT01191840|560389511|FG000|Overall Study|Withdrawal by Subject|2|||
155261253|NCT01191840|560389512|FG001|Overall Study|Withdrawal by Subject|0|||
155261254|NCT04669600|560389513|FG000|Overall Study|Withdrawal by Subject|1|||
155261255|NCT04669600|560389513|FG000|Overall Study|Other|6|||
155261256|NCT00331344|560389523|FG000|Phase I|Adverse Event|0|||
155261257|NCT00331344|560389524|FG001|Phase I|Adverse Event|0|||
155261258|NCT00331344|560389525|FG002|Phase I|Adverse Event|0|||
155261259|NCT00331344|560389526|FG003|Phase I|Adverse Event|1|||
155261260|NCT00331344|560389527|FG004|Phase I|Adverse Event|2|||
155261261|NCT00331344|560389528|FG005|Phase I|Adverse Event|2|||
155261262|NCT00331344|560389529|FG006|Phase I|Adverse Event|0|||
155261263|NCT00331344|560389530|FG007|Phase I|Adverse Event|1|||
155261264|NCT00331344|560389531|FG008|Phase I|Adverse Event|0|||
155261265|NCT00331344|560389523|FG000|Phase II|Death|0|||
155261266|NCT00331344|560389524|FG001|Phase II|Death|0|||
155261267|NCT00331344|560389525|FG002|Phase II|Death|0|||
155261268|NCT00331344|560389526|FG003|Phase II|Death|0|||
155261269|NCT00331344|560389527|FG004|Phase II|Death|0|||
155261270|NCT00331344|560389528|FG005|Phase II|Death|0|||
155261271|NCT00331344|560389529|FG006|Phase II|Death|0|||
155261272|NCT00331344|560389530|FG007|Phase II|Death|0|||
155261273|NCT00331344|560389531|FG008|Phase II|Death|4|||
155261274|NCT04538144|560389532|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
155261275|NCT04538144|560389533|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
155261276|NCT04538144|560389534|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
155261277|NCT04538144|560389535|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
155261278|NCT02228967|560389536|FG000|Overall Study|Lost to Follow-up|146|||
155261279|NCT02228967|560389537|FG001|Overall Study|Lost to Follow-up|142|||
155261280|NCT02228967|560389536|FG000|Overall Study|Withdrawal by Subject|13|||
155261281|NCT02228967|560389537|FG001|Overall Study|Withdrawal by Subject|18|||
155261282|NCT01264380|560389538|FG000|Period C|Disease Progression|0|||
155261283|NCT01264380|560389539|FG001|Period C|Disease Progression|0|||
155261284|NCT01264380|560389540|FG002|Period C|Disease Progression|4|||
155261285|NCT01264380|560389538|FG000|Period C|Death|0|||
155261286|NCT01264380|560389539|FG001|Period C|Death|0|||
155261287|NCT01264380|560389540|FG002|Period C|Death|2|||
155261288|NCT01264380|560389538|FG000|Period C|Follow-up for survival status|0|||
155261289|NCT01264380|560389539|FG001|Period C|Follow-up for survival status|0|||
155261290|NCT01264380|560389540|FG002|Period C|Follow-up for survival status|6|||
155261291|NCT01264380|560389538|FG000|Period C|Withdrawal by Subject|0|||
155261292|NCT01264380|560389539|FG001|Period C|Withdrawal by Subject|0|||
155261293|NCT01264380|560389540|FG002|Period C|Withdrawal by Subject|1|||
155261294|NCT01264380|560389538|FG000|Period C|Adverse Event|0|||
155261295|NCT01264380|560389539|FG001|Period C|Adverse Event|0|||
155261296|NCT01264380|560389540|FG002|Period C|Adverse Event|1|||
155261297|NCT04207840|560389542|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
155261298|NCT04207840|560389543|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
155261299|NCT04207840|560389544|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
155261300|NCT04207840|560389542|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
155261301|NCT04207840|560389543|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
155261302|NCT04207840|560389544|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
155261303|NCT03243422|560389545|FG000|Overall Study|Death|20|||
155261304|NCT03243422|560389546|FG001|Overall Study|Death|21|||
155261305|NCT03243422|560389545|FG000|Overall Study|Lost to Follow-up|9|||
155261306|NCT03243422|560389546|FG001|Overall Study|Lost to Follow-up|21|||
155261307|NCT03243422|560389545|FG000|Overall Study|Withdrawal by Subject|22|||
155261308|NCT03243422|560389546|FG001|Overall Study|Withdrawal by Subject|8|||
155261309|NCT02173054|560389547|FG000|Overall Study|lack of compliance|1|||
155261310|NCT02173054|560389548|FG001|Overall Study|lack of compliance|0|||
155261311|NCT02173054|560389549|FG002|Overall Study|lack of compliance|0|||
155261312|NCT02173054|560389547|FG000|Overall Study|Withdrawal by Subject|0|||
155261313|NCT02173054|560389548|FG001|Overall Study|Withdrawal by Subject|0|||
155261314|NCT02173054|560389549|FG002|Overall Study|Withdrawal by Subject|1|||
155261315|NCT01330316|560389550|FG000|Overall Study|Adverse Event|2|||
155261316|NCT01330316|560389551|FG001|Overall Study|Adverse Event|2|||
155261317|NCT01330316|560389550|FG000|Overall Study|Lack of Efficacy|0|||
155261318|NCT01330316|560389551|FG001|Overall Study|Lack of Efficacy|10|||
155261319|NCT01330316|560389550|FG000|Overall Study|Lost to Follow-up|0|||
155261320|NCT01330316|560389551|FG001|Overall Study|Lost to Follow-up|1|||
155261321|NCT01330316|560389550|FG000|Overall Study|Withdrawal by Subject|0|||
155261322|NCT01330316|560389551|FG001|Overall Study|Withdrawal by Subject|1|||
155261323|NCT01330316|560389550|FG000|Overall Study|other than above|0|||
155261324|NCT01330316|560389551|FG001|Overall Study|other than above|1|||
155261325|NCT01337986|560389554|FG000|Overall Study|Adverse Event|2|||
155261326|NCT01337986|560389555|FG001|Overall Study|Adverse Event|2|||
155261327|NCT01337986|560389554|FG000|Overall Study|Lost to Follow-up|1|||
155261328|NCT01337986|560389555|FG001|Overall Study|Lost to Follow-up|0|||
155261329|NCT01337986|560389554|FG000|Overall Study|Protocol Violation|0|||
155261330|NCT01337986|560389555|FG001|Overall Study|Protocol Violation|3|||
155261331|NCT01520402|560389557|FG000|Overall Study|Withdrawal by Subject|2|||
155261332|NCT01520402|560389557|FG000|Overall Study|Physician Decision|3|||
155261333|NCT02287584|560389558|FG000|the Double-blind Phase|Adverse Event|17|||
155261334|NCT02287584|560389559|FG001|the Double-blind Phase|Adverse Event|17|||
155261335|NCT02287584|560389560|FG002|the Double-blind Phase|Adverse Event|12|||
155261336|NCT02287584|560389561|FG003|the Double-blind Phase|Adverse Event|0|||
155261337|NCT02287584|560389562|FG004|the Double-blind Phase|Adverse Event|0|||
155261338|NCT02287584|560389563|FG005|the Double-blind Phase|Adverse Event|0|||
155261339|NCT02287584|560389558|FG000|the Double-blind Phase|Lack of Efficacy|18|||
155261340|NCT02287584|560389559|FG001|the Double-blind Phase|Lack of Efficacy|8|||
155261341|NCT02287584|560389560|FG002|the Double-blind Phase|Lack of Efficacy|8|||
155261342|NCT02287584|560389561|FG003|the Double-blind Phase|Lack of Efficacy|0|||
155261343|NCT02287584|560389562|FG004|the Double-blind Phase|Lack of Efficacy|0|||
155261344|NCT02287584|560389563|FG005|the Double-blind Phase|Lack of Efficacy|0|||
155261345|NCT02287584|560389558|FG000|the Double-blind Phase|Lost to Follow-up|0|||
155261346|NCT02287584|560389559|FG001|the Double-blind Phase|Lost to Follow-up|1|||
155261347|NCT02287584|560389560|FG002|the Double-blind Phase|Lost to Follow-up|1|||
155261348|NCT02287584|560389561|FG003|the Double-blind Phase|Lost to Follow-up|0|||
155261349|NCT02287584|560389562|FG004|the Double-blind Phase|Lost to Follow-up|0|||
155261350|NCT02287584|560389563|FG005|the Double-blind Phase|Lost to Follow-up|0|||
155261351|NCT02287584|560389558|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
155261352|NCT02287584|560389559|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
155261353|NCT02287584|560389560|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
155261354|NCT02287584|560389561|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
155261355|NCT02287584|560389562|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
155261356|NCT02287584|560389563|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
155261357|NCT02287584|560389558|FG000|the Double-blind Phase|Pregnancy|0|||
155261358|NCT02287584|560389559|FG001|the Double-blind Phase|Pregnancy|1|||
155261359|NCT02287584|560389560|FG002|the Double-blind Phase|Pregnancy|0|||
155261360|NCT02287584|560389561|FG003|the Double-blind Phase|Pregnancy|0|||
155261361|NCT02287584|560389562|FG004|the Double-blind Phase|Pregnancy|0|||
155261362|NCT02287584|560389563|FG005|the Double-blind Phase|Pregnancy|0|||
155261363|NCT02287584|560389558|FG000|the Double-blind Phase|Protocol Violation|0|||
155261364|NCT02287584|560389559|FG001|the Double-blind Phase|Protocol Violation|3|||
155261365|NCT02287584|560389560|FG002|the Double-blind Phase|Protocol Violation|0|||
155261366|NCT02287584|560389561|FG003|the Double-blind Phase|Protocol Violation|0|||
155261367|NCT02287584|560389562|FG004|the Double-blind Phase|Protocol Violation|0|||
155261368|NCT02287584|560389563|FG005|the Double-blind Phase|Protocol Violation|0|||
155261369|NCT02287584|560389558|FG000|the Double-blind Phase|other reasons|0|||
155261370|NCT02287584|560389559|FG001|the Double-blind Phase|other reasons|0|||
155261371|NCT02287584|560389560|FG002|the Double-blind Phase|other reasons|1|||
155261372|NCT02287584|560389561|FG003|the Double-blind Phase|other reasons|0|||
155261373|NCT02287584|560389562|FG004|the Double-blind Phase|other reasons|0|||
155261374|NCT02287584|560389563|FG005|the Double-blind Phase|other reasons|0|||
155261375|NCT02287584|560389558|FG000|the Open-label Phase|Did not receive drug|0|||
155261376|NCT02287584|560389559|FG001|the Open-label Phase|Did not receive drug|0|||
155261377|NCT02287584|560389560|FG002|the Open-label Phase|Did not receive drug|0|||
155261378|NCT02287584|560389561|FG003|the Open-label Phase|Did not receive drug|7|||
155261379|NCT02287584|560389562|FG004|the Open-label Phase|Did not receive drug|6|||
155261380|NCT02287584|560389563|FG005|the Open-label Phase|Did not receive drug|4|||
155261381|NCT02287584|560389558|FG000|the Open-label Phase|Adverse Event|0|||
155261382|NCT02287584|560389559|FG001|the Open-label Phase|Adverse Event|0|||
155261383|NCT02287584|560389560|FG002|the Open-label Phase|Adverse Event|0|||
155261384|NCT02287584|560389561|FG003|the Open-label Phase|Adverse Event|15|||
155607055|NCT03217968|561649624|FG000|Overall Study|Lost to Follow-up|1|||
155261385|NCT02287584|560389562|FG004|the Open-label Phase|Adverse Event|12|||
155261386|NCT02287584|560389563|FG005|the Open-label Phase|Adverse Event|16|||
155261387|NCT02287584|560389558|FG000|the Open-label Phase|Lack of Efficacy|0|||
155261388|NCT02287584|560389559|FG001|the Open-label Phase|Lack of Efficacy|0|||
155261389|NCT02287584|560389560|FG002|the Open-label Phase|Lack of Efficacy|0|||
155261390|NCT02287584|560389561|FG003|the Open-label Phase|Lack of Efficacy|8|||
155261391|NCT02287584|560389562|FG004|the Open-label Phase|Lack of Efficacy|3|||
155261392|NCT02287584|560389563|FG005|the Open-label Phase|Lack of Efficacy|7|||
155261393|NCT02287584|560389558|FG000|the Open-label Phase|Lost to Follow-up|0|||
155261394|NCT02287584|560389559|FG001|the Open-label Phase|Lost to Follow-up|0|||
155261395|NCT02287584|560389560|FG002|the Open-label Phase|Lost to Follow-up|0|||
155261396|NCT02287584|560389561|FG003|the Open-label Phase|Lost to Follow-up|4|||
155261397|NCT02287584|560389562|FG004|the Open-label Phase|Lost to Follow-up|1|||
155261398|NCT02287584|560389563|FG005|the Open-label Phase|Lost to Follow-up|2|||
155261399|NCT02287584|560389558|FG000|the Open-label Phase|Withdrawal by Subject|0|||
155261400|NCT02287584|560389559|FG001|the Open-label Phase|Withdrawal by Subject|0|||
155261401|NCT02287584|560389560|FG002|the Open-label Phase|Withdrawal by Subject|0|||
155261402|NCT02287584|560389561|FG003|the Open-label Phase|Withdrawal by Subject|18|||
155261403|NCT02287584|560389562|FG004|the Open-label Phase|Withdrawal by Subject|29|||
155261404|NCT02287584|560389563|FG005|the Open-label Phase|Withdrawal by Subject|21|||
155261405|NCT02287584|560389558|FG000|the Open-label Phase|non-compliance|0|||
155261406|NCT02287584|560389559|FG001|the Open-label Phase|non-compliance|0|||
155261407|NCT02287584|560389560|FG002|the Open-label Phase|non-compliance|0|||
155261408|NCT02287584|560389561|FG003|the Open-label Phase|non-compliance|2|||
155261409|NCT02287584|560389562|FG004|the Open-label Phase|non-compliance|5|||
155261410|NCT02287584|560389563|FG005|the Open-label Phase|non-compliance|1|||
155261411|NCT02287584|560389558|FG000|the Open-label Phase|other reasons|0|||
155261412|NCT02287584|560389559|FG001|the Open-label Phase|other reasons|0|||
155261413|NCT02287584|560389560|FG002|the Open-label Phase|other reasons|0|||
155261414|NCT02287584|560389561|FG003|the Open-label Phase|other reasons|3|||
155261415|NCT02287584|560389562|FG004|the Open-label Phase|other reasons|6|||
155261416|NCT02287584|560389563|FG005|the Open-label Phase|other reasons|6|||
155261417|NCT03430063|560389567|FG000|Overall Study|Adverse Event|0|||
155261418|NCT03430063|560389568|FG001|Overall Study|Adverse Event|1|||
155261419|NCT03430063|560389569|FG002|Overall Study|Adverse Event|0|||
155261420|NCT03430063|560389567|FG000|Overall Study|Death|3|||
155261421|NCT03430063|560389568|FG001|Overall Study|Death|2|||
155261422|NCT03430063|560389569|FG002|Overall Study|Death|3|||
155261423|NCT03430063|560389567|FG000|Overall Study|Lost to Follow-up|0|||
155261424|NCT03430063|560389568|FG001|Overall Study|Lost to Follow-up|1|||
155261425|NCT03430063|560389569|FG002|Overall Study|Lost to Follow-up|0|||
155261426|NCT03430063|560389567|FG000|Overall Study|Withdrawal by Subject|0|||
155261427|NCT03430063|560389568|FG001|Overall Study|Withdrawal by Subject|0|||
155261428|NCT03430063|560389569|FG002|Overall Study|Withdrawal by Subject|1|||
155261429|NCT03430063|560389567|FG000|Overall Study|Withdrawal of consent|3|||
155261430|NCT03430063|560389568|FG001|Overall Study|Withdrawal of consent|1|||
155261431|NCT03430063|560389569|FG002|Overall Study|Withdrawal of consent|2|||
155261432|NCT03430063|560389567|FG000|Overall Study|Progressive disease|1|||
155261433|NCT03430063|560389568|FG001|Overall Study|Progressive disease|2|||
155261434|NCT03430063|560389569|FG002|Overall Study|Progressive disease|1|||
155261435|NCT03430063|560389567|FG000|Overall Study|Other un-specified|1|||
155261436|NCT03430063|560389568|FG001|Overall Study|Other un-specified|1|||
155261437|NCT03430063|560389569|FG002|Overall Study|Other un-specified|0|||
155261438|NCT03430063|560389567|FG000|Overall Study|Randomized, but never treated|0|||
155261439|NCT03430063|560389568|FG001|Overall Study|Randomized, but never treated|0|||
155261440|NCT03430063|560389569|FG002|Overall Study|Randomized, but never treated|1|||
155261441|NCT03124199|560389570|FG000|Overall Study|Lost to Follow-up|4|||
155261442|NCT03086018|560389571|FG000|Final Testing for End of Trial|Adverse Event|1|||
155261443|NCT03086018|560389571|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
155261444|NCT01892345|560389572|FG000|Overall Study|Adverse Event|0|||
155261445|NCT01892345|560389573|FG001|Overall Study|Adverse Event|2|||
155261446|NCT01892345|560389572|FG000|Overall Study|Death|1|||
155261447|NCT01892345|560389573|FG001|Overall Study|Death|0|||
155261448|NCT01892345|560389572|FG000|Overall Study|Lost to Follow-up|3|||
155261449|NCT01892345|560389573|FG001|Overall Study|Lost to Follow-up|0|||
155261450|NCT01892345|560389572|FG000|Overall Study|Withdrawal by Subject|12|||
155261451|NCT01892345|560389573|FG001|Overall Study|Withdrawal by Subject|1|||
155261452|NCT00621543|560389577|FG000|Overall Study|Lost to Follow-up|23|||
155261453|NCT02192970|560389578|FG000|Overall Study|Lost to Follow-up|6|||
155261454|NCT02192970|560389579|FG001|Overall Study|Lost to Follow-up|0|||
155261455|NCT03745222|560389580|FG000|Overall Study|Withdrawal by Subject|0|||
155261456|NCT03745222|560389581|FG001|Overall Study|Withdrawal by Subject|1|||
155261457|NCT03745222|560389582|FG002|Overall Study|Withdrawal by Subject|0|||
155261458|NCT00792103|560389583|FG000|Overall Study|Enrolled, not treated|15|||
155261459|NCT00792103|560389583|FG000|Overall Study|Lost to Follow-up|17|||
155491710|NCT00910000|561225496|FG000|Overall Study|Withdrawal by Subject|0|||
155491711|NCT00910000|561225497|FG001|Overall Study|Withdrawal by Subject|0|||
155261460|NCT00792103|560389583|FG000|Overall Study|Adverse Event|25|||
155261461|NCT00792103|560389583|FG000|Overall Study|Withdrawal by Subject|52|||
155261462|NCT00792103|560389583|FG000|Overall Study|Protocol Violation|10|||
155261463|NCT00792103|560389583|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
155261464|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
155261465|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
155261466|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
155261467|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
155261468|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261469|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
155261470|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261471|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261472|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261473|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
155261474|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261475|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261476|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261477|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
155261478|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261479|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261480|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
155261481|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
155261482|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
155261483|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
155261484|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261485|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261486|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261487|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
155261488|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
155261489|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
155261490|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
155261491|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
155261492|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
155261493|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
155261494|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
155261495|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
155261496|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261497|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261498|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261499|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
155261500|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261501|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261502|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261503|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
155261504|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261505|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261506|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261507|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
155261508|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261509|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261510|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
155261511|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261512|NCT05479604|560389588|FG000|Overall Study|Lost to Follow-up|1|||
155261513|NCT05479604|560389589|FG001|Overall Study|Lost to Follow-up|5|||
155261514|NCT01591382|560389590|FG000|Overall Study|Discharged Prior to Study Completion|2|||
155261515|NCT01591382|560389591|FG001|Overall Study|Discharged Prior to Study Completion|1|||
155261516|NCT01591382|560389590|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
155261517|NCT01591382|560389591|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
155261518|NCT04252742|560389593|FG000|Overall Study|Decision by sponsor|0|||
155261519|NCT04252742|560389594|FG001|Overall Study|Decision by sponsor|2|||
155261520|NCT04252742|560389593|FG000|Overall Study|Withdrawal by Subject|15|||
155261521|NCT04252742|560389594|FG001|Overall Study|Withdrawal by Subject|9|||
155261522|NCT04252742|560389593|FG000|Overall Study|Lost to Follow-up|0|||
155261523|NCT04252742|560389594|FG001|Overall Study|Lost to Follow-up|1|||
155261524|NCT02068495|560389601|FG000|Overall Study|Case Report Forms Uncollected|60|||
155261525|NCT02068495|560389601|FG000|Overall Study|Protocol Deviation|49|||
155261526|NCT01666808|560389604|FG000|Overall Study|Lost to Follow-up|9|||
155261527|NCT01666808|560389605|FG001|Overall Study|Lost to Follow-up|15|||
155261528|NCT01666808|560389604|FG000|Overall Study|Withdrawal by Subject|3|||
155261529|NCT01666808|560389605|FG001|Overall Study|Withdrawal by Subject|1|||
155261530|NCT01666808|560389604|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
155261531|NCT01666808|560389605|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
155261532|NCT02220894|560389609|FG000|Overall Study|Adverse Event|127|||
155261533|NCT02220894|560389610|FG001|Overall Study|Adverse Event|74|||
155261534|NCT02220894|560389609|FG000|Overall Study|Death|418|||
155261535|NCT02220894|560389610|FG001|Overall Study|Death|508|||
155261536|NCT02220894|560389609|FG000|Overall Study|Lost to Follow-up|0|||
155261537|NCT02220894|560389610|FG001|Overall Study|Lost to Follow-up|4|||
155261538|NCT02220894|560389609|FG000|Overall Study|Site Terminated by Sponsor|2|||
155261539|NCT02220894|560389610|FG001|Overall Study|Site Terminated by Sponsor|0|||
155261540|NCT02220894|560389609|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
155261541|NCT02220894|560389610|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
155261542|NCT02220894|560389609|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155261543|NCT02220894|560389610|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155261544|NCT02220894|560389609|FG000|Overall Study|Withdrawal by Subject|10|||
155261545|NCT02220894|560389610|FG001|Overall Study|Withdrawal by Subject|9|||
155261546|NCT03217747|560389611|FG000|Overall Study|Adverse Event|0|||
155261547|NCT03217747|560389612|FG001|Overall Study|Adverse Event|1|||
155261548|NCT03217747|560389613|FG002|Overall Study|Adverse Event|0|||
155261549|NCT03217747|560389614|FG003|Overall Study|Adverse Event|0|||
155261550|NCT03217747|560389615|FG004|Overall Study|Adverse Event|0|||
155261551|NCT03217747|560389616|FG005|Overall Study|Adverse Event|0|||
155261552|NCT03217747|560389617|FG006|Overall Study|Adverse Event|0|||
155261553|NCT03217747|560389618|FG007|Overall Study|Adverse Event|0|||
155261554|NCT03217747|560389619|FG008|Overall Study|Adverse Event|0|||
155261555|NCT03217747|560389620|FG009|Overall Study|Adverse Event|0|||
155261556|NCT03217747|560389621|FG010|Overall Study|Adverse Event|0|||
155261557|NCT03217747|560389622|FG011|Overall Study|Adverse Event|0|||
155261558|NCT03217747|560389623|FG012|Overall Study|Adverse Event|1|||
155261559|NCT03217747|560389624|FG013|Overall Study|Adverse Event|1|||
155261560|NCT03217747|560389611|FG000|Overall Study|Death|0|||
155261561|NCT03217747|560389612|FG001|Overall Study|Death|0|||
155261562|NCT03217747|560389613|FG002|Overall Study|Death|0|||
155261563|NCT03217747|560389614|FG003|Overall Study|Death|0|||
155261564|NCT03217747|560389615|FG004|Overall Study|Death|0|||
155261565|NCT03217747|560389616|FG005|Overall Study|Death|0|||
155261566|NCT03217747|560389617|FG006|Overall Study|Death|0|||
155261567|NCT03217747|560389618|FG007|Overall Study|Death|0|||
155261568|NCT03217747|560389619|FG008|Overall Study|Death|1|||
155261569|NCT03217747|560389620|FG009|Overall Study|Death|0|||
155261570|NCT03217747|560389621|FG010|Overall Study|Death|0|||
155261571|NCT03217747|560389622|FG011|Overall Study|Death|0|||
155261572|NCT03217747|560389623|FG012|Overall Study|Death|0|||
155261573|NCT03217747|560389624|FG013|Overall Study|Death|0|||
155261574|NCT03217747|560389611|FG000|Overall Study|Lack of Efficacy|12|||
155261575|NCT03217747|560389612|FG001|Overall Study|Lack of Efficacy|6|||
155261576|NCT03217747|560389613|FG002|Overall Study|Lack of Efficacy|15|||
155261577|NCT03217747|560389614|FG003|Overall Study|Lack of Efficacy|11|||
155261578|NCT03217747|560389615|FG004|Overall Study|Lack of Efficacy|3|||
155261579|NCT03217747|560389616|FG005|Overall Study|Lack of Efficacy|14|||
155261580|NCT03217747|560389617|FG006|Overall Study|Lack of Efficacy|10|||
155261581|NCT03217747|560389618|FG007|Overall Study|Lack of Efficacy|4|||
155261582|NCT03217747|560389619|FG008|Overall Study|Lack of Efficacy|2|||
155261583|NCT03217747|560389620|FG009|Overall Study|Lack of Efficacy|7|||
155261584|NCT03217747|560389621|FG010|Overall Study|Lack of Efficacy|3|||
155261585|NCT03217747|560389622|FG011|Overall Study|Lack of Efficacy|1|||
155261586|NCT03217747|560389623|FG012|Overall Study|Lack of Efficacy|3|||
155261587|NCT03217747|560389624|FG013|Overall Study|Lack of Efficacy|1|||
155261588|NCT03217747|560389611|FG000|Overall Study|Withdrawal by Subject|2|||
155261589|NCT03217747|560389612|FG001|Overall Study|Withdrawal by Subject|1|||
155261590|NCT03217747|560389613|FG002|Overall Study|Withdrawal by Subject|1|||
155261591|NCT03217747|560389614|FG003|Overall Study|Withdrawal by Subject|1|||
155261592|NCT03217747|560389615|FG004|Overall Study|Withdrawal by Subject|1|||
155261593|NCT03217747|560389616|FG005|Overall Study|Withdrawal by Subject|2|||
155261594|NCT03217747|560389617|FG006|Overall Study|Withdrawal by Subject|1|||
155261595|NCT03217747|560389618|FG007|Overall Study|Withdrawal by Subject|0|||
155261596|NCT03217747|560389619|FG008|Overall Study|Withdrawal by Subject|0|||
155261597|NCT03217747|560389620|FG009|Overall Study|Withdrawal by Subject|0|||
155261598|NCT03217747|560389621|FG010|Overall Study|Withdrawal by Subject|0|||
155261599|NCT03217747|560389622|FG011|Overall Study|Withdrawal by Subject|1|||
155261600|NCT03217747|560389623|FG012|Overall Study|Withdrawal by Subject|0|||
155261601|NCT03217747|560389624|FG013|Overall Study|Withdrawal by Subject|1|||
155261602|NCT03217747|560389611|FG000|Overall Study|Toxicity and progression|1|||
155261603|NCT03217747|560389612|FG001|Overall Study|Toxicity and progression|0|||
155261604|NCT03217747|560389613|FG002|Overall Study|Toxicity and progression|0|||
155261605|NCT03217747|560389614|FG003|Overall Study|Toxicity and progression|0|||
155261606|NCT03217747|560389615|FG004|Overall Study|Toxicity and progression|0|||
155261607|NCT03217747|560389616|FG005|Overall Study|Toxicity and progression|0|||
155261608|NCT03217747|560389617|FG006|Overall Study|Toxicity and progression|0|||
155261609|NCT03217747|560389618|FG007|Overall Study|Toxicity and progression|0|||
155261610|NCT03217747|560389619|FG008|Overall Study|Toxicity and progression|0|||
155261611|NCT03217747|560389620|FG009|Overall Study|Toxicity and progression|0|||
155261612|NCT03217747|560389621|FG010|Overall Study|Toxicity and progression|0|||
155261613|NCT03217747|560389622|FG011|Overall Study|Toxicity and progression|0|||
155261614|NCT03217747|560389623|FG012|Overall Study|Toxicity and progression|0|||
155261615|NCT03217747|560389624|FG013|Overall Study|Toxicity and progression|0|||
155261616|NCT03217747|560389611|FG000|Overall Study|Removal of sole target lesion|1|||
155261617|NCT03217747|560389612|FG001|Overall Study|Removal of sole target lesion|0|||
155261618|NCT03217747|560389613|FG002|Overall Study|Removal of sole target lesion|0|||
155261619|NCT03217747|560389614|FG003|Overall Study|Removal of sole target lesion|0|||
155261620|NCT03217747|560389615|FG004|Overall Study|Removal of sole target lesion|0|||
155261621|NCT03217747|560389616|FG005|Overall Study|Removal of sole target lesion|0|||
155261622|NCT03217747|560389617|FG006|Overall Study|Removal of sole target lesion|0|||
155261623|NCT03217747|560389618|FG007|Overall Study|Removal of sole target lesion|0|||
155261624|NCT03217747|560389619|FG008|Overall Study|Removal of sole target lesion|0|||
155261625|NCT03217747|560389620|FG009|Overall Study|Removal of sole target lesion|0|||
155261626|NCT03217747|560389621|FG010|Overall Study|Removal of sole target lesion|0|||
155261627|NCT03217747|560389622|FG011|Overall Study|Removal of sole target lesion|0|||
155261628|NCT03217747|560389623|FG012|Overall Study|Removal of sole target lesion|0|||
155261629|NCT03217747|560389624|FG013|Overall Study|Removal of sole target lesion|0|||
155261630|NCT03217747|560389611|FG000|Overall Study|Stroke|0|||
155261631|NCT03217747|560389612|FG001|Overall Study|Stroke|0|||
155261632|NCT03217747|560389613|FG002|Overall Study|Stroke|0|||
155261633|NCT03217747|560389614|FG003|Overall Study|Stroke|0|||
155261634|NCT03217747|560389615|FG004|Overall Study|Stroke|0|||
155261635|NCT03217747|560389616|FG005|Overall Study|Stroke|1|||
155261636|NCT03217747|560389617|FG006|Overall Study|Stroke|0|||
155261637|NCT03217747|560389618|FG007|Overall Study|Stroke|0|||
155261638|NCT03217747|560389619|FG008|Overall Study|Stroke|0|||
155261639|NCT03217747|560389620|FG009|Overall Study|Stroke|0|||
155261640|NCT03217747|560389621|FG010|Overall Study|Stroke|0|||
155261641|NCT03217747|560389622|FG011|Overall Study|Stroke|1|||
155261642|NCT03217747|560389623|FG012|Overall Study|Stroke|0|||
155261643|NCT03217747|560389624|FG013|Overall Study|Stroke|0|||
155261644|NCT03996291|560389625|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
155261645|NCT03996291|560389626|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
155261646|NCT03996291|560389627|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
155261647|NCT03996291|560389628|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
155261648|NCT03996291|560389629|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
155261649|NCT03996291|560389630|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
155261650|NCT03996291|560389631|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
155261651|NCT03996291|560389632|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
155261652|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261653|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261654|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261655|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261656|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261657|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
155261658|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
155261659|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261660|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261661|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261662|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261663|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261664|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
155261665|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261666|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
155261667|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261668|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
155261669|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
155261670|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
155261671|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
155261672|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
155261673|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
155261674|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
155261675|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
155261676|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261677|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261678|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261679|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261680|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
155261681|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261682|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261683|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261684|NCT04098250|560389635|FG000|Overall Study|Withdrawal by Subject|1|||
155261685|NCT04098250|560389636|FG001|Overall Study|Withdrawal by Subject|0|||
155261686|NCT04098250|560389635|FG000|Overall Study|Lost to Follow-up|0|||
155261687|NCT04098250|560389636|FG001|Overall Study|Lost to Follow-up|1|||
155261688|NCT00394355|560389637|FG000|Overall Study|Adverse Event|10|||
155261689|NCT00394355|560389638|FG001|Overall Study|Adverse Event|6|||
155261690|NCT00394355|560389639|FG002|Overall Study|Adverse Event|7|||
155261691|NCT00394355|560389640|FG003|Overall Study|Adverse Event|8|||
155261692|NCT00394355|560389637|FG000|Overall Study|Did not meet protocol eligibility|1|||
155261693|NCT00394355|560389638|FG001|Overall Study|Did not meet protocol eligibility|5|||
155261694|NCT00394355|560389639|FG002|Overall Study|Did not meet protocol eligibility|4|||
155261695|NCT00394355|560389640|FG003|Overall Study|Did not meet protocol eligibility|2|||
155261696|NCT00394355|560389637|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
155261697|NCT00394355|560389638|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
155261698|NCT00394355|560389639|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
155261699|NCT00394355|560389640|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
155261700|NCT00394355|560389637|FG000|Overall Study|Subject withdrawal - related to drug|1|||
155261701|NCT00394355|560389638|FG001|Overall Study|Subject withdrawal - related to drug|0|||
155261702|NCT00394355|560389639|FG002|Overall Study|Subject withdrawal - related to drug|0|||
155261703|NCT00394355|560389640|FG003|Overall Study|Subject withdrawal - related to drug|0|||
155261704|NCT00394355|560389637|FG000|Overall Study|Lost to Follow-up|7|||
155261705|NCT00394355|560389638|FG001|Overall Study|Lost to Follow-up|5|||
155261706|NCT00394355|560389639|FG002|Overall Study|Lost to Follow-up|4|||
155261707|NCT00394355|560389640|FG003|Overall Study|Lost to Follow-up|3|||
155261708|NCT00394355|560389637|FG000|Overall Study|Noncompliance with protocol|4|||
155261709|NCT00394355|560389638|FG001|Overall Study|Noncompliance with protocol|3|||
155261710|NCT00394355|560389639|FG002|Overall Study|Noncompliance with protocol|10|||
155261711|NCT00394355|560389640|FG003|Overall Study|Noncompliance with protocol|8|||
155261712|NCT00394355|560389637|FG000|Overall Study|Administrative|0|||
155261713|NCT00394355|560389638|FG001|Overall Study|Administrative|1|||
155261714|NCT00394355|560389639|FG002|Overall Study|Administrative|1|||
155261715|NCT00394355|560389640|FG003|Overall Study|Administrative|1|||
155261716|NCT00394355|560389637|FG000|Overall Study|Lack of Efficacy|0|||
155261717|NCT00394355|560389638|FG001|Overall Study|Lack of Efficacy|0|||
155261718|NCT00394355|560389639|FG002|Overall Study|Lack of Efficacy|2|||
155261719|NCT00394355|560389640|FG003|Overall Study|Lack of Efficacy|3|||
155261720|NCT02612064|560389644|FG000|Overall Study|Withdrawal by Subject|1|||
155261721|NCT02612064|560389645|FG001|Overall Study|Withdrawal by Subject|1|||
155261722|NCT02612064|560389644|FG000|Overall Study|Other|0|||
155261723|NCT02612064|560389645|FG001|Overall Study|Other|2|||
155261724|NCT00284141|560390718|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
155261725|NCT00284141|560390718|FG000|Overall Study|Adverse Event|19|||
155261726|NCT00284141|560390718|FG000|Overall Study|Participant's request|9|||
155261727|NCT00284141|560390718|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
155261728|NCT00284141|560390718|FG000|Overall Study|Clinical deterioration / death|2|||
155261729|NCT00284141|560390718|FG000|Overall Study|General decline|1|||
155261730|NCT00284141|560390718|FG000|Overall Study|Pneumonia|1|||
155261731|NCT00284141|560390718|FG000|Overall Study|Did not take study medication|2|||
155261732|NCT00284141|560390718|FG000|Overall Study|Ongoing treatment|2|||
155261733|NCT01995539|560390720|FG000|Overall Study|Screening Failure|1|||
155261734|NCT01995539|560390720|FG000|Overall Study|Withdrawal by Investigator|15|||
155261735|NCT01995539|560390720|FG000|Overall Study|Withdrawal by Subject|11|||
155261736|NCT01995539|560390720|FG000|Overall Study|Lost to Follow-up|5|||
155261737|NCT01995539|560390720|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
155261738|NCT03474107|560390723|FG000|Overall Study|Adverse Event|42|||
155261739|NCT03474107|560390724|FG001|Overall Study|Adverse Event|46|||
155261740|NCT03474107|560390723|FG000|Overall Study|Death|2|||
155261741|NCT03474107|560390724|FG001|Overall Study|Death|2|||
155261742|NCT03474107|560390723|FG000|Overall Study|Lost to Follow-up|0|||
155261743|NCT03474107|560390724|FG001|Overall Study|Lost to Follow-up|1|||
155261744|NCT03474107|560390723|FG000|Overall Study|Progressive Disease|177|||
155261745|NCT03474107|560390724|FG001|Overall Study|Progressive Disease|180|||
155261746|NCT03474107|560390723|FG000|Overall Study|Protocol Violation|1|||
155261747|NCT03474107|560390724|FG001|Overall Study|Protocol Violation|1|||
155261748|NCT03474107|560390723|FG000|Overall Study|Withdrawal by Subject|15|||
155261749|NCT03474107|560390724|FG001|Overall Study|Withdrawal by Subject|27|||
155261750|NCT03474107|560390723|FG000|Overall Study|Physician Decision|7|||
155261751|NCT03474107|560390724|FG001|Overall Study|Physician Decision|22|||
155261752|NCT03474107|560390723|FG000|Overall Study|Miscellaneous|1|||
155261753|NCT03474107|560390724|FG001|Overall Study|Miscellaneous|6|||
155261754|NCT00659984|560390728|FG000|Overall Study|Adverse Event|1|||
155261755|NCT02487810|560390729|FG000|Overall Study|Withdrawal by Subject|1|||
155261756|NCT02487810|560390730|FG001|Overall Study|Withdrawal by Subject|0|||
155261757|NCT01287611|560390732|FG000|Overall Study|Lost to Follow-up|29|||
155261758|NCT01287611|560390733|FG001|Overall Study|Lost to Follow-up|16|||
155261759|NCT01287611|560390732|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
155261760|NCT01287611|560390733|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
155261761|NCT00763958|560390734|FG000|Overall Study|did not meet final criteria|4|||
155261762|NCT00763958|560390735|FG001|Overall Study|did not meet final criteria|4|||
155261763|NCT00763958|560390734|FG000|Overall Study|Lost to Follow-up|10|||
155261764|NCT00763958|560390735|FG001|Overall Study|Lost to Follow-up|2|||
155261765|NCT00763958|560390734|FG000|Overall Study|Believed they were receiving placebo|0|||
155261766|NCT00763958|560390735|FG001|Overall Study|Believed they were receiving placebo|5|||
155261767|NCT04074590|560390736|FG000|Overall Study|Adverse Event|1|||
155261768|NCT04074590|560390737|FG001|Overall Study|Adverse Event|0|||
155261769|NCT04074590|560390736|FG000|Overall Study|Physician Decision|1|||
155261770|NCT04074590|560390737|FG001|Overall Study|Physician Decision|0|||
155261771|NCT04074590|560390736|FG000|Overall Study|Withdrawal by Subject|2|||
155261772|NCT04074590|560390737|FG001|Overall Study|Withdrawal by Subject|0|||
155261773|NCT01281202|560390740|FG000|Overall Study|Adverse Event|2|||
155261774|NCT01281202|560390741|FG001|Overall Study|Adverse Event|0|||
155261775|NCT01281202|560390740|FG000|Overall Study|Withdrawal by Subject|2|||
155261776|NCT01281202|560390741|FG001|Overall Study|Withdrawal by Subject|2|||
155261777|NCT01281202|560390740|FG000|Overall Study|Protocol Violation|11|||
155261778|NCT01281202|560390741|FG001|Overall Study|Protocol Violation|10|||
155261779|NCT01281202|560390740|FG000|Overall Study|Administrative|2|||
155261780|NCT01281202|560390741|FG001|Overall Study|Administrative|8|||
155261781|NCT01281202|560390740|FG000|Overall Study|Lost to Follow-up|11|||
155261782|NCT01281202|560390741|FG001|Overall Study|Lost to Follow-up|13|||
155261783|NCT01281202|560390740|FG000|Overall Study|Incarceration|0|||
155261784|NCT01281202|560390741|FG001|Overall Study|Incarceration|3|||
155261785|NCT04581200|560390742|FG000|Overall Study|Lost to Follow-up|6|||
155261786|NCT04581200|560390743|FG001|Overall Study|Lost to Follow-up|5|||
155261787|NCT03131960|560390744|FG000|Overall Study|Adverse Event|0|||
155261788|NCT03131960|560390745|FG001|Overall Study|Adverse Event|1|||
155261789|NCT04359784|560390749|FG000|Overall Study|Death|2|||
155261790|NCT02063828|560390753|FG000|Overall Study|Withdrawal by Subject|4|||
155261791|NCT02063828|560390754|FG001|Overall Study|Withdrawal by Subject|6|||
155261792|NCT02063828|560390755|FG002|Overall Study|Withdrawal by Subject|3|||
155261793|NCT02063828|560390753|FG000|Overall Study|Death|0|||
155261794|NCT02063828|560390754|FG001|Overall Study|Death|0|||
155261795|NCT02063828|560390755|FG002|Overall Study|Death|1|||
155261796|NCT02753595|560390756|FG000|Overall Study|Sponsor termination|2|||
155261797|NCT02753595|560390757|FG001|Overall Study|Sponsor termination|2|||
155261798|NCT01064297|560390761|FG000|Overall Study|Lost to Follow-up|791|||
155261799|NCT01064297|560390762|FG001|Overall Study|Lost to Follow-up|48|||
155261800|NCT01064297|560390763|FG002|Overall Study|Lost to Follow-up|133|||
155261801|NCT00504426|560390766|FG000|Overall Study|Adverse Event|0|||
155261802|NCT00504426|560390767|FG001|Overall Study|Adverse Event|0|||
155261803|NCT00504426|560390768|FG002|Overall Study|Adverse Event|2|||
155261804|NCT00504426|560390769|FG003|Overall Study|Adverse Event|0|||
155261805|NCT00504426|560390766|FG000|Overall Study|Protocol Violation|1|||
155261806|NCT00504426|560390767|FG001|Overall Study|Protocol Violation|1|||
155261807|NCT00504426|560390768|FG002|Overall Study|Protocol Violation|2|||
155261808|NCT00504426|560390769|FG003|Overall Study|Protocol Violation|0|||
155261809|NCT00504426|560390766|FG000|Overall Study|Withdrawal by Subject|2|||
155261810|NCT00504426|560390767|FG001|Overall Study|Withdrawal by Subject|0|||
155261811|NCT00504426|560390768|FG002|Overall Study|Withdrawal by Subject|0|||
155261812|NCT00504426|560390769|FG003|Overall Study|Withdrawal by Subject|0|||
155261813|NCT03248375|560390772|FG000|Overall Study|Lost to Follow-up|5|||
155261814|NCT00633464|560390777|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
155261815|NCT00633464|560390778|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
155261816|NCT00633464|560390777|FG000|Overall Study|Never Treated (Randomized in error)|0|||
155261817|NCT00633464|560390778|FG001|Overall Study|Never Treated (Randomized in error)|1|||
155261818|NCT00717860|560390779|FG000|Overall Study|Clinical adverse experience|5|||
155261819|NCT00717860|560390780|FG001|Overall Study|Clinical adverse experience|9|||
155261820|NCT00717860|560390779|FG000|Overall Study|Laboratory adverse experience|2|||
155261821|NCT00717860|560390780|FG001|Overall Study|Laboratory adverse experience|2|||
155261822|NCT00717860|560390779|FG000|Overall Study|Lack of Efficacy|7|||
155261823|NCT00717860|560390780|FG001|Overall Study|Lack of Efficacy|13|||
155261824|NCT00717860|560390779|FG000|Overall Study|Discontinued for other reason|6|||
155261825|NCT00717860|560390780|FG001|Overall Study|Discontinued for other reason|1|||
155261826|NCT00717860|560390779|FG000|Overall Study|Withdrew consent|7|||
155261827|NCT00717860|560390780|FG001|Overall Study|Withdrew consent|3|||
155261828|NCT00698646|560390784|FG000|Overall Study|Adverse Event|8|||
155261829|NCT00698646|560390785|FG001|Overall Study|Adverse Event|7|||
155261830|NCT00698646|560390786|FG002|Overall Study|Adverse Event|8|||
155261831|NCT00698646|560390784|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
155261832|NCT00698646|560390785|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
155261833|NCT00698646|560390786|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
155261834|NCT00698646|560390784|FG000|Overall Study|Protocol Deviation|6|||
155261835|NCT00698646|560390785|FG001|Overall Study|Protocol Deviation|2|||
155261836|NCT00698646|560390786|FG002|Overall Study|Protocol Deviation|3|||
155261837|NCT00698646|560390784|FG000|Overall Study|Withdrawal by Subject|10|||
155261838|NCT00698646|560390785|FG001|Overall Study|Withdrawal by Subject|11|||
155261839|NCT00698646|560390786|FG002|Overall Study|Withdrawal by Subject|8|||
155261840|NCT00698646|560390784|FG000|Overall Study|Lost to Follow-up|0|||
155261841|NCT00698646|560390785|FG001|Overall Study|Lost to Follow-up|0|||
155261842|NCT00698646|560390786|FG002|Overall Study|Lost to Follow-up|2|||
155261843|NCT00698646|560390784|FG000|Overall Study|Administrative problems|1|||
155261844|NCT00698646|560390785|FG001|Overall Study|Administrative problems|0|||
155261845|NCT00698646|560390786|FG002|Overall Study|Administrative problems|1|||
155261846|NCT00511875|560390792|FG000|Overall Study|Lost to Follow-up|4|||
155261847|NCT00511875|560390793|FG001|Overall Study|Lost to Follow-up|0|||
155261848|NCT00511875|560390792|FG000|Overall Study|Missing variables|1|||
155261849|NCT00511875|560390793|FG001|Overall Study|Missing variables|0|||
155261850|NCT02686034|560390795|FG000|Run-In Period 1|Eligibility|12|||
155261851|NCT02686034|560390796|FG001|Run-In Period 1|Eligibility|10|||
155261852|NCT02686034|560390795|FG000|Run-In Period 1|Withdrawal by Subject|4|||
155261853|NCT02686034|560390796|FG001|Run-In Period 1|Withdrawal by Subject|3|||
155261854|NCT02686034|560390795|FG000|Run-In Period 1|Lost to Follow-up|4|||
155261855|NCT02686034|560390796|FG001|Run-In Period 1|Lost to Follow-up|4|||
155261856|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
155261857|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
155261858|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
155261859|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
155261860|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Adverse Event|0|||
155261861|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Adverse Event|2|||
155261862|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
155261863|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
155261864|NCT02686034|560390795|FG000|Open Label Period 3|Lost to Follow-up|0|||
155261865|NCT02686034|560390796|FG001|Open Label Period 3|Lost to Follow-up|1|||
155261866|NCT00459342|560390797|FG000|Overall Study|Not eligible|1|||
155261867|NCT00542880|560390798|FG000|Period 1|Eligibility criteria not fulfilled|2|||
155261868|NCT00542880|560390799|FG001|Period 1|Eligibility criteria not fulfilled|6|||
155261869|NCT00542880|560390798|FG000|Period 1|Adverse Event|2|||
155261870|NCT00542880|560390799|FG001|Period 1|Adverse Event|2|||
155261871|NCT00542880|560390798|FG000|Period 1|Development of study-specific criteria|1|||
155261872|NCT00542880|560390799|FG001|Period 1|Development of study-specific criteria|2|||
155261873|NCT00542880|560390798|FG000|Period 1|Withdrawal by Subject|1|||
155261874|NCT00542880|560390799|FG001|Period 1|Withdrawal by Subject|1|||
155261875|NCT00542880|560390798|FG000|Period 1|Protocol Violation|0|||
155261876|NCT00542880|560390799|FG001|Period 1|Protocol Violation|1|||
155261877|NCT00542880|560390798|FG000|Period 2|Adverse Event|5|||
155261878|NCT00542880|560390799|FG001|Period 2|Adverse Event|7|||
155261879|NCT00542880|560390798|FG000|Period 2|Eligibility not fulfilled|0|||
155261880|NCT00542880|560390799|FG001|Period 2|Eligibility not fulfilled|1|||
155261881|NCT00542880|560390798|FG000|Period 2|Discontinuation criteria|2|||
155261882|NCT00542880|560390799|FG001|Period 2|Discontinuation criteria|0|||
155261883|NCT00542880|560390798|FG000|Period 2|Severe non-compliance|0|||
155261884|NCT00542880|560390799|FG001|Period 2|Severe non-compliance|1|||
155261885|NCT00542880|560390798|FG000|Period 2|Other|0|||
155261886|NCT00542880|560390799|FG001|Period 2|Other|1|||
155261887|NCT00542880|560390798|FG000|Period 3|Adverse Event|0|||
155261888|NCT00542880|560390799|FG001|Period 3|Adverse Event|2|||
155261889|NCT00696384|560390800|FG000|Open Label Phase|Adverse Event|27|||
155261890|NCT00696384|560390801|FG001|Open Label Phase|Adverse Event|0|||
155261891|NCT00696384|560390802|FG002|Open Label Phase|Adverse Event|0|||
155261892|NCT00696384|560390800|FG000|Open Label Phase|Protocol Violation|18|||
155261893|NCT00696384|560390801|FG001|Open Label Phase|Protocol Violation|0|||
155261894|NCT00696384|560390802|FG002|Open Label Phase|Protocol Violation|0|||
155261895|NCT00696384|560390800|FG000|Open Label Phase|Lost to Follow-up|24|||
155261896|NCT00696384|560390801|FG001|Open Label Phase|Lost to Follow-up|0|||
155261897|NCT00696384|560390802|FG002|Open Label Phase|Lost to Follow-up|0|||
155261898|NCT00696384|560390800|FG000|Open Label Phase|Withdrawal by Subject|37|||
155261899|NCT00696384|560390801|FG001|Open Label Phase|Withdrawal by Subject|0|||
155261900|NCT00696384|560390802|FG002|Open Label Phase|Withdrawal by Subject|0|||
155261901|NCT00696384|560390800|FG000|Open Label Phase|Other|6|||
155261902|NCT00696384|560390801|FG001|Open Label Phase|Other|0|||
155261903|NCT00696384|560390802|FG002|Open Label Phase|Other|0|||
155261904|NCT00696384|560390800|FG000|Open Label Phase|Lack of Efficacy|3|||
155261905|NCT00696384|560390801|FG001|Open Label Phase|Lack of Efficacy|0|||
155261906|NCT00696384|560390802|FG002|Open Label Phase|Lack of Efficacy|0|||
155261907|NCT00696384|560390800|FG000|Open Label Phase|Physician Decision|4|||
155261908|NCT00696384|560390801|FG001|Open Label Phase|Physician Decision|0|||
155261909|NCT00696384|560390802|FG002|Open Label Phase|Physician Decision|0|||
155261910|NCT00696384|560390800|FG000|Double Blind Phase|Adverse Event|0|||
155261911|NCT00696384|560390801|FG001|Double Blind Phase|Adverse Event|2|||
155261912|NCT00696384|560390802|FG002|Double Blind Phase|Adverse Event|2|||
155261913|NCT00696384|560390800|FG000|Double Blind Phase|Lost to Follow-up|0|||
155261914|NCT00696384|560390801|FG001|Double Blind Phase|Lost to Follow-up|2|||
155261915|NCT00696384|560390802|FG002|Double Blind Phase|Lost to Follow-up|1|||
155261916|NCT00696384|560390800|FG000|Double Blind Phase|Withdrawal by Subject|0|||
155261917|NCT00696384|560390801|FG001|Double Blind Phase|Withdrawal by Subject|4|||
155261918|NCT00696384|560390802|FG002|Double Blind Phase|Withdrawal by Subject|3|||
155261919|NCT00696384|560390800|FG000|Double Blind Phase|Lack of Efficacy|0|||
155261920|NCT00696384|560390801|FG001|Double Blind Phase|Lack of Efficacy|1|||
155261921|NCT00696384|560390802|FG002|Double Blind Phase|Lack of Efficacy|0|||
155261922|NCT00696384|560390800|FG000|Double Blind Phase|Physician Decision|0|||
155261923|NCT00696384|560390801|FG001|Double Blind Phase|Physician Decision|2|||
155261924|NCT00696384|560390802|FG002|Double Blind Phase|Physician Decision|0|||
155261925|NCT01678131|560390803|FG000|Overall Study|Adverse Event|0|||
155261926|NCT01678131|560390804|FG001|Overall Study|Adverse Event|1|||
155261927|NCT01678131|560390805|FG002|Overall Study|Adverse Event|0|||
155261928|NCT01678131|560390803|FG000|Overall Study|Withdrawal by Subject|0|||
155261929|NCT01678131|560390804|FG001|Overall Study|Withdrawal by Subject|0|||
155261930|NCT01678131|560390805|FG002|Overall Study|Withdrawal by Subject|2|||
155261931|NCT00558064|560390806|FG000|Overall Study|Adverse Event|3|||
155261932|NCT00558064|560390807|FG001|Overall Study|Adverse Event|2|||
155261933|NCT00558064|560390806|FG000|Overall Study|Lack of Efficacy|0|||
155261934|NCT00558064|560390807|FG001|Overall Study|Lack of Efficacy|1|||
155261935|NCT00558064|560390806|FG000|Overall Study|Protocol Violation|1|||
155261936|NCT00558064|560390807|FG001|Overall Study|Protocol Violation|0|||
155261937|NCT00558064|560390806|FG000|Overall Study|Lost to Follow-up|0|||
155261938|NCT00558064|560390807|FG001|Overall Study|Lost to Follow-up|1|||
155261939|NCT00558064|560390806|FG000|Overall Study|Withdrawal by Subject|0|||
155261940|NCT00558064|560390807|FG001|Overall Study|Withdrawal by Subject|1|||
155261941|NCT00558064|560390806|FG000|Overall Study|No visit within allowance period|1|||
155261942|NCT00558064|560390807|FG001|Overall Study|No visit within allowance period|0|||
155261943|NCT02027402|560390809|FG000|Overall Study|Withdrawal by Subject|4|||
155261944|NCT02027402|560390810|FG001|Overall Study|Withdrawal by Subject|1|||
155261945|NCT00982930|560390815|FG000|Overall Study|Adverse Event|1|||
155261946|NCT00982930|560390815|FG000|Overall Study|Withdrawal by Subject|1|||
155261947|NCT00982930|560390815|FG000|Overall Study|Administrative Problems|2|||
155261948|NCT00941798|560390816|FG000|Overall Study|Withdrawal by Subject|72|||
155261949|NCT00941798|560390817|FG001|Overall Study|Withdrawal by Subject|74|||
155261950|NCT00941798|560390816|FG000|Overall Study|Adverse Event|43|||
155261951|NCT00941798|560390817|FG001|Overall Study|Adverse Event|23|||
155261952|NCT00941798|560390816|FG000|Overall Study|Lost to Follow-up|29|||
155261953|NCT00941798|560390817|FG001|Overall Study|Lost to Follow-up|23|||
155261954|NCT00941798|560390816|FG000|Overall Study|Protocol Violation|17|||
155261955|NCT00941798|560390817|FG001|Overall Study|Protocol Violation|20|||
155261956|NCT00941798|560390816|FG000|Overall Study|Administrative problems|13|||
155261957|NCT00941798|560390817|FG001|Overall Study|Administrative problems|23|||
155261958|NCT00941798|560390816|FG000|Overall Study|Lack of Efficacy|10|||
155261959|NCT00941798|560390817|FG001|Overall Study|Lack of Efficacy|17|||
155261960|NCT00941798|560390816|FG000|Overall Study|Patient's inability to use device|6|||
155261961|NCT00941798|560390817|FG001|Overall Study|Patient's inability to use device|1|||
155261962|NCT00941798|560390816|FG000|Overall Study|Abnormal test procedure results|3|||
155261963|NCT00941798|560390817|FG001|Overall Study|Abnormal test procedure results|1|||
155261964|NCT00941798|560390816|FG000|Overall Study|Abnormal laboratory values|1|||
155261965|NCT00941798|560390817|FG001|Overall Study|Abnormal laboratory values|2|||
155261966|NCT00941798|560390816|FG000|Overall Study|Death|0|||
155261967|NCT00941798|560390817|FG001|Overall Study|Death|1|||
155261968|NCT04179721|560390820|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
155261969|NCT04179721|560390821|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
155261970|NCT04179721|560390820|FG000|Overall Study|Lost to Follow-up|0|||
155261971|NCT04179721|560390821|FG001|Overall Study|Lost to Follow-up|1|||
155261972|NCT04225988|560390822|FG000|Overall Study|Withdrawal by Subject|2|||
155261973|NCT04225988|560390823|FG001|Overall Study|Withdrawal by Subject|0|||
155261974|NCT00404495|560390824|FG000|Overall Study|Death|37|||
155261975|NCT00404495|560390825|FG001|Overall Study|Death|11|||
155261976|NCT00404495|560390824|FG000|Overall Study|Lost to Follow-up|5|||
155261977|NCT00404495|560390825|FG001|Overall Study|Lost to Follow-up|0|||
155261978|NCT00404495|560390824|FG000|Overall Study|Other|1|||
155261979|NCT00404495|560390825|FG001|Overall Study|Other|0|||
155261980|NCT00404495|560390824|FG000|Overall Study|Withdrawal by Subject|1|||
155261981|NCT00404495|560390825|FG001|Overall Study|Withdrawal by Subject|0|||
155261982|NCT03904043|560390826|FG000|Overall Study|Adverse Event|1|||
155261983|NCT03904043|560390827|FG001|Overall Study|Adverse Event|1|||
155261984|NCT03904043|560390826|FG000|Overall Study|Withdrawal by Subject|1|||
155261985|NCT03904043|560390827|FG001|Overall Study|Withdrawal by Subject|0|||
155261986|NCT03904043|560390826|FG000|Overall Study|Non-compliance|1|||
155261987|NCT03904043|560390827|FG001|Overall Study|Non-compliance|0|||
155261988|NCT03904043|560390826|FG000|Overall Study|Did not start treatment|1|||
155261989|NCT03904043|560390827|FG001|Overall Study|Did not start treatment|0|||
155261990|NCT01493960|560392638|FG000|Overall Study|Adverse Event|0|||
155261991|NCT01493960|560392639|FG001|Overall Study|Adverse Event|1|||
155261992|NCT01493960|560392638|FG000|Overall Study|Lack of Efficacy|15|||
155261993|NCT01493960|560392639|FG001|Overall Study|Lack of Efficacy|9|||
155261994|NCT01493960|560392638|FG000|Overall Study|Protocol Violation|3|||
155261995|NCT01493960|560392639|FG001|Overall Study|Protocol Violation|0|||
155261996|NCT01493960|560392638|FG000|Overall Study|Withdrawal by Subject|10|||
155261997|NCT01493960|560392639|FG001|Overall Study|Withdrawal by Subject|4|||
155261998|NCT01493960|560392638|FG000|Overall Study|Non-specified|4|||
155261999|NCT01493960|560392639|FG001|Overall Study|Non-specified|4|||
155262000|NCT03935217|560392640|FG000|Overall Study|Adverse Event|1|||
155262001|NCT03935217|560392641|FG001|Overall Study|Adverse Event|0|||
155262002|NCT03935217|560392640|FG000|Overall Study|Lost to Follow-up|0|||
155262003|NCT03935217|560392641|FG001|Overall Study|Lost to Follow-up|1|||
155262004|NCT03935217|560392640|FG000|Overall Study|Withdrawal by Subject|0|||
155262005|NCT03935217|560392641|FG001|Overall Study|Withdrawal by Subject|2|||
155262006|NCT01160484|560392643|FG000|Overall Study|Lack of Efficacy|9|||
155262007|NCT01160484|560392643|FG000|Overall Study|Adverse Event|6|||
155262008|NCT01160484|560392643|FG000|Overall Study|Withdrawal by Subject|2|||
155262009|NCT01160484|560392643|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
155262010|NCT00332332|560392644|FG000|Overall Study|Adverse Event|13|||
155262011|NCT00332332|560392644|FG000|Overall Study|Death|1|||
155262012|NCT00332332|560392644|FG000|Overall Study|Withdrawal by Subject|8|||
155262013|NCT00332332|560392644|FG000|Overall Study|Physician Decision|1|||
155262014|NCT00332332|560392644|FG000|Overall Study|Lost to Follow-up|3|||
155262015|NCT00332332|560392644|FG000|Overall Study|Protocol deviation|4|||
155262016|NCT00332332|560392644|FG000|Overall Study|Noncompliance|2|||
155262017|NCT00332332|560392644|FG000|Overall Study|Disease progression|2|||
155262018|NCT00332332|560392644|FG000|Overall Study|Other|18|||
155262019|NCT00332332|560392644|FG000|Overall Study|Did not receive study treatment|16|||
155262020|NCT00755222|560392653|FG000|Overall Study|Withdrawal by Subject|4|||
155262021|NCT00755222|560392654|FG001|Overall Study|Withdrawal by Subject|2|||
155262022|NCT00755222|560392653|FG000|Overall Study|Adverse Event|2|||
155262023|NCT00755222|560392654|FG001|Overall Study|Adverse Event|0|||
155262024|NCT00755222|560392653|FG000|Overall Study|Protocol Violation|2|||
155262025|NCT00755222|560392654|FG001|Overall Study|Protocol Violation|0|||
155262026|NCT01147822|560392661|FG000|Overall Study|Lost to Follow-up|14|||
155262027|NCT01147822|560392662|FG001|Overall Study|Lost to Follow-up|6|||
155262028|NCT01147822|560392661|FG000|Overall Study|Withdrawal by Subject|10|||
155262029|NCT01147822|560392662|FG001|Overall Study|Withdrawal by Subject|16|||
155262030|NCT01147822|560392661|FG000|Overall Study|Physician Decision|9|||
155262031|NCT01147822|560392662|FG001|Overall Study|Physician Decision|8|||
155262032|NCT01147822|560392661|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
155262033|NCT01147822|560392662|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
155262034|NCT01147822|560392661|FG000|Overall Study|Protocol Violation|1|||
155262035|NCT01147822|560392662|FG001|Overall Study|Protocol Violation|1|||
155262036|NCT04382924|560392666|FG000|Overall Study|Death|2|||
155262037|NCT04382924|560392667|FG001|Overall Study|Death|5|||
155262038|NCT04382924|560392668|FG002|Overall Study|Death|4|||
155262039|NCT04382924|560392666|FG000|Overall Study|Protocol Violation|0|||
155262040|NCT04382924|560392667|FG001|Overall Study|Protocol Violation|1|||
155262041|NCT04382924|560392668|FG002|Overall Study|Protocol Violation|1|||
155262042|NCT04382924|560392666|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
155262043|NCT04382924|560392667|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
155262044|NCT04382924|560392668|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
155262045|NCT04382924|560392666|FG000|Overall Study|Withdrawal by Subject|6|||
155262046|NCT04382924|560392667|FG001|Overall Study|Withdrawal by Subject|3|||
155262047|NCT04382924|560392668|FG002|Overall Study|Withdrawal by Subject|6|||
155262048|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
155262049|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
155262050|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
155262051|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
155262052|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
155262053|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
155262054|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
155262055|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
155262056|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
155262057|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
155262058|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
155262059|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
155262060|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
155262061|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
155262062|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
155262063|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
155262064|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
155262065|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
155262066|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
155262067|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
155262068|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
155262069|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
155262070|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
155262071|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
155262072|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
155262073|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
155262074|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
155262075|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
155262076|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
155262077|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
155262078|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
155262079|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
155262080|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
155262081|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155262082|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
155262083|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
155262084|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155262085|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
155262086|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
155262087|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
155262088|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
155262089|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155262090|NCT01932697|560392673|FG000|Overall Study|Received a different amount of tx|1|||
155262091|NCT01932697|560392674|FG001|Overall Study|Received a different amount of tx|0|||
155262092|NCT01932697|560392673|FG000|Overall Study|Ineligible|1|||
155262093|NCT01932697|560392674|FG001|Overall Study|Ineligible|0|||
155262094|NCT00215540|560392688|FG000|Overall Study|Withdrew from study medication|1|||
155262095|NCT00215540|560392689|FG001|Overall Study|Withdrew from study medication|0|||
155262096|NCT00215540|560392690|FG002|Overall Study|Withdrew from study medication|0|||
155262097|NCT03010462|560392691|FG000|Overall Study|Withdrawal by Subject|3|||
155262098|NCT03010462|560392692|FG001|Overall Study|Withdrawal by Subject|1|||
155262099|NCT01492686|560392693|FG000|Double-blind Phase|Adverse Event|0|||
155262100|NCT01492686|560392694|FG001|Double-blind Phase|Adverse Event|2|||
155262101|NCT01492686|560392693|FG000|Double-blind Phase|Physician Decision|0|||
155262102|NCT01492686|560392694|FG001|Double-blind Phase|Physician Decision|1|||
155262103|NCT01492686|560392693|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155262104|NCT01492686|560392694|FG001|Double-blind Phase|Withdrawal by Subject|2|||
155262105|NCT01492686|560392693|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
155262106|NCT01492686|560392694|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
155262107|NCT01492686|560392693|FG000|Open-label Phase|Adverse Event|1|||
155262108|NCT01492686|560392694|FG001|Open-label Phase|Adverse Event|2|||
155262109|NCT01492686|560392693|FG000|Open-label Phase|Physician Decision|1|||
155262110|NCT01492686|560392694|FG001|Open-label Phase|Physician Decision|0|||
155262111|NCT01492686|560392693|FG000|Open-label Phase|Withdrawal by Subject|6|||
155262112|NCT01492686|560392694|FG001|Open-label Phase|Withdrawal by Subject|7|||
155262113|NCT01492686|560392693|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
155262114|NCT01492686|560392694|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
155262115|NCT02313909|560392695|FG000|Overall Study|Consent withdrawn by participant|33|||
155262116|NCT02313909|560392696|FG001|Overall Study|Consent withdrawn by participant|33|||
155262117|NCT02313909|560392695|FG000|Overall Study|Lost to Follow-up|24|||
155262118|NCT02313909|560392696|FG001|Overall Study|Lost to Follow-up|17|||
155262119|NCT02798211|560392697|FG000|Period 1|Adverse Event|1|||
155262120|NCT02798211|560392698|FG001|Period 1|Adverse Event|1|||
155262121|NCT02798211|560392699|FG002|Period 1|Adverse Event|0|||
155262122|NCT02798211|560392700|FG003|Period 1|Adverse Event|0|||
155262123|NCT02798211|560392701|FG004|Period 1|Adverse Event|0|||
155262124|NCT02798211|560392702|FG005|Period 1|Adverse Event|0|||
155262125|NCT02798211|560392697|FG000|Period 1|Lost to Follow-up|2|||
155262126|NCT02798211|560392698|FG001|Period 1|Lost to Follow-up|1|||
155262127|NCT02798211|560392699|FG002|Period 1|Lost to Follow-up|0|||
155262128|NCT02798211|560392700|FG003|Period 1|Lost to Follow-up|0|||
155262129|NCT02798211|560392701|FG004|Period 1|Lost to Follow-up|0|||
155262130|NCT02798211|560392702|FG005|Period 1|Lost to Follow-up|0|||
155262131|NCT02798211|560392697|FG000|Period 1|Protocol Violation|0|||
155262132|NCT02798211|560392698|FG001|Period 1|Protocol Violation|0|||
155262133|NCT02798211|560392699|FG002|Period 1|Protocol Violation|2|||
155262134|NCT02798211|560392700|FG003|Period 1|Protocol Violation|0|||
155262135|NCT02798211|560392701|FG004|Period 1|Protocol Violation|0|||
155262136|NCT02798211|560392702|FG005|Period 1|Protocol Violation|0|||
155262137|NCT02798211|560392697|FG000|Period 1|Withdrawal by Subject|1|||
155262138|NCT02798211|560392698|FG001|Period 1|Withdrawal by Subject|1|||
155262139|NCT02798211|560392699|FG002|Period 1|Withdrawal by Subject|0|||
155262140|NCT02798211|560392700|FG003|Period 1|Withdrawal by Subject|0|||
155262141|NCT02798211|560392701|FG004|Period 1|Withdrawal by Subject|0|||
155262142|NCT02798211|560392702|FG005|Period 1|Withdrawal by Subject|0|||
155262143|NCT02798211|560392697|FG000|Period 1|Death|0|||
155262144|NCT02798211|560392698|FG001|Period 1|Death|0|||
155262145|NCT02798211|560392699|FG002|Period 1|Death|1|||
155262146|NCT02798211|560392700|FG003|Period 1|Death|0|||
155262147|NCT02798211|560392701|FG004|Period 1|Death|0|||
155262148|NCT02798211|560392702|FG005|Period 1|Death|0|||
155262149|NCT02798211|560392697|FG000|Period 1|Withdrawal of Informed Consent|2|||
155262150|NCT02798211|560392698|FG001|Period 1|Withdrawal of Informed Consent|7|||
155262151|NCT02798211|560392699|FG002|Period 1|Withdrawal of Informed Consent|3|||
155262152|NCT02798211|560392700|FG003|Period 1|Withdrawal of Informed Consent|0|||
155262153|NCT02798211|560392701|FG004|Period 1|Withdrawal of Informed Consent|0|||
155262154|NCT02798211|560392702|FG005|Period 1|Withdrawal of Informed Consent|0|||
155262155|NCT02798211|560392697|FG000|Period 2|Withdrawal by Subject|2|||
155262156|NCT02798211|560392698|FG001|Period 2|Withdrawal by Subject|0|||
155262157|NCT02798211|560392699|FG002|Period 2|Withdrawal by Subject|0|||
155262158|NCT02798211|560392700|FG003|Period 2|Withdrawal by Subject|0|||
155262159|NCT02798211|560392701|FG004|Period 2|Withdrawal by Subject|2|||
155262160|NCT02798211|560392702|FG005|Period 2|Withdrawal by Subject|2|||
155262161|NCT02798211|560392697|FG000|Period 2|Adverse Event|5|||
155262162|NCT02798211|560392698|FG001|Period 2|Adverse Event|0|||
155262163|NCT02798211|560392699|FG002|Period 2|Adverse Event|0|||
155262164|NCT02798211|560392700|FG003|Period 2|Adverse Event|0|||
155262165|NCT02798211|560392701|FG004|Period 2|Adverse Event|1|||
155262166|NCT02798211|560392702|FG005|Period 2|Adverse Event|0|||
155262167|NCT02798211|560392697|FG000|Period 2|Lack of Efficacy|1|||
155262168|NCT02798211|560392698|FG001|Period 2|Lack of Efficacy|0|||
155262169|NCT02798211|560392699|FG002|Period 2|Lack of Efficacy|0|||
155262170|NCT02798211|560392700|FG003|Period 2|Lack of Efficacy|1|||
155262171|NCT02798211|560392701|FG004|Period 2|Lack of Efficacy|0|||
155262172|NCT02798211|560392702|FG005|Period 2|Lack of Efficacy|1|||
155262173|NCT02798211|560392697|FG000|Period 2|Lost to Follow-up|3|||
155262174|NCT02798211|560392698|FG001|Period 2|Lost to Follow-up|0|||
155262175|NCT02798211|560392699|FG002|Period 2|Lost to Follow-up|0|||
155262176|NCT02798211|560392700|FG003|Period 2|Lost to Follow-up|0|||
155262177|NCT02798211|560392701|FG004|Period 2|Lost to Follow-up|2|||
155262178|NCT02798211|560392702|FG005|Period 2|Lost to Follow-up|0|||
155262179|NCT02798211|560392697|FG000|Period 2|Physician Decision|1|||
155262180|NCT02798211|560392698|FG001|Period 2|Physician Decision|0|||
155262181|NCT02798211|560392699|FG002|Period 2|Physician Decision|0|||
155262182|NCT02798211|560392700|FG003|Period 2|Physician Decision|1|||
155262183|NCT02798211|560392701|FG004|Period 2|Physician Decision|1|||
155262184|NCT02798211|560392702|FG005|Period 2|Physician Decision|0|||
155262185|NCT02798211|560392697|FG000|Period 2|Pregnancy|0|||
155262186|NCT02798211|560392698|FG001|Period 2|Pregnancy|0|||
155262187|NCT02798211|560392699|FG002|Period 2|Pregnancy|0|||
155262188|NCT02798211|560392700|FG003|Period 2|Pregnancy|2|||
155262189|NCT02798211|560392701|FG004|Period 2|Pregnancy|0|||
155262190|NCT02798211|560392702|FG005|Period 2|Pregnancy|0|||
155262191|NCT02798211|560392697|FG000|Period 2|Technical problems|1|||
155262192|NCT02798211|560392698|FG001|Period 2|Technical problems|0|||
155262193|NCT02798211|560392699|FG002|Period 2|Technical problems|0|||
155262194|NCT02798211|560392700|FG003|Period 2|Technical problems|1|||
155262195|NCT02798211|560392701|FG004|Period 2|Technical problems|0|||
155262196|NCT02798211|560392702|FG005|Period 2|Technical problems|0|||
155262197|NCT02798211|560392697|FG000|Period 2|Withdrawal of Informed Consent|1|||
155262198|NCT02798211|560392698|FG001|Period 2|Withdrawal of Informed Consent|0|||
155262199|NCT02798211|560392699|FG002|Period 2|Withdrawal of Informed Consent|0|||
155262200|NCT02798211|560392700|FG003|Period 2|Withdrawal of Informed Consent|2|||
155262201|NCT02798211|560392701|FG004|Period 2|Withdrawal of Informed Consent|2|||
155262202|NCT02798211|560392702|FG005|Period 2|Withdrawal of Informed Consent|3|||
155262203|NCT01782872|560392703|FG000|Overall Study|Protocol Violation|0|||
155262204|NCT01782872|560392704|FG001|Overall Study|Protocol Violation|0|||
155262205|NCT01782872|560392705|FG002|Overall Study|Protocol Violation|0|||
155262206|NCT01782872|560392706|FG003|Overall Study|Protocol Violation|1|||
155262207|NCT01782872|560392703|FG000|Overall Study|Withdrawal by Subject|0|||
155262208|NCT01782872|560392704|FG001|Overall Study|Withdrawal by Subject|1|||
155262209|NCT01782872|560392705|FG002|Overall Study|Withdrawal by Subject|0|||
155262210|NCT01782872|560392706|FG003|Overall Study|Withdrawal by Subject|0|||
155262211|NCT03505476|560392707|FG000|Overall Study|Physician Decision|18|||
155262212|NCT03505476|560392707|FG000|Overall Study|Device Malfunctioned|101|||
155262213|NCT03505476|560392707|FG000|Overall Study|Data Corrupt|6|||
155262214|NCT03505476|560392707|FG000|Overall Study|Device application insufficiant|3|||
155262215|NCT02748694|560392708|FG000|Overall Study|Voluntary Withdrawal|0|||
155262216|NCT02748694|560392709|FG001|Overall Study|Voluntary Withdrawal|0|||
155262217|NCT02748694|560392710|FG002|Overall Study|Voluntary Withdrawal|0|||
155262218|NCT02748694|560392711|FG003|Overall Study|Voluntary Withdrawal|0|||
155262219|NCT02748694|560392712|FG004|Overall Study|Voluntary Withdrawal|0|||
155262220|NCT02748694|560392713|FG005|Overall Study|Voluntary Withdrawal|0|||
155262221|NCT02748694|560392714|FG006|Overall Study|Voluntary Withdrawal|0|||
155262222|NCT02748694|560392715|FG007|Overall Study|Voluntary Withdrawal|0|||
155262223|NCT02748694|560392716|FG008|Overall Study|Voluntary Withdrawal|0|||
155262224|NCT02748694|560392717|FG009|Overall Study|Voluntary Withdrawal|0|||
155262225|NCT02748694|560392718|FG010|Overall Study|Voluntary Withdrawal|0|||
155262226|NCT02748694|560392719|FG011|Overall Study|Voluntary Withdrawal|0|||
155262227|NCT02748694|560392720|FG012|Overall Study|Voluntary Withdrawal|0|||
155262228|NCT02748694|560392721|FG013|Overall Study|Voluntary Withdrawal|0|||
155262229|NCT02748694|560392722|FG014|Overall Study|Voluntary Withdrawal|2|||
155262230|NCT04026165|560392725|FG000|Run-in Placebo Period|Enrollment Error|13|||
155262231|NCT04026165|560392726|FG001|Run-in Placebo Period|Enrollment Error|0|||
155262232|NCT04026165|560392727|FG002|Run-in Placebo Period|Enrollment Error|0|||
155262233|NCT04026165|560392728|FG003|Run-in Placebo Period|Enrollment Error|0|||
155262234|NCT04026165|560392725|FG000|Run-in Placebo Period|Run-in Failure|4|||
155262235|NCT04026165|560392726|FG001|Run-in Placebo Period|Run-in Failure|0|||
155262236|NCT04026165|560392727|FG002|Run-in Placebo Period|Run-in Failure|0|||
155262237|NCT04026165|560392728|FG003|Run-in Placebo Period|Run-in Failure|0|||
155262238|NCT04026165|560392725|FG000|Run-in Placebo Period|Protocol Violation|2|||
155262239|NCT04026165|560392726|FG001|Run-in Placebo Period|Protocol Violation|0|||
155262240|NCT04026165|560392727|FG002|Run-in Placebo Period|Protocol Violation|0|||
155262241|NCT04026165|560392728|FG003|Run-in Placebo Period|Protocol Violation|0|||
155262242|NCT04026165|560392725|FG000|Run-in Placebo Period|Withdrew Consent|2|||
155262243|NCT04026165|560392726|FG001|Run-in Placebo Period|Withdrew Consent|0|||
155262244|NCT04026165|560392727|FG002|Run-in Placebo Period|Withdrew Consent|0|||
155262245|NCT04026165|560392728|FG003|Run-in Placebo Period|Withdrew Consent|0|||
155262246|NCT04026165|560392725|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
155262247|NCT04026165|560392726|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262248|NCT04026165|560392727|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262249|NCT04026165|560392728|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262250|NCT04026165|560392725|FG000|Run-in SEL Period|Run-in Failure|0|||
155262251|NCT04026165|560392726|FG001|Run-in SEL Period|Run-in Failure|26|||
155262252|NCT04026165|560392727|FG002|Run-in SEL Period|Run-in Failure|0|||
155262253|NCT04026165|560392728|FG003|Run-in SEL Period|Run-in Failure|0|||
155262254|NCT04026165|560392725|FG000|Run-in SEL Period|Withdrew Consent|0|||
155262255|NCT04026165|560392726|FG001|Run-in SEL Period|Withdrew Consent|10|||
155262256|NCT04026165|560392727|FG002|Run-in SEL Period|Withdrew Consent|0|||
155262257|NCT04026165|560392728|FG003|Run-in SEL Period|Withdrew Consent|0|||
155262258|NCT04026165|560392725|FG000|Run-in SEL Period|Enrollment Error|0|||
155262259|NCT04026165|560392726|FG001|Run-in SEL Period|Enrollment Error|4|||
155262260|NCT04026165|560392727|FG002|Run-in SEL Period|Enrollment Error|0|||
155262261|NCT04026165|560392728|FG003|Run-in SEL Period|Enrollment Error|0|||
155262262|NCT04026165|560392725|FG000|Run-in SEL Period|Protocol Violation|0|||
155262263|NCT04026165|560392726|FG001|Run-in SEL Period|Protocol Violation|3|||
155262264|NCT04026165|560392727|FG002|Run-in SEL Period|Protocol Violation|0|||
155262265|NCT04026165|560392728|FG003|Run-in SEL Period|Protocol Violation|0|||
155262266|NCT04026165|560392725|FG000|Run-in SEL Period|Investigator's Discretion|0|||
155262267|NCT04026165|560392726|FG001|Run-in SEL Period|Investigator's Discretion|2|||
155262268|NCT04026165|560392727|FG002|Run-in SEL Period|Investigator's Discretion|0|||
155262269|NCT04026165|560392728|FG003|Run-in SEL Period|Investigator's Discretion|0|||
155262270|NCT04026165|560392725|FG000|Run-in SEL Period|Death|0|||
155262271|NCT04026165|560392726|FG001|Run-in SEL Period|Death|1|||
155262272|NCT04026165|560392727|FG002|Run-in SEL Period|Death|0|||
155262273|NCT04026165|560392728|FG003|Run-in SEL Period|Death|0|||
155262274|NCT04026165|560392725|FG000|Randomized Period|Withdrew Consent|0|||
155262275|NCT04026165|560392726|FG001|Randomized Period|Withdrew Consent|0|||
155262276|NCT04026165|560392727|FG002|Randomized Period|Withdrew Consent|5|||
155262277|NCT04026165|560392728|FG003|Randomized Period|Withdrew Consent|8|||
155262278|NCT04026165|560392725|FG000|Randomized Period|Death|0|||
155262279|NCT04026165|560392726|FG001|Randomized Period|Death|0|||
155262280|NCT04026165|560392727|FG002|Randomized Period|Death|5|||
155262281|NCT04026165|560392728|FG003|Randomized Period|Death|7|||
155262282|NCT04026165|560392725|FG000|Randomized Period|Investigator's Discretion|0|||
155262283|NCT04026165|560392726|FG001|Randomized Period|Investigator's Discretion|0|||
155262284|NCT04026165|560392727|FG002|Randomized Period|Investigator's Discretion|2|||
155262285|NCT04026165|560392728|FG003|Randomized Period|Investigator's Discretion|2|||
155262286|NCT04026165|560392725|FG000|Randomized Period|Lost to Follow-up|0|||
155262287|NCT04026165|560392726|FG001|Randomized Period|Lost to Follow-up|0|||
155262288|NCT04026165|560392727|FG002|Randomized Period|Lost to Follow-up|2|||
155262289|NCT04026165|560392728|FG003|Randomized Period|Lost to Follow-up|2|||
155262290|NCT01059630|560392731|FG000|Overall Study|Death|100|||
155262291|NCT01059630|560392732|FG001|Overall Study|Death|84|||
155262292|NCT01059630|560392731|FG000|Overall Study|Lost to Follow-up|4|||
155262293|NCT01059630|560392732|FG001|Overall Study|Lost to Follow-up|1|||
155262294|NCT01059630|560392731|FG000|Overall Study|Physician Decision|2|||
155262295|NCT01059630|560392732|FG001|Overall Study|Physician Decision|4|||
155262296|NCT01059630|560392731|FG000|Overall Study|Withdrawal by Subject|21|||
155262297|NCT01059630|560392732|FG001|Overall Study|Withdrawal by Subject|14|||
155262298|NCT03170375|560392733|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
155262299|NCT03170375|560392734|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
155262300|NCT03170375|560392735|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
155262301|NCT03170375|560392733|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
155262302|NCT03170375|560392734|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
155262303|NCT03170375|560392735|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
155262304|NCT00441701|560392736|FG000|Overall Study|Adverse Event|3|||
155262305|NCT00441701|560392737|FG001|Overall Study|Adverse Event|2|||
155262306|NCT00441701|560392738|FG002|Overall Study|Adverse Event|1|||
155262307|NCT00441701|560392739|FG003|Overall Study|Adverse Event|0|||
155262308|NCT00441701|560392740|FG004|Overall Study|Adverse Event|2|||
155262309|NCT00441701|560392741|FG005|Overall Study|Adverse Event|2|||
155262310|NCT00441701|560392742|FG006|Overall Study|Adverse Event|0|||
155262311|NCT00441701|560392743|FG007|Overall Study|Adverse Event|0|||
155262312|NCT00441701|560392744|FG008|Overall Study|Adverse Event|0|||
155262313|NCT00441701|560392745|FG009|Overall Study|Adverse Event|0|||
155262314|NCT00441701|560392736|FG000|Overall Study|Lack of Efficacy|2|||
155262315|NCT00441701|560392737|FG001|Overall Study|Lack of Efficacy|0|||
155262316|NCT00441701|560392738|FG002|Overall Study|Lack of Efficacy|2|||
155262317|NCT00441701|560392739|FG003|Overall Study|Lack of Efficacy|2|||
155262318|NCT00441701|560392740|FG004|Overall Study|Lack of Efficacy|0|||
155262319|NCT00441701|560392741|FG005|Overall Study|Lack of Efficacy|1|||
155262320|NCT00441701|560392742|FG006|Overall Study|Lack of Efficacy|0|||
155262321|NCT00441701|560392743|FG007|Overall Study|Lack of Efficacy|0|||
155262322|NCT00441701|560392744|FG008|Overall Study|Lack of Efficacy|0|||
155262323|NCT00441701|560392745|FG009|Overall Study|Lack of Efficacy|0|||
155262324|NCT00441701|560392736|FG000|Overall Study|Withdrawal by Subject|0|||
155262325|NCT00441701|560392737|FG001|Overall Study|Withdrawal by Subject|2|||
155262326|NCT00441701|560392738|FG002|Overall Study|Withdrawal by Subject|1|||
155262327|NCT00441701|560392739|FG003|Overall Study|Withdrawal by Subject|1|||
155262328|NCT00441701|560392740|FG004|Overall Study|Withdrawal by Subject|0|||
155262329|NCT00441701|560392741|FG005|Overall Study|Withdrawal by Subject|0|||
155262330|NCT00441701|560392742|FG006|Overall Study|Withdrawal by Subject|0|||
155262331|NCT00441701|560392743|FG007|Overall Study|Withdrawal by Subject|0|||
155262332|NCT00441701|560392744|FG008|Overall Study|Withdrawal by Subject|0|||
155262333|NCT00441701|560392745|FG009|Overall Study|Withdrawal by Subject|0|||
155262334|NCT00077064|560392746|FG000|Overall Study|Adverse Event|0|||
155262335|NCT00077064|560392747|FG001|Overall Study|Adverse Event|4|||
155262336|NCT00077064|560392746|FG000|Overall Study|Patient refusal|0|||
155262337|NCT00077064|560392747|FG001|Overall Study|Patient refusal|2|||
155262338|NCT02007434|560392753|FG000|Overall Study|Lost to Follow-up|0|||
155262339|NCT02007434|560392754|FG001|Overall Study|Lost to Follow-up|1|||
155262340|NCT02007434|560392755|FG002|Overall Study|Lost to Follow-up|0|||
155262341|NCT02007434|560392756|FG003|Overall Study|Lost to Follow-up|0|||
155262342|NCT02007434|560392757|FG004|Overall Study|Lost to Follow-up|0|||
155262343|NCT02007434|560392758|FG005|Overall Study|Lost to Follow-up|0|||
155262344|NCT02007434|560392759|FG006|Overall Study|Lost to Follow-up|0|||
155262345|NCT02007434|560392760|FG007|Overall Study|Lost to Follow-up|0|||
155262346|NCT02007434|560392753|FG000|Overall Study|Non-compliance|1|||
155262347|NCT02007434|560392754|FG001|Overall Study|Non-compliance|0|||
155262348|NCT02007434|560392755|FG002|Overall Study|Non-compliance|1|||
155262349|NCT02007434|560392756|FG003|Overall Study|Non-compliance|0|||
155262350|NCT02007434|560392757|FG004|Overall Study|Non-compliance|0|||
155262351|NCT02007434|560392758|FG005|Overall Study|Non-compliance|0|||
155262352|NCT02007434|560392759|FG006|Overall Study|Non-compliance|0|||
155262353|NCT02007434|560392760|FG007|Overall Study|Non-compliance|0|||
155262354|NCT03299686|560392774|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
155262355|NCT03299686|560392775|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
155262356|NCT03299686|560392774|FG000|Treatment Epoch|Physician Decision|1|||
155262357|NCT03299686|560392775|FG001|Treatment Epoch|Physician Decision|0|||
155262358|NCT03299686|560392774|FG000|Treatment Epoch|Adverse Event|8|||
155262359|NCT03299686|560392775|FG001|Treatment Epoch|Adverse Event|4|||
155262360|NCT03299686|560392774|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
155262361|NCT03299686|560392775|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
155262362|NCT02709005|560392776|FG000|Overall Study|Lost to Follow-up|1|||
155262363|NCT02709005|560392777|FG001|Overall Study|Lost to Follow-up|1|||
155262364|NCT02709005|560392776|FG000|Overall Study|Withdrawal by Subject|3|||
155607056|NCT03217968|561649624|FG000|Overall Study|Protocol Violation|6|||
155262365|NCT02709005|560392777|FG001|Overall Study|Withdrawal by Subject|0|||
155262366|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
155262367|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
155262368|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
155262369|NCT02535364|560392783|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
155262370|NCT02535364|560392783|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
155262371|NCT02535364|560392783|FG000|Part B Screening|Death|2|||
155262372|NCT02535364|560392783|FG000|Part B Screening|Physician Decision|1|||
155262373|NCT02535364|560392783|FG000|Part B Screening|Withdrawal by Subject|1|||
155262374|NCT02535364|560392783|FG000|Part B Screening|Adverse Event|1|||
155262375|NCT02535364|560392783|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
155262376|NCT02535364|560392783|FG000|Study Treatment|Death|1|||
155262377|NCT02535364|560392783|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
155262378|NCT02535364|560392783|FG000|12-Month Follow-up Period|Disease progression|22|||
155262379|NCT02535364|560392783|FG000|12-Month Follow-up Period|Death|5|||
155262380|NCT02535364|560392783|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
155262381|NCT02535364|560392783|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
155262382|NCT02535364|560392783|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
155262383|NCT02889133|560392789|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
155262384|NCT02889133|560392790|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
155262385|NCT02889133|560392789|FG000|Completed Primary Outcome|Manufacturing error|3|||
155262386|NCT02889133|560392790|FG001|Completed Primary Outcome|Manufacturing error|8|||
155262387|NCT02889133|560392789|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
155262388|NCT02889133|560392790|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
155262389|NCT02889133|560392789|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
155262390|NCT02889133|560392790|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
155262391|NCT02889133|560392789|FG000|Completed Primary Outcome|Protocol Violation|1|||
155262392|NCT02889133|560392790|FG001|Completed Primary Outcome|Protocol Violation|0|||
155262393|NCT02889133|560392789|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
155262394|NCT02889133|560392790|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
155262395|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
155262396|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
155262397|NCT02889133|560392789|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
155262398|NCT02889133|560392790|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
155262399|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
155262400|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
155262401|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
155262402|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
155262403|NCT01375205|560392791|FG000|Overall Study|Lost to Follow-up|15|||
155262404|NCT01375205|560392792|FG001|Overall Study|Lost to Follow-up|12|||
155262405|NCT01375205|560392791|FG000|Overall Study|Withdrawal by Subject|6|||
155262406|NCT01375205|560392792|FG001|Overall Study|Withdrawal by Subject|1|||
155262407|NCT01148862|560392793|FG000|Second Intervention|Withdrawal by Subject|0|||
155262408|NCT01148862|560392794|FG001|Second Intervention|Withdrawal by Subject|2|||
155262409|NCT04270747|560392795|FG000|Through Week 16|Adverse Event|1|||
155262410|NCT04270747|560392796|FG001|Through Week 16|Adverse Event|2|||
155262411|NCT04270747|560392797|FG002|Through Week 16|Adverse Event|0|||
155262412|NCT04270747|560392795|FG000|Through Week 16|Death|0|||
155262413|NCT04270747|560392796|FG001|Through Week 16|Death|2|||
155262414|NCT04270747|560392797|FG002|Through Week 16|Death|0|||
155262415|NCT04270747|560392795|FG000|Through Week 16|Consent Withdrawn|3|||
155262416|NCT04270747|560392796|FG001|Through Week 16|Consent Withdrawn|3|||
155262417|NCT04270747|560392797|FG002|Through Week 16|Consent Withdrawn|0|||
155262418|NCT04270747|560392795|FG000|Through Week 16|Physician Decision|1|||
155262419|NCT04270747|560392796|FG001|Through Week 16|Physician Decision|1|||
155262420|NCT04270747|560392797|FG002|Through Week 16|Physician Decision|0|||
155262421|NCT04270747|560392795|FG000|Through Week 16|Lost to Follow-up|2|||
155262422|NCT04270747|560392796|FG001|Through Week 16|Lost to Follow-up|0|||
155262423|NCT04270747|560392797|FG002|Through Week 16|Lost to Follow-up|0|||
155262424|NCT04270747|560392795|FG000|Through Week 16|Protocol Violation|1|||
155262425|NCT04270747|560392796|FG001|Through Week 16|Protocol Violation|2|||
155262426|NCT04270747|560392797|FG002|Through Week 16|Protocol Violation|0|||
155262427|NCT04270747|560392795|FG000|Through Week 16|Protocol Specified Criteria|6|||
155262428|NCT04270747|560392796|FG001|Through Week 16|Protocol Specified Criteria|7|||
155262429|NCT04270747|560392797|FG002|Through Week 16|Protocol Specified Criteria|0|||
155262430|NCT04270747|560392795|FG000|Through Week 16|Miscellaneous|1|||
155262431|NCT04270747|560392796|FG001|Through Week 16|Miscellaneous|1|||
155262432|NCT04270747|560392797|FG002|Through Week 16|Miscellaneous|0|||
155262433|NCT04270747|560392795|FG000|Post Week 16|Adverse Event|7|||
155262434|NCT04270747|560392796|FG001|Post Week 16|Adverse Event|5|||
155262435|NCT04270747|560392797|FG002|Post Week 16|Adverse Event|1|||
155262436|NCT04270747|560392795|FG000|Post Week 16|Death|2|||
155262437|NCT04270747|560392796|FG001|Post Week 16|Death|0|||
155262438|NCT04270747|560392797|FG002|Post Week 16|Death|2|||
155262439|NCT04270747|560392795|FG000|Post Week 16|Consent Withdrawn|4|||
155262440|NCT04270747|560392796|FG001|Post Week 16|Consent Withdrawn|3|||
155262441|NCT04270747|560392797|FG002|Post Week 16|Consent Withdrawn|6|||
155262442|NCT04270747|560392795|FG000|Post Week 16|Physician Decision|3|||
155262443|NCT04270747|560392796|FG001|Post Week 16|Physician Decision|1|||
155262444|NCT04270747|560392797|FG002|Post Week 16|Physician Decision|1|||
155262445|NCT04270747|560392795|FG000|Post Week 16|Lost to Follow-up|2|||
155262446|NCT04270747|560392796|FG001|Post Week 16|Lost to Follow-up|1|||
155262447|NCT04270747|560392797|FG002|Post Week 16|Lost to Follow-up|0|||
155262448|NCT04270747|560392795|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
155262449|NCT04270747|560392796|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
155262450|NCT04270747|560392797|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
155262451|NCT04270747|560392795|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
155262452|NCT04270747|560392796|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
155262453|NCT04270747|560392797|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
155262454|NCT04270747|560392795|FG000|Post Week 16|Miscellaneous|1|||
155262455|NCT04270747|560392796|FG001|Post Week 16|Miscellaneous|0|||
155262456|NCT04270747|560392797|FG002|Post Week 16|Miscellaneous|1|||
155262457|NCT05597722|560392802|FG000|Overall Study|Study was terminated|6|||
155262458|NCT05597722|560392803|FG001|Overall Study|Study was terminated|1|||
155262459|NCT04108000|560392804|FG000|Overall Study|Death of patient|1|||
155262460|NCT04108000|560392805|FG001|Overall Study|Death of patient|0|||
155262461|NCT04108000|560392806|FG002|Overall Study|Death of patient|1|||
155262462|NCT04108000|560392807|FG003|Overall Study|Death of patient|0|||
155262463|NCT04108000|560392804|FG000|Overall Study|Withdrawal by Subject|2|||
155262464|NCT04108000|560392805|FG001|Overall Study|Withdrawal by Subject|2|||
155262465|NCT04108000|560392806|FG002|Overall Study|Withdrawal by Subject|0|||
155262466|NCT04108000|560392807|FG003|Overall Study|Withdrawal by Subject|0|||
155262467|NCT04108000|560392804|FG000|Overall Study|Death of surrogate partner|0|||
155262468|NCT04108000|560392805|FG001|Overall Study|Death of surrogate partner|1|||
155262469|NCT04108000|560392806|FG002|Overall Study|Death of surrogate partner|0|||
155262470|NCT04108000|560392807|FG003|Overall Study|Death of surrogate partner|1|||
155262471|NCT05559866|560392812|FG000|Overall Study|Withdrawal by Subject|1|||
155262472|NCT05559866|560392813|FG001|Overall Study|Withdrawal by Subject|0|||
155262473|NCT03750006|560392814|FG000|Overall Study|Withdrawal by Subject|8|||
155262474|NCT03750006|560392814|FG000|Overall Study|COVID PANDEMIC|11|||
155262475|NCT05619003|560392815|FG000|Overall Study|Adverse Event|1|||
155262476|NCT03538951|560392816|FG000|Overall Study|Withdrawal by Subject|1|||
155262477|NCT03538951|560392817|FG001|Overall Study|Withdrawal by Subject|2|||
155262478|NCT07018999|560392822|FG000|Overall Study|Protocol Violation|0|||
155262479|NCT07018999|560392823|FG001|Overall Study|Protocol Violation|1|||
155262480|NCT07018999|560392822|FG000|Overall Study|Incomplete data entry|4|||
155262481|NCT07018999|560392823|FG001|Overall Study|Incomplete data entry|7|||
155262482|NCT03444376|560392824|FG000|Part A|Disease relapse or Progression|1|||
155262483|NCT03444376|560392824|FG000|Part A|Withdrawal by Subject|2|||
155262484|NCT03444376|560392824|FG000|Part A|Adverse Event|1|||
155262485|NCT03444376|560392824|FG000|Part B|Disease relapse or Progression|18|||
155262486|NCT03444376|560392824|FG000|Part B|Withdrawal by Subject|2|||
155262487|NCT03444376|560392824|FG000|Part B|Adverse Event|2|||
155262488|NCT03444376|560392824|FG000|Part B|Physician Decision|1|||
155262489|NCT03444376|560392824|FG000|Part C|Disease relapse or Progression|43|||
155262490|NCT03444376|560392824|FG000|Part C|Withdrawal by Subject|5|||
155262491|NCT03444376|560392824|FG000|Part C|Adverse Event|2|||
155262492|NCT03444376|560392824|FG000|Part C|Physician Decision|2|||
155262493|NCT03444376|560392824|FG000|Part C|Death|1|||
155262494|NCT00856167|560392826|FG000|Period 1|Withdrawal by Subject|1|||
155262495|NCT00856167|560392827|FG001|Period 1|Withdrawal by Subject|4|||
155262496|NCT00856167|560392828|FG002|Period 1|Withdrawal by Subject|0|||
155262497|NCT00856167|560392829|FG003|Period 1|Withdrawal by Subject|0|||
155262498|NCT00856167|560392826|FG000|Period 1|Lost to Follow-up|2|||
155262499|NCT00856167|560392827|FG001|Period 1|Lost to Follow-up|1|||
155262500|NCT00856167|560392828|FG002|Period 1|Lost to Follow-up|0|||
155262501|NCT00856167|560392829|FG003|Period 1|Lost to Follow-up|0|||
155262502|NCT00856167|560392826|FG000|Period 2|Lost to Follow-up|0|||
155262503|NCT00856167|560392827|FG001|Period 2|Lost to Follow-up|0|||
155262504|NCT00856167|560392828|FG002|Period 2|Lost to Follow-up|3|||
155262505|NCT00856167|560392829|FG003|Period 2|Lost to Follow-up|1|||
155262506|NCT00856167|560392826|FG000|Period 2|Withdrawal by Subject|0|||
155262507|NCT00856167|560392827|FG001|Period 2|Withdrawal by Subject|0|||
155262508|NCT00856167|560392828|FG002|Period 2|Withdrawal by Subject|2|||
155262509|NCT00856167|560392829|FG003|Period 2|Withdrawal by Subject|4|||
155262510|NCT03237858|560394476|FG000|Overall Study|Death|19|||
155262511|NCT03237858|560394476|FG000|Overall Study|Withdrawal by Subject|37|||
155262512|NCT02026232|560394479|FG000|Overall Study|incomplete visit/missing data|3|||
155262513|NCT02026232|560394480|FG001|Overall Study|incomplete visit/missing data|2|||
155262514|NCT01108458|560394481|FG000|Overall Study|Withdrawal by Subject|1|||
155262515|NCT01382602|560394482|FG000|Overall Study|Protocol Violation|0|||
155262516|NCT01382602|560394483|FG001|Overall Study|Protocol Violation|3|||
155262517|NCT01382602|560394482|FG000|Overall Study|Withdrawal by Subject|0|||
155262518|NCT01382602|560394483|FG001|Overall Study|Withdrawal by Subject|1|||
155262519|NCT05056870|560394487|FG000|Period 1|Site COVID-19 Related|3|||
155262520|NCT05056870|560394488|FG001|Period 1|Site COVID-19 Related|3|||
155262521|NCT05056870|560394487|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155262522|NCT05056870|560394488|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155262523|NCT05056870|560394487|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
155262524|NCT05056870|560394488|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155262525|NCT05056870|560394487|FG000|Period 2|COVID-19 Related|1|||
155262526|NCT05056870|560394488|FG001|Period 2|COVID-19 Related|0|||
155262527|NCT05056870|560394487|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
155262528|NCT05056870|560394488|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
155262529|NCT01114204|560394494|FG000|Overall Study|Adverse Event|3|||
155262530|NCT01114204|560394495|FG001|Overall Study|Adverse Event|2|||
155262531|NCT01114204|560394494|FG000|Overall Study|Lost to Follow-up|1|||
155262532|NCT01114204|560394495|FG001|Overall Study|Lost to Follow-up|0|||
155262533|NCT01114204|560394494|FG000|Overall Study|Withdrawal by Subject|10|||
155262534|NCT01114204|560394495|FG001|Overall Study|Withdrawal by Subject|6|||
155262535|NCT01114204|560394494|FG000|Overall Study|Death|1|||
155262536|NCT01114204|560394495|FG001|Overall Study|Death|0|||
155262537|NCT01114204|560394494|FG000|Overall Study|Other-Personal reasons|2|||
155262538|NCT01114204|560394495|FG001|Overall Study|Other-Personal reasons|0|||
155262539|NCT01114204|560394494|FG000|Overall Study|Other-Medical monitor request|1|||
155262540|NCT01114204|560394495|FG001|Overall Study|Other-Medical monitor request|0|||
155262541|NCT01114204|560394494|FG000|Overall Study|Other-Participant request|2|||
155262542|NCT01114204|560394495|FG001|Overall Study|Other-Participant request|0|||
155262543|NCT01114204|560394494|FG000|Overall Study|Other-Protocol Violation|1|||
155262544|NCT01114204|560394495|FG001|Overall Study|Other-Protocol Violation|0|||
155262545|NCT02255357|560394497|FG000|Overall Study|Physician Decision|10|||
155262546|NCT02255357|560394498|FG001|Overall Study|Physician Decision|24|||
155262547|NCT00509236|560394501|FG000|Overall Study|Adverse Event|7|||
155262548|NCT00509236|560394502|FG001|Overall Study|Adverse Event|9|||
155262549|NCT00509236|560394501|FG000|Overall Study|Withdrawal by Subject|5|||
155262550|NCT00509236|560394502|FG001|Overall Study|Withdrawal by Subject|10|||
155262551|NCT00509236|560394501|FG000|Overall Study|Protocol Violation|3|||
155262552|NCT00509236|560394502|FG001|Overall Study|Protocol Violation|0|||
155262553|NCT00509236|560394501|FG000|Overall Study|Excluded Medication|1|||
155262554|NCT00509236|560394502|FG001|Overall Study|Excluded Medication|1|||
155262555|NCT00509236|560394501|FG000|Overall Study|Scheduled Kidney Transplant|1|||
155262556|NCT00509236|560394502|FG001|Overall Study|Scheduled Kidney Transplant|0|||
155262557|NCT00927355|560394505|FG000|Overall Study|Adverse Event|1|||
155262558|NCT00927355|560394506|FG001|Overall Study|Adverse Event|1|||
155262559|NCT01572389|560394507|FG000|Overall Study|Death|1|||
155262560|NCT01572389|560394508|FG001|Overall Study|Death|3|||
155262561|NCT01572389|560394507|FG000|Overall Study|Withdrawal by Subject|14|||
155262562|NCT01572389|560394508|FG001|Overall Study|Withdrawal by Subject|2|||
155262563|NCT01572389|560394507|FG000|Overall Study|Lost to Follow-up|25|||
155262564|NCT01572389|560394508|FG001|Overall Study|Lost to Follow-up|14|||
155262565|NCT01572389|560394507|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
155262566|NCT01572389|560394508|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
155262567|NCT00499863|560394509|FG000|Overall Study|Lack of Efficacy|21|||
155262568|NCT00499863|560394510|FG001|Overall Study|Lack of Efficacy|27|||
155262569|NCT00499863|560394509|FG000|Overall Study|Protocol Violation|12|||
155262570|NCT00499863|560394510|FG001|Overall Study|Protocol Violation|7|||
155262571|NCT00499863|560394509|FG000|Overall Study|Withdrawal by Subject|6|||
155262572|NCT00499863|560394510|FG001|Overall Study|Withdrawal by Subject|4|||
155262573|NCT00499863|560394509|FG000|Overall Study|Adverse Event|8|||
155262574|NCT00499863|560394510|FG001|Overall Study|Adverse Event|2|||
155262575|NCT00499863|560394509|FG000|Overall Study|Sponsor decision|2|||
155262576|NCT00499863|560394510|FG001|Overall Study|Sponsor decision|2|||
155262577|NCT00499863|560394509|FG000|Overall Study|Lost to Follow-up|1|||
155262578|NCT00499863|560394510|FG001|Overall Study|Lost to Follow-up|1|||
155262579|NCT00571701|560394511|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
155262580|NCT00571701|560394512|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
155262581|NCT00571701|560394511|FG000|First Intervention 12 Months|Death|1|||
155262582|NCT00571701|560394512|FG001|First Intervention 12 Months|Death|0|||
155262583|NCT00571701|560394511|FG000|Second Intervention 12 Months|Adverse Event|0|||
155262584|NCT00571701|560394512|FG001|Second Intervention 12 Months|Adverse Event|1|||
155262585|NCT00571701|560394511|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
155262586|NCT00571701|560394512|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
155262587|NCT00691132|560394515|FG000|Overall Study|Adverse Event|2|||
155262588|NCT00691132|560394516|FG001|Overall Study|Adverse Event|3|||
155262589|NCT00691132|560394515|FG000|Overall Study|Withdrawal by Subject|10|||
155262590|NCT00691132|560394516|FG001|Overall Study|Withdrawal by Subject|10|||
155262591|NCT04766086|560394517|FG000|Overall Study|Lost to Follow-up|3|||
155491712|NCT00910000|561225498|FG002|Overall Study|Withdrawal by Subject|1|||
155262592|NCT04766086|560394518|FG001|Overall Study|Lost to Follow-up|5|||
155262593|NCT04766086|560394519|FG002|Overall Study|Lost to Follow-up|3|||
155262594|NCT04766086|560394517|FG000|Overall Study|Withdrawal by Subject|1|||
155262595|NCT04766086|560394518|FG001|Overall Study|Withdrawal by Subject|1|||
155262596|NCT04766086|560394519|FG002|Overall Study|Withdrawal by Subject|2|||
155262597|NCT04766086|560394517|FG000|Overall Study|Other|0|||
155262598|NCT04766086|560394518|FG001|Overall Study|Other|0|||
155262599|NCT04766086|560394519|FG002|Overall Study|Other|1|||
155262600|NCT01959347|560394522|FG000|Overall Study|Protocol Violation|9|||
155262601|NCT01959347|560394523|FG001|Overall Study|Protocol Violation|7|||
155262602|NCT03541044|560394524|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
155262603|NCT03541044|560394525|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
155262604|NCT03541044|560394524|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
155262605|NCT03541044|560394525|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
155262606|NCT01282801|560394526|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
155262607|NCT01282801|560394527|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
155262608|NCT01060553|560394528|FG000|Overall Study|Lost to Follow-up|3|||
155262609|NCT01060553|560394529|FG001|Overall Study|Lost to Follow-up|5|||
155262610|NCT01060553|560394528|FG000|Overall Study|Withdrawal by Subject|5|||
155262611|NCT01060553|560394529|FG001|Overall Study|Withdrawal by Subject|5|||
155262612|NCT01060553|560394528|FG000|Overall Study|Lack of Efficacy|1|||
155262613|NCT01060553|560394529|FG001|Overall Study|Lack of Efficacy|0|||
155262614|NCT00312702|560394530|FG000|Immunization Phase|Lost to Follow-up|0|||
155262615|NCT00312702|560394531|FG001|Immunization Phase|Lost to Follow-up|1|||
155262616|NCT00312702|560394532|FG002|Immunization Phase|Lost to Follow-up|0|||
155262617|NCT01462162|560394535|FG000|Overall Study|Adverse Event|5|||
155262618|NCT01462162|560394535|FG000|Overall Study|Lack of Efficacy|4|||
155262619|NCT01462162|560394535|FG000|Overall Study|Abnormal laboratory parameters|1|||
155262620|NCT01462162|560394535|FG000|Overall Study|Other|2|||
155262621|NCT03485911|560394536|FG000|Part 1|Perceived lack of efficacy|1|||
155262622|NCT03485911|560394537|FG001|Part 1|Perceived lack of efficacy|1|||
155262623|NCT03485911|560394538|FG002|Part 1|Perceived lack of efficacy|2|||
155262624|NCT03485911|560394539|FG003|Part 1|Perceived lack of efficacy|0|||
155262625|NCT03485911|560394536|FG000|Part 1|Subject withdrew consent|0|||
155262626|NCT03485911|560394537|FG001|Part 1|Subject withdrew consent|1|||
155262627|NCT03485911|560394538|FG002|Part 1|Subject withdrew consent|0|||
155262628|NCT03485911|560394539|FG003|Part 1|Subject withdrew consent|1|||
155262629|NCT03485911|560394536|FG000|Part 1|Lab abnormalities/AEs|3|||
155262630|NCT03485911|560394537|FG001|Part 1|Lab abnormalities/AEs|1|||
155262631|NCT03485911|560394538|FG002|Part 1|Lab abnormalities/AEs|1|||
155262632|NCT03485911|560394539|FG003|Part 1|Lab abnormalities/AEs|0|||
155262633|NCT03485911|560394536|FG000|Part 1|Withdrew Consent prior to dosing|0|||
155262634|NCT03485911|560394537|FG001|Part 1|Withdrew Consent prior to dosing|0|||
155262635|NCT03485911|560394538|FG002|Part 1|Withdrew Consent prior to dosing|0|||
155262636|NCT03485911|560394539|FG003|Part 1|Withdrew Consent prior to dosing|1|||
155262637|NCT03485911|560394536|FG000|Part 1|Other NOS|0|||
155262638|NCT03485911|560394537|FG001|Part 1|Other NOS|0|||
155262639|NCT03485911|560394538|FG002|Part 1|Other NOS|0|||
155262640|NCT03485911|560394539|FG003|Part 1|Other NOS|1|||
155262641|NCT03485911|560394536|FG000|Part 2|Perceived lack of efficacy|5|||
155262642|NCT03485911|560394537|FG001|Part 2|Perceived lack of efficacy|3|||
155262643|NCT03485911|560394538|FG002|Part 2|Perceived lack of efficacy|0|||
155262644|NCT03485911|560394539|FG003|Part 2|Perceived lack of efficacy|2|||
155262645|NCT03485911|560394536|FG000|Part 2|Subject withdrew consent|1|||
155262646|NCT03485911|560394537|FG001|Part 2|Subject withdrew consent|0|||
155262647|NCT03485911|560394538|FG002|Part 2|Subject withdrew consent|2|||
155262648|NCT03485911|560394539|FG003|Part 2|Subject withdrew consent|1|||
155262649|NCT03485911|560394536|FG000|Part 2|Lab abnormalities/AEs|1|||
155262650|NCT03485911|560394537|FG001|Part 2|Lab abnormalities/AEs|2|||
155262651|NCT03485911|560394538|FG002|Part 2|Lab abnormalities/AEs|0|||
155262652|NCT03485911|560394539|FG003|Part 2|Lab abnormalities/AEs|0|||
155262653|NCT03485911|560394536|FG000|Part 2|Other NOS|0|||
155262654|NCT03485911|560394537|FG001|Part 2|Other NOS|1|||
155262655|NCT03485911|560394538|FG002|Part 2|Other NOS|0|||
155262656|NCT03485911|560394539|FG003|Part 2|Other NOS|0|||
155262657|NCT03485911|560394536|FG000|Part 2|Intercurrent illness/new medical condition|1|||
155262658|NCT03485911|560394537|FG001|Part 2|Intercurrent illness/new medical condition|0|||
155262659|NCT03485911|560394538|FG002|Part 2|Intercurrent illness/new medical condition|0|||
155262660|NCT03485911|560394539|FG003|Part 2|Intercurrent illness/new medical condition|0|||
155262661|NCT03485911|560394536|FG000|Part 2|Investigator judgement|1|||
155262662|NCT03485911|560394537|FG001|Part 2|Investigator judgement|0|||
155262663|NCT03485911|560394538|FG002|Part 2|Investigator judgement|0|||
155262664|NCT03485911|560394539|FG003|Part 2|Investigator judgement|0|||
155262665|NCT03485911|560394536|FG000|Part 3|Perceived lack of efficacy|2|||
155262666|NCT03485911|560394537|FG001|Part 3|Perceived lack of efficacy|2|||
155262667|NCT03485911|560394538|FG002|Part 3|Perceived lack of efficacy|2|||
155262668|NCT03485911|560394539|FG003|Part 3|Perceived lack of efficacy|0|||
155262669|NCT03485911|560394536|FG000|Part 3|Subject withdrew consent|1|||
155262670|NCT03485911|560394537|FG001|Part 3|Subject withdrew consent|4|||
155262671|NCT03485911|560394538|FG002|Part 3|Subject withdrew consent|0|||
155262672|NCT03485911|560394539|FG003|Part 3|Subject withdrew consent|1|||
155262673|NCT03485911|560394536|FG000|Part 3|Lab abnormalities/AEs|1|||
155262674|NCT03485911|560394537|FG001|Part 3|Lab abnormalities/AEs|1|||
155262675|NCT03485911|560394538|FG002|Part 3|Lab abnormalities/AEs|0|||
155262676|NCT03485911|560394539|FG003|Part 3|Lab abnormalities/AEs|2|||
155262677|NCT03485911|560394536|FG000|Part 3|Other NOS|1|||
155262678|NCT03485911|560394537|FG001|Part 3|Other NOS|1|||
155262679|NCT03485911|560394538|FG002|Part 3|Other NOS|0|||
155262680|NCT03485911|560394539|FG003|Part 3|Other NOS|0|||
155262681|NCT03485911|560394536|FG000|Part 3|Intercurrent illness/new medical condition|0|||
155262682|NCT03485911|560394537|FG001|Part 3|Intercurrent illness/new medical condition|1|||
155262683|NCT03485911|560394538|FG002|Part 3|Intercurrent illness/new medical condition|1|||
155262684|NCT03485911|560394539|FG003|Part 3|Intercurrent illness/new medical condition|0|||
155262685|NCT03485911|560394536|FG000|Part 3|Sponsor discontinuation|1|||
155262686|NCT03485911|560394537|FG001|Part 3|Sponsor discontinuation|0|||
155262687|NCT03485911|560394538|FG002|Part 3|Sponsor discontinuation|0|||
155262688|NCT03485911|560394539|FG003|Part 3|Sponsor discontinuation|0|||
155262689|NCT03485911|560394536|FG000|Part 3|Berotralstat provided by alternative means|13|||
155262690|NCT03485911|560394537|FG001|Part 3|Berotralstat provided by alternative means|13|||
155262691|NCT03485911|560394538|FG002|Part 3|Berotralstat provided by alternative means|7|||
155262692|NCT03485911|560394539|FG003|Part 3|Berotralstat provided by alternative means|7|||
155262693|NCT01215357|560394540|FG000|Overall Study|Withdrawal by Subject|3|||
155262694|NCT01215357|560394540|FG000|Overall Study|Protocol Violation|9|||
155262695|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
155262696|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
155262697|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
155262698|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
155262699|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
155262700|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
155262701|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
155262702|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
155262703|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
155262704|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
155262705|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
155262706|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
155262707|NCT03333928|560394541|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
155262708|NCT03333928|560394542|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
155262709|NCT03333928|560394543|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
155262710|NCT03333928|560394541|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
155262711|NCT03333928|560394542|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
155262712|NCT03333928|560394543|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
155262713|NCT03333928|560394541|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
155262714|NCT03333928|560394542|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
155262715|NCT03333928|560394543|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
155262716|NCT03333928|560394541|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
155262717|NCT03333928|560394542|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
155262718|NCT03333928|560394543|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
155262719|NCT01674621|560394554|FG000|Overall Study|Adverse Event|3|||
155262720|NCT01674621|560394555|FG001|Overall Study|Adverse Event|2|||
155262721|NCT01674621|560394556|FG002|Overall Study|Adverse Event|5|||
155262722|NCT01674621|560394557|FG003|Overall Study|Adverse Event|5|||
155262723|NCT01674621|560394558|FG004|Overall Study|Adverse Event|1|||
155262724|NCT01674621|560394554|FG000|Overall Study|Inability to Complete Study Procedures|0|||
155262725|NCT01674621|560394555|FG001|Overall Study|Inability to Complete Study Procedures|0|||
155262726|NCT01674621|560394556|FG002|Overall Study|Inability to Complete Study Procedures|0|||
155262727|NCT01674621|560394557|FG003|Overall Study|Inability to Complete Study Procedures|0|||
155262728|NCT01674621|560394558|FG004|Overall Study|Inability to Complete Study Procedures|2|||
155262729|NCT01674621|560394554|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262730|NCT01674621|560394555|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262731|NCT01674621|560394556|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262732|NCT01674621|560394557|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
155262733|NCT01674621|560394558|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262734|NCT01674621|560394554|FG000|Overall Study|Withdrawal by Subject|2|||
155262735|NCT01674621|560394555|FG001|Overall Study|Withdrawal by Subject|5|||
155262736|NCT01674621|560394556|FG002|Overall Study|Withdrawal by Subject|2|||
155262737|NCT01674621|560394557|FG003|Overall Study|Withdrawal by Subject|0|||
155262738|NCT01674621|560394558|FG004|Overall Study|Withdrawal by Subject|1|||
155262739|NCT01674621|560394554|FG000|Overall Study|Other than specified|0|||
155262740|NCT01674621|560394555|FG001|Overall Study|Other than specified|1|||
155262741|NCT01674621|560394556|FG002|Overall Study|Other than specified|0|||
155262742|NCT01674621|560394557|FG003|Overall Study|Other than specified|0|||
155262743|NCT01674621|560394558|FG004|Overall Study|Other than specified|2|||
155262744|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
155262745|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
155262746|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
155262747|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
155262748|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155262749|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155262750|NCT01859793|560394559|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155262751|NCT01859793|560394560|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155262752|NCT04543188|560394561|FG000|Phase 1a|Adverse Event|0|||
155262753|NCT04543188|560394562|FG001|Phase 1a|Adverse Event|0|||
155262754|NCT04543188|560394563|FG002|Phase 1a|Adverse Event|0|||
155262755|NCT04543188|560394564|FG003|Phase 1a|Adverse Event|1|||
155262756|NCT04543188|560394565|FG004|Phase 1a|Adverse Event|0|||
155262757|NCT04543188|560394566|FG005|Phase 1a|Adverse Event|0|||
155262758|NCT04543188|560394567|FG006|Phase 1a|Adverse Event|1|||
155262759|NCT04543188|560394568|FG007|Phase 1a|Adverse Event|0|||
155262760|NCT04543188|560394569|FG008|Phase 1a|Adverse Event|0|||
155262761|NCT04543188|560394570|FG009|Phase 1a|Adverse Event|0|||
155262762|NCT04543188|560394571|FG010|Phase 1a|Adverse Event|0|||
155262763|NCT04543188|560394572|FG011|Phase 1a|Adverse Event|0|||
155262764|NCT04543188|560394573|FG012|Phase 1a|Adverse Event|0|||
155262765|NCT04543188|560394574|FG013|Phase 1a|Adverse Event|0|||
155262766|NCT04543188|560394575|FG014|Phase 1a|Adverse Event|0|||
155262767|NCT04543188|560394561|FG000|Phase 1a|Other (Death)|0|||
155262768|NCT04543188|560394562|FG001|Phase 1a|Other (Death)|1|||
155262769|NCT04543188|560394563|FG002|Phase 1a|Other (Death)|0|||
155262770|NCT04543188|560394564|FG003|Phase 1a|Other (Death)|0|||
155262771|NCT04543188|560394565|FG004|Phase 1a|Other (Death)|1|||
155262772|NCT04543188|560394566|FG005|Phase 1a|Other (Death)|0|||
155262773|NCT04543188|560394567|FG006|Phase 1a|Other (Death)|0|||
155262774|NCT04543188|560394568|FG007|Phase 1a|Other (Death)|0|||
155262775|NCT04543188|560394569|FG008|Phase 1a|Other (Death)|0|||
155262776|NCT04543188|560394570|FG009|Phase 1a|Other (Death)|1|||
155262777|NCT04543188|560394571|FG010|Phase 1a|Other (Death)|0|||
155262778|NCT04543188|560394572|FG011|Phase 1a|Other (Death)|0|||
155262779|NCT04543188|560394573|FG012|Phase 1a|Other (Death)|0|||
155262780|NCT04543188|560394574|FG013|Phase 1a|Other (Death)|0|||
155262781|NCT04543188|560394575|FG014|Phase 1a|Other (Death)|0|||
155262782|NCT04543188|560394561|FG000|Phase 1a|Lost to Follow-up|0|||
155262783|NCT04543188|560394562|FG001|Phase 1a|Lost to Follow-up|0|||
155262784|NCT04543188|560394563|FG002|Phase 1a|Lost to Follow-up|0|||
155262785|NCT04543188|560394564|FG003|Phase 1a|Lost to Follow-up|0|||
155262786|NCT04543188|560394565|FG004|Phase 1a|Lost to Follow-up|0|||
155262787|NCT04543188|560394566|FG005|Phase 1a|Lost to Follow-up|0|||
155262788|NCT04543188|560394567|FG006|Phase 1a|Lost to Follow-up|0|||
155262789|NCT04543188|560394568|FG007|Phase 1a|Lost to Follow-up|0|||
155262790|NCT04543188|560394569|FG008|Phase 1a|Lost to Follow-up|0|||
155262791|NCT04543188|560394570|FG009|Phase 1a|Lost to Follow-up|0|||
155262792|NCT04543188|560394571|FG010|Phase 1a|Lost to Follow-up|1|||
155262793|NCT04543188|560394572|FG011|Phase 1a|Lost to Follow-up|0|||
155262794|NCT04543188|560394573|FG012|Phase 1a|Lost to Follow-up|0|||
155262795|NCT04543188|560394574|FG013|Phase 1a|Lost to Follow-up|0|||
155262796|NCT04543188|560394575|FG014|Phase 1a|Lost to Follow-up|0|||
155262797|NCT04543188|560394561|FG000|Phase 1a|Progressive Disease|2|||
155262798|NCT04543188|560394562|FG001|Phase 1a|Progressive Disease|2|||
155262799|NCT04543188|560394563|FG002|Phase 1a|Progressive Disease|3|||
155262800|NCT04543188|560394564|FG003|Phase 1a|Progressive Disease|1|||
155262801|NCT04543188|560394565|FG004|Phase 1a|Progressive Disease|4|||
155262802|NCT04543188|560394566|FG005|Phase 1a|Progressive Disease|2|||
155262803|NCT04543188|560394567|FG006|Phase 1a|Progressive Disease|3|||
155262804|NCT04543188|560394568|FG007|Phase 1a|Progressive Disease|4|||
155262805|NCT04543188|560394569|FG008|Phase 1a|Progressive Disease|1|||
155262806|NCT04543188|560394570|FG009|Phase 1a|Progressive Disease|0|||
155262807|NCT04543188|560394571|FG010|Phase 1a|Progressive Disease|4|||
155262808|NCT04543188|560394572|FG011|Phase 1a|Progressive Disease|0|||
155262809|NCT04543188|560394573|FG012|Phase 1a|Progressive Disease|0|||
155262810|NCT04543188|560394574|FG013|Phase 1a|Progressive Disease|0|||
155262811|NCT04543188|560394575|FG014|Phase 1a|Progressive Disease|0|||
155262812|NCT04543188|560394561|FG000|Phase 1a|Study terminated by sponsor|0|||
155262813|NCT04543188|560394562|FG001|Phase 1a|Study terminated by sponsor|0|||
155262814|NCT04543188|560394563|FG002|Phase 1a|Study terminated by sponsor|0|||
155262815|NCT04543188|560394564|FG003|Phase 1a|Study terminated by sponsor|0|||
155262816|NCT04543188|560394565|FG004|Phase 1a|Study terminated by sponsor|1|||
155262817|NCT04543188|560394566|FG005|Phase 1a|Study terminated by sponsor|0|||
155262818|NCT04543188|560394567|FG006|Phase 1a|Study terminated by sponsor|0|||
155262819|NCT04543188|560394568|FG007|Phase 1a|Study terminated by sponsor|0|||
155262820|NCT04543188|560394569|FG008|Phase 1a|Study terminated by sponsor|0|||
155262821|NCT04543188|560394570|FG009|Phase 1a|Study terminated by sponsor|0|||
155262822|NCT04543188|560394571|FG010|Phase 1a|Study terminated by sponsor|1|||
155262823|NCT04543188|560394572|FG011|Phase 1a|Study terminated by sponsor|0|||
155262824|NCT04543188|560394573|FG012|Phase 1a|Study terminated by sponsor|0|||
155262825|NCT04543188|560394574|FG013|Phase 1a|Study terminated by sponsor|0|||
155262826|NCT04543188|560394575|FG014|Phase 1a|Study terminated by sponsor|0|||
155262827|NCT04543188|560394561|FG000|Phase 1a|Withdrawal by Subject|0|||
155262828|NCT04543188|560394562|FG001|Phase 1a|Withdrawal by Subject|0|||
155262829|NCT04543188|560394563|FG002|Phase 1a|Withdrawal by Subject|0|||
155262830|NCT04543188|560394564|FG003|Phase 1a|Withdrawal by Subject|0|||
155262831|NCT04543188|560394565|FG004|Phase 1a|Withdrawal by Subject|3|||
155262832|NCT04543188|560394566|FG005|Phase 1a|Withdrawal by Subject|0|||
155262833|NCT04543188|560394567|FG006|Phase 1a|Withdrawal by Subject|0|||
155262834|NCT04543188|560394568|FG007|Phase 1a|Withdrawal by Subject|0|||
155262835|NCT04543188|560394569|FG008|Phase 1a|Withdrawal by Subject|1|||
155262836|NCT04543188|560394570|FG009|Phase 1a|Withdrawal by Subject|1|||
155262837|NCT04543188|560394571|FG010|Phase 1a|Withdrawal by Subject|2|||
155262838|NCT04543188|560394572|FG011|Phase 1a|Withdrawal by Subject|0|||
155262839|NCT04543188|560394573|FG012|Phase 1a|Withdrawal by Subject|0|||
155262840|NCT04543188|560394574|FG013|Phase 1a|Withdrawal by Subject|0|||
155262841|NCT04543188|560394575|FG014|Phase 1a|Withdrawal by Subject|0|||
155262842|NCT04543188|560394561|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
155262843|NCT04543188|560394562|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
155262844|NCT04543188|560394563|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
155262845|NCT04543188|560394564|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
155262846|NCT04543188|560394565|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
155262847|NCT04543188|560394566|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
155262848|NCT04543188|560394567|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
155262849|NCT04543188|560394568|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
155262850|NCT04543188|560394569|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
155262851|NCT04543188|560394570|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
155262852|NCT04543188|560394571|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
155262853|NCT04543188|560394572|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
155262854|NCT04543188|560394573|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
155262855|NCT04543188|560394574|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
155262856|NCT04543188|560394575|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
155262857|NCT04543188|560394561|FG000|Phase 1a|Other|0|||
155262858|NCT04543188|560394562|FG001|Phase 1a|Other|0|||
155262859|NCT04543188|560394563|FG002|Phase 1a|Other|0|||
155262860|NCT04543188|560394564|FG003|Phase 1a|Other|0|||
155262861|NCT04543188|560394565|FG004|Phase 1a|Other|0|||
155262862|NCT04543188|560394566|FG005|Phase 1a|Other|0|||
155262863|NCT04543188|560394567|FG006|Phase 1a|Other|0|||
155262864|NCT04543188|560394568|FG007|Phase 1a|Other|0|||
155262865|NCT04543188|560394569|FG008|Phase 1a|Other|0|||
155262866|NCT04543188|560394570|FG009|Phase 1a|Other|1|||
155262867|NCT04543188|560394571|FG010|Phase 1a|Other|0|||
155262868|NCT04543188|560394572|FG011|Phase 1a|Other|0|||
155262869|NCT04543188|560394573|FG012|Phase 1a|Other|0|||
155262870|NCT04543188|560394574|FG013|Phase 1a|Other|0|||
155262871|NCT04543188|560394575|FG014|Phase 1a|Other|0|||
155262872|NCT04543188|560394561|FG000|Phase 1b|Adverse Event|0|||
155262873|NCT04543188|560394562|FG001|Phase 1b|Adverse Event|0|||
155262874|NCT04543188|560394563|FG002|Phase 1b|Adverse Event|0|||
155262875|NCT04543188|560394564|FG003|Phase 1b|Adverse Event|0|||
155262876|NCT04543188|560394565|FG004|Phase 1b|Adverse Event|0|||
155262877|NCT04543188|560394566|FG005|Phase 1b|Adverse Event|0|||
155262878|NCT04543188|560394567|FG006|Phase 1b|Adverse Event|0|||
155262879|NCT04543188|560394568|FG007|Phase 1b|Adverse Event|0|||
155262880|NCT04543188|560394569|FG008|Phase 1b|Adverse Event|0|||
155262881|NCT04543188|560394570|FG009|Phase 1b|Adverse Event|0|||
155262882|NCT04543188|560394571|FG010|Phase 1b|Adverse Event|0|||
155262883|NCT04543188|560394572|FG011|Phase 1b|Adverse Event|0|||
155262884|NCT04543188|560394573|FG012|Phase 1b|Adverse Event|0|||
155262885|NCT04543188|560394574|FG013|Phase 1b|Adverse Event|0|||
155262886|NCT04543188|560394575|FG014|Phase 1b|Adverse Event|2|||
155262887|NCT04543188|560394561|FG000|Phase 1b|Other (Death)|0|||
155262888|NCT04543188|560394562|FG001|Phase 1b|Other (Death)|0|||
155262889|NCT04543188|560394563|FG002|Phase 1b|Other (Death)|0|||
155262890|NCT04543188|560394564|FG003|Phase 1b|Other (Death)|0|||
155262891|NCT04543188|560394565|FG004|Phase 1b|Other (Death)|0|||
155262892|NCT04543188|560394566|FG005|Phase 1b|Other (Death)|0|||
155262893|NCT04543188|560394567|FG006|Phase 1b|Other (Death)|0|||
155262894|NCT04543188|560394568|FG007|Phase 1b|Other (Death)|0|||
155491713|NCT00910000|561225499|FG003|Overall Study|Withdrawal by Subject|0|||
155491714|NCT00910000|561225500|FG004|Overall Study|Withdrawal by Subject|1|||
155262895|NCT04543188|560394569|FG008|Phase 1b|Other (Death)|0|||
155262896|NCT04543188|560394570|FG009|Phase 1b|Other (Death)|0|||
155262897|NCT04543188|560394571|FG010|Phase 1b|Other (Death)|0|||
155262898|NCT04543188|560394572|FG011|Phase 1b|Other (Death)|0|||
155262899|NCT04543188|560394573|FG012|Phase 1b|Other (Death)|1|||
155262900|NCT04543188|560394574|FG013|Phase 1b|Other (Death)|0|||
155262901|NCT04543188|560394575|FG014|Phase 1b|Other (Death)|1|||
155262902|NCT04543188|560394561|FG000|Phase 1b|Progressive Disease|0|||
155262903|NCT04543188|560394562|FG001|Phase 1b|Progressive Disease|0|||
155262904|NCT04543188|560394563|FG002|Phase 1b|Progressive Disease|0|||
155491715|NCT00910000|561225501|FG005|Overall Study|Withdrawal by Subject|0|||
155491716|NCT04637815|561225502|FG000|Overall Study|Death|1|||
155491717|NCT04637815|561225503|FG001|Overall Study|Death|0|||
155491718|NCT04637815|561225502|FG000|Overall Study|Lost to Follow-up|5|||
155491719|NCT04637815|561225503|FG001|Overall Study|Lost to Follow-up|2|||
155491720|NCT02594384|561225504|FG000|Overall Study|Disease Progression|3|||
155491721|NCT02594384|561225505|FG001|Overall Study|Disease Progression|7|||
155491722|NCT02594384|561225506|FG002|Overall Study|Disease Progression|0|||
155491723|NCT02594384|561225507|FG003|Overall Study|Disease Progression|2|||
155491724|NCT02594384|561225508|FG004|Overall Study|Disease Progression|2|||
155491725|NCT02594384|561225509|FG005|Overall Study|Disease Progression|12|||
155491726|NCT02594384|561225510|FG006|Overall Study|Disease Progression|5|||
155491727|NCT02594384|561225511|FG007|Overall Study|Disease Progression|5|||
155491728|NCT02594384|561225504|FG000|Overall Study|Adverse Event|0|||
155491729|NCT02594384|561225505|FG001|Overall Study|Adverse Event|1|||
155491730|NCT02594384|561225506|FG002|Overall Study|Adverse Event|4|||
155491731|NCT02594384|561225507|FG003|Overall Study|Adverse Event|1|||
155491732|NCT02594384|561225508|FG004|Overall Study|Adverse Event|0|||
155491733|NCT02594384|561225509|FG005|Overall Study|Adverse Event|6|||
155491734|NCT02594384|561225510|FG006|Overall Study|Adverse Event|1|||
155491735|NCT02594384|561225511|FG007|Overall Study|Adverse Event|1|||
155491736|NCT02594384|561225504|FG000|Overall Study|Withdrawal by Subject|0|||
155491737|NCT02594384|561225505|FG001|Overall Study|Withdrawal by Subject|0|||
155491738|NCT02594384|561225506|FG002|Overall Study|Withdrawal by Subject|0|||
155491739|NCT02594384|561225507|FG003|Overall Study|Withdrawal by Subject|1|||
155491740|NCT02594384|561225508|FG004|Overall Study|Withdrawal by Subject|0|||
155491741|NCT02594384|561225509|FG005|Overall Study|Withdrawal by Subject|0|||
155491742|NCT02594384|561225510|FG006|Overall Study|Withdrawal by Subject|0|||
155491743|NCT02594384|561225511|FG007|Overall Study|Withdrawal by Subject|1|||
155491744|NCT02594384|561225504|FG000|Overall Study|Physician Decision|0|||
155491745|NCT02594384|561225505|FG001|Overall Study|Physician Decision|0|||
155491746|NCT02594384|561225506|FG002|Overall Study|Physician Decision|0|||
155491747|NCT02594384|561225507|FG003|Overall Study|Physician Decision|0|||
155491748|NCT02594384|561225508|FG004|Overall Study|Physician Decision|0|||
155491749|NCT02594384|561225509|FG005|Overall Study|Physician Decision|1|||
155491750|NCT02594384|561225510|FG006|Overall Study|Physician Decision|2|||
155491751|NCT02594384|561225511|FG007|Overall Study|Physician Decision|0|||
155491752|NCT02594384|561225504|FG000|Overall Study|Progressive Leukocytosis|0|||
155491753|NCT02594384|561225505|FG001|Overall Study|Progressive Leukocytosis|0|||
155491754|NCT02594384|561225506|FG002|Overall Study|Progressive Leukocytosis|1|||
155491755|NCT02594384|561225507|FG003|Overall Study|Progressive Leukocytosis|0|||
155491756|NCT02594384|561225508|FG004|Overall Study|Progressive Leukocytosis|0|||
155491757|NCT02594384|561225509|FG005|Overall Study|Progressive Leukocytosis|0|||
155491758|NCT02594384|561225510|FG006|Overall Study|Progressive Leukocytosis|0|||
155491759|NCT02594384|561225511|FG007|Overall Study|Progressive Leukocytosis|0|||
155491760|NCT02594384|561225504|FG000|Overall Study|Lack of Efficacy|0|||
155491761|NCT02594384|561225505|FG001|Overall Study|Lack of Efficacy|0|||
155491762|NCT02594384|561225506|FG002|Overall Study|Lack of Efficacy|0|||
155491763|NCT02594384|561225507|FG003|Overall Study|Lack of Efficacy|0|||
155491764|NCT02594384|561225508|FG004|Overall Study|Lack of Efficacy|1|||
155491765|NCT02594384|561225509|FG005|Overall Study|Lack of Efficacy|0|||
155491766|NCT02594384|561225510|FG006|Overall Study|Lack of Efficacy|0|||
155491767|NCT02594384|561225511|FG007|Overall Study|Lack of Efficacy|0|||
155491768|NCT02594384|561225504|FG000|Overall Study|Substantial noncompliance|0|||
155491769|NCT02594384|561225505|FG001|Overall Study|Substantial noncompliance|0|||
155491770|NCT02594384|561225506|FG002|Overall Study|Substantial noncompliance|0|||
155491771|NCT02594384|561225507|FG003|Overall Study|Substantial noncompliance|0|||
155491772|NCT02594384|561225508|FG004|Overall Study|Substantial noncompliance|0|||
155491773|NCT02594384|561225509|FG005|Overall Study|Substantial noncompliance|0|||
155491774|NCT02594384|561225510|FG006|Overall Study|Substantial noncompliance|1|||
155491775|NCT02594384|561225511|FG007|Overall Study|Substantial noncompliance|0|||
155491776|NCT01049360|561225514|FG000|Period 1|Adverse Event|0|||
155491777|NCT01049360|561225515|FG001|Period 1|Adverse Event|1|||
155491778|NCT01049360|561225516|FG002|Period 1|Adverse Event|0|||
155491779|NCT01049360|561225517|FG003|Period 1|Adverse Event|1|||
155491780|NCT01049360|561225518|FG004|Period 1|Adverse Event|0|||
155491781|NCT01049360|561225519|FG005|Period 1|Adverse Event|0|||
155491782|NCT01049360|561225520|FG006|Period 1|Adverse Event|0|||
155491783|NCT01049360|561225521|FG007|Period 1|Adverse Event|1|||
155491784|NCT01049360|561225522|FG008|Period 1|Adverse Event|0|||
155491785|NCT01049360|561225523|FG009|Period 1|Adverse Event|0|||
155491786|NCT01049360|561225524|FG010|Period 1|Adverse Event|0|||
155491787|NCT01049360|561225525|FG011|Period 1|Adverse Event|0|||
155491788|NCT01049360|561225526|FG012|Period 1|Adverse Event|1|||
155491789|NCT01049360|561225527|FG013|Period 1|Adverse Event|1|||
155491790|NCT01049360|561225528|FG014|Period 1|Adverse Event|0|||
155491791|NCT01049360|561225529|FG015|Period 1|Adverse Event|0|||
155491792|NCT01049360|561225530|FG016|Period 1|Adverse Event|1|||
155491793|NCT01049360|561225531|FG017|Period 1|Adverse Event|0|||
155491794|NCT01049360|561225532|FG018|Period 1|Adverse Event|1|||
155491795|NCT01049360|561225533|FG019|Period 1|Adverse Event|0|||
155262905|NCT04543188|560394564|FG003|Phase 1b|Progressive Disease|0|||
155262906|NCT04543188|560394565|FG004|Phase 1b|Progressive Disease|0|||
155262907|NCT04543188|560394566|FG005|Phase 1b|Progressive Disease|0|||
155262908|NCT04543188|560394567|FG006|Phase 1b|Progressive Disease|0|||
155262909|NCT04543188|560394568|FG007|Phase 1b|Progressive Disease|0|||
155262910|NCT04543188|560394569|FG008|Phase 1b|Progressive Disease|0|||
155262911|NCT04543188|560394570|FG009|Phase 1b|Progressive Disease|0|||
155262912|NCT04543188|560394571|FG010|Phase 1b|Progressive Disease|0|||
155262913|NCT04543188|560394572|FG011|Phase 1b|Progressive Disease|0|||
155262914|NCT04543188|560394573|FG012|Phase 1b|Progressive Disease|2|||
155262915|NCT04543188|560394574|FG013|Phase 1b|Progressive Disease|1|||
155262916|NCT04543188|560394575|FG014|Phase 1b|Progressive Disease|5|||
155262917|NCT04543188|560394561|FG000|Phase 1b|Study Terminated By Sponsor|0|||
155262918|NCT04543188|560394562|FG001|Phase 1b|Study Terminated By Sponsor|0|||
155262919|NCT04543188|560394563|FG002|Phase 1b|Study Terminated By Sponsor|0|||
155262920|NCT04543188|560394564|FG003|Phase 1b|Study Terminated By Sponsor|0|||
155262921|NCT04543188|560394565|FG004|Phase 1b|Study Terminated By Sponsor|0|||
155262922|NCT04543188|560394566|FG005|Phase 1b|Study Terminated By Sponsor|0|||
155262923|NCT04543188|560394567|FG006|Phase 1b|Study Terminated By Sponsor|0|||
155262924|NCT04543188|560394568|FG007|Phase 1b|Study Terminated By Sponsor|0|||
155262925|NCT04543188|560394569|FG008|Phase 1b|Study Terminated By Sponsor|0|||
155262926|NCT04543188|560394570|FG009|Phase 1b|Study Terminated By Sponsor|0|||
155262927|NCT04543188|560394571|FG010|Phase 1b|Study Terminated By Sponsor|0|||
155262928|NCT04543188|560394572|FG011|Phase 1b|Study Terminated By Sponsor|1|||
155262929|NCT04543188|560394573|FG012|Phase 1b|Study Terminated By Sponsor|1|||
155262930|NCT04543188|560394574|FG013|Phase 1b|Study Terminated By Sponsor|0|||
155262931|NCT04543188|560394575|FG014|Phase 1b|Study Terminated By Sponsor|1|||
155262932|NCT04543188|560394561|FG000|Phase 1b|Withdrawal by Subject|0|||
155262933|NCT04543188|560394562|FG001|Phase 1b|Withdrawal by Subject|0|||
155262934|NCT04543188|560394563|FG002|Phase 1b|Withdrawal by Subject|0|||
155262935|NCT04543188|560394564|FG003|Phase 1b|Withdrawal by Subject|0|||
155262936|NCT04543188|560394565|FG004|Phase 1b|Withdrawal by Subject|0|||
155262937|NCT04543188|560394566|FG005|Phase 1b|Withdrawal by Subject|0|||
155262938|NCT04543188|560394567|FG006|Phase 1b|Withdrawal by Subject|0|||
155262939|NCT04543188|560394568|FG007|Phase 1b|Withdrawal by Subject|0|||
155262940|NCT04543188|560394569|FG008|Phase 1b|Withdrawal by Subject|0|||
155262941|NCT04543188|560394570|FG009|Phase 1b|Withdrawal by Subject|0|||
155262942|NCT04543188|560394571|FG010|Phase 1b|Withdrawal by Subject|0|||
155262943|NCT04543188|560394572|FG011|Phase 1b|Withdrawal by Subject|0|||
155262944|NCT04543188|560394573|FG012|Phase 1b|Withdrawal by Subject|0|||
155262945|NCT04543188|560394574|FG013|Phase 1b|Withdrawal by Subject|0|||
155262946|NCT04543188|560394575|FG014|Phase 1b|Withdrawal by Subject|2|||
155262947|NCT03815019|560394576|FG000|Overall Study|Withdrawal by Subject|6|||
155262948|NCT03815019|560394577|FG001|Overall Study|Withdrawal by Subject|8|||
155262949|NCT05960097|560394580|FG000|Overall Study|Lost to Follow-up|3|||
155262950|NCT05960097|560394581|FG001|Overall Study|Lost to Follow-up|1|||
155262951|NCT05960097|560394582|FG002|Overall Study|Lost to Follow-up|1|||
155262952|NCT05960097|560394583|FG003|Overall Study|Lost to Follow-up|2|||
155262953|NCT05960097|560394584|FG004|Overall Study|Lost to Follow-up|1|||
155262954|NCT05960097|560394585|FG005|Overall Study|Lost to Follow-up|1|||
155262955|NCT05960097|560394586|FG006|Overall Study|Lost to Follow-up|2|||
155262956|NCT05960097|560394587|FG007|Overall Study|Lost to Follow-up|3|||
155262957|NCT05960097|560394580|FG000|Overall Study|Physician Decision|0|||
155262958|NCT05960097|560394581|FG001|Overall Study|Physician Decision|0|||
155262959|NCT05960097|560394582|FG002|Overall Study|Physician Decision|0|||
155262960|NCT05960097|560394583|FG003|Overall Study|Physician Decision|0|||
155262961|NCT05960097|560394584|FG004|Overall Study|Physician Decision|0|||
155262962|NCT05960097|560394585|FG005|Overall Study|Physician Decision|0|||
155262963|NCT05960097|560394586|FG006|Overall Study|Physician Decision|1|||
155262964|NCT05960097|560394587|FG007|Overall Study|Physician Decision|0|||
155262965|NCT05960097|560394580|FG000|Overall Study|Withdrawal by Subject|1|||
155262966|NCT05960097|560394581|FG001|Overall Study|Withdrawal by Subject|0|||
155262967|NCT05960097|560394582|FG002|Overall Study|Withdrawal by Subject|0|||
155262968|NCT05960097|560394583|FG003|Overall Study|Withdrawal by Subject|1|||
155262969|NCT05960097|560394584|FG004|Overall Study|Withdrawal by Subject|1|||
155262970|NCT05960097|560394585|FG005|Overall Study|Withdrawal by Subject|0|||
155262971|NCT05960097|560394586|FG006|Overall Study|Withdrawal by Subject|0|||
155491796|NCT01049360|561225514|FG000|Period 1|Did not meet inc/exc criteria|0|||
155491797|NCT01049360|561225515|FG001|Period 1|Did not meet inc/exc criteria|0|||
155262972|NCT05960097|560394587|FG007|Overall Study|Withdrawal by Subject|0|||
155262973|NCT05960097|560394580|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262974|NCT05960097|560394581|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262975|NCT05960097|560394582|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
155262976|NCT05960097|560394583|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262977|NCT05960097|560394584|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262978|NCT05960097|560394585|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155491798|NCT01049360|561225516|FG002|Period 1|Did not meet inc/exc criteria|0|||
155491799|NCT01049360|561225517|FG003|Period 1|Did not meet inc/exc criteria|0|||
155491800|NCT01049360|561225518|FG004|Period 1|Did not meet inc/exc criteria|0|||
155491801|NCT01049360|561225519|FG005|Period 1|Did not meet inc/exc criteria|0|||
155491802|NCT01049360|561225520|FG006|Period 1|Did not meet inc/exc criteria|0|||
155491803|NCT01049360|561225521|FG007|Period 1|Did not meet inc/exc criteria|1|||
155491804|NCT01049360|561225522|FG008|Period 1|Did not meet inc/exc criteria|1|||
155491805|NCT01049360|561225523|FG009|Period 1|Did not meet inc/exc criteria|0|||
155491806|NCT01049360|561225524|FG010|Period 1|Did not meet inc/exc criteria|0|||
155491807|NCT01049360|561225525|FG011|Period 1|Did not meet inc/exc criteria|0|||
155491808|NCT01049360|561225526|FG012|Period 1|Did not meet inc/exc criteria|0|||
155491809|NCT01049360|561225527|FG013|Period 1|Did not meet inc/exc criteria|0|||
155491810|NCT01049360|561225528|FG014|Period 1|Did not meet inc/exc criteria|0|||
155491811|NCT01049360|561225529|FG015|Period 1|Did not meet inc/exc criteria|0|||
155491812|NCT01049360|561225530|FG016|Period 1|Did not meet inc/exc criteria|0|||
155491813|NCT01049360|561225531|FG017|Period 1|Did not meet inc/exc criteria|0|||
155491814|NCT01049360|561225532|FG018|Period 1|Did not meet inc/exc criteria|0|||
155491815|NCT01049360|561225533|FG019|Period 1|Did not meet inc/exc criteria|0|||
155491816|NCT01049360|561225514|FG000|Period 1|Withdrawal by Subject|0|||
155491817|NCT01049360|561225515|FG001|Period 1|Withdrawal by Subject|0|||
155491818|NCT01049360|561225516|FG002|Period 1|Withdrawal by Subject|0|||
155491819|NCT01049360|561225517|FG003|Period 1|Withdrawal by Subject|0|||
155491820|NCT01049360|561225518|FG004|Period 1|Withdrawal by Subject|0|||
155491821|NCT01049360|561225519|FG005|Period 1|Withdrawal by Subject|0|||
155491822|NCT01049360|561225520|FG006|Period 1|Withdrawal by Subject|0|||
155491823|NCT01049360|561225521|FG007|Period 1|Withdrawal by Subject|0|||
155491824|NCT01049360|561225522|FG008|Period 1|Withdrawal by Subject|1|||
155491825|NCT01049360|561225523|FG009|Period 1|Withdrawal by Subject|0|||
155491826|NCT01049360|561225524|FG010|Period 1|Withdrawal by Subject|1|||
155491827|NCT01049360|561225525|FG011|Period 1|Withdrawal by Subject|0|||
155491828|NCT01049360|561225526|FG012|Period 1|Withdrawal by Subject|1|||
155491829|NCT01049360|561225527|FG013|Period 1|Withdrawal by Subject|0|||
155491830|NCT01049360|561225528|FG014|Period 1|Withdrawal by Subject|0|||
155491831|NCT01049360|561225529|FG015|Period 1|Withdrawal by Subject|0|||
155491832|NCT01049360|561225530|FG016|Period 1|Withdrawal by Subject|0|||
155491833|NCT01049360|561225531|FG017|Period 1|Withdrawal by Subject|0|||
155491834|NCT01049360|561225532|FG018|Period 1|Withdrawal by Subject|0|||
155491835|NCT01049360|561225533|FG019|Period 1|Withdrawal by Subject|0|||
155491836|NCT01049360|561225514|FG000|Period 2|Protocol Violation|0|||
155491837|NCT01049360|561225515|FG001|Period 2|Protocol Violation|0|||
155491838|NCT01049360|561225516|FG002|Period 2|Protocol Violation|0|||
155491839|NCT01049360|561225517|FG003|Period 2|Protocol Violation|1|||
155491840|NCT01049360|561225518|FG004|Period 2|Protocol Violation|0|||
155491841|NCT01049360|561225519|FG005|Period 2|Protocol Violation|0|||
155491842|NCT01049360|561225520|FG006|Period 2|Protocol Violation|0|||
155491843|NCT01049360|561225521|FG007|Period 2|Protocol Violation|0|||
155491844|NCT01049360|561225522|FG008|Period 2|Protocol Violation|0|||
155491845|NCT01049360|561225523|FG009|Period 2|Protocol Violation|0|||
155491846|NCT01049360|561225524|FG010|Period 2|Protocol Violation|0|||
155491847|NCT01049360|561225525|FG011|Period 2|Protocol Violation|0|||
155491848|NCT01049360|561225526|FG012|Period 2|Protocol Violation|0|||
155491849|NCT01049360|561225527|FG013|Period 2|Protocol Violation|0|||
155491850|NCT01049360|561225528|FG014|Period 2|Protocol Violation|1|||
155491851|NCT01049360|561225529|FG015|Period 2|Protocol Violation|1|||
155491852|NCT01049360|561225530|FG016|Period 2|Protocol Violation|0|||
155491853|NCT01049360|561225531|FG017|Period 2|Protocol Violation|0|||
155491854|NCT01049360|561225532|FG018|Period 2|Protocol Violation|0|||
155491855|NCT01049360|561225533|FG019|Period 2|Protocol Violation|0|||
155491856|NCT01049360|561225514|FG000|Period 2|Adverse Event|0|||
155491857|NCT01049360|561225515|FG001|Period 2|Adverse Event|1|||
155491858|NCT01049360|561225516|FG002|Period 2|Adverse Event|0|||
155491859|NCT01049360|561225517|FG003|Period 2|Adverse Event|0|||
155491860|NCT01049360|561225518|FG004|Period 2|Adverse Event|0|||
155491861|NCT01049360|561225519|FG005|Period 2|Adverse Event|0|||
155491862|NCT01049360|561225520|FG006|Period 2|Adverse Event|0|||
155491863|NCT01049360|561225521|FG007|Period 2|Adverse Event|0|||
155491864|NCT01049360|561225522|FG008|Period 2|Adverse Event|1|||
155491865|NCT01049360|561225523|FG009|Period 2|Adverse Event|0|||
155491866|NCT01049360|561225524|FG010|Period 2|Adverse Event|0|||
155491867|NCT01049360|561225525|FG011|Period 2|Adverse Event|0|||
155491868|NCT01049360|561225526|FG012|Period 2|Adverse Event|0|||
155491869|NCT01049360|561225527|FG013|Period 2|Adverse Event|0|||
155491870|NCT01049360|561225528|FG014|Period 2|Adverse Event|0|||
155491871|NCT01049360|561225529|FG015|Period 2|Adverse Event|0|||
155491872|NCT01049360|561225530|FG016|Period 2|Adverse Event|0|||
155491873|NCT01049360|561225531|FG017|Period 2|Adverse Event|0|||
155491874|NCT01049360|561225532|FG018|Period 2|Adverse Event|0|||
155491875|NCT01049360|561225533|FG019|Period 2|Adverse Event|1|||
155491876|NCT01049360|561225514|FG000|Period 2|Withdrawal by Subject|0|||
155491877|NCT01049360|561225515|FG001|Period 2|Withdrawal by Subject|0|||
155491878|NCT01049360|561225516|FG002|Period 2|Withdrawal by Subject|0|||
155491879|NCT01049360|561225517|FG003|Period 2|Withdrawal by Subject|1|||
155491880|NCT01049360|561225518|FG004|Period 2|Withdrawal by Subject|0|||
155491881|NCT01049360|561225519|FG005|Period 2|Withdrawal by Subject|0|||
155491882|NCT01049360|561225520|FG006|Period 2|Withdrawal by Subject|0|||
155491883|NCT01049360|561225521|FG007|Period 2|Withdrawal by Subject|0|||
155491884|NCT01049360|561225522|FG008|Period 2|Withdrawal by Subject|0|||
155491885|NCT01049360|561225523|FG009|Period 2|Withdrawal by Subject|0|||
155491886|NCT01049360|561225524|FG010|Period 2|Withdrawal by Subject|0|||
155491887|NCT01049360|561225525|FG011|Period 2|Withdrawal by Subject|0|||
155491888|NCT01049360|561225526|FG012|Period 2|Withdrawal by Subject|0|||
155491889|NCT01049360|561225527|FG013|Period 2|Withdrawal by Subject|0|||
155262979|NCT05960097|560394586|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262980|NCT05960097|560394587|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262981|NCT01784068|560394588|FG000|NTCS Phase|Adverse Event|5|||
155262982|NCT01784068|560394589|FG001|NTCS Phase|Adverse Event|0|||
155262983|NCT01784068|560394588|FG000|NTCS Phase|Physician Decision|2|||
155262984|NCT01784068|560394589|FG001|NTCS Phase|Physician Decision|0|||
155262985|NCT01784068|560394588|FG000|NTCS Phase|Patient/guardian decision|3|||
155262986|NCT01784068|560394589|FG001|NTCS Phase|Patient/guardian decision|0|||
155262987|NCT01784068|560394588|FG000|NTCS Phase|Death|2|||
155262988|NCT01784068|560394589|FG001|NTCS Phase|Death|0|||
155262989|NCT01784068|560394588|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
155262990|NCT01784068|560394589|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
155262991|NCT01784068|560394588|FG000|TFR Phase|Physician Decision|0|||
155262992|NCT01784068|560394589|FG001|TFR Phase|Physician Decision|1|||
155262993|NCT01784068|560394588|FG000|TFR Phase|Patient/guardian decision|0|||
155262994|NCT01784068|560394589|FG001|TFR Phase|Patient/guardian decision|3|||
155262995|NCT01784068|560394588|FG000|TFR Phase|Death|0|||
155262996|NCT01784068|560394589|FG001|TFR Phase|Death|1|||
155262997|NCT01784068|560394588|FG000|TFR Phase|Lack of Efficacy|0|||
155262998|NCT01784068|560394589|FG001|TFR Phase|Lack of Efficacy|88|||
155262999|NCT01489189|560394606|FG000|Overall Study|Withdrawal by Subject|20|||
155263000|NCT01489189|560394607|FG001|Overall Study|Withdrawal by Subject|23|||
155263001|NCT01489189|560394606|FG000|Overall Study|Death|10|||
155263002|NCT01489189|560394607|FG001|Overall Study|Death|8|||
155263003|NCT01489189|560394606|FG000|Overall Study|Missed Visit|1|||
155263004|NCT01489189|560394607|FG001|Overall Study|Missed Visit|4|||
155263005|NCT00112580|560394608|FG000|Overall Study|Adverse Event|1|||
155263006|NCT00112580|560394609|FG001|Overall Study|Adverse Event|2|||
155263007|NCT00112580|560394608|FG000|Overall Study|Disease progression|5|||
155263008|NCT00112580|560394609|FG001|Overall Study|Disease progression|16|||
155263009|NCT00112580|560394608|FG000|Overall Study|Participant withdrew consent|2|||
155263010|NCT00112580|560394609|FG001|Overall Study|Participant withdrew consent|1|||
155263011|NCT06027619|560394610|FG000|Overall Study|Adverse Event|0|||
155263012|NCT06027619|560394611|FG001|Overall Study|Adverse Event|0|||
155263013|NCT06027619|560394612|FG002|Overall Study|Adverse Event|1|||
155263014|NCT03075501|560396316|FG000|Overall Study|Scheduling difficulties|15|||
155263015|NCT03075501|560396317|FG001|Overall Study|Scheduling difficulties|9|||
155263016|NCT03610737|560396324|FG000|Overall Study|Withdrawal by Subject|1|||
155263017|NCT03610737|560396325|FG001|Overall Study|Withdrawal by Subject|5|||
155263018|NCT03610737|560396324|FG000|Overall Study|Death|1|||
155263019|NCT03610737|560396325|FG001|Overall Study|Death|0|||
155263020|NCT03610737|560396324|FG000|Overall Study|Not treated|5|||
155263021|NCT03610737|560396325|FG001|Overall Study|Not treated|2|||
155263022|NCT03610737|560396324|FG000|Overall Study|Missed Visit|1|||
155263023|NCT03610737|560396325|FG001|Overall Study|Missed Visit|2|||
155263024|NCT01392300|560396326|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
155263025|NCT01392300|560396327|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
155263026|NCT01392300|560396328|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
155263027|NCT01392300|560396326|FG000|Main Period (MP)|Withdrawal by Subject|5|||
155263028|NCT01392300|560396327|FG001|Main Period (MP)|Withdrawal by Subject|1|||
155263029|NCT01392300|560396328|FG002|Main Period (MP)|Withdrawal by Subject|0|||
155263030|NCT01392300|560396326|FG000|Main Period (MP)|Lost to Follow-up|3|||
155263031|NCT01392300|560396327|FG001|Main Period (MP)|Lost to Follow-up|3|||
155263032|NCT01392300|560396328|FG002|Main Period (MP)|Lost to Follow-up|0|||
155263033|NCT01392300|560396326|FG000|Main Period (MP)|Non-compliance|1|||
155491890|NCT01049360|561225528|FG014|Period 2|Withdrawal by Subject|1|||
155263034|NCT01392300|560396327|FG001|Main Period (MP)|Non-compliance|0|||
155263035|NCT01392300|560396328|FG002|Main Period (MP)|Non-compliance|0|||
155263036|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
155263037|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
155263038|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
155263039|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
155263040|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
155263041|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
155491891|NCT01049360|561225529|FG015|Period 2|Withdrawal by Subject|0|||
155491892|NCT01049360|561225530|FG016|Period 2|Withdrawal by Subject|0|||
155491893|NCT01049360|561225531|FG017|Period 2|Withdrawal by Subject|0|||
155491894|NCT01049360|561225532|FG018|Period 2|Withdrawal by Subject|0|||
155491895|NCT01049360|561225533|FG019|Period 2|Withdrawal by Subject|1|||
155491896|NCT01049360|561225514|FG000|Period 2|Lack of Efficacy|0|||
155491897|NCT01049360|561225515|FG001|Period 2|Lack of Efficacy|0|||
155491898|NCT01049360|561225516|FG002|Period 2|Lack of Efficacy|0|||
155491899|NCT01049360|561225517|FG003|Period 2|Lack of Efficacy|0|||
155491900|NCT01049360|561225518|FG004|Period 2|Lack of Efficacy|0|||
155491901|NCT01049360|561225519|FG005|Period 2|Lack of Efficacy|1|||
155491902|NCT01049360|561225520|FG006|Period 2|Lack of Efficacy|0|||
155491903|NCT01049360|561225521|FG007|Period 2|Lack of Efficacy|0|||
155491904|NCT01049360|561225522|FG008|Period 2|Lack of Efficacy|0|||
155491905|NCT01049360|561225523|FG009|Period 2|Lack of Efficacy|0|||
155491906|NCT01049360|561225524|FG010|Period 2|Lack of Efficacy|0|||
155491907|NCT01049360|561225525|FG011|Period 2|Lack of Efficacy|0|||
155491908|NCT01049360|561225526|FG012|Period 2|Lack of Efficacy|0|||
155491909|NCT01049360|561225527|FG013|Period 2|Lack of Efficacy|0|||
155491910|NCT01049360|561225528|FG014|Period 2|Lack of Efficacy|0|||
155491911|NCT01049360|561225529|FG015|Period 2|Lack of Efficacy|0|||
155491912|NCT01049360|561225530|FG016|Period 2|Lack of Efficacy|0|||
155491913|NCT01049360|561225531|FG017|Period 2|Lack of Efficacy|0|||
155491914|NCT01049360|561225532|FG018|Period 2|Lack of Efficacy|0|||
155491915|NCT01049360|561225533|FG019|Period 2|Lack of Efficacy|0|||
155491916|NCT01049360|561225514|FG000|Period 4|Protocol Violation|0|||
155491917|NCT01049360|561225515|FG001|Period 4|Protocol Violation|0|||
155491918|NCT01049360|561225516|FG002|Period 4|Protocol Violation|0|||
155491919|NCT01049360|561225517|FG003|Period 4|Protocol Violation|0|||
155491920|NCT01049360|561225518|FG004|Period 4|Protocol Violation|0|||
155491921|NCT01049360|561225519|FG005|Period 4|Protocol Violation|0|||
155491922|NCT01049360|561225520|FG006|Period 4|Protocol Violation|0|||
155491923|NCT01049360|561225521|FG007|Period 4|Protocol Violation|0|||
155491924|NCT01049360|561225522|FG008|Period 4|Protocol Violation|0|||
155491925|NCT01049360|561225523|FG009|Period 4|Protocol Violation|0|||
155491926|NCT01049360|561225524|FG010|Period 4|Protocol Violation|0|||
155491927|NCT01049360|561225525|FG011|Period 4|Protocol Violation|0|||
155491928|NCT01049360|561225526|FG012|Period 4|Protocol Violation|0|||
155491929|NCT01049360|561225527|FG013|Period 4|Protocol Violation|0|||
155491930|NCT01049360|561225528|FG014|Period 4|Protocol Violation|0|||
155491931|NCT01049360|561225529|FG015|Period 4|Protocol Violation|0|||
155491932|NCT01049360|561225530|FG016|Period 4|Protocol Violation|0|||
155491933|NCT01049360|561225531|FG017|Period 4|Protocol Violation|1|||
155491934|NCT01049360|561225532|FG018|Period 4|Protocol Violation|0|||
155491935|NCT01049360|561225533|FG019|Period 4|Protocol Violation|0|||
155491936|NCT01049360|561225514|FG000|Period 4|Withdrawal by Subject|0|||
155491937|NCT01049360|561225515|FG001|Period 4|Withdrawal by Subject|0|||
155491938|NCT01049360|561225516|FG002|Period 4|Withdrawal by Subject|0|||
155491939|NCT01049360|561225517|FG003|Period 4|Withdrawal by Subject|1|||
155491940|NCT01049360|561225518|FG004|Period 4|Withdrawal by Subject|0|||
155491941|NCT01049360|561225519|FG005|Period 4|Withdrawal by Subject|0|||
155491942|NCT01049360|561225520|FG006|Period 4|Withdrawal by Subject|0|||
155491943|NCT01049360|561225521|FG007|Period 4|Withdrawal by Subject|0|||
155491944|NCT01049360|561225522|FG008|Period 4|Withdrawal by Subject|0|||
155491945|NCT01049360|561225523|FG009|Period 4|Withdrawal by Subject|0|||
155491946|NCT01049360|561225524|FG010|Period 4|Withdrawal by Subject|0|||
155491947|NCT01049360|561225525|FG011|Period 4|Withdrawal by Subject|0|||
155491948|NCT01049360|561225526|FG012|Period 4|Withdrawal by Subject|0|||
155491949|NCT01049360|561225527|FG013|Period 4|Withdrawal by Subject|0|||
155491950|NCT01049360|561225528|FG014|Period 4|Withdrawal by Subject|0|||
155491951|NCT01049360|561225529|FG015|Period 4|Withdrawal by Subject|0|||
155491952|NCT01049360|561225530|FG016|Period 4|Withdrawal by Subject|0|||
155491953|NCT01049360|561225531|FG017|Period 4|Withdrawal by Subject|0|||
155491954|NCT01049360|561225532|FG018|Period 4|Withdrawal by Subject|0|||
155491955|NCT01049360|561225533|FG019|Period 4|Withdrawal by Subject|0|||
155491956|NCT02058849|561225534|FG000|Overall Study|Hospitalization|1|||
155491957|NCT02058849|561225535|FG001|Overall Study|Hospitalization|1|||
155491958|NCT02058849|561225534|FG000|Overall Study|Death|1|||
155491959|NCT02058849|561225535|FG001|Overall Study|Death|0|||
155491960|NCT02058849|561225534|FG000|Overall Study|Lost to Follow-up|1|||
155491961|NCT02058849|561225535|FG001|Overall Study|Lost to Follow-up|0|||
155491962|NCT02058849|561225534|FG000|Overall Study|Withdrawal by Subject|4|||
155491963|NCT02058849|561225535|FG001|Overall Study|Withdrawal by Subject|0|||
155491964|NCT05147311|561225538|FG000|Overall Study|Did not complete survey|2|||
155491965|NCT05147311|561225539|FG001|Overall Study|Did not complete survey|1|||
155491966|NCT05147311|561225538|FG000|Overall Study|Patient too sick|1|||
155491967|NCT05147311|561225539|FG001|Overall Study|Patient too sick|2|||
155491968|NCT05147311|561225538|FG000|Overall Study|Death|0|||
155491969|NCT05147311|561225539|FG001|Overall Study|Death|1|||
155491970|NCT05147311|561225538|FG000|Overall Study|Declined survey|1|||
155491971|NCT05147311|561225539|FG001|Overall Study|Declined survey|0|||
155491972|NCT00145795|561225541|FG000|Overall Study|Adverse Event|1|||
155491973|NCT00145795|561225542|FG001|Overall Study|Adverse Event|0|||
155491974|NCT01539512|561225547|FG000|Overall Study|Adverse Event|9|||
155491975|NCT01539512|561225548|FG001|Overall Study|Adverse Event|7|||
155491976|NCT01539512|561225547|FG000|Overall Study|Physician Decision|1|||
155491977|NCT01539512|561225548|FG001|Overall Study|Physician Decision|1|||
155491978|NCT01539512|561225547|FG000|Overall Study|Withdrawal by Subject|12|||
155491979|NCT01539512|561225548|FG001|Overall Study|Withdrawal by Subject|5|||
155491980|NCT01539512|561225547|FG000|Overall Study|Richter's Transformation|1|||
155491981|NCT01539512|561225548|FG001|Overall Study|Richter's Transformation|0|||
155491982|NCT02388906|561225553|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
155491983|NCT02388906|561225554|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155491984|NCT02388906|561225553|FG000|Treatment Period|Disease progression|121|||
155491985|NCT02388906|561225554|FG001|Treatment Period|Disease progression|100|||
155491986|NCT02388906|561225553|FG000|Treatment Period|Study drug toxicity|41|||
155491987|NCT02388906|561225554|FG001|Treatment Period|Study drug toxicity|208|||
155491988|NCT02388906|561225553|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
155491989|NCT02388906|561225554|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
155491990|NCT02388906|561225553|FG000|Treatment Period|Participant request to stop treatment|5|||
155491991|NCT02388906|561225554|FG001|Treatment Period|Participant request to stop treatment|9|||
155491992|NCT02388906|561225553|FG000|Treatment Period|Participant withdrew consent|2|||
155491993|NCT02388906|561225554|FG001|Treatment Period|Participant withdrew consent|3|||
155491994|NCT02388906|561225553|FG000|Treatment Period|Poor/non-compliance|0|||
155491995|NCT02388906|561225554|FG001|Treatment Period|Poor/non-compliance|1|||
155491996|NCT02388906|561225553|FG000|Treatment Period|Participant no longer meets study criteria|0|||
155491997|NCT02388906|561225554|FG001|Treatment Period|Participant no longer meets study criteria|1|||
155491998|NCT02388906|561225553|FG000|Treatment Period|Other reasons|3|||
155491999|NCT02388906|561225554|FG001|Treatment Period|Other reasons|3|||
155492000|NCT04365387|561225555|FG000|Overall Study|Adverse Event|4|||
155492001|NCT04365387|561225556|FG001|Overall Study|Adverse Event|2|||
155492002|NCT04365387|561225555|FG000|Overall Study|Participants request|14|||
155492003|NCT04365387|561225556|FG001|Overall Study|Participants request|14|||
155492004|NCT04365387|561225555|FG000|Overall Study|Lost to Follow-up|8|||
155492005|NCT04365387|561225556|FG001|Overall Study|Lost to Follow-up|5|||
155492006|NCT04365387|561225555|FG000|Overall Study|Protocol deviation|3|||
155492007|NCT04365387|561225556|FG001|Overall Study|Protocol deviation|4|||
155492008|NCT04365387|561225555|FG000|Overall Study|Participant compliance with visit schedule|1|||
155492009|NCT04365387|561225556|FG001|Overall Study|Participant compliance with visit schedule|0|||
155492010|NCT04365387|561225555|FG000|Overall Study|Participant incarcerated|1|||
155492011|NCT04365387|561225556|FG001|Overall Study|Participant incarcerated|0|||
155492012|NCT04365387|561225555|FG000|Overall Study|Participant moved out of town (relocated)|0|||
155492013|NCT04365387|561225556|FG001|Overall Study|Participant moved out of town (relocated)|1|||
155492014|NCT04365387|561225555|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
155492015|NCT04365387|561225556|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
155492016|NCT04365387|561225555|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
155492017|NCT04365387|561225556|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
155492018|NCT05770401|561225565|FG000|Overall Study|Lost to Follow-up|5|||
155492019|NCT05770401|561225566|FG001|Overall Study|Lost to Follow-up|4|||
155492020|NCT00402298|561225567|FG000|Overall Study|Withdrawal by Subject|1|||
155492021|NCT00402298|561225568|FG001|Overall Study|Withdrawal by Subject|0|||
155492022|NCT00480077|561225569|FG000|Overall Study|Death|19|||
155492023|NCT00480077|561225570|FG001|Overall Study|Death|15|||
155492024|NCT00480077|561225569|FG000|Overall Study|early exit|12|||
155492025|NCT00480077|561225570|FG001|Overall Study|early exit|11|||
155492026|NCT05966129|561225571|FG000|Overall Study|Death|1|||
155492027|NCT05966129|561225572|FG001|Overall Study|Death|2|||
155492028|NCT05966129|561225571|FG000|Overall Study|Lost to Follow-up|63|||
155492029|NCT05966129|561225572|FG001|Overall Study|Lost to Follow-up|66|||
155492030|NCT05966129|561225571|FG000|Overall Study|Protocol Violation|1|||
155492031|NCT05966129|561225572|FG001|Overall Study|Protocol Violation|0|||
155492032|NCT05966129|561225571|FG000|Overall Study|Withdrawal by Subject|26|||
155492033|NCT05966129|561225572|FG001|Overall Study|Withdrawal by Subject|25|||
155492034|NCT05966129|561225571|FG000|Overall Study|Surgery not completed|63|||
155492035|NCT05966129|561225572|FG001|Overall Study|Surgery not completed|69|||
155492036|NCT05966129|561225571|FG000|Overall Study|Surgery logistics issue|2|||
155492037|NCT05966129|561225572|FG001|Overall Study|Surgery logistics issue|1|||
155492038|NCT05182840|561225573|FG000|Run-in Period|Not treated|0|||
155492039|NCT05182840|561225574|FG001|Run-in Period|Not treated|1|||
155492040|NCT05182840|561225575|FG002|Run-in Period|Not treated|0|||
155492041|NCT05182840|561225576|FG003|Run-in Period|Not treated|0|||
155492042|NCT05182840|561225577|FG004|Run-in Period|Not treated|0|||
155492043|NCT05182840|561225578|FG005|Run-in Period|Not treated|0|||
155492044|NCT05182840|561225579|FG006|Run-in Period|Not treated|0|||
155492045|NCT05182840|561225580|FG007|Run-in Period|Not treated|0|||
155492046|NCT05182840|561225581|FG008|Run-in Period|Not treated|0|||
155492047|NCT05182840|561225582|FG009|Run-in Period|Not treated|0|||
155492048|NCT05182840|561225573|FG000|Run-in Period|Other reason but not sponsor termination|14|||
155492049|NCT05182840|561225574|FG001|Run-in Period|Other reason but not sponsor termination|18|||
155492050|NCT05182840|561225575|FG002|Run-in Period|Other reason but not sponsor termination|0|||
155492051|NCT05182840|561225576|FG003|Run-in Period|Other reason but not sponsor termination|0|||
155492052|NCT05182840|561225577|FG004|Run-in Period|Other reason but not sponsor termination|0|||
155492053|NCT05182840|561225578|FG005|Run-in Period|Other reason but not sponsor termination|0|||
155492054|NCT05182840|561225579|FG006|Run-in Period|Other reason but not sponsor termination|0|||
155492055|NCT05182840|561225580|FG007|Run-in Period|Other reason but not sponsor termination|0|||
155492056|NCT05182840|561225581|FG008|Run-in Period|Other reason but not sponsor termination|0|||
155492057|NCT05182840|561225582|FG009|Run-in Period|Other reason but not sponsor termination|0|||
155492058|NCT05182840|561225573|FG000|Run-in Period|No reason available|2|||
155492059|NCT05182840|561225574|FG001|Run-in Period|No reason available|2|||
155492060|NCT05182840|561225575|FG002|Run-in Period|No reason available|0|||
155492061|NCT05182840|561225576|FG003|Run-in Period|No reason available|0|||
155492062|NCT05182840|561225577|FG004|Run-in Period|No reason available|0|||
155492063|NCT05182840|561225578|FG005|Run-in Period|No reason available|0|||
155492064|NCT05182840|561225579|FG006|Run-in Period|No reason available|0|||
155492065|NCT05182840|561225580|FG007|Run-in Period|No reason available|0|||
155492066|NCT05182840|561225581|FG008|Run-in Period|No reason available|0|||
155492067|NCT05182840|561225582|FG009|Run-in Period|No reason available|0|||
155492068|NCT05182840|561225573|FG000|Run-in Period|Burden of study procedures|2|||
155492069|NCT05182840|561225574|FG001|Run-in Period|Burden of study procedures|2|||
155492070|NCT05182840|561225575|FG002|Run-in Period|Burden of study procedures|0|||
155492071|NCT05182840|561225576|FG003|Run-in Period|Burden of study procedures|0|||
155492072|NCT05182840|561225577|FG004|Run-in Period|Burden of study procedures|0|||
155492073|NCT05182840|561225578|FG005|Run-in Period|Burden of study procedures|0|||
155492074|NCT05182840|561225579|FG006|Run-in Period|Burden of study procedures|0|||
155492075|NCT05182840|561225580|FG007|Run-in Period|Burden of study procedures|0|||
155492076|NCT05182840|561225581|FG008|Run-in Period|Burden of study procedures|0|||
155492077|NCT05182840|561225582|FG009|Run-in Period|Burden of study procedures|0|||
155492078|NCT05182840|561225573|FG000|Run-in Period|Change of residence|1|||
155492079|NCT05182840|561225574|FG001|Run-in Period|Change of residence|0|||
155492080|NCT05182840|561225575|FG002|Run-in Period|Change of residence|0|||
155492081|NCT05182840|561225576|FG003|Run-in Period|Change of residence|0|||
155492082|NCT05182840|561225577|FG004|Run-in Period|Change of residence|0|||
155492083|NCT05182840|561225578|FG005|Run-in Period|Change of residence|0|||
155492084|NCT05182840|561225579|FG006|Run-in Period|Change of residence|0|||
155492085|NCT05182840|561225580|FG007|Run-in Period|Change of residence|0|||
155492086|NCT05182840|561225581|FG008|Run-in Period|Change of residence|0|||
155492087|NCT05182840|561225582|FG009|Run-in Period|Change of residence|0|||
155492088|NCT05182840|561225573|FG000|Run-in Period|Adverse Event|5|||
155492089|NCT05182840|561225574|FG001|Run-in Period|Adverse Event|5|||
155492090|NCT05182840|561225575|FG002|Run-in Period|Adverse Event|0|||
155492091|NCT05182840|561225576|FG003|Run-in Period|Adverse Event|0|||
155492092|NCT05182840|561225577|FG004|Run-in Period|Adverse Event|0|||
155492093|NCT05182840|561225578|FG005|Run-in Period|Adverse Event|0|||
155492094|NCT05182840|561225579|FG006|Run-in Period|Adverse Event|0|||
155492095|NCT05182840|561225580|FG007|Run-in Period|Adverse Event|0|||
155492096|NCT05182840|561225581|FG008|Run-in Period|Adverse Event|0|||
155492097|NCT05182840|561225582|FG009|Run-in Period|Adverse Event|0|||
155492098|NCT05182840|561225573|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
155492099|NCT05182840|561225574|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
155492100|NCT05182840|561225575|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492101|NCT05182840|561225576|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492102|NCT05182840|561225577|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492103|NCT05182840|561225578|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492104|NCT05182840|561225579|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492105|NCT05182840|561225580|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492106|NCT05182840|561225581|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492107|NCT05182840|561225582|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155492108|NCT05182840|561225573|FG000|Treatment Period|Reason missing|0|||
155492109|NCT05182840|561225574|FG001|Treatment Period|Reason missing|0|||
155492110|NCT05182840|561225575|FG002|Treatment Period|Reason missing|1|||
155492111|NCT05182840|561225576|FG003|Treatment Period|Reason missing|0|||
155492112|NCT05182840|561225577|FG004|Treatment Period|Reason missing|0|||
155492113|NCT05182840|561225578|FG005|Treatment Period|Reason missing|0|||
155492114|NCT05182840|561225579|FG006|Treatment Period|Reason missing|0|||
155492115|NCT05182840|561225580|FG007|Treatment Period|Reason missing|0|||
155492116|NCT05182840|561225581|FG008|Treatment Period|Reason missing|0|||
155492117|NCT05182840|561225582|FG009|Treatment Period|Reason missing|0|||
155492118|NCT05182840|561225573|FG000|Treatment Period|Other but not sponsor termination|0|||
155492119|NCT05182840|561225574|FG001|Treatment Period|Other but not sponsor termination|0|||
155492120|NCT05182840|561225575|FG002|Treatment Period|Other but not sponsor termination|8|||
155492121|NCT05182840|561225576|FG003|Treatment Period|Other but not sponsor termination|6|||
155492122|NCT05182840|561225577|FG004|Treatment Period|Other but not sponsor termination|6|||
155492123|NCT05182840|561225578|FG005|Treatment Period|Other but not sponsor termination|7|||
155492124|NCT05182840|561225579|FG006|Treatment Period|Other but not sponsor termination|5|||
155492125|NCT05182840|561225580|FG007|Treatment Period|Other but not sponsor termination|8|||
155492126|NCT05182840|561225581|FG008|Treatment Period|Other but not sponsor termination|7|||
155492127|NCT05182840|561225582|FG009|Treatment Period|Other but not sponsor termination|2|||
155492128|NCT05182840|561225573|FG000|Treatment Period|Protocol deviation|0|||
155492129|NCT05182840|561225574|FG001|Treatment Period|Protocol deviation|0|||
155492130|NCT05182840|561225575|FG002|Treatment Period|Protocol deviation|0|||
155492131|NCT05182840|561225576|FG003|Treatment Period|Protocol deviation|0|||
155492132|NCT05182840|561225577|FG004|Treatment Period|Protocol deviation|0|||
155492133|NCT05182840|561225578|FG005|Treatment Period|Protocol deviation|0|||
155492134|NCT05182840|561225579|FG006|Treatment Period|Protocol deviation|0|||
155492135|NCT05182840|561225580|FG007|Treatment Period|Protocol deviation|0|||
155492136|NCT05182840|561225581|FG008|Treatment Period|Protocol deviation|1|||
155492137|NCT05182840|561225582|FG009|Treatment Period|Protocol deviation|0|||
155492138|NCT05182840|561225573|FG000|Treatment Period|No reason available|0|||
155492139|NCT05182840|561225574|FG001|Treatment Period|No reason available|0|||
155492140|NCT05182840|561225575|FG002|Treatment Period|No reason available|0|||
155492141|NCT05182840|561225576|FG003|Treatment Period|No reason available|1|||
155492142|NCT05182840|561225577|FG004|Treatment Period|No reason available|0|||
155492143|NCT05182840|561225578|FG005|Treatment Period|No reason available|2|||
155492144|NCT05182840|561225579|FG006|Treatment Period|No reason available|0|||
155492145|NCT05182840|561225580|FG007|Treatment Period|No reason available|1|||
155492146|NCT05182840|561225581|FG008|Treatment Period|No reason available|0|||
155492147|NCT05182840|561225582|FG009|Treatment Period|No reason available|0|||
155492148|NCT05182840|561225573|FG000|Treatment Period|Burden of study procedures|0|||
155492149|NCT05182840|561225574|FG001|Treatment Period|Burden of study procedures|0|||
155492150|NCT05182840|561225575|FG002|Treatment Period|Burden of study procedures|0|||
155492151|NCT05182840|561225576|FG003|Treatment Period|Burden of study procedures|0|||
155492152|NCT05182840|561225577|FG004|Treatment Period|Burden of study procedures|1|||
155492153|NCT05182840|561225578|FG005|Treatment Period|Burden of study procedures|0|||
155492154|NCT05182840|561225579|FG006|Treatment Period|Burden of study procedures|0|||
155492155|NCT05182840|561225580|FG007|Treatment Period|Burden of study procedures|0|||
155492156|NCT05182840|561225581|FG008|Treatment Period|Burden of study procedures|0|||
155492157|NCT05182840|561225582|FG009|Treatment Period|Burden of study procedures|0|||
155492158|NCT05182840|561225573|FG000|Treatment Period|Change of residence|0|||
155492159|NCT05182840|561225574|FG001|Treatment Period|Change of residence|0|||
155492160|NCT05182840|561225575|FG002|Treatment Period|Change of residence|0|||
155492161|NCT05182840|561225576|FG003|Treatment Period|Change of residence|0|||
155492162|NCT05182840|561225577|FG004|Treatment Period|Change of residence|0|||
155492163|NCT05182840|561225578|FG005|Treatment Period|Change of residence|1|||
155492164|NCT05182840|561225579|FG006|Treatment Period|Change of residence|0|||
155492165|NCT05182840|561225580|FG007|Treatment Period|Change of residence|0|||
155492166|NCT05182840|561225581|FG008|Treatment Period|Change of residence|0|||
155492167|NCT05182840|561225582|FG009|Treatment Period|Change of residence|0|||
155492168|NCT05182840|561225573|FG000|Treatment Period|Adverse Event|0|||
155492169|NCT05182840|561225574|FG001|Treatment Period|Adverse Event|0|||
155492170|NCT05182840|561225575|FG002|Treatment Period|Adverse Event|4|||
155492171|NCT05182840|561225576|FG003|Treatment Period|Adverse Event|16|||
155492172|NCT05182840|561225577|FG004|Treatment Period|Adverse Event|12|||
155492173|NCT05182840|561225578|FG005|Treatment Period|Adverse Event|6|||
155492174|NCT05182840|561225579|FG006|Treatment Period|Adverse Event|4|||
155492175|NCT05182840|561225580|FG007|Treatment Period|Adverse Event|8|||
155492176|NCT05182840|561225581|FG008|Treatment Period|Adverse Event|16|||
155492177|NCT05182840|561225582|FG009|Treatment Period|Adverse Event|5|||
155492178|NCT05182840|561225573|FG000|Treatment Period|Not treated with study drug|0|||
155492179|NCT05182840|561225574|FG001|Treatment Period|Not treated with study drug|0|||
155492180|NCT05182840|561225575|FG002|Treatment Period|Not treated with study drug|0|||
155492181|NCT05182840|561225576|FG003|Treatment Period|Not treated with study drug|1|||
155492182|NCT05182840|561225577|FG004|Treatment Period|Not treated with study drug|0|||
155492183|NCT05182840|561225578|FG005|Treatment Period|Not treated with study drug|0|||
155492184|NCT05182840|561225579|FG006|Treatment Period|Not treated with study drug|1|||
155492185|NCT05182840|561225580|FG007|Treatment Period|Not treated with study drug|1|||
155492186|NCT05182840|561225581|FG008|Treatment Period|Not treated with study drug|0|||
155492187|NCT05182840|561225582|FG009|Treatment Period|Not treated with study drug|0|||
155492188|NCT00412360|561225585|FG000|Overall Study|Lost to Follow-up|0|||
155492189|NCT00412360|561225586|FG001|Overall Study|Lost to Follow-up|1|||
155492190|NCT00412360|561225585|FG000|Overall Study|Not Transplanted|1|||
155492191|NCT00412360|561225586|FG001|Overall Study|Not Transplanted|2|||
155492192|NCT01078974|561225589|FG000|Overall Study|Adverse Event|3|||
155492193|NCT01393444|561225590|FG000|Overall Study|Withdrawal by Subject|1|||
155492194|NCT01393444|561225590|FG000|Overall Study|Determined ineligible during screening.|2|||
155492195|NCT01397409|561225593|FG000|Stage 2|Adverse Event|0|||
155492196|NCT01397409|561225594|FG001|Stage 2|Adverse Event|0|||
155492197|NCT01397409|561225595|FG002|Stage 2|Adverse Event|0|||
155492198|NCT01397409|561225596|FG003|Stage 2|Adverse Event|0|||
155492199|NCT01397409|561225597|FG004|Stage 2|Adverse Event|6|||
155492200|NCT01397409|561225598|FG005|Stage 2|Adverse Event|3|||
155492201|NCT01397409|561225599|FG006|Stage 2|Adverse Event|0|||
155492202|NCT01397409|561225600|FG007|Stage 2|Adverse Event|0|||
155492203|NCT01397409|561225601|FG008|Stage 2|Adverse Event|0|||
155492204|NCT01397409|561225602|FG009|Stage 2|Adverse Event|0|||
155492205|NCT01397409|561225593|FG000|Stage 2|Personal Reasons|0|||
155492206|NCT01397409|561225594|FG001|Stage 2|Personal Reasons|0|||
155492207|NCT01397409|561225595|FG002|Stage 2|Personal Reasons|0|||
155492208|NCT01397409|561225596|FG003|Stage 2|Personal Reasons|0|||
155492209|NCT01397409|561225597|FG004|Stage 2|Personal Reasons|1|||
155492210|NCT01397409|561225598|FG005|Stage 2|Personal Reasons|0|||
155492211|NCT01397409|561225599|FG006|Stage 2|Personal Reasons|0|||
155492212|NCT01397409|561225600|FG007|Stage 2|Personal Reasons|0|||
155492213|NCT01397409|561225601|FG008|Stage 2|Personal Reasons|0|||
155492214|NCT01397409|561225602|FG009|Stage 2|Personal Reasons|0|||
155492215|NCT01397409|561225593|FG000|Stage 2|Other Miscellaneous Reasons|0|||
155492216|NCT01397409|561225594|FG001|Stage 2|Other Miscellaneous Reasons|0|||
155492217|NCT01397409|561225595|FG002|Stage 2|Other Miscellaneous Reasons|0|||
155492218|NCT01397409|561225596|FG003|Stage 2|Other Miscellaneous Reasons|0|||
155492219|NCT01397409|561225597|FG004|Stage 2|Other Miscellaneous Reasons|1|||
155492220|NCT01397409|561225598|FG005|Stage 2|Other Miscellaneous Reasons|1|||
155492221|NCT01397409|561225599|FG006|Stage 2|Other Miscellaneous Reasons|0|||
155492222|NCT01397409|561225600|FG007|Stage 2|Other Miscellaneous Reasons|0|||
155492223|NCT01397409|561225601|FG008|Stage 2|Other Miscellaneous Reasons|0|||
155492224|NCT01397409|561225602|FG009|Stage 2|Other Miscellaneous Reasons|0|||
155492225|NCT01397409|561225593|FG000|Stage 3|Adverse Event|0|||
155492226|NCT01397409|561225594|FG001|Stage 3|Adverse Event|0|||
155492227|NCT01397409|561225595|FG002|Stage 3|Adverse Event|0|||
155492228|NCT01397409|561225596|FG003|Stage 3|Adverse Event|0|||
155492229|NCT01397409|561225597|FG004|Stage 3|Adverse Event|0|||
155492230|NCT01397409|561225598|FG005|Stage 3|Adverse Event|0|||
155492231|NCT01397409|561225599|FG006|Stage 3|Adverse Event|0|||
155492232|NCT01397409|561225600|FG007|Stage 3|Adverse Event|1|||
155492233|NCT01397409|561225601|FG008|Stage 3|Adverse Event|0|||
155492234|NCT01397409|561225602|FG009|Stage 3|Adverse Event|0|||
155492235|NCT01397409|561225593|FG000|Stage 3|Other Miscellaneous Reasons|0|||
155492236|NCT01397409|561225594|FG001|Stage 3|Other Miscellaneous Reasons|0|||
155492237|NCT01397409|561225595|FG002|Stage 3|Other Miscellaneous Reasons|0|||
155492238|NCT01397409|561225596|FG003|Stage 3|Other Miscellaneous Reasons|0|||
155492239|NCT01397409|561225597|FG004|Stage 3|Other Miscellaneous Reasons|0|||
155492240|NCT01397409|561225598|FG005|Stage 3|Other Miscellaneous Reasons|0|||
155492241|NCT01397409|561225599|FG006|Stage 3|Other Miscellaneous Reasons|0|||
155492242|NCT01397409|561225600|FG007|Stage 3|Other Miscellaneous Reasons|1|||
155492243|NCT01397409|561225601|FG008|Stage 3|Other Miscellaneous Reasons|0|||
155492244|NCT01397409|561225602|FG009|Stage 3|Other Miscellaneous Reasons|0|||
155492245|NCT03418727|561225603|FG000|Overall Study|Adverse Event|1|||
155492246|NCT03418727|561225604|FG001|Overall Study|Adverse Event|2|||
155492247|NCT03418727|561225605|FG002|Overall Study|Adverse Event|0|||
155492248|NCT03418727|561225603|FG000|Overall Study|Withdrawal by Subject|0|||
155492249|NCT03418727|561225604|FG001|Overall Study|Withdrawal by Subject|0|||
155492250|NCT03418727|561225605|FG002|Overall Study|Withdrawal by Subject|2|||
155492251|NCT03145207|561225606|FG000|Overall Study|volunteer started taking allergy shots|1|||
155492252|NCT03145207|561225606|FG000|Overall Study|baseline blood pressure high|1|||
155492253|NCT01396434|561225608|FG000|Overall Study|Lost to Follow-up|1|||
155492254|NCT01396434|561225609|FG001|Overall Study|Lost to Follow-up|0|||
155492255|NCT01396434|561225610|FG002|Overall Study|Lost to Follow-up|0|||
155492256|NCT01396434|561225608|FG000|Overall Study|Other|10|||
155492257|NCT01396434|561225609|FG001|Overall Study|Other|0|||
155492258|NCT01396434|561225610|FG002|Overall Study|Other|0|||
155492259|NCT00509223|561227168|FG000|Overall Study|Lost to Follow-up|1|||
155492260|NCT00509223|561227169|FG001|Overall Study|Lost to Follow-up|1|||
155492261|NCT00509223|561227168|FG000|Overall Study|Adverse Event|1|||
155492262|NCT00509223|561227169|FG001|Overall Study|Adverse Event|1|||
155492263|NCT00509223|561227168|FG000|Overall Study|Withdrawal by Subject|25|||
155492264|NCT00509223|561227169|FG001|Overall Study|Withdrawal by Subject|6|||
155492265|NCT00509223|561227168|FG000|Overall Study|Including: subject change of address|5|||
155492266|NCT00509223|561227169|FG001|Overall Study|Including: subject change of address|2|||
155492267|NCT00509223|561227168|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
155492268|NCT00509223|561227169|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
155492269|NCT03839693|561227176|FG000|Overall Study|Lost to Follow-up|0|||
155492270|NCT03839693|561227177|FG001|Overall Study|Lost to Follow-up|2|||
155492271|NCT03839693|561227178|FG002|Overall Study|Lost to Follow-up|2|||
155492272|NCT03839693|561227176|FG000|Overall Study|Withdrawal by Subject|1|||
155492273|NCT03839693|561227177|FG001|Overall Study|Withdrawal by Subject|0|||
155492274|NCT03839693|561227178|FG002|Overall Study|Withdrawal by Subject|2|||
155492275|NCT03839693|561227176|FG000|Overall Study|subject moved out of the area|1|||
155492276|NCT03839693|561227177|FG001|Overall Study|subject moved out of the area|0|||
155492277|NCT03839693|561227178|FG002|Overall Study|subject moved out of the area|0|||
155492278|NCT00700115|561227187|FG000|Overall Study|Withdrawal by Subject|1|||
155492279|NCT00700115|561227188|FG001|Overall Study|Withdrawal by Subject|0|||
155492280|NCT00700115|561227187|FG000|Overall Study|Lost to Follow-up|0|||
155492281|NCT00700115|561227188|FG001|Overall Study|Lost to Follow-up|1|||
155492282|NCT02983305|561227189|FG000|Overall Study|incomplete data|2|||
155492283|NCT02983305|561227190|FG001|Overall Study|incomplete data|0|||
155492284|NCT00706901|561227191|FG000|Overall Study|Lost to Follow-up|2|||
155492285|NCT00706901|561227192|FG001|Overall Study|Lost to Follow-up|3|||
155492286|NCT00706901|561227193|FG002|Overall Study|Lost to Follow-up|2|||
155492287|NCT00706901|561227191|FG000|Overall Study|Withdrawal by Subject|4|||
155492288|NCT00706901|561227192|FG001|Overall Study|Withdrawal by Subject|2|||
155492289|NCT00706901|561227193|FG002|Overall Study|Withdrawal by Subject|5|||
155492290|NCT00706901|561227191|FG000|Overall Study|In Jail|1|||
155492291|NCT00706901|561227192|FG001|Overall Study|In Jail|0|||
155492292|NCT00706901|561227193|FG002|Overall Study|In Jail|1|||
155492293|NCT00706901|561227191|FG000|Overall Study|Death|1|||
155492294|NCT00706901|561227192|FG001|Overall Study|Death|0|||
155492295|NCT00706901|561227193|FG002|Overall Study|Death|0|||
155492296|NCT00822237|561227194|FG000|Dose 1 Vaccination|Not vaccinated|3|||
155492297|NCT00822237|561227195|FG001|Dose 1 Vaccination|Not vaccinated|0|||
155492298|NCT00822237|561227194|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
155492299|NCT00822237|561227195|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
155492300|NCT00822237|561227194|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
155492301|NCT00822237|561227195|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
155492302|NCT00822237|561227194|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
155492303|NCT00822237|561227195|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
155492304|NCT00822237|561227194|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
155492305|NCT00822237|561227195|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
155492306|NCT03433482|561227196|FG000|Overall Study|Lost to Follow-up|1|||
155492307|NCT03433482|561227197|FG001|Overall Study|Lost to Follow-up|0|||
155492308|NCT03433482|561227198|FG002|Overall Study|Lost to Follow-up|1|||
155492309|NCT03433482|561227199|FG003|Overall Study|Lost to Follow-up|1|||
155492310|NCT03433482|561227196|FG000|Overall Study|Withdrawal by Subject|0|||
155492311|NCT03433482|561227197|FG001|Overall Study|Withdrawal by Subject|0|||
155492312|NCT03433482|561227198|FG002|Overall Study|Withdrawal by Subject|1|||
155492313|NCT03433482|561227199|FG003|Overall Study|Withdrawal by Subject|0|||
155492314|NCT03433482|561227196|FG000|Overall Study|Unknown reason|0|||
155492315|NCT03433482|561227197|FG001|Overall Study|Unknown reason|0|||
155492316|NCT03433482|561227198|FG002|Overall Study|Unknown reason|2|||
155492317|NCT03433482|561227199|FG003|Overall Study|Unknown reason|0|||
155492318|NCT01646268|561227203|FG000|Overall Study|Adverse Event|6|||
155492319|NCT01646268|561227204|FG001|Overall Study|Adverse Event|7|||
155492320|NCT01646268|561227203|FG000|Overall Study|Lack of Efficacy|1|||
155492321|NCT01646268|561227204|FG001|Overall Study|Lack of Efficacy|3|||
155492322|NCT01646268|561227203|FG000|Overall Study|Protocol Violation|0|||
155492323|NCT01646268|561227204|FG001|Overall Study|Protocol Violation|1|||
155492324|NCT01646268|561227203|FG000|Overall Study|Withdrawal by Subject|2|||
155492325|NCT01646268|561227204|FG001|Overall Study|Withdrawal by Subject|5|||
155492326|NCT01646268|561227203|FG000|Overall Study|Other|2|||
155492327|NCT01646268|561227204|FG001|Overall Study|Other|0|||
155492328|NCT01473602|561227209|FG000|Overall Study|Adverse Event|1|||
155492329|NCT01473602|561227210|FG001|Overall Study|Adverse Event|2|||
155492330|NCT01473602|561227209|FG000|Overall Study|Death|0|||
155492331|NCT01473602|561227210|FG001|Overall Study|Death|1|||
155492332|NCT01473602|561227209|FG000|Overall Study|Lost to Follow-up|1|||
155492333|NCT01473602|561227210|FG001|Overall Study|Lost to Follow-up|1|||
155492334|NCT01473602|561227209|FG000|Overall Study|Withdrawal by Subject|5|||
155492335|NCT01473602|561227210|FG001|Overall Study|Withdrawal by Subject|4|||
155492336|NCT01473602|561227209|FG000|Overall Study|Physician Decision|1|||
155492337|NCT01473602|561227210|FG001|Overall Study|Physician Decision|0|||
155492338|NCT00449761|561227211|FG000|Overall Study|Disease progression|12|||
155492339|NCT00449761|561227211|FG000|Overall Study|Death|5|||
155492340|NCT00449761|561227211|FG000|Overall Study|New cancer therapy|1|||
155492341|NCT00518531|561227214|FG000|Treatment Period 1|Adverse Event|5|||
155492342|NCT00518531|561227215|FG001|Treatment Period 1|Adverse Event|0|||
155492343|NCT00518531|561227214|FG000|Treatment Period 1|Lost to Follow-up|5|||
155492344|NCT00518531|561227215|FG001|Treatment Period 1|Lost to Follow-up|3|||
155492345|NCT00518531|561227214|FG000|Treatment Period 1|Physician Decision|1|||
155492346|NCT00518531|561227215|FG001|Treatment Period 1|Physician Decision|0|||
155492347|NCT00518531|561227214|FG000|Treatment Period 1|Protocol Violation|2|||
155492348|NCT00518531|561227215|FG001|Treatment Period 1|Protocol Violation|0|||
155492349|NCT00518531|561227214|FG000|Treatment Period 1|Withdrawal by Subject|4|||
155492350|NCT00518531|561227215|FG001|Treatment Period 1|Withdrawal by Subject|6|||
155492351|NCT00518531|561227214|FG000|Treatment Period 1|Early crossover|1|||
155492352|NCT00518531|561227215|FG001|Treatment Period 1|Early crossover|3|||
155492353|NCT00518531|561227214|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155492354|NCT00518531|561227215|FG001|Treatment Period 2|Withdrawal by Subject|8|||
155492355|NCT00518531|561227214|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
155492356|NCT00518531|561227215|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
155492357|NCT00518531|561227214|FG000|Treatment Period 2|Adverse Event|1|||
155492358|NCT00518531|561227215|FG001|Treatment Period 2|Adverse Event|7|||
155492359|NCT00518531|561227214|FG000|Treatment Period 2|Protocol-specified criteria|0|||
155492360|NCT00518531|561227215|FG001|Treatment Period 2|Protocol-specified criteria|1|||
155492361|NCT00518531|561227214|FG000|Treatment Period 2|Non-compliance|1|||
155492362|NCT00518531|561227215|FG001|Treatment Period 2|Non-compliance|2|||
155492363|NCT00054639|561227216|FG000|Overall Study|Lack of Efficacy|1|||
155492364|NCT00054639|561227216|FG000|Overall Study|Physician Decision|1|||
155492365|NCT04621227|561227221|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
155492366|NCT04621227|561227221|FG000|Period 3 (29 Days)|Adverse Event|1|||
155492367|NCT04621227|561227221|FG000|Period 8 (2 Days)|Adverse Event|1|||
155492368|NCT02916056|561227222|FG000|Overall Study|Adverse Event|6|||
155492369|NCT02916056|561227222|FG000|Overall Study|Lost to Follow-up|1|||
155492370|NCT02916056|561227222|FG000|Overall Study|Other|12|||
155492371|NCT02916056|561227222|FG000|Overall Study|Protocol Violation|1|||
155492372|NCT02916056|561227222|FG000|Overall Study|Withdrawal by Subject|8|||
155492373|NCT02916056|561227222|FG000|Overall Study|Study Terminated by Sponsor|269|||
155492374|NCT00124709|561227223|FG000|Overall Study|Randomized but did not take medication|3|||
155492375|NCT00124709|561227224|FG001|Overall Study|Randomized but did not take medication|1|||
155492376|NCT00124709|561227223|FG000|Overall Study|Adverse Event|3|||
155492377|NCT00124709|561227224|FG001|Overall Study|Adverse Event|0|||
155492378|NCT00124709|561227223|FG000|Overall Study|Lack of Efficacy|5|||
155492379|NCT00124709|561227224|FG001|Overall Study|Lack of Efficacy|10|||
155492380|NCT00124709|561227223|FG000|Overall Study|Protocol Violation|3|||
155492381|NCT00124709|561227224|FG001|Overall Study|Protocol Violation|5|||
155492382|NCT00124709|561227223|FG000|Overall Study|Withdrawal by Subject|127|||
155492383|NCT00124709|561227224|FG001|Overall Study|Withdrawal by Subject|136|||
155492384|NCT00124709|561227223|FG000|Overall Study|Lost to Follow-up|114|||
155492385|NCT00124709|561227224|FG001|Overall Study|Lost to Follow-up|120|||
155492386|NCT01491737|561227231|FG000|Overall Study|Withdrawal by Subject|20|||
155492387|NCT01491737|561227232|FG001|Overall Study|Withdrawal by Subject|17|||
155492388|NCT01491737|561227231|FG000|Overall Study|Lost to Follow-up|2|||
155492389|NCT01491737|561227232|FG001|Overall Study|Lost to Follow-up|10|||
155492390|NCT01491737|561227231|FG000|Overall Study|Death|63|||
155492391|NCT01491737|561227232|FG001|Overall Study|Death|57|||
155492392|NCT01491737|561227231|FG000|Overall Study|Study Termination by Sponsor|36|||
155492393|NCT01491737|561227232|FG001|Overall Study|Study Termination by Sponsor|36|||
155492394|NCT01491737|561227231|FG000|Overall Study|Reason Not Specified|8|||
155492395|NCT01491737|561227232|FG001|Overall Study|Reason Not Specified|9|||
155492396|NCT02506101|561227237|FG000|Overall Study|Transportation issues|1|||
155492397|NCT02506101|561227238|FG001|Overall Study|Transportation issues|0|||
155492398|NCT02506101|561227237|FG000|Overall Study|No enrollment and staff unavailability|1|||
155492399|NCT02506101|561227238|FG001|Overall Study|No enrollment and staff unavailability|0|||
155492400|NCT01308476|561227239|FG000|Overall Study|Lost to Follow-up|2|||
155492401|NCT01308476|561227240|FG001|Overall Study|Lost to Follow-up|2|||
155492402|NCT01308476|561227239|FG000|Overall Study|Other|1|||
155492403|NCT01308476|561227240|FG001|Overall Study|Other|0|||
155492404|NCT00812968|561227241|FG000|Overall Study|Relapse after erythroid response|6|||
155492405|NCT00812968|561227241|FG000|Overall Study|Disease progression|1|||
155492406|NCT00812968|561227241|FG000|Overall Study|No further treatment required|1|||
155492407|NCT00812968|561227241|FG000|Overall Study|Study closed due to marketing approval|3|||
155492408|NCT02696382|561227242|FG000|Overall Study|Death|7|||
155492409|NCT02696382|561227243|FG001|Overall Study|Death|2|||
155492410|NCT02696382|561227242|FG000|Overall Study|Withdrawal by Subject|5|||
155492411|NCT02696382|561227243|FG001|Overall Study|Withdrawal by Subject|12|||
155492412|NCT02696382|561227242|FG000|Overall Study|Lost to Follow-up|4|||
155492413|NCT02696382|561227243|FG001|Overall Study|Lost to Follow-up|7|||
155492414|NCT00494234|561227244|FG000|Overall Study|Withdrawal by Subject|1|||
155492415|NCT00494234|561227245|FG001|Overall Study|Withdrawal by Subject|0|||
155492416|NCT00494234|561227244|FG000|Overall Study|Disease progression|11|||
155492417|NCT00494234|561227245|FG001|Overall Study|Disease progression|8|||
155492418|NCT00494234|561227244|FG000|Overall Study|Death|2|||
155492419|NCT00494234|561227245|FG001|Overall Study|Death|1|||
155492420|NCT00505765|561227251|FG000|Overall Study|Withdrawal by Subject|1|||
155492421|NCT00505765|561227252|FG001|Overall Study|Withdrawal by Subject|0|||
155492422|NCT00505765|561227253|FG002|Overall Study|Withdrawal by Subject|0|||
155492423|NCT00505765|561227251|FG000|Overall Study|Adverse Event|1|||
155492424|NCT00505765|561227252|FG001|Overall Study|Adverse Event|2|||
155492425|NCT00505765|561227253|FG002|Overall Study|Adverse Event|0|||
155492426|NCT00505765|561227251|FG000|Overall Study|Noncompliance|0|||
155492427|NCT00505765|561227252|FG001|Overall Study|Noncompliance|1|||
155492428|NCT00505765|561227253|FG002|Overall Study|Noncompliance|3|||
155492429|NCT02743117|561227254|FG000|Overall Study|Lost to Follow-up|0|||
155492430|NCT02743117|561227255|FG001|Overall Study|Lost to Follow-up|1|||
155492431|NCT02743117|561227254|FG000|Overall Study|Other|1|||
155492432|NCT02743117|561227255|FG001|Overall Study|Other|0|||
155492433|NCT01207219|561227257|FG000|Overall Study|changed diagnosis during study period|5|||
155492434|NCT01207219|561227258|FG001|Overall Study|changed diagnosis during study period|3|||
155492435|NCT01207219|561227259|FG002|Overall Study|changed diagnosis during study period|1|||
155492436|NCT01207219|561227257|FG000|Overall Study|Lost to Follow-up|6|||
155492437|NCT01207219|561227258|FG001|Overall Study|Lost to Follow-up|8|||
155492438|NCT01207219|561227259|FG002|Overall Study|Lost to Follow-up|6|||
155492439|NCT01012609|561227260|FG000|Overall Study|Withdrawal by Subject|1|||
155492440|NCT01012609|561227261|FG001|Overall Study|Withdrawal by Subject|1|||
155492441|NCT00924820|561227262|FG000|Overall Study|Death|2|||
155492442|NCT00924820|561227262|FG000|Overall Study|Ineligible, Screen Failure|5|||
155492443|NCT01725217|561227263|FG000|Overall Study|Withdrawal by Subject|1|||
155492444|NCT01725217|561227264|FG001|Overall Study|Withdrawal by Subject|0|||
155492445|NCT01725217|561227265|FG002|Overall Study|Withdrawal by Subject|0|||
155492446|NCT00585468|561227266|FG000|First Intervention|Withdrawal by Subject|1|||
155492447|NCT00585468|561227267|FG001|First Intervention|Withdrawal by Subject|1|||
155492448|NCT03919669|561227268|FG000|Overall Study|Withdrawal by Subject|1|||
155492449|NCT03919669|561227269|FG001|Overall Study|Withdrawal by Subject|0|||
155492450|NCT03919669|561227270|FG002|Overall Study|Withdrawal by Subject|0|||
155492451|NCT01265875|561227271|FG000|Overall Study|Uncooperative/unreliable|1|||
155492452|NCT02369874|561227274|FG000|Overall Study|Lost to Follow-up|2|||
155492453|NCT02369874|561227275|FG001|Overall Study|Lost to Follow-up|2|||
155492454|NCT02369874|561227276|FG002|Overall Study|Lost to Follow-up|2|||
155492455|NCT02369874|561227274|FG000|Overall Study|Withdrawal by Subject|7|||
155492456|NCT02369874|561227275|FG001|Overall Study|Withdrawal by Subject|9|||
155492457|NCT02369874|561227276|FG002|Overall Study|Withdrawal by Subject|27|||
155492458|NCT02369874|561227274|FG000|Overall Study|Miscellaneous|1|||
155492459|NCT02369874|561227275|FG001|Overall Study|Miscellaneous|1|||
155492460|NCT02369874|561227276|FG002|Overall Study|Miscellaneous|0|||
155492461|NCT02369874|561227274|FG000|Overall Study|On Treatment/Off Study|34|||
155492462|NCT02369874|561227275|FG001|Overall Study|On Treatment/Off Study|45|||
155492463|NCT02369874|561227276|FG002|Overall Study|On Treatment/Off Study|32|||
155492464|NCT02331680|561227277|FG000|Overall Study|Adverse Event|3|||
155492465|NCT02331680|561227278|FG001|Overall Study|Adverse Event|0|||
155492466|NCT02331680|561227279|FG002|Overall Study|Adverse Event|2|||
155492467|NCT02331680|561227277|FG000|Overall Study|Physician Decision|1|||
155492468|NCT02331680|561227278|FG001|Overall Study|Physician Decision|1|||
155492469|NCT02331680|561227279|FG002|Overall Study|Physician Decision|2|||
155492470|NCT02331680|561227277|FG000|Overall Study|Withdrawal by Subject|0|||
155492471|NCT02331680|561227278|FG001|Overall Study|Withdrawal by Subject|1|||
155492472|NCT02331680|561227279|FG002|Overall Study|Withdrawal by Subject|2|||
155492473|NCT02331680|561227277|FG000|Overall Study|Met withdrawal criteria|2|||
155492474|NCT02331680|561227278|FG001|Overall Study|Met withdrawal criteria|2|||
155492475|NCT02331680|561227279|FG002|Overall Study|Met withdrawal criteria|5|||
155492476|NCT02331680|561227277|FG000|Overall Study|Non-compliance with study drug|0|||
155492477|NCT02331680|561227278|FG001|Overall Study|Non-compliance with study drug|0|||
155492478|NCT02331680|561227279|FG002|Overall Study|Non-compliance with study drug|1|||
155492479|NCT02331680|561227277|FG000|Overall Study|Protocol Violation|0|||
155492480|NCT02331680|561227278|FG001|Overall Study|Protocol Violation|0|||
155492481|NCT02331680|561227279|FG002|Overall Study|Protocol Violation|3|||
155492482|NCT04505592|561227280|FG000|Overall Study|Death|2|||
155492483|NCT04505592|561227281|FG001|Overall Study|Death|1|||
155492484|NCT04784455|561227286|FG000|Overall Study|Death|4|||
155492485|NCT04298229|561227287|FG000|Overall Study|Physician Decision|1|||
155492486|NCT04298229|561227288|FG001|Overall Study|Physician Decision|1|||
155492487|NCT04298229|561227287|FG000|Overall Study|Withdrawal by Subject|1|||
155492488|NCT04298229|561227288|FG001|Overall Study|Withdrawal by Subject|1|||
155492489|NCT04298229|561227287|FG000|Overall Study|Did not receive IV loop diuretics|2|||
155492490|NCT04298229|561227288|FG001|Overall Study|Did not receive IV loop diuretics|0|||
155492491|NCT00262119|561227289|FG000|Overall Study|Lost to Follow-up|38|||
155492492|NCT00262119|561227290|FG001|Overall Study|Lost to Follow-up|51|||
155492493|NCT00262119|561227291|FG002|Overall Study|Lost to Follow-up|42|||
155492494|NCT00262119|561227289|FG000|Overall Study|Death|20|||
155492495|NCT00262119|561227290|FG001|Overall Study|Death|19|||
155492496|NCT00262119|561227291|FG002|Overall Study|Death|16|||
155492497|NCT00859313|561227292|FG000|Overall Study|Lack of Efficacy|2|||
155492498|NCT00859313|561227292|FG000|Overall Study|Adverse Event|1|||
155492499|NCT00859313|561227292|FG000|Overall Study|staff error|1|||
155492500|NCT05939388|561227297|FG000|Overall Study|Lost to Follow-up|1|||
155492501|NCT03901274|561227298|FG000|Overall Study|Lost to Follow-up|120|||
155492502|NCT03901274|561227299|FG001|Overall Study|Lost to Follow-up|124|||
155492503|NCT03901274|561227298|FG000|Overall Study|Withdrawal by Subject|0|||
155492504|NCT03901274|561227299|FG001|Overall Study|Withdrawal by Subject|6|||
155492505|NCT05570604|561227300|FG000|Overall Study|Lost to Follow-up|1|||
155492506|NCT05570604|561227301|FG001|Overall Study|Lost to Follow-up|5|||
155492507|NCT05570604|561227300|FG000|Overall Study|Illness|2|||
155492508|NCT05570604|561227301|FG001|Overall Study|Illness|2|||
155492509|NCT04527380|561227302|FG000|Overall Study|Lack of Efficacy|0|||
155492510|NCT04527380|561227303|FG001|Overall Study|Lack of Efficacy|1|||
155492511|NCT04527380|561227302|FG000|Overall Study|Withdrawal by Subject|1|||
155492512|NCT04527380|561227303|FG001|Overall Study|Withdrawal by Subject|0|||
155492513|NCT04479358|561227304|FG000|Overall Study|Withdrawal by Subject|0|||
155492514|NCT04479358|561227305|FG001|Overall Study|Withdrawal by Subject|0|||
155492515|NCT04479358|561227306|FG002|Overall Study|Withdrawal by Subject|1|||
155492516|NCT04479358|561227307|FG003|Overall Study|Withdrawal by Subject|0|||
155492517|NCT04479358|561227308|FG004|Overall Study|Withdrawal by Subject|0|||
155492518|NCT04479358|561227309|FG005|Overall Study|Withdrawal by Subject|1|||
155492519|NCT03655951|561227310|FG000|Overall Study|Lost to Follow-up|39|||
155492520|NCT03655951|561227311|FG001|Overall Study|Lost to Follow-up|20|||
155492521|NCT03655951|561227310|FG000|Overall Study|Withdrawal by Subject|0|||
155492522|NCT03655951|561227311|FG001|Overall Study|Withdrawal by Subject|1|||
155492523|NCT04678557|561227312|FG000|Overall Study|Withdrawal by Subject|1|||
155492524|NCT04678557|561227313|FG001|Overall Study|Withdrawal by Subject|0|||
155492525|NCT04678557|561227312|FG000|Overall Study|Lack of Efficacy|0|||
155492526|NCT04678557|561227313|FG001|Overall Study|Lack of Efficacy|13|||
155492527|NCT04678557|561227312|FG000|Overall Study|Safety Evaluation|0|||
155492528|NCT04678557|561227313|FG001|Overall Study|Safety Evaluation|1|||
155492529|NCT03280628|561229687|FG000|Overall Study|Lost to Follow-up|8|||
155492530|NCT03280628|561229688|FG001|Overall Study|Lost to Follow-up|6|||
155492531|NCT03280628|561229689|FG002|Overall Study|Lost to Follow-up|11|||
155492532|NCT01361308|561229690|FG000|Overall Study|Withdrawal by Subject|9|||
155492533|NCT01361308|561229691|FG001|Overall Study|Withdrawal by Subject|13|||
155492534|NCT01361308|561229690|FG000|Overall Study|Physician Decision|3|||
155492535|NCT01361308|561229691|FG001|Overall Study|Physician Decision|3|||
155492536|NCT01361308|561229690|FG000|Overall Study|Lack of Efficacy|2|||
155492537|NCT01361308|561229691|FG001|Overall Study|Lack of Efficacy|0|||
155492538|NCT01361308|561229690|FG000|Overall Study|Protocol Violation|1|||
155492539|NCT01361308|561229691|FG001|Overall Study|Protocol Violation|0|||
155492540|NCT01361308|561229690|FG000|Overall Study|Lost to Follow-up|5|||
155492541|NCT01361308|561229691|FG001|Overall Study|Lost to Follow-up|4|||
155492542|NCT01361308|561229690|FG000|Overall Study|Adverse Event|8|||
155492543|NCT01361308|561229691|FG001|Overall Study|Adverse Event|4|||
155492544|NCT01361308|561229690|FG000|Overall Study|Eligibility Criteria Not Met|2|||
155492545|NCT01361308|561229691|FG001|Overall Study|Eligibility Criteria Not Met|3|||
155492546|NCT01361308|561229690|FG000|Overall Study|Failed C-SSRS|5|||
155492547|NCT01361308|561229691|FG001|Overall Study|Failed C-SSRS|2|||
155492548|NCT01361308|561229690|FG000|Overall Study|Other|0|||
155492549|NCT01361308|561229691|FG001|Overall Study|Other|1|||
155492550|NCT02503215|561229692|FG000|Overall Study|Unable to wear compression stockings|1|||
155492551|NCT02503215|561229692|FG000|Overall Study|Unable to use positive airway pressure|2|||
155492552|NCT04478994|561229693|FG000|Overall Study|Withdrawal by Subject|1|||
155492553|NCT04478994|561229694|FG001|Overall Study|Withdrawal by Subject|1|||
155492554|NCT01728376|561229697|FG000|Overall Study|Adverse Event|1|||
155492555|NCT01728376|561229698|FG001|Overall Study|Adverse Event|1|||
155492556|NCT01728376|561229699|FG002|Overall Study|Adverse Event|1|||
155492557|NCT01728376|561229700|FG003|Overall Study|Adverse Event|1|||
155492558|NCT01728376|561229701|FG004|Overall Study|Adverse Event|1|||
155492559|NCT01728376|561229702|FG005|Overall Study|Adverse Event|0|||
155492560|NCT01728376|561229697|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
155492561|NCT01728376|561229698|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
155492562|NCT01728376|561229699|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
155492563|NCT01728376|561229700|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
155492564|NCT01728376|561229701|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
155492565|NCT01728376|561229702|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
155492566|NCT01728376|561229697|FG000|Overall Study|No relevant bacteria|2|||
155492567|NCT01728376|561229698|FG001|Overall Study|No relevant bacteria|0|||
155492568|NCT01728376|561229699|FG002|Overall Study|No relevant bacteria|0|||
155492569|NCT01728376|561229700|FG003|Overall Study|No relevant bacteria|0|||
155492570|NCT01728376|561229701|FG004|Overall Study|No relevant bacteria|1|||
155492571|NCT01728376|561229702|FG005|Overall Study|No relevant bacteria|1|||
155492572|NCT01728376|561229697|FG000|Overall Study|Did not receive treatment|0|||
155492573|NCT01728376|561229698|FG001|Overall Study|Did not receive treatment|1|||
155492574|NCT01728376|561229699|FG002|Overall Study|Did not receive treatment|0|||
155492575|NCT01728376|561229700|FG003|Overall Study|Did not receive treatment|0|||
155492576|NCT01728376|561229701|FG004|Overall Study|Did not receive treatment|0|||
155492577|NCT01728376|561229702|FG005|Overall Study|Did not receive treatment|0|||
155492578|NCT01728376|561229697|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
155492579|NCT01728376|561229698|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
155492580|NCT01728376|561229699|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
155492581|NCT01728376|561229700|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
155492582|NCT01728376|561229701|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
155492583|NCT01728376|561229702|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
155492584|NCT05299359|561229705|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
155492585|NCT05299359|561229706|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
155492586|NCT05299359|561229705|FG000|Main Part: Day 1 up to Day 366|Other|2|||
155492587|NCT05299359|561229706|FG001|Main Part: Day 1 up to Day 366|Other|0|||
155492588|NCT05299359|561229705|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
155492589|NCT05299359|561229706|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
155492590|NCT05299359|561229705|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
155492591|NCT05299359|561229706|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
155492592|NCT05299359|561229705|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
155492593|NCT05299359|561229706|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
155492594|NCT05299359|561229705|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
155492595|NCT05299359|561229706|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
155492596|NCT05299359|561229705|FG000|Extension Part: Day 1 to Day 366|Other|0|||
155492597|NCT05299359|561229706|FG001|Extension Part: Day 1 to Day 366|Other|1|||
155492598|NCT03110107|561229707|FG000|Treatment Period|Disease Progression|3|||
155492599|NCT03110107|561229708|FG001|Treatment Period|Disease Progression|9|||
155492600|NCT03110107|561229709|FG002|Treatment Period|Disease Progression|8|||
155492601|NCT03110107|561229710|FG003|Treatment Period|Disease Progression|11|||
155492602|NCT03110107|561229711|FG004|Treatment Period|Disease Progression|8|||
155492603|NCT03110107|561229712|FG005|Treatment Period|Disease Progression|4|||
155492604|NCT03110107|561229713|FG006|Treatment Period|Disease Progression|6|||
155492605|NCT03110107|561229714|FG007|Treatment Period|Disease Progression|7|||
155492606|NCT03110107|561229715|FG008|Treatment Period|Disease Progression|2|||
155492607|NCT03110107|561229716|FG009|Treatment Period|Disease Progression|10|||
155492608|NCT03110107|561229717|FG010|Treatment Period|Disease Progression|5|||
155492609|NCT03110107|561229718|FG011|Treatment Period|Disease Progression|2|||
155492610|NCT03110107|561229719|FG012|Treatment Period|Disease Progression|0|||
155492611|NCT03110107|561229720|FG013|Treatment Period|Disease Progression|5|||
155492612|NCT03110107|561229721|FG014|Treatment Period|Disease Progression|14|||
155492613|NCT03110107|561229722|FG015|Treatment Period|Disease Progression|14|||
155492614|NCT03110107|561229723|FG016|Treatment Period|Disease Progression|4|||
155492615|NCT03110107|561229724|FG017|Treatment Period|Disease Progression|3|||
155492616|NCT03110107|561229725|FG018|Treatment Period|Disease Progression|16|||
155492617|NCT03110107|561229726|FG019|Treatment Period|Disease Progression|14|||
155492618|NCT03110107|561229727|FG020|Treatment Period|Disease Progression|12|||
155492619|NCT03110107|561229728|FG021|Treatment Period|Disease Progression|16|||
155492620|NCT03110107|561229729|FG022|Treatment Period|Disease Progression|18|||
155492621|NCT03110107|561229730|FG023|Treatment Period|Disease Progression|13|||
155492622|NCT03110107|561229731|FG024|Treatment Period|Disease Progression|16|||
155492623|NCT03110107|561229732|FG025|Treatment Period|Disease Progression|31|||
155492624|NCT03110107|561229707|FG000|Treatment Period|Study drug toxicity|1|||
155492625|NCT03110107|561229708|FG001|Treatment Period|Study drug toxicity|0|||
155492626|NCT03110107|561229709|FG002|Treatment Period|Study drug toxicity|1|||
155492627|NCT03110107|561229710|FG003|Treatment Period|Study drug toxicity|2|||
155492628|NCT03110107|561229711|FG004|Treatment Period|Study drug toxicity|0|||
155492629|NCT03110107|561229712|FG005|Treatment Period|Study drug toxicity|3|||
155492630|NCT03110107|561229713|FG006|Treatment Period|Study drug toxicity|1|||
155492631|NCT03110107|561229714|FG007|Treatment Period|Study drug toxicity|1|||
155492632|NCT03110107|561229715|FG008|Treatment Period|Study drug toxicity|3|||
155492633|NCT03110107|561229716|FG009|Treatment Period|Study drug toxicity|2|||
155492634|NCT03110107|561229717|FG010|Treatment Period|Study drug toxicity|0|||
155492635|NCT03110107|561229718|FG011|Treatment Period|Study drug toxicity|2|||
155492636|NCT03110107|561229719|FG012|Treatment Period|Study drug toxicity|0|||
155492637|NCT03110107|561229720|FG013|Treatment Period|Study drug toxicity|0|||
155492638|NCT03110107|561229721|FG014|Treatment Period|Study drug toxicity|2|||
155492639|NCT03110107|561229722|FG015|Treatment Period|Study drug toxicity|3|||
155492640|NCT03110107|561229723|FG016|Treatment Period|Study drug toxicity|3|||
155492641|NCT03110107|561229724|FG017|Treatment Period|Study drug toxicity|3|||
155492642|NCT03110107|561229725|FG018|Treatment Period|Study drug toxicity|1|||
155492643|NCT03110107|561229726|FG019|Treatment Period|Study drug toxicity|2|||
155492644|NCT03110107|561229727|FG020|Treatment Period|Study drug toxicity|2|||
155492645|NCT03110107|561229728|FG021|Treatment Period|Study drug toxicity|0|||
155492646|NCT03110107|561229729|FG022|Treatment Period|Study drug toxicity|2|||
155492647|NCT03110107|561229730|FG023|Treatment Period|Study drug toxicity|6|||
155492648|NCT03110107|561229731|FG024|Treatment Period|Study drug toxicity|7|||
155492649|NCT03110107|561229732|FG025|Treatment Period|Study drug toxicity|6|||
155492650|NCT03110107|561229707|FG000|Treatment Period|Death|0|||
155492651|NCT03110107|561229708|FG001|Treatment Period|Death|0|||
155492652|NCT03110107|561229709|FG002|Treatment Period|Death|0|||
155492653|NCT03110107|561229710|FG003|Treatment Period|Death|0|||
155492654|NCT03110107|561229711|FG004|Treatment Period|Death|0|||
155492655|NCT03110107|561229712|FG005|Treatment Period|Death|0|||
155492656|NCT03110107|561229713|FG006|Treatment Period|Death|0|||
155492657|NCT03110107|561229714|FG007|Treatment Period|Death|0|||
155492658|NCT03110107|561229715|FG008|Treatment Period|Death|0|||
155492659|NCT03110107|561229716|FG009|Treatment Period|Death|0|||
155492660|NCT03110107|561229717|FG010|Treatment Period|Death|0|||
155492661|NCT03110107|561229718|FG011|Treatment Period|Death|0|||
155492662|NCT03110107|561229719|FG012|Treatment Period|Death|1|||
155492663|NCT03110107|561229720|FG013|Treatment Period|Death|0|||
155492664|NCT03110107|561229721|FG014|Treatment Period|Death|0|||
155492665|NCT03110107|561229722|FG015|Treatment Period|Death|0|||
155492666|NCT03110107|561229723|FG016|Treatment Period|Death|0|||
155492667|NCT03110107|561229724|FG017|Treatment Period|Death|0|||
155492668|NCT03110107|561229725|FG018|Treatment Period|Death|0|||
155492669|NCT03110107|561229726|FG019|Treatment Period|Death|0|||
155492670|NCT03110107|561229727|FG020|Treatment Period|Death|0|||
155492671|NCT03110107|561229728|FG021|Treatment Period|Death|0|||
155492672|NCT03110107|561229729|FG022|Treatment Period|Death|0|||
155492673|NCT03110107|561229730|FG023|Treatment Period|Death|0|||
155492674|NCT03110107|561229731|FG024|Treatment Period|Death|0|||
155492675|NCT03110107|561229732|FG025|Treatment Period|Death|0|||
155492676|NCT03110107|561229707|FG000|Treatment Period|Adverse Event|0|||
155492677|NCT03110107|561229708|FG001|Treatment Period|Adverse Event|0|||
155492678|NCT03110107|561229709|FG002|Treatment Period|Adverse Event|1|||
155492679|NCT03110107|561229710|FG003|Treatment Period|Adverse Event|0|||
155492680|NCT03110107|561229711|FG004|Treatment Period|Adverse Event|0|||
155492681|NCT03110107|561229712|FG005|Treatment Period|Adverse Event|2|||
155492682|NCT03110107|561229713|FG006|Treatment Period|Adverse Event|0|||
155492683|NCT03110107|561229714|FG007|Treatment Period|Adverse Event|2|||
155492684|NCT03110107|561229715|FG008|Treatment Period|Adverse Event|0|||
155492685|NCT03110107|561229716|FG009|Treatment Period|Adverse Event|1|||
155492686|NCT03110107|561229717|FG010|Treatment Period|Adverse Event|0|||
155492687|NCT03110107|561229718|FG011|Treatment Period|Adverse Event|0|||
155492688|NCT03110107|561229719|FG012|Treatment Period|Adverse Event|0|||
155492689|NCT03110107|561229720|FG013|Treatment Period|Adverse Event|0|||
155492690|NCT03110107|561229721|FG014|Treatment Period|Adverse Event|0|||
155492691|NCT03110107|561229722|FG015|Treatment Period|Adverse Event|2|||
155492692|NCT03110107|561229723|FG016|Treatment Period|Adverse Event|0|||
155492693|NCT03110107|561229724|FG017|Treatment Period|Adverse Event|1|||
155492694|NCT03110107|561229725|FG018|Treatment Period|Adverse Event|2|||
155492695|NCT03110107|561229726|FG019|Treatment Period|Adverse Event|1|||
155492696|NCT03110107|561229727|FG020|Treatment Period|Adverse Event|4|||
155492697|NCT03110107|561229728|FG021|Treatment Period|Adverse Event|2|||
155492698|NCT03110107|561229729|FG022|Treatment Period|Adverse Event|2|||
155492699|NCT03110107|561229730|FG023|Treatment Period|Adverse Event|2|||
155492700|NCT03110107|561229731|FG024|Treatment Period|Adverse Event|2|||
155492701|NCT03110107|561229732|FG025|Treatment Period|Adverse Event|4|||
155492702|NCT03110107|561229707|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
155492703|NCT03110107|561229708|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
155492704|NCT03110107|561229709|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
155492705|NCT03110107|561229710|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
155492706|NCT03110107|561229711|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
155492707|NCT03110107|561229712|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
155492708|NCT03110107|561229713|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
155492709|NCT03110107|561229714|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
155492710|NCT03110107|561229715|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
155492711|NCT03110107|561229716|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
155492712|NCT03110107|561229717|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
155492713|NCT03110107|561229718|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
155492714|NCT03110107|561229719|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
155492715|NCT03110107|561229720|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
155492716|NCT03110107|561229721|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
155492717|NCT03110107|561229722|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
155492718|NCT03110107|561229723|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
155492719|NCT03110107|561229724|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
155492720|NCT03110107|561229725|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
155492721|NCT03110107|561229726|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
155492722|NCT03110107|561229727|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
155492723|NCT03110107|561229728|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
155492724|NCT03110107|561229729|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
155492725|NCT03110107|561229730|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
155492726|NCT03110107|561229731|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
155492727|NCT03110107|561229732|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
155492728|NCT03110107|561229707|FG000|Treatment Period|Participant withdrew consent|0|||
155492729|NCT03110107|561229708|FG001|Treatment Period|Participant withdrew consent|0|||
155492730|NCT03110107|561229709|FG002|Treatment Period|Participant withdrew consent|1|||
155492731|NCT03110107|561229710|FG003|Treatment Period|Participant withdrew consent|0|||
155492732|NCT03110107|561229711|FG004|Treatment Period|Participant withdrew consent|4|||
155492733|NCT03110107|561229712|FG005|Treatment Period|Participant withdrew consent|3|||
155492734|NCT03110107|561229713|FG006|Treatment Period|Participant withdrew consent|0|||
155492735|NCT03110107|561229714|FG007|Treatment Period|Participant withdrew consent|0|||
155492736|NCT03110107|561229715|FG008|Treatment Period|Participant withdrew consent|0|||
155492737|NCT03110107|561229716|FG009|Treatment Period|Participant withdrew consent|1|||
155492738|NCT03110107|561229717|FG010|Treatment Period|Participant withdrew consent|0|||
155492739|NCT03110107|561229718|FG011|Treatment Period|Participant withdrew consent|0|||
155492740|NCT03110107|561229719|FG012|Treatment Period|Participant withdrew consent|0|||
155492741|NCT03110107|561229720|FG013|Treatment Period|Participant withdrew consent|0|||
155492742|NCT03110107|561229721|FG014|Treatment Period|Participant withdrew consent|0|||
155492743|NCT03110107|561229722|FG015|Treatment Period|Participant withdrew consent|0|||
155492744|NCT03110107|561229723|FG016|Treatment Period|Participant withdrew consent|0|||
155492745|NCT03110107|561229724|FG017|Treatment Period|Participant withdrew consent|0|||
155492746|NCT03110107|561229725|FG018|Treatment Period|Participant withdrew consent|0|||
155492747|NCT03110107|561229726|FG019|Treatment Period|Participant withdrew consent|1|||
155492748|NCT03110107|561229727|FG020|Treatment Period|Participant withdrew consent|0|||
155492749|NCT03110107|561229728|FG021|Treatment Period|Participant withdrew consent|2|||
155492750|NCT03110107|561229729|FG022|Treatment Period|Participant withdrew consent|0|||
155492751|NCT03110107|561229730|FG023|Treatment Period|Participant withdrew consent|0|||
155492752|NCT03110107|561229731|FG024|Treatment Period|Participant withdrew consent|0|||
155492753|NCT03110107|561229732|FG025|Treatment Period|Participant withdrew consent|2|||
155492754|NCT03110107|561229707|FG000|Treatment Period|Participants no longer meets study criteria|0|||
155492755|NCT03110107|561229708|FG001|Treatment Period|Participants no longer meets study criteria|0|||
155492756|NCT03110107|561229709|FG002|Treatment Period|Participants no longer meets study criteria|0|||
155492757|NCT03110107|561229710|FG003|Treatment Period|Participants no longer meets study criteria|0|||
155492758|NCT03110107|561229711|FG004|Treatment Period|Participants no longer meets study criteria|0|||
155492759|NCT03110107|561229712|FG005|Treatment Period|Participants no longer meets study criteria|0|||
155492760|NCT03110107|561229713|FG006|Treatment Period|Participants no longer meets study criteria|0|||
155492761|NCT03110107|561229714|FG007|Treatment Period|Participants no longer meets study criteria|0|||
155492762|NCT03110107|561229715|FG008|Treatment Period|Participants no longer meets study criteria|0|||
155492763|NCT03110107|561229716|FG009|Treatment Period|Participants no longer meets study criteria|0|||
155492764|NCT03110107|561229717|FG010|Treatment Period|Participants no longer meets study criteria|0|||
155492765|NCT03110107|561229718|FG011|Treatment Period|Participants no longer meets study criteria|0|||
155492766|NCT03110107|561229719|FG012|Treatment Period|Participants no longer meets study criteria|0|||
155492767|NCT03110107|561229720|FG013|Treatment Period|Participants no longer meets study criteria|0|||
155492768|NCT03110107|561229721|FG014|Treatment Period|Participants no longer meets study criteria|0|||
155492769|NCT03110107|561229722|FG015|Treatment Period|Participants no longer meets study criteria|0|||
155492770|NCT03110107|561229723|FG016|Treatment Period|Participants no longer meets study criteria|0|||
155492771|NCT03110107|561229724|FG017|Treatment Period|Participants no longer meets study criteria|0|||
155492772|NCT03110107|561229725|FG018|Treatment Period|Participants no longer meets study criteria|0|||
155492773|NCT03110107|561229726|FG019|Treatment Period|Participants no longer meets study criteria|0|||
155492774|NCT03110107|561229727|FG020|Treatment Period|Participants no longer meets study criteria|0|||
155492775|NCT03110107|561229728|FG021|Treatment Period|Participants no longer meets study criteria|0|||
155492776|NCT03110107|561229729|FG022|Treatment Period|Participants no longer meets study criteria|0|||
155492777|NCT03110107|561229730|FG023|Treatment Period|Participants no longer meets study criteria|1|||
155492778|NCT03110107|561229731|FG024|Treatment Period|Participants no longer meets study criteria|0|||
155492779|NCT03110107|561229732|FG025|Treatment Period|Participants no longer meets study criteria|0|||
155492780|NCT03110107|561229707|FG000|Treatment Period|Other Reasons|0|||
155492781|NCT03110107|561229708|FG001|Treatment Period|Other Reasons|0|||
155492782|NCT03110107|561229709|FG002|Treatment Period|Other Reasons|1|||
155492783|NCT03110107|561229710|FG003|Treatment Period|Other Reasons|1|||
155492784|NCT03110107|561229711|FG004|Treatment Period|Other Reasons|0|||
155492785|NCT03110107|561229712|FG005|Treatment Period|Other Reasons|1|||
155492786|NCT03110107|561229713|FG006|Treatment Period|Other Reasons|0|||
155492787|NCT03110107|561229714|FG007|Treatment Period|Other Reasons|0|||
155492788|NCT03110107|561229715|FG008|Treatment Period|Other Reasons|0|||
155492789|NCT03110107|561229716|FG009|Treatment Period|Other Reasons|0|||
155492790|NCT03110107|561229717|FG010|Treatment Period|Other Reasons|0|||
155492791|NCT03110107|561229718|FG011|Treatment Period|Other Reasons|0|||
155492792|NCT03110107|561229719|FG012|Treatment Period|Other Reasons|0|||
155492793|NCT03110107|561229720|FG013|Treatment Period|Other Reasons|0|||
155492794|NCT03110107|561229721|FG014|Treatment Period|Other Reasons|0|||
155492795|NCT03110107|561229722|FG015|Treatment Period|Other Reasons|0|||
155492796|NCT03110107|561229723|FG016|Treatment Period|Other Reasons|0|||
155492797|NCT03110107|561229724|FG017|Treatment Period|Other Reasons|0|||
155492798|NCT03110107|561229725|FG018|Treatment Period|Other Reasons|0|||
155492799|NCT03110107|561229726|FG019|Treatment Period|Other Reasons|0|||
155492800|NCT03110107|561229727|FG020|Treatment Period|Other Reasons|0|||
155492801|NCT03110107|561229728|FG021|Treatment Period|Other Reasons|0|||
155492802|NCT03110107|561229729|FG022|Treatment Period|Other Reasons|0|||
155492803|NCT03110107|561229730|FG023|Treatment Period|Other Reasons|0|||
155492804|NCT03110107|561229731|FG024|Treatment Period|Other Reasons|1|||
155492805|NCT03110107|561229732|FG025|Treatment Period|Other Reasons|0|||
155492806|NCT03927989|561229735|FG000|Overall Study|Withdrawal by Subject|0|||
155492807|NCT03927989|561229736|FG001|Overall Study|Withdrawal by Subject|1|||
155492808|NCT02593175|561229737|FG000|Overall Study|Adverse Event|5|||
155492809|NCT02593175|561229737|FG000|Overall Study|Disease progression|4|||
155492810|NCT03772574|561229741|FG000|Overall Study|Protocol Violation|2|||
155492811|NCT03772574|561229742|FG001|Overall Study|Protocol Violation|0|||
155492812|NCT03772574|561229743|FG002|Overall Study|Protocol Violation|0|||
155492813|NCT03772574|561229741|FG000|Overall Study|Discomfort|0|||
155492814|NCT03772574|561229742|FG001|Overall Study|Discomfort|5|||
155492815|NCT03772574|561229743|FG002|Overall Study|Discomfort|4|||
155492816|NCT03586427|561229746|FG000|Overall Study|Lost to Follow-up|0|||
155492817|NCT03586427|561229747|FG001|Overall Study|Lost to Follow-up|3|||
155492818|NCT03586427|561229748|FG002|Overall Study|Lost to Follow-up|1|||
155492819|NCT03586427|561229749|FG003|Overall Study|Lost to Follow-up|3|||
155492820|NCT03586427|561229750|FG004|Overall Study|Lost to Follow-up|3|||
155492821|NCT03586427|561229746|FG000|Overall Study|Withdrawal by Subject|0|||
155492822|NCT03586427|561229747|FG001|Overall Study|Withdrawal by Subject|1|||
155492823|NCT03586427|561229748|FG002|Overall Study|Withdrawal by Subject|2|||
155492824|NCT03586427|561229749|FG003|Overall Study|Withdrawal by Subject|1|||
155492825|NCT03586427|561229750|FG004|Overall Study|Withdrawal by Subject|1|||
155492826|NCT03586427|561229746|FG000|Overall Study|Adverse Event|0|||
155492827|NCT03586427|561229747|FG001|Overall Study|Adverse Event|0|||
155492828|NCT03586427|561229748|FG002|Overall Study|Adverse Event|1|||
155492829|NCT03586427|561229749|FG003|Overall Study|Adverse Event|0|||
155492830|NCT03586427|561229750|FG004|Overall Study|Adverse Event|0|||
155492831|NCT03586427|561229746|FG000|Overall Study|Protocol Violation|0|||
155492832|NCT03586427|561229747|FG001|Overall Study|Protocol Violation|0|||
155492833|NCT03586427|561229748|FG002|Overall Study|Protocol Violation|1|||
155492834|NCT03586427|561229749|FG003|Overall Study|Protocol Violation|0|||
155492835|NCT03586427|561229750|FG004|Overall Study|Protocol Violation|1|||
155492836|NCT03586427|561229746|FG000|Overall Study|Noncompliance with study drug|0|||
155492837|NCT03586427|561229747|FG001|Overall Study|Noncompliance with study drug|0|||
155492838|NCT03586427|561229748|FG002|Overall Study|Noncompliance with study drug|1|||
155492839|NCT03586427|561229749|FG003|Overall Study|Noncompliance with study drug|0|||
155492840|NCT03586427|561229750|FG004|Overall Study|Noncompliance with study drug|0|||
155492841|NCT03193996|561229751|FG000|Overall Study|Withdrawal by Subject|4|||
155492842|NCT03193996|561229751|FG000|Overall Study|Lost to Follow-up|4|||
155492843|NCT03193996|561229751|FG000|Overall Study|Physician Decision|2|||
155492844|NCT03193996|561229751|FG000|Overall Study|Pregnancy|1|||
155492845|NCT03193996|561229751|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
155492846|NCT03193996|561229751|FG000|Overall Study|Complicating disease|1|||
155492847|NCT00593385|561229754|FG000|Overall Study|Death|14|||
155492848|NCT00593385|561229754|FG000|Overall Study|Lost to Follow-up|17|||
155492849|NCT00593385|561229754|FG000|Overall Study|Withdrawal by Subject|9|||
155492850|NCT01471197|561229755|FG000|Overall Study|Disease Progression|4|||
155492851|NCT01471197|561229756|FG001|Overall Study|Disease Progression|2|||
155492852|NCT01471197|561229755|FG000|Overall Study|Death|1|||
155492853|NCT01471197|561229756|FG001|Overall Study|Death|0|||
155492854|NCT01471197|561229755|FG000|Overall Study|Study Drug Toxicity|1|||
155492855|NCT01471197|561229756|FG001|Overall Study|Study Drug Toxicity|0|||
155492856|NCT00924313|561229759|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
155492857|NCT01298362|561229763|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
155492858|NCT01298362|561229764|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
155492859|NCT01453296|561229768|FG000|Treatment Period 1|Adverse Event|0|||
155492860|NCT01453296|561229769|FG001|Treatment Period 1|Adverse Event|1|||
155492861|NCT01453296|561229768|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
155492862|NCT01453296|561229769|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
155492863|NCT01453296|561229768|FG000|Treatment Period 2|Adverse Event|1|||
155492864|NCT01453296|561229769|FG001|Treatment Period 2|Adverse Event|0|||
155492865|NCT01453296|561229768|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155492866|NCT01453296|561229769|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155492867|NCT00620776|561229770|FG000|Overall Study|Did not receive treatment|3|||
155492868|NCT00620776|561229771|FG001|Overall Study|Did not receive treatment|5|||
155492869|NCT00620776|561229770|FG000|Overall Study|Adverse Event|2|||
155492870|NCT00620776|561229771|FG001|Overall Study|Adverse Event|3|||
155492871|NCT00620776|561229770|FG000|Overall Study|Lack of Efficacy|2|||
155492872|NCT00620776|561229771|FG001|Overall Study|Lack of Efficacy|1|||
155492873|NCT00620776|561229770|FG000|Overall Study|Lost to Follow-up|2|||
155492874|NCT00620776|561229771|FG001|Overall Study|Lost to Follow-up|5|||
155492875|NCT00620776|561229770|FG000|Overall Study|Withdrawal by Subject|3|||
155492876|NCT00620776|561229771|FG001|Overall Study|Withdrawal by Subject|2|||
155492877|NCT04983589|561229772|FG000|Overall Study|Withdrawal by Subject|0|||
155492878|NCT04983589|561229773|FG001|Overall Study|Withdrawal by Subject|3|||
155492879|NCT04983589|561229772|FG000|Overall Study|COVID-19 Infection|1|||
155492880|NCT04983589|561229773|FG001|Overall Study|COVID-19 Infection|0|||
155492881|NCT04983589|561229772|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
155492882|NCT04983589|561229773|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
155492883|NCT00761969|561229774|FG000|Overall Study|Death|112|||
155492884|NCT00761969|561229775|FG001|Overall Study|Death|47|||
155492885|NCT00761969|561229774|FG000|Overall Study|Lost to Follow-up|88|||
155492886|NCT00761969|561229775|FG001|Overall Study|Lost to Follow-up|93|||
155492887|NCT03155269|561229778|FG000|Overall Study|Withdrawal by Subject|4|||
155492888|NCT03155269|561229779|FG001|Overall Study|Withdrawal by Subject|5|||
155492889|NCT03155269|561229778|FG000|Overall Study|Lost to Follow-up|1|||
155492890|NCT03155269|561229779|FG001|Overall Study|Lost to Follow-up|2|||
155492891|NCT00455923|561229784|FG000|Overall Study|Pregnancy|0|||
155492892|NCT00455923|561229785|FG001|Overall Study|Pregnancy|2|||
155492893|NCT00455923|561229784|FG000|Overall Study|Other|3|||
155492894|NCT00455923|561229785|FG001|Overall Study|Other|1|||
155492895|NCT02686749|561229786|FG000|Overall Study|terminated for poor enrollment|2|||
155492896|NCT02686749|561229787|FG001|Overall Study|terminated for poor enrollment|2|||
155492897|NCT02319642|561229790|FG000|Overall Study|Adverse Event|2|||
155492898|NCT02319642|561229791|FG001|Overall Study|Adverse Event|4|||
155492899|NCT02319642|561229790|FG000|Overall Study|Lack of Efficacy|1|||
155492900|NCT02319642|561229791|FG001|Overall Study|Lack of Efficacy|1|||
155492901|NCT02319642|561229790|FG000|Overall Study|Withdrawal by Subject|1|||
155492902|NCT02319642|561229791|FG001|Overall Study|Withdrawal by Subject|1|||
155492903|NCT00483119|561229792|FG000|Overall Study|Adverse Event|0|||
155492904|NCT00483119|561229793|FG001|Overall Study|Adverse Event|1|||
155492905|NCT00483119|561229792|FG000|Overall Study|Physician Decision|1|||
155492906|NCT00483119|561229793|FG001|Overall Study|Physician Decision|0|||
155492907|NCT04409509|561229794|FG000|Overall Study|Failure to meet randomization requirement|1|||
155492908|NCT04409509|561229795|FG001|Overall Study|Failure to meet randomization requirement|0|||
155492909|NCT04409509|561229794|FG000|Overall Study|Adverse Event|0|||
155492910|NCT04409509|561229795|FG001|Overall Study|Adverse Event|1|||
155492911|NCT04409509|561229794|FG000|Overall Study|Death|11|||
155492912|NCT04409509|561229795|FG001|Overall Study|Death|10|||
155492913|NCT04409509|561229794|FG000|Overall Study|Non-compliance with study drug|0|||
155492914|NCT04409509|561229795|FG001|Overall Study|Non-compliance with study drug|1|||
155492915|NCT04409509|561229794|FG000|Overall Study|Lost to Follow-up|0|||
155492916|NCT04409509|561229795|FG001|Overall Study|Lost to Follow-up|3|||
155492917|NCT04409509|561229794|FG000|Overall Study|Withdrawal by Subject|0|||
155492918|NCT04409509|561229795|FG001|Overall Study|Withdrawal by Subject|3|||
155492919|NCT04409509|561229794|FG000|Overall Study|Randomized by mistake|0|||
155492920|NCT04409509|561229795|FG001|Overall Study|Randomized by mistake|1|||
155492921|NCT04409509|561229794|FG000|Overall Study|Other|1|||
155492922|NCT04409509|561229795|FG001|Overall Study|Other|1|||
155492923|NCT04668066|561229796|FG000|Part 1: Treatment Phase|Adverse Event|0|||
155492924|NCT04668066|561229797|FG001|Part 1: Treatment Phase|Adverse Event|0|||
155492925|NCT04668066|561229798|FG002|Part 1: Treatment Phase|Adverse Event|0|||
155492926|NCT04668066|561229799|FG003|Part 1: Treatment Phase|Adverse Event|0|||
155492927|NCT04668066|561229800|FG004|Part 1: Treatment Phase|Adverse Event|0|||
155492928|NCT04668066|561229801|FG005|Part 1: Treatment Phase|Adverse Event|0|||
155492929|NCT04668066|561229802|FG006|Part 1: Treatment Phase|Adverse Event|0|||
155492930|NCT04668066|561229803|FG007|Part 1: Treatment Phase|Adverse Event|0|||
155492931|NCT04668066|561229804|FG008|Part 1: Treatment Phase|Adverse Event|0|||
155492932|NCT04668066|561229805|FG009|Part 1: Treatment Phase|Adverse Event|0|||
155492933|NCT04668066|561229806|FG010|Part 1: Treatment Phase|Adverse Event|0|||
155492934|NCT04668066|561229807|FG011|Part 1: Treatment Phase|Adverse Event|1|||
155492935|NCT04668066|561229808|FG012|Part 1: Treatment Phase|Adverse Event|1|||
155492936|NCT04668066|561229809|FG013|Part 1: Treatment Phase|Adverse Event|0|||
155492937|NCT04668066|561229810|FG014|Part 1: Treatment Phase|Adverse Event|0|||
155492938|NCT04668066|561229811|FG015|Part 1: Treatment Phase|Adverse Event|0|||
155492939|NCT04668066|561229812|FG016|Part 1: Treatment Phase|Adverse Event|0|||
155492940|NCT04668066|561229813|FG017|Part 1: Treatment Phase|Adverse Event|0|||
155492941|NCT04668066|561229814|FG018|Part 1: Treatment Phase|Adverse Event|0|||
155492942|NCT04668066|561229796|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492943|NCT04668066|561229797|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492944|NCT04668066|561229798|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
155492945|NCT04668066|561229799|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492946|NCT04668066|561229800|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492947|NCT04668066|561229801|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492948|NCT04668066|561229802|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492949|NCT04668066|561229803|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492950|NCT04668066|561229804|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492951|NCT04668066|561229805|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492952|NCT04668066|561229806|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492953|NCT04668066|561229807|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492954|NCT04668066|561229808|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492955|NCT04668066|561229809|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492956|NCT04668066|561229810|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492957|NCT04668066|561229811|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492958|NCT04668066|561229812|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492959|NCT04668066|561229813|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492960|NCT04668066|561229814|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
155492961|NCT04668066|561229796|FG000|Part 1: Treatment Phase|Other|0|||
155492962|NCT04668066|561229797|FG001|Part 1: Treatment Phase|Other|0|||
155492963|NCT04668066|561229798|FG002|Part 1: Treatment Phase|Other|0|||
155492964|NCT04668066|561229799|FG003|Part 1: Treatment Phase|Other|0|||
155492965|NCT04668066|561229800|FG004|Part 1: Treatment Phase|Other|0|||
155492966|NCT04668066|561229801|FG005|Part 1: Treatment Phase|Other|0|||
155492967|NCT04668066|561229802|FG006|Part 1: Treatment Phase|Other|0|||
155492968|NCT04668066|561229803|FG007|Part 1: Treatment Phase|Other|0|||
155492969|NCT04668066|561229804|FG008|Part 1: Treatment Phase|Other|0|||
155492970|NCT04668066|561229805|FG009|Part 1: Treatment Phase|Other|0|||
155492971|NCT04668066|561229806|FG010|Part 1: Treatment Phase|Other|0|||
155492972|NCT04668066|561229807|FG011|Part 1: Treatment Phase|Other|1|||
155492973|NCT04668066|561229808|FG012|Part 1: Treatment Phase|Other|0|||
155492974|NCT04668066|561229809|FG013|Part 1: Treatment Phase|Other|0|||
155492975|NCT04668066|561229810|FG014|Part 1: Treatment Phase|Other|0|||
155492976|NCT04668066|561229811|FG015|Part 1: Treatment Phase|Other|0|||
155492977|NCT04668066|561229812|FG016|Part 1: Treatment Phase|Other|0|||
155492978|NCT04668066|561229813|FG017|Part 1: Treatment Phase|Other|0|||
155492979|NCT04668066|561229814|FG018|Part 1: Treatment Phase|Other|0|||
155492980|NCT04668066|561229796|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492981|NCT04668066|561229797|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492982|NCT04668066|561229798|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492983|NCT04668066|561229799|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492984|NCT04668066|561229800|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492985|NCT04668066|561229801|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492986|NCT04668066|561229802|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492987|NCT04668066|561229803|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492988|NCT04668066|561229804|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492989|NCT04668066|561229805|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492990|NCT04668066|561229806|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492991|NCT04668066|561229807|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492992|NCT04668066|561229808|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
155492993|NCT04668066|561229809|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492994|NCT04668066|561229810|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492995|NCT04668066|561229811|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
155492996|NCT04668066|561229812|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492997|NCT04668066|561229813|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492998|NCT04668066|561229814|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155492999|NCT04668066|561229796|FG000|Part 1: Follow-Up|Adverse Event|0|||
155493000|NCT04668066|561229797|FG001|Part 1: Follow-Up|Adverse Event|0|||
155493001|NCT04668066|561229798|FG002|Part 1: Follow-Up|Adverse Event|0|||
155493002|NCT04668066|561229799|FG003|Part 1: Follow-Up|Adverse Event|0|||
155493003|NCT04668066|561229800|FG004|Part 1: Follow-Up|Adverse Event|0|||
155493004|NCT04668066|561229801|FG005|Part 1: Follow-Up|Adverse Event|0|||
155493005|NCT04668066|561229802|FG006|Part 1: Follow-Up|Adverse Event|0|||
155493006|NCT04668066|561229803|FG007|Part 1: Follow-Up|Adverse Event|0|||
155493007|NCT04668066|561229804|FG008|Part 1: Follow-Up|Adverse Event|0|||
155493008|NCT04668066|561229805|FG009|Part 1: Follow-Up|Adverse Event|0|||
155493009|NCT04668066|561229806|FG010|Part 1: Follow-Up|Adverse Event|0|||
155493010|NCT04668066|561229807|FG011|Part 1: Follow-Up|Adverse Event|1|||
155493011|NCT04668066|561229808|FG012|Part 1: Follow-Up|Adverse Event|0|||
155493012|NCT04668066|561229809|FG013|Part 1: Follow-Up|Adverse Event|0|||
155493013|NCT04668066|561229810|FG014|Part 1: Follow-Up|Adverse Event|0|||
155493014|NCT04668066|561229811|FG015|Part 1: Follow-Up|Adverse Event|0|||
155493015|NCT04668066|561229812|FG016|Part 1: Follow-Up|Adverse Event|0|||
155493016|NCT04668066|561229813|FG017|Part 1: Follow-Up|Adverse Event|0|||
155493017|NCT04668066|561229814|FG018|Part 1: Follow-Up|Adverse Event|0|||
155493018|NCT04668066|561229796|FG000|Part 1: Follow-Up|Other|0|||
155493019|NCT04668066|561229797|FG001|Part 1: Follow-Up|Other|0|||
155493020|NCT04668066|561229798|FG002|Part 1: Follow-Up|Other|0|||
155493021|NCT04668066|561229799|FG003|Part 1: Follow-Up|Other|0|||
155493022|NCT04668066|561229800|FG004|Part 1: Follow-Up|Other|0|||
155493023|NCT04668066|561229801|FG005|Part 1: Follow-Up|Other|0|||
155493024|NCT04668066|561229802|FG006|Part 1: Follow-Up|Other|0|||
155493025|NCT04668066|561229803|FG007|Part 1: Follow-Up|Other|0|||
155493026|NCT04668066|561229804|FG008|Part 1: Follow-Up|Other|0|||
155493027|NCT04668066|561229805|FG009|Part 1: Follow-Up|Other|0|||
155493028|NCT04668066|561229806|FG010|Part 1: Follow-Up|Other|0|||
155493029|NCT04668066|561229807|FG011|Part 1: Follow-Up|Other|1|||
155493030|NCT04668066|561229808|FG012|Part 1: Follow-Up|Other|1|||
155493031|NCT04668066|561229809|FG013|Part 1: Follow-Up|Other|0|||
155493032|NCT04668066|561229810|FG014|Part 1: Follow-Up|Other|0|||
155493033|NCT04668066|561229811|FG015|Part 1: Follow-Up|Other|0|||
155493034|NCT04668066|561229812|FG016|Part 1: Follow-Up|Other|0|||
155493035|NCT04668066|561229813|FG017|Part 1: Follow-Up|Other|0|||
155493036|NCT04668066|561229814|FG018|Part 1: Follow-Up|Other|0|||
155493037|NCT04668066|561229796|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493038|NCT04668066|561229797|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493039|NCT04668066|561229798|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493040|NCT04668066|561229799|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493041|NCT04668066|561229800|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493042|NCT04668066|561229801|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493043|NCT04668066|561229802|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493044|NCT04668066|561229803|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493045|NCT04668066|561229804|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493046|NCT04668066|561229805|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493047|NCT04668066|561229806|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493048|NCT04668066|561229807|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493049|NCT04668066|561229808|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
155493050|NCT04668066|561229809|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493051|NCT04668066|561229810|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493052|NCT04668066|561229811|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
155493053|NCT04668066|561229812|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493054|NCT04668066|561229813|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493055|NCT04668066|561229814|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
155493056|NCT04668066|561229796|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493057|NCT04668066|561229797|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493058|NCT04668066|561229798|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493059|NCT04668066|561229799|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493060|NCT04668066|561229800|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493061|NCT04668066|561229801|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493062|NCT04668066|561229802|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493063|NCT04668066|561229803|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493064|NCT04668066|561229804|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493065|NCT04668066|561229805|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493066|NCT04668066|561229806|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493067|NCT04668066|561229807|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493068|NCT04668066|561229808|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493069|NCT04668066|561229809|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493070|NCT04668066|561229810|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493071|NCT04668066|561229811|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493072|NCT04668066|561229812|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493073|NCT04668066|561229813|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
155493074|NCT04668066|561229814|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
155493075|NCT04668066|561229796|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493076|NCT04668066|561229797|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493077|NCT04668066|561229798|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493078|NCT04668066|561229799|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493079|NCT04668066|561229800|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493080|NCT04668066|561229801|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493081|NCT04668066|561229802|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493082|NCT04668066|561229803|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493083|NCT04668066|561229804|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493084|NCT04668066|561229805|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493085|NCT04668066|561229806|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493086|NCT04668066|561229807|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493087|NCT04668066|561229808|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493088|NCT04668066|561229809|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493089|NCT04668066|561229810|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493090|NCT04668066|561229811|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493091|NCT04668066|561229812|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493092|NCT04668066|561229813|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
155493093|NCT04668066|561229814|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
155493094|NCT04668066|561229796|FG000|Part 2: Treatment Phase|Other|0|||
155493095|NCT04668066|561229797|FG001|Part 2: Treatment Phase|Other|0|||
155493096|NCT04668066|561229798|FG002|Part 2: Treatment Phase|Other|0|||
155493097|NCT04668066|561229799|FG003|Part 2: Treatment Phase|Other|0|||
155493098|NCT04668066|561229800|FG004|Part 2: Treatment Phase|Other|0|||
155493099|NCT04668066|561229801|FG005|Part 2: Treatment Phase|Other|0|||
155493100|NCT04668066|561229802|FG006|Part 2: Treatment Phase|Other|0|||
155493101|NCT04668066|561229803|FG007|Part 2: Treatment Phase|Other|0|||
155493102|NCT04668066|561229804|FG008|Part 2: Treatment Phase|Other|0|||
155493103|NCT04668066|561229805|FG009|Part 2: Treatment Phase|Other|0|||
155493104|NCT04668066|561229806|FG010|Part 2: Treatment Phase|Other|0|||
155493105|NCT04668066|561229807|FG011|Part 2: Treatment Phase|Other|0|||
155493106|NCT04668066|561229808|FG012|Part 2: Treatment Phase|Other|0|||
155493107|NCT04668066|561229809|FG013|Part 2: Treatment Phase|Other|0|||
155493108|NCT04668066|561229810|FG014|Part 2: Treatment Phase|Other|0|||
155493109|NCT04668066|561229811|FG015|Part 2: Treatment Phase|Other|0|||
155493110|NCT04668066|561229812|FG016|Part 2: Treatment Phase|Other|0|||
155493111|NCT04668066|561229813|FG017|Part 2: Treatment Phase|Other|0|||
155493112|NCT04668066|561229814|FG018|Part 2: Treatment Phase|Other|1|||
155493113|NCT04668066|561229796|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493114|NCT04668066|561229797|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493115|NCT04668066|561229798|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493116|NCT04668066|561229799|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493117|NCT04668066|561229800|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493118|NCT04668066|561229801|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493119|NCT04668066|561229802|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493120|NCT04668066|561229803|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493121|NCT04668066|561229804|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493122|NCT04668066|561229805|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493123|NCT04668066|561229806|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493124|NCT04668066|561229807|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493125|NCT04668066|561229808|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493126|NCT04668066|561229809|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493127|NCT04668066|561229810|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493128|NCT04668066|561229811|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493129|NCT04668066|561229812|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493130|NCT04668066|561229813|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
155493131|NCT04668066|561229814|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
155493132|NCT02219477|561229815|FG000|Overall Study|Adverse Event|0|||
155493133|NCT02219477|561229816|FG001|Overall Study|Adverse Event|1|||
155493134|NCT02219477|561229817|FG002|Overall Study|Adverse Event|1|||
155493135|NCT02219477|561229815|FG000|Overall Study|Withdrawal by Subject|0|||
155493136|NCT02219477|561229816|FG001|Overall Study|Withdrawal by Subject|1|||
155493137|NCT02219477|561229817|FG002|Overall Study|Withdrawal by Subject|0|||
155493138|NCT00596466|561229818|FG000|Overall Study|Lack of Efficacy|5|||
155493139|NCT00596466|561229818|FG000|Overall Study|Adverse Event|4|||
155493140|NCT00596466|561229818|FG000|Overall Study|Withdrawal by Subject|2|||
155493141|NCT00596466|561229818|FG000|Overall Study|Protocol Violation|2|||
155493142|NCT00596466|561229818|FG000|Overall Study|Unpecified|2|||
155493143|NCT00596466|561229818|FG000|Overall Study|Enrolled, not treated|2|||
155493144|NCT01891669|561229819|FG000|Overall Study|Death|0|||
155493145|NCT01891669|561229820|FG001|Overall Study|Death|0|||
155493146|NCT01891669|561229821|FG002|Overall Study|Death|0|||
155493147|NCT01891669|561229822|FG003|Overall Study|Death|0|||
155493148|NCT01891669|561229823|FG004|Overall Study|Death|0|||
155493149|NCT01891669|561229824|FG005|Overall Study|Death|0|||
155493150|NCT01891669|561229825|FG006|Overall Study|Death|0|||
155493151|NCT01891669|561229826|FG007|Overall Study|Death|1|||
155493152|NCT01891669|561229827|FG008|Overall Study|Death|0|||
155493153|NCT01891669|561229828|FG009|Overall Study|Death|1|||
155493154|NCT01891669|561229819|FG000|Overall Study|Withdrawal by Subject|1|||
155493155|NCT01891669|561229820|FG001|Overall Study|Withdrawal by Subject|1|||
155493156|NCT01891669|561229821|FG002|Overall Study|Withdrawal by Subject|0|||
155493157|NCT01891669|561229822|FG003|Overall Study|Withdrawal by Subject|0|||
155493158|NCT01891669|561229823|FG004|Overall Study|Withdrawal by Subject|0|||
155493159|NCT01891669|561229824|FG005|Overall Study|Withdrawal by Subject|0|||
155493160|NCT01891669|561229825|FG006|Overall Study|Withdrawal by Subject|1|||
155493161|NCT01891669|561229826|FG007|Overall Study|Withdrawal by Subject|2|||
155493162|NCT01891669|561229827|FG008|Overall Study|Withdrawal by Subject|1|||
155493163|NCT01891669|561229828|FG009|Overall Study|Withdrawal by Subject|1|||
155493164|NCT01891669|561229819|FG000|Overall Study|Other|1|||
155493165|NCT01891669|561229820|FG001|Overall Study|Other|0|||
155493166|NCT01891669|561229821|FG002|Overall Study|Other|0|||
155493167|NCT01891669|561229822|FG003|Overall Study|Other|0|||
155493168|NCT01891669|561229823|FG004|Overall Study|Other|0|||
155493169|NCT01891669|561229824|FG005|Overall Study|Other|0|||
155493170|NCT01891669|561229825|FG006|Overall Study|Other|0|||
155493171|NCT01891669|561229826|FG007|Overall Study|Other|1|||
155493172|NCT01891669|561229827|FG008|Overall Study|Other|0|||
155493173|NCT01891669|561229828|FG009|Overall Study|Other|0|||
155493174|NCT01015118|561229829|FG000|Overall Study|Protocol Violation|5|||
155493175|NCT01015118|561229830|FG001|Overall Study|Protocol Violation|6|||
155493176|NCT01015118|561229829|FG000|Overall Study|Withdrawal by Subject|103|||
155493177|NCT01015118|561229830|FG001|Overall Study|Withdrawal by Subject|27|||
155493178|NCT01015118|561229829|FG000|Overall Study|Other Adverse Event (AE)|141|||
155493179|NCT01015118|561229830|FG001|Overall Study|Other Adverse Event (AE)|33|||
155493180|NCT01015118|561229829|FG000|Overall Study|Worsening or AE of underlying disease|5|||
155493181|NCT01015118|561229830|FG001|Overall Study|Worsening or AE of underlying disease|4|||
155493182|NCT01015118|561229829|FG000|Overall Study|Progressive disease|364|||
155493183|NCT01015118|561229830|FG001|Overall Study|Progressive disease|229|||
155493184|NCT01015118|561229829|FG000|Overall Study|Not treated|9|||
155493185|NCT01015118|561229830|FG001|Overall Study|Not treated|5|||
155493186|NCT01015118|561229829|FG000|Overall Study|Other than stated above|42|||
155493187|NCT01015118|561229830|FG001|Overall Study|Other than stated above|23|||
155493188|NCT00071006|561229833|FG000|Overall Study|Lack of Efficacy|7|||
155493189|NCT00071006|561229833|FG000|Overall Study|Adverse Event|1|||
155493190|NCT00071006|561229833|FG000|Overall Study|Withdrawal by Subject|1|||
155493191|NCT00071006|561229833|FG000|Overall Study|Other|3|||
155493192|NCT05261126|561229834|FG000|Overall Study|Death|0|||
155493193|NCT05261126|561229835|FG001|Overall Study|Death|0|||
155493194|NCT05261126|561229836|FG002|Overall Study|Death|1|||
155493195|NCT05261126|561229837|FG003|Overall Study|Death|0|||
155493196|NCT05261126|561229838|FG004|Overall Study|Death|0|||
155493197|NCT05261126|561229834|FG000|Overall Study|Lost to Follow-up|0|||
155493198|NCT05261126|561229835|FG001|Overall Study|Lost to Follow-up|0|||
155493199|NCT05261126|561229836|FG002|Overall Study|Lost to Follow-up|0|||
155493200|NCT05261126|561229837|FG003|Overall Study|Lost to Follow-up|0|||
155493201|NCT05261126|561229838|FG004|Overall Study|Lost to Follow-up|1|||
155493202|NCT05261126|561229834|FG000|Overall Study|Physician Decision|1|||
155493203|NCT05261126|561229835|FG001|Overall Study|Physician Decision|0|||
155493204|NCT05261126|561229836|FG002|Overall Study|Physician Decision|0|||
155493205|NCT05261126|561229837|FG003|Overall Study|Physician Decision|0|||
155493206|NCT05261126|561229838|FG004|Overall Study|Physician Decision|0|||
155493207|NCT05261126|561229834|FG000|Overall Study|Screen Failure|0|||
155493208|NCT05261126|561229835|FG001|Overall Study|Screen Failure|0|||
155493209|NCT05261126|561229836|FG002|Overall Study|Screen Failure|0|||
155493210|NCT05261126|561229837|FG003|Overall Study|Screen Failure|0|||
155493211|NCT05261126|561229838|FG004|Overall Study|Screen Failure|1|||
155493212|NCT05261126|561229834|FG000|Overall Study|Withdrawal by Subject|1|||
155493213|NCT05261126|561229835|FG001|Overall Study|Withdrawal by Subject|0|||
155493214|NCT05261126|561229836|FG002|Overall Study|Withdrawal by Subject|1|||
155493215|NCT05261126|561229837|FG003|Overall Study|Withdrawal by Subject|1|||
155493216|NCT05261126|561229838|FG004|Overall Study|Withdrawal by Subject|0|||
155493217|NCT05261126|561229834|FG000|Overall Study|Not Recorded|0|||
155493218|NCT05261126|561229835|FG001|Overall Study|Not Recorded|0|||
155493219|NCT05261126|561229836|FG002|Overall Study|Not Recorded|0|||
155493220|NCT05261126|561229837|FG003|Overall Study|Not Recorded|1|||
155493221|NCT05261126|561229838|FG004|Overall Study|Not Recorded|0|||
155493222|NCT05116241|561229843|FG000|Study|Withdrawal by Subject|5|||
155493223|NCT05116241|561229844|FG001|Study|Withdrawal by Subject|2|||
155493224|NCT05116241|561229845|FG002|Study|Withdrawal by Subject|1|||
155493225|NCT05116241|561229843|FG000|Study|Lost to Follow-up|0|||
155493226|NCT05116241|561229844|FG001|Study|Lost to Follow-up|2|||
155493227|NCT05116241|561229845|FG002|Study|Lost to Follow-up|2|||
155493228|NCT00938366|561229857|FG000|Overall Study|Withdrawal by Subject|1|||
155493229|NCT00938366|561229858|FG001|Overall Study|Withdrawal by Subject|0|||
155493230|NCT02396849|561229859|FG000|Overall Study|Lost to Follow-up|1|||
155493231|NCT02396849|561229860|FG001|Overall Study|Lost to Follow-up|1|||
155493232|NCT02396849|561229859|FG000|Overall Study|Did not tolerate intervention|1|||
155493233|NCT02396849|561229860|FG001|Overall Study|Did not tolerate intervention|1|||
155493234|NCT03328325|561229861|FG000|Overall Study|Lost to Follow-up|4|||
155493235|NCT03328325|561229861|FG000|Overall Study|Physician Decision|1|||
155493236|NCT03328325|561229861|FG000|Overall Study|Withdrawal by Subject|3|||
155493237|NCT03328325|561229861|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
155493238|NCT00931515|561229862|FG000|Overall Study|Lost to Follow-up|2|||
155493239|NCT00931515|561229863|FG001|Overall Study|Lost to Follow-up|5|||
155493240|NCT01054443|561229864|FG000|Overall Study|Withdrawal by Subject|0|||
155493241|NCT01054443|561229865|FG001|Overall Study|Withdrawal by Subject|0|||
155493242|NCT01054443|561229866|FG002|Overall Study|Withdrawal by Subject|0|||
155493243|NCT01054443|561229867|FG003|Overall Study|Withdrawal by Subject|1|||
155493244|NCT00985114|561229868|FG000|Overall Study|Adverse Event|1|||
155493245|NCT00985114|561229869|FG001|Overall Study|Adverse Event|0|||
155493246|NCT00985114|561229868|FG000|Overall Study|Withdrawal by Subject|0|||
155493247|NCT00985114|561229869|FG001|Overall Study|Withdrawal by Subject|2|||
155493248|NCT02950831|561229870|FG000|Overall Study|Lost to Follow-up|1|||
155493249|NCT02950831|561229870|FG000|Overall Study|Withdrawal by Subject|3|||
155493250|NCT02950831|561229870|FG000|Overall Study|stimulation trail failure|5|||
155493251|NCT01869959|561229873|FG000|Randomization Period|Physician Decision|0|||
155493252|NCT01869959|561229874|FG001|Randomization Period|Physician Decision|0|||
155493253|NCT01869959|561229875|FG002|Randomization Period|Physician Decision|0|||
155493254|NCT01869959|561229876|FG003|Randomization Period|Physician Decision|0|||
155493255|NCT01869959|561229877|FG004|Randomization Period|Physician Decision|1|||
155493256|NCT01869959|561229873|FG000|Treatment Period|Adverse Event|1|||
155493257|NCT01869959|561229874|FG001|Treatment Period|Adverse Event|0|||
155493258|NCT01869959|561229875|FG002|Treatment Period|Adverse Event|3|||
155493259|NCT01869959|561229876|FG003|Treatment Period|Adverse Event|1|||
155493260|NCT01869959|561229877|FG004|Treatment Period|Adverse Event|0|||
155493261|NCT01869959|561229873|FG000|Treatment Period|Sponsor decision|0|||
155493262|NCT01869959|561229874|FG001|Treatment Period|Sponsor decision|1|||
155493263|NCT01869959|561229875|FG002|Treatment Period|Sponsor decision|0|||
155493264|NCT01869959|561229876|FG003|Treatment Period|Sponsor decision|1|||
155493265|NCT01869959|561229877|FG004|Treatment Period|Sponsor decision|0|||
155493266|NCT01869959|561229873|FG000|Treatment Period|Withdrawal by Subject|0|||
155493267|NCT01869959|561229874|FG001|Treatment Period|Withdrawal by Subject|1|||
155493268|NCT01869959|561229875|FG002|Treatment Period|Withdrawal by Subject|0|||
155493269|NCT01869959|561229876|FG003|Treatment Period|Withdrawal by Subject|0|||
155493270|NCT01869959|561229877|FG004|Treatment Period|Withdrawal by Subject|0|||
155493271|NCT01965600|561229878|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
155493272|NCT01965600|561229879|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
155493273|NCT01965600|561229880|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
155493274|NCT01965600|561229881|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
155493275|NCT01965600|561229878|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
155493276|NCT01965600|561229879|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
155493277|NCT01965600|561229880|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
155493278|NCT01965600|561229881|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
155493279|NCT01965600|561229878|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
155493280|NCT01965600|561229879|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
155493281|NCT01965600|561229880|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
155493282|NCT01965600|561229881|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
155493283|NCT01965600|561229878|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
155493284|NCT01965600|561229879|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
155493285|NCT01965600|561229880|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
155493286|NCT01965600|561229881|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
155493287|NCT01965600|561229878|FG000|Second Intervention|Study terminated by Sponsor|0|||
155493288|NCT01965600|561229879|FG001|Second Intervention|Study terminated by Sponsor|0|||
155493289|NCT01965600|561229880|FG002|Second Intervention|Study terminated by Sponsor|2|||
155493290|NCT01965600|561229881|FG003|Second Intervention|Study terminated by Sponsor|2|||
155493291|NCT00157157|561229885|FG000|Overall Study|Withdrawal by Subject|6|||
155493292|NCT00157157|561229885|FG000|Overall Study|Physician Decision|1|||
155493293|NCT00157157|561229885|FG000|Overall Study|Lost to Follow-up|1|||
155493294|NCT00157157|561229885|FG000|Overall Study|Enrolled in another study|1|||
155493295|NCT00157157|561229885|FG000|Overall Study|Met exclusion criteria|1|||
155493296|NCT00157157|561229885|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
155493297|NCT02260804|561229886|FG000|Induction Study Period|Protocol Violation|2|||
155493298|NCT02260804|561229887|FG001|Induction Study Period|Protocol Violation|0|||
155493299|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
155493300|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
155493301|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
155493302|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
155493303|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
155493304|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
155493305|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
155493306|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
155493307|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
155493308|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
155493309|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
155493310|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
155493311|NCT02260804|561229886|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
155493312|NCT02260804|561229887|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
155493313|NCT02260804|561229886|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
155493314|NCT02260804|561229887|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
155493315|NCT02260804|561229886|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
155493316|NCT02260804|561229887|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
155493317|NCT02260804|561229886|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
155493318|NCT02260804|561229887|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
155607057|NCT05268016|561649627|FG000|Overall Study|Unacceptable toxicity or AE|2|||
155607058|NCT05268016|561649628|FG001|Overall Study|Unacceptable toxicity or AE|2|||
155607059|NCT05268016|561649629|FG002|Overall Study|Unacceptable toxicity or AE|4|||
155607060|NCT05268016|561649630|FG003|Overall Study|Unacceptable toxicity or AE|3|||
155607061|NCT05268016|561649631|FG004|Overall Study|Unacceptable toxicity or AE|1|||
155607062|NCT05268016|561649627|FG000|Overall Study|Withdrawal by Subject|1|||
155607063|NCT05268016|561649628|FG001|Overall Study|Withdrawal by Subject|3|||
155607064|NCT05268016|561649629|FG002|Overall Study|Withdrawal by Subject|2|||
155607065|NCT05268016|561649630|FG003|Overall Study|Withdrawal by Subject|2|||
155607066|NCT05268016|561649631|FG004|Overall Study|Withdrawal by Subject|1|||
155607067|NCT05268016|561649627|FG000|Overall Study|Lost to Follow-up|4|||
155607068|NCT05268016|561649628|FG001|Overall Study|Lost to Follow-up|7|||
155607069|NCT05268016|561649629|FG002|Overall Study|Lost to Follow-up|1|||
155607070|NCT05268016|561649630|FG003|Overall Study|Lost to Follow-up|3|||
155607071|NCT05268016|561649631|FG004|Overall Study|Lost to Follow-up|5|||
155607072|NCT05268016|561649627|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
155607073|NCT05268016|561649628|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155607074|NCT05268016|561649629|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155607075|NCT05268016|561649630|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
155607076|NCT05268016|561649631|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155607077|NCT05268016|561649627|FG000|Overall Study|Lack of Efficacy|0|||
155607078|NCT05268016|561649628|FG001|Overall Study|Lack of Efficacy|0|||
155607079|NCT05268016|561649629|FG002|Overall Study|Lack of Efficacy|0|||
155607080|NCT05268016|561649630|FG003|Overall Study|Lack of Efficacy|0|||
155607081|NCT05268016|561649631|FG004|Overall Study|Lack of Efficacy|4|||
155607082|NCT05268016|561649627|FG000|Overall Study|Physician Decision|0|||
155607083|NCT05268016|561649628|FG001|Overall Study|Physician Decision|0|||
155607084|NCT05268016|561649629|FG002|Overall Study|Physician Decision|0|||
155607085|NCT05268016|561649630|FG003|Overall Study|Physician Decision|1|||
155607086|NCT05268016|561649631|FG004|Overall Study|Physician Decision|0|||
155607087|NCT05268016|561649627|FG000|Overall Study|Other|1|||
155607088|NCT05268016|561649628|FG001|Overall Study|Other|0|||
155607089|NCT05268016|561649629|FG002|Overall Study|Other|1|||
155607090|NCT05268016|561649630|FG003|Overall Study|Other|2|||
155607091|NCT05268016|561649631|FG004|Overall Study|Other|0|||
155607092|NCT02943785|561649632|FG000|Overall Study|Adverse Event|112|||
155263042|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
155263043|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
155263044|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
155263045|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Death|0|||
155263046|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Death|0|||
155263047|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Death|4|||
155263048|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
155263049|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
155263050|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
155263051|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
155263052|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
155263053|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
155263054|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
155263055|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
155263056|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
155263057|NCT02207725|560396329|FG000|Overall Study|Did Not Receive Treatment|0|||
155263058|NCT02207725|560396330|FG001|Overall Study|Did Not Receive Treatment|1|||
155263059|NCT02207725|560396331|FG002|Overall Study|Did Not Receive Treatment|1|||
155263060|NCT02207725|560396332|FG003|Overall Study|Did Not Receive Treatment|1|||
155263061|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263062|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263063|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
155263064|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263065|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
155263066|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
155263067|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
155263068|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
155263069|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
155263070|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
155263071|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
155263072|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
155263073|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
155263074|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
155263075|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
155263076|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
155263077|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263078|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263079|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263080|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
155263081|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
155263082|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263083|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263084|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
155263085|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263086|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
155263087|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
155607093|NCT02943785|561649633|FG001|Overall Study|Adverse Event|97|||
155607094|NCT02943785|561649632|FG000|Overall Study|Withdrawal by Subject|63|||
155263088|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
155263089|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
155263090|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
155263091|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263092|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263093|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263094|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
155263095|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
155263096|NCT02799472|560396340|FG000|Overall Study|Withdrawal by Subject|2|||
155263097|NCT02799472|560396341|FG001|Overall Study|Withdrawal by Subject|4|||
155263098|NCT02799472|560396340|FG000|Overall Study|Lack of Efficacy|2|||
155263099|NCT02799472|560396341|FG001|Overall Study|Lack of Efficacy|0|||
155263100|NCT02799472|560396340|FG000|Overall Study|Lost to Follow-up|0|||
155263101|NCT02799472|560396341|FG001|Overall Study|Lost to Follow-up|1|||
155263102|NCT01966003|560396342|FG000|Overall Study|Death|43|||
155263103|NCT01966003|560396343|FG001|Overall Study|Death|36|||
155263104|NCT01966003|560396342|FG000|Overall Study|Protocol Violation|6|||
155263105|NCT01966003|560396343|FG001|Overall Study|Protocol Violation|4|||
155263106|NCT01966003|560396342|FG000|Overall Study|Lost to Follow-up|4|||
155263107|NCT01966003|560396343|FG001|Overall Study|Lost to Follow-up|3|||
155263108|NCT01966003|560396342|FG000|Overall Study|Physician Decision|12|||
155263109|NCT01966003|560396343|FG001|Overall Study|Physician Decision|13|||
155263110|NCT01966003|560396342|FG000|Overall Study|Withdrawal by Subject|29|||
155263111|NCT01966003|560396343|FG001|Overall Study|Withdrawal by Subject|19|||
155263112|NCT01966003|560396342|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
155263113|NCT01966003|560396343|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
155263114|NCT01966003|560396342|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
155263115|NCT01966003|560396343|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
155263116|NCT01966003|560396342|FG000|Overall Study|Other|1|||
155263117|NCT01966003|560396343|FG001|Overall Study|Other|1|||
155263118|NCT02801669|560396344|FG000|Overall Study|Death|66|||
155263119|NCT02801669|560396345|FG001|Overall Study|Death|69|||
155263120|NCT02801669|560396344|FG000|Overall Study|Withdrawal by Subject|81|||
155263121|NCT02801669|560396345|FG001|Overall Study|Withdrawal by Subject|77|||
155263122|NCT02801669|560396344|FG000|Overall Study|Other|4|||
155263123|NCT02801669|560396345|FG001|Overall Study|Other|6|||
155263124|NCT00674570|560396346|FG000|Overall Study|Withdrawal by Subject|0|||
155263125|NCT00674570|560396347|FG001|Overall Study|Withdrawal by Subject|2|||
155263126|NCT00674570|560396348|FG002|Overall Study|Withdrawal by Subject|0|||
155263127|NCT02569437|560396350|FG000|Overall Study|Lost to Follow-up|12|||
155263128|NCT02569437|560396351|FG001|Overall Study|Lost to Follow-up|14|||
155263129|NCT00985985|560396352|FG000|Overall Study|Adverse Event|4|||
155263130|NCT00985985|560396353|FG001|Overall Study|Adverse Event|2|||
155263131|NCT00985985|560396354|FG002|Overall Study|Adverse Event|2|||
155263132|NCT00985985|560396355|FG003|Overall Study|Adverse Event|2|||
155263133|NCT00985985|560396352|FG000|Overall Study|Lost to Follow-up|4|||
155263134|NCT00985985|560396353|FG001|Overall Study|Lost to Follow-up|11|||
155263135|NCT00985985|560396354|FG002|Overall Study|Lost to Follow-up|2|||
155263136|NCT00985985|560396355|FG003|Overall Study|Lost to Follow-up|3|||
155263137|NCT00985985|560396352|FG000|Overall Study|Protocol Violation|1|||
155263138|NCT00985985|560396353|FG001|Overall Study|Protocol Violation|2|||
155263139|NCT00985985|560396354|FG002|Overall Study|Protocol Violation|0|||
155263140|NCT00985985|560396355|FG003|Overall Study|Protocol Violation|1|||
155263141|NCT00985985|560396352|FG000|Overall Study|Lack of Efficacy|5|||
155263142|NCT00985985|560396353|FG001|Overall Study|Lack of Efficacy|6|||
155263143|NCT00985985|560396354|FG002|Overall Study|Lack of Efficacy|1|||
155263144|NCT00985985|560396355|FG003|Overall Study|Lack of Efficacy|3|||
155263145|NCT00985985|560396352|FG000|Overall Study|Withdrawal by Subject|4|||
155263146|NCT00985985|560396353|FG001|Overall Study|Withdrawal by Subject|2|||
155263147|NCT00985985|560396354|FG002|Overall Study|Withdrawal by Subject|2|||
155263148|NCT00985985|560396355|FG003|Overall Study|Withdrawal by Subject|2|||
155263149|NCT00985985|560396352|FG000|Overall Study|Other Reason|6|||
155263150|NCT00985985|560396353|FG001|Overall Study|Other Reason|1|||
155263151|NCT00985985|560396354|FG002|Overall Study|Other Reason|4|||
155263152|NCT00985985|560396355|FG003|Overall Study|Other Reason|2|||
155263153|NCT02343003|560396356|FG000|Overall Study|Withdrawal by Subject|9|||
155263154|NCT02343003|560396357|FG001|Overall Study|Withdrawal by Subject|4|||
155263155|NCT02343003|560396356|FG000|Overall Study|Lost to Follow-up|5|||
155263156|NCT02343003|560396357|FG001|Overall Study|Lost to Follow-up|1|||
155263157|NCT02343003|560396356|FG000|Overall Study|Protocol Violation|1|||
155263158|NCT02343003|560396357|FG001|Overall Study|Protocol Violation|0|||
155263159|NCT02343003|560396356|FG000|Overall Study|Death|0|||
155263160|NCT02343003|560396357|FG001|Overall Study|Death|1|||
155263161|NCT02343003|560396356|FG000|Overall Study|exclusion criteria met|1|||
155263162|NCT02343003|560396357|FG001|Overall Study|exclusion criteria met|1|||
155263163|NCT02343003|560396356|FG000|Overall Study|terminated by sponsor|2|||
155263164|NCT02343003|560396357|FG001|Overall Study|terminated by sponsor|0|||
155263165|NCT01153269|560396360|FG000|Overall Study|Withdrawal by Subject|1|||
155263166|NCT01153269|560396360|FG000|Overall Study|Antiretroviral therapy break|1|||
155263167|NCT02635724|560396371|FG000|Overall Study|Withdrawal by Subject|0|||
155263168|NCT02635724|560396372|FG001|Overall Study|Withdrawal by Subject|1|||
155263169|NCT02635724|560396373|FG002|Overall Study|Withdrawal by Subject|0|||
155263170|NCT02424591|560396378|FG000|Overall Study|Protocol Violation|2|||
155263171|NCT02424591|560396379|FG001|Overall Study|Protocol Violation|3|||
155263172|NCT00770432|560396380|FG000|Overall Study|Other|4|||
155263173|NCT00770432|560396381|FG001|Overall Study|Other|6|||
155263174|NCT00770432|560396380|FG000|Overall Study|Non-compliance|0|||
155263175|NCT00770432|560396381|FG001|Overall Study|Non-compliance|1|||
155263176|NCT01453348|560396382|FG000|Overall Study|Death|0|||
155263177|NCT01453348|560396383|FG001|Overall Study|Death|0|||
155263178|NCT01453348|560396384|FG002|Overall Study|Death|1|||
155263179|NCT01453348|560396382|FG000|Overall Study|Withdrawal by Subject|0|||
155263180|NCT01453348|560396383|FG001|Overall Study|Withdrawal by Subject|1|||
155263181|NCT01453348|560396384|FG002|Overall Study|Withdrawal by Subject|0|||
155263182|NCT01453348|560396382|FG000|Overall Study|Protocol Violation|1|||
155263183|NCT01453348|560396383|FG001|Overall Study|Protocol Violation|0|||
155263184|NCT01453348|560396384|FG002|Overall Study|Protocol Violation|0|||
155263185|NCT01498822|560396387|FG000|Overall Study|Protocol Violation|8|||
155263186|NCT01498822|560396388|FG001|Overall Study|Protocol Violation|4|||
155263187|NCT01498822|560396387|FG000|Overall Study|Other Reason|5|||
155263188|NCT01498822|560396388|FG001|Overall Study|Other Reason|2|||
155263189|NCT01498822|560396387|FG000|Overall Study|Lack of Efficacy|7|||
155263190|NCT01498822|560396388|FG001|Overall Study|Lack of Efficacy|2|||
155263191|NCT01498822|560396387|FG000|Overall Study|AE, non-serious non-fatal|8|||
155263192|NCT01498822|560396388|FG001|Overall Study|AE, non-serious non-fatal|17|||
155263193|NCT01498822|560396387|FG000|Overall Study|SAE, non-fatal|2|||
155263194|NCT01498822|560396388|FG001|Overall Study|SAE, non-fatal|2|||
155263195|NCT01498822|560396387|FG000|Overall Study|Adverse Event, serious fatal|1|||
155263196|NCT01498822|560396388|FG001|Overall Study|Adverse Event, serious fatal|1|||
155263197|NCT01498822|560396387|FG000|Overall Study|Withdrawal by Subject|15|||
155263198|NCT01498822|560396388|FG001|Overall Study|Withdrawal by Subject|25|||
155263199|NCT01498822|560396387|FG000|Overall Study|Lost to Follow-up|8|||
155263200|NCT01498822|560396388|FG001|Overall Study|Lost to Follow-up|3|||
155263201|NCT03592277|560396392|FG000|Overall Study|Withdrawal by Subject|6|||
155263202|NCT03592277|560396393|FG001|Overall Study|Withdrawal by Subject|8|||
155263203|NCT01781390|560396394|FG000|Overall Study|Withdrawal of Consent|0|||
155263204|NCT01781390|560396395|FG001|Overall Study|Withdrawal of Consent|3|||
155263205|NCT01781390|560396396|FG002|Overall Study|Withdrawal of Consent|1|||
155263206|NCT01781390|560396394|FG000|Overall Study|Lost to Follow-up|1|||
155263207|NCT01781390|560396395|FG001|Overall Study|Lost to Follow-up|1|||
155263208|NCT01781390|560396396|FG002|Overall Study|Lost to Follow-up|1|||
155263209|NCT01781390|560396394|FG000|Overall Study|Adverse Event|1|||
155263210|NCT01781390|560396395|FG001|Overall Study|Adverse Event|2|||
155263211|NCT01781390|560396396|FG002|Overall Study|Adverse Event|1|||
155263212|NCT01781390|560396394|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
155263213|NCT01781390|560396395|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
155263214|NCT01781390|560396396|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
155263215|NCT04707196|560396397|FG000|Overall Study|Withdrawal by Subject|9|||
155263216|NCT04707196|560396398|FG001|Overall Study|Withdrawal by Subject|6|||
155263217|NCT04707196|560396397|FG000|Overall Study|Lost to Follow-up|1|||
155263218|NCT04707196|560396398|FG001|Overall Study|Lost to Follow-up|0|||
155263219|NCT04707196|560396397|FG000|Overall Study|Protocol Violation|4|||
155263220|NCT04707196|560396398|FG001|Overall Study|Protocol Violation|1|||
155263221|NCT04707196|560396397|FG000|Overall Study|Adverse Event|2|||
155263222|NCT04707196|560396398|FG001|Overall Study|Adverse Event|2|||
155263223|NCT04707196|560396397|FG000|Overall Study|Death|3|||
155263224|NCT04707196|560396398|FG001|Overall Study|Death|1|||
155263225|NCT04707196|560396397|FG000|Overall Study|Non-compliance with study drug|1|||
155263226|NCT04707196|560396398|FG001|Overall Study|Non-compliance with study drug|0|||
155263227|NCT04707196|560396397|FG000|Overall Study|Progressive disease|9|||
155263228|NCT04707196|560396398|FG001|Overall Study|Progressive disease|10|||
155263229|NCT01862796|560396400|FG000|Overall Study|Prohibited medications|0|||
155263230|NCT01862796|560396401|FG001|Overall Study|Prohibited medications|0|||
155263231|NCT01862796|560396402|FG002|Overall Study|Prohibited medications|1|||
155263232|NCT04404478|560396403|FG000|Overall Study|Withdrawal by Subject|1|||
155263233|NCT04404478|560396404|FG001|Overall Study|Withdrawal by Subject|3|||
155263234|NCT03056534|560396414|FG000|Overall Study|Participant withdrew consent|8|||
155263235|NCT03056534|560396414|FG000|Overall Study|Participant not able to return|6|||
155263236|NCT03056534|560396414|FG000|Overall Study|Lost to Follow-up|37|||
155263237|NCT03056534|560396414|FG000|Overall Study|Investigator judgment|1|||
155263238|NCT03056534|560396414|FG000|Overall Study|Death|4|||
155263239|NCT03056534|560396414|FG000|Overall Study|Adverse Event|1|||
155263240|NCT03056534|560396414|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
155263241|NCT04146896|560396417|FG000|Overall Study|Adverse Event|5|||
155263242|NCT04146896|560396418|FG001|Overall Study|Adverse Event|8|||
155263243|NCT04146896|560396417|FG000|Overall Study|Lack of Efficacy|3|||
155263244|NCT04146896|560396418|FG001|Overall Study|Lack of Efficacy|2|||
155263245|NCT04146896|560396417|FG000|Overall Study|Lost to Follow-up|0|||
155263246|NCT04146896|560396418|FG001|Overall Study|Lost to Follow-up|1|||
155263247|NCT04146896|560396417|FG000|Overall Study|Non-compliance|5|||
155263248|NCT04146896|560396418|FG001|Overall Study|Non-compliance|4|||
155263249|NCT04146896|560396417|FG000|Overall Study|Withdrawal by Subject|3|||
155263250|NCT04146896|560396418|FG001|Overall Study|Withdrawal by Subject|5|||
155263251|NCT04146896|560396417|FG000|Overall Study|Randomized in error|1|||
155263252|NCT04146896|560396418|FG001|Overall Study|Randomized in error|2|||
155263253|NCT01597505|560396419|FG000|Overall Study|Physician Decision|5|||
155263254|NCT01597505|560396420|FG001|Overall Study|Physician Decision|0|||
155263255|NCT01597505|560396419|FG000|Overall Study|Adverse Event|19|||
155263256|NCT01597505|560396420|FG001|Overall Study|Adverse Event|7|||
155263257|NCT01597505|560396419|FG000|Overall Study|Lost to Follow-up|4|||
155263258|NCT01597505|560396420|FG001|Overall Study|Lost to Follow-up|2|||
155263259|NCT01597505|560396419|FG000|Overall Study|Withdrawal by Subject|10|||
155263260|NCT01597505|560396420|FG001|Overall Study|Withdrawal by Subject|18|||
155263261|NCT01597505|560396419|FG000|Overall Study|Other|5|||
155263262|NCT01597505|560396420|FG001|Overall Study|Other|6|||
155263263|NCT01597505|560396419|FG000|Overall Study|Missing|1|||
155263264|NCT01597505|560396420|FG001|Overall Study|Missing|0|||
155263265|NCT02675465|560396421|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263266|NCT02675465|560396422|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263267|NCT02675465|560396423|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
155263268|NCT02675465|560396424|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
155263269|NCT02675465|560396425|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263270|NCT02675465|560396426|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263271|NCT02675465|560396421|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263272|NCT02675465|560396422|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263273|NCT02675465|560396423|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
155263274|NCT02675465|560396424|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263275|NCT02675465|560396425|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263276|NCT02675465|560396426|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263277|NCT02675465|560396421|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
155263278|NCT02675465|560396422|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
155263279|NCT02675465|560396423|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
155263280|NCT02675465|560396424|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
155263281|NCT02675465|560396425|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
155263282|NCT02675465|560396426|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
155263283|NCT02675465|560396421|FG000|Stage 4: Long Term Extension|Death|0|||
155263284|NCT02675465|560396422|FG001|Stage 4: Long Term Extension|Death|0|||
155263285|NCT02675465|560396423|FG002|Stage 4: Long Term Extension|Death|0|||
155263286|NCT02675465|560396424|FG003|Stage 4: Long Term Extension|Death|1|||
155263287|NCT02675465|560396425|FG004|Stage 4: Long Term Extension|Death|0|||
155263288|NCT02675465|560396426|FG005|Stage 4: Long Term Extension|Death|0|||
155263289|NCT05031078|560396427|FG000|Overall Study|Withdrawal by Subject|0|||
155263290|NCT05031078|560396428|FG001|Overall Study|Withdrawal by Subject|1|||
155263291|NCT05031078|560396429|FG002|Overall Study|Withdrawal by Subject|0|||
155263292|NCT05398796|560396432|FG000|Overall Study|Participant moved from the area|0|||
155263293|NCT05398796|560396433|FG001|Overall Study|Participant moved from the area|1|||
155263294|NCT05398796|560396434|FG002|Overall Study|Participant moved from the area|0|||
155263295|NCT05398796|560396435|FG003|Overall Study|Participant moved from the area|0|||
155263296|NCT05004688|560396436|FG000|Overall Study|Protocol Violation|7|||
155263297|NCT05004688|560396436|FG000|Overall Study|Physician Decision|2|||
155263298|NCT05004688|560396436|FG000|Overall Study|Withdrawal by Subject|2|||
155263299|NCT00728962|560396437|FG000|Implant Placement Surgery|Adverse Event|8|||
155263300|NCT00728962|560396437|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
155263301|NCT00728962|560396437|FG000|Implant Placement Surgery|Protocol Violation|1|||
155263302|NCT00728962|560396437|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
155263303|NCT00728962|560396437|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
155263304|NCT04954586|560396438|FG000|Overall Study|Withdrawal by Subject|5|||
155263305|NCT00532155|560396439|FG000|Overall Study|Adverse Event|66|||
155263306|NCT00532155|560396440|FG001|Overall Study|Adverse Event|123|||
155263307|NCT00532155|560396439|FG000|Overall Study|Lack of Efficacy|332|||
155263308|NCT00532155|560396440|FG001|Overall Study|Lack of Efficacy|255|||
155263309|NCT00532155|560396439|FG000|Overall Study|Protocol Violation|1|||
155263310|NCT00532155|560396440|FG001|Overall Study|Protocol Violation|3|||
155263311|NCT00532155|560396439|FG000|Overall Study|Lost to Follow-up|2|||
155263312|NCT00532155|560396440|FG001|Overall Study|Lost to Follow-up|0|||
155263313|NCT00532155|560396439|FG000|Overall Study|Physician Decision|16|||
155263314|NCT00532155|560396440|FG001|Overall Study|Physician Decision|15|||
155263315|NCT00532155|560396439|FG000|Overall Study|Withdrawal by Subject|23|||
155263316|NCT00532155|560396440|FG001|Overall Study|Withdrawal by Subject|44|||
155263317|NCT00532155|560396439|FG000|Overall Study|Consent withdrawn|5|||
155263318|NCT00532155|560396440|FG001|Overall Study|Consent withdrawn|7|||
155263319|NCT00532155|560396439|FG000|Overall Study|Moved|1|||
155263320|NCT00532155|560396440|FG001|Overall Study|Moved|0|||
155263321|NCT00532155|560396439|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
155263322|NCT00532155|560396440|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
155263323|NCT00532155|560396439|FG000|Overall Study|Occurence of a second cancer|0|||
155263324|NCT00532155|560396440|FG001|Overall Study|Occurence of a second cancer|1|||
155263325|NCT00532155|560396439|FG000|Overall Study|Occurence of a secondary cancer|0|||
155263326|NCT00532155|560396440|FG001|Overall Study|Occurence of a secondary cancer|1|||
155263327|NCT00532155|560396439|FG000|Overall Study|Promotor ended study|1|||
155263328|NCT00532155|560396440|FG001|Overall Study|Promotor ended study|0|||
155263329|NCT00532155|560396439|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
155263330|NCT00532155|560396440|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
155263331|NCT00532155|560396439|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
155263332|NCT00532155|560396440|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
155263333|NCT00532155|560396439|FG000|Overall Study|Study stopped|1|||
155263334|NCT00532155|560396440|FG001|Overall Study|Study stopped|0|||
155263335|NCT00532155|560396439|FG000|Overall Study|Study terminated by sponsor|1|||
155263336|NCT00532155|560396440|FG001|Overall Study|Study terminated by sponsor|0|||
155263337|NCT00532155|560396439|FG000|Overall Study|Study termination stop further treatment|4|||
155263338|NCT00532155|560396440|FG001|Overall Study|Study termination stop further treatment|0|||
155263339|NCT00532155|560396439|FG000|Overall Study|Did not receive study medication|2|||
155263340|NCT00532155|560396440|FG001|Overall Study|Did not receive study medication|6|||
155263341|NCT03483038|560396441|FG000|Overall Study|Subjects still in follow-up|18|||
155263342|NCT02134925|560396442|FG000|Overall Study|Withdrawal by Subject|1|||
155263343|NCT02134925|560396443|FG001|Overall Study|Withdrawal by Subject|0|||
155263344|NCT02134925|560396442|FG000|Overall Study|Cancel|1|||
155263345|NCT02134925|560396443|FG001|Overall Study|Cancel|6|||
155263346|NCT04027348|560396444|FG000|Overall Study|Adverse Event|2|||
155263347|NCT02158884|560396445|FG000|Baseline Assessment|Missed performance assessment|3|||
155263348|NCT02158884|560396445|FG000|Baseline Assessment|Missed SMFA|1|||
155263349|NCT02158884|560396445|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
155263350|NCT02158884|560396445|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
155263351|NCT02158884|560396445|FG000|6 Month Assessment|Missed SMFA|20|||
155263352|NCT02158884|560396445|FG000|12 Month Assessment|Missed SMFA|17|||
155263353|NCT02487472|560396446|FG000|Overall Study|Did not complete telephonic interviews|9|||
155263354|NCT02487472|560396446|FG000|Overall Study|Other|2|||
155263355|NCT01313286|560396447|FG000|Period 1|Withdrawal by Subject|2|||
155263356|NCT01313286|560396448|FG001|Period 1|Withdrawal by Subject|0|||
155263357|NCT04843930|560396449|FG000|Randomization|Withdrawal by Subject|6|||
155263358|NCT04843930|560396450|FG001|Randomization|Withdrawal by Subject|6|||
155263359|NCT04843930|560396451|FG002|Randomization|Withdrawal by Subject|0|||
155263360|NCT04843930|560396452|FG003|Randomization|Withdrawal by Subject|0|||
155263361|NCT04843930|560396449|FG000|Week 6 Assessment|Adverse Event|3|||
155263362|NCT04843930|560396450|FG001|Week 6 Assessment|Adverse Event|0|||
155263363|NCT04843930|560396451|FG002|Week 6 Assessment|Adverse Event|0|||
155263364|NCT04843930|560396452|FG003|Week 6 Assessment|Adverse Event|0|||
155263365|NCT04843930|560396449|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
155263366|NCT04843930|560396450|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
155263367|NCT04843930|560396451|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
155263368|NCT04843930|560396452|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
155263369|NCT04843930|560396449|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
155263370|NCT04843930|560396450|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
155263371|NCT04843930|560396451|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
155263372|NCT04843930|560396452|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
155263373|NCT05158296|560396453|FG000|Overall Study|Sponsor Decision|2|||
155263374|NCT05158296|560396454|FG001|Overall Study|Sponsor Decision|3|||
155263375|NCT05158296|560396455|FG002|Overall Study|Sponsor Decision|2|||
155263376|NCT02552238|560396456|FG000|Overall Study|Withdrawal by Subject|2|||
155263377|NCT02552238|560396456|FG000|Overall Study|Adverse Event|2|||
155263378|NCT04241094|560396460|FG000|Overall Study|Dropped out of treatment|4|||
155263379|NCT04241094|560396460|FG000|Overall Study|Ineligible after clinical assessment|2|||
155263380|NCT04241094|560396460|FG000|Overall Study|Lost to Follow-up|2|||
155263381|NCT01669798|560396461|FG000|Overall Study|Physician Decision|5|||
155263382|NCT05918978|560396462|FG000|Overall Study|Study Terminated by Sponsor|17|||
155263383|NCT05918978|560396463|FG001|Overall Study|Study Terminated by Sponsor|11|||
155263384|NCT05918978|560396462|FG000|Overall Study|Withdrawal by Subject|1|||
155263385|NCT05918978|560396463|FG001|Overall Study|Withdrawal by Subject|1|||
155263386|NCT05918978|560396462|FG000|Overall Study|Adverse Event|1|||
155263387|NCT05918978|560396463|FG001|Overall Study|Adverse Event|0|||
155263388|NCT05918978|560396462|FG000|Overall Study|Other|0|||
155263389|NCT05918978|560396463|FG001|Overall Study|Other|1|||
155263390|NCT00622180|560396464|FG000|Overall Study|Lost to Follow-up|1|||
155263391|NCT00622180|560396465|FG001|Overall Study|Lost to Follow-up|2|||
155263392|NCT00279201|560396466|FG000|Initiation|Death|1|||
155263393|NCT00279201|560396467|FG001|Initiation|Death|5|||
155263394|NCT00279201|560396468|FG002|Initiation|Death|0|||
155263395|NCT00279201|560396469|FG003|Initiation|Death|0|||
155263396|NCT00279201|560396470|FG004|Initiation|Death|0|||
155263397|NCT00279201|560396471|FG005|Initiation|Death|0|||
155263398|NCT00279201|560396466|FG000|Initiation|Adverse Event|6|||
155263399|NCT00279201|560396467|FG001|Initiation|Adverse Event|15|||
155263400|NCT00279201|560396468|FG002|Initiation|Adverse Event|0|||
155263401|NCT00279201|560396469|FG003|Initiation|Adverse Event|0|||
155263402|NCT00279201|560396470|FG004|Initiation|Adverse Event|0|||
155263403|NCT00279201|560396471|FG005|Initiation|Adverse Event|0|||
155263404|NCT00279201|560396466|FG000|Initiation|Lost to Follow-up|42|||
155263405|NCT00279201|560396467|FG001|Initiation|Lost to Follow-up|41|||
155263406|NCT00279201|560396468|FG002|Initiation|Lost to Follow-up|0|||
155263407|NCT00279201|560396469|FG003|Initiation|Lost to Follow-up|0|||
155263408|NCT00279201|560396470|FG004|Initiation|Lost to Follow-up|0|||
155263409|NCT00279201|560396471|FG005|Initiation|Lost to Follow-up|0|||
155263410|NCT00279201|560396466|FG000|Initiation|Entry Criteria Exclusion|7|||
155263411|NCT00279201|560396467|FG001|Initiation|Entry Criteria Exclusion|9|||
155263412|NCT00279201|560396468|FG002|Initiation|Entry Criteria Exclusion|0|||
155263413|NCT00279201|560396469|FG003|Initiation|Entry Criteria Exclusion|0|||
155263414|NCT00279201|560396470|FG004|Initiation|Entry Criteria Exclusion|0|||
155263415|NCT00279201|560396471|FG005|Initiation|Entry Criteria Exclusion|0|||
155263416|NCT00279201|560396466|FG000|Initiation|Protocol Violation|9|||
155263417|NCT00279201|560396467|FG001|Initiation|Protocol Violation|10|||
155263418|NCT00279201|560396468|FG002|Initiation|Protocol Violation|0|||
155263419|NCT00279201|560396469|FG003|Initiation|Protocol Violation|0|||
155263420|NCT00279201|560396470|FG004|Initiation|Protocol Violation|0|||
155263421|NCT00279201|560396471|FG005|Initiation|Protocol Violation|0|||
155263422|NCT00279201|560396466|FG000|Initiation|Withdrawal by Subject|35|||
155263423|NCT00279201|560396467|FG001|Initiation|Withdrawal by Subject|41|||
155263424|NCT00279201|560396468|FG002|Initiation|Withdrawal by Subject|0|||
155263425|NCT00279201|560396469|FG003|Initiation|Withdrawal by Subject|0|||
155263426|NCT00279201|560396470|FG004|Initiation|Withdrawal by Subject|0|||
155263427|NCT00279201|560396471|FG005|Initiation|Withdrawal by Subject|0|||
155263428|NCT00279201|560396466|FG000|Initiation|Physician Decision|15|||
155263429|NCT00279201|560396467|FG001|Initiation|Physician Decision|18|||
155263430|NCT00279201|560396468|FG002|Initiation|Physician Decision|0|||
155263431|NCT00279201|560396469|FG003|Initiation|Physician Decision|0|||
155263432|NCT00279201|560396470|FG004|Initiation|Physician Decision|0|||
155263433|NCT00279201|560396471|FG005|Initiation|Physician Decision|0|||
155263434|NCT00279201|560396466|FG000|Initiation|Sponsor Decision|13|||
155263435|NCT00279201|560396467|FG001|Initiation|Sponsor Decision|5|||
155263436|NCT00279201|560396468|FG002|Initiation|Sponsor Decision|0|||
155263437|NCT00279201|560396469|FG003|Initiation|Sponsor Decision|0|||
155263438|NCT00279201|560396470|FG004|Initiation|Sponsor Decision|0|||
155263439|NCT00279201|560396471|FG005|Initiation|Sponsor Decision|0|||
155263440|NCT00279201|560396466|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263441|NCT00279201|560396467|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
155263442|NCT00279201|560396468|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263443|NCT00279201|560396469|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263444|NCT00279201|560396470|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263445|NCT00279201|560396471|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263446|NCT00279201|560396466|FG000|Maintenance|Lack of Efficacy|32|||
155263447|NCT00279201|560396467|FG001|Maintenance|Lack of Efficacy|30|||
155263448|NCT00279201|560396468|FG002|Maintenance|Lack of Efficacy|0|||
155263449|NCT00279201|560396469|FG003|Maintenance|Lack of Efficacy|0|||
155263450|NCT00279201|560396470|FG004|Maintenance|Lack of Efficacy|0|||
155263451|NCT00279201|560396471|FG005|Maintenance|Lack of Efficacy|0|||
155263452|NCT00279201|560396466|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
155263453|NCT00279201|560396467|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
155263454|NCT00279201|560396468|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263455|NCT00279201|560396469|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263456|NCT00279201|560396470|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263457|NCT00279201|560396471|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263458|NCT00279201|560396466|FG000|Maintenance|Adverse Event|4|||
155263459|NCT00279201|560396467|FG001|Maintenance|Adverse Event|4|||
155263460|NCT00279201|560396468|FG002|Maintenance|Adverse Event|0|||
155263461|NCT00279201|560396469|FG003|Maintenance|Adverse Event|0|||
155263462|NCT00279201|560396470|FG004|Maintenance|Adverse Event|0|||
155263463|NCT00279201|560396471|FG005|Maintenance|Adverse Event|0|||
155263464|NCT00279201|560396466|FG000|Maintenance|Death|4|||
155263465|NCT00279201|560396467|FG001|Maintenance|Death|4|||
155263466|NCT00279201|560396468|FG002|Maintenance|Death|0|||
155263467|NCT00279201|560396469|FG003|Maintenance|Death|0|||
155263468|NCT00279201|560396470|FG004|Maintenance|Death|0|||
155263469|NCT00279201|560396471|FG005|Maintenance|Death|0|||
155263470|NCT00279201|560396466|FG000|Maintenance|Lost to Follow-up|17|||
155263471|NCT00279201|560396467|FG001|Maintenance|Lost to Follow-up|13|||
155263472|NCT00279201|560396468|FG002|Maintenance|Lost to Follow-up|0|||
155263473|NCT00279201|560396469|FG003|Maintenance|Lost to Follow-up|0|||
155263474|NCT00279201|560396470|FG004|Maintenance|Lost to Follow-up|0|||
155263475|NCT00279201|560396471|FG005|Maintenance|Lost to Follow-up|0|||
155263476|NCT00279201|560396466|FG000|Maintenance|Entry Criteria Exclusion|1|||
155263477|NCT00279201|560396467|FG001|Maintenance|Entry Criteria Exclusion|4|||
155263478|NCT00279201|560396468|FG002|Maintenance|Entry Criteria Exclusion|0|||
155263479|NCT00279201|560396469|FG003|Maintenance|Entry Criteria Exclusion|0|||
155263480|NCT00279201|560396470|FG004|Maintenance|Entry Criteria Exclusion|0|||
155263481|NCT00279201|560396471|FG005|Maintenance|Entry Criteria Exclusion|0|||
155263482|NCT00279201|560396466|FG000|Maintenance|Protocol Violation|16|||
155263483|NCT00279201|560396467|FG001|Maintenance|Protocol Violation|24|||
155263484|NCT00279201|560396468|FG002|Maintenance|Protocol Violation|0|||
155263485|NCT00279201|560396469|FG003|Maintenance|Protocol Violation|0|||
155263486|NCT00279201|560396470|FG004|Maintenance|Protocol Violation|0|||
155263487|NCT00279201|560396471|FG005|Maintenance|Protocol Violation|0|||
155263488|NCT00279201|560396466|FG000|Maintenance|Withdrawal by Subject|18|||
155263489|NCT00279201|560396467|FG001|Maintenance|Withdrawal by Subject|18|||
155263490|NCT00279201|560396468|FG002|Maintenance|Withdrawal by Subject|0|||
155263491|NCT00279201|560396469|FG003|Maintenance|Withdrawal by Subject|0|||
155263492|NCT00279201|560396470|FG004|Maintenance|Withdrawal by Subject|0|||
155263493|NCT00279201|560396471|FG005|Maintenance|Withdrawal by Subject|0|||
155263494|NCT00279201|560396466|FG000|Maintenance|Physician Decision|9|||
155263495|NCT00279201|560396467|FG001|Maintenance|Physician Decision|9|||
155263496|NCT00279201|560396468|FG002|Maintenance|Physician Decision|0|||
155263497|NCT00279201|560396469|FG003|Maintenance|Physician Decision|0|||
155263498|NCT00279201|560396470|FG004|Maintenance|Physician Decision|0|||
155263499|NCT00279201|560396471|FG005|Maintenance|Physician Decision|0|||
155263500|NCT00279201|560396466|FG000|Maintenance|Sponsor Decision|4|||
155263501|NCT00279201|560396467|FG001|Maintenance|Sponsor Decision|0|||
155263502|NCT00279201|560396468|FG002|Maintenance|Sponsor Decision|0|||
155263503|NCT00279201|560396469|FG003|Maintenance|Sponsor Decision|0|||
155263504|NCT00279201|560396470|FG004|Maintenance|Sponsor Decision|0|||
155263505|NCT00279201|560396471|FG005|Maintenance|Sponsor Decision|0|||
155263506|NCT00279201|560396466|FG000|Maintenance|HbA1c>7.5%|123|||
155263507|NCT00279201|560396467|FG001|Maintenance|HbA1c>7.5%|126|||
155263508|NCT00279201|560396468|FG002|Maintenance|HbA1c>7.5%|0|||
155263509|NCT00279201|560396469|FG003|Maintenance|HbA1c>7.5%|0|||
155263510|NCT00279201|560396470|FG004|Maintenance|HbA1c>7.5%|0|||
155263511|NCT00279201|560396471|FG005|Maintenance|HbA1c>7.5%|0|||
155263512|NCT00279201|560396466|FG000|Intensification Addendum|Withdrawal by Subject|0|||
155263513|NCT00279201|560396467|FG001|Intensification Addendum|Withdrawal by Subject|0|||
155263514|NCT00279201|560396468|FG002|Intensification Addendum|Withdrawal by Subject|12|||
155263515|NCT00279201|560396469|FG003|Intensification Addendum|Withdrawal by Subject|14|||
155263516|NCT00279201|560396470|FG004|Intensification Addendum|Withdrawal by Subject|9|||
155263517|NCT00279201|560396471|FG005|Intensification Addendum|Withdrawal by Subject|18|||
155263518|NCT00279201|560396466|FG000|Intensification Addendum|Lost to Follow-up|0|||
155263519|NCT00279201|560396467|FG001|Intensification Addendum|Lost to Follow-up|0|||
155263520|NCT00279201|560396468|FG002|Intensification Addendum|Lost to Follow-up|4|||
155263521|NCT00279201|560396469|FG003|Intensification Addendum|Lost to Follow-up|6|||
155263522|NCT00279201|560396470|FG004|Intensification Addendum|Lost to Follow-up|7|||
155263523|NCT00279201|560396471|FG005|Intensification Addendum|Lost to Follow-up|7|||
155263524|NCT00279201|560396466|FG000|Intensification Addendum|Protocol Violation|0|||
155263525|NCT00279201|560396467|FG001|Intensification Addendum|Protocol Violation|0|||
155263526|NCT00279201|560396468|FG002|Intensification Addendum|Protocol Violation|2|||
155263527|NCT00279201|560396469|FG003|Intensification Addendum|Protocol Violation|2|||
155263528|NCT00279201|560396470|FG004|Intensification Addendum|Protocol Violation|6|||
155263529|NCT00279201|560396471|FG005|Intensification Addendum|Protocol Violation|6|||
155263530|NCT00279201|560396466|FG000|Intensification Addendum|Adverse Event|0|||
155263531|NCT00279201|560396467|FG001|Intensification Addendum|Adverse Event|0|||
155263532|NCT00279201|560396468|FG002|Intensification Addendum|Adverse Event|0|||
155263533|NCT00279201|560396469|FG003|Intensification Addendum|Adverse Event|4|||
155263534|NCT00279201|560396470|FG004|Intensification Addendum|Adverse Event|1|||
155263535|NCT00279201|560396471|FG005|Intensification Addendum|Adverse Event|3|||
155263536|NCT00279201|560396466|FG000|Intensification Addendum|Physician Decision|0|||
155263537|NCT00279201|560396467|FG001|Intensification Addendum|Physician Decision|0|||
155263538|NCT00279201|560396468|FG002|Intensification Addendum|Physician Decision|4|||
155263539|NCT00279201|560396469|FG003|Intensification Addendum|Physician Decision|1|||
155263540|NCT00279201|560396470|FG004|Intensification Addendum|Physician Decision|3|||
155263541|NCT00279201|560396471|FG005|Intensification Addendum|Physician Decision|2|||
155263542|NCT00279201|560396466|FG000|Intensification Addendum|Sponsor Decision|0|||
155263543|NCT00279201|560396467|FG001|Intensification Addendum|Sponsor Decision|0|||
155263544|NCT00279201|560396468|FG002|Intensification Addendum|Sponsor Decision|0|||
155263545|NCT00279201|560396469|FG003|Intensification Addendum|Sponsor Decision|0|||
155263546|NCT00279201|560396470|FG004|Intensification Addendum|Sponsor Decision|1|||
155263547|NCT00279201|560396471|FG005|Intensification Addendum|Sponsor Decision|1|||
155263548|NCT00279201|560396466|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
155263549|NCT00279201|560396467|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
155263550|NCT00279201|560396468|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
155263551|NCT00279201|560396469|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
155263552|NCT00279201|560396470|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
155263553|NCT00279201|560396471|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
155263554|NCT00279201|560396466|FG000|Intensification Addendum|Lack of Efficacy|0|||
155263555|NCT00279201|560396467|FG001|Intensification Addendum|Lack of Efficacy|0|||
155263556|NCT00279201|560396468|FG002|Intensification Addendum|Lack of Efficacy|0|||
155263557|NCT00279201|560396469|FG003|Intensification Addendum|Lack of Efficacy|1|||
155263558|NCT00279201|560396470|FG004|Intensification Addendum|Lack of Efficacy|1|||
155263559|NCT00279201|560396471|FG005|Intensification Addendum|Lack of Efficacy|0|||
155263560|NCT00279201|560396466|FG000|Intensification Addendum|Death|0|||
155263561|NCT00279201|560396467|FG001|Intensification Addendum|Death|0|||
155263562|NCT00279201|560396468|FG002|Intensification Addendum|Death|0|||
155263563|NCT00279201|560396469|FG003|Intensification Addendum|Death|0|||
155263564|NCT00279201|560396470|FG004|Intensification Addendum|Death|1|||
155263565|NCT00279201|560396471|FG005|Intensification Addendum|Death|0|||
155263566|NCT02272725|560396475|FG000|Overall Study|equipment malfunction|2|||
155263567|NCT02272725|560396476|FG001|Overall Study|equipment malfunction|0|||
155263568|NCT01816763|560398163|FG000|Overall Study|The main reason for an incomplete survey|4|||
155263569|NCT01816763|560398164|FG001|Overall Study|The main reason for an incomplete survey|15|||
155263570|NCT01816763|560398165|FG002|Overall Study|The main reason for an incomplete survey|11|||
155263571|NCT01373931|560398172|FG000|Lead-in Period|Adverse Event|2|||
155263572|NCT01373931|560398173|FG001|Lead-in Period|Adverse Event|0|||
155263573|NCT01373931|560398172|FG000|Period 1|Adverse Event|2|||
155263574|NCT01373931|560398173|FG001|Period 1|Adverse Event|0|||
155263575|NCT01373931|560398172|FG000|Period 1|Withdrawal by Subject|0|||
155263576|NCT01373931|560398173|FG001|Period 1|Withdrawal by Subject|2|||
155263577|NCT00742079|560398174|FG000|Overall Study|Lost to Follow-up|0|||
155263578|NCT00742079|560398175|FG001|Overall Study|Lost to Follow-up|1|||
155263579|NCT00991341|560398176|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
155263580|NCT00991341|560398177|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
155263581|NCT00991341|560398176|FG000|Overall Study|Death|3|||
155263582|NCT00991341|560398177|FG001|Overall Study|Death|0|||
155263583|NCT00991341|560398176|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
155263584|NCT00991341|560398177|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
155263585|NCT00991341|560398176|FG000|Overall Study|Physician Decision|1|||
155263586|NCT00991341|560398177|FG001|Overall Study|Physician Decision|2|||
155263587|NCT00991341|560398176|FG000|Overall Study|Withdrawal by Subject|3|||
155263588|NCT00991341|560398177|FG001|Overall Study|Withdrawal by Subject|4|||
155263589|NCT04461795|560398179|FG000|Overall Study|Lost to Follow-up|2|||
155263590|NCT04461795|560398179|FG000|Overall Study|Withdrawal by Subject|2|||
155263591|NCT04461795|560398179|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
155263592|NCT00615264|560398180|FG000|Overall Study|Withdrawal by Subject|17|||
155263593|NCT00615264|560398181|FG001|Overall Study|Withdrawal by Subject|19|||
155263594|NCT00615264|560398180|FG000|Overall Study|Lost to Follow-up|6|||
155263595|NCT00615264|560398181|FG001|Overall Study|Lost to Follow-up|13|||
155263596|NCT00615264|560398180|FG000|Overall Study|Adverse Event|8|||
155263597|NCT00615264|560398181|FG001|Overall Study|Adverse Event|5|||
155263598|NCT00615264|560398180|FG000|Overall Study|Death|1|||
155263599|NCT00615264|560398181|FG001|Overall Study|Death|1|||
155263600|NCT00615264|560398180|FG000|Overall Study|Protocol Violation|11|||
155263601|NCT00615264|560398181|FG001|Overall Study|Protocol Violation|7|||
155263602|NCT00615264|560398180|FG000|Overall Study|Not defined|7|||
155263603|NCT00615264|560398181|FG001|Overall Study|Not defined|4|||
155263604|NCT00615264|560398180|FG000|Overall Study|Dermal Hypersensitivity|0|||
155263605|NCT00615264|560398181|FG001|Overall Study|Dermal Hypersensitivity|3|||
155263606|NCT00058422|560398182|FG000|Overall Study|Not treated|2|||
155263607|NCT00185640|560398183|FG000|Overall Study|Not Eligible|4|||
155263608|NCT00185640|560398183|FG000|Overall Study|Withdrawal by Subject|3|||
155263609|NCT00185640|560398183|FG000|Overall Study|Death|138|||
155263610|NCT02396537|560398192|FG000|Overall Study|Protocol Violation|0|||
155263611|NCT02396537|560398193|FG001|Overall Study|Protocol Violation|1|||
155263612|NCT01982435|560398194|FG000|Overall Study|Adverse Event|1|||
155263613|NCT01982435|560398195|FG001|Overall Study|Adverse Event|0|||
155263614|NCT00871403|560398196|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
155263615|NCT00871403|560398197|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
155263616|NCT00871403|560398198|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
155263617|NCT00871403|560398196|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
155263618|NCT00871403|560398197|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
155263619|NCT00871403|560398198|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
155263620|NCT00871403|560398196|FG000|Combination Treatment Phase|Adverse Event|0|||
155263621|NCT00871403|560398197|FG001|Combination Treatment Phase|Adverse Event|17|||
155263622|NCT00871403|560398198|FG002|Combination Treatment Phase|Adverse Event|2|||
155263623|NCT00871403|560398196|FG000|Combination Treatment Phase|Disease Progression|0|||
155263624|NCT00871403|560398197|FG001|Combination Treatment Phase|Disease Progression|8|||
155263625|NCT00871403|560398198|FG002|Combination Treatment Phase|Disease Progression|5|||
155263626|NCT00871403|560398196|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
155263627|NCT00871403|560398197|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
155263628|NCT00871403|560398198|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
155263629|NCT00871403|560398196|FG000|Combination Treatment Phase|Physician Decision|0|||
155263630|NCT00871403|560398197|FG001|Combination Treatment Phase|Physician Decision|1|||
155263631|NCT00871403|560398198|FG002|Combination Treatment Phase|Physician Decision|3|||
155263632|NCT00871403|560398196|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
155263633|NCT00871403|560398197|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
155263634|NCT00871403|560398198|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
155263635|NCT00871403|560398196|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
155263636|NCT00871403|560398197|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
155263637|NCT00871403|560398198|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
155263638|NCT00708435|560398202|FG000|Overall Study|Death / Serious Adverse Event|10|||
155263639|NCT00708435|560398203|FG001|Overall Study|Death / Serious Adverse Event|5|||
155263640|NCT00708435|560398202|FG000|Overall Study|Lost to Follow-up|9|||
155263641|NCT00708435|560398203|FG001|Overall Study|Lost to Follow-up|4|||
155263642|NCT00708435|560398202|FG000|Overall Study|Withdrawal by Subject|3|||
155263643|NCT00708435|560398203|FG001|Overall Study|Withdrawal by Subject|7|||
155263644|NCT00708435|560398202|FG000|Overall Study|Adverse Event|1|||
155263645|NCT00708435|560398203|FG001|Overall Study|Adverse Event|0|||
155263646|NCT00708435|560398202|FG000|Overall Study|Protocol Violation|0|||
155263647|NCT00708435|560398203|FG001|Overall Study|Protocol Violation|1|||
155263648|NCT00708435|560398202|FG000|Overall Study|Intervention by primary care physician|1|||
155263649|NCT00708435|560398203|FG001|Overall Study|Intervention by primary care physician|0|||
155263650|NCT00708435|560398202|FG000|Overall Study|Refused hospitalization|1|||
155263651|NCT00708435|560398203|FG001|Overall Study|Refused hospitalization|0|||
155263652|NCT01691521|560398204|FG000|Overall Study|Adverse Event|4|||
155263653|NCT01691521|560398205|FG001|Overall Study|Adverse Event|0|||
155263654|NCT01691521|560398206|FG002|Overall Study|Adverse Event|1|||
155263655|NCT01691521|560398204|FG000|Overall Study|Lack of Efficacy|1|||
155263656|NCT01691521|560398205|FG001|Overall Study|Lack of Efficacy|1|||
155263657|NCT01691521|560398206|FG002|Overall Study|Lack of Efficacy|2|||
155263658|NCT01691521|560398204|FG000|Overall Study|Protocol Violation|0|||
155263659|NCT01691521|560398205|FG001|Overall Study|Protocol Violation|3|||
155263660|NCT01691521|560398206|FG002|Overall Study|Protocol Violation|0|||
155263661|NCT01691521|560398204|FG000|Overall Study|Lost to Follow-up|0|||
155263662|NCT01691521|560398205|FG001|Overall Study|Lost to Follow-up|2|||
155263663|NCT01691521|560398206|FG002|Overall Study|Lost to Follow-up|2|||
155263664|NCT01691521|560398204|FG000|Overall Study|Physician Decision|2|||
155263665|NCT01691521|560398205|FG001|Overall Study|Physician Decision|1|||
155263666|NCT01691521|560398206|FG002|Overall Study|Physician Decision|0|||
155263667|NCT01691521|560398204|FG000|Overall Study|Withdrawal by Subject|5|||
155263668|NCT01691521|560398205|FG001|Overall Study|Withdrawal by Subject|9|||
155263669|NCT01691521|560398206|FG002|Overall Study|Withdrawal by Subject|4|||
155263670|NCT03954743|560398207|FG000|Overall Study|Adverse Event|1|||
155263671|NCT03954743|560398208|FG001|Overall Study|Adverse Event|0|||
155263672|NCT03954743|560398207|FG000|Overall Study|Lost to Follow-up|6|||
155263673|NCT03954743|560398208|FG001|Overall Study|Lost to Follow-up|4|||
155263674|NCT03954743|560398207|FG000|Overall Study|Protocol Violation|1|||
155263675|NCT03954743|560398208|FG001|Overall Study|Protocol Violation|0|||
155263676|NCT03954743|560398207|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
155263677|NCT03954743|560398208|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
155263678|NCT03954743|560398207|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155263679|NCT03954743|560398208|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155263680|NCT02281760|560398209|FG000|Overall Study|Withdrawal by Subject|1|||
155263681|NCT00860067|560398210|FG000|Overall Study|Lost to Follow-up|46|||
155263682|NCT00860067|560398211|FG001|Overall Study|Lost to Follow-up|9|||
155263683|NCT00860067|560398212|FG002|Overall Study|Lost to Follow-up|9|||
155263684|NCT00860067|560398210|FG000|Overall Study|Withdrawal by Subject|4|||
155263685|NCT00860067|560398211|FG001|Overall Study|Withdrawal by Subject|0|||
155263686|NCT00860067|560398212|FG002|Overall Study|Withdrawal by Subject|0|||
155263687|NCT00860067|560398210|FG000|Overall Study|Pregnancy|1|||
155263688|NCT00860067|560398211|FG001|Overall Study|Pregnancy|0|||
155263689|NCT00860067|560398212|FG002|Overall Study|Pregnancy|0|||
155263690|NCT00100932|560398213|FG000|Overall Study|Adverse Event|11|||
155263691|NCT00100932|560398214|FG001|Overall Study|Adverse Event|2|||
155607095|NCT02943785|561649633|FG001|Overall Study|Withdrawal by Subject|126|||
155607096|NCT02943785|561649632|FG000|Overall Study|Physician Decision|23|||
155607097|NCT02943785|561649633|FG001|Overall Study|Physician Decision|47|||
155607098|NCT02943785|561649632|FG000|Overall Study|Death|46|||
155607099|NCT02943785|561649633|FG001|Overall Study|Death|46|||
155607100|NCT02943785|561649632|FG000|Overall Study|Lost to Follow-up|1|||
155607101|NCT02943785|561649633|FG001|Overall Study|Lost to Follow-up|0|||
155607102|NCT02943785|561649632|FG000|Overall Study|Other|16|||
155607103|NCT02943785|561649633|FG001|Overall Study|Other|19|||
155263692|NCT00100932|560398213|FG000|Overall Study|Withdrawal by Subject|6|||
155607104|NCT02943785|561649632|FG000|Overall Study|Did not receive any study medication|21|||
155607105|NCT02943785|561649633|FG001|Overall Study|Did not receive any study medication|28|||
155607106|NCT01281956|561649636|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
155607107|NCT01281956|561649637|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
155607108|NCT01904903|561649648|FG000|Overall Study|Withdrawal by Subject|1|||
155607109|NCT03578146|561649649|FG000|Overall Study|Did Not Receive Treatment|1|||
155607110|NCT03578146|561649650|FG001|Overall Study|Did Not Receive Treatment|0|||
155263693|NCT00100932|560398214|FG001|Overall Study|Withdrawal by Subject|0|||
155263694|NCT00100932|560398213|FG000|Overall Study|Progressive Disease|44|||
155263695|NCT00100932|560398214|FG001|Overall Study|Progressive Disease|18|||
155263696|NCT00100932|560398213|FG000|Overall Study|Physician Decision|7|||
155263697|NCT00100932|560398214|FG001|Overall Study|Physician Decision|5|||
155263698|NCT00100932|560398213|FG000|Overall Study|Other|5|||
155263699|NCT00100932|560398214|FG001|Overall Study|Other|2|||
155263700|NCT02387996|560398219|FG000|Overall Study|Disease Progression|167|||
155263701|NCT02387996|560398219|FG000|Overall Study|Study Drug Toxicity|31|||
155263702|NCT02387996|560398219|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
155263703|NCT02387996|560398219|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
155263704|NCT02387996|560398219|FG000|Overall Study|Subject Withdrew Consent|5|||
155263705|NCT02387996|560398219|FG000|Overall Study|Lost to Follow-up|1|||
155263706|NCT02387996|560398219|FG000|Overall Study|Poor/Non-Compliance|1|||
155263707|NCT02387996|560398219|FG000|Overall Study|Other Reasons|5|||
155263708|NCT02387996|560398219|FG000|Overall Study|Death|1|||
155263709|NCT02756832|560398224|FG000|Overall Study|Lost for Observation after Baseline|6|||
155263710|NCT02756832|560398224|FG000|Overall Study|Lost for Observation|13|||
155263711|NCT02756832|560398224|FG000|Overall Study|Patient's Unwillingness|12|||
155263712|NCT02756832|560398224|FG000|Overall Study|Insufficient Efficacy|2|||
155263713|NCT02756832|560398224|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
155263714|NCT02756832|560398224|FG000|Overall Study|Reason not Specified|9|||
155263715|NCT02756832|560398224|FG000|Overall Study|Protocol Deviation|10|||
155263716|NCT00622713|560398225|FG000|Overall Study|Adverse Event|35|||
155263717|NCT00622713|560398225|FG000|Overall Study|Administrative problems|4|||
155263718|NCT00622713|560398225|FG000|Overall Study|Withdrawal by Subject|11|||
155263719|NCT00622713|560398225|FG000|Overall Study|Lost to Follow-up|5|||
155263720|NCT00622713|560398225|FG000|Overall Study|Death|2|||
155263721|NCT00622713|560398225|FG000|Overall Study|Subject no longer required study drug|1|||
155263722|NCT00622713|560398225|FG000|Overall Study|Did not meet eligibility criteria|1|||
155263723|NCT03728972|560398236|FG000|Overall Study|Death|1|||
155263724|NCT03728972|560398237|FG001|Overall Study|Death|0|||
155263725|NCT03728972|560398236|FG000|Overall Study|Lack of Efficacy|1|||
155263726|NCT03728972|560398237|FG001|Overall Study|Lack of Efficacy|0|||
155263727|NCT03728972|560398236|FG000|Overall Study|Physician Decision|3|||
155263728|NCT03728972|560398237|FG001|Overall Study|Physician Decision|0|||
155263729|NCT03728972|560398236|FG000|Overall Study|Disease progression|4|||
155263730|NCT03728972|560398237|FG001|Overall Study|Disease progression|3|||
155263731|NCT00895622|560398245|FG000|Overall Study|Protocol Violation|5|||
155263732|NCT00895622|560398246|FG001|Overall Study|Protocol Violation|4|||
155263733|NCT00895622|560398247|FG002|Overall Study|Protocol Violation|4|||
155263734|NCT03635489|560398251|FG000|Overall Study|Death|19|||
155263735|NCT03635489|560398252|FG001|Overall Study|Death|13|||
155263736|NCT03635489|560398251|FG000|Overall Study|Lost to Follow-up|1|||
155263737|NCT03635489|560398252|FG001|Overall Study|Lost to Follow-up|2|||
155263738|NCT03635489|560398251|FG000|Overall Study|Withdrawal by Subject|1|||
155263739|NCT03635489|560398252|FG001|Overall Study|Withdrawal by Subject|2|||
155263740|NCT03635489|560398251|FG000|Overall Study|Study Ended by Sponsor|28|||
155263741|NCT03635489|560398252|FG001|Overall Study|Study Ended by Sponsor|34|||
155263742|NCT02010632|560398253|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
155263743|NCT02010632|560398254|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
155263744|NCT01547299|560398255|FG000|Overall Study|Withdrawal by Subject|2|||
155263745|NCT01547299|560398256|FG001|Overall Study|Withdrawal by Subject|2|||
155263746|NCT01987817|560398257|FG000|Overall Study|Adverse Event|4|||
155263747|NCT01987817|560398258|FG001|Overall Study|Adverse Event|0|||
155263748|NCT01987817|560398257|FG000|Overall Study|Withdrawal by Subject|1|||
155263749|NCT01987817|560398258|FG001|Overall Study|Withdrawal by Subject|1|||
155263750|NCT01987817|560398257|FG000|Overall Study|Physician Decision|1|||
155263751|NCT01987817|560398258|FG001|Overall Study|Physician Decision|0|||
155263752|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
155263753|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263754|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263755|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263756|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263757|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263758|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263759|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
155263760|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263761|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263762|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263763|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263764|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263765|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263766|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
155263767|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263768|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263769|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263770|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263771|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263772|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263773|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
155263774|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263775|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263776|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263777|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263778|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263779|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263780|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
155263781|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263782|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263783|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263784|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263785|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263786|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263787|NCT01576718|560398261|FG000|Treatment Period|Adverse Event|0|||
155263788|NCT01576718|560398262|FG001|Treatment Period|Adverse Event|1|||
155263789|NCT01576718|560398263|FG002|Treatment Period|Adverse Event|1|||
155263790|NCT01576718|560398264|FG003|Treatment Period|Adverse Event|1|||
155263791|NCT01576718|560398265|FG004|Treatment Period|Adverse Event|1|||
155263792|NCT01576718|560398266|FG005|Treatment Period|Adverse Event|1|||
155263793|NCT01576718|560398267|FG006|Treatment Period|Adverse Event|0|||
155263794|NCT01576718|560398261|FG000|Treatment Period|Withdrawal by Subject|0|||
155263795|NCT01576718|560398262|FG001|Treatment Period|Withdrawal by Subject|1|||
155263796|NCT01576718|560398263|FG002|Treatment Period|Withdrawal by Subject|1|||
155263797|NCT01576718|560398264|FG003|Treatment Period|Withdrawal by Subject|0|||
155263798|NCT01576718|560398265|FG004|Treatment Period|Withdrawal by Subject|2|||
155263799|NCT01576718|560398266|FG005|Treatment Period|Withdrawal by Subject|4|||
155263800|NCT01576718|560398267|FG006|Treatment Period|Withdrawal by Subject|2|||
155263801|NCT01576718|560398261|FG000|Treatment Period|Physician Decision|0|||
155263802|NCT01576718|560398262|FG001|Treatment Period|Physician Decision|1|||
155263803|NCT01576718|560398263|FG002|Treatment Period|Physician Decision|1|||
155263804|NCT01576718|560398264|FG003|Treatment Period|Physician Decision|1|||
155263805|NCT01576718|560398265|FG004|Treatment Period|Physician Decision|1|||
155263806|NCT01576718|560398266|FG005|Treatment Period|Physician Decision|0|||
155263807|NCT01576718|560398267|FG006|Treatment Period|Physician Decision|0|||
155263808|NCT01576718|560398261|FG000|Treatment Period|Protocol Violation|0|||
155263809|NCT01576718|560398262|FG001|Treatment Period|Protocol Violation|5|||
155263810|NCT01576718|560398263|FG002|Treatment Period|Protocol Violation|4|||
155263811|NCT01576718|560398264|FG003|Treatment Period|Protocol Violation|10|||
155263812|NCT01576718|560398265|FG004|Treatment Period|Protocol Violation|6|||
155263813|NCT01576718|560398266|FG005|Treatment Period|Protocol Violation|8|||
155263814|NCT01576718|560398267|FG006|Treatment Period|Protocol Violation|12|||
155263815|NCT01576718|560398261|FG000|Treatment Period|Sponsor request|0|||
155263816|NCT01576718|560398262|FG001|Treatment Period|Sponsor request|1|||
155263817|NCT01576718|560398263|FG002|Treatment Period|Sponsor request|0|||
155263818|NCT01576718|560398264|FG003|Treatment Period|Sponsor request|0|||
155263819|NCT01576718|560398265|FG004|Treatment Period|Sponsor request|0|||
155263820|NCT01576718|560398266|FG005|Treatment Period|Sponsor request|1|||
155263821|NCT01576718|560398267|FG006|Treatment Period|Sponsor request|0|||
155263822|NCT01576718|560398261|FG000|Treatment Period|Met stopping criteria|0|||
155263823|NCT01576718|560398262|FG001|Treatment Period|Met stopping criteria|16|||
155263824|NCT01576718|560398263|FG002|Treatment Period|Met stopping criteria|13|||
155263825|NCT01576718|560398264|FG003|Treatment Period|Met stopping criteria|19|||
155263826|NCT01576718|560398265|FG004|Treatment Period|Met stopping criteria|16|||
155263827|NCT01576718|560398266|FG005|Treatment Period|Met stopping criteria|33|||
155263828|NCT01576718|560398267|FG006|Treatment Period|Met stopping criteria|15|||
155607111|NCT03578146|561649651|FG002|Overall Study|Did Not Receive Treatment|0|||
155607112|NCT03578146|561649652|FG003|Overall Study|Did Not Receive Treatment|0|||
155263829|NCT01576718|560398261|FG000|Treatment Period|Lost to Follow-up|0|||
155263830|NCT01576718|560398262|FG001|Treatment Period|Lost to Follow-up|0|||
155263831|NCT01576718|560398263|FG002|Treatment Period|Lost to Follow-up|0|||
155263832|NCT01576718|560398264|FG003|Treatment Period|Lost to Follow-up|0|||
155263833|NCT01576718|560398265|FG004|Treatment Period|Lost to Follow-up|1|||
155263834|NCT01576718|560398266|FG005|Treatment Period|Lost to Follow-up|0|||
155263835|NCT01576718|560398267|FG006|Treatment Period|Lost to Follow-up|0|||
155263836|NCT01576718|560398261|FG000|Treatment Period|Noncompliance to study medication|0|||
155263837|NCT01576718|560398262|FG001|Treatment Period|Noncompliance to study medication|0|||
155263838|NCT01576718|560398263|FG002|Treatment Period|Noncompliance to study medication|0|||
155263839|NCT01576718|560398264|FG003|Treatment Period|Noncompliance to study medication|0|||
155263840|NCT01576718|560398265|FG004|Treatment Period|Noncompliance to study medication|0|||
155263841|NCT01576718|560398266|FG005|Treatment Period|Noncompliance to study medication|1|||
155263842|NCT01576718|560398267|FG006|Treatment Period|Noncompliance to study medication|1|||
155263843|NCT01874145|560398268|FG000|Core Period|Non-compliance|1|||
155263844|NCT01874145|560398269|FG001|Core Period|Non-compliance|0|||
155263845|NCT01874145|560398268|FG000|Core Period|Protocol Violation|1|||
155263846|NCT01874145|560398269|FG001|Core Period|Protocol Violation|1|||
155263847|NCT01874145|560398268|FG000|Core Period|Physician Decision|1|||
155263848|NCT01874145|560398269|FG001|Core Period|Physician Decision|1|||
155263849|NCT01874145|560398268|FG000|Core Period|Adverse Event|0|||
155263850|NCT01874145|560398269|FG001|Core Period|Adverse Event|1|||
155263851|NCT01874145|560398268|FG000|Core Period|Withdrawal by Subject|0|||
155263852|NCT01874145|560398269|FG001|Core Period|Withdrawal by Subject|4|||
155263853|NCT01874145|560398268|FG000|Extension Period|Adverse Event|3|||
155263854|NCT01874145|560398269|FG001|Extension Period|Adverse Event|2|||
155263855|NCT01874145|560398268|FG000|Extension Period|Withdrawal by Subject|2|||
155263856|NCT01874145|560398269|FG001|Extension Period|Withdrawal by Subject|1|||
155263857|NCT01874145|560398268|FG000|Extension Period|Lost to Follow-up|1|||
155263858|NCT01874145|560398269|FG001|Extension Period|Lost to Follow-up|1|||
155263859|NCT04631705|560398270|FG000|Overall Study|Withdrawal by Subject|0|||
155263860|NCT04631705|560398271|FG001|Overall Study|Withdrawal by Subject|0|||
155263861|NCT04631705|560398272|FG002|Overall Study|Withdrawal by Subject|0|||
155263862|NCT04631705|560398273|FG003|Overall Study|Withdrawal by Subject|0|||
155263863|NCT04631705|560398274|FG004|Overall Study|Withdrawal by Subject|0|||
155263864|NCT04631705|560398275|FG005|Overall Study|Withdrawal by Subject|0|||
155263865|NCT04631705|560398276|FG006|Overall Study|Withdrawal by Subject|1|||
155263866|NCT04631705|560398277|FG007|Overall Study|Withdrawal by Subject|0|||
155263867|NCT04631705|560398278|FG008|Overall Study|Withdrawal by Subject|0|||
155263868|NCT06387472|560398286|FG000|Overall Study|Withdrawal by Subject|1|||
155263869|NCT06387472|560398286|FG000|Overall Study|Lost to Follow-up|2|||
155263870|NCT06387472|560398286|FG000|Overall Study|Physician Decision|1|||
155263871|NCT04182880|560398287|FG000|Overall Study|Pregnancy|1|||
155263872|NCT04182880|560398288|FG001|Overall Study|Pregnancy|0|||
155263873|NCT02036645|560398289|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263874|NCT02036645|560398290|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263875|NCT02036645|560398291|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263876|NCT02036645|560398292|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263877|NCT02036645|560398293|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263878|NCT02036645|560398294|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263879|NCT02036645|560398295|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
155263880|NCT02036645|560398296|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263881|NCT02036645|560398297|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263882|NCT02036645|560398298|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263883|NCT02036645|560398299|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263884|NCT02036645|560398300|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263885|NCT02036645|560398289|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263886|NCT02036645|560398290|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263887|NCT02036645|560398291|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263888|NCT02036645|560398292|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
155263889|NCT02036645|560398293|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263890|NCT02036645|560398294|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263891|NCT02036645|560398295|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263892|NCT02036645|560398296|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263893|NCT02036645|560398297|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263894|NCT02036645|560398298|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263895|NCT02036645|560398299|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263896|NCT02036645|560398300|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263897|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
155263898|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
155263899|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
155263900|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
155263901|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
155263902|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
155263903|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
155263904|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
155263905|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
155263906|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
155263907|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
155263908|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
155263909|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
155263910|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
155263911|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
155263912|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
155263913|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
155263914|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
155263915|NCT01806584|560398315|FG000|Overall Study|Adverse Event|2|||
155263916|NCT01806584|560398316|FG001|Overall Study|Adverse Event|1|||
155263917|NCT01806584|560398315|FG000|Overall Study|Death|1|||
155263918|NCT01806584|560398316|FG001|Overall Study|Death|0|||
155263919|NCT01806584|560398315|FG000|Overall Study|Lost to Follow-up|0|||
155263920|NCT01806584|560398316|FG001|Overall Study|Lost to Follow-up|2|||
155263921|NCT01806584|560398315|FG000|Overall Study|Study terminated by sponsor|9|||
155263922|NCT01806584|560398316|FG001|Overall Study|Study terminated by sponsor|14|||
155263923|NCT01806584|560398315|FG000|Overall Study|Withdrawal by Subject|1|||
155263924|NCT01806584|560398316|FG001|Overall Study|Withdrawal by Subject|1|||
155263925|NCT01806584|560398315|FG000|Overall Study|Other unspecified|1|||
155263926|NCT01806584|560398316|FG001|Overall Study|Other unspecified|0|||
155263927|NCT03995784|560398321|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
155263928|NCT04739761|560398325|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
155263929|NCT04739761|560398326|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
155263930|NCT04739761|560398325|FG000|Overall Study|By complete response from the participant|1|||
155263931|NCT04739761|560398326|FG001|Overall Study|By complete response from the participant|0|||
155607113|NCT03578146|561649653|FG004|Overall Study|Did Not Receive Treatment|0|||
155607114|NCT03578146|561649654|FG005|Overall Study|Did Not Receive Treatment|2|||
155607115|NCT03578146|561649649|FG000|Overall Study|Lost to Follow-up|0|||
155263932|NCT04739761|560398325|FG000|Overall Study|Lost to Follow-up|3|||
155263933|NCT04739761|560398326|FG001|Overall Study|Lost to Follow-up|3|||
155607116|NCT03578146|561649650|FG001|Overall Study|Lost to Follow-up|1|||
155607117|NCT03578146|561649651|FG002|Overall Study|Lost to Follow-up|1|||
155607118|NCT03578146|561649652|FG003|Overall Study|Lost to Follow-up|0|||
155607119|NCT03578146|561649653|FG004|Overall Study|Lost to Follow-up|0|||
155607120|NCT03578146|561649654|FG005|Overall Study|Lost to Follow-up|1|||
155607121|NCT01634659|561649659|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
155263934|NCT04739761|560398325|FG000|Overall Study|Death|13|||
155263935|NCT04739761|560398326|FG001|Overall Study|Death|13|||
155263936|NCT04739761|560398325|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
155263937|NCT04739761|560398326|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
155263938|NCT04739761|560398325|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
155263939|NCT04739761|560398326|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
155263940|NCT04739761|560398325|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
155263941|NCT04739761|560398326|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
155263942|NCT04739761|560398325|FG000|Overall Study|Adverse Event|0|||
155263943|NCT04739761|560398326|FG001|Overall Study|Adverse Event|3|||
155263944|NCT04739761|560398325|FG000|Overall Study|Participant decision|1|||
155263945|NCT04739761|560398326|FG001|Overall Study|Participant decision|0|||
155263946|NCT04739761|560398325|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
155263947|NCT04739761|560398326|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
155263948|NCT04739761|560398325|FG000|Overall Study|Participant immediately started next line of treatment|1|||
155263949|NCT04739761|560398326|FG001|Overall Study|Participant immediately started next line of treatment|0|||
155263950|NCT04739761|560398325|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
155263951|NCT04739761|560398326|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
155263952|NCT04739761|560398325|FG000|Overall Study|Lack of clinical benefit|1|||
155263953|NCT04739761|560398326|FG001|Overall Study|Lack of clinical benefit|0|||
155263954|NCT04739761|560398325|FG000|Overall Study|Disease progression|5|||
155263955|NCT04739761|560398326|FG001|Overall Study|Disease progression|5|||
155263956|NCT04739761|560398325|FG000|Overall Study|Withdrawal by Subject|14|||
155263957|NCT04739761|560398326|FG001|Overall Study|Withdrawal by Subject|13|||
155263958|NCT04739761|560398325|FG000|Overall Study|Protocol Violation|1|||
155263959|NCT04739761|560398326|FG001|Overall Study|Protocol Violation|0|||
155263960|NCT04739761|560398325|FG000|Overall Study|Physician Decision|2|||
155263961|NCT04739761|560398326|FG001|Overall Study|Physician Decision|0|||
155263962|NCT03881696|560398327|FG000|Overall Study|Adverse Event|2|||
155263963|NCT03881696|560398328|FG001|Overall Study|Adverse Event|0|||
155263964|NCT03881696|560398327|FG000|Overall Study|Withdrawal by Subject|2|||
155263965|NCT03881696|560398328|FG001|Overall Study|Withdrawal by Subject|0|||
155263966|NCT03881696|560398327|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
155263967|NCT03881696|560398328|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
155263968|NCT03881696|560398327|FG000|Overall Study|Failure to meet continuation criteria|1|||
155263969|NCT03881696|560398328|FG001|Overall Study|Failure to meet continuation criteria|0|||
155263970|NCT01061333|560398330|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
155263971|NCT01061333|560398331|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
155263972|NCT01186328|560399999|FG000|Overall Study|Death|1|||
155263973|NCT01186328|560400000|FG001|Overall Study|Death|0|||
155263974|NCT01186328|560400001|FG002|Overall Study|Death|0|||
155263975|NCT02202434|560400002|FG000|Overall Study|Death|70|||
155263976|NCT02202434|560400003|FG001|Overall Study|Death|39|||
155263977|NCT02202434|560400004|FG002|Overall Study|Death|13|||
155263978|NCT02202434|560400005|FG003|Overall Study|Death|27|||
155263979|NCT02202434|560400002|FG000|Overall Study|Lost to Follow-up|1|||
155263980|NCT02202434|560400003|FG001|Overall Study|Lost to Follow-up|1|||
155263981|NCT02202434|560400004|FG002|Overall Study|Lost to Follow-up|1|||
155263982|NCT02202434|560400005|FG003|Overall Study|Lost to Follow-up|0|||
155263983|NCT02202434|560400002|FG000|Overall Study|Physician Decision|2|||
155263984|NCT02202434|560400003|FG001|Overall Study|Physician Decision|3|||
155263985|NCT02202434|560400004|FG002|Overall Study|Physician Decision|0|||
155263986|NCT02202434|560400005|FG003|Overall Study|Physician Decision|0|||
155263987|NCT02202434|560400002|FG000|Overall Study|Withdrawal by Subject|13|||
155263988|NCT02202434|560400003|FG001|Overall Study|Withdrawal by Subject|14|||
155263989|NCT02202434|560400004|FG002|Overall Study|Withdrawal by Subject|1|||
155263990|NCT02202434|560400005|FG003|Overall Study|Withdrawal by Subject|4|||
155263991|NCT02202434|560400002|FG000|Overall Study|Completed Study|1|||
155263992|NCT02202434|560400003|FG001|Overall Study|Completed Study|0|||
155263993|NCT02202434|560400004|FG002|Overall Study|Completed Study|0|||
155263994|NCT02202434|560400005|FG003|Overall Study|Completed Study|0|||
155263995|NCT02202434|560400002|FG000|Overall Study|Visit Missed|21|||
155263996|NCT02202434|560400003|FG001|Overall Study|Visit Missed|12|||
155263997|NCT02202434|560400004|FG002|Overall Study|Visit Missed|0|||
155263998|NCT02202434|560400005|FG003|Overall Study|Visit Missed|5|||
155263999|NCT02202434|560400002|FG000|Overall Study|Other|1|||
155264000|NCT02202434|560400003|FG001|Overall Study|Other|0|||
155264001|NCT02202434|560400004|FG002|Overall Study|Other|0|||
155264002|NCT02202434|560400005|FG003|Overall Study|Other|1|||
155264003|NCT04858802|560400006|FG000|Overall Study|Lost to Follow-up|1|||
155264004|NCT04858802|560400007|FG001|Overall Study|Lost to Follow-up|1|||
155264005|NCT04858802|560400006|FG000|Overall Study|Withdrawal by Subject|1|||
155264006|NCT04858802|560400007|FG001|Overall Study|Withdrawal by Subject|1|||
155264007|NCT02714868|560400009|FG000|Overall Study|Withdrawal by Subject|3|||
155264008|NCT02714868|560400010|FG001|Overall Study|Withdrawal by Subject|0|||
155264009|NCT02714868|560400009|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
155264010|NCT02714868|560400010|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
155264011|NCT02714868|560400009|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
155264012|NCT02714868|560400010|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
155264013|NCT00710606|560400016|FG000|Overall Study|Adverse Event|0|||
155264014|NCT00710606|560400017|FG001|Overall Study|Adverse Event|2|||
155264015|NCT02670538|560400020|FG000|Overall Study|Withdrawal of Consent|8|||
155264016|NCT02670538|560400021|FG001|Overall Study|Withdrawal of Consent|6|||
155264017|NCT02670538|560400022|FG002|Overall Study|Withdrawal of Consent|5|||
155264018|NCT02670538|560400020|FG000|Overall Study|Lost to Follow-up|8|||
155264019|NCT02670538|560400021|FG001|Overall Study|Lost to Follow-up|12|||
155264020|NCT02670538|560400022|FG002|Overall Study|Lost to Follow-up|7|||
155264021|NCT02670538|560400020|FG000|Overall Study|Adverse Event|5|||
155264022|NCT02670538|560400021|FG001|Overall Study|Adverse Event|5|||
155264023|NCT02670538|560400022|FG002|Overall Study|Adverse Event|11|||
155264024|NCT02670538|560400020|FG000|Overall Study|Lack of Efficacy|7|||
155264025|NCT02670538|560400021|FG001|Overall Study|Lack of Efficacy|1|||
155264026|NCT02670538|560400022|FG002|Overall Study|Lack of Efficacy|2|||
155264027|NCT02670538|560400020|FG000|Overall Study|Protocol Violation|3|||
155264028|NCT02670538|560400021|FG001|Overall Study|Protocol Violation|4|||
155264029|NCT02670538|560400022|FG002|Overall Study|Protocol Violation|1|||
155264030|NCT02670538|560400020|FG000|Overall Study|Noncompliance with Study Drug|1|||
155264031|NCT02670538|560400021|FG001|Overall Study|Noncompliance with Study Drug|3|||
155264032|NCT02670538|560400022|FG002|Overall Study|Noncompliance with Study Drug|2|||
155264033|NCT02670538|560400020|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155264034|NCT02670538|560400021|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155264035|NCT02670538|560400022|FG002|Overall Study|Other Miscellaneous Reasons|2|||
155264036|NCT05648357|560400023|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
155264042|NCT00674323|560400029|FG000|Overall Study|Adverse Event|0|||
155264043|NCT00674323|560400030|FG001|Overall Study|Adverse Event|1|||
155264044|NCT00674323|560400031|FG002|Overall Study|Adverse Event|0|||
155264045|NCT00674323|560400029|FG000|Overall Study|Protocol Violation|1|||
155264046|NCT00674323|560400030|FG001|Overall Study|Protocol Violation|0|||
155264047|NCT00674323|560400031|FG002|Overall Study|Protocol Violation|0|||
155264048|NCT02243202|560400033|FG000|Overall Study|Adverse Event|5|||
155264049|NCT02243202|560400034|FG001|Overall Study|Adverse Event|6|||
155264050|NCT02243202|560400035|FG002|Overall Study|Adverse Event|10|||
155264051|NCT02243202|560400036|FG003|Overall Study|Adverse Event|4|||
155264052|NCT02243202|560400033|FG000|Overall Study|Lost to Follow-up|9|||
155264053|NCT02243202|560400034|FG001|Overall Study|Lost to Follow-up|9|||
155264054|NCT02243202|560400035|FG002|Overall Study|Lost to Follow-up|14|||
155264055|NCT02243202|560400036|FG003|Overall Study|Lost to Follow-up|11|||
155264056|NCT02243202|560400033|FG000|Overall Study|Protocol Violation|3|||
155264057|NCT02243202|560400034|FG001|Overall Study|Protocol Violation|1|||
155264058|NCT02243202|560400035|FG002|Overall Study|Protocol Violation|2|||
155264059|NCT02243202|560400036|FG003|Overall Study|Protocol Violation|1|||
155264060|NCT02243202|560400033|FG000|Overall Study|Withdrawal by Subject|7|||
155264061|NCT02243202|560400034|FG001|Overall Study|Withdrawal by Subject|6|||
155264062|NCT02243202|560400035|FG002|Overall Study|Withdrawal by Subject|4|||
155264063|NCT02243202|560400036|FG003|Overall Study|Withdrawal by Subject|4|||
155264064|NCT02243202|560400033|FG000|Overall Study|Other|1|||
155264065|NCT02243202|560400034|FG001|Overall Study|Other|3|||
155264066|NCT02243202|560400035|FG002|Overall Study|Other|1|||
155264067|NCT02243202|560400036|FG003|Overall Study|Other|2|||
155264068|NCT02243202|560400033|FG000|Overall Study|Randomized but not received treatment|0|||
155264069|NCT02243202|560400034|FG001|Overall Study|Randomized but not received treatment|0|||
155264070|NCT02243202|560400035|FG002|Overall Study|Randomized but not received treatment|0|||
155264071|NCT02243202|560400036|FG003|Overall Study|Randomized but not received treatment|1|||
155264072|NCT02013388|560400039|FG000|Overall Study|work emergency|1|||
155264073|NCT02013388|560400040|FG001|Overall Study|work emergency|0|||
155264074|NCT02013388|560400041|FG002|Overall Study|work emergency|0|||
155264075|NCT02013388|560400042|FG003|Overall Study|work emergency|0|||
155264076|NCT02013388|560400043|FG004|Overall Study|work emergency|1|||
155264077|NCT02013388|560400044|FG005|Overall Study|work emergency|0|||
155264078|NCT02013388|560400045|FG006|Overall Study|work emergency|0|||
155264079|NCT02013388|560400046|FG007|Overall Study|work emergency|0|||
155264080|NCT02110732|560400061|FG000|Overall Study|Physician Decision|5|||
155264081|NCT02110732|560400062|FG001|Overall Study|Physician Decision|2|||
155264082|NCT02110732|560400061|FG000|Overall Study|Lost to Follow-up|1|||
155264083|NCT02110732|560400062|FG001|Overall Study|Lost to Follow-up|1|||
155264084|NCT00633932|560400063|FG000|Overall Study|Adverse Event|1|||
155264085|NCT00633932|560400064|FG001|Overall Study|Adverse Event|3|||
155264086|NCT00633932|560400065|FG002|Overall Study|Adverse Event|4|||
155264087|NCT00633932|560400063|FG000|Overall Study|Withdrawal by Subject|3|||
155264088|NCT00633932|560400064|FG001|Overall Study|Withdrawal by Subject|9|||
155264089|NCT00633932|560400065|FG002|Overall Study|Withdrawal by Subject|1|||
155264090|NCT00633932|560400063|FG000|Overall Study|Lost to Follow-up|1|||
155264091|NCT00633932|560400064|FG001|Overall Study|Lost to Follow-up|0|||
155264092|NCT00633932|560400065|FG002|Overall Study|Lost to Follow-up|2|||
155264093|NCT00633932|560400063|FG000|Overall Study|Protocol Violation|5|||
155607122|NCT01634659|561649660|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
155607123|NCT01634659|561649659|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
155607124|NCT01634659|561649660|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
155607125|NCT00586508|561649661|FG000|Overall Study|Progressive disease|52|||
155607126|NCT00586508|561649662|FG001|Overall Study|Progressive disease|8|||
155607127|NCT00586508|561649661|FG000|Overall Study|Death|0|||
155607128|NCT00586508|561649662|FG001|Overall Study|Death|1|||
155607129|NCT00586508|561649661|FG000|Overall Study|Adverse Event|12|||
155607130|NCT00586508|561649662|FG001|Overall Study|Adverse Event|4|||
155607131|NCT00586508|561649661|FG000|Overall Study|Withdrawal by Subject|4|||
155607132|NCT00586508|561649662|FG001|Overall Study|Withdrawal by Subject|0|||
155607133|NCT02079636|561649663|FG000|Overall Study|Death|2|||
155607134|NCT02079636|561649664|FG001|Overall Study|Death|1|||
155607135|NCT02079636|561649665|FG002|Overall Study|Death|0|||
155607136|NCT02079636|561649666|FG003|Overall Study|Death|5|||
155607137|NCT02079636|561649667|FG004|Overall Study|Death|1|||
155607138|NCT02079636|561649668|FG005|Overall Study|Death|2|||
155607139|NCT02079636|561649669|FG006|Overall Study|Death|1|||
155607140|NCT02079636|561649670|FG007|Overall Study|Death|0|||
155607141|NCT02079636|561649671|FG008|Overall Study|Death|0|||
155607142|NCT02079636|561649672|FG009|Overall Study|Death|0|||
155607143|NCT02079636|561649673|FG010|Overall Study|Death|0|||
155264094|NCT00633932|560400064|FG001|Overall Study|Protocol Violation|2|||
155264095|NCT00633932|560400065|FG002|Overall Study|Protocol Violation|3|||
155264096|NCT00633932|560400063|FG000|Overall Study|Physician Decision|0|||
155264097|NCT00633932|560400064|FG001|Overall Study|Physician Decision|0|||
155607144|NCT02079636|561649674|FG011|Overall Study|Death|1|||
155607145|NCT02079636|561649675|FG012|Overall Study|Death|1|||
155607146|NCT02079636|561649676|FG013|Overall Study|Death|0|||
155607147|NCT02079636|561649677|FG014|Overall Study|Death|2|||
155607148|NCT02079636|561649663|FG000|Overall Study|Adverse Event|1|||
155607149|NCT02079636|561649664|FG001|Overall Study|Adverse Event|1|||
155607150|NCT02079636|561649665|FG002|Overall Study|Adverse Event|0|||
155607151|NCT02079636|561649666|FG003|Overall Study|Adverse Event|1|||
155607152|NCT02079636|561649667|FG004|Overall Study|Adverse Event|1|||
155607153|NCT02079636|561649668|FG005|Overall Study|Adverse Event|2|||
155607154|NCT02079636|561649669|FG006|Overall Study|Adverse Event|0|||
155607155|NCT02079636|561649670|FG007|Overall Study|Adverse Event|0|||
155607156|NCT02079636|561649671|FG008|Overall Study|Adverse Event|0|||
155607157|NCT02079636|561649672|FG009|Overall Study|Adverse Event|0|||
155607158|NCT02079636|561649673|FG010|Overall Study|Adverse Event|0|||
155607159|NCT02079636|561649674|FG011|Overall Study|Adverse Event|0|||
155607160|NCT02079636|561649675|FG012|Overall Study|Adverse Event|0|||
155607161|NCT02079636|561649676|FG013|Overall Study|Adverse Event|0|||
155607162|NCT02079636|561649677|FG014|Overall Study|Adverse Event|0|||
155607163|NCT02079636|561649663|FG000|Overall Study|Progressive disease|0|||
155607164|NCT02079636|561649664|FG001|Overall Study|Progressive disease|0|||
155607165|NCT02079636|561649665|FG002|Overall Study|Progressive disease|0|||
155607166|NCT02079636|561649666|FG003|Overall Study|Progressive disease|2|||
155607167|NCT02079636|561649667|FG004|Overall Study|Progressive disease|0|||
155607168|NCT02079636|561649668|FG005|Overall Study|Progressive disease|0|||
155607169|NCT02079636|561649669|FG006|Overall Study|Progressive disease|0|||
155607170|NCT02079636|561649670|FG007|Overall Study|Progressive disease|0|||
155607171|NCT02079636|561649671|FG008|Overall Study|Progressive disease|0|||
155607172|NCT02079636|561649672|FG009|Overall Study|Progressive disease|0|||
155607173|NCT02079636|561649673|FG010|Overall Study|Progressive disease|0|||
155607174|NCT02079636|561649674|FG011|Overall Study|Progressive disease|0|||
155607175|NCT02079636|561649675|FG012|Overall Study|Progressive disease|1|||
155607176|NCT02079636|561649676|FG013|Overall Study|Progressive disease|0|||
155607177|NCT02079636|561649677|FG014|Overall Study|Progressive disease|0|||
155607178|NCT02079636|561649663|FG000|Overall Study|Withdrawal by Subject|0|||
155607179|NCT02079636|561649664|FG001|Overall Study|Withdrawal by Subject|0|||
155607180|NCT02079636|561649665|FG002|Overall Study|Withdrawal by Subject|0|||
155607181|NCT02079636|561649666|FG003|Overall Study|Withdrawal by Subject|4|||
155607182|NCT02079636|561649667|FG004|Overall Study|Withdrawal by Subject|0|||
155607183|NCT02079636|561649668|FG005|Overall Study|Withdrawal by Subject|1|||
155607184|NCT02079636|561649669|FG006|Overall Study|Withdrawal by Subject|0|||
155607185|NCT02079636|561649670|FG007|Overall Study|Withdrawal by Subject|0|||
155607186|NCT02079636|561649671|FG008|Overall Study|Withdrawal by Subject|0|||
155607187|NCT02079636|561649672|FG009|Overall Study|Withdrawal by Subject|2|||
155607188|NCT02079636|561649673|FG010|Overall Study|Withdrawal by Subject|1|||
155607189|NCT02079636|561649674|FG011|Overall Study|Withdrawal by Subject|1|||
155607190|NCT02079636|561649675|FG012|Overall Study|Withdrawal by Subject|1|||
155607191|NCT02079636|561649676|FG013|Overall Study|Withdrawal by Subject|0|||
155607192|NCT02079636|561649677|FG014|Overall Study|Withdrawal by Subject|2|||
155607193|NCT02079636|561649663|FG000|Overall Study|Physician Decision|0|||
155607194|NCT02079636|561649664|FG001|Overall Study|Physician Decision|0|||
155607195|NCT02079636|561649665|FG002|Overall Study|Physician Decision|0|||
155607196|NCT02079636|561649666|FG003|Overall Study|Physician Decision|0|||
155607197|NCT02079636|561649667|FG004|Overall Study|Physician Decision|0|||
155607198|NCT02079636|561649668|FG005|Overall Study|Physician Decision|1|||
155607199|NCT02079636|561649669|FG006|Overall Study|Physician Decision|0|||
155607200|NCT02079636|561649670|FG007|Overall Study|Physician Decision|0|||
155607201|NCT02079636|561649671|FG008|Overall Study|Physician Decision|0|||
155607202|NCT02079636|561649672|FG009|Overall Study|Physician Decision|1|||
155607203|NCT02079636|561649673|FG010|Overall Study|Physician Decision|1|||
155607204|NCT02079636|561649674|FG011|Overall Study|Physician Decision|0|||
155607205|NCT02079636|561649675|FG012|Overall Study|Physician Decision|0|||
155607206|NCT02079636|561649676|FG013|Overall Study|Physician Decision|0|||
155607207|NCT02079636|561649677|FG014|Overall Study|Physician Decision|1|||
155607208|NCT02079636|561649663|FG000|Overall Study|Lost to Follow-up|0|||
155607209|NCT02079636|561649664|FG001|Overall Study|Lost to Follow-up|0|||
155607210|NCT02079636|561649665|FG002|Overall Study|Lost to Follow-up|0|||
155607211|NCT02079636|561649666|FG003|Overall Study|Lost to Follow-up|0|||
155607212|NCT02079636|561649667|FG004|Overall Study|Lost to Follow-up|0|||
155607213|NCT02079636|561649668|FG005|Overall Study|Lost to Follow-up|0|||
155607214|NCT02079636|561649669|FG006|Overall Study|Lost to Follow-up|0|||
155607215|NCT02079636|561649670|FG007|Overall Study|Lost to Follow-up|1|||
155607216|NCT02079636|561649671|FG008|Overall Study|Lost to Follow-up|0|||
155607217|NCT02079636|561649672|FG009|Overall Study|Lost to Follow-up|0|||
155607218|NCT02079636|561649673|FG010|Overall Study|Lost to Follow-up|0|||
155607219|NCT02079636|561649674|FG011|Overall Study|Lost to Follow-up|0|||
155607220|NCT02079636|561649675|FG012|Overall Study|Lost to Follow-up|0|||
155607221|NCT02079636|561649676|FG013|Overall Study|Lost to Follow-up|0|||
155607222|NCT02079636|561649677|FG014|Overall Study|Lost to Follow-up|0|||
155607223|NCT02918552|561649678|FG000|Overall Study|Failed Pharmacokinetics|1|||
155607224|NCT02918552|561649679|FG001|Overall Study|Failed Pharmacokinetics|0|||
155264098|NCT00633932|560400065|FG002|Overall Study|Physician Decision|1|||
155264099|NCT00633932|560400063|FG000|Overall Study|Doctor's judgement|1|||
155264100|NCT00633932|560400064|FG001|Overall Study|Doctor's judgement|0|||
155264101|NCT00633932|560400065|FG002|Overall Study|Doctor's judgement|0|||
155264102|NCT00633932|560400063|FG000|Overall Study|Moved Away|1|||
155264103|NCT00633932|560400064|FG001|Overall Study|Moved Away|0|||
155264104|NCT00633932|560400065|FG002|Overall Study|Moved Away|0|||
155264105|NCT04836858|560400066|FG000|Overall Study|Adverse Event|0|||
155264106|NCT04836858|560400067|FG001|Overall Study|Adverse Event|0|||
155264107|NCT04836858|560400068|FG002|Overall Study|Adverse Event|0|||
155264108|NCT04836858|560400069|FG003|Overall Study|Adverse Event|1|||
155264109|NCT04836858|560400066|FG000|Overall Study|Lost to Follow-up|1|||
155264110|NCT04836858|560400067|FG001|Overall Study|Lost to Follow-up|0|||
155264111|NCT04836858|560400068|FG002|Overall Study|Lost to Follow-up|0|||
155264112|NCT04836858|560400069|FG003|Overall Study|Lost to Follow-up|0|||
155264113|NCT04836858|560400066|FG000|Overall Study|Subject/Guardian decision|3|||
155264114|NCT04836858|560400067|FG001|Overall Study|Subject/Guardian decision|0|||
155264115|NCT04836858|560400068|FG002|Overall Study|Subject/Guardian decision|0|||
155264116|NCT04836858|560400069|FG003|Overall Study|Subject/Guardian decision|1|||
155264117|NCT04836858|560400066|FG000|Overall Study|Randomized but not treated|4|||
155264118|NCT04836858|560400067|FG001|Overall Study|Randomized but not treated|0|||
155264119|NCT04836858|560400068|FG002|Overall Study|Randomized but not treated|0|||
155264120|NCT04836858|560400069|FG003|Overall Study|Randomized but not treated|0|||
155264121|NCT00539643|560400070|FG000|Overall Study|Adverse Event|1|||
155264122|NCT00539643|560400071|FG001|Overall Study|Adverse Event|0|||
155264123|NCT00539643|560400070|FG000|Overall Study|Death|2|||
155264124|NCT00539643|560400071|FG001|Overall Study|Death|1|||
155264125|NCT00539643|560400070|FG000|Overall Study|Physician Decision|3|||
155264126|NCT00539643|560400071|FG001|Overall Study|Physician Decision|1|||
155264127|NCT00539643|560400070|FG000|Overall Study|Withdrawal by Subject|0|||
155264128|NCT00539643|560400071|FG001|Overall Study|Withdrawal by Subject|1|||
155264129|NCT02228395|560400072|FG000|First Intervention Period|No longer willing to participate|1|||
155264130|NCT02228395|560400073|FG001|First Intervention Period|No longer willing to participate|0|||
155264131|NCT02228395|560400074|FG002|First Intervention Period|No longer willing to participate|0|||
155264132|NCT02228395|560400072|FG000|First Intervention Period|Unable to comply with study dates|0|||
155264133|NCT02228395|560400073|FG001|First Intervention Period|Unable to comply with study dates|1|||
155264134|NCT02228395|560400074|FG002|First Intervention Period|Unable to comply with study dates|1|||
155264135|NCT01446796|560400075|FG000|Overall Study|Withdrawal by Subject|1|||
155264136|NCT01446796|560400076|FG001|Overall Study|Withdrawal by Subject|0|||
155264137|NCT00988221|560400077|FG000|Part I|Adverse Event|0|||
155264138|NCT00988221|560400078|FG001|Part I|Adverse Event|1|||
155264139|NCT00988221|560400079|FG002|Part I|Adverse Event|2|||
155264140|NCT00988221|560400080|FG003|Part I|Adverse Event|0|||
155264141|NCT00988221|560400077|FG000|Part I|Insufficient Therapeutic Response|4|||
155264142|NCT00988221|560400078|FG001|Part I|Insufficient Therapeutic Response|6|||
155264143|NCT00988221|560400079|FG002|Part I|Insufficient Therapeutic Response|5|||
155264144|NCT00988221|560400080|FG003|Part I|Insufficient Therapeutic Response|0|||
155264145|NCT00988221|560400077|FG000|Part I|Refused Treatment|0|||
155264146|NCT00988221|560400078|FG001|Part I|Refused Treatment|2|||
155264147|NCT00988221|560400079|FG002|Part I|Refused Treatment|1|||
155264148|NCT00988221|560400080|FG003|Part I|Refused Treatment|0|||
155264149|NCT00988221|560400077|FG000|Part I|Lost to Follow-up|0|||
155264150|NCT00988221|560400078|FG001|Part I|Lost to Follow-up|1|||
155264151|NCT00988221|560400079|FG002|Part I|Lost to Follow-up|0|||
155264152|NCT00988221|560400080|FG003|Part I|Lost to Follow-up|0|||
155264153|NCT00988221|560400077|FG000|Part II|Adverse Event|1|||
155264154|NCT00988221|560400078|FG001|Part II|Adverse Event|0|||
155264155|NCT00988221|560400079|FG002|Part II|Adverse Event|0|||
155264156|NCT00988221|560400080|FG003|Part II|Adverse Event|1|||
155264157|NCT00988221|560400077|FG000|Part II|Withdrawal by Subject|0|||
155264158|NCT00988221|560400078|FG001|Part II|Withdrawal by Subject|0|||
155264159|NCT00988221|560400079|FG002|Part II|Withdrawal by Subject|2|||
155264160|NCT00988221|560400080|FG003|Part II|Withdrawal by Subject|2|||
155264161|NCT00988221|560400077|FG000|Part II|Reason not Specified|0|||
155264162|NCT00988221|560400078|FG001|Part II|Reason not Specified|0|||
155264163|NCT00988221|560400079|FG002|Part II|Reason not Specified|1|||
155264164|NCT00988221|560400080|FG003|Part II|Reason not Specified|0|||
155264165|NCT00988221|560400077|FG000|Part III|Adverse Event|1|||
155264166|NCT00988221|560400078|FG001|Part III|Adverse Event|0|||
155264167|NCT00988221|560400079|FG002|Part III|Adverse Event|1|||
155264168|NCT00988221|560400080|FG003|Part III|Adverse Event|0|||
155264169|NCT00988221|560400077|FG000|Part III|Insufficient Therapeutic Response|0|||
155264170|NCT00988221|560400078|FG001|Part III|Insufficient Therapeutic Response|1|||
155264171|NCT00988221|560400079|FG002|Part III|Insufficient Therapeutic Response|1|||
155264172|NCT00988221|560400080|FG003|Part III|Insufficient Therapeutic Response|0|||
155264173|NCT00988221|560400077|FG000|Part III|Refused Treatment|0|||
155264174|NCT00988221|560400078|FG001|Part III|Refused Treatment|0|||
155264175|NCT00988221|560400079|FG002|Part III|Refused Treatment|1|||
155264176|NCT00988221|560400080|FG003|Part III|Refused Treatment|0|||
155607225|NCT02918552|561649678|FG000|Overall Study|Withdrawal by Subject|0|||
155607226|NCT02918552|561649679|FG001|Overall Study|Withdrawal by Subject|1|||
155607227|NCT02918552|561649678|FG000|Overall Study|Lost to Follow-up|0|||
155607228|NCT02918552|561649679|FG001|Overall Study|Lost to Follow-up|1|||
155607229|NCT04395274|561649680|FG000|Overall Study|Lost to Follow-up|20|||
155607230|NCT04395274|561649681|FG001|Overall Study|Lost to Follow-up|11|||
155607231|NCT04395274|561649680|FG000|Overall Study|Withdrawal by Subject|13|||
155607232|NCT04395274|561649681|FG001|Overall Study|Withdrawal by Subject|10|||
155607233|NCT04395274|561649680|FG000|Overall Study|Moved Abroad|0|||
155607234|NCT04395274|561649681|FG001|Overall Study|Moved Abroad|1|||
155607235|NCT03325894|561649682|FG000|Overall Study|Adverse Event|2|||
155607236|NCT03325894|561649683|FG001|Overall Study|Adverse Event|3|||
155607237|NCT03325894|561649682|FG000|Overall Study|Protocol Violation|1|||
155607238|NCT03325894|561649683|FG001|Overall Study|Protocol Violation|2|||
155607239|NCT03325894|561649682|FG000|Overall Study|Withdrawal by Subject|10|||
155607240|NCT03325894|561649683|FG001|Overall Study|Withdrawal by Subject|6|||
155607241|NCT03325894|561649682|FG000|Overall Study|Lost to Follow-up|4|||
155607242|NCT03325894|561649683|FG001|Overall Study|Lost to Follow-up|9|||
155607243|NCT03325894|561649682|FG000|Overall Study|Lack of Efficacy|8|||
155607244|NCT03325894|561649683|FG001|Overall Study|Lack of Efficacy|14|||
155607245|NCT03325894|561649682|FG000|Overall Study|Study Terminated by Sponsor|38|||
155607246|NCT03325894|561649683|FG001|Overall Study|Study Terminated by Sponsor|43|||
155607247|NCT03325894|561649682|FG000|Overall Study|Other (Not received Treatment)|1|||
155607248|NCT03325894|561649683|FG001|Overall Study|Other (Not received Treatment)|0|||
155607249|NCT01876979|561649684|FG000|Overall Study|Physician Decision|2|||
155607250|NCT01876979|561649685|FG001|Overall Study|Physician Decision|3|||
155607251|NCT01362244|561649687|FG000|Overall Study|Adverse Event|3|||
155607252|NCT01362244|561649688|FG001|Overall Study|Adverse Event|5|||
155607253|NCT01362244|561649687|FG000|Overall Study|Lack of Efficacy|5|||
155607254|NCT01362244|561649688|FG001|Overall Study|Lack of Efficacy|11|||
155607255|NCT01362244|561649687|FG000|Overall Study|Lost to Follow-up|0|||
155607256|NCT01362244|561649688|FG001|Overall Study|Lost to Follow-up|2|||
155607257|NCT01362244|561649687|FG000|Overall Study|Protocol Violation|5|||
155607258|NCT01362244|561649688|FG001|Overall Study|Protocol Violation|1|||
155607259|NCT01362244|561649687|FG000|Overall Study|Withdrawal by Subject|2|||
155607260|NCT01362244|561649688|FG001|Overall Study|Withdrawal by Subject|1|||
155607261|NCT01362244|561649687|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
155607262|NCT01362244|561649688|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
155607263|NCT01362244|561649687|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
155607264|NCT01362244|561649688|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
155607265|NCT01712334|561649689|FG000|Treatment Period 1|Randomized in Error|0|||
155607266|NCT01712334|561649690|FG001|Treatment Period 1|Randomized in Error|2|||
155607267|NCT02919267|561649693|FG000|Overall Study|Protocol Violation|0|||
155607268|NCT02919267|561649694|FG001|Overall Study|Protocol Violation|3|||
155607269|NCT02919267|561649695|FG002|Overall Study|Protocol Violation|3|||
155607270|NCT02919267|561649696|FG003|Overall Study|Protocol Violation|4|||
155607271|NCT03467763|561649697|FG000|Overall Study|Lost to Follow-up|1|||
155607272|NCT03467763|561649697|FG000|Overall Study|Protocol Violation|2|||
155607273|NCT02407054|561649698|FG000|Overall Study|Adverse Event|1|||
155607274|NCT02407054|561649699|FG001|Overall Study|Adverse Event|4|||
155607275|NCT02407054|561649700|FG002|Overall Study|Adverse Event|1|||
155607276|NCT02407054|561649698|FG000|Overall Study|Non-compliance with Study|0|||
155607277|NCT02407054|561649699|FG001|Overall Study|Non-compliance with Study|2|||
155607278|NCT02407054|561649700|FG002|Overall Study|Non-compliance with Study|1|||
155607279|NCT02407054|561649698|FG000|Overall Study|Physician Decision|1|||
155607280|NCT02407054|561649699|FG001|Overall Study|Physician Decision|3|||
155607281|NCT02407054|561649700|FG002|Overall Study|Physician Decision|3|||
155607282|NCT02407054|561649698|FG000|Overall Study|Withdrawal by Subject|5|||
155607283|NCT02407054|561649699|FG001|Overall Study|Withdrawal by Subject|9|||
155607284|NCT02407054|561649700|FG002|Overall Study|Withdrawal by Subject|2|||
155607285|NCT00932698|561649703|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
155607286|NCT00932698|561649704|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
155607287|NCT00932698|561649705|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
155607288|NCT00932698|561649706|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
155607289|NCT00932698|561649707|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
155607290|NCT00932698|561649708|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
155607291|NCT00932698|561649709|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
155607292|NCT00932698|561649710|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
155607293|NCT00932698|561649711|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
155607294|NCT00932698|561649712|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
155607295|NCT00932698|561649713|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
155607296|NCT00932698|561649703|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607297|NCT00932698|561649704|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155607298|NCT00932698|561649705|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607299|NCT00932698|561649706|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155607300|NCT00932698|561649707|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607301|NCT00932698|561649708|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155607302|NCT00932698|561649709|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155607303|NCT00932698|561649710|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607304|NCT00932698|561649711|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607305|NCT00932698|561649712|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607306|NCT00932698|561649713|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155607307|NCT00932698|561649703|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
155607308|NCT00932698|561649704|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
155607309|NCT00932698|561649705|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
155607310|NCT00932698|561649706|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
155607311|NCT00932698|561649707|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
155607312|NCT00932698|561649708|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
155607313|NCT00932698|561649709|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
155607314|NCT00932698|561649710|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
155607315|NCT00932698|561649711|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
155607316|NCT00932698|561649712|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
155607317|NCT00932698|561649713|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
155607318|NCT00932698|561649703|FG000|Part 1 (Dose Escalation)|Other|0|||
155607319|NCT00932698|561649704|FG001|Part 1 (Dose Escalation)|Other|0|||
155607320|NCT00932698|561649705|FG002|Part 1 (Dose Escalation)|Other|1|||
155607321|NCT00932698|561649706|FG003|Part 1 (Dose Escalation)|Other|0|||
155607322|NCT00932698|561649707|FG004|Part 1 (Dose Escalation)|Other|0|||
155607323|NCT00932698|561649708|FG005|Part 1 (Dose Escalation)|Other|0|||
155607324|NCT00932698|561649709|FG006|Part 1 (Dose Escalation)|Other|1|||
155607325|NCT00932698|561649710|FG007|Part 1 (Dose Escalation)|Other|0|||
155607326|NCT00932698|561649711|FG008|Part 1 (Dose Escalation)|Other|0|||
155607327|NCT00932698|561649712|FG009|Part 1 (Dose Escalation)|Other|0|||
155607328|NCT00932698|561649713|FG010|Part 1 (Dose Escalation)|Other|0|||
155607329|NCT00932698|561649703|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607330|NCT00932698|561649704|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607331|NCT00932698|561649705|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607332|NCT00932698|561649706|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607333|NCT00932698|561649707|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607334|NCT00932698|561649708|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607335|NCT00932698|561649709|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
155607336|NCT00932698|561649710|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
155607337|NCT00932698|561649711|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
155607338|NCT00932698|561649712|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
155607339|NCT00932698|561649713|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
155607340|NCT00932698|561649703|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607341|NCT00932698|561649704|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607342|NCT00932698|561649705|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607343|NCT00932698|561649706|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607344|NCT00932698|561649707|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607345|NCT00932698|561649708|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607346|NCT00932698|561649709|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607347|NCT00932698|561649710|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
155607348|NCT00932698|561649711|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
155607349|NCT00932698|561649712|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
155607350|NCT00932698|561649713|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155607351|NCT00932698|561649703|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
155607352|NCT00932698|561649704|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
155607353|NCT00932698|561649705|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
155607354|NCT00932698|561649706|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
155607355|NCT00932698|561649707|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
155607356|NCT00932698|561649708|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
155607357|NCT00932698|561649709|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
155607358|NCT00932698|561649710|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
155607359|NCT00932698|561649711|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
155607360|NCT00932698|561649712|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
155607361|NCT00932698|561649713|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
155607362|NCT04438499|561649716|FG000|Overall Study|Lack of Efficacy|3|||
155721298|NCT03361137|562077816|FG001|Overall Study|Reason not specified|0|||
155721299|NCT03361137|562077817|FG002|Overall Study|Reason not specified|0|||
155721300|NCT03361137|562077818|FG003|Overall Study|Reason not specified|0|||
155721301|NCT03361137|562077819|FG004|Overall Study|Reason not specified|0|||
155721302|NCT03009058|562077822|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
155721303|NCT05556265|562077823|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155721304|NCT05556265|562077824|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
155721305|NCT05556265|562077825|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155721306|NCT05556265|562077826|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155721307|NCT05556265|562077827|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155721308|NCT05556265|562077823|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155721309|NCT05556265|562077824|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
155721310|NCT05556265|562077825|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155721311|NCT05556265|562077826|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155721312|NCT05556265|562077827|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155721313|NCT05556265|562077823|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155721314|NCT05556265|562077824|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
155721315|NCT05556265|562077825|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155721316|NCT05556265|562077826|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155721317|NCT05556265|562077827|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155721318|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
155721319|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
155721320|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
155721321|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
155721322|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
155721323|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
155721324|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
155721325|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
155721326|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
155721327|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
155721328|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
155721329|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
155721330|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
155721331|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
155721332|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
155721333|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155721334|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
155721335|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155721336|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155721337|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
155721338|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155721339|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155721340|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
155721341|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155721342|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
155721343|NCT05556265|562077823|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155721344|NCT05556265|562077824|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155721345|NCT05556265|562077825|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
155721346|NCT05556265|562077826|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155721347|NCT05556265|562077827|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
155721348|NCT03077542|562077830|FG000|Overall Study|Death|4|||
155721349|NCT03077542|562077831|FG001|Overall Study|Death|0|||
155721350|NCT03077542|562077830|FG000|Overall Study|Physician Decision|6|||
155721351|NCT03077542|562077831|FG001|Overall Study|Physician Decision|1|||
155721352|NCT03077542|562077830|FG000|Overall Study|Withdrawal by Subject|0|||
155721353|NCT03077542|562077831|FG001|Overall Study|Withdrawal by Subject|1|||
155721354|NCT00795704|562077832|FG000|Overall Study|Withdrawal by Subject|3|||
155721355|NCT00795704|562077833|FG001|Overall Study|Withdrawal by Subject|2|||
155721356|NCT00795704|562077832|FG000|Overall Study|Adverse Event|1|||
155721357|NCT00795704|562077833|FG001|Overall Study|Adverse Event|1|||
155721358|NCT03980730|562077834|FG000|Overall Study|Study Terminated by Sponsor|0|||
155721359|NCT03980730|562077835|FG001|Overall Study|Study Terminated by Sponsor|3|||
155721360|NCT03980730|562077834|FG000|Overall Study|Adverse Event|2|||
155721361|NCT03980730|562077835|FG001|Overall Study|Adverse Event|0|||
155721362|NCT03980730|562077834|FG000|Overall Study|Sponsor Request|0|||
155721363|NCT03980730|562077835|FG001|Overall Study|Sponsor Request|1|||
155721364|NCT01300728|562077836|FG000|Overall Study|Withdrawal by Subject|1|||
155721365|NCT01300728|562077837|FG001|Overall Study|Withdrawal by Subject|1|||
155721366|NCT01300728|562077836|FG000|Overall Study|Physician Decision|1|||
155721367|NCT01300728|562077837|FG001|Overall Study|Physician Decision|0|||
155721368|NCT03474588|562077845|FG000|Overall Study|Withdrawal by Subject|4|||
155721369|NCT03474588|562077846|FG001|Overall Study|Withdrawal by Subject|3|||
155721370|NCT03474588|562077845|FG000|Overall Study|Death|0|||
155721371|NCT03474588|562077846|FG001|Overall Study|Death|1|||
155721372|NCT00945009|562077850|FG000|Overall Study|Lack of Efficacy|10|||
155721373|NCT00945009|562077851|FG001|Overall Study|Lack of Efficacy|0|||
155721374|NCT00945009|562077852|FG002|Overall Study|Lack of Efficacy|0|||
155721375|NCT00945009|562077850|FG000|Overall Study|Physician Decision|21|||
155721376|NCT00945009|562077851|FG001|Overall Study|Physician Decision|4|||
155721377|NCT00945009|562077852|FG002|Overall Study|Physician Decision|3|||
155721378|NCT00945009|562077850|FG000|Overall Study|Protocol Violation|6|||
155721379|NCT00945009|562077851|FG001|Overall Study|Protocol Violation|1|||
155721380|NCT00945009|562077852|FG002|Overall Study|Protocol Violation|0|||
155721381|NCT00945009|562077850|FG000|Overall Study|Withdrawal by Subject|1|||
155721382|NCT00945009|562077851|FG001|Overall Study|Withdrawal by Subject|0|||
155721383|NCT00945009|562077852|FG002|Overall Study|Withdrawal by Subject|0|||
155721384|NCT00945009|562077850|FG000|Overall Study|Ineligible|6|||
155721385|NCT00945009|562077851|FG001|Overall Study|Ineligible|1|||
155721386|NCT00945009|562077852|FG002|Overall Study|Ineligible|0|||
155721387|NCT00945009|562077850|FG000|Overall Study|Inevaluable|0|||
155721388|NCT00945009|562077851|FG001|Overall Study|Inevaluable|1|||
155721389|NCT00945009|562077852|FG002|Overall Study|Inevaluable|0|||
155721390|NCT00945009|562077850|FG000|Overall Study|Refusal of further protocol|1|||
155721391|NCT00945009|562077851|FG001|Overall Study|Refusal of further protocol|0|||
155721392|NCT00945009|562077852|FG002|Overall Study|Refusal of further protocol|0|||
155264177|NCT00954733|560400081|FG000|Overall Study|blood gas machine did not work|1|||
155264178|NCT03579290|560400082|FG000|Overall Study|Lost to Follow-up|9|||
155264179|NCT02712398|560400092|FG000|Overall Study|Withdrawal by Subject|6|||
155264180|NCT02712398|560400092|FG000|Overall Study|Lost to Follow-up|6|||
155264181|NCT02712398|560400092|FG000|Overall Study|Sponsor Decision|1|||
155264182|NCT02712398|560400092|FG000|Overall Study|Physician Decision|1|||
155264183|NCT02712398|560400092|FG000|Overall Study|Death|2|||
155264184|NCT02712398|560400092|FG000|Overall Study|Re-operation|21|||
155264185|NCT01725386|560400094|FG000|Overall Study|Death|84|||
155264186|NCT01725386|560400095|FG001|Overall Study|Death|40|||
155264187|NCT01725386|560400094|FG000|Overall Study|Lost to Follow-up|81|||
155264188|NCT01725386|560400095|FG001|Overall Study|Lost to Follow-up|6|||
155264189|NCT01725386|560400094|FG000|Overall Study|Withdrawal by Subject|10|||
155264190|NCT01725386|560400095|FG001|Overall Study|Withdrawal by Subject|0|||
155264191|NCT00879996|560400099|FG000|Overall Study|Lost to Follow-up|7|||
155264192|NCT00879996|560400100|FG001|Overall Study|Lost to Follow-up|6|||
155264193|NCT00879996|560400099|FG000|Overall Study|non-compliance|6|||
155264194|NCT00879996|560400100|FG001|Overall Study|non-compliance|4|||
155264195|NCT00879996|560400099|FG000|Overall Study|Physician Decision|1|||
155264196|NCT00879996|560400100|FG001|Overall Study|Physician Decision|2|||
155264197|NCT00879996|560400099|FG000|Overall Study|psychiatric problem|0|||
155264198|NCT00879996|560400100|FG001|Overall Study|psychiatric problem|1|||
155264199|NCT00879996|560400099|FG000|Overall Study|put on parole|1|||
155264200|NCT00879996|560400100|FG001|Overall Study|put on parole|0|||
155264201|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264202|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264203|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264204|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
155264205|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264206|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264207|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264208|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
155264209|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264210|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264211|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
155264212|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264213|NCT02914314|560400105|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264214|NCT02914314|560400106|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264215|NCT02914314|560400107|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
155264216|NCT02914314|560400108|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264217|NCT02914314|560400105|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264218|NCT02914314|560400106|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264219|NCT02914314|560400107|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
155264220|NCT02914314|560400108|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264221|NCT04772053|560400109|FG000|Overall Study|Physician Decision|2|||
155264222|NCT04772053|560400109|FG000|Overall Study|Withdrawal by Subject|3|||
155264223|NCT04772053|560400109|FG000|Overall Study|Study Terminated by Sponsor|1|||
155264224|NCT03107377|560400110|FG000|Overall Study|Adverse Event|3|||
155264225|NCT03107377|560400111|FG001|Overall Study|Adverse Event|3|||
155264226|NCT03107377|560400110|FG000|Overall Study|Protocol Violation|9|||
155264227|NCT03107377|560400111|FG001|Overall Study|Protocol Violation|12|||
155264228|NCT03107377|560400110|FG000|Overall Study|Physician Decision|3|||
155264229|NCT03107377|560400111|FG001|Overall Study|Physician Decision|6|||
155264230|NCT03107377|560400110|FG000|Overall Study|Pregnancy|7|||
155264231|NCT03107377|560400111|FG001|Overall Study|Pregnancy|7|||
155264232|NCT03107377|560400110|FG000|Overall Study|Withdrawal by Subject|16|||
155264233|NCT03107377|560400111|FG001|Overall Study|Withdrawal by Subject|22|||
155264234|NCT03107377|560400110|FG000|Overall Study|Lost to Follow-up|37|||
155264235|NCT03107377|560400111|FG001|Overall Study|Lost to Follow-up|34|||
155264236|NCT03107377|560400110|FG000|Overall Study|Other reason not specified|16|||
155264237|NCT03107377|560400111|FG001|Overall Study|Other reason not specified|15|||
155264238|NCT03787680|560400112|FG000|Overall Study|Physician Decision|2|||
155264239|NCT03787680|560400113|FG001|Overall Study|Physician Decision|3|||
155264240|NCT03787680|560400112|FG000|Overall Study|Adverse Event|7|||
155264241|NCT03787680|560400113|FG001|Overall Study|Adverse Event|3|||
155264242|NCT03787680|560400112|FG000|Overall Study|Withdrawal by Subject|2|||
155264243|NCT03787680|560400113|FG001|Overall Study|Withdrawal by Subject|1|||
155264244|NCT05454410|560400116|FG000|Overall Study|Withdrawal by Subject|0|||
155264245|NCT05454410|560400117|FG001|Overall Study|Withdrawal by Subject|0|||
155264246|NCT05454410|560400118|FG002|Overall Study|Withdrawal by Subject|1|||
155264247|NCT05454410|560400119|FG003|Overall Study|Withdrawal by Subject|1|||
155264248|NCT01368900|560400124|FG000|Overall Study|Lost to Follow-up|7|||
155264249|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
155264250|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
155264251|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
155264252|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
155264253|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
155264254|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
155264255|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
155264256|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
155264257|NCT00654901|560400131|FG000|Overall Study|Lost to Follow-up|1|||
155264258|NCT00654901|560400132|FG001|Overall Study|Lost to Follow-up|0|||
155264259|NCT00654901|560400133|FG002|Overall Study|Lost to Follow-up|1|||
155264260|NCT00654901|560400134|FG003|Overall Study|Lost to Follow-up|0|||
155264261|NCT00654901|560400131|FG000|Overall Study|Withdrawal by Subject|3|||
155264262|NCT00654901|560400132|FG001|Overall Study|Withdrawal by Subject|0|||
155264263|NCT00654901|560400133|FG002|Overall Study|Withdrawal by Subject|1|||
155264264|NCT00654901|560400134|FG003|Overall Study|Withdrawal by Subject|0|||
155264265|NCT00652938|560400139|FG000|Overall Study|Adverse Event|1|||
155264266|NCT00652938|560400140|FG001|Overall Study|Adverse Event|0|||
155264267|NCT00652938|560400141|FG002|Overall Study|Adverse Event|2|||
155264268|NCT00652938|560400139|FG000|Overall Study|Withdrawal by Subject|0|||
155264269|NCT00652938|560400140|FG001|Overall Study|Withdrawal by Subject|6|||
155264270|NCT00652938|560400141|FG002|Overall Study|Withdrawal by Subject|1|||
155264271|NCT00652938|560400139|FG000|Overall Study|Lost to Follow-up|0|||
155264272|NCT00652938|560400140|FG001|Overall Study|Lost to Follow-up|0|||
155264273|NCT00652938|560400141|FG002|Overall Study|Lost to Follow-up|2|||
155264274|NCT00652938|560400139|FG000|Overall Study|fear of blood sampling|0|||
155264275|NCT00652938|560400140|FG001|Overall Study|fear of blood sampling|1|||
155264276|NCT00652938|560400141|FG002|Overall Study|fear of blood sampling|0|||
155264277|NCT00782496|560400145|FG000|Overall Study|Lost to Follow-up|14|||
155264278|NCT00782496|560400146|FG001|Overall Study|Lost to Follow-up|15|||
155264279|NCT00117156|560400148|FG000|Overall Study|Adverse Event|9|||
155264280|NCT00117156|560400148|FG000|Overall Study|Physician Decision|1|||
155264281|NCT00117156|560400148|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
155264282|NCT02070484|560400150|FG000|Overall Study|Withdrawal by Subject|1|||
155264283|NCT02070484|560400151|FG001|Overall Study|Withdrawal by Subject|0|||
155264284|NCT01521884|560400152|FG000|Overall Study|Non Responders|10|||
155264285|NCT01521884|560400152|FG000|Overall Study|Adverse Event|5|||
155264286|NCT01521884|560400152|FG000|Overall Study|Pregnancy|1|||
155264287|NCT01521884|560400152|FG000|Overall Study|Withdrawal by Subject|1|||
155264288|NCT01521884|560400152|FG000|Overall Study|Physician Decision|2|||
155264289|NCT01521884|560400152|FG000|Overall Study|Protocol Violation|3|||
155264290|NCT01521884|560400152|FG000|Overall Study|Participant non-eligible|1|||
155264291|NCT01521884|560400152|FG000|Overall Study|Lost to Follow-up|4|||
155264292|NCT02821819|560400153|FG000|Overall Study|Protocol Violation|1|||
155264293|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
155264294|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
155264295|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
155264296|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
155264297|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Other|0|||
155264298|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Other|1|||
155264299|NCT00975221|560402688|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
155264300|NCT00975221|560402689|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
155264301|NCT00975221|560402688|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
155264302|NCT00975221|560402689|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
155264303|NCT00975221|560402688|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
155264304|NCT00975221|560402689|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
155264305|NCT01862991|560402692|FG000|Overall Study|Lost to Follow-up|2|||
155264306|NCT01862991|560402693|FG001|Overall Study|Lost to Follow-up|1|||
155264307|NCT01862991|560402694|FG002|Overall Study|Lost to Follow-up|1|||
155264308|NCT01862991|560402692|FG000|Overall Study|Protocol Violation|1|||
155264309|NCT01862991|560402693|FG001|Overall Study|Protocol Violation|0|||
155264310|NCT01862991|560402694|FG002|Overall Study|Protocol Violation|0|||
155264311|NCT00857805|560402698|FG000|Overall Study|Withdrawal by Subject|1|||
155264312|NCT00857805|560402699|FG001|Overall Study|Withdrawal by Subject|1|||
155264313|NCT01289041|560402700|FG000|Overall Study|Adverse Event|24|||
155264314|NCT01289041|560402700|FG000|Overall Study|Physician Decision|1|||
155264315|NCT01289041|560402700|FG000|Overall Study|Progressive Disease|41|||
155264316|NCT01289041|560402700|FG000|Overall Study|Withdrawal by Subject|3|||
155264317|NCT01289041|560402700|FG000|Overall Study|Death|1|||
155264318|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Adverse Event|0|||
155264319|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Adverse Event|0|||
155264320|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Adverse Event|0|||
155264321|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Adverse Event|0|||
155264322|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Adverse Event|0|||
155264323|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Adverse Event|1|||
155264324|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Adverse Event|0|||
155264325|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Adverse Event|1|||
155264326|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Adverse Event|0|||
155264327|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Adverse Event|0|||
155264328|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264329|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264330|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264331|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264332|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264333|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264334|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264335|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264336|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264337|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264338|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Physician Decision|0|||
155264339|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Physician Decision|0|||
155264340|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Physician Decision|0|||
155264341|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Physician Decision|0|||
155264342|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Physician Decision|0|||
155264343|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Physician Decision|0|||
155264344|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Physician Decision|1|||
155264345|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Physician Decision|0|||
155264346|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Physician Decision|0|||
155264347|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Physician Decision|0|||
155264348|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264349|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264350|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
155264351|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264352|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264353|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264354|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264355|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264356|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264357|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264358|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Adverse Event|0|||
155264359|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Adverse Event|1|||
155264360|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Adverse Event|0|||
155264361|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Adverse Event|0|||
155264362|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Adverse Event|1|||
155264363|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Adverse Event|1|||
155264364|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Adverse Event|0|||
155264365|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Adverse Event|0|||
155264366|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Adverse Event|0|||
155264367|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Adverse Event|0|||
155264368|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Physician Decision|0|||
155264369|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Physician Decision|0|||
155264370|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Physician Decision|0|||
155264371|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Physician Decision|0|||
155264372|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Physician Decision|0|||
155264373|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Physician Decision|1|||
155264374|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Physician Decision|0|||
155264375|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Physician Decision|0|||
155264376|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Physician Decision|0|||
155264377|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Physician Decision|0|||
155264378|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264379|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264380|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264381|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
155264382|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
155264383|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264384|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264385|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264386|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264387|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264388|NCT01250119|560402716|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
155264389|NCT01250119|560402717|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
155264390|NCT01250119|560402716|FG000|Diagnostic Phase|Participants Not Tested|44|||
155264391|NCT01250119|560402717|FG001|Diagnostic Phase|Participants Not Tested|0|||
155264392|NCT01250119|560402716|FG000|Treatment Phase|Progressive Disease|0|||
155264393|NCT01250119|560402717|FG001|Treatment Phase|Progressive Disease|32|||
155264394|NCT01250119|560402716|FG000|Treatment Phase|Death|0|||
155264395|NCT01250119|560402717|FG001|Treatment Phase|Death|2|||
155264396|NCT01250119|560402716|FG000|Treatment Phase|Withdrawal by Subject|0|||
155264397|NCT01250119|560402717|FG001|Treatment Phase|Withdrawal by Subject|1|||
155264398|NCT01250119|560402716|FG000|Treatment Phase|Adverse Event|0|||
155264399|NCT01250119|560402717|FG001|Treatment Phase|Adverse Event|2|||
155264400|NCT01250119|560402716|FG000|Treatment Phase|Unknown reason|0|||
155264401|NCT01250119|560402717|FG001|Treatment Phase|Unknown reason|4|||
155264402|NCT04887948|560402728|FG000|Overall Study|Death|1|||
155264403|NCT04887948|560402729|FG001|Overall Study|Death|0|||
155264404|NCT04887948|560402730|FG002|Overall Study|Death|0|||
155264405|NCT04887948|560402728|FG000|Overall Study|Lost to Follow-up|1|||
155264406|NCT04887948|560402729|FG001|Overall Study|Lost to Follow-up|0|||
155264407|NCT04887948|560402730|FG002|Overall Study|Lost to Follow-up|3|||
155264408|NCT04887948|560402728|FG000|Overall Study|Physician Decision|0|||
155264409|NCT04887948|560402729|FG001|Overall Study|Physician Decision|4|||
155264410|NCT04887948|560402730|FG002|Overall Study|Physician Decision|1|||
155264411|NCT04887948|560402728|FG000|Overall Study|Protocol Violation|1|||
155264412|NCT04887948|560402729|FG001|Overall Study|Protocol Violation|1|||
155264413|NCT04887948|560402730|FG002|Overall Study|Protocol Violation|0|||
155264414|NCT04887948|560402728|FG000|Overall Study|Withdrawal by Subject|0|||
155264415|NCT04887948|560402729|FG001|Overall Study|Withdrawal by Subject|6|||
155264416|NCT04887948|560402730|FG002|Overall Study|Withdrawal by Subject|1|||
155264417|NCT04887948|560402728|FG000|Overall Study|No longer met eligibility criteria|1|||
155264418|NCT04887948|560402729|FG001|Overall Study|No longer met eligibility criteria|2|||
155264419|NCT04887948|560402730|FG002|Overall Study|No longer met eligibility criteria|1|||
155264420|NCT04887948|560402728|FG000|Overall Study|Other|2|||
155264421|NCT04887948|560402729|FG001|Overall Study|Other|1|||
155264422|NCT04887948|560402730|FG002|Overall Study|Other|1|||
155264423|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
155264424|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
155264425|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Adverse Event|2|||
155264426|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Adverse Event|5|||
155264427|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
155264428|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
155264429|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
155264430|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
155264431|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Randomized by error|0|||
155264432|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Randomized by error|5|||
155264433|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
155264434|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
155264435|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
155264436|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
155264437|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Change of residence location|0|||
155264438|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Change of residence location|1|||
155264439|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
155264440|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
155264441|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
155264442|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
155264443|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
155264444|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
155264445|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
155264446|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
155264447|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
155264448|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
155264449|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Study site closure|1|||
155264450|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Study site closure|0|||
155264451|NCT00787319|560402733|FG000|Overall Study|Lost to Follow-up|2|||
155264452|NCT00787319|560402733|FG000|Overall Study|Withdrawal by Subject|15|||
155264453|NCT00787319|560402733|FG000|Overall Study|Adverse Event|3|||
155264454|NCT00787319|560402733|FG000|Overall Study|Objective progression or relapse|30|||
155264455|NCT00787319|560402733|FG000|Overall Study|Lack of Efficacy|1|||
155264456|NCT00787319|560402733|FG000|Overall Study|Budget exhausted/exceeded|1|||
155264457|NCT00787319|560402733|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
155264458|NCT00787319|560402733|FG000|Overall Study|No health insurance reimbursement|2|||
155264459|NCT00787319|560402733|FG000|Overall Study|Stabilized disease findings|3|||
155264460|NCT00787319|560402733|FG000|Overall Study|Inactive disease|5|||
155264461|NCT02312856|560402734|FG000|Overall Study|Death|1|||
155264462|NCT02312856|560402734|FG000|Overall Study|Lost to Follow-up|3|||
155264463|NCT01932294|560402735|FG000|Overall Study|Death|43|||
155264464|NCT01932294|560402735|FG000|Overall Study|Lost to Follow-up|8|||
155264465|NCT01932294|560402735|FG000|Overall Study|VAD Implantation|20|||
155264466|NCT01932294|560402735|FG000|Overall Study|Heart Transplantation|16|||
155264467|NCT01932294|560402735|FG000|Overall Study|Transferred to other hospitals|12|||
155264468|NCT04415151|560402736|FG000|Overall Study|Death|1|||
155264469|NCT04415151|560402737|FG001|Overall Study|Death|1|||
155264470|NCT04415151|560402736|FG000|Overall Study|Withdrawal by Subject|1|||
155264471|NCT04415151|560402737|FG001|Overall Study|Withdrawal by Subject|0|||
155264472|NCT00409786|560402738|FG000|Overall Study|Withdrawal by Subject|3|||
155264473|NCT00638235|560402739|FG000|Overall Study|Lost to Follow-up|31|||
155264474|NCT00638235|560402740|FG001|Overall Study|Lost to Follow-up|3|||
155264475|NCT00638235|560402741|FG002|Overall Study|Lost to Follow-up|18|||
155264476|NCT00638235|560402742|FG003|Overall Study|Lost to Follow-up|10|||
155264477|NCT00638235|560402743|FG004|Overall Study|Lost to Follow-up|13|||
155264478|NCT00638235|560402744|FG005|Overall Study|Lost to Follow-up|26|||
155264479|NCT00638235|560402745|FG006|Overall Study|Lost to Follow-up|0|||
155264480|NCT00638235|560402746|FG007|Overall Study|Lost to Follow-up|1|||
155264481|NCT00638235|560402747|FG008|Overall Study|Lost to Follow-up|18|||
155264482|NCT00597714|560402752|FG000|Overall Study|Death|56|||
155264483|NCT00597714|560402753|FG001|Overall Study|Death|46|||
155264484|NCT00597714|560402754|FG002|Overall Study|Death|0|||
155264485|NCT00597714|560402752|FG000|Overall Study|Recipient death|0|||
155264486|NCT00597714|560402753|FG001|Overall Study|Recipient death|0|||
155264487|NCT00597714|560402754|FG002|Overall Study|Recipient death|10|||
155264488|NCT01641926|560402763|FG000|Overall Study|Adverse Event|5|||
155264489|NCT01641926|560402764|FG001|Overall Study|Adverse Event|2|||
155264490|NCT01641926|560402765|FG002|Overall Study|Adverse Event|3|||
155264491|NCT01641926|560402766|FG003|Overall Study|Adverse Event|1|||
155264492|NCT01641926|560402763|FG000|Overall Study|Lost to Follow-up|2|||
155264493|NCT01641926|560402764|FG001|Overall Study|Lost to Follow-up|2|||
155264494|NCT01641926|560402765|FG002|Overall Study|Lost to Follow-up|1|||
155264495|NCT01641926|560402766|FG003|Overall Study|Lost to Follow-up|0|||
155264496|NCT01641926|560402763|FG000|Overall Study|Physician Decision|6|||
155264497|NCT01641926|560402764|FG001|Overall Study|Physician Decision|5|||
155264498|NCT01641926|560402765|FG002|Overall Study|Physician Decision|0|||
155264499|NCT01641926|560402766|FG003|Overall Study|Physician Decision|1|||
155264500|NCT01641926|560402763|FG000|Overall Study|Protocol Violation|1|||
155264501|NCT01641926|560402764|FG001|Overall Study|Protocol Violation|0|||
155264502|NCT01641926|560402765|FG002|Overall Study|Protocol Violation|0|||
155264503|NCT01641926|560402766|FG003|Overall Study|Protocol Violation|1|||
155264504|NCT01641926|560402763|FG000|Overall Study|Withdrawal by Subject|13|||
155264505|NCT01641926|560402764|FG001|Overall Study|Withdrawal by Subject|5|||
155264506|NCT01641926|560402765|FG002|Overall Study|Withdrawal by Subject|6|||
155264507|NCT01641926|560402766|FG003|Overall Study|Withdrawal by Subject|1|||
155264508|NCT01641926|560402763|FG000|Overall Study|Not Treated|1|||
155264509|NCT01641926|560402764|FG001|Overall Study|Not Treated|1|||
155264510|NCT01641926|560402765|FG002|Overall Study|Not Treated|1|||
155264511|NCT01641926|560402766|FG003|Overall Study|Not Treated|0|||
155264512|NCT03673462|560402767|FG000|Overall Study|Adverse Event|11|||
155264513|NCT03673462|560402768|FG001|Overall Study|Adverse Event|1|||
155264514|NCT03673462|560402767|FG000|Overall Study|Protocol Violation|25|||
155264515|NCT03673462|560402768|FG001|Overall Study|Protocol Violation|11|||
155264516|NCT03673462|560402767|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
155264517|NCT03673462|560402768|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
155264518|NCT03673462|560402767|FG000|Overall Study|Lost to Follow-up|102|||
155264519|NCT03673462|560402768|FG001|Overall Study|Lost to Follow-up|19|||
155264520|NCT01480596|560402774|FG000|Overall Study|Adverse Event|3|||
155264521|NCT01480596|560402775|FG001|Overall Study|Adverse Event|0|||
155264522|NCT01480596|560402774|FG000|Overall Study|MG exacerbation or change in medication|2|||
155264523|NCT01480596|560402775|FG001|Overall Study|MG exacerbation or change in medication|2|||
155264524|NCT02387216|560402776|FG000|Overall Study|Progressive disease|2|||
155264525|NCT02387216|560402777|FG001|Overall Study|Progressive disease|0|||
155264526|NCT02387216|560402776|FG000|Overall Study|Withdrawal by Subject|3|||
155264527|NCT02387216|560402777|FG001|Overall Study|Withdrawal by Subject|5|||
155264528|NCT02387216|560402776|FG000|Overall Study|Physician Decision|2|||
155264529|NCT02387216|560402777|FG001|Overall Study|Physician Decision|0|||
155264530|NCT02387216|560402776|FG000|Overall Study|Sponsor Decision|28|||
155264531|NCT02387216|560402777|FG001|Overall Study|Sponsor Decision|12|||
155264532|NCT02387216|560402776|FG000|Overall Study|Death|60|||
155264533|NCT02387216|560402777|FG001|Overall Study|Death|23|||
155264534|NCT02387216|560402776|FG000|Overall Study|Other|5|||
155264535|NCT02387216|560402777|FG001|Overall Study|Other|4|||
155264536|NCT02387216|560402776|FG000|Overall Study|Lost to Follow-up|0|||
155264537|NCT02387216|560402777|FG001|Overall Study|Lost to Follow-up|3|||
155264538|NCT02917265|560402780|FG000|Overall Study|Physician Decision|1|||
155264539|NCT02917265|560402781|FG001|Overall Study|Physician Decision|0|||
155264540|NCT02917265|560402780|FG000|Overall Study|Withdrawal by Subject|1|||
155264541|NCT02917265|560402781|FG001|Overall Study|Withdrawal by Subject|0|||
155264542|NCT00979602|560402792|FG000|Overall Study|Serious Adverse Event|5|||
155264543|NCT00979602|560402793|FG001|Overall Study|Serious Adverse Event|3|||
155264544|NCT00979602|560402792|FG000|Overall Study|Protocol Violation|3|||
155264545|NCT00979602|560402793|FG001|Overall Study|Protocol Violation|0|||
155264546|NCT00979602|560402792|FG000|Overall Study|Withdrawal by Subject|31|||
155264547|NCT00979602|560402793|FG001|Overall Study|Withdrawal by Subject|25|||
155264548|NCT00979602|560402792|FG000|Overall Study|Lost to Follow-up|100|||
155264549|NCT00979602|560402793|FG001|Overall Study|Lost to Follow-up|96|||
155264550|NCT00979602|560402792|FG000|Overall Study|Migrated/moved from study area|3|||
155264551|NCT00979602|560402793|FG001|Overall Study|Migrated/moved from study area|6|||
155264552|NCT00979602|560402792|FG000|Overall Study|Others|3|||
155264553|NCT00979602|560402793|FG001|Overall Study|Others|3|||
155264554|NCT01216163|560402797|FG000|Overall Study|Withdrawal by Subject|1|||
155264555|NCT01216163|560402798|FG001|Overall Study|Withdrawal by Subject|1|||
155264556|NCT01216163|560402799|FG002|Overall Study|Withdrawal by Subject|0|||
155264557|NCT02002182|560402801|FG000|Overall Study|Withdraw from study|3|||
155264558|NCT02002182|560402802|FG001|Overall Study|Withdraw from study|1|||
155264559|NCT02002182|560402801|FG000|Overall Study|Health Reasons|1|||
155264560|NCT02002182|560402802|FG001|Overall Study|Health Reasons|0|||
155264561|NCT02002182|560402801|FG000|Overall Study|Death|1|||
155264562|NCT02002182|560402802|FG001|Overall Study|Death|0|||
155264563|NCT03879408|560402813|FG000|Overall Study|Lost to Follow-up|0|||
155264564|NCT03879408|560402814|FG001|Overall Study|Lost to Follow-up|3|||
155264565|NCT03879408|560402815|FG002|Overall Study|Lost to Follow-up|2|||
155264566|NCT03879408|560402816|FG003|Overall Study|Lost to Follow-up|1|||
155264567|NCT03879408|560402817|FG004|Overall Study|Lost to Follow-up|0|||
155264568|NCT03879408|560402813|FG000|Overall Study|Withdrawal by Subject|2|||
155264569|NCT03879408|560402814|FG001|Overall Study|Withdrawal by Subject|1|||
155264570|NCT03879408|560402815|FG002|Overall Study|Withdrawal by Subject|1|||
155264571|NCT03879408|560402816|FG003|Overall Study|Withdrawal by Subject|0|||
155264572|NCT03879408|560402817|FG004|Overall Study|Withdrawal by Subject|1|||
155264573|NCT01320943|560402818|FG000|Overall Study|Lost to Follow-up|1|||
155264574|NCT01320943|560402819|FG001|Overall Study|Lost to Follow-up|0|||
155264575|NCT01320943|560402818|FG000|Overall Study|Physician Decision|0|||
155264576|NCT01320943|560402819|FG001|Overall Study|Physician Decision|1|||
155264577|NCT01320943|560402818|FG000|Overall Study|Randomized but not Treated|0|||
155264578|NCT01320943|560402819|FG001|Overall Study|Randomized but not Treated|1|||
155264579|NCT01490125|560402820|FG000|Period I|Adverse Event|4|||
155264580|NCT01490125|560402821|FG001|Period I|Adverse Event|1|||
155264581|NCT01490125|560402822|FG002|Period I|Adverse Event|1|||
155264582|NCT01490125|560402823|FG003|Period I|Adverse Event|3|||
155264583|NCT01490125|560402824|FG004|Period I|Adverse Event|2|||
155264584|NCT01490125|560402825|FG005|Period I|Adverse Event|4|||
155264585|NCT01490125|560402820|FG000|Period I|Protocol Violation|1|||
155264586|NCT01490125|560402821|FG001|Period I|Protocol Violation|1|||
155264587|NCT01490125|560402822|FG002|Period I|Protocol Violation|1|||
155264588|NCT01490125|560402823|FG003|Period I|Protocol Violation|1|||
155264589|NCT01490125|560402824|FG004|Period I|Protocol Violation|0|||
155264590|NCT01490125|560402825|FG005|Period I|Protocol Violation|0|||
155264591|NCT01490125|560402820|FG000|Period I|Withdrawal by Subject|1|||
155264592|NCT01490125|560402821|FG001|Period I|Withdrawal by Subject|3|||
155264593|NCT01490125|560402822|FG002|Period I|Withdrawal by Subject|2|||
155264594|NCT01490125|560402823|FG003|Period I|Withdrawal by Subject|1|||
155264595|NCT01490125|560402824|FG004|Period I|Withdrawal by Subject|2|||
155264596|NCT01490125|560402825|FG005|Period I|Withdrawal by Subject|1|||
155264597|NCT01490125|560402820|FG000|Period II|Adverse Event|2|||
155264598|NCT01490125|560402821|FG001|Period II|Adverse Event|3|||
155264599|NCT01490125|560402822|FG002|Period II|Adverse Event|2|||
155264600|NCT01490125|560402823|FG003|Period II|Adverse Event|2|||
155264601|NCT01490125|560402824|FG004|Period II|Adverse Event|4|||
155264602|NCT01490125|560402825|FG005|Period II|Adverse Event|2|||
155264603|NCT01490125|560402820|FG000|Period II|Protocol Violation|0|||
155264604|NCT01490125|560402821|FG001|Period II|Protocol Violation|0|||
155264605|NCT01490125|560402822|FG002|Period II|Protocol Violation|1|||
155264606|NCT01490125|560402823|FG003|Period II|Protocol Violation|1|||
155264607|NCT01490125|560402824|FG004|Period II|Protocol Violation|0|||
155264608|NCT01490125|560402825|FG005|Period II|Protocol Violation|0|||
155264609|NCT01490125|560402820|FG000|Period II|Lost to Follow-up|0|||
155264610|NCT01490125|560402821|FG001|Period II|Lost to Follow-up|1|||
155264611|NCT01490125|560402822|FG002|Period II|Lost to Follow-up|0|||
155264612|NCT01490125|560402823|FG003|Period II|Lost to Follow-up|0|||
155264613|NCT01490125|560402824|FG004|Period II|Lost to Follow-up|0|||
155264614|NCT01490125|560402825|FG005|Period II|Lost to Follow-up|0|||
155264615|NCT01490125|560402820|FG000|Period II|Withdrawal by Subject|1|||
155264616|NCT01490125|560402821|FG001|Period II|Withdrawal by Subject|0|||
155264617|NCT01490125|560402822|FG002|Period II|Withdrawal by Subject|0|||
155264618|NCT01490125|560402823|FG003|Period II|Withdrawal by Subject|0|||
155264619|NCT01490125|560402824|FG004|Period II|Withdrawal by Subject|0|||
155264620|NCT01490125|560402825|FG005|Period II|Withdrawal by Subject|0|||
155264621|NCT01490125|560402820|FG000|Period III|Adverse Event|3|||
155264622|NCT01490125|560402821|FG001|Period III|Adverse Event|1|||
155264623|NCT01490125|560402822|FG002|Period III|Adverse Event|0|||
155264624|NCT01490125|560402823|FG003|Period III|Adverse Event|1|||
155264625|NCT01490125|560402824|FG004|Period III|Adverse Event|0|||
155264626|NCT01490125|560402825|FG005|Period III|Adverse Event|0|||
155264627|NCT01490125|560402820|FG000|Period III|Death|0|||
155264628|NCT01490125|560402821|FG001|Period III|Death|0|||
155264629|NCT01490125|560402822|FG002|Period III|Death|0|||
155264630|NCT01490125|560402823|FG003|Period III|Death|1|||
155264631|NCT01490125|560402824|FG004|Period III|Death|0|||
155264632|NCT01490125|560402825|FG005|Period III|Death|0|||
155264633|NCT01490125|560402820|FG000|Period III|Lack of Efficacy|0|||
155264634|NCT01490125|560402821|FG001|Period III|Lack of Efficacy|0|||
155264635|NCT01490125|560402822|FG002|Period III|Lack of Efficacy|0|||
155264636|NCT01490125|560402823|FG003|Period III|Lack of Efficacy|0|||
155264637|NCT01490125|560402824|FG004|Period III|Lack of Efficacy|1|||
155264638|NCT01490125|560402825|FG005|Period III|Lack of Efficacy|0|||
155264639|NCT05458024|560402827|FG000|Overall Study|Withdrawal by Subject|1|||
155264640|NCT05458024|560402828|FG001|Overall Study|Withdrawal by Subject|1|||
155264641|NCT04522180|560402829|FG000|Overall Study|Investigator judgement|3|||
155264642|NCT04522180|560402830|FG001|Overall Study|Investigator judgement|4|||
155264643|NCT04522180|560402829|FG000|Overall Study|Voluntary withdrawal|1|||
155264644|NCT04522180|560402830|FG001|Overall Study|Voluntary withdrawal|0|||
155264645|NCT04522180|560402829|FG000|Overall Study|Pregnancy|0|||
155264646|NCT04522180|560402830|FG001|Overall Study|Pregnancy|1|||
155264647|NCT04522180|560402829|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
155264648|NCT04522180|560402830|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
155264649|NCT04522180|560402829|FG000|Overall Study|Reason not specified|8|||
155264650|NCT04522180|560402830|FG001|Overall Study|Reason not specified|5|||
155264651|NCT05807919|560402831|FG000|Overall Study|Received antibiotics - excluded|0|||
155264652|NCT05807919|560402832|FG001|Overall Study|Received antibiotics - excluded|1|||
155264653|NCT05807919|560402831|FG000|Overall Study|Withdrawal by Subject|0|||
155264654|NCT05807919|560402832|FG001|Overall Study|Withdrawal by Subject|3|||
155264655|NCT05807919|560402831|FG000|Overall Study|Adverse Event|1|||
155264656|NCT05807919|560402832|FG001|Overall Study|Adverse Event|1|||
155264657|NCT01931735|560402839|FG000|Randomized Phase|Lost to Follow-up|2|||
155264658|NCT01931735|560402840|FG001|Randomized Phase|Lost to Follow-up|2|||
155264659|NCT01931735|560402841|FG002|Randomized Phase|Lost to Follow-up|5|||
155264660|NCT01931735|560402842|FG003|Randomized Phase|Lost to Follow-up|0|||
155264661|NCT01931735|560402839|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
155264662|NCT01931735|560402840|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
155264663|NCT01931735|560402841|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
155264664|NCT01931735|560402842|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
155264665|NCT01931735|560402839|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264666|NCT01931735|560402840|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264667|NCT01931735|560402841|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264668|NCT01931735|560402842|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
155264669|NCT02719990|560402843|FG000|Overall Study|Physician Decision|2|||
155264670|NCT02719990|560402843|FG000|Overall Study|Withdrawal by Subject|2|||
155264671|NCT02719990|560402843|FG000|Overall Study|Study Terminated By Sponsor|32|||
155264672|NCT02404389|560402844|FG000|Overall Study|Adverse Event|1|||
155264673|NCT02404389|560402845|FG001|Overall Study|Adverse Event|0|||
155264674|NCT02404389|560402846|FG002|Overall Study|Adverse Event|1|||
155264675|NCT02404389|560402847|FG003|Overall Study|Adverse Event|0|||
155264676|NCT02404389|560402848|FG004|Overall Study|Adverse Event|2|||
155264677|NCT02404389|560402844|FG000|Overall Study|Subject/guardian decision|1|||
155264678|NCT02404389|560402845|FG001|Overall Study|Subject/guardian decision|0|||
155264679|NCT02404389|560402846|FG002|Overall Study|Subject/guardian decision|0|||
155264680|NCT02404389|560402847|FG003|Overall Study|Subject/guardian decision|1|||
155264681|NCT02404389|560402848|FG004|Overall Study|Subject/guardian decision|1|||
155264682|NCT03324880|560402849|FG000|Overall Study|Adverse Event|0|||
155264683|NCT03324880|560402850|FG001|Overall Study|Adverse Event|2|||
155264684|NCT03324880|560402849|FG000|Overall Study|Withdrawal by Subject|2|||
155264685|NCT03324880|560402850|FG001|Overall Study|Withdrawal by Subject|2|||
155264686|NCT03324880|560402849|FG000|Overall Study|Lost to Follow-up|0|||
155264687|NCT03324880|560402850|FG001|Overall Study|Lost to Follow-up|1|||
155264688|NCT03324880|560402849|FG000|Overall Study|Product Recall|0|||
155264689|NCT03324880|560402850|FG001|Overall Study|Product Recall|1|||
155264690|NCT01412801|560402851|FG000|Overall Study|Death|0|||
155264691|NCT01412801|560402852|FG001|Overall Study|Death|1|||
155264692|NCT01412801|560402853|FG002|Overall Study|Death|0|||
155264693|NCT01412801|560402854|FG003|Overall Study|Death|4|||
155264694|NCT01412801|560402855|FG004|Overall Study|Death|2|||
155264695|NCT01412801|560402856|FG005|Overall Study|Death|2|||
155264696|NCT01412801|560402851|FG000|Overall Study|Lost to Follow-up|1|||
155264697|NCT01412801|560402852|FG001|Overall Study|Lost to Follow-up|2|||
155264698|NCT01412801|560402853|FG002|Overall Study|Lost to Follow-up|4|||
155264699|NCT01412801|560402854|FG003|Overall Study|Lost to Follow-up|0|||
155264700|NCT01412801|560402855|FG004|Overall Study|Lost to Follow-up|1|||
155264701|NCT01412801|560402856|FG005|Overall Study|Lost to Follow-up|1|||
155264702|NCT01412801|560402851|FG000|Overall Study|Withdrawal by Subject|3|||
155264703|NCT01412801|560402852|FG001|Overall Study|Withdrawal by Subject|2|||
155264704|NCT01412801|560402853|FG002|Overall Study|Withdrawal by Subject|1|||
155264705|NCT01412801|560402854|FG003|Overall Study|Withdrawal by Subject|0|||
155264706|NCT01412801|560402855|FG004|Overall Study|Withdrawal by Subject|0|||
155264707|NCT01412801|560402856|FG005|Overall Study|Withdrawal by Subject|0|||
155264708|NCT01412801|560402851|FG000|Overall Study|Relocated to another area|0|||
155264709|NCT01412801|560402852|FG001|Overall Study|Relocated to another area|0|||
155264710|NCT01412801|560402853|FG002|Overall Study|Relocated to another area|2|||
155264711|NCT01412801|560402854|FG003|Overall Study|Relocated to another area|0|||
155264712|NCT01412801|560402855|FG004|Overall Study|Relocated to another area|0|||
155264713|NCT01412801|560402856|FG005|Overall Study|Relocated to another area|0|||
155264714|NCT00717314|560402860|FG000|Overall Study|Adverse Event|3|||
155264715|NCT00717314|560402861|FG001|Overall Study|Adverse Event|2|||
155264716|NCT00717314|560402860|FG000|Overall Study|Protocol Violation|1|||
155264717|NCT00717314|560402861|FG001|Overall Study|Protocol Violation|0|||
155264718|NCT00717314|560402860|FG000|Overall Study|Lost to Follow-up|1|||
155264719|NCT00717314|560402861|FG001|Overall Study|Lost to Follow-up|5|||
155264720|NCT00717314|560402860|FG000|Overall Study|Withdrawal by Subject|1|||
155264721|NCT00717314|560402861|FG001|Overall Study|Withdrawal by Subject|3|||
155264722|NCT05076149|560402862|FG000|Overall Study|Adverse Event|3|||
155264723|NCT05076149|560402863|FG001|Overall Study|Adverse Event|9|||
155264724|NCT05076149|560402862|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155264725|NCT05076149|560402863|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
155264726|NCT05076149|560402862|FG000|Overall Study|Lost to Follow-up|0|||
155264727|NCT05076149|560402863|FG001|Overall Study|Lost to Follow-up|1|||
155264728|NCT05076149|560402862|FG000|Overall Study|Commercial drug is available for participant|0|||
155264729|NCT05076149|560402863|FG001|Overall Study|Commercial drug is available for participant|1|||
155264730|NCT05076149|560402862|FG000|Overall Study|Other non compliance|1|||
155264731|NCT05076149|560402863|FG001|Overall Study|Other non compliance|1|||
155264732|NCT05076149|560402862|FG000|Overall Study|Physician Decision|0|||
155264733|NCT05076149|560402863|FG001|Overall Study|Physician Decision|1|||
155264734|NCT05076149|560402862|FG000|Overall Study|Other|5|||
155264735|NCT05076149|560402863|FG001|Overall Study|Other|4|||
155264736|NCT05096208|560402864|FG000|Overall Study|Lost to Follow-up|3|||
155264737|NCT05096208|560402865|FG001|Overall Study|Lost to Follow-up|5|||
155264738|NCT05096208|560402866|FG002|Overall Study|Lost to Follow-up|5|||
155264739|NCT05096208|560402867|FG003|Overall Study|Lost to Follow-up|2|||
155264740|NCT05096208|560402864|FG000|Overall Study|Withdrawal by Subject|0|||
155264741|NCT05096208|560402865|FG001|Overall Study|Withdrawal by Subject|1|||
155264742|NCT05096208|560402866|FG002|Overall Study|Withdrawal by Subject|2|||
155264743|NCT05096208|560402867|FG003|Overall Study|Withdrawal by Subject|3|||
155264744|NCT05096208|560402864|FG000|Overall Study|No longer met eligibility criteria|1|||
155264745|NCT05096208|560402865|FG001|Overall Study|No longer met eligibility criteria|0|||
155264746|NCT05096208|560402866|FG002|Overall Study|No longer met eligibility criteria|0|||
155264747|NCT05096208|560402867|FG003|Overall Study|No longer met eligibility criteria|0|||
155264748|NCT05096208|560402864|FG000|Overall Study|Other|0|||
155264749|NCT05096208|560402865|FG001|Overall Study|Other|0|||
155264750|NCT05096208|560402866|FG002|Overall Study|Other|1|||
155264751|NCT05096208|560402867|FG003|Overall Study|Other|0|||
155264752|NCT02087501|560402868|FG000|Overall Study|Death|7|||
155264753|NCT02087501|560402868|FG000|Overall Study|Open repair of aneurysm|1|||
155264754|NCT02087501|560402868|FG000|Overall Study|Lost to Follow-up|2|||
155264755|NCT00094328|560402869|FG000|Overall Study|Lost to Follow-up|1|||
155264756|NCT01483937|560402872|FG000|Overall Study|Withdrawal by Subject|4|||
155264757|NCT01483937|560402873|FG001|Overall Study|Withdrawal by Subject|3|||
155264758|NCT01919970|560402874|FG000|Overall Study|Withdrawal by Subject|3|||
155264759|NCT01919970|560402875|FG001|Overall Study|Withdrawal by Subject|0|||
155264760|NCT02213328|560402876|FG000|Overall Study|Withdrawal by Subject|10|||
155264761|NCT02213328|560402876|FG000|Overall Study|Physician Decision|2|||
155264762|NCT02213328|560402876|FG000|Overall Study|Lost to Follow-up|16|||
155264763|NCT00990340|560402877|FG000|First 14-day Treatment|Not Compliant|2|||
155264764|NCT00990340|560402878|FG001|First 14-day Treatment|Not Compliant|1|||
155264765|NCT00990340|560402877|FG000|First 14-day Treatment|Lost to Follow-up|2|||
155264766|NCT00990340|560402878|FG001|First 14-day Treatment|Lost to Follow-up|1|||
155264767|NCT00990340|560402877|FG000|First 14-day Treatment|Protocol Violation|2|||
155264768|NCT00990340|560402878|FG001|First 14-day Treatment|Protocol Violation|2|||
155264769|NCT04615182|560402879|FG000|Overall Study|Re-transplanted|2|||
155264770|NCT04615182|560402879|FG000|Overall Study|Protocol Violation|6|||
155264771|NCT04615182|560402879|FG000|Overall Study|Death|6|||
155264772|NCT04615182|560402879|FG000|Overall Study|Death and protocol violation|1|||
155264773|NCT01126060|560402880|FG000|Overall Study|Protocol Violation|0|||
155264774|NCT01126060|560402881|FG001|Overall Study|Protocol Violation|2|||
155264775|NCT00402337|560402882|FG000|Overall Study|Adverse Event|0|||
155264776|NCT00402337|560402883|FG001|Overall Study|Adverse Event|2|||
155264777|NCT00402337|560402884|FG002|Overall Study|Adverse Event|2|||
155264778|NCT00402337|560402885|FG003|Overall Study|Adverse Event|3|||
155264779|NCT00402337|560402886|FG004|Overall Study|Adverse Event|2|||
155264780|NCT00402337|560402882|FG000|Overall Study|Noncompliance|0|||
155264781|NCT00402337|560402883|FG001|Overall Study|Noncompliance|0|||
155264782|NCT00402337|560402884|FG002|Overall Study|Noncompliance|0|||
155264783|NCT00402337|560402885|FG003|Overall Study|Noncompliance|0|||
155264784|NCT00402337|560402886|FG004|Overall Study|Noncompliance|2|||
155264785|NCT00402337|560402882|FG000|Overall Study|Withdrawal by Subject|5|||
155264786|NCT00402337|560402883|FG001|Overall Study|Withdrawal by Subject|3|||
155264787|NCT00402337|560402884|FG002|Overall Study|Withdrawal by Subject|1|||
155264788|NCT00402337|560402885|FG003|Overall Study|Withdrawal by Subject|6|||
155264789|NCT00402337|560402886|FG004|Overall Study|Withdrawal by Subject|4|||
155264790|NCT00402337|560402882|FG000|Overall Study|Lost to Follow-up|0|||
155264791|NCT00402337|560402883|FG001|Overall Study|Lost to Follow-up|0|||
155264792|NCT00402337|560402884|FG002|Overall Study|Lost to Follow-up|1|||
155264793|NCT00402337|560402885|FG003|Overall Study|Lost to Follow-up|2|||
155264794|NCT00402337|560402886|FG004|Overall Study|Lost to Follow-up|0|||
155264795|NCT00402337|560402882|FG000|Overall Study|Physician Decision|0|||
155264796|NCT00402337|560402883|FG001|Overall Study|Physician Decision|0|||
155264797|NCT00402337|560402884|FG002|Overall Study|Physician Decision|0|||
155264798|NCT00402337|560402885|FG003|Overall Study|Physician Decision|1|||
155264799|NCT00402337|560402886|FG004|Overall Study|Physician Decision|0|||
155264800|NCT00402337|560402882|FG000|Overall Study|Other Reason|0|||
155264801|NCT00402337|560402883|FG001|Overall Study|Other Reason|1|||
155264802|NCT00402337|560402884|FG002|Overall Study|Other Reason|0|||
155264803|NCT00402337|560402885|FG003|Overall Study|Other Reason|0|||
155264804|NCT00402337|560402886|FG004|Overall Study|Other Reason|0|||
155264805|NCT03565068|560402887|FG000|Overall Study|Protocol Violation|0|||
155264806|NCT03565068|560402888|FG001|Overall Study|Protocol Violation|0|||
155264807|NCT03565068|560402889|FG002|Overall Study|Protocol Violation|0|||
155264808|NCT03565068|560402890|FG003|Overall Study|Protocol Violation|0|||
155264809|NCT03565068|560402891|FG004|Overall Study|Protocol Violation|1|||
155264810|NCT03565068|560402892|FG005|Overall Study|Protocol Violation|0|||
155264811|NCT03565068|560402893|FG006|Overall Study|Protocol Violation|0|||
155264812|NCT03565068|560402894|FG007|Overall Study|Protocol Violation|1|||
155264813|NCT03565068|560402895|FG008|Overall Study|Protocol Violation|0|||
155264814|NCT03565068|560402887|FG000|Overall Study|Sponsor decision|0|||
155264815|NCT03565068|560402888|FG001|Overall Study|Sponsor decision|0|||
155264816|NCT03565068|560402889|FG002|Overall Study|Sponsor decision|0|||
155264817|NCT03565068|560402890|FG003|Overall Study|Sponsor decision|0|||
155264818|NCT03565068|560402891|FG004|Overall Study|Sponsor decision|1|||
155264819|NCT03565068|560402892|FG005|Overall Study|Sponsor decision|1|||
155264820|NCT03565068|560402893|FG006|Overall Study|Sponsor decision|0|||
155264821|NCT03565068|560402894|FG007|Overall Study|Sponsor decision|0|||
155264822|NCT03565068|560402895|FG008|Overall Study|Sponsor decision|0|||
155264823|NCT03565068|560402887|FG000|Overall Study|Withdrawal by Subject|0|||
155264824|NCT03565068|560402888|FG001|Overall Study|Withdrawal by Subject|0|||
155264825|NCT03565068|560402889|FG002|Overall Study|Withdrawal by Subject|1|||
155264826|NCT03565068|560402890|FG003|Overall Study|Withdrawal by Subject|0|||
155264827|NCT03565068|560402891|FG004|Overall Study|Withdrawal by Subject|2|||
155264828|NCT03565068|560402892|FG005|Overall Study|Withdrawal by Subject|0|||
155264829|NCT03565068|560402893|FG006|Overall Study|Withdrawal by Subject|1|||
155264830|NCT03565068|560402894|FG007|Overall Study|Withdrawal by Subject|5|||
155264831|NCT03565068|560402895|FG008|Overall Study|Withdrawal by Subject|1|||
155264832|NCT03565068|560402887|FG000|Overall Study|Physician Decision|0|||
155264833|NCT03565068|560402888|FG001|Overall Study|Physician Decision|0|||
155264834|NCT03565068|560402889|FG002|Overall Study|Physician Decision|0|||
155264835|NCT03565068|560402890|FG003|Overall Study|Physician Decision|0|||
155264836|NCT03565068|560402891|FG004|Overall Study|Physician Decision|0|||
155264837|NCT03565068|560402892|FG005|Overall Study|Physician Decision|0|||
155264838|NCT03565068|560402893|FG006|Overall Study|Physician Decision|0|||
155264839|NCT03565068|560402894|FG007|Overall Study|Physician Decision|1|||
155264840|NCT03565068|560402895|FG008|Overall Study|Physician Decision|0|||
155264841|NCT03565068|560402887|FG000|Overall Study|Lost to Follow-up|0|||
155264842|NCT03565068|560402888|FG001|Overall Study|Lost to Follow-up|0|||
155264843|NCT03565068|560402889|FG002|Overall Study|Lost to Follow-up|0|||
155264844|NCT03565068|560402890|FG003|Overall Study|Lost to Follow-up|0|||
155264845|NCT03565068|560402891|FG004|Overall Study|Lost to Follow-up|0|||
155264846|NCT03565068|560402892|FG005|Overall Study|Lost to Follow-up|0|||
155264847|NCT03565068|560402893|FG006|Overall Study|Lost to Follow-up|0|||
155264848|NCT03565068|560402894|FG007|Overall Study|Lost to Follow-up|1|||
155264849|NCT03565068|560402895|FG008|Overall Study|Lost to Follow-up|0|||
155264850|NCT02764775|560404986|FG000|Overall Study|Death|1|||
155264851|NCT02764775|560404986|FG000|Overall Study|Lost to Follow-up|2|||
155264852|NCT02764775|560404986|FG000|Overall Study|Withdrawal by Subject|3|||
155264853|NCT00429494|560404987|FG000|Overall Study|Withdrawal by Subject|9|||
155264854|NCT00429494|560404987|FG000|Overall Study|Death|6|||
155264855|NCT00976703|560404990|FG000|Overall Study|Physician Decision|1|||
155264856|NCT00976703|560404991|FG001|Overall Study|Physician Decision|1|||
155264857|NCT00976703|560404990|FG000|Overall Study|ineligible for study|2|||
155264858|NCT00976703|560404991|FG001|Overall Study|ineligible for study|2|||
155264859|NCT02243631|560404994|FG000|Overall Study|no synovial fluid on second aspirate|0|||
155264860|NCT02243631|560404995|FG001|Overall Study|no synovial fluid on second aspirate|1|||
155264861|NCT01992549|560405000|FG000|Overall Study|Lost to Follow-up|2|||
155264862|NCT01992549|560405000|FG000|Overall Study|Serious Adverse Event|1|||
155264863|NCT01992549|560405000|FG000|Overall Study|Product Switch to Extend Half Life|1|||
155264864|NCT00840996|560405002|FG000|Overall Study|Withdrawal by Subject|1|||
155264865|NCT00840996|560405003|FG001|Overall Study|Withdrawal by Subject|0|||
155264866|NCT04022889|560405004|FG000|Stage 1: Period 1|Adverse Event|1|||
155264867|NCT04022889|560405005|FG001|Stage 1: Period 1|Adverse Event|0|||
155264868|NCT04022889|560405006|FG002|Stage 1: Period 1|Adverse Event|0|||
155264869|NCT04022889|560405004|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
155264870|NCT04022889|560405005|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
155264871|NCT04022889|560405006|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
155264872|NCT04022889|560405004|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
155264873|NCT04022889|560405005|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
155264874|NCT04022889|560405006|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
155264875|NCT04022889|560405004|FG000|Stage 2|Screen Failure|0|||
155264876|NCT04022889|560405005|FG001|Stage 2|Screen Failure|0|||
155264877|NCT04022889|560405006|FG002|Stage 2|Screen Failure|3|||
155264878|NCT04022889|560405004|FG000|Stage 2|Ineligible for apheresis donation|0|||
155264879|NCT04022889|560405005|FG001|Stage 2|Ineligible for apheresis donation|0|||
155264880|NCT04022889|560405006|FG002|Stage 2|Ineligible for apheresis donation|2|||
155264881|NCT04022889|560405004|FG000|Stage 2|Adverse Event|0|||
155264882|NCT04022889|560405005|FG001|Stage 2|Adverse Event|0|||
155264883|NCT04022889|560405006|FG002|Stage 2|Adverse Event|2|||
155264884|NCT04022889|560405004|FG000|Stage 2|Protocol Violation|0|||
155264885|NCT04022889|560405005|FG001|Stage 2|Protocol Violation|0|||
155264886|NCT04022889|560405006|FG002|Stage 2|Protocol Violation|1|||
155264887|NCT04022889|560405004|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
155264888|NCT04022889|560405005|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
155264889|NCT04022889|560405006|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
155264890|NCT01900054|560405010|FG000|Overall Study|Physician Decision|1|||
155264891|NCT01900054|560405010|FG000|Overall Study|Withdrawal by Subject|1|||
155264892|NCT02762981|560405013|FG000|Overall Study|Adverse Event|2|||
155264893|NCT02762981|560405014|FG001|Overall Study|Adverse Event|3|||
155264894|NCT02762981|560405015|FG002|Overall Study|Adverse Event|1|||
155264895|NCT02762981|560405016|FG003|Overall Study|Adverse Event|1|||
155264896|NCT02762981|560405017|FG004|Overall Study|Adverse Event|3|||
155264897|NCT02762981|560405013|FG000|Overall Study|Physician Decision|0|||
155264898|NCT02762981|560405014|FG001|Overall Study|Physician Decision|1|||
155264899|NCT02762981|560405015|FG002|Overall Study|Physician Decision|0|||
155264900|NCT02762981|560405016|FG003|Overall Study|Physician Decision|0|||
155264901|NCT02762981|560405017|FG004|Overall Study|Physician Decision|1|||
155264902|NCT02762981|560405013|FG000|Overall Study|Disease progression|11|||
155264903|NCT02762981|560405014|FG001|Overall Study|Disease progression|23|||
155264904|NCT02762981|560405015|FG002|Overall Study|Disease progression|4|||
155264905|NCT02762981|560405016|FG003|Overall Study|Disease progression|10|||
155264906|NCT02762981|560405017|FG004|Overall Study|Disease progression|1|||
155264907|NCT02762981|560405013|FG000|Overall Study|Enrolled not treated|1|||
155264908|NCT02762981|560405014|FG001|Overall Study|Enrolled not treated|5|||
155264909|NCT02762981|560405015|FG002|Overall Study|Enrolled not treated|0|||
155264910|NCT02762981|560405016|FG003|Overall Study|Enrolled not treated|2|||
155264911|NCT02762981|560405017|FG004|Overall Study|Enrolled not treated|0|||
155264912|NCT02762981|560405013|FG000|Overall Study|Other|2|||
155264913|NCT02762981|560405014|FG001|Overall Study|Other|3|||
155264914|NCT02762981|560405015|FG002|Overall Study|Other|1|||
155264915|NCT02762981|560405016|FG003|Overall Study|Other|0|||
155264916|NCT02762981|560405017|FG004|Overall Study|Other|0|||
155264917|NCT02762981|560405013|FG000|Overall Study|Missing|1|||
155264918|NCT02762981|560405014|FG001|Overall Study|Missing|0|||
155264919|NCT02762981|560405015|FG002|Overall Study|Missing|0|||
155264920|NCT02762981|560405016|FG003|Overall Study|Missing|0|||
155264921|NCT02762981|560405017|FG004|Overall Study|Missing|0|||
155264922|NCT02762981|560405013|FG000|Overall Study|Withdrawal by Subject|0|||
155264923|NCT02762981|560405014|FG001|Overall Study|Withdrawal by Subject|5|||
155264924|NCT02762981|560405015|FG002|Overall Study|Withdrawal by Subject|1|||
155264925|NCT02762981|560405016|FG003|Overall Study|Withdrawal by Subject|3|||
155264926|NCT02762981|560405017|FG004|Overall Study|Withdrawal by Subject|0|||
155264927|NCT00957931|560405018|FG000|Overall Study|Death|4|||
155264928|NCT00605319|560405023|FG000|Overall Study|Adverse Event|6|||
155264929|NCT02991482|560405025|FG000|Overall Study|Disease progression|56|||
155264930|NCT02991482|560405026|FG001|Overall Study|Disease progression|47|||
155264931|NCT02991482|560405025|FG000|Overall Study|Death|4|||
155264932|NCT02991482|560405026|FG001|Overall Study|Death|4|||
155264933|NCT02991482|560405025|FG000|Overall Study|Adverse Event|1|||
155264934|NCT02991482|560405026|FG001|Overall Study|Adverse Event|6|||
155264935|NCT02991482|560405025|FG000|Overall Study|Patient decision|1|||
155264936|NCT02991482|560405026|FG001|Overall Study|Patient decision|1|||
155264937|NCT02991482|560405025|FG000|Overall Study|Physician Decision|0|||
155264938|NCT02991482|560405026|FG001|Overall Study|Physician Decision|6|||
155264939|NCT02991482|560405025|FG000|Overall Study|Clinical deterioration|1|||
155264940|NCT02991482|560405026|FG001|Overall Study|Clinical deterioration|0|||
155264941|NCT02991482|560405025|FG000|Overall Study|Patient feeling too unwell|1|||
155264942|NCT02991482|560405026|FG001|Overall Study|Patient feeling too unwell|0|||
155264943|NCT02991482|560405025|FG000|Overall Study|Worsening of performance status|0|||
155264944|NCT02991482|560405026|FG001|Overall Study|Worsening of performance status|1|||
155264945|NCT02991482|560405025|FG000|Overall Study|Death prior to study drug initiation|1|||
155264946|NCT02991482|560405026|FG001|Overall Study|Death prior to study drug initiation|0|||
155264947|NCT02991482|560405025|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
155264948|NCT02991482|560405026|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
155264949|NCT02887989|560405027|FG000|Overall Study|Withdrawal by Subject|8|||
155264950|NCT02887989|560405028|FG001|Overall Study|Withdrawal by Subject|11|||
155264951|NCT02887989|560405027|FG000|Overall Study|Death|1|||
155264952|NCT02887989|560405028|FG001|Overall Study|Death|0|||
155264953|NCT02045433|560405029|FG000|Overall Study|Withdrawal by Subject|1|||
155264954|NCT01559454|560405030|FG000|Overall Study|Lost to Follow-up|3|||
155264955|NCT01559454|560405031|FG001|Overall Study|Lost to Follow-up|2|||
155264956|NCT01559454|560405030|FG000|Overall Study|Withdrawal by Subject|0|||
155264957|NCT01559454|560405031|FG001|Overall Study|Withdrawal by Subject|1|||
155264958|NCT01559454|560405030|FG000|Overall Study|Physician Decision|0|||
155264959|NCT01559454|560405031|FG001|Overall Study|Physician Decision|1|||
155264960|NCT01559454|560405030|FG000|Overall Study|Protocol Violation|0|||
155264961|NCT01559454|560405031|FG001|Overall Study|Protocol Violation|1|||
155264962|NCT01559454|560405030|FG000|Overall Study|Lack of Efficacy|0|||
155264963|NCT01559454|560405031|FG001|Overall Study|Lack of Efficacy|1|||
155264964|NCT00462670|560405036|FG000|Overall Study|Adverse Event|3|||
155264965|NCT00462670|560405037|FG001|Overall Study|Adverse Event|5|||
155264966|NCT00462670|560405036|FG000|Overall Study|Lack of Efficacy|1|||
155264967|NCT00462670|560405037|FG001|Overall Study|Lack of Efficacy|0|||
155264968|NCT00462670|560405036|FG000|Overall Study|Protocol Violation|1|||
155264969|NCT00462670|560405037|FG001|Overall Study|Protocol Violation|0|||
155264970|NCT00462670|560405036|FG000|Overall Study|Resolution of signs and symptoms|0|||
155264971|NCT00462670|560405037|FG001|Overall Study|Resolution of signs and symptoms|2|||
155264972|NCT00482274|560405038|FG000|Overall Study|Adverse Event|1|||
155264973|NCT03075904|560405045|FG000|Overall Study|Physician Decision|3|||
155264974|NCT03075904|560405045|FG000|Overall Study|Need for Medication not Permitted|1|||
155264975|NCT01588990|560405046|FG000|Phase A|Withdrawal by Subject|5|||
155264976|NCT01588990|560405046|FG000|Phase A|Physician Decision|11|||
155264977|NCT01588990|560405046|FG000|Phase A|Other|14|||
155264978|NCT01588990|560405046|FG000|Phase A|Lost to Follow-up|1|||
155264979|NCT01588990|560405046|FG000|Phase A|Death|5|||
155264980|NCT01588990|560405046|FG000|Phase A|Adverse Event|28|||
155264981|NCT01588990|560405046|FG000|Phase A|Still on therapy at end of study|6|||
155264982|NCT01588990|560405046|FG000|Phase B|Adverse Event|2|||
155264983|NCT01588990|560405046|FG000|Phase B|Still on therapy at end of study|5|||
155264984|NCT01588990|560405046|FG000|Phase B|Withdrawal by Subject|3|||
155264985|NCT01588990|560405046|FG000|Phase B|Physician Decision|4|||
155264986|NCT01588990|560405046|FG000|Phase B|Other|2|||
155264987|NCT01287520|560405047|FG000|Overall Study|Adverse Event|2|||
155264988|NCT01287520|560405048|FG001|Overall Study|Adverse Event|2|||
155264989|NCT01287520|560405049|FG002|Overall Study|Adverse Event|2|||
155264990|NCT01287520|560405050|FG003|Overall Study|Adverse Event|1|||
155264991|NCT01287520|560405051|FG004|Overall Study|Adverse Event|1|||
155264992|NCT01287520|560405052|FG005|Overall Study|Adverse Event|2|||
155264993|NCT01287520|560405053|FG006|Overall Study|Adverse Event|0|||
155264994|NCT01287520|560405054|FG007|Overall Study|Adverse Event|2|||
155264995|NCT01287520|560405055|FG008|Overall Study|Adverse Event|0|||
155264996|NCT01287520|560405047|FG000|Overall Study|Physician Decision|1|||
155264997|NCT01287520|560405048|FG001|Overall Study|Physician Decision|1|||
155264998|NCT01287520|560405049|FG002|Overall Study|Physician Decision|2|||
155264999|NCT01287520|560405050|FG003|Overall Study|Physician Decision|0|||
155265000|NCT01287520|560405051|FG004|Overall Study|Physician Decision|1|||
155265001|NCT01287520|560405052|FG005|Overall Study|Physician Decision|1|||
155265002|NCT01287520|560405053|FG006|Overall Study|Physician Decision|0|||
155265003|NCT01287520|560405054|FG007|Overall Study|Physician Decision|1|||
155265004|NCT01287520|560405055|FG008|Overall Study|Physician Decision|0|||
155265005|NCT01287520|560405047|FG000|Overall Study|Progressive disease|0|||
155265006|NCT01287520|560405048|FG001|Overall Study|Progressive disease|4|||
155265007|NCT01287520|560405049|FG002|Overall Study|Progressive disease|1|||
155265008|NCT01287520|560405050|FG003|Overall Study|Progressive disease|6|||
155265009|NCT01287520|560405051|FG004|Overall Study|Progressive disease|1|||
155265010|NCT01287520|560405052|FG005|Overall Study|Progressive disease|0|||
155265011|NCT01287520|560405053|FG006|Overall Study|Progressive disease|2|||
155265012|NCT01287520|560405054|FG007|Overall Study|Progressive disease|2|||
155265013|NCT01287520|560405055|FG008|Overall Study|Progressive disease|4|||
155265014|NCT01287520|560405047|FG000|Overall Study|Withdrawal by Subject|0|||
155265015|NCT01287520|560405048|FG001|Overall Study|Withdrawal by Subject|0|||
155265016|NCT01287520|560405049|FG002|Overall Study|Withdrawal by Subject|0|||
155265017|NCT01287520|560405050|FG003|Overall Study|Withdrawal by Subject|0|||
155265018|NCT01287520|560405051|FG004|Overall Study|Withdrawal by Subject|0|||
155265019|NCT01287520|560405052|FG005|Overall Study|Withdrawal by Subject|1|||
155265020|NCT01287520|560405053|FG006|Overall Study|Withdrawal by Subject|0|||
155265021|NCT01287520|560405054|FG007|Overall Study|Withdrawal by Subject|0|||
155265022|NCT01287520|560405055|FG008|Overall Study|Withdrawal by Subject|1|||
155265023|NCT03587142|560405056|FG000|Overall Study|Lost to Follow-up|5|||
155265024|NCT03587142|560405057|FG001|Overall Study|Lost to Follow-up|3|||
155265025|NCT03587142|560405056|FG000|Overall Study|Did not complete the f4 visit|3|||
155265026|NCT03587142|560405057|FG001|Overall Study|Did not complete the f4 visit|7|||
155265027|NCT01800201|560405058|FG000|Overall Study|Withdrawal by Subject|2|||
155265028|NCT01800201|560405059|FG001|Overall Study|Withdrawal by Subject|0|||
155265029|NCT01800201|560405058|FG000|Overall Study|patient privacy concerns|1|||
155265030|NCT01800201|560405059|FG001|Overall Study|patient privacy concerns|1|||
155265031|NCT01800201|560405058|FG000|Overall Study|did not want to use device|0|||
155265032|NCT01800201|560405059|FG001|Overall Study|did not want to use device|1|||
155265033|NCT01800201|560405058|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
155265034|NCT01800201|560405059|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
155265035|NCT04503096|560405062|FG000|Overall Study|Withdrawal by Subject|3|||
155265036|NCT01576367|560405063|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155265037|NCT01576367|560405063|FG000|Overall Study|Moved to commercial use after 6 months|1|||
155265038|NCT04359771|560405067|FG000|Overall Study|Lack of Efficacy|2|||
155265039|NCT04359771|560405068|FG001|Overall Study|Lack of Efficacy|2|||
155265040|NCT00909480|560405073|FG000|Overall Study|Adverse Event|5|||
155265041|NCT00909480|560405074|FG001|Overall Study|Adverse Event|3|||
155265042|NCT00909480|560405073|FG000|Overall Study|Protocol Violation|6|||
155265043|NCT00909480|560405074|FG001|Overall Study|Protocol Violation|8|||
155265044|NCT00909480|560405073|FG000|Overall Study|Withdrawal criteria|9|||
155265045|NCT00909480|560405074|FG001|Overall Study|Withdrawal criteria|11|||
155265046|NCT00909480|560405073|FG000|Overall Study|Unclassified|18|||
155265047|NCT00909480|560405074|FG001|Overall Study|Unclassified|19|||
155265048|NCT03528174|560405077|FG000|Overall Study|Adverse Event|1|||
155265049|NCT03528174|560405077|FG000|Overall Study|sensors dislodged|1|||
155265050|NCT02904902|560405080|FG000|Overall Study|Withdrawal by Subject|1|||
155265051|NCT01719237|560405081|FG000|Overall Study|Physician Decision|0|||
155265052|NCT01719237|560405082|FG001|Overall Study|Physician Decision|1|||
155265053|NCT02118337|560405090|FG000|Overall Study|Other|1|||
155265054|NCT02118337|560405091|FG001|Overall Study|Other|0|||
155265055|NCT02118337|560405092|FG002|Overall Study|Other|0|||
155265056|NCT02118337|560405093|FG003|Overall Study|Other|0|||
155265057|NCT02118337|560405094|FG004|Overall Study|Other|2|||
155265058|NCT02118337|560405095|FG005|Overall Study|Other|3|||
155265059|NCT02118337|560405096|FG006|Overall Study|Other|1|||
155265060|NCT02118337|560405097|FG007|Overall Study|Other|28|||
155265061|NCT02118337|560405098|FG008|Overall Study|Other|15|||
155265062|NCT02118337|560405090|FG000|Overall Study|Lost to Follow-up|0|||
155265063|NCT02118337|560405091|FG001|Overall Study|Lost to Follow-up|0|||
155265064|NCT02118337|560405092|FG002|Overall Study|Lost to Follow-up|0|||
155265065|NCT02118337|560405093|FG003|Overall Study|Lost to Follow-up|0|||
155265066|NCT02118337|560405094|FG004|Overall Study|Lost to Follow-up|0|||
155265067|NCT02118337|560405095|FG005|Overall Study|Lost to Follow-up|0|||
155265068|NCT02118337|560405096|FG006|Overall Study|Lost to Follow-up|0|||
155265069|NCT02118337|560405097|FG007|Overall Study|Lost to Follow-up|1|||
155265070|NCT02118337|560405098|FG008|Overall Study|Lost to Follow-up|0|||
155265071|NCT02118337|560405090|FG000|Overall Study|Withdrawal by Subject|1|||
155265072|NCT02118337|560405091|FG001|Overall Study|Withdrawal by Subject|3|||
155265073|NCT02118337|560405092|FG002|Overall Study|Withdrawal by Subject|2|||
155265074|NCT02118337|560405093|FG003|Overall Study|Withdrawal by Subject|1|||
155265075|NCT02118337|560405094|FG004|Overall Study|Withdrawal by Subject|2|||
155265076|NCT02118337|560405095|FG005|Overall Study|Withdrawal by Subject|2|||
155265077|NCT02118337|560405096|FG006|Overall Study|Withdrawal by Subject|1|||
155265078|NCT02118337|560405097|FG007|Overall Study|Withdrawal by Subject|4|||
155265079|NCT02118337|560405098|FG008|Overall Study|Withdrawal by Subject|2|||
155265080|NCT02118337|560405090|FG000|Overall Study|Death|2|||
155265081|NCT02118337|560405091|FG001|Overall Study|Death|2|||
155265082|NCT02118337|560405092|FG002|Overall Study|Death|1|||
155265083|NCT02118337|560405093|FG003|Overall Study|Death|2|||
155265084|NCT02118337|560405094|FG004|Overall Study|Death|5|||
155265085|NCT02118337|560405095|FG005|Overall Study|Death|1|||
155265086|NCT02118337|560405096|FG006|Overall Study|Death|2|||
155265087|NCT02118337|560405097|FG007|Overall Study|Death|9|||
155265088|NCT02118337|560405098|FG008|Overall Study|Death|4|||
155265089|NCT00453102|560405100|FG000|Overall Study|Withdrawal by Subject|2|||
155265090|NCT05400746|560405105|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
155265091|NCT05400746|560405106|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
155265092|NCT05400746|560405107|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
155265093|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
155265094|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
155265095|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
155265096|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265097|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265098|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265099|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
155265100|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Physician Decision|4|||
155265101|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Physician Decision|1|||
155265102|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Physician Decision|3|||
155265103|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Physician Decision|0|||
155265104|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Physician Decision|0|||
155265105|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Physician Decision|1|||
155265106|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Physician Decision|0|||
155265107|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Other|0|||
155265108|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Other|1|||
155265109|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Other|0|||
155265110|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Other|0|||
155265111|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Other|0|||
155265112|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Other|0|||
155265113|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Other|0|||
155265114|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265115|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265116|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265117|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265118|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265119|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265120|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
155265121|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
155265122|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
155265123|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
155265124|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
155265125|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
155265126|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
155265127|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
155265128|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Pregnancy|0|||
155265129|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Pregnancy|0|||
155265130|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Pregnancy|1|||
155265131|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Pregnancy|0|||
155265132|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Pregnancy|0|||
155265133|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Pregnancy|0|||
155265134|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Pregnancy|0|||
155265135|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265136|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265137|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
155265138|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265139|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265140|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265141|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265142|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265143|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265144|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265145|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265146|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265147|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265148|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265149|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Other|0|||
155265150|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Other|1|||
155265151|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Other|0|||
155265152|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Other|0|||
155265153|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Other|0|||
155265154|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Other|0|||
155265155|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Other|0|||
155265156|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
155265157|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265158|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
155265159|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265160|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265161|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265162|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265163|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265164|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
155265165|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265166|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
155265167|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265168|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265169|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
155265170|NCT03724396|560405115|FG000|Overall Study|Lost to Follow-up|1|||
155265171|NCT03724396|560405116|FG001|Overall Study|Lost to Follow-up|1|||
155265172|NCT03724396|560405115|FG000|Overall Study|Withdrawal by Subject|1|||
155265173|NCT03724396|560405116|FG001|Overall Study|Withdrawal by Subject|0|||
155265174|NCT03489057|560405117|FG000|Overall Study|Lost to Follow-up|16|||
155265175|NCT03489057|560405118|FG001|Overall Study|Lost to Follow-up|16|||
155265176|NCT03489057|560405119|FG002|Overall Study|Lost to Follow-up|14|||
155265177|NCT03489057|560405120|FG003|Overall Study|Lost to Follow-up|14|||
155265178|NCT03489057|560405117|FG000|Overall Study|Withdrawal by Subject|12|||
155265179|NCT03489057|560405118|FG001|Overall Study|Withdrawal by Subject|12|||
155265180|NCT03489057|560405119|FG002|Overall Study|Withdrawal by Subject|8|||
155265181|NCT03489057|560405120|FG003|Overall Study|Withdrawal by Subject|8|||
155265182|NCT03489057|560405117|FG000|Overall Study|Protocol Violation|7|||
155265183|NCT03489057|560405118|FG001|Overall Study|Protocol Violation|7|||
155265184|NCT03489057|560405119|FG002|Overall Study|Protocol Violation|2|||
155265185|NCT03489057|560405120|FG003|Overall Study|Protocol Violation|2|||
155265186|NCT00943306|560405123|FG000|Overall Study|Physician Decision|1|||
155265187|NCT00943306|560405123|FG000|Overall Study|Death|1|||
155265188|NCT00943306|560405123|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
155265189|NCT00733980|560405124|FG000|Overall Study|Adverse Event|5|||
155265190|NCT00733980|560405125|FG001|Overall Study|Adverse Event|2|||
155265191|NCT00733980|560405124|FG000|Overall Study|Lack of Efficacy|0|||
155265192|NCT00733980|560405125|FG001|Overall Study|Lack of Efficacy|1|||
155265193|NCT00733980|560405124|FG000|Overall Study|Protocol Violation|2|||
155265194|NCT00733980|560405125|FG001|Overall Study|Protocol Violation|1|||
155265195|NCT00733980|560405124|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
155265196|NCT00733980|560405125|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
155265197|NCT00733980|560405124|FG000|Overall Study|Lost to Follow-up|6|||
155265198|NCT00733980|560405125|FG001|Overall Study|Lost to Follow-up|11|||
155265199|NCT00733980|560405124|FG000|Overall Study|Physician Decision|2|||
155265200|NCT00733980|560405125|FG001|Overall Study|Physician Decision|3|||
155265201|NCT00733980|560405124|FG000|Overall Study|Withdrawal by Subject|6|||
155265202|NCT00733980|560405125|FG001|Overall Study|Withdrawal by Subject|2|||
155265203|NCT02739347|560405126|FG000|Overall Study|Adverse Event|3|||
155265204|NCT02739347|560405127|FG001|Overall Study|Adverse Event|0|||
155265205|NCT02739347|560405126|FG000|Overall Study|Protocol Violation|0|||
155265206|NCT02739347|560405127|FG001|Overall Study|Protocol Violation|1|||
155265207|NCT02739347|560405126|FG000|Overall Study|Lost to Follow-up|0|||
155265208|NCT02739347|560405127|FG001|Overall Study|Lost to Follow-up|2|||
155265209|NCT01235403|560405129|FG000|Overall Study|Adverse Event|14|||
155265210|NCT01235403|560405129|FG000|Overall Study|Lost to Follow-up|2|||
155265211|NCT01235403|560405129|FG000|Overall Study|Withdrawal by Subject|4|||
155265212|NCT01235403|560405129|FG000|Overall Study|Lack of Efficacy|2|||
155265213|NCT01235403|560405129|FG000|Overall Study|Other reasons for premature termination|4|||
155265214|NCT03682705|560405130|FG000|Overall Study|Adverse Event|1|||
155265215|NCT03682705|560405131|FG001|Overall Study|Adverse Event|1|||
155265216|NCT03682705|560405132|FG002|Overall Study|Adverse Event|1|||
155265217|NCT03682705|560405133|FG003|Overall Study|Adverse Event|0|||
155265218|NCT03682705|560405134|FG004|Overall Study|Adverse Event|1|||
155265219|NCT03682705|560405135|FG005|Overall Study|Adverse Event|1|||
155265220|NCT03682705|560405130|FG000|Overall Study|Withdrawal by Subject|1|||
155265221|NCT03682705|560405131|FG001|Overall Study|Withdrawal by Subject|3|||
155265222|NCT03682705|560405132|FG002|Overall Study|Withdrawal by Subject|2|||
155265223|NCT03682705|560405133|FG003|Overall Study|Withdrawal by Subject|4|||
155265224|NCT03682705|560405134|FG004|Overall Study|Withdrawal by Subject|0|||
155265225|NCT03682705|560405135|FG005|Overall Study|Withdrawal by Subject|1|||
155265226|NCT03682705|560405130|FG000|Overall Study|Other, not specified|0|||
155265227|NCT03682705|560405131|FG001|Overall Study|Other, not specified|0|||
155265228|NCT03682705|560405132|FG002|Overall Study|Other, not specified|0|||
155265229|NCT03682705|560405133|FG003|Overall Study|Other, not specified|1|||
155265230|NCT03682705|560405134|FG004|Overall Study|Other, not specified|2|||
155265231|NCT03682705|560405135|FG005|Overall Study|Other, not specified|0|||
155265232|NCT03682705|560405130|FG000|Overall Study|Lost to Follow-up|0|||
155265233|NCT03682705|560405131|FG001|Overall Study|Lost to Follow-up|0|||
155265234|NCT03682705|560405132|FG002|Overall Study|Lost to Follow-up|0|||
155265235|NCT03682705|560405133|FG003|Overall Study|Lost to Follow-up|0|||
155265236|NCT03682705|560405134|FG004|Overall Study|Lost to Follow-up|3|||
155265237|NCT03682705|560405135|FG005|Overall Study|Lost to Follow-up|0|||
155265238|NCT00265330|560405136|FG000|Overall Study|Adverse Event|41|||
155265239|NCT00265330|560405136|FG000|Overall Study|Lost to Follow-up|8|||
155265240|NCT00265330|560405136|FG000|Overall Study|Withdrawal by Subject|34|||
155265241|NCT00265330|560405136|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
155265242|NCT00265330|560405136|FG000|Overall Study|Lack of Efficacy|4|||
155265243|NCT00265330|560405136|FG000|Overall Study|Family Scheduling Conflicts|1|||
155265244|NCT00265330|560405136|FG000|Overall Study|Began Taking Formulary Geodon|1|||
155265245|NCT00265330|560405136|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
155265246|NCT00265330|560405136|FG000|Overall Study|Site Closed by Sponsor|1|||
155265247|NCT00265330|560405136|FG000|Overall Study|Principal Investigators Request|1|||
155265248|NCT00265330|560405136|FG000|Overall Study|Withdrew Consent|1|||
155265249|NCT00265330|560405136|FG000|Overall Study|Protocol Violation|1|||
155265250|NCT04043962|560405137|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
155265251|NCT04043962|560405137|FG000|Post-Treatment|Withdrawal by Subject|5|||
155265252|NCT04043962|560405137|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
155265253|NCT02658630|560405138|FG000|Overall Study|Withdrawal by Subject|4|||
155265254|NCT02613221|560405139|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
155265255|NCT02613221|560405139|FG000|Overall Study|Adverse Event|2|||
155265256|NCT02613221|560405139|FG000|Overall Study|Voluntary Discontinuation|1|||
155265257|NCT02613221|560405139|FG000|Overall Study|Delayed Treatment|1|||
155265258|NCT02613221|560405139|FG000|Overall Study|Enrolled but Not Treated|1|||
155265259|NCT01786330|560405147|FG000|Overall Study|Withdrawal by Subject|0|||
155265260|NCT01786330|560405148|FG001|Overall Study|Withdrawal by Subject|1|||
155265261|NCT01786330|560405147|FG000|Overall Study|Lost to Follow-up|0|||
155265262|NCT01786330|560405148|FG001|Overall Study|Lost to Follow-up|1|||
155265263|NCT01786330|560405147|FG000|Overall Study|Excluded intraoperatively|0|||
155265264|NCT01786330|560405148|FG001|Overall Study|Excluded intraoperatively|1|||
155265265|NCT01786330|560405147|FG000|Overall Study|Protocol Violation|1|||
155265266|NCT01786330|560405148|FG001|Overall Study|Protocol Violation|0|||
155265267|NCT00311155|560406987|FG000|Overall Study|Adverse Event|21|||
155265268|NCT00311155|560406987|FG000|Overall Study|Withdrawal by Subject|17|||
155265269|NCT00311155|560406987|FG000|Overall Study|Did not meet entry criteria|55|||
155265270|NCT01590771|560406993|FG000|Overall Study|Other Protocol Specified Criteria|5|||
155265271|NCT01590771|560406994|FG001|Overall Study|Other Protocol Specified Criteria|14|||
155265272|NCT01590771|560406993|FG000|Overall Study|Withdrawal by Subject|8|||
155265273|NCT01590771|560406994|FG001|Overall Study|Withdrawal by Subject|15|||
155265274|NCT01590771|560406993|FG000|Overall Study|Protocol Violation|1|||
155265275|NCT01590771|560406994|FG001|Overall Study|Protocol Violation|2|||
155265276|NCT01590771|560406993|FG000|Overall Study|Lost to Follow-up|1|||
155265277|NCT01590771|560406994|FG001|Overall Study|Lost to Follow-up|1|||
155265278|NCT01590771|560406993|FG000|Overall Study|Lack of Efficacy|1|||
155265279|NCT01590771|560406994|FG001|Overall Study|Lack of Efficacy|0|||
155265280|NCT01590771|560406993|FG000|Overall Study|Adverse Event|3|||
155265281|NCT01590771|560406994|FG001|Overall Study|Adverse Event|7|||
155265282|NCT01785628|560406997|FG000|Overall Study|Lost to Follow-up|2|||
155265283|NCT01785628|560406998|FG001|Overall Study|Lost to Follow-up|3|||
155265284|NCT00767104|560407001|FG000|Overall Study|Lost to Follow-up|1|||
155265285|NCT00767104|560407002|FG001|Overall Study|Lost to Follow-up|2|||
155265286|NCT03285295|560407005|FG000|Alinity s HBsAg|Protocol Violation|11|||
155265287|NCT03285295|560407006|FG001|Alinity s HBsAg|Protocol Violation|0|||
155265288|NCT03285295|560407007|FG002|Alinity s HBsAg|Protocol Violation|0|||
155265289|NCT03285295|560407008|FG003|Alinity s HBsAg|Protocol Violation|0|||
155265290|NCT03285295|560407009|FG004|Alinity s HBsAg|Protocol Violation|0|||
155265291|NCT03285295|560407005|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
155265292|NCT03285295|560407006|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265293|NCT03285295|560407007|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265294|NCT03285295|560407008|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265295|NCT03285295|560407009|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265296|NCT03285295|560407005|FG000|Alinity s HBsAg|No Results Generated|74|||
155265297|NCT03285295|560407006|FG001|Alinity s HBsAg|No Results Generated|6|||
155265298|NCT03285295|560407007|FG002|Alinity s HBsAg|No Results Generated|0|||
155265299|NCT03285295|560407008|FG003|Alinity s HBsAg|No Results Generated|0|||
155265300|NCT03285295|560407009|FG004|Alinity s HBsAg|No Results Generated|0|||
155265301|NCT03285295|560407005|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
155265302|NCT03285295|560407006|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
155265303|NCT03285295|560407007|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
155265304|NCT03285295|560407008|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
155265305|NCT03285295|560407009|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
155265306|NCT03285295|560407005|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
155265307|NCT03285295|560407006|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265308|NCT03285295|560407007|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265309|NCT03285295|560407008|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265310|NCT03285295|560407009|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265311|NCT03285295|560407005|FG000|Alinity s HTLV I/II|No Results Generated|70|||
155265312|NCT03285295|560407006|FG001|Alinity s HTLV I/II|No Results Generated|0|||
155265313|NCT03285295|560407007|FG002|Alinity s HTLV I/II|No Results Generated|0|||
155265314|NCT03285295|560407008|FG003|Alinity s HTLV I/II|No Results Generated|0|||
155265315|NCT03285295|560407009|FG004|Alinity s HTLV I/II|No Results Generated|0|||
155265316|NCT03285295|560407005|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
155265317|NCT03285295|560407006|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265318|NCT03285295|560407007|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265319|NCT03285295|560407008|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265320|NCT03285295|560407009|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265321|NCT03285295|560407005|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
155265322|NCT03285295|560407006|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
155265323|NCT03285295|560407007|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
155265324|NCT03285295|560407008|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
155265325|NCT03285295|560407009|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
155265326|NCT03285295|560407005|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
155265327|NCT03285295|560407006|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265328|NCT03285295|560407007|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265329|NCT03285295|560407008|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265330|NCT03285295|560407009|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265331|NCT03285295|560407005|FG000|Alinity s Anti-HCV|No Results Generated|71|||
155265332|NCT03285295|560407006|FG001|Alinity s Anti-HCV|No Results Generated|0|||
155265333|NCT03285295|560407007|FG002|Alinity s Anti-HCV|No Results Generated|0|||
155265334|NCT03285295|560407008|FG003|Alinity s Anti-HCV|No Results Generated|0|||
155265335|NCT03285295|560407009|FG004|Alinity s Anti-HCV|No Results Generated|0|||
155265336|NCT03285295|560407005|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
155265337|NCT03285295|560407006|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265338|NCT03285295|560407007|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265339|NCT03285295|560407008|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265340|NCT03285295|560407009|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265341|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
155265342|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265343|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265344|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265345|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265346|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
155265347|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265348|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265349|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265350|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265351|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
155265352|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265353|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265354|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265355|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265356|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
155265357|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265358|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265359|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265360|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265361|NCT03285295|560407005|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
155265362|NCT03285295|560407006|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
155265363|NCT03285295|560407007|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
155265364|NCT03285295|560407008|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
155265365|NCT03285295|560407009|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
155265366|NCT03285295|560407005|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
155265367|NCT03285295|560407006|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
155265368|NCT03285295|560407007|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265369|NCT03285295|560407008|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265370|NCT03285295|560407009|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265371|NCT03285295|560407005|FG000|Alinity s Anti-HBc|No Results Generated|70|||
155265372|NCT03285295|560407006|FG001|Alinity s Anti-HBc|No Results Generated|0|||
155265373|NCT03285295|560407007|FG002|Alinity s Anti-HBc|No Results Generated|0|||
155265374|NCT03285295|560407008|FG003|Alinity s Anti-HBc|No Results Generated|0|||
155265375|NCT03285295|560407009|FG004|Alinity s Anti-HBc|No Results Generated|0|||
155265376|NCT03285295|560407005|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
155265377|NCT03285295|560407006|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265378|NCT03285295|560407007|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265379|NCT03285295|560407008|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265380|NCT03285295|560407009|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265381|NCT03285295|560407005|FG000|Alinity s Chagas|Protocol Violation|76|||
155265382|NCT03285295|560407006|FG001|Alinity s Chagas|Protocol Violation|0|||
155265383|NCT03285295|560407007|FG002|Alinity s Chagas|Protocol Violation|0|||
155265384|NCT03285295|560407008|FG003|Alinity s Chagas|Protocol Violation|0|||
155265385|NCT03285295|560407009|FG004|Alinity s Chagas|Protocol Violation|0|||
155265386|NCT03285295|560407005|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
155265387|NCT03285295|560407006|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
155265388|NCT03285295|560407007|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
155265389|NCT03285295|560407008|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
155265390|NCT03285295|560407009|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
155265391|NCT03285295|560407005|FG000|Alinity s Chagas|No Results Generated|105|||
155265392|NCT03285295|560407006|FG001|Alinity s Chagas|No Results Generated|0|||
155265393|NCT03285295|560407007|FG002|Alinity s Chagas|No Results Generated|0|||
155265394|NCT03285295|560407008|FG003|Alinity s Chagas|No Results Generated|0|||
155265395|NCT03285295|560407009|FG004|Alinity s Chagas|No Results Generated|0|||
155265396|NCT03285295|560407005|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
155265397|NCT03285295|560407006|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265398|NCT03285295|560407007|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265399|NCT03285295|560407008|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265400|NCT03285295|560407009|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265401|NCT03015116|560407010|FG000|Overall Study|Lost to Follow-up|3|||
155265402|NCT03015116|560407011|FG001|Overall Study|Lost to Follow-up|0|||
155265403|NCT03015116|560407012|FG002|Overall Study|Lost to Follow-up|2|||
155265404|NCT03015116|560407010|FG000|Overall Study|Withdrawal by Subject|3|||
155265405|NCT03015116|560407011|FG001|Overall Study|Withdrawal by Subject|1|||
155265406|NCT03015116|560407012|FG002|Overall Study|Withdrawal by Subject|0|||
155265407|NCT03015116|560407010|FG000|Overall Study|Subject has New Medical Status|1|||
155265408|NCT03015116|560407011|FG001|Overall Study|Subject has New Medical Status|0|||
155265409|NCT03015116|560407012|FG002|Overall Study|Subject has New Medical Status|0|||
155265410|NCT03015116|560407010|FG000|Overall Study|Physician Decision|0|||
155265411|NCT03015116|560407011|FG001|Overall Study|Physician Decision|1|||
155265412|NCT03015116|560407012|FG002|Overall Study|Physician Decision|0|||
155265413|NCT02200939|560407016|FG000|Overall Study|Participant withdrew consent|0|||
155265414|NCT02200939|560407017|FG001|Overall Study|Participant withdrew consent|1|||
155265415|NCT02200939|560407016|FG000|Overall Study|Lost to Follow-up|2|||
155265416|NCT02200939|560407017|FG001|Overall Study|Lost to Follow-up|9|||
155265417|NCT02200939|560407016|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
155265418|NCT02200939|560407017|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
155265419|NCT04567693|560407018|FG000|Overall Study|Death|0|||
155265420|NCT04567693|560407019|FG001|Overall Study|Death|0|||
155265421|NCT04567693|560407020|FG002|Overall Study|Death|2|||
155265422|NCT04567693|560407018|FG000|Overall Study|Lost to Follow-up|1|||
155265423|NCT04567693|560407019|FG001|Overall Study|Lost to Follow-up|0|||
155265424|NCT04567693|560407020|FG002|Overall Study|Lost to Follow-up|2|||
155265425|NCT04567693|560407018|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
155265426|NCT04567693|560407019|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
155265427|NCT04567693|560407020|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
155265428|NCT04867785|560407021|FG000|Overall Study|Adverse Event|1|||
155265429|NCT04867785|560407022|FG001|Overall Study|Adverse Event|0|||
155265430|NCT04867785|560407023|FG002|Overall Study|Adverse Event|1|||
155265431|NCT04867785|560407024|FG003|Overall Study|Adverse Event|0|||
155265432|NCT04867785|560407025|FG004|Overall Study|Adverse Event|0|||
155265433|NCT04867785|560407026|FG005|Overall Study|Adverse Event|0|||
155265434|NCT04867785|560407027|FG006|Overall Study|Adverse Event|0|||
155265435|NCT04867785|560407028|FG007|Overall Study|Adverse Event|2|||
155265436|NCT04867785|560407021|FG000|Overall Study|Lost to Follow-up|4|||
155265437|NCT04867785|560407022|FG001|Overall Study|Lost to Follow-up|4|||
155265438|NCT04867785|560407023|FG002|Overall Study|Lost to Follow-up|3|||
155265439|NCT04867785|560407024|FG003|Overall Study|Lost to Follow-up|2|||
155265440|NCT04867785|560407025|FG004|Overall Study|Lost to Follow-up|0|||
155265441|NCT04867785|560407026|FG005|Overall Study|Lost to Follow-up|1|||
155265442|NCT04867785|560407027|FG006|Overall Study|Lost to Follow-up|0|||
155265443|NCT04867785|560407028|FG007|Overall Study|Lost to Follow-up|1|||
155265444|NCT04867785|560407021|FG000|Overall Study|Withdrawal by Subject|6|||
155265445|NCT04867785|560407022|FG001|Overall Study|Withdrawal by Subject|2|||
155265446|NCT04867785|560407023|FG002|Overall Study|Withdrawal by Subject|2|||
155265447|NCT04867785|560407024|FG003|Overall Study|Withdrawal by Subject|1|||
155265448|NCT04867785|560407025|FG004|Overall Study|Withdrawal by Subject|2|||
155265449|NCT04867785|560407026|FG005|Overall Study|Withdrawal by Subject|0|||
155265450|NCT04867785|560407027|FG006|Overall Study|Withdrawal by Subject|2|||
155265451|NCT04867785|560407028|FG007|Overall Study|Withdrawal by Subject|5|||
155265452|NCT04867785|560407021|FG000|Overall Study|Physician Decision|0|||
155265453|NCT04867785|560407022|FG001|Overall Study|Physician Decision|0|||
155265454|NCT04867785|560407023|FG002|Overall Study|Physician Decision|0|||
155265455|NCT04867785|560407024|FG003|Overall Study|Physician Decision|0|||
155265456|NCT04867785|560407025|FG004|Overall Study|Physician Decision|0|||
155265457|NCT04867785|560407026|FG005|Overall Study|Physician Decision|0|||
155265458|NCT04867785|560407027|FG006|Overall Study|Physician Decision|0|||
155265459|NCT04867785|560407028|FG007|Overall Study|Physician Decision|1|||
155265460|NCT04867785|560407021|FG000|Overall Study|Inadvertent Enrollment|0|||
155265461|NCT04867785|560407022|FG001|Overall Study|Inadvertent Enrollment|0|||
155265462|NCT04867785|560407023|FG002|Overall Study|Inadvertent Enrollment|0|||
155265463|NCT04867785|560407024|FG003|Overall Study|Inadvertent Enrollment|1|||
155265464|NCT04867785|560407025|FG004|Overall Study|Inadvertent Enrollment|1|||
155265465|NCT04867785|560407026|FG005|Overall Study|Inadvertent Enrollment|0|||
155265466|NCT04867785|560407027|FG006|Overall Study|Inadvertent Enrollment|0|||
155265467|NCT04867785|560407028|FG007|Overall Study|Inadvertent Enrollment|1|||
155265468|NCT04867785|560407021|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155265469|NCT04867785|560407022|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155265470|NCT04867785|560407023|FG002|Overall Study|Eligibility Criteria Not Met|0|||
155265471|NCT04867785|560407024|FG003|Overall Study|Eligibility Criteria Not Met|0|||
155265472|NCT04867785|560407025|FG004|Overall Study|Eligibility Criteria Not Met|0|||
155265473|NCT04867785|560407026|FG005|Overall Study|Eligibility Criteria Not Met|0|||
155265474|NCT04867785|560407027|FG006|Overall Study|Eligibility Criteria Not Met|0|||
155265475|NCT04867785|560407028|FG007|Overall Study|Eligibility Criteria Not Met|1|||
155265476|NCT00553202|560407041|FG000|Overall Study|Death|16|||
155265477|NCT00553202|560407041|FG000|Overall Study|Lost to Follow-up|1|||
155265478|NCT00553202|560407041|FG000|Overall Study|Physician Decision|28|||
155265479|NCT00553202|560407041|FG000|Overall Study|Withdrawal by Subject|1|||
155265480|NCT00553202|560407041|FG000|Overall Study|No donor identified|16|||
155265481|NCT00553202|560407041|FG000|Overall Study|Fails to meet organ function|6|||
155265482|NCT00369681|560407042|FG000|Overall Study|Death|1|||
155265483|NCT02966002|560407046|FG000|Overall Study|Withdrawal by Subject|2|||
155265484|NCT02966002|560407046|FG000|Overall Study|Adverse Event|1|||
155265485|NCT02966002|560407046|FG000|Overall Study|Lost to Follow-up|1|||
155265486|NCT01350141|560407047|FG000|Overall Study|Lost to Follow-up|1|||
155265487|NCT01350141|560407048|FG001|Overall Study|Lost to Follow-up|0|||
155265488|NCT01350141|560407049|FG002|Overall Study|Lost to Follow-up|1|||
155265489|NCT01350141|560407047|FG000|Overall Study|Withdrawal by Subject|1|||
155265490|NCT01350141|560407048|FG001|Overall Study|Withdrawal by Subject|0|||
155265491|NCT01350141|560407049|FG002|Overall Study|Withdrawal by Subject|0|||
155265492|NCT01350141|560407047|FG000|Overall Study|Randomized but not treated|1|||
155265493|NCT01350141|560407048|FG001|Overall Study|Randomized but not treated|0|||
155265494|NCT01350141|560407049|FG002|Overall Study|Randomized but not treated|0|||
155265495|NCT02367716|560407050|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
155265496|NCT01473381|560407051|FG000|Overall Study|Adverse Event|8|||
155265497|NCT01473381|560407052|FG001|Overall Study|Adverse Event|20|||
155265498|NCT01473381|560407053|FG002|Overall Study|Adverse Event|25|||
155265499|NCT01473381|560407054|FG003|Overall Study|Adverse Event|17|||
155265500|NCT01473381|560407051|FG000|Overall Study|Insufficient Therapeutic Response|10|||
155265501|NCT01473381|560407052|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155265502|NCT01473381|560407053|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155265503|NCT01473381|560407054|FG003|Overall Study|Insufficient Therapeutic Response|3|||
155265504|NCT01473381|560407051|FG000|Overall Study|Protocol Violation|17|||
155265505|NCT01473381|560407052|FG001|Overall Study|Protocol Violation|23|||
155265506|NCT01473381|560407053|FG002|Overall Study|Protocol Violation|19|||
155265507|NCT01473381|560407054|FG003|Overall Study|Protocol Violation|17|||
155265508|NCT01473381|560407051|FG000|Overall Study|Withdrawal of Consent|20|||
155265509|NCT01473381|560407052|FG001|Overall Study|Withdrawal of Consent|21|||
155265510|NCT01473381|560407053|FG002|Overall Study|Withdrawal of Consent|20|||
155265511|NCT01473381|560407054|FG003|Overall Study|Withdrawal of Consent|26|||
155265512|NCT01473381|560407051|FG000|Overall Study|Lost to Follow-up|25|||
155265513|NCT01473381|560407052|FG001|Overall Study|Lost to Follow-up|28|||
155265514|NCT01473381|560407053|FG002|Overall Study|Lost to Follow-up|35|||
155265515|NCT01473381|560407054|FG003|Overall Study|Lost to Follow-up|23|||
155265516|NCT01473381|560407051|FG000|Overall Study|Other Reasons|0|||
155265517|NCT01473381|560407052|FG001|Overall Study|Other Reasons|0|||
155265518|NCT01473381|560407053|FG002|Overall Study|Other Reasons|1|||
155265519|NCT01473381|560407054|FG003|Overall Study|Other Reasons|3|||
155265520|NCT02508532|560407060|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265521|NCT02508532|560407061|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265522|NCT02508532|560407062|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265523|NCT02508532|560407063|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265524|NCT02508532|560407064|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265525|NCT02508532|560407065|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265526|NCT02508532|560407066|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
155265527|NCT02508532|560407067|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265528|NCT02508532|560407068|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265529|NCT02508532|560407060|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265530|NCT02508532|560407061|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265531|NCT02508532|560407062|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265532|NCT02508532|560407063|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265533|NCT02508532|560407064|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265534|NCT02508532|560407065|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265535|NCT02508532|560407066|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265536|NCT02508532|560407067|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
155265537|NCT02508532|560407068|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265538|NCT02508532|560407060|FG000|Part 2 - Treatment|Disease Progression|0|||
155265539|NCT02508532|560407061|FG001|Part 2 - Treatment|Disease Progression|0|||
155265540|NCT02508532|560407062|FG002|Part 2 - Treatment|Disease Progression|0|||
155265541|NCT02508532|560407063|FG003|Part 2 - Treatment|Disease Progression|0|||
155265542|NCT02508532|560407064|FG004|Part 2 - Treatment|Disease Progression|0|||
155265543|NCT02508532|560407065|FG005|Part 2 - Treatment|Disease Progression|0|||
155265544|NCT02508532|560407066|FG006|Part 2 - Treatment|Disease Progression|0|||
155265545|NCT02508532|560407067|FG007|Part 2 - Treatment|Disease Progression|0|||
155265546|NCT02508532|560407068|FG008|Part 2 - Treatment|Disease Progression|118|||
155265547|NCT02508532|560407060|FG000|Part 2 - Treatment|Adverse Event|0|||
155265548|NCT02508532|560407061|FG001|Part 2 - Treatment|Adverse Event|0|||
155265549|NCT02508532|560407062|FG002|Part 2 - Treatment|Adverse Event|0|||
155265550|NCT02508532|560407063|FG003|Part 2 - Treatment|Adverse Event|0|||
155265551|NCT02508532|560407064|FG004|Part 2 - Treatment|Adverse Event|0|||
155265552|NCT02508532|560407065|FG005|Part 2 - Treatment|Adverse Event|0|||
155265553|NCT02508532|560407066|FG006|Part 2 - Treatment|Adverse Event|0|||
155265554|NCT02508532|560407067|FG007|Part 2 - Treatment|Adverse Event|0|||
155265555|NCT02508532|560407068|FG008|Part 2 - Treatment|Adverse Event|49|||
155265556|NCT02508532|560407060|FG000|Part 2 - Treatment|Physician Decision|0|||
155265557|NCT02508532|560407061|FG001|Part 2 - Treatment|Physician Decision|0|||
155265558|NCT02508532|560407062|FG002|Part 2 - Treatment|Physician Decision|0|||
155265559|NCT02508532|560407063|FG003|Part 2 - Treatment|Physician Decision|0|||
155265560|NCT02508532|560407064|FG004|Part 2 - Treatment|Physician Decision|0|||
155265561|NCT02508532|560407065|FG005|Part 2 - Treatment|Physician Decision|0|||
155265562|NCT02508532|560407066|FG006|Part 2 - Treatment|Physician Decision|0|||
155265563|NCT02508532|560407067|FG007|Part 2 - Treatment|Physician Decision|0|||
155265564|NCT02508532|560407068|FG008|Part 2 - Treatment|Physician Decision|12|||
155265565|NCT02508532|560407060|FG000|Part 2 - Treatment|Administrative|0|||
155265566|NCT02508532|560407061|FG001|Part 2 - Treatment|Administrative|0|||
155265567|NCT02508532|560407062|FG002|Part 2 - Treatment|Administrative|0|||
155265568|NCT02508532|560407063|FG003|Part 2 - Treatment|Administrative|0|||
155265569|NCT02508532|560407064|FG004|Part 2 - Treatment|Administrative|0|||
155265570|NCT02508532|560407065|FG005|Part 2 - Treatment|Administrative|0|||
155265571|NCT02508532|560407066|FG006|Part 2 - Treatment|Administrative|0|||
155265572|NCT02508532|560407067|FG007|Part 2 - Treatment|Administrative|0|||
155265573|NCT02508532|560407068|FG008|Part 2 - Treatment|Administrative|3|||
155265574|NCT02508532|560407060|FG000|Part 2 - Treatment|Sponsor Decision|0|||
155265575|NCT02508532|560407061|FG001|Part 2 - Treatment|Sponsor Decision|0|||
155265576|NCT02508532|560407062|FG002|Part 2 - Treatment|Sponsor Decision|0|||
155265577|NCT02508532|560407063|FG003|Part 2 - Treatment|Sponsor Decision|0|||
155265578|NCT02508532|560407064|FG004|Part 2 - Treatment|Sponsor Decision|0|||
155265579|NCT02508532|560407065|FG005|Part 2 - Treatment|Sponsor Decision|0|||
155265580|NCT02508532|560407066|FG006|Part 2 - Treatment|Sponsor Decision|0|||
155265581|NCT02508532|560407067|FG007|Part 2 - Treatment|Sponsor Decision|0|||
155265582|NCT02508532|560407068|FG008|Part 2 - Treatment|Sponsor Decision|28|||
155265583|NCT02508532|560407060|FG000|Part 2 - Treatment|Death|0|||
155265584|NCT02508532|560407061|FG001|Part 2 - Treatment|Death|0|||
155265585|NCT02508532|560407062|FG002|Part 2 - Treatment|Death|0|||
155265586|NCT02508532|560407063|FG003|Part 2 - Treatment|Death|0|||
155265587|NCT02508532|560407064|FG004|Part 2 - Treatment|Death|0|||
155265588|NCT02508532|560407065|FG005|Part 2 - Treatment|Death|0|||
155265589|NCT02508532|560407066|FG006|Part 2 - Treatment|Death|0|||
155265590|NCT02508532|560407067|FG007|Part 2 - Treatment|Death|0|||
155265591|NCT02508532|560407068|FG008|Part 2 - Treatment|Death|1|||
155265592|NCT02508532|560407060|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
155265593|NCT02508532|560407061|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
155265594|NCT02508532|560407062|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
155265595|NCT02508532|560407063|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
155265596|NCT02508532|560407064|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
155265597|NCT02508532|560407065|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
155265598|NCT02508532|560407066|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
155265599|NCT02508532|560407067|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
155265600|NCT02508532|560407068|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
155265601|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
155265602|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265603|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265604|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265605|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265606|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265607|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265608|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
155265609|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
155265610|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
155265611|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265612|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
155265613|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265614|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265615|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265616|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265617|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265618|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
155265619|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Death|0|||
155265620|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Death|4|||
155265621|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Death|2|||
155265622|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Death|4|||
155265623|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Death|3|||
155265624|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Death|0|||
155265625|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Death|0|||
155265626|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Death|1|||
155265627|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Death|111|||
155265628|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265629|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265630|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265631|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265632|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265633|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265634|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265635|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265636|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
155265637|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265638|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265639|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265640|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265641|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265642|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265643|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265644|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265645|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
155265646|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265647|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265648|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
155265649|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265650|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
155265651|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265652|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265653|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265654|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
155265655|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265656|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265657|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265658|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265659|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265660|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265661|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265662|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265663|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
155265664|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265665|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265666|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265667|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265668|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265669|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
155265670|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
155265671|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265672|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
155265673|NCT02768662|560407069|FG000|Overall Study|Adverse Event|1|||
155265674|NCT02768662|560407069|FG000|Overall Study|Lost to Follow-up|4|||
155265675|NCT02768662|560407069|FG000|Overall Study|Withdrawal by Subject|3|||
155265676|NCT02768662|560407069|FG000|Overall Study|Study terminated by Sponsor|78|||
155265677|NCT04041440|560407071|FG000|Overall Study|Withdrawal by Subject|0|||
155265678|NCT04041440|560407072|FG001|Overall Study|Withdrawal by Subject|1|||
155265679|NCT04041440|560407071|FG000|Overall Study|Lost to Follow-up|0|||
155265680|NCT04041440|560407072|FG001|Overall Study|Lost to Follow-up|1|||
155265681|NCT02306265|560407073|FG000|Overall Study|Withdrawal by Subject|1|||
155265682|NCT01346514|560407074|FG000|Overall Study|Lost to Follow-up|19|||
155265683|NCT01346514|560407075|FG001|Overall Study|Lost to Follow-up|30|||
155265684|NCT01346514|560407074|FG000|Overall Study|Withdrawal by Subject|7|||
155265685|NCT01346514|560407075|FG001|Overall Study|Withdrawal by Subject|3|||
155265686|NCT01346514|560407074|FG000|Overall Study|Death|3|||
155265687|NCT01346514|560407075|FG001|Overall Study|Death|4|||
155265688|NCT03002038|560407077|FG000|Overall Study|Adverse Event|3|||
155265689|NCT03002038|560407078|FG001|Overall Study|Adverse Event|1|||
155265690|NCT03002038|560407077|FG000|Overall Study|Withdrawal by Subject|8|||
155265691|NCT03002038|560407078|FG001|Overall Study|Withdrawal by Subject|4|||
155265692|NCT03002038|560407077|FG000|Overall Study|Immigration to another region|0|||
155265693|NCT03002038|560407078|FG001|Overall Study|Immigration to another region|2|||
155265694|NCT04251065|560407079|FG000|Overall Study|Death|2|||
155265695|NCT04251065|560407079|FG000|Overall Study|Lack of Efficacy|3|||
155265696|NCT04251065|560407079|FG000|Overall Study|Death|1|||
155265697|NCT04296890|560407080|FG000|Overall Study|Withdrawal by Subject|1|||
155265698|NCT04296890|560407080|FG000|Overall Study|Death|62|||
155265699|NCT04296890|560407080|FG000|Overall Study|Lost to Follow-up|3|||
155265700|NCT04296890|560407080|FG000|Overall Study|Other than specified|2|||
155265701|NCT02237508|560407082|FG000|Overall Study|Withdrawal by Subject|0|||
155265702|NCT02237508|560407083|FG001|Overall Study|Withdrawal by Subject|2|||
155265703|NCT02237508|560407084|FG002|Overall Study|Withdrawal by Subject|0|||
155265704|NCT02237508|560407085|FG003|Overall Study|Withdrawal by Subject|1|||
155265705|NCT02237508|560407086|FG004|Overall Study|Withdrawal by Subject|0|||
155265706|NCT02237508|560407087|FG005|Overall Study|Withdrawal by Subject|1|||
155265707|NCT02237508|560407088|FG006|Overall Study|Withdrawal by Subject|1|||
155265708|NCT02237508|560407089|FG007|Overall Study|Withdrawal by Subject|0|||
155265709|NCT02237508|560407090|FG008|Overall Study|Withdrawal by Subject|1|||
155265710|NCT02237508|560407091|FG009|Overall Study|Withdrawal by Subject|0|||
155265711|NCT02237508|560407082|FG000|Overall Study|Physician Decision|0|||
155265712|NCT02237508|560407083|FG001|Overall Study|Physician Decision|1|||
155265713|NCT02237508|560407084|FG002|Overall Study|Physician Decision|0|||
155265714|NCT02237508|560407085|FG003|Overall Study|Physician Decision|0|||
155265715|NCT02237508|560407086|FG004|Overall Study|Physician Decision|0|||
155265716|NCT02237508|560407087|FG005|Overall Study|Physician Decision|0|||
155265717|NCT02237508|560407088|FG006|Overall Study|Physician Decision|0|||
155265718|NCT02237508|560407089|FG007|Overall Study|Physician Decision|0|||
155265719|NCT02237508|560407090|FG008|Overall Study|Physician Decision|0|||
155265720|NCT02237508|560407091|FG009|Overall Study|Physician Decision|0|||
155265721|NCT02237508|560407082|FG000|Overall Study|Protocol Violation|0|||
155265722|NCT02237508|560407083|FG001|Overall Study|Protocol Violation|0|||
155265723|NCT02237508|560407084|FG002|Overall Study|Protocol Violation|1|||
155265724|NCT02237508|560407085|FG003|Overall Study|Protocol Violation|0|||
155265725|NCT02237508|560407086|FG004|Overall Study|Protocol Violation|0|||
155265726|NCT02237508|560407087|FG005|Overall Study|Protocol Violation|0|||
155265727|NCT02237508|560407088|FG006|Overall Study|Protocol Violation|0|||
155265728|NCT02237508|560407089|FG007|Overall Study|Protocol Violation|0|||
155265729|NCT02237508|560407090|FG008|Overall Study|Protocol Violation|0|||
155265730|NCT02237508|560407091|FG009|Overall Study|Protocol Violation|0|||
155265731|NCT01650519|560407092|FG000|Overall Study|Withdrawal by Subject|1|||
155265732|NCT01650519|560407093|FG001|Overall Study|Withdrawal by Subject|0|||
155265733|NCT00747123|560407095|FG000|Overall Study|Investigator's request|0|||
155265734|NCT00747123|560407096|FG001|Overall Study|Investigator's request|0|||
155265735|NCT00747123|560407097|FG002|Overall Study|Investigator's request|1|||
155265736|NCT00747123|560407098|FG003|Overall Study|Investigator's request|0|||
155265737|NCT00747123|560407095|FG000|Overall Study|Withdrew consent|0|||
155265738|NCT00747123|560407096|FG001|Overall Study|Withdrew consent|1|||
155265739|NCT00747123|560407097|FG002|Overall Study|Withdrew consent|0|||
155265740|NCT00747123|560407098|FG003|Overall Study|Withdrew consent|0|||
155265741|NCT00747123|560407095|FG000|Overall Study|Adverse Event|0|||
155265742|NCT00747123|560407096|FG001|Overall Study|Adverse Event|1|||
155265743|NCT00747123|560407097|FG002|Overall Study|Adverse Event|0|||
155265744|NCT00747123|560407098|FG003|Overall Study|Adverse Event|1|||
155265745|NCT02277743|560407101|FG000|Overall Study|Protocol Violation|1|||
155265746|NCT02277743|560407102|FG001|Overall Study|Protocol Violation|1|||
155265747|NCT02277743|560407103|FG002|Overall Study|Protocol Violation|1|||
155265748|NCT02277743|560407101|FG000|Overall Study|Adverse Event|10|||
155265749|NCT02277743|560407102|FG001|Overall Study|Adverse Event|6|||
155265750|NCT02277743|560407103|FG002|Overall Study|Adverse Event|6|||
155265751|NCT02277743|560407101|FG000|Overall Study|Lack of Efficacy|11|||
155265752|NCT02277743|560407102|FG001|Overall Study|Lack of Efficacy|4|||
155265753|NCT02277743|560407103|FG002|Overall Study|Lack of Efficacy|3|||
155265754|NCT02277743|560407101|FG000|Overall Study|Other than specified above|18|||
155265755|NCT02277743|560407102|FG001|Overall Study|Other than specified above|5|||
155265756|NCT02277743|560407103|FG002|Overall Study|Other than specified above|16|||
155265757|NCT01224158|560407107|FG000|Overall Study|Withdrawal by Subject|1|||
155265758|NCT01224158|560407108|FG001|Overall Study|Withdrawal by Subject|0|||
155265759|NCT02055157|560407111|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265760|NCT02055157|560407112|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
155265761|NCT02055157|560407113|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265762|NCT02055157|560407114|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265763|NCT02055157|560407111|FG000|Initial 6 Months|Adverse Event|0|||
155265764|NCT02055157|560407112|FG001|Initial 6 Months|Adverse Event|0|||
155265765|NCT02055157|560407113|FG002|Initial 6 Months|Adverse Event|0|||
155265766|NCT02055157|560407114|FG003|Initial 6 Months|Adverse Event|1|||
155265767|NCT02055157|560407111|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
155265768|NCT02055157|560407112|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
155265769|NCT02055157|560407113|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
155265770|NCT02055157|560407114|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
155265771|NCT02055157|560407111|FG000|18-month Extension|Investigator decision|0|||
155265772|NCT02055157|560407112|FG001|18-month Extension|Investigator decision|1|||
155265773|NCT02055157|560407113|FG002|18-month Extension|Investigator decision|0|||
155265774|NCT02055157|560407114|FG003|18-month Extension|Investigator decision|0|||
155265775|NCT02055157|560407111|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
155265776|NCT02055157|560407112|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265777|NCT02055157|560407113|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265778|NCT02055157|560407114|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265779|NCT03976466|560407115|FG000|Overall Study|Lost to Follow-up|1|||
155265780|NCT03976466|560407116|FG001|Overall Study|Lost to Follow-up|3|||
155265781|NCT00733499|560407119|FG000|Pre-operative|Protocol Violation|0|||
155265782|NCT00733499|560407120|FG001|Pre-operative|Protocol Violation|1|||
155265783|NCT00733499|560407119|FG000|3 Months Follow-up|Death|1|||
155265784|NCT00733499|560407120|FG001|3 Months Follow-up|Death|2|||
155265785|NCT00733499|560407119|FG000|6 Months Follow-up|Death|0|||
155265786|NCT00733499|560407120|FG001|6 Months Follow-up|Death|2|||
155265787|NCT00733499|560407119|FG000|6 Months Follow-up|Adverse Event|0|||
155265788|NCT00733499|560407120|FG001|6 Months Follow-up|Adverse Event|1|||
155265789|NCT00733499|560407119|FG000|12 Months Follow-up|Death|2|||
155265790|NCT00733499|560407120|FG001|12 Months Follow-up|Death|1|||
155265791|NCT00733499|560407119|FG000|24 Months Follow-up|Death|0|||
155265792|NCT00733499|560407120|FG001|24 Months Follow-up|Death|1|||
155265793|NCT00733499|560407119|FG000|5 Year Followup|Adverse Event|2|||
155265794|NCT00733499|560407120|FG001|5 Year Followup|Adverse Event|2|||
155265795|NCT00733499|560407119|FG000|5 Year Followup|Non device related AE|0|||
155265796|NCT00733499|560407120|FG001|5 Year Followup|Non device related AE|1|||
155265797|NCT00733499|560407119|FG000|5 Year Followup|Revision of Study Implant|0|||
155265798|NCT00733499|560407120|FG001|5 Year Followup|Revision of Study Implant|1|||
155265799|NCT00733499|560407119|FG000|5 Year Followup|Lost to Follow-up|2|||
155265800|NCT00733499|560407120|FG001|5 Year Followup|Lost to Follow-up|0|||
155265801|NCT00733499|560407119|FG000|5 Year Followup|Death|13|||
155265802|NCT00733499|560407120|FG001|5 Year Followup|Death|19|||
155265803|NCT00733499|560407119|FG000|5 Year Followup|missing, unable to locate|0|||
155265804|NCT00733499|560407120|FG001|5 Year Followup|missing, unable to locate|1|||
155265805|NCT00733499|560407119|FG000|5 Year Followup|Withdrawal by Subject|4|||
155265806|NCT00733499|560407120|FG001|5 Year Followup|Withdrawal by Subject|1|||
155265807|NCT00733499|560407119|FG000|10 Year Followup|Death|9|||
155265808|NCT00733499|560407120|FG001|10 Year Followup|Death|7|||
155265809|NCT00733499|560407119|FG000|10 Year Followup|Adverse Event|3|||
155265810|NCT00733499|560407120|FG001|10 Year Followup|Adverse Event|3|||
155265811|NCT00733499|560407119|FG000|10 Year Followup|Lost to Follow-up|3|||
155265812|NCT00733499|560407120|FG001|10 Year Followup|Lost to Follow-up|2|||
155265813|NCT00733499|560407119|FG000|10 Year Followup|Withdrawal by Subject|5|||
155265814|NCT00733499|560407120|FG001|10 Year Followup|Withdrawal by Subject|5|||
155265815|NCT00733499|560407119|FG000|10 Year Followup|missing, unable to locate|0|||
155265816|NCT00733499|560407120|FG001|10 Year Followup|missing, unable to locate|2|||
155265817|NCT00576732|560407121|FG000|DOUBLE BLIND|Adverse Event|0|||
155265818|NCT00576732|560407122|FG001|DOUBLE BLIND|Adverse Event|0|||
155265819|NCT00576732|560407123|FG002|DOUBLE BLIND|Adverse Event|1|||
155265820|NCT00576732|560407124|FG003|DOUBLE BLIND|Adverse Event|0|||
155265821|NCT00576732|560407125|FG004|DOUBLE BLIND|Adverse Event|0|||
155265822|NCT00576732|560407126|FG005|DOUBLE BLIND|Adverse Event|0|||
155265823|NCT00576732|560407121|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
155265824|NCT00576732|560407122|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
155265825|NCT00576732|560407123|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
155265826|NCT00576732|560407124|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
155265827|NCT00576732|560407125|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
155265828|NCT00576732|560407126|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
155265829|NCT00576732|560407121|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
155265830|NCT00576732|560407122|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
155265831|NCT00576732|560407123|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
155265832|NCT00576732|560407124|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
155265833|NCT00576732|560407125|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
155265834|NCT00576732|560407126|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
155265835|NCT00576732|560407121|FG000|DOUBLE BLIND|OTHER|0|||
155265836|NCT00576732|560407122|FG001|DOUBLE BLIND|OTHER|2|||
155265837|NCT00576732|560407123|FG002|DOUBLE BLIND|OTHER|1|||
155265838|NCT00576732|560407124|FG003|DOUBLE BLIND|OTHER|0|||
155265839|NCT00576732|560407125|FG004|DOUBLE BLIND|OTHER|0|||
155265840|NCT00576732|560407126|FG005|DOUBLE BLIND|OTHER|0|||
155265841|NCT00576732|560407121|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
155265842|NCT00576732|560407122|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
155265843|NCT00576732|560407123|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
155265844|NCT00576732|560407124|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
155265845|NCT00576732|560407125|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
155265846|NCT00576732|560407126|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
155265847|NCT00576732|560407121|FG000|DOUBLE BLIND|Protocol Violation|1|||
155265848|NCT00576732|560407122|FG001|DOUBLE BLIND|Protocol Violation|0|||
155265849|NCT00576732|560407123|FG002|DOUBLE BLIND|Protocol Violation|0|||
155265850|NCT00576732|560407124|FG003|DOUBLE BLIND|Protocol Violation|0|||
155265851|NCT00576732|560407125|FG004|DOUBLE BLIND|Protocol Violation|0|||
155265852|NCT00576732|560407126|FG005|DOUBLE BLIND|Protocol Violation|0|||
155265853|NCT00576732|560407121|FG000|OPEN LABEL|Adverse Event|0|||
155265854|NCT00576732|560407122|FG001|OPEN LABEL|Adverse Event|0|||
155265855|NCT00576732|560407123|FG002|OPEN LABEL|Adverse Event|0|||
155265856|NCT00576732|560407124|FG003|OPEN LABEL|Adverse Event|4|||
155265857|NCT00576732|560407125|FG004|OPEN LABEL|Adverse Event|0|||
155265858|NCT00576732|560407126|FG005|OPEN LABEL|Adverse Event|1|||
155265859|NCT00576732|560407121|FG000|OPEN LABEL|Lost to Follow-up|0|||
155265860|NCT00576732|560407122|FG001|OPEN LABEL|Lost to Follow-up|0|||
155265861|NCT00576732|560407123|FG002|OPEN LABEL|Lost to Follow-up|0|||
155265862|NCT00576732|560407124|FG003|OPEN LABEL|Lost to Follow-up|2|||
155265863|NCT00576732|560407125|FG004|OPEN LABEL|Lost to Follow-up|1|||
155265864|NCT00576732|560407126|FG005|OPEN LABEL|Lost to Follow-up|1|||
155265865|NCT00576732|560407121|FG000|OPEN LABEL|Withdrawal by Subject|0|||
155265866|NCT00576732|560407122|FG001|OPEN LABEL|Withdrawal by Subject|0|||
155265867|NCT00576732|560407123|FG002|OPEN LABEL|Withdrawal by Subject|0|||
155265868|NCT00576732|560407124|FG003|OPEN LABEL|Withdrawal by Subject|1|||
155265869|NCT00576732|560407125|FG004|OPEN LABEL|Withdrawal by Subject|0|||
155265870|NCT00576732|560407126|FG005|OPEN LABEL|Withdrawal by Subject|1|||
155265871|NCT00576732|560407121|FG000|OPEN LABEL|OTHER|0|||
155265872|NCT00576732|560407122|FG001|OPEN LABEL|OTHER|0|||
155265873|NCT00576732|560407123|FG002|OPEN LABEL|OTHER|0|||
155265874|NCT00576732|560407124|FG003|OPEN LABEL|OTHER|0|||
155265875|NCT00576732|560407125|FG004|OPEN LABEL|OTHER|0|||
155265876|NCT00576732|560407126|FG005|OPEN LABEL|OTHER|2|||
155265877|NCT00576732|560407121|FG000|OPEN LABEL|Lack of Efficacy|0|||
155265878|NCT00576732|560407122|FG001|OPEN LABEL|Lack of Efficacy|0|||
155265879|NCT00576732|560407123|FG002|OPEN LABEL|Lack of Efficacy|0|||
155265880|NCT00576732|560407124|FG003|OPEN LABEL|Lack of Efficacy|2|||
155265881|NCT00576732|560407125|FG004|OPEN LABEL|Lack of Efficacy|2|||
155265882|NCT00576732|560407126|FG005|OPEN LABEL|Lack of Efficacy|3|||
155265883|NCT00576732|560407121|FG000|OPEN LABEL|Protocol Violation|0|||
155265884|NCT00576732|560407122|FG001|OPEN LABEL|Protocol Violation|0|||
155265885|NCT00576732|560407123|FG002|OPEN LABEL|Protocol Violation|0|||
155265886|NCT00576732|560407124|FG003|OPEN LABEL|Protocol Violation|2|||
155265887|NCT00576732|560407125|FG004|OPEN LABEL|Protocol Violation|1|||
155265888|NCT00576732|560407126|FG005|OPEN LABEL|Protocol Violation|0|||
155265889|NCT02978443|560407127|FG000|Overall Study|Withdrawal by Subject|1|||
155265890|NCT02978443|560407127|FG000|Overall Study|Adverse Event|3|||
155265891|NCT02978443|560407127|FG000|Overall Study|Disease Progression on study|6|||
155265892|NCT02978443|560407127|FG000|Overall Study|Death|1|||
155265893|NCT02978443|560407127|FG000|Overall Study|Physician Decision|1|||
155265894|NCT02978443|560407127|FG000|Overall Study|Switch to alternative therapy|1|||
155265895|NCT02978443|560407127|FG000|Overall Study|Refused further treatment|1|||
155265896|NCT02296190|560407128|FG000|Overall Study|Lost to Follow-up|0|||
155265897|NCT02296190|560407129|FG001|Overall Study|Lost to Follow-up|0|||
155265898|NCT02296190|560407130|FG002|Overall Study|Lost to Follow-up|0|||
155265899|NCT02296190|560407131|FG003|Overall Study|Lost to Follow-up|0|||
155265900|NCT02296190|560407132|FG004|Overall Study|Lost to Follow-up|1|||
155265901|NCT02296190|560407133|FG005|Overall Study|Lost to Follow-up|0|||
155265902|NCT02296190|560407128|FG000|Overall Study|Failure to induce PSVT|6|||
155265903|NCT02296190|560407129|FG001|Overall Study|Failure to induce PSVT|10|||
155265904|NCT02296190|560407130|FG002|Overall Study|Failure to induce PSVT|5|||
155265905|NCT02296190|560407131|FG003|Overall Study|Failure to induce PSVT|13|||
155265906|NCT02296190|560407132|FG004|Overall Study|Failure to induce PSVT|8|||
155265907|NCT02296190|560407133|FG005|Overall Study|Failure to induce PSVT|0|||
155265908|NCT02296190|560407128|FG000|Overall Study|Physician Decision|1|||
155265909|NCT02296190|560407129|FG001|Overall Study|Physician Decision|1|||
155265910|NCT02296190|560407130|FG002|Overall Study|Physician Decision|0|||
155265911|NCT02296190|560407131|FG003|Overall Study|Physician Decision|1|||
155265912|NCT02296190|560407132|FG004|Overall Study|Physician Decision|2|||
155265913|NCT02296190|560407133|FG005|Overall Study|Physician Decision|0|||
155265914|NCT02296190|560407128|FG000|Overall Study|Withdrawal by Subject|0|||
155265915|NCT02296190|560407129|FG001|Overall Study|Withdrawal by Subject|1|||
155265916|NCT02296190|560407130|FG002|Overall Study|Withdrawal by Subject|0|||
155265917|NCT02296190|560407131|FG003|Overall Study|Withdrawal by Subject|0|||
155265918|NCT02296190|560407132|FG004|Overall Study|Withdrawal by Subject|0|||
155265919|NCT02296190|560407133|FG005|Overall Study|Withdrawal by Subject|0|||
155265920|NCT02296190|560407128|FG000|Overall Study|PSVT < 5 minutes|5|||
155265921|NCT02296190|560407129|FG001|Overall Study|PSVT < 5 minutes|6|||
155265922|NCT02296190|560407130|FG002|Overall Study|PSVT < 5 minutes|6|||
155265923|NCT02296190|560407131|FG003|Overall Study|PSVT < 5 minutes|6|||
155265924|NCT02296190|560407132|FG004|Overall Study|PSVT < 5 minutes|5|||
155265925|NCT02296190|560407133|FG005|Overall Study|PSVT < 5 minutes|0|||
155265926|NCT02296190|560407128|FG000|Overall Study|Patient was given Propofol|0|||
155265927|NCT02296190|560407129|FG001|Overall Study|Patient was given Propofol|1|||
155265928|NCT02296190|560407130|FG002|Overall Study|Patient was given Propofol|0|||
155265929|NCT02296190|560407131|FG003|Overall Study|Patient was given Propofol|1|||
155265930|NCT02296190|560407132|FG004|Overall Study|Patient was given Propofol|0|||
155265931|NCT02296190|560407133|FG005|Overall Study|Patient was given Propofol|0|||
155265932|NCT02296190|560407128|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
155265933|NCT02296190|560407129|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
155265934|NCT02296190|560407130|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
155265935|NCT02296190|560407131|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
155265936|NCT02296190|560407132|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
155265937|NCT02296190|560407133|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
155265938|NCT02296190|560407128|FG000|Overall Study|Blood pressure <100 after sedation|0|||
155265939|NCT02296190|560407129|FG001|Overall Study|Blood pressure <100 after sedation|0|||
155265940|NCT02296190|560407130|FG002|Overall Study|Blood pressure <100 after sedation|0|||
155265941|NCT02296190|560407131|FG003|Overall Study|Blood pressure <100 after sedation|1|||
155265942|NCT02296190|560407132|FG004|Overall Study|Blood pressure <100 after sedation|0|||
155265943|NCT02296190|560407133|FG005|Overall Study|Blood pressure <100 after sedation|0|||
155265944|NCT02296190|560407128|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265945|NCT02296190|560407129|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
155265946|NCT02296190|560407130|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
155265947|NCT02296190|560407131|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265948|NCT02296190|560407132|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265949|NCT02296190|560407133|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265950|NCT02296190|560407128|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
155265951|NCT02296190|560407129|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
155265952|NCT02296190|560407130|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
155265953|NCT02296190|560407131|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
155265954|NCT02296190|560407132|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
155265955|NCT02296190|560407133|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
155265956|NCT02296190|560407128|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265957|NCT02296190|560407129|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
155265958|NCT02296190|560407130|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265959|NCT02296190|560407131|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265960|NCT02296190|560407132|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265961|NCT02296190|560407133|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265962|NCT02296190|560407128|FG000|Overall Study|Lab result not available in time|1|||
155265963|NCT02296190|560407129|FG001|Overall Study|Lab result not available in time|0|||
155265964|NCT02296190|560407130|FG002|Overall Study|Lab result not available in time|0|||
155265965|NCT02296190|560407131|FG003|Overall Study|Lab result not available in time|0|||
155265966|NCT02296190|560407132|FG004|Overall Study|Lab result not available in time|0|||
155265967|NCT02296190|560407133|FG005|Overall Study|Lab result not available in time|0|||
155265968|NCT00682643|560407135|FG000|Overall Study|Adverse Event|12|||
155265969|NCT00682643|560407136|FG001|Overall Study|Adverse Event|23|||
155265970|NCT00682643|560407135|FG000|Overall Study|Lack of Efficacy|2|||
155265971|NCT00682643|560407136|FG001|Overall Study|Lack of Efficacy|0|||
155265972|NCT00682643|560407135|FG000|Overall Study|Protocol Violation|38|||
155265973|NCT00682643|560407136|FG001|Overall Study|Protocol Violation|76|||
155265974|NCT00682643|560407135|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
155265975|NCT00682643|560407136|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155265976|NCT00682643|560407135|FG000|Overall Study|Lost to Follow-up|1|||
155265977|NCT00682643|560407136|FG001|Overall Study|Lost to Follow-up|6|||
155265978|NCT00682643|560407135|FG000|Overall Study|Physician Decision|2|||
155265979|NCT00682643|560407136|FG001|Overall Study|Physician Decision|6|||
155265980|NCT00682643|560407135|FG000|Overall Study|Withdrawal by Subject|19|||
155265981|NCT00682643|560407136|FG001|Overall Study|Withdrawal by Subject|53|||
155265982|NCT00682643|560407135|FG000|Overall Study|Did Not Receive Study Drug|1|||
155265983|NCT00682643|560407136|FG001|Overall Study|Did Not Receive Study Drug|1|||
155265984|NCT01875185|560407137|FG000|Overall Study|study was terminated|52|||
155265985|NCT01875185|560407138|FG001|Overall Study|study was terminated|48|||
155265986|NCT00263328|560407139|FG000|Overall Study|Death|0|||
155265987|NCT00263328|560407140|FG001|Overall Study|Death|0|||
155265988|NCT00263328|560407141|FG002|Overall Study|Death|1|||
155265989|NCT00263328|560407139|FG000|Overall Study|Lost to Follow-up|1|||
155265990|NCT00263328|560407140|FG001|Overall Study|Lost to Follow-up|1|||
155265991|NCT00263328|560407141|FG002|Overall Study|Lost to Follow-up|0|||
155265992|NCT00263328|560407139|FG000|Overall Study|Withdrawal by Subject|3|||
155265993|NCT00263328|560407140|FG001|Overall Study|Withdrawal by Subject|0|||
155265994|NCT00263328|560407141|FG002|Overall Study|Withdrawal by Subject|1|||
155265995|NCT00263328|560407139|FG000|Overall Study|Other|3|||
155265996|NCT00263328|560407140|FG001|Overall Study|Other|0|||
155265997|NCT00263328|560407141|FG002|Overall Study|Other|1|||
155265998|NCT00263328|560407139|FG000|Overall Study|Adverse Event|1|||
155265999|NCT00263328|560407140|FG001|Overall Study|Adverse Event|1|||
155266000|NCT00263328|560407141|FG002|Overall Study|Adverse Event|4|||
155266001|NCT01301274|560407146|FG000|Overall Study|Physician Decision|2|||
155266002|NCT01301274|560407147|FG001|Overall Study|Physician Decision|1|||
155266003|NCT02917941|560407148|FG000|Treatment Period|Adverse Event|11|||
155266004|NCT02917941|560407148|FG000|Treatment Period|Progressive Disease|11|||
155266005|NCT02917941|560407148|FG000|Treatment Period|Reason not Specified|2|||
155266006|NCT02917941|560407148|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
155266007|NCT02917941|560407148|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
155266008|NCT01893827|560407149|FG000|Overall Study|Lost to Follow-up|19|||
155266009|NCT01893827|560407150|FG001|Overall Study|Lost to Follow-up|26|||
155266010|NCT00399763|560407151|FG000|Overall Study|Lost to Follow-up|2|||
155266011|NCT00399763|560407152|FG001|Overall Study|Lost to Follow-up|3|||
155266012|NCT03389477|560407155|FG000|Step 1|Withdrawal by Subject|1|||
155266013|NCT03389477|560407156|FG001|Step 1|Withdrawal by Subject|0|||
155266014|NCT03389477|560407155|FG000|Step 2|Withdrawal by Subject|1|||
155266015|NCT03389477|560407156|FG001|Step 2|Withdrawal by Subject|2|||
155266016|NCT03389477|560407155|FG000|Step 2|Disease progression|1|||
155266017|NCT03389477|560407156|FG001|Step 2|Disease progression|0|||
155266018|NCT03389477|560407155|FG000|Step 2|Death|0|||
155266019|NCT03389477|560407156|FG001|Step 2|Death|1|||
155266020|NCT03389477|560407155|FG000|Step 2|Poor performance status and nutrition|0|||
155266021|NCT03389477|560407156|FG001|Step 2|Poor performance status and nutrition|1|||
155266022|NCT03389477|560407155|FG000|Step 3|Withdrawal after 3 cycles|0|||
155266023|NCT03389477|560407156|FG001|Step 3|Withdrawal after 3 cycles|1|||
155266024|NCT03389477|560407155|FG000|Step 3|Still receiving active treatment|4|||
155266025|NCT03389477|560407156|FG001|Step 3|Still receiving active treatment|0|||
155266026|NCT03389477|560407155|FG000|Step 3|Progressive disease after 2 cycles|1|||
155266027|NCT03389477|560407156|FG001|Step 3|Progressive disease after 2 cycles|0|||
155266028|NCT03403426|560407157|FG000|Overall Study|Death|1|||
155266029|NCT03403426|560407157|FG000|Overall Study|Lost to Follow-up|2|||
155266030|NCT03520400|560407160|FG000|Overall Study|Physician Decision|15|||
155266031|NCT03520400|560407161|FG001|Overall Study|Physician Decision|7|||
155266032|NCT00445679|560407164|FG000|Overall Study|Adverse Event|22|||
155266033|NCT00445679|560407165|FG001|Overall Study|Adverse Event|12|||
155266034|NCT00445679|560407166|FG002|Overall Study|Adverse Event|30|||
155266035|NCT00445679|560407167|FG003|Overall Study|Adverse Event|19|||
155266036|NCT00445679|560407164|FG000|Overall Study|Failed to return|1|||
155266037|NCT00445679|560407165|FG001|Overall Study|Failed to return|3|||
155266038|NCT00445679|560407166|FG002|Overall Study|Failed to return|2|||
155266039|NCT00445679|560407167|FG003|Overall Study|Failed to return|2|||
155266040|NCT00445679|560407164|FG000|Overall Study|Physician Decision|0|||
155266041|NCT00445679|560407165|FG001|Overall Study|Physician Decision|0|||
155266042|NCT00445679|560407166|FG002|Overall Study|Physician Decision|1|||
155266043|NCT00445679|560407167|FG003|Overall Study|Physician Decision|0|||
155266044|NCT00445679|560407164|FG000|Overall Study|Lost to Follow-up|10|||
155266045|NCT00445679|560407165|FG001|Overall Study|Lost to Follow-up|6|||
155266046|NCT00445679|560407166|FG002|Overall Study|Lost to Follow-up|6|||
155266047|NCT00445679|560407167|FG003|Overall Study|Lost to Follow-up|5|||
155266048|NCT00445679|560407164|FG000|Overall Study|Compliance|3|||
155266049|NCT00445679|560407165|FG001|Overall Study|Compliance|2|||
155266050|NCT00445679|560407166|FG002|Overall Study|Compliance|1|||
155266051|NCT00445679|560407167|FG003|Overall Study|Compliance|2|||
155266052|NCT00445679|560407164|FG000|Overall Study|Withdrawal of Informed Consent|0|||
155266053|NCT00445679|560407165|FG001|Overall Study|Withdrawal of Informed Consent|0|||
155266054|NCT00445679|560407166|FG002|Overall Study|Withdrawal of Informed Consent|1|||
155266055|NCT00445679|560407167|FG003|Overall Study|Withdrawal of Informed Consent|0|||
155266056|NCT00445679|560407164|FG000|Overall Study|Protocol Violation|2|||
155266057|NCT00445679|560407165|FG001|Overall Study|Protocol Violation|3|||
155266058|NCT00445679|560407166|FG002|Overall Study|Protocol Violation|3|||
155266059|NCT00445679|560407167|FG003|Overall Study|Protocol Violation|1|||
155266060|NCT00445679|560407164|FG000|Overall Study|Withdrawal by Subject|8|||
155266061|NCT00445679|560407165|FG001|Overall Study|Withdrawal by Subject|14|||
155266062|NCT00445679|560407166|FG002|Overall Study|Withdrawal by Subject|20|||
155266063|NCT00445679|560407167|FG003|Overall Study|Withdrawal by Subject|18|||
155266064|NCT00445679|560407164|FG000|Overall Study|Lack of Efficacy|2|||
155266065|NCT00445679|560407165|FG001|Overall Study|Lack of Efficacy|6|||
155266066|NCT00445679|560407166|FG002|Overall Study|Lack of Efficacy|2|||
155266067|NCT00445679|560407167|FG003|Overall Study|Lack of Efficacy|0|||
155266068|NCT01654601|560407168|FG000|1st Administration|Withdrawal by Subject|2|||
155266069|NCT01654601|560407169|FG001|1st Administration|Withdrawal by Subject|0|||
155266070|NCT01654601|560407168|FG000|1st Administration|Protocol Violation|0|||
155266071|NCT01654601|560407169|FG001|1st Administration|Protocol Violation|2|||
155266072|NCT01654601|560407168|FG000|2nd Administration|Adverse Event|1|||
155266073|NCT01654601|560407169|FG001|2nd Administration|Adverse Event|0|||
155266074|NCT01654601|560407168|FG000|2nd Administration|Protocol Violation|0|||
155266075|NCT01654601|560407169|FG001|2nd Administration|Protocol Violation|1|||
155266076|NCT02636270|560407170|FG000|Overall Study|Adverse Event|1|||
155266077|NCT02636270|560407171|FG001|Overall Study|Adverse Event|0|||
155266078|NCT02636270|560407172|FG002|Overall Study|Adverse Event|0|||
155266079|NCT02636270|560407170|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
155266080|NCT02636270|560407171|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
155266081|NCT02636270|560407172|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
155266082|NCT01833143|560407173|FG000|Overall Study|Not Treated|1|||
155266083|NCT00909428|560407174|FG000|Overall Study|Lost to Follow-up|13|||
155266084|NCT00909428|560407175|FG001|Overall Study|Lost to Follow-up|10|||
155266085|NCT00909428|560407176|FG002|Overall Study|Lost to Follow-up|9|||
155266086|NCT03021668|560407177|FG000|Overall Study|Physician Decision|0|||
155266087|NCT03021668|560407178|FG001|Overall Study|Physician Decision|1|||
